FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Hennen, J
   Blomeke, B
AF Hennen, Jennifer
   Bloemeke, Brunhilde
TI Keratinocytes Improve Prediction of Sensitization Potential and Potency
   of Chemicals with THP-1 Cells
SO ALTEX-ALTERNATIVES TO ANIMAL EXPERIMENTATION
LA English
DT Article
DE inflammatory microenvironment; skin sensitization potency; cross talk;
   THP-1; HaCaT keratinocytes
ID ALLERGIC CONTACT-DERMATITIS; LYMPH-NODE ASSAY; ADVERSE OUTCOME PATHWAY;
   SKIN SENSITIZATION; P-PHENYLENEDIAMINE; DENDRITIC CELLS; PEPTIDE
   REACTIVITY; N-ACETYLATION; LINE THP-1; T-CELLS
AB In vitro approaches to address key steps of chemical-induced skin sensitization have been developed, but there is uncertainty how keratinocytes, which play a crucial role not only regarding xenobiotic metabolism but also skin inflammation, impact on a chemical's potential and potency to activate dendritic cells. We investigated these aspects by coculturing THP-1 cells, as surrogate dendritic cells, with HaCaT keratinocytes. We tested our HaCaT/THP-1 model with a set of 14 sensitizers, containing 7 prohaptens, and 10 non-sensitizers. Compared to exposing THP-1 alone, coculturing resulted in up to 3.1-fold enhanced maximal CD86 and/or CD54 upregulation on THP-1, and improved concentration-dependency. All 14 sensitizers were found positive for CD86 and/or CD54 upregulation based on Delta mean fluorescence intensity (MFI) >= 10 for CD86 and Delta MFI >= 50 for CD54. Only 1 of 10 non-sensitizers was false-positive. Remarkably, coculture with HaCaT keratinocytes improved the rank correlation of the estimated minimum chemical concentrations inducing a positive response in vitro with in vivo data on sensitization potency, especially for CD54 (Spearman: r = 0.739, p = 0.006; CD86: r = 0.571, p = 0.041). These promising data suggest that the coculture model has the potential to support the prediction of sensitization potency based on in vitro data.
C1 [Hennen, Jennifer; Bloemeke, Brunhilde] Trier Univ, Dept Environm Toxicol, Univ Ring 15, D-54296 Trier, Germany.
RP Blomeke, B (reprint author), Trier Univ, Dept Environm Toxicol, Univ Ring 15, D-54296 Trier, Germany.
EM bloemeke@uni-trier.de
FU Federal Office of Public Health, Switzerland [11.004203]; Federal
   Ministry of Education and Research (Germany)Federal Ministry of
   Education & Research (BMBF)
FX The authors thank Natalie Lobes and Tim Kinitz for excellent technical
   assistance. This study was partly supported by the Federal Office of
   Public Health, Switzerland (11.004203) and by the Program for Women
   Professors of the Federal Ministry of Education and Research (Germany).
CR Adler S, 2011, ARCH TOXICOL, V85, P367, DOI 10.1007/s00204-011-0693-2
   Aeby P, 2009, J INVEST DERMATOL, V129, P99, DOI 10.1038/jid.2008.209
   Basketter DA, 1999, J APPL TOXICOL, V19, P261, DOI 10.1002/(SICI)1099-1263(199907/08)19:4<261::AID-JAT572>3.0.CO;2-5
   Basketter DA, 2014, DERMATITIS, V25, P11, DOI 10.1097/DER.0000000000000003
   Basketter DA, 2011, REGUL TOXICOL PHARM, V61, P137, DOI 10.1016/j.yrtph.2011.07.004
   Bergstrom MA, 2007, J INVEST DERMATOL, V127, P1145, DOI 10.1038/sj.jid.5700638
   Bocchietto E, 2007, INT J IMMUNOPATH PH, V20, P259, DOI 10.1177/039463200702000206
   BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761
   Casati S, 2009, ATLA-ALTERN LAB ANIM, V37, P305, DOI 10.1177/026119290903700313
   Chipinda I, 2011, TOXICOL APPL PHARM, V252, P268, DOI 10.1016/j.taap.2011.02.018
   Comrie WA, 2015, J CELL BIOL, V208, P457, DOI 10.1083/jcb.201406120
   Ezendam J, 2016, ARCH TOXICOL, V90, P2861, DOI 10.1007/s00204-016-1842-4
   Gerberick GF, 2009, TOXICOL SCI, V112, P164, DOI 10.1093/toxsci/kfp192
   Gerberick GF, 2005, DERMATITIS, V16, P157, DOI 10.2310/6620.2005.05040
   Gibson A, 2015, CHEM RES TOXICOL, V28, P2069, DOI 10.1021/acs.chemrestox.5b00294
   Gober Michael D., 2008, V10, P1, DOI 10.1159/000131410
   Goebel C, 2014, TOXICOL APPL PHARM, V274, P480, DOI 10.1016/j.taap.2013.11.016
   Goncalo M, 2015, J APPL TOXICOL, V35, P398, DOI 10.1002/jat.3033
   Grabbe S, 1996, J CLIN INVEST, V98, P1158, DOI 10.1172/JCI118899
   Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221
   Hennen J, 2011, TOXICOL SCI, V123, P501, DOI 10.1093/toxsci/kfr174
   Hubo M, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00082
   ICCVAM, 2009, NIH PUBLICATION
   Jaworska JS, 2015, ARCH TOXICOL, V89, P2355, DOI 10.1007/s00204-015-1634-2
   Kaplan DH, 2012, NAT REV IMMUNOL, V12, P114, DOI 10.1038/nri3150
   Kawakubo Y, 2000, J PHARMACOL EXP THER, V292, P150
   Khan FD, 2007, J PHARMACOL EXP THER, V323, P771, DOI 10.1124/jpet.107.126615
   Krasteva M, 1996, CLIN EXP ALLERGY, V26, P563, DOI 10.1111/j.1365-2222.1996.tb00577.x
   Krutz NL, 2015, TOXICOL SCI, V147, P515, DOI 10.1093/toxsci/kfv148
   LINSLEY PS, 1991, J EXP MED, V173, P721, DOI 10.1084/jem.173.3.721
   Loveless SE, 1996, TOXICOLOGY, V108, P141, DOI 10.1016/0300-483X(95)03279-O
   MacKay C, 2013, ALTEX-ALTERN ANIM EX, V30, P473, DOI 10.14573/altex.2013.4.473
   Merckel F, 2013, TOXICOL LETT, V218, P266, DOI 10.1016/j.toxlet.2013.02.008
   Natsch A, 2015, TOXICOL SCI, V143, P319, DOI 10.1093/toxsci/kfu229
   Natsch A, 2013, TOXICOL SCI, V135, P356, DOI 10.1093/toxsci/kft160
   Nukada Y, 2012, TOXICOL IN VITRO, V26, P1150, DOI 10.1016/j.tiv.2012.07.001
   OECD, 2012, SER TEST ASS, V168
   Pasparakis M, 2014, NAT REV IMMUNOL, V14, P289, DOI 10.1038/nri3646
   PATTEN CJ, 1993, CHEM RES TOXICOL, V6, P511, DOI 10.1021/tx00034a019
   Piroird C, 2015, TOXICOL IN VITRO, V29, P901, DOI 10.1016/j.tiv.2015.03.009
   Rovida C, 2013, ALTEX-ALTERN ANIM EX, V30, P231, DOI 10.14573/altex.2013.2.231
   Teunis MAT, 2014, ALTEX-ALTERN ANIM EX, V31, P251, DOI http://dx.doi.org/10.14573/altex.1308021
   Tietze C, 2008, J TOXICOL ENV HEAL A, V71, P965, DOI 10.1080/15287390801989168
   TSUCHIYA S, 1980, INT J CANCER, V26, P171, DOI 10.1002/ijc.2910260208
   Urbisch D, 2016, CHEM RES TOXICOL, V29, P901, DOI 10.1021/acs.chemrestox.6b00055
   WILLIS CM, 1988, CONTACT DERMATITIS, V18, P20, DOI 10.1111/j.1600-0536.1988.tb05484.x
   Yoshida Y, 2003, TOXICOL IN VITRO, V17, P221, DOI 10.1016/S0887-2333(03)00006-7
NR 47
TC 6
Z9 7
U1 0
U2 1
PU SPEKTRUM AKADEMISCHER VERLAG-SPRINGER-VERLAG GMBH
PI HEILDEBERG
PA TIERGARTENSTRASSE 17, HEILDEBERG, 69121, GERMANY
SN 1868-596X
EI 1868-8551
J9 ALTEX-ALTERN ANIM EX
JI ALTEX-Altern. Anim. Exp.
PY 2017
VL 34
IS 2
BP 279
EP 288
DI 10.14573/altex.1606171
PG 10
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA EU0FN
UT WOS:000400684700008
PM 27768804
OA DOAJ Gold
DA 2019-10-23
ER

PT J
AU [Anonymous]
AF [Anonymous]
TI UK: Development of an adverse outcome pathway (AOP) for cardiotoxicity
SO ALTEX-ALTERNATIVES TO ANIMAL EXPERIMENTATION
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SPEKTRUM AKADEMISCHER VERLAG-SPRINGER-VERLAG GMBH
PI HEILDEBERG
PA TIERGARTENSTRASSE 17, HEILDEBERG, 69121, GERMANY
SN 1868-596X
EI 1868-8551
J9 ALTEX-ALTERN ANIM EX
JI ALTEX-Altern. Anim. Exp.
PY 2017
VL 34
IS 2
BP 327
EP 327
PG 1
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA EU0FN
UT WOS:000400684700027
OA DOAJ Gold
DA 2019-10-23
ER

PT J
AU Liang, SX
   Yin, L
   Yu, KS
   Hofmann, MC
   Yu, XZ
AF Liang, Shenxuan
   Yin, Lei
   Yu, Kevin Shengyang
   Hofmann, Marie-Claude
   Yu, Xiaozhong
TI High-Content Analysis Provides Mechanistic Insights into the Testicular
   Toxicity of Bisphenol A and Selected Analogues in Mouse Spermatogonial
   Cells
SO TOXICOLOGICAL SCIENCES
LA English
DT Article
DE bisphenol A; bisphenol S; bisphenol AF; and tetrabromobisphenol A; C18-4
   spermatogonial cell line; high-content analysis; cell cycle; DNA damage
   responses; cytoskeleton
ID IN-UTERO EXPOSURE; MALE REPRODUCTIVE TOXICITY; ADVERSE OUTCOME PATHWAYS;
   INDUCED LIVER-INJURY; LINE STEM-CELLS; DI(N-BUTYL) PHTHALATE;
   GERM-CELLS; STEM/PROGENITOR CELLS; H2AX PHOSPHORYLATION; HUMAN
   HEPATOTOXICITY
AB Bisphenol A (BPA), an endocrine-disrupting compound, was found to be a testicular toxicant in animal models. Bisphenol S (BPS), bisphenol AF (BPAF), and tetrabromobisphenol A (TBBPA) were recently introduced to the market as alternatives to BPA. However, toxicological data of these compounds in the male reproductive system are still limited so far. This study developed and validated an automated multi-parametric high-content analysis (HCA) using the C18-4 spermatogonial cell line as a model. We applied these validated HCA, including nuclear morphology, DNA content, cell cycle progression, DNA synthesis, cytoskeleton integrity, and DNA damage responses, to characterize and compare the testicular toxicities of BPA and 3 selected commercial available BPA analogues, BPS, BPAF, and TBBPA. HCA revealed BPAF and TBBPA exhibited higher spermatogonial toxicities as compared with BPA and BPS, including dose-and time-dependent alterations in nuclear morphology, cell cycle, DNA damage responses, and perturbation of the cytoskeleton. Our results demonstrated that this specific culture model together with HCA can be utilized for quantitative screening and discriminating of chemical-specific testicular toxicity in spermatogonial cells. It also provides a fast and cost-effective approach for the identification of environmental chemicals that could have detrimental effects on reproduction.
C1 [Liang, Shenxuan; Yin, Lei; Yu, Kevin Shengyang; Yu, Xiaozhong] Univ Georgia, Coll Publ Hlth, Dept Environm Hlth Sci, 150 Green St, Athens, GA 30602 USA.
   [Yin, Lei] ReproTox Biotech LLC, 111 Riverbend Dr, Athens, GA USA.
   [Hofmann, Marie-Claude] MD Anderson Canc Ctr, Dept Endocrine Neoplasia & Hormonal Disorders, 1515 Holcombe Blvd,Unit 1105, Houston, TX USA.
   [Yu, Kevin Shengyang] UCSF Med Sch, 513 Parnassus Ave, San Francisco, CA 94143 USA.
RP Yu, XZ (reprint author), Univ Georgia, Coll Publ Hlth, Dept Environm Hlth Sci, 150 Green St, Athens, GA 30602 USA.
EM yuxz@uga.edu
OI yu, xiaozhong/0000-0002-5523-9583; Hofmann,
   Marie-Claude/0000-0002-4899-8039
FU Centers for Disease Control and PreventionUnited States Department of
   Health & Human ServicesCenters for Disease Control & Prevention - USA;
   National Institute for Occupational Safety and Health (NIOSH)United
   States Department of Health & Human ServicesCenters for Disease Control
   & Prevention - USANational Institute for Occupational Safety & Health
   (NIOSH) [R21 OH 010473]; National Institute of Environmental Health
   Sciences of the National Institutes of HealthUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Environmental Health Sciences (NIEHS)
   [R43ES027374]; Alternatives Research & Development Foundation (ARDF);
   University of Georgia Startup Research funding [1025AR715005]
FX This work was supported by the Centers for Disease Control and
   Prevention, The National Institute for Occupational Safety and Health
   (NIOSH) under award number R21 OH 010473; National Institute of
   Environmental Health Sciences of the National Institutes of Health under
   award number R43ES027374; Alternatives Research & Development Foundation
   (ARDF) and University of Georgia Startup Research funding
   (1025AR715005).
CR Ali S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106245
   Anguissola S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108025
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Audebert M, 2011, ARCH TOXICOL, V85, P1463, DOI 10.1007/s00204-011-0721-2
   Auerbach S, 2016, ENVIRON HEALTH PERSP, V124, P1141, DOI 10.1289/ehp.1510456
   Bouskine A, 2009, ENVIRON HEALTH PERSP, V117, P1053, DOI 10.1289/ehp.0800367
   Braun JM, 2011, PEDIATRICS, V128, P873, DOI 10.1542/peds.2011-1335
   Braydich-Stolle L, 2005, TOXICOL SCI, V88, P412, DOI 10.1093/toxsci/kfi256
   Braydich-Stolle LK, 2010, TOXICOL SCI, V116, P577, DOI 10.1093/toxsci/kfq148
   Calafat AM, 2005, ENVIRON HEALTH PERSP, V113, P391
   Calafat AM, 2008, ENVIRON HEALTH PERSP, V116, P39, DOI 10.1289/ehp.10753
   Carwile JL, 2011, ENVIRON RES, V111, P825, DOI 10.1016/j.envres.2011.05.014
   Chen D, 2016, ENVIRON SCI TECHNOL, V50, P5438, DOI 10.1021/acs.est.5b05387
   Colnot T, 2014, ARCH TOXICOL, V88, P553, DOI 10.1007/s00204-013-1180-8
   D'Cruz SC, 2012, FOOD CHEM TOXICOL, V50, P1124, DOI 10.1016/j.fct.2011.11.041
   Darzynkiewicz Zbigniew, 2006, Methods Mol Biol, V314, P81
   Dolinoy DC, 2007, P NATL ACAD SCI USA, V104, P13056, DOI 10.1073/pnas.0703739104
   Ehrlich S, 2012, ENVIRON HEALTH PERSP, V120, P978, DOI 10.1289/ehp.1104307
   Eladak S, 2015, FERTIL STERIL, V103, P11, DOI 10.1016/j.fertnstert.2014.11.005
   Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337
   Feng YX, 2012, TOXICOL LETT, V211, P201, DOI 10.1016/j.toxlet.2012.03.802
   Ferrara D, 2006, ENDOCRINOLOGY, V147, P5352, DOI 10.1210/en.2006-0527
   Fic A, 2013, ARH HIG RADA TOKSIKO, V64, P189, DOI 10.2478/10004-1254-64-2013-2319
   Fisher JS, 2003, HUM REPROD, V18, P1383, DOI 10.1093/humrep/deg273
   Friedman KP, 2016, TOXICOL SCI, V151, P160, DOI 10.1093/toxsci/kfw034
   Gassman NR, 2016, ENVIRON HEALTH PERSP, V124, P1241, DOI 10.1289/EHP237
   Golestaneh N, 2009, REPRODUCTION, V138, P151, DOI 10.1530/REP-08-0510
   Habert R, 2014, REPRODUCTION, V147, pR119, DOI 10.1530/REP-13-0497
   Harris S, 2015, REPROD TOXICOL, V58, P149, DOI 10.1016/j.reprotox.2015.10.002
   He ZP, 2008, STEM CELLS, V26, P266, DOI 10.1634/stemcells.2007-0436
   Hofmann MC, 2005, STEM CELLS, V23, P200, DOI 10.1634/stemcells.2003-0036
   Hofmann MC, 2005, DEV BIOL, V279, P114, DOI 10.1016/j.ydbio.2004.12.006
   Jin PP, 2013, J BIOMED RES, V27, P135, DOI 10.7555/JBR.27.20120076
   Kameoka S, 2014, TOXICOL SCI, V137, P76, DOI 10.1093/toxsci/kft239
   Kang JH, 2006, TOXICOLOGY, V226, P79, DOI 10.1016/j.tox.2006.06.009
   Karmaus AL, 2016, FOOD CHEM TOXICOL, V92, P188, DOI 10.1016/j.fct.2016.04.012
   Kavlock R, 2012, CHEM RES TOXICOL, V25, P1287, DOI 10.1021/tx3000939
   Keri RA, 2007, REPROD TOXICOL, V24, P240, DOI 10.1016/j.reprotox.2007.06.008
   Kitamura S, 2005, TOXICOL SCI, V84, P249, DOI 10.1093/toxsci/kfi074
   Kleymenova E, 2005, BIOL REPROD, V73, P482, DOI 10.1095/biolreprod.104.037184
   Kokkinaki M, 2009, BIOL REPROD, V80, P707, DOI 10.1095/biolreprod.108.073809
   Kuriyama SN, 2005, ENVIRON HEALTH PERSP, V113, P149, DOI 10.1289/ehp.7421
   Lakind JS, 2011, J EXPO SCI ENV EPID, V21, P272, DOI 10.1038/jes.2010.9
   Lang IA, 2008, JAMA-J AM MED ASSOC, V300, P1303, DOI 10.1001/jama.300.11.1303
   Lassen TH, 2014, ENVIRON HEALTH PERSP, V122, P478, DOI 10.1289/ehp.1307309
   Lee HJ, 2003, TOXICOL SCI, V75, P40, DOI 10.1093/toxsci/kfg150
   Lee S, 2013, CHEMOSPHERE, V93, P434, DOI 10.1016/j.chemosphere.2013.05.029
   Lei B., 2016, ENVIRON TOXICOL, DOI [10.1002/tox.22234, DOI 10.1002/TOX.22234.]
   Lie PPY, 2009, FASEB J, V23, P2555, DOI 10.1096/fj.06-070573
   Liu C, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.203
   Lucas BEG, 2012, TOXICOLOGY, V299, P10, DOI 10.1016/j.tox.2012.04.011
   Mahood IK, 2007, ENVIRON HEALTH PERSP, V115, P55, DOI 10.1289/ehp.9366
   Marchetti C, 2006, DNA REPAIR, V5, P788, DOI 10.1016/j.dnarep.2006.03.011
   Martin HL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088338
   Melzer D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008673
   Nikolova T, 2014, TOXICOL SCI, V140, P103, DOI 10.1093/toxsci/kfu066
   O'Brien PJ, 2006, ARCH TOXICOL, V80, P580, DOI 10.1007/s00204-006-0091-3
   Oatley JA, 2008, ANNU REV CELL DEV BI, V24, P263, DOI 10.1146/annurev.cellbio.24.110707.175355
   Pacchierotti F, 2008, MUTAT RES-GEN TOX EN, V651, P64, DOI 10.1016/j.mrgentox.2007.10.009
   Perez P, 1998, ENVIRON HEALTH PERSP, V106, P167, DOI 10.1289/ehp.98106167
   Perkins EJ, 2015, TOXICOL SCI, V148, P14, DOI 10.1093/toxsci/kfv181
   Persson M, 2013, J PHARMACOL TOX MET, V68, P302, DOI 10.1016/j.vascn.2013.08.001
   Pfeifer D, 2015, ENVIRON HEALTH PERSP, V123, P1271, DOI 10.1289/ehp.1409199
   Radio NM, 2008, TOXICOL SCI, V105, P106, DOI 10.1093/toxsci/kfn114
   Ramery E, 2014, ENVIRON TOXICOL, V29, P310, DOI 10.1002/tox.21759
   Repetto G, 2008, NAT PROTOC, V3, P1125, DOI 10.1038/nprot.2008.75
   Riu A, 2011, ENVIRON HEALTH PERSP, V119, P1227, DOI 10.1289/ehp.1003328
   Rochester JR, 2013, REPROD TOXICOL, V42, P132, DOI 10.1016/j.reprotox.2013.08.008
   Roelofs MJE, 2015, TOXICOLOGY, V329, P10, DOI 10.1016/j.tox.2015.01.003
   Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858
   Roukos V, 2015, NAT PROTOC, V10, P334, DOI 10.1038/nprot.2015.016
   Saffarini CM, 2012, J ANDROL, V33, P505, DOI 10.2164/jandrol.111.013706
   Sakaue M, 2001, J OCCUP HEALTH, V43, P185, DOI 10.1539/joh.43.185
   Saldutti LP, 2013, ALTEX-ALTERN ANIM EX, V30, P353, DOI 10.14573/altex.2013.3.353
   Schoonen WGEJ, 2005, TOXICOL IN VITRO, V19, P491, DOI 10.1016/j.tiv.2005.01.002
   Sidhu JS, 2006, TOXICOL SCI, V89, P475, DOI 10.1093/toxsci/kfj032
   Sirenko O, 2015, ASSAY DRUG DEV TECHN, V13, P402, DOI 10.1089/adt.2015.655
   Sun X, 2011, MOL BIOL REP, V38, P3993, DOI 10.1007/s11033-010-0517-0
   Tiwari D, 2013, REPROD TOXICOL, V40, P60, DOI 10.1016/j.reprotox.2013.05.013
   Ullah H, 2016, CHEMOSPHERE, V152, P383, DOI 10.1016/j.chemosphere.2016.02.125
   Usman A, 2016, CHEMOSPHERE, V158, P131, DOI 10.1016/j.chemosphere.2016.05.070
   Vandenberg LN, 2007, REPROD TOXICOL, V24, P139, DOI 10.1016/j.reprotox.2007.07.010
   Versaevel M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1668
   Vinggaard AM, 2008, CHEM RES TOXICOL, V21, P813, DOI 10.1021/tx7002382
   Wang HF, 2016, TOXICOL SCI, V152, P145, DOI 10.1093/toxsci/kfw070
   Webster M, 2009, J CELL SCI, V122, P1477, DOI 10.1242/jcs.037333
   Wegner S., 2014, J TOXICOL ENV HLTH S, V6, P161
   Wegner S., 2013, CURR PROTOC TOXICOL, DOI [10.1002/0471140856.tx1610s55, DOI 10.1002/0471140856.TX1610S55.]
   Wu S, 2012, FOOD CHEM TOXICOL, V50, P3100, DOI 10.1016/j.fct.2012.06.029
   Xiao X, 2014, HUM REPROD, V29, P1279, DOI 10.1093/humrep/deu011
   Xu JHJ, 2008, TOXICOL SCI, V105, P97, DOI 10.1093/toxsci/kfn109
   Xu JJ, 2004, CHEM-BIOL INTERACT, V150, P115, DOI 10.1016/j.cbi.2004.09.011
   Yoshihara S, 2004, TOXICOL SCI, V78, P50, DOI 10.1093/toxsci/kfh047
   Yu X, 2003, TOXICOL SCI, V72, P274
   Yu XZ, 2009, TOXICOL APPL PHARM, V239, P325, DOI 10.1016/j.taap.2009.06.014
   Yu XZ, 2005, TOXICOL SCI, V84, P378, DOI 10.1093/toxsci/kfi085
   Zhang XW, 2011, TOXICOL SCI, V121, P320, DOI 10.1093/toxsci/kfr061
   Zhang ZZ, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-67
   Zhao XX, 2015, MUTAT RES-FUND MOL M, V777, P33, DOI 10.1016/j.mrfmmm.2015.04.006
   Zhivotosky B, 2001, Curr Protoc Cell Biol, VChapter 18, DOI 10.1002/0471143030.cb1803s12
NR 100
TC 8
Z9 10
U1 2
U2 26
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1096-6080
EI 1096-0929
J9 TOXICOL SCI
JI Toxicol. Sci.
PD JAN
PY 2017
VL 155
IS 1
BP 43
EP 60
DI 10.1093/toxsci/kfw178
PG 18
WC Toxicology
SC Toxicology
GA EO9XL
UT WOS:000397041300005
PM 27633978
OA Bronze, Green Published
DA 2019-10-23
ER

PT J
AU Villeneuve, DL
   Jensen, KM
   Cavallin, JE
   Durhan, EJ
   Garcia-Reyero, N
   Kahl, MD
   Leino, RL
   Makynen, EA
   Wehmas, LC
   Perkins, EJ
   Ankley, GT
AF Villeneuve, Daniel L.
   Jensen, Kathleen M.
   Cavallin, Jenna E.
   Durhan, Elizabeth J.
   Garcia-Reyero, Natalia
   Kahl, Michael D.
   Leino, Richard L.
   Makynen, Elizabeth A.
   Wehmas, Leah C.
   Perkins, Edward J.
   Ankley, Gerald T.
TI Effects of the antimicrobial contaminant triclocarban, and co-exposure
   with the androgen 17-trenbolone, on reproductive function and ovarian
   transcriptome of the fathead minnow (Pimephales promelas)
SO ENVIRONMENTAL TOXICOLOGY AND CHEMISTRY
LA English
DT Article
DE Adverse outcome pathway; Contaminants of emerging concern; Reproductive
   toxicity; Toxicity mechanisms; Endocrine-disrupting compounds
ID ENDOCRINE DISRUPTION; WASTE-WATER; TRICLOSAN; EXPRESSION; GENE;
   BIOACCUMULATION; VINCLOZOLIN; KEGG
AB Triclocarban (TCC) is an antimicrobial agent routinely detected in surface waters that has been hypothesized to interact with the vertebrate endocrine system. The present study examined the effects of TCC alone and in combination with the model endocrine disruptor 17-trenbolone (TRB) on fish reproductive function. Adult Pimephales promelas were continuously exposed to either 1 mu g TCC/L or 5 mu g TCC/L, to 0.5 mu g TRB/L, or to a mixture (MIX) of 5 mu g TCC/L and 0.5 mu g TRB/L for 22 d, and a variety of reproductive and endocrine-related endpoints were examined. Cumulative fecundity was significantly reduced in fathead minnows exposed to TRB, MIX, or 5 mu g TCC/L. Exposure to 1 mu g TCC/L had no effect on reproduction. In general, both TRB and MIX treatments caused similar physiological effects, evoking significant reductions in female plasma vitellogenin, estradiol, and testosterone, and significant increases in male plasma estradiol. Based on analysis of the ovarian transcriptome, there were potential pathway impacts that were common to both TRB- and TCC-containing treatment groups. In most cases, however, those pathways were more plausibly linked to differences in reproductive status than to androgen-specific functions. Overall, TCC was reproductively toxic to fish at concentrations at or near those that have been measured in surface water. There was little evidence that TCC elicits reproductive toxicity through a specific mode of endocrine or reproductive action, nor that it could augment the androgenic effects of TRB. Nonetheless, the relatively small margin of safety between some measured environmental concentrations and effect concentrations suggests that concern is warranted. Environ Toxicol Chem 2017;36:231-242. Published 2016 Wiley Periodicals Inc. on behalf of SETAC. This article is a US government work and, as such, is in the public domain in the United States of America.
C1 [Villeneuve, Daniel L.; Jensen, Kathleen M.; Cavallin, Jenna E.; Durhan, Elizabeth J.; Kahl, Michael D.; Makynen, Elizabeth A.; Wehmas, Leah C.; Ankley, Gerald T.] US EPA, Mid Continent Ecol Div, Duluth, MN 55804 USA.
   [Garcia-Reyero, Natalia; Perkins, Edward J.] US Army Engn Res & Dev Ctr, Vicksburg, MS USA.
   [Leino, Richard L.] Univ Minnesota Duluth, Sch Med, Dept Anat & Cell Biol, Duluth, MN USA.
   [Wehmas, Leah C.] Oregon State Univ, Environm & Mol Toxicol, Corvallis, OR 97331 USA.
RP Villeneuve, DL (reprint author), US EPA, Mid Continent Ecol Div, Duluth, MN 55804 USA.
EM villeneuve.dan@epa.gov
FU USEPA Chemical Safety for Sustainability (CSS) Research Program
FX The authors thank L. Thomas and S. Seidl for additional technical
   support and J. Haselman for critical feedback on the manuscript. Funding
   for this work was provided in part by the USEPA Chemical Safety for
   Sustainability (CSS) Research Program.
CR Ahn KC, 2008, ENVIRON HEALTH PERSP, V116, P1203, DOI 10.1289/ehp.11200
   American Cleaning Institute, 2002, TRICL CONS SOAP DET
   Ankley GT, 2010, AQUAT TOXICOL, V99, P389, DOI 10.1016/j.aquatox.2010.05.020
   Ankley GT, 2003, ENVIRON TOXICOL CHEM, V22, P1350, DOI 10.1002/etc.5620220623
   [Anonymous], 2016, AND REC AG LEAD REPR
   Blake LS, 2010, ENVIRON TOXICOL CHEM, V29, P1367, DOI 10.1002/etc.166
   Bobe J, 2009, COMP BIOCHEM PHYS A, V153, P63, DOI 10.1016/j.cbpa.2008.10.021
   Brausch JM, 2011, CHEMOSPHERE, V82, P1518, DOI 10.1016/j.chemosphere.2010.11.018
   Chalew TEA, 2009, J AM WATER RESOUR AS, V45, P4, DOI 10.1111/j.1752-1688.2008.00284.x
   Chen JG, 2008, ENDOCRINOLOGY, V149, P1173, DOI 10.1210/en.2007-1057
   Christen V, 2010, CHEMOSPHERE, V81, P1245, DOI 10.1016/j.chemosphere.2010.09.031
   Chung E, 2011, P NATL ACAD SCI USA, V108, P17732, DOI 10.1073/pnas.1115187108
   Coogan MA, 2007, CHEMOSPHERE, V67, P1911, DOI 10.1016/j.chemosphere.2006.12.027
   Davis AP, 2015, NUCLEIC ACIDS RES, V43, pD914, DOI 10.1093/nar/gku935
   Duleba AJ, 2011, REPROD SCI, V18, P119, DOI 10.1177/1933719110382581
   Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207
   Ekman DR, 2011, ENVIRON TOXICOL CHEM, V30, P319, DOI 10.1002/etc.406
   Fabregat A, 2016, NUCLEIC ACIDS RES, V44, pD481, DOI 10.1093/nar/gkv1351
   GERDES U, 1992, J REPROD FERTIL, V95, P539
   Halden RU, 2005, ENVIRON SCI TECHNOL, V39, P1420, DOI 10.1021/es049071e
   Higgins CP, 2009, ENVIRON TOXICOL CHEM, V28, P2580, DOI 10.1897/09-013.1
   Hosseini G, 1996, J BIOL CHEM, V271, P22090, DOI 10.1074/jbc.271.36.22090
   Jensen KM, 2001, COMP BIOCHEM PHYS C, V128, P127, DOI 10.1016/S1532-0456(00)00185-X
   Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27
   Kanehisa M, 2016, NUCLEIC ACIDS RES, V44, pD457, DOI 10.1093/nar/gkv1070
   Kolpin DW, 2002, ENVIRON SCI TECHNOL, V36, P1202, DOI 10.1021/es011055j
   Korte JJ, 2000, ENVIRON TOXICOL CHEM, V19, P972, DOI 10.1002/etc.5620190426
   Lee KE, 2011, ENDOCRINE ACTIVE CHE
   Leino RL, 2005, ENVIRON TOXICOL PHAR, V19, P85, DOI 10.1016/j.etap.2004.05.010
   Li ZH, 2011, CAN J FISH AQUAT SCI, V68, P1528, DOI 10.1139/f2011-066
   Markiewski MM, 2007, TRENDS IMMUNOL, V28, P184, DOI 10.1016/j.it.2007.02.006
   Martinovic D, 2008, ENVIRON TOXICOL CHEM, V27, P478, DOI 10.1897/07-206R.1
   McMaster M.E., 1995, CAN TECH REP FISH AQ, P1
   Milacic Marija, 2012, Cancers (Basel), V4, P1180, DOI 10.3390/cancers4041180
   Morisseau C, 2009, ENVIRON HEALTH PERSP, V117, P1867, DOI 10.1289/ehp.0900834
   Nilsson EE, 2003, BIOL REPROD, V69, P1265, DOI 10.1095/biolreprod.103.018671
   PARR EL, 1974, BIOL REPROD, V11, P483, DOI 10.1095/biolreprod11.5.483
   Perencevich EN, 2001, AM J INFECT CONTROL, V29, P281, DOI 10.1067/mic.2001.115469
   Reimers M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000786
   Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01
   Sapkota A, 2007, ENVIRON RES, V103, P21, DOI 10.1016/j.envres.2006.03.006
   Schebb NH, 2011, AQUAT TOXICOL, V105, P448, DOI 10.1016/j.aquatox.2011.07.020
   Schebb NH, 2011, ENVIRON SCI TECHNOL, V45, P3109, DOI 10.1021/es103650m
   Schultz MM, 2012, ARCH ENVIRON CON TOX, V63, P114, DOI 10.1007/s00244-011-9748-x
   Thomson SA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-500
   Tonoli D, 2015, CHEM RES TOXICOL, V28, P955, DOI 10.1021/tx5005369
   US Environmental Protection Agency, 2002, 600R01067 US EPA
   Villeneuve DL, 2007, TOXICOL SCI, V98, P395, DOI 10.1093/toxsci/kfm124
   Witorsch RJ, 2010, CRIT REV TOXICOL, V40, P1, DOI 10.3109/10408444.2010.515563
   Ying GG, 2007, ENVIRON POLLUT, V150, P300, DOI 10.1016/j.envpol.2007.02.013
   Yueh MF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037705
NR 51
TC 9
Z9 9
U1 1
U2 36
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0730-7268
EI 1552-8618
J9 ENVIRON TOXICOL CHEM
JI Environ. Toxicol. Chem.
PD JAN
PY 2017
VL 36
IS 1
BP 231
EP 242
DI 10.1002/etc.3531
PG 12
WC Environmental Sciences; Toxicology
SC Environmental Sciences & Ecology; Toxicology
GA EG4QW
UT WOS:000391029800029
PM 27312088
OA Green Accepted
DA 2019-10-23
ER

PT J
AU Hartung, T
AF Hartung, Thomas
TI Utility of the adverse outcome pathway concept in drug development
SO EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY
LA English
DT Editorial Material
DE Toxicology for the 21st century; mechanistic toxicology; omics
   technologies; hazard; chemicals
ID INTEGRATED TESTING STRATEGIES; HUMAN TOXOME; FOOD; THOUGHT;
   METABOLOMICS; TOXICOLOGY; TOXICITY
C1 [Hartung, Thomas] Johns Hopkins Bloomberg Sch Publ Hlth, CAAT, Baltimore, MD USA.
   [Hartung, Thomas] Univ Konstanz, CAAT, Pharmacol & Toxicol, Constance, Germany.
RP Hartung, T (reprint author), Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA.
EM THartun1@jhu.edu
CR Bouhifd M, 2015, ALTEX-ALTERN ANIM EX, V32, P319, DOI 10.14573/altex.1509161
   Bouhifd M, 2015, ALTEX-ALTERN ANIM EX, V32, P112, DOI [10.14573/altex.1502091, http://dx.doi.org/10.14573/altex.1502091]
   Bouhifd M, 2013, J APPL TOXICOL, V33, P1365, DOI 10.1002/jat.2874
   Hartung T, 2008, ALTEX-ALTERN TIEREXP, V25, P3
   Hartung T, 2007, ALTEX-ALTERN TIEREXP, V24, P143
   Hartung T, 2013, ALTEX-ALTERN ANIM EX, V30, P119, DOI 10.14573/altex.2013.2.119
   Hartung T, 2013, ALTEX-ALTERN ANIM EX, V30, P3, DOI 10.14573/altex.2013.1.003
   Hartung T, 2012, ALTEX-ALTERN ANIM EX, V29, P119, DOI 10.14573/altex.2012.2.119
   Hartung T, 2011, ALTEX-ALTERN ANIM EX, V28, P83, DOI 10.14573/altex.2011.2.083
   Kleensang A, 2014, ALTEX-ALTERN ANIM EX, V31, P53, DOI 10.14573/altex.1309261
   Maertens A, 2017, ARCH TOXICOL, V91, P217, DOI 10.1007/s00204-016-1695-x
   Maertens A, 2015, ARCH TOXICOL, V89, P743, DOI 10.1007/s00204-015-1509-6
   Ramirez T, 2013, ALTEX-ALTERN ANIM EX, V30, P209, DOI 10.14573/altex.2013.2.209
   Rovida C, 2015, ALTEX-ALTERN ANIM EX, V32, P25, DOI [http://dx.doi.org/10.14573/altex.1411011, 10.14573/altex.1506201]
   Tollefsen KE, 2014, REGUL TOXICOL PHARM, V70, P629, DOI 10.1016/j.yrtph.2014.09.009
NR 15
TC 11
Z9 11
U1 0
U2 5
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1742-5255
EI 1744-7607
J9 EXPERT OPIN DRUG MET
JI Expert Opin. Drug Metab. Toxicol.
PD JAN
PY 2017
VL 13
IS 1
BP 1
EP 3
DI 10.1080/17425255.2017.1246535
PG 3
WC Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Toxicology
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Toxicology
GA EG0UI
UT WOS:000390747300001
PM 27718748
OA Bronze
DA 2019-10-23
ER

PT J
AU Kuijper, IA
   Yang, H
   Van De Water, B
   Beltman, JB
AF Kuijper, Isoude A.
   Yang, Huan
   Van De Water, Bob
   Beltman, Joost B.
TI Unraveling cellular pathways contributing to drug-induced liver injury
   by dynamical modeling
SO EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY
LA English
DT Review
DE Drug induced liver injury (DILI); dynamical modeling; ordinary
   differential equations; stress pathway; death pathway; predictive
   toxicology; cell fate; adverse outcome pathway
ID NF-KAPPA-B; UNFOLDED PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM STRESS;
   P53-MDM2 FEEDBACK LOOP; MATHEMATICAL-MODEL; SYSTEMS BIOLOGY; DNA-DAMAGE;
   TRANSLATION ATTENUATION; TRANSCRIPTION FACTOR; MAMMALIAN-CELLS
AB Introduction: Drug-induced liver injury (DILI) is a significant threat to human health and a major problem in drug development. It is hard to predict due to its idiosyncratic nature and which does not show up in animal trials. Hepatic adaptive stress response pathway activation is generally observed in drug-induced liver injury. Dynamical pathway modeling has the potential to foresee adverse effects of drugs before they go in trial. Ordinary differential equation modeling can offer mechanistic insight, and allows us to study the dynamical behavior of stress pathways involved in DILI.Areas covered: This review provides an overview on the progress of the dynamical modeling of stress and death pathways pertinent to DILI, i.e. pathways relevant for oxidative stress, inflammatory stress, DNA damage, unfolded proteins, heat shock and apoptosis. We also discuss the required steps for applying such modeling to the liver.Expert opinion: Despite the strong progress made since the turn of the century, models of stress pathways have only rarely been specifically applied to describe pathway dynamics for DILI. We argue that with minor changes, in some cases only to parameter values, many of these models can be repurposed for application in DILI research. Combining both dynamical models with in vitro testing might offer novel screening methods for the harmful side-effects of drugs.
C1 [Kuijper, Isoude A.; Yang, Huan; Van De Water, Bob; Beltman, Joost B.] Leiden Univ, Leiden Acad Ctr Drug Res, Div Toxicol, Leiden, Netherlands.
RP Beltman, JB (reprint author), Leiden Univ, Leiden Acad Ctr Drug Res, Div Toxicol, Leiden, Netherlands.
EM j.b.beltman@lacdr.leidenuniv.nl
OI Yang, Huan/0000-0002-3471-8235
FU Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO,
   InnoSysTox) [40-42600-98-14016]; European Research Council (ERC,
   EUToxRisk21) [681002]
FX This work was supported by grants from the Nederlandse Organisatie voor
   Wetenschappelijk Onderzoek (NWO, InnoSysTox, number 40-42600-98-14016,
   to B van de Water and JB Beltman) and from the European Research Council
   (ERC, EUToxRisk21, number 681002, to to B van de Water and JB Beltman).
CR Akerfelt M, 2010, NAT REV MOL CELL BIO, V11, P545, DOI 10.1038/nrm2938
   Bar-Or RL, 2000, P NATL ACAD SCI USA, V97, P11250, DOI 10.1073/pnas.210171597
   Basak S, 2012, IMMUNOL REV, V246, P221, DOI 10.1111/j.1600-065X.2011.01092.x
   Batchelor E, 2008, MOL CELL, V30, P277, DOI 10.1016/j.molcel.2008.03.016
   Batchelor E, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.20
   Beard D. A., 2008, CHEM BIOPHYSICS QUAN
   Bhatia SN, 2014, NAT BIOTECHNOL, V32, P760, DOI 10.1038/nbt.2989
   Bhattacharya S, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00462
   Brown MK, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00263
   Bryan HK, 2013, BIOCHEM PHARMACOL, V85, P705, DOI 10.1016/j.bcp.2012.11.016
   Cai XD, 2009, J COMPUT BIOL, V16, P917, DOI 10.1089/cmb.2008.0231
   Carlotti F, 2000, J BIOL CHEM, V275, P41028, DOI 10.1074/jbc.M006179200
   Chaves M, 2009, MODEL SIMUL SCI ENG, P19, DOI 10.1007/978-0-8176-4751-3_2
   Chen MJ, 2015, J HEPATOL, V63, P503, DOI 10.1016/j.jhep.2015.04.016
   Chen MJ, 2014, BIOMARK MED, V8, P201, DOI 10.2217/bmm.13.146
   Chen X, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-73
   Cucinotta FA, 2008, RADIAT RES, V169, P214, DOI 10.1667/RR1035.1
   Curtu R, 2010, ADV EXP MED BIOL, V680, P261, DOI 10.1007/978-1-4419-5913-3_30
   Danhof M, 2008, TRENDS PHARMACOL SCI, V29, P186, DOI 10.1016/j.tips.2008.01.007
   Dara L, 2011, HEPATOLOGY, V53, P1752, DOI 10.1002/hep.24279
   Dolan D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055190
   Dolan DWP, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004246
   Eissing T, 2004, J BIOL CHEM, V279, P36892, DOI 10.1074/jbc.M404893200
   Ekins S, 2007, BRIT J PHARMACOL, V152, P9, DOI 10.1038/sj.bjp.0707305
   Elias J, 2014, BBA-PROTEINS PROTEOM, V1844, P232, DOI 10.1016/j.bbapap.2013.09.019
   Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337
   Erguler K, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-16
   Fung M, 2001, DRUG INF J, V35, P293, DOI 10.1177/009286150103500134
   Fussenegger M, 2000, NAT BIOTECHNOL, V18, P768
   Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225
   Hamon J, 2014, BMC SYST BIOL, V8, DOI 10.1186/1752-0509-8-76
   Han D, 2010, ADVERSE DRUG REACT, V196, P267
   Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8
   Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787
   Helleday T, 2014, NAT REV GENET, V15, P585, DOI 10.1038/nrg3729
   Herpers B, 2016, ARCH TOXICOL, V90, P1163, DOI 10.1007/s00204-015-1536-3
   Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270
   Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914
   Huber H, 2009, ESSENTIALS OF APOPTOSIS, SECOND EDITION, P283, DOI 10.1007/978-1-60327-381-7_12
   Huber HJ, 2011, BBA-MOL CELL RES, V1813, P608, DOI 10.1016/j.bbamcr.2010.10.004
   Hussain SP, 2003, NAT REV CANCER, V3, P276, DOI 10.1038/nrc1046
   Hussaini SH, 2007, EXPERT OPIN DRUG SAF, V6, P673, DOI 10.1517/14740338.6.6.673
   Ikeyama S, 2001, J HEPATOL, V35, P53, DOI 10.1016/S0168-8278(01)00053-8
   Junkin M, 2016, CELL REP, V15, P411, DOI 10.1016/j.celrep.2016.03.033
   Kaplowitz N, 2004, CLIN INFECT DIS, V38, pS44, DOI 10.1086/381446
   Keener J., 2009, MATH PHYSL CELLULAR
   Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492
   Kitano H, 2002, NATURE, V420, P206, DOI 10.1038/nature01254
   Kregel KC, 2002, J APPL PHYSIOL, V92, P2177, DOI 10.1152/japplphysiol.01267.2001
   Krishna S, 2006, P NATL ACAD SCI USA, V103, P10840, DOI 10.1073/pnas.0604085103
   Lahav G, 2004, NAT GENET, V36, P147, DOI 10.1038/ng1293
   Lavrik IN, 2010, CURR OPIN BIOTECH, V21, P551, DOI 10.1016/j.copbio.2010.07.001
   Lavrik IN, 2009, MOL BIOSYST, V5, P1105, DOI 10.1039/b905129p
   Leclerc E, 2015, CELL BIOL TOXICOL, V31, P173, DOI 10.1007/s10565-015-9302-0
   Lecomte S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056085
   Lee TK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000599
   Lee WM, 2003, SEMIN LIVER DIS, V23, P217
   Li Y, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030186, 10.1371/journal.pone.0030835, 10.1371/journal.pone.0029003]
   Lipniacki T, 2004, J THEOR BIOL, V228, P195, DOI 10.1016/j.jtbi.2004.01.001
   LITTLE E, 1995, J BIOL CHEM, V270, P9526, DOI 10.1074/jbc.270.16.9526
   Longo DM, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003112
   Ma L, 2005, P NATL ACAD SCI USA, V102, P14266, DOI 10.1073/pnas.0501352102
   McMillan DR, 1998, J BIOL CHEM, V273, P7523, DOI 10.1074/jbc.273.13.7523
   Messner S, 2013, ARCH TOXICOL, V87, P209, DOI 10.1007/s00204-012-0968-2
   Mihalas GI, 2000, J BIOL SYST, V8, P21, DOI 10.1142/S0218339000000031
   National Research Council, 2007, TOXICITY TESTING 21, V2007
   Nebert DW, 2006, NAT REV CANCER, V6, P947, DOI 10.1038/nrc2015
   Newton K, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a006049
   Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011
   OECD, 2013, SER TEST ASS, V2013, P1
   Parrish AB, 2013, COLD SPRING HARB PER, V5, DOI DOI 10.1101/CSHPERSPECT.A008672
   Passos JF, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.5
   Peper A, 1998, INT J HYPERTHER, V14, P97, DOI 10.3109/02656739809018218
   Petre I, 2011, NAT COMPUT, V10, P595, DOI 10.1007/s11047-010-9216-y
   Pincus D, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000415
   Przybylak KR, 2012, EXPERT OPIN DRUG MET, V8, P201, DOI 10.1517/17425255.2012.648613
   Ramadori G, 2001, EUR J GASTROEN HEPAT, V13, P777, DOI 10.1097/00042737-200107000-00004
   Ramaiahgari SC, 2014, ARCH TOXICOL, V88, P1083, DOI 10.1007/s00204-014-1215-9
   Rehm M, 2013, METHODS, V61, P165, DOI 10.1016/j.ymeth.2013.04.007
   Reichard JF, 2007, NUCLEIC ACIDS RES, V35, P7074, DOI 10.1093/nar/gkm638
   Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199
   Roos WP, 2016, NAT REV CANCER, V16, P20, DOI 10.1038/nrc.2015.2
   Royle K, 2013, BIOTECHNOL LETT, V35, P1961, DOI 10.1007/s10529-013-1297-0
   Rutkowski DT, 2006, PLOS BIOL, V4, P2024, DOI 10.1371/journal.pbio.0040374
   Scheff JD, 2015, BIOPHYS J, V109, P182, DOI 10.1016/j.bpj.2015.06.027
   Schleich K, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-44
   Schmitz O, 2002, DIABETES METAB, V28, pS14
   Spassova MA, 2015, OXID MED CELL LONGEV, DOI 10.1155/2015/764375
   Spencer SL, 2011, CELL, V144, P926, DOI 10.1016/j.cell.2011.03.002
   Stracker Travis H., 2013, Frontiers in Genetics, V4, P37, DOI 10.3389/fgene.2013.00037
   Sun L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025618
   Taleei R, 2013, RADIAT RES, V179, P530, DOI 10.1667/RR3123.1
   Talemi SR, 2015, SCI REP-UK, V5, DOI 10.1038/srep13540
   Tay S, 2010, NATURE, V466, P267, DOI 10.1038/nature09145
   Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012
   Trusina A, 2010, DIABETES OBES METAB, V12, P27, DOI 10.1111/j.1463-1326.2010.01274.x
   Trusina A, 2008, P NATL ACAD SCI USA, V105, P20280, DOI 10.1073/pnas.0803476105
   Tsui R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8068
   Turner DA, 2010, J CELL SCI, V123, P2834, DOI 10.1242/jcs.069641
   van Riel NAW, 2006, BRIEF BIOINFORM, V7, P364, DOI 10.1093/bib/bbl040
   Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101
   Vinken M, 2015, CHEM RES TOXICOL, V28, P1391, DOI 10.1021/acs.chemrestox.5b00208
   Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038
   Wardyn JD, 2015, BIOCHEM SOC T, V43, P621, DOI 10.1042/BST20150014
   West S, 2015, J MATH BIOL, V70, P591, DOI 10.1007/s00285-014-0775-x
   Williams RA, 2014, COMPUTATION, V2, P131, DOI 10.3390/computation2040131
   Williams RA, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aac6503
   Wilmes A, 2013, J PROTEOMICS, V79, P180, DOI 10.1016/j.jprot.2012.11.022
   Wilson AGE, 2011, NEW HORIZONS PREDICT
   Wink S, 2017, ARCH TOXICOL, V91, P1367, DOI 10.1007/s00204-016-1781-0
   Wink S, 2014, CHEM RES TOXICOL, V27, P338, DOI 10.1021/tx4004038
   Wurstle ML, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.36
   Yde P, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-115
   Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0
   Zambrano S, 2014, J THEOR BIOL, V347, P44, DOI 10.1016/j.jtbi.2014.01.015
   Zhang Q, 2007, PLOS COMPUT BIOL, V3, P345, DOI 10.1371/journal.pcbi.0030024
   Zhang Q, 2010, TOXICOL APPL PHARM, V244, P84, DOI 10.1016/j.taap.2009.08.018
   Zhang Q, 2009, TOXICOL APPL PHARM, V237, P345, DOI 10.1016/j.taap.2009.04.005
   Zhang TL, 2009, BIOPHYS J, V97, P415, DOI 10.1016/j.bpj.2009.04.053
NR 119
TC 3
Z9 3
U1 1
U2 14
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1742-5255
EI 1744-7607
J9 EXPERT OPIN DRUG MET
JI Expert Opin. Drug Metab. Toxicol.
PD JAN
PY 2017
VL 13
IS 1
BP 5
EP 17
DI 10.1080/17425255.2017.1234607
PG 13
WC Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Toxicology
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Toxicology
GA EG0UI
UT WOS:000390747300002
PM 27609146
DA 2019-10-23
ER

PT B
AU Dorman, DC
   Chiu, W
   Hales, BF
   Hauser, RB
   Johnson, KJ
   Robinson, KA
   Rooney, AA
   Rudel, R
   Sathyanarayana, S
   Schantz, SL
   Waters, K
   Martel, SNJ
   Mantus, EK
   O'Doughda, L
   Karalic-Loncarevic, M
   Rose-Crawford, R
   Dawson, T
   Farland, WH
   Becker, RA
   Colglazier, EW
   DiToro, DM
   Driscoll, CT
   Fairbrother, A
   Gray, G
   Hamburg, SP
   Hiatt, RA
   Kacew, S
   Matthews, HS
   Perciasepe, R
   Postlewaite, RC
   Ratner, MA
   Rose, JB
   Solomon, GM
   Sussman, RM
   Swackhammer, DL
   Thorne, PS
   Fryberger, TA
   Wassel, RA
AF Dorman, David C.
   Chiu, Weihsueh
   Hales, Barbara F.
   Hauser, Russ B.
   Johnson, Kamin J.
   Robinson, Karen A.
   Rooney, Andrew A.
   Rudel, Ruthann
   Sathyanarayana, Sheela
   Schantz, Susan L.
   Waters, Katrina
   Martel, Susan N. J.
   Mantus, Ellen K.
   O'Doughda, Linda
   Karalic-Loncarevic, Mirsada
   Rose-Crawford, Radiah
   Dawson, Tamara
   Farland, William H.
   Becker, Richard A.
   Colglazier, E. William
   DiToro, Dominic M.
   Driscoll, Charles T., Jr.
   Fairbrother, Anne
   Gray, George
   Hamburg, Steven P.
   Hiatt, Robert A.
   Kacew, Sameul
   Matthews, H. Scott
   Perciasepe, Robert
   Postlewaite, R. Craig
   Ratner, Mark A.
   Rose, Joan B.
   Solomon, Gina M.
   Sussman, Robert M.
   Swackhammer, Deborah L.
   Thorne, Peter S.
   Fryberger, Teresa A.
   Wassel, Raymond A.
CA Comm Endocrine-Related Low-Dose To
   Board Environm Studies Toxicology
   Div Earth Life Studies
   Natl Acad Sci
   Natl Acad Engn
   Natl Acad Med
GP Natl Acad Sci Engn Med
TI Strategy for Evaluating Low-Dose Effects
SO APPLICATION OF SYSTEMATIC REVIEW METHODS IN AN OVERALL STRATEGY FOR
   EVALUATING LOW-DOSE TOXICITY FROM ENDOCRINE ACTIVE CHEMICALS
LA English
DT Article; Book Chapter
ID ENDOCRINE-DISRUPTING CHEMICALS; ENVIRONMENTAL-HEALTH SCIENCE; ADVERSE
   OUTCOME PATHWAYS; MAMMARY-GLAND TUMORS; RISK-ASSESSMENT; BISPHENOL-A;
   REPRODUCTIVE DEVELOPMENT; DEVELOPMENTAL EXPOSURE; ANOGENITAL DISTANCE;
   SILICONE WRISTBANDS
C1 [Dorman, David C.] North Carolina State Univ, Dept Mol Biomed Sci, Toxicol, Raleigh, NC 27695 USA.
   [Chiu, Weihsueh] Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Vet Integrat Biosci, College Stn, TX USA.
   [Hales, Barbara F.] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada.
   [Hauser, Russ B.] Harvard TH Chan Sch Publ Hlth, Dept Environm Hlth, Reprod Physiol, Boston, MA USA.
   [Hauser, Russ B.] Harvard TH Chan Sch Publ Hlth, Dept Environm Hlth, Environm & Occupat Epidemiol, Boston, MA USA.
   [Johnson, Kamin J.] Dow Chem Co USA, Toxicol & Environm Res & Consulting Funct, Midland, MI 48674 USA.
   [Robinson, Karen A.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA.
   [Robinson, Karen A.] Johns Hopkins Univ, Evidence Based Practice Ctr, Baltimore, MD USA.
   [Rooney, Andrew A.] Natl Toxicol Program, Res Triangle Pk, NC USA.
   [Rudel, Ruthann] Silent Spring Inst, Res, Newton, MA USA.
   [Sathyanarayana, Sheela] Univ Washington, Dept Pediat, Seattle, WA 98195 USA.
   [Sathyanarayana, Sheela] Univ Washington, Dept Environm & Occupat Hlth Sci, Seattle, WA 98195 USA.
   [Schantz, Susan L.] Univ Illinois, Coll Vet Med, Dept Comparat Biosci, Toxicol, Urbana, IL 61801 USA.
   [Waters, Katrina] Pacific Northwest Natl Lab, Div Biol Sci, Richland, WA 99352 USA.
   [Karalic-Loncarevic, Mirsada] Tech Informat Ctr, Washington, DC USA.
   [Rose-Crawford, Radiah] Editorial Projects, Washington, DC USA.
   [Farland, William H.] Colorado State Univ, Ft Collins, CO 80523 USA.
   [Becker, Richard A.] Amer Chem Council, Washington, DC USA.
   [Colglazier, E. William] Amer Assoc Advancement Sci, Washington, DC USA.
   [DiToro, Dominic M.] Univ Delaware, Newark, DE USA.
   [Driscoll, Charles T., Jr.] Syracuse Univ, Syracuse, NY USA.
   [Fairbrother, Anne] Exponent Inc, Philomath, OR USA.
   [Gray, George] George Washington Univ, Washington, DC USA.
   [Hamburg, Steven P.] Environm Def Fund, New York, NY USA.
   [Hiatt, Robert A.] Univ Calif San Francisco, San Francisco, CA 94143 USA.
   [Kacew, Sameul] Univ Ottawa, Ottawa, ON, Canada.
   [Matthews, H. Scott] Carnegie Mellon Univ, Pittsburgh, PA 15213 USA.
   [Perciasepe, Robert] Ctr Climate & Energy Solut, Arlington, VA USA.
   [Ratner, Mark A.] Northwestern Univ, Evanston, IL USA.
   [Rose, Joan B.] Michigan State Univ, E Lansing, MI 48824 USA.
   [Solomon, Gina M.] Calif Environm Protect Agcy, Sacramento, CA USA.
   [Sussman, Robert M.] Sussman & Associates, Washington, DC USA.
   [Swackhammer, Deborah L.] Univ Minnesota, St Paul, MN 55108 USA.
   [Thorne, Peter S.] Univ Iowa, Iowa City, IA USA.
RP Dorman, DC (reprint author), North Carolina State Univ, Dept Mol Biomed Sci, Toxicol, Raleigh, NC 27695 USA.
CR Ankley GT, 2015, TOXICOL SCI, V144, P259, DOI 10.1093/toxsci/kfu320
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Auerbach S, 2016, ENVIRON HEALTH PERSP, V124, P1141, DOI 10.1289/ehp.1510456
   Avillach P, 2013, J AM MED INFORM ASSN, V20, P446, DOI 10.1136/amiajnl-2012-001083
   Aylward LL, 2014, J TOXICOL ENV HEAL B, V17, P45, DOI 10.1080/10937404.2013.864250
   Aylward LL, 2013, ENVIRON HEALTH PERSP, V121, P287, DOI 10.1289/ehp.1205740
   Bars R, 2012, REGUL TOXICOL PHARM, V64, P143, DOI 10.1016/j.yrtph.2012.06.013
   Beekhuijzen M, 2016, REPROD TOXICOL, V64, P64, DOI 10.1016/j.reprotox.2016.04.002
   Bell SM, 2016, TOXICOL SCI, V150, P510, DOI 10.1093/toxsci/kfw017
   Bellofiore N, 2017, AM J OBSTET GYNECOL, V216, DOI 10.1016/j.ajog.2016.07.041
   Bernanke J, 2009, REV ENVIRON CONTAM T, V198, P1, DOI 10.1007/978-0-387-09647-6_1
   Blystone CR, 2010, TOXICOL SCI, V116, P640, DOI 10.1093/toxsci/kfq147
   Bradman A, 2013, ENVIRON HEALTH PERSP, V121, P118, DOI 10.1289/ehp.1104808
   Bruner-Tran KL, 2017, REPROD TOXICOL, V68, P59, DOI 10.1016/j.reprotox.2016.07.007
   Burney RO, 2012, FERTIL STERIL, V98, P511, DOI 10.1016/j.fertnstert.2012.06.029
   CDC, 2015, 4 NAT REP HUM EXP EN
   Centers for Disease Control and Prevention, 2009, 4 NAT REP HUM EXP EN
   Conolly RB, 2017, ENVIRON SCI TECHNOL, V51, P4661, DOI 10.1021/acs.est.6b06230
   Crump KS, 2016, RISK ANAL, V36, P1803, DOI [10.1111/risa.12748, 10.1111/risa.12556]
   Diamanti-Kandarakis E, 2009, ENDOCR REV, V30, P293, DOI 10.1210/er.2009-0002
   Donald CE, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.160433
   Duke JD, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002614
   EPA (U. S. Environmental Protection Agency), 2000, EPA600R98053F OFF RE
   Eskenazi B, 2002, ENVIRON HEALTH PERSP, V110, P629, DOI 10.1289/ehp.02110629
   Foster PMD, 2014, TOXICOL PATHOL, V42, P1165, DOI 10.1177/0192623314534920
   Friedman GD, 2009, BREAST CANCER RES TR, V116, P187, DOI 10.1007/s10549-008-0123-1
   Gagne JJ, 2016, CLIN PHARMACOL THER, V100, P558, DOI 10.1002/cpt.429
   Geyh AS, 1999, J EXPO ANAL ENV EPID, V9, P143, DOI 10.1038/sj.jea.7500001
   Goodman SN, 2016, SCIENCE, V352, P1180, DOI 10.1126/science.aaf5406
   Gore AC, 2015, ENDOCR REV, V36, pE1, DOI 10.1210/er.2015-1010
   Gurulingappa H, 2012, J BIOMED SEMANT, V3, DOI 10.1186/2041-1480-3-15
   Hammel SC, 2016, ENVIRON SCI TECHNOL, V50, P4483, DOI 10.1021/acs.est.6b00030
   Harpaz R, 2012, CLIN PHARMACOL THER, V91, P1010, DOI 10.1038/clpt.2012.50
   Hartle JC, 2016, ENVIRON RES, V150, P375, DOI 10.1016/j.envres.2016.06.008
   Hass U., 2013, INPUT REACH REV 2013
   Hauben M, 2007, DRUG SAFETY, V30, P143, DOI 10.2165/00002018-200730020-00004
   Heindel J J, 1988, Reprod Toxicol, V2, P273, DOI 10.1016/0890-6238(88)90031-7
   Hoover RN, 2011, NEW ENGL J MED, V365, P1304, DOI 10.1056/NEJMoa1013961
   Huffling K, 2016, ENVIRON HEALTH PERSP, V124, pA118, DOI 10.1289/EHP358
   Ibrahim H, 2016, J BIOMED INFORM, V60, P294, DOI 10.1016/j.jbi.2016.02.009
   *IOM, 2012, BREAST CANC ENV LIF
   Jefferson WN, 2013, MOL ENDOCRINOL, V27, P1666, DOI 10.1210/me.2013-1211
   Jenkins S, 2007, REPROD TOXICOL, V23, P391, DOI 10.1016/j.reprotox.2006.10.004
   Kim KN, 2016, ENVIRON RES, V145, P61, DOI 10.1016/j.envres.2015.11.021
   Kim TS, 2010, J TOXICOL ENV HEAL A, V73, P1544, DOI 10.1080/15287394.2010.511579
   King CM, 2016, J PATHOL, V238, P185, DOI 10.1002/path.4657
   Lardon J, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.4304
   Lewis RC, 2015, INT J ENV RES PUB HE, V12, P6098, DOI 10.3390/ijerph120606098
   Li Y, 2014, J AM MED INFORM ASSN, V21, P308, DOI 10.1136/amiajnl-2013-001718
   Liu CH, 2014, ENVIRON SCI POLLUT R, V21, P5457, DOI 10.1007/s11356-014-2570-z
   Macon MB, 2013, J MAMMARY GLAND BIOL, V18, P43, DOI 10.1007/s10911-013-9275-7
   Makris SL, 2011, ENVIRON HEALTH PERSP, V119, P1047, DOI 10.1289/ehp.1002676
   Marty MS, 2009, BIRTH DEFECTS RES B, V86, P470, DOI 10.1002/bdrb.20208
   McMahon AW, 2015, PHARMACOEPIDEM DR S, V24, P785, DOI 10.1002/pds.3813
   Mihaylov NL, 2015, BEHAV SCI-BASEL, V5, P121, DOI 10.3390/bs5010121
   NASEM (National Academies of Sciences Engineering and Medicine), 2017, US 21 CENT SCI IMPR
   NASEM (National Academies of Sciences Engineering and Medicine), 2015, APPL MOD TOX PRED AC
   National Research Council (NRC), 2006, HUM BIOM ENV CHEM
   Nayyar T, 2007, REPROD TOXICOL, V23, P326, DOI 10.1016/j.reprotox.2006.09.007
   NEWBOLD RR, 1982, CANCER RES, V42, P2003
   Newbold RR, 2004, TOXICOL APPL PHARM, V199, P142, DOI 10.1016/j.taap.2003.11.033
   Newbold RR, 2004, REPROD TOXICOL, V18, P399, DOI 10.1016/j.reprotox.2004.01.007
   Nikfarjam A, 2015, J AM MED INFORM ASSN, V22, P671, DOI 10.1093/jamia/ocu041
   NRC, 2011, REV ENV PROT AG DRAF
   NRC, 2009, SCI DEC ADV RISK ASS
   NRC, 2006, HLTH RISKS DIOX REL
   NRC, 2014, REV EPA INT RISK INF
   NRC, 2012, EXP SCI 21 CENT VIS
   NRC, 1991, HUM EXP ASS AIRB POL
   NRC (National Research Council), 2007, TOX TEST 21 CENT VIS
   NTP (National Toxicology Program), 2015, HDB COND LIT BAS HLT
   O'Connell SG, 2014, ENVIRON SCI TECHNOL, V48, P3327, DOI 10.1021/es405022f
   Oliveira M, 2016, ENVIRON POLLUT, V208, P382, DOI 10.1016/j.envpol.2015.10.004
   Omoike OE, 2015, REPROD TOXICOL, V53, P99, DOI 10.1016/j.reprotox.2015.04.005
   Patel CJ, 2014, REPROD TOXICOL, V45, P1, DOI 10.1016/j.reprotox.2013.12.005
   Patel CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010746
   Perera FP, 2003, ENVIRON HEALTH PERSP, V111, P201, DOI 10.1289/ehp.5742
   Peretz J, 2014, ENVIRON HEALTH PERSP, V122, P775, DOI 10.1289/ehp.1307728
   Platt R, 2012, PHARMACOEPIDEM DR S, V21, P1, DOI 10.1002/pds.2343
   Pontes H, 2014, DRUG SAFETY, V37, P471, DOI 10.1007/s40264-014-0180-9
   Puchalski MA, 2015, ENVIRON SCI-PROC IMP, V17, P358, DOI 10.1039/c4em00531g
   Reed CE, 2013, BIRTH DEFECTS RES C, V99, P134, DOI 10.1002/bdrc.21035
   REVESZ C, 1960, ENDOCRINOLOGY, V66, P140
   RIER SE, 1993, FUND APPL TOXICOL, V21, P433, DOI 10.1006/faat.1993.1119
   Rooney AA, 2014, ENVIRON HEALTH PERSP, V122, P711, DOI 10.1289/ehp.1307972
   Rudel RA, 2007, CANCER, V109, P2635, DOI 10.1002/cncr.22653
   Rudel RA, 2014, ENVIRON HEALTH PERSP, V122, P881, DOI 10.1289/ehp.1307455
   Rudel RA, 2011, ENVIRON HEALTH PERSP, V119, P1053, DOI 10.1289/ehp.1002864
   Saillenfait AM, 2008, REPROD TOXICOL, V26, P107, DOI 10.1016/j.reprotox.2008.07.006
   Salazar-Martinez Eduardo, 2004, Environ Health, V3, P8, DOI 10.1186/1476-069X-3-8
   Sarkar U, 2011, HEALTH SERV RES, V46, P1517, DOI 10.1111/j.1475-6773.2011.01269.x
   Sarker A, 2015, J BIOMED INFORM, V53, P196, DOI 10.1016/j.jbi.2014.11.002
   Sather ME, 2016, ENVIRON SCI-PROC IMP, V18, P819, DOI 10.1039/c6em00210b
   Sathyanarayana S, 2015, J PEDIAT UROL, V11
   Scholze M, 2007, ENVIRON HEALTH PERSP, V115, P84, DOI 10.1289/ehp.9364
   Schotland P, 2016, EUR J PHARM SCI, V94, P84, DOI 10.1016/j.ejps.2016.06.009
   Schwarzman MR, 2015, ENVIRON HEALTH PERSP, V123, P1255, DOI 10.1289/ehp.1408337
   Shetty KD, 2011, J AM MED INFORM ASSN, V18, P668, DOI 10.1136/amiajnl-2011-000096
   Skakkebaek NE, 2011, J CLIN ENDOCR METAB, V96, P3056, DOI 10.1210/jc.2011-1269
   Slayden OD, 2016, HANDB EXP PHARMACOL, V232, P191, DOI 10.1007/164_2015_22
   Smith MT, 2016, ENVIRON HEALTH PERSP, V124, P713, DOI 10.1289/ehp.1509912
   Sobus JR, 2015, ENVIRON HEALTH PERSP, V123, P919, DOI 10.1289/ehp.1409177
   Solomon PA, 2008, J AIR WASTE MANAGE, V58, P164, DOI 10.3155/1047-3289.58.2.164
   Subramaniam RP, 2007, RISK ANAL, V27, P1237, DOI 10.1111/j.1539-6924.2007.00968.x
   Swan SH, 2005, ENVIRON HEALTH PERSP, V113, P1056, DOI 10.1289/ehp.8100
   Tan YM, 2012, J TOXICOL ENV HEAL B, V15, P22, DOI 10.1080/10937404.2012.632360
   Tatonetti NP, 2012, J AM MED INFORM ASSN, V19, P79, DOI 10.1136/amiajnl-2011-000214
   Taylor RN, 2015, SEMIN REPROD MED, V33, P246, DOI 10.1055/s-0035-1554920
   Teeguarden J, 2013, FOOD CHEM TOXICOL, V62, P949, DOI 10.1016/j.fct.2013.08.001
   Teeguarden JG, 2015, TOXICOL APPL PHARM, V288, P131, DOI 10.1016/j.taap.2015.01.009
   Thayer KA, 2007, ENVIRON HEALTH PERSP, V115, P1351, DOI 10.1289/ehp.10135
   Thayer KA, 2015, ENVIRON INT, V83, P107, DOI 10.1016/j.envint.2015.06.008
   Trifiro G, 2009, PHARMACOEPIDEM DR S, V18, P1176, DOI 10.1002/pds.1836
   Tsai DH, 2012, PART FIBRE TOXICOL, V9, DOI 10.1186/1743-8977-9-24
   Vandenberg L. N., 2013, ENDOCR DISRUPTORS, V1, P1, DOI DOI 10.4161/ENDO.26490
   Vercellini P, 2014, NAT REV ENDOCRINOL, V10, P261, DOI 10.1038/nrendo.2013.255
   Wang Wei, 2011, AMIA Annu Symp Proc, V2011, P1464
   Wetmore BA, 2012, TOXICOL SCI, V125, P157, DOI 10.1093/toxsci/kfr254
   WHO-The Importance of Pharmacovigilance 2002 WHO, 2002, IMP PHARM SAF MON ME
   Winnenburg R, 2015, J BIOMED INFORM, V57, P425, DOI 10.1016/j.jbi.2015.08.022
   Woodruff TJ, 2014, ENVIRON HEALTH PERSP, V122, P1007, DOI 10.1289/ehp.1307175
   Yang XX, 2015, TOXICOL APPL PHARM, V289, P442, DOI 10.1016/j.taap.2015.10.016
   Yoon M, 2012, CRIT REV TOXICOL, V42, P633, DOI 10.3109/10408444.2012.692115
   Zoller HM, 2017, HEALTH COMMUN, V32, P219, DOI 10.1080/10410236.2015.1118735
NR 124
TC 0
Z9 0
U1 0
U2 0
PU NATL ACADEMIES PRESS
PI WASHINGTON
PA 2101 CONSTITUTION AVE, WASHINGTON, DC 20418 USA
BN 978-0-309-45862-7
PY 2017
BP 21
EP 40
D2 10.17226/24758
PG 20
WC Toxicology
SC Toxicology
GA BM7PJ
UT WOS:000468284200003
DA 2019-10-23
ER

PT B
AU Tyack, PL
   Bailey, H
   Crocker, DE
   Estes, JE
   Francis, CD
   Harwood, J
   Schwacke, LH
   Thomas, L
   Wartzok, D
   Mayer, LA
   Armbrust, EV
   Arrigo, KR
   Benitez-Nelson, C
   Colwell, RR
   Cooksey, SW
   Halpern, D
   Humphris, SE
   Mccay, BJ
   Murawski, SA
   Orcutt, JA
   Ozkan-Haller, HT
   Smith, MD
   Spring, M
   Wartzok, D
   White, LD
AF Tyack, Peter L.
   Bailey, Helen
   Crocker, Daniel E.
   Estes, James E.
   Francis, Clinton D.
   Harwood, John
   Schwacke, Lori H.
   Thomas, Len
   Wartzok, Douglas
   Mayer, Larry A.
   Armbrust, E. Virginia
   Arrigo, Kevin R.
   Benitez-Nelson, Claudia
   Colwell, Rita R.
   Cooksey, Sarah W.
   Halpern, David
   Humphris, Susan E.
   Mccay, Bonnie J.
   Murawski, Steven A.
   Orcutt, John A.
   Ozkan-Haller, H. Tuba
   Smith, Martin D.
   Spring, Margaret
   Wartzok, Douglas
   White, Lisa D.
CA Comm Assessment Cumulative Effects
   Ocean Studies Board
   Div Earth Life Studies
   Natl Acad Sci Engn Med
GP Natl Acad Sci Engn Med
TI Assessing Interactions Among Stressors
SO APPROACHES TO UNDERSTANDING THE CUMULATIVE EFFECTS OF STRESSORS ON
   MARINE MAMMALS
LA English
DT Article; Book Chapter
C1 [Tyack, Peter L.; Harwood, John; Thomas, Len] Univ St Andrews, St Andrews, Fife, Scotland.
   [Bailey, Helen] Univ Maryland, Ctr Environm Sci, Solomons, MD USA.
   [Crocker, Daniel E.] Sonoma State Univ, Rohnert Pk, CA 94928 USA.
   [Estes, James E.] Univ Calif Santa Cruz, Santa Cruz, CA 95064 USA.
   [Francis, Clinton D.] Calif Polytech State Univ San Luis Obispo, San Luis Obispo, CA 93407 USA.
   [Schwacke, Lori H.] NOAA, Hollings Marine Lab, Charleston, SC USA.
   [Wartzok, Douglas; Wartzok, Douglas] Florida Int Univ, Miami, FL 33199 USA.
   [Mayer, Larry A.] Univ New Hampshire, Durham, NH 03824 USA.
   [Armbrust, E. Virginia] Univ Washington, Seattle, WA 98195 USA.
   [Arrigo, Kevin R.] Stanford Univ, Stanford, CA 94305 USA.
   [Benitez-Nelson, Claudia] Univ South Carolina, Columbia, SC 29208 USA.
   [Colwell, Rita R.] Univ Maryland, College Pk, MD 20742 USA.
   [Cooksey, Sarah W.] State Delaware, Dover, DE USA.
   [Halpern, David] Jet Prop Lab, Pasadena, CA USA.
   [Humphris, Susan E.] Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA.
   [Mccay, Bonnie J.] Rutgers State Univ, New Brunswick, NJ USA.
   [Murawski, Steven A.] Univ S Florida, St Petersburg, FL USA.
   [Orcutt, John A.] Scripps Inst Oceanog, La Jolla, CA USA.
   [Ozkan-Haller, H. Tuba] Oregon State Univ, Corvallis, OR 97331 USA.
   [Smith, Martin D.] Duke Univ, Durham, NC USA.
   [Spring, Margaret] Monterey Bay Aquarium, Monterey, CA USA.
   [White, Lisa D.] Univ Calif Berkeley, Berkeley, CA 94720 USA.
   [White, Lisa D.] San Francisco State Univ, San Francisco, CA 94132 USA.
RP Tyack, PL (reprint author), Univ St Andrews, St Andrews, Fife, Scotland.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU NATL ACADEMIES PRESS
PI WASHINGTON
PA 2101 CONSTITUTION AVE, WASHINGTON, DC 20418 USA
BN 978-0-309-44048-6
PY 2017
BP 41
EP 57
D2 10.17226/23479
PG 17
WC Ecology; Marine & Freshwater Biology
SC Environmental Sciences & Ecology; Marine & Freshwater Biology
GA BM9IO
UT WOS:000470983900006
DA 2019-10-23
ER

PT J
AU Warheit, DB
   Kreiling, R
   Levy, LS
AF Warheit, D. B.
   Kreiling, R.
   Levy, L. S.
TI Relevance of the rat lung tumor response to particle overload for human
   risk assessment-Update and interpretation of new data since ILSI 2000
SO TOXICOLOGY
LA English
DT Review
DE Particle overload; Species differences; Adverse outcome pathway; Poorly
   soluble particles; Nonhuman primates; Rats
ID CARBON-BLACK EXPOSURE; ALVEOLAR-INTERSTITIAL REGION; CHRONIC INHALATION
   TOXICITY; TITANIUM-DIOXIDE; CANCER-MORTALITY; DIESEL EXHAUST; SUBCHRONIC
   INHALATION; PULMONARY RESPONSES; OCCUPATIONAL-EXPOSURE; COHORT MORTALITY
AB The relevance of particle-overload related lung tumors in rats for human risk assessment following chronic inhalation exposures to poorly soluble particulates (PSP) has been a controversial issue for more than three decades. In 1998, an ILSI (International Life Sciences) Working Group of health scientists was convened to address this issue of applicability of experimental study findings of lung neoplasms in rats for lifetime-exposed production workers to PSPs. A full consensus view was not reached by the Workshop participants, although it was generally acknowledged that the findings of lung tumors in rats following chronic inhalation, particle-overload PSP exposures occurred only in rats and no other tested species; and that there was an absence of lung cancers in PSP-exposed production workers. Since the publication of the ILSI Workshop report in 2000, there have been important new data published on the human relevance issue. A thorough and comprehensive review of the health effects literature on poorly soluble particles/lung overload was undertaken and published by an ECETOC (European Centre for Ecotoxicology and Toxicology of Chemicals) Task Force in 2013. One of the significant conclusions derived from that technical report was that the rat is unique amongst all species in developing lung tumors under chronic inhalation overload exposures to PSPs.
   Accordingly, the objective of this review is to provide important insights on the fundamental differences in pulmonary responses between experimentally-exposed rats, other experimental species and occupationally-exposed humans. Briefly, five central factors are described by the following issues.
   Interspecies differences in lung responses of rats vs. other rodents, triggering different adverse outcome pathways (AOPs);
   Interspecies differences in inhaled particle kinetics in rats vs nonhuman primates and humans triggering differential particle-related pulmonary responses.
   Advanced and updated human respiratory tract deposition and retention models allowing more realistic particle translocation/retention estimates.
   Differences in morphologies and characterizations of rat vs. human pulmonary tumor types and locations within the respiratory tract.
   Comprehensive in-depth analysis of available epidemiological data from PSP production workers that demonstrate no correlation between particle exposures and lung cancers or other non-malignant respiratory diseases.
   Focusing on these five interrelated/convergent factors clearly demonstrate an inappropriateness in concluding that the findings of lung tumors in rats exposed chronically to high concentrations of PSPs are accurate representations of the risks of lung cancer in PSP-exposed production workers. The most plausible conclusion that can be reached is that results from chronic particle-overload inhalation studies with PSPs in rats have no relevance for determining lung cancer risks in production workers exposed for a working lifetime to these poorly soluble particulate-types. (C) 2016 Published by Elsevier Ireland Ltd.
C1 [Warheit, D. B.] Chemours Co, Wilmington, DE 19898 USA.
   [Kreiling, R.] Clariant Prod DE GmbH, Sulzbach, Germany.
   [Levy, L. S.] Cranfield Univ, Cranfield MK43 0AL, Beds, England.
RP Warheit, DB (reprint author), Chemours Co, Wilmington, DE 19898 USA.
EM david.warheit@gmail.com
CR Abraham AG, 2010, J OCCUP ENVIRON MED, V52, P1035, DOI 10.1097/JOM.0b013e3181f73afc
   Baan RA, 2007, INHAL TOXICOL, V19, P213, DOI 10.1080/08958370701497903
   Bermudez E, 2004, TOXICOL SCI, V77, P347, DOI 10.1093/toxsci/kfh019
   Bermudez E, 2002, TOXICOL SCI, V70, P86, DOI 10.1093/toxsci/70.1.86
   Boffetta P, 2004, CANCER CAUSE CONTROL, V15, P697, DOI 10.1023/B:CACO.0000036188.23970.22
   BOLTON RE, 1983, BRIT J IND MED, V40, P264
   Boorman GA, 1996, TOXICOL PATHOL, V24, P564, DOI 10.1177/019262339602400505
   Borm PYA, 2000, INHAL TOXICOL, V12, P1
   Buchte SF, 2006, J OCCUP ENVIRON MED, V48, P1242, DOI 10.1097/01.jom.0000215710.17519.cd
   CARLTON WW, 1994, FUND APPL TOXICOL, V23, P304, DOI 10.1006/faat.1994.1108
   Carter JM, 2006, J OCCUP ENVIRON MED, V48, P1265, DOI 10.1097/01.jom.0000230489.06025.14
   CHEN JL, 1988, J OCCUP ENVIRON MED, V30, P937, DOI 10.1097/00043764-198812000-00011
   Dell LD, 2006, J OCCUP ENVIRON MED, V48, P1219, DOI 10.1097/01.jom.0000218701.62658.a2
   Dell LD, 2015, J OCCUP ENVIRON MED, V57, P984, DOI 10.1097/JOM.0000000000000511
   ECETOC, 2013, 122 ECETOC
   Elder A, 2005, TOXICOL SCI, V88, P614, DOI 10.1093/toxsci/kfi327
   Ellis ED, 2013, AM J IND MED, V56, P282, DOI 10.1002/ajim.22137
   Ellis ED, 2010, J OCCUP ENVIRON MED, V52, P303, DOI 10.1097/JOM.0b013e3181d0bee2
   Fryzek JP, 2003, J OCCUP ENVIRON MED, V45, P400, DOI 10.1097/01.jom.0000058338.05741.45
   Green FHY, 2000, INHAL TOXICOL, V12, P59, DOI 10.1080/089583700196545
   Gregoratto D, 2011, RADIAT PROT DOSIM, V144, P353, DOI 10.1093/rpd/ncq314
   Gregoratto D, 2010, J RADIOL PROT, V30, P491, DOI 10.1088/0952-4746/30/3/005
   Hartwig A., 2015, REPLY PERMANENT SENA
   HEINRICH U, 1995, INHAL TOXICOL, V7, P533, DOI 10.3109/08958379509015211
   Heinrich U., 1994, TOXIC CARCINOGENIC E, P433
   HODGSON JT, 1985, ARCH ENVIRON HEALTH, V40, P261, DOI 10.1080/00039896.1985.10545929
   International Agency for Research on Cancer [IARC], 1996, IARC MON EV CARC RIS, V65, P149
   International Commission on Radiological Protection (ICRP), 1994, ICRP PUBL, V66
   KLONNE DR, 1987, AM J IND MED, V11, P375, DOI 10.1002/ajim.4700110312
   Knaapen AM, 2004, INT J CANCER, V109, P799, DOI 10.1002/ijc.11708
   Kuempel ED, 2001, REGUL TOXICOL PHARM, V34, P88, DOI 10.1006/rtph.2001.1480
   LEE KP, 1985, TOXICOL APPL PHARM, V79, P179, DOI 10.1016/0041-008X(85)90339-4
   LEE KP, 1986, ENVIRON RES, V41, P144, DOI 10.1016/S0013-9351(86)80177-3
   Levy L.S., 1994, TOXIC CARCINOGENIC E
   LEVY LS, 1995, INDOOR ENVIRON, V4, P254
   LEWIS TR, 1989, J AM COLL TOXICOL, V8, P345, DOI 10.3109/10915818909019560
   MACFARLAND HN, 1982, ANN OCCUP HYG, V26, P213, DOI 10.1093/annhyg/26.2.213
   Mauderly JL, 1996, FUND APPL TOXICOL, V30, P233, DOI 10.1006/faat.1996.0061
   MAUDERLY JL, 1987, FUND APPL TOXICOL, V9, P208, DOI 10.1016/0272-0590(87)90044-3
   Mauderly JL, 1997, ENVIRON HEALTH PERSP, V105, P1337, DOI 10.2307/3433557
   McClellan RO, 1997, ENVIRON HEALTH PERSP, V105, P1363, DOI 10.2307/3433560
   Morfeld P, 2006, J OCCUP ENVIRON MED, V48, P1230, DOI 10.1097/01.jom.0000215282.23531.b9
   Morfeld P, 2006, J OCCUP ENVIRON MED, V48, P1253, DOI 10.1097/01.jom.0000215344.77132.99
   Morfeld P, 2007, AM J IND MED, V50, P565, DOI 10.1002/ajim.20491
   Morfeld P, 2016, PART FIBRE TOXICOL, V13, DOI 10.1186/s12989-015-0112-6
   Morfeld P, 2015, PART FIBRE TOXICOL, V12, DOI 10.1186/s12989-015-0079-3
   Morfeld P, 2010, J OCCUP MED TOXICOL, V5, DOI 10.1186/1745-6673-5-23
   Morfeld P, 2009, AM J IND MED, V52, P890, DOI 10.1002/ajim.20754
   Morrow P.E., 1988, FUNDAM APPL TOXICOL, V10, P279
   NIKULA KJ, 1995, FUND APPL TOXICOL, V25, P80, DOI 10.1006/faat.1995.1042
   Nikula KJ, 2001, ENVIRON HEALTH PERSP, V109, P311, DOI 10.2307/3454888
   Nikula KJ, 1997, FUND APPL TOXICOL, V37, P37, DOI 10.1006/faat.1997.2297
   Nikula KJ, 2000, INHAL TOXICOL, V12, P97, DOI 10.1080/089583700196554
   NIOSH, 2011, NIOSH CURR INT B, V63
   OBERDORSTER G, 1995, REGUL TOXICOL PHARM, V21, P123, DOI 10.1006/rtph.1995.1017
   Pauluhn J, 2014, PART FIBRE TOXICOL, V11, DOI 10.1186/s12989-014-0072-2
   Pauluhn J, 2011, TOXICOLOGY, V279, P176, DOI 10.1016/j.tox.2010.10.009
   PCRARM, 1997, PRES COMM RISK ASS R, V2, p[65, 67]
   Ramanakumar AV, 2008, INT J CANCER, V122, P183, DOI 10.1002/ijc.23021
   Schultz M, 1996, INHAL TOXICOL, V8, P433, DOI 10.3109/08958379609005439
   Sorahan T, 2007, AM J IND MED, V50, P555, DOI 10.1002/ajim.20481
   The Health Effects Institute, 1995, DIES EXH CRIT AN EM
   WAGNER WD, 1969, TOXICOL APPL PHARM, V15, P10, DOI 10.1016/0041-008X(69)90127-6
   Warheit DB, 2006, J OCCUP ENVIRON MED, V48, P1308, DOI 10.1097/01.jom.0000215385.71548.b0
   Warheit DB, 1997, TOXICOL APPL PHARM, V145, P10, DOI 10.1006/taap.1997.8102
   Wehner A P, 1979, Prog Exp Tumor Res, V24, P177
   Wellmann J, 2006, OCCUP ENVIRON MED, V63, P513, DOI 10.1136/oem.2006.026526
   WHO, 2010, IARC MONOG EVAL CARC, V93, P43
   WOLFF RK, 1987, FUND APPL TOXICOL, V9, P154, DOI 10.1016/0272-0590(87)90162-X
NR 69
TC 12
Z9 12
U1 0
U2 18
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0300-483X
J9 TOXICOLOGY
JI Toxicology
PD DEC 30
PY 2016
VL 374
BP 42
EP 59
DI 10.1016/j.tox.2016.11.013
PG 18
WC Pharmacology & Pharmacy; Toxicology
SC Pharmacology & Pharmacy; Toxicology
GA EG0ST
UT WOS:000390743200005
PM 27876671
OA Other Gold
DA 2019-10-23
ER

PT J
AU Norona, LM
   Nguyen, DG
   Gerber, DA
   Presnell, SC
   LeCluyse, EL
AF Norona, Leah M.
   Nguyen, Deborah G.
   Gerber, David A.
   Presnell, Sharon C.
   LeCluyse, Edward L.
TI Modeling Compound-Induced Fibrogenesis In Vitro Using Three-Dimensional
   Bioprinted Human Liver Tissues
SO TOXICOLOGICAL SCIENCES
LA English
DT Article
DE liver fibrosis in vitro; 3D bioprinted liver; compound-induced liver
   injury
ID HEPATIC STELLATE CELLS; HEPATOCYTE CULTURES; ANIMAL-MODELS; FIBROSIS;
   THIOACETAMIDE; METHOTREXATE; EXPRESSION; INJURY; INFLAMMATION; PSORIASIS
AB Compound-induced liver injury leading to fibrosis remains a challenge for the development of an Adverse Outcome Pathway useful for human risk assessment. Latency to detection and lack of early, systematically detectable biomarkers make it difficult to characterize the dynamic and complex intercellular interactions that occur during progressive liver injury. Here, we demonstrate the utility of bioprinted tissue constructs comprising primary hepatocytes, hepatic stellate cells, and endothelial cells to model methotrexate-and thioacetamide-induced liver injury leading to fibrosis. Repeated, low-concentration exposure to these compounds enabled the detection and differentiation of multiple modes of liver injury, including hepatocellular damage, and progressive fibrogenesis characterized by the deposition and accumulation of fibrillar collagens in patterns analogous to those described in clinical samples obtained from patients with fibrotic liver injury. Transient cytokine production and upregulation of fibrosis-associated genes ACTA2 and COL1A1 mimics hallmark features of a classic wound-healing response. A surge in proinflammatory cytokines (eg, IL-8, IL-1 beta) during the early culture time period is followed by concentration-and treatment-dependent alterations in immunomodulatory and chemotactic cytokines such as IL-13, IL-6, and MCP-1. These combined data provide strong proof-of-concept that 3D bioprinted liver tissues can recapitulate drug-, chemical-, and TGF-beta 1-induced fibrogenesis at the cellular, molecular, and histological levels and underscore the value of the model for further exploration of compound-specific fibrogenic responses. This novel system will enable a more comprehensive characterization of key attributes unique to fibrogenic agents during the onset and progression of liver injury as well as mechanistic insights, thus improving compound risk assessment.
C1 [Norona, Leah M.; LeCluyse, Edward L.] Univ North Carolina Chapel Hill, Curriculum Toxicol, Chapel Hill, NC 27599 USA.
   [Norona, Leah M.] Univ North Carolina Chapel Hill, Eshelman Sch Pharm, Div Pharmacotherapy & Expt Therapeut, Chapel Hill, NC 27599 USA.
   [Norona, Leah M.; LeCluyse, Edward L.] Inst Drug Safety Sci, 6 Davis Dr, Res Triangle Pk, NC 27709 USA.
   [Nguyen, Deborah G.; Presnell, Sharon C.] Organovo Inc, Res & Dev, San Diego, CA 92121 USA.
   [Gerber, David A.] Univ North Carolina Chapel Hill, Dept Surg, Chapel Hill, NC 27599 USA.
RP Norona, LM (reprint author), Inst Drug Safety Sci, 6 Davis Dr, Res Triangle Pk, NC 27709 USA.
EM norona@email.unc.edu
FU National Institutes of Health (NIH), Initiative for Maximizing Student
   Diversity (IMSD) at University of North Carolina at Chapel Hill [R25
   GM055336]; National Institute of Environmental Health Sciences (NIEHS)
   Toxicology Training Grant [T32 ES007126]; Organovo, Inc.
FX This work was supported by the National Institutes of Health (NIH),
   Initiative for Maximizing Student Diversity (IMSD) at University of
   North Carolina at Chapel Hill [R25 GM055336 to L.M.N.], and National
   Institute of Environmental Health Sciences (NIEHS) Toxicology Training
   Grant [T32 ES007126 to L.M.N.], and Organovo, Inc. The content is the
   authors' own and does not reflect the views of the NIH. The research
   described in this article has been reviewed by Organovo, Inc., San
   Diego, and approved for publication. Approval does not signify that the
   contents necessarily reflect the views and policies of the Company, nor
   does the mention of trade names of commercial products constitute
   endorsement or recommendation for use.
CR Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Attallah AM, 2007, J IMMUNOASS IMMUNOCH, V28, P155, DOI 10.1080/15321810701212088
   Baeck C, 2012, GUT, V61, P416, DOI 10.1136/gutjnl-2011-300304
   Barker J, 2011, J EUR ACAD DERMATOL, V25, P758, DOI 10.1111/j.1468-3083.2010.03932.x
   Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282
   BUSSO N, 1990, BIOCHEM BIOPH RES CO, V171, P647, DOI 10.1016/0006-291X(90)91195-X
   Canbay A, 2004, HEPATOLOGY, V39, P273, DOI 10.1002/hep.20051
   Carpino G, 2005, DIGEST LIVER DIS, V37, P349, DOI 10.1016/j.dld.2004.11.009
   Chilakapati J, 2005, DRUG METAB DISPOS, V33, P1877, DOI 10.1124/dmd.105.005520
   CHOI I, 1994, CLIN EXP IMMUNOL, V95, P530
   Czaja AJ, 2014, WORLD J GASTROENTERO, V20, P2515, DOI 10.3748/wjg.v20.i10.2515
   de Bovenkamp MV, 2007, TOXICOL IN VITRO, V21, P545, DOI 10.1016/j.tiv.2006.12.009
   El Taghdouini A, 2015, FIBROGENESIS TISSUE, V8, DOI 10.1186/s13069-015-0031-z
   Ferslew BC, 2014, TOXICOL SCI, V139, P99, DOI 10.1093/toxsci/kfu033
   Fogel-Petrovic M, 2007, INT IMMUNOPHARMACOL, V7, P1924, DOI 10.1016/j.intimp.2007.07.003
   Forgacs G., 2014, US Patent, Patent No. [US 8852932 B2, 5582932]
   Forgacs G., 2012, US patent, Patent No. [US 8,241,905 B2, 8241905]
   Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007
   Gieling RG, 2009, AM J PHYSIOL-GASTR L, V296, pG1324, DOI 10.1152/ajpgi.90564.2008
   GUILLOUZO A, 1993, TOXICOLOGY, V82, P209, DOI 10.1016/0300-483X(93)90065-Z
   Hajovsky H, 2012, CHEM RES TOXICOL, V25, P1955, DOI 10.1021/tx3002719
   Jakab K, 2008, TISSUE ENG PT A, V14, P413, DOI 10.1089/tea.2007.0173
   Ju C, 2005, TOXICOLOGY, V209, P109, DOI 10.1016/j.tox.2004.12.017
   Kisseleva T, 2012, P NATL ACAD SCI USA, V109, P9448, DOI 10.1073/pnas.1201840109
   Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev
   LeCluyse EL, 2012, CRIT REV TOXICOL, V42, P501, DOI 10.3109/10408444.2012.682115
   Leite SB, 2016, BIOMATERIALS, V78, P1, DOI 10.1016/j.biomaterials.2015.11.026
   Lindsay K, 2009, RHEUMATOLOGY, V48, P569, DOI 10.1093/rheumatology/kep023
   Liu Y, 2013, AM J PHYSIOL-GASTR L, V304, pG449, DOI 10.1152/ajpgi.00199.2012
   Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0
   Matsukura S, 2010, CLIN EXP ALLERGY, V40, P763, DOI 10.1111/j.1365-2222.2010.03474.x
   Maybury CM, 2014, BRIT J DERMATOL, V171, P17, DOI 10.1111/bjd.12941
   Motomura Y, 2005, AM J PHYSIOL-GASTR L, V288, pG143, DOI 10.1152/ajpgi.00186.2004
   MULLER A, 1988, EXP PATHOL-JENA, V34, P229
   Murphy K., 2015, US Patetnt, Patent No. [US 20120116568 A1, 20120116568]
   Murphy SV, 2014, NAT BIOTECHNOL, V32, P773, DOI 10.1038/nbt.2958
   Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4
   Nguyen DG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158674
   Osuga T, 2015, INT J CLIN EXP PATHO, V8, P1961
   Pellicoro A, 2014, NAT REV IMMUNOL, V14, P181, DOI 10.1038/nri3623
   Puche JE, 2013, COMPR PHYSIOL, V3, P1473, DOI 10.1002/cphy.c120035
   Qazi BS, 2011, INT J INFLAMM, DOI 10.4061/2011/908468
   ROGIERS V, 1993, TOXICOLOGY, V82, P193, DOI 10.1016/0300-483X(93)02611-J
   SCHMITTGRAFF A, 1991, AM J PATHOL, V138, P1233
   Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089
   Sebastiani G, 2006, WORLD J GASTROENTERO, V12, P3682, DOI 10.3748/wjg.v12.i23.3682
   Shepherd B. R., 2015, US Patent, Patent No. [US9222932, 9222932]
   Shiozawa Kazuko, 2005, Mod Rheumatol, V15, P405, DOI 10.1007/s10165-005-0434-6
   Starkel P, 2011, BEST PRACT RES CL GA, V25, P319, DOI 10.1016/j.bpg.2011.02.004
   Tacke F, 2014, J HEPATOL, V60, P1090, DOI 10.1016/j.jhep.2013.12.025
   Thiele G. M., 2015, CURR MOL PHARM
   Veidal SS, 2011, FIBROGENESIS TISSUE, V4, DOI 10.1186/1755-1536-4-22
   Westra IM, 2016, TOXICOL IN VITRO, V35, P77, DOI 10.1016/j.tiv.2016.05.012
NR 53
TC 28
Z9 30
U1 0
U2 10
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1096-6080
EI 1096-0929
J9 TOXICOL SCI
JI Toxicol. Sci.
PD DEC
PY 2016
VL 154
IS 2
BP 354
EP 367
DI 10.1093/toxsci/kfw169
PG 14
WC Toxicology
SC Toxicology
GA EJ5VJ
UT WOS:000393286500017
PM 27605418
OA Green Published
DA 2019-10-23
ER

PT J
AU Wolters, JEJ
   van Herwijnen, MHM
   Theunissen, DHJ
   Jennen, DGJ
   Van den Hof, WFPM
   de Kok, TMCM
   Schaap, FG
   van Breda, SGJ
   Kleinjans, JCS
AF Wolters, Jarno E. J.
   van Herwijnen, Marcel H. M.
   Theunissen, Daniel H. J.
   Jennen, Danyel G. J.
   Van den Hof, Wim F. P. M.
   de Kok, Theo M. C. M.
   Schaap, Frank G.
   van Breda, Simone G. J.
   Kleinjans, Jos C. S.
TI Integrative "-Omics" Analysis in Primary Human Hepatocytes Unravels
   Persistent Mechanisms of Cyclosporine A-Induced Cholestasis
SO CHEMICAL RESEARCH IN TOXICOLOGY
LA English
DT Article
ID GENE-EXPRESSION ANALYSIS; SALT EXPORT PUMP; BILE-ACIDS; IN-VITRO;
   INDUCED HEPATOTOXICITY; CANALICULAR MEMBRANE; ADAPTIVE RESPONSE; NUCLEAR
   RECEPTORS; LIVER-DISEASE; RAT-LIVER
AB Cyclosporine A (CsA) is an undecapeptide with strong immunosuppressant activities and is used a lot after organ transplantation. Furthermore, it may induce cholestasis in the liver. In general, the drug-induced cholestasis (DIC) pathway includes genes involved in the uptake, synthesis, conjugation, and secretion of bile acids. However, whether CsA-induced changes in the cholestasis pathway in vitro are persistent for repeated dose toxicity has not yet been investigated. To explore this, primary human hepatocytes (PHH) were exposed to a subcytotoxic dose of 30 itM CsA daily for 3 and 5 days. To investigate the persistence of induced changes upon terminating CsA exposure after 5 days, a subset of PHH was subjected to a washout period (WO-period) of 3 days. Multiple-omics analyses, comprising whole genome analysis of DNA methylation, gene expression, and microRNA expression, were performed. The CsA-treatment resulted after 3 and 5 days, respectively, in 476 and 20 differentially methylated genes (DMGs), 1353 and 1481 differentially expressed genes (DEGs), and in 22 and 29 differentially expressed microRNAs (DE-miRs). Cholestasis-related pathways appeared induced during CsA-treatment. Interestingly, 828 persistent DEGs and 6 persistent DE-miRs but no persistent DMGs were found after the WO-period. These persistent DEGs and DE-miRs showed concordance for 22 genes. Furthermore, 29 persistent DEGs changed into the same direction as observed in livers from cholestasis patients. None of those 29 DEGs which among others relate to oxidative stress and lipid metabolism are yet present in the DIC pathway or cholestasis adverse outcome pathway (AOP) thus presenting novel findings. In summary, we have demonstrated for the first time a persistent impact of repeated dose administration of CsA on genes and microRNAs related to DIC in the gold standard human liver in vitro model with PHH.
C1 [Wolters, Jarno E. J.; van Herwijnen, Marcel H. M.; Theunissen, Daniel H. J.; Jennen, Danyel G. J.; Van den Hof, Wim F. P. M.; de Kok, Theo M. C. M.; van Breda, Simone G. J.; Kleinjans, Jos C. S.] Maastricht Univ, Dept Toxicogen, GROW Sch Oncol & Dev Biol, POB 616, NL-6200 MD Maastricht, Netherlands.
   [Schaap, Frank G.] Maastricht Univ, Dept Surg, NL-6200 MD Maastricht, Netherlands.
RP Wolters, JEJ (reprint author), Maastricht Univ, Dept Toxicogen, GROW Sch Oncol & Dev Biol, POB 616, NL-6200 MD Maastricht, Netherlands.
EM j.wolters@maastrichtuniversity.nl
FU FP7 project DETECTIVE [266838]
FX This work was supported by the FP7 project DETECTIVE [grant number
   266838].
CR [Anonymous], 1990, IARC Monogr Eval Carcinog Risks Hum, V50, P77
   Bjornsson E, 2005, HEPATOLOGY, V42, P481, DOI 10.1002/hep.20800
   BOHME M, 1993, FEBS LETT, V333, P193, DOI 10.1016/0014-5793(93)80403-H
   BOHME M, 1994, GASTROENTEROLOGY, V107, P255
   Cheng F, 2011, J THEOR BIOL, V290, P27, DOI 10.1016/j.jtbi.2011.08.009
   Coonen MLJ, 2015, SOURCE CODE BIOL MED, V10, DOI 10.1186/s13029-015-0035-5
   Cui YX, 2010, PHARMACOGENOMICS, V11, P573, DOI [10.2217/pgs.10.37, 10.2217/PGS.10.37]
   Deferme L, 2016, CHEM RES TOXICOL, V29, P1428, DOI 10.1021/acs.chemrestox.6b00090
   Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207
   Eijssen LMT, 2013, NUCLEIC ACIDS RES, V41, pW71, DOI 10.1093/nar/gkt293
   Fischer S, 1996, CLIN CHIM ACTA, V251, P173, DOI 10.1016/0009-8981(96)06305-X
   Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405
   Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80
   Hsu SD, 2011, NUCLEIC ACIDS RES, V39, pD163, DOI 10.1093/nar/gkq1107
   Huang WD, 2003, P NATL ACAD SCI USA, V100, P4156, DOI 10.1073/pnas.0630614100
   Hung CC, 2008, PHARMACOGENET GENOM, V18, P390, DOI 10.1097/FPC.0b013e3282f85e36
   Jennen DGJ, 2010, TOXICOL SCI, V115, P66, DOI 10.1093/toxsci/kfq026
   Jennings P, 2009, TOXICOL IN VITRO, V23, P486, DOI 10.1016/j.tiv.2008.12.023
   KADMON M, 1993, GASTROENTEROLOGY, V104, P1507, DOI 10.1016/0016-5085(93)90363-H
   Kamburov A, 2011, NUCLEIC ACIDS RES, V39, pD712, DOI 10.1093/nar/gkq1156
   Kienhuis AS, 2013, TOXICOL LETT, V221, P225, DOI 10.1016/j.toxlet.2013.06.236
   Kis E, 2012, TOXICOL IN VITRO, V26, P1294, DOI 10.1016/j.tiv.2011.11.002
   Kock K, 2014, DRUG METAB DISPOS, V42, P665, DOI 10.1124/dmd.113.054304
   Lee WM, 2003, NEW ENGL J MED, V349, P474, DOI 10.1056/NEJMra021844
   Limonciel A, 2015, TOXICOL IN VITRO, V30, P7, DOI 10.1016/j.tiv.2014.12.011
   Magkoufopoulou C, 2011, MUTAGENESIS, V26, P593, DOI 10.1093/mutage/ger021
   Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362
   MOSELEY RH, 1990, J PHARMACOL EXP THER, V253, P974
   O'Connell S, 2012, TOXICOL SCI, V126, P101, DOI 10.1093/toxsci/kfr330
   Oorts M, 2016, TOXICOL IN VITRO, V34, P179, DOI 10.1016/j.tiv.2016.03.008
   Padda MS, 2011, HEPATOLOGY, V53, P1377, DOI 10.1002/hep.24229
   Pentchev K, 2010, BIOINFORMATICS, V26, P2796, DOI 10.1093/bioinformatics/btq522
   Perez MJ, 2009, WORLD J GASTROENTERO, V15, P1677, DOI 10.3748/wjg.15.1677
   Rieswijk L, 2016, TOXICOLOGY, V350, P31, DOI 10.1016/j.tox.2016.05.002
   ROMAN ID, 1994, BIOCHEM PHARMACOL, V48, P2181, DOI 10.1016/0006-2952(94)90352-2
   ROMAN ID, 1990, HEPATOLOGY, V12, P83, DOI 10.1002/hep.1840120114
   Roman ID, 2003, TOXICOL SCI, V71, P276, DOI 10.1093/toxsci/71.2.276
   Romiti N, 2002, TOXICOL APPL PHARM, V183, P83, DOI 10.1006/taap.2002.9461
   Schaap FG, 2014, NAT REV GASTRO HEPAT, V11, P55, DOI 10.1038/nrgastro.2013.151
   Schaap FG, 2009, HEPATOLOGY, V49, P1228, DOI 10.1002/hep.22771
   Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23
   van Breda SGJ, 2015, ARCH TOXICOL, V89, P1959, DOI 10.1007/s00204-014-1351-2
   Van den Hof WFPM, 2015, TOXICOL IN VITRO, V29, P489, DOI 10.1016/j.tiv.2014.12.016
   Vinken M, 2013, TOXICOL SCI, V136, P97, DOI 10.1093/toxsci/kft177
   Wagner M, 2010, SEMIN LIVER DIS, V30, P160, DOI 10.1055/s-0030-1253225
   Wenniger LMD, 2010, DIGEST LIVER DIS, V42, P409, DOI 10.1016/j.dld.2010.03.015
   Xie W, 2001, P NATL ACAD SCI USA, V98, P3375, DOI 10.1073/pnas.051014398
   Xu J, 2011, BIOCHEM BIOPH RES CO, V408, P363, DOI 10.1016/j.bbrc.2011.02.039
   Yamazaki M, 2005, XENOBIOTICA, V35, P737, DOI 10.1080/00498250500136676
   Yasumiba S, 2001, BIOCHEM J, V354, P591, DOI 10.1042/0264-6021:3540591
   Young MD, 2011, NUCLEIC ACIDS RES, V39, P7415, DOI 10.1093/nar/gkr416
   Yuryev A, 2009, EXPERT OPIN DRUG DIS, V4, P1307, DOI 10.1517/17460440903413488
   Zollner G, 2006, MOL PHARMACEUT, V3, P231, DOI 10.1021/mp060010s
NR 53
TC 5
Z9 5
U1 0
U2 3
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0893-228X
EI 1520-5010
J9 CHEM RES TOXICOL
JI Chem. Res. Toxicol.
PD DEC
PY 2016
VL 29
IS 12
BP 2164
EP 2174
DI 10.1021/acs.chemrestox.6b00337
PG 11
WC Chemistry, Medicinal; Chemistry, Multidisciplinary; Toxicology
SC Pharmacology & Pharmacy; Chemistry; Toxicology
GA EF4KR
UT WOS:000390294700022
PM 27989131
DA 2019-10-23
ER

PT J
AU Aigner, A
   Buesen, R
   Gant, T
   Gooderham, N
   Greim, H
   Hackermuller, J
   Hubesch, B
   Laffont, M
   Marczylo, E
   Meister, G
   Petrick, JS
   Rasoulpour, RJ
   Sauer, UG
   Schmidt, K
   Seitz, H
   Slack, F
   Sukata, T
   van der Vies, SM
   Verhaert, J
   Witwer, KW
   Poole, A
AF Aigner, Achim
   Buesen, Roland
   Gant, Tim
   Gooderham, Nigel
   Greim, Helmut
   Hackermuller, Jorg
   Hubesch, Bruno
   Laffont, Madeleine
   Marczylo, Emma
   Meister, Gunter
   Petrick, Jay S.
   Rasoulpour, Reza J.
   Sauer, Ursula G.
   Schmidt, Kerstin
   Seitz, Herve
   Slack, Frank
   Sukata, Tokuo
   van der Vies, Saskia M.
   Verhaert, Jan
   Witwer, Kenneth W.
   Poole, Alan
TI Advancing the use of noncoding RNA in regulatory toxicology: Report of
   an ECETOC workshop
SO REGULATORY TOXICOLOGY AND PHARMACOLOGY
LA English
DT Article
DE Noncoding RNA (ncRNA); Regulatory toxicology; Biomarker; Gene
   expression; Phenotypic consequence; Adverse-outcome-pathway
ID HEAT-SHOCK RESPONSE; MICRORNA PROFILES; EXPRESSION PROFILES; DNA
   METHYLATION; GENE-EXPRESSION; PLANT MIRNAS; IN-VITRO; CANCER; LONG;
   PATHWAYS
AB The European Centre for the Ecotoxicology and Toxicology of Chemicals (ECETOC) organised a workshop to discuss the state-of-the-art research on noncoding RNAs (ncRNAs) as biomarkers in regulatory toxicology and as analytical and therapeutic agents. There was agreement that ncRNA expression profiling data requires careful evaluation to determine the utility of specific ncRNAs as biomarkers. To advance the use of ncRNA in regulatory toxicology, the following research priorities were identified: (1) Conduct comprehensive literature reviews to identify possibly suitable ncRNAs and areas of toxicology where ncRNA expression profiling could address prevailing scientific deficiencies. (2) Develop consensus on how to conduct ncRNA expression profiling in a toxicological context. (3) Conduct experimental projects, including, e.g., rat (90-day) oral toxicity studies, to evaluate the toxicological relevance of the expression profiles of selected ncRNAs. Thereby, physiological ncRNA expression profiles should be established, including the biological variability of healthy individuals. To substantiate the relevance of key ncRNAs for cell homeostasis or pathogenesis, molecular events should be dose -dependently linked with substance induced apical effects. Applying a holistic approach, knowledge on ncRNAs, 'omics and epigenetics technologies should be integrated into adverse outcome pathways to improve the understanding of the functional roles of ncRNAs within a regulatory context. Crown Copyright (C) 2016 Published by Elsevier Inc.
C1 [Aigner, Achim] Univ Leipzig, Clin Pharmacol, Rudolf Boehm Inst Pharmacol & Toxicol, D-04107 Leipzig, Germany.
   [Buesen, Roland] BASF SE, D-67056 Ludwigshafen, Germany.
   [Gant, Tim; Marczylo, Emma] Publ Hlth England, Ctr Radiat Chem & Environm Hazards, Harwell Campus, Chilton OX11 0RQ, Oxon, England.
   [Gooderham, Nigel] Imperial Coll London, Dept Surg & Canc, Computat & Syst Med, London SW7 2AZ, England.
   [Greim, Helmut] Tech Univ Munich, D-85354 Freising Weihenstephan, Germany.
   [Hackermuller, Jorg] UFZ Helmholtz Ctr Environm Res, Dept Mol Syst Biol, Young Investigators Grp Bioinformat & Transcript, D-04318 Leipzig, Germany.
   [Hubesch, Bruno] European Chem Council Cefic Long Range Res Initia, B-1160 Brussels, Belgium.
   [Hubesch, Bruno] Hubesch Consult BVBA, B-1600 Sint Pieters Leeuw, Belgium.
   [Laffont, Madeleine; Poole, Alan] European Ctr Ecotoxicol & Toxicol Chem ECETOC, B-1160 Brussels, Belgium.
   [Meister, Gunter] Univ Regensburg, Biochem Ctr Regensburg, D-93053 Regensburg, Germany.
   [Petrick, Jay S.] Monsanto Co, St Louis, MO 63167 USA.
   [Rasoulpour, Reza J.] Dow AgroSci, Indianapolis, IN 46268 USA.
   [Sauer, Ursula G.] Sci Consultancy, Anim Welf, D-85579 Neubiberg, Germany.
   [Schmidt, Kerstin] BioMath GmbH, D-18055 Rostock, Germany.
   [Seitz, Herve] CNRS, IGH, F-34396 Montpellier 5, France.
   [Slack, Frank] Harvard Med Sch, BIDMC Canc Ctr, Beth Israel Deaconess Med Ctr, Dept Pathol,Inst RNA Med, Boston, MA 02215 USA.
   [Sukata, Tokuo] Sumitomo Chem Europe, B-1830 Machelen, Belgium.
   [van der Vies, Saskia M.] Vrije Univ Amsterdam Med Ctr, Neurosci Amsterdam, NL-1081 HV Amsterdam, Netherlands.
   [Verhaert, Jan] Monsanto Co, B-1150 Brussels, Belgium.
   [Witwer, Kenneth W.] Johns Hopkins Univ, Sch Med, Baltimore, MD 21205 USA.
RP Poole, A (reprint author), ECETOC AISBL, Ave Edmond Van Nieuwenhuyse 2,Bte 8, B-1160 Brussels, Belgium.
EM alan.poole@ecetoc.org
RI Witwer, Kenneth W./G-1626-2013; Hackermuller, Jorg/F-2494-2016
OI Witwer, Kenneth W./0000-0003-1664-4233; Hackermuller,
   Jorg/0000-0003-4920-7072; Seitz, Herve/0000-0001-8172-5393
FU European Centre for Ecotoxicology and Toxicology of Chemicals (ECETOC);
   Long-range Research Initiative of the European Chemical Industry Council
   (Cefic)
FX The workshop was co-sponsored by the European Centre for Ecotoxicology
   and Toxicology of Chemicals (ECETOC) and the Long-range Research
   Initiative of the European Chemical Industry Council (Cefic). We are
   indebted to Christine and Sofia Yannakas (ECETOC) for their support in
   organising and holding the workshop.
CR Adams BD, 2016, CANCER RES, V76, P927, DOI 10.1158/0008-5472.CAN-15-2321
   Akinjo O.O., 2016, TOXICOL RES
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Arrigo P, 2015, BIOMED RES INT, DOI 10.1155/2015/761703
   Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242
   Baier SR, 2014, J NUTR, V144, P1495, DOI 10.3945/jn.114.196436
   Baker M, 2010, NAT METHODS, V7, P687, DOI 10.1038/nmeth0910-687
   Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002
   Bauer T, 2016, MOL SYST BIOL, V12, DOI 10.15252/msb.20156520
   Bhan A, 2014, J STEROID BIOCHEM, V141, P160, DOI 10.1016/j.jsbmb.2014.02.002
   Boll K, 2013, ONCOGENE, V32, P277, DOI 10.1038/onc.2012.55
   Brocke-Heidrich K, 2004, BLOOD, V103, P242, DOI 10.1182/blood-2003-04-1048
   Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997
   Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282
   Chiang VSC, 2014, CELL BIOL INT, V38, P1345, DOI 10.1002/cbin.10346
   Chin LJ, 2008, CELL RES, V18, P983, DOI 10.1038/cr.2008.290
   Croce CM, 2010, NAT BIOTECHNOL, V28, P931, DOI 10.1038/nbt0910-931
   Dai X, 2015, ADV DRUG DELIVER REV, V81, P184, DOI 10.1016/j.addr.2014.09.010
   Della Vedova CB, 2005, GENETICS, V170, P1989, DOI 10.1534/genetics.105.043406
   Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111
   Dickinson B, 2013, NAT BIOTECHNOL, V31, P965, DOI 10.1038/nbt.2737
   Dueck A, 2014, BIOL CHEM, V395, P611, DOI 10.1515/hsz-2014-0116
   Ebert MS, 2010, CURR BIOL, V20, pR858, DOI 10.1016/j.cub.2010.08.052
   Fabbri M, 2007, P NATL ACAD SCI USA, V104, P15805, DOI 10.1073/pnas.0707628104
   Floris I, 2015, ARTERIOSCL THROM VAS, V35, P664, DOI 10.1161/ATVBAHA.114.304730
   Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108
   Frizzi A, 2014, J AGR FOOD CHEM, V62, P12067, DOI 10.1021/jf503756v
   Gant T. W., 2015, PREDICTIVE TOXICOLOG
   Gapp K, 2014, NAT NEUROSCI, V17, P667, DOI 10.1038/nn.3695
   Gooderham NJ, 2014, TOXICOL LETT, V228, P127, DOI 10.1016/j.toxlet.2014.04.015
   Greathouse KL, 2012, MOL CANCER RES, V10, P546, DOI 10.1158/1541-7786.MCR-11-0605
   Grunweller A, 2016, PHARMAZIE, V71, P8, DOI 10.1691/ph.2016.5738
   Gupta S, 2014, NATURE, V512, P101, DOI 10.1038/nature13382
   Hackermuller J, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r48
   Hannon GJ, 2004, NATURE, V431, P371, DOI 10.1038/nature02870
   He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552
   Hentze MW, 2013, EMBO J, V32, P923, DOI 10.1038/emboj.2013.53
   Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936
   Ivashuta SI, 2009, FOOD CHEM TOXICOL, V47, P353, DOI 10.1016/j.fct.2008.11.025
   Jain K, 2014, CELL STRESS CHAPERON, V19, P801, DOI 10.1007/s12192-014-0504-9
   Jensen Peter D, 2013, GM Crops Food, V4, P90, DOI 10.4161/gmcr.25285
   Johnson CD, 2007, CANCER RES, V67, P7713, DOI 10.1158/0008-5472.CAN-07-1083
   Jonas S, 2015, NAT REV GENET, V16, P421, DOI 10.1038/nrg3965
   Jose AM, 2015, GENESIS, V53, P395, DOI 10.1002/dvg.22871
   Juliano R, 2009, MOL PHARMACEUT, V6, P686, DOI 10.1021/mp900093r
   Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341
   Kasinski AL, 2011, NAT REV CANCER, V11, P849, DOI 10.1038/nrc3166
   Kato M, 2009, ONCOGENE, V28, P2419, DOI 10.1038/onc.2009.106
   Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644
   Klase Z, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-63
   Koseki M, 2005, PLANT CELL PHYSIOL, V46, P1879, DOI 10.1093/pcp/pci192
   Koufaris C, 2013, TOXICOLOGY, V314, P247, DOI 10.1016/j.tox.2013.10.004
   Koufaris C, 2013, TOXICOL SCI, V131, P337, DOI 10.1093/toxsci/kfs302
   Koufaris C, 2012, TOXICOL SCI, V128, P532, DOI 10.1093/toxsci/kfs170
   Kowalski MP, 2015, INT J BIOCHEM CELL B, V66, P20, DOI [10.1016/j.bioce1.2015.07.003, 10.1016/j.biocel.2015.07.003]
   Kuramochi-Miyagawa S, 2008, GENE DEV, V22, P908, DOI 10.1101/gad.1640708
   Lam JKW, 2015, MOL THER-NUCL ACIDS, V4, DOI 10.1038/mtna.2015.23
   Laterza OF, 2009, CLIN CHEM, V55, P1977, DOI [10.1373/clinchem.2009.131737, 10.1373/clinchem.2009.131797]
   Lawrie CH, 2008, BRIT J HAEMATOL, V141, P672, DOI 10.1111/j.1365-2141.2008.07077.x
   Lin SB, 2014, NAT CELL BIOL, V16, P129, DOI 10.1038/ncb2914
   Ling H, 2013, NAT REV DRUG DISCOV, V12, P847, DOI 10.1038/nrd4140
   Liu WM, 2012, P NATL ACAD SCI USA, V109, P490, DOI 10.1073/pnas.1110368109
   Loffler D, 2007, BLOOD, V110, P1330, DOI 10.1182/blood-2007-03-081133
   Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702
   Lundin KE, 2015, HUM GENE THER, V26, P475, DOI 10.1089/hum.2015.070
   Marczylo E. L, 2016, CRIT REV TOXICOL
   Marczylo EL, 2012, EPIGENETICS-US, V7, P432, DOI 10.4161/epi.19794
   Martens-Uzunova ES, 2013, CANCER LETT, V340, P201, DOI 10.1016/j.canlet.2012.11.058
   Meister G, 2013, NAT REV GENET, V14, P447, DOI 10.1038/nrg3462
   Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105
   Mlotshwa S, 2015, CELL RES, V25, P521, DOI 10.1038/cr.2015.25
   Moazed D, 2009, NATURE, V457, P413, DOI 10.1038/nature07756
   O'Neill MJ, 2011, DRUG DISCOV TODAY, V16, P203, DOI 10.1016/j.drudis.2011.01.003
   OECD, 2012, APP 1 COLL WORK DEF
   Tosar JP, 2015, NUCLEIC ACIDS RES, V43, P5601, DOI 10.1093/nar/gkv432
   Petrick JS, 2015, REGUL TOXICOL PHARM, V71, P8, DOI 10.1016/j.yrtph.2014.10.016
   Petrick JS, 2013, REGUL TOXICOL PHARM, V66, P167, DOI 10.1016/j.yrtph.2013.03.008
   Pritchard CC, 2012, NAT REV GENET, V13, P358, DOI 10.1038/nrg3198
   Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902
   Rodgers AB, 2015, P NATL ACAD SCI USA, V112, P13699, DOI 10.1073/pnas.1508347112
   Rodgers AB, 2013, J NEUROSCI, V33, P9003, DOI 10.1523/JNEUROSCI.0914-13.2013
   Russell WMS, 1959, PRINCIPLES HUMANE EX
   Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014
   Schmidt K, 2016, ARCH TOXICOL, V90, P731, DOI 10.1007/s00204-015-1487-8
   Schraivogel D, 2014, TRENDS BIOCHEM SCI, V39, P420, DOI 10.1016/j.tibs.2014.07.004
   Schramedei K, 2011, ONCOGENE, V30, P2975, DOI 10.1038/onc.2011.15
   Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228
   Singh MS, 2016, CURR OPIN BIOTECH, V39, P28, DOI 10.1016/j.copbio.2015.12.011
   Snow JW, 2013, RNA BIOL, V10, P1107, DOI 10.4161/rna.24909
   Stadler PF, 2009, MOL BIOL EVOL, V26, P1975, DOI 10.1093/molbev/msp112
   Stowe HM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113163
   Tonge DP, 2016, BMC MOL BIOL, V17, DOI 10.1186/s12867-016-0057-9
   Trerotola M, 2015, HUM GENOMICS, V9, DOI 10.1186/s40246-015-0041-3
   Tuteja JH, 2004, PLANT CELL, V16, P819, DOI 10.1105/tpc.021352
   van Dongen HM, 2016, MICROBIOL MOL BIOL R, V80, P369, DOI 10.1128/MMBR.00063-15
   Wagschal A, 2012, CELL, V150, P1147, DOI 10.1016/j.cell.2012.08.004
   Ward J, 2012, WORLD J GASTROENTERO, V18, P2798, DOI 10.3748/wjg.v18.i22.2798
   Watanabe T, 2008, NATURE, V453, P539, DOI 10.1038/nature06908
   Watanabe T, 2006, GENE DEV, V20, P1732, DOI 10.1101/gad.1425706
   Watanabe T, 2011, SCIENCE, V332, P848, DOI 10.1126/science.1203919
   Weber JA, 2010, CLIN CHEM, V56, P1733, DOI 10.1373/clinchem.2010.147405
   Wheeler DS, 2007, FREE RADICAL BIO MED, V42, P1, DOI 10.1016/j.freeradbiomed.2006.08.028
   Williams Z, 2015, CELL REP, V13, P854, DOI 10.1016/j.celrep.2015.09.030
   Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228
   Wittrup A, 2015, NAT BIOTECHNOL, V33, P870, DOI 10.1038/nbt.3298
   Witwer KW, 2015, J NUTR BIOCHEM, V26, P1685, DOI 10.1016/j.jnutbio.2015.09.004
   Witwer KW, 2014, BIOESSAYS, V36, P394, DOI 10.1002/bies.201300150
   Witwer KW, 2013, RNA BIOL, V10, P1080, DOI 10.4161/rna.25246
   Wong RLY, 2015, EPIGENETICS-US, V10, P127, DOI 10.1080/15592294.2015.1009768
   Wright Mathew W., 2011, Human Genomics, V5, P90
   Zhang P, 2015, CELL RES, V25, P193, DOI [10.1038/cr.2015.4, 10.1038/cr.2015.14]
NR 111
TC 5
Z9 5
U1 0
U2 4
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0273-2300
EI 1096-0295
J9 REGUL TOXICOL PHARM
JI Regul. Toxicol. Pharmacol.
PD DEC
PY 2016
VL 82
BP 127
EP 139
DI 10.1016/j.yrtph.2016.09.018
PG 13
WC Medicine, Legal; Pharmacology & Pharmacy; Toxicology
SC Legal Medicine; Pharmacology & Pharmacy; Toxicology
GA EE6PU
UT WOS:000389735500012
PM 27663666
DA 2019-10-23
ER

PT J
AU Patlewicz, G
   Casati, S
   Basketter, DA
   Asturiol, D
   Roberts, DW
   Lepoittevin, JP
   Worth, AP
   Aschberger, K
AF Patlewicz, Grace
   Casati, Silvia
   Basketter, David A.
   Asturiol, David
   Roberts, David W.
   Lepoittevin, Jean-Pierre
   Worth, Andrew P.
   Aschberger, Karin
TI Can currently available non-animal methods detect pre and pro-haptens
   relevant for skin sensitization?
SO REGULATORY TOXICOLOGY AND PHARMACOLOGY
LA English
DT Article
DE Adverse Outcome Pathway; Skin sensitization; Pre-hapten; Pro-hapten;
   DPRA; h-CLAT; KeratinoSens (TM); Reaction mechanistic domain
ID APPLICABILITY DOMAIN CLASSIFICATION; SCREENING CONTACT ALLERGENS;
   ADVERSE OUTCOME PATHWAYS; LYMPH-NODE ASSAY; IN-VITRO; PEPTIDE
   REACTIVITY; AIR EXPOSURE; TIMES-SS; ACTIVATION; METABOLISM
AB Predictive testing to characterize substances for their skin sensitization potential has historically been based on animal tests such as the Local Lymph Node Assay (LLNA). In recent years, regulations in the cosmetics and chemicals sectors have provided strong impetus to develop non-animal alternatives. Three test methods have undergone OECD validation: the direct peptide reactivity assay (DPRA), the KeratinoSens (TM) and the human Cell Line Activation Test (h-CLAT). Whilst these methods perform relatively well in predicting LLNA results, a concern raised is their ability to predict chemicals that need activation to be sensitizing (pre- or pro-haptens). This current study reviewed an EURL ECVAM dataset of 127 substances for which information was available in the LLNA and three non-animal test methods. Twenty eight of the sensitizers needed to be activated, with the majority being pre-haptens. These were correctly identified by 1 or more of the test methods. Six substances were categorized exclusively as pro-haptens, but were correctly identified by at least one of the cell-based assays. The analysis here showed that skin metabolism was not likely to be a major consideration for assessing sensitization potential and that sensitizers requiring activation could be identified correctly using one or more of the current non-animal methods. Published by Elsevier Inc.
C1 [Patlewicz, Grace] US EPA, Natl Ctr Computat Toxicol, Res Triangle Pk, NC 27711 USA.
   [Casati, Silvia; Asturiol, David; Worth, Andrew P.; Aschberger, Karin] European Commiss, Joint Res Ctr, Directorate Hlth Consumers & Reference Mat F, Chem Safety & Alternat Methods Unit, Ispra, VA, Italy.
   [Basketter, David A.] DABMEB Consultancy Ltd, Sharnbrook, Beds, England.
   [Roberts, David W.] Liverpool John Moores Univ, Sch Pharm & Biomol Sci, Liverpool, Merseyside, England.
   [Lepoittevin, Jean-Pierre] CNRS UMR 7177, Inst Chem, Strasbourg, France.
   [Lepoittevin, Jean-Pierre] Univ Strasbourg, Strasbourg, France.
RP Patlewicz, G (reprint author), US EPA, Off Res & Dev, Natl Ctr Computat Toxicol, Res Triangle Pk, NC 27709 USA.
EM patlewicz.grace@epa.gov
RI Worth, Andrew/R-8495-2019; Worth, Andrew Paul/O-3055-2019
OI Worth, Andrew Paul/0000-0002-5303-0452; Patlewicz,
   Grace/0000-0003-3863-9689
CR Adler S, 2011, ARCH TOXICOL, V85, P367, DOI 10.1007/s00204-011-0693-2
   [Anonymous], 2015, 442C OECD
   Aptula AO, 2005, CHEM RES TOXICOL, V18, P1420, DOI 10.1021/tx050075m
   Ashikaga T, 2006, TOXICOL IN VITRO, V20, P767, DOI 10.1016/j.tiv.2005.10.012
   Asturiol D., 2016, TOXICOL IN VITRO
   Basketter D, 2015, REGUL TOXICOL PHARM, V73, P660, DOI 10.1016/j.yrtph.2015.10.005
   Basketter DA, 2014, DERMATITIS, V25, P11, DOI 10.1097/DER.0000000000000003
   Bergstrom MA, 2006, CHEM RES TOXICOL, V19, P760, DOI 10.1021/tx060006n
   Casati S., 2016, 27752 EUR EN
   Dimitrov SD, 2005, INT J TOXICOL, V24, P189, DOI 10.1080/10915810591000631
   EC EURL ECVAM, 2013, REC DIR PEPT REACT A
   EC EURL ECVAM, 2015, REC HUM CELL LIN ACT
   EC EURL-ECVAM, 2014, REC KERATINOSENSTM A, P42
   ECHA, 2016, GUID INF REQ CHEM SA
   Edwards SW, 2016, J PHARMACOL EXP THER, V356, P170, DOI 10.1124/jpet.115.228239
   Emter R, 2010, TOXICOL APPL PHARM, V245, P281, DOI 10.1016/j.taap.2010.03.009
   FOUSSEREAU J, 1983, CONTACT DERMATITIS, V9, P233, DOI 10.1111/j.1600-0536.1983.tb04373.x
   Gerberick GF, 2007, TOXICOL SCI, V97, P417, DOI 10.1093/toxsci/kfm064
   Gerberick GF, 2005, DERMATITIS, V16, P157, DOI 10.2310/6620.2005.05040
   Gerberick GF, 2004, TOXICOL SCI, V81, P332, DOI 10.1093/toxsci/kfh213
   Goebel C, 2012, REGUL TOXICOL PHARM, V63, P40, DOI 10.1016/j.yrtph.2012.02.007
   Hagvall L, 2007, CHEM RES TOXICOL, V20, P807, DOI 10.1021/tx700017v
   Hagvall L, 2008, TOXICOL APPL PHARM, V233, P308, DOI 10.1016/j.taap.2008.08.014
   Karlberg AT, 2008, CHEM RES TOXICOL, V21, P53, DOI 10.1021/tx7002239
   Karlberg AT, 2013, CONTACT DERMATITIS, V69, P323, DOI 10.1111/cod.12127
   Kern PS, 2010, DERMATITIS, V21, P8, DOI 10.2310/6620.2009.09038
   Kleinstreuer NC, 2016, REGUL TOXICOL PHARM, V76, P39, DOI 10.1016/j.yrtph.2016.01.007
   Lepoittevin JP, 2006, CONTACT DERMATITIS, V54, P73, DOI 10.1111/j.0105-1873.2006.00795.x
   Moss E, 2016, CHEM RES TOXICOL, V29, P1172, DOI 10.1021/acs.chemrestox.6b00148
   Natsch A, 2008, TOXICOL SCI, V102, P110, DOI 10.1093/toxsci/kfm259
   OECD, 2012, SER TEST ASS, V168
   OECD, 2015, 442D OECD
   Patlewicz G, 2014, SAR QSAR ENVIRON RES, V25, P367, DOI 10.1080/1062936X.2014.900520
   Patlewicz G, 2008, CHEM RES TOXICOL, V21, P521, DOI 10.1021/tx700338q
   Patlewicz G, 2007, REGUL TOXICOL PHARM, V48, P225, DOI 10.1016/j.yrtph.2007.03.003
   Roberts DW, 2008, J APPL TOXICOL, V28, P377, DOI 10.1002/jat.1289
   Roberts DW, 2007, CHEM RES TOXICOL, V20, P1019, DOI 10.1021/tx700024w
   Roberts DW, 2007, CHEM RES TOXICOL, V20, P44, DOI 10.1021/tx060121y
   Rudback J, 2012, CHEM RES TOXICOL, V25, P713, DOI 10.1021/tx200486f
   SMITH CK, 2001, ALLERGIC CONTACT DER
   The National Academies of Sciences Engineering and Medicine, 2015, APPL MOD TOX APPR PR
   Urbisch D, 2016, CHEM RES TOXICOL, V29, P901, DOI 10.1021/acs.chemrestox.6b00055
   Wiegand C, 2014, SKIN PHARMACOL PHYS, V27, P263, DOI 10.1159/000358272
   Zuang V., 2015, 27474 EUR EN
NR 44
TC 17
Z9 17
U1 0
U2 18
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0273-2300
EI 1096-0295
J9 REGUL TOXICOL PHARM
JI Regul. Toxicol. Pharmacol.
PD DEC
PY 2016
VL 82
BP 147
EP 155
DI 10.1016/j.yrtph.2016.08.007
PG 9
WC Medicine, Legal; Pharmacology & Pharmacy; Toxicology
SC Legal Medicine; Pharmacology & Pharmacy; Toxicology
GA EE6PU
UT WOS:000389735500014
PM 27569201
DA 2019-10-23
ER

PT J
AU Feswick, A
   Loughery, JR
   Isaacs, MA
   Munkittrick, KR
   Martyniuk, CJ
AF Feswick, April
   Loughery, Jennifer R.
   Isaacs, Meghan A.
   Munkittrick, Kelly R.
   Martyniuk, Christopher J.
TI Molecular initiating events of the intersex phenotype: Low-dose exposure
   to 17 alpha-ethinylestradiol rapidly regulates molecular networks
   associated with gonad differentiation in the adult fathead minnow testis
SO AQUATIC TOXICOLOGY
LA English
DT Article
DE Subnetwork enrichment analysis; Sperm maturation; Adverse outcome
   pathway; Doublesex and mab-3 related transcription; factor 1; Forkhead
   box L2
ID DARTER ETHEOSTOMA-CAERULEUM; MEDAKA ORYZIAS-LATIPES; MUNICIPAL
   WASTE-WATER; ZEBRAFISH DANIO-RERIO; GENE-EXPRESSION PROFILES; GRAND
   RIVER-BASIN; ENDOCRINE DISRUPTION; PIMEPHALES-PROMELAS; REPRODUCTIVE
   SUCCESS; LUTEINIZING-HORMONE
AB Intersex, or the presence of oocytes in the testes, has been documented in fish following exposure to wastewater effluent and estrogenic compounds. However, the molecular networks underlying the inter sex condition are not completely known. To address this, we exposed male fathead minnows to a low, environmentally-relevant concentration of 17alpha-ethinylestradiol (EE2) (15 ng/L) and measured the transcriptome response in the testis after 96 h to identify early molecular initiating events that may proceed the intersex condition. The short-term exposure to EE2 did not affect gonadosomatic index and proportion of gametes within the testes. However, the production of 11-ketotestosterone and testosterone from the testis in vitro was decreased relative to controls. Expression profiling using a 8 x 60 K fathead minnow microarray identified 10 transcripts that were differentially expressed in the testes, the most dramatic change being that of coagulation factor XIII A chain (20-fold increase). Transcripts that included guanine nucleotide binding protein (Beta Polypeptide 2), peroxisome proliferator-activated receptor delta, and WNK lysine deficient protein kinase la, were down-regulated by EE2. Subnetwork enrichment analysis revealed that EE2 suppressed transcriptional networks associated with steroid metabolism, hormone biosynthesis, and sperm mobility. Most interesting was that gene networks associated with doublesex and mab-3 related transcription factor 1 (dmrt1) were suppressed in the adult testis, despite the fact that dmrt1 itself was not different in expression from control males. Transcriptional networks involving forkhead box L2 (foxl2) (transcript involved in ovarian follicle development) were increased in expression in the testis. Noteworthy was that a gene network associated to granulosa cell development was increased over 100%, suggesting that this transcriptome network may be important for monitoring estrogenic exposures. Other cell processes rapidly downregulated by EE2 at the transcript level included glucose homeostasis, response to heavy metal, amino acid catabolism, and the cyclooxygenase pathway. Conversely, lymphocyte chemotaxis, intermediate filament polymerization, glucocorticoid metabolism, carbohydrate utilization, and anterior/posterior axis specification were increased. These data provide new insight into the transcriptional responses that are perturbed prior to gonadal remodeling and intersex following exposure to estrogens. These data demonstrate that low concentrations of EE2 (1) rapidly suppresses male hormone production, (2) down-regulate molecular networks related to male sex differentiation, and (3) induce transcriptional networks related to granulosa cell development in the adult testis. These responses are hypothesized to be key molecular initiating events that occur prior to the development of the intersex phenotype following estrogenic exposures. (C) 2016 Elsevier B.V. All rights reserved.
C1 Univ New Brunswick, Canadian Rivers Inst, St John, NB E2L 4L5, Canada.
   Univ New Brunswick, Dept Biol, St John, NB E2L 4L5, Canada.
   [Martyniuk, Christopher J.] Univ Florida, Coll Vet Med, Ctr Environm & Human Toxicol, Gainesville, FL 32611 USA.
   [Martyniuk, Christopher J.] Univ Florida, Coll Vet Med, Dept Physiol Sci, UF Genet Inst, Gainesville, FL 32611 USA.
RP Martyniuk, CJ (reprint author), Ctr Environm & Human Toxicol, Box 110885,471 Mowry Dr, Gainesville, FL 32611 USA.; Martyniuk, CJ (reprint author), Univ Florida, Coll Vet Med, Ctr Environm & Human Toxicol, Gainesville, FL 32611 USA.; Martyniuk, CJ (reprint author), Univ Florida, Coll Vet Med, Dept Physiol Sci, UF Genet Inst, Gainesville, FL 32611 USA.
EM cmartyni@yahoo.ca
RI Munkittrick, Kelly/AAB-8929-2019
FU NSERCNatural Sciences and Engineering Research Council of Canada
   [386275-2010]; New Brunswick Innovation Foundation Research Initiative
   graduate student grant
FX NSERC Grant Application 386275-2010 to CJM, New Brunswick Innovation
   Foundation Research Initiative graduate student grant to CJM, and a
   Canada Research Chair to CJM and KRM.
CR Akingbemi BT, 2004, ENDOCRINOLOGY, V145, P592, DOI 10.1210/en.2003-1174
   Ankley GT, 2008, AQUAT TOXICOL, V88, P69, DOI 10.1016/j.aquatox.2008.03.005
   Atanassova N, 2005, REPRODUCTION, V129, P589, DOI 10.1530/rep.1.00546
   Bahamonde PA, 2015, AQUAT TOXICOL, V159, P290, DOI 10.1016/j.aquatox.2014.11.023
   Bahamonde PA, 2015, AQUAT TOXICOL, V159, P302, DOI 10.1016/j.aquatox.2014.11.022
   Bahamonde PA, 2013, GEN COMP ENDOCR, V192, P25, DOI 10.1016/j.ygcen.2013.04.005
   Balch GC, 2004, ENVIRON TOXICOL CHEM, V23, P782, DOI 10.1897/02-539
   Baron D, 2004, J MOL ENDOCRINOL, V33, P705, DOI 10.1677/jme.1.01566
   Caspillo NR, 2014, COMP BIOCHEM PHYS C, V164, P35, DOI 10.1016/j.cbpc.2014.04.003
   Ciparis S, 2012, SCI TOTAL ENVIRON, V414, P268, DOI 10.1016/j.scitotenv.2011.10.017
   Colli-Dula RC, 2014, AQUAT TOXICOL, V156, P148, DOI 10.1016/j.aquatox.2014.08.008
   Dammann AA, 2011, AQUAT TOXICOL, V105, P559, DOI 10.1016/j.aquatox.2011.08.011
   Depiereux S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098531
   Fenske M, 2005, ENVIRON TOXICOL CHEM, V24, P1088, DOI 10.1897/04-096R1.1
   Feswick A, 2014, GEN COMP ENDOCR, V203, P106, DOI 10.1016/j.ygcen.2014.01.003
   Filby AL, 2007, AQUAT TOXICOL, V81, P219, DOI 10.1016/j.aquatox.2006.12.003
   Filby AL, 2006, J MOL ENDOCRINOL, V37, P121, DOI 10.1677/jme.1.01997
   Flores-Valverde AM, 2010, ENVIRON SCI TECHNOL, V44, P3552, DOI 10.1021/es9039049
   French VA, 2015, SCI TOTAL ENVIRON, V536, P639, DOI 10.1016/j.scitotenv.2015.07.114
   Fuzzen MLM, 2015, AQUAT TOXICOL, V160, P106, DOI 10.1016/j.aquatox.2015.01.009
   Garcia-Reyero N, 2014, ENVIRON SCI TECHNOL, V48, P4546, DOI 10.1021/es4042258
   Garcia-Reyero N, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-308
   Gorelick DA, 2014, ENVIRON HEALTH PERSP, V122, P356, DOI 10.1289/ehp.1307329
   Hamid H, 2012, WATER RES, V46, P5813, DOI 10.1016/j.watres.2012.08.002
   Hirakawa I, 2012, CHEMOSPHERE, V87, P668, DOI 10.1016/j.chemosphere.2011.12.047
   Hoffmann JL, 2006, AQUAT TOXICOL, V79, P233, DOI 10.1016/j.aquatox.2006.06.009
   Hogan NS, 2010, AQUAT TOXICOL, V98, P148, DOI 10.1016/j.aquatox.2010.02.002
   Iwanowicz LR, 2016, ECOTOX ENVIRON SAFE, V124, P50, DOI 10.1016/j.ecoenv.2015.09.035
   Jobling S, 2006, ENVIRON HEALTH PERSP, V114, P32, DOI 10.1289/ehp.8050
   Katsu Y, 2007, ENVIRON SCI TECHNOL, V41, P3368, DOI 10.1021/es062797l
   Kidd KA, 2007, P NATL ACAD SCI USA, V104, P8897, DOI 10.1073/pnas.0609568104
   Kloas W, 2009, ANN NY ACAD SCI, V1163, P187, DOI 10.1111/j.1749-6632.2009.04453.x
   Lange R, 2001, ENVIRON TOXICOL CHEM, V20, P1216, DOI 10.1002/etc.5620200610
   Langlois VS, 2013, MECH DEVELOP, V130, P304, DOI 10.1016/j.mod.2012.12.002
   Martyniuk CJ, 2006, PHYSIOL GENOMICS, V27, P328, DOI 10.1152/physiolgenomics.00090.2006
   Martyniuk CJ, 2010, AQUAT TOXICOL, V98, P344, DOI 10.1016/j.aquatox.2010.03.007
   Masuyama H, 2012, CHROMOSOME RES, V20, P163, DOI 10.1007/s10577-011-9264-x
   Mathews E, 2009, TOXICOL SCI, V112, P331, DOI 10.1093/toxsci/kfp207
   Matson CK, 2011, NATURE, V476, P101, DOI 10.1038/nature10239
   MCMASTER ME, 1992, CAN TECH REPT FISH A, V1836, P29
   Mehinto AC, 2015, WATER RES, V83, P303, DOI 10.1016/j.watres.2015.06.050
   Miller HD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052479
   Minkina A, 2014, DEV CELL, V29, P511, DOI 10.1016/j.devcel.2014.04.017
   Nash JP, 2004, ENVIRON HEALTH PERSP, V112, P1725, DOI 10.1289/ehp.7209
   Nikitin A, 2003, BIOINFORMATICS, V19, P2155, DOI 10.1093/bioinformatics/btg290
   Nozu R, 2015, SEX DEV, V9, P118, DOI 10.1159/000373902
   Ornostay A, 2016, GEN COMP ENDOCR, V225, P23, DOI 10.1016/j.ygcen.2015.09.005
   Oropesa AL, 2014, ENVIRON TOXICOL, V29, P1182, DOI 10.1002/tox.21850
   Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45
   Pradhan A, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.119016
   Prokkola JM, 2016, ECOTOX ENVIRON SAFE, V124, P96, DOI 10.1016/j.ecoenv.2015.09.039
   Qin F, 2013, COMP BIOCHEM PHYS C, V157, P192, DOI 10.1016/j.cbpc.2012.11.002
   Salian S, 2009, TOXICOLOGY, V265, P56, DOI 10.1016/j.tox.2009.09.012
   Salierno JD, 2009, ENVIRON TOXICOL CHEM, V28, P953, DOI 10.1897/08-111.1
   Santos EM, 2007, AQUAT TOXICOL, V83, P134, DOI 10.1016/j.aquatox.2007.03.019
   Schulz RW, 2007, ENVIRON SCI TECHNOL, V41, P6305, DOI 10.1021/es070785+
   Shen ZG, 2014, GENET SEL EVOL, V46, DOI 10.1186/1297-9686-46-26
   Tetreault GR, 2011, AQUAT TOXICOL, V104, P278, DOI 10.1016/j.aquatox.2011.05.008
   Uhlenhaut NH, 2009, CELL, V139, P1130, DOI 10.1016/j.cell.2009.11.021
   Urbatzka R, 2006, GEN COMP ENDOCR, V146, P119, DOI 10.1016/j.ygcen.2005.10.005
   Vajda AM, 2011, AQUAT TOXICOL, V103, P213, DOI 10.1016/j.aquatox.2011.02.007
   Vrooman LA, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004949
   Wang DS, 2007, MOL ENDOCRINOL, V21, P712, DOI 10.1210/me.2006-0248
   Weber LP, 2004, ENVIRON TOXICOL CHEM, V23, P792, DOI 10.1897/02-570
   Xu H, 2008, AQUAT TOXICOL, V88, P1, DOI 10.1016/j.aquatox.2008.01.020
   Zhao YB, 2014, ENVIRON SCI TECHNOL, V48, P2413, DOI 10.1021/es4052796
NR 66
TC 8
Z9 8
U1 2
U2 37
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-445X
EI 1879-1514
J9 AQUAT TOXICOL
JI Aquat. Toxicol.
PD DEC
PY 2016
VL 181
BP 46
EP 56
DI 10.1016/j.aquatox.2016.10.021
PG 11
WC Marine & Freshwater Biology; Toxicology
SC Marine & Freshwater Biology; Toxicology
GA ED8EN
UT WOS:000389104900006
PM 27810492
DA 2019-10-23
ER

PT J
AU Ezendam, J
   Braakhuis, HM
   Vandebriel, RJ
AF Ezendam, Janine
   Braakhuis, Hedwig M.
   Vandebriel, Rob J.
TI State of the art in non-animal approaches for skin sensitization
   testing: from individual test methods towards testing strategies
SO ARCHIVES OF TOXICOLOGY
LA English
DT Review
DE Skin sensitization; Alternatives to animal testing; Testing strategies;
   Hazard assessment; Adverse outcome pathway
ID LINE ACTIVATION TEST; ADVERSE OUTCOME PATHWAY; TEST H-CLAT;
   INTER-LABORATORY REPRODUCIBILITY; ALLERGIC CONTACT-DERMATITIS; EPIDERMAL
   EQUIVALENT ASSAY; LYMPH-NODE ASSAY; IN-VITRO ASSAYS; QUANTITATIVE
   RISK-ASSESSMENT; PEPTIDE REACTIVITY ASSAY
AB The hazard assessment of skin sensitizers relies mainly on animal testing, but much progress is made in the development, validation and regulatory acceptance and implementation of non-animal predictive approaches. In this review, we provide an update on the available computational tools and animal-free test methods for the prediction of skin sensitization hazard. These individual test methods address mostly one mechanistic step of the process of skin sensitization induction. The adverse outcome pathway (AOP) for skin sensitization describes the key events (KEs) that lead to skin sensitization. In our review, we have clustered the available test methods according to the KE they inform: the molecular initiating event (MIE/KE1)-protein binding, KE2-keratinocyte activation, KE3-dendritic cell activation and KE4-T cell activation and proliferation. In recent years, most progress has been made in the development and validation of in vitro assays that address KE2 and KE3. No standardized in vitro assays for T cell activation are available; thus, KE4 cannot be measured in vitro. Three non-animal test methods, addressing either the MIE, KE2 or KE3, are accepted as OECD test guidelines, and this has accelerated the development of integrated or defined approaches for testing and assessment (e.g. testing strategies). The majority of these approaches are mechanism-based, since they combine results from multiple test methods and/or computational tools that address different KEs of the AOP to estimate skin sensitization potential and sometimes potency. Other approaches are based on statistical tools. Until now, eleven different testing strategies have been published, the majority using the same individual information sources. Our review shows that some of the defined approaches to testing and assessment are able to accurately predict skin sensitization hazard, sometimes even more accurate than the currently used animal test. A few defined approaches are developed to provide an estimate of the potency sub-category of a skin sensitizer as well, but these approaches need further independent evaluation with a new dataset of chemicals. To conclude, this update shows that the field of non-animal approaches for skin sensitization has evolved greatly in recent years and that it is possible to predict skin sensitization hazard without animal testing.
C1 [Ezendam, Janine; Braakhuis, Hedwig M.; Vandebriel, Rob J.] Natl Inst Publ Hlth & Environm RIVM, Ctr Hlth Protect, Dept Innovat Testing Strategies, POB 1, NL-3720 BA Bilthoven, Netherlands.
RP Ezendam, J (reprint author), Natl Inst Publ Hlth & Environm RIVM, Ctr Hlth Protect, Dept Innovat Testing Strategies, POB 1, NL-3720 BA Bilthoven, Netherlands.
EM Janine.Ezendam@rivm.nl
RI Vandebriel, Rob/P-6769-2019
OI Vandebriel, Rob/0000-0001-9140-952X
FU ZonMwNetherlands Organization for Health Research and Development
   [114022001]; Dutch Ministries of Economic Affairs and of Health, Welfare
   and Sports
FX We highly appreciate the critical comments and suggestions of Prof. Dr.
   Aldert Piersma of the RIVM. This review was written within the context
   of a research project funded by ZonMw (Grant No. 114022001; Systems
   toxicology supported data infrastructure for human risk assessment). In
   addition, the Dutch Ministries of Economic Affairs and of Health,
   Welfare and Sports are acknowledged for supporting this work.
CR Adler S, 2011, ARCH TOXICOL, V85, P367, DOI 10.1007/s00204-011-0693-2
   Albrekt AS, 2014, BMC PHARMACOL TOXICO, V15, DOI 10.1186/2050-6511-15-5
   Alepee N, 2015, TOXICOL IN VITRO, V30, P373, DOI 10.1016/j.tiv.2015.09.028
   Alves VM, 2015, TOXICOL APPL PHARM, V284, P273, DOI 10.1016/j.taap.2014.12.013
   Api AM, 2008, REGUL TOXICOL PHARM, V52, P3, DOI 10.1016/j.yrtph.2007.10.008
   Aptula AO, 2006, CHEM RES TOXICOL, V19, P1097, DOI 10.1021/tx0601004
   Ashikaga T, 2010, ATLA-ALTERN LAB ANIM, V38, P275, DOI 10.1177/026119291003800403
   Avonto C, 2015, TOXICOL APPL PHARM, V289, P177, DOI 10.1016/j.taap.2015.09.027
   BARRATT MD, 1994, TOXICOL IN VITRO, V8, P837, DOI 10.1016/0887-2333(94)90081-7
   BARRATT MD, 1994, TOXICOL IN VITRO, V8, P1053, DOI 10.1016/0887-2333(94)90244-5
   Basketter DA, 2005, CONTACT DERMATITIS, V52, P39, DOI 10.1111/j.0105-1873.2005.00490.x
   Basketter D, 2007, ATLA-ALTERN LAB ANIM, V35, P137, DOI 10.1177/026119290703500124
   Basketter D, 2015, REGUL TOXICOL PHARM, V73, P660, DOI 10.1016/j.yrtph.2015.10.005
   Bauch C, 2012, REGUL TOXICOL PHARM, V63, P489, DOI 10.1016/j.yrtph.2012.05.013
   Bauch C, 2011, TOXICOL IN VITRO, V25, P1162, DOI 10.1016/j.tiv.2011.05.030
   Casati S, 2005, ATLA-ALTERN LAB ANIM, V33, P47, DOI 10.1177/026119290503300108
   Chaudhry Q, 2010, CHEM CENT J, V4, DOI 10.1186/1752-153X-4-S1-S5
   Coleman KP, 2015, APPL IN VITRO TOXICO, V1, P13
   Corsini E, 2013, TOXICOL IN VITRO, V27, P1127, DOI 10.1016/j.tiv.2012.05.018
   Corsini E, 2009, TOXICOL IN VITRO, V23, P789, DOI 10.1016/j.tiv.2009.04.005
   Cottrez F, 2016, TOXICOL IN VITRO, V32, P248, DOI 10.1016/j.tiv.2016.01.007
   Cottrez F, 2015, TOXICOL IN VITRO, V29, P787, DOI 10.1016/j.tiv.2015.02.012
   Dancik Y, 2013, ADV DRUG DELIVER REV, V65, P221, DOI 10.1016/j.addr.2012.01.006
   Davies M, 2011, TOXICOL SCI, V119, P308, DOI 10.1093/toxsci/kfq326
   Dietz L, 2013, TOXICOL IN VITRO, V27, P1157, DOI 10.1016/j.tiv.2012.08.013
   Dimitrov SD, 2005, INT J TOXICOL, V24, P189, DOI 10.1080/10915810591000631
   dos Santos GG, 2009, TOXICOL APPL PHARM, V236, P372, DOI 10.1016/j.taap.2009.02.004
   dos Santos GG, 2011, TOXICOL IN VITRO, V25, P347, DOI 10.1016/j.tiv.2010.10.008
   Dumont C., 2015, APPL IN VITRO TOXICO, V1, P147, DOI DOI 10.1089/AIVT.2015.0003
   Dumont C, 2016, TOXICOL IN VITRO, V34, P220, DOI 10.1016/j.tiv.2016.04.008
   Enoch SJ, 2008, SAR QSAR ENVIRON RES, V19, P555, DOI 10.1080/10629360802348985
   Enslein K, 1997, FOOD CHEM TOXICOL, V35, P1091, DOI 10.1016/S0278-6915(97)87277-8
   EURL ECVAM, 2015, EURL ECVAM REC HUM C
   EURL-ECVAM, 2015, EURL ECVAM STAT REP
   EURL-ECVAM, 2013, EURL ECVAM REC DIR P
   EURL-ECVAM, 2014, EURL ECVAM REC KER A
   Frombach J, 2017, ARCH TOXICOL, V91, P339, DOI 10.1007/s00204-016-1722-y
   Galbiati V, 2011, TOXICOL IN VITRO, V25, P724, DOI 10.1016/j.tiv.2010.12.011
   Gealy R, 1996, HUM EXP TOXICOL, V15, P489, DOI 10.1177/096032719601500605
   Gerberick GF, 2007, TOXICOL SCI, V97, P417, DOI 10.1093/toxsci/kfm064
   Gerberick GF, 2009, TOXICOL SCI, V112, P164, DOI 10.1093/toxsci/kfp192
   Gerberick GF, 2004, TOXICOL SCI, V81, P332, DOI 10.1093/toxsci/kfh213
   Gibbs S, 2013, TOXICOL APPL PHARM, V272, P529, DOI 10.1016/j.taap.2013.07.003
   Griem P, 2003, REGUL TOXICOL PHARM, V38, P269, DOI 10.1016/j.yrtph.2003.07.001
   Hartung T, 2013, ALTEX-ALTERN ANIM EX, V30, P3, DOI 10.14573/altex.2013.1.003
   Hirota M, 2009, J TOXICOL SCI, V34, P139, DOI 10.2131/jts.34.139
   Hoffmann S, 2015, ALTEX-ALTERN ANIM EX, V32, P379, DOI [http://dx.doi.org/10.14573/altex.1505051, 10.14573/altex.1505051]
   Hooyberghs J, 2008, TOXICOL APPL PHARM, V231, P103, DOI 10.1016/j.taap.2008.03.014
   Ibrahim R, 2012, J PHARM SCI-US, V101, P2094, DOI 10.1002/jps.23106
   Jaworska J, 2013, J APPL TOXICOL, V33, P1353, DOI 10.1002/jat.2869
   Jaworska J, 2011, ALTEX-ALTERN ANIM EX, V28, P211, DOI 10.14573/altex.2011.3.211
   Jaworska Joanna, 2010, ALTEX, V27, P231
   Jaworska JS, 2015, ARCH TOXICOL, V89, P2355, DOI 10.1007/s00204-015-1634-2
   Johansson H, 2014, TOXICOL SCI, V139, P362, DOI 10.1093/toxsci/kfu046
   Johansson H, 2013, TOXICOL IN VITRO, V27, P1163, DOI 10.1016/j.tiv.2012.05.019
   Johansson H, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-399
   Johnson R, 1997, ENVIRON HEALTH PERSP, V105, P986
   Kagatani S, 2010, J INVEST DERMATOL, V130, P175, DOI 10.1038/jid.2009.229
   Karlberg AT, 2008, CHEM RES TOXICOL, V21, P53, DOI 10.1021/tx7002239
   Kimber I, 2011, TOXICOL SCI, V120, pS238, DOI 10.1093/toxsci/kfq346
   Klopman G, 2005, PREDICTIVE TOXICOLOGY, P423
   Lambrechts N, 2011, TOXICOL LETT, V203, P106, DOI 10.1016/j.toxlet.2011.02.015
   Lambrechts N, 2010, TOXICOL SCI, V116, P122, DOI 10.1093/toxsci/kfq108
   Lambrechts N, 2010, TOXICOL LETT, V196, P95, DOI 10.1016/j.toxlet.2010.04.003
   Langton K, 2006, CONTACT DERMATITIS, V55, P342, DOI 10.1111/j.1600-0536.2006.00969.x
   Luechtefeld T, 2015, J APPL TOXICOL, V35, P1361, DOI 10.1002/jat.3172
   MacKay C, 2013, ALTEX-ALTERN ANIM EX, V30, P473, DOI 10.14573/altex.2013.4.473
   Macmillan DS, 2016, REGUL TOXICOL PHARM, V76, P30, DOI 10.1016/j.yrtph.2016.01.009
   Martin SF, 2011, ALLERGY, V66, P1152, DOI 10.1111/j.1398-9995.2011.02652.x
   Martin SF, 2010, CELL MOL LIFE SCI, V67, P4171, DOI 10.1007/s00018-010-0495-3
   Maxwell G, 2014, TOXICOL IN VITRO, V28, P8, DOI 10.1016/j.tiv.2013.10.013
   McKim JM, 2012, CUTAN OCUL TOXICOL, V31, P292, DOI 10.3109/15569527.2012.667031
   McKim JM, 2010, CUTAN OCUL TOXICOL, V29, P171, DOI 10.3109/15569527.2010.483869
   Mitragotri S, 2011, INT J PHARMACEUT, V418, P115, DOI 10.1016/j.ijpharm.2011.02.023
   Natsch A, 2008, TOXICOL SCI, V106, P464, DOI 10.1093/toxsci/kfn194
   Natsch A, 2015, TOXICOL SCI, V143, P319, DOI 10.1093/toxsci/kfu229
   Natsch A, 2013, J APPL TOXICOL, V33, P1337, DOI 10.1002/jat.2868
   Natsch A, 2011, TOXICOL IN VITRO, V25, P733, DOI 10.1016/j.tiv.2010.12.014
   Natsch A, 2010, TOXICOL SCI, V113, P284, DOI 10.1093/toxsci/kfp228
   Nukada Y, 2013, TOXICOL IN VITRO, V27, P609, DOI 10.1016/j.tiv.2012.11.006
   Nukada Y, 2011, CONTACT DERMATITIS, V65, P343, DOI 10.1111/j.1600-0536.2011.01952.x
   OECD, 2012, ADV OUTC PATHW SKI 1, V168, P1
   OECD, 2015, OECD GUID TEST CHEM
   OECD, 1992, OECD GUID TEST CHEM
   OECD, 2014, GUID GROUP CHEM
   OECD, 2016, SER TEST ASS
   OECD, 2016, OECD GUID TEST CHEM
   OECD, 2007, GUID GROUP CHEM OECD
   Organisation for Economic Cooperation and Development (OECD), 2010, OECD GUID TEST CHEM
   Organization for Economic Co-operation and Development (OECD), 2010, GUID TEST CHEM
   Patlewicz G, 2014, REGUL TOXICOL PHARM, V69, P529, DOI 10.1016/j.yrtph.2014.06.001
   Pendlington RU, 2008, CUTAN OCUL TOXICOL, V27, P283, DOI 10.1080/15569520802327005
   Piroird C, 2015, TOXICOL IN VITRO, V29, P901, DOI 10.1016/j.tiv.2015.03.009
   Pirone JR, 2014, ALTEX-ALTERN ANIM EX, V31, P336, DOI http://dx.doi.org/10.14573/altex.1310151
   Publishing O, 2008, SER TEST ASS NO 88, V88
   Ramirez T, 2016, TOXICOL IN VITRO, V32, P278, DOI 10.1016/j.tiv.2016.01.004
   Ramirez T, 2014, TOXICOL IN VITRO, V28, P1482, DOI 10.1016/j.tiv.2014.08.002
   Reuter H, 2015, TOXICOL IN VITRO, V29, P976, DOI 10.1016/j.tiv.2015.03.021
   Richter A, 2013, TOXICOL IN VITRO, V27, P1180, DOI 10.1016/j.tiv.2012.08.007
   Roberts DW, 2008, J APPL TOXICOL, V28, P443, DOI 10.1002/jat.1293
   Rorije E, 2013, REGUL TOXICOL PHARM, V67, P146, DOI 10.1016/j.yrtph.2013.06.003
   Rovida C, 2015, ALTEX-ALTERN ANIM EX, V32, P25, DOI [http://dx.doi.org/10.14573/altex.1411011, 10.14573/altex.1506201]
   Saito K, 2013, TOXICOL IN VITRO, V27, P2213, DOI 10.1016/j.tiv.2013.08.007
   Sakaguchi H, 2006, TOXICOL IN VITRO, V20, P774, DOI 10.1016/j.tiv.2005.10.014
   Sakaguchi H, 2010, TOXICOL IN VITRO, V24, P1810, DOI 10.1016/j.tiv.2010.05.012
   Schneider K, 2004, REGUL TOXICOL PHARM, V39, P245, DOI 10.1016/j.yrtph.2004.02.002
   Schreiner M, 2007, ALLERGY, V62, P1419, DOI 10.1111/j.1398-9995.2007.01511.x
   Sonnenburg A, 2015, ARCH TOXICOL, V89, P2339, DOI 10.1007/s00204-014-1406-4
   Strickland J, 2016, J APPL TOXICOL, V36, P1150, DOI 10.1002/jat.3281
   Suzuki M, 2009, TOXICOL IN VITRO, V23, P687, DOI 10.1016/j.tiv.2009.02.002
   Takahashi T, 2011, TOXICOL SCI, V124, P359, DOI 10.1093/toxsci/kfr237
   Takenouchi O, 2015, J APPL TOXICOL, V35, P1318, DOI 10.1002/jat.3127
   Takenouchi O, 2013, J TOXICOL SCI, V38, P599, DOI 10.2131/jts.38.599
   Teubner W, 2013, REGUL TOXICOL PHARM, V67, P468, DOI 10.1016/j.yrtph.2013.09.007
   Teunis M, 2013, TOXICOL IN VITRO, V27, P1135, DOI 10.1016/j.tiv.2012.06.004
   Tollefsen KE, 2014, REGUL TOXICOL PHARM, V70, P629, DOI 10.1016/j.yrtph.2014.09.009
   Tsujita-Inoue K, 2014, TOXICOL IN VITRO, V28, P626, DOI 10.1016/j.tiv.2014.01.003
   Urbisch D, 2015, REGUL TOXICOL PHARM, V71, P337, DOI 10.1016/j.yrtph.2014.12.008
   van der Veen JW, 2014, CRIT REV TOXICOL, V44, P590, DOI 10.3109/10408444.2014.925425
   van der Veen JW, 2014, REGUL TOXICOL PHARM, V69, P371, DOI 10.1016/j.yrtph.2014.04.018
   van der Veen JW, 2013, TOXICOL IN VITRO, V27, P314, DOI 10.1016/j.tiv.2012.08.023
   Van der Veen JW, 2011, CONTACT DERMATITIS
   Van Och FMM, 2005, TOXICOLOGY, V210, P95, DOI 10.1016/j.tox.2005.01.004
   Vandebriel RJ, 2010, CRIT REV TOXICOL, V40, P389, DOI 10.3109/10408440903524262
   Vocanson M, 2014, T LYMPHOCYTES TOOLS
   Yamamoto Y, 2015, J APPL TOXICOL, V35, P1348, DOI 10.1002/jat.3139
NR 126
TC 37
Z9 39
U1 1
U2 14
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0340-5761
EI 1432-0738
J9 ARCH TOXICOL
JI Arch. Toxicol.
PD DEC
PY 2016
VL 90
IS 12
BP 2861
EP 2883
DI 10.1007/s00204-016-1842-4
PG 23
WC Toxicology
SC Toxicology
GA EB9FH
UT WOS:000387697600002
PM 27629427
DA 2019-10-23
ER

PT J
AU Dilger, M
   Orasche, J
   Zimmermann, R
   Paur, HR
   Diabate, S
   Weiss, C
AF Dilger, Marco
   Orasche, Juergen
   Zimmermann, Ralf
   Paur, Hanns-Rudolf
   Diabate, Silvia
   Weiss, Carsten
TI Toxicity of wood smoke particles in human A549 lung epithelial cells:
   the role of PAHs, soot and zinc
SO ARCHIVES OF TOXICOLOGY
LA English
DT Article
DE Wood smoke; Particulate matter; Lung epithelial cells; Polycyclic
   aromatic hydrocarbons; Soot; Metals
ID IN-VITRO EXPOSURE; METAL-OXIDE NANOPARTICLES; OXYGEN SPECIES FORMATION;
   PARTICULATE MATTER; OXIDATIVE STRESS; INFLAMMATORY RESPONSE; COMBUSTION
   CONDITIONS; SILICA NANOPARTICLES; SOURCE APPORTIONMENT; BIOMASS
   COMBUSTION
AB Indoor air pollution is associated with increased morbidity and mortality. Specifically, the health impact of emissions from domestic burning of biomass and coal is most relevant and is estimated to contribute to over 4 million premature deaths per year worldwide. Wood is the main fuel source for biomass combustion and the shift towards renewable energy sources will further increase emissions from wood combustion even in developed countries. However, little is known about the constituents of wood smoke and biological mechanisms that are responsible for adverse health effects. We exposed A549 lung epithelial cells to collected wood smoke particles and found an increase in cellular reactive oxygen species as well as a response to bioavailable polycyclic aromatic hydrocarbons. In contrast, cell vitality and regulation of the pro-inflammatory cytokine interleukin-8 were not affected. Using a candidate approach, we could recapitulate WSP toxicity by the combined actions of its constituents soot, metals and PAHs. The soot fraction and metals were found to be the most important factors for ROS formation, whereas the PAH response can be mimicked by the model PAH benzo[a]pyrene. Strikingly, PAHs adsorbed to WSPs were even more potent in activating target gene expression than B[a]P individually applied in suspension. As PAHs initiate multiple adverse outcome pathways and are prominent carcinogens, their role as key pollutants in wood smoke and its health effects warrants further investigation. The presented results suggest that each of the investigated constituents soot, metals and PAHs are major contributors to WSP toxicity. Mitigation strategies to prevent adverse health effects of wood combustion should therefore not only aim at reducing the emitted soot and PAHs but also the metal content, through the use of more efficient combustion appliances, and particle precipitation techniques, respectively.
C1 [Dilger, Marco; Diabate, Silvia; Weiss, Carsten] Karlsruhe Inst Technol, Inst Toxicol & Genet, Campus North,Hermann von Helmholtz Pl 1, D-76344 Eggenstein Leopoldshafen, Germany.
   [Orasche, Juergen; Zimmermann, Ralf] Helmholtz Zentrum Munchen, Joint Mass Spectrometry Ctr, Comprehens Mol Analyt, Ingolstadter Landstr 1, D-85764 Neuherberg, Germany.
   [Zimmermann, Ralf] Univ Rostock, Inst Chem, Joint Mass Spectrometry Ctr, Chair Analyt Chem, Dr Lorenz Weg 1, D-18051 Rostock, Germany.
   [Paur, Hanns-Rudolf] Karlsruhe Inst Technol, Inst Tech Chem, Campus North,Hermann von Helmholtz Pl 1, D-76344 Eggenstein Leopoldshafen, Germany.
RP Weiss, C (reprint author), Karlsruhe Inst Technol, Inst Toxicol & Genet, Campus North,Hermann von Helmholtz Pl 1, D-76344 Eggenstein Leopoldshafen, Germany.
EM carsten.weiss@kit.edu
RI Weiss, Carsten/I-1811-2013; Paur, Hanns-Rudolf/H-1340-2013
OI Paur, Hanns-Rudolf/0000-0001-5133-9459; Weiss,
   Carsten/0000-0002-5380-3208; Dilger, Marco/0000-0002-9038-3863
CR Aam BB, 2007, ARCH TOXICOL, V81, P441, DOI 10.1007/s00204-006-0164-3
   Baird WM, 2005, ENVIRON MOL MUTAGEN, V45, P106, DOI 10.1002/em.20095
   Belis CA, 2013, ATMOS ENVIRON, V69, P94, DOI 10.1016/j.atmosenv.2012.11.009
   Beyersmann D, 2008, ARCH TOXICOL, V82, P493, DOI 10.1007/s00204-008-0313-y
   BImSch G, 2014, BUND IMM BIMSCHG
   Bolling AK, 2012, PART FIBRE TOXICOL, V9, DOI 10.1186/1743-8977-9-45
   Bologa A., 2011, INT J PLASMA ENV SCI, V5, P168
   Bonjour S, 2013, ENVIRON HEALTH PERSP, V121, P784, DOI 10.1289/ehp.1205987
   Bonlokke JH, 2014, J OCCUP ENVIRON MED, V56, P177, DOI 10.1097/JOM.0000000000000067
   Borm PJA, 2005, TOXICOL APPL PHARM, V205, P157, DOI 10.1016/j.taap.2004.10.020
   Briede JJ, 2004, FREE RADICAL RES, V38, P995, DOI 10.1080/10715760400000976
   Cassee FR, 2013, INHAL TOXICOL, V25, P802, DOI 10.3109/08958378.2013.850127
   Choi AMK, 1996, AM J RESP CELL MOL, V15, P9, DOI 10.1165/ajrcmb.15.1.8679227
   Chuang HC, 2011, SCI TOTAL ENVIRON, V409, P4781, DOI 10.1016/j.scitotenv.2011.07.041
   Corsini E, 2013, ARCH TOXICOL, V87, P2187, DOI 10.1007/s00204-013-1071-z
   Danielsen PH, 2011, CHEM RES TOXICOL, V24, P168, DOI 10.1021/tx100407m
   Deschamps E, 2014, ENVIRON GEOCHEM HLTH, V36, P225, DOI 10.1007/s10653-013-9560-9
   Diabate S, 2011, ANAL BIOANAL CHEM, V401, P3197, DOI 10.1007/s00216-011-5102-4
   DOCKERY DW, 1994, ANNU REV PUBL HEALTH, V15, P107, DOI 10.1146/annurev.pu.15.050194.000543
   Donauer J, 2012, ARCH TOXICOL, V86, P329, DOI 10.1007/s00204-011-0757-3
   Eichbaum K, 2014, SCI TOTAL ENVIRON, V487, P37, DOI 10.1016/j.scitotenv.2014.03.057
   Ezzati M, 2000, ENVIRON HEALTH PERSP, V108, P833, DOI 10.2307/3434990
   Forchhammer L, 2012, PART FIBRE TOXICOL, V9, DOI 10.1186/1743-8977-9-7
   Fritsch-Decker S, 2011, PART FIBRE TOXICOL, V8, DOI 10.1186/1743-8977-8-23
   Fukano Y, 2006, EXP TOXICOL PATHOL, V57, P411, DOI 10.1016/j.etp.2005.12.001
   Garza KM, 2008, INT J NANOMED, V3, P83
   Gauggel S, 2012, ALTEX-ALTERN ANIM EX, V29, P183, DOI 10.14573/altex.2012.2.183
   Gauggel-Lewandowski S, 2013, CHEM-BIOL INTERACT, V206, P411, DOI 10.1016/j.cbi.2013.05.015
   Gebel T, 2014, ARCH TOXICOL, V88, P2191, DOI 10.1007/s00204-014-1383-7
   Ghio AJ, 2012, OCCUP ENVIRON MED, V69, P170, DOI 10.1136/oem.2011.065276
   Greven FE, 2012, AM J IND MED, V55, P54, DOI 10.1002/ajim.21012
   Happo MS, 2013, SCI TOTAL ENVIRON, V443, P256, DOI 10.1016/j.scitotenv.2012.11.004
   Herseth JI, 2013, TOXICOL LETT, V221, P110, DOI 10.1016/j.toxlet.2013.06.209
   Iba MM, 2006, MUTAT RES-GEN TOX EN, V606, P1, DOI 10.1016/j.mrgentox.2006.02.007
   Jalava PI, 2010, ATMOS ENVIRON, V44, P1691, DOI 10.1016/j.atmosenv.2009.12.034
   Janssen N. A., 2012, HLTH EFFECTS BLACK C, P1
   Jensen A, 2014, ENVIRON MOL MUTAGEN, V55, P652, DOI 10.1002/em.21877
   Johansson LS, 2004, ATMOS ENVIRON, V38, P4183, DOI 10.1016/j.atmosenv.2004.04.020
   Johnston FH, 2012, ENVIRON HEALTH PERSP, V120, P695, DOI 10.1289/ehp.1104422
   Karlsson HL, 2008, CHEM RES TOXICOL, V21, P1726, DOI 10.1021/tx800064j
   Kato M, 2004, CANCER EPIDEM BIOMAR, V13, P1005
   Kocbach A, 2008, TOXICOL APPL PHARM, V232, P317, DOI 10.1016/j.taap.2008.07.002
   Kocbach A, 2008, TOXICOLOGY, V247, P123, DOI 10.1016/j.tox.2008.02.014
   Kocbach Bolling Anette, 2009, Part Fibre Toxicol, V6, P29, DOI 10.1186/1743-8977-6-29
   Limbach LK, 2007, ENVIRON SCI TECHNOL, V41, P4158, DOI 10.1021/es062629t
   McCracken JP, 2007, ENVIRON HEALTH PERSP, V115, P996, DOI 10.1289/ehp.9888
   Monteiller C, 2007, OCCUP ENVIRON MED, V64, P609, DOI 10.1136/oem.2005.024802
   Moriguchi T, 2003, P NATL ACAD SCI USA, V100, P5652, DOI 10.1073/pnas.1037886100
   Naeher LP, 2007, INHAL TOXICOL, V19, P67, DOI 10.1080/08958370600985875
   Nebert DW, 2006, NAT REV CANCER, V6, P947, DOI 10.1038/nrc2015
   Neitzel R, 2009, J EXPO SCI ENV EPID, V19, P349, DOI 10.1038/jes.2008.21
   Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397
   NISBET ICT, 1992, REGUL TOXICOL PHARM, V16, P290, DOI 10.1016/0273-2300(92)90009-X
   Noonan CW, 2012, OCCUP ENVIRON MED, V69, P354, DOI 10.1136/oemed-2011-100394
   O'Brien J, 2000, EUR J BIOCHEM, V267, P5421, DOI 10.1046/j.1432-1327.2000.01606.x
   Oberdorster Gunter, 2005, Part Fibre Toxicol, V2, P8, DOI 10.1186/1743-8977-2-8
   Oeder S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126536
   Oh SY, 2012, ENVIRON GEOCHEM HLTH, V34, P105, DOI 10.1007/s10653-011-9416-0
   Orasche J, 2011, ATMOS CHEM PHYS, V11, P8977, DOI 10.5194/acp-11-8977-2011
   Orasche J, 2012, ENERG FUEL, V26, P6695, DOI 10.1021/ef301295k
   Orasche J, 2013, ENERG FUEL, V27, P1482, DOI 10.1021/ef301506h
   Panas A, 2013, NANOTOXICOLOGY, V7, P259, DOI 10.3109/17435390.2011.652206
   Panas A, 2014, BEILSTEIN J NANOTECH, V5, P1590, DOI 10.3762/bjnano.5.171
   Park JH, 2008, P NATL ACAD SCI USA, V105, P6846, DOI 10.1073/pnas.0802776105
   Paur HR, 2008, J VERBRAUCH LEBENSM, V3, P319, DOI 10.1007/s00003-008-0356-2
   Pudasainee D, 2014, FUEL PROCESS TECHNOL, V120, P54, DOI 10.1016/j.fuproc.2013.12.010
   Pulskamp K, 2007, TOXICOL LETT, V168, P58, DOI 10.1016/j.toxlet.2006.11.001
   Riddervold IS, 2012, PART FIBRE TOXICOL, V9, DOI 10.1186/1743-8977-9-12
   Ruh H, 2012, TOXICOL LETT, V208, P41, DOI 10.1016/j.toxlet.2011.09.009
   Saber AT, 2012, NANOTOXICOLOGY, V6, P453, DOI 10.3109/17435390.2011.587900
   Sanhueza PA, 2009, J AIR WASTE MANAGE, V59, P1481, DOI 10.3155/1047-3289.59.12.1481
   Schmidl C, 2008, ATMOS ENVIRON, V42, P126, DOI 10.1016/j.atmosenv.2007.09.028
   Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73
   Schreck I, 2009, TOXICOLOGY, V259, P91, DOI 10.1016/j.tox.2009.02.006
   Sehlstedt M, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-21
   Singh A, 2006, PLOS MED, V3, P1865, DOI 10.1371/journal.pmed.0030420
   Stephanie V, 2011, INHAL TOXICOL, V23, P627, DOI 10.3109/08958378.2011.599445
   Stockfelt L, 2013, INHAL TOXICOL, V25, P417, DOI 10.3109/08958378.2013.798387
   Stockfelt L, 2012, INHAL TOXICOL, V24, P47, DOI 10.3109/08958378.2011.633281
   Stoeger T, 2009, ENVIRON HEALTH PERSP, V117, P54, DOI 10.1289/ehp.11370
   STOHS SJ, 1995, FREE RADICAL BIO MED, V18, P321, DOI 10.1016/0891-5849(94)00159-H
   Straif K., 2013, IARC SCI PUBLICATION, V161
   Swiston JR, 2008, EUR RESPIR J, V32, P129, DOI 10.1183/09031936.00097707
   Tapanainen M, 2011, ATMOS ENVIRON, V45, P7546, DOI 10.1016/j.atmosenv.2011.03.065
   Thurston GD, 2011, ATMOS ENVIRON, V45, P3924, DOI 10.1016/j.atmosenv.2011.04.070
   Torvela T, 2014, ATMOS ENVIRON, V87, P65, DOI 10.1016/j.atmosenv.2014.01.028
   Torvela T, 2014, CHEM RES TOXICOL, V27, P1516, DOI 10.1021/tx500142f
   Totlandsdal AI, 2015, ENVIRON TOXICOL, V30, P188, DOI 10.1002/tox.21884
   Uski O, 2014, ATMOS ENVIRON, V89, P623, DOI 10.1016/j.atmosenv.2014.02.036
   Wu WD, 2013, FREE RADICAL BIO MED, V65, P57, DOI 10.1016/j.freeradbiomed.2013.05.048
NR 90
TC 32
Z9 32
U1 7
U2 76
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0340-5761
EI 1432-0738
J9 ARCH TOXICOL
JI Arch. Toxicol.
PD DEC
PY 2016
VL 90
IS 12
BP 3029
EP 3044
DI 10.1007/s00204-016-1659-1
PG 16
WC Toxicology
SC Toxicology
GA EB9FH
UT WOS:000387697600010
PM 26838041
DA 2019-10-23
ER

PT J
AU Allen, TEH
   Goodman, JM
   Gutsell, S
   Russell, PJ
AF Allen, Timothy E. H.
   Goodman, Jonathan M.
   Gutsell, Steve
   Russell, Paul J.
TI A History of the Molecular Initiating Event
SO CHEMICAL RESEARCH IN TOXICOLOGY
LA English
DT Article
ID ADVERSE OUTCOME PATHWAYS; HEALTH-RISK ASSESSMENT; IN-SILICO PROFILER;
   SKIN SENSITIZATION; CONCEPTUAL-FRAMEWORK; END-POINTS; TOXICITY;
   TOXICOLOGY; CHEMICALS; MODE
AB The adverse outcome pathway (AOP) framework provides an alternative to traditional in vivo experiments for the risk assessment of chemicals. AOPs consist of a number of key events (KEs) linked by key event relationships across a range of biological organization backed by scientific evidence. The first ICE in the pathway is the molecular initiating event (MIE) the initial chemical trigger that starts an AOP. Over the past 3 years the AOP conceptual framework has gained a large amount of momentum in toxicology as an alternative to animal methods, and so the MIE has come into the spotlight. What is an MIE? How can MIEs be measured or predicted? What research is currently contributing to our understanding of MIEs? In this Perspective we outline answers to these key questions.
C1 [Allen, Timothy E. H.; Goodman, Jonathan M.] Univ Cambridge, Dept Chem, Ctr Mol Informat, Lensfield Rd, Cambridge CB2 1EW, England.
   [Gutsell, Steve; Russell, Paul J.] Unilever Safety & Environm Assurance Ctr, Colworth Sci Pk, Sharnbrook MK44 1LQ, Beds, England.
RP Goodman, JM (reprint author), Univ Cambridge, Dept Chem, Ctr Mol Informat, Lensfield Rd, Cambridge CB2 1EW, England.
EM jmg11@cam.ac.uk
RI Goodman, Jonathan M/A-2123-2008
OI Goodman, Jonathan M/0000-0002-8693-9136; Allen,
   Timothy/0000-0001-7369-0901
FU Unilever
FX The authors acknowledge financial support from Unilever.
CR Aardema MJ, 2002, MUTAT RES-FUND MOL M, V499, P13, DOI 10.1016/S0027-5107(01)00292-5
   Allen TEH, 2014, CHEM RES TOXICOL, V27, P2100, DOI 10.1021/tx500345j
   ANDERSEN ME, 1987, TOXICOL APPL PHARM, V87, P185, DOI 10.1016/0041-008X(87)90281-X
   Angrish MM, 2015, CHEM RES TOXICOL, V28, P551, DOI 10.1021/acs.chemrestox.5b00024
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Aptula AO, 2006, CHEM RES TOXICOL, V19, P1097, DOI 10.1021/tx0601004
   AUER CM, 1990, ENVIRON HEALTH PERSP, V87, P183, DOI 10.2307/3431024
   Becker RA, 2015, REGUL TOXICOL PHARM, V72, P514, DOI 10.1016/j.yrtph.2015.04.004
   Benigni R, 2013, CHEM REV, V113, P2940, DOI 10.1021/cr300206t
   Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235
   BONDESSON I, 1989, CELL BIOL TOXICOL, V5, P331, DOI 10.1007/BF01795360
   Burden N, 2015, J APPL TOXICOL, V35, P971, DOI 10.1002/jat.3165
   Caldwell DJ, 2014, CHEMOSPHERE, V115, P4, DOI 10.1016/j.chemosphere.2014.01.021
   Casalegno M, 2013, J CHEM INF MODEL, V53, P1113, DOI 10.1021/ci400130n
   *COMM TOX TEST ASS, 2007, TOX TEST 21 CENT VIS
   Dent MP, 2015, ENVIRON INT, V83, P94, DOI 10.1016/j.envint.2015.06.009
   Enoch SJ, 2010, CHEM RES TOXICOL, V23, P1547, DOI 10.1021/tx100218h
   Enoch SJ, 2011, ATLA-ALTERN LAB ANIM, V39, P131, DOI 10.1177/026119291103900206
   Enoch SJ, 2009, CHEM RES TOXICOL, V22, P1447, DOI 10.1021/tx9001463
   Enoch SJ, 2008, CHEM RES TOXICOL, V21, P513, DOI 10.1021/tx700322g
   Gutsell S, 2013, TOXICOL RES-UK, V2, P299, DOI 10.1039/c3tx50024a
   Hartung T, 2009, NATURE, V460, P208, DOI 10.1038/460208a
   Hartung T, 2009, TOXICOL SCI, V109, P18, DOI 10.1093/toxsci/kfp059
   Henry CJ, 2003, INT J TOXICOL, V22, P3, DOI 10.1080/10915810390181454
   Hofer T, 2004, ARCH TOXICOL, V78, P549, DOI 10.1007/s00204-004-0577-9
   Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492
   Knapen D, 2015, REPROD TOXICOL, V56, P52, DOI 10.1016/j.reprotox.2015.04.003
   Knudsen TB, 2015, TOXICOL SCI, V143, P256, DOI 10.1093/toxsci/kfu234
   Kohonen P, 2013, MOL INFORM, V32, P47, DOI 10.1002/minf.201200114
   LaLone CA, 2013, AQUAT TOXICOL, V144, P141, DOI 10.1016/j.aquatox.2013.09.004
   Leist M, 2008, ALTEX-ALTERN TIEREXP, V25, P103
   Leist M, 2014, ALTEX-ALTERN ANIM EX, V31, P341, DOI 10.14573/altex.1406091
   MacGregor JT, 2003, TOXICOL SCI, V75, P236, DOI 10.1093/toxsci/kfg197
   Madden JC, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0584
   Marchetti F, 2016, ENVIRON MOL MUTAGEN, V57, P87, DOI 10.1002/em.21986
   Martin TM, 2013, J CHEM INF MODEL, V53, P2229, DOI 10.1021/ci400267h
   Maxwell G, 2014, TOXICOL IN VITRO, V28, P8, DOI 10.1016/j.tiv.2013.10.013
   Mellor CL, 2016, CRIT REV TOXICOL, V46, P138, DOI 10.3109/10408444.2015.1089471
   Nelms MD, 2015, ARCH TOXICOL, V89, P733, DOI 10.1007/s00204-014-1277-8
   Nelms MD, 2015, CHEM RES TOXICOL, V28, P1891, DOI 10.1021/acs.chemrestox.5b00275
   OECD, 2011, OECD SER TEST ASS
   OECD, 2012, PROP TEMPL GUID DEV
   Patlewicz G, 2016, CHEM RES TOXICOL, V29, P438, DOI 10.1021/acs.chemrestox.5b00388
   Pognan F, 2004, PHARMACOGENOMICS, V5, P879, DOI 10.1517/14622416.5.7.879
   Roberts DW, 2014, CHEM RES TOXICOL, V27, P240, DOI 10.1021/tx400355n
   Roberts DW, 2011, CHEM RES TOXICOL, V24, P1003, DOI 10.1021/tx100420w
   Roberts DW, 2007, CHEM RES TOXICOL, V20, P1019, DOI 10.1021/tx700024w
   Russell WMS, 1959, PRINCIPLES HUMANE EX
   Sanderson PN, 2016, TOXICOL RES-UK, V5, P34, DOI 10.1039/c5tx00246j
   Schultz TW, 2006, SAR QSAR ENVIRON RES, V17, P413, DOI 10.1080/10629360600884371
   SEXTON K, 1995, TOXICOLOGY, V102, P3, DOI 10.1016/0300-483X(95)03033-C
   Steinmetz FP, 2015, MOL INFORM, V34, P171, DOI 10.1002/minf.201400188
   Tollefsen KE, 2014, REGUL TOXICOL PHARM, V70, P629, DOI 10.1016/j.yrtph.2014.09.009
   Tsakovska I, 2014, INT J MOL SCI, V15, P7651, DOI 10.3390/ijms15057651
   Villeneuve DL, 2011, ENVIRON TOXICOL CHEM, V30, P1, DOI 10.1002/etc.396
   Vinken M, 2013, TOXICOLOGY, V312, P158, DOI 10.1016/j.tox.2013.08.011
   von Stackelberg K, 2015, RISK ANAL, V35, P971, DOI 10.1111/risa.12425
   Wu SD, 2013, CHEM RES TOXICOL, V26, P1840, DOI 10.1021/tx400226u
   Yang C., 2013, 52 ANN M SOC TOX SAN
   Yauk CL, 2015, ENVIRON MOL MUTAGEN, V56, P724, DOI 10.1002/em.21954
   Yin Y., 2014, RESEARCH, V1, P996
NR 61
TC 9
Z9 10
U1 2
U2 20
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0893-228X
EI 1520-5010
J9 CHEM RES TOXICOL
JI Chem. Res. Toxicol.
PD DEC
PY 2016
VL 29
IS 12
BP 2060
EP 2070
DI 10.1021/acs.chemrestox.6b00341
PG 11
WC Chemistry, Medicinal; Chemistry, Multidisciplinary; Toxicology
SC Pharmacology & Pharmacy; Chemistry; Toxicology
GA EF4KR
UT WOS:000390294700011
PM 27989138
DA 2019-10-23
ER

PT J
AU Ma, J
   Li, RB
   Qu, GB
   Liu, HY
   Yan, B
   Xia, T
   Liu, YJ
   Liu, SJ
AF Ma, Juan
   Li, Ruibin
   Qu, Guangbo
   Liu, Huiyu
   Yan, Bing
   Xia, Tian
   Liu, Yajun
   Liu, Sijin
TI Carbon nanotubes stimulate synovial inflammation by inducing systemic
   pro-inflammatory cytokines
SO NANOSCALE
LA English
DT Article
ID CELLULAR UPTAKE; OXIDATIVE STRESS; GRAPHENE OXIDE; PROTEIN CORONA;
   DRUG-DELIVERY; RECEPTOR 4; NANOPARTICLES; HOMEOSTASIS; EXPRESSION;
   NECROSIS
AB Carbon nanotubes (CNTs) have promising applications in a wide range of biomedical fields, including imaging, drug/gene delivery and other therapeutics; however, the biosafety concerns of CNTs should be addressed. To date, many reports have documented the toxicological effects on the cells, tissue or organs that are in direct contact with the tubes; however, there is limited evidence to unravel the secondary toxicity upon CNT treatment. Moreover, more effort is needed to gain a definitive understanding of the adverse outcome pathway (AOP) for CNTs, and a pragmatic framework for risk assessment has not been established yet. In the current study, we aimed to decipher the secondary toxicity to joints under CNT exposure. We demonstrated that carboxylated multi-wall CNTs (MWCNTs-COOH) significantly provoked systemic pro-inflammatory responses, leading to synovial inflammation within knee joints, as evidenced by the infiltration of pro-inflammatory cells in the synovium and meniscus. Mechanistic studies showed that MWCNTs-COOH stimulated pro-inflammatory effects by activating macrophages, and the secreted pro-inflammatory cytokines primed the synoviocytes and chondrocytes, resulting in enhanced production of a large array of enzymes involved in articular cartilage degeneration, including matrix metalloproteinase (MMP) members and cyclooxygenase (COX) members, and increased enzymatic activity of MMPs was demonstrated. Blockade of the cytokines by antibodies significantly attenuated the production of these enzymes. Our current study thus suggests that there is a novel secondary toxicity of CNTs, namely a new AOP to understand the indirect effects of carbon nanotubes: synovial inflammation due to the alteration of the priming state of synoviocytes and chondrocytes under CNT-induced systemic inflammatory conditions.
C1 [Ma, Juan; Qu, Guangbo; Liu, Sijin] Chinese Acad Sci, Res Ctr Ecoenvironm Sci, State Key Lab Environm Chem & Ecotoxicol, Beijing 100085, Peoples R China.
   [Li, Ruibin; Xia, Tian] Univ Calif Los Angeles, Dept Med, Div NanoMed, Los Angeles, CA 90095 USA.
   [Li, Ruibin] Soochow Univ, Collaborat Innovat Ctr Radiat Med Jiangsu Higher, Sch Radiol & Interdisciplinary Sci RAD X, Suzhou 215123, Peoples R China.
   [Liu, Huiyu] Beijing Univ Chem Technol, Coll Life Sci & Technol, Beijing Key Lab Bioproc, Beijing 100029, Peoples R China.
   [Yan, Bing] Shandong Univ, Sch Chem & Chem Engn, Jinan 250100, Peoples R China.
   [Liu, Yajun] Peking Univ, Hlth Sci Ctr, Beijing Jishuitan Hosp, Beijing 100035, Peoples R China.
RP Liu, SJ (reprint author), Chinese Acad Sci, Res Ctr Ecoenvironm Sci, State Key Lab Environm Chem & Ecotoxicol, Beijing 100085, Peoples R China.
EM sjliu@rcees.ac.cn
RI XIA, TIAN/C-3158-2013; Qu, Guangbo/R-6605-2016
OI XIA, TIAN/0000-0003-0123-1305; liu, hui yu/0000-0003-4465-8501; Qu,
   Guangbo/0000-0002-5220-7009
FU national "973" programmeNational Basic Research Program of China
   [2014CB932000]; Strategic Priority Research Program of the Chinese
   Academy of SciencesChinese Academy of Sciences [XDB14000000]; National
   Natural Science Foundation of ChinaNational Natural Science Foundation
   of China [21425731, 21077128, 81373039, 91543124, 21637004]; One Hundred
   Talents (Bairen A) program of Chinese Academy of Sciences; New Century
   National Millions of Talents Project
FX This work was supported by a grant under the national "973" programme
   (grant number 2014CB932000), the Strategic Priority Research Program of
   the Chinese Academy of Sciences (grant no. XDB14000000) and grants from
   the National Natural Science Foundation of China (grant numbers
   21425731, 21077128, 81373039, 91543124 and 21637004). This work was also
   supported by One Hundred Talents (Bairen A) program of Chinese Academy
   of Sciences (TX) and the New Century National Millions of Talents
   Project (YL).
CR Abramson SB, 1999, OSTEOARTHR CARTILAGE, V7, P380, DOI 10.1053/joca.1998.0217
   Akutsu M, 2013, J ORAL PATHOL MED, V42, P491, DOI 10.1111/jop.12040
   Al Faraj A, 2009, NANO LETT, V9, P1023, DOI 10.1021/nl8032608
   Albini A, 2015, INT J NANOMED, V10, P6133, DOI 10.2147/IJN.S85275
   Andersson JT, 2015, POLYCYCL AROMAT COMP, V35, P330, DOI 10.1080/10406638.2014.991042
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Aravind SSJ, 2011, J PHYS CHEM C, V115, P16737, DOI 10.1021/jp201672p
   Bai YH, 2010, NAT NANOTECHNOL, V5, P683, DOI [10.1038/NNANO.2010.153, 10.1038/nnano.2010.153]
   Biju V, 2014, CHEM SOC REV, V43, P744, DOI 10.1039/c3cs60273g
   Bohrer D, 2001, J PHARMACEUT BIOMED, V26, P811, DOI 10.1016/S0731-7085(01)00459-9
   Boulanger G, 2014, ENVIRON HEALTH-GLOB, V13, DOI 10.1186/1476-069X-13-59
   Brennan FM, 2008, J CLIN INVEST, V118, P3537, DOI 10.1172/JCI36389
   Briknarova K, 2001, J BIOL CHEM, V276, P27613, DOI 10.1074/jbc.M101105200
   Bussy C, 2016, NANOSCALE, V8, P590, DOI 10.1039/c5nr06625e
   Chang LQ, 2016, NANOSCALE, V8, P3181, DOI 10.1039/c5nr06694h
   Cheng LC, 2013, NANOSCALE, V5, P3547, DOI 10.1039/c3nr34276j
   Chimenti MS, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.246
   Chithrani BD, 2007, NANO LETT, V7, P1542, DOI 10.1021/nl070363y
   Choi EM, 2010, FOOD CHEM TOXICOL, V48, P2607, DOI 10.1016/j.fct.2010.06.029
   Choy E, 2012, RHEUMATOLOGY, V51, pV3, DOI 10.1093/rheumatology/kes113
   Chronopoulos DD, 2015, NANOSCALE, V7, P2750, DOI 10.1039/c4nr06543c
   COLLIER IE, 1988, J BIOL CHEM, V263, P6579
   Crescio C, 2014, NANOSCALE, V6, P9599, DOI 10.1039/c4nr02711f
   Cui XQ, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1274-1
   De Paoli SH, 2014, BIOMATERIALS, V35, P6182, DOI 10.1016/j.biomaterials.2014.04.067
   Delogu LG, 2012, P NATL ACAD SCI USA, V109, P16612, DOI 10.1073/pnas.1208312109
   Di Crescenzo A, 2011, NANOSCALE, V3, P925, DOI 10.1039/c0nr00444h
   Donaldson K, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-5
   Dong J, 2015, NANOTOXICOLOGY, V9, P658, DOI 10.3109/17435390.2015.1009187
   Farrera C, 2014, NANOSCALE, V6, P6974, DOI 10.1039/c3nr06047k
   Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661
   Gao NN, 2011, ACS NANO, V5, P4581, DOI 10.1021/nn200283g
   Geng HZ, 2007, J AM CHEM SOC, V129, P7758, DOI 10.1021/ja0722224
   Grogan Shawn P, 2010, Int J Clin Rheumtol, V5, P199, DOI 10.2217/ijr.10.3
   Guha M, 2001, CELL SIGNAL, V13, P85, DOI 10.1016/S0898-6568(00)00149-2
   He XQ, 2011, CHEM RES TOXICOL, V24, P2237, DOI 10.1021/tx200351d
   Hwang JY, 2013, NANOSCALE, V5, P487, DOI 10.1039/c2nr31581e
   Jackson P, 2012, MUTAT RES-GEN TOX EN, V745, P73, DOI 10.1016/j.mrgentox.2011.09.018
   Kapoor M, 2011, NAT REV RHEUMATOL, V7, P33, DOI 10.1038/nrrheum.2010.196
   Kawai T, 2009, INT IMMUNOL, V21, P317, DOI 10.1093/intimm/dxp017
   Kim JS, 2012, MOL ORAL MICROBIOL, V27, P149, DOI 10.1111/j.2041-1014.2012.00639.x
   Kotas ME, 2015, CELL, V160, P816, DOI 10.1016/j.cell.2015.02.010
   Lacerda L, 2013, NANOSCALE, V5, P10242, DOI 10.1039/c3nr03184e
   Lesniak A, 2012, ACS NANO, V6, P5845, DOI 10.1021/nn300223w
   Li N, 2008, FREE RADICAL BIO MED, V44, P1689, DOI 10.1016/j.freeradbiomed.2008.01.028
   Li Q, 2013, J SOLID STATE ELECTR, V17, P2959, DOI 10.1007/s10008-013-2203-3
   Li RB, 2013, ACS NANO, V7, P2352, DOI 10.1021/nn305567s
   [李帅 Li Shuai], 2011, [水文, Hydrology], V31, P35
   Liao WH, 2013, ACS APPL MATER INTER, V5, P3975, DOI 10.1021/am400811p
   Liu SJ, 2007, J CLIN INVEST, V117, P3296, DOI 10.1172/JCI32084
   Liu Z, 2008, CANCER RES, V68, P6652, DOI 10.1158/0008-5472.CAN-08-1468
   Lu YC, 2011, J AGR FOOD CHEM, V59, P4969, DOI 10.1021/jf1046738
   Lv QX, 2015, ENVIRON POLLUT, V199, P219, DOI 10.1016/j.envpol.2015.02.008
   Ma J, 2015, ACS NANO, V9, P10498, DOI 10.1021/acsnano.5b04751
   Maess M. B., 2013, J IMMUNOL METHODS, P76
   Mano SS, 2013, INT J MOL SCI, V14, P13154, DOI 10.3390/ijms140713154
   Martinon F, 2010, EUR J IMMUNOL, V40, P616, DOI 10.1002/eji.200940168
   McDevitt MR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000907
   McInnes IB, 2007, NAT REV IMMUNOL, V7, P429, DOI 10.1038/nri2094
   Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397
   Osamu T., 2010, CELL, V140, P805
   Otero M, 2007, ARTHRITIS RES THER, V9, DOI 10.1188/ar.2292
   Palomaki J, 2011, ACS NANO, V5, P6861, DOI 10.1021/nn200595c
   Pasare C, 2004, MICROBES INFECT, V6, P1382, DOI 10.1016/j.micinf.2004.08.018
   Pascarelli NA, 2013, J APPL TOXICOL, V33, P1506, DOI 10.1002/jat.2912
   Pietroiusti A, 2012, NANOSCALE, V4, P1231, DOI 10.1039/c2nr11688j
   Poland CA, 2008, NAT NANOTECHNOL, V3, P423, DOI 10.1038/nnano.2008.111
   Poulsen SS, 2015, TOXICOL APPL PHARM, V283, P210, DOI 10.1016/j.taap.2015.01.011
   Qu C, 2012, GENE, V493, P9, DOI 10.1016/j.gene.2011.11.046
   Qu GB, 2013, ACS NANO, V7, P5732, DOI 10.1021/nn402330b
   Rockel J. S., 2016, NAT REV RHEUMATOL, DOI [10.1038/nrrheum.2016.166, DOI 10.1038/NRRHEUM.2016.166.]
   Roldo M, 2013, ANNU REP PROG CHEM C, V109, P10, DOI 10.1039/c3pc90010j
   Rousseau JC, 2007, NAT CLIN PRACT RHEUM, V3, P346, DOI 10.1038/ncprheum0508
   Ruibin L., 2014, NANOTECHNOLOGY, V25
   Rushton Lesley, 2007, Reviews on Environmental Health, V22, P195
   Ryman-Rasmussen JP, 2009, NAT NANOTECHNOL, V4, P747, DOI [10.1038/nnano.2009.305, 10.1038/NNANO.2009.305]
   Shipkowski KA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128888
   Singh R, 2006, P NATL ACAD SCI USA, V103, P3357, DOI 10.1073/pnas.0509009103
   Sorbara MT, 2011, CELL RES, V21, P558, DOI 10.1038/cr.2011.20
   Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022
   Tarantino G, 2011, WORLD J GASTROENTERO, V17, P3776, DOI 10.3748/wjg.v17.i33.3776
   Troeberg L, 2012, BBA-PROTEINS PROTEOM, V1824, P133, DOI 10.1016/j.bbapap.2011.06.020
   Turabekova M, 2014, NANOSCALE, V6, P3488, DOI 10.1039/c3nr05772k
   Tweedale G, 2002, NAT REV CANCER, V2, P311, DOI 10.1038/nrc774
   Umar S, 2013, CELL IMMUNOL, V284, P51, DOI 10.1016/j.cellimm.2013.07.004
   Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034
   Wang JTW, 2016, J CONTROL RELEASE, V224, P22, DOI 10.1016/j.jconrel.2015.12.039
   Wang X., 2012, MATH PROBL ENG, V2012, P12, DOI DOI 10.1016/J.AUTC0N.2012.10.012
   Wang X, 2011, ACS NANO, V5, P9772, DOI 10.1021/nn2033055
   Wang X, 2010, ACS NANO, V4, P7241, DOI 10.1021/nn102112b
   Yan LA, 2011, NANOSCALE, V3, P362, DOI 10.1039/c0nr00647e
   Yang ZX, 2014, NANOSCALE, V6, P663, DOI 10.1039/c3nr04535h
   Yoong SL, 2015, NANOSCALE, V7, P13907, DOI 10.1039/c5nr00980d
   Zaga-Clavellina V, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-13
   Zelinkova Z, 2015, POLYCYCL AROMAT COMP, V35, P248, DOI 10.1080/10406638.2014.918550
   Zhang LW, 2015, NANOSCALE, V7, P16204, DOI 10.1039/c5nr03752b
   Zhang MF, 2015, NANOSCALE, V7, P2834, DOI 10.1039/c4nr06175f
   Zhang SP, 2014, CELL SIGNAL, V26, P2539, DOI 10.1016/j.cellsig.2014.07.029
   Zhang Y, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.48
   Zhao Y, 2016, MOL MED REP, V14, P1901, DOI 10.3892/mmr.2016.5518
   Zhao YL, 2014, NANOSCALE, V6, P4275, DOI 10.1039/c3nr06784j
NR 101
TC 14
Z9 14
U1 9
U2 60
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2040-3364
EI 2040-3372
J9 NANOSCALE
JI Nanoscale
PD NOV 14
PY 2016
VL 8
IS 42
BP 18070
EP 18086
DI 10.1039/c6nr06041b
PG 17
WC Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials
   Science, Multidisciplinary; Physics, Applied
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA EB5PD
UT WOS:000387427400010
PM 27714147
DA 2019-10-23
ER

PT J
AU Cheng, WY
   Zhang, Q
   Schroeder, A
   Villeneuve, DL
   Ankley, GT
   Conolly, R
AF Cheng, Wan-Yun
   Zhang, Qiang
   Schroeder, Anthony
   Villeneuve, Daniel L.
   Ankley, Gerald T.
   Conolly, Rory
TI Editor's Highlight: Computational Modeling of Plasma Vitellogenin
   Alterations in Response to Aromatase Inhibition in Fathead Minnows
SO TOXICOLOGICAL SCIENCES
LA English
DT Article
DE endocrine toxicology; aquatic toxicology; environmental toxicology;
   predictive toxicology; in vitro and altenatives; adverse outcome
   pathway; computational toxicology
ID CHARACTERIZE ADAPTIVE RESPONSES; REPRODUCTIVE ENDOCRINE AXIS;
   PIMEPHALES-PROMELAS; DANIO-RERIO; EXPRESSION; GENE; RECEPTOR; FISH;
   TRANSCRIPTION; DISPOSITION
AB In vertebrates, conversion of testosterone into 17 beta-estradiol (E2) is catalyzed by cytochrome P450 (CYP) 19A aromatase. An important role of E2 in oviparous vertebrates such as fish is stimulation of hepatic synthesis of the glycolipoprotein vitellogenin (VTG), an egg yolk precursor essential to oocyte development and larval survival. In fathead minnows (FHMs) (Pimephales promelas) exposed to the aromatase inhibitor fadrozole, plasma VTG levels do not change in concert with plasma E2 levels. Specifically, while plasma VTG and E2 levels both drop quickly when aromatase is first inhibited, the recovery of plasma VTG upon cessation of aromatase inhibition is substantially delayed relative to the recovery of plasma E2. We modified an existing computational model of the FHM hypothalamic-pituitary-gonadal axis to evaluate alternative hypotheses that might explain this delay. In the first hypothesis, a feedback loop involving active transport of VTG from the blood into the ovary is used. The activity of the transporter is negatively regulated by ovarian VTG. In the second hypothesis, a type 1 coherent feed-forward loop is implemented in the liver. This loop has 2 arms, both requiring E2 activation. The first arm describes direct, canonical E2-driven transcriptional induction of VTG, and the second describes an E2-driven intermediate transcriptional regulator that is also required for VTG synthesis. Both hypotheses accurately described the observed VTG dynamics. This result could be used to guide design of laboratory experiments intended to determine if either of the motifs, or perhaps even both of them, actually do control VTG dynamics in FHMs exposed to aromatase inhibitors.
C1 [Cheng, Wan-Yun] Oak Ridge Inst Sci & Educ, Oak Ridge, TN USA.
   [Cheng, Wan-Yun; Conolly, Rory] US EPA, Integrated Syst Toxicol Div, Natl Hlth & Effects Res Lab, Off Res & Dev, Res Triangle Pk, NC 27711 USA.
   [Zhang, Qiang] Emory Univ, Rollins Sch Publ Hlth, Dept Environm Hlth, Atlanta, GA 30322 USA.
   [Schroeder, Anthony] Univ Minnesota Crookston, Math Sci & Technol Dept, Crookston, MN USA.
   [Villeneuve, Daniel L.; Ankley, Gerald T.] US EPA, Mid Continent Ecol Div, Natl Hlth & Environm Effects Res Lab, Off Res & Dev, Duluth, MN USA.
RP Conolly, R (reprint author), US EPA, Integrated Syst Toxicol Div, Natl Hlth & Effects Res Lab, Off Res & Dev, Res Triangle Pk, NC 27711 USA.
EM conolly.rory@epa.gov
CR Alon U., 2016, INTRO SYSTEMS BIOL
   Ankley GT, 2007, ENVIRON TOXICOL CHEM, V26, P1214, DOI 10.1897/06-428R.1
   Ankley GT, 2015, TOXICOL SCI, V144, P259, DOI 10.1093/toxsci/kfu320
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Ankley GT, 2009, TOXICOL SCI, V112, P344, DOI 10.1093/toxsci/kfp227
   Ankley GT, 2005, TOXICOL SCI, V86, P300, DOI 10.1093/toxsci/kfi202
   Ankley GT, 2002, TOXICOL SCI, V67, P121, DOI 10.1093/toxsci/67.1.121
   Ankley GT, 2001, ENVIRON TOXICOL CHEM, V20, P1276, DOI 10.1002/etc.5620200616
   BABIN P, 2007, FISH OOCYTE BASIC ST
   Breen M, 2016, COMP BIOCHEM PHYS C, V183, P36, DOI 10.1016/j.cbpc.2016.02.002
   Breen M, 2013, TOXICOL SCI, V133, P234, DOI 10.1093/toxsci/kft067
   Hiramatsu N, 2015, GEN COMP ENDOCR, V221, P9, DOI 10.1016/j.ygcen.2015.01.025
   Ingalls BP, 2003, J THEOR BIOL, V222, P23, DOI 10.1016/S0022-5193(03)00011-0
   Keifer J, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00009
   Keys DA, 1999, TOXICOL SCI, V49, P172, DOI 10.1093/toxsci/49.2.172
   Kong HJ, 2014, INT J MOL SCI, V15, P18804, DOI 10.3390/ijms151018804
   LEDREAN Y, 1995, J MOL ENDOCRINOL, V15, P37, DOI 10.1677/jme.0.0150037
   Leino RL, 2005, ENVIRON TOXICOL PHAR, V19, P85, DOI 10.1016/j.etap.2004.05.010
   Li ZH, 2011, CAN J FISH AQUAT SCI, V68, P1528, DOI 10.1139/f2011-066
   Miller DH, 2004, ECOTOX ENVIRON SAFE, V59, P1, DOI 10.1016/j.ecoenv.2004.05.005
   Miracle A, 2006, ECOTOX ENVIRON SAFE, V63, P337, DOI 10.1016/j.ecoenv.2005.12.002
   Mizuta H, 2013, COMP BIOCHEM PHYS B, V166, P81, DOI 10.1016/j.cbpb.2013.07.005
   Mol M, 2014, BBA-GEN SUBJECTS, V1840, P71, DOI 10.1016/j.bbagen.2013.08.018
   OPRESKO LK, 1987, J BIOL CHEM, V262, P4109
   Parhizgari Z, 2014, ENVIRON TOXICOL CHEM, V33, P1064, DOI 10.1002/etc.2504
   Robyr D, 2000, J BIOL CHEM, V275, P28291
   Schmid T, 2002, TOXICOL LETT, V131, P65, DOI 10.1016/S0378-4274(02)00043-7
   Skolness SY, 2011, AQUAT TOXICOL, V103, P170, DOI 10.1016/j.aquatox.2011.02.016
   Teo BY, 1999, FEBS LETT, V459, P57, DOI 10.1016/S0014-5793(99)01212-0
   Villeneuve D. L., 2016, AROMATASE INHIBITION
   Villeneuve DL, 2013, TOXICOL SCI, V133, P225, DOI 10.1093/toxsci/kft068
   Villeneuve DL, 2012, MUTAT RES-GEN TOX EN, V746, P151, DOI 10.1016/j.mrgentox.2011.12.016
   Villeneuve DL, 2009, ENVIRON HEALTH PERSP, V117, P624, DOI 10.1289/ehp.11891
   Wang H, 2005, GENE, V356, P91, DOI 10.1016/j.gene.2005.03.041
   Watanabe KH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146594
   Zhang Q, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130031
   Zhong LQ, 2014, AQUAT TOXICOL, V149, P1, DOI 10.1016/j.aquatox.2014.01.022
NR 37
TC 5
Z9 5
U1 1
U2 19
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1096-6080
EI 1096-0929
J9 TOXICOL SCI
JI Toxicol. Sci.
PD NOV
PY 2016
VL 154
IS 1
BP 78
EP 89
DI 10.1093/toxsci/kfw142
PG 12
WC Toxicology
SC Toxicology
GA ED6CA
UT WOS:000388940900009
PM 27503384
DA 2019-10-23
ER

PT J
AU Pleil, JD
AF Pleil, Joachim D.
TI Breath biomarkers in toxicology
SO ARCHIVES OF TOXICOLOGY
LA English
DT Review
DE Human exposome; Exhaled breath; Breath condensate; Cellular respiration;
   Mass spectrometry; Adverse outcome pathway
ID VOLATILE ORGANIC-COMPOUNDS; REACTION-MASS-SPECTROMETRY; THROUGHPUT
   SCREENING ASSAYS; IN-VIVO DISCOVERY; ION FLOW TUBE; EXHALED BREATH;
   HELICOBACTER-PYLORI; LUNG-CANCER; PTR-MS; ENVIRONMENTAL EXPOSURE
AB Exhaled breath has joined blood and urine as a valuable resource for sampling and analyzing biomarkers in human media for assessing exposure, uptake metabolism, and elimination of toxic chemicals. This article focuses current use of exhaled gas, aerosols, and vapor in human breath, the methods for collection, and ultimately the use of the resulting data. Some advantages of breath are the noninvasive and self-administered nature of collection, the essentially inexhaustible supply, and that breath sampling does not produce potentially infectious waste such as needles, wipes, bandages, and glassware. In contrast to blood and urine, breath samples can be collected on demand in rapid succession and so allow toxicokinetic observations of uptake and elimination in any time frame. Furthermore, new technologies now allow capturing condensed breath vapor directly, or just the aerosol fraction alone, to gain access to inorganic species, lung pH, proteins and protein fragments, cellular DNA, and whole microorganisms from the pulmonary microbiome. Future applications are discussed, especially the use of isotopically labeled probes, non-targeted (discovery) analysis, cellular level toxicity testing, and ultimately assessing "crowd breath" of groups of people and the relation to dose of airborne and other environmental chemicals at the population level.
C1 [Pleil, Joachim D.] US EPA, Off Res & Dev, Res Triangle Pk, NC 27711 USA.
RP Pleil, JD (reprint author), US EPA, Off Res & Dev, Res Triangle Pk, NC 27711 USA.
EM pleil.joachim@epa.gov
CR Adeleye Y, 2015, TOXICOLOGY, V332, P102, DOI 10.1016/j.tox.2014.02.007
   Almstrand AC, 2009, ANAL CHEM, V81, P662, DOI 10.1021/ac802055k
   AMANN A, 2005, BREATH ANAL CLIN DIA
   Amann A, 2014, J BREATH RES, V8, DOI 10.1088/1752-7155/8/3/034001
   Amann A, 2014, J BREATH RES, V8, DOI 10.1088/1752-7155/8/1/016003
   Angrish MM, 2015, CHEM RES TOXICOL, V28, P551, DOI 10.1021/acs.chemrestox.5b00024
   Arasaradnam RP, 2016, J BREATH RES, V10, DOI 10.1088/1752-7155/10/1/016012
   Ashley DL, 1996, ENVIRON HEALTH PERSP, V104, P871, DOI 10.2307/3433004
   Astashkina A, 2012, PHARMACOL THERAPEUT, V134, P82, DOI 10.1016/j.pharmthera.2012.01.001
   Baccarelli A, 2009, CURR OPIN PEDIATR, V21, P243, DOI 10.1097/MOP.0b013e32832925cc
   Baraldi E, 2009, ITAL J PEDIATR, V35, DOI 10.1186/1824-7288-35-30
   Baranska A, 2015, J BREATH RES, V9, DOI 10.1088/1752-7155/9/4/047102
   Barker M, 2006, EUR RESPIR J, V27, P929, DOI 10.1183/09031936.06.00085105
   Basanta M, 2010, ANALYST, V135, P315, DOI 10.1039/b916374c
   Baumbach JI, 1999, APPL SPECTROSC, V53, p338A, DOI 10.1366/0003702991947847
   Beauchamp J, 2011, J BREATH RES, V5, DOI 10.1088/1752-7155/5/3/037103
   Beauchamp J, 2010, J BREATH RES, V4, DOI 10.1088/1752-7155/4/2/026006
   Benor S, 2015, J BREATH RES, V9, DOI 10.1088/1752-7155/9/2/026001
   Bhogal N, 2005, TRENDS BIOTECHNOL, V23, P299, DOI 10.1016/j.tibtech.2005.04.006
   Buckley TJ, 1997, J AIR WASTE MANAGE, V47, P739, DOI 10.1080/10473289.1997.10463934
   Bugrim A, 2004, DRUG DISCOV TODAY, V9, P127, DOI 10.1016/S1359-6446(03)02971-4
   Cao WQ, 2007, CRIT REV ANAL CHEM, V37, P3, DOI 10.1080/10408340600976499
   Cao WQ, 2006, CLIN CHEM, V52, P800, DOI 10.1373/clinchem.2005.063545
   CHINERY RL, 1993, RISK ANAL, V13, P51, DOI 10.1111/j.1539-6924.1993.tb00728.x
   Christ-Crain M, 2007, EUR RESPIR J, V30, P556, DOI 10.1183/09031936.00166106
   Clayton TA, 2009, P NATL ACAD SCI USA, V106, P14728, DOI 10.1073/pnas.0904489106
   CROSSLEY JR, 1979, LANCET, V1, P472
   Crosson ER, 2002, ANAL CHEM, V74, P2003, DOI 10.1021/ac025511d
   Cunnington AJ, 2002, POSTGRAD MED J, V78, P233, DOI 10.1136/pmj.78.918.233
   CUTLER AF, 1995, GASTROENTEROLOGY, V109, P136, DOI 10.1016/0016-5085(95)90278-3
   Dix DJ, 2007, TOXICOL SCI, V95, P5, DOI 10.1093/toxsci/kfl103
   Dobrev ID, 2001, ARCH TOXICOL, V75, P134, DOI 10.1007/s002040100216
   DROZ PO, 1986, J OCCUP ENVIRON MED, V28, P593, DOI 10.1097/00043764-198608000-00014
   DUBOWSKI KM, 1974, CLIN CHEM, V20, P966
   Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887
   Eder AF, 1998, CLIN CHEM, V44, P168
   Fens N, 2009, AM J RESP CRIT CARE, V180, P1076, DOI 10.1164/rccm.200906-0939OC
   Filipiak W, 2015, J BREATH RES, V9, DOI 10.1088/1752-7155/9/1/016004
   Filipiak W, 2014, J BREATH RES, V8, DOI 10.1088/1752-7155/8/2/027111
   Filipiak W, 2010, CANCER EPIDEM BIOMAR, V19, P182, DOI 10.1158/1055-9965.EPI-09-0162
   FISEROVABERGEROVA V, 1979, DRUG METAB REV, V9, P43, DOI 10.3109/03602537909046433
   Fridman GY, 2015, ANN BIOMED ENG, V43, P2175, DOI 10.1007/s10439-015-1247-1
   Funk WE, 2015, J ENV ANAL TOXICOL S, VS7, P002, DOI [10.4172/2161-0525, DOI 10.4172/2161-0525.S7-002]
   GARRICK MD, 1973, NEW ENGL J MED, V288, P1265, DOI 10.1056/NEJM197306142882403
   GARRIOTT JC, 1981, CLIN TOXICOL, V18, P471, DOI 10.3109/15563658108990271
   Ghimenti S, 2013, J BREATH RES, V7, DOI 10.1088/1752-7155/7/3/036001
   GORDON SM, 1990, J CHROMATOGR, V511, P291, DOI 10.1016/S0021-9673(01)93292-3
   GORDON SM, 1988, ATMOS ENVIRON, V22, P2165, DOI 10.1016/0004-6981(88)90126-6
   Gordon SM, 1995, ENV HLTH PERSPECT, V110, P689
   Gotschi T, 2008, EPIDEMIOLOGY, V19, P690, DOI 10.1097/EDE.0b013e318181650f
   Gregus M, 2015, J BREATH RES, V9, DOI 10.1088/1752-7155/9/2/027107
   Grob NM, 2008, J BREATH RES, V2, DOI 10.1088/1752-7155/2/3/037004
   GUTHRIE R, 1963, PEDIATRICS, V32, P338
   HARVING H, 1991, AM REV RESPIR DIS, V143, P751, DOI 10.1164/ajrccm/143.4_Pt_1.751
   Holmgren H, 2010, J AEROSOL SCI, V41, P439, DOI 10.1016/j.jaerosci.2010.02.011
   Horvath I, 2005, EUR RESPIR J, V26, P523, DOI 10.1183/09031936.05.00029705
   Hubbard HF, 2009, J CHROMATOGR B, V877, P3652, DOI 10.1016/j.jchromb.2009.09.008
   Hunt J, 2002, J ALLERGY CLIN IMMUN, V110, P28, DOI 10.1067/mai.2002.124966
   Inglese J, 2007, NAT CHEM BIOL, V3, P466, DOI 10.1038/nchembio.2007.17
   Jackson AS, 2007, AM J RESP CRIT CARE, V175, P222, DOI 10.1164/rccm.200601-107OC
   JARVIS MJ, 1980, BRIT MED J, V281, P484, DOI 10.1136/bmj.281.6238.484
   Jezierski T, 2015, J BREATH RES, V9, DOI 10.1088/1752-7155/9/2/027001
   Johanson G, 2000, CRIT REV TOXICOL, V30, P307, DOI 10.1080/10408440091159220
   Johnson GR, 2009, J AEROSOL MED PULM D, V22, P229, DOI 10.1089/jamp.2008.0720
   Judson RS, 2010, ENVIRON HEALTH PERSP, V118, P485, DOI 10.1289/ehp.0901392
   Kavlock R, 2012, CHEM RES TOXICOL, V25, P1287, DOI 10.1021/tx3000939
   KHARITONOV SA, 1995, AM J RESP CRIT CARE, V152, P609, DOI 10.1164/ajrccm.152.2.7543345
   Kischkel S, 2010, CLIN CHIM ACTA, V411, P1637, DOI 10.1016/j.cca.2010.06.005
   Kumar S, 2004, BIOTECHNOL LETT, V26, P1, DOI 10.1023/B:BILE.0000009469.69116.03
   Kushch I, 2008, J BREATH RES, V2, DOI 10.1088/1752-7155/2/2/026002
   Laleman I, 2014, J BREATH RES, V8, DOI 10.1088/1752-7155/8/1/017103
   Lazar Z, 2014, J BREATH RES, V8, DOI 10.1088/1752-7155/8/4/046002
   Lin Y S, 2005, Occup Environ Med, V62, P750, DOI 10.1136/oem.2004.013102
   Lindinger W, 1998, CHEM SOC REV, V27, P347, DOI 10.1039/a827347z
   Lioy PJ, 2011, ENVIRON HEALTH PERSP, V119, pA466, DOI 10.1289/ehp.1104387
   Lippmann M, 2000, ANNU REV PUBL HEALTH, V21, P309, DOI 10.1146/annurev.publhealth.21.1.309
   Lirk P, 2004, INT J MASS SPECTROM, V239, P221, DOI 10.1016/j.ijms.2004.07.016
   Liu J, 2007, EUR RESPIR J, V30, P807, DOI 10.1183/09031936.00080207
   Liu L, 2009, ENVIRON HEALTH PERSP, V117, P668, DOI 10.1289/ehp11813
   LOGAN RPH, 1991, GUT, V32, P1461, DOI 10.1136/gut.32.12.1461
   Luchner M, 2012, BIOTECHNOL BIOENG, V109, P3059, DOI 10.1002/bit.24579
   Madden MC, 2014, PART FIBRE TOXICOL, V11, DOI [10.1186/s12989-014-0037, 10.1186/s12989-014-0037-5]
   Mannino DM, 2003, AM J MED, V114, P758, DOI 10.1016/S0002-9343(03)00185-2
   MANOLIS A, 1983, CLIN CHEM, V29, P5
   Marks DM, 2003, CYTOTECHNOLOGY, V42, P21, DOI 10.1023/A:1026103405618
   Matz G, 1996, J CHROMATOGR A, V750, P141, DOI 10.1016/0021-9673(96)00289-0
   Miekisch W, 2004, CLIN CHIM ACTA, V347, P25, DOI 10.1016/j.cccn.2004.04.023
   Miekisch W, 2008, CLIN CHIM ACTA, V395, P32, DOI 10.1016/j.cca.2008.04.021
   Milazzo L, 2005, J ANTIMICROB CHEMOTH, V55, P84, DOI 10.1093/jac/dkh497
   Miller GW, 2014, TOXICOL SCI, V137, P1, DOI 10.1093/toxsci/kft251
   Modak A, 2009, J BREATH RES, V3, DOI 10.1088/1752-7155/3/4/040201
   Modak AS, 2007, J BREATH RES, V1, DOI 10.1088/1752-7155/1/1/014003
   Modak AS, 2013, J BREATH RES, V7, DOI 10.1088/1752-7155/7/3/037103
   Modak AS, 2010, PERS MED, V7, P643, DOI 10.2217/PME.10.61
   Moritz F, 2015, J BREATH RES, V9, DOI 10.1088/1752-7155/9/2/027105
   MORRIS JF, 1976, WESTERN J MED, V125, P110
   Mutlu GM, 2001, AM J RESP CRIT CARE, V164, P731, DOI 10.1164/ajrccm.164.5.2101032
   Opdam FL, 2015, J BREATH RES, V9, DOI 10.1088/1752-7155/9/2/026003
   Parker GJ, 2000, J BIOMOL SCREEN, V5, P77, DOI 10.1177/108705710000500204
   Patel CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010746
   Pelclova D, 2015, J BREATH RES, V9, DOI 10.1088/1752-7155/9/3/036008
   PELLIZZARI ED, 1992, J EXPO ANAL ENV EPID, V2, P341
   Penttinen P, 2001, ENVIRON HEALTH PERSP, V109, P319, DOI 10.2307/3454889
   Perbellini L, 2003, INT ARCH OCC ENV HEA, V76, P461, DOI 10.1007/s00420-003-0436-7
   Pleil JD, 2007, BIOMARKERS, V12, P331, DOI 10.1080/13547500701246334
   Pleil JD, 1997, CLIN CHEM, V43, P723
   Pleil JD, 1998, RISK ANAL, V18, P585, DOI 10.1111/j.1539-6924.1998.tb00372.x
   Pleil JD, 2008, J BREATH RES, V2, DOI 10.1088/1752-7155/2/2/026001
   Pleil JD, 2008, J TOXICOL ENV HEAL B, V11, P613, DOI 10.1080/10937400701724329
   Pleil JD, 2016, J BREATH RES, V10, DOI 10.1088/1752-7155/10/1/010201
   Pleil JD, 2016, J BREATH RES, V10, DOI 10.1088/1752-7155/10/1/012001
   Pleil JD, 2015, J BREATH RES, V9, DOI 10.1088/1752-7155/9/3/039001
   Pleil JD, 2014, J BREATH RES, V8, DOI 10.1088/1752-7155/8/3/037107
   Pleil JD, 2014, J BREATH RES, V8, DOI 10.1088/1752-7155/8/2/029001
   Pleil JD, 2013, ANAL CHEM, V85, P9984, DOI 10.1021/ac402306f
   Pleil JD, 2012, J TOXICOL ENV HEAL B, V15, P264, DOI 10.1080/10937404.2012.672148
   Pleil JD, 2011, J BREATH RES, V5, DOI 10.1088/1752-7155/5/4/046005
   Polk DB, 2010, NAT REV CANCER, V10, P403, DOI 10.1038/nrc2857
   Possemiers S, 2009, CURR PHARM DESIGN, V15, P2051, DOI 10.2174/138161209788489159
   Rager JE, 2016, ENVIRON INT, V88, P269, DOI 10.1016/j.envint.2015.12.008
   Rappaport SM, 2014, ENVIRON HEALTH PERSP, V122, P769, DOI 10.1289/ehp.1308015
   Rappaport SM, 2012, BIOMARKERS, V17, P483, DOI 10.3109/1354750X.2012.691553
   Rappaport SM, 2011, J EXPO SCI ENV EPID, V21, P5, DOI 10.1038/jes.2010.50
   Rappaport SM, 2010, SCIENCE, V330, P460, DOI 10.1126/science.1192603
   Risby TH, 2006, APPL PHYS B-LASERS O, V85, P421, DOI 10.1007/s00340-006-2280-4
   Risby TH, 2014, ANAL SCI, V14, P22
   Santini G, 2016, J BREATH RES, V10, DOI 10.1088/1752-7155/10/1/017102
   Savides MC, 1983, J APPL TOXICOL, V3, P96, DOI 10.1002/jat.2550030209
   Scannell C, 1996, AM J RESP CRIT CARE, V154, P24, DOI 10.1164/ajrccm.154.1.8680687
   Schellekens RCA, 2011, BRIT J CLIN PHARMACO, V72, P879, DOI 10.1111/j.1365-2125.2011.04071.x
   Seemann R, 2014, J BREATH RES, V8, DOI 10.1088/1752-7155/8/1/017101
   Sethi S, 2013, CLIN MICROBIOL REV, V26, P462, DOI 10.1128/CMR.00020-13
   Sexton K, 2004, AM SCI, V92, P38, DOI 10.1511/2004.45.921
   Shestivska V, 2015, J BREATH RES, V9, DOI 10.1088/1752-7155/9/2/027104
   SHIMADA T, 1994, J PHARMACOL EXP THER, V270, P414
   Skogstrand K, 2005, CLIN CHEM, V51, P1854, DOI 10.1373/clinchem.2005.052241
   Sleator RD, 2010, MED HYPOTHESES, V74, P214, DOI 10.1016/j.mehy.2009.08.047
   Smith D, 2005, MASS SPECTROM REV, V24, P661, DOI 10.1002/mas.20033
   Smith D, 2002, AM J CLIN NUTR, V76, P1295
   Smith D, 2011, TRAC-TREND ANAL CHEM, V30, P945, DOI 10.1016/j.trac.2011.05.001
   Smith MT, 2009, ENVIRON HEALTH PERSP, V117, pA334, DOI 10.1289/ehp.12812
   Soldatow VY, 2013, TOXICOL RES-UK, V2, P23, DOI 10.1039/c2tx20051a
   Soyer OU, 2006, ALLERGY, V61, P1016, DOI 10.1111/j.1398-9995.2006.01064.x
   Spanel P, 1996, MED BIOL ENG COMPUT, V34, P409, DOI 10.1007/BF02523843
   Spliethoff HM, 2008, ENVIRON SCI TECHNOL, V42, P5361, DOI 10.1021/es8006244
   Spooner N, 2009, ANAL CHEM, V81, P1557, DOI 10.1021/ac8022839
   Stamyr K, 2015, ARCH TOXICOL, V89, P1287, DOI 10.1007/s00204-014-1310-y
   Stiegel MA, 2015, BIOMARKERS, V20, P35, DOI 10.3109/1354750X.2014.988646
   Stix G, 2003, SCI AM, V289, P26, DOI 10.1038/scientificamerican1203-26
   Sun S, 2007, NAT REV CANCER, V7, P778, DOI 10.1038/nrc2190
   Taucher J, 1996, J AGR FOOD CHEM, V44, P3778, DOI 10.1021/jf960640e
   Teeguarden JG, 2016, ENVIRON SCI TECHNOL, V50, P4579, DOI 10.1021/acs.est.5b05311
   Thomas DJ, 2001, TOXICOL APPL PHARM, V176, P127, DOI 10.1006/taap.2001.9258
   Tice RR, 2013, ENVIRON HEALTH PERSP, V121, P756, DOI 10.1289/ehp.1205784
   Tollefsen KE, 2014, REGUL TOXICOL PHARM, V70, P629, DOI 10.1016/j.yrtph.2014.09.009
   Tu RH, 2004, AVIAT SPACE ENVIR MD, V75, P49
   Ussher JR, 2013, ATHEROSCLEROSIS, V231, P456, DOI 10.1016/j.atherosclerosis.2013.10.013
   Vaittinen O, 2013, CURR ANAL CHEM, V9, P463, DOI 10.2174/1573411011309030016
   Vrijheid M, 2014, ENVIRON HEALTH PERSP, V122, P535, DOI 10.1289/ehp.1307204
   WALLACE L, 1993, J EXPO ANAL ENV EPID, V3, P75
   WALLACE L, 1987, ARCH ENVIRON HEALTH, V42, P272, DOI 10.1080/00039896.1987.9935820
   Wallace L, 1986, ENVIRON HEALTH PER S, V104, P861
   WALLACE LA, 1987, TOXICOL LETT, V35, P113, DOI 10.1016/0378-4274(87)90094-4
   WALLACE LA, 1987, ENVIRON RES, V43, P290, DOI 10.1016/S0013-9351(87)80030-0
   WALSH ME, 1983, INJURY, V15, P62, DOI 10.1016/0020-1383(83)90165-1
   WESTER RC, 1986, J TOXICOL ENV HEALTH, V18, P567, DOI 10.1080/15287398609530894
   Wild CP, 2005, CANCER EPIDEM BIOMAR, V14, P1847, DOI 10.1158/1055-9965.EPI-05-0456
   Wild CP, 2012, CANCER EPIDEM BIOMAR, V14, P1847
   Williams J, 2016, J BREATH RES, V10, DOI 10.1088/1752-7155/10/3/032001
   Williams J, 2016, SCI REP-UK, V6, DOI 10.1038/srep25464
   Zhu JJ, 2013, J BREATH RES, V7, DOI 10.1088/1752-7155/7/1/016003
NR 171
TC 11
Z9 11
U1 0
U2 40
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0340-5761
EI 1432-0738
J9 ARCH TOXICOL
JI Arch. Toxicol.
PD NOV
PY 2016
VL 90
IS 11
BP 2669
EP 2682
DI 10.1007/s00204-016-1817-5
PG 14
WC Toxicology
SC Toxicology
GA EA1VR
UT WOS:000386380700007
PM 27585664
OA Bronze
DA 2019-10-23
ER

PT J
AU Amorim, MJB
   Roca, CP
   Scott-Fordsmand, JJ
AF Amorim, Monica J. B.
   Roca, Carlos P.
   Scott-Fordsmand, Janeck J.
TI Effect assessment of engineered nanoparticles in solid media - Current
   insight and the way forward
SO ENVIRONMENTAL POLLUTION
LA English
DT Article
DE High-throughput screening (HTS); High-effect screening (HES); High
   content analysis (HCA); Safety; Systems toxicology; Adverse outcome
   pathway (AOP); Biostatistics
ID METAL-OXIDE NANOPARTICLES; SYSTEMS-PHARMACOLOGY; SILVER NANOPARTICLES;
   RNA-SEQ; TOXICITY; MODEL; REPRODUCIBILITY; MECHANISMS; STRESS; IMPACT
AB Engineered Nanoparticles (ENPs) present novel/added challenges to the established effect assessment modus operandi, requiring an update of used methods. ENPs are dimensionally and physically different from conventional chemicals, which imply that the metrics with which we relate effect and the type of effect responses are different from that of the conventional approach. Effects on organisms are often preceded by changes on the sub-organismal level (cell, genes), dedicated tools have vast potential to detect earlier (and link to) effects on higher levels of organization. High-throughput screening (HTS) is rapid, cost-effective and specific. One way forward is to link HTS to population outcomes, targeting a systems toxicology approach. Although the benefits of integrating various levels of information may seem obvious, this is an even more decisive aspect when rapid answers are needed for ENPs. Here we rank the available tools/methods, highlight main study gaps and list priority needs and the way forward. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Amorim, Monica J. B.] Univ Aveiro, Dept Biol, Aveiro, Portugal.
   [Amorim, Monica J. B.] CESAM, Aveiro, Portugal.
   [Scott-Fordsmand, Janeck J.] Aarhus Univ, Dept Biosci, Vejlsovej 25,POB 314, DK-8600 Silkeborg, Denmark.
   [Roca, Carlos P.] Univ Rovira & Virgili, Dept Chem Engn, Tarragona, Catalonia, Spain.
RP Amorim, MJB (reprint author), Univ Aveiro, Dept Biol, Aveiro, Portugal.
EM mjamorim@ua.pt
RI Amorim, Monica/G-8590-2011; Roca, Carlos P./F-3846-2014;
   Scott-Fordsmand, Janeck/J-6019-2013
OI Amorim, Monica/0000-0001-8137-3295; Roca, Carlos P./0000-0003-0230-1926;
   Scott-Fordsmand, Janeck/0000-0002-2260-1224
CR Benjamini Y, 2010, BIOMETRICAL J, V52, P708, DOI 10.1002/bimj.200900299
   Black MB, 2014, TOXICOL SCI, V137, P385, DOI 10.1093/toxsci/kft249
   Castro-Ferreira MP, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-302
   Eom HJ, 2015, CHEM-BIOL INTERACT, V239, P153, DOI 10.1016/j.cbi.2015.06.031
   Gomes SIL, 2013, J HAZARD MATER, V254, P336, DOI 10.1016/j.jhazmat.2013.04.005
   Karlsson HL, 2008, CHEM RES TOXICOL, V21, P1726, DOI 10.1021/tx800064j
   Kell DB, 2014, DRUG DISCOV TODAY, V19, P171, DOI 10.1016/j.drudis.2013.07.014
   Khatri P, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002375
   Landsiedel R., 2015, ENV POLLUT
   Levard C, 2012, ENVIRON SCI TECHNOL, V46, P6900, DOI 10.1021/es2037405
   Limbach LK, 2007, ENVIRON SCI TECHNOL, V41, P4158, DOI 10.1021/es062629t
   Money ES, 2012, SCI TOTAL ENVIRON, V426, P436, DOI 10.1016/j.scitotenv.2012.03.064
   OECD, 2012, PROP TEMPL GUID DEV
   Ong KJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090650
   Peijnenburg W., 2015, ENV POLLUT
   Peng RD, 2011, SCIENCE, V334, P1226, DOI 10.1126/science.1213847
   Pokhrel S, 2013, ACCOUNTS CHEM RES, V46, P632, DOI 10.1021/ar300032q
   Puzyn T, 2011, NAT NANOTECHNOL, V6, P175, DOI [10.1038/nnano.2011.10, 10.1038/NNANO.2011.10]
   Roca C. P., 2012, EFFICIENT DESIGNING, P89, DOI 10.1039/9781849735476-00089
   Scott-Fordsmand JJ, 2014, NANO TODAY, V9, P546, DOI 10.1016/j.nantod.2014.07.001
   Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239
   Stone V., 2013, RES PRIORITIZATION D
   Su ZQ, 2014, NAT BIOTECHNOL, V32, P903, DOI 10.1038/nbt.2957
   Tarca AL, 2009, BIOINFORMATICS, V25, P75, DOI 10.1093/bioinformatics/btn577
   Vecchio G, 2012, NANOMED-NANOTECHNOL, V8, P1, DOI 10.1016/j.nano.2011.11.001
   Vinken M, 2014, ARCH TOXICOL, V88, P1, DOI 10.1007/s00204-013-1093-6
   Winter GE, 2012, NAT CHEM BIOL, V8, P905, DOI [10.1038/NCHEMBIO.1085, 10.1038/nchembio.1085]
NR 27
TC 13
Z9 13
U1 0
U2 14
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0269-7491
EI 1873-6424
J9 ENVIRON POLLUT
JI Environ. Pollut.
PD NOV
PY 2016
VL 218
BP 1370
EP 1375
DI 10.1016/j.envpol.2015.08.048
PG 6
WC Environmental Sciences
SC Environmental Sciences & Ecology
GA DZ1JZ
UT WOS:000385596000149
PM 26549753
DA 2019-10-23
ER

PT J
AU Milsk, R
   Cavallin, JE
   Durhan, EJ
   Jensen, KM
   Kahl, MD
   Makynen, EA
   Martinovic-Weigelt, D
   Mueller, N
   Schroeder, A
   Villeneuve, DL
   Ankley, GT
AF Milsk, Rebecca
   Cavallin, Jenna E.
   Durhan, Elizabeth J.
   Jensen, Kathleen M.
   Kahl, Michael D.
   Makynen, Elizabeth A.
   Martinovic-Weigelt, Dalma
   Mueller, Nathan
   Schroeder, Anthony
   Villeneuve, Daniel L.
   Ankley, Gerald T.
TI A study of temporal effects of the model anti-androgen flutamide on
   components of the hypothalamic-pituitary-gonadal axis in adult fathead
   minnows
SO AQUATIC TOXICOLOGY
LA English
DT Article
DE Androgen receptor; Antagonist; Flutamide; Fish; Reproduction; Adverse
   outcome pathway
ID RAINBOWFISH MELANOTAENIA-FLUVIATILIS; ENDOCRINE-DISRUPTING CHEMICALS;
   ADVERSE OUTCOME PATHWAYS; TERM REPRODUCTION ASSAY; MEDAKA
   ORYZIAS-LATIPES; PIMEPHALES-PROMELAS; SEXUAL DEVELOPMENT; OOCYTE
   MATURATION; END-POINTS; ANDROGEN
AB The aim of this study was to investigate temporal changes in the hypothalamic-pituitary-gonadal (HPG) axis of fathead minnows (Pimephales promelas) treated with the model androgen receptor (AR) antagonist flutamide. Reproductively-mature fish were exposed in a flow-through test to analytically-confirmed concentrations of either 50 or 500 mu g flutamide/L for 8 d, followed by an 8-d recovery period in clean water. Fish were sampled at 1, 2, 4 and 8 days during each phase of the experiment. Flutamide (500 mu 4/1.) caused significant reductions in relative gonad size of the females on day 8 of the exposure and day 1 of the recovery, and reduced expression of secondary sex characteristics in males during the exposure phase of the experiment. Ex vivo gonadal synthesis of testosterone in both sexes (and 17 beta-estradiol in females) was reduced in the 500 mu g/I. treatment within 2 d of exposure; however, steroid synthesis returned to levels comparable to controls by the end of the exposure portion of the test. Ex vivo testosterone synthesis in males exposed to 50 mu g flutamide/L was greater than in controls on days 4 and 8 of the exposure. Both the enhanced steroid production in the low treatment males, and return to control levels in the high treatment males and females during chemical exposure are indicative of a compensatory HPG response. One contributor to this response could be increased expression of genes responsible for enzymes involved in steroid synthesis; for example, transcripts for both cytochrome P450 side- chain cleavage and 11 beta-hydroxysteroid dehydrogenase were significantly elevated in flutamideexposed males. Overall, responses of the HPG axis in adult male and female fathead minnows exposed to flutamide were both dynamic and comparatively rapid during exposure and recovery. These observations have ramifications both for the development of short-term fish assays to detect endocrine-active chemicals, and the derivation of robust adverse outcome pathways for AR antagonists in fish. Published by Elsevier B.V.
C1 [Milsk, Rebecca] Oak Ridge Inst Sci Educ Res Participat Program, Midcontinent Ecol Div, Duluth, MN USA.
   [Cavallin, Jenna E.] Badger Tech Serv, Midcontinent Ecol Div, Duluth, MN USA.
   [Durhan, Elizabeth J.; Jensen, Kathleen M.; Kahl, Michael D.; Makynen, Elizabeth A.; Villeneuve, Daniel L.; Ankley, Gerald T.] US EPA, Midcontinent Ecol Div, 6201 Congdon Blvd, Duluth, MN 55804 USA.
   [Martinovic-Weigelt, Dalma] Univ St Thomas, Dept Biol, St Paul, MN USA.
   [Mueller, Nathan] Harvard Univ, Organism & Evolutionary Biol, Cambridge, MA 02138 USA.
   [Schroeder, Anthony] Univ Minnesota Crookston, Dept Biol, Crookston, MN USA.
RP Ankley, GT (reprint author), US EPA, Midcontinent Ecol Div, 6201 Congdon Blvd, Duluth, MN 55804 USA.
EM ankley.gerald@epa.gov
OI Martinovic-Weigelt, Dalma/0000-0002-9973-4965
FU US EPA Chemical Safety for Sustainability Research Program
FX We thank Kellie Fay for helpful comments on an earlier draft of this
   paper. Funding for this work was provided in part by the US EPA Chemical
   Safety for Sustainability Research Program. Mention of trade names or
   commercial products does not constitute endorsement or recommendation
   for use. The contents of this manuscript neither constitute, nor
   necessarily reflect US EPA policy.
CR Ankley GT, 2015, TOXICOL SCI, V144, P259, DOI 10.1093/toxsci/kfu320
   Ankley GT, 2014, ENVIRON TOXICOL CHEM, V33, P2529, DOI 10.1002/etc.2708
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Ankley GT, 2009, AQUAT TOXICOL, V92, P168, DOI 10.1016/j.aquatox.2009.01.013
   Ankley GT, 2004, ENVIRON SCI TECHNOL, V38, P6322, DOI 10.1021/es040022b
   Baatrup E, 2001, ENVIRON HEALTH PERSP, V109, P1063, DOI 10.2307/3454962
   Bayley M, 2002, AQUAT TOXICOL, V56, P227, DOI 10.1016/S0166-445X(01)00210-7
   Becker RA, 2015, REGUL TOXICOL PHARM, V72, P514, DOI 10.1016/j.yrtph.2015.04.004
   Bhatia H, 2016, AQUAT TOXICOL, V170, P72, DOI 10.1016/j.aquatox.2015.11.010
   Bhatia H, 2014, ECOTOX ENVIRON SAFE, V109, P143, DOI 10.1016/j.ecoenv.2014.07.027
   Bhatia H, 2014, ENVIRON TOXICOL CHEM, V33, P1098, DOI 10.1002/etc.2524
   BROGDEN RN, 1989, DRUGS, V38, P185, DOI 10.2165/00003495-198938020-00003
   Danylchuk AJ, 2001, BEHAV ECOL, V12, P482, DOI 10.1093/beheco/12.4.482
   Filby AL, 2007, AQUAT TOXICOL, V81, P219, DOI 10.1016/j.aquatox.2006.12.003
   Forsgren KL, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.111.098772
   Garcia-Reyero N, 2009, ENVIRON SCI TECHNOL, V43, P2614, DOI 10.1021/es8024484
   GOLDSPIEL BR, 1990, DICP ANN PHARMAC, V24, P616, DOI 10.1177/106002809002400612
   Hammes SR, 2004, MOL ENDOCRINOL, V18, P769, DOI 10.1210/me.2003-0317
   Jensen KM, 2004, AQUAT TOXICOL, V70, P99, DOI 10.1016/j.aquatox.2004.06.012
   Jensen KM, 2001, COMP BIOCHEM PHYS C, V128, P127, DOI 10.1016/S1532-0456(00)00185-X
   Kang I.J., 2006, MAR ENV RES S, V62, P253
   Katsiadaki I, 2006, ENVIRON HEALTH PERSP, V114, P115, DOI 10.1289//ehp.8063
   Korte JJ, 2000, ENVIRON TOXICOL CHEM, V19, P972, DOI 10.1002/etc.5620190426
   Kortner TM, 2009, J TOXICOL ENV HEAL A, V72, P184, DOI 10.1080/15287390802539020
   Leon A, 2007, AQUAT TOXICOL, V82, P195, DOI 10.1016/j.aquatox.2007.02.012
   Lor Y, 2015, REPROD TOXICOL, V58, P111, DOI 10.1016/j.reprotox.2015.09.003
   Lutz LB, 2001, P NATL ACAD SCI USA, V98, P13728, DOI 10.1073/pnas.241471598
   Martinovic D, 2008, ENVIRON TOXICOL CHEM, V27, P478, DOI 10.1897/07-206R.1
   Martinovic-Weigelt D, 2011, AQUAT TOXICOL, V101, P447, DOI 10.1016/j.aquatox.2010.10.003
   MCMASTER ME, 1995, PROTOCOL MEASURING I
   Nakamura A, 2014, J APPL TOXICOL, V34, P545, DOI 10.1002/jat.2934
   Organisation for Economic Cooperation and Development, 2010, WORKSH REP OECD COUN
   Organization for Economic Development, 2010, FISH SHORT TERM REPR
   Panter GH, 2004, AQUAT TOXICOL, V70, P11, DOI 10.1016/j.aquatox.2004.06.007
   Rajakumar A, 2012, AQUAT TOXICOL, V110, P123, DOI 10.1016/j.aquatox.2011.12.018
   Rostkowski P, 2011, ENVIRON SCI TECHNOL, V45, P10660, DOI 10.1021/es202966c
   Schiller V, 2014, AQUAT TOXICOL, V155, P62, DOI 10.1016/j.aquatox.2014.06.005
   Sun LW, 2016, ENVIRON TOXICOL, V31, P1591, DOI 10.1002/tox.22163
   Villeneuve DL, 2007, TOXICOL SCI, V98, P395, DOI 10.1093/toxsci/kfm124
   Villeneuve DL, 2007, ENVIRON SCI TECHNOL, V41, P321, DOI 10.1021/es061739x
   Villeneuve DL, 2009, ENVIRON HEALTH PERSP, V117, P624, DOI 10.1289/ehp.11891
NR 41
TC 0
Z9 0
U1 0
U2 18
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-445X
EI 1879-1514
J9 AQUAT TOXICOL
JI Aquat. Toxicol.
PD NOV
PY 2016
VL 180
BP 164
EP 172
DI 10.1016/j.aquatox.2016.09.021
PG 9
WC Marine & Freshwater Biology; Toxicology
SC Marine & Freshwater Biology; Toxicology
GA ED3VW
UT WOS:000388777600017
PM 27716581
DA 2019-10-23
ER

PT J
AU Ankley, G
   Escher, B
   Hartung, T
   Shah, I
AF Ankley, Gerald
   Escher, Beate
   Hartung, Thomas
   Shah, Imran
TI Pathway-Based Approaches for Environmental Monitoring and Risk
   Assessment
SO CHEMICAL RESEARCH IN TOXICOLOGY
LA English
DT Editorial Material
C1 [Ankley, Gerald] Univ Minnesota, Dept Fisheries Wildlife & Conservat Biol, St Paul, MN 55108 USA.
   [Ankley, Gerald; Shah, Imran] US EPA, Durham, NC 27711 USA.
   [Escher, Beate] Univ Queensland, Natl Res Ctr Environm Toxicol, Coopers Plains, Qld 4108, Australia.
   [Hartung, Thomas] Johns Hopkins Univ, Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA.
RP Hartung, T (reprint author), 615 N Wolfe St,Room W7035, Baltimore, MD 21205 USA.
EM thartun1@jhu.edu
RI Escher, Beate/C-7992-2009; Shah, Syed I/B-8275-2011
OI Escher, Beate/0000-0002-5304-706X; Shah, Imran/0000-0003-0808-0140
CR Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
NR 1
TC 5
Z9 5
U1 1
U2 23
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0893-228X
EI 1520-5010
J9 CHEM RES TOXICOL
JI Chem. Res. Toxicol.
PD NOV
PY 2016
VL 29
IS 11
BP 1789
EP 1790
DI 10.1021/acs.chemrestox.6b00321
PG 2
WC Chemistry, Medicinal; Chemistry, Multidisciplinary; Toxicology
SC Pharmacology & Pharmacy; Chemistry; Toxicology
GA ED0QY
UT WOS:000388548200001
PM 27933860
DA 2019-10-23
ER

PT J
AU Cote, I
   Andersen, ME
   Ankley, GT
   Barone, S
   Birnbaum, LS
   Boekelheide, K
   Bois, F
   Burgoon, LD
   Chiu, WA
   Crawford-Brown, D
   Crofton, KM
   DeVito, M
   Devlin, RB
   Edwards, SW
   Guyton, KZ
   Hattis, D
   Judson, RS
   Knight, D
   Krewski, D
   Lambert, J
   Maull, EA
   Mendrick, D
   Paoli, GM
   Patel, CJ
   Perkins, EJ
   Poje, G
   Portier, CJ
   Rusyn, I
   Schulte, PA
   Simeonov, A
   Smith, MT
   Thayer, KA
   Thomas, RS
   Thomas, R
   Tice, RR
   Vandenberg, JJ
   Villeneuve, DL
   Wesselkamper, S
   Whelan, M
   Whittaker, C
   White, R
   Xia, M
   Yauk, C
   Zeise, L
   Zhao, J
   DeWoskin, RS
AF Cote, Ila
   Andersen, Melvin E.
   Ankley, Gerald T.
   Barone, Stanley
   Birnbaum, Linda S.
   Boekelheide, Kim
   Bois, FredericY.
   Burgoon, Lyle D.
   Chiu, Weihsueh A.
   Crawford-Brown, Douglas
   Crofton, Kevin M.
   DeVito, Michael
   Devlin, Robert B.
   Edwards, Stephen W.
   Guyton, Kathryn Z.
   Hattis, Dale
   Judson, Richard S.
   Knight, Derek
   Krewski, Daniel
   Lambert, Jason
   Maull, Elizabeth Anne
   Mendrick, Donna
   Paoli, Gregory M.
   Patel, Chirag Jagdish
   Perkins, Edward J.
   Poje, Gerald
   Portier, Christopher J.
   Rusyn, Ivan
   Schulte, Paul A.
   Simeonov, Anton
   Smith, Martyn T.
   Thayer, Kristina A.
   Thomas, Russell S.
   Thomas, Reuben
   Tice, Raymond R.
   Vandenberg, John J.
   Villeneuve, Daniel L.
   Wesselkamper, Scott
   Whelan, Maurice
   Whittaker, Christine
   White, Ronald
   Xia, Menghang
   Yauk, Carole
   Zeise, Lauren
   Zhao, Jay
   DeWoskin, Robert S.
TI The Next Generation of Risk Assessment Multi-Year Study-Highlights of
   Findings, Applications to Risk Assessment, and Future Directions
SO ENVIRONMENTAL HEALTH PERSPECTIVES
LA English
DT Review
ID ADVERSE OUTCOME PATHWAYS; BRONCHIAL EPITHELIAL-CELLS; THROUGHPUT
   SCREENING DATA; IN-VIVO HAZARD; ENVIRONMENTAL CHEMICALS; HUMAN HEALTH;
   GENE-EXPRESSION; POPULATION VARIABILITY; PREDICTIVE TOXICOLOGY;
   ESTROGEN-RECEPTOR
AB BACKGROUND: The Next Generation (NexGen) of Risk Assessment effort is a multi-year collaboration among several organizations evaluating new, potentially more efficient molecular, computational, and systems biology approaches to risk assessment. This article summarizes our findings, suggests applications to risk assessment, and identifies strategic research directions.
   OBJECTIVE: Our specific objectives were to test whether advanced biological data and methods could better inform our understanding of public health risks posed by environmental exposures.
   METHODS: New data and methods were applied and evaluated for use in hazard identification and dose-response assessment. Biomarkers of exposure and effect, and risk characterization were also examined. Consideration was given to various decision contexts with increasing regulatory and public health impacts. Data types included transcriptomics, genomics, and proteomics. Methods included molecular epidemiology and clinical studies, bioinformatic knowledge mining, pathway and network analyses, short-duration in vivo and in vitro bioassays, and quantitative structure activity relationship modeling.
   DISCUSSION: NexGen has advanced our ability to apply new science by more rapidly identifying chemicals and exposures of potential concern, helping characterize mechanisms of action that influence conclusions about causality, exposure-response relationships, susceptibility and cumulative risk, and by elucidating new biomarkers of exposure and effects. Additionally, NexGen has fostered extensive discussion among risk scientists and managers and improved confidence in interpreting and applying new data streams.
   CONCLUSIONS: While considerable uncertainties remain, thoughtful application of new knowledge to risk assessment appears reasonable for augmenting major scope assessments, forming the basis for or augmenting limited scope assessments, and for prioritization and screening of very data limited chemicals.
C1 [Cote, Ila; Vandenberg, John J.; DeWoskin, Robert S.] US EPA, Natl Ctr Environm Assessment, Washington, DC 20460 USA.
   [Andersen, Melvin E.] ScitoVation, Res Triangle Pk, NC USA.
   [Ankley, Gerald T.; Villeneuve, Daniel L.] US EPA, Natl Hlth & Environm Effects Res Lab, Duluth, MN USA.
   [Barone, Stanley] US EPA, Off Chem Safety & Pollut Prevent, Washington, DC 20460 USA.
   [Birnbaum, Linda S.; DeVito, Michael; Maull, Elizabeth Anne; Thayer, Kristina A.; Tice, Raymond R.] NIEHS, POB 12233, Res Triangle Pk, NC 27709 USA.
   [Birnbaum, Linda S.; DeVito, Michael; Maull, Elizabeth Anne; Thayer, Kristina A.; Tice, Raymond R.] NIH, Natl Toxicol Program, DHHS, Res Triangle Pk, NC USA.
   [Boekelheide, Kim] Brown Univ, Dept Pathol & Lab Med, Providence, RI 02912 USA.
   [Bois, FredericY.] Inst Natl Environm Ind & Risques, Unite Modeles Icotoxicol & Toxicol, Verneuil En Halatte, France.
   [Burgoon, Lyle D.] US Army, Engineer Res & Dev Ctr, Res Triangle Pk, NC USA.
   [Chiu, Weihsueh A.; Rusyn, Ivan] Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Vet Integrat Biosci, College Stn, TX USA.
   [Crawford-Brown, Douglas] Univ Cambridge, Dept Land Econ, Cambridge, England.
   [Crofton, Kevin M.; Judson, Richard S.; Thomas, Russell S.] Natl Ctr Computat Toxicol, Res Triangle Pk, NC USA.
   [Devlin, Robert B.; Edwards, Stephen W.] US EPA, Natl Hlth & Environm Effects Res Lab, Res Triangle Pk, NC 27711 USA.
   [Guyton, Kathryn Z.] Int Agcy Res Canc, Lyon, France.
   [Hattis, Dale] Clark Univ, George Perkins Marsh Inst, Worcester, MA 01610 USA.
   [Knight, Derek] European Chem Agcy, Helsinki, Finland.
   [Krewski, Daniel] Univ Ottawa, McLaughlin Ctr Populat Hlth Risk Assessment, Ottawa, ON, Canada.
   [Lambert, Jason; Wesselkamper, Scott; Zhao, Jay] US EPA, Natl Ctr Environm Assessment, Cincinnati, OH 45268 USA.
   [Mendrick, Donna] US FDA, Natl Ctr Toxicol Res, Jefferson, AR 72079 USA.
   [Paoli, Gregory M.] Risk Sci Int, Ottawa, ON, Canada.
   [Patel, Chirag Jagdish] Harvard Med Sch, Dept Biomed Informat, Boston, MA USA.
   [Perkins, Edward J.] US Army, Engineer Res & Dev Ctr, Vicksburg, MS USA.
   [Poje, Gerald] Grant Consulting Grp, Washington, DC USA.
   [Portier, Christopher J.] Environm Def Fund, Washington, DE USA.
   [Schulte, Paul A.; Whittaker, Christine] Ctr Dis Control & Prevent, Natl Inst Occupat Safety & Hlth, Educ & Informat Div, Cincinnati, OH USA.
   [Simeonov, Anton; Xia, Menghang] NIH, Natl Ctr Adv Translat Sci, DHHS, Bethesda, MD USA.
   [Smith, Martyn T.] Univ Calif Berkeley, Sch Publ Hlth, Div Environm Hlth Sci, Berkeley, CA 94720 USA.
   [Thomas, Reuben] Univ Calif San Francisco, Gladstone Inst, San Francisco, CA 94143 USA.
   [Whelan, Maurice] European Commiss Joint Res Ctr, Syst Toxicol Unit, Ispra, Italy.
   [White, Ronald] Ctr Effect Govt, Washington, DE USA.
   [Yauk, Carole] Hlth Canada, Environm Hlth Sci & Res Bur, Ottawa, ON, Canada.
   [Zeise, Lauren] Calif EPA, Off Environm Hlth Hazard Assessment, Oakland, CA USA.
RP Cote, I (reprint author), US EPA, Reg 8,Room 8152,1595 Wynkoop St, Denver, CO 80202 USA.
EM cote.ila@epa.gov
RI Burgoon, Lyle D./I-2894-2019; Rusyn, Ivan/S-2426-2016; Bois,
   Frederic/E-9241-2012
OI Burgoon, Lyle D./0000-0003-4977-5352; Bois,
   Frederic/0000-0002-4154-0391; Vandenberg, John/0000-0003-2619-9460;
   Andersen, Melvin/0000-0002-3894-4811; DeVito,
   Michael/0000-0003-1258-4894; Birnbaum, Linda/0000-0001-5429-5658
FU NIEHS NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Environmental
   Health Sciences (NIEHS) [P30 ES023512, R00 ES023504, K99 ES023504, R21
   ES025052, P42 ES005948]
CR Abdo N, 2015, ENVIRON INT, V85, P147, DOI 10.1016/j.envint.2015.09.012
   Abdo N, 2015, ENVIRON HEALTH PERSP, V123, P458, DOI 10.1289/ehp.1408775
   Adeleye Y, 2015, TOXICOLOGY, V332, P102, DOI 10.1016/j.tox.2014.02.007
   Ankley GT, 2013, ENVIRON TOXICOL CHEM, V32, P1084, DOI 10.1002/etc.2151
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   [Anonymous], 2013, SER TEST ASS
   Attene-Ramos MS, 2015, ENVIRON HEALTH PERSP, V123, P49, DOI 10.1289/ehp.1408642
   Attene-Ramos MS, 2013, DRUG DISCOV TODAY, V18, P716, DOI 10.1016/j.drudis.2013.05.015
   Audouze K, 2013, SCI REP-UK, V3, DOI 10.1038/srep02712
   Bell SM, 2016, TOXICOL SCI, V150, P510, DOI 10.1093/toxsci/kfw017
   Bell SM, 2015, ENVIRON HEALTH PERSP, V123, P1193, DOI 10.1289/ehp.1409138
   Bourdon-Lacombe JA, 2015, REGUL TOXICOL PHARM, V72, P292, DOI 10.1016/j.yrtph.2015.04.010
   Carter H, 2013, CURR OPIN GENET DEV, V23, P611, DOI 10.1016/j.gde.2013.10.003
   Casey W, 2015, J AM ASSOC LAB ANIM, V54, P170
   Cho HY, 2013, OXID MED CELL LONGEV, V2013, DOI [10.1155/2013/254069, DOI 10.1155/2013/254069]
   Cote I, 2012, ENVIRON HEALTH PERSP, V120, P1499, DOI 10.1289/ehp.1104870
   Cox LA, 2014, REGUL TOXICOL PHARM, V69, P443, DOI 10.1016/j.yrtph.2014.05.010
   Crawford-Brown D., 2013, J ENV PROT IRVINE CA, V4, P238
   CRUMP KS, 1976, CANCER RES, V36, P2973
   Davis AP, 2015, NUCLEIC ACIDS RES, V43, pD914, DOI 10.1093/nar/gku935
   DeWoskin RS, 2014, ENCY TOXICOLOGY, V4, P948
   Diaz Ochoa Juan G, 2012, Front Pharmacol, V3, P204, DOI 10.3389/fphar.2012.00204
   Dimas AS, 2014, DIABETES, V63, P2158, DOI 10.2337/db13-0949
   Duncan KE, 2012, AM J RESP CRIT CARE, V185, pA4291, DOI [10.1164/ajrccm-conference.2012.185.1_MeetingAbstracts.A4291, DOI 10.1164/AJRCCM-CONFERENCE.2012.185.1_MEETINGABSTRACTS.A4291]
   EC (European Commission), 2016, SEURAT 1 REPL VIV RE
   EC JRC (European Commission Joint Research Centre), 2015, EURL ECVAM STAT REP
   ECHA, 2016, OECD EU TEST GUID
   ECHA. (European Chemical Agency), 2016, ECHA NEWS QSAR TOOLB
   Eduati F, 2015, NAT BIOTECHNOL, V33, P933, DOI 10.1038/nbt.3299
   Esposito S, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-31
   Freitas Jaime, 2014, Curr Chem Genom Transl Med, V8, P36, DOI 10.2174/2213988501408010036
   French JE, 2015, ENVIRON HEALTH PERSP, V123, P237, DOI 10.1289/ehp.1408202
   Friend S., 2013, PRES NAT AC SCI M IN
   Garcia-Reyero N, 2015, ENVIRON SCI TECHNOL, V49, P3, DOI 10.1021/es504976d
   Geer LY, 2010, NUCLEIC ACIDS RES, V38, pD492, DOI 10.1093/nar/gkp858
   Ghantous A, 2015, MUTAGENESIS, V30, P733, DOI 10.1093/mutage/gev010
   Godderis L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039205
   Golbraikh A., 2012, HDB COMPUTATIONAL CH, P1309
   Goldsmith Michael R, 2012, Methods Mol Biol, V929, P139
   Harrill AH, 2009, GENOME RES, V19, P1507, DOI 10.1101/gr.090241.108
   Harrill AH, 2009, TOXICOL SCI, V110, P235, DOI 10.1093/toxsci/kfp096
   Hatch GE, 2014, TOXICOL SCI, V141, P198, DOI 10.1093/toxsci/kfu115
   Hatzimichael E, 2013, J DRUG DELIV, DOI 10.1155/2013/529312
   Hood Leroy, 2012, Genomics Proteomics & Bioinformatics, V10, P181, DOI 10.1016/j.gpb.2012.08.004
   Hsu CW, 2014, SCI REP-UK, V4, DOI 10.1038/srep06437
   Huang RL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10425
   Huang RL, 2014, SCI REP-UK, V4, DOI 10.1038/srep05664
   Hubal EAC, 2009, TOXICOL SCI, V111, P226, DOI 10.1093/toxsci/kfp159
   IARC, 2010, IARC MONOGR EVAL CAR, V92
   IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2012, IARC MON EV CARC RIS, V100F, P249
   Ideker T, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2011.99
   Inadera H, 2013, ENVIRON HEALTH PREV, V18, P185, DOI 10.1007/s12199-013-0328-8
   JRC (Joint Research Centre), 2016, ALT AN TEST SAF ASS
   Judson R, 2014, BASIC CLIN PHARMACOL, V115, P69, DOI 10.1111/bcpt.12239
   Judson R, 2013, ALTEX-ALTERN ANIM EX, V30, P51, DOI 10.14573/altex.2013.1.051
   Judson RS, 2015, TOXICOL SCI, V148, P137, DOI 10.1093/toxsci/kfv168
   Judson RS, 2012, INT J MOL SCI, V13, P1805, DOI 10.3390/ijms13021805
   Judson RS, 2011, CHEM RES TOXICOL, V24, P451, DOI 10.1021/tx100428e
   Judson RS, 2010, ENVIRON SCI TECHNOL, V44, P5979, DOI 10.1021/es102150z
   Kasahara DI, 2015, AM J PHYSIOL-LUNG C, V309, pL736, DOI 10.1152/ajplung.00372.2014
   Kavlock R, 2012, CHEM RES TOXICOL, V25, P1287, DOI 10.1021/tx3000939
   Kleinstreuer NC, 2016, REGUL TOXICOL PHARM, V76, P39, DOI 10.1016/j.yrtph.2016.01.007
   Kleinstreuer NC, 2014, NAT BIOTECHNOL, V32, P583, DOI 10.1038/nbt.2914
   Knudsen T. B., 2011, HDB SYSTEMS TOXICOLO, P599
   Knudsen Thomas, 2013, Methods Mol Biol, V947, P343, DOI 10.1007/978-1-62703-131-8_26
   Knudsen TB, 2015, TOXICOL SCI, V143, P256, DOI 10.1093/toxsci/kfu234
   Krewski D, 2014, ENVIRON HEALTH PERSP, V122, P796, DOI 10.1289/ehp.1307260
   Krewski D, 2011, ANNU REV PUBL HEALTH, V32, P161, DOI 10.1146/annurev-publhealth-031210-101153
   LaLone CA, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2014.0022
   Langley G, 2015, ENVIRON HEALTH PERSP, V123, pA268, DOI 10.1289/ehp.1510345
   Lock EF, 2012, TOXICOL SCI, V126, P578, DOI 10.1093/toxsci/kfs023
   Mansouri K, 2016, ENVIRON HEALTH PERSP, V124, P1023, DOI 10.1289/ehp.1510267
   Mattes W, 2014, ADV CLIN CHEM, V67, P1, DOI 10.1016/bs.acc.2014.09.001
   McConnell ER, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110379
   McCullough SD, 2016, TOXICOL SCI, V150, P216, DOI 10.1093/toxsci/kfv324
   McCullough SD, 2014, AM J RESP CELL MOL, V51, P426, DOI 10.1165/rcmb.2013-0515OC
   McHale CM, 2014, ANN NY ACAD SCI, V1310, P74, DOI 10.1111/nyas.12382
   McHale CM, 2012, CARCINOGENESIS, V33, P240, DOI 10.1093/carcin/bgr297
   McHale CM, 2011, ENVIRON HEALTH PERSP, V119, P628, DOI 10.1289/ehp.1002546
   Mendrick DL, 2011, PHARMACOGENOMICS, V12, P235, DOI 10.2217/PGS.10.184
   Mortensen HM, 2013, TOXICOL APPL PHARM, V271, P395, DOI 10.1016/j.taap.2011.01.015
   NAFTA (North American Free Trade Agreement Technical Working Group on Pesticides), 2012, Q UANT STRUCT ACT RE
   National Research Council (NRC), 2014, REV EPAS INT RISK IN
   NHGRI (National Human Genome Research Institute), 2015, CATALOG PUBLISHED GE
   NIEHS (National Institute of Environmental Health Sciences), 2015, NIEHS SING NUCL POL
   Nishihara K, 2016, MUTAGENESIS, V31, P69, DOI 10.1093/mutage/gev055
   NRC, 2007, TOXICITY TESTING 21
   NRC, 2009, SCI DEC ADV RISK ASS
   NRC, 2011, STAND COMM US EM SCI
   O'Shea SH, 2011, TOXICOL SCI, V119, P398, DOI 10.1093/toxsci/kfq322
   OECD, 2016, IECD QSAR TOOLB VERS
   OECD, 2016, OTH ACT MOL SCREEN T
   Padilla S, 2012, REPROD TOXICOL, V33, P174, DOI 10.1016/j.reprotox.2011.10.018
   Painter K, 2014, INTEGR ENVIRON ASSES, V10, P37, DOI 10.1002/ieam.1486
   Patel CJ, 2013, GENOME MED, V5, DOI 10.1186/gm462
   Patel CJ, 2013, HUM GENET, V132, P495, DOI 10.1007/s00439-012-1258-z
   Patel CJ, 2012, BIOINFORMATICS, V28, pI121, DOI 10.1093/bioinformatics/bts229
   Perkins EJ, 2013, ENVIRON HEALTH PERSP, V121, P1002, DOI 10.1289/ehp.1306638
   Politi R, 2014, TOXICOL APPL PHARM, V280, P177, DOI 10.1016/j.taap.2014.07.009
   Rotroff DM, 2013, CHEM RES TOXICOL, V26, P1097, DOI 10.1021/tx400117y
   Rotroff DM, 2010, TOXICOL SCI, V117, P348, DOI 10.1093/toxsci/kfq220
   Rusyn I, 2012, TOXICOL SCI, V127, P1, DOI 10.1093/toxsci/kfs095
   Ryan KR, 2016, NEUROTOXICOLOGY, V53, P271, DOI 10.1016/j.neuro.2016.02.003
   Schadt EE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3002132
   Settivari RS, 2015, J AM ASSOC LAB ANIM, V54, P214
   Shah I, 2010, J TOXICOL ENV HEAL B, V13, P314, DOI 10.1080/10937404.2010.483948
   Sipes NS, 2013, CHEM RES TOXICOL, V26, P878, DOI [10.1021/tx400021f, 10.1021/tx400021]
   Sipes NS, 2011, TOXICOL SCI, V124, P109, DOI 10.1093/toxsci/kfr220
   Sipes NS, 2011, BIRTH DEFECTS RES C, V93, P256, DOI 10.1002/bdrc.20214
   Smith MT, 2016, ENVIRON HEALTH PERSP, V124, P713, DOI 10.1289/ehp.1509912
   Smith MT, 2011, CHEM-BIOL INTERACT, V192, P155, DOI 10.1016/j.cbi.2011.02.010
   Smith MT, 2010, ANNU REV PUBL HEALTH, V31, P133, DOI 10.1146/annurev.publhealth.012809.103646
   Thayer KA, 2012, ENVIRON HEALTH PERSP, V120, P779, DOI 10.1289/ehp.1104597
   Thienpont B, 2011, ENVIRON SCI TECHNOL, V45, P7525, DOI 10.1021/es202248h
   Thomas R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091828
   Thomas R, 2013, ENVIRON MOL MUTAGEN, V54, P566, DOI 10.1002/em.21801
   Thomas R, 2012, INT J ENV RES PUB HE, V9, P2479, DOI 10.3390/ijerph9072479
   Thomas RS, 2013, TOXICOL SCI, V136, P4, DOI 10.1093/toxsci/kft178
   Thomas RS, 2013, TOXICOL SCI, V134, P180, DOI 10.1093/toxsci/kft094
   Thomas RS, 2013, TOXICOL SCI, V131, P629, DOI 10.1093/toxsci/kfs314
   Thomas RS, 2012, TOXICOL SCI, V128, P398, DOI 10.1093/toxsci/kfs159
   Thomas RS, 2012, MUTAT RES-GEN TOX EN, V746, P135, DOI 10.1016/j.mrgentox.2012.01.007
   Thomas RS, 2011, TOXICOL SCI, V120, P194, DOI 10.1093/toxsci/kfq355
   Tice RR, 2013, ENVIRON HEALTH PERSP, V121, P756, DOI 10.1289/ehp.1205784
   Tollefsen KE, 2014, REGUL TOXICOL PHARM, V70, P629, DOI 10.1016/j.yrtph.2014.09.009
   U.S. EPA, 2015, 601K15002 US EPA
   U.S. EPA, 2011, EPA600R11101
   U.S. EPA, 2015, 601K15003 US EPA
   U.S. EPA, 2013, IRIS TOX REV BENZ PY
   U.S. EPA, 2013, EPA600R10076
   U.S. EPA, 2015, ISCA CHEM SUBST INV
   U.S. EPA, 2014, EPA600R14004
   U.S. EPA, 2011, US OM TECHN INF RISK
   U.S. EPA, 2011, END DISR SCEEN PROGR
   U.S. EPA, 2016, SCI ACT INN RES SUST
   U.S. EPA (U. S. Environmental Protection Agency), 2011, EPA600R11100
   USDHHS (U.S. Department of Health and Human Services), 2014, HLTH CONS SMOK 50 YE
   Venkatapathy Raghuraman, 2013, Methods Mol Biol, V930, P305, DOI 10.1007/978-1-62703-059-5_14
   Vermeulen R, 2004, ANN OCCUP HYG, V48, P105, DOI 10.1093/annhyg/meh005
   Villeneuve D, 2014, ENVIRON TOXICOL CHEM, V33, P158, DOI 10.1002/etc.2403
   Vinken M, 2013, TOXICOLOGY, V312, P158, DOI 10.1016/j.tox.2013.08.011
   Wambaugh JF, 2015, TOXICOL SCI, V147, P55, DOI 10.1093/toxsci/kfv118
   Wang NCY, 2012, J TOXICOL, DOI 10.1155/2012/410143
   Wang NCY, 2012, REGUL TOXICOL PHARM, V63, P10, DOI 10.1016/j.yrtph.2012.02.006
   Wang NCY, 2011, REGUL TOXICOL PHARM, V59, P215, DOI 10.1016/j.yrtph.2010.09.019
   Weiss JN, 2012, CIRC RES, V111, P493, DOI 10.1161/CIRCRESAHA.112.269084
   Wetmore BA, 2013, TOXICOL SCI, V132, P327, DOI 10.1093/toxsci/kft012
   Wetmore BA, 2012, TOXICOL SCI, V125, P157, DOI 10.1093/toxsci/kfr254
   Wright FA, 2012, PHARMACOGENOMICS, V13, P343, DOI [10.2217/PGS.11.185, 10.2217/pgs.11.185]
   Wu WD, 2015, ENVIRON HEALTH PERSP, V123, P231, DOI 10.1289/ehp.1307379
   Zeise L, 2013, ENVIRON HEALTH PERSP, V121, P23, DOI 10.1289/ehp.1205687
   Zhang LP, 2014, ENVIRON MOL MUTAGEN, V55, P679, DOI 10.1002/em.21885
NR 152
TC 29
Z9 30
U1 1
U2 73
PU US DEPT HEALTH HUMAN SCIENCES PUBLIC HEALTH SCIENCE
PI RES TRIANGLE PK
PA NATL INST HEALTH, NATL INST ENVIRONMENTAL HEALTH SCIENCES, PO BOX 12233,
   RES TRIANGLE PK, NC 27709-2233 USA
SN 0091-6765
EI 1552-9924
J9 ENVIRON HEALTH PERSP
JI Environ. Health Perspect.
PD NOV
PY 2016
VL 124
IS 11
BP 1671
EP 1682
DI 10.1289/EHP233
PG 12
WC Environmental Sciences; Public, Environmental & Occupational Health;
   Toxicology
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health; Toxicology
GA EA8UF
UT WOS:000386913800010
PM 27091369
OA DOAJ Gold, Green Published
DA 2019-10-23
ER

PT J
AU Ankley, GT
   LaLone, CA
   Gray, LE
   Villeneuve, DL
   Hornung, MW
AF Ankley, Gerald T.
   LaLone, Carlie A.
   Gray, L. Earl
   Villeneuve, Daniel L.
   Hornung, Michael W.
TI EVALUATION OF THE SCIENTIFIC UNDERPINNINGS FOR IDENTIFYING ESTROGENIC
   CHEMICALS IN NONMAMMALIAN TAXA USING MAMMALIAN TEST SYSTEMS
SO ENVIRONMENTAL TOXICOLOGY AND CHEMISTRY
LA English
DT Article
DE Prioritization; Species extrapolation; Estrogen; Hazard assessment
ID ADVERSE OUTCOME PATHWAYS; ENDOCRINE DISRUPTION; RISK-ASSESSMENT;
   RECEPTOR-ALPHA; IN-VITRO; ENVIRONMENTAL ESTROGENS; UTEROTROPHIC
   BIOASSAY; AQUATIC ENVIRONMENT; SPECIES-DIFFERENCES; MOLECULAR-CLONING
AB The US Environmental Protection Agency has responsibility for assessing endocrine activity of more than 10 000 chemicals, a task that cannot reasonably be achieved solely through use of available mammalian and nonmammalian in vivo screening assays. Hence, it has been proposed that chemicals be prioritized for in vivo testing using data from in vitro high-throughput assays for specific endocrine system targets. Recent efforts focused on potential estrogenic chemicals-specifically those that activate estrogen receptor-alpha (ER alpha)-have broadly demonstrated feasibility of the approach. However, a major uncertainty is whether prioritization based on mammalian (primarily human) high-throughput assays accurately reflects potential chemical-ER alpha interactions in nonmammalian species. The authors conducted a comprehensive analysis of cross-species comparability of chemical-ER alpha interactions based on information concerning structural attributes of estrogen receptors, in vitro binding and transactivation data for ER alpha, and the effects of a range of chemicals on estrogen-signaling pathways in vivo. Overall, this integrated analysis suggests that chemicals with moderate to high estrogenic potency in mammalian systems also should be priority chemicals in nonmammalian vertebrates. However, the degree to which the prioritization approach might be applicable to invertebrates is uncertain because of a lack of knowledge of the biological role(s) of possible ER alpha orthologs found in phyla such as annelids. Further, comparative analysis of in vitro data for fish and reptiles suggests that mammalian-based assays may not effectively capture ER alpha interactions for low-affinity chemicals in all vertebrate classes. Published 2016 Wiley Periodicals Inc. on behalf of SETAC. This article is a US Government work and, as such, is in the public domain in the United States of America.
C1 [Ankley, Gerald T.; LaLone, Carlie A.; Villeneuve, Daniel L.; Hornung, Michael W.] US EPA, Midcontinent Ecol Div, Duluth, MN 55804 USA.
   [Gray, L. Earl] US EPA, Tox Assessment Div, Res Triangle Pk, NC 27711 USA.
RP Ankley, GT (reprint author), US EPA, Midcontinent Ecol Div, Duluth, MN 55804 USA.
EM ankley.gerald@epa.gov
OI gray jr, leon earl/0000-0002-1111-4754
CR Ankley GT, 2013, ENVIRON TOXICOL CHEM, V32, P1084, DOI 10.1002/etc.2151
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   [Anonymous], 1998, END DISR SCREEN TEST
   Aris AZ, 2014, ENVIRON INT, V69, P104, DOI 10.1016/j.envint.2014.04.011
   Bouter A, 2010, BBA-GENE REGUL MECH, V1799, P546, DOI 10.1016/j.bbagrm.2010.07.003
   Bridgham JT, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000191
   Brown AR, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0576
   Browne P, 2015, ENVIRON SCI TECHNOL, V49, P8804, DOI 10.1021/acs.est.5b02641
   Brzozowski AM, 1997, NATURE, V389, P753, DOI 10.1038/39645
   Dang ZC, 2011, TOXICOL LETT, V201, P152, DOI 10.1016/j.toxlet.2010.12.020
   Dang ZC, 2010, TOXICOL LETT, V192, P298, DOI 10.1016/j.toxlet.2009.11.004
   Davis LK, 2010, J STEROID BIOCHEM, V122, P272, DOI 10.1016/j.jsbmb.2010.05.009
   Ellem SJ, 2009, ANN NY ACAD SCI, V1155, P174, DOI 10.1111/j.1749-6632.2009.04360.x
   Feng Q, 2014, STEROIDS, V90, P39, DOI 10.1016/j.steroids.2014.06.008
   Garcia-Alonso J, 2005, INVERTEBR REPROD DEV, V48, P95, DOI 10.1080/07924259.2005.9652175
   Garcia-Reyero N, 2015, ENVIRON SCI TECHNOL, V49, P3, DOI 10.1021/es504976d
   Griffin LB, 2013, ENDOCRINOLOGY, V154, P4158, DOI 10.1210/en.2013-1446
   Gruber CJ, 2004, TRENDS ENDOCRIN MET, V15, P73, DOI 10.1016/j.tem.2004.01.008
   Gunnarsson L, 2008, ENVIRON SCI TECHNOL, V42, P5807, DOI 10.1021/es8005173
   HART JE, 1990, PHARMACOL THERAPEUT, V47, P203, DOI 10.1016/0163-7258(90)90087-I
   Henttu PMA, 1997, MOL CELL BIOL, V17, P1832, DOI 10.1128/MCB.17.4.1832
   Heringa M, 2004, ENVIRON SCI TECHNOL, V38, P6236
   Hornung MW, 2014, SAR QSAR ENVIRON RES, V25, P289, DOI 10.1080/1062936X.2014.898692
   Huang YW, 2005, ENVIRON TOXICOL CHEM, V24, P2002, DOI 10.1897/04-378R1.1
   Hutchinson TH, 2006, ENVIRON HEALTH PERSP, V114, P106, DOI 10.1289/ehp.8062
   Kanno J, 2003, ENVIRON HEALTH PERSP, V111, P1550, DOI 10.1289/ehp.5870
   Katsu Y, 2010, ENDOCRINOLOGY, V151, P5710, DOI 10.1210/en.2010-0356
   Katsu Y, 2010, GEN COMP ENDOCR, V168, P496, DOI 10.1016/j.ygcen.2010.06.010
   Katsu Y, 2010, GEN COMP ENDOCR, V168, P220, DOI 10.1016/j.ygcen.2010.01.002
   Keay J, 2006, ENDOCRINOLOGY, V147, P3861, DOI 10.1210/en.2006-0363
   Keay J, 2009, ENDOCRINOLOGY, V150, P1731, DOI 10.1210/en.2008-1338
   Klinge CM, 2001, NUCLEIC ACIDS RES, V29, P2905, DOI 10.1093/nar/29.14.2905
   Kunz PY, 2006, TOXICOL SCI, V90, P349, DOI 10.1093/toxsci/kfj082
   LaLone CA, 2013, AQUAT TOXICOL, V144, P141, DOI 10.1016/j.aquatox.2013.09.004
   Laurenson JP, 2014, AAPS J, V16, P299, DOI 10.1208/s12248-014-9561-3
   Matthews J, 2000, J STEROID BIOCHEM, V74, P223, DOI 10.1016/S0960-0760(00)00126-6
   Matthews JB, 2002, J STEROID BIOCHEM, V82, P181, DOI 10.1016/S0960-0760(02)00159-0
   McInerney EM, 1996, MOL ENDOCRINOL, V10, P1519, DOI 10.1210/me.10.12.1519
   McRobb FM, 2014, ENVIRON SCI TECHNOL, V48, P1964, DOI 10.1021/es404568a
   Miyagawa S, 2014, ENVIRON SCI TECHNOL, V48, P5254, DOI 10.1021/es5002659
   Nagler JJ, 2007, GENE, V392, P164, DOI 10.1016/j.gene.2006.12.030
   Naidoo V, 2008, GEN COMP ENDOCR, V159, P188, DOI 10.1016/j.ygcen.2008.08.010
   Nilsson S, 2010, PROTEINS CELL REGUL, V8, P91, DOI 10.1007/978-90-481-3303-1_5
   Norris DO, 2014, VERTEBRATE ENDOCRINO
   Organisation for Economic Co-operation and Development, 2013, SER TEST ASS, V184
   Organisation of Economic Co-operation and Development, 2010, SER TEST ASS, V135, P34
   Owens JW, 2002, CRIT REV TOXICOL, V32, P445, DOI 10.1080/20024091064291
   Perkins EJ, 2013, ENVIRON HEALTH PERSP, V121, P1002, DOI 10.1289/ehp.1306638
   Rider CV, 2010, ENVIRON TOXICOL CHEM, V29, P2064, DOI 10.1002/etc.233
   Rider CV, 2009, ENVIRON TOXICOL CHEM, V28, P2175, DOI 10.1897/09-018.1
   Rider CV, 2009, TOXICOL LETT, V184, P85, DOI 10.1016/j.toxlet.2008.10.015
   Russom CL, 2014, ENVIRON TOXICOL CHEM, V33, P2157, DOI 10.1002/etc.2662
   Schmieder PK, 2004, ENVIRON SCI TECHNOL, V38, P6333, DOI 10.1021/es0495314
   Segner H, 2013, GEN COMP ENDOCR, V191, P190, DOI 10.1016/j.ygcen.2013.05.015
   Seibert H, 2002, TOXICOL IN VITRO, V16, P289, DOI 10.1016/S0887-2333(02)00014-0
   Sumida K, 2003, J STEROID BIOCHEM, V84, P33, DOI 10.1016/S0960-0760(03)00003-7
   SUMPTER JP, 1995, ENVIRON HEALTH PERSP, V103, P173, DOI 10.2307/3432529
   Tanenbaum DM, 1998, P NATL ACAD SCI USA, V95, P5998, DOI 10.1073/pnas.95.11.5998
   Thornton JW, 2003, SCIENCE, V301, P1714, DOI 10.1126/science.1086185
   Thornton JW, 2001, P NATL ACAD SCI USA, V98, P5671, DOI 10.1073/pnas.091553298
   Tohyama S, 2015, ENVIRON SCI TECHNOL, V49, P7439, DOI 10.1021/acs.est.5b00704
   US Environmental Protection Agency, 2014, INT BIOACT EXP RANK
   Venkatesh B, 2007, PLOS BIOL, V5, P932, DOI 10.1371/journal.pbio.0050101
   Vrtacnik P, 2014, BIOCHEM MEDICA, V24, P329, DOI 10.11613/BM.2014.035
   Wheeler JR, 2005, TOXICOL MECH METHOD, V15, P293, DOI 10.1080/15376520590968789
   *WHO, 2002, GLOB ASS STAT OF SCI
   Yost EE, 2014, ENVIRON SCI TECHNOL, V48, P5211, DOI 10.1021/es404093n
NR 67
TC 11
Z9 11
U1 2
U2 17
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0730-7268
EI 1552-8618
J9 ENVIRON TOXICOL CHEM
JI Environ. Toxicol. Chem.
PD NOV
PY 2016
VL 35
IS 11
BP 2806
EP 2816
DI 10.1002/etc.3456
PG 11
WC Environmental Sciences; Toxicology
SC Environmental Sciences & Ecology; Toxicology
GA EA2XU
UT WOS:000386461000019
PM 27074246
DA 2019-10-23
ER

PT J
AU Ruiter, S
   Sippel, J
   Bouwmeester, MC
   Lommelaars, T
   Beekhof, P
   Hodemaekers, HM
   Bakker, F
   van den Brandhof, EJ
   Pennings, JLA
   van der Ven, LTM
AF Ruiter, Sander
   Sippel, Josefine
   Bouwmeester, Manon C.
   Lommelaars, Tobias
   Beekhof, Piet
   Hodemaekers, Hennie M.
   Bakker, Frank
   van den Brandhof, Evert-Jan
   Pennings, Jeroen L. A.
   van der Ven, Leo T. M.
TI Programmed Effects in Neurobehavior and Antioxidative Physiology in
   Zebrafish Embryonically Exposed to Cadmium: Observations and
   Hypothesized Adverse Outcome Pathway Framework
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Article
DE developmental origins of health and disease (DOHaD); programming;
   epigenetics; DNA methylation; cadmium; glutathione;
   S-adenosyl-methionine; oxidative stress; adverse outcome pathway (AOP);
   zebrafish
ID OXIDATIVE STRESS; DNA METHYLATION; MALIGNANT-TRANSFORMATION;
   DEVELOPMENTAL ORIGINS; CELLS; EXPRESSION; BEHAVIOR; DISEASE; REDOX;
   MECHANISMS
AB Non-communicable diseases (NCDs) are a major cause of premature mortality. Recent studies show that predispositions for NCDs may arise from early-life exposure to low concentrations of environmental contaminants. This developmental origins of health and disease (DOHaD) paradigm suggests that programming of an embryo can be disrupted, changing the homeostatic set point of biological functions. Epigenetic alterations are a possible underlying mechanism. Here, we investigated the DOHaD paradigm by exposing zebrafish to subtoxic concentrations of the ubiquitous contaminant cadmium during embryogenesis, followed by growth under normal conditions. Prolonged behavioral responses to physical stress and altered antioxidative physiology were observed approximately ten weeks after termination of embryonal exposure, at concentrations that were 50-3200-fold below the direct embryotoxic concentration, and interpreted as altered developmental programming. Literature was explored for possible mechanistic pathways that link embryonic subtoxic cadmium to the observed apical phenotypes, more specifically, the probability of molecular mechanisms induced by cadmium exposure leading to altered DNA methylation and subsequently to the observed apical phenotypes. This was done using the adverse outcome pathway model framework, and assessing key event relationship plausibility by tailored Bradford-Hill analysis. Thus, cadmium interaction with thiols appeared to be the major contributor to late-life effects. Cadmium-thiol interactions may lead to depletion of the methyl donor S-adenosyl-methionine, resulting in methylome alterations, and may, additionally, result in oxidative stress, which may lead to DNA oxidation, and subsequently altered DNA methyltransferase activity. In this way, DNA methylation may be affected at a critical developmental stage, causing the observed apical phenotypes.
C1 [Ruiter, Sander; Sippel, Josefine; Bouwmeester, Manon C.; Lommelaars, Tobias; Beekhof, Piet; Hodemaekers, Hennie M.; Bakker, Frank; Pennings, Jeroen L. A.; van der Ven, Leo T. M.] Natl Inst Publ Hlth & Environm RIVM, Ctr Hlth Protect, NL-3720 BA Bilthoven 1, Netherlands.
   [van den Brandhof, Evert-Jan] Natl Inst Publ Hlth & Environm RIVM, Ctr Environm Qual, NL-3720 BA Bilthoven 1, Netherlands.
RP van der Ven, LTM (reprint author), Natl Inst Publ Hlth & Environm RIVM, Ctr Hlth Protect, NL-3720 BA Bilthoven 1, Netherlands.
EM piet.beekhof@rivm.nl; hennie.hodemaekers@rivm.nl; frank.bakker@rivm.nl;
   evert-jan.van.den.brandhof@rivm.nl; jeroen.pennings@rivm.nl;
   leo.van.der.ven@rivm.nl
FU Ministry of Health, Welfare and Sports [5.1.2]
FX The authors would like to acknowledge Diedier Neuzeret and Florent
   Varenne with setting up and customizing the Viewpoint system, and
   Juliette Legler and Jessica Legradi (Free University, Amsterdam) for
   logistic support. This study has been performed by order and for the
   account of The Netherlands Food and Consumer Product Safety Authority
   (NVWA), and we thank Jacqueline JM Castenmiller (NVWA) for her active
   support. The study was further supported by the Ministry of Health,
   Welfare and Sports, project 5.1.2.
CR Alyea RA, 2012, J PHARMACOL TOX MET, V66, P207, DOI 10.1016/j.vascn.2012.05.005
   Antonio MT, 1998, J APPL TOXICOL, V18, P83, DOI 10.1002/(SICI)1099-1263(199803/04)18:2<83::AID-JAT480>3.0.CO;2-1
   Balbus JM, 2013, LANCET, V381, P3, DOI 10.1016/S0140-6736(12)61609-2
   Baxi DB, 2012, J MATERN-FETAL NEO M, V25, P831, DOI 10.3109/14767058.2011.599456
   Becker RA, 2015, REGUL TOXICOL PHARM, V72, P514, DOI 10.1016/j.yrtph.2015.04.004
   Benbrahim-Tallaa L, 2007, ENVIRON HEALTH PERSP, V115, P1454, DOI 10.1289/ehp.10207
   Birben E, 2012, WORLD ALLERGY ORGAN, V5, P9, DOI 10.1097/WOX.0b013e3182439613
   Blaser RE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036931
   Bloom D. E., 2011, GLOBAL EC BURDEN NON
   Bouwmeester MC, 2016, TOXICOL APPL PHARM, V291, P84, DOI 10.1016/j.taap.2015.12.012
   CHRISTMAN JK, 1995, P NATL ACAD SCI USA, V92, P7347, DOI 10.1073/pnas.92.16.7347
   Cianca V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069661
   Ercal Nuran, 2001, Current Topics in Medicinal Chemistry, V1, P529, DOI 10.2174/1568026013394831
   Fabbri M, 2012, ALTEX-ALTERN ANIM EX, V29, P173, DOI 10.14573/altex.2012.2.173
   Fernandes Y, 2015, BEHAV BRAIN RES, V292, P102, DOI 10.1016/j.bbr.2015.05.060
   Fernandes Y, 2015, INT J NEUROPSYCHOPH, V18, DOI 10.1093/ijnp/pyu089
   Filipic M, 2012, MUTAT RES-FUND MOL M, V733, P69, DOI 10.1016/j.mrfmmm.2011.09.002
   Fox DA, 2012, NEUROTOXICOLOGY, V33, P810, DOI 10.1016/j.neuro.2011.12.016
   Franco R, 2008, CANCER LETT, V266, P6, DOI 10.1016/j.canlet.2008.02.026
   Garrido M, 2013, OXID MED CELL LONGEV, DOI 10.1155/2013/729804
   Glazer L, 2016, NEUROTOXICOLOGY, V52, P134, DOI 10.1016/j.neuro.2015.11.012
   Godfrey K M, 2001, Public Health Nutr, V4, P611
   Grandjean P, 2014, LANCET NEUROL, V13, P330, DOI 10.1016/S1474-4422(13)70278-3
   Greally JM, 2013, ALTEX-ALTERN ANIM EX, V30, P445, DOI 10.14573/altex.2013.4.445
   Groh KJ, 2015, CHEMOSPHERE, V120, P778, DOI 10.1016/j.chemosphere.2014.10.006
   GRUENBAUM Y, 1981, FEBS LETT, V124, P67, DOI 10.1016/0014-5793(81)80055-5
   Hanson MA, 2015, BEST PRACT RES CL OB, V29, P24, DOI 10.1016/j.bpobgyn.2014.06.007
   Hermsen SAB, 2011, TOXICOL IN VITRO, V25, P745, DOI 10.1016/j.tiv.2011.01.005
   Hirano T, 1997, TOXICOL APPL PHARM, V147, P9, DOI 10.1006/taap.1997.8260
   Jin YX, 2015, NEUROTOXICOL TERATOL, V48, P9, DOI 10.1016/j.ntt.2015.01.002
   Jones DP, 2002, METHOD ENZYMOL, V348, P93, DOI 10.1016/S0076-6879(02)48630-2
   Kalueff AV, 2013, ZEBRAFISH, V10, P70, DOI 10.1089/zeb.2012.0861
   Kloypan C, 2015, CELL BIOCHEM FUNCT, V33, P375, DOI 10.1002/cbf.3124
   Kusch RC, 2008, ENVIRON TOXICOL CHEM, V27, P705, DOI 10.1897/07-273.1
   Lopez E, 2006, FREE RADICAL BIO MED, V40, P940, DOI 10.1016/j.freeradbiomed.2005.10.062
   Mathur P, 2011, BEHAV BRAIN RES, V219, P234, DOI 10.1016/j.bbr.2011.01.019
   Mueller KP, 2010, J NEUROSCI METH, V186, P29, DOI 10.1016/j.jneumeth.2009.10.020
   OECD, 2014, US HDB SUPPL GUID DO
   Ojeda NB, 2012, HYPERTENSION, V60, P114, DOI 10.1161/HYPERTENSIONAHA.112.192955
   Pittman JT, 2014, PHYSIOL BEHAV, V123, P174, DOI 10.1016/j.physbeh.2013.10.023
   Poirier LA, 2002, ENVIRON HEALTH PERSP, V110, P793, DOI 10.1289/ehp.02110s5793
   Quig D, 1998, Altern Med Rev, V3, P262
   Rani A, 2014, INT J ENVIRON HEAL R, V24, P378, DOI 10.1080/09603123.2013.835032
   Ray PD, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00201
   Razmiafshari M, 2000, TOXICOL APPL PHARM, V166, P1, DOI 10.1006/taap.2000.8950
   Ronco AM, 2010, TOXICOL IN VITRO, V24, P1532, DOI 10.1016/j.tiv.2010.07.003
   Shi HH, 2005, COMP BIOCHEM PHYS C, V140, P115, DOI 10.1016/j.cca.2005.01.009
   Slob W, 2002, TOXICOL SCI, V66, P298, DOI 10.1093/toxsci/66.2.298
   Somji S., 2011, CANC CELL INT, V11
   Stangenberg S, 2015, INT J BIOCHEM CELL B, V64, P81, DOI 10.1016/j.biocel.2015.03.017
   Stepniewska J, 2015, CURR PROTEIN PEPT SC, V16, P243, DOI 10.2174/1389203716666150224150508
   Takiguchi M, 2003, EXP CELL RES, V286, P355, DOI 10.1016/S0014-4827(03)00062-4
   TAN NW, 1990, BIOCHEMISTRY-US, V29, P9234, DOI 10.1021/bi00491a018
   THIESEN HJ, 1991, BIOCHEM BIOPH RES CO, V176, P551, DOI 10.1016/S0006-291X(05)80219-0
   Timme-Laragy AR, 2013, FREE RADICAL BIO MED, V65, P89, DOI 10.1016/j.freeradbiomed.2013.06.011
   TURK PW, 1995, CARCINOGENESIS, V16, P1253, DOI 10.1093/carcin/16.5.1253
   Valko M, 2016, ARCH TOXICOL, V90, P1, DOI 10.1007/s00204-015-1579-5
   Wang B, 2012, CURR MED CHEM, V19, P2611, DOI 10.2174/092986712800492913
   Wang B, 2013, OXID MED CELL LONGEV, DOI 10.1155/2013/898034
   Wang J, 2015, INT J BIOL MACROMOL, V77, P59, DOI 10.1016/j.ijbiomac.2015.02.037
   Watjen W, 2004, BIOMETALS, V17, P65, DOI 10.1023/A:1024405119018
   Xiao CL, 2015, TOXICOL SCI, V145, P80, DOI 10.1093/toxsci/kfv019
   Yara S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063456
   Yin J, 2014, J ZHEJIANG UNIV-SC B, V15, P766, DOI 10.1631/jzus.B1400091
   Yoshioka N, 2008, J OCCUP HEALTH, V50, P229, DOI 10.1539/joh.L7125
   Zachara BA, 2015, ADV CLIN CHEM, V68, P131, DOI 10.1016/bs.acc.2014.11.006
   Zhou R, 2013, J PSYCHIATR RES, V47, P1535, DOI 10.1016/j.jpsychires.2013.05.013
   Zhou ZH, 2012, TOXICOL SCI, V125, P412, DOI 10.1093/toxsci/kfr320
   Zhu HY, 2011, J APPL TOXICOL, V31, P484, DOI 10.1002/jat.1673
NR 69
TC 7
Z9 9
U1 2
U2 9
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD NOV
PY 2016
VL 17
IS 11
AR 1830
DI 10.3390/ijms17111830
PG 22
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA ED4HV
UT WOS:000388809600064
OA DOAJ Gold, Green Published
DA 2019-10-23
ER

PT J
AU Rodrigues, RM
   Chaudhari, U
   Kollipara, L
   Sachinidis, A
   Zahedi, RP
   Sickmann, A
   Keun, H
   Kopp-Schneider, A
   Jiang, XQ
   De Kock, J
   Vanhaecke, T
   Rogiers, VM
   Vinken, M
AF Rodrigues, Robim M.
   Chaudhari, Umesh
   Kollipara, Laxmikanth
   Sachinidis, Agapios
   Zahedi, Rene P.
   Sickmann, Albert
   Keun, Hector
   Kopp-Schneider, Annette
   Jiang, Xiaoqi
   De Kock, Joery
   Vanhaecke, Tamara
   Rogiers, Vera M.
   Vinken, Mathieu
TI In vitro verification of an adverse outcome pathway of cholestasis
SO HEPATOLOGY
LA English
DT Meeting Abstract
CT 67th Annual Meeting of the
   American-Association-for-the-Study-of-Liver-Diseases (AASLD)
CY NOV 11-15, 2016
CL Boston, MA
SP Amer Assoc Study Liver Dis
C1 [Rodrigues, Robim M.; De Kock, Joery; Vanhaecke, Tamara; Rogiers, Vera M.; Vinken, Mathieu] Vrije Univ Brussel, Toxicol, Brussels, Belgium.
   [Chaudhari, Umesh; Sachinidis, Agapios] Univ Cologne, Inst Neurophysiol, Cologne, Germany.
   [Chaudhari, Umesh; Sachinidis, Agapios] Univ Cologne, Ctr Mol Med, Cologne, Germany.
   [Kollipara, Laxmikanth; Zahedi, Rene P.; Sickmann, Albert] Leibniz Inst Analyt Wissensch, Dortmund, Germany.
   [Keun, Hector] Imperial Coll London, Dept Surg & Canc, Computat & Syst Med, London, England.
   [Kopp-Schneider, Annette; Jiang, Xiaoqi] German Canc Res Ctr, Div Biostat, Heidelberg, Germany.
RI Sickmann, Albert/A-1010-2011; Vinken, Mathieu/H-7513-2013; Rodrigues,
   Robim/K-1366-2015
OI Sickmann, Albert/0000-0002-2388-5265; Vinken,
   Mathieu/0000-0001-5115-8893; Rodrigues, Robim/0000-0003-2927-6791
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0270-9139
EI 1527-3350
J9 HEPATOLOGY
JI Hepatology
PD OCT
PY 2016
VL 64
SU 1
MA 519
BP 261A
EP 262A
PG 2
WC Gastroenterology & Hepatology
SC Gastroenterology & Hepatology
GA DY9YT
UT WOS:000385493801261
DA 2019-10-23
ER

PT J
AU Boyes, WK
AF Boyes, W. K.
TI A 21st century update on neurotoxicity risk assessment
SO TOXICOLOGY LETTERS
LA English
DT Meeting Abstract
CT 14th International Congress of Toxicology in conjunction with the 10th
   Mexican Congress of Toxicology
CY OCT 02-09, 2016
CL Merida, MEXICO
C1 [Boyes, W. K.] US EPA, Res Triangle Pk, NC 27711 USA.
FU USEPAUnited States Environmental Protection Agency
FX USEPA: This abstract does not reflect EPA policy.
NR 0
TC 0
Z9 0
U1 1
U2 2
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0378-4274
EI 1879-3169
J9 TOXICOL LETT
JI Toxicol. Lett.
PD OCT
PY 2016
VL 259
SU S
MA S28-5
BP S51
EP S52
DI 10.1016/j.toxlet.2016.07.125
PG 2
WC Toxicology
SC Toxicology
GA EO7CF
UT WOS:000396848100134
DA 2019-10-23
ER

PT J
AU Fadeel, B
AF Fadeel, B.
TI Systems biology approaches in nanosafety research with special reference
   to carbon-based nanomaterials
SO TOXICOLOGY LETTERS
LA English
DT Meeting Abstract
CT 14th International Congress of Toxicology in conjunction with the 10th
   Mexican Congress of Toxicology
CY OCT 02-09, 2016
CL Merida, MEXICO
C1 [Fadeel, B.] Karolinska Inst, Inst Environm Med, NNL, Stockholm, Sweden.
NR 0
TC 0
Z9 0
U1 0
U2 3
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0378-4274
EI 1879-3169
J9 TOXICOL LETT
JI Toxicol. Lett.
PD OCT
PY 2016
VL 259
SU S
MA S11-3
BP S21
EP S21
DI 10.1016/j.toxlet.2016.07.094
PG 1
WC Toxicology
SC Toxicology
GA EO7CF
UT WOS:000396848100054
DA 2019-10-23
ER

PT J
AU Leist, M
AF Leist, M.
TI Construction principles of adverse outcome pathways (AOP) and their use
   for integration of diverse toxicological information
SO TOXICOLOGY LETTERS
LA English
DT Meeting Abstract
CT 14th International Congress of Toxicology in conjunction with the 10th
   Mexican Congress of Toxicology
CY OCT 02-09, 2016
CL Merida, MEXICO
C1 [Leist, M.] Univ Konstanz, Vitro Toxicol & Biomed, Constance, Germany.
FU EFSA
FX EFSA.
NR 0
TC 0
Z9 0
U1 1
U2 3
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0378-4274
EI 1879-3169
J9 TOXICOL LETT
JI Toxicol. Lett.
PD OCT
PY 2016
VL 259
SU S
MA S34-3
BP S61
EP S62
DI 10.1016/j.toxlet.2016.07.154
PG 3
WC Toxicology
SC Toxicology
GA EO7CF
UT WOS:000396848100158
DA 2019-10-23
ER

PT J
AU Viviani, B
AF Viviani, B.
TI Adverse Outcome Pathway: Redox-cycling of a chemical initiated by
   electrons released by the mitochondrial respiratory chain leading to
   parkinsonian motor deficits
SO TOXICOLOGY LETTERS
LA English
DT Meeting Abstract
CT 14th International Congress of Toxicology in conjunction with the 10th
   Mexican Congress of Toxicology
CY OCT 02-09, 2016
CL Merida, MEXICO
C1 [Viviani, B.] Univ Milan, Dept Pharmacol & Biomol Sci, Milan, Italy.
FU European Food Safety Authority
FX European Food Safety Authority.
NR 0
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0378-4274
EI 1879-3169
J9 TOXICOL LETT
JI Toxicol. Lett.
PD OCT
PY 2016
VL 259
SU S
MA S34-5
BP S62
EP S62
DI 10.1016/j.toxlet.2016.07.156
PG 1
WC Toxicology
SC Toxicology
GA EO7CF
UT WOS:000396848100160
DA 2019-10-23
ER

PT J
AU Wilks, MF
AF Wilks, M. F.
TI Pesticides and Parkinson's disease - What is the evidence from
   epidemiological and experimental studies?
SO TOXICOLOGY LETTERS
LA English
DT Meeting Abstract
CT 14th International Congress of Toxicology in conjunction with the 10th
   Mexican Congress of Toxicology
CY OCT 02-09, 2016
CL Merida, MEXICO
C1 [Wilks, M. F.] Univ Basel, Swiss Ctr Appl Human Toxicol, CH-4003 Basel, Switzerland.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0378-4274
EI 1879-3169
J9 TOXICOL LETT
JI Toxicol. Lett.
PD OCT
PY 2016
VL 259
SU S
MA S15-5
BP S29
EP S29
DI 10.1016/j.toxlet.2016.07.642
PG 1
WC Toxicology
SC Toxicology
GA EO7CF
UT WOS:000396848100074
DA 2019-10-23
ER

PT J
AU Sullivan, K
AF Sullivan, Kristie
TI It Takes a Village: Stakeholder Participation is Essential to
   Transforming Science
SO ATLA-ALTERNATIVES TO LABORATORY ANIMALS
LA English
DT Article
DE Adverse Outcome Pathways; non-animal testing; replacement; training
ID SKIN SENSITIZATION HAZARD; SYSTEMIC TOXICITY; ANIMAL USE; CHEMICALS;
   PARADIGM; BARRIERS; US
AB Efforts toward replacing the use of animals in toxicology testing have begun to make significant headway in the last several years, due to co-operative and pragmatic efforts on the part of many stakeholders, and the public pressure that non-governmental advocacy organisations represent. Science-focused advocacy organisations have a unique role to play in these efforts, as they often have flexibility to adapt quickly to keep a project going and forge connections among different kinds of stakeholders to help encourage buy-in. This year, meaningful progress has been made, especially in regulatory laws and policies, which will lead to the replacement of animals in toxicology testing. In order to keep this momentum, we need to measure progress - but this requires improved transparency and regular reporting of animal use. In addition, we should consider how strategies that have successfully reduced and replaced animal use in toxicology can be applied to basic biomedical research practices.
C1 [Sullivan, Kristie] Phys Comm Responsible Med, Washington, DC 20016 USA.
RP Sullivan, K (reprint author), Phys Comm Responsible Med, Washington, DC 20016 USA.
EM ksullivan@pcrm.org
CR [Anonymous], 2012, OECD SER TEST ASS, V168
   Arrowsmith J, 2012, NAT REV DRUG DISCOV, V11, P17, DOI 10.1038/nrd3630
   Baker E., 2015, REGULATORY UPDATES A
   Becker RA, 2006, REGUL TOXICOL PHARM, V46, P18, DOI 10.1016/j.yrtph.2006.06.001
   Bones VC, 2014, ATLA-ALTERN LAB ANIM, V42, P171, DOI 10.1177/026119291404200305
   Clippinger A. J., 2016, ALTEX
   Clippinger AJ, 2016, ARCH TOXICOL, V90, P1769, DOI 10.1007/s00204-016-1717-8
   Edwards SW, 2016, J PHARMACOL EXP THER, V356, P170, DOI 10.1124/jpet.115.228239
   EPA, 2016, RETR AN GUID WAIV AC
   European Chemicals Agency (ECHA), 2015, GUID INF REQ CHEM SA
   Funk C, 2015, AM POLITICS SCI ISSU
   Goodman J, 2015, J MED ETHICS, V41, P567, DOI 10.1136/medethics-2014-102404
   Kleinstreuer N., 2015, REGULATORY TOXICOLOG, V76, P39
   Landesmann B., 2016, OECD SERIES ADVERSE, V3
   Langley G, 2015, ENVIRON HEALTH PERSP, V123, pA268, DOI 10.1289/ehp.1510345
   Langley GR, 2014, DRUG DISCOV TODAY, V19, P1114, DOI 10.1016/j.drudis.2014.03.013
   Moore NP, 2013, REGUL TOXICOL PHARM, V66, P30, DOI 10.1016/j.yrtph.2013.02.005
   NRC, 2007, TOXICITY TESTING 21
   Nukada Y, 2012, TOXICOL IN VITRO, V26, P1150, DOI 10.1016/j.tiv.2012.07.001
   OECD, 2016, OECD SER TEST ASS, V237
   Patlewicz G, 2014, REGUL TOXICOL PHARM, V69, P529, DOI 10.1016/j.yrtph.2014.06.001
   Pistollato F, 2016, ONCOTARGET
   Russell WMS, 1959, PRINCIPLES HUMANE EX
   Sauer UG, 2016, ATLA-ALTERN LAB ANIM, V44, P281, DOI 10.1177/026119291604400311
   Seidle T, 2011, ALTEX-ALTERN ANIM EX, V28, P95, DOI 10.14573/altex.2011.2.095
   Strickland J, 2016, J APPL TOXICOL, V36, P1150, DOI 10.1002/jat.3281
   Urbisch D, 2015, REGUL TOXICOL PHARM, V71, P337, DOI 10.1016/j.yrtph.2014.12.008
   Willett C, 2014, ALTEX-ALTERN ANIM EX, V31, P500, DOI http://dx.doi.org/10.14573/altex.1401281
   Yauk C, 2016, OECD SERIES ADVERSE, V3
NR 29
TC 1
Z9 1
U1 0
U2 1
PU FRAME
PI NOTTINGHAM
PA RUSSELL & BURCH HOUSE 96-98 NORTH SHERWOOD ST, NOTTINGHAM NG1 4EE,
   NOTTS, ENGLAND
SN 0261-1929
J9 ATLA-ALTERN LAB ANIM
JI ATLA-Altern. Lab. Anim.
PD OCT
PY 2016
VL 44
IS 5
BP 411
EP 415
DI 10.1177/026119291604400517
PG 5
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA EQ2UU
UT WOS:000397927100002
PM 27805823
DA 2019-10-23
ER

PT J
AU Basketter, D
AF Basketter, David
TI Skin Sensitisation, Adverse Outcome Pathways and Alternatives
SO ATLA-ALTERNATIVES TO LABORATORY ANIMALS
LA English
DT Article
DE hazard identification; in vitro methods; Local Lymph Node Assay; risk
   assessment; skin sensitisation
ID LYMPH-NODE ASSAY; QUANTITATIVE RISK-ASSESSMENT; NONANIMAL TEST METHODS;
   IN-VITRO; CONTACT ALLERGENS; HAZARD IDENTIFICATION; PEPTIDE REACTIVITY;
   POTENCY; CATEGORIZATION; COMPILATION
AB For toxicologists who are in any way associated with skin sensitisation, the last two decades have seen a series of fundamental changes. We have migrated from old-style guinea-pig assays, via the refined and reduced Local Lymph Node Assay (LLNA), to witness the imminent dominance of in vitro and in silico methods. Yet, over the same period, the use of the output data for human safety assurance has evolved from 'black box' risk assessment, via the quantitative risk assessment enabled by the LLNA measurement of potency, to a new period of relative uncertainty. This short review will endeavour to address these topics, all the while keeping a focus on three essential principles: a) that skin sensitisation potential is intrinsic in the molecular structure of the chemical; b) that test methods should have a mechanistic foundation; and finally c) that the only reason for undertaking any skin sensitisation work has to be the protection of human health.
C1 [Basketter, David] DABMEB Consultancy Ltd, Sharnbrook, Beds, England.
RP Basketter, D (reprint author), DABMEB Consultancy Ltd, Sharnbrook, Beds, England.
EM dabmebconsultancyltd@me.com
CR Andersen K. E., 1985, CONTACT ALLERGY PRED, V14, P1
   [Anonymous], 2012, OECD SER TEST ASS, V168
   Api AM, 2008, REGUL TOXICOL PHARM, V52, P3, DOI 10.1016/j.yrtph.2007.10.008
   Ashikaga T, 2010, ATLA-ALTERN LAB ANIM, V38, P275, DOI 10.1177/026119291003800403
   Basketter DA, 2015, HUM EXP TOXICOL, V34, P1222, DOI 10.1177/0960327115601760
   Basketter DA, 1999, J APPL TOXICOL, V19, P261, DOI 10.1002/(SICI)1099-1263(199907/08)19:4<261::AID-JAT572>3.0.CO;2-5
   Basketter D, 2016, REGUL TOXICOL PHARM, V74, P105, DOI 10.1016/j.yrtph.2015.11.013
   Basketter D, 2015, REGUL TOXICOL PHARM, V73, P660, DOI 10.1016/j.yrtph.2015.10.005
   Basketter DA, 2007, CONTACT DERMATITIS, V57, P70, DOI 10.1111/j.1600-0536.2007.01141.x
   Basketter DA, 2014, DERMATITIS, V25, P11, DOI 10.1097/DER.0000000000000003
   Basketter DA, 2012, CONTACT DERMATITIS, V67, P1, DOI 10.1111/j.1600-0536.2012.02131.x
   BOTHAM PA, 1991, FOOD CHEM TOXICOL, V29, P275, DOI 10.1016/0278-6915(91)90025-3
   BUEHLER EV, 1965, ARCH DERMATOL, V91, P171, DOI 10.1001/archderm.1965.01600080079017
   Cronin M T, 1994, SAR QSAR Environ Res, V2, P159, DOI 10.1080/10629369408029901
   Dean JH, 2001, REGUL TOXICOL PHARM, V34, P258, DOI 10.1006/rtph.2001.1497
   Draize JH, 1944, J PHARMACOL EXP THER, V82, P377
   DUPUIS G, 1982, CONTACT DERMATITIS S
   Gaide O, 2015, NAT MED, V21, P647, DOI 10.1038/nm.3860
   Gerberick G F, 2000, Am J Contact Dermat, V11, P3
   Gerberick GF, 2007, TOXICOL SCI, V97, P417, DOI 10.1093/toxsci/kfm064
   Gerberick GF, 2005, DERMATITIS, V16, P157, DOI 10.2310/6620.2005.05040
   Jaworska J. S., 2015, ARCH TOXICOL, V89, P69
   Kern PS, 2010, DERMATITIS, V21, P8, DOI 10.2310/6620.2009.09038
   KIMBER I, 1992, FOOD CHEM TOXICOL, V30, P165, DOI 10.1016/0278-6915(92)90153-C
   KIMBER I, 1989, ARCH TOXICOL, V63, P274, DOI 10.1007/BF00278640
   Kimber I, 1997, HUM ECOL RISK ASSESS, V3, P385, DOI 10.1080/10807039709383695
   Kimber I, 2012, CONTACT DERMATITIS, V67, P179, DOI 10.1111/j.1600-0536.2012.02148.x
   Landsteiner K, 1935, J EXP MED, V61, P643, DOI 10.1084/jem.61.5.643
   Lepoittevin JP, 2011, CONTACT DERMATITIS, FIFTH EDITION, P91, DOI 10.1007/978-3-642-03827-3_4
   MAGNUSSON B, 1970, ALLERGIC CONTACT DER
   Martin SF, 2015, CURR OPIN ALLERGY CL, V15, P124, DOI 10.1097/ACI.0000000000000142
   McFadden JP, 2000, CONTACT DERMATITIS, V42, P123, DOI 10.1034/j.1600-0536.2000.042003123.x
   Natsch A, 2007, TOXICOL IN VITRO, V21, P1220, DOI 10.1016/j.tiv.2007.03.016
   Natsch A, 2015, TOXICOL SCI, V143, P319, DOI 10.1093/toxsci/kfu229
   Nukada Y, 2013, TOXICOL IN VITRO, V27, P609, DOI 10.1016/j.tiv.2012.11.006
   OECD, 2015, OECD QSAR TOOLB VERS
   OECD, 2015, OECD GUID TEST CHE C
   OECD, 2015, OECD GUID TEST CHE D
   OECD, 2015, OECD GUID TEST CHEM
   Patlewicz G, 2007, SAR QSAR ENVIRON RES, V18, P515, DOI 10.1080/10629360701427872
   Patlewicz G, 2014, SAR QSAR ENVIRON RES, V25, P367, DOI 10.1080/1062936X.2014.900520
   Reisinger K, 2015, TOXICOL IN VITRO, V29, P259, DOI 10.1016/j.tiv.2014.10.018
   Roberts DW, 2011, CHEM RES TOXICOL, V24, P1003, DOI 10.1021/tx100420w
   Robinson M., 1996, TOXICOLOGY CONTACT H, P152
   ROBINSON MK, 1990, TOXICOLOGY, V61, P91, DOI 10.1016/0300-483X(90)90012-6
   Rustemeyer T, 2011, CONTACT DERMATITIS, FIFTH EDITION, P43, DOI 10.1007/978-3-642-03827-3_3
   Schwensen JF, 2016, EXPERT REV CLIN IMMU, V12, P289, DOI 10.1586/1744666X.2016.1120159
   UN, 2015, UN GLOB HARM SYST CL
   Urbisch D, 2015, REGUL TOXICOL PHARM, V71, P337, DOI 10.1016/j.yrtph.2014.12.008
   van der Veen JW, 2016, J IMMUNOTOXICOL, V13, P1, DOI 10.3109/1547691X.2014.975897
   van der Veen JW, 2014, REGUL TOXICOL PHARM, V69, P371, DOI 10.1016/j.yrtph.2014.04.018
NR 51
TC 3
Z9 5
U1 1
U2 3
PU FRAME
PI NOTTINGHAM
PA RUSSELL & BURCH HOUSE 96-98 NORTH SHERWOOD ST, NOTTINGHAM NG1 4EE,
   NOTTS, ENGLAND
SN 0261-1929
J9 ATLA-ALTERN LAB ANIM
JI ATLA-Altern. Lab. Anim.
PD OCT
PY 2016
VL 44
IS 5
BP 431
EP 436
DI 10.1177/026119291604400501
PG 6
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA EQ2UU
UT WOS:000397927100004
PM 27805825
DA 2019-10-23
ER

PT J
AU Melbourne, J
   Bishop, P
   Brown, J
   Stoddart, G
AF Melbourne, Jodie
   Bishop, Patricia
   Brown, Jeffrey
   Stoddart, Gilly
TI A Multi-faceted Approach to Achieving the Global Acceptance of
   Animal-free Research Methods
SO ATLA-ALTERNATIVES TO LABORATORY ANIMALS
LA English
DT Article
DE animal testing; AOP; chemical testing; cosmetics testing; data
   requirements; harmonisation; ICAPO; nanomaterials testing; non-animal;
   OECD; pesticide testing; QSAR; REACH; risk assessment; Three Rs;
   validation; webinars
ID ADVERSE OUTCOME PATHWAYS
AB In 2015, the PETA International Science Consortium Ltd. was awarded the Lush Training Prize for its broad approach to education and training on the effective use of human-relevant, non-animal research techniques. The prize was awarded for work that included hosting workshops and webinars, initiating in-person training sessions and developing educational resources. The Consortium works closely with industry and regulatory agencies to identify and overcome barriers to the validation and use of alternatives to animal testing, by using an approach that identifies, promotes and verifies the implementation of these methods. The Consortium's recent activities toward replacing tests on animals for nanomaterials, pesticides and medical devices, are described, as examples of projects with broad applicability aimed at large-scale regulatory change.
C1 [Melbourne, Jodie; Bishop, Patricia; Brown, Jeffrey; Stoddart, Gilly] PETA Int Sci Consortium Ltd, Soc Bldg,8 All Saints St, London N1 9RL, England.
RP Melbourne, J (reprint author), PETA Int Sci Consortium Ltd, Soc Bldg,8 All Saints St, London N1 9RL, England.
CR Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Burden N, 2015, J APPL TOXICOL, V35, P971, DOI 10.1002/jat.3165
   Clippinger A. J., 2016, ALTEX IN PRESS
   Clippinger AJ, 2016, ARCH TOXICOL, V90, P1769, DOI 10.1007/s00204-016-1717-8
   Groff K, 2015, BIOTECHNOL ADV, V33, P1787, DOI 10.1016/j.biotechadv.2015.10.004
   Kleinstreuer NC, 2016, REGUL TOXICOL PHARM, V76, P39, DOI 10.1016/j.yrtph.2016.01.007
   Koduri C., 2016, PESTICIDES REGISTRAT
   NTP, 2015, WORKSH ALT APPR ID A
   Polk WW, 2016, PART FIBRE TOXICOL, V13, DOI 10.1186/s12989-016-0131-y
   Sharma M, 2016, ARCH TOXICOL, V90, P1605, DOI 10.1007/s00204-016-1742-7
   Stoddart G, 2014, ATLA-ALTERN LAB ANIM, V42, P387, DOI 10.1177/026119291404200608
   Winder C, 2005, J HAZARD MATER, V125, P29, DOI 10.1016/j.jhazmat.2005.05.035
NR 12
TC 0
Z9 0
U1 0
U2 18
PU FRAME
PI NOTTINGHAM
PA RUSSELL & BURCH HOUSE 96-98 NORTH SHERWOOD ST, NOTTINGHAM NG1 4EE,
   NOTTS, ENGLAND
SN 0261-1929
J9 ATLA-ALTERN LAB ANIM
JI ATLA-Altern. Lab. Anim.
PD OCT
PY 2016
VL 44
IS 5
BP 495
EP 498
DI 10.1177/026119291604400511
PG 4
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA EQ2UU
UT WOS:000397927100011
PM 27805832
DA 2019-10-23
ER

PT J
AU Makris, SL
   Scott, CS
   Fox, J
   Knudsen, TB
   Hotchkiss, AK
   Arzuaga, X
   Euling, SY
   Powers, CM
   Jinot, J
   Hogan, KA
   Abbott, BD
   Hunter, ES
   Narotsky, MG
AF Makris, Susan L.
   Scott, Cheryl Siegel
   Fox, John
   Knudsen, Thomas B.
   Hotchkiss, Andrew K.
   Arzuaga, Xabier
   Euling, Susan Y.
   Powers, Christina M.
   Jinot, Jennifer
   Hogan, Karen A.
   Abbott, Barbara D.
   Hunter, E. Sidney, III
   Narotsky, Michael G.
TI A systematic evaluation of the potential effects of trichloroethylene
   exposure on cardiac development
SO REPRODUCTIVE TOXICOLOGY
LA English
DT Review
DE Trichloroethylene; TCE; Cardiac; Malformations; AOP
AB The 2011 EPA trichloroethylene (TCE) IRIS assessment, used developmental cardiac defects from a controversial drinking water study in rats (Johnson et al. [51]), along with several other studies/endpoints to derive reference values. An updated literature search of TCE-related developmental cardiac defects was conducted. Study quality, strengths, and limitations were assessed. A putative adverse outcome pathway (ADP). construct was developed to explore key events for the most commonly observed cardiac dysmorphologies, particularly those involved with epithelial-mesenchymal transition (EMT) of endothelial origin (EndMT); several candidate pathways were identified. A hypothesis-driven weight-of-evidence analysis of epidemiological, toxicological, in vitro, in ovo, and mechanistic/AOP data concluded that TCE has the potential to cause cardiac defects in humans when exposure occurs at sufficient doses during a sensitive window of fetal development. The study by Johnson et al. [51] was reaffirmed as suitable for hazard characterization and reference value derivation, though acknowledging study limitations and uncertainties. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
C1 [Makris, Susan L.; Scott, Cheryl Siegel; Fox, John; Arzuaga, Xabier; Euling, Susan Y.; Jinot, Jennifer; Hogan, Karen A.] US EPA, Off Res & Dev, Natl Ctr Environm Assessment, Washington, DC 20460 USA.
   [Hotchkiss, Andrew K.] US EPA, Off Res & Dev, Natl Ctr Environm Assessment, Res Triangle Pk, NC 27711 USA.
   [Abbott, Barbara D.; Hunter, E. Sidney, III; Narotsky, Michael G.] US EPA, Off Res & Dev, Natl Hlth & Environm Effects Res Lab, Res Triangle Pk, NC 27711 USA.
   [Knudsen, Thomas B.] US EPA, Off Res & Dev, Natl Ctr Computat Toxicol, Res Triangle Pk, NC 27711 USA.
   [Powers, Christina M.] US EPA, Off Transportat & Air Qual, Assessment & Stand Div, Ann Arbor, MI 48105 USA.
RP Makris, SL (reprint author), US EPA, Off Res & Dev, Natl Ctr Environm Assessment, Washington, DC 20460 USA.
EM makris.susan@epa.gov
OI Fox, John/0000-0003-4386-010X; Abbott, Barbara/0000-0001-8996-5842
CR AIA (Aerospace Industries Association), 090453900 AIA
   [Anonymous], 2012, EFSA J, V10, DOI 10.2903/j.efsa.2012.2579
   ATSDR (Agency for Toxic Substances and Disease Registry), 2013, PRIOR LIST HAZ SUBST
   ATSDR (Agency for Toxic Substances and Disease Registry), 2006, HLTH CONS END AR INV
   ATSDR (Agency for Toxic Substances and Disease Registry), 2014, PUBL HLTH STAT TRICH
   ATSDR (Agency for Toxic Substances and Disease Registry), 2008, HLTH CONS HLTH STAT
   Boldenow E, 2015, REPROD TOXICOL, V52, P1, DOI 10.1016/j.reprotox.2015.01.007
   Bove F, 2002, ENVIRON HEALTH PERSP, V110, P61
   Bove FJ, 1996, TOXICOL IND HEALTH, V12, P255, DOI 10.1177/074823379601200213
   BOVE FJ, 1995, AM J EPIDEMIOL, V141, P850, DOI 10.1093/oxfordjournals.aje.a117521
   Boyer AS, 2000, TOXICOL SCI, V53, P109, DOI 10.1093/toxsci/53.1.109
   Brender JD, 2014, ENVIRON HEALTH-GLOB, V13, DOI 10.1186/1476-069X-13-96
   BROSS G, 1983, TOXICOLOGY, V28, P283, DOI 10.1016/0300-483X(83)90002-1
   Bukowski J, 2014, CRIT REV TOXICOL, V44, P581, DOI 10.3109/10408444.2014.910755
   Caldwell PT, 2008, TOXICOL SCI, V104, P135, DOI 10.1093/toxsci/kfn078
   Carney EW, 2006, BIRTH DEFECTS RES B, V77, P405, DOI 10.1002/bdrb.20091
   Chiu WHA, 2013, ENVIRON HEALTH PERSP, V121, P303, DOI 10.1289/ehp.1205879
   Collier JM, 2003, BIRTH DEFECTS RES A, V67, P488, DOI 10.1002/bdra.10073
   COSBY NC, 1992, FUND APPL TOXICOL, V19, P268, DOI 10.1016/0272-0590(92)90160-J
   DAWSON BV, 1990, J AM COLL CARDIOL, V16, P1304, DOI 10.1016/0735-1097(90)90569-B
   DAWSON BV, 1993, J AM COLL CARDIOL, V21, P1466, DOI 10.1016/0735-1097(93)90325-U
   DORFMUELLER MA, 1979, TOXICOLOGY, V14, P153, DOI 10.1016/0300-483X(79)90061-1
   Dow JL, 2000, TOXICOLOGY, V146, P123, DOI 10.1016/S0300-483X(00)00156-6
   Drake VJ, 2006, TOXICOL SCI, V94, P153, DOI 10.1093/toxsci/kfl083
   Drake VJ, 2006, ENVIRON HEALTH PERSP, V114, P842, DOI 10.1289/ehp.8781
   ELOVAARA E, 1979, TOXICOLOGY, V12, P111, DOI 10.1016/0300-483X(79)90037-4
   EPSTEIN DL, 1992, TERATOLOGY, V46, P225, DOI 10.1002/tera.1420460306
   Fisher JW, 2001, INT J TOXICOL, V20, P257, DOI 10.1080/109158101753252992
   Forand SP, 2012, ENVIRON HEALTH PERSP, V120, P616, DOI 10.1289/ehp.1103884
   Frieden LA, 2010, DEV DYNAM, V239, P3226, DOI 10.1002/dvdy.22458
   Friedman LM, 2010, FUNDAMENTALS OF CLINICAL TRIALS, FOURTH EDITION, P427, DOI 10.1007/978-1-4419-1586-3_20
   FUNG KY, 1994, RISK ANAL, V14, P639, DOI 10.1111/j.1539-6924.1994.tb00277.x
   Fung KY, 1998, RISK ANAL, V18, P329, DOI 10.1111/j.1539-6924.1998.tb01299.x
   Gilboa SM, 2012, OCCUP ENVIRON MED, V69, P628, DOI 10.1136/oemed-2011-100536
   GOLDBERG SJ, 1990, J AM COLL CARDIOL, V16, P155, DOI 10.1016/0735-1097(90)90473-3
   Green T, 2004, OCCUP ENVIRON MED, V61, P312, DOI 10.1136/oem.2003.007153
   HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104
   Hardin BD, 2005, BIRTH DEFECTS RES A, V73, P931, DOI 10.1002/bdra.20192
   HARDIN BD, 1981, SCAND J WORK ENV HEA, V7, P66
   Hardin BD, 2004, ENVIRON HEALTH PERSP, V112, pA607, DOI 10.1289/ehp.112-a607b
   Hassoun E, 2005, J BIOCHEM MOL TOXIC, V19, P52, DOI 10.1002/jbt.20051
   HEALY TEJ, 1982, BRIT J ANAESTH, V54, P337, DOI 10.1093/bja/54.3.337
   HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503
   Hunter ES, 1996, TERATOLOGY, V54, P57
   Jenkins KJ, 2007, CIRCULATION, V115, P2995, DOI 10.1161/CIRCULATIONAHA.106.183216
   Jensen B, 2013, BBA-MOL CELL RES, V1833, P783, DOI 10.1016/j.bbamcr.2012.10.004
   Johnson P., 2014, COMMUNICATION
   Johnson P., 2008, COMMUNICATION
   Johnson PD, 2005, ENVIRON HEALTH PERSP, V113, pA18
   Johnson PD, 2004, ENVIRON HEALTH PERSP, V112, pA608, DOI 10.1289/ehp.112-a608
   Johnson PD, 2003, ENVIRON HEALTH PERSP, V111, P289, DOI 10.1289/ehp.5125
   Johnson PD, 1998, J AM COLL CARDIOL, V32, P540, DOI 10.1016/S0735-1097(98)00232-0
   Kovacic JC, 2012, CIRCULATION, V125, P1795, DOI 10.1161/CIRCULATIONAHA.111.040352
   KREWSKI D, 1995, RISK ANAL, V15, P29, DOI 10.1111/j.1539-6924.1995.tb00090.x
   LAGAKOS SW, 1986, J AM STAT ASSOC, V81, P583, DOI 10.2307/2288982
   LOEBER CP, 1988, PEDIATR RES, V24, P740, DOI 10.1203/00006450-198812000-00018
   Makwana O, 2013, CARDIOVASC TOXICOL, V13, P77, DOI 10.1007/s12012-012-9180-0
   Makwana O, 2010, CARDIOVASC TOXICOL, V10, P100, DOI 10.1007/s12012-010-9066-y
   Mishima N, 2006, BIRTH DEFECTS RES A, V76, P517, DOI 10.1002/bdra.20283
   NAROTSKY MG, 1995, J TOXICOL ENV HEALTH, V45, P145, DOI 10.1080/15287399509531987
   NAROTSKY MG, 1995, FUND APPL TOXICOL, V27, P203, DOI 10.1006/faat.1995.1125
   NRC, 2011, REV ENV PROT AG DRAF
   NRC (National Research Council), 2006, ASS HUM HLTH RISKS T
   Ou JS, 2003, TOXICOL SCI, V73, P90, DOI 10.1093/toxsci/kfg062
   Palbykin B, 2011, CARDIOVASC TOXICOL, V11, P204, DOI 10.1007/s12012-011-9113-3
   RAO JNK, 1992, BIOMETRICS, V48, P577, DOI 10.2307/2532311
   Richards AA, 2010, CURR CARDIOL REV, V6, P91, DOI 10.2174/157340310791162703
   Rothman K, 1998, MODERN EPIDEMIOLOGY
   Rothman KJ, 2008, MODERN EPIDEMIOLOGY
   Ruckart PZ, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-104
   Rufer ES, 2010, TOXICOL SCI, V113, P444, DOI 10.1093/toxsci/kfp269
   Saillenfait AM, 1995, ARCH TOXICOL, V70, P71, DOI 10.1007/BF02733666
   SCHWETZ BA, 1975, TOXICOL APPL PHARM, V32, P84, DOI 10.1016/0041-008X(75)90197-0
   Selmin O, 2005, CELL BIOL TOXICOL, V21, P83, DOI 10.1007/s10565-005-0124-3
   Ornella IS, 2008, CARDIOVASC TOXICOL, V8, P47, DOI 10.1007/s12012-008-9014-2
   Shoukri M. M., 2007, ANAL CORRELATED DATA
   SMITH MK, 1992, TERATOLOGY, V46, P217, DOI 10.1002/tera.1420460305
   SMITH MK, 1989, TERATOLOGY, V40, P445, DOI 10.1002/tera.1420400506
   STAPLES RE, 1974, TERATOLOGY, V9, pA37
   Stephen LJ, 2007, DEV BIOL, V302, P66, DOI 10.1016/j.ydbio.2006.08.058
   STUCKHARDT JL, 1984, TERATOGEN CARCIN MUT, V4, P181, DOI 10.1002/tcm.1770040203
   TIKKANEN J, 1988, AM J IND MED, V14, P1, DOI 10.1002/ajim.4700140102
   TIKKANEN J, 1991, TERATOLOGY, V43, P591, DOI 10.1002/tera.1420430614
   U.S. Environmental Protection Agency, 2014, BENCHM DOS SOFTW BMD
   US Environmental Protection Agency, 1991, EPA600FR91001 RISK A
   US Environmental Protection Agency, 2011, EPA635R09011F
   US EPA, 2006, EPA600R05093F OFF RE
   von Gise A, 2012, CIRC RES, V110, P1628, DOI 10.1161/CIRCRESAHA.111.259960
   Watson RE, 2006, REPROD TOXICOL, V21, P117, DOI 10.1016/j.reprotox.2005.07.013
   Williams FE, 2006, J BIOCHEM MOL TOXIC, V20, P183, DOI 10.1002/jbt.20135
   Wilson JG, 1965, TERATOLOGY PRINCIPLE, P262
   Wilson PD, 1998, AM J EPIDEMIOL, V148, P414
   Yauck JS, 2004, BIRTH DEFECTS RES A, V70, P808, DOI 10.1002/bdra.20060
NR 93
TC 14
Z9 15
U1 0
U2 6
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0890-6238
J9 REPROD TOXICOL
JI Reprod. Toxicol.
PD OCT
PY 2016
VL 65
BP 321
EP 358
DI 10.1016/j.reprotox.2016.08.014
PG 38
WC Reproductive Biology; Toxicology
SC Reproductive Biology; Toxicology
GA DZ6RZ
UT WOS:000385990900035
PM 27575429
OA Other Gold
DA 2019-10-23
ER

PT J
AU Delrue, N
   Sachana, M
   Sakuratani, Y
   Gourmelon, A
   Leinala, E
   Diderich, R
AF Delrue, Nathalie
   Sachana, Magdalini
   Sakuratani, Yuki
   Gourmelon, Anne
   Leinala, Eeva
   Diderich, Robert
TI The Adverse Outcome Pathway Concept: A Basis for Developing Regulatory
   Decision-making Tools
SO ATLA-ALTERNATIVES TO LABORATORY ANIMALS
LA English
DT Article
DE Adverse Outcome Pathways; chemical assessment; IATA; in vitro; mechanism
   of action; QSAR; skin sensitisation
AB The Adverse Outcome Pathway (AOP) concept is expected to guide risk assessors in their work to use all existing information on the effects of chemicals on humans and wildlife, and to target the generation of additional information to the regulatory objective. AOPs will therefore be used in the Organisation for Economic Co-operation and Development (OECD) chemical safety programme, as underlying scientific rationales for the development of alternative methods for hazard assessment, such as read-across, in vitro test methods or the development of integrated testing strategies that have the potential to replace animal tests. As a proof-of-concept, the OECD has developed an AOP for skin sensitisation, and as a follow-up has: a) implemented the AOP into the OECD QSAR Toolbox, so that information related to the Key Events (KEs)in the AOP can be used to group chemicals that are expected to act by the same mechanism and hence have the same skin sensitisation potential; b) developed alternative test methods for the KEs, so that ultimately chemicals can be tested for skin sensitisation without the use of animal tests. The development of integrated testing strategies based on the AOP is ongoing. Building on this proof-of-concept, the OECD has launched an AOP development programme with a first batch of AOPs published in 2016. A number of IT tools, which together form an AOP Knowledge Base, are at various stages of development, and support the construction of AOPs and their use in the development of integrated approaches for testing and assessment. Following the publication of the first batch of AOPs, OECD member countries will decide on priorities for their use in supporting the development of tools for regulatory use.
C1 [Delrue, Nathalie; Sachana, Magdalini; Sakuratani, Yuki; Gourmelon, Anne; Leinala, Eeva; Diderich, Robert] Org Econ Co Operat & Dev OECD, 2 Rue Andre Pascal, F-75116 Paris, France.
RP Diderich, R (reprint author), Org Econ Co Operat & Dev OECD, 2 Rue Andre Pascal, F-75116 Paris, France.
EM Bob.DIDERICH@oecd.org
CR Diderich R., 2007, RISK ASSESSMENT CHEM, P623, DOI 10.1007/978-1-4020-6102-8_16
   Diderich R, 2010, SILICO TOXICOLOGY PR, P390
   Dimitrov SD, 2016, SAR QSAR ENVIRON RES, V27, P203, DOI 10.1080/1062936X.2015.1136680
   ECHA, 2014, ILL EX OECD QSAR T 1
   JRC, 2012, DIR PEPT REACT ASS D
   OECD, 2012, OECD SER TEST ASS 1, V168
   OECD, 2016, OECD QSAR TOOLB VERS
   OECD, 2016, WORK PLAN TEST GUID
   OECD, 2014, OECD SER TEST ASS
   OECD, 2014, OECD SER TEST ASS, V194
   OECD, 2010, OECD GUID TEST CHE A
   OECD, 2011, OECD SER TEST ASS
   OECD, 1986, OECD GUID TEST CHEM, V4
   OECD, 1992, OECD GUID TEST CHEM
   OECD, 2012, OECD SER TEST ASS 2, V168
   OECD, 2016, OECD SER ADV OUTC PA, V1
   OECD, 2005, OECD SER TEST ASS
   OECD (Organisation for Economic Cooperation and Development), 1981, C8130 OECD
   OECD (Organization for Economic Cooperation and Development), 2010, CUTT COSTS CHEM MAN
   Organisation for Economic Co-operation and Development (OECD), 2013, OECD SER TEST ASS, V184
   Organisation for Economic Cooperation and Development (OECD), 2010, OECD GUID TEST CHEM
   Sonich-Mullin C, 2001, REGUL TOXICOL PHARM, V34, P146, DOI 10.1006/rtph.2001.1493
   UN, 2013, UN GLOB HARM SYST CL
   van Leeuwen K, 2009, SAR QSAR ENVIRON RES, V20, P207, DOI 10.1080/10629360902949179
   VERHAAR HJM, 1992, CHEMOSPHERE, V25, P471, DOI 10.1016/0045-6535(92)90280-5
   Worth A. P., 2007, RISK ASSESSMENT CHEM, P427
NR 26
TC 12
Z9 13
U1 0
U2 4
PU FRAME
PI NOTTINGHAM
PA RUSSELL & BURCH HOUSE 96-98 NORTH SHERWOOD ST, NOTTINGHAM NG1 4EE,
   NOTTS, ENGLAND
SN 0261-1929
J9 ATLA-ALTERN LAB ANIM
JI ATLA-Altern. Lab. Anim.
PD OCT
PY 2016
VL 44
IS 5
BP 417
EP 429
DI 10.1177/026119291604400504
PG 13
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA EQ2UU
UT WOS:000397927100003
PM 27805824
DA 2019-10-23
ER

PT J
AU Gerberick, GF
AF Gerberick, G. Frank
TI The Use of Peptide Reactivity Assays for Skin Sensitisation Hazard
   Identification and Risk Assessment
SO ATLA-ALTERNATIVES TO LABORATORY ANIMALS
LA English
DT Article
DE hazard identification; in vitro methods; integrated testing strategy;
   peptide reactivity; risk assessment; skin sensitisation
ID LYMPH-NODE ASSAY; SCREENING CONTACT ALLERGENS; IN-VITRO METHODS;
   5-CHLORO-2-METHYLISOTHIAZOL-3-ONE MCI; 2-METHYLISOTHIAZOL-3-ONE MI;
   CHEMICAL SELECTIVITY; MODEL NUCLEOPHILES; COVALENT BINDING; GLUTATHIONE;
   HAPTEN
AB Over the past 20 years or more, investigators have been developing non-animal test methods for use in assessing the skin sensitisation potential of chemicals. In parallel with this effort, the key biological events of skin sensitisation have been well-characterised in an Adverse Outcome Pathway (AOP) proposed by the Organisation for Economic Co-operation and Development (OECD). The key molecular initiating event of this AOP is haptenation or covalent modification of epidermal proteins. In this review, the strengths and limitations of the Direct Peptide Reactivity Assay (DPRA) are described, and the more recently developed Peroxidase Peptide Reactivity Assay (PPRA). The DPRA has been formally validated and incorporated into an OECD Test Guideline (TG442C). The DPRA shows promise for assisting in hazard identification as well as for assessing skin sensitisation potency when used in an integrated testing strategy.
C1 [Gerberick, G. Frank] Procter & Gamble Co, Mason Business Ctr, Cincinnati, OH 45040 USA.
RP Gerberick, GF (reprint author), Procter & Gamble Co, Mason Business Ctr, Cincinnati, OH 45040 USA.
EM gerberick.gf@pg.com
CR Adler S, 2011, ARCH TOXICOL, V85, P367, DOI 10.1007/s00204-011-0693-2
   Ahlfors SR, 2003, SKIN PHARMACOL APPL, V16, P59, DOI 10.1159/000068288
   Aleksic M, 2009, TOXICOL SCI, V108, P401, DOI 10.1093/toxsci/kfp030
   Alvarez-Sanchez R, 2004, CHEM RES TOXICOL, V17, P1280, DOI 10.1021/tx049935+
   Alvarez-Sanchez R, 2004, BIOORG MED CHEM LETT, V14, P365, DOI 10.1016/j.bmcl.2003.11.002
   Alvarez-Sanchez R, 2003, CHEM RES TOXICOL, V16, P627, DOI 10.1021/tx0256634
   [Anonymous], 2012, OECD SER TEST ASS, V168
   Aptula AO, 2006, TOXICOL IN VITRO, V20, P239, DOI 10.1016/j.tiv.2005.07.003
   Basketter DA, 2002, FOOD CHEM TOXICOL, V40, P593, DOI 10.1016/S0278-6915(01)00130-2
   Bauch C, 2012, REGUL TOXICOL PHARM, V63, P489, DOI 10.1016/j.yrtph.2012.05.013
   Chipinda I, 2010, CHEM RES TOXICOL, V23, P918, DOI 10.1021/tx100003w
   Dearman RJ, 1999, J APPL TOXICOL, V19, P299, DOI 10.1002/(SICI)1099-1263(199909/10)19:5<299::AID-JAT591>3.0.CO;2-C
   Dupuis G., 1982, ALLERGIC CONTACT DER
   Enoch SJ, 2009, CHEM RES TOXICOL, V22, P1447, DOI 10.1021/tx9001463
   EURL ECVAM, 2012, DIR PEPT REACT ASS D
   EURL-ECVAM, 2013, EURL ECVAM REC DIR P
   Gerberick F, 2008, ATLA-ALTERN LAB ANIM, V36, P215, DOI 10.1177/026119290803600210
   Gerberick G F, 2000, Am J Contact Dermat, V11, P3
   Gerberick GF, 2007, TOXICOL SCI, V97, P417, DOI 10.1093/toxsci/kfm064
   Gerberick GF, 2009, TOXICOL SCI, V112, P164, DOI 10.1093/toxsci/kfp192
   Gerberick GF, 2004, TOXICOL SCI, V81, P332, DOI 10.1093/toxsci/kfh213
   Hartung T, 2004, ATLA-ALTERN LAB ANIM, V32, P467, DOI 10.1177/026119290403200503
   Jaworska J., 2013, ARCH TOXICOL, V89, P2355
   Jaworska J, 2013, J APPL TOXICOL, V33, P1353, DOI 10.1002/jat.2869
   Jaworska J, 2011, ALTEX-ALTERN ANIM EX, V28, P211, DOI 10.14573/altex.2011.3.211
   Kato Hiroshi, 2003, J Toxicol Sci, V28, P19, DOI 10.2131/jts.28.19
   Kimber I, 2002, CONTACT DERMATITIS, V47, P315, DOI 10.1034/j.1600-0536.2002.470601.x
   KIMBER I, 1994, TOXICOLOGY, V93, P13, DOI 10.1016/0300-483X(94)90193-7
   Landsteiner K, 1936, J EXP MED, V64, P625, DOI 10.1084/jem.64.4.625
   Lepoittevin J-P, 1998, ALLERGIC CONTACT DER
   Meschkat E, 2001, CHEM RES TOXICOL, V14, P110, DOI 10.1021/tx000225n
   Natsch A, 2007, TOXICOL IN VITRO, V21, P1220, DOI 10.1016/j.tiv.2007.03.016
   Natsch A., 2007, J APPL TOXICOL, V33, P1337
   Natsch A, 2008, TOXICOL SCI, V106, P464, DOI 10.1093/toxsci/kfn194
   Nukada Y, 2013, TOXICOL IN VITRO, V27, P609, DOI 10.1016/j.tiv.2012.11.006
   OECD, 2015, OECD GUID TEST CHE C
   Roberts DW, 2008, J APPL TOXICOL, V28, P377, DOI 10.1002/jat.1289
   Ryan CA, 2001, TOXICOL IN VITRO, V15, P43, DOI 10.1016/S0887-2333(00)00059-X
   Schultz TW, 2005, SAR QSAR ENVIRON RES, V16, P313, DOI 10.1080/10659360500204152
   Strickland J, 2017, J APPL TOXICOL, V37, P347, DOI 10.1002/jat.3366
   Troutman JA, 2011, TOXICOL SCI, V122, P422, DOI 10.1093/toxsci/kfr101
   Tsujita-Inoue K, 2014, TOXICOL IN VITRO, V28, P626, DOI 10.1016/j.tiv.2014.01.003
   United Nations, 2011, STSGAC1030 UN
   van der Veen JW, 2014, REGUL TOXICOL PHARM, V69, P371, DOI 10.1016/j.yrtph.2014.04.018
   Wong CL, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00053
NR 45
TC 4
Z9 4
U1 0
U2 2
PU FRAME
PI NOTTINGHAM
PA RUSSELL & BURCH HOUSE 96-98 NORTH SHERWOOD ST, NOTTINGHAM NG1 4EE,
   NOTTS, ENGLAND
SN 0261-1929
J9 ATLA-ALTERN LAB ANIM
JI ATLA-Altern. Lab. Anim.
PD OCT
PY 2016
VL 44
IS 5
BP 437
EP 442
DI 10.1177/026119291604400506
PG 6
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA EQ2UU
UT WOS:000397927100005
PM 27805826
DA 2019-10-23
ER

PT J
AU Natsch, A
   Emter, R
AF Natsch, Andreas
   Emter, Roger
TI Nrf2 Activation as a Key Event Triggered by Skin Sensitisers: The
   Development of the Stable KeratinoSens Reporter Gene Assay
SO ATLA-ALTERNATIVES TO LABORATORY ANIMALS
LA English
DT Article
DE Adverse Outcome Pathway; KeratinoSens; N2f2; reporter cell line; skin
   sensitisation
ID NONANIMAL TEST METHODS; CELL-LINE; CONTACT SENSITIZERS; PEPTIDE
   REACTIVITY; EXPRESSION CHANGES; DENDRITIC CELLS; IDENTIFICATION;
   CHEMICALS; POTENCY; PATHWAY
AB The 21st century paradigm for toxicology and the adverse outcome pathway concept envisage a future toxicology largely based on mechanistic in vitro assays and relying mainly on cellular models. In the skin sensitisation field, this concept was not intuitive at the beginning. Given the high structural diversity of skin sensitising molecules, classical receptor binding as the molecular initiating event in a cell-based assay could be excluded from the start, leaving the question of how cells could sense potential skin sensitising chemicals and be able to differentiate them from non-sensitisers. When we entered this field in 2006, we realised that, in another emerging field of toxicology, detailed work on the antioxidant/electrophile sensing pathway Keap1/Nrf2/ARE was being performed. We postulated that, based on their intrinsic electrophilicity, a large structural variety of skin sensitisers would activate this pathway. This was demonstrated in a preliminary pilot study with an existing, breast cancer-derived reporter cell line. Broader confirmation of this initial hypothesis then came from a multitude of genome-wide studies, in which sensitiser-induced changes to the transcriptome were investigated. The results showed that this regulatory pathway is indeed the most common regulatory pathway activated by sensitisers at the gene expression level, and the underlying event in keratinocytes has become formalised as a Key Event in the Organisation for Economic Co-operation and Development (OECD) Adverse Outcome Pathway for sensitisation. These studies led to the development of the KeratinoSens (R) assay, which became the first cell-based in vitro test for skin sensitisation to be endorsed by a European Union Reference Laboratory for Alternatives to Animal Testing (EURL ECVAM) statement and an OECD Test Guideline. More recently, a number of studies have further developed this approach into 3-D skin models. Here, we review the underlying mechanism and the development of the KeratinoSens assay. We also present data on the stability of the assay over time, which is a key requirement for a cell-based biological assay to be endorsed in a regulatory context.
C1 [Natsch, Andreas; Emter, Roger] Givaudan Schweiz AG, Ueberlandstrasse 138, CH-8600 Dubendorf, Switzerland.
RP Natsch, A (reprint author), Givaudan Schweiz AG, Ueberlandstrasse 138, CH-8600 Dubendorf, Switzerland.
EM andreas.natsch@givaudan.com
FU Givaudan Schweiz AG
FX This work was entirely funded by Givaudan Schweiz AG.
CR Ade N, 2009, TOXICOL SCI, V107, P451, DOI 10.1093/toxsci/kfn243
   Arkusz J, 2010, TOXICOL LETT, V199, P51, DOI 10.1016/j.toxlet.2010.08.005
   Ashikaga T, 2002, TOXICOL IN VITRO, V16, P711, DOI 10.1016/S0887-2333(02)00060-7
   Bauch C, 2012, REGUL TOXICOL PHARM, V63, P489, DOI 10.1016/j.yrtph.2012.05.013
   BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761
   Cottrez F, 2015, TOXICOL IN VITRO, V29, P787, DOI 10.1016/j.tiv.2015.02.012
   Dinkova-Kostova AT, 2005, CHEM RES TOXICOL, V18, P1779, DOI 10.1021/tx050217c
   Dumont C, 2016, TOXICOL IN VITRO, V34, P220, DOI 10.1016/j.tiv.2016.04.008
   Emter R, 2015, TOXICOL APPL PHARM, V288, P281, DOI 10.1016/j.taap.2015.07.027
   Emter R, 2015, TOXICOL IN VITRO, V29, P688, DOI 10.1016/j.tiv.2015.02.003
   Emter R, 2013, TOXICOL IN VITRO, V27, P2225, DOI 10.1016/j.tiv.2013.09.009
   Emter R, 2010, TOXICOL APPL PHARM, V245, P281, DOI 10.1016/j.taap.2010.03.009
   Gerberick F, 2008, ATLA-ALTERN LAB ANIM, V36, P215, DOI 10.1177/026119290803600210
   Gerberick GF, 2004, TOXICOL SCI, V81, P332, DOI 10.1093/toxsci/kfh213
   Hooyberghs J, 2008, TOXICOL APPL PHARM, V231, P103, DOI 10.1016/j.taap.2008.03.014
   Jaworska JS, 2015, ARCH TOXICOL, V89, P2355, DOI 10.1007/s00204-015-1634-2
   Johansson H, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-399
   Karlberg AT, 2008, CHEM RES TOXICOL, V21, P53, DOI 10.1021/tx7002239
   Lou H, 2006, MOL PHARMACOL, V69, P1662, DOI 10.1124/mol.105.019794
   MacLeod AK, 2009, CARCINOGENESIS, V30, P1571, DOI 10.1093/carcin/bgp176
   McKim JM, 2012, CUTAN OCUL TOXICOL, V31, P292, DOI 10.3109/15569527.2012.667031
   Motohashi H, 2004, TRENDS MOL MED, V10, P549, DOI 10.1016/j.molmed.2004.09.003
   Natsch A, 2008, TOXICOL SCI, V106, P464, DOI 10.1093/toxsci/kfn194
   Natsch A, 2008, TOXICOL SCI, V102, P110, DOI 10.1093/toxsci/kfm259
   Natsch A, 2015, ARCH TOXICOL, V89, P1645, DOI 10.1007/s00204-015-1555-0
   Natsch A, 2015, TOXICOL SCI, V143, P319, DOI 10.1093/toxsci/kfu229
   Natsch A, 2013, TOXICOL SCI, V135, P356, DOI 10.1093/toxsci/kft160
   Natsch A, 2011, TOXICOL IN VITRO, V25, P733, DOI 10.1016/j.tiv.2010.12.014
   Neves BM, 2008, TOXICOL LETT, V177, P74, DOI 10.1016/j.toxlet.2007.12.006
   Neves BM, 2013, CHEM RES TOXICOL, V26, P368, DOI 10.1021/tx300472d
   Neves BM, 2011, TOXICOL APPL PHARM, V250, P87, DOI 10.1016/j.taap.2010.10.003
   Ramirez T, 2014, TOXICOL IN VITRO, V28, P1482, DOI 10.1016/j.tiv.2014.08.002
   Ryan CA, 2004, TOXICOL LETT, V150, P301, DOI 10.1016/j.toxlet.2004.02.002
   Suzuki T., 2011, BIOCH RES INT, V2011, P1
   Tsujita-Inoue K, 2016, J APPL TOXICOL, V36, P956, DOI 10.1002/jat.3234
   Urbisch D, 2016, CHEM RES TOXICOL, V29, P901, DOI 10.1021/acs.chemrestox.6b00055
   Urbisch D, 2015, REGUL TOXICOL PHARM, V71, P337, DOI 10.1016/j.yrtph.2014.12.008
   van der Veen JWD, 2015, TOXICOL IN VITRO, V29, P81, DOI 10.1016/j.tiv.2014.08.010
   van der Veen JW, 2013, TOXICOL IN VITRO, V27, P314, DOI 10.1016/j.tiv.2012.08.023
   Vandebriel RJ, 2010, TOXICOL SCI, V117, P81, DOI 10.1093/toxsci/kfq182
   Wakabayashi N, 2004, P NATL ACAD SCI USA, V101, P2040, DOI 10.1073/pnas.0307301101
NR 41
TC 10
Z9 10
U1 1
U2 1
PU FRAME
PI NOTTINGHAM
PA RUSSELL & BURCH HOUSE 96-98 NORTH SHERWOOD ST, NOTTINGHAM NG1 4EE,
   NOTTS, ENGLAND
SN 0261-1929
J9 ATLA-ALTERN LAB ANIM
JI ATLA-Altern. Lab. Anim.
PD OCT
PY 2016
VL 44
IS 5
BP 443
EP 451
DI 10.1177/026119291604400513
PG 9
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA EQ2UU
UT WOS:000397927100006
PM 27805827
DA 2019-10-23
ER

PT J
AU Schultz, TW
   Dimitrova, G
   Dimitrov, S
   Mekenyan, OG
AF Schultz, Terry W.
   Dimitrova, Gergana
   Dimitrov, Sabcho
   Mekenyan, Ovanes G.
TI The Adverse Outcome Pathway for Skin Sensitisation: Moving Closer to
   Replacing Animal Testing
SO ATLA-ALTERNATIVES TO LABORATORY ANIMALS
LA English
DT Article
DE adverse outcome pathway; integrated approaches to testing and
   assessment; OECD QSAR Toolbox; skin sensitisation
ID LINE ACTIVATION TEST; PEPTIDE REACTIVITY ASSAY; NEURAL-NETWORK ANALYSIS;
   RISK-ASSESSMENT MODEL; TEST H-CLAT; HAZARD IDENTIFICATION; TEST BATTERY;
   TIMES-SS; POTENCY; CHEMICALS
AB This article outlines the work of the Organisation for Economic Co-operation and Development (OECD) that led to being jointly awarded the 2015 Lush Black Box Prize. The award-winning work centred on the development of 'The Adverse Outcome Pathway for Skin Sensitisation Initiated by Covalent Binding to Proteins'. This Adverse Outcome Pathway (AOP) has provided the mechanistic basis for the integration of skin sensitisation-related information. Recent developments in integrated approaches to testing and assessment, based on the AOP, are summarised. The impact of the AOP on regulatory policy and on the Three Rs are discussed. An overview of the next generation of the skin sensitisation AOP module in the OECD QSAR Toolbox, based on more-recent work at the Laboratory of Mathematical Chemistry, is also presented.
C1 [Schultz, Terry W.] Univ Tennessee, Coll Vet Med, Knoxville, TN 37996 USA.
   [Dimitrova, Gergana; Dimitrov, Sabcho; Mekenyan, Ovanes G.] Zlatarov Univ, LMC, Burgas, Bulgaria.
RP Schultz, TW (reprint author), 1112 Looking Glass Lane, Knoxville, TN 37919 USA.
EM tschultz@utk.edu
CR [Anonymous], 2012, OECD SER TEST ASS, V168
   Ashikaga T, 2006, TOXICOL IN VITRO, V20, P767, DOI 10.1016/j.tiv.2005.10.012
   Basketter D, 2015, REGUL TOXICOL PHARM, V73, P660, DOI 10.1016/j.yrtph.2015.10.005
   Canipa S.J., 2016, REGULATORY TOXICOLOG, V76, P33
   Dumont C, 2016, TOXICOL IN VITRO, V34, P220, DOI 10.1016/j.tiv.2016.04.008
   Enoch SJ, 2011, CRIT REV TOXICOL, V41, P783, DOI 10.3109/10408444.2011.598141
   Gerberick F, 2008, ATLA-ALTERN LAB ANIM, V36, P215, DOI 10.1177/026119290803600210
   Gerberick GF, 2004, TOXICOL SCI, V81, P332, DOI 10.1093/toxsci/kfh213
   Hirota M, 2015, J APPL TOXICOL, V35, P1333, DOI 10.1002/jat.3105
   Jaworska J, 2013, J APPL TOXICOL, V33, P1353, DOI 10.1002/jat.2869
   Jaworska JS, 2015, ARCH TOXICOL, V89, P2355, DOI 10.1007/s00204-015-1634-2
   Karlberg AT, 2008, CHEM RES TOXICOL, V21, P53, DOI 10.1021/tx7002239
   Kimber I, 2011, TOXICOL SCI, V120, pS238, DOI 10.1093/toxsci/kfq346
   Luechtefeld T, 2015, J APPL TOXICOL, V35, P1361, DOI 10.1002/jat.3172
   Natsch A, 2008, TOXICOL SCI, V102, P110, DOI 10.1093/toxsci/kfm259
   Natsch A, 2014, ISSUES TOXICOL, V19, P265
   Natsch A, 2015, TOXICOL SCI, V143, P319, DOI 10.1093/toxsci/kfu229
   Natsch A, 2010, TOXICOL SCI, V113, P284, DOI 10.1093/toxsci/kfp228
   Nukada Y, 2013, TOXICOL IN VITRO, V27, P609, DOI 10.1016/j.tiv.2012.11.006
   *OECD, 1992, OECD GUID TEST CHEM, V406
   OECD, 2016, ENVJMHA201611 OECD
   OECD, 2011, OECD SER TEST ASS, V139, P9
   OECD, 2010, GUID TEST CHEM B, V442B
   OECD, 2010, OECD GUID TEST CHE A, V442A
   OECD, 2010, OECD GUID TEST CHEM, V429
   OECD, 2011, OECD SER TEST ASS
   OECD, 2015, OECD GUID TEST CHEM, V442D
   Patlewicz G, 2014, SAR QSAR ENVIRON RES, V25, P367, DOI 10.1080/1062936X.2014.900520
   Patlewicz G, 2007, REGUL TOXICOL PHARM, V48, P225, DOI 10.1016/j.yrtph.2007.03.003
   Patlewicz G, 2014, REGUL TOXICOL PHARM, V69, P529, DOI 10.1016/j.yrtph.2014.06.001
   POTTS RO, 1992, PHARMACEUT RES, V9, P663, DOI 10.1023/A:1015810312465
   Ramirez T, 2014, TOXICOL IN VITRO, V28, P1482, DOI 10.1016/j.tiv.2014.08.002
   Rorije E, 2013, REGUL TOXICOL PHARM, V67, P146, DOI 10.1016/j.yrtph.2013.06.003
   Sakaguchi H, 2009, CELL BIOL TOXICOL, V25, P109, DOI 10.1007/s10565-008-9059-9
   Schwobel JAH, 2011, CHEM REV, V111, P2562, DOI 10.1021/cr100098n
   Shen J, 2014, FOOD CHEM TOXICOL, V74, P164, DOI 10.1016/j.fct.2014.09.015
   Takenouchi O, 2015, J APPL TOXICOL, V35, P1318, DOI 10.1002/jat.3127
   Tsujita-Inoue K, 2015, J TOXICOL SCI, V40, P193, DOI 10.2131/jts.40.193
   Tsujita-Inoue K, 2014, TOXICOL IN VITRO, V28, P626, DOI 10.1016/j.tiv.2014.01.003
   Urbisch D, 2015, REGUL TOXICOL PHARM, V71, P337, DOI 10.1016/j.yrtph.2014.12.008
   van der Veen JW, 2014, CRIT REV TOXICOL, V44, P590, DOI 10.3109/10408444.2014.925425
   van der Veen JW, 2014, REGUL TOXICOL PHARM, V69, P371, DOI 10.1016/j.yrtph.2014.04.018
NR 42
TC 3
Z9 4
U1 0
U2 2
PU FRAME
PI NOTTINGHAM
PA RUSSELL & BURCH HOUSE 96-98 NORTH SHERWOOD ST, NOTTINGHAM NG1 4EE,
   NOTTS, ENGLAND
SN 0261-1929
J9 ATLA-ALTERN LAB ANIM
JI ATLA-Altern. Lab. Anim.
PD OCT
PY 2016
VL 44
IS 5
BP 453
EP 460
DI 10.1177/026119291604400515
PG 8
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA EQ2UU
UT WOS:000397927100007
PM 27805828
DA 2019-10-23
ER

PT J
AU Simon, TW
   Zhu, YL
   Dourson, ML
   Beck, NB
AF Simon, Ted W.
   Zhu, Yiliang
   Dourson, Michael L.
   Beck, Nancy B.
TI Bayesian methods for uncertainty factor application for derivation of
   reference values
SO REGULATORY TOXICOLOGY AND PHARMACOLOGY
LA English
DT Article
DE Uncertainty factor; Bayesian methods; Reference dose; Reference
   concentration; Risk assessment; Hazard assessment
ID NONCANCER RISK-ASSESSMENT; RESPONSE RELATIONSHIP ANALYSIS; ADDRESSING
   HUMAN VARIABILITY; ADVERSE OUTCOME PATHWAYS; TO-CHRONIC EXTRAPOLATION;
   REFERENCE DOSE RFD; HOT-PLATE TEST; HUMAN HEALTH; ENVIRONMENTAL
   CHEMICALS; TOXICITY DATA
AB In 2014, the National Research Council (NRC) published Review of EPA's Integrated Risk Information System (IRIS) Process that considers methods EPA uses for developing toxicity criteria for non-carcinogens. These criteria are the Reference Dose (RfD) for oral exposure and Reference Concentration (RfC) for inhalation exposure. The NRC Review suggested using Bayesian methods for application of uncertainty factors (UFs) to adjust the point of departure dose or concentration to a level considered to be without adverse effects for the human population. The NRC foresaw Bayesian methods would be potentially useful for combining toxicity data from disparate sources high throughput assays, animal testing, and observational epidemiology. UFs represent five distinct areas for which both adjustment and consideration of uncertainty may be needed. NRC suggested UFs could be represented as Bayesian prior distributions, illustrated the use of a log-normal distribution to represent the composite UF, and combined this distribution with a log-normal distribution representing uncertainty in the point of departure (POD) to reflect the overall uncertainty. Here, we explore these suggestions and present a refinement of the methodology suggested by NRC that considers each individual UF as a distribution. From an examination of 24 evaluations from EPA's IRIS program, when individual UFs were represented using this approach, the geometric mean fold change in the value of the RfD or RfC increased from 3 to over 30, depending on the number of individual UFs used and the sophistication of the assessment. We present example calculations and recommendations for implementing the refined NRC methodology. (C) 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license.
C1 [Simon, Ted W.] Ted Simon LLC, 4184 Johnston Rd, Winston, GA 30187 USA.
   [Zhu, Yiliang] Univ S Florida, Dept Epidemiol & Biostat, 13201 Bruce B Downs,MDC56, Tampa, FL 33612 USA.
   [Dourson, Michael L.] Univ Cincinnati, TERA Ctr, Coll Med, 160 Panzeca Way, Cincinnati, OH 45267 USA.
   [Beck, Nancy B.] Amer Chem Council, Regulatory Sci Policy Regulatory & Tech Affairs, 700 2nd St NE, Washington, DC 20002 USA.
RP Simon, TW (reprint author), Ted Simon LLC, 4184 Johnston Rd, Winston, GA 30187 USA.
EM ted@tedsimon-toxicology.com
RI Simon, Ted/M-9188-2013
OI Simon, Ted/0000-0001-9405-3020
FU American Chemistry Council (ACC)
FX The American Chemistry Council (ACC) provided support to TWS, MLD, and
   YZ. NBB is an employee of ACC. The authors retain sole responsibility
   for the content of this paper. The American Chemistry Council had an
   opportunity to review this text as part of their internal clearance;
   however, this paper is exclusively the work product of the authors and
   does not necessarily represent views or policies of the ACC or the
   authors' employers. We also wish to acknowledge the contribution of one
   of the peer reviewers whose thoughtful suggestions improved this paper
   considerably.
CR Abdo N, 2015, ENVIRON INT, V85, P147, DOI 10.1016/j.envint.2015.09.012
   Abdo N, 2015, ENVIRON HEALTH PERSP, V123, P458, DOI 10.1289/ehp.1408775
   Baird SJS, 1996, HUM ECOL RISK ASSESS, V2, P79, DOI 10.1080/10807039.1996.10387463
   BARNES DG, 1988, REGUL TOXICOL PHARM, V8, P471, DOI 10.1016/0273-2300(88)90047-5
   Becker RA, 2015, REGUL TOXICOL PHARM, V72, P514, DOI 10.1016/j.yrtph.2015.04.004
   Blackburn K, 2015, REGUL TOXICOL PHARM, V72, P202, DOI 10.1016/j.yrtph.2015.04.006
   Bogen KT, 2014, DOSE-RESPONSE, V12, P386, DOI 10.2203/dose-response.13-019.Bogen
   Bois FY, 2010, TOXICOLOGY, V278, P256, DOI 10.1016/j.tox.2010.06.007
   Bokkers BGH, 2007, CRIT REV TOXICOL, V37, P355, DOI 10.1080/10408440701249224
   Bokkers BGH, 2005, TOXICOL SCI, V85, P1033, DOI 10.1093/toxsci/kfi144
   Bruckner JV, 2000, REGUL TOXICOL PHARM, V31, P280, DOI 10.1006/rtph.2000.1393
   Bruhn J, 2003, ANESTH ANALG, V96, P142, DOI 10.1213/01.ANE.0000039193.74733.69
   Burin GJ, 1999, REGUL TOXICOL PHARM, V30, P209, DOI 10.1006/rtph.1999.1351
   Burmaster D. E., 1991, GROUND WATER MON SUM
   BURMASTER DE, 1994, RISK ANAL, V14, P477, DOI 10.1111/j.1539-6924.1994.tb00265.x
   BURMASTER DE, 1993, RISK ANAL, V13, P131, DOI 10.1111/j.1539-6924.1993.tb01058.x
   Calabrese EJ, 2015, ARCH TOXICOL, V89, P647, DOI 10.1007/s00204-015-1454-4
   Calabrese EJ, 2009, ARCH TOXICOL, V83, P203, DOI 10.1007/s00204-009-0412-4
   CAVALLERI A, 1994, NEUROSCI LETT, V179, P162, DOI 10.1016/0304-3940(94)90959-8
   Chiu W. A., 2015, ENV HLTH PERSPECT
   Clark A.J., 1933, MODE ACTION DRUGS CE
   Crump KS, 2003, TOXICOL SCI, V74, P485, DOI 10.1093/toxsci/kfg117
   CULLEN AC, 1994, RISK ANAL, V14, P389, DOI 10.1111/j.1539-6924.1994.tb00257.x
   Dome J.L.C.M., 2005, TOXICOL SOC, V86, P20
   Dourson M, 1996, REGUL TOXICOL PHARM, V24, P107, DOI 10.1006/rtph.1996.0115
   Dourson M., 1991, STAT TOXICOLOGY
   Dourson M L, 1983, Regul Toxicol Pharmacol, V3, P224, DOI 10.1016/0273-2300(83)90030-2
   Dourson M, 2013, CRIT REV TOXICOL, V43, P467, DOI 10.3109/10408444.2013.807223
   Dourson ML, 1997, REGUL TOXICOL PHARM, V25, P121, DOI 10.1006/rtph.1996.1079
   Dourson ML, 1996, REGUL TOXICOL PHARM, V24, P108, DOI 10.1006/rtph.1996.0116
   DOURSON ML, 1992, TOXICOL IND HEALTH, V8, P171, DOI 10.1177/074823379200800304
   DOURSON ML, 1993, SCAND J WORK ENV HEA, V19, P115
   ECHEVERRIA D, 1995, J OCCUP ENVIRON MED, V37, P667, DOI 10.1097/00043764-199506000-00008
   Felter S, 1998, HUM ECOL RISK ASSESS, V4, P245, DOI 10.1080/10807039891284316
   Gaylor DW, 2000, RISK ANAL, V20, P245, DOI 10.1111/0272-4332.202023
   Haber LT, 2002, REGUL TOXICOL PHARM, V35, P177, DOI 10.1006/rtph.2001.1517
   Hasegawa R, 2010, REGUL TOXICOL PHARM, V58, P237, DOI 10.1016/j.yrtph.2010.06.006
   Hattis D, 2002, DRUG CHEM TOXICOL, V25, P403, DOI 10.1081/DCT-120014793
   Helton JC, 1996, RELIAB ENG SYST SAFE, V54, P91, DOI 10.1016/S0951-8320(96)00066-X
   Hennessey VG, 2010, BIOMETRICS, V66, P1275, DOI 10.1111/j.1541-0420.2010.01403.x
   Hertzberg R. C., 1993, TOXICOLOGY CHEM MIXT
   Hill RA, 1996, HUM ECOL RISK ASSESS, V2, P636, DOI 10.1080/10807039609383641
   Hughes DA, 2010, J CLIN PHARMACOL, V50, P17, DOI 10.1177/0091270008329555
   Igarashi T, 1996, REGUL TOXICOL PHARM, V23, P193, DOI 10.1006/rtph.1996.0043
   Igarashi Toshiji, 1996, Journal of Toxicological Sciences, V21, P497
   Jacobs J. P., 2011, NAS REV SLAM EPAS FO
   Jones DR, 2009, REGUL TOXICOL PHARM, V53, P217, DOI 10.1016/j.yrtph.2009.01.011
   LEHMAN AJ, 1954, ASSOC FOOD DRUG OFF, V18, P33
   LEWIS SC, 1990, REGUL TOXICOL PHARM, V11, P314, DOI 10.1016/0273-2300(90)90030-F
   Limpert E, 2001, BIOSCIENCE, V51, P341, DOI 10.1641/0006-3568(2001)051[0341:LNDATS]2.0.CO;2
   Linkov I, 2009, SCI TOTAL ENVIRON, V407, P5199, DOI 10.1016/j.scitotenv.2009.05.004
   Luszczki JJ, 2008, PHARMACOL REP, V60, P409
   Luszczki JJ, 2010, PHARMACOL REP, V62, P942
   Meek M. E., 1994, ENV CARCINOGEN ECO C, V12, P105
   Meek ME, 2002, TOXICOLOGY, V181, P115, DOI 10.1016/S0300-483X(02)00265-2
   National Research Council NRC, 2007, SCI REV PROP RISK AS
   National Research Council (NRC), 2014, REV EPAS INT RISK IN
   National Research Council (NRC), 2007, MOD ENV REG DEC MAK
   NIOSH (National Institute for Occupational Safety and Health, 1976, CRIT REC STAND OCC E
   NRC, 2011, REV ENV PROT AG DRAF
   NRC, 1994, SCI JUDG RISK ASS
   NRC, 2009, SCI DEC ADV RISK ASS
   NRC, 2006, HLTH RISKS DIOX REL
   Patlewicz G, 2015, REGUL TOXICOL PHARM, V71, P463, DOI 10.1016/j.yrtph.2015.02.011
   Patlewicz G, 2013, REGUL TOXICOL PHARM, V65, P259, DOI 10.1016/j.yrtph.2012.12.008
   Pelekis M, 2004, REGUL TOXICOL PHARM, V40, P264, DOI 10.1016/j.yrtph.2004.07.004
   Pelekis M, 2003, RISK ANAL, V23, P1239, DOI 10.1111/j.0272-4332.2003.00398.x
   Pieters MN, 1998, REGUL TOXICOL PHARM, V27, P108, DOI 10.1006/rtph.1997.1196
   Price PS, 2008, TOXICOL APPL PHARM, V233, P64, DOI 10.1016/j.taap.2008.03.026
   Price PS, 1997, RISK ANAL, V17, P427, DOI 10.1111/j.1539-6924.1997.tb00883.x
   Renwick AG, 1998, REGUL TOXICOL PHARM, V27, P3, DOI 10.1006/rtph.1997.1195
   Rozman KK, 1996, DRUG METAB REV, V28, P29, DOI 10.3109/03602539608993990
   Shao K., 2013, RISK ANAL
   Simon T., 2014, ENV RISK ASSESSMENT
   Simon T, 2008, TOXICOL SCI, V106, P519, DOI 10.1093/toxsci/kfn176
   Simon T, 2011, HUM EXP TOXICOL, V30, P795, DOI 10.1177/0960327110379252
   Simon T, 2009, TOXICOL SCI, V112, P490, DOI 10.1093/toxsci/kfp232
   Slob W, 2014, CRIT REV TOXICOL, V44, P270, DOI 10.3109/10408444.2013.853726
   Stedeford T, 2007, J ENVIRON SCI HEAL C, V25, P245, DOI 10.1080/10590500701569430
   Swartout JC, 1998, RISK ANAL, V18, P271, DOI 10.1111/j.1539-6924.1998.tb01294.x
   Tatum V, 2015, INTEGR ENVIRON ASSES, V11, P298, DOI 10.1002/ieam.1584
   Teuschler LK, 1999, REGUL TOXICOL PHARM, V30, pS19, DOI 10.1006/rtph.1999.1321
   USEPA, 1992, GUID RISK CHAR RISK
   USEPA, 2014, GUID APPL QUANT DAT
   USEPA, 2013, IRIS TOX REV METH NO
   USEPA, 1994, METH DER INH PEF CON
   USEPA, 2012, BENCHM DOS TECHN GUI
   USEPA, 2012, IRIS TOX REV TETR
   USEPA, 2002, IRIS TOX REV PHEN
   USEPA, 2011, INT RISK INF SYST IR
   [USEPA Response O. o. E. a. R. and Agency U. S. E. P], 1989, RISK ASS GUID SUP, VI
   USEPA Toxicological, 2013, 123911 USEPA CAS
   USEPA-United States Environmental Protection Agency, 2002, REV REF DOS REF CONC
   USEPA-United States Environmental Protection Agency, 2001, RISK ASS GUID SUP A
   Villeneuve DL, 2014, TOXICOL SCI, V142, P312, DOI 10.1093/toxsci/kfu199
   Villeneuve DL, 2014, TOXICOL SCI, V142, P321, DOI 10.1093/toxsci/kfu200
   Von Stackelberg K., 1993, HAZMAT WORLD     MAR
   Waddell WJ, 2008, TOXICOL APPL PHARM, V228, P156, DOI 10.1016/j.taap.2007.12.004
   Waddell WJ, 2010, J TOXICOL SCI, V35, P1, DOI 10.2131/jts.35.1
   Waddell WJ, 2003, TOXICOL SCI, V72, P158, DOI 10.1093/toxsci/kfg004
   [WHO IPCS], 2005, CHEM SPEC ADJ FACT I
   WHO/IPCS, 2014, GUID DOC EV EXPR UNC
   Wilson A, 2014, BIOMETRICS, V70, P237, DOI 10.1111/biom.12114
   Zeise L, 2013, ENVIRON HEALTH PERSP, V121, P23, DOI 10.1289/ehp.1205687
   Zhu YL, 2007, RISK ANAL, V27, P447, DOI 10.1111/j.1539-6924.2007.00897.x
NR 105
TC 5
Z9 5
U1 0
U2 11
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0273-2300
EI 1096-0295
J9 REGUL TOXICOL PHARM
JI Regul. Toxicol. Pharmacol.
PD OCT
PY 2016
VL 80
BP 9
EP 24
DI 10.1016/j.yrtph.2016.05.018
PG 16
WC Medicine, Legal; Pharmacology & Pharmacy; Toxicology
SC Legal Medicine; Pharmacology & Pharmacy; Toxicology
GA DW0EY
UT WOS:000383314900002
PM 27211295
OA Other Gold
DA 2019-10-23
ER

PT J
AU Kienzler, A
   Bopp, SK
   van der Linden, S
   Berggren, E
   Worth, A
AF Kienzler, Aude
   Bopp, Stephanie K.
   van der Linden, Sander
   Berggren, Elisabet
   Worth, Andrew
TI Regulatory assessment of chemical mixtures: Requirements, current
   approaches and future perspectives
SO REGULATORY TOXICOLOGY AND PHARMACOLOGY
LA English
DT Editorial Material
DE Mixture; Combined effect; Risk assessment; Regulation
ID MAXIMUM CUMULATIVE RATIO; DISINFECTION BY-PRODUCTS; RISK-ASSESSMENT;
   PESTICIDE MIXTURES; INDOOR ENVIRONMENT; FLAME RETARDANTS; EXPOSURE
   ASSESSMENT; BIOMONITORING DATA; HAZARD ASSESSMENT; DRINKING-WATER
AB This paper reviews regulatory requirements and recent case studies to illustrate how the risk assessment (RA) of chemical mixtures is conducted, considering both the effects on human health and on the environment. A broad range of chemicals, regulations and RA methodologies are covered, in order to identify mixtures of concern, gaps in the regulatory framework, data needs, and further work to be carried out. Also the current and potential future use of novel tools (Adverse Outcome Pathways, in silico tools, toxicokinetic modelling, etc.) in the RA of combined effects were reviewed.
   The assumptions made in the RA, predictive model specifications and the choice of toxic reference values can greatly influence the assessment outcome, and should therefore be specifically justified. Novel tools could support mixture RA mainly by providing a better understanding of the underlying mechanisms of combined effects. Nevertheless, their use is currently limited because of a lack of guidance, data, and expertise. More guidance is needed to facilitate their application. As far as the authors are aware, no prospective RA concerning chemicals related to various regulatory sectors has been performed to date, even though numerous chemicals are registered under several regulatory frameworks. (C) 2016 The Authors. Published by Elsevier Inc.
C1 [Bopp, Stephanie K.] European Commiss, Joint Res Ctr, Inst Hlth & Consumer Protect, Syst Toxicol Unit, Via Enrico Fermi 2749, I-21027 Ispra, VA, Italy.
   [Bopp, Stephanie K.] EURL ECVAM, Via Enrico Fermi 2749, I-21027 Ispra, VA, Italy.
RP Bopp, SK (reprint author), European Commiss, Joint Res Ctr, Inst Hlth & Consumer Protect, Syst Toxicol Unit, Via Enrico Fermi 2749, I-21027 Ispra, VA, Italy.; Bopp, SK (reprint author), EURL ECVAM, Via Enrico Fermi 2749, I-21027 Ispra, VA, Italy.
EM Stephanie.BOPP@ec.europa.eu
RI Worth, Andrew Paul/O-3055-2019; Worth, Andrew/R-8495-2019
OI Worth, Andrew Paul/0000-0002-5303-0452; Bopp,
   Stephanie/0000-0003-1082-8007
CR Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Backhaus T, 2004, ENVIRON SCI TECHNOL, V38, P6363, DOI 10.1021/es0497678
   Backhaus T, 2014, WATER RES, V49, P157, DOI 10.1016/j.watres.2013.11.005
   Backhaus T, 2012, ENVIRON SCI TECHNOL, V46, P2564, DOI 10.1021/es2034125
   Becker K, 2009, INT J HYG ENVIR HEAL, V212, P685, DOI 10.1016/j.ijheh.2009.08.002
   Belanger SE, 2015, ENVIRON TOXICOL CHEM, V34, P2864, DOI 10.1002/etc.3132
   Berg T, 2015, MAR POLLUT BULL, V96, P18, DOI 10.1016/j.marpolbul.2015.04.050
   Boobis A, 2011, CRIT REV TOXICOL, V41, P369, DOI 10.3109/10408444.2010.543655
   Boon PE, 2015, FOOD CHEM TOXICOL, V79, P13, DOI 10.1016/j.fct.2014.08.004
   Bopp S., 2015, SCI METHODOLOGIES AS
   Cedergreen N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096580
   Cedergreen N, 2012, SCI TOTAL ENVIRON, V427, P229, DOI 10.1016/j.scitotenv.2012.03.086
   Christiansen S, 2009, ENVIRON HEALTH PERSP, V117, P1839, DOI 10.1289/ehp.0900689
   COLIN ME, 1992, PESTIC SCI, V36, P115, DOI 10.1002/ps.2780360206
   de Boer J, 2016, CHEMOSPHERE, V147, P1, DOI 10.1016/j.chemosphere.2015.12.005
   De Brouwere K, 2014, SCI TOTAL ENVIRON, V479, P267, DOI 10.1016/j.scitotenv.2014.01.083
   De Zwart D, 2005, ENVIRON TOXICOL CHEM, V24, P2665, DOI 10.1897/04-639R.1
   Delfosse V, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9089
   Delmaar C, 2015, J EXPO SCI ENV EPID, V25, P317, DOI 10.1038/jes.2014.68
   Dewalque L, 2014, TOXICOL LETT, V231, P161, DOI 10.1016/j.toxlet.2014.06.028
   EC, 2012, CHEM MIX COM, V252
   ECHA, 2012, GUID INF REQU CHEM S
   ECHA, 2013, GUID IMPL REACH GUID
   ECHA, 2014, TRANS GUID BIOC PROD
   ECHA, 2015, GUID BIOC PROD REG B, VIII
   EFSA, 2012, GUID USE PROB METH M
   EFSA, 2014, EFSA J EUR FOOD SAF
   EFSA Scientific Committee (SC), 2015, GUID UNC EFSA SCI AS
   EMEA, 2006, GUID ENV RISK ASS ME
   Evans R. M., 2015, SCI TOTAL ENV
   Fromme H, 2016, INT J HYG ENVIR HEAL, V219, P1, DOI 10.1016/j.ijheh.2015.08.004
   Garthwaite D., 2015, EFSA SUPPORTNG PUBLI, V2015:EN-846
   Gosens I, 2014, J EXPO SCI ENV EPID, V24, P208, DOI 10.1038/jes.2013.33
   Gregorio V, 2014, WIRES WATER, V1, P229, DOI 10.1002/wat2.1018
   Gregorio V, 2013, ENVIRON TOXICOL CHEM, V32, P2387, DOI 10.1002/etc.2320
   Groten JP, 2000, REGUL TOXICOL PHARM, V31, P77, DOI 10.1006/rtph.1999.1356
   Gutierrez S, 2008, ENVIRON INT, V34, P773, DOI 10.1016/j.envint.2008.01.002
   Han XL, 2013, J EXPO SCI ENV EPID, V23, P343, DOI 10.1038/jes.2012.74
   Han XL, 2011, INT J ENV RES PUB HE, V8, P4729, DOI 10.3390/ijerph8124729
   Hoffman K, 2015, ENVIRON HEALTH PERSP, V123, P160, DOI 10.1289/ehp.1408669
   Jeong CH, 2012, ENVIRON SCI TECHNOL, V46, P12120, DOI 10.1021/es3024226
   Junghans M, 2006, AQUAT TOXICOL, V76, P93, DOI 10.1016/j.aquatox.2005.10.001
   Kennedy MC, 2015, FOOD CHEM TOXICOL, V79, P32, DOI 10.1016/j.fct.2014.09.009
   Kienzler A., 2014, MAPPING ASSESSMENT E
   Kortenkamp A, 2010, INT J ANDROL, V33, P463, DOI 10.1111/j.1365-2605.2009.01047.x
   Kortenkamp A, 2009, STATE ART REPORT MIX
   Laetz CA, 2009, ENVIRON HEALTH PERSP, V117, P348, DOI 10.1289/ehp.0800096
   Law R., 2010, JRC SCI TECHNICAL RE
   Le Cann P, 2011, INT J HYG ENVIR HEAL, V215, P1, DOI 10.1016/j.ijheh.2011.07.008
   Lim YW, 2014, SCI TOTAL ENVIRON, V470, P1376, DOI 10.1016/j.scitotenv.2013.09.013
   Malaj E, 2014, P NATL ACAD SCI USA, V111, P9549, DOI 10.1073/pnas.1321082111
   Meek ME, 2011, REGUL TOXICOL PHARM, V60, pS1, DOI 10.1016/j.yrtph.2011.03.010
   Nieuwenhuijsen MJ, 2009, J WATER HEALTH, V7, P185, DOI 10.2166/wh.2009.073
   Nowell LH, 2014, SCI TOTAL ENVIRON, V476, P144, DOI 10.1016/j.scitotenv.2013.12.088
   OECD, 2011, WHO OECD ILSI HESI I, V140
   Ohe T, 2004, MUTAT RES-REV MUTAT, V567, P109, DOI 10.1016/j.mrrev.2004.08.003
   Price P, 2014, FOOD ADDIT CONTAM A, V31, P414, DOI 10.1080/19440049.2013.865145
   Price Paul, 2012, Environmental Sciences Europe, V24, P34, DOI 10.1186/2190-4715-24-34
   Qian H, 2015, J EXPO SCI ENV EPID, V25, P249, DOI 10.1038/jes.2014.24
   Reif DM, 2013, BIOINFORMATICS, V29, P402, DOI 10.1093/bioinformatics/bts686
   Reif DM, 2010, ENVIRON HEALTH PERSP, V118, P1714, DOI 10.1289/ehp.1002180
   Rico A., 2015, INTEGR ENV ASSESS MA
   Salthammer T, 2003, INDOOR AIR, V13, P49, DOI 10.1034/j.1600-0668.2003.01150.x
   Sammataro D., 2011, HONEY BEE COLONY HLT
   Sarigiannis DA, 2011, ENVIRON INT, V37, P743, DOI 10.1016/j.envint.2011.01.005
   SCHER SCCS SCENIHR, 2012, SCHER SCCS SCENIHR O
   Scientific Committee on Consumer Safety (SCCS), 2015, SCCS NOT GUID TEST C
   Tang JYM, 2014, WATER RES, V60, P289, DOI 10.1016/j.watres.2014.04.043
   USEPA, 2002, ORG PEST REV CUM RIS
   USEPA, 2006, TRIAZ CUM RISK ASS
   USEPA, 1999, GUID ID PEST CHEM OT
   USEPA, 2006, EPA600R060134
   USEPA, 2006, CUM RISK CHLOR PEST
   USEPA, 2002, GUID CUM RISK ASS PE
   USEPA, 2003, EPA630P2001F
   USEPA, 1987, EPA600887045
   USEPA, 2000, SUPPL GUID COND HLTH
   USEPA, 2007, REV N METH CARB CUM
   USEPA (U. S. Environmental Protection Agency), 1989, EPA540189002
   WHO, 2014, 11 WHO IPCS HARM
   WHO IPCS, 2009, 7 WHO IPCS
   World Health Organization, 2014, COMB MULT EXP HLTH S
NR 82
TC 53
Z9 53
U1 5
U2 45
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0273-2300
EI 1096-0295
J9 REGUL TOXICOL PHARM
JI Regul. Toxicol. Pharmacol.
PD OCT
PY 2016
VL 80
BP 321
EP 334
DI 10.1016/j.yrtph.2016.05.020
PG 14
WC Medicine, Legal; Pharmacology & Pharmacy; Toxicology
SC Legal Medicine; Pharmacology & Pharmacy; Toxicology
GA DW0EY
UT WOS:000383314900036
PM 27211294
OA Other Gold
DA 2019-10-23
ER

PT J
AU LaLone, CA
   Villeneuve, DL
   Lyons, D
   Helgen, HW
   Robinson, SL
   Swintek, JA
   Saari, TW
   Ankley, GT
AF LaLone, Carlie A.
   Villeneuve, Daniel L.
   Lyons, David
   Helgen, Henry W.
   Robinson, Serina L.
   Swintek, Joseph A.
   Saari, Travis W.
   Ankley, Gerald T.
TI Sequence Alignment to Predict Across Species Susceptibility (SeqAPASS):
   A Web-Based Tool for Addressing the Challenges of Cross-Species
   Extrapolation of Chemical Toxicity
SO TOXICOLOGICAL SCIENCES
LA English
DT Article
DE sequence similarity; methoxyfenozide; tebufenozide; neonicotinoids;
   strobilurins; pollinator susceptibility
ID NICOTINIC ACETYLCHOLINE-RECEPTOR; CYTOCHROME-B GENE; LOOP-D;
   NEONICOTINOID INSECTICIDES; ECDYSONE RECEPTOR; RISK-ASSESSMENT;
   FUNGICIDES; RESISTANCE; AGONIST; AZOXYSTROBIN
AB Conservation of a molecular target across species can be used as a line-of-evidence to predict the likelihood of chemical susceptibility. The web-based Sequence Alignment to Predict Across Species Susceptibility (SeqAPASS; https://seqapass.epa.gov/seqapass/) application was developed to simplify, streamline, and quantitatively assess protein sequence/structural similarity across taxonomic groups as a means to predict relative intrinsic susceptibility. The intent of the tool is to allow for evaluation of any potential protein target while remaining amenable to variable degrees of protein characterization, in the context of available information about the chemical/protein interaction and the molecular target itself. To accommodate this flexibility in the analysis, 3 levels of evaluation were developed. The first level of the SeqAPASS analysis compares primary amino acid sequences to a query sequence, calculating a metric for sequence similarity (including detection of orthologs); the second level evaluates sequence similarity within selected functional domains (eg, ligand-binding domain); and the third level of analysis compares individual amino acid residue positions of importance for protein conformation and/or interaction with the chemical upon binding. Each level of the SeqAPASS analysis provides additional evidence to apply toward rapid, screening-level assessments of probable cross species susceptibility. Such analyses can support prioritization of chemicals for further evaluation, selection of appropriate species for testing, extrapolation of empirical toxicity data, and/or assessment of the cross-species relevance of adverse outcome pathways. Three case studies are described herein to demonstrate application of the SeqAPASS tool: the first 2 focused on predictions of pollinator susceptibility to molt-accelerating compounds and neonicotinoid insecticides, and the third on evaluation of cross-species susceptibility to strobilurin fungicides. These analyses illustrate challenges in species extrapolation and demonstrate the broad utility of SeqAPASS for risk-based decision making and research.
C1 [LaLone, Carlie A.; Villeneuve, Daniel L.; Saari, Travis W.; Ankley, Gerald T.] US EPA, Natl Hlth & Environm Effects Res Lab, Off Res & Dev, Mid Continent Ecol Div, Duluth, MN 55804 USA.
   [Lyons, David] US EPA, Off Res & Dev, Natl Ctr Computat Toxicol, Res Triangle Pk, NC USA.
   [Helgen, Henry W.] CSC Govt Solut LLC, Willmar, MN USA.
   [Robinson, Serina L.] St Olaf Coll, Dept Chem, Northfield, MN USA.
   [Swintek, Joseph A.] Badger Tech Serv, Duluth, MN USA.
RP LaLone, CA (reprint author), US EPA Mid Continent Ecol Div, 6201 Congdon Blvd, Duluth, MN 55804 USA.
EM lalone.carlie@epa.gov
RI Lyons, David/G-3459-2011
OI Lyons, David/0000-0002-2966-5634
FU U.S. Environmental Protection AgencyUnited States Environmental
   Protection Agency
FX This work was supported by the U.S. Environmental Protection Agency.
CR Altenhoff AM, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002514
   ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2
   Amor F, 2012, PEST MANAG SCI, V68, P1586, DOI 10.1002/ps.3353
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Antes I, 2010, PROTEINS, V78, P1084, DOI 10.1002/prot.22629
   Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770
   Balba H, 2007, J ENVIRON SCI HEAL B, V42, P441, DOI 10.1080/03601230701316465
   Bartlett DW, 2002, PEST MANAG SCI, V58, P649, DOI 10.1002/ps.520
   Bass C, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-51
   Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235
   Billas IML, 2003, NATURE, V426, P91, DOI 10.1038/nature02112
   Bonneton F, 2003, MOL BIOL EVOL, V20, P541, DOI 10.1093/molbev/msg054
   Carlson G. R., 2000, ACS S SERIES
   Carlson GR, 2001, PEST MANAG SCI, V57, P115, DOI 10.1002/1526-4998(200102)57:2<115::AID-PS245>3.0.CO;2-A
   Carlson HA, 2002, CURR PHARM DESIGN, V8, P1571, DOI 10.2174/1381612023394232
   Carmichael JA, 2005, J BIOL CHEM, V280, P22258, DOI 10.1074/jbc.M500661200
   Castresana J, 2001, MOL BIOL EVOL, V18, P465, DOI 10.1093/oxfordjournals.molbev.a003825
   Dani JA, 2007, ANNU REV PHARMACOL, V47, P699, DOI 10.1146/annurev.pharmtox.47.120505.105214
   Dederer H, 2013, INSECT MOL BIOL, V22, P183, DOI 10.1111/imb.12014
   Diaz-Espejo A, 2012, J PLANT PHYSIOL, V169, P379, DOI 10.1016/j.jplph.2011.11.014
   Dow Chemical Company, 2014, PROD SAF ASS ADSORBS, P1
   Elbert A, 2008, PEST MANAG SCI, V64, P1099, DOI 10.1002/ps.1616
   Erdmanis L, 2012, BIOCHEMISTRY-US, V51, P4627, DOI 10.1021/bi300522s
   Genchi C, 2000, Vet Ther, V1, P71
   Grasso V, 2006, PEST MANAG SCI, V62, P465, DOI 10.1002/ps.1236
   Ihara Makoto, 2007, Invertebrate Neuroscience, V7, P47, DOI 10.1007/s10158-006-0043-x
   Ishii H, 2007, PHYTOPATHOLOGY, V97, P1458, DOI 10.1094/PHYTO-97-11-1458
   Ishii H, 2001, PHYTOPATHOLOGY, V91, P1166, DOI 10.1094/PHYTO.2001.91.12.1166
   Jeschke P, 2008, PEST MANAG SCI, V64, P1084, DOI 10.1002/ps.1631
   Jones AK, 2006, GENOME RES, V16, P1422, DOI 10.1101/gr.4549206
   Jones AK, 2010, ADV EXP MED BIOL, V683, P25
   Kavlock R, 2012, CHEM RES TOXICOL, V25, P1287, DOI 10.1021/tx3000939
   Kim YS, 2003, PHYTOPATHOLOGY, V93, P891, DOI 10.1094/PHYTO.2003.93.7.891
   LaLone CA, 2013, AQUAT TOXICOL, V144, P141, DOI 10.1016/j.aquatox.2013.09.004
   LaLone CA, 2013, ENVIRON TOXICOL CHEM, V32, P2528, DOI 10.1002/etc.2330
   Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404
   Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503
   Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009
   Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189
   Matsuda K, 2000, BRIT J PHARMACOL, V130, P981, DOI 10.1038/sj.bjp.0703374
   Mc-Call J.W., 2004, J APPL RES VETERINAR, V2, P74
   McRobb FM, 2014, ENVIRON SCI TECHNOL, V48, P1964, DOI 10.1021/es404568a
   Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256
   National Research Council, 2007, TOX TEST 21 CENT VIS
   Organisation of Economic Cooperation and Development, 2013, GUID DOC DEV ASS ADV, V184, P1
   Papadopoulos JS, 2007, BIOINFORMATICS, V23, P1073, DOI 10.1093/bioinformatics/btm076
   R Core Team, 2014, R LANG ENV STAT COMP
   Remm M, 2001, J MOL BIOL, V314, P1041, DOI 10.1006/jmbi.2000.5197
   Rodrigues ET, 2013, ENVIRON INT, V53, P18, DOI 10.1016/j.envint.2012.12.005
   Russom CL, 2014, ENVIRON TOXICOL CHEM, V33, P2157, DOI 10.1002/etc.2662
   Rust MK, 2005, TRENDS PARASITOL, V21, P232, DOI 10.1016/j.pt.2005.03.010
   Shimomura M, 2005, NEUROSCI LETT, V385, P168, DOI 10.1016/j.neulet.2005.05.014
   Shimomura M, 2004, NEUROSCI LETT, V363, P195, DOI 10.1016/j.neulet.2003.12.115
   Shimomura M, 2003, BRAIN RES, V991, P71, DOI 10.1016/j.brainres.2003.08.005
   Shimomura M, 2006, MOL PHARMACOL, V70, P1255, DOI 10.1124/mol.106.026815
   Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631
   Tomizawa M, 2003, ANNU REV ENTOMOL, V48, P339, DOI 10.1146/annurev.ento.48.091801.112731
   Tomizawa M, 2001, PEST MANAG SCI, V57, P914, DOI 10.1002/ps.349
   Tomizawa M, 2008, P NATL ACAD SCI USA, V105, P1728, DOI 10.1073/pnas.0711724105
   Toshima K, 2009, NEUROPHARMACOLOGY, V56, P264, DOI 10.1016/j.neuropharm.2008.08.022
   Walker SD, 2013, CHEMOSPHERE, V93, P2568, DOI 10.1016/j.chemosphere.2013.09.074
   Warming TP, 2009, ENVIRON TOXICOL CHEM, V28, P374, DOI 10.1897/08-279.1
   Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1
   Wieman H, 2004, MINI-REV MED CHEM, V4, P793
   Zhang YJ, 2010, PESTIC BIOCHEM PHYS, V98, P151, DOI 10.1016/j.pestbp.2010.04.007
NR 65
TC 23
Z9 23
U1 3
U2 22
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1096-6080
EI 1096-0929
J9 TOXICOL SCI
JI Toxicol. Sci.
PD OCT
PY 2016
VL 153
IS 2
BP 228
EP 245
DI 10.1093/toxsci/kfw119
PG 18
WC Toxicology
SC Toxicology
GA EC1XN
UT WOS:000387902200003
PM 27370413
DA 2019-10-23
ER

PT J
AU Yang, LH
   Zhou, BS
   Zha, JM
   Wang, ZJ
AF Yang, Lihua
   Zhou, Bingsheng
   Zha, Jinmiao
   Wang, Zijian
TI Mechanistic study of chlordecone-induced endocrine disruption: Based on
   an adverse outcome pathway network
SO CHEMOSPHERE
LA English
DT Article
DE Chlordecone; Chinese rare minnow (Gobiocypris rams); Endocrine
   disruption; Adverse outcome pathway (AOP)
ID MEDAKA ORYZIAS-LATIPES; MINNOW PIMEPHALES-PROMELAS; GENE-EXPRESSION;
   GOBIOCYPRIS-RARUS; DMRT1 EXPRESSION; RISK-ASSESSMENT; DANIO-RERIO;
   BISPHENOL-A; TESTIS-OVA; RECEPTOR
AB The adverse outcome pathway (AOP) framework could be helpful for chemical risk assessment and mechanistic research. The aim of the present study was to unravel the mechanism of chlordecone-induced endocrine disruption by illustrating the main molecular initiating event (MIE)/perturbations responsible for the observed effects. In silico simulations were performed to predict the MIE(s), and the results pointed to agonistic interaction with estrogen receptors (ER alpha, ER beta), androgen receptor (AR), cytochrome P450 (CYP19A) by chlordecone. In vivo endocrine disruptions were evaluated in rare minnow (Gobiocypris rarus) exposed to 0.01, 0.1, 1 and 10 mu g L-1 chlordecone from 2 h post-fertilization until sexually mature. In the females, increases of vitellogenin (vtg) mRNA levels in liver and gonad, plasma estradiol (E2), testosterone (T) and E2/T, and renalsomatic index confirmed the role of agonism of ER and CYP19A as MIEs, but the decreased gonadosomatic index, degenerated ovaries as well as the feed forward response pointed to other potential but important MIEs and corresponding AOPs. In the males, increased E2/T ratio, increased testis vtg mRNA levels and occurrence of intersex confirmed the roles of agonism of ERa and CYP19A as main MIEs in chlordecone-induced endocrine disruptions. Our results also fetches out the limit of AOPs in predicting the adverse outcomes and explaining the mechanism of chemicals at present, thus reflected a critical need for expanding AOPs and AOP network before using it in chemical risk assessment. (C) 2016 Published by Elsevier Ltd.
C1 [Yang, Lihua; Zhou, Bingsheng] Chinese Acad Sci, Inst Hydrobiol, State Key Lab Freshwater Ecol & Biotechnol, Wuhan 430072, Peoples R China.
   [Zha, Jinmiao] Chinese Acad Sci, Ecoenvironm Sci Res Ctr, State Key Lab Drinking Water Sci & Technol, POB 2871,Shuangqing Rd 18, Beijing 100085, Peoples R China.
   [Zha, Jinmiao] Chinese Acad Sci, Ecoenvironm Sci Res Ctr, Beijing Key Lab Ind Wastewater Treatment & Reuse, Beijing 100085, Peoples R China.
   [Wang, Zijian] Chinese Acad Sci, Ecoenvironm Sci Res Ctr, State Key Lab Environm Aquat Chem, POB 2871, Beijing 100085, Peoples R China.
RP Zha, JM (reprint author), Chinese Acad Sci, Ecoenvironm Sci Res Ctr, State Key Lab Drinking Water Sci & Technol, POB 2871,Shuangqing Rd 18, Beijing 100085, Peoples R China.
EM jinmiaozha@gmail.com
OI zhou, bing sheng/0000-0003-0119-1868
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [21307153, 21407166]; Beijing Natural Science
   FoundationBeijing Natural Science Foundation [8152017]
FX This work was supported by the National Natural Science Foundation of
   China (21307153, 21407166), and Beijing Natural Science Foundation
   (8152017).
CR Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Balthazart J, 2001, J STEROID BIOCHEM, V79, P261, DOI 10.1016/S0960-0760(01)00143-1
   Bjornstrom L, 2005, MOL ENDOCRINOL, V19, P833, DOI 10.1210/me.2004-0486
   Boucher O, 2013, NEUROTOXICOLOGY, V35, P162, DOI 10.1016/j.neuro.2013.01.007
   Brayman MJ, 2012, MOL ENDOCRINOL, V26, P2, DOI 10.1210/me.2011-1015
   Chen ZG, 1999, MOL CELL ENDOCRINOL, V158, P131, DOI 10.1016/S0303-7207(99)00172-0
   Dong KW, 1996, MOL CELL ENDOCRINOL, V117, P241, DOI 10.1016/0303-7207(95)03760-8
   Faroon O, 1995, TOXICOL IND HEALTH, V11, P1, DOI 10.1177/074823379501100601
   Fester L, 2016, J STEROID BIOCHEM, V160, P9, DOI 10.1016/j.jsbmb.2015.10.009
   Fitzgerald AC, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.115.132316
   GHOSH S, 1995, MAR ENVIRON RES, V39, P159, DOI 10.1016/0141-1136(94)00036-O
   Gray MA, 1997, ENVIRON TOXICOL CHEM, V16, P1082, DOI 10.1002/etc.5620160531
   Groh KJ, 2015, CHEMOSPHERE, V120, P764, DOI 10.1016/j.chemosphere.2014.09.068
   Guldner L, 2010, ENVIRON RES, V110, P146, DOI 10.1016/j.envres.2009.10.015
   Guo YQ, 2005, BIOCHEM BIOPH RES CO, V330, P950, DOI 10.1016/j.bbrc.2005.03.066
   Hogan NS, 2010, AQUAT TOXICOL, V98, P148, DOI 10.1016/j.aquatox.2010.02.002
   IARC, 1979, IARC MON EV CARC RIS
   Knapen D, 2015, REPROD TOXICOL, V56, P52, DOI 10.1016/j.reprotox.2015.04.003
   Kuiper GGJM, 1998, ENDOCRINOLOGY, V139, P4252, DOI 10.1210/en.139.10.4252
   Kurosawa T, 2002, ENDOCR J, V49, P465, DOI 10.1507/endocrj.49.465
   Lange R, 2001, ENVIRON TOXICOL CHEM, V20, P1216, DOI 10.1002/etc.5620200610
   Li L, 2007, J MOL ENDOCRINOL, V38, P569, DOI 10.1677/JME-07-0003
   Lindeman RE, 2015, CURR BIOL, V25, P764, DOI 10.1016/j.cub.2015.01.034
   Liu CS, 2009, AQUAT TOXICOL, V93, P131, DOI 10.1016/j.aquatox.2009.04.005
   Luellen DR, 2006, SCI TOTAL ENVIRON, V358, P286, DOI 10.1016/j.scitotenv.2005.08.046
   Marchand O, 2000, BBA-GENE STRUCT EXPR, V1493, P180, DOI 10.1016/S0167-4781(00)00186-X
   Marlatt VL, 2008, MOL CELL ENDOCRINOL, V283, P38, DOI 10.1016/j.mce.2007.10.013
   Matson CK, 2010, DEV CELL, V19, P612, DOI 10.1016/j.devcel.2010.09.010
   Metcalfe CD, 2001, ENVIRON TOXICOL CHEM, V20, P297, DOI [10.1897/1551-5028(2001)020<0297:EPOCDI>2.0.CO;2, 10.1002/etc.5620200210]
   NAGAHAMA Y, 1995, CURR TOP DEV BIOL, V30, P103, DOI 10.1016/S0070-2153(08)60565-7
   Nash JP, 2004, ENVIRON HEALTH PERSP, V112, P1725, DOI 10.1289/ehp.7209
   NLM, 2004, CHLORD
   Ohtani H, 2003, COMP BIOCHEM PHYS C, V134, P215, DOI 10.1016/S1532-0456(02)00252-1
   Park CB, 2010, AQUAT TOXICOL, V96, P273, DOI 10.1016/j.aquatox.2009.11.006
   Pawlowski S, 2004, ECOTOX ENVIRON SAFE, V57, P330, DOI 10.1016/j.ecoenv.2003.07.019
   Scippo ML, 2004, ANAL BIOANAL CHEM, V378, P664, DOI 10.1007/s00216-003-2251-0
   Seki M, 2002, ENVIRON TOXICOL CHEM, V21, P1692, DOI [10.1897/1551-5028(2002)021<1692:EOEOTR>2.0.CO;2, 10.1002/etc.5620210822]
   Shibata K, 2002, GEN COMP ENDOCR, V127, P232, DOI 10.1016/S0016-6480(02)00039-4
   Spano L, 2004, AQUAT TOXICOL, V66, P369, DOI 10.1016/j.aquatox.2003.10.009
   SRIVASTAVA AK, 1994, B ENVIRON CONTAM TOX, V53, P186
   U.N.E.P, 2007, 3 M PERS ORG POLL RE
   U.S. EPA, 1986, FIN REP EV 4 TOX CHE
   U.S. National Institutes of Health NIH, 2016, DAT PUBCH BIOASS
   Van den Belt K, 2001, ARCH ENVIRON CON TOX, V41, P458, DOI 10.1007/s002440010272
   Wang H, 2005, GENE, V356, P91, DOI 10.1016/j.gene.2005.03.041
   Wang J., 1992, Acta Hydrobiologica Sinica, V16, P165
   Weil SJ, 1998, J CLIN ENDOCR METAB, V83, P2479, DOI 10.1210/jc.83.7.2479
   WILLIAMS J, 1989, TOXICOL APPL PHARM, V98, P413, DOI 10.1016/0041-008X(89)90170-1
   Wolf JC, 2004, TOXICOL PATHOL, V32, P600, DOI 10.1080/01926230490515201
   Yang LH, 2011, AQUAT TOXICOL, V104, P153, DOI 10.1016/j.aquatox.2011.04.005
   Yang LH, 2010, AQUAT TOXICOL, V97, P204, DOI 10.1016/j.aquatox.2009.09.005
   Yaron Z, 2011, ENCYCLOPEDIA OF FISH PHYSIOLOGY: FROM GENOME TO ENVIRONMENT, VOLS 1-3, P1500
   Yaron Z, 2003, INT REV CYTOL, V225, P131, DOI 10.1016/S0074-7696(05)25004-0
   Zha JM, 2007, CHEMOSPHERE, V66, P488, DOI 10.1016/j.chemosphere.2006.05.071
   Zha JM, 2006, CHEM-BIOL INTERACT, V161, P26, DOI 10.1016/j.cbi.2006.02.010
   Zhang M, 2008, ECOTOX ENVIRON SAFE, V71, P384, DOI 10.1016/j.ecoenv.2007.10.014
   Zhou BS, 2015, J ENVIRON SCI-CHINA, V35, P191, DOI 10.1016/j.jes.2015.07.001
NR 57
TC 2
Z9 3
U1 3
U2 40
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0045-6535
EI 1879-1298
J9 CHEMOSPHERE
JI Chemosphere
PD OCT
PY 2016
VL 161
BP 372
EP 381
DI 10.1016/j.chemosphere.2016.07.034
PG 10
WC Environmental Sciences
SC Environmental Sciences & Ecology
GA DU7QH
UT WOS:000382409200045
PM 27448318
DA 2019-10-23
ER

PT J
AU Batke, M
   Gutlein, M
   Partosch, F
   Gundert-Remy, U
   Helma, C
   Kramer, S
   Maunz, A
   Seeland, M
   Bitsch, A
AF Batke, Monika
   Guetlein, Martin
   Partosch, Falko
   Gundert-Remy, Ursula
   Helma, Christoph
   Kramer, Stefan
   Maunz, Andreas
   Seeland, Madeleine
   Bitsch, Annette
TI Innovative Strategies to Develop Chemical Categories Using a Combination
   of Structural and Toxicological Properties
SO FRONTIERS IN PHARMACOLOGY
LA English
DT Article
DE non-animal methods; QSAR; read across; Predictive Clustering Tree (PCT)
   method; toxicological and structural similarity
ID REPEATED-DOSE TOXICITY; ETHYLENE-GLYCOL; READ-ACROSS; PREDICTION;
   CLASSIFICATION; METABOLITES; SUBSTANCES; MODELS; SAFETY; LEVEL
AB Interest is increasing in the development of non-animal methods for toxicological evaluations. These methods are however, particularly challenging for complex toxicological endpoints such as repeated dose toxicity. European Legislation, e.g., the European Union's Cosmetic Directive and REACH, demands the use of alternative methods. Frameworks, such as the Read-across Assessment Framework or the Adverse Outcome Pathway Knowledge Base, support the development of these methods. The aim of the project presented in this publication was to develop substance categories for a read-across with complex endpoints of toxicity based on existing databases. The basic conceptual approach was to combine structural similarity with shared mechanisms of action. Substances with similar chemical structure and toxicological profile form candidate categories suitable for read-across. We combined two databases on repeated dose toxicity. RepDose database, and ELINCS database to form a common database for the identification of categories. The resulting database contained physicochemical, structural, and toxicological data, which were refined and curated for cluster analyses. We applied the Predictive Clustering Tree (POT) approach for clustering chemicals based on structural and on toxicological information to detect groups of chemicals with similar toxic profiles and pathways/mechanisms of toxicity. As many of the experimental toxicity values were not available, this data was imputed by predicting them with a multi-label classification method, prior to clustering. The clustering results were evaluated by assessing chemical and toxicological similarities with the aim of identifying clusters with a concordance between structural information and toxicity profiles/mechanisms. From these chosen clusters, seven were selected for a quantitative read-across, based on a small ratio of NOAEL of the members with the highest and the lowest NOAEL in the cluster (<5). We discuss the limitations of the approach. Based on this analysis we propose improvements for a follow-up approach, such as incorporation of metabolic information and more detailed mechanistic information. The software enables the user to allocate a substance in a cluster and to use this information for a possible read across. The clustering tool is provided as a free web service, accessible at http://mIcreach.informatik.uni-mainz.de.
C1 [Batke, Monika; Bitsch, Annette] Fraunhofer Inst Toxikol & Expt Med, Dept Chem Beureilung Dantenbanken & Expertensyst, Hannover, Germany.
   [Guetlein, Martin; Kramer, Stefan] Johannes Gutenberg Univ Mainz, Inst Informat, Mainz, Germany.
   [Partosch, Falko] Univ Med Gottingen, Inst Arbeits Sozial & Umweltmed, Gottingen, Germany.
   [Gundert-Remy, Ursula] Charite, Inst Klin Pharmakol & Toxikol, Berlin, Germany.
   [Helma, Christoph] In Silico Toxicol GmbH, Basel, Switzerland.
   [Maunz, Andreas] Oncotest GmbH, Freiburg, Germany.
   [Seeland, Madeleine] Tech Univ Munich, Inst Informat, Munich, Germany.
RP Gundert-Remy, U (reprint author), Charite, Inst Klin Pharmakol & Toxikol, Berlin, Germany.
EM ursula.gundert-remy@charite.de
OI Helma, Christoph/0000-0002-2640-798X
FU German Federal Ministry of Education and ResearchFederal Ministry of
   Education & Research (BMBF) [0315546A-D]
FX The work was supported by grants of the German Federal Ministry of
   Education and Research (0315546A-D).
CR Anger LT, 2012, N-S ARCH PHARMACOL, V385, P6
   [Anonymous], 2007, OECD ENV HLTH SAF PU, V69
   Barabair F. T., 2009, JRC SCI TECHNICAL RE
   Bitsch A, 2006, REGUL TOXICOL PHARM, V46, P202, DOI 10.1016/j.yrtph.2006.05.013
   Blocked H., 1998, P 15 INT C MACH LEAR, P55
   Breiman L., 1984, CLASSIFICATION REGRE
   Brzezicki JM, 2003, J ANAL TOXICOL, V27, P569, DOI 10.1093/jat/27.8.569
   Cassano A, 2014, J ENVIRON SCI HEAL C, V32, P273, DOI 10.1080/10590501.2014.938955
   CAVE DA, 1990, FUND APPL TOXICOL, V14, P199, DOI 10.1016/0272-0590(90)90245-F
   Cherkasov A, 2014, J MED CHEM, V57, P4977, DOI 10.1021/jm4004285
   De Groef B, 2006, EUR J ENDOCRINOL, V155, P17, DOI 10.1530/eje.1.02190
   Dougherty J., 1995, Machine Learning. Proceedings of the Twelfth International Conference on Machine Learning, P194
   Durant JL, 2002, J CHEM INF COMP SCI, V42, P1273, DOI 10.1021/ci010132r
   *ECETOC, 1995, 64 ECETOC
   ECHA, 2012, GUID INF REQ CHEM B, P195
   ECHA, 2008, GUID INF REQ CHEM SA, P134
   ECHA, 2015, READ ACR ASS FRAM RA
   Ekholm R, 1997, ENDOCRINOLOGY, V138, P2871, DOI 10.1210/en.138.7.2871
   Fumarola A, 2010, EXP CLIN ENDOCR DIAB, V118, P678, DOI 10.1055/s-0030-1253420
   Greene N, 2010, BIOORG MED CHEM LETT, V20, P5308, DOI 10.1016/j.bmcl.2010.06.129
   Gutlein M, 2012, J CHEMINFORMATICS, V4, DOI 10.1186/1758-2946-4-7
   Haider N, 2010, MOLECULES, V15, P5079, DOI 10.3390/molecules15085079
   Hughes JD, 2008, BIOORG MED CHEM LETT, V18, P4872, DOI 10.1016/j.bmcl.2008.07.071
   Japkowicz N., 2002, Intelligent Data Analysis, V6, P429
   Jerez JM, 2010, ARTIF INTELL MED, V50, P105, DOI 10.1016/j.artmed.2010.05.002
   Jolly R, 2015, REGUL TOXICOL PHARM, V71, P388, DOI 10.1016/j.yrtph.2015.01.010
   Kalkhof H, 2012, ARCH TOXICOL, V86, P17, DOI 10.1007/s00204-011-0732-z
   Kaneko MAN, 2015, J TOXICOL SCI, V40, P77, DOI 10.2131/jts.40.77
   Krautt JA, 2008, CLIN J AM SOC NEPHRO, V3, P208, DOI 10.2215/CJN.03220807
   Low Y, 2013, CHEM RES TOXICOL, V26, P1199, DOI 10.1021/tx400110f
   Lu SY, 2012, TOXICOL IN VITRO, V26, P613, DOI 10.1016/j.tiv.2012.01.025
   Mangelsdorf I, 2003, REGUL TOXICOL PHARM, V37, P356, DOI 10.1016/S0273-2300(03)00026-6
   Maunz A, 2008, SAR QSAR ENVIRON RES, V19, P413, DOI 10.1080/10629360802358430
   Maunz A, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00038
   MILLER RR, 1984, ENVIRON HEALTH PERSP, V57, P233, DOI 10.2307/3429921
   NAFTA TWG, 2012, QUANT STRUCT ACT REL, P186
   National Research Council, 2007, TOXICITY TESTING 21
   O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-33
   OECD, 2011, OECD SER TEST ASS
   OECD, 1998, GUID TEST CHEM
   Organisation for Economic Co-operation and Development (OECD), 2013, OECD SER TEST ASS, V184
   Patlewicz G, 2014, ALTEX-ALTERN ANIM EX, V31, P387, DOI 10.14573/altex.1410071
   Patlewicz G, 2013, REGUL TOXICOL PHARM, V67, P1, DOI 10.1016/j.yrtph.2013.06.002
   Read J, 2011, MACH LEARN, V85, P333, DOI 10.1007/s10994-011-5256-5
   Rupp B, 2010, ARCH TOXICOL, V84, P681, DOI 10.1007/s00204-010-0532-x
   Sakuratani Y, 2013, SAR QSAR ENVIRON RES, V24, P617, DOI 10.1080/1062936X.2013.773375
   Sakuratani Y, 2013, SAR QSAR ENVIRON RES, V24, P35, DOI 10.1080/1062936X.2012.728995
   SCCS, 2015, SCCS156415
   Schafer J., 1997, CHAPMAN HALL CRC MON, P448
   Schep LJ, 2009, CLIN TOXICOL, V47, P525, DOI 10.1080/15563650903086444
   Schilter B, 2014, REGUL TOXICOL PHARM, V68, P275, DOI 10.1016/j.yrtph.2013.08.018
   SHEETZ MP, 1976, J CELL BIOL, V70, P247, DOI 10.1083/jcb.70.1.247
   Tsoumakas G., 2007, INT J DATA WAREHOUS, V3, P1, DOI DOI 10.4018/JDWM.2007070101
   Venkatapathy R, 2004, J CHEM INF COMP SCI, V44, P1623, DOI 10.1021/ci049903s
   Viinamaki J, 2015, J ANAL TOXICOL, V39, P481, DOI 10.1093/jat/bkv044
   Wu SD, 2010, REGUL TOXICOL PHARM, V56, P67, DOI 10.1016/j.yrtph.2009.09.006
   Yamada T, 2014, REGUL TOXICOL PHARM, V70, P711, DOI 10.1016/j.yrtph.2014.10.011
   Yamada T, 2013, J TOXICOL SCI, V38, P291, DOI 10.2131/jts.38.291
   Yamada T, 2013, REGUL TOXICOL PHARM, V65, P189, DOI 10.1016/j.yrtph.2012.12.001
   Yamada T, 2012, J TOXICOL SCI, V37, P503
   Zhuang WJ, 2008, THESIS
NR 61
TC 3
Z9 3
U1 0
U2 7
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1663-9812
J9 FRONT PHARMACOL
JI Front. Pharmacol.
PD SEP 21
PY 2016
VL 7
AR 321
DI 10.3389/fphar.2016.00321
PG 19
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA DW3PG
UT WOS:000383553500001
PM 27708580
OA DOAJ Gold, Green Published
DA 2019-10-23
ER

PT J
AU Clewell, RA
   Miller, MM
   Andersen, ME
AF Clewell, R. A.
   Miller, M. M.
   Andersen, M. E.
TI Adverse outcome pathway driven development of human cell-based assays
   sufficient for safety assessment of estrogenic chemicals
SO TOXICOLOGY LETTERS
LA English
DT Meeting Abstract
CT 52nd Congress of the European-Societies-of-Toxicology (EUROTOX)
CY SEP 04-07, 2016
CL Seville, SPAIN
SP European Soc Toxicol
C1 [Clewell, R. A.; Miller, M. M.; Andersen, M. E.] ScitoVationUnited States, Res Triangle Pk, NC USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0378-4274
EI 1879-3169
J9 TOXICOL LETT
JI Toxicol. Lett.
PD SEP 16
PY 2016
VL 258
SU S
MA P08-011
BP S142
EP S143
DI 10.1016/j.toxlet.2016.06.1554
PG 2
WC Toxicology
SC Toxicology
GA EW3XN
UT WOS:000402436700421
DA 2019-10-23
ER

PT J
AU Eberini, I
   Palazzolo, L
   Peijnenburg, A
   Guerrini, U
   Parravicini, C
   Moretto, A
   Bovee, T
AF Eberini, I.
   Palazzolo, L.
   Peijnenburg, A.
   Guerrini, U.
   Parravicini, C.
   Moretto, A.
   Bovee, T.
TI In silico prioritization for endocrine active substances (EAS) and their
   in vitro validation
SO TOXICOLOGY LETTERS
LA English
DT Meeting Abstract
CT 52nd Congress of the European-Societies-of-Toxicology (EUROTOX)
CY SEP 04-07, 2016
CL Seville, SPAIN
SP European Soc Toxicol
C1 [Eberini, I.; Guerrini, U.; Parravicini, C.] Univ Milan, Dipartimento Sci Farmacol & Biomol, Milan, Italy.
   [Palazzolo, L.; Moretto, A.] Univ Milan, Dipartimento Sci Biomed & Clin L Sacco, Milan, Italy.
   [Peijnenburg, A.; Bovee, T.] Wageningen Univ, RIKILT Inst Food Safety, Wageningen, Netherlands.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0378-4274
EI 1879-3169
J9 TOXICOL LETT
JI Toxicol. Lett.
PD SEP 16
PY 2016
VL 258
SU S
MA P05-018
BP S120
EP S120
DI 10.1016/j.toxlet.2016.06.1486
PG 1
WC Toxicology
SC Toxicology
GA EW3XN
UT WOS:000402436700354
DA 2019-10-23
ER

PT J
AU Mellor, CL
   Ellison, CM
   Enoch, SJ
   Jais, DM
   Madden, JC
   Soares, S
   Tagliati, CA
   Cronin, MT
AF Mellor, C. L.
   Ellison, C. M.
   Enoch, S. J.
   Jais, D. M.
   Madden, J. C.
   Soares, S.
   Tagliati, C. A.
   Cronin, M. T.
TI Assessment of in silico approaches to predict adverse effects to the
   kidney and bladder
SO TOXICOLOGY LETTERS
LA English
DT Meeting Abstract
CT 52nd Congress of the European-Societies-of-Toxicology (EUROTOX)
CY SEP 04-07, 2016
CL Seville, SPAIN
SP European Soc Toxicol
C1 [Mellor, C. L.; Ellison, C. M.; Enoch, S. J.; Jais, D. M.; Madden, J. C.; Cronin, M. T.] Liverpool John Moores Univ, Sch Pharm & Biomol Sci, Liverpool, Merseyside, England.
   [Soares, S.; Tagliati, C. A.] Univ Fed Minas Gerais, Dept Anal Clin & Toxicol, Belo Horizonte, MG, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0378-4274
EI 1879-3169
J9 TOXICOL LETT
JI Toxicol. Lett.
PD SEP 16
PY 2016
VL 258
SU S
MA P05-009
BP S117
EP S117
DI 10.1016/j.toxlet.2016.06.1477
PG 1
WC Toxicology
SC Toxicology
GA EW3XN
UT WOS:000402436700345
DA 2019-10-23
ER

PT J
AU Boobis, AR
AF Boobis, Alan R.
TI Utility of AOPs/MOAs in assessing the effects of endocrine disruptors
SO TOXICOLOGY LETTERS
LA English
DT Meeting Abstract
CT 52nd Congress of the European-Societies-of-Toxicology (EUROTOX)
CY SEP 04-07, 2016
CL Seville, SPAIN
SP European Soc Toxicol
C1 [Boobis, Alan R.] Imperial Coll London, Dept Med, London, England.
RI Boobis, Alan/E-1536-2018
OI Boobis, Alan/0000-0003-3371-386X
NR 0
TC 0
Z9 0
U1 0
U2 2
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0378-4274
EI 1879-3169
J9 TOXICOL LETT
JI Toxicol. Lett.
PD SEP 16
PY 2016
VL 258
SU S
MA S10-3
BP S28
EP S28
DI 10.1016/j.toxlet.2016.06.1210
PG 1
WC Toxicology
SC Toxicology
GA EW3XN
UT WOS:000402436700081
DA 2019-10-23
ER

PT J
AU Enoch, S
AF Enoch, Steve
TI Computational tools and their role in integrative approaches
SO TOXICOLOGY LETTERS
LA English
DT Meeting Abstract
CT 52nd Congress of the European-Societies-of-Toxicology (EUROTOX)
CY SEP 04-07, 2016
CL Seville, SPAIN
SP European Soc Toxicol
C1 [Enoch, Steve] Sch Pharm & Biomol Sci, Brighton, E Sussex, England.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0378-4274
EI 1879-3169
J9 TOXICOL LETT
JI Toxicol. Lett.
PD SEP 16
PY 2016
VL 258
SU S
MA CEC1-5
BP S3
EP S3
DI 10.1016/j.toxlet.2016.06.030
PG 1
WC Toxicology
SC Toxicology
GA EW3XN
UT WOS:000402436700007
DA 2019-10-23
ER

PT J
AU Knudsen, TB
AF Knudsen, Thomas B.
TI Computational modeling and simulation of developmental toxicity
SO TOXICOLOGY LETTERS
LA English
DT Meeting Abstract
CT 52nd Congress of the European-Societies-of-Toxicology (EUROTOX)
CY SEP 04-07, 2016
CL Seville, SPAIN
SP European Soc Toxicol
C1 [Knudsen, Thomas B.] Natl Ctr Computat Toxicol, Res Triangle Pk, NC USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0378-4274
EI 1879-3169
J9 TOXICOL LETT
JI Toxicol. Lett.
PD SEP 16
PY 2016
VL 258
SU S
MA W01-5
BP S40
EP S40
DI 10.1016/j.toxlet.2016.06.1245
PG 1
WC Toxicology
SC Toxicology
GA EW3XN
UT WOS:000402436700116
DA 2019-10-23
ER

PT J
AU Ootsubo, Y
   Miyazawa, M
   Mizumachi, H
   Nishijo, T
   Saito, K
   Sakaguchi, H
AF Ootsubo, Y.
   Miyazawa, M.
   Mizumachi, H.
   Nishijo, T.
   Saito, K.
   Sakaguchi, H.
TI Hazard identification of chemicals showing moderate to strong skin
   sensitizing potency by using two-test batteries out of three test
   methods addressing first three key events of the AOP
SO TOXICOLOGY LETTERS
LA English
DT Meeting Abstract
CT 52nd Congress of the European-Societies-of-Toxicology (EUROTOX)
CY SEP 04-07, 2016
CL Seville, SPAIN
SP European Soc Toxicol
C1 [Ootsubo, Y.; Miyazawa, M.; Mizumachi, H.; Nishijo, T.; Saito, K.; Sakaguchi, H.] Kao Corp, Safety Sci Res, Ichikai, Tochigi, Japan.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0378-4274
EI 1879-3169
J9 TOXICOL LETT
JI Toxicol. Lett.
PD SEP 16
PY 2016
VL 258
SU S
MA P01-031
BP S71
EP S71
DI 10.1016/j.toxlet.2016.06.1341
PG 1
WC Toxicology
SC Toxicology
GA EW3XN
UT WOS:000402436700210
DA 2019-10-23
ER

PT J
AU Price, A
AF Price, Anna
TI Using mechanistic information in application of an Adverse Outcome
   Pathway (AOP) concept for developmental neurotoxicity evaluation
SO TOXICOLOGY LETTERS
LA English
DT Meeting Abstract
CT 52nd Congress of the European-Societies-of-Toxicology (EUROTOX)
CY SEP 04-07, 2016
CL Seville, SPAIN
SP European Soc Toxicol
C1 [Price, Anna] European Commiss, Joint Res Ctr, Inst Hlth & Consumer Protect, Ispra, Italy.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0378-4274
EI 1879-3169
J9 TOXICOL LETT
JI Toxicol. Lett.
PD SEP 16
PY 2016
VL 258
SU S
MA S02-5
BP S17
EP S17
DI 10.1016/j.toxlet.2016.06.1175
PG 1
WC Toxicology
SC Toxicology
GA EW3XN
UT WOS:000402436700048
DA 2019-10-23
ER

PT J
AU Rossi, LH
AF Rossi, Laura H.
TI How to use non-animal test methods for skin sensitisation in the context
   of REACH Regulation
SO TOXICOLOGY LETTERS
LA English
DT Meeting Abstract
CT 52nd Congress of the European-Societies-of-Toxicology (EUROTOX)
CY SEP 04-07, 2016
CL Seville, SPAIN
SP European Soc Toxicol
C1 [Rossi, Laura H.] European Chem Agcy, Evaluat, Helsinki, Finland.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0378-4274
EI 1879-3169
J9 TOXICOL LETT
JI Toxicol. Lett.
PD SEP 16
PY 2016
VL 258
SU S
MA CEC1-1
BP S2
EP S2
DI 10.1016/j.toxlet.2016.06.026
PG 1
WC Toxicology
SC Toxicology
GA EW3XN
UT WOS:000402436700003
DA 2019-10-23
ER

PT J
AU Vinken, M
AF Vinken, Mathieu
TI The adverse outcome pathway for cholestatic liver injury: From
   mechanisms to predictive human toxicology
SO TOXICOLOGY LETTERS
LA English
DT Meeting Abstract
CT 52nd Congress of the European-Societies-of-Toxicology (EUROTOX)
CY SEP 04-07, 2016
CL Seville, SPAIN
SP European Soc Toxicol
C1 [Vinken, Mathieu] Vrije Univ Brussel, Dept In Vitro Toxicol, Brussels, Belgium.
NR 0
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0378-4274
EI 1879-3169
J9 TOXICOL LETT
JI Toxicol. Lett.
PD SEP 16
PY 2016
VL 258
SU S
MA W07-2
BP S47
EP S47
DI 10.1016/j.toxlet.2016.06.1271
PG 1
WC Toxicology
SC Toxicology
GA EW3XN
UT WOS:000402436700141
DA 2019-10-23
ER

PT J
AU Wilks, MF
AF Wilks, Martin F.
TI Pesticides and Parkinson's disease - What is the evidence from
   epidemiological and experimental studies?
SO TOXICOLOGY LETTERS
LA English
DT Meeting Abstract
CT 52nd Congress of the European-Societies-of-Toxicology (EUROTOX)
CY SEP 04-07, 2016
CL Seville, SPAIN
SP European Soc Toxicol
C1 [Wilks, Martin F.] Univ Basel, Swiss Ctr Appl Human Toxicol, Basel, Switzerland.
RI Wilks, Martin F/N-2150-2014
OI Wilks, Martin F/0000-0003-3984-5935
NR 0
TC 1
Z9 1
U1 0
U2 1
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0378-4274
EI 1879-3169
J9 TOXICOL LETT
JI Toxicol. Lett.
PD SEP 16
PY 2016
VL 258
SU S
MA S09-2
BP S26
EP S27
DI 10.1016/j.toxlet.2016.06.1204
PG 2
WC Toxicology
SC Toxicology
GA EW3XN
UT WOS:000402436700075
DA 2019-10-23
ER

PT J
AU Corvaro, M
   Gehen, S
   Andrews, K
   Chatfield, R
   Macleod, F
   Mikolajczak, H
   Moore, J
   Mehta, J
AF Corvaro, M.
   Gehen, S.
   Andrews, K.
   Chatfield, R.
   Macleod, F.
   Mikolajczak, H.
   Moore, J.
   Mehta, J.
TI Re-shaping acute toxicity testing of agrochemical formulations by
   combining the GHS ATE formula and in vitro approaches
SO TOXICOLOGY LETTERS
LA English
DT Meeting Abstract
CT 52nd Congress of the European-Societies-of-Toxicology (EUROTOX)
CY SEP 04-07, 2016
CL Seville, SPAIN
SP European Soc Toxicol
C1 [Corvaro, M.; Andrews, K.; Chatfield, R.; Macleod, F.; Mehta, J.] Dow Agrosci Ltd, Abingdon, Oxon, England.
   [Gehen, S.; Mikolajczak, H.; Moore, J.] Dow Agrosci LCC, Indianapolis, IN USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0378-4274
EI 1879-3169
J9 TOXICOL LETT
JI Toxicol. Lett.
PD SEP 16
PY 2016
VL 258
SU S
MA P22-014
BP S310
EP S310
DI 10.1016/j.toxlet.2016.06.2058
PG 1
WC Toxicology
SC Toxicology
GA EW3XN
UT WOS:000402436700931
DA 2019-10-23
ER

PT J
AU Di Renzo, F
   Moretto, A
   Battistoni, M
   Beronius, A
   Zilliacus, J
   Hanberg, A
   Menegola, E
AF Di Renzo, F.
   Moretto, A.
   Battistoni, M.
   Beronius, A.
   Zilliacus, J.
   Hanberg, A.
   Menegola, E.
TI Skeletal cranio-facial dysmorphogenesis: Suggestions for a new AOP
SO TOXICOLOGY LETTERS
LA English
DT Meeting Abstract
CT 52nd Congress of the European-Societies-of-Toxicology (EUROTOX)
CY SEP 04-07, 2016
CL Seville, SPAIN
SP European Soc Toxicol
C1 [Di Renzo, F.; Battistoni, M.; Menegola, E.] Univ Milan, Dipartimento Biosci, Milan, Italy.
   [Moretto, A.] Univ Milan, Dipartimento Sci Clin & Biomed, Milan, Italy.
   [Beronius, A.; Zilliacus, J.; Hanberg, A.] Karolinska Inst, Inst Environm Med, Stockholm, Sweden.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0378-4274
EI 1879-3169
J9 TOXICOL LETT
JI Toxicol. Lett.
PD SEP 16
PY 2016
VL 258
SU S
MA P20-026
BP S302
EP S302
DI 10.1016/j.toxlet.2016.06.2108
PG 1
WC Toxicology
SC Toxicology
GA EW3XN
UT WOS:000402436700906
DA 2019-10-23
ER

PT J
AU Richarz, A
   Bois, FY
   Exner, T
   Judson, R
   Mahony, C
   Ouedraogo, G
   Paini, A
   White, A
   Worth, A
   Berggren, E
AF Richarz, A.
   Bois, F. Y.
   Exner, T.
   Judson, R.
   Mahony, C.
   Ouedraogo, G.
   Paini, A.
   White, A.
   Worth, A.
   Berggren, E.
TI Applied chemical safety assessment case study for repeated dose toxicity
   integrating non-animal methods
SO TOXICOLOGY LETTERS
LA English
DT Meeting Abstract
CT 52nd Congress of the European-Societies-of-Toxicology (EUROTOX)
CY SEP 04-07, 2016
CL Seville, SPAIN
SP European Soc Toxicol
C1 [Richarz, A.; Paini, A.; Worth, A.; Berggren, E.] European Commiss, Joint Res Ctr, IHCP, Syst Toxicol Unit, Ispra, Italy.
   [Richarz, A.; Paini, A.; Worth, A.; Berggren, E.] EURL ECVAM, Ispra, Italy.
   [Bois, F. Y.] INERIS, Verneuil En Halatte, France.
   [Exner, T.] Douglasconnect, Basel, Switzerland.
   [Judson, R.] US EPA, NCCT, Res Triangle Pk, NC 27711 USA.
   [Mahony, C.] Procter & Gamble, Egham, Surrey, England.
   [Ouedraogo, G.] LOreal R&I, Aulnay Sous Bois, France.
   [White, A.] Unilever PLC, Bedford, England.
RI Worth, Andrew Paul/O-3055-2019; Worth, Andrew/R-8495-2019; Bois,
   Frederic/E-9241-2012
OI Worth, Andrew Paul/0000-0002-5303-0452; Bois,
   Frederic/0000-0002-4154-0391
FU European Community's 7th Framework program (FP7); Cosmetics Europe
FX The funding from the European Community's 7th Framework program
   (FP7/2007-2013) and from Cosmetics Europe is gratefully acknowledged.
   The abstract does not reflect US EPA policy.
CR Gocht T, 2015, ALTEX-ALTERN ANIM EX, V32, P9, DOI http://dx.doi.org/10.14573/altex.1408041
NR 1
TC 0
Z9 0
U1 0
U2 2
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0378-4274
EI 1879-3169
J9 TOXICOL LETT
JI Toxicol. Lett.
PD SEP 16
PY 2016
VL 258
SU S
MA P12-061
BP S224
EP S225
DI 10.1016/j.toxlet.2016.06.1807
PG 2
WC Toxicology
SC Toxicology
GA EW3XN
UT WOS:000402436700673
DA 2019-10-23
ER

PT J
AU Warheit, DB
   Kreiling, R
   Levy, L
AF Warheit, D. B.
   Kreiling, R.
   Levy, L.
TI Relevance of particle overload rat lung tumor responses for human risk
   assessment
SO TOXICOLOGY LETTERS
LA English
DT Meeting Abstract
CT 52nd Congress of the European-Societies-of-Toxicology (EUROTOX)
CY SEP 04-07, 2016
CL Seville, SPAIN
SP European Soc Toxicol
C1 [Warheit, D. B.] Chemours Co, Wilmington, DE USA.
   [Levy, L.] Cranfield Univ, Cranfield, Beds, England.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0378-4274
EI 1879-3169
J9 TOXICOL LETT
JI Toxicol. Lett.
PD SEP 16
PY 2016
VL 258
SU S
MA P12-063
BP S225
EP S225
DI 10.1016/j.toxlet.2016.06.1810
PG 1
WC Toxicology
SC Toxicology
GA EW3XN
UT WOS:000402436700675
DA 2019-10-23
ER

PT J
AU Boyles, MSP
   Ranninger, C
   Reischl, R
   Rurik, M
   Tessadri, R
   Kohlbacher, O
   Duschl, A
   Huber, CG
AF Boyles, Matthew S. P.
   Ranninger, Christina
   Reischl, Roland
   Rurik, Marc
   Tessadri, Richard
   Kohlbacher, Oliver
   Duschl, Albert
   Huber, Christian G.
TI Copper oxide nanoparticle toxicity profiling using untargeted
   metabolomics
SO PARTICLE AND FIBRE TOXICOLOGY
LA English
DT Article
DE Untargeted metabolomics; Copper oxide nanoparticles; Apoptosis;
   Oxidative stress; Toxicity profiling; Adverse outcome pathways
ID TITANIUM-DIOXIDE NANOPARTICLES; CELL-VOLUME REGULATION; OXIDATIVE
   STRESS; EPITHELIAL-CELLS; IN-VITRO; TIO2 NANOPARTICLES; CUO
   NANOPARTICLES; MASS-SPECTROMETRY; 1-METHYLNICOTINAMIDE MNA;
   MAGNETIC-RESONANCE
AB Background: The rapidly increasing number of engineered nanoparticles (NPs), and products containing NPs, raises concerns for human exposure and safety. With this increasing, and ever changing, catalogue of NPs it is becoming more difficult to adequately assess the toxic potential of new materials in a timely fashion. It is therefore important to develop methods which can provide high-throughput screening of biological responses. The use of omics technologies, including metabolomics, can play a vital role in this process by providing relatively fast, comprehensive, and cost-effective assessment of cellular responses. These techniques thus provide the opportunity to identify specific toxicity pathways and to generate hypotheses on how to reduce or abolish toxicity.
   Results: We have used untargeted metabolome analysis to determine differentially expressed metabolites in human lung epithelial cells (A549) exposed to copper oxide nanoparticles (CuO NPs). Toxicity hypotheses were then generated based on the affected pathways, and critically tested using more conventional biochemical and cellular assays. CuO NPs induced regulation of metabolites involved in oxidative stress, hypertonic stress, and apoptosis. The involvement of oxidative stress was clarified more easily than apoptosis, which involved control experiments to confirm specific metabolites that could be used as standard markers for apoptosis; based on this we tentatively propose methylnicotinamide as a generic metabolic marker for apoptosis.
   Conclusions: Our findings are well aligned with the current literature on CuO NP toxicity. We thus believe that untargeted metabolomics profiling is a suitable tool for NP toxicity screening and hypothesis generation.
C1 [Boyles, Matthew S. P.; Duschl, Albert] Salzburg Univ, Div Allergy & Immunol, Dept Mol Biol, Hellbrunner Str 34, A-5020 Salzburg, Austria.
   [Ranninger, Christina; Reischl, Roland; Huber, Christian G.] Salzburg Univ, Div Chem & Bioanalyt, Dept Mol Biol, Hellbrunner Str 34, A-5020 Salzburg, Austria.
   [Rurik, Marc; Kohlbacher, Oliver] Univ Tubingen, Ctr Bioinformat, Tubingen, Germany.
   [Rurik, Marc; Kohlbacher, Oliver] Univ Tubingen, Dept Comp Sci, Sand 14, D-72076 Tubingen, Germany.
   [Tessadri, Richard] Univ Innsbruck, Inst Mineral & Petrog, Fac Geo & Atmospher Sci, Innrain 52, A-6020 Innsbruck, Austria.
   [Kohlbacher, Oliver] Univ Tubingen, Quantitat Biol Ctr, Morgenstelle 10, D-72076 Tubingen, Germany.
   [Kohlbacher, Oliver] Univ Tubingen, Fac Med, Geissweg 3, D-72076 Tubingen, Germany.
   [Kohlbacher, Oliver] Max Planck Inst Dev Biol, Spemannstr 35, D-72076 Tubingen, Germany.
RP Duschl, A (reprint author), Salzburg Univ, Div Allergy & Immunol, Dept Mol Biol, Hellbrunner Str 34, A-5020 Salzburg, Austria.; Huber, CG (reprint author), Salzburg Univ, Div Chem & Bioanalyt, Dept Mol Biol, Hellbrunner Str 34, A-5020 Salzburg, Austria.
EM albert.duschl@sbg.ac.at; c.huber@sbg.ac.at
RI Reischl, Roland J/I-4046-2012; Huber, Christian G. G/E-5445-2011;
   Duschl, Albert/E-5872-2011
OI Reischl, Roland J/0000-0003-3331-6565; Huber, Christian G.
   G/0000-0001-8358-1880; Duschl, Albert/0000-0002-7034-9860
FU European Union (EU) Seventh Framework Programme (FP7) under grant
   agreements EC [263215, 263147]
FX The research leading to these results has received funding from the
   European Union (EU) Seventh Framework Programme (FP7/2007-2013) under
   grant agreements EC-GA No. 263215 'MARINA' and No. 263147
   (NanoValid-Development of reference methods for hazard identification,
   risk assessment and LCA of engineered nanomaterials).
CR AKSOY S, 1994, J BIOL CHEM, V269, P14835
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Arredondo Miguel, 2005, Molecular Aspects of Medicine, V26, P313, DOI 10.1016/j.mam.2005.07.010
   Aslund MLW, 2012, ENVIRON SCI TECHNOL, V46, P1111, DOI 10.1021/es202327k
   ATSDR Agency for Toxic Substances and Disease Registry, 2004, TOX PROF COPP
   Avila MA, 2004, INT J BIOCHEM CELL B, V36, P2125, DOI 10.1016/j.biocel.2003.11.016
   Benton HP, 2015, ANAL CHEM, V87, P884, DOI 10.1021/ac5025649
   Berthold M., 2008, DATA ANAL MACHINE LE
   Bloomfield V., 2014, CHAPMAN HALL CRC R S
   Bondarenko O, 2013, ARCH TOXICOL, V87, P1181, DOI 10.1007/s00204-013-1079-4
   Boyles MSP, 2015, TOXICOL IN VITRO, V29, P1513, DOI 10.1016/j.tiv.2015.06.012
   Brenner SA, 2015, J OCCUP ENVIRON HYG, V12, P469, DOI 10.1080/15459624.2015.1018515
   Brown DM, 2007, AM J PHYSIOL-LUNG C, V292, pL1444, DOI 10.1152/ajplung.00162.2006
   Brown DM, 2004, AM J PHYSIOL-LUNG C, V286, pL344, DOI 10.1152/ajplung.00139.2003
   Brown DM, 2001, TOXICOL APPL PHARM, V175, P191, DOI 10.1006/taap.2001.9240
   Bu Q, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/12/125105
   Bussy C, 2012, PART FIBRE TOXICOL, V9, DOI 10.1186/1743-8977-9-46
   Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985
   Garcia-Canaveras JC, 2015, ELECTROPHORESIS, V36, P2294, DOI 10.1002/elps.201500095
   Chambers MC, 2012, NAT BIOTECHNOL, V30, P918, DOI 10.1038/nbt.2377
   Chen J, 2005, J BIOL CHEM, V280, P16354, DOI 10.1074/jbc.M411134200
   Chlopicki S, 2007, BRIT J PHARMACOL, V152, P230, DOI 10.1038/sj.bjp.0707383
   Cho WS, 2012, NANOTOXICOLOGY, V6, P22, DOI 10.3109/17435390.2011.552810
   Chou CC, 2008, NANO LETT, V8, P437, DOI 10.1021/nl0723634
   Clift MJD, 2010, NANOTOXICOLOGY, V4, P139, DOI 10.3109/17435390903276925
   Clippinger AJ, 2016, ARCH TOXICOL, V90, P1769, DOI 10.1007/s00204-016-1717-8
   Cronholm P, 2013, SMALL, V9, P970, DOI 10.1002/smll.201201069
   Cuillel M, 2014, NANOSCALE, V6, P1707, DOI 10.1039/c3nr05041f
   Curtin JF, 2002, J IMMUNOL METHODS, V265, P49, DOI 10.1016/S0022-1759(02)00070-4
   Duncan R, 2011, MOL PHARMACEUT, V8, P2101, DOI 10.1021/mp200394t
   Edelmann MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114390
   Fahmy B, 2009, TOXICOL IN VITRO, V23, P1365, DOI 10.1016/j.tiv.2009.08.005
   Feng JH, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/39/395101
   Festa RA, 2011, CURR BIOL
   Forstermann U, 2012, EUR HEART J, V33, P829, DOI 10.1093/eurheartj/ehr304
   Franchi-Gazzola R, 2006, ACTA PHYSIOL, V187, P273, DOI 10.1111/j.1748-1716.2006.01552.x
   Gaetke LM, 2014, ARCH TOXICOL, V88, P1929, DOI 10.1007/s00204-014-1355-y
   Gaetke LM, 2003, TOXICOLOGY, V189, P147, DOI 10.1016/S0300-483X(03)00159-8
   Garcia-Contreras R, 2015, BIOMATERIALS, V57, P33, DOI 10.1016/j.biomaterials.2015.03.059
   Gioria S, 2016, NANOTOXICOLOGY, V10, P736, DOI 10.3109/17435390.2015.1121412
   Hakumaki JM, 2003, TRENDS PHARMACOL SCI, V24, P146, DOI 10.1016/S0165-6147(03)00032-4
   Halterman JA, 2012, AM J PHYSIOL-CELL PH, V302, pC1, DOI 10.1152/ajpcell.00327.2011
   Ham S, 2012, J NANOPART RES, V14, DOI 10.1007/s11051-012-1126-8
   Hartung T, 2009, NATURE, V460, P208, DOI 10.1038/460208a
   Horio M, 1997, AM J PHYSIOL-CELL PH, V272, pC804
   Jin CY, 2013, J APPL TOXICOL, V33, P1442, DOI 10.1002/jat.2808
   Johnston H, 2013, CRIT REV TOXICOL, V43, P1, DOI 10.3109/10408444.2012.738187
   Karlsson HL, 2008, CHEM RES TOXICOL, V21, P1726, DOI 10.1021/tx800064j
   Karlsson HL, 2014, PART FIBRE TOXICOL, V11, DOI 10.1186/s12989-014-0041-9
   Kettunen MI, 2005, PROG NUCL MAG RES SP, V47, P175, DOI 10.1016/j.pnmrs.2005.08.005
   Khashan KS, 2016, ARAB J SCI ENG, V41, P301, DOI 10.1007/s13369-015-1733-7
   Kitchin KT, 2014, ENVIRON SCI-NANO, V1, P466, DOI 10.1039/c4en00096j
   Kruman I, 1998, J NEUROSCI RES, V51, P293, DOI 10.1002/(SICI)1097-4547(19980201)51:3<293::AID-JNR3>3.0.CO;2-B
   Lakhani SA, 2006, SCIENCE, V311, P847, DOI 10.1126/science.1115035
   Lee JH, 2008, INVEST OPHTH VIS SCI, V49, P1827, DOI 10.1167/iovs.07-1142
   Lei RH, 2008, TOXICOL APPL PHARM, V232, P292, DOI 10.1016/j.taap.2008.06.026
   Li JQ, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/45/455102
   Li TWH, 2009, MOL PHARMACOL, V76, P192, DOI 10.1124/mol.108.054411
   Liu LF, 2000, ANN NY ACAD SCI, V922, P1
   Lopez-Rodriguez C, 2001, IMMUNITY, V15, P47, DOI 10.1016/S1074-7613(01)00165-0
   Lu XY, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/5/055101
   Lutz NW, 2003, FEBS LETT, V544, P123, DOI 10.1016/S0014-5793(03)00489-7
   Lv MY, 2015, BIOANALYSIS, V7, P1527, DOI 10.4155/bio.15.83
   Mateuszuk L, 2009, PHARMACOL REP, V61, P76
   Midander K, 2009, SMALL, V5, P389, DOI 10.1002/smll.200801220
   Mikhailenko V, 2009, NATO SCI PEACE SECUR, P67, DOI 10.1007/978-1-4020-9491-0_5
   Monopoli MP, 2011, J AM CHEM SOC, V133, P2525, DOI 10.1021/ja107583h
   Moschini E, 2013, TOXICOL LETT, V222, P102, DOI 10.1016/j.toxlet.2013.07.019
   Ogata S, 1998, BIOSCI BIOTECH BIOCH, V62, P2351, DOI 10.1271/bbb.62.2351
   Okada Y, 2001, COMP BIOCHEM PHYS A, V130, P377, DOI 10.1016/S1095-6433(01)00424-X
   Palmer D, 2004, BEHAV AQUEOUS ELECTR
   Patti GJ, 2012, NAT REV MOL CELL BIO, V13, P263, DOI 10.1038/nrm3314
   Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45
   Piret JP, 2014, J NANOPART RES, V16, DOI 10.1007/s11051-014-2337-y
   Piret JP, 2012, NANOTOXICOLOGY, V6, P789, DOI 10.3109/17435390.2011.625127
   Prohaska JR, 2008, AM J CLIN NUTR, V88, p826S
   Ranninger C, 2015, J BIOL CHEM, V290, P19121, DOI 10.1074/jbc.M115.644146
   Ratnasekhar C, 2015, NANOTOXICOLOGY, V9, P994, DOI 10.3109/17435390.2014.993345
   Reyes VC, 2016, ENVIRON TOXICOL CHEM, V35, P1148, DOI 10.1002/etc.3254
   Sarkar A, 2011, TOXICOLOGY, V290, P208, DOI 10.1016/j.tox.2011.09.086
   Schlinkert P, 2015, J NANOBIOTECHNOL, V13, DOI 10.1186/s12951-014-0062-4
   Semisch A, 2014, PART FIBRE TOXICOL, V11, DOI 10.1186/1743-8977-11-10
   Siddiqui MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069534
   Silva LP, 2013, ANAL CHEM, V85, P9536, DOI 10.1021/ac401559v
   Smith CA, 2005, THER DRUG MONIT, V27, P747, DOI 10.1097/01.ftd.0000179845.53213.39
   Sohm B, 2015, PROTEOMICS, V15, P98, DOI 10.1002/pmic.201400101
   Stone V, 2016, RISK ANAL, V36, P1538, DOI 10.1111/risa.12645
   Studer AM, 2010, TOXICOL LETT, V197, P169, DOI 10.1016/j.toxlet.2010.05.012
   Stuehr D, 2001, J BIOL CHEM, V276, P14533, DOI 10.1074/jbc.R100011200
   Sturm M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-163
   Sumner LW, 2007, METABOLOMICS, V3, P211, DOI 10.1007/s11306-007-0082-2
   Tabet L, 2011, PART FIBRE TOXICOL, V8, DOI 10.1186/1743-8977-8-3
   Tang M, 2011, J NANOSCI NANOTECHNO, V11, P3065, DOI 10.1166/jnn.2011.3604
   Thit A, 2015, TOXICOL IN VITRO, V29, P1053, DOI 10.1016/j.tiv.2015.03.020
   Tiwari PM, 2014, BIOMATERIALS, V35, P9484, DOI 10.1016/j.biomaterials.2014.07.032
   Triboulet S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124496
   Tucci P, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.76
   Vance ME, 2015, BEILSTEIN J NANOTECH, V6, P1769, DOI 10.3762/bjnano.6.181
   Viant MR, 2003, ENVIRON SCI TECHNOL, V37, P4982, DOI 10.1021/es034281x
   Vidovic S, 2015, ANTIMICROB AGENTS CH, V59, P3317, DOI 10.1128/AAC.00363-15
   Wang JY, 2009, NEUROTOXICOLOGY, V30, P926, DOI 10.1016/j.neuro.2009.09.005
   Wang T, 2014, AQUAT TOXICOL, V152, P96, DOI 10.1016/j.aquatox.2014.03.023
   Wang ZY, 2012, CHEM RES TOXICOL, V25, P1512, DOI 10.1021/tx3002093
   Want EJ, 2010, NAT PROTOC, V5, P1005, DOI 10.1038/nprot.2010.50
   Wilmes A, 2013, J PROTEOMICS, V79, P180, DOI 10.1016/j.jprot.2012.11.022
   Wischmeyer PE, 2001, J APPL PHYSIOL, V90, P2403
   Wozniacka A, 2005, CLIN EXP DERMATOL, V30, P632, DOI 10.1111/j.1365-2230.2005.01908.x
   Yin SP, 2014, J NANOPART RES, V16, DOI 10.1007/s11051-014-2274-9
   ZABLOCKI K, 1991, P NATL ACAD SCI USA, V88, P7820, DOI 10.1073/pnas.88.17.7820
   Zhang LM, 2013, BIOMATERIALS, V34, P7117, DOI 10.1016/j.biomaterials.2013.05.043
   Zhu Y, 2015, PART FIBRE TOXICOL, V12, DOI 10.1186/s12989-014-0075-z
   Ziegler TR, 2005, INTENS CARE MED, V31, P1079, DOI 10.1007/s00134-005-2690-5
NR 112
TC 24
Z9 24
U1 1
U2 47
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1743-8977
J9 PART FIBRE TOXICOL
JI Part. Fibre Toxicol.
PD SEP 8
PY 2016
VL 13
AR 49
DI 10.1186/s12989-016-0160-6
PG 20
WC Toxicology
SC Toxicology
GA DX6EP
UT WOS:000384476500001
PM 27609141
OA DOAJ Gold, Green Published
DA 2019-10-23
ER

PT J
AU von Goetz, N
AF von Goetz, Natalie
TI Organizing Exposure Data Is Beyond Conceptualization
SO ENVIRONMENTAL SCIENCE & TECHNOLOGY
LA English
DT Letter
ID AGGREGATE CONSUMER EXPOSURE; MODEL; PRODUCTS
C1 [von Goetz, Natalie] Swiss Fed Inst Technol Zurich, Inst Chem & Bioengn, Zurich, Switzerland.
RP von Goetz, N (reprint author), Swiss Fed Inst Technol Zurich, Inst Chem & Bioengn, Zurich, Switzerland.
EM Natalie.von.goetz@chem.ethz.ch
CR Dudzina T, 2015, ENVIRON INT, V79, P8, DOI 10.1016/j.envint.2015.03.006
   Fenner K, 2000, ENVIRON SCI TECHNOL, V34, P3809, DOI 10.1021/es0000347
   Fenner K., 2005, ENVIRON SCI TECHNOL, V44, P8360
   Manova E, 2015, ENVIRON INT, V74, P249, DOI 10.1016/j.envint.2014.09.008
   Oldring PKT, 2014, FOOD ADDIT CONTAM A, V31, P444, DOI 10.1080/19440049.2013.862348
   Teeguarden JG, 2016, ENVIRON SCI TECHNOL, V50, P4579, DOI 10.1021/acs.est.5b05311
   van der Voet H, 2015, FOOD CHEM TOXICOL, V79, P5, DOI 10.1016/j.fct.2014.10.014
   Zartarian V, 2005, J EXPO ANAL ENV EPID, V15, P1, DOI 10.1038/sj.jea.7500411
NR 8
TC 1
Z9 1
U1 0
U2 2
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0013-936X
EI 1520-5851
J9 ENVIRON SCI TECHNOL
JI Environ. Sci. Technol.
PD SEP 6
PY 2016
VL 50
IS 17
BP 8919
EP 8920
DI 10.1021/acs.est.6b02402
PG 2
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA DV3FG
UT WOS:000382805800001
PM 27501826
DA 2019-10-23
ER

PT J
AU Teeguarden, JG
   Tan, YM
   Edwards, SW
   Leonard, JA
   Anderson, KA
   Corley, RA
   Kile, ML
   Simonich, SLM
   Stone, D
   Tanguay, RL
   Waters, KM
   Harper, SL
   Williams, DE
AF Teeguarden, Justin G.
   Tan, Yu-Mei
   Edwards, Stephen W.
   Leonard, Jeremy A.
   Anderson, Kim A.
   Corley, Richard A.
   Kile, Molly L.
   Simonich, Staci L. Massey
   Stone, David
   Tanguay, Robert L.
   Waters, Katrina M.
   Harper, Stacey. L.
   Williams, David E.
TI Expanding on Successful Concepts, Models, and Organization
SO ENVIRONMENTAL SCIENCE & TECHNOLOGY
LA English
DT Letter
C1 [Teeguarden, Justin G.; Corley, Richard A.; Waters, Katrina M.] Pacific Northwest Natl Lab, Hlth Effects & Exposure Sci, Richland, WA 99352 USA.
   [Teeguarden, Justin G.; Anderson, Kim A.; Corley, Richard A.; Simonich, Staci L. Massey; Stone, David; Tanguay, Robert L.; Waters, Katrina M.; Harper, Stacey. L.; Williams, David E.] Oregon State Univ, Dept Environm & Mol Toxicol, Corvallis, OR 93771 USA.
   [Kile, Molly L.] Oregon State Univ, Sch Biol & Populat Hlth Sci, Corvallis, OR 93771 USA.
   [Tan, Yu-Mei] US EPA, Natl Exposure Res Lab, Durham, NC 27709 USA.
   [Edwards, Stephen W.] US EPA, Natl Hlth & Environm Effects Res Lab, Durham, NC 27709 USA.
   [Leonard, Jeremy A.] Oak Ridge Inst Sci & Educ, Oak Ridge, TN 37831 USA.
   [Harper, Stacey. L.] Oregon State Univ, Sch Chem Biol & Environm Engn, Corvallis, OR 97331 USA.
RP Teeguarden, JG (reprint author), Pacific Northwest Natl Lab, Hlth Effects & Exposure Sci, Richland, WA 99352 USA.; Teeguarden, JG (reprint author), Oregon State Univ, Dept Environm & Mol Toxicol, Corvallis, OR 93771 USA.
EM jt@pnnl.gov
OI Corley, Richard/0000-0003-2877-9194; Waters, Katrina/0000-0003-4696-5396
CR NRC, 2012, EXP SCI 21 CENT VIS
   Teeguarden JG, 2016, ENVIRON SCI TECHNOL, V50, P4579, DOI 10.1021/acs.est.5b05311
   U. S. Environmental Protection Agency (U. S. EPA) Office of Pesticide Programs, 2001, GEN PRINC PERF AGGR
   von Goetz N, 2016, ENVIRON SCI TECHNOL, V50, P8919, DOI 10.1021/acs.est.6b02402
NR 4
TC 1
Z9 1
U1 1
U2 9
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0013-936X
EI 1520-5851
J9 ENVIRON SCI TECHNOL
JI Environ. Sci. Technol.
PD SEP 6
PY 2016
VL 50
IS 17
BP 8921
EP 8922
DI 10.1021/acs.est.6b03027
PG 2
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA DV3FG
UT WOS:000382805800002
PM 27509267
DA 2019-10-23
ER

PT J
AU Roh, JY
   Lee, HJ
   Kwon, JH
AF Roh, Ji-Yeon
   Lee, Hyun-Jeoung
   Kwon, Jung-Hwan
TI Internal Concentration and Time Are Important Modifiers of Toxicity: The
   Case of Chlorpyrifos on Caenorhabditis elegans
SO ENVIRONMENTAL SCIENCE & TECHNOLOGY
LA English
DT Article
ID GENE-EXPRESSION; ORGANIC-CHEMICALS; END-POINTS; ACETYLCHOLINESTERASE
   INHIBITION; ORGANOPHOSPHORUS INSECTICIDE; DAPHNIA-MAGNA; EXPOSURE;
   METABOLISM; BIOACCUMULATION; ECOTOXICOLOGY
AB The internal concentration of chemicals in exposed organisms changes over time due to absorption, distribution, metabolism, and excretion processes since chemicals are taken up from the environment. Internal concentration and time are very important modifiers of toxicity when biomarkers are used to evaluate the potential hazards and risks of environmental pollutants. In this study, the responses of molecular biomarkers, and the fate of chemicals in the body, were comprehensively investigated to determine cause-and-effect relationships over time. Chlorpyrifos (CP) was selected as a model chemical, and Caenorhabditis elegans was exposed to CP for 4 h using the passive dosing method. Worms were then monitored in fresh medium during a 48-h recovery regime. The mRNA expression of genes related to CYP metabolism (cyp3Sa2 and cyp3Sa3) increased during the constant exposure phase. The body residue of CP decreased once it reached a peak level during the early stage of exposure, indicating that the initial uptake of CP rapidly induced biotransformation with the synthesis of new CYP metabolic proteins. The residual chlorpyrifos-oxon concentration, an acetylcholinesterase (AChE) inhibitor, continuously increased even after the recovery regime started. These delayed toxicokinetics seem to be important for the extension of AChE inhibition for up to 9 h after the start of the recovery regime. Comprehensive investigation into the molecular initiation events and changes in the internal concentrations of chemical species provide insight into response causality within the framework of an adverse outcome pathway.
C1 [Roh, Ji-Yeon; Lee, Hyun-Jeoung; Kwon, Jung-Hwan] Korea Univ, Div Environm Sci & Ecol Engn, 145 Anam Ro, Seoul 02841, South Korea.
RP Kwon, JH (reprint author), Korea Univ, Div Environm Sci & Ecol Engn, 145 Anam Ro, Seoul 02841, South Korea.
EM junghwankwon@korea.ac.kr
FU National Research Foundation of Korea (NRF)National Research Foundation
   of Korea [2013R1A1A2060473]; Korea University
FX This research was supported by the National Research Foundation of Korea
   (NRF) (Grant 2013R1A1A2060473) and a Korea University Grant.
CR ABDULLAH AR, 1994, ENVIRON TOXICOL CHEM, V13, P1861, DOI 10.1002/etc.5620131118
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Ardestani MM, 2014, ENVIRON TOXICOL CHEM, V33, P1570, DOI 10.1002/etc.2585
   Ashauer R, 2012, ENVIRON SCI TECHNOL, V46, P3498, DOI 10.1021/es204611h
   Ashauer R, 2011, ENVIRON TOXICOL CHEM, V30, P2519, DOI 10.1002/etc.639
   Bayen S, 2009, ENVIRON SCI TECHNOL, V43, P2206, DOI 10.1021/es8029895
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Busby-Hjerpe AL, 2010, TOXICOLOGY, V268, P55, DOI 10.1016/j.tox.2009.11.022
   Crane AL, 2012, TOXICOLOGY, V293, P115, DOI 10.1016/j.tox.2012.01.006
   Eaton DL, 2008, CRIT REV TOXICOL, V38, P1, DOI [10.1080/10408440802272158, 10.1080/10408440802272158 ]
   Elersek T., 2001, PESTICIDES IMPACTS P, P243
   ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9
   Escher Beate I., 2011, Integrated Environmental Assessment and Management, V7, P28, DOI 10.1002/ieam.100
   Escher BI, 2004, ENVIRON SCI TECHNOL, V38, p455A, DOI 10.1021/es0406740
   Fulton MH, 2001, ENVIRON TOXICOL CHEM, V20, P37, DOI [10.1897/1551-5028(2001)020<0037:AIIEFA>2.0.CO;2, 10.1002/etc.5620200104]
   Golding I, 2005, CELL, V123, P1025, DOI 10.1016/j.cell.2005.09.031
   Groh KJ, 2015, CHEMOSPHERE, V120, P764, DOI 10.1016/j.chemosphere.2014.09.068
   Gruber J, 2009, FEBS LETT, V583, P3377, DOI 10.1016/j.febslet.2009.09.051
   HABIG C, 1991, CHOLINESTERASE INHIB, P19
   Harlow PH, 2016, SCI REP-UK, V6, DOI 10.1038/srep22965
   Houde M, 2013, AQUAT TOXICOL, V140, P213, DOI 10.1016/j.aquatox.2013.06.008
   Jeon J, 2013, ECOTOX ENVIRON SAFE, V98, P28, DOI 10.1016/j.ecoenv.2013.09.033
   Jiang Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148014
   Klaassen C, 2001, CASARETT DOULLS TOXI
   Kumar A, 2010, ECOTOX ENVIRON SAFE, V73, P1503, DOI 10.1016/j.ecoenv.2010.07.016
   Kwon HC, 2012, ENVIRON SCI TECHNOL, V46, P12550, DOI 10.1021/es3035363
   Kwon JH, 2009, CHEMOSPHERE, V76, P83, DOI 10.1016/j.chemosphere.2009.02.023
   Leung MCK, 2010, TOXICOL SCI, V118, P444, DOI 10.1093/toxsci/kfq295
   Lewis JA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-291
   Lionetto M. G., 2011, ACETYLCHOLINESTERASE
   Mackay D, 2014, REV ENVIRON CONTAM T, V231, P35, DOI 10.1007/978-3-319-03865-0_3
   Mayer P, 2003, ENVIRON SCI TECHNOL, V37, p184A, DOI 10.1021/es032433i
   McCarty L. S., 2011, Integrated Environmental Assessment and Management, V7, P7, DOI 10.1002/ieam.98
   Menzel R, 2005, ARCH BIOCHEM BIOPHYS, V438, P93, DOI 10.1016/j.abb.2005.03.020
   Menzel R, 2001, ARCH BIOCHEM BIOPHYS, V395, P158, DOI 10.1006/abbi.2001.2568
   Patil VK, 2010, DRUG CHEM TOXICOL, V33, P160, DOI 10.3109/01480540903196816
   Rajini PS, 2008, J TOXICOL ENV HEAL A, V71, P1043, DOI 10.1080/15287390801989002
   Roh JY, 2008, ECOTOX ENVIRON SAFE, V71, P483, DOI 10.1016/j.ecoenv.2007.11.007
   Roh JY, 2014, ENVIRON SCI TECHNOL, V48, P10475, DOI 10.1021/es5027773
   Roh JY, 2011, CHEMOSPHERE, V84, P1356, DOI 10.1016/j.chemosphere.2011.05.010
   Rubach MN, 2010, ENVIRON TOXICOL CHEM, V29, P2225, DOI 10.1002/etc.273
   Sanchez-Hernandez JC, 2014, SCI TOTAL ENVIRON, V490, P445, DOI 10.1016/j.scitotenv.2014.05.037
   Spurgeon DJ, 2005, ENVIRON SCI TECHNOL, V39, P5327, DOI 10.1021/es050033k
   Vogs C, 2015, ENVIRON TOXICOL CHEM, V34, P100, DOI 10.1002/etc.2764
   Xia XH, 2015, ENVIRON SCI TECHNOL, V49, P4911, DOI 10.1021/acs.est.5b00071
   Zanger UM, 2013, PHARMACOL THERAPEUT, V138, P103, DOI 10.1016/j.pharmthera.2012.12.007
NR 46
TC 3
Z9 5
U1 2
U2 31
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0013-936X
EI 1520-5851
J9 ENVIRON SCI TECHNOL
JI Environ. Sci. Technol.
PD SEP 6
PY 2016
VL 50
IS 17
BP 9689
EP 9696
DI 10.1021/acs.est.6b02751
PG 8
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA DV3FG
UT WOS:000382805800087
PM 27490261
DA 2019-10-23
ER

PT J
AU Alexander, PG
   Clark, KL
   Tuan, RS
AF Alexander, Peter G.
   Clark, Karen L.
   Tuan, Rocky S.
TI Prenatal exposure to environmental factors and congenital limb defects
SO BIRTH DEFECTS RESEARCH PART C-EMBRYO TODAY-REVIEWS
LA English
DT Review
DE prenatal exposure; environmental factors; congenital limb defects;
   teratogens; limb development; in vitro toxicity testing; organotypic
   culture models; microphysiological systems; anticonvulsant; phenytoin;
   valproic acid; thalidomide; ethanol; diabetes; misoprostol; warfarin;
   cadmium
ID RETINOIC ACID SYNTHESIS; PLURIPOTENT STEM-CELLS; FETAL ALCOHOL SYNDROME;
   FUEL-MEDIATED TERATOGENESIS; DENSITY MICROMASS CULTURES; NITRIC-OXIDE
   SYNTHASE; INDUCED BIRTH-DEFECTS; OXIDATIVE DNA-DAMAGE; IN-VITRO MODEL;
   NF-KAPPA-B
AB Limb congenital defects afflict approximately 0.6:1000 live births. In addition to genetic factors, prenatal exposure to drugs and environmental toxicants, represents a major contributing factor to limb defects. Examples of well-recognized limb teratogenic agents include thalidomide, warfarin, valproic acid, misoprostol, and phenytoin. While the mechanism by which these agents cause dymorphogenesis is increasingly clear, prediction of the limb teratogenicity of many thousands of as yet uncharacterized environmental factors (pollutants) remains inexact. This is limited by the insufficiencies of currently available models. Specifically, in vivo approaches using guideline animal models have inherently deficient predictive power due to genomic and anatomic differences that complicate mechanistic comparisons. On the other hand, in vitro two-dimensional (2D) cell cultures, while accessible for cellular and molecular experimentation, do not reflect the three-dimensional (3D) morphogenetic events in vivo nor systemic influences. More robust and accessible models based on human cells that accurately replicate specific processes of embryonic limb development are needed to enhance limb teratogenesis prediction and to permit mechanistic analysis of the adverse outcome pathways. Recent advances in elucidating mechanisms of normal development will aid in the development of process-specific 3D cell cultures within specialized bioreactors to support multicellular microtissues or organoid constructs that will lead to increased understanding of cell functions, cell-to-cell signaling, pathway networks, and mechanisms of toxicity. The promise is prompting researchers to look to such 3D microphysiological systems to help sort out complex and often subtle interactions relevant to developmental malformations that would not be evident by standard 2D cell culture testing. Birth Defects Research (Part C) 108:243-273, 2016. (c) 2016 Wiley Periodicals, Inc.
C1 [Alexander, Peter G.; Clark, Karen L.; Tuan, Rocky S.] Univ Pittsburgh, Sch Med, Ctr Cellular & Mol Engn, Dept Orthopaed Surg, 450 Technol Dr,Room 221, Pittsburgh, PA 15219 USA.
RP Tuan, RS (reprint author), Univ Pittsburgh, Sch Med, Ctr Cellular & Mol Engn, Dept Orthopaed Surg, 450 Technol Dr,Room 221, Pittsburgh, PA 15219 USA.
EM rst13@pitt.edu
FU U.S. Environmental Protection AgencyUnited States Environmental
   Protection Agency [EPA R835736]
FX This work is supported in part by the U.S. Environmental Protection
   Agency (EPA R835736 - Vanderbilt-Pittsburgh Resource for Organotypic
   Models for Predictive Toxicology), and the Arthur J. Rooney, Sr,
   Endowment in Sports Medicine, University of Pittsburgh School of
   Medicine.
CR Aberg A, 2001, EARLY HUM DEV, V61, P85, DOI 10.1016/S0378-3782(00)00125-0
   ADAMS J, 1990, NEUROTOXICOL TERATOL, V12, P203, DOI 10.1016/0892-0362(90)90092-Q
   Akazawa Shoichi, 2005, Congenital Anomalies, V45, P73, DOI 10.1111/j.1741-4520.2005.00070.x
   Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802
   Akiyama H, 2004, GENE DEV, V18, P1072, DOI 10.1101/gad.1171104
   Akiyama H, 2011, J BONE MINER METAB, V29, P390, DOI 10.1007/s00774-011-0273-9
   Alexander PG, 2003, BIRTH DEFECTS RES A, V67, P219, DOI 10.1002/bdra.10041
   Allen JL, 2012, MOL BIOL CELL, V23, P3731, DOI 10.1091/mbc.E12-03-0172
   Allen VM, 2007, J OBSTET GYNAECOL CA, V29, P927, DOI 10.1016/S1701-2163(16)32653-6
   Alvarez J, 2002, DEVELOPMENT, V129, P1913
   Alvarez J, 2001, DEV DYNAM, V221, P311, DOI 10.1002/dvdy.1141
   Amarilio R, 2007, DEVELOPMENT, V134, P3917, DOI 10.1242/dev.008441
   AMIZUKA N, 1994, J CELL BIOL, V126, P1611, DOI 10.1083/jcb.126.6.1611
   Anderson E, 2012, TRENDS GENET, V28, P364, DOI 10.1016/j.tig.2012.03.012
   [Anonymous], 2006, BIRTH DEFECTS RES A, V76, P837
   [Anonymous], 2010, HAND FACTS NEWS HAND
   Arrington CB, 2010, AM J MED GENET A, V152A, P2919, DOI 10.1002/ajmg.a.33718
   Augustine-Rauch K, 2007, BIRTH DEFECTS RES B, V80, P497, DOI 10.1002/bdrb.20132
   AULTHOUSE AL, 1994, TERATOLOGY, V49, P208, DOI 10.1002/tera.1420490317
   Ayadi A, 2001, MECH DEVELOP, V102, P205, DOI 10.1016/S0925-4773(01)00289-1
   Baack ML, 2014, REPROD TOXICOL, V46, P129, DOI 10.1016/j.reprotox.2014.03.013
   Barnes GL, 1996, DIFFERENTIATION, V61, P13, DOI 10.1046/j.1432-0436.1996.6110013.x
   Barnes GL, 1997, DEV BIOL, V189, P95, DOI 10.1006/dbio.1997.8663
   BARR M, 1973, TERATOLOGY, V7, P237, DOI 10.1002/tera.1420070304
   Barrow JR, 2003, GENE DEV, V17, P394, DOI 10.1101/gad.1044903
   Bartels E, 2012, CLIN DYSMORPHOL, V21, P191, DOI 10.1097/MCD.0b013e328358243c
   Basketter DA, 2012, ALTEX-ALTERN ANIM EX, V29, P5, DOI 10.14573/altex.2012.1.003
   Basson CT, 1997, NAT GENET, V15, P30, DOI 10.1038/ng0197-30
   Bedard T, 2015, AM J MED GENET A, V167, P2599, DOI 10.1002/ajmg.a.37240
   Bendall AJ, 2000, GENE, V247, P17, DOI 10.1016/S0378-1119(00)00081-0
   Bi J, 2001, DEV GROWTH DIFFER, V43, P553
   Bi WM, 1999, NAT GENET, V22, P85
   Blaheta RA, 2002, MED RES REV, V22, P492, DOI 10.1002/med.10017
   Bobick BE, 2009, BIRTH DEFECTS RES C, V87, P351, DOI 10.1002/bdrc.20167
   Bohring A, 1999, AM J MED GENET, V87, P99, DOI 10.1002/(SICI)1096-8628(19991119)87:2<99::AID-AJMG1>3.0.CO;2-Q
   Borestrom C, 2014, STEM CELL TRANSL MED, V3, P433, DOI 10.5966/sctm.2013-0138
   Bornes TD, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/s13075-014-0432-1
   Bradley EW, 2015, J BIOL CHEM, V290, P118, DOI 10.1074/jbc.M114.596247
   BrandSaberi B, 1996, DEV BIOL, V179, P303, DOI 10.1006/dbio.1996.0260
   BRAUN AG, 1979, NATURE, V282, P507, DOI 10.1038/282507a0
   Brent RL, 2004, PEDIATRICS, V113, P957
   Brosens E, 2014, EUR J MED GENET, V57, P440, DOI 10.1016/j.ejmg.2014.05.009
   BROWN NA, 1987, ARCH TOXICOL, P105
   Buckingham M, 2003, J ANAT, V202, P59, DOI 10.1046/j.1469-7580.2003.00139.x
   BURKE AC, 1995, DEVELOPMENT, V121, P333
   Bushdid PB, 2001, DEV BIOL, V237, P107, DOI 10.1006/dbio.2001.0356
   BUTTKE TM, 1994, IMMUNOL TODAY, V15, P7, DOI 10.1016/0167-5699(94)90018-3
   Cannito S, 2010, ANTIOXID REDOX SIGN, V12, P1383, DOI 10.1089/ars.2009.2737
   Capdevila J, 2001, ANNU REV CELL DEV BI, V17, P87, DOI 10.1146/annurev.cellbio.17.1.87
   Castori M, 2008, AM J MED GENET A, V146A, P1259, DOI 10.1002/ajmg.a.32288
   Caterson E, 2002, MOL BIOTECHNOL, V20, P245, DOI 10.1385/MB:20:3:245
   CDC, 2015, BIRTH DEF TOOL KIT
   CHANG SC, 1994, J BIOL CHEM, V269, P28227
   Chen YP, 1998, J EXP ZOOL, V282, P691
   Cheng X, 2014, CURR PHARM DESIGN, V20, P5430, DOI 10.2174/1381612820666140205144534
   Chernoff N, 2010, BIRTH DEFECTS RES B, V89, P300, DOI 10.1002/bdrb.20258
   Chou CF, 2002, J BIOL CHEM, V277, P25209, DOI 10.1074/jbc.M201947200
   Chrisman K, 2004, BIRTH DEFECTS RES A, V70, P163, DOI 10.1002/bdra.20019
   Christ B, 2002, INT J DEV BIOL, V46, P905
   Coelho KEFA, 2000, AM J MED GENET, V95, P297, DOI 10.1002/1096-8628(20001211)95:4<297::AID-AJMG1>3.3.CO;2-B
   Coleman CM, 2003, ANAT REC PART A, V275A, P1117, DOI 10.1002/ar.a.10125
   Coleman CM, 2003, MECH DEVELOP, V120, P823, DOI 10.1016/S0925-4773(03)00067-4
   Correa Adolfo, 2007, Birth Defects Res A Clin Mol Teratol, V79, P65
   Correia KM, 2000, MECH DEVELOP, V91, P19, DOI 10.1016/S0925-4773(99)00260-9
   COSTA SH, 1993, LANCET, V341, P1258, DOI 10.1016/0140-6736(93)91156-G
   Crosnier C, 2000, HEPATOLOGY, V32, P574, DOI 10.1053/jhep.2000.16600
   Cui YX, 2009, J BIOL CHEM, V284, P24925, DOI 10.1074/jbc.M109.026609
   Cullinane J, 2009, REPROD TOXICOL, V28, P335, DOI 10.1016/j.reprotox.2009.05.069
   Dal Pizzol TD, 2006, REPROD TOXICOL, V22, P666, DOI 10.1016/j.reprotox.2006.03.015
   DAMATO RJ, 1994, P NATL ACAD SCI USA, V91, P4082, DOI 10.1073/pnas.91.9.4082
   Decker RS, 2014, MATRIX BIOL, V39, P5, DOI 10.1016/j.matbio.2014.08.006
   Delfini MC, 2000, MECH DEVELOP, V96, P247, DOI 10.1016/S0925-4773(00)00384-1
   DeLise AM, 2002, J CELL BIOCHEM, V87, P342, DOI 10.1002/jcb.10308
   DeLise AM, 2000, METH MOL B, V137, P359
   Deltour L, 1996, FASEB J, V10, P1050
   Derfoul A, 2006, STEM CELLS, V24, P1487, DOI 10.1634/stemcells.2005-0415
   Di Renzo F, 2013, BIRTH DEFECTS RES B, V98, P328, DOI 10.1002/bdrb.21069
   Diekman BO, 2012, P NATL ACAD SCI USA, V109, P19172, DOI 10.1073/pnas.1210422109
   DiMasi JA, 2003, J HEALTH ECON, V22, P151, DOI 10.1016/S0167-6296(02)00126-1
   Dolk H, 2003, BRIT MED BULL, V68, P25, DOI 10.1093/bmb/ldg024
   Dolk H, 2010, ADV EXP MED BIOL, V686, P349, DOI 10.1007/978-90-481-9485-8_20
   DUESTER G, 1991, ALCOHOL CLIN EXP RES, V15, P568, DOI 10.1111/j.1530-0277.1991.tb00562.x
   DUMPERT K, 1984, ECOTOX ENVIRON SAFE, V8, P55, DOI 10.1016/0147-6513(84)90041-1
   DUNCAN PA, 1993, AM J MED GENET, V47, P75, DOI 10.1002/ajmg.1320470116
   Ema M, 2010, REPROD TOXICOL, V29, P49, DOI 10.1016/j.reprotox.2009.09.003
   Eriksson UJ, 1999, NAT MED, V5, P715, DOI 10.1038/10420
   Eriksson UJ, 2009, SEMIN FETAL NEONAT M, V14, P85, DOI 10.1016/j.siny.2008.11.001
   Esch MB, 2011, ANNU REV BIOMED ENG, V13, P55, DOI [10.1146/annurev-bioeng-071910-124629, 10.1146/annurev-biocng-071910-124629]
   Ettlin RA, 2010, J TOXICOL PATHOL, V23, P189, DOI 10.1293/tox.23.189
   Fantel AG, 1996, TERATOLOGY, V53, P196, DOI 10.1002/(SICI)1096-9926(199603)53:3<196::AID-TERA7>3.0.CO;2-2
   Fantel AG, 2002, ANN NY ACAD SCI, V959, P424, DOI 10.1111/j.1749-6632.2002.tb02112.x
   Faroon O., 2012, TOXICOLOGICAL PROFIL
   FAUSTMAN EM, 1988, MUTAT RES, V205, P355, DOI 10.1016/0165-1218(88)90027-4
   FEINBERG RN, 1991, ANAT REC, V231, P136, DOI 10.1002/ar.1092310115
   Ferrari D, 1998, DEV BIOL, V197, P12, DOI 10.1006/dbio.1998.8880
   FINNELL RH, 1991, REPROD TOXICOL, V5, P281, DOI 10.1016/0890-6238(91)90090-3
   FINNELL RH, 1991, PHARMACOL TOXICOL, V69, P223, DOI 10.1111/bcpt.1991.69.4.223
   FLAMME I, 1995, DEV BIOL, V171, P399, DOI 10.1006/dbio.1995.1291
   FLINT OP, 1984, TOXICOL APPL PHARM, V76, P383, DOI 10.1016/0041-008X(84)90020-6
   Francis-West PH, 1999, DEVELOPMENT, V126, P1305
   Frias JL, 2007, AM J MED GENET A, V143A, P2904, DOI 10.1002/ajmg.a.32071
   FROSTER UG, 1992, AM J MED GENET, V44, P782, DOI 10.1002/ajmg.1320440612
   Fujimaki R, 2006, J BONE MINER METAB, V24, P191, DOI 10.1007/s00774-005-0671-y
   Fujita T, 2004, J CELL BIOL, V166, P85, DOI 10.1083/jcb.200401138
   Furumatsu T, 2010, ACTA MED OKAYAMA, V64, P155
   Galceran J, 1999, GENE DEV, V13, P709, DOI 10.1101/gad.13.6.709
   Ganan Y, 1998, DEV BIOL, V196, P33, DOI 10.1006/dbio.1997.8843
   Ganan Y, 1996, DEVELOPMENT, V122, P2349
   Gao XG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108510
   Garcia-Barcelo MM, 2008, AM J MED GENET A, V146A, P3181, DOI 10.1002/ajmg.a.32426
   Garciadiego-Cazares D, 2004, DEVELOPMENT, V131, P4735, DOI 10.1242/dev.01345
   GAUNT SJ, 1994, DEV DYNAM, V199, P229, DOI 10.1002/aja.1001990307
   Genest DR, 1999, CLIN DYSMORPHOL, V8, P53
   Germiller JA, 1997, J ORTHOP RES, V15, P362, DOI 10.1002/jor.1100150308
   Giele H, 2001, J HAND SURG-AM, V26A, P628, DOI 10.1053/jhsu.2001.26121
   Gillick J, 2002, PEDIATR SURG INT, V18, P576, DOI 10.1007/s00383-002-0859-3
   Gishen K, 2014, J CRANIOFAC SURG, V25, P284, DOI 10.1097/SCS.0000000000000480
   Goldfarb CA, 2015, J HAND SURG-AM, V40, P127, DOI 10.1016/j.jhsa.2014.10.038
   GOLDMAN AS, 1984, CURR TOP DEV BIOL, V19, P217, DOI 10.1016/S0070-2153(08)60401-9
   Gonzalez CH, 1998, LANCET, V351, P1624, DOI 10.1016/S0140-6736(97)12363-7
   GRABOWSKI CT, 1958, AM J ANAT, V103, P313, DOI 10.1002/aja.1001030302
   Graziadio C, 2010, AM J MED GENET A, V152A, P2134, DOI 10.1002/ajmg.a.33548
   Grummer MA, 1995, ALCOHOL CLIN EXP RES, V19, P1376, DOI 10.1111/j.1530-0277.1995.tb00995.x
   Guzzo RM, 2013, J CELL BIOCHEM, V114, P480, DOI 10.1002/jcb.24388
   HALE JE, 1988, J BIOL CHEM, V263, P5820
   Han CL, 1998, EUR J BIOCHEM, V254, P25, DOI 10.1046/j.1432-1327.1998.2540025.x
   Hartmann C, 2001, CELL, V104, P341, DOI 10.1016/S0092-8674(01)00222-7
   Hattori T, 2010, DEVELOPMENT, V137, P901, DOI 10.1242/dev.045203
   Healy C, 1999, DEV DYNAM, V215, P69, DOI 10.1002/(SICI)1097-0177(199905)215:1<69::AID-DVDY8>3.0.CO;2-N
   Herion NJ, 2014, BIRTH DEFECTS RES A, V100, P608, DOI 10.1002/bdra.23283
   Hernandez-Martinez R, 2011, DEV GROWTH DIFFER, V53, P245, DOI 10.1111/j.1440-169X.2010.01246.x
   HERRMANN J, 1980, EUR J PEDIATR, V133, P221, DOI 10.1007/BF00496080
   Hiraki Y, 1997, J BIOL CHEM, V272, P32419, DOI 10.1074/jbc.272.51.32419
   Hiramatsu K, 2011, J CLIN INVEST, V121, P640, DOI 10.1172/JCI44605
   Holden ST, 2006, J MED GENET, V43, P750, DOI 10.1136/jmg.2006.041673
   Holmes LB, 2001, NEW ENGL J MED, V344, P1132, DOI 10.1056/NEJM200104123441504
   Holmes LB, 2002, AM J MED GENET, V112, P297, DOI 10.1002/ajmg.10781
   Hovland DN, 1999, TERATOLOGY, V60, P13, DOI 10.1002/(SICI)1096-9926(199907)60:1<13::AID-TERA6>3.0.CO;2-B
   Howard M, 2016, IN VITRO CELL DEV-AN, V52, P182, DOI 10.1007/s11626-015-9960-5
   HOWE AM, 1992, TERATOLOGY, V46, P379, DOI 10.1002/tera.1420460408
   HUNTER ES, 1989, AM J PHYSIOL, V257, pE269
   Iimura T, 2007, DEV GROWTH DIFFER, V49, P265, DOI 10.1111/j.1440-169x.2007.00928.x
   Ito T, 2011, CELL MOL LIFE SCI, V68, P1569, DOI 10.1007/s00018-010-0619-9
   Ito T, 2010, SCIENCE, V327, P1345, DOI 10.1126/science.1177319
   Iwamoto M, 2007, DEV BIOL, V305, P40, DOI 10.1016/j.ydbio.2007.01.037
   Iwamoto M, 2013, BIRTH DEFECTS RES C, V99, P192, DOI 10.1002/bdrc.21042
   JELINEK R, 1982, TERATOGEN CARCIN MUT, V2, P255, DOI 10.1002/1520-6866(1990)2:3/4<255::AID-TCM1770020307>3.0.CO;2-M
   JOHNSON EM, 1980, J ENVIRON PATHOL TOX, V4, P153
   JOHNSON RL, 1994, CELL, V79, P1165, DOI 10.1016/0092-8674(94)90008-6
   JONES KL, 1975, TERATOLOGY, V12, P1, DOI 10.1002/tera.1420120102
   JurimaRomet M, 1996, TOXICOLOGY, V112, P69, DOI 10.1016/0300-483X(96)03352-5
   Kalter H, 2003, NEUROTOXICOL TERATOL, V25, P131, DOI 10.1016/S0892-0362(03)00010-2
   KAPRONBRAS CM, 1992, TERATOLOGY, V46, P191, DOI 10.1002/tera.1420460212
   Karsenty G, 2009, ANNU REV CELL DEV BI, V25, P629, DOI 10.1146/annurev.cellbio.042308.113308
   KEIR WJ, 1991, ALCOHOL CLIN EXP RES, V15, P560, DOI 10.1111/j.1530-0277.1991.tb00560.x
   Kengaku M, 1998, SCIENCE, V280, P1274, DOI 10.1126/science.280.5367.1274
   Kim JH, 2001, CLIN GENET, V59, P306, DOI 10.1034/j.1399-0004.2001.590503.x
   Kipnes J, 2003, OSTEOARTHR CARTILAGE, V11, P442, DOI 10.1016/S1063-4584(03)00055-4
   Knobloch J, 2008, MOL CELL BIOL, V28, P529, DOI 10.1128/MCB.00533-07
   Kobolak J, 2016, METHODS, V99, P62, DOI 10.1016/j.ymeth.2015.09.016
   KOSEKI H, 1993, DEVELOPMENT, V119, P649
   KOTCH LE, 1992, TERATOLOGY, V46, P323, DOI 10.1002/tera.1420460403
   KOYAMA E, 1995, DEV DYNAM, V203, P152, DOI 10.1002/aja.1002030204
   Koyama E, 2010, DEVELOPMENT, V137, P3795, DOI 10.1242/dev.053447
   Koyama N, 2013, STEM CELLS DEV, V22, P102, DOI 10.1089/scd.2012.0127
   L'Hote CGM, 2005, EXP CELL RES, V304, P417, DOI 10.1016/j.yexcr.2004.11.012
   Lallemand Y, 2009, DEV BIOL, V331, P189, DOI 10.1016/j.ydbio.2009.04.038
   LAMMER EJ, 1987, TERATOLOGY, V35, P465, DOI 10.1002/tera.1420350319
   LAYTON WM, 1979, TERATOLOGY, V19, P229, DOI 10.1002/tera.1420190213
   LENZ W, 1988, TERATOLOGY, V38, P203, DOI 10.1002/tera.1420380303
   Li QY, 1997, NAT GENET, V15, P21
   Li XZ, 2012, DIABETES, V61, P2084, DOI 10.2337/db11-1624
   Liao XY, 2007, TOXICOL APPL PHARM, V225, P47, DOI 10.1016/j.taap.2007.06.005
   Lien WH, 2006, CURR OPIN CELL BIOL, V18, P499, DOI 10.1016/j.ceb.2006.07.001
   Liu J, 2010, REPROD TOXICOL, V29, P286, DOI 10.1016/j.reprotox.2010.02.001
   Liu WW, 2013, J BIOCHEM MOL TOXIC, V27, P17, DOI 10.1002/jbt.21470
   LOESER RF, 1991, CONNECT TISSUE RES, V26, P135, DOI 10.3109/03008209109152432
   Logan C, 1997, DEVELOPMENT, V124, P2317
   Loomis CA, 1998, DEVELOPMENT, V125, P1137
   LOUGHNAN PM, 1973, LANCET, V1, P70
   Lv FJ, 2014, STEM CELLS, V32, P1408, DOI 10.1002/stem.1681
   Macias D, 1996, ANAT EMBRYOL, V193, P533
   MacKinnon Y, 2010, BIRTH DEFECTS RES A, V88, P707, DOI 10.1002/bdra.20703
   Majumder S, 2009, BRIT J PHARMACOL, V158, P1720, DOI 10.1111/j.1476-5381.2009.00446.x
   Maleski MP, 1996, EXP CELL RES, V225, P55, DOI 10.1006/excr.1996.0156
   Malik S, 2014, CLIN GENET, V85, P203, DOI 10.1111/cge.12276
   Marcelle C, 1997, DEVELOPMENT, V124, P3955
   Marques-Dias MJ, 2003, BIRTH DEFECTS RES A, V67, P1002, DOI 10.1002/bdra.10144
   MARTIN ML, 1991, BRAIN RES, V554, P223, DOI 10.1016/0006-8993(91)90193-Y
   Martinez-Frias ML, 1998, AM J MED GENET, V76, P291, DOI 10.1002/(SICI)1096-8628(19980401)76:4<291::AID-AJMG3>3.0.CO;2-T
   Massa V, 2005, PHARMACOGENET GENOM, V15, P787, DOI 10.1097/01.fpc.0000170914.11898.3a
   May PA, 2001, ALCOHOL RES HEALTH, V25, P159
   McBride JL, 1998, MECH DEVELOP, V77, P201, DOI 10.1016/S0925-4773(98)00142-7
   McCredie J, 1999, J BONE JOINT SURG BR, V81B, P9, DOI 10.1302/0301-620X.81B1.8448
   McCubrey JA, 2006, ANTIOXID REDOX SIGN, V8, P1775, DOI 10.1089/ars.2006.8.1775
   Meganathan K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044228
   Mehndiratta S, 2010, ARCH GYNECOL OBSTET, V282, P335, DOI 10.1007/s00404-010-1369-5
   Mello MA, 1999, IN VITRO CELL DEV-AN, V35, P262
   Mello MA, 2006, J ORTHOP RES, V24, P2095, DOI 10.1002/jor.20233
   Menegola Elena, 2006, Birth Defects Research, V78, P345, DOI 10.1002/bdrc.20082
   Menke DB, 2008, DEVELOPMENT, V135, P2543, DOI 10.1242/dev.017384
   Merino R, 1999, ANN NY ACAD SCI, V887, P120, DOI 10.1111/j.1749-6632.1999.tb07927.x
   MESSERLE K, 1982, TERATOLOGY, V25, P61, DOI 10.1002/tera.1420250109
   Michaud JL, 1997, DEVELOPMENT, V124, P1453
   Minina E, 2002, DEV CELL, V3, P439, DOI 10.1016/S1534-5807(02)00261-7
   Mirkes Philip E., 2008, Congenital Anomalies, V48, P7, DOI 10.1111/j.1741-4520.2007.00175.x
   MITROVIC D, 1982, ACTA ANAT, V113, P313
   Mok GF, 2011, REPRODUCTION, V141, P301, DOI 10.1530/REP-10-0394
   Moldovan L, 2006, CARDIOVASC RES, V71, P236, DOI 10.1016/j.cardiores.2006.05.003
   MOREIRA AL, 1993, J EXP MED, V177, P1675, DOI 10.1084/jem.177.6.1675
   Mueller MB, 2008, ARTHRITIS RHEUM-US, V58, P1377, DOI 10.1002/art.23370
   MUMMERY CL, 1984, TERATOLOGY, V29, P271, DOI 10.1002/tera.1420290213
   Mundy C, 2011, DEV BIOL, V351, P70, DOI 10.1016/j.ydbio.2010.12.022
   Murray S, 1996, CLIN OBSTET GYNECOL, V39, P474, DOI 10.1097/00003081-199606000-00021
   Nakaya Y, 2004, DEV CELL, V7, P425, DOI 10.1016/j.devcel.2004.08.003
   Nanka O, 2006, DEV DYNAM, V235, P723, DOI 10.1002/dvdy.20689
   NAU H, 1994, CIBA F SYMP, V181, P144
   NAU H, 1991, PHARMACOL TOXICOL, V69, P310, DOI 10.1111/j.1600-0773.1991.tb01303.x
   NAU H, 1986, ENVIRON HEALTH PERSP, V70, P113, DOI 10.2307/3430348
   Nelson KK, 2004, FREE RADICAL BIO MED, V37, P768, DOI 10.1016/j.freeradbiomed.2004.06.008
   Neubert R, 1995, LIFE SCI, V58, P295, DOI 10.1016/0024-3205(95)02290-2
   Neubert R, 1999, NATURE, V400, P419, DOI 10.1038/22685
   NEW DAT, 1976, J EMBRYOL EXP MORPH, V36, P133
   Niederreither K, 2002, DEVELOPMENT, V129, P3563
   Nimmagadda S, 2007, DEV DYNAM, V236, P1358, DOI 10.1002/dvdy.21134
   O'Rahilley RR, 1996, HUMAN EMBRYOLOGY TER
   OBERLENDER SA, 1994, DEVELOPMENT, V120, P177
   Ochi K, 2006, OSTEOARTHR CARTILAGE, V14, P30, DOI 10.1016/j.joca.2005.07.015
   Ohuchi H, 1997, DEVELOPMENT, V124, P2235
   Olson H, 2000, REGUL TOXICOL PHARM, V32, P56, DOI 10.1006/rtph.2000.1399
   ORIOLI IM, 1986, J MED GENET, V23, P328, DOI 10.1136/jmg.23.4.328
   Ornoy A, 1999, TERATOLOGY, V60, P376, DOI 10.1002/(SICI)1096-9926(199912)60:6<376::AID-TERA10>3.3.CO;2-H
   Ornoy A, 2009, REPROD TOXICOL, V28, P1, DOI 10.1016/j.reprotox.2009.02.014
   Outani H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077365
   Panman L, 2003, J ANAT, V202, P3, DOI 10.1046/j.1469-7580.2003.00138.x
   Papaconstantinou AD, 2003, BIRTH DEFECTS RES B, V68, P456, DOI 10.1002/bdrb.10044
   Paradis FH, 2015, TOXICOL SCI, V148, P220, DOI 10.1093/toxsci/kfv174
   PARDANAUD L, 1989, DEVELOPMENT, V105, P473
   Parman T, 1999, NAT MED, V5, P582
   PAULI RM, 1986, TERATOLOGY, V33, P273, DOI 10.1002/tera.1420330304
   Penaloza C, 2006, HISTOCHEM CELL BIOL, V126, P149, DOI 10.1007/s00418-006-0214-1
   Piddington R L, 1985, Prog Clin Biol Res, V171, P295
   PIERSMA AH, 1995, REPROD TOXICOL, V9, P275, DOI 10.1016/0890-6238(95)00009-Y
   Piersma AH, 2004, TOXICOL LETT, V149, P147, DOI 10.1016/j.toxlet.2003.12.029
   PIERSMA AH, 1993, TOXICOL IN VITRO, V7, P615, DOI 10.1016/0887-2333(93)90095-M
   Pitsillides AA, 2008, DEV DYNAM, V237, P2284, DOI 10.1002/dvdy.21654
   Pizette S, 2001, DEVELOPMENT, V128, P4463
   PRATT RM, 1985, P NATL ACAD SCI USA, V82, P5791, DOI 10.1073/pnas.82.17.5791
   PRATT RM, 1984, CURR TOP DEV BIOL, V19, P81, DOI 10.1016/S0070-2153(08)60396-8
   PRICE PA, 1982, P NATL ACAD SCI-BIOL, V79, P7734, DOI 10.1073/pnas.79.24.7734
   Prockop DJ, 2001, CYTOTHERAPY, V3, P393, DOI 10.1080/146532401753277229
   Provot S, 2007, J CELL BIOL, V177, P451, DOI 10.1083/jcb.200612023
   Pudliszewski M, 2005, INT J DEV BIOL, V49, P355, DOI 10.1387/ijdb.041956mp
   PULLARKAT RK, 1991, ALCOHOL CLIN EXP RES, V15, P565, DOI 10.1111/j.1530-0277.1991.tb00561.x
   Rahman I, 2004, BIOCHEM PHARMACOL, V68, P1255, DOI 10.1016/j.bcp.2004.05.042
   RANDALL CL, 1979, TERATOLOGY, V19, P305, DOI 10.1002/tera.1420190305
   Reece EA, 2012, CURR DIABETES REP, V12, P24, DOI 10.1007/s11892-011-0251-6
   Rifas L, 1997, P NATL ACAD SCI USA, V94, P7549, DOI 10.1073/pnas.94.14.7549
   Rosano A, 2000, AM J MED GENET, V93, P110, DOI 10.1002/1096-8628(20000717)93:2<110::AID-AJMG6>3.0.CO;2-9
   ROSENQUIST GC, 1971, J EMBRYOL EXP MORPH, V25, P85
   Rynn L., 2008, Morbidity and Mortality Weekly Report, V57, P1
   Sadeque AJM, 1997, J PHARMACOL EXP THER, V283, P698
   Sadler TW, 1994, DEV TOXICOLOGY, P53
   Saito D, 2002, DEVELOPMENT, V129, P211
   SANDERS DD, 1991, TERATOLOGY, V44, P335, DOI 10.1002/tera.1420440310
   Sauer H, 2000, AM J PATHOL, V156, P151, DOI 10.1016/S0002-9440(10)64714-1
   SAUNDERS JW, 1974, DEV BIOL, V38, P41, DOI 10.1016/0012-1606(74)90257-7
   SCHMID BP, 1983, TOXICOL APPL PHARM, V69, P326, DOI 10.1016/0041-008X(83)90256-9
   Schreiner CM, 2009, BIRTH DEFECTS RES A, V85, P588, DOI 10.1002/bdra.20577
   Scott WJ, 2005, REPROD TOXICOL, V19, P479, DOI 10.1016/j.reprotox.2004.11.013
   Selevan SG, 2000, ENVIRON HEALTH PERSP, V108, P451, DOI 10.2307/3454536
   SHESKIN J, 1965, CLIN PHARMACOL THER, V6, P303
   Shukunami C, 1999, FEBS LETT, V456, P165, DOI 10.1016/S0014-5793(99)00931-X
   Singhal S, 1999, NEW ENGL J MED, V341, P1565, DOI 10.1056/NEJM199911183412102
   Sitruk-Ware R, 1998, LANCET, V352, P323, DOI 10.1016/S0140-6736(05)60300-5
   Smith CA, 1995, TERATOLOGY, V52, P333, DOI 10.1002/tera.1420520604
   Solomon BD, 2013, MOL SYNDROMOL, V4, P27, DOI 10.1159/000345406
   Solomon Lauren A., 2008, Birth Defects Research, V84, P123, DOI 10.1002/bdrc.20124
   Sosic D, 1997, DEV BIOL, V185, P229, DOI 10.1006/dbio.1997.8561
   Spielmann H, 2002, ATLA-ALTERN LAB ANIM, V30, P33, DOI 10.1177/026119290203002S05
   St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072
   Stankiewicz P, 2009, AM J HUM GENET, V84, P780, DOI 10.1016/j.ajhg.2009.05.005
   Stephens TD, 2000, TERATOLOGY, V61, P189, DOI 10.1002/(SICI)1096-9926(200003)61:3<189::AID-TERA6>3.0.CO;2-W
   STEPHENS TD, 1988, TERATOLOGY, V38, P229, DOI 10.1002/tera.1420380307
   Stevenson RE, 2013, MOL SYNDROMOL, V4, P7, DOI 10.1159/000346192
   STEVENSON RE, 1986, PEDIATRICS, V78, P451
   Storm EE, 1999, DEV BIOL, V209, P11, DOI 10.1006/dbio.1999.9241
   STORM EE, 1994, NATURE, V368, P639, DOI 10.1038/368639a0
   Sugimura Y, 2009, DIABETOLOGIA, V52, P962, DOI 10.1007/s00125-009-1312-0
   Sulik KK, 1997, HDB DEV TOXICOLOGY, P43
   Suter-Dick L, 2015, STEM CELLS DEV, V24, P1284, DOI 10.1089/scd.2014.0540
   Sutherland ML, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt361
   Svineng G, 2008, CONNECT TISSUE RES, V49, P197, DOI 10.1080/03008200802143166
   Szeto DP, 1999, GENE DEV, V13, P484, DOI 10.1101/gad.13.4.484
   Szumska D, 2008, GENE DEV, V22, P1465, DOI 10.1101/gad.479408
   Tabin CJ, 1998, NATURE, V396, P322, DOI 10.1038/24516
   Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019
   Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024
   Thackray H, 2001, Pediatr Rev, V22, P47, DOI 10.1542/pir.22-2-47
   Therapontos C, 2009, P NATL ACAD SCI USA, V106, P8573, DOI 10.1073/pnas.0901505106
   THERY C, 1995, DEV GENET, V17, P90
   Thevenod F, 2009, TOXICOL APPL PHARM, V238, P221, DOI 10.1016/j.taap.2009.01.013
   Thompson J, 2005, REPROD TOXICOL, V20, P539, DOI 10.1016/j.reprotox.2005.04.016
   Thompson J, 2008, REPROD TOXICOL, V25, P304, DOI 10.1016/j.reprotox.2008.02.001
   Tiboni GM, 2003, PEDIATR RES, V54, P69, DOI 10.1203/01.PDR.0000069840.78984.76
   Tickle C, 2015, J ANAT, V227, P418, DOI 10.1111/joa.12361
   TITTLE TV, 1992, LIFE SCI, V50, pPL79, DOI 10.1016/0024-3205(92)90104-W
   Tonegawa A, 1998, DEV BIOL, V202, P172, DOI 10.1006/dbio.1998.8895
   TROSKO JE, 1982, TERATOGEN CARCIN MUT, V2, P31, DOI 10.1002/1520-6866(1990)2:1<31::AID-TCM1770020105>3.0.CO;2-2
   Tung EWY, 2011, MOL PHARMACOL, V80, P979, DOI 10.1124/mol.111.072314
   Vargesson N, 2015, BIRTH DEFECTS RES C, V105, P140, DOI 10.1002/bdrc.21096
   WARKANY J, 1976, TERATOLOGY, V14, P205, DOI 10.1002/tera.1420140211
   Warren S, 2000, TOXICOLOGY, V142, P119, DOI 10.1016/S0300-483X(99)00132-8
   Webb Ellen, 2014, Reviews on Environmental Health, V29, P307, DOI 10.1515/reveh-2014-0057
   Webster William S., 2007, Birth Defects Research, V81, P215, DOI 10.1002/bdrc.20102
   WEBSTER WS, 1983, TERATOLOGY, V27, P231, DOI 10.1002/tera.1420270211
   WEBSTER WS, 1980, TERATOLOGY, V21, P79, DOI 10.1002/tera.1420210110
   Wei YY, 2012, EUR CELLS MATER, V23, P1
   Weinhold B, 2009, ENVIRON HEALTH PERSP, V117, pA440, DOI 10.1289/ehp.117-a440
   Wells Peter G, 2005, Toxicol Appl Pharmacol, V207, P354, DOI 10.1016/j.taap.2005.01.061
   Wells PG, 2009, TOXICOL SCI, V108, P4, DOI 10.1093/toxsci/kfn263
   Wester U, 2002, PRENATAL DIAG, V22, P663, DOI 10.1002/pd.352
   White DG, 2003, DIFFERENTIATION, V71, P251, DOI 10.1046/j.1432-0436.2003.7104502.x
   WILEY MJ, 1983, TERATOLOGY, V28, P341, DOI 10.1002/tera.1420280306
   Wilffert B, 2011, PHARMACOGENOMICS, V12, P547, DOI [10.2217/pgs.10.201, 10.2217/PGS.10.201]
   Williams DR, 2005, BIOCHEM BIOPH RES CO, V334, P960, DOI 10.1016/j.bbrc.2005.06.189
   WILSON JG, 1977, HDB TERATOLOGY, V1, P47
   Winberg J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085313
   Wu WS, 2008, CANCER METAST REV, V27, P303, DOI 10.1007/s10555-008-9112-4
   Xu B, 2011, P NATL ACAD SCI USA, V108, P4888, DOI 10.1073/pnas.1018161108
   Xu B, 2013, P NATL ACAD SCI USA, V110, P17480, DOI 10.1073/pnas.1312022110
   Yin M, 2001, DEV DYNAM, V222, P522, DOI 10.1002/dvdy.1212
   Yin M, 2002, J BONE MINER RES, V17, P56, DOI 10.1359/jbmr.2002.17.1.56
   Yvernogeau L, 2012, DEVELOPMENT, V139, P277, DOI 10.1242/dev.067678
   Zachman RD, 1998, ALCOHOL CLIN EXP RES, V22, P1544, DOI 10.1097/00000374-199810000-00026
   Zachman RD, 2001, BIOL NEONATE, V80, P152, DOI 10.1159/000047135
   Zakeri ZF, 1997, MUTAT RES-FUND MOL M, V396, P149, DOI 10.1016/S0027-5107(97)00181-4
   Zeller R, 2009, NAT REV GENET, V10, P845, DOI 10.1038/nrg2681
   Zhang K, 2012, CELL ADHES MIGR, V6, P20, DOI 10.4161/cam.18702
   Zhao XL, 2009, CURR BIOL, V19, P1050, DOI 10.1016/j.cub.2009.04.059
   Zhao ZY, 2012, REPROD SCI, V19, P823, DOI 10.1177/1933719111434543
   ZIMMERMAN EF, 1990, TERATOLOGY, V41, P453, DOI 10.1002/tera.1420410410
   Zuzarte-Luis V, 2005, SEMIN CELL DEV BIOL, V16, P261, DOI 10.1016/j.semcdb.2004.12.004
NR 343
TC 5
Z9 5
U1 0
U2 23
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1542-975X
EI 1542-9768
J9 BIRTH DEFECTS RES C
JI Birth Defects Res. Part C-Embryo Today-Rev.
PD SEP
PY 2016
VL 108
IS 3
BP 243
EP 273
DI 10.1002/bdrc.21140
PG 31
WC Developmental Biology; Reproductive Biology
SC Developmental Biology; Reproductive Biology
GA EA9EA
UT WOS:000386942800004
PM 27768243
DA 2019-10-23
ER

PT J
AU Rubitski, EE
   Cheung, JR
   Spellman, RA
   Engel, ME
   Schuler, M
AF Rubitski, E. E.
   Cheung, J. R.
   Spellman, R. A.
   Engel, M. E.
   Schuler, M.
TI Practical Aspects of High Content Imaging and Mechanistic Biomarkers in
   the Pharmaceutical Industry.
SO ENVIRONMENTAL AND MOLECULAR MUTAGENESIS
LA English
DT Meeting Abstract
CT 47th Annual Meeting of the
   Environmental-Mutagenesis-and-Genomics-Society
CY SEP 24-28, 2016
CL Kansas City, MO
SP Environm Mutagenesis & Genom Soc
C1 [Rubitski, E. E.; Cheung, J. R.; Spellman, R. A.; Engel, M. E.; Schuler, M.] Pfizer Inc, Groton, CT 06340 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0893-6692
EI 1098-2280
J9 ENVIRON MOL MUTAGEN
JI Environ. Mol. Mutagen.
PD SEP
PY 2016
VL 57
SU 1
MA S35
BP S48
EP S48
PG 1
WC Environmental Sciences; Genetics & Heredity; Toxicology
SC Environmental Sciences & Ecology; Genetics & Heredity; Toxicology
GA DW4BQ
UT WOS:000383587400042
DA 2019-10-23
ER

PT J
AU Martyniuk, CJ
   Simmons, DB
AF Martyniuk, Christopher J.
   Simmons, Denina B.
TI Spotlight on environmental omics and toxicology: a long way in a short
   time
SO COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY D-GENOMICS & PROTEOMICS
LA English
DT Editorial Material
ID VARIABILITY; EXPRESSION
AB The applications for high throughput omics technologies in environmental science have increased dramatically in recent years. Transcriptomics, proteomics, and metabolomics have been used to study how chemicals in our environment affect both aquatic and terrestrial organisms, and the characterization of molecular initiating events is a significant goal in toxicology to better predict adverse responses to toxicants. This special journal edition demonstrates the scope of the science that leverages omics-based methods in both laboratory and wild populations within the context of environmental toxicology, ranging from fish to mammals. It is important to recognize that the environment comprises one axis of the One Health concept - the idea that human health is unequivocally intertwined to our environment and to the organisms that inhabit that environment. We have much to learn from a comparative approach, and studies that integrate the transcriptome, proteome, and the metabolome are expected to offer the most detailed mechanism-based adverse outcome pathways that are applicable for use in both environmental monitoring and risk assessment. (C) 2016 Elsevier Inc. All rights reserved.
C1 [Martyniuk, Christopher J.] Univ Florida, Genet Inst, Dept Physiol Sci, Gainesville, FL 32611 USA.
   [Martyniuk, Christopher J.] Univ Florida, Genet Inst, Ctr Environm & Human Toxicol, Gainesville, FL 32611 USA.
   [Simmons, Denina B.] Environm & Climate Change Canada, Water Sci & Technol, Burlington, ON, Canada.
RP Martyniuk, CJ (reprint author), Univ Florida, Genet Inst, Dept Physiol Sci, Gainesville, FL 32611 USA.; Martyniuk, CJ (reprint author), Univ Florida, Genet Inst, Ctr Environm & Human Toxicol, Gainesville, FL 32611 USA.
EM cmartyn@ufl.edu
OI Simmons, Denina/0000-0002-9472-7192
CR Armengaud J, 2014, J PROTEOMICS, V105, P5, DOI 10.1016/j.jprot.2014.01.007
   Bahamonde PA, 2016, ENVIRON TOXICOL CHEM, V35, P20, DOI 10.1002/etc.3218
   Collette TW, 2016, COMP BIOCHEM PHYS D, V19, P190, DOI 10.1016/j.cbd.2016.01.001
   Collette TW, 2010, ENVIRON SCI TECHNOL, V44, P6881, DOI 10.1021/es1011884
   Colli-Dula RC, 2016, COMP BIOCHEM PHYS D, V19, P129, DOI 10.1016/j.cbd.2016.02.001
   Dreier DA, 2016, COMP BIOCHEM PHYS D, V19, P151, DOI 10.1016/j.cbd.2016.05.005
   Ekman DR, 2012, ENVIRON SCI TECHNOL, V46, P9673, DOI 10.1021/es3014634
   Garayzar ABS, 2016, COMP BIOCHEM PHYS D, V19, P102, DOI 10.1016/j.cbd.2016.04.004
   Kovacevic V, 2016, COMP BIOCHEM PHYS D, V19, P199, DOI 10.1016/j.cbd.2016.01.004
   Larkin Patrick, 2003, Environmental Health Perspectives, V111, P29
   Liang XF, 2016, COMP BIOCHEM PHYS D, V19, P174, DOI 10.1016/j.cbd.2016.06.007
   Liu Q, 2013, AQUAT TOXICOL, V140, P356, DOI 10.1016/j.aquatox.2013.06.018
   Martyniuk CJ, 2016, COMP BIOCHEM PHYS D, V19, P140, DOI 10.1016/j.cbd.2016.06.003
   Martyniuk CJ, 2013, COMP BIOCHEM PHYS D, V8, P283, DOI 10.1016/j.cbd.2013.08.002
   Nuwaysir EF, 1999, MOL CARCINOGEN, V24, P153, DOI 10.1002/(SICI)1098-2744(199903)24:3<153::AID-MC1>3.0.CO;2-P
   Osachoff HL, 2016, COMP BIOCHEM PHYS D, V19, P112, DOI 10.1016/j.cbd.2016.02.002
   Poynton HC, 2007, ENVIRON SCI TECHNOL, V41, P1044, DOI 10.1021/es0615573
   Reo NV, 2002, DRUG CHEM TOXICOL, V25, P375, DOI 10.1081/DCT-120014789
   Rise ML, 2004, GENOME RES, V14, P478, DOI 10.1101/gr.1687304
   Shepard JL, 2000, MAR ENVIRON RES, V50, P337, DOI 10.1016/S0141-1136(00)00065-9
   Simmons DBD, 2016, COMP BIOCHEM PHYS D, V19, P181, DOI 10.1016/j.cbd.2016.03.003
   Simmons DBD, 2015, ENVIRON TOXICOL CHEM, V34, P1693, DOI 10.1002/etc.3002
   Smith LC, 2016, COMP BIOCHEM PHYS D, V19, P159, DOI 10.1016/j.cbd.2016.04.003
   Vidal-Dorsch DE, 2016, CHEMOSPHERE, V144, P193, DOI 10.1016/j.chemosphere.2015.08.019
   Wang RL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114178
   Wang ZJ, 2016, COMP BIOCHEM PHYS D, V19, P120, DOI 10.1016/j.cbd.2016.05.003
NR 26
TC 10
Z9 10
U1 2
U2 39
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1744-117X
EI 1878-0407
J9 COMP BIOCHEM PHYS D
JI Comp. Biochem. Physiol. D-Genomics Proteomics
PD SEP
PY 2016
VL 19
BP 97
EP 101
DI 10.1016/j.cbd.2016.06.010
PG 5
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA DU7TA
UT WOS:000382416300011
PM 27398986
DA 2019-10-23
ER

PT J
AU Te, JA
   AbdulHameed, MDM
   Wallqvist, A
AF Te, Jerez A.
   AbdulHameed, Mohamed Diwan M.
   Wallqvist, Anders
TI Systems toxicology of chemically induced liver and kidney injuries:
   histopathology-associated gene co-expression modules
SO JOURNAL OF APPLIED TOXICOLOGY
LA English
DT Article
DE co-expression modules; toxicogenomics; systems toxicology;
   nephrotoxicity; hepatotoxicity; histopathology; adverse outcome pathways
ID DRUG DISCOVERY; FIBROSIS; TOXICOGENOMICS; RATS; ORGANIZATION;
   PHARMACOLOGY; MECHANISMS; EXPRESSION; BIOMARKERS; DATABASE
AB Organ injuries caused by environmental chemical exposures or use of pharmaceutical drugs pose a serious health risk that may be difficult to assess because of a lack of non-invasive diagnostic tests. Mapping chemical injuries to organ-specific histopathology outcomes via biomarkers will provide a foundation for designing precise and robust diagnostic tests. We identified co-expressed genes (modules) specific to injury endpoints using the Open Toxicogenomics Project-Genomics Assisted Toxicity Evaluation System (TG-GATEs) - a toxicogenomics database containing organ-specific gene expression data matched to dose- and time-dependent chemical exposures and adverse histopathology assessments in Sprague-Dawley rats. We proposed a protocol for selecting gene modules associated with chemical-induced injuries that classify 11 liver and eight kidney histopathology endpoints based on dose-dependent activation of the identified modules. We showed that the activation of the modules for a particular chemical exposure condition, i.e., chemical-time-dose combination, correlated with the severity of histopathological damage in a dose-dependent manner. Furthermore, the modules could distinguish different types of injuries caused by chemical exposures as well as determine whether the injury module activation was specific to the tissue of origin (liver and kidney). The generated modules provide a link between toxic chemical exposures, different molecular initiating events among underlying molecular pathways and resultant organ damage. Published 2016. This article is a U.S. Government work and is in the public domain in the USA. Journal of Applied Toxicology published by John Wiley & Sons, Ltd.
   We proposed a protocol for selecting gene co-expression modules associated with chemical-induced injuries that classify 11 liver and eight kidney histopathology endpoints based on dose-dependent activation of the identified modules. We showed that the activation of the modules for a particular chemical exposure correlated with the severity of histopathological damage and could distinguish different types of organ-specific injuries. The generated modules provide a link between toxic chemical exposures, different molecular initiating events among underlying molecular pathways, and resultant organ damage.
C1 [Te, Jerez A.; AbdulHameed, Mohamed Diwan M.; Wallqvist, Anders] US Army, Med Res & Mat Command, High Performance Comp Software Applicat Inst, Dept Def Biotechnol,Telemed & Adv Technol Res Ctr, Ft Detrick, MD 21702 USA.
RP Wallqvist, A (reprint author), ATTN MCMR TT, 504 Scott St, Ft Detrick, MD 21702 USA.
EM sven.a.wallqvist.civ@mail.mil
RI wallqvist, anders/W-2584-2019
OI wallqvist, anders/0000-0002-9775-7469
FU U.S. Army Medical Research and Materiel Command (Fort Detrick, MD) as
   part of the U.S. Army's Network Science Initiative; Defense Threat
   Reduction AgencyUnited States Department of DefenseDefense Threat
   Reduction Agency [CBCall14-CBS-05-2-0007]
FX The authors were supported by the U.S. Army Medical Research and
   Materiel Command (Fort Detrick, MD) as part of the U.S. Army's Network
   Science Initiative, and by the Defense Threat Reduction Agency grant
   CBCall14-CBS-05-2-0007. The opinions and assertions contained herein are
   the private views of the authors and are not to be construed as official
   or as reflecting the views of the U.S. Army or of the U.S. Department of
   Defense. This paper has been approved for public release with unlimited
   distribution.
CR AbdulHameed MDM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112193
   Adams LA, 2011, J GASTROEN HEPATOL, V26, P802, DOI 10.1111/j.1440-1746.2010.06612.x
   Bai JPF, 2013, ANNU REV PHARMACOL, V53, P451, DOI 10.1146/annurev-pharmtox-011112-140248
   Bergmann S, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.031902
   Blomme EAG, 2009, TOXICOL LETT, V186, P22, DOI 10.1016/j.toxlet.2008.09.017
   Bourgon R, 2010, P NATL ACAD SCI USA, V107, P9546, DOI 10.1073/pnas.0914005107
   Chobert MN, 2012, LAB INVEST, V92, P135, DOI 10.1038/labinvest.2011.143
   Davis AP, 2011, NUCLEIC ACIDS RES, V39, pD1067, DOI 10.1093/nar/gkq813
   DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409
   Dieterle F, 2010, NAT BIOTECHNOL, V28, P455, DOI 10.1038/nbt.1625
   FUKUSHIMA S, 1979, TOXICOL APPL PHARM, V48, P145, DOI 10.1016/S0041-008X(79)80017-4
   Ganter B, 2006, PHARMACOGENOMICS, V7, P1025, DOI 10.2217/14622416.7.7.1025
   Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80
   Gresham V, 2009, ADV DRUG DELIVER REV, V61, P369, DOI 10.1016/j.addr.2008.12.002
   Hussainzada N, 2014, BMC PHARMACOL TOXICO, V15, DOI 10.1186/2050-6511-15-15
   Igarashi Y, 2015, NUCLEIC ACIDS RES, V43, pD921, DOI 10.1093/nar/gku955
   Ihmels J, 2002, NAT GENET, V31, P370, DOI 10.1038/ng941
   Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249
   Iskar M, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.20
   Kauffmann Audrey, 2009, Bioinformatics, V25, P415, DOI 10.1093/bioinformatics/btn647
   Liedtke C, 2013, FIBROGENESIS TISSUE, V6, DOI 10.1186/1755-1536-6-19
   Madejczyk MS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127327
   Nakazato K, 2010, J GASTROEN HEPATOL, V25, P1692, DOI 10.1111/j.1440-1746.2009.06187.x
   Nasr SH, 2014, AM J KIDNEY DIS, V63, P148, DOI 10.1053/j.ajkd.2013.06.023
   Panagiotou G, 2012, SAR QSAR ENVIRON RES, V23, P221, DOI 10.1080/1062936X.2012.657237
   Parkes Julie, 2012, Comp Hepatol, V11, P5, DOI 10.1186/1476-5926-11-5
   Permenter MG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083751
   Powers D. M. W., 2011, J MACH LEARN TECHNOL, V2, P37, DOI DOI 10.9735/2229-3981
   Probert PME, 2014, TOXICOL RES-UK, V3, P98, DOI 10.1039/c3tx50069a
   Rinaldo A, 2005, GENET EPIDEMIOL, V28, P193, DOI 10.1002/gepi.20056
   Segal E, 2004, NAT GENET, V36, P1090, DOI 10.1038/ng1434
   Smalley JL, 2010, TOXICOLOGY, V268, P143, DOI 10.1016/j.tox.2009.09.014
   Speir RW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126622
   Sturla SJ, 2014, CHEM RES TOXICOL, V27, P314, DOI 10.1021/tx400410s
   Tawa GJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107230
   Vinken M, 2013, CURR MED CHEM, V20, P3011, DOI 10.2174/0929867311320240006
   Yuasa T, 2014, J TOXICOL PATHOL, V27, P97, DOI 10.1293/tox.2013-0048
NR 37
TC 7
Z9 7
U1 0
U2 15
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0260-437X
EI 1099-1263
J9 J APPL TOXICOL
JI J. Appl. Toxicol.
PD SEP
PY 2016
VL 36
IS 9
BP 1137
EP 1149
DI 10.1002/jat.3278
PG 13
WC Toxicology
SC Toxicology
GA DR5PD
UT WOS:000379954000007
PM 26725466
OA Green Published
DA 2019-10-23
ER

PT J
AU Strickland, J
   Zang, QD
   Kleinstreuer, N
   Paris, M
   Lehmann, DM
   Choksi, N
   Matheson, J
   Jacobs, A
   Lowit, A
   Allen, D
   Casey, W
AF Strickland, Judy
   Zang, Qingda
   Kleinstreuer, Nicole
   Paris, Michael
   Lehmann, David M.
   Choksi, Neepa
   Matheson, Joanna
   Jacobs, Abigail
   Lowit, Anna
   Allen, David
   Casey, Warren
TI Integrated decision strategies for skin sensitization hazard
SO JOURNAL OF APPLIED TOXICOLOGY
LA English
DT Article
DE skin sensitization; allergic contact dermatitis; integrated decision
   strategy; machine learning; LLNA; DPRA; KeratinoSens; h-CLAT; support
   vector machine
ID LYMPH-NODE ASSAY; LINE ACTIVATION TEST; TEST H-CLAT; PEPTIDE REACTIVITY
   ASSAY; PIG MAXIMIZATION TEST; RISK-ASSESSMENT MODEL; IN-VITRO METHODS;
   PREDICTIVE PERFORMANCE; CONTACT ALLERGENS; TESTING STRATEGY
AB One of the top priorities of the Interagency Coordinating Committee for the Validation of Alternative Methods (ICCVAM) is the identification and evaluation of non-animal alternatives for skin sensitization testing. Although skin sensitization is a complex process, the key biological events of the process have been well characterized in an adverse outcome pathway (AOP) proposed by the Organisation for Economic Co-operation and Development (OECD). Accordingly, ICCVAM is working to develop integrated decision strategies based on the AOP using in vitro, in chemico and in silico information. Data were compiled for 120 substances tested in the murine local lymph node assay (LLNA), direct peptide reactivity assay (DPRA), human cell line activation test (h-CLAT) and KeratinoSens assay. Data for six physicochemical properties, which may affect skin penetration, were also collected, and skin sensitization read-across predictions were performed using OECD QSAR Toolbox. All data were combined into a variety of potential integrated decision strategies to predict LLNA outcomes using a training set of 94 substances and an external test set of 26 substances. Fifty-four models were built using multiple combinations of machine learning approaches and predictor variables. The seven models with the highest accuracy (89-96% for the test set and 96-99% for the training set) for predicting LLNA outcomes used a support vector machine (SVM) approach with different combinations of predictor variables. The performance statistics of the SVM models were higher than any of the non-animal tests alone and higher than simple test battery approaches using these methods. These data suggest that computational approaches are promising tools to effectively integrate data sources to identify potential skin sensitizers without animal testing. Published 2016. This article has been contributed to by US Government employees and their work is in the public domain in the USA.
   The Interagency Coordinating Committee for the Validation of Alternative Methods (ICCVAM) evaluated a non-animal decision strategies to predict skin sensitization. Machine learning approaches integrated in vitro, in chemico and in silico data and six physicochemical properties for 120 substances to predict murine local lymph node assay (LLNA) outcomes. The seven models with the highest accuracy used a support vector machine with different combinations of predictor variables. The models outperformed individual non-animal methods and test batteries. This suggests that computational approaches are promising tools to effectively integrate data to identify potential skin sensitizers without animal testing.
C1 [Strickland, Judy; Zang, Qingda; Kleinstreuer, Nicole; Paris, Michael; Choksi, Neepa; Allen, David] ILS, Res Triangle Pk, NC 27709 USA.
   [Lehmann, David M.] US EPA, NHEERL, EPHD, CIB, Res Triangle Pk, NC 27709 USA.
   [Matheson, Joanna] US Consumer Prod Safety Commiss, Bethesda, MD 20814 USA.
   [Jacobs, Abigail] US FDA, CDER, Silver Spring, MD 20993 USA.
   [Lowit, Anna] US EPA, OCSPP, OPP, HED, Washington, DC 20460 USA.
   [Casey, Warren] NIEHS, NIH, DNTP, NICEATM, Res Triangle Pk, NC 27709 USA.
RP Casey, W (reprint author), NIEHS, NIH, DNTP, NICEATM, POB 12233, Res Triangle Pk, NC 27709 USA.
EM warren.casey@nih.gov
RI Kleinstreuer, Nicole/F-7203-2019
OI Kleinstreuer, Nicole/0000-0002-7914-3682
FU federal funds from the NIEHS, NIH of NICEATM [HHSN273201500010C]
FX The authors thank Drs D. Germolec, B.A. Merrick, R. Luebke and M. Ward
   for their thoughtful critical review of this manuscript. This project
   was funded in whole or in part with federal funds from the NIEHS, NIH
   under contract HHSN273201500010C to ILS in support of NICEATM.
CR AltTox, 2014, TOX ENDP TESTS SKIN
   Anderson Stacey E, 2011, J Allergy (Cairo), V2011, P424203, DOI 10.1155/2011/424203
   Angers-Loustau A, 2011, REGUL TOXICOL PHARM, V60, P300, DOI 10.1016/j.yrtph.2011.04.006
   Ashikaga T, 2006, TOXICOL IN VITRO, V20, P767, DOI 10.1016/j.tiv.2005.10.012
   Ashikaga T, 2010, ATLA-ALTERN LAB ANIM, V38, P275, DOI 10.1177/026119291003800403
   Ball N, 2011, REGUL TOXICOL PHARM, V60, P389, DOI 10.1016/j.yrtph.2011.05.007
   Basketter DA, 1996, FOOD CHEM TOXICOL, V34, P985, DOI 10.1016/S0278-6915(96)00059-2
   Basketter DA, 2006, CONTACT DERMATITIS, V55, P178, DOI 10.1111/j.1600-0536.2006.00906.x
   Bauch C, 2012, REGUL TOXICOL PHARM, V63, P489, DOI 10.1016/j.yrtph.2012.05.013
   Bauch C, 2011, TOXICOL IN VITRO, V25, P1162, DOI 10.1016/j.tiv.2011.05.030
   Birnbaum LS, 2013, ENVIRON HEALTH PERSP, V121, pA40, DOI 10.1289/ehp.1206292
   Bruckner AL, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.1.e3
   *EC, 2003, OFFICIAL J EUROPEA L, V66, P26
   Emter R, 2010, TOXICOL APPL PHARM, V245, P281, DOI 10.1016/j.taap.2010.03.009
   Estrada E, 2003, CHEM RES TOXICOL, V16, P1226, DOI 10.1021/tx034093k
   European Chemicals Agency (ECHA), 2015, GUID INF REQ CHEM SA
   Gerberick GF, 2007, TOXICOL SCI, V97, P417, DOI 10.1093/toxsci/kfm064
   Gerberick GF, 2009, TOXICOL SCI, V112, P164, DOI 10.1093/toxsci/kfp192
   Gerberick GF, 2005, DERMATITIS, V16, P157, DOI 10.2310/6620.2005.05040
   Gerberick GF, 2004, TOXICOL SCI, V81, P332, DOI 10.1093/toxsci/kfh213
   Guyard-Nicodeme M, 2015, J APPL TOXICOL, V35, P48, DOI 10.1002/jat.2986
   Hirota M, 2015, J APPL TOXICOL, V35, P1333, DOI 10.1002/jat.3105
   Jaworska J, 2013, J APPL TOXICOL, V33, P1353, DOI 10.1002/jat.2869
   Jaworska J, 2011, ALTEX-ALTERN ANIM EX, V28, P211, DOI 10.14573/altex.2011.3.211
   Joint Research Centre of the European Union, 2014, EURL ECVAM REC KERAT
   Joint Research Centre of the European Union, 2015, EURL ECVAM REC HUM C
   Joint Research Centre of the European Union, 2013, EURL ECVAM REC DIR P
   Kern PS, 2010, DERMATITIS, V21, P8, DOI 10.2310/6620.2009.09038
   Kimber I, 2011, TOXICOL SCI, V120, pS238, DOI 10.1093/toxsci/kfq346
   Kreiling R, 2008, FOOD CHEM TOXICOL, V46, P1896, DOI 10.1016/j.fct.2008.01.019
   Kuhn M, 2013, APPL PREDICTIVE MODE
   Luechtefeld T, 2015, J APPL TOXICOL, V35, P1361, DOI 10.1002/jat.3172
   MacKay C, 2013, ALTEX-ALTERN ANIM EX, V30, P473, DOI 10.14573/altex.2013.4.473
   Mehling A, 2012, ARCH TOXICOL, V86, P1273, DOI 10.1007/s00204-012-0867-6
   Montelius J, 1998, ACTA DERM-VENEREOL, V78, P433
   Murphy Kenneth, 2012, JANEWAYS IMMUNOBIOLO
   Natsch A, 2008, TOXICOL SCI, V102, P110, DOI 10.1093/toxsci/kfm259
   Natsch A, 2014, ISSUES TOXICOL, V19, P265
   Natsch A, 2013, TOXICOL SCI, V135, P356, DOI 10.1093/toxsci/kft160
   Natsch A, 2013, J APPL TOXICOL, V33, P1337, DOI 10.1002/jat.2868
   Natsch A, 2009, TOXICOL SCI, V107, P106, DOI 10.1093/toxsci/kfn204
   NIEHS, 2013, FED REGISTER, V78, P68076
   Nukada Y, 2013, TOXICOL IN VITRO, V27, P609, DOI 10.1016/j.tiv.2012.11.006
   Nukada Y, 2012, TOXICOL IN VITRO, V26, P1150, DOI 10.1016/j.tiv.2012.07.001
   Nukada Y, 2011, CONTACT DERMATITIS, V65, P343, DOI 10.1111/j.1600-0536.2011.01952.x
   OECD, 2014, OECD QSAR TOOLB
   OECD, 2010, TEST 429 SKIN SENS L
   OECD, 2009, OECD SER TEST ASS, V102
   OECD, 2015, TEST 442D IN VITR SK
   OECD, 2012, OECD SER TEST ASS 2, V168
   OECD, 2015, DRAFT PROP NEW TEST
   OECD, 2015, TEST 442C CHEM SKIN
   Patlewicz G, 2014, REGUL TOXICOL PHARM, V69, P529, DOI 10.1016/j.yrtph.2014.06.001
   Pirone JR, 2014, ALTEX-ALTERN ANIM EX, V31, P336, DOI http://dx.doi.org/10.14573/altex.1310151
   R Core Team, 2013, R LANG ENV STAT COMP
   Reisinger K, 2015, TOXICOL IN VITRO, V29, P259, DOI 10.1016/j.tiv.2014.10.018
   Roberts DW, 2008, J APPL TOXICOL, V28, P377, DOI 10.1002/jat.1289
   Rovida C, 2015, ALTEX-ALTERN ANIM EX, V32, P25, DOI [http://dx.doi.org/10.14573/altex.1411011, 10.14573/altex.1506201]
   Russell W. M. S., 1959, PRINCIPLES HUMANE EX
   Sailstad DM, 2001, REGUL TOXICOL PHARM, V34, P249, DOI 10.1006/rtph.2001.1496
   Sakaguchi H, 2010, TOXICOL IN VITRO, V24, P1810, DOI 10.1016/j.tiv.2010.05.012
   Schmidt M, 2015, J DTSCH DERMATOL GES, V13, P653, DOI 10.1111/ddg.12673
   Schoeters G, 2010, J TOXICOL ENV HEAL B, V13, P232, DOI 10.1080/10937404.2010.483938
   SMITH CK, 2001, ALLERGIC CONTACT DER
   Takenouchi O, 2015, J APPL TOXICOL, V35, P1318, DOI 10.1002/jat.3127
   Takenouchi O, 2013, J TOXICOL SCI, V38, P599, DOI 10.2131/jts.38.599
   The European Parliament and the Council of the European Union, 2006, OFFICIAL J EUROPEA L, P1
   Thyssen JP, 2007, CONTACT DERMATITIS, V57, P287, DOI 10.1111/j.1600-0536.2007.01220.x
   Tsujita-Inoue K, 2014, TOXICOL IN VITRO, V28, P626, DOI 10.1016/j.tiv.2014.01.003
   UN, 2013, GLOB HARM SYS CLASS
   Urbisch D, 2015, REGUL TOXICOL PHARM, V71, P337, DOI 10.1016/j.yrtph.2014.12.008
   van der Veen JW, 2014, REGUL TOXICOL PHARM, V69, P371, DOI 10.1016/j.yrtph.2014.04.018
   van Och FMM, 2000, TOXICOLOGY, V146, P49, DOI 10.1016/S0300-483X(00)00165-7
   Vocanson M, 2006, INT ARCH ALLERGY IMM, V140, P231, DOI 10.1159/000093248
   Williams ES, 2009, CRIT REV TOXICOL, V39, P553, DOI 10.1080/10408440903036056
   Williams WC, 2015, J APPL TOXICOL, V35, P29, DOI 10.1002/jat.2983
   Yang CH, 2015, J CHEM INF MODEL, V55, P510, DOI 10.1021/ci500667v
NR 77
TC 36
Z9 38
U1 1
U2 32
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0260-437X
EI 1099-1263
J9 J APPL TOXICOL
JI J. Appl. Toxicol.
PD SEP
PY 2016
VL 36
IS 9
BP 1150
EP 1162
DI 10.1002/jat.3281
PG 13
WC Toxicology
SC Toxicology
GA DR5PD
UT WOS:000379954000008
PM 26851134
OA Green Accepted
DA 2019-10-23
ER

PT J
AU Morgan, MM
   Johnson, BP
   Livingston, MK
   Schuler, LA
   Alarid, ET
   Sung, KE
   Beebe, DJ
AF Morgan, Molly M.
   Johnson, Brian P.
   Livingston, Megan K.
   Schuler, Linda A.
   Alarid, Elaine T.
   Sung, Kyung E.
   Beebe, David J.
TI Personalized in vitro cancer models to predict therapeutic response:
   Challenges and a framework for improvement
SO PHARMACOLOGY & THERAPEUTICS
LA English
DT Review
DE Adverse outcome pathway; Chemotherapy sensitivity and resistance assays;
   Targeted therapy; Microenvironment; Personalized medicine
ID ESTROGEN-RECEPTOR-ALPHA; POSITIVE BREAST-CANCER; ENDOTHELIAL
   GROWTH-FACTOR; 3-DIMENSIONAL 3D CULTURE; EPITHELIAL OVARIAN-CANCER;
   DRUG-METABOLIZING-ENZYMES; ADVERSE OUTCOME PATHWAYS; MULTIPLE-MYELOMA
   CELLS; ENDOCRINE RESISTANCE; TUMOR MICROENVIRONMENT
AB Personalized cancer therapy focuses on characterizing the relevant phenotypes of the patient, as well as the patient's tumor, to predict the most effective cancer therapy. Historically, these methods have not proven predictive in regards to predicting therapeutic response. Emerging culture platforms are designed to better recapitulate the in vivo environment, thus, there is renewed interest in integrating patient samples into in vitro cancer models to assess therapeutic response. Successful examples of translating in vitro response to clinical relevance are limited due to issues with patient sample acquisition, variability and culture. We will review traditional and emerging in vitro models for personalized medicine, focusing on the technologies, microenvironmental components, and readouts utilized. We will then offer our perspective on how to apply a framework derived from toxicology and ecology towards designing improved personalized in vitro models of cancer. The framework serves as a tool for identifying optimal readouts and culture conditions, thus maximizing the information gained from each patient sample. (C) 2016 Published by Elsevier Inc.
C1 [Morgan, Molly M.; Johnson, Brian P.; Livingston, Megan K.; Sung, Kyung E.; Beebe, David J.] Univ Wisconsin, Biomed Engn, Madison, WI USA.
   [Schuler, Linda A.] Univ Wisconsin, Dept Comparat Biosci, 2015 Linden Dr W, Madison, WI 53706 USA.
   [Alarid, Elaine T.; Beebe, David J.] Univ Wisconsin, Dept Oncol, Madison, WI USA.
RP Sung, KE (reprint author), US FDA, Ctr Biol Evaluat & Res, Div Cellular & Gene Therapies, 10903 New Hampshire Ave,WO 52-72-3206, Silver Spring, MD 20993 USA.; Beebe, DJ (reprint author), 1111 Highland Ave,Room 6009, Madison, WI 53705 USA.
EM Kyung.Sung@fda.hhs.gov; djbeebe@wisc.edu
OI Alarid, Elaine/0000-0002-9426-7974
FU EPA grant [83573701]; University of Wisconsin Carbone Cancer Center [P30
   CA014520]; NIHUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [T32 CA157322,
   R01CA186134]; Movember Prostate Cancer Foundation Challenge Award
FX This review was supported by EPA grant number 83573701, University of
   Wisconsin Carbone Cancer Center, grant P30 CA014520, NIH T32 CA157322,
   NIH R01CA186134 and Movember Prostate Cancer Foundation Challenge Award.
CR Aboussekhra A, 2011, INT J DEV BIOL, V55, P841, DOI 10.1387/ijdb.113362aa
   ALBINI A, 1986, P NATL ACAD SCI USA, V83, P8182, DOI 10.1073/pnas.83.21.8182
   Allinen M, 2004, CANCER CELL, V6, P17, DOI 10.1016/j.ccr.2004.06.010
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Applanat MP, 2008, ADV EXP MED BIOL, V617, P437, DOI 10.1007/978-0-387-69080-3_42
   Bailey ST, 2012, P NATL ACAD SCI USA, V109, P18060, DOI 10.1073/pnas.1018858109
   Bartlett R, 2014, TRANSL ONCOL, V7, P657, DOI 10.1016/j.tranon.2014.10.006
   BERTELSEN CA, 1984, CANCER, V53, P1240, DOI 10.1002/1097-0142(19840315)53:6<1240::AID-CNCR2820530604>3.0.CO;2-Y
   Beverage JN, 2007, J PHARM SCI-US, V96, P2224, DOI 10.1002/jps.20892
   Bevilacqua G, 2010, VIRCHOWS ARCH, V456, P449, DOI 10.1007/s00428-010-0887-7
   Bhagwandin S, 2015, ANN SURG ONCOL, V22, P2573, DOI 10.1245/s10434-014-4330-1
   Bin Kim J, 2004, BREAST CANCER RES TR, V85, P281, DOI 10.1023/B:BREA.0000025418.88785.2b
   Birgersdotter A, 2005, SEMIN CANCER BIOL, V15, P405, DOI 10.1016/j.semcancer.2005.06.009
   Bischel LL, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1007-5
   Bischel LL, 2013, BIOMATERIALS, V34, P1471, DOI 10.1016/j.biomaterials.2012.11.005
   Bjornstrom L, 2005, MOL ENDOCRINOL, V19, P833, DOI 10.1210/me.2004-0486
   Blackwell KL, 2000, CLIN CANCER RES, V6, P4359
   Blevins-Primeau AS, 2009, CANCER RES, V69, P1892, DOI 10.1158/0008-5472.CAN-08-3708
   Bohrer LR, 2012, MOL CANCER RES, V10, P1294, DOI 10.1158/1541-7786.MCR-12-0275
   Bosch TM, 2006, CLIN PHARMACOKINET, V45, P253, DOI 10.2165/00003088-200645030-00003
   Boulder U. o. C., 2015, BIOTECHNOL BIOENG, V103, P655
   Bourdeau V, 2004, MOL ENDOCRINOL, V18, P1411, DOI 10.1210/me.2003-0441
   BRACKE ME, 1994, CANCER RES, V54, P4607
   Bulun SE, 2009, ANN NY ACAD SCI, V1155, P121, DOI 10.1111/j.1749-6632.2009.03705.x
   Burrell RA, 2013, NATURE, V501, P338, DOI 10.1038/nature12625
   Burstein HJ, 2011, J CLIN ONCOL, V29, P3328, DOI 10.1200/JCO.2011.36.0354
   Butterick TA, 2014, JOVE-J VIS EXP, DOI 10.3791/51305
   Caldon C. E., 2014, FRONT ONCOL, V4
   Calippe B, 2010, J IMMUNOL, V185, P1169, DOI 10.4049/jimmunol.0902383
   Calon A, 2015, NAT GENET, V47, P320, DOI 10.1038/ng.3225
   Campbell L, 2014, J INVEST DERMATOL, V134, P2447, DOI 10.1038/jid.2014.175
   Cavalieri E, 2000, J Natl Cancer Inst Monogr, P75
   Chang JC, 2003, LANCET, V362, P362, DOI 10.1016/S0140-6736(03)14023-8
   Chen L, 2012, BIOMATERIALS, V33, P1437, DOI 10.1016/j.biomaterials.2011.10.056
   Chin L, 2011, NAT MED, V17, P297, DOI 10.1038/nm.2323
   Chitcholtan K, 2013, EXP CELL RES, V319, P75, DOI 10.1016/j.yexcr.2012.09.012
   Ciocca DR, 1997, TRENDS ENDOCRIN MET, V8, P313, DOI 10.1016/S1043-2760(97)00122-7
   Clarke M, 1998, LANCET, V351, P1451
   Cree IA, 1997, TOXICOL IN VITRO, V11, P553, DOI 10.1016/S0887-2333(97)00060-X
   Cree IA, 2007, ANTI-CANCER DRUG, V18, P1093, DOI 10.1097/CAD.0b013e3281de727e
   Cree IA, 2010, CURR OPIN PHARMACOL, V10, P375, DOI 10.1016/j.coph.2010.05.001
   Cronin-Fenton DP, 2014, FUTURE ONCOL, V10, P107, DOI [10.2217/FON.13.168, 10.2217/fon.13.168]
   Dabrosin C, 2003, INT J CANCER, V107, P535, DOI 10.1002/ijc.11398
   Dabrosin C, 2003, BREAST CANCER RES TR, V78, P1, DOI 10.1023/A:1022133219353
   Dairkee SH, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-47
   Davies MA, 2010, ONCOGENE, V29, P5545, DOI 10.1038/onc.2010.323
   DEMIRPENCE E, 1993, J STEROID BIOCHEM, V46, P355, DOI 10.1016/0960-0760(93)90225-L
   Desoize B, 1998, ANTICANCER RES, V18, P4147
   Desta Z, 2004, J PHARMACOL EXP THER, V310, P1062, DOI 10.1124/jpet.104.065607
   Dias-Santagata D, 2010, EMBO MOL MED, V2, P146, DOI 10.1002/emmm.201000070
   Dirat B, 2011, CANCER RES, V71, P2455, DOI 10.1158/0008-5472.CAN-10-3323
   Doisneau-Sixou SF, 2003, ENDOCR-RELAT CANCER, V10, P179, DOI 10.1677/erc.0.0100179
   Edwards SW, 2016, J PHARMACOL EXP THER, V356, P170, DOI 10.1124/jpet.115.228239
   Ellis PA, 1997, INT J CANCER, V72, P608, DOI 10.1002/(SICI)1097-0215(19970807)72:4<608::AID-IJC10>3.0.CO;2-7
   Estes DA, 2007, BRIT J HAEMATOL, V139, P20, DOI 10.1111/j.1365-2141.2007.06763.x
   Felty Q, 2005, ONCOGENE, V24, P4883, DOI 10.1038/sj.onc.1208667
   Felty Quentin, 2005, J Carcinog, V4, P1, DOI 10.1186/1477-3163-4-1
   Ferrara N, 2004, NAT REV DRUG DISCOV, V3, P391, DOI 10.1038/nrd1381
   Ferriss J Stuart, 2010, Rev Obstet Gynecol, V3, P49
   Fisher B, 1998, J NATL CANCER I, V90, P1371, DOI 10.1093/jnci/90.18.1371
   Fruehauf JP, 2005, J CLIN ONCOL, V23, P3641, DOI 10.1200/JCO.2005.05.281
   Fruehauf JP, 2002, ENDOCR-RELAT CANCER, V9, P171, DOI 10.1677/erc.0.0090171
   Gajewski TF, 2013, NAT IMMUNOL, V14, P1014, DOI 10.1038/ni.2703
   Gallion H, 2006, INT J GYNECOL CANCER, V16, P194, DOI 10.1111/j.1525-1438.2006.00301.x
   Gao D, 2014, CELL, V159, P176, DOI 10.1016/j.cell.2014.08.016
   Gerets HHJ, 2009, TOXICOL IN VITRO, V23, P319, DOI 10.1016/j.tiv.2008.11.012
   Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205
   Ginsburg GS, 2001, TRENDS BIOTECHNOL, V19, P491, DOI 10.1016/S0167-7799(01)01814-5
   Gjerde J, 2008, ANN ONCOL, V19, P56, DOI 10.1093/annonc/mdm434
   Gottesman MM, 2002, ANNU REV MED, V53, P615, DOI 10.1146/annurev.med.53.082901.103929
   Gravendeel LAM, 2009, CANCER RES, V69, P9065, DOI 10.1158/0008-5472.CAN-09-2307
   Hall JM, 2001, J BIOL CHEM, V276, P36869, DOI 10.1074/jbc.R100029200
   Harris L, 2007, J CLIN ONCOL, V25, P5287, DOI 10.1200/JCO.2007.14.2364
   Haslam SZ, 2003, BREAST CANCER RES, V5, P208, DOI 10.1186/bcr615
   Hayashi SI, 2003, ENDOCR-RELAT CANCER, V10, P193, DOI 10.1677/erc.0.0100193
   Hayes EL, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0542-y
   HAYWARD SW, 1995, IN VITRO CELL DEV-AN, V31, P14
   Herzog TJ, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.01.059
   Hidalgo M, 2011, MOL CANCER THER, V10, P1311, DOI 10.1158/1535-7163.MCT-11-0233
   Higashiyama M, 2010, LUNG CANCER, V68, P472, DOI 10.1016/j.lungcan.2009.07.005
   Hirsch FR, 2008, J THORAC ONCOL, V3, P1468, DOI 10.1097/JTO.0b013e318189f551
   Hirschhaeuser F, 2010, J BIOTECHNOL, V148, P3, DOI 10.1016/j.jbiotec.2010.01.012
   Hoelder S, 2012, MOL ONCOL, V6, P155, DOI 10.1016/j.molonc.2012.02.004
   Hooper K., 2011, MULTIPLEXING CELL BA
   Hsiao AY, 2009, BIOMATERIALS, V30, P3020, DOI 10.1016/j.biomaterials.2009.02.047
   Hsieh CH, 2015, BIOMED RES INT, DOI 10.1155/2015/470283
   Huang L, 2015, NAT MED, V21, P1364, DOI 10.1038/nm.3973
   Improta-Brears T, 1999, P NATL ACAD SCI USA, V96, P4686, DOI 10.1073/pnas.96.8.4686
   Ioachim E, 2002, EUR J CANCER, V38, P2362, DOI 10.1016/S0959-8049(02)00210-1
   Iusuf D, 2011, J PHARMACOL EXP THER, V337, P710, DOI 10.1124/jpet.110.178301
   Ivshina AV, 2006, CANCER RES, V66, P10292, DOI 10.1158/0008-5472.CAN-05-4414
   Iyer L., 2002, Pharmacogenomics Journal, V2, P43, DOI 10.1038/sj.tpj.6500072
   Jeon JS, 2015, P NATL ACAD SCI USA, V112, P214, DOI 10.1073/pnas.1417115112
   Jimenez-Torres J. A., 2015, ADV HEALTHC MAT
   Johansson I, 2011, TOXICOL SCI, V120, P1, DOI 10.1093/toxsci/kfq374
   Joo WD, 2009, J GYNECOL ONCOL, V20, P96, DOI 10.3802/jgo.2009.20.2.96
   Justice BA, 2009, DRUG DISCOV TODAY, V14, P102, DOI 10.1016/j.drudis.2008.11.006
   Kenny PA, 2007, MOL ONCOL, V1, P84, DOI 10.1016/j.molonc.2007.02.004
   Khademhosseini A, 2006, P NATL ACAD SCI USA, V103, P2480, DOI 10.1073/pnas.0507681102
   Kim KL, 2005, AM J RESP CELL MOL, V33, P541, DOI 10.1165/rcmb.2004-0355OC
   Kiyotani K, 2012, DRUG METAB PHARMACOK, V27, P122, DOI 10.2133/dmpk.DMPK-11-RV-084
   Kondo J, 2011, P NATL ACAD SCI USA, V108, P6235, DOI 10.1073/pnas.1015938108
   Kuss JT, 1997, BREAST CANCER RES TR, V42, P265, DOI 10.1023/A:1005758127114
   Lazarus P, 2009, ANN NY ACAD SCI, V1155, P99, DOI 10.1111/j.1749-6632.2009.04114.x
   Lee AV, 1999, MOL ENDOCRINOL, V13, P787, DOI 10.1210/me.13.5.787
   Leonard RCF, 2009, BREAST, V18, P218, DOI 10.1016/j.breast.2009.05.004
   Lim JSL, 2011, BRIT J CLIN PHARMACO, V71, P737, DOI 10.1111/j.1365-2125.2011.03905.x
   Liotta L, 2000, NAT REV GENET, V1, P48, DOI 10.1038/35049567
   Loeb L A., 2003, MULTIPLE MUTATIONS C
   Loessner D, 2010, BIOMATERIALS, V31, P8494, DOI 10.1016/j.biomaterials.2010.07.064
   Longo DL, 2012, NEW ENGL J MED, V366, P956, DOI 10.1056/NEJMe1200656
   Lu P., 2012, EXTRACELLULAR MATRIX
   Majety M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127948
   Mao Y, 2013, CANCER METAST REV, V32, P303, DOI 10.1007/s10555-012-9415-3
   Marchese S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045767
   Marchionni Luigi, 2007, Evid Rep Technol Assess (Full Rep), P1
   Markovina S, 2008, MOL CANCER RES, V6, P1356, DOI 10.1158/1541-7786.MCR-08-0108
   Massarweh S, 2006, ENDOCR-RELAT CANCER, V13, pS15, DOI 10.1677/erc.1.01273
   Matsuo K, 2010, GYNECOL ONCOL, V116, P61, DOI 10.1016/j.ygyno.2009.09.018
   Matsuoka H, 2009, EXP CELL RES, V315, P2022, DOI 10.1016/j.yexcr.2009.04.009
   McAlpine JN, 2008, GYNECOL ONCOL, V110, P360, DOI 10.1016/j.ygyno.2008.05.019
   McCallum HM, 1996, BREAST CANCER RES TR, V39, P247, DOI 10.1007/BF01806153
   McDonnell DP, 2002, SCIENCE, V296, P1642, DOI 10.1126/science.1071884
   McNamara DA, 2001, EUR J SURG ONCOL, V27, P714, DOI 10.1053/ejso.2001.1177
   Mehta RS, 2001, BREAST CANCER RES TR, V66, P225, DOI 10.1023/A:1010604502627
   Mi ZB, 2008, ANTICANCER RES, V28, P1733
   Mitra A, 2013, TRENDS BIOTECHNOL, V31, P347, DOI 10.1016/j.tibtech.2013.03.006
   Mobley JA, 2004, CARCINOGENESIS, V25, P3, DOI 10.1093/carcin/bgg175
   Mor G, 1998, J STEROID BIOCHEM, V67, P403, DOI 10.1016/S0960-0760(98)00143-5
   MORALES DE, 1995, CIRCULATION, V91, P755, DOI 10.1161/01.CIR.91.3.755
   Musgrove EA, 2009, NAT REV CANCER, V9, P631, DOI 10.1038/nrc2713
   Mustata RC, 2013, CELL REP, V5, P421, DOI 10.1016/j.celrep.2013.09.005
   Normanno N, 2005, ENDOCR-RELAT CANCER, V12, P721, DOI 10.1677/erc.1.00857
   Novaro V, 2003, J CELL SCI, V116, P2975, DOI 10.1242/jcs.00523
   Nyga A, 2011, J CELL COMMUN SIGNAL, V5, P239, DOI 10.1007/s12079-011-0132-4
   O'Lone R, 2004, MOL ENDOCRINOL, V18, P1859, DOI 10.1210/me.2003-0044
   Obeid E, 2013, INT J ONCOL, V43, P5, DOI 10.3892/ijo.2013.1938
   OECD, 2013, US HDB SUPPL GUID DO
   OECD, 2012, PROP TEMPL GUID DEV
   Ogino S, 2012, EXPERT REV MOL DIAGN, V12, P621, DOI [10.1586/erm.12.46, 10.1586/ERM.12.46]
   Ong SM, 2010, BIOMATERIALS, V31, P1180, DOI 10.1016/j.biomaterials.2009.10.049
   Orlando L, 2010, CANCER TREAT REV, V36, pS67, DOI 10.1016/S0305-7372(10)70023-2
   Osborne CK, 2011, ANNU REV MED, V62, P233, DOI 10.1146/annurev-med-070909-182917
   Pak C, 2015, INTEGR BIOL-UK, V7, P643, DOI 10.1039/c5ib00071h
   Pampaloni F, 2007, NAT REV MOL CELL BIO, V8, P839, DOI 10.1038/nrm2236
   Pan TH, 2015, CANCER LETT, V365, P89, DOI 10.1016/j.canlet.2015.05.019
   Pao W, 2005, PLOS MED, V2, P57, DOI 10.1371/journal.pmed.0020017
   Paoletti C, 2015, CLIN CANCER RES, V21, P2487, DOI 10.1158/1078-0432.CCR-14-1913
   Pickl M, 2009, ONCOGENE, V28, P461, DOI 10.1038/onc.2008.394
   Place AE, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2912
   Platet N, 2004, CRIT REV ONCOL HEMAT, V51, P55, DOI 10.1016/j.critrevonc.2004.02.001
   Provenzano PP, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-11
   Provenzano PP, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-38
   Richard S., 2015, PLOS CURR, V7
   Roden DM, 2008, CLIN PHARMACOL THER, V84, P362, DOI 10.1038/clpt.2008.89
   Roop RP, 2012, FUTURE ONCOL, V8, P273, DOI [10.2217/FON.12.8, 10.2217/fon.12.8]
   Ruppen J, 2015, LAB CHIP, V15, P3076, DOI 10.1039/c5lc00454c
   Russo J, 2006, J STEROID BIOCHEM, V102, P89, DOI 10.1016/j.jsbmb.2006.09.004
   Sachs N, 2014, CURR OPIN GENET DEV, V24, P68, DOI 10.1016/j.gde.2013.11.012
   Sackmann EK, 2014, NATURE, V507, P181, DOI 10.1038/nature13118
   Sadlonova A, 2005, BREAST CANCER RES, V7, pR46, DOI 10.1186/bcr949
   Saji S, 2005, ONCOGENE, V24, P4531, DOI 10.1038/sj.onc.1208646
   SALMON SE, 1978, NEW ENGL J MED, V298, P1321, DOI 10.1056/NEJM197806152982401
   Samson DJ, 2004, J CLIN ONCOL, V22, P3618, DOI 10.1200/JCO.2004.04.077
   Santen RJ, 1997, J STEROID BIOCHEM, V61, P267
   Santini MT, 1999, INT J RADIAT BIOL, V75, P787, DOI 10.1080/095530099139845
   Sasai Y, 2012, DEVELOPMENT, V139, P4111, DOI 10.1242/dev.079590
   Sastre-Serra J., 2015, CELL PHYSIOL BIOCHEM, V29, P261
   Sastre-Serra J, 2012, INT J BIOCHEM CELL B, V44, P1901, DOI [10.1016/j.bioce1.2012.07.012, 10.1016/j.biocel.2012.07.012]
   Sastre-Serra J, 2010, FREE RADICAL BIO MED, V48, P506, DOI 10.1016/j.freeradbiomed.2009.11.025
   Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050
   Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935
   Sawyers C, 2004, NATURE, V432, P294, DOI 10.1038/nature03095
   Schrag D, 2004, J CLIN ONCOL, V22, P3631, DOI 10.1200/JCO.2004.05.065
   Sengupta K, 2003, INT J ONCOL, V22, P609
   Sequist LV, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002003
   SEVIN BU, 1988, GYNECOL ONCOL, V31, P191, DOI 10.1016/0090-8258(88)90293-4
   Shamir ER, 2014, NAT REV MOL CELL BIO, V15, P647, DOI 10.1038/nrm3873
   Shield K, 2009, GYNECOL ONCOL, V113, P143, DOI 10.1016/j.ygyno.2008.11.032
   Shou J, 2004, JNCI-J NATL CANCER I, V96, P926, DOI 10.1093/jnci/djh166
   Sikora K, 1999, ANN ONCOL, V10, P385, DOI 10.1023/A:1008367822016
   Simoncini T, 2004, STEROIDS, V69, P537, DOI 10.1016/j.steroids.2004.05.009
   Simpson ER, 2003, J STEROID BIOCHEM, V86, P225, DOI 10.1016/S0960-0760(03)00360-1
   Singer CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066573
   Soon PSH, 2013, ENDOCR-RELAT CANCER, V20, P1, DOI 10.1530/ERC-12-0227
   Sounni NE, 2013, CLIN CHEM, V59, P85, DOI 10.1373/clinchem.2012.185363
   Sung KE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076373
   Takebayashi K, 2013, CANCER CHEMOTH PHARM, V72, P217, DOI 10.1007/s00280-013-2189-7
   Tan JX, 2011, INT J DEV BIOL, V55, P851, DOI 10.1387/ijdb.113365jt
   Tan MHE, 2015, ACTA PHARMACOL SIN, V36, P3, DOI 10.1038/aps.2014.18
   Tan ME, 2014, ACTA PHARM SIN, V36, P3, DOI [10.1038/aps.2014.18, DOI 10.1038/APS.2014.18]
   THOMPSON EW, 1988, CANCER RES, V48, P6764
   Tomalik-Scharte D, 2008, PHARMACOGENOMICS J, V8, P4, DOI 10.1038/sj.tpj.6500462
   Tsimberidou A. -M., 2012, PERSONALIZED MED PHA
   TUXHORN JA, 2002, CLIN CANC RES, V8
   Ugurel S, 2006, CLIN CANCER RES, V12, P5454, DOI 10.1158/1078-0432.CCR-05-2763
   van de Wetering M, 2015, CELL, V161, P933, DOI 10.1016/j.cell.2015.03.053
   van 't Veer LJ, 2008, NATURE, V452, P564, DOI 10.1038/nature06915
   VANLANDEGHEM AAJ, 1985, CANCER RES, V45, P2900
   Vinken M, 2013, TOXICOLOGY, V312, P158, DOI 10.1016/j.tox.2013.08.011
   Wang TN, 2002, SURGERY, V132, P220, DOI 10.1067/msy.2002.125353
   WANG TTY, 1995, CANCER RES, V55, P2487
   Weaver VM, 1997, J CELL BIOL, V137, P231, DOI 10.1083/jcb.137.1.231
   WEBB P, 1995, MOL ENDOCRINOL, V9, P443, DOI 10.1210/me.9.4.443
   Weiswald LB, 2015, NEOPLASIA, V17, P1, DOI 10.1016/j.neo.2014.12.004
   Williams JA, 2000, CANCER RES, V60, P4667
   Wilmes A, 2013, J PROTEOMICS, V79, P180, DOI 10.1016/j.jprot.2012.11.022
   Wolf K, 2009, SEMIN CELL DEV BIOL, V20, P931, DOI 10.1016/j.semcdb.2009.08.005
   Wu B, 2008, WORLD J GASTROENTERO, V14, P3064, DOI 10.3748/wjg.14.3064
   Xu X, 2014, BIOTECHNOL ADV, V32, P1256, DOI 10.1016/j.biotechadv.2014.07.009
   Xu Y, 2008, ANN ONCOL, V19, P1423, DOI 10.1093/annonc/mdn155
   Xu ZY, 2013, BIOMATERIALS, V34, P4109, DOI 10.1016/j.biomaterials.2013.02.045
   Yager JD, 2006, NEW ENGL J MED, V354, P270, DOI 10.1056/NEJMra050776
   Yamada KM, 2007, CELL, V130, P601, DOI 10.1016/j.cell.2007.08.006
   Yamaguchi Yuri, 2007, Breast Cancer, V14, P175, DOI 10.2325/jbcs.975
   Yamamoto M, 2014, CANCER SCI, V105, P81, DOI 10.1111/cas.12302
   Yang J, 2000, ONCOL REP, V7, P17
   Young EWK, 2012, BLOOD, V119, pE76, DOI 10.1182/blood-2011-10-384347
   Young EWK, 2010, CHEM SOC REV, V39, P1036, DOI 10.1039/b909900j
   Zervantonakis IK, 2012, P NATL ACAD SCI USA, V109, P13515, DOI 10.1073/pnas.1210182109
   Zhang GJ, 1999, CLIN CANCER RES, V5, P2971
   Zhang XHF, 2013, CLIN CANCER RES, V19, P6389, DOI 10.1158/1078-0432.CCR-13-0838
   Zheng S., 2011, PLOS ONE, V6
   Zivadinovic D., 2004, BREAST CANC RES, V7
NR 224
TC 17
Z9 18
U1 5
U2 25
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0163-7258
J9 PHARMACOL THERAPEUT
JI Pharmacol. Ther.
PD SEP
PY 2016
VL 165
BP 79
EP 92
DI 10.1016/j.pharmthera.2016.05.007
PG 14
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA DW7GH
UT WOS:000383818700007
PM 27218886
OA Green Accepted
DA 2019-10-23
ER

PT J
AU Papamokos, G
   Silins, I
AF Papamokos, George
   Silins, Ilona
TI Combining QSAR Modeling and Text-Mining Techniques to Link Chemical
   Structures and Carcinogenic Modes of Action
SO FRONTIERS IN PHARMACOLOGY
LA English
DT Article
DE carcinogens; mode of action; text mining; QSAR; risk assessment;
   toxicity; prediction
ID ADVERSE OUTCOME PATHWAYS; CANCER; RISK; LEUKEMIA; INFORMATION;
   MECHANISMS; PESTICIDES; PREDICTION; RELEVANCE; FRAMEWORK
AB There is an increasing need for new reliable non-animal based methods to predict and test toxicity of chemicals. Quantitative structure-activity relationship (QSAR), a computer-based method linking chemical structures with biological activities, is used in predictive toxicology. In this study, we tested the approach to combine QSAR data with literature profiles of carcinogenic modes of action automatically generated by a text-mining tool. The aim was to generate data patterns to identify associations between chemical structures and biological mechanisms related to carcinogenesis. Using these two methods, individually and combined, we evaluated 96 rat carcinogens of the hematopoietic system, liver, lung, and skin. We found that skin and lung rat carcinogens were mainly mutagenic, while the group of carcinogens affecting the hematopoietic system and the liver also included a large proportion of non-mutagens. The automatic literature analysis showed that mutagenicity was a frequently reported endpoint in the literature of these carcinogens, however, less common endpoints such as immunosuppression and hormonal receptor-mediated effects were also found in connection with some of the carcinogens, results of potential importance for certain target organs. The combined approach, using QSAR and text-mining techniques, could be useful for identifying more detailed information on biological mechanisms and the relation with chemical structures. The method can be particularly useful in increasing the understanding of structure and activity relationships for non-mutagens.
C1 [Papamokos, George] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA.
   [Papamokos, George] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA.
   [Papamokos, George] Univ Ioannina, Dept Phys, Ioannina, Greece.
   [Papamokos, George] Fdn Res & Technol, Inst Mol Biol & Biotechnol, Biomed Res Div, Iraklion, Greece.
   [Silins, Ilona] Karolinska Inst, Inst Environm Med, Stockholm, Sweden.
RP Silins, I (reprint author), Karolinska Inst, Inst Environm Med, Stockholm, Sweden.
EM Ilona.Silins@ki.se
OI Papamokos, George/0000-0002-7671-2798
CR ADAMSON RH, 1981, ENVIRON HEALTH PERSP, V39, P93, DOI 10.2307/3429283
   Alam MS, 2016, TISSUE CELL, V48, P35, DOI 10.1016/j.tice.2015.12.001
   Ali I, 2016, TOXICOL LETT, V241, P32, DOI 10.1016/j.toxlet.2015.11.003
   ASHBY J, 1993, MUTAT RES, V286, P3, DOI 10.1016/0027-5107(93)90003-X
   Benigni R., 2008, 23241 EUR EUR COMM
   Benigni R, 2006, CURR COMPUT-AID DRUG, V2, P169, DOI 10.2174/157340906777441663
   Benigni R, 2014, EXPERT OPIN DRUG MET, V10, P1199, DOI 10.1517/17425255.2014.934670
   Benigni R, 2013, CHEM REV, V113, P2940, DOI 10.1021/cr300206t
   Benigni R, 2011, CHEM REV, V111, P2507, DOI 10.1021/cr100222q
   Boobis AR, 2008, CRIT REV TOXICOL, V38, P87, DOI 10.1080/10408440701749421
   Bugelski PJ, 2010, INT J TOXICOL, V29, P435, DOI 10.1177/1091581810374654
   Cherkasov A, 2014, J MED CHEM, V57, P4977, DOI 10.1021/jm4004285
   Christiani DC, 2011, NEW ENGL J MED, V364, P791, DOI 10.1056/NEJMp1006634
   Cohen AM, 2005, BRIEF BIOINFORM, V6, P57, DOI 10.1093/bib/6.1.57
   Combes RD, 2012, ADV EXP MED BIOL, V745, P96, DOI 10.1007/978-1-4614-3055-1_7
   Edwards SW, 2016, J PHARMACOL EXP THER, V356, P170, DOI 10.1124/jpet.115.228239
   Ferrari T, 2013, SAR QSAR ENVIRON RES, V24, P631, DOI 10.1080/1062936X.2013.773376
   Ferrari T, 2010, CHEM CENT J, V4, DOI 10.1186/1752-153X-4-S1-S2
   Fleuren WWM, 2015, METHODS, V74, P97, DOI 10.1016/j.ymeth.2015.01.015
   Frankish H, 2003, LANCET, V361, P1278, DOI 10.1016/S0140-6736(03)13038-3
   Gonzalez GH, 2016, BRIEF BIOINFORM, V17, P33, DOI 10.1093/bib/bbv087
   Graham MJ, 2008, TOXICOLOGY, V254, P184, DOI 10.1016/j.tox.2008.09.002
   Guo Y., 2014, P COLING 25 INT C CO
   HANSCH C, 1962, NATURE, V194, P178, DOI 10.1038/194178b0
   International Agency for Research on Cancer [IARC], 2015, LIST CLASS CANC SIT, V1
   Kadekar S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043209
   Kirchmair J, 2015, NAT REV DRUG DISCOV, V14, P387, DOI 10.1038/nrd4581
   Kleinstreuer NC, 2016, REGUL TOXICOL PHARM, V76, P39, DOI 10.1016/j.yrtph.2016.01.007
   Korhonen A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033427
   Korhonen A, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-303
   Landrigan PJ, 2011, ENVIRON HEALTH PERSP, V119, pA280, DOI 10.1289/ehp.1103871
   Laurier D, 2014, J RADIOL PROT, V34, pR53, DOI 10.1088/0952-4746/34/3/R53
   Leal AD, 2016, CANCER EPIDEM BIOMAR, V25, P151, DOI 10.1158/1055-9965.EPI-15-0613
   Lima BS, 2000, REGUL TOXICOL PHARM, V32, P135
   Luijten M, 2016, CRIT REV TOXICOL, V46, P615, DOI 10.3109/10408444.2016.1171294
   Ma YB, 2011, TOXICOLOGY, V282, P146, DOI 10.1016/j.tox.2011.01.024
   Mortelmans K, 2000, MUTAT RES-FUND MOL M, V455, P29, DOI 10.1016/S0027-5107(00)00064-6
   Pelkonen O, 2010, FRONT PHARMACOL, V1, DOI 10.3389/fphar.2010.00003
   Poynter JN, 2013, BRIT J CANCER, V109, P1895, DOI 10.1038/bjc.2013.507
   Silins I, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00145
   Sonich-Mullin C, 2001, REGUL TOXICOL PHARM, V34, P146, DOI 10.1006/rtph.2001.1493
   Traversa G, 1998, PHARMACOEPIDEM DR S, V7, P113, DOI 10.1002/(SICI)1099-1557(199803/04)7:2<113::AID-PDS329>3.0.CO;2-9
   Upson K, 2013, ENVIRON HEALTH PERSP, V121, P1319, DOI 10.1289/ehp.1306648
   *US EPA, 2005, GUID CARC RISK ASS
   Vinken M, 2013, TOXICOLOGY, V312, P158, DOI 10.1016/j.tox.2013.08.011
   WEININGER D, 1988, J CHEM INF COMP SCI, V28, P31, DOI 10.1021/ci00057a005
   Wu S, 2016, NATURE, V529, P43, DOI 10.1038/nature16166
   Zhu F, 2013, J BIOMED INFORM, V46, P200, DOI 10.1016/j.jbi.2012.10.007
   Zweigenbaum P, 2007, BRIEF BIOINFORM, V8, P358, DOI 10.1093/bib/bbm045
NR 49
TC 2
Z9 2
U1 0
U2 16
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015,
   SWITZERLAND
SN 1663-9812
J9 FRONT PHARMACOL
JI Front. Pharmacol.
PD AUG 30
PY 2016
VL 7
AR 284
DI 10.3389/fphar.2016.00284
PG 9
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA DU3KY
UT WOS:000382110500002
PM 27625608
OA DOAJ Gold, Green Published
DA 2019-10-23
ER

PT J
AU Huaux, F
   de Bousies, VD
   Parent, MA
   Orsi, M
   Uwambayinema, F
   Devosse, R
   Ibouraadaten, S
   Yakoub, Y
   Panin, N
   Palmai-Pallag, M
   van der Bruggen, P
   Bailly, C
   Marega, R
   Marbaix, E
   Lison, D
AF Huaux, Francois
   de Bousies, Virginie d'Ursel
   Parent, Marie-Astrid
   Orsi, Micaela
   Uwambayinema, Francine
   Devosse, Raynal
   Ibouraadaten, Saloua
   Yakoub, Yousof
   Panin, Nadtha
   Palmai-Pallag, Mihaly
   van der Bruggen, Pierre
   Bailly, Christian
   Marega, Riccardo
   Marbaix, Etienne
   Lison, Dominique
TI Mesothelioma response to carbon nanotubes is associated with an early
   and selective accumulation of immunosuppressive monocytic cells
SO PARTICLE AND FIBRE TOXICOLOGY
LA English
DT Article
DE Immunosuppression; Inflammation; Mesothelioma; Myeloid cells; Carbon
   nanotubes; Asbestos; Crocidolite; Fibers; Rats and mice
ID TUMOR-ASSOCIATED MACROPHAGES; RAT PERITONEAL-CAVITY; SUPPRESSOR-CELLS;
   MALIGNANT MESOTHELIOMA; PLEURAL MESOTHELIOMA; ABDOMINAL-CAVITY; T-CELLS;
   ASBESTOS; CANCER; MICROENVIRONMENT
AB Background: The asbestos-like toxicity of some engineered carbon nanotubes (CNT), notably their capacity to induce mesothelioma, is a serious cause of concern for public health. Here we show that carcinogenic CNT induce an early and sustained immunosuppressive response characterized by the accumulation of monocytic Myeloid Derived Suppressor Cells (M-MDSC) that counteract effective immune surveillance of tumor cells.
   Methods: Wistar rats and C57BL/6 mice were intraperitoneally injected with carcinogenic multi-walled Mitsui-7 CNT (CNT-7) or crocidolite asbestos. Peritoneal mesothelioma development and immune cell accumulation were assessed until 12 months. Leukocyte sub-populations were identified by recording expression of CD11b/c and His48 by flow cytometry. The immunosuppressive activity on T lymphocytes of purified peritoneal leukocytes was assessed in a co-culture assay with activated spleen cells.
   Results: We demonstrate that long and short mesotheliomagenic CNT-7 injected in the peritoneal cavity of rats induced, like asbestos, an early and selective accumulation of monocytic cells (CD11b/c(int) and His48(hi)) which possess the ability to suppress polyclonal activation of T lymphocytes and correspond to M-MDSC. Peritoneal M-MDSC persisted during the development of peritoneal mesothelioma in CNT-7-treated rats but were only transiently recruited after non-carcinogenic CNT (CNT-M, CNT-T) injection. Peritoneal M-MDSC did not accumulate in mice which are resistant to mesothelioma development.
   Conclusions: Our data provide new insights into the initial pathogenic events induced by CNT, adding a new component to the adverse outcome pathway leading to mesothelioma development. The specificity of the M-MDSC response after carcinogenic CNT exposure highlights the interest of this response for detecting the ability of new nanomaterials to cause cancer.
C1 [Huaux, Francois; de Bousies, Virginie d'Ursel; Parent, Marie-Astrid; Orsi, Micaela; Uwambayinema, Francine; Devosse, Raynal; Ibouraadaten, Saloua; Yakoub, Yousof; Panin, Nadtha; Palmai-Pallag, Mihaly; Lison, Dominique] Catholic Univ Louvain, IREC, Louvain Ctr Toxicol & Appl Pharmacol LTAP, Ave Mounier 53 Bte B1-52-12, B-1200 Brussels, Belgium.
   [van der Bruggen, Pierre] Catholic Univ Louvain, Ludwig Inst Canc Res, Brussels Branch, de Duve Inst, Brussels, Belgium.
   [Bailly, Christian] Catholic Univ Louvain, IMCN, Bio & Soft Matter BSMA, Louvain La Neuve, Belgium.
   [Marega, Riccardo] Univ Namur, Dept Chem, Namur, Belgium.
   [Marbaix, Etienne] Catholic Univ Louvain, de Duve Inst, Brussels, Belgium.
RP Huaux, F (reprint author), Catholic Univ Louvain, IREC, Louvain Ctr Toxicol & Appl Pharmacol LTAP, Ave Mounier 53 Bte B1-52-12, B-1200 Brussels, Belgium.
EM francois.huaux@uclouvain.be
OI Lison, Dominique/0000-0001-6557-2518
FU Fonds de la Recherche Scientifique Medicale (FRSM)Fonds de la Recherche
   Scientifique - FNRS; Actions de Recherche Concertees, Communaute
   francaise de Belgique, Direction de la Recherche Scientifique [ARC
   09/14-021]; Fondation Contre le Cancer; Fonds de la Recherche
   Scientifique (FNRS)Fonds de la Recherche Scientifique - FNRS [PDR
   T.0119.13 14633768]; European CommissionEuropean Commission Joint
   Research Centre [FP7-HEALTH-F4-2008, 202047]
FX This work was funded by the Fonds de la Recherche Scientifique Medicale
   (FRSM), by Actions de Recherche Concertees, Communaute francaise de
   Belgique, Direction de la Recherche Scientifique (ARC 09/14-021), by the
   Fondation Contre le Cancer, by the Fonds de la Recherche Scientifique
   (FNRS; Project PDR T.0119.13 14633768), by the European Commission under
   FP7-HEALTH-F4-2008 (Contract no. 202047). F.H. is a Research Associate
   with the FNRS, Belgium.
CR Arina A, 2015, CURR OPIN IMMUNOL, V33, P120, DOI 10.1016/j.coi.2015.02.006
   Burt BM, 2011, CANCER-AM CANCER SOC, V117, P5234, DOI 10.1002/cncr.26143
   Chew SH, 2015, FREE RADICAL BIO MED, V86, P166, DOI 10.1016/j.freeradbiomed.2015.05.002
   Crusz SM, 2015, NAT REV CLIN ONCOL, V12, P584, DOI 10.1038/nrclinonc.2015.105
   Cullen RT, 2002, INHAL TOXICOL, V14, P685, DOI 10.1080/08958370290084584
   Dolen Y, 2015, CELL IMMUNOL, V295, P29, DOI 10.1016/j.cellimm.2015.02.005
   Donaldson K, 2013, ADV DRUG DELIVER REV, V65, P2078, DOI 10.1016/j.addr.2013.07.014
   Fridlender ZG, 2010, MOL THER, V18, P1947, DOI 10.1038/mt.2010.159
   Grosse Y, 2014, LANCET ONCOL, V15, P1427, DOI 10.1016/S1470-2045(14)71109-X
   Hegmans JPJJ, 2006, EUR RESPIR J, V27, P1086, DOI 10.1183/09031936.06.00135305
   Hillegass JM, 2010, J TOXICOL ENV HEAL A, V73, P423, DOI 10.1080/15287390903486568
   Huaux F, 2015, J PATHOL, V235, P698, DOI 10.1002/path.4487
   Izzi V, 2012, CANCER LETT, V322, P18, DOI 10.1016/j.canlet.2012.02.034
   Jaurand MCF, 2009, PART FIBRE TOXICOL, V6, DOI 10.1186/1743-8977-6-16
   Joyce JA, 2015, SCIENCE, V348, P74, DOI 10.1126/science.aaa6204
   Kane AB, 2006, INHAL TOXICOL, V18, P1001, DOI 10.1080/08958370600835393
   Kohyama N, 1996, AM J IND MED, V30, P515, DOI 10.1002/(SICI)1097-0274(199611)30:5<515::AID-AJIM1>3.0.CO;2-S
   Lang DS, 2001, TOXICOLOGY, V159, P81, DOI 10.1016/S0300-483X(00)00415-7
   Marvel D, 2015, J CLIN INVEST, V125, P3356, DOI 10.1172/JCI80005
   Miller BG, 1999, ANN OCCUP HYG, V43, P155, DOI 10.1016/S0003-4878(99)00018-6
   Miselis NR, 2011, CANCER MICROENVIRON, V4, P39, DOI 10.1007/s12307-010-0048-1
   Muller J, 2008, CHEM RES TOXICOL, V21, P1698, DOI 10.1021/tx800101p
   Muller J, 2009, TOXICOL SCI, V110, P442, DOI 10.1093/toxsci/kfp100
   Nagai H, 2011, P NATL ACAD SCI USA, V108, pE1330, DOI 10.1073/pnas.1110013108
   Poland CA, 2008, NAT NANOTECHNOL, V3, P423, DOI 10.1038/nnano.2008.111
   POTT F, 1995, ANN OCCUP HYG, V39, P771, DOI 10.1016/0003-4878(95)00055-J
   Pott F, 1980, IARC Sci Publ, P337
   POTT F, 1994, ENVIRON HEALTH PERSP, V102, P145, DOI 10.2307/3432075
   Rabinovich GA, 2007, ANNU REV IMMUNOL, V25, P267, DOI 10.1146/annurev.immunol.25.022106.141609
   Rittinghausen S, 2014, PART FIBRE TOXICOL, V11, DOI 10.1186/s12989-014-0059-z
   Rudge G, 2007, J IMMUNOL, V178, P4089, DOI 10.4049/jimmunol.178.7.4089
   Shvedova AA, 2015, CANCER RES, V75, P1615, DOI 10.1158/0008-5472.CAN-14-2376
   Shvedova AA, 2013, SMALL, V9, P1691, DOI 10.1002/smll.201201470
   Talmadge JE, 2013, NAT REV CANCER, V13, P739, DOI 10.1038/nrc3581
   Thellung S, 2015, CURR DRUG TARGETS
   Turley SJ, 2015, NAT REV IMMUNOL, V15, P669, DOI 10.1038/nri3902
   Ugel S, 2015, J CLIN INVEST, V125, P3365, DOI 10.1172/JCI80006
   Vaslet CA, 2002, TOXICOL SCI, V68, P331, DOI 10.1093/toxsci/68.2.331
   Veltman JD, 2010, BRIT J CANCER, V103, P629, DOI 10.1038/sj.bjc.6605814
   Veltman JD, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-464
   Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862
   Wong RM, 2014, AM J RESP CELL MOL, V50, P870, DOI 10.1165/rcmb.2013-0472TR
   Xu JG, 2014, CANCER SCI, V105, P763, DOI 10.1111/cas.12437
   Yang YP, 2015, J CLIN INVEST, V125, P3335, DOI 10.1172/JCI83871
   Yu EQ, 2016, HISTOCHEM CELL BIOL, V145, P659, DOI 10.1007/s00418-016-1406-y
   Zhang C, 2012, INFECT IMMUN, V80, P3634, DOI 10.1128/IAI.00668-12
NR 46
TC 10
Z9 10
U1 0
U2 7
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1743-8977
J9 PART FIBRE TOXICOL
JI Part. Fibre Toxicol.
PD AUG 23
PY 2016
VL 13
AR 46
DI 10.1186/s12989-016-0158-0
PG 10
WC Toxicology
SC Toxicology
GA DT8MU
UT WOS:000381745700001
PM 27549627
OA DOAJ Gold, Green Published
DA 2019-10-23
ER

PT J
AU Thompson, R
AF Thompson, Richard
TI Risk assessing bioactivation: a pharmaceutical challenge
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
C1 [Thompson, Richard] AstraZeneca, DMPK, Resp Inflammat & Autoimmun iMed, Molndal, Sweden.
EM richard.thompson@astrazeneca.com
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD AUG 20
PY 2016
VL 252
MA 37
PG 1
WC Chemistry, Multidisciplinary
SC Chemistry
GA VC1TV
UT WOS:000431460404655
DA 2019-10-23
ER

PT J
AU Sarigiannis, DA
   Salifoglou, A
AF Sarigiannis, Dimosthenis A.
   Salifoglou, Athanasios
TI Research directives toward deciphering adverse outcome pathways induced
   by environmental metallotoxins Dimosthenis A Sarigiannis and Athanasios
   Salifoglou
SO CURRENT OPINION IN CHEMICAL ENGINEERING
LA English
DT Article
ID GENE-EXPRESSION; HEAVY-METALS; HEXAVALENT CHROMIUM; MASS-SPECTROMETRY;
   CADMIUM EXPOSURE; IN-VITRO; MIRNA EXPRESSION; ARSENIC EXPOSURE; DNA
   METHYLATION; MOLECULAR-BASIS
AB Environmental metallotoxins (Cd, Hg, Pb, As, Cr) influence profusely human health. Consequently, clear research directives are required to probe the complexity of risk and disease associations with exposure to metallotoxins. Systems biology approaches targeting the exposome provide efficient routes to organ-tissue profiling, while concurrently distinguishing physiology from deviating potential disease states. Sample processing and biophysical-biochemical methods in concert with metallotoxin speciation describe hybrid molecular interactions with extra/intracellular targets, establishing networks on normal physiology-aberrant functions at the cellular, tissue-organ and whole organism levels. Omics technologies, combined with bioinformatics, delineate emerging interactions, generating profiles, genotypic-phenotypic relationships, and biomarkers key to elucidating adverse outcomes on health. Collectively, the emerging exposome description provides tools expediting physiology-disease assessment and validation, further supporting preventive diagnostic-prognostic and potentially therapeutic technologies.
C1 [Sarigiannis, Dimosthenis A.; Salifoglou, Athanasios] Aristotle Univ Thessaloniki, Dept Chem Engn, GR-54124 Thessaloniki, Greece.
RP Salifoglou, A (reprint author), Aristotle Univ Thessaloniki, Dept Chem Engn, GR-54124 Thessaloniki, Greece.
EM sarigiannis@auth.gr
CR Abreu PL, 2014, BIOMETALS, V27, P409, DOI 10.1007/s10534-014-9726-7
   Garcia-Sevillano MA, 2014, J PROTEOMICS, V104, P4, DOI 10.1016/j.jprot.2014.02.032
   Garcia-Sevillano MA, 2014, J PROTEOMICS, V104, P66, DOI 10.1016/j.jprot.2014.02.011
   [Anonymous], 2016, CHROMIUM
   Antwi SO, 2015, CANCER CAUSE CONTROL, V26, P1583, DOI 10.1007/s10552-015-0652-y
   Aon MA, 2014, SYSTEMS BIOL METABOL
   Ayensu Wellington K, 2006, Int J Environ Res Public Health, V3, P141, DOI 10.3390/ijerph2006030018
   Baranowska-Bosiacka I, 2012, BRAIN RES, V1435, P56, DOI 10.1016/j.brainres.2011.11.062
   Baroni T, 2015, CYTOKINE, V72, P9, DOI 10.1016/j.cyto.2014.12.002
   Bocca B, 2004, SPECTROCHIM ACTA B, V59, P559, DOI 10.1016/j.sab.2004.02.007
   Booth SC, 2011, METALLOMICS, V3, P1142, DOI 10.1039/c1mt00070e
   Bosch AC, 2016, J SCI FOOD AGR, V96, P32, DOI 10.1002/jsfa.7360
   Bose-O'Reilly S, 2010, SCI TOTAL ENVIRON, V408, P796, DOI 10.1016/j.scitotenv.2009.10.051
   Bose-O'Reilly S, 2010, SCI TOTAL ENVIRON, V408, P713, DOI 10.1016/j.scitotenv.2009.10.070
   Bourdineaud JP, 2012, INT J MOL SCI, V13, P7710, DOI 10.3390/ijms13067710
   Carrier G, 2001, TOXICOL APPL PHARM, V171, P50, DOI 10.1006/taap.2000.9113
   Demartini DR, 2014, J PROTEOMICS, V104, P24, DOI 10.1016/j.jprot.2014.04.014
   Dhal B, 2013, J HAZARD MATER, V250, P272, DOI 10.1016/j.jhazmat.2013.01.048
   Diez S, 2009, REV ENVIRON CONTAM T, V198, P111, DOI 10.1007/978-0-387-09647-6_3
   Duarte NC, 2007, P NATL ACAD SCI USA, V104, P1777, DOI 10.1073/pnas.0610772104
   Duker AA, 2005, ENVIRON INT, V31, P631, DOI 10.1016/j.envint.2004.10.020
   Ellis JK, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-61
   Engstrom KS, 2010, FREE RADICAL BIO MED, V48, P1211, DOI 10.1016/j.freeradbiomed.2010.02.004
   Falnoga I, 2016, ENV RES
   FERGUSON JF, 1972, WATER RES, V6, P1259, DOI 10.1016/0043-1354(72)90052-8
   Gai K, 2016, ENVIRON SCI TECHNOL, V50, P3342, DOI 10.1021/acs.est.5b04247
   Gao Y, 2011, ENVIRON SCI TECHNOL, V45, P8605, DOI 10.1021/es203101f
   Gao YH, 2014, ENVIRON SCI TECHNOL, V48, P6409, DOI 10.1021/es500750w
   Garcia-Sevillano MA, 2015, J CHROMATOGR B, V985, P75, DOI 10.1016/j.jchromb.2015.01.029
   Garcia-Sevillano MA, 2013, BIOMETALS, V26, P651, DOI 10.1007/s10534-013-9642-2
   Garelick H, 2008, REV ENVIRON CONTAM T, V197, P17, DOI 10.1007/978-0-387-79284-2_2
   Gavin IM, 2007, ENVIRON MOL MUTAGEN, V48, P650, DOI 10.1002/em.20331
   Geier DA, 2015, CLIN CHIM ACTA, V444, P212, DOI 10.1016/j.cca.2015.02.030
   Go YM, 2014, TOXICOL SCI, V139, P59, DOI 10.1093/toxsci/kfu018
   Gu YG, 2015, MAR POLLUT BULL, V101, P852, DOI 10.1016/j.marpolbul.2015.11.019
   Hanson ML, 2012, TOXICOL APPL PHARM, V261, P196, DOI 10.1016/j.taap.2012.04.002
   Jablonska-Czapla M, 2015, INT J ENV RES PUB HE, V12, P4739, DOI 10.3390/ijerph120504739
   Jerby L, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.56
   Kasperczyk A, 2012, TOXICOLOGY, V301, P79, DOI 10.1016/j.tox.2012.07.002
   Keller C, 2005, PLANT SOIL, V276, P69, DOI 10.1007/s11104-005-3101-y
   Kippler M, 2012, ENVIRON RES, V112, P164, DOI 10.1016/j.envres.2011.11.012
   Kumar S, 2016, FRONT ENV SCI-SWITZ, V4, DOI 10.3389/fenvs.2016.00042
   Laurenza I, 2013, INT J DEV NEUROSCI, V31, P679, DOI 10.1016/j.ijdevneu.2013.03.002
   Legrain P, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009993
   Li CX, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151225
   Linos A, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-50
   Madejczyk MS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127327
   Malm O, 1998, ENVIRON RES, V77, P73, DOI 10.1006/enrs.1998.3828
   Martinez-Pacheco M, 2014, GENE, V533, P508, DOI 10.1016/j.gene.2013.09.049
   Mason RP, 2009, MERCURY FATE AND TRANSPORT IN THE GLOBAL ATMOSPHERE, P173, DOI 10.1007/978-0-387-93958-2_7
   Mazumdar M, 2012, ENVIRON HEALTH PERSP, V120, P702, DOI 10.1289/ehp.1104474
   McElwee MK, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-698
   Meisner M, 2015, SYSTEMS BIOL TOXICOL, P86
   Moraetis D, 2012, APPL GEOCHEM, V27, P1170, DOI 10.1016/j.apgeochem.2012.03.005
   Nair AR, 2015, J APPL TOXICOL, V35, P478, DOI 10.1002/jat.3047
   Niu YZ, 2015, J IMMUNOTOXICOL, V12, P92, DOI 10.3109/1547691X.2014.899412
   Oresic M., 2014, SYSTEMS BIOL APPROAC
   Poulin J., 2008, WHO ENV BURDEN DIS S, V16
   Rager JE, 2014, ENVIRON MOL MUTAGEN, V55, P196, DOI 10.1002/em.21842
   Ray PD, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00201
   Rivera MB, 2016, SCI TOTAL ENVIRON, V560, P254, DOI 10.1016/j.scitotenv.2016.04.029
   Rose S, 2015, J TOXICOL, DOI 10.1155/2015/573701
   Sanchez-Martin FJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080558
   Sanders AP, 2015, EPIGENOMICS-UK, V7, P885, DOI 10.2217/epi.15.54
   Sanders AP, 2014, EPIGENETICS-US, V9, P212, DOI 10.4161/epi.26798
   Schneider JS, 2011, TOXICOL APPL PHARM, V256, P179, DOI 10.1016/j.taap.2011.08.008
   Schneider JS, 2014, TOXICOL SCI, V141, P29, DOI 10.1093/toxsci/kfu101
   Schrimpe-Rutledge AC, 2012, J PROTEOME RES, V11, P3520, DOI 10.1021/pr3002996
   Sen A, 2015, EPIGENOMICS-UK, V7, P379, DOI 10.2217/epi.15.2
   Senut MC, 2014, TOXICOL SCI, V139, P142, DOI 10.1093/toxsci/kfu028
   Sharpe MA, 2013, J TOXICOL
   Shotyk W, 2005, MET IONS BIOL SYST, V43, P239
   Steckling N, 2014, ENVIRON HEALTH-GLOB, V13, DOI 10.1186/1476-069X-13-111
   Sturchio E, 2014, SCI TOTAL ENVIRON, V472, P672, DOI 10.1016/j.scitotenv.2013.11.092
   Suess C, 2009, MOL CELL PROTEOMICS, V8, P393, DOI 10.1074/mcp.M800157-MCP200
   Sun YY, 2014, SCI TOTAL ENVIRON, V493, P487, DOI 10.1016/j.scitotenv.2014.06.017
   Suvagandha D, 2014, INT J ENV RES PUB HE, V11, P3661, DOI 10.3390/ijerph110403661
   Thomas M.A., 2002, GEOCHEM-EXPLOR ENV A, V2, P211
   Tilley Sloane K., 2015, SYSTEMS BIOL TOXICOL, P117, DOI [10.1016/B978-0-12-801564-3.00006-7, DOI 10.1016/B978-0-12-801564-3.00006-7]
   Vas J, 2008, ANN NY ACAD SCI, V1143, P240, DOI 10.1196/annals.1443.022
   WETTERHAHN KE, 1989, SCI TOTAL ENVIRON, V86, P113, DOI 10.1016/0048-9697(89)90199-X
   Wild CP, 2005, CANCER EPIDEM BIOMAR, V14, P1847, DOI 10.1158/1055-9965.EPI-05-0456
   Winans B, 2011, REPROD TOXICOL, V31, P327, DOI 10.1016/j.reprotox.2010.09.004
   Xu HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068737
   Yoshida M, 2014, J TOXICOL SCI, V39, P561, DOI 10.2131/jts.39.561
   Yoshida M, 2011, J TOXICOL SCI, V36, P73, DOI 10.2131/jts.36.73
NR 86
TC 4
Z9 4
U1 0
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 2211-3398
J9 CURR OPIN CHEM ENG
JI Curr. Opin. Chem. Eng.
PD AUG
PY 2016
VL 13
SI SI
BP 161
EP 169
DI 10.1016/j.coche.2016.09.010
PG 9
WC Biotechnology & Applied Microbiology; Engineering, Chemical
SC Biotechnology & Applied Microbiology; Engineering
GA ED0EJ
UT WOS:000388515500021
DA 2019-10-23
ER

PT J
AU Gong, P
   Perkins, EJ
AF Gong, Ping
   Perkins, Edward J.
TI Earthworm toxicogenomics: A renewed genome-wide quest for novel
   biomarkers and mechanistic insights
SO APPLIED SOIL ECOLOGY
LA English
DT Article; Proceedings Paper
CT 10th International Symposium on Earthworm Ecology (ISEE)
CY JUN, 2014
CL Athens, GA
DE Earthworm; Biomarker; Toxicological mechanism; Toxicogenomics;
   Toxicotranscriptomics; Toxicoproteomics; Toxicometabolomics
ID NMR-BASED METABOLOMICS; EXPRESSED SEQUENCE TAGS; SUBLETHAL PHENANTHRENE
   EXPOSURE; ADVERSE OUTCOME PATHWAYS; EISENIA-FOETIDA; GENE-EXPRESSION;
   LUMBRICUS-RUBELLUS; H-1-NMR METABOLOMICS; ENDOSULFAN EXPOSURE;
   RISK-ASSESSMENT
AB As sentinel species, earthworms such as Eisenia spp. and Lumbricus spp. have been considered among the best bioindicators or biomonitors for soil ecosystems owing to their close contact with the environment and essential roles in soil pedogenesis, structure, fertility and the terrestrial food chain. Earthworms have also been used extensively for assessing environmental risk and chemical toxicity in laboratory and field settings. In the past two decades, a comprehensive set of transcriptomic, proteomic, metabolomic and bioinformatic tools have been developed and applied to assess ecological impacts of contaminated soils on earthworms. In this review, we summarize recent progress made in earthworm toxicogenomics, with an emphasis on earthworm toxicotranscriptomics, examine novel biomarkers discovered and mechanistic insights gained through toxicogenomics studies, discuss currently existing technical hurdles to be resolved in order to move ahead, and finally provide some remarks on the future perspectives of this interdisciplinary and promising field. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license.
C1 [Gong, Ping; Perkins, Edward J.] US Army, Environm Lab, Engineer Res & Dev Ctr, 3909 Halls Ferry Rd, Vicksburg, MS 39180 USA.
RP Gong, P (reprint author), US Army, Environm Lab, Engineer Res & Dev Ctr, 3909 Halls Ferry Rd, Vicksburg, MS 39180 USA.
EM ping.gong@usace.army.mil
CR Afshari CA, 2011, TOXICOL SCI, V120, pS225, DOI 10.1093/toxsci/kfq373
   Agbo SO, 2013, COMP BIOCHEM PHYS C, V157, P183, DOI 10.1016/j.cbpc.2012.11.005
   Andre J, 2010, ENVIRON POLLUT, V158, P883, DOI 10.1016/j.envpol.2009.09.021
   Ankley GT, 2006, ENVIRON SCI TECHNOL, V40, P4055, DOI 10.1021/es0630184
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Asensio V, 2013, SCI TOTAL ENVIRON, V442, P344, DOI 10.1016/j.scitotenv.2012.09.048
   Aslund MLW, 2012, ENVIRON SCI TECHNOL, V46, P1111, DOI 10.1021/es202327k
   Aslund MLW, 2011, ECOTOXICOLOGY, V20, P836, DOI 10.1007/s10646-011-0638-9
   Aslund MW, 2013, ENVIRON POLLUT, V182, P263, DOI 10.1016/j.envpol.2013.07.026
   Aslund MW, 2012, ECOTOXICOLOGY, V21, P1947, DOI 10.1007/s10646-012-0928-x
   Baylay AJ, 2012, ECOTOXICOLOGY, V21, P1436, DOI 10.1007/s10646-012-0897-0
   Brown SAE, 2010, ENVIRON POLLUT, V158, P2117, DOI 10.1016/j.envpol.2010.02.023
   Brown SAE, 2009, ENVIRON CHEM, V6, P432, DOI 10.1071/EN09054
   Brulle F, 2010, ENVIRON POLLUT, V158, P2793, DOI 10.1016/j.envpol.2010.06.019
   Bundy JG, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-25
   Bundy JG, 2007, ENVIRON SCI TECHNOL, V41, P4458, DOI 10.1021/es0700303
   Bundy JG, 2004, ECOTOXICOLOGY, V13, P797, DOI 10.1007/s10646-003-4477-1
   Bundy JG, 2002, ENVIRON TOXICOL CHEM, V21, P1966, DOI 10.1002/etc.5620210926
   Bundy JG, 2001, FEBS LETT, V500, P31, DOI 10.1016/S0014-5793(01)02582-0
   Calzolai L, 2007, COMP BIOCHEM PHYS D, V2, P245, DOI 10.1016/j.cbd.2007.04.007
   Carrera J, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r96
   Cho SJ, 2001, INVERTEBR REPROD DEV, V40, P103, DOI 10.1080/07924259.2001.9652710
   Das S., 2010, HDB RES COMPUTATIONA
   Dong ZC, 2013, SCI CHINA LIFE SCI, V56, P960, DOI 10.1007/s11427-013-4557-2
   Edwards C.A., 1996, BIOL ECOLOGY EARTHWO
   Edwards Clive A., 2004, P3
   Elsworth B., 2010, 9 INT S EARTHW EC, V9
   Engelmann P, 2011, SOIL BIOL, V24, P229, DOI 10.1007/978-3-642-14636-7_14
   Fontanetti CS, 2011, SOIL CONTAMINATION, P143
   Forbes VE, 2006, ENVIRON TOXICOL CHEM, V25, P272, DOI 10.1897/05-257R.1
   Gibb JOT, 1997, BIOMARKERS, V2, P295, DOI 10.1080/135475097231526
   Givaudan N, 2014, SOIL BIOL BIOCHEM, V73, P49, DOI 10.1016/j.soilbio.2014.01.032
   Gong P, 2007, ENVIRON SCI TECHNOL, V41, P8195, DOI 10.1021/es0716352
   Gong P, 2012, ENVIRON SCI TECHNOL, V46, P1223, DOI 10.1021/es203642e
   Gong P, 2012, ENVIRON SCI TECHNOL, V46, P19, DOI 10.1021/es201187u
   Gong P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014266
   Gong P, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S1-S15
   Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176
   Graves PR, 2002, MICROBIOL MOL BIOL R, V66, P39, DOI 10.1128/MMBR.66.1.39-63.2002
   Greenslade P, 2007, AUST J EXP AGR, V47, P424, DOI 10.1071/EA05264
   Guo Q, 2009, METABOLOMICS, V5, P72, DOI 10.1007/s11306-008-0153-z
   Hamadeh H. K, 2004, TOXICOGENOMICS PRINC
   He F, 2009, J BIOTECHNOL, V144, P190, DOI 10.1016/j.jbiotec.2009.07.013
   Hernandez-Soriano MC, 2014, ENVIRONMENTAL RISK ASSESSMENT OF SOIL CONTAMINATION, P459, DOI 10.5772/58294
   Hirano T, 2011, SENSORS-BASEL, V11, P11157, DOI 10.3390/s111211157
   Hogeweg P, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002021
   Hoheisel JD, 2006, NAT REV GENET, V7, P200, DOI 10.1038/nrg1809
   Ji CL, 2013, J PROTEOMICS, V91, P405, DOI 10.1016/j.jprot.2013.08.004
   Jiang QH, 2009, NUCLEIC ACIDS RES, V37, pD98, DOI 10.1093/nar/gkn714
   Johnson CD, 2007, CANCER RES, V67, P7713, DOI 10.1158/0008-5472.CAN-07-1083
   Jones OAH, 2008, CHEMOSPHERE, V71, P601, DOI 10.1016/j.chemosphere.2007.08.056
   Kammenga JE, 2000, REV ENVIRON CONTAM T, V164, P93
   Keller M, 2009, MICROBIOL MOL BIOL R, V73, P62, DOI 10.1128/MMBR.00028-08
   Kelmansky Diana M, 2013, Methods Mol Biol, V972, P15, DOI 10.1007/978-1-60327-337-4_2
   Kille P, 2013, SOIL BIOL BIOCHEM, V57, P524, DOI 10.1016/j.soilbio.2012.10.014
   Kim HS, 2012, CRYOLETTERS, V33, P1
   Kloeke AEEV, 2014, ENVIRON TOXICOL CHEM, V33, P412, DOI 10.1002/etc.2446
   Komiyama K., 2014, 10 INT S EARTHW EC I, P29
   Kuperman RG, 2003, PEDOBIOLOGIA, V47, P617, DOI 10.1016/S0031-4056(04)70245-0
   Lankadurai BP, 2013, METABOLITES, V3, P718, DOI 10.3390/metabo3030718
   Lankadurai BP, 2013, ENVIRON REV, V21, P180, DOI 10.1139/er-2013-0011
   Lankadurai BP, 2013, METABOLOMICS, V9, P44, DOI 10.1007/s11306-012-0427-3
   Lankadurai BP, 2012, ENVIRON CHEM, V9, P502, DOI 10.1071/EN12112
   Lankadurai BP, 2011, ENVIRON POLLUT, V159, P2845, DOI 10.1016/j.envpol.2011.04.044
   Lankadurai BP, 2011, ENVIRON CHEM, V8, P105, DOI 10.1071/EN10094
   Lee MS, 2005, BIOCHEM BIOPH RES CO, V328, P1196, DOI 10.1016/j.bbrc.2005.01.079
   Lenz EM, 2005, METABOLOMICS, V1, P123, DOI 10.1007/s11306-005-4435-4
   Li Y, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S10-S20
   Li YH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011014
   Liebeke M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081271
   Lourenco J, 2013, ECOTOX ENVIRON SAFE, V88, P16, DOI 10.1016/j.ecoenv.2012.10.011
   Santoyo MM, 2011, ENVIRON POLLUT, V159, P2387, DOI 10.1016/j.envpol.2011.06.041
   McKelvie JR, 2013, ENVIRON POLLUT, V175, P75, DOI 10.1016/j.envpol.2012.12.018
   McKelvie JR, 2011, ENVIRON POLLUT, V159, P3620, DOI 10.1016/j.envpol.2011.08.002
   McKelvie JR, 2010, ENVIRON POLLUT, V158, P2150, DOI 10.1016/j.envpol.2010.02.022
   McKelvie JR, 2009, METABOLOMICS, V5, P84, DOI 10.1007/s11306-008-0122-6
   Mehta JP, 2011, METHODS MOL BIOL, V784, P41, DOI 10.1007/978-1-61779-289-2_4
   Mudiam MKR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081077
   Nan XF, 2012, NEUROCOMPUTING, V92, P36, DOI 10.1016/j.neucom.2011.09.035
   National Research Council, 2005, COMM TOX INF NON WOR
   Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236
   Novo M, 2013, MOL BIOL EVOL, V30, P1614, DOI 10.1093/molbev/mst074
   OECD, 2011, 10 OECD GLOB FOR PAR, P1, DOI DOI 10.1787/9789264203785-EN
   OECD (Organization for Economic Co-operation and Development), 2013, GUID DOC DEV ASS ADV
   Owen J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-266
   Owzar K, 2011, CTS-CLIN TRANSL SCI, V4, P466, DOI 10.1111/j.1752-8062.2011.00309.x
   Parkinson J, 2004, BIOINFORMATICS, V20, P1398, DOI 10.1093/bioinformatics/bth101
   Parkinson J, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-31
   Perkins EJ, 2011, ENVIRON TOXICOL CHEM, V30, P22, DOI 10.1002/etc.374
   Pirooznia M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S7-S7
   Pirooznia M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S2-S11
   Rochfort SJ, 2009, METABOLOMICS, V5, P95, DOI 10.1007/s11306-008-0140-4
   Roembke J., 2002, GERM BRAZ WORKSH NEO, P543
   Sanchez-Hernandez JC, 2006, REV ENVIRON CONTAM T, V188, P85, DOI 10.1007/978-0-387-32964-2_3
   Scott-Fordsmand JJ, 2000, REV ENVIRON CONTAM T, V165, P117
   Simon R, 2007, CANCER INFORM, V3, P11
   Simpson MJ, 2009, ANAL BIOANAL CHEM, V394, P137, DOI 10.1007/s00216-009-2612-4
   Snape JR, 2004, AQUAT TOXICOL, V67, P143, DOI 10.1016/j.aquatox.2003.11.011
   Sturzenbaum SR, 2009, P R SOC B, V276, P789, DOI 10.1098/rspb.2008.1510
   Sturzenbaum SR, 2003, PEDOBIOLOGIA, V47, P447, DOI 10.1016/S0031-4056(04)70220-6
   Sturzenbaum SR, 1998, APPL SOIL ECOL, V9, P495, DOI 10.1016/S0929-1393(98)00111-5
   Sutekova E., 2011, ACTA ENV U COMENIANA, V19, P358
   Svendsen C, 2008, ENVIRON SCI TECHNOL, V42, P4208, DOI 10.1021/es702745d
   Taylor EL, 2008, TOXICOLOGY, V246, P34, DOI 10.1016/j.tox.2007.12.030
   Van Aggelen G, 2010, ENVIRON HEALTH PERSP, V118, P1, DOI 10.1289/ehp.0900985
   van Dijk EL, 2014, TRENDS GENET, V30, P418, DOI 10.1016/j.tig.2014.07.001
   van Straalen Nico M, 2008, J Biol, V7, P19, DOI 10.1186/jbiol80
   Vasseur P, 2014, CURR ZOOL, V60, P255, DOI 10.1093/czoolo/60.2.255
   Vermeirssen V, 2009, MOL BIOSYST, V5, P1817, DOI [10.1039/b908108a, 10.1039/B908108a]
   Wang X., 2012, NAT SCI, V4, P869
   Wang X, 2011, DEV COMP IMMUNOL, V35, P525, DOI 10.1016/j.dci.2010.12.014
   Wang X, 2010, PROTEOMICS, V10, P4476, DOI 10.1002/pmic.201000209
   Wang X, 2010, J PROTEOME RES, V9, P6547, DOI 10.1021/pr1007398
   Wang X, 2010, ECOTOX ENVIRON SAFE, V73, P1214, DOI 10.1016/j.ecoenv.2010.07.015
   Wang X, 2010, PROTEOMICS, V10, P1095, DOI 10.1002/pmic.200900488
   Warne MA, 2000, BIOMARKERS, V5, P56, DOI 10.1080/135475000230541
   Weeks JM, 2004, ECOTOXICOLOGY, V13, P817, DOI 10.1007/s10646-003-4479-z
   Weeraratna Ashani T, 2007, Methods Mol Biol, V377, P1
   Weinberg MS, 2009, HUM MOL GENET, V18, pR27, DOI 10.1093/hmg/ddp070
   Welle Stephen, 2013, Methods Mol Biol, V972, P1, DOI 10.1007/978-1-60327-337-4_1
   Whelan M., 2013, 26389 EUR EN, P1
   Wu SJ, 2013, CHEMOSPHERE, V93, P963, DOI 10.1016/j.chemosphere.2013.05.062
   Yang Y, 2013, IEEE INT WORK GENOM, P45, DOI 10.1109/GENSIPS.2013.6735927
   Yang Y, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S14-S3
   Yuk J, 2013, ENVIRON POLLUT, V175, P35, DOI 10.1016/j.envpol.2012.12.007
   Yuk J, 2012, ECOTOXICOLOGY, V21, P1301, DOI 10.1007/s10646-012-0884-5
   Yuk J, 2011, ENVIRON CHEM, V8, P281, DOI 10.1071/EN11033
   Yuk J, 2010, ENVIRON CHEM, V7, P524, DOI 10.1071/EN10084
   Zhang LJ, 2014, J HAZARD MATER, V273, P239, DOI 10.1016/j.jhazmat.2014.03.018
NR 129
TC 6
Z9 6
U1 1
U2 34
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0929-1393
EI 1873-0272
J9 APPL SOIL ECOL
JI Appl. Soil Ecol.
PD AUG
PY 2016
VL 104
BP 12
EP 24
DI 10.1016/j.apsoil.2015.11.005
PG 13
WC Soil Science
SC Agriculture
GA DX2XT
UT WOS:000384237600003
OA Other Gold
DA 2019-10-23
ER

PT J
AU Shatkin, JA
   Ong, KJ
   Beaudrie, C
   Clippinger, AJ
   Hendren, CO
   Haber, LT
   Hill, M
   Holden, P
   Kennedy, AJ
   Kim, B
   MacDonell, M
   Powers, CM
   Sharma, M
   Sheremeta, L
   Stone, V
   Sultan, Y
   Turley, A
   White, RH
AF Shatkin, J. A.
   Ong, Kimberly J.
   Beaudrie, Christian
   Clippinger, Amy J.
   Hendren, Christine Ogilvie
   Haber, Lynne T.
   Hill, Myriam
   Holden, Patricia
   Kennedy, Alan J.
   Kim, Baram
   MacDonell, Margaret
   Powers, Christina M.
   Sharma, Monita
   Sheremeta, Lorraine
   Stone, Vicki
   Sultan, Yasir
   Turley, Audrey
   White, Ronald H.
TI Advancing Risk Analysis for Nanoscale Materials: Report from an
   International Workshop on the Role of Alternative Testing Strategies for
   Advancement
SO RISK ANALYSIS
LA English
DT Article
DE Alternative testing strategies; expert workshop; nanomaterials;
   nanotoxicology; risk analysis
ID IN-VITRO; ENGINEERED NANOMATERIALS; NANOPARTICLES; TOXICITY;
   NANOTOXICOLOGY; IDENTIFICATION; HEALTH; CYTOTOXICITY; DOSIMETRY;
   FRAMEWORK
AB The Society for Risk Analysis (SRA) has a history of bringing thought leadership to topics of emerging risk. In September 2014, the SRA Emerging Nanoscale Materials Specialty Group convened an international workshop to examine the use of alternative testing strategies (ATS) for manufactured nanomaterials (NM) from a risk analysis perspective. Experts in NM environmental health and safety, human health, ecotoxicology, regulatory compliance, risk analysis, and ATS evaluated and discussed the state of the science for in vitro and other alternatives to traditional toxicology testing for NM. Based on this review, experts recommended immediate and near-term actions that would advance ATS use in NM risk assessment. Three focal areashuman health, ecological health, and exposure considerationsshaped deliberations about information needs, priorities, and the next steps required to increase confidence in and use of ATS in NM risk assessment. The deliberations revealed that ATS are now being used for screening, and that, in the near term, ATS could be developed for use in read-across or categorization decision making within certain regulatory frameworks. Participants recognized that leadership is required from within the scientific community to address basic challenges, including standardizing materials, protocols, techniques and reporting, and designing experiments relevant to real-world conditions, as well as coordination and sharing of large-scale collaborations and data. Experts agreed that it will be critical to include experimental parameters that can support the development of adverse outcome pathways. Numerous other insightful ideas for investment in ATS emerged throughout the discussions and are further highlighted in this article.
C1 [Shatkin, J. A.; Ong, Kimberly J.] Vireo Advisors LLC, POB 51368, Boston, MA 02130 USA.
   [Beaudrie, Christian] Compass RM, Vancouver, CA USA.
   [Clippinger, Amy J.; Sharma, Monita] PETA Int Sci Consortium Ltd, London, England.
   [Hendren, Christine Ogilvie] Duke Univ, Ctr Environm Implicat NanoTechnol, Durham, NC USA.
   [Haber, Lynne T.] TERA, Cincinnati, OH USA.
   [Hill, Myriam] Hlth Canada, Ottawa, ON, Canada.
   [Holden, Patricia] Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, ERI, Santa Barbara, CA 93106 USA.
   [Holden, Patricia] Univ Calif Santa Barbara, UC CEIN, Santa Barbara, CA 93106 USA.
   [Kennedy, Alan J.] US Army Engn Res & Dev Ctr, Environm Lab, Vicksburg, MS USA.
   [MacDonell, Margaret] Argonne Natl Lab, Div Environm Sci, 9700 S Cass Ave, Argonne, IL 60439 USA.
   [Powers, Christina M.] US EPA, Off Air & Radiat, Off Transportat & Air Qual, Ann Arbor, MI USA.
   [Sheremeta, Lorraine] Alberta Ingenu Labs, Edmonton, AB, Canada.
   [Stone, Vicki] Heriot Watt Univ, John Muir Bldg Gait 1, Edinburgh, Midlothian, Scotland.
   [Sultan, Yasir] Environm Canada, Gatineau, PQ, Canada.
   [Turley, Audrey] ICF Int, Durham, NC USA.
   [White, Ronald H.] RH White Consultants, Silver Spring, MD USA.
RP Shatkin, JA (reprint author), Vireo Advisors LLC, POB 51368, Boston, MA 02130 USA.
EM jashatkin@gmail.com
OI Haber, Lynne/0000-0001-5384-642X; Stone, Vicki/0000-0001-8346-7471
FU National Science FoundationNational Science Foundation (NSF); Society
   for Risk Analysis Emerging Nanoscale Materials Specialty Group; Alberta
   Ingenuity Labs; PETA International Science Consortium Ltd.; Bergeson
   Campbell PC; American Chemistry Council; Keller and Heckman LLP;
   Toxicology Excellence in Risk Assessment
FX The views expressed in this article are those of the authors and do not
   necessarily represent the views or policies or positions of their
   respective organizations. The authors wish to acknowledge the generous
   support of the following workshop co-sponsors: the National Science
   Foundation; the Society for Risk Analysis Emerging Nanoscale Materials
   Specialty Group; Alberta Ingenuity Labs; PETA International Science
   Consortium Ltd.; Bergeson & Campbell PC; American Chemistry Council;
   Keller and Heckman LLP; Toxicology Excellence in Risk Assessment; and
   in-kind contributions from: American Chemical Society, Center for the
   Environmental Implications of Nanotechnology; George Washington
   University Milken Institute for Public Health, Society for Toxicology
   Nanotoxicology Specialty Section; Society for Toxicology and Chemistry
   Nanotechnology Advisory Group; Sustainable Nanotechnology Organization;
   UC Center for the Environmental Implications of Nanotechnology; and U.S.
   Army Engineer Research and Development Center. The authors further wish
   to acknowledge the cooperation of the Organisation for Economic
   Cooperation and Development Working Party on Manufactured Nanomaterials.
CR American Society for Testing and Materials, 2015, NAN STAND
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Antunovic B, 2011, EFSA J, V9, DOI 10.2903/j.efsa.2011.2140
   Arts JHE, 2014, REGUL TOXICOL PHARM, V70, P492, DOI 10.1016/j.yrtph.2014.07.025
   Bai W, 2010, J NANOPART RES, V12, P1645, DOI 10.1007/s11051-009-9740-9
   Brown DM, 2001, TOXICOL APPL PHARM, V175, P191, DOI 10.1006/taap.2001.9240
   Cedervall T, 2007, P NATL ACAD SCI USA, V104, P2050, DOI 10.1073/pnas.0608582104
   Cohen JM, 2014, PART FIBRE TOXICOL, V11, DOI 10.1186/1743-8977-11-20
   Collier ZA, 2015, J NANOPART RES, V17, DOI 10.1007/s11051-015-2943-3
   Fent K, 2010, AQUAT TOXICOL, V100, P218, DOI 10.1016/j.aquatox.2010.02.019
   Ge Y, 2012, APPL ENVIRON MICROB, V78, P6749, DOI 10.1128/AEM.00941-12
   Grieger KD, 2014, ENV SYSTEMS DECISION, V35, P42
   Holden PA, 2013, ACCOUNTS CHEM RES, V46, P813, DOI 10.1021/ar300069t
   International Organization for Standardization, 2012, 13014 ISOTR
   Klein CL, 2012, ARCH TOXICOL, V86, P1137, DOI 10.1007/s00204-012-0834-2
   Kroll A, 2011, PART FIBRE TOXICOL, V8, DOI 10.1186/1743-8977-8-9
   Krug HF, 2014, ANGEW CHEM INT EDIT, V53, P12304, DOI 10.1002/anie.201403367
   Kuhnel D, 2009, AQUAT TOXICOL, V93, P91, DOI 10.1016/j.aquatox.2009.04.003
   Kuempel E, 2015, SOC TOX ANN M SAN DI
   Lammer E, 2009, COMP BIOCHEM PHYS C, V149, P196, DOI 10.1016/j.cbpc.2008.11.006
   Laurent S, 2012, PLOS ONE, V7, P306, DOI 10.1371/journal.pone.0029997
   Lynch I, 2009, NAT NANOTECHNOL, V4, P546, DOI 10.1038/nnano.2009.248
   Maynard A, GETTING GRIPS NANOMA
   Meek MEB, 2013, TOXICOLOGY, V313, P185, DOI 10.1016/j.tox.2012.09.015
   Meesters JAJ, 2014, ENVIRON SCI TECHNOL, V48, P5726, DOI 10.1021/es500548h
   Mueller NC, 2008, ENVIRON SCI TECHNOL, V42, P4447, DOI 10.1021/es7029637
   National Institute for Public Health and the Environment (RIVM), 2002, 650010030 RIVM RIVA
   National Research Council, 2007, TOXICITY TESTING 21
   National Research Council, 2015, RES STRATEGY ENV MEN
   Nel A, 2013, ACCOUNTS CHEM RES, V46, P607, DOI 10.1021/ar300022h
   Oberdorster G, 2005, ENVIRON HEALTH PERSP, V113, P823, DOI 10.1289/ehp.7339
   Oberdorster Gunter, 2005, Part Fibre Toxicol, V2, P8, DOI 10.1186/1743-8977-2-8
   Ong KJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090650
   Organisation for Economic Co operation and Development, 2012, SER SAF MAN NAN, V36
   Organisation for Economic Co-operation and Development, 2012, SER SAF MAN NAN, V33
   Organisation for Economic Co-operation and Development, 2012, SER SAF MAN NAN, V35
   Organisation for Economic Co-operation and Development, 2014, ORG EC COOP DEV SER, V203
   Organisation for Economic Co-operation and Development, 2016, SER SAF MAN NAN, V64
   Petersen EJ, 2015, ENVIRON SCI TECHNOL, V49, P9532, DOI 10.1021/acs.est.5b00997
   Petersen EJ, 2014, ENVIRON SCI TECHNOL, V48, P4226, DOI 10.1021/es4052999
   Poland CA, 2014, PART FIBRE TOXICOL, V11, DOI 10.1186/s12989-014-0042-8
   Schrurs F, 2012, NAT NANOTECHNOL, V7, P546, DOI 10.1038/nnano.2012.148
   Sharma M, 2016, RISK ANAL, V36, P1551, DOI 10.1111/risa.12581
   Shatkin JA, 2016, RISK ANAL, V36, P1564, DOI 10.1111/risa.12642
   Shatkin JA, 2010, RISK ANAL, V30, P1680, DOI 10.1111/j.1539-6924.2010.01493.x
   Shatkin Jo Anne, 2012, NANOTECHNOLOGY HLTH
   Stone V, 2016, RISK ANAL, V36, P1538, DOI 10.1111/risa.12645
   Stone V, 2014, PART FIBRE TOXICOL, V11, DOI 10.1186/1743-8977-11-9
   Stone V, 2009, CRIT REV TOXICOL, V39, P613, DOI 10.1080/10408440903120975
   Teeguarden JG, 2007, TOXICOL SCI, V95, P300, DOI 10.1093/toxsci/kfl165
   Valencia PM, 2012, NAT NANOTECHNOL, V7, P623, DOI 10.1038/nnano.2012.168
   von der Kammer F, 2012, ENVIRON TOXICOL CHEM, V31, P32, DOI 10.1002/etc.723
   Weir A, 2012, ENVIRON SCI TECHNOL, V46, P2242, DOI 10.1021/es204168d
   Winkler DA, 2013, TOXICOLOGY, V313, P15, DOI 10.1016/j.tox.2012.11.005
   Worle-Knirsch JM, 2006, NANO LETT, V6, P1261, DOI 10.1021/nl060177c
   Xia T, 2013, ENVIRON HEALTH PERSP, V121, P683, DOI 10.1289/ehp.1306561
   Youtie J, 2011, J NANOSCI NANOTECHNO, V11, P158, DOI 10.1166/jnn.2011.3840
   Zhang Y, 2009, WATER RES, V43, P4249, DOI 10.1016/j.watres.2009.06.005
   Zhu XS, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/19/195103
   Zuin S, 2011, NANOTOXICOLOGY, V5, P445, DOI 10.3109/17435390.2010.512986
NR 60
TC 6
Z9 7
U1 0
U2 13
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0272-4332
EI 1539-6924
J9 RISK ANAL
JI Risk Anal.
PD AUG
PY 2016
VL 36
IS 8
SI SI
BP 1520
EP 1537
DI 10.1111/risa.12683
PG 18
WC Public, Environmental & Occupational Health; Mathematics,
   Interdisciplinary Applications; Social Sciences, Mathematical Methods
SC Public, Environmental & Occupational Health; Mathematics; Mathematical
   Methods In Social Sciences
GA DW6OU
UT WOS:000383771600004
PM 27510619
DA 2019-10-23
ER

PT J
AU Iida, M
   Fujii, S
   Uchida, M
   Nakamura, H
   Kagami, Y
   Agusa, T
   Hirano, M
   Bak, SM
   Kim, EY
   Iwata, H
AF Iida, Midori
   Fujii, Satoshi
   Uchida, Masaya
   Nakamura, Hiroshi
   Kagami, Yoshihiro
   Agusa, Tetsuro
   Hirano, Masashi
   Bak, Su-Min
   Kim, Eun-Young
   Iwata, Hisato
TI Identification of aryl hydrocarbon receptor signaling pathways altered
   in TCDD-treated red seabream embryos by transcriptome analysis
SO AQUATIC TOXICOLOGY
LA English
DT Article
DE TCDD; Red seabream; Microarray; Transcriptome; Gene set enrichment
   analysis
ID ZEBRAFISH DANIO-RERIO; 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN TCDD;
   PAGRUS-MAJOR; ESTROGEN-RECEPTOR; RAINBOW-TROUT; TOXICITY; EXPRESSION;
   DIOXIN; CELLS; AHR2
AB 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) induces a broad spectrum of toxic effects including craniofacial malformation and neural damage in fish embryos. These effects are mainly mediated by the aryl hydrocarbon receptor (AHR). However, the mode of action between TCDD-induced AHR activation and adverse outcomes is not yet understood. To provide a comprehensive picture of the AHR signaling pathway in fish embryos exposed to TCDD, red seabream (Pagrus major) embryos were treated with graded concentrations of TCDD (0.3-37 nM) in seawater, or with a mixture of TCDD and 500 nM CH223191, an AHR-specific antagonist. The transcriptome of red seabream embryos was analyzed using a custom-made microarray with 6000 probes specifically prepared for this species. A Jonckheere-Terpstra test was performed to screen for genes that demonstrated altered mRNA expression levels following TCDD exposure. The signals of 1217 genes (as human homologs) were significantly altered in a TCDD concentration-dependent manner (q-value < 0.2). Notably, the TCDD-induced alteration in mRNA expression was alleviated by co-exposure to CH223191, suggesting that the mRNA expression level of these genes was regulated by AHR. To identify TCDD-activated pathways, the microarray data were further subjected to gene set enrichment analysis (GSEA) and functional protein-protein interaction (PPI) network analysis. GSEA demonstrated that the effects of TCDD on sets of genes involved calcium, mitogen-activated protein kinase (MAPK), actin cytoskeleton, chemokine, T cell receptor, melanoma, vascular endothelial growth factor (VEGF), axon guidance, and renal cell carcinoma signaling pathways. These results suggest the hypotheses that TCDD induces immunosuppression via the calcium, MAPK, chemokine, and T cell receptor signaling pathways, neurotoxicity via VEGF signaling, and axon guidance alterations and teratogenicity via the dysregulation of the actin cytoskeleton and melanoma and renal cell carcinoma signaling pathways. Furthermore, the PPI network analysis indicated that the adverse outcome pathways of TCDD in the embryos might be propagated through several hub genes such as cell division control protein 42, phosphoinositide-3-kinase regulatory subunit 1, and guanine nucleotide binding proteins. Understanding these pathways potentially allows for exploring the adverse outcome pathway of the effects of TCDD on the red seabream embryos. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Iida, Midori; Hirano, Masashi; Iwata, Hisato] Ehime Univ, CMES, Bunkyo Cho 2-5, Matsuyama, Ehime 7908577, Japan.
   [Iida, Midori; Fujii, Satoshi] Kyusyu Inst Technol, Comp Sci & Syst Engn, Iizuka, Fukuoka 8200067, Japan.
   [Uchida, Masaya; Nakamura, Hiroshi; Kagami, Yoshihiro] Mizuki Biotech Co Ltd, Kurume, Fukuoka 8390864, Japan.
   [Agusa, Tetsuro] Prefectural Univ Kumamoto, Grad Sch Environm & Symbiot Sci, Kumamoto 8620920, Japan.
   [Bak, Su-Min; Kim, Eun-Young] Kyung Hee Univ, Dept Life & Nanopharmaceut Sci, Seoul 130701, South Korea.
   [Bak, Su-Min; Kim, Eun-Young] Kyung Hee Univ, Dept Biol, Seoul 130701, South Korea.
RP Iwata, H (reprint author), Ehime Univ, CMES, Bunkyo Cho 2-5, Matsuyama, Ehime 7908577, Japan.
EM redgreen@bio.kyutech.ac.jp; sfujii@bio.kyutech.ac.jp;
   uchida@mizuki-bio.co.jp; ocean@mizuki-bio.co.jp;
   kagami@mizuki-bio.co.jp; te-agusa@pu-kumamoto.ac.jp;
   m-hirano@agr.ehime-u.ac.jp; ladyofkorea@naver.com; eykim08@khu.ac.kr;
   iwatah@agr.ehime-u.ac.jp
OI Iwata, Hisato/0000-0002-6867-0532
FU Japan Society for the Promotion of Science (JSPS)Ministry of Education,
   Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for
   the Promotion of Science [26220103, 25660228, 25118521]; Ministry of
   Education, Culture, Sports, Science and Technology, Japan (MEXT)Ministry
   of Education, Culture, Sports, Science and Technology, Japan (MEXT);
   Basic Science Research Program through National Research Foundation of
   Korea (NRF) - Ministry of Education, Science and Technology
   [2013R1A1A2A10010043, 2012K2A2A4021504]
FX The authors thank for late Prof. Akinori Sarai for his suggestion and
   help. Our thanks are also given to Dr. Yasuhiro Shima (Goto Laboratory,
   Seikai National Fisheries Research Institute, Fisheries Research Agency,
   Japan) for providing red seabream eggs. This work was supported by
   Grants-in-Aid for Scientific Research (S) [No. 26220103], Challenging
   Exploratory Research [No. 25660228], and Joint Research Project under
   the Japan-Korea Basic Scientific Cooperation Program for FY 2016 from
   Japan Society for the Promotion of Science (JSPS), which were given to
   Hisato Iwata. This study was also supported by the Ministry of
   Education, Culture, Sports, Science and Technology, Japan (MEXT) to a
   project on Joint Usage/Research Center Leading Academia in Marine and
   Environmental Research (LaMer). Grant-in-Aid for Scientific Research on
   Innovative Areas "Transcription Cycle"[25118521] was provided to Satoshi
   Fujii from JSPS. Funding support was also given to E-Y. Kim from the
   Basic Science Research Program through the National Research Foundation
   of Korea (NRF) funded by the Ministry of Education, Science and
   Technology [2013R1A1A2A10010043 and 2012K2A2A4021504].
CR Akahoshi E., 2006, ENV HLTH, V7, P5
   Andreasen EA, 2002, MOL PHARMACOL, V62, P234, DOI 10.1124/mol.62.2.234
   Antkiewicz DS, 2005, TOXICOL SCI, V84, P368, DOI 10.1093/toxsci/kfi073
   Bak SM, 2013, ENVIRON SCI TECHNOL, V47, P2877, DOI 10.1021/es304423w
   Baker TR, 2014, TOXICOL SCI, V138, P403, DOI 10.1093/toxsci/kfu006
   Barbera MJ, 2001, J BIOL CHEM, V276, P1486, DOI 10.1074/jbc.M006246200
   Broberg P, 2015, SAGX STAT ANAL GENEC
   Bugel SM, 2013, AQUAT TOXICOL, V126, P1, DOI 10.1016/j.aquatox.2012.09.019
   Carmeliet P, 2013, CELL MOL LIFE SCI, V70, P1763, DOI 10.1007/s00018-013-1283-7
   Chang CT, 2013, TOXICOL APPL PHARM, V270, P174, DOI 10.1016/j.taap.2013.04.010
   Cheshenko K, 2007, TOXICOL SCI, V96, P255, DOI 10.1093/toxsci/kfm003
   Dong W, 2002, TOXICOL SCI, V69, P191, DOI 10.1093/toxsci/69.1.191
   FernandezSalguero PM, 1996, TOXICOL APPL PHARM, V140, P173, DOI 10.1006/taap.1996.0210
   Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669
   Frawley R, 2011, ENVIRON HEALTH PERSP, V119, P371, DOI 10.1289/ehp.1002358
   Gillesby BE, 1998, ENVIRON TOXICOL CHEM, V17, P3, DOI 10.1002/etc.5620170102
   Henry TR, 1997, TOXICOL APPL PHARM, V142, P56, DOI 10.1006/taap.1996.8024
   Hill A, 2003, TOXICOL SCI, V76, P392, DOI 10.1093/toxsci/kfg241
   Hornug MW, 1999, TOXICOL SCI, V47, P40, DOI 10.1093/toxsci/47.1.40
   Hutz R J, 2006, Tren Reprod Bio, V2, P1
   Iida M, 2014, AQUAT TOXICOL, V154, P39, DOI 10.1016/j.aquatox.2014.05.001
   Iida M, 2013, AQUAT TOXICOL, V128, P193, DOI 10.1016/j.aquatox.2012.12.009
   Ishida M, 2015, INT J CANCER, V137, P299, DOI 10.1002/ijc.29398
   Ivnitski-Steele I, 2005, CARDIOVASC TOXICOL, V5, P215, DOI 10.1385/CT:5:2:215
   Ivnitski-Steele ID, 2004, BIRTH DEFECTS RES A, V70, P51, DOI 10.1002/bdra.10151
   JONCKHEERE AR, 1954, BIOMETRIKA, V41, P133, DOI 10.1093/biomet/41.1-2.133
   Karchner SI, 2005, BIOCHEM J, V392, P153, DOI 10.1042/BJ20050713
   Karman BN, 2012, TOXICOL APPL PHARM, V264, P1, DOI 10.1016/j.taap.2012.07.031
   Karras JG, 1996, TOXICOL APPL PHARM, V137, P275, DOI 10.1006/taap.1996.0081
   Kim MJ, 2012, ENVIRON HEALTH PERSP, V120, P508, DOI 10.1289/ehp.1104282
   Kim SY, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-144
   Lahvis GP, 1998, BIOCHEM PHARMACOL, V56, P781, DOI 10.1016/S0006-2952(98)00134-8
   Lamia KA, 2011, NATURE, V480, P552, DOI 10.1038/nature10700
   Lanham KA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028020
   Li ZH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077292
   Liu Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100910
   Luecke S, 2010, PIGM CELL MELANOMA R, V23, P828, DOI 10.1111/j.1755-148X.2010.00762.x
   Machado RM, 2014, HORM MOL BIOL CLIN I, V18, P47, DOI 10.1515/hmbci-2013-0057
   Matthews Jason, 2006, Nucl Recept Signal, V4, pe016
   Mavroudis PD, 2013, J INNATE IMMUN, V5, P153, DOI 10.1159/000342427
   McHale CM, 2007, TOXICOLOGY, V229, P101, DOI 10.1016/j.tox.2006.10.004
   Menuet A, 2004, J MOL ENDOCRINOL, V32, P975, DOI 10.1677/jme.0.0320975
   Michael AK, 2015, MOL CELL, V58, P743, DOI 10.1016/j.molcel.2015.03.031
   Mimura J, 2003, BBA-GEN SUBJECTS, V1619, P263, DOI 10.1016/S0304-4165(02)00485-3
   Murray IA, 2014, NAT REV CANCER, V14, P801, DOI 10.1038/nrc3846
   PETERSON RE, 1993, CRIT REV TOXICOL, V23, P283, DOI 10.3109/10408449309105013
   Prasch AL, 2003, TOXICOL SCI, V76, P138, DOI 10.1093/toxsci/kfg202
   Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412
   Roberts Jessica K, 2013, F1000Res, V2, P173, DOI 10.12688/f1000research.2-173.v2
   Sanchez-Martin FJ, 2011, J NEUROCHEM, V118, P153, DOI 10.1111/j.1471-4159.2011.07291.x
   Sartor MA, 2009, ENVIRON HEALTH PERSP, V117, P1139, DOI 10.1289/ehp.0800485
   Schwarz Q, 2004, GENE DEV, V18, P2822, DOI 10.1101/gad.322904
   Seok SH, 2008, J VET SCI, V9, P351, DOI 10.4142/jvs.2008.9.4.351
   Shimba S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025231
   Simpson ER, 2002, ANNU REV PHYSIOL, V64, P93, DOI 10.1146/annurev.physiol.64.081601.142703
   Smyth G. K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027
   SPITSBERGEN JM, 1986, VET IMMUNOL IMMUNOP, V12, P263, DOI 10.1016/0165-2427(86)90130-3
   Stamnes M, 2002, CURR OPIN CELL BIOL, V14, P428, DOI 10.1016/S0955-0674(02)00349-6
   Stangherlin A, 2013, J BIOL CHEM, V288, P26505, DOI 10.1074/jbc.R113.457564
   Tan ZQ, 2002, BIOCHEM PHARMACOL, V64, P771, DOI 10.1016/S0006-2952(02)01138-3
   Tanaka S, 2010, SURGERY, V147, P405, DOI 10.1016/j.surg.2009.09.037
   Tanguay RL, 1999, BBA-GENE STRUCT EXPR, V1444, P35, DOI 10.1016/S0167-4781(98)00252-8
   Teraoka H, 2002, TOXICOL SCI, V65, P192, DOI 10.1093/toxsci/65.2.192
   Teraoka H, 2006, AQUAT TOXICOL, V78, P103, DOI 10.1016/j.aquatox.2006.02.009
   Terman JR, 2013, CURR OPIN CELL BIOL, V25, P30, DOI 10.1016/j.ceb.2012.10.009
   Terpstra T.J., 1952, INDAGATIONES MATHEMA, V14, P327, DOI DOI 10.1016/S1385-7258(52)50043-X
   Ton C, 2006, BIRTH DEFECTS RES A, V76, P553, DOI 10.1002/bdra.20281
   Tsai MJ, 2015, J MOL MED, V93, P1257, DOI 10.1007/s00109-015-1304-0
   van Dongen Stijn, 2000, THESIS
   Vieira JM, 2007, DEVELOPMENT, V134, P1833, DOI 10.1242/dev.002402
   Villano CM, 2006, TOXICOL APPL PHARM, V210, P212, DOI 10.1016/j.taap.2005.05.001
   Vogel CFA, 2004, J BIOL CHEM, V279, P8886, DOI 10.1074/jbc.M310190200
   Wu GM, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-12-r112
   Xiong KM, 2008, MOL PHARMACOL, V74, P1544, DOI 10.1124/mol.108.050435
   Yamada T, 2014, J CRANIO MAXILL SURG, V42, P1, DOI 10.1016/j.jcms.2013.01.024
   Yamauchi M, 2005, COMP BIOCHEM PHYS C, V141, P177, DOI 10.1016/j.cca.2005.06.003
   Yamauchi M, 2006, AQUAT TOXICOL, V80, P166, DOI 10.1016/j.aquatox.2006.08.006
   Yang SH, 2003, GENE, V320, P3, DOI 10.1016/S0378-1119(03)00816-3
   Ziouzenkova O, 2008, FEBS LETT, V582, P32, DOI 10.1016/j.febslet.2007.11.081
   Zucchini-Pascal N, 2012, FOOD CHEM TOXICOL, V50, P3963, DOI 10.1016/j.fct.2012.08.009
NR 80
TC 4
Z9 4
U1 2
U2 27
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-445X
EI 1879-1514
J9 AQUAT TOXICOL
JI Aquat. Toxicol.
PD AUG
PY 2016
VL 177
BP 156
EP 170
DI 10.1016/j.aquatox.2016.05.014
PG 15
WC Marine & Freshwater Biology; Toxicology
SC Marine & Freshwater Biology; Toxicology
GA DT5NK
UT WOS:000381529700017
PM 27288597
DA 2019-10-23
ER

PT J
AU Incardona, JP
   Scholz, NL
AF Incardona, John P.
   Scholz, Nathaniel L.
TI The influence of heart developmental anatomy on cardiotoxicity-based
   adverse outcome pathways in fish
SO AQUATIC TOXICOLOGY
LA English
DT Review
DE Embryo; Larvae; Polycyclic aromatic hydrocarbon; PAH; Oil spill; Heart;
   Zebrafish; Salmon; Herring; Tuna
ID POLYCYCLIC AROMATIC-HYDROCARBONS; EARLY-LIFE STAGES; MAHI
   CORYPHAENA-HIPPURUS; HERRING CLUPEA-PALLASI; WEATHERED CRUDE-OIL;
   FUNDULUS-HETEROCLITUS; EMBRYONIC-DEVELOPMENT; ZEBRAFISH DEVELOPMENT;
   MOLECULAR INDICATORS; CARDIAC TOXICITY
AB The developing fish heart is vulnerable to a diverse array of toxic chemical contaminants in freshwater, estuarine, and marine habitats. Globally occurring examples of cardiotoxic agents include dioxins, polychlorinated biphenyls (PCBs), and polycyclic aromatic hydrocarbons (PAHs). The disruption of cardiac function during the process of heart morphogenesis can lead to adverse outcome pathways (AOPs) that can negatively affect fish survival at hatching as well as later life stages. Proximal impacts include cardiogenic fluid accumulation (edema) and defects of the body axis and jaw that preclude larval feeding. More subtle changes in heart development can produce permanent structural defects in the heart that reduce cardiac output and swimming performance in older fish. In recent decades, the presence of edema in fish embryos and larvae has been a very common bioindicator of cardiotoxicity. However, the different ways that edema forms in fish from different habitats (i.e., freshwater vs. marine, pelagic vs. demersal) has not been rigorously examined. Oil spills are an important source of PAH5 in fish spawning areas worldwide, and research is revealing how patterns of cardiogenic edema are shaped by species-specific differences in developmental anatomy and ionoregulatory physiology. Here we review the visible evidence for circulatory disruption across nine freshwater and marine fish species, exposed to crude oils from different parts of the world. We focus on the close interconnectedness of the cardiovascular and osmoregulatory systems during early development, and corresponding implications for fish in hyperosmotic and hyposmotic habitats. Finally, we suggest there may be poorly understood adverse outcomes pathways related to osmotic gradients and water movement within embryos, the latter causing extreme shifts in tissue osmolality. Published by Elsevier B.V.
C1 [Incardona, John P.; Scholz, Nathaniel L.] Natl Marine Fisheries Serv, Environm & Fisheries Sci Div, Northwest Fisheries Sci Ctr, NOAA Fisheries, 2725 Montlake Blvd E, Seattle, WA 98112 USA.
RP Incardona, JP (reprint author), Natl Marine Fisheries Serv, Environm & Fisheries Sci Div, Northwest Fisheries Sci Ctr, NOAA Fisheries, 2725 Montlake Blvd E, Seattle, WA 98112 USA.
EM John.Incardona@noaa.gov
RI Scholz, Nathaniel L/L-1642-2013
OI Scholz, Nathaniel L/0000-0001-6207-0272
FU Prince William Sound Regional Citizens Advisory Council; Deepwater
   Horizon Oil Spill Trustees; Research Council of NorwayResearch Council
   of Norway; Institute of Marine Research-Norway
FX We thank the Deepwater Horizon Oil Spill Trustees and Prince William
   Sound Regional Citizens Advisory Council for funding the studies
   conducted by our team at NOAA's Northwest Fisheries Science Center, and
   the Research Council of Norway for funding collaborative studies on
   haddock with the Institute of Marine Research-Norway. We also appreciate
   constructive comments by Dr. David Hinton on a draft version of the
   manuscript.
CR Adams J, 2014, ENVIRON TOXICOL CHEM, V33, P825, DOI 10.1002/etc.2497
   Adams J, 2014, ENVIRON TOXICOL CHEM, V33, P107, DOI 10.1002/etc.2397
   Brette F, 2014, SCIENCE, V343, P772, DOI 10.1126/science.1242747
   Carls MG, 1999, ENVIRON TOXICOL CHEM, V18, P481, DOI 10.1002/etc.5620180317
   Carney SA, 2004, MOL PHARMACOL, V66, P512
   Carvalho L, 2010, TRENDS CELL BIOL, V20, P586, DOI 10.1016/j.tcb.2010.06.009
   Clark BW, 2010, AQUAT TOXICOL, V99, P232, DOI 10.1016/j.aquatox.2010.05.004
   Edmunds RC, 2015, SCI REP-UK, V5, DOI 10.1038/srep17326
   Esbaugh AJ, 2016, SCI TOTAL ENVIRON, V543, P644, DOI 10.1016/j.scitotenv.2015.11.068
   Evans DH, 2008, AM J PHYSIOL-REG I, V295, pR704, DOI 10.1152/ajpregu.90337.2008
   GUGGINO WB, 1980, AM J PHYSIOL, V238, pR36
   GUGGINO WB, 1980, AM J PHYSIOL, V238, pR42
   Heintz RA, 2000, MAR ECOL PROG SER, V208, P205, DOI 10.3354/meps208205
   Heintz RA, 2007, INTEGR ENVIRON ASSES, V3, P351, DOI 10.1002/ieam.5630030306
   Hicken CE, 2011, P NATL ACAD SCI USA, V108, P7086, DOI 10.1073/pnas.1019031108
   Hill AJ, 2004, TOXICOL SCI, V78, P78, DOI 10.1093/toxsci/kfh056
   Hiroi J, 1998, ZOOL SCI, V15, P455, DOI 10.2108/0289-0003(1998)15[455:DSOCCI]2.0.CO;2
   Hwang PP, 2011, AM J PHYSIOL-REG I, V301, pR28, DOI 10.1152/ajpregu.00047.2011
   Incardona J.P., 2015, SCI REP, V5, P17326
   Incardona JP, 2006, TOXICOL APPL PHARM, V217, P308, DOI 10.1016/j.taap.2006.09.018
   Incardona JP, 2014, P NATL ACAD SCI USA, V111, pE1510, DOI 10.1073/pnas.1320950111
   Incardona JP, 2013, AQUAT TOXICOL, V142, P303, DOI 10.1016/j.aquatox.2013.08.011
   Incardona JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030116
   Incardona JP, 2012, P NATL ACAD SCI USA, V109, pE51, DOI 10.1073/pnas.1108884109
   Incardona JP, 2011, TOXICOL APPL PHARM, V257, P242, DOI 10.1016/j.taap.2011.09.010
   Incardona JP, 2009, ENVIRON SCI TECHNOL, V43, P201, DOI 10.1021/es802270t
   Incardona JP, 2005, ENVIRON HEALTH PERSP, V113, P1755, DOI 10.1289/ehp.8230
   Incardona JP, 2004, TOXICOL APPL PHARM, V196, P191, DOI 10.1016/j.taap.2003.11.026
   Isogai S, 2001, DEV BIOL, V230, P278, DOI 10.1006/dbio.2000.9995
   Jung JH, 2015, ENVIRON SCI TECHNOL, V49, P13639, DOI 10.1021/acs.est.5b03729
   Jung JH, 2013, CHEMOSPHERE, V91, P1146, DOI 10.1016/j.chemosphere.2013.01.019
   Lanham KA, 2014, TOXICOL SCI, V141, P141, DOI 10.1093/toxsci/kfu111
   Madison BN, 2015, AQUAT TOXICOL, V165, P222, DOI 10.1016/j.aquatox.2015.06.006
   Mager EM, 2014, ENVIRON SCI TECHNOL, V48, P7053, DOI 10.1021/es501628k
   Martin JD, 2014, ENVIRON TOXICOL CHEM, V33, P677, DOI 10.1002/etc.2486
   Marty GD, 1997, CAN J FISH AQUAT SCI, V54, P1846, DOI 10.1139/cjfas-54-8-1846
   McIntyre JK, 2016, ENVIRON SCI TECHNOL, V50, P1561, DOI 10.1021/acs.est.5b04786
   McIntyre JK, 2016, ENVIRON SCI TECHNOL, V50, P1570, DOI 10.1021/acs.est.5b04928
   Mclntosh W.C., 1890, T R SOC EDINB, V35, P665
   Meek A., 1924, FISH INVESTIG 2, VII, P3
   Miyanishi H, 2013, AM J PHYSIOL-REG I, V304, pR423, DOI 10.1152/ajpregu.00384.2012
   Prasch AL, 2003, TOXICOL SCI, V76, P138, DOI 10.1093/toxsci/kfg202
   Rice Stanley D., 2001, Reviews in Fisheries Science, V9, P165, DOI 10.1080/20016491101744
   Sackville M, 2012, J COMP PHYSIOL B, V182, P781, DOI 10.1007/s00360-012-0660-0
   Serluca FC, 2002, CURR BIOL, V12, P492, DOI 10.1016/S0960-9822(02)00694-2
   SHELBOURNE JE, 1956, J MAR BIOL ASSOC UK, V35, P177, DOI 10.1017/S0025315400009048
   SHELBOURNE JE, 1956, J MAR BIOL ASSOC UK, V35, P275, DOI 10.1017/S0025315400009103
   SHELBOURNE JE, 1955, NATURE, V176, P743, DOI 10.1038/176743a0
   SHELBOURNE JE, 1957, NATURE, V180, P920, DOI 10.1038/180920a0
   Sorhus E., 2016, SCI REP IN PRESS
   Sorhus E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124376
   Staudt D, 2012, ANNU REV GENET, V46, P397, DOI 10.1146/annurev-genet-110711-155646
   Stockard CR, 1915, AM J ANAT, V18, P227, DOI 10.1002/aja.1000180205
   Tamargo J, 2004, CARDIOVASC RES, V62, P9, DOI 10.1016/j.cardiores.2003.12.026
   Teraoka H, 2003, BIOCHEM BIOPH RES CO, V304, P223, DOI 10.1016/S0006-291X(03)00576-X
   Tingaud-Sequeira A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-38
   Van Tiem LA, 2011, TOXICOL APPL PHARM, V254, P280, DOI 10.1016/j.taap.2011.05.002
   Warren KS, 1998, AM J PHYSIOL-HEART C, V275, pH1
NR 58
TC 37
Z9 37
U1 6
U2 92
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-445X
EI 1879-1514
J9 AQUAT TOXICOL
JI Aquat. Toxicol.
PD AUG
PY 2016
VL 177
BP 515
EP 525
DI 10.1016/j.aquatox.2016.06.016
PG 11
WC Marine & Freshwater Biology; Toxicology
SC Marine & Freshwater Biology; Toxicology
GA DT5NK
UT WOS:000381529700052
PM 27447099
DA 2019-10-23
ER

PT J
AU Dumont, C
   Barroso, J
   Matys, I
   Worth, A
   Casati, S
AF Dumont, Coralie
   Barroso, Joao
   Matys, Izabela
   Worth, Andrew
   Casati, Silvia
TI Analysis of the Local Lymph Node Assay (LLNA) variability for assessing
   the prediction of skin sensitisation potential and potency of chemicals
   with non-animal approaches
SO TOXICOLOGY IN VITRO
LA English
DT Article
DE LLNA variability; Alternative methods; GHS/CLP; ECETOC; Validation
ID ADVERSE OUTCOME PATHWAY; IN-VITRO METHODS; TEST BATTERY; CELL-LINE;
   ACTIVATION; IDENTIFICATION; VALIDATION; VEHICLE
AB The knowledge of the biological mechanisms leading to the induction of skin sensitisation has favoured in recent years the development of alternative non-animal methods. During the formal validation process, results from the Local Lymph Node Assay (LLNA) are generally used as reference data to assess the predictive capacity of the non animal tests. This study reports an analysis of the variability of the LLNA for a set of chemicals for which multiple studies are available and considers three hazard classification schemes: POS/NEG, GHS/CLP and ECETOC. As the type of vehicle used in a LLNA study is known to influence to some extent the results, two analyses were performed: considering the solvent used to test the chemicals and without considering the solvent. The results show that the number of discordant classifications increases when a chemical is,tested in more than one solvent Moreover, it can be concluded that study results leading to classification in the strongest classes (1A and EXT) seem to be more reliable than those in the weakest classes. This study highlights the importance of considering the variability of the reference data when evaluating non-animal tests. (C) 2016 The Authors. Published by Elsevier Ltd.
C1 [Dumont, Coralie; Barroso, Joao; Matys, Izabela; Worth, Andrew; Casati, Silvia] European Commiss, Joint Res Ctr, Ispra, Italy.
RP Casati, S (reprint author), Joint Res Ctr, Via E Fermi 2749, I-21027 Ispra, VA, Italy.
EM silvia.casati@ec.europa.eu
RI Worth, Andrew Paul/O-3055-2019
OI Worth, Andrew Paul/0000-0002-5303-0452
CR Adriaens E, 2014, ARCH TOXICOL, V88, P701, DOI 10.1007/s00204-013-1156-8
   Anderson S.E., 2011, J ALLERGY, DOI DOI 10.1155/2011/424203
   [Anonymous], 2012, OECD SER TEST ASS, V168
   Asturiol D., 2016, TOXICOL IN VIT UNPUB
   Barroso J., 2016, ARCH TOXICO IN PRESS
   Basketter DA, 2002, FOOD CHEM TOXICOL, V40, P593, DOI 10.1016/S0278-6915(01)00130-2
   Basketter DA, 2001, FOOD CHEM TOXICOL, V39, P621, DOI 10.1016/S0278-6915(00)00169-1
   Basketter DA, 2014, DERMATITIS, V25, P11, DOI 10.1097/DER.0000000000000003
   Bauch C, 2012, REGUL TOXICOL PHARM, V63, P489, DOI 10.1016/j.yrtph.2012.05.013
   Casati S, 2009, ATLA-ALTERN LAB ANIM, V37, P305, DOI 10.1177/026119290903700313
   Cottrez F, 2015, TOXICOL IN VITRO, V29, P787, DOI 10.1016/j.tiv.2015.02.012
   ECETOC, 2003, 87 ECETOC
   EURL ECVAM, 2012, DIR PEPT REACT ASS D
   EURL ECVAM, 2013, JRC SCI POLICY REPOR
   EURL ECVAM, 2015, HUM CELL LIN ACT TES
   EURL ECVAM, 2014, EURL ECVAM REC KERAT
   EURL ECVAM, 2015, EURL ECVAM REC HUM C
   Gibbs S, 2013, TOXICOL APPL PHARM, V272, P529, DOI 10.1016/j.taap.2013.07.003
   Hirota M, 2015, J APPL TOXICOL, V35, P1333, DOI 10.1002/jat.3105
   Hoffmann S, 2015, ALTEX-ALTERN ANIM EX, V32, P379, DOI [http://dx.doi.org/10.14573/altex.1505051, 10.14573/altex.1505051]
   Jaworska J, 2013, J APPL TOXICOL, V33, P1353, DOI 10.1002/jat.2869
   Jaworska JS, 2015, ARCH TOXICOL, V89, P2355, DOI 10.1007/s00204-015-1634-2
   Johansson H, 2014, BASIC CLIN PHARMACOL, V115, P110, DOI 10.1111/bcpt.12199
   Johansson H, 2014, TOXICOL SCI, V139, P362, DOI 10.1093/toxsci/kfu046
   Jowsey IR, 2008, CUTAN OCUL TOXICOL, V27, P67, DOI 10.1080/15569520801904655
   Maxwell G, 2014, TOXICOL IN VITRO, V28, P8, DOI 10.1016/j.tiv.2013.10.013
   Natsch A, 2015, TOXICOL SCI, V143, P319, DOI 10.1093/toxsci/kfu229
   Nukada Y, 2013, TOXICOL IN VITRO, V27, P609, DOI 10.1016/j.tiv.2012.11.006
   OECD, 2015, OECD TEST GUID 442D
   OECD, 2015, OECD TEST GUID 442C
   OECD, 2009, OECD TEST GUID 429 T
   Piroird C, 2015, TOXICOL IN VITRO, V29, P901, DOI 10.1016/j.tiv.2015.03.009
   Ramirez T, 2016, TOXICOL IN VITRO, V32, P278, DOI 10.1016/j.tiv.2016.01.004
   Reisinger K., 2015, J APPL TOXICOL, V35, P1318
   Takenouchi O, 2015, J APPL TOXICOL, V35, P1318, DOI 10.1002/jat.3127
   UN, 2015, GLOB HARM SYST CLASS
   Urbisch D, 2015, REGUL TOXICOL PHARM, V71, P337, DOI 10.1016/j.yrtph.2014.12.008
   van der Veen JW, 2014, REGUL TOXICOL PHARM, V69, P371, DOI 10.1016/j.yrtph.2014.04.018
NR 38
TC 23
Z9 24
U1 0
U2 2
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0887-2333
J9 TOXICOL IN VITRO
JI Toxicol. Vitro
PD AUG
PY 2016
VL 34
BP 220
EP 228
DI 10.1016/j.tiv.2016.04.008
PG 9
WC Toxicology
SC Toxicology
GA DQ5VR
UT WOS:000379273800027
PM 27085510
OA Other Gold
DA 2019-10-23
ER

PT J
AU Loizou, GD
AF Loizou, George D.
TI Animal-Free Chemical Safety Assessment
SO FRONTIERS IN PHARMACOLOGY
LA English
DT Review
DE animal-free; safety; assessment; metabolomics; personalized; medicine;
   biosensors
ID ADVERSE OUTCOME PATHWAYS; ON-A-CHIP; SYSTEMS BIOLOGY; RISK-ASSESSMENT;
   IN-VIVO; PRECISION MEDICINE; GUT MICROBIOTA; HUMAN EXPOSURE;
   CELL-CULTURE; HUMAN TOXOME
AB The exponential growth of the Internet of Things and the global popularity and remarkable decline in cost of the mobile phone is driving the digital transformation of medical practice. The rapidly maturing digital, non-medical world of mobile (wireless) devices, cloud computing and social networking is coalescing with the emerging digital medical world of omics data, biosensors and advanced imaging which offers the increasingly realistic prospect of personalized medicine. Described as a potential "seismic" shift from the current "healthcare" model to a "wellness" paradigm that is predictive, preventative, personalized and participatory, this change is based on the development of increasingly sophisticated biosensors which can track and measure key biochemical variables in people. Additional key drivers in this shift are metabolomic and proteomic signatures, which are increasingly being reported as pre-symptomatic, diagnostic and prognostic of toxicity and disease. These advancements also have profound implications for toxicological evaluation and safety assessment of pharmaceuticals and environmental chemicals. An approach based primarily on human in vivo and high-throughput in vitro human cell-line data is a distinct possibility. This would transform current chemical safety assessment practice which operates in a human "data poor" to a human "data rich" environment. This could also lead to a seismic shift from the current animal-based to an animal-free chemical safety assessment paradigm.
C1 [Loizou, George D.] Hlth & Safety Execut, Hlth & Safety Lab, Hlth Risks, Buxton, England.
RP Loizou, GD (reprint author), Hlth & Safety Execut, Hlth & Safety Lab, Hlth Risks, Buxton, England.
EM george.loizou@hsl.gsi.gov.uk
FU Health and Safety Executive (HSE)
FX This publication and the work it describes were funded by the Health and
   Safety Executive (HSE). Its contents, including any opinions and/or
   conclusions expressed, are those of the author alone and do not
   necessarily reflect HSE policy.
CR Adler S, 2011, ARCH TOXICOL, V85, P367, DOI 10.1007/s00204-011-0693-2
   Alyass A, 2015, BMC MED GENOMICS, V8, DOI 10.1186/s12920-015-0108-y
   Andersen ME, 2005, REPROD TOXICOL, V19, P327, DOI 10.1016/j.reprotox.2004.12.004
   Andersen ME, 2003, TOXICOL LETT, V138, P9, DOI 10.1016/S0378-4274(02)00375-2
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Armitage EG, 2014, J PHARMACEUT BIOMED, V87, P1, DOI 10.1016/j.jpba.2013.08.041
   Arnot JA, 2012, ENVIRON HEALTH PERSP, V120, P1565, DOI 10.1289/ehp.1205355
   Arnot JA, 2010, ENVIRON TOXICOL CHEM, V29, P45, DOI 10.1002/etc.15
   Astashkina A, 2012, PHARMACOL THERAPEUT, V134, P82, DOI 10.1016/j.pharmthera.2012.01.001
   Athersuch T, 2016, ARCH BIOCHEM BIOPHYS, V589, P177, DOI 10.1016/j.abb.2015.10.007
   Bains S., 2009, CONCEPT, V1
   Barton HA, 1998, HUM ECOL RISK ASSESS, V4, P75, DOI 10.1080/10807039891284226
   Bessems JG, 2014, REGUL TOXICOL PHARM, V68, P119, DOI 10.1016/j.yrtph.2013.11.008
   Bouhifd M, 2015, ALTEX-ALTERN ANIM EX, V32, P112, DOI [10.14573/altex.1502091, http://dx.doi.org/10.14573/altex.1502091]
   Bouhifd M, 2014, BASIC CLIN PHARMACOL, V115, P24, DOI 10.1111/bcpt.12198
   Bouhifd M, 2013, J APPL TOXICOL, V33, P1365, DOI 10.1002/jat.2874
   Braun R, 2014, ADV EXP MED BIOL, V844, P153, DOI 10.1007/978-1-4939-2095-2_8
   Burden N, 2015, J APPL TOXICOL, V35, P971, DOI 10.1002/jat.3165
   Burgoon LD, 2008, TOXICOL SCI, V104, P412, DOI 10.1093/toxsci/kfn083
   Calvani R, 2010, INT J OBESITY, V34, P1095, DOI 10.1038/ijo.2010.44
   Chen R, 2012, CURR OPIN PHARMACOL, V12, P623, DOI 10.1016/j.coph.2012.07.011
   Clarke CJ, 2008, TOXICOL PATHOL, V36, P140, DOI 10.1177/0192623307310947
   Clayton TA, 2006, NATURE, V440, P1073, DOI 10.1038/nature04648
   Clewell HJ, 2008, TOXICOL APPL PHARM, V231, P122, DOI 10.1016/j.taap.2008.04.021
   Clewell RA, 2008, REGUL TOXICOL PHARM, V50, P129, DOI 10.1016/j.yrtph.2007.10.012
   Coecke S, 2013, TOXICOL IN VITRO, V27, P1570, DOI 10.1016/j.tiv.2012.06.012
   Coen M, 2008, CHEM RES TOXICOL, V21, P9, DOI 10.1021/tx700335d
   Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523
   Collins FS, 2004, NATURE, V429, P475, DOI 10.1038/nature02628
   Conolly RB, 1995, TOXICOL LETT, V82-3, P901, DOI 10.1016/0378-4274(95)03528-1
   Cote I., 2014, EPA600R14004
   De Wever B., 2015, APPL VITR TOXICOL, V1, P5, DOI [10.1089/aivt.2014.0011, DOI 10.1089/AIVT.2014.0011]
   Dearry A., 2013, EM SCI ENV HLTH DEC
   Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X
   Dudka I, 2014, ENVIRON INT, V68, P71, DOI 10.1016/j.envint.2014.03.015
   Dumas ME, 2012, MOL BIOSYST, V8, P2494, DOI 10.1039/c2mb25167a
   Edwards SW, 2016, J PHARMACOL EXP THER, V356, P170, DOI 10.1124/jpet.115.228239
   Eisenstein M, 2015, NATURE, V527, pS2, DOI 10.1038/527S2a
   Ellis JK, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-61
   European Food Safety Authority, 2014, EFSA J, V12, DOI [10.2903/j.efsa.2014.3835, 10.2903/j.efsa.2014.3595]
   Fan R, 2008, NAT BIOTECHNOL, V26, P1373, DOI 10.1038/nbt.1507
   Feinberg AP, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001262
   Feinberg AP, 2010, NAT BIOTECHNOL, V28, P1049, DOI 10.1038/nbt1010-1049
   Fentem J, 2004, ATLA-ALTERN LAB ANIM, V32, P617, DOI 10.1177/026119290403200612
   Fiehn O, 2001, COMP FUNCT GENOM, V2, P155, DOI 10.1002/cfg.82
   Galas D. J., 2009, IBC, V1, P26
   Gao W, 2016, NATURE, V529, P509, DOI 10.1038/nature16521
   Gao YH, 2014, ENVIRON SCI TECHNOL, V48, P6409, DOI 10.1021/es500750w
   Gasparri R, 2016, J BREATH RES, V10, DOI 10.1088/1752-7155/10/1/016007
   Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234
   Griffin JL, 2004, CURR DRUG METAB, V5, P389, DOI 10.2174/1389200043335432
   Guarner F, 2003, LANCET, V361, P512, DOI 10.1016/S0140-6736(03)12489-0
   Guo LN, 2015, P NATL ACAD SCI USA, V112, pE4901, DOI 10.1073/pnas.1508425112
   Harrill AH, 2008, EXPERT OPIN DRUG MET, V4, P1379, DOI [10.1517/17425250802489099, 10.1517/17425255.4.11.1379 ]
   Heinemann J, 2014, J AM SOC MASS SPECTR, V25, P1755, DOI 10.1007/s13361-014-0922-z
   Holmes E, 2007, Ernst Schering Found Symp Proc, P227
   Holmes E, 2008, CELL, V134, P714, DOI 10.1016/j.cell.2008.08.026
   Hood L., 2013, HDB SYSTEMS BIOL, P445
   Hood L, 2015, BMC MED, V13, DOI 10.1186/s12916-014-0238-7
   Hood L, 2012, BIOTECHNOL J, V7, P992, DOI 10.1002/biot.201100306
   Hood L, 2011, NAT REV CLIN ONCOL, V8, P184, DOI 10.1038/nrclinonc.2010.227
   Huang RL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10425
   Huh D, 2013, NAT PROTOC, V8, P2135, DOI 10.1038/nprot.2013.137
   Huh D, 2012, LAB CHIP, V12, P2156, DOI 10.1039/c2lc40089h
   Huh D, 2010, SCIENCE, V328, P1662, DOI 10.1126/science.1188302
   IGHRC, 1999, PHYS BAS PHARM MOD P
   Jack John, 2013, Methods Mol Biol, V930, P375, DOI 10.1007/978-1-62703-059-5_17
   Jansen KA, 2015, BBA-MOL CELL RES, V1853, P3043, DOI 10.1016/j.bbamcr.2015.05.007
   Johanson G, 1999, AM J IND MED, P101
   Jones DP, 2012, ANNU REV NUTR, V32, P183, DOI 10.1146/annurev-nutr-072610-145159
   Kamburov A, 2013, NUCLEIC ACIDS RES, V41, pD793, DOI 10.1093/nar/gks1055
   Kankainen M, 2011, BIOINFORMATICS, V27, P1878, DOI 10.1093/bioinformatics/btr278
   Keun HC, 2002, CHEM RES TOXICOL, V15, P1380, DOI 10.1021/tx0255774
   Kim S, 2012, DATABASE-OXFORD, DOI 10.1093/database/bas042
   Kinross J, 2009, CURR PHARM DESIGN, V15, P1537, DOI 10.2174/138161209788168119
   Kinross James M, 2008, Curr Gastroenterol Rep, V10, P396, DOI 10.1007/s11894-008-0075-y
   Konvalina G., 2013, ACC CHEM RES
   Kosmides Alyssa K., 2013, Critical Reviews in Biomedical Engineering, V41, P205
   Kotera M, 2012, METHODS MOL BIOL, V802, P19, DOI 10.1007/978-1-61779-400-1_2
   Kraly JR, 2009, ANAL CHIM ACTA, V653, P23, DOI 10.1016/j.aca.2009.08.037
   Krilaviciute A, 2015, ONCOTARGET, V6, P38643, DOI 10.18632/oncotarget.5938
   Kuo CH, 2012, CHEM RES TOXICOL, V25, P676, DOI 10.1021/tx200465e
   Leung EL, 2013, BRIEF BIOINFORM, V14, P491, DOI 10.1093/bib/bbs043
   Li M, 2008, P NATL ACAD SCI USA, V105, P2117, DOI 10.1073/pnas.0712038105
   LIN CQ, 1993, FASEB J, V7, P737
   Lipscomb JC, 2008, PHARMACOL THERAPEUT, V118, P82, DOI 10.1016/j.pharmthera.2008.01.006
   Loizou G, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00056
   Loscalzo J, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100163
   Loscalzo J, 2011, WIRES SYST BIOL MED, V3, P619, DOI 10.1002/wsbm.144
   Louisse J, 2012, EXPERT OPIN DRUG MET, V8, P11, DOI 10.1517/17425255.2012.639762
   Lyons MA, 2008, ENVIRON HEALTH PERSP, V116, P1040, DOI 10.1289/ehp.11079
   MacFie J, 1999, GUT, V45, P223, DOI 10.1136/gut.45.2.223
   Maher AD, 2007, ANAL CHEM, V79, P5204, DOI 10.1021/ac070212f
   Mak HC, 2015, CELL SYST, V1, P254, DOI 10.1016/j.cels.2015.10.007
   Mastrangelo A, 2014, CURR TOP MED CHEM, V14, P2627
   McNally K, 2012, J TOXICOL, DOI 10.1155/2012/760281
   McNally K, 2014, TOXICOLOGY, V315, P70, DOI 10.1016/j.tox.2013.07.009
   McNally K, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00031
   Monte AA, 2014, HUM GENOMICS, V8, DOI 10.1186/s40246-014-0016-9
   Moreno EL, 2015, LAB CHIP, V15, P2419, DOI 10.1039/c5lc00180c
   Nicholson JK, 2008, NATURE, V455, P1054, DOI 10.1038/4551054a
   Nicholson JK, 2008, J PROTEOME RES, V7, P3637, DOI 10.1021/pr8005099
   Nicholson Jeremy K, 2006, Discov Med, V6, P63
   Nicholson JK, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100095
   Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813
   Nicholson JK, 2005, NAT REV MICROBIOL, V3, P431, DOI 10.1038/nrmicro1152
   Nicholson JK, 2004, NAT BIOTECHNOL, V22, P1268, DOI 10.1038/nbt1015
   NRC, 2007, TOX TEST 21 CENT VIS, P146
   Pamies D, 2014, EXP BIOL MED, V239, P1096, DOI 10.1177/1535370214537738
   Piersma AH, 2014, CRIT REV TOXICOL, V44, P876, DOI 10.3109/10408444.2014.940445
   Posma JM, 2014, BIOINFORMATICS, V30, P893, DOI 10.1093/bioinformatics/btt612
   Prot JM, 2012, ANN BIOMED ENG, V40, P1228, DOI 10.1007/s10439-011-0480-5
   Prot JM, 2011, BIOTECHNOL BIOENG, V108, P1704, DOI 10.1002/bit.23104
   Prot JM, 2012, TOXICOL APPL PHARM, V259, P270, DOI 10.1016/j.taap.2011.12.017
   Raamsdonk LM, 2001, NAT BIOTECHNOL, V19, P45
   Rabinowitz J D, 2011, Cold Spring Harb Symp Quant Biol, V76, P235, DOI 10.1101/sqb.2011.76.010694
   Rattray NJW, 2014, TRENDS BIOTECHNOL, V32, P538, DOI 10.1016/j.tibtech.2014.08.003
   Rehm HL, 2015, NEW ENGL J MED, V372, P2235, DOI 10.1056/NEJMsr1406261
   Sakurai N, 2011, NUCLEIC ACIDS RES, V39, pD677, DOI 10.1093/nar/gkq989
   Sand S, 2006, TOXICOL SCI, V90, P241, DOI 10.1093/toxsci/kfj057
   Sand S, 2012, J APPL TOXICOL, V32, P843, DOI 10.1002/jat.2757
   SCHOENENBERGER CA, 1994, J CELL SCI, V107, P527
   Schumacher A, 2014, APPL TRANSL GENOM, V3, P105, DOI 10.1016/j.atg.2014.09.010
   Serkova NJ, 2011, AM J RESP CRIT CARE, V184, P647, DOI 10.1164/rccm.201103-0474CI
   Shen HQ, 2013, ENVIRON SCI TECHNOL, V47, P8843, DOI 10.1021/es402025n
   Shimizu K, 2006, J TRAUMA, V60, P126, DOI 10.1097/01.ta.0000197374.99755.fe
   Shintu L, 2012, ANAL CHEM, V84, P1840, DOI 10.1021/ac2011075
   Siva N, 2015, LANCET, V385, P103, DOI 10.1016/S0140-6736(14)62453-3
   Smarr L, 2012, BIOTECHNOL J, V7, P980, DOI 10.1002/biot.201100495
   Smith AST, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt370
   Snouber LC, 2013, TOXICOL SCI, V132, P8, DOI 10.1093/toxsci/kfs230
   Sobradillo P, 2011, ARCH BRONCONEUMOL, V47, P35, DOI 10.1016/j.arbres.2010.09.009
   Sonner Z, 2015, BIOMICROFLUIDICS, V9, DOI 10.1063/1.4921039
   Stanberry L, 2013, METABOLITES, V3, P741, DOI 10.3390/metabo3030741
   Stobbe MD, 2014, BRIEF BIOINFORM, V15, P455, DOI 10.1093/bib/bbs060
   Sturla SJ, 2014, CHEM RES TOXICOL, V27, P314, DOI 10.1021/tx400410s
   Sulek K, 2014, THERANOSTICS, V4, P953, DOI 10.7150/thno.9265
   Tan YM, 2007, J EXPO SCI ENV EPID, V17, P591, DOI 10.1038/sj.jes.7500540
   Thomas RS, 2013, TOXICOL SCI, V136, P4, DOI 10.1093/toxsci/kft178
   Topol E, 2012, CREATIVE DESTRUCTION
   Topol EJ, 2015, JAMA-J AM MED ASSOC, V313, P353, DOI 10.1001/jama.2014.17125
   Topol EJ, 2014, CELL, V157, P241, DOI 10.1016/j.cell.2014.02.012
   Topol EJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000484
   Trietsch SJ, 2013, LAB CHIP, V13, P3548, DOI 10.1039/c3lc50210d
   Tseng Peter, 2014, Lab Chip, V14, P828, DOI 10.1039/c4lc90001d
   Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414
   van Duinen V, 2015, CURR OPIN BIOTECH, V35, P118, DOI 10.1016/j.copbio.2015.05.002
   Veenstra TD, 2012, GENOME MED, V4, DOI 10.1186/gm339
   Vinken M, 2013, TOXICOLOGY, V312, P158, DOI 10.1016/j.tox.2013.08.011
   Wachter A, 2015, BIOINFORMATICS, V31, P3072, DOI 10.1093/bioinformatics/btv323
   Wambaugh JF, 2015, TOXICOL SCI, V147, P55, DOI 10.1093/toxsci/kfv118
   Wambaugh JF, 2014, ENVIRON SCI TECHNOL, V48, P12760, DOI 10.1021/es503583j
   Wambaugh JF, 2013, ENVIRON SCI TECHNOL, V47, P8479, DOI 10.1021/es400482g
   Wang ZH, 2015, J PROTEOME RES, V14, P2583, DOI 10.1021/acs.jproteome.5b00134
   Weaver VM, 1997, J CELL BIOL, V137, P231, DOI 10.1083/jcb.137.1.231
   Wetmore BA, 2015, TOXICOL SCI, V148, P121, DOI 10.1093/toxsci/kfv171
   Wikoff WR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057639
   Wikoff WR, 2009, P NATL ACAD SCI USA, V106, P3698, DOI 10.1073/pnas.0812874106
   Williams AJ, 2012, DRUG DISCOV TODAY, V17, P1188, DOI 10.1016/j.drudis.2012.05.016
   Wishart DS, 2007, BRIEF BIOINFORM, V8, P279, DOI 10.1093/bib/bbm030
   Wishart DS, 2016, METABOLITES, V6, DOI 10.3390/metabo6010010
   Wishart DS, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002805
   Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065
   Wishart DS, 2009, NUCLEIC ACIDS RES, V37, pD603, DOI 10.1093/nar/gkn810
   Witze A, 2014, NATURE, V515, P324, DOI 10.1038/nature.2014.16347
   Xia JG, 2010, BIOINFORMATICS, V26, P2342, DOI 10.1093/bioinformatics/btq418
   Xia JG, 2010, NUCLEIC ACIDS RES, V38, pW71, DOI 10.1093/nar/gkq329
   Zhang AH, 2013, OMICS, V17, P495, DOI 10.1089/omi.2012.0090
   Zhang AH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064381
   Zhang QA, 2010, J TOXICOL ENV HEAL B, V13, P253, DOI 10.1080/10937404.2010.483943
   Zhu YL, 2008, BIOINFORMATICS, V24, P2798, DOI 10.1093/bioinformatics/btn520
   Zhukova A, 2014, J COMPUT BIOL, V21, P534, DOI 10.1089/cmb.2013.0143
NR 172
TC 3
Z9 3
U1 0
U2 21
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1663-9812
J9 FRONT PHARMACOL
JI Front. Pharmacol.
PD JUL 21
PY 2016
VL 7
AR 218
DI 10.3389/fphar.2016.00218
PG 15
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA DR7PZ
UT WOS:000380093500001
PM 27493630
OA DOAJ Gold, Green Published
DA 2019-10-23
ER

PT J
AU Sun, JX
   Tang, S
   Peng, H
   Saunders, DMV
   Doering, JA
   Hecker, M
   Jones, PD
   Giesy, JP
   Wiseman, S
AF Sun, Jianxian
   Tang, Song
   Peng, Hui
   Saunders, David M. V.
   Doering, Jon A.
   Hecker, Markus
   Jones, Paul D.
   Giesy, John P.
   Wiseman, Steve
TI Combined Transcriptomic and Proteomic Approach to Identify Toxicity
   Pathways in Early Life Stages of Japanese Medaka (Oryzias latipes)
   Exposed to 1,2,5,6-Tetrabromocyclooctane (TBCO)
SO ENVIRONMENTAL SCIENCE & TECHNOLOGY
LA English
DT Article
ID BROMINATED FLAME RETARDANTS; ADVERSE OUTCOME PATHWAYS; EARLY FISH
   DEVELOPMENT; CONCEPTUAL-FRAMEWORK; PIMEPHALES-PROMELAS; ZEBRAFISH
   EMBRYOS; RISK-ASSESSMENT; ECOTOXICOLOGY; EXPRESSION; HBCD
AB Currently, the novel brominated flame retardant 1,2,5,6-tetrabromocyclooctane (TBCO) is considered a potential replacement for hexabromocyclododecane (HBCD). Therefore, use of TBCO could increase in the near future. To assess potential toxicological risks to aquatic organisms, embryos of Japanese medaka (Olyzias latipes) were exposed to 10, 100, or 1000 mu g/L TBCO from 2 h postfertilization until 1 day post-hatch. TBCO accumulated in embryos in the order of 0.43-1.3 X 10(4)-fold, and the rate constant of accumulation was 1.7-1.8 per day. The number of days to hatch and the hatching success of embryos exposed to the medium and the greatest concentrations of TBCO were impaired. Responses of the transcriptome (RNA-seq) and proteome were characterized in embryos exposed to 100 mu g/L TBCO because this was the least concentration of TBCO that caused an effect on hatching. Consistent with effects on hatching, proteins whose abundances were reduced by exposure to TBCO were enriched in embryo development and hatching pathways. Also, on the basis of the responses of transcriptome and proteome, it was predicted that TBCO might impair vision and contraction of cardiac muscle, respectively, and these effects were confirmed by targeted bioassays. This study provided a comprehensive understanding of effects of TBCO on medaka at early life stages and illustrated the power of "omics" to explain and predict phenotypic responses to chemicals.
C1 [Sun, Jianxian; Peng, Hui; Saunders, David M. V.; Doering, Jon A.; Hecker, Markus; Jones, Paul D.; Giesy, John P.; Wiseman, Steve] Univ Saskatchewan, Toxicol Ctr, Saskatoon, SK S7N 5B3, Canada.
   [Tang, Song; Hecker, Markus; Jones, Paul D.] Univ Saskatchewan, Sch Environm & Sustainabil, Saskatoon, SK S7N 5C8, Canada.
   [Giesy, John P.] Univ Saskatchewan, Dept Vet Biomed Sci, Saskatoon, SK S7N 5B4, Canada.
   [Giesy, John P.] Michigan State Univ, Dept Zool, Ctr Integrat Toxicol, E Lansing, MI 48824 USA.
   [Giesy, John P.] Univ Hong Kong, Sch Biol Sci, Hong Kong 999077, Hong Kong, Peoples R China.
   [Giesy, John P.] Nanjing Univ, Sch Environm, State Key Lab Pollut Control & Resource Reuse, Nanjing 210093, Jiangsu, Peoples R China.
   [Wiseman, Steve] Univ Lethbridge, Dept Biol, Lethbridge, AB T1K 3M4, Canada.
RP Peng, H; Wiseman, S (reprint author), Univ Saskatchewan, Toxicol Ctr, Saskatoon, SK S7N 5B3, Canada.; Wiseman, S (reprint author), Univ Lethbridge, Dept Biol, Lethbridge, AB T1K 3M4, Canada.
EM huisci@gmail.com; steve.wiseman@uleth.ca
RI ; Jones, Paul/O-2046-2015
OI Tang, Song/0000-0003-3219-1422; Jones, Paul/0000-0002-7483-5380
FU Canada Research Chair programCanada Research Chairs; Department of
   Biology and Chemistry, City University of Hong Kong; State Key
   Laboratory in Marine Pollution, City University of Hong KongCity
   University of Hong Kong; "High-Level Foreign Experts" program - State
   Administration of Foreign Experts Affairs, the P. R. China
   [GDW20223200120]; Chinese Academy of SciencesChinese Academy of
   Sciences; Natural Science and Engineering Research Council of
   CanadaNatural Sciences and Engineering Research Council of Canada
   [326415-07]; Western Economic Diversification Canada [6578, 6807];
   Canada Foundation for Infrastructure
FX J.P.G. and M.H. were supported by the Canada Research Chair program.
   J.P.G. is also supported by a Visiting Distinguished Professorship in
   the Department of Biology and Chemistry and State Key Laboratory in
   Marine Pollution, City University of Hong Kong, the 2012 "High-Level
   Foreign Experts" (GDW20223200120) program funded by the State
   Administration of Foreign Experts Affairs, the P. R. China to Nanjing
   University, and the Einstein Professor Program of the Chinese Academy of
   Sciences. The research was supported by a Discovery Grant from the
   Natural Science and Engineering Research Council of Canada (project no.
   326415-07) to J.P.G. and a grant from the Western Economic
   Diversification Canada (project no. 6578 and 6807) to J.P.G. The authors
   acknowledge the support of an instrumentation grant from the Canada
   Foundation for Infrastructure.
CR Ankley GT, 2006, ENVIRON SCI TECHNOL, V40, P4055, DOI 10.1021/es0630184
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Belanger SE, 2010, AQUAT TOXICOL, V97, P88, DOI 10.1016/j.aquatox.2009.11.020
   Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101
   Chen ZY, 2008, CARDIOVASC RES, V79, P97, DOI 10.1093/cvr/cvn073
   Danilova N, 2008, BLOOD, V112, P5228, DOI 10.1182/blood-2008-01-132290
   De Wit C. A., 2010, ENVIRON CHEM, V16, P241
   Dodson RE, 2012, ENVIRON SCI TECHNOL, V46, P13056, DOI 10.1021/es303879n
   Doering JA, 2016, ENVIRON SCI TECHNOL, V50, P4826, DOI 10.1021/acs.est.6b00490
   Dong W, 2010, TOXICOL SCI, V118, P213, DOI 10.1093/toxsci/kfq254
   Embry MR, 2010, AQUAT TOXICOL, V97, P79, DOI 10.1016/j.aquatox.2009.12.008
   EU Monitor, 2008, PROP DIR EUR PARL CO, P543
   Fan HY, 2003, BIOL REPROD, V69, P1552, DOI 10.1095/biolreprod.103.015685
   Fent K, 2011, AQUAT TOXICOL, V105, P25, DOI 10.1016/j.aquatox.2011.06.008
   Fernie KJ, 2011, ENVIRON TOXICOL CHEM, V30, P2570, DOI 10.1002/etc.652
   Fisk P. R., 2008, PRIORITISATION FLAME, P1
   Gao ZG, 2014, DEV NEUROBIOL, V74, P1123, DOI 10.1002/dneu.22188
   Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86
   Gonzalez-Nunez V, 2010, STEM CELLS, V28, P1399, DOI 10.1002/stem.461
   Handley-Goldstone HM, 2005, TOXICOL SCI, V85, P683, DOI 10.1093/toxsci/kfi116
   Hensley MR, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-45
   Hong HZ, 2014, AQUAT TOXICOL, V152, P173, DOI 10.1016/j.aquatox.2014.04.010
   Ionita MA, 2007, EXP EYE RES, V84, P1, DOI 10.1016/j.exer.2005.12.012
   Iwamatsu T, 2004, MECH DEVELOP, V121, P605, DOI 10.1016/j.mod.2004.03.012
   Kasahara M, 2007, NATURE, V447, P714, DOI 10.1038/nature05846
   Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36
   Kondo T, 2005, CHEMOSPHERE, V61, P1299, DOI 10.1016/j.chemosphere.2005.03.058
   Lietti E, 2007, ARCH ENVIRON CON TOX, V53, P571, DOI 10.1007/s00244-006-0250-9
   Liu XF, 2014, J PROTEOME RES, V13, P1223, DOI 10.1021/pr400669d
   Lubzens E, 2010, GEN COMP ENDOCR, V165, P367, DOI 10.1016/j.ygcen.2009.05.022
   Mankidy R, 2014, TOXICOL LETT, V224, P141, DOI 10.1016/j.toxlet.2013.10.018
   Marentette JR, 2015, AQUAT TOXICOL, V164, P108, DOI 10.1016/j.aquatox.2015.04.024
   Morandi GD, 2015, ENVIRON SCI TECHNOL, V49, P12395, DOI 10.1021/acs.est.5b02586
   Muirhead EK, 2006, ENVIRON SCI TECHNOL, V40, P523, DOI 10.1021/es0513178
   Neely A, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00209
   Ohtoshi A, 2004, CURR BIOL, V14, P530, DOI 10.1016/j.cub.2004.02.027
   Peng H, 2014, ENVIRON SCI TECHNOL, V48, P1058, DOI 10.1021/es404867w
   Pillai S, 2014, P NATL ACAD SCI USA, V111, P3490, DOI 10.1073/pnas.1319388111
   Pratt JM, 2002, MOL CELL PROTEOMICS, V1, P579, DOI 10.1074/mcp.M200046-MCP200
   Sanz-Landaluze J, 2015, ENVIRON SCI TECHNOL, V49, P1860, DOI 10.1021/es504685c
   Saunders DMV, 2015, AQUAT TOXICOL, V160, P180, DOI 10.1016/j.aquatox.2015.01.018
   Saunders DMV, 2013, TOXICOL LETT, V223, P252, DOI 10.1016/j.toxlet.2013.09.009
   Schecter A, 2010, ENVIRON HEALTH PERSP, V118, P357, DOI 10.1289/ehp.0901345
   Schirmer K, 2010, ANAL BIOANAL CHEM, V397, P917, DOI 10.1007/s00216-010-3662-3
   Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303
   Snape JR, 2004, AQUAT TOXICOL, V67, P143, DOI 10.1016/j.aquatox.2003.11.011
   Solt LA, 2012, TRENDS ENDOCRIN MET, V23, P619, DOI 10.1016/j.tem.2012.05.012
   Stapleton HM, 2006, MAR POLLUT BULL, V52, P522, DOI 10.1016/j.marpolbul.2005.09.045
   Stearns G, 2007, J NEUROSCI, V27, P13866, DOI 10.1523/JNEUROSCI.3136-07.2007
   Suhring R, 2016, SCI TOTAL ENVIRON, V542, P578, DOI 10.1016/j.scitotenv.2015.10.085
   Sun JX, 2015, ENVIRON SCI TECHNOL, V49, P1621, DOI 10.1021/es505378b
   Timme-Laragy AR, 2006, CHEMOSPHERE, V62, P1097, DOI 10.1016/j.chemosphere.2005.05.037
   Tyler CR, 1996, REV FISH BIOL FISHER, V6, P287, DOI 10.1007/BF00122584
   Villalobos SA, 2000, AQUAT TOXICOL, V48, P309, DOI 10.1016/S0166-445X(99)00032-6
   Villeneuve D, 2014, ENVIRON TOXICOL CHEM, V33, P158, DOI 10.1002/etc.2403
   Villeneuve DL, 2014, TOXICOL SCI, V142, P312, DOI 10.1093/toxsci/kfu199
   Villeneuve DL, 2014, TOXICOL SCI, V142, P321, DOI 10.1093/toxsci/kfu200
   Volz DC, 2011, TOXICOL SCI, V123, P349, DOI 10.1093/toxsci/kfr185
   Wu MF, 2013, ECOTOXICOLOGY, V22, P1200, DOI 10.1007/s10646-013-1107-4
   Yang J, 1999, EMBO J, V18, P2174, DOI 10.1093/emboj/18.8.2174
   Yokoyama S, 2000, PROG RETIN EYE RES, V19, P385, DOI 10.1016/S1350-9462(00)00002-1
   Zuber M. E., 2014, JOVE-J VIS EXP, V88
NR 62
TC 10
Z9 10
U1 7
U2 72
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0013-936X
EI 1520-5851
J9 ENVIRON SCI TECHNOL
JI Environ. Sci. Technol.
PD JUL 19
PY 2016
VL 50
IS 14
BP 7781
EP 7790
DI 10.1021/acs.est.6b01249
PG 10
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA DS0OD
UT WOS:000380295700057
PM 27322799
DA 2019-10-23
ER

PT J
AU Vogs, C
   Altenburger, R
AF Vogs, Carolina
   Altenburger, Rolf
TI Time-Dependent Effects in Algae for Chemicals with Different Adverse
   Outcome Pathways: A Novel Approach
SO ENVIRONMENTAL SCIENCE & TECHNOLOGY
LA English
DT Article
ID INTERNAL EFFECT CONCENTRATIONS; RISK-ASSESSMENT; ORGANIC-CHEMICALS;
   SCENEDESMUS-VACUOLATUS; PHARMACODYNAMIC MODELS; AQUATIC TOXICITY;
   ECOTOXICOLOGY; GROWTH; BIOCONCENTRATION; CONTRIBUTES
AB Chemicals affect unicellular algae as a result of toxicokinetic and toxicodynamic processes. The internal concentration of chemicals in algae cells typically reaches equilibrium within minutes, while damage cumulatively increases over hours. The time gap between the steady state of internal exposure and damage development is thus suspected to span up to hours, mainly due to toxicodynamic processes. The quantification of rate-limited toxicodynamic processes, aggregated as a progressive effect from an initiating molecular event through biological key events toward the adverse outcome on algae growth inhibition, might discriminate between different adverse outcome pathways (AOPs). To support our hypothesis, we selected six chemicals according to different physicochemical properties and three distinctly dissimilar AOPs. The time courses of internal concentrations were linked to the observed affected growth using toxicokinetic toxicodynamic modeling. Effects on cell growth were explained by effect progression and not by the time to reach internal equilibrium concentration. Effect progression rates ranged over 6 orders of magnitude for all chemicals but varied by less than 1 order of magnitude within similar AOP (photosystem II inhibitors > reactive chemicals > lipid biosynthesis inhibitors), meaning that inhibitors of photosystem II advance an effect toward algae growth fastest compared to reactive chemicals and inhibitors of lipid biosynthesis.
C1 [Vogs, Carolina; Altenburger, Rolf] Helmholtz Ctr Environm Res, Dept Bioanalyt Ecotoxicol, Leipzig, Germany.
   [Vogs, Carolina] Karolinska Inst, Inst Environm Med, SE-17177 Stockholm, Sweden.
RP Vogs, C (reprint author), Helmholtz Ctr Environm Res, Dept Bioanalyt Ecotoxicol, Leipzig, Germany.; Vogs, C (reprint author), Karolinska Inst, Inst Environm Med, SE-17177 Stockholm, Sweden.
EM carolina.vogs@ki.se
FU German Federal Ministry of Education and ResearchFederal Ministry of
   Education & Research (BMBF) [FKZ 0315399]; Helmholtz Research Program
   "Chemicals in the Environment"; Helmholtz Interdisciplinary Graduate
   School for Environmental Research ("HiGrade"); European UnionEuropean
   Union (EU) [603437]
FX This research was funded by the German Federal Ministry of Education and
   Research within the project ProDarT (FKZ 0315399). The Helmholtz
   Research Program "Chemicals in the Environment" and the Helmholtz
   Interdisciplinary Graduate School for Environmental Research ("HiGrade")
   supported this study. Further support through the SOLUTIONS project
   (European Union, grant agreement no. 603437) is acknowledged. The
   authors are grateful to J. Kruger and K. Herold for excellent technical
   support.
CR Altenburger R, 2004, ENVIRON SCI TECHNOL, V38, P6353, DOI 10.1021/es049528k
   Altenburger R, 2008, J ENVIRON QUAL, V37, P16, DOI 10.2134/jeq2006.0556
   Altenburger R, 2006, ENVIRON SCI TECHNOL, V40, P6163, DOI 10.1021/es060338e
   Altenburger Rolf, 2009, Integrated Environmental Assessment and Management, V5, P62, DOI 10.1897/IEAM_2008-038.1
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Ashauer R, 2008, ENVIRON TOXICOL CHEM, V27, P1817, DOI 10.1897/07-642
   Ashauer R, 2007, ENVIRON SCI TECHNOL, V41, P5535, DOI 10.1021/es070283w
   Ashauer R, 2007, ENVIRON SCI TECHNOL, V41, P1480, DOI 10.1021/es061727b
   Ashauer R, 2013, ENVIRON TOXICOL CHEM, V32, P954, DOI 10.1002/etc.2144
   Ashauer R, 2010, J ENVIRON MONITOR, V12, P2056, DOI 10.1039/c0em00234h
   Ashauer R, 2010, ENVIRON SCI TECHNOL, V44, P3963, DOI 10.1021/es903478b
   Boger P, 2000, PEST MANAG SCI, V56, P497
   Danhof M, 2008, TRENDS PHARMACOL SCI, V29, P186, DOI 10.1016/j.tips.2008.01.007
   Danhof M, 2007, ANNU REV PHARMACOL, V47, P357, DOI 10.1146/annurev.pharmtox.47.120505.105154
   Escher Beate I., 2011, Integrated Environmental Assessment and Management, V7, P28, DOI 10.1002/ieam.100
   Escher BI, 2002, ENVIRON SCI TECHNOL, V36, P4201, DOI 10.1021/es015848h
   FAHL GM, 1995, AQUAT TOXICOL, V31, P175, DOI 10.1016/0166-445X(94)00067-Z
   Faust M, 2003, AQUAT TOXICOL, V63, P43, DOI 10.1016/S0166-445X(02)00133-9
   Forbes VE, 2012, ENVIRON TOXICOL CHEM, V31, P2663, DOI 10.1002/etc.2009
   Forbes VE, 2006, ENVIRON TOXICOL CHEM, V25, P272, DOI 10.1897/05-257R.1
   Franz S, 2008, AQUAT TOXICOL, V90, P102, DOI 10.1016/j.aquatox.2008.08.003
   Hartung T, 2009, NATURE, V460, P1080, DOI 10.1038/4601080a
   Hock B., 1995, HERBICIDES DEV USE A
   Jager T, 2006, ECOTOXICOLOGY, V15, P305, DOI 10.1007/s10646-006-0060-x
   Jager T, 2011, ENVIRON SCI TECHNOL, V45, P2529, DOI 10.1021/es103092a
   Jamers A, 2010, ENVIRON TOXICOL CHEM, V29, P893, DOI 10.1002/etc.102
   Jin JY, 2003, J PHARMACOL EXP THER, V307, P93, DOI 10.1124/jpet.103.053256
   Junghans M, 2003, PEST MANAG SCI, V59, P1101, DOI 10.1002/ps.735
   Jusko WJ, 2013, J PHARM SCI-US, V102, P2930, DOI 10.1002/jps.23590
   Lee JH, 2002, ENVIRON SCI TECHNOL, V36, P3131, DOI 10.1021/es011202d
   Legierse KCHM, 1999, ENVIRON SCI TECHNOL, V33, P917, DOI 10.1021/es9805066
   Mager DE, 2003, DRUG METAB DISPOS, V31, P510, DOI 10.1124/dmd.31.5.510
   Magni P, 2006, MATH BIOSCI, V200, P127, DOI 10.1016/j.mbs.2005.12.028
   Malaj E, 2014, P NATL ACAD SCI USA, V111, P9549, DOI 10.1073/pnas.1321082111
   Manthey M, 1993, SCI TOTAL ENVIRON S, V134, P453
   MCCARTY LS, 1993, ENVIRON SCI TECHNOL, V27, P1719
   Nobusawa T, 2012, GENES CELLS, V17, P709, DOI 10.1111/j.1365-2443.2012.01619.x
   Pillai S, 2014, P NATL ACAD SCI USA, V111, P3490, DOI 10.1073/pnas.1319388111
   Sans-Piche F, 2010, MAR ENVIRON RES, V69, pS28, DOI 10.1016/j.marenvres.2009.12.004
   Simeoni M, 2004, CANCER RES, V64, P1094, DOI 10.1158/0008-5472.CAN-03-2524
   Verhaar HJM, 1999, ENVIRON SCI TECHNOL, V33, P758, DOI 10.1021/es980507y
   Villeneuve DL, 2011, ENVIRON TOXICOL CHEM, V30, P1, DOI 10.1002/etc.396
   Vogs C, 2015, ENVIRON TOXICOL CHEM, V34, P100, DOI 10.1002/etc.2764
   Vogs C, 2013, ENVIRON TOXICOL CHEM, V32, P1161, DOI 10.1002/etc.2139
NR 44
TC 3
Z9 3
U1 4
U2 34
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0013-936X
EI 1520-5851
J9 ENVIRON SCI TECHNOL
JI Environ. Sci. Technol.
PD JUL 19
PY 2016
VL 50
IS 14
BP 7770
EP 7780
DI 10.1021/acs.est.6b00529
PG 11
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA DS0OD
UT WOS:000380295700056
PM 27149222
DA 2019-10-23
ER

PT J
AU Fowles, JR
   Banton, MI
   Boogaard, PJ
   Ketelslegers, HB
   Rohde, AM
AF Fowles, Jeff R.
   Banton, Marcy I.
   Boogaard, Peter J.
   Ketelslegers, Hans B.
   Rohde, Arlean M.
TI Assessment of petroleum streams for thyroid toxicity
SO TOXICOLOGY LETTERS
LA English
DT Article
DE Thyroid; Petroleum streams; Hydrocarbon; PAH; Polycyclic aromatic
   hydrocarbons; Hormone
ID DEVELOPMENTAL TOXICITY; HYDROCARBON TOXICITY; ANIMAL RESPONSE; VAPORS;
   CANCER; RATS; GLAND; MICE
AB The thyroid gland, and its associated endocrine hormones, is a growing area of interest in regulatory toxicology due to its important role in metabolism, growth and development. This report presents a review of the toxicology data on chemically complex petroleum streams for thyroid hormone effects.
   Toxicological summaries and studies from all available published and un-published sources were considered, drawing upon the European REACH regulatory submissions for 19 petroleum streams, with in depth review of 11 individual study reports and 31 published papers on related products or environmental settings. Findings relevant to thyroid pathology or thyroid hormone homeostasis were specifically sought, summarized, and discussed. A total of 349 studies of 28-days or longer duration were considered in the review, including data on mice, rats, rabbits, dogs, humans, and fish. The thyroid was almost invariably not a target organ in these studies. Three rodent studies did find thyroid effects; one on a jet fuel product (JP-8), and two studies on a heavy fuel oil product (F-179). The JP-8 product differs from other fuels due to the presence of additives, and the finding of reduced T4 levels in mice in the study occurred at a dose that is above that expected to occur in environmental settings (e.g. 2000 mg/kg). The finding for F-179 involved thyroid inflammation at 10-55 mg/kg that co-occurred with liver pathology in rats, indicating a possible secondary effect with questionable relevance to humans. In the few cases where findings did occur, the polycyclic aromatic hydrocarbon (PAH) content was higher than in related substances, and, in support of one possible adverse outcome pathway, one in-vitro study reported reduced thyroid peroxidase (TPO) activity with exposure to some PAH compounds (pyrene, benzo(k) fluoranthene, and benzo(e)pyrene). However, it could not be determined from the data available for this review, whether these specific PAH compounds were substantially higher in the JP-8 or F-179 products than in studies in which thyroid effects were not observed. Thus, a few products may carry a weak potential to affect the thyroid at high doses in rodents, possibly through secondary effects on the rodent liver or possibly through a pathway involving the inhibition of TPO by specific members of the PAH family.
   Human epidemiology evidence found weak and inconsistent effects on the thyroid but without identification of specific chemicals involved. Two studies in petroleum workers, which found a lower rate of morbidity and mortality overall, reported a statistically significant increase in thyroid cancer, but the small number of cases could not exclude confounding variables as possible explanations for the statistical findings.
   Overall, the available data indicates a low potential for thyroid hormone effects from exposure to petroleum streams, especially when the aromatic content is low. Because regulatory studies for most chemicals do not include detailed thyroid function or receptor studies, it remains possible that subclinical effects on this system may exist that were not detectable using conventional pathology or hormone measurements. (C) 2016 The Authors. Published by Elsevier Ireland Ltd.
C1 [Fowles, Jeff R.] Tox Log Consulting, Santa Rosa, CA 95407 USA.
   [Banton, Marcy I.] LyondellBasell, Houston, TX 77010 USA.
   [Boogaard, Peter J.] Shell Int BV, NL-2015 AN The Hague, Netherlands.
   [Ketelslegers, Hans B.] Exxonmobil Petr & Chem, B-1831 Machelen, Belgium.
   [Rohde, Arlean M.] Concawe, B-1160 Brussels, Belgium.
RP Fowles, JR (reprint author), Tox Log Consulting, Santa Rosa, CA 95407 USA.
EM tox-logic@hotmail.com
RI Boogaard, Peter J/H-4890-2019
OI Boogaard, Peter J/0000-0002-6964-6681
FU CONCAWE Health Toxicology SubGroup
FX The author would like to thank the CONCAWE Health Toxicology SubGroup
   for funding this review and for the provision of access to all needed
   technical materials to complete the detailed toxicological assessment.
CR API, 1989, 3633220 API NEW MEX
   API, 1985, 171002 API MD TEG LA
   API, 1983, 17031 API BORR LAB I
   ARCO, 1993, 90 DAY DERM TOX STUD, V1
   ARCO, 1987, 28 DAY DERM TOX STUD
   ATSDR (Agency for Toxic Substances and Disease Registry), 1998, TOX PROF JET FUELS J
   Baines CJ, 2004, OCCUP MED-OXFORD, V54, P408, DOI 10.1093/occmed/kqh083
   Borgert CJ, 2011, REGUL TOXICOL PHARM, V61, P185, DOI 10.1016/j.yrtph.2011.07.007
   Brar NK, 2010, AQUAT TOXICOL, V96, P203, DOI 10.1016/j.aquatox.2009.10.023
   CARPENTER CP, 1977, TOXICOL APPL PHARM, V41, P251, DOI 10.1016/0041-008X(77)90025-4
   CARPENTER CP, 1977, TOXICOL APPL PHARM, V41, P261, DOI 10.1016/0041-008X(77)90026-6
   Choksi NY, 2003, BIRTH DEFECTS RES B, V68, P479, DOI 10.1002/bdrb.10045
   CONCAWE, 2010, CHEM SAF REP BIT B
   Dalbey WE, 1996, J TOXICOL ENV HEALTH, V47, P77, DOI 10.1080/009841096161942
   de Freitas CU, 2010, ENVIRON RES, V110, P112, DOI 10.1016/j.envres.2009.10.009
   DIVINE BJ, 1987, AM J IND MED, V11, P189, DOI 10.1002/ajim.4700110208
   Gandhi M, 2011, THYROID, V21, P1331, DOI 10.1089/thy.2011.0269
   Gentes ML, 2007, ARCH ENVIRON CON TOX, V53, P287, DOI 10.1007/s00244-006-0070-y
   Gilbert ME, 2012, NEUROTOXICOLOGY, V33, P842, DOI 10.1016/j.neuro.2011.11.005
   Gray TM, 2013, REGUL TOXICOL PHARM, V67, pS4, DOI 10.1016/j.yrtph.2012.11.014
   International Agency for Research on Cancer (IARC), 1989, IARC MONOGR, V45, P39
   Jameson JL, 2010, HARRISONS ENDOCRINOL, P62
   Keil DE, 2003, TOXICOL SCI, V76, P347, DOI 10.1093/toxsci/kfg244
   Lewandowski TA, 2004, REGUL TOXICOL PHARM, V39, P348, DOI 10.1016/j.yrtph.2004.03.002
   Maier J, 2006, ENDOCRINOLOGY, V147, P3391, DOI 10.1210/en.2005-1669
   Mattie, 2000, AFRLHEWPTR20000067 O
   McClain RM, 1995, MUTAT RES-FUND MOL M, V333, P131, DOI 10.1016/0027-5107(95)00139-5
   MCCONNELL EE, 1992, REGUL TOXICOL PHARM, V16, P177, DOI 10.1016/0273-2300(92)90056-F
   McKee RH, 2014, INT J TOXICOL, V33, p52S, DOI 10.1177/1091581813504224
   McMillen S., 2001, RISK BASED DECISION, P233
   Miller MD, 2009, ENVIRON HEALTH PERSP, V117, P1033, DOI 10.1289/ehp.0800247
   Murray FJ, 2013, REGUL TOXICOL PHARM, V67, pS60, DOI 10.1016/j.yrtph.2013.04.004
   Murray FJ, 2013, REGUL TOXICOL PHARM, V67, pS46, DOI 10.1016/j.yrtph.2013.05.003
   Paul KB, 2013, TOXICOLOGY, V312, P97, DOI 10.1016/j.tox.2013.08.006
   Perkins EJ, 2013, ENVIRON HEALTH PERSP, V121, P1002, DOI 10.1289/ehp.1306638
   Poon R, 1996, TOXICOLOGY, V109, P129, DOI 10.1016/0300-483X(96)03326-4
   Ron E, 2006, CANC EPIDEMIOLOGY PR
   Sathiakumar N, 2001, J OCCUP ENVIRON MED, V43, P166, DOI 10.1097/00043764-200102000-00017
   Siemiatycki J., 2006, CANC EPIDEMIOLOGY PR
   Song M, 2012, J ENVIRON MONITOR, V14, P2121, DOI 10.1039/c2em30106g
   Stephens SM, 1997, J FISH BIOL, V50, P953, DOI 10.1111/j.1095-8649.1997.tb01621.x
   Trimmer GW, 2004, TOXICOL PATHOL, V32, P439, DOI 10.1080/01926230490465865
   Uzma Nazia, 2008, Int J Environ Res Public Health, V5, P139, DOI 10.3390/ijerph2008050019
   VYSKOCIL A, 1988, J APPL TOXICOL, V8, P239, DOI 10.1002/jat.2550080403
   Wong O, 2000, REGUL TOXICOL PHARM, V32, P78, DOI 10.1006/rtph.2000.1410
   Zabka TS, 2011, TOXICOL PATHOL, V39, P664, DOI 10.1177/0192623311406934
   Zhu PF, 2009, CHEMOSPHERE, V77, P883, DOI 10.1016/j.chemosphere.2009.08.054
   Zoeller RT, 2007, THYROID, V17, P811, DOI 10.1089/thy.2007.0107
NR 48
TC 5
Z9 5
U1 2
U2 19
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0378-4274
EI 1879-3169
J9 TOXICOL LETT
JI Toxicol. Lett.
PD JUL 8
PY 2016
VL 254
BP 52
EP 62
DI 10.1016/j.toxlet.2016.05.001
PG 11
WC Toxicology
SC Toxicology
GA DM2QA
UT WOS:000376190300007
PM 27150732
OA Other Gold
DA 2019-10-23
ER

PT J
AU Maruya, KA
   Dodder, NG
   Mehinto, AC
   Denslow, ND
   Schlenk, D
   Snyder, SA
   Weisberg, SB
AF Maruya, Keith A.
   Dodder, Nathan G.
   Mehinto, Alvine C.
   Denslow, Nancy D.
   Schlenk, Daniel
   Snyder, Shane A.
   Weisberg, Stephen B.
TI A tiered, integrated biological and chemical monitoring framework for
   contaminants of emerging concern in aquatic ecosystems
SO INTEGRATED ENVIRONMENTAL ASSESSMENT AND MANAGEMENT
LA English
DT Article
DE Aquatic ecosystems; Bioanalytical tools; Contaminants of emerging
   concern (CECs); Monitoring; Nontargeted chemical analysis
ID ADVERSE OUTCOME PATHWAYS; FLIGHT MASS-SPECTROMETRY; IN-VITRO BIOASSAYS;
   WASTE-WATER; RECYCLED WATER; MARINE ENVIRONMENTS; DIRECTED ANALYSIS;
   TOXICITY; IDENTIFICATION; SEDIMENT
AB The chemical-specific risk-based paradigm that informs monitoring and assessment of environmental contaminants does not apply well to the many thousands of new chemicals that are being introduced into ambient receiving waters. We propose a tiered framework that incorporates bioanalytical screening tools and diagnostic nontargeted chemical analysis to more effectively monitor for contaminants of emerging concern (CECs). The framework is based on a comprehensive battery of in vitro bioassays to first screen for a broad spectrum of CECs and nontargeted analytical methods to identify bioactive contaminants missed by the currently favored targeted analyses. Water quality managers in California have embraced this strategy with plans to further develop and test this framework in regional and statewide pilot studies on waterbodies that receive discharge from municipal wastewater treatment plants and stormwater runoff. In addition to directly informing decisions, the data obtained using this framework can be used to construct and validate models that better predict CEC occurrence and toxicity. The adaptive interplay among screening results, diagnostic assessment and predictive modeling will allow managers to make decisions based on the most current and relevant information, instead of extrapolating from parameters with questionable linkage to CEC impacts. Integr Environ Assess Manag 2016;12:540-547. (c) 2015 SETAC
C1 [Maruya, Keith A.; Dodder, Nathan G.; Mehinto, Alvine C.; Weisberg, Stephen B.] Southern Calif Coastal Water Res Project Author, Costa Mesa, CA 92626 USA.
   [Denslow, Nancy D.] Univ Florida, Dept Physiol Sci, Ctr Environm & Human Toxicol, Gainesville, FL 32610 USA.
   [Schlenk, Daniel] Univ Calif Riverside, Dept Environm Sci, Riverside, CA 92521 USA.
   [Snyder, Shane A.] Univ Arizona, Dept Chem & Environm Engn, Tucson, AZ USA.
RP Maruya, KA (reprint author), Southern Calif Coastal Water Res Project Author, Costa Mesa, CA 92626 USA.
EM keithm@sccwrp.org
RI Weisberg, Stephen B/B-2477-2008; Dodder, Nathan/C-7971-2015; Snyder,
   Shane/A-3302-2011
OI Weisberg, Stephen B/0000-0002-0655-9425; Dodder,
   Nathan/0000-0001-5913-1767; Snyder, Shane/0000-0003-2709-9840
FU State of California [12-134-250]
FX We thank the California Science Advisory Panel for CEC Monitoring and
   SCCWRP's Commission Technical Advisory Group for helping to evolve the
   ideas presented in this article. This work was supported by the State of
   California (Agreement No. 12-134-250).
CR Addeck A, 2012, TALANTA, V88, P73, DOI 10.1016/j.talanta.2011.10.009
   Allan IJ, 2006, TRAC-TREND ANAL CHEM, V25, P704, DOI 10.1016/j.trac.2006.05.009
   Allan IJ, 2006, TALANTA, V69, P302, DOI 10.1016/j.talanta.2005.09.043
   Andersen ME, 2005, TRENDS BIOTECHNOL, V23, P122, DOI 10.1016/j.tibtech.2005.01.007
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   [Anonymous], 2013, SER TEST ASS
   Bobeldijk I, 2001, J CHROMATOGR A, V929, P63, DOI 10.1016/S0021-9673(01)01156-6
   Brack W, 2015, SCI TOTAL ENVIRON, V503, P22, DOI 10.1016/j.scitotenv.2014.05.143
   Cwiertny DM, 2014, ENVIRON SCI TECHNOL, V48, P11737, DOI 10.1021/es503425w
   Escher BI, 2008, J ENVIRON MONITOR, V10, P612, DOI 10.1039/b800949j
   Escher BI, 2014, ENVIRON SCI TECHNOL, V48, P1940, DOI 10.1021/es403899t
   Furuichi T, 2004, WATER RES, V38, P4491, DOI 10.1016/j.watres.2004.08.007
   GOBAS FAPC, 1995, ENVIRON SCI TECHNOL, V29, P2038, DOI 10.1021/es00008a024
   Hamers Timo, 2010, Integrated Environmental Assessment and Management, V6, P761, DOI 10.1002/ieam.75
   Hoh E, 2012, ENVIRON SCI TECHNOL, V46, P8001, DOI 10.1021/es301139q
   Hutchinson TH, 2013, MAR POLLUT BULL, V74, P517, DOI 10.1016/j.marpolbul.2013.06.012
   Ibanez M, 2005, RAPID COMMUN MASS SP, V19, P169, DOI 10.1002/rcm.1764
   Jarosova B, 2012, ENVIRON INT, V45, P22, DOI 10.1016/j.envint.2012.04.001
   Koh CH, 2001, ENVIRON POLLUT, V111, P437, DOI 10.1016/S0269-7491(00)00087-7
   Leusch FDL, 2014, WATER RES, V50, P420, DOI 10.1016/j.watres.2013.10.056
   Leusch FDL, 2010, ENVIRON SCI TECHNOL, V44, P3853, DOI 10.1021/es903899d
   MacLatchy DL, 2003, ENVIRON TOXICOL CHEM, V22, P996, DOI [10.1897/1551-5028(2003)022<0996:DOASRE>2.0.CO;2, 10.1002/etc.5620220507]
   Maruya KA, 2014, INTEGR ENVIRON ASSES, V10, P69, DOI 10.1002/ieam.1483
   Mehinto AC, 2015, WATER RES, V83, P303, DOI 10.1016/j.watres.2015.06.050
   OECD, 2012, FISH SHORT TERM REPR
   Raimondo S, 2009, ENVIRON TOXICOL CHEM, V28, P2409, DOI 10.1897/08-540.1
   Schmitt S, 2012, ENVIRON SCI POLLUT R, V19, P3350, DOI 10.1007/s11356-012-0852-x
   Scott PD, 2014, ENVIRON SCI POLLUT R, V21, P12951, DOI 10.1007/s11356-014-3235-7
   Sengupta A, 2014, ENVIRON TOXICOL CHEM, V33, P350, DOI 10.1002/etc.2457
   Shaul NJ, 2015, ENVIRON SCI TECHNOL, V49, P1328, DOI 10.1021/es505156q
   Snyder SA, 2014, J AM WATER WORKS ASS, V106, P38, DOI 10.5942/jawwa.2014.106.0126
   Suzuki G, 2011, ENVIRON SCI TECHNOL, V45, P10203, DOI 10.1021/es2024274
   Tang JYM, 2013, WATER RES, V47, P5594, DOI 10.1016/j.watres.2013.06.037
   USEPA, 2007, VAL FISH SHORT TERM
   [USEPA] US Environmental Protection Agency, 2013, VAL MED MUL IN PRESS
   [USEPA] US Environmental Protection Agency, 2009, 100K09001 EPA
   Van der Linden SC, 2008, ENVIRON SCI TECHNOL, V42, P5814, DOI 10.1021/es702897y
   Vanderford BJ, 2014, ANAL CHEM, V86, P774, DOI 10.1021/ac403274a
   Worth A, 2011, 24705 JRCICHP EUR EN
NR 39
TC 17
Z9 17
U1 4
U2 49
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1551-3777
EI 1551-3793
J9 INTEGR ENVIRON ASSES
JI Integr. Environ. Assess. Manag.
PD JUL
PY 2016
VL 12
IS 3
BP 540
EP 547
DI 10.1002/ieam.1702
PG 8
WC Environmental Sciences; Toxicology
SC Environmental Sciences & Ecology; Toxicology
GA DQ9SJ
UT WOS:000379549300017
PM 26426153
DA 2019-10-23
ER

PT J
AU Muth-Kohne, E
   Westphal-Settele, K
   Bruckner, J
   Konradi, S
   Schiller, V
   Schafers, C
   Teigeler, M
   Fenske, M
AF Muth-Koehne, Elke
   Westphal-Settele, Kathi
   Brueckner, Jasmin
   Konradi, Sabine
   Schiller, Viktoria
   Schaefers, Christoph
   Teigeler, Matthias
   Fenske, Martina
TI Linking the response of endocrine regulated genes to adverse effects on
   sex differentiation improves comprehension of aromatase inhibition in a
   Fish Sexual Development Test
SO AQUATIC TOXICOLOGY
LA English
DT Article
DE Aromatase inhibition; Zebrafish; qPCR; Fadrozole; Fish sexual
   development test (FSDT); Adverse outcome pathway (AOP)
ID ZEBRAFISH DANIO-RERIO; FATHEAD MINNOW; AQUATIC TOXICOLOGY; OUTCOME
   PATHWAYS; EXPRESSION; FADROZOLE; VITELLOGENIN; ECOTOXICOLOGY; ESTROGEN;
   ASSAY
AB The Fish Sexual Development Test (FSDT) is a non-reproductive test to assess adverse effects of endocrine disrupting chemicals. With the present study it was intended to evaluate whether gene expression end-points would serve as predictive markers of endocrine disruption in a FSDT. For proof-of-concept, a FSDT according to the OECD TG 234 was conducted with the non-steroidal aromatase inhibitor fadrozole (test concentrations: 10 mu g/L, 32 mu g/L, 100 mu g/L) using zebrafish (Danio rerio). Gene expression analyses using quantitative RT-PCR were included at 48 h, 96 h, 28 days and 63 days post fertilization (hpf, dpf). The selection of genes aimed at finding molecular endpoints which could be directly linked to the adverse apical effects of aromatase inhibition. The most prominent effects of fadrozole exposure on the sexual development of zebrafish were a complete sex ratio shift towards males and an acceleration of gonad maturation already at low fadrozole concentrations (10 mu g/L). Due to the specific inhibition of the aromatase enzyme (Cyp19) by fadrozole and thus, the conversion of C19-androgens to C18-estrogens, the steroid hormone balance controlling the sex ratio of zebrafish was altered. The resulting key event is the regulation of directly estrogen-responsive genes. Subsequently, gene expression of vitellogenin I (vtg1) and of the aromatase cyp19a1b isoform (cyp19a1b), were down-regulated upon fadrozole treatment compared to controls. For example, mRNA levels of vtg1 were down-regulated compared to the controls as early as 48 hpf and 96 hpf. Further regulated genes cumulated in pathways suggested to be controlled by endocrine mechanisms, like the steroid and terpenoid synthesis pathway (e.g. mevalonate (diphospho) decarboxylase (mvd), lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase; lss), methylsterol monooxygenase I (sc4mol)) and in lipid transport/metabolic processes (steroidogenic acute regulatory protein (star), apolipoprotein Eb (apoEb)). Taken together, this study demonstrated that the existing Adverse Outcome Pathway (AOP) for aromatase inhibition in fish can be translated to the life-stage of sexual differentiation. We were further able to identify MoA-specific marker gene expression which can be instrumental in defining new measurable key events (ICE) of existing or new AOPs related to endocrine disruption. (C) 2016 The Author(s). Published by Elsevier B.V.
C1 [Muth-Koehne, Elke; Schaefers, Christoph; Teigeler, Matthias] Fraunhofer IME, Dept Ecotoxicol, Aberg 1, D-57392 Schmallenberg, Germany.
   [Westphal-Settele, Kathi; Brueckner, Jasmin; Konradi, Sabine] German Environm Agcy UBA, Woerlitzer Pl 1, D-06844 Dessau, Germany.
   [Schiller, Viktoria] Fraunhofer IME, Attract Grp UNIFISH, Forckenbeckstr 6, D-52074 Aachen, Germany.
   [Fenske, Martina] Fraunhofer IME, Project Grp Translat Med & Pharmacol TMP, Forckenbeckstr 6, D-52074 Aachen, Germany.
RP Muth-Kohne, E (reprint author), Fraunhofer IME, Dept Ecotoxicol, Aberg 1, D-57392 Schmallenberg, Germany.
EM elke.muth-koehne@ime.fraunhofer.de
RI Fenske, Martina/K-8830-2013
OI Fenske, Martina/0000-0002-7511-2491; Eilebrecht,
   Elke/0000-0003-0180-8936
FU German Federal Ministry for the Environment, Nature Conservation,
   Building and Nuclear Safety [FKZ 371263418]; Landes-Offensive zur
   Entwicklung Wissenschaftlich-okonomischer Exzellenz (LOEWE) of the
   Federal State of Hessen, Germany
FX This project was funded by the German Federal Ministry for the
   Environment, Nature Conservation, Building and Nuclear Safety (FKZ
   371263418). Martina Fenske was also co-funded by the Landes-Offensive
   zur Entwicklung Wissenschaftlich-okonomischer Exzellenz (LOEWE) of the
   Federal State of Hessen, Germany. We thank Helmut Segner and Lisa
   Baumann, Centre for Fish and Wildlife Health, University of Bern, for
   performance of histopathological examinations. We also thank Walter
   Bohmer for performing the chemical analysis and Maike Lutter and Tom
   Lingner (all Fraunhofer IME) for assisting in the qPCR analysis.
CR Afonso LOB, 2000, AQUACULTURE, V188, P175, DOI 10.1016/S0044-8486(00)00335-5
   Ankley GT, 2006, ENVIRON SCI TECHNOL, V40, P4055, DOI 10.1021/es0630184
   Ankley GT, 2015, TOXICOL SCI, V144, P259, DOI 10.1093/toxsci/kfu320
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Ankley GT, 2009, AQUAT TOXICOL, V92, P168, DOI 10.1016/j.aquatox.2009.01.013
   Ankley GT, 2005, TOXICOL SCI, V86, P300, DOI 10.1093/toxsci/kfi202
   Ankley GT, 2002, TOXICOL SCI, V67, P121, DOI 10.1093/toxsci/67.1.121
   Baumann L, 2015, ENVIRON SCI POLLUT R, V22, P16417, DOI 10.1007/s11356-014-3486-3
   Baumann L, 2013, AQUAT TOXICOL, V128, P34, DOI 10.1016/j.aquatox.2012.11.016
   Belanger SE, 2010, AQUAT TOXICOL, V97, P88, DOI 10.1016/j.aquatox.2009.11.020
   Bradbury SP, 2004, ENVIRON SCI TECHNOL, V38, p463A, DOI 10.1021/es040675s
   Brown AR, 2011, ENVIRON SCI TECHNOL, V45, P4166, DOI 10.1021/es200122r
   BROWNE LJ, 1991, J MED CHEM, V34, P725, DOI 10.1021/jm00106a038
   CALLARD GV, 1978, AM ZOOL, V18, P511
   Diekmann M, 2005, J APPL ICHTHYOL, V21, P451, DOI 10.1111/j.1439-0426.2005.00622.x
   Fenske M, 2004, AQUAT TOXICOL, V67, P105, DOI 10.1016/j.aquatox.2003.10.008
   Fenske M, 2001, COMP BIOCHEM PHYS C, V129, P217, DOI 10.1016/S1532-0456(01)00194-6
   Filby AL, 2007, AQUAT TOXICOL, V81, P219, DOI 10.1016/j.aquatox.2006.12.003
   Hao RX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079020
   HEPPELL SA, 1995, ENVIRON HEALTH PERSP, V103, P9, DOI 10.2307/3432500
   Johns SM, 2011, ENVIRON TOXICOL, V26, P195, DOI 10.1002/tox.20545
   Kagawa H, 2003, BIOL REPROD, V68, P1562, DOI 10.1095/biolreprod.102.008219
   Kinnberg K, 2007, COMP BIOCHEM PHYS C, V145, P165, DOI 10.1016/j.cbpc.2006.11.002
   Kortenkamp A., 2011, STATE ART ASSESSMENT
   Kramer VJ, 2011, ENVIRON TOXICOL CHEM, V30, P64, DOI 10.1002/etc.375
   Laier P, 2006, TOXICOL APPL PHARM, V213, P160, DOI 10.1016/j.taap.2005.10.013
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Maack G, 2003, J FISH BIOL, V62, P895, DOI 10.1046/j.1095-8649.2003.00074.x
   Meek ME, 2014, J APPL TOXICOL, V34, P1, DOI 10.1002/jat.2949
   Morthorst JE, 2010, AQUAT TOXICOL, V98, P336, DOI 10.1016/j.aquatox.2010.03.008
   Muncke J, 2006, ENVIRON TOXICOL CHEM, V25, P2734, DOI 10.1897/05-683R.1
   Nikinmaa M, 2011, AQUAT TOXICOL, V105, P16, DOI 10.1016/j.aquatox.2011.05.019
   NRC (National Research Council), 2007, TOX TEST 21 CENT VIS
   OECD, 2013, OECD SER TEST ASS, V184
   OECD, 2014, OECD SER TEST ASS
   [OECD [OECD] Organization for Economic Cooperation and Development], 2012, OECD SER TEST ASS
   OECD, 2010, OECD SER TEST ASS
   OECD, 2012, OECD SER TEST ASS, V150
   OECD, 2011, OECD SER TEST ASS, V156
   Pereira MLAM, 2014, ENVIRON TOXICOL, V29, P199, DOI 10.1002/tox.20786
   Perkins EJ, 2015, TOXICOL SCI, V148, P14, DOI 10.1093/toxsci/kfv181
   Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45
   Piersma AH, 2006, BASIC CLIN PHARMACOL, V98, P427, DOI 10.1111/j.1742-7843.2006.pto_373.x
   Reinecke M, 2010, BIOL REPROD, V82, P656, DOI 10.1095/biolreprod.109.080093
   Russell WMS, 1959, PRINCIPLES HUMANE EX
   Sawle AD, 2010, TOXICOL SCI, V118, P128, DOI 10.1093/toxsci/kfq237
   Schiller V, 2014, AQUAT TOXICOL, V155, P62, DOI 10.1016/j.aquatox.2014.06.005
   Schiller V, 2013, REPROD TOXICOL, V42, P210, DOI 10.1016/j.reprotox.2013.09.003
   Schiller V, 2013, COMP BIOCHEM PHYS C, V157, P41, DOI 10.1016/j.cbpc.2012.09.005
   Scholz S, 2009, SEX DEV, V3, P136, DOI 10.1159/000223078
   Scholz S, 2008, MOL CELL ENDOCRINOL, V293, P57, DOI 10.1016/j.mce.2008.06.008
   Segner H, 2011, AQUAT TOXICOL, V105, P50, DOI 10.1016/j.aquatox.2011.06.016
   Segner H, 2009, COMP BIOCHEM PHYS C, V149, P187, DOI 10.1016/j.cbpc.2008.10.099
   Seki M, 2006, ENVIRON TOXICOL CHEM, V25, P2742, DOI 10.1897/05-647R.1
   Sharpe RL, 2007, GEN COMP ENDOCR, V151, P34, DOI 10.1016/j.ygcen.2006.11.005
   TAKAHASHI H, 1977, Bulletin of the Faculty of Fisheries Hokkaido University, V28, P57
   Takatsu K, 2013, SCI REP-UK, V3, DOI 10.1038/srep03400
   Thorpe KL, 2011, AQUAT TOXICOL, V105, P412, DOI 10.1016/j.aquatox.2011.07.012
   Trant JM, 2001, J EXP ZOOL, V290, P475, DOI 10.1002/jez.1090
   Villeneuve DL, 2014, TOXICOL SCI, V142, P312, DOI 10.1093/toxsci/kfu199
   Villeneuve DL, 2013, TOXICOL SCI, V133, P225, DOI 10.1093/toxsci/kft068
   Villeneuve DL, 2011, ENVIRON TOXICOL CHEM, V30, P1, DOI 10.1002/etc.396
   Villeneuve DL, 2009, ENVIRON TOXICOL CHEM, V28, P1767, DOI 10.1897/08-653.1
   Wang H, 2005, GENE, V356, P91, DOI 10.1016/j.gene.2005.03.041
   Wang RL, 2010, AQUAT TOXICOL, V98, P230, DOI 10.1016/j.aquatox.2010.02.021
   Wheeler JR, 2013, CHEMOSPHERE, V92, P1067, DOI 10.1016/j.chemosphere.2013.01.102
   WOLTERING DM, 1984, AQUAT TOXICOL, V5, P1, DOI 10.1016/0166-445X(84)90028-6
   Zhang XW, 2008, ENVIRON TOXICOL CHEM, V27, P2504, DOI 10.1897/08-082.1
NR 68
TC 11
Z9 11
U1 0
U2 45
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-445X
EI 1879-1514
J9 AQUAT TOXICOL
JI Aquat. Toxicol.
PD JUL
PY 2016
VL 176
BP 116
EP 127
DI 10.1016/j.aquatox.2016.04.018
PG 12
WC Marine & Freshwater Biology; Toxicology
SC Marine & Freshwater Biology; Toxicology
GA DO4EL
UT WOS:000377734500013
PM 27130971
OA Other Gold
DA 2019-10-23
ER

PT J
AU Leontaridou, M
   Gabbert, S
   Van Ierland, EC
   Worth, AP
   Landsiedel, R
AF Leontaridou, Maria
   Gabbert, Silke
   Van Ierland, Ekko C.
   Worth, Andrew P.
   Landsiedel, Robert
TI Evaluation of Non-animal Methods for Assessing Skin Sensitisation
   Hazard: A Bayesian Value-of-Information Analysis
SO ATLA-ALTERNATIVES TO LABORATORY ANIMALS
LA English
DT Article
DE animal testing; Bayesian Value-of-Information analysis; non-animal
   methods; replacement; sequential testing strategies; skin sensitisation
ID CONTACT-DERMATITIS; TESTING STRATEGIES; ALLERGIES; CHEMICALS; COST;
   METHYLCHLOROISOTHIAZOLINONE/METHYLISOTHIAZOLINONE; IMPLEMENTATION;
   POPULATION; PREVALENCE; TOOL
AB This paper offers a Bayesian Value-of-Information (VOI) analysis for guiding the development of non-animal testing strategies, balancing information gains from testing with the expected social gains and costs from the adoption of regulatory decisions. Testing is assumed to have value, if, and only if, the information revealed from testing triggers a welfare-improving decision on the use (or non-use) of a substance. As an illustration, our VOI model is applied to a set of five individual non-animal prediction methods used for skin sensitisation hazard assessment, seven battery combinations of these methods, and 236 sequential 2-test and 3-test strategies. Their expected values are quantified and compared to the expected value of the local lymph node assay (LLNA) as the animal method. We find that battery and sequential combinations of non-animal prediction methods reveal a significantly higher expected value than the LLNA. This holds for the entire range of prior beliefs. Furthermore, our results illustrate that the testing strategy with the highest expected value does not necessarily have to follow the order of key events in the sensitisation adverse outcome pathway (AOP).
C1 [Leontaridou, Maria; Gabbert, Silke; Van Ierland, Ekko C.] Wageningen Univ, Environm Econ & Nat Resources Grp, Wageningen, Netherlands.
   [Leontaridou, Maria; Landsiedel, Robert] BASF SE, Expt Toxicol & Ecol, Ludwigshafen, Germany.
   [Worth, Andrew P.] European Commiss, EURL ECVAM, Directorate F Hlth Consumer & Reference Mat, Joint Res Ctr, Ispra, Italy.
RP Leontaridou, M (reprint author), Wageningen Univ, Environm Econ & Nat Resources Grp, NL-6700 EW Wageningen, Netherlands.
EM maria.leontaridou@wur.nl
RI Worth, Andrew Paul/O-3055-2019; Worth, Andrew/R-8495-2019; Landsiedel,
   Robert/D-1960-2012
OI Worth, Andrew Paul/0000-0002-5303-0452; Landsiedel,
   Robert/0000-0003-3756-1904
CR [Anonymous], 2012, OECD SER TEST ASS, V168
   [Anonymous], 2015, ANAL IMPORTS KATHON
   Basketter D, 2012, REGUL TOXICOL PHARM, V64, P9, DOI 10.1016/j.yrtph.2012.06.003
   Basketter DA, 2014, DERMATITIS, V25, P11, DOI 10.1097/DER.0000000000000003
   Bauch C, 2012, REGUL TOXICOL PHARM, V63, P489, DOI 10.1016/j.yrtph.2012.05.013
   Claxton K, 2004, HEALTH TECHNOL ASSES, V8, P1
   Claxton K, 1999, HEALTH ECON, V8, P269, DOI 10.1002/(SICI)1099-1050(199905)8:3<269::AID-HEC425>3.0.CO;2-D
   COOPER JA, 1979, BRIT J CANCER, V39, P87, DOI 10.1038/bjc.1979.10
   ECHA, 2014, US ALT TEST AN REACH
   ECHA, 2014, STAT PREF STUD EX EC
   Emter R, 2010, TOXICOL APPL PHARM, V245, P281, DOI 10.1016/j.taap.2010.03.009
   ENNEVER FK, 1990, PROG CLIN BIOL RES, V340, P295
   European Commission, EUROSTAT
   Gabbert S, 2013, HUM ECOL RISK ASSESS, V19, P1067, DOI 10.1080/10807039.2012.685810
   Gabbert S, 2010, NAT RESOUR FORUM, V34, P155, DOI 10.1111/j.1477-8947.2010.01300.x
   Gerberick GF, 2007, TOXICOL SCI, V97, P417, DOI 10.1093/toxsci/kfm064
   Goebel C, 2012, REGUL TOXICOL PHARM, V63, P40, DOI 10.1016/j.yrtph.2012.02.007
   Halvarsson K., 2007, International Journal of Cosmetic Science, V29, P69, DOI 10.1111/j.1467-2494.2007.00364.x
   Hartung T, 2009, NATURE, V460, P208, DOI 10.1038/460208a
   Held L., 2014, APPL STAT INFERENCE
   Hoffmann S, 2005, TOXICOL SCI, V85, P422, DOI 10.1093/toxsci/kfi099
   HOWSON C, 1991, NATURE, V350, P371, DOI 10.1038/350371a0
   Jaworska J, 2013, J APPL TOXICOL, V33, P1353, DOI 10.1002/jat.2869
   Jaworska J, 2011, ALTEX-ALTERN ANIM EX, V28, P211, DOI 10.14573/altex.2011.3.211
   Jaworska Joanna, 2010, ALTEX, V27, P231
   Jaworska J, 2010, REGUL TOXICOL PHARM, V57, P157, DOI 10.1016/j.yrtph.2010.02.003
   Kimber I, 2002, INT IMMUNOPHARMACOL, V2, P201, DOI 10.1016/S1567-5769(01)00173-4
   Koch L, 2006, J CLEAN PROD, V14, P31, DOI 10.1016/j.jclepro.2005.06.003
   LAVE LB, 1988, NATURE, V336, P631, DOI 10.1038/336631a0
   Leiva-Salinas M, 2014, DERMATITIS, V25, P130, DOI 10.1097/DER.0000000000000041
   Luechtefeld T, 2015, J APPL TOXICOL, V35, P1361, DOI 10.1002/jat.3172
   Mehling A, 2012, ARCH TOXICOL, V86, P1273, DOI 10.1007/s00204-012-0867-6
   Natsch A, 2013, J APPL TOXICOL, V33, P1337, DOI 10.1002/jat.2868
   Norlen H, 2014, ATLA-ALTERN LAB ANIM, V42, P115, DOI 10.1177/026119291404200204
   OECD, 2012, QSAR TOOLB
   OECD, 2015, OECD GUID TEST CHEM
   OECD, 2015, CHEM SKIN SENS DIR P
   OMENN GS, 1995, MOL CARCINOGEN, V14, P37, DOI 10.1002/mc.2940140108
   Park ME, 2014, DERMATOL CLIN, V32, P1, DOI 10.1016/j.det.2013.09.006
   Patlewicz G, 2015, REGUL TOXICOL PHARM, V71, P463, DOI 10.1016/j.yrtph.2015.02.011
   Patlewicz G, 2014, REGUL TOXICOL PHARM, V69, P529, DOI 10.1016/j.yrtph.2014.06.001
   Ramirez T, 2014, TOXICOL IN VITRO, V28, P1482, DOI 10.1016/j.tiv.2014.08.002
   Reisinger K, 2015, TOXICOL IN VITRO, V29, P259, DOI 10.1016/j.tiv.2014.10.018
   Ricci Giampaolo, 2006, J Pediatr Health Care, V20, P311, DOI 10.1016/j.pedhc.2006.04.009
   Rorije E, 2013, REGUL TOXICOL PHARM, V67, P146, DOI 10.1016/j.yrtph.2013.06.003
   Rovida C, 2015, ALTEX-ALTERN ANIM EX, V32, P25, DOI [http://dx.doi.org/10.14573/altex.1411011, 10.14573/altex.1506201]
   Sakaguchi H, 2006, TOXICOL IN VITRO, V20, P774, DOI 10.1016/j.tiv.2005.10.014
   Schnuch A, 1997, CONTACT DERMATITIS, V37, P200, DOI 10.1111/j.1600-0536.1997.tb02435.x
   Schnuch A, 2012, ALLERGY, V67, P847, DOI 10.1111/j.1398-9995.2012.02834.x
   Schnuch A, 2011, BRIT J DERMATOL, V164, P1316, DOI 10.1111/j.1365-2133.2011.10253.x
   Stein V, 2007, WIEN MED WOCHENSCHR, V157, P248, DOI 10.1007/s10354-007-0421-y
   Stterstrom B, 2014, CONTACT DERMATITIS, V71, P154, DOI 10.1111/cod.12231
   Thyssen JP, 2007, CONTACT DERMATITIS, V57, P287, DOI 10.1111/j.1600-0536.2007.01220.x
   Tollefsen KE, 2014, REGUL TOXICOL PHARM, V70, P629, DOI 10.1016/j.yrtph.2014.09.009
   Urbisch D, 2015, REGUL TOXICOL PHARM, V71, P337, DOI 10.1016/j.yrtph.2014.12.008
   Uter W, 2013, CONTACT DERMATITIS, V69, P231, DOI 10.1111/cod.12123
   Uter W, 2012, CONTACT DERMATITIS, V67, P125, DOI 10.1111/j.1600-0536.2012.02075.x
   van der Veen JW, 2014, REGUL TOXICOL PHARM, V69, P371, DOI 10.1016/j.yrtph.2014.04.018
   Van Leeuwen CJ, 2007, RISK ASSESSMENT CHEM
   VANDERSCHOUW YT, 1995, INVEST RADIOL, V30, P334, DOI 10.1097/00004424-199506000-00002
   Varian H., 2003, INTERMEDIATE MICROEC
   Verboom P, 2002, BRIT J DERMATOL, V147, P716, DOI 10.1046/j.1365-2133.2002.04964.x
   Vinken M, 2014, ARCH TOXICOL, V88, P1, DOI 10.1007/s00204-013-1093-6
   Vinken M, 2013, TOXICOLOGY, V312, P158, DOI 10.1016/j.tox.2013.08.011
   Wallace AD, 2012, PROG MOL BIOL TRANSL, V112, P89, DOI 10.1016/B978-0-12-415813-9.00004-0
   Witt CM, 2009, DERMATOLOGY, V219, P329, DOI 10.1159/000248854
   Worth A., 2014, ALTERNATIVE METHODS
   Yokota F, 2004, RISK ANAL, V24, P1625, DOI 10.1111/j.0272-4332.2004.00555.x
   Yokota F, 2004, RISK ANAL, V24, P635, DOI 10.1111/j.0272-4332.2004.00464.x
NR 69
TC 4
Z9 4
U1 0
U2 2
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0261-1929
EI 2632-3559
J9 ATLA-ALTERN LAB ANIM
JI ATLA-Altern. Lab. Anim.
PD JUL
PY 2016
VL 44
IS 3
BP 255
EP 269
DI 10.1177/026119291604400309
PG 15
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA EQ2UR
UT WOS:000397926800008
PM 27494625
DA 2019-10-23
ER

PT J
AU Gust, KA
   Collier, ZA
   Mayo, ML
   Stanley, JK
   Gong, P
   Chappell, MA
AF Gust, Kurt A.
   Collier, Zachary A.
   Mayo, Michael L.
   Stanley, Jacob K.
   Gong, Ping
   Chappell, Mark A.
TI Limitations of toxicity characterization in life cycle assessment: Can
   adverse outcome pathways provide a new foundation?
SO INTEGRATED ENVIRONMENTAL ASSESSMENT AND MANAGEMENT
LA English
DT Article
DE Life cycle assessment; Quantitative adverse outcome pathway; Toxicity
   assessment; Characterization factor
ID MULTICRITERIA DECISION-ANALYSIS; REPRODUCTIVE ENDOCRINE AXIS;
   RISK-ASSESSMENT; SKIN SENSITIZATION; ADAPTIVE RESPONSES; MULTIMEDIA
   FATE; IPCS FRAMEWORK; PART I; UNCERTAINTY; IMPACT
AB Life cycle assessment (LCA) has considerable merit for holistic evaluation of product planning, development, production, and disposal, with the inherent benefit of providing a forecast of potential health and environmental impacts. However, a technical review of current life cycle impact assessment (LCIA) methods revealed limitations within the biological effects assessment protocols, including: simplistic assessment approaches and models; an inability to integrate emerging types of toxicity data; a reliance on linear impact assessment models; a lack of methods to mitigate uncertainty; and no explicit consideration of effects in species of concern. The purpose of the current study is to demonstrate that a new concept in toxicological and regulatory assessment, the adverse outcome pathway (AOP), has many useful attributes of potential use to ameliorate many of these problems, to expand data utility and model robustness, and to enable more accurate and defensible biological effects assessments within LCIA. Background, context, and examples have been provided to demonstrate these potential benefits. We additionally propose that these benefits can be most effectively realized through development of quantitative AOPs (qAOPs) crafted to meet the needs of the LCIA framework. As a means to stimulate qAOP research and development in support of LCIA, we propose 3 conceptual classes of qAOP, each with unique inherent attributes for supporting LCIA: 1) mechanistic, including computational toxicology models; 2) probabilistic, including Bayesian networks and supervised machine learning models; and 3) weight of evidence, including models built using decision-analytic methods. Overall, we have highlighted a number of potential applications of qAOPs that can refine and add value to LCIA. As the AOP concept and support framework matures, we see the potential for qAOPs to serve a foundational role for next-generation effects characterization within LCIA. Integr Environ Assess Manag 2016;12:580-590. Published 2015. This article is a US Government work and is in the public domain in the USA.
C1 [Gust, Kurt A.; Collier, Zachary A.; Mayo, Michael L.; Stanley, Jacob K.; Gong, Ping; Chappell, Mark A.] US Army Engineer Res & Dev Ctr, Vicksburg, MS 39180 USA.
RP Gust, KA (reprint author), US Army Engineer Res & Dev Ctr, Vicksburg, MS 39180 USA.
EM Kurt.A.Gust@usace.army.mil
FU Military Materials in the Environment (MME) Program for the US Army
   Engineer Research & Development (ERDC) Laboratory
FX Opinions, interpretations, conclusions, and recommendations are those of
   the author(s) and are not necessarily endorsed by the US Army. We extend
   kind thanks to the anonymous peer reviewers for their insights and
   expertise, which helped to substantially refine the content of this
   paper. This work was funded through the Military Materials in the
   Environment (MME) Program for the US Army Engineer Research &
   Development (ERDC) Laboratory.
CR Adverse Outcome Pathway Knowledge Base, 2014, US HDB GUID DOC DE S
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Beckon W, 2008, ENVIRON SCI TECHNOL, V42, P1308, DOI 10.1021/es071148m
   Bjorklund AE, 2002, INT J LIFE CYCLE ASS, V7, P64, DOI 10.1065/lca2001.12/071
   Boobis AR, 2008, CRIT REV TOXICOL, V38, P87, DOI 10.1080/10408440701749421
   Boobis AR, 2006, CRIT REV TOXICOL, V36, P781, DOI 10.1080/10408440600977677
   Brandes LJ, 1996, 719101029 RIVM NAT I
   Breen M, 2013, TOXICOL SCI, V133, P234, DOI 10.1093/toxsci/kft067
   Brentrup F, 2001, EUR J AGRON, V14, P221, DOI 10.1016/S1161-0301(00)00098-8
   Chapman PM, 1998, ENVIRON TOXICOL CHEM, V17, P99, DOI 10.1002/etc.5620170112
   CHARNIAK E, 1991, AI MAG, V12, P50
   Cristianini N, 2000, INTRO SUPPORT VECTOR
   Ekvall T, 2007, WASTE MANAGE, V27, P989, DOI 10.1016/j.wasman.2007.02.015
   Garcia-Reyero N, 2011, ECOTOXICOLOGY, V20, P580, DOI 10.1007/s10646-011-0623-3
   Garcia-Reyero N, 2011, ENVIRON TOXICOL CHEM, V30, P265, DOI 10.1002/etc.401
   Goedkoop M, 2009, 1 MIN HOUS SPAT PLAN
   Gough D, 2007, APPL PRACTICE BASED, V22, P213, DOI DOI 10.1080/02671520701296189
   GUINEE J, 1993, CHEMOSPHERE, V26, P1925, DOI 10.1016/0045-6535(93)90086-K
   HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503
   Huijbregts M, 2010, USETOX USER MANUAL
   Huijbregts MAJ, 2003, ENVIRON SCI TECHNOL, V37, P2600, DOI 10.1021/es020971+
   Huijbregts MAJ, 2000, CHEMOSPHERE, V41, P541, DOI 10.1016/S0045-6535(00)00030-8
   Humbert S, 2009, SCI TOTAL ENVIRON, V407, P4812, DOI 10.1016/j.scitotenv.2009.05.024
   ISO, 2006, 14040 ISO
   Jolliet O, 2003, INT J LIFE CYCLE ASS, V8, P324, DOI 10.1007/BF02978505
   Kramer VJ, 2011, ENVIRON TOXICOL CHEM, V30, P64, DOI 10.1002/etc.375
   LaLone CA, 2013, ENVIRON TOXICOL CHEM, V32, P2528, DOI 10.1002/etc.2330
   Larsen HF, 2007, INT J LIFE CYCLE ASS, V12, P24, DOI 10.1065/lca2006.12.287
   Li ZH, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-63
   Linkov I, 2011, ENVIRON SCI TECHNOL, V45, P5068, DOI 10.1021/es100959q
   Linkov I, 2011, RISK ANAL, V31, P1211, DOI 10.1111/j.1539-6924.2011.01585.x
   Linkov I, 2009, SCI TOTAL ENVIRON, V407, P5199, DOI 10.1016/j.scitotenv.2009.05.004
   Lloyd SM, 2007, J IND ECOL, V11, P161, DOI 10.1162/jiec.2007.1136
   MacKay C, 2013, ALTEX-ALTERN ANIM EX, V30, P473, DOI 10.14573/altex.2013.4.473
   Maxwell G, 2014, TOXICOL IN VITRO, V28, P8, DOI 10.1016/j.tiv.2013.10.013
   Mayo M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130494
   Mayo M, 2014, SCI TOTAL ENVIRON, V494, P104, DOI 10.1016/j.scitotenv.2014.06.061
   Menzie C, 1996, HUM ECOL RISK ASSESS, V2, P277, DOI 10.1080/10807039609383609
   Miller DH, 2007, ENVIRON TOXICOL CHEM, V26, P521, DOI 10.1897/06-318R.1
   Norris G., 2002, MANY DIMENSIONS UNCE
   NRC, 2007, TOXICITY TESTING 21
   NRC, 2009, SCI DEC ADV RISK ASS
   OECD, 2013, STPNANO201222FINAL, P1
   [OECD] Organization for Economic Co-operation and Development, 2011, WORKSH US MECH INF F, P1
   Olsen SI, 2001, ENVIRON IMPACT ASSES, V21, P385
   Owens JW, 1997, RISK ANAL, V17, P359, DOI 10.1111/j.1539-6924.1997.tb00874.x
   Owens JW, 1996, INT J LCA, V1, P151
   Owens JW, 1997, J IND ECOL, V1, P37, DOI DOI 10.1162/JIEC.1997.1.1.37
   Paul KB, 2013, TOXICOL IN VITRO, V27, P2049, DOI 10.1016/j.tiv.2013.07.008
   Pennington DW, 2004, ENVIRON TOXICOL CHEM, V23, P1796, DOI 10.1897/03-157
   Perkins EJ, 2013, ENVIRON HEALTH PERSP, V121, P1002, DOI 10.1289/ehp.1306638
   Perkins EJ, 2011, ENVIRON TOXICOL CHEM, V30, P22, DOI 10.1002/etc.374
   Perkins R, 2003, ENVIRON TOXICOL CHEM, V22, P1666, DOI 10.1897/01-171
   Potting J, 1997, INT J LIFE CYCLE ASS, V2, P171, DOI 10.1007/BF02978815
   Pourret O, 2008, BAYESIAN NETWORKS PR
   Rosenbaum RK, 2008, INT J LIFE CYCLE ASS, V13, P532, DOI 10.1007/s11367-008-0038-4
   Rosenbaum RK, 2011, INT J LIFE CYCLE ASS, V16, P710, DOI 10.1007/s11367-011-0316-4
   Ross S, 2002, INT J LIFE CYCLE ASS, V7, P47, DOI 10.1007/BF02978909
   Russom CL, 2014, ENVIRON TOXICOL CHEM, V33, P2157, DOI 10.1002/etc.2662
   Safe SH, 1998, ENVIRON HEALTH PERSP, V106, P1051, DOI 10.2307/3434151
   Seager TP, 2008, J IND ECOL, V12, P282, DOI 10.1111/j.1530-9290.2008.00048.x
   Seppala J, 2004, INT J LIFE CYCLE ASS, V9, P90, DOI 10.1065/lca2004.02.145
   Shoemaker JE, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-89
   Suter GW, 2011, SCI TOTAL ENVIRON, V409, P1406, DOI 10.1016/j.scitotenv.2010.12.029
   Swaen G, 2009, J CLIN EPIDEMIOL, V62, P270, DOI 10.1016/j.jclinepi.2008.06.013
   Tallarida RJ, 2012, J PHARMACOL EXP THER, V342, P2, DOI 10.1124/jpet.112.193474
   TRUHAUT R, 1991, FOOD ADDIT CONTAM, V8, P151, DOI 10.1080/02652039109373965
   Udo de Haes H A, 1999, INT J LCA, V4, P66
   Van de Meent D, 2005, ENVIRON TOXICOL CHEM, V24, P1573, DOI 10.1897/04-496R.1
   van Zelm R, 2007, INTEGR ENVIRON ASSES, V3, P203, DOI 10.1897/IEAM_2006-013.1
   van Zelm R, 2013, ENVIRON SCI TECHNOL, V47, P9274, DOI 10.1021/es305107s
   Villeneuve DL, 2013, TOXICOL SCI, V133, P225, DOI 10.1093/toxsci/kft068
   Vinken M, 2013, TOXICOL SCI, V136, P97, DOI 10.1093/toxsci/kft177
   Vinken M, 2013, TOXICOLOGY, V312, P158, DOI 10.1016/j.tox.2013.08.011
   Watanabe KH, 2011, ENVIRON TOXICOL CHEM, V30, P9, DOI 10.1002/etc.373
   Waters MD, 2004, NAT REV GENET, V5, P936, DOI 10.1038/nrg1493
   Weed DL, 2005, RISK ANAL, V25, P1545, DOI 10.1111/j.1539-6924.2005.00699.x
   Wilbanks MS, 2014, TOXICOL SCI, V141, P44, DOI 10.1093/toxsci/kfu104
   Willett C, 2014, ALTEX-ALTERN ANIM EX, V31, P407, DOI http://dx.doi.org/10.14573/altex.1401283
   Willett C, 2014, ALTEX-ALTERN ANIM EX, V31, P500, DOI http://dx.doi.org/10.14573/altex.1401281
   Zou M, 2005, BIOINFORMATICS, V21, P71, DOI 10.1093/bioinformatics/bth463
NR 81
TC 6
Z9 7
U1 3
U2 29
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1551-3777
EI 1551-3793
J9 INTEGR ENVIRON ASSES
JI Integr. Environ. Assess. Manag.
PD JUL
PY 2016
VL 12
IS 3
BP 580
EP 590
DI 10.1002/ieam.1708
PG 11
WC Environmental Sciences; Toxicology
SC Environmental Sciences & Ecology; Toxicology
GA DQ9SJ
UT WOS:000379549300021
PM 26331849
DA 2019-10-23
ER

PT J
AU El-Masri, H
   Kleinstreuer, N
   Hines, RN
   Adams, L
   Tal, T
   Isaacs, K
   Wetmore, BA
   Tan, YM
AF El-Masri, Hisham
   Kleinstreuer, Nicole
   Hines, Ronald N.
   Adams, Linda
   Tal, Tamara
   Isaacs, Kristin
   Wetmore, Barbara A.
   Tan, Yu-Mei
TI Integration of Life-Stage Physiologically Based Pharmacokinetic Models
   with Adverse Outcome Pathways and Environmental Exposure Models to
   Screen for Environmental Hazards
SO TOXICOLOGICAL SCIENCES
LA English
DT Article
DE PBPK; AOPs; life-stage; developmental toxicology; environmental
   toxicology
ID BLOOD-FLOW; IN-VITRO; PBPK MODELS; HUMAN FETUS; DEVELOPMENTAL
   EXPRESSION; TOXCAST PROGRAM; CARDIAC-OUTPUT; DUCTUS VENOSUS; TOXICITY;
   DOSIMETRY
AB A computational framework was developed to assist in screening and prioritizing chemicals based on their dosimetry, toxicity, and potential exposures. The overall strategy started with contextualizing chemical activity observed in high-throughput toxicity screening (HTS) by mapping these assays to biological events described in Adverse Outcome Pathways (AOPs). Next, in vitro to in vivo (IVIVE) extrapolation was used to convert an in vitro dose to an external exposure level, which was compared with potential exposure levels to derive an AOP-based margins of exposure (MOE). In this study, the framework was applied to estimate MOEs for chemicals that can potentially cause developmental toxicity following a putative AOP for fetal vasculogenesis/angiogenesis. A physiologically based pharmacokinetic (PBPK) model was developed to describe chemical disposition during pregnancy, fetal, neonatal, and infant to adulthood stages. Using this life-stage PBPK model, maternal exposures were estimated that would yield fetal blood levels equivalent to the chemical concentration that altered in vitro activity of selected HTS assays related to the most sensitive vasculogenesis/angiogenesis putative AOP. The resulting maternal exposure estimates were then compared with potential exposure levels using literature data or exposure models to derive AOP-based MOEs.
C1 [El-Masri, Hisham; Hines, Ronald N.; Adams, Linda; Tal, Tamara] US EPA, Natl Human & Environm Effects Res Lab, Off Res & Dev, Res Triangle Pk, NC USA.
   [Kleinstreuer, Nicole] Natl Inst Environm Hlth Sci, Natl Toxicol Program, Interagency Ctr Evaluat Alternat Toxicol Methods, Res Triangle Pk, NC USA.
   [Isaacs, Kristin; Tan, Yu-Mei] US EPA, Natl Exposure Res Lab, Off Res & Dev, Res Triangle Pk, NC USA.
   [Wetmore, Barbara A.] ScitoVation, Res Triangle Pk, NC USA.
RP El-Masri, H (reprint author), US EPA, Natl Human & Environm Effects Res Lab, Off Res & Dev, Res Triangle Pk, NC USA.
EM el-masri.hisham@epa.gov
RI Kleinstreuer, Nicole/F-7203-2019; Tal, Tamara/O-5414-2019
OI Kleinstreuer, Nicole/0000-0002-7914-3682; Tal,
   Tamara/0000-0001-8365-9385; Hines, Ronald/0000-0002-3094-4200; Isaacs,
   Kristin/0000-0001-9547-1654
CR Alcorn J, 2003, ADV DRUG DELIVER REV, V55, P667, DOI 10.1016/S0169-409X(03)00030-9
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   ATSDR, 2015, TOX PROF PE IN PRESS
   Barter ZE, 2007, CURR DRUG METAB, V8, P33, DOI 10.2174/138920007779315053
   Baschat AA, 2006, ULTRASOUND OBST GYN, V27, P349, DOI 10.1002/uog.2762
   Brown RP, 1997, TOXICOL IND HEALTH, V13, P407, DOI 10.1177/074823379701300401
   Clewell RA, 2007, J TOXICOL ENV HEAL A, V70, P408, DOI 10.1080/15287390600755216
   COULTHARD MG, 1994, ARCH DIS CHILD, V71, P281, DOI 10.1136/adc.71.3.281-a
   DAWES GS, 1968, P ROY SOC MED, V61, P1227, DOI 10.1177/003591576806111P207
   Dix DJ, 2007, TOXICOL SCI, V95, P5, DOI 10.1093/toxsci/kfl103
   Gentry PR, 2003, REGUL TOXICOL PHARM, V38, P1, DOI 10.1016/S0273-2300(03)00047-3
   Goldsmith MR, 2014, FOOD CHEM TOXICOL, V65, P269, DOI 10.1016/j.fct.2013.12.029
   Haugen G, 2004, ULTRASOUND OBST GYN, V24, P599, DOI 10.1002/uog.1744
   Hines RN, 2013, INT J PHARMACEUT, V452, P3, DOI 10.1016/j.ijpharm.2012.05.079
   Hines R. N., 2012, ENCY DRUG METABOLISM, P1
   Hines RN, 2008, PHARMACOL THERAPEUT, V118, P250, DOI 10.1016/j.pharmthera.2008.02.005
   Isaacs KK, 2014, ENVIRON SCI TECHNOL, V48, P12750, DOI 10.1021/es502513w
   JEGIER W, 1963, BRIT HEART J, V25, P425
   Judson RS, 2011, CHEM RES TOXICOL, V24, P451, DOI 10.1021/tx100428e
   Kavlock R, 2012, CHEM RES TOXICOL, V25, P1287, DOI 10.1021/tx3000939
   Kessler J, 2006, ULTRASOUND OBST GYN, V28, P890, DOI 10.1002/uog.3857
   Kessler J, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.12.038
   Kiserud T, 2000, AM J OBSTET GYNECOL, V182, P147, DOI 10.1016/S0002-9378(00)70504-7
   Kleinstreuer N, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002996
   Kleinstreuer NC, 2014, NAT BIOTECHNOL, V32, P583, DOI 10.1038/nbt.2914
   Knudsen TB, 2011, BIRTH DEFECTS RES C, V93, P312, DOI 10.1002/bdrc.20223
   Loccisano AE, 2013, J TOXICOL ENV HEAL A, V76, P25, DOI 10.1080/15287394.2012.722523
   LUECKE RH, 1995, INT J BIOMED COMPUT, V39, P337, DOI 10.1016/0020-7101(95)01115-U
   Martin SA, 2015, TOXICOL SCI, V143, P512, DOI 10.1093/toxsci/kfu246
   Midasch O, 2007, INT ARCH OCC ENV HEA, V80, P643, DOI 10.1007/s00420-006-0165-9
   Mielke G, 2001, CIRCULATION, V103, P1662, DOI 10.1161/01.CIR.103.12.1662
   Poirier A, 2009, MOL PHARMACEUT, V6, P1716, DOI 10.1021/mp8002495
   Poirier A, 2009, J PHARMACOKINET PHAR, V36, P585, DOI 10.1007/s10928-009-9139-3
   Rotroff DM, 2010, TOXICOL SCI, V117, P348, DOI 10.1093/toxsci/kfq220
   RUDOLPH AM, 1985, CIRC RES, V57, P811, DOI 10.1161/01.RES.57.6.811
   Smith GCS, 2002, BJOG-INT J OBSTET GY, V109, P721
   Strikwold M, 2013, ARCH TOXICOL, V87, P1709, DOI 10.1007/s00204-013-1107-4
   Tal TL, 2014, REPROD TOXICOL, V48, P51, DOI 10.1016/j.reprotox.2014.05.014
   Tayman Cuneyt, 2011, J Pediatr Pharmacol Ther, V16, P170, DOI 10.5863/1551-6776-16.3.170
   Trudel D, 2008, RISK ANAL, V28, P251, DOI 10.1111/j.1539-6924.2008.01017.x
   Valentin J., 2003, BASIC ANATOMICAL PHY
   VEILLE JC, 1993, AM J OBSTET GYNECOL, V169, P1399, DOI 10.1016/0002-9378(93)90407-A
   Wang LQ, 2004, DRUG METAB DISPOS, V32, P1162, DOI 10.1124/dmd.104.000273
   Wetmore BA, 2014, TOXICOL SCI, V142, P210, DOI 10.1093/toxsci/kfu169
   Wetmore BA, 2012, TOXICOL SCI, V125, P157, DOI 10.1093/toxsci/kfr254
   Zaya MJ, 2006, DRUG METAB DISPOS, V34, P2097, DOI 10.1124/dmd.106.011387
NR 46
TC 13
Z9 15
U1 0
U2 10
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1096-6080
EI 1096-0929
J9 TOXICOL SCI
JI Toxicol. Sci.
PD JUL
PY 2016
VL 152
IS 1
BP 230
EP 243
DI 10.1093/toxsci/kfw082
PG 14
WC Toxicology
SC Toxicology
GA DT2AA
UT WOS:000381282000020
PM 27208077
OA Green Published
DA 2019-10-23
ER

PT J
AU Benigni, R
   Bossa, C
   Tcheremenskaia, O
AF Benigni, Romualdo
   Bossa, Cecilia
   Tcheremenskaia, Olga
TI A data-based exploration of the adverse outcome pathway for skin
   sensitization points to the necessary requirements for its prediction
   with alternative methods
SO REGULATORY TOXICOLOGY AND PHARMACOLOGY
LA English
DT Article
DE Skin sensitization; Alternative; Human health; Modeling; QSAR;
   Structure-activity; Prediction; Adverse outcome pathways
ID CHEMICALS; CARCINOGENICITY; HAZARD; MODELS
AB This paper presents new data-based analyses on the ability of alternative methods to predict the skin sensitization potential of chemicals. It appears that skin sensitization, as shown in humans and rodents, can be predicted with good accuracy both with in vitro assays and QSAR approaches. The accuracy is about the same: 85-90%. Given that every biological measure has inherent uncertainty, this performance is quite remarkable. Overall, there is a good correlation between human data and experimental in vivo systems, except for sensitizers of intermediate potency. This uncertainty/variability is probably the reason why alternative methods are quite efficient in predicting both strong and non-sensitizers, but not the intermediate potency sensitizers. A detailed analysis of the predictivity of the individual approaches shows that the biological in vitro assays have limited added value in respect to the in chemico/QSAR ones, and suggests that the primary interaction with proteins is the rate-limiting step of the entire process. This confirms evidence from other fields (e.g., carcinogenicity, QSAR) indicating that successful predictive models are based on the parameterization of a few mechanistic features/events, whereas the consideration of all events supposedly involved in a toxicity pathway contributes to increase the uncertainty of the predictions. (C) 2016 Elsevier Inc. All rights reserved.
C1 [Benigni, Romualdo; Bossa, Cecilia; Tcheremenskaia, Olga] Ist Super Sanita, Environm & Hlth Dept, Viale Regina Elena 299, I-00161 Rome, Italy.
RP Benigni, R (reprint author), Ist Super Sanita, Environm & Hlth Dept, Viale Regina Elena 299, I-00161 Rome, Italy.
EM Romualdo.benigni@gmail.com
RI Bossa, Cecilia/K-4454-2016
OI Bossa, Cecilia/0000-0003-2084-2902; Tcheremenskaia,
   Olga/0000-0002-5029-3484; Tcheremenskaia, Olga/0000-0002-2824-2648
CR [Anonymous], 2012, OECD SER TEST ASS, V168
   Ashikaga T, 2006, TOXICOL IN VITRO, V20, P767, DOI 10.1016/j.tiv.2005.10.012
   Basketter DA, 2014, DERMATITIS, V25, P11, DOI 10.1097/DER.0000000000000003
   BENIGNI R, 1994, AM J PHYSIOL, V266, pR1697
   Benigni R, 2007, J ENVIRON SCI HEAL C, V25, P53, DOI 10.1080/10590500701201828
   Benigni R, 2015, J ENVIRON SCI HEAL C, V33, P422, DOI 10.1080/10590501.2015.1096885
   Benigni R, 2014, EXPERT OPIN DRUG MET, V10, P1199, DOI 10.1517/17425255.2014.934670
   Benigni R, 2011, CHEM REV, V111, P2507, DOI 10.1021/cr100222q
   Cherkasov A, 2014, J MED CHEM, V57, P4977, DOI 10.1021/jm4004285
   Dearden JC, 2015, CHEM RES TOXICOL, V28, P1975, DOI 10.1021/acs.chemrestox.5b00197
   Emter R, 2010, TOXICOL APPL PHARM, V245, P281, DOI 10.1016/j.taap.2010.03.009
   Franke R., 2003, QUANTITATIVE STRUCTU, P1
   FRANKE R, 1984, THEORETICAL DRUG DES
   Gerberick GF, 2004, TOXICOL SCI, V81, P332, DOI 10.1093/toxsci/kfh213
   Goebel C, 2012, REGUL TOXICOL PHARM, V63, P40, DOI 10.1016/j.yrtph.2012.02.007
   Hansch C., 1995, EXPLORING QSAR 1 FUN
   Hoffmann S, 2015, ALTEX-ALTERN ANIM EX, V32, P379, DOI [http://dx.doi.org/10.14573/altex.1505051, 10.14573/altex.1505051]
   Kubinyi H, 1993, 3D QSAR DRUG DESIGN
   Mekenyan O, 2012, SAR QSAR ENVIRON RES, V23, P553, DOI 10.1080/1062936X.2012.679689
   Natsch A, 2008, TOXICOL SCI, V106, P464, DOI 10.1093/toxsci/kfn194
   Natsch A, 2015, TOXICOL SCI, V143, P319, DOI 10.1093/toxsci/kfu229
   Reisinger K, 2015, TOXICOL IN VITRO, V29, P259, DOI 10.1016/j.tiv.2014.10.018
   SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615
   Teubner W, 2013, REGUL TOXICOL PHARM, V67, P468, DOI 10.1016/j.yrtph.2013.09.007
   TOPLISS JG, 1979, J MED CHEM, V22, P1238, DOI 10.1021/jm00196a017
   Transtrum MK, 2015, J CHEM PHYS, V143, DOI 10.1063/1.4923066
   Tun K, 2011, CURR COMPUT-AID DRUG, V7, P206, DOI 10.2174/157340911796504297
   Tute M.S., 1990, COMPREHENSIVE MED CH, V4, P1
   UN, 2011, STSGAC1030REV4 UN
   Urbisch D, 2015, REGUL TOXICOL PHARM, V71, P337, DOI 10.1016/j.yrtph.2014.12.008
   Vinken M, 2013, TOXICOLOGY, V312, P158, DOI 10.1016/j.tox.2013.08.011
NR 31
TC 3
Z9 3
U1 0
U2 7
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0273-2300
EI 1096-0295
J9 REGUL TOXICOL PHARM
JI Regul. Toxicol. Pharmacol.
PD JUL
PY 2016
VL 78
BP 45
EP 52
DI 10.1016/j.yrtph.2016.04.003
PG 8
WC Medicine, Legal; Pharmacology & Pharmacy; Toxicology
SC Legal Medicine; Pharmacology & Pharmacy; Toxicology
GA DN8GA
UT WOS:000377316000005
PM 27090483
DA 2019-10-23
ER

PT J
AU Margiotta-Casaluci, L
   Owen, SF
   Huerta, B
   Rodriguez-Mozaz, S
   Kugathas, S
   Barcelo, D
   Rand-Weaver, M
   Sumpter, JP
AF Margiotta-Casaluci, Luigi
   Owen, Stewart F.
   Huerta, Belinda
   Rodriguez-Mozaz, Sara
   Kugathas, Subramanian
   Barcelo, Damia
   Rand-Weaver, Mariann
   Sumpter, John P.
TI Internal exposure dynamics drive the Adverse Outcome Pathways of
   synthetic glucocorticoids in fish (vol 6, 21978, 2016)
SO SCIENTIFIC REPORTS
LA English
DT Correction
RI Margiotta-Casaluci, Luigi/A-5402-2011
OI Margiotta-Casaluci, Luigi/0000-0001-6938-0396; Huerta,
   Belinda/0000-0003-4392-4898; Owen, Stewart/0000-0003-1398-7142
CR Margiotta-Casaluci L, 2016, SCI REP-UK, V6, DOI 10.1038/srep21978
NR 1
TC 0
Z9 0
U1 0
U2 11
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD JUN 20
PY 2016
VL 6
AR 28122
DI 10.1038/srep28122
PG 1
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DO8KA
UT WOS:000378031000001
PM 27323248
OA DOAJ Gold, Green Published
DA 2019-10-23
ER

PT J
AU Kumar, KLS
   Tangadpalliwar, SR
   Desai, A
   Singh, VK
   Jere, A
AF Kumar, Konda Leela Sarath
   Tangadpalliwar, Sujit R.
   Desai, Aarti
   Singh, Vivek K.
   Jere, Abhay
TI Integrated Computational Solution for Predicting Skin Sensitization
   Potential of Molecules
SO PLOS ONE
LA English
DT Article
ID ADVERSE OUTCOME PATHWAY; ALLERGIC CONTACT-DERMATITIS; LYMPH-NODE DATA;
   IN-VITRO; FORCE FIELD; READ-ACROSS; QSAR MODELS; MECHANISMS; SYSTEMS;
   CLASSIFICATION
AB Introduction
   Skin sensitization forms a major toxicological endpoint for dermatology and cosmetic products. Recent ban on animal testing for cosmetics demands for alternative methods. We developed an integrated computational solution (SkinSense) that offers a robust solution and addresses the limitations of existing computational tools i.e. high false positive rate and/or limited coverage.
   Results
   The key components of our solution include: QSAR models selected from a combinatorial set, similarity information and literature-derived sub-structure patterns of known skin protein reactive groups. Its prediction performance on a challenge set of molecules showed accuracy = 75.32%, CCR = 74.36%, sensitivity = 70.00% and specificity = 78.72%, which is better than several existing tools including VEGA (accuracy = 45.00% and CCR = 54.17% with 'High' reliability scoring), DEREK (accuracy = 72.73% and CCR = 71.44%) and TOPKAT (accuracy = 60.00% and CCR = 61.67%). Although, TIMES-SS showed higher predictive power (accuracy = 90.00% and CCR = 92.86%), the coverage was very low (only 10 out of 77 molecules were predicted reliably).
   Conclusions
   Owing to improved prediction performance and coverage, our solution can serve as a useful expert system towards Integrated Approaches to Testing and Assessment for skin sensitization. It would be invaluable to cosmetic/dermatology industry for pre-screening their molecules, and reducing time, cost and animal testing.
C1 [Kumar, Konda Leela Sarath; Tangadpalliwar, Sujit R.; Desai, Aarti; Singh, Vivek K.; Jere, Abhay] Persistent Syst Ltd, LABS, Pune, Maharashtra, India.
   [Kumar, Konda Leela Sarath; Tangadpalliwar, Sujit R.] Natl Inst Pharmaceut Educ & Res, Dept Pharmacoinformat, Vaishali, Bihar, India.
RP Jere, A (reprint author), Persistent Syst Ltd, LABS, Pune, Maharashtra, India.
EM abhay_jere@persistent.com
CR Alves VM, 2015, TOXICOL APPL PHARM, V284, P262, DOI 10.1016/j.taap.2014.12.014
   Anderson Stacey E, 2011, J Allergy (Cairo), V2011, P424203, DOI 10.1155/2011/424203
   [Anonymous], 2010, VLIFEMDS MOLECULAR D
   Aptula AO, 2006, CHEM RES TOXICOL, V19, P1097, DOI 10.1021/tx0601004
   Bauch C, 2012, REGUL TOXICOL PHARM, V63, P489, DOI 10.1016/j.yrtph.2012.05.013
   Blum LC, 2011, J COMPUT AID MOL DES, V25, P637, DOI 10.1007/s10822-011-9436-y
   Bruce CL, 2007, J CHEM INF MODEL, V47, P219, DOI 10.1021/ci600332j
   Chaudhry Q, 2010, CHEM CENT J, V4, DOI 10.1186/1752-153X-4-S1-S5
   Chipinda Itai, 2011, J Allergy (Cairo), V2011, P839682, DOI 10.1155/2011/839682
   Cronin M T, 1994, SAR QSAR Environ Res, V2, P159, DOI 10.1080/10629369408029901
   Divkovic M, 2005, CONTACT DERMATITIS, V53, P189, DOI 10.1111/j.0105-1873.2005.00683.x
   Dudek AZ, 2006, COMB CHEM HIGH T SCR, V9, P213, DOI 10.2174/138620706776055539
   Emter R, 2013, TOXICOL IN VITRO, V27, P2225, DOI 10.1016/j.tiv.2013.09.009
   Emter R, 2010, TOXICOL APPL PHARM, V245, P281, DOI 10.1016/j.taap.2010.03.009
   Enoch SJ, 2008, SAR QSAR ENVIRON RES, V19, P555, DOI 10.1080/10629360802348985
   Enoch SJ, 2009, QSAR COMB SCI, V28, P696, DOI 10.1002/qsar.200960011
   Enslein K, 1997, FOOD CHEM TOXICOL, V35, P1091, DOI 10.1016/S0278-6915(97)87277-8
   EU. REGULATION (EC), 2006, OFFICIAL JOURNAL OF
   Garg P, 2015, MOL DIVERS, V19, P163, DOI 10.1007/s11030-014-9562-2
   Gerberick GF, 2005, DERMATITIS, V16, P157, DOI 10.2310/6620.2005.05040
   Greene N, 2002, ADV DRUG DELIVER REV, V54, P417, DOI 10.1016/S0169-409X(02)00012-1
   Halgren TA, 1996, J COMPUT CHEM, V17, P520, DOI 10.1002/(SICI)1096-987X(199604)17:6<520::AID-JCC2>3.3.CO;2-W
   Halgren TA, 1996, J COMPUT CHEM, V17, P490, DOI 10.1002/(SICI)1096-987X(199604)17:5/6<490::AID-JCC1>3.0.CO;2-P
   Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI DOI 10.1145/1656274.1656278
   Heller S, 2013, J CHEMINFORMATICS, V5, DOI 10.1186/1758-2946-5-7
   Hewitt M, 2010, REPROD TOXICOL, V30, P147, DOI 10.1016/j.reprotox.2009.12.003
   Johansson H, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-399
   Johnson M. A., 1990, CONCEPTS APPL MOL SI
   Karlberg AT, 2008, CHEM RES TOXICOL, V21, P53, DOI 10.1021/tx7002239
   Kern PS, 2010, DERMATITIS, V21, P8, DOI 10.2310/6620.2009.09038
   Kimber I, 2001, TOXICOL SCI, V59, P198, DOI 10.1093/toxsci/59.2.198
   Li SQ, 2005, J CHEM INF MODEL, V45, P952, DOI 10.1021/ci050049u
   Low Y, 2011, CHEM RES TOXICOL, V24, P1251, DOI 10.1021/tx200148a
   MacKay C, 2013, ALTEX-ALTERN ANIM EX, V30, P473, DOI 10.14573/altex.2013.4.473
   Magee PS, 2000, QUANT STRUCT-ACT REL, V19, P356, DOI 10.1002/1521-3838(200010)19:4<356::AID-QSAR356>3.0.CO;2-I
   Nantasenamat C, 2014, CHEM PAP, V68, P697, DOI 10.2478/s11696-013-0498-2
   Natsch A, 2013, J APPL TOXICOL, V33, P1337, DOI 10.1002/jat.2868
   Natsch A, 2009, TOXICOL SCI, V107, P106, DOI 10.1093/toxsci/kfn204
   Nukada Y, 2013, TOXICOL IN VITRO, V27, P609, DOI 10.1016/j.tiv.2012.11.006
   O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-33
   O'Boyle NM, 2008, CHEM CENT J, V2, DOI 10.1186/1752-153X-2-5
   [Organisation of Economic Cooperation and Development (OECD) OECD], 2012, OECD GUID TEST CHEM, P1, DOI DOI 10.1787/9789264185203-EN
   Patlewicz G, 2007, SAR QSAR ENVIRON RES, V18, P515, DOI 10.1080/10629360701427872
   Patlewicz G, 2008, JRC SCI TECH REP EUR, P23225
   Patlewicz G, 2008, QSAR COMB SCI, V27, P60, DOI 10.1002/qsar.200710067
   Patlewicz G, 2014, REGUL TOXICOL PHARM, V69, P529, DOI 10.1016/j.yrtph.2014.06.001
   Piroird C, 2015, TOXICOL IN VITRO, V29, P901, DOI 10.1016/j.tiv.2015.03.009
   Ravetti MG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003111
   Ren YY, 2006, ANAL CHIM ACTA, V572, P272, DOI 10.1016/j.aca.2006.05.027
   Roberts DW, 2007, CHEM RES TOXICOL, V20, P1321, DOI 10.1021/tx700169w
   Roberts DW, 2007, CHEM RES TOXICOL, V20, P44, DOI 10.1021/tx060121y
   Rodford R, 2003, ENVIRON TOXICOL CHEM, V22, P1855, DOI 10.1897/01-438
   Ruet Rossignol Martine, 2005, Altern Lab Anim, V33 Suppl 1, P19
   Ryan D, 2011, WAO WHITE BOOK ALLER, P5
   Sakaguchi H, 2007, TOXICOL LETT, V172, pS93, DOI 10.1016/j.toxlet.2007.05.257
   Schlede E, 2003, TOXICOLOGY, V193, P219, DOI 10.1016/S0300-483X(03)00266-X
   Singla Deepak, 2011, BMC Pharmacology, V11, P5, DOI 10.1186/1471-2210-11-5
   Teubner W, 2013, REGUL TOXICOL PHARM, V67, P468, DOI 10.1016/j.yrtph.2013.09.007
   Tou J., 1977, PATTERN RECOGNITION
   Tropsha A, 2010, MOL INFORM, V29, P476, DOI 10.1002/minf.201000061
   van der Veen JW, 2014, CRIT REV TOXICOL, V44, P590, DOI 10.3109/10408444.2014.925425
   Vocanson M, 2009, ALLERGY, V64, P1699, DOI 10.1111/j.1398-9995.2009.02082.x
   Yao XJ, 2004, J CHEM INF COMP SCI, V44, P1257, DOI 10.1021/ci049965i
   Yap CW, 2011, J COMPUT CHEM, V32, P1466, DOI 10.1002/jcc.21707
NR 64
TC 4
Z9 4
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 7
PY 2016
VL 11
IS 6
AR e0155419
DI 10.1371/journal.pone.0155419
PG 22
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DO1TC
UT WOS:000377561000003
PM 27271321
OA DOAJ Gold, Green Published
DA 2019-10-23
ER

PT J
AU Bohme, A
   Laqua, A
   Schuurmann, G
AF Boehme, Alexander
   Laqua, Anja
   Schueuermann, Gerrit
TI Chemoavailability of Organic Electrophiles: Impact of Hydrophobicity and
   Reactivity on Their Aquatic Excess Toxicity
SO CHEMICAL RESEARCH IN TOXICOLOGY
LA English
DT Article
ID STRUCTURAL ALERTS; APPLICABILITY DOMAIN; SKIN SENSITIZATION; IN-VITRO;
   PREDICTION; CLASSIFICATION; IDENTIFICATION; ECOTOXICOLOGY; MECHANISMS;
   TOXICOLOGY
AB Organic electrophiles have been recognized as important components of the exposome that can be characterized as cumulative totality of exposure in the organism in response to environmental perturbation. For such compounds, chemical reactivity may contribute significantly to the toxicological profile through covalent attacks at nudeophilic sites of peptides such as glutathione (GSH), proteins, lipid components, and the DNA and RNA. Employing a Michael acceptor set of 58 alpha,beta-unsaturated carbonyls with 15 ketones, 18 aldehydes, and 25 esters, the hydrophobicity and reactivity contributions to their toxicity enhancement T-e over baseline narcosis with the ciliates Tetrahymena pyriformis is analyzed through a conceptual model, featuring toxicokinetic phase transfer steps and the reactive molecular initiating event (MIE) at endogenous target sites exposed to water-rich or water-poor compartments. To this end, hydrophobicity was quantified by the octanol/water partition coefficient, K-ow, electrophilic reactivity through second-order rate constants of reaction with GSH in a kinetic chemoassay, k(GSH), and T-e as the ratio of narcosis-level vs experimental concentration yielding 50% growth inhibition of the ciliates within 48 h of exposure. The observed decrease of log T-e with increasing log K-ow can be traced back to a rate-determining impact of the toxicant transfer from the membrane to the intracellular cytosol. Moreover, the recently introduced concept of chemoavailability is shown to enable, from knowledge of log K-ow and log k(GSH) alone, a screening-level discrimination between reactive and hydrophobic MIEs triggering predominantly alone or in parallel respective adverse outcome pathways (AOPs) including the diffusion-control limit of reactive MIE saturation. As such, chemoavailability may aid in evaluating prevalent MLEs expected for a given organic electrophile and in assessing its toxicological profile within AOP schemes addressing aquatic toxicity.
C1 [Boehme, Alexander; Laqua, Anja; Schueuermann, Gerrit] Helmholtz Ctr Environm Res, UFZ Dept Ecol Chem, Permoserstr 15, D-04318 Leipzig, Germany.
   [Laqua, Anja; Schueuermann, Gerrit] Tech Univ Bergakad Freiberg, Inst Organ Chem, Leipziger Str 29, D-09596 Freiberg, Germany.
   [Laqua, Anja] PolyComply Hoechst GmbH, Ind Pk Hochst, Bldg F 821, D-65926 Frankfurt, Germany.
RP Schuurmann, G (reprint author), Helmholtz Ctr Environm Res, UFZ Dept Ecol Chem, Permoserstr 15, D-04318 Leipzig, Germany.; Schuurmann, G (reprint author), Tech Univ Bergakad Freiberg, Inst Organ Chem, Leipziger Str 29, D-09596 Freiberg, Germany.
EM gerrit.schuurmann@ufz.de
RI Schuurmann, Gerrit/E-7962-2017
OI Schuurmann, Gerrit/0000-0002-3789-1703
FU EUEuropean Union (EU) [GOCE-CT-2007-037017]; BMBFFederal Ministry of
   Education & Research (BMBF) [FKZ 031A422A, 031A422B]
FX Financial support through the EU-funded project OSIRIS (Optimized
   Strategies for Risk Assessment of Industrial Chemicals through
   Integration of Non-Test and Test Information, contract no.
   GOCE-CT-2007-037017) and the BMBF-funded project ProHapTox (Development
   of a Reactivity-Based Non-Animal Testing Strategy for Identifying the
   Skin Sensitization Potential of Electrophilic and Pro Electrophilic
   Chemicals within the Framework of REACH, FKZ 031A422A and 031A422B) is
   gratefully acknowledged.
CR Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Blaschke U, 2012, CHEM RES TOXICOL, V25, P170, DOI 10.1021/tx200395k
   Blaschke U, 2010, CHEM RES TOXICOL, V23, P1936, DOI 10.1021/tx100298w
   Bohme A, 2009, CHEM RES TOXICOL, V22, P742, DOI 10.1021/tx800492x
   Bohme A, 2010, CHEM RES TOXICOL, V23, P1905, DOI 10.1021/tx100226n
   Bolton JL, 2000, CHEM RES TOXICOL, V13, P135, DOI 10.1021/tx9902082
   Butterfield DA, 2010, BBA-MOL CELL BIOL L, V1801, P924, DOI 10.1016/j.bbalip.2010.02.005
   Collins FS, 2008, SCIENCE, V319, P906, DOI 10.1126/science.1154619
   DENEER JW, 1988, AQUAT TOXICOL, V13, P195, DOI 10.1016/0166-445X(88)90052-5
   DENEER JW, 1988, AQUAT TOXICOL, V12, P185, DOI 10.1016/0166-445X(88)90035-5
   Enoch SJ, 2012, CHEM RES TOXICOL, V25, P2490, DOI 10.1021/tx3003092
   Enoch SJ, 2010, CRIT REV TOXICOL, V40, P728, DOI 10.3109/10408444.2010.494175
   Escher BI, 2002, ENVIRON SCI TECHNOL, V36, P4201, DOI 10.1021/es015848h
   Hartung T, 2009, NATURE, V460, P208, DOI 10.1038/460208a
   HERMENS JLM, 1990, ENVIRON HEALTH PERSP, V87, P219, DOI 10.2307/3431028
   Hernandez-Fonseca K, 2008, J NEUROSCI RES, V86, P1768, DOI 10.1002/jnr.21634
   Karlberg AT, 2008, CHEM RES TOXICOL, V21, P53, DOI 10.1021/tx7002239
   LIPNICK RL, 1991, SCI TOTAL ENVIRON, V109, P131, DOI 10.1016/0048-9697(91)90175-E
   LoPachin RM, 2009, CHEM RES TOXICOL, V22, P1499, DOI 10.1021/tx900147g
   Martyniuk CJ, 2011, CHEM RES TOXICOL, V24, P2302, DOI 10.1021/tx200437y
   MCCARTY LS, 1993, ENVIRON SCI TECHNOL, V27, P1719
   Mekenyan O, 2014, CHEM RES TOXICOL, V27, P219, DOI 10.1021/tx400345b
   Mekenyan O, 2010, CHEM RES TOXICOL, V23, P1519, DOI 10.1021/tx100161j
   Meylan W. M., 2008, KOWWIN V1 67A
   MILLER EC, 1981, CANCER, V47, P1055, DOI 10.1002/1097-0142(19810301)47:5+<1055::AID-CNCR2820471302>3.0.CO;2-3
   Miller GW, 2014, TOXICOL SCI, V137, P1, DOI 10.1093/toxsci/kft251
   Mulliner D, 2013, MOL INFORM, V32, P98, DOI 10.1002/minf.201200101
   Natsch A, 2011, CHEM RES TOXICOL, V24, P2018, DOI 10.1021/tx2003678
   Netzeva TI, 2003, SAR QSAR ENVIRON RES, V14, P265, DOI 10.1080/1062936032000101501
   Pals JA, 2011, ENVIRON SCI TECHNOL, V45, P5791, DOI 10.1021/es2008159
   Rappaport SM, 2010, SCIENCE, V330, P460, DOI 10.1126/science.1192603
   Rauniyar N, 2009, PROTEOMICS, V9, P5188, DOI 10.1002/pmic.200900116
   Roberts DW, 2008, J APPL TOXICOL, V28, P377, DOI 10.1002/jat.1289
   Roberts DW, 2007, CHEM RES TOXICOL, V20, P44, DOI 10.1021/tx060121y
   Roberts DW, 2006, CHEM RES TOXICOL, V19, P1228, DOI 10.1021/tx060102o
   Schramm F, 2011, ENVIRON SCI TECHNOL, V45, P5812, DOI 10.1021/es200081n
   Schuurmann G, 2008, J CHEM INF MODEL, V48, P2140, DOI 10.1021/ci800253u
   Schultz TW, 2006, CELL BIOL TOXICOL, V22, P339, DOI 10.1007/s10565-006-0079-z
   Schultz TW, 2005, SAR QSAR ENVIRON RES, V16, P313, DOI 10.1080/10659360500204152
   Schwobel JAH, 2011, CHEMOSPHERE, V85, P1066, DOI 10.1016/j.chemosphere.2011.07.037
   Thaens D, 2012, CHEM RES TOXICOL, V25, P2092, DOI 10.1021/tx3001412
   Wells Peter G, 2010, Handb Exp Pharmacol, P131, DOI 10.1007/978-3-642-00663-0_6
   Wild CP, 2005, CANCER EPIDEM BIOMAR, V14, P1847, DOI 10.1158/1055-9965.EPI-05-0456
   Wondrousch D, 2010, J PHYS CHEM LETT, V1, P1605, DOI 10.1021/jz100247x
NR 44
TC 12
Z9 12
U1 0
U2 23
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0893-228X
EI 1520-5010
J9 CHEM RES TOXICOL
JI Chem. Res. Toxicol.
PD JUN
PY 2016
VL 29
IS 6
BP 952
EP 962
DI 10.1021/acs.chemrestox.5b00398
PG 11
WC Chemistry, Medicinal; Chemistry, Multidisciplinary; Toxicology
SC Pharmacology & Pharmacy; Chemistry; Toxicology
GA DP3CJ
UT WOS:000378369700003
PM 27096880
DA 2019-10-23
ER

PT J
AU Ebbrell, DJ
   Madden, JC
   Cronin, MTD
   Schultz, TW
   Enoch, SJ
AF Ebbrell, David J.
   Madden, Judith C.
   Cronin, Mark T. D.
   Schultz, Terry W.
   Enoch, Steven J.
TI Development of a Fragment-Based in Silico Profiler for Michael Addition
   Thiol Reactivity
SO CHEMICAL RESEARCH IN TOXICOLOGY
LA English
DT Article
ID ELECTROPHILIC REACTION CHEMISTRY; TRANSITION-STATE CALCULATIONS;
   STRUCTURAL ALERTS; AQUATIC TOXICITY; PROTEIN-BINDING;
   EXPERIMENTAL-VERIFICATION; ACCEPTOR REACTIVITY; GLUTATHIONE; PREDICTION;
   ALDEHYDES
AB The Adverse Outcome Pathway (AOP) paradigm details the existing knowledge that links the initial interaction between a chemical and a biological system, termed the molecular initiating event (MIE), through a series of intermediate events, to an adverse effect. An important example of a well-defined MIE is the formation of a covalent bond between a biological nucleophile and an electrophilic compound. This particular MIE has been associated with various toxicological end points such as acute aquatic toxicity, skin sensitization, and respiratory sensitization. This study has investigated the calculated parameters that are required to predict the rate of chemical bond formation (reactivity) of a dataset of Michael acceptors. Reactivity of these compounds toward glutathione was predicted using a combination of a calculated activation energy value (Ea calculated using density functional theory (DFT) calculation at the B3YLP/6-31G+(d) level of theory, and solvent-accessible surface area values (SAS) at the a carbon. To further develop the method, a fragment-based algorithm was developed enabling the reactivity to be predicted for Michael acceptors without the need to perform the time-consuming DFT calculations. Results showed the developed fragment method was successful in predicting the reactivity of the Michael acceptors excluding two sets of chemicals: volatile esters with an extended substituent at the beta-carbon and chemicals containing a conjugated benzene ring as part of the polarizing group. Additionally the study also demonstrated the ease with which the approach can be extended to other chemical classes by the calculation of additional fragments and their associated Ea, and SAS values. The resulting method is likely to be of use in regulatory toxicology tools where an understanding of covalent bond formation as a potential MIE is important within the AOP paradigm.
C1 [Ebbrell, David J.; Madden, Judith C.; Cronin, Mark T. D.; Enoch, Steven J.] Liverpool John Moores Univ, Sch Pharm & Bimole Sci, Byrom St, Liverpool L3 3AF, Merseyside, England.
   [Schultz, Terry W.] Univ Tennessee, Coll Vet Med, Dept Comparat Med, POB 1071, Knoxville, TN 37996 USA.
RP Enoch, SJ (reprint author), Liverpool John Moores Univ, Sch Pharm & Bimole Sci, Byrom St, Liverpool L3 3AF, Merseyside, England.
EM s.j.enoch@ljmu.ac.uk
FU LUSH from Liverpool John Moores University
FX The research described in this article was funded in part by the 2013
   LUSH prize for cosmetics and a research bursary to D.J.E. from Liverpool
   John Moores University.
CR Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Aptula AO, 2006, CHEM RES TOXICOL, V19, P1097, DOI 10.1021/tx0601004
   Aptula AO, 2009, CHEM RES TOXICOL, V22, P1541, DOI [10.1021/tx9000330, 10.1021/tx9000336]
   Bajot F, 2011, SAR QSAR ENVIRON RES, V22, P51, DOI 10.1080/1062936X.2010.528449
   Bohme A, 2010, CHEM RES TOXICOL, V23, P1905, DOI 10.1021/tx100226n
   Cee VJ, 2015, J MED CHEM, V58, P9171, DOI 10.1021/acs.jmedchem.5b01018
   Dahal UP, 2016, MEDCHEMCOMM, V7, P864, DOI 10.1039/c6md00017g
   Enoch SJ, 2013, CHEM RES TOXICOL, V26, P767, DOI 10.1021/tx4000655
   Enoch SJ, 2011, CRIT REV TOXICOL, V41, P783, DOI 10.3109/10408444.2011.598141
   Enoch SJ, 2009, CHEM RES TOXICOL, V22, P1447, DOI 10.1021/tx9001463
   Frisch M. J., 2009, GAUSSIAN 09 REVISION
   Kalgutkar AS, 2009, CHEM BIODIVERS, V6, P2115, DOI 10.1002/cbdv.200900055
   Mekenyan O, 2007, CHEM RES TOXICOL, V20, P1927, DOI 10.1021/tx700249q
   Mulliner D, 2011, ORG BIOMOL CHEM, V9, P8400, DOI 10.1039/c1ob06065a
   Nelms MD, 2013, SAR QSAR ENVIRON RES, V24, P695, DOI 10.1080/1062936X.2013.792874
   Obach RS, 2008, CHEM RES TOXICOL, V21, P1814, DOI 10.1021/tx800161s
   Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084
   Przybylak KR, 2013, ISSUES TOXICOL, V17, P44, DOI 10.1039/9781849734400-00044
   Rodriguez-Sanchez N, 2013, SAR QSAR ENVIRON RES, V24, P963, DOI 10.1080/1062936X.2013.820793
   Schultz TW, 2007, CHEM RES TOXICOL, V20, P1359, DOI 10.1021/tx700212u
   Schultz TW, 2005, SAR QSAR ENVIRON RES, V16, P313, DOI 10.1080/10659360500204152
   Schwobel JAH, 2010, SAR QSAR ENVIRON RES, V21, P693, DOI 10.1080/1062936X.2010.528943
   Schwobel JAH, 2011, CHEMOSPHERE, V85, P1066, DOI 10.1016/j.chemosphere.2011.07.037
   Schwobel JAH, 2010, CHEM RES TOXICOL, V23, P1576, DOI 10.1021/tx100172x
   VERHAAR HJM, 1992, CHEMOSPHERE, V25, P471, DOI 10.1016/0045-6535(92)90280-5
   Yarbrough JW, 2007, CHEM RES TOXICOL, V20, P558, DOI 10.1021/tx600344a
NR 26
TC 6
Z9 6
U1 0
U2 25
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0893-228X
EI 1520-5010
J9 CHEM RES TOXICOL
JI Chem. Res. Toxicol.
PD JUN
PY 2016
VL 29
IS 6
BP 1073
EP 1081
DI 10.1021/acs.chemrestox.6b00099
PG 9
WC Chemistry, Medicinal; Chemistry, Multidisciplinary; Toxicology
SC Pharmacology & Pharmacy; Chemistry; Toxicology
GA DP3CJ
UT WOS:000378369700015
PM 27100370
DA 2019-10-23
ER

PT J
AU Cox, LA
   Popken, DA
   Kaplan, AM
   Plunkett, LM
   Becker, RA
AF Cox, Louis Anthony (Tony)
   Popken, Douglas A.
   Kaplan, A. Michael
   Plunkett, Laura M.
   Becker, Richard A.
TI How well can in vitro data predict in vivo effects of chemicals? Rodent
   carcinogenicity as a case study
SO REGULATORY TOXICOLOGY AND PHARMACOLOGY
LA English
DT Article
DE Carcinogenesis; Prediction modeling; High throughput screening
ID BRADFORD-HILL CONSIDERATIONS; ADVERSE OUTCOME PATHWAYS; SCIENTIFIC
   CONFIDENCE; RELEVANCE; FRAMEWORK; MODE; PERTURBATIONS; MECHANISMS;
   WEIGHT
AB A recent research article by the National Center for Computational Toxicology (NCCT) (Kleinstreuer et al., 2013), indicated that high throughput screening (HTS) data from assays linked to hallmarks and presumed pathways of carcinogenesis could be used to predict classification of pesticides as either (a) possible, probable or likely rodent carcinogens; or (b) not likely carcinogens or evidence of non-carcinogenicity. Using independently developed software to validate the computational results, we replicated the majority of the results reported. We also found that the prediction model correlating cancer pathway bioactivity scores with in vivo carcinogenic effects in rodents was not robust. A change of classification of a single chemical in the test set was capable of changing the overall study conclusion about the statistical significance of the correlation. Furthermore, in the subset of pesticide compounds used in model validation, the accuracy of prediction was no better than chance for about three quarters of the chemicals (those with fewer than 7 positive outcomes in HTS assays representing the 11 histopathological endpoints used in model development), suggesting that the prediction model was not adequate to predict cancer hazard for most of these chemicals. Although the utility of the model for humans is also unclear because a number of the rodent responses modeled (e.g., mouse liver tumors, rat thyroid tumors, rat testicular tumors, etc.) are not considered biologically relevant to human responses, the data examined imply the need for further research with HTS assays and improved models, which might help to predict classifications of in vivo carcinogenic responses in rodents for the pesticide considered, and thus reduce the need for testing in laboratory animals. (C) 2016 The Authors. Published by Elsevier Inc.
C1 [Cox, Louis Anthony (Tony); Popken, Douglas A.] Cox Associates, 503 Franklin St, Denver, CO 80218 USA.
   [Kaplan, A. Michael] A Michael Kaplan & Associates LLC, 23 Wilkinson Dr, Landenberg, PA 19350 USA.
   [Plunkett, Laura M.] Integrat Biostrategies LLC, 1127 Eldridge Pkwy,Suite 300-335, Houston, TX 77077 USA.
   [Becker, Richard A.] Amer Chem Council, 700 Second St NE, Washington, DC 20002 USA.
RP Plunkett, LM (reprint author), Integrat Biostrategies LLC, 1127 Eldridge Pkwy,Suite 300-335, Houston, TX 77077 USA.
EM tcoxdenver@aol.com; amkaplan1@comcast.net; Implunkett@inbiostrat.com;
   Rick_Becker@americanchemistry.com
FU American Chemistry Council (ACC)
FX The authors had complete control over the design, conduct,
   interpretation, and reporting of the analyses included in this
   manuscript. The contents of this manuscript are solely the
   responsibility of the authors and do not necessarily reflect the views
   or policies of their employers. L.A. Cox, D. Popken, L Plunkett and A.M.
   Kaplan received funding to support this research from the American
   Chemistry Council (ACC). R. Becker is employed by ACC, a trade
   association of U. S. chemical manufacturers.
CR Becker RA, 2015, REGUL TOXICOL PHARM, V72, P514, DOI 10.1016/j.yrtph.2015.04.004
   Benigni R, 2004, MUTAT RES-REV MUTAT, V566, P49, DOI 10.1016/S1383-5742(03)00051-6
   Borgert CJ, 2015, REGUL TOXICOL PHARM, V72, P538, DOI 10.1016/j.yrtph.2015.04.018
   Cohen S.M., 2003, TOXICOL SCI, V78, P181
   Cohen SM, 2011, TOXICOL SCI, V120, pS76, DOI 10.1093/toxsci/kfq365
   Cook JC, 1999, CRIT REV TOXICOL, V29, P169, DOI 10.1080/10408449991349203
   Cox LA, 2014, REGUL TOXICOL PHARM, V69, P443, DOI 10.1016/j.yrtph.2014.05.010
   Gaylor DW, 2005, REGUL TOXICOL PHARM, V41, P128, DOI 10.1016/j.yrtph.2004.11.001
   Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013
   Hill, 1998, EPA630R97002
   Judson RS, 2015, TOXICOL SCI, V148, P137, DOI 10.1093/toxsci/kfv168
   Kerr KF, 2014, EPIDEMIOLOGY, V25, P114, DOI 10.1097/EDE.0000000000000018
   Kleinstreuer NC, 2013, TOXICOL SCI, V131, P40, DOI 10.1093/toxsci/kfs285
   Knight A, 2006, ATLA-ALTERN LAB ANIM, V34, P19, DOI 10.1177/026119290603400117
   Maronpot RR, 2009, J TOXICOL PATHOL, V22, P11, DOI 10.1293/tox.22.11
   McElduff F, 2010, ADV PHYSIOL EDUC, V34, P128, DOI 10.1152/advan.00017.2010
   Meek ME, 2014, J APPL TOXICOL, V34, P595, DOI 10.1002/jat.2984
   Patlewicz G, 2003, ENVIRON TOXICOL CHEM, V22, P1885, DOI 10.1897/01-461
   Patlewicz G, 2015, REGUL TOXICOL PHARM, V71, P463, DOI 10.1016/j.yrtph.2015.02.011
   Proctor DM, 2007, TOXICOL SCI, V98, P313, DOI 10.1093/toxsci/kfm075
   Simon TW, 2014, CRIT REV TOXICOL, V44, P17, DOI 10.3109/10408444.2014.931925
   Slikker W, 2004, TOXICOL APPL PHARM, V201, P203, DOI 10.1016/j.taap.2004.06.019
   Smith M.T., 2015, ENV HLTH PE IN PRESS
   Snyder RD, 2004, ENVIRON MOL MUTAGEN, V43, P143, DOI 10.1002/em.20013
   Thomas RS, 2013, TOXICOL SCI, V136, P4, DOI 10.1093/toxsci/kft178
   Thomas RS, 2012, TOXICOL SCI, V128, P398, DOI 10.1093/toxsci/kfs159
   Valerio LG, 2007, TOXICOL APPL PHARM, V222, P1, DOI 10.1016/j.taap.2007.03.012
   Valerio LG, 2010, MOL NUTR FOOD RES, V54, P186, DOI 10.1002/mnfr.200900259
   Villeneuve DL, 2014, TOXICOL SCI, V142, P312, DOI 10.1093/toxsci/kfu199
   Villeneuve DL, 2014, TOXICOL SCI, V142, P321, DOI 10.1093/toxsci/kfu200
   Walmsley RM, 2011, BRIT J PHARMACOL, V162, P1250, DOI 10.1111/j.1476-5381.2010.01131.x
   Zhang Q, 2014, ENVIRON HEALTH PERSP, V122, P1261, DOI 10.1289/ehp.1408244
NR 32
TC 6
Z9 6
U1 0
U2 9
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0273-2300
EI 1096-0295
J9 REGUL TOXICOL PHARM
JI Regul. Toxicol. Pharmacol.
PD JUN
PY 2016
VL 77
BP 54
EP 64
DI 10.1016/j.yrtph.2016.02.005
PG 11
WC Medicine, Legal; Pharmacology & Pharmacy; Toxicology
SC Legal Medicine; Pharmacology & Pharmacy; Toxicology
GA DN1FY
UT WOS:000376812900007
PM 26879462
OA Other Gold
DA 2019-10-23
ER

PT J
AU Wikoff, DS
   Rager, JE
   Haws, LC
   Borghoff, SJ
AF Wikoff, D. S.
   Rager, J. E.
   Haws, L. C.
   Borghoff, S. J.
TI A high dose mode of action for tetrabromobisphenol A-induced uterine
   adenocarcinomas in Wistar Han rats: A critical evaluation of key events
   in an adverse outcome pathway framework
SO REGULATORY TOXICOLOGY AND PHARMACOLOGY
LA English
DT Article
DE TBBPA; AOP; Estrogen; Sulfotransferase; Mode of action; Uterine tumor
ID BROMINATED FLAME RETARDANTS; POLYBROMINATED DIPHENYL ETHERS; BLOOD
   GLUTAMATE LEVELS; SPRAGUE-DAWLEY RATS; IN-VITRO; ENDOMETRIAL CANCER;
   BISPHENOL-A; ESTROGEN-RECEPTOR; RISK-ASSESSMENT; EXPOSURE ASSESSMENT
AB TBBPA is a non-genotoxic flame retardant used to improve fire safety in a wide variety of consumer products. Estimated human exposures to TBBPA are very low (<0.000084 mg/kg-day), relative to the doses (500 and 1000 mg/kg-day of TBBPA) administered in a recent bioassay that resulted in uterine tumors in Wistar Han rats following chronic exposure. As part of an effort to characterize the relevance of the uterine tumors to humans, data and biological knowledge relevant to the progression of events associated with TBBPA-induced uterine tumors in female rats were organized in an adverse outcome pathway (AOP) framework. Based on a review of possible MOAs for chemically induced uterine tumors and available TBBPA data sets, a plausible molecular initiating event (MIE) was the ability of TBBPA to bind to and inhibit estrogen sulfotransferases, the enzymes responsible for sulfation of estradiol. Subsequent key events in the AOP, including increased bioavailability of unconjugated estrogens in uterine tissue, would occur as a result of decreased sulfation, leading to a disruption in estrogen homeostasis, increased expression of estrogen responsive genes, cell proliferation, and hyperplasia. Available data support subsequent key events, including generation of reactive quinones from the metabolism of estrogens, followed by DNA damage that could contribute to the development of uterine tumors. Uncertainties associated with human relevance are highlighted by potential strain/species sensitivities to development of uterine tumors, as well as the characterization of a dose-dependent MIE. For the latter, it was determined that the TBBPA metabolic profile is altered at high doses (such as those used in the cancer bioassay), and thus an MIE that is only operative under repeated high dose, administration. The MIE and subsequent key events for the development of TBBPA-induced uterine tumors are not feasible in humans given differences in the kinetic and dynamic factors associated with high dose exposures in rats relative to human exposure levels to TBBPA. (C) 2016 The Authors. Published by Elsevier Inc.
C1 [Wikoff, D. S.; Rager, J. E.; Haws, L. C.] ToxStrategies, Austin, TX USA.
   [Borghoff, S. J.] ToxStrategies, Cary, NC USA.
RP Wikoff, DS (reprint author), 9390 Res Blvd, Austin, TX 78759 USA.
EM dwikoff@toxstrategies.com
FU North American Flame Retardant Alliance (NAFRA) of the American
   Chemistry Council (ACC)
FX The authors thank Dr. Chad Thompson for his insightful comments on the
   evaluation of TBBPA MoA within an AOP framework. This work was funded by
   the North American Flame Retardant Alliance (NAFRA) of the American
   Chemistry Council (ACC). The funders were given the opportunity to
   review the draft manuscript; the purpose of such review was to allow
   input on the clarity of the science presented but not in interpretation
   of the research findings. The researchers' scientific conclusions and
   professional judgments were not subject to the funders' control; the
   contents of this manuscript reflect solely the view of the authors. The
   authors employment affiliation is as shown on the cover page.
   ToxStrategies is a private consulting firm providing services on
   toxicology and risk assessment issues to private and public
   organizations.
CR AKINS JR, 1989, CLIN CHIM ACTA, V184, P219, DOI 10.1016/0009-8981(89)90054-5
   ALISON RH, 1994, TOXICOL PATHOL, V22, P179, DOI 10.1177/019262339402200211
   Allen TEH, 2014, CHEM RES TOXICOL, V27, P2100, DOI 10.1021/tx500345j
   [Anonymous], 2011, EFSA J, V9, DOI 10.2903/j.efsa.2011.2477
   Bansal N, 2009, CANCER CONTROL, V16, P8, DOI 10.1177/107327480901600102
   Bartels PH, 2012, GYNECOL ONCOL, V125, P129, DOI 10.1016/j.ygyno.2011.12.422
   Behnisch PA, 2003, ENVIRON INT, V29, P861, DOI 10.1016/S0160-4120(03)00105-3
   Blom MJ, 2001, DRUG METAB DISPOS, V29, P76
   Boobis AR, 2006, CRIT REV TOXICOL, V36, P781, DOI 10.1080/10408440600977677
   Borghoff SJ, 2016, TOXICOL REP, V3, P190, DOI 10.1016/j.toxrep.2016.01.007
   Canton RF, 2006, TOXICOL APPL PHARM, V216, P274, DOI 10.1016/j.taap.2006.05.007
   Cariou R, 2008, CHEMOSPHERE, V73, P1036, DOI 10.1016/j.chemosphere.2008.07.084
   Cavalieri E, 2014, MOL ASPECTS MED, V36, P1, DOI 10.1016/j.mam.2013.08.002
   Choi JY, 2005, CANCER EPIDEM BIOMAR, V14, P1090, DOI 10.1158/1055-9965.EPI-04-0688
   Colnot T, 2014, ARCH TOXICOL, V88, P553, DOI 10.1007/s00204-013-1180-8
   Cope RB, 2015, TOXICOLOGY, V329, P49, DOI 10.1016/j.tox.2014.12.013
   DEERBERG F, 1981, VET PATHOL, V18, P707, DOI 10.1177/030098588101800601
   Dorosh A, 2011, FOLIA BIOL-PRAGUE, V57, P35
   (Dow) The Dow Chemical Company, 1975, RES 90 DAY TOX STUD
   Dunnick JK, 2015, TOXICOL PATHOL, V43, P464, DOI 10.1177/0192623314557335
   ELSINGHORST TAM, 1984, VET QUART, V6, P200, DOI 10.1080/01652176.1984.9693937
   (EU) European Union, 2006, RISK ASS REP 2 2 6 2, V63
   European Commission, 2015, THRESH TOX CONC
   Falany JL, 1998, CHEM-BIOL INTERACT, V109, P329, DOI 10.1016/S0009-2797(97)00143-9
   FOX H, 1984, PATHOL RES PRACT, V179, P13, DOI 10.1016/S0344-0338(84)80055-2
   Gaylor DW, 2005, REGUL TOXICOL PHARM, V41, P128, DOI 10.1016/j.yrtph.2004.11.001
   Germer S, 2006, TOXICOLOGY, V218, P229, DOI 10.1016/j.tox.2005.10.019
   Golden RJ, 1997, REGUL TOXICOL PHARM, V26, P142, DOI 10.1006/rtph.1997.1161
   Gosavi RA, 2013, ENVIRON HEALTH PERSP, V121, P1194, DOI 10.1289/ehp.1306902
   Hamers T, 2006, TOXICOL SCI, V92, P157, DOI 10.1093/toxsci/kfj187
   Harju M, 2007, ENVIRON TOXICOL CHEM, V26, P816, DOI 10.1897/06-308R.1
   Harleman JH, 2012, TOXICOL PATHOL, V40, P926, DOI 10.1177/0192623312444621
   Harvey JB, 2015, TOXICOL PATHOL, V43, P1103, DOI 10.1177/0192623315599256
   Health Canada/Environment Canada, 2013, SCREEN ASS REP PHEN
   Helleday T, 1999, MUTAT RES-GEN TOX EN, V439, P137, DOI 10.1016/S1383-5718(98)00186-7
   Hilliard G D, 1979, Recent Results Cancer Res, V66, P49
   Hirata H, 2008, CANCER, V112, P1964, DOI 10.1002/cncr.23392
   (IARC) International Agency for Research on Cancer, 2012, PHARM REV HUM CARC A, V100A
   (IPCS) International Programme on Chemical Safety, 2007, 4 IPCS 2
   (IPCS) International Programme on Chemical Safety, 2007, 4 IPCS 1
   Jakobsson K, 2002, CHEMOSPHERE, V46, P709, DOI 10.1016/S0045-6535(01)00235-1
   Jefcoate C R, 2000, J Natl Cancer Inst Monogr, P95
   Judson RS, 2015, TOXICOL SCI, V148, P137, DOI 10.1093/toxsci/kfv168
   Kang MJ, 2009, J TOXICOL ENV HEAL A, V72, P1439, DOI 10.1080/15287390903212907
   Karageorgi S, 2011, GYNECOL ONCOL, V121, P54, DOI 10.1016/j.ygyno.2010.11.014
   KEGG, 2015, KYOTO ENCY GENES GEN
   Kester MHA, 2002, J CLIN ENDOCR METAB, V87, P1142, DOI 10.1210/jc.87.3.1142
   Kicinski M., 2012, ENV HLTH, V14, P11
   Kim UJ, 2014, ENVIRON POLLUT, V184, P193, DOI 10.1016/j.envpol.2013.08.034
   Kitamura S, 2005, TOXICOL SCI, V84, P249, DOI 10.1093/toxsci/kfi074
   Klaunig JE, 2016, REGUL TOXICOL PHARM, V74, pS44, DOI 10.1016/j.yrtph.2015.06.021
   Knudsen GA, 2014, TOXICOL REP, V1, P214, DOI 10.1016/j.toxrep.2014.03.005
   Korner W, 1998, CHEMOSPHERE, V37, P2395, DOI 10.1016/S0045-6535(98)00297-5
   Kuester RK, 2007, TOXICOL SCI, V96, P237, DOI 10.1093/toxsci/kfm006
   KURMAN RJ, 1985, CANCER, V56, P403, DOI 10.1002/1097-0142(19850715)56:2<403::AID-CNCR2820560233>3.0.CO;2-X
   Lai DY, 2015, FOOD CHEM TOXICOL, V80, P206, DOI 10.1016/j.fct.2015.03.023
   Lax SF, 2000, CANCER-AM CANCER SOC, V88, P814, DOI 10.1002/(SICI)1097-0142(20000215)88:4<814::AID-CNCR12>3.3.CO;2-L
   Lee HK, 2012, J TOXICOL SCI, V37, P431, DOI 10.2131/jts.37.431
   Li J, 2010, TOXICOL IN VITRO, V24, P201, DOI 10.1016/j.tiv.2009.09.008
   Liehr JG, 2000, ENDOCR REV, V21, P40, DOI 10.1210/er.21.1.40
   Lingeman C H, 1979, Recent Results Cancer Res, V66, P1
   Liu Fu-Shing, 2007, Taiwan J Obstet Gynecol, V46, P26, DOI 10.1016/S1028-4559(08)60102-3
   Meek ME, 2014, J APPL TOXICOL, V34, P1, DOI 10.1002/jat.2949
   Meek ME, 2003, CRIT REV TOXICOL, V33, P591, DOI 10.1080/10408440390250136
   Meerts IATM, 2001, ENVIRON HEALTH PERSP, V109, P399, DOI 10.1289/ehp.01109399
   Miller D, 2001, ENVIRON HEALTH PERSP, V109, P133, DOI 10.2307/3434765
   MILLER W R, 1987, Steroids, V50, P537, DOI 10.1016/0039-128X(87)90037-7
   Molina-Molina JM, 2013, TOXICOL APPL PHARM, V272, P127, DOI 10.1016/j.taap.2013.05.015
   MORTELMANS K, 1986, ENVIRON MOL MUTAGEN, V8, P1, DOI 10.1002/em.2860080802
   NAGAOKA T, 1990, J CANCER RES CLIN, V116, P623, DOI 10.1007/BF01637084
   Nagy E, 2014, BRIT J CANCER, V110, P2874, DOI 10.1038/bjc.2014.263
   NIH Molecular Libraries Screening Center Network, 2014, INH HSD17BETA4 UNKN
   (NTP) National Toxicology Program, 2014, TECHN REP TOX STUD T
   NTP National Toxicology Program, 2013, NIH PUBLICATION
   OECD, 2013, OECD SER TEST ASS, V184
   Ohta R, 2012, J TOXICOL SCI, V37, P879, DOI 10.2131/jts.37.879
   Osimitz T. G., 2016, HUM EXP TOXICOL
   Plataniotis G, 2010, ANN ONCOL, V21, pv41, DOI 10.1093/annonc/mdq245
   Poteracki J, 1998, TOXICOL SCI, V45, P1
   Rager J. E., 2015, SYSTEMS BIOL TOXICOL
   Riu A, 2011, ENVIRON HEALTH PERSP, V119, P1227, DOI 10.1289/ehp.1003328
   Riu A, 2011, TOXICOL SCI, V122, P372, DOI 10.1093/toxsci/kfr132
   Rizner TL, 2013, MOL CELL ENDOCRINOL, V381, P124, DOI [10.1016/j.mce.213.07.026, 10.1016/j.mce.2013.07.026]
   Sanders J. M., 2014, TOXICOLOGIST, p922d
   Schauer UMD, 2006, TOXICOL SCI, V91, P49, DOI 10.1093/toxsci/kfj132
   Schicht M, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4539
   Shi ZX, 2013, SCI TOTAL ENVIRON, V452, P10, DOI 10.1016/j.scitotenv.2013.02.038
   Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166
   Sjodin A, 2003, ENVIRON INT, V29, P829, DOI 10.1016/S0160-4120(03)00108-9
   Slikker W, 2004, TOXICOL APPL PHARM, V201, P226, DOI 10.1016/j.taap.2004.06.027
   Suzuki G, 2013, ENVIRON SCI TECHNOL, V47, P2898, DOI 10.1021/es304691a
   TANAKA T, 1983, PATHOL RES PRACT, V178, P20, DOI 10.1016/S0344-0338(83)80081-8
   TANG FY, 1984, BIOL REPROD, V31, P399, DOI 10.1095/biolreprod31.2.399
   Tsesis S, 2013, GYNECOL ENDOCRINOL, V29, P912, DOI 10.3109/09513590.2013.813467
   US Environmental Protection Agency, 2005, EPA630P03001F
   (US EPA) U.S. Environmental Protection Agency, 2015, 740R14004 US EPA
   Utsunomiya H, 2004, CLIN CANCER RES, V10, P5850, DOI 10.1158/1078-0432.CCR-04-0040
   Van der Ven LTM, 2008, TOXICOLOGY, V245, P76, DOI 10.1016/j.tox.2007.12.009
   van der Zee M, 2013, J PATHOL, V230, P48, DOI 10.1002/path.4160
   Wang LQ, 2006, CURR DRUG METAB, V7, P83, DOI 10.2174/138920006774832596
   Wikoff D, 2015, J APPL TOXICOL, V35, P1292, DOI 10.1002/jat.3132
   Xu YL, 2012, CANCER SCI, V103, P1000, DOI 10.1111/j.1349-7006.2012.02258.x
   Yager JD, 1996, ANNU REV PHARMACOL, V36, P203, DOI 10.1146/annurev.pa.36.040196.001223
   Yoshida M, 2012, J TOXICOL PATHOL, V25, P241, DOI 10.1293/tox.25.241
   Zalko D, 2006, CHEMOSPHERE, V64, P318, DOI 10.1016/j.chemosphere.2005.12.053
   Zhuang SL, 2014, CHEM RES TOXICOL, V27, P1769, DOI 10.1021/tx500232b
   Zlotnik A, 2011, BIOL REPROD, V84, P581, DOI 10.1095/biolreprod.110.088120
NR 107
TC 4
Z9 4
U1 1
U2 17
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0273-2300
EI 1096-0295
J9 REGUL TOXICOL PHARM
JI Regul. Toxicol. Pharmacol.
PD JUN
PY 2016
VL 77
BP 143
EP 159
DI 10.1016/j.yrtph.2016.01.018
PG 17
WC Medicine, Legal; Pharmacology & Pharmacy; Toxicology
SC Legal Medicine; Pharmacology & Pharmacy; Toxicology
GA DN1FY
UT WOS:000376812900017
PM 26828025
OA Other Gold
DA 2019-10-23
ER

PT J
AU Baumann, J
   Gassmann, K
   Masjosthusmann, S
   DeBoer, D
   Bendt, F
   Giersiefer, S
   Fritsche, E
AF Baumann, Jenny
   Gassmann, Kathrin
   Masjosthusmann, Stefan
   DeBoer, Denise
   Bendt, Farina
   Giersiefer, Susanne
   Fritsche, Ellen
TI Comparative human and rat neurospheres reveal species differences in
   chemical effects on neurodevelopmental key events
SO ARCHIVES OF TOXICOLOGY
LA English
DT Article
DE Neurosphere; Human; Rat; Developmental Neurotoxicity; In vitro; Species
   difference
ID ADVERSE OUTCOME PATHWAYS; NEURAL PROGENITOR CELLS; DEVELOPMENTAL
   NEUROTOXICITY; IN-VITRO; PRENATAL EXPOSURE; RISK-ASSESSMENT;
   METHYLMERCURY EXPOSURE; REGULATORY PURPOSES; ALTERNATIVE METHODS;
   TOXICITY
AB The developing brain is highly vulnerable to the adverse effects of chemicals, resulting in neurodevelopmental disorders in humans. Currently, animal experiments in the rat are the gold standard for developmental neurotoxicity (DNT) testing; however, these guideline studies are insufficient in terms of animal use, time and costs and bear the issue of species extrapolation. Therefore, the necessity for alternative methods that predict DNT of chemicals faster, cheaper and with a high predictivity for humans is internationally agreed on. In this respect, we developed an in vitro model for DNT key event screening, which is based on primary human and rat neural progenitor cells grown as neurospheres. They are able to mimic basic processes of early fetal brain development and enable an investigation of species differences between humans and rodents in corresponding cellular models. The goal of this study was to investigate to what extent human and rat neurospheres were able to correctly predict the DNT potential of a well-characterized training set of nine chemicals by investigating effects on progenitor cell proliferation, migration and neuronal differentiation in parallel to cell viability, and to compare these chemical responses between human and rat neurospheres. We demonstrate that (1) by correlating these human and rat in vitro results to existing in vivo data, human and rat neurospheres classified most compounds correctly and thus may serve as a valuable component of a modular DNT testing strategy and (2) human and rat neurospheres differed in their sensitivity to most chemicals, reflecting toxicodynamic species differences of chemicals.
C1 [Baumann, Jenny; Gassmann, Kathrin; Masjosthusmann, Stefan; DeBoer, Denise; Bendt, Farina; Giersiefer, Susanne; Fritsche, Ellen] IUF Leibniz Res Inst Environm Med, Modern Risk Assessment & Sphere Biol, Aufm Hennekamp 50, D-40225 Dusseldorf, Germany.
RP Fritsche, E (reprint author), IUF Leibniz Res Inst Environm Med, Modern Risk Assessment & Sphere Biol, Aufm Hennekamp 50, D-40225 Dusseldorf, Germany.
EM ellen.fritsche@uni-duesseldorf.de
FU German Ministry of Education and Research (BMBF)Federal Ministry of
   Education & Research (BMBF) [0315522E, 16V0899]
FX This work was supported by the German Ministry of Education and Research
   (BMBF Grants 0315522E and 16V0899). The authors thank Dr. Julia Tigges
   for critical review of the manuscript.
CR Alepee N, 2014, ALTEX-ALTERN ANIM EX, V31, P441, DOI 10.14573/altex.1406111
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Ayuso-Sacido A, 2010, J NEURO-ONCOL, V97, P323, DOI 10.1007/s11060-009-0035-x
   Bal-Price A, 2015, ARCH TOXICOL, V89, P269, DOI 10.1007/s00204-015-1464-2
   Bal-Price A, 2015, CRIT REV TOXICOL, V45, P83, DOI 10.3109/10408444.2014.981331
   Bal-Price AK, 2012, ALTEX-ALTERN ANIM EX, V29, P202, DOI 10.14573/altex.2012.2.202
   Bassanini S, 2007, NEUROBIOL DIS, V26, P481, DOI 10.1016/j.nbd.2007.02.008
   Baumann Jenny, 2014, Curr Protoc Toxicol, V59, DOI 10.1002/0471140856.tx1221s59
   Bellanger M, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-3
   BORNHAUSEN M, 1980, TOXICOL APPL PHARM, V56, P305, DOI 10.1016/0041-008X(80)90062-9
   Breier JM, 2010, NEUROTOXICOL TERATOL, V32, P4, DOI 10.1016/j.ntt.2009.06.005
   BURBACHER TM, 1990, NEUROTOXICOL TERATOL, V12, P191, DOI 10.1016/0892-0362(90)90091-P
   Burgess-Herbert SL, 2013, TOXICOL APPL PHARM, V271, P372, DOI 10.1016/j.taap.2011.11.011
   Castoldi AF, 2001, BRAIN RES BULL, V55, P197, DOI 10.1016/S0361-9230(01)00458-0
   Cattabeni F, 1997, PHYSIOL REV, V77, P199
   CHEN WJ, 1979, TERATOLOGY, V20, P31, DOI 10.1002/tera.1420200107
   Clancy B, 2007, NEUROINFORMATICS, V5, P79, DOI 10.1385/NI:5:1:1
   Coecke S, 2007, ENVIRON HEALTH PERSP, V115, P924, DOI 10.1289/ehp.9427
   Crofton KM, 2011, ALTEX-ALTERN ANIM EX, V28, P9
   Croom EL, 2015, TOXICOL APPL PHARM, V283, P9, DOI 10.1016/j.taap.2014.11.006
   Dam K, 1998, DEV BRAIN RES, V108, P39, DOI 10.1016/S0165-3806(98)00028-5
   Daston GP, 2010, BIRTH DEFECTS RES B, V89, P526, DOI 10.1002/bdrb.20276
   de Groot DMG, 2005, REPROD TOXICOL, V20, P417, DOI 10.1016/j.reprotox.2005.04.006
   Foti SB, 2013, INT J DEV NEUROSCI, V31, P434, DOI 10.1016/j.ijdevneu.2013.03.008
   Gassmann K, 2010, ENVIRON HEALTH PERSP, V118, P1571, DOI 10.1289/ehp.0901545
   Gassrnann K, 2012, TOXICOL IN VITRO, V26, P993, DOI 10.1016/j.tiv.2012.04.025
   Go HS, 2012, NEUROPHARMACOLOGY, V63, P1028, DOI 10.1016/j.neuropharm.2012.07.028
   Goldman LR, 2000, ENVIRON HEALTH PERSP, V108, P443, DOI 10.2307/3454535
   Grandjean P, 2006, LANCET, V368, P2167, DOI 10.1016/S0140-6736(06)69665-7
   Grandjean P, 2014, LANCET NEUROL, V13, P330, DOI 10.1016/S1474-4422(13)70278-3
   Harrill JA, 2011, TOXICOL APPL PHARM, V256, P268, DOI 10.1016/j.taap.2011.02.013
   Howard AS, 2005, TOXICOL APPL PHARM, V207, P112, DOI 10.1016/j.taap.2005.12.008
   Jiang YZ, 2010, J HISTOCHEM CYTOCHEM, V58, P679, DOI 10.1369/jhc.2010.955955
   Karlsson M, 1996, ANTIMICROB AGENTS CH, V40, P1104, DOI 10.1128/AAC.40.5.1104
   Kisby GE, 2009, DNA REPAIR, V8, P400, DOI 10.1016/j.dnarep.2008.12.002
   Kleinstreuer NC, 2014, NAT BIOTECHNOL, V32, P583, DOI 10.1038/nbt.2914
   Krewski D, 2010, J TOXICOL ENV HEAL B, V13, P51, DOI 10.1080/10937404.2010.483176
   L'Episcopo F, 2013, J NEUROSCI, V33, P1462, DOI 10.1523/JNEUROSCI.3206-12.2013
   Lein P, 2005, ENVIRON TOXICOL PHAR, V19, P735, DOI 10.1016/j.etap.2004.12.035
   Lein P, 2007, ENVIRON HEALTH PERSP, V115, P764, DOI 10.1289/ehp.9841
   Leist M, 2013, ARCH TOXICOL, V87, P563, DOI 10.1007/s00204-013-1038-0
   Lewandowski TA, 2003, TOXICOL SCI, V75, P124, DOI 10.1093/toxsci/kfg151
   Moors M, 2007, TOXICOL APPL PHARM, V221, P57, DOI 10.1016/j.taap.2007.02.018
   Moors M, 2009, ENVIRON HEALTH PERSP, V117, P1131, DOI 10.1289/ehp.0800207
   NRC (National Research Council), 2007, TOX TEST 21 CENT VIS
   OECD, 2007, TEST GUID 426 OECD G
   Patlewicz G, 2015, REGUL TOXICOL PHARM, V71, P463, DOI 10.1016/j.yrtph.2015.02.011
   PONCE RA, 1994, TOXICOL APPL PHARM, V127, P83, DOI 10.1006/taap.1994.1142
   Rauh VA, 2006, PEDIATRICS, V118, pE1845, DOI 10.1542/peds.2006-0338
   RODIER PM, 1995, ENVIRON HEALTH PERSP, V103, P73, DOI 10.2307/3432351
   Rotroff DM, 2014, ENVIRON SCI TECHNOL, V48, P8706, DOI 10.1021/es502676e
   Rotroff DM, 2010, TOXICOL SCI, V117, P348, DOI 10.1093/toxsci/kfq220
   Schettler T, 2001, ENVIRON HEALTH PERSP, V109, P813, DOI 10.2307/3454643
   Seidle T, 2009, TOXICOL IN VITRO, V23, P1576, DOI 10.1016/j.tiv.2009.06.012
   Somel M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001214
   SPENCER PS, 1991, NEUROLOGY, V41, P62, DOI 10.1212/WNL.41.5_Suppl_2.62
   Timchalk C, 2006, TOXICOLOGY, V220, P13, DOI 10.1016/j.tox.2005.11.011
   Tollefsen KE, 2014, REGUL TOXICOL PHARM, V70, P629, DOI 10.1016/j.yrtph.2014.09.009
   USEPA, 1998, HTLH EFF TEST GUID O
   Yamada KM, 2007, CELL, V130, P601, DOI 10.1016/j.cell.2007.08.006
   Yang D, 2008, TOXICOL APPL PHARM, V228, P32, DOI 10.1016/j.taap.2007.11.005
   Zhang YE, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001179
NR 62
TC 22
Z9 22
U1 1
U2 15
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0340-5761
EI 1432-0738
J9 ARCH TOXICOL
JI Arch. Toxicol.
PD JUN
PY 2016
VL 90
IS 6
BP 1415
EP 1427
DI 10.1007/s00204-015-1568-8
PG 13
WC Toxicology
SC Toxicology
GA DM5SA
UT WOS:000376409100012
PM 26216354
DA 2019-10-23
ER

PT J
AU Benfenati, E
   Berggren, E
   Fritsche, E
   Hartung, T
   Slikker, W
   Spielmann, H
   Testai, E
   Tice, RR
   Tiramani, M
   Villenave, R
AF Benfenati, Emilio
   Berggren, Elisabet
   Fritsche, Ellen
   Hartung, Thomas
   Slikker, William, Jr.
   Spielmann, Horst
   Testai, Emanuela
   Tice, Raymond R.
   Tiramani, Manuela
   Villenave, Remi
TI Novel chemical hazard characterisation approaches
SO EFSA JOURNAL
LA English
DT Article
DE hazard characterisation; AOP; MoA; QSAR; integrated assessment;
   microphysiological systems
ID INTEGRATED TESTING STRATEGIES; HUMAN TOXOME; SYSTEMS TOXICOLOGY;
   RISK-ASSESSMENT; TOXICITY; THOUGHT; FOOD
AB There is a fundamental change in thinking within the regulatory community due to a better understanding of the underlying biology of adverse effects to human health and the environment. The development of alternatives to use laboratory animals has become a priority. In addition, technological progress is impacting greatly on the amount of data available and on the ways to process and analyse it. Topics, such as identification of adverse outcome pathways (AOPs) and modes of action (MoA), together with integrated assessment and testing approaches (IATAs), represent fundamental tools for hazard identification and characterisation of a chemical. Complex endpoints cannot be predicted by a single standalone non-animal test; thus, a major challenge is the complex nature of biological systems. Microphysiological systems (MPS) will enable more complex in vitro human models that better simulate the organ's biology and function by combining different cell types in a specific three-dimensional configuration that simulates functional organs. The process of validation of new approaches needs to be considered in terms of efficiency and length. Regulators might still not have enough confidence to adopt and apply these new approaches: this phase is very challenging and the activities performed by assay developers are not yet addressing the regulatory requirements needs sufficiently. The IATAs provide a framework to consistently evaluate new approach data and could assist in understanding their relevance for specific endpoints. The data need to be reproducible, understandable and statistically sound: indeed, a major issue lies in the interpretation and integration of the results based on subjective assessment, which relies on expert judgement. A well-defined mechanistic characterisation is proposed as a way forward to ensure the relevance of new cell-based test systems. (C) 2016 European Food Safety Authority. EFSA Journal published by John Wiley and Sons Ltd on behalf of European Food Safety Authority.
C1 [Benfenati, Emilio] Ist Ric Farmacol Mario Negri, Milan, Italy.
   [Berggren, Elisabet] European Commiss, Joint Res Ctr, Ispra, Italy.
   [Fritsche, Ellen] IUF Leibniz Res Inst Environm Med, Dusseldorf, Germany.
   [Hartung, Thomas] Johns Hopkins Univ, Baltimore, MD 21218 USA.
   [Slikker, William, Jr.] US FDA, Rockville, MD 20857 USA.
   [Spielmann, Horst] Free Univ Berlin, Berlin, Germany.
   [Testai, Emanuela] Ist Super Sanita, Rome, Italy.
   [Tice, Raymond R.] NIEHS, POB 12233, Res Triangle Pk, NC 27709 USA.
   [Tiramani, Manuela] European Food Safety Author, Parma, Italy.
   [Villenave, Remi] Emulate, Boston, MA USA.
RP Benfenati, E (reprint author), Ist Ric Farmacol Mario Negri, Milan, Italy.
EM editor-in-chief.efsajournal@efsa.europa.eu
CR Berggren E, 2015, ENVIRON HEALTH PERSP, V123, P1232, DOI 10.1289/ehp.1409342
   Bessems J, 2015, JRC SCI POLICY REPOR, DOI 10.2788/197633
   Bessems JG, 2014, REGUL TOXICOL PHARM, V68, P119, DOI 10.1016/j.yrtph.2013.11.008
   Blaauboer BJ, 2012, ALTEX-ALTERN ANIM EX, V29, P411, DOI 10.14573/altex.2012.4.411
   Bouhifd M, 2015, ALTEX-ALTERN ANIM EX, V32, P112, DOI [10.14573/altex.1502091, http://dx.doi.org/10.14573/altex.1502091]
   Bouhifd M, 2014, BASIC CLIN PHARMACOL, V115, P24, DOI 10.1111/bcpt.12198
   Coecke S, 2005, ATLA-ALTERN LAB ANIM, V33, P261, DOI 10.1177/026119290503300313
   Coecke S, 2013, TOXICOL IN VITRO, V27, P1570, DOI 10.1016/j.tiv.2012.06.012
   Daston G, 2015, ARCH TOXICOL, V89, P15, DOI 10.1007/s00204-014-1421-5
   European Commission, 2013, ADDR NEW CHALL RISK
   Hartung T, 2013, ALTEX-ALTERN ANIM EX, V30, P119, DOI 10.14573/altex.2013.2.119
   Hartung T, 2013, ALTEX-ALTERN ANIM EX, V30, P3, DOI 10.14573/altex.2013.1.003
   Hartung T, 2012, ALTEX-ALTERN ANIM EX, V29, P119, DOI 10.14573/altex.2012.2.119
   Hartung T, 2011, ALTEX-ALTERN ANIM EX, V28, P83, DOI 10.14573/altex.2011.2.083
   Knudsen TB, 2015, TOXICOL SCI, V143, P256, DOI 10.1093/toxsci/kfu234
   Leist M, 2014, CONSENSUS REPORT FUT, DOI 10.14573/altex.1406091
   Mueller SO, 2015, TOXICOL IN VITRO, V30, P4, DOI 10.1016/j.tiv.2014.09.016
   OECD, 2015, WORKSH FRAM DEV US I
   Pamies D, 2014, EXP BIOL MED, V239, P1096, DOI 10.1177/1535370214537738
   Rovida C, 2015, ALTEX-ALTERN ANIM EX, V32, P25, DOI [http://dx.doi.org/10.14573/altex.1411011, 10.14573/altex.1506201]
   Schultz TW, 2015, REGUL TOXICOL PHARM, V72, P586, DOI 10.1016/j.yrtph.2015.05.016
NR 21
TC 3
Z9 3
U1 0
U2 4
PU EUROPEAN FOOD SAFETY AUTHORITY-EFSA
PI PARMA
PA EUROPEAN FOOD SAFETY AUTHORITY-EFSA, PARMA, 00000, ITALY
SN 1831-4732
J9 EFSA J
JI EFSA J.
PD JUN
PY 2016
VL 14
SU 1
SI SI
AR UNSP s0506
DI 10.2903/j.efsa.2016.s0506
PG 10
WC Food Science & Technology
SC Food Science & Technology
GA FF5UA
UT WOS:000409062500006
OA DOAJ Gold
DA 2019-10-23
ER

PT J
AU Doering, JA
   Tang, S
   Peng, H
   Eisner, BK
   Sun, JX
   Giesy, JP
   Wiseman, S
   Hecker, M
AF Doering, Jon A.
   Tang, Song
   Peng, Hui
   Eisner, Bryanna K.
   Sun, Jianxian
   Giesy, John P.
   Wiseman, Steve
   Hecker, Markus
TI High Conservation in Transcriptomic and Proteomic Response of White
   Sturgeon to Equipotent Concentrations of 2,3,7,8-TCDD, PCB 77, and
   Benzo[a]pyrene
SO ENVIRONMENTAL SCIENCE & TECHNOLOGY
LA English
DT Article
ID ARYL-HYDROCARBON RECEPTORS; POLYCYCLIC AROMATIC-HYDROCARBONS; TOXIC
   EQUIVALENCY FACTORS; DIOXIN-LIKE COMPOUNDS; LIFE STAGE MORTALITY;
   DIBENZO-P-DIOXIN; TROUT ONCORHYNCHUS-MYKISS; ADVERSE OUTCOME PATHWAYS;
   LIGAND-BINDING DOMAIN; DEVELOPMENTAL TOXICITY
AB Adverse effects associated with exposure to dioxin-like compounds (DLCs) are mediated primarily through activation of the aryl hydrocarbon receptor (AHR). However, little is known about the cascades of events that link activation of the AHR to apical adverse effects. Therefore, this study used high-throughput, next-generation molecular tools to investigate similarities and differences in whole transcriptome and whole proteome responses to equipotent concentrations of three agonists of the AHR, 2,3,7,8-TCDD, PCB 77, and benzo[a]pyrene, in livers of a nonmodel fish, the white sturgeon (Acipenser transmontanus). A total of 926 and 658 unique transcripts were up- and down-regulated, respectively, by one or more of the three chemicals. Of the transcripts shared by responses to all three chemicals, 85% of up-regulated transcripts and 75% of down-regulated transcripts had the same magnitude of response. A total of 290 and 110 unique proteins were up- and down-regulated, respectively, by one or more of the three chemicals. Of the proteins shared by responses to all three chemicals, 70% of up-regulated proteins and 48% of down-regulated proteins had the same magnitude of response. Among treatments there was 68% similarity between the global transcriptome and global proteome. Pathway analysis revealed that perturbed physiological processes were indistinguishable between equipotent concentrations of the three chemicals. The results of this study contribute toward more completely describing adverse outcome pathways associated with activation of the AHR.
C1 [Doering, Jon A.] Univ Saskatchewan, Toxicol Grad Program, 44 Campus Dr, Saskatoon, SK S7N 5B3, Canada.
   [Doering, Jon A.; Peng, Hui; Eisner, Bryanna K.; Sun, Jianxian; Giesy, John P.; Wiseman, Steve; Hecker, Markus] Univ Saskatchewan, Toxicol Ctr, 44 Campus Dr, Saskatoon, SK S7N 5B3, Canada.
   [Tang, Song; Hecker, Markus] Univ Saskatchewan, Sch Environm & Sustainabil, Saskatoon, SK S7N 5C8, Canada.
   [Giesy, John P.] Univ Saskatchewan, Dept Vet Biomed Sci, Saskatoon, SK S7N 5B4, Canada.
RP Doering, JA (reprint author), Univ Saskatchewan, Toxicol Grad Program, 44 Campus Dr, Saskatoon, SK S7N 5B3, Canada.; Doering, JA; Hecker, M (reprint author), Univ Saskatchewan, Toxicol Ctr, 44 Campus Dr, Saskatoon, SK S7N 5B3, Canada.; Hecker, M (reprint author), Univ Saskatchewan, Sch Environm & Sustainabil, Saskatoon, SK S7N 5C8, Canada.
EM jad929@mail.usask.ca; markus.hecker@usask.ca
OI Tang, Song/0000-0003-3219-1422
FU Canada Research Chair programCanada Research Chairs; NSERC Discovery
   GrantNatural Sciences and Engineering Research Council of Canada
   [371854-20]; Vanier Canada Graduate Scholarship
FX Research was supported through the Canada Research Chair program to M.H.
   and an NSERC Discovery Grant (Grant # 371854-20) to M.H. J.A.D. was
   supported through the Vanier Canada Graduate Scholarship.
CR Alexeyenko A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010465
   Andreasen EA, 2007, TOXICOL SCI, V95, P215, DOI 10.1093/toxsci/kfl119
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Billiard SM, 1999, ENVIRON TOXICOL CHEM, V18, P2070, DOI 10.1002/etc.5620180927
   Billiard SM, 2002, COMP BIOCHEM PHYS B, V133, P55, DOI 10.1016/S1096-4959(02)00105-7
   Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101
   Boutros PC, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-419
   Brinkmann M, 2016, SCI TOTAL ENVIRON, V541, P412, DOI 10.1016/j.scitotenv.2015.09.087
   Buckler J, 2015, ENVIRON TOXICOL CHEM, V34, P1417, DOI 10.1002/etc.2950
   Carney SA, 2004, MOL PHARMACOL, V66, P512
   Carney SA, 2006, MOL PHARMACOL, V70, P549, DOI 10.1124/mol.106.025304
   Dalton TP, 2002, CHEM-BIOL INTERACT, V141, P77, DOI 10.1016/S0009-2797(02)00067-4
   Denison MS, 1998, B ENVIRON CONTAM TOX, V61, P557, DOI 10.1007/PL00002973
   Doering JA, 2015, ENVIRON SCI TECHNOL, V49, P4681, DOI 10.1021/acs.est.5b00085
   Doering JA, 2014, ENVIRON SCI TECHNOL, V48, P8219, DOI 10.1021/es502054h
   Doering JA, 2014, AQUAT TOXICOL, V150, P27, DOI 10.1016/j.aquatox.2014.02.009
   Doering JA, 2013, ENVIRON SCI POLLUT R, V20, P1219, DOI 10.1007/s11356-012-1203-7
   Doering JA, 2012, AQUAT TOXICOL, V114, P125, DOI 10.1016/j.aquatox.2012.02.015
   Dray S, 2003, ECOLOGY, V84, P3078, DOI 10.1890/03-0178
   Eisner BK, 2016, ENVIRON TOXICOL CHEM, V35, P173, DOI 10.1002/etc.3173
   Elonen GE, 1998, ENVIRON TOXICOL CHEM, V17, P472, DOI 10.1002/etc.5620170319
   Garner LVT, 2012, COMP BIOCHEM PHYS C, V155, P573, DOI 10.1016/j.cbpc.2012.01.007
   Giesy JP, 2002, AQUAT TOXICOL, V59, P35, DOI 10.1016/S0166-445X(01)00235-1
   Hahn ME, 2002, CHEM-BIOL INTERACT, V141, P131, DOI 10.1016/S0009-2797(02)00070-4
   Huang LX, 2014, CHEMOSPHERE, V108, P55, DOI 10.1016/j.chemosphere.2014.02.078
   Jayasundara N, 2015, TOXICOL SCI, V143, P469, DOI 10.1093/toxsci/kfu245
   Johnson RD, 1998, ENVIRON TOXICOL CHEM, V17, P2408, DOI 10.1002/etc.5620171207
   Juschke C, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-11-r133
   King-Heiden TC, 2012, MOL CELL ENDOCRINOL, V354, P121, DOI 10.1016/j.mce.2011.09.027
   KLEEMAN JM, 1988, FUND APPL TOXICOL, V10, P206, DOI 10.1016/0272-0590(88)90304-1
   Kopec AK, 2010, TOXICOL SCI, V118, P286, DOI 10.1093/toxsci/kfq236
   Lammi L, 2004, AM J HUM GENET, V74, P1043, DOI 10.1086/386293
   Li ZH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077292
   Liu FY, 2012, AQUAT TOXICOL, V114, P182, DOI 10.1016/j.aquatox.2012.02.024
   Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126
   Mathew LK, 2009, BIOCHEM PHARMACOL, V77, P498, DOI 10.1016/j.bcp.2008.09.025
   Mehta V, 2008, TOXICOL SCI, V104, P303, DOI 10.1093/toxsci/kfn095
   Mellor CL, 2016, CRIT REV TOXICOL, V46, P138, DOI 10.3109/10408444.2015.1089471
   Neilson A. H., 1998, PAHS RELATED COMPOUN
   NISBET ICT, 1992, REGUL TOXICOL PHARM, V16, P290, DOI 10.1016/0273-2300(92)90009-X
   Okey AB, 2007, TOXICOL SCI, V98, P5, DOI 10.1093/toxsci/kfm096
   Park YJ, 2014, SCI TOTAL ENVIRON, V491, P271, DOI 10.1016/j.scitotenv.2014.03.129
   Planchart A, 2010, CHEM RES TOXICOL, V23, P480, DOI 10.1021/tx9003165
   Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303
   Shou M, 1996, BIOCHEMISTRY-US, V35, P15807, DOI 10.1021/bi962042z
   SPITSBERGEN JM, 1988, J TOXICOL ENV HEALTH, V23, P359, DOI 10.1080/15287398809531120
   SPITSBERGEN JM, 1986, VET IMMUNOL IMMUNOP, V12, P263, DOI 10.1016/0165-2427(86)90130-3
   SPITSBERGEN JM, 1988, J TOXICOL ENV HEALTH, V23, P333, DOI 10.1080/15287398809531119
   Teraoka H, 2009, TOXICOL APPL PHARM, V234, P33, DOI 10.1016/j.taap.2008.09.021
   Teraoka H, 2006, AQUAT TOXICOL, V78, P103, DOI 10.1016/j.aquatox.2006.02.009
   Timme-Laragy AR, 2007, AQUAT TOXICOL, V85, P241, DOI 10.1016/j.aquatox.2007.09.005
   Timme-Laragy AR, 2009, TOXICOL SCI, V109, P217, DOI 10.1093/toxsci/kfp038
   Tomanek L, 2011, ANNU REV MAR SCI, V3, P373, DOI 10.1146/annurev-marine-120709-142729
   Toomey BH, 2001, AQUAT TOXICOL, V53, P127, DOI 10.1016/S0166-445X(00)00161-2
   Van den Berg M, 1998, ENVIRON HEALTH PERSP, V106, P775, DOI 10.1289/ehp.98106775
   Van Tiem LA, 2011, TOXICOL APPL PHARM, V254, P280, DOI 10.1016/j.taap.2011.05.002
   Villeneuve DL, 2014, TOXICOL SCI, V142, P312, DOI 10.1093/toxsci/kfu199
   Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839
   Walker MK, 1996, FUND APPL TOXICOL, V30, P178, DOI 10.1006/faat.1996.0054
   WALKER MK, 1991, CAN J FISH AQUAT SCI, V48, P875, DOI 10.1139/f91-104
   Walter GL, 2000, AQUAT TOXICOL, V50, P287, DOI 10.1016/S0166-445X(00)00095-3
   Whitehead A, 2010, MOL ECOL, V19, P5186, DOI 10.1111/j.1365-294X.2010.04829.x
   Wuehr M, 2014, CURR BIOL, V24, P1467, DOI 10.1016/j.cub.2014.05.044
   Yamauchi M, 2006, AQUAT TOXICOL, V80, P166, DOI 10.1016/j.aquatox.2006.08.006
   ZABEL EW, 1995, TOXICOL APPL PHARM, V134, P204, DOI 10.1006/taap.1995.1185
   ZABEL EW, 1995, AQUAT TOXICOL, V31, P315, DOI 10.1016/0166-445X(94)00075-2
NR 66
TC 9
Z9 9
U1 4
U2 41
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0013-936X
EI 1520-5851
J9 ENVIRON SCI TECHNOL
JI Environ. Sci. Technol.
PD MAY 3
PY 2016
VL 50
IS 9
BP 4826
EP 4835
DI 10.1021/acs.est.6b00490
PG 10
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA DL3GE
UT WOS:000375521400027
PM 27070345
DA 2019-10-23
ER

PT J
AU Teeguarden, JG
   Tan, YM
   Edwards, SW
   Leonard, JA
   Anderson, KA
   Corley, RA
   Kile, ML
   Simonich, SM
   Stone, D
   Tanguay, RL
   Waters, KM
   Harper, SL
   Williams, DE
AF Teeguarden, Justin G.
   Tan, Yu-Mei
   Edwards, Stephen W.
   Leonard, Jeremy A.
   Anderson, Kim A.
   Corley, Richard A.
   Kile, Molly L.
   Simonich, Staci M.
   Stone, David
   Tanguay, Robert L.
   Waters, Katrina M.
   Harper, Stacey L.
   Williams, David E.
TI Completing the Link between Exposure Science and Toxicology for Improved
   Environmental Health Decision Making: The Aggregate Exposure Pathway
   Framework
SO ENVIRONMENTAL SCIENCE & TECHNOLOGY
LA English
DT Article
ID ADVERSE OUTCOME PATHWAYS; PERSONAL CARE PRODUCTS; CONSUMER EXPOSURE;
   RISK ASSESSMENTS; MODEL; DOSIMETRY; CHEMICALS; PESTICIDES; EMISSIONS;
   IMPACT
C1 [Teeguarden, Justin G.; Corley, Richard A.; Waters, Katrina M.] Pacific NW Natl Lab, Hlth Effects & Exposure Sci, Richland, WA 99352 USA.
   [Teeguarden, Justin G.; Anderson, Kim A.; Corley, Richard A.; Simonich, Staci M.; Stone, David; Tanguay, Robert L.; Waters, Katrina M.; Harper, Stacey L.; Williams, David E.] Oregon State Univ, Dept Environm & Mol Toxicol, Corvallis, OR 93771 USA.
   [Kile, Molly L.] Oregon State Univ, Sch Biol & Populat Hlth Sci, Corvallis, OR 93771 USA.
   [Tan, Yu-Mei] US EPA, Natl Exposure Res Lab, Durham, NC 27709 USA.
   [Edwards, Stephen W.] US EPA, Natl Hlth & Environm Effects Res Lab, Durham, NC 27709 USA.
   [Leonard, Jeremy A.] Oak Ridge Inst Sci & Educ, Oak Ridge, TN 37831 USA.
   [Harper, Stacey L.] Oregon State Univ, Sch Chem Biol & Environm Engn, Corvallis, OR 97331 USA.
RP Teeguarden, JG (reprint author), Pacific NW Natl Lab, Hlth Effects & Exposure Sci, Richland, WA 99352 USA.; Teeguarden, JG (reprint author), Oregon State Univ, Dept Environm & Mol Toxicol, Corvallis, OR 93771 USA.
EM justin.teeg-uarden@pnl.gov
OI Corley, Richard/0000-0003-2877-9194; Waters, Katrina/0000-0003-4696-5396
FU National Institute of Environmental Health SciencesUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Environmental Health Sciences (NIEHS)
   [P42ES016465]; Laboratory Directed Research and Development program at
   the Pacific Northwest National Laboratory (PNNL); DOEUnited States
   Department of Energy (DOE) [DE-AC05-76RLO 1830]
FX This work (J.G.T.) was supported by P42ES016465 (Oregon State
   University-PNNL) by the National Institute of Environmental Health
   Sciences and the Laboratory Directed Research and Development program at
   the Pacific Northwest National Laboratory (PNNL) and is a contribution
   of the Global Forensic Chemical Exposure Assessment for the
   Environmental Exposome project. PNNL is a multiprogram national
   laboratory operated by Battelle for the DOE under Contract DE-AC05-76RLO
   1830. The U.S. Environmental Protection Agency has provided
   administrative review and has approved for publication.
CR Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   [Anonymous], 2013, US HDB SUPPL GUID DO, P53
   Checkoway H, 2015, J OCCUP ENVIRON MED, V57, P785, DOI 10.1097/JOM.0000000000000466
   Clayton CA, 2003, J EXPO ANAL ENV EPID, V13, P100, DOI 10.1038/sj.jea.7500261
   Cowan-Ellsberry CE, 2009, REGUL TOXICOL PHARM, V55, P321, DOI 10.1016/j.yrtph.2009.08.004
   Delmaar C, 2015, J EXPO SCI ENV EPID, V25, P317, DOI 10.1038/jes.2014.68
   Garcia-Reyero N, 2015, ENVIRON SCI TECHNOL, V49, P3, DOI 10.1021/es504976d
   Gosens I, 2014, J EXPO SCI ENV EPID, V24, P208, DOI 10.1038/jes.2013.33
   Groh KJ, 2015, CHEMOSPHERE, V120, P778, DOI 10.1016/j.chemosphere.2014.10.006
   Hellweg S, 2009, ENVIRON SCI TECHNOL, V43, P1670, DOI 10.1021/es8018176
   Hubal EAC, 2010, J EXPO SCI ENV EPID, V20, P231, DOI 10.1038/jes.2008.70
   Isaacs KK, 2014, ENVIRON SCI TECHNOL, V48, P12750, DOI 10.1021/es502513w
   Jolliet O, 2015, ENVIRON SCI TECHNOL, V49, P8924, DOI 10.1021/acs.est.5b01083
   Kennedy MC, 2015, FOOD CHEM TOXICOL, V79, P45, DOI 10.1016/j.fct.2014.12.012
   Kennedy MC, 2015, FOOD CHEM TOXICOL, V79, P32, DOI 10.1016/j.fct.2014.09.009
   Kephalopoulos S, 2007, J EXPO SCI ENV EPID, V17, pS90, DOI 10.1038/sj.jes.7500605
   Mattingly CJ, 2012, ENVIRON SCI TECHNOL, V46, P3046, DOI 10.1021/es2033857
   MCKONE T, 1993, CALTOX MULTIMEDIA TO
   NRC, 2012, EXP SCI 21 CENT VIS
   NRC (National Research Council), 2007, TOX TEST 21 CENT VIS
   OECD Organization for Economic Co-operation and Development, 2013, GUID DOC DEV ASS ADV, V184 ENV/JM/MONO(2013) 6, P45
   Pang YH, 2002, ENVIRON HEALTH PERSP, V110, P235, DOI 10.1289/ehp.02110235
   Rosenbaum RK, 2011, INT J LIFE CYCLE ASS, V16, P710, DOI 10.1007/s11367-011-0316-4
   Safford B, 2015, REGUL TOXICOL PHARM, V72, P673, DOI 10.1016/j.yrtph.2015.05.017
   Tolls J, 2016, INTEGR ENVIRON ASSES, V12, P185, DOI 10.1002/ieam.1662
   Tornero-Velez R, 2012, TOXICOL SCI, V130, P33, DOI 10.1093/toxsci/kfs236
   Tozer SA, 2015, FOOD CHEM TOXICOL, V83, P103, DOI 10.1016/j.fct.2015.06.005
   Villeneuve DL, 2014, TOXICOL SCI, V142, P312, DOI 10.1093/toxsci/kfu199
   Villeneuve DL, 2014, TOXICOL SCI, V142, P321, DOI 10.1093/toxsci/kfu200
   Wambaugh JF, 2015, TOXICOL SCI, V147, P55, DOI 10.1093/toxsci/kfv118
   Wambaugh JF, 2014, ENVIRON SCI TECHNOL, V48, P12760, DOI 10.1021/es503583j
   Wetmore BA, 2015, TOXICOL SCI, V148, P121, DOI 10.1093/toxsci/kfv171
   Wetmore BA, 2014, TOXICOL SCI, V142, P210, DOI 10.1093/toxsci/kfu169
   Wetmore BA, 2013, TOXICOL SCI, V132, P327, DOI 10.1093/toxsci/kft012
   Wetmore BA, 2012, TOXICOL SCI, V125, P157, DOI 10.1093/toxsci/kfr254
   Wild CP, 2005, CANCER EPIDEM BIOMAR, V14, P1847, DOI 10.1158/1055-9965.EPI-05-0456
   Wormuth M, 2007, RISK ANAL, V27, P979, DOI 10.1111/j.1539-6924.2007.00936.x
   Yu R, 2015, TOXICOL SCI, V146, P170, DOI 10.1093/toxsci/kfv079
NR 38
TC 40
Z9 42
U1 2
U2 77
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0013-936X
EI 1520-5851
J9 ENVIRON SCI TECHNOL
JI Environ. Sci. Technol.
PD MAY 3
PY 2016
VL 50
IS 9
BP 4579
EP 4586
DI 10.1021/acs.est.5b05311
PG 8
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA DL3GE
UT WOS:000375521400001
PM 26759916
OA Green Accepted
DA 2019-10-23
ER

PT J
AU Wilder, CS
   Wegner, SH
   Smith, MN
   Harris, S
   Hong, SW
   Griffith, WC
   Faustman, EM
AF Wilder, C. S.
   Wegner, S. H.
   Smith, M. N.
   Harris, S.
   Hong, S. W.
   Griffith, W. C.
   Faustman, E. M.
TI Organotypic Modeling Platform for Adverse Outcome Pathways of Male
   Reproductive and Developmental Processes
SO BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY
LA English
DT Meeting Abstract
C1 [Wilder, C. S.; Wegner, S. H.; Smith, M. N.; Harris, S.; Hong, S. W.; Griffith, W. C.; Faustman, E. M.] Univ Washington, Dept Environm & Occupat Hlth Sci, Seattle, WA 98195 USA.
   [Wilder, C. S.; Wegner, S. H.; Smith, M. N.; Harris, S.; Hong, S. W.; Griffith, W. C.; Faustman, E. M.] Univ Washington, Inst Risk Anal & Risk Commun, Seattle, WA 98195 USA.
NR 0
TC 0
Z9 0
U1 1
U2 2
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1542-0752
EI 1542-0760
J9 BIRTH DEFECTS RES A
JI Birth Defects Res. Part A-Clin. Mol. Teratol.
PD MAY
PY 2016
VL 106
IS 5
SI SI
MA P41
BP 423
EP 423
PG 1
WC Developmental Biology; Toxicology
SC Developmental Biology; Toxicology
GA DQ2HT
UT WOS:000379024100145
DA 2019-10-23
ER

PT J
AU Forbes, VE
   Galic, N
AF Forbes, Valery E.
   Galic, Nika
TI Next-generation ecological risk assessment: Predicting risk from
   molecular initiation to ecosystem service delivery
SO ENVIRONMENT INTERNATIONAL
LA English
DT Article
DE Adverse outcome pathways; Ecological protection goals; Ecosystem
   services; Environmental management; Mechanistic effect models;
   Predictive systems models
ID INDIVIDUAL-BASED MODEL; MECHANISTIC EFFECT MODELS; AGENT-BASED MODEL;
   PESTICIDE EXPOSURE; POPULATION-MODELS; SUPPORT; VITELLOGENIN;
   CHALLENGES; FRAMEWORK; STRESSORS
AB Ecological risk assessment is the process of evaluating how likely it is that the environment may be impacted as the result of exposure to one or more chemicals and/or other stressors. It is not playing as large a role in environmental management decisions as it should be. A core challenge is that risk assessments often do not relate directly or transparently to protection goals. There have been exciting developments in in vitro testing and high throughput systems that measure responses to chemicals at molecular and biochemical levels of organization, but the linkage between such responses and impacts of regulatory significance-whole organisms, populations, communities, and ecosystems - are not easily predictable. This article describes some recent developments that are directed at bridging this gap and providing more predictive models that can make robust links between what we typically measure in risk assessments and what we aim to protect. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Forbes, Valery E.; Galic, Nika] Coll Biol Sci, Dept Ecol Evolut & Behav, 123 Snyder Hall,1475 Gortner Ave, St Paul, MN 55018 USA.
RP Forbes, VE (reprint author), Coll Biol Sci, Dept Ecol Evolut & Behav, 123 Snyder Hall,1475 Gortner Ave, St Paul, MN 55018 USA.
EM veforbes@umn.edu; ngalic@umn.edu
RI Forbes, Valery/P-9360-2019
OI Forbes, Valery/0000-0001-9819-9385; Galic, Nika/0000-0002-4344-3464
FU SETAC; NIMBioSNational Science Foundation (NSF)NSF - Directorate for
   Biological Sciences (BIO)
FX We thank our colleagues from the Marie Curie ITN CREAM project, the
   SETAC-sponsored MODELINK workshop, the NIMBioS-sponsored Investigative
   Workshop on Predictive Models for Ecological Risk Assessment, University
   of Nebraska-Lincoln, and University of Minnesota for stimulating
   discussions that inspired this manuscript.
CR Aagaard A, 2014, EFSA J, V12, DOI 10.2903/j.efsa.2014.3589
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Ashauer R, 2007, ENVIRON SCI TECHNOL, V41, P1480, DOI 10.1021/es061727b
   Augusiak J, 2014, ECOL MODEL, V280, P117, DOI 10.1016/j.ecolmodel.2013.11.009
   Barnthouse LW, 2004, ENVIRON TOXICOL CHEM, V23, P500, DOI 10.1897/02-521
   Becher MA, 2014, J APPL ECOL, V51, P470, DOI 10.1111/1365-2664.12222
   Calow P, 1997, ENVIRON TOXICOL CHEM, V16, P1983, DOI 10.1002/etc.5620160931
   de Roos Andre M., 1997, Population and Community Biology Series, V18, P119
   Dohmen P., 2015, INTEGR ENVIRON ASSES, V12, P67
   Forbes VE, 2015, INTEGR ENVIRON ASSES, V11, P348, DOI 10.1002/ieam.1628
   Forbes VE, 2013, INTEGR ENVIRON ASSES, V9, P269, DOI 10.1002/ieam.1368
   Forbes VE, 2012, ENVIRON TOXICOL CHEM, V31, P2663, DOI 10.1002/etc.2009
   Forbes VE, 2011, HUM ECOL RISK ASSESS, V17, P287, DOI 10.1080/10807039.2011.552391
   Forbes Valery E., 2009, Integrated Environmental Assessment and Management, V5, P167, DOI 10.1897/IEAM_2008-029.1
   Forbes VE, 2002, BIOSCIENCE, V52, P249, DOI 10.1641/0006-3568(2002)052[0249:EIERAB]2.0.CO;2
   Forbes VE, ENV TOXICOL CHEM
   Galic N, 2014, ENVIRON TOXICOL CHEM, V33, P1476, DOI 10.1002/etc.2481
   Galic Nika, 2010, Integrated Environmental Assessment and Management, V6, P338, DOI 10.1002/ieam.68
   Garcia-Reyero N, 2011, ENVIRON TOXICOL CHEM, V30, P265, DOI 10.1002/etc.401
   Gergs A, 2013, SCI REP-UK, V3, DOI 10.1038/srep02036
   Grimm V., 2005, INDIVIDUAL BASED MOD
   Grimm V, 2014, ECOL MODEL, V280, P129, DOI 10.1016/j.ecolmodel.2014.01.018
   Grimm V, 2013, INTEGR ENVIRON ASSES, V9, pE58, DOI 10.1002/ieam.1423
   Grimm V, 2010, ECOL MODEL, V221, P2760, DOI 10.1016/j.ecolmodel.2010.08.019
   Grimm V, 2009, ENVIRON SCI POLLUT R, V16, P614, DOI 10.1007/s11356-009-0228-z
   Groh Ksenia J, 2015, Environ Toxicol Chem, V34, P1935, DOI 10.1002/etc.3042
   Hanson N, 2011, ENVIRON TOXICOL CHEM, V30, P2372, DOI 10.1002/etc.636
   Hommen U, 2016, INTEGR ENVIRON ASSES, V12, P21, DOI 10.1002/ieam.1704
   Hunka AD, 2013, RISK ANAL, V33, P68, DOI 10.1111/j.1539-6924.2012.01835.x
   Ibrahim L, 2014, ECOL MODEL, V280, P65, DOI [10.1016/j.ecolmode1.2013.08.001, 10.1016/j.ecolmodel.2013.08.001]
   Johnston ASA, 2014, ECOL MODEL, V280, P5, DOI 10.1016/j.ecolmodel.2013.09.012
   Jonsson M, 2014, METHODS ECOL EVOL, V5, P243, DOI 10.1111/2041-210X.12149
   Kattwinkel M, 2014, ENVIRON TOXICOL CHEM, V33, P1458, DOI 10.1002/etc.2500
   Kim J, 2006, MAR ENVIRON RES, V62, pS426, DOI 10.1016/j.marenvres.2006.04.022
   Kooijman S., 2010, DYNAMIC ENERGY BUDGE
   Li ZH, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-63
   Liu C, 2014, ECOL MODEL, V280, P30, DOI 10.1016/j.ecolmodel.2013.09.007
   Liu C, 2013, ECOL MODEL, V248, P92, DOI 10.1016/j.ecolmodel.2012.09.016
   Martin BT, 2013, ECOTOXICOLOGY, V22, P574, DOI 10.1007/s10646-013-1049-x
   Meli M, 2013, ECOL MODEL, V250, P338, DOI 10.1016/j.ecolmodel.2012.11.010
   Miller DH, 2007, ENVIRON TOXICOL CHEM, V26, P521, DOI 10.1897/06-318R.1
   Mooij WM, 2010, AQUAT ECOL, V44, P633, DOI 10.1007/s10452-010-9339-3
   Munns WR, 2015, INTEGR ENVIRON ASSES, V11, P332, DOI 10.1002/ieam.1620
   Murphy CA, 2005, REPROD TOXICOL, V19, P395, DOI 10.1016/j.reprotox.2004.09.006
   Nichols JW, 2011, ENVIRON TOXICOL CHEM, V30, P39, DOI 10.1002/etc.376
   Nienstedt KM, 2012, SCI TOTAL ENVIRON, V415, P31, DOI 10.1016/j.scitotenv.2011.05.057
   NRC, 2009, SCI DEC ADV RISK ASS
   NRC (National Research Council), 2013, ASS RISKS END THREAT
   Park RA, 2008, ECOL MODEL, V213, P1, DOI 10.1016/j.ecolmodel.2008.01.015
   Pastorok R., 2002, CHEM EFFECTS POPULAT
   Phillips M.B., 2015, ENV HLTH PERSPECT
   Poff NL, 1997, J N AM BENTHOL SOC, V16, P391, DOI 10.2307/1468026
   Preuss TG, 2009, ECOL MODEL, V220, P310, DOI 10.1016/j.ecolmodel.2008.09.018
   Reed M, 2016, INTEGR ENVIRON ASSES, V12, P58, DOI 10.1002/ieam.1713
   SCHER (Scientific Committee on Health and Environmental Risks) SCENIHR (Scientific Committee on Emerging and Newly Identified Health Risks) SCCS (Scientific Committee on Consumer Safety), 2013, MAK RISK ASS MOR REL
   Schmolke A, 2010, ENVIRON TOXICOL CHEM, V29, P1006, DOI 10.1002/etc.120
   Schroeder AL, 2016, ENVIRON TOXICOL CHEM, V35, P513, DOI 10.1002/etc.3309
   Scientific Committee on Health and Environmental Risks (SCHER) Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR) Scientific Committee on Consumer Safety (SCCS), 2013, ADDR NEW CHALL RISK
   Sousa T, 2008, PHILOS T R SOC B, V363, P2453, DOI 10.1098/rstb.2007.2230
   Stadnicka-Michalak J, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500302
   Sundling K, 2014, MATH BIOSCI ENG, V11, P621, DOI 10.3934/mbe.2014.11.621
   Thorbek P., 2009, ECOLOGICAL MODELS RE
   Topping CJ, 2015, AM NAT, V186, P669, DOI 10.1086/683181
   Topping CJ, 2003, ECOL MODEL, V167, P65, DOI 10.1016/S0304-3800(03)00173-X
   Traas TP, 2004, ENVIRON TOXICOL CHEM, V23, P521, DOI 10.1897/02-524
   Van Leewen C.J., 2007, RISK ASSESSMENT CHEM
   Vandewalle M, 2010, BIODIVERS CONSERV, V19, P2921, DOI 10.1007/s10531-010-9798-9
NR 67
TC 22
Z9 22
U1 1
U2 52
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0160-4120
EI 1873-6750
J9 ENVIRON INT
JI Environ. Int.
PD MAY
PY 2016
VL 91
BP 215
EP 219
DI 10.1016/j.envint.2016.03.002
PG 5
WC Environmental Sciences
SC Environmental Sciences & Ecology
GA DL4TQ
UT WOS:000375630500022
PM 26985654
DA 2019-10-23
ER

PT J
AU Kupsco, A
   Schlenk, D
AF Kupsco, Allison
   Schlenk, Daniel
TI STAGE SUSCEPTIBILITY OF JAPANESE MEDAKA (ORYZIAS LATIPES) TO
   SELENOMETHIONINE AND HYPERSALINE DEVELOPMENTAL TOXICITY
SO ENVIRONMENTAL TOXICOLOGY AND CHEMISTRY
LA English
DT Article
DE Selenium; Salinity; Climate change; Developmental toxicity; Mixture
   toxicity
ID SWIM BLADDER INFLATION; SELENO-L-METHIONINE; MONOOXYGENASE ACTIVITY;
   FISH; EXPRESSION; SALINITY; BIOTRANSFORMATION; MECHANISMS; IMPACTS;
   LARVAE
AB Anthropogenic disturbance of seleniferous soils can lead to selenium contamination of waterways. Although selenium is an essential micronutrient, bioaccumulation and maternal transfer of proteinaceous selenomethionine (SeMet) can result in embryo toxicity. Furthermore, as the climate changes, the salinity of spawning grounds in water-restrained estuaries is increasing. Although a small increase in salinity may not directly impact adult fish, it may alter the detoxification strategies of developing organisms. Previous research indicates that hypersalinity may potentiate SeMet embryo toxicity at an early developmental stage. However, embryonic development is a complex, spatiotemporal process with a constantly shifting cellular microenvironment. To generate thresholds and an adverse outcome pathway for the interactions between selenium and salinity, we sought to identify windows of susceptibility for lethality and deformities in the Japanese medaka (Oryzias latipes). Embryos were treated in freshwater or saltwater for 24 h with 0.5 mu M, 5 mu M, and 50 mu M SeMet at 6 different developmental stages (9, 17, 25, 29, 34, and 38). Survival, hatch, deformities (total, type, and severity), and days to hatch were quantified. Selenium embryo tissue measurements were performed. Selenomethionine exposures of 5 mu M and 50 mu M significantly decreased survival and hatch at all stages. However, SeMet uptake was stage-dependent and increased with stage. Stage 17 (early neurulation) was identified as the most susceptible stage for lethality and deformities. Selenomethionine in saltwater caused significantly greater toxicity than freshwater at stage 25 (early organogenesis), suggesting a role for liver and osmoregulatory organogenesis in toxicity. (C) 2015 SETAC
C1 [Kupsco, Allison] Univ Calif Riverside, Environm Toxicol Program, Riverside, CA 92521 USA.
   [Schlenk, Daniel] Univ Calif Riverside, Dept Environm Sci, Riverside, CA 92521 USA.
RP Kupsco, A (reprint author), Univ Calif Riverside, Environm Toxicol Program, Riverside, CA 92521 USA.
EM akups001@ucr.edu
FU National Research Service Award Institutional Training Grant [T32
   ES018827]; National Water Research Institute and Southern California
   Salinity Coalition Fellowship; University of
   California-Riverside/Agricultural Experiment Station Resource Allocation
   Program
FX The present work was supported by a National Research Service Award
   Institutional Training Grant (T32 ES018827), the National Water Research
   Institute and Southern California Salinity Coalition Fellowship, and the
   University of California-Riverside/Agricultural Experiment Station
   Resource Allocation Program. The authors declare no conflict of
   interest.
CR Alderdice D.F., 1988, P163
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   BATTAGLENE SC, 1990, AQUACULTURE, V86, P431, DOI 10.1016/0044-8486(90)90331-G
   BLAXTER JHS, 1988, FISH PHYSIOL, V11, P1
   CHATAIN B, 1994, AQUACULTURE, V119, P371, DOI 10.1016/0044-8486(94)90301-8
   Czesny SJ, 2005, T AM FISH SOC, V134, P1011, DOI 10.1577/T04-016.1
   Delta Science Council, 2013, FIN DRAFT DELT PLAN
   Egloff M, 1996, AQUAT SCI, V58, P15, DOI 10.1007/BF00877637
   EL-Alfy A, 2002, MAR ENVIRON RES, V54, P275, DOI 10.1016/S0141-1136(02)00183-6
   Fan TWM, 2002, AQUAT TOXICOL, V57, P65, DOI 10.1016/S0166-445X(01)00261-2
   HERMANUTZ RO, 1992, B ENVIRON CONTAM TOX, V49, P290
   Hinton DE, 2004, COMP HEPATOLOGY, V3, P30
   Holm J, 2005, ENVIRON TOXICOL CHEM, V24, P2373, DOI 10.1897/04-402R1.1
   Holm J, 2003, BIG FISH BANG, P257
   Iwamatsu T, 2004, MECH DEVELOP, V121, P605, DOI 10.1016/j.mod.2004.03.012
   Janmohamed A, 2004, BIOCHEM PHARMACOL, V68, P73, DOI 10.1016/j.bcp.2004.02.036
   Janz D. M., 2010, ECOLOGICAL ASSESSMEN, P141, DOI DOI 10.1201/EBK1439826775-C6
   Kirchen R.V., 1976, JAPANESE MEDAKA ITS
   Krause RJ, 2006, CHEM RES TOXICOL, V19, P1643, DOI 10.1021/tx0601915
   Kupsco A, 2014, ENVIRON SCI TECHNOL, V48, P7062, DOI 10.1021/es5019948
   LANGILLE RM, 1987, J MORPHOL, V193, P135, DOI 10.1002/jmor.1051930203
   Lavado R, 2012, AQUAT TOXICOL, V108, P18, DOI 10.1016/j.aquatox.2011.07.001
   Lemly AD, 2002, AQUAT TOXICOL, V57, P39, DOI 10.1016/S0166-445X(01)00264-8
   LEMLY AD, 1993, ENVIRON MONIT ASSESS, V28, P83, DOI 10.1007/BF00547213
   Lemly AD, 1997, ECOTOX ENVIRON SAFE, V37, P259, DOI 10.1006/eesa.1997.1554
   LEMLY AD, 1993, ECOTOX ENVIRON SAFE, V26, P181, DOI 10.1006/eesa.1993.1049
   MARTY GD, 1995, T AM FISH SOC, V124, P623, DOI 10.1577/1548-8659(1995)124<0623:NOCBLJ>2.3.CO;2
   MONROY A, 1961, EMBRYOLOGIA, V6, P151, DOI 10.1111/j.1440-169X.1961.tb00120.x
   Muscatello JR, 2006, ENVIRON SCI TECHNOL, V40, P6506, DOI 10.1021/es060661h
   Ohlendorf Harry M., 2011, Integrated Environmental Assessment and Management, V7, P314, DOI 10.1002/ieam.157
   Outridge P. M., 1999, Environmental Reviews, V7, P81, DOI 10.1139/er-7-2-81
   Phibbs J, 2011, ECOTOX ENVIRON SAFE, V74, P1855, DOI 10.1016/j.ecoenv.2011.06.015
   Presser TS, 2004, HAND EXPL G, V8, P299
   PYRON M, 1989, B ENVIRON CONTAM TOX, V42, P609, DOI 10.1007/BF01700245
   R Core Team, 2012, R LANG ENV STAT COMP
   Ramirez P, 2002, ARCH ENVIRON CON TOX, V42, P431, DOI 10.1007/s00244-001-0037-y
   Schlenk D, 1996, BIOCHEM PHARMACOL, V52, P815, DOI 10.1016/0006-2952(96)00358-9
   Schlenk D, 2003, TOXICOL SCI, V75, P309, DOI 10.1093/toxsci/kfg184
   SUGA N, 1963, EMBRYOLOGIA, V8, P63, DOI 10.1111/j.1440-169X.1963.tb00186.x
   Thermes V, 2010, GENE EXPR PATTERNS, V10, P185, DOI 10.1016/j.gep.2010.04.001
   Timbrell JA, 2009, PRINCIPLES BIOCH TOX, P193
   Villalobos SA, 2000, AQUAT TOXICOL, V48, P309, DOI 10.1016/S0166-445X(99)00032-6
   Wong PP, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P361
   Woolley LD, 2010, REV AQUACULT, V2, P181, DOI 10.1111/j.1753-5131.2010.01035.x
   YAMAGAMI K, 1992, INT REV CYTOL, V136, P51, DOI 10.1016/S0074-7696(08)62050-1
   Yasutake J, 2004, MECH DEVELOP, V121, P883, DOI 10.1016/j.mod.2004.03.008
NR 46
TC 5
Z9 5
U1 0
U2 18
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0730-7268
EI 1552-8618
J9 ENVIRON TOXICOL CHEM
JI Environ. Toxicol. Chem.
PD MAY
PY 2016
VL 35
IS 5
BP 1247
EP 1256
DI 10.1002/etc.3268
PG 10
WC Environmental Sciences; Toxicology
SC Environmental Sciences & Ecology; Toxicology
GA DJ9QH
UT WOS:000374547500024
PM 26442765
OA Green Accepted
DA 2019-10-23
ER

PT J
AU Daneshian, M
   Kamp, H
   Hengstler, J
   Leist, M
   van de Water, B
AF Daneshian, Mardas
   Kamp, Hennicke
   Hengstler, Jan
   Leist, Marcel
   van de Water, Bob
TI Highlight report: Launch of a large integrated European in vitro
   toxicology project: EU-ToxRisk
SO ARCHIVES OF TOXICOLOGY
LA English
DT Editorial Material
ID STRESS-RESPONSE PATHWAYS; DEVELOPMENTAL NEUROTOXICITY; TOXICITY; FUTURE;
   SYSTEMS; HEPATOTOXICITY; IDENTIFICATION; TOXICANTS; DESIGN
AB The integrated European project, EU-ToxRisk, proudly sees itself as "flagship" exploring new alternative-to-animal approaches to chemical safety evaluation. It promotes mechanism-based toxicity testing and risk assessment according to the principles laid down for toxicology for the twenty-first century. The project was officially launched in January 2016 with a kickoff meeting in Egmond aan Zee, the Netherlands. Over 100 scientists representing academia and industry as well as regulatory authorities attended the inaugural meeting. The project will integrate advances in in vitro and in silico toxicology, read-across methods, and adverse outcome pathways. EU-ToxRisk will continue to make use of the case study strategy deployed in SEURAT-1, a FP7 initiative ended in December 2015. Even though the development of new non-animal methods is one target of EU-ToxRisk, the project puts special emphasis on their acceptance and implementation in regulatory contexts. This a,not sign30 million Horizon 2020 project involves 38 European partners and one from the USA. EU-ToxRisk aims at the "development of a new way of risk assessment.".
C1 [Daneshian, Mardas; Leist, Marcel] Univ Konstanz, Ctr Alternat Anim Testing Europe, Constance, Germany.
   [Kamp, Hennicke] BASF SE, Ludwigshafen, Germany.
   [Hengstler, Jan] TU Dortmund, Leibniz Res Ctr Working Environm & Human Factors, Dortmund, Germany.
   [Leist, Marcel] Univ Konstanz, Dept Vitro Toxicol & Biomed, Constance, Germany.
   [van de Water, Bob] Leiden Univ, Leiden Acad Ctr Drug Res, Div Toxicol, Leiden, Netherlands.
RP Leist, M (reprint author), Univ Konstanz, Ctr Alternat Anim Testing Europe, Constance, Germany.; Leist, M (reprint author), Univ Konstanz, Dept Vitro Toxicol & Biomed, Constance, Germany.
EM Marcel.Leist@uni-konstanz.de
RI Leist, Marcel/D-2133-2010
OI Leist, Marcel/0000-0002-3778-8693; Hengstler, Jan/0000-0002-1427-5246
CR Bal-Price A, 2015, ARCH TOXICOL, V89, P269, DOI 10.1007/s00204-015-1464-2
   Ball N, 2016, ALTEX, DOI 10.14573/altex.1601251
   Basketter DA, 2012, ALTEX-ALTERN ANIM EX, V29, P5, DOI 10.14573/altex.2012.1.003
   Berggren E, 2015, ENVIRON HEALTH PERSP, V123, P1232, DOI 10.1289/ehp.1409342
   Bouhifd M, 2015, ALTEX-ALTERN ANIM EX, V32, P112, DOI [10.14573/altex.1502091, http://dx.doi.org/10.14573/altex.1502091]
   Carrio P, 2016, ARCH TOXICOL, V90, P2445, DOI 10.1007/s00204-015-1618-2
   Daston G, 2015, ARCH TOXICOL, V89, P15, DOI 10.1007/s00204-014-1421-5
   EU-ToxRisk, 2015, ALTEX, V32, P403
   Ghallab A, 2016, J HEPATOL, V64, P860, DOI 10.1016/j.jhep.2015.11.018
   Gocht T, 2015, ALTEX-ALTERN ANIM EX, V32, P9, DOI http://dx.doi.org/10.14573/altex.1408041
   Godoy P, 2013, ARCH TOXICOL, V87, P1315, DOI 10.1007/s00204-013-1078-5
   Grinberg M, 2014, ARCH TOXICOL, V88, P2261, DOI 10.1007/s00204-014-1400-x
   Hengstler JG, 2012, ARCH TOXICOL, V86, P13, DOI 10.1007/s00204-011-0798-7
   Huang RL, 2014, SCI REP-UK, V4, DOI 10.1038/srep05664
   Jennings P, 2014, ARCH TOXICOL, V88, P2099, DOI 10.1007/s00204-014-1410-8
   Jennings P, 2013, ARCH TOXICOL, V87, P13, DOI 10.1007/s00204-012-0974-4
   Jennings P, 2013, ARCH TOXICOL, V87, P49, DOI 10.1007/s00204-012-0919-y
   Kleinstreuer NC, 2014, NAT BIOTECHNOL, V32, P583, DOI 10.1038/nbt.2914
   Krug AK, 2013, ARCH TOXICOL, V87, P123, DOI 10.1007/s00204-012-0967-3
   Leist M, 2008, ALTEX-ALTERN TIEREXP, V25, P103
   Leist M, 2014, ALTEX-ALTERN ANIM EX, V31, P341, DOI 10.14573/altex.1406091
   Liu J, 2015, CHEM RES TOXICOL, V28, P738, DOI 10.1021/tx500501h
   Luechtefeld T, 2015, J APPL TOXICOL, V35, P1361, DOI 10.1002/jat.3172
   Muller EB, 2015, ENVIRON SCI TECHNOL, V49, P11817, DOI 10.1021/acs.est.5b01837
   NRC (National Research Council), 2007, TOX TEST 21 CENT VIS
   Pallocca G, 2016, ARCH TOXICOL, V90, P159, DOI 10.1007/s00204-015-1658-7
   Patlewicz G, 2014, ALTEX-ALTERN ANIM EX, V31, P387, DOI 10.14573/altex.1410071
   Rempel E, 2015, ARCH TOXICOL, V89, P1599, DOI 10.1007/s00204-015-1573-y
   Rovida C, 2015, ALTEX-ALTERN ANIM EX, V32, P171, DOI 10.14573/altex.1506201
   Rovida C, 2015, ALTEX-ALTERN ANIM EX, V32, P25, DOI [http://dx.doi.org/10.14573/altex.1411011, 10.14573/altex.1506201]
   Sauer JM, 2015, INT J TOXICOL, V34, P346, DOI 10.1177/1091581815576551
   Schaap MM, 2015, ARCH TOXICOL, V89, P2413, DOI 10.1007/s00204-014-1368-6
   Schliess F, 2014, HEPATOLOGY, V60, P2040, DOI 10.1002/hep.27136
   Scholz S, 2013, REGUL TOXICOL PHARM, V67, P506, DOI 10.1016/j.yrtph.2013.10.003
   Shah I, 2016, ENVIRON HEALTH PERSP, V124, P910, DOI 10.1289/ehp.1409029
   Tollefsen KE, 2014, REGUL TOXICOL PHARM, V70, P629, DOI 10.1016/j.yrtph.2014.09.009
   van der Burg B, 2015, REPROD TOXICOL, V55, P114, DOI 10.1016/j.reprotox.2015.01.008
   van Vliet E, 2014, ALTEX-ALTERN ANIM EX, V31, P479, DOI http://dx.doi.org/10.14573/altex.1405271
   Wink S, 2014, CHEM RES TOXICOL, V27, P338, DOI 10.1021/tx4004038
   Zhu H, 2016, ALTEX, DOI 10.14573/altex.1601252
NR 40
TC 27
Z9 27
U1 0
U2 14
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0340-5761
EI 1432-0738
J9 ARCH TOXICOL
JI Arch. Toxicol.
PD MAY
PY 2016
VL 90
IS 5
BP 1021
EP 1024
DI 10.1007/s00204-016-1698-7
PG 4
WC Toxicology
SC Toxicology
GA DJ6EQ
UT WOS:000374303400001
PM 27017488
OA Green Published, Other Gold
DA 2019-10-23
ER

PT J
AU Leonard, JA
   Tan, YM
   Gilbert, M
   Isaacs, K
   El-Masri, H
AF Leonard, Jeremy A.
   Tan, Yu-Mei
   Gilbert, Mary
   Isaacs, Kristin
   El-Masri, Hisham
TI Estimating Margin of Exposure to Thyroid Peroxidase Inhibitors Using
   High-Throughput in vitro Data, High-Throughput Exposure Modeling, and
   Physiologically Based Pharmacokinetic/Pharmacodynamic Modeling
SO TOXICOLOGICAL SCIENCES
LA English
DT Article
DE thyroid peroxidase; adverse outcome pathway; margin of exposure; PBPK;
   PD model; high-throughput in vitro assay
ID NEWLY DEVELOPED RADIOIMMUNOASSAY; THYROPEROXIDASE INHIBITION; TISSUE
   DISTRIBUTION; TRICLOSAN; PHARMACOKINETICS; METHIMAZOLE;
   PROPYLTHIOURACIL; PHARMACOLOGY; HORMONES; RAT
AB Some pharmaceuticals and environmental chemicals bind the thyroid peroxidase (TPO) enzyme and disrupt thyroid hormone production. The potential for TPO inhibition is a function of both the binding affinity and concentration of the chemical within the thyroid gland. The former can be determined through in vitro assays, and the latter is influenced by pharmacokinetic properties, along with environmental exposure levels. In this study, a physiologically based pharmacokinetic (PBPK) model was integrated with a pharmacodynamic (PD) model to establish internal doses capable of inhibiting TPO in relation to external exposure levels predicted through exposure modeling. The PBPK/PD model was evaluated using published serum or thyroid gland chemical concentrations or circulating thyroxine (T-4) and triiodothyronine (T-3) hormone levels measured in rats and humans. After evaluation, the model was used to estimate human equivalent intake doses resulting in reduction of T-4 and T-3 levels by 10% (ED10) for 6 chemicals of varying TPO-inhibiting potencies. These chemicals were methimazole, 6-propylthiouracil, resorcinol, benzophenone-2, 2-mercaptobenzothiazole, and triclosan. Margin of exposure values were estimated for these chemicals using the ED10 and predicted population exposure levels for females of child-bearing age. The modeling approach presented here revealed that examining hazard or exposure alone when prioritizing chemicals for risk assessment may be insufficient, and that consideration of pharmacokinetic properties is warranted. This approach also provides a mechanism for integrating in vitro data, pharmacokinetic properties, and exposure levels predicted through high-throughput means when interpreting adverse outcome pathways based on biological responses.
C1 [Leonard, Jeremy A.] Oak Ridge Inst Sci & Educ, Oak Ridge, TN 37831 USA.
   [Leonard, Jeremy A.; Tan, Yu-Mei; Isaacs, Kristin] US EPA, Natl Exposure Res Lab, Res Triangle Pk, NC 27709 USA.
   [Gilbert, Mary; El-Masri, Hisham] US EPA, Natl Hlth & Environm Effects Res Lab, 109 TW Alexander Dr Mail Code B105-03, Res Triangle Pk, NC 27709 USA.
RP El-Masri, H (reprint author), US EPA, Natl Hlth & Environm Effects Res Lab, 109 TW Alexander Dr Mail Code B105-03, Res Triangle Pk, NC 27709 USA.
EM el-masri.hisham@epa.gov
OI Isaacs, Kristin/0000-0001-9547-1654
FU Oak Ridge Institute for Science and Education Research Participation
   Program at the U.S. EPA
FX Jeremy Leonard was funded through the Oak Ridge Institute for Science
   and Education Research Participation Program at the U.S. EPA.
CR Allmyr M, 2009, BASIC CLIN PHARMACOL, V105, P339, DOI 10.1111/j.1742-7843.2009.00455.x
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Anton R, 2010, EFSA J, V8, DOI [10.2903/j.efsa.2006.373, 10.2903/j.efsa.2010.1673]
   Brown RP, 1997, TOXICOL IND HEALTH, V13, P407, DOI 10.1177/074823379701300401
   Carroll R, 2010, THER ADV ENDOCRINOL, V1, P139, DOI 10.1177/2042018810382481
   Choksi NY, 2003, BIRTH DEFECTS RES B, V68, P479, DOI 10.1002/bdrb.10045
   Cooper DS, 2005, NEW ENGL J MED, V352, P905, DOI 10.1056/NEJMra042972
   COOPER DS, 1983, ENDOCRINOLOGY, V113, P921, DOI 10.1210/endo-113-3-921
   COOPER DS, 1984, ENDOCRINOLOGY, V114, P786, DOI 10.1210/endo-114-3-786
   COOPER DS, 1984, J CLIN ENDOCR METAB, V58, P473, DOI 10.1210/jcem-58-3-473
   Crofton KM, 2007, ENVIRON TOXICOL PHAR, V24, P194, DOI 10.1016/j.etap.2007.04.008
   Crofton KM, 2005, ENVIRON HEALTH PERSP, V113, P1549, DOI 10.1289/ehp.8195
   Edwards SW, 2016, J PHARMACOL EXP THER, V356, P170, DOI 10.1124/jpet.115.228239
   Ekerot P, 2013, PHARM RES-DORDR, V30, P1513, DOI 10.1007/s11095-013-0989-4
   Gilbert ME, 2012, NEUROTOXICOLOGY, V33, P842, DOI 10.1016/j.neuro.2011.11.005
   GILES HG, 1982, CLIN PHARMACOL THER, V31, P559, DOI 10.1038/clpt.1982.78
   Goldsmith MR, 2014, FOOD CHEM TOXICOL, V65, P269, DOI 10.1016/j.fct.2013.12.029
   Groh KJ, 2015, CHEMOSPHERE, V120, P764, DOI 10.1016/j.chemosphere.2014.09.068
   HENGSTMANN JH, 1985, KLIN WOCHENSCHR, V63, P1212, DOI 10.1007/BF01733780
   HUFFMAN L, 1986, LIFE SCI, V39, P2143, DOI 10.1016/0024-3205(86)90365-6
   International Agency for Research on Cancer (IARC), 2012, SOM CHEM PRES IND CO, V101
   Isaacs KK, 2014, ENVIRON SCI TECHNOL, V48, P12750, DOI 10.1021/es502513w
   Jameson J. L., 2001, HARRISONS PRINCIPLES, P2048
   Jeon HK, 2008, TOXICOLOGY, V248, P89, DOI 10.1016/j.tox.2008.02.009
   Judson RS, 2011, CHEM RES TOXICOL, V24, P451, DOI 10.1021/tx100428e
   Jugan ML, 2010, BIOCHEM PHARMACOL, V79, P939, DOI 10.1016/j.bcp.2009.11.006
   KAMPMANN JP, 1981, CLIN PHARMACOKINET, V6, P401, DOI 10.2165/00003088-198106060-00001
   KAMPMANN JP, 1974, ACTA PHARMACOL TOX, V35, P35
   MARCHANT B, 1972, J CLIN ENDOCR METAB, V34, P847, DOI 10.1210/jcem-34-5-847
   MCGUIRE RA, 1981, J CLIN ENDOCR METAB, V53, P852, DOI 10.1210/jcem-53-4-852
   MERKER PC, 1982, RES COMMUN CHEM PATH, V38, P367
   Merrill EA, 2005, TOXICOL SCI, V83, P25, DOI 10.1093/toxsci/kfi017
   NICOLOFF JT, 1972, J CLIN INVEST, V51, P473, DOI 10.1172/JCI106835
   Nong A, 2008, J TOXICOL ENV HEAL A, V71, P413, DOI 10.1080/15287390701838697
   ODELL WD, 1967, J CLIN INVEST, V46, P953, DOI 10.1172/JCI105601
   OPPENHEI.JH, 1972, J CLIN INVEST, V51, P2493, DOI 10.1172/JCI107063
   OPPENHEIMER JH, 1968, NEW ENGL J MED, V278, P1153, DOI 10.1056/NEJM196805232782107
   Paul KB, 2014, CHEM RES TOXICOL, V27, P387, DOI 10.1021/tx400310w
   Paul KB, 2013, TOXICOLOGY, V312, P97, DOI 10.1016/j.tox.2013.08.006
   Paul KB, 2010, TOXICOL SCI, V113, P367, DOI 10.1093/toxsci/kfp271
   Pesce L, 2014, INT J PEDIATR ENDOCR, DOI 10.1186/1687-9856-2014-8
   Phillips MB, 2016, ENVIRON HEALTH PERSP, V124, P53, DOI 10.1289/ehp.1409450
   Queckenberg C, 2010, ANTIMICROB AGENTS CH, V54, P570, DOI 10.1128/AAC.00615-09
   REFETOFF S, 1970, ENDOCRINOLOGY, V86, P793, DOI 10.1210/endo-86-4-793
   RIDGWAY EC, 1974, J CLIN INVEST, V53, P895, DOI 10.1172/JCI107630
   Rodgers T, 2005, J PHARM SCI-US, V94, P1259, DOI 10.1002/jps.20322
   Rodgers T, 2006, J PHARM SCI-US, V95, P1238, DOI 10.1002/jps.20502
   Sandborgh-Englund G, 2006, J TOXICOL ENV HEAL A, V69, P1861, DOI 10.1080/15287390600631706
   Sarver JG, 1997, ENVIRON HEALTH PERSP, V105, P1204, DOI 10.2307/3433898
   SILVA JE, 1984, J CLIN INVEST, V73, P898, DOI 10.1172/JCI111313
   SITAR DS, 1973, J PHARMACOL EXP THER, V184, P432
   SKELLERN GG, 1980, BRIT J CLIN PHARMACO, V9, P137, DOI 10.1111/j.1365-2125.1980.tb05823.x
   Stoker TE, 2010, TOXICOL SCI, V117, P45, DOI 10.1093/toxsci/kfq180
   Thompson A, 2005, WATER ENVIRON RES, V77, P63, DOI 10.2175/106143005X41636
   Tollefsen KE, 2014, REGUL TOXICOL PHARM, V70, P629, DOI 10.1016/j.yrtph.2014.09.009
   United States Environmental Protection Agency (USEPA), 1994, 738R94027 USEPA DEP, P168
   United States Environmental Protection Agency (USEPA), 2011, EPA600R090052F OFF R
   Wambaugh JF, 2014, ENVIRON SCI TECHNOL, V48, P12760, DOI 10.1021/es503583j
   WARTOFSK.L, 1971, J CLIN ENDOCR METAB, V33, P488, DOI 10.1210/jcem-33-3-488
   Wu JL, 2009, CHIN J CHROMATOGR, V27, P724
   Zoeller RT, 2007, CRIT REV TOXICOL, V37, P11, DOI 10.1080/10408440601123446
   Zorrilla LM, 2009, TOXICOL SCI, V107, P56, DOI 10.1093/toxsci/kfn225
NR 62
TC 7
Z9 8
U1 3
U2 15
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1096-6080
EI 1096-0929
J9 TOXICOL SCI
JI Toxicol. Sci.
PD MAY
PY 2016
VL 151
IS 1
BP 57
EP 70
DI 10.1093/toxsci/kfw022
PG 14
WC Toxicology
SC Toxicology
GA DM9CU
UT WOS:000376662800006
PM 26865668
OA Green Published
DA 2019-10-23
ER

PT J
AU Xiao, HX
   Kuckelkorn, J
   Nusser, LK
   Floehr, T
   Hennig, MP
   Ross-Nickoll, M
   Schaffer, A
   Hollert, H
AF Xiao, Hongxia
   Kuckelkorn, Jochen
   Nuesser, Leonie Katharina
   Floehr, Tilman
   Hennig, Michael Patrick
   Ross-Nickoll, Martina
   Schaeffer, Andreas
   Hollert, Henner
TI The metabolite 3,4,3 ',4 '-tetrachloroazobenzene (TCAB) exerts a higher
   ecotoxicity than the parent compounds 3,4-dichloroaniline (3,4-DCA) and
   propanil
SO SCIENCE OF THE TOTAL ENVIRONMENT
LA English
DT Article
DE Propanil; 3,4,3 ',4 '-Tetrachloroazobenzene (TCAB); AhR-mediated
   activity; Endocrine disrupting; Zebrafish; Quantitative structure
   activity response model (QSAR)
ID ARYL-HYDROCARBON RECEPTOR; ADVERSE OUTCOME PATHWAYS; ZEBRAFISH
   DANIO-RERIO; POLYCYCLIC AROMATIC-HYDROCARBONS; ENVIRONMENTAL
   RISK-ASSESSMENT; EFFECT-DIRECTED ANALYSIS; EARLY FISH DEVELOPMENT;
   DIOXIN-LIKE COMPOUNDS; EMBRYO TOXICITY TEST; FRESH-WATER FISH
AB 3,4,3',4'-tetrachloroazobenzene (TCAB) is not commercially manufactured but formed as an unwanted by-product in the manufacturing of 3,4-dichloroaniline (3,4-DCA) or metabolized from the degradation of chloranilide herbicides, like propanil. While a considerable amount of research has been done concerning the toxicological and ecotoxicological effects of propanil and 3,4-DCA, limited information is available on TCAB. Our study examined the toxicity of TCAB in comparison to its parent compounds propanil and 3,4-DCA, using a battery of bioassays including in vitro with aryl hydrocarbon receptor (AhR) mediated activity by the 7-ethoxyresorufin-O-deethylase (EROD) assay and micro-EROD, endocrine-disrupting activity with chemically activated luciferase gene expression (CALUX) as well as in vivo with fish embryo toxicity (FET) assays with Danio rerio. Moreover, the quantitative structure activity response (QSAR) concepts were applied to simulate the binding affinity of TCAB to certain human receptors. It was shown that TCAB has a strong binding affinity to the AhR in EROD and micro-EROD induction assay, with the toxic equivalency factor (TEF) of 8.7 x 10(-4) and 1.2 x 10(-5), respectively. TCAB presented to be a weak endocrine disrupting compound with a value of estradiol equivalence factor (EEF) of 6.4 x 10(-9) and dihydrotestosterone equivalency factor (DEF) of 1.1 x 10(-10). No acute lethal effects of TCAB were discovered in FET test after 96 h of exposure. Major sub-lethal effects detected were heart oedema, yolk malformation, as well as absence of blood flow and tail deformation. QSAR modelling suggested an elevated risk to environment, particularly with respect to binding to the AhR. An adverse effect potentially triggering ER beta, mineralocorticoid, glucocorticoid and progesterone receptor activities might be expected. Altogether, the results obtained suggest that TCAB exerts a higher toxicity than both propanil and 3,4-DCA. This should be considered when assessing the impact of these compounds for the environment and also for regulatory decisions. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Xiao, Hongxia; Kuckelkorn, Jochen; Nuesser, Leonie Katharina; Floehr, Tilman; Hennig, Michael Patrick; Ross-Nickoll, Martina; Schaeffer, Andreas; Hollert, Henner] Rhein Westfal TH Aachen, Inst Environm Res, Worringerweg 1, D-52074 Aachen, Germany.
   [Schaeffer, Andreas; Hollert, Henner] Nanjing Univ, Sch Environm, State Key Lab Pollut Control & Resource Reuse, Xianlin Ave 163, Nanjing 210023, Jiangsu, Peoples R China.
   [Ross-Nickoll, Martina; Schaeffer, Andreas; Hollert, Henner] Chongqing Univ, Coll Resources & Environm Sci, Tiansheng Rd Beibei 1, Chongqing 400715, Peoples R China.
   [Hollert, Henner] Tongji Univ, Key Lab Yangtze Water Environm, Minist Educ, Siping Rd 1239, Shanghai 200092, Peoples R China.
RP Xiao, HX; Hollert, H (reprint author), Rhein Westfal TH Aachen, Inst Environm Res, Worringerweg 1, D-52074 Aachen, Germany.
EM xiao.hongxia@bio5.rwth-aachen.de; jochen.kuckelkorn@bio5.rwth-aachen.de;
   leonie.nuesser@rwth-aachen.de; floehr@bio5.rwth-aachen.de;
   michael.hennig@rwth-aachen.de; ross@bio5.rwth-aachen.de;
   andreas.schaeffer@bio5.rwth-aachen.de;
   henner.hollert@bio5.rwth-aachen.de
OI Kuckelkorn, Jochen/0000-0002-3476-8603
FU Federal Ministry of Education and Research, Germany (BMBF)Federal
   Ministry of Education & Research (BMBF) [FKZ 02WT]; MICROTOX project
   ("Transformation, Bioaccumulation and Toxicity of Organic
   Micropollutants in the Yangtze Three Gorges Reservoir") [FKZ 02WT1141];
   Chinese Scholarship CouncilChina Scholarship Council
FX The authors acknowledge the financial support by the Federal Ministry of
   Education and Research, Germany (BMBF) with the project framework of
   "Yangtze-Hydro-Sustainable Management of the Newly Created Ecosystem at
   the Three Gorges Dam" (No. FKZ 02WT; www.yangtzeproject.de). This study
   has been carried out as part of the MICROTOX project ("Transformation,
   Bioaccumulation and Toxicity of Organic Micropollutants in the Yangtze
   Three Gorges Reservoir", No. FKZ 02WT1141). We want to express our
   gratitude to Drs. Niels Bols and Lucy Lee from the University of
   Waterloo, Canada, who kindly provided the CYP1A expressing
   fibroblast-like permanent cell line RTL-W1 from primary hepatocytes of
   rainbow trout (Oncorhynchus mykiss). Our gratitude also goes to
   BioDetection Systems (Amsterdam, The Netherlands) for supporting the
   investigations of CALUX assays. In addition, Hongxia Xiao received a
   personal grant supported by the scholarship programme Chinese
   Scholarship Council.
CR ALLINSON G, 1995, CHEMOSPHERE, V30, P233, DOI 10.1016/0045-6535(94)00386-9
   ALLINSON G, 1995, CHEMOSPHERE, V30, P223, DOI 10.1016/0045-6535(94)00385-8
   Altenburger R, 2015, SCI TOTAL ENVIRON, V512, P540, DOI 10.1016/j.scitotenv.2014.12.057
   Andersson E, 2009, ENVIRON SCI POLLUT R, V16, P521, DOI 10.1007/s11356-009-0121-9
   Andreasen EA, 2002, TOXICOL SCI, V68, P403, DOI 10.1093/toxsci/68.2.403
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   [Anonymous], ISO73463
   Antkiewicz DS, 2005, TOXICOL SCI, V84, P368, DOI 10.1093/toxsci/kfi073
   BABICH H, 1990, J PHARM SCI-US, V79, P592, DOI 10.1002/jps.2600790709
   Baki B., 2000, WILD WEEDY RICE RICE
   BANK PA, 1992, EUR J PHARM-ENVIRON, V228, P85, DOI 10.1016/0926-6917(92)90016-6
   BDS, 2013, AN SAMPL U2 OS CALUX
   Belair CD, 2001, DEV DYNAM, V222, P581, DOI 10.1002/dvdy.1213
   Bergmann A, 2012, ENVIRON SCI POLLUT R, V19, P1341, DOI 10.1007/s11356-011-0645-7
   Bhusari S, 2014, TOXICOL PATHOL, V42, P555, DOI 10.1177/0192623313491169
   Billiard SM, 2006, TOXICOL SCI, V92, P526, DOI 10.1093/toxsci/kfl011
   Bols NC, 1999, ECOTOX ENVIRON SAFE, V44, P118, DOI 10.1006/eesa.1999.1808
   Bonefeld-Jorgensen EC, 2001, TOXICOLOGY, V158, P141, DOI 10.1016/S0300-483X(00)00368-1
   BORDELEAU L M, 1971, Soil Biology and Biochemistry, V3, P281, DOI 10.1016/0038-0717(71)90036-8
   Boverhof DR, 2006, MOL PHARMACOL, V69, P1599, DOI 10.1124/mol.105.019638
   Brack W, 2015, SCI TOTAL ENVIRON, V503, P22, DOI 10.1016/j.scitotenv.2014.05.143
   Bradshaw TD, 2002, CURR PHARM DESIGN, V8, P2475, DOI 10.2174/1381612023392784
   Braunbeck T, 2005, ALTEX-ALTERN TIEREXP, V22, P87
   Brinkmann M, 2014, ENVIRON SCI TECHNOL, V48, P5892, DOI 10.1021/es405731j
   BUNCE NJ, 1979, CHEMOSPHERE, V8, P283, DOI 10.1016/0045-6535(79)90110-3
   BURGE WD, 1973, SOIL SCI SOC AM J, V37, P392, DOI 10.2136/sssaj1973.03615995003700030024x
   CALL DJ, 1983, ARCH ENVIRON CON TOX, V12, P175, DOI 10.1007/BF01059578
   CAREY AE, 1980, PESTIC MONIT J, V14, P23
   Carney SA, 2004, MOL PHARMACOL, V66, P512
   CHISAKA H, 1970, J AGR FOOD CHEM, V18, P854, DOI 10.1021/jf60171a032
   Christen V, 2010, AQUAT TOXICOL, V96, P167, DOI 10.1016/j.aquatox.2009.11.021
   CRONIN MTD, 1995, QUANT STRUCT-ACT REL, V14, P1, DOI 10.1002/qsar.19950140102
   Daley JM, 2009, CHEMOSPHERE, V75, P1500, DOI 10.1016/j.chemosphere.2009.02.013
   de Almeida A.D., 2000, J CHROMATOGR A, V879, P13, DOI DOI 10.1016/S0021-9673(00)00372-1
   DEUEL LE, 1977, J ENVIRON QUAL, V6, P127, DOI 10.2134/jeq1977.00472425000600020005x
   Di Paolo C, 2015, AQUAT TOXICOL, V169, P168, DOI 10.1016/j.aquatox.2015.10.014
   Di Paolo C, 2015, ENVIRON SCI EUR, V27, DOI 10.1186/s12302-015-0040-y
   Di Paolo C, 2010, ENVIRON SCI TECHNOL, V44, P7548, DOI 10.1021/es101247e
   DIMUCCIO A, 1984, ECOTOX ENVIRON SAFE, V8, P511, DOI 10.1016/0147-6513(84)90010-1
   Doering JA, 2013, ENVIRON SCI POLLUT R, V20, P1219, DOI 10.1007/s11356-012-1203-7
   Eichbaum K, 2014, SCI TOTAL ENVIRON, V487, P37, DOI 10.1016/j.scitotenv.2014.03.057
   Elonen GE, 1998, ENVIRON TOXICOL CHEM, V17, P472, DOI 10.1002/etc.5620170319
   Embry MR, 2010, AQUAT TOXICOL, V97, P79, DOI 10.1016/j.aquatox.2009.12.008
   FIEDLER H, 1990, TOXICOL ENVIRON CHEM, V29, P157, DOI 10.1080/02772249009357628
   Floehr T, 2015, SCI TOTAL ENVIRON, V538, P191, DOI 10.1016/j.scitotenv.2015.07.044
   Gianessi L., 2011, CHINAS AGR SUCCESS R
   Giesy JP, 2002, MAR POLLUT BULL, V45, P3, DOI 10.1016/S0025-326X(02)00097-8
   GILBERT P, 1980, ARCH ENVIRON CON TOX, V9, P533, DOI 10.1007/BF01056933
   GILBERTSON M, 1992, FISHERIES, V17, P26
   Grimes AC, 2008, TOXICOL SCI, V106, P193, DOI 10.1093/toxsci/kfn154
   Grube A., 2011, PESTICIDES IND SALES
   Grund S., 2011, THESIS HEIDELBERG U
   Gustavsson LK, 2004, ENVIRON SCI POLLUT R, V11, P379, DOI 10.1065/espr2004.06.207
   Harry GJ, 2014, TOXICS, V2, P496, DOI 10.3390/toxics2030496
   Heger S, 2012, ENERG ENVIRON SCI, V5, P9778, DOI 10.1039/c2ee21623j
   Hill J., 1981, ARCH ENVIRON HEALTH, V36, P11
   Hollert Henner, 2003, Journal of Soils and Sediments, V3, P197, DOI 10.1065/jss2003.09.085
   Houtman CJ, 2009, ANAL CHIM ACTA, V637, P247, DOI 10.1016/j.aca.2008.09.037
   Hsia M T, 1977, Res Commun Chem Pathol Pharmacol, V17, P225
   Hsia S.M.T., 1980, DRUG CHEM TOXICOL, V3, P47
   Jana NR, 1999, BIOCHEM BIOPH RES CO, V256, P462, DOI 10.1006/bbrc.1999.0367
   Karpouzas DG, 2005, AGRON SUSTAIN DEV, V25, P35, DOI 10.1051/agro:2004053
   KEARNEY PC, 1970, WEED SCI, V18, P464, DOI 10.1017/S0043174500078450
   Keiter S, 2008, ANAL BIOANAL CHEM, V390, P2009, DOI 10.1007/s00216-007-1652-x
   Keiter S, 2006, ENVIRON SCI POLLUT R, V13, P308, DOI 10.1065/espr2006.04.300
   Kharat I, 1996, J BIOL CHEM, V271, P10533, DOI 10.1074/jbc.271.18.10533
   KOJIMA T, 1994, CANCER RES, V54, P1446
   KRISHNAN V, 1995, MOL CELL BIOL, V15, P6710
   Kruhlak NL, 2007, ADV DRUG DELIVER REV, V59, P43, DOI 10.1016/j.addr.2006.10.008
   Labrada R., 2003, P 20 SESS INT RIC CO
   Lammer E, 2009, COMP BIOCHEM PHYS C, V149, P196, DOI 10.1016/j.cbpc.2008.11.006
   LANGE M, 1995, CHEMOSPHERE, V30, P2087, DOI 10.1016/0045-6535(95)00088-P
   LEE LEJ, 1993, CELL BIOL TOXICOL, V9, P279, DOI 10.1007/BF00755606
   Legler J, 2002, SCI TOTAL ENVIRON, V293, P69, DOI 10.1016/S0048-9697(01)01146-9
   Lu B., 2008, P 5 INT WEED SCI C
   Maletz S, 2015, SCI TOTAL ENVIRON, V536, P729, DOI 10.1016/j.scitotenv.2015.07.053
   Maletz S, 2013, WATER RES, V47, P1545, DOI 10.1016/j.watres.2012.12.008
   Mandal PK, 2005, J COMP PHYSIOL B, V175, P221, DOI 10.1007/s00360-005-0483-3
   McGee S.P., 2013, TOXICOL SCI, P1
   MCMILLAN DC, 1990, TOXICOL APPL PHARM, V103, P90, DOI 10.1016/0041-008X(90)90265-V
   MCMILLAN DC, 1988, FUND APPL TOXICOL, V11, P429, DOI 10.1016/0272-0590(88)90107-8
   Meyer W, 2014, SCI TOTAL ENVIRON, V497, P634, DOI 10.1016/j.scitotenv.2014.07.103
   Modi S, 2012, DRUG DISCOV TODAY, V17, P135, DOI 10.1016/j.drudis.2011.10.022
   Morrow D, 2004, J STEROID BIOCHEM, V88, P27, DOI 10.1016/j.jsbmb.2003.10.005
   MORSE DL, 1979, CLIN TOXICOL, V15, P13, DOI 10.3109/15563657908992475
   Muster WG, 2008, DRUG DISCOV TODAY, V13, P303, DOI 10.1016/j.drudis.2007.12.007
   NAGEL R, 1991, ECOTOX ENVIRON SAFE, V21, P157, DOI 10.1016/0147-6513(91)90017-J
   NIIMI AJ, 1983, CAN J FISH AQUAT SCI, V40, P306, DOI 10.1139/f83-045
   Nilsson S, 2001, PHYSIOL REV, V81, P1535
   NRC (National Research Council), 2007, TOX TEST 21 CENT VIS
   NTP, 1991, NAT TOX PROGR EX SUM
   NTP, 1998, TOX REP SER, V65
   [NTP] National Toxicology Program, 2010, NTP TECHN REP TOX CA
   OECD, 2013, SER TEST ASSESS, V6, P1
   Ohtake F, 2003, NATURE, V423, P545, DOI 10.1038/nature01606
   Organisation for Economic Co-operation and Development OECD , 2013, TEST 236 FISH EMBR A
   Otte JC, 2010, AQUAT TOXICOL, V100, P38, DOI 10.1016/j.aquatox.2010.07.006
   Peddinghaus S, 2012, REPROD TOXICOL, V33, P224, DOI 10.1016/j.reprotox.2011.12.005
   Perera A, 1999, AGR ECOSYST ENVIRON, V72, P255, DOI 10.1016/S0167-8809(98)00184-4
   POLAND A, 1982, ANNU REV PHARMACOL, V22, P517, DOI 10.1146/annurev.pa.22.040182.002505
   POLAND A, 1976, SCIENCE, V194, P627, DOI 10.1126/science.136041
   POTHULURI JV, 1991, J ENVIRON QUAL, V20, P330, DOI 10.2134/jeq1991.00472425002000020002x
   Primel EG, 2007, J BRAZIL CHEM SOC, V18, P585, DOI 10.1590/S0103-50532007000300014
   Radovic JR, 2014, ENVIRON SCI TECHNOL, V48, P3074, DOI 10.1021/es404859m
   Rao AN, 2007, ADV AGRON, V93, P153, DOI 10.1016/S0065-2113(06)93004-1
   Redelstein R, 2015, ENVIRON SCI POLLUT R, V22, P16290, DOI 10.1007/s11356-015-5328-3
   SAFE S, 1991, PHARMACOL TOXICOL, V69, P400, DOI 10.1111/j.1600-0773.1991.tb01321.x
   Safe S., 2006, INHIBITORY AH RECEPT
   Safe SH, 1998, ENVIRON HEALTH PERSP, V106, P1051, DOI 10.2307/3434151
   Salazar KD, 2006, TOXICOL SCI, V93, P62, DOI 10.1093/toxsci/kfl038
   Santos TCR, 1998, ENVIRON SCI TECHNOL, V32, P3479, DOI 10.1021/es980212k
   Sapari P, 2012, ENVIRON MONIT ASSESS, V184, P6347, DOI 10.1007/s10661-011-2424-9
   Scheil V, 2009, ECOTOXICOLOGY, V18, P355, DOI 10.1007/s10646-008-0291-0
   Schiller V, 2014, AQUAT TOXICOL, V155, P62, DOI 10.1016/j.aquatox.2014.06.005
   Schiwy A, 2015, NAT PROTOC, V10, P1728, DOI 10.1038/nprot.2015.108
   Schiwy S, 2015, ENVIRON SCI POLLUT R, V22, P16305, DOI 10.1007/s11356-014-3185-0
   SCHRANKEL KR, 1982, ARCH ENVIRON CON TOX, V11, P195, DOI 10.1007/BF01054896
   Seok SH, 2008, J VET SCI, V9, P351, DOI 10.4142/jvs.2008.9.4.351
   Singh BP, 2010, TOXICOL PATHOL, V38, P372, DOI 10.1177/0192623310362708
   SINGH J, 1991, B ENVIRON CONTAM TOX, V47, P822, DOI 10.1007/BF01689510
   Singh J., 1989, J ASSOC OFF ANA CHEM, V73, P749
   Sonneveld E, 2006, TOXICOL SCI, V89, P173, DOI 10.1093/toxsci/kfj009
   Sonneveld E, 2005, TOXICOL SCI, V83, P136, DOI 10.1093/toxsci/kfi005
   Sorg O, 2014, TOXICOL LETT, V230, P225, DOI 10.1016/j.toxlet.2013.10.039
   SPINK DC, 1994, J STEROID BIOCHEM, V51, P251, DOI 10.1016/0960-0760(94)90037-X
   STEGEMAN JJ, 1989, MOL PHARMACOL, V36, P723
   Strahle U, 2012, REPROD TOXICOL, V33, P128, DOI 10.1016/j.reprotox.2011.06.121
   TANAKA FS, 1981, J AGR FOOD CHEM, V29, P227, DOI 10.1021/jf00104a005
   Taylor J S, 1979, Ann N Y Acad Sci, V320, P295, DOI 10.1111/j.1749-6632.1979.tb56612.x
   ter Veld MGR, 2006, J AGR FOOD CHEM, V54, P4407, DOI 10.1021/jf052864f
   Teraoka H, 2002, TOXICOL SCI, V65, P192, DOI 10.1093/toxsci/65.2.192
   Thomas KV, 2002, CHEMOSPHERE, V49, P247, DOI 10.1016/S0045-6535(02)00316-8
   U.S. Geological Survey (USGS), 2015, PEST NAT SYNTH PROJ
   van Birgelen APJM, 1999, TOXICOL APPL PHARM, V156, P147, DOI 10.1006/taap.1999.8640
   Van den Berg M, 2006, TOXICOL SCI, V93, P223, DOI 10.1093/toxsci/kfl055
   van der Oost R, 2003, ENVIRON TOXICOL PHAR, V13, P57, DOI 10.1016/S1382-6689(02)00126-6
   van der Woude H, 2005, MOL NUTR FOOD RES, V49, P763, DOI 10.1002/mnfr.200500036
   VANBIRGELEN APJM, 1995, TOXICOL APPL PHARM, V132, P1, DOI 10.1006/taap.1995.1080
   Vedani A, 2015, TOXICOL LETT, V232, P519, DOI 10.1016/j.toxlet.2014.09.004
   Vedani A, 2012, TOXICOL APPL PHARM, V261, P142, DOI 10.1016/j.taap.2012.03.018
   Vedani A, 2009, ALTEX-ALTERN TIEREXP, V26, P167
   Villeneuve D, 2014, ENVIRON TOXICOL CHEM, V33, P158, DOI 10.1002/etc.2403
   Villeneuve DL, 2000, ENVIRON TOXICOL CHEM, V19, P2835, DOI 10.1002/etc.5620191131
   Volz DC, 2011, TOXICOL SCI, V123, P349, DOI 10.1093/toxsci/kfr185
   WALKER MK, 1994, ENVIRON TOXICOL CHEM, V13, P817, DOI 10.1002/etc.5620130517
   Wassenberg DM, 2004, ENVIRON HEALTH PERSP, V112, P1658, DOI 10.1289/ehp.7168
   Wernersson AS, 2015, ENVIRON SCI EUR, V27, P1, DOI 10.1186/s12302-015-0039-4
   WHO, 2004, PROP DRINK WAT BACKG
   Whyte JJ, 2000, CRIT REV TOXICOL, V30, P347, DOI 10.1080/10408440091159239
   Willett KL, 1997, ARCH ENVIRON CON TOX, V32, P442, DOI 10.1007/s002449900211
   Yozzo KL, 2013, AQUAT TOXICOL, V126, P346, DOI 10.1016/j.aquatox.2012.09.008
   Zhang C.X., 2007, 16 INT PLANT PROT C
   Zhang W, 2005, WEED TECHNOL, V19, P293, DOI 10.1614/WT-03-250R1
   Zhang Z., 2001, P 18 AS PAC WEED SCI, P211
   Zhang Ze Pu, 2003, Weed Biology and Management, V3, P197, DOI 10.1046/j.1444-6162.2003.00105.x
   Zhu B, 2013, CHEMOSPHERE, V90, P1132, DOI 10.1016/j.chemosphere.2012.09.021
   Zhu LY, 2015, CHEMOSPHERE, V131, P34, DOI 10.1016/j.chemosphere.2015.02.031
   Zodrow JM, 2004, AQUAT TOXICOL, V66, P25, DOI 10.1016/j.aquatox.2003.07.002
NR 158
TC 9
Z9 9
U1 1
U2 50
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0048-9697
EI 1879-1026
J9 SCI TOTAL ENVIRON
JI Sci. Total Environ.
PD MAY 1
PY 2016
VL 551
BP 304
EP 316
DI 10.1016/j.scitotenv.2016.02.019
PG 13
WC Environmental Sciences
SC Environmental Sciences & Ecology
GA DH2BT
UT WOS:000372589800033
PM 26878642
DA 2019-10-23
ER

PT J
AU Ellison, CM
   Piechota, P
   Madden, JC
   Enoch, SJ
   Cronin, MTD
AF Ellison, Claire M.
   Piechota, Przemyslaw
   Madden, Judith C.
   Enoch, Steven J.
   Cronin, Mark T. D.
TI Adverse Outcome Pathway (AOP) Informed Modeling of Aquatic Toxicology:
   QSARs, Read-Across, and Interspecies Verification of Modes of Action
SO ENVIRONMENTAL SCIENCE & TECHNOLOGY
LA English
DT Article
ID FISH EMBRYO TOXICITY; BASE-LINE; ENVIRONMENTAL-POLLUTANTS; QUANTITATIVE
   STRUCTURE; PROTEIN-BINDING; ANIONIC SURFACTANTS; STRUCTURAL ALERTS;
   VERHAAR SCHEME; POLAR NARCOSIS; FATHEAD MINNOW
AB Alternative approaches have been promoted to reduce the number of vertebrate and invertebrate animals required for the assessment of the potential of compounds to cause harm to the aquatic environment. A key philosophy in the development of alternatives is a greater understanding of the relevant adverse outcome pathway (AOP). One alternative method is the fish embryo toxicity (FET) assay. Although the trends in potency have been shown to be equivalent in embryo and adult assays, a detailed mechanistic analysis of the toxicity data has yet to be performed; such analysis is vital for a full understanding of the AOP. The research presented herein used an updated implementation of the Verhaar scheme to categorize compounds into AOP-informed categories. These were then used in mechanistic (quantitative) structure activity relationship ((Q)SAR) analysis to show that the descriptors governing the distinct mechanisms of acute fish toxicity are capable of modeling data from the FET assay. The results show that compounds do appear to exhibit the same mechanisms of toxicity across life stages. Thus, this mechanistic analysis supports the argument that the FET assay is a suitable alternative testing strategy for the specified mechanisms and that understanding the AOPs is useful for toxicity prediction across test systems.
C1 [Ellison, Claire M.; Piechota, Przemyslaw; Madden, Judith C.; Enoch, Steven J.; Cronin, Mark T. D.] Liverpool John Moores Univ, Sch Pharm & Biomol Sci, Byrom St, Liverpool L3 3AF, Merseyside, England.
RP Madden, JC (reprint author), Liverpool John Moores Univ, Sch Pharm & Biomol Sci, Byrom St, Liverpool L3 3AF, Merseyside, England.
EM j.c.madden@ljmu.ac.uk
FU eTOX project under the Innovative Medicines Initiative Joint Undertaking
   (IMI-JU) [115002]
FX This work has been funded in part by the eTOX project, grant agreement
   number 115002, under the Innovative Medicines Initiative Joint
   Undertaking (IMI-JU).
CR Anand M, 1998, DRUG CHEM TOXICOL, V21, P35, DOI 10.3109/01480549809017849
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Antczak P, 2015, ENVIRON SCI TECHNOL, V49, P11132, DOI 10.1021/acs.est.5b02707
   Bajot F, 2011, SAR QSAR ENVIRON RES, V22, P51, DOI 10.1080/1062936X.2010.528449
   Belanger SE, 2013, ENVIRON TOXICOL CHEM, V32, P1768, DOI 10.1002/etc.2244
   Bermudez-Saldana JM, 2006, PEST MANAG SCI, V62, P819, DOI 10.1002/ps.1233
   Boxall ABA, 1997, SETAC SP P, P263
   Colovic MB, 2013, CURR NEUROPHARMACOL, V11, P315, DOI 10.2174/1570159X11311030006
   CRONIN MTD, 1991, SCI TOTAL ENVIRON, V109, P431, DOI 10.1016/0048-9697(91)90198-N
   DEARDEN JC, 1995, CHEMOSPHERE, V31, P2521, DOI 10.1016/0045-6535(95)00121-N
   Ellison CM, 2008, SAR QSAR ENVIRON RES, V19, P751, DOI 10.1080/10629360802550366
   Ellison CM, 2015, CHEMOSPHERE, V139, P146, DOI 10.1016/j.chemosphere.2015.06.009
   Ellison CM, 2011, EXPERT OPIN DRUG MET, V7, P1481, DOI 10.1517/17425255.2011.629186
   Enoch SJ, 2008, CHEMOSPHERE, V73, P243, DOI 10.1016/j.chemosphere.2008.06.052
   Enoch SJ, 2008, CHEMOSPHERE, V71, P1225, DOI 10.1016/j.chemosphere.2007.12.011
   Enoch SJ, 2013, SAR QSAR ENVIRON RES, V24, P651, DOI 10.1080/1062936X.2013.773377
   Enoch SJ, 2011, CRIT REV TOXICOL, V41, P783, DOI 10.3109/10408444.2011.598141
   Enoch SJ, 2011, ATLA-ALTERN LAB ANIM, V39, P131, DOI 10.1177/026119291103900206
   Enoch SJ, 2008, CHEM RES TOXICOL, V21, P513, DOI 10.1021/tx700322g
   Escher BI, 2004, ENVIRON SCI TECHNOL, V38, p455A, DOI 10.1021/es0406740
   Escher BI, 2002, ENVIRON SCI TECHNOL, V36, P1971, DOI 10.1021/es015844c
   Frisch MJ, 2009, GAUSSIAN 09
   Groh KJ, 2015, CHEMOSPHERE, V120, P764, DOI 10.1016/j.chemosphere.2014.09.068
   HERMENS JLM, 1990, ENVIRON HEALTH PERSP, V87, P219, DOI 10.2307/3431028
   Hodges G, 2006, CHEMOSPHERE, V63, P1443, DOI 10.1016/j.chemosphere.2005.10.001
   Hodges G, 2006, CHEMOSPHERE, V64, P17, DOI 10.1016/j.chemosphere.2005.12.021
   Jeffries MKS, 2014, ENVIRON TOXICOL CHEM, V33, P2584, DOI 10.1002/etc.2718
   Kluver N, 2015, ENVIRON SCI TECHNOL, V49, P7002, DOI 10.1021/acs.est.5b01910
   Kluver N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090619
   Knobel M, 2012, ENVIRON SCI TECHNOL, V46, P9690, DOI 10.1021/es301729q
   Konnecker G, 2011, ECOTOX ENVIRON SAFE, V74, P1445, DOI 10.1016/j.ecoenv.2011.04.015
   Kramer NI, 2009, TOXICOL IN VITRO, V23, P1372, DOI 10.1016/j.tiv.2009.07.029
   Kretschmann A, 2012, ENVIRON TOXICOL CHEM, V31, P2014, DOI 10.1002/etc.1905
   LaLone CA, 2013, AQUAT TOXICOL, V144, P141, DOI 10.1016/j.aquatox.2013.09.004
   LaLone CA, 2013, ENVIRON TOXICOL CHEM, V32, P2528, DOI 10.1002/etc.2330
   Lammer E, 2009, TOXICOL IN VITRO, V23, P1436, DOI 10.1016/j.tiv.2009.05.014
   Lammer E, 2009, COMP BIOCHEM PHYS C, V149, P196, DOI 10.1016/j.cbpc.2008.11.006
   Laqua A., 2013, FAKULTAT CHEM PHYS
   Li NY, 2003, J BIOL CHEM, V278, P8516, DOI 10.1074/jbc.M210432200
   LIPNICK RL, 1991, SCI TOTAL ENVIRON, V109, P131, DOI 10.1016/0048-9697(91)90175-E
   Martin TM, 2015, SAR QSAR ENVIRON RES, V26, P245, DOI 10.1080/1062936X.2015.1018939
   MCKIM JM, 1987, ENVIRON HEALTH PERSP, V71, P171, DOI 10.2307/3430424
   Nelms MD, 2015, ARCH TOXICOL, V89, P733, DOI 10.1007/s00204-014-1277-8
   Nelms MD, 2013, SAR QSAR ENVIRON RES, V24, P695, DOI 10.1080/1062936X.2013.792874
   Nendza M, 2014, SAR QSAR ENVIRON RES, V25, P393, DOI 10.1080/1062936X.2014.907205
   Organisation for Economic Co-operation and Development, 2013, GUID TEST CHEM
   Pavan M, 2008, SAR QSAR ENVIRON RES, V19, P785, DOI 10.1080/10629360802550390
   Richarz AN, 2014, SAR QSAR ENVIRON RES, V25, P325, DOI 10.1080/1062936X.2014.898693
   Roberts DW, 2010, CHEM RES TOXICOL, V23, P228, DOI [10.1021/tx90003648, 10.1021/tx9003648]
   Roberts DW, 2003, QSAR COMB SCI, V22, P226, DOI 10.1002/qsar.200390016
   Roberts DW, 2004, SURF SCI CRC, V123, P271
   Ross W. C. J., 1962, BIOL ALKYLATING AGEN
   ROTH SH, 1980, FED PROC, V39, P1595
   Russom CL, 1997, ENVIRON TOXICOL CHEM, V16, P948, DOI 10.1002/etc.5620160514
   Schultz TW, 2010, ISSUES TOXICOL, V7, P346
   Schultz TW, 2010, SAR QSAR ENVIRON RES, V21, P681, DOI 10.1080/1062936X.2010.528933
   Schultz TW, 1997, ENVIRON TOXICOL CHEM, V16, P357, DOI 10.1002/etc.5620160235
   Schultz TW, 1997, SETAC SP P, P329
   Schultz TW, 1997, AQUAT TOXICOL, V39, P267, DOI 10.1016/S0166-445X(97)00031-3
   Short J, 2010, ECOTOX ENVIRON SAFE, V73, P1484, DOI 10.1016/j.ecoenv.2010.03.006
   Steinmetz FP, 2014, SCI TOTAL ENVIRON, V482, P358, DOI 10.1016/j.scitotenv.2014.02.115
   Su LM, 2014, SCI TOTAL ENVIRON, V484, P137, DOI 10.1016/j.scitotenv.2014.03.040
   Thomas P, 2015, ENVIRON SCI TECHNOL, V49, P12289, DOI 10.1021/acs.est.5b02873
   Tollefsen KE, 2014, REGUL TOXICOL PHARM, V70, P629, DOI 10.1016/j.yrtph.2014.09.009
   United States Environmental Protection Agency (U.S. EPA), 2015, EST PROGR INT SUIT M
   Vaes WHJ, 1998, ENVIRON TOXICOL CHEM, V17, P1380, DOI 10.1002/etc.5620170723
   VAN WEZEL A, 1995, CRIT REV TOXICOL, V25, P255, DOI 10.3109/10408449509089890
   VEITH GD, 1989, XENOBIOTICA, V19, P555, DOI 10.3109/00498258909042295
   VERHAAR HJM, 1992, CHEMOSPHERE, V25, P471, DOI 10.1016/0045-6535(92)90280-5
   Villeneuve D, 2014, ENVIRON TOXICOL CHEM, V33, P158, DOI 10.1002/etc.2403
   Yuan H, 2007, J MOL GRAPH MODEL, V26, P327, DOI 10.1016/j.jmgm.2006.12.009
NR 71
TC 16
Z9 16
U1 5
U2 60
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0013-936X
EI 1520-5851
J9 ENVIRON SCI TECHNOL
JI Environ. Sci. Technol.
PD APR 5
PY 2016
VL 50
IS 7
BP 3995
EP 4007
DI 10.1021/acs.est.5b05918
PG 13
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA DI7CD
UT WOS:000373655800082
PM 26889772
DA 2019-10-23
ER

PT J
AU Thompson, CM
   Bichteler, A
   Rager, JE
   Suh, M
   Proctor, DM
   Haws, LC
   Harris, MA
AF Thompson, Chad M.
   Bichteler, Anne
   Rager, Julia E.
   Suh, Mina
   Proctor, Deborah M.
   Haws, Laurie C.
   Harris, Mark A.
TI Comparison of in vivo genotoxic and carcinogenic potency to augment mode
   of action analysis: Case study with hexavalent chromium
SO MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS
LA English
DT Article
DE Carcinogenicity; Genotoxicity; Hexavalent chromium; Mode of action; Risk
   assessment
ID ADVERSE OUTCOME PATHWAYS; B6C3F1 MICE; F344 RATS;
   GASTROINTESTINAL-TRACT; CONCEPTUAL-FRAMEWORK; MICRONUCLEUS ASSAYS; MOUSE
   DUODENUM; RODENT TISSUES; ORAL-EXPOSURE; K-RAS
AB Recent analyses highlighted by the International Workshops on Genotoxicity Testing Working Group on Quantitative Approaches to Genetic Toxicology Risk Assessment have identified a correlation between (log) estimates of a carcinogen's in vivo genotoxic potency and in vivo carcinogenic potency in typical laboratory animal models, even when the underlying data have not been matched for tissue, species, or strain. Such a correlation could have important implications for risk assessment, including informing the mode of action (MOA) of specific carcinogens. When in vivo genotoxic potency is weak relative to carcinogenic potency, MOAs other than genotoxicity (e.g., endocrine disruption or regenerative hyperplasia) may be operational. Herein, we review recent in vivo genotoxicity and carcinogenicity data for hexavalent chromium (Cr(VI)), following oral ingestion, in relevant tissues and species in the context of the aforementioned correlation. Potency estimates were generated using benchmark doses, or no observable-adverse-effect-levels when data were not amenable to dose-response modeling. While the ratio between log values for carcinogenic and genotoxic potency was >= 1 for many compounds, the ratios for several Cr(VI) datasets (including in target tissue) were less than unity. In fact, the ratios for Cr(V1) clustered closely with ratios for chloroform and diethanolamine, two chemicals posited to have non-genotoxic MOAs. These findings suggest that genotoxicity may not play a major role in the cancers observed in rodents following exposure to high concentrations of Cr(V1) in drinking water a finding consistent with recent MOA and adverse outcome pathway (AOP) analyses concerning Cr(VI). This semi quantitative analysis, therefore, may be useful to augment traditional MOA and AOP analyses. More case examples will be needed to further explore the general applicability and validity of this approach for human health risk assessment. (C) 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license (http://creativecommons.orgilicenses/by/4.0/).
C1 [Thompson, Chad M.; Harris, Mark A.] ToxStrategies Inc, 23123 Cinco Ranch Blvd,Suite 220, Katy, TX 77494 USA.
   [Bichteler, Anne; Rager, Julia E.; Haws, Laurie C.] ToxStrategies Inc, Austin, TX USA.
   [Suh, Mina; Proctor, Deborah M.] ToxStrategies Inc, Mission Viejo, CA USA.
RP Thompson, CM (reprint author), ToxStrategies Inc, 23123 Cinco Ranch Blvd,Suite 220, Katy, TX 77494 USA.
EM cthompson@toxstrategies.com
OI Bichteler, Anne/0000-0003-1822-8057
FU Cr(VI) Panel of the American Chemistry Council
FX This work was supported by the Cr(VI) Panel of the American Chemistry
   Council.
CR Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   [Anonymous], 2008, NIH PUBLICATION, V08-5897, P08
   Becker RA, 2015, REGUL TOXICOL PHARM, V72, P514, DOI 10.1016/j.yrtph.2015.04.004
   Brig A.E., 2010, CANC RISK ASSESSMENT, P699
   Bucher John R, 2007, Toxic Rep Ser, P1
   Chen JB, 1999, MUTAT RES-GEN TOX EN, V444, P347, DOI 10.1016/S1383-5718(99)00099-6
   Cohen SM, 2010, CRIT REV TOXICOL, V40, P531, DOI 10.3109/10408441003742903
   COHEN SM, 1990, SCIENCE, V249, P1007, DOI 10.1126/science.2204108
   Cullen JM, 2016, TOXICOL PATHOL, V44, P279, DOI 10.1177/0192623315611501
   De Flora S, 2006, MUTAT RES-GEN TOX EN, V610, P38, DOI 10.1016/j.mrgentox.2006.06.011
   Feng Y, 2011, GASTROENTEROLOGY, V141, P1003, DOI 10.1053/j.gastro.2011.05.007
   Golden RJ, 1997, REGUL TOXICOL PHARM, V26, P142, DOI 10.1006/rtph.1997.1161
   Gordon E, 2007, J APPL TOXICOL, V27, P519, DOI 10.1002/jat.1265
   Hamada S, 2015, MUTAT RES-GEN TOX EN, V780, P2, DOI 10.1016/j.mrgentox.2015.01.001
   Haney J, 2015, REGUL TOXICOL PHARM, V73, P834, DOI 10.1016/j.yrtph.2015.10.011
   Health Canada, 2015, CHROM DRINK WAT DOC
   Hernandez L.G., 2012, ESTIMATING CARCINOGE
   Hernandez LG, 2011, ENVIRON MOL MUTAGEN, V52, P518, DOI 10.1002/em.20651
   Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211
   Kirman CR, 2012, CHEM-BIOL INTERACT, V200, P45, DOI 10.1016/j.cbi.2012.08.016
   Leung HW, 2005, REGUL TOXICOL PHARM, V43, P260, DOI 10.1016/j.yrtph.2005.08.001
   Luo FJ, 2009, INT J EXP PATHOL, V90, P558, DOI 10.1111/j.1365-2613.2009.00667.x
   MacGregor JT, 2015, MUTAT RES-GEN TOX EN, V783, P66, DOI 10.1016/j.mrgentox.2014.10.008
   MAK, 2015, MAK COLL OCC HLTH SA
   McCarroll N, 2010, ENVIRON MOL MUTAGEN, V51, P89, DOI 10.1002/em.20525
   MCCONNELL EE, 1986, J NATL CANCER I, V76, P283
   Meek ME, 2014, J APPL TOXICOL, V34, P1, DOI 10.1002/jat.2949
   Morita T, 2011, MUTAGENESIS, V26, P223, DOI 10.1093/mutage/geq066
   Myers MB, 2014, METHODS MOL BIOL, V1105, P345, DOI 10.1007/978-1-62703-739-6_27
   NCI, 1977, NAT CANC I CARCINOGE, V15
   NTP, 2001, NIH PUBLICATION
   O'Brien TJ, 2013, MUTAT RES-GEN TOX EN, V754, P15, DOI 10.1016/j.mrgentox.2013.03.008
   OECD, 2009, SER TEST ASS
   Sanchez-Martin FJ, 2015, TOXICOL SCI, V146, P52, DOI 10.1093/toxsci/kfv070
   Slob W., 2013, PROAST61 3 BENCKMARK
   Slob W, 2014, CRIT REV TOXICOL, V44, P270, DOI 10.3109/10408444.2013.853726
   Soeteman-Hernandez L.G., 2015, MUTAGENESIS
   Sonich-Mullin C, 2001, REGUL TOXICOL PHARM, V34, P146, DOI 10.1006/rtph.2001.1493
   Stout MD, 2009, ENVIRON HEALTH PERSP, V117, P716, DOI 10.1289/ehp.0800208
   Suh M, 2014, FOOD CHEM TOXICOL, V65, P381, DOI 10.1016/j.fct.2014.01.009
   Thompson CM, 2015, ENVIRON MOL MUTAGEN, V56, P621, DOI 10.1002/em.21952
   Thompson CM, 2015, MUTAT RES-GEN TOX EN, V789, P61, DOI 10.1016/j.mrgentox.2015.05.004
   Thompson CM, 2015, TOXICOL SCI, V143, P16, DOI 10.1093/toxsci/kfu206
   Thompson CM, 2013, CRIT REV TOXICOL, V43, P244, DOI 10.3109/10408444.2013.768596
   Thompson CM, 2012, REGUL TOXICOL PHARM, V64, P68, DOI 10.1016/j.yrtph.2012.05.019
   Thompson CM, 2012, TOXICOL SCI, V125, P79, DOI 10.1093/toxsci/kfr280
   Thompson CM, 2011, TOXICOL SCI, V123, P58, DOI 10.1093/toxsci/kfr164
   U.S. EPA, 2001, TOX REV CHLOR SUPP S
   U.S. EPA Captan, 2004, FED REGISTER, V69, P68357
   Uno Y, 2015, MUTAT RES-GEN TOX EN, V783, P19, DOI 10.1016/j.mrgentox.2015.03.001
   *US EPA, 2005, GUID CARC RISK ASS
   Wicki A, 2010, SWISS MED WKLY, V140, P14, DOI 10.4414/smw.2010.13112
   Wignall JA, 2014, ENVIRON HEALTH PERSP, V122, P499, DOI 10.1289/ehp.1307539
NR 53
TC 3
Z9 3
U1 0
U2 10
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1383-5718
EI 1879-3592
J9 MUTAT RES-GEN TOX EN
JI Mutat. Res. Genet. Toxicol. Environ. Mutagen.
PD APR
PY 2016
VL 800
BP 28
EP 34
DI 10.1016/j.mrgentox.2016.01.008
PG 7
WC Biotechnology & Applied Microbiology; Genetics & Heredity; Toxicology
SC Biotechnology & Applied Microbiology; Genetics & Heredity; Toxicology
GA DL3DT
UT WOS:000375515100004
PM 27085472
OA Other Gold
DA 2019-10-23
ER

PT J
AU Hutchinson, TH
   Wheeler, JR
   Gourmelon, A
   Burden, N
AF Hutchinson, Thomas H.
   Wheeler, James R.
   Gourmelon, Anne
   Burden, Natalie
TI Promoting the 3Rs to enhance the OECD fish toxicity testing framework
SO REGULATORY TOXICOLOGY AND PHARMACOLOGY
LA English
DT Article
DE Aquatic; Chemicals; Effluent; Hazard; Risk; Safety
ID ADVERSE OUTCOME PATHWAYS
AB Fish toxicity testing has been conducted since the 1860's in order to help define safe levels of chemical contaminants in lakes, rivers and coastal waters. The historical emphasis on acute lethality testing of chemicals has more recently focussed on long term sublethal effects of chemicals on fish and their prey species. Fish toxicity testing is now embedded in much environment legislation on chemical safety while it is recognized that animal use should be Replaced, Reduced and Refined (the 3Rs) where possible. The OECD Fish Toxicity Testing Framework provides a useful structure with which to address the needs of environmental safety assessment whilst implementing the 3Rs. This commentary aims to promote the implementation of the recommendations of the OECD Fish Toxicity Testing Framework. (C) 2016 Elsevier Inc. All rights reserved.
C1 [Hutchinson, Thomas H.] Univ Plymouth, Sch Biol Sci, Plymouth PL4 8AA, Devon, England.
   [Wheeler, James R.] Dow AgroSci, 3B Pk Sq,Milton Pk, Abingdon OX14 4RN, Oxon, England.
   [Gourmelon, Anne] Org Econ Cooperat & Dev, 2 Rue Andre Pascal, F-75775 Paris 16, France.
   [Burden, Natalie] NC3Rs, Gibbs Bldg,215 Euston Rd, London NW1 2BE, England.
RP Hutchinson, TH (reprint author), Univ Plymouth, Sch Biol Sci, Plymouth PL4 8AA, Devon, England.
EM tom.hutchinson@plymouth.ac.uk; jrwheeler@dow.com;
   anne.gourmelon@oecd.org; natalie.burden@nc3rs.org.uk
CR Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Burden N., 2015, INTEGR ENVIRON ASSES, V1703
   Burden N, 2015, J APPL TOXICOL, V35, P971, DOI 10.1002/jat.3165
   *ECETOC, 2007, 102 ECETOC
   Hunn J.B., 1989, I497098 US DEP INT F
   Hutchinson TH, 2009, AQUAT TOXICOL, V91, P197, DOI 10.1016/j.aquatox.2008.11.009
   OECD, 2015, OECD SER TEST ASS, V215
   OECD, 2012, OECD SER TEST ASS, V171
   SPRAGUE JB, 1971, WATER RES, V5, P245, DOI 10.1016/0043-1354(71)90171-0
NR 9
TC 2
Z9 2
U1 0
U2 3
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0273-2300
EI 1096-0295
J9 REGUL TOXICOL PHARM
JI Regul. Toxicol. Pharmacol.
PD APR
PY 2016
VL 76
BP 231
EP 233
DI 10.1016/j.yrtph.2016.02.006
PG 3
WC Medicine, Legal; Pharmacology & Pharmacy; Toxicology
SC Legal Medicine; Pharmacology & Pharmacy; Toxicology
GA DL3DK
UT WOS:000375514200028
PM 26873775
DA 2019-10-23
ER

PT J
AU Bell, SM
   Angrish, MM
   Wood, CE
   Edwards, SW
AF Bell, Shannon M.
   Angrish, Michelle M.
   Wood, Charles E.
   Edwards, Stephen W.
TI Integrating Publicly Available Data to Generate Computationally
   Predicted Adverse Outcome Pathways for Fatty Liver
SO TOXICOLOGICAL SCIENCES
LA English
DT Article
DE computationally predicted adverse outcome pathways; cpAOP; TG-GATEs;
   network integration; fatty liver; steatosis
ID CARBON-TETRACHLORIDE; ONTOLOGY; DISEASE; IDENTIFICATION; STRATEGIES;
   FRAMEWORK; CHEMICALS; BIOLOGY; OBESITY
AB New in vitro testing strategies make it possible to design testing batteries for large numbers of environmental chemicals. Full utilization of the results requires knowledge of the underlying biological networks and the adverse outcome pathways (AOPs) that describe the route from early molecular perturbations to an adverse outcome. Curation of a formal AOP is a time-intensive process and a rate-limiting step to designing these test batteries. Here, we describe a method for integrating publicly available data in order to generate computationally predicted AOP (cpAOP) scaffolds, which can be leveraged by domain experts to shorten the time for formal AOP development. A network-based workflow was used to facilitate the integration of multiple data types to generate cpAOPs. Edges between graph entities were identified through direct experimental or literature information, or computationally inferred using frequent itemset mining. Data from the TG-GATEs and ToxCast programs were used to channel large-scale toxicogenomics information into a cpAOP network (cpAOPnet) of over 20 000 relationships describing connections between chemical treatments, phenotypes, and perturbed pathways as measured by differential gene expression and high-throughput screening targets. The resulting fatty liver cpAOPnet is available as a resource to the community. Subnetworks of cpAOPs for a reference chemical (carbon tetrachloride, CCl4) and outcome (fatty liver) were compared with published mechanistic descriptions. In both cases, the computational approaches approximated the manually curated AOPs. The cpAOPnet can be used for accelerating expert-curated AOP development and to identify pathway targets that lack genomic markers or high-throughput screening tests. It can also facilitate identification of key events for designing test batteries and for classification and grouping of chemicals for follow up testing.
C1 [Bell, Shannon M.] Oak Ridge Inst Sci & Educ, Oak Ridge, TN USA.
   [Bell, Shannon M.; Angrish, Michelle M.; Wood, Charles E.; Edwards, Stephen W.] US EPA, Integrated Syst Toxicol Div, Natl Hlth & Environm Effects Res Lab, Off Res & Dev, Res Triangle Pk, NC 27711 USA.
   [Bell, Shannon M.] NTP Interagcy Ctr Evaluat Alternat Toxicol Method, Res Triangle Pk, NC USA.
RP Edwards, SW (reprint author), US EPA, Integrated Syst Toxicol Div, Natl Hlth & Environm Effects Res Lab, Off Res & Dev, 109 TW Alexander Dr,Mail Code B105-03, Res Triangle Pk, NC 27709 USA.
EM edwards.stephen@epa.gov
FU U. S. Environmental Protection AgencyUnited States Environmental
   Protection Agency
FX This work was supported by the U. S. Environmental Protection Agency.
   S.M.B. was supported by an appointment to the Internship/Research
   Participation Program at the Office of Research and Development, U.S.
   EPA, administered by the Oak Ridge Institute for Science and Education
   through an interagency agreement between the U.S. Department of Energy
   and the U.S. EPA.
CR AIYAR AS, 1964, BIOCHEM J, V90, P558, DOI 10.1042/bj0900558
   Al-Eryani L, 2015, TOXICOL PATHOL, V43, P482, DOI 10.1177/0192623314549960
   Angrish M., TOXICOL SCI IN PRESS, V43, P482
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556
   Bell SM, 2015, ENVIRON HEALTH PERSP, V123, P1193, DOI 10.1289/ehp.1409138
   Bell SM, 2014, P SIAM INT C DAT MIN, V2014, P551
   Browne P, 2015, ENVIRON SCI TECHNOL, V49, P8804, DOI 10.1021/acs.est.5b02641
   Croft D, 2014, NUCLEIC ACIDS RES, V42, pD472, DOI 10.1093/nar/gkt1102
   EPA, 2010, TOX REV CARB TETR CA
   Garcia-Reyero N, 2015, ENVIRON SCI TECHNOL, V49, P3, DOI 10.1021/es504976d
   Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80
   Hahsler M, 2005, J STAT SOFTW, V14
   Hahsler M., 2014, J STAT SOFTW, V14, P1
   Huber W, 2015, NAT METHODS, V12, P115, DOI [10.1038/NMETH.3252, 10.1038/nmeth.3252]
   Igarashi Y, 2015, NUCLEIC ACIDS RES, V43, pD921, DOI 10.1093/nar/gku955
   Judson RS, 2010, ENVIRON HEALTH PERSP, V118, P485, DOI 10.1289/ehp.0901392
   Kavlock R, 2012, CHEM RES TOXICOL, V25, P1287, DOI 10.1021/tx3000939
   Knapen D, 2015, REPROD TOXICOL, V56, P52, DOI 10.1016/j.reprotox.2015.04.003
   Kohler S, 2014, NUCLEIC ACIDS RES, V42, pD966, DOI 10.1093/nar/gkt1026
   Luechtefeld T, 2015, J APPL TOXICOL, V35, P1361, DOI 10.1002/jat.3172
   Meek ME, 2014, J APPL TOXICOL, V34, P1, DOI 10.1002/jat.2949
   Milacic Marija, 2012, Cancers (Basel), V4, P1180, DOI 10.3390/cancers4041180
   Newbold RR, 2007, REPROD TOXICOL, V23, P290, DOI 10.1016/j.reprotox.2006.12.010
   Noureddin M, 2015, CLIN LIVER DIS, V19, P361, DOI 10.1016/j.cld.2015.01.012
   Oki Noffisat O, 2016, Curr Environ Health Rep, V3, P53, DOI 10.1007/s40572-016-0079-y
   R Core Team, 2016, R LANG ENV STAT COMP
   Rovida C, 2015, ALTEX-ALTERN ANIM EX, V32, P25, DOI [http://dx.doi.org/10.14573/altex.1411011, 10.14573/altex.1506201]
   Schurer SC, 2011, J BIOMOL SCREEN, V16, P415, DOI 10.1177/1087057111400191
   STERN P. H., 1965, J LIPID RES, V6, P278
   Villeneuve DL, 2014, TOXICOL SCI, V142, P312, DOI 10.1093/toxsci/kfu199
   Villeneuve DL, 2014, TOXICOL SCI, V142, P321, DOI 10.1093/toxsci/kfu200
   Weber LWD, 2003, CRIT REV TOXICOL, V33, P105, DOI 10.1080/713611034
NR 33
TC 29
Z9 30
U1 0
U2 21
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1096-6080
EI 1096-0929
J9 TOXICOL SCI
JI Toxicol. Sci.
PD APR
PY 2016
VL 150
IS 2
BP 510
EP 520
DI 10.1093/toxsci/kfw017
PG 11
WC Toxicology
SC Toxicology
GA DJ5ET
UT WOS:000374230300022
PM 26895641
DA 2019-10-23
ER

PT J
AU Patlewicz, G
   Fitzpatrick, JM
AF Patlewicz, Grace
   Fitzpatrick, Jeremy M.
TI Current and Future Perspectives on the Development, Evaluation, and
   Application of in Silico Approaches for Predicting Toxicity
SO CHEMICAL RESEARCH IN TOXICOLOGY
LA English
DT Review
ID DERMAL SENSITIZATION THRESHOLD; INDUCED LIVER-INJURY; VIVO TOXICOLOGICAL
   OUTCOMES; STRUCTURAL INCLUSION RULES; THROUGHPUT SCREENING DATA;
   DECISION-SUPPORT-SYSTEM; READ-ACROSS; APPLICABILITY DOMAIN; QSAR MODELS;
   COMPUTATIONAL PREDICTION
AB Exploiting non-testing approaches to predict toxicity early in the drug-discovery development cycle is a helpful component in minimizing expensive drug failures due to toxicity being identified in late development or even during clinical trials. Changes in regulations in the industrial chemicals and cosmetics sectors in recent years have prompted a significant number of advances in the development; application, and assessment of non-testing approaches,, such as (Q)SARs. Many efforts have also been undertaken to establish guiding principles for performing read-across within category and analogue approaches. This review offers a perspective, as taken from these sectors, of the current status of non-testing approaches, their evolution in light of the advances in high-throughput approaches and constructs such as adverse outcome pathways, and their potential relevance for drug discovery. It also proposes a workflow for how non-testing approaches could be practically integrated within testing and assessment strategies.
C1 [Patlewicz, Grace; Fitzpatrick, Jeremy M.] US EPA, NCCT, Res Triangle Pk, NC 27711 USA.
RP Patlewicz, G (reprint author), US EPA, NCCT, Res Triangle Pk, NC 27711 USA.
EM gpatlewicz@gmail.com
OI Patlewicz, Grace/0000-0003-3863-9689
CR Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   [Anonymous], 2010, TR109 ECETOC
   [Anonymous], 116 SAR ECETOC
   [Anonymous], APPL MOD TOX APPR PR, DOI [10.17226/21775, DOI 10.17226/21775]
   [Anonymous], 2014, OECD SER TEST ASS, V194
   [Anonymous], 2012, ADV OUT PATH SKIN SE
   [Anonymous], 2004, OECD PRINC VAL REG P
   [Anonymous], 2015, ECHA15R07EN
   [Anonymous], 2001, WHIT PAP STRAT FUT C
   [Anonymous], 2015, SER TEST ASS, V215
   [Anonymous], 2011, REP WORKSH US MECH I, V138
   Antunovic B, 2012, EFSA J, V10, DOI 10.2903/j.efsa.2012.2750
   Ball N, 2014, REGUL TOXICOL PHARM, V68, P212, DOI 10.1016/j.yrtph.2013.12.007
   Becker RA, 2015, REGUL TOXICOL PHARM, V71, P398, DOI 10.1016/j.yrtph.2015.01.008
   Benigni R, 2008, MUTAT RES-REV MUTAT, V659, P248, DOI 10.1016/j.mrrev.2008.05.003
   Blackburn K, 2014, REGUL TOXICOL PHARM, V68, P353, DOI 10.1016/j.yrtph.2014.01.004
   Blackburn K, 2011, REGUL TOXICOL PHARM, V60, P120, DOI 10.1016/j.yrtph.2011.03.002
   Bouder Frederic, 2008, Expert Rev Clin Pharmacol, V1, P241, DOI 10.1586/17512433.1.2.241
   Bowes J, 2012, NAT REV DRUG DISCOV, V11, P909, DOI 10.1038/nrd3845
   BRADBURY SP, 1990, EURO CH ENV, V1, P295
   Braga RC, 2014, CURR TOP MED CHEM, V14, P1399, DOI 10.2174/1568026614666140506124442
   Carthew P, 2009, FOOD CHEM TOXICOL, V47, P1287, DOI 10.1016/j.fct.2009.02.024
   Chen MJ, 2014, BIOMARK MED, V8, P201, DOI 10.2217/bmm.13.146
   Chen MJ, 2013, TOXICOL SCI, V136, P242, DOI 10.1093/toxsci/kft189
   Cook D, 2014, NAT REV DRUG DISCOV, V13, P419, DOI 10.1038/nrd4309
   Cronin M, 2013, CHEM TOXICITY PREDIC
   Dearden JC, 1997, ATLA-ALTERN LAB ANIM, V25, P223
   Dietrich R., 2010, SILICO TOXICOLOGY PR, P385
   Dimitrov S, 2005, J CHEM INF MODEL, V45, P839, DOI 10.1021/ci0500381
   Escher SE, 2010, REGUL TOXICOL PHARM, V58, P259, DOI 10.1016/j.yrtph.2010.06.009
   European Chemicals Agency, 2008, GUID INF REQ CHEM SA
   Gini G, 2014, SAR QSAR ENVIRON RES, V25, P999, DOI 10.1080/1062936X.2014.976267
   Greene N, 2010, CHEM RES TOXICOL, V23, P1215, DOI 10.1021/tx1000865
   Hewitt M, 2013, CRIT REV TOXICOL, V43, P537, DOI 10.3109/10408444.2013.811215
   Hughes JD, 2008, BIOORG MED CHEM LETT, V18, P4872, DOI 10.1016/j.bmcl.2008.07.071
   Jaworska J, 2005, ATLA-ALTERN LAB ANIM, V33, P445, DOI 10.1177/026119290503300508
   Jaworska JS, 2003, ENVIRON HEALTH PERSP, V111, P1358, DOI 10.1289/ehp.5757
   Jing YK, 2015, FUTURE MED CHEM, V7, P571, DOI 10.4155/fmc.15.18
   Kroes R, 2004, FOOD CHEM TOXICOL, V42, P65, DOI 10.1016/j.fct.2003.08.006
   Low Y, 2013, CHEM RES TOXICOL, V26, P1199, DOI 10.1021/tx400110f
   Low Y, 2011, CHEM RES TOXICOL, V24, P1251, DOI 10.1021/tx200148a
   MCKIM JM, 1987, ENVIRON HEALTH PERSP, V71, P171, DOI 10.2307/3430424
   Mekenyan O, 2012, SAR QSAR ENVIRON RES, V23, P553, DOI 10.1080/1062936X.2012.679689
   Mekenyan O, 2014, CHEM RES TOXICOL, V27, P219, DOI 10.1021/tx400345b
   MUELLER L, 2006, REGUL TOXICOL PHARM, V44, P198
   Myshkin E, 2012, CHEM BIOL DRUG DES, V80, P406, DOI 10.1111/j.1747-0285.2012.01411.x
   Netzeva TI, 2005, ATLA-ALTERN LAB ANIM, V33, P155, DOI 10.1177/026119290503300209
   Norinder U, 2015, REGUL TOXICOL PHARM, V71, P279, DOI 10.1016/j.yrtph.2014.12.021
   Organisation for Economic Co operation and Development, 2012, SER TEST ASS, V168
   Organisation for Economic Co-operation and Development, 2007, OECD SER TEST ASS, V69
   Otieno MA, 2010, PREDICTIVE TOXICOLOG, P230
   Patlewicz G, 2008, SAR QSAR ENVIRON RES, V19, P397, DOI 10.1080/10629360802083848
   Patlewicz G, 2015, REGUL TOXICOL PHARM, V72, P117, DOI 10.1016/j.yrtph.2015.03.015
   Patlewicz G, 2014, SAR QSAR ENVIRON RES, V25, P367, DOI 10.1080/1062936X.2014.900520
   Patlewicz G, 2011, SAR QSAR ENVIRON RES, V22, P67, DOI 10.1080/1062936X.2010.528448
   Patlewicz G., 2015, ACS ANN M AUG 16 20
   Patlewicz G., 2015, VALIDATION ALTERNATI
   Patlewicz G, 2015, REGUL TOXICOL PHARM, V71, P463, DOI 10.1016/j.yrtph.2015.02.011
   Patlewicz G, 2014, ALTEX-ALTERN ANIM EX, V31, P387, DOI 10.14573/altex.1410071
   Patlewicz G, 2014, REGUL TOXICOL PHARM, V69, P529, DOI 10.1016/j.yrtph.2014.06.001
   Patlewicz G, 2013, REGUL TOXICOL PHARM, V67, P1, DOI 10.1016/j.yrtph.2013.06.002
   Patlewicz G, 2013, REGUL TOXICOL PHARM, V65, P226, DOI 10.1016/j.yrtph.2012.12.004
   PATLEWICZ GY, 2008, 23225 EUR EN
   Petkov PI, 2015, REGUL TOXICOL PHARM, V72, P17, DOI 10.1016/j.yrtph.2015.03.003
   Price DA, 2009, EXPERT OPIN DRUG MET, V5, P921, DOI 10.1517/17425250903042318
   Prieto P, 2013, TOXICOL IN VITRO, V27, P1357, DOI 10.1016/j.tiv.2012.07.013
   Przybylak KR, 2012, EXPERT OPIN DRUG MET, V8, P201, DOI 10.1517/17425255.2012.648613
   Raunio H, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00033
   Richard A., 2015, CHEMOTYPES EXPLORE T
   Roberts DW, 2015, REGUL TOXICOL PHARM, V72, P683, DOI 10.1016/j.yrtph.2015.03.001
   Rodgers AD, 2010, CHEM RES TOXICOL, V23, P724, DOI 10.1021/tx900451r
   Safford RJ, 2008, REGUL TOXICOL PHARM, V51, P195, DOI 10.1016/j.yrtph.2008.02.010
   Safford RJ, 2011, REGUL TOXICOL PHARM, V60, P218, DOI 10.1016/j.yrtph.2011.03.009
   Saliner AG, 2007, SAR QSAR ENVIRON RES, V18, P331, DOI 10.1080/10629360701304014
   Saliner AG, 2006, CURR COMPUT-AID DRUG, V2, P105, DOI 10.2174/157340906777441681
   Schultz TW, 2015, REGUL TOXICOL PHARM, V72, P586, DOI 10.1016/j.yrtph.2015.05.016
   Sedykh A, 2011, ENVIRON HEALTH PERSP, V119, P364, DOI 10.1289/ehp.1002476
   Shah F, 2014, CHEM RES TOXICOL, V27, P86, DOI 10.1021/tx400343t
   Shah I., 2015, REGUL TOXIC IN PRESS
   Tan YY, 2012, J MOL MODEL, V18, P1023, DOI 10.1007/s00894-011-1136-y
   Tanimoto T., 1957, 1957 IBM
   Tollefsen KE, 2014, REGUL TOXICOL PHARM, V70, P629, DOI 10.1016/j.yrtph.2014.09.009
   Tsakovska I, 2007, SAR QSAR ENVIRON RES, V18, P221, DOI 10.1080/10629360701304063
   VERHAAR HJM, 1992, CHEMOSPHERE, V25, P471, DOI 10.1016/0045-6535(92)90280-5
   Wang SC, 2013, CURR TOP MED CHEM, V13, P1317
   Wetmore BA, 2012, TOXICOL SCI, V125, P157, DOI 10.1093/toxsci/kfr254
   Wisniowska B, 2015, J APPL TOXICOL, V35, P1030, DOI 10.1002/jat.3095
   Worth A, 2014, 26797 EUR
   Worth A. P., 2007, RISK ASSESSMENT CHEM, P427
   Worth AP, 2004, ATLA-ALTERN LAB ANIM, V32, P703, DOI 10.1177/026119290403201s117
   Wu SD, 2013, CHEM RES TOXICOL, V26, P1840, DOI 10.1021/tx400226u
   Wu SD, 2010, REGUL TOXICOL PHARM, V56, P67, DOI 10.1016/j.yrtph.2009.09.006
   Yang CH, 2015, J CHEM INF MODEL, V55, P510, DOI 10.1021/ci500667v
NR 93
TC 26
Z9 26
U1 2
U2 38
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0893-228X
EI 1520-5010
J9 CHEM RES TOXICOL
JI Chem. Res. Toxicol.
PD APR
PY 2016
VL 29
IS 4
BP 438
EP 451
DI 10.1021/acs.chemrestox.5b00388
PG 14
WC Chemistry, Medicinal; Chemistry, Multidisciplinary; Toxicology
SC Pharmacology & Pharmacy; Chemistry; Toxicology
GA DJ9BJ
UT WOS:000374508700002
PM 26686752
DA 2019-10-23
ER

PT J
AU Nelson, KR
   Schroeder, AL
   Ankley, GT
   Blackwell, BR
   Blanksma, C
   Degitz, SJ
   Flynn, KM
   Jensen, KM
   Johnson, RD
   Kahl, MD
   Knapen, D
   Kosian, PA
   Milsk, RY
   Randolph, EC
   Saari, T
   Stinckens, E
   Vergauwen, L
   Villeneuve, DL
AF Nelson, Krysta R.
   Schroeder, Anthony L.
   Ankley, Gerald T.
   Blackwell, Brett R.
   Blanksma, Chad
   Degitz, Sigmund J.
   Flynn, Kevin M.
   Jensen, Kathleen M.
   Johnson, Rodney D.
   Kahl, Michael D.
   Knapen, Dries
   Kosian, Patricia A.
   Milsk, Rebecca Y.
   Randolph, Eric C.
   Saari, Travis
   Stinckens, Evelyn
   Vergauwen, Lucia
   Villeneuve, Daniel L.
TI Impaired anterior swim bladder inflation following exposure to the
   thyroid peroxidase inhibitor 2-mercaptobenzothiazole part I: Fathead
   minnow
SO AQUATIC TOXICOLOGY
LA English
DT Article
DE Adverse outcome pathway; Cyprinid; Endocrine disruption; Swim bladder;
   Fish early life stage
ID ADVERSE OUTCOME PATHWAYS; XENOPUS-LAEVIS; PIMEPHALES-PROMELAS;
   SWIMBLADDER INFLATION; CONCEPTUAL-FRAMEWORK; ZEBRAFISH; HORMONES;
   INNERVATION; METHIMAZOLE; RESPONSES
AB In the present study, a hypothesized adverse outcome pathway linking inhibition of thyroid peroxidase (TPO) activity to impaired swim bladder inflation was investigated in two experiments in which fathead minnows (Pimephales promelas) were exposed to 2-mercaptobenzothiazole (MBT). Continuous exposure to 1 mg MBT/L for up to 22 days had no effect on inflation of the posterior chamber of the swim bladder, which typically inflates around 6 days post fertilization (dpf), a period during which maternally-derived thyroid hormone is presumed to be present. In contrast, inflation of the anterior swim bladder, which occurs around 14 dpf, was impacted. Specifically, at 14 dpf, approximately 50% of fish exposed to 1 mg MBT/L did not have an inflated anterior swim bladder. In fish exposed to MBT through 21 or 22 dpf, the anterior swim bladder was able to inflate, but the ratio of the anterior/posterior chamber length was significantly reduced compared to controls. Both abundance of thyroid peroxidase mRNA and thyroid follicle histology suggest that fathead minnows mounted a compensatory response to the presumed inhibition of TPO activity by MBT. Time-course characterization showed that fish exposed to MBT for at least 4 days prior to normal anterior swim bladder inflation had significant reductions in anterior swim bladder size, relative to the posterior chamber, compared to controls. These results, along with similar results observed in zebrafish (see part II, this issue) are consistent with the hypothesis that thyroid hormone signaling plays a significant role in mediating anterior swim bladder inflation and development in cyprinids, and that role can be disrupted by exposure to thyroid hormone synthesis inhibitors. Nonetheless, possible thyroid independent actions of MBT on anterior swim bladder inflation cannot be ruled out based on the present results. Overall, although anterior swim bladder inflation has not been directly linked to survival as posterior swim bladder inflation has, potential links to adverse ecological outcomes are plausible given involvement of the anterior chamber in sound production and detection. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Nelson, Krysta R.; Schroeder, Anthony L.; Ankley, Gerald T.; Degitz, Sigmund J.; Flynn, Kevin M.; Jensen, Kathleen M.; Johnson, Rodney D.; Kahl, Michael D.; Kosian, Patricia A.; Randolph, Eric C.; Saari, Travis; Villeneuve, Daniel L.] US EPA, Off Res & Dev, Natl Hlth & Environm Effects Res Lab, Mid Continent Ecol Div, 6201 Congdon Blvd, Duluth, MN 55804 USA.
   [Schroeder, Anthony L.] Univ Minnesota Twin Cities, Water Resources Ctr, 1985 Lower Buford Circle, St Paul, MN 55108 USA.
   [Blackwell, Brett R.; Milsk, Rebecca Y.] US EPA, ORISE, Res Participat Program,Mid Continent Ecol Div, Off Res & Dev,Natl Hlth & Environm Effects Res La, 6201 Congdon Blvd, Duluth, MN 55804 USA.
   [Blanksma, Chad] US EPA, Badger Tech Serv, Off Res & Dev, Natl Hlth & Environm Effects Res Lab,Mid Continen, 6201 Congdon Blvd, Duluth, MN 55804 USA.
   [Knapen, Dries; Stinckens, Evelyn; Vergauwen, Lucia] Univ Antwerp, Dept Vet Sci, Zebrafishlab Vet Physiol & Biochem, Univ Pl 1, B-2610 Antwerp, Belgium.
RP Schroeder, AL (reprint author), US EPA, Off Res & Dev, Natl Hlth & Environm Effects Res Lab, Mid Continent Ecol Div, 6201 Congdon Blvd, Duluth, MN 55804 USA.
EM aschroed@crk.umn.edu
OI Stinckens, Evelyn/0000-0001-7538-190X; Knapen,
   Dries/0000-0003-0472-8114; Blackwell, Brett/0000-0003-1296-4539
CR Ankley GT, 2015, TOXICOL SCI, V144, P259, DOI 10.1093/toxsci/kfu320
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Bagci E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123285
   BROWN CL, 1988, J EXP ZOOL, V248, P168, DOI 10.1002/jez.1402480207
   Burns FR, 2016, ENVIRON TOXICOL CHEM, V35, P212, DOI 10.1002/etc.3186
   Crane HM, 2006, TOXICOL SCI, V93, P278, DOI 10.1093/toxsci/kfl063
   Crane HM, 2004, GEN COMP ENDOCR, V139, P55, DOI 10.1016/j.ygcen.2004.07.004
   Czesny SJ, 2005, T AM FISH SOC, V134, P1011, DOI 10.1577/T04-016.1
   Degitz SJ, 2005, TOXICOL SCI, V87, P353, DOI 10.1093/toxsci/kfi246
   Devlin E.W., 1996, EPA600R96079
   Dong W, 2013, AQUAT TOXICOL, V132, P190, DOI 10.1016/j.aquatox.2013.02.008
   Fay R, 2009, INTEGR ZOOL, V4, P26, DOI 10.1111/j.1749-4877.2008.00132.x
   Finney JL, 2006, J COMP NEUROL, V495, P587, DOI 10.1002/cne.20948
   Green JW, 2014, ENVIRON TOXICOL CHEM, V33, P1108, DOI 10.1002/etc.2530
   Grim KC, 2009, TOXICOL PATHOL, V37, P415, DOI 10.1177/0192623309335063
   Hagenaars A, 2014, AQUAT TOXICOL, V157, P225, DOI 10.1016/j.aquatox.2014.10.017
   Heijlen M, 2014, ENDOCRINOLOGY, V155, P1547, DOI 10.1210/en.2013-1660
   Hornung MW, 2015, TOXICOL SCI, V146, P254, DOI 10.1093/toxsci/kfv090
   Kurata M, 2014, AQUAC RES, V45, P882, DOI 10.1111/are.12027
   Lechner W, 2008, J EXP BIOL, V211, P1681, DOI 10.1242/jeb.016436
   Liu YW, 2002, DIFFERENTIATION, V70, P36, DOI 10.1046/j.1432-0436.2002.700104.x
   OECD, 1992, TEST 210 FISH EARL L
   Opitz R, 2006, TOXICOL SCI, V90, P337, DOI 10.1093/toxsci/kfj083
   Oris JT, 2012, ENVIRON TOXICOL CHEM, V31, P370, DOI 10.1002/etc.747
   Paul KB, 2013, TOXICOLOGY, V312, P97, DOI 10.1016/j.tox.2013.08.006
   POPPER AN, 1974, J EXP BIOL, V60, P295
   Power DM, 2001, COMP BIOCHEM PHYS C, V130, P447, DOI 10.1016/S1532-0456(01)00271-X
   Robertson GN, 2007, J MORPHOL, V268, P967, DOI 10.1002/jmor.10558
   Stinckens E., 2016, AQUAT TOXICOL
   Tietge JE, 2005, ENVIRON TOXICOL CHEM, V24, P926, DOI 10.1897/04-105R.1
   Tietge JE, 2013, AQUAT TOXICOL, V126, P128, DOI 10.1016/j.aquatox.2012.10.013
   U. S. Environmental Protection Agency (U. S. EPA), 2014, END DISR SCREEN PROG
   Villeneuve D, 2014, ENVIRON TOXICOL CHEM, V33, P158, DOI 10.1002/etc.2403
   Volz DC, 2011, TOXICOL SCI, V123, P349, DOI 10.1093/toxsci/kfr185
   WABUKEBUNOTI MAN, 1983, GEN COMP ENDOCR, V49, P320, DOI 10.1016/0016-6480(83)90150-8
   Winata CL, 2009, DEV BIOL, V331, P222, DOI 10.1016/j.ydbio.2009.04.035
   Wisenden BD, 2008, ENVIRON BIOL FISH, V81, P141, DOI 10.1007/s10641-006-9181-6
   Woolley LD, 2010, REV AQUACULT, V2, P181, DOI 10.1111/j.1753-5131.2010.01035.x
   Zoeller RT, 2007, CRIT REV TOXICOL, V37, P11, DOI 10.1080/10408440601123446
NR 39
TC 14
Z9 14
U1 1
U2 42
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-445X
EI 1879-1514
J9 AQUAT TOXICOL
JI Aquat. Toxicol.
PD APR
PY 2016
VL 173
BP 192
EP 203
DI 10.1016/j.aquatox.2015.12.024
PG 12
WC Marine & Freshwater Biology; Toxicology
SC Marine & Freshwater Biology; Toxicology
GA DH3MA
UT WOS:000372689900019
PM 26852267
DA 2019-10-23
ER

PT J
AU Fabbri, E
   Franzellitti, S
AF Fabbri, Elena
   Franzellitti, Silvia
TI HUMAN PHARMACEUTICALS IN THE MARINE ENVIRONMENT: FOCUS ON EXPOSURE AND
   BIOLOGICAL EFFECTS IN ANIMAL SPECIES
SO ENVIRONMENTAL TOXICOLOGY AND CHEMISTRY
LA English
DT Review
DE Pharmaceuticals; Marine environment; Marine fauna; Biomarkers; Mode of
   action
ID PERSONAL CARE PRODUCTS; NONSTEROIDAL ANTIINFLAMMATORY DRUG; ADVERSE
   OUTCOME PATHWAYS; RISK-ASSESSMENT; OXIDATIVE STRESS;
   MYTILUS-GALLOPROVINCIALIS; RUDITAPES-PHILIPPINARUM; RELEVANT
   CONCENTRATIONS; COASTAL ENVIRONMENT; LYSOSOMAL MEMBRANE
AB Marine waters have been poorly investigated for the occurrence of pharmaceutical contamination. Recent data confirm that pharmaceuticals occur widely in marine and coastal environments; therefore, assessment of potential risk to marine species needs further efforts. The present study represents the first extensive review of pharmaceutical contamination in marine environments addressing the effects on the marine biota analyzed at the molecular, cellular, and individual levels. Because pharmaceuticals differ from conventional pollutants, being designed to interact with specific physiological pathways at low doses, the most recent evidence on modes of action and physiological alterations on marine animal species are discussed. Data on spatial distributions of pharmaceuticals in waters and sediments, as well as bioaccumulation rates, are also presented. The present review also seeks to expand knowledge of how the quality of coastal and marine environments could be efficiently monitored to anticipate possible health and environmental risks. (C) 2015 SETAC
C1 [Fabbri, Elena; Franzellitti, Silvia] Univ Bologna, Dept Biol Geol & Environm Sci, Ravenna, Italy.
   [Fabbri, Elena; Franzellitti, Silvia] Univ Bologna, Interdept Ctr Environm Sci Res, Ravenna, Italy.
RP Fabbri, E (reprint author), Univ Bologna, Dept Biol Geol & Environm Sci, Ravenna, Italy.; Fabbri, E (reprint author), Univ Bologna, Interdept Ctr Environm Sci Res, Ravenna, Italy.
EM elena.fabbri@unibo.it
OI Franzellitti, Silvia/0000-0001-6104-7812; FABBRI,
   Elena/0000-0002-9957-8202
CR Aguirre-Martinez GV, 2015, CHEMOSPHERE, V120, P75, DOI 10.1016/j.chemosphere.2014.05.087
   Aguirre-Martinez GV, 2013, ECOTOX ENVIRON SAFE, V97, P47, DOI 10.1016/j.ecoenv.2013.07.002
   Aguirre-Martinez GV, 2013, ENVIRON MONIT ASSESS, V185, P3783, DOI 10.1007/s10661-012-2827-2
   Aguirre-Martinez GV, 2013, J ENVIRON SCI, V25, P1408, DOI 10.1016/S1001-0742(12)60207-1
   Almeida A, 2014, AQUAT TOXICOL, V156, P74, DOI 10.1016/j.aquatox.2014.08.002
   Ankley GT, 2007, ENVIRON SCI TECHNOL, V41, P8211, DOI 10.1021/es072658j
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Antunes SC, 2013, ENVIRON SCI POLLUT R, V20, P6658, DOI 10.1007/s11356-013-1784-9
   Banni M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128468
   Bayen S, 2013, ENVIRON POLLUT, V182, P1, DOI 10.1016/j.envpol.2013.06.028
   Bossus MC, 2014, AQUAT TOXICOL, V151, P46, DOI 10.1016/j.aquatox.2013.11.025
   Brooks BW, 2003, TOXICOL LETT, V142, P169, DOI 10.1016/S0378-4274(03)00066-3
   Bueno MJM, 2016, ENVIRON SCI POLLUT R, V23, P5019, DOI 10.1007/s11356-014-3796-5
   Bueno MJM, 2013, J CHROMATOGR A, V1305, P27, DOI 10.1016/j.chroma.2013.06.071
   Burridge L, 2010, AQUACULTURE, V306, P7, DOI 10.1016/j.aquaculture.2010.05.020
   Canesi L, 2007, GEN COMP ENDOCR, V153, P40, DOI 10.1016/j.ygcen.2007.02.005
   Cantwell MG, 2010, CHEMOSPHERE, V78, P347, DOI 10.1016/j.chemosphere.2009.11.021
   Chen G, 1996, J NEUROCHEM, V67, P2079
   Chen H, 2015, MAR POLLUT BULL, V90, P181, DOI 10.1016/j.marpolbul.2014.10.053
   CHMP, 2006, EMEACHMPSWP444700
   Christen V, 2010, AQUAT TOXICOL, V96, P167, DOI 10.1016/j.aquatox.2009.11.021
   Cortez FS, 2012, ENVIRON POLLUT, V168, P145, DOI 10.1016/j.envpol.2012.04.024
   Crain CM, 2009, ANN NY ACAD SCI, V1162, P39, DOI 10.1111/j.1749-6632.2009.04496.x
   Moreno-Bondi MC, 2009, ANAL BIOANAL CHEM, V395, P921, DOI 10.1007/s00216-009-2920-8
   Dailianis S, 2005, FREE RADICAL RES, V39, P1059, DOI 10.1080/10715760500243765
   Daniel WA, 1997, PHARMACOL TOXICOL, V80, P62, DOI 10.1111/j.1600-0773.1997.tb00285.x
   Daughton CG, 2014, SCI TOTAL ENVIRON, V466, P315, DOI 10.1016/j.scitotenv.2013.06.111
   Daughton CG, 2013, SCI TOTAL ENVIRON, V443, P324, DOI 10.1016/j.scitotenv.2012.10.092
   Daughton CG, 2009, ENVIRON TOXICOL CHEM, V28, P2495, DOI 10.1897/08-382.1
   de Wit CA, 2006, CHEMOSPHERE, V64, P209, DOI 10.1016/j.chemosphere.2005.12.029
   Di Poi C, 2016, ENVIRON SCI POLLUT R, V23, P5002, DOI 10.1007/s11356-014-3702-1
   Di Poi C, 2014, AQUAT TOXICOL, V151, P36, DOI 10.1016/j.aquatox.2013.12.026
   Di Poi C, 2013, AQUAT TOXICOL, V132, P84, DOI 10.1016/j.aquatox.2013.02.004
   Emnet P, 2015, ENVIRON RES, V136, P331, DOI 10.1016/j.envres.2014.10.019
   European Centre for Ecotoxicology Toxicology of Chemicals, 2007, 102 EUR CTR EC TOX C
   Fabbri E, 2015, ANN NY ACAD SCI, V1340, P20, DOI 10.1111/nyas.12605
   Fabbri E, 2010, J EXP ZOOL PART A, V313A, P179, DOI 10.1002/jez.592
   Fabbri R, 2014, MAR ENVIRON RES, V99, P1, DOI 10.1016/j.marenvres.2014.05.007
   Fenet H, 2014, ENVIRON INT, V68, P177, DOI 10.1016/j.envint.2014.03.025
   Fent K, 2006, AQUAT TOXICOL, V76, P122, DOI 10.1016/j.aquatox.2005.09.009
   Fong PP, 2003, J EXP ZOOL PART A, V298A, P67, DOI 10.1002/a.10279
   Ford AT, 2016, ENVIRON TOXICOL CHEM, V35, P794, DOI 10.1002/etc.3087
   Franzellitti S, 2015, ENVIRON POLLUT, V205, P60, DOI 10.1016/j.envpol.2015.05.020
   Franzellitti S, 2014, AQUAT TOXICOL, V151, P14, DOI 10.1016/j.aquatox.2013.11.016
   Franzellitti S, 2013, AQUAT TOXICOL, V140, P249, DOI 10.1016/j.aquatox.2013.06.005
   Franzellitti S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061634
   Franzellitti S, 2011, AQUAT TOXICOL, V101, P299, DOI 10.1016/j.aquatox.2010.11.001
   Froehner S, 2012, MAR POLLUT BULL, V64, P75, DOI 10.1016/j.marpolbul.2011.10.021
   Fu W, 2008, ENVIRON TOXICOL CHEM, V28, P1372
   Garnerot F, 2006, GEN COMP ENDOCR, V149, P278, DOI 10.1016/j.ygcen.2006.06.008
   Gaw S, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0572
   Gilroy EAM, 2012, CHEMOSPHERE, V86, P578, DOI 10.1016/j.chemosphere.2011.10.022
   Glassmeyer ST, 2008, FATE PHARM ENV WATER
   Gomez E, 2012, ENVIRON SCI POLLUT R, V19, P2561, DOI 10.1007/s11356-012-0964-3
   Gonzalez-Ortegon E, 2013, J HAZARD MATER, V263, P233, DOI 10.1016/j.jhazmat.2013.09.041
   Gonzalez-Rey M, 2014, AQUAT TOXICOL, V153, P12, DOI 10.1016/j.aquatox.2014.02.006
   Gonzalez-Rey M, 2014, AQUAT TOXICOL, V148, P221, DOI 10.1016/j.aquatox.2014.01.011
   Gonzalez-Rey M, 2013, ENVIRON POLLUT, V173, P200, DOI 10.1016/j.envpol.2012.10.018
   Gonzalez-Rey M, 2012, ENVIRON TOXICOL PHAR, V33, P361, DOI 10.1016/j.etap.2011.12.017
   Guler Y, 2010, AQUAT TOXICOL, V99, P397, DOI 10.1016/j.aquatox.2010.05.019
   Gunnarsson L, 2008, ENVIRON SCI TECHNOL, V42, P5807, DOI 10.1021/es8005173
   Hutchinson TH, 2013, MAR POLLUT BULL, V74, P517, DOI 10.1016/j.marpolbul.2013.06.012
   Juan-Garcia A, 2006, ELECTROPHORESIS, V27, P2240, DOI 10.1002/elps.200500868
   Klosterhaus SL, 2013, ENVIRON INT, V54, P92, DOI 10.1016/j.envint.2013.01.009
   Knight J, 1999, BBA-MOL CELL BIOL L, V1436, P467, DOI 10.1016/S0005-2760(98)00153-2
   Koutsogiannaki S, 2006, AQUAT TOXICOL, V78, P315, DOI 10.1016/j.aquatox.2006.04.004
   Koutsogiannaki S, 2014, AQUAT TOXICOL, V146, P186, DOI 10.1016/j.aquatox.2013.11.005
   Lacoste A, 2001, GEN COMP ENDOCR, V122, P252, DOI 10.1006/gcen.2001.7643
   Lahti M, 2012, ENVIRON TOXICOL CHEM, V31, P1831, DOI 10.1002/etc.1879
   Li HQ, 2003, MAR POLICY, V27, P333, DOI 10.1016/S0308-597X(03)00045-9
   Li WH, 2012, ENVIRON POLLUT, V162, P56, DOI 10.1016/j.envpol.2011.10.022
   Liang XM, 2013, CHEMOSPHERE, V92, P1410, DOI 10.1016/j.chemosphere.2013.03.044
   Liebig M, 2014, TOXICS, V2, DOI 10.3390/toxics2010035
   Luna-Acosta A, 2012, CHEMOSPHERE, V87, P1335, DOI 10.1016/j.chemosphere.2012.02.022
   Maranho LA, 2014, ENVIRON RES, V134, P353, DOI 10.1016/j.envres.2014.08.014
   Martin-Diaz L, 2009, AQUAT TOXICOL, V94, P177, DOI 10.1016/j.aquatox.2009.06.015
   Matozzo V, 2014, TOXICOL IN VITRO, V28, P778, DOI 10.1016/j.tiv.2014.02.006
   McEneff G, 2014, SCI TOTAL ENVIRON, V476, P317, DOI 10.1016/j.scitotenv.2013.12.123
   Mesquita SR, 2011, CHEMOSPHERE, V85, P967, DOI 10.1016/j.chemosphere.2011.06.067
   Milan M, 2013, AQUAT TOXICOL, V126, P17, DOI 10.1016/j.aquatox.2012.10.007
   Minguez L, 2014, ECOTOXICOLOGY, V23, P1744, DOI 10.1007/s10646-014-1339-y
   Montezinho LP, 2007, BIPOLAR DISORD, V9, P290, DOI 10.1111/j.1399-5618.2007.00354.x
   Moore MN, 2006, AUTOPHAGY, V2, P217, DOI 10.4161/auto.2663
   Morando MB, 2009, AQUAT TOXICOL, V95, P164, DOI 10.1016/j.aquatox.2009.10.015
   Munari M, 2014, MAR ENVIRON RES, V94, P32, DOI 10.1016/j.marenvres.2013.11.007
   Na GS, 2013, MAR POLLUT BULL, V69, P233, DOI 10.1016/j.marpolbul.2012.12.028
   National Library of Medicine Specialized Information Services, 2005, HAZ SUBST DAT HSDB
   Neumann B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118571
   Neuparth T, 2014, AQUAT TOXICOL, V155, P337, DOI 10.1016/j.aquatox.2014.07.009
   Nichols JW, 2015, ENVIRON TOXICOL CHEM, V34, P1425, DOI 10.1002/etc.2948
   Owen SF, 2009, AQUAT TOXICOL, V93, P217, DOI 10.1016/j.aquatox.2009.05.009
   Rand-Weaver M, 2013, ENVIRON SCI TECHNOL, V47, P11384, DOI 10.1021/es402065a
   Santos LHMLM, 2010, J HAZARD MATER, V175, P45, DOI 10.1016/j.jhazmat.2009.10.100
   Santos NAG, 2008, TOXICOL IN VITRO, V22, P1820, DOI 10.1016/j.tiv.2008.08.004
   Schmidt W, 2011, MAR POLLUT BULL, V62, P1389, DOI 10.1016/j.marpolbul.2011.04.043
   Schmitt Heike, 2010, Integrated Environmental Assessment and Management, V6, P588, DOI 10.1897/IEAM_2009-053.1
   Shpakov AO, 2005, ANN NY ACAD SCI, V1040, P466, DOI 10.1196/annals.1327.092
   Sole M, 2010, ANAL BIOANAL CHEM, V396, P649, DOI 10.1007/s00216-009-3182-1
   Spongberg AL, 2011, WATER RES, V45, P6709, DOI 10.1016/j.watres.2011.10.004
   Tierney AJ, 2001, COMP BIOCHEM PHYS A, V128, P791, DOI 10.1016/S1095-6433(00)00320-2
   Togola A, 2007, ANAL CHEM, V79, P6734, DOI 10.1021/ac070559i
   United Nations-Water, 2015, DECADES WEEKLY  0206
   Viarengo A, 2007, COMP BIOCHEM PHYS C, V146, P281, DOI 10.1016/j.cbpc.2007.04.011
   Weir MR, 2009, POSTGRAD MED, V121, P90, DOI 10.3810/pgm.2009.05.2007
   Wille K, 2011, ANAL BIOANAL CHEM, V400, P1459, DOI 10.1007/s00216-011-4878-6
   Wille K, 2010, ANAL BIOANAL CHEM, V397, P1797, DOI 10.1007/s00216-010-3702-z
   Zhang GF, 2012, NATURE, V490, P49, DOI 10.1038/nature11413
NR 107
TC 45
Z9 47
U1 0
U2 86
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0730-7268
EI 1552-8618
J9 ENVIRON TOXICOL CHEM
JI Environ. Toxicol. Chem.
PD APR
PY 2016
VL 35
IS 4
BP 799
EP 812
DI 10.1002/etc.3131
PG 14
WC Environmental Sciences; Toxicology
SC Environmental Sciences & Ecology; Toxicology
GA DH0RB
UT WOS:000372490300006
PM 26111460
DA 2019-10-23
ER

PT J
AU Scott, WC
   Du, BW
   Haddad, SP
   Breed, CS
   Saari, GN
   Kelly, M
   Broach, L
   Chambliss, CK
   Brooks, BW
AF Scott, W. Casan
   Du, Bowen
   Haddad, Samuel P.
   Breed, Christopher S.
   Saari, Gavin N.
   Kelly, Martin
   Broach, Linda
   Chambliss, C. Kevin
   Brooks, Bryan W.
TI PREDICTED AND OBSERVED THERAPEUTIC DOSE EXCEEDANCES OF IONIZABLE
   PHARMACEUTICALS IN FISH PLASMA FROM URBAN COASTAL SYSTEMS
SO ENVIRONMENTAL TOXICOLOGY AND CHEMISTRY
LA English
DT Article
DE Pharmaceutical; Hazard/risk assessment; Bioaccumulation; Adverse outcome
   pathway; Municipal effluent; Water quality; Fate and transport;
   Biomonitoring
ID PERSONAL CARE PRODUCTS; FRESH-WATER INFLOW; AQUATIC TOXICITY;
   DISSOLVED-OXYGEN; TIDAL ESTUARY; PH; QUALITY; DIEL; BIOCONCENTRATION;
   DIPHENHYDRAMINE
AB Instream flows of the rapidly urbanizing watersheds and estuaries of the Gulf of Mexico in Texas (USA) are increasingly dominated by reclaimed waters. Though ionizable pharmaceuticals have received increasing attention in freshwaters, many research questions remain unanswered, particularly in tidally influenced urban coastal systems, which experience significant spatiotemporal variability in pH that influences bioavailability and bioaccumulation. The authors coupled fish plasma modeling of therapeutic hazard values with field monitoring of water chemistry variability and pharmaceutical occurrence to examine whether therapeutic hazards to fish existed within these urban coastal ecosystems and whether therapeutic hazards differed within and among coastal locations and seasons. Spatial and temporal fluctuations in pH within study sites altered the probability of encountering pharmaceutical hazards to fish. Significant water quality differences were consistently observed among traditional parameters and pharmaceuticals collected from surface and bottom waters, which are rarely sampled during routine surface water quality assessments. The authors then compared modeling predictions of fish plasma concentrations of pharmaceuticals to measured plasma levels from various field-collected fish species. Diphenhydramine and diltiazem were observed in plasma of multiple species, and diltiazem exceeded human therapeutic doses in largemouth bass, catfish, and mullet inhabiting these urban estuaries. Though the present study only examined a small number of target analytes, which represent a microcosm of the exposome of these fish, coastal systems are anticipated to be more strongly influenced by continued urbanization, altered instream flows, and population growth in the future. Unfortunately, aquatic toxicology information for diltiazem and many other pharmaceuticals is not available for marine and estuarine organisms, but such field observations suggest that potential adverse outcomes should be examined. (C) 2015 SETAC
C1 [Scott, W. Casan; Du, Bowen; Haddad, Samuel P.; Breed, Christopher S.; Saari, Gavin N.; Chambliss, C. Kevin; Brooks, Bryan W.] Baylor Univ, Ctr Reservoir & Aquat Syst Res, Dept Environm Sci, Waco, TX 76798 USA.
   [Kelly, Martin; Broach, Linda] Texas Commiss Environm Qual, Houston, TX USA.
   [Chambliss, C. Kevin] Baylor Univ, Dept Chem & Biochem, Waco, TX 76798 USA.
RP Brooks, BW (reprint author), Baylor Univ, Ctr Reservoir & Aquat Syst Res, Dept Environm Sci, Waco, TX 76798 USA.
EM Bryan_Brooks@baylor.edu
RI Guenat, Heather/H-6528-2014; Brooks, Bryan W/B-2612-2010
OI Brooks, Bryan W/0000-0002-6277-9852
FU National Sea Grant Office, National Oceanic and Atmospheric
   Administration, US Department of CommerceNational Oceanic Atmospheric
   Admin (NOAA) - USA [NA10OAR4170099]; Glasscock Fund for Excellence in
   Environmental Science; Center for Reservoir and Aquatic Systems
   Research; Department of Environmental Science at Baylor University
FX The present study was supported in part by an institutional grant
   (NA10OAR4170099) to the Texas Sea Grant College Program from the
   National Sea Grant Office, National Oceanic and Atmospheric
   Administration, US Department of Commerce (to B.W. Brooks and C.K.
   Chambliss). Additional support was provided by the Glasscock Fund for
   Excellence in Environmental Science, the Center for Reservoir and
   Aquatic Systems Research, and the Department of Environmental Science at
   Baylor University. We thank K. Connors, S. Williams, and L. Kristofco
   for field assistance. We also thank J. Back for laboratory support of
   nutrient analysis.
CR Ankley GT, 2007, ENVIRON SCI TECHNOL, V41, P8211, DOI 10.1021/es072658j
   Beck NG, 2000, ESTUARIES, V23, P177, DOI 10.2307/1352825
   Berninger JP, 2011, ENVIRON TOXICOL CHEM, V30, P2065, DOI 10.1002/etc.590
   Berninger JP, 2010, TOXICOL LETT, V193, P69, DOI 10.1016/j.toxlet.2009.12.006
   Boxall ABA, 2012, ENVIRON HEALTH PERSP, V120, P1221, DOI 10.1289/ehp.1104477
   Brain RA, 2008, ENVIRON SCI TECHNOL, V42, P8965, DOI 10.1021/es801611a
   Brooks B, 2012, HUMAN PHARM ENV CURR
   Brooks BW, 2010, NATO SCI PEACE SECUR, P491, DOI 10.1007/978-94-007-1770-1_26
   Brooks BW, 2014, AQUAT TOXICOL, V151, P61, DOI 10.1016/j.aquatox.2014.01.007
   Brooks BW, 2009, ENVIRON TOXICOL CHEM, V28, P2469, DOI 10.1897/09-325.1
   Brooks BW, 2006, HYDROBIOLOGIA, V556, P365, DOI 10.1007/s10750-004-0189-7
   Brown JN, 2007, ENVIRON TOXICOL PHAR, V24, P267, DOI 10.1016/j.etap.2007.06.005
   Cai WJ, 1998, LIMNOL OCEANOGR, V43, P657, DOI 10.4319/lo.1998.43.4.0657
   Caldwell DJ, 2014, CHEMOSPHERE, V115, P4, DOI 10.1016/j.chemosphere.2014.01.021
   Connors KA, 2013, ENVIRON TOXICOL CHEM, V32, P1810, DOI 10.1002/etc.2240
   Daughton C, 2011, ENV CONTAMINANTS BIO, P286
   Du B, 2012, J CHROMATOGR A, V1253, P177, DOI 10.1016/j.chroma.2012.07.026
   Du BW, 2016, ENVIRON TOXICOL CHEM, V35, P966, DOI 10.1002/etc.3221
   Du B, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2014.0058
   Du BW, 2014, SCI TOTAL ENVIRON, V466, P976, DOI 10.1016/j.scitotenv.2013.07.126
   Elliott M, 2002, ESTUAR COAST SHELF S, V55, P815, DOI 10.1006/ecss.2002.1031
   Escher BI, 2000, ENVIRON SCI TECHNOL, V34, P3954, DOI 10.1021/es0010709
   Ferguson EM, 2013, WATER RES, V47, P1604, DOI 10.1016/j.watres.2012.12.020
   Fick J, 2010, REGUL TOXICOL PHARM, V58, P516, DOI 10.1016/j.yrtph.2010.08.025
   Fick J, 2010, ENVIRON SCI TECHNOL, V44, P2661, DOI 10.1021/es903440m
   Fitzhugh RD, 1999, BIOGEOCHEMISTRY, V47, P39
   Fitzsimmons PN, 2001, AQUAT TOXICOL, V55, P23, DOI 10.1016/S0166-445X(01)00174-6
   Gaw S, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0572
   Gunnarsson L, 2008, ENVIRON SCI TECHNOL, V42, P5807, DOI 10.1021/es8005173
   Hansch C., 1979, SUBSTITUENT CONSTANT
   Henderson LJ, 1908, AM J PHYSIOL, V21, P427
   Hernandez MA, 2006, BASIC PHARM UNDERSTA
   HOLM S, 1979, SCAND J STAT, V6, P65
   Hubertz ED, 1999, ESTUARIES, V22, P814, DOI 10.2307/1353114
   Huggett DB, 2003, HUM ECOL RISK ASSESS, V9, P1789, DOI 10.1080/10807030390260498
   Kent AD, 2004, MICROB ECOL, V48, P550, DOI 10.1007/s00248-004-0244-y
   Klosterhaus SL, 2013, ENVIRON INT, V54, P92, DOI 10.1016/j.envint.2013.01.009
   Kolpin DW, 2002, ENVIRON SCI TECHNOL, V36, P1202, DOI 10.1021/es011055j
   Kookana RS, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0586
   Kwon Y., 2001, HDB ESSENTIAL PHARM
   LaLone CA, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2014.0022
   Lara-Martin PA, 2014, MAR POLLUT BULL, V85, P710, DOI 10.1016/j.marpolbul.2014.01.022
   Li HQ, 2003, MAR POLICY, V27, P333, DOI 10.1016/S0308-597X(03)00045-9
   Longley W.L., 1994, FRESHWATER INFLOWS T
   Maberly SC, 1996, FRESHWATER BIOL, V35, P579, DOI 10.1111/j.1365-2427.1996.tb01770.x
   Manallack DT, 2007, PERSPECT MED CHEM, V1, P25
   Margiotta-Casaluci L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110467
   Marques SC, 2006, J PLANKTON RES, V28, P297, DOI 10.1093/plankt/fbi126
   Martinez ML, 2007, ECOL ECON, V63, P254, DOI 10.1016/j.ecolecon.2006.10.022
   McDonald JH, 2009, HDB BIOL STAT
   McRobb FM, 2014, ENVIRON SCI TECHNOL, V48, P1964, DOI 10.1021/es404568a
   Mikes O, 2010, B ENVIRON CONTAM TOX, V85, P556, DOI 10.1007/s00128-010-0150-6
   MONTAGNA PA, 1992, ESTUARIES, V15, P307, DOI 10.2307/1352779
   Montagna PA, 2002, ESTUARIES, V25, P1436, DOI 10.1007/BF02692237
   Muylaert K, 2000, ESTUAR COAST SHELF S, V50, P673, DOI 10.1006/ecss.2000.0590
   Nakamura Y, 2008, CHEMOSPHERE, V70, P865, DOI 10.1016/j.chemosphere.2007.06.089
   National Research Council, 2005, SCI INSTR FLOWS REV
   NELSON BW, 1994, HYDROBIOLOGIA, V285, P7, DOI 10.1007/BF00005649
   Nichols JW, 2015, ENVIRON TOXICOL CHEM, V34, P1425, DOI 10.1002/etc.2948
   Nocker A, 2004, APPL ENVIRON MICROB, V70, P6834, DOI 10.1128/AEM.70.11.6834-6845.2004
   Orvos DR, 2002, ENVIRON TOXICOL CHEM, V21, P1338, DOI 10.1002/etc.5620210703
   Posthuma L, 2010, SPECIES SENSITIVITY
   Pritchard DW, 1967, ESTUARIES, P3
   RABALAIS NN, 1994, ESTUARIES, V17, P850, DOI 10.2307/1352753
   Ramirez AJ, 2009, ENVIRON TOXICOL CHEM, V28, P2587, DOI 10.1897/08-561.1
   Rice J, 2013, ENVIRON SCI TECHNOL, V47, P11099, DOI 10.1021/es402792s
   Roelke DL, 2012, CAN J FISH AQUAT SCI, V69, P1389, DOI [10.1139/f2012-019, 10.1139/F2012-019]
   Rudd MA, 2014, INTEGR ENVIRON ASSES, V10, P576, DOI 10.1002/ieam.1551
   Small C, 2003, J COASTAL RES, V19, P584
   Solomon KR, 2002, ENVIRON ECOL RISK AS, P285
   Summers JK, 1997, ENVIRON MONIT ASSESS, V45, P319
   Texas Commission of Environmental Quality, 2012, GUID ASS REP SURF WA
   Texas Commission on Environmental Quality, 2012, SURF WAT QUAL MON PR
   US Environmental Protection Agency, 1996, 820B96001 US EPA
   US Environmental Protection Agency, 2013, 822R13001 US EPA
   *US EPA, 2009, 822D09001 US EPA
   Valenti Theodore W., 2011, Integrated Environmental Assessment and Management, V7, P636, DOI 10.1002/ieam.202
   Valenti TW, 2012, ENVIRON SCI TECHNOL, V46, P2427, DOI 10.1021/es204164b
   Valenti TW, 2009, ENVIRON TOXICOL CHEM, V28, P2685, DOI 10.1897/08-546.1
   Wahlberg C, 2011, WATER SCI TECHNOL, V63, P1772, DOI 10.2166/wst.2011.124
   Watkins CD, 2014, B ENVIRON CONTAM TOX, V93, P13, DOI 10.1007/s00128-014-1248-z
   Watkins JB, 2010, CASARETT DOULLS ESSE
   Wetzel RG, 2001, LIMNOLOGY LAKE RIVER
   Yang Y, 2011, J HAZARD MATER, V190, P588, DOI 10.1016/j.jhazmat.2011.03.092
NR 84
TC 25
Z9 25
U1 0
U2 44
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0730-7268
EI 1552-8618
J9 ENVIRON TOXICOL CHEM
JI Environ. Toxicol. Chem.
PD APR
PY 2016
VL 35
IS 4
BP 983
EP 995
DI 10.1002/etc.3236
PG 13
WC Environmental Sciences; Toxicology
SC Environmental Sciences & Ecology; Toxicology
GA DH0RB
UT WOS:000372490300025
PM 27003720
DA 2019-10-23
ER

PT J
AU Stinckens, E
   Vergauwen, L
   Schroeder, AL
   Maho, W
   Blackwell, BR
   Witters, H
   Blust, R
   Ankley, GT
   Covaci, A
   Villeneuve, DL
   Knapen, D
AF Stinckens, Evelyn
   Vergauwen, Lucia
   Schroeder, Anthony L.
   Maho, Walid
   Blackwell, Brett R.
   Witters, Hilda
   Blust, Ronny
   Ankley, Gerald T.
   Covaci, Adrian
   Villeneuve, Daniel L.
   Knapen, Dries
TI Impaired anterior swim bladder inflation following exposure to the
   thyroid peroxidase inhibitor 2-mercaptobenzothiazole part II: Zebrafish
SO AQUATIC TOXICOLOGY
LA English
DT Article
DE Thyroid disruption; 2-Mercaptobenzothiazole; Zebrafish embryo; Swim
   bladder inflation; Fish early-life stage; Adverse outcome pathway
ID ADVERSE OUTCOME PATHWAYS; THYROPEROXIDASE INHIBITION; IODOTHYRONINE
   DEIODINASES; EMBRYONIC-DEVELOPMENT; LARVAL DEVELOPMENT; HORMONE;
   SWIMBLADDER; INNERVATION; PERFORMANCE; EXPRESSION
AB Disruption of the thyroid hormone (TH) system, an important mode of action, can lead to ecologically relevant adverse outcomes, especially during embryonic development. The present study characterizes the effects of disruption of TH synthesis on swim bladder inflation during zebrafish early-life stages using 2-mercaptobenzothiazole (MBT), a thyroid peroxidase (TPO) inhibitor. Zebrafish were exposed to different MBT concentrations until 120/168 h post fertilization (hpf) and 32 days post fertilization (dpf), in two sets of experiments, to investigate the effects of TPO inhibition on posterior and anterior swim bladder inflation respectively, as well as whole body thyroid hormone concentrations (triiodothyronine (T3) and its prohormone, thyroxine (T4)). At 120 hpf, MBT did not directly impair posterior chamber inflation or size, while anterior chamber inflation and size was impaired at 32 dpf. As previously shown in amphibians and mammals, we confirmed that MBT inhibits TPO in fish. Whole-body T4 decreased after MBT exposure at both time points, while T3 levels were unaltered. There was a significant relationship between T4 levels and the anterior chamber surface at 32 dpf. The absence of effects on posterior chamber inflation can possibly be explained by maternal transfer of T4 into the eggs. These maternally derived THs are depleted at 32 dpf and cannot offset TPO inhibition, resulting in impaired anterior chamber inflation. Therefore, we hypothesize that TPO inhibition only inhibits swim bladder inflation during late development, after depletion of maternally derived T4. In a previous study, we showed that iodothyronine deiodinase (ID) knockdown impaired posterior chamber inflation during early development. Our findings, in parallel with similar effects observed in fathead minnow (see part I, this issue) suggest that thyroid disruption impacts swim bladder inflation, and imply an important distinction among specific subtypes of TH disrupting chemicals. However, the existence of another - yet unknown - mode of action of MBT impacting swim bladder inflation cannot be excluded. These results can be helpful for delineating adverse outcome pathways (AOPs) linking TPO inhibition, ID inhibition and other TH related molecular initiating events, to impaired swim bladder inflation in fish during early life stages. Such AOPs can support the use of in vitro enzyme inhibition assays for predicting reduced survival due to impaired posterior and anterior chamber inflation. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Stinckens, Evelyn; Vergauwen, Lucia; Knapen, Dries] Univ Antwerp, Dept Vet Sci, Zebrafishlab Vet Physiol & Biochem, Univ Pl 1, B-2610 Antwerp, Belgium.
   [Schroeder, Anthony L.; Blackwell, Brett R.; Ankley, Gerald T.; Villeneuve, Daniel L.] US EPA, Off Res & Dev, Natl Hlth & Environm Effects Res Lab, Mid Continent Ecol Div, 6201 Congdon Blvd, Duluth, MN 55804 USA.
   [Maho, Walid; Covaci, Adrian] Univ Antwerp, Dept Pharmaceut Sci, Toxicol Ctr, Univ Pl 1, B-2610 Antwerp, Belgium.
   [Witters, Hilda] Flemish Inst Technol Res VITO, Appl Bio & Mol Syst ABS, Boeretang 200, B-2400 Mol, Belgium.
   [Blust, Ronny] Univ Antwerp, Dept Biol, Syst Physiol & Ecotoxicol Res SPHERE, Groenenborgerlaan 171, B-2020 Antwerp, Belgium.
   [Schroeder, Anthony L.] Univ Minnesota Twin Cities, Water Resources Ctr, 1985 Lower Buford Circle, St Paul, MN 55108 USA.
RP Knapen, D (reprint author), ZEBRAFISHLAB Vet Physiol & Biochem, Dept Vet Sci, Campus Drie Eiken,Univ Pl 1,UC 173, B-2610 Antwerp, Belgium.
EM dries.knapen@uantwerpen.be
RI Covaci, Adrian/A-9058-2008; Witters, Hilda/V-5754-2019
OI Covaci, Adrian/0000-0003-0527-1136; Witters, Hilda/0000-0002-2026-3962;
   Stinckens, Evelyn/0000-0001-7538-190X; Blackwell,
   Brett/0000-0003-1296-4539; Knapen, Dries/0000-0003-0472-8114; Vergauwen,
   Lucia/0000-0002-6534-7473
FU Cefic Long-range Research Initiative [LRI-ECO20-UA]; ECETOC
FX This work was funded by the Cefic Long-range Research Initiative
   (http://www.cefic-lri.org/) project LRI-ECO20-UA (Development of an
   alternative testing strategy for the fish early life-stage test for
   predicting chronic toxicity) with support of ECETOC. The views expressed
   in this paper are those of the authors and do not necessarily reflect
   the views or policies of the U.S. Environmental Protection Agency.
   Mention of trade names or commercial products does not constitute
   endorsement or recommendation for use.
CR Alt B, 2006, DEV DYNAM, V235, P1872, DOI 10.1002/dvdy.20831
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Bagci E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123285
   BIANCO AC, 1987, J CLIN INVEST, V79, P295, DOI 10.1172/JCI112798
   Bianco AC, 2006, J CLIN INVEST, V116, P2571, DOI 10.1172/JCI29812
   Brown DD, 1997, P NATL ACAD SCI USA, V94, P13011, DOI 10.1073/pnas.94.24.13011
   Chang JH, 2012, ZOOL SCI, V29, P181, DOI 10.2108/zsj.29.181
   Choi TY, 2007, PIGM CELL RES, V20, P120, DOI 10.1111/j.1600-0749.2007.00365.x
   Crane HM, 2004, GEN COMP ENDOCR, V139, P55, DOI 10.1016/j.ygcen.2004.07.004
   Czesny SJ, 2005, T AM FISH SOC, V134, P1011, DOI 10.1577/T04-016.1
   De Groef B, 2013, FRONTIERS ENDOCRINOL, V4, P1, DOI [10.3389/fendo.2013.00001, DOI 10.3389/FEND0.2013.00063]
   Dentice M, 2013, BBA-GEN SUBJECTS, V1830, P3937, DOI 10.1016/j.bbagen.2012.05.007
   Dong W, 2013, AQUAT TOXICOL, V132, P190, DOI 10.1016/j.aquatox.2013.02.008
   Dumbarton TC, 2010, J EXP BIOL, V213, P2536, DOI 10.1242/jeb.039792
   Elsalini OA, 2003, DEV GENES EVOL, V212, P593, DOI 10.1007/s00427-002-0279-3
   FIEHN O, 1994, ANAL CHIM ACTA, V295, P297, DOI 10.1016/0003-2670(94)80235-1
   Finney JL, 2006, J COMP NEUROL, V495, P587, DOI 10.1002/cne.20948
   Freyberger A, 2006, TOXICOLOGY, V217, P169, DOI 10.1016/j.tox.2005.09.005
   Haba G, 2011, J OBSTET GYNAECOL RE, V37, P1549, DOI 10.1111/j.1447-0756.2011.01573.x
   Hagenaars A, 2014, AQUAT TOXICOL, V157, P225, DOI 10.1016/j.aquatox.2014.10.017
   Heijlen M, 2014, ENDOCRINOLOGY, V155, P1547, DOI 10.1210/en.2013-1660
   Heijlen M, 2013, GEN COMP ENDOCR, V188, P289, DOI 10.1016/j.ygcen.2013.04.004
   Hornung MW, 2015, TOXICOL SCI, V146, P254, DOI 10.1093/toxsci/kfv090
   Jomaa B, 2014, ALTEX-ALTERN ANIM EX, V31, P303, DOI http://dx.doi.org/10.14573/altex.1402011
   Kohrle J, 2002, METHOD ENZYMOL, V347, P125
   Kress E, 2009, J BIOL CHEM, V284, P1234, DOI 10.1074/jbc.M806548200
   Li ZY, 2012, COMPUT ENG APPL, V2012, P1, DOI DOI 10.1371/J0URNAL.P0NE.0040132
   Lindsey BW, 2011, J EXP ZOOL PART A, V315A, P302, DOI 10.1002/jez.677
   Lindsey BW, 2010, ZEBRAFISH, V7, P85, DOI 10.1089/zeb.2009.0616
   Liu YW, 2002, DIFFERENTIATION, V70, P36, DOI 10.1046/j.1432-0436.2002.700104.x
   Nelson KR, 2016, AQUAT TOXICOL, V173, P192, DOI 10.1016/j.aquatox.2015.12.024
   OECD, 2013, TEST 210 FISH EARL L, DOI [10.1787/9789264203785-en, DOI 10.1787/9789264203785-EN]
   OECD, 2013, TEST 236 FISH EMBR A, DOI [10.1787/9789264203709-en, DOI 10.1787/9789264203709-EN]
   Paul KB, 2014, CHEM RES TOXICOL, V27, P387, DOI 10.1021/tx400310w
   Paul KB, 2013, TOXICOLOGY, V312, P97, DOI 10.1016/j.tox.2013.08.006
   Plateroti M, 2006, MOL CELL BIOL, V26, P3204, DOI 10.1128/MCB.26.8.3204-3214.2006
   REDDY PK, 1991, GEN COMP ENDOCR, V81, P484, DOI 10.1016/0016-6480(91)90176-7
   Reider M, 2014, BIRTH DEFECTS RES B, V101, P347, DOI 10.1002/bdrb.21118
   Rennie P.J., 1988, CHROMATOGRAPHIA, V26, P279
   Robertson GN, 2007, J MORPHOL, V268, P967, DOI 10.1002/jmor.10558
   Rodriguez DM, 2004, B ENVIRON CONTAM TOX, V73, P818, DOI 10.1007/s00128-004-0500-3
   Rosebrough RW, 2006, COMP BIOCHEM PHYS A, V143, P35, DOI 10.1016/j.cbpa.2005.10.019
   Roy G, 2006, BIOINORG CHEM APPL, DOI 10.1155/BCA/2006/23214
   Shepherdley CA, 2002, AM J PHYSIOL-REG I, V283, pR1155, DOI 10.1152/ajpregu.00015.2002
   Smith FM, 2011, AUTON NEUROSCI-BASIC, V165, P140, DOI 10.1016/j.autneu.2010.08.002
   SOLLMANN T, 1949, J GEN PHYSIOL, V32, P671, DOI 10.1085/jgp.32.6.671
   Stephensen E, 2005, AQUAT TOXICOL, V75, P136, DOI 10.1016/j.aquatox.2005.07.008
   STOLOW MA, 1995, NUCLEIC ACIDS RES, V23, P2555, DOI 10.1093/nar/23.13.2555
   Thienpont B, 2011, ENVIRON SCI TECHNOL, V45, P7525, DOI 10.1021/es202248h
   Tietge JE, 2013, AQUAT TOXICOL, V126, P128, DOI 10.1016/j.aquatox.2012.10.013
   US EPA, 1994, RER EL DEC RED SOD Z
   Villeneuve D, 2014, ENVIRON TOXICOL CHEM, V33, P158, DOI 10.1002/etc.2403
   Walpita CN, 2007, GEN COMP ENDOCR, V152, P206, DOI 10.1016/j.ygcen.2007.02.020
   Walpita CN, 2009, ENDOCRINOLOGY, V150, P530, DOI 10.1210/en.2008-0457
   Winata CL, 2009, DEV BIOL, V331, P222, DOI 10.1016/j.ydbio.2009.04.035
   Witeska M, 2014, FISH PHYSIOL BIOCHEM, V40, P151, DOI 10.1007/s10695-013-9832-4
   Woolley LD, 2010, REV AQUACULT, V2, P181, DOI 10.1111/j.1753-5131.2010.01035.x
   Yin A, 2012, BBA-MOL CELL RES, V1823, P236, DOI 10.1016/j.bbamcr.2011.09.018
   Yin A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018431
   Zheng W, 2011, PLOS ONE, V6, pe24019
   Zoeller RT, 2005, CRIT REV TOXICOL, V35, P771, DOI 10.1080/10408440591007313
NR 61
TC 18
Z9 19
U1 2
U2 40
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0166-445X
EI 1879-1514
J9 AQUAT TOXICOL
JI Aquat. Toxicol.
PD APR
PY 2016
VL 173
BP 204
EP 217
DI 10.1016/j.aquatox.2015.12.023
PG 14
WC Marine & Freshwater Biology; Toxicology
SC Marine & Freshwater Biology; Toxicology
GA DH3MA
UT WOS:000372689900020
PM 26818709
DA 2019-10-23
ER

PT J
AU Kleinstreuer, NC
   Sullivan, K
   Allen, D
   Edwards, S
   Mendrick, DL
   Embry, M
   Matheson, J
   Rowlands, JC
   Munn, S
   Maull, E
   Casey, W
AF Kleinstreuer, Nicole C.
   Sullivan, Kristie
   Allen, David
   Edwards, Stephen
   Mendrick, Donna L.
   Embry, Michelle
   Matheson, Joanna
   Rowlands, J. Craig
   Munn, Sharon
   Maull, Elizabeth
   Casey, Warren
TI Adverse outcome pathways: From research to regulation scientific
   workshop report
SO REGULATORY TOXICOLOGY AND PHARMACOLOGY
LA English
DT Article
DE AOP; Workshop; Toxicology; Pathway; Regulatory; Quantitative;
   Application; Acceptance; Criteria; Computational
ID DILUTION MASS-SPECTROMETRY; EARLY FISH DEVELOPMENT; THYROPEROXIDASE
   INHIBITION; CONCEPTUAL-FRAMEWORK; VASCULAR DEVELOPMENT; TESTING
   STRATEGY; DECISION-MAKING; IPCS FRAMEWORK; MODE; CONFIDENCE
AB An adverse outcome pathway (AOP) helps to organize existing knowledge on chemical mode of action, starting with a molecular initiating event such as receptor binding, continuing through key events, and ending with an adverse outcome such as reproductive impairment. AOPs can help identify knowledge gaps where more research is needed to understand the underlying mechanisms, aid in chemical hazard characterization, and guide the development of new testing approaches that use fewer or no animals. A September 2014 workshop in Bethesda, Maryland considered how the AOP concept could improve regulatory assessments of chemical toxicity. Scientists from 21 countries, representing industry, academia, regulatory agencies, and special interest groups, attended the workshop, titled Adverse Outcome Pathways: From Research to Regulation. Workshop plenary presentations were followed by breakout sessions that considered regulatory acceptance of AOPs and AOP-based tools, criteria for building confidence in an AOP for regulatory use, and requirements to build quantitative AOPs and AOP networks. Discussions during the closing session emphasized a need to increase transparent and inclusive collaboration, especially with disciplines outside of toxicology. Additionally, to increase impact, working groups should be established to systematically prioritize and develop AOPs. Multiple collaborative projects and follow-up activities resulted from the workshop. (C) 2016 Elsevier Inc. All rights reserved.
C1 [Kleinstreuer, Nicole C.; Maull, Elizabeth; Casey, Warren] NIEHS, Natl Toxicol Program, Interagency Ctr Evaluat Alternat Toxicol Methods, POB 12233, Res Triangle Pk, NC 27709 USA.
   [Sullivan, Kristie] Phys Comm Responsible Med, Washington, DC USA.
   [Allen, David] Integrated Lab Syst Inc, Res Triangle Pk, NC USA.
   [Edwards, Stephen] US EPA, Natl Hlth & Environm Effects Res Lab, Res Triangle Pk, NC 27711 USA.
   [Mendrick, Donna L.] US FDA, Natl Ctr Toxicol Res, Jefferson, AR 72079 USA.
   [Embry, Michelle] ILSI Hlth & Environm Sci Inst, Washington, DC USA.
   [Matheson, Joanna] US Consumer Prod Safety Commiss, Rockville, MD USA.
   [Rowlands, J. Craig] Dow Chem Co USA, Midland, MI 48674 USA.
   [Munn, Sharon] Commiss European Communities, Joint Res Ctr, I-21020 Ispra, Italy.
RP Kleinstreuer, NC (reprint author), POB 13501, Res Triangle Pk, NC 27709 USA.
EM Nicole.kleinstreuer@nih.gov
RI Kleinstreuer, Nicole/F-7203-2019
OI Kleinstreuer, Nicole/0000-0002-7914-3682
FU federal funds from the NIEHS, NIH [HHSN273201400003C,
   HHSN273201500010C]; NICEATM
FX The authors would like to thank all of the workshop presenters and
   breakout group moderators, Hristo Aladjov for assisting in creation of
   Fig. 3, George Daston for his contributions to the workshop steering
   committee discussions, Catherine Sprankle for editorial comments,
   NICEATM staff Michael Paris, Steven Morefield, Neepa Choksi, and
   Catherine Sprankle for assistance with organizing and running the
   workshop, and PCRM staff Arya Birdie and Mallory Huff for their
   assistance with organizing the workshop. Nicole Kleinstreuer and David
   Allen were supported by federal funds from the NIEHS, NIH under Contract
   Numbers HHSN273201400003C and HHSN273201500010C to Integrated Laboratory
   Systems, Inc., in support of NICEATM. The views represented in this
   paper are those of the authors solely, and do not represent the official
   policy of the U.S. EPA, FDA, NIH, or any other federal government
   organization.
CR Andreotti G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133382
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Bal-Price A, 2015, CRIT REV TOXICOL, V45, P83, DOI 10.3109/10408444.2014.981331
   Becker RA, 2015, REGUL TOXICOL PHARM, V73, P172, DOI 10.1016/j.yrtph.2015.06.015
   Becker RA, 2015, REGUL TOXICOL PHARM, V72, P514, DOI 10.1016/j.yrtph.2015.04.004
   Boobis AR, 2008, CRIT REV TOXICOL, V38, P87, DOI 10.1080/10408440701749421
   Boobis AR, 2006, CRIT REV TOXICOL, V36, P781, DOI 10.1080/10408440600977677
   Browne P, 2015, ENVIRON SCI TECHNOL, V49, P8804, DOI 10.1021/acs.est.5b02641
   Carmichael N, 2011, CRIT REV TOXICOL, V41, P175, DOI 10.3109/10408444.2010.541225
   Chang X., 2015, APPL IN VITRO TOXICO, V1, P33, DOI DOI 10.1089/AIVT.2014.0005
   Cox LA, 2014, REGUL TOXICOL PHARM, V69, P443, DOI 10.1016/j.yrtph.2014.05.010
   Edwards SW, 2016, J PHARMACOL EXP THER, V356, P170, DOI 10.1124/jpet.115.228239
   Garcia-Reyero N, 2015, ENVIRON SCI TECHNOL, V49, P3, DOI 10.1021/es504976d
   Groh KJ, 2015, CHEMOSPHERE, V120, P764, DOI 10.1016/j.chemosphere.2014.09.068
   Groh KJ, 2015, CHEMOSPHERE, V120, P778, DOI 10.1016/j.chemosphere.2014.10.006
   Hatch GE, 2014, TOXICOL SCI, V141, P198, DOI 10.1093/toxsci/kfu115
   Kleinstreuer NC, 2011, ENVIRON HEALTH PERSP, V119, P1596, DOI 10.1289/ehp.1103412
   Knudsen TB, 2011, BIRTH DEFECTS RES C, V93, P312, DOI 10.1002/bdrc.20223
   Meek ME, 2014, J APPL TOXICOL, V34, P1, DOI 10.1002/jat.2949
   Murk AJ, 2013, TOXICOL IN VITRO, V27, P1320, DOI 10.1016/j.tiv.2013.02.012
   NRC (National Research Council), 2007, TOX TEST 21 CENT VIS
   OECD, 2015, TEST 442D IN VITR SK
   OECD, 2015, SER TEST ASS, V215
   OECD, 2014, US HDB SUPPL GUID DO
   OECD, 2015, TEST 442C CHEM SKIN
   OECD (Organisation for Economic Co operation and Development), 2012, ADV OUTC PATHW SKI 1
   OECD (Organization for Economic Co-operation and Development), 2013, GUID DOC DEV ASS ADV
   Patlewicz G, 2015, REGUL TOXICOL PHARM, V71, P463, DOI 10.1016/j.yrtph.2015.02.011
   Paul KB, 2014, CHEM RES TOXICOL, V27, P387, DOI 10.1021/tx400310w
   Paul KB, 2013, TOXICOLOGY, V312, P97, DOI 10.1016/j.tox.2013.08.006
   Perkins EJ, 2015, TOXICOL SCI, V148, P14, DOI 10.1093/toxsci/kfv181
   Pirone JR, 2014, ALTEX-ALTERN ANIM EX, V31, P336, DOI http://dx.doi.org/10.14573/altex.1310151
   Rattner BA, 2014, ENVIRON SCI TECHNOL, V48, P8433, DOI 10.1021/es501740n
   Scholl PF, 2006, CHEM RES TOXICOL, V19, P44, DOI 10.1021/tx050251r
   Scholl PF, 2006, CANCER EPIDEM BIOMAR, V15, P823, DOI 10.1158/1055-9965.EPI-05-0890
   Tice RR, 2013, ENVIRON HEALTH PERSP, V121, P756, DOI 10.1289/ehp.1205784
   Tollefsen KE, 2014, REGUL TOXICOL PHARM, V70, P629, DOI 10.1016/j.yrtph.2014.09.009
   Villeneuve D, 2014, ENVIRON TOXICOL CHEM, V33, P158, DOI 10.1002/etc.2403
   Villeneuve DL, 2014, TOXICOL SCI, V142, P312, DOI 10.1093/toxsci/kfu199
   Villeneuve DL, 2014, TOXICOL SCI, V142, P321, DOI 10.1093/toxsci/kfu200
   Vinken M, 2013, TOXICOL SCI, V136, P97, DOI 10.1093/toxsci/kft177
   Volz DC, 2011, TOXICOL SCI, V123, P349, DOI 10.1093/toxsci/kfr185
   Wetmore BA, 2013, TOXICOL SCI, V132, P327, DOI 10.1093/toxsci/kft012
   Wright RS, 2013, CURR OPIN CARDIOL, V28, P389, DOI 10.1097/HCO.0b013e328362059d
   Zeise L, 2013, ENVIRON HEALTH PERSP, V121, P23, DOI 10.1289/ehp.1205687
NR 45
TC 21
Z9 22
U1 2
U2 21
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0273-2300
EI 1096-0295
J9 REGUL TOXICOL PHARM
JI Regul. Toxicol. Pharmacol.
PD APR
PY 2016
VL 76
BP 39
EP 50
DI 10.1016/j.yrtph.2016.01.007
PG 12
WC Medicine, Legal; Pharmacology & Pharmacy; Toxicology
SC Legal Medicine; Pharmacology & Pharmacy; Toxicology
GA DL3DK
UT WOS:000375514200005
PM 26774756
DA 2019-10-23
ER

PT J
AU Angrish, MM
   Kaiser, JP
   McQueen, CA
   Chorley, BN
AF Angrish, Michelle M.
   Kaiser, Jonathan Phillip
   McQueen, Charlene A.
   Chorley, Brian N.
TI Tipping the Balance: Hepatotoxicity and the 4 Apical Key Events of
   Hepatic Steatosis
SO TOXICOLOGICAL SCIENCES
LA English
DT Review
DE non-alcoholic fatty liver disease; steatosis; adverse outcome pathway;
   mechanistic toxicology; high-throughput screening assays; chemical risk
   assessment
ID NONALCOHOLIC FATTY LIVER; STEAROYL-COA DESATURASE-1; ELEMENT-BINDING
   PROTEIN-1C; X-RECEPTOR LXR; ACID-METABOLISM; NUTRITIONAL REGULATION;
   MEDIATED INDUCTION; NUCLEAR RECEPTORS; GENE-EXPRESSION; CROSS-TALK
AB Hepatic steatosis is a condition were fat accumulates in the liver and it is associated with extra-hepatic diseases related to metabolic syndrome and systemic energy metabolism. If not reversed, steatosis can progress to steatohepatitis and irreversible stages of liver disease including fibrosis, cirrhosis, hepatocellular carcinoma, and death. From a public health standpoint, identifying chemical exposures that may be factors in steatosis etiology are important for preventing hepatotoxicity and liver disease progression. It is therefore important to identify the biological events that are key for steatosis pathology mediated by chemical exposure. In this review, we give a current overview of the complex biological cascades that can disrupt lipid homeostasis in hepatocytes in the context of 4 apical key events central to hepatic lipid retention: hepatic fatty acid (FA) uptake, de novo FA and lipid synthesis, FA oxidation, and lipid efflux. Our goal is to review these key cellular events and visually summarize them using a network for application in pathway-based toxicity testing. This effort provides a foundation to improve next-generation chemical screening efforts that may be used to prevent and ultimately reverse the growing incidence of fatty liver disease in our population.
C1 [Angrish, Michelle M.; McQueen, Charlene A.; Chorley, Brian N.] US EPA, Natl Hlth & Environm Effects Res Lab, Off Res & Dev, Res Triangle Pk, NC 27709 USA.
   [Kaiser, Jonathan Phillip] US EPA, Natl Ctr Environm Assessment, Off Res & Dev, Cincinnati, OH 45268 USA.
RP Chorley, BN (reprint author), Natl Hlth & Environm Effects Res Lab, 109 TW Alexander Dr,Mail Drop B-105-03, Res Triangle Pk, NC 27711 USA.
EM chorley.brian@epa.gov
FU U.S. Environmental Protection Agency Office of Research and
   DevelopmentUnited States Environmental Protection Agency
FX Internal funding for this study came from the U.S. Environmental
   Protection Agency Office of Research and Development.
CR Al Sharif M, 2014, PPAR RES, DOI 10.1155/2014/432647
   Al-Eryani L, 2015, TOXICOL PATHOL, V43, P482, DOI 10.1177/0192623314549960
   Angrish MM, 2012, TOXICOL SCI, V128, P377, DOI 10.1093/toxsci/kfs155
   Angrish MM, 2011, TOXICOL SCI, V124, P299, DOI 10.1093/toxsci/kfr226
   Angrish MM, 2013, TOXICOL SCI, V131, P108, DOI 10.1093/toxsci/kfs277
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Antherieu S, 2011, HEPATOLOGY, V53, P1895, DOI 10.1002/hep.24290
   Berlanga A, 2014, CLIN EXP GASTROENTER, V7, P221, DOI 10.2147/CEG.S62831
   Biddinger SB, 2005, DIABETES, V54, P1314, DOI 10.2337/diabetes.54.5.1314
   Boron WF, 2008, MED PHYSL
   Brownsey RW, 2006, BIOCHEM SOC T, V34, P223, DOI 10.1042/BST0340223
   Cave M, 2010, HEPATOLOGY, V51, P474, DOI 10.1002/hep.23321
   Chan DI, 2010, BIOCHEM J, V430, P1, DOI 10.1042/BJ20100462
   Fromenty B, 1997, J HEPATOL, V26, P43, DOI 10.1016/S0168-8278(97)80496-5
   Gibbons GF, 2004, BIOCHEM SOC T, V32, P59, DOI 10.1042/BST0320059
   GIBBONS GF, 1990, BIOCHEM J, V268, P1
   Glatz JFC, 2010, PHYSIOL REV, V90, P367, DOI 10.1152/physrev.00003.2009
   Granneman JG, 2009, J BIOL CHEM, V284, P34538, DOI 10.1074/jbc.M109.068478
   Greco D, 2008, AM J PHYSIOL-GASTR L, V294, pG1281, DOI 10.1152/ajpgi.00074.2008
   Grun F, 2009, MOL ENDOCRINOL, V23, P1127, DOI 10.1210/me.2008-0485
   Grun F, 2009, MOL CELL ENDOCRINOL, V304, P19, DOI 10.1016/j.mce.2009.02.018
   Grun F, 2006, ENDOCRINOLOGY, V147, pS50, DOI 10.1210/en.2005-1129
   Guillou H, 2010, PROG LIPID RES, V49, P186, DOI 10.1016/j.plipres.2009.12.002
   Handschin C, 2005, ARCH BIOCHEM BIOPHYS, V433, P387, DOI 10.1016/j.abb.2004.08.030
   Hardwick JP, 2009, PPAR RES, DOI 10.1155/2009/952734
   Huang C, 2014, J INTEGR MED-JIM, V12, P76, DOI 10.1016/S2095-4964(14)60013-3
   Ide T, 2003, MOL ENDOCRINOL, V17, P1255, DOI 10.1210/me.2002-0191
   Iizuka K, 2004, P NATL ACAD SCI USA, V101, P7281, DOI 10.1073/pnas.0401516101
   Judson R, 2014, BASIC CLIN PHARMACOL, V115, P69, DOI 10.1111/bcpt.12239
   Judson RS, 2010, ENVIRON HEALTH PERSP, V118, P485, DOI 10.1289/ehp.0901392
   Kaiser JP, 2012, INT J TOXICOL, V31, P551, DOI 10.1177/1091581812466418
   Kavlock R, 2010, J TOXICOL ENV HEAL B, V13, P197, DOI 10.1080/10937404.2010.483935
   Kavlock RJ, 2009, RISK ANAL, V29, P485, DOI 10.1111/j.1539-6924.2008.01168.x
   Konno Y, 2008, DRUG METAB PHARMACOK, V23, P8, DOI 10.2133/dmpk.23.8
   Lee AH, 2008, SCIENCE, V320, P1492, DOI 10.1126/science.1158042
   Lee JH, 2010, GASTROENTEROLOGY, V139, P653, DOI 10.1053/j.gastro.2010.03.033
   Lee R. G., 1994, DIAGNOSTIC LIVER PAT
   Li C, 2015, ARTERIOSCL THROM VAS, V35, P1080, DOI 10.1161/ATVBAHA.114.304584
   Marchesini G, 2003, HEPATOLOGY, V37, P917, DOI 10.1053/jhep.2003.50161
   Mitro N, 2007, NATURE, V445, P219, DOI 10.1038/nature05449
   Miyazaki M, 2004, J BIOL CHEM, V279, P25164, DOI 10.1074/jbc.M402781200
   Miyazaki M, 2007, CELL METAB, V6, P484, DOI 10.1016/j.cmet.2007.10.014
   Noureddin M, 2015, CLIN LIVER DIS, V19, P361, DOI 10.1016/j.cld.2015.01.012
   Ntambi JM, 2004, PROG LIPID RES, V43, P91, DOI 10.1016/S0163-7827(03)00039-0
   Ota T, 2008, J CLIN INVEST, V118, P316, DOI 10.1172/JCI32752
   Pereira IVA, 2011, EXPERT REV GASTROENT, V5, P245, DOI [10.1586/EGH.11.22, 10.1586/egh.11.22]
   Rakhshandehroo M, 2010, PPAR RES, DOI 10.1155/2010/612089
   SAVOLAINEN VT, 1993, ALCOHOL CLIN EXP RES, V17, P1112, DOI 10.1111/j.1530-0277.1993.tb05673.x
   Swedenborg E, 2009, J MOL ENDOCRINOL, V43, P1, DOI 10.1677/JME-08-0132
   Szalowska E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086795
   Trauner M, 2010, BBA-MOL CELL BIOL L, V1801, P299, DOI 10.1016/j.bbalip.2009.10.007
   Villeneuve DL, 2014, TOXICOL SCI, V142, P312, DOI 10.1093/toxsci/kfu199
   Villeneuve DL, 2014, TOXICOL SCI, V142, P321, DOI 10.1093/toxsci/kfu200
   Wahlang B, 2013, TOXICOL PATHOL, V41, P343, DOI 10.1177/0192623312468517
   Weber LWD, 2003, CRIT REV TOXICOL, V33, P105, DOI 10.1080/713611034
   Wolfrum C, 2006, CELL METAB, V3, P99, DOI 10.1016/j.cmet.2006.01.001
   WOOD R, 1969, ARCH BIOCHEM BIOPHYS, V131, P495, DOI 10.1016/0003-9861(69)90421-4
   Xiao L, 2010, ADV DRUG DELIVER REV, V62, P1316, DOI 10.1016/j.addr.2010.07.006
   Yen CLE, 2008, J LIPID RES, V49, P2283, DOI 10.1194/jlr.R800018-JLR200
   Yoshikawa T, 2003, MOL ENDOCRINOL, V17, P1240, DOI 10.1210/me.2002-0190
   Zhao CY, 2010, J ENDOCRINOL, V204, P233, DOI 10.1677/JOE-09-0271
NR 61
TC 20
Z9 21
U1 0
U2 13
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1096-6080
EI 1096-0929
J9 TOXICOL SCI
JI Toxicol. Sci.
PD APR
PY 2016
VL 150
IS 2
BP 261
EP 268
DI 10.1093/toxsci/kfw018
PG 8
WC Toxicology
SC Toxicology
GA DJ5ET
UT WOS:000374230300002
PM 26980302
OA Bronze
DA 2019-10-23
ER

PT J
AU Ramirez, T
   Stein, N
   Aumann, A
   Remus, T
   Edwards, A
   Norman, KG
   Ryan, C
   Bader, JE
   Fehr, M
   Burleson, F
   Foertsch, L
   Wang, XH
   Gerberick, F
   Beilstein, P
   Hoffmann, S
   Mehling, A
   van Ravenzwaay, B
   Landsiedel, R
AF Ramirez, Tzutzuy
   Stein, Nadine
   Aumann, Alexandra
   Remus, Tina
   Edwards, Amber
   Norman, Kimberly G.
   Ryan, Cindy
   Bader, Jackie E.
   Fehr, Markus
   Burleson, Florence
   Foertsch, Leslie
   Wang, Xiaohong
   Gerberick, Frank
   Beilstein, Paul
   Hoffmann, Sebastian
   Mehling, Annette
   van Ravenzwaay, Bennard
   Landsiedel, Robert
TI Intra- and inter-laboratory reproducibility and accuracy of the LuSens
   assay: A reporter gene-cell line to detect keratinocyte activation by
   skin sensitizers
SO TOXICOLOGY IN VITRO
LA English
DT Article
ID LYMPH-NODE ASSAY; CONTACT ALLERGENS; CLASSIFICATION; PREDICTION;
   CHEMICALS; POTENCY; POPULATION; PREVALENCE; TOXICITY; HAZARD
AB Several non-animal methods are now available to address the key events leading to skin sensitization as defined by the adverse outcome pathway. The KeratinoSens (TM) assay addresses the cellular event of keratinocyte activation and is a method accepted under OECD TG 442D. In this study, the results of an inter-laboratory evaluation of the "me-too" LuSens assay, a bioassay that uses a human keratinocyte cell line harboring a reporter gene construct composed of the rat antioxidant response element (ARE) of the NADPH:quinone oxidoreductase 1 gene and the luciferase gene, are described. Earlier in-house validation with 74 substances showed an accuracy of 82% in comparison to human data. When used in a battery of non-animal methods, even higher predictivity is achieved. To meet European validation criteria, a multicenter study was conducted in 5 laboratories. The study was divided into two phases, to assess 1) transferability of the method, and 2) reproducibility and accuracy. Phase I was performed by testing 8 non-coded test substances; the results showed a good transferability to naive laboratories even without on-site training. Phase II was performed with 20 coded test substances (performance standards recommended by OECD, 2015). In this phase, the intra- and inter-laboratory reproducibility as well as accuracy of the method was evaluated. The data demonstrate a remarkable reproducibility of 100% and an accuracy of over 80% in identifying skin sensitizers, indicating a good concordance with in vivo data. These results demonstrate good transferability, reliability and accuracy of the method thereby achieving the standards necessary for use in a regulatory setting to detect skin sensitizers. (C) 2016 The Authors. Published by Elsevier Ltd.
C1 [Ramirez, Tzutzuy; Stein, Nadine; Aumann, Alexandra; van Ravenzwaay, Bennard; Landsiedel, Robert] BASF SE, Expt Toxicol & Ecol, Ludwigshafen, Germany.
   [Remus, Tina; Fehr, Markus; Beilstein, Paul] DSM Nutr Prod AG, Kaiseraugst, Switzerland.
   [Edwards, Amber; Burleson, Florence] Burleson Res Technol, Morrisville, NC USA.
   [Norman, Kimberly G.; Bader, Jackie E.] Inst In Vitro Sci, Gaithersburg, MD USA.
   [Ryan, Cindy; Foertsch, Leslie; Wang, Xiaohong; Gerberick, Frank] Procter & Gamble Co, Mason, OH USA.
   [Hoffmann, Sebastian] Seh Consultancy Serv, Paderborn, Germany.
   [Mehling, Annette] BASF Personal Care & Nutr GmbH, Ludwigshafen, Germany.
RP Landsiedel, R (reprint author), BASF SE, Expt Toxicol & Ecol, Ludwigshafen, Germany.
EM robert.landsiedel@basf.com
RI Landsiedel, Robert/D-1960-2012
OI Landsiedel, Robert/0000-0003-3756-1904; Hoffmann,
   Sebastian/0000-0002-3214-7678; Bader, Jackie/0000-0002-8383-7898
CR [Anonymous], 2010, 429 TG OECD
   [Anonymous], 1992, 406 OECD TG
   [Anonymous], 2005, SSCP086305
   [Anonymous], 2010, OECD TEST GUID TG 44
   Aptula AO, 2006, CHEM RES TOXICOL, V19, P1097, DOI 10.1021/tx0601004
   Aptula AO, 2009, CHEM RES TOXICOL, V22, P1541, DOI [10.1021/tx9000330, 10.1021/tx9000336]
   Basketter D, 2008, SKIN PHARMACOL PHYS, V21, P191, DOI 10.1159/000135635
   Basketter DA, 1999, FOOD CHEM TOXICOL, V37, P1167, DOI 10.1016/S0278-6915(99)00112-X
   Basketter DA, 2014, DERMATITIS, V25, P11, DOI 10.1097/DER.0000000000000003
   Bruckner AL, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.1.e3
   Emter R., 2015, TOXICOL APPL PHARM
   Emter R, 2010, TOXICOL APPL PHARM, V245, P281, DOI 10.1016/j.taap.2010.03.009
   Gerberick G F, 2001, Am J Contact Dermat, V12, P156, DOI 10.1053/ajcd.2001.23926
   Gerberick GF, 2005, DERMATITIS, V16, P157, DOI 10.2310/6620.2005.05040
   ICCVAM, 2010, NIH PUBLICATION, V10-7553
   ICCVAM, 1999, NIH PUBLICATION
   Kimber I, 2003, FOOD CHEM TOXICOL, V41, P1799, DOI 10.1016/S0278-6915(03)00223-0
   Lunder T, 2000, CONTACT DERMATITIS, V43, P107, DOI 10.1034/j.1600-0536.2000.043002107.x
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Natsch A., 2015, ARCH TOXICOL
   Natsch A, 2008, TOXICOL SCI, V102, P110, DOI 10.1093/toxsci/kfm259
   Natsch A, 2011, TOXICOL IN VITRO, V25, P733, DOI 10.1016/j.tiv.2010.12.014
   Nguyen SH, 2008, CONTACT DERMATITIS, V58, P101, DOI 10.1111/j.1600-0536.2007.01281.x
   Nukada Y, 2012, TOXICOL IN VITRO, V26, P1150, DOI 10.1016/j.tiv.2012.07.001
   OECD, 2015, 442C OECD TG
   OECD, 2012, SER TEST ASS, V168
   OECD, 2015, SER TEST ASS, V213
   OECD, 2015, 442D OECD TG
   OECD ENV/JM/MONO(2012)10/PART2, 2012, SER TEST ASS, V168
   Patlewicz G, 2008, CHEM RES TOXICOL, V21, P521, DOI 10.1021/tx700338q
   Ramirez T, 2014, TOXICOL IN VITRO, V28, P1482, DOI 10.1016/j.tiv.2014.08.002
   Roberts DW, 2007, CHEM RES TOXICOL, V20, P1019, DOI 10.1021/tx700024w
   Thyssen JP, 2007, CONTACT DERMATITIS, V57, P287, DOI 10.1111/j.1600-0536.2007.01220.x
   Urbisch D, 2015, REGUL TOXICOL PHARM, V71, P337, DOI 10.1016/j.yrtph.2014.12.008
NR 34
TC 17
Z9 18
U1 1
U2 3
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0887-2333
J9 TOXICOL IN VITRO
JI Toxicol. Vitro
PD APR
PY 2016
VL 32
BP 278
EP 286
DI 10.1016/j.tiv.2016.01.004
PG 9
WC Toxicology
SC Toxicology
GA DH4MU
UT WOS:000372760900031
PM 26796489
OA Other Gold
DA 2019-10-23
ER

PT J
AU Oki, NO
   Edwards, SW
AF Oki, Noffisat O.
   Edwards, Stephen W.
TI An integrative data mining approach to identifying adverse outcome
   pathway signatures
SO TOXICOLOGY
LA English
DT Article
DE Adverse outcome pathway (AOP); cpAOP; Steatosis; Glaucoma
ID ARYL-HYDROCARBON RECEPTOR; FATTY LIVER-DISEASE; CELL-DIFFERENTIATION;
   TRUNCATING MUTATIONS; CYTOCHROME P4501B1; HEPATIC STEATOSIS;
   LIPID-METABOLISM; CYP1B1 GENE; PPAR-ALPHA; IDENTIFICATION
AB The Adverse Outcome Pathway (AOP) framework is a tool for making biological connections and summarizing key information across different levels of biological organization to connect biological perturbations at the molecular level to adverse outcomes for an individual or population. Computational approaches to explore and determine these connections can accelerate the assembly of AOPs. By leveraging the wealth of publicly available data covering chemical effects on biological systems, computationally-predicted AOPs (cpAOPs) were assembled via data mining of high-throughput screening (HTS) in vitro data, in vivo data and other disease phenotype information. Frequent Itemset Mining (FIM) was used to find associations between the gene targets of ToxCast HTS assays and disease data from Comparative Toxicogenomics Database (CTD) by using the chemicals as the common aggregators between datasets. The method was also used to map gene expression data to disease data from CTD. A cpAOP network was defined by considering genes and diseases as nodes and FIM associations as edges. This network contained 18,283 gene to disease associations for the ToxCast data and 110,253 for CTD gene expression. Two case studies show the value of the cpAOP network by extracting subnetworks focused either on fatty liver disease or the Aryl Hydrocarbon Receptor (AHR). The subnetwork surrounding fatty liver disease included many genes known to play a role in this disease. When querying the cpAOP network with the AHR gene, an interesting subnetwork including glaucoma was identified. While substantial literature exists to support the potential for AHR ligands to elicit glaucoma, it was not explicitly captured in the public annotation information in CTD. The subnetwork from this analysis suggests a cpAOP that includes changes in CYP1B1 expression, which has been previously established in the literature as a primary cause of glaucoma. These case studies highlight the value in integrating multiple data sources when defining cpAOPs for HTS data. (C) 2016 Published by Elsevier Ireland Ltd.
C1 [Oki, Noffisat O.] Oak Ridge Inst Sci & Educ, Oak Ridge, TN USA.
   [Edwards, Stephen W.] US EPA, Integrated Syst Toxicol Div, Natl Hlth & Environm Effects Res Lab, Off Res & Dev, Res Triangle Pk, NC 27711 USA.
RP Edwards, SW (reprint author), 109 TW Alexander Dr,Mail Code B305 01, Res Triangle Pk, NC 27709 USA.
EM oki.noffisat@epa.gov; edwards.stephen@epa.gov
FU U. S. Environmental Protection AgencyUnited States Environmental
   Protection Agency
FX The authors thank Carolyn Mattingly and the CTD team for invaluable
   assistance in working with their data. Shannon Bell originally adapted
   the FIM method for defining cpAOP networks from toxicogenomics data and
   was extremely helpful in further adapting that workflow for this study.
   Finally, we thank Rong-Lin Wang and Brian Chorley for constructive
   comments on the manuscript and Mark Nelms and Christopher Grant for
   reviewing the supplemental files. The information in this document has
   been funded wholly (or in part) by the U. S. Environmental Protection
   Agency. It has been subjected to review by the National Health and
   Environmental Effects Research Laboratory and approved for publication.
   Approval does not signify that the contents reflect the views of the
   Agency, nor does mention of trade names or commercial products
   constitute endorsement or recommendation for use.
CR Agrawal R., 1993, SIGMOD Record, V22, P207, DOI 10.1145/170035.170072
   Agrawal R., 1994, VLDB, P487, DOI DOI 10.1016/J.INS.2006.09.018
   Alexander DL, 1998, J CELL SCI, V111, P3311
   Angrish MM, 2016, TOXICOL SCI, V150, P261, DOI 10.1093/toxsci/kfw018
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Attene-Ramos MS, 2013, DRUG DISCOV TODAY, V18, P716, DOI 10.1016/j.drudis.2013.05.015
   Bai LA, 2011, HEPATOLOGY, V53, P1164, DOI 10.1002/hep.24155
   Beischlag TV, 2008, CRIT REV EUKAR GENE, V18, P207, DOI 10.1615/CritRevEukarGeneExpr.v18.i3.20
   Bell SM, 2016, TOXICOL SCI, V150, P510, DOI 10.1093/toxsci/kfw017
   Bell SM, 2015, ENVIRON HEALTH PERSP, V123, P1193, DOI 10.1289/ehp.1409138
   Bell SM, 2014, P SIAM INT C DAT MIN, V2014, P551
   Borgelt C, 2012, WIRES DATA MIN KNOWL, V2, P437, DOI 10.1002/widm.1074
   Brake PB, 1998, MOL PHARMACOL, V54, P825
   Croft D, 2014, NUCLEIC ACIDS RES, V42, pD472, DOI 10.1093/nar/gkt1102
   Davis AP, 2015, NUCLEIC ACIDS RES, V43, pD914, DOI 10.1093/nar/gku935
   Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649
   Hahsler M, 2005, COMPUTATIONAL ENV MI
   Hao N, 2013, BIOCHEM PHARMACOL, V86, P561, DOI 10.1016/j.bcp.2013.07.004
   Hardwick J.P., 2009, PPAR RES
   Hewitt KN, 2004, ENDOCRINOLOGY, V145, P1842, DOI 10.1210/en.2003-1369
   Hu BJ, 2015, CHEM RES TOXICOL, V28, P2210, DOI 10.1021/acs.chemrestox.5b00369
   Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211
   Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923
   Jacob A, 2015, BRAIN RES, V1613, P27, DOI 10.1016/j.brainres.2015.03.049
   Jacob A, 2011, FLUIDS BARRIERS CNS, V8, DOI 10.1186/2045-8118-8-23
   Judson RS, 2010, ENVIRON HEALTH PERSP, V118, P485, DOI 10.1289/ehp.0901392
   Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076
   LEE SST, 1995, MOL CELL BIOL, V15, P3012
   Mascanfroni ID, 2015, NAT MED, V21, P638, DOI 10.1038/nm.3868
   Messina-Baas OM, 2007, OPHTHALMIC RES, V39, P17, DOI 10.1159/000097902
   Milacic Marija, 2012, Cancers (Basel), V4, P1180, DOI 10.3390/cancers4041180
   Moran-Salvador E, 2011, FASEB J, V25, P2538, DOI 10.1096/fj.10-173716
   Motojima K, 1998, J BIOL CHEM, V273, P16710, DOI 10.1074/jbc.273.27.16710
   Nakajima T, 2004, HEPATOLOGY, V40, P972, DOI 10.1002/hep.20399
   Nguyen NT, 2013, INT IMMUNOL, V25, P335, DOI 10.1093/intimm/dxt011
   Nebert DW, 2004, J BIOL CHEM, V279, P23847, DOI 10.1074/jbc.R400004200
   Pawlak M, 2015, J HEPATOL, V62, P720, DOI 10.1016/j.jhep.2014.10.039
   Peng C.-Y.J., 2016, REAL DATA ANAL, V2006, P31
   Peters JM, 1997, CARCINOGENESIS, V18, P2029, DOI 10.1093/carcin/18.11.2029
   Pyper Sean R, 2010, Nucl Recept Signal, V8, pe002, DOI 10.1621/nrs.08002
   Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880
   R Core Team, 2016, R LANG ENV STAT COMP
   Rao MS, 2004, HEPATOLOGY, V40, P783, DOI 10.1002/hep.20453
   Reddy JK, 2006, AM J PHYSIOL-GASTR L, V290, pG852, DOI 10.1152/ajpgi.00521.2005
   Reddy JK, 2004, AM J PATHOL, V164, P2305, DOI 10.1016/S0002-9440(10)63787-X
   Seo YS, 2008, J GASTROEN HEPATOL, V23, P102, DOI 10.1111/j.1440-1746.2006.04819.x
   Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303
   Shehin SE, 2000, J BIOL CHEM, V275, P6770, DOI 10.1074/jbc.275.10.6770
   Stockinger B, 2014, ANNU REV IMMUNOL, V32, P403, DOI 10.1146/annurev-immunol-032713-120245
   Stoilov I, 1997, HUM MOL GENET, V6, P641, DOI 10.1093/hmg/6.4.641
   Tsuchiya Y, 2003, J BIOCHEM, V133, P583, DOI 10.1093/jb/mvg075
   Vasiliou V, 2008, ANNU REV PHARMACOL, V48, P333, DOI 10.1146/annurev.pharmtox.48.061807.154729
   Viswakarma N, 2010, PPAR RES, DOI 10.1155/2010/250126
   Volotinen M, 2009, INVEST OPHTH VIS SCI, V50, P3099, DOI 10.1167/iovs.08-2790
   Yang XH, 2008, J CELL BIOCHEM, V104, P402, DOI 10.1002/jcb.21630
   Yu ST, 2003, J BIOL CHEM, V278, P498, DOI 10.1074/jbc.M210062200
   Zhang H, 2013, J LIPID RES, V54, P345, DOI 10.1194/jlr.M028969
NR 57
TC 14
Z9 15
U1 1
U2 22
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0300-483X
J9 TOXICOLOGY
JI Toxicology
PD MAR 28
PY 2016
VL 350
BP 49
EP 61
DI 10.1016/j.tox.2016.04.004
PG 13
WC Pharmacology & Pharmacy; Toxicology
SC Pharmacology & Pharmacy; Toxicology
GA DO4GJ
UT WOS:000377739500006
PM 27108252
DA 2019-10-23
ER

PT J
AU Oldenkamp, R
   Huijbregts, MAJ
   Ragas, AMJ
AF Oldenkamp, Rik
   Huijbregts, Mark A. J.
   Ragas, Ad M. J.
TI Uncertainty and variability in human exposure limits - a
   chemical-specific approach for ciprofloxacin and methotrexate
SO CRITICAL REVIEWS IN TOXICOLOGY
LA English
DT Review
DE benchmark dose; Monte Carlo; pharmaceuticals; probabilistic; risk
   assessment; toxicodynamics; toxicokinetics; two-dimensional
ID HEALTH-RISK ASSESSMENT; LOW-DOSE METHOTREXATE; INCREASED ORAL
   BIOAVAILABILITY; STEADY-STATE PHARMACOKINETICS; BACTERICIDAL ACTIVITY;
   TISSUE PENETRATION; URINARY-EXCRETION; BIOEQUIVALENCE EVALUATION; HUMAN
   PHARMACEUTICALS; BENCHMARK APPROACH
AB Human exposure limits (HELs) for chemicals with a toxicological threshold are traditionally derived using default assessment factors that account for variations in exposure duration, species sensitivity and individual sensitivity. The present paper elaborates a probabilistic approach for human hazard characterization and the derivation of HELs. It extends the framework for evaluating and expressing uncertainty in hazard characterization recently proposed by WHO-IPCS, i.e. by the incorporation of chemical-specific data on human variability in toxicokinetics. The incorporation of human variability in toxicodynamics was based on the variation between adverse outcome pathways (AOPs). Furthermore, sources of interindividual variability and uncertainty are propagated separately throughout the derivation process. The outcome is a two-dimensional human dose distribution that quantifies the population fraction exceeding a pre-selected critical effect level with an estimate of the associated uncertainty. This enables policy makers to set separate standards for the fraction of the population to be protected and the confidence level of the assessment. The main sources of uncertainty in the human dose distribution can be identified in order to plan new research for reducing uncertainty. Additionally, the approach enables quantification of the relative risk for specific subpopulations. The approach is demonstrated for two pharmaceuticals, i.e. the antibiotic ciprofloxacin and the antineoplastic methotrexate. For both substances, the probabilistic HEL is mainly influenced by uncertainty originating from: (1) the point of departure (PoD), (2) extrapolation from sub-acute to chronic toxicity and (3) interspecies extrapolation. However, when assessing the tails of the two-dimensional human dose distributions, i.e. the section relevant for the derivation of human exposure limits, interindividual variability in toxicodynamics also becomes important.
C1 [Oldenkamp, Rik; Huijbregts, Mark A. J.; Ragas, Ad M. J.] Radboud Univ Nijmegen, Inst Wetland & Water Res, Dept Environm Sci, POB 9010, NL-6500 GL Nijmegen, Netherlands.
RP Oldenkamp, R (reprint author), Radboud Univ Nijmegen, Inst Wetland & Water Res, Dept Environm Sci, POB 9010, NL-6500 GL Nijmegen, Netherlands.
EM r.oldenkamp@science.ru.nl
RI Huijbregts, Mark A.J./B-8971-2011; Ragas, Ad/C-3231-2011
OI Huijbregts, Mark A.J./0000-0002-7037-680X; 
FU EUEuropean Union (EU) [265346]
FX The authors' affiliations are as shown on the cover page. This research
   was carried out as part of the EU funded FP7 project PHARMAS (contract
   no. 265346). The authors have sole responsibility for the writing and
   content of the paper.
CR Abdallah RM, 2002, DRUG DEV IND PHARM, V28, P423, DOI 10.1081/DDC-120003003
   Adriaenssens N, 2011, J ANTIMICROB CHEMOTH, V66, P47, DOI 10.1093/jac/dkr457
   ALBERTIONI F, 1995, EUR J CLIN PHARMACOL, V47, P507
   ALLEN BC, 1994, FUND APPL TOXICOL, V23, P487, DOI 10.1006/faat.1994.1133
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Bailer AJ, 2005, INT J RISK ASSESS MA, V5, P344
   Baird SJS, 1996, HUM ECOL RISK ASSESS, V2, P79, DOI 10.1080/10807039.1996.10387463
   BALIS FM, 1983, CANCER RES, V43, P2342
   Batke M, 2011, TOXICOL LETT, V205, P122, DOI 10.1016/j.toxlet.2011.05.1030
   BENDER SW, 1986, INFECTION, V14, P17, DOI 10.1007/BF01644804
   Bercu JP, 2008, REGUL TOXICOL PHARM, V50, P420, DOI 10.1016/j.yrtph.2008.01.014
   BERGAN T, 1986, EUR J CLIN MICROBIOL, V5, P187, DOI 10.1007/BF02013984
   Bokkers BGH, 2007, CRIT REV TOXICOL, V37, P355, DOI 10.1080/10408440701249224
   Bokkers BGH, 2005, TOXICOL SCI, V85, P1033, DOI 10.1093/toxsci/kfi144
   Boy D, 2004, INT J ANTIMICROB AG, V23, pS6, DOI 10.1016/j.ijantimicag.2003.09.006
   Busschaert P, 2011, RISK ANAL, V31, P1295, DOI 10.1111/j.1539-6924.2011.01592.x
   CAPECCHI PL, 1995, CLIN PHARMACOL THER, V57, P446, DOI 10.1016/0009-9236(95)90215-5
   CBS, 2012, BEV GESL LEEFT BURG
   CHRISTENSSON BA, 1992, ANTIMICROB AGENTS CH, V36, P2512, DOI 10.1128/AAC.36.11.2512
   Chukwuani CM, 2000, BIOL PHARM BULL, V23, P968
   COSTEFF H, 1966, ARCH DIS CHILD, V41, P681, DOI 10.1136/adc.41.220.681
   CRUMP B, 1983, ANTIMICROB AGENTS CH, V24, P784, DOI 10.1128/AAC.24.5.784
   CRUMP KS, 1984, FUND APPL TOXICOL, V4, P854, DOI 10.1016/0272-0590(84)90107-6
   Cullen A.C., 1999, PROBABILISTIC TECHNI
   Cunningham VL, 2009, REGUL TOXICOL PHARM, V53, P39, DOI 10.1016/j.yrtph.2008.10.006
   DAVIS RL, 1985, ANTIMICROB AGENTS CH, V28, P74, DOI 10.1128/AAC.28.1.74
   DAVIS RL, 1987, ANTIMICROB AGENTS CH, V31, P915, DOI 10.1128/AAC.31.6.915
   Dekkers S, 2001, ENVIRON TOXICOL PHAR, V10, P33, DOI 10.1016/S1382-6689(01)00068-0
   Di Marco MP, 2004, THER DRUG MONIT, V26, P401, DOI 10.1097/00007691-200408000-00010
   Dorne JLCM, 2010, TOXICOLOGY, V268, P156, DOI 10.1016/j.tox.2009.11.004
   Dorne JLCM, 2005, FOOD CHEM TOXICOL, V43, P203, DOI 10.1016/j.fct.2004.05.011
   Dorne JLCM, 2004, FOOD CHEM TOXICOL, V42, P275, DOI 10.1016/j.fct.2003.09.002
   Dourson M L, 1983, Regul Toxicol Pharmacol, V3, P224, DOI 10.1016/0273-2300(83)90030-2
   EFSA European Food Safety Authority, 2009, EFSA J, V1150, P1, DOI DOI 10.2903/J.EFSA.2009.1150
   Epstein M, 1996, J AM SOC NEPHROL, V7, P1106
   Fitzhugh O.G., 1954, ASSOC FOOD DRUG OFF, V18, P33
   FORREST A, 1988, ANTIMICROB AGENTS CH, V32, P1537, DOI 10.1128/AAC.32.10.1537
   Forster C, 1996, ARCH TOXICOL, V70, P474, DOI 10.1007/s002040050301
   Foster KR, 2000, SCIENCE, V288, P979, DOI 10.1126/science.288.5468.979
   FOURTILLAN JB, 1990, MED MALADIES INFECT, V20, P33, DOI 10.1016/S0399-077X(05)81021-2
   Frey HC, 1999, RISK ANAL, V19, P109, DOI 10.1111/j.1539-6924.1999.tb00393.x
   FROST RW, 1989, CLIN PHARMACOL THER, V45, P608, DOI 10.1038/clpt.1989.81
   Gaylor DW, 2000, RISK ANAL, V20, P245, DOI 10.1111/0272-4332.202023
   Groeneveld CN, 2004, HUM ECOL RISK ASSESS, V10, P709, DOI 10.1080/10807030490484318
   Gunnarsson L, 2008, ENVIRON SCI TECHNOL, V42, P5807, DOI 10.1021/es8005173
   HALL C, 1988, TOXICOL PATHOL, V16, P10, DOI 10.1177/019262338801600102
   Hamilton RA, 1997, BRIT J RHEUMATOL, V36, P86
   Hassan Y., 2007, SMJ Singapore Medical Journal, V48, P819
   Hattis D, 2003, RISK ANAL, V23, P117, DOI 10.1111/1539-6924.00295
   Hattis D, 1999, ANN NY ACAD SCI, V895, P286, DOI 10.1111/j.1749-6632.1999.tb08092.x
   Hattis D, 2007, TOXICOKINETICS RISK, P69
   HOFFLER D, 1984, EUR J CLIN MICROBIOL, V3, P363
   HOFFMAN FO, 1994, RISK ANAL, V14, P707, DOI 10.1111/j.1539-6924.1994.tb00281.x
   Huizer D, 2012, TOXICOL LETT, V214, P154, DOI 10.1016/j.toxlet.2012.08.016
   IARC, 1987, IARC MONOGRAPHS EVAL
   Iqbal MP, 1998, BIOPHARM DRUG DISPOS, V19, P163, DOI 10.1002/(SICI)1099-081X(199804)19:3<163::AID-BDD82>3.3.CO;2-C
   Jeong SH, 2009, REGUL TOXICOL PHARM, V53, P209, DOI 10.1016/j.yrtph.2009.01.004
   Kalberlah F, 1998, 11606113 FED I OCC S
   Kumar A, 2010, REGUL TOXICOL PHARM, V57, P146, DOI 10.1016/j.yrtph.2010.02.002
   Kummerer K., 2009, UMWELTRISIKOBEWERTUN
   Kurnik D, 2003, ALIMENT PHARM THERAP, V18, P57, DOI 10.1046/j.0269-2813.2003.01614.x
   LEBBE C, 1994, ANN RHEUM DIS, V53, P475, DOI 10.1136/ard.53.7.475
   LEBEL M, 1986, ANTIMICROB AGENTS CH, V29, P501, DOI 10.1128/AAC.29.3.501
   LEBEL M, 1986, ANTIMICROB AGENTS CH, V30, P260, DOI 10.1128/AAC.30.2.260
   LETTIERI JT, 1992, ANTIMICROB AGENTS CH, V36, P993, DOI 10.1128/AAC.36.5.993
   Li P, 2004, ACTA PHARMACOL SIN, V25, P1262
   LJUNGBERG B, 1989, EUR J CLIN MICROBIOL, V8, P515, DOI 10.1007/BF01967470
   LOMAESTRO BM, 1991, ANTIMICROB AGENTS CH, V35, P1004, DOI 10.1128/AAC.35.5.1004
   Maya MT, 2003, EUR J DRUG METAB PH, V28, P129, DOI 10.1007/BF03190501
   Nauta MJ, 2000, INT J FOOD MICROBIOL, V57, P9, DOI 10.1016/S0168-1605(00)00225-7
   OECD, 2008, TEST 407 REP DOS 28
   Ohbayashi M, 2010, J TOXICOL SCI, V35, P653, DOI 10.2131/jts.35.653
   Ohnishi M, 2009, BIOL PHARM BULL, V32, P1080, DOI 10.1248/bpb.32.1080
   Oldenkamp R, 2013, ENVIRON INT, V51, P13, DOI 10.1016/j.envint.2012.09.010
   Oliphant CM, 2002, AM FAM PHYSICIAN, V65, P455
   Orman ES, 2011, CLIN GASTROENTEROL H, V9, P517, DOI 10.1016/j.cgh.2011.02.019
   Peltola H, 1998, PEDIATRICS, V101, P658, DOI 10.1542/peds.101.4.658
   PELTOLA H, 1992, ANTIMICROB AGENTS CH, V36, P1086, DOI 10.1128/AAC.36.5.1086
   PINKERTON CR, 1982, CANCER CHEMOTH PHARM, V10, P36
   POLK RE, 1989, ANTIMICROB AGENTS CH, V33, P1841, DOI 10.1128/AAC.33.11.1841
   Price PS, 1997, RISK ANAL, V17, P427, DOI 10.1111/j.1539-6924.1997.tb00883.x
   Ragas AMJ, 2011, J INTEGR ENVIRON SCI, V8, P195, DOI 10.1080/1943815X.2011.597769
   Ragas AMJ, 2009, J EXPO SCI ENV EPID, V19, P201, DOI 10.1038/jes.2008.13
   Ragas AMJ, 1998, REGUL TOXICOL PHARM, V27, P251, DOI 10.1006/rtph.1998.1212
   RENWICK AG, 1993, FOOD ADDIT CONTAM, V10, P275, DOI 10.1080/02652039309374152
   Renwick AG, 1998, REGUL TOXICOL PHARM, V27, P3, DOI 10.1006/rtph.1997.1195
   Renwick AG, 2001, HUM ECOL RISK ASSESS, V7, P165, DOI 10.1080/20018091094286
   Schneider K, 2006, REGUL TOXICOL PHARM, V44, P172, DOI 10.1016/j.yrtph.2005.11.001
   Schriks M, 2010, WATER RES, V44, P461, DOI 10.1016/j.watres.2009.08.023
   Schwab BW, 2005, REGUL TOXICOL PHARM, V42, P296, DOI 10.1016/j.yrtph.2005.05.005
   Shao K, 2013, TOXICOL APPL PHARM, V272, P767, DOI 10.1016/j.taap.2013.08.006
   SLOB W, 1994, RISK ANAL, V14, P571, DOI 10.1111/j.1539-6924.1994.tb00271.x
   Slob W, 1998, RISK ANAL, V18, P787, DOI 10.1111/j.1539-6924.1998.tb01121.x
   Slob W, 2002, TOXICOL SCI, V66, P298, DOI 10.1093/toxsci/66.2.298
   Slob W, 2014, CRIT REV TOXICOL, V44, P270, DOI 10.3109/10408444.2013.853726
   SONNEVELD P, 1986, CANCER CHEMOTH PHARM, V18, P111
   Stephens MC, 2005, J PEDIATR GASTR NUTR, V40, P445, DOI 10.1097/01.MPG.0000157588.27125.50
   STUHT H, 1995, ANTIMICROB AGENTS CH, V39, P1045, DOI 10.1128/AAC.39.5.1045
   Thuo N, 2011, J ANTIMICROB CHEMOTH, V66, P2336, DOI 10.1093/jac/dkr314
   Tian HH, 2007, BULL HOSP JT DIS, V65, P168
   Travis KZ, 2005, REGUL TOXICOL PHARM, V43, P280, DOI 10.1016/j.yrtph.2005.07.003
   U.S. EPA, 2001, RISK ASS GUID SUP A, Viii
   US FDA, 2013, DRUG LAB CIPRO NDA 0
   Vakily M, 2005, J CLIN PHARMACOL, V45, P1179, DOI 10.1177/0091270005280100
   van der Voet H, 2007, RISK ANAL, V27, P351, DOI 10.1111/j.1539-6924.2007.00887.x
   Vermeire T, 1999, CRIT REV TOXICOL, V29, P439, DOI 10.1080/10408449991349249
   von Keutz E, 2004, ARCH TOXICOL, V78, P418, DOI 10.1007/s00204-004-0551-6
   Wagenlehner FME, 2006, INT J ANTIMICROB AG, V28, P551, DOI 10.1016/j.ijantimicag.2006.07.026
   Wagenlehner FME, 2003, ANTIMICROB AGENTS CH, V47, P3789, DOI 10.1128/AAC.47.12.3789-3794.2003
   Walker W, 2003, INTEGR ASSESS, V4, P5, DOI DOI 10.1076/IAIJ.4.1.5.16466
   Washington C, 2006, AM J HEALTH-SYST PH, V63, P653, DOI 10.2146/ajhp050355
   Webb S, 2003, TOXICOL LETT, V142, P157, DOI 10.1016/S0378-4274(03)00071-7
   WHO, 2014, 11 WHO IPCS
   WISE R, 1986, INFECTION, V14, pS196, DOI 10.1007/BF01667843
   Woutersen RA, 2001, FOOD CHEM TOXICOL, V39, P697, DOI 10.1016/S0278-6915(01)00015-1
   Wu FC, 2004, ECOL MODEL, V177, P393, DOI 10.1016/j.ecolmodel.2004.02.016
   YUK JH, 1989, ANTIMICROB AGENTS CH, V33, P1118, DOI 10.1128/AAC.33.7.1118
NR 117
TC 2
Z9 2
U1 0
U2 17
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1040-8444
EI 1547-6898
J9 CRIT REV TOXICOL
JI Crit. Rev. Toxicol.
PD MAR 15
PY 2016
VL 46
IS 3
BP 261
EP 278
DI 10.3109/10408444.2015.1112768
PG 18
WC Toxicology
SC Toxicology
GA DC8VD
UT WOS:000369496900003
PM 26648512
DA 2019-10-23
ER

PT J
AU Labib, S
   Williams, A
   Yauk, CL
   Nikota, JK
   Wallin, H
   Vogel, U
   Halappanavar, S
AF Labib, Sarah
   Williams, Andrew
   Yauk, Carole L.
   Nikota, Jake K.
   Wallin, Hakan
   Vogel, Ulla
   Halappanavar, Sabina
TI Nano-risk Science: application of toxicogenomics in an adverse outcome
   pathway framework for risk assessment of multi-walled carbon nanotubes
SO PARTICLE AND FIBRE TOXICOLOGY
LA English
DT Article
DE Nano; Risk assessment; Toxicogenomics; Adverse outcome pathways;
   Benchmark dose; Case study; Lung fibrosis
ID GENE-EXPRESSION CHANGES; ACUTE-PHASE RESPONSE; PULMONARY-FIBROSIS;
   INFLAMMATORY RESPONSES; INHALATION EXPOSURE; PHYSICOCHEMICAL PROPERTIES;
   LUNG FIBROBLAST; CANCER-RISK; MOUSE LUNG; BLEOMYCIN
AB Background: A diverse class of engineered nanomaterials (ENMs) exhibiting a wide array of physical-chemical properties that are associated with toxicological effects in experimental animals is in commercial use. However, an integrated framework for human health risk assessment (HHRA) of ENMs has yet to be established. Rodent 2-year cancer bioassays, clinical chemistry, and histopathological endpoints are still considered the 'gold standard' for detecting substance-induced toxicity in animal models. However, the use of data derived from alternative toxicological tools, such as genome-wide expression profiling and in vitro high-throughput assays, are gaining acceptance by the regulatory community for hazard identification and for understanding the underlying mode-of-action. Here, we conducted a case study to evaluate the application of global gene expression data in deriving pathway-based points of departure (PODs) for multi-walled carbon nanotube (MWCNT)-induced lung fibrosis, a non-cancer endpoint of regulatory importance.
   Methods: Gene expression profiles from the lungs of mice exposed to three individual MWCNTs with different physical-chemical properties were used within the framework of an adverse outcome pathway (AOP) for lung fibrosis to identify key biological events linking MWCNT exposure to lung fibrosis. Significantly perturbed pathways were categorized along the key events described in the AOP. Benchmark doses (BMDs) were calculated for each perturbed pathway and were used to derive transcriptional BMDs for each MWCNT.
   Results: Similar biological pathways were perturbed by the different MWCNT types across the doses and post-exposure time points studied. The pathway BMD values showed a time-dependent trend, with lower BMDs for pathways perturbed at the earlier post-exposure time points (24 h, 3d). The transcriptional BMDs were compared to the apical BMDs derived by the National Institute for Occupational Safety and Health (NIOSH) using alveolar septal thickness and fibrotic lesions endpoints. We found that regardless of the type of MWCNT, the BMD values for pathways associated with fibrosis were 14.0-30.4 mu g/mouse, which are comparable to the BMDs derived by NIOSH for MWCNT-induced lung fibrotic lesions (21.0-27.1 mu g/mouse).
   Conclusions: The results demonstrate that transcriptomic data can be used to as an effective mechanism-based method to derive acceptable levels of exposure to nanomaterials in product development when epidemiological data are unavailable.
C1 [Labib, Sarah; Williams, Andrew; Yauk, Carole L.; Nikota, Jake K.; Halappanavar, Sabina] Hlth Canada, Environm Hlth Sci & Res Bur, Ottawa, ON K1A 0K9, Canada.
   [Wallin, Hakan] Natl Res Ctr Working Environm, Lerso Pkalle 105, DK-2100 Copenhagen, Denmark.
   [Wallin, Hakan] Univ Copenhagen, Dept Publ Hlth, DK-1353 Copenhagen K, Denmark.
   [Vogel, Ulla] Tech Univ Denmark, Dept Micro & Nanotechnol, DK-2800 Lyngby, Denmark.
RP Halappanavar, S (reprint author), Hlth Canada, Environm Hlth Sci & Res Bur, Ottawa, ON K1A 0K9, Canada.
EM sabina.halappanavar@hc-sc.gc.ca
RI Wallin, Hakan/I-6459-2012; Vogel, Ulla/I-5048-2012
OI Wallin, Hakan/0000-0001-7716-0166; Vogel, Ulla/0000-0001-6807-1524
FU Health Canada Genomics Research and Development Initiative; Health
   Canada Chemicals Management Plan - Nano
FX Health Canada Genomics Research and Development Initiative; Health
   Canada Chemicals Management Plan - Nano.
CR Andersen ME, 2010, TOXICOL SCI, V118, P716, DOI 10.1093/toxsci/kfq303
   [Anonymous], 2013, SER TEST ASS
   Azad N, 2013, NANOTOXICOLOGY, V7, P157, DOI 10.3109/17435390.2011.647929
   Bantsimba-Malanda C, 2010, AM J RESP CRIT CARE, V182, P385, DOI 10.1164/rccm.200907-1164OC
   Barron L, 2011, AM J PHYSIOL-GASTR L, V300, pG723, DOI 10.1152/ajpgi.00414.2010
   Bercu JP, 2010, REGUL TOXICOL PHARM, V58, P369, DOI 10.1016/j.yrtph.2010.08.002
   Birch ME, 2011, ANN OCCUP HYG, V55, P1016, DOI 10.1093/annhyg/mer073
   Black MB, 2012, TOXICOL SCI, V127, P199, DOI 10.1093/toxsci/kfs069
   Bourdon JA, 2012, ENVIRON MOL MUTAGEN, V53, P462, DOI 10.1002/em.21706
   Bourdon JA, 2012, TOXICOL SCI, V127, P474, DOI 10.1093/toxsci/kfs119
   Bourdon JA, 2012, PART FIBRE TOXICOL, V9, DOI 10.1186/1743-8977-9-5
   Bourdon-Lacombe JA, 2015, REGUL TOXICOL PHARM, V72, P292, DOI 10.1016/j.yrtph.2015.04.010
   Chepelev NL, 2015, CRIT REV TOXICOL, V45, P44, DOI 10.3109/10408444.2014.973935
   Dahm MM, 2013, ANN OCCUP HYG, V57, P328, DOI 10.1093/annhyg/mes079
   Damoiseaux R, 2011, NANOSCALE, V3, P1345, DOI 10.1039/c0nr00618a
   Davis JA, 2011, TOXICOL APPL PHARM, V254, P181, DOI 10.1016/j.taap.2010.10.016
   Ding LH, 2005, NANO LETT, V5, P2448, DOI 10.1021/nl051748o
   Doak SH, 2009, MUTAGENESIS, V24, P285, DOI 10.1093/mutage/gep010
   Donaldson K, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-5
   Dong J, 2016, NANOTOXICOLOGY, V10, P699, DOI 10.3109/17435390.2015.1110758
   Dymacek Julian, 2014, ACM BCB, V2014, P122
   Dymacek J, 2015, TOXICOL SCI, V144, P51, DOI 10.1093/toxsci/kfu262
   Erdely A, 2013, PART FIBRE TOXICOL, V10
   Fichtner-Feigl S, 2006, NAT MED, V12, P99, DOI 10.1038/nm1332
   Gasse P, 2007, J CLIN INVEST, V117, P3786, DOI 10.1172/JCI32285
   Gharaee-Kermani M, 1998, J LEUKOCYTE BIOL, V64, P657
   Griffiths SM, 2011, ANAL CHEM, V83, P3778, DOI 10.1021/ac200103x
   Guadagnini R, 2015, NANOTOXICOLOGY, V9, P25, DOI 10.3109/17435390.2013.855830
   Guo NL, 2012, J TOXICOL ENV HEAL A, V75, P1129, DOI 10.1080/15287394.2012.699852
   Halappanavar S, 2015, ENVIRON MOL MUTAGEN, V56, P245, DOI 10.1002/em.21936
   Halappanavar S, 2011, ENVIRON MOL MUTAGEN, V52, P425, DOI 10.1002/em.20639
   Hamadeh Hisham K., 2002, Current Issues in Molecular Biology, V4, P45
   Hamadeh HK, 2002, TOXICOL SCI, V67, P219, DOI 10.1093/toxsci/67.2.219
   Hamadeh HK, 2002, TOXICOL SCI, V67, P232, DOI 10.1093/toxsci/67.2.232
   Han JH, 2008, INHAL TOXICOL, V20, P741, DOI 10.1080/08958370801942238 
   Husain M, 2015, TOXICOL APPL PHARM, V289, P573, DOI 10.1016/j.taap.2015.11.003
   Husain M, 2013, TOXICOL APPL PHARM, V269, P250, DOI 10.1016/j.taap.2013.03.018
   Jackson AF, 2014, TOXICOL APPL PHARM, V274, P63, DOI 10.1016/j.taap.2013.10.019
   Jackson P, 2012, MUTAT RES-GEN TOX EN, V745, P73, DOI 10.1016/j.mrgentox.2011.09.018
   Jakubzick C, 2003, J IMMUNOL, V171, P2684, DOI 10.4049/jimmunol.171.5.2684
   KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460
   Kisin ER, 2007, J TOXICOL ENV HEAL A, V70, P2071, DOI 10.1080/15287390701601251
   Kroll A, 2009, EUR J PHARM BIOPHARM, V72, P370, DOI 10.1016/j.ejpb.2008.08.009
   Lai DY, 2012, WIRES NANOMED NANOBI, V4, P1, DOI 10.1002/wnan.162
   Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev
   Lee JH, 2010, INHAL TOXICOL, V22, P369, DOI 10.3109/08958370903367359
   Liu JY, 1998, AM J PATHOL, V153, P1839, DOI 10.1016/S0002-9440(10)65698-2
   Liu TJ, 2004, J IMMUNOL, V173, P3425, DOI 10.4049/jimmunol.173.5.3425
   Ma-Hock L, 2009, TOXICOL SCI, V112, P468, DOI 10.1093/toxsci/kfp146
   Maynard AD, 2004, J TOXICOL ENV HEAL A, V67, P87, DOI 10.1080/15287390490253688
   Mercer RR, 2011, PART FIBRE TOXICOL, V8, DOI 10.1186/1743-8977-8-21
   Methner M, 2010, J OCCUP ENVIRON HYG, V7, P163, DOI 10.1080/15459620903508066
   Moffat I, 2015, CRIT REV TOXICOL, V45, P1, DOI 10.3109/10408444.2014.973934
   Muller J, 2005, TOXICOL APPL PHARM, V207, P221, DOI 10.1016/j.taap.2005.01.008
   Nikota J, METAANALYSI IN PRESS
   NIOSH, 2013, NIOSH CURR INT B, V65
   NRC (National Research Council), 2007, TOX TEST 21 CENT VIS
   Oberdorster G, 2015, J TOXICOL ENV HEAL B, V18, P121, DOI 10.1080/10937404.2015.1051611
   Patlolla A, 2010, ETHNIC DIS, V20, P1
   Pauluhn J, 2010, TOXICOL SCI, V113, P226, DOI 10.1093/toxsci/kfp247
   PIGUET PF, 1993, CYTOKINE, V5, P57, DOI 10.1016/1043-4666(93)90024-Y
   Porter DW, 2010, TOXICOLOGY, V269, P136, DOI 10.1016/j.tox.2009.10.017
   Poulsen SS, 2015, TOXICOL APPL PHARM, V284, P16, DOI 10.1016/j.taap.2014.12.011
   Poulsen SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080452
   Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL
   Ravichandran P, 2011, J BIOL CHEM, V286, P29725, DOI 10.1074/jbc.M111.251884
   Rydman EM, 2015, TOXICOL SCI, V147, P140, DOI 10.1093/toxsci/kfv112
   Rydman EM, 2014, PART FIBRE TOXICOL, V11, DOI 10.1186/s12989-014-0048-2
   Saito F, 2008, AM J RESP CELL MOL, V38, P566, DOI 10.1165/rcmb.2007-0299OC
   Sato E, 2000, EUR RESPIR J, V16, P951
   Shvedova AA, 2008, AM J RESP CELL MOL, V38, P579, DOI 10.1165/rcmb.2007-0255OC
   Snyder-Talkington BN, 2015, TOXICOLOGY, V328, P66, DOI 10.1016/j.tox.2014.12.012
   Snyder-Talkington BN, 2013, TOXICOL APPL PHARM, V272, P476, DOI 10.1016/j.taap.2013.06.026
   Stone V, 2014, PART FIBRE TOXICOL, V11, DOI 10.1186/1743-8977-11-9
   Stone V, 2009, CRIT REV TOXICOL, V39, P613, DOI 10.1080/10408440903120975
   Sun BB, 2015, SMALL, V11, P2087, DOI 10.1002/smll.201402859
   Thomas RS, 2013, TOXICOL SCI, V136, P4, DOI 10.1093/toxsci/kft178
   Thomas RS, 2011, TOXICOL SCI, V120, P194, DOI 10.1093/toxsci/kfq355
   Vietti G, 2015, NANOTOXICOL IN PRESS
   Vietti G, 2013, PART FIBRE TOXICOL, V10, DOI 10.1186/1743-8977-10-52
   Villeneuve DL, 2014, TOXICOL SCI, V142, P312, DOI 10.1093/toxsci/kfu199
   Villeneuve DL, 2014, TOXICOL SCI, V142, P321, DOI 10.1093/toxsci/kfu200
   Wang P, 2015, SMALL, V11, P446, DOI 10.1002/smll.201303588
   Wang P, 2013, SMALL, V9, P3799, DOI 10.1002/smll.201300607
   Wang X, 2010, ACS NANO, V4, P7241, DOI 10.1021/nn102112b
   Wang XJ, 2013, INT J NANOMED, V8, P1733, DOI 10.2147/IJN.S44211
   Waters MD, 2010, MUTAT RES-REV MUTAT, V705, P184, DOI 10.1016/j.mrrev.2010.04.005
   Webster AF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136764
   Williams A, BEILSTEIN J IN PRESS
   Wilson MS, 2009, MUCOSAL IMMUNOL, V2, P103, DOI 10.1038/mi.2008.85
   Wilson MS, 2010, J EXP MED, V207, P535, DOI 10.1084/jem.20092121
   Wilson VS, 2013, TOXICOL APPL PHARM, V271, P299, DOI 10.1016/j.taap.2011.01.017
   Yang LL, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-387
   Yoshizaki A, 2010, J IMMUNOL, V185, P2502, DOI 10.4049/jimmunol.0901778
NR 94
TC 35
Z9 37
U1 1
U2 52
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1743-8977
J9 PART FIBRE TOXICOL
JI Part. Fibre Toxicol.
PD MAR 15
PY 2016
VL 13
AR 15
DI 10.1186/s12989-016-0125-9
PG 17
WC Toxicology
SC Toxicology
GA DG3JW
UT WOS:000371966500001
PM 26979667
OA DOAJ Gold, Green Published
DA 2019-10-23
ER

PT J
AU Sasagawa, S
   Nishimura, Y
   Kon, T
   Yamanaka, Y
   Murakami, S
   Ashikawa, Y
   Yuge, M
   Okabe, S
   Kawaguchi, K
   Kawase, R
   Tanaka, T
AF Sasagawa, Shota
   Nishimura, Yuhei
   Kon, Tetsuo
   Yamanaka, Yukiko
   Murakami, Soichiro
   Ashikawa, Yoshifumi
   Yuge, Mizuki
   Okabe, Shiko
   Kawaguchi, Koki
   Kawase, Reiko
   Tanaka, Toshio
TI DNA Damage Response Is Involved in the Developmental Toxicity of
   Mebendazole in Zebrafish Retina
SO FRONTIERS IN PHARMACOLOGY
LA English
DT Article
DE systems toxicology; benzimidazole; ATM; DNA damage response;
   developmental toxicity; zebrafish
ID SYSTEMS TOXICOLOGY; INTERACTION NETWORKS; CYTOSCAPE PLUGIN; C-JUN;
   ALBENDAZOLE; GENE; ATM; PHOSPHORYLATION; NEUROTOXICITY; ACTIVATION
AB Intestinal helminths cause iron-deficiency anemia in pregnant women, associated with premature delivery, low birth weight, maternal ill health, and maternal death. Although benzimidazole compounds such as mebendazole (MBZ) are highly efficacious against helminths, there are limited data on its use during pregnancy. In this study, we performed in vivo imaging of the retinas of zebrafish larvae exposed to MBZ, and found that exposure to MBZ during 2 and 3 days post-fertilization caused malformation of the retinal layers. To identify the molecular mechanism underlying the developmental toxicity of MBZ, we performed transcriptome analysis of zebrafish eyes. The analysis revealed that the DNA damage response was involved in the developmental toxicity of MBZ. We were also able to demonstrate that inhibition of ATM significantly attenuated the apoptosis induced by MBZ in the zebrafish retina. These results suggest that MBZ causes developmental toxicity in the zebrafish retina at least partly by activating the DNA damage response, including ATM signaling, providing a potential adverse outcome pathway in the developmental toxicity of MBZ in mammals.
C1 [Sasagawa, Shota; Nishimura, Yuhei; Kon, Tetsuo; Yamanaka, Yukiko; Murakami, Soichiro; Ashikawa, Yoshifumi; Yuge, Mizuki; Okabe, Shiko; Kawaguchi, Koki; Kawase, Reiko; Tanaka, Toshio] Mie Univ, Grad Sch Med, Dept Mol & Cellular Pharmacol Pharmacogen & Pharm, Tsu, Mie 514, Japan.
   [Nishimura, Yuhei; Tanaka, Toshio] Mie Univ, Med Zebrafish Res Ctr, Tsu, Mie 514, Japan.
   [Nishimura, Yuhei; Tanaka, Toshio] Mie Univ, Grad Sch Med, Dept Syst Pharmacol, Tsu, Mie 514, Japan.
   [Nishimura, Yuhei; Tanaka, Toshio] Mie Univ, Ind Technol Innovat Inst, Dept Omics Med, Tsu, Mie 514, Japan.
   [Nishimura, Yuhei; Tanaka, Toshio] Mie Univ, Life Sci Res Ctr, Dept Bioinformat, Tsu, Mie 514, Japan.
RP Tanaka, T (reprint author), Mie Univ, Grad Sch Med, Dept Mol & Cellular Pharmacol Pharmacogen & Pharm, Tsu, Mie 514, Japan.; Tanaka, T (reprint author), Mie Univ, Med Zebrafish Res Ctr, Tsu, Mie 514, Japan.; Tanaka, T (reprint author), Mie Univ, Grad Sch Med, Dept Syst Pharmacol, Tsu, Mie 514, Japan.; Tanaka, T (reprint author), Mie Univ, Ind Technol Innovat Inst, Dept Omics Med, Tsu, Mie 514, Japan.; Tanaka, T (reprint author), Mie Univ, Life Sci Res Ctr, Dept Bioinformat, Tsu, Mie 514, Japan.
EM tanaka@doc.medic.mie-u.ac.jp
OI Nishimura, Yuhei/0000-0003-1901-8799
FU JSPS KAKENHIMinistry of Education, Culture, Sports, Science and
   Technology, Japan (MEXT)Japan Society for the Promotion of
   ScienceGrants-in-Aid for Scientific Research (KAKENHI) [25670127,
   15K15051, 24510069]; JST A-step [AS262Z00004Q]; Long-range Research
   Initiative of the Japan Chemical Industrial Association [13_PT01-01];
   Johns Hopkins Center for Alternatives to Animal Testing [2012-17]
FX This work was supported in part by JSPS KAKENHI (25670127, 15K15051,
   24510069), JST A-step (AS262Z00004Q), the Long-range Research Initiative
   of the Japan Chemical Industrial Association (13_PT01-01), and the Johns
   Hopkins Center for Alternatives to Animal Testing (2012-17). We are
   grateful to Ryo Shioda (Perkin-Elmer) for the quantitative assessment of
   IPL of zebrafish retina using Volocity. We also thank Junko Koiwa,
   Hiroko Nakayama, Yuka Hayakawa, Yuka Takahashi, Chizuru Hirota, and
   Michiko Ariyoshi for assistance with the experiments, and Rie Ikeyama
   and Yuka Mizutani for secretarial support.
CR Ackermann J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019090
   Bal-Price AK, 2012, ALTEX-ALTERN ANIM EX, V29, P202, DOI 10.14573/altex.2012.2.202
   Banh S, 2013, TOXICOL SCI, V133, P298, DOI 10.1093/toxsci/kft069
   Barzilai A, 2008, DNA REPAIR, V7, P1010, DOI 10.1016/j.dnarep.2008.03.005
   Behl M, 2015, NEUROTOXICOL TERATOL, V52, P181, DOI 10.1016/j.ntt.2015.09.003
   Bhoumik A, 2005, MOL CELL, V18, P577, DOI 10.1016/j.molcel.2005.04.015
   Biehlmaier O, 2001, CELL TISSUE RES, V306, P199, DOI 10.1007/s004410100447
   Bindea G, 2013, BIOINFORMATICS, V29, P661, DOI 10.1093/bioinformatics/btt019
   Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101
   Boix N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121308
   Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055
   Carlsson G, 2013, AQUAT TOXICOL, V126, P30, DOI 10.1016/j.aquatox.2012.10.008
   Carlsson G, 2011, REPROD TOXICOL, V32, P129, DOI 10.1016/j.reprotox.2011.05.015
   Chaki M, 2012, CELL, V150, P533, DOI 10.1016/j.cell.2012.06.028
   Dayan AD, 2003, ACTA TROP, V86, P141, DOI 10.1016/S0001-706X(03)00031-7
   Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60
   Geiger K, 2012, MOL BIOL CELL, V23, P2226, DOI 10.1091/mbc.E11-06-0535
   Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80
   Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245
   Giunta S, 2010, J CELL BIOL, V190, P197, DOI 10.1083/jcb.200911156
   Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727
   Howe EA, 2011, BIOINFORMATICS, V27, P3209, DOI 10.1093/bioinformatics/btr490
   Janky R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003731
   Kelder T, 2012, NUCLEIC ACIDS RES, V40, pD1301, DOI 10.1093/nar/gkr1074
   Kelsh RN, 1996, DEVELOPMENT, V123, P369
   Kim JK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065242
   Kitambi SS, 2009, MECH DEVELOP, V126, P464, DOI 10.1016/j.mod.2009.01.002
   Kristiansen M, 2010, J NEUROSCI, V30, P10820, DOI 10.1523/JNEUROSCI.2824-10.2010
   Lau E, 2012, J CELL SCI, V125, P2815, DOI 10.1242/jcs.095000
   Law R, 2010, CAN FAM PHYSICIAN, V56, P239
   Liang GS, 1996, J BIOL CHEM, V271, P1695, DOI 10.1074/jbc.271.3.1695
   Lindaman LL, 2013, MOL CELL ENDOCRINOL, V365, P316, DOI 10.1016/j.mce.2012.11.012
   Liu JX, 2007, COMP BIOCHEM PHYS B, V147, P56, DOI 10.1016/j.cbpb.2006.12.014
   Locatelli C, 2004, REDOX REP, V9, P89, DOI 10.1179/135100004225004751
   Lopez-Romero P., 2013, AGI4X44PREPROCESS PR
   Maglott D, 2011, NUCLEIC ACIDS RES, V39, pD52, DOI 10.1093/nar/gkq1237
   Martin-Oliva D, 2015, INVEST OPHTH VIS SCI, V56, P1301, DOI 10.1167/iovs.14-15828
   Mattsson A, 2012, REPROD TOXICOL, V34, P31, DOI 10.1016/j.reprotox.2012.02.007
   Mizuno K, 2011, ARCH TOXICOL, V85, P199, DOI 10.1007/s00204-010-0584-y
   MORGAN UM, 1993, ANTIMICROB AGENTS CH, V37, P328, DOI 10.1128/AAC.37.2.328
   Mpairwe H, 2014, PARASITE IMMUNOL, V36, P328, DOI 10.1111/pim.12101
   Nishimura D, 2001, BIOTECH SOFTWARE INT, V2, P117, DOI DOI 10.1089/152791601750294344
   Nishimura Y, 2016, CONGENIT ANOM, V56, P18, DOI 10.1111/cga.12142
   Nishimura Y, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00199
   Nishimura Y, 2015, CONGENIT ANOM, V55, P1, DOI 10.1111/cga.12079
   Nishimura Y, 2013, ACS CHEM NEUROSCI, V4, P1183, DOI 10.1021/cn400010t
   O'Driscoll M, 2008, DNA REPAIR, V7, P1039, DOI 10.1016/j.dnarep.2008.03.018
   Patel K, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-160
   Poruchynsky MS, 2015, P NATL ACAD SCI USA, V112, P1571, DOI 10.1073/pnas.1416418112
   Rodrigues PMG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069209
   Salam RA, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005547.pub3
   Sasagawa S, 2016, ACS CHEM BIOL, V11, P381, DOI 10.1021/acschembio.5b00751
   Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303
   Shao L, 2009, J EXP MED, V206, P1435, DOI 10.1084/jem.20082251
   Sherman MH, 2011, TRENDS CELL BIOL, V21, P312, DOI 10.1016/j.tcb.2011.01.004
   Sipes NS, 2011, BIRTH DEFECTS RES C, V93, P256, DOI 10.1002/bdrc.20214
   Sturla SJ, 2014, CHEM RES TOXICOL, V27, P314, DOI 10.1021/tx400410s
   Varga ZM, 2011, METHOD CELL BIOL, V104, P453, DOI 10.1016/B978-0-12-374814-0.00024-0
   Watanabe K, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-101
   Watanabe K, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-116
   Wei F, 2011, CURR MED CHEM, V18, P5476, DOI 10.2174/092986711798194388
   Westerfield M., 2007, GUIDE LAB USE ZEBRAF
   WHITTAKER SG, 1992, TOXICOL APPL PHARM, V113, P144, DOI 10.1016/0041-008X(92)90019-O
   Winterhalter C, 2014, BIOINFORMATICS, V30, P1029, DOI 10.1093/bioinformatics/btt732
   Xu K, 2002, DRUG DEVELOP RES, V55, P91, DOI 10.1002/ddr.10023
   Yang CY, 2011, MOL CELL, V44, P597, DOI 10.1016/j.molcel.2011.09.016
NR 66
TC 7
Z9 8
U1 0
U2 15
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015,
   SWITZERLAND
SN 1663-9812
J9 FRONT PHARMACOL
JI Front. Pharmacol.
PD MAR 14
PY 2016
VL 7
AR 57
DI 10.3389/fphar.2016.00057
PG 11
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA DG1VB
UT WOS:000371854500005
PM 27014071
OA DOAJ Gold, Green Published
DA 2019-10-23
ER

PT J
AU Ingle, B
   Veber, B
   Nichols, J
   Tornero-Velez, R
AF Ingle, Brandall
   Veber, Brandon
   Nichols, John
   Tornero-Velez, Rogelio
TI Human health and the environment: Predicting plasma protein binding and
   metabolic clearance rates of environmentally relevant chemicals
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
C1 [Ingle, Brandall; Tornero-Velez, Rogelio] US EPA, Natl Exposure Res Lab, Res Triangle Pk, NC 27711 USA.
   [Veber, Brandon] Oak Ridge Inst Sci & Educ, Oak Ridge, TN USA.
   [Veber, Brandon; Nichols, John] US EPA, Natl Hlth Exposure Effects Res Lab, Duluth, MN USA.
EM brandallingle@gmail.com
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD MAR 13
PY 2016
VL 251
MA 347
PG 1
WC Chemistry, Multidisciplinary
SC Chemistry
GA VC1WO
UT WOS:000431903806273
DA 2019-10-23
ER

PT J
AU Marchetti, F
   Massarotti, A
   Yauk, CL
   Pacchierotti, F
   Russo, A
AF Marchetti, Francesco
   Massarotti, Alberto
   Yauk, Carole L.
   Pacchierotti, Francesca
   Russo, Antonella
TI The adverse outcome pathway (AOP) for chemical binding to tubulin in
   oocytes leading to aneuploid offspring
SO ENVIRONMENTAL AND MOLECULAR MUTAGENESIS
LA English
DT Review
DE chromosome missegregation; colchicine; female germ cells; meiotic
   spindle; microtubules; tubulin
ID GRISEOFULVIN-INDUCED ANEUPLOIDY; SPINDLE-ASSEMBLY CHECKPOINT; MOUSE
   GERM-CELLS; METAPHASE-II OOCYTES; POLO-LIKE KINASE-1;
   COLCHICINE-BINDING; MEIOTIC MATURATION; CHROMOSOME SEGREGATION;
   IN-VITRO; CYTOGENETIC ANALYSIS
AB The Organisation for Economic Co-operation and Development (OECD) has launched the Adverse Outcome Pathway (AOP) Programme to advance knowledge of pathways of toxicity and improve the use of mechanistic information in risk assessment. An AOP links a molecular initiating event (MIE) to an adverse outcome (AO) through intermediate key events (KE). Here, we present the scientific evidence in support of an AOP whereby chemicals that bind to tubulin cause microtubule depolymerization resulting in spindle disorganization followed by altered chromosome alignment and segregation and the generation of aneuploidy in female germ cells, ultimately leading to aneuploidy in the offspring. Aneuploidy, an abnormal number of chromosomes that is not an exact multiple of the haploid number, is a well-known cause of human disease and represents a major cause of infertility, pregnancy failure, and serious genetic disorders in the offspring. Among chemicals that induce aneuploidy in female germ cells, a large majority impairs microtubule dynamics and spindle function. Colchicine, a prototypical chemical that binds to tubulin and causes microtubule depolymerization, is used here to illustrate the AOP. This AOP is specific to female germ cells exposed during the periovulation period. Although the majority of the data come from rodent studies, the available evidence suggests that the MIE and KEs are conserved across species and would occur in human oocytes. The development of AOPs related to mutagenicity in germ cells is expected to aid the identification of potential hazards to germ cell genomic integrity and support regulatory efforts to protect population health. Environ. Mol. Mutagen. 57:87-113, 2016. (c) 2015 Her Majesty the Queen in Right of Canada.
C1 [Marchetti, Francesco; Yauk, Carole L.] Hlth Canada, Environm Hlth Sci & Res Bur, Ottawa, ON K1A 0K9, Canada.
   [Massarotti, Alberto] Univ Piemonte Orientale, Dipartimento Sci Farmaco, Novara, Italy.
   [Pacchierotti, Francesca] ENEA CR Casaccia, Lab Biosafety & Risk Assessment, Div Hlth Protect Technol, Rome, Italy.
   [Russo, Antonella] Univ Padua, Dept Biol, Padua, Italy.
RP Marchetti, F (reprint author), Hlth Canada, Environm Hlth Sci & Res Bur, Ottawa, ON K1A 0K9, Canada.
EM francesco.marchetti@hc-sc.gc.ca
RI Russo, Antonella/K-8970-2016
OI Russo, Antonella/0000-0001-6691-257X
FU Health Canada Intramural Funding; Department of Biology, University of
   Padova, Italy
FX Grant sponsor: Health Canada Intramural Funding (FM & CY) and Department
   of Biology, University of Padova, Italy (AR).
CR Palma GA, 2012, SCI WORLD J, DOI 10.1100/2012/938138
   Allard P, 2013, ENVIRON HEALTH PERSP, V121, P717, DOI 10.1289/ehp.1206301
   Amos LA, 2004, ORG BIOMOL CHEM, V2, P2153, DOI 10.1039/b403634d
   Barrett SL, 2007, BIOL REPROD, V76, P949, DOI 10.1095/biolreprod.106.057141
   Becker RA, 2015, REGUL TOXICOL PHARM, V72, P541
   Bendsen E, 2006, HUM REPROD, V21, P30, DOI 10.1093/humrep/dei280
   BENNETT WF, 1980, CELL, V22, P621, DOI 10.1016/0092-8674(80)90372-4
   BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3
   Berrieman HK, 2004, LANCET ONCOL, V5, P158, DOI 10.1016/S1470-2045(04)01411-1
   Bhattacharya R, 2009, J BIOL CHEM, V284, P13023, DOI 10.1074/jbc.M900167200
   Birchler JA, 2001, DEV BIOL, V234, P275, DOI 10.1006/dbio.2001.0262
   BORUM K, 1961, EXP CELL RES, V24, P495, DOI 10.1016/0014-4827(61)90449-9
   Botta M, 2009, TOP CURR CHEM, V286, P279, DOI 10.1007/128_2008_20
   BROWER PT, 1982, DEV BIOL, V90, P144, DOI 10.1016/0012-1606(82)90219-6
   BUCCIONE R, 1990, BIOL REPROD, V43, P543, DOI 10.1095/biolreprod43.4.543
   Cao YK, 2005, REPRODUCTION, V130, P431, DOI 10.1530/rep.1.00391
   Cha HJ, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001379
   Chiang T, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.094367
   CHRETIEN D, 1991, BIOL CELL, V71, P161, DOI 10.1016/0248-4900(91)90062-R
   Clement MJ, 2008, BIOCHEMISTRY-US, V47, P13016, DOI 10.1021/bi801136q
   Clift D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8217
   Coderch C, 2012, ANTI-CANCER AGENT ME, V12, P219, DOI 10.2174/187152012800228841
   CUTTS JH, 1960, CANCER RES, V20, P1023
   CZEIZEL AE, 1993, LANCET, V341, P539, DOI 10.1016/0140-6736(93)90293-P
   DAMATO RJ, 1994, P NATL ACAD SCI USA, V91, P3964, DOI 10.1073/pnas.91.9.3964
   DAVIDSE LC, 1978, BIOCHIM BIOPHYS ACTA, V543, P82, DOI 10.1016/0304-4165(78)90456-7
   DeMarini DM, 2012, ENVIRON MOL MUTAGEN, V53, P166, DOI 10.1002/em.21685
   Desbene Stephanie, 2002, Current Medicinal Chemistry - Anti-Cancer Agents, V2, P71, DOI 10.2174/1568011023354353
   DONAHUE RP, 1968, J EXP ZOOL, V169, P237, DOI 10.1002/jez.1401690210
   DOWNES CS, 1991, P NATL ACAD SCI USA, V88, P8895, DOI 10.1073/pnas.88.20.8895
   Dutcher SK, 2001, CURR OPIN CELL BIOL, V13, P49, DOI 10.1016/S0955-0674(00)00173-3
   EDWARDS RG, 1959, J ENDOCRINOL, V18, P292, DOI 10.1677/joe.0.0180292
   Eichenlaub-Ritter U, 2007, BIOL REPROD, V76, P784, DOI 10.1095/biolreprod.106.055111
   Eichenlaub-Ritter U, 2012, INT J DEV BIOL, V56, P841, DOI 10.1387/ijdb.120141ue
   EICHENLAUBRITTER U, 1989, CYTOGENET CELL GENET, V52, P170, DOI 10.1159/000132871
   Engelborghs Y, 1998, EUR BIOPHYS J BIOPHY, V27, P437, DOI 10.1007/s002490050154
   Epstein CJ., 1988, ANEUPLOIDY B, P9
   EVERETT CA, 1995, GENET RES, V66, P35, DOI 10.1017/S0016672300034376
   FADDY MJ, 1983, J ENDOCRINOL, V96, P23, DOI 10.1677/joe.0.0960023
   Fojo AT, 2008, ROLE MICROTUBULES CE
   Foley EA, 2013, NAT REV MOL CELL BIO, V14, P25, DOI 10.1038/nrm3494
   Fragouli E, 2014, MOL HUM REPROD, V20, P117, DOI 10.1093/molehr/gat073
   Fragouli E, 2013, HUM GENET, V132, P1001, DOI 10.1007/s00439-013-1309-0
   Frias S, 2003, CANCER RES, V63, P44
   FRIEDMAN PA, 1978, BIOCHIM BIOPHYS ACTA, V544, P605, DOI 10.1016/0304-4165(78)90334-3
   GARLAND DL, 1978, BIOCHEMISTRY-US, V17, P4266, DOI 10.1021/bi00613a024
   GENEROSO WM, 1989, MUTAT RES, V210, P313, DOI 10.1016/0027-5107(89)90092-4
   George M A, 1996, Mol Hum Reprod, V2, P445, DOI 10.1093/molehr/2.6.445
   Gianaroli L, 2010, HUM REPROD, V25, P2374, DOI 10.1093/humrep/deq123
   Gigant B, 2005, NATURE, V435, P519, DOI 10.1038/nature03566
   Gui LM, 2012, DEVELOPMENT, V139, P1941, DOI 10.1242/dev.078352
   Gupta S, 2003, MOL CELL BIOCHEM, V253, P41, DOI 10.1023/A:1026045100219
   HAMEL E, 1981, BIOCHIM BIOPHYS ACTA, V675, P226, DOI 10.1016/0304-4165(81)90231-2
   Hamel E, 2003, CELL BIOCHEM BIOPHYS, V38, P1, DOI 10.1385/CBB:38:1:1
   Handyside AH, 2012, BBA-MOL BASIS DIS, V1822, P1913, DOI 10.1016/j.bbadis.2012.07.007
   Hassold T, 2007, HUM MOL GENET, V16, pR203, DOI 10.1093/hmg/ddm243
   HEANEY D, 1976, AM J MED SCI, V271, P233, DOI 10.1097/00000441-197603000-00014
   Hecht F, 1987, ANEUPLOIDY A, P9
   Hentgen V, 2013, SEMIN ARTHRITIS RHEU, V43, P387, DOI 10.1016/j.semarthrit.2013.04.011
   HIMES RH, 1991, PHARMACOL THERAPEUT, V51, P257, DOI 10.1016/0163-7258(91)90081-V
   Hoffman DB, 2001, MOL BIOL CELL, V12, P1995, DOI 10.1091/mbc.12.7.1995
   Hoffmann S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027143
   Holubcova Z, 2015, SCIENCE, V348, P1143, DOI 10.1126/science.aaa9529
   HUMMLER E, 1988, CHROMOSOMA, V97, P224, DOI 10.1007/BF00292965
   HUMMLER E, 1985, CYTOGENET CELL GENET, V39, P161, DOI 10.1159/000132128
   Hunt PA, 2002, SCIENCE, V296, P2181, DOI 10.1126/science.1071907
   Ibanez E, 2003, BIOL REPROD, V68, P1249, DOI 10.1095/biolreprod.102.008292
   Jeffay SC, 1996, REPROD TOXICOL, V10, P183, DOI 10.1016/0890-6238(96)00020-2
   Johnson J, 2004, NATURE, V428, P145, DOI 10.1038/nature02316
   Johnson J, 2005, CELL, V122, P303, DOI 10.1016/j.cell.2005.06.031
   Jones KT, 2012, EXP CELL RES, V318, P1394, DOI 10.1016/j.yexcr.2012.02.012
   Jordan Mary Ann, 2008, P47, DOI 10.1007/978-1-59745-336-3_3
   Kingston DGI, 2009, J NAT PROD, V72, P507, DOI 10.1021/np800568j
   Kitajima TS, 2011, CELL, V146, P568, DOI 10.1016/j.cell.2011.07.031
   Kolano A, 2012, P NATL ACAD SCI USA, V109, pE1858, DOI 10.1073/pnas.1204686109
   KOOPMAN P, 1990, NATURE, V348, P450, DOI 10.1038/348450a0
   Kops GJPL, 2005, NAT REV CANCER, V5, P773, DOI 10.1038/nrc1714
   Kuliev Anver, 2003, Reprod Biomed Online, V6, P54
   LAMBEIR A, 1981, J BIOL CHEM, V256, P3279
   Lane SIR, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4444
   Lane SIR, 2012, DEVELOPMENT, V139, P1947, DOI 10.1242/dev.077040
   Lara-Gonzalez P, 2012, CURR BIOL, V22, pR966, DOI 10.1016/j.cub.2012.10.006
   LEETE E, 1963, J AM CHEM SOC, V85, P3666, DOI 10.1021/ja00905a030
   Lei L, 2013, P NATL ACAD SCI USA, V110, P8585, DOI 10.1073/pnas.1306189110
   Leland S, 2009, P NATL ACAD SCI USA, V106, P12776, DOI 10.1073/pnas.0903075106
   Lesmes-Fabian C, 2013, INT J ENV RES PUB HE, V10, P1168, DOI 10.3390/ijerph10041168
   Li HL, 2002, STRUCTURE, V10, P1317, DOI 10.1016/S0969-2126(02)00827-4
   Lightfoot DA, 2006, DEV BIOL, V289, P384, DOI 10.1016/j.ydbio.2005.11.001
   Liu S, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.05.011
   Lodish H, 2003, MICROTUBULES MOL CEL
   LOVELLBADGE R, 1990, DEVELOPMENT, V109, P635
   Lu Y, 2012, PHARM RES-DORDR, V29, P2943, DOI 10.1007/s11095-012-0828-z
   LUDUENA RF, 1977, J BIOL CHEM, V252, P7006
   Luduena RF, 2013, INT REV CEL MOL BIO, V302, P41, DOI 10.1016/B978-0-12-407699-0.00002-9
   Magli MC, 2001, MOL CELL ENDOCRINOL, V183, pS29, DOI 10.1016/S0303-7207(01)00574-3
   MAGNUSON T, 1985, J EXP ZOOL, V236, P353, DOI 10.1002/jez.1402360313
   MAILHES JB, 1994, MUTAGENESIS, V9, P541, DOI 10.1093/mutage/9.6.541
   Mailhes JB, 1999, MUTAT RES-FUND MOL M, V423, P79, DOI 10.1016/S0027-5107(98)00228-0
   Mailhes JB, 2005, CYTOGENET GENOME RES, V111, P384, DOI 10.1159/000086916
   Mailhes JB, 1997, ENVIRON MOL MUTAGEN, V29, P367, DOI 10.1002/(SICI)1098-2280(1997)29:4<367::AID-EM4>3.0.CO;2-7
   MAILHES JB, 1993, ENVIRON MOL MUTAGEN, V22, P107, DOI 10.1002/em.2850220209
   MAILHES JB, 1987, ENVIRON MOL MUTAGEN, V10, P183, DOI 10.1002/em.2850100208
   MAILHES JB, 1993, MUTAT RES, V300, P155, DOI 10.1016/0165-1218(93)90047-H
   MAILHES JB, 1990, MUTAT RES, V242, P89, DOI 10.1016/0165-1218(90)90034-Y
   MAILHES JB, 1987, GAMETE RES, V18, P77, DOI 10.1002/mrd.1120180109
   MAILHES JB, 1988, MUTAT RES, V198, P145, DOI 10.1016/0027-5107(88)90049-8
   MAILHES JB, 1992, MUTAGENESIS, V7, P303, DOI 10.1093/mutage/7.4.303
   Mailhes JB, 2010, EXP REV OBST GYN, V5, P687
   Manandhar G, 2005, BIOL REPROD, V72, P2, DOI 10.1095/biolreprod.104.031245
   Marchetti F, 1999, BIOL REPROD, V61, P948, DOI 10.1095/biolreprod61.4.948
   Marchetti F, 2001, P NATL ACAD SCI USA, V98, P3952, DOI 10.1073/pnas.061404598
   MARCHETTI F, 1992, MUTAT RES, V266, P151, DOI 10.1016/0027-5107(92)90182-2
   MARCHETTI F, 1994, ENVIRON MOL MUTAGEN, V23, P179, DOI 10.1002/em.2850230305
   Marchetti F, 1996, MUTAGENESIS, V11, P195, DOI 10.1093/mutage/11.2.195
   Marchetti F, 2010, CELL CYCLE, V9, P58, DOI 10.4161/cc.9.1.10348
   MARSTON JH, 1964, J EXP ZOOL, V155, P237, DOI 10.1002/jez.1401550211
   Massarotti A, 2012, CHEMMEDCHEM, V7, P33, DOI 10.1002/cmdc.201100361
   Mauro V, 2013, APOPTOSIS, V18, P480, DOI 10.1007/s10495-012-0800-8
   McGulnness BE, 2009, CURR BIOL, V19, P369, DOI 10.1016/j.cub.2009.01.064
   McLaren A, 2003, DEV BIOL, V262, P1, DOI 10.1016/S0012-1606(03)00214-8
   Meng XQ, 2004, J REPROD DEVELOP, V50, P97, DOI 10.1262/jrd.50.97
   Mertzanidou A, 2013, HUM REPROD, V28, P256, DOI 10.1093/humrep/des362
   MIDGLEY AR, 1959, SCIENCE, V130, P40, DOI 10.1126/science.130.3366.40
   Miller HP, 2010, METHOD CELL BIOL, V95, P3, DOI 10.1016/S0091-679X(10)95001-2
   Miller LM, 2010, METHOD CELL BIOL, V95, P105, DOI 10.1016/S0091-679X(10)95007-3
   MONK M, 1981, J EMBRYOL EXP MORPH, V63, P75
   Munne Santiago, 2002, Reprod Biomed Online, V4, P183
   Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163
   Nagaoka SI, 2012, NAT REV GENET, V13, P493, DOI 10.1038/nrg3245
   Nagaoka SI, 2011, CURR BIOL, V21, P651, DOI 10.1016/j.cub.2011.03.003
   Nicolaidis P, 1998, HUM REPROD, V13, P313, DOI 10.1093/humrep/13.2.313
   OECD, 2014, OECD US HDB S
   OECD, 2015, ADV OUTC PATHW MOL S
   Pacchierotti F, 1995, TERATOGEN CARCIN MUT, V15, P217, DOI 10.1002/tcm.1770150502
   Pacchierotti F, 2011, CYTOGENET GENOME RES, V133, P254, DOI 10.1159/000323284
   Panda D, 1996, J BIOL CHEM, V271, P29807, DOI 10.1074/jbc.271.47.29807
   Pepling ME, 1998, DEVELOPMENT, V125, P3323
   Pepling ME, 2001, DEV BIOL, V234, P339, DOI 10.1006/dbio.2001.0269
   Pepling ME, 2006, GENESIS, V44, P622, DOI 10.1002/dvg.20258
   Pepling ME, 2012, REPRODUCTION, V143, P139, DOI 10.1530/REP-11-0299
   PERREAULT SD, 1992, TOXICOL APPL PHARM, V114, P225, DOI 10.1016/0041-008X(92)90072-Z
   Pettit GR, 1998, J MED CHEM, V41, P1688, DOI 10.1021/jm970644q
   Pfender S, 2015, NATURE, V524, P239, DOI 10.1038/nature14568
   Rai SS, 1996, J BIOL CHEM, V271, P14707, DOI 10.1074/jbc.271.25.14707
   Ravelli RBG, 2004, NATURE, V428, P198, DOI 10.1038/nature02393
   Reber S, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a015784
   Risinger AL, 2009, CANCER TREAT REV, V35, P255, DOI 10.1016/j.ctrv.2008.11.001
   Robbins WA, 1997, NAT GENET, V16, P74, DOI 10.1038/ng0597-74
   ROCHDI M, 1992, HUM EXP TOXICOL, V11, P510, DOI 10.1177/096032719201100612
   ROSE D, 1990, CELL, V60, P1009, DOI 10.1016/0092-8674(90)90349-J
   Russell LB, 1976, CHEM MUTAGENS PRINCI, V4, P55
   RUSSO A, 1988, MUTAT RES, V202, P215, DOI 10.1016/0027-5107(88)90185-6
   SALAMANCA F, 1974, ANN GENET-PARIS, V17, P135
   SALMON ED, 1984, J CELL BIOL, V99, P1066, DOI 10.1083/jcb.99.3.1066
   Savoian Matthew S, 2015, J Biomol Tech, V26, P66, DOI 10.7171/jbt.15-2602-004
   SCHILSTRA MJ, 1989, J BIOL CHEM, V264, P8827
   SCHRAMM RD, 1993, BIOL REPROD, V48, P349, DOI 10.1095/biolreprod48.2.349
   Schrodinger L., 2010, PYMOL MOL GRAPHICS S
   Schuh M, 2007, CELL, V130, P484, DOI 10.1016/j.cell.2007.06.025
   SCHULTZ RM, 1977, J CELL SCI, V24, P167
   Sebestova J, 2012, CELL CYCLE, V11, P3011, DOI 10.4161/cc.21398
   Shao H, 2013, J CELL BIOL, V201, P191, DOI 10.1083/jcb.201211041
   Shen Y, 2005, REPROD TOXICOL, V19, P459, DOI 10.1016/j.reprotox.2004.09.007
   SHEU CW, 1992, MUTAT RES, V280, P181, DOI 10.1016/0165-1218(92)90047-4
   Slobodnick A, 2015, AM J MED, V128, P461, DOI 10.1016/j.amjmed.2014.12.010
   SORENSEN RA, 1976, DEV BIOL, V50, P531, DOI 10.1016/0012-1606(76)90172-X
   Stanton RA, 2011, MED RES REV, V31, P443, DOI 10.1002/med.20242
   SUGAWARA S, 1980, CYTOGENET CELL GENET, V28, P251, DOI 10.1159/000131538
   Sun FY, 2005, MUTAGENESIS, V20, P65, DOI 10.1093/mutage/gei010
   TARKOWSKI AK, 1966, CYTOGENETICS, V5, P394, DOI 10.1159/000129914
   Tateno H, 2002, MUTAT RES-FUND MOL M, V502, P1, DOI 10.1016/S0027-5107(02)00021-0
   Tateno H, 2001, MUTAT RES-FUND MOL M, V476, P139, DOI 10.1016/S0027-5107(01)00101-4
   TATENO H, 1995, MUTAT RES-FUND MOL M, V327, P237, DOI 10.1016/0027-5107(94)00192-8
   TEASE C, 1986, MUTAT RES, V173, P31, DOI 10.1016/0165-7992(86)90007-2
   THOMAS G, 1989, EUR J CLIN PHARMACOL, V37, P79
   TIVERON C, 1992, MUTAT RES, V266, P143, DOI 10.1016/0027-5107(92)90181-Z
   Tong C, 2002, BIOL REPROD, V67, P546, DOI 10.1095/biolreprod67.2.546
   TOSO RJ, 1993, BIOCHEMISTRY-US, V32, P1285, DOI 10.1021/bi00056a013
   Vanneste E, 2012, SEMIN REPROD MED, V30, P302, DOI 10.1055/s-0032-1313909
   Vanneste E, 2009, NAT MED, V15, P577, DOI 10.1038/nm.1924
   Verdier-Pinard P, 1998, MOL PHARMACOL, V53, P62
   Villeneuve DL, 2014, TOXICOL SCI, V142, P312, DOI 10.1093/toxsci/kfu199
   Villeneuve DL, 2014, TOXICOL SCI, V142, P321, DOI 10.1093/toxsci/kfu200
   Vinken M, 2013, TOXICOLOGY, V312, P158, DOI 10.1016/j.tox.2013.08.011
   Visagie MH, 2011, CANCER CELL INT, V11, DOI 10.1186/1475-2867-11-43
   WALLACE SL, 1973, METABOLISM, V21, P749, DOI 10.1016/0026-0495(73)90247-3
   WARFIELD RK, 1974, SCIENCE, V186, P1219, DOI 10.1126/science.186.4170.1219
   WARTENBERG H, 1982, ANAT EMBRYOL, V165, P253, DOI 10.1007/BF00305481
   WEISENBE.RC, 1970, BIOCHEMISTRY-US, V9, P4110, DOI 10.1021/bi00823a012
   WEISENBERG RC, 1968, BIOCHEMISTRY-US, V7, P4466, DOI 10.1021/bi00852a043
   White GJ, 1980, VET HUM TOXICOL, V22, P43
   Williams BR, 2009, CANCER RES, V69, P5289, DOI 10.1158/0008-5472.CAN-09-0944
   WILSON L, 1982, J MOL BIOL, V159, P125, DOI 10.1016/0022-2836(82)90035-3
   WILSON L, 1984, J CELL BIOL, V99, P37, DOI 10.1083/jcb.99.1.37
   Xu K, 2002, DRUG DEVELOP RES, V55, P91, DOI 10.1002/ddr.10023
   Xu XL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049303
   Yanagida M, 2005, PHILOS T R SOC B, V360, P609, DOI 10.1098/rstb.2004.1615
   Yao LJ, 2004, BIOL REPROD, V70, P1392, DOI 10.1095/biolreprod.103.025155
   Yao LJ, 2003, CELL MOL BIOL, V49, P399
   Yauk CL, 2015, ENVIRON MOL MUTAGEN, V56, P724, DOI 10.1002/em.21954
   Yauk CL, 2015, MUTAT RES-GEN TOX EN, V783, P36, DOI 10.1016/j.mrgentox.2015.01.008
   Yauk CL, 2013, ENVIRON MOL MUTAGEN, V54, P79, DOI 10.1002/em.21757
   Yauk CL, 2015, ALKYLATION DNA MALE
   Yenjerla M, 2009, J PHARMACOL EXP THER, V328, P390, DOI 10.1124/jpet.108.143537
   Yin S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003516
   Yun Y, 2014, CELL CYCLE, V13, P1938, DOI 10.4161/cc.28897
   ZAVALA F, 1980, J MED CHEM, V23, P546, DOI 10.1021/jm00179a014
NR 207
TC 7
Z9 7
U1 0
U2 14
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0893-6692
EI 1098-2280
J9 ENVIRON MOL MUTAGEN
JI Environ. Mol. Mutagen.
PD MAR
PY 2016
VL 57
IS 2
BP 87
EP 113
DI 10.1002/em.21986
PG 27
WC Environmental Sciences; Genetics & Heredity; Toxicology
SC Environmental Sciences & Ecology; Genetics & Heredity; Toxicology
GA DE0SB
UT WOS:000370333500001
PM 26581746
DA 2019-10-23
ER

PT J
AU Schroeder, AL
   Ankley, GT
   Houck, KA
   Villeneuve, DL
AF Schroeder, Anthony L.
   Ankley, Gerald T.
   Houck, Keith A.
   Villeneuve, Daniel L.
TI Environmental surveillance and monitoringThe next frontiers for
   high-throughput toxicology
SO ENVIRONMENTAL TOXICOLOGY AND CHEMISTRY
LA English
DT Article
DE ToxCast; Tox21; Mixture; Adverse outcome pathway
ID TOXICOGENOMICS; CHEMICALS; SUPPORT; RISK; PROGRAM; UPDATE; TOOLS; ACTOR;
   LINE
AB High-throughput toxicity testing technologies along with the World Wide Web are revolutionizing both generation of and access to data regarding the biological activities that chemicals can elicit when they interact with specific proteins, genes, or other targets in the body of an organism. To date, however, most of the focus has been on the application of such data to assessment of individual chemicals. The authors suggest that environmental surveillance and monitoring represent the next frontiers for high-throughput toxicity testing. Resources already exist in curated databases of chemical-biological interactions, including highly standardized quantitative dose-response data generated from nascent high-throughput toxicity testing programs such as ToxCast and Tox21, to link chemicals detected through environmental analytical chemistry to known biological activities. The emergence of the adverse outcome pathway framework and the associated knowledge base for linking molecular-level or pathway-level perturbations of biological systems to adverse outcomes traditionally considered in risk assessment and regulatory decision-making through a series of measurable biological changes provides a critical link between activity and hazard. Furthermore, environmental samples can be directly analyzed via high-throughput toxicity testing platforms to provide an unprecedented breadth of biological activity characterization that integrates the effects of all compounds present in a mixture, whether known or not. Novel application of these chemical-biological interaction data provides an opportunity to transform scientific characterization of potential hazards associated with exposure to complex mixtures of environmental contaminants. (c) 2016 SETAC
C1 [Schroeder, Anthony L.] Univ Minnesota Twin Cities, Water Resources Ctr, St Paul, MN USA.
   [Schroeder, Anthony L.; Ankley, Gerald T.; Villeneuve, Daniel L.] US EPA, Midcontinent Ecol Div, Natl Hlth & Environm Effects Res Lab, Duluth, MN USA.
   [Houck, Keith A.] US EPA, Natl Ctr Computat Toxicol, Off Res & Dev, Res Triangle Pk, NC USA.
RP Schroeder, AL (reprint author), Univ Minnesota Twin Cities, Water Resources Ctr, St Paul, MN USA.; Schroeder, AL (reprint author), US EPA, Midcontinent Ecol Div, Natl Hlth & Environm Effects Res Lab, Duluth, MN USA.
EM aschroed@umn.edu
RI Houck, Keith/G-8654-2014
OI Houck, Keith/0000-0002-0055-2249
CR Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Becker RA, 2015, REGUL TOXICOL PHARM, V71, P398, DOI 10.1016/j.yrtph.2015.01.008
   Bento AP, 2014, NUCLEIC ACIDS RES, V42, pD1083, DOI 10.1093/nar/gkt1031
   Blake LS, 2010, ENVIRON TOXICOL CHEM, V29, P1367, DOI 10.1002/etc.166
   Broderius SJ, 1991, STP ASTM, V14, P107
   Cavallin JE, 2016, ENVIRON TOXICOL CHEM, V35, P702, DOI 10.1002/etc.3228
   Davis AP, 2015, NUCLEIC ACIDS RES, V43, pD914, DOI 10.1093/nar/gku935
   Egeghy PP, 2012, SCI TOTAL ENVIRON, V414, P159, DOI 10.1016/j.scitotenv.2011.10.046
   Ekman DR, 2013, ENVIRON PRAC, V15, P409, DOI [10.1017/S1466046613000458, 10.1017/0S1466046613000458]
   Fonger GC, 2000, TOXICOL IND HEALTH, V16, P4, DOI 10.1177/074823370001600101
   Ganter B, 2006, PHARMACOGENOMICS, V7, P1025, DOI 10.2217/14622416.7.7.1025
   Igarashi Y, 2015, NUCLEIC ACIDS RES, V43, pD921, DOI 10.1093/nar/gku955
   Judson R, 2008, TOXICOL APPL PHARM, V233, P7, DOI 10.1016/j.taap.2007.12.037
   Judson R, 2009, ENVIRON HEALTH PERSP, V117, P685, DOI 10.1289/ehp.0800168
   Judson RS, 2012, INT J MOL SCI, V13, P1805, DOI 10.3390/ijms13021805
   Judson RS, 2010, ENVIRON HEALTH PERSP, V118, P485, DOI 10.1289/ehp.0901392
   Kahl MD, 2014, ENVIRON TOXICOL CHEM, V33, P1584, DOI 10.1002/etc.2591
   Kavlock R, 2012, CHEM RES TOXICOL, V25, P1287, DOI 10.1021/tx3000939
   Kuhn M, 2014, NUCLEIC ACIDS RES, V42, pD401, DOI 10.1093/nar/gkt1207
   LaLone CA, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2014.0022
   LaLone CA, 2013, AQUAT TOXICOL, V144, P141, DOI 10.1016/j.aquatox.2013.09.004
   Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939
   Lee KE, 2015, CHEM EMERING CONCERN
   Martin MT, 2010, CHEM RES TOXICOL, V23, P578, DOI 10.1021/tx900325g
   Martinovic-Weigelt D, 2014, ENVIRON SCI TECHNOL, V48, P2385, DOI 10.1021/es404027n
   National Research Council, 2007, TOX TEST 21 CENT VIS
   Society for Advancement of Adverse Outcome Pathways, 2014, AOP KNOWL BAS
   Tang JYM, 2013, WATER RES, V47, P3300, DOI 10.1016/j.watres.2013.03.011
   Tice RR, 2013, ENVIRON HEALTH PERSP, V121, P756, DOI 10.1289/ehp.1205784
   Wang YL, 2014, NUCLEIC ACIDS RES, V42, pD1075, DOI 10.1093/nar/gkt978
   Waters M, 2008, NUCLEIC ACIDS RES, V36, pD892, DOI 10.1093/nar/gkm755
   Weller MG, 2012, SENSORS-BASEL, V12, P9181, DOI 10.3390/s120709181
   Wishart D, 2015, NUCLEIC ACIDS RES, V43, pD928, DOI 10.1093/nar/gku1004
NR 33
TC 32
Z9 33
U1 0
U2 32
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0730-7268
EI 1552-8618
J9 ENVIRON TOXICOL CHEM
JI Environ. Toxicol. Chem.
PD MAR
PY 2016
VL 35
IS 3
BP 513
EP 525
DI 10.1002/etc.3309
PG 13
WC Environmental Sciences; Toxicology
SC Environmental Sciences & Ecology; Toxicology
GA DF6YY
UT WOS:000371505800001
PM 26923854
DA 2019-10-23
ER

PT J
AU Cavallin, JE
   Jensen, KM
   Kahl, MD
   Villeneuve, DL
   Lee, KE
   Schroeder, AL
   Mayasich, J
   Eid, EP
   Nelson, KR
   Milsk, RY
   Blackwell, BR
   Berninger, JP
   LaLone, CA
   Blanksma, C
   Jicha, T
   Elonen, C
   Johnson, R
   Ankley, GT
AF Cavallin, Jenna E.
   Jensen, Kathleen M.
   Kahl, Michael D.
   Villeneuve, Daniel L.
   Lee, Kathy E.
   Schroeder, Anthony L.
   Mayasich, Joe
   Eid, Evan P.
   Nelson, Krysta R.
   Milsk, Rebecca Y.
   Blackwell, Brett R.
   Berninger, Jason P.
   LaLone, Carlie A.
   Blanksma, Chad
   Jicha, Terri
   Elonen, Colleen
   Johnson, Rodney
   Ankley, Gerald T.
TI PATHWAY-BASED APPROACHES FOR ASSESSMENT OF REAL-TIME EXPOSURE TO AN
   ESTROGENIC WASTEWATER TREATMENT PLANT EFFLUENT ON FATHEAD MINNOW
   REPRODUCTION
SO ENVIRONMENTAL TOXICOLOGY AND CHEMISTRY
LA English
DT Article
DE Wastewater treatment plant; Fish; Reproduction; Estrogens
ID ENDOCRINE-DISRUPTING CHEMICALS; ACTIVATION ASSAY T47D-KBLUC;
   PIMEPHALES-PROMELAS; IN-VITRO; METABOLIZING ENZYMES; PIPERONYL BUTOXIDE;
   STEROID ESTROGENS; STABLY EXPRESSES; OXIDATIVE STRESS; GENE-EXPRESSION
AB Wastewater treatment plant (WWTP) effluents are known contributors of chemical mixtures into the environment. Of particular concern are endocrine-disrupting compounds, such as estrogens, which can affect the hypothalamic-pituitary-gonadal axis function in exposed organisms. The present study examined reproductive effects in fathead minnows exposed for 21 d to a historically estrogenic WWTP effluent. Fathead minnow breeding pairs were held in control water or 1 of 3 effluent concentrations (5%, 20%, and 100%) in a novel onsite, flow-through system providing real-time exposure. The authors examined molecular and biochemical endpoints representing key events along adverse outcome pathways linking estrogen receptor activation and other molecular initiating events to reproductive impairment. In addition, the authors used chemical analysis of the effluent to construct a chemical-gene interaction network to aid in targeted gene expression analyses and identifying potentially impacted biological pathways. Cumulative fecundity was significantly reduced in fish exposed to 100% effluent but increased in those exposed to 20% effluent, the approximate dilution factor in the receiving waters. Plasma vitellogenin concentrations in males increased in a dose-dependent manner with effluent concentration; however, male fertility was not impacted. Although in vitro analyses, analytical chemistry, and biomarker responses confirmed the effluent was estrogenic, estrogen receptor agonists were unlikely the primary driver of impaired reproduction. The results provide insights into the significance of pathway-based effects with regard to predicting adverse reproductive outcomes. Published 2015 by Wiley Periodicals Inc. on behalf of SETAC. This article is a US Government work, and as such, is in the public domain in the United States of America.
C1 [Cavallin, Jenna E.; Milsk, Rebecca Y.; Blackwell, Brett R.] US EPA, ORISE Res Participat Program, Off Res & Dev, Natl Hlth & Environm Effects Res Lab,Midcontinent, Duluth, MN USA.
   [Cavallin, Jenna E.] Univ Minnesota, Integrated Biosci Grad Program, Duluth, MN 55812 USA.
   [Jensen, Kathleen M.; Kahl, Michael D.; Villeneuve, Daniel L.; Eid, Evan P.; Nelson, Krysta R.; Berninger, Jason P.; LaLone, Carlie A.; Jicha, Terri; Elonen, Colleen; Johnson, Rodney; Ankley, Gerald T.] US EPA, Off Res & Dev, Natl Hlth & Environm Effects Res Lab, Midcontinent Ecol Div, Duluth, MN USA.
   [Lee, Kathy E.] US Geol Survey, Tox Subst Hydrol Program, Grand Rapids, MI USA.
   [Schroeder, Anthony L.] Univ Minnesota, Water Resources Ctr, Natl Hlth & Environm Effects Res Lab,Midcontinent, US Environm Protect Agcy,Off Res & Dev, Duluth, MN 55812 USA.
   [Mayasich, Joe] Western Lake Super Sanit Dist, Duluth, MN USA.
   [Blanksma, Chad] US EPA, Badger Tech Serv, Off Res & Dev, Natl Hlth & Environm Effects Res Lab,Mid Continen, Duluth, MN USA.
RP Cavallin, JE (reprint author), US EPA, ORISE Res Participat Program, Off Res & Dev, Natl Hlth & Environm Effects Res Lab,Midcontinent, Duluth, MN USA.; Cavallin, JE (reprint author), Univ Minnesota, Integrated Biosci Grad Program, Duluth, MN 55812 USA.
EM cavallin.jenna@epa.gov
RI Berninger, Jason/O-2401-2016
OI Berninger, Jason/0000-0003-3045-7899; Blackwell,
   Brett/0000-0003-1296-4539
FU University of Minnesota-US Environmental Protection Agency Cooperative
   Training Partnership
FX We thank the staff and management at the Western Lake Superior Sanitary
   District. Additional technical support was provided by A. Parrella
   (Western Lake Superior Sanitary District), K. Lott (Badger Technical
   Services), F. Whiteman, M. Lee, M. Hughes, E. Randolph, T. Saari
   (USEPA), and S. Robinson (USEPA GRO intern). We also thank members of
   the US Geological Survey National Water Quality Laboratory, who
   conducted the analytical measurements of the water samples and S. Langer
   for assistance with water sample coordination. We thank D. Mount for
   reviewing an earlier draft of the present study. J. Cavallin was
   supported in part by the University of Minnesota-US Environmental
   Protection Agency Cooperative Training Partnership.
CR Aerni HR, 2004, ANAL BIOANAL CHEM, V378, P688, DOI 10.1007/s00216-003-2276-4
   American Public Health Association, 1998, STANDARD METHODS EXA
   Ankley GT, 2007, ENVIRON TOXICOL CHEM, V26, P1214, DOI 10.1897/06-428R.1
   Ankley GT, 2015, TOXICOL SCI, V144, P259, DOI 10.1093/toxsci/kfu320
   Ankley GT, 2014, ENVIRON TOXICOL CHEM, V33, P2529, DOI 10.1002/etc.2708
   Ankley GT, 2001, ENVIRON TOXICOL CHEM, V20, P1276, DOI 10.1002/etc.5620200616
   Atekwana EA, 2004, J APPL GEOPHYS, V56, P281, DOI 10.1016/j.jappgeo.2004.08.003
   Basu NK, 2004, J BIOL CHEM, V279, P28320, DOI 10.1074/jbc.M401396200
   Bermudez DS, 2012, INT J ANDROL, V35, P397, DOI 10.1111/j.1365-2605.2012.01278.x
   Bermudez DS, 2010, TOXICOL SCI, V116, P477, DOI 10.1093/toxsci/kfq156
   Bole-Feysot C, 1998, ENDOCR REV, V19, P225, DOI 10.1210/er.19.3.225
   Borst P, 1999, BBA-BIOMEMBRANES, V1461, P347, DOI 10.1016/S0005-2736(99)00167-4
   Braga O, 2005, ENVIRON SCI TECHNOL, V39, P3351, DOI 10.1021/es0501767
   Brooks BW, 2006, HYDROBIOLOGIA, V556, P365, DOI 10.1007/s10750-004-0189-7
   BRUNGS WA, 1971, J FISH RES BOARD CAN, V28, P1119, DOI 10.1139/f71-166
   Burns FR, 2016, ENVIRON TOXICOL CHEM, V35, P212, DOI 10.1002/etc.3186
   Caldwell DJ, 2008, ENVIRON SCI TECHNOL, V42, P7046, DOI 10.1021/es800633q
   Caldwell DJ, 2012, ENVIRON TOXICOL CHEM, V31, P1396, DOI 10.1002/etc.1825
   Carey RO, 2009, ENVIRON MANAGE, V44, P205, DOI 10.1007/s00267-009-9309-5
   Cavallin JE, 2014, ENVIRON TOXICOL CHEM, V33, P1849, DOI 10.1002/etc.2627
   Corsi SR, 2011, SCI TOTAL ENVIRON, V409, P4847, DOI 10.1016/j.scitotenv.2011.08.014
   Crissman JW, 2004, TOXICOL PATHOL, V32, P126, DOI 10.1080/01926230490268756
   Davis AP, 2013, NUCLEIC ACIDS RES, V41, pD1104, DOI 10.1093/nar/gks994
   Davis JM, 2013, ENVIRON SCI TECHNOL, V47, P10628, DOI 10.1021/es401961j
   Diani-Moore S, 2006, DRUG METAB DISPOS, V34, P1376, DOI 10.1124/dmd.106.009498
   Field JA, 1996, ENVIRON SCI TECHNOL, V30, P3544, DOI 10.1021/es960191z
   Filby AL, 2007, ENVIRON SCI TECHNOL, V41, P8187, DOI 10.1021/es071278v
   Foreman WT, 2012, METHODS NWQL B, V5
   Freeman ME, 2000, PHYSIOL REV, V80, P1523
   Furlong ET, 2014, METHODS NATL WATER B, V5
   Giessmann T, 2004, CLIN PHARMACOL THER, V76, P192, DOI 10.1016/j.clpt.2004.04.011
   Goasduff T, 1996, BIOCHEM PHARMACOL, V52, P1915, DOI 10.1016/S0006-2952(96)00522-9
   Guillette LJ, 2001, REPRODUCTION, V122, P857, DOI 10.1530/reprod/122.6.857
   Harries JE, 2000, ENVIRON SCI TECHNOL, V34, P3003, DOI 10.1021/es991292a
   Hotchkiss AK, 2008, TOXICOL SCI, V105, P235, DOI 10.1093/toxsci/kfn030
   Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923
   Jensen KM, 2001, COMP BIOCHEM PHYS C, V128, P127, DOI 10.1016/S1532-0456(00)00185-X
   Jobling S, 1996, ENVIRON TOXICOL CHEM, V15, P194, DOI 10.1002/etc.5620150218
   JOBLING S, 1993, AQUAT TOXICOL, V27, P361, DOI 10.1016/0166-445X(93)90064-8
   Johnson R, 2009, SERIES TESTING ASSES, V123, P14
   Joubert BR, 2012, ENVIRON HEALTH PERSP, V120, P1425, DOI 10.1289/ehp.1205412
   Kahl MD, 2014, ENVIRON TOXICOL CHEM, V33, P1584, DOI 10.1002/etc.2591
   Kavanagh RJ, 2011, AQUAT TOXICOL, V101, P214, DOI 10.1016/j.aquatox.2010.09.021
   Kidd KA, 2007, P NATL ACAD SCI USA, V104, P8897, DOI 10.1073/pnas.0609568104
   Korte JJ, 2000, ENVIRON TOXICOL CHEM, V19, P972, DOI 10.1002/etc.5620190426
   Kuhn M, 2008, NUCLEIC ACIDS RES, V36, pD684, DOI 10.1093/nar/gkm795
   Lepine J, 2004, J CLIN ENDOCR METAB, V89, P5222, DOI 10.1210/jc.2004-0331
   Leusch FDL, 2010, ENVIRON SCI TECHNOL, V44, P3853, DOI 10.1021/es903899d
   Liu ZH, 2010, WATER RES, V44, P567, DOI 10.1016/j.watres.2009.03.025
   Long Y, 2011, COMP BIOCHEM PHYS C, V153, P381, DOI 10.1016/j.cbpc.2011.01.002
   Martinovic D, 2008, ENVIRON SCI TECHNOL, V42, P3421, DOI 10.1021/es0708013
   Martinovic D, 2007, ENVIRON TOXICOL CHEM, V26, P271, DOI 10.1897/06-065R.1
   Martinovic-Weigelt D, 2014, ENVIRON SCI TECHNOL, V48, P2385, DOI 10.1021/es404027n
   McMaster ME, 1995, CAN TECH REP FISH AQ, P1
   Milkiewicz P, 2003, GUT, V52, P300, DOI 10.1136/gut.52.2.300
   Miranda ACL, 1999, TISSUE CELL, V31, P480, DOI 10.1054/tice.1999.0045
   Muguruma M, 2007, TOXICOLOGY, V236, P61, DOI 10.1016/j.tox.2007.03.025
   Nebert DW, 2000, BIOCHEM PHARMACOL, V59, P65, DOI 10.1016/S0006-2952(99)00310-X
   Oscarson M, 2006, CLIN PHARMACOL THER, V80, P440, DOI 10.1016/j.clpt.2006.08.013
   Parks LG, 1999, COMP BIOCHEM PHYS C, V123, P113, DOI 10.1016/S0742-8413(99)00010-9
   Patino R, 2002, FISH PHYSIOL BIOCHEM, V26, P57, DOI 10.1023/A:1023311613987
   Pawlowski S, 2004, ECOTOX ENVIRON SAFE, V57, P330, DOI 10.1016/j.ecoenv.2003.07.019
   Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476
   Price RJ, 2004, FOOD CHEM TOXICOL, V42, P899, DOI 10.1016/j.fct.2004.01.013
   Puntarulo S, 1998, FREE RADICAL BIO MED, V24, P1324, DOI 10.1016/S0891-5849(97)00463-2
   Ryu DY, 1997, CHEM-BIOL INTERACT, V105, P53, DOI 10.1016/S0009-2797(97)00035-5
   Samer CF, 2010, BRIT J PHARMACOL, V160, P919, DOI 10.1111/j.1476-5381.2010.00709.x
   Shappell NW, 2010, AQUAT TOXICOL, V100, P1, DOI 10.1016/j.aquatox.2010.07.005
   Skolness SY, 2013, TOXICOL SCI, V132, P284, DOI 10.1093/toxsci/kft010
   SUMPTER JP, 1995, ENVIRON HEALTH PERSP, V103, P173, DOI 10.2307/3432529
   Sun GB, 2006, TOXICOL LETT, V164, P44, DOI 10.1016/j.toxlet.2005.11.015
   Sun QF, 2008, ENVIRON TOXICOL PHAR, V25, P20, DOI 10.1016/j.etap.2007.08.003
   Thorpe KL, 2007, AQUAT TOXICOL, V85, P176, DOI 10.1016/j.aquatox.2007.08.012
   THURSTON RV, 1986, T AM FISH SOC, V115, P196, DOI 10.1577/1548-8659(1986)115<196:CTOATF>2.0.CO;2
   Thurston RV, 1979, EPA600379091
   Tilton F, 2002, AQUAT TOXICOL, V61, P211, DOI 10.1016/S0166-445X(02)00058-9
   Tollefsen KE, 2008, ECOTOX ENVIRON SAFE, V69, P163, DOI 10.1016/j.ecoenv.2007.04.010
   U.S. Environmental Protection Agency, 2013, TECHNICAL REPORT
   US Environmental Protection Agency, 2005, 68W01023 EPA
   US Environmental Protection Agency, 2011, TECHNICAL REPORT
   US EPA, 2002, TECHNICAL REPORT
   US EPA, 1987, TECHNICAL REPORT
   Van den Belt K, 2004, AQUAT TOXICOL, V66, P183, DOI 10.1016/j.aquatox.2003.09.004
   Villeneuve DL, 2007, TOXICOL SCI, V98, P395, DOI 10.1093/toxsci/kfm124
   Wehmas LC, 2011, ENVIRON TOXICOL CHEM, V30, P439, DOI 10.1002/etc.388
   Whyte JJ, 2000, CRIT REV TOXICOL, V30, P347, DOI 10.1080/10408440091159239
   Wilson VS, 2004, TOXICOL SCI, V81, P69, DOI 10.1093/toxsci/kfh180
   Wilson VS, 2002, TOXICOL SCI, V66, P69, DOI 10.1093/toxsci/66.1.69
   You L, 2004, CHEM-BIOL INTERACT, V147, P233, DOI 10.1016/j.cbi.2004.01.006
   Zaugg SD, 2006, METHODS NATL WATER B, V5
NR 90
TC 19
Z9 19
U1 1
U2 40
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0730-7268
EI 1552-8618
J9 ENVIRON TOXICOL CHEM
JI Environ. Toxicol. Chem.
PD MAR
PY 2016
VL 35
IS 3
BP 702
EP 716
DI 10.1002/etc.3228
PG 15
WC Environmental Sciences; Toxicology
SC Environmental Sciences & Ecology; Toxicology
GA DF6YY
UT WOS:000371505800019
PM 26332155
DA 2019-10-23
ER

PT J
AU Collier, ZA
   Gust, KA
   Gonzalez-Morales, B
   Gong, P
   Wilbanks, MS
   Linkov, I
   Perkins, EJ
AF Collier, Zachary A.
   Gust, Kurt A.
   Gonzalez-Morales, Benette
   Gong, Ping
   Wilbanks, Mitchell S.
   Linkov, Igor
   Perkins, Edward J.
TI A weight of evidence assessment approach for adverse outcome pathways
SO REGULATORY TOXICOLOGY AND PHARMACOLOGY
LA English
DT Article
DE Adverse outcome pathway; Weight of evidence; Quantitative AOP; Molecular
   initiating event; Mode of action; Key event relationships; Bradford Hill
   criteria
ID PROLIFERATOR-ACTIVATED RECEPTOR; GAMMA-AMINOBUTYRIC-ACID; BOBWHITE
   COLINUS-VIRGINIANUS; BRADFORD-HILL CONSIDERATIONS; PALMITOYLTRANSFERASE
   I GENE; NUCLEAR HORMONE-RECEPTORS; CEREBELLAR GRANULE CELLS; OF-EVIDENCE
   FRAMEWORK; PPAR-ALPHA; NORTHERN BOBWHITE
AB The adverse outcome pathway (AOP) is a framework to mechanistically link molecular initiating events to adverse biological outcomes. From a regulatory perspective, it is of crucial importance to determine the confidence for the AOP in question as well as the quality of data available in supporting this evaluation. A weight of evidence approach has been proposed for this task, but many of the existing frameworks for weight of evidence evaluation are qualitative and there is not clear guidance regarding how weight of evidence should be calculated for an AOP. In this paper we advocate the use of a subject matter expertise driven approach for weight of evidence evaluation based on criteria and metrics related to data quality and the strength of causal linkages between key events. As a demonstration, we notionally determine weight of evidence scores for two AOPs: Non-competitive ionotropic GABA receptor antagonism leading to epileptic seizures, and Antagonist-binding and stabilization of a co-repressor to the peroxisome proliferator-activated receptor alpha (PPAR alpha) signaling complex ultimately causing starvation like weight loss. Published by Elsevier Ltd.
C1 [Collier, Zachary A.; Gust, Kurt A.; Gong, Ping; Wilbanks, Mitchell S.; Linkov, Igor; Perkins, Edward J.] US Army Engineer Res & Dev Ctr, Environm Lab, Vicksburg, MS USA.
   [Gonzalez-Morales, Benette] Univ Puerto Rico, Mayaguez, PR USA.
RP Collier, ZA (reprint author), 3909 Halls Ferry Rd, Vicksburg, MS 39180 USA.
EM zac4nf@virginia.edu
RI Leite, Paulo Emilio C/N-3443-2013
OI Leite, Paulo Emilio C/0000-0002-1783-1228
FU US Army Environmental Quality/Installations (EQ/I) research program
FX This work was funded by the US Army Environmental Quality/Installations
   (EQ/I) research program. Permission was granted by the Chief of
   Engineers to publish this material. The views and opinions expressed in
   this paper are those of the individual authors and not those of the U.S.
   Army, or other sponsor organizations.
CR Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Ankley GT, 1998, SETAC TECH PUBLICAT, P349
   AOP-Wiki, 2014, US HDB SUPPL GUID DO
   Aoyama T, 1998, J BIOL CHEM, V273, P5678, DOI 10.1074/jbc.273.10.5678
   Babot Z, 2007, J NEUROSCI RES, V85, P3687, DOI 10.1002/jnr.21433
   Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002
   Balls M, 2006, ATLA-ALTERN LAB ANIM, V34, P603, DOI 10.1177/026119290603400604
   Becker RA, 2015, REGUL TOXICOL PHARM, V72, P514, DOI 10.1016/j.yrtph.2015.04.004
   Belton V., 2002, MULTIPLE CRITERIA DE
   Boobis AR, 2008, CRIT REV TOXICOL, V38, P87, DOI 10.1080/10408440701749421
   Boobis AR, 2006, CRIT REV TOXICOL, V36, P781, DOI 10.1080/10408440600977677
   Bottomley PA, 2000, J MARKETING RES, V37, P508, DOI 10.1509/jmkr.37.4.508.18794
   Brandt JM, 1998, J BIOL CHEM, V273, P23786, DOI 10.1074/jbc.273.37.23786
   Bromfield E. B., 2006, BASIC MECH UNDERLYIN
   Buckingham SD, 2005, MOL PHARMACOL, V68, P942, DOI 10.1124/mol.105.015313
   Burton GA, 2002, HUM ECOL RISK ASSESS, V8, P1675, DOI 10.1080/20028091056854
   Cahill GF, 2006, ANNU REV NUTR, V26, P1, DOI 10.1146/annurev.nutr.26.061505.111258
   Chapman PM, 2002, HUM ECOL RISK ASSESS, V8, P1489, DOI 10.1080/20028091057457
   Chebib M, 1999, CLIN EXP PHARMACOL P, V26, P937, DOI 10.1046/j.1440-1681.1999.03151.x
   Chen LG, 2006, P NATL ACAD SCI USA, V103, P5185, DOI 10.1073/pnas.0600370103
   Coo H, 2004, NEUROEPIDEMIOLOGY, V23, P1, DOI 10.1159/000073969
   Deng YP, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-S11-S1
   Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649
   DICHTER MA, 1987, SCIENCE, V237, P157, DOI 10.1126/science.3037700
   DREYER C, 1992, CELL, V68, P879, DOI 10.1016/0092-8674(92)90031-7
   Evans RM, 2004, NAT MED, V10, P355, DOI 10.1038/nm1025
   FELIG P, 1970, AM J CLIN NUTR, V23, P986
   FELIG P, 1970, SCIENCE, V167, P1003, DOI 10.1126/science.167.3920.1003
   Forbes VE, 2002, HUM ECOL RISK ASSESS, V8, P1625, DOI 10.1080/20028091057529
   GALLO V, 1985, J NEUROSCI, V5, P2432
   Garcia-Reyero N, 2011, ECOTOXICOLOGY, V20, P580, DOI 10.1007/s10646-011-0623-3
   Gong P, 2007, ENVIRON TOXICOL CHEM, V26, P954, DOI 10.1897/06-361R.1
   Gong P, 2015, BIOMARK MED, V9, P1225, DOI 10.2217/bmm.15.58
   Good I.J., 1985, BAYESIAN STATISTICS, V2, P249
   GOOD IJ, 1960, J ROY STAT SOC B, V22, P319
   GOODMAN AD, 1966, J CLIN INVEST, V45, P612, DOI 10.1172/JCI105375
   Gough D, 2007, APPL PRACTICE BASED, V22, P213, DOI DOI 10.1080/02671520701296189
   Grapentine L, 2002, HUM ECOL RISK ASSESS, V8, P1549, DOI 10.1080/20028091057475
   GULICK T, 1994, P NATL ACAD SCI USA, V91, P11012, DOI 10.1073/pnas.91.23.11012
   Gust K.A., 2015, P INT S SUST SYST TE, DOI [http://dx.doi.org/10.6084/m9.figshare.1517802, DOI 10.6084/M9.FIGSHARE.1517802]
   Gust KA, 2011, ENVIRON TOXICOL CHEM, V30, P1852, DOI 10.1002/etc.558
   Gust KA, 2011, AQUAT TOXICOL, V101, P135, DOI 10.1016/j.aquatox.2010.09.011
   Gust KA, 2009, TOXICOL SCI, V110, P168, DOI 10.1093/toxsci/kfp091
   HABLITZ JJ, 1984, J NEUROPHYSIOL, V51, P1011
   Hertzberg RC, 2002, ENVIRON HEALTH PERSP, V110, P965, DOI 10.1289/ehp.02110s6965
   HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503
   Hristozov DR, 2014, NANOTOXICOLOGY, V8, P72, DOI 10.3109/17435390.2012.750695
   Johnson MS, 2007, ENVIRON TOXICOL CHEM, V26, P1481, DOI 10.1897/06-525.1
   Juarez E. H., 2014, Autonomic & Autacoid Pharmacology, V34, P1, DOI 10.1111/aap.12016
   KASHIWAYA Y, 1994, J BIOL CHEM, V269, P25502
   Keeney RL, 2005, OPER RES, V53, P1, DOI 10.1287/opre.1040.0158
   Kersten S, 2014, MOL METAB, V3, P354, DOI 10.1016/j.molmet.2014.02.002
   Kramer VJ, 2011, ENVIRON TOXICOL CHEM, V30, P64, DOI 10.1002/etc.375
   KUFFLER SW, 1958, J NEUROPHYSIOL, V21, P589
   LAZAROW PB, 1978, J BIOL CHEM, V253, P1522
   Linkov I, 2015, ALTEX-ALTERN ANIM EX, V32, P3, DOI 10.14573/altex.1412231
   Linkov I, 2011, RISK ANAL, V31, P1211, DOI 10.1111/j.1539-6924.2011.01585.x
   Linkov I, 2009, SCI TOTAL ENVIRON, V407, P5199, DOI 10.1016/j.scitotenv.2009.05.004
   MANNAERTS GP, 1993, PEROXISOMES BIOL IMP, P19
   MARTIN TE, 1987, ANNU REV ECOL SYST, V18, P453, DOI 10.1146/annurev.es.18.110187.002321
   Mascaro C, 1998, J BIOL CHEM, V273, P8560, DOI 10.1074/jbc.273.15.8560
   McDonald BG, 2007, INTEGR ENVIRON ASSES, V3, P476, DOI 10.1897/IEAM_2007-017.1
   McKay S. K., 2012, TNEMRRPEBA1216 ERDC
   Meek ME, 2014, J APPL TOXICOL, V34, P595, DOI 10.1002/jat.2984
   Menzie C, 1996, HUM ECOL RISK ASSESS, V2, P277, DOI 10.1080/10807039609383609
   Michels G, 2007, CRIT REV BIOCHEM MOL, V42, P3, DOI 10.1080/10409230601146219
   Miura M, 1997, J NEUROPHYSIOL, V78, P2269
   Nagy L, 1999, GENE DEV, V13, P3209, DOI 10.1101/gad.13.24.3209
   NEWLAND CF, 1992, J PHYSIOL-LONDON, V447, P191, DOI 10.1113/jphysiol.1992.sp018998
   Nisbet RM, 2000, J ANIM ECOL, V69, P913, DOI 10.1046/j.1365-2656.2000.00448.x
   OECD, 2013, OECD ENV HLTH SAF PU, V184
   Olsen RW, 2009, NEUROPHARMACOLOGY, V56, P141, DOI 10.1016/j.neuropharm.2008.07.045
   Owen OE, 2005, BIOCHEM MOL BIOL EDU, V33, P246, DOI 10.1002/bmb.2005.49403304246
   Patlewicz G, 2015, REGUL TOXICOL PHARM, V71, P463, DOI 10.1016/j.yrtph.2015.02.011
   Pawson R., 2003, 18 ESRC UK CTR EV BA
   Potthoff MJ, 2009, P NATL ACAD SCI USA, V106, P10853, DOI 10.1073/pnas.0904187106
   Quinn MJ, 2013, ECOTOXICOLOGY, V22, P231, DOI 10.1007/s10646-012-1019-8
   Quinn MJ, 2009, ENVIRON TOXICOL CHEM, V28, P1266, DOI 10.1897/08-418.1
   Roberts M, 2009, EVALUATION SCI LIT H
   Robinson PA, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.041924
   Russom CL, 2014, ENVIRON TOXICOL CHEM, V33, P2157, DOI 10.1002/etc.2662
   Saaty T.L., 1980, ANAL HIERARCHY PROCE
   Sanderson LM, 2010, PHYSIOL GENOMICS, V41, P42, DOI 10.1152/physiolgenomics.00127.2009
   Sengupta S, 2010, NATURE, V468, P1100, DOI 10.1038/nature09584
   SQUIRES RF, 1984, LIFE SCI, V35, P1439, DOI 10.1016/0024-3205(84)90159-0
   Staples CA, 2002, HUM ECOL RISK ASSESS, V8, P1083, DOI 10.1080/1080-700291905837
   STILLWELL WG, 1981, ORGAN BEHAV HUM PERF, V28, P62, DOI 10.1016/0030-5073(81)90015-5
   Suter GW, 2011, SCI TOTAL ENVIRON, V409, P1406, DOI 10.1016/j.scitotenv.2010.12.029
   Swaen G, 2009, J CLIN EPIDEMIOL, V62, P270, DOI 10.1016/j.jclinepi.2008.06.013
   Tardiff RG, 2006, REGUL TOXICOL PHARM, V45, P185, DOI 10.1016/j.yrtph.2006.03.001
   U. S. EPA, 2003, SUMM GEN ASS FACT EV
   US EPA, 2011, WEIGHT EV EV RES EDS
   Villeneuve DL, 2014, TOXICOL SCI, V142, P312, DOI 10.1093/toxsci/kfu199
   Villeneuve DL, 2014, TOXICOL SCI, V142, P321, DOI 10.1093/toxsci/kfu200
   Villeneuve DL, 2011, ENVIRON TOXICOL CHEM, V30, P1, DOI 10.1002/etc.396
   Vinken M, 2013, TOXICOL SCI, V136, P97, DOI 10.1093/toxsci/kft177
   Von Winterfeldt D., 1986, DECISION ANAL BEHAV
   Warner CM, 2012, ENVIRON SCI TECHNOL, V46, P7790, DOI 10.1021/es300495c
   Watanabe M, 2002, INT REV CYTOL, V213, P1
   Weed DL, 2005, RISK ANAL, V25, P1545, DOI 10.1111/j.1539-6924.2005.00699.x
   Williams LR, 2011, ENVIRON HEALTH PERSP, V119, P357, DOI 10.1289/ehp.1002588
   Xu HE, 2002, NATURE, V415, P813, DOI 10.1038/415813a
NR 102
TC 14
Z9 15
U1 2
U2 25
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0273-2300
EI 1096-0295
J9 REGUL TOXICOL PHARM
JI Regul. Toxicol. Pharmacol.
PD MAR
PY 2016
VL 75
BP 46
EP 57
DI 10.1016/j.yrtph.2015.12.014
PG 12
WC Medicine, Legal; Pharmacology & Pharmacy; Toxicology
SC Legal Medicine; Pharmacology & Pharmacy; Toxicology
GA DE5NF
UT WOS:000370677000006
PM 26724267
DA 2019-10-23
ER

PT J
AU Vietti, G
   Lison, D
   van den Brule, S
AF Vietti, Giulia
   Lison, Dominique
   van den Brule, Sybille
TI Mechanisms of lung fibrosis induced by carbon nanotubes: towards an
   Adverse Outcome Pathway (AOP)
SO PARTICLE AND FIBRE TOXICOLOGY
LA English
DT Review
DE Carbon nanotube; Lung fibrosis; AOP; Fibroblast; Macrophage; Epithelial
   cell; Mechanisms
ID IN-VITRO; INHALATION EXPOSURE; PULMONARY TOXICITY; OXIDATIVE STRESS; RAT
   LUNG; INFLAMMASOME ACTIVATION; CROCIDOLITE ASBESTOS; FIBROGENIC
   RESPONSE; FIBROTIC RESPONSE; EPITHELIAL-CELLS
AB Several experimental studies have shown that carbon nanotubes (CNT) can induce respiratory effects, including lung fibrosis. The cellular and molecular events through which these effects develop are, however, not clearly elucidated. The purpose of the present review was to analyze the key events involved in the lung fibrotic reaction induced by CNT and to assess their relationships. We thus address current knowledge and gaps with a view to draft an Adverse Outcome Pathway (AOP) concerning the fibrotic potential of CNT.
   As for many inhaled particles, CNT can indirectly activate fibroblasts through the release of pro-inflammatory (IL-1 beta) and pro-fibrotic (PDGF and TGF-beta) mediators by inflammatory cells (macrophages and epithelial cells) via the induction of oxidative stress, inflammasome or NF-kappa B. We also highlight here direct effects of CNT on fibroblasts, which appear as a new mode of toxicity relatively specific for CNT. Direct effects of CNT on fibroblasts include the induction of fibroblast proliferation, differentiation and collagen production via ERK 1/2 or Smad signaling. We also point out the physico-chemical properties of CNT important for their toxicity and the relationship between in vitro and in vivo effects. This knowledge provides evidence to draft an AOP for the fibrogenic activity of CNT, which allows developing simple in vitro models contributing to predict the CNT effects in lung fibrosis, and risk assessment tools for regulatory decision.
C1 [Vietti, Giulia; Lison, Dominique; van den Brule, Sybille] Catholic Univ Louvain, Louvain Ctr Toxicol & Appl Pharmacol, Ave E Mounier,52 Bte B1-52-12, B-1200 Brussels, Belgium.
RP Vietti, G (reprint author), Catholic Univ Louvain, Louvain Ctr Toxicol & Appl Pharmacol, Ave E Mounier,52 Bte B1-52-12, B-1200 Brussels, Belgium.
EM giulia.vietti@uclouvain.be
OI Lison, Dominique/0000-0001-6557-2518
FU Fonds de la Recherche Scientifique (FNRS), BelgiumFonds de la Recherche
   Scientifique - FNRS
FX Giulia Vietti is a Research Fellow of the Fonds de la Recherche
   Scientifique (FNRS), Belgium.
CR Aiso S, 2010, IND HEALTH, V48, P783, DOI 10.2486/indhealth.MS1129
   Alarifi S, 2015, INT J TOXICOL, V34, P258, DOI 10.1177/1091581815584799
   Aldieri E, 2013, J TOXICOL ENV HEAL A, V76, P1056, DOI 10.1080/15287394.2013.834855
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Azad N, 2013, NANOTOXICOLOGY, V7, P157, DOI 10.3109/17435390.2011.647929
   Boyles MSP, 2015, TOXICOL IN VITRO, V29, P1513, DOI 10.1016/j.tiv.2015.06.012
   Cesta MF, 2010, AM J RESP CELL MOL, V43, P142, DOI 10.1165/rcmb.2009-0113OC
   Chang CC, 2012, NANOTOXICOLOGY, V6, P600, DOI 10.3109/17435390.2011.594913
   Chen T, 2014, TOXICOL LETT, V226, P150, DOI 10.1016/j.toxlet.2014.02.004
   Chou CC, 2008, NANO LETT, V8, P437, DOI 10.1021/nl0723634
   Di Giorgio ML, 2011, MUTAT RES-GEN TOX EN, V722, P20, DOI 10.1016/j.mrgentox.2011.02.008
   Donaldson K, 2013, ADV DRUG DELIVER REV, V65, P2078, DOI 10.1016/j.addr.2013.07.014
   Donaldson K, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-5
   Dong J, 2015, ARCH TOXICOL, V89, P621, DOI 10.1007/s00204-014-1428-y
   Elgrabli D, 2008, TOXICOLOGY, V253, P131, DOI 10.1016/j.tox.2008.09.004
   Fenoglio I, 2012, CHEM RES TOXICOL, V25, P74, DOI 10.1021/tx200255h
   Hamilton RF, 2013, INHAL TOXICOL, V25, P199, DOI 10.3109/08958378.2013.775197
   He XQ, 2011, CHEM RES TOXICOL, V24, P2237, DOI 10.1021/tx200351d
   Hirano S, 2010, TOXICOL APPL PHARM, V249, P8, DOI 10.1016/j.taap.2010.08.019
   Hussain S, 2014, PART FIBRE TOXICOL, V11, DOI 10.1186/1743-8977-11-28
   Jacobsen NR, 2008, ENVIRON MOL MUTAGEN, V49, P476, DOI 10.1002/em.20406
   Kagan VE, 2006, TOXICOL LETT, V165, P88, DOI 10.1016/j.toxlet.2006.02.001
   Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104
   Kanno S, 2015, ARCH TOXICOL, V89, P73, DOI 10.1007/s00204-014-1238-2
   Kasai T, 2015, NANOTOXICOLOGY, V9, P413, DOI 10.3109/17435390.2014.933903
   Katwa P, 2012, SMALL, V8, P2904, DOI 10.1002/smll.201200873
   Kobayashi N, 2010, TOXICOLOGY, V276, P143, DOI 10.1016/j.tox.2010.07.021
   Kolosnjaj-Tabi J, 2010, ACS NANO, V4, P1481, DOI 10.1021/nn901573w
   LASKY JA, 1995, AM J RESP CELL MOL, V12, P162, DOI 10.1165/ajrcmb.12.2.7865215
   Li RB, 2013, ACS NANO, V7, P2352, DOI 10.1021/nn305567s
   Ma-Hock L, 2009, TOXICOL SCI, V112, P468, DOI 10.1093/toxsci/kfp146
   Mangum James B, 2006, Part Fibre Toxicol, V3, P15, DOI 10.1186/1743-8977-3-15
   Manke A, 2014, INT J MOL SCI, V15, P7444, DOI 10.3390/ijms15057444
   Manke A, 2013, TOXICOL MECH METHOD, V23, P196, DOI 10.3109/15376516.2012.753967
   Maruyama K, 2015, BIOMED RES INT, DOI 10.1155/2015/793186
   Mercer RR, 2008, AM J PHYSIOL-LUNG C, V294, pL87, DOI 10.1152/ajplung.00186.2007
   Mercer RR, 2013, PART FIBRE TOXICOL, V10, DOI 10.1186/1743-8977-10-33
   Mercer RR, 2011, PART FIBRE TOXICOL, V8, DOI 10.1186/1743-8977-8-21
   Mercer RR, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-28
   Meunier E, 2012, NANOMED-NANOTECHNOL, V8, P987, DOI 10.1016/j.nano.2011.11.004
   Muller J, 2005, TOXICOL APPL PHARM, V207, P221, DOI 10.1016/j.taap.2005.01.008
   Muller J, 2008, CHEM RES TOXICOL, V21, P1698, DOI 10.1021/tx800101p
   Murray AR, 2012, PART FIBRE TOXICOL, V9, DOI 10.1186/1743-8977-9-10
   Nagai H, 2011, P NATL ACAD SCI USA, V108, pE1330, DOI 10.1073/pnas.1110013108
   NIOSH D., 2013, NIOSH D CURR INT B, V65
   Nymark P, 2014, PART FIBRE TOXICOL, V11, DOI 10.1186/1743-8977-11-4
   Ohba T, 2014, J TOXICOL SCI, V39, P499, DOI 10.2131/jts.39.499
   Palomaki J, 2011, ACS NANO, V5, P6861, DOI 10.1021/nn200595c
   Park EJ, 2011, ARCH TOXICOL, V85, P1121, DOI 10.1007/s00204-011-0655-8
   Patel HJ, 2013, J EXPO SCI ENV EPID, V23, P101, DOI 10.1038/jes.2012.75
   Poland CA, 2008, NAT NANOTECHNOL, V3, P423, DOI 10.1038/nnano.2008.111
   Porter AE, 2009, ACS NANO, V3, P1485, DOI 10.1021/nn900416z
   Porter DW, 2013, NANOTOXICOLOGY, V7, P1179, DOI 10.3109/17435390.2012.719649
   Porter DW, 2010, TOXICOLOGY, V269, P136, DOI 10.1016/j.tox.2009.10.017
   Ravichandran P, 2009, J BIOCHEM MOL TOXIC, V23, P333, DOI 10.1002/jbt.20296
   Rittinghausen S, 2014, PART FIBRE TOXICOL, V11, DOI 10.1186/s12989-014-0059-z
   Rothen-Rutishauser B, 2010, NANOTOXICOLOGY, V4, P331, DOI 10.3109/17435390.2010.489161
   Rotoli BM, 2009, HUM EXP TOXICOL, V28, P361, DOI 10.1177/0960327109105159
   Ryman-Rasmussen JP, 2009, NAT NANOTECHNOL, V4, P747, DOI [10.1038/nnano.2009.305, 10.1038/NNANO.2009.305]
   Sanchez VC, 2009, WIRES NANOMED NANOBI, V1, P511, DOI 10.1002/wnan.41
   Sargent LM, 2014, PART FIBRE TOXICOL, V11, DOI 10.1186/1743-8977-11-3
   Sharma CS, 2007, J NANOSCI NANOTECHNO, V7, P2466, DOI 10.1166/jnn.2007.431
   Shvedova AA, 2008, AM J PHYSIOL-LUNG C, V295, pL552, DOI 10.1152/ajplung.90287.2008
   Shvedova AA, 2008, TOXICOL APPL PHARM, V231, P235, DOI 10.1016/j.taap.2008.04.018
   Shvedova AA, 2014, FREE RADICAL BIO MED, V73, P154, DOI 10.1016/j.freeradbiomed.2014.05.010
   Shvedova AA, 2005, AM J PHYSIOL-LUNG C, V289, pL698, DOI 10.1152/ajplung.00084.2005
   Shvedova AA, 2014, AM J PHYSIOL-LUNG C, V306, pL170, DOI 10.1152/ajplung.00167.2013
   Shvedova AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030923
   Snyder RJ, 2014, INT J NANOMED, V9, P4093, DOI 10.2147/IJN.S65567
   Snyder-Talkington BN, 2016, J APPL TOXICOL, V36, P161, DOI 10.1002/jat.3157
   Snyder-Talkington BN, 2015, TOXICOLOGY, V328, P66, DOI 10.1016/j.tox.2014.12.012
   Snyder-Talkington BN, 2013, TOXICOL SCI, V133, P79, DOI 10.1093/toxsci/kft019
   Sun BB, 2015, SMALL, V11, P2087, DOI 10.1002/smll.201402859
   Sweeney S, 2015, INT J NANOMED, V10, P3115, DOI 10.2147/IJN.S77867
   Sweeney S, 2014, CARBON, V78, P26, DOI 10.1016/j.carbon.2014.06.033
   Tamminen JA, 2012, J CELL BIOCHEM, V113, P2234, DOI 10.1002/jcb.24094
   Taylor AJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106870
   Taylor ES, 2013, LANGMUIR, V29, P6323, DOI 10.1021/la400561t
   Teeguarden JG, 2011, TOXICOL SCI, V120, P123, DOI 10.1093/toxsci/kfq363
   Treumann S, 2013, TOXICOL SCI, V134, P103, DOI 10.1093/toxsci/kft089
   van Berlo D, 2014, ARCH TOXICOL, V88, P1725, DOI 10.1007/s00204-014-1220-z
   Vietti G, 2015, NANOTOXICOLOGY, V7, P1
   Vietti G, 2013, PART FIBRE TOXICOL, V10, DOI 10.1186/1743-8977-10-52
   Visalli G, 2015, TOXICOL IN VITRO, V29, P352, DOI 10.1016/j.tiv.2014.12.004
   Wang LY, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-31
   Wang LY, 2010, J TOXICOL ENV HEAL A, V73, P410, DOI 10.1080/15287390903486550
   Wang P, 2013, SMALL
   Wang P, 2015, SMALL, V11, P446, DOI 10.1002/smll.201303588
   Wang X, 2015, ACS NANO, V9, P3032, DOI 10.1021/nn507243w
   Wang X, 2012, NANO LETT, V12, P3050, DOI 10.1021/nl300895y
   Wang X, 2011, ACS NANO, V5, P9772, DOI 10.1021/nn2033055
   Wang X, 2010, ACS NANO, V4, P7241, DOI 10.1021/nn102112b
   Warshamana GS, 2001, EXP MOL PATHOL, V71, P13, DOI 10.1006/exmp.2001.2376
   Wynn TA, 2011, J EXP MED, V208, P1339, DOI 10.1084/jem.20110551
   Xu JG, 2012, CANCER SCI, V103, P2045, DOI 10.1111/cas.12005
   Yang H, 2009, J APPL TOXICOL, V29, P69, DOI 10.1002/jat.1385
   Zhang YL, 2013, J MOL MED, V91, P117, DOI 10.1007/s00109-012-0940-x
NR 97
TC 44
Z9 45
U1 1
U2 49
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1743-8977
J9 PART FIBRE TOXICOL
JI Part. Fibre Toxicol.
PD FEB 29
PY 2016
VL 13
AR 11
DI 10.1186/s12989-016-0123-y
PG 23
WC Toxicology
SC Toxicology
GA DF4BT
UT WOS:000371293000001
PM 26926090
OA DOAJ Gold, Green Published
DA 2019-10-23
ER

PT J
AU Margiotta-Casaluci, L
   Owen, SF
   Huerta, B
   Rodriguez-Mozaz, S
   Kugathas, S
   Barcelo, D
   Rand-Weaver, M
   Sumpter, JP
AF Margiotta-Casaluci, Luigi
   Owen, Stewart F.
   Huerta, Belinda
   Rodriguez-Mozaz, Sara
   Kugathas, Subramanian
   Barcelo, Damia
   Rand-Weaver, Mariann
   Sumpter, John P.
TI Internal exposure dynamics drive the Adverse Outcome Pathways of
   synthetic glucocorticoids in fish
SO SCIENTIFIC REPORTS
LA English
DT Article
ID RISK-ASSESSMENT; BECLOMETHASONE DIPROPIONATE; HUMAN PHARMACEUTICALS;
   FATHEAD MINNOWS; PHARMACOKINETICS; DEXAMETHASONE; TOXICITY; TOXICOLOGY;
   PHARMACODYNAMICS; BIOAVAILABILITY
AB The Adverse Outcome Pathway (AOP) framework represents a valuable conceptual tool to systematically integrate existing toxicological knowledge from a mechanistic perspective to facilitate predictions of chemical-induced effects across species. However, its application for decision-making requires the transition from qualitative to quantitative AOP (qAOP). Here we used a fish model and the synthetic glucocorticoid beclomethasone dipropionate (BDP) to investigate the role of chemical-specific properties, pharmacokinetics, and internal exposure dynamics in the development of qAOPs. We generated a qAOP network based on drug plasma concentrations and focused on immunodepression, skin androgenisation, disruption of gluconeogenesis and reproductive performance. We showed that internal exposure dynamics and chemical-specific properties influence the development of qAOPs and their predictive power. Comparing the effects of two different glucocorticoids, we highlight how relatively similar in vitro hazard-based indicators can lead to different in vivo risk. This discrepancy can be predicted by their different uptake potential, pharmacokinetic (PK) and pharmacodynamic (PD) profiles. We recommend that the development phase of qAOPs should include the application of species-species uptake and physiologically-based PK/PD models. This integration will significantly enhance the predictive power, enabling a more accurate assessment of the risk and the reliable transferability of qAOPs across chemicals.
C1 [Margiotta-Casaluci, Luigi; Kugathas, Subramanian; Sumpter, John P.] Brunel Univ London, Inst Environm Hlth & Societies, London UB8 3PH, England.
   [Margiotta-Casaluci, Luigi; Owen, Stewart F.] AstraZeneca, Global Environm, Alderley Pk, Macclesfield SK10 4TF, Cheshire, England.
   [Huerta, Belinda; Rodriguez-Mozaz, Sara; Barcelo, Damia] Univ Girona, Catalan Inst Water Res ICRA, Sci & Technol Pk, Girona 17003, Spain.
   [Barcelo, Damia] IDAEA CSIC, Dept Environm Chem, Water & Soil Qual Res Grp, Jordi Girona 18-26, Barcelona 08034, Spain.
   [Rand-Weaver, Mariann] Brunel Univ London, Coll Hlth & Life Sci, London UB8 3PH, England.
RP Margiotta-Casaluci, L (reprint author), Brunel Univ London, Inst Environm Hlth & Societies, London UB8 3PH, England.; Margiotta-Casaluci, L (reprint author), AstraZeneca, Global Environm, Alderley Pk, Macclesfield SK10 4TF, Cheshire, England.
EM Luigi.Margiotta-Casaluci@brunel.ac.uk
RI Margiotta-Casaluci, Luigi/A-5402-2011; Rodriguez-Mozaz, Sara/P-6048-2014
OI Margiotta-Casaluci, Luigi/0000-0001-6938-0396; Rodriguez-Mozaz,
   Sara/0000-0003-2962-8144; Huerta, Belinda/0000-0003-4392-4898; Owen,
   Stewart/0000-0003-1398-7142
FU Biotechnology and Biological Sciences Research Council
   (BBSRC)Biotechnology and Biological Sciences Research Council (BBSRC)
   [BB/100646X/1]; AstraZeneca Global Safety, Health and Environment
   research programme; Biotechnology and Biological Sciences Research
   CouncilBiotechnology and Biological Sciences Research Council (BBSRC)
   [BB/I00646X/1]
FX This work was funded by a Biotechnology and Biological Sciences Research
   Council (BBSRC) Research Grant (BB/100646X/1), co-funded by the
   AstraZeneca Global Safety, Health and Environment research programme, to
   JPS and MR-W supporting LM-C.
CR Almroth BMC, 2015, SCI TOTAL ENVIRON, V511, P37, DOI 10.1016/j.scitotenv.2014.12.016
   Andersen ME, 2008, TOXICOL SCI, V105, P368, DOI 10.1093/toxsci/kfn097
   Andersen ME, 2010, TOXICOL SCI, V117, P17, DOI 10.1093/toxsci/kfq188
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   [Anonymous], 2007, NATL RES COUNCIL TOX
   Berninger JP, 2016, ENVIRON TOXICOL CHEM, V35, P1007, DOI 10.1002/etc.2965
   Caldwell DJ, 2014, CHEMOSPHERE, V115, P4, DOI 10.1016/j.chemosphere.2014.01.021
   Daley-Yates PT, 2001, BRIT J CLIN PHARMACO, V51, P400, DOI 10.1046/j.0306-5251.2001.01374.x
   Escher Beate I., 2011, Integrated Environmental Assessment and Management, V7, P28, DOI 10.1002/ieam.100
   Fent K, 2011, AQUAT TOXICOL, V105, P25, DOI 10.1016/j.aquatox.2011.06.008
   Fielden MR, 2001, TOXICOL SCI, V60, P6, DOI 10.1093/toxsci/60.1.6
   Groh KJ, 2015, CHEMOSPHERE, V120, P764, DOI 10.1016/j.chemosphere.2014.09.068
   Hochhaus G, 2001, J CLIN PHARMACOL, V41, P425, DOI 10.1177/00912700122010285
   Hubal EAC, 2010, J EXPO SCI ENV EPID, V20, P231, DOI 10.1038/jes.2008.70
   Huggett DB, 2003, HUM ECOL RISK ASSESS, V9, P1789, DOI 10.1080/10807030390260498
   Issar M, 2006, EUR RESPIR J, V27, P511, DOI 10.1183/09031936.06.00060005
   Kadmiel M, 2013, TRENDS PHARMACOL SCI, V34, P518, DOI 10.1016/j.tips.2013.07.003
   Knapen D, 2015, REPROD TOXICOL, V56, P52, DOI 10.1016/j.reprotox.2015.04.003
   Kugathas S, 2013, ENVIRON SCI TECHNOL, V47, P9487, DOI 10.1021/es4019332
   LaLone CA, 2012, ENVIRON TOXICOL CHEM, V31, P611, DOI 10.1002/etc.1729
   Li ZH, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-63
   LOEW D, 1986, EUR J CLIN PHARMACOL, V30, P225, DOI 10.1007/BF00614309
   Margiotta-Casaluci L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110467
   Margiotta-Casaluci L, 2013, AQUAT TOXICOL, V128, P113, DOI 10.1016/j.aquatox.2012.12.003
   Marks B., TOOLS DISCOVERY CHAR
   McCarty L. S., 2011, Integrated Environmental Assessment and Management, V7, P7, DOI 10.1002/ieam.98
   Muller PY, 2002, BIOTECHNIQUES, V32, P1372
   Page DM, 2013, BLOOD, V122, pE1, DOI 10.1182/blood-2012-12-471029
   Panter GH, 2000, ENVIRON SCI TECHNOL, V34, P2756, DOI 10.1021/es991117u
   Perkins EJ, 2011, ENVIRON TOXICOL CHEM, V30, P22, DOI 10.1002/etc.374
   Plenge RM, 2013, NAT REV DRUG DISCOV, V12, P581, DOI 10.1038/nrd4051
   Queckenberg C, 2011, CLIN THER, V33, P1831, DOI 10.1016/j.clinthera.2011.10.006
   Rand-Weaver M, 2013, ENVIRON SCI TECHNOL, V47, P11384, DOI 10.1021/es402065a
   Reinert KH, 2002, ENVIRON TOXICOL CHEM, V21, P1977, DOI [10.1897/1551-5028(2002)021<1977:EAOTVO>2.0.CO;2, 10.1002/etc.5620210928]
   Thrupp J. T., 2015, SETAC EUR 25 ANN M
   Villeneuve DL, 2014, TOXICOL SCI, V142, P312, DOI 10.1093/toxsci/kfu199
   Watanabe KH, 2011, ENVIRON TOXICOL CHEM, V30, P9, DOI 10.1002/etc.373
   Yoon M, 2015, TOXICOLOGY, V332, P1, DOI 10.1016/j.tox.2015.02.002
   Zar J. H, 2010, BIOSTATISTICAL ANAL
   Zhao S, 2012, ANNU REV PHARMACOL, V52, P505, DOI 10.1146/annurev-pharmtox-010611-134520
   Zucchi S, 2013, ENVIRON SCI TECHNOL, V47, P12548, DOI 10.1021/es403800y
NR 41
TC 11
Z9 11
U1 0
U2 29
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD FEB 26
PY 2016
VL 6
AR 21978
DI 10.1038/srep21978
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DE8XI
UT WOS:000370919600001
PM 26917256
OA DOAJ Gold, Green Published
DA 2019-10-23
ER

PT J
AU Angrish, MM
   Pleil, JD
   Stiegel, MA
   Madden, MC
   Moser, VC
   Herr, DW
AF Angrish, Michelle M.
   Pleil, Joachim D.
   Stiegel, Matthew A.
   Madden, Michael C.
   Moser, Virginia C.
   Herr, David W.
TI Taxonomic applicability of inflammatory cytokines in adverse outcome
   pathway (AOP) development
SO JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART A-CURRENT ISSUES
LA English
DT Article
ID IN-VITRO; EMERGING TECHNOLOGIES; BIOMONITORING DATA; SAFETY ASSESSMENT;
   RISK-ASSESSMENT; CHEMOKINES; BIOMARKERS; MECHANISMS; TOXICITY; HORMONES
AB Cytokines, low-molecular-weight messenger proteins that act as intercellular immunomodulatory signals, have become a mainstream preclinical marker for assessing the systemic inflammatory response to external stressors. The challenge is to quantitate from healthy subjects cytokine levels that are below or at baseline and relate those dynamic and complex cytokine signatures of exposures with the inflammatory and repair pathways. Thus, highly sensitive, specific, and precise analytical and statistical methods are critically important. Investigators at the U.S. Environmental Protection Agency (EPA) have implemented advanced technologies and developed statistics for evaluating panels of inflammatory cytokines in human blood, exhaled breath condensate, urine samples, and murine biological media. Advanced multiplex, bead-based, and automated analytical platforms provided sufficient sensitivity, precision, and accuracy over the traditional enzyme-linked immunosorbent assay (ELISA). Thus, baseline cytokine levels can be quantified from healthy human subjects and animals and compared to an in vivo exposure response from an environmental chemical. Specifically, patterns of cytokine responses in humans exposed to environmental levels of ozone and diesel exhaust, and in rodents exposed to selected pesticides (such as fipronil and carbaryl), were used as case studies to generally assess the taxonomic applicability of cytokine responses. The findings in this study may aid in the application of measureable cytokine markers in future adverse outcome pathway (AOP)-based toxicity testing. Data from human and animal studies were coalesced and the possibility of using cytokines as key events (KE) to bridge species responses to external stressors in an AOP-based framework was explored.
C1 [Angrish, Michelle M.] US EPA, Integrated Sci & Toxicol Div, NHEERL ORD, Res Triangle Pk, NC 27711 USA.
   [Pleil, Joachim D.] US EPA, Human Exposure & Atmospher Sci Div, NERL ORD, 109 TW Alexander Dr, Res Triangle Pk, NC 27709 USA.
   [Stiegel, Matthew A.] US EPA, ORISE, Res Triangle Pk, NC 27711 USA.
   [Madden, Michael C.] US EPA, Environm Publ Hlth Div, NHEERL ORD, Chapel Hill, NC USA.
   [Moser, Virginia C.] US EPA, Neurotoxicol Branch, Tox Assessment Div NHEERL ORD, Res Triangle Pk, NC 27711 USA.
   [Herr, David W.] US EPA, Tox Assessment Div, NHEERL ORD, Res Triangle Pk, NC USA.
RP Pleil, JD (reprint author), US EPA, Human Exposure & Atmospher Sci Div, NERL ORD, 109 TW Alexander Dr, Res Triangle Pk, NC 27709 USA.
EM pleil@unc.edu
CR Adeleye Y, 2015, TOXICOLOGY, V332, P102, DOI 10.1016/j.tox.2014.02.007
   Angrish MM, 2015, CHEM RES TOXICOL, V28, P551, DOI 10.1021/acs.chemrestox.5b00024
   ARAI K, 1990, ANNU REV BIOCHEM, V59, P783, DOI 10.1146/annurev.bi.59.070190.004031
   Berg Ellen L., 2006, Journal of Pharmacological and Toxicological Methods, V53, P67, DOI 10.1016/j.vascn.2005.06.003
   Bouman A, 2005, HUM REPROD UPDATE, V11, P411, DOI 10.1093/humupd/dmi008
   Boverhof DR, 2006, TOXICOL SCI, V94, P398, DOI 10.1093/toxsci/kfl100
   Chen WM, 2014, NANOTOXICOLOGY, V8, P11, DOI 10.3109/17435390.2013.848302
   Chowdhury F, 2009, J IMMUNOL METHODS, V340, P55, DOI 10.1016/j.jim.2008.10.002
   Chung KF, 1999, THORAX, V54, P825, DOI 10.1136/thx.54.9.825
   Csaba G, 2014, ACTA MICROBIOL IMM H, V61, P241, DOI 10.1556/AMicr.61.2014.3.1
   Dorshkind K, 2000, ENDOCR REV, V21, P292, DOI 10.1210/er.21.3.292
   Duramad P, 2011, INT J ENV RES PUB HE, V8, P1388, DOI 10.3390/ijerph8051388
   Fischer SK, 2015, AAPS J, V17, P93, DOI 10.1208/s12248-014-9682-8
   Foster Barbara, 2007, Curr Protoc Immunol, VChapter 6, DOI 10.1002/0471142735.im0624s78
   Gangur V, 2002, VET IMMUNOL IMMUNOP, V86, P127, DOI 10.1016/S0165-2427(02)00018-1
   Gerard C, 2001, NAT IMMUNOL, V2, P108, DOI 10.1038/84209
   Goodman RB, 1996, AM J RESP CRIT CARE, V154, P602, DOI 10.1164/ajrccm.154.3.8810593
   HOFMANN W, 1989, HEALTH PHYS, V57, P41, DOI 10.1097/00004032-198907001-00005
   Houck KA, 2009, J BIOMOL SCREEN, V14, P1054, DOI 10.1177/1087057109345525
   Huang QB, 2014, EXPERT OPIN DRUG MET, V10, P1241, DOI 10.1517/17425255.2014.934671
   Judson R, 2014, BASIC CLIN PHARMACOL, V115, P69, DOI 10.1111/bcpt.12239
   LaLone CA, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2014.0022
   Locatelli V, 2010, ENDOCR DEV, V17, P108, DOI 10.1159/000262533
   Luckey SW, 2001, EXP MOL PATHOL, V71, P226, DOI 10.1006/exmp.2001.2399
   Luebke RW, 2006, J TOXICOL ENV HEAL B, V9, P1, DOI 10.1080/15287390500194326
   Madden MC, 2014, PART FIBRE TOXICOL, V11, DOI [10.1186/s12989-014-0037, 10.1186/s12989-014-0037-5]
   Martignoni M, 2006, EXPERT OPIN DRUG MET, V2, P875, DOI 10.1517/17425255.2.6.875
   Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731
   Mladineo I, 2010, FISH SHELLFISH IMMUN, V29, P487, DOI 10.1016/j.fsi.2010.05.008
   Mnif W, 2011, INT J ENV RES PUB HE, V8, P2265, DOI 10.3390/ijerph8062265
   Mora J, 2014, AAPS J, V16, P1175, DOI 10.1208/s12248-014-9660-1
   Moser VC, 2015, TOXICOL APPL PHARM, V282, P161, DOI 10.1016/j.taap.2014.11.016
   Muller PY, 2009, CLIN PHARMACOL THER, V85, P247, DOI 10.1038/clpt.2008.273
   Nan YM, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-11
   Perkins EJ, 2011, ENVIRON TOXICOL CHEM, V30, P22, DOI 10.1002/etc.374
   Phadnis-Moghe AS, 2015, TOXICOL SCI, V144, P39, DOI 10.1093/toxsci/kfu257
   Pleil JD, 2015, J BREATH RES, V9, DOI 10.1088/1752-7155/9/3/039001
   Pleil JD, 2014, J TOXICOL ENV HEAL B, V17, P341, DOI 10.1080/10937404.2014.956854
   Pleil JD, 2013, J TOXICOL ENV HEAL A, V76, P747, DOI 10.1080/15287394.2013.821394
   Pleil JD, 2012, TOXICOL LETT, V215, P201, DOI 10.1016/j.toxlet.2012.10.011
   Procaccini C, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00143
   Raphael I, 2015, CYTOKINE, V74, P5, DOI 10.1016/j.cyto.2014.09.011
   Rappaport SM, 2012, J EPIDEMIOL COMMUN H, V66, P99, DOI 10.1136/jech-2011-200726
   Rappaport SM, 2010, SCIENCE, V330, P460, DOI 10.1126/science.1192603
   Rissin DM, 2010, NAT BIOTECHNOL, V28, P595, DOI 10.1038/nbt.1641
   Romagnani S, 2000, ANN ALLERG ASTHMA IM, V85, P9, DOI 10.1016/S1081-1206(10)62426-X
   Shvedova AA, 2013, J TOXICOL ENV HEAL A, V76, P907, DOI 10.1080/15287394.2013.825217
   Snyder-Talkington BN, 2012, J TOXICOL ENV HEAL B, V15, P468, DOI 10.1080/10937404.2012.736856
   Sternberg EM, 2001, J ENDOCRINOL, V169, P429, DOI 10.1677/joe.0.1690429
   Stiegel M. A., 2016, PLOS ONE UNPUB
   Stiegel MA, 2015, BIOMARKERS, V20, P35, DOI 10.3109/1354750X.2014.988646
   Suntharalingam G, 2006, NEW ENGL J MED, V355, P1018, DOI 10.1056/NEJMoa063842
   Tarrant JM, 2010, TOXICOL SCI, V117, P4, DOI 10.1093/toxsci/kfq134
   Villarino AV, 2015, J IMMUNOL, V194, P21, DOI 10.4049/jimmunol.1401867
   Villeneuve DL, 2014, TOXICOL SCI, V142, P312, DOI 10.1093/toxsci/kfu199
   Villeneuve DL, 2014, TOXICOL SCI, V142, P321, DOI 10.1093/toxsci/kfu200
   Vos JG, 1995, TOXICOL LETT, V82-3, P385, DOI 10.1016/0378-4274(95)03489-7
   Wasinger V. C., 2013, INT J PROTEOMICS, V2013, DOI DOI 10.1155/2013/180605
   Wiedermann FJ, 2004, CHEST, V125, P212, DOI 10.1378/chest.125.1.212
   World Health Organization, 2012, GUID IMM RISK ASS CH
   Yoon K, 2014, J TOXICOL ENV HEAL B, V17, P127, DOI 10.1080/10937404.2014.882194
   Yoshie O, 2000, INT J HEMATOL, V72, P399
NR 62
TC 10
Z9 10
U1 0
U2 4
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1528-7394
EI 1087-2620
J9 J TOXICOL ENV HEAL A
JI J. Toxicol. Env. Health Part A
PD FEB 16
PY 2016
VL 79
IS 4
BP 184
EP 196
DI 10.1080/15287394.2016.1138923
PG 13
WC Environmental Sciences; Public, Environmental & Occupational Health;
   Toxicology
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health; Toxicology
GA DI8XE
UT WOS:000373784900005
PM 26914248
DA 2019-10-23
ER

PT J
AU Mellor, CL
   Steinmetz, FP
   Cronin, MTD
AF Mellor, Claire L.
   Steinmetz, Fabian P.
   Cronin, Mark T. D.
TI The identification of nuclear receptors associated with hepatic
   steatosis to develop and extend adverse outcome pathways
SO CRITICAL REVIEWS IN TOXICOLOGY
LA English
DT Review
DE Adverse outcome pathway (AOP); hepatic toxicity; mechanisms of toxicity;
   nuclear receptor; steatosis
ID CONSTITUTIVE ANDROSTANE RECEPTOR; PREGNANE X RECEPTOR; ELEMENT-BINDING
   PROTEIN-1C; THYROID-HORMONE RECEPTORS; ARYL-HYDROCARBON RECEPTOR;
   FATTY-ACID SYNTHESIS; VITAMIN-D-RECEPTOR; PROLIFERATOR-ACTIVATED
   RECEPTORS; LIPID-METABOLISM; PROGESTERONE-RECEPTOR
AB The development of adverse outcome pathways (AOPs) is becoming a key component of twenty-first century toxicology. AOPs provide a conceptual framework that links the molecular initiating event to an adverse outcome through organized toxicological knowledge, bridging the gap from chemistry to toxicological effect. As nuclear receptors (NRs) play essential roles for many physiological processes within the body, they are used regularly as drug targets for therapies to treat many diseases including diabetes, cancer and neurodegenerative diseases. Due to the heightened development of NR ligands, there is increased need for the identification of related AOPs to facilitate their risk assessment. Many NR ligands have been linked specifically to steatosis. This article reviews and summarizes the role of NR and their importance with links between NR examined to identify plausible putative AOPs. The following NRs are shown to induce hepatic steatosis upon ligand binding: aryl hydrocarbon receptor, constitutive androstane receptor, oestrogen receptor, glucocorticoid receptor, farnesoid X receptor, liver X receptor, peroxisome proliferator-activated receptor, pregnane X receptor and the retinoic acid receptor. A preliminary, putative AOP was formed for NR binding linked to hepatic steatosis as the adverse outcome.
C1 [Mellor, Claire L.; Steinmetz, Fabian P.; Cronin, Mark T. D.] Liverpool John Moores Univ, Sch Pharm & Biomol Sci, Liverpool L3 3AF, Merseyside, England.
RP Cronin, MTD (reprint author), Liverpool John Moores Univ, Sch Pharm & Biomol Sci, Byrom St, Liverpool L3 3AF, Merseyside, England.
EM m.t.cronin@ljmu.ac.uk
FU European CommunityEuropean Community (EC) [266835]; Cosmetics Europe
FX The research leading to these results has received funding from the
   European Community's Seventh Framework Program (FP7/2007-2013) under
   grant agreement no. 266835 and from Cosmetics Europe. More information
   is available at www.cosmostox.eu.
CR Adler S, 2011, ARCH TOXICOL, V85, P367, DOI 10.1007/s00204-011-0693-2
   Al Sharif M, 2014, PPAR RES, DOI 10.1155/2014/432647
   Alizadeh F, 2014, INT IMMUNOPHARMACOL, V18, P43, DOI 10.1016/j.intimp.2013.10.027
   Anbalagan Muralidharan, 2012, Nucl Recept Signal, V10, pe001, DOI 10.1621/nrs.10001
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Apriletti JW, 1998, CLIN EXP PHARMACOL P, V25, pS2, DOI 10.1111/j.1440-1681.1998.tb02293.x
   Arnett MG, 2011, MOL CELL ENDOCRINOL, V336, P2, DOI 10.1016/j.mce.2010.11.011
   Azzout-Marniche D, 2000, BIOCHEM J, V350, P389, DOI 10.1042/0264-6021:3500389
   BAES M, 1994, MOL CELL BIOL, V14, P1544, DOI 10.1128/MCB.14.3.1544
   Bahn Rebecca S, 2009, Thyroid, V19, P673, DOI 10.1089/thy.2009.0169
   Bandyopadhyay GK, 2006, DIABETES, V55, P2277, DOI 10.2337/db06-0062
   Barral RL, 2014, PROGESTIN ONLY CONTR, P25
   Baulieu EE, 2000, STEROIDS, V65, P605, DOI 10.1016/S0039-128X(00)00173-2
   Bertilsson G, 1998, P NATL ACAD SCI USA, V95, P12208, DOI 10.1073/pnas.95.21.12208
   Biddie SC, 2012, RHEUMATOLOGY, V51, P403, DOI 10.1093/rheumatology/ker215
   BIESALSKI HK, 1989, TOXICOLOGY, V57, P117, DOI 10.1016/0300-483X(89)90161-3
   Bitter A, 2015, ARCH TOXICOL, V89, P2089, DOI 10.1007/s00204-014-1348-x
   Boverhof DR, 2006, TOXICOL SCI, V94, P398, DOI 10.1093/toxsci/kfl100
   Bultink IEM, 2013, EXPERT OPIN PHARMACO, V14, P185, DOI 10.1517/14656566.2013.761975
   Burden N, 2015, J APPL TOXICOL, V35, P971, DOI 10.1002/jat.3165
   Buttgereit F, 2012, BULL HOSP JT DIS, V70, pS26
   Chambellan-Tison C, 2007, ARCH PEDIATRIE, V14, P1328, DOI 10.1016/j.arcped.2007.08.005
   Cherrington NJ, 2002, J PHARMACOL EXP THER, V300, P97, DOI 10.1124/jpet.300.1.97
   Chourbaji S, 2008, BRAIN RES REV, V57, P554, DOI 10.1016/j.brainresrev.2007.04.008
   Christin-Maitre S, 2000, NEW ENGL J MED, V342, P946, DOI 10.1056/NEJM200003303421307
   Claudel T, 2003, GASTROENTEROLOGY, V125, P544, DOI 10.1016/S0016-5085(03)00896-5
   Claudel T, 2005, ARTERIOSCL THROM VAS, V25, P2020, DOI 10.1161/01.ATV.0000178994.21828.a7
   Coenraads PJ, 2012, NEW ENGL J MED, V367, P1829, DOI 10.1056/NEJMcp1104084
   Couse JF, 1999, ENDOCR REV, V20, P358, DOI 10.1210/er.20.3.358
   Crescioli C, 2014, BIOMED RES INT, DOI 10.1155/2014/949730
   Cronin MTD, 2004, PREDICTING CHEM TOXI, P392
   Dalakas MC, 2010, NAT REV RHEUMATOL, V6, P129, DOI 10.1038/nrrheum.2010.2
   DeManno D, 2003, STEROIDS, V68, P1019, DOI 10.1016/j.steroids.2003.09.008
   Dentin R, 2006, J NUTR, V136, P1145
   DREYER C, 1992, CELL, V68, P879, DOI 10.1016/0092-8674(92)90031-7
   Edelman JL, 2010, OPHTHALMOLOGICA, V224, P25, DOI 10.1159/000315158
   ELFERINK CJ, 1990, J BIOL CHEM, V265, P20708
   ENGELKEN SF, 1981, ATHEROSCLEROSIS, V38, P177, DOI 10.1016/0021-9150(81)90114-3
   Miquilena-Colina ME, 2011, GUT, V60, P1394, DOI 10.1136/gut.2010.222844
   Fardet L, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e4928
   Foretz M, 1999, P NATL ACAD SCI USA, V96, P12737, DOI 10.1073/pnas.96.22.12737
   FORMAN BM, 1995, CELL, V81, P687, DOI 10.1016/0092-8674(95)90530-8
   Forrest D, 2000, THYROID, V10, P41, DOI 10.1089/thy.2000.10.41
   Forster C, 2002, P NATL ACAD SCI USA, V99, P15578, DOI 10.1073/pnas.192561299
   Foster DW, 2012, J CLIN INVEST, V122, P1958, DOI 10.1172/JCI63967
   Gellersen B, 2009, HUM REPROD UPDATE, V15, P119, DOI 10.1093/humupd/dmn044
   Gelmann EP, 2002, J CLIN ONCOL, V20, P3001, DOI 10.1200/JCO.2002.10.018
   Gizzo S, 2014, GYNECOL ENDOCRINOL, V30, P902, DOI 10.3109/09513590.2014.964638
   Gocht T, 2015, ALTEX-ALTERN ANIM EX, V32, P9, DOI http://dx.doi.org/10.14573/altex.1408041
   GONZALEZ FJ, 1991, PROG CLIN BIOL RES, V372, P11
   Gougelet A, 2005, J STEROID BIOCHEM, V94, P71, DOI 10.1016/j.jsbmb.2005.01.018
   Grefhorst A, 2002, J BIOL CHEM, V277, P34182, DOI 10.1074/jbc.M204887200
   Groh KJ, 2015, CHEMOSPHERE, V120, P764, DOI 10.1016/j.chemosphere.2014.09.068
   Gustaftson JA, 2003, TRENDS PHARMACOL SCI, V24, P479, DOI 10.1016/S0165-6147(03)00229-3
   Haas DM, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003511.pub3
   Hakim A, 2012, DRUGS, V72, P1299, DOI 10.2165/11634350-000000000-00000
   HANSSON P, 1983, HORM METAB RES, V15, P449, DOI 10.1055/s-2007-1018751
   Harris WP, 2009, NAT CLIN PRACT UROL, V6, P76, DOI 10.1038/ncpuro1296
   Hartung T, 2011, ALTEX-ALTERN ANIM EX, V28, P83, DOI 10.14573/altex.2011.2.083
   Hashimoto T, 1999, J BIOL CHEM, V274, P19228, DOI 10.1074/jbc.274.27.19228
   Haussler MR, 2008, NUTR REV, V66, pS98, DOI 10.1111/j.1753-4887.2008.00093.x
   He JH, 2011, EXP BIOL MED, V236, P1116, DOI 10.1258/ebm.2011.011128
   Heldring N, 2007, PHYSIOL REV, V87, P905, DOI 10.1152/physrev.00026.2006
   HEYMAN RA, 1992, CELL, V68, P397, DOI 10.1016/0092-8674(92)90479-V
   Hoekstra M, 2009, MOL PHARMACEUT, V6, P182, DOI 10.1021/mp800131d
   Honkakoski P, 1998, MOL PHARMACOL, V53, P597
   Horwitz Kathyrn B., 1996, P283
   Howard WR, 2000, TOXICOL APPL PHARM, V163, P195, DOI 10.1006/taap.1999.8869
   Huang WD, 2004, J CLIN INVEST, V113, P137, DOI 10.1172/JCI200418385
   Hubal EAC, 2010, J TOXICOL ENV HEAL B, V13, P299, DOI 10.1080/10937404.2010.483947
   Ihunnah CA, 2011, BBA-MOL BASIS DIS, V1812, P956, DOI 10.1016/j.bbadis.2011.01.014
   ISER JH, 1975, NEW ENGL J MED, V293, P378, DOI 10.1056/NEJM197508212930804
   ISSEMANN I, 1990, NATURE, V347, P645, DOI 10.1038/347645a0
   Janowski BA, 1996, NATURE, V383, P728, DOI 10.1038/383728a0
   Jia YZ, 2009, GENE EXPRESSION, V14, P291, DOI 10.3727/105221609788681213
   Jung UJ, 2011, BBA-MOL CELL BIOL L, V1811, P491, DOI 10.1016/j.bbalip.2011.06.003
   Karas RH, 2001, J CLIN INVEST, V108, P611
   Kasimanickam VR, 2013, THERIOGENOLOGY, V79, P1010, DOI 10.1016/j.theriogenology.2013.01.011
   Kast HR, 2002, J BIOL CHEM, V277, P2908, DOI 10.1074/jbc.M109326200
   Kawaguchi M, 2003, J DERMATOL, V30, P801, DOI 10.1111/j.1346-8138.2003.tb00481.x
   Kawano Y, 2010, ARCH BIOCHEM BIOPHYS, V504, P221, DOI 10.1016/j.abb.2010.09.001
   Kiernan DF, 2009, EXPERT OPIN PHARMACO, V10, P2511, DOI 10.1517/14656560903160671
   King TL, 2010, PHARM WOMENS HLTH, P372
   Kliewer SA, 1998, CELL, V92, P73, DOI 10.1016/S0092-8674(00)80900-9
   KLIEWER SA, 1994, P NATL ACAD SCI USA, V91, P7355, DOI 10.1073/pnas.91.15.7355
   Kuiper GGJM, 1997, ENDOCRINOLOGY, V138, P863, DOI 10.1210/en.138.3.863
   Laffitte BA, 2000, J BIOL CHEM, V275, P10638, DOI 10.1074/jbc.275.14.10638
   LAZAR MA, 1993, ENDOCR REV, V14, P184, DOI 10.1210/er.14.2.184
   LEE SST, 1995, MOL CELL BIOL, V15, P3012
   Lelliott CJ, 2005, FASEB J, V19, P1108, DOI 10.1096/fj.04-3196com
   Letteron P, 1997, AM J PHYSIOL-GASTR L, V272, pG1141
   Lewis-Tuffin LJ, 2007, MOL CELL BIOL, V27, P2266, DOI 10.1128/MCB.01439-06
   Leyden JJ, 2005, CLIN THER, V27, P216, DOI 10.1016/j.clinthera.2005.02.009
   Li T, 2012, EXPERT OPIN THER TAR, V16, P1075, DOI 10.1517/14728222.2012.715634
   LI W, 1994, ARCH BIOCHEM BIOPHYS, V315, P279, DOI 10.1006/abbi.1994.1501
   Lin JZ, 2012, ENDOCRINOLOGY, V153, P6136, DOI 10.1210/en.2011-2081
   Liu ZJ, 2014, SUBCELL BIOCHEM, V70, P203, DOI 10.1007/978-94-017-9050-5_10
   LOIREAU A, 1986, BIOCHEM PHARMACOL, V35, P1691, DOI 10.1016/0006-2952(86)90325-4
   Love JD, 2006, ELS, DOI [10.1038/npg.els.0006024, DOI 10.1038/NPG.ELS.0006024]
   Lu NZ, 2006, PHARMACOL REV, V58, P782, DOI 10.1124/pr.58.4.9
   Ma WL, 2014, ENDOCR-RELAT CANCER, V21, pR165, DOI 10.1530/ERC-13-0283
   Maglich JM, 2009, J LIPID RES, V50, P439, DOI 10.1194/jlr.M800226-JLR200
   Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362
   MISRAHI M, 1987, BIOCHEM BIOPH RES CO, V143, P740, DOI 10.1016/0006-291X(87)91416-1
   Morani A, 2006, P NATL ACAD SCI USA, V103, P7165, DOI 10.1073/pnas.0602194103
   Moreau A, 2008, MOL PHARM, V5, P35, DOI 10.1021/mp700103m
   Moya M, 2010, CHEM-BIOL INTERACT, V184, P376, DOI 10.1016/j.cbi.2010.01.008
   MURPHY AA, 1993, J CLIN ENDOCR METAB, V76, P513, DOI 10.1210/jc.76.2.513
   Naik M A, 2008, Indian J Nephrol, V18, P125, DOI 10.4103/0971-4065.43693
   National Research Council (NRC), 2007, TOX TEST 21 CENT 132
   Nebert DW, 2004, J BIOL CHEM, V279, P23847, DOI 10.1074/jbc.R400004200
   Nguyen P, 2008, J ANIM PHYSIOL AN N, V92, P272, DOI 10.1111/j.1439-0396.2007.00752.x
   Niittynen M, 2007, TOXICOLOGY, V235, P39, DOI 10.1016/j.tox.2007.03.012
   Norman AW, 2006, ENDOCRINOLOGY, V147, P5542, DOI 10.1210/en.2006-0946
   O'Bryant CL, 2008, PHARMACOTHERAPY, V28, P1071, DOI 10.1592/phco.28.8.1071
   Osabe M, 2008, DRUG METAB DISPOS, V36, P294, DOI 10.1124/dmd.107.017731
   Parks DJ, 1999, SCIENCE, V284, P1365, DOI 10.1126/science.284.5418.1365
   Patlewicz G, 2015, REGUL TOXICOL PHARM, V71, P463, DOI 10.1016/j.yrtph.2015.02.011
   Peet DJ, 1998, CELL, V93, P693, DOI 10.1016/S0092-8674(00)81432-4
   Pelclova Daniela, 2006, Reviews on Environmental Health, V21, P119
   Peraza MA, 2006, TOXICOL SCI, V90, P269, DOI 10.1093/toxsci/kfj062
   Perez E, 2012, BBA-MOL CELL BIOL L, V1821, P57, DOI 10.1016/j.bbalip.2011.04.003
   Peters JM, 2005, J MOL MED-JMM, V83, P774, DOI 10.1007/s00109-005-0678-9
   Peters JM, 1997, J BIOL CHEM, V272, P27307, DOI 10.1074/jbc.272.43.27307
   Petitti DB, 2003, NEW ENGL J MED, V349, P1443, DOI 10.1056/NEJMcp030751
   Postic C, 2008, J CLIN INVEST, V118, P829, DOI 10.1172/JCI34275
   Raparti Girish, 2013, Indian J Endocrinol Metab, V17, P211, DOI 10.4103/2230-8210.109663
   Reddy JK, 2006, AM J PHYSIOL-GASTR L, V290, pG853
   Repa JJ, 2002, J BIOL CHEM, V277, P18793, DOI 10.1074/jbc.M109927200
   Repa JJ, 2000, SCIENCE, V289, P1524, DOI 10.1126/science.289.5484.1524
   Rosano GMC, 2001, INT J FERTIL WOMEN M, V46, P248
   Rose AJ, 2010, J STEROID BIOCHEM, V122, P10, DOI 10.1016/j.jsbmb.2010.02.010
   Rosen MB, 2008, TOXICOL PATHOL, V36, P592, DOI 10.1177/0192623308318208
   Rossier MF, 2006, CELL CALCIUM, V40, P155, DOI 10.1016/j.ceca.2006.04.020
   Roy AK, 1999, VITAM HORM, V55, P309
   Saini SPS, 2004, MOL PHARMACOL, V65, P292, DOI 10.1124/mol.65.2.292
   Satoh H, 2013, BIOL PHARM BULL, V36, P616
   Schultz JR, 2000, GENE DEV, V14, P2831, DOI 10.1101/gad.850400
   Sevilla LM, 2013, J INVEST DERMATOL, V133, P361, DOI 10.1038/jid.2012.281
   SHALITA AR, 1988, J AM ACAD DERMATOL, V19, P197, DOI 10.1016/S0190-9622(88)70164-4
   Shimizu T, 2007, ANN SURG, V245, P297, DOI 10.1097/01.sla.0000232523.88621.17
   Silverman MN, 2012, ANN NY ACAD SCI, V1261, P55, DOI 10.1111/j.1749-6632.2012.06633.x
   Singer EA, 2012, UROL ONCOL-SEMIN ORI, V30, pS15, DOI 10.1016/j.urolonc.2011.09.003
   Sitruk-Ware R, 2003, CONTRACEPTION, V68, P409, DOI 10.1016/S0010-7824(03)00171-9
   Skouby S O, 1991, Int J Fertil, V36 Suppl 1, P32
   SMITH G, 1993, BIOCHEM J, V289, P807, DOI 10.1042/bj2890807
   Spitz IM, 2006, CURR OPIN INVEST DR, V7, P882
   Sueyoshi T, 1999, J BIOL CHEM, V274, P6043, DOI 10.1074/jbc.274.10.6043
   Sugatani J, 2001, HEPATOLOGY, V33, P1232, DOI 10.1053/jhep.2001.24172
   Suino K, 2004, MOL CELL, V16, P893, DOI 10.1016/j.molcel.2004.11.036
   TAKEDA K, 1992, J CLIN ENDOCR METAB, V74, P49, DOI 10.1210/jcem.74.1.1727829
   Thomin A, 2014, EXPERT OPIN DRUG SAF, V13, P893, DOI 10.1517/14740338.2014.921678
   THONG KJ, 1992, BRIT J OBSTET GYNAEC, V99, P1004, DOI 10.1111/j.1471-0528.1992.tb13707.x
   Torra IP, 2003, MOL ENDOCRINOL, V17, P259, DOI 10.1210/me.2002-0120
   Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703
   Vatner DF, 2013, AM J PHYSIOL-ENDOC M, V305, pE89, DOI 10.1152/ajpendo.00573.2012
   Venkatesh M, 2011, MOL PHARMACOL, V80, P124, DOI 10.1124/mol.111.071787
   Vilasco M, 2011, BREAST CANCER RES TR, V130, P1, DOI 10.1007/s10549-011-1689-6
   Vinken M, 2015, CHEM RES TOXICOL, V28, P1391, DOI 10.1021/acs.chemrestox.5b00208
   Vinken M, 2013, TOXICOLOGY, V312, P158, DOI 10.1016/j.tox.2013.08.011
   Wada T, 2009, TRENDS ENDOCRIN MET, V20, P273, DOI 10.1016/j.tem.2009.03.003
   Wang L, 2001, P NATL ACAD SCI USA, V98, P2792, DOI 10.1073/pnas.041617498
   Watkins RE, 2001, SCIENCE, V292, P2329, DOI 10.1126/science.1060762
   Waxman DJ, 1999, ARCH BIOCHEM BIOPHYS, V369, P11, DOI 10.1006/abbi.1999.1351
   Weinstein RS, 2010, AGING CELL, V9, P147, DOI 10.1111/j.1474-9726.2009.00545.x
   Wellington K, 2002, DRUGS, V62, P491, DOI 10.2165/00003495-200262030-00006
   Xie W, 2000, NATURE, V406, P435, DOI 10.1038/35019116
   Xie W, 2003, P NATL ACAD SCI USA, V100, P4150, DOI 10.1073/pnas.0438010100
   Yaghmaei Sepideh, 2013, In Silico Pharmacology, V1, P2, DOI 10.1186/2193-9616-1-2
   Yamamoto Y, 2004, CANCER RES, V64, P7197, DOI 10.1158/0008-5472.CAN-04-1459
   Ye L, 2003, J MED CHEM, V46, P1580, DOI 10.1021/jm021080f
   Yin Y, 2012, EUR J CLIN INVEST, V42, P1189, DOI 10.1111/j.1365-2362.2012.02706.x
   Zafrani ES, 2004, VIRCHOWS ARCH, V444, P3, DOI 10.1007/s00428-003-0943-7
   Zaghini I, 2002, J BIOL CHEM, V277, P1324, DOI 10.1074/jbc.M106375200
   Zambrana Jorge T, 2005, Braz J Otorhinolaryngol, V71, P374
   Zen M, 2011, AUTOIMMUN REV, V10, P305, DOI 10.1016/j.autrev.2010.11.009
   Zhang L, 1999, BIOCHEM J, V340, P255, DOI 10.1042/0264-6021:3400255
   Zhang WH, 2001, P NATL ACAD SCI USA, V98, P6330
   Zhao A, 2004, DNA CELL BIOL, V23, P519, DOI 10.1089/1044549041562267
NR 179
TC 21
Z9 21
U1 0
U2 32
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1040-8444
EI 1547-6898
J9 CRIT REV TOXICOL
JI Crit. Rev. Toxicol.
PD FEB 7
PY 2016
VL 46
IS 2
BP 138
EP 152
DI 10.3109/10408444.2015.1089471
PG 15
WC Toxicology
SC Toxicology
GA DB3YI
UT WOS:000368449400002
PM 26451809
DA 2019-10-23
ER

PT J
AU Mellor, CL
   Steinmetz, FP
   Cronin, MTD
AF Mellor, Claire L.
   Steinmetz, Fabian P.
   Cronin, Mark T. D.
TI Using Molecular Initiating Events to Develop a Structural Alert Based
   Screening Workflow for Nuclear Receptor Ligands Associated with Hepatic
   Steatosis
SO CHEMICAL RESEARCH IN TOXICOLOGY
LA English
DT Article
ID ADVERSE OUTCOME PATHWAYS; RISK-ASSESSMENT; IN-SILICO; FRAMEWORK;
   BINDING; TOXICITY; AGONISTS; BETA; ECOTOXICOLOGY; TOXICOLOGY
AB In silico models are essential for the development of integrated alternative methods to identify organ level toxicity and lead toward the replacement of animal testing. These models include (quantitative) structure activity relationships ((Q)SARs) and, importantly, the identification of structural alerts associated with defined toxicological end points. Structural alerts are able both to predict toxicity directly and assist in the formation of categories to facilitate read across. They are particularly important to decipher the myriad mechanisms of action that result in organ level toxicity. The aim of this study was to develop novel structural alerts for nuclear receptor (NR) ligands that are associated with inducing hepatic steatosis and to show the vast number of existing data that are available. Current knowledge on NR agonists was extended with data from the ChEMBL database (12,713 chemicals in total) of bioactive molecules and from studying NR ligand-binding interactions within the protein database (PDB, 624 human NR structure files). A computational structural alert based workflow was developed using KNIME from these data using molecular fragments and other relevant chemical features. In total, 214 structural features were recorded computationally as SMARTS strings, and therefore, they can be used for grouping and screening during drug development and hazard assessment and provide knowledge to anchor adverse outcome pathways (AOPs) via their molecular initiating events (MIEs).
C1 [Mellor, Claire L.; Steinmetz, Fabian P.; Cronin, Mark T. D.] Liverpool John Moores Univ, Sch Pharm & Biomol Sci, Byrom St, Liverpool L3 3AF, Merseyside, England.
RP Cronin, MTD (reprint author), Liverpool John Moores Univ, Sch Pharm & Biomol Sci, Byrom St, Liverpool L3 3AF, Merseyside, England.
EM M.T.Cronin@ljmu.ac.uk
FU European CommunityEuropean Community (EC) [266835]; Cosmetics Europe
FX The research leading to these results has received funding from the
   European Community's Seventh Framework Program (FP7/2007-2013) under
   grant agreement no. 266835 (COSMOS Project) and from Cosmetics Europe.
   More information is available at www.cosmostox.eu.
CR Akwabi-Ameyaw A, 2011, BIOORG MED CHEM LETT, V21, P6154, DOI 10.1016/j.bmcl.2011.08.034
   Allen TEH, 2014, CHEM RES TOXICOL, V27, P2100, DOI 10.1021/tx500345j
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   AOP WIKI, 2015, AOP WIK NR LINK HEP
   Barkhem T, 1998, MOL PHARMACOL, V54, P105
   Bento AP, 2014, NUCLEIC ACIDS RES, V42, pD1083, DOI 10.1093/nar/gkt1031
   Biggadike K, 2009, P NATL ACAD SCI USA, V106, P18114, DOI 10.1073/pnas.0909125106
   Brown Karen, 2002, Expert Opin Drug Saf, V1, P253, DOI 10.1517/14740338.1.3.253
   Chichester C, 2015, DRUG DISCOV TODAY, V20, P399, DOI 10.1016/j.drudis.2014.11.006
   Damstra T, 2002, INT PROGRAMME CHEM S
   DeLisle RK, 2001, J MOL GRAPH MODEL, V20, P155, DOI 10.1016/S1093-3263(01)00115-2
   Diderich R, 2010, ISSUES TOXICOL, V7, P385
   Enoch SJ, 2011, CRIT REV TOXICOL, V41, P783, DOI 10.3109/10408444.2011.598141
   Enoch SJ, 2010, CRIT REV TOXICOL, V40, P728, DOI 10.3109/10408444.2010.494175
   Francis GA, 2003, ANNU REV PHYSIOL, V65, P261, DOI 10.1146/annurev.physiol.65.092101.142528
   Fratev F, 2015, INT J MOL SCI, V16, P15405, DOI 10.3390/ijms160715405
   Glass CK, 2000, GENE DEV, V14, P121
   Groh KJ, 2015, CHEMOSPHERE, V120, P764, DOI 10.1016/j.chemosphere.2014.09.068
   Gutsell S, 2013, TOXICOL RES-UK, V2, P299, DOI 10.1039/c3tx50024a
   Hartung T, 2013, ALTEX-ALTERN ANIM EX, V30, P3, DOI 10.14573/altex.2013.1.003
   Hartung T, 2009, NATURE, V460, P208, DOI 10.1038/460208a
   Jordan VC, 2003, NAT REV DRUG DISCOV, V2, P205, DOI 10.1038/nrd1031
   Klaholz BP, 2000, J MOL BIOL, V302, P155, DOI 10.1006/jmbi.2000.4032
   Kruger FA, 2015, BIOINFORMATICS, V31, P776, DOI 10.1093/bioinformatics/btu711
   MAGLICH JM, 2001, GENOME BIOL, V2
   MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X
   Mellor CL, 2016, CRIT REV TOXICOL, V46, P138, DOI 10.3109/10408444.2015.1089471
   National Research Council (NRC), 2007, TOX TEST 21 CENT VIS
   Nelms MD, 2015, CHEM RES TOXICOL, V28, P1891, DOI 10.1021/acs.chemrestox.5b00275
   Patlewicz G, 2015, REGUL TOXICOL PHARM, V71, P463, DOI 10.1016/j.yrtph.2015.02.011
   Roberts LR, 2011, BIOORG MED CHEM LETT, V21, P5680, DOI 10.1016/j.bmcl.2011.08.041
   Shiizaki K, 2014, MOL PHARMACOL, V85, P279, DOI 10.1124/mol.113.088856
   Sonoda J, 2008, FEBS LETT, V582, P2, DOI 10.1016/j.febslet.2007.11.016
   Steinmetz FP, 2015, MOL INFORM, V34, P171, DOI 10.1002/minf.201400188
   Stepan AF, 2011, CHEM RES TOXICOL, V24, P1345, DOI 10.1021/tx200168d
   Tsakovska I, 2014, INT J MOL SCI, V15, P7651, DOI 10.3390/ijms15057651
   Villeneuve DL, 2014, TOXICOL SCI, V142, P321, DOI 10.1093/toxsci/kfu200
   Vinken M, 2015, CHEM RES TOXICOL, V28, P1391, DOI 10.1021/acs.chemrestox.5b00208
   Vinken M, 2013, TOXICOLOGY, V312, P158, DOI 10.1016/j.tox.2013.08.011
   Wang O., 2003, CLIN PHARMACOKINET, V42, P1331
   Watkins RE, 2001, SCIENCE, V292, P2329, DOI 10.1126/science.1060762
   Worth AP, 2004, PREDICTING CHEMICAL TOXICITY AND FATE, P391
NR 42
TC 11
Z9 11
U1 1
U2 20
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0893-228X
EI 1520-5010
J9 CHEM RES TOXICOL
JI Chem. Res. Toxicol.
PD FEB
PY 2016
VL 29
IS 2
BP 203
EP 212
DI 10.1021/acs.chemrestox.5b00480
PG 10
WC Chemistry, Medicinal; Chemistry, Multidisciplinary; Toxicology
SC Pharmacology & Pharmacy; Chemistry; Toxicology
GA DE1OA
UT WOS:000370395100009
PM 26787004
OA Green Accepted
DA 2019-10-23
ER

PT J
AU More, S
   Mortensen, A
   Ricci, A
   Silano, V
   Knutsen, KH
   Rychen, G
   Naegeli, H
   Turck, D
   Jeger, MJ
   Ockleford, C
   Benford, D
   Halldorsson, T
   Hardy, A
   Noteborn, H
   Schlatter, JR
   Solecki, R
AF More, Simon
   Mortensen, Alicja
   Ricci, Antonia
   Silano, Vittorio
   Knutsen, Katrine Helle
   Rychen, Guido
   Naegeli, Hanspeter
   Turck, Dominique
   Jeger, Michael John
   Ockleford, Colin
   Benford, Diane
   Halldorsson, Thorhallur
   Hardy, Anthony
   Noteborn, Hubert
   Schlatter, Josef R.
   Solecki, Roland
CA EFSA Scientific Comm
TI Coverage of endangered species in environmental risk assessments at EFSA
SO EFSA JOURNAL
LA English
DT Article
DE endangered species; environmental risk assessment; food production;
   plant protection products; genetically modified organisms; feed
   additives; invasive alien species
ID PLANT-PROTECTION PRODUCTS; BT-MAIZE POLLEN; ASSESSING CONTAMINANT
   SENSITIVITY; ECO-EVOLUTIONARY EXPERIENCE; MECHANISTIC EFFECT MODELS;
   ADVERSE OUTCOME PATHWAYS; LONG-TERM TRENDS; SCIENTIFIC OPINION;
   ECOLOGICAL RISK; POPULATION VIABILITY
AB The EFSA performs environmental risk assessment (ERA) for single potential stressors such as plant protection products, genetically modified organisms and feed additives, and for invasive alien species that are harmful to plant health. This ERA focusses primarily on the use or spread of such potential stressors in an agricultural context, but also considers the impact on the wider environment. It is important to realise that the above potential stressors in most cases contribute a minor proportion of the total integrated pressure that ecosystems experience. The World Wildlife Fund listed the relative attribution of threats contributing to the declines in animal populations as follows: 37% from exploitation (fishing, hunting, etc.), 31% habitat degradation and change, 13% from habitat loss, 7% from climate change, and only 5% from invasive species, 4% from pollution and 2% from disease. In this scientific opinion, the Scientific Committee gathered scientific knowledge on the extent of coverage of endangered species in current ERA schemes that fall under the remit of EFSA. The legal basis and the relevant ecological and biological features used to classify a species as endangered are investigated. The characteristics that determine vulnerability of endangered species are reviewed. Whether endangered species are more at risk from exposure to potential stressors than other nontarget species is discussed, but specific protection goals for endangered species are not given. Due to a lack of effect and exposure data for the vast majority of endangered species, the reliability of using data from other species is a key issue for their ERA. This issue and other uncertainties are discussed when reviewing the coverage of endangered species in current ERA schemes. Potential tools, such as population and landscape modelling and trait-based approaches, for extending the coverage of endangered species in current ERA schemes, are explored and reported. (C) European Food Safety Authority, 2016
RI Ockleford, Colin D/A-2921-2009
OI Ockleford, Colin D/0000-0002-0410-8233
CR Aagaard A, 2013, EFSA J, V11, DOI 10.2903/j.efsa.2013.3290
   Aagaard A, 2015, EFSA J, V13, DOI 10.2903/j.efsa.2015.3996
   Aagaard A, 2014, EFSA J, V12, DOI 10.2903/j.efsa.2014.3589
   Aagaard A, 2014, EFSA J, V12, DOI 10.2903/j.efsa.2014.3800
   Aldenberg T, 2000, ECOTOX ENVIRON SAFE, V46, P1, DOI 10.1006/eesa.1999.1869
   Aldrich AP, 2009, AGRARFORSCHUNG, V16, P466
   Andersson HC, 2011, EFSA J, V9, DOI 10.2903/j.efsa.2011.2316
   Andersson HC, 2010, EFSA J, V8, DOI 10.2903/j.efsa.2010.1879
   Andow DA, 2006, NAT BIOTECHNOL, V24, P749, DOI [10.1038/nbt0706-749, 10.1038/nbt0706-751]
   Andreoletti O, 2010, EFSA J, V8, DOI 10.2903/j.efsa.2009.1680
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   [Anonymous], 2006, EFSA J, V4, DOI 10.2903/j.efsa.2006.301
   [Anonymous], 2008, EFSA J, V6, DOI 10.2903/j.efsa.2008.842
   [Anonymous], 2004, 11 ISPM
   [Anonymous], 2014, R LANG ENV STAT COMP
   [Anonymous], 2013, SER TEST ASS
   Aquilina G, 2011, EFSA J, V9, DOI 10.2903/j.efsa.2011.2012
   Arpaia S., 2010, COLLECTION BIOSAFETY, V5, P12
   Arpaia S, 2013, EFSA J, V11, DOI 10.2903/j.efsa.2013.3200
   Axelsson EP, 2011, CHEMOECOLOGY, V21, P161, DOI 10.1007/s00049-011-0080-8
   Axelsson EP, 2010, ECOSYSTEMS, V13, P1049, DOI 10.1007/s10021-010-9373-y
   Baas J, 2010, SCI TOTAL ENVIRON, V408, P3740, DOI 10.1016/j.scitotenv.2009.09.037
   Baker R, 2011, EFSA J, V9, DOI 10.2903/j.efsa.2011.2460
   Baker R, 2015, EFSA J, V13, DOI 10.2903/j.efsa.2015.4079
   Baker R, 2014, EFSA J, V12, DOI 10.2903/j.efsa.2014.3641
   Banks JE, 2014, ECOL APPL, V24, P770, DOI 10.1890/13-0937.1
   Banks JE, 2010, RISK ANAL, V30, P175, DOI 10.1111/j.1539-6924.2009.01349.x
   Barney JN, 2008, BIOL INVASIONS, V10, P259, DOI 10.1007/s10530-007-9127-8
   Bartsch D, 2010, SUGAR TECH, V12, P201, DOI 10.1007/s12355-010-0053-1
   Begon M., 1996, ECOLOGY INDIVIDUALS
   Beissinger SR, 1998, J WILDLIFE MANAGE, V62, P821, DOI 10.2307/3802534
   Beissinger SR, 2002, POPULATION VIABILITY
   Besser JM, 2005, ARCH ENVIRON CON TOX, V48, P155, DOI 10.1007/s00244-003-0039-z
   Biga LM, 2013, ENVIRON TOXICOL CHEM, V32, P2855, DOI 10.1002/etc.2379
   Billeter R, 2008, J APPL ECOL, V45, P141, DOI 10.1111/j.1365-2664.2007.01393.x
   Bilz M, 2011, EUROPEAN RED LIST VA
   BLOSSEY B, 1995, J ECOL, V83, P887, DOI 10.2307/2261425
   Boesten J, 2012, EFSA J, V10, DOI 10.2903/j.efsa.2012.2668
   Boobis AR, 2006, CRIT REV TOXICOL, V36, P781, DOI 10.1080/10408440600977677
   Boyles JG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000672
   Brock TCM, 2010, ENVIRON TOXICOL CHEM, V29, P1994, DOI 10.1002/etc.238
   Bruhl CA, 2013, SCI REP-UK, V3, DOI 10.1038/srep01135
   Bruhl CA, 2011, ENVIRON TOXICOL CHEM, V30, P2465, DOI 10.1002/etc.650
   Buss DS, 2008, PESTIC BIOCHEM PHYS, V90, P141, DOI 10.1016/j.pestbp.2007.12.001
   Callaway RM, 2000, SCIENCE, V290, P521, DOI 10.1126/science.290.5491.521
   Callicott JB, 1999, CONSERV BIOL, V13, P22, DOI 10.1046/j.1523-1739.1999.97333.x
   Campbell A, 2007, VET POISONS INFORM S
   Carlsson Nils O.L., 2006, P61
   Carlsson NOL, 2004, ECOLOGY, V85, P1575, DOI 10.1890/03-3146
   Carstens Keri, 2014, GM Crops Food, V5, P11, DOI 10.4161/gmcr.26560
   Caswell H., 2000, MATRIX POPULATION MO
   Causton HC, 2001, MOL BIOL CELL, V12, P323, DOI 10.1091/mbc.12.2.323
   Chambers CP, 2010, ECOL APPL, V20, P1949, DOI 10.1890/09-0598.1
   Chelinho S, 2014, APPL SOIL ECOL, V83, P200, DOI 10.1016/j.apsoil.2013.06.009
   Chelinho S, 2011, ECOTOX ENVIRON SAFE, V74, P2002, DOI 10.1016/j.ecoenv.2011.07.015
   Chen D, 2010, ENVIRON POLLUT, V158, P1883, DOI 10.1016/j.envpol.2009.10.042
   Chevre A. M., 2004, Introgression from genetically modified plants into wild relatives, P235, DOI 10.1079/9780851998169.0235
   Claudianos C, 2006, INSECT MOL BIOL, V15, P615, DOI 10.1111/j.1365-2583.2006.00672.x
   Collen B, 2012, SPINELESS STATUS TRE
   Craig PS, 2012, J R STAT SOC A STAT, V175, P243, DOI 10.1111/j.1467-985X.2011.00716.x
   CRAWLEY MJ, 1993, NATURE, V363, P620, DOI 10.1038/363620a0
   Crosse JD, 2012, ENVIRON POLLUT, V161, P93, DOI 10.1016/j.envpol.2011.10.003
   Dauber J, 2003, AGR ECOSYST ENVIRON, V98, P321, DOI 10.1016/S0167-8809(03)00092-6
   Davidson C, 2007, ECOL APPL, V17, P587, DOI 10.1890/06-0181
   de Bello F, 2010, BIODIVERS CONSERV, V19, P2873, DOI 10.1007/s10531-010-9850-9
   de Boer J, 2010, ENVIRON POLLUT, V158, P1228, DOI 10.1016/j.envpol.2010.01.026
   De Lange HJ, 2010, SCI TOTAL ENVIRON, V408, P3871, DOI 10.1016/j.scitotenv.2009.11.009
   De Lange HJ, 2009, ENVIRON TOXICOL CHEM, V28, P2233, DOI [10.1897/08-626.S1, 10.1897/08-626.1]
   De Man F, 2014, THESIS
   DeAngelis D. L, 1992, INDIVIDUAL BASED MOD
   Devos Y, 2009, ENVIRON MONIT ASSESS, V149, P303, DOI 10.1007/s10661-008-0204-y
   DIEHL S, 1988, OIKOS, V53, P207, DOI 10.2307/3566064
   DIEHL S, 1992, ECOLOGY, V73, P1646, DOI 10.2307/1940017
   Diekotter T, 2010, AGR ECOSYST ENVIRON, V137, P108, DOI 10.1016/j.agee.2010.01.008
   Dietz R, 2011, ENVIRON SCI TECHNOL, V45, P1458, DOI 10.1021/es1028734
   DRIVER CJ, 1991, ENVIRON TOXICOL CHEM, V10, P21, DOI 10.1002/etc.5620100104
   DUECK TA, 1984, ANGEW BOT, V58, P47
   Dwyer FJ, 2005, ARCH ENVIRON CON TOX, V48, P143, DOI 10.1007/s00244-003-3038-1
   Easterling MR, 2000, ECOLOGY, V81, P694, DOI 10.1890/0012-9658(2000)081[0694:SSSAAN]2.0.CO;2
   Ebner BC, 2009, MAR FRESHWATER RES, V60, P371, DOI 10.1071/MF08159
   EC (European Commission), 2011, OUR LIF INS OUR NAT
   ECORYS for The Netherlands Ministry of VROM (Ministry of Housing Spatial Planning and the Environment), 2007, GREEN BLUE VEIN AGR
   Edmonds ST, 2010, CONDOR, V112, P789, DOI 10.1525/cond.2010.100145
   Edmonds ST, 2012, ENVIRON POLLUT, V171, P148, DOI [10.1016/j.envpol.2012.07.044, 10.1016/j.envPol.2012.07.044]
   EFSA, 2009, EFSA J, V7, DOI 10.2903/j.efsa.2009.306r
   EFSA, 2007, EFSA J, V5, P529, DOI [10.2903/j.efsa.2007.529/epdf, DOI 10.2903/J.EFSA.2007.529]
   *EFSA, 2006, EFSA J, V438, P1, DOI DOI 10.2903/J.EFSA.2007.438
   EFSA (European Food Safety Authority), 2010, EFSA J, V8, P1544, DOI DOI 10.2903/J.EFSA.2010.1544
   EFSA (European Food Safety Authority), 2012, EFSA J SPEC ISS NO 1
   EFSA (European Food Safety Authority), 2014, EFSA SCI C SUMM REP, DOI [10.2805/57358, DOI 10.2805/57358]
   EFSA (European Food Safety Authority), 2011, EFSA SUPP PUBL
   EFSA (European Food Safety Authority), 2013, EFSA SCI C SUMM REP, DOI [10.2805/53269, DOI 10.2805/53269]
   EFSA GMO Panel (EFSA GMO Panel on Genetically Modified Organisms), 2011, EFSA J, V9, P2193, DOI [DOI 10.2903/J.EFSA.2011.2193, 10.2903/j.efsa.2011.2193]
   EFSA GMO Panel (EFSA Panel on Genetically Modified Organisms), 2011, EFSA J, V9, P2150, DOI [10.2903/j.efsa.2011.2150, DOI 10.2903/J.EFSA.2011.2150]
   EFSA Sci Comm, 2015, EFSA J, V13, DOI 10.2903/j.efsa.2015.4080
   EFSA Scientific Committee, EFSA J IN PRESS
   EFSA Scientific Committee, 2009, EFSA J, V7, P1051, DOI DOI 10.2903/J.EFSA.2009.1051
   Eisenberg C, 2010, WOLFS TOOTH KEYSTONE
   Ellis E, 2008, ENCY EARTH ENV INFOR
   Ellstrand NC, 2003, SYNTHESIS ECOLOGY EV, P1
   Endo T, 2006, ENVIRON POLLUT, V144, P145, DOI 10.1016/j.envpol.2005.12.035
   Estes J. A., 2010, TROPHIC CASCADES PRE
   European Commission (EC), 2014, GUID SUPP NAT 2000 F
   European Food Safety Authority, 2014, EFSA J, V12, DOI 10.2903/j.efsa.2014.3638
   European Food Safety Authority, 2014, EFSA J, V12, DOI 10.2903/j.efsa.2014.3734
   European Food Safety Authority, 2014, EFSA J, V12, DOI 10.2903/j.efsa.2014.3594
   European Food Safety Authority, 2013, EFSA J, V11, DOI 10.2903/j.efsa.2013.3295
   European Food Safety Authority, 2013, EFSA J, V11, DOI 10.2903/j.efsa.2013.3068
   European Food Safety Authority, 2013, EFSA J, V11, DOI 10.2903/j.efsa.2013.3067
   European Food Safety Authority, 2013, EFSA J, V11, DOI 10.2903/j.efsa.2013.3066
   European Food Safety Authority, 2009, EFSA J, V7, P1438, DOI DOI 10.2903/J.EFSA.2009.1438
   European Food Safety Authority, 2010, EFSA J, V8, P1821, DOI DOI 10.2903/J.EFSA.2010.1821
   Fairchild JE, 2008, ENVIRON TOXICOL CHEM, V27, P623, DOI 10.1897/07-342.1
   FAO (Food and Agriculture Organization of the United Nations), 2005, ISPM NO 11 PEST RISK, P114
   Fisher DO, 2004, TRENDS ECOL EVOL, V19, P391, DOI 10.1016/j.tree.2004.05.004
   Fisher RA, 1943, J ANIM ECOL, V12, P42, DOI 10.2307/1411
   FitzJohn RG, 2007, EUPHYTICA, V158, P209, DOI 10.1007/s10681-007-9444-0
   Forum for the Coordination of Pesticide Fate Models and Their Use, 2001, SANCO48022001REV2 FO
   Fox R, 2011, INSECT CONSERVATION, V4, P2010, DOI [10.1111/j.1752-4598.00117.x, DOI 10.1111/J.1752-4598.00117.X]
   Frankham R., 2002, INTRO CONSERVATION G
   FREEMARK K, 1995, AGR ECOSYST ENVIRON, V52, P67, DOI 10.1016/0167-8809(94)00534-L
   Fryday S., 2012, EFSA SUPPORTING PUBL, V343, P348
   Furches MS, 2013, AM J BOT, V100, P2092, DOI 10.3732/ajb.1300037
   Gabsi F, 2014, ECOL MODEL, V280, P18, DOI 10.1016/j.ecolmodel.2013.06.018
   Gaertner M, 2014, DIVERS DISTRIB, V20, P733, DOI 10.1111/ddi.12182
   Galic N, 2014, ENVIRON TOXICOL CHEM, V33, P1446, DOI 10.1002/etc.2607
   Garcia-Reyero N, 2011, ECOTOXICOLOGY, V20, P580, DOI 10.1007/s10646-011-0623-3
   Giddings JM, 2014, REV ENVIRON CONTAM T, V231, P119, DOI 10.1007/978-3-319-03865-0_5
   Gilioli G, 2014, SCI TOTAL ENVIRON, V468, P475, DOI 10.1016/j.scitotenv.2013.08.068
   Gonzalez-Suarez M, 2013, ECOL LETT, V16, P242, DOI 10.1111/ele.12035
   Gray A, 2012, COLLECT BIOSAFETY RE, V6, P10
   Grimm V., 2005, INDIVIDUAL BASED MOD
   Grimm V, 2014, ECOL MODEL, V280, P1, DOI 10.1016/j.ecolmodel.2014.01.017
   Gunderson LH, 2000, ANNU REV ECOL SYST, V31, P425, DOI 10.1146/annurev.ecolsys.31.1.425
   Gunnarsson L, 2008, ENVIRON SCI TECHNOL, V42, P5807, DOI 10.1021/es8005173
   Haimes Y. Y., 2015, RISK MODELING ASSESS
   HANSKI I, 1991, BIOL J LINN SOC, V42, P3, DOI 10.1111/j.1095-8312.1991.tb00548.x
   Harrington R, 2010, BIODIVERS CONSERV, V19, P2773, DOI 10.1007/s10531-010-9834-9
   Hendrickx F, 2007, J APPL ECOL, V44, P340, DOI 10.1111/j.1365-2664.2006.01270.x
   Hendriks AJ, 2001, ENVIRON TOXICOL CHEM, V20, P1399, DOI 10.1002/etc.5620200703
   Hickey GL, 2012, ENVIRON TOXICOL CHEM, V31, P1903, DOI 10.1002/etc.1891
   Hickey GL, 2012, RISK ANAL, V32, P1232, DOI 10.1111/j.1539-6924.2011.01728.x
   Hilbeck A, 2014, ECOL INDIC, V36, P367, DOI 10.1016/j.ecolind.2013.07.016
   Hirai M, 2012, CONSERV GENET, V13, P837, DOI 10.1007/s10592-012-0333-2
   Holmstrup M, 2010, SCI TOTAL ENVIRON, V408, P3746, DOI 10.1016/j.scitotenv.2009.10.067
   Holst N, 2013, ECOL MODEL, V250, P126, DOI 10.1016/j.ecolmodel.2012.11.006
   Hooper DU, 2002, BIODIVERSITY AND ECOSYSTEM FUNCTIONING: SYNTHESIS AND PERSPECTIVES, P195
   Hulme PE, 2013, SCIENCE, V339, P522, DOI 10.1126/science.339.6119.522
   Icoz I, 2008, SOIL BIOL BIOCHEM, V40, P559, DOI 10.1016/j.soilbio.2007.11.002
   IUCN, 2012, IUCN RED LIST CAT CR
   IUCN 2015, 2015, IUCN RED LIST THREAT
   [IUCN] INTERNATIONAL UNION FOR CONSERVATION OF NATURE, 2014, GUID US IUCN RED LIS
   IUCN (International Union for the Conservation of Nature, 2014, TABL 3A STAT CAT SUM
   Jagers op Akkerhuis GAJM, 1993, THESIS
   Jahn T., 2014, PROTECTION BIODIVERS
   James MR, 2000, FRESHWATER BIOL, V44, P311, DOI 10.1046/j.1365-2427.2000.00563.x
   Jenczewski Eric, 2003, Environmental Biosafety Research, V2, P9, DOI 10.1051/ebr:2003001
   JESCHKE JM, 2012, NEOBIOTA, V14, P1, DOI DOI 10.3897/neobiota.14.3435
   Jeschke JM, 2008, ECOGRAPHY, V31, P124, DOI 10.1111/j.2007.0906-7590.05343.x
   Jeschke JM, 2014, DIVERS DISTRIB, V20, P1229, DOI 10.1111/ddi.12258
   Jeschke JM, 2009, EVOL ECOL, V23, P867, DOI 10.1007/s10682-008-9276-y
   Johnson DL, 1997, J ENVIRON QUAL, V26, P581, DOI 10.2134/jeq1997.00472425002600030002x
   Johnson RM, 2008, TOXICOGENOMICS APIS
   Jongbloed RH, 1996, ECOTOX ENVIRON SAFE, V34, P279, DOI 10.1006/eesa.1996.0072
   Jorgensen RB, 2009, ENVIRON SCI POLLUT R, V16, P389, DOI 10.1007/s11356-009-0142-4
   Kattwinkel M, 2012, EFSA SUPPORT PUBL EN, VEN-338, P98
   Keane RM, 2002, TRENDS ECOL EVOL, V17, P164, DOI 10.1016/S0169-5347(02)02499-0
   KEELER KH, 1989, BIO-TECHNOL, V7, P1134
   Koeman JH, 2000, ORAL COMMUNICATION H
   Koh LP, 2004, CONSERV BIOL, V18, P1571, DOI 10.1111/j.1523-1739.2004.00468.x
   Korsloot A., 2004, ENV STRESS CELLULAR
   Kotiaho JS, 2005, P NATL ACAD SCI USA, V102, P1963, DOI 10.1073/pnas.0406718102
   Kotze DJ, 2003, OECOLOGIA, V135, P138, DOI 10.1007/s00442-002-1174-3
   Kretschmann A, 2012, ENVIRON TOXICOL CHEM, V31, P2014, DOI 10.1002/etc.1905
   Kuiters AT, 2010, 2022 ALT
   LaLone CA, 2013, AQUAT TOXICOL, V144, P141, DOI 10.1016/j.aquatox.2013.09.004
   LANDE R, 1993, AM NAT, V142, P911, DOI 10.1086/285580
   LARRICK SR, 1978, HYDROBIOLOGIA, V61, P257, DOI 10.1007/BF00044451
   Lavorel S, 1997, TRENDS ECOL EVOL, V12, P474, DOI 10.1016/S0169-5347(97)01219-6
   Leimu R, 2006, J ECOL, V94, P942, DOI 10.1111/j.1365-2745.2006.01150.x
   Lenhardt PP, 2015, BASIC APPL ECOL, V16, P54, DOI 10.1016/j.baae.2014.10.005
   Lewis DS, 2011, J ECON ENTOMOL, V104, P1986, DOI 10.1603/EC11132
   Liess M, 2010, CONSIDERING PROTECTE
   Liess M, 2011, ECOTOXICOLOGY, V20, P1328, DOI 10.1007/s10646-011-0689-y
   LINDENMAYER DB, 1993, ENVIRON MANAGE, V17, P745, DOI 10.1007/BF02393895
   Lodge DM, 1998, ECOL STU AN, V131, P149
   Loos M, 2010, SCI TOTAL ENVIRON, V408, P3908, DOI 10.1016/j.scitotenv.2009.11.045
   Luck GW, 2003, TRENDS ECOL EVOL, V18, P331, DOI 10.1016/S0169-5347(03)00100-9
   Luoma SN, 2005, ENVIRON SCI TECHNOL, V39, P1921, DOI 10.1021/es048947e
   Luttik R, 2005, ECOTOXICOLOGY, V14, P817, DOI 10.1007/s10646-005-0030-8
   Luttik Robert, 2011, Integrated Environmental Assessment and Management, V7, P459, DOI 10.1002/ieam.183
   MAgPIE, 2013, SETAC WORKSH ROM 22
   MAgPIE, 2014, EC WORKSH BRUSS 10 D
   Magurran AE, 2004, MEASURING BIOL DIVER
   Mayer F.L, 1986, MANUAL ACUTE TOXICIT
   MAYNARD DJ, 1981, CAN J FISH AQUAT SCI, V38, P772, DOI 10.1139/f81-105
   McGill BJ, 2006, TRENDS ECOL EVOL, V21, P178, DOI 10.1016/j.tree.2006.02.002
   McKinney ML, 1997, ANNU REV ECOL SYST, V28, P495, DOI 10.1146/annurev.ecolsys.28.1.495
   Meek ME, 2014, J APPL TOXICOL, V34, P595, DOI 10.1002/jat.2984
   Meissle M, 2012, EFSA SUPP PUBL, VEN-334
   Millennium Ecosystem Assessment (MA), 2003, EC HUM WELL BEING FR
   Monastersky R, 2014, NATURE, V516, P159, DOI 10.1038/516158a
   Montoya JM, 2009, ECOLOGY, V90, P2426, DOI 10.1890/08-0657.1
   Mora C, 2013, SCIENCE, V341, DOI 10.1126/science.1237254
   More S, 2016, EFSA J, V14, DOI 10.2903/j.efsa.2016.4313
   Munns WR, 2006, ECOL SOC, V11
   [NAS] National Academy of Sciences, 2013, ASS RISKS END THREAT
   NEWTON I, 1993, ENVIRON POLLUT, V79, P143, DOI 10.1016/0269-7491(93)90064-U
   Nickson TE, 2008, PLANT PHYSIOL, V147, P494, DOI 10.1104/pp.108.118422
   Nienstedt KM, 2012, SCI TOTAL ENVIRON, V415, P31, DOI 10.1016/j.scitotenv.2011.05.057
   NRC, 2007, TOXICITY TESTING 21
   NUNNEY L, 1993, TRENDS ECOL EVOL, V8, P234, DOI 10.1016/0169-5347(93)90197-W
   Oaks JL, 2004, NATURE, V427, P630, DOI 10.1038/nature02317
   Perry JN, 2010, P ROY SOC B-BIOL SCI, V277, P1417, DOI 10.1098/rspb.2009.2091
   Perry JN, 2013, ECOL MODEL, V268, P103, DOI 10.1016/j.ecolmodel.2013.08.004
   Perry JN, 2012, J APPL ECOL, V49, P29, DOI 10.1111/j.1365-2664.2011.02083.x
   Persson L, 1998, ECOL STU AN, V131, P3
   Peters H, 2014, THESIS
   Pimm SL, 2014, SCIENCE, V344, P987, DOI 10.1126/science.1246752
   Pirovano A, 2014, ATLA-ALTERN LAB ANIM, V42, P59, DOI 10.1177/026119291404200109
   Pirovano A, 2012, ENVIRON SCI TECHNOL, V46, P5168, DOI 10.1021/es204506g
   Posthuma L, 2002, SPECIES SENSITIVITY
   PRESTON FW, 1948, ECOLOGY, V29, P254, DOI 10.2307/1930989
   RABINOWITZ D., 1981, BIOL ASPECTS RARE PL, P205
   Raimondo S, 2008, ENVIRON TOXICOL CHEM, V27, P2599, DOI 10.1897/08-157.1
   RAND GM, 1984, FUNDAMENTALS AQUATIC
   Raybould Alan, 2006, Environmental Biosafety Research, V5, P119, DOI 10.1051/ebr:2007004
   Raybould Alan, 2010, Environmental Biosafety Research, V9, P123, DOI 10.1051/ebr/2011101
   Raybould A, 2011, J AGR FOOD CHEM, V59, P5877, DOI 10.1021/jf1042079
   Raybould A, 2005, BIOL SCI SER, P169
   Reynolds John D., 2003, P195
   Ricklefs R. E., 1990, ECOLOGY
   Ricklefs RE, 1999, ECOLOGY
   Ripple WJ, 2014, SCIENCE, V343, P151, DOI 10.1126/science.1241484
   RISEBROUGH RW, 1967, NATURE, V216, P589, DOI 10.1038/216589a0
   Roff D. A., 2002, LIFE HIST EVOLUTION
   Romeis J, 2006, NAT BIOTECHNOL, V24, P63, DOI 10.1038/nbt1180
   Romeis J, 2008, NAT BIOTECHNOL, V26, P203, DOI 10.1038/nbt1381
   Romeis J, 2014, TRANSGENIC RES, V23, P995, DOI 10.1007/s11248-014-9791-2
   Romeis J, 2013, CHEMOSPHERE, V90, P901, DOI 10.1016/j.chemosphere.2012.09.035
   Romeis J, 2011, TRANSGENIC RES, V20, P1, DOI 10.1007/s11248-010-9446-x
   Rose RI, 2007, WHITE PAPER TIER BAS
   Rosi-Marshall EJ, 2007, P NATL ACAD SCI USA, V104, P16204, DOI 10.1073/pnas.0707177104
   Rubach MN, 2011, ARCH ENVIRON CON TOX, V60, P708, DOI 10.1007/s00244-010-9582-6
   Rubach Mascha N., 2011, Integrated Environmental Assessment and Management, V7, P172, DOI 10.1002/ieam.105
   Ruckdeschel P, 2006, S4 CLASSES DISTRIBUT, P6
   Rust AJ, 2004, ENVIRON TOXICOL CHEM, V23, P2587, DOI 10.1897/03-354
   Sanvido O, 2012, ENVIRON SCI POLICY, V15, P82, DOI 10.1016/j.envsci.2011.08.006
   Sappington LC, 2001, ENVIRON TOXICOL CHEM, V20, P2869, DOI 10.1002/etc.5620201229
   Saul WC, 2015, ECOL LETT, V18, P236, DOI 10.1111/ele.12408
   Saul Wolf-Christian, 2013, NeoBiota, V17, P57
   Scheffers BR, 2012, TRENDS ECOL EVOL, V27, P501, DOI 10.1016/j.tree.2012.05.008
   Schneider MK, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5151
   Segner H, 2011, AQUAT TOXICOL, V105, P50, DOI 10.1016/j.aquatox.2011.06.016
   SHAFFER ML, 1981, BIOSCIENCE, V31, P131, DOI 10.2307/1308256
   SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x
   Shrestha B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018046
   Simberloff D, 2013, TRENDS ECOL EVOL, V28, P58, DOI 10.1016/j.tree.2012.07.013
   SIMKISS K, 1990, FUNCT ECOL, V4, P303, DOI 10.2307/2389590
   Spromberg JA, 2005, ENVIRON TOXICOL CHEM, V24, P1532, DOI 10.1897/04-160.1
   Spromberg JA, 1998, ENVIRON TOXICOL CHEM, V17, P1640, DOI 10.1002/etc.5620170828
   Spurgeon DJ, 2010, SCI TOTAL ENVIRON, V408, P3725, DOI 10.1016/j.scitotenv.2010.02.038
   STEBBING ARD, 1985, MAR POLLUT BULL, V16, P383, DOI 10.1016/0025-326X(85)90286-3
   Stehle S, 2015, ENVIRON SCI POLLUT R, V22, P19632, DOI 10.1007/s11356-015-5148-5
   STENERSEN J, 1992, SOIL BIOL BIOCHEM, V24, P1761, DOI 10.1016/0038-0717(92)90184-Y
   Stephenson GL, 1998, ADV EARTHWORM ECOTOX, P67
   Stuijfzand SC, 2000, ENVIRON TOXICOL CHEM, V19, P582, DOI [10.1897/1551-5028(2000)019<0582:VDTIOD>2.3.CO;2, 10.1002/etc.5620190309]
   Suter II G W, 1993, ECOLOGICAL RISK ASSE
   Tank JL, 2010, P NATL ACAD SCI USA, V107, P17645, DOI 10.1073/pnas.1006925107
   Tierney KB, 2010, AQUAT TOXICOL, V96, P2, DOI 10.1016/j.aquatox.2009.09.019
   Topping CJ, 2014, ENVIRON TOXICOL CHEM, V33, P1499, DOI 10.1002/etc.2388
   Topping CJ, 2003, ECOL MODEL, V167, P65, DOI 10.1016/S0304-3800(03)00173-X
   Traas TP, 1996, ECOTOX ENVIRON SAFE, V34, P264, DOI 10.1006/eesa.1996.0071
   Traas TP, 2002, SPECIES SENSITIVITY, P133
   Trussell GC, 2006, ECOL LETT, V9, P1245, DOI 10.1111/j.1461-0248.2006.00981.x
   US-EPA (United States Environmental Protection Agency), 2015, ONL DOC PROT END SPE
   Usseglio-Polatera P, 2000, FRESHWATER BIOL, V43, P175, DOI 10.1046/j.1365-2427.2000.00535.x
   Van den Brink PJ, 2013, INTEGR ENVIRON ASSES, V9, pE47, DOI 10.1002/ieam.1443
   Van Valkenburgh B, 2004, SCIENCE, V306, P101, DOI 10.1126/science.1102417
   van Wijngaarden RPA, 2015, PEST MANAG SCI, V71, P1059, DOI 10.1002/ps.3937
   Vanderwalle M, 2008, REV PAPER CONCEPTS D
   VANSTRAALEN NM, 1994, NETH J ZOOL, V44, P112, DOI 10.1163/156854294X00097
   VANWIJNGAARDEN R, 1993, B ENVIRON CONTAM TOX, V51, P716, DOI 10.1007/BF00201650
   VERHAAR HJM, 1992, CHEMOSPHERE, V25, P471, DOI 10.1016/0045-6535(92)90280-5
   Verhaegen D, 2013, TREE GENET GENOMES, V9, P511, DOI 10.1007/s11295-012-0575-7
   Villeneuve D, 2014, ENVIRON TOXICOL CHEM, V33, P158, DOI 10.1002/etc.2403
   Vyas NB, 2007, ENVIRON MONIT ASSESS, V133, P209, DOI 10.1007/s10661-006-9573-2
   WALKER CH, 1983, AGR ECOSYST ENVIRON, V9, P211, DOI 10.1016/0167-8809(83)90042-7
   WALKER CH, 1987, COMP BIOCHEM PHYS C, V86, P379, DOI 10.1016/0742-8413(87)90099-5
   Walker CH, 1999, ECOTOXICOLOGY, V8, P425, DOI 10.1023/A:1008995400871
   Weir SM, 2010, ENVIRON POLLUT, V158, P3596, DOI 10.1016/j.envpol.2010.08.011
   Weltje L, 2013, ENVIRON TOXICOL CHEM, V32, P984, DOI 10.1002/etc.2149
   WHITTAKER R H, 1972, Taxon, V21, P213, DOI 10.2307/1218190
   WHO (World Health Organisation), 2004, IPCS RISK ASS TERMIN
   WHO (World Health Organization), 2007, HARM PROJ DOC 4 1
   Wilkinson Mike, 2009, Environmental Biosafety Research, V8, P1, DOI 10.1051/ebr/2009003
   Wilkinson MJ, 2007, BIOSAFETY REV, V3, P42
   Wolt JD, 2010, TRANSGENIC RES, V19, P425, DOI 10.1007/s11248-009-9321-9
   Woodcock BA, 2005, AGR ECOSYST ENVIRON, V107, P255, DOI 10.1016/j.agee.2004.10.029
   WWF (World Wildlife Foundation), 2014, MAIN THREATS WWF LIV
   Zeigler SL, 2013, CONSERV BIOL, V27, P1265, DOI 10.1111/cobi.12130
NR 301
TC 11
Z9 11
U1 0
U2 4
PU EUROPEAN FOOD SAFETY AUTHORITY-EFSA
PI PARMA
PA EUROPEAN FOOD SAFETY AUTHORITY-EFSA, PARMA, 00000, ITALY
EI 1831-4732
J9 EFSA J
JI EFSA J.
PD FEB
PY 2016
VL 14
IS 2
AR UNSP 4312
DI 10.2903/j.efsa.2016.4312
PG 124
WC Food Science & Technology
SC Food Science & Technology
GA FF5PY
UT WOS:000409046500001
OA DOAJ Gold
DA 2019-10-23
ER

PT J
AU Lake, AD
   Wood, CE
   Bhat, VS
   Chorley, BN
   Carswell, GK
   Sey, YM
   Kenyon, EM
   Padnos, B
   Moore, TM
   Tennant, AH
   Schmid, JE
   George, BJ
   Ross, DG
   Hughes, MF
   Corton, JC
   Simmons, JE
   McQueen, CA
   Hester, SD
AF Lake, April D.
   Wood, Charles E.
   Bhat, Virunya S.
   Chorley, Brian N.
   Carswell, Gleta K.
   Sey, Yusupha M.
   Kenyon, Elaina M.
   Padnos, Beth
   Moore, Tanya M.
   Tennant, Alan H.
   Schmid, Judith E.
   George, Barbara Jane
   Ross, David G.
   Hughes, Michael F.
   Corton, J. Christopher
   Simmons, Jane Ellen
   McQueen, Charlene A.
   Hester, Susan D.
TI Dose and Effect Thresholds for Early Key Events in a PPAR alpha-Mediated
   Mode of Action
SO TOXICOLOGICAL SCIENCES
LA English
DT Article
DE mode of action; adverse outcome pathway; benchmark dose; peroxisome
   proliferator-activated receptor-alpha; liver carcinogenesis; phthalate
ID ANDROSTANE RECEPTOR CAR; RISK-ASSESSMENT; FRAMEWORK; CONCORDANCE;
   PHTHALATE; TOXICITY; DI(2-ETHYLHEXYL)PHTHALATE; HEPATOCARCINOGENESIS;
   PROLIFERATION; TECHNOLOGIES
AB Current strategies for predicting adverse health outcomes of environmental chemicals are centered on early key events in toxicity pathways. However, quantitative relationships between early molecular changes in a given pathway and later health effects are often poorly defined. The goal of this study was to evaluate short-term key event indicators using qualitative and quantitative methods in an established pathway of mouse liver tumorigenesis mediated by peroxisome proliferator-activated receptor alpha (PPAR alpha). Male B6C3F1 mice were exposed for 7 days to di (2-ethylhexyl) phthalate (DEHP), di-n-octyl phthalate (DNOP), and n-butyl benzyl phthalate (BBP), which vary in PPAR alpha activity and liver tumorigenicity. Each phthalate increased expression of select PPARa target genes at 7 days, while only DEHP significantly increased liver cell proliferation labeling index (LI). Transcriptional benchmark dose (BMDT) estimates for dose-related genomic markers stratified phthalates according to hypothetical tumorigenic potencies, unlike BMDs for non-genomic endpoints (relative liver weights or proliferation). The 7-day BMDT values for Acot1 as a surrogate measure for PPAR alpha activation were 29, 370, and 676 mg/kg/day for DEHP, DNOP, and BBP, respectively, distinguishing DEHP (liver tumor BMD of 35 mg/kg/day) from non-tumorigenic DNOP and BBP. Effect thresholds were generated using linear regression of DEHP effects at 7 days and 2-year tumor incidence values to anchor early response molecular indicators and a later phenotypic outcome. Thresholds varied widely by marker, from 2-fold (Pdk4 and proliferation LI) to 30-fold (Acot1) induction to reach hypothetical tumorigenic expression levels. These findings highlight key issues in defining thresholds for biological adversity based on molecular changes.
C1 [Lake, April D.] Univ N Carolina, Curriculum Toxicol, Chapel Hill, NC 27599 USA.
   [Lake, April D.] US EPA, ORD, NHEERL, ORISE, Res Triangle Pk, NC 27711 USA.
   [Lake, April D.; Wood, Charles E.; Chorley, Brian N.; Carswell, Gleta K.; Sey, Yusupha M.; Kenyon, Elaina M.; Padnos, Beth; Moore, Tanya M.; Tennant, Alan H.; Ross, David G.; Hughes, Michael F.; Corton, J. Christopher; Simmons, Jane Ellen; McQueen, Charlene A.; Hester, Susan D.] US EPA, ORD, NHEERL, Integrated Syst Toxicol Div, Res Triangle Pk, NC 27711 USA.
   [Bhat, Virunya S.] NSF Int, Ann Arbor, MI 48105 USA.
   [Schmid, Judith E.] US EPA, ORD, NHEERL, Toxicol Assessment Div, Res Triangle Pk, NC 27711 USA.
   [George, Barbara Jane] US EPA, ORD, NHEERL, Off Associate Director Hlth, Res Triangle Pk, NC 27711 USA.
RP Hester, SD (reprint author), US EPA, ORD, NHEERL, Integrated Syst Toxicol Div, Res Triangle Pk, NC 27711 USA.
EM hester.susan@epa.gov
OI Kenyon, Elaina/0000-0001-8781-2391
FU U.S. Environmental Protection Agency Office of Research and
   DevelopmentUnited States Environmental Protection Agency
FX U.S. Environmental Protection Agency Office of Research and Development.
CR Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Bhat VS, 2013, TOXICOL SCI, V136, P205, DOI 10.1093/toxsci/kft182
   Boobis AR, 2006, CRIT REV TOXICOL, V36, P781, DOI 10.1080/10408440600977677
   BURKE MD, 1983, CHEM-BIOL INTERACT, V45, P243
   Chiu WHA, 2013, TOXICOL APPL PHARM, V271, P309, DOI 10.1016/j.taap.2010.03.019
   Corton JC, 2014, CRIT REV TOXICOL, V44, P1, DOI 10.3109/10408444.2013.835784
   David RM, 1999, TOXICOL SCI, V50, P195, DOI 10.1093/toxsci/50.2.195
   David RM, 2000, TOXICOL SCI, V58, P377, DOI 10.1093/toxsci/58.2.377
   Davis JA, 2011, TOXICOL APPL PHARM, V254, P181, DOI 10.1016/j.taap.2010.10.016
   Dongol B, 2007, J LIPID RES, V48, P1781, DOI 10.1194/jlr.M700119-JLR200
   Elcombe CR, 2014, CRIT REV TOXICOL, V44, P64, DOI 10.3109/10408444.2013.835786
   Eveillard A, 2009, BIOCHEM PHARMACOL, V77, P1735, DOI 10.1016/j.bcp.2009.02.023
   Geter DR, 2014, TOXICOL SCI, V138, P425, DOI 10.1093/toxsci/kfu014
   GUENGERICH FP, 1982, XENOBIOTICA, V12, P701, DOI 10.3109/00498258209038945
   KENNEDY SW, 1994, ANAL BIOCHEM, V222, P217, DOI 10.1006/abio.1994.1476
   KLUWE WM, 1982, J TOXICOL ENV HEALTH, V10, P797, DOI 10.1080/15287398209530296
   LeBaron MJ, 2014, TOXICOL SCI, V142, P74, DOI 10.1093/toxsci/kfu155
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Meek ME, 2014, J APPL TOXICOL, V34, P1, DOI 10.1002/jat.2949
   National Toxicology Program (NTP), 1982, ABSTR TR 213 BUT BEN
   NRC (National Research Council), 2007, TOX TEST 21 CENT VIS
   OECD, 2007, ENV HLTH SAF PUBL SE
   Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304
   Ren HZ, 2010, TOXICOL SCI, V113, P45, DOI 10.1093/toxsci/kfp251
   Seo KW, 2004, FOOD CHEM TOXICOL, V42, P107, DOI 10.1016/j.fct.2003.08.010
   Simon TW, 2014, CRIT REV TOXICOL, V44, P17, DOI 10.3109/10408444.2014.931925
   Thomas R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063308
   Thomas RS, 2007, TOXICOL SCI, V96, P40, DOI 10.1093/toxsci/kfl171
   Thomas RS, 2013, TOXICOL SCI, V136, P4, DOI 10.1093/toxsci/kft178
   Thomas RS, 2013, TOXICOL SCI, V134, P180, DOI 10.1093/toxsci/kft094
   Thomas RS, 2012, MUTAT RES-GEN TOX EN, V746, P135, DOI 10.1016/j.mrgentox.2012.01.007
   Thoolen B, 2010, TOXICOL PATHOL, V38, p5S, DOI 10.1177/0192623310386499
   Tice RR, 2013, ENVIRON HEALTH PERSP, V121, P756, DOI 10.1289/ehp.1205784
   Tollefsen K. E., 2014, REGUL TOXICOL PHARM
   [USEPA] United States Environmental Protection Agency, 2012, EPA100R12001 RISK AS
   Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034
   Wettenhall JM, 2004, BIOINFORMATICS, V20, P3705, DOI 10.1093/bioinformatics/bth449
   Wignall JA, 2014, ENVIRON HEALTH PERSP, V122, P499, DOI 10.1289/ehp.1307539
   Wood CE, 2015, TOXICOL PATHOL, V43, P760, DOI 10.1177/0192623315576005
   Wood CE, 2014, TOXICOL SCI, V139, P21, DOI 10.1093/toxsci/kfu025
   Yang LL, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-387
   Zhang Q, 2014, ENVIRON HEALTH PERSP, V122, P1261, DOI 10.1289/ehp.1408244
NR 42
TC 9
Z9 9
U1 0
U2 8
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1096-6080
EI 1096-0929
J9 TOXICOL SCI
JI Toxicol. Sci.
PD FEB
PY 2016
VL 149
IS 2
BP 312
EP 325
DI 10.1093/toxsci/kfv236
PG 14
WC Toxicology
SC Toxicology
GA DF8NF
UT WOS:000371613900008
PM 26519955
DA 2019-10-23
ER

PT J
AU Taylor, NS
   Merrifield, R
   Williams, TD
   Chipman, JK
   Lead, JR
   Viant, MR
AF Taylor, Nadine S.
   Merrifield, Ruth
   Williams, Tim D.
   Chipman, J. Kevin
   Lead, Jamie R.
   Viant, Mark R.
TI Molecular toxicity of cerium oxide nanoparticles to the freshwater alga
   Chlamydomonas reinhardtii is associated with supra-environmental
   exposure concentrations
SO NANOTOXICOLOGY
LA English
DT Article
DE Adverse outcome pathway; gene; mass spectrometry; nanomaterial;
   nanotoxicology
ID ADVERSE OUTCOME PATHWAYS; CEO2 NANOPARTICLES; ENGINEERED NANOPARTICLES;
   TOXICOGENOMIC RESPONSES; CONCEPTUAL-FRAMEWORK; RISK-ASSESSMENT;
   DAPHNIA-MAGNA; ECOTOXICITY; FATE; BEHAVIOR
AB Ceria nanoparticles (NPs) are widely used as fuel catalysts and consequently are likely to enter the environment. Their potential impacts on. biota at environmentally relevant concentrations, including uptake and toxicity, remain to be elucidated and quantitative data on which to assess risk are sparse. Therefore, a definitive assessment of the molecular and phenotypic effects of ceria NPs was undertaken, using well-characterised mono-dispersed NPs as their toxicity is likely to be higher, enabling a conservative hazard assessment. Unbiased transcriptomics and metabolomics approaches were used to investigate the potential toxicity of tightly constrained 4-5nm ceria NPs to the unicellular green alga, Chlamydomonas reinhardtii, a sentinel freshwater species. A wide range of exposure concentrations were investigated from predicted environmental levels, to support hazard assessment, to supra-environmental levels to provide insight into molecular toxicity pathways. Ceria NPs were internalised into intracellular vesicles within C. reinhardtii, yet caused no significant effect on algal growth at any exposure concentration. Molecular perturbations were only detected at supra-environmental ceria NP-concentrations, primarily down-regulation of photosynthesis and carbon fixation with associated effects on energy metabolism. For acute exposures to small mono-dispersed particles, it can be concluded there should be little concern regarding their dispersal into the environment for this trophic level.
C1 [Taylor, Nadine S.; Williams, Tim D.; Chipman, J. Kevin; Viant, Mark R.] Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England.
   [Merrifield, Ruth; Lead, Jamie R.] Univ S Carolina, Arnold Sch Publ Hlth, SmartState Ctr Environm Nanosci & Risk, Environm Hlth Sci, Columbia, SC 29208 USA.
   [Merrifield, Ruth; Lead, Jamie R.] Univ Birmingham, Sch Geog Earth & Environm Sci, Birmingham B15 2TT, W Midlands, England.
RP Viant, MR (reprint author), Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England.
EM M.Viant@bham.ac.uk
RI ; Viant, Mark/B-6339-2009
OI Williams, Timothy/0000-0002-5857-3851; Viant, Mark/0000-0001-5898-4119
FU UK Natural Environment Research CouncilNERC Natural Environment Research
   Council [NE/H008764/1, NE/H013148/1]; Center for Environmental
   Nanoscience and Risk; Advantage West Midlands (AWM); Natural Environment
   Research CouncilNERC Natural Environment Research Council [NE/H008764/1,
   NE/H013148/1]
FX We thank the UK Natural Environment Research Council (NE/H008764/1 and
   NE/H013148/1) and the Center for Environmental Nanoscience and Risk for
   financial support. The FT-ICR mass spectrometer used in this research
   was obtained through the Birmingham Science City Translational Medicine:
   Experimental Medicine Network of Excellence project, with support from
   Advantage West Midlands (AWM).
CR Ankley GT, 2006, ENVIRON SCI TECHNOL, V40, P4055, DOI 10.1021/es0630184
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Baalousha M, 2012, ENVIRON SCI TECHNOL, V46, P6134, DOI 10.1021/es301167x
   Baalousha M, 2012, ENVIRON TOXICOL CHEM, V31, P994, DOI 10.1002/etc.1786
   Baalousha M, 2012, ENVIRON TOXICOL CHEM, V31, P983, DOI 10.1002/etc.1785
   BOXALL ABA, 2007, CURRENT FUTURE PREDI
   Cassee FR, 2011, CRIT REV TOXICOL, V41, P213, DOI 10.3109/10408444.2010.529105
   Celardo I, 2011, NANOSCALE, V3, P1411, DOI 10.1039/c0nr00875c
   Evseeva T, 2010, CHEMOSPHERE, V81, P1320, DOI 10.1016/j.chemosphere.2010.08.028
   Fall M, 2007, NANOTOXICOLOGY, V1, P227, DOI 10.1080/17435390701763090
   Hassellov M, 2008, ECOTOXICOLOGY, V17, P344, DOI 10.1007/s10646-008-0225-x
   Hendren CO, 2011, ENVIRON SCI TECHNOL, V45, P2562, DOI 10.1021/es103300g
   Hoshino T, 2001, J NON-CRYST SOLIDS, V283, P129, DOI 10.1016/S0022-3093(01)00364-7
   Jamers A, 2013, BIOMETALS, V26, P731, DOI 10.1007/s10534-013-9648-9
   Johnson AC, 2012, ENVIRON TOXICOL CHEM, V31, P2582, DOI 10.1002/etc.1983
   Klaine SJ, 2008, ENVIRON TOXICOL CHEM, V27, P1825, DOI 10.1897/08-090.1
   Lee SW, 2009, ENVIRON TOXICOL PHAR, V28, P86, DOI 10.1016/j.etap.2009.03.001
   Lowry GV, 2012, ENVIRON SCI TECHNOL, V46, P7027, DOI 10.1021/es204608d
   Madl AK, 2009, CRIT REV TOXICOL, V39, P629, DOI 10.1080/10408440903133788
   Maynard AD, 2006, NATURE, V444, P267, DOI 10.1038/444267a
   Merrifield RC, 2013, ENVIRON SCI TECHNOL, V47, P12426, DOI 10.1021/es402541z
   Navarro E, 2008, ECOTOXICOLOGY, V17, P372, DOI 10.1007/s10646-008-0214-0
   OECD, 2002, GUID TEST CHEM FRESH
   Park B, 2008, INHAL TOXICOL, V20, P547, DOI 10.1080/08958370801915309 
   Park EJ, 2008, TOXICOLOGY, V245, P90, DOI 10.1016/j.tox.2007.12.022
   Pelletier DA, 2010, APPL ENVIRON MICROB, V76, P7981, DOI 10.1128/AEM.00650-10
   Poma A, 2008, CURR GENOMICS, V9, P571, DOI 10.2174/138920208786847962
   Poynton HC, 2012, ENVIRON SCI TECHNOL, V46, P6288, DOI 10.1021/es3001618
   Rodea-Palomares I, 2012, AQUAT TOXICOL, V122, P133, DOI 10.1016/j.aquatox.2012.06.005
   Rodea-Palomares I, 2011, TOXICOL SCI, V119, P135, DOI 10.1093/toxsci/kfq311
   Rogers NJ, 2010, ENVIRON CHEM, V7, P50, DOI 10.1071/EN09123
   Seaton A, 2010, J R SOC INTERFACE, V7, pS119, DOI 10.1098/rsif.2009.0252.focus
   Simon DF, 2013, APPL ENVIRON MICROB, V79, P4774, DOI 10.1128/AEM.00998-13
   Snape JR, 2004, AQUAT TOXICOL, V67, P143, DOI 10.1016/j.aquatox.2003.11.011
   Sturla SJ, 2014, CHEM RES TOXICOL, V27, P314, DOI 10.1021/tx400410s
   Tejamaya M, 2012, ENVIRON SCI TECHNOL, V46, P7011, DOI 10.1021/es2038596
   Thill A, 2006, ENVIRON SCI TECHNOL, V40, P6151, DOI 10.1021/es060999b
   Tiede K, 2009, J CHROMATOGR A, V1216, P503, DOI 10.1016/j.chroma.2008.09.008
   Tsyusko OV, 2012, ENVIRON SCI TECHNOL, V46, P4115, DOI 10.1021/es2033108
   Van Hoecke K, 2009, ENVIRON SCI TECHNOL, V43, P4537, DOI 10.1021/es9002444
   Volz DC, 2011, TOXICOL SCI, V123, P349, DOI 10.1093/toxsci/kfr185
   Wang ZY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036961
   Xia T, 2008, ACS NANO, V2, P2121, DOI 10.1021/nn800511k
   Zhang HF, 2011, ENVIRON SCI TECHNOL, V45, P3725, DOI 10.1021/es103309n
NR 44
TC 37
Z9 39
U1 2
U2 82
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1743-5390
EI 1743-5404
J9 NANOTOXICOLOGY
JI Nanotoxicology
PD JAN 2
PY 2016
VL 10
IS 1
BP 32
EP 41
DI 10.3109/17435390.2014.1002868
PG 10
WC Nanoscience & Nanotechnology; Toxicology
SC Science & Technology - Other Topics; Toxicology
GA DG1FL
UT WOS:000371810900004
PM 25740379
OA Green Published, Bronze
DA 2019-10-23
ER

PT S
AU Muller, Y
   Zhu, L
   Crawford, SE
   Kuppers, S
   Schiwy, S
   Hollert, H
AF Mueller, Y.
   Zhu, L.
   Crawford, S. E.
   Kueppers, S.
   Schiwy, S.
   Hollert, H.
BA Drewes, JE
   Letzel, T
BF Drewes, JE
   Letzel, T
TI The Utility of Exposure and Effect-Based Analysis in the
   Ecotoxicological Assessment of Transformation Products
SO ASSESSING TRANSFORMATION PRODUCTS OF CHEMICALS BY NON-TARGET AND SUSPECT
   SCREENING - STRATEGIES AND WORKFLOWS, VOL 2
SE ACS Symposium Series
LA English
DT Proceedings Paper
CT Symp on Assessing Transformation Products by Non-Target and Suspected
   Target Screening: The New Frontier in Environmental Chemistry and
   Engineering
CY AUG 16-20, 2015
CL Boston, MA
SP Amer Chem Soc, Div Environm Chem Inc
ID WHOLE EFFLUENT ASSESSMENT; ADVERSE OUTCOME PATHWAYS; VITRO MICRONUCLEUS
   TEST; WASTE-WATER; SURFACE-WATER; FRESH-WATER; EMERGING CONTAMINANTS;
   ORGANIC CONTAMINANTS; ESTROGENIC ACTIVITY; DRINKING-WATER
AB The exponential increase of organic chemicals and their associated transformation products (TPs) is a growing concern in natural and engineered systems. The identification of TPs of emerging contaminants is a major challenge due to the great diversity of chemicals, the unknown or incomplete understanding of degradation processes, the complexity of the matrices under which the chemicals may be present, and their low concentrations in the environment. More importantly, there is a lack of knowledge regarding toxicity, biological endpoints, and other tools available for the toxicological assessment of both the known and unknown TPs. This chapter discusses some of the most relevant parameters and limitations regarding the toxicological assessment of TPs.
C1 [Mueller, Y.; Zhu, L.; Crawford, S. E.; Schiwy, S.; Hollert, H.] Rhein Westfal TH Aachen, Dept Ecosyst Anal, ABBt Aachen Biol & Biotechnol, Inst Environm Res Biol 5, Worringerweg 1, D-52074 Aachen, Germany.
   [Zhu, L.; Kueppers, S.] Forschungszentrum Julich, Cent Inst Engn Elect & Analyt Analyt ZEA 3, Wilhelm Johnen Str, D-52428 Julich, Germany.
RP Crawford, SE (reprint author), Rhein Westfal TH Aachen, Dept Ecosyst Anal, ABBt Aachen Biol & Biotechnol, Inst Environm Res Biol 5, Worringerweg 1, D-52074 Aachen, Germany.
EM sarah.crawford@bio5.rwth-aachen.de
OI Zhu, Linyan/0000-0003-2036-1447; Crawford, Sarah/0000-0003-4341-701X
CR Abdel-Massih R. M., 2013, J ENV ENG ECOL SCI, DOI [10.7243/2050-1323-2-4, DOI 10.7243/2050-1323-2-4]
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   BERRIDGE MV, 1993, ARCH BIOCHEM BIOPHYS, V303, P474, DOI 10.1006/abbi.1993.1311
   Biselli S, 2005, J SOIL SEDIMENT, V5, P171, DOI 10.1065/jss2004.10.124.1
   Blaha L., 2004, SOP PROCEDURE DETERM
   Bletsou AA, 2015, TRAC-TREND ANAL CHEM, V66, P32, DOI 10.1016/j.trac.2014.11.009
   Boix C, 2016, J HAZARD MATER, V302, P175, DOI 10.1016/j.jhazmat.2015.09.053
   Bopp S., 2008, BMC PHARM, V1, P1
   Brack W, 2005, ENVIRON SCI POLLUT R, V12, P252, DOI 10.1065/espr2005.08.286
   Brack W, 2015, SCI TOTAL ENVIRON, V503, P22, DOI 10.1016/j.scitotenv.2014.05.143
   Brack Werner, 2012, Environmental Sciences Europe, V24, P29, DOI 10.1186/2190-4715-24-29
   Braunbeck T, 2005, ALTEX-ALTERN TIEREXP, V22, P87
   Braunbeck T, 2015, ENVIRON SCI POLLUT R, V22, P16247, DOI 10.1007/s11356-014-3814-7
   Brinkmann M, 2010, J SOIL SEDIMENT, V10, P1347, DOI 10.1007/s11368-010-0271-x
   Bundschuh M, 2011, J HAZARD MATER, V192, P772, DOI 10.1016/j.jhazmat.2011.05.079
   Bundschuh M, 2011, WATER RES, V45, P3999, DOI 10.1016/j.watres.2011.05.007
   Bundschuh M, 2011, ENVIRON SCI TECHNOL, V45, P3774, DOI 10.1021/es104195h
   Caldwell DJ, 2012, ENVIRON TOXICOL CHEM, V31, P1396, DOI 10.1002/etc.1825
   Chaves A, 2008, CHEMOSPHERE, V71, P629, DOI 10.1016/j.chemosphere.2007.11.015
   Chen XJ, 2012, WATER RES, V46, P2247, DOI 10.1016/j.watres.2012.01.039
   Collins R., 2011, 8 PUBL OFF EUR UN, P1
   COOPER CM, 1993, J ENVIRON QUAL, V22, P402, DOI 10.2134/jeq1993.00472425002200030003x
   DeLorenzo ME, 2008, ENVIRON TOXICOL, V23, P224, DOI 10.1002/tox.20327
   Di Paolo C, 2016, WATER RES, V104, P473, DOI 10.1016/j.watres.2016.08.018
   Doering JA, 2015, ENVIRON SCI TECHNOL, V49, P4681, DOI 10.1021/acs.est.5b00085
   Donner E, 2013, SCI TOTAL ENVIRON, V443, P870, DOI 10.1016/j.scitotenv.2012.11.059
   EC European Commission, 2011, 27 EC, P1
   Edmondson JM, 1988, J TISSUE CULT METHOD, V11, P15, DOI [DOI 10.1007/BF01404408, 10.1007/BF01404408]
   Emelogu ES, 2013, SCI TOTAL ENVIRON, V445, P261, DOI 10.1016/j.scitotenv.2012.12.053
   Environmental Protection Agency (EPA), 1996, 738R95033 EPA RED, P1
   Escher BI, 2008, J ENVIRON MONITOR, V10, P622, DOI 10.1039/b800951a
   Escher BI, 2011, WATER RES, V45, P75, DOI 10.1016/j.watres.2010.08.019
   European Chemicals Agency (ECHA), 2016, ECH16G02EN, P1
   European Commission, 2003, 20719 EUR EN, P1
   Farre M, 2003, TRAC-TREND ANAL CHEM, V22, P299, DOI 10.1016/S0165-9936(03)00504-1
   Fatta-Kassinos D, 2011, CHEMOSPHERE, V85, P693, DOI 10.1016/j.chemosphere.2011.06.082
   Fenech M, 2000, MUTAT RES-FUND MOL M, V455, P81, DOI 10.1016/S0027-5107(00)00065-8
   Garcia-Kaufer M, 2012, ENVIRON SCI POLLUT R, V19, P1719, DOI 10.1007/s11356-011-0686-y
   Gartiser S, 2009, J ENVIRON MONITOR, V11, P359, DOI 10.1039/b805746j
   Gartiser S, 2010, ENVIRON SCI POLLUT R, V17, P1149, DOI 10.1007/s11356-009-0290-6
   Gartiser S, 2010, ENVIRON SCI POLLUT R, V17, P856, DOI 10.1007/s11356-009-0289-z
   Gasser L, 2007, ENVIRON SCI TECHNOL, V41, P2445, DOI 10.1021/es062805y
   Gonzalez RJ, 2001, TOXICOL IN VITRO, V15, P257, DOI 10.1016/S0887-2333(01)00014-5
   Gracia T, 2008, ENVIRON SCI POLLUT R, V15, P332, DOI 10.1007/s11356-008-0011-6
   Gust M, 2010, WATER RES, V44, P4517, DOI 10.1016/j.watres.2010.06.019
   Harries JE, 1997, ENVIRON TOXICOL CHEM, V16, P534, DOI 10.1002/etc.5620160320
   Hecker M, 2007, ENVIRON SCI POLLUT R, V14, P23, DOI 10.1065/espr2007.03.402
   Hecker Markus, 2011, Environmental Sciences Europe, V23, P15, DOI 10.1186/2190-4715-23-15
   Hecker M, 2011, ENVIRON SCI POLLUT R, V18, P503, DOI 10.1007/s11356-010-0396-x
   Helbling DE, 2010, ENVIRON SCI TECHNOL, V44, P6621, DOI 10.1021/es100970m
   Hladik ML, 2008, SCI TOTAL ENVIRON, V390, P155, DOI 10.1016/j.scitotenv.2007.09.042
   Inostroza PA, 2016, ENVIRON POLLUT, V214, P77, DOI 10.1016/j.envpol.2016.03.064
   International Organization for Standardization (ISO), 2007, 8589 ISO, P1
   Isidori M, 2006, CHEMOSPHERE, V63, P785, DOI 10.1016/j.chemosphere.2005.07.078
   Isidori M, 2005, SCI TOTAL ENVIRON, V348, P93, DOI 10.1016/j.scitotenv.2004.12.068
   Jarosova B, 2014, ENVIRON INT, V64, P98, DOI 10.1016/j.envint.2013.12.009
   Jolibois B, 2006, ANN OCCUP HYG, V50, P189, DOI 10.1093/annhyg/mei051
   Josse R, 2012, MUTAGENESIS, V27, P295, DOI 10.1093/mutage/ger076
   Kase R., 2009, Umweltwissenschaften und Schadstoff-Forschung, V21, P339, DOI 10.1007/s12302-009-0072-2
   Kern S, 2009, ENVIRON SCI TECHNOL, V43, P7039, DOI 10.1021/es901979h
   Kidd KA, 2007, P NATL ACAD SCI USA, V104, P8897, DOI 10.1073/pnas.0609568104
   Kirsch-Volders M, 2003, MUTAT RES-GEN TOX EN, V540, P153, DOI 10.1016/j.mrgentox.2003.07.005
   Kramer VJ, 2011, ENVIRON TOXICOL CHEM, V30, P64, DOI 10.1002/etc.375
   Lahnsteiner F, 2008, ATLA-ALTERN LAB ANIM, V36, P299, DOI 10.1177/026119290803600308
   Leusch F., 2008, GLOBAL WATER RES COA, P1
   Leusch FDL, 2010, ENVIRON SCI TECHNOL, V44, P3853, DOI 10.1021/es903899d
   Liney KE, 2006, ENVIRON HEALTH PERSP, V114, P81, DOI 10.1289/ehp.8058
   Loos R, 2009, ENVIRON POLLUT, V157, P561, DOI 10.1016/j.envpol.2008.09.020
   Magdeburg A, 2014, WATER RES, V50, P35, DOI 10.1016/j.watres.2013.11.041
   Maier D, 2015, WATER RES, V72, P127, DOI 10.1016/j.watres.2014.08.050
   Maletz S, 2013, WATER RES, V47, P1545, DOI 10.1016/j.watres.2012.12.008
   Vidal JLM, 2009, J CHROMATOGR A, V1216, P6767, DOI 10.1016/j.chroma.2009.08.013
   McClain JS, 2003, ENVIRON TOXICOL CHEM, V22, P361, DOI 10.1002/etc.5620220217
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Murk AJ, 2002, ENVIRON TOXICOL CHEM, V21, P16, DOI 10.1002/etc.5620210103
   Neale PA, 2015, ENVIRON SCI TECHNOL, V49, P14614, DOI 10.1021/acs.est.5b04083
   O'Brien J, 2000, EUR J BIOCHEM, V267, P5421, DOI 10.1046/j.1432-1327.2000.01606.x
   OECD, 2011, OECD GUID TEST CHEM, P1, DOI [DOI 10.1787/9789264203785-EN, 10.1787/9789264069947-en]
   OECD, 2013, STPNANO201222FINAL, P1
   Orrego R, 2006, ENVIRON TOXICOL CHEM, V25, P2280, DOI 10.1897/05-385R.1
   OSPAR, 2007, OSPAR PRACT STUD 200, P1
   Petrie B, 2015, WATER RES, V72, P3, DOI 10.1016/j.watres.2014.08.053
   Radjenovic J, 2009, TRAC-TREND ANAL CHEM, V28, P562, DOI 10.1016/j.trac.2009.02.006
   Reifferscheid G, 2008, MUTAT RES-GEN TOX EN, V649, P15, DOI 10.1016/j.mrgentox.2007.07.015
   Roberts AP, 2005, ENVIRON TOXICOL CHEM, V24, P3092, DOI 10.1897/05-137R.1
   Routledge EJ, 1997, J BIOL CHEM, V272, P3280, DOI 10.1074/jbc.272.6.3280
   Schiwy S, 2015, ENVIRON SCI POLLUT R, V22, P16305, DOI 10.1007/s11356-014-3185-0
   Schmidt T. C., 2014, 47042600001J MKULNV, P1
   Schmitt C, 2010, ECOTOX ENVIRON SAFE, V73, P1574, DOI 10.1016/j.ecoenv.2010.07.014
   SLATER TF, 1963, BIOCHIM BIOPHYS ACTA, V77, P383, DOI 10.1016/0006-3002(63)90513-4
   Stalter D, 2011, WATER RES, V45, P1015, DOI 10.1016/j.watres.2010.10.008
   Stalter D, 2010, WATER RES, V44, P2610, DOI 10.1016/j.watres.2010.01.023
   Stalter D, 2010, WATER RES, V44, P439, DOI 10.1016/j.watres.2009.07.025
   Strahle U, 2012, REPROD TOXICOL, V33, P128, DOI 10.1016/j.reprotox.2011.06.121
   Van der Linden SC, 2008, ENVIRON SCI TECHNOL, V42, P5814, DOI 10.1021/es702897y
   van Leeuwen DM, 2011, MUTAGENESIS, V26, P27, DOI 10.1093/mutage/geq074
   Villeneuve D, 2014, ENVIRON TOXICOL CHEM, V33, P158, DOI 10.1002/etc.2403
   Wernersson AS, 2015, ENVIRON SCI EUR, V27, P1, DOI 10.1186/s12302-015-0039-4
   Whatley A, 2010, SOUTHEAST NAT, V9, P497, DOI 10.1656/058.009.0308
   Zhu LY, 2016, WATER RES, V102, P52, DOI 10.1016/j.watres.2016.06.005
NR 100
TC 3
Z9 3
U1 1
U2 1
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 SIXTEENTH ST NW, WASHINGTON, DC 20036 USA
SN 0097-6156
EI 1947-5918
BN 978-0-8412-3195-5
J9 ACS SYM SER
JI ACS Symp. Ser.
PY 2016
VL 1242
BP 89
EP +
PG 11
WC Chemistry, Analytical; Environmental Sciences
SC Chemistry; Environmental Sciences & Ecology
GA BI1FB
UT WOS:000405641600005
DA 2019-10-23
ER

PT S
AU Whelan, M
   Eskes, C
AF Whelan, Maurice
   Eskes, Chantra
BE Eskes, C
   Whelan, M
TI Evolving the Principles and Practice of Validation for New Alternative
   Approaches to Toxicity Testing
SO VALIDATION OF ALTERNATIVE METHODS FOR TOXICITY TESTING
SE Advances in Experimental Medicine and Biology
LA English
DT Article; Book Chapter
ID IN-VITRO; CHEMICALS; SELECTION; BIOACTIVITY; WORKSHOP
AB Validation is essential for the translation of newly developed alternative approaches to animal testing into tools and solutions suitable for regulatory applications. Formal approaches to validation have emerged over the past 20 years or so and although they have helped greatly to progress the field, it is essential that the principles and practice underpinning validation continue to evolve to keep pace with scientific progress. The modular approach to validation should be exploited to encourage more innovation and flexibility in study design and to increase efficiency in filling data gaps. With the focus now on integrated approaches to testing and assessment that are based on toxicological knowledge captured as adverse outcome pathways, and which incorporate the latest in vitro and computational methods, validation needs to adapt to ensure it adds value rather than hinders progress. Validation needs to be pursued both at the method level, to characterise the performance of in vitro methods in relation their ability to detect any association of a chemical with a particular pathway or key toxicological event, and at the methodological level, to assess how integrated approaches can predict toxicological endpoints relevant for regulatory decision making. To facilitate this, more emphasis needs to be given to the development of performance standards that can be applied to classes of methods and integrated approaches that provide similar information. Moreover, the challenge of selecting the right reference chemicals to support validation needs to be addressed more systematically, consistently and in a manner that better reflects the state of the science. Above all however, validation requires true partnership between the development and user communities of alternative methods and the appropriate investment of resources.
C1 [Whelan, Maurice] European Commiss, Joint Res Ctr, Ispra, Italy.
   [Eskes, Chantra] SeCAM Serv & Consultat Alternat Methods, Magliaso, Switzerland.
RP Whelan, M (reprint author), European Commiss, Joint Res Ctr, Ispra, Italy.
EM maurice.whelan@ec.europa.eu
CR Arnold SF, 1996, ENVIRON HEALTH PERSP, V104, P544, DOI 10.2307/3432996
   BALLS M, 1990, ATLA-ALTERN LAB ANIM, V18, P313
   Bouhifd M, 2012, FOOD CHEM TOXICOL, V50, P2084, DOI 10.1016/j.fct.2012.03.046
   Brown NA, 2002, ATLA-ALTERN LAB ANIM, V30, P177, DOI 10.1177/026119290203000205
   Browne P, 2015, ENVIRON SCI TECHNOL, V49, P8804, DOI 10.1021/acs.est.5b02641
   Casati S, 2009, ATLA-ALTERN LAB ANIM, V37, P305, DOI 10.1177/026119290903700313
   EFSA, 2015, EFSA SCI COMM OP DRA
   Eskes C, 2007, ALTERN LAB ANIM, V35, P1
   GHS, 2015, GLOB HARM SYST CLASS
   Hartung T, 2004, ATLA-ALTERN LAB ANIM, V32, P467, DOI 10.1177/026119290403200503
   Huang RL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10425
   Jennings P, 2014, ARCH TOXICOL, V88, P2099, DOI 10.1007/s00204-014-1410-8
   Judson R, 2015, INTEGRATED MODEL CHE, P1
   Judson R, 2014, BASIC CLIN PHARMACOL, V115, P69, DOI 10.1111/bcpt.12239
   Judson R, 2013, ALTEX-ALTERN ANIM EX, V30, P51, DOI 10.14573/altex.2013.1.051
   Kinsner-Ovaskainen A, 2012, ATLA-ALTERN LAB ANIM, V40, P175, DOI 10.1177/026119291204000310
   Kirkland D, 2016, MUTAT RES-GEN TOX EN, V795, P7, DOI 10.1016/j.mrgentox.2015.10.006
   Kleinstreuer NC, 2016, ENVIRON HEALTH PERSP, V124, P556, DOI 10.1289/ehp.1510183
   OECD, 2005, OECD SER TEST ASS
   OECD, 2016, GUID DOC RE IN PRESS
   OECD, 2014, OECD SER TEST ASS
   [OECD [OECD] Organization for Economic Cooperation and Development], 2012, OECD SER TEST ASS
   OECD, 2014, SER TEST ASS
   OECD (Organisation for Economic Co-operation and Development), 2012, OECD GUID TEST CHEM, DOI [10.1787/9789264185388-en, DOI 10.1787/9789264185388-EN]
   Pazos P, 2010, REPROD TOXICOL, V30, P161, DOI 10.1016/j.reprotox.2010.04.001
   RAAF, 2015, READ ASS FRAM
   WHO, 2014, 11 WHO
NR 27
TC 2
Z9 2
U1 0
U2 3
PU SPRINGER INT PUBLISHING AG
PI CHAM
PA GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND
SN 0065-2598
BN 978-3-319-33826-2; 978-3-319-33824-8
J9 ADV EXP MED BIOL
JI Adv.Exp.Med.Biol.
PY 2016
VL 856
BP 387
EP 399
DI 10.1007/978-3-319-33826-2_15
D2 10.1007/978-3-319-33826-2
PG 13
WC Medicine, Research & Experimental; Toxicology
SC Research & Experimental Medicine; Toxicology
GA BH5HH
UT WOS:000400937400017
PM 27671731
DA 2019-10-23
ER

PT S
AU Webster, AF
   Lambert, IB
   Yauk, CL
AF Webster, A. Francina
   Lambert, Iain B.
   Yauk, Carole L.
BE Waters, MD
   Thomas, RS
TI Toxicogenomics Case Study: Furan
SO TOXICOGENOMICS IN PREDICTIVE CARCINOGENICITY
SE Issues in Toxicology
LA English
DT Article; Book Chapter
ID ADVERSE OUTCOME PATHWAY; GENE-EXPRESSION ANALYSIS; HEALTH-RISK
   ASSESSMENT; EXPOSURE MOE APPROACH; IN-VIVO; CELL-PROLIFERATION;
   LIVER-CANCER; F344 RATS; TOXICITY; 21ST-CENTURY
C1 [Webster, A. Francina; Lambert, Iain B.] Carleton Univ, Dept Biol, 1125 Colonel By Dr, Ottawa, ON, Canada.
   [Webster, A. Francina; Yauk, Carole L.] Hlth Canada, Environm Hlth Sci & Res Bur, 50 Colombine Driveway, Ottawa, ON, Canada.
RP Yauk, CL (reprint author), Hlth Canada, Environm Hlth Sci & Res Bur, 50 Colombine Driveway, Ottawa, ON, Canada.
EM carole.yauk@canada.ca
CR Auerbach SS, 2015, J APPL TOXICOL, V35, P766, DOI 10.1002/jat.3068
   Auerbach SS, 2010, TOXICOL APPL PHARM, V243, P300, DOI 10.1016/j.taap.2009.11.021
   Bass BP, 2014, ARCH PATHOL LAB MED, V138, P1520, DOI 10.5858/arpa.2013-0691-RA
   Becker RA, 2015, REGUL TOXICOL PHARM, V72, P514, DOI 10.1016/j.yrtph.2015.04.004
   Bourdon JA, 2013, TOXICOLOGY, V303, P83, DOI 10.1016/j.tox.2012.10.014
   Bourdon JA, 2012, TOXICOL SCI, V127, P474, DOI 10.1093/toxsci/kfs119
   Bourdon-Lacombe JA, 2015, REGUL TOXICOL PHARM, V72, P292, DOI 10.1016/j.yrtph.2015.04.010
   Budczies J, 2011, J HISTOCHEM CYTOCHEM, V59, P146, DOI 10.1369/jhc.2010.956607
   Burden N, 2015, J APPL TOXICOL, V35, P971, DOI 10.1002/jat.3165
   Burden N, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002156
   BURKA LT, 1991, J TOXICOL ENV HEALTH, V34, P245, DOI 10.1080/15287399109531564
   CARFAGNA MA, 1993, TOXICOL APPL PHARM, V123, P265, DOI 10.1006/taap.1993.1245
   Carthew P, 2010, FOOD CHEM TOXICOL, V48, pS69, DOI 10.1016/j.fct.2009.10.017
   Carthew P, 2010, FOOD CHEM TOXICOL, V48, pS98, DOI 10.1016/j.fct.2009.10.035
   Cederbaum A, 2009, EXPERT OPIN DRUG MET, V5, P1223, DOI 10.1517/17425250903143769
   Churchwell MI, 2015, FOOD CHEM TOXICOL, V86, P1, DOI 10.1016/j.fct.2015.08.029
   Crews C, 2007, FOOD ADDIT CONTAM, V24, P108, DOI 10.1080/02652030701329934
   Crews C, 2009, FOOD ADDIT CONTAM B, V2, P95, DOI 10.1080/02652030903095408
   Ding W, 2012, TOXICOL APPL PHARM, V261, P164, DOI 10.1016/j.taap.2012.03.021
   Dix DJ, 2007, TOXICOL SCI, V95, P5, DOI 10.1093/toxsci/kfl103
   Dong H, 2015, DIS MARKERS, DOI 10.1155/2015/625659
   Ellinger-Ziegelbauer H, 2009, TOXICOL LETT, V186, P36, DOI 10.1016/j.toxlet.2008.08.017
   Farragher SM, 2008, HISTOCHEM CELL BIOL, V130, P435, DOI 10.1007/s00418-008-0479-7
   FranssonSteen R, 1997, TOXICOLOGY, V118, P195, DOI 10.1016/S0300-483X(97)03618-4
   Gates LA, 2014, DRUG METAB DISPOS, V42, P1132, DOI 10.1124/dmd.114.057794
   Gates LA, 2012, DRUG METAB DISPOS, V40, P596, DOI 10.1124/dmd.111.043679
   Gonzalez FJ, 2005, MUTAT RES-FUND MOL M, V569, P101, DOI 10.1016/j.mrfmmm.2004.04.021
   GORSKY LD, 1984, J BIOL CHEM, V259, P6812
   Han ZG, 2012, ANNU REV GENOM HUM G, V13, P171, DOI 10.1146/annurev-genom-090711-163752
   Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9
   Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013
   Hasnip S, 2006, FOOD ADDIT CONTAM A, V23, P219, DOI 10.1080/02652030500539766
   Hickling KC, 2010, TOXICOL PATHOL, V38, P230, DOI 10.1177/0192623309357946
   Holsapple MP, 2006, TOXICOL SCI, V89, P51, DOI 10.1093/toxsci/kfj001
   IARC, 1995, DRY CLEAN SOM CHLOR
   Jackson AF, 2013, J PHARMACOL TOX MET, V68, P260, DOI 10.1016/j.vascn.2013.02.008
   Jackson AF, 2014, TOXICOL APPL PHARM, V274, P63, DOI 10.1016/j.taap.2013.10.019
   Jacobson TAS, 2011, INT J ONCOL, V38, P1075, DOI 10.3892/ijo.2011.936
   Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]
   Judson R, 2014, BASIC CLIN PHARMACOL, V115, P69, DOI 10.1111/bcpt.12239
   Judson RS, 2010, ENVIRON HEALTH PERSP, V118, P485, DOI 10.1289/ehp.0901392
   KEDDERIS GL, 1993, TOXICOL APPL PHARM, V123, P274, DOI 10.1006/taap.1993.1246
   Kellert M, 2008, CHEM RES TOXICOL, V21, P761, DOI 10.1021/tx7004212
   Kensler TW, 2011, TOXICOL SCI, V120, pS28, DOI 10.1093/toxsci/kfq283
   Kew MC, 2013, J GASTROINTEST LIVER, V22, P305
   Khalaf N, 2015, CLIN GASTROENTEROL H, V13, P1521, DOI 10.1016/j.cgh.2015.01.030
   Kleinstreuer NC, 2014, NAT BIOTECHNOL, V32, P583, DOI 10.1038/nbt.2914
   Klopfleisch R, 2011, HISTOL HISTOPATHOL, V26, P797, DOI 10.14670/HH-26.797
   Knapen D, 2015, REPROD TOXICOL, V56, P52, DOI 10.1016/j.reprotox.2015.04.003
   Knudsen TB, 2011, TOXICOLOGY, V282, P1, DOI 10.1016/j.tox.2010.12.010
   Krewski D, 2010, J TOXICOL ENV HEAL B, V13, P51, DOI 10.1080/10937404.2010.483176
   Labib S, 2012, TOXICOL SCI, V129, P213, DOI 10.1093/toxsci/kfs177
   Landesmann B, 2013, ATLA-ALTERN LAB ANIM, V41, P461, DOI 10.1177/026119291304100609
   LARSON JL, 1994, FUND APPL TOXICOL, V23, P537, DOI 10.1006/faat.1994.1138
   Linton K, 2012, J MOL DIAGN, V14, P223, DOI 10.1016/j.jmoldx.2012.01.008
   Liu J, 2015, CHEM RES TOXICOL, V28, P738, DOI 10.1021/tx500501h
   Lu Y, 2008, FREE RADICAL BIO MED, V44, P723, DOI 10.1016/j.freeradbiomed.2007.11.004
   Ma Q, 2012, PHARMACOL REV, V64, P1055, DOI 10.1124/pr.110.004333
   MacKay C, 2013, ALTEX-ALTERN ANIM EX, V30, P473, DOI 10.14573/altex.2013.4.473
   Maertens RM, 2013, TOXICOLOGY, V308, P60, DOI 10.1016/j.tox.2013.03.008
   MAGA JA, 1979, CRC CR REV FOOD SCI, V11, P355, DOI 10.1080/10408397909527268
   Manibusan MK, 2007, J ENVIRON SCI HEAL C, V25, P185, DOI 10.1080/10590500701569398
   Merrick BA, 2012, CHEM RES TOXICOL, V25, P1132, DOI 10.1021/tx3000945
   Min LH, 2012, NAT CELL BIOL, V14, P1203, DOI 10.1038/ncb2590
   Morisco F, 2014, J CLIN GASTROENTEROL, V48, pS87, DOI 10.1097/MCG.0000000000000240
   Moro S, 2012, MOL NUTR FOOD RES, V56, P1197, DOI 10.1002/mnfr.201200093
   Moser GJ, 2009, EXP TOXICOL PATHOL, V61, P101, DOI 10.1016/j.etp.2008.06.006
   Nakagawa H., 2012, PATHOL RES INT
   Nesnow S, 2009, TOXICOL SCI, V110, P68, DOI 10.1093/toxsci/kfp076
   NTP, 1993, NTP TECHN REP TOX CA
   OECD, 2009, OECD GUID TEST CHEM
   Oishi N, 2014, LIVER CANCER, V3, P71, DOI 10.1159/000343863
   Padilla S, 2012, REPROD TOXICOL, V33, P174, DOI 10.1016/j.reprotox.2011.10.018
   Pye C, 2014, FOOD ADDIT CONTAM B, V7, P43, DOI 10.1080/19393210.2013.835874
   Recio L, 2013, TOXICOL SCI, V135, P369, DOI 10.1093/toxsci/kft153
   Rinn J. L., 2012, GENOME REGULATION LO
   RUSSELL WMS, 1959, PRINCIPLES HUMAN EXP
   Russom CL, 2014, ENVIRON TOXICOL CHEM, V33, P2157, DOI 10.1002/etc.2662
   Sadi A, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-253
   Setiawan VW, 2015, GASTROENTEROLOGY, V148, P118, DOI 10.1053/j.gastro.2014.10.005
   Settivari RS, 2015, J AM ASSOC LAB ANIM, V54, P214
   Stanger BZ, 2015, ANNU REV PHYSIOL, V77, P179, DOI 10.1146/annurev-physiol-021113-170255
   Templin MV, 1996, CANCER LETT, V108, P225, DOI 10.1016/S0304-3835(96)04427-8
   Thomas RS, 2013, TOXICOL SCI, V136, P4, DOI 10.1093/toxsci/kft178
   Thomas RS, 2013, TOXICOL SCI, V134, P180, DOI 10.1093/toxsci/kft094
   Tonk ECM, 2015, REPROD TOXICOL, V55, P104, DOI 10.1016/j.reprotox.2014.10.008
   Vinken M, 2013, TOXICOL SCI, V136, P97, DOI 10.1093/toxsci/kft177
   Waters MD, 2010, MUTAT RES-REV MUTAT, V705, P184, DOI 10.1016/j.mrrev.2010.04.005
   Webster AF, 2015, TOXICOL SCI, V148, P460, DOI 10.1093/toxsci/kfv195
   Webster AF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136764
   Yang LL, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-387
   Yanger K, 2011, DEV DYNAM, V240, P521, DOI 10.1002/dvdy.22561
   Yao CDQ, 2012, TOXICOL APPL PHARM, V260, P135, DOI 10.1016/j.taap.2012.02.001
   Yauk CL, 2015, ENVIRON MOL MUTAGEN, V56, P724, DOI 10.1002/em.21954
   Yoon M, 2015, TOXICOLOGY, V332, P1, DOI 10.1016/j.tox.2015.02.002
NR 95
TC 1
Z9 1
U1 0
U2 0
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, CAMBRIDGE CB4 4WF, CAMBS, ENGLAND
SN 1757-7179
BN 978-1-78262-405-9; 978-1-78262-162-1
J9 ISSUES TOXICOL
PY 2016
VL 28
BP 390
EP 422
D2 10.1039/9781782624059
PG 33
WC Toxicology
SC Toxicology
GA BH5EM
UT WOS:000400843100013
DA 2019-10-23
ER

PT S
AU Bushel, PR
AF Bushel, Pierre R.
BE Waters, MD
   Thomas, RS
TI Bioinformatics of Genomics in the Assessment of Cancer
SO TOXICOGENOMICS IN PREDICTIVE CARCINOGENICITY
SE Issues in Toxicology
LA English
DT Article; Book Chapter
ID GENE-EXPRESSION DATA; ADVERSE OUTCOME PATHWAYS; REGULATORY NETWORKS;
   SIGNAL-TRANSDUCTION; MICROARRAY; PATTERNS; THRESHOLDS; DATABASE; TIME;
   TOOL
C1 [Bushel, Pierre R.] NIEHS, Biostat & Computat Biol Branch, POB 12233, Res Triangle Pk, NC 27709 USA.
RP Bushel, PR (reprint author), NIEHS, Biostat & Computat Biol Branch, POB 12233, Res Triangle Pk, NC 27709 USA.
EM bushel@niehs.nih.gov
CR Alberghina L, 2005, SYSTEMS BIOL DEFINIT
   ALDRIDGE WN, 1986, ANNU REV PHARMACOL, V26, P39
   Aluru S, 2006, HDB COMPUTATIONAL MO
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Bargou RC, 1996, J EXP MED, V183, P1205, DOI 10.1084/jem.183.3.1205
   Bellman R., 1957, DYNAMIC PROGRAMMING
   Bennett BD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044635
   Breslin T, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-163
   Bushel PR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034286
   Bushel Pierre R., 2009, Journal of Bioinformatics and Computational Biology, V7, P193, DOI 10.1142/S021972000900400X
   Bushel PR, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-15
   Casarett L. J., 2001, CASARETT DOULLS TOXI
   Chang C, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-S5-S6
   Cheng KO, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-210
   Chou JW, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-272
   Chou JW, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-427
   Emmert-Streib F, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00015
   FARMER JH, 1980, J ENVIRON PATHOL TOX, V3, P55
   FRY RJM, 1989, CANCER INVEST, V7, P299, DOI 10.3109/07357908909039852
   Gallagher J, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-344
   Groh KJ, 2015, CHEMOSPHERE, V120, P778, DOI 10.1016/j.chemosphere.2014.10.006
   Gusenleitner D, 2012, BIOINFORMATICS, V28, P2484, DOI 10.1093/bioinformatics/bts438
   Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5
   Ji LP, 2005, BIOINFORMATICS, V21, P509, DOI 10.1093/bioinformatics/bti026
   Kaiser J, 2012, SCIENCE, V335, P651, DOI 10.1126/science.335.6069.651
   Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27
   Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076
   Kauffman S, 2004, J THEOR BIOL, V230, P581, DOI 10.1016/j.jtbi.2003.12.017
   Kirsch-Volders M, 2000, MUTAT RES-GEN TOX EN, V464, P3, DOI 10.1016/S1383-5718(99)00161-8
   Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412
   KOTIN P, 1976, ANN NY ACAD SCI, V271, P22, DOI 10.1111/j.1749-6632.1976.tb23088.x
   Krull M, 2003, NUCLEIC ACIDS RES, V31, P97, DOI 10.1093/nar/gkg089
   Langmead CJ, 2003, J COMPUT BIOL, V10, P521, DOI 10.1089/10665270360688165
   Lee ST, 2011, J NEURO-ONCOL, V102, P19, DOI 10.1007/s11060-010-0286-6
   Lengauer T., 2001, ACM SPECIAL INTEREST, P1
   Leung E, 2006, BIOINFORMATICS, V22, P367, DOI 10.1093/bioinformatics/bti778
   LITTLEFIELD NA, 1980, J ENVIRON PATHOL TOX, V3, P17
   Liu DL, 2004, BIOINFORMATICS, V20, P2521, DOI 10.1093/bioinformatics/bth274
   Liu LZ, 2014, BMC SYST BIOL, V8, DOI [10.1186/1752-0509-8-S3-S1, 10.1186/1752-0509-8-73]
   Lobenhofer EK, 2004, TOXICOL PATHOL, V32, P482, DOI 10.1080/01926230490483324
   Lonergan Peter E, 2011, J Carcinog, V10, P20, DOI 10.4103/1477-3163.83937
   LOWNDES NF, 1989, MOL CELL BIOL, V9, P3758, DOI 10.1128/MCB.9.9.3758
   Lutz WK, 2000, HUM EXP TOXICOL, V19, P566, DOI 10.1191/096032700701546488
   Madeira SC, 2004, IEEE ACM T COMPUT BI, V1, P24, DOI 10.1109/TCBB.2004.2
   Maojo V, 2012, INT J NANOMED, V7, P3867, DOI 10.2147/IJN.S24582
   Mar JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025445
   MESAROVIC MD, 1968, P 3 SYST S CAS I TEC
   Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092
   Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118
   Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180
   Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797
   NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4
   Niehrs C, 1999, NATURE, V402, P483, DOI 10.1038/990025
   Nuwaysir EF, 1999, MOL CARCINOGEN, V24, P153, DOI 10.1002/(SICI)1098-2744(199903)24:3<153::AID-MC1>3.0.CO;2-P
   Paules R, 2003, ENVIRON HEALTH PERSP, V111, pA338, DOI 10.1289/ehp.111-a338
   Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093
   Purchase IFH, 1995, REGUL TOXICOL PHARM, V22, P199, DOI 10.1006/rtph.1995.0001
   Ramaswamy S, 2001, P NATL ACAD SCI USA, V98, P15149, DOI 10.1073/pnas.211566398
   Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2
   Ritchie MD, 2015, NAT REV GENET, V16, P85, DOI 10.1038/nrg3868
   Ross DT, 2000, NAT GENET, V24, P227, DOI 10.1038/73432
   Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434
   SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467
   Scherf U, 2000, NAT GENET, V24, P236, DOI 10.1038/73439
   Shaffer AL, 2001, IMMUNITY, V15, P375, DOI 10.1016/S1074-7613(01)00194-7
   Shi LM, 2010, NAT BIOTECHNOL, V28, P827, DOI 10.1038/nbt.1665
   Simon R, 2005, NAT CLIN PRACT ONCOL, V2, P223, DOI 10.1038/ncponc0176
   Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100
   Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098
   STADEN R, 1977, NUCLEIC ACIDS RES, V4, P4037, DOI 10.1093/nar/4.11.4037
   Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102
   Tamayo P, 1999, P NATL ACAD SCI USA, V96, P2907, DOI 10.1073/pnas.96.6.2907
   Thomas RS, 2013, TOXICOL SCI, V134, P180, DOI 10.1093/toxsci/kft094
   Tomasetti C, 2015, SCIENCE, V347, P78, DOI 10.1126/science.1260825
   UPTON AC, 1970, RADIAT RES, V41, P467, DOI 10.2307/3572837
   Villeneuve DL, 2014, TOXICOL SCI, V142, P312, DOI 10.1093/toxsci/kfu199
   Villeneuve DL, 2014, TOXICOL SCI, V142, P321, DOI 10.1093/toxsci/kfu200
   Vinken M, 2015, CHEM RES TOXICOL, V28, P1391, DOI 10.1021/acs.chemrestox.5b00208
   Vinken M, 2013, TOXICOLOGY, V312, P158, DOI 10.1016/j.tox.2013.08.011
   Volinia S, 2013, P NATL ACAD SCI USA, V110, P7413, DOI 10.1073/pnas.1304977110
   Waddell WJ, 2003, TOXICOL SCI, V72, P158, DOI 10.1093/toxsci/kfg004
   Wang C, 2014, NAT BIOTECHNOL, V32, P926, DOI 10.1038/nbt.3001
   Wang Y, 2006, BIOINFORMATICS, V22, P2413, DOI 10.1093/bioinformatics/btl396
   Wang Z, 2010, TRANSL ONCOL, V3, P1, DOI 10.1593/tlo.09250
   Waters M, 2008, NUCLEIC ACIDS RES, V36, pD892, DOI 10.1093/nar/gkm755
   Williams-DeVane CR, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-119
   Wingender E, 2000, NUCLEIC ACIDS RES, V28, P316, DOI 10.1093/nar/28.1.316
   Wingender E, 2001, NUCLEIC ACIDS RES, V29, P281, DOI 10.1093/nar/29.1.281
   Yang LL, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-387
   Yoon S, 2005, IEEE ACM T COMPUT BI, V2, P339, DOI 10.1109/TCBB.2005.55
   Zhu HL, 2012, NUCLEIC ACIDS RES, V40, P10657, DOI 10.1093/nar/gks860
NR 91
TC 1
Z9 1
U1 0
U2 1
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, CAMBRIDGE CB4 4WF, CAMBS, ENGLAND
SN 1757-7179
BN 978-1-78262-405-9; 978-1-78262-162-1
J9 ISSUES TOXICOL
PY 2016
VL 28
BP 442
EP 483
D2 10.1039/9781782624059
PG 42
WC Toxicology
SC Toxicology
GA BH5EM
UT WOS:000400843100015
DA 2019-10-23
ER

PT J
AU Bridges, J
   Solomon, KR
AF Bridges, Jim
   Solomon, Keith R.
TI Quantitative weight-of-evidence analysis of the persistence,
   bioaccumulation, toxicity, and potential for long-range transport of the
   cyclic volatile methyl siloxanes
SO JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART B-CRITICAL REVIEWS
LA English
DT Review
ID TROPHIC MAGNIFICATION FACTORS; ADVERSE OUTCOME PATHWAYS;
   ORGANIC-CHEMICALS; RISK-ASSESSMENT; END-POINTS;
   DECAMETHYLCYCLOPENTASILOXANE D5; PARTITION-COEFFICIENTS; UNEXPECTED
   OCCURRENCE; EVIDENCE FRAMEWORK; ANTARCTIC SOILS
AB Cyclic volatile methyl siloxanes (cVMSs) are highly volatile and have an unusual combination of physicochemical properties, which are unlike those of halocarbon-based chemicals used to establish criteria for identification of persistent organic pollutants (POPs) that undergo long-range transport (LRT). A transparent quantitative weight of evidence (QWoE) evaluation was conducted to characterize their properties. Measurements of concentrations of cVMSs in the environment are challenging, but currently, concentrations measured in robust studies are all less than thresholds of toxicity. The cVMSs are moderately persistent in air with half-lives 11d (greater than the criterion of 2d) but these compounds partition into the atmosphere, the final sink. The cVMSs are rapidly degraded in dry soils, partition from wet soils into the atmosphere, and are not classifiable as persistent in soils. Persistence in water and sediment is variable, but the greatest concentrations in the environment are observed in sediments. Based upon the measurements that have been made in the environment, cVMSs should not be classified as persistent. Studies in food webs support a conclusion that the cVMSs do not biomagnify, a conclusion that is consistent with results of toxicokinetic studies. Concentrations in air in remote locations are small and deposition has not been detected. Taken together, evidence indicates that traditional measures of persistence and biomagnification used for legacy POP are not suitable for cVMS. Refined approaches used here suggest that cVMSs are not classifiable as persistent, bioaccumulative, or toxic. Further, these chemicals do not undergo LRT in the sense of legacy POPs.
C1 [Bridges, Jim] Univ Surrey, Dept Toxicol & Environm Hlth, Guildford, Surrey, England.
   [Solomon, Keith R.] Univ Guelph, Sch Environm Sci, Ctr Toxicol, Guelph, ON, Canada.
RP Solomon, KR (reprint author), Univ Guelph, Ctr Toxicol, 2120 Bovey Bldg,Gordon St, Guelph, ON N1G 2W1, Canada.; Solomon, KR (reprint author), Univ Guelph, Dept Environm Biol, 2120 Bovey Bldg,Gordon St, Guelph, ON N1G 2W1, Canada.
EM ksolomon@uoguelph.ca
OI Solomon, Keith R/0000-0002-8496-6413
CR Andersen ME, 2008, TOXICOL LETT, V179, P85, DOI 10.1016/j.toxlet.2008.04.007
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Arrate J.A., 2004, LIMNETICA, V23, P25
   ATKINSON R, 1991, ENVIRON SCI TECHNOL, V25, P863, DOI 10.1021/es00017a005
   Becker RA, 2015, REGUL TOXICOL PHARM, V72, P514, DOI 10.1016/j.yrtph.2015.04.004
   Borga K, 2013, ENVIRON SCI TECHNOL, V47, P14394, DOI 10.1021/es404374j
   Borga K, 2012, ENVIRON SCI TECHNOL, V46, P6347, DOI 10.1021/es300875d
   Borga K, 2012, INTEGR ENVIRON ASSES, V8, P64, DOI 10.1002/ieam.244
   Borgert CJ, 2014, BIRTH DEFECTS RES B, V101, P90, DOI 10.1002/bdrb.21096
   Borgert CJ, 2011, REGUL TOXICOL PHARM, V61, P185, DOI 10.1016/j.yrtph.2011.07.007
   Burkhard LP, 2013, ENVIRON SCI TECHNOL, V47, P1186, DOI 10.1021/es305253r
   Burkhard LP, 2012, INTEGR ENVIRON ASSES, V8, P17, DOI 10.1002/ieam.260
   Burkhard LP, 2012, INTEGR ENVIRON ASSES, V8, P32, DOI 10.1002/ieam.218
   Chapman PM, 2007, ENVIRON INT, V33, P492, DOI 10.1016/j.envint.2006.09.001
   Czub G, 2004, ENVIRON SCI TECHNOL, V38, P2406, DOI 10.1021/es034871v
   EC/ HC (Environment Canada and Health Canada), 2008, SCREEN ASS CHALL DOD
   EC/ HC (Environment Canada and Health Canada), 2008, SCREEN ASS CHALL OCT
   Environment Agency, 2014, D5 PBT VPVB EV
   Environment Agency, 2014, D4 PBT VPVB EV
   European Chemicals Agency, 2010, PRACT GUID 2 REP WEI
   Fairbrother A, 2015, ENVIRON TOXICOL CHEM, V34, P2715, DOI 10.1002/etc.3041
   Genualdi S, 2011, ENVIRON SCI TECHNOL, V45, P3349, DOI 10.1021/es200301j
   Giesy JP, 2016, INTEGR ENVIRON ASSES, V12, P572, DOI 10.1002/ieam.1729
   Giesy John P., 2014, Environmental Sciences Europe, V26, P29, DOI 10.1186/s12302-014-0029-y
   Gobas FAPC, 2015, ENVIRON TOXICOL CHEM, V34, P2703, DOI 10.1002/etc.3242
   Gobas FAPC, 2015, ENVIRON TOXICOL CHEM, V34, P2723, DOI 10.1002/etc.2942
   Gobas Frank A. P. C., 2009, Integrated Environmental Assessment and Management, V5, P624, DOI 10.1897/IEAM_2008-089.1
   Goedkoop W, 2005, ENVIRON TOXICOL CHEM, V24, P2725, DOI 10.1897/04-523R.1
   Goss KU, 2013, ENVIRON TOXICOL CHEM, V32, P1663, DOI 10.1002/etc.2229
   Gough D, 2007, APPL PRACTICE BASED, V22, P213, DOI DOI 10.1080/02671520701296189
   HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503
   Horii Y, 2008, ARCH ENVIRON CON TOX, V55, P701, DOI 10.1007/s00244-008-9172-z
   Humberstone AJ, 1997, ADV DRUG DELIVER REV, V25, P103, DOI 10.1016/S0169-409X(96)00494-2
   Kierkegaard A, 2013, CHEMOSPHERE, V93, P789, DOI 10.1016/j.chemosphere.2012.10.050
   Kierkegaard A, 2011, ENVIRON SCI TECHNOL, V45, P5936, DOI 10.1021/es200707r
   Kozerski GE, 2014, ENVIRON TOXICOL CHEM, V33, P1937, DOI 10.1002/etc.2640
   Krogseth IS, 2013, ENVIRON SCI TECHNOL, V47, P502, DOI 10.1021/es3040208
   Lutter R, 2015, RISK ANAL, V35, P186, DOI 10.1111/risa.12277
   Mackay D, 2015, ENVIRON TOXICOL CHEM, V34, P2687, DOI 10.1002/etc.2934
   Mackay D, 2015, ENVIRON TOXICOL CHEM, V34, P2689, DOI 10.1002/etc.2941
   Mackay D, 2015, ENVIRON SCI TECHNOL, V49, P11913, DOI 10.1021/acs.est.5b03195
   Mackay D, 2015, ENVIRON SCI TECHNOL, V49, P7507, DOI 10.1021/acs.est.5b01936
   Mackay D, 2014, CHEMOSPHERE, V111, P359, DOI 10.1016/j.chemosphere.2014.04.033
   Madronich S, 2015, PHOTOCH PHOTOBIO SCI, V14, P149, DOI 10.1039/c4pp90037e
   McDonald BG, 2007, INTEGR ENVIRON ASSES, V3, P476, DOI 10.1897/IEAM_2007-017.1
   McLachlan MS, 2010, ENVIRON SCI TECHNOL, V44, P5365, DOI 10.1021/es100411w
   Moermond Caroline T. A., 2012, Integrated Environmental Assessment and Management, V8, P359, DOI 10.1002/ieam.1248
   Montemayor BP, 2013, CHEMOSPHERE, V93, P735, DOI 10.1016/j.chemosphere.2012.10.043
   Nilsson HC, 2000, MAR ECOL PROG SER, V197, P139, DOI 10.3354/meps197139
   Norwood WP, 2013, CHEMOSPHERE, V93, P805, DOI 10.1016/j.chemosphere.2012.10.052
   Parrott JL, 2013, CHEMOSPHERE, V93, P813, DOI 10.1016/j.chemosphere.2012.10.053
   Rhomberg LR, 2010, CRIT REV TOXICOL, V40, P671, DOI 10.3109/10408444.2010.499504
   Sanchis J, 2015, ENVIRON SCI TECHNOL, V49, P7510, DOI 10.1021/acs.est.5b02184
   SEHSC, 2007, LONG RANGE TRANSP PO
   Seston R. M., 2014, INTEGR ENVIRON ASSES, V10, P142, DOI DOI 10.1002/IEAM.1495
   Siloxane D5 Board of Review, 2011, REP BOARD REV DEC D5
   Solomon K, 2000, CROP PROT, V19, P649, DOI 10.1016/S0261-2194(00)00086-7
   Stephenson GL, 2000, ENVIRON TOXICOL CHEM, V19, P2968, DOI [10.1897/1551-5028(2000)019<2968:UONRTF>2.0.CO;2, 10.1002/etc.5620191218]
   Talalay PG, 2007, ANN GLACIOL, V47, P82, DOI 10.3189/172756407786857785
   *UN NAT ENV PROGR, 2001, STOCKH CONV PERS ORG
   United Nations Economic Commission for Europe, 1998, PROT 1979 CONV LONG
   United States Environmental Protection Agency, 1998, GUID EC RISK ASS
   Van der Kraak GJ, 2014, CRIT REV TOXICOL, V44, P1, DOI 10.3109/10408444.2014.967836
   van der Linde A, 2001, CHEMOSPHERE, V44, P423, DOI 10.1016/S0045-6535(00)00213-7
   Velicogna J, 2012, CHEMOSPHERE, V87, P77, DOI 10.1016/j.chemosphere.2011.11.064
   Wang DG, 2013, CHEMOSPHERE, V93, P711, DOI 10.1016/j.chemosphere.2012.10.041
   Wang DG, 2013, CHEMOSPHERE, V93, P766, DOI 10.1016/j.chemosphere.2012.10.047
   Wang R, 2009, ENVIRON INT, V35, P900, DOI 10.1016/j.envint.2009.03.009
   Wania F, 2006, ENVIRON SCI TECHNOL, V40, P569, DOI 10.1021/es051406k
   Wania F, 2003, ENVIRON SCI TECHNOL, V37, P1344, DOI 10.1021/es026019e
   Warner NA, 2015, ENVIRON SCI TECHNOL, V49, P7504, DOI 10.1021/acs.est.5b01612
   Webster E, 1998, ENVIRON TOXICOL CHEM, V17, P2148, DOI 10.1002/etc.5620171104
   Weed DL, 2005, RISK ANAL, V25, P1545, DOI 10.1111/j.1539-6924.2005.00699.x
   Wheeler JR, 2014, REGUL TOXICOL PHARM, V69, P289, DOI 10.1016/j.yrtph.2014.05.021
   Whelan MJ, 2013, CHEMOSPHERE, V93, P794, DOI 10.1016/j.chemosphere.2012.10.051
   Woodburn K, 2013, CHEMOSPHERE, V93, P779, DOI 10.1016/j.chemosphere.2012.10.049
   Xu SH, 1999, ENVIRON SCI TECHNOL, V33, P4034, DOI 10.1021/es990099d
   Xu SH, 1998, ENVIRON SCI TECHNOL, V32, P1199, DOI 10.1021/es9708676
   Xu SH, 1999, ENVIRON SCI TECHNOL, V33, P603, DOI 10.1021/es980803a
   Xu SH, 2014, ENVIRON SCI TECHNOL, V48, P11748, DOI 10.1021/es503465b
   Xu SH, 2013, CHEMOSPHERE, V93, P835, DOI 10.1016/j.chemosphere.2012.10.056
   Xu SH, 2013, J CHEM ENG DATA, V58, P136, DOI 10.1021/je301005b
   Xu SH, 2012, ANAL CHEM, V84, P1948, DOI 10.1021/ac202953t
NR 83
TC 6
Z9 6
U1 0
U2 17
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1093-7404
EI 1521-6950
J9 J TOXICOL ENV HEAL B
JI J. Toxicol. Env. Health-Pt b-Crit. Rev.
PY 2016
VL 19
IS 8
BP 345
EP 379
DI 10.1080/10937404.2016.1200505
PG 35
WC Environmental Sciences; Public, Environmental & Occupational Health;
   Toxicology
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health; Toxicology
GA ED2RB
UT WOS:000388694800002
PM 27656778
OA Bronze
DA 2019-10-23
ER

PT S
AU Vinken, M
AF Vinken, Mathieu
BE Benfenati, E
TI Adverse Outcome Pathways as Tools to Assess Drug-Induced Toxicity
SO IN SILICO METHODS FOR PREDICTING DRUG TOXICITY
SE Methods in Molecular Biology
LA English
DT Article; Book Chapter
DE AOP; Drug safety; Steatosis; Fibrosis; Cholestasis
ID SALT EXPORT PUMP; MECHANISMS; FRAMEWORK; INHIBITION; DISEASE
AB Adverse outcome pathways (AOPs) are novel tools in toxicology and human risk assessment with broad potential. AOPs are designed to provide a clear-cut mechanistic representation of toxicological effects that span over different layers of biological organization. AOPs share a common structure consisting of a molecular initiating event, a series of key events connected by key event relationships, and an adverse outcome. Development and evaluation of AOPs ideally complies with guidelines issued by the Organization for Economic Cooperation and Development. AOP frameworks have yet been proposed for major types of drug-induced injury, especially in the liver, including steatosis, fibrosis, and cholestasis. These newly postulated AOPs can serve a number of purposes pertinent to safety assessment of drugs, in particular the establishment of quantitative structure-activity relationships, the development of novel in vitro toxicity screening tests, and the elaboration of prioritization strategies.
C1 [Vinken, Mathieu] Vrije Univ Brussel, Inst Pharmaceut, Dept In Vitro Toxicol & Dermatocosmetol, Brussels, Belgium.
RP Vinken, M (reprint author), Vrije Univ Brussel, Inst Pharmaceut, Dept In Vitro Toxicol & Dermatocosmetol, Brussels, Belgium.
RI Vinken, Mathieu/H-7513-2013
OI Vinken, Mathieu/0000-0001-5115-8893; VUB, IVTD/0000-0002-5016-4789
FU European Research CouncilEuropean Research Council (ERC) [335476]
CR Amacher DE, 2011, EXPERT OPIN DRUG MET, V7, P949, DOI 10.1517/17425255.2011.577740
   Andersen M., 2012, REPLACEMENT IN VIVO, V2, P347
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Begriche K, 2011, J HEPATOL, V54, P773, DOI 10.1016/j.jhep.2010.11.006
   Bogdanffy MS, 2001, TOXICOL SCI, V61, P18, DOI 10.1093/toxsci/61.1.18
   Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265
   Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003
   Friedman SL, 2010, NAT REV GASTRO HEPAT, V7, P425, DOI 10.1038/nrgastro.2010.97
   HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503
   Hirano H, 2006, MOL PHARMACEUT, V3, P252, DOI 10.1021/mp060004w
   Hofmann A. F., 2009, LIVER BIOL PATHOBIOL, P289
   Honorio Kathia M, 2008, Open Med Chem J, V2, P87, DOI 10.2174/1874104500802010087
   Judson R, 2013, ALTEX-ALTERN ANIM EX, V30, P51, DOI 10.14573/altex.2013.1.051
   Julien E, 2009, CRIT REV FOOD SCI, V49, P682, DOI 10.1080/10408390903110692
   LANDESMANN B, 2012, 75689 JRC
   Lee UE, 2011, BEST PRACT RES CL GA, V25, P195, DOI 10.1016/j.bpg.2011.02.005
   Meek ME, 2003, CRIT REV TOXICOL, V33, P591, DOI 10.1080/10408440390250136
   NRC, 2007, TOXICITY TESTING 21
   OECD, 2013, SER TEST ASS, V184, P1
   Padda MS, 2011, HEPATOLOGY, V53, P1377, DOI 10.1002/hep.24229
   Ramachandran R, 2009, J CLIN PATHOL, V62, P481, DOI 10.1136/jcp.2008.058248
   Saito H, 2009, AAPS J, V11, P581, DOI 10.1208/s12248-009-9137-9
   Schoemaker MH, 2004, HEPATOLOGY, V39, P1563, DOI 10.1002/hep.20246
   Seed J, 2005, CRIT REV TOXICOL, V35, P663, DOI 10.1080/10408440591007133
   U.S. Environmental Protection Agency (EPA), 2005, EPA630P03001F, P1
   Villeneuve DL, 2014, TOXICOL SCI, V142, P312, DOI 10.1093/toxsci/kfu199
   Villeneuve DL, 2014, TOXICOL SCI, V142, P321, DOI 10.1093/toxsci/kfu200
   Vinken M, 2013, CURR MED CHEM, V20, P3011, DOI 10.2174/0929867311320240006
   Vinken M, 2013, TOXICOL SCI, V136, P97, DOI 10.1093/toxsci/kft177
   Vinken M, 2013, TOXICOLOGY, V312, P158, DOI 10.1016/j.tox.2013.08.011
   Vinken M, 2012, ARCH TOXICOL, V86, P405, DOI 10.1007/s00204-011-0769-z
   Wagner M, 2009, J HEPATOL, V51, P565, DOI 10.1016/j.jhep.2009.05.012
   Warner DJ, 2012, DRUG METAB DISPOS, V40, P2332, DOI 10.1124/dmd.112.047068
   Woolbright BL, 2012, WORLD J GASTROENTERO, V18, P4985, DOI 10.3748/wjg.v18.i36.4985
   Yozzo KL, 2013, AQUAT TOXICOL, V126, P346, DOI 10.1016/j.aquatox.2012.09.008
   Zimmerman H J, 2000, Clin Liver Dis, V4, P73, DOI 10.1016/S1089-3261(05)70097-0
   Zollner G, 2006, WIEN MED WOCHENSCHR, V156, P380, DOI 10.1007/s10354-006-0312-7
   Zollner G, 2008, CLIN LIVER DIS, V12, P1, DOI 10.1016/j.cld.2007.11.010
NR 38
TC 6
Z9 6
U1 1
U2 6
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013, UNITED STATES
SN 1064-3745
EI 1940-6029
BN 978-1-4939-3609-0; 978-1-4939-3607-6
J9 METHODS MOL BIOL
JI Methods Mol. Biol.
PY 2016
VL 1425
BP 325
EP 337
DI 10.1007/978-1-4939-3609-0_14
D2 10.1007/978-1-4939-3609-0
PG 13
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Pharmacology & Pharmacy
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy
GA BG2YT
UT WOS:000387782000015
PM 27311472
OA Green Accepted
DA 2019-10-23
ER

PT S
AU Mansouri, K
   Judson, RS
AF Mansouri, Kamel
   Judson, Richard S.
BE Benfenati, E
TI In Silico Study of In Vitro GPCR Assays by QSAR Modeling
SO IN SILICO METHODS FOR PREDICTING DRUG TOXICITY
SE Methods in Molecular Biology
LA English
DT Article; Book Chapter
DE QSAR; GPCR; ToxCast; Toxicity; Machine learning
ID LEAST-SQUARES REGRESSION; EPAS TOXCAST PROGRAM; ENVIRONMENTAL CHEMICALS;
   PLS-REGRESSION; TOXICITY; TOXICOLOGY; RECEPTOR
AB The US EPA's ToxCast program is screening thousands of chemicals of environmental interest in hundreds of in vitro high-throughput screening (HTS) assays. One goal is to prioritize chemicals for more detailed analyses based on activity in assays that target molecular initiating events (MIEs) of adverse outcome pathways (AOPs). However, the chemical space of interest for environmental exposure is much wider than ToxCast's chemical library. In silico methods such as quantitative structure-activity relationships (QSARs) are proven and cost--effective approaches to predict biological activity for untested chemicals. However, empirical data is needed to build and validate QSARs. ToxCast has developed datasets for about 2000 chemicals ideal for training and testing QSAR models. The overall goal of the present work was to develop QSAR models to fill the data gaps in larger environmental chemical lists. The specific aim of the current work was to build QSAR models for 18 G-protein-coupled receptor (GPCR) assays, part of the aminergic family. Two QSAR modeling strategies were adopted: classification models were developed to separate chemicals into active/ non-active classes, and then regression models were built to predict the potency values of the bioassays for the active chemicals. Multiple software programs were used to calculate constitutional, topological, and substructural molecular descriptors from two-dimensional (2D) chemical structures. Model-fitting methods included PLSDA (partial least square discriminant analysis), SVMs (support vector machines), kNNs (k-nearest neighbors), and PLSs (partial least squares). Genetic algorithms (GAs) were applied as a variable selection technique to select the most predictive molecular descriptors for each assay. N-fold cross-validation (CV) coupled with multi-criteria decision-making fitting criteria was used to evaluate the models. Finally, the models were applied to make predictions within the established chemical space limits. The most accurate model was for the bovine nonselective dopamine receptor (bDR_ NS) GPCR assay, for which the classification balanced accuracy reached 0.96 in fitting and 0.95 in fivefold CV, with only two latent variables. These results demonstrate the accuracy of QSAR models to predict the biological activity of chemicals specifically for each one of the studied assays.
C1 [Mansouri, Kamel] US EPA, ORISE, Natl Ctr Computat Toxicol, Off Res & Dev, Res Triangle Pk, NC 27711 USA.
   [Judson, Richard S.] US EPA, Natl Ctr Computat Toxicol, Off Res & Dev, Res Triangle Pk, NC 27711 USA.
RP Mansouri, K (reprint author), US EPA, ORISE, Natl Ctr Computat Toxicol, Off Res & Dev, Res Triangle Pk, NC 27711 USA.
RI Williams, Antony/C-3089-2009
OI Williams, Antony/0000-0002-2668-4821; Mansouri,
   Kamel/0000-0002-6426-8036
CR [Anonymous], 2013, MATLAB VERS 8 2
   Ballabio D, 2009, CHEMOMETR INTELL LAB, V98, P115, DOI 10.1016/j.chemolab.2009.05.007
   Benigni R, 2013, J ENVIRON SCI HEAL C, V31, P201, DOI 10.1080/10590501.2013.824188
   Benigni R, 2010, J ENVIRON SCI HEAL C, V28, P272, DOI 10.1080/10590501.2010.525781
   Berthold M. R., 2007, KNIME KONSTANZ INFOR
   Boser B. E., 1992, Proceedings of the Fifth Annual ACM Workshop on Computational Learning Theory, P144, DOI 10.1145/130385.130401
   Bourne H, 2007, GPCRS DEORPHANIZATIO, DOI [10.1007/978-3-540-48982-5, DOI 10.1007/978-3-540-48982-5]
   Chang C-C, 2001, LIBSVM LIB SUPPORT V
   ChemAxon, 2014, CHEMAXON STAND CHEM
   Cherkasov A, 2014, J MED CHEM, V57, P4977, DOI 10.1021/jm4004285
   Consonni V, 2010, J CHEMOMETR, V24, P194, DOI 10.1002/cem.1290
   Consonni V, 2009, J CHEM INF MODEL, V49, P1669, DOI 10.1021/ci900115y
   CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411
   Cronin MTD, 2010, ISSUES TOXICOL, V7, P1, DOI 10.1039/9781849732093
   Dearden JC, 2009, SAR QSAR ENVIRON RES, V20, P241, DOI 10.1080/10629360902949567
   DEJONG S, 1993, CHEMOMETR INTELL LAB, V18, P251, DOI 10.1016/0169-7439(93)85002-X
   Dix DJ, 2007, TOXICOL SCI, V95, P5, DOI 10.1093/toxsci/kfl103
   Egeghy PP, 2012, SCI TOTAL ENVIRON, V414, P159, DOI 10.1016/j.scitotenv.2011.10.046
   Fliri AF, 2005, P NATL ACAD SCI USA, V102, P261, DOI 10.1073/pnas.0407790101
   Houck KA, 2009, J BIOMOL SCREEN, V14, P1054, DOI 10.1177/1087057109345525
   Janzen WP, 2006, CHEM BIOL DRUG DES, V67, P85, DOI 10.1111/j.1747-0285.2005.00325.x
   Judson R, 2014, BASIC CLIN PHARMACOL, V115, P69, DOI 10.1111/bcpt.12239
   Judson R, 2009, ENVIRON HEALTH PERSP, V117, P685, DOI 10.1289/ehp.0800168
   Judson RS, 2015, TOXICOL SCI, V148, P137, DOI 10.1093/toxsci/kfv168
   Judson RS, 2010, ENVIRON HEALTH PERSP, V118, P485, DOI 10.1289/ehp.0901392
   Kavlock R, 2012, CHEM RES TOXICOL, V25, P1287, DOI 10.1021/tx3000939
   Knight AW, 2009, REGUL TOXICOL PHARM, V55, P188, DOI 10.1016/j.yrtph.2009.07.004
   KOWALSKI BR, 1972, ANAL CHEM, V44, P1405, DOI 10.1021/ac60316a008
   Krewski D, 2010, J TOXICOL ENV HEAL B, V13, P51, DOI 10.1080/10937404.2010.483176
   Leardi R, 1998, CHEMOMETR INTELL LAB, V41, P195, DOI 10.1016/S0169-7439(98)00051-3
   Mansouri K, 2016, CERAPP COLLABORATIVE, DOI [10.1289/ehp.1510267, DOI 10.1289/EHP.1510267]
   Martin MT, 2011, BIOL REPROD, V85, P327, DOI 10.1095/biolreprod.111.090977
   Martin MT, 2010, CHEM RES TOXICOL, V23, P578, DOI 10.1021/tx900325g
   Mevik BH, 2007, J STAT SOFTW, V18, P1
   Muster WG, 2008, DRUG DISCOV TODAY, V13, P303, DOI 10.1016/j.drudis.2007.12.007
   NIH, 2015, PUBCHEM PROJ
   Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199
   Reusch W, 2013, EXAMPLES CHEM REACTI
   Rotroff DM, 2013, CHEM RES TOXICOL, V26, P1097, DOI 10.1021/tx400117y
   Rotroff DM, 2010, J TOXICOL ENV HEAL B, V13, P329, DOI 10.1080/10937404.2010.483949
   Sinclair CJ, 2009, HANDB ENVIRON CHEM, V2, P177, DOI 10.1007/698_2_019
   Sipes NS, 2013, CHEM RES TOXICOL, V26, P878, DOI [10.1021/tx400021f, 10.1021/tx400021]
   Sipes NS, 2011, TOXICOL SCI, V124, P109, DOI 10.1093/toxsci/kfr220
   Sitzmann M, 2008, SAR QSAR ENVIRON RES, V19, P1, DOI 10.1080/10629360701843540
   STAHLE L, 1987, Journal of Chemometrics, V1, P185, DOI 10.1002/cem.1180010306
   Todeschini R., 2008, HDB MOL DESCRIPTORS
   Vedani A, 2009, ATLA-ALTERN LAB ANIM, V37, P477, DOI 10.1177/026119290903700506
   Whitacre DM, 2008, REV ENV CONTAMINATIO, V199
   Wold S, 2001, CHEMOMETR INTELL LAB, V58, P109, DOI 10.1016/S0169-7439(01)00155-1
   Worth A. P., 2005, CHARACTERISATION QUA
   Yap CW, 2011, J COMPUT CHEM, V32, P1466, DOI 10.1002/jcc.21707
NR 51
TC 5
Z9 5
U1 0
U2 5
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013, UNITED STATES
SN 1064-3745
BN 978-1-4939-3609-0; 978-1-4939-3607-6
J9 METHODS MOL BIOL
JI Methods Mol. Biol.
PY 2016
VL 1425
BP 361
EP 381
DI 10.1007/978-1-4939-3609-0_16
D2 10.1007/978-1-4939-3609-0
PG 21
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Pharmacology & Pharmacy
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy
GA BG2YT
UT WOS:000387782000017
PM 27311474
DA 2019-10-23
ER

PT J
AU Balcombe, J
AF Balcombe, Jonathan
TI INT: OECD launches a new series on adverse outcome pathways
SO ALTEX-ALTERNATIVES TO ANIMAL EXPERIMENTATION
LA English
DT News Item
C1 [Balcombe, Jonathan] Humane Soc, Inst Sci & Policy, Anim Sentience, Washington, DC 20037 USA.
RP Balcombe, J (reprint author), Humane Soc, Inst Sci & Policy, Anim Sentience, Washington, DC 20037 USA.
EM jbalcombe@humanesociety.org
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SPEKTRUM AKADEMISCHER VERLAG-SPRINGER-VERLAG GMBH
PI HEILDEBERG
PA TIERGARTENSTRASSE 17, HEILDEBERG, 69121, GERMANY
SN 1868-596X
EI 1868-8551
J9 ALTEX-ALTERN ANIM EX
JI ALTEX-Altern. Anim. Exp.
PY 2016
VL 33
IS 4
BP 481
EP 481
PG 1
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA EB5RY
UT WOS:000387439200018
OA DOAJ Gold
DA 2019-10-23
ER

PT J
AU Martins, JD
   Silva, A
   Ferreira, I
   Goncalo, M
   Custodio, JBA
   Lopes, MC
   Domingues, MRM
   Neves, BM
   Cruz, MT
AF Martins, J. D.
   Silva, A.
   Ferreira, I.
   Goncalo, M.
   Custodio, J. B. A.
   Lopes, M. C.
   Domingues, M. R. M.
   Neves, B. M.
   Cruz, M. T.
TI Adenosine diphosphate involvement in THP-1 maturation triggered by the
   contact allergen 1-fluoro-2,4-dinitrobenzene
SO TOXICOLOGY RESEARCH
LA English
DT Article
ID HUMAN DENDRITIC CELLS; IN-VITRO; ADENINE-NUCLEOTIDES; EXTRACELLULAR ATP;
   P2Y RECEPTORS; PURINERGIC RECEPTORS; MYELOID LEUKOCYTES; SIGNALING
   PATHWAYS; TNF-ALPHA; EXPRESSION
AB Dendritic cells' (DC) activation is considered a key event in the adverse outcome pathway for skin sensitization elicited by covalent binding of chemicals to proteins. The mechanisms underlying DC activation by contact sensitizers are not completely understood. However, several "danger signals" are pointed as relevant effectors. Among these extra-cellular early danger signals, purines may be crucial for the development of xenoinflammation and several reports indicate their involvement in contact allergic reactions. In the present work we used the DC-surrogate monocytic cell line THP-1, cultured alone or co-cultured with the human keratinocyte cell line HaCaT, to explore the contribution of extracellular adenine nucleotides to THP-1 maturation triggered by the extreme contact sensitizer, 1-fluoro-2,4-dinitrobenzene (DNFB). We found that THP-1 maturation induced by DNFB is impaired after purinergic signaling inhibition, and that the transcription of the purinergic metabotropic receptors P2Y2 and P2Y11 is modulated by the sensitizer. We also detected that THP-1 cells only partially hydrolyse extracellular adenosine triphosphate, leading to accumulation of the mono-phosphate derivative, AMP. We detected different and non-overlapping activation patterns of mitogen activated protein kinases by DNFB and extracellular nucleotides. Overall, our results indicate that THP-1 maturation induced by DNFB is strongly modulated by extracellular adenine nucleotides through metabotropic purinergic receptors. This knowledge unveils a molecular toxicity pathway evoked by sensitizers and involved in THP-1 maturation, a DC-surrogate cell line thoroughly used in in vitro tests for the identification of skin allergens.
C1 [Martins, J. D.; Custodio, J. B. A.; Lopes, M. C.; Neves, B. M.; Cruz, M. T.] Univ Coimbra, Fac Pharm, P-3000548 Coimbra, Portugal.
   [Martins, J. D.; Silva, A.; Ferreira, I.; Custodio, J. B. A.; Lopes, M. C.; Neves, B. M.; Cruz, M. T.] Univ Coimbra, CNC Ctr Neurosci & Cell Biol, P-3004517 Coimbra, Portugal.
   [Goncalo, M.] Univ Coimbra, Univ Hosp, Dept Dermatol, P-3000075 Coimbra, Portugal.
   [Goncalo, M.] Univ Coimbra, Fac Med, P-3000075 Coimbra, Portugal.
   [Domingues, M. R. M.; Neves, B. M.] Univ Aveiro, QOPNA, Mass Spectrometry Ctr, Dept Chem, Campus Univ Santiago, P-3810193 Aveiro, Portugal.
RP Martins, JD (reprint author), Univ Coimbra, Fac Pharm, P-3000548 Coimbra, Portugal.; Martins, JD (reprint author), Univ Coimbra, CNC Ctr Neurosci & Cell Biol, P-3004517 Coimbra, Portugal.
EM jdmartins@oninet.pt; trosete@ff.uc.pt
RI Domingues, Rosario M/K-7444-2014; Ferreira, Isabel C.F.R./E-8500-2013;
   Rosete, Maria teresa Cruz/F-5288-2013; Neves, Bruno/L-2557-2016; Cruz,
   Maria Teresa/AAA-7151-2019
OI Domingues, Rosario M/0000-0001-5357-3601; Ferreira, Isabel
   C.F.R./0000-0003-4910-4882; Rosete, Maria teresa
   Cruz/0000-0001-9846-6754; Neves, Bruno/0000-0001-7391-3124; Cruz, Maria
   Teresa/0000-0001-9846-6754; Custodio, Jose/0000-0001-5694-966X;
   Ferreira, Isabel/0000-0002-4934-917X; Silva, Ana/0000-0002-4041-0376
FU Fundo Europeu de Desenvolvimento Regional - FEDER funds through the
   Operational Programme Competitiveness Factors - COMPETE; national funds
   by FCT - Foundation for Science and Technology under the strategic
   project [UID/NEU/04539/2013, SFRH/BD/73065/2010]; Johns Hopkins Center
   for Alternatives to Animal Testing [2014-07]; ToxVitroTesting, Quadro de
   Referencia Estrategico Nacional (QREN) - Empresas em co-promocao
   [38977]; FEDEREuropean Union (EU) [REDE/1504/REM/2005]; Fundacao para a
   Ciencia e a Tecnologia (FCT, Portugal); European UnionEuropean Union
   (EU); QREN; COMPETE;  [PEst-C/QUI/UI0062/2013]; 
   [FCOMP-01-0124-FEDER-037296]
FX This work was supported by Fundo Europeu de Desenvolvimento Regional -
   FEDER funds through the Operational Programme Competitiveness Factors -
   COMPETE and national funds by FCT - Foundation for Science and
   Technology under the strategic project [UID/NEU/04539/2013] and grant
   [SFRH/BD/73065/2010] to Martins J. D.; by the Johns Hopkins Center for
   Alternatives to Animal Testing [project ref: 2014-07]; and by
   ToxVitroTesting, Quadro de Referencia Estrategico Nacional (QREN) -
   Empresas em co-promocao [project ref: 38977]. Thanks are due to Fundacao
   para a Ciencia e a Tecnologia (FCT, Portugal); European Union; QREN;
   COMPETE; and FEDER for funding the project [REDE/1504/REM/2005] (that
   concerns the Portuguese Mass Spectrometry Network), and the projects
   [PEst-C/QUI/UI0062/2013] and [FCOMP-01-0124-FEDER-037296] (that concerns
   the QOPNA research unit).
CR Adrian K, 2000, BBA-GENE STRUCT EXPR, V1492, P127, DOI 10.1016/S0167-4781(00)00094-4
   Aga M, 2002, J LEUKOCYTE BIOL, V72, P222
   Alcaraz L, 2003, BIOORG MED CHEM LETT, V13, P4043, DOI 10.1016/j.bmcl.2003.08.033
   Arrighi JF, 2001, J IMMUNOL, V166, P3837, DOI 10.4049/jimmunol.166.6.3837
   Ashikaga T, 2006, TOXICOL IN VITRO, V20, P767, DOI 10.1016/j.tiv.2005.10.012
   Baranowska-Bosiacka I, 2005, CELL MOL BIOL LETT, V10, P217
   BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761
   Bours MJL, 2006, PHARMACOL THERAPEUT, V112, P358, DOI 10.1016/j.pharmthera.2005.04.013
   Cardoso CMP, 2003, TOXICOL IN VITRO, V17, P663, DOI 10.1016/S0887-2333(03)00106-1
   Caunt CJ, 2006, TRENDS ENDOCRIN MET, V17, P276, DOI 10.1016/j.tem.2006.07.008
   Clifford EE, 1997, AM J PHYSIOL-CELL PH, V273, pC973
   Czajkowski R, 2004, BRIT J PHARMACOL, V141, P497, DOI 10.1038/sj.bjp.0705639
   da Cruz CM, 2006, BRIT J PHARMACOL, V147, P324, DOI 10.1038/sj.bjp.0706559
   Deaglio S, 2011, ADV PHARMACOL, V61, P301, DOI 10.1016/B978-0-12-385526-8.00010-2
   Di Virgilio F, 2009, CURR OPIN PHARMACOL, V9, P507, DOI 10.1016/j.coph.2009.06.021
   Dixon CJ, 1999, BRIT J PHARMACOL, V127, P1680, DOI 10.1038/sj.bjp.0702653
   Ferrari D, 2000, FASEB J, V14, P2466, DOI 10.1096/fj.00-0031com
   Goldsmith ZG, 2007, ONCOGENE, V26, P3122, DOI 10.1038/sj.onc.1210407
   Grabbe S, 1996, J CLIN INVEST, V98, P1158, DOI 10.1172/JCI118899
   Humphreys BD, 1998, J LEUKOCYTE BIOL, V64, P265
   Into T, 2002, INFECT IMMUN, V70, P3586, DOI 10.1128/IAI.70.7.3586-3591.2002
   Khoa ND, 2001, J IMMUNOL, V167, P4026, DOI 10.4049/jimmunol.167.7.4026
   Kobayashi K, 2008, J NEUROSCI, V28, P2892, DOI 10.1523/JNEUROSCI.5589-07.2008
   Kukulski F., 2011, MOL MECH PURINE PYRI, P263
   la Sala A, 2002, BLOOD, V99, P1715, DOI 10.1182/blood.V99.5.1715
   la Sala A, 2001, J IMMUNOL, V166, P1611, DOI 10.4049/jimmunol.166.3.1611
   Lazarowski ER, 2011, ADV PHARMACOL, V61, P221, DOI 10.1016/B978-0-12-385526-8.00008-4
   Liu QH, 1999, FEBS LETT, V445, P402, DOI 10.1016/S0014-5793(99)00161-1
   Mamedova LK, 2006, BIOCHEM PHARMACOL, V72, P1031, DOI 10.1016/j.bcp.2006.07.017
   Marteau F, 2004, J LEUKOCYTE BIOL, V76, P796, DOI 10.1189/jlb.0104032
   Martin KA, 1997, MOL PHARMACOL, V51, P97
   Martin SF, 2008, J EXP MED, V205, P2151, DOI 10.1084/jem.20070509
   Martin SF, 2012, CURR OPIN IMMUNOL, V24, P720, DOI 10.1016/j.coi.2012.08.003
   Martin SF, 2012, EXP DERMATOL, V21, P382, DOI 10.1111/j.1600-0625.2012.01471.x
   Mitjans M, 2010, TOXICOL IN VITRO, V24, P1803, DOI 10.1016/j.tiv.2010.06.001
   Miyazawa M, 2008, J TOXICOL SCI, V33, P71, DOI 10.2131/jts.33.71
   Mizuashi M, 2005, J INVEST DERMATOL, V124, P579, DOI 10.1111/j.0022-202X.2005.23624.x
   Mizumoto N, 2003, J INVEST DERMATOL, V121, P1066, DOI 10.1046/j.1523-1747.2003.12558.x
   Mizumoto N, 2002, NAT MED, V8, P358, DOI 10.1038/nm0402-358
   Muller T, 2010, ALLERGY, V65, P1545, DOI 10.1111/j.1398-9995.2010.02426.x
   Neves BM, 2011, TOXICOL APPL PHARM, V250, P87, DOI 10.1016/j.taap.2010.10.003
   Neves BM, 2009, MOL IMMUNOL, V46, P2481, DOI 10.1016/j.molimm.2009.05.021
   Novitskiy SV, 2008, BLOOD, V112, P1822, DOI 10.1182/blood-2008-02-136325
   OECD, 2014, ADV OUTC PATHW SKIN
   Onami K, 2014, J INVEST DERMATOL, V134, P1951, DOI 10.1038/jid.2014.93
   Peiser M, 2012, CELL MOL LIFE SCI, V69, P763, DOI 10.1007/s00018-011-0846-8
   Praetorius HA, 2009, PURINERG SIGNAL, V5, P433, DOI 10.1007/s11302-009-9146-2
   Rayah A, 2012, MICROBES INFECT, V14, P1254, DOI 10.1016/j.micinf.2012.07.006
   Ring S, 2009, J ALLERGY CLIN IMMUN, V123, P1287, DOI 10.1016/j.jaci.2009.03.022
   Roggen EL, 2014, BASIC CLIN PHARMACOL, V115, P32, DOI 10.1111/bcpt.12202
   Schnurr M, 2005, BLOOD, V105, P1582, DOI 10.1182/blood-2004-05-1718
   Schulte G, 2003, CELL SIGNAL, V15, P813, DOI 10.1016/S0898-6568(03)00058-5
   STOCCHI V, 1985, ANAL BIOCHEM, V146, P118, DOI 10.1016/0003-2697(85)90405-1
   Stokes L, 2006, BRIT J PHARMACOL, V149, P880, DOI 10.1038/sj.bjp.0706933
   Tan CY, 2010, CELL MOL LIFE SCI, V67, P445, DOI 10.1007/s00018-009-0191-3
   Trompezinski S, 2008, TOXICOL APPL PHARM, V230, P397, DOI 10.1016/j.taap.2008.03.012
   Weber FC, 2010, J EXP MED, V207, P2609, DOI 10.1084/jem.20092489
   Wilkin F, 2002, EUR J IMMUNOL, V32, P2409, DOI 10.1002/1521-4141(200209)32:9<2409::AID-IMMU2409>3.0.CO;2-H
   Wilkin F, 2001, J IMMUNOL, V166, P7172, DOI 10.4049/jimmunol.166.12.7172
   Wortzel Inbal, 2011, Genes Cancer, V2, P195, DOI 10.1177/1947601911407328
   Yegutkin GG, 2002, BIOCHEM J, V367, P121, DOI 10.1042/BJ20020439
   Yoshida Y, 2003, TOXICOL IN VITRO, V17, P221, DOI 10.1016/S0887-2333(03)00006-7
NR 62
TC 0
Z9 0
U1 0
U2 7
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2045-452X
EI 2045-4538
J9 TOXICOL RES-UK
JI Toxicol. Res.
PY 2016
VL 5
IS 6
BP 1512
EP 1521
DI 10.1039/c6tx00240d
PG 10
WC Toxicology
SC Toxicology
GA EB0DJ
UT WOS:000387013300002
PM 30090452
OA Green Published
DA 2019-10-23
ER

PT J
AU Zhu, H
   Bouhifd, M
   Donley, E
   Egnash, L
   Kleinstreuer, N
   Kroese, ED
   Liu, ZC
   Luechtefeld, T
   Palmer, J
   Pamies, D
   Shen, J
   Strauss, V
   Wu, SD
   Hartung, T
AF Zhu, Hao
   Bouhifd, Mounir
   Donley, Elizabeth
   Egnash, Laura
   Kleinstreuer, Nicole
   Kroese, E. Dinant
   Liu, Zhichao
   Luechtefeld, Thomas
   Palmer, Jessica
   Pamies, David
   Shen, Jie
   Strauss, Volker
   Wu, Shengde
   Hartung, Thomas
TI Supporting Read-Across Using Biological Data
SO ALTEX-ALTERNATIVES TO ANIMAL EXPERIMENTATION
LA English
DT Article
DE read-across; biological similarity; safety assessment; big data
ID COMPARATIVE TOXICOGENOMICS DATABASE; COMPUTATIONAL TOXICOLOGY RESOURCE;
   DETECTING REPRODUCTIVE TOXICANTS; ADVERSE OUTCOME PATHWAY; VITRO TEST
   BATTERY; IN-VITRO; RISK-ASSESSMENT; ENVIRONMENTAL CHEMICALS;
   REGISTRATIONS 2008-2014; DEVELOPMENTAL TOXICITY
AB Read-across, i.e., filling toxicological data gaps by relating to similar chemicals for which test data are available, is usually done based on chemical similarity. Besides structure and physico-chemical properties, biological similarity based on biological data adds extra strength to this process. In the simplest case, chemically similar substances also show similar test results in relevant in vitro assays. This is a well-established method for the read-across of, e.g., genotoxicity assays. Larger datasets of biological and toxicological properties of hundreds and thousands of substances are becoming available, enabling big data approaches in read-across studies. In the context of developing Good Read-Across Practice guidance, a number of case studies using various big data sources were evaluated to assess the contribution of biological data to enriching read-across. An example is given for the US EPA's ToxCast dataset which allows read-across for high quality uterotrophic assays for estrogenic endocrine disruption. Similarly, an example is given for REACH registration data that enhances read-across for acute toxicity studies. A different approach is taken using omics data to establish biological similarity: Examples are given for in vitro stem cell models and short-term in vivo repeated dose studies in rats used to support read-across and category formation. These preliminary biological data-driven read-across studies show the way towards the generation of new read-across approaches that can inform chemical safety assessment.
C1 [Zhu, Hao] Rutgers State Univ, Dept Chem, Camden, NJ USA.
   [Zhu, Hao] Rutgers State Univ, Ctr Computat & Integrat Biol, Camden, NJ USA.
   [Bouhifd, Mounir; Luechtefeld, Thomas; Pamies, David; Hartung, Thomas] Johns Hopkins Bloomberg Sch Publ Hlth, CAAT, Baltimore, MD USA.
   [Donley, Elizabeth; Egnash, Laura; Palmer, Jessica] Stemina Biomarker Discovery Inc, Madison, WI USA.
   [Kleinstreuer, Nicole] NIEHS, Natl Toxicol Program, Interagency Ctr Evaluat Alternat Toxicol Methods, POB 12233, Res Triangle Pk, NC 27709 USA.
   [Kroese, E. Dinant] TNO, Risk Anal Prod Dev, Zeist, Netherlands.
   [Liu, Zhichao] US FDA, NCTR, Little Rock, AR USA.
   [Shen, Jie] Res Inst Fragrance Mat Inc, Woodcliff Lake, NJ USA.
   [Strauss, Volker] BASF Aktiengesellsch Expt Toxicol & Ecol, Ludwigshafen, Germany.
   [Wu, Shengde] Procter & Gamble, Cincinnati, OH USA.
   [Hartung, Thomas] Univ Konstanz, CAAT Europe, Constance, Germany.
RP Hartung, T (reprint author), Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Alternat Anim Testing, 615 North Wolfe St, Baltimore, MD 21205 USA.
EM thartun1@jhu.edu
RI Kleinstreuer, Nicole/F-7203-2019
OI Kleinstreuer, Nicole/0000-0002-7914-3682; Palmer,
   Jessica/0000-0001-7373-4118; Pamies, David/0000-0002-1224-573X; Strauss,
   Volker/0000-0001-7363-9663
FU NIEHS training grant [T32 ES007141]; EU Horizon 2020 project EUToxRisk
FX T.L. was supported by NIEHS training grant (T32 ES007141). Support from
   the EU Horizon 2020 project EUToxRisk is gratefully appreciated.
CR Abdo A, 2009, CHEMMEDCHEM, V4, P210, DOI 10.1002/cmdc.200800290
   Adcock C., 2009, PESTICIDE RESIDUES 2, P317
   Adler S, 2011, ARCH TOXICOL, V85, P367, DOI 10.1007/s00204-011-0693-2
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Austin CP, 2004, SCIENCE, V306, P1138, DOI 10.1126/science.1105511
   Ball N, 2016, ALTEX-ALTERN ANIM EX, V33, P149, DOI 10.14573/altex.1601251
   Betts KS, 2013, ENVIRON HEALTH PERSP, V121, pA228, DOI 10.1289/ehp.121-a228
   Blaauboer BJ, 2012, ALTEX-ALTERN ANIM EX, V29, P411, DOI 10.14573/altex.2012.4.411
   Bosgra S, 2015, REPROD TOXICOL, V55, P73, DOI 10.1016/j.reprotox.2014.11.001
   Bouhifd M, 2015, ALTEX-ALTERN ANIM EX, V32, P319, DOI 10.14573/altex.1509161
   Bouhifd M, 2013, J APPL TOXICOL, V33, P1365, DOI 10.1002/jat.2874
   Daston GP, 2010, BIRTH DEFECTS RES B, V89, P526, DOI 10.1002/bdrb.20276
   Davis AP, 2015, NUCLEIC ACIDS RES, V43, pD914, DOI 10.1093/nar/gku935
   DENTONKELAAR EM, 1991, PESTICIDE RESIDUES F
   Dewhurst I., 2006, WHOPCS061, P281
   Dix DJ, 2007, TOXICOL SCI, V95, P5, DOI 10.1093/toxsci/kfl103
   ECETOC, 2008, 11 ECETOC
   ECETOC, 2013, 25 ECETOC
   ECETOC, 2010, 19 ECETOC
   Fonger GC, 2000, TOXICOL IND HEALTH, V16, P4, DOI 10.1177/074823370001600101
   Ganter B, 2005, J BIOTECHNOL, V119, P219, DOI 10.1016/j.jbiotec.2005.03.022
   Gaulton A, 2012, NUCLEIC ACIDS RES, V40, pD1100, DOI 10.1093/nar/gkr777
   Gramatica P, 2007, QSAR COMB SCI, V26, P694, DOI 10.1002/qsar.200610151
   Hartung T, 2004, ATLA-ALTERN LAB ANIM, V32, P467, DOI 10.1177/026119290403200503
   Hartung T, 2007, ALTEX-ALTERN TIEREXP, V24, P67
   Hartung T, 2013, ALTEX-ALTERN ANIM EX, V30, P3, DOI 10.14573/altex.2013.1.003
   Hartung T, 2010, ALTEX-ALTERN ANIM EX, V27, P3
   Hartung T, 2009, ALTEX-ALTERN TIEREXP, V26, P155
   Hecker M, 2011, ENVIRON SCI POLLUT R, V18, P503, DOI 10.1007/s11356-010-0396-x
   Hengstler JG, 2006, TOXICOLOGY, V220, P232, DOI 10.1016/j.tox.2005.12.2005
   Hermsen SAB, 2011, TOXICOL IN VITRO, V25, P745, DOI 10.1016/j.tiv.2011.01.005
   Inglese J, 2006, P NATL ACAD SCI USA, V103, P11473, DOI 10.1073/pnas.0604348103
   Judson R, 2008, TOXICOL APPL PHARM, V233, P7, DOI 10.1016/j.taap.2007.12.037
   Judson RS, 2012, INT J MOL SCI, V13, P1805, DOI 10.3390/ijms13021805
   Judson RS, 2010, ENVIRON HEALTH PERSP, V118, P485, DOI 10.1289/ehp.0901392
   Kamp H, 2012, TOXICOL LETT, V215, P143, DOI 10.1016/j.toxlet.2012.09.015
   Kim M. T., 2016, ENV HLTH PE IN PRESS
   Kim MT, 2014, PHARM RES-DORDR, V31, P1002, DOI 10.1007/s11095-013-1222-1
   Kleensang A, 2014, ALTEX-ALTERN ANIM EX, V31, P53, DOI 10.14573/altex.1309261
   Kleinstreuer N. C., 2015, ENV HLTH PERSPECT
   Kleinstreuer NC, 2014, NAT BIOTECHNOL, V32, P583, DOI 10.1038/nbt.2914
   Kleinstreuer NC, 2011, ENVIRON HEALTH PERSP, V119, P1596, DOI 10.1289/ehp.1103412
   Klopman G, 1999, ENVIRON TOXICOL CHEM, V18, P2497, DOI 10.1002/etc.5620181116
   Klopman G, 2004, SAR QSAR ENVIRON RES, V15, P251, DOI 10.1080/10629360410001724897
   Knudsen TB, 2011, BIRTH DEFECTS RES C, V93, P312, DOI 10.1002/bdrc.20223
   Kohonen P, 2013, MOL INFORM, V32, P47, DOI 10.1002/minf.201200114
   Kroese ED, 2015, REPROD TOXICOL, V55, P11, DOI 10.1016/j.reprotox.2014.10.003
   Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939
   Leist M, 2014, ALTEX-ALTERN ANIM EX, V31, P341, DOI 10.14573/altex.1406091
   Linkov I, 2015, ALTEX-ALTERN ANIM EX, V32, P3, DOI 10.14573/altex.1412231
   Looser R, 2005, METABOLOME ANALYSES: STRATEGIES FOR SYSTEMS BIOLOGY, P103, DOI 10.1007/0-387-25240-1_7
   Low Y, 2013, CHEM RES TOXICOL, V26, P1199, DOI 10.1021/tx400110f
   Luechtefeld T, 2016, ALTEX-ALTERN ANIM EX, V33, P135, DOI 10.14573/altex.1510055
   Luechtefeld T, 2016, ALTEX-ALTERN ANIM EX, V33, P111, DOI 10.14573/altex.1510054
   Luechtefeld T, 2016, ALTEX-ALTERN ANIM EX, V33, P123, DOI 10.14573/altex.1510053
   Luechtefeld T, 2016, ALTEX-ALTERN ANIM EX, V33, P95, DOI 10.14573/altex.1510052
   Maggiora GM, 2006, J CHEM INF MODEL, V46, P1535, DOI 10.1021/ci060117s
   Mattingly CJ, 2006, J EXP ZOOL PART A, V305A, P689, DOI 10.1002/jez.a.307
   Mattingly CJ, 2006, TOXICOL SCI, V92, P587, DOI 10.1093/toxsci/kfl008
   Mattingly CJ, 2004, PHARMACOGENOMICS J, V4, P5, DOI 10.1038/sj.tpj.6500225
   Mattingly CJ, 2003, ENVIRON HEALTH PERSP, V111, P793, DOI 10.1289/txg.6028
   McHale CM, 2010, MUTAT RES-REV MUTAT, V705, P172, DOI 10.1016/j.mrrev.2010.04.001
   Mellert W, 2011, TOXICOL LETT, V207, P173, DOI 10.1016/j.toxlet.2011.08.013
   Montoya GA, 2014, TOXICOL LETT, V225, P240, DOI 10.1016/j.toxlet.2013.12.010
   Moss GP, 2002, TOXICOL IN VITRO, V16, P299, DOI 10.1016/S0887-2333(02)00003-6
   Palmer Jessica A, 2013, Birth Defects Res B Dev Reprod Toxicol, V98, P343, DOI 10.1002/bdrb.21078
   Pamies D, 2011, REPRODUCTIVE AND DEVELOPMENTAL TOXICOLOGY, P135, DOI 10.1016/B978-0-12-382032-7.10011-6
   Patlewicz G, 2014, ALTEX-ALTERN ANIM EX, V31, P387, DOI 10.14573/altex.1410071
   Piersma AH, 2013, REPROD TOXICOL, V38, P53, DOI 10.1016/j.reprotox.2013.03.002
   Ramirez T, 2013, ALTEX-ALTERN ANIM EX, V30, P209, DOI 10.14573/altex.2013.2.209
   Reif DM, 2010, ENVIRON HEALTH PERSP, V118, P1714, DOI 10.1289/ehp.1002180
   Rovida C, 2015, ALTEX-ALTERN ANIM EX, V32, P171, DOI 10.14573/altex.1506201
   Schenk B, 2010, REPROD TOXICOL, V30, P200, DOI 10.1016/j.reprotox.2010.05.012
   Scholz G, 1999, CELLS TISSUES ORGANS, V165, P203, DOI 10.1159/000016700
   Schultz TW, 2003, J MOL STRUC-THEOCHEM, V622, P23, DOI 10.1016/S0166-1280(02)00615-2
   Sipes NS, 2013, CHEM RES TOXICOL, V26, P878, DOI [10.1021/tx400021f, 10.1021/tx400021]
   Solimeo R, 2012, CHEM RES TOXICOL, V25, P2763, DOI 10.1021/tx300393v
   Sonneveld E, 2005, TOXICOL SCI, V83, P136, DOI 10.1093/toxsci/kfi005
   Strauss V, 2009, TOXICOL LETT, V191, P88, DOI 10.1016/j.toxlet.2009.08.004
   Suter L, 2011, TOXICOL APPL PHARM, V252, P73, DOI 10.1016/j.taap.2010.10.008
   Thomas CJ, 2009, CURR TOP MED CHEM, V9, P1181, DOI 10.2174/156802609789753644
   Thomas RS, 2012, MUTAT RES-GEN TOX EN, V746, P135, DOI 10.1016/j.mrgentox.2012.01.007
   Thomas RS, 2011, TOXICOL SCI, V120, P194, DOI 10.1093/toxsci/kfq355
   Uehara T, 2010, MOL NUTR FOOD RES, V54, P218, DOI 10.1002/mnfr.200900169
   Uibel F, 2015, REPROD TOXICOL, V55, P30, DOI 10.1016/j.reprotox.2014.09.009
   van der Burg, 2013, HIGH THROUGHPUT SCRE, P519
   van der Burg B, 2011, REPROD TOXICOL, V31, P558, DOI 10.1016/j.reprotox.2011.02.012
   van Duursen MBM, 2010, TOXICOL LETT, V192, P271, DOI 10.1016/j.toxlet.2009.11.001
   van Ravenzwaay B, 2014, TOXICOL LETT, V227, P20, DOI 10.1016/j.toxlet.2014.03.004
   van Ravenzwaay B, 2012, MUTAT RES-GEN TOX EN, V746, P144, DOI 10.1016/j.mrgentox.2012.01.006
   van Ravenzwaay B, 2010, TOXICOL LETT, V198, P159, DOI 10.1016/j.toxlet.2010.06.009
   van Ravenzwaay B, 2010, OMICS PERSPECTIVE ON CANCER RESEARCH, P141, DOI 10.1007/978-90-481-2675-0_8
   van Ravenzwaay B., 2015, DEV DATA BA IN PRESS
   van Vliet E, 2011, ALTEX-ALTERN ANIM EX, V28, P17, DOI 10.14573/altex.2011.1.017
   Vinken M, 2013, TOXICOL SCI, V136, P97, DOI 10.1093/toxsci/kft177
   Vinken M, 2013, TOXICOLOGY, V312, P158, DOI 10.1016/j.tox.2013.08.011
   Vinken M, 2012, ARCH TOXICOL, V86, P405, DOI 10.1007/s00204-011-0769-z
   Wang WY, 2015, PHARM RES-DORDR, V32, P3055, DOI 10.1007/s11095-015-1687-1
   Wang YL, 2010, NUCLEIC ACIDS RES, V38, pD255, DOI 10.1093/nar/gkp965
   Wang YL, 2009, NUCLEIC ACIDS RES, V37, pW623, DOI 10.1093/nar/gkp456
   Waters M, 2008, NUCLEIC ACIDS RES, V36, pD892, DOI 10.1093/nar/gkm755
   Wu SD, 2013, CHEM RES TOXICOL, V26, P1840, DOI 10.1021/tx400226u
   Yang CH, 2013, TOXICOL LETT, V221, pS80, DOI 10.1016/j.toxlet.2013.05.082
   Yoshida M., 2015, PESTICIDE RESIDUES 2, P357
   Youssef J, 1998, CRIT REV TOXICOL, V28, P1, DOI 10.1080/10408449891344182
   Zarn J., 2006, PESTICIDE RESIDUES 2, P325
   Zhang J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099863
   Zhu H, 2008, J CHEM INF MODEL, V48, P766, DOI 10.1021/ci700443v
   Zhu H, 2014, CHEM RES TOXICOL, V27, P1643, DOI 10.1021/tx500145h
   Zhu H, 2009, CHEM RES TOXICOL, V22, P1913, DOI 10.1021/tx900189p
NR 110
TC 31
Z9 31
U1 0
U2 17
PU SPEKTRUM AKADEMISCHER VERLAG-SPRINGER-VERLAG GMBH
PI HEILDEBERG
PA TIERGARTENSTRASSE 17, HEILDEBERG, 69121, GERMANY
SN 1868-596X
EI 1868-8551
J9 ALTEX-ALTERN ANIM EX
JI ALTEX-Altern. Anim. Exp.
PY 2016
VL 33
IS 2
BP 167
EP 182
DI 10.14573/altex.1601252
PG 16
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA DZ0FI
UT WOS:000385512500008
PM 26863516
OA DOAJ Gold, Green Published, Green Accepted
DA 2019-10-23
ER

PT J
AU Rohr, JR
   Salice, CJ
   Nisbet, RM
AF Rohr, Jason R.
   Salice, Christopher J.
   Nisbet, Roger M.
TI The pros and cons of ecological risk assessment based on data from
   different levels of biological organization
SO CRITICAL REVIEWS IN TOXICOLOGY
LA English
DT Review
DE Adverse outcome pathways; assessment endpoint; communities; ecosystems;
   extrapolation; mathematical model; measurement endpoint; mechanistic
   effect models; mesocosms; multi-species systems; populations; scale
ID FRESH-WATER GASTROPOD; ENERGY BUDGET THEORY; SPECIES-SENSITIVITY
   DISTRIBUTIONS; FECAL INDICATOR BACTERIA; MATRIX POPULATION-MODELS;
   INDIVIDUAL-BASED MODELS; PITUITARY-GONADAL AXIS; COMPLEX LIFE-CYCLES;
   MULTIPLE END-POINTS; AGENT-BASED MODELS
AB Ecological risk assessment (ERA) is the process used to evaluate the safety of manufactured chemicals to the environment. Here we review the pros and cons of ERA across levels of biological organization, including suborganismal (e.g., biomarkers), individual, population, community, ecosystem and landscapes levels. Our review revealed that level of biological organization is often related negatively with ease at assessing cause-effect relationships, ease of high-throughput screening of large numbers of chemicals (it is especially easier for suborganismal endpoints), and uncertainty of the ERA because low levels of biological organization tend to have a large distance between their measurement (what is quantified) and assessment endpoints (what is to be protected). In contrast, level of biological organization is often related positively with sensitivity to important negative and positive feedbacks and context dependencies within biological systems, and ease at capturing recovery from adverse contaminant effects. Some endpoints did not show obvious trends across levels of biological organization, such as the use of vertebrate animals in chemical testing and ease at screening large numbers of species, and other factors lacked sufficient data across levels of biological organization, such as repeatability, variability, cost per study and cost per species of effects assessment, the latter of which might be a more defensible way to compare costs of ERAs than cost per study. To compensate for weaknesses of ERA at any particular level of biological organization, we also review mathematical modeling approaches commonly used to extrapolate effects across levels of organization. Finally, we provide recommendations for next generation ERA, submitting that if there is an ideal level of biological organization to conduct ERA, it will only emerge if ERA is approached simultaneously from the bottom of biological organization up as well as from the top down, all while employing mathematical modeling approaches where possible to enhance ERA. Because top-down ERA is unconventional, we also offer some suggestions for how it might be implemented efficaciously. We hope this review helps researchers in the field of ERA fill key information gaps and helps risk assessors identify the best levels of biological organization to conduct ERAs with differing goals.
C1 [Rohr, Jason R.] Univ S Florida, Dept Integrat Biol, SCA 110, Tampa, FL 33647 USA.
   [Salice, Christopher J.] Towson Univ, Dept Biol Sci, Towson, MD USA.
   [Nisbet, Roger M.] Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA.
RP Rohr, JR (reprint author), Univ S Florida, Dept Integrat Biol, SCA 110, Tampa, FL 33647 USA.
EM jasonrohr@gmail.com
FU National Science FoundationNational Science Foundation (NSF)
   [EF-1241889]; National Institutes of HealthUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USA
   [R01GM109499, R01TW010286]; US Department of AgricultureUnited States
   Department of Agriculture (USDA) [NRI 2006-01370, 2009-35102-0543]; US
   Environmental Protection AgencyUnited States Environmental Protection
   Agency [CAREER 83518801, EF-0830117, 835797, 83580002]; US National
   Science FoundationNational Science Foundation (NSF); U.S. Air Force
   Civil Engineer Center [FA8903-12-C-008]; Strategic Environmental
   Research and Development Program [16 ER02-014/ER-2627]
FX This research was supported by grants from the National Science
   Foundation (EF-1241889), National Institutes of Health (R01GM109499,
   R01TW010286), US Department of Agriculture (NRI 2006-01370,
   2009-35102-0543) and US Environmental Protection Agency (CAREER
   83518801) to J.R.R. RMN had support from the US National Science
   Foundation and the US Environmental Protection Agency under Cooperative
   Agreement Number EF-0830117 and from the US Environmental Protection
   Agency under grant 835797. CJS was supported by the U.S. Air Force Civil
   Engineer Center (contract number FA8903-12-C-008), the US Environmental
   Protection Agency (grant number 83580002) and the Strategic
   Environmental Research and Development Program (grant number 16
   ER02-014/ER-2627). Any opinions, findings and conclusions or
   recommendations expressed in this material are those of the authors and
   do not necessarily reflect the views of any of the provided funding
   agencies. The affiliation of the authors is as shown on the cover page
   and includes universities only. CJS was a former employee of the USEPA.
CR Ahlers J, 2008, ENVIRON SCI POLLUT R, V15, P565, DOI 10.1007/s11356-008-0043-y
   Ananthasubramaniam B, 2015, ECOL APPL, V25, P1691, DOI 10.1890/14-0498.1
   Anderson RM, 1991, INFECT DIS HUMANS DY
   Ankley GT, 2006, ENVIRON SCI TECHNOL, V40, P4055, DOI 10.1021/es0630184
   Ankley GT, 2013, ENVIRON TOXICOL CHEM, V32, P1084, DOI 10.1002/etc.2151
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   [Anonymous], TIME VERSION 3 0 BET
   Antczak P, 2015, ENVIRON SCI TECHNOL, V49, P11132, DOI 10.1021/acs.est.5b02707
   Ashauer R, 2011, ENVIRON TOXICOL CHEM, V30, P2519, DOI 10.1002/etc.639
   Ashauer R, 2010, J ENVIRON MONITOR, V12, P2056, DOI 10.1039/c0em00234h
   ASTM, 2011, ANN BOOK ASTM STAND, P1048
   Augusiak J, 2014, ECOL MODEL, V280, P117, DOI 10.1016/j.ecolmodel.2013.11.009
   Augustine S, 2011, COMP BIOCHEM PHYS A, V159, P275, DOI 10.1016/j.cbpa.2011.03.016
   Baas J, 2015, ECOTOXICOLOGY, V24, P657, DOI 10.1007/s10646-014-1413-5
   Baas J, 2010, SCI TOTAL ENVIRON, V408, P3735, DOI 10.1016/j.scitotenv.2009.10.066
   BAIRD DJ, 1990, FUNCT ECOL, V4, P399, DOI 10.2307/2389602
   Baird DJ, 2007, ECOTOX ENVIRON SAFE, V67, P296, DOI 10.1016/j.ecoenv.2006.07.001
   Barron MG, 2003, ENVIRON TOXICOL CHEM, V22, P650, DOI 10.1002/etc.5620220326
   Bartell SM, 2003, HUM ECOL RISK ASSESS, V9, P907, DOI 10.1080/713610016
   Beketov MA, 2013, P NATL ACAD SCI USA, V110, P11039, DOI 10.1073/pnas.1305618110
   Beketov MA, 2012, ENVIRON POLLUT, V162, P247, DOI 10.1016/j.envpol.2011.11.011
   Berninger JP, 2014, ENVIRON SCI TECHNOL, V48, P2404, DOI 10.1021/es4040254
   Billoir E, 2007, ECOL MODEL, V203, P204, DOI 10.1016/j.ecolmodel.2006.11.021
   Boone MD, 2004, ECOL APPL, V14, P685, DOI 10.1890/02-5308
   Boone MD, 2015, BIOSCIENCE, V65, P227, DOI 10.1093/biosci/biu229
   Boone MD, 2014, BIOSCIENCE, V64, P917, DOI 10.1093/biosci/biu138
   Boyle TP, 1997, ECOL APPL, V7, P1099
   Bradbury SP, 2003, ENVIRON TOXICOL CHEM, V22, P1789, DOI 10.1897/01-234
   Bulun SE, 1999, ENDOCR-RELAT CANCER, V6, P293, DOI 10.1677/erc.0.0060293
   Burden N, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002156
   CAIRNS J, 1983, HYDROBIOLOGIA, V100, P47, DOI 10.1007/BF00027421
   CAIRNS J, 1987, HYDROBIOLOGIA, V153, P87, DOI 10.1007/BF00005507
   CAIRNS J, 1993, ENVIRON TOXICOL CHEM, V12, P609, DOI 10.1002/etc.5620120401
   CAIRNS J, 1986, BIOSCIENCE, V36, P670, DOI 10.2307/1310388
   Cairns J, 1996, ECOL APPL, V6, P790, DOI 10.2307/2269484
   Cajaraville MP, 2000, SCI TOTAL ENVIRON, V247, P295, DOI 10.1016/S0048-9697(99)00499-4
   Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148
   Cardinale BJ, 2011, NATURE, V472, P86, DOI 10.1038/nature09904
   Carlisle DM, 2005, FRESHWATER BIOL, V50, P380, DOI 10.1111/j.1365-2427.2004.01323.x
   Caswell H, 2012, STRUCTURED POPULATIO
   Caswell H, 2001, MATRIX POPULATION MO
   Chandler GT, 2004, ENVIRON TOXICOL CHEM, V23, P117, DOI 10.1897/03-124
   Civitello DJ, 2015, P NATL ACAD SCI USA, V112, P8667, DOI 10.1073/pnas.1506279112
   Civitello DJ, 2012, P ROY SOC B-BIOL SCI, V279, P3146, DOI 10.1098/rspb.2012.0684
   Clements WH, 2009, ENVIRON TOXICOL CHEM, V28, P1789, DOI 10.1897/09-140.1
   Cohen J, P NATL ACAD IN PRESS
   Cothran RD, 2013, EVOL APPL, V6, P832, DOI 10.1111/eva.12069
   Courchamp F, 1999, TRENDS ECOL EVOL, V14, P405, DOI 10.1016/S0169-5347(99)01683-3
   Crane M, 2000, ENVIRON TOXICOL CHEM, V19, P516, DOI 10.1002/etc.5620190234
   de Groot RS, 2002, ECOL ECON, V41, P393, DOI 10.1016/S0921-8009(02)00089-7
   De Laender F, 2009, ECOTOX ENVIRON SAFE, V72, P310, DOI 10.1016/j.ecoenv.2008.07.014
   De Laender F, 2008, ENVIRON INT, V34, P390, DOI 10.1016/j.envint.2007.09.006
   De Laender F, 2008, CHEMOSPHERE, V71, P529, DOI 10.1016/j.chemosphere.2007.09.052
   de Roos A. M., 2013, POPULATION COMMUNITY
   de Roos AM, 2014, PSPMANALYSIS MATLAB
   DEROOS AM, 1992, AM NAT, V139, P123, DOI 10.1086/285316
   Douglas MR, 2015, J APPL ECOL, V52, P250, DOI 10.1111/1365-2664.12372
   Dunne JA, 2002, P NATL ACAD SCI USA, V99, P12917, DOI 10.1073/pnas.192407699
   Ebenman B, 2005, TRENDS ECOL EVOL, V20, P568, DOI 10.1016/j.tree.2005.06.011
   EFSA (European Food Safety Authority), 2006, EFSA J, V329, P1
   EFSA PoPPPatR, 2014, EFSA J, V3589, P1
   EFSA PoPPPatR, 2013, EFSA J, V3290, P1
   Ehrsam M, 2016, ENVIRON TOXICOL CHEM, V35, P2239, DOI 10.1002/etc.3377
   Engelen B, 1998, APPL ENVIRON MICROB, V64, P2814
   Erickson RA, 2014, ECOL MODEL, V275, P37, DOI 10.1016/j.ecolmodel.2013.12.015
   Escher BI, 2002, ENVIRON SCI TECHNOL, V36, P4201, DOI 10.1021/es015848h
   EU (European Union), 2001, WHIT PAP STRAT FUT C
   Ewer J, 1997, J EXP BIOL, V200, P869
   Fairchild JF, 2002, ARCH ENVIRON CON TOX, V43, P198, DOI 10.1007/s00244-002-1208-1
   FAIRCHILD JF, 1994, ARCH ENVIRON CON TOX, V27, P527, DOI 10.1007/BF00214845
   Fleeger JW, 2003, SCI TOTAL ENVIRON, V317, P207, DOI 10.1016/S0048-9697(03)00141-4
   Focks A, 2014, ECOL MODEL, V280, P102, DOI [10.1016/j.ecolmode1.2013.09.023, 10.1016/j.ecolmodel.2013.09.023]
   Forbes VE, 2015, INTEGR ENVIRON ASSES, V11, P348, DOI 10.1002/ieam.1628
   Forbes VE, 2008, ENVIRON TOXICOL CHEM, V27, P1987, DOI 10.1897/08-029.1
   Forbes VE, 2013, INTEGR ENVIRON ASSES, V9, pE75, DOI 10.1002/ieam.1425
   Forbes VE, 2011, HUM ECOL RISK ASSESS, V17, P287, DOI 10.1080/10807039.2011.552391
   Forbes Valery E, 2010, Integr Environ Assess Manag, V6, P191, DOI 10.1002/ieam.25
   Forbes VE, 2006, ENVIRON TOXICOL CHEM, V25, P272, DOI 10.1897/05-257R.1
   Forbes VE, 2002, HUM ECOL RISK ASSESS, V8, P473, DOI 10.1080/20028091057033
   Forbes VE, 2002, PHILOS T ROY SOC B, V357, P1299, DOI 10.1098/rstb.2002.1129
   Forbes VE, 2001, ECOL APPL, V11, P1249, DOI 10.2307/3061025
   Fujiwara M, 2005, ECOLOGY, V86, P1441, DOI 10.1890/04-1351
   Galic Nika, 2010, Integrated Environmental Assessment and Management, V6, P338, DOI 10.1002/ieam.68
   Ge Y, 2014, ENVIRON SCI TECHNOL, V48, P13489, DOI [10.1021/es50231646, 10.1021/es5031646]
   Ge YG, 2011, ENVIRON SCI TECHNOL, V45, P1659, DOI 10.1021/es103040t
   Gergs A, 2013, SCI REP-UK, V3, DOI 10.1038/srep02036
   Graney RL, 1994, AQUATIC MESOSOCM STU
   Grimm V., 2005, INDIVIDUAL BASED MOD
   Grimm V, 2006, ECOL MODEL, V198, P115, DOI 10.1016/j.ecolmodel.2006.04.023
   Grimm V, 2014, ECOL MODEL, V280, P129, DOI 10.1016/j.ecolmodel.2014.01.018
   Grimm V, 2013, INTEGR ENVIRON ASSES, V9, pE58, DOI 10.1002/ieam.1423
   Grimm V, 2012, PHILOS T R SOC B, V367, P298, DOI 10.1098/rstb.2011.0180
   Grimm V, 2010, ECOL MODEL, V221, P2760, DOI 10.1016/j.ecolmodel.2010.08.019
   Guenard G, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3239
   Guenard G, 2011, ECOL APPL, V21, P3178, DOI 10.1890/10-2242.1
   Halstead NT, 2015, CHEMOSPHERE, V135, P265, DOI 10.1016/j.chemosphere.2015.03.091
   Halstead NT, 2014, ECOL LETT, V17, P932, DOI 10.1111/ele.12295
   Hammond JI, 2012, EVOL APPL, V5, P593, DOI 10.1111/j.1752-4571.2011.00237.x
   Hanazato T, 1998, ENVIRON POLLUT, V101, P361, DOI 10.1016/S0269-7491(98)00053-0
   Handy RD, 2003, ECOTOXICOLOGY, V12, P331, DOI 10.1023/A:1022527432252
   Hansen F, 1999, FUNCT ECOL, V13, P157, DOI 10.1046/j.1365-2435.1999.00299.x
   Hanski I, 1998, NATURE, V396, P41, DOI 10.1038/23876
   Hayes EH, 2004, HUM ECOL RISK ASSESS, V10, P299, DOI 10.1080/10807030490438256
   Hecker M, 2008, ANAL BIOANAL CHEM, V390, P287, DOI 10.1007/s00216-007-1657-5
   Heckmann LH, 2007, TOXICOL LETT, V172, P137, DOI 10.1016/j.toxlet.2007.06.001
   HILL IR, 1994, FRESHWATER FIELD TES
   Hofer T, 2004, ARCH TOXICOL, V78, P549, DOI 10.1007/s00204-004-0577-9
   Holden PA, 2013, ACCOUNTS CHEM RES, V46, P813, DOI 10.1021/ar300069t
   Holt RD, 1997, AM NAT, V149, P745, DOI 10.1086/286018
   Hommen Udo, 2010, Integrated Environmental Assessment and Management, V6, P325, DOI 10.1002/ieam.69
   Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922
   Hose GC, 2004, ARCH ENVIRON CON TOX, V47, P511, DOI 10.1007/s00244-003-3212-5
   Hua J, 2013, EVOL APPL, V6, P1028, DOI 10.1111/eva.12083
   HUNSAKER CT, 1990, ENVIRON MANAGE, V14, P325, DOI 10.1007/BF02394200
   Ibrahim L, 2014, ECOL MODEL, V280, P65, DOI [10.1016/j.ecolmode1.2013.08.001, 10.1016/j.ecolmodel.2013.08.001]
   Ibrahim L, 2013, ENVIRON SCI POLLUT R, V20, P2679, DOI 10.1007/s11356-013-1471-x
   IVES AR, 1995, ECOLOGY, V76, P926, DOI 10.2307/1939357
   Jager T., 2015, MAKING SENSE CHEM ST
   Jager T, 2013, J THEOR BIOL, V328, P9, DOI 10.1016/j.jtbi.2013.03.011
   Jager T, 2012, ECOL MODEL, V225, P74, DOI 10.1016/j.ecolmodel.2011.11.012
   Jager T, 2012, ENVIRON TOXICOL CHEM, V31, P228, DOI 10.1002/etc.746
   Jager T, 2011, ENVIRON SCI TECHNOL, V45, P8180, DOI 10.1021/es2030559
   Jager T, 2011, ENVIRON SCI TECHNOL, V45, P2529, DOI 10.1021/es103092a
   Jager T, 2010, ECOTOXICOLOGY, V19, P351, DOI 10.1007/s10646-009-0417-z
   Jayawardena UA, 2016, ECOHEALTH, V13, P111, DOI 10.1007/s10393-016-1103-2
   Jennings DE, 2012, ECOTOXICOLOGY, V21, P569, DOI 10.1007/s10646-011-0817-8
   Joern A, 1996, ENVIRON TOXICOL CHEM, V15, P407, DOI 10.1002/etc.5620150401
   Johnsen K, 2001, BIOL FERT SOILS, V33, P443, DOI 10.1007/s003740100351
   Johnson LR, 2013, ECOLOGY, V94, P882, DOI 10.1890/12-0650.1
   Jones R., 2004, OVERVIEW ECOLOGICAL
   Kamo M, 2008, HUM ECOL RISK ASSESS, V14, P714, DOI 10.1080/10807030802235110
   Kattwinkel M, 2015, ENVIRON REV, V23, P382, DOI 10.1139/er-2015-0013
   Kearney MR, 2015, BIOSCIENCE, V65, P341, DOI 10.1093/biosci/biv013
   Kidd KA, 2007, P NATL ACAD SCI USA, V104, P8897, DOI 10.1073/pnas.0609568104
   Kimberly DA, 2014, ECOTOXICOLOGY, V23, P809, DOI 10.1007/s10646-014-1221-y
   Kimberly DA, 2013, ENVIRON TOXICOL CHEM, V32, P1337, DOI 10.1002/etc.2198
   Klaniscek T, 2006, ECOL MODEL, V196, P407, DOI 10.1016/j.ecolmodel.2006.02.023
   Klanjscek T, 2007, ECOL APPL, V17, P2233, DOI 10.1890/06-0426.1
   Klanjscek T, 2013, ECOTOXICOLOGY, V22, P319, DOI 10.1007/s10646-012-1028-7
   Klanjscek T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0026955
   Kooijman S., 2010, DYNAMIC ENERGY BUDGE
   Kooijman S., 1996, ANAL AQUATIC TOXICIT
   Kooijman SALM, 2008, BIOL REV, V83, P533, DOI 10.1111/j.1469-185X.2008.00053.x
   KOOIJMAN SALM, 1984, ECOTOX ENVIRON SAFE, V8, P254, DOI 10.1016/0147-6513(84)90029-0
   Kooijman SALM, 2001, PHILOS T ROY SOC B, V356, P331, DOI 10.1098/rstb.2000.0771
   Kooijman SALM, 2000, DYNAMIC ENERGY MASS
   Kramer VJ, 2011, ENVIRON TOXICOL CHEM, V30, P64, DOI 10.1002/etc.375
   LaLone CA, 2013, AQUAT TOXICOL, V144, P141, DOI 10.1016/j.aquatox.2013.09.004
   LaLone CA, 2013, ENVIRON TOXICOL CHEM, V32, P2528, DOI 10.1002/etc.2330
   Landis Wayne G., 2011, Integrated Environmental Assessment and Management, V7, pVI, DOI 10.1002/ieam.249
   Landis WG, 2003, HUM ECOL RISK ASSESS, V9, P1415, DOI 10.1080/10807030390250912
   Landis WG, 2002, HUM ECOL RISK ASSESS, V8, P193, DOI 10.1080/20028091056827
   Landis WG, 2003, HUM ECOL RISK ASSESS, V9, P1317, DOI 10.1080/10807030390248500
   Landis WG, 1997, HUM ECOL RISK ASSESS, V3, P287, DOI 10.1080/10807039709383685
   LARSEN DP, 1986, ENVIRON TOXICOL CHEM, V5, P179, DOI 10.1002/etc.5620050209
   Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x
   Levin SA, 1989, ECOTOXICOLOGY PROBLE
   Li ZH, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-63
   Liess M, 2005, ENVIRON TOXICOL CHEM, V24, P954, DOI 10.1897/03-652.1
   Liess M, 2001, ENVIRON TOXICOL CHEM, V20, P2088, DOI 10.1002/etc.5620200931
   Liess M, 2013, ENVIRON SCI TECHNOL, V47, P8862, DOI 10.1021/es401346d
   Liess M, 2011, ECOTOXICOLOGY, V20, P1328, DOI 10.1007/s10646-011-0689-y
   Lika K, 2011, J SEA RES, V66, P270, DOI 10.1016/j.seares.2011.07.010
   Luna TO, 2013, ENVIRON TOXICOL CHEM, V32, P2771, DOI 10.1002/etc.2372
   Luttik Robert, 2011, Integrated Environmental Assessment and Management, V7, P459, DOI 10.1002/ieam.183
   Maltby L, 2005, ENVIRON TOXICOL CHEM, V24, P379, DOI 10.1897/04-025R.1
   Maron JL, 2006, P R SOC B, V273, P2575, DOI 10.1098/rspb.2006.3587
   Marquet PA, 2014, BIOSCIENCE, V64, P701, DOI 10.1093/biosci/biu098
   Martin B, 2014, ECOL APPL, V24, P1972, DOI 10.1890/14-0656.1
   Martin BT, 2013, ECOTOXICOLOGY, V22, P574, DOI 10.1007/s10646-013-1049-x
   Martin BT, 2012, METHODS ECOL EVOL, V3, P445, DOI 10.1111/j.2041-210X.2011.00168.x
   Martin LB, 2010, ANN NY ACAD SCI, V1195, P129, DOI 10.1111/j.1749-6632.2010.05454.x
   Martinovic-Weigelt D, 2014, ENVIRON SCI TECHNOL, V48, P2385, DOI 10.1021/es404027n
   McMahon TA, 2013, ENVIRON SCI TECHNOL, V47, P7958, DOI 10.1021/es401725s
   McMahon TA, 2012, ECOL LETT, V15, P714, DOI 10.1111/j.1461-0248.2012.01790.x
   McMahon TA, 2011, ENVIRON HEALTH PERSP, V119, P1098, DOI 10.1289/ehp.1002956
   Meaney MJ, 1996, DEV NEUROSCI-BASEL, V18, P49, DOI 10.1159/000111395
   Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING BI
   Moe SJ, 2002, ECOLOGY, V83, P1597, DOI 10.2307/3071980
   Muller EB, 2014, J SEA RES, V94, P29, DOI 10.1016/j.seares.2013.12.013
   Muller EB, 2010, ECOTOXICOLOGY, V19, P48, DOI 10.1007/s10646-009-0385-3
   Muller EB, 2010, ECOTOXICOLOGY, V19, P38, DOI 10.1007/s10646-009-0384-4
   Muller EB, 2009, J THEOR BIOL, V259, P44, DOI 10.1016/j.jtbi.2009.03.004
   Munns WR, 2015, INTEGR ENVIRON ASSES, V11, P666, DOI 10.1002/ieam.1631
   Murphy CA, 2005, REPROD TOXICOL, V19, P395, DOI 10.1016/j.reprotox.2004.09.006
   Murphy CA, 2008, AQUAT TOXICOL, V86, P470, DOI 10.1016/j.aquatox.2007.12.009
   Nabholz JV, 1997, ECOL APPL, V7, P1094
   Naito W, 2002, WATER RES, V36, P1, DOI 10.1016/S0043-1354(01)00200-7
   Nel A, 2013, ACCOUNTS CHEM RES, V46, P607, DOI 10.1021/ar300022h
   Newman MC, 2000, ENVIRON TOXICOL CHEM, V19, P508, DOI 10.1002/etc.5620190233
   NIEDERLEHNER BR, 1990, ARCH ENVIRON CON TOX, V19, P62, DOI 10.1007/BF01059813
   Nielsen MB, 2014, ECOTOXICOLOGY, V23, P404, DOI 10.1007/s10646-014-1205-y
   Nilsen BM, 2004, ANAL BIOANAL CHEM, V378, P621, DOI 10.1007/s00216-003-2241-2
   Nisbet RM, 2000, J ANIM ECOL, V69, P913, DOI 10.1046/j.1365-2656.2000.00448.x
   Nisbet RM, 2010, PHILOS T R SOC B, V365, P3541, DOI 10.1098/rstb.2010.0167
   Nisbet Roger M., 1996, P257, DOI 10.1016/B978-012627255-0/50015-X
   Noyes PD, 2009, ENVIRON INT, V35, P971, DOI 10.1016/j.envint.2009.02.006
   OECD, 2006, CURR APPR STAT AN EC
   OECD, 2015, OECD GUID TEST CHEM
   PapeLindstrom PA, 1997, ENVIRON TOXICOL CHEM, V16, P2415, DOI 10.1002/etc.5620161130
   Park J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023211
   Park RA, 2008, ECOL MODEL, V213, P1, DOI 10.1016/j.ecolmodel.2008.01.015
   Parng C, 2002, ASSAY DRUG DEV TECHN, V1, P41, DOI 10.1089/154065802761001293
   Pastorok RA, 2003, HUM ECOL RISK ASSESS, V9, P939, DOI 10.1080/713610017
   PONTASCH KW, 1989, ENVIRON TOXICOL CHEM, V8, P521, DOI 10.1002/etc.5620080609
   PONTASCH KW, 1991, ARCH ENVIRON CON TOX, V20, P103, DOI 10.1007/BF01065335
   Posthuma L, 2001, SPECIES SENSITIVITY
   Preziosi DV, 2008, SCI TOTAL ENVIRON, V406, P491, DOI 10.1016/j.scitotenv.2008.06.063
   Priester JH, 2012, P NATL ACAD SCI USA, V109, pE2451, DOI 10.1073/pnas.1205431109
   Raffel TR, 2006, FUNCT ECOL, V20, P819, DOI 10.1111/j.1365-2435.2006.01159.x
   Raffel TR, 2013, NAT CLIM CHANGE, V3, P146, DOI [10.1038/nclimate1659, 10.1038/NCLIMATE1659]
   Raffel TR, 2009, J PARASITOL, V95, P1548, DOI 10.1645/GE-2078.1
   Ramsey PW, 2005, ECOL LETT, V8, P1201, DOI 10.1111/j.1461-0248.2005.00821.x
   Relyea RA, 2005, ECOL APPL, V15, P618, DOI 10.1890/03-5342
   Relyea RA, 2005, ECOL APPL, V15, P1125, DOI 10.1890/04-0559
   Relyea RA, 2003, ECOL APPL, V13, P1515, DOI 10.1890/02-5298
   Relyea R, 2006, ECOL LETT, V9, P1157, DOI 10.1111/j.1461-0248.2006.00966.x
   Rohr JR, 2008, NATURE, V455, P1235, DOI 10.1038/nature07281
   Rohr JR, 2008, ECOL APPL, V18, P1743, DOI 10.1890/07-1429.1
   Rohr JR, 2006, TRENDS ECOL EVOL, V21, P606, DOI 10.1016/j.tree.2006.07.002
   Rohr JR, 2016, INTEGR ENVIRON ASSES, V12, P273, DOI 10.1002/ieam.1668
   Rohr JR, 2015, P NATL ACAD SCI USA, V112, P3008, DOI 10.1073/pnas.1415971112
   Rohr JR, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1502
   Rohr JR, 2013, CONSERV BIOL, V27, P741, DOI 10.1111/cobi.12086
   Rohr JR, 2013, ENVIRON TOXICOL CHEM, V32, P93, DOI 10.1002/etc.2036
   Rohr JR, 2012, ENVIRON TOXICOL CHEM, V31, P973, DOI 10.1002/etc.1796
   Rohr JR, 2011, GLOBAL CHANGE BIOL, V17, P657, DOI 10.1111/j.1365-2486.2010.02301.x
   Rohr JR, 2010, CONSERV LETT, V3, P143, DOI 10.1111/j.1755-263X.2010.00114.x
   Rohr JR, 2010, ENVIRON HEALTH PERSP, V118, P20, DOI 10.1289/ehp.0901164
   Rohr JR, 2009, OECOLOGIA, V159, P447, DOI 10.1007/s00442-008-1208-6
   Rohr JR, 2006, ENVIRON HEALTH PERSP, V114, P46, DOI 10.1289/ehp.8405
   Rohr JR, 2005, ECOL APPL, V15, P1135, DOI 10.1890/03-5353
   Rohr JR, 2005, ENVIRON TOXICOL CHEM, V24, P1253, DOI 10.1897/04-448R.1
   Rohr JR, 2004, ECOL APPL, V14, P1028, DOI 10.1890/03-5087
   Rohr JR, 2003, ENVIRON TOXICOL CHEM, V22, P2385, DOI 10.1897/02-528
   Salice CJ, 2013, ECOTOXICOLOGY, V22, P42, DOI 10.1007/s10646-012-1001-5
   Salice CJ, 2011, ENVIRON TOXICOL CHEM, V30, P2874, DOI 10.1002/etc.680
   Salice CJ, 2011, ENVIRON POLLUT, V159, P3334, DOI 10.1016/j.envpol.2011.08.033
   Salice CJ, 2009, ARCH ENVIRON CON TOX, V56, P785, DOI 10.1007/s00244-008-9203-9
   Salice CJ, 2003, ENVIRON TOXICOL CHEM, V22, P678, DOI 10.1002/etc.5620220329
   Salice CJ, 2002, ENVIRON TOXICOL CHEM, V21, P1398, DOI [10.1897/1551-5028(2002)021<1398:RTCAPI>2.0.CO;2, 10.1002/etc.5620210710]
   Schafer RB, 2014, ENVIRON TOXICOL CHEM, V33, P1193, DOI 10.1002/etc.2569
   Scheffer M, 2003, TRENDS ECOL EVOL, V18, P648, DOI 10.1016/j.tree.2003.09.002
   Scheffer M, 2009, NATURE, V461, P53, DOI 10.1038/nature08227
   Schlaepfer MA, 2002, TRENDS ECOL EVOL, V17, P474, DOI 10.1016/S0169-5347(02)02580-6
   Schmolke A, 2010, TRENDS ECOL EVOL, V25, P479, DOI 10.1016/j.tree.2010.05.001
   Schmolke A, 2010, ENVIRON TOXICOL CHEM, V29, P1006, DOI 10.1002/etc.120
   Scholz S, 2013, REGUL TOXICOL PHARM, V67, P506, DOI 10.1016/j.yrtph.2013.10.003
   Schotthoefer AM, 2011, ECOL APPL, V21, P1257, DOI 10.1890/10-0374.1
   Semlitsch RD, 2000, OECOLOGIA, V125, P179, DOI 10.1007/s004420000443
   Sibly RM, 2013, METHODS ECOL EVOL, V4, P151, DOI 10.1111/2041-210x.12002
   SIBLY RM, 1989, BIOL J LINN SOC, V37, P101, DOI 10.1111/j.1095-8312.1989.tb02007.x
   Skelly DK, 2001, OIKOS, V94, P198, DOI 10.1034/j.1600-0706.2001.t01-1-11105.x
   Sourisseau S, 2008, WATER RES, V42, P1167, DOI 10.1016/j.watres.2007.08.039
   Spromberg JA, 1998, ENVIRON TOXICOL CHEM, V17, P1640, DOI 10.1002/etc.5620170828
   Stadnicka-Michalak J, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500302
   Staley ZR, 2014, ECOL APPL, V24, P1945, DOI 10.1890/13-1242.1
   Staley ZR, 2012, APPL ENVIRON MICROB, V78, P8146, DOI 10.1128/AEM.01815-12
   Staley ZR, 2011, APPL ENVIRON MICROB, V77, P8765, DOI 10.1128/AEM.06044-11
   Staley ZR, 2010, ENVIRON MICROBIOL, V12, P3150, DOI 10.1111/j.1462-2920.2010.02287.x
   Stampfli NC, 2011, AQUAT TOXICOL, V104, P116, DOI 10.1016/j.aquatox.2011.04.004
   Stark JD, 2004, P NATL ACAD SCI USA, V101, P732, DOI 10.1073/pnas.0304903101
   Stark JD, 2003, ANNU REV ENTOMOL, V48, P505, DOI 10.1146/annurev.ento.48.091801.112621
   Stark J, 2005, DECIS ENG, P1
   STAY FS, 1989, ARCH ENVIRON CON TOX, V18, P866, DOI 10.1007/BF01160302
   Stephens PA, 1999, TRENDS ECOL EVOL, V14, P401, DOI 10.1016/S0169-5347(99)01684-5
   Stevenson LM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074456
   Stone WW, 2014, ENVIRON SCI TECHNOL, V48, P11025, DOI 10.1021/es5025367
   Sturla SJ, 2014, CHEM RES TOXICOL, V27, P314, DOI 10.1021/tx400410s
   Sundling K, 2014, MATH BIOSCI ENG, V11, P621, DOI 10.3934/mbe.2014.11.621
   Suter GW, 2005, INTEGR ENVIRON ASSES, V1, P397, DOI 10.1002/ieam.5630010409
   Suter Glenn W. III, 2008, Integrated Environmental Assessment and Management, V4, P285, DOI 10.1897/IEAM_2007-062
   SUTER GW, 1990, ENVIRON MANAGE, V14, P9, DOI 10.1007/BF02394015
   SUTER GW, 2007, ECOLOGICAL RISK ASSE
   Taub FB, 1997, ECOL APPL, V7, P1083, DOI 10.1890/1051-0761(1997)007[1083:AESRTP]2.0.CO;2
   Taub FB, 1997, ECOL APPL, V7, P1103
   Thorbek P., 2009, ECOLOGICAL MODELS RE
   Topping CJ, 2016, SCI TOTAL ENVIRON, V541, P1477, DOI 10.1016/j.scitotenv.2015.10.042
   Topping CJ, 2015, SCI TOTAL ENVIRON, V537, P159, DOI 10.1016/j.scitotenv.2015.07.152
   Topping CJ, 2014, ENVIRON TOXICOL CHEM, V33, P1499, DOI 10.1002/etc.2388
   Touart LW, 1997, ECOL APPL, V7, P1086
   Traas TP, 2004, ENVIRON TOXICOL CHEM, V23, P521, DOI 10.1897/02-524
   USEPA, 1992, EPA630R92001
   USEPA, 1993, PEST RER PROGR REP
   USEPA, 1998, EPA630R95002F
   USEPA, 2000, EPA823R00008
   USEPA, 2003, GEN EC ASS ENDP GEAE, P67
   van den Brink PJ, 2006, INTEGR ENVIRON ASSES, V2, P202, DOI 10.1002/ieam.5630020302
   Van den Brink PJ, 2013, INTEGR ENVIRON ASSES, V9, pE47, DOI 10.1002/ieam.1443
   Van den Brink PJ, 2013, ENVIRON TOXICOL CHEM, V32, P972, DOI 10.1002/etc.2210
   Van den Brink PJ, 2002, ENVIRON TOXICOL CHEM, V21, P2500, DOI 10.1002/etc.5620211132
   van der Vaart E, 2016, ECOL MODEL, V326, P113, DOI 10.1016/j.ecolmodel.2015.08.012
   van der Vaart E, 2015, ECOL MODEL, V312, P182, DOI 10.1016/j.ecolmodel.2015.05.020
   Voccia I, 1999, TOXICOL IND HEALTH, V15, P119, DOI 10.1191/074823399678846637
   Vonesh JR, 2009, OECOLOGIA, V160, P379, DOI 10.1007/s00442-009-1301-5
   Vonesh JR, 2002, OECOLOGIA, V133, P325, DOI 10.1007/s00442-002-1039-9
   WALKER BH, 1992, CONSERV BIOL, V6, P18, DOI 10.1046/j.1523-1739.1992.610018.x
   Walthall WK, 1997, ENVIRON TOXICOL CHEM, V16, P1068, DOI 10.1002/etc.5620160529
   Watanabe KH, 2009, TOXICOL SCI, V109, P180, DOI 10.1093/toxsci/kfp069
   Wendt-Rasch L, 2014, ENVIRON TOXICOL CHEM, V33, P1196, DOI 10.1002/etc.2571
   WIDDOWS J, 1995, MAR ECOL PROG SER, V127, P131, DOI 10.3354/meps127131
   Wiegers JK, 1998, HUM ECOL RISK ASSESS, V4, P1125, DOI 10.1080/10807039891285036
   Wintermantel TM, 2006, NEURON, V52, P271, DOI 10.1016/j.neuron.2006.07.023
NR 303
TC 22
Z9 22
U1 9
U2 60
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1040-8444
EI 1547-6898
J9 CRIT REV TOXICOL
JI Crit. Rev. Toxicol.
PY 2016
VL 46
IS 9
BP 756
EP 784
DI 10.1080/10408444.2016.1190685
PG 29
WC Toxicology
SC Toxicology
GA DY8LK
UT WOS:000385381400002
PM 27340745
OA Green Accepted
DA 2019-10-23
ER

PT J
AU Edwards, S
   Oki, N
   Bell, S
   Nelms, M
   Tan, C
AF Edwards, Stephen
   Oki, Noffisat
   Bell, Shannon
   Nelms, Mark
   Tan, Cecelia
TI Computationally-predicted aops and systems toxicology
SO DRUG METABOLISM REVIEWS
LA English
DT Meeting Abstract
CT 20th North American Meeting of the
   International-Society-for-the-Study-of-Xenobiotics (ISSX)
CY OCT 18-22, 2015
CL Orlando, FL
SP Int Soc Study Xenobiot
C1 [Edwards, Stephen; Oki, Noffisat; Bell, Shannon; Nelms, Mark; Tan, Cecelia] US EPA, Res Triangle Pk, NC 27711 USA.
   [Oki, Noffisat; Bell, Shannon; Nelms, Mark] Oak Ridge Inst Sci & Educ, Oak Ridge, TN USA.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0360-2532
EI 1097-9883
J9 DRUG METAB REV
JI Drug Metab. Rev.
PY 2016
VL 48
SU 1
MA S13
BP 12
EP 12
PG 1
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA DS4IO
UT WOS:000380744900020
DA 2019-10-23
ER

PT J
AU Maxwell, G
AF Maxwell, Gavin
TI Applying the skin sensitization AOP to human health risk assessment
SO DRUG METABOLISM REVIEWS
LA English
DT Meeting Abstract
CT 20th North American Meeting of the
   International-Society-for-the-Study-of-Xenobiotics (ISSX)
CY OCT 18-22, 2015
CL Orlando, FL
SP Int Soc Study Xenobiot
C1 [Maxwell, Gavin] Unilever, Bedford, England.
CR Friedmann P, 1983, CLIN EXP IMMUNOL, V53, P709
   FRIEDMANN PS, 1983, CLIN EXP IMMUNOL, V53, P709
   MacKay C, 2013, ALTEX, V30, P473
   MacKay C, 2013, ALTEX-ALTERN ANIM EX, V30, P473, DOI 10.14573/altex.2013.4.473
NR 4
TC 0
Z9 0
U1 0
U2 2
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0360-2532
EI 1097-9883
J9 DRUG METAB REV
JI Drug Metab. Rev.
PY 2016
VL 48
SU 1
MA S14
BP 13
EP 13
PG 1
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA DS4IO
UT WOS:000380744900021
DA 2019-10-23
ER

PT J
AU Anastas, ND
AF Anastas, Nicholas D.
TI Connecting toxicology and chemistry to ensure safer chemical design
SO GREEN CHEMISTRY
LA English
DT Article
ID ADVERSE OUTCOME PATHWAYS; RISK-ASSESSMENT; TOXICITY; SUPPORT;
   PREDICTION; FRAMEWORK; HAZARD; TOOLS
AB Designing safer, healthier and sustainable products and processes requires the engagement of toxicologists and the incorporation of twenty-first century toxicology principles and practices. As the demand for safer products increases, scientists must incorporate toxicology as early as possible as part of a comprehensive design strategy to minimize or eliminate toxicity prior to product development. Hazard reduction through molecular design benefits from trans-disciplinary collaboration among chemists, toxicologists and environmental scientists, and must be initiated at the design stage of chemicals synthesis. The path forward requires a sustained multi-pronged commitment to embedding the principles of toxicology into the chemistry curriculum, developing a framework that articulates maxims for sustainable design, promoting research collaboration among allied professional scientists and supporting education and outreach efforts at every opportunity, to technical and non-technical audiences, that highlight the natural nexus between toxicology and chemistry.
C1 [Anastas, Nicholas D.] NRMRL, Cincinnati, OH 45268 USA.
   [Anastas, Nicholas D.] US EPA, Off Res & Dev, Washington, DC 20460 USA.
RP Anastas, ND (reprint author), NRMRL, Cincinnati, OH 45268 USA.; Anastas, ND (reprint author), US EPA, Off Res & Dev, Washington, DC 20460 USA.
EM anastas.nicholas@epa.gov
CR Alfonsi K, 2008, GREEN CHEM, V10, P31, DOI 10.1039/b711717e
   Anastas N. D., 2008, THESIS
   Anastas N. D., 2005, CHEM HLTH SAFETY, P9
   Anastas N. D., 2012, GREEN TECHNIQUES ORG
   Anastas P. T., 1998, GREEN CHEM THEORY PR, P135
   Anastas P.T., 1997, J CLEAN PROD, V5, P97
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Ariens, 1966, ANGEW FORSCH, V10, P429
   Ball N., 2016, ALTEX LINE, P14
   Barratt MD, 2000, CELL BIOL TOXICOL, V16, P1, DOI 10.1023/A:1007676602908
   Borgert CJ, 2015, REGUL TOXICOL PHARM, V72, P538, DOI 10.1016/j.yrtph.2015.04.018
   Connors KA, 2014, ENVIRON TOXICOL CHEM, V33, P1894, DOI 10.1002/etc.2614
   Dahlin JL, 2014, FUTURE MED CHEM, V6, P1265, DOI [10.4155/FMC.14.60, 10.4155/fmc.14.60]
   DeVito S., 1996, ACS SYM SER, V640, P2
   DeVito S. C., 1996, ACS S SERIES, V640
   Hamilton A., 1928, CHEM MED, P374
   Jordan A, 2015, CHEM SOC REV, V44, P8200, DOI 10.1039/c5cs00444f
   Jusdon R. S., 2012, INT J MIL SCI, V13, P1805
   Kavlock R, 2010, J TOXICOL ENV HEAL B, V13, P197, DOI 10.1080/10937404.2010.483935
   Kobayashi N, 2002, MAR POLLUT BULL, V44, P748, DOI 10.1016/S0025-326X(02)00052-8
   Kostal J, 2015, P NATL ACAD SCI USA, V112, P6289, DOI 10.1073/pnas.1314991111
   Lai DY, 1996, ACS SYM SER, V640, P62
   Lau C, 2007, TOXICOL SCI, V99, P366, DOI 10.1093/toxsci/kfm128
   Maertens A., 2014, ALTEX, V31, p3/14
   McPartland J, 2015, ENVIRON HEALTH PERSP, V123, P1, DOI 10.1289/ehp.1408601
   NAS (National Academy of Sciences), 2014, COMM REV IRIS PROC B
   NRC, 2007, TOXICITY TESTING 21
   Patlewicz G, 2015, REGUL TOXICOL PHARM, V71, P463, DOI 10.1016/j.yrtph.2015.02.011
   Pereira DA, 2007, BRIT J PHARMACOL, V152, P53, DOI 10.1038/sj.bjp.0707373
   Petrov P. I., 2009, SAR QSAR ENVIRON RES, V20, P657
   Schultz TW, 2015, REGUL TOXICOL PHARM, V72, P586, DOI 10.1016/j.yrtph.2015.05.016
   Segal D, 2015, REGUL TOXICOL PHARM, V72, P94, DOI 10.1016/j.yrtph.2015.03.005
   Smith M. B., 2013, MARCHS ADV ORGANIC C, P2088
   Tollefsen KE, 2014, REGUL TOXICOL PHARM, V70, P629, DOI 10.1016/j.yrtph.2014.09.009
   Villeneuve DL, 2014, TOXICOL SCI, V142, P312, DOI 10.1093/toxsci/kfu199
   Villeneuve DL, 2014, TOXICOL SCI, V142, P321, DOI 10.1093/toxsci/kfu200
   Vouchkova A., 2010, CHEM REV, V110, P5845
NR 37
TC 8
Z9 8
U1 1
U2 8
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1463-9262
EI 1463-9270
J9 GREEN CHEM
JI Green Chem.
PY 2016
VL 18
IS 16
BP 4325
EP 4331
DI 10.1039/c6gc00758a
PG 7
WC Chemistry, Multidisciplinary; Green & Sustainable Science & Technology
SC Chemistry; Science & Technology - Other Topics
GA DT4HM
UT WOS:000381440800002
DA 2019-10-23
ER

PT J
AU Kristofco, LA
   Cruz, LC
   Haddad, SP
   Behra, ML
   Chambliss, CK
   Brooks, BW
AF Kristofco, Lauren A.
   Cruz, Luis Colon
   Haddad, Samuel P.
   Behra, Martine L.
   Chambliss, C. Kevin
   Brooks, Bryan W.
TI Age matters: Developmental stage of Danio rerio larvae influences
   photomotor response thresholds to diazinion or diphenhydramine
SO AQUATIC TOXICOLOGY
LA English
DT Article
DE Alternative toxicity test methods; Behavior; Comparative pharmacology
   and toxicology; Developmental toxicology; Photomotor response
ID RATIONAL MOLECULAR DESIGN; PERSONAL CARE PRODUCTS; IN-VITRO;
   ACETYLCHOLINESTERASE INHIBITION; LOCOMOTOR-ACTIVITY; ACUTE TOXICITY;
   LIFE STAGES; ZEBRAFISH; CHLORPYRIFOS; BEHAVIOR
AB Because basic toxicological data is unavailable for the majority of industrial compounds, High Throughput Screening (HTS) assays using the embryonic and larval zebrafish provide promising approaches to define bioactivity profiles and identify potential adverse outcome pathways for previously understudied chemicals. Unfortunately, standardized approaches, including HTS experimental designs, for examining fish behavioral responses to contaminants are rarely available. In the present study, we examined movement behavior of larval zebrafish over 7 days (4-10 days post fertilization or dpf) during typical daylight workday hours to determine whether intrinsic activity differed with age and time of day. We then employed an early life stage approach using the Fish Embryo Test (FET) at multiple developmental ages to evaluate whether photomotor response (PMR) behavior differed with zebrafish age following exposure to diazinon (DZN), a well-studied orthophosphate insecticide, and diphenhydramine (DPH), an antihistamine that also targets serotonin reuptake transporters and the acetylcholine receptor. 72 h studies were conducted at 1-4, 4-7 and 7-10 dpf, followed by behavioral observations using a ViewPoint system at 4, 7 and 10 dpf. Distance traveled and swimming speeds were quantified; nominal treatment levels were analytically verified by isotope-dilution LC-MSMS. Larval zebrafish locomotion displayed significantly different (p < 0.05) activity profiles over the course of typical daylight and workday hours, and these time of day PMR activity profiles were similar across ages examined (4-10 dpf). 10 dpf zebrafish larvae were consistently more sensitive to DPH than either the 4 or 7 dpf larvae with an environmentally realistic lowest observed effect concentration of 200 ng/L. Though ELS and FET studies with zebrafish typically focus on mortality or teratogenicity in 0-4 dpf organisms, behavioral responses of slightly older fish were several orders of magnitude more sensitive to DPH. Our observations highlight the importance of understanding the influence of time of day on intrinsic locomotor activity, and the age-specific hazards of aquatic contaminants to fish behavior. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Kristofco, Lauren A.; Haddad, Samuel P.; Chambliss, C. Kevin; Brooks, Bryan W.] Baylor Univ, Ctr Reservoir & Aquat Syst Res, Dept Environm Sci, Waco, TX 76798 USA.
   [Cruz, Luis Colon; Behra, Martine L.] Univ Puerto Rico, Sch Med, Dept Anat & Neurobiol, Med Sci Campus, San Juan, PR 00936 USA.
   [Chambliss, C. Kevin] Baylor Univ, Dept Chem, POB 97348, Waco, TX 76798 USA.
RP Brooks, BW (reprint author), Baylor Univ, Ctr Reservoir & Aquat Syst Res, Dept Environm Sci, Waco, TX 76798 USA.
EM Bryan_Brooks@baylor.edu
RI Guenat, Heather/H-6528-2014; Brooks, Bryan W/B-2612-2010
OI Brooks, Bryan W/0000-0002-6277-9852; /0000-0001-8107-6565
FU National Science FoundationNational Science Foundation (NSF)
   [CHE-1339637]; Environmental Protection Agency through the Molecular
   Design Research Network; NSF-CREST grant PRCEN (Puerto Rico Center for
   Environmental Neuroscience) [HRD-1137725]; Research Centers for Minority
   Institution, Seed monies for young investigators (RCMI/NIH) [G12
   RR03051]; Research Centers for Minority Institution, equipment for core
   labs (RCMI/NIH) [8G12MD007600]; Puerto-Rican Science Trust
FX This work was supported by the C. Gus Glasscock, Jr. Endowed Fund for
   Excellence in Environmental Sciences grant to LAK with additional
   support provided by the National Science Foundation (CHE-1339637) and
   Environmental Protection Agency to BWB through the Molecular Design
   Research Network (modrn.yale.edu). We thank W. Baylor Steele, Gavin N.
   Saari and Dr. Jone Corrales for laboratory assistance. LC was supported
   by a NSF-CREST grant PRCEN (Puerto Rico Center for Environmental
   Neuroscience) #HRD-1137725. Work performed at the RCM-UPR was further
   supported by Research Centers for Minority Institution, Seed monies for
   young investigators (RCMI/NIH, #G12 RR03051), Research Centers for
   Minority Institution, equipment for core labs (RCMI/NIH, # 8G12MD007600)
   and The Puerto-Rican Science Trust.
CR Ahmad F, 2013, BEHAV PROCESS, V92, P88, DOI 10.1016/j.beproc.2012.10.014
   Beauvais SL, 2001, ECOTOX ENVIRON SAFE, V49, P84, DOI 10.1006/eesa.2000.2032
   Belanger SE, 2013, ENVIRON TOXICOL CHEM, V32, P1768, DOI 10.1002/etc.2244
   Berninger JP, 2011, ENVIRON TOXICOL CHEM, V30, P2065, DOI 10.1002/etc.590
   Berninger JP, 2010, TOXICOL LETT, V193, P69, DOI 10.1016/j.toxlet.2009.12.006
   Boxall ABA, 2012, ENVIRON HEALTH PERSP, V120, P1221, DOI 10.1289/ehp.1104477
   Brooks BW, 2014, AQUAT TOXICOL, V151, P61, DOI 10.1016/j.aquatox.2014.01.007
   Brooks BW, 2009, ENVIRON TOXICOL CHEM, V28, P2469, DOI 10.1897/09-325.1
   Brooks BW, 2003, TOXICOL LETT, V142, P169, DOI 10.1016/S0378-4274(03)00066-3
   Burgess HA, 2007, J EXP BIOL, V210, P2526, DOI 10.1242/jeb.003939
   Caldwell D.J., 2014, CHEMOSPHERE
   Chen TH, 2011, AQUAT TOXICOL, V102, P162, DOI 10.1016/j.aquatox.2011.01.010
   Connors KA, 2014, ENVIRON TOXICOL CHEM, V33, P1894, DOI 10.1002/etc.2614
   Connors KA, 2013, ENVIRON TOXICOL CHEM, V32, P1810, DOI 10.1002/etc.2240
   Dobbins LL, 2008, ENVIRON TOXICOL CHEM, V27, P2608, DOI 10.1897/08-126.1
   Dreier DA, 2015, REGUL TOXICOL PHARM, V72, P185, DOI 10.1016/j.yrtph.2015.04.009
   Eddins D, 2010, NEUROTOXICOL TERATOL, V32, P99, DOI 10.1016/j.ntt.2009.02.005
   Eriksson KS, 1998, EUR J NEUROSCI, V10, P3799, DOI 10.1046/j.1460-9568.1998.00394.x
   FENT K, 1994, ARCH ENVIRON CON TOX, V27, P224
   Fitzsimmons PN, 2001, AQUAT TOXICOL, V55, P23, DOI 10.1016/S0166-445X(01)00174-6
   Ford A.T., 2015, ENV TOXICOL CHEM
   Gaikowski MP, 1996, ECOTOX ENVIRON SAFE, V34, P252, DOI 10.1006/eesa.1996.0070
   Gaworecki KM, 2009, ENVIRON TOXICOL CHEM, V28, P105, DOI 10.1897/08-001.1
   Gunnarsson L, 2008, ENVIRON SCI TECHNOL, V42, P5807, DOI 10.1021/es8005173
   Hamm JT, 2000, AQUAT TOXICOL, V48, P403, DOI 10.1016/S0166-445X(99)00065-X
   Hamm JT, 2001, TOXICOL SCI, V61, P304, DOI 10.1093/toxsci/61.2.304
   Huggett DB, 2003, HUM ECOL RISK ASSESS, V9, P1789, DOI 10.1080/10807030390260498
   Huggett DB, 2003, TOXICOL SCI, V72, P77, DOI 10.1093/toxsci/kfg017
   Ingebretson JJ, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00109
   Kalueff AV, 2013, ZEBRAFISH, V10, P70, DOI 10.1089/zeb.2012.0861
   Kavlock R, 2012, CHEM RES TOXICOL, V25, P1287, DOI 10.1021/tx3000939
   KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302
   Kluver N, 2015, ENVIRON SCI TECHNOL, V49, P7002, DOI 10.1021/acs.est.5b01910
   Knobel M, 2012, ENVIRON SCI TECHNOL, V46, P9690, DOI 10.1021/es301729q
   Kokel D, 2010, NAT CHEM BIOL, V6, P231, DOI 10.1038/NCHEMBIO.307
   Koprucu K, 2004, PESTIC BIOCHEM PHYS, V80, P47, DOI 10.1016/j.pestbp.2004.05.004
   Kristofco LA, 2015, AAPS J, V17, P175, DOI 10.1208/s12248-014-9677-5
   Lammer E, 2009, COMP BIOCHEM PHYS C, V149, P196, DOI 10.1016/j.cbpc.2008.11.006
   Levin ED, 2004, NEUROTOXICOL TERATOL, V26, P719, DOI 10.1016/j.ntt.2004.06.013
   Truong L, 2014, TOXICOL SCI, V137, P212, DOI 10.1093/toxsci/kft235
   Little E.E., 1993, AM FISH SOC S
   LITTLE EE, 1990, ENVIRON TOXICOL CHEM, V9, P13, DOI 10.1002/etc.5620090103
   MacPhail RC, 2009, NEUROTOXICOLOGY, V30, P52, DOI 10.1016/j.neuro.2008.09.011
   MARTY GD, 1990, AQUAT TOXICOL, V17, P45, DOI 10.1016/0166-445X(90)90011-D
   Nagel R, 2002, ALTEX-ALTERN TIEREXP, V19, P38
   Nichols JW, 2015, ENVIRON TOXICOL CHEM, V34, P1425, DOI 10.1002/etc.2948
   Noyes PD, 2015, TOXICOL SCI, V145, P177, DOI 10.1093/toxsci/kfv044
   NRC, 2015, TOX TEST 21 CENT VIS, P216
   Organisation for Economic Co-operation and Development OECD , 2013, TEST 236 FISH EMBR A
   Padilla S, 2012, REPROD TOXICOL, V33, P174, DOI 10.1016/j.reprotox.2011.10.018
   Padilla S, 2011, NEUROTOXICOL TERATOL, V33, P624, DOI 10.1016/j.ntt.2011.08.005
   Perez J, 2013, ENVIRON SCI POLLUT R, V20, P4671, DOI 10.1007/s11356-012-1443-6
   Perkins EJ, 2013, ENVIRON HEALTH PERSP, V121, P1002, DOI 10.1289/ehp.1306638
   Raftery TD, 2014, ENVIRON SCI TECHNOL, V48, P804, DOI 10.1021/es404322p
   Richendrfer H, 2015, NEUROTOXICOLOGY, V49, P50, DOI 10.1016/j.neuro.2015.05.002
   Richendrfer H, 2012, NEUROTOXICOL TERATOL, V34, P458, DOI 10.1016/j.ntt.2012.04.010
   Rico EP, 2011, NEUROTOXICOL TERATOL, V33, P608, DOI 10.1016/j.ntt.2011.07.007
   Rovida C, 2009, ALTEX-ALTERN TIEREXP, V26, P187
   Rudd, 2014, INTEGR ENVIRON ASSES, V10, P576
   Rusyn I, 2010, ENVIRON HEALTH PERSP, V118, P1047, DOI 10.1289/ehp.1001925
   Saint-Amant L, 1998, J NEUROBIOL, V37, P622, DOI 10.1002/(SICI)1097-4695(199812)37:4<622::AID-NEU10>3.0.CO;2-S
   Schaafsma G, 2009, REGUL TOXICOL PHARM, V53, P70, DOI 10.1016/j.yrtph.2008.11.003
   Scheil V, 2009, ECOTOXICOLOGY, V18, P355, DOI 10.1007/s10646-008-0291-0
   Schnorr SJ, 2012, BEHAV BRAIN RES, V228, P367, DOI 10.1016/j.bbr.2011.12.016
   Sisman T, 2010, TOXICOL IND HEALTH, V26, P567, DOI 10.1177/0748233710373089
   Steenbergen PJ, 2011, BEHAV BRAIN RES, V222, P15, DOI 10.1016/j.bbr.2011.03.025
   Tilton FA, 2011, COMP BIOCHEM PHYS C, V153, P9, DOI 10.1016/j.cbpc.2010.07.008
   Usenko CY, 2011, ENVIRON TOXICOL CHEM, V30, P1865, DOI 10.1002/etc.570
   Valenti Theodore W., 2011, Integrated Environmental Assessment and Management, V7, P636, DOI 10.1002/ieam.202
   Valenti TW, 2012, ENVIRON SCI TECHNOL, V46, P2427, DOI 10.1021/es204164b
   Voutchkova AM, 2011, GREEN CHEM, V13, P2373, DOI 10.1039/c1gc15651a
   Voutchkova-Kostal AM, 2012, GREEN CHEM, V14, P1001, DOI 10.1039/c2gc16385c
   Weisbrod AV, 2007, ENVIRON HEALTH PERSP, V115, P255, DOI 10.1289/ehp.9424
   Yen J, 2011, NEUROTOXICOL TERATOL, V33, P735, DOI 10.1016/j.ntt.2011.10.004
NR 74
TC 23
Z9 23
U1 0
U2 31
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-445X
EI 1879-1514
J9 AQUAT TOXICOL
JI Aquat. Toxicol.
PD JAN
PY 2016
VL 170
BP 344
EP 354
DI 10.1016/j.aquatox.2015.09.011
PG 11
WC Marine & Freshwater Biology; Toxicology
SC Marine & Freshwater Biology; Toxicology
GA DB5OW
UT WOS:000368564500037
PM 26431593
OA Green Accepted
DA 2019-10-23
ER

PT J
AU Phillips, MB
   Leonard, JA
   Grulke, CM
   Chang, DT
   Edwards, SW
   Brooks, R
   Goldsmith, MR
   El-Masri, H
   Tan, YM
AF Phillips, Martin B.
   Leonard, Jeremy A.
   Grulke, Christopher M.
   Chang, Daniel T.
   Edwards, Stephen W.
   Brooks, Raina
   Goldsmith, Michael-Rock
   El-Masri, Hisham
   Tan, Yu-Mei
TI A Workflow to Investigate Exposure and Pharmacokinetic Influences on
   High-Throughput in Vitro Chemical Screening Based on Adverse Outcome
   Pathways
SO ENVIRONMENTAL HEALTH PERSPECTIVES
LA English
DT Article
ID OCCUPATIONAL-EXPOSURE; DRUG DISCOVERY; TOXICITY; INHIBITION; TOXICOLOGY;
   ACETYLCHOLINESTERASE; ECOTOXICOLOGY; APPLICABILITY; CHLORPYRIFOS;
   PENTAMIDINE
AB BACKGROUND: Adverse outcome pathways (AOPs) link adverse effects in individuals or populations to a molecular initiating event (MIE) that can be quantified using in vitro methods. Practical application of AOPs in chemical-specific risk assessment requires incorporation of knowledge on exposure, along with absorption, distribution, metabolism, and excretion (ADME) properties of chemicals.
   OBJECTIVES: We developed a conceptual workflow to examine exposure and ADME properties in relation to an MIE. The utility of this workflow was evaluated using a previously established AOP, acetylcholinesterase (AChE) inhibition.
   METHODS: Thirty chemicals found to inhibit human AChE in the ToxCast (TM) assay were examined with respect to their exposure, absorption potential, and ability to cross the blood-brain barrier (BBB). Structures of active chemicals were compared against structures of 1,029 inactive chemicals to detect possible parent compounds that might have active metabolites.
   RESULTS: Application of the workflow screened 10 "low-priority" chemicals of 30 active chemicals. Fifty-two of the 1,029 inactive chemicals exhibited a similarity threshold of >= 75% with their nearest active neighbors. Of these 52 compounds, 30 were excluded due to poor absorption or distribution. The remaining 22 compounds may inhibit AChE in vivo either directly or as a result of metabolic activation.
   CONCLUSIONS: The incorporation of exposure and ADME properties into the conceptual workflow eliminated 10 "low-priority" chemicals that may otherwise have undergone additional, resource-consuming analyses. Our workflow also increased confidence in interpretation of in vitro results by identifying possible "false negatives."
C1 [Phillips, Martin B.; Leonard, Jeremy A.] Oak Ridge Inst Sci & Educ, Oak Ridge, TN USA.
   [Grulke, Christopher M.] Lockheed Martin, Res Triangle Pk, NC USA.
   [Chang, Daniel T.; Goldsmith, Michael-Rock] Chem Comp Grp Inc, Montreal, PQ, Canada.
   [Edwards, Stephen W.; El-Masri, Hisham] US EPA, Natl Hlth & Environm Effects Res Lab, Res Triangle Pk, NC 27711 USA.
   [Brooks, Raina] Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL USA.
   [Tan, Yu-Mei] US EPA, Natl Exposure Res Lab, Res Triangle Pk, NC 27711 USA.
RP Tan, YM (reprint author), 109 TW Alexander Dr,Mail Code E205-01, Res Triangle Pk, NC 27709 USA.
EM tan.cecilia@epa.gov
OI Grulke, Christopher/0000-0001-5606-7560; Phillips,
   Martin/0000-0002-6282-529X
FU Oak Ridge Institute for Science and Education Research Participation
   Program at the U.S. EPA
FX M.B.P. and J.A.L. were funded through the Oak Ridge Institute for
   Science and Education Research Participation Program at the U.S. EPA.
CR Abass K, 2010, CHEM-BIOL INTERACT, V185, P163, DOI 10.1016/j.cbi.2010.03.024
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   [Anonymous], 2013, TECHN TRANSF NETW AI
   Baell J, 2014, NATURE, V513, P481, DOI 10.1038/513481a
   Baell JB, 2010, J MED CHEM, V53, P2719, DOI 10.1021/jm901137j
   Baldi P, 2010, J CHEM INF MODEL, V50, P1205, DOI 10.1021/ci100010v
   Beach JR, 1999, OCCUP MED-OXFORD, V49, P243, DOI 10.1093/occmed/49.4.243
   Beresford N, 2000, TOXICOL APPL PHARM, V162, P22, DOI 10.1006/taap.1999.8817
   Berman T, 2012, INT J HYG ENVIR HEAL, V215, P138, DOI 10.1016/j.ijheh.2011.09.006
   Berman T, 2011, ENVIRON INT, V37, P198, DOI 10.1016/j.envint.2010.09.002
   Bernhoft RA, 2012, J ENVIRON PUBLIC HEA, DOI 10.1155/2012/460508
   Bertz RJ, 1997, CLIN PHARMACOKINET, V32, P210, DOI 10.2165/00003088-199732030-00004
   Boscolo M, 2009, J BIOL REG HOMEOS AG, V23, P217
   CHAMBERS JE, 1993, FUND APPL TOXICOL, V21, P111, DOI 10.1006/faat.1993.1079
   Chang D. T., 2012, PARAMETERS PESTICIDE, V1099, P245
   Clayton G. D., 1994, PATTYS IND HYGIENE T
   Cochran RC, 1996, REV ENVIRON CONTAM T, V146, P1
   Cone M., 2010, INSECTICIDE BE BANNE
   Cui N, 2011, ENVIRON POLLUT, V159, P609, DOI 10.1016/j.envpol.2010.09.036
   Dejobert Y, 1997, CONTACT DERMATITIS, V37, P95, DOI 10.1111/j.1600-0536.1997.tb00050.x
   Duprey Z, 2008, J AM MOSQUITO CONTR, V24, P42, DOI 10.2987/5559.1
   Eaton DL, 2008, CRIT REV TOXICOL, V38, P1, DOI [10.1080/10408440802272158, 10.1080/10408440802272158 ]
   Egeghy PP, 2012, SCI TOTAL ENVIRON, V414, P159, DOI 10.1016/j.scitotenv.2011.10.046
   EMEA (European Agency for the Evaluation of Medical Products), 1999, EMEAMRL00195FINAL
   EXTOXNET (Extension Toxicology Network), 1996, PEST IF PROF METH
   EXTOXNET (Extension Toxicology Network), 1993, PEST INF PROF OX
   Goldsmith Michael R, 2012, Methods Mol Biol, V929, P139
   Groh KJ, 2015, CHEMOSPHERE, V120, P764, DOI 10.1016/j.chemosphere.2014.09.068
   GUPTA RC, 1994, J TOXICOL ENV HEALTH, V43, P383, DOI 10.1080/15287399409531931
   Horvath D, 2009, J CHEM INF MODEL, V49, P1762, DOI 10.1021/ci9000579
   Houtappel M, 2008, CONTACT DERMATITIS, V59, P116, DOI 10.1111/j.1600-0536.2008.01336.x
   HUSSAIN M, 1990, ARCH ENVIRON CON TOX, V19, P197, DOI 10.1007/BF01056087
   Jaworska J, 2005, ATLA-ALTERN LAB ANIM, V33, P445, DOI 10.1177/026119290503300508
   Kapui Z, 2003, J PHARMACOL EXP THER, V305, P451, DOI 10.1124/jpet.102.044263
   Knudsen TB, 2011, TOXICOLOGY, V282, P1, DOI 10.1016/j.tox.2010.12.010
   Kohlhaas KL, 2006, U.S. Patent Application Publication, Patent No. [US2006/0211686 A1, 20060211686]
   Kosaka K, 2011, DRUG METAB DISPOS, V39, P1495, DOI 10.1124/dmd.111.040030
   Lapenna S, 2012, ATLA-ALTERN LAB ANIM, V40, P313, DOI 10.1177/026119291204000604
   LeBlanc GA, 2011, DET REV PAP IN PRES
   Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1
   Mackay D, 2014, REV ENVIRON CONTAM T, V231, P35, DOI 10.1007/978-3-319-03865-0_3
   Mauri A, 2006, MATCH-COMMUN MATH CO, V56, P237
   McGill A, 2005, FASEB J, V19, P1012, DOI 10.1096/fj.04-2664fje
   Metro TX, 2011, J ORG CHEM, V76, P2594, DOI 10.1021/jo102471r
   MONTGOMERY AB, 1990, CHEST, V98, P386, DOI 10.1378/chest.98.2.386
   NIOSH (National Institute for Occupational Safety and Health), 1983, NAT OCC EXP SURV COD
   Ostrea EM, 2014, ENVIRON RES, V131, P13, DOI 10.1016/j.envres.2014.01.003
   Ouattara B, 2009, J MOL NEUROSCI, V38, P128, DOI 10.1007/s12031-008-9137-8
   R & D Focus Drug News, 2007, SSR 150106 SAN AV PH
   Rahman SA, 2009, J CHEMINFORMATICS, V1, DOI 10.1186/1758-2946-1-12
   Rautio J, 2008, NAT REV DRUG DISCOV, V7, P255, DOI 10.1038/nrd2468
   Roberts C, 2001, CNS DRUG REV, V7, P433
   Roberts T, 1999, METABOLIC PATHWAY 2, P79
   Russom CL, 2014, ENVIRON TOXICOL CHEM, V33, P2157, DOI 10.1002/etc.2662
   Schilmann A, 2010, OCCUP ENVIRON MED, V67, P323, DOI 10.1136/oem.2009.047175
   Sehgal VN, 2014, INT J DERMATOL, V53, pE449, DOI 10.1111/j.1365-4632.2012.05611.x
   Shlomi T, 2008, NAT BIOTECHNOL, V26, P1003, DOI 10.1038/nbt.1487
   Smegal DC, 2000, HUMAN HLTH RISK ASSE
   Stanforth RW, 2007, QSAR COMB SCI, V26, P837, DOI 10.1002/qsar.200630086
   Steinbeck C, 2003, J CHEM INF COMP SCI, V43, P493, DOI 10.1021/ci025584y
   Tan YM, 2012, J TOXICOL ENV HEAL B, V15, P22, DOI 10.1080/10937404.2012.632360
   TOXNET, 2013, GENT VIOL
   TOXNET (Toxicology Data Network), 2002, DOD BENZ SULF AC
   Travassos AR, 2011, CONTACT DERMATITIS, V65, P276, DOI 10.1111/j.1600-0536.2011.01968.x
   U.S. EPA, 2008, CARB IRED FACTS
   U.S. EPA, 2011, EPAHQOPP200808500025
   U.S. EPA, 2012, RISK ASS
   U.S. EPA, 2006, RER EL DEC NAL
   U.S. EPA, 2010, TOX FOR TOXC DAT
   U.S. EPA, 2012, EPA601R12011
   U.S. EPA, 2014, TOX FOR ADV NEXT GEN
   U.S. EPA (U.S. Environmental Protection Agency), 1994, EPA738F94020
   UNM (University of New Mexico), 2014, BAD
   Van Scoy AR, 2013, REV ENVIRON CONTAM T, V222, P93, DOI 10.1007/978-1-4614-4717-7_3
   Vedani A, 2009, ATLA-ALTERN LAB ANIM, V37, P477, DOI 10.1177/026119290903700506
   Villeneuve DL, 2014, TOXICOL SCI, V142, P321, DOI 10.1093/toxsci/kfu200
   Vinken M, 2013, TOXICOL SCI, V136, P97, DOI 10.1093/toxsci/kft177
   Watanabe KH, 2011, ENVIRON TOXICOL CHEM, V30, P9, DOI 10.1002/etc.373
   Willett P, 1998, J CHEM INF COMP SCI, V38, P983, DOI 10.1021/ci9800211
   Wyld PJ, 1992, 7786 US EPA
NR 80
TC 10
Z9 10
U1 0
U2 36
PU US DEPT HEALTH HUMAN SCIENCES PUBLIC HEALTH SCIENCE
PI RES TRIANGLE PK
PA NATL INST HEALTH, NATL INST ENVIRONMENTAL HEALTH SCIENCES, PO BOX 12233,
   RES TRIANGLE PK, NC 27709-2233 USA
SN 0091-6765
EI 1552-9924
J9 ENVIRON HEALTH PERSP
JI Environ. Health Perspect.
PD JAN
PY 2016
VL 124
IS 1
BP 53
EP 60
DI 10.1289/ehp.1409450
PG 8
WC Environmental Sciences; Public, Environmental & Occupational Health;
   Toxicology
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health; Toxicology
GA DA1XQ
UT WOS:000367589600015
PM 25978103
OA DOAJ Gold, Green Published
DA 2019-10-23
ER

PT J
AU Sanderson, PN
   Simpson, W
   Cubberley, R
   Aleksic, M
   Gutsell, S
   Russell, PJ
AF Sanderson, Paul N.
   Simpson, Wendy
   Cubberley, Richard
   Aleksic, Maja
   Gutsell, Stephen
   Russell, Paul J.
TI Mechanistic understanding of molecular initiating events (MIEs) using
   NMR spectroscopy
SO TOXICOLOGY RESEARCH
LA English
DT Article
ID SKIN SENSITIZATION POTENCY; SCREENING CONTACT ALLERGENS; PEPTIDE
   REACTIVITY ASSAY; RISK-ASSESSMENT; IN-VITRO; CHEMICAL-REACTIVITY;
   ELECTROPHILIC REACTIVITY; FRAGRANCE ALLERGENS; COVALENT BINDING; ACID
   ANHYDRIDES
AB Toxicological risk assessments in the 21st century are increasingly being driven by the Adverse Outcome Pathways (AOP) conceptual framework in which the Molecular Initiating Event (MIE) is of fundamental importance to pathway progression. For those MIEs that involve covalent chemical reactions, such as protein haptenation, determination of relative rates and mechanisms of reactions is a prerequisite for their understanding. The utility of NMR spectroscopy as an experimental technique for effectively providing reaction rate and mechanistic information for early assessment of likely MIE(s) has been demonstrated. To demonstrate the concept, model systems exemplifying common chemical reactions involved in the covalent modification of proteins were utilized; these involved chemical reactions of electrophilic species (representing different mechanistic classes) with simple amine and thiol nucleophiles acting as surrogates for the reactive groups of lysine and cysteine protein side chains respectively. Such molecular interactions are recognized as critical mechanisms in a variety of chemical and drug toxicities, including respiratory and skin sensitization and liver toxicity as well as being the key mechanism of action for a number of therapeutic agents.
C1 [Sanderson, Paul N.; Simpson, Wendy; Cubberley, Richard; Aleksic, Maja; Gutsell, Stephen; Russell, Paul J.] Unilever Safety & Environm Assurance Ctr, Bedford MK44 1LQ, England.
RP Sanderson, PN (reprint author), Unilever Safety & Environm Assurance Ctr, Colworth Sci Pk, Bedford MK44 1LQ, England.
EM paul.sanderson@unilever.com
CR Aleksic M, 2009, TOXICOL SCI, V108, P401, DOI 10.1093/toxsci/kfp030
   Allen TEH, 2014, CHEM RES TOXICOL, V27, P2100, DOI 10.1021/tx500345j
   Andres GO, 2001, J ORG CHEM, V66, P7653, DOI 10.1021/jo010499v
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Aptula AO, 2006, TOXICOL IN VITRO, V20, P239, DOI 10.1016/j.tiv.2005.07.003
   Aptula AO, 2006, CHEM RES TOXICOL, V19, P1097, DOI 10.1021/tx0601004
   Asturiol D., 2011, JRC SCI TECHNICAL RE
   Atkins PW., 1978, PHYS CHEM
   BARRATT MD, 1994, TOXICOL IN VITRO, V8, P823, DOI 10.1016/0887-2333(94)90077-9
   Bessems JGM, 2001, CRIT REV TOXICOL, V31, P55, DOI 10.1080/20014091111677
   Chan K, 2008, J APPL TOXICOL, V28, P1004, DOI 10.1002/jat.1366
   Chipinda I, 2014, TOXICOLOGY, V315, P101, DOI 10.1016/j.tox.2013.11.009
   Chipinda I, 2010, CHEM RES TOXICOL, V23, P918, DOI 10.1021/tx100003w
   Cohen SD, 1997, TOXICOL APPL PHARM, V143, P1, DOI 10.1006/taap.1996.8074
   Dennehy MK, 2006, CHEM RES TOXICOL, V19, P20, DOI 10.1021/tx050312l
   Dent MP, 2015, ENVIRON INT, V83, P94, DOI 10.1016/j.envint.2015.06.009
   EDER E, 1991, MUTAGENESIS, V6, P261, DOI 10.1093/mutage/6.4.261
   EDER E, 1982, XENOBIOTICA, V12, P831, DOI 10.3109/00498258209038955
   Flavien S., 2012, ORG PROCESS RES DEV, P61
   Gerberick F, 2008, ATLA-ALTERN LAB ANIM, V36, P215, DOI 10.1177/026119290803600210
   Gerberick GF, 2007, TOXICOL SCI, V97, P417, DOI 10.1093/toxsci/kfm064
   Gerberick GF, 2004, TOXICOL SCI, V81, P332, DOI 10.1093/toxsci/kfh213
   Helaskoski E, 2009, CONTACT DERMATITIS, V60, P214, DOI 10.1111/j.1600-0536.2009.01526.x
   Kramer VJ, 2011, ENVIRON TOXICOL CHEM, V30, P64, DOI 10.1002/etc.375
   Krewski D, 2010, J TOXICOL ENV HEAL B, V13, P51, DOI 10.1080/10937404.2010.483176
   Liebler DC, 2008, CHEM RES TOXICOL, V21, P117, DOI 10.1021/tx700235t
   MacKay C, 2013, ALTEX-ALTERN ANIM EX, V30, P473, DOI 10.14573/altex.2013.4.473
   Mah R, 2014, BIOORG MED CHEM LETT, V24, P33, DOI 10.1016/j.bmcl.2013.10.003
   MCCARTHY TJ, 1994, FUND APPL TOXICOL, V22, P543, DOI 10.1006/faat.1994.1061
   National Research Council, 2007, TOXICITY TESTING 21
   Natsch A, 2007, TOXICOL IN VITRO, V21, P1220, DOI 10.1016/j.tiv.2007.03.016
   Natsch A, 2008, TOXICOL SCI, V106, P464, DOI 10.1093/toxsci/kfn194
   Natsch A, 2010, CHEM RES TOXICOL, V23, P1913, DOI 10.1021/tx1002707
   Natsch A, 2009, TOXICOL SCI, V107, P106, DOI 10.1093/toxsci/kfn204
   OECD - Organization for Economic Co-Operation and Development Environment, 2011, WORKSH US MECH INF F
   Parkinson E, 2014, TOXICOL SCI, V142, P239, DOI 10.1093/toxsci/kfu168
   Patlewicz GY, 2004, CONTACT DERMATITIS, V50, P91, DOI 10.1111/j.0105-1873.2004.00322.x
   Reynolds F., 2014, BIOCHEMIST, V36, P19
   Roberts DW, 2008, J APPL TOXICOL, V28, P443, DOI 10.1002/jat.1293
   Roberts DW, 2007, CHEM RES TOXICOL, V20, P44, DOI 10.1021/tx060121y
   Roberts DW, 2009, CHEM RES TOXICOL, V22, P592, DOI 10.1021/tx800431x
   ROBERTS DW, 1983, FOOD CHEM TOXICOL, V21, P811, DOI 10.1016/0278-6915(83)90217-X
   ROBERTS DW, 1987, CONTACT DERMATITIS, V17, P281, DOI 10.1111/j.1600-0536.1987.tb01478.x
   Roggen EL, 2014, BASIC CLIN PHARMACOL, V115, P32, DOI 10.1111/bcpt.12202
   Schwobel JAH, 2011, CHEM REV, V111, P2562, DOI 10.1021/cr100098n
   Singh J, 2011, NAT REV DRUG DISCOV, V10, P307, DOI 10.1038/nrd3410
   Thompson VR, 2013, CHEM RES TOXICOL, V26, P1263, DOI 10.1021/tx400188w
   Tollefsen KE, 2014, REGUL TOXICOL PHARM, V70, P629, DOI 10.1016/j.yrtph.2014.09.009
   Tzouros M, 2009, CHEM RES TOXICOL, V22, P853, DOI 10.1021/tx800426x
   VENABLES KM, 1989, BRIT J IND MED, V46, P222
   Vila A, 2008, CHEM RES TOXICOL, V21, P432, DOI 10.1021/tx700347w
   Vinken M, 2013, TOXICOLOGY, V312, P158, DOI 10.1016/j.tox.2013.08.011
   Vocanson M, 2007, CONTACT DERMATITIS, V57, P361, DOI 10.1111/j.1600-0536.2007.01276.x
   Wang HM, 2001, BIOCHEMISTRY-US, V40, P3316, DOI 10.1021/bi002786j
   Westmoreland C., 2013, 21 CENTURY SAFETY SC
   Wisnewski AV, 2013, TOXICOL IN VITRO, V27, P662, DOI 10.1016/j.tiv.2012.11.013
NR 56
TC 4
Z9 4
U1 0
U2 14
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2045-452X
EI 2045-4538
J9 TOXICOL RES-UK
JI Toxicol. Res.
PY 2016
VL 5
IS 1
BP 34
EP 44
DI 10.1039/c5tx00246j
PG 11
WC Toxicology
SC Toxicology
GA CZ0YO
UT WOS:000366832700002
PM 30090324
OA Green Published
DA 2019-10-23
ER

PT J
AU Ba, Q
   Huang, C
   Fu, YJ
   Li, JY
   Li, JQ
   Chu, RA
   Jia, XD
   Wang, H
AF Ba, Qian
   Huang, Chao
   Fu, Yijing
   Li, Junyang
   Li, Jingquan
   Chu, Ruiai
   Jia, Xudong
   Wang, Hui
TI Cumulative metabolic effects of low-dose benzo(a)pyrene exposure on
   human cells
SO TOXICOLOGY RESEARCH
LA English
DT Article
ID POLYCYCLIC AROMATIC-HYDROCARBONS; QUANTIFICATION; CARCINOGENESIS;
   RESPONSES; SERUM; TOOL
AB Benzo(a)pyrene (B[a]P) is a common environmental and foodborne pollutant which has been identified as a Group I carcinogen. Although the carcinogenicity of B[a]P has been illustrated, its comprehensive influence on metabolism and further relevance in adverse health outcomes are not well understood. To investigate the global metabolic effects of long-term B[a]P exposure at environmental dosage, we utilized the human SMMC-7721 cell-based B[a]P exposure models to perform a metabolomics study and network analysis. A total of 316 biochemicals were identified and 104 metabolites were found to be significantly altered. Bioinformatics analysis showed that the amino acid, carbohydrate, and lipid metabolism pathways and the nucleotide metabolism pathway were influenced by prolonged B[a]P exposure. Notably, the metabolic effects of B[a]P varied with different dosages. In addition, B[a]P exposure caused a decline in the glycolysis process but enhanced the glycolytic capability of SMMC-7721 cells in vitro. These findings establish the overall B[a]P-induced metabolic network, characterize the metabolic effects of chronic and environmental B[a]P exposure on human-relevant cells, and enhance the understanding of the adverse outcome pathway frame of B[a]P.
C1 [Ba, Qian; Huang, Chao; Fu, Yijing; Li, Junyang; Li, Jingquan; Chu, Ruiai; Wang, Hui] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Key Lab Food Safety Res, Shanghai, Peoples R China.
   [Ba, Qian; Li, Jingquan; Chu, Ruiai; Jia, Xudong; Wang, Hui] Minist Hlth, Key Lab Food Safety Risk Assessment, Beijing, Peoples R China.
   [Wang, Hui] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai, Peoples R China.
RP Ba, Q (reprint author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Key Lab Food Safety Res, Shanghai, Peoples R China.
EM jiaxudong@cfsa.net.cn; huiwang@sibs.ac.cn
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [81573161, 81427805, 91529305, 81302809, 31401611];
   Ministry of Science and Technology of ChinaMinistry of Science and
   Technology, China [2012CB720804]; Key Research Program of the Chinese
   Academy of SciencesChinese Academy of Sciences [KSZD-EW-Z-021,
   KSZD-EW-Z-019]; Instrument Developing Project of the Chinese Academy of
   Sciences; Science and Technology Commission of Shanghai
   MunicipalityScience & Technology Commission of Shanghai Municipality
   (STCSM) [14391901800]; Key Laboratory of Food Safety Research of INS,
   SIBS, CAS
FX This work was supported by grants from the National Natural Science
   Foundation of China (81573161, 81427805, 91529305, 81302809 and
   31401611), the Ministry of Science and Technology of China
   (2012CB720804), the Key Research Program (KSZD-EW-Z-021 and
   KSZD-EW-Z-019) and the Instrument Developing Project of the Chinese
   Academy of Sciences, the Science and Technology Commission of Shanghai
   Municipality (14391901800), and the Key Laboratory of Food Safety
   Research of INS, SIBS, CAS.
CR Adeleye Y, 2015, TOXICOLOGY, V332, P102, DOI 10.1016/j.tox.2014.02.007
   Ba Q, 2015, ENVIRON HEALTH PERSP, V123, P246, DOI 10.1289/ehp.1408524
   Benford D, 2010, FOOD CHEM TOXICOL, V48, pS42, DOI 10.1016/j.fct.2009.09.039
   Butcher EC, 2004, NAT BIOTECHNOL, V22, P1253, DOI 10.1038/nbt1017
   Davila DR, 1996, TOXICOL APPL PHARM, V139, P333, DOI 10.1006/taap.1996.0173
   Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h
   GELBOIN HV, 1980, PHYSIOL REV, V60, P1107
   Gibb Steven, 2008, Reprod Toxicol, V25, P136, DOI 10.1016/j.reprotox.2007.10.013
   Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013
   Karnovsky A, 2012, BIOINFORMATICS, V28, P373, DOI 10.1093/bioinformatics/btr661
   Lankadurai BP, 2011, ENVIRON POLLUT, V159, P2845, DOI 10.1016/j.envpol.2011.04.044
   Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551
   Mendola P, 2002, MENT RETARD DEV D R, V8, P188, DOI 10.1002/mrdd.10033
   Min LF, 2011, TOXICOL MECH METHOD, V21, P374, DOI 10.3109/15376516.2010.551555
   Neal MS, 2008, REPROD TOXICOL, V25, P100, DOI 10.1016/j.reprotox.2007.10.012
   Ohta T, 2009, TOXICOL PATHOL, V37, P521, DOI 10.1177/0192623309336152
   Phillips DH, 1999, MUTAT RES-GEN TOX EN, V443, P139, DOI 10.1016/S1383-5742(99)00016-2
   PHILLIPS DH, 1983, NATURE, V303, P468, DOI 10.1038/303468a0
   RIVEDAL E, 1981, CANCER RES, V41, P2950
   Rubin H, 2001, CARCINOGENESIS, V22, P1903, DOI 10.1093/carcin/22.12.1903
   Smith Jason E., 2010, OFF J EUR COMMUN L, V1.1, P1, DOI DOI 10.2202/2152-2812.1013
   Srivastava SK, 2000, CANCER LETT, V153, P35, DOI 10.1016/S0304-3835(00)00333-5
   Srogi K, 2007, ENVIRON CHEM LETT, V5, P169, DOI 10.1007/s10311-007-0095-0
   Talaska G, 1996, P NATL ACAD SCI USA, V93, P7789, DOI 10.1073/pnas.93.15.7789
   Viant MR, 2013, METABOLOMICS, V9, pS144, DOI 10.1007/s11306-012-0412-x
   Wang XX, 2015, MOL BIOSYST, V11, P753, DOI 10.1039/c4mb00565a
   Williams TD, 2009, ENVIRON SCI TECHNOL, V43, P6341, DOI 10.1021/es9008689
   WOLTERBEEK APM, 1995, CANCER LETT, V89, P107, DOI 10.1016/0304-3835(95)90165-5
NR 28
TC 4
Z9 4
U1 2
U2 19
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2045-452X
EI 2045-4538
J9 TOXICOL RES-UK
JI Toxicol. Res.
PY 2016
VL 5
IS 1
BP 107
EP 115
DI 10.1039/c5tx00378d
PG 9
WC Toxicology
SC Toxicology
GA CZ0YO
UT WOS:000366832700008
PM 30090330
OA Green Published
DA 2019-10-23
ER

PT J
AU Jacobs, MN
   Colacci, A
   Louekari, K
   Luijten, M
   Hakkert, BC
   Paparella, M
   Vasseur, P
AF Jacobs, Miriam N.
   Colacci, Annamaria
   Louekari, Kimmo
   Luijten, Mirjam
   Hakkert, Betty C.
   Paparella, Martin
   Vasseur, Paule
TI International Regulatory Needs for Development of an IATA for
   Non-Genotoxic Carcinogenic Chemical Substances
SO ALTEX-ALTERNATIVES TO ANIMAL EXPERIMENTATION
LA English
DT Article
DE non-genotoxic carcinogens; integrated approaches to testing and
   assessment of chemicals
ID HAMSTER-EMBRYO CELLS; PROLIFERATOR-ACTIVATED RECEPTOR; CHRONIC
   ETHANOL-CONSUMPTION; ARYL-HYDROCARBON RECEPTOR; ADVERSE OUTCOME
   PATHWAYS; HEALTH-RISK ASSESSMENT; LOW-DOSE EXPOSURES; C-MYC EXPRESSION;
   IN-VITRO; DNA METHYLATION
AB Although regulatory requirements for carcinogenicity testing of chemicals vary according to product sector and regulatory jurisdiction, the standard approach starts with a battery of genotoxicity tests. If any of the in vivo genotoxicity tests are positive, a lifetime rodent cancer bioassay may be requested, which allows the detection of non-genotoxic carcinogens (NGTxC). However, under most chemical regulations the cancer bioassay is rarely requested, specific requests to obtain information on non-genotoxic mechanisms of carcinogenicity are few, and there are no OECD approved screening methods. When the in vitro genotoxicity battery is negative, usually no further carcinogenicity testing is requested. Consequently NGTxC might remain unidentified and therefore the risks they may pose to human health will not be managed. In contrast to genotoxic carcinogens NGTxC act through a large variety of specific mechanisms, and a panel of tests covering multiple biological traits will be needed.
   The development of an integrated approach to testing and assessment (IATA) of NGTxC could assist regulatory decision makers. We examine what NGTxC are and discuss chemical regulatory requirements and limitations. With a strong drive to reduce animal testing and costs in mind, it is essential that proper and robust alternatives for animal testing methods (3Rs) for addressing non-genotoxic modes of action are developed and used. Therefore relevant in vitro mechanisms and assays are described and tentatively organized in levels of information, indicating both a possible structure of the future IATA for NGTxC and associated OECD Test Guideline development priorities.
C1 [Jacobs, Miriam N.] Publ Hlth England, Dept Toxicol, Ctr Radiat Chem & Environm Hazards, Chilton OX11 0RQ, Oxon, England.
   [Colacci, Annamaria] Environm Protect & Hlth Prevent Agcy, Ctr Environm Toxicol & Risk Assessment, Bologna, Emilia Romagna, Italy.
   [Louekari, Kimmo] European Chem Agcy, Helsinki, Finland.
   [Luijten, Mirjam] Natl Inst Publ Hlth & Environm RIVM, Ctr Hlth Protect, Bilthoven, Netherlands.
   [Hakkert, Betty C.] Natl Inst Publ Hlth & Environm RIVM, Ctr Safety Subst & Prod VSP, Dept Ind Chem, Bur REACH, Bilthoven, Netherlands.
   [Paparella, Martin] Environm Agcy Austria, Chem & Biocides, Vienna, Austria.
   [Vasseur, Paule] Univ Lorraine, CNRS UMR 7360, Metz, France.
RP Jacobs, MN (reprint author), Publ Hlth England, Dept Toxicol, Ctr Radiat Chem & Environm Hazards, Chilton OX11 0RQ, Oxon, England.
EM Miriam.Jacobs@phe.gov.uk
OI COLACCI, ANNAMARIA/0000-0001-7426-6985
CR Albanito L, 2015, ENVIRON HEALTH PERSP, V123, P493, DOI 10.1289/ehp.1408586
   Albini A, 2010, CURR OPIN CELL BIOL, V22, P677, DOI 10.1016/j.ceb.2010.08.017
   Alden CL, 2011, VET PATHOL, V48, P772, DOI 10.1177/0300985811400445
   Alexander J, 2013, EFSA J, V11, DOI 10.2903/j.efsa.2013.3132
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Annys E, 2014, REGUL TOXICOL PHARM, V69, P234, DOI 10.1016/j.yrtph.2014.04.009
   [Anonymous], 1996, IARC Monogr Eval Carcinog Risks Hum, V66, P35
   [Anonymous], 1991, IARC Monogr Eval Carcinog Risks Hum, V53, P353
   [Anonymous], 2012, IARC MON EV CARC R F
   Arora S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078023
   ASHBY J, 1991, MUTAT RES, V257, P229, DOI 10.1016/0165-1110(91)90003-E
   Bakkar A, 2016, MOL BIOL REP, V43, P229, DOI 10.1007/s11033-016-3948-4
   Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533
   Basketter DA, 2012, ALTEX-ALTERN ANIM EX, V29, P5, DOI 10.14573/altex.2012.1.003
   Beiter T, 2009, CELL MOL LIFE SCI, V66, P94, DOI 10.1007/s00018-008-8381-y
   Benigni R, 2014, EXPERT OPIN DRUG MET, V10, P1199, DOI 10.1517/17425255.2014.934670
   Benigni R, 2013, CHEM REV, V113, P2940, DOI 10.1021/cr300206t
   Benigni R, 2012, EXPERT OPIN DRUG MET, V8, P407, DOI 10.1517/17425255.2012.666238
   Bernstein E, 2008, P NATL ACAD SCI USA, V105, P1533, DOI 10.1073/pnas.0711632105
   BESSI H, 1995, CARCINOGENESIS, V16, P237, DOI 10.1093/carcin/16.2.237
   Bhatia SN, 2014, NAT BIOTECHNOL, V32, P760, DOI 10.1038/nbt.2989
   Bibikova M, 2011, GENOMICS, V98, P288, DOI 10.1016/j.ygeno.2011.07.007
   Billington R, 2010, CRIT REV TOXICOL, V40, P35, DOI 10.3109/10408440903367741
   Biswas G, 2008, P NATL ACAD SCI USA, V105, P186, DOI 10.1073/pnas.0706183104
   Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937
   Black AT, 2008, TOXICOL APPL PHARM, V231, P384, DOI 10.1016/j.taap.2008.05.014
   Browne P, 2015, ENVIRON SCI TECHNOL, V49, P8804, DOI 10.1021/acs.est.5b02641
   Caporali A, 2011, VASC PHARMACOL, V55, P79, DOI 10.1016/j.vph.2011.06.006
   Casey SC, 2015, CARCINOGENESIS, V36, pS160, DOI 10.1093/carcin/bgv035
   Chang XL, 2013, CHEM-BIOL INTERACT, V206, P248, DOI 10.1016/j.cbi.2013.09.010
   Chepelev NL, 2015, CRIT REV TOXICOL, V45, P44, DOI 10.3109/10408444.2014.973935
   Choudhari SK, 2013, WORLD J SURG ONCOL, V11, DOI 10.1186/1477-7819-11-118
   Corton JC, 2014, CRIT REV TOXICOL, V44, P1, DOI 10.3109/10408444.2013.835784
   Creton S, 2012, MUTAGENESIS, V27, P93, DOI 10.1093/mutage/ger053
   Cruciani V, 1999, TOXICOL IN VITRO, V13, P445, DOI 10.1016/S0887-2333(99)00016-8
   Cruciani VR, 1997, INT J CANCER, V73, P240, DOI 10.1002/(SICI)1097-0215(19971009)73:2<240::AID-IJC14>3.0.CO;2-J
   Das MT, 2014, INDIAN J EXP BIOL, V52, P1052
   Davis CD, 2000, J NUTR, V130, P2903
   Dhalluin S, 1997, CARCINOGENESIS, V18, P2217, DOI 10.1093/carcin/18.11.2217
   Dhalluin S, 1998, INT J CANCER, V75, P744, DOI 10.1002/(SICI)1097-0215(19980302)75:5<744::AID-IJC13>3.3.CO;2-C
   DICKER E, 1992, ARCH BIOCHEM BIOPHYS, V293, P274, DOI 10.1016/0003-9861(92)90395-D
   Doull J, 1999, REGUL TOXICOL PHARM, V29, P327, DOI 10.1006/rtph.1999.1296
   Down TA, 2008, NAT BIOTECHNOL, V26, P779, DOI 10.1038/nbt1414
   [ECHA European Chemicals Agency], 2015, ECHA15R07EN
   ECHA, 2008, GUID INF REQ CHEM SA
   EFSA (European Food Safety Authority), 2014, EFSA SUPP PUBL
   EKSTROM G, 1989, BIOCHEM PHARMACOL, V38, P1313, DOI 10.1016/0006-2952(89)90338-9
   Ellinger-Ziegelbauer H, 2005, MUTAT RES-FUND MOL M, V575, P61, DOI 10.1016/j.mrfmmm.2005.02.004
   Ellinger-Ziegelbauer H, 2009, TOXICOL LETT, V186, P36, DOI 10.1016/j.toxlet.2008.08.017
   Embry MR, 2014, CRIT REV TOXICOL, V44, P6, DOI 10.3109/10408444.2014.931924
   Ferecatu I, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-18
   Filomeni G, 2015, CELL DEATH DIFFER, V22, P377, DOI 10.1038/cdd.2014.150
   Fjodorova N, 2010, CHEM CENT J, V4, DOI 10.1186/1752-153X-4-S1-S3
   Forcet C, 2001, P NATL ACAD SCI USA, V98, P3416, DOI 10.1073/pnas.051378298
   GARVEY LK, 1987, CARCINOGENESIS, V8, P285, DOI 10.1093/carcin/8.2.285
   Gibson DA, 2014, ENDOCR-RELAT CANCER, V21, pT13, DOI 10.1530/ERC-13-0342
   Go RE, 2015, J STEROID BIOCHEM, V147, P24, DOI 10.1016/j.jsbmb.2014.11.003
   Goll V, 1999, TOXICOL APPL PHARM, V160, P21, DOI 10.1006/taap.1999.8737
   Goodson WH, 2015, CARCINOGENESIS, V36, pS254, DOI 10.1093/carcin/bgv039
   Gottmann E, 2001, ENVIRON HEALTH PERSP, V109, P509, DOI 10.2307/3454710
   Grady WM, 2004, CANCER METAST REV, V23, P11, DOI 10.1023/A:1025861527711
   Gray GM, 1995, REGUL TOXICOL PHARM, V22, P283, DOI 10.1006/rtph.1995.0011
   Greally JM, 2013, ALTEX-ALTERN ANIM EX, V30, P445, DOI 10.14573/altex.2013.4.445
   Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9
   Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013
   Hartley PD, 2009, CELL, V137, P445, DOI 10.1016/j.cell.2009.02.043
   Heindryckx F, 2009, INT J EXP PATHOL, V90, P367, DOI 10.1111/j.1365-2613.2009.00656.x
   Hengstler JG, 2015, TOXICOL LETT, V238, pS38, DOI 10.1016/j.toxlet.2015.08.103
   Herceg Z, 2013, CARCINOGENESIS, V34, P1955, DOI 10.1093/carcin/bgt212
   Hernandez LG, 2009, MUTAT RES-REV MUTAT, V682, P94, DOI 10.1016/j.mrrev.2009.07.002
   Hiragami-Hamada K, 2009, EPIGENET CHROMATIN, V2, DOI 10.1186/1756-8935-2-14
   Hovey RC, 2011, TOXICOL SCI, V119, P380, DOI 10.1093/toxsci/kfq337
   Hu ZW, 2015, CARCINOGENESIS, V36, pS184, DOI 10.1093/carcin/bgv036
   Huang GY, 2015, BIOMED PHARMACOTHER, V72, P135, DOI 10.1016/j.biopha.2015.04.013
   IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2013, IARC Monogr Eval Carcinog Risks Hum, V101, P9
   ICH, 2014, ICH HARM TRIP GUID A
   Jacobs MN, 2004, TOXICOLOGY, V205, P43, DOI 10.1016/j.tox.2004.06.036
   Jacobs MN, 2003, J STEROID BIOCHEM, V84, P117, DOI 10.1016/S0960-0760(03)00021-9
   Jaworska J, 2011, ALTEX-ALTERN ANIM EX, V28, P211, DOI 10.14573/altex.2011.3.211
   Jaworska Joanna, 2010, ALTEX, V27, P231
   Jing HI, 2008, MOL CELL, V29, P232, DOI 10.1016/j.molcel.2007.11.020
   Judson R, 2014, BASIC CLIN PHARMACOL, V115, P69, DOI 10.1111/bcpt.12239
   Khatami M, 2008, EXPERT OPIN BIOL TH, V8, P1461, DOI [10.1517/14712598.8.10.1461 , 10.1517/14712590802358201]
   Kleinstreuer NC, 2013, TOXICOL SCI, V131, P40, DOI 10.1093/toxsci/kfs285
   Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008
   Kravchenko J, 2015, CARCINOGENESIS, V36, pS111, DOI 10.1093/carcin/bgv033
   KUKIELKA E, 1992, ALCOHOL ALCOHOLISM, V27, P233
   Landkocz Y, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-524
   Lang D, 1996, DRUG METAB DISPOS, V24, P859
   Lang DH, 1997, CHEM RES TOXICOL, V10, P1037, DOI 10.1021/tx970081l
   Lempiainen H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018216
   Lewis DFV, 1996, CYTOCHROMES P450 STR
   Lima BS, 2000, REGUL TOXICOL PHARM, V32, P135
   Lin LC, 2014, CLIN EXP METASTAS, V31, P881, DOI 10.1007/s10585-014-9677-y
   Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514
   Liu Q, 2016, TUMOR BIOL, V37, P11421, DOI 10.1007/s13277-016-4986-1
   Liu WM, 2012, P NATL ACAD SCI USA, V109, P490, DOI 10.1073/pnas.1110368109
   Lo Piparo E, 2014, REGUL TOXICOL PHARM, V70, P370, DOI 10.1016/j.yrtph.2014.07.010
   Lo Piparo E, 2011, REGUL TOXICOL PHARM, V60, P354, DOI 10.1016/j.yrtph.2011.05.003
   Lucas IK, 2015, PLANTA MED, V81, P1038, DOI 10.1055/s-0035-1546129
   Lv Z., 2015, OBESITY SILVER SPRIN, V24, P368
   Ma Hong, 2012, Zhonghua Nan Ke Xue, V18, P783
   Maire MA, 2007, MUTAT RES-GEN TOX EN, V631, P124, DOI 10.1016/j.mrgentox.2007.03.008
   Maire MA, 2005, TOXICOL LETT, V158, P237, DOI 10.1016/j.toxlet.2005.04.004
   Marczylo E., 2016, CRIT REV TO IN PRESS
   Marone PA, 2014, REGUL TOXICOL PHARM, V68, P108, DOI [10.1016/j.yrtph.201.3.11.011, 10.1016/j.yrtph.2013.11.011]
   Martens U, 1996, CANCER LETT, V104, P21, DOI 10.1016/0304-3835(96)04218-8
   Marx U, 2012, ATLA-ALTERN LAB ANIM, V40, P235, DOI 10.1177/026119291204000504
   Maunz A, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00038
   McKee RH, 2000, REGUL TOXICOL PHARM, V32, P51, DOI 10.1006/rtph.2000.1407
   Meek ME, 2014, J APPL TOXICOL, V34, P1, DOI 10.1002/jat.2949
   Mehlen P, 2004, J CLIN ONCOL, V22, P3420, DOI 10.1200/JCO.2004.02.019
   Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107
   Melnick RL, 2001, ENVIRON HEALTH PERSP, V109, P437, DOI 10.2307/3454700
   Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008
   Miousse IR, 2015, TOXICOLOGY, V335, P11, DOI 10.1016/j.tox.2015.06.009
   Mitra AP, 2006, J CLIN ONCOL, V24, P5552, DOI 10.1200/JCO.2006.08.2073
   Moggs JG, 2004, TOXICOL APPL PHARM, V196, P422, DOI 10.1016/j.taap.2004.01.009
   Murphy KA, 2004, J BIOL CHEM, V279, P25284, DOI 10.1074/jbc.M402168200
   Murray IA, 2014, NAT REV CANCER, V14, P801, DOI 10.1038/nrc3846
   Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441
   Nakanishi K, 2005, CANCER-AM CANCER SOC, V103, P307, DOI 10.1002/cncr.20774
   Narayanan KB, 2015, CARCINOGENESIS, V36, pS89, DOI 10.1093/carcin/bgv032
   NAS-National Academy of Sciences, 2007, TOX TEST 21 CENT
   National Toxicology Program, 2011, Rep Carcinog, V12, P83
   National Toxicology Program, 2008, REP CARCINOG BACKGR, V8-5974, P1
   Newbold RR, 2006, ENDOCRINOLOGY, V147, pS11, DOI 10.1210/en.2005-1164
   Nieminen T, 2014, BBA-GEN SUBJECTS, V1840, P454, DOI 10.1016/j.bbagen.2013.10.005
   Nishida N, 2013, DIGEST DIS, V31, P447, DOI 10.1159/000355243
   NTP (National Toxicology Program), 2014, REP CARC
   NTP-National Toxicology Program, 2006, NATL TOXICOL PROGRAM, P4
   OECD, 2012, TEST NO 455 PERF BAS
   OECD, 2007, SER TEST ASS, V31
   OECD, 2012, OECD SER TEST ASS, V163
   OECD, 2014, OECD SER TEST ASS, V194
   OECD, 2011, TEST NO 456 H295R ST
   OECD, 2015, OECD SER TEST ASS, V214
   Organisation for Economic Co-operation and Development (OECD), 2013, OECD SER TEST ASS, V184
   Ostling P, 2011, CANCER RES, V71, P1956, DOI 10.1158/0008-5472.CAN-10-2421
   Pant K, 2010, MUTAT RES-GEN TOX EN, V698, P6, DOI 10.1016/j.mrgentox.2010.02.017
   Paolillo N, 2011, INT J IMMUNOPATH PH, V24, P861, DOI 10.1177/039463201102400405
   Paparella M., 2016, ALTEX
   Paparella M, 2013, ALTEX-ALTERN ANIM EX, V30, P131, DOI 10.14573/altex.2013.2.131
   PARKE DV, 1994, ENVIRON HEALTH PERSP, V102, P852, DOI 10.2307/3432116
   Patlewicz G, 2008, SAR QSAR ENVIRON RES, V19, P495, DOI 10.1080/10629360802083871
   PEROCCO P, 1995, JPN J CANCER RES, V86, P941, DOI 10.1111/j.1349-7006.1995.tb03005.x
   Prestigiacomo V, 2015, TOXICOL LETT, V238, pS281, DOI 10.1016/j.toxlet.2015.08.809
   Quignot N, 2012, TOXICOL IN VITRO, V26, P107, DOI 10.1016/j.tiv.2011.11.004
   Rahden-Staron I, 2001, MUTAT RES-GEN TOX EN, V498, P57, DOI 10.1016/S1383-5718(01)00267-4
   Rakitsky VN, 2000, TERATOGEN CARCIN MUT, V20, P229, DOI 10.1002/1520-6866(2000)20:4<229::AID-TCM5>3.0.CO;2-M
   Ramachandran SD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139345
   Rathmell Kimryn W, 2015, Oncoscience, V2, P81
   Ren HZ, 2010, TOXICOL SCI, V113, P45, DOI 10.1093/toxsci/kfp251
   Rieger Aja M, 2011, J Vis Exp, DOI 10.3791/2597
   Rovida C, 2015, ALTEX-ALTERN ANIM EX, V32, P25, DOI [http://dx.doi.org/10.14573/altex.1411011, 10.14573/altex.1506201]
   Roy D, 2008, MOL CELL BIOL, V28, P50, DOI 10.1128/MCB.01251-07
   Sanderson JT, 2000, TOXICOL SCI, V54, P121, DOI 10.1093/toxsci/54.1.121
   Schaap MM, 2015, ARCH TOXICOL, V89, P2413, DOI 10.1007/s00204-014-1368-6
   Schaap MM, 2012, ARCH TOXICOL, V86, P1717, DOI 10.1007/s00204-012-0883-6
   Serafimova R, 2007, SAR QSAR ENVIRON RES, V18, P389, DOI 10.1080/10629360601053992
   Serezani CH, 2008, AM J RESP CELL MOL, V39, P127, DOI 10.1165/rcmb.2008-0091TR
   Simpkins JW, 2011, TOXICOL SCI, V123, P441, DOI 10.1093/toxsci/kfr176
   Sistare FD, 2011, TOXICOL PATHOL, V39, P716, DOI 10.1177/0192623311406935
   Skeberdis VA, 2001, NEUROPHARMACOLOGY, V40, P856, DOI 10.1016/S0028-3908(01)00005-3
   Smith MT, 2016, ENVIRON HEALTH PERSP, V124, P713, DOI 10.1289/ehp.1509912
   Soldatow VY, 2013, TOXICOL RES-UK, V2, P23, DOI 10.1039/c2tx20051a
   Song HX, 2015, TOXICOL IN VITRO, V30, P521, DOI 10.1016/j.tiv.2015.09.009
   Song Lingyun, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.prot5384
   Sonnenschein C, 2013, J BIOSCIENCES, V38, P651, DOI 10.1007/s12038-013-9335-6
   Suh DH, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00041
   Suzuki M, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-4-r36
   Swierenga S H, 1992, IARC Sci Publ, P165
   Thomson JP, 2014, MUTAT RES-GEN TOX EN, V764, P3, DOI 10.1016/j.mrgentox.2013.08.007
   Thomson JP, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-r93, 10.1186/gb-2012-13-10-R93]
   Tollefsen KE, 2014, REGUL TOXICOL PHARM, V70, P629, DOI 10.1016/j.yrtph.2014.09.009
   U.S. EPA (United States Environmental Protection Agency), 2005, FED REGISTER, V70, P17765
   *US EPA OFF PEST P, 2002, GROUP SER TRIAZ PEST
   Vaccari M, 2015, TOXICOL IN VITRO, V29, P1240, DOI 10.1016/j.tiv.2014.10.002
   Vainio H., 1992, IARC SCI PUBL, V116, P629
   van Grunsven L, 2015, TOXICOL LETT, V238, pS38, DOI 10.1016/j.toxlet.2015.08.104
   Vermeire T, 1999, CRIT REV TOXICOL, V29, P439, DOI 10.1080/10408449991349249
   Viljoen KS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119462
   Villeneuve DL, 2014, TOXICOL SCI, V142, P312, DOI 10.1093/toxsci/kfu199
   Wang C, 2011, CLIN CHEM, V57, P1722, DOI 10.1373/clinchem.2011.169714
   WHO, 2014, 11 WHO
   WHO, 2007, 4 WHO
   Wong RLY, 2013, CLIN CANCER RES, V19, P3732, DOI 10.1158/1078-0432.CCR-13-0021
   Woo YT, 2003, QUANTITATIVE STRUCTU
   Wu QH, 2015, CURR DRUG TARGETS, V16, P13, DOI 10.2174/1389450116666150113121054
   Wu SD, 2010, REGUL TOXICOL PHARM, V56, P67, DOI 10.1016/j.yrtph.2009.09.006
   Yang W, 2008, J TOXICOL ENV HEAL A, V71, P289, DOI 10.1080/15287390701738467
   Zhang H, 2015, CHEM RES TOXICOL, V28, P1196, DOI 10.1021/acs.chemrestox.5b00028
   Zhang XA, 2011, J MOL ENDOCRINOL, V46, pR11, DOI 10.1677/JME-10-0053
NR 193
TC 22
Z9 22
U1 4
U2 9
PU SPEKTRUM AKADEMISCHER VERLAG-SPRINGER-VERLAG GMBH
PI HEILDEBERG
PA TIERGARTENSTRASSE 17, HEILDEBERG, 69121, GERMANY
SN 1868-596X
EI 1868-8551
J9 ALTEX-ALTERN ANIM EX
JI ALTEX-Altern. Anim. Exp.
PY 2016
VL 33
IS 4
BP 359
EP 392
DI 10.14573/altex.1601201
PG 34
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA EB5RY
UT WOS:000387439200003
PM 27120445
OA DOAJ Gold
DA 2019-10-23
ER

PT S
AU Mateo, R
   Lacorte, S
   Taggart, MA
AF Mateo, Rafael
   Lacorte, Silvia
   Taggart, Mark A.
BE Mateo, R
   Arroyo, B
   Garcia, JT
TI An Overview of Recent Trends in Wildlife Ecotoxicology
SO CURRENT TRENDS IN WILDLIFE RESEARCH
SE Wildlife Research Monographs
LA English
DT Article; Book Chapter
ID PERSISTENT ORGANIC POLLUTANTS; ENVIRONMENTALLY RELEVANT CONCENTRATIONS;
   ADVERSE OUTCOME PATHWAYS; ANTICOAGULANT RODENTICIDES; REPRODUCTIVE
   SUCCESS; EGGSHELL THICKNESS; MARINE-ENVIRONMENT; BIOMONITORING TOOL;
   RISK-ASSESSMENT; PLASTIC DEBRIS
C1 [Mateo, Rafael] UCLM, JCCM, Grp Wildlife Toxicol, Inst Invest Recursos Cineget IREC,CSIC, Ronda de Toledo S-N, Ciudad Real 13071, Spain.
   [Lacorte, Silvia] CSIC, IDAEA, Dept Environm Chem, Jordi Girona 18-26, ES-08034 Barcelona, Catalonia, Spain.
   [Taggart, Mark A.] Univ Highlands & Isl, Environm Res Inst, Dept Environm Contaminat & Ecol Hlth, Castle St, Thurso KW14 7JD, Caithness, England.
RP Mateo, R (reprint author), UCLM, JCCM, Grp Wildlife Toxicol, Inst Invest Recursos Cineget IREC,CSIC, Ronda de Toledo S-N, Ciudad Real 13071, Spain.
EM Rafael.mateo@uclm.es
CR Albert CA, 2010, ARCH ENVIRON CON TOX, V58, P451, DOI 10.1007/s00244-009-9402-z
   Almeida JR, 2010, ECOTOXICOLOGY, V19, P1369, DOI 10.1007/s10646-010-0523-y
   Alonso MB, 2012, ENVIRON INT, V47, P99, DOI 10.1016/j.envint.2012.06.010
   Andrady AL, 2011, MAR POLLUT BULL, V62, P1596, DOI 10.1016/j.marpolbul.2011.05.030
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   [Anonymous], 2011, ENV CONTAMINANTS BIO
   Anza I, 2014, APPL ENVIRON MICROB, V80, P4251, DOI 10.1128/AEM.00949-14
   Arnold KE, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0492
   Baker ME, 2009, ENVIRON HEALTH PERSP, V117, P223, DOI 10.1289/ehp.11627
   Baldwin DH, 2009, ECOL APPL, V19, P2004, DOI 10.1890/08-1891.1
   Bars R, 2012, REGUL TOXICOL PHARM, V64, P143, DOI 10.1016/j.yrtph.2012.06.013
   Basu N, 2005, ENVIRON TOXICOL CHEM, V24, P1444, DOI 10.1897/04-048R.1
   Basu N, 2009, ENVIRON TOXICOL CHEM, V28, P133, DOI 10.1897/08-251.1
   Bean TG, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0575
   Benninghoff AD, 2007, TOXICOL SCI, V95, P1, DOI 10.1093/toxsci/kfl157
   Berny PJ, 1997, CHEMOSPHERE, V35, P1817, DOI 10.1016/S0045-6535(97)00242-7
   Beyer WN, 2007, ENVIRON TOXICOL CHEM, V26, P1040, DOI 10.1897/06-304R.1
   Bodkin JL, 2012, MAR ECOL PROG SER, V447, P273, DOI 10.3354/meps09523
   Bourret V, 2008, AQUAT TOXICOL, V86, P76, DOI 10.1016/j.aquatox.2007.10.003
   Boxall ABA, 2012, ENVIRON HEALTH PERSP, V120, P1221, DOI 10.1289/ehp.1104477
   Brar NK, 2010, AQUAT TOXICOL, V96, P203, DOI 10.1016/j.aquatox.2009.10.023
   Brodin T, 2013, SCIENCE, V339, P814, DOI 10.1126/science.1226850
   Burkholder J, 2007, ENVIRON HEALTH PERSP, V115, P308, DOI 10.1289/ehp.8839
   Bustnes JO, 2007, J TOXICOL ENV HEAL A, V68, P97
   Cardiel IE, 2011, ECOTOX ENVIRON SAFE, V74, P911, DOI 10.1016/j.ecoenv.2010.12.015
   Carson R., 1962, SILENT SPRING
   Casanova-Nakayama A, 2011, MAR POLLUT BULL, V63, P412, DOI 10.1016/j.marpolbul.2011.05.007
   Celander MC, 2011, AQUAT TOXICOL, V105, P72, DOI 10.1016/j.aquatox.2011.06.002
   Chalew TEA, 2009, J AM WATER RESOUR AS, V45, P4, DOI 10.1111/j.1752-1688.2008.00284.x
   Chipperfield MP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8233
   Colles A, 2008, CHEMOSPHERE, V73, P907, DOI 10.1016/j.chemosphere.2008.07.002
   Cortinovis S, 2008, CHEMOSPHERE, V73, P320, DOI 10.1016/j.chemosphere.2008.05.071
   Cui BS, 2011, ENVIRON POLLUT, V159, P1297, DOI 10.1016/j.envpol.2011.01.024
   Custer CM, 2011, EMERG TOP ECOTOXICOL, V3, P45, DOI 10.1007/978-0-387-89432-4_3
   Cuthbert R, 2007, BIOL LETTERS, V3, P90, DOI 10.1098/rsbl.2006.0554
   Cuthbert RJ, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0574
   Decaens T, 2006, EUR J SOIL BIOL, V42, pS23, DOI 10.1016/j.ejsobi.2006.07.001
   Dowding CV, 2010, ENVIRON POLLUT, V158, P161, DOI 10.1016/j.envpol.2009.07.017
   Dullinger S, 2013, P NATL ACAD SCI USA, V110, P7342, DOI 10.1073/pnas.1216303110
   Eason CT, 2002, ECOTOXICOLOGY, V11, P35, DOI 10.1023/A:1013793029831
   Eens M, 2013, ENVIRON INT, V51, P141, DOI 10.1016/j.envint.2012.11.003
   Ek KH, 2004, SCI TOTAL ENVIRON, V334, P149, DOI 10.1016/j.scitotenv.2004.04.067
   Elliott JE, 2008, ENVIRON TOXICOL CHEM, V27, P452, DOI 10.1897/07-178R.1
   Elliott JE, 2013, SCIENCE, V340, P556, DOI 10.1126/science.1235197
   Elliott JE, 2011, EMERG TOP ECOTOXICOL, V3, P1, DOI 10.1007/978-0-387-89432-4_1
   Fernie KJ, 2008, TOXICOL SCI, V102, P171, DOI 10.1093/toxsci/kfm295
   Fernie KJ, 2009, ENVIRON SCI TECHNOL, V43, P2124, DOI 10.1021/es8027346
   Fick J, 2010, REGUL TOXICOL PHARM, V58, P516, DOI 10.1016/j.yrtph.2010.08.025
   Finkelstein ME, 2012, P NATL ACAD SCI USA, V109, P11449, DOI 10.1073/pnas.1203141109
   Fisher IJ, 2006, BIOL CONSERV, V131, P421, DOI 10.1016/j.biocon.2006.02.018
   Fox GA, 2001, ENVIRON HEALTH PERSP, V109, P853, DOI 10.2307/3454647
   Frederick P, 2011, P ROY SOC B-BIOL SCI, V278, P1851, DOI 10.1098/rspb.2010.2189
   Gabriel MW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040163
   Gagne F, 2012, CHEMOSPHERE, V89, P615, DOI 10.1016/j.chemosphere.2012.05.063
   Gaiser BK, 2012, ENVIRON TOXICOL CHEM, V31, P144, DOI 10.1002/etc.703
   Garcia-Fernandez AJ, 2013, ENVIRON SCI TECHNOL, V47, P3028, DOI 10.1021/es302758x
   Gibbons D, 2015, ENVIRON SCI POLLUT R, V22, P103, DOI 10.1007/s11356-014-3180-5
   Gomez-Ramirez P, 2014, ENVIRON INT, V67, P12, DOI 10.1016/j.envint.2014.02.004
   Goulson D, 2014, NATURE, V511, P295, DOI 10.1038/nature13642
   Green RE, 2012, FOOD CHEM TOXICOL, V50, P4180, DOI 10.1016/j.fct.2012.08.032
   Gregory MR, 2009, PHILOS T R SOC B, V364, P2013, DOI 10.1098/rstb.2008.0265
   Guertin DA, 2012, J WILDLIFE MANAGE, V76, P1540, DOI 10.1002/jwmg.439
   Guertin DA, 2010, ENVIRON TOXICOL CHEM, V29, P275, DOI 10.1002/etc.53
   Gunnarsson L, 2008, ENVIRON SCI TECHNOL, V42, P5807, DOI 10.1021/es8005173
   Gunnarsson L, 2009, ENVIRON TOXICOL CHEM, V28, P2639, DOI 10.1897/09-120.1
   Gutleb AC, 2010, ENVIRON SCI TECHNOL, V44, P3149, DOI 10.1021/es903029j
   Hallmann CA, 2014, NATURE, V511, P341, DOI 10.1038/nature13531
   Harris CA, 2011, ENVIRON HEALTH PERSP, V119, P306, DOI 10.1289/ehp.1002555
   Hartwig E, 2007, MAR POLLUT BULL, V54, P595, DOI 10.1016/j.marpolbul.2007.01.027
   Heath JA, 2005, AUK, V122, P255, DOI 10.1642/0004-8038(2005)122[0255:RAMCHA]2.0.CO;2
   Hecker M, 2007, ENVIRON SCI POLLUT R, V14, P23, DOI 10.1065/espr2007.03.402
   Hendriks AJ, 2005, ENVIRON TOXICOL CHEM, V24, P2267, DOI 10.1897/05-122.1
   Henny CJ, 2009, ECOTOXICOLOGY, V18, P802, DOI 10.1007/s10646-009-0323-4
   Henry M, 2012, SCIENCE, V336, P348, DOI 10.1126/science.1215039
   Hoffman DJ, 2003, HDB ECOTOXICOLOGY
   Houde M, 2008, ENVIRON SCI TECHNOL, V42, P3893, DOI 10.1021/es703184s
   Houde M, 2011, ENVIRON SCI TECHNOL, V45, P7962, DOI 10.1021/es104326w
   Ikemoto T, 2004, ARCH ENVIRON CON TOX, V47, P402, DOI 10.1007/s00244-004-3188-9
   Jackson AK, 2011, AUK, V128, P759, DOI 10.1525/auk.2011.11106
   Jagannath A, 2008, J APPL ECOL, V45, P133, DOI 10.1111/j.1365-2664.2007.01386.x
   Jaspers VLB, 2008, ENVIRON INT, V34, P741, DOI 10.1016/j.envint.2007.12.002
   Jaspers VLB, 2009, SCI TOTAL ENVIRON, V407, P1447, DOI 10.1016/j.scitotenv.2008.10.030
   Jobling S, 2006, ENVIRON HEALTH PERSP, V114, P32, DOI 10.1289/ehp.8050
   Johansen P, 2004, SCI TOTAL ENVIRON, V331, P189, DOI 10.1016/j.scitotenv.2004.03.029
   Karchner SI, 2006, P NATL ACAD SCI USA, V103, P6252, DOI 10.1073/pnas.0509950103
   Kidd KA, 2007, P NATL ACAD SCI USA, V104, P8897, DOI 10.1073/pnas.0609568104
   La Merrill M, 2013, ENVIRON HEALTH PERSP, V121, P162, DOI 10.1289/ehp.1205485
   Lahr J, 2010, SCI TOTAL ENVIRON, V408, P3891, DOI 10.1016/j.scitotenv.2009.11.018
   Landis Wayne G., 2011, Integrated Environmental Assessment and Management, V7, pVI, DOI 10.1002/ieam.249
   Larsson DGJ, 2007, J HAZARD MATER, V148, P751, DOI 10.1016/j.jhazmat.2007.07.008
   Laskowski R, 2010, SCI TOTAL ENVIRON, V408, P3763, DOI 10.1016/j.scitotenv.2010.01.043
   Lavoie RA, 2015, ENVIRON SCI TECHNOL, V49, P863, DOI 10.1021/es502813t
   Laycock I, 2012, ECOTOXICOLOGY, V21, P1937, DOI 10.1007/s10646-012-0927-y
   Lazarus RS, 2015, INTEGR ENVIRON ASSES, V11, P118, DOI 10.1002/ieam.1570
   Lemarchand C, 2010, CHEMOSPHERE, V80, P1120, DOI 10.1016/j.chemosphere.2010.06.026
   Letcher RJ, 2010, SCI TOTAL ENVIRON, V408, P2995, DOI 10.1016/j.scitotenv.2009.10.038
   Li YX, 2012, J HAZARD MATER, V219, P221, DOI 10.1016/j.jhazmat.2012.03.083
   Lilienthal H, 2006, ENV HLTH PERSPECT, V114, P196
   Liu XY, 2009, ENVIRON SCI TECHNOL, V43, P6357, DOI 10.1021/es901079z
   Lopez-Antia A, 2015, ENVIRON RES, V136, P97, DOI 10.1016/j.envres.2014.10.023
   Lopez-Antia A, 2014, SCI TOTAL ENVIRON, V496, P179, DOI 10.1016/j.scitotenv.2014.07.031
   Lovvorn JR, 2013, MAR ECOL PROG SER, V489, P245, DOI 10.3354/meps10439
   Luttik R, 2005, ECOTOXICOLOGY, V14, P817, DOI 10.1007/s10646-005-0030-8
   Mahler GJ, 2012, NAT NANOTECHNOL, V7, P264, DOI [10.1038/nnano.2012.3, 10.1038/NNANO.2012.3]
   Margalida A, 2014, SCIENCE, V346, P1296, DOI 10.1126/science.1260260
   Martinez-Haro M, 2008, ECOTOX ENVIRON SAFE, V69, P396, DOI 10.1016/j.ecoenv.2007.05.006
   Martinez-Haro M, 2011, ENVIRON SCI TECHNOL, V45, P6153, DOI 10.1021/es2009242
   Mateo R, 2006, ENVIRON TOXICOL CHEM, V25, P203, DOI 10.1897/04-460R.1
   Mateo R, 2003, J TOXICOL ENV HEAL A, V66, P1371, DOI 10.1080/15287390390199220
   Mateo R, 2014, ENVIRON INT, V63, P163, DOI 10.1016/j.envint.2013.11.006
   Mateo Rafael, 2009, P71
   Matranga V, 2012, MAR ENVIRON RES, V76, P32, DOI 10.1016/j.marenvres.2012.01.006
   McKinlay R, 2008, ENVIRON INT, V34, P168, DOI 10.1016/j.envint.2007.07.013
   Meyer JN, 2010, AQUAT TOXICOL, V100, P140, DOI 10.1016/j.aquatox.2010.07.016
   Miller DH, 2007, ENVIRON TOXICOL CHEM, V26, P521, DOI 10.1897/06-318R.1
   Mineau P, 2005, ECOTOXICOLOGY, V14, P775, DOI 10.1007/s10646-005-0028-2
   Mommaerts V, 2010, ECOTOXICOLOGY, V19, P207, DOI 10.1007/s10646-009-0406-2
   Moore CJ, 2008, ENVIRON RES, V108, P131, DOI 10.1016/j.envres.2008.07.025
   Movalli P, 2008, MONITORING RAPTORS, P37
   Murray M, 2011, J ZOO WILDLIFE MED, V42, P88, DOI 10.1638/2010-0188.1
   Murvoll KM, 2006, ENVIRON TOXICOL CHEM, V25, P190, DOI 10.1897/04-333R.1
   Naidoo V, 2010, BIOL LETTERS, V6, P339, DOI 10.1098/rsbl.2009.0818
   Nash JP, 2004, ENVIRON HEALTH PERSP, V112, P1725, DOI 10.1289/ehp.7209
   Noel M, 2014, ENVIRON SCI TECHNOL, V48, P7560, DOI 10.1021/es500631g
   Oaks JL, 2004, NATURE, V427, P630, DOI 10.1038/nature02317
   Oehlmann J, 2009, PHILOS T R SOC B, V364, P2047, DOI 10.1098/rstb.2008.0242
   Pilsner JR, 2010, MOL ECOL, V19, P307, DOI 10.1111/j.1365-294X.2009.04452.x
   Poletta GL, 2011, ECOTOX ENVIRON SAFE, V74, P852, DOI 10.1016/j.ecoenv.2010.12.005
   Prosser P, 2005, ECOTOXICOLOGY, V14, P679, DOI 10.1007/s10646-005-0018-4
   Raimondo S, 2008, ENVIRON TOXICOL CHEM, V27, P2599, DOI 10.1897/08-157.1
   Rattner BA, 2014, ENVIRON SCI TECHNOL, V48, P8433, DOI 10.1021/es501740n
   Rattner BA, 2011, ENVIRON TOXICOL CHEM, V30, P1213, DOI 10.1002/etc.490
   Reid N, 2013, ECOL INDIC, V26, P5, DOI 10.1016/j.ecolind.2012.10.017
   Richards N, 2012, CARBOFURAN AND WILDLIFE POISONING: GLOBAL PERSPECTIVES AND FORENSIC APPROACHES, P1
   Richards NL, 2011, EUR J WILDLIFE RES, V57, P1107, DOI 10.1007/s10344-011-0513-2
   Riley SPD, 2007, J WILDLIFE MANAGE, V71, P1874, DOI 10.2193/2005-615
   Ross PS, 2003, HUM ECOL RISK ASSESS, V9, P303, DOI 10.1080/727073292
   Sanchez-Barbudo IS, 2012, SCI TOTAL ENVIRON, V420, P280, DOI 10.1016/j.scitotenv.2012.01.028
   Sarabia J, 2008, AVIAN DIS, V52, P540, DOI 10.1637/8251-020508-Case.1
   Scheifler R, 2006, SCI TOTAL ENVIRON, V371, P197, DOI 10.1016/j.scitotenv.2006.09.011
   Scholz S, 2013, REGUL TOXICOL PHARM, V67, P506, DOI 10.1016/j.yrtph.2013.10.003
   Seitz F, 2013, AQUAT TOXICOL, V126, P163, DOI 10.1016/j.aquatox.2012.10.015
   Shaw SD, 2005, MAR POLLUT BULL, V50, P1069, DOI 10.1016/j.marpolbul.2005.04.010
   Shore RF, 2006, J WILDLIFE MANAGE, V70, P588, DOI 10.2193/0022-541X(2006)70[588:DFDOAR]2.0.CO;2
   Shore RF, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0570
   Simpson VR, 2011, VET REC, V169, P49, DOI 10.1136/vr.d1929
   Snape JR, 2004, AQUAT TOXICOL, V67, P143, DOI 10.1016/j.aquatox.2003.11.011
   Southard GM, 2010, J AM WATER RESOUR AS, V46, P14, DOI 10.1111/j.1752-1688.2009.00387.x
   Souza DM, 2015, GLOBAL CHANGE BIOL, V21, P32, DOI 10.1111/gcb.12709
   Stahl Thorsten, 2011, Environmental Sciences Europe, V23, P38, DOI 10.1186/2190-4715-23-38
   Taggart MA, 2011, ENVIRON INT, V37, P18, DOI 10.1016/j.envint.2010.06.007
   Tartu S, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0317
   Teuten EL, 2009, PHILOS T R SOC B, V364, P2027, DOI 10.1098/rstb.2008.0284
   Thomas PJ, 2011, ENVIRON INT, V37, P914, DOI 10.1016/j.envint.2011.03.010
   Topping CJ, 2004, ENVIRON TOXICOL CHEM, V23, P509, DOI 10.1897/02-524a
   Ucan-Marin F, 2009, TOXICOL SCI, V107, P440, DOI 10.1093/toxsci/kfn240
   van Zelm R, 2014, CHEMOSPHERE, V100, P175, DOI 10.1016/j.chemosphere.2013.11.037
   Vandegehuchte MB, 2014, MUTAT RES-GEN TOX EN, V764, P36, DOI 10.1016/j.mrgentox.2013.08.008
   Vasseur P, 2006, CHEMOSPHERE, V62, P1033, DOI 10.1016/j.chemosphere.2005.05.043
   Veldhoen N, 2014, ENVIRON SCI TECHNOL, V48, P10439, DOI 10.1021/es502539g
   Wang CY, 2006, CHEM RES TOXICOL, V19, P1595, DOI 10.1021/tx060218k
   Watanabe KH, 2011, ENVIRON TOXICOL CHEM, V30, P9, DOI 10.1002/etc.373
   Watson RT, 2009, INGESTION LEAD SPENT
   Weiss B, 2011, J NEUROL SCI, V305, P11, DOI 10.1016/j.jns.2011.03.014
   Wellington EMH, 2013, LANCET INFECT DIS, V13, P155, DOI 10.1016/S1473-3099(12)70317-1
   Whitehead A, 2012, P ROY SOC B-BIOL SCI, V279, P427, DOI 10.1098/rspb.2011.0847
   Zoeller RT, 2007, CRIT REV TOXICOL, V37, P11, DOI 10.1080/10408440601123446
   Zorrilla I, 2015, CONSERV BIOL, V29, P587, DOI 10.1111/cobi.12417
   Zuccato E, 2008, WATER RES, V42, P961, DOI 10.1016/j.watres.2007.09.010
NR 169
TC 1
Z9 1
U1 0
U2 1
PU SPRINGER INTERNATIONAL PUBLISHING AG
PI CHAM
PA GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND
SN 2366-8733
EI 2366-8741
BN 978-3-319-27912-1; 978-3-319-27910-7
J9 WILDL RES MONOGR
PY 2016
VL 1
BP 125
EP 150
DI 10.1007/978-3-319-27912-1_6
D2 10.1007/978-3-319-27912-1
PG 26
WC Biodiversity Conservation; Ecology
SC Biodiversity & Conservation; Environmental Sciences & Ecology
GA BM6XN
UT WOS:000467468400007
DA 2019-10-23
ER

PT J
AU Edwards, SW
   Tan, YM
   Villeneuve, DL
   Meek, ME
   McQueen, CA
AF Edwards, Stephen W.
   Tan, Yu-Mei
   Villeneuve, Daniel L.
   Meek, M. E.
   McQueen, Charlene A.
TI Adverse Outcome Pathways-Organizing Toxicological Information to Improve
   Decision Making
SO JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
LA English
DT Review
ID BRADFORD-HILL CONSIDERATIONS; IN-VIVO EXTRAPOLATION; MODE-OF-ACTION;
   RISK-ASSESSMENT; SCIENTIFIC CONFIDENCE; SKIN SENSITIZATION; HUMAN
   RELEVANCE; ENVIRONMENTAL CHEMICALS; CONCEPTUAL-FRAMEWORK; RESPONSE
   FRAMEWORK
AB The number of chemicals for which environmental regulatory decisions are required far exceeds the current capacity for toxicity testing. High-throughput screening commonly used for drug discovery has the potential to increase this capacity. The adverse outcome pathway (AOP) concept has emerged as a framework for connecting high-throughput toxicity testing (HTT) and other results to potential impacts on human and wildlife populations. As a result of international efforts, the AOP development process is now well-defined and efforts are underway to broaden the participation through outreach and training. One key principle is that AOPs represent the chemical-agnostic portions of pathways to increase the generalizability of their application from early key events to overt toxicity. The closely related mode of action framework extends the AOP as needed when evaluating the potential risk of a specific chemical. This in turn enables integrated approaches to testing and assessment (IATA), which incorporate results of assays at various levels of biologic organization such as in silico; HTT; chemical-specific aspects including absorption, distribution, metabolism, and excretion (ADME); and an AOP describing the biologic basis of toxicity. Thus, it is envisaged that provision of limited information regarding both the AOP for critical effects and the ADME for any chemical associated with any adverse outcome would allow for the development of IATA and permit more detailed AOP and ADME research, where higher precision is needed based on the decision context.
C1 [Edwards, Stephen W.; McQueen, Charlene A.] US EPA, Integrated Syst Toxicol Div, Natl Hlth & Environm Effects Res Lab, Off Res & Dev, Res Triangle Pk, NC 27711 USA.
   [Tan, Yu-Mei] US EPA, Human Exposure & Atmospher Sci Div, Natl Exposure Res Lab, Off Res & Dev, Res Triangle Pk, NC 27711 USA.
   [Villeneuve, Daniel L.] US EPA, Midcontinent Ecol Div, Natl Hlth & Environm Effects Res Lab, Off Res & Dev, Duluth, MN USA.
   [Meek, M. E.] Univ Ottawa, Fac Med, McLaughlin Ctr Risk Sci, Ottawa, ON, Canada.
RP Edwards, SW (reprint author), US EPA, Integrated Syst Toxicol Div, Natl Hlth & Environm Effects Res Lab, Off Res & Dev, 109 TW Alexander Dr MD B305-01,Room B340H, Res Triangle Pk, NC 27711 USA.
EM Edwards.stephen@epa.gov
FU U. S. Environmental Protection AgencyUnited States Environmental
   Protection Agency
FX The information in this document has been funded wholly (or in part) by
   the U. S. Environmental Protection Agency. It has been subjected to
   review by the National Health and Environmental Effects Research
   Laboratory and approved for publication. Approval does not signify that
   the contents reflect the views of the Agency, nor does mention of trade
   names or commercial products constitute endorsement or recommendation
   for use.
CR Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Attene-Ramos MS, 2013, DRUG DISCOV TODAY, V18, P716, DOI 10.1016/j.drudis.2013.05.015
   Becker RA, 2015, REGUL TOXICOL PHARM, V72, P514, DOI 10.1016/j.yrtph.2015.04.004
   Berggren E, 2015, ENVIRON HEALTH PERSP, V123, P1232, DOI 10.1289/ehp.1409342
   Boobis AR, 2008, CRIT REV TOXICOL, V38, P87, DOI 10.1080/10408440701749421
   Boobis AR, 2006, CRIT REV TOXICOL, V36, P781, DOI 10.1080/10408440600977677
   Browne P, 2015, ENVIRON SCI TECHNOL, V49, P8804, DOI 10.1021/acs.est.5b02641
   Burden N, 2015, J APPL TOXICOL, V35, P971, DOI 10.1002/jat.3165
   Collins FS, 2008, SCIENCE, V319, P906, DOI 10.1126/science.1154619
   Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523
   Environmental Protection Agency (EPA), 2009, 8901600 EPA OPPTS
   Environmental Protection Agency (EPA), 2011, INT APPR TEST ASS ST
   EPA U. S. Environmental Protection Agency, 2005, GUID CARC RISK ASS R
   Friend SH, 2014, SCIENCE, V344, P970, DOI 10.1126/science.1255648
   Garcia-Reyero N, 2015, ENVIRON SCI TECHNOL, V49, P3, DOI 10.1021/es504976d
   Groh KJ, 2015, CHEMOSPHERE, V120, P764, DOI 10.1016/j.chemosphere.2014.09.068
   Isaacs KK, 2014, ENVIRON SCI TECHNOL, V48, P12750, DOI 10.1021/es502513w
   Jaworska J, 2013, J APPL TOXICOL, V33, P1353, DOI 10.1002/jat.2869
   Judson R, 2008, TOXICOL APPL PHARM, V233, P7, DOI 10.1016/j.taap.2007.12.037
   Judson RS, 2015, TOXICOL SCI, V148, P137, DOI 10.1093/toxsci/kfv168
   Julien E, 2009, CRIT REV FOOD SCI, V49, P682, DOI 10.1080/10408390903110692
   Kavlock R, 2012, CHEM RES TOXICOL, V25, P1287, DOI 10.1021/tx3000939
   Knapen D, 2015, REPROD TOXICOL, V56, P52, DOI 10.1016/j.reprotox.2015.04.003
   Kramer VJ, 2011, ENVIRON TOXICOL CHEM, V30, P64, DOI 10.1002/etc.375
   Krewski D, 2010, J TOXICOL ENV HEAL B, V13, P51, DOI 10.1080/10937404.2010.483176
   LaLone CA, 2013, AQUAT TOXICOL, V144, P141, DOI 10.1016/j.aquatox.2013.09.004
   Landesmann B., 2012, DESCRIPTION PROTOTYP
   MacKay C, 2013, ALTEX-ALTERN ANIM EX, V30, P473, DOI 10.14573/altex.2013.4.473
   Maxwell G, 2014, TOXICOL IN VITRO, V28, P8, DOI 10.1016/j.tiv.2013.10.013
   Meek ME, 2014, J APPL TOXICOL, V34, P1, DOI 10.1002/jat.2949
   Meek ME, 2008, J TOXICOL ENV HEAL B, V11, P681, DOI 10.1080/10937400801985648
   Meek MEB, 2008, ENVIRON MOL MUTAGEN, V49, P110, DOI 10.1002/em.20369
   Meek ME, 2014, J APPL TOXICOL, V34, P595, DOI 10.1002/jat.2984
   Meek ME, 2003, CRIT REV TOXICOL, V33, P591, DOI 10.1080/10408440390250136
   NRC (National Research Council), 2007, TOX TEST 21 CENT VIS
   OECD, 2011, ENV DIR JOINT M CHEM
   OECD, 2013, ENV DIR JOINT M CHEM
   Organisation for Economic Co-operation and Development (OECD), 2015, ENV DIR JOINT M CHEM
   Organisation for Economic Co-operation and Development (OECD), 2014, ENV DIR JOINT M CHEM
   Organisation for Economic Co- operation and Development (OECD), 2009, ENV DIR JOINT M CHEM
   Patlewicz G, 2015, REGUL TOXICOL PHARM, V72, P117, DOI 10.1016/j.yrtph.2015.03.015
   Patlewicz G, 2015, REGUL TOXICOL PHARM, V71, P463, DOI 10.1016/j.yrtph.2015.02.011
   Patlewicz G, 2014, REGUL TOXICOL PHARM, V69, P529, DOI 10.1016/j.yrtph.2014.06.001
   Perkins EJ, 2015, TOXICOL SCI, V148, P14, DOI 10.1093/toxsci/kfv181
   Phillips MB, 2016, ENVIRON HEALTH PERSP, V124, P53, DOI 10.1289/ehp.1409450
   Reisinger K, 2015, TOXICOL IN VITRO, V29, P259, DOI 10.1016/j.tiv.2014.10.018
   Schadt EE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3002132
   Schadt EE, 2009, NAT REV DRUG DISCOV, V8, P286, DOI 10.1038/nrd2826
   Seed J, 2005, CRIT REV TOXICOL, V35, P663, DOI 10.1080/10408440591007133
   Simon TW, 2014, CRIT REV TOXICOL, V44, P17, DOI 10.3109/10408444.2014.931925
   Sonich-Mullin C, 2001, REGUL TOXICOL PHARM, V34, P146, DOI 10.1006/rtph.2001.1493
   Terry C, 2016, REGUL TOXICOL PHARM, V75, P89, DOI 10.1016/j.yrtph.2015.10.003
   Thomas RS, 2013, TOXICOL SCI, V136, P4, DOI 10.1093/toxsci/kft178
   Tice RR, 2013, ENVIRON HEALTH PERSP, V121, P756, DOI 10.1289/ehp.1205784
   Tollefsen KE, 2014, REGUL TOXICOL PHARM, V70, P629, DOI 10.1016/j.yrtph.2014.09.009
   van der Veen JW, 2014, REGUL TOXICOL PHARM, V69, P371, DOI 10.1016/j.yrtph.2014.04.018
   Villeneuve DL, 2014, TOXICOL SCI, V142, P312, DOI 10.1093/toxsci/kfu199
   Villeneuve DL, 2014, TOXICOL SCI, V142, P321, DOI 10.1093/toxsci/kfu200
   Villeneuve DL, 2011, ENVIRON TOXICOL CHEM, V30, P1, DOI 10.1002/etc.396
   Wambaugh JF, 2014, ENVIRON SCI TECHNOL, V48, P12760, DOI 10.1021/es503583j
   Wetmore BA, 2015, TOXICOLOGY, V332, P94, DOI 10.1016/j.tox.2014.05.012
   Willett C, 2014, ALTEX-ALTERN ANIM EX, V31, P500, DOI http://dx.doi.org/10.14573/altex.1401281
   Yauk CL, 2015, ENVIRON MOL MUTAGEN, V56, P724, DOI 10.1002/em.21954
   Yoon M, 2015, TOXICOLOGY, V332, P1, DOI 10.1016/j.tox.2015.02.002
NR 64
TC 65
Z9 68
U1 1
U2 48
PU AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3995 USA
SN 0022-3565
EI 1521-0103
J9 J PHARMACOL EXP THER
JI J. Pharmacol. Exp. Ther.
PD JAN
PY 2016
VL 356
IS 1
BP 170
EP 181
DI 10.1124/jpet.115.228239
PG 12
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA CZ2NN
UT WOS:000366942000018
PM 26537250
OA Bronze
HC Y
HP N
DA 2019-10-23
ER

PT B
AU Simpson, SL
   Campana, O
   Ho, KT
AF Simpson, S. L.
   Campana, O.
   Ho, K. T.
BE Blasco, J
   Chapman, PM
   Campana, O
   Hampel, M
TI Sediment Toxicity Testing
SO MARINE ECOTOXICOLOGY: CURRENT KNOWLEDGE AND FUTURE ISSUES
LA English
DT Article; Book Chapter
ID FRESH-WATER SEDIMENTS; AMPHIPOD MELITA-PLUMULOSA; DYNAMIC ENERGY BUDGET;
   ARENACEODENTATA ANNELIDA POLYCHAETA; CLOSTERIUM EHREMBERG LEWIN; COPEPOD
   NITOCRA-SPINIPES; ADVERSE OUTCOME PATHWAYS; PASSIVE SAMPLING METHODS;
   ESTUARINE SEDIMENTS; CONTAMINATED SEDIMENTS
C1 [Simpson, S. L.] CSIRO Land & Water, Sydney, NSW, Australia.
   [Campana, O.] Univ York, York, N Yorkshire, England.
   [Ho, K. T.] US EPA, Narragansett, RI USA.
RP Simpson, SL (reprint author), CSIRO Land & Water, Sydney, NSW, Australia.
RI Simpson, Stuart L/A-6044-2011; campana, olivia/P-9207-2017
OI Simpson, Stuart L/0000-0003-1759-0564; campana,
   olivia/0000-0002-3756-5254
CR Adams M. S., 2016, SEDIMENT QUALITY ASS, p255e264
   Adams MS, 2004, ENVIRON TOXICOL CHEM, V23, P1957, DOI 10.1897/03-232
   Akagi J, 2014, CYTOM PART A, V85A, P537, DOI 10.1002/cyto.a.22464
   Aller J. Y., 2001, ORGANISMSEDIMENT INT
   Amato ED, 2014, ENVIRON SCI TECHNOL, V48, P4485, DOI 10.1021/es404850f
   American Society for Testing and Materials (ASTM), 2010, ANN BOOK ASTM STAND
   American Society for Testing and Materials ASTM C 1218-99, 2008, ANN BOOK ASTM STAND
   Anderson B. S., 1996, TECHNIQUES AQUATIC T, P609
   Ankley G. T., 1995, Journal of Aquatic Ecosystem Health, V4, P133, DOI 10.1007/BF00116649
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   ANKLEY GT, 1990, ENVIRON TOXICOL CHEM, V9, P313, DOI 10.1002/etc.5620090307
   ANKLEY GT, 1995, ENVIRON SCI TECHNOL, V29, P2828, DOI 10.1021/es00011a019
   [Anonymous], 2013, ANN BOOK ASTM STAND
   [Anonymous], ANN BOOK ASTM STAND
   Araujo CVM, 2012, ECOTOXICOLOGY, V21, P750, DOI 10.1007/s10646-011-0835-6
   Araujo CVM, 2010, SCI TOTAL ENVIRON, V408, P822, DOI 10.1016/j.scitotenv.2009.10.018
   Araujo GS, 2013, MAR POLLUT BULL, V75, P62, DOI 10.1016/j.marpolbul.2013.08.005
   ASTM, 2012, ANN BOOK ASTM STAND
   ASTM, 2014, ANN BOOK ASTM STAND, V04
   Baker M, 2011, NATURE, V471, P661, DOI 10.1038/471661a
   Bat L, 1998, J EXP MAR BIOL ECOL, V226, P217, DOI 10.1016/S0022-0981(97)00249-9
   Batley G.E., 2016, SEDIMENT QUALITY ASS, P15
   Beaudouin R, 2012, ECOTOXICOLOGY, V21, P1225, DOI 10.1007/s10646-012-0877-4
   Belzunce-Segarra MJ, 2015, ENVIRON POLLUT, V204, P48, DOI 10.1016/j.envpol.2015.03.048
   Besser JM, 1998, ENVIRON TOXICOL CHEM, V17, P2310
   Besser JM, 2013, ENVIRON TOXICOL CHEM, V32, P2495, DOI 10.1002/etc.2271
   Biales AD, 2013, ENVIRON SCI TECHNOL, V47, P1306, DOI 10.1021/es304274a
   Boldina-Cosqueric I, 2010, ECOTOX ENVIRON SAFE, V73, P1733, DOI 10.1016/j.ecoenv.2010.08.008
   Bouchet Philippe, 2006, P31
   Bridges TS, 1997, ENVIRON TOXICOL CHEM, V16, P1650, DOI 10.1002/etc.5620160813
   Bridges TS, 1997, ENVIRON TOXICOL CHEM, V16, P1659, DOI 10.1002/etc.5620160814
   Brumbaugh WG, 2013, ENVIRON TOXICOL CHEM, V32, P2482, DOI 10.1002/etc.2272
   Bull DC, 2002, B ENVIRON CONTAM TOX, V68, P852, DOI 10.1007/s00128-002-0033-6
   Burgess RM, 2004, ARCH ENVIRON CON TOX, V47, P440, DOI 10.1007/s00244-004-4003-3
   Burgess RM, 2000, ENVIRON TOXICOL CHEM, V19, P982, DOI 10.1002/etc.5620190427
   Burgess RM, 2003, MAR POLLUT BULL, V46, P607, DOI 10.1016/S0025-326X(03)00038-9
   Burgess RM, 2007, ENVIRON TOXICOL CHEM, V26, P61, DOI 10.1897/06-014R.1
   Burgess RM, 2011, HANDB ENVIRON CHEM, V15, P19, DOI 10.1007/978-3-642-18384-3_2
   Burton GA, 2010, ENVIRON TOXICOL CHEM, V29, P2625, DOI 10.1002/etc.332
   Camargo JBDA, 2015, MAR POLLUT BULL, V91, P511, DOI 10.1016/j.marpolbul.2014.10.015
   Campana O, 2013, ENVIRON SCI TECHNOL, V47, P7483, DOI 10.1021/es4009272
   Campana O, 2012, ENVIRON SCI TECHNOL, V46, P6835, DOI 10.1021/es2045844
   Carr RS, 2003, POREWATER TOXICITY T
   Cartlidge R., 2015, P SOC PHOTO-OPT INS
   Casado-Martinez MC, 2010, ENVIRON POLLUT, V158, P3071, DOI 10.1016/j.envpol.2010.06.026
   Casado-Martinez MC, 2006, CIENC MAR, V32, P149, DOI 10.7773/cm.v32i12.1039
   Castro H, 2006, MAR POLLUT BULL, V53, P91, DOI 10.1016/j.marpolbul.2005.09.029
   Chandler G. Thomas, 1996, P23
   Chandler GT, 1997, ENVIRON TOXICOL CHEM, V16, P2339, DOI 10.1002/etc.5620161120
   Chapman PM, 1998, CAN J FISH AQUAT SCI, V55, P2221, DOI 10.1139/cjfas-55-10-2221
   Chapman PM, 2002, MAR POLLUT BULL, V44, P359, DOI 10.1016/S0025-326X(01)00243-0
   Chariton AA, 2014, ENVIRON TOXICOL CHEM, V33, P359, DOI 10.1002/etc.2450
   Chariton AA, 2011, ECOTOXICOLOGY, V20, P706, DOI 10.1007/s10646-011-0612-6
   Chariton AA, 2010, MAR FRESHWATER RES, V61, P1109, DOI 10.1071/MF09263
   Ciutat A, 2003, ENVIRON TOXICOL CHEM, V22, P1574, DOI 10.1002/etc.5620220721
   Collins PC, 2013, MAR POLICY, V42, P198, DOI 10.1016/j.marpol.2013.01.020
   Costa FO, 1998, ECOTOX ENVIRON SAFE, V40, P81, DOI 10.1006/eesa.1998.1646
   Costa FO, 2005, MAR ENVIRON RES, V60, P93, DOI 10.1016/j.marenvres.2004.08.005
   Dafforn KA, 2012, ENVIRON POLLUT, V163, P207, DOI 10.1016/j.envpol.2011.12.029
   DeFoe DL, 1998, ENVIRON POLLUT, V99, P123, DOI 10.1016/S0269-7491(97)00159-0
   Di Toro DM, 2000, ENVIRON TOXICOL CHEM, V19, P1971, DOI 10.1002/etc.5620190804
   Ducrot V, 2007, ENVIRON TOXICOL CHEM, V26, P1774, DOI 10.1897/06-556R.1
   Edge KJ, 2014, CHEMOSPHERE, V100, P16, DOI 10.1016/j.chemosphere.2014.01.001
   Edge KJ, 2012, ECOTOXICOLOGY, V21, P1415, DOI 10.1007/s10646-012-0895-2
   Environment Canada, 2002, EPS1RM42
   European Commission, 2012, ADDR NEW CHALL RISK
   Farrar J. D., 2011, ERDCTNDOERR14
   Fathallah S, 2012, B ENVIRON CONTAM TOX, V88, P1001, DOI 10.1007/s00128-012-0603-1
   Fox M, 2014, ENVIRON TOXICOL CHEM, V33, P937, DOI 10.1002/etc.2515
   Gao JJ, 2015, CHEMOSPHERE, V128, P7, DOI 10.1016/j.chemosphere.2015.01.007
   GEROULD S, 1986, ENVIRON TOXICOL CHEM, V5, P667, DOI 10.1002/etc.5620050707
   Gomiero A, 2013, SCI TOTAL ENVIRON, V442, P534, DOI 10.1016/j.scitotenv.2012.10.023
   Greenstein D, 2008, ENVIRON TOXICOL CHEM, V27, P933, DOI 10.1897/07-285.1
   Griscom SB, 2004, ESTUARIES, V27, P826, DOI 10.1007/BF02912044
   Groh KJ, 2015, CHEMOSPHERE, V120, P764, DOI 10.1016/j.chemosphere.2014.09.068
   Hack LA, 2008, ECOTOX ENVIRON SAFE, V70, P469, DOI 10.1016/j.ecoenv.2007.12.008
   Harris CA, 2014, ENVIRON SCI TECHNOL, V48, P3100, DOI 10.1021/es4047507
   Hassan SM, 1996, ENVIRON TOXICOL CHEM, V15, P2198, DOI 10.1002/etc.5620151214
   Hellou J, 2011, ENVIRON SCI POLLUT R, V18, P1, DOI 10.1007/s11356-010-0367-2
   Hill NA, 2013, ENVIRON POLLUT, V173, P182, DOI 10.1016/j.envpol.2012.09.029
   Ho KT, 2013, ENVIRON TOXICOL CHEM, V32, P2424, DOI 10.1002/etc.2359
   Ho KT, 2013, ENVIRON TOXICOL CHEM, V32, P384, DOI 10.1002/etc.2067
   Ho KT, 2009, ENVIRON SCI TECHNOL, V43, P6857, DOI 10.1021/es900215x
   Ho Kay T., 2009, V5, P75, DOI 10.1007/698_5_108
   Ho KT, 1999, ENVIRON TOXICOL, V14, P235, DOI 10.1002/(SICI)1522-7278(199905)14:2<235::AID-TOX4>3.0.CO;2-J
   Ho KT, 2004, ENVIRON TOXICOL CHEM, V23, P2124, DOI 10.1897/03-407
   Ho KT, 1999, ENVIRON TOXICOL CHEM, V18, P207, DOI 10.1002/etc.5620180216
   Ho KT, 2002, MAR POLLUT BULL, V44, P286, DOI 10.1016/S0025-326X(01)00251-X
   Hook SE, 2014, INTEGR ENVIRON ASSES, V10, P327, DOI [10.1002/ieam.1530, 10]
   Hook SE, 2014, ENVIRON SCI TECHNOL, V48, P3504, DOI 10.1021/es405322s
   Hutchins CM, 2008, ENVIRON SCI TECHNOL, V42, P2912, DOI 10.1021/es702673w
   Hutchinson TH, 1998, CHEMOSPHERE, V36, P129, DOI 10.1016/S0045-6535(97)10025-X
   Jager T, 2011, J SEA RES, V66, P456, DOI 10.1016/j.seares.2011.04.003
   Johnston EL, 2009, ENVIRON POLLUT, V157, P1745, DOI 10.1016/j.envpol.2009.02.017
   Kennedy AJ, 2009, MAR ENVIRON RES, V68, P118, DOI 10.1016/j.marenvres.2009.04.010
   Keppler CJ, 2002, B ENVIRON CONTAM TOX, V68, P43, DOI 10.1007/s00128-001-0217-5
   King CK, 2010, ARCH ENVIRON CON TOX, V58, P657, DOI 10.1007/s00244-009-9413-9
   Knezovich JP, 1996, B ENVIRON CONTAM TOX, V57, P450, DOI 10.1007/s001289900211
   KOOIJMAN SALM, 1989, FUNCT ECOL, V3, P325, DOI 10.2307/2389373
   Kovatch CE, 1999, MAR POLLUT BULL, V38, P692, DOI 10.1016/S0025-326X(99)00029-6
   Krell B, 2011, ENVIRON TOXICOL CHEM, V30, P1935, DOI 10.1002/etc.585
   Krull M, 2014, ECOTOX ENVIRON SAFE, V106, P195, DOI 10.1016/j.ecoenv.2014.04.038
   Kuhn A, 2000, ENVIRON TOXICOL CHEM, V19, P2364, DOI [10.1897/1551-5028(2000)019<2364:POPLRF>2.3.CO;2, 10.1002/etc.5620190929]
   Kuhn A, 2002, ENVIRON TOXICOL CHEM, V21, P865, DOI 10.1002/etc.5620210425
   Lee JW, 2015, J ENVIRON SCI-CHINA, V35, P115, DOI 10.1016/j.jes.2015.05.002
   Li JY, 2013, ENVIRON TOXICOL CHEM, V32, P2888, DOI 10.1002/etc.2387
   Lydy MJ, 2014, INTEGR ENVIRON ASSES, V10, P167, DOI 10.1002/ieam.1503
   Mann RM, 2009, ENVIRON TOXICOL CHEM, V28, P1244, DOI 10.1897/08-346.1
   Martin BT, 2013, ECOTOXICOLOGY, V22, P574, DOI 10.1007/s10646-013-1049-x
   Martin BT, 2012, METHODS ECOL EVOL, V3, P445, DOI 10.1111/j.2041-210X.2011.00168.x
   Martin-Diaz ML, 2004, TRAC-TREND ANAL CHEM, V23, P807, DOI 10.1016/j.trac.2004.07.012
   Martins M, 2012, ECOTOX ENVIRON SAFE, V85, P96, DOI 10.1016/j.ecoenv.2012.08.008
   Maruya KA, 2012, INTEGR ENVIRON ASSES, V8, P659, DOI 10.1002/ieam.135
   McGee BL, 2004, ENVIRON TOXICOL CHEM, V23, P1751, DOI 10.1897/03-326
   MILLER DC, 1990, ARCH ENVIRON CON TOX, V19, P40, DOI 10.1007/BF01059811
   Miller RJ, 2010, ENVIRON SCI TECHNOL, V44, P7329, DOI 10.1021/es100247x
   Monserrat JM, 2007, COMP BIOCHEM PHYS C, V146, P221, DOI 10.1016/j.cbpc.2006.08.012
   Moore DW, 1997, ENVIRON TOXICOL CHEM, V16, P1020, DOI 10.1002/etc.5620160523
   Morales-Caselles C, 2008, ENVIRON MONIT ASSESS, V142, P219, DOI 10.1007/s10661-007-9926-5
   Moreira SM, 2005, ENVIRON TOXICOL CHEM, V24, P2010, DOI 10.1897/04-473R1.1
   Moreira SM, 2006, AQUAT TOXICOL, V78, P186, DOI 10.1016/j.aquatox.2006.03.001
   Moreno-Garrido I, 2003, ECOTOX ENVIRON SAFE, V54, P290, DOI 10.1016/S0147-6513(02)00077-5
   Moreno-Garrido I, 2003, B ENVIRON CONTAM TOX, V70, P242, DOI 10.1007/s00128-002-0183-6
   Moreno-Garrido I, 2007, ESTUAR COAST SHELF S, V71, P278, DOI 10.1016/j.ecss.2006.08.003
   MUDROCH A, 1995, MANUAL AQUATIC SEDIM
   Newman C. M, 2010, FUNDAMENTALS ECOTOXI
   NFESC (Naval Facility Engineering Services Center), 2003, SPEC PUBL
   Northcott GL, 2000, ENVIRON TOXICOL CHEM, V19, P2418, DOI 10.1002/etc.5620191005
   OECD, 2013, SER TEST ASS, V184
   Olsgard F, 1999, MAR POLLUT BULL, V38, P448, DOI 10.1016/S0025-326X(98)90202-8
   Organisation for Economic Co-operation and Development (OECD), 2006, OECD SER TEST ASS
   Peijnenburg WJGM, 2014, INTEGR ENVIRON ASSES, V10, P179, DOI 10.1002/ieam.1502
   Pelletier MC, 1997, ENVIRON TOXICOL CHEM, V16, P2190, DOI 10.1002/etc.5620161029
   Perez-Landa V, 2011, ENVIRON TOXICOL CHEM, V30, P1430, DOI 10.1002/etc.513
   Perron MM, 2013, ENVIRON TOXICOL CHEM, V32, P2182, DOI 10.1002/etc.2321
   Peterson GS, 1996, ENVIRON TOXICOL CHEM, V15, P2147, DOI 10.1002/etc.5620151210
   Rainbow PS, 2007, ENVIRON INT, V33, P576, DOI 10.1016/j.envint.2006.05.007
   Ramos-Gomez J, 2011, MAR POLLUT BULL, V62, P1538, DOI 10.1016/j.marpolbul.2011.03.045
   Regoli F, 2004, AQUAT TOXICOL, V68, P167, DOI 10.1016/j.aquatox.2004.03.011
   Regoli F, 2014, MAR ENVIRON RES, V93, P106, DOI 10.1016/j.marenvres.2013.07.006
   Riba I, 2004, ENVIRON TOXICOL CHEM, V23, P1100, DOI 10.1897/023-601
   RINGWOOD AH, 1992, ARCH ENVIRON CON TOX, V22, P288
   Ringwood AH, 1998, ENVIRON MONIT ASSESS, V51, P247, DOI 10.1023/A:1005995521173
   Rodrigues ET, 2014, ENVIRON INT, V70, P158, DOI 10.1016/j.envint.2014.05.018
   Rodriguez-Romero A, 2013, ECOTOX ENVIRON SAFE, V92, P281, DOI 10.1016/j.ecoenv.2013.02.015
   Rosen G, 2011, ENVIRON TOXICOL CHEM, V30, P730, DOI 10.1002/etc.438
   Scarlett A, 2007, MAR ENVIRON RES, V63, P457, DOI 10.1016/j.marenvres.2006.12.006
   Scarlett A, 2007, HUM ECOL RISK ASSESS, V13, P506, DOI 10.1080/10807030701341035
   Schlekat C. E., 2015, DEV BIOAVAILABILITY
   Simpson S.L., 2016, SEDIMENT QUALITY ASS, P47
   Simpson S.L., 2016, SEDIMENT QUALITY ASS, P77
   Simpson SL, 2005, ENVIRON SCI TECHNOL, V39, P7089, DOI 10.1021/es050765c
   Simpson SL, 2005, ENVIRON SCI TECHNOL, V39, P837, DOI 10.1021/es048815l
   Simpson SL, 2004, CHEMOSPHERE, V54, P597, DOI 10.1016/j.chemosphere.2003.08.007
   Simpson SL, 2003, ENVIRON TOXICOL CHEM, V22, P424, DOI 10.1002/etc.5620220225
   Simpson SL, 2007, INTEGR ENVIRON ASSES, V3, P18, DOI 10.1002/ieam.5630030103
   Simpson SL, 2013, CHEMOSPHERE, V93, P2499, DOI 10.1016/j.chemosphere.2013.08.100
   Simpson SL, 2012, CHEMOSPHERE, V88, P953, DOI 10.1016/j.chemosphere.2012.03.026
   Simpson SL, 2011, CHEMOSPHERE, V85, P1487, DOI 10.1016/j.chemosphere.2011.08.044
   Simpson SL, 2011, ENVIRON TOXICOL CHEM, V30, P2326, DOI 10.1002/etc.633
   Spadaro DA, 2008, ARCH ENVIRON CON TOX, V55, P593, DOI 10.1007/s00244-008-9153-2
   Spadaro D. A., 2016, SEDIMENT QUALITY ASS, P265
   Spadaro D. A., 2016, SEDIMENT QUALITY ASS, P285
   Spadaro D. A., 2016, SEDIMENT QUALITY ASS, P276
   Strom D, 2011, ENVIRON TOXICOL CHEM, V30, P1599, DOI 10.1002/etc.531
   Swartz RC, 1997, ENVIRON TOXICOL CHEM, V16, P2151, DOI 10.1002/etc.5620161023
   Taylor AM, 2010, OCEANOGR OCEAN ENG, P1
   Taylor A.M., 2016, SEDIMENT QUALITY ASS, P157
   United Nations Environment Programme (UNEP), 2010, HARMF SUBST HAZ WAST
   USEPA, 2006, EPA240B06001 OFF ENV
   USEPA, 1996, EPA600R96054 OFF RES
   USEPA, 2014, SW846 USEPA
   USEPA, 1994, 600R94025 OFF RES DE
   USEPA, 2001, EPA823B01002
   USEPA, 2000, EPA600R99064 OFF RES
   USEPA, 2007, EPA600R07080 OFF RES
   USEPA (United States Environmental Protection Agency), 2005, EPA600R02011 OFF RES
   USEPA] US Environmental Protection Agency, 2003, EPA600R02013 OFF RES
   [USEPA] US Environmental Protection Agency, 2006, EPA240B06003 OFF ENV
   USEPA (US Environmental Protection Agency), 1993, EPA600R93183 OFF RES
   [USEPA] US Environmental Protection Agency, 2012, EPA600R02012 OFF RES
   Van Geest JL, 2014, AQUACULTURE, V434, P233, DOI 10.1016/j.aquaculture.2014.08.025
   Van Geest JL, 2014, AQUACULTURE, V430, P98, DOI 10.1016/j.aquaculture.2014.03.044
   van Midwoud PM, 2011, INTEGR BIOL-UK, V3, P509, DOI 10.1039/c0ib00119h
   Vandegehuchte MB, 2013, ENVIRON TOXICOL CHEM, V32, P1048, DOI 10.1002/etc.2156
   Vangheluwe MLU, 2013, ENVIRON TOXICOL CHEM, V32, P2507, DOI 10.1002/etc.2373
   Villeneuve DL, 2014, TOXICOL SCI, V142, P312, DOI 10.1093/toxsci/kfu199
   Villeneuve DL, 2014, TOXICOL SCI, V142, P321, DOI 10.1093/toxsci/kfu200
   Volkenborn N, 2010, LIMNOL OCEANOGR, V55, P1231, DOI 10.4319/lo.2010.55.3.1231
   VONBERTALANFFY L, 1957, Q REV BIOL, V32, P217, DOI 10.1086/401873
   Wang FY, 1999, ENVIRON TOXICOL CHEM, V18, P2526, DOI 10.1002/etc.5620181120
   Ward DJ, 2013, ENVIRON SCI TECHNOL, V47, P5947, DOI 10.1021/es400152a
   Ward DJ, 2013, ENVIRON TOXICOL CHEM, V32, P644, DOI 10.1002/etc.2086
   WILLIAMS KA, 1986, OECOLOGIA, V70, P362, DOI 10.1007/BF00379498
   Word JQ, 2005, USE OF SEDIMENT: QUALITY GUIDELINES AND RELATED TOOLS FOR THE ASSESSMENT OF CONTAMINATED SEDIMENTS, P633
   Zhao Y, 2007, ENVIRON TOXICOL CHEM, V26, P543, DOI 10.1897/06-398R.1
   Zheng GX, 2014, MAR POLLUT BULL, V84, P147, DOI 10.1016/j.marpolbul.2014.05.019
   Zheng GX, 2013, MAR POLLUT BULL, V72, P231, DOI 10.1016/j.marpolbul.2013.03.035
NR 198
TC 8
Z9 8
U1 0
U2 0
PU ACADEMIC PRESS LTD-ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL ROAD, LONDON NW1 7DX, ENGLAND
BN 978-0-12-803372-2; 978-0-12-803371-5
PY 2016
BP 199
EP 237
DI 10.1016/B978-0-12-803371-5.00007-2
PG 39
WC Marine & Freshwater Biology; Toxicology
SC Marine & Freshwater Biology; Toxicology
GA BI6KR
UT WOS:000413430900008
DA 2019-10-23
ER

PT S
AU Patlewicz, G
   Worth, AP
   Ball, N
AF Patlewicz, Grace
   Worth, Andrew P.
   Ball, Nicholas
BE Eskes, C
   Whelan, M
TI Validation of Computational Methods
SO VALIDATION OF ALTERNATIVE METHODS FOR TOXICITY TESTING
SE Advances in Experimental Medicine and Biology
LA English
DT Article; Book Chapter
DE (Quantitative) Structure Activity Relationship [(Q)SAR]; OECD Validation
   Principles; Read-across; Adverse Outcome Pathways (AOPs); Integrated
   Approaches to Testing and Assessment (IATA)
ID ADVERSE OUTCOME PATHWAYS; READ-ACROSS; APPLICABILITY DOMAINS; SKIN
   SENSITIZATION; SCIENTIFIC CONFIDENCE; END-POINTS; TIMES-SS; TOXICITY;
   FRAMEWORK; MODELS
AB In this chapter, we provide an overview of how (Quantitative) Structure Activity Relationships, (Q)SARs, are validated and applied for regulatory purposes. We outline how chemical categories are derived to facilitate endpoint specific read-across using tools such as the OECD QSAR Toolbox and discuss some of the current difficulties in addressing the residual uncertainties of read-across. Finally we put forward a perspective of how non-testing approaches may evolve in light of the advances in new and emerging technologies and how these fit within the Adverse Outcome Pathway (AOP) framework.
C1 [Patlewicz, Grace] Dupont Haskell Global Ctr Hlth & Environm Sci, Newark, DE 19711 USA.
   [Patlewicz, Grace] US EPA, Natl Ctr Computat Toxicol, Res Triangle Pk, NC 27711 USA.
   [Worth, Andrew P.] European Commiss, Joint Res Ctr, Ispra, Italy.
   [Ball, Nicholas] Dow Chem Co USA, Toxicol & Environm Res & Consulting, Environm Hlth & Safety, CH-8810 Zurich, Switzerland.
RP Patlewicz, G (reprint author), Dupont Haskell Global Ctr Hlth & Environm Sci, Newark, DE 19711 USA.; Patlewicz, G (reprint author), US EPA, Natl Ctr Computat Toxicol, Res Triangle Pk, NC 27711 USA.
EM patlewig@hotmail.com
RI Worth, Andrew/R-8495-2019; Worth, Andrew Paul/O-3055-2019
OI Worth, Andrew Paul/0000-0002-5303-0452; Patlewicz,
   Grace/0000-0003-3863-9689
CR Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   [Anonymous], 2012, OECD SER TEST ASS, V168
   [Anonymous], 2002, WORKSH REG ACC SET P
   Aptula AO, 2006, CHEM RES TOXICOL, V19, P1097, DOI 10.1021/tx0601004
   Ball N, 2016, ALTEX-ALTERN ANIM EX, V33, P149, DOI 10.14573/altex.1601251
   Blackburn K, 2014, REGUL TOXICOL PHARM, V68, P353, DOI 10.1016/j.yrtph.2014.01.004
   Blackburn K, 2011, REGUL TOXICOL PHARM, V60, P120, DOI 10.1016/j.yrtph.2011.03.002
   Chakravarti SK, 2012, J CHEM INF MODEL, V52, P2609, DOI [10.1021/ci300111r, 10.1021/ci300111rl]
   CRAMER GM, 1978, FOOD COSMET TOXICOL, V16, P255, DOI 10.1016/S0015-6264(76)80522-6
   Cronin MTD, 2003, ENVIRON HEALTH PERSP, V111, P1391, DOI 10.1289/ehp.5760
   de Raat K, 2014, WORLD C AN ALT 24 28
   Dimitrov S, 2005, J CHEM INF MODEL, V45, P839, DOI 10.1021/ci0500381
   ECETOC, 2012, 116 ECETOC
   ECETOC, 2009, 109 ECETOC
   ECHA, 2012, GUID IMPL REACH VERS
   ECHA, 2012, PRACT GUID 5 REP Q S
   ECHA, 2008, GUID INF REQ CHEM SA
   ECHA, 2015, READ ACR ASS FRAM RA
   Ellison CM, 2011, J CHEM INF MODEL, V51, P975, DOI 10.1021/ci1000967
   Ellison CM, 2009, ATLA-ALTERN LAB ANIM, V37, P533, DOI 10.1177/026119290903700510
   Enoch SJ, 2013, SAR QSAR ENVIRON RES, V24, P651, DOI 10.1080/1062936X.2013.773377
   Enoch SJ, 2012, SAR QSAR ENVIRON RES, V23, P649, DOI 10.1080/1062936X.2012.679691
   Eriksson L, 2003, ENVIRON HEALTH PERSP, V111, P1361, DOI 10.1289/ehp.5758
   Jaworska J, 2002, SAR QSAR ENVIRON RES, V13, P307, DOI 10.1080/10629360290002794
   Jaworska J., 2005, DAYL CHEM INF SYST, V33, P445
   Jennen D, 2014, TOXICOL LETT, V229, pS4, DOI 10.1016/j.toxlet.2014.06.042
   Mekenyan O, 2014, CHEM RES TOXICOL, V27, P219, DOI 10.1021/tx400345b
   Naciff JM, 2013, TOXICOLOGIST PS, V549, P117
   Netzeva TI, 2005, ATLA-ALTERN LAB ANIM, V33, P155, DOI 10.1177/026119290503300209
   Nikolova-Jeliazkova N, 2005, ATLA-ALTERN LAB ANIM, V33, P461, DOI 10.1177/026119290503300510
   OECD, 2014, OECD SER TEST ASS, V194
   OECD, 2011, OECD SER TEST ASS
   OECD, 2014, US TOOLB AOP WORKFL
   OECD, 2007, OECD SER TEST ASS, V69
   OECD, 2004, ENVJMMONO200424 OECD
   OECD, 2007, OECD SER TEST ASS, V80
   Patlewicz G, 2008, SAR QSAR ENVIRON RES, V19, P397, DOI 10.1080/10629360802083848
   Patlewicz G, 2015, REGUL TOXICOL PHARM, V72, P117, DOI 10.1016/j.yrtph.2015.03.015
   Patlewicz G, 2014, SAR QSAR ENVIRON RES, V25, P367, DOI 10.1080/1062936X.2014.900520
   Patlewicz G, 2011, SAR QSAR ENVIRON RES, V22, P67, DOI 10.1080/1062936X.2010.528448
   Patlewicz G, 2014, WORKSH MIT TOX PATHW
   Patlewicz G, 2007, REGUL TOXICOL PHARM, V48, P225, DOI 10.1016/j.yrtph.2007.03.003
   Patlewicz G, 2016, CHEM RES TOXICOL, V29, P438, DOI 10.1021/acs.chemrestox.5b00388
   Patlewicz G, 2015, REGUL TOXICOL PHARM, V71, P463, DOI 10.1016/j.yrtph.2015.02.011
   Patlewicz G, 2014, ALTEX-ALTERN ANIM EX, V31, P387, DOI 10.14573/altex.1410071
   Patlewicz G, 2014, REGUL TOXICOL PHARM, V69, P529, DOI 10.1016/j.yrtph.2014.06.001
   Patlewicz G, 2013, REGUL TOXICOL PHARM, V67, P1, DOI 10.1016/j.yrtph.2013.06.002
   Patlewicz G, 2013, REGUL TOXICOL PHARM, V65, P226, DOI 10.1016/j.yrtph.2012.12.004
   Schultz TW, 2015, REGUL TOXICOL PHARM, V72, P586, DOI 10.1016/j.yrtph.2015.05.016
   Schultz TW, 2007, CHEM RES TOXICOL, V20, P1359, DOI 10.1021/tx700212u
   Schultz TW, 2005, SAR QSAR ENVIRON RES, V16, P313, DOI 10.1080/10659360500204152
   van Ravenzwaay B, 2013, TOXICOL LETT, V221, pS27, DOI 10.1016/j.toxlet.2013.06.096
   VERHAAR HJM, 1992, CHEMOSPHERE, V25, P471, DOI 10.1016/0045-6535(92)90280-5
   Worth A, 2011, 24705 JRC EUR EN
   Worth AP, 2005, 21866 JRC EUR EN
   Wu SD, 2010, REGUL TOXICOL PHARM, V56, P67, DOI 10.1016/j.yrtph.2009.09.006
NR 56
TC 5
Z9 5
U1 0
U2 2
PU SPRINGER INT PUBLISHING AG
PI CHAM
PA GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND
SN 0065-2598
BN 978-3-319-33826-2; 978-3-319-33824-8
J9 ADV EXP MED BIOL
JI Adv.Exp.Med.Biol.
PY 2016
VL 856
BP 165
EP 187
DI 10.1007/978-3-319-33826-2_6
D2 10.1007/978-3-319-33826-2
PG 23
WC Medicine, Research & Experimental; Toxicology
SC Research & Experimental Medicine; Toxicology
GA BH5HH
UT WOS:000400937400008
PM 27671722
DA 2019-10-23
ER

PT S
AU Worth, AP
   Patlewicz, G
AF Worth, Andrew P.
   Patlewicz, Grace
BE Eskes, C
   Whelan, M
TI Integrated Approaches to Testing and Assessment
SO VALIDATION OF ALTERNATIVE METHODS FOR TOXICITY TESTING
SE Advances in Experimental Medicine and Biology
LA English
DT Article; Book Chapter
DE Integrated approach to testing and assessment (IATA); Integrated testing
   strategy (ITS); Predictive toxicology; Adverse outcome pathway; Chemical
   safety assessment
ID SCREENING CONTACT ALLERGENS; EPAA-ECVAM WORKSHOP; SKIN SENSITIZATION;
   TOXICOLOGICAL CONCERN; RISK-ASSESSMENT; OSIRIS WEIGHT; END-POINTS;
   CRAMER CLASSIFICATION; SCIENTIFIC CONFIDENCE; ALTERNATIVE METHODS
AB In this chapter, we explain how Integrated Approaches to Testing and Assessment (IATA) offer a means of integrating and translating the data generated by toxicity testing methods, thereby serving as flexible and suitable tools for toxicological decision making in the twenty-first century. In addition to traditional in vitro and in vivo testing methods, IATA are increasingly incorporating newly developed in vitro systems and measurement technologies such as high throughput screening and high content imaging. Computational approaches are also being used in IATA development, both as a means of generating data (e.g. QSARs), interpreting data (bioinformatics and chemoinformatics), and as a means of integrating multiple sources of data (e.g. expert systems, bayesian models). Decision analytic methods derived from socioeconomic theory can also play a role in developing flexible and optimal IATA solutions. Some of the challenges involved in the development, validation and implementation of IATA are also discussed.
C1 [Worth, Andrew P.] European Commiss, Joint Res Ctr, Ispra, Italy.
   [Patlewicz, Grace] Dupont Haskell Global Ctr Hlth & Environm Sci, Newark, DE USA.
   [Patlewicz, Grace] US EPA, NCCT, Res Triangle Pk, NC 27711 USA.
RP Worth, AP (reprint author), European Commiss, Joint Res Ctr, Ispra, Italy.
EM andrew.worth@ec.europa.eu
RI Worth, Andrew/R-8495-2019; Worth, Andrew Paul/O-3055-2019
OI Worth, Andrew Paul/0000-0002-5303-0452; Patlewicz,
   Grace/0000-0003-3863-9689
CR Ahlers J, 2008, ENVIRON SCI POLLUT R, V15, P565, DOI 10.1007/s11356-008-0043-y
   [Anonymous], 2012, OECD SER TEST ASS, V168
   Antunovic B, 2012, EFSA J, V10, DOI 10.2903/j.efsa.2012.2750
   Aptula AO, 2006, TOXICOL IN VITRO, V20, P239, DOI 10.1016/j.tiv.2005.07.003
   Aptula AO, 2006, CHEM RES TOXICOL, V19, P1097, DOI 10.1021/tx0601004
   Becker RA, 2014, 53 ANN M SOC TOX 23
   Bhattacharya S, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00462
   Blaauboer BJ, 2010, J TOXICOL ENV HEAL B, V13, P242, DOI 10.1080/10937404.2010.483940
   Blaauboer BJ, 1999, ATLA-ALTERN LAB ANIM, V27, P229, DOI 10.1177/026119299902700211
   BLAAUBOER BJ, 1994, TOXICOL IN VITRO, V8, P845, DOI 10.1016/0887-2333(94)90083-3
   Buist H, 2013, REGUL TOXICOL PHARM, V67, P170, DOI 10.1016/j.yrtph.2013.01.002
   Clemedson C, 2007, ATLA-ALTERN LAB ANIM, V35, P33, DOI 10.1177/026119290703500102
   Council of Canadian Academies, 2012, INT EM TECHN CHEM SA
   Cox LA, 2014, REGUL TOXICOL PHARM, V69, P443, DOI 10.1016/j.yrtph.2014.05.010
   CRAMER GM, 1978, FOOD COSMET TOXICOL, V16, P255, DOI 10.1016/S0015-6264(76)80522-6
   De Wever B, 2012, TOXICOL IN VITRO, V26, P526, DOI 10.1016/j.tiv.2012.01.009
   DeJongh J, 1999, TOXICOL IN VITRO, V13, P549, DOI 10.1016/S0887-2333(99)00030-2
   Dewhurst I, 2013, REGUL TOXICOL PHARM, V65, P168, DOI 10.1016/j.yrtph.2012.03.007
   ECHA, 2012, GUID INF REQ CHEM SA
   Emter R, 2010, TOXICOL APPL PHARM, V245, P281, DOI 10.1016/j.taap.2010.03.009
   Gabbert S, 2013, HUM ECOL RISK ASSESS, V19, P1067, DOI 10.1080/10807039.2012.685810
   Gabbert S, 2010, HUM ECOL RISK ASSESS, V16, P603, DOI 10.1080/10807031003788840
   Gajewska M, 2014, TOXICOL LETT, V227, P189, DOI 10.1016/j.toxlet.2014.03.013
   Gerberick GF, 2007, TOXICOL SCI, V97, P417, DOI 10.1093/toxsci/kfm064
   Gerberick GF, 2004, TOXICOL SCI, V81, P332, DOI 10.1093/toxsci/kfh213
   Grindon C, 2008, ATLA-ALTERN LAB ANIM, V36, P7, DOI 10.1177/026119290803601s03
   Hartung T, 2013, ALTEX-ALTERN ANIM EX, V30, P3, DOI 10.14573/altex.2013.1.003
   Hennes EC, 2012, TOXICOL LETT, V211, P296, DOI 10.1016/j.toxlet.2012.03.795
   Hoffmann S, 2010, REGUL TOXICOL PHARM, V58, P395, DOI 10.1016/j.yrtph.2010.08.004
   IOM (Institute of Medicine), 2010, EV BIOM SURR ENDP CH
   Jaworska J, 2013, J APPL TOXICOL, V33, P1353, DOI 10.1002/jat.2869
   Jaworska Joanna, 2010, ALTEX, V27, P231
   Jaworska J, 2010, REGUL TOXICOL PHARM, V57, P157, DOI 10.1016/j.yrtph.2010.02.003
   Kalkhof H, 2012, ARCH TOXICOL, V86, P17, DOI 10.1007/s00204-011-0732-z
   Kinsner-Ovaskainen A, 2012, ATLA-ALTERN LAB ANIM, V40, P175, DOI 10.1177/026119291204000310
   Kinsner-Ovaskainen A, 2009, ATLA-ALTERN LAB ANIM, V37, P437, DOI 10.1177/026119290903700413
   Lapenna S., 2011, 24898 JRC EUR
   Marx-Stoelting P, 2009, ATLA-ALTERN LAB ANIM, V37, P313, DOI 10.1177/026119290903700314
   Maxwell G, 2014, TOXICOL IN VITRO, V28, P8, DOI 10.1016/j.tiv.2013.10.013
   Meek ME, 2014, J APPL TOXICOL, V34, P1, DOI 10.1002/jat.2949
   Munro IC, 1996, FOOD CHEM TOXICOL, V34, P829, DOI 10.1016/S0278-6915(96)00049-X
   Nel AE, 2013, ACS NANO, V7, P6422, DOI 10.1021/nn4037927
   Norlen H, 2014, ATLA-ALTERN LAB ANIM, V42, P115, DOI 10.1177/026119291404200204
   NRC (National Research Council), 2007, TOX TEST 21 CENT VIS
   Nukada Y, 2013, TOXICOL IN VITRO, V27, P609, DOI 10.1016/j.tiv.2012.11.006
   OECD, 2014, OECD SER ASS, V211, P35
   OECD, 2015, TEST GUID 442C CHEM
   OECD, 2015, TEST GUID 442D VITR
   OECD, 2014, US TOOLB AOP WORKFL
   OECD, 2015, ENVJMHA20151 OECD
   OECD, 2016, ENVJMHA201610 OECD
   OECD, 2002, TEST 404 AC DERM IRR
   OECD, 2007, ENVJMMONO20072
   Oomen AG, 2014, NANOTOXICOLOGY, V8, P334, DOI 10.3109/17435390.2013.802387
   Organisation for Economic Co-operation and Development (OECD), 2013, OECD SER TEST ASS, V184
   Patlewicz G, 2015, REGUL TOXICOL PHARM, V71, P463, DOI 10.1016/j.yrtph.2015.02.011
   Patlewicz G, 2014, REGUL TOXICOL PHARM, V69, P529, DOI 10.1016/j.yrtph.2014.06.001
   Patlewicz G, 2013, REGUL TOXICOL PHARM, V65, P259, DOI 10.1016/j.yrtph.2012.12.008
   Piersma AH, 2013, REPROD TOXICOL, V38, P53, DOI 10.1016/j.reprotox.2013.03.002
   Python F, 2007, TOXICOL APPL PHARM, V220, P113, DOI 10.1016/j.taap.2006.12.026
   Reif DM, 2010, ENVIRON HEALTH PERSP, V118, P1714, DOI 10.1289/ehp.1002180
   Roberts DW, 2008, J APPL TOXICOL, V28, P443, DOI 10.1002/jat.1293
   Roberts DW, 2014, J APPL TOXICOL, V34, P436, DOI 10.1002/jat.2943
   Roberts DW, 2009, ECOTOXICOLOGY MODELI, P61, DOI DOI 10.1007/978-1-4419-0197-2_3
   Rorije E, 2013, REGUL TOXICOL PHARM, V67, P146, DOI 10.1016/j.yrtph.2013.06.003
   Rotroff DM, 2013, ENVIRON HEALTH PERSP, V121, P7, DOI 10.1289/ehp.1205065
   Rovida C, 2007, ATLA-ALTERN LAB ANIM, V35, P317, DOI 10.1177/026119290703500311
   Rowbotham AL, 2011, FOOD CHEM TOXICOL, V49, P1661, DOI 10.1016/j.fct.2011.03.050
   Sakaguchi H, 2007, TOXICOL LETT, V172, pS93, DOI 10.1016/j.toxlet.2007.05.257
   Schaafsma G, 2009, REGUL TOXICOL PHARM, V53, P70, DOI 10.1016/j.yrtph.2008.11.003
   Schultz TW, 2005, SAR QSAR ENVIRON RES, V16, P313, DOI 10.1080/10659360500204152
   Stone V, 2014, PART FIBRE TOXICOL, V11, DOI 10.1186/1743-8977-11-9
   Thomas RS, 2013, TOXICOL SCI, V136, P4, DOI 10.1093/toxsci/kft178
   Thomas RS, 2012, TOXICOL SCI, V128, P398, DOI 10.1093/toxsci/kfs159
   Tluczkiewicz I, 2011, REGUL TOXICOL PHARM, V61, P340, DOI 10.1016/j.yrtph.2011.09.005
   Tluczkiewicz I, 2013, REGUL TOXICOL PHARM, V67, P157, DOI 10.1016/j.yrtph.2013.02.004
   Tollefsen KE, 2014, REGUL TOXICOL PHARM, V70, P629, DOI 10.1016/j.yrtph.2014.09.009
   United Nations, 2013, STSGAC1030REV4 UN
   VansLeeuwen CJ, 2007, RISK ASSESSMENT CHEM, P467
   Vermeire T, 2013, REGUL TOXICOL PHARM, V67, P136, DOI 10.1016/j.yrtph.2013.01.007
   Vermeire T, 2010, REGUL TOXICOL PHARM, V58, P408, DOI 10.1016/j.yrtph.2010.08.007
   Willett CE, 2011, TOXICOL SCI, V123, P15, DOI 10.1093/toxsci/kfr145
   Worth A. P., 2000, THESIS LIVERPOOL J M
   Worth AP, 2010, CHALL ADV COMPUT CHE, V8, P367, DOI 10.1007/978-1-4020-9783-6_13
   Worth AP, 1999, ATLA-ALTERN LAB ANIM, V27, P161, DOI 10.1177/026119299902700115
   Worth AP, 2001, ATLA-ALTERN LAB ANIM, V29, P557, DOI 10.1177/026119290102900511
   Worth AP, 2001, ATLA-ALTERN LAB ANIM, V29, P135, DOI 10.1177/026119290102900210
   Worth AP, 1998, ATLA-ALTERN LAB ANIM, V26, P709
   Worth AP, 2004, PREDICTING CHEM TOXI, P389
NR 89
TC 8
Z9 11
U1 0
U2 3
PU SPRINGER INT PUBLISHING AG
PI CHAM
PA GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND
SN 0065-2598
BN 978-3-319-33826-2; 978-3-319-33824-8
J9 ADV EXP MED BIOL
JI Adv.Exp.Med.Biol.
PY 2016
VL 856
BP 317
EP 342
DI 10.1007/978-3-319-33826-2_13
D2 10.1007/978-3-319-33826-2
PG 26
WC Medicine, Research & Experimental; Toxicology
SC Research & Experimental Medicine; Toxicology
GA BH5HH
UT WOS:000400937400015
PM 27671729
DA 2019-10-23
ER

PT J
AU Zhu, Y
   Ma, XF
   Su, GY
   Yu, LQ
   Letcher, RJ
   Hou, J
   Yu, HX
   Giesy, JP
   Liu, CS
AF Zhu, Ya
   Ma, Xufa
   Su, Guanyong
   Yu, Liqin
   Letcher, Robert J.
   Hou, Jie
   Yu, Hongxia
   Giesy, John P.
   Liu, Chunsheng
TI Environmentally Relevant Concentrations of the Flame Retardant
   Tris(1,3-dichloro-2-propyl) Phosphate Inhibit Growth of Female Zebrafish
   and Decrease Fecundity
SO ENVIRONMENTAL SCIENCE & TECHNOLOGY
LA English
DT Article
ID MESSENGER-RNA EXPRESSION; PERFORMANCE LIQUID-CHROMATOGRAPHY; CHICKEN
   EMBRYONIC HEPATOCYTES; ADVERSE OUTCOME PATHWAYS; MASS-SPECTROMETRY
   METHOD; IN-VITRO METABOLISM; ENDOCRINE DISRUPTION; TRIPHENYL PHOSPHATE;
   DANIO-RERIO; DEVELOPMENTAL EXPOSURE
AB Bioconcentrations of tris(1,3-dichloro-2-propyl) phosphate (TDCIPP) in brain, gonad, and liver as well as effects on fecundity and development of zebrafish (Danio rerio) were determined. Zebrafish (1-month old) were exposed to environmentally relevant concentrations of 29 +/- 2.1, 600 +/- 21, or 6300 +/- 130 ng TDCIPP/L. After 120 days of exposure, TDCIPP accumulated in the brain, gonad, and liver with bioconcentration factors of 460, 38, and 87 in females and 26, SS, and 110 in males, respectively. TDCIPP accumulated to a greater extent in brains of females than those of males. Exposure to 6300 +/- 130 ng TDCIPP/L resulted in significantly (P < 0.05) fewer eggs being produced, but the histology of the gonad, plasma concentrations of estradiol and 11-ketotestosterone, and expression of genes involved in hypothalamic pituitary gonadal liver axis were not significantly (P > 0.05) different between individuals exposed to TDCIPP and the unexposed control fish. Exposure to TDCIPP resulted in shorter body length, lighter body mass, and lower gonadal somatic index in females. These effects were possibly due to down-regulation of expression of genes along the growth hormone/insulin-like growth factor (GH/IGF) axis. Correlations between the production of eggs and developmental parameters or expression of genes along the GH/IGF axis further suggested that environmentally relevant concentrations of TDCIPP could have adverse effects on reproduction, possibly due to the inhibition of the growth of females.
C1 [Zhu, Ya; Ma, Xufa; Yu, Liqin; Hou, Jie; Liu, Chunsheng] Huazhong Agr Univ, Coll Fisheries, Wuhan 430070, Peoples R China.
   [Liu, Chunsheng] Hunan Agr Univ, Collaborat Innovat Ctr Efficient & Hlth Prod Fish, Changsha 410128, Hunan, Peoples R China.
   [Su, Guanyong] Nanjing Univ, Sch Environm, State Key Lab Pollut Control & Resource Reuse, Nanjing 210089, Jiangsu, Peoples R China.
   [Su, Guanyong; Letcher, Robert J.; Yu, Hongxia; Giesy, John P.] Carleton Univ, Dept Chem, Ottawa, ON K1S 5B6, Canada.
   [Giesy, John P.] Univ Saskatchewan, Dept Vet Biomed Sci, Saskatoon, SK S7N 5B3, Canada.
   [Giesy, John P.] Univ Saskatchewan, Toxicol Ctr, Saskatoon, SK S7N 5B3, Canada.
   [Giesy, John P.] Michigan State Univ, Dept Zool, E Lansing, MI 48824 USA.
   [Giesy, John P.] Michigan State Univ, Ctr Integrat Toxicol, E Lansing, MI 48824 USA.
RP Su, GY (reprint author), Nanjing Univ, Sch Environm, State Key Lab Pollut Control & Resource Reuse, Nanjing 210089, Jiangsu, Peoples R China.
EM guanyong.su85@gmail.com; liuchunshengidid@126.com
RI ZHU, YA/K-5919-2019; Su, Guanyong/A-7747-2017
OI ZHU, YA/0000-0001-8987-2048; Su, Guanyong/0000-0003-4356-5194
FU Fundamental Research Funds for the Central UniversitiesFundamental
   Research Funds for the Central Universities [2662015PY036]; National
   Natural Science Foundation of ChinaNational Natural Science Foundation
   of China [21207063, 21307162]; Huazhong Agricultural University
   Scientific & Technological Self-innovation Foundation [2014RC001];
   Environmental Monitoring Funds of Jiangsu Province [1405]; Canada
   Research Chair programCanada Research Chairs; "High Level Foreign
   Experts" program - State Administration of Foreign Experts Affairs, the
   P.R. China [GDT20143200016]; Einstein Professor Program of the Chinese
   Academy of Sciences; Natural Science and Engineering Research Council of
   CanadaNatural Sciences and Engineering Research Council of Canada
   [326415-07]; Western Economic Diversification Canada [6578, 6807,
   000012711]; Canada Foundation for Infrastructure
FX This work was supported by Fundamental Research Funds for the Central
   Universities (2662015PY036), National Natural Science Foundation of
   China (21207063 and 21307162), Huazhong Agricultural University
   Scientific & Technological Self-innovation Foundation (2014RC001), and
   Environmental Monitoring Funds of Jiangsu Province (1405). J.P.G. was
   supported by the Canada Research Chair program and as a concurrent
   professor of the University of Nanjing as well as by 2012 "High Level
   Foreign Experts" (#GDT20143200016) program, funded by the State
   Administration of Foreign Experts Affairs, the P.R. China to Nanjing
   University and the Einstein Professor Program of the Chinese Academy of
   Sciences. The research was supported by a Discovery Grant from the
   Natural Science and Engineering Research Council of Canada (Project #
   326415-07) and a grant from the Western Economic Diversification Canada
   (Project # 6578, 6807, and 000012711). The authors wish to acknowledge
   the support of an instrumentation grant from the Canada Foundation for
   Infrastructure.
CR Andresen JA, 2004, SCI TOTAL ENVIRON, V332, P155, DOI 10.1016/j.scitotenv.2004.04.021
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Bacaloni A, 2007, RAPID COMMUN MASS SP, V21, P1123, DOI 10.1002/rcm.2937
   Burger J, 2007, ENVIRON RES, V104, P135, DOI 10.1016/j.envres.2006.08.002
   Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797
   Cao SX, 2012, ENVIRON TOXICOL CHEM, V31, P1478, DOI 10.1002/etc.1872
   Carignan CC, 2013, ENVIRON INT, V55, P56, DOI 10.1016/j.envint.2013.02.004
   Ceresana, 2015, MARK STUD FLAM RET
   Chen D, 2012, J CHROMATOGR A, V1220, P169, DOI 10.1016/j.chroma.2011.11.046
   Chu SG, 2015, ANAL CHIM ACTA, V885, P183, DOI 10.1016/j.aca.2015.05.024
   Crump D, 2012, TOXICOL SCI, V126, P140, DOI 10.1093/toxsci/kfs015
   Cyr DG, 1996, REV FISH BIOL FISHER, V6, P165
   Dang Y, 2015, AQUAT TOXICOL, V160, P69, DOI 10.1016/j.aquatox.2015.01.003
   Dishaw LV, 2014, TOXICOL SCI, V142, P445, DOI 10.1093/toxsci/kfu194
   Dishaw LV, 2011, TOXICOL APPL PHARM, V256, P281, DOI 10.1016/j.taap.2011.01.005
   Farhat A, 2014, ENVIRON TOXICOL CHEM, V33, P2842, DOI 10.1002/etc.2755
   Farhat A, 2014, TOXICOL APPL PHARM, V275, P104, DOI 10.1016/j.taap.2013.12.020
   Farhat A, 2013, TOXICOL SCI, V134, P92, DOI 10.1093/toxsci/kft100
   Fu J, 2013, ENVIRON SCI TECHNOL, V47, P10574, DOI 10.1021/es401265q
   Garcia-Reyero N, 2015, ENVIRON SCI TECHNOL, V49, P3, DOI 10.1021/es504976d
   Greaves AK, 2014, ENVIRON SCI TECHNOL, V48, P7942, DOI 10.1021/es501334w
   Han XB, 2013, ENVIRON POLLUT, V182, P120, DOI 10.1016/j.envpol.2013.06.045
   Hartmann PC, 2004, CHEMOSPHERE, V57, P781, DOI 10.1016/j.chemosphere.2004.08.051
   Hu MY, 2014, MAR POLLUT BULL, V86, P569, DOI 10.1016/j.marpolbul.2014.06.009
   Hutchinson TH, 2006, ENVIRON HEALTH PERSP, V114, P106, DOI 10.1289/ehp.8062
   Kojima H, 2013, TOXICOLOGY, V314, P76, DOI [10.1016/j.cox.2013.09.004, 10.1016/j.tox.2013.09.004]
   Li J, 2015, SCI REP-UK, V5, DOI 10.1038/srep10562
   Lij H, 2015, ENVIRON SCI TECHNOL, V49, P12975, DOI 10.1021/acs.est.5b03294
   Liu CS, 2013, AQUAT TOXICOL, V128, P147, DOI 10.1016/j.aquatox.2012.12.010
   Liu CS, 2010, AQUAT TOXICOL, V96, P70, DOI 10.1016/j.aquatox.2009.09.012
   Liu X, 2013, AQUAT TOXICOL, V134, P104, DOI 10.1016/j.aquatox.2013.03.013
   Liu X, 2012, AQUAT TOXICOL, V114, P173, DOI 10.1016/j.aquatox.2012.02.019
   Ma YQ, 2013, ANAL CHIM ACTA, V786, P47, DOI 10.1016/j.aca.2013.04.062
   Marklund A, 2005, J ENVIRON MONITOR, V7, P814, DOI 10.1039/b505587c
   Mcgee SP, 2012, ENVIRON HEALTH PERSP, V120, P1585, DOI 10.1289/ehp.1205316
   Meeker JD, 2013, ENVIRON HEALTH PERSP, V121, P580, DOI 10.1289/ehp.1205907
   NRC, 2007, VIS STRAT
   Reinecke M, 2005, GEN COMP ENDOCR, V142, P20, DOI 10.1016/j.ygcen.2005.01.016
   Reinecke M, 2010, BIOL REPROD, V82, P656, DOI 10.1095/biolreprod.109.080093
   Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73
   Stackelberg PE, 2006, SCI TOTAL ENVIRON, V354, P93, DOI 10.1016/j.scitotenv.2005.04.012
   Su GY, 2015, ENVIRON SCI TECH LET, V2, P100, DOI 10.1021/acs.estlett.5b00041
   Su G, 2014, J CHROMATOGR A, V1374, P85, DOI 10.1016/j.chroma.2014.11.022
   Su GY, 2014, ENVIRON SCI TECHNOL, V48, P13511, DOI 10.1021/es5039547
   Sundkvist AM, 2010, J ENVIRON MONITOR, V12, P943, DOI 10.1039/b921910b
   Ta N, 2014, TOXICOL LETT, V227, P164, DOI 10.1016/j.toxlet.2014.03.023
   Van den Eede N, 2013, TOXICOL LETT, V223, P9, DOI 10.1016/j.toxlet.2013.08.012
   van der Veen I, 2012, CHEMOSPHERE, V88, P1119, DOI 10.1016/j.chemosphere.2012.03.067
   Villeneuve DL, 2014, TOXICOL SCI, V142, P312, DOI 10.1093/toxsci/kfu199
   Villeneuve DL, 2014, TOXICOL SCI, V142, P321, DOI 10.1093/toxsci/kfu200
   Wang QW, 2015, ENVIRON SCI TECHNOL, V49, P5123, DOI 10.1021/acs.est.5b00558
   Wang QW, 2015, AQUAT TOXICOL, V160, P163, DOI 10.1016/j.aquatox.2015.01.014
   Wang QW, 2015, AQUAT TOXICOL, V158, P108, DOI 10.1016/j.aquatox.2014.11.001
   Wang QW, 2013, AQUAT TOXICOL, V126, P207, DOI 10.1016/j.aquatox.2012.11.009
   Wang XW, 2011, J CHROMATOGR A, V1218, P6705, DOI 10.1016/j.chroma.2011.07.067
   Yu LQ, 2014, ENVIRON TOXICOL CHEM, V33, P1354, DOI 10.1002/etc.2562
   Zhang Q, 2014, ENVIRON SCI TECHNOL, V48, P6995, DOI 10.1021/es5007862
NR 57
TC 32
Z9 33
U1 12
U2 111
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0013-936X
EI 1520-5851
J9 ENVIRON SCI TECHNOL
JI Environ. Sci. Technol.
PD DEC 15
PY 2015
VL 49
IS 24
BP 14579
EP 14587
DI 10.1021/acs.est.5b03849
PG 9
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA CZ1NK
UT WOS:000366872300081
PM 26512412
DA 2019-10-23
ER

PT J
AU Cavallin, JE
   Schroeder, AL
   Jensen, KM
   Villeneuve, DL
   Blackwell, BR
   Carlson, K
   Kahl, MD
   LaLone, CA
   Randolph, EC
   Ankley, GT
AF Cavallin, J. E.
   Schroeder, A. L.
   Jensen, K. M.
   Villeneuve, D. L.
   Blackwell, B. R.
   Carlson, K.
   Kahl, M. D.
   LaLone, C. A.
   Randolph, E. C.
   Ankley, G. T.
TI Evaluation of whole-mount in situ hybridization as a tool for
   pathway-based toxicological research with early-life stage fathead
   minnows
SO AQUATIC TOXICOLOGY
LA English
DT Article
DE Development; Adverse outcome pathway; Fathead minnow; Endocrine
   disruption
ID ADVERSE OUTCOME PATHWAYS; WATER TREATMENT PLANTS; EARLY FISH
   DEVELOPMENT; PIMEPHALES-PROMELAS; GENE-EXPRESSION; WASTE-WATER;
   CONCEPTUAL-FRAMEWORK; ZEBRAFISH; ESTROGENS; 17-ALPHA-ETHYNYLESTRADIOL
AB Early-life stage fish can be more sensitive to toxicants than adults, so delineating mechanisms of perturbation of biological pathways by chemicals during this life stage is crucial. Whole-mount in situ hybridization (WISH) paired with quantitative real-time polymerase chain reaction (QPCR) assays can enhance pathway-based analyses through determination of specific tissues where changes in gene expression are occurring. While WISH has frequently been used in zebrafish (Danio rerio), this technology has not previously been applied to fathead minnows (Pimephales promelas), another well-established small fish model species. The objective of the present study was to adapt WISH to fathead minnow embryos and larvae, and use the approach to evaluate the effects of estrone, an environmentally-relevant estrogen receptor (ER) agonist. Embryos were exposed via the water to 0, 18 or 1800 ng estrone/L (0, 0.067 and 6.7 nM) for 3 or 6 days in a solvent-free, flow-through test system. Relative transcript abundance of three estrogen-responsive genes, estrogen receptor-alpha (esr1), cytochrome P450-aromatase B (cyp19b), and vitellogenin (vtg) was examined in pooled whole embryos using QPCR, and the spatial distribution of up-regulated gene transcripts was examined in individual fish using WISH. After 3 days of exposure to 1800 ng estrone/L, esr1 and cyp19b were significantly up-regulated, while vtg mRNA expression was not affected. After 6 days of exposure to 1800 ng estrone/L, transcripts for all three genes were significantly up-regulated. Corresponding WISH assays revealed spatial distribution of esr1 and vtg in the liver region, an observation consistent with activation of the hepatic ER. This study clearly demonstrates the potential utility of WISH, in conjunction with QPCR, to examine the mechanistic basis of the effects of toxicants on early-life stage fathead minnows. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Cavallin, J. E.] Univ Minnesota, Integrated Biosci Grad Program, Duluth, MN 55812 USA.
   [Schroeder, A. L.] Univ Minnesota, Water Resources Ctr, US EPA, Midcontinent Ecol Div,Off Res & Dev,Natl Hlth & E, Duluth, MN 55804 USA.
   [Jensen, K. M.; Villeneuve, D. L.; Kahl, M. D.; LaLone, C. A.; Randolph, E. C.; Ankley, G. T.] US EPA, Off Res & Dev, Natl Hlth & Environm Effects Res Lab, Midcontinent Ecol Div, Duluth, MN 55804 USA.
   [Blackwell, B. R.] US EPA, ORISE Res Participat Program, Off Res & Dev, Natl Hlth & Environm Effects Res Lab,Midcontinent, Duluth, MN 55804 USA.
   [Carlson, K.] Univ St Thomas, Dept Biol, St Paul, MN 55105 USA.
RP Cavallin, JE (reprint author), Univ Minnesota, Integrated Biosci Grad Program, 1035 Univ Dr, Duluth, MN 55812 USA.
EM cavallin.jenna@epa.gov
OI Blackwell, Brett/0000-0003-1296-4539
FU University of Minnesota-U.S. Environmental Protection Agency Cooperative
   Training Partnership
FX We thank Krysta Nelson (EPA), Joe Korte (EPA), Kevin Lott (Badger
   Technical Services), and Dalma Martinovic-Weigelt (University of St.
   Thomas) for additional technical support and assistance. We also thank
   Jon Haselman for reviewing an earlier draft of this manuscript. J.
   Cavallin was supported in part by the University of Minnesota-U.S.
   Environmental Protection Agency Cooperative Training Partnership. This
   article has been reviewed in accordance with official U.S. EPA policy.
   Mention of products or trade names does not indicate endorsement or
   recommendation for use. Conclusions drawn in this study neither
   constitute nor reflect the view or policies of the U.S. EPA.
CR Ankley GT, 2006, AQUAT TOXICOL, V78, P91, DOI 10.1016/j.aquatox.2006.01.018
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Ankley GT, 2004, ILAR J, V45, P469, DOI 10.1093/ilar.45.4.469
   Ankley GT, 2001, ENVIRON TOXICOL CHEM, V20, P1276, DOI 10.1002/etc.5620200616
   Belfroid AC, 1999, SCI TOTAL ENVIRON, V225, P101, DOI 10.1016/S0048-9697(98)00336-2
   Burns F., 2015, ENV TOXICOL IN PRESS, DOI 10.1002/etc.3186
   Callard GV, 2001, J STEROID BIOCHEM, V79, P305, DOI 10.1016/S0960-0760(01)00147-9
   Carlson KM, 2009, J NEUROGENET, V23, P313, DOI 10.1080/01677060802399976
   Cavallin J. E., 2015, ENV TOXICOL IN PRESS, DOI [10.1002/etc3228, DOI 10.1002/ETC3228]
   Dong W, 2013, AQUAT TOXICOL, V132, P190, DOI 10.1016/j.aquatox.2013.02.008
   Filby AL, 2007, ENVIRON SCI TECHNOL, V41, P8187, DOI 10.1021/es071278v
   Flick RW, 2014, AQUAT TOXICOL, V152, P353, DOI 10.1016/j.aquatox.2014.04.026
   Jensen KM, 2001, COMP BIOCHEM PHYS C, V128, P127, DOI 10.1016/S1532-0456(00)00185-X
   Johns SM, 2011, ENVIRON TOXICOL, V26, P195, DOI 10.1002/tox.20545
   Jowett T, 2001, METHODS, V23, P345, DOI 10.1006/meth.2000.1147
   Leet JK, 2013, SEX DEV, V7, P303, DOI 10.1159/000353877
   Leet JK, 2011, J APPL TOXICOL, V31, P379, DOI 10.1002/jat.1682
   MCKIM JM, 1977, J FISH RES BOARD CAN, V34, P1148, DOI 10.1139/f77-172
   Miege C, 2009, ENVIRON POLLUT, V157, P1721, DOI 10.1016/j.envpol.2008.11.045
   Palevitch O, 2007, CELL TISSUE RES, V327, P313, DOI 10.1007/s00441-006-0279-0
   PUSCHEL AW, 1992, DEVELOPMENT, V114, P643
   Servos MR, 2005, SCI TOTAL ENVIRON, V336, P155, DOI 10.1016/j.scitotenv.2004.05.025
   SUMPTER JP, 1995, ENVIRON HEALTH PERSP, V103, P173, DOI 10.2307/3432529
   Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514
   United States Environmental Protection Agency, 1996, PREV PEST TOX SUBST
   US Environmental Protection Agency, 1996, EPA600R96079
   van Aerle R, 2002, ECOTOXICOLOGY, V11, P423, DOI 10.1023/A:1021053217513
   Van den Belt K, 2004, AQUAT TOXICOL, V66, P183, DOI 10.1016/j.aquatox.2003.09.004
   Villeneuve D, 2014, ENVIRON TOXICOL CHEM, V33, P158, DOI 10.1002/etc.2403
   Villeneuve DL, 2007, TOXICOL SCI, V98, P395, DOI 10.1093/toxsci/kfm124
   Villeneuve DL, 2006, AQUAT TOXICOL, V76, P353, DOI 10.1016/j.aquatox.2005.10.016
   Volz DC, 2011, TOXICOL SCI, V123, P349, DOI 10.1093/toxsci/kfr185
   Wehmas LC, 2011, ENVIRON TOXICOL CHEM, V30, P439, DOI 10.1002/etc.388
   Yang H, 1999, J HISTOCHEM CYTOCHEM, V47, P431, DOI 10.1177/002215549904700402
NR 34
TC 6
Z9 6
U1 1
U2 19
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-445X
EI 1879-1514
J9 AQUAT TOXICOL
JI Aquat. Toxicol.
PD DEC
PY 2015
VL 169
BP 19
EP 26
DI 10.1016/j.aquatox.2015.10.002
PG 8
WC Marine & Freshwater Biology; Toxicology
SC Marine & Freshwater Biology; Toxicology
GA CZ3TV
UT WOS:000367027800003
PM 26485527
DA 2019-10-23
ER

PT J
AU Kodavanti, PRS
   Joyce, ER
   Moore-Smith, DA
   Besas, J
   Richards, JE
   Beasley, TE
   Evansky, P
   Bushnell, PJ
AF Kodavanti, Prasada Rao S.
   Royland, Joyce E.
   Moore-Smith, Debra A.
   Besas, Jonathan
   Richards, Judy E.
   Beasley, Tracey E.
   Evansky, Paul
   Bushnell, Philip J.
TI Acute and subchronic toxicity of inhaled toluene in male Long-Evans
   rats: Oxidative stress markers in brain
SO NEUROTOXICOLOGY
LA English
DT Article
DE Toluene; Oxidative stress; Solvents; Antioxidants; Protein carbonyls;
   Aconitase; Neurotoxicity
ID CENTRAL-NERVOUS-SYSTEM; NAD(P)H-QUINONE OXIDOREDUCTASE 1; ADULT RATS;
   LIPID-PEROXIDATION; MITOCHONDRIAL-DNA; ACUTE EXPOSURE; PPM TOLUENE;
   COMPLEX-I; ANTIOXIDANT; INHALATION
AB The effects of exposure to volatile organic compounds (VOCs), which are of concern to the EPA, are poorly understood, in part because of insufficient characterization of how human exposure duration impacts VOC effects. Two inhalation studies with multiple endpoints, one acute and one subchronic, were conducted to seek effects of the VOC, toluene, in rats and to compare the effects between acute and subchronic exposures. Adult male Long-Evans rats were exposed to toluene vapor (n = 6 per group) at a concentration of 0 or 1019 +/- 14 ppm for 6 h in the acute study and at 0 +/- 0, 10 +/- 1.4, 97 +/- 7, or 995 +/- 43 ppm for 6 h/d, 5 d/week for 13 weeks in the subchronic study. For the acute study, brains were dissected on ice within 30 min of the end of exposure, while for the subchronic study, brains were dissected 18 h after the last exposure. Frontal cortex, hippocampus, cerebellum, and striatum were assayed for a variety of oxidative stress (OS) parameters including total aconitase (TA), protein carbonyls, glutathione peroxidase (GPX), glutathione reductase (GRD), glutathione transferase (GST), gamma-glutamylcysteine synthetase (GCS), superoxide dismutase (SOD), total antioxidants (TAS), NADPH quinone oxidoreductase-1 (NQO1), and NADH ubiquinone reductase (UBIQ-RD) activities using commercially available kits. Following acute exposure, UBIQ-RD, GCS and GRD were increased significantly only in the cerebellum, while TAS was increased in frontal cortex. On the other hand, subchronic exposure affected several OS markers including increases in NQO1 and UBIQ-RD. The effect of subchronic toluene exposure on SOD and TAS was greater in the striatum than in the other brain regions. TA activity (involved in maintaining iron homeostasis and an indicator of DNA damage) was inhibited in striatum and cerebellum, increased in hippocampus, and unchanged in frontal cortex. Protein carbonyls increased significantly in both the frontal cortex and cerebellum. In general, the results showed that acute exposure to toluene affected OS parameters to a lesser extent than did subchronic exposure. These results suggest that toluene exposure induces OS in the brain and this may be a component of an adverse outcome pathway for some of the neurotoxic effects reported following toluene exposure. Published by Elsevier Inc.
C1 [Kodavanti, Prasada Rao S.; Moore-Smith, Debra A.; Besas, Jonathan; Beasley, Tracey E.; Bushnell, Philip J.] US EPA, ORD, NHEERL, Neurotoxicol Branch, Res Triangle Pk, NC 27711 USA.
   [Royland, Joyce E.] US EPA, ORD, NHEERL, Genet & Cellular Toxicol Branch, Res Triangle Pk, NC 27711 USA.
   [Richards, Judy E.] US EPA, ORD, NHEERL, Cardiopulm & Immunotoxicol Branch, Res Triangle Pk, NC 27711 USA.
   [Evansky, Paul] US EPA, ORD, NHEERL, Inhalat Toxicol Facil, Res Triangle Pk, NC 27711 USA.
RP Kodavanti, PRS (reprint author), US EPA, NHEERL ORD, Tox Assessment Div, Neurotoxicol Branch, B 105-04,109 TW Alexander Dr, Res Triangle Pk, NC 27711 USA.
EM kodavanti.prasada@epa.gov
CR Agency for Toxic Substances Disease Registry (ATSDR), 1994, TOX PROF TOL UPD
   Aydin K, 2009, AM J NEURORADIOL, V30, P1922, DOI 10.3174/ajnr.A1728
   Back SH, 2009, CELL METAB, V10, P13, DOI 10.1016/j.cmet.2009.06.002
   Bale AS, 2002, BRIT J PHARMACOL, V137, P375, DOI 10.1038/sj.bjp.0704874
   Baydas G, 2005, EUR J PHARMACOL, V512, P181, DOI 10.1016/j.ejphar.2005.02.038
   Beasley TE, 2010, NEUROTOXICOL TERATOL, V32, P611, DOI 10.1016/j.ntt.2010.05.005
   Beckstead MJ, 2001, J BIOL CHEM, V276, P24959, DOI 10.1074/jbc.M011627200
   Bello RI, 2001, J BIOL CHEM, V276, P44379, DOI 10.1074/jbc.M107168200
   Benignus VA, 2009, TOXICOL SCI, V109, P296, DOI 10.1093/toxsci/kfp063
   Berenguer P, 2003, PHARMACOL BIOCHEM BE, V74, P997, DOI 10.1016/S0091-3057(03)00027-3
   Bondy S.C, 1994, PRINCIPLES NEUROTOXI, P563
   BONDY SC, 1995, ARCH TOXICOL, V69, P410, DOI 10.1007/s002040050192
   Boyes WK, 2007, TOXICOL SCI, V99, P572, DOI 10.1093/toxsci/kfm172
   Bushnell PJ, 2007, TOXICOL SCI, V99, P181, DOI 10.1093/toxsci/kfm146
   Chen XJ, 2005, SCIENCE, V307, P714, DOI 10.1126/science.1106391
   Cormier A, 2001, BRAIN RES, V900, P72, DOI 10.1016/S0006-8993(01)02254-5
   Cruz SL, 2000, BRIT J PHARMACOL, V131, P1303, DOI 10.1038/sj.bjp.0703666
   Deleu D, 2000, J TOXICOL-CLIN TOXIC, V38, P37, DOI 10.1081/CLT-100100913
   ECHEVERRIA D, 1991, BRIT J IND MED, V48, P750
   EPA, 1994, 749F94021A EPA
   Fariss MW, 2005, MOL INTERV, V5, P94, DOI 10.1124/mi.5.2.7
   Filley CM, 2004, J NEUROPATH EXP NEUR, V63, P1
   FORNAZZARI L, 1983, ACTA NEUROL SCAND, V67, P319
   Friguet B, 2000, ANN NY ACAD SCI, V908, P143
   GLOWINSKI J, 1966, J NEUROCHEM, V13, P655, DOI 10.1111/j.1471-4159.1966.tb09873.x
   Gordon CJ, 2010, J TOXICOL ENV HEAL A, V73, P301, DOI 10.1080/15287390903421144
   Greenberg MM, 1997, ENVIRON RES, V72, P1, DOI 10.1006/enrs.1996.3686
   Halifeoglu I, 2000, CELL BIOCHEM FUNCT, V18, P263, DOI 10.1002/1099-0844(200012)18:4<263::AID-CBF882>3.0.CO;2-1
   HALLIWELL B, 1995, BIOCHEM PHARMACOL, V49, P1341, DOI 10.1016/0006-2952(95)00088-H
   Hayashi T, 2003, J CEREBR BLOOD F MET, V23, P1117, DOI 10.1097/01.WCB.0000089600.87125.AD
   Hester SD, 2012, NEUROTOXICOL TERATOL, V34, P530, DOI 10.1016/j.ntt.2012.08.004
   Hester SD, 2011, NEUROTOXICOL TERATOL, V33, P521, DOI 10.1016/j.ntt.2011.07.008
   Huerta-Rivas A, 2012, PHARMACOL BIOCHEM BE, V102, P48, DOI 10.1016/j.pbb.2012.03.018
   JASKOT RH, 1983, J ANAL TOXICOL, V7, P86, DOI 10.1093/jat/7.2.86
   Kamran S, 1998, NEURORADIOLOGY, V40, P519, DOI 10.1007/s002340050637
   Kenyon EM, 2008, J TOXICOL ENV HEAL A, V71, P249, DOI 10.1080/15287390701528363
   Kobald SO, 2015, NEUROTOXICOLOGY, V48, P50, DOI 10.1016/j.neuro.2015.03.005
   Kodavanti P.R.S., 1999, NEUROTOXICOLOGY, P157
   Kodavanti PRS, 2011, TOXICOL APPL PHARM, V256, P386, DOI 10.1016/j.taap.2011.04.012
   LIND C, 1990, METHOD ENZYMOL, V186, P287
   LOW LK, 1988, TOXICOL IND HEALTH, V4, P49
   MATTIA CJ, 1993, MOL CHEM NEUROPATHOL, V18, P313, DOI 10.1007/BF03160122
   MATTIA CJ, 1993, BIOCHEM PHARMACOL, V46, P103, DOI 10.1016/0006-2952(93)90353-X
   Meulenberg CJW, 2003, TOXICOLOGY, V190, P243, DOI 10.1016/S0300-483X(03)00190-2
   MILLER NJ, 1993, CLIN SCI, V84, P407, DOI 10.1042/cs0840407
   Myhre O, 2004, TOXICOL SCI, V80, P296, DOI 10.1093/toxsci/kfh166
   O'Leary-Moore SK, 2009, NEUROTOXICOL TERATOL, V31, P382, DOI 10.1016/j.ntt.2009.07.005
   Oshiro WM, 2011, TOXICOL SCI, V123, P180, DOI 10.1093/toxsci/kfr162
   PRYOR GT, 1995, HDB NEUROTOXICOLOGY, P377
   Raina AK, 1999, REDOX REP, V4, P23, DOI 10.1179/135100099101534701
   Riegel AC, 2004, ANN NY ACAD SCI, V1025, P543, DOI 10.1196/annals.1316.079
   RITOV VB, 1995, ARCH BIOCHEM BIOPHYS, V321, P140, DOI 10.1006/abbi.1995.1379
   Rosenberg NL, 2002, J TOXICOL-CLIN TOXIC, V40, P21, DOI 10.1081/CLT-120002883
   Schapira AHV, 1998, BBA-BIOENERGETICS, V1364, P261, DOI 10.1016/S0005-2728(98)00032-2
   SEELIG GF, 1984, J BIOL CHEM, V259, P3534
   Shadel GS, 2005, TRENDS BIOCHEM SCI, V30, P294, DOI 10.1016/j.tibs.2005.04.007
   Sieger D, 2000, FREE RADICAL BIO MED, V29, P246, DOI 10.1016/S0891-5849(00)00310-5
   STADTMAN ER, 1992, SCIENCE, V257, P1220, DOI 10.1126/science.1355616
   van Muiswinkel FL, 2004, NEUROBIOL AGING, V25, P1253, DOI 10.1016/j.neurobiolaging.2003.12.010
   Von Euler G., 1994, TOXINS AIR WATER, V3, P301
   von Euler M, 2000, EXP NEUROL, V163, P1, DOI 10.1006/exnr.1999.7288
   VONEULER G, 1993, TOXICOLOGY, V77, P223, DOI 10.1016/0300-483X(93)90162-L
   WANG JD, 1993, ENVIRON RES, V61, P107, DOI 10.1006/enrs.1993.1054
   WEISS H, 1991, EUR J BIOCHEM, V197, P563, DOI 10.1111/j.1432-1033.1991.tb15945.x
   Win-Shwe TT, 2012, J APPL TOXICOL, V32, P126, DOI 10.1002/jat.1643
   Win-Shwe TT, 2010, TOXICOL LETT, V198, P93, DOI 10.1016/j.toxlet.2010.06.022
   Zhvania MG, 2012, BRAIN RES BULL, V87, P187, DOI 10.1016/j.brainresbull.2011.10.021
NR 67
TC 8
Z9 8
U1 1
U2 23
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0161-813X
EI 1872-9711
J9 NEUROTOXICOLOGY
JI Neurotoxicology
PD DEC
PY 2015
VL 51
BP 10
EP 19
DI 10.1016/j.neuro.2015.09.001
PG 10
WC Neurosciences; Pharmacology & Pharmacy; Toxicology
SC Neurosciences & Neurology; Pharmacology & Pharmacy; Toxicology
GA CZ2SC
UT WOS:000366953900002
PM 26343380
DA 2019-10-23
ER

PT J
AU Downes, N
   Foster, J
AF Downes, Noel
   Foster, John
TI Regulatory Forum Opinion Piece: Carcinogen Risk Assessment: The Move
   from Screens to Science
SO TOXICOLOGIC PATHOLOGY
LA English
DT Article
DE cancer; bioassays; transgenic animals; human relevance; mouse; rodent
   bioassay
ID NATIONAL-TOXICOLOGY-PROGRAM; HISTORICAL CONTROL DATA; POTENCY-DATABASE
   CPDB; GENERAL LITERATURE; SAFETY ASSESSMENT; CHRONIC TOXICITY; RODENT
   BIOASSAY; CANCER HAZARDS; LONG-TERM; LIFE-SPAN
AB Throughout the last 50 years, the paradigm for carcinogenicity assessment has depended on lifetime bioassays in rodents. Since 1997, the International Conference on Harmonisation (ICH) S1B has permitted the use of a 2-year rodent bioassay (usually in the rat) and an alternative, genetically modified mouse model to support cancer risk assessment of pharmaceuticals. Since its introduction, it has become apparent that many of the stated advantages of the 6-month Tg mouse bioassay have, in actual fact, not been realized, and the concern exists that an albeit imperfect, 2-year mouse bioassay has been replaced by a similarly imperfect 6-month equivalent. This essay argues strongly that model systems, using cancer as the end point, should be discontinued, and that the recent initiatives, from the Organization for Economic Cooperation and Development and Institute of Peace and Conflict Studies, on mode of action, adverse outcome pathways, and human relevance framework should be embraced as being risk assessments based upon the available science. The recent suggested revisions to the ICH S1 guidelines, utilizing carcinogenicity assessment documents, go some way to developing a science-based risk assessment that does not depend almost entirely on a single, imperfect, cancer-based end point in nonrelevant animal species.
C1 [Downes, Noel] Sequani Ltd, Ledbury HR8 1LH, Hereford, England.
RP Downes, N (reprint author), Sequani Ltd, Bromyard Rd, Ledbury HR8 1LH, Hereford, England.
EM noel.downes@sequani.com
CR Agrawal AK, 2005, FASEB J, V19, P470, DOI 10.1096/fj.04-2550fje
   Alden CL, 2011, VET PATHOL, V48, P772, DOI 10.1177/0300985811400445
   Alden CL, 1996, TOXICOL PATHOL, V24, P722, DOI 10.1177/019262339602400610
   Andersen ME, 2009, TOXICOL SCI, V107, P324, DOI 10.1093/toxsci/kfn255
   APOSTOLOU A, 1990, REGUL TOXICOL PHARM, V11, P68, DOI 10.1016/0273-2300(90)90008-Y
   Boobis AR, 2006, CRIT REV TOXICOL, V36, P781, DOI 10.1080/10408440600977677
   BOS JL, 1989, CANCER RES, V49, P4682
   BOX GEP, 1975, J AM STAT ASSOC, V70, P70, DOI 10.2307/2285379
   Carmichael NG, 1997, ENVIRON HEALTH PERSP, V105, P1196, DOI 10.1289/ehp.971051196
   CARR CJ, 1991, REGUL TOXICOL PHARM, V14, P78, DOI 10.1016/0273-2300(91)90053-X
   Cohen SM, 2001, TOXICOL SCI, V64, P14, DOI 10.1093/toxsci/64.1.14
   Deschl U, 2002, TOXICOL PATHOL, V30, P80, DOI 10.1080/01926230252824743
   Doe JE, 2006, CRIT REV TOXICOL, V36, P37, DOI 10.1080/10408440531370
   Dolinoy DC, 2007, P NATL ACAD SCI USA, V104, P13056, DOI 10.1073/pnas.0703739104
   Ennever FK, 2003, REGUL TOXICOL PHARM, V38, P52, DOI 10.1016/S0273-2300(03)00068-0
   Flammang TJ, 1997, REGUL TOXICOL PHARM, V26, P230, DOI 10.1006/rtph.1997.1125
   Food and Drug Administration, 2008, GUID IND SIC R2 DOS
   Friedrich A, 2011, REGUL TOXICOL PHARM, V60, P225, DOI 10.1016/j.yrtph.2011.04.001
   Gold LS, 2005, TOXICOL SCI, V85, P747, DOI 10.1093/toxsci/kfi161
   GOLD LS, 1989, ENVIRON HEALTH PERSP, V81, P211, DOI 10.2307/3430831
   Gold LS, 1999, ENVIRON HEALTH PERSP, V107, P527
   Groh KJ, 2015, CHEMOSPHERE, V120, P764, DOI 10.1016/j.chemosphere.2014.09.068
   Hartung T, 2009, NATURE, V460, P208, DOI 10.1038/460208a
   Haseman J, 2001, FOOD CHEM TOXICOL, V39, P739, DOI 10.1016/S0278-6915(01)00010-2
   HASEMAN JK, 1992, FUND APPL TOXICOL, V19, P207, DOI 10.1016/0272-0590(92)90153-9
   Hayes AW, 2011, REGUL TOXICOL PHARM, V60, pS1, DOI 10.1016/j.yrtph.2010.10.002
   Huff J, 1999, ANN NY ACAD SCI, V895, P56, DOI 10.1111/j.1749-6632.1999.tb08077.x
   Huff J, 2008, ENVIRON HEALTH PERSP, V116, P1439, DOI 10.1289/ehp.10716
   ICH (The International Conference on Harmonisation), 1997, HARM TRIP GUID TEST
   ICH (The International Conference on Harmonisation), 2008, ICHG HARM TRIP GUID
   JACKSON RC, 1995, TOXICOLOGY, V102, P197, DOI 10.1016/0300-483X(95)03048-K
   Jacobs A, 2005, TOXICOL SCI, V88, P18, DOI 10.1093/toxsci/kfi248
   Jacobs AC, 2013, VET PATHOL, V50, P324, DOI 10.1177/0300985812450727
   Keenan C, 2009, TOXICOL PATHOL, V37, P679, DOI 10.1177/0192623309336154
   LEHMAN A J, 1949, Food Drug Cosmet Law Q, V4, P412
   Lehman A.J., 1955, FOOD DRUG COSMET LAW, V10, P679
   Li Z., 2009, BMC P 3, V3, pS2
   Lin ZW, 2012, TOXICOL SCI, V126, P114, DOI 10.1093/toxsci/kfr339
   McClain RM, 2001, TOXICOL PATHOL, V29, P128, DOI 10.1080/019262301753178537
   MCCONNELL EE, 1989, J AM COLL TOXICOL, V8, P1115, DOI 10.3109/10915818909018071
   Nambiar PR, 2012, TOXICOL PATHOL, V40, P614, DOI 10.1177/0192623311436181
   National Academy of Science, 2007, TOXICITY TESTING 21
   NEWBOLD RR, 1982, CANCER RES, V42, P2003
   Osimitz TG, 2013, FOOD CHEM TOXICOL, V60, P550, DOI 10.1016/j.fct.2013.08.020
   Prior IA, 2012, CANCER RES, V72, P2457, DOI 10.1158/0008-5472.CAN-11-2612
   Reddy MV, 2010, VET PATHOL, V47, P614, DOI 10.1177/0300985810373242
   Sistare FD, 2011, TOXICOL PATHOL, V39, P716, DOI 10.1177/0192623311406935
   Soffritti M., 2004, EUR J ONCOL, V9, P91
   Soffritti M, 2007, ENVIRON HEALTH PERSP, V115, P1293, DOI 10.1289/ehp.10271
   Sonich-Mullin C, 2001, REGUL TOXICOL PHARM, V34, P146, DOI 10.1006/rtph.2001.1493
   Sonne SB, 2008, INT J ANDROL, V31, P275, DOI 10.1111/j.1365-2605.2007.00855.x
   Swan SH, 2006, ENVIRON HEALTH PERSP, V114, pA88, DOI 10.1289/ehp.114-a88b
   Tamaoki N, 2001, TOXICOL PATHOL, V29, P81, DOI 10.1080/019262301753178492
   TOTH B, 1968, CANCER RES, V28, P727
   VanOosterhout JPJ, 1997, REGUL TOXICOL PHARM, V25, P6, DOI 10.1006/rtph.1996.1077
   Vinken M, 2013, TOXICOLOGY, V312, P158, DOI 10.1016/j.tox.2013.08.011
   Ward JM, 2007, J TOXICOL PATHOL, V20, P13, DOI DOI 10.1293/T0X.20.13
NR 57
TC 7
Z9 8
U1 0
U2 4
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0192-6233
EI 1533-1601
J9 TOXICOL PATHOL
JI Toxicol. Pathol.
PD DEC
PY 2015
VL 43
IS 8
BP 1064
EP 1073
DI 10.1177/0192623315598578
PG 10
WC Pathology; Toxicology
SC Pathology; Toxicology
GA CX5JT
UT WOS:000365738600003
PM 26296629
OA Bronze
DA 2019-10-23
ER

PT J
AU Yauk, CL
   Lambert, IB
   Meek, ME
   Douglas, GR
   Marchetti, F
AF Yauk, Carole L.
   Lambert, Iain B.
   Meek, M. E. (Bette)
   Douglas, George R.
   Marchetti, Francesco
TI Development of the adverse outcome pathway "alkylation of DNA in male
   premeiotic germ cells leading to heritable mutations" using the OECD's
   users' handbook supplement
SO ENVIRONMENTAL AND MOLECULAR MUTAGENESIS
LA English
DT Article
DE germ cell; adverse outcome pathway; alkylation; weight of evidence;
   heritable mutation
ID BASE EXCISION-REPAIR; ETHYL-N-NITROSOUREA; COPY NUMBER VARIATION;
   DE-NOVO MUTATIONS; TRANSGENIC MICE; METHYL METHANESULFONATE; LOCUS
   MUTATIONS; RISK-ASSESSMENT; ISOPROPYL METHANESULFONATE;
   IONIZING-RADIATION
AB The Organisation for Economic Cooperation and Development's (OECD) Adverse Outcome Pathway (AOP) programme aims to develop a knowledgebase of all known pathways of toxicity that lead to adverse effects in humans and ecosystems. A Users' Handbook was recently released to provide supplementary guidance on AOP development. This article describes one AOPalkylation of DNA in male premeiotic germ cells leading to heritable mutations. This outcome is an important regulatory endpoint. The AOP describes the biological plausibility and empirical evidence supporting that compounds capable of alkylating DNA cause germ cell mutations and subsequent mutations in the offspring of exposed males. Alkyl adducts are subject to DNA repair; however, at high doses the repair machinery becomes saturated. Lack of repair leads to replication of alkylated DNA and ensuing mutations in male premeiotic germ cells. Mutations that do not impair spermatogenesis persist and eventually are present in mature sperm. Thus, the mutations are transmitted to the offspring. Although there are some gaps in empirical support and evidence for essentiality of the key events for certain aspects of this AOP, the overall AOP is generally accepted as dogma and applies broadly to any species that produces sperm. The AOP was developed and used in an iterative process to test and refine the Users' Handbook, and is one of the first publicly available AOPs. It is our hope that this AOP will be leveraged to develop other AOPs in this field to advance method development, computational models to predict germ cell effects, and integrated testing strategies. Environ. Mol. Mutagen. 56:724-750, 2015. (c) 2015 Her Majesty the Queen in Right of Canada.
C1 [Yauk, Carole L.; Douglas, George R.; Marchetti, Francesco] Hlth Canada, Environm Hlth Sci & Res Bur, Ottawa, ON K1A 0L2, Canada.
   [Lambert, Iain B.] Carleton Univ, Dept Biol, Ottawa, ON K1S 5B6, Canada.
   [Meek, M. E. (Bette)] Univ Ottawa, R Samuel McLaughlin Ctr Populat Hlth Risk Assessm, Ottawa, ON, Canada.
RP Yauk, CL (reprint author), Ctr Environm Hlth, PL 0803A,Tunneys Pasture, Ottawa, ON, Canada.
EM carole.yauk@hc-sc.gc.ca
RI Douglas, George/V-8276-2019
OI Yauk, Carole/0000-0003-4919-876X; Marchetti,
   Francesco/0000-0002-9435-4867
FU Canadian Regulatory System for Biotechnology Reproduced
FX Grant sponsor: Canadian Regulatory System for Biotechnology Reproduced
   with the permission of the Minister of the environment.
CR [Academies NRCotN BE1R VII], 2006, HLTH RISKS EXP LOW L
   Adewoye AB, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7684
   Adimoolam S, 2003, DNA REPAIR, V2, P947, DOI 10.1016/S1568-7864(03)00087-9
   Adler ID, 1996, MUTAT RES-FUND MOL M, V352, P169, DOI 10.1016/0027-5107(95)00223-5
   Allay E, 1999, ONCOGENE, V18, P3783, DOI 10.1038/sj.onc.1202697
   Allgayer J, 2013, NUCLEIC ACIDS RES, V41, P8559, DOI 10.1093/nar/gkt620
   Barnett LB, 2002, ENVIRON MOL MUTAGEN, V40, P251, DOI 10.1002/em.10114
   BASU AK, 1990, MUTAT RES, V233, P189, DOI 10.1016/0027-5107(90)90162-W
   Beal MA, 2012, MUTAT RES-REV MUTAT, V750, P96, DOI 10.1016/j.mrrev.2011.11.002
   BERANEK DT, 1990, MUTAT RES, V231, P11, DOI 10.1016/0027-5107(90)90173-2
   Boyko AR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000083
   BRONSTEIN SM, 1992, CANCER RES, V52, P2008
   BRONSTEIN SM, 1991, CANCER RES, V51, P5188
   Brooks TM, 1997, MUTAT RES-GEN TOX EN, V388, P219, DOI 10.1016/S1383-5718(96)00119-2
   Brown JA, 2011, DNA REPAIR, V10, P24, DOI 10.1016/j.dnarep.2010.09.005
   Campbell CD, 2013, TRENDS GENET, V29, P575, DOI 10.1016/j.tig.2013.04.005
   CLERMONT Y, 1972, PHYSIOL REV, V52, P198
   Conrad DF, 2011, NAT GENET, V43, P712, DOI 10.1038/ng.862
   Davis AP, 1998, GENETICS, V148, P7
   DEGROOT AJL, 1994, MUTAT RES, V307, P61, DOI 10.1016/0027-5107(94)90278-X
   DeMarini DM, 2012, ENVIRON MOL MUTAGEN, V53, P166, DOI 10.1002/em.21685
   Dianov GL, 2013, NUCLEIC ACIDS RES, V41, P3483, DOI 10.1093/nar/gkt076
   DOUGLAS GR, 1995, P NATL ACAD SCI USA, V92, P7485, DOI 10.1073/pnas.92.16.7485
   Drablos F, 2004, DNA REPAIR, V3, P1389, DOI 10.1016/j.dnarep.2004.05.004
   Dubrova YE, 2008, ENVIRON MOL MUTAGEN, V49, P308, DOI 10.1002/em.20385
   Duncan T, 2002, P NATL ACAD SCI USA, V99, P16660, DOI 10.1073/pnas.262589799
   Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247
   Eastmond DA, 2009, MUTAGENESIS, V24, P341, DOI 10.1093/mutage/gep014
   EHLING UH, 1991, MUTAT RES, V250, P447, DOI 10.1016/0027-5107(91)90201-X
   ELLISON KS, 1989, P NATL ACAD SCI USA, V86, P8620, DOI 10.1073/pnas.86.22.8620
   Fang Q, 2010, J BIOL CHEM, V12, P885
   FAVOR J, 1990, MUTAT RES, V231, P47, DOI 10.1016/0027-5107(90)90175-4
   FAVOR J, 1986, MUTAT RES, V162, P69, DOI 10.1016/0027-5107(86)90072-2
   Favor J, 1997, MUTAT RES-FUND MOL M, V374, P193, DOI 10.1016/S0027-5107(96)00229-1
   Gilissen C, 2014, NATURE, V511, P344, DOI 10.1038/nature13394
   Girirajan S, 2011, ANNU REV GENET, V45, P203, DOI 10.1146/annurev-genet-102209-163544
   Gocke E, 2009, MUTAT RES-GEN TOX EN, V678, P101, DOI 10.1016/j.mrgentox.2009.04.005
   Hanawalt PC, 2003, MUTAT RES-REV MUTAT, V544, P107, DOI 10.1016/j.mrrev.2003.06.002
   Hoischen A, 2010, NAT GENET, V42, P483, DOI 10.1038/ng.581
   Iyama T, 2013, DNA REPAIR, V12, P620, DOI 10.1016/j.dnarep.2013.04.015
   Kaina B, 2007, DNA REPAIR, V6, P1079, DOI 10.1016/j.dnarep.2007.03.008
   Kamino K, 1995, EXP TOXICOL PATHOL, V47, P443, DOI 10.1016/S0940-2993(11)80324-6
   KANG H, 1992, CANCER RES, V52, P5307
   KATOH M, 1994, MUTAT RES-GENET TOX, V341, P17, DOI 10.1016/0165-1218(94)90020-5
   Katoh M, 1997, MUTAT RES-GEN TOX EN, V388, P229, DOI 10.1016/S1383-5718(96)00121-0
   Koberle B, 1999, CURR BIOL, V9, P273, DOI 10.1016/S0960-9822(99)80118-3
   Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396
   Kozmin SG, 2013, GENETICS, V193, P803, DOI 10.1534/genetics.112.147421
   Kryukov GV, 2007, AM J HUM GENET, V80, P727, DOI 10.1086/513473
   Ku CS, 2013, J MED GENET, V50, P203, DOI 10.1136/jmedgenet-2013-101519
   Ku CS, 2012, HUM GENOMICS, V6, DOI 10.1186/1479-7364-6-27
   Kultz D, 2005, ANNU REV PHYSIOL, V67, P225, DOI 10.1146/annurev.physiol.67.040403.103635
   Labib S, 2012, TOXICOL SCI, V129, P213, DOI 10.1093/toxsci/kfs177
   Lambert LB, 2005, MUTAT RES-REV MUTAT, V590, P1, DOI 10.1016/j.mrrev.2005.04.002
   Latypov VF, 2012, MOL CELL, V47, P50, DOI 10.1016/j.molcel.2012.04.028
   LEWIS SE, 1991, MUTAT RES, V249, P311, DOI 10.1016/0027-5107(91)90005-9
   Liegibel UM, 1997, MUTAT RES-GEN TOX EN, V388, P213, DOI 10.1016/S1383-5718(96)00118-0
   Liu Y, 2009, J BIOL CHEM, V284, P28352, DOI 10.1074/jbc.M109.050286
   Lupski JR, 2011, CELL, V147, P32, DOI 10.1016/j.cell.2011.09.008
   Lupski JR, 2010, NAT GENET, V42, P1036, DOI 10.1038/ng1210-1036
   Lutz WK, 2009, MUTAT RES-GEN TOX EN, V678, P118, DOI 10.1016/j.mrgentox.2009.05.010
   Lynch M, 2010, P NATL ACAD SCI USA, V107, P961, DOI 10.1073/pnas.0912629107
   Malik AI, 2013, MUTAGENESIS, V28, P543, DOI 10.1093/mutage/get031
   Malik AI, 2012, ENVIRON MOL MUTAGEN, V53, P10, DOI 10.1002/em.20668
   Marchetti F, 2007, P NATL ACAD SCI USA, V104, P17725, DOI 10.1073/pnas.0705257104
   Marchetti Francesco, 2005, Birth Defects Res C Embryo Today, V75, P112, DOI 10.1002/bdrc.20040
   Marchetti F, 2011, P NATL ACAD SCI USA, V108, P12811, DOI 10.1073/pnas.1106896108
   Martenies SE, 2013, TOXICOLOGY, V307, P66, DOI 10.1016/j.tox.2013.02.005
   Mattison JD, 1997, MUTAT RES-GEN TOX EN, V388, P123, DOI 10.1016/S1383-5718(96)00108-8
   Meek ME, 2010, CHEM-BIOL INTERACT, V184, P279, DOI 10.1016/j.cbi.2010.02.006
   Menoni H, 2012, NUCLEIC ACIDS RES, V40, P692, DOI 10.1093/nar/gkr761
   Mientjes EJ, 1996, CARCINOGENESIS, V17, P2449, DOI 10.1093/carcin/17.11.2449
   Mientjes EJ, 1998, ENVIRON MOL MUTAGEN, V31, P18, DOI 10.1002/(SICI)1098-2280(1998)31:1<18::AID-EM4>3.3.CO;2-T
   Mirkin SM, 2007, NATURE, V447, P932, DOI 10.1038/nature05977
   Morrow EM, 2010, J AM ACAD CHILD PSY, V49, P1091, DOI 10.1016/j.jaac.2010.08.009
   Muller L, 2009, TOXICOL LETT, V190, P317, DOI 10.1016/j.toxlet.2009.04.003
   NAGAO T, 1987, MUTAT RES, V177, P171
   NEHLS P, 1984, EMBO J, V3, P327, DOI 10.1002/j.1460-2075.1984.tb01806.x
   Norris MB, 2010, MUTAT RES-FUND MOL M, V688, P36, DOI 10.1016/j.mrfmmm.2010.02.008
   O'Brien JM, 2015, ENVIRON MOL MUTAGEN, V56, P347, DOI 10.1002/em.21932
   O'Brien JM, 2014, JOVE-J VIS EXP, DOI 10.3791/51576
   O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989
   OECD, 1997, TEST 471 BACT REV MU
   OECD, 2013, TEST 488 TRANSG ROD
   OECD, 1997, TEST 476 IN VITR MAM
   Oliva A, 2001, HUM REPROD, V16, P1768, DOI 10.1093/humrep/16.8.1768
   Olsen Ann-Karin, 2005, Toxicol Appl Pharmacol, V207, P521, DOI 10.1016/j.taap.2005.01.060
   Paul C, 2013, NAT REV UROL, V10, P227, DOI 10.1038/nrurol.2013.18
   Pegg AE, 2011, CHEM RES TOXICOL, V24, P618, DOI 10.1021/tx200031q
   Pozniak Anton, 2009, AIDS Res Ther, V6, P18, DOI 10.1186/1742-6405-6-18
   Renault D, 1997, MUTAT RES-GEN TOX EN, V388, P145, DOI 10.1016/S1383-5718(96)00111-8
   Roach JC, 2010, SCIENCE, V328, P636, DOI 10.1126/science.1186802
   Russell LB, 2004, GENETICA, V122, P25, DOI 10.1007/s10709-004-1443-7
   Russell LB, 2007, MUTAT RES-FUND MOL M, V616, P181, DOI 10.1016/j.mrfmmm.2006.11.003
   RUSSELL WL, 1982, P NATL ACAD SCI-BIOL, V79, P3589, DOI 10.1073/pnas.79.11.3589
   RUSSELL WL, 1979, P NATL ACAD SCI USA, V76, P5818, DOI 10.1073/pnas.76.11.5818
   Sancar A, 2003, CHEM REV, V103, P2203, DOI 10.1021/cr0204348
   Sasaki H, 2008, NAT REV GENET, V9, P129, DOI 10.1038/nrg2295
   Scharer OD, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012609
   Scherer E, 1987, IARC SCI PUBL, V84, P55
   SEGA GA, 1986, MUTAT RES, V159, P65, DOI 10.1016/0027-5107(86)90113-2
   Seiler F, 1997, MUTAT RES-DNA REPAIR, V385, P205, DOI 10.1016/S0921-8777(97)00043-8
   Selby PB, 2004, MUTAT RES-FUND MOL M, V545, P81, DOI 10.1016/j.mrfmmm.2003.09.014
   Seo YR, 2004, EXP MOL MED, V36, P505, DOI 10.1038/emm.2004.64
   Shelby MD, 1997, MUTAT RES-GEN TOX EN, V388, P99, DOI 10.1016/S1383-5718(96)00106-4
   SHIMA A, 1994, ENVIRON HEALTH PERSP, V102, P33, DOI 10.1289/ehp.94102s1233
   Shrivastav N, 2010, CARCINOGENESIS, V31, P59, DOI 10.1093/carcin/bgp262
   SINGER B, 1989, P NATL ACAD SCI USA, V86, P8271, DOI 10.1073/pnas.86.21.8271
   Singer TM, 2010, ENVIRON MOL MUTAGEN, V51, P919, DOI 10.1002/em.20613
   Skopek TR, 1996, ENVIRON MOL MUTAGEN, V28, P376
   Smallwood SA, 2011, NAT GENET, V43, P811, DOI 10.1038/ng.864
   Sun JX, 2012, NAT GENET, V44, P1161, DOI 10.1038/ng.2398
   Sundheim O, 2008, DNA REPAIR, V7, P1916, DOI 10.1016/j.dnarep.2008.07.015
   Suzuki T, 1997, MUTAT RES-GEN TOX EN, V388, P155, DOI 10.1016/S1383-5718(96)00112-X
   Swayne BG, 2012, MUTAT RES-FUND MOL M, V737, P1, DOI 10.1016/j.mrfmmm.2012.07.002
   Swenberg JA, 2008, CHEM RES TOXICOL, V21, P253, DOI 10.1021/tx700408t
   Thomas AD, 2013, TOXICOL SCI, V132, P87, DOI 10.1093/toxsci/kfs341
   Tinwell H, 1997, MUTAT RES-GEN TOX EN, V388, P179, DOI 10.1016/S1383-5718(96)00115-5
   Tollefsen KE, 2014, REGUL TOXICOL PHARM, V70, P629, DOI 10.1016/j.yrtph.2014.09.009
   Tosal L, 1998, MUTAGENESIS, V13, P375, DOI 10.1093/mutage/13.4.375
   vanDelft JHM, 1997, MUTAT RES-GEN TOX EN, V388, P165, DOI 10.1016/S1383-5718(96)00113-1
   VANDELFT JHM, 1995, MUTAGENESIS, V10, P209, DOI 10.1093/mutage/10.3.209
   VANZEELAND AA, 1990, MUTAT RES, V231, P55, DOI 10.1016/0027-5107(90)90176-5
   Verhofstad N, 2008, MUTAGENESIS, V23, P241, DOI 10.1093/mutage/gen022
   Vilarino-Guell C, 2003, MUTAT RES-FUND MOL M, V526, P63, DOI 10.1016/S0027-5107(03)00016-2
   Villeneuve DL, 2014, TOXICOL SCI, V142, P312, DOI 10.1093/toxsci/kfu199
   Villeneuve DL, 2014, TOXICOL SCI, V142, P321, DOI 10.1093/toxsci/kfu200
   Vissers LELM, 2010, NAT GENET, V42, P1109, DOI 10.1038/ng.712
   WATERS MD, 1994, MUTAT RES-GENET TOX, V341, P109, DOI 10.1016/0165-1218(94)90093-0
   WATERS MD, 1991, ENVIRON HEALTH PERSP, V96, P41, DOI 10.2307/3431206
   Wyatt MD, 1999, BIOESSAYS, V21, P668, DOI 10.1002/(SICI)1521-1878(199908)21:8<668::AID-BIES6>3.3.CO;2-4
   XIAO W, 1995, MUTAT RES-DNA REPAIR, V336, P133, DOI 10.1016/0921-8777(94)00048-B
   Yank CL, 2013, MUTAT RES IN PRESS, DOI [10.1016/j.mrgentox.2015.01.008, DOI 10.1016/J.MRGENT0X.2015.01.008]
   Yauk CL, 2013, ENVIRON MOL MUTAGEN, V54, P79, DOI 10.1002/em.21757
   Yauk CL, 2002, MUTAT RES-FUND MOL M, V500, P147, DOI 10.1016/S0027-5107(02)00005-2
   Yauk CL, 2012, MUTAT RES, V752, P6
   York SJ, 2006, J BIOL CHEM, V281, P22674, DOI 10.1074/jbc.M603667200
NR 137
TC 17
Z9 17
U1 0
U2 9
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0893-6692
EI 1098-2280
J9 ENVIRON MOL MUTAGEN
JI Environ. Mol. Mutagen.
PD DEC
PY 2015
VL 56
IS 9
BP 724
EP 750
DI 10.1002/em.21954
PG 27
WC Environmental Sciences; Genetics & Heredity; Toxicology
SC Environmental Sciences & Ecology; Genetics & Heredity; Toxicology
GA CV9YV
UT WOS:000364646000002
PM 26010389
DA 2019-10-23
ER

PT J
AU Di Paolo, C
   Groh, KJ
   Zennegg, M
   Vermeirssen, ELM
   Murk, AJ
   Eggen, RIL
   Hollert, H
   Werner, I
   Schirmer, K
AF Di Paolo, Carolina
   Groh, Ksenia J.
   Zennegg, Markus
   Vermeirssen, Etienne L. M.
   Murk, Albertinka J.
   Eggen, Rik I. L.
   Hollert, Henner
   Werner, Inge
   Schirmer, Kristin
TI Early life exposure to PCB126 results in delayed mortality and growth
   impairment in the zebrafish larvae
SO AQUATIC TOXICOLOGY
LA English
DT Article
DE Zebrafish; Early life stages; Delayed effects; Sublethal effects;
   Growth; PCB126
ID POLYCHLORINATED BIPHENYL CONGENERS; ADVERSE OUTCOME PATHWAYS; SPECIES
   XENOPUS-LAEVIS; EMBRYO TOXICITY TEST; DANIO-RERIO; DEVELOPMENTAL
   TOXICITY; SUBLETHAL EXPOSURE; ORGANIC-SUBSTANCES; INTEGRATIVE MODEL;
   THYROID-HORMONES
AB The occurrence of chronic or delayed toxicity resulting from the exposure to sublethal chemical concentrations is an increasing concern in environmental risk assessment. The Fish Embryo Toxicity (FET) test with zebrafish provides a reliable prediction of acute toxicity in adult fish, but it cannot yet be applied to predict the occurrence of chronic or delayed toxicity. Identification of sublethal FET endpoints that can assist in predicting the occurrence of chronic or delayed toxicity would be advantageous. The present study characterized the occurrence of delayed toxicity in zebrafish larvae following early exposure to PCB126, previously described to cause delayed effects in the common sole. The first aim was to investigate the occurrence and temporal profiles of delayed toxicity during zebrafish larval development and compare them to those previously described for sole to evaluate the suitability of zebrafish as a model fish species for delayed toxicity assessment. The second aim was to examine the correlation between the sublethal endpoints assessed during embryonal and early larval development and the delayed effects observed during later larval development. After exposure to PCB126 (3-3000 ng/L) until 5 days post fertilization (dpf), larvae were reared in clean water until 14 or 28 dpf. Mortality and sublethal morphological and behavioural endpoints were recorded daily, and growth was assessed at 28 dpf. Early life exposure to PCB126 caused delayed mortality (300 ng/L and 3000 ng/L) as well as growth impairment and delayed development (100 ng/L) during the clean water period. Effects on swim bladder inflation and cartilaginous tissues within 5 dpf were the most promising for predicting delayed mortality and sublethal effects, such as decreased standard length, delayed metamorphosis, reduced inflation of swim bladder and column malformations. The EC50 value for swim bladder inflation at 5 dpf (169 ng/L) was similar to the LC50 value at 8 dpf (188 and 202 ng/L in two experiments). Interestingly, the patterns of delayed mortality and delayed effects on growth and development were similar between sole and zebrafish. This indicates the comparability of critical developmental stages across divergent fish species such as a cold water marine flatfish and a tropical freshwater cyprinid. Additionally, sublethal effects in early embryo-larval stages were found promising for predicting delayed lethal and sublethal effects of PCB126. Therefore, the proposed method with zebrafish is expected to provide valuable information on delayed mortality and delayed sublethal effects of chemicals and environmental samples that may be extrapolated to other species. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Di Paolo, Carolina; Vermeirssen, Etienne L. M.; Werner, Inge] Swiss Ctr Appl Ecotoxicol Eawag EPFL, CH-8600 Dubendorf, Switzerland.
   [Di Paolo, Carolina; Hollert, Henner] Rhein Westfal TH Aachen, Inst Environm Res, Dept Ecosyst Anal, D-52074 Aachen, Germany.
   [Groh, Ksenia J.; Eggen, Rik I. L.; Schirmer, Kristin] Eawag, Swiss Fed Inst Aquat Sci & Technol, CH-8600 Dubendorf, Switzerland.
   [Groh, Ksenia J.] ETH, Dept Chem & Appl Biosci, CH-8093 Zurich, Switzerland.
   [Zennegg, Markus] Empa, Swiss Fed Labs Mat Sci & Technol, Lab Adv Analyt Technol, CH-8600 Dubendorf, Switzerland.
   [Murk, Albertinka J.] Wageningen Univ, Marine Anim Ecol Grp, NL-6708 WD Wageningen, Netherlands.
   [Murk, Albertinka J.] Wageningen UR, Inst Marine Resources & Ecosyst Studies, IMARES, NL-1780 AB Den Helder, Netherlands.
   [Eggen, Rik I. L.; Schirmer, Kristin] ETH, Dept Environm Syst Sci, CH-8092 Zurich, Switzerland.
   [Schirmer, Kristin] EPF Lausanne, Sch Architecture Civil & Environm Engn, CH-1015 Lausanne, Switzerland.
RP Di Paolo, C (reprint author), Rhein Westfal TH Aachen, Inst Environm Res Biol 5, Dept Ecosyst Anal, Worringerweg 1, D-52074 Aachen, Germany.
EM carolina.dipaolo@bio5.rwth-aachen.de; ksenia.groh@eawag.ch;
   markus.zennegg@empa.ch; etienne.vermeirssen@oekotoxzentrum.ch;
   tinka.murk@wur.nl; rik.eggen@eawag.ch;
   henner.hollert@bio5.rwth-aachen.de; inge.werner@oekotoxzentrum.ch;
   kristin.schirmer@eawag.ch
RI Di Paolo, Carolina/B-7995-2016
OI Di Paolo, Carolina/0000-0002-4281-1034; Groh, Ksenia/0000-0002-3778-4721
FU Oekotoxzentrum Eawag-EPFL
FX Thanks to the colleagues at the Swiss Centre for Applied Ecotoxicology
   (Oekotoxzentrum) Eawag-EPFL, particularly to Dr. Cornelia Kienle and Dr.
   Petra Kunz for the fruitful discussions and wise advices along the
   planning and development of experiments, and to Roger Gauch for the help
   in the laboratory. Thanks to the colleagues at Eawag, particularly to
   Melanie Knobel for the practical information on the FET test. Thanks to
   Nadine Sigrist and Aron Christoffel at Empa for the help with the
   chemical analysis. Thanks to Prof. Stephan Neuhauss and Kara Dannenhauer
   at the University of Zurich for providing us with the adult zebrafish.
   Special thanks to Dr. Edwin Foekema at IMARES institute for the great
   opportunity to learn the prolonged early life stage test method with
   common sole. This study was funded by the Oekotoxzentrum Eawag-EPFL.
CR [Anonymous], 2007, 15088 ISO
   ASTM, 2008, E171112 ASTM
   Baker TR, 2014, TOXICOL SCI, V138, P403, DOI 10.1093/toxsci/kfu006
   Baker TR, 2013, TOXICOL SCI, V135, P241, DOI 10.1093/toxsci/kft144
   Beggel S, 2012, SCI TOTAL ENVIRON, V426, P160, DOI 10.1016/j.scitotenv.2012.04.005
   Belanger SE, 2013, ENVIRON TOXICOL CHEM, V32, P1768, DOI 10.1002/etc.2244
   Braunbeck T, 2005, ALTEX-ALTERN TIEREXP, V22, P87
   Budi EH, 2008, DEVELOPMENT, V135, P2603, DOI 10.1242/dev.019299
   Carney SA, 2006, BIRTH DEFECTS RES A, V76, P7, DOI 10.1002/bdra.20216
   CHATAIN B, 1994, AQUACULTURE, V119, P371, DOI 10.1016/0044-8486(94)90301-8
   Chollett D, 2014, ENVIRON TOXICOL CHEM, V33, P784, DOI 10.1002/etc.2477
   Coe TS, 2009, ECOTOXICOLOGY, V18, P144, DOI 10.1007/s10646-008-0267-0
   Couillard CM, 2011, MAR ENVIRON RES, V71, P257, DOI 10.1016/j.marenvres.2011.01.010
   Daley JM, 2014, REV ENVIRON CONTAM T, V227, P107, DOI 10.1007/978-3-319-01327-5_4
   Daley JM, 2013, CHEMOSPHERE, V92, P10, DOI 10.1016/j.chemosphere.2013.03.036
   Daley JM, 2009, CHEMOSPHERE, V75, P1500, DOI 10.1016/j.chemosphere.2009.02.013
   Di Paolo C, 2015, ENVIRON SCI EUR, V27, DOI 10.1186/s12302-015-0040-y
   Di Paolo C, 2010, ENVIRON SCI TECHNOL, V44, P7548, DOI 10.1021/es101247e
   Elonen GE, 1998, ENVIRON TOXICOL CHEM, V17, P472, DOI 10.1002/etc.5620170319
   Embry MR, 2010, AQUAT TOXICOL, V97, P79, DOI 10.1016/j.aquatox.2009.12.008
   EU, 2010, OFF J EUR UNION L, VL276, P33
   Floyd EY, 2008, ENVIRON TOXICOL CHEM, V27, P1780, DOI 10.1897/07-448.1
   Flynn EJ, 2009, J LIPID RES, V50, P1641, DOI 10.1194/jlr.M800590-JLR200
   Foekema EM, 2012, ENVIRON TOXICOL CHEM, V31, P1381, DOI 10.1002/etc.1836
   Foekema EM, 2014, ECOTOX ENVIRON SAFE, V101, P14, DOI 10.1016/j.ecoenv.2013.12.006
   Foekema EM, 2008, AQUAT TOXICOL, V90, P197, DOI 10.1016/j.aquatox.2008.08.015
   Grimes AC, 2008, TOXICOL SCI, V106, P193, DOI 10.1093/toxsci/kfn154
   Groh KJ, 2015, CHEMOSPHERE, V120, P764, DOI 10.1016/j.chemosphere.2014.09.068
   Groh KJ, 2011, FISH PHYSIOL BIOCHEM, V37, P619, DOI 10.1007/s10695-010-9464-x
   Gutleb AC, 1999, ENVIRON TOXICOL PHAR, V8, P1, DOI 10.1016/S1382-6689(99)00023-X
   Gutleb AC, 2000, SCI TOTAL ENVIRON, V262, P147, DOI 10.1016/S0048-9697(00)00598-2
   Gutleb AC, 2007, SCI TOTAL ENVIRON, V381, P307, DOI 10.1016/j.scitotenv.2007.03.002
   Hamilton P. B., 2015, FISH FISH
   HAWKER DW, 1988, ENVIRON SCI TECHNOL, V22, P382, DOI 10.1021/es00169a004
   Heintz RA, 2000, MAR ECOL PROG SER, V208, P205, DOI 10.3354/meps208205
   Henry TR, 1997, TOXICOL APPL PHARM, V142, P56, DOI 10.1006/taap.1996.8024
   Hicken CE, 2011, P NATL ACAD SCI USA, V108, P7086, DOI 10.1073/pnas.1019031108
   Imrie D, 2010, DEV DYNAM, V239, P3013, DOI 10.1002/dvdy.22443
   ISO t. I.O. f. S, 1996, WAT QUAL DET AC LE 2
   Jager KJ, 2008, KIDNEY INT, V74, P560, DOI 10.1038/ki.2008.217
   Jonsson ME, 2007, TOXICOL SCI, V100, P180, DOI 10.1093/toxsci/kfm207
   Jonsson ME, 2007, TOXICOL APPL PHARM, V221, P29, DOI 10.1016/j.taap.2007.02.017
   Jonsson ME, 2012, TOXICOL APPL PHARM, V265, P166, DOI 10.1016/j.taap.2012.09.023
   Kienle C, 2009, ECOTOX ENVIRON SAFE, V72, P1740, DOI 10.1016/j.ecoenv.2009.04.014
   King Heiden TC, 2009, TOXICOL SCI, V109, P75, DOI 10.1093/toxsci/kfp048
   King-Heiden TC, 2012, MOL CELL ENDOCRINOL, V354, P121, DOI 10.1016/j.mce.2011.09.027
   Knobel M, 2012, ENVIRON SCI TECHNOL, V46, P9690, DOI 10.1021/es301729q
   Kuhnert A, 2013, ENVIRON TOXICOL CHEM, V32, P1819, DOI 10.1002/etc.2239
   Lammer E, 2009, COMP BIOCHEM PHYS C, V149, P196, DOI 10.1016/j.cbpc.2008.11.006
   Lanham KA, 2012, TOXICOL SCI, V127, P360, DOI 10.1093/toxsci/kfs103
   Lavergne E, 2015, MAR POLLUT BULL, V95, P658, DOI 10.1016/j.marpolbul.2015.01.006
   LeBaron MJ, 2010, MUTAT RES-REV MUTAT, V705, P83, DOI 10.1016/j.mrrev.2010.04.003
   Li J, 2011, ENVIRON SCI TECHNOL, V45, P9750, DOI 10.1021/es202420g
   Liedtke A, 2008, ENVIRON TOXICOL, V23, P59, DOI 10.1002/tox.20305
   Lindsey BW, 2010, ZEBRAFISH, V7, P85, DOI 10.1089/zeb.2009.0616
   Liu YW, 2002, DIFFERENTIATION, V70, P36, DOI 10.1046/j.1432-0436.2002.700104.x
   Lung SC, 2000, CHEMOSPHERE, V41, P1857, DOI 10.1016/S0045-6535(00)00082-5
   Markovich ML, 2007, ZEBRAFISH, V4, P69, DOI 10.1089/zeb.2006.9993
   Martin L, 2010, TOXICOL SCI, V117, P36, DOI 10.1093/toxsci/kfq187
   Melvin SD, 2013, CHEMOSPHERE, V93, P2217, DOI 10.1016/j.chemosphere.2013.07.036
   Miller GW, 2012, J NUTR BIOCHEM, V23, P478, DOI 10.1016/j.jnutbio.2011.02.002
   Mirbahai L., 2013, MUTAT RES, V764-765, P10
   Moser VC, 2011, TOXICOL PATHOL, V39, P36, DOI 10.1177/0192623310385255
   Na YR, 2009, ECOTOX ENVIRON SAFE, V72, P714, DOI 10.1016/j.ecoenv.2008.09.015
   Nacci DE, 2010, ESTUAR COAST, V33, P853, DOI 10.1007/s12237-009-9257-6
   Nagel R, 2002, ALTEX-ALTERN TIEREXP, V19, P38
   Nilsson CB, 2002, CRIT REV TOXICOL, V32, P211, DOI 10.1080/20024091064228
   Nyholm JR, 2008, CHEMOSPHERE, V73, P203, DOI 10.1016/j.chemosphere.2008.04.033
   OECD, 2010, GUID DOC AQ TOX TEST
   OECD, 2013, TEST 236 FISH EMBR T
   Organisation for Economic Co-operation and Development OECD, 2013, TEST 210 FISH EARL L
   Oris JT, 2012, ENVIRON TOXICOL CHEM, V31, P370, DOI 10.1002/etc.747
   Parichy DM, 2009, DEV DYNAM, V238, P2975, DOI 10.1002/dvdy.22113
   Parichy DM, 2003, DEV BIOL, V256, P242, DOI 10.1016/S0012-1606(03)00015-0
   Paris JR, 2015, EVOL APPL, V8, P573, DOI 10.1111/eva.12266
   Petersen GI, 1998, ENVIRON TOXICOL CHEM, V17, P1385, DOI 10.1002/etc.5620170724
   Power DM, 2001, COMP BIOCHEM PHYS C, V130, P447, DOI 10.1016/S1532-0456(01)00271-X
   Rombough P, 2002, J EXP BIOL, V205, P1787
   Rossi L, 2004, SCI TOTAL ENVIRON, V322, P179, DOI 10.1016/S0048-9697(03)00361-9
   Sanz-Landaluze J, 2015, ENVIRON SCI TECHNOL, V49, P1860, DOI 10.1021/es504685c
   Schiller V, 2013, COMP BIOCHEM PHYS C, V157, P41, DOI 10.1016/j.cbpc.2012.09.005
   Schneider AR, 2007, ENVIRON SCI TECHNOL, V41, P1097, DOI 10.1021/es0607584
   Scholz S, 2013, REGUL TOXICOL PHARM, V67, P506, DOI 10.1016/j.yrtph.2013.10.003
   Selderslaghs IWT, 2013, NEUROTOXICOL TERATOL, V37, P44, DOI 10.1016/j.ntt.2013.01.003
   Seok SH, 2008, J VET SCI, V9, P351, DOI 10.4142/jvs.2008.9.4.351
   Sipes NS, 2011, BIRTH DEFECTS RES C, V93, P256, DOI 10.1002/bdrc.20214
   Sisman T, 2007, TOXICOL IND HEALTH, V23, P529, DOI 10.1177/0748233708089042
   Sloman KA, 2012, J FISH BIOL, V81, P2175, DOI 10.1111/j.1095-8649.2012.03435.x
   Soffientino B, 2010, COMP BIOCHEM PHYS C, V152, P9, DOI 10.1016/j.cbpc.2010.02.006
   Tanguay Robert L., 2008, V447, P63, DOI 10.1007/978-1-59745-242-7_5
   Tanneberger K, 2013, ENVIRON SCI TECHNOL, V47, P1110, DOI 10.1021/es303505z
   Van den Berg M, 1998, ENVIRON HEALTH PERSP, V106, P775, DOI 10.1289/ehp.98106775
   Van der Jagt K. M., 2004, JRC29111
   Villeneuve D, 2014, ENVIRON TOXICOL CHEM, V33, P158, DOI 10.1002/etc.2403
   Volz DC, 2011, TOXICOL SCI, V123, P349, DOI 10.1093/toxsci/kfr185
   Waits ER, 2011, TOXICOL SCI, V122, P466, DOI 10.1093/toxsci/kfr136
   Weil M, 2009, ENVIRON TOXICOL CHEM, V28, P1970, DOI 10.1897/08-627.1
   Wernersson AS, 2015, ENVIRON SCI EUR, V27, P1, DOI 10.1186/s12302-015-0039-4
   Whitehead A, 2012, P ROY SOC B-BIOL SCI, V279, P427, DOI 10.1098/rspb.2011.0847
   Wolz J, 2008, ENVIRON SCI POLLUT R, V15, P536, DOI 10.1007/s11356-008-0056-6
   Wolska L, 2005, ANAL BIOANAL CHEM, V382, P1389, DOI 10.1007/s00216-005-3280-7
   Xiong KM, 2008, MOL PHARMACOL, V74, P1544, DOI 10.1124/mol.108.050435
   Yokoi H, 2009, DEV BIOL, V329, P1, DOI 10.1016/j.ydbio.2009.01.002
   Zgheib S, 2012, WATER RES, V46, P6683, DOI 10.1016/j.watres.2011.12.012
NR 104
TC 25
Z9 25
U1 3
U2 42
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-445X
EI 1879-1514
J9 AQUAT TOXICOL
JI Aquat. Toxicol.
PD DEC
PY 2015
VL 169
BP 168
EP 178
DI 10.1016/j.aquatox.2015.10.014
PG 11
WC Marine & Freshwater Biology; Toxicology
SC Marine & Freshwater Biology; Toxicology
GA CZ3TV
UT WOS:000367027800017
PM 26551687
OA Green Accepted
DA 2019-10-23
ER

PT J
AU Jaworska, JS
   Natsch, A
   Ryan, C
   Strickland, J
   Ashikaga, T
   Miyazawa, M
AF Jaworska, Joanna S.
   Natsch, Andreas
   Ryan, Cindy
   Strickland, Judy
   Ashikaga, Takao
   Miyazawa, Masaaki
TI Bayesian integrated testing strategy (ITS) for skin sensitization
   potency assessment: a decision support system for quantitative weight of
   evidence and adaptive testing strategy
SO ARCHIVES OF TOXICOLOGY
LA English
DT Article
DE Integrated testing strategy; Skin sensitization; Bayesian network; LLNA
   potency class
ID IN-VITRO DATA; TEST H-CLAT; SCREENING CONTACT ALLERGENS; DATA ASSESSMENT
   PARADIGM; NEURAL-NETWORK ANALYSIS; NONANIMAL TEST METHODS;
   RISK-ASSESSMENT; CELL-LINE; CHEMICAL SENSITIZERS; PEPTIDE REACTIVITY
AB The presented Bayesian network Integrated Testing Strategy (ITS-3) for skin sensitization potency assessment is a decision support system for a risk assessor that provides quantitative weight of evidence, leading to a mechanistically interpretable potency hypothesis, and formulates adaptive testing strategy for a chemical. The system was constructed with an aim to improve precision and accuracy for predicting LLNA potency beyond ITS-2 (Jaworska et al., J Appl Toxicol 33(11):1353-1364, 2013) by improving representation of chemistry and biology. Among novel elements are corrections for bioavailability both in vivo and in vitro as well as consideration of the individual assays' applicability domains in the prediction process. In ITS-3 structure, three validated alternative assays, DPRA, KeratinoSens and h-CLAT, represent first three key events of the adverse outcome pathway for skin sensitization. The skin sensitization potency prediction is provided as a probability distribution over four potency classes. The probability distribution is converted to Bayes factors to: 1) remove prediction bias introduced by the training set potency distribution and 2) express uncertainty in a quantitative manner, allowing transparent and consistent criteria to accept a prediction. The novel ITS-3 database includes 207 chemicals with a full set of in vivo and in vitro data. The accuracy for predicting LLNA outcomes on the external test set (n = 60) was as follows: hazard (two classes)-100 %, GHS potency classification (three classes)-96 %, potency (four classes)-89 %. This work demonstrates that skin sensitization potency prediction based on data from three key events, and often less, is possible, reliable over broad chemical classes and ready for practical applications.
C1 [Jaworska, Joanna S.] Procter & Gamble Co, B-1853 Strombeek Bever, Belgium.
   [Natsch, Andreas] Givaudan Schweiz AG, CH-8600 Dubendorf, Switzerland.
   [Ryan, Cindy] Procter & Gamble Co, Mason, OH 45040 USA.
   [Strickland, Judy] ILS Contractor Supporting NICEATM, Res Triangle Pk, NC 27709 USA.
   [Ashikaga, Takao] Shisheido Co Ltd, Tokyo, Japan.
   [Miyazawa, Masaaki] Kao Corp, R&D Safety Sci Res, Haga, Tochigi 3213497, Japan.
RP Jaworska, JS (reprint author), Procter & Gamble Co, B-1853 Strombeek Bever, Belgium.
EM Jaworska.j@pg.com
OI Natsch, Andreas/0000-0003-2231-2489
FU NIEHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Environmental
   Health Sciences (NIEHS) [HHSN273201500010C]
FX Roger Emter generated new KeratinoSens data. Leslie Foertsch generated
   new DPRA data. Morihiko Hirota and Yuuki Ootsubo generated new h-CLAT
   data. Data generation was partially funded by Research Institute of
   Fragrance Materials. Yuri Dancik was involved in the early stages of
   data compilation. Judy Strickland was supported by NIEHS contract
   HHSN273201500010C in support of NICEATM.
CR Adler S, 2011, ARCH TOXICOL, V85, P367, DOI 10.1007/s00204-011-0693-2
   Alves VM, 2015, TOXICOL APPL PHARM, V284, P273, DOI 10.1016/j.taap.2014.12.013
   AP, 2012, US TODAY
   Api AM, 2008, REGUL TOXICOL PHARM, V52, P3, DOI 10.1016/j.yrtph.2007.10.008
   Ashikaga T, 2006, TOXICOL IN VITRO, V20, P767, DOI 10.1016/j.tiv.2005.10.012
   Ball N, 2011, REGUL TOXICOL PHARM, V60, P389, DOI 10.1016/j.yrtph.2011.05.007
   Basketter D, 2010, J APPL TOXICOL, V30, P289, DOI 10.1002/jat.1510
   Basketter DA, 2012, ALTEX-ALTERN ANIM EX, V29, P5, DOI 10.14573/altex.2012.1.003
   Basketter DA, 2009, J APPL TOXICOL, V29, P545, DOI 10.1002/jat.1443
   Bauch C, 2012, REGUL TOXICOL PHARM, V63, P489, DOI 10.1016/j.yrtph.2012.05.013
   Beltrani VS, 2006, ANN ALLERG ASTHMA IM, V97, pS1, DOI 10.1016/S1081-1206(10)60811-3
   Bodin A, 2003, CHEM RES TOXICOL, V16, P575, DOI 10.1021/tx025609n
   Bohme A, 2009, CHEM RES TOXICOL, V22, P742, DOI 10.1021/tx800492x
   Boeniger MF, 2003, INT ARCH OCC ENV HEA, V76, P387, DOI 10.1007/s00420-002-0425-2
   Brase J., 2009, MODELING SIMULATION
   Bus JS, 2009, TOXICOL SCI, V112, P297, DOI 10.1093/toxsci/kfp234
   COHEN S, 1966, J AM CHEM SOC, V88, P1533, DOI 10.1021/ja00959a040
   Dancik Y, 2013, ADV DRUG DELIVER REV, V65, P221, DOI 10.1016/j.addr.2012.01.006
   de Groot AC, 1994, PATCH TESTING TEST C
   De Wever B, 2012, TOXICOL IN VITRO, V26, P526, DOI 10.1016/j.tiv.2012.01.009
   Dimitrov SD, 2005, INT J TOXICOL, V24, P189, DOI 10.1080/10915810591000631
   Dinkova-Kostova AT, 2005, CHEM RES TOXICOL, V18, P1779, DOI 10.1021/tx050217c
   El Ali Z, 2013, TOXICOL SCI, V134, P39, DOI 10.1093/toxsci/kft084
   Emter R, 2010, TOXICOL APPL PHARM, V245, P281, DOI 10.1016/j.taap.2010.03.009
   Esser PR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041340
   European Parliament and Council, 2009, OFFICIAL J EUROPEA L, V342, P59
   Gerberick GF, 2007, TOXICOL SCI, V97, P417, DOI 10.1093/toxsci/kfm064
   Gerberick GF, 2005, DERMATITIS, V16, P157, DOI 10.2310/6620.2005.05040
   Gerberick GF, 2004, TOXICOL SCI, V81, P332, DOI 10.1093/toxsci/kfh213
   Gerberick GF, 2001, CONTACT DERMATITIS, V45, P333, DOI 10.1034/j.1600-0536.2001.450603.x
   Goodman SN, 1999, ANN INTERN MED, V130, P1005, DOI 10.7326/0003-4819-130-12-199906150-00019
   Groothuis FA, 2015, TOXICOLOGY, V332, P30, DOI 10.1016/j.tox.2013.08.012
   Hartung T, 2013, ALTEX-ALTERN ANIM EX, V30, P3, DOI 10.14573/altex.2013.1.003
   Hoffmann S, 2015, LLNA VARIABILITY ESS
   ICCVAM, 2011, ICCVAM TEST METH EV
   Jaworska J, 2013, J APPL TOXICOL, V33, P1353, DOI 10.1002/jat.2869
   Jaworska J, 2011, ALTEX-ALTERN ANIM EX, V28, P211, DOI 10.14573/altex.2011.3.211
   Jaworska Joanna, 2010, ALTEX, V27, P231
   Jaworska J, 2010, REGUL TOXICOL PHARM, V57, P157, DOI 10.1016/j.yrtph.2010.02.003
   Joint Research Centre of the European Union, 2014, EURL ECVAM REC KERAT
   Joint Research Centre of the European Union, 2015, EURL ECVAM REC HUM C
   Joint Research Centre of the European Union, 2013, EURL ECVAM REC DIR P
   Jowsey IR, 2006, J APPL TOXICOL, V26, P341, DOI 10.1002/jat.1146
   Kagatani S, 2010, J INVEST DERMATOL, V130, P175, DOI 10.1038/jid.2009.229
   Kimber I, 2003, FOOD CHEM TOXICOL, V41, P1799, DOI 10.1016/S0278-6915(03)00223-0
   Kimber I, 2011, TOXICOL SCI, V120, pS238, DOI 10.1093/toxsci/kfq346
   Kjaerulff U. B., 2013, BAYESIAN NETWORKS IN
   Kramer NI, 2012, CHEM RES TOXICOL, V25, P436, DOI 10.1021/tx200479k
   Lucas PJF, 2004, ARTIF INTELL MED, V30, P201, DOI 10.1016/j.artmed.2003.11.001
   Luechtefeld T, 2015, J APPL TOXICOL, V35, P1361, DOI 10.1002/jat.3172
   Maxwell G, 2008, ATLA-ALTERN LAB ANIM, V36, P521, DOI 10.1177/026119290803600510
   McKim JM, 2010, CUTAN OCUL TOXICOL, V29, P171, DOI 10.3109/15569527.2010.483869
   Mehling A, 2012, ARCH TOXICOL, V86, P1273, DOI 10.1007/s00204-012-0867-6
   MIDDLETON E, 1998, ALLERGY PRINCIPLES P
   Miyazawa M, 2008, J TOXICOL SCI, V33, P51, DOI 10.2131/jts.33.51
   Natsch A, 2014, ISSUES IN TOXICOLOGY, V19, P364
   Natsch A, 2015, TOXICOL SCI, V143, P319, DOI 10.1093/toxsci/kfu229
   Natsch A, 2013, J APPL TOXICOL, V33, P1337, DOI 10.1002/jat.2868
   Natsch A, 2011, CHEM RES TOXICOL, V24, P2018, DOI 10.1021/tx2003678
   Natsch A, 2010, TOXICOL SCI, V113, P284, DOI 10.1093/toxsci/kfp228
   Natsch A, 2009, TOXICOL SCI, V107, P106, DOI 10.1093/toxsci/kfn204
   NIOSH, 2012, SKIN EXP EFF WORKPL
   Nukada Y, 2013, TOXICOL IN VITRO, V27, P609, DOI 10.1016/j.tiv.2012.11.006
   Nukada Y, 2012, TOXICOL IN VITRO, V26, P1150, DOI 10.1016/j.tiv.2012.07.001
   OECD, 2015, TEST 442D IN VITR SK
   OECD, 2015, PROP NEW TE IN PRESS
   OECD, 2015, ADV OUTC PATHW MOL S
   OECD, 2012, OECD SER TEST ASS 16
   OECD, 2015, TEST 442C CHEM SKIN
   OECD, 2010, TEST 429 SKIN SENSIT
   Patlewicz G, 2014, SAR QSAR ENVIRON RES, V25, P367, DOI 10.1080/1062936X.2014.900520
   Patlewicz G, 2014, REGUL TOXICOL PHARM, V69, P529, DOI 10.1016/j.yrtph.2014.06.001
   Pirone JR, 2014, ALTEX-ALTERN ANIM EX, V31, P336, DOI http://dx.doi.org/10.14573/altex.1310151
   Reisinger K, 2015, TOXICOL IN VITRO, V29, P259, DOI 10.1016/j.tiv.2014.10.018
   Roberts DW, 2008, J APPL TOXICOL, V28, P377, DOI 10.1002/jat.1289
   Roberts DW, 2007, CHEM RES TOXICOL, V20, P1321, DOI 10.1021/tx700169w
   Rovida C, 2015, ALTEX-ALTERN ANIM EX, V32, P25, DOI [http://dx.doi.org/10.14573/altex.1411011, 10.14573/altex.1506201]
   Sasseville Denis, 2008, Allergy Asthma Clin Immunol, V4, P59, DOI 10.1186/1710-1492-4-2-59
   Skold M, 2002, CONTACT DERMATITIS, V46, P267, DOI 10.1034/j.1600-0536.2002.460504.x
   Su B, 2009, COMPUT MATH METHOD M, V10, P9, DOI 10.1080/17486700801982713
   Takenouchi O, 2013, J TOXICOL SCI, V38, P599, DOI 10.2131/jts.38.599
   Tsujita-Inoue K, 2015, J TOXICOL SCI, V40, P193, DOI 10.2131/jts.40.193
   Tsujita-Inoue K, 2014, TOXICOL IN VITRO, V28, P626, DOI 10.1016/j.tiv.2014.01.003
   UN, 2013, GLOB HARM SYST CLASS
   UNEP, 2005, OECD SIDS PHTHAL ANH
   Urbisch D, 2015, REGUL TOXICOL PHARM, V71, P337, DOI 10.1016/j.yrtph.2014.12.008
   van der Veen JW, 2014, REGUL TOXICOL PHARM, V69, P371, DOI 10.1016/j.yrtph.2014.04.018
   van der Veen JW, 2013, ARCH TOXICOL, V87, P763, DOI 10.1007/s00204-012-0976-2
   Villeneuve DL, 2014, TOXICOL SCI, V142, P312, DOI 10.1093/toxsci/kfu199
   Villeneuve DL, 2014, TOXICOL SCI, V142, P321, DOI 10.1093/toxsci/kfu200
   Weber FC, 2010, J EXP MED, V207, P2609, DOI 10.1084/jem.20092489
NR 91
TC 54
Z9 59
U1 0
U2 13
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0340-5761
EI 1432-0738
J9 ARCH TOXICOL
JI Arch. Toxicol.
PD DEC
PY 2015
VL 89
IS 12
BP 2355
EP 2383
DI 10.1007/s00204-015-1634-2
PG 29
WC Toxicology
SC Toxicology
GA CY1GR
UT WOS:000366155200014
PM 26612363
DA 2019-10-23
ER

PT J
AU Noor, F
AF Noor, Fozia
TI A shift in paradigm towards human biology-based systems for
   cholestatic-liver diseases
SO JOURNAL OF PHYSIOLOGY-LONDON
LA English
DT Review
ID PRIMARY BILIARY-CIRRHOSIS; ADVERSE OUTCOME PATHWAY; IN-VITRO MODEL;
   PRIMARY HUMAN HEPATOCYTES; VITAMIN-D-RECEPTOR; BILE-ACIDS; HEPARG CELLS;
   EXTRACELLULAR-MATRIX; SPECIES-DIFFERENCES; NUCLEAR RECEPTORS
AB Cholestatic-liver diseases (CLDs) arise from diverse causes ranging from genetic factors to drug-induced cholestasis. The so-called diseases of civilization (obesity, diabetes, metabolic disorders, non-alcoholic liver disease, cardiovascular diseases, etc.) are intricately implicated in liver and gall bladder diseases. Although CLDs have been extensively studied, there seem to be important gaps in the understanding of human disease. Despite the fact that many animal models exist and substantial clinical data are available, translation of this knowledge towards therapy has been disappointingly limited. Recent advances in liver cell culture such as in vivo-like 3D cultivation of human primary hepatic cells, human induced pluripotent stem cell-derived hepatocytes; and cutting-edge analytical techniques such as omics' technologies and high-content screenings could play a decisive role in deeper mechanistic understanding of CLDs. This Topical Review proposes a roadmap to human biology-based research using omics technologies providing quantitative information on mechanisms in an adverse outcome/disease pathway framework. With modern sensitive tools, a shift in paradigm in human disease research seems timely and even inevitable to overcome species barriers in translation.
C1 [Noor, Fozia] Univ Saarland, Biochem Engn Inst, D-66123 Saarbrucken, Germany.
RP Noor, F (reprint author), Univ Saarland, Biochem Engn Inst, D-66123 Saarbrucken, Germany.
EM fozia.noor@mx.uni-saarland.de
RI Noor, Fozia/D-5899-2013
OI Noor, Fozia/0000-0002-1490-5527
FU European CommunityEuropean Community (EC) [267038]; Cosmetics Europe
FX Humane Society International (HSI) provided support for the writing of
   this article. The author is a researcher working on the SEURAT-1 NOTOX
   project funded by the European Community's Seventh Framework Programme
   (FP7/2007-2013) under grant agreement No 267038 and Cosmetics Europe.
CR Adeleye Y, 2015, TOXICOLOGY, V332, P102, DOI 10.1016/j.tox.2014.02.007
   Ananthanarayanan M, 2011, AM J PHYSIOL-GASTR L, V300, pG771, DOI 10.1152/ajpgi.00499.2010
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Asgari S, 2010, J HEPATOL, V53, P738, DOI 10.1016/j.jhep.2010.05.009
   Bale SS, 2014, EXP BIOL MED, V239, P1180, DOI 10.1177/1535370214531872
   Begley M, 2005, FEMS MICROBIOL REV, V29, P625, DOI 10.1016/j.femsre.2004.09.003
   Bergquist A, 2015, BEST PRACT RES CL GA, V29, P221, DOI 10.1016/j.bpg.2015.02.003
   Beyoglu D, 2013, J HEPATOL, V59, P842, DOI 10.1016/j.jhep.2013.05.030
   Bhatia SN, 2014, NAT BIOTECHNOL, V32, P760, DOI 10.1038/nbt.2989
   Billiet T, 2014, BIOMATERIALS, V35, P49, DOI 10.1016/j.biomaterials.2013.09.078
   BISSELL MJ, 1982, J THEOR BIOL, V99, P31, DOI 10.1016/0022-5193(82)90388-5
   Bjornsson E, 2005, HEPATOLOGY, V42, P481, DOI 10.1002/hep.20800
   Bourzac K, 2014, NATURE, V513, pS4, DOI 10.1038/513S4a
   Carbone M, 2013, GASTROENTEROLOGY, V144, P560, DOI 10.1053/j.gastro.2012.12.005
   De Fabiani E, 2003, J BIOL CHEM, V278, P39124, DOI 10.1074/jbc.M305079200
   Farina A, 2014, COMPR PHYSIOL, V4, P91, DOI 10.1002/cphy.c130016
   Fiehn O, 2002, PLANT MOL BIOL, V48, P155, DOI 10.1023/A:1013713905833
   Garcia-Reyero N, 2015, ENVIRON SCI TECHNOL, V49, P3, DOI 10.1021/es504976d
   Gevaert E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105171
   Ghodsizadeh A, 2010, STEM CELL REV REP, V6, P622, DOI 10.1007/s12015-010-9189-3
   Godoy P, 2013, ARCH TOXICOL, V87, P3, DOI 10.1007/s00204-012-0981-5
   Goodwin B, 2003, MOL ENDOCRINOL, V17, P386, DOI 10.1210/me.2002-0246
   Guillouzo A, 2007, CHEM-BIOL INTERACT, V168, P66, DOI 10.1016/j.cbi.2006.12.003
   Gunness P, 2013, TOXICOL SCI, V133, P67, DOI 10.1093/toxsci/kft021
   Halilbasic E, 2013, J HEPATOL, V58, P155, DOI 10.1016/j.jhep.2012.08.002
   HEUMAN DM, 1989, J LIPID RES, V30, P719
   Hofmann AF, 2008, CELL MOL LIFE SCI, V65, P2461, DOI 10.1007/s00018-008-7568-6
   Houten SM, 2006, EMBO J, V25, P1419, DOI 10.1038/sj.emboj.7601049
   Ishizawa M, 2008, J LIPID RES, V49, P763, DOI 10.1194/jlr.M700293-JLR200
   Jacquemin E, 1999, J HEPATOL, V31, P377, DOI 10.1016/S0168-8278(99)80240-2
   Jemnitz K, 2010, TOXICOL SCI, V115, P80, DOI 10.1093/toxsci/kfq044
   Jones ML, 2014, EXPERT OPIN BIOL TH, V14, P467, DOI 10.1517/14712598.2014.880420
   Gomez-Lechon MJ, 2014, EXPERT OPIN DRUG MET, V10, P1553, DOI 10.1517/17425255.2014.967680
   Kanebratt KP, 2008, DRUG METAB DISPOS, V36, P1444, DOI 10.1124/dmd.107.020016
   Kanebratt KP, 2008, DRUG METAB DISPOS, V36, P137, DOI 10.1124/dmd.107.017418
   Kaplan MM, 2005, NEW ENGL J MED, V353, P1261, DOI 10.1056/NEJMra043898
   Karasov WH, 2011, ANNU REV PHYSIOL, V73, P69, DOI 10.1146/annurev-physiol-012110-142152
   Keitel V, 2005, HEPATOLOGY, V41, P1160, DOI 10.1002/hep.20682
   Keitel V, 2008, WORLD J GASTROENTERO, V14, P5620, DOI 10.3748/wjg.14.5620
   Khanna R, 2011, IMMUNOL CELL BIOL, V89, P330, DOI 10.1038/icb.2010.173
   Khetani SR, 2008, NAT BIOTECHNOL, V26, P120, DOI 10.1038/nbt1361
   Kleensang A, 2014, ALTEX-ALTERN ANIM EX, V31, P53, DOI 10.14573/altex.1309261
   Klein S, 2016, TOXICOL SCI, V149, P55, DOI 10.1093/toxsci/kfv218
   Klein S, 2012, WIRES SYST BIOL MED, V4, P261, DOI 10.1002/wsbm.1167
   Krawczyk M, 2010, NAT REV GASTRO HEPAT, V7, P669, DOI 10.1038/nrgastro.2010.170
   Kurdi P, 2006, J BACTERIOL, V188, P1979, DOI 10.1128/JB.188.5.1979-1986.2006
   Lam P, 2005, BIOCHEMISTRY-US, V44, P12598, DOI 10.1021/bi050943e
   Landesmann B, 2013, ATLA-ALTERN LAB ANIM, V41, P461, DOI 10.1177/026119291304100609
   Lankisch TO, 2011, HEPATOLOGY, V53, P875, DOI 10.1002/hep.24103
   Le Beyec J, 2007, EXP CELL RES, V313, P3066, DOI 10.1016/j.yexcr.2007.04.022
   Lefebvre P, 2009, PHYSIOL REV, V89, P147, DOI 10.1152/physrev.00010.2008
   Leslie EM, 2007, J PHARMACOL EXP THER, V321, P1170, DOI 10.1124/jpet.106.119073
   Li TG, 2015, CURR OPIN GASTROEN, V31, P159, DOI 10.1097/MOG.0000000000000156
   Liu Y, 2013, AM J PHYSIOL-GASTR L, V304, pG449, DOI 10.1152/ajpgi.00199.2012
   Makishima M, 2002, SCIENCE, V296, P1313, DOI 10.1126/science.1070477
   Mann ER, 2013, IMMUNOL LETT, V150, P30, DOI 10.1016/j.imlet.2013.01.007
   Mantis NJ, 2010, IMMUNOL INVEST, V39, P383, DOI 10.3109/08820131003622635
   Martignoni M, 2006, EXPERT OPIN DRUG MET, V2, P875, DOI 10.1517/17425255.2.6.875
   Martinez-Becerra P, 2011, MOL PHARMACOL, V79, P596, DOI 10.1124/mol.110.069971
   McCracken KW, 2014, NATURE, V516, P400, DOI 10.1038/nature13863
   Mells GF, 2013, J AUTOIMMUN, V46, P41, DOI 10.1016/j.jaut.2013.07.004
   Mullenbach R, 2011, DIGEST DIS, V29, P72, DOI 10.1159/000324137
   Mueller D, 2014, TOXICOL IN VITRO, V28, P104, DOI 10.1016/j.tiv.2013.06.024
   Mueller D, 2012, EUR J PHARM SCI, V45, P716, DOI 10.1016/j.ejps.2012.01.014
   Navaneethan U, 2015, GASTROENTEROL REP, V3, P136, DOI 10.1093/gastro/gou066
   Nieuwdorp M, 2014, GASTROENTEROLOGY, V146, P1525, DOI 10.1053/j.gastro.2014.02.008
   OECD, 2012, SER TEST ASS, V168
   Oertelt S, 2006, J IMMUNOL, V177, P1655, DOI 10.4049/jimmunol.177.3.1655
   Osterreicher CH, 2012, CURR OPIN GASTROEN, V28, P239, DOI 10.1097/MOG.0b013e32835264d9
   Paine AJ, 2004, TOXICOL IN VITRO, V18, P187, DOI 10.1016/S0887-2333(03)00146-2
   Pang XY, 2007, ISME J, V1, P156, DOI 10.1038/ismej.2007.23
   Patlewicz G, 2013, REGUL TOXICOL PHARM, V65, P259, DOI 10.1016/j.yrtph.2012.12.008
   Pollheimer MJ, 2014, MOL ASPECTS MED, V37, P35, DOI 10.1016/j.mam.2013.10.001
   Pound P, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3387
   Poupon R, 2000, J HEPATOL, V32, P129, DOI 10.1016/S0168-8278(00)80421-3
   Ramaiahgari SC, 2014, ARCH TOXICOL, V88, P1083, DOI 10.1007/s00204-014-1215-9
   Ramirez T, 2013, ALTEX-ALTERN ANIM EX, V30, P209, DOI 10.14573/altex.2013.2.209
   Russell DW, 2009, J LIPID RES, V50, pS120, DOI 10.1194/jlr.R800026-JLR200
   Schwartz RE, 2014, BIOTECHNOL ADV, V32, P504, DOI 10.1016/j.biotechadv.2014.01.003
   Selmi C, 2004, GASTROENTEROLOGY, V127, P485, DOI 10.1053/S0016-5085(04)00841-8
   Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110
   Shaheen NJ, 2006, AM J GASTROENTEROL, V101, P2128, DOI 10.1111/j.1572-0241.2006.00723.x
   Siller R, 2013, CURR GENE THER, V13, P99, DOI 10.2174/1566523211313020004
   Sirenko O, 2014, ASSAY DRUG DEV TECHN, V12, P43, DOI 10.1089/adt.2013.520
   Sirica AE, 2008, HEPATOLOGY, V48, P2040, DOI 10.1002/hep.22623
   Smith Z, 2013, MOL CELL ENDOCRINOL, V368, P59, DOI 10.1016/j.mce.2012.04.008
   Spencer VA, 2007, ADV CANCER RES, V97, P275, DOI 10.1016/S0065-230X(06)97012-2
   Suter CM, 2004, NAT GENET, V36, P497, DOI 10.1038/ng1342
   Thomas C, 2008, NAT REV DRUG DISCOV, V7, P678, DOI 10.1038/nrd2619
   Tolosa L, 2015, ARCH TOXICOL, V89, P1847, DOI 10.1007/s00204-014-1334-3
   Torres DM, 2012, CLIN GASTROENTEROL H, V10, P837, DOI 10.1016/j.cgh.2012.03.011
   Trottier J, 2012, DIGEST LIVER DIS, V44, P303, DOI 10.1016/j.dld.2011.10.025
   Tsuneyama K, 2012, INT J HEPATOL, DOI 10.1155/2012/403954
   Ueno Y, 2010, CURR OPIN GASTROEN, V26, P274, DOI 10.1097/MOG.0b013e32833755aa
   Villeneuve DL, 2014, TOXICOL SCI, V142, P312, DOI 10.1093/toxsci/kfu199
   Villeneuve DL, 2014, TOXICOL SCI, V142, P321, DOI 10.1093/toxsci/kfu200
   Vinken M, 2013, TOXICOL SCI, V136, P97, DOI 10.1093/toxsci/kft177
   Wang L, 2013, J PROTEOMICS, V91, P569, DOI 10.1016/j.jprot.2013.08.019
   Wang RX, 2001, P NATL ACAD SCI USA, V98, P2011, DOI 10.1073/pnas.031465498
   Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330
   Wei J, 2009, J DIGEST DIS, V10, P85, DOI 10.1111/j.1751-2980.2009.00369.x
   Willett C, 2014, ALTEX-ALTERN ANIM EX, V31, P407, DOI http://dx.doi.org/10.14573/altex.1401283
   Williams R, 2006, HEPATOLOGY, V44, P521, DOI 10.1002/hep.21347
   Woolbright BL, 2015, TOXICOL APPL PHARM, V283, P168, DOI 10.1016/j.taap.2015.01.015
   Xu R, 2007, J BIOL CHEM, V282, P14992, DOI 10.1074/jbc.M610316200
   Zhang YC, 2012, LIVER INT, V32, P58, DOI 10.1111/j.1478-3231.2011.02662.x
   Zollner G, 2009, BRIT J PHARMACOL, V156, P7, DOI 10.1111/j.1476-5381.2008.00030.x
NR 107
TC 8
Z9 10
U1 0
U2 10
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-3751
EI 1469-7793
J9 J PHYSIOL-LONDON
JI J. Physiol.-London
PD DEC 1
PY 2015
VL 593
IS 23
BP 5043
EP 5055
DI 10.1113/JP271124
PG 13
WC Neurosciences; Physiology
SC Neurosciences & Neurology; Physiology
GA CX5VL
UT WOS:000365770500007
PM 26417843
OA Green Published
DA 2019-10-23
ER

PT J
AU Langley, G
   Austin, CP
   Balapure, AK
   Birnbaum, LS
   Bucher, JR
   Fentem, J
   Fitzpatrick, SC
   Fowle, JR
   Kavlock, RJ
   Kitano, H
   Lidbury, BA
   Muotri, AR
   Peng, SQ
   Sakharov, D
   Seidle, T
   Trez, T
   Tonevitsky, A
   van De Stolpe, A
   Whelan, M
   Willett, C
AF Langley, Gill
   Austin, Christopher P.
   Balapure, Anil K.
   Birnbaum, Linda S.
   Bucher, John R.
   Fentem, Julia
   Fitzpatrick, Suzanne C.
   Fowle, John R.
   Kavlock, Robert J.
   Kitano, Hiroaki
   Lidbury, Brett A.
   Muotri, Alysson R.
   Peng, Shuang-Qing
   Sakharov, Dmitry
   Seidle, Troy
   Trez, Thales
   Tonevitsky, Alexander
   van de Stolpe, Anja
   Whelan, Maurice
   Willett, Catherine
TI Lessons from Toxicology: Developing a 21st-Century Paradigm for Medical
   Research
SO ENVIRONMENTAL HEALTH PERSPECTIVES
LA English
DT Article
ID PLURIPOTENT STEM-CELLS; ALZHEIMERS-DISEASE; MODELS; PATHWAYS; PROTEIN
AB Biomedical developments in the 21st century provide an unprecedented opportunity to gain a dynamic systems-level and human-specific understanding of the causes and pathophysiologies of disease. This understanding is a vital need, in view of continuing failures in health research, drug discovery, and clinical translation. The full potential of advanced approaches may not be achieved within a 20th-century conceptual framework dominated by animal models. Novel technologies are being integrated into environmental health research and are also applicable to disease research, but these advances need a new medical research and drug discovery paradigm to gain maximal benefits. We suggest a new conceptual framework that repurposes the 21st-century transition underway in toxicology. Human disease should be conceived as resulting from integrated extrinsic and intrinsic causes, with research focused on modern human-specific models to understand disease pathways at multiple biological levels that are analogous to adverse outcome pathways in toxicology. Systems biology tools should be used to integrate and interpret data about disease causation and pathophysiology. Such an approach promises progress in overcoming the current roadblocks to understanding human disease and successful drug discovery and translation. A discourse should begin now to identify and consider the many challenges and questions that need to be solved.
C1 [Langley, Gill] Humane Soc Int, Res & Toxicol Dept, London N1 7LY, England.
   [Austin, Christopher P.] NIH, Natl Ctr Adv Translat Sci, US Dept HHS, Bethesda, MD 20892 USA.
   [Balapure, Anil K.] CSIR Cent Drug Res Inst, Div Biochem, Lucknow, Uttar Pradesh, India.
   [Birnbaum, Linda S.] NIEHS, Res Triangle Pk, NC 27709 USA.
   [Birnbaum, Linda S.] NIH, NTP, DHHS, Res Triangle Pk, NC USA.
   [Bucher, John R.] NIEHS, Div NTP, NIH, DHHS, Res Triangle Pk, NC 27709 USA.
   [Fentem, Julia] Unilever R&D, SEAC, Sharnbrook, Beds, England.
   [Fitzpatrick, Suzanne C.] US FDA, Off Ctr Director, Ctr Food Safety & Appl Nutr, Rockville, MD 20857 USA.
   [Fowle, John R.] Sci Inform LLC, Pittsboro, NC USA.
   [Kavlock, Robert J.] US EPA, Off Res & Dev, Washington, DC 20460 USA.
   [Kitano, Hiroaki] Syst Biol Inst, Tokyo, Japan.
   [Lidbury, Brett A.] Australian Natl Univ, John Curtin Sch Med Res, Genom & Predict Med, Canberra, ACT 2601, Australia.
   [Muotri, Alysson R.] Univ Calif San Diego, Sch Med, Dept Pediat, Rady Childrens Hosp San Diego,Dept Cellular & Mol, La Jolla, CA 92093 USA.
   [Peng, Shuang-Qing] Acad Mil Med Sci, Inst Dis Control & Prevent, Evaluat & Res Ctr Toxicol, Beijing, Peoples R China.
   [Sakharov, Dmitry] Sci Res Ctr Bioclinicum, Moscow, Russia.
   [Seidle, Troy] Humane Soc Int, Res & Toxicol Dept, Montreal, PQ, Canada.
   [Trez, Thales] Univ Fed Alfenas, Inst Sci & Technol, Alfenas, Brazil.
   [Tonevitsky, Alexander] Natl Ctr Med Radiol Res, Obninsk, Russia.
   [van de Stolpe, Anja] Philips Res, Eindhoven, Netherlands.
   [Whelan, Maurice] Commiss European Communities, Joint Res Ctr, Inst Hlth & Consumer Protect, I-21020 Ispra, Italy.
   [Willett, Catherine] Humane Soc United States, Regulatory Toxicol Risk Assessment & Alternat, Washington, DC USA.
RP Langley, G (reprint author), Humane Soc Int, 5 Underwood St, London N1 7LY, England.
EM glangley@hsi.org
RI Tonevitsky, Alexander/R-5596-2019; Sakharov, Dmitry
   Andreevich/E-3067-2014
OI Tonevitsky, Alexander/0000-0002-7079-7145; Seidle,
   Troy/0000-0002-1341-2181; Lidbury, Brett/0000-0003-2211-989X; Birnbaum,
   Linda/0000-0001-5429-5658; BALAPURE, ANIL/0000-0003-1213-4586
CR Andreev VP, 2012, J PROTEOME RES, V11, P3053, DOI 10.1021/pr3001546
   Beach TG, 2013, J ALZHEIMERS DIS, V33, pS219, DOI 10.3233/JAD-2012-129020
   Bellin M, 2012, NAT REV MOL CELL BIO, V13, P713, DOI 10.1038/nrm3448
   Benam KH, 2015, ANNU REV PATHOL-MECH, V10, P195, DOI 10.1146/annurev-pathol-012414-040418
   Birnbaum LS, 2010, ENVIRON HEALTH PERSP, V118, pA327, DOI 10.1289/ehp.1002661
   Choi SH, 2014, NATURE, V515, P274, DOI 10.1038/nature13800
   Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523
   Collins FS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002747
   Ghosh S, 2011, NAT REV GENET, V12, P821, DOI 10.1038/nrg3096
   Gohlke JM, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-46
   Jimenez Connie R, 2014, Am Soc Clin Oncol Educ Book, pe504, DOI 10.14694/EdBook_AM.2014.34.e504
   Kaitin KI, 2011, CLIN PHARMACOL THER, V89, P183, DOI 10.1038/clpt.2010.286
   Koren E, 2007, CLIN IMMUNOL, V124, P26, DOI 10.1016/j.clim.2007.03.544
   Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248
   Langley GR, 2014, DRUG DISCOV TODAY, V19, P1114, DOI 10.1016/j.drudis.2014.03.013
   Lango H, 2008, J INTERN MED, V263, P16, DOI 10.1111/j.1365-2796.2007.01895.x
   Ledford H, 2008, NATURE, V453, P843, DOI 10.1038/453843a
   Lioy PJ, 2011, ENVIRON HEALTH PERSP, V119, pA466, DOI 10.1289/ehp.1104387
   Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016
   Mitne-Neto M, 2011, HUM MOL GENET, V20, P3642, DOI 10.1093/hmg/ddr284
   Muotri AR, 2016, BIOL PSYCHIAT, V79, P642, DOI 10.1016/j.biopsych.2015.03.012
   NRC, 2007, TOXICITY TESTING 21
   OECD, 2012, OECD SER TEST ASS 1
   Organisation for Economic Co-operation and Development (OECD), 2013, OECD SER TEST ASS, V184
   Pound P, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3387
   Rosen C, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-20
   Scannell JW, 2012, NAT REV DRUG DISCOV, V11, P191, DOI 10.1038/nrd3681
   Scientific Committee on Health and Environmental Risks (SCHER) Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR) Scientific Committee on Consumer Safety (SCCS), 2013, ADDR NEW CHALL RISK
   Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110
   Shenderov B. A., 2014, MICROB ECOL HEALTH D, V8, DOI DOI 10.3402/MEHD.V25.24145
   Singh N, 2011, CANCER SCI, V102, P1059, DOI 10.1111/j.1349-7006.2011.01893.x
   Tonevitsky Alexander G., 2013, BMC Physiology, V13, P9, DOI 10.1186/1472-6793-13-9
   Twine NA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016266
   van de Stolpe A, 2015, RSC ADV, V5, P18451, DOI 10.1039/c4ra15794j
   van de Stolpe A, 2013, LAB CHIP, V13, P3449, DOI 10.1039/c3lc50248a
   van der Sijde MR, 2014, BBA-MOL BASIS DIS, V1842, P1903, DOI 10.1016/j.bbadis.2014.04.025
   Vinken M, 2013, TOXICOL SCI, V136, P97, DOI 10.1093/toxsci/kft177
   Weibrecht I, 2013, NAT PROTOC, V8, P355, DOI 10.1038/nprot.2013.006
   Willett C., 2014, ENCY TOXICOLOGY, V1, P95
   Zanella F, 2014, TRENDS CARDIOVAS MED, V24, P32, DOI 10.1016/j.tcm.2013.06.002
   Zerhouni EA, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008294
NR 41
TC 36
Z9 37
U1 1
U2 14
PU US DEPT HEALTH HUMAN SCIENCES PUBLIC HEALTH SCIENCE
PI RES TRIANGLE PK
PA NATL INST HEALTH, NATL INST ENVIRONMENTAL HEALTH SCIENCES, PO BOX 12233,
   RES TRIANGLE PK, NC 27709-2233 USA
SN 0091-6765
EI 1552-9924
J9 ENVIRON HEALTH PERSP
JI Environ. Health Perspect.
PD NOV
PY 2015
VL 123
IS 11
BP A268
EP A272
DI 10.1289/ehp.1510345
PG 5
WC Environmental Sciences; Public, Environmental & Occupational Health;
   Toxicology
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health; Toxicology
GA DA1VW
UT WOS:000367584600001
PM 26523530
OA DOAJ Gold, Green Published
DA 2019-10-23
ER

PT J
AU Debeuckelaere, C
   Berl, V
   Elbayed, K
   Moussallieh, FM
   Namer, IJ
   Lepoittevin, JP
AF Debeuckelaere, Camille
   Berl, Valerie
   Elbayed, Karim
   Moussallieh, Francois-Marie
   Namer, Izzie-Jacques
   Lepoittevin, J. -P.
TI Matrix Effect of Human Reconstructed Epidermis on the Chemoselectivity
   of a Skin Sensitizing alpha-Methylene-gamma-Butyrolactone: Consequences
   for the Development of in Chemico Alternative Methods
SO CHEMICAL RESEARCH IN TOXICOLOGY
LA English
DT Article
ID SCREENING CONTACT ALLERGENS; PEPTIDE REACTIVITY ASSAY; HUMAN
   SERUM-ALBUMIN; AMINO-ACIDS; COVALENT BINDING; DENDRITIC CELLS;
   GLUTATHIONE; LACTONE; MODEL; VITRO
AB Adoption of new legislations and social pressure are pushing toward the development of alternative methods to the use of animals for the assessment of most toxicological end-points including skin sensitization. To that respect, much efforts have been put in the first step of the adverse outcome pathway focusing on chemical interactions taking place between sensitizing chemicals or haptens and epidermal proteins. However, these in chemico approaches have been so far only based on the use of model nucleophiles, amino acids, peptides, or proteins in water/buffer solution and focused mainly on thiol reactivity. These studies even if bringing a valuable set of information are very far from reflecting chemical interactions that may happen between a xenobiotic and nudeophiles present in a complex heterogeneous tissue such as the epidermis. Recently, we have shown that using a high-resolution magic angle spinning (HRMAS) nuclear magnetic resonance (NMR) technique it was possible to characterize chemical interactions taking place between a skin sensitizer and nudeophilic amino acids present in a 3-D reconstructed human epidermis (RHE). We have now compared the chemical reactivity and chemoselectivity of a sensitizing alpha-methylene-gamma-butyrolactone toward human serum albumin used as a model protein and RHE. Using this technique, we showed that amino acid modifications by this hapten was different according to the model used and that in RHE histidine residues seem to have an important role in the formation of adducts. Obviously, the role of histidine in the induction of skin sensitization has been so far neglected and should probably be taken into account for the refinement of in chemico approaches for the detection and potency classification of skin sensitizers.
C1 [Debeuckelaere, Camille; Berl, Valerie; Elbayed, Karim; Moussallieh, Francois-Marie; Lepoittevin, J. -P.] CNRS, Inst Chem, UMR 7177, F-67081 Strasbourg, France.
   [Debeuckelaere, Camille; Berl, Valerie; Elbayed, Karim; Moussallieh, Francois-Marie; Namer, Izzie-Jacques; Lepoittevin, J. -P.] Univ Strasbourg, F-67081 Strasbourg, France.
   [Elbayed, Karim; Moussallieh, Francois-Marie; Namer, Izzie-Jacques] CNRS, Lab Sci Ingenieur Informat & Imagerie ICube, UMR 7357, F-67081 Strasbourg, France.
RP Lepoittevin, JP (reprint author), CNRS, Inst Chem, UMR 7177, 4 Rue Blaise Pascal, F-67081 Strasbourg, France.
EM jplepoit@unistra.fr
OI NAMER, Izzie Jacques/0000-0003-1822-7759
FU Centre National de la Recherche Scientifique (CNRS, France)Centre
   National de la Recherche Scientifique (CNRS)
FX This research was partly supported by an interdisciplinary grant
   (Physic-Chemistry-Biology Interface Program) of the Centre National de
   la Recherche Scientifique (CNRS, France).
CR Alvarez-Sanchez R, 2004, CHEM RES TOXICOL, V17, P1280, DOI 10.1021/tx049935+
   [Anonymous], 2001, OECD GUIDELINES TEST, P1, DOI [10.1787/20745788., DOI 10.1787/20745788, 10.1787/20745788]
   [Anonymous], 1967, OFF J EUR COMMUN, V196, P1
   [Anonymous], 2006, OFF J EUR UNION L, VL 396, P1
   [Anonymous], 1999, OFF J EUR COMMUN L, VL200, P1
   Aptula AO, 2006, TOXICOL IN VITRO, V20, P239, DOI 10.1016/j.tiv.2005.07.003
   Casati S, 2005, ATLA-ALTERN LAB ANIM, V33, P47, DOI 10.1177/026119290503300108
   DUPUIS G, 1974, CAN J BIOCHEM CELL B, V52, P575, DOI 10.1139/o74-083
   Eilstein J, 2014, ARCH TOXICOL, V88, P1681, DOI 10.1007/s00204-014-1218-6
   Elbayed K, 2013, CHEM RES TOXICOL, V26, P136, DOI 10.1021/tx300428u
   Fleischel O, 2009, CHEM RES TOXICOL, V22, P1106, DOI 10.1021/tx9000539
   Franot C, 1993, Bioorg Med Chem, V1, P389, DOI 10.1016/S0968-0896(00)82146-X
   Fuchs S, 2007, EUR J ORG CHEM, P1145, DOI 10.1002/ejoc.200600611
   Gamerdinger K, 2003, J EXP MED, V197, P1345, DOI 10.1084/jem.20030121
   Gerberick G.F., 2008, ATLA-ALTERN LAB ANIM, V36, P215
   Gerberick GF, 2007, TOXICOL SCI, V97, P417, DOI 10.1093/toxsci/kfm064
   Gerberick GF, 2004, TOXICOL SCI, V81, P332, DOI 10.1093/toxsci/kfh213
   Gotz C, 2012, EXP DERMATOL, V21, P358, DOI 10.1111/j.1600-0625.2012.01486.x
   Kato Hiroshi, 2003, J Toxicol Sci, V28, P19, DOI 10.2131/jts.28.19
   Kunzmann MH, 2011, BIOCHEMISTRY-US, V50, P910, DOI 10.1021/bi101858g
   KUPCHAN SM, 1970, SCIENCE, V168, P376, DOI 10.1126/science.168.3929.376
   Landsteiner K, 1936, J EXP MED, V64, P625, DOI 10.1084/jem.64.4.625
   Lepoittevin JP, 2011, CONTACT DERMATITIS, FIFTH EDITION, P91, DOI 10.1007/978-3-642-03827-3_4
   Lepoittevin JP, 2009, CHEM REC, V9, P258, DOI 10.1002/tcr.200900013
   Meschkat E, 2001, CHEM RES TOXICOL, V14, P118, DOI 10.1021/tx000226f
   Migdal C, 2013, TOXICOL SCI, V133, P259, DOI 10.1093/toxsci/kft075
   MONDER C, 1970, BIOCHEMISTRY-US, V9, P2489, DOI 10.1021/bi00814a015
   Netzlaff F, 2005, EUR J PHARM BIOPHARM, V60, P167, DOI DOI 10.1016/J.EJPB.2005.03.004
   PONEC M, 1995, ATLA-ALTERN LAB ANIM, V23, P97
   ROSDY M, 1990, J INVEST DERMATOL, V95, P409, DOI 10.1111/1523-1747.ep12555510
   SCHAEFFER M, 1990, CONTACT DERMATITIS, V22, P32, DOI 10.1111/j.1600-0536.1990.tb01502.x
   Schmidt M, 2010, NAT IMMUNOL, V11, P814, DOI 10.1038/ni.1919
   Schultz TW, 2005, SAR QSAR ENVIRON RES, V16, P313, DOI 10.1080/10659360500204152
   TALAGA P, 1989, TETRAHEDRON, V45, P5029, DOI 10.1016/S0040-4020(01)81082-6
   TALAGA P, 1990, BIOORG CHEM, V18, P199, DOI 10.1016/0045-2068(90)90042-4
   Troutman JA, 2011, TOXICOL SCI, V122, P422, DOI 10.1093/toxsci/kfr101
   Wisnewski AV, 2011, CHEM RES TOXICOL, V24, P1686, DOI 10.1021/tx2002433
   2003, OFFICIAL J EUR UNI L, V66, P26
NR 38
TC 1
Z9 1
U1 0
U2 2
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0893-228X
EI 1520-5010
J9 CHEM RES TOXICOL
JI Chem. Res. Toxicol.
PD NOV
PY 2015
VL 28
IS 11
BP 2192
EP 2198
DI 10.1021/acs.chemrestox.5b00363
PG 7
WC Chemistry, Medicinal; Chemistry, Multidisciplinary; Toxicology
SC Pharmacology & Pharmacy; Chemistry; Toxicology
GA CW4RW
UT WOS:000364980800015
PM 26496248
DA 2019-10-23
ER

PT J
AU Heise, T
   Schmidt, F
   Knebel, C
   Rieke, S
   Haider, W
   Pfeil, R
   Kneuer, C
   Niemann, L
   Marx-Stoelting, P
AF Heise, T.
   Schmidt, F.
   Knebel, C.
   Rieke, S.
   Haider, W.
   Pfeil, R.
   Kneuer, C.
   Niemann, L.
   Marx-Stoelting, P.
TI Hepatotoxic effects of (tri)azole fungicides in a broad dose range
SO ARCHIVES OF TOXICOLOGY
LA English
DT Article
DE Liver; Low dose; Phenobarbital; Triazole; Adverse outcome pathway
ID TRIAZOLE CONAZOLE FUNGICIDES; CONSTITUTIVE ANDROSTANE RECEPTOR;
   ENDOCRINE-DISRUPTING CHEMICALS; GENE-EXPRESSION; MOUSE-LIVER;
   TRANSCRIPTIONAL PROFILES; PROPICONAZOLE; RAT; MYCLOBUTANIL; TRIADIMEFON
AB The toxicological relevance of effects observed at molecular stage, which occur at dose levels well below classical no-observed adverse effect levels is currently subject to controversial scientific debate. While the importance of molecular effects for the identification of a mode of action or an adverse outcome pathway is undisputed, their impact for other regulatory purposes remains uncertain. Here, we report the results of a 28-day rat-feeding study including three widely used hepatotoxic (tri)azole fungicides (cyproconazole, epoxiconazole and prochloraz) administered individually at five dose levels, ranging from slightly above the reference values to a clear toxic effect dose. Parameters analysed included pathology, histopathology, clinical chemistry and particularly effects on the molecular level. Since azole fungicides are considered to cause liver toxicity by a mechanism involving the constitutive androstane receptor (CAR), a known CAR activator (phenobarbital, PB) was administered to investigate potential similarities between triazoles and PB-mediated liver toxicity by pathway-focused gene expression analysis. Our results show an increase in liver weights and additionally histopathological changes (hepatocellular hypertrophy) for all substances at the top dose levels. The effects on liver weight were most pronounced for cyproconazole by which also the animals receiving the next lower dose were affected. In addition, vacuolisation of hepatocytes was observed at the top dose level. No such findings were obtained with any substance at lower doses to which consumers and operators might be exposed to. In contrast, the expression of sensitive marker genes (like some cytochrome-P-450 isoforms) was significantly affected also at the lower dose levels. While some of these changes, like the induction of genes related to fatty acid and phospholipid metabolism (e.g. Fasn, Fat/Cd36, Ppargc1a) or xenobiotic metabolism (Cyp1a1, Cyp2b1, Cyp3a2), could be associated with high dose effects like hepatocellular vacuolisation or hypertrophy, a histopathological correlate was lacking for others.
C1 [Heise, T.; Schmidt, F.; Knebel, C.; Rieke, S.; Pfeil, R.; Kneuer, C.; Niemann, L.; Marx-Stoelting, P.] BfR Fed Inst Risk Assessment, Berlin, Germany.
   [Haider, W.] Inst Anim Pathol, Berlin, Germany.
RP Marx-Stoelting, P (reprint author), BfR Fed Inst Risk Assessment, Berlin, Germany.
EM Philip.marx-stoelting@bfr.bund.de
CR Amaral JD, 2010, DISCOV MED, V9, P145
   [Anonymous], 2008, EFSA J, V6, DOI 10.2903/j.efsa.2008.176r
   Beausoleil C, 2013, CHEMOSPHERE, V93, P847, DOI 10.1016/j.chemosphere.2013.06.043
   Boobis AR, 2008, CRIT REV TOXICOL, V38, P87, DOI 10.1080/10408440701749421
   Currie RA, 2014, TOXICOLOGY
   Dewhurst I, 2004, JOINT WHO FAO M PEST
   Edwards SG, 2010, FOOD ADDIT CONTAM A, V27, P629, DOI 10.1080/19440040903515942
   EFSA, 2011, EFSA J, V9, P2323, DOI DOI 10.2903/J.EFSA.2011.2323
   European Food Safety Authority, 2010, EFSA J, V8, DOI 10.2903/j.efsa.2010.1897
   Goetz AK, 2006, TOXICOL APPL PHARM, V215, P274, DOI 10.1016/j.taap.2006.02.016
   Goetz AK, 2009, SYST BIOL REPROD MED, V55, P214, DOI 10.3109/19396360903234045
   Goetz AK, 2009, TOXICOL SCI, V110, P449, DOI 10.1093/toxsci/kfp098
   Goetz AK, 2009, TOXICOL APPL PHARM, V238, P80, DOI 10.1016/j.taap.2009.04.016
   Handschin C, 2009, TRENDS PHARMACOL SCI, V30, P322, DOI 10.1016/j.tips.2009.03.006
   Heseltine E, 2001, IARC MON EV CARC RIS, V79, P161
   Hester S, 2012, TOXICOL SCI, V127, P54, DOI 10.1093/toxsci/kfs086
   Hester SD, 2006, TOXICOL PATHOL, V34, P879, DOI 10.1080/01926230601047824
   Jacobsen PR, 2012, REPROD TOXICOL, V34, P237, DOI 10.1016/j.reprotox.2012.05.099
   Leone TC, 2005, PLOS BIOL, V3, P672, DOI 10.1371/journal.pbio.0030101
   Long M, 2003, TOXICOLOGY, V194, P77, DOI 10.1016/j.tox.2003.08.001
   Menegola E, 2006, REPROD TOXICOL, V22, P186, DOI 10.1016/j.reprotox.2006.04.008
   Myers JP, 2009, ENVIRON HEALTH PERSP, V117, P309, DOI 10.1289/ehp.0800173
   Nesnow S, 2009, TOXICOL SCI, V110, P68, DOI 10.1093/toxsci/kfp076
   OECD, 2008, REP DOS 28 DAY OR TO
   OECD, 2013, SER TEST ASS, V184
   Peffer RC, 2007, TOXICOL SCI, V99, P315, DOI 10.1093/toxsci/kfm154
   Rhomberg LR, 2012, REGUL TOXICOL PHARM, V64, P130, DOI 10.1016/j.yrtph.2012.06.015
   Sun G, 2007, XENOBIOTICA, V37, P180, DOI 10.1080/00498250601059942
   Sun GB, 2005, TOXICOL LETT, V155, P277, DOI 10.1016/j.toxlet.2004.10.006
   Tamura K, 2013, TOXICOL LETT, V221, P47, DOI 10.1016/j.toxlet.2013.05.011
   Trosken ER, 2006, TOXICOLOGY, V228, P24, DOI 10.1016/j.tox.2006.08.007
   Trosken ER, 2004, ENDOCR RES, V30, P387, DOI 10.1081/ERC-200035093
   Tully DB, 2006, TOXICOL APPL PHARM, V215, P260, DOI 10.1016/j.taap.2006.02.015
   Vanden Bossche H, 1988, Skin Pharmacol, V1, P176
   Vandenberg LN, 2012, ENDOCR REV, V33, P378, DOI 10.1210/er.2011-1050
   Vinken M, 2013, TOXICOLOGY, V312, P158, DOI 10.1016/j.tox.2013.08.011
   Ward WO, 2006, TOXICOL PATHOL, V34, P863, DOI 10.1080/01926230601047832
   Wolf DC, 2006, TOXICOL PATHOL, V34, P895, DOI 10.1080/01926230601047808
   Zarn JA, 2003, ENVIRON HEALTH PERSP, V111, P255, DOI 10.1289/ehp.5785
NR 39
TC 19
Z9 19
U1 0
U2 31
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0340-5761
EI 1432-0738
J9 ARCH TOXICOL
JI Arch. Toxicol.
PD NOV
PY 2015
VL 89
IS 11
BP 2105
EP 2117
DI 10.1007/s00204-014-1336-1
PG 13
WC Toxicology
SC Toxicology
GA CX0WK
UT WOS:000365417800017
PM 25182419
DA 2019-10-23
ER

PT J
AU Grafstrom, RC
   Nymark, P
   Hongisto, V
   Spjuth, O
   Ceder, R
   Willighagen, E
   Hardy, B
   Kaski, S
   Kohonen, P
AF Grafstrom, Roland C.
   Nymark, Penny
   Hongisto, Vesa
   Spjuth, Ola
   Ceder, Rebecca
   Willighagen, Egon
   Hardy, Barry
   Kaski, Samuel
   Kohonen, Pekka
TI Toward the Replacement of Animal Experiments through the
   Bioinformatics-driven Analysis of 'Omics' Data from Human Cell Cultures
SO ATLA-ALTERNATIVES TO LABORATORY ANIMALS
LA English
DT Article
DE alternative methods; adverse outcome pathway; benchmark dose;
   bioinformatics; databases; in silico; systems toxicology; toxicogenomics
ID RISK-ASSESSMENT; PREDICTIVE TOXICOLOGY; BIG DATA; TOXICITY; CANCER;
   CHEMICALS; PATHWAYS; MODELS; KERATINOCYTES; MECHANISMS
AB This paper outlines the work for which Roland Grafstrom and Pekka Kohonen were awarded the 2014 Lush Science Prize. The research activities of the Grafstrom laboratory have, for many years, covered cancer biology studies, as well as the development and application of toxicity-predictive in vitro models to determine chemical safety. Through the integration of in silico analyses of diverse types of genomics data (transcriptomic and proteomic), their efforts have proved to fit well into the recently-developed Adverse Outcome Pathway paradigm. Genomics analysis within state-of-the-art cancer biology research and Toxicology in the 21st Century concepts share many technological tools. A key category within the Three Rs paradigm is the Replacement of animals in toxicity testing with alternative methods, such as bioinformatics-driven analyses of data obtained from human cell cultures exposed to diverse toxicants. This work was recently expanded within the pan-European SEURAT-1 project (Safety Evaluation Ultimately Replacing Animal Testing), to replace repeat-dose toxicity testing with data-rich analyses of sophisticated cell culture models. The aims and objectives of the SEURAT project have been to guide the application, analysis, interpretation and storage of 'omics' technology-derived data within the service-oriented sub-project, ToxBank. Particularly addressing the Lush Science Prize focus on the relevance of toxicity pathways, a 'data warehouse' that is under continuous expansion, coupled with the development of novel data storage and management methods for toxicology, serve to address data integration across multiple 'omics' technologies. The prize winners' guiding principles and concepts for modern knowledge management of toxicological data are summarised. The translation of basic discovery results ranged from chemical-testing and material-testing data, to information relevant to human health and environmental safety.
C1 [Grafstrom, Roland C.; Nymark, Penny; Ceder, Rebecca; Kohonen, Pekka] Karolinska Inst, Inst Environm Med, S-17177 Stockholm, Sweden.
   [Hongisto, Vesa] Misvik Biol Corp, Dept Toxicol, Turku, Finland.
   [Spjuth, Ola] Karolinska Inst, Dept Med Epidemiol & Biostat, Swedish E Sci Res Ctr, Stockholm, Sweden.
   [Spjuth, Ola] Uppsala Univ, Dept Pharmaceut Biosci, Uppsala, Sweden.
   [Spjuth, Ola] Uppsala Univ, Sci Life Lab, Uppsala, Sweden.
   [Willighagen, Egon] Maastricht Univ, Dept Bioinformat BiGCat, NL-6200 MD Maastricht, Netherlands.
   [Hardy, Barry] Douglas Connect GmbH, Zeiningen, Switzerland.
   [Kaski, Samuel] Aalto Univ, Helsinki Inst Informat Technol, Dept Comp Sci, Helsinki, Finland.
RP Grafstrom, RC (reprint author), Karolinska Inst, Inst Environm Med, Box 210, S-17177 Stockholm, Sweden.
EM roland.grafstrom@ki.se
RI Spjuth, Ola/Q-2638-2019; Kohonen, Pekka/F-9596-2011; Willighagen,
   Egon/C-6136-2008; Kaski, Samuel/B-6684-2008; Grafstrom,
   Roland/N-7217-2016
OI Spjuth, Ola/0000-0002-8083-2864; Kohonen, Pekka/0000-0002-7845-3611;
   Willighagen, Egon/0000-0001-7542-0286; Kaski,
   Samuel/0000-0003-1925-9154; Nymark, Penny/0000-0002-3435-7775
FU Swedish Cancer and Allergy Fund; Swedish Research CouncilSwedish
   Research Council; Swedish Fund for Research without Animal Experiments;
   Karolinska InstitutetKarolinska Institutet
FX The research outlined in this article was funded, in part, by the
   following: the Swedish Cancer and Allergy Fund, the Swedish Research
   Council, the Swedish Fund for Research without Animal Experiments and
   the Karolinska Institutet.
CR Adeleye Y, 2015, TOXICOLOGY, V332, P102, DOI 10.1016/j.tox.2014.02.007
   Afshari CA, 2011, TOXICOL SCI, V120, pS225, DOI 10.1093/toxsci/kfq373
   Andersen ME, 2015, ARCH TOXICOL, V89, P809, DOI 10.1007/s00204-015-1512-y
   Attene-Ramos MS, 2015, ENVIRON HEALTH PERSP, V123, P49, DOI 10.1289/ehp.1408642
   Berggren E., 2015, ENV HLTH PERSPECTIVE
   Blei DM, 2014, ANNU REV STAT APPL, V1, P203, DOI 10.1146/annurev-statistics-022513-115657
   Ceder R, 2007, ATLA-ALTERN LAB ANIM, V35, P621, DOI 10.1177/026119290703500603
   Ceder R, 2012, AM J PATHOL, V180, P457, DOI 10.1016/j.ajpath.2011.10.016
   Chen MJ, 2014, BIOMARK MED, V8, P201, DOI 10.2217/bmm.13.146
   Chen MJ, 2012, TOXICOL SCI, V130, P217, DOI 10.1093/toxsci/kfs223
   Clewell RA, 2014, TOXICOL SCI, V142, P56, DOI 10.1093/toxsci/kfu153
   Costello JC, 2014, NAT BIOTECHNOL, V32, P1202, DOI 10.1038/nbt.2877
   Daston G, 2015, ARCH TOXICOL, V89, P15, DOI 10.1007/s00204-014-1421-5
   Davis AP, 2015, NUCLEIC ACIDS RES, V43, pD914, DOI 10.1093/nar/gku935
   Duan QN, 2014, NUCLEIC ACIDS RES, V42, pW449, DOI 10.1093/nar/gku476
   El-Hachem N., 2015, ENV HLTH PERSPECTIVE
   Embry MR, 2014, CRIT REV TOXICOL, V44, P6, DOI 10.3109/10408444.2014.931924
   Gusenleitner D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102579
   Igarashi Y, 2015, NUCLEIC ACIDS RES, V43, pD921, DOI 10.1093/nar/gku955
   Kleinstreuer NC, 2014, NAT BIOTECHNOL, V32, P583, DOI 10.1038/nbt.2914
   Knudsen TB, 2015, TOXICOL SCI, V143, P256, DOI 10.1093/toxsci/kfu234
   Kohonen P, 2014, BASIC CLIN PHARMACOL, V115, P50, DOI 10.1111/bcpt.12257
   Kohonen P, 2013, MOL INFORM, V32, P47, DOI 10.1002/minf.201200114
   Krewski D, 2014, ENVIRON HEALTH PERSP, V122, P796, DOI 10.1289/ehp.1307260
   Lamb J, 2007, NAT REV CANCER, V7, P54, DOI 10.1038/nrc2044
   Leist M, 2014, ALTEX-ALTERN ANIM EX, V31, P341, DOI 10.14573/altex.1406091
   Ma'ayan A, 2014, TRENDS PHARMACOL SCI, V35, P450, DOI 10.1016/j.tips.2014.07.001
   National Research Council, 2007, TOX TEST 21 CENT VIS
   Natsoulis G, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.9
   Parkkinen JA, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-113
   Simmons SO, 2009, TOXICOL SCI, V111, P202, DOI 10.1093/toxsci/kfp140
   Smalley JL, 2010, TOXICOLOGY, V268, P143, DOI 10.1016/j.tox.2009.09.014
   Spjuth O, 2015, BIOL DIRECT, V10, DOI 10.1186/s13062-015-0071-8
   Thomas RS, 2013, TOXICOL SCI, V136, P4, DOI 10.1093/toxsci/kft178
   Thomas RS, 2011, TOXICOL SCI, V120, P194, DOI 10.1093/toxsci/kfq355
   Tralau T, 2015, ARCH TOXICOL, V89, P823, DOI 10.1007/s00204-015-1510-0
   Villeneuve DL, 2014, TOXICOL SCI, V142, P312, DOI 10.1093/toxsci/kfu199
   Villeneuve DL, 2014, TOXICOL SCI, V142, P321, DOI 10.1093/toxsci/kfu200
   Wambaugh JF, 2015, TOXICOL SCI, V147, P55, DOI 10.1093/toxsci/kfv118
   Wetmore BA, 2015, TOXICOLOGY, V332, P94, DOI 10.1016/j.tox.2014.05.012
   Zhu H, 2014, CHEM RES TOXICOL, V27, P1643, DOI 10.1021/tx500145h
NR 41
TC 13
Z9 14
U1 2
U2 33
PU FRAME
PI NOTTINGHAM
PA RUSSELL & BURCH HOUSE 96-98 NORTH SHERWOOD ST, NOTTINGHAM NG1 4EE,
   NOTTS, ENGLAND
SN 0261-1929
J9 ATLA-ALTERN LAB ANIM
JI ATLA-Altern. Lab. Anim.
PD NOV
PY 2015
VL 43
IS 5
BP 325
EP 332
DI 10.1177/026119291504300506
PG 8
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA DB3TO
UT WOS:000368434900009
PM 26551289
DA 2019-10-23
ER

PT J
AU Perkins, EJ
   Antczak, P
   Burgoon, L
   Falciani, F
   Garcia-Reyero, N
   Gutsell, S
   Hodges, G
   Kienzler, A
   Knapen, D
   McBride, M
   Willett, C
AF Perkins, Edward J.
   Antczak, Philipp
   Burgoon, Lyle
   Falciani, Francesco
   Garcia-Reyero, Natalia
   Gutsell, Steve
   Hodges, Geoff
   Kienzler, Aude
   Knapen, Dries
   McBride, Mary
   Willett, Catherine
TI Adverse Outcome Pathways for Regulatory Applications: Examination of
   Four Case Studies With Different Degrees of Completeness and Scientific
   Confidence
SO TOXICOLOGICAL SCIENCES
LA English
DT Article
DE mode of action; regulatory toxicology; risk assessment; hazard
   assessment; tox21
ID ENDOCRINE-DISRUPTING CHEMICALS; QUANTITATIVE RISK-ASSESSMENT; MINNOW
   PIMEPHALES-PROMELAS; EARLY FISH DEVELOPMENT; BASE-LINE TOXICITY;
   LYMPH-NODE ASSAY; SKIN SENSITIZATION; FATHEAD MINNOW;
   CONCEPTUAL-FRAMEWORK; ENVIRONMENTAL-POLLUTANTS
AB Adverse outcome pathways (AOPs) offer a pathway-based toxicological framework to support hazard assessment and regulatory decision-making. However, little has been discussed about the scientific confidence needed, or how complete a pathway should be, before use in a specific regulatory application. Here we review four case studies to explore the degree of scientific confidence and extent of completeness (in terms of causal events) that is required for an AOP to be useful for a specific purpose in a regulatory application: (i) Membrane disruption (Narcosis) leading to respiratory failure (low confidence), (ii) Hepatocellular proliferation leading to cancer (partial pathway, moderate confidence), (iii) Covalent binding to proteins leading to skin sensitization (high confidence), and (iv) Aromatase inhibition leading to reproductive dysfunction in fish (high confidence). Partially complete AOPs with unknown molecular initiating events, such as 'Hepatocellular proliferation leading to cancer', were found to be valuable. We demonstrate that scientific confidence in these pathways can be increased though the use of unconventional information (eg, computational identification of potential initiators). AOPs at all levels of confidence can contribute to specific uses. A significant statistical or quantitative relationship between events and/or the adverse outcome relationships is a common characteristic of AOPs, both incomplete and complete, that have specific regulatory uses. For AOPs to be useful in a regulatory context they must be at least as useful as the tools that regulators currently possess, or the techniques currently employed by regulators.
C1 [Perkins, Edward J.; Burgoon, Lyle] US Army Engineer Res & Dev Ctr, Environm Lab, Vicksburg, MS 39180 USA.
   [Antczak, Philipp; Falciani, Francesco] Univ Liverpool, Inst Integrat Biol, Liverpool L69 3BX, Merseyside, England.
   [Garcia-Reyero, Natalia] Mississippi State Univ, Inst Genom Biocomp & Biotechnol, Starkville, MS USA.
   [Gutsell, Steve; Hodges, Geoff] Unilever, Sharnbrook MK44 1LQ, Beds, England.
   [Kienzler, Aude] JRC Inst Hlth & Consumer Protect, Ispra, Italy.
   [Knapen, Dries] Univ Antwerp, Zebrafishlab, B-2610 Antwerp, Belgium.
   [McBride, Mary] Agilent Technol, Washington, DC USA.
   [Willett, Catherine] Humane Soc United States, Washington, DE USA.
RP Perkins, EJ (reprint author), US Army Engineer Res & Dev Ctr, 3909 Halls Ferry Rd, Vicksburg, MS 39180 USA.
EM edward.j.perkins@usace.army.mil
RI Antczak, Philipp/L-5879-2019; Burgoon, Lyle D./I-2894-2019
OI Antczak, Philipp/0000-0001-9600-7757; Burgoon, Lyle
   D./0000-0003-4977-5352; Knapen, Dries/0000-0003-0472-8114
FU American Chemistry Council; BioDetection Systems; European Centre for
   Ecotoxicology and Toxicology of Chemicals; Environment Canada; European
   Commission Directorate General Joint Research Center; Human Toxicology
   Project Consortium; International Life Sciences Institute-Health and
   Environmental Science Institute; Research Council of NorwayResearch
   Council of Norway [221455]; Society for Environmental Toxicology and
   Chemistry; U.S. Army Engineer Research and Development Center; U.S.
   Environmental Protection AgencyUnited States Environmental Protection
   Agency
FX Support for the workshop was provided by the American Chemistry Council,
   BioDetection Systems, European Centre for Ecotoxicology and Toxicology
   of Chemicals, Environment Canada, European Commission Directorate
   General Joint Research Center, Human Toxicology Project Consortium,
   International Life Sciences Institute-Health and Environmental Science
   Institute, the Research Council of Norway (221455), Society for
   Environmental Toxicology and Chemistry, U.S. Army Engineer Research and
   Development Center, and the U.S. Environmental Protection Agency.
CR Ankley GT, 2014, ENVIRON TOXICOL CHEM, V33, P2529, DOI 10.1002/etc.2708
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   [Anonymous], 2013, SER TEST ASS
   Antczak P, 2015, ENVIRON SCI TECHNOL, V49, P11132, DOI 10.1021/acs.est.5b02707
   Api AM, 2008, REGUL TOXICOL PHARM, V52, P3, DOI 10.1016/j.yrtph.2007.10.008
   Argese E, 2001, ENVIRON TOXICOL CHEM, V20, P826, DOI 10.1002/etc.5620200418
   Austin TJ, 2014, SAR QSAR ENVIRON RES, V25, P147, DOI 10.1080/1062936X.2013.871577
   Becker RA, 2015, REGUL TOXICOL PHARM, V72, P514, DOI 10.1016/j.yrtph.2015.04.004
   Bhattacharya S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020887
   Black SM, 2008, AM J PHYSIOL-CELL PH, V294, pC345, DOI 10.1152/ajpcell.00216.2007
   Boobis AR, 2008, CRIT REV TOXICOL, V38, P87, DOI 10.1080/10408440701749421
   Boobis AR, 2006, CRIT REV TOXICOL, V36, P781, DOI 10.1080/10408440600977677
   Breen M, 2013, TOXICOL SCI, V133, P234, DOI 10.1093/toxsci/kft067
   Claeys L, 2013, ENVIRON TOXICOL CHEM, V32, P2217, DOI 10.1002/etc.2301
   Cote I, 2012, ENVIRON HEALTH PERSP, V120, P1499, DOI 10.1289/ehp.1104870
   Dethloff G. M., 2000, 20000005 USGSBRD
   Dom N, 2012, ENVIRON SCI TECHNOL, V46, P10, DOI 10.1021/es201095r
   Dom N, 2012, CHEMOSPHERE, V86, P56, DOI 10.1016/j.chemosphere.2011.08.050
   Dourson M, 2014, REGUL TOXICOL PHARM, V68, P387, DOI 10.1016/j.yrtph.2014.01.011
   Elsharkawy AM, 2007, HEPATOLOGY, V46, P590, DOI 10.1002/hep.21802
   Escher BI, 2002, AQUAT SCI, V64, P20, DOI 10.1007/s00027-002-8052-2
   *EUR COMM, 2006, OFFICIAL J EUROPEA L, V396, P1
   Falanga A, 2013, J THROMB HAEMOST, V11, P223, DOI 10.1111/jth.12075
   FAUTZ R, 1991, MUTAT RES, V253, P173, DOI 10.1016/0165-1161(91)90130-Z
   Garcia-Reyero N, 2015, ENVIRON SCI TECHNOL, V49, P3, DOI 10.1021/es504976d
   Gerberick GF, 2007, METHODS, V41, P54, DOI 10.1016/j.ymeth.2006.07.006
   Groh KJ, 2015, CHEMOSPHERE, V120, P764, DOI 10.1016/j.chemosphere.2014.09.068
   Groh KJ, 2015, CHEMOSPHERE, V120, P778, DOI 10.1016/j.chemosphere.2014.10.006
   Hecker M, 2011, ENVIRON SCI POLLUT R, V18, P503, DOI 10.1007/s11356-010-0396-x
   HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503
   Jaworska J, 2013, J APPL TOXICOL, V33, P1353, DOI 10.1002/jat.2869
   JBRC Japan Bioassay Research Center, 1998, 2 YEAR STUD 1 4 DIOX
   Judson RS, 2011, CHEM RES TOXICOL, V24, P451, DOI 10.1021/tx100428e
   Julien E, 2009, CRIT REV FOOD SCI, V49, P682, DOI 10.1080/10408390903110692
   Kano H, 2009, FOOD CHEM TOXICOL, V47, P2776, DOI 10.1016/j.fct.2009.08.012
   Kasai T, 2009, INHAL TOXICOL, V21, P889, DOI 10.1080/08958370802629610
   Kasthuri RS, 2009, J CLIN ONCOL, V27, P4834, DOI 10.1200/JCO.2009.22.6324
   Katoh M, 2007, STEM CELL REV, V3, P30, DOI 10.1007/s12015-007-0006-6
   KIMBER I, 1989, ARCH TOXICOL, V63, P274, DOI 10.1007/BF00278640
   KING M E, 1973, Environmental Health Perspectives, V5, P163, DOI 10.2307/3428124
   Kleensang A., 2013, ALTEX, V31, P53
   Kleinstreuer NC, 2014, NAT BIOTECHNOL, V32, P583, DOI 10.1038/nbt.2914
   KOCIBA RJ, 1974, TOXICOL APPL PHARM, V30, P275, DOI 10.1016/0041-008X(74)90099-4
   Kramer VJ, 2011, ENVIRON TOXICOL CHEM, V30, P64, DOI 10.1002/etc.375
   Kvolik S, 2010, SURG ONCOL, V19, pE33, DOI 10.1016/j.suronc.2009.03.008
   Linkov I, 2015, ALTEX-ALTERN ANIM EX, V32, P3, DOI 10.14573/altex.1412231
   LUNDBERG I, 1987, CANCER LETT, V36, P29, DOI 10.1016/0304-3835(87)90099-1
   MacKay C, 2013, ALTEX-ALTERN ANIM EX, V30, P473, DOI 10.14573/altex.2013.4.473
   Mackay D, 2009, SAR QSAR ENVIRON RES, V20, P393, DOI 10.1080/10629360902949153
   Matsumoto H, 2009, CANCER INFORM, V7, P253
   Maxwell G, 2014, TOXICOL IN VITRO, V28, P8, DOI 10.1016/j.tiv.2013.10.013
   Meek ME, 2014, J APPL TOXICOL, V34, P1, DOI 10.1002/jat.2949
   Miller DH, 2007, ENVIRON TOXICOL CHEM, V26, P521, DOI 10.1897/06-318R.1
   Moeini A, 2012, LIVER CANCER, V1, P83, DOI 10.1159/000342405
   Nannelli A, 2005, ARCH TOXICOL, V79, P74, DOI 10.1007/s00204-004-0590-z
   NCI National Cancer Institute, 1978, NCICGTR80
   NRC (National Research Council), 2007, TOX TEST 21 CENT
   Nukada Y, 2013, TOXICOL IN VITRO, V27, P609, DOI 10.1016/j.tiv.2012.11.006
   OECD, 2009, OECD SER TEST ASS, V102
   [OECD [OECD] Organization for Economic Cooperation and Development], 2012, OECD SER TEST ASS
   OECD Organisation for Economic Co-operation and Development, 2013, US HDB S GUID DOC DE
   OECD Organization for Economic Cooperation and Development, 2009, OECD ENV DIR JOINT M
   Patlewicz G, 2015, REGUL TOXICOL PHARM, V71, P463, DOI 10.1016/j.yrtph.2015.02.011
   Pirone JR, 2014, ALTEX-ALTERN ANIM EX, V31, P336, DOI http://dx.doi.org/10.14573/altex.1310151
   Roberts DW, 2011, CHEM RES TOXICOL, V24, P1003, DOI 10.1021/tx100420w
   Rotroff DM, 2013, ENVIRON HEALTH PERSP, V121, P7, DOI 10.1289/ehp.1205065
   Rovida C, 2015, ALTEX-ALTERN ANIM EX, V32, P171, DOI 10.14573/altex.1506201
   Russom CL, 1997, ENVIRON TOXICOL CHEM, V16, P948, DOI 10.1002/etc.5620160514
   Sandermann H, 2008, CHEMOSPHERE, V72, P1256, DOI 10.1016/j.chemosphere.2008.05.002
   Shoemaker JE, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-89
   SIMPSON ER, 1994, ENDOCR REV, V15, P342, DOI 10.1210/er.15.3.342
   Sonich-Mullin C, 2001, REGUL TOXICOL PHARM, V34, P146, DOI 10.1006/rtph.2001.1493
   Tatsumi K, 2009, WORLD J GASTROENTERO, V15, P5307, DOI 10.3748/wjg.15.5307
   Tollefsen KE, 2014, REGUL TOXICOL PHARM, V70, P629, DOI 10.1016/j.yrtph.2014.09.009
   Toronen P, 1999, FEBS LETT, V451, P142, DOI 10.1016/S0014-5793(99)00524-4
   USEPA, 2005, EPA630P03001F
   USEPA United State Environmental Protection Agency, 2013, EPA635R11003F
   USEPA United States Environmental Protection Agency, 1998, EDSTAC END DISR SCRE
   USEPA United States Environmental Protection Agency, 2012, PRIOR END DISR SCREE
   USEPA United States Environmental Protection Agency, 2009, ECOSAR OFF POLL TOX
   [USEPA] US Environmental Protection Agency, 2011, END DISR SCREEN PROG
   van der Veen JW, 2014, CRIT REV TOXICOL, V44, P590, DOI 10.3109/10408444.2014.925425
   VAN WEZEL A, 1995, CRIT REV TOXICOL, V25, P255, DOI 10.3109/10408449509089890
   VEITH GD, 1983, CAN J FISH AQUAT SCI, V40, P743, DOI 10.1139/f83-096
   VERHAAR HJM, 1992, CHEMOSPHERE, V25, P471, DOI 10.1016/0045-6535(92)90280-5
   Villeneuve D, 2014, ENVIRON TOXICOL CHEM, V33, P158, DOI 10.1002/etc.2403
   Villeneuve DL, 2014, TOXICOL SCI, V142, P312, DOI 10.1093/toxsci/kfu199
   Villeneuve DL, 2014, TOXICOL SCI, V142, P321, DOI 10.1093/toxsci/kfu200
   Volz DC, 2011, TOXICOL SCI, V123, P349, DOI 10.1093/toxsci/kfr185
   Willett C., 2014, PATHWAY BASED TOXICI
   Zoppoli P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-154
NR 91
TC 30
Z9 32
U1 1
U2 38
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1096-6080
EI 1096-0929
J9 TOXICOL SCI
JI Toxicol. Sci.
PD NOV
PY 2015
VL 148
IS 1
BP 14
EP 25
DI 10.1093/toxsci/kfv181
PG 12
WC Toxicology
SC Toxicology
GA CX2SU
UT WOS:000365547900003
PM 26500288
DA 2019-10-23
ER

PT J
AU Luechtefeld, T
   Maertens, A
   Mckim, JM
   Hartung, T
   Kleensang, A
   Sa-Rocha, V
AF Luechtefeld, Thomas
   Maertens, Alexandra
   McKim, James M.
   Hartung, Thomas
   Kleensang, Andre
   Sa-Rocha, Vanessa
TI Probabilistic hazard assessment for skin sensitization potency by
   dose-response modeling using feature elimination instead of quantitative
   structure-activity relationships
SO JOURNAL OF APPLIED TOXICOLOGY
LA English
DT Article
DE LLNA; in vitro; skin sensitization; integrated testing strategy; machine
   learning; hidden Markov model; QSAR; feature selection
ID INTEGRATED TESTING STRATEGIES; HUMAN CELL-LINES; IN-VITRO METHODS; TEST
   H-CLAT; CONTACT-DERMATITIS; TOXICOLOGY; RECOMMENDATIONS; IDENTIFICATION;
   EPIDEMIOLOGY; PREDICTION
AB Supervised learning methods promise to improve integrated testing strategies (ITS), but must be adjusted to handle high dimensionality and dose-response data. ITS approaches are currently fueled by the increasing mechanistic understanding of adverse outcome pathways (AOP) and the development of tests reflecting these mechanisms. Simple approaches to combine skin sensitization data sets, such as weight of evidence, fail due to problems in information redundancy and high dimensionality. The problem is further amplified when potency information (dose/response) of hazards would be estimated. Skin sensitization currently serves as the foster child for AOP and ITS development, as legislative pressures combined with a very good mechanistic understanding of contact dermatitis have led to test development and relatively large high-quality data sets. We curated such a data set and combined a recursive variable selection algorithm to evaluate the information available through in silico, in chemico and in vitro assays. Chemical similarity alone could not cluster chemicals' potency, and in vitro models consistently ranked high in recursive feature elimination. This allows reducing the number of tests included in an ITS. Next, we analyzed with a hidden Markov model that takes advantage of an intrinsic inter-relationship among the local lymph node assay classes, i.e. the monotonous connection between local lymph node assay and dose. The dose-informed random forest/hidden Markov model was superior to the dose-naive random forest model on all data sets. Although balanced accuracy improvement may seem small, this obscures the actual improvement in misclassifications as the dose-informed hidden Markov model strongly reduced " false-negatives" (i.e. extreme sensitizers as non-sensitizer) on all data sets. Copyright (c) 2015 John Wiley & Sons, Ltd.
   Supervised learning methods promise to improve integrated testing strategies. We curated a skin sensitization data set and evaluated the information from in silico, in chemico and in vitro assays by recursive variable selection. Cell assays consistently ranked high in the feature elimination. A hidden Markov model taking advantage of monotonicity between local lymph node assay and dose is shown to outperform dose-naive models on all data sets and strongly reduce extreme sensitizers classified as non-sensitizers.
C1 [Luechtefeld, Thomas; Maertens, Alexandra; Hartung, Thomas; Kleensang, Andre; Sa-Rocha, Vanessa] Johns Hopkins Med Inst, Bloomberg Sch Publ Hlth, Ctr Alternat Anim Testing, Baltimore, MD 21205 USA.
   [McKim, James M.] Iontox, Kalamazoo, MI USA.
   [Hartung, Thomas] Univ Konstanz, Ctr Alternat Anim Testing Europe, Constance, Germany.
   [Sa-Rocha, Vanessa] Natura Inovacao, Cajamar, Brazil.
RP Hartung, T (reprint author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, 615 N Wolfe St,W7035, Baltimore, MD 21205 USA.
EM THartung@jhsph.edu
OI Kleensang, Andre/0000-0002-4564-7399
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico -
   CNPqNational Council for Scientific and Technological Development (CNPq)
   [238194/2012-4]; NIEHSUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Environmental Health Sciences (NIEHS) [PA-08-190, T32 ES007141]
FX The authors would like to thank Dr. Joanna Jaworska (P&G, Brussels), Dr.
   Andreas Natsch from Givaudan (Dubendorf, Switzerland) for the fruitful
   discussions and sharing unpublished experimental data. This work was
   supported by Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico - CNPq (no. 238194/2012-4). CNPq had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript. Financial support to Alexandra Maertens
   by an NIEHS Research Supplement to Promote Diversity in Health-Related
   Research (PA-08-190) and to Thomas Luechtefeld by an NIEHS training
   grant (T32 ES007141) is greatfully appreciated.
CR Adler S, 2011, ARCH TOXICOL, V85, P367, DOI 10.1007/s00204-011-0693-2
   Ashikaga T, 2006, TOXICOL IN VITRO, V20, P767, DOI 10.1016/j.tiv.2005.10.012
   Basketter D, 2007, ATLA-ALTERN LAB ANIM, V35, P137, DOI 10.1177/026119290703500124
   Bauch C, 2012, REGUL TOXICOL PHARM, V63, P489, DOI 10.1016/j.yrtph.2012.05.013
   BAUM LE, 1966, ANN MATH STAT, V37, P1554, DOI 10.1214/aoms/1177699147
   Bolton EE, 2010, ANN REP COMP CHEM, V4, P217, DOI 10.1016/S1574-1400(08)00012-1
   Breiman L., 2003, MACH LEARN, V45, P5
   Casati S, 2005, ATLA-ALTERN LAB ANIM, V33, P47, DOI 10.1177/026119290503300108
   Diderich R, 2010, ISSUES TOXICOL, V7, P385
   Dimitrov SD, 2005, INT J TOXICOL, V24, P189, DOI 10.1080/10915810591000631
   Emter R, 2010, TOXICOL APPL PHARM, V245, P281, DOI 10.1016/j.taap.2010.03.009
   European Commission Joint Research Centre, 2013, 26383 EUR EUR COMM J
   European Commission Joint Research Centre, 2014, 26427 EUR EUR COMM J
   Gerberick GF, 2007, TOXICOL SCI, V97, P417, DOI 10.1093/toxsci/kfm064
   Gerberick GF, 2005, DERMATITIS, V16, P157, DOI 10.2310/6620.2005.05040
   Gerberick GF, 2004, CONTACT DERMATITIS, V50, P274, DOI 10.1111/j.0105-1873.2004.00290.x
   Hartung T, 2013, ALTEX-ALTERN ANIM EX, V30, P3, DOI 10.14573/altex.2013.1.003
   Hartung T, 2009, NATURE, V460, P1080, DOI 10.1038/4601080a
   Hartung T, 2009, NATURE, V460, P208, DOI 10.1038/460208a
   Hartung T, 2009, TOXICOL SCI, V109, P18, DOI 10.1093/toxsci/kfp059
   Hirota M, 2013, TOXICOL IN VITRO, V27, P1233, DOI 10.1016/j.tiv.2013.02.013
   Jaworska J, 2013, J APPL TOXICOL, V33, P1353, DOI 10.1002/jat.2869
   Jaworska J, 2011, ALTEX-ALTERN ANIM EX, V28, P211, DOI 10.14573/altex.2011.3.211
   Kirkland DJ, 2005, MUTAT RES-GEN TOX EN, V588, P88, DOI 10.1016/j.mrgentox.2005.09.006
   Klekota J, 2008, BIOINFORMATICS, V24, P2518, DOI 10.1093/bioinformatics/btn479
   Maxwell G, 2014, TOXICOL IN VITRO, V28, P8, DOI 10.1016/j.tiv.2013.10.013
   McDonald JC, 2006, OCCUP MED-OXFORD, V56, P398, DOI 10.1093/occmed/kql039
   McKim JM, 2012, CUTAN OCUL TOXICOL, V31, P292, DOI 10.3109/15569527.2012.667031
   McKim JM, 2010, CUTAN OCUL TOXICOL, V29, P171, DOI 10.3109/15569527.2010.483869
   National Research Council, 2007, TOXICITY TESTING 21
   Natsch A, 2013, J APPL TOXICOL, V33, P1337, DOI 10.1002/jat.2868
   Natsch A, 2009, TOXICOL SCI, V107, P106, DOI 10.1093/toxsci/kfn204
   Nukada Y, 2013, TOXICOL IN VITRO, V27, P609, DOI 10.1016/j.tiv.2012.11.006
   OECD, 1992, TEST 406 SKIN SENS
   OECD, 2015, TEST 442D VITR SKIN
   OECD, 2010, TEST 429 SKIN SENS
   OECD, 2015, TEST 442C CHEM SKIN
   Patlewicz G, 2014, REGUL TOXICOL PHARM, V69, P529, DOI 10.1016/j.yrtph.2014.06.001
   Pedregosa F, 2011, J MACH LEARN RES, V12, P2825
   Peiser M, 2012, CELL MOL LIFE SCI, V69, P763, DOI 10.1007/s00018-011-0846-8
   Python F, 2007, TOXICOL APPL PHARM, V220, P113, DOI 10.1016/j.taap.2006.12.026
   Rovida C, 2015, ALTEX-ALTERN ANIM EX, V32, P25, DOI [http://dx.doi.org/10.14573/altex.1411011, 10.14573/altex.1506201]
   Rovida C, 2009, ALTEX-ALTERN TIEREXP, V26, P187
   Sakaguchi H, 2006, TOXICOL IN VITRO, V20, P774, DOI 10.1016/j.tiv.2005.10.014
   SANDERSON DM, 1991, HUM EXP TOXICOL, V10, P261, DOI 10.1177/096032719101000405
   SIDS OECD, 2005, PHTHALIC ANHYDRIDE C
   Tetko IV, 2005, J COMPUT AID MOL DES, V19, P453, DOI 10.1007/s10822-005-8694-y
   Thyssen JP, 2007, CONTACT DERMATITIS, V57, P287, DOI 10.1111/j.1600-0536.2007.01220.x
   Thyssen JP, 2007, CONTACT DERMATITIS, V56, P185, DOI 10.1111/j.1600-0536.2006.01058.x
   Todeschini R, 2009, MOL DESCRIPTORS CHEM
   Tollefsen KE, 2014, REGUL TOXICOL PHARM, V70, P629, DOI 10.1016/j.yrtph.2014.09.009
   Urbisch D, 2015, REGUL TOXICOL PHARM, V71, P337, DOI 10.1016/j.yrtph.2014.12.008
   VITERBI AJ, 1967, IEEE T INFORM THEORY, V13, P260, DOI 10.1109/TIT.1967.1054010
   Warshaw EM, 2012, DERMATITIS, V23, P258, DOI 10.1097/DER.0b013e318273a3b8
NR 54
TC 22
Z9 22
U1 0
U2 10
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0260-437X
EI 1099-1263
J9 J APPL TOXICOL
JI J. Appl. Toxicol.
PD NOV
PY 2015
VL 35
IS 11
BP 1361
EP 1371
DI 10.1002/jat.3172
PG 11
WC Toxicology
SC Toxicology
GA CS6WG
UT WOS:000362223300013
PM 26046447
OA Green Accepted
DA 2019-10-23
ER

PT J
AU Fetter, E
   Baldauf, L
   Da Fonte, DF
   Ortmann, J
   Scholz, S
AF Fetter, Eva
   Baldauf, Lisa
   Da Fonte, Dillon F.
   Ortmann, Julia
   Scholz, Stefan
TI Comparative analysis of goitrogenic effects of phenylthiourea and
   methimazole in zebrafish embryos
SO REPRODUCTIVE TOXICOLOGY
LA English
DT Article
DE Endocrine disruption; Adverse outcome pathways; Danio rerio; Behaviour;
   Alternatives to animal testing; Thyroxine; Teratogenic effects;
   Ecotoxicology
ID THYROID ENDOCRINE SYSTEM; DANIO-RERIO; LOCOMOTOR-ACTIVITY; INTERNAL
   CONCENTRATIONS; TRANSGENIC ZEBRAFISH; WATERBORNE EXPOSURE; HORMONE;
   MODEL; QUANTIFICATION; TERATOGENICITY
AB Craniofacial malformations, reduced locomotion and induction of genes encoding for enzymes involved in thyroid hormone synthesis were assessed using methimazole and N-phenylthiourea in zebrafish embryos. Gene expression, the most sensitive endpoint (EC50.MMI =372-765 mu M, EC50-PTU = 7.6-8.6 mu M), was analysed in wild-type and in a transgenic strain, tg(tg:mCherry), expressing mCherry fluorescence protein under the control of the thyroglobulin gene. Reduction of locomotion and craniofacial malformations were observed at one or two orders of magnitude above concentrations affecting gene expression, respectively. Both effects could be linked to the malformations caused by reduced thyroxin levels. Our results show that due to the presence of the autoregulatory loop of the hypothalamus pituitary thyroid axis, various molecular initiating events of thyroid disruption are amenable for the zebrafish embryo. We propose the tg(tg:mCherry) bioassay as a sensitive tool in medium scale screening of goitrogens, given the minimal effort for sample preparation and analysis of gene expression. (C)2015 Elsevier Inc. All rights reserved.
C1 [Fetter, Eva; Baldauf, Lisa; Da Fonte, Dillon F.; Ortmann, Julia; Scholz, Stefan] UFZ Helmholtz Ctr Environm Res, Dept Bioanalyt Ecotoxicol, D-04318 Leipzig, Germany.
   [Da Fonte, Dillon F.] Univ Ottawa, Dept Biol, Ctr Adv Res Environm Genom, Ottawa, ON K1N 6N5, Canada.
RP Fetter, E (reprint author), UFZ Helmholtz Ctr Environm Res, Dept Bioanalyt Ecotoxicol, Permoserstr 15, D-04318 Leipzig, Germany.
EM fettervica@gmail.com
RI Scholz, Stefan/B-7776-2014
OI Scholz, Stefan/0000-0002-6990-4716
FU German Federal Environmental Foundation (DBU); DAAD RISE Programme;
   Helmholtz Centre for Environmental ResearchHelmholtz Association
FX The work of Eva Fetter was supported by a scholarship of the German
   Federal Environmental Foundation (DBU). The research stay of Dillon F.
   Da Fonte at the UFZ was supported by the DAAD RISE Programme. The
   authors thank Prof. Sabine Costagliola and Dr. Robert Opitz (University
   of Brussels) for providing the tg(tg:mCherry) transgenic zebrafish
   strain. The authors thank Dr. Rolf Altenburger for the helpful
   discussion on toxicokinetics and for suggestions on the manuscript. The
   work was also partially supported by the research topic CITE (chemicals
   in the environment) of the Helmholtz Centre for Environmental Research.
CR Alt B, 2006, DEV DYNAM, V235, P1872, DOI 10.1002/dvdy.20831
   Bergstrom U, 2003, TOXICOL PATHOL, V31, P379, DOI 10.1080/01926230390201101
   Bohnsack BL, 2013, DEV BIOL, V373, P300, DOI 10.1016/j.ydbio.2012.11.005
   Bohnsack BL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022991
   Brown SB, 2004, ENVIRON TOXICOL CHEM, V23, P1680, DOI 10.1897/03-242
   Brox S, 2014, AQUAT TOXICOL, V157, P134, DOI 10.1016/j.aquatox.2014.10.008
   Brox S, 2014, ANAL BIOANAL CHEM, V406, P4831, DOI 10.1007/s00216-014-7929-y
   Brozyna AA, 2008, INT J CANCER, V123, P1448, DOI 10.1002/ijc.23664
   Campinho MA, 2013, AQUAT TOXICOL, V140, P279, DOI 10.1016/j.aquatox.2013.06.014
   Coady K, 2010, ENVIRON TOXICOL CHEM, V29, P869, DOI [10.1002/ete.74, 10.1002/etc.74]
   Crane HM, 2006, TOXICOL SCI, V93, P278, DOI 10.1093/toxsci/kfl063
   Darras VM, 2011, J THROID RES, DOI 10.4061/2011/402320
   Diav-Citrin O, 2002, TERATOLOGY, V65, P38, DOI 10.1002/tera.1096
   Garcia-Reyero N, 2014, ENVIRON INT, V63, P216, DOI 10.1016/j.envint.2013.11.012
   Guo SW, 2001, ANN HUM BIOL, V28, P111
   Heijlen M, 2014, ENDOCRINOLOGY, V155, P1547, DOI 10.1210/en.2013-1660
   Irons TD, 2010, NEUROTOXICOL TERATOL, V32, P84, DOI 10.1016/j.ntt.2009.04.066
   Ji C, 2012, TOXICOL APPL PHARM, V262, P149, DOI 10.1016/j.taap.2012.04.029
   Jomaa B, 2014, ALTEX-ALTERN ANIM EX, V31, P303, DOI http://dx.doi.org/10.14573/altex.1402011
   Knobel M, 2012, ENVIRON SCI TECHNOL, V46, P9690, DOI 10.1021/es301729q
   Komoike Y, 2013, BIRTH DEFECTS RES B, V98, P222, DOI 10.1002/bdrb.21057
   Kuhnert A, 2013, ENVIRON TOXICOL CHEM, V32, P1819, DOI 10.1002/etc.2239
   Lam SH, 2005, GEN COMP ENDOCR, V142, P325, DOI 10.1016/j.ygcen.2005.02.004
   Li ZR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040132
   Little AG, 2014, J EXP BIOL, V217, P718, DOI 10.1242/jeb.096602
   Little AG, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-26
   Liu CS, 2013, CHEMOSPHERE, V93, P2327, DOI 10.1016/j.chemosphere.2013.08.026
   LIU WK, 1989, IMMUNOBIOLOGY, V180, P23, DOI 10.1016/S0171-2985(89)80027-0
   Liu Y, 2011, ECOTOXICOLOGY, V20, P47, DOI 10.1007/s10646-010-0555-3
   Liu YW, 2002, DIFFERENTIATION, V70, P36, DOI 10.1046/j.1432-0436.2002.700104.x
   Lohr H, 2011, ANNU REV PHYSIOL, V73, P183, DOI 10.1146/annurev-physiol-012110-142320
   Miller MD, 2009, ENVIRON HEALTH PERSP, V117, P1033, DOI 10.1289/ehp.0800247
   Morais RDVS, 2013, ENDOCRINOLOGY, V154, P4365, DOI 10.1210/en.2013-1308
   Murk AJ, 2013, TOXICOL IN VITRO, V27, P1320, DOI 10.1016/j.tiv.2013.02.012
   Nabholz JV, 1994, EPA748R93002 OFF POL
   Naderi M, 2014, AQUAT TOXICOL, V148, P195, DOI 10.1016/j.aquatox.2014.01.009
   Nagel R, 2002, ALTEX-ALTERN TIEREXP, V19, P38
   NYDEGGER H, 1978, EXPERIENTIA, V34, P1319, DOI 10.1007/BF01981444
   Opitz R, 2012, DEV BIOL, V372, P203, DOI 10.1016/j.ydbio.2012.09.011
   Opitz R, 2011, MOL ENDOCRINOL, V25, P1579, DOI 10.1210/me.2011-0046
   Organisation for Economic Co-operation and Development OECD , 2013, TEST 236 FISH EMBR A
   Pardo-Martin C, 2010, NAT METHODS, V7, P634, DOI [10.1038/nmeth.1481, 10.1038/NMETH.1481]
   Patrick L, 2009, ALTERN MED REV, V14, P326
   Peravali R, 2011, BIOTECHNIQUES, V50, P319, DOI 10.2144/000113669
   Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45
   Raldua D, 2009, ENVIRON SCI TECHNOL, V43, P6844, DOI 10.1021/es9012454
   RICE SA, 1987, FUND APPL TOXICOL, V8, P531, DOI 10.1016/0272-0590(87)90138-2
   Schmidt F, 2011, J THROID RES, DOI 10.4061/2011/376243
   Selderslaghs IWT, 2013, NEUROTOXICOL TERATOL, V37, P44, DOI 10.1016/j.ntt.2013.01.003
   Selderslaghs IWT, 2010, NEUROTOXICOL TERATOL, V32, P460, DOI 10.1016/j.ntt.2010.03.002
   Sharma P, 2013, GEN COMP ENDOCR, V184, P111, DOI 10.1016/j.ygcen.2012.12.018
   Shi XJ, 2009, CHEMOSPHERE, V77, P1010, DOI 10.1016/j.chemosphere.2009.07.074
   Shivaprasad H S, 2012, J Nat Sci Biol Med, V3, P43, DOI 10.4103/0976-9668.95946
   Strahle U, 2012, REPROD TOXICOL, V33, P128, DOI 10.1016/j.reprotox.2011.06.121
   Terrien X, 2011, AQUAT TOXICOL, V105, P13, DOI 10.1016/j.aquatox.2011.04.007
   Thienpont B, 2011, ENVIRON SCI TECHNOL, V45, P7525, DOI 10.1021/es202248h
   Tiefenbach J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009797
   Wang QW, 2014, NANOTOXICOLOGY, V8, P196, DOI 10.3109/17435390.2013.875232
   Wang QW, 2013, AQUAT TOXICOL, V126, P207, DOI 10.1016/j.aquatox.2012.11.009
   Westerfield M., 1993, ZEBRAFISH BOOK GUIDE
   Yan W, 2012, CHEMOSPHERE, V87, P1301, DOI 10.1016/j.chemosphere.2012.01.041
   Yu LQ, 2010, AQUAT TOXICOL, V97, P226, DOI 10.1016/j.aquatox.2009.10.022
   Zheng XM, 2012, ENVIRON SCI TECHNOL, V46, P12943, DOI 10.1021/es303289n
   Zoeller RT, 2003, RISK ANAL, V23, P143, DOI 10.1111/1539-6924.00296
NR 64
TC 10
Z9 10
U1 2
U2 45
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0890-6238
J9 REPROD TOXICOL
JI Reprod. Toxicol.
PD NOV
PY 2015
VL 57
BP 10
EP 20
DI 10.1016/j.reprotox.2015.04.012
PG 11
WC Reproductive Biology; Toxicology
SC Reproductive Biology; Toxicology
GA CQ0XQ
UT WOS:000360322300003
PM 25962731
DA 2019-10-23
ER

PT J
AU Bal-Price, A
   Munn, S
   Sachana, M
AF Bal-Price, A.
   Munn, S.
   Sachana, M.
TI Application of the Adverse Outcome Pathway (AOP) concept for evaluation
   of developmental neurotoxicity triggered by N-methyl-D-aspartate
   receptor (NMDAR) antagonists
SO TOXICOLOGY LETTERS
LA English
DT Meeting Abstract
CT 51st Congress of the European-Societies-of-Toxicology (EUROTOX)
CY SEP 13-16, 2015
CL Portuguese Soc Pharmacol, Sect Toxicol, Porto, PORTUGAL
SP European Soc Toxicol
HO Portuguese Soc Pharmacol, Sect Toxicol
C1 [Bal-Price, A.; Munn, S.; Sachana, M.] European Commiss Joint Res Ctr, Inst Hlth & Consumer Protect, Ispra, Italy.
NR 0
TC 0
Z9 0
U1 0
U2 3
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0378-4274
EI 1879-3169
J9 TOXICOL LETT
JI Toxicol. Lett.
PD OCT 16
PY 2015
VL 238
IS 2
SU S
MA P03-113
BP S126
EP S126
DI 10.1016/j.toxlet.2015.08.399
PG 1
WC Toxicology
SC Toxicology
GA DE5SY
UT WOS:000370693801236
DA 2019-10-23
ER

PT J
AU Borges, T
   Kloslova, Z
   Swiatek, A
AF Borges, T.
   Kloslova, Z.
   Swiatek, A.
TI Novel approaches and their applications in risk assessment of chemicals
SO TOXICOLOGY LETTERS
LA English
DT Meeting Abstract
CT 51st Congress of the European-Societies-of-Toxicology (EUROTOX)
CY SEP 13-16, 2015
CL Portuguese Soc Pharmacol, Sect Toxicol, Porto, PORTUGAL
SP European Soc Toxicol
HO Portuguese Soc Pharmacol, Sect Toxicol
C1 [Borges, T.] Gen Directorate Hlth, Occupat & Environm Hlth Div, Lisbon, Portugal.
   [Kloslova, Z.] European Chem Agcy, Dir E, Finland.
   [Swiatek, A.] EC, Joint Res Ctr, IHCP, ECVAM,DB ALM, Milan, Italy.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0378-4274
EI 1879-3169
J9 TOXICOL LETT
JI Toxicol. Lett.
PD OCT 16
PY 2015
VL 238
IS 2
SU S
MA P03-008
BP S91
EP S91
DI 10.1016/j.toxlet.2015.08.303
PG 1
WC Toxicology
SC Toxicology
GA DE5SY
UT WOS:000370693801140
DA 2019-10-23
ER

PT J
AU Cronin, M
   Bois, F
   Fioravanzo, E
   Meinl, T
   Neagu, D
   Worth, A
   Yang, C
   Richarz, AN
AF Cronin, M.
   Bois, F.
   Fioravanzo, E.
   Meinl, T.
   Neagu, D.
   Worth, A.
   Yang, C.
   Richarz, A. -N.
TI Computational chemistry solutions supporting chemical safety assessment:
   Lessons learned for using in silico approaches
SO TOXICOLOGY LETTERS
LA English
DT Meeting Abstract
CT 51st Congress of the European-Societies-of-Toxicology (EUROTOX)
CY SEP 13-16, 2015
CL Portuguese Soc Pharmacol, Sect Toxicol, Porto, PORTUGAL
SP European Soc Toxicol
HO Portuguese Soc Pharmacol, Sect Toxicol
C1 [Cronin, M.; Richarz, A. -N.] Liverpool John Moores Univ, Sch Pharm & Chem, Liverpool L3 3AF, Merseyside, England.
   [Bois, F.] Inst Natl Environm Ind & Risques INERIS, Verneuil En Halatte, France.
   [Fioravanzo, E.] Soluz Informat Srl S IN, Vicenza, Italy.
   [Meinl, T.] KNIME Com AG, Zurich, Switzerland.
   [Neagu, D.] Univ Bradford, Sch Elect Engn & Comp Sci, Bradford BD7 1DP, W Yorkshire, England.
   [Worth, A.] Commiss European Communities, Joint Res Ctr, Inst Hlth & Consumer Protect, I-21020 Ispra, Italy.
   [Yang, C.] Altamira LLC, Columbus, OH USA.
RI Bois, Frederic/E-9241-2012; Worth, Andrew Paul/O-3055-2019; Worth,
   Andrew/R-8495-2019
OI Bois, Frederic/0000-0002-4154-0391; Worth, Andrew
   Paul/0000-0002-5303-0452; 
NR 0
TC 0
Z9 0
U1 0
U2 3
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0378-4274
EI 1879-3169
J9 TOXICOL LETT
JI Toxicol. Lett.
PD OCT 16
PY 2015
VL 238
IS 2
SU S
MA P06-015
BP S169
EP S170
DI 10.1016/j.toxlet.2015.08.576
PG 2
WC Toxicology
SC Toxicology
GA DE5SY
UT WOS:000370693801354
DA 2019-10-23
ER

PT J
AU Cronin, M
   Madden, J
   Mellor, C
   Przybylak, K
   Schultz, T
   Steinmetz, F
   Richarz, AN
AF Cronin, M.
   Madden, J.
   Mellor, C.
   Przybylak, K.
   Schultz, T.
   Steinmetz, F.
   Richarz, A. -N.
TI Supporting read-across predictions of toxicity Going beyond molecular
   similarity
SO TOXICOLOGY LETTERS
LA English
DT Meeting Abstract
CT 51st Congress of the European-Societies-of-Toxicology (EUROTOX)
CY SEP 13-16, 2015
CL Portuguese Soc Pharmacol, Sect Toxicol, Porto, PORTUGAL
SP European Soc Toxicol
HO Portuguese Soc Pharmacol, Sect Toxicol
C1 [Cronin, M.; Madden, J.; Mellor, C.; Przybylak, K.; Steinmetz, F.; Richarz, A. -N.] Liverpool John Moores Univ, Sch Pharm & Chem, Liverpool L3 3AF, Merseyside, England.
   [Schultz, T.] Univ Tennessee, Coll Vet Med, Knoxville, TN USA.
NR 0
TC 0
Z9 0
U1 0
U2 3
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0378-4274
EI 1879-3169
J9 TOXICOL LETT
JI Toxicol. Lett.
PD OCT 16
PY 2015
VL 238
IS 2
SU S
MA P06-009
BP S167
EP S167
DI 10.1016/j.toxlet.2015.08.570
PG 1
WC Toxicology
SC Toxicology
GA DE5SY
UT WOS:000370693801348
DA 2019-10-23
ER

PT J
AU Ipema, J
   Gaca, M
   Phillips, G
   McKim, J
AF Ipema, J.
   Gaca, M.
   Phillips, G.
   McKim, J., Jr.
TI An in vitro evaluation of nicotine kinetics utilizing a human airway
   model (Mucilair (TM)) combined with an integrated multi-organ culture
   plate
SO TOXICOLOGY LETTERS
LA English
DT Meeting Abstract
CT 51st Congress of the European-Societies-of-Toxicology (EUROTOX)
CY SEP 13-16, 2015
CL Portuguese Soc Pharmacol, Sect Toxicol, Porto, PORTUGAL
SP European Soc Toxicol
HO Portuguese Soc Pharmacol, Sect Toxicol
C1 [Ipema, J.; Gaca, M.; Phillips, G.] British Amer Tobacco, R&D Ctr, Southampton, Hants, England.
   [McKim, J., Jr.] IONTOX LLC, Kalamazoo, MI USA.
NR 0
TC 0
Z9 0
U1 0
U2 4
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0378-4274
EI 1879-3169
J9 TOXICOL LETT
JI Toxicol. Lett.
PD OCT 16
PY 2015
VL 238
IS 2
SU S
MA P07-009
BP S176
EP S177
DI 10.1016/j.toxlet.2015.08.513
PG 2
WC Toxicology
SC Toxicology
GA DE5SY
UT WOS:000370693801372
DA 2019-10-23
ER

PT J
AU Jain, G
   White, A
   Carmichael, P
   Krishnakumar, NM
   Rajeshwara, N
   Subramanian, K
   Das, S
   Cooper, SL
   Vethamanickam, J
   Middleton, A
   Glavin, S
   Raghavan, A
AF Jain, G.
   White, A.
   Carmichael, P.
   Krishnakumar, N. M.
   Rajeshwara, N.
   Subramanian, K.
   Das, S.
   Cooper, S. L.
   Vethamanickam, J.
   Middleton, A.
   Glavin, S.
   Raghavan, A.
TI A systems biology model of oxidative stress that distinguishes adaptive
   and adverse cellular responses
SO TOXICOLOGY LETTERS
LA English
DT Meeting Abstract
CT 51st Congress of the European-Societies-of-Toxicology (EUROTOX)
CY SEP 13-16, 2015
CL Portuguese Soc Pharmacol, Sect Toxicol, Porto, PORTUGAL
SP European Soc Toxicol
HO Portuguese Soc Pharmacol, Sect Toxicol
C1 [Jain, G.; Vethamanickam, J.] Unilever, Safety & Environm Assurance Ctr, Bangalore, Karnataka, India.
   [White, A.; Carmichael, P.; Cooper, S. L.; Middleton, A.; Glavin, S.; Raghavan, A.] Unilever, Safety & Environm Assurance Ctr, Colworth, England.
   [Krishnakumar, N. M.; Rajeshwara, N.; Subramanian, K.; Das, S.] Strand Life Sci, Syst Biol, Bangalore, Karnataka, India.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0378-4274
EI 1879-3169
J9 TOXICOL LETT
JI Toxicol. Lett.
PD OCT 16
PY 2015
VL 238
IS 2
SU S
MA P06-022
BP S172
EP S172
DI 10.1016/j.toxlet.2015.08.583
PG 1
WC Toxicology
SC Toxicology
GA DE5SY
UT WOS:000370693801361
DA 2019-10-23
ER

PT J
AU Kolle, S
   Urbisch, D
   Mehling, A
   Honarvar, N
   Hernandez, TR
   van Ravenzwaay, B
   Landsiedel, R
AF Kolle, S.
   Urbisch, D.
   Mehling, A.
   Honarvar, N.
   Hernandez, T. Ramirez
   van Ravenzwaay, B.
   Landsiedel, R.
TI Assessing skin sensitization in mice and men using non-animal test
   methods
SO TOXICOLOGY LETTERS
LA English
DT Meeting Abstract
CT 51st Congress of the European-Societies-of-Toxicology (EUROTOX)
CY SEP 13-16, 2015
CL Portuguese Soc Pharmacol, Sect Toxicol, Porto, PORTUGAL
SP European Soc Toxicol
HO Portuguese Soc Pharmacol, Sect Toxicol
C1 [Kolle, S.; Urbisch, D.; Honarvar, N.; Hernandez, T. Ramirez; van Ravenzwaay, B.; Landsiedel, R.] BASF SE, Expt Toxicol & Ecol, Ludwigshafen, Germany.
   [Mehling, A.] BASF Personal Care & Nutr GmbH, Dusseldorf, Germany.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0378-4274
EI 1879-3169
J9 TOXICOL LETT
JI Toxicol. Lett.
PD OCT 16
PY 2015
VL 238
IS 2
SU S
MA P07-015
BP S178
EP S178
DI 10.1016/j.toxlet.2015.08.516
PG 1
WC Toxicology
SC Toxicology
GA DE5SY
UT WOS:000370693801375
DA 2019-10-23
ER

PT J
AU Munn, S
   Gerloff, K
   Landesmann, B
   Palosaari, T
   Worth, A
   Whelan, M
AF Munn, S.
   Gerloff, K.
   Landesmann, B.
   Palosaari, T.
   Worth, A.
   Whelan, M.
TI Using AOPs to predict Nanoparticle-induced liver toxicity
SO TOXICOLOGY LETTERS
LA English
DT Meeting Abstract
CT 51st Congress of the European-Societies-of-Toxicology (EUROTOX)
CY SEP 13-16, 2015
CL Portuguese Soc Pharmacol, Sect Toxicol, Porto, PORTUGAL
SP European Soc Toxicol
HO Portuguese Soc Pharmacol, Sect Toxicol
C1 [Munn, S.; Gerloff, K.; Landesmann, B.; Palosaari, T.; Worth, A.; Whelan, M.] European Commiss, Ispra, Italy.
RI Worth, Andrew Paul/O-3055-2019; Worth, Andrew/R-8495-2019
OI Worth, Andrew Paul/0000-0002-5303-0452; 
NR 0
TC 0
Z9 0
U1 0
U2 3
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0378-4274
EI 1879-3169
J9 TOXICOL LETT
JI Toxicol. Lett.
PD OCT 16
PY 2015
VL 238
IS 2
SU S
MA P08-032
BP S205
EP S206
DI 10.1016/j.toxlet.2015.08.614
PG 2
WC Toxicology
SC Toxicology
GA DE5SY
UT WOS:000370693801446
DA 2019-10-23
ER

PT J
AU Piroird, C
   Ovigne, JM
   Rousset, F
   Teissier, SM
   Gomes, C
   Cotovio, J
   Alepee, N
   Leblanc, V
AF Piroird, C.
   Ovigne, J. M.
   Rousset, F.
   Teissier, S. Martinozzi
   Gomes, C.
   Cotovio, J.
   Alepee, N.
   Leblanc, V.
TI The Activation of Dendritic Cell Event in the Adverse Outcome Pathway
   for Skin Sensitization addressed by U-SENS (TM)
SO TOXICOLOGY LETTERS
LA English
DT Meeting Abstract
CT 51st Congress of the European-Societies-of-Toxicology (EUROTOX)
CY SEP 13-16, 2015
CL Portuguese Soc Pharmacol, Sect Toxicol, Porto, PORTUGAL
SP European Soc Toxicol
HO Portuguese Soc Pharmacol, Sect Toxicol
C1 [Piroird, C.; Rousset, F.; Teissier, S. Martinozzi; Gomes, C.; Cotovio, J.; Alepee, N.; Leblanc, V.] LOreal R&I, Aulnay Sous Bois, France.
   [Ovigne, J. M.] EPISKIN, Lyon, France.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0378-4274
EI 1879-3169
J9 TOXICOL LETT
JI Toxicol. Lett.
PD OCT 16
PY 2015
VL 238
IS 2
SU S
MA P14-013
BP S325
EP S325
DI 10.1016/j.toxlet.2015.08.926
PG 1
WC Toxicology
SC Toxicology
GA DE5SY
UT WOS:000370693801762
DA 2019-10-23
ER

PT J
AU Rand, M
   Montgomery, S
   Vorojeikina, D
   Huang, W
   MacKay, TF
   Anholt, RR
AF Rand, M.
   Montgomery, S.
   Vorojeikina, D.
   Huang, W.
   MacKay, T. F.
   Anholt, R. R.
TI Drosophotoxicolgy takes flight: Genomic elucidation of adverse outcome
   pathways of mercury toxicity in the fruit fly
SO TOXICOLOGY LETTERS
LA English
DT Meeting Abstract
CT 51st Congress of the European-Societies-of-Toxicology (EUROTOX)
CY SEP 13-16, 2015
CL Portuguese Soc Pharmacol, Sect Toxicol, Porto, PORTUGAL
SP European Soc Toxicol
HO Portuguese Soc Pharmacol, Sect Toxicol
C1 [Rand, M.; Montgomery, S.; Vorojeikina, D.] Univ Rochester, Environm Med, Rochester, NY 14627 USA.
   [Huang, W.; MacKay, T. F.; Anholt, R. R.] N Carolina State Univ, Dept Biol Sci, Genet Program, Raleigh, NC 27695 USA.
RI Anholt, Robert/S-5977-2019
NR 0
TC 0
Z9 0
U1 1
U2 3
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0378-4274
EI 1879-3169
J9 TOXICOL LETT
JI Toxicol. Lett.
PD OCT 16
PY 2015
VL 238
IS 2
SU S
MA W14-5
BP S55
EP S55
DI 10.1016/j.toxlet.2015.08.153
PG 1
WC Toxicology
SC Toxicology
GA DE5SY
UT WOS:000370693801042
DA 2019-10-23
ER

PT J
AU Tsakovska, I
   Al Sharif, M
   Fioravanzo, E
   Bassan, A
   Kovarich, S
   Vitcheva, V
   Mostrag-Szlichtyng, A
   Yang, C
   Steinmetz, F
   Cronin, M
AF Tsakovska, I.
   Al Sharif, M.
   Fioravanzo, E.
   Bassan, A.
   Kovarich, S.
   Vitcheva, V.
   Mostrag-Szlichtyng, A.
   Yang, C.
   Steinmetz, F.
   Cronin, M.
TI In silico approaches to support liver toxicity screening of chemicals:
   Case study on molecular modelling of ligands-nuclear receptors
   interactions to predict potential steatogenic effects
SO TOXICOLOGY LETTERS
LA English
DT Meeting Abstract
CT 51st Congress of the European-Societies-of-Toxicology (EUROTOX)
CY SEP 13-16, 2015
CL Portuguese Soc Pharmacol, Sect Toxicol, Porto, PORTUGAL
SP European Soc Toxicol
HO Portuguese Soc Pharmacol, Sect Toxicol
C1 [Tsakovska, I.; Al Sharif, M.] Inst Biophys & Biomed Engn, Sofia, Bulgaria.
   [Fioravanzo, E.; Bassan, A.; Kovarich, S.] S IN Soluzioni Informat SRL, Vicenza, Italy.
   [Vitcheva, V.; Yang, C.] Mol Networks GmbH, Erlangen, NY USA.
   [Vitcheva, V.; Mostrag-Szlichtyng, A.; Yang, C.] Altamira LLC, Columbus, OH USA.
   [Steinmetz, F.; Cronin, M.] Liverpool John Moores Univ, Liverpool L3 5UX, Merseyside, England.
NR 0
TC 0
Z9 0
U1 0
U2 2
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0378-4274
EI 1879-3169
J9 TOXICOL LETT
JI Toxicol. Lett.
PD OCT 16
PY 2015
VL 238
IS 2
SU S
MA P06-026
BP S173
EP S173
DI 10.1016/j.toxlet.2015.08.585
PG 1
WC Toxicology
SC Toxicology
GA DE5SY
UT WOS:000370693801363
DA 2019-10-23
ER

PT J
AU van Grunsven, L
AF van Grunsven, L.
TI A 3D liver co-culture system for evaluating drug-induced adverse outcome
   pathways leading to fibrosis
SO TOXICOLOGY LETTERS
LA English
DT Meeting Abstract
CT 51st Congress of the European-Societies-of-Toxicology (EUROTOX)
CY SEP 13-16, 2015
CL Portuguese Soc Pharmacol, Sect Toxicol, Porto, PORTUGAL
SP European Soc Toxicol
HO Portuguese Soc Pharmacol, Sect Toxicol
C1 [van Grunsven, L.] Vrije Univ Brussel, Liver Cell Biol Lab, Brussels, Belgium.
NR 0
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0378-4274
EI 1879-3169
J9 TOXICOL LETT
JI Toxicol. Lett.
PD OCT 16
PY 2015
VL 238
IS 2
SU S
MA W04-4
BP S38
EP S39
DI 10.1016/j.toxlet.2015.08.104
PG 2
WC Toxicology
SC Toxicology
GA DE5SY
UT WOS:000370693800105
DA 2019-10-23
ER

PT J
AU Whelan, M
AF Whelan, M.
TI Safety evaluation ultimately replacing animal testing: The SEURAT-1
   approach?
SO TOXICOLOGY LETTERS
LA English
DT Meeting Abstract
CT 51st Congress of the European-Societies-of-Toxicology (EUROTOX)
CY SEP 13-16, 2015
CL Portuguese Soc Pharmacol, Sect Toxicol, Porto, PORTUGAL
SP European Soc Toxicol
HO Portuguese Soc Pharmacol, Sect Toxicol
C1 [Whelan, M.] Commiss European Communities, Joint Res Ctr, Inst Hlth & Consumer Protect, I-21020 Ispra, Italy.
NR 0
TC 0
Z9 0
U1 0
U2 5
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0378-4274
EI 1879-3169
J9 TOXICOL LETT
JI Toxicol. Lett.
PD OCT 16
PY 2015
VL 238
IS 2
SU S
MA W04-1
BP S37
EP S38
DI 10.1016/j.toxlet.2015.08.101
PG 2
WC Toxicology
SC Toxicology
GA DE5SY
UT WOS:000370693800102
DA 2019-10-23
ER

PT J
AU Wildwater, M
   Kerkhof, E
   Lokman, C
   Pieters, R
AF Wildwater, M.
   Kerkhof, E.
   Lokman, C.
   Pieters, R.
TI C. elegans as robust, high throughput in vivo system for hazard
   assessment
SO TOXICOLOGY LETTERS
LA English
DT Meeting Abstract
CT 51st Congress of the European-Societies-of-Toxicology (EUROTOX)
CY SEP 13-16, 2015
CL Portuguese Soc Pharmacol, Sect Toxicol, Porto, PORTUGAL
SP European Soc Toxicol
HO Portuguese Soc Pharmacol, Sect Toxicol
C1 [Wildwater, M.; Kerkhof, E.; Lokman, C.] Univ Appl Sci Arnhem & Nijmegen, Bioctr, Nijmegen, Netherlands.
   [Pieters, R.] Univ Appl Sci, Innovat Testing, Utrecht, Netherlands.
   [Pieters, R.] Univ Utrecht, IRAS, Utrecht, Netherlands.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0378-4274
EI 1879-3169
J9 TOXICOL LETT
JI Toxicol. Lett.
PD OCT 16
PY 2015
VL 238
IS 2
SU S
MA W14-1
BP S53
EP S53
DI 10.1016/j.toxlet.2015.08.149
PG 1
WC Toxicology
SC Toxicology
GA DE5SY
UT WOS:000370693801038
DA 2019-10-23
ER

PT J
AU Wittwehr, C
   Munn, S
   Landesmann, B
   Whelan, M
AF Wittwehr, C.
   Munn, S.
   Landesmann, B.
   Whelan, M.
TI Adverse Outcome Pathways Knowledge Base (AOP-KB)
SO TOXICOLOGY LETTERS
LA English
DT Meeting Abstract
CT 51st Congress of the European-Societies-of-Toxicology (EUROTOX)
CY SEP 13-16, 2015
CL Portuguese Soc Pharmacol, Sect Toxicol, Porto, PORTUGAL
SP European Soc Toxicol
HO Portuguese Soc Pharmacol, Sect Toxicol
C1 [Wittwehr, C.; Munn, S.; Landesmann, B.; Whelan, M.] Commiss European Communities, Joint Res Ctr, I-21020 Ispra, Italy.
NR 0
TC 0
Z9 0
U1 0
U2 3
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0378-4274
EI 1879-3169
J9 TOXICOL LETT
JI Toxicol. Lett.
PD OCT 16
PY 2015
VL 238
IS 2
SU S
MA P13-104
BP S309
EP S309
DI 10.1016/j.toxlet.2015.08.884
PG 1
WC Toxicology
SC Toxicology
GA DE5SY
UT WOS:000370693801721
DA 2019-10-23
ER

PT J
AU Oldenkamp, R
   Huijbregts, M
   Ragas, A
AF Oldenkamp, R.
   Huijbregts, M.
   Ragas, A.
TI Uncertainty and variability in human exposure limits - A
   chemical-specific approach with ciprofloxacin and methotrexate
SO TOXICOLOGY LETTERS
LA English
DT Meeting Abstract
CT 51st Congress of the European-Societies-of-Toxicology (EUROTOX)
CY SEP 13-16, 2015
CL Portuguese Soc Pharmacol, Sect Toxicol, Porto, PORTUGAL
SP European Soc Toxicol
HO Portuguese Soc Pharmacol, Sect Toxicol
C1 [Oldenkamp, R.; Huijbregts, M.; Ragas, A.] Radboud Univ Nijmegen, Environm Sci, NL-6525 ED Nijmegen, Netherlands.
RI Huijbregts, Mark A.J./B-8971-2011; Ragas, Ad/C-3231-2011
OI Huijbregts, Mark A.J./0000-0002-7037-680X; 
NR 0
TC 0
Z9 0
U1 0
U2 4
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0378-4274
EI 1879-3169
J9 TOXICOL LETT
JI Toxicol. Lett.
PD OCT 16
PY 2015
VL 238
IS 2
SU S
MA P03-035
BP S98
EP S98
DI 10.1016/j.toxlet.2015.08.325
PG 1
WC Toxicology
SC Toxicology
GA DE5SY
UT WOS:000370693801162
DA 2019-10-23
ER

PT J
AU Muller, EB
   Lin, SJ
   Nisbet, RM
AF Muller, Erik B.
   Lin, Sijie
   Nisbet, Roger M.
TI Quantitative Adverse Outcome Pathway Analysis of Hatching in Zebrafish
   with CuO Nanoparticles
SO ENVIRONMENTAL SCIENCE & TECHNOLOGY
LA English
DT Article
ID ECOLOGICAL RISK-ASSESSMENT; COPPER; TOXICITY; EMBRYOS; ECOTOXICOLOGY;
   ASTACIN; MODELS; LARVAE; FISH; FATE
AB This study develops and evaluates a mechanistic model of the hatching of zebrafish eggs that were exposed to CuO engineered nanoparticles (ENP) in a high-throughput screening system and places this model in an adverse outcome pathway (AOP) that also includes CuO ENP dissolution and Cu bioaccumulation. Cu2+ inhibits the proteolytic activity of Zebrafish Hatching Enzyme 1 and thereby delay or impair hatching success. This study demonstrates that noncompetitive inhibition kinetics describe the impact of dissolved Cu on hatching; it is estimated that indefinitely long exposure to 1.88 mu M dissolved Cu in the environment reduces hatching enzyme activity by 50%. The complexity arising from CuO ENP dissolution and CuO ENP assisted bioaccumulation of Cu has led to apparently contradictory findings about ion versus "nano" effects on hatching. Model-mediated data analyses indicate that, relative to copper salts, CuO ENPs increase the uptake rates of Cu into the perivitelline space up to 8 times. The toxicity assessment framework in this study can be adapted to accommodate other types of toxicant, environmental samples and other aquatic oviparous species.
C1 [Muller, Erik B.] Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93106 USA.
   [Lin, Sijie] Univ Calif Los Angeles, Ctr Environm Implicat Nanotechnol, Los Angeles, CA 90095 USA.
   [Nisbet, Roger M.] Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA.
RP Muller, EB (reprint author), Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93106 USA.
EM erik.muller@lifesci.ucsb.edu
RI Nisbet, Roger/B-6951-2014; Lin, Sijie/S-8428-2016
OI Lin, Sijie/0000-0002-6970-8221; Muller, Erik/0000-0003-2300-0727
FU U.S. National Science FoundationNational Science Foundation (NSF); U.S.
   Environmental Protection AgencyUnited States Environmental Protection
   Agency [DBI-1266377]
FX We thank Tjalling Jager for sharing Matlab code for the estimation of
   parameter values, Jing Hua for providing data files, Linda Dong and
   William Ueng for the support on zebrafish care and spawning and Suman
   Pokhrel and Lutz Madler for providing CuO nanoparticles. We are also
   indebted to Tin Klanjscek and Gary Cherr for valuable discussions. We
   are also indebted to the three anonymous reviewers, whose suggestions
   and comments led to substantial improvements in the paper. This research
   was supported by the U.S. National Science Foundation and the U.S.
   Environmental Protection Agency under Cooperative Agreement Number
   DBI-1266377. Any opinions, findings, and conclusions or recommendations
   expressed in this material are those of the authors and do not
   necessarily reflect the views of the National Science Foundation or the
   U.S. Environmental Protection Agency. This work has not been subjected
   to EPA review and no official endorsement should be inferred.
CR Adeleye AS, 2014, ENVIRON SCI TECHNOL, V48, P12561, DOI 10.1021/es5033426
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Bai W, 2010, J NANOSCI NANOTECHNO, V10, P8670, DOI 10.1166/jnn.2010.2686
   DAVE G, 1991, ARCH ENVIRON CON TOX, V21, P126, DOI 10.1007/BF01055567
   Forbes VE, 2013, INTEGR ENVIRON ASSES, V9, pE75, DOI 10.1002/ieam.1425
   George S, 2011, ACS NANO, V5, P1805, DOI 10.1021/nn102734s
   GOMISRUTH FX, 1994, J BIOL CHEM, V269, P17111
   Hernandez PP, 2011, BIOL RES, V44, P7, DOI 10.4067/S0716-97602011000100002
   Hill AJ, 2005, TOXICOL SCI, V86, P6, DOI 10.1093/toxsci/kfi110
   Hua J, 2014, ENVIRON TOXICOL CHEM, V33, P1774, DOI 10.1002/etc.2615
   Inohaya K, 1997, DEV GROWTH DIFFER, V39, P191
   Jager T, 2005, ENVIRON SCI TECHNOL, V39, P8307, DOI 10.1021/es050817y
   Jager T, 2011, ENVIRON SCI TECHNOL, V45, P8180, DOI 10.1021/es2030559
   Jager T, 2011, ENVIRON SCI TECHNOL, V45, P2529, DOI 10.1021/es103092a
   Jezierska B, 2009, FISH PHYSIOL BIOCHEM, V35, P625, DOI 10.1007/s10695-008-9284-4
   Johnson A, 2007, AQUAT TOXICOL, V84, P431, DOI 10.1016/j.aquatox.2007.07.003
   Kooijman SALM, 1996, RISK ANAL, V16, P445, DOI 10.1111/j.1539-6924.1996.tb01091.x
   Lin SJ, 2013, SMALL, V9, P1776, DOI 10.1002/smll.201202128
   Lin SJ, 2011, ACS NANO, V5, P7284, DOI 10.1021/nn202116p
   Muller EB, 2010, ECOTOXICOLOGY, V19, P48, DOI 10.1007/s10646-009-0385-3
   Nel A, 2013, ACCOUNTS CHEM RES, V46, P607, DOI 10.1021/ar300022h
   Palmer FB, 1998, ENVIRON TOXICOL CHEM, V17, P1538, DOI 10.1002/etc.5620170814
   Teoh WY, 2010, NANOSCALE, V2, P1324, DOI 10.1039/c0nr00017e
   Xia T, 2013, SMALL, V9, P1428, DOI 10.1002/smll.201201700
   Zhou SL, 2009, AQUAT TOXICOL, V95, P339, DOI 10.1016/j.aquatox.2009.10.006
   Zhu MT, 2013, ACCOUNTS CHEM RES, V46, P622, DOI 10.1021/ar300031y
NR 26
TC 24
Z9 26
U1 8
U2 107
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0013-936X
EI 1520-5851
J9 ENVIRON SCI TECHNOL
JI Environ. Sci. Technol.
PD OCT 6
PY 2015
VL 49
IS 19
BP 11817
EP 11824
DI 10.1021/acs.est.5b01837
PG 8
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA CT2JZ
UT WOS:000362629100065
PM 26378804
DA 2019-10-23
ER

PT J
AU Stiegel, MA
   Pleil, JD
   Sobus, JR
   Angrish, MM
   Morgan, MK
AF Stiegel, M. A.
   Pleil, J. D.
   Sobus, J. R.
   Angrish, M. M.
   Morgan, M. K.
TI Kidney injury biomarkers and urinary creatinine variability in nominally
   healthy adults
SO BIOMARKERS
LA English
DT Article
DE Computational biology; environmental pollution; ecotoxicology; growth
   factors; cytokines; inflammatory mediators; immunotoxicity;
   metabol(n)omics
ID ENDOTHELIAL GROWTH-FACTOR; BIOMONITORING DATA; CHEMICAL-EXPOSURE;
   SYSTEMS BIOLOGY; RISK-ASSESSMENT; BREATH; OSTEOACTIVIN; MARKERS; CANCER;
   POPULATION
AB Environmental exposure diagnostics use creatinine concentrations in urine aliquots as the internal standard for dilution normalization of all other excreted metabolites when urinary excretion rate data are not available. This is a reasonable approach for healthy adults as creatinine is a human metabolite that is continually produced in skeletal muscles and presumably excreted in the urine at a stable rate. However, creatinine also serves as a biomarker for glomerular filtration rate (efficiency) of the kidneys, so undiagnosed kidney function impairment could affect this commonly applied dilution calculation. The United States Environmental Protection Agency (US EPA) has recently conducted a study that collected approximately 2600 urine samples from 50 healthy adults, aged 19-50 years old, in North Carolina in 2009-2011. Urinary ancillary data (creatinine concentration, total void volume, elapsed time between voids), and participant demographic data (race, gender, height, and body weight) were collected. A representative subset of 280 urine samples from 29 participants was assayed using a new kidney injury panel (KIP). In this article, we investigated the relationships of KIP biomarkers within and between subjects and also calculated their interactions with measured creatinine levels. The aims of this work were to document the analytical methods (procedures, sensitivity, stability, etc.), provide summary statistics for the KIP biomarkers in healthy adults without diagnosed disease (distribution, fold range, central tendency, variance), and to develop an understanding as to how urinary creatinine level varies with respect to the individual KIP proteins. Results show that new instrumentation and data reduction methods have sufficient sensitivity to measure KIP levels in nominally healthy urine samples, that linear regression between creatinine concentration and urinary excretion explains only about 68% of variability, that KIP markers are poorly correlated with creatinine (r(2) approximate to 0.34), and that statistical outliers of KIP markers are not random, but are clustered within certain subjects. In addition, we interpret these new adverse outcome pathways based in vivo biomarkers for their potential use as intermediary chemicals that may be diagnostic of kidney adverse outcomes to environmental exposure.
C1 [Stiegel, M. A.] Univ N Carolina, Dept Environm Sci & Engn, Gillings Sch Publ Hlth, Chapel Hill, NC USA.
   [Stiegel, M. A.; Angrish, M. M.] US EPA, ORISE, Res Triangle Pk, NC 27711 USA.
   [Pleil, J. D.; Sobus, J. R.; Morgan, M. K.] US EPA, Natl Exposure Res Lab, Off Res & Dev, Res Triangle Pk, NC 27711 USA.
RP Pleil, JD (reprint author), US EPA, Natl Exposure Res Lab, Off Res & Dev, Res Triangle Pk, NC 27711 USA.
EM pleil.joachim@epa.gov
OI Sobus, Jon/0000-0003-0740-6604
CR Ahmed ARH, 2012, AM J PATHOL, V180, P904, DOI 10.1016/j.ajpath.2011.11.022
   Andersen EM, 2014, J TOXICOL ENV HEAL A, V77, P1114, DOI 10.1080/15287394.2014.922391
   Angerer J, 2007, INT J HYG ENVIR HEAL, V210, P201, DOI 10.1016/j.ijheh.2007.01.024
   Angrish MM, 2015, CHEM RES TOXICOL, V28, P551, DOI 10.1021/acs.chemrestox.5b00024
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Au WW, 2007, INT J HYG ENVIR HEAL, V210, P239, DOI 10.1016/j.ijheh.2006.11.001
   Barr DB, 2005, ENVIRON HEALTH PERSP, V113, P192, DOI 10.1289/ehp.7337
   Bean HD, 2015, BIOMARKERS, V20, P1, DOI 10.3109/1354750X.2014.985254
   Becker J, 2013, AM J ROENTGENOL, V200, P827, DOI 10.2214/AJR.12.9872
   BOENIGER MF, 1993, AM IND HYG ASSOC J, V54, P615, DOI 10.1202/0002-8894(1993)054<0615:IOURUT>2.0.CO;2
   Bolt MJG, 2005, J NUTR BIOCHEM, V16, P286, DOI 10.1016/j.jnutbio.2004.12.011
   Bonventre JV, 2010, NAT BIOTECHNOL, V28, P436, DOI 10.1038/nbt0510-436
   Branten AJW, 2000, NEPHRON, V85, P120, DOI 10.1159/000045644
   Chadeau-Hyam M, 2013, ENVIRON MOL MUTAGEN, V54, P542, DOI 10.1002/em.21797
   Choudhury D, 2006, NAT CLIN PRACT NEPHR, V2, P80, DOI 10.1038/ncpneph0076
   Doi K, 2010, CURR VASC PHARMACOL, V8, P122, DOI 10.2174/157016110790226606
   Edwards SW, 2008, TOXICOL SCI, V106, P312, DOI 10.1093/toxsci/kfn190
   Fuchs TC, 2011, AAPS J, V13, P615, DOI 10.1208/s12248-011-9301-x
   Giffen PS, 2002, TOXICOL PATHOL, V30, P365, DOI 10.1080/01926230252929945
   Halloy S., 2005, COMPLEXITY INT, V12, P1
   Harrell FE, 2015, SPRINGER SER STAT, P63, DOI 10.1007/978-3-319-19425-7_4
   Henderson AR, 2006, CLIN CHIM ACTA, V366, P112, DOI 10.1016/j.cca.2005.11.007
   Hill RH, 1995, ENVIRON RES, V71, P99, DOI 10.1006/enrs.1995.1071
   Hoeben A, 2004, PHARMACOL REV, V56, P549, DOI 10.1124/pr.56.4.3
   Houck KA, 2009, J BIOMOL SCREEN, V14, P1054, DOI 10.1177/1087057109345525
   Hubal EAC, 2010, J TOXICOL ENV HEAL B, V13, P299, DOI 10.1080/10937404.2010.483947
   Hudmon KS, 1997, CANCER EPIDEM BIOMAR, V6, P565
   Jones SE, 2002, INT J BIOCHEM CELL B, V34, P427, DOI 10.1016/S1357-2725(01)00155-8
   Kavlock R, 2010, J TOXICOL ENV HEAL B, V13, P197, DOI 10.1080/10937404.2010.483935
   Lee HW, 2013, STAT APPL GENET MOL, V12, P207, DOI 10.1515/sagmb-2012-0067
   Limpert E, 2001, BIOSCIENCE, V51, P341, DOI 10.1641/0006-3568(2001)051[0341:LNDATS]2.0.CO;2
   Lind PM, 2013, ENVIRON INT, V55, P1, DOI 10.1016/j.envint.2013.01.017
   LIOY PJ, 1990, INT J EPIDEMIOL, V19, pS53, DOI 10.1093/ije/19.Supplement_1.S53
   Lock EA, 2010, TOXICOL SCI, V116, P1, DOI 10.1093/toxsci/kfq128
   Lu SS, 2014, BIOMARKERS, V19, P332, DOI 10.3109/1354750X.2014.910553
   Meeker JD, 2013, ENVIRON HEALTH PERSP, V121, P580, DOI 10.1289/ehp.1205907
   Muscat JE, 2011, BIOMARKERS, V16, P206, DOI 10.3109/1354750X.2010.538084
   Nakamura A, 2007, EXP TOXICOL PATHOL, V59, P53, DOI 10.1016/j.etp.2007.03.005
   Patel CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010746
   Patel-Chamberlin M, 2011, KIDNEY INT, V79, P1138, DOI 10.1038/ki.2011.28
   Paustenbach D, 2006, ENVIRON HEALTH PERSP, V114, P1143, DOI 10.1289/chp.8755
   Phillips M, 2008, CLIN CHIM ACTA, V393, P76, DOI 10.1016/j.cca.2008.02.021
   Pleil JD, 2007, BIOMARKERS, V12, P331, DOI 10.1080/13547500701246334
   Pleil JD, 2008, J TOXICOL ENV HEAL B, V11, P613, DOI 10.1080/10937400701724329
   Pleil JD, 2007, ENVIRON SCI TECHNOL, V41, P7286, DOI 10.1021/es070714a
   Pleil JD, 2014, J TOXICOL ENV HEAL B, V17, P341, DOI 10.1080/10937404.2014.956854
   Pleil JD, 2014, J BREATH RES, V8, DOI 10.1088/1752-7155/8/2/029001
   Pleil JD, 2013, ANAL CHEM, V85, P9984, DOI 10.1021/ac402306f
   Pleil JD, 2013, J TOXICOL ENV HEAL A, V76, P747, DOI 10.1080/15287394.2013.821394
   Pleil JD, 2012, TOXICOL LETT, V215, P201, DOI 10.1016/j.toxlet.2012.10.011
   Pleil JD, 2012, J EXPO SCI ENV EPID, V22, P317, DOI 10.1038/jes.2012.5
   Pleil JD, 2012, J TOXICOL ENV HEAL B, V15, P264, DOI 10.1080/10937404.2012.672148
   Pleil JD, 2011, J BREATH RES, V5, DOI 10.1088/1752-7155/5/4/046005
   Pleil JD, 2011, CHEMOSPHERE, V84, P716, DOI 10.1016/j.chemosphere.2011.03.017
   Pleil JD, 2011, J BREATH RES, V5, DOI 10.1088/1752-7155/5/3/037104
   Pleil JD, 2011, BIOMARKERS, V16, P99, DOI 10.3109/1354750X.2010.541565
   Pleil JD, 2009, BIOMARKERS, V14, P560, DOI 10.3109/13547500903186460
   Rappaport SM, 2012, BIOMARKERS, V17, P483, DOI 10.3109/1354750X.2012.691553
   Rappaport SM, 2012, J EPIDEMIOL COMMUN H, V66, P99, DOI 10.1136/jech-2011-200726
   Rappaport SM, 2010, SCIENCE, V330, P460, DOI 10.1126/science.1192603
   RICHARDS FJ, 1959, J EXP BOT, V10, P290, DOI 10.1093/jxb/10.2.290
   Sheng MHC, 2008, FEBS LETT, V582, P1451, DOI 10.1016/j.febslet.2008.03.030
   Siew ED, 2011, J AM SOC NEPHROL, V22, P810, DOI [10.1681/ASN.201.0080796, 10.1681/ASN.2010080796]
   Sobus JR, 2015, ENVIRON HEALTH PERSP, V123, P919, DOI 10.1289/ehp.1409177
   Sobus JR, 2011, SCI TOTAL ENVIRON, V409, P4875, DOI 10.1016/j.scitotenv.2011.07.046
   Sondag GR, 2014, J CELL PHYSIOL, V229, P955, DOI 10.1002/jcp.24512
   Stiegel MA, 2015, BIOMARKERS, V20, P35, DOI 10.3109/1354750X.2014.988646
   Tan YM, 2012, J TOXICOL ENV HEAL B, V15, P22, DOI 10.1080/10937404.2012.632360
   United States Environmental Protection Agency (USEPA), 2008, EPA600R08062 OFF RES
   Vaidya VS, 2010, NAT BIOTECHNOL, V28, P478, DOI 10.1038/nbt.1623
   Vaidya VS, 2006, AM J PHYSIOL-RENAL, V290, pF517, DOI 10.1152/ajprenal.00291.2005
   Villeneuve DL, 2014, TOXICOL SCI, V142, P312, DOI 10.1093/toxsci/kfu199
   Villeneuve DL, 2014, TOXICOL SCI, V142, P321, DOI 10.1093/toxsci/kfu200
   Vinken M, 2013, TOXICOLOGY, V312, P158, DOI 10.1016/j.tox.2013.08.011
   Wambaugh JF, 2013, ENVIRON SCI TECHNOL, V47, P8479, DOI 10.1021/es400482g
   Yu Y, 2010, NAT BIOTECHNOL, V28, P470, DOI 10.1038/nbt.1624
NR 76
TC 8
Z9 8
U1 0
U2 8
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1354-750X
EI 1366-5804
J9 BIOMARKERS
JI Biomarkers
PD OCT 3
PY 2015
VL 20
IS 6-7
BP 436
EP 452
DI 10.3109/1354750X.2015.1094136
PG 17
WC Biotechnology & Applied Microbiology; Toxicology
SC Biotechnology & Applied Microbiology; Toxicology
GA CX4EM
UT WOS:000365651700012
PM 26616147
DA 2019-10-23
ER

PT J
AU Benigni, R
   Battistelli, CL
   Bossa, C
   Giuliani, A
   Tcheremenskaia, O
AF Benigni, Romualdo
   Battistelli, Chiara Laura
   Bossa, Cecilia
   Giuliani, Alessandro
   Tcheremenskaia, Olga
TI Alternative Toxicity Testing: Analyses on Skin Sensitization, ToxCast
   Phases I and II, and Carcinogenicity Provide Indications on How to Model
   Mechanisms Linked to Adverse Outcome Pathways
SO JOURNAL OF ENVIRONMENTAL SCIENCE AND HEALTH PART C-ENVIRONMENTAL
   CARCINOGENESIS & ECOTOXICOLOGY REVIEWS
LA English
DT Review
DE ToxCast assays; limitations; mechanistic coverage; adverse outcome
   pathways; skin sensitization; carcinogenicity; endocrine disruption
ID CELL-TRANSFORMATION; RISK-ASSESSMENT; HAZARD; CHEMICALS; IDENTIFICATION;
   ANIMALS; SAFETY; ASSAYS; QSAR
AB This article studies alternative toxicological approaches, with new (skin sensitization, ToxCast) and previous (carcinogenicity) analyses. Quantitative modeling of rate-limiting steps in skin sensitization and carcinogenicity predicts the majority of toxicants. Similarly, successful (Quantitative) Structure-Activity Relationships models exploit the quantification of only one, or few rate-limiting steps. High-throughput assays within ToxCast point to promising associations with endocrine disruption, whereas markers for pathways intermediate events have limited correlation with most endpoints. Since the pathways may be very different (often not simple linear chains of events), quantitative analysis is necessary to identify the type of mechanism and build the appropriate model.
C1 [Benigni, Romualdo; Battistelli, Chiara Laura; Bossa, Cecilia; Giuliani, Alessandro; Tcheremenskaia, Olga] Ist Super Sanita, Dept Environm & Hlth, I-00161 Rome, Italy.
RP Benigni, R (reprint author), Ist Super Sanita, Dept Environm & Hlth, Viale Regina Elena 299, I-00161 Rome, Italy.
EM romualdo.benigni@gmail.com
RI Giuliani, Alessandro/K-7589-2016; Bossa, Cecilia/K-4454-2016
OI Giuliani, Alessandro/0000-0002-4640-804X; Bossa,
   Cecilia/0000-0003-2084-2902; Tcheremenskaia, Olga/0000-0002-5029-3484;
   battistelli, chiara laura/0000-0003-2386-0727; Tcheremenskaia,
   Olga/0000-0002-2824-2648
CR Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Ashikaga T, 2006, TOXICOL IN VITRO, V20, P767, DOI 10.1016/j.tiv.2005.10.012
   Basketter DA, 2012, ALTEX-ALTERN ANIM EX, V29, P5, DOI 10.14573/altex.2012.1.003
   Benigni R, 2013, MUTAT RES, V578, P56
   Benigni R, 2012, COMPUTATIONAL TOXICO, P67
   Benigni R, 2008, J CHEM INF MODEL, V48, P971, DOI 10.1021/ci8000088
   Benigni R, 2007, ENVIRON MOL MUTAGEN, V48, P754, DOI 10.1002/em.20355
   Benigni R, 2015, MUTAT RES-GEN TOX EN, V779, P35, DOI 10.1016/j.mrgentox.2015.02.001
   Benigni R, 2014, EXPERT OPIN DRUG MET, V10, P1199, DOI 10.1517/17425255.2014.934670
   Benigni R, 2013, J ENVIRON SCI HEAL C, V31, P201, DOI 10.1080/10590501.2013.824188
   Benigni R, 2013, MUTAGENESIS, V28, P107, DOI 10.1093/mutage/ges059
   Benigni R, 2012, EXPERT OPIN DRUG MET, V8, P407, DOI 10.1517/17425255.2012.666238
   Benigni R, 2011, CHEM REV, V111, P2507, DOI 10.1021/cr100222q
   Benigni R, 2010, J ENVIRON SCI HEAL C, V28, P272, DOI 10.1080/10590501.2010.525781
   Cherkasov A, 2014, J MED CHEM, V57, P4977, DOI 10.1021/jm4004285
   Dix DJ, 2007, TOXICOL SCI, V95, P5, DOI 10.1093/toxsci/kfl103
   Emter R, 2010, TOXICOL APPL PHARM, V245, P281, DOI 10.1016/j.taap.2010.03.009
   Franke R., 1984, THEORETICAL DRUG DES
   Franke R., 2003, QUANTITATIVE STRUCTU, P1
   Garrington TP, 1999, CURR OPIN CELL BIOL, V11, P211, DOI 10.1016/S0955-0674(99)80028-3
   Gerberick GF, 2004, TOXICOL SCI, V81, P332, DOI 10.1093/toxsci/kfh213
   Goebel C, 2012, REGUL TOXICOL PHARM, V63, P40, DOI 10.1016/j.yrtph.2012.02.007
   Haga K, 2007, CANCER SCI, V98, P147, DOI 10.1111/j.1349-7006.2006.00373.x
   Hansch C, 2002, CHEM REV, V102, P783, DOI 10.1021/cr0102009
   Hansch C, 1995, EXPLORING QSAR
   Judson R, 2008, TOXICOL APPL PHARM, V233, P7, DOI 10.1016/j.taap.2007.12.037
   Kavlock RJ, 2012, ALTERNATIVE TESTING, P180
   Kavlock RJ, 2009, RISK ANAL, V29, P485, DOI 10.1111/j.1539-6924.2008.01168.x
   Kubinyi H, 1993, 3D QSAR DRUG DESIGN
   Lai DY, 1996, ACS SYM SER, P1
   Lilienblum W, 2008, ARCH TOXICOL, V82, P211, DOI 10.1007/s00204-008-0279-9
   Liu J, 2015, CHEM RES TOXICOL, V28, P738, DOI 10.1021/tx500501h
   Mauthe RJ, 2001, TOXICOL PATHOL, V29, P138, DOI 10.1080/019262301753178546
   Nguyen-Ba G, 1999, ONCOL REP, V6, P925
   Organisation for Economic Co-Operation and Development, 2012, SER TEST ASS
   Organisation for Economic Co-operation and Development, 2014, OECD SER TEST ASS
   Schmidt C, 2009, J NATL CANCER I, V101, P910, DOI 10.1093/jnci/djp191
   Scholz S, 2013, REGUL TOXICOL PHARM, V67, P506, DOI 10.1016/j.yrtph.2013.10.003
   Sipes NS, 2013, CHEM RES TOXICOL, V26, P878, DOI [10.1021/tx400021f, 10.1021/tx400021]
   Stuard SB, 1999, TOXICOL SCI, V48, P366
   SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615
   Thomas RS, 2013, TOXICOL SCI, V136, P4, DOI 10.1093/toxsci/kft178
   Thomas RS, 2012, TOXICOL SCI, V128, P398, DOI 10.1093/toxsci/kfs159
   TOPLISS JG, 1979, J MED CHEM, V22, P1238, DOI 10.1021/jm00196a017
   Tun K, 2011, CURR COMPUT-AID DRUG, V7, P206, DOI 10.2174/157340911796504297
   Tute MS, 1990, COMPREHENSIVE MED CH, V33, P1
   Urbisch D, 2015, REGUL TOXICOL PHARM, V71, P337, DOI 10.1016/j.yrtph.2014.12.008
   van Leeuwen K, 2009, SAR QSAR ENVIRON RES, V20, P207, DOI 10.1080/10629360902949179
   Vinken M, 2013, TOXICOLOGY, V312, P158, DOI 10.1016/j.tox.2013.08.011
   Voosen P, 2015, CHRON HIGH ED   0316
   Woo YT, 2001, PATTYS TOXICOLOGY, P969
   WOO YT, 2003, QUANTITATIVE STRUCTU, P41
   Worth A, 2014, JRC SCI POLICY REPOR, VRC91361
   YAMASAKI H, 1995, TOXICOL LETT, V77, P55, DOI 10.1016/0378-4274(95)03272-X
   Yamasaki H, 1995, MUTAT RES-FUND MOL M, V333, P181, DOI 10.1016/0027-5107(95)00144-1
   Zeiger E, 1998, REGUL TOXICOL PHARM, V28, P85, DOI 10.1006/rtph.1998.1234
   ZHANG LT, 1992, CHEM-BIOL INTERACT, V81, P149, DOI 10.1016/0009-2797(92)90032-G
NR 57
TC 5
Z9 5
U1 1
U2 18
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1059-0501
EI 1532-4095
J9 J ENVIRON SCI HEAL C
JI J. Environ. Sci. Health Pt. C-Environ. Carcinog. Ecotoxicol. Rev.
PD OCT 2
PY 2015
VL 33
IS 4
BP 422
EP 443
DI 10.1080/10590501.2015.1096885
PG 22
WC Oncology; Environmental Sciences; Toxicology
SC Oncology; Environmental Sciences & Ecology; Toxicology
GA CX4QD
UT WOS:000365684500003
PM 26398111
DA 2019-10-23
ER

PT J
AU Prochazka, E
   Escher, BI
   Plewa, MJ
   Leusch, FDL
AF Prochazka, Erik
   Escher, Beate I.
   Plewa, Michael J.
   Leusch, Frederic D. L.
TI In Vitro Cytotoxicity and Adaptive Stress Responses to Selected
   Haloacetic Acid and Halobenzoquinone Water Disinfection Byproducts
SO CHEMICAL RESEARCH IN TOXICOLOGY
LA English
DT Article
ID CELL TOXICOGENOMIC ANALYSIS; DRINKING-WATER; OXIDATIVE STRESS;
   BROMO-BENZOQUINONES; COLORECTAL-CANCER; BLADDER-CANCER; TOXICITY;
   GENOTOXICITY; PATHWAY; ASSAY
AB The process of disinfecting drinking water inadvertently leads to the formation of numerous disinfection byproducts (DBPs). Some of these are mutagenic, genotoidc, teratogenic, and cytotoxic, as well as potentially carcinogenic both in vivo and in vitro. We investigated the in vitro biological activity of five DBPs: three monohaloacetic acids (monoHAAs) [chloroacetic acid (CAA), bromoacetic acid (BAA), and iodoacetic acid (IAA)] and two novel halobenzoquinones (HBQs) [2,6-dichloro-p-benzoquinone (DCBQ) and 2,6-dibromo-p-benzoquinone]. We focused particularly on cytotoxidty and induction of two adaptive stress response pathways: the oxidative stress responsive Nrf2/ARE and DNA-damage responsive p53 pathways. All five DBPs were cytotoidc to the Caco-2 cell line after a 4 h exposure, and all DBPs induced both of the adaptive stress response pathways, Nrf2/ARE and p53, in the micromolar range, as measured by two beta-lactamase-based reporter gene assays. The decreasing order of potency for all three endpoints for the five DBPs was IAA similar to BAA > DCBQ similar to DBBQ > CAA. Induction of oxidative stress was previously proposed to be the molecular initiating event (MIE) for both classes of DBPs. However, comparing the levels of activation of the two pathways uncovered that the Nrf2/ARE pathway was the more sensitive endpoint for HAAs, whereas the p53 pathway was more sensitive in the case of HBQs. Therefore, the DNA damage-responsive p53 pathway may be an important piece of information to fill in a gap in the adverse outcome pathway framework for the assessment of HBQs. Finally, we cautiously compared the potential risk of the two novel HBQs using a benchmarking approach to that of the well-studied CAA, which suggested that their relative risk may be lower than that of BAA and IAA.
C1 [Prochazka, Erik; Escher, Beate I.; Leusch, Frederic D. L.] Griffith Univ, Sch Environm, Australian Rivers Inst, Smart Water Res Ctr, Gold Coast, Qld 4222, Australia.
   [Escher, Beate I.] UFZ Helmholtz Ctr Environm Res, Cell Toxicol, D-04318 Leipzig, Germany.
   [Escher, Beate I.] Univ Tubingen, Ctr Appl Geosci, Environm Toxicol, D-72074 Tubingen, Germany.
   [Plewa, Michael J.] Univ Illinois, Ctr Adv Mat Purificat Water Syst, Dept Crop Sci, Urbana, IL 61801 USA.
   [Plewa, Michael J.] Univ Illinois, Ctr Adv Mat Purificat Water Syst, Safe Global Water Inst, Urbana, IL 61801 USA.
   [Plewa, Michael J.] Univ Illinois, Ctr Adv Mat Purificat Water Syst, Sci & Technol, Urbana, IL 61801 USA.
RP Prochazka, E (reprint author), Griffith Univ, Sch Environm, Australian Rivers Inst, Smart Water Res Ctr, Gold Coast, Qld 4222, Australia.
EM e.prochazka@griffith.edu.au
RI Escher, Beate/C-7992-2009; Leusch, Frederic/A-2806-2011; Prochazka,
   Erik/L-1924-2018
OI Escher, Beate/0000-0002-5304-706X; Leusch, Frederic/0000-0002-6934-4587;
   Prochazka, Erik/0000-0002-3622-647X
FU Australian Postgraduate Award (APA) ScholarshipAustralian Government;
   Griffith UniversityGriffith University
FX E.P. is a recipient of an Australian Postgraduate Award (APA)
   Scholarship administered by Griffith University, and the project was
   funded by the Griffith University's funding scheme for graduate research
   students.
CR Allen TEH, 2014, CHEM RES TOXICOL, V27, P2100, DOI 10.1021/tx500345j
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Attene-Ramos MS, 2010, ENVIRON SCI TECHNOL, V44, P7206, DOI 10.1021/es1000193
   Attia SM, 2014, MUTAGENESIS, V29, P55, DOI 10.1093/mutage/get063
   Baird L, 2011, ARCH TOXICOL, V85, P241, DOI 10.1007/s00204-011-0674-5
   Bolton JL, 2000, CHEM RES TOXICOL, V13, P135, DOI 10.1021/tx9902082
   Brown CJ, 2009, NAT REV CANCER, V9, P862, DOI 10.1038/nrc2763
   Bull RJ, 2011, TOXICOLOGY, V286, P1, DOI 10.1016/j.tox.2011.05.004
   Cemeli E, 2006, ENVIRON SCI TECHNOL, V40, P1878, DOI 10.1021/es051602r
   Chen CH, 2013, TOXICOLOGY, V303, P72, DOI 10.1016/j.tox.2012.10.008
   Cutler D, 2005, DEMOGRAPHY, V42, P1, DOI 10.1353/dem.2005.0002
   Dad A, 2013, ENVIRON MOL MUTAGEN, V54, P629, DOI 10.1002/em.21795
   Dinkova-Kostova AT, 2015, FREE RADICAL BIO MED, V88, P179, DOI 10.1016/j.freeradbiomed.2015.04.036
   Du HY, 2013, ENVIRON SCI TECHNOL, V47, P2823, DOI 10.1021/es303762p
   EFRON B, 1987, J AM STAT ASSOC, V82, P171, DOI 10.2307/2289144
   Escher BI, 2014, ENVIRON SCI TECHNOL, V48, P1940, DOI 10.1021/es403899t
   Escher BI, 2012, J ENVIRON MONITOR, V14, P2877, DOI 10.1039/c2em30506b
   Farre MJ, 2013, WATER RES, V47, P5409, DOI 10.1016/j.watres.2013.06.017
   Franco R, 2009, MUTAT RES-GEN TOX EN, V674, P3, DOI 10.1016/j.mrgentox.2008.11.012
   GWYNN RH, 1953, BRIT J CANCER, V7, P482, DOI 10.1038/bjc.1953.50
   Hanson ML, 2004, ENVIRON POLLUT, V130, P385, DOI 10.1016/j.envpol.2003.12.017
   HAYES FD, 1973, TOXICOL APPL PHARM, V26, P93, DOI 10.1016/0041-008X(73)90089-6
   Hrudey SE, 2012, DISINFECTION BY-PRODUCTS: RELEVANCE TO HUMAN HEALTH, P1
   Huang RF, 2013, ANAL CHEM, V85, P4520, DOI 10.1021/ac400160r
   Invitrogen, 2006, CELLSENSOR ARE BLA H
   Invitrogen, 2010, CELLSENSOR P53RE BLA
   Jennings P, 2013, ARCH TOXICOL, V87, P49, DOI 10.1007/s00204-012-0919-y
   Jeong CH, 2015, ENVIRON SCI TECHNOL, V49, P13749, DOI 10.1021/es506358x
   Jeong CH, 2012, ENVIRON SCI TECHNOL, V46, P12120, DOI 10.1021/es3024226
   Klaunig JE, 2011, TOXICOL APPL PHARM, V254, P86, DOI 10.1016/j.taap.2009.11.028
   KOIVUSALO M, 1994, AM J PUBLIC HEALTH, V84, P1223, DOI 10.2105/AJPH.84.8.1223
   KOIVUSALO M, 1995, ARCH ENVIRON HEALTH, V50, P269, DOI 10.1080/00039896.1995.9935953
   Konsoula R, 2005, TOXICOL IN VITRO, V19, P675, DOI 10.1016/j.tiv.2005.03.006
   Lente G, 2004, J PHOTOCH PHOTOBIO A, V163, P249, DOI 10.1016/j.jphotochem.2003.12.005
   Li JH, 2015, CHEM RES TOXICOL, V28, P306, DOI 10.1021/tx500494r
   Li JH, 2014, TOXICOL SCI, V141, P335, DOI 10.1093/toxsci/kfu088
   Liu Y, 2006, P NATL ACAD SCI USA, V103, P976, DOI 10.1073/pnas.0510146103
   Malich G, 1997, TOXICOLOGY, V124, P179, DOI 10.1016/S0300-483X(97)00151-0
   Muellner MG, 2010, ENVIRON MOL MUTAGEN, V51, P205, DOI 10.1002/em.20530
   National Toxicology Program, 1992, NATL TOXICOL PROGRAM, V396, P1
   [NHMRC NRMMC N. H. M. R Council N. R. M. M], 2011, AUSTR DRINK WAT GUID
   OECD, 2013, OECD ENV HLTH SAF PU, V184
   Osburn WO, 2008, MUTAT RES-REV MUTAT, V659, P31, DOI 10.1016/j.mrrev.2007.11.006
   Pals J, 2013, ENVIRON SCI TECHNOL, V47, P12514, DOI 10.1021/es403171b
   Pals JA, 2011, ENVIRON SCI TECHNOL, V45, P5791, DOI 10.1021/es2008159
   Plewa M. J., 2009, MAMMALIAN CELL CYTOT
   Plewa M. J., 2015, OCCURRENCE FORMATION
   Plewa M. J., 2011, ENCY ENV HLTH, V1, P806
   Plewa MJ, 2010, ENVIRON MOL MUTAGEN, V51, P871, DOI 10.1002/em.20585
   Plewa MJ, 2008, ACS SYM SER, V995, P36
   Plewa MJ, 2004, ENVIRON SCI TECHNOL, V38, P4713, DOI 10.1021/es049971v
   Qin F, 2010, ANGEW CHEM INT EDIT, V49, P790, DOI 10.1002/anie.200904934
   Rahman MB, 2010, INT J EPIDEMIOL, V39, P733, DOI 10.1093/ije/dyp371
   Ramis G, 2013, BIOMED MICRODEVICES, V15, P985, DOI 10.1007/s10544-013-9790-8
   Richard AM, 1996, TERATOLOGY, V53, P352, DOI 10.1002/(SICI)1096-9926(199606)53:6<352::AID-TERA6>3.0.CO;2-1
   Richardson S.D., 2012, EMERGING ORGANIC CON, P93
   Richardson SD, 2008, ENVIRON SCI TECHNOL, V42, P8330, DOI 10.1021/es801169k
   Richardson SD, 2007, MUTAT RES-REV MUTAT, V636, P178, DOI 10.1016/j.mrrev.2007.09.001
   Rivera-Nunez Z, 2013, J OCCUP ENVIRON MED, V55, P1125, DOI 10.1097/JOM.0b013e3182a4ffe4
   Simpson KL, 1998, WATER RES, V32, P1522, DOI 10.1016/S0043-1354(97)00341-2
   Singh K., 2008, BOOTSTRAP STAT METHO, P14
   Swan SH, 1998, EPIDEMIOLOGY, V9, P126, DOI 10.1097/00001648-199803000-00005
   USEPA, 2009, NAT PRIM DRINK WAT R
   Vega-Rodriguez J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128212
   Villanueva CM, 2004, EPIDEMIOLOGY, V15, P357, DOI 10.1097/01.ede.0000121380.02594.fc
   Villanueva CM, 2003, WATER RES, V37, P953, DOI 10.1016/S0043-1354(02)00411-6
   Vine KL, 2007, J MED CHEM, V50, P5109, DOI 10.1021/jm0704189
   Wang S, 2014, ENVIRON SCI TECHNOL, V48, P13478, DOI 10.1021/es502855x
   Wang W, 2014, ANAL CHEM, V86, P4982, DOI 10.1021/ac5007238
   Wang W, 2013, ENVIRON SCI TECHNOL, V47, P3275, DOI 10.1021/es304938x
   Wei X, 2013, ENVIRON SCI TECHNOL, V47, P5913, DOI 10.1021/es304786b
   Wei X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059677
   WHO, 2011, GUID DRINK WAT QUAL
   Yang Y, 2014, ENVIRON SCI TECHNOL, V48, P12362, DOI 10.1021/es503621e
   Yeh RYL, 2014, WATER RES, V59, P172, DOI 10.1016/j.watres.2014.04.002
   Zhang SH, 2010, MUTAT RES-GEN TOX EN, V703, P174, DOI 10.1016/j.mrgentox.2010.08.014
   Zhao YL, 2012, WATER RES, V46, P4351, DOI 10.1016/j.watres.2012.05.032
   Zhao YL, 2010, ANAL CHEM, V82, P4599, DOI 10.1021/ac100708u
   Zlokarnik G, 1998, SCIENCE, V279, P84, DOI 10.1126/science.279.5347.84
NR 79
TC 24
Z9 24
U1 9
U2 88
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0893-228X
EI 1520-5010
J9 CHEM RES TOXICOL
JI Chem. Res. Toxicol.
PD OCT
PY 2015
VL 28
IS 10
BP 2059
EP 2068
DI 10.1021/acs.chemrestox.5b00283
PG 10
WC Chemistry, Medicinal; Chemistry, Multidisciplinary; Toxicology
SC Pharmacology & Pharmacy; Chemistry; Toxicology
GA CU0QW
UT WOS:000363224800018
PM 26327680
DA 2019-10-23
ER

PT J
AU Biales, AD
   Denton, DL
   Riordan, D
   Breuer, R
   Batt, AL
   Crane, DB
   Schoenfuss, HL
AF Biales, Adam D.
   Denton, Debra L.
   Riordan, Dan
   Breuer, Richard
   Batt, Angela L.
   Crane, David B.
   Schoenfuss, Heiko L.
TI Complex Watersheds, Collaborative Teams: Assessing Pollutant Presence
   and Effects in the San Francisco Delta
SO INTEGRATED ENVIRONMENTAL ASSESSMENT AND MANAGEMENT
LA English
DT Article
DE Alternative endpoints; Biomarkers; Gene expression; Integrated
   assessment; Watershed assessment
ID MINNOW PIMEPHALES-PROMELAS; ADVERSE OUTCOME PATHWAYS; PERSONAL CARE
   PRODUCTS; WASTE-WATER; FATHEAD MINNOW; PHARMACEUTICALS; VITELLOGENIN;
   EXPRESSION; TOXICITY; FISH
AB There is a great diversity of sources of chemical contaminants and stressors over large geographic areas. Chemical contaminant inputs and magnitude can potentially exhibit wide seasonal variation over large geographic areas. Together, these factors make linking exposure to monitored chemical contaminants and effects difficult. In practice, this linkage typically relies on relatively limited chemical occurrence data loosely coupled with individual effects, and population- or community-level assessments. Increased discriminatory power may be gained by approaching watershed level assessment in a more holistic manner, drawing from a number of disciplines that target endpoints spanning levels of the biological hierarchy. Using the Sacramento River as a case study, the present study aimed to 1) evaluate the performance of new analytical and biomarker tools in a real world setting and their potential for linking occurrence and effect; 2) characterize the effects of geographic and temporal variability through the integration of suborganismal, tissue, and individual level endpoints, as well as extensive chemical analyses; 3) identify knowledge gaps and research needs that limit the implementation of this holistic approach; and 4) provide an experimental design workflow for these types of assessments. Sites were selected to target inputs into the Sacramento River as it transitions from an agricultural to a mixed but primarily urban landscape. Chemical analyses were conducted on surface water samples at each site in both the spring and fall for pesticides, hormones, and active pharmaceutical ingredients (APIs). Active pharmaceutical ingredients were more often detected across sampling events in the fall; however, at the most downstream site the number of analytes detected and their concentrations were greater in the spring, which may be due to seasonal differences in rainfall. Changes in gene and protein expression targeting endocrine and reproductive effects were observed within each sampling event; however, they were inconsistent across seasons. Larval mortality at the most downstream site was seen in both seasons; however, behavioral changes were only observed in the spring. No clear linkages of specific analyte exposure to biological response were observed, nor were linkages across biological levels of organization. This failure may have resulted from limitations of the scope of molecular endpoints used, inconsistent timing of exposure, or discordance of analytical chemistry through grab sampling and longer term, integrative exposure. Together, results indicate a complicated view of the watershed. (C) 2015 SETAC
C1 [Biales, Adam D.; Batt, Angela L.] US EPA, Off Res & Dev, Cincinnati, OH 45268 USA.
   [Denton, Debra L.] US EPA, Sacramento, CA USA.
   [Riordan, Dan] Calif Dept Water Resources, West Sacramento, CA USA.
   [Breuer, Richard] State Water Resources Control Board, Sacramento, CA USA.
   [Crane, David B.] Calif Dept Fish & Wildlife, Rancho Cordova, CA USA.
   [Schoenfuss, Heiko L.] St Cloud State Univ, Aquat Toxicol Lab, St Cloud, MN 56301 USA.
RP Biales, AD (reprint author), US EPA, Off Res & Dev, Cincinnati, OH 45268 USA.
EM biales.adam@epa.gov
OI Schoenfuss, Heiko/0000-0001-5464-992X
CR Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Batt AL, 2008, ANAL CHEM, V80, P5021, DOI 10.1021/ac800066n
   Biales AD, 2007, ENVIRON TOXICOL CHEM, V26, P287, DOI 10.1897/06-213R.1
   Biales AD, 2011, AQUAT TOXICOL, V105, P618, DOI 10.1016/j.aquatox.2011.08.021
   Brian JV, 2008, SCI TOTAL ENVIRON, V397, P72, DOI 10.1016/j.scitotenv.2008.02.036
   Burgess RM, 2011, HANDB ENVIRON CHEM, V15, P19, DOI 10.1007/978-3-642-18384-3_2
   CASIDA JE, 1983, ANNU REV PHARMACOL, V23, P413, DOI 10.1146/annurev.pa.23.040183.002213
   DROPPO IG, 1995, ENVIRON SCI TECHNOL, V29, P161, DOI 10.1021/es00001a021
   Epstein L., 2000, California Agriculture, V54, P14
   Esperanza M, 2004, ENVIRON SCI TECHNOL, V38, P3028, DOI 10.1021/es0350886
   Gabe M, 1976, HISTOLOGICAL TECHNIQ, P1132
   Gan J, 2005, J ENVIRON QUAL, V34, P836, DOI 10.2134/jeq2004.0240
   Hinck JE, 2009, AQUAT TOXICOL, V95, P60, DOI 10.1016/j.aquatox.2009.08.001
   Hoogeweg CG, 2012, ACS SYM SER, V1111, P303
   Hyndman KM, 2010, AQUAT TOXICOL, V96, P264, DOI 10.1016/j.aquatox.2009.11.004
   Jeffries MKS, 2012, ENVIRON SCI TECHNOL, V46, P1877, DOI 10.1021/es2039097
   Jobling S, 1998, ENVIRON SCI TECHNOL, V32, P2498, DOI 10.1021/es9710870
   Korner O, 2008, AQUAT TOXICOL, V90, P188, DOI 10.1016/j.aquatox.2008.08.012
   Kolpin DW, 2002, ENVIRON SCI TECHNOL, V36, P1202, DOI 10.1021/es011055j
   Laetz CA, 2014, AQUAT TOXICOL, V146, P38, DOI 10.1016/j.aquatox.2013.10.022
   Lee Ho-Sun, 2008, Environmental Health and Preventive Medicine, V13, P84, DOI 10.1007/s12199-007-0009-6
   Loraine GA, 2006, ENVIRON SCI TECHNOL, V40, P687, DOI 10.1021/es051380x
   Martinovic D, 2008, ENVIRON SCI TECHNOL, V42, P3421, DOI 10.1021/es0708013
   Mcgee MR, 2009, AQUAT TOXICOL, V91, P355, DOI 10.1016/j.aquatox.2008.12.002
   Miller DH, 2007, ENVIRON TOXICOL CHEM, V26, P521, DOI 10.1897/06-318R.1
   Painter MM, 2009, ENVIRON TOXICOL CHEM, V28, P2677, DOI 10.1897/08-556.1
   Panter GH, 2002, ENVIRON TOXICOL CHEM, V21, P319, DOI 10.1002/etc.5620210213
   Parks LG, 1999, COMP BIOCHEM PHYS C, V123, P113, DOI 10.1016/S0742-8413(99)00010-9
   Schultz MM, 2012, ARCH ENVIRON CON TOX, V63, P114, DOI 10.1007/s00244-011-9748-x
   Sui Q, 2011, ENVIRON SCI TECHNOL, V45, P3341, DOI 10.1021/es200248d
   Syed KH, 2003, J HYDROL, V271, P1, DOI 10.1016/S0022-1694(02)00311-6
   [USEPA] US Environmental Protection Agency, 2007, 821R08002 USEPA
   Vajda AM, 2008, ENVIRON SCI TECHNOL, V42, P3407, DOI 10.1021/es0720661
   van Aerle R, 2002, ECOTOXICOLOGY, V11, P423, DOI 10.1023/A:1021053217513
   Viarengo A, 1999, BIOMARKERS, V4, P455, DOI 10.1080/135475099230615
   Wainwright Peter C., 1994, P42
   Wang RL, 2008, ENVIRON TOXICOL CHEM, V27, P664, DOI 10.1897/07-192.1
   Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484
   Watanabe KH, 2011, ENVIRON TOXICOL CHEM, V30, P9, DOI 10.1002/etc.373
   Werner I, 2010, PELAGIC ORGANISM DEC
   Weston DP, 2015, ENVIRON TOXICOL CHEM, V34, P649, DOI 10.1002/etc.2850
   Weston DP, 2005, ENVIRON SCI TECHNOL, V39, P9778, DOI 10.1021/es0506354
NR 42
TC 5
Z9 5
U1 0
U2 28
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1551-3777
EI 1551-3793
J9 INTEGR ENVIRON ASSES
JI Integr. Environ. Assess. Manag.
PD OCT
PY 2015
VL 11
IS 4
BP 674
EP 688
DI 10.1002/ieam.1633
PG 15
WC Environmental Sciences; Toxicology
SC Environmental Sciences & Ecology; Toxicology
GA CT5KN
UT WOS:000362848700015
PM 25779725
DA 2019-10-23
ER

PT J
AU Franzellitti, S
   Buratti, S
   Du, B
   Haddad, SP
   Chambliss, CK
   Brooks, BW
   Fabbri, E
AF Franzellitti, Silvia
   Buratti, Sara
   Du, Bowen
   Haddad, Samuel P.
   Chambliss, C. Kevin
   Brooks, Bryan W.
   Fabbri, Elena
TI A multibiomarker approach to explore interactive effects of propranolol
   and fluoxetine in marine mussels
SO ENVIRONMENTAL POLLUTION
LA English
DT Article
DE Marine mussel; Fluoxetine; Propranolol; Bioaccumulation; Biomarkers;
   Lysosomal responses; Drug-drug interaction; Adverse outcome pathway
ID PERSONAL CARE PRODUCTS; REAL-TIME PCR; GENE-EXPRESSION;
   MYTILUS-GALLOPROVINCIALIS; ANTIDEPRESSANT FLUOXETINE; MASS-SPECTROMETRY;
   STRESS SYNDROME; EXPERT-SYSTEM; PHARMACEUTICALS; ENVIRONMENT
AB A multi-biomarker approach, including several lysosomal parameters, activity and mRNA expression of antioxidant enzymes, and DNA damage, was employed to investigate the nominal effects of 0.3 ng/L fluoxetine (FX) and 0.3 ng/L propranolol (PROP) alone or in combination (0.3 ng/L FX + 0.3 ng/L PROP) on Mediterranean mussels after a 7 day treatment. FX co-exposure appears to facilitate PROP bioaccumulation because PROP only accumulated in digestive gland of FX + PROP treated mussels. Lysosomal parameters were significantly impaired by FX + PROP treatment, while no clear antioxidant responses at the catalytic and transcriptional levels were observed. Biomarker responses led to a "medium stress level" diagnosis in FX + PROP treated mussels, according to the Expert System, whereas 0.3 ng/L PROP or FX alone did not induce consistent stress conditions. These findings suggest vulnerability of coastal marine mussels to FX and PROP contamination at environmentally relevant levels. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Franzellitti, Silvia; Fabbri, Elena] Univ Bologna, Dept Biol Geol & Environm Sci, I-40100 Bologna, Italy.
   [Franzellitti, Silvia; Buratti, Sara; Fabbri, Elena] Univ Bologna, Interdept Ctr Environm Sci Res, I-48123 Ravenna, Italy.
   [Du, Bowen; Haddad, Samuel P.; Brooks, Bryan W.] Baylor Univ, Dept Environm Sci, Waco, TX 76798 USA.
   [Chambliss, C. Kevin] Baylor Univ, Dept Chem & Biochem, Waco, TX 76798 USA.
RP Franzellitti, S (reprint author), Univ Bologna, Dept Biol Geol & Environm Sci BIGEA, Via St Alberto 163, I-48123 Ravenna, Italy.
EM silvia.franzellitti@unibo.it
RI Brooks, Bryan W/B-2612-2010; Guenat, Heather/H-6528-2014
OI Brooks, Bryan W/0000-0002-6277-9852; FABBRI, Elena/0000-0002-9957-8202;
   Franzellitti, Silvia/0000-0001-6104-7812
FU MEECE EU-FP7 Project; Italian Ministry of University and
   ResearchMinistero dell' Istruzione, dell' Universita e della Ricerca
   (MIUR) [RFO2013]
FX The research has been funded by MEECE EU-FP7 Project, and Italian
   Ministry of University and Research (RFO2013) to E.F.
CR Bard SM, 2000, AQUAT TOXICOL, V48, P357, DOI 10.1016/S0166-445X(00)00088-6
   Bayen S, 2013, ENVIRON POLLUT, V182, P1, DOI 10.1016/j.envpol.2013.06.028
   Benotti MJ, 2007, ENVIRON SCI TECHNOL, V41, P5795, DOI 10.1021/es0629965
   Boxall ABA, 2012, ENVIRON HEALTH PERSP, V120, P1221, DOI 10.1289/ehp.1104477
   Brausch JM, 2012, REV ENVIRON CONTAM T, V218, P1, DOI 10.1007/978-1-4614-3137-4_1
   Bringolf RB, 2010, ENVIRON TOXICOL CHEM, V29, P1311, DOI 10.1002/etc.157
   Brooks BW, 2014, AQUAT TOXICOL, V151, P61, DOI 10.1016/j.aquatox.2014.01.007
   Brooks BW, 2003, CHEMOSPHERE, V52, P135, DOI 10.1016/S0045-6535(03)00103-6
   Bueno MJM, 2014, ANAL BIOANAL CHEM, V406, P601, DOI 10.1007/s00216-013-7477-x
   Bueno MJM, 2013, J CHROMATOGR A, V1305, P27, DOI 10.1016/j.chroma.2013.06.071
   Caldwell DJ, 2014, CHEMOSPHERE, V115, P4, DOI 10.1016/j.chemosphere.2014.01.021
   Connors KA, 2013, CHIRALITY, V25, P763, DOI 10.1002/chir.22211
   Connors KA, 2013, ENVIRON TOXICOL CHEM, V32, P1810, DOI 10.1002/etc.2240
   Dagnino A, 2007, BIOMARKERS, V12, P155, DOI 10.1080/13547500601037171
   Daniel WA, 2003, PROG NEURO-PSYCHOPH, V27, P65, DOI 10.1016/S0278-5846(02)00317-2
   Daniel WA, 1997, PHARMACOL TOXICOL, V80, P62, DOI 10.1111/j.1600-0773.1997.tb00285.x
   Daughton CG, 1999, ENVIRON HEALTH PERSP, V107, P907, DOI 10.2307/3434573
   Du B, 2012, J CHROMATOGR A, V1253, P177, DOI 10.1016/j.chroma.2012.07.026
   Du B, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2014.0058
   Du BW, 2014, SCI TOTAL ENVIRON, V466, P976, DOI 10.1016/j.scitotenv.2013.07.126
   Ericson H, 2010, AQUAT TOXICOL, V99, P223, DOI 10.1016/j.aquatox.2010.04.017
   Fenet H, 2014, ENVIRON INT, V68, P177, DOI 10.1016/j.envint.2014.03.025
   Franzellitti S, 2005, BIOCHEM BIOPH RES CO, V336, P1157, DOI 10.1016/j.bbrc.2005.08.244
   Franzellitti S, 2014, AQUAT TOXICOL, V146, P264, DOI 10.1016/j.aquatox.2013.11.019
   Franzellitti S, 2014, AQUAT TOXICOL, V151, P14, DOI 10.1016/j.aquatox.2013.11.016
   Franzellitti S, 2013, AQUAT TOXICOL, V140, P249, DOI 10.1016/j.aquatox.2013.06.005
   Franzellitti S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061634
   Franzellitti S, 2011, AQUAT TOXICOL, V101, P299, DOI 10.1016/j.aquatox.2010.11.001
   Franzellitti S, 2010, COMP BIOCHEM PHYS C, V152, P24, DOI 10.1016/j.cbpc.2010.02.010
   Gagne F, 2009, BIOCHEM INSIGHTS, V2, P51
   Gaw S, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0572
   Gomez E, 2012, ENVIRON SCI POLLUT R, V19, P2561, DOI 10.1007/s11356-012-0964-3
   Gonzalez-Rey M, 2013, ENVIRON POLLUT, V173, P200, DOI 10.1016/j.envpol.2012.10.018
   Gunnarsson L., 2012, HUMAN PHARM ENV, P85
   Gunnarsson L, 2008, ENVIRON SCI TECHNOL, V42, P5807, DOI 10.1021/es8005173
   Gust M, 2009, ENVIRON POLLUT, V157, P423, DOI 10.1016/j.envpol.2008.09.040
   Hardman J.G., 2001, GOODMAN GILMANS PHAR, P2148
   Izagirre U, 2009, ENVIRON POLLUT, V157, P1544, DOI 10.1016/j.envpol.2009.01.011
   Jiang JJ, 2014, MAR POLLUT BULL, V85, P391, DOI 10.1016/j.marpolbul.2013.12.045
   Kazmi F, 2013, DRUG METAB DISPOS, V41, P897, DOI 10.1124/dmd.112.050054
   Kolpin DW, 2002, ENVIRON SCI TECHNOL, V36, P1202, DOI 10.1021/es011055j
   Koutsogiannaki S, 2014, AQUAT TOXICOL, V146, P186, DOI 10.1016/j.aquatox.2013.11.005
   Kwon JW, 2006, ENVIRON TOXICOL CHEM, V25, P2561, DOI 10.1897/05-613R.1
   Lazzara R, 2012, AQUAT TOXICOL, V106, P123, DOI 10.1016/j.aquatox.2011.11.003
   Lee MD, 2006, XENOBIOTICA, V36, P1013, DOI 10.1080/00498250600861785
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MARATHE PH, 1994, DRUG METAB DISPOS, V22, P237
   Martin-Diaz L, 2009, AQUAT TOXICOL, V94, P177, DOI 10.1016/j.aquatox.2009.06.015
   Martinez-Gomez C, 2008, J ENVIRON MONITOR, V10, P490, DOI 10.1039/b800441m
   McRobb FM, 2014, ENVIRON SCI TECHNOL, V48, P1964, DOI 10.1021/es404568a
   Mimeault C, 2006, TOXICOLOGY, V228, P140, DOI 10.1016/j.tox.2006.08.025
   Munari M, 2014, MAR ENVIRON RES, V94, P32, DOI 10.1016/j.marenvres.2013.11.007
   Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36
   Ramirez AJ, 2007, ANAL CHEM, V79, P3155, DOI 10.1021/ac062215i
   Ramirez AJ, 2009, ENVIRON TOXICOL CHEM, V28, P2587, DOI 10.1897/08-561.1
   Ramos-Gomez J, 2011, ENVIRON POLLUT, V159, P1914, DOI 10.1016/j.envpol.2011.03.030
   Regoli F, 2014, MAR ENVIRON RES, V93, P106, DOI 10.1016/j.marenvres.2013.07.006
   Rudd MA, 2014, INTEGR ENVIRON ASSES, V10, P576, DOI 10.1002/ieam.1551
   Schmitt Heike, 2010, Integrated Environmental Assessment and Management, V6, P588, DOI 10.1897/IEAM_2009-053.1
   Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73
   Sole M, 2010, ANAL BIOANAL CHEM, V396, P649, DOI 10.1007/s00216-009-3182-1
   Stanley JK, 2007, CHEMOSPHERE, V69, P9, DOI 10.1016/j.chemosphere.2007.04.080
   Terman A, 2004, INT J BIOCHEM CELL B, V36, P1400, DOI 10.1016/j.biocel.2003.08.009
   UNEP/RAMOGE, 1999, MAN BIOM REC MED POL, P39
   Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034
   Vasskog T, 2008, J CHROMATOGR A, V1185, P194, DOI 10.1016/j.chroma.2008.01.063
   Venier P, 2006, MUTAT RES-FUND MOL M, V602, P121, DOI 10.1016/j.mrfmmm.2006.08.007
   Viarengo A, 2007, COMP BIOCHEM PHYS C, V146, P281, DOI 10.1016/j.cbpc.2007.04.011
   Viarengo A, 2000, MAR ENVIRON RES, V49, P483, DOI 10.1016/S0141-1136(00)00027-1
   Weir MR, 2009, POSTGRAD MED, V121, P90, DOI 10.3810/pgm.2009.05.2007
   Wille K, 2011, J CHROMATOGR A, V1218, P9162, DOI 10.1016/j.chroma.2011.10.039
   Wille K, 2010, ANAL BIOANAL CHEM, V397, P1797, DOI 10.1007/s00216-010-3702-z
   Yamamoto H, 2009, WATER RES, V43, P351, DOI 10.1016/j.watres.2008.10.039
   Yang Y, 2011, J HAZARD MATER, V190, P588, DOI 10.1016/j.jhazmat.2011.03.092
NR 74
TC 24
Z9 26
U1 0
U2 31
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0269-7491
EI 1873-6424
J9 ENVIRON POLLUT
JI Environ. Pollut.
PD OCT
PY 2015
VL 205
BP 60
EP 69
DI 10.1016/j.envpol.2015.05.020
PG 10
WC Environmental Sciences
SC Environmental Sciences & Ecology
GA CS8AM
UT WOS:000362308100008
PM 26017112
DA 2019-10-23
ER

PT J
AU Becker, RA
   Patlewicz, G
   Simon, TW
   Rowlands, JC
   Budinsky, RA
AF Becker, Richard A.
   Patlewicz, Grace
   Simon, Ted W.
   Rowlands, J. Craig
   Budinsky, Robert A.
TI The adverse outcome pathway for rodent liver tumor promotion by
   sustained activation of the aryl hydrocarbon receptor
SO REGULATORY TOXICOLOGY AND PHARMACOLOGY
LA English
DT Article
DE Adverse outcome pathway; Aryl hydrocarbon receptor; Liver tumor
   promotion; Mode of action
ID SPRAGUE-DAWLEY RATS; DOSE-RESPONSE FRAMEWORK;
   2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN TCDD INTOXICATION; BRADFORD-HILL
   CONSIDERATIONS; MESSENGER-RNA EXPRESSION; HEPATIC PROGENITOR CELLS;
   GENE-EXPRESSION; AH RECEPTOR; HUMAN RELEVANCE; ESTROGEN-RECEPTOR
AB An Adverse Outcome Pathway (AOP) represents the existing knowledge of a biological pathway leading from initial molecular interactions of a toxicant and progressing through a series of key events (KEs), culminating with an apical adverse outcome (AO) that has to be of regulatory relevance. An AOP based on the mode of action (MOA) of rodent liver tumor promotion by dioxin-like compounds (DLCs) has been developed and the weight of evidence (WOE) of lcey event relationships (KERs) evaluated using evolved Bradford Hill considerations. Dioxins and DLCs are potent aryl hydrocarbon receptor (AHR) ligands that cause a range of species-specific adverse outcomes. The occurrence of KEs is necessary for inducing downstream biological responses and KEs may occur at the molecular, cellular, tissue and organ levels. The common convention is that an AOP begins with the toxicant interaction with a biological response element; for this AOP, this initial event is binding of a DLC ligand to the AHR. Data from mechanistic studies, lifetime bioassays and approximately thirty initiation-promotion studies have established dioxin and DLCs as rat liver tumor promoters. Such studies clearly show that sustained AHR activation, weeks or months in duration, is necessary to induce rodent liver tumor promotion hence, sustained AHR activation is deemed the molecular initiating event (MIE). After this MIE, subsequent KEs are I) changes in cellular growth homeostasis likely associated with expression changes in a number of genes and observed as development of hepatic foci and decreases in apoptosis within foci; 2) extensive liver toxicity observed as the constellation of effects called toxic hepatopathy; 3) cellular proliferation and hyperplasia in several hepatic cell types. This progression of KEs culminates in the AO, the development of hepatocellular adenomas and carcinomas and cholangiolar carcinomas. A rich data set provides both qualitative and quantitative knowledge of the progression of this AOP through KEs and the KERs. Thus, the WoE for this AOP is judged to be strong. Species-specific effects of dioxins and DLCs are well known humans are less responsive than rodents and rodent species differ in sensitivity between strains. Consequently, application of this AOP to evaluate potential human health risks must take these differences into account. 0 2015 The Authors. Published by Elsevier Inc.
C1 [Becker, Richard A.] Amer Chem Council, Regulatory & Tech Affairs Dept, Washington, DC 20002 USA.
   [Patlewicz, Grace] DuPont Haskell Global Ctr Hlth & Environm Sci, Newark, DE 19711 USA.
   [Simon, Ted W.] Ted Simon LLC, Winston, GA 30187 USA.
   [Rowlands, J. Craig; Budinsky, Robert A.] Dow Chem Co USA, Toxicol & Environm Res & Consulting, Midland, MI 48674 USA.
RP Becker, RA (reprint author), Amer Chem Council, 700 2nd St NE, Washington, DC 20002 USA.
EM rick_becker@americanchemistry.com
RI Simon, Ted/M-9188-2013
OI Simon, Ted/0000-0001-9405-3020; Patlewicz, Grace/0000-0003-3863-9689
FU American Chemistry Council (ACC)
FX The authors had complete control over the design, conduct,
   interpretation, and reporting of the analyses included in this
   manuscript. The contents of this manuscript are solely the
   responsibility of the authors and do not necessarily reflect the views
   or policies of their employers. Ted Simon received funding to support
   this research from the American Chemistry Council (ACC). Craig Rowlands
   and Robert Budinsky are employed by a company engaged in chemical
   product manufacturing and remediation of soils and sediments containing
   dioxins. Richard Becker is employed by ACC, a trade association of U. S.
   chemical manufacturers. Note: during development of this manuscript
   Grace Patlewicz was employed by a company engaged in chemical product
   manufacturing; subsequently she became an employee of the National
   Center for Computational Toxicology, U.S. Environmental Protection
   Agency.
CR Abel J, 2010, BIOL CHEM, V391, P1235, DOI 10.1515/BC.2010.128
   Abraham K, 2002, CLIN PHARMACOL THER, V72, P163, DOI 10.1067/mcp.2002.126408
   Akintobi AM, 2007, TOXICOL APPL PHARM, V220, P9, DOI 10.1016/j.taap.2006.12.002
   Alison MR, 2005, STEM CELL REV, V1, P253, DOI 10.1385/SCR:1:3:253
   Ambolet-Camoit A, 2010, TOXICOL SCI, V115, P501, DOI 10.1093/toxsci/kfq082
   Andersen ME, 1997, TOXICOL APPL PHARM, V144, P145, DOI 10.1006/taap.1996.8067
   Andersen ME, 2014, CRIT REV TOXICOL, V44, P50, DOI 10.3109/10408444.2013.835785
   Andersson P, 2002, P NATL ACAD SCI USA, V99, P9990, DOI 10.1073/pnas.152706299
   Andrysik Z, 2013, ARCH TOXICOL, V87, P491, DOI 10.1007/s00204-012-0963-7
   Angrish MM, 2011, TOXICOL SCI, V124, P299, DOI 10.1093/toxsci/kfr226
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Bager Y, 1997, ENVIRON TOXICOL PHAR, V3, P257, DOI 10.1016/S1382-6689(97)00021-5
   Banerjee S, 2011, MUTAT RES-REV MUTAT, V728, P47, DOI 10.1016/j.mrrev.2011.06.001
   Becker RA, 2015, REGUL TOXICOL PHARM, V72, P514, DOI 10.1016/j.yrtph.2015.04.004
   BEEBE LE, 1995, CANCER RES, V55, P4875
   Beischlag TV, 2008, CRIT REV EUKAR GENE, V18, P207, DOI 10.1615/CritRevEukarGeneExpr.v18.i3.20
   Bendall SC, 2012, NAT BIOTECHNOL, V30, P639, DOI 10.1038/nbt.2283
   BERTAZZI PA, 1989, AM J EPIDEMIOL, V129, P1187, DOI 10.1093/oxfordjournals.aje.a115240
   Black MB, 2012, TOXICOL SCI, V127, P199, DOI 10.1093/toxsci/kfs069
   Bock KW, 2005, BIOCHEM PHARMACOL, V69, P1403, DOI 10.1016/j.bcp.2005.02.004
   Boobis AR, 2008, CRIT REV TOXICOL, V38, P87, DOI 10.1080/10408440701749421
   Boobis AR, 2006, CRIT REV TOXICOL, V36, P781, DOI 10.1080/10408440600977677
   Boobis AR, 2009, CRIT REV FOOD SCI, V49, P690, DOI 10.1080/10408390903098673
   Boutros PC, 2011, TOXICOL APPL PHARM, V251, P119, DOI 10.1016/j.taap.2010.12.010
   Boutros PC, 2009, TOXICOL SCI, V112, P245, DOI 10.1093/toxsci/kfp191
   Boutros PC, 2004, BIOCHEM BIOPH RES CO, V321, P707, DOI 10.1016/j.bbrc.2004.06.177
   Boverhof DR, 2006, TOXICOL SCI, V94, P398, DOI 10.1093/toxsci/kfl100
   Boverhof DR, 2005, TOXICOL SCI, V85, P1048, DOI 10.1093/toxsci/kfi162
   Brauze D, 2012, ENVIRON TOXICOL PHAR, V34, P819, DOI 10.1016/j.etap.2012.09.004
   Brunnberg S, 2006, TOXICOLOGY, V224, P191, DOI 10.1016/j.tox.2006.04.045
   BUCHMANN A, 1994, CARCINOGENESIS, V15, P1143, DOI 10.1093/carcin/15.6.1143
   Budinsky RA, 2014, CRIT REV TOXICOL, V44, P83, DOI 10.3109/10408444.2013.835787
   Budinsky RA, 2010, TOXICOL SCI, V118, P224, DOI 10.1093/toxsci/kfq238
   CALVERT GM, 1992, JAMA-J AM MED ASSOC, V267, P2209, DOI 10.1001/jama.267.16.2209
   Carlson EA, 2009, TOXICOL SCI, V112, P257, DOI 10.1093/toxsci/kfp200
   Carmichael N, 2011, CRIT REV TOXICOL, V41, P175, DOI 10.3109/10408444.2010.541225
   Chang H, 2005, J TOXICOL ENV HEAL A, V68, P1567, DOI 10.1080/15287390590967513
   Chia NY, 2012, WIRES SYST BIOL MED, V4, P39, DOI 10.1002/wsbm.151
   Chopra M, 2011, CRIT REV TOXICOL, V41, P292, DOI 10.3109/10408444.2010.524635
   Chopra M, 2010, CELL BIOL TOXICOL, V26, P391, DOI 10.1007/s10565-010-9151-9
   Chopra M, 2009, TOXICOL SCI, V111, P49, DOI 10.1093/toxsci/kfp128
   Coenraads PJ, 1999, BRIT J DERMATOL, V141, P694
   Cohen SM, 2011, TOXICOL SCI, V120, pS76, DOI 10.1093/toxsci/kfq365
   Cohen SM, 2003, CRIT REV TOXICOL, V33, P581, DOI 10.1080/10408440390250073
   Cohen SM, 2004, TOXICOL SCI, V78, P181, DOI 10.1093/toxsci/kfh073
   COHEN SM, 1990, SCIENCE, V249, P1007, DOI 10.1126/science.2204108
   Collins JJ, 2009, J OCCUP ENVIRON MED, V51, P1212, DOI 10.1097/JOM.0b013e3181badd4e
   Collins JJ, 2009, AM J EPIDEMIOL, V170, P501, DOI 10.1093/aje/kwp153
   Connor KT, 2008, J EXPO SCI ENV EPID, V18, P369, DOI 10.1038/sj.jes.7500607
   Connor KT, 2006, J TOXICOL ENV HEAL B, V9, P147, DOI 10.1080/15287390500196487
   Conolly RB, 1997, TOXICOL APPL PHARM, V146, P281, DOI 10.1006/taap.1997.8248
   Cox LA, 2014, REGUL TOXICOL PHARM, V69, P443, DOI 10.1016/j.yrtph.2014.05.010
   Davis JW, 2001, CANCER RES, V61, P3314
   DELLAPORTA G, 1987, TUMORI J, V73, P99
   Dellarco V, 2012, J NUTR, V142, p2192S, DOI 10.3945/jn.111.157396
   Denison MS, 2011, TOXICOL SCI, V124, P1, DOI 10.1093/toxsci/kfr218
   Denison MS, 2003, ANNU REV PHARMACOL, V43, P309, DOI 10.1146/annurev.pharmtox.43.100901.135828
   Dere E, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-193
   Dietrich C, 2002, TOXICOL APPL PHARM, V183, P117, DOI 10.1006/taap.2002.9475
   Dietrich C, 2010, CARCINOGENESIS, V31, P1319, DOI 10.1093/carcin/bgq028
   Dragan YP, 2000, FOOD ADDIT CONTAM A, V17, P289, DOI 10.1080/026520300283360
   DRAGAN YP, 1992, CARCINOGENESIS, V13, P1389, DOI 10.1093/carcin/13.8.1389
   Drewe W. C., 2014, TOXICOLOGY, V2014, P2256
   Du LP, 2006, J PHARMACOL EXP THER, V319, P1162, DOI 10.1124/jpet.106.111724
   Ellinger-Ziegelbauer H, 2005, MUTAT RES-FUND MOL M, V575, P61, DOI 10.1016/j.mrfmmm.2005.02.004
   Ellinger-Ziegelbauer H, 2008, MUTAT RES-FUND MOL M, V637, P23, DOI 10.1016/j.mrfmmm.2007.06.010
   Fattore E, 2000, TOXICOL APPL PHARM, V165, P184, DOI 10.1006/taap.2000.8943
   Fenner-Crisp PA, 2012, J NUTR, V142, p2199S, DOI 10.3945/jn.111.157388
   Fielden MR, 2007, TOXICOL SCI, V99, P90, DOI 10.1093/toxsci/kfm156
   Fielden MR, 2011, TOXICOL SCI, V124, P54, DOI 10.1093/toxsci/kfr202
   Flaveny CA, 2010, TOXICOL SCI, V114, P217, DOI 10.1093/toxsci/kfp308
   Fletcher N, 2005, TOXICOL APPL PHARM, V207, P1, DOI 10.1016/j.taap.2004.12.003
   Fletcher N, 2001, TOXICOL SCI, V62, P166, DOI 10.1093/toxsci/62.1.166
   Forgacs AL, 2010, TOXICOL APPL PHARM, V246, P58, DOI 10.1016/j.taap.2010.04.006
   Forrester AR, 2014, J DERMATOL SCI, V73, P10, DOI 10.1016/j.jdermsci.2013.09.001
   Franc MA, 2008, ARCH TOXICOL, V82, P809, DOI 10.1007/s00204-008-0303-0
   Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007
   Furness SGB, 2009, PHARMACOL THERAPEUT, V124, P336, DOI 10.1016/j.pharmthera.2009.09.004
   Gasiewicz TA, 2008, CRIT REV EUKAR GENE, V18, P279, DOI 10.1615/CritRevEukarGeneExpr.v18.i4.10
   George CL, 2011, EPIGENOMICS-UK, V3, P471, DOI [10.2217/epi.11.66, 10.2217/EPI.11.66]
   Geusau A, 2005, J INVEST DERMATOL, V124, P275, DOI 10.1111/j.0022-202X.2004.23541.x
   Geusau A, 2001, ENVIRON HEALTH PERSP, V109, P865, DOI 10.2307/3454832
   GHEZZI I, 1982, SCAND J WORK ENV HEA, V8, P176
   GOODMAN DG, 1992, REGUL TOXICOL PHARM, V15, P245, DOI 10.1016/0273-2300(92)90036-9
   GRAHAM MJ, 1988, CARCINOGENESIS, V9, P1935, DOI 10.1093/carcin/9.11.1935
   Guzelian P, 2006, HUM EXP TOXICOL, V25, P99, DOI 10.1191/0960327106ht594oa
   Haarmann-Stemmann T, 2007, DRUG METAB DISPOS, V35, P2262, DOI 10.1124/dmd.107.016253
   Hailey JR, 2005, TOXICOL PATHOL, V33, P165, DOI 10.1080/01926230590888324
   HAKANSSON H, 1989, J NUTR, V119, P573
   Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013
   Hankinson O, 2009, MOL INTERV, V9, P116, DOI 10.1124/mi.9.3.4
   Harrill JA, 2013, TOXICOL APPL PHARM, V272, P503, DOI 10.1016/j.taap.2013.06.024
   Heise T, 2012, CURR MED CHEM, V19, P1721
   Herrmann S, 2002, CARCINOGENESIS, V23, P1861, DOI 10.1093/carcin/23.11.1861
   HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503
   Hiraku Y, 2001, INT J CANCER, V92, P333, DOI 10.1002/ijc.1193
   Hoegberg P, 2005, CHEM-BIOL INTERACT, V156, P25, DOI 10.1016/j.cbi.2005.06.006
   Hu Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066258
   Ikeda H, 2004, BIOCHEM J, V380, P515, DOI 10.1042/BJ20031948
   Ip BC, 2014, NUTRIENTS, V6, P124, DOI 10.3390/nu6010124
   Jaramillo MC, 2013, GENE DEV, V27, P2179, DOI 10.1101/gad.225680.113
   JONES G, 1975, EXPERIENTIA, V31, P1315, DOI 10.1007/BF01945801
   Ju QA, 2011, EXP DERMATOL, V20, P320, DOI 10.1111/j.1600-0625.2010.01204.x
   Julien E, 2009, CRIT REV FOOD SCI, V49, P682, DOI 10.1080/10408390903110692
   Knerr S, 2006, MOL NUTR FOOD RES, V50, P378, DOI 10.1002/mnfr.200500183
   Knight B, 2000, J EXP MED, V192, P1809, DOI 10.1084/jem.192.12.1809
   KOCIBA RJ, 1978, TOXICOL APPL PHARM, V46, P279, DOI 10.1016/0041-008X(78)90075-3
   Kumar MB, 2001, J BIOL CHEM, V276, P42302, DOI 10.1074/jbc.M104798200
   Kumar R, 2004, MOL CARCINOGEN, V41, P221, DOI 10.1002/mc.20056
   Kwak MK, 2001, MOL MED, V7, P135, DOI 10.1007/BF03401947
   Lambert GH, 2006, ENVIRON SCI TECHNOL, V40, P6176, DOI 10.1021/es0608646
   Le Vee M, 2010, TOXICOL IN VITRO, V24, P1775, DOI 10.1016/j.tiv.2010.07.001
   Lee KC, 2001, TRENDS ENDOCRIN MET, V12, P191, DOI 10.1016/S1043-2760(01)00392-7
   Lees MJ, 1999, MOL CELL BIOL, V19, P5811
   Libbrecht L, 2001, AM J SURG PATHOL, V25, P1388, DOI 10.1097/00000478-200111000-00006
   Libbrecht L, 2006, WORLD J GASTROENTERO, V12, P6261, DOI 10.3748/wjg.v12.i39.6261
   Liby KT, 2012, PHARMACOL REV, V64, P972, DOI 10.1124/pr.111.004846
   Loertscher JA, 2001, TOXICOL APPL PHARM, V175, P121, DOI 10.1006/taap.2001.9202
   Lu H, 2011, TOXICOL APPL PHARM, V256, P122, DOI 10.1016/j.taap.2011.07.019
   LUCIER GW, 1991, CANCER RES, V51, P1391
   Luebeck EG, 2000, TOXICOL APPL PHARM, V167, P63, DOI 10.1006/taap.2000.8980
   Ma Q, 2001, BIOCHEM BIOPH RES CO, V289, P499, DOI 10.1006/bbrc.2001.5987
   Ma Q, 2012, PHARMACOL REV, V64, P1055, DOI 10.1124/pr.110.004333
   Ma Q, 2011, EXPERT OPIN DRUG MET, V7, P1267, DOI 10.1517/17425255.2011.614947
   MARONPOT RR, 1993, ENVIRON HEALTH PERSP, V101, P634
   Matthews J, 2005, MOL CELL BIOL, V25, P5317, DOI 10.1128/MCB.25.13.5317-5328.2005
   Matthews Jason, 2006, Nucl Recept Signal, V4, pe016
   McBride DI, 2009, J OCCUP ENVIRON MED, V51, P1049, DOI 10.1097/JOM.0b013e3181b571ae
   Meek ME, 2014, J APPL TOXICOL, V34, P1, DOI 10.1002/jat.2949
   Meek MEB, 2008, ENVIRON MOL MUTAGEN, V49, P110, DOI 10.1002/em.20369
   Meek ME, 2014, J APPL TOXICOL, V34, P595, DOI 10.1002/jat.2984
   Meek MEB, 2013, REGUL TOXICOL PHARM, V66, P234, DOI 10.1016/j.yrtph.2013.03.012
   Meek ME, 2003, CRIT REV TOXICOL, V33, P591, DOI 10.1080/10408440390250136
   MOCARELLI P, 1986, JAMA-J AM MED ASSOC, V256, P2687, DOI 10.1001/jama.256.19.2687
   MOCARELLI P, 1991, J TOXICOL ENV HEALTH, V32, P357, DOI 10.1080/15287399109531490
   Moennikes O, 2004, CANCER RES, V64, P4707, DOI 10.1158/0008-5472.CAN-03-0875
   Moffat ID, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-263
   Moolgavkar SH, 1996, TOXICOL APPL PHARM, V138, P31, DOI 10.1006/taap.1996.0094
   MOSES M, 1985, J AM ACAD DERMATOL, V12, P497, DOI 10.1016/S0190-9622(85)70070-9
   Nakamura A, 2013, INT J MOL SCI, V14, P21240, DOI 10.3390/ijms141121240
   Navarro SL, 2011, DRUG METAB DISPOS, V39, P1650, DOI 10.1124/dmd.111.039149
   Navarro SL, 2009, CANCER PREV RES, V2, P345, DOI 10.1158/1940-6207.CAPR-08-0178
   Nguyen LP, 2008, CHEM RES TOXICOL, V21, P102, DOI 10.1021/tx7001965
   Nie AY, 2006, MOL CARCINOGEN, V45, P914, DOI 10.1002/mc.20205
   NTP, 1982, NATL TOX PROGR TECH, V201, P1
   NTP, 1980, NATL TOXICOL PROGRAM, V198, P1
   NTP, 2006, NATL TOXICOL PROGRAM, P4
   NTP, 2014, NATL TOXICOL PROGRAM, P1
   NTP, 1982, NATL TOXICOL PROGRAM, V209, P1
   NTP, 2006, NATL TOXICOL PROGRAM, P1
   NTP, 2010, NATL TOXICOL PROGRAM, P1
   Okey AB, 2007, TOXICOL SCI, V98, P5, DOI 10.1093/toxsci/kfm096
   Onozuka D, 2009, AM J EPIDEMIOL, V169, P86, DOI 10.1093/aje/kwn295
   Organisation for Economic Cooperation and Development, 2014, ENVJMMONO20136 ORG E
   Organisation for Economic Cooperation and Development, 2015, ADV OUTC PATHW MOL S
   Organisation for Economic Cooperation and Development, 2013, ENVJMMONO20136 ORG E
   Osburn WO, 2008, TOXICOL SCI, V104, P218, DOI 10.1093/toxsci/kfn079
   Ovando BJ, 2006, TOXICOL SCI, V94, P428, DOI 10.1093/toxsci/kfl111
   Ovando BJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-583
   Paajarvi G, 2005, CARCINOGENESIS, V26, P201, DOI 10.1093/carcin/bgh289
   Paku S, 2001, AM J PATHOL, V158, P1313, DOI 10.1016/S0002-9440(10)64082-5
   Partch CL, 2010, J CELL PHYSIOL, V223, P553, DOI 10.1002/jcp.22067
   Patlewicz G, 2015, REGUL TOXICOL PHARM, V71, P463, DOI 10.1016/j.yrtph.2015.02.011
   Patlewicz G, 2013, REGUL TOXICOL PHARM, V65, P259, DOI 10.1016/j.yrtph.2012.12.008
   Perissi V, 2005, NAT REV MOL CELL BIO, V6, P542, DOI 10.1038/nrm1680
   Peterson S, 2009, CANCER EPIDEM BIOMAR, V18, P3118, DOI 10.1158/1055-9965.EPI-09-0589
   Petkov PI, 2010, SAR QSAR ENVIRON RES, V21, P187, DOI 10.1080/10629360903570933
   Pierre S, 2014, TOXICOL SCI, V137, P114, DOI 10.1093/toxsci/kft236
   Pintilie DG, 2010, LAB INVEST, V90, P1199, DOI 10.1038/labinvest.2010.88
   Pocchiari F, 1979, Ann N Y Acad Sci, V320, P311, DOI 10.1111/j.1749-6632.1979.tb56614.x
   POLAND A, 1979, CANCER RES, V39, P3341
   Prochazkova J, 2011, TOXICOL SCI, V122, P349, DOI 10.1093/toxsci/kfr129
   Prochazkova J, 2011, TOXICOLOGY, V279, P146, DOI 10.1016/j.tox.2010.10.003
   RANDERATH K, 1990, TOXICOL APPL PHARM, V103, P271, DOI 10.1016/0041-008X(90)90229-N
   Reen RK, 2002, ARCH BIOCHEM BIOPHYS, V408, P93, DOI 10.1016/S0003-9861(02)00518-0
   REGGIANI G, 1980, J TOXICOL ENV HEALTH, V6, P27, DOI 10.1080/15287398009529828
   Roberts RA, 1997, FUND APPL TOXICOL, V38, P107, DOI 10.1006/faat.1997.2331
   Rowlands J. C., 2011, CHEMOSPHERE
   Rowlands JC, 1996, MOL PHARMACOL, V50, P538
   Sahin MB, 2008, LIVER TRANSPLANT, V14, P333, DOI 10.1002/lt.21380
   Sand S, 2006, TOXICOL SCI, V90, P241, DOI 10.1093/toxsci/kfj057
   Sato S, 2013, TOXICOL APPL PHARM, V273, P90, DOI 10.1016/j.taap.2013.08.017
   Saurat JH, 2010, DERMATOLOGY, V221, P23, DOI 10.1159/000290672
   Saurat JH, 2012, TOXICOL SCI, V125, P310, DOI 10.1093/toxsci/kfr223
   Schmidt CK, 2003, ARCH TOXICOL, V77, P371, DOI 10.1007/s00204-003-0457-8
   SCHRENK D, 1994, CARCINOGENESIS, V15, P509, DOI 10.1093/carcin/15.3.509
   Schrenk D, 2004, TOXICOL LETT, V149, P43, DOI 10.1016/j.toxlet.2003.12.019
   Schwarz M, 2000, TOXICOL LETT, V112, P69, DOI 10.1016/S0378-4274(99)00247-7
   Seed J, 2005, CRIT REV TOXICOL, V35, P663, DOI 10.1080/10408440591007133
   Senoo H, 2010, CELL BIOL INT, V34, P1247, DOI 10.1042/CBI20100321
   Shelton P, 2013, FASEB J, V27, P414, DOI 10.1096/fj.12-217257
   Silkworth JB, 2005, TOXICOL SCI, V87, P508, DOI 10.1093/toxsci/kfi261
   Simon T, 2009, TOXICOL SCI, V112, P490, DOI 10.1093/toxsci/kfp232
   Simon TW, 2014, CRIT REV TOXICOL, V44, P17, DOI 10.3109/10408444.2014.931925
   Sobus JR, 2011, SCI TOTAL ENVIRON, V409, P4875, DOI 10.1016/j.scitotenv.2011.07.046
   Sonich-Mullin C, 2001, REGUL TOXICOL PHARM, V34, P146, DOI 10.1006/rtph.2001.1493
   Sorg O, 2014, TOXICOL LETT, V230, P225, DOI 10.1016/j.toxlet.2013.10.039
   Soshilov A, 2011, J BIOL CHEM, V286, P35275, DOI 10.1074/jbc.M111.246439
   STINCHCOMBE S, 1995, CARCINOGENESIS, V16, P1271, DOI 10.1093/carcin/16.6.1271
   Sutter CH, 2010, TOXICOL SCI, V118, P704, DOI 10.1093/toxsci/kfq262
   Sutter CH, 2011, TOXICOL SCI, V124, P128, DOI 10.1093/toxsci/kfr205
   Sutter CH, 2009, P NATL ACAD SCI USA, V106, P4266, DOI 10.1073/pnas.0900874106
   Tanaka M, 2011, J BIOCHEM, V149, P231, DOI 10.1093/jb/mvr001
   TANAKA T, 1990, CARCINOGENESIS, V11, P1403, DOI 10.1093/carcin/11.8.1403
   Tang NJ, 2008, TOXICOL LETT, V177, P182, DOI 10.1016/j.toxlet.2008.01.011
   Tappenden DM, 2013, J TOXICOL, DOI 10.1155/2013/279829
   Teeguarden JG, 1999, TOXICOL SCI, V51, P211, DOI 10.1093/toxsci/51.2.211
   Tomasetti C, 2015, SCIENCE, V347, P78, DOI 10.1126/science.1260825
   TRITSCHER AM, 1992, CANCER RES, V52, P3436
   Tsai CC, 2004, VITAM HORM, V68, P93
   Tsai PC, 2007, SCI TOTAL ENVIRON, V374, P216, DOI 10.1016/j.scitotenv.2006.12.024
   TURTELTAUB KW, 1990, P NATL ACAD SCI USA, V87, P5288, DOI 10.1073/pnas.87.14.5288
   Umannova L, 2007, TOXICOL SCI, V99, P79, DOI 10.1093/toxsci/kfm149
   United States Environmental Protection Agency (USEPA), 2014, SCI ACT CHEM SAF RES
   Uno S, 2009, TOXICOL APPL PHARM, V237, P119, DOI 10.1016/j.taap.2009.03.001
   US EPA, 2005, GUID CARC RISK ASS
   van Delft JHM, 2005, MUTAT RES-FUND MOL M, V575, P17, DOI 10.1016/j.mrfmmm.2005.02.006
   Van den Berg M, 2006, TOXICOL SCI, V93, P223, DOI 10.1093/toxsci/kfl055
   Vezina CM, 2004, ENVIRON HEALTH PERSP, V112, P1636, DOI 10.1289/txg.7253
   VICKERS AEM, 1989, CANCER RES, V49, P6512
   Vickers AEM, 1996, CARCINOGENESIS, V17, P1235, DOI 10.1093/carcin/17.6.1235
   Villeneuve DL, 2014, TOXICOL SCI, V142, P312, DOI 10.1093/toxsci/kfu199
   Villeneuve DL, 2014, TOXICOL SCI, V142, P321, DOI 10.1093/toxsci/kfu200
   Vondracek J, 2009, CHEM-BIOL INTERACT, V180, P226, DOI 10.1016/j.cbi.2009.03.011
   Walker NJ, 2006, MOL NUTR FOOD RES, V50, P934, DOI 10.1002/mnfr.200600031
   Wang LP, 2013, ARCH BIOCHEM BIOPHYS, V537, P31, DOI 10.1016/j.abb.2013.06.001
   Wang X, 2003, P NATL ACAD SCI USA, V100, P11881, DOI 10.1073/pnas.1734199100
   Wang YJ, 2011, J HAZARD MATER, V186, P869, DOI 10.1016/j.jhazmat.2010.11.082
   WASSOM JS, 1978, MUTAT RES, V47, P141, DOI 10.1016/0165-1110(77)90001-X
   Watanabe T, 2012, MUTAT RES-GEN TOX EN, V747, P164, DOI 10.1016/j.mrgentox.2012.04.011
   Weiss C, 2008, ONCOGENE, V27, P2198, DOI 10.1038/sj.onc.1210859
   Westerink WMA, 2008, ARCH TOXICOL, V82, P909, DOI 10.1007/s00204-008-0317-7
   WHO IPCS, 1998, ASS HLTH RISK DIOX R
   Whysner J, 1996, PHARMACOL THERAPEUT, V71, P193, DOI 10.1016/0163-7258(96)00068-X
   Wincent E, 2009, J BIOL CHEM, V284, P2690, DOI 10.1074/jbc.M808321200
   WOLFLE D, 1993, CELL BIOL TOXICOL, V9, P15, DOI 10.1007/BF00755137
   Worner W, 1996, CANCER RES, V56, P1272
   Worner W, 1998, ENVIRON TOXICOL PHAR, V6, P239, DOI 10.1016/S1382-6689(98)00040-4
   Yamamoto R, 2013, EXP TOXICOL PATHOL, V65, P845, DOI 10.1016/j.etp.2012.12.003
   Yao CDQ, 2012, TOXICOL APPL PHARM, V260, P135, DOI 10.1016/j.taap.2012.02.001
   Yates MS, 2007, MOL CANCER THER, V6, P154, DOI 10.1158/1535-7163.MCT-06-0516
   Yates MS, 2007, ACTA PHARMACOL SIN, V28, P1331, DOI 10.1111/j.1745-7254.2007.00688.x
   Zhang Q, 2007, PLOS COMPUT BIOL, V3, P345, DOI 10.1371/journal.pcbi.0030024
   Zhao YY, 2008, CHEMOSPHERE, V73, P86, DOI 10.1016/j.chemosphere.2008.05.018
NR 244
TC 17
Z9 18
U1 1
U2 23
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0273-2300
EI 1096-0295
J9 REGUL TOXICOL PHARM
JI Regul. Toxicol. Pharmacol.
PD OCT
PY 2015
VL 73
IS 1
BP 172
EP 190
DI 10.1016/j.yrtph.2015.06.015
PG 19
WC Medicine, Legal; Pharmacology & Pharmacy; Toxicology
SC Legal Medicine; Pharmacology & Pharmacy; Toxicology
GA CR5UU
UT WOS:000361410700018
PM 26145830
OA Other Gold
DA 2019-10-23
ER

PT J
AU Yamada, T
   Tanaka, Y
   Hasegawa, R
   Sakuratani, Y
   Yamazoe, Y
   Ono, A
   Hirose, A
   Hayashi, M
AF Yamada, Takashi
   Tanaka, Yushiro
   Hasegawa, Ryuichi
   Sakuratani, Yuki
   Yamazoe, Yasushi
   Ono, Atsushi
   Hirose, Akihiko
   Hayashi, Makoto
TI Authors' response to Letter to the Editor by Jeff Kelsey et al.
   "Response to 'Development of a category approach to predict the
   testicular toxicity of chemical substances structurally related to
   ethylene glycol methyl ether.'" 2015
SO REGULATORY TOXICOLOGY AND PHARMACOLOGY
LA English
DT Letter
DE Category approach; Repeated-dose toxicity; Testicular toxicity;
   Methoxyacetic acid; Adverse outcome pathway
C1 [Yamada, Takashi; Tanaka, Yushiro; Hasegawa, Ryuichi; Sakuratani, Yuki] Natl Inst Technol & Evaluat, Kisarazu, Japan.
RP Yamada, T (reprint author), Natl Inst Technol & Evaluat, Kisarazu, Japan.
EM yamada-takashi@nite.go.jp
OI Ono, Atsushi/0000-0001-5056-0442
CR Yamada T, 2014, REGUL TOXICOL PHARM, V70, P711, DOI 10.1016/j.yrtph.2014.10.011
NR 1
TC 0
Z9 0
U1 0
U2 0
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0273-2300
EI 1096-0295
J9 REGUL TOXICOL PHARM
JI Regul. Toxicol. Pharmacol.
PD OCT
PY 2015
VL 73
IS 1
BP 209
EP 209
DI 10.1016/j.yrtph.2015.07.002
PG 1
WC Medicine, Legal; Pharmacology & Pharmacy; Toxicology
SC Legal Medicine; Pharmacology & Pharmacy; Toxicology
GA CR5UU
UT WOS:000361410700022
PM 26165563
DA 2019-10-23
ER

PT J
AU Natsch, A
   Emter, R
AF Natsch, Andreas
   Emter, Roger
TI Reporter cell lines for skin sensitization testing
SO ARCHIVES OF TOXICOLOGY
LA English
DT Review
DE Skin sensitization; Reporter cell line; In vitro testing; Adverse
   outcome pathway; Mechanistic toxicology; Gene expression; Nrf2;
   Interleukin-8
ID IN-VITRO METHODS; ACTIVATED PROTEIN-KINASE; GENE-EXPRESSION CHANGES;
   LYMPH-NODE ASSAY; DENDRITIC CELLS; OXIDATIVE STRESS; CONTACT ALLERGEN;
   CHEMICAL SENSITIZATION; HAZARD IDENTIFICATION; DEPENDENT ACTIVATION
AB Skin sensitization has been described as an adverse outcome pathway (AOP), comprising a number of molecular events leading to the final adverse effect. In a new paradigm of toxicology, attempts are made to collect information using single mechanistic tests addressing different targets along such an AOP and to then integrate this information to arrive at a final toxicological prediction. This proposal is strongly influenced by the availability of methods for high-throughput screening of cellular events. Reporter cell lines are a particularly useful tool in such screening paradigms, as they can deliver highly reproducible and easily measureable results, and they can be designed to quantify induction or suppression at the transcription level of very specific molecular targets within cells. The first cell-based assay for skin sensitization, which has recently received ECVAM and OECD endorsement, is the reporter cell assay KeratinoSens (TM), reflecting activation of the Nrf2 pathway, and other assays measuring the Nrf2 pathway are under development or validation. An alternative approach (THP-G8) was recently developed based on activation of the Interleukin-8 gene. Here, we review these assays, their role in the AOP, their mechanistic interrelationships, their use for hazard and risk assessment, and their application in integrated testing strategies. At the same time, this study reviews (1) other cellular markers for sensitizers, and the potential to develop new reporter gene assays providing additional, non-redundant information, and (2) it presents approaches and new experimental data on attempts to further improve the predictivity of the existing assay.
C1 [Natsch, Andreas; Emter, Roger] Givaudan Schweiz AG, Biosci, CH-8600 Dubendorf, Switzerland.
RP Natsch, A (reprint author), Givaudan Schweiz AG, Biosci, Ueberlandstr 138, CH-8600 Dubendorf, Switzerland.
EM andreas.natsch@givaudan.com
OI Natsch, Andreas/0000-0003-2231-2489
CR Ade N, 2009, TOXICOL SCI, V107, P451, DOI 10.1093/toxsci/kfn243
   Aiba S, 2003, J INVEST DERMATOL, V120, P390, DOI 10.1046/j.1523-1747.2003.12065.x
   Alam J, 2000, J BIOL CHEM, V275, P27694
   Alam J, 2007, AM J RESP CELL MOL, V36, P166, DOI 10.1165/rcmb.2006-0340TR
   Aleksic M, 2009, TOXICOL SCI, V108, P401, DOI 10.1093/toxsci/kfp030
   Alloul-Ramdhani M, 2014, TOXICOL IN VITRO, V28, P982, DOI 10.1016/j.tiv.2014.04.007
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Antonopoulos C, 2008, J LEUKOCYTE BIOL, V83, P361, DOI 10.1189/jlb.0604352
   Arkusz J, 2010, TOXICOL LETT, V199, P51, DOI 10.1016/j.toxlet.2010.08.005
   Arrighi JF, 2001, J IMMUNOL, V166, P3837, DOI 10.4049/jimmunol.166.6.3837
   Ashikaga T, 2006, TOXICOL IN VITRO, V20, P767, DOI 10.1016/j.tiv.2005.10.012
   Ashikaga T, 2002, TOXICOL IN VITRO, V16, P711, DOI 10.1016/S0887-2333(02)00060-7
   Azam P, 2006, TOXICOL APPL PHARM, V212, P14, DOI 10.1016/j.taap.2005.06.018
   Ball N, 2011, REGUL TOXICOL PHARM, V60, P389, DOI 10.1016/j.yrtph.2011.05.007
   Basketter DA, 1996, CONTACT DERMATITIS, V35, P146, DOI 10.1111/j.1600-0536.1996.tb02332.x
   Basketter D, 2007, ATLA-ALTERN LAB ANIM, V35, P137, DOI 10.1177/026119290703500124
   Basketter DA, 2007, CONTACT DERMATITIS, V57, P70, DOI 10.1111/j.1600-0536.2007.01141.x
   Bauch C, 2012, REGUL TOXICOL PHARM, V63, P489, DOI 10.1016/j.yrtph.2012.05.013
   Bauch C, 2011, TOXICOL IN VITRO, V25, P1162, DOI 10.1016/j.tiv.2011.05.030
   Bloom DA, 2003, J BIOL CHEM, V278, P44675, DOI 10.1074/jbc.M307633200
   Bonifas J, 2010, TOXICOL IN VITRO, V24, P973, DOI 10.1016/j.tiv.2009.12.023
   Casati S, 2009, ATLA-ALTERN LAB ANIM, V37, P305, DOI 10.1177/026119290903700313
   Chen C, 2004, FREE RADICAL BIO MED, V37, P1578, DOI 10.1016/j.freeradbiomed.2004.07.021
   Coquette A, 2003, TOXICOL IN VITRO, V17, P311, DOI 10.1016/S0887-2333(03)00019-5
   Corsini E, 2009, TOXICOL IN VITRO, V23, P789, DOI 10.1016/j.tiv.2009.04.005
   Cotovio J, 1997, IN VITRO TOXICOL, V10, P207
   Cottrez F, 2015, TOXICOL IN VITRO, V29, P787, DOI 10.1016/j.tiv.2015.02.012
   Dearman RJ, 2003, J TOXICOL-CUTAN OCUL, V22, P69, DOI 10.1081/CUS-120020313
   Delaine T, 2014, CHEM RES TOXICOL, V27, P1860, DOI 10.1021/tx500297d
   Delaine T, 2011, CHEM RES TOXICOL, V24, P1312, DOI 10.1021/tx200196s
   Dietz L, 2009, PROTEOMICS, V9, P4298, DOI 10.1002/pmic.200900051
   ECVAM, 2014, EURL ECVAM REC KERAT
   El Ali Z, 2013, TOXICOL SCI, V134, P39, DOI 10.1093/toxsci/kft084
   Emter R, 2015, TOXICOL IN VITRO, V29, P688, DOI 10.1016/j.tiv.2015.02.003
   Emter R, 2013, TOXICOL IN VITRO, V27, P2225, DOI 10.1016/j.tiv.2013.09.009
   Emter R, 2010, TOXICOL APPL PHARM, V245, P281, DOI 10.1016/j.taap.2010.03.009
   ENK AH, 1992, P NATL ACAD SCI USA, V89, P1398, DOI 10.1073/pnas.89.4.1398
   Esser PR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041340
   Gerberick GF, 2004, TOXICOL SCI, V81, P332, DOI 10.1093/toxsci/kfh213
   Gibbs S, 2013, TOXICOL APPL PHARM, V272, P529, DOI 10.1016/j.taap.2013.07.003
   Gildea LA, 2006, J INVEST DERMATOL, V126, P1813, DOI 10.1038/sj.jid.5700319
   Hitzler M, 2013, TOXICOL IN VITRO, V27, P1659, DOI 10.1016/j.tiv.2013.04.009
   Hooyberghs J, 2008, TOXICOL APPL PHARM, V231, P103, DOI 10.1016/j.taap.2008.03.014
   ICCVAM, 2009, NIH PUBL
   Ishikawa M, 2005, FREE RADICAL BIO MED, V38, P1344, DOI 10.1016/j.freeradbiomed.2005.01.021
   Jacobs AT, 2007, J BIOL CHEM, V282, P33412, DOI 10.1074/jbc.M706799200
   Jaworska J, 2013, J APPL TOXICOL, V33, P1353, DOI 10.1002/jat.2869
   Jaworska J, 2011, ALTEX-ALTERN ANIM EX, V28, P211, DOI 10.14573/altex.2011.3.211
   Johansson H, 2013, TOXICOL IN VITRO, V27, P1163, DOI 10.1016/j.tiv.2012.05.019
   Johansson H, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-399
   Judson RS, 2010, ENVIRON HEALTH PERSP, V118, P485, DOI 10.1289/ehp.0901392
   Kagatani S, 2010, J INVEST DERMATOL, V130, P175, DOI 10.1038/jid.2009.229
   Karlberg AT, 2008, CHEM RES TOXICOL, V21, P53, DOI 10.1021/tx7002239
   Kern S, 2014, ANAL BIOANAL CHEM, V406, P6165, DOI 10.1007/s00216-014-8066-3
   Kim HJ, 2008, J ALLERGY CLIN IMMUN, V121, P1255, DOI 10.1016/j.jaci.2008.01.016
   Kimber I, 2000, BRIT J DERMATOL, V142, P401, DOI 10.1046/j.1365-2133.2000.03349.x
   Kimber I, 2011, TOXICOL SCI, V120, pS238, DOI 10.1093/toxsci/kfq346
   Lau WKW, 2012, TOXICOL SCI, V125, P569, DOI 10.1093/toxsci/kfr305
   Lepoittevin JP, 2006, CONTACT DERMATITIS, V54, P73, DOI 10.1111/j.0105-1873.2006.00795.x
   Lou H, 2006, MOL PHARMACOL, V69, P1662, DOI 10.1124/mol.105.019794
   Luis A, 2014, FREE RADICAL BIO MED, V77, P217, DOI 10.1016/j.freeradbiomed.2014.09.008
   MacLeod AK, 2009, CARCINOGENESIS, V30, P1571, DOI 10.1093/carcin/bgp176
   Manome H, 1999, IMMUNOLOGY, V98, P481, DOI 10.1046/j.1365-2567.1999.00916.x
   Martin SF, 2012, CURR OPIN IMMUNOL, V24, P720, DOI 10.1016/j.coi.2012.08.003
   McKim JM, 2012, CUTAN OCUL TOXICOL, V31, P292, DOI 10.3109/15569527.2012.667031
   McNamee PM, 2008, REGUL TOXICOL PHARM, V52, P24, DOI 10.1016/j.yrtph.2007.10.019
   Megherbi R, 2009, TOXICOL APPL PHARM, V238, P120, DOI 10.1016/j.taap.2009.05.001
   Migdal C, 2013, TOXICOL SCI, V133, P259, DOI 10.1093/toxsci/kft075
   Miller D, 2001, ENVIRON HEALTH PERSP, V109, P133, DOI 10.2307/3434765
   Mitjans M, 2008, TOXICOL IN VITRO, V22, P386, DOI 10.1016/j.tiv.2007.10.005
   Miyazawa M, 2012, J DERMATOL SCI, V68, P73, DOI 10.1016/j.jdermsci.2012.08.003
   Miyazawa M, 2008, J TOXICOL SCI, V33, P51, DOI 10.2131/jts.33.51
   Mohamadzadeh M, 1994, Exp Dermatol, V3, P298, DOI 10.1111/j.1600-0625.1994.tb00292.x
   Motohashi H, 2004, TRENDS MOL MED, V10, P549, DOI 10.1016/j.molmed.2004.09.003
   Natsch A, 2011, TOXICOLOGICAL SCI S, V120, P214
   Natsch A, 2008, TOXICOL SCI, V106, P464, DOI 10.1093/toxsci/kfn194
   Natsch A, 2008, TOXICOL SCI, V102, P110, DOI 10.1093/toxsci/kfm259
   Natsch A, 2014, ISSUES TOXICOL, V19, P265
   Natsch A, 2015, TOXICOL SCI, V143, P319, DOI 10.1093/toxsci/kfu229
   Natsch A, 2013, TOXICOL SCI, V135, P356, DOI 10.1093/toxsci/kft160
   Natsch A, 2013, J APPL TOXICOL, V33, P1337, DOI 10.1002/jat.2868
   Natsch A, 2011, TOXICOL IN VITRO, V25, P733, DOI 10.1016/j.tiv.2010.12.014
   Natsch A, 2010, TOXICOL SCI, V113, P284, DOI 10.1093/toxsci/kfp228
   Natsch A, 2009, TOXICOL SCI, V107, P106, DOI 10.1093/toxsci/kfn204
   Neves BM, 2013, CHEM RES TOXICOL, V26, P368, DOI 10.1021/tx300472d
   Neves BM, 2011, TOXICOL APPL PHARM, V250, P87, DOI 10.1016/j.taap.2010.10.003
   Niklasson IB, 2011, CHEM RES TOXICOL, V24, P542, DOI 10.1021/tx100417r
   Niklasson IB, 2009, CHEM RES TOXICOL, V22, P1787, DOI 10.1021/tx900193s
   Nukada Y, 2008, J TOXICOL SCI, V33, P175, DOI 10.2131/jts.33.175
   O'Boyle NM, 2012, CHEM RES TOXICOL, V25, P2469, DOI 10.1021/tx300305k
   OECD, 2012, OECD ENV HLTH SAF PU, P10
   Pellegatti P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002599
   Piret JP, 2012, NANOSCALE, V4, P7168, DOI 10.1039/c2nr31785k
   Python F, 2007, TOXICOL APPL PHARM, V220, P113, DOI 10.1016/j.taap.2006.12.026
   Python F, 2009, TOXICOL APPL PHARM, V239, P273, DOI 10.1016/j.taap.2009.06.003
   Ramirez T, 2014, TOXICOL IN VITRO, V28, P1482, DOI 10.1016/j.tiv.2014.08.002
   Reichard JF, 2007, NUCLEIC ACIDS RES, V35, P7074, DOI 10.1093/nar/gkm638
   Reuter H, 2011, TOXICOL IN VITRO, V25, P315, DOI 10.1016/j.tiv.2010.09.016
   Roberts DW, 2008, J APPL TOXICOL, V28, P443, DOI 10.1002/jat.1293
   Roberts DW, 2009, CHEM RES TOXICOL, V22, P592, DOI 10.1021/tx800431x
   Rovida C, 2015, ALTEX-ALTERN ANIM EX, V32, P25, DOI [http://dx.doi.org/10.14573/altex.1411011, 10.14573/altex.1506201]
   Ryan CA, 2004, J TOXICOL-CUTAN OCUL, V23, P91, DOI 10.1081/CUS-120030167
   Ryan CA, 2004, TOXICOL LETT, V150, P301, DOI 10.1016/j.toxlet.2004.02.002
   Saito K, 2013, TOXICOL IN VITRO, V27, P2213, DOI 10.1016/j.tiv.2013.08.007
   Sakaguchi H, 2007, TOXICOL LETT, V172, pS93, DOI 10.1016/j.toxlet.2007.05.257
   Shukla SJ, 2010, DRUG DISCOV TODAY, V15, P997, DOI 10.1016/j.drudis.2010.07.007
   Skold M, 2002, CONTACT DERMATITIS, V46, P267, DOI 10.1034/j.1600-0536.2002.460504.x
   Spielmann H, 1998, TOXICOL IN VITRO, V12, P305, DOI 10.1016/S0887-2333(98)00006-X
   Takahashi T, 2011, TOXICOL SCI, V124, P359, DOI 10.1093/toxsci/kfr237
   Teissier SM, 2015, MODELES EVALUATION P
   Teunis M, 2013, TOXICOL IN VITRO, V27, P1135, DOI 10.1016/j.tiv.2012.06.004
   Toebak MJ, 2006, TOXICOL IN VITRO, V20, P117, DOI 10.1016/j.tiv.2005.06.039
   Urbisch D, 2015, REGUL TOXICOL PHARM, V71, P337, DOI 10.1016/j.yrtph.2014.12.008
   van der Veen JWD, 2015, TOXICOL IN VITRO, V29, P81, DOI 10.1016/j.tiv.2014.08.010
   van der Veen JW, 2014, REGUL TOXICOL PHARM, V69, P371, DOI 10.1016/j.yrtph.2014.04.018
   van der Veen JW, 2013, ARCH TOXICOL, V87, P763, DOI 10.1007/s00204-012-0976-2
   van der Veen JW, 2013, TOXICOL IN VITRO, V27, P314, DOI 10.1016/j.tiv.2012.08.023
   Van Eiji S, 2012, PLOS ONE, V7, DOI DOI 10.1371/J0URNAL.P0NE.0041721
   Van Och FMM, 2005, TOXICOLOGY, V210, P95, DOI 10.1016/j.tox.2005.01.004
   Vandebriel RJ, 2010, TOXICOL SCI, V117, P81, DOI 10.1093/toxsci/kfq182
   Vocanson M, 2008, J INVEST DERMATOL, V128, P2119, DOI 10.1038/jid.2008.15
   Wahlberg J E, 1985, Curr Probl Dermatol, V14, P59
   Wakabayashi N, 2004, P NATL ACAD SCI USA, V101, P2040, DOI 10.1073/pnas.0307301101
   Wang XJ, 2006, CANCER RES, V66, P10983, DOI 10.1158/0008-5472.CAN-06-2298
   Weber FC, 2010, J EXP MED, V207, P2609, DOI 10.1084/jem.20092489
   Wilson VS, 2004, TOXICOL SCI, V81, P69, DOI 10.1093/toxsci/kfh180
   Yusuf N, 2009, J IMMUNOL, V182, P675, DOI 10.4049/jimmunol.182.1.675
   Zhang XL, 2005, EUR J IMMUNOL, V35, P3258, DOI 10.1002/eji.200526116
   Zipper LM, 2000, BIOCHEM BIOPH RES CO, V278, P484, DOI 10.1006/bbrc.2000.3830
NR 129
TC 13
Z9 14
U1 2
U2 9
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0340-5761
EI 1432-0738
J9 ARCH TOXICOL
JI Arch. Toxicol.
PD OCT
PY 2015
VL 89
IS 10
BP 1645
EP 1668
DI 10.1007/s00204-015-1555-0
PG 24
WC Toxicology
SC Toxicology
GA CR7NC
UT WOS:000361536100001
PM 26194644
DA 2019-10-23
ER

PT J
AU Nelms, MD
   Mellor, CL
   Cronin, MTD
   Madden, JC
   Enoch, SJ
AF Nelms, Mark D.
   Mellor, Claire L.
   Cronin, Mark T. D.
   Madden, Judith C.
   Enoch, Steven J.
TI Development of an in Silico Profiler for Mitochondrial Toxicity
SO CHEMICAL RESEARCH IN TOXICOLOGY
LA English
DT Article
ID RAT-LIVER MITOCHONDRIA; NONSTEROIDAL ANTIINFLAMMATORY DRUGS;
   LOCAL-ANESTHETIC BUPIVACAINE; ELECTRON-TRANSPORT CHAIN; ADVERSE OUTCOME
   PATHWAY; OXIDATIVE-PHOSPHORYLATION; PERMEABILITY TRANSITION; HEPATOCYTE
   APOPTOSIS; BILE-ACIDS; QUANTITATIVE STRUCTURE
AB This study outlines the analysis of mitochondria' toxicity for a variety of pharmaceutical drugs extracted from Zhang et al. ((2009) Toxicol. In Vitro, 23, 134-140). These chemicals were grouped into categories based upon structural similarity. Subsequently, mechanistic analysis was undertaken for each category to identify the molecular initiating event driving mitochondria' toxicity. The mechanistic information elucidated during the analysis enabled mechanismbased structural alerts to be developed and combined together to form an in silico profiler. This profiler is envisaged to be used to develop chemical categories based upon similar mechanisms as part of the adverse outcome pathway paradigm. Additionally, the profiler could be utilized in screening large data sets in order to identify chemicals with the potential to induce mitochondrial toxicity.
C1 [Nelms, Mark D.; Mellor, Claire L.; Cronin, Mark T. D.; Madden, Judith C.; Enoch, Steven J.] Liverpool John Moores Univ, Sch Pharm & Biomol Sci, Liverpool L3 3AF, Merseyside, England.
RP Enoch, SJ (reprint author), Liverpool John Moores Univ, Sch Pharm & Biomol Sci, Byrom St, Liverpool L3 3AF, Merseyside, England.
EM s.j.enoch@ljmu.ac.uk
FU European CommunityEuropean Community (EC) [266835]; Cosmetics Europe
FX Funding from the European Community's Seventh Framework Program
   (FP7/2007-2013) COSMOS Project under grant agreement no. 266835 and from
   Cosmetics Europe is gratefully acknowledged.
CR Adler S, 2011, ARCH TOXICOL, V85, P367, DOI 10.1007/s00204-011-0693-2
   ALMOTREFI AA, 1992, EUR J PHARMACOL, V215, P231, DOI 10.1016/0014-2999(92)90032-Y
   Amacher DE, 2005, CURR MED CHEM, V12, P1829, DOI 10.2174/0929867054546663
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   [Anonymous], 2012, GUID DEV ASS ADV OUT
   [Anonymous], QSAR TOOLB
   [Anonymous], 2015, OECD WEBPAGE DESCRIB
   [Anonymous], 2009, REP READ ACR CAT 1 3, P1
   Balijepalli S, 1999, NEUROPHARMACOLOGY, V38, P567, DOI 10.1016/S0028-3908(98)00215-9
   Battaglia V, 2005, J BIOL CHEM, V280, P33864, DOI 10.1074/jbc.M502391200
   Boelsterli UA, 2002, DRUG SAFETY, V25, P633, DOI 10.2165/00002018-200225090-00003
   Brunmair B, 2004, DIABETES, V53, P1052, DOI 10.2337/diabetes.53.4.1052
   Cela O, 2010, MITOCHONDRION, V10, P487, DOI 10.1016/j.mito.2010.05.005
   Chan Katie, 2005, Expert Opin Drug Metab Toxicol, V1, P655, DOI 10.1517/17425255.1.4.655
   Cohen BH, 2001, CLEV CLIN J MED, V68, P625, DOI 10.3949/ccjm.68.7.625
   Cronin MTD, 2013, ISSUES TOXICOL, V17, P1, DOI 10.1039/9781849734400
   DABADIE P, 1987, FEBS LETT, V226, P77, DOI 10.1016/0014-5793(87)80554-9
   Dippenaar J. M., 2007, S AFR J ANAESTH ANAL, V13, P23
   Dykens J.A., 2008, DRUG INDUCED MITOCHO
   Dykens JA, 2007, DRUG DISCOV TODAY, V12, P777, DOI 10.1016/j.drudis.2007.07.013
   Dykens JA, 2007, EXPERT REV MOL DIAGN, V7, P161, DOI 10.1586/14737159.7.2.161
   ECHA, 2008, GUID INF REQ CHEM SA
   *ECHA, 2010, PRACT GUID 6 REP REA
   Enoch SJ, 2008, SAR QSAR ENVIRON RES, V19, P555, DOI 10.1080/10629360802348985
   Enoch SJ, 2011, CRIT REV TOXICOL, V41, P783, DOI 10.3109/10408444.2011.598141
   Enoch SJ, 2010, CRIT REV TOXICOL, V40, P728, DOI 10.3109/10408444.2010.494175
   ETO K, 1985, ACTA MED OKAYAMA, V39, P289
   Faubion WA, 1999, J CLIN INVEST, V103, P137, DOI 10.1172/JCI4765
   GALLAGHER CH, 1965, BIOCHEM PHARMACOL, V14, P789, DOI 10.1016/0006-2952(65)90098-5
   Gerwirtz D. A, 1999, BIOCHEM PHARMACOL, V57, P727
   GUTH PS, 1964, INT REV NEUROBIOL, V7, P231, DOI 10.1016/S0074-7742(08)60269-X
   Gutsell S, 2013, TOXICOL RES-UK, V2, P299, DOI 10.1039/c3tx50024a
   HATEFI Y, 1985, ANNU REV BIOCHEM, V54, P1015, DOI 10.1146/annurev.bi.54.070185.005055
   Hewitt M, 2013, CRIT REV TOXICOL, V43, P537, DOI 10.3109/10408444.2013.811215
   Jaeschke H, 2002, TOXICOL SCI, V65, P166, DOI 10.1093/toxsci/65.2.166
   KAPPUS H, 1986, BIOCHEM PHARMACOL, V35, P1, DOI 10.1016/0006-2952(86)90544-7
   KELLER BJ, 1992, TOXICOLOGY, V71, P49, DOI 10.1016/0300-483X(92)90053-H
   Kim JS, 2003, BIOCHEM BIOPH RES CO, V304, P463, DOI 10.1016/S0006-291X(03)00618-1
   Kleszczynski K, 2011, TOXICOL APPL PHARM, V251, P163, DOI 10.1016/j.taap.2011.01.002
   Kleszczynski K, 2009, TOXICOL APPL PHARM, V235, P182, DOI 10.1016/j.taap.2008.11.021
   Kowaltowski AJ, 2001, FEBS LETT, V495, P12, DOI 10.1016/S0014-5793(01)02316-X
   KRAHENBUHL S, 1994, HEPATOLOGY, V19, P471, DOI 10.1016/0270-9139(94)90027-2
   Krahenbuhl S, 2001, J HEPATOL, V34, P334, DOI 10.1016/S0168-8278(00)00106-9
   Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006
   LANGLEY AE, 1990, J TOXICOL ENV HEALTH, V29, P329, DOI 10.1080/15287399009531395
   Lemasters JJ, 2009, BBA-BIOENERGETICS, V1787, P1395, DOI 10.1016/j.bbabio.2009.06.009
   LUCASHERON B, 1994, NEUROSCI LETT, V169, P97, DOI 10.1016/0304-3940(94)90365-4
   Masubuchi Y, 1998, J PHARMACOL EXP THER, V287, P208
   Masubuchi Y, 2006, DRUG METAB PHARMACOK, V21, P347, DOI 10.2133/dmpk.21.347
   MATSUBARA T, 1968, J BIOCHEM, V63, P156, DOI 10.1093/oxfordjournals.jbchem.a128756
   Mehta R., 2008, DRUG INDUCED MITOCHO
   Moreno-Sanchez R, 1999, BIOCHEM PHARMACOL, V57, P743, DOI 10.1016/S0006-2952(98)00330-X
   Nadanaciva S, 2007, TOXICOL APPL PHARM, V223, P277, DOI 10.1016/j.taap.2007.06.003
   Nadanaciva S, 2007, TOXICOL IN VITRO, V21, P902, DOI 10.1016/j.tiv.2007.01.011
   Nadanaciva S, 2011, CURR PHARM DESIGN, V17, P2100, DOI 10.2174/138161211796904795
   Naven RT, 2013, TOXICOL SCI, V131, P271, DOI 10.1093/toxsci/kfs279
   Nixon GL, 2013, FUTURE MED CHEM, V5, P1573, DOI 10.4155/fmc.13.121
   Ohkuma Y, 2001, FREE RADICAL RES, V34, P595, DOI 10.1080/10715760100300491
   Palmeira CM, 2004, TOXICOLOGY, V203, P1, DOI 10.1016/j.tox.2004.06.001
   Perez MJ, 2009, WORLD J GASTROENTERO, V15, P1677, DOI 10.3748/wjg.15.1677
   Pessayre D., 2008, DRUG INDUCED MITOCHO
   Pieczenik SR, 2007, EXP MOL PATHOL, V83, P84, DOI 10.1016/j.yexmp.2006.09.008
   Qiao L, 2001, MOL BIOL CELL, V12, P2629, DOI 10.1091/mbc.12.9.2629
   Roberts DW, 2007, CHEM RES TOXICOL, V20, P1019, DOI 10.1021/tx700024w
   Rodrigues CMP, 1999, CELL DEATH DIFFER, V6, P842, DOI 10.1038/sj.cdd.4400560
   Rolo AP, 2004, TOXICOL SCI, V79, P196, DOI 10.1093/toxsci/kfh078
   SAITO K, 1982, TOXICOL APPL PHARM, V65, P347, DOI 10.1016/0041-008X(82)90380-5
   Sakuratani Y, 2013, SAR QSAR ENVIRON RES, V24, P617, DOI 10.1080/1062936X.2013.773375
   SCHNELLMANN RG, 1990, TOXICOL IN VITRO, V4, P71, DOI 10.1016/0887-2333(90)90012-I
   SCHNELLMANN RG, 1990, BIOCHIM BIOPHYS ACTA, V1016, P344, DOI 10.1016/0005-2728(90)90167-3
   SCHONFELD P, 1992, FEBS LETT, V304, P273, DOI 10.1016/0014-5793(92)80636-U
   Siraki AG, 2005, CHEM-BIOL INTERACT, V151, P177, DOI 10.1016/j.cbi.2004.12.006
   Sokol RJ, 2001, PEDIATR RES, V49, P519, DOI 10.1203/00006450-200104000-00014
   SPIVEY JR, 1993, J CLIN INVEST, V92, P17, DOI 10.1172/JCI116546
   Spycher S, 2008, CHEM RES TOXICOL, V21, P911, DOI 10.1021/tx700391f
   Starkov AA, 2002, TOXICOL SCI, V66, P244, DOI 10.1093/toxsci/66.2.244
   SUN XC, 1992, J BIOL CHEM, V267, P19147
   Sztark F, 1997, BIOCHEM MOL BIOL INT, V43, P997
   Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312
   TERADA H, 1990, J BIOL CHEM, V265, P7837
   TERADA H, 1990, ENVIRON HEALTH PERSP, V87, P213, DOI 10.2307/3431027
   Uyemura SA, 1997, ARCH BIOCHEM BIOPHYS, V342, P231, DOI 10.1006/abbi.1997.9985
   Vinken M, 2014, ARCH TOXICOL, V88, P1, DOI 10.1007/s00204-013-1093-6
   Vinken M, 2013, TOXICOL SCI, V136, P97, DOI 10.1093/toxsci/kft177
   Vinken M, 2013, TOXICOLOGY, V312, P158, DOI 10.1016/j.tox.2013.08.011
   Wallace KB, 2013, TOXICOL LETT, V222, P257, DOI 10.1016/j.toxlet.2013.07.025
   Wallace KB, 2003, PHARMACOL TOXICOL, V93, P105, DOI 10.1034/j.1600-0773.2003.930301.x
   Wallace KB, 2000, ANNU REV PHARMACOL, V40, P353, DOI 10.1146/annurev.pharmtox.40.1.353
   WEI YH, 1985, BIOCHEM PHARMACOL, V34, P911, DOI 10.1016/0006-2952(85)90589-1
   Winklhofer-Roob B. M., 1996, Hepatology, V24, p338A
   Yerushalmi B, 2001, HEPATOLOGY, V33, P616, DOI 10.1053/jhep.2001.22702
   Yin XM, 2003, CURR MOL MED, V3, P491, DOI 10.2174/1566524033479555
   Zhang H, 2009, TOXICOL IN VITRO, V23, P134, DOI 10.1016/j.tiv.2008.09.017
NR 93
TC 9
Z9 9
U1 0
U2 15
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0893-228X
EI 1520-5010
J9 CHEM RES TOXICOL
JI Chem. Res. Toxicol.
PD OCT
PY 2015
VL 28
IS 10
BP 1891
EP 1902
DI 10.1021/acs.chemrestox.5b00275
PG 12
WC Chemistry, Medicinal; Chemistry, Multidisciplinary; Toxicology
SC Pharmacology & Pharmacy; Chemistry; Toxicology
GA CU0QW
UT WOS:000363224800003
PM 26375963
DA 2019-10-23
ER

PT J
AU Antczak, P
   White, TA
   Giri, A
   Michelangeli, F
   Viant, MR
   Cronin, MTD
   Vulpe, C
   Falciani, F
AF Antczak, Philipp
   White, Thomas A.
   Giri, Anirudha
   Michelangeli, Francesco
   Viant, Mark R.
   Cronin, Mark T. D.
   Vulpe, Chris
   Falciani, Francesco
TI Systems Biology Approach Reveals a Calcium-Dependent Mechanism for Basal
   Toxicity in Daphnia magna
SO ENVIRONMENTAL SCIENCE & TECHNOLOGY
LA English
DT Article
ID ENDOPLASMIC-RETICULUM; TUMOR PROMOTER; POLAR NARCOSIS; IDENTIFICATION;
   ECOTOXICOLOGY; THAPSIGARGIN; CYTOSCAPE; ALGORITHM; NETWORKS; DEATH
AB The expanding diversity and ever increasing amounts of man-made chemicals discharged to the environment pose largely unknown hazards to ecosystem and human health. The concept of adverse outcome pathways (AOPs) emerged as a comprehensive framework for risk assessment. However, the limited mechanistic information available for most chemicals and a lack of biological pathway annotation in many species represent significant challenges to effective implementation of this approach. Here, a systems level, multistep modeling strategy demonstrates how to integrate information on chemical structure with mechanistic insight from genomic studies, and phenotypic effects to define a putative adverse outcome pathway. Results indicated that transcriptional changes indicative of intracellular calcium mobilization were significantly overrepresented in Daphnia magna (DM) exposed to sublethal doses of presumed narcotic chemicals with log K-ow >= 1.8. Treatment of DM with a calcium ATPase pump inhibitor substantially recapitulated the common transcriptional changes. We hypothesize that calcium mobilization is a potential key molecular initiating event in DM basal (narcosis) toxicity. Heart beat rate analysis and metabolome analysis indicated sublethal effects consistent with perturbations of Calcium preceding overt acute toxicity. Together, the results indicate that altered calcium homeostasis may be a key early event in basal toxicity or narcosis induced by lipophilic compounds.
C1 [Antczak, Philipp; Falciani, Francesco] Univ Liverpool, Inst Integrat Biol, Ctr Computat Biol & Modelling, Liverpool L69 7ZB, Merseyside, England.
   [White, Thomas A.; Michelangeli, Francesco; Viant, Mark R.] Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England.
   [Giri, Anirudha] Assam Univ, Silchar 788011, India.
   [Cronin, Mark T. D.] Liverpool John Moores Univ, Sch Pharm & Chem, Liverpool L3 3AF, Merseyside, England.
   [Vulpe, Chris] Univ Calif Berkeley, Nutr Sci & Toxicol, Berkeley, CA 94720 USA.
RP Vulpe, C (reprint author), Univ Calif Berkeley, Nutr Sci & Toxicol, Berkeley, CA 94720 USA.
EM vulpe@berkeley.edu; ffalciani@liv.ac.uk
RI Antczak, Philipp/L-5879-2019; Viant, Mark/B-6339-2009
OI Antczak, Philipp/0000-0001-9600-7757; Viant, Mark/0000-0001-5898-4119;
   Vulpe, Chris/0000-0001-5134-8929
FU Natural Environment Research Council (NERC)NERC Natural Environment
   Research Council [NE/1028246/2]; NSFNational Science Foundation (NSF)
   [CBET-1066358]; Department of Biotechnology, Govt. of India under CREST
   programme; NERCNERC Natural Environment Research Council; Cefas seedcorn
   funding [DP247]; Natural Environment Research CouncilNERC Natural
   Environment Research Council [NE/I028246/2, NE/I028246/1]; National
   Centre for the Replacement, Refinement and Reduction of Animals in
   Research (NC3Rs) [G0800702/1]
FX This work was supported by a Natural Environment Research Council (NERC)
   Grant [NE/1028246/2] to F.F., a NSF (CBET-1066358) grant to C.V., by the
   Department of Biotechnology, Govt. of India under CREST programme to
   A.G., and support to T.W. by the NERC and Cefas seedcorn funding through
   project DP247.
CR Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Antczak P, 2013, ENVIRON SCI TECHNOL, V47, P11747, DOI 10.1021/es402819c
   Antczak P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012385
   Bemardi P, 1999, EUR J BIOCHEM, V264, P687
   Berridge MJ, 2002, CELL CALCIUM, V32, P235, DOI 10.1016/S0143416002001823
   Biales AD, 2013, ENVIRON SCI TECHNOL, V47, P1306, DOI 10.1021/es304274a
   BRADBURY SP, 1989, AQUATIC TOXICOLOGY H, V12, P59
   Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324
   Brostrom MA, 2003, CELL CALCIUM, V34, P345, DOI 10.1016/S0143-4160(03)00127-1
   Claeys L, 2013, ENVIRON TOXICOL CHEM, V32, P2217, DOI 10.1002/etc.2301
   Cui Q, 2008, NAT BIOTECHNOL, V26, P162, DOI 10.1038/nbt0208-162
   Dzialowski EM, 2006, ARCH ENVIRON CON TOX, V50, P503, DOI 10.1007/s00244-005-0121-9
   Ekins S, 2006, DRUG METAB DISPOS, V34, P495, DOI 10.1124/dmd.105.008458
   Escher BI, 2002, ENVIRON SCI TECHNOL, V36, P4201, DOI 10.1021/es015848h
   Fent K, 2011, AQUAT TOXICOL, V105, P25, DOI 10.1016/j.aquatox.2011.06.008
   Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211
   JACKSON TR, 1988, BIOCHEM J, V253, P81, DOI 10.1042/bj2530081
   Jacobson J, 2002, J CELL SCI, V115, P1175
   Kilham SS, 1998, HYDROBIOLOGIA, V377, P147, DOI 10.1023/A:1003231628456
   Lee E, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000217
   Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7
   MICHELANGELI F, 1991, ANAL BIOCHEM, V194, P231, DOI 10.1016/0003-2697(91)90223-G
   Morris JH, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-436
   Poynton HC, 2007, ENVIRON SCI TECHNOL, V41, P1044, DOI 10.1021/es0615573
   Qian T, 1999, TOXICOL APPL PHARM, V154, P117, DOI 10.1006/taap.1998.8580
   Roberts DW, 2003, QSAR COMB SCI, V22, P226, DOI 10.1002/qsar.200390016
   Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303
   Southam AD, 2011, ENVIRON SCI TECHNOL, V45, P3759, DOI 10.1021/es103814d
   Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102
   Sumpter JR, 2003, PURE APPL CHEM, V75, P2355, DOI 10.1351/pac200375112355
   Tetko IV, 2005, J COMPUT AID MOL DES, V19, P453, DOI 10.1007/s10822-005-8694-y
   THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466
   Trevino V, 2006, BIOINFORMATICS, V22, P1154, DOI 10.1093/bioinformatics/btl074
   Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498
   Verhaar HJM, 1996, J CHEMOMETR, V10, P149, DOI 10.1002/(SICI)1099-128X(199603)10:2<149::AID-CEM414>3.0.CO;2-F
   von der Ohe PC, 2005, CHEM RES TOXICOL, V18, P536, DOI 10.1021/tx0497954
   Williams TD, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002126
NR 37
TC 12
Z9 13
U1 1
U2 59
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0013-936X
EI 1520-5851
J9 ENVIRON SCI TECHNOL
JI Environ. Sci. Technol.
PD SEP 15
PY 2015
VL 49
IS 18
BP 11132
EP 11140
DI 10.1021/acs.est.5b02707
PG 9
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA CR5WT
UT WOS:000361415800045
PM 26244374
OA Green Accepted
DA 2019-10-23
ER

PT J
AU Eom, HJ
   Roca, CP
   Roh, JY
   Chatterjee, N
   Jeong, JS
   Shim, I
   Kim, HM
   Kim, PJ
   Choi, K
   Giralt, F
   Choi, J
AF Eom, Hyun-Jeong
   Roca, Carlos P.
   Roh, Ji-Yeon
   Chatterjee, Nivedita
   Jeong, Jae-Seong
   Shim, Ilseob
   Kim, Hyun-Mi
   Kim, Phil-Je
   Choi, Kyunghee
   Giralt, Francesc
   Choi, Jinhee
TI A systems toxicology approach on the mechanism of uptake and toxicity of
   MWCNT in Caenorhabditis elegans
SO CHEMICO-BIOLOGICAL INTERACTIONS
LA English
DT Article
DE Multiwall carbon nanotubes; Caenorhabditis elegans; Phagocytosis;
   Adverse outcome pathway; Systems toxicology
ID WALLED CARBON NANOTUBES; ASBESTOS-LIKE PATHOGENICITY; NF-KAPPA-B;
   C-ELEGANS; CELL-MIGRATION; IN-VIVO; NANOPARTICLE TOXICITY;
   ENDOPLASMIC-RETICULUM; SILVER NANOPARTICLES; QUALITY-CONTROL
AB The increased volumes of carbon nanotubes (CNTs) being utilized in industrial and biomedical processes carries with it an increased risk of unintentional release into the environment, requiring a thorough hazard and risk assessment. In this study, the toxicity of pristine and hydroxylated (OH-) multiwall CNTs (MWCNTs) was investigated in the nematode Caenorhabditis elegans using an integrated systems toxicology approach. To gain an insight into the toxic mechanism of MWCNTs, microarray and proteomics were conducted for C. elegans followed by pathway analyses. The results of pathway analyses suggested endocytosis, phagocytosis, oxidative stress and endoplasmic reticulum (ER) stress, as potential mechanisms of uptake and toxicity, which were subsequently investigated using loss-of-function mutants of genes of those pathways. The expression of phagocytosis related genes (i.e. ced-10 and rab-7) were significantly increased upon exposure to OH-MWCNT, concomitantly with the rescued toxicity by loss-of-function mutants of those genes, such as ced-10(n3246) and rab-7(ok511). An increased sensitivity of the hsp-4(gk514) mutant by OH-MWCNT, along with a decreased expression of hsp-4 at both gene and protein level suggests that MWCNTs may affect ER stress response in C elegans. Collectively, the results implied phagocytosis to be a potential mechanism of uptake of MWCNTs, and ER and oxidative stress as potential mechanisms of toxicity. The integrated systems toxicology approach applied in this study provided a comprehensive insight into the toxic mechanism of MWCNTs in C elegans, which may eventually be used to develop an "Adverse Outcome Pathway (AOP)", a recently introduced concept as a conceptual framework to link molecular level responses to higher level effects. (C) 2015 Elsevier Ireland Ltd. All rights reserved.
C1 [Eom, Hyun-Jeong; Roh, Ji-Yeon; Chatterjee, Nivedita; Jeong, Jae-Seong; Choi, Jinhee] Univ Seoul, Grad Sch Energy & Environm Syst Engn, Sch Environm Engn, Seoul 130743, South Korea.
   [Roca, Carlos P.; Giralt, Francesc] Univ Rovira & Virgili, Dept Engn Quim, E-43007 Tarragona, Catalunya, Spain.
   [Shim, Ilseob; Kim, Hyun-Mi; Kim, Phil-Je; Choi, Kyunghee] Natl Inst Environm Res, Risk Assessment Div, Inchon 404708, South Korea.
RP Choi, J (reprint author), Univ Seoul, Grad Sch Energy & Environm Syst Engn, Sch Environm Engn, Seoul 130743, South Korea.
EM jinhchoi@uos.ac.kr
RI Roca, Carlos P./F-3846-2014
OI Roca, Carlos P./0000-0003-0230-1926; Chatterjee,
   Nivedita/0000-0002-6080-4495
FU Mid-career Researcher Program through the National Research Foundation
   of Korea (NRF) - Ministry of Science, ICT and Future Planning
   [2013R1A2A2A03010980]; Korean Ministry of Environment through National
   Institute of Environmental Science (NIER); Korean Ministry of
   Environment through "Environmental Health RD Program" [2012001370009];
   EU FP7 project MODERN [309314-2]; NIH Office of Research Infrastructure
   Programs [P40 OD010440]
FX This work was supported by Mid-career Researcher Program through the
   National Research Foundation of Korea (NRF) funded by the Ministry of
   Science, ICT and Future Planning (2013R1A2A2A03010980) and also by a
   grant from the Korean Ministry of Environment through National Institute
   of Environmental Science (NIER) and through "Environmental Health R&D
   Program" (2012001370009). C.P. Roca and F. Giralt acknowledge support
   from the EU FP7 project MODERN, Contract No. 309314-2. The authors thank
   to Prof Robert Rallo at Universitat Rovira i Virgili for his kind
   reading of the manuscript. Wildtype (N2) and mutant strains (described
   in Table S2) were provided by the CGC, which is funded by NIH Office of
   Research Infrastructure Programs (P40 OD010440).
CR Agola JO, 2012, ACS CHEM BIOL, V7, P1095, DOI 10.1021/cb3001099
   Albini A, 2010, NANOMED-NANOTECHNOL, V6, P277, DOI 10.1016/j.nano.2009.08.001
   Ali-Boucetta H, 2013, ANGEW CHEM INT EDIT, V52, P2274, DOI 10.1002/anie.201207664
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Azad N, 2013, NANOTOXICOLOGY, V7, P157, DOI 10.3109/17435390.2011.647929
   Cai D, 2005, NAT METHODS, V2, P449, DOI 10.1038/NMETH761
   Chen PH, 2013, BIOMATERIALS, V34, P5661, DOI 10.1016/j.biomaterials.2013.03.093
   Cheng JP, 2007, ENVIRON TOXICOL CHEM, V26, P708, DOI 10.1897/06-272R.1
   Cherukuri P, 2004, J AM CHEM SOC, V126, P15638, DOI 10.1021/ja0466311
   Choi BK, 2003, MOL CELL PROTEOMICS, V2, P1086, DOI 10.1074/mcp.M300036-MCP200
   Choi J, 2014, ENVIRON CHEM, V11, P227, DOI 10.1071/EN13187
   Donaldson K, 2013, ADV DRUG DELIVER REV, V65, P2078, DOI 10.1016/j.addr.2013.07.014
   Donaldson K, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-5
   Du J, 2013, ENVIRON TOXICOL PHAR, V36, P451, DOI 10.1016/j.etap.2013.05.007
   Galloway T, 2010, ENVIRON POLLUT, V158, P1748, DOI 10.1016/j.envpol.2009.11.013
   Gass MH, 2006, NANO LETT, V6, P376, DOI 10.1021/nl521020g
   Grant B, 1999, MOL BIOL CELL, V10, P4311, DOI 10.1091/mbc.10.12.4311
   Grant B, 2001, NAT CELL BIOL, V3, P573, DOI 10.1038/35078549
   Guo Jian, 2011, Beijing Da Xue Xue Bao Yi Xue Ban, V43, P342
   He XQ, 2011, CHEM RES TOXICOL, V24, P2237, DOI 10.1021/tx200351d
   Hegde PS, 2003, CURR OPIN BIOTECH, V14, P647, DOI 10.1016/j.copbio.2003.10.006
   Hsieh WY, 2012, AM J RESP CELL MOL, V46, P257, DOI 10.1165/rcmb.2011-0010OC
   Irazoqui JE, 2010, NAT REV IMMUNOL, V10, P47, DOI 10.1038/nri2689
   Jain KK, 2012, EXPERT OPIN DRUG DIS, V7, P1029, DOI 10.1517/17460441.2012.722078
   Jin H, 2008, NANO LETT, V8, P1577, DOI 10.1021/nl072969s
   Kaletta T, 2006, NAT REV DRUG DISCOV, V5, P387, DOI 10.1038/nrd2031
   Kam NWS, 2004, J AM CHEM SOC, V126, P6850, DOI 10.1021/ja0486059
   Kam NWS, 2005, J AM CHEM SOC, V127, P6021, DOI 10.1021/ja050062v
   Kirkegaard T, 2010, NATURE, V463, P549, DOI 10.1038/nature08710
   Klaper R, 2010, AQUAT TOXICOL, V100, P211, DOI 10.1016/j.aquatox.2010.07.023
   Kostarelos K, 2007, NAT NANOTECHNOL, V2, P108, DOI 10.1038/nnano.2006.209
   Kostova Z, 2003, EMBO J, V22, P2309, DOI 10.1093/emboj/cdg227
   Koumenis C, 2006, CURR MOL MED, V6, P55, DOI 10.2174/156652406775574604
   Lant B, 2010, INT J BIOL SCI, V6, P9
   Leung MCK, 2010, TOXICOL SCI, V118, P444, DOI 10.1093/toxsci/kfq295
   Li RB, 2013, ACS NANO, V7, P2352, DOI 10.1021/nn305567s
   Li XM, 2012, J NANOMATER, DOI 10.1155/2012/548389
   Ma C, 2008, CARBON, V46, P706, DOI 10.1016/j.carbon.2008.01.019
   Mambula SS, 2006, J IMMUNOL, V177, P7849, DOI 10.4049/jimmunol.177.11.7849
   Mouchet F, 2010, NANOMEDICINE-UK, V5, P963, DOI [10.2217/nnm.10.60, 10.2217/NNM.10.60]
   Nunez C, 2006, J BACTERIOL, V188, P2792, DOI 10.1128/JB.188.8.2792-2800.2006
   Peynshaert K, 2014, CHEM REV, V114, P7581, DOI 10.1021/cr400372p
   Pillai S, 2014, P NATL ACAD SCI USA, V111, P3490, DOI 10.1073/pnas.1319388111
   Poland CA, 2008, NAT NANOTECHNOL, V3, P423, DOI 10.1038/nnano.2008.111
   Polla BS, 2007, IMMUNOLOGY, V120, P230, DOI 10.1111/j.1365-2567.2006.02494.x
   Pondman KM, 2014, NANOMED-NANOTECHNOL, V10, P1287, DOI 10.1016/j.nano.2014.02.010
   Reddien PW, 2000, NAT CELL BIOL, V2, P131
   Reddy ARN, 2010, TOXICOL MECH METHOD, V20, P267, DOI 10.3109/15376516.2010.484077
   Roh JY, 2009, ENVIRON SCI TECHNOL, V43, P3933, DOI 10.1021/es803477u
   Schnorr JM, 2011, CHEM MATER, V23, P646, DOI 10.1021/cm102406h
   Schwartz SL, 2007, J CELL SCI, V120, P3905, DOI 10.1242/jcs.015909
   Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239
   Srivastava RK, 2011, NANOTOXICOLOGY, V5, P195, DOI 10.3109/17435390.2010.503944
   Sun Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021073
   Tasis D, 2006, CHEM REV, V106, P1105, DOI 10.1021/cr050569o
   Taylor U, 2012, ADV EXP MED BIOL, V733, P125, DOI 10.1007/978-94-007-2555-3_12
   Taylor U, 2014, NANOTOXICOLOGY, V8, P118, DOI 10.3109/17435390.2013.859321
   Tiedemann D, 2014, ANALYST, V139, P931, DOI 10.1039/c3an01463k
   Tsyusko OV, 2012, ENVIRON SCI TECHNOL, V46, P4115, DOI 10.1021/es2033108
   Vardharajula S, 2012, INT J NANOMED, V7, P5361, DOI 10.2147/IJN.S35832
   Wang XC, 2003, SCIENCE, V302, P1563, DOI 10.1126/science.1087641
   Wang X, 2012, TOXICOL IN VITRO, V26, P799, DOI 10.1016/j.tiv.2012.05.010
   Wang XW, 2006, P NATL ACAD SCI USA, V103, P4204, DOI 10.1073/pnas.0507044103
   Wu HC, 2010, J MATER CHEM, V20, P1036, DOI 10.1039/b911099m
   Wu YC, 2001, DEV CELL, V1, P491, DOI 10.1016/S1534-5807(01)00056-9
   Wu YC, 1998, NATURE, V392, P501, DOI 10.1038/33163
   Ye SF, 2009, BIOCHEM BIOPH RES CO, V379, P643, DOI 10.1016/j.bbrc.2008.12.137
   Yu XM, 2008, PLOS BIOL, V6, P581, DOI 10.1371/journal.pbio.0060061
   Yu XM, 2006, DEV CELL, V10, P743, DOI 10.1016/j.devcel.2006.04.007
   Zhang R, 2012, INT J BIOCHEM CELL B, V44, P224, DOI 10.1016/j.biocel.2011.10.019
   Zhang XY, 2011, J NANOPART RES, V13, P6941, DOI 10.1007/s11051-011-0603-9
   Zhang YH, 2001, MOL BIOL CELL, V12, P2011, DOI 10.1091/mbc.12.7.2011
   Zhao XC, 2012, ENVIRON INT, V40, P244, DOI 10.1016/j.envint.2011.12.003
   Zhao YL, 2014, NANOSCALE, V6, P4275, DOI 10.1039/c3nr06784j
   Zhao YL, 2013, RSC ADV, V3, P5741, DOI 10.1039/c2ra22798c
NR 75
TC 18
Z9 19
U1 4
U2 47
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0009-2797
EI 1872-7786
J9 CHEM-BIOL INTERACT
JI Chem.-Biol. Interact.
PD SEP 5
PY 2015
VL 239
BP 153
EP 163
DI 10.1016/j.cbi.2015.06.031
PG 11
WC Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Toxicology
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Toxicology
GA CR5SZ
UT WOS:000361405600017
PM 26111764
DA 2019-10-23
ER

PT J
AU Pleil, JD
   Beauchamp, JD
   Miekisch, W
   Funk, WE
AF Pleil, Joachim D.
   Beauchamp, Jonathan D.
   Miekisch, Wolfram
   Funk, William E.
TI Adapting biomarker technologies to adverse outcome pathways (AOPs)
   research: current thoughts on using in vivo discovery for developing in
   vitro target methods
SO JOURNAL OF BREATH RESEARCH
LA English
DT Article
DE toxicity testing; breath analysis; molecular initiating event
ID ADDUCTS
C1 [Pleil, Joachim D.] US EPA, Natl Exposure Res Lab, Off Res & Dev, Res Triangle Pk, NC 27711 USA.
   [Beauchamp, Jonathan D.] Fraunhofer IVV, Dept Sensory Analyt, D-85354 Freising Weihenstephan, Germany.
   [Miekisch, Wolfram] Univ Med Ctr Rostock, Dept Anaesthesia & Intens Care Med, Rostock, Germany.
   [Funk, William E.] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA.
RP Pleil, JD (reprint author), US EPA, Natl Exposure Res Lab, Off Res & Dev, Res Triangle Pk, NC 27711 USA.
EM pleil.joachim@epa.gov; jonathan.beauchamp@ivv.fraunhofer.de;
   wolfram.miekisch@uni-rostock.de; w-funk@northwestern.edu
RI Miekisch, Wolfram/I-1300-2019; Beauchamp, Jonathan/J-6914-2014
OI Beauchamp, Jonathan/0000-0003-1405-7625; Miekisch,
   Wolfram/0000-0003-1619-0315
CR Adeleye Y, 2015, TOXICOLOGY, V332, P102, DOI 10.1016/j.tox.2014.02.007
   Angrish MM, 2015, CHEM RES TOXICOL, V28, P551, DOI 10.1021/acs.chemrestox.5b00024
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Bailey KA, 2014, TOXICOL SCI, V139, P328, DOI 10.1093/toxsci/kfu053
   Bean HD, 2015, BIOMARKERS, V20, P1, DOI 10.3109/1354750X.2014.985254
   Beauchamp J, 2013, MEAS SCI TECHNOL, V24, DOI 10.1088/0957-0233/24/12/125003
   Beauchamp J, 2011, J BREATH RES, V5, DOI 10.1088/1752-7155/5/3/037103
   Beauchamp J D, 2015, BIOMARKER VALIDATION
   Beauchamp J, 2008, J BREATH RES, V2, DOI 10.1088/1752-7155/2/4/046001
   Bergmann A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123980
   Costello BD, 2014, J BREATH RES, V8, DOI 10.1088/1752-7155/8/1/014001
   Cristescu S, 2014, AJP LUNG, V307
   EPA, 2014, SCI ACT CHEM SAF RES
   Funk WE, 2008, CANCER EPIDEM BIOMAR, V17, P1896, DOI 10.1158/1055-9965.EPI-08-0356
   Funk WE, 2010, ANAL BIOCHEM, V400, P61, DOI 10.1016/j.ab.2010.01.006
   Ghimenti S, 2013, J BREATH RES, V7
   Herbig J, 2008, J BREATH RES, V2, DOI 10.1088/1752-7155/2/3/037008
   Judson RS, 2011, CHEM RES TOXICOL, V24, P451, DOI 10.1021/tx100428e
   Kamysek S, 2011, ANAL BIOANAL CHEM, V401, P2093, DOI 10.1007/s00216-011-5099-8
   Kischkel S, 2010, CLIN CHIM ACTA, V411, P1637, DOI 10.1016/j.cca.2010.06.005
   Miekisch W, 2014, BIOANALYSIS, V6, P1275, DOI 10.4155/bio.14.86
   OECD, 2013, ORG EC COOP DEV ADV
   Pleil J D, 2012, TOXICOL LETT
   Pleil J D, 2012, J BREATH RES, V6, P201
   Pleil JD, 2014, J BREATH RES, V8, DOI 10.1088/1752-7155/8/2/029001
   Pleil JD, 2013, ANAL CHEM, V85, P9984, DOI 10.1021/ac402306f
   Pleil JD, 2013, J BREATH RES, V7, DOI 10.1088/1752-7155/7/2/029001
   Pleil JD, 2013, J BREATH RES, V7, DOI 10.1088/1752-7155/7/1/017107
   Pleil Joachim D, 2011, J Breath Res, V5, P029001, DOI 10.1088/1752-7155/5/2/029001
   Pleil Joachim D, 2010, J Breath Res, V4, P029001, DOI 10.1088/1752-7155/4/2/029001
   Rappaport SM, 2012, TOXICOL LETT, V213, P83, DOI 10.1016/j.toxlet.2011.04.002
   Risby TH, 2010, OPT ENG, V49, DOI 10.1117/1.3498768
   Smith D, 2014, J BREATH RES, V8, DOI 10.1088/1752-7155/8/2/027101
   Spacek L A, 2015, BIOMARKERS IN PRESS
   Tittel FK, 2012, PROC SPIE, V8223, DOI 10.1117/12.912273
   Trefz P, 2013, ANAL CHEM, V85, P10321, DOI 10.1021/ac402298v
   Trefz P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076868
   Villeneuve DL, 2014, TOXICOL SCI, V142, P312, DOI 10.1093/toxsci/kfu199
NR 38
TC 13
Z9 13
U1 2
U2 11
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1752-7155
EI 1752-7163
J9 J BREATH RES
JI J. Breath Res.
PD SEP
PY 2015
VL 9
IS 3
AR 039001
DI 10.1088/1752-7155/9/3/039001
PG 6
WC Biochemical Research Methods; Respiratory System
SC Biochemistry & Molecular Biology; Respiratory System
GA CW1YY
UT WOS:000364789300014
PM 26173025
DA 2019-10-23
ER

PT J
AU Scholz, S
AF Scholz, Stefan
TI In Response: Quantitative adverse outcome pathways for prediction of
   adverse effects-An academic perspective
SO ENVIRONMENTAL TOXICOLOGY AND CHEMISTRY
LA English
DT Editorial Material
ID CONCEPTUAL-FRAMEWORK; RISK-ASSESSMENT; ECOTOXICOLOGY; TOXICITY; MODEL
C1 UFZ, Helmholtz Ctr Environm Res, Dept Bioanalyt Ecotoxicol, Leipzig, Germany.
RP Scholz, S (reprint author), UFZ, Helmholtz Ctr Environm Res, Dept Bioanalyt Ecotoxicol, Leipzig, Germany.
RI Scholz, Stefan/B-7776-2014
OI Scholz, Stefan/0000-0002-6990-4716
CR Abbas R, 1997, TOXICOL APPL PHARM, V145, P192, DOI 10.1006/taap.1997.8168
   Altenburger R, 2015, SCI TOTAL ENVIRON, V512, P540, DOI 10.1016/j.scitotenv.2014.12.057
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Forbes VE, 2006, ENVIRON TOXICOL CHEM, V25, P272, DOI 10.1897/05-257R.1
   Kretschmann A, 2012, ENVIRON TOXICOL CHEM, V31, P2014, DOI 10.1002/etc.1905
   Leist M, 2008, ALTEX-ALTERN TIEREXP, V25, P103
   MacKay C, 2013, ALTEX-ALTERN ANIM EX, V30, P473, DOI 10.14573/altex.2013.4.473
   Perkins EJ, 2013, ENVIRON HEALTH PERSP, V121, P1002, DOI 10.1289/ehp.1306638
   Phillips MB, 2016, ENVIRON HEALTH PERSP, V124, P53, DOI 10.1289/ehp.1409450
   Russom CL, 2014, ENVIRON TOXICOL CHEM, V33, P2157, DOI 10.1002/etc.2662
   Schultz TW, 2006, SAR QSAR ENVIRON RES, V17, P413, DOI 10.1080/10629360600884371
   Segner H, 2007, NATO SCI PEACE SECUR, P39, DOI 10.1007/978-1-4020-6335-0_4
NR 12
TC 2
Z9 2
U1 2
U2 20
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0730-7268
EI 1552-8618
J9 ENVIRON TOXICOL CHEM
JI Environ. Toxicol. Chem.
PD SEP
PY 2015
VL 34
IS 9
BP 1935
EP 1937
DI 10.1002/etc.3043
PG 3
WC Environmental Sciences; Toxicology
SC Environmental Sciences & Ecology; Toxicology
GA CQ3KJ
UT WOS:000360500600001
PM 26313028
DA 2019-10-23
ER

PT J
AU Wheeler, JR
   Weltje, L
AF Wheeler, James R.
   Weltje, Lennart
TI In response: Adverse outcome pathways-An industry perspective
SO ENVIRONMENTAL TOXICOLOGY AND CHEMISTRY
LA English
DT Editorial Material
C1 [Wheeler, James R.] Dow AgroSci, Abingdon, Oxon, England.
   [Weltje, Lennart] BASF SE, Limburgerhof, Germany.
RP Wheeler, JR (reprint author), Dow AgroSci, Abingdon, Oxon, England.
OI Weltje, Lennart/0000-0002-5191-4158
CR Allen JW, 2006, TOXICOL PATHOL, V34, P853, DOI 10.1080/01926230601047816
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Ankley GT, 2009, AQUAT TOXICOL, V92, P168, DOI 10.1016/j.aquatox.2009.01.013
   Bogen K, 1994, RISK ANAL, V14, P477
   Ferreira D, 2010, CHEMOSPHERE, V79, P914, DOI 10.1016/j.chemosphere.2010.03.024
   Kramer VJ, 2011, ENVIRON TOXICOL CHEM, V30, P64, DOI 10.1002/etc.375
   Stadnicka-Michalak J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092303
   U. S. Environmental Protection Agency (U. S. EPA), 2014, END DISR SCREEN PROG
   Wheeler JR, 2005, TOXICOL MECH METHOD, V15, P293, DOI 10.1080/15376520590968789
NR 9
TC 5
Z9 5
U1 0
U2 8
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0730-7268
EI 1552-8618
J9 ENVIRON TOXICOL CHEM
JI Environ. Toxicol. Chem.
PD SEP
PY 2015
VL 34
IS 9
BP 1937
EP 1938
DI 10.1002/etc.3044
PG 2
WC Environmental Sciences; Toxicology
SC Environmental Sciences & Ecology; Toxicology
GA CQ3KJ
UT WOS:000360500600002
PM 26313030
DA 2019-10-23
ER

PT J
AU Villeneuve, DL
AF Villeneuve, Daniel L.
TI In Response: The path forward for the adverse outcome pathway
   framework-A regulatory perspective
SO ENVIRONMENTAL TOXICOLOGY AND CHEMISTRY
LA English
DT Editorial Material
C1 US EPA, Mid Continent Ecol Div, Duluth, MN 55804 USA.
RP Villeneuve, DL (reprint author), US EPA, Mid Continent Ecol Div, Duluth, MN 55804 USA.
CR Ankley GT, 2015, TOXICOL SCI, V144, P259, DOI 10.1093/toxsci/kfu320
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Krewski D, 2010, J TOXICOL ENV HEAL B, V13, P51, DOI 10.1080/10937404.2010.483176
   Meek ME, 2014, J APPL TOXICOL, V34, P1, DOI 10.1002/jat.2949
   Organisation for Economic Co-operation and Development, 2015, ADV OUTC PATHW KNOWL
   Organisation for Economic Co-operation and Development, 2013, SER TEST ASS, V184
   Organisation for Economic Cooperation and Development, 2015, ADV OUTC PATHW MOL S
   US Environmental Protection Agency, 2015, COMP TOX RES COMPTOX
   Villeneuve DL, 2014, TOXICOL SCI, V142, P312, DOI 10.1093/toxsci/kfu199
   Villeneuve DL, 2014, TOXICOL SCI, V142, P321, DOI 10.1093/toxsci/kfu200
NR 10
TC 2
Z9 2
U1 0
U2 5
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0730-7268
EI 1552-8618
J9 ENVIRON TOXICOL CHEM
JI Environ. Toxicol. Chem.
PD SEP
PY 2015
VL 34
IS 9
BP 1938
EP 1940
DI 10.1002/etc.3045
PG 3
WC Environmental Sciences; Toxicology
SC Environmental Sciences & Ecology; Toxicology
GA CQ3KJ
UT WOS:000360500600003
PM 26313031
DA 2019-10-23
ER

PT J
AU Smetanova, S
   Riedl, J
   Zitzkat, D
   Altenburger, R
   Busch, W
AF Smetanova, Sona
   Riedl, Janet
   Zitzkat, Dimitar
   Altenburger, Rolf
   Busch, Wibke
TI High-throughput concentration-response analysis for omics datasets
SO ENVIRONMENTAL TOXICOLOGY AND CHEMISTRY
LA English
DT Article
DE Ecotoxicogenomics; Biostatistics; Dose-response modeling; Mixture
   toxicity; Zebrafish embryo; Myriophyllum
ID RISK-ASSESSMENT; GENE-EXPRESSION; TOXICITY; MICROPOLLUTANTS; HORMESIS;
   EMBRYO
AB Omics-based methods are increasingly used in current ecotoxicology. Therefore, a large number of observations for various toxic substances and organisms are available and may be used for identifying modes of action, adverse outcome pathways, or novel biomarkers. For these purposes, good statistical analysis of toxicogenomic data is vital. In contrast to established ecotoxicological techniques, concentration-response modeling is rarely used for large datasets. Instead, statistical hypothesis testing is prevalent, which provides only a limited scope for inference. The present study therefore applied automated concentration-response modeling for 3 different ecotoxicotranscriptomic and ecotoxicometabolomic datasets. The modeling process was performed by simultaneously applying 9 different regression models, representing distinct mechanistic, toxicological, and statistical ideas that result in different curve shapes. The best-fitting models were selected by using Akaike's information criterion. The linear and exponential models represented the best data description for more than 50% of responses. Models generating U-shaped curves were frequently selected for transcriptomic signals (30%), and sigmoid models were identified as best fit for many metabolomic signals (21%). Thus, selecting the models from an array of different types seems appropriate, because concentration-response functions may vary because of the observed response type, and they also depend on the compound, the organism, and the investigated concentration and exposure duration range. The application of concentration-response models can help to further tap the potential of omics data and is a necessary step for quantitative mixture effect assessment at the molecular response level. Environ Toxicol Chem 2015;34:2167-2180. (c) 2015 SETAC
C1 [Smetanova, Sona] Masaryk Univ, Fac Sci, Res Ctr Tox Cpds Environm RECETOX, CS-61137 Brno, Czech Republic.
   [Smetanova, Sona; Riedl, Janet; Zitzkat, Dimitar; Altenburger, Rolf; Busch, Wibke] Dept Bioanalyt Ecotoxicol, UFZ Helmholtz Ctr Environm Res, Leipzig, Germany.
RP Altenburger, R (reprint author), UFZ Helmholtz Ctr Environm Res, Dept Bioanalyt Ecotoxicol, Leipzig, Germany.
EM rolf.altenburger@ufz.de
RI Busch, Wibke/I-9348-2012; Smetanova, Sona/L-2252-2013
OI Busch, Wibke/0000-0002-5497-6266; 
FU DBU (Deutsche Bundesstiftung Umwelt) Scholarship Program [AZ 30013/436];
   CEE Countries; Czech Ministry of EducationMinistry of Education, Youth &
   Sports - Czech Republic [L01214]; HGF program topic CITE (Chemicals in
   the Environment); EU-FP7 collaborative project SOLUTIONS [603437]
FX This research was supported by the DBU (Deutsche Bundesstiftung Umwelt)
   Scholarship Program (AZ 30013/436) with CEE Countries and supported by
   the Czech Ministry of Education (L01214). The present study was also
   supported through the HGF program topic CITE (Chemicals in the
   Environment) and the EU-FP7 collaborative project SOLUTIONS (grant
   agreement no. 603437). We thank T. Luckenbach and S. Scholz for valuable
   comments on the draft manuscript.
CR Aggarwal C.C., 2013, OUTLIER ANAL, DOI [10.1007/978-1-4614-6396-2, DOI 10.1007/978-1-4614-6396-2]
   Agilent Technologies, 2015, EARR
   AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705
   Altenburger R, 2003, PAHS ECOTOXICOLOGICA, P297, DOI 10.1002/0470867132.CH16
   Altenburger R, 2013, ENVIRON TOXICOL CHEM, V32, P1685, DOI 10.1002/etc.2294
   Altenburger R, 2012, ENVIRON SCI TECHNOL, V46, P2508, DOI 10.1021/es2038036
   Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003
   Bates DM, 1988, NONLINEAR REGRESSION
   Belz RG, 2008, SCI TOTAL ENVIRON, V404, P77, DOI 10.1016/j.scitotenv.2008.06.008
   Belz RG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033432
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289
   Benson WH, 2007, ENVIRON MOL MUTAGEN, V48, P359, DOI 10.1002/em.20302
   Bornkamp B, 2014, R PACK VER 0 9 11
   Burgoon LD, 2008, TOXICOL SCI, V104, P412, DOI 10.1093/toxsci/kfn083
   Calabrese EJ, 2005, ENVIRON POLLUT, V138, P378, DOI 10.1016/j.envpol.2004.10.001
   Calabrese EJ, 2001, TOXICOL SCI, V62, P330, DOI 10.1093/toxsci/62.2.330
   Calzolai L, 2007, COMP BIOCHEM PHYS D, V2, P245, DOI 10.1016/j.cbd.2007.04.007
   Chongsuvivatwong V, 2012, R PACK VERS 2 15 1 0
   Denslow ND, 2007, MOL BIOSYST, V3, P172, DOI 10.1039/b612802p
   Ding W, 2011, HDB RES COMPUTATIONA, P79
   Escher BI, 2014, ENVIRON SCI TECHNOL, V48, P1940, DOI 10.1021/es403899t
   Gou N, 2011, ENVIRON SCI TECHNOL, V45, P5410, DOI 10.1021/es200455p
   Gundel U, 2012, ECOTOX ENVIRON SAFE, V76, P11, DOI 10.1016/j.ecoenv.2011.10.010
   Hermsen SAB, 2013, TOXICOL APPL PHARM, V272, P161, DOI 10.1016/j.taap.2013.05.037
   Hermsen SAB, 2012, TOXICOL SCI, V127, P303, DOI 10.1093/toxsci/kfs092
   Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425
   Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211
   Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923
   Hummel J, 2010, METABOLOMICS, V6, P322, DOI 10.1007/s11306-010-0198-7
   Kefford BJ, 2008, ENVIRON POLLUT, V151, P516, DOI 10.1016/j.envpol.2007.04.019
   KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302
   Kluender C, 2009, METABOLOMICS, V5, P59, DOI 10.1007/s11306-008-0139-x
   Kopec AK, 2010, TOXICOL SCI, V118, P286, DOI 10.1093/toxsci/kfq236
   Lemos MFL, 2010, PROTEOMICS, V10, P873, DOI 10.1002/pmic.200900470
   Maletzki Dirk, 2010, Umweltwissenschaften und Schadstoff-Forschung, V22, P702, DOI 10.1007/s12302-010-0171-0
   Myung IJ, 2003, J MATH PSYCHOL, V47, P90, DOI 10.1016/S0022-2496(02)00028-7
   National Center for Biotechnology Information, 2015, GENE EXPRESSION OMNI
   OECD, 2006, OECD SER TEST ASS, V54, P1
   Pillai S, 2014, P NATL ACAD SCI USA, V111, P3490, DOI 10.1073/pnas.1319388111
   Riedl J, 2012, AQUAT BOT, V102, P34, DOI 10.1016/j.aquabot.2012.03.017
   Ritz C, 2005, J STAT SOFTW, V12, P1
   Ritz C, 2010, ENVIRON TOXICOL CHEM, V29, P220, DOI 10.1002/etc.7
   Sans-Piche F, 2010, MAR ENVIRON RES, V69, pS28, DOI 10.1016/j.marenvres.2009.12.004
   Scholze M, 2001, ENVIRON TOXICOL CHEM, V20, P448, DOI 10.1002/etc.5620200228
   Schwarzenbach RP, 2006, SCIENCE, V313, P1072, DOI 10.1126/science.1127291
   Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y
   Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23
   Thomas RS, 2007, TOXICOL SCI, V98, P240, DOI 10.1093/toxsci/kfm092
   Thomas RS, 2013, TOXICOL SCI, V136, P4, DOI 10.1093/toxsci/kft178
   Thomas RS, 2012, MUTAT RES-GEN TOX EN, V746, P135, DOI 10.1016/j.mrgentox.2012.01.007
   Yang LL, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-387
NR 51
TC 8
Z9 9
U1 5
U2 55
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0730-7268
EI 1552-8618
J9 ENVIRON TOXICOL CHEM
JI Environ. Toxicol. Chem.
PD SEP
PY 2015
VL 34
IS 9
BP 2167
EP 2180
DI 10.1002/etc.3025
PG 14
WC Environmental Sciences; Toxicology
SC Environmental Sciences & Ecology; Toxicology
GA CQ3KJ
UT WOS:000360500600031
PM 25900799
DA 2019-10-23
ER

PT J
AU Buckley, B
   Farraj, A
AF Buckley, Barbara
   Farraj, Aimen
TI Conceptual model for assessing criteria air pollutants in a
   multipollutant context: A modified adverse outcome pathway approach
SO TOXICOLOGY
LA English
DT Review
DE Air pollution; Criteria pollutants; Multipollutant; Adverse outcome
   pathway
ID NITROGEN-DIOXIDE EXPOSURE; SHORT-TERM EXPOSURE; OZONE EXPOSURE;
   PARTICULATE MATTER; VASCULAR FUNCTION; BRONCHIAL REACTIVITY; ENDOTHELIAL
   FUNCTION; POLLUTION EXPOSURE; ASTHMATIC SUBJECTS; INHALED ALLERGEN
AB Air pollution consists of a complex mixture of particulate and gaseous components. Individual criteria and other hazardous air pollutants have been linked to adverse respiratory and cardiovascular health outcomes. However, assessing risk of air pollutant mixtures is difficult since components are present in different combinations and concentrations in ambient air. Recent mechanistic studies have limited utility because of the inability to link measured changes to adverse outcomes that are relevant to risk assessment. New approaches are needed to address this challenge. The purpose of this manuscript is to describe a conceptual model, based on the adverse outcome pathway approach, which connects initiating events at the cellular and molecular level to population-wide impacts. This may facilitate hazard assessment of air pollution mixtures. In the case reports presented here, airway hyperresponsiveness and endothelial dysfunction are measurable endpoints that serve to integrate the effects of individual criteria air pollutants found in inhaled mixtures. This approach incorporates information from experimental and observational studies into a sequential series of higher order effects.
   The proposed model has the potential to facilitate multipollutant risk assessment by providing a framework that can be used to converge the effects of air pollutants in light of common underlying mechanisms. This approach may provide a ready-to-use tool to facilitate evaluation of health effects resulting from exposure to air pollution mixtures. Published by Elsevier Ireland Ltd.
C1 [Buckley, Barbara] US EPA, Natl Ctr Environm Assessment, Off Res & Dev, Res Triangle Pk, NC 27711 USA.
   [Farraj, Aimen] US EPA, Natl Hlth & Environm Effects Res Lab, Off Res & Dev, Res Triangle Pk, NC 27711 USA.
RP Buckley, B (reprint author), 109 TW Alexander Dr,Mail Code B243-01, Res Triangle Pk, NC 27711 USA.
EM buckley.barbara@epa.gov
CR Alexis NE, 2010, INHAL TOXICOL, V22, P593, DOI 10.3109/08958371003596587
   Anderson JT, 2011, FREE RADICAL BIO MED, V50, P1679, DOI 10.1016/j.freeradbiomed.2011.03.015
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   ARIS RM, 1993, AM REV RESPIR DIS, V148, P1363, DOI 10.1164/ajrccm/148.5.1363
   Barath S, 2013, TOXICOL SCI, V135, P292, DOI 10.1093/toxsci/kft157
   Barck C, 2002, RESP MED, V96, P907, DOI 10.1053/rmed.2002.1374
   Batalha JRF, 2002, ENVIRON HEALTH PERSP, V110, P1191, DOI 10.1289/ehp.021101191
   BECKETT WS, 1985, J APPL PHYSIOL, V59, P1879
   Bevelander M, 2007, J IMMUNOL, V179, P3680, DOI 10.4049/jimmunol.179.6.3680
   Bosson J, 2003, CLIN EXP ALLERGY, V33, P777, DOI 10.1046/j.1365-2222.2003.01662.x
   Brauner EV, 2008, PART FIBRE TOXICOL, V5, DOI 10.1186/1743-8977-5-13
   Briet M, 2007, HYPERTENSION, V50, P970, DOI 10.1161/HYPERTENSIONAHA.107.095844
   Brook RD, 2002, CIRCULATION, V105, P1534, DOI 10.1161/01.CIR.0000013838.94747.64
   Brook RD, 2012, J AM COLL CARDIOL, V60, P2167, DOI 10.1016/j.jacc.2012.08.974
   Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1
   Brook RD, 2009, HYPERTENSION, V54, P659, DOI 10.1161/HYPERTENSIONAHA.109.130237
   Busse WW, 2010, CHEST, V138, p4S, DOI 10.1378/chest.10-0100
   Chuang GC, 2009, AM J PHYSIOL-LUNG C, V297, pL209, DOI 10.1152/ajplung.00102.2009
   Ckless K, 2011, BBA-GEN SUBJECTS, V1810, P1025, DOI 10.1016/j.bbagen.2011.03.005
   Cockcroft DW, 2006, J ALLERGY CLIN IMMUN, V118, P551, DOI 10.1016/j.jaci.2006.07.012
   Comhair SAA, 2010, ANTIOXID REDOX SIGN, V12, P93, DOI [10.1089/ars.2008.2425, 10.1089/ARS.2008.2425]
   Courtois A, 2008, ENVIRON HEALTH PERSP, V116, P1294, DOI 10.1289/ehp.11021
   Cozzi E, 2006, AM J PHYSIOL-HEART C, V291, pH894, DOI 10.1152/ajpheart.01362.2005
   Dales R, 2007, INT ARCH OCC ENV HEA, V81, P159, DOI 10.1007/s00420-007-0199-7
   Endemann DH, 2004, J AM SOC NEPHROL, V15, P1983, DOI 10.1097/01.ASN.0000132474.50966.DA
   Ezratty V, 2014, ENVIRON HEALTH PERSP, V122, P850, DOI 10.1289/ehp.1307240
   Fakhri AA, 2009, ENVIRON HEALTH PERSP, V117, P1287, DOI 10.1289/ehp.0900541
   Flammer AJ, 2012, CIRCULATION, V126, P753, DOI 10.1161/CIRCULATIONAHA.112.093245
   FOLINSBEE LJ, 1992, TOXICOL IND HEALTH, V8, P273
   Foster WM, 2000, J APPL PHYSIOL, V89, P1804
   Frampton MW, 1999, AM J RESP CRIT CARE, V159, P1134, DOI 10.1164/ajrccm.159.4.9807057
   Frampton MW, 2002, AM J PHYSIOL-LUNG C, V282, pL155
   Freed AN, 1996, RESP PHYSIOL, V105, P95, DOI 10.1016/0034-5687(96)00040-0
   Garantziotis S, 2010, AM J RESP CRIT CARE, V181, P666, DOI 10.1164/rccm.200903-0381OC
   Gilmour MI, 1996, FUND APPL TOXICOL, V31, P65, DOI 10.1006/faat.1996.0076
   Gong H, 2001, CHEST, V119, P402, DOI 10.1378/chest.119.2.402
   GUNNISON AF, 1974, AM IND HYG ASSOC J, V35, P288, DOI 10.1080/0002889748507036
   GUNNISON AF, 1981, ENVIRON RES, V24, P432, DOI 10.1016/0013-9351(81)90171-7
   HAZUCHA MJ, 1989, J APPL PHYSIOL, V67, P1535
   Hernandez ML, 2010, J ALLERGY CLIN IMMUN, V126, P537, DOI 10.1016/j.jaci.2010.06.043
   Hollingsworth JW, 2010, J ALLERGY CLIN IMMUN, V125, P1167, DOI 10.1016/j.jaci.2010.03.001
   Hollingsworth JW, 2004, AM J RESP CRIT CARE, V170, P126, DOI 10.1164/rccm.200311-1499OC
   HOLTZMAN MJ, 1979, AM REV RESPIR DIS, V120, P1059
   Jerrett M, 2009, NEW ENGL J MED, V360, P1085, DOI 10.1056/NEJMoa0803894
   Joad JP, 1996, TOXICOL APPL PHARM, V141, P561, DOI 10.1006/taap.1996.0323
   Johns DO, 2012, ENVIRON HEALTH PERSP, V120, P1238, DOI 10.1289/ehp.1204939
   Johns DO, 2011, INHAL TOXICOL, V23, P33, DOI 10.3109/08958378.2010.539290
   Jorres R, 1996, AM J RESP CRIT CARE, V153, P56
   Kloek J, 2010, J PHYSIOL PHARMACOL, V61, P67
   Knuckles TL, 2008, TOXICOL APPL PHARM, V230, P346, DOI 10.1016/j.taap.2008.03.010
   KOBAYASHI T, 1995, FUND APPL TOXICOL, V25, P154, DOI 10.1006/faat.1995.1049
   Kobayashi T, 1990, Agents Actions Suppl, V31, P71
   Koike Y, 2007, AM J RESP CELL MOL, V37, P322, DOI 10.1165/rcmb.2006-0423OC
   Krishnan RM, 2012, J AM COLL CARDIOL, V60, P2158, DOI 10.1016/j.jacc.2012.08.973
   Larsen ST, 2010, J TOXICOL ENV HEAL A, V73, P738, DOI 10.1080/15287391003614034
   Lee LY, 2001, ENVIRON HEALTH PERSP, V109, P585, DOI 10.2307/3454674
   Mabalirajan U, 2010, J ALLERGY CLIN IMMUN, V125, P626, DOI 10.1016/j.jaci.2009.10.065
   Madden JA, 2012, NEUROLOGY, V79, pS58, DOI 10.1212/WNL.0b013e3182695836
   Matalon S, 2009, FASEB J, V23, P1415, DOI 10.1096/fj.08-120568
   Mills NL, 2008, ENVIRON HEALTH PERSP, V116, P709, DOI 10.1289/ehp.11016
   Mills NL, 2005, CIRCULATION, V112, P3930, DOI 10.1161/CIRCULATIONAHA.105.588962
   MOHSENIN V, 1991, J APPL PHYSIOL, V70, P1456
   MOHSENIN V, 1987, AM REV RESPIR DIS, V136, P1408, DOI 10.1164/ajrccm/136.6.1408
   Moller P, 2011, CRIT REV TOXICOL, V41, P339, DOI 10.3109/10408444.2010.533152
   MYERS DJ, 1986, AM REV RESPIR DIS, V133, P1154
   NADEL JA, 1965, J APPL PHYSIOL, V20, P164
   Newby DE, 2015, EUR HEART J, V36, P83, DOI 10.1093/eurheartj/ehu458
   NIEDING GV, 1979, ENVIRON HEALTH PERSP, V29, P137
   O'Byrne PM, 2009, CLIN EXP ALLERGY, V39, P181, DOI 10.1111/j.1365-2222.2008.03172.x
   O'Neill MS, 2005, CIRCULATION, V111, P2913, DOI 10.1161/CIRCULATIONAHA.104.517110
   Paffett M.L., 2015, TOXICOL SCI
   Pathmanathan S, 2003, OCCUP ENVIRON MED, V60, P892, DOI 10.1136/oem.60.11.892
   Peden DB, 1997, J ALLERGY CLIN IMMUN, V100, P802, DOI 10.1016/S0091-6749(97)70277-X
   Peretz A, 2008, ENVIRON HEALTH PERSP, V116, P937, DOI 10.1289/ehp.11027
   Plopper CG, 2007, TOXICOL PATHOL, V35, P97, DOI 10.1080/01926230601132030
   Rajagopalan S, 2005, CIRCULATION, V111, P2869, DOI 10.1161/CIRCULATIONAHA.105.540872
   RIEDEL F, 1988, J ALLERGY CLIN IMMUN, V82, P527, DOI 10.1016/0091-6749(88)90961-X
   Robertson S, 2013, TOXICOL SCI, V134, P304, DOI 10.1093/toxsci/kft107
   Rusznak C, 1996, THORAX, V51, P1105, DOI 10.1136/thx.51.11.1105
   Shah AP, 2008, ENVIRON HEALTH PERSP, V116, P375, DOI [10.1289/chp.10323, 10.1289/ehp.10323]
   SNASHALL PD, 1982, THORAX, V37, P118, DOI 10.1136/thx.37.2.118
   Song AJ, 2012, TOXICOL LETT, V214, P320, DOI 10.1016/j.toxlet.2012.09.010
   Srebot V, 2009, CARDIOVASC ULTRASOUN, V7, DOI 10.1186/1476-7120-7-30
   Suissa L, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-004060
   Sun QH, 2005, JAMA-J AM MED ASSOC, V294, P3003, DOI 10.1001/jama.294.23.3003
   Thomas H V, 1967, J Air Pollut Control Assoc, V17, P33
   TUNNICLIFFE WS, 1994, LANCET, V344, P1733, DOI 10.1016/S0140-6736(94)92886-X
   U.S. EPA, 2009, EPA600R08139F
   U.S. EPA, 2008, EPA600R08071
   U.S. EPA, 2013, EPA600R10076F
   U.S. EPA (U.S. Environmental Protection Agency), 2013, EPA600R13202
   U.S. EPA (U.S. Environmental Protection Agency), 2008, EPA6001R08047F
   van der Vliet A, 2011, BBA-GEN SUBJECTS, V1810, P1035, DOI 10.1016/j.bbagen.2011.03.004
   Voynow JA, 2011, BBA-GEN SUBJECTS, V1810, P1091, DOI 10.1016/j.bbagen.2011.04.016
   WANG JH, 1995, INT ARCH ALLERGY IMM, V107, P103, DOI 10.1159/000236944
   Yost BL, 2005, AM J PHYSIOL-LUNG C, V289, pL627, DOI 10.1152/ajplung.00377.2004
   Zanobetti A, 2014, ENVIRON HEALTH PERSP, V122, P242, DOI 10.1289/ehp.1206136
NR 97
TC 2
Z9 2
U1 3
U2 31
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0300-483X
J9 TOXICOLOGY
JI Toxicology
PD SEP 1
PY 2015
VL 335
BP 85
EP 94
DI 10.1016/j.tox.2015.07.007
PG 10
WC Pharmacology & Pharmacy; Toxicology
SC Pharmacology & Pharmacy; Toxicology
GA CQ3QM
UT WOS:000360517600011
PM 26196529
DA 2019-10-23
ER

PT J
AU Zhou, BS
AF Zhou, Bingsheng
TI Adverse outcome pathway: Framework, application, and challenges in
   chemical risk assessment
SO JOURNAL OF ENVIRONMENTAL SCIENCES
LA English
DT Article
ID SCIENTIFIC CONFIDENCE; ECOTOXICOLOGY; MODEL; INHIBITION; STRATEGIES;
   SUPPORT
C1 Chinese Acad Sci, Inst Hydrobiol, Wuhan, Peoples R China.
RP Zhou, BS (reprint author), Chinese Acad Sci, Inst Hydrobiol, Wuhan, Peoples R China.
EM bszhou@ihb.ac.cn
OI zhou, bing sheng/0000-0003-0119-1868
CR Adeleye Y, 2015, TOXICOLOGY, V332, P102, DOI 10.1016/j.tox.2014.02.007
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Becker RA, 2015, REGUL TOXICOL PHARM, V72, P514, DOI 10.1016/j.yrtph.2015.04.004
   Belanger SE, 2010, AQUAT TOXICOL, V97, P88, DOI 10.1016/j.aquatox.2009.11.020
   Cosme MM, 2015, GEN COMP ENDOCR, V219, P89, DOI 10.1016/j.ygcen.2015.01.013
   Fetter E, 2015, REPROD TOXI IN PRESS
   Groh KJ, 2015, CHEMOSPHERE, V120, P764, DOI 10.1016/j.chemosphere.2014.09.068
   Hutchinson TH, 2013, MAR POLLUT BULL, V74, P517, DOI 10.1016/j.marpolbul.2013.06.012
   Kloas W, 2006, J CHROMATOGR A, V1130, P16, DOI 10.1016/j.chroma.2006.04.001
   Knapen D, 2015, REPROD TOXICOL, V56, P52, DOI 10.1016/j.reprotox.2015.04.003
   Lammer E, 2009, COMP BIOCHEM PHYS C, V149, P196, DOI 10.1016/j.cbpc.2008.11.006
   Landesmann B, 2013, ATLA-ALTERN LAB ANIM, V41, P461, DOI 10.1177/026119291304100609
   Lee JW, 2015, J ENVIRON SCI-CHINA, V35, P115, DOI 10.1016/j.jes.2015.05.002
   Nie J, 2014, J ENVIRON SCI-CHINA, V26, P432, DOI 10.1016/S1001-0742(13)60424-6
   NRC, 2007, TOXICITY TESTING 21
   Patlewicz G, 2015, REGUL TOXICOL PHARM, V71, P463, DOI 10.1016/j.yrtph.2015.02.011
   Phillips M.B., 2015, ENV HLTH PE IN PRESS
   Scholz S, 2008, MOL CELL ENDOCRINOL, V293, P57, DOI 10.1016/j.mce.2008.06.008
   Scholz S, 2008, ENVIRON SCI POLLUT R, V15, P394, DOI 10.1007/s11356-008-0018-z
   Tollefsen KE, 2014, REGUL TOXICOL PHARM, V70, P629, DOI 10.1016/j.yrtph.2014.09.009
   Villeneuve DL, 2014, TOXICOL SCI, V142, P312, DOI 10.1093/toxsci/kfu199
   Villeneuve DL, 2014, TOXICOL SCI, V142, P321, DOI 10.1093/toxsci/kfu200
   Vinken M, 2013, TOXICOL SCI, V136, P97, DOI 10.1093/toxsci/kft177
   Vinken M, 2013, TOXICOLOGY, V312, P158, DOI 10.1016/j.tox.2013.08.011
   Wang X.F., 2015, J ENVIRON SCI, V29, P201
   Yozzo KL, 2013, AQUAT TOXICOL, V126, P346, DOI 10.1016/j.aquatox.2012.09.008
   Yu LQ, 2010, AQUAT TOXICOL, V97, P226, DOI 10.1016/j.aquatox.2009.10.022
   Zhu N, 2013, J ENVIRON SCI-CHINA, V25, P2123, DOI 10.1016/S1001-0742(12)60261-7
NR 28
TC 17
Z9 18
U1 1
U2 23
PU SCIENCE PRESS
PI BEIJING
PA 16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA
SN 1001-0742
EI 1878-7320
J9 J ENVIRON SCI-CHINA
JI J. Environ. Sci.
PD SEP 1
PY 2015
VL 35
BP 191
EP 193
DI 10.1016/j.jes.2015.07.001
PG 3
WC Environmental Sciences
SC Environmental Sciences & Ecology
GA CT7GI
UT WOS:000362982300023
PM 26354708
DA 2019-10-23
ER

PT J
AU Lee, JW
   Won, EJ
   Raisuddin, S
   Lee, JS
AF Lee, Jin Wuk
   Won, Eun-Ji
   Raisuddin, Sheikh
   Lee, Jae-Seong
TI Significance of adverse outcome pathways in biomarker-based
   environmental risk assessment in aquatic organisms
SO JOURNAL OF ENVIRONMENTAL SCIENCES-CHINA
LA English
DT Review
DE Adverse outcome pathway; Biomarker; Omics; Environmental risk
   assessment; Aquatic organisms; Interspecific difference
ID COPEPOD TIGRIOPUS-JAPONICUS; ZEBRAFISH DANIO-RERIO; POLYCYCLIC
   AROMATIC-HYDROCARBONS; SUPEROXIDE-DISMUTASE SOD; SEDIMENT QUALITY TRIAD;
   EARLY-LIFE STAGES; SILVER NANOPARTICLES; ORYZIAS-LATIPES; RAINBOW-TROUT;
   GENE-EXPRESSION
AB In environmental risk assessments (ERA), biomarkers have been widely used as an early warning signal of environmental contamination. However, biomarker responses have limitation due to its low relevance to adverse outcomes (e.g., fluctuations in community structure, decreases in population size, and other similar ecobiologically relevant indicators of community structure and function). To mitigate these limitations, the concept of adverse outcome pathways (AOPs) was developed. An AOP is an analytical, sequentially progressive pathway that links a molecular initiating event (MIE) to an adverse outcome. Recently, AOPs have been recognized as a potential informational tool by which the implications of molecular biomarkers in ERA can be better understood. To demonstrate the utility of AOPs in biomarker-based ERA, here we discuss a series of three different biological repercussions caused by exposure to benzo(a)pyrene (BaP), silver nanoparticles (AgNPs), and selenium (Se). Using mainly aquatic invertebrates and selected vertebrates as model species, we focus on the development of the AOP concept. Aquatic organisms are suitable bioindicator species whose entire lifespans can be observed over a short period; moreover, these species can be studied on the molecular and population levels. Also, interspecific differences between aquatic organisms are important to consider in an AOP framework, since these differences are an integral part of the natural environment. The development of an environmental pollutant-mediated AOP may enable a better understanding of the effects of environmental pollutants in different scenarios in the diverse community of an ecosystem. (C) 2015 The Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences. Published by Elsevier B.V.
C1 [Lee, Jin Wuk; Won, Eun-Ji; Lee, Jae-Seong] Sungkyunkwan Univ, Coll Sci, Dept Biol Sci, Suwon 440746, South Korea.
   [Raisuddin, Sheikh] Hamdard Univ, Dept Med Elementol & Toxicol, New Delhi 110062, India.
RP Lee, JS (reprint author), Sungkyunkwan Univ, Coll Sci, Dept Biol Sci, Suwon 440746, South Korea.
EM jslee2@skku.edu
RI Lee, Jae-Seong/H-6013-2015
OI Lee, Jae-Seong/0000-0003-0944-5172; Lee, jin wuk/0000-0003-0047-070X;
   Raisuddin, Sheikh/0000-0003-0913-8906
FU Ministry of Oceans and Fisheries, Korea [20140342]; "Korea-Polar Ocean
   Development: K-POD" grant - Ministry of Oceans and Fisheries, Korea
   [PM14030]
FX This research was a part of the project (20140342) titled "Development
   of techniques for assessment and management of hazardous chemicals in
   the marine environment" funded by the Ministry of Oceans and Fisheries,
   Korea to Jae-Seong Lee. This work was also supported by the "Korea-Polar
   Ocean Development: K-POD" grant (project no. PM14030) funded by the
   Ministry of Oceans and Fisheries, Korea.
CR ADAMS SM, 2002, BIOL INDICATORS AQUA
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Arora S, 2008, TOXICOL LETT, V179, P93, DOI 10.1016/j.toxlet.2008.04.009
   Asharani PV, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/25/255102
   Bar-Ilan O, 2009, SMALL, V5, P1897, DOI 10.1002/smll.200801716
   Berninger JP, 2014, ENVIRON SCI TECHNOL, V48, P2404, DOI 10.1021/es4040254
   Biales AD, 2013, ENVIRON SCI TECHNOL, V47, P1306, DOI 10.1021/es304274a
   Bo J., 2012, ENVIRON TOXICOL, V29, P517
   Bo J, 2014, MAR POLLUT BULL, V85, P463, DOI 10.1016/j.marpolbul.2014.05.023
   Bo Jun, 2010, Acta Scientiarum Naturalium Universitatis Sunyatseni, V49, P93
   Boelsterli U.A., 2007, MECH TOXICOLOGY
   Borgert CJ, 2004, TOXICOL APPL PHARM, V201, P85, DOI 10.1016/j.taap.2004.05.005
   Caldwell DJ, 2014, CHEMOSPHERE, V115, P4, DOI 10.1016/j.chemosphere.2014.01.021
   Carlson C, 2008, J PHYS CHEM B, V112, P13608, DOI 10.1021/jp712087m
   Chapman PM, 2005, SMALL SCALE FRESHWATER TOXICITY INVESTIGATIONS, VOL 2: HAZARD ASSESSMENT SCHEMES, P305
   Chapman PM, 1996, ECOTOXICOLOGY, V5, P327, DOI 10.1007/BF00119054
   CHAPMAN PM, 1986, ENVIRON TOXICOL CHEM, V5, P957, DOI 10.1002/etc.5620051104
   Chaty S, 2004, AQUAT TOXICOL, V69, P81, DOI 10.1016/j.aquatox.2004.04.011
   Chikae M, 2004, ENVIRON TOXICOL PHAR, V16, P141, DOI 10.1016/j.etap.2003.11.007
   Choi JE, 2010, AQUAT TOXICOL, V100, P151, DOI 10.1016/j.aquatox.2009.12.012
   CLEVELAND L, 1993, AQUAT TOXICOL, V27, P265, DOI 10.1016/0166-445X(93)90058-9
   Colbourne JK, 2011, SCIENCE, V331, P555, DOI 10.1126/science.1197761
   Cole LK, 2001, DEV BIOL, V240, P123, DOI 10.1006/dbio.2001.0432
   Cook PM, 2003, ENVIRON SCI TECHNOL, V37, P3864, DOI 10.1021/es034045m
   Corrales J, 2014, COMP BIOCHEM PHYS C, V163, P37, DOI 10.1016/j.cbpc.2014.02.005
   Dahms HU, 2011, AQUAT TOXICOL, V101, P1, DOI 10.1016/j.aquatox.2010.09.006
   David RM, 2012, CHEMOSPHERE, V88, P912, DOI 10.1016/j.chemosphere.2012.03.018
   De Coninck DIM, 2014, ENVIRON SCI TECHNOL, V48, P3513, DOI 10.1021/es4053363
   De Riu N, 2014, AQUAT TOXICOL, V148, P65, DOI 10.1016/j.aquatox.2013.12.030
   DEKRUIJF HAM, 1991, COMP BIOCHEM PHYS C, V100, P291, DOI 10.1016/0742-8413(91)90171-O
   Dellarco V, 2012, J NUTR, V142, p2192S, DOI 10.3945/jn.111.157396
   Diez S, 2002, WATER RES, V36, P905, DOI 10.1016/S0043-1354(01)00305-0
   *ECETOC, 2007, 102 ECETOC
   Fan TWM, 2002, AQUAT TOXICOL, V57, P65, DOI 10.1016/S0166-445X(01)00261-2
   FitzGerald RE, 2014, TOXICOL LETT, V230, P368, DOI 10.1016/j.toxlet.2014.05.002
   Foldbjerg R, 2009, TOXICOL LETT, V190, P156, DOI 10.1016/j.toxlet.2009.07.009
   Garcia-Reyero N, 2014, ENVIRON SCI TECHNOL, V48, P4546, DOI 10.1021/es4042258
   HAASCH ML, 1993, FUND APPL TOXICOL, V20, P72, DOI 10.1006/faat.1993.1009
   Hahn ME, 2002, CHEM-BIOL INTERACT, V141, P131, DOI 10.1016/S0009-2797(02)00070-4
   Hamilton SJ, 2004, SCI TOTAL ENVIRON, V326, P1, DOI 10.1016/j.scitotenv.2004.01.019
   Han J, 2014, AQUAT TOXICOL, V152, P308, DOI 10.1016/j.aquatox.2014.04.027
   Hofelt CS, 2001, REGUL TOXICOL PHARM, V33, P60, DOI 10.1006/rtph.2000.1438
   Hook SE, 2010, J FISH BIOL, V77, P1999, DOI 10.1111/j.1095-8649.2010.02814.x
   Hook SE, 2014, ENVIRON SCI TECHNOL, V48, P3504, DOI 10.1021/es405322s
   HUANG MT, 1992, CARCINOGENESIS, V13, P2183, DOI 10.1093/carcin/13.11.2183
   Hutchinson TH, 2013, MAR POLLUT BULL, V74, P517, DOI 10.1016/j.marpolbul.2013.06.012
   Hwang DS, 2014, MITOCHONDR DNA, V25, P29, DOI 10.3109/19401736.2013.775274
   Hwang DS, 2013, ZOOL STUD, V52, DOI 10.1186/1810-522X-52-13
   Iijima N, 2007, ACTA HISTOCHEM CYTOC, V40, P1, DOI 10.1267/ahc.06013
   INGERSOLL CG, 1990, ENVIRON TOXICOL CHEM, V9, P1171, DOI 10.1002/etc.5620090908
   Irons TD, 2013, PHARMACOL BIOCHEM BE, V103, P792, DOI 10.1016/j.pbb.2012.12.010
   Janer G, 2007, ECOTOXICOLOGY, V16, P145, DOI 10.1007/s10646-006-0110-4
   Kashiwada S, 2012, ENVIRON SCI TECHNOL, V46, P6278, DOI 10.1021/es2045647
   Keay J, 2009, ENDOCRINOLOGY, V150, P1731, DOI 10.1210/en.2008-1338
   Kim BM, 2014, AQUAT TOXICOL, V152, P232, DOI 10.1016/j.aquatox.2014.04.008
   Kim BM, 2011, CHEMOSPHERE, V84, P1467, DOI 10.1016/j.chemosphere.2011.04.043
   Kim RO, 2013, ENVIRON SCI TECHNOL, V47, P13804, DOI 10.1021/es403269v
   Koenig S, 2012, AQUAT TOXICOL, V108, P11, DOI 10.1016/j.aquatox.2011.10.016
   Kramer VJ, 2011, ENVIRON TOXICOL CHEM, V30, P64, DOI 10.1002/etc.375
   Krewski D, 2010, J TOXICOL ENV HEAL B, V13, P51, DOI 10.1080/10937404.2010.483176
   Kupsco A, 2014, ENVIRON SCI TECHNOL, V48, P7062, DOI 10.1021/es5019948
   Kwok KWH, 2012, AQUAT TOXICOL, V120, P59, DOI 10.1016/j.aquatox.2012.04.012
   Lavado R, 2011, AQUAT TOXICOL, V108, P18
   Leal E, 2013, HORM BEHAV, V64, P113, DOI 10.1016/j.yhbeh.2013.05.008
   Lee J. W., 2012, ENVIRON TOXICOL, V13, P1032
   Lee JS, 2011, HYDROBIOLOGIA, V662, P65, DOI 10.1007/s10750-010-0516-0
   Lee JS, 2010, MAR ENVIRON RES, V69, pS21, DOI 10.1016/j.marenvres.2009.12.003
   Lee JW, 2015, ENVIRON TOXICOL PHAR, V39, P1041, DOI 10.1016/j.etap.2015.03.010
   Lee KJ, 2007, ACS NANO, V1, P133, DOI 10.1021/nn700048y
   Lemly A.D., 2002, SPR S ENV M
   Lemly AD, 1997, ECOTOX ENVIRON SAFE, V37, P259, DOI 10.1006/eesa.1997.1554
   Lerebours A, 2014, ENVIRON SCI TECHNOL, V48, P10448, DOI 10.1021/es502591p
   Levine SL, 1999, AQUAT TOXICOL, V46, P279, DOI 10.1016/S0166-445X(98)00124-6
   Li RX, 2011, MAR ENVIRON RES, V71, P86, DOI 10.1016/j.marenvres.2010.11.002
   Li YH, 2013, J MATER CHEM B, V1, P6365, DOI 10.1039/c3tb21168a
   Lin JG, 2003, WATER SCI TECHNOL, V47, P233
   Lin PP, 2003, TOXICOL SCI, V71, P20, DOI 10.1093/toxsci/71.1.20
   Livingstone DR, 1998, COMP BIOCHEM PHYS A, V120, P43, DOI 10.1016/S1095-6433(98)10008-9
   Ma Y, 2012, FOOD CHEM TOXICOL, V50, P2854, DOI 10.1016/j.fct.2012.04.037
   Maier A, 2004, J TOXICOL ENV HEAL A, V67, P687, DOI 10.1080/15287390490428161
   Martinovic-Weigelt D, 2014, ENVIRON SCI TECHNOL, V48, P2385, DOI 10.1021/es404027n
   Massarsky A, 2013, CHEMOSPHERE, V92, P59, DOI 10.1016/j.chemosphere.2013.02.060
   Maurer-Jones MA, 2013, ANAL CHEM, V85, P3036, DOI 10.1021/ac303636s
   Misra S, 2009, TOXICOL IN VITRO, V23, P1249, DOI 10.1016/j.tiv.2009.07.031
   Myers MS, 1998, MAR ENVIRON RES, V46, P197, DOI 10.1016/S0141-1136(98)00010-5
   National Research Council, 2007, TOXICITY TESTING 21
   Nijhawan D, 2000, ANNU REV NEUROSCI, V23, P73, DOI 10.1146/annurev.neuro.23.1.73
   OECD, 2012, PROP TEMPL GUID DEV
   Oehlmann J, 2007, ECOTOXICOLOGY, V16, P29, DOI 10.1007/s10646-006-0109-x
   Ortiz-Delgado JB, 2004, J MOL HISTOL, V35, P29
   Palace VP, 2004, ECOTOX ENVIRON SAFE, V58, P17, DOI 10.1016/j.ecoenv.2003.08.019
   Peters LD, 1998, COMP BIOCHEM PHYS C, V121, P361, DOI 10.1016/S0742-8413(98)10057-9
   Pham CH, 2012, ECOTOX ENVIRON SAFE, V78, P239, DOI 10.1016/j.ecoenv.2011.11.034
   Phillips DH, 2007, NAT PROTOC, V2, P2772, DOI 10.1038/nprot.2007.394
   Ploch SA, 1998, TOXICOL APPL PHARM, V149, P90, DOI 10.1006/taap.1997.8359
   POIRIER MC, 1992, CHEM RES TOXICOL, V5, P749, DOI 10.1021/tx00030a003
   Quednow K, 2009, ENVIRON SCI POLLUT R, V16, P630, DOI 10.1007/s11356-009-0169-6
   Raisuddin S, 2007, AQUAT TOXICOL, V83, P161, DOI 10.1016/j.aquatox.2007.04.005
   Reichert WL, 1998, MUTAT RES-REV MUTAT, V411, P215, DOI 10.1016/S1383-5742(98)00014-3
   Rewitz KF, 2006, COMP BIOCHEM PHYS C, V143, P363, DOI 10.1016/j.cbpc.2006.04.001
   Rhee JS, 2013, COMP BIOCHEM PHYS C, V158, P216, DOI 10.1016/j.cbpc.2013.08.005
   Rhee JS, 2013, ENVIRON SCI TECHNOL, V47, P4804, DOI 10.1021/es400186r
   Rhee JS, 2011, MAR POLLUT BULL, V63, P277, DOI 10.1016/j.marpolbul.2011.04.023
   Robichaud CO, 2009, ENVIRON SCI TECHNOL, V43, P4227, DOI 10.1021/es8032549
   ROSS JA, 1995, CANCER RES, V55, P1039
   SCHULTZ R, 1990, B ENVIRON CONTAM TOX, V45, P568, DOI 10.1007/BF01700630
   Selvaraj V, 2013, ECOTOX ENVIRON SAFE, V87, P80, DOI 10.1016/j.ecoenv.2012.09.028
   SPALLHOLZ JE, 1994, FREE RADICAL BIO MED, V17, P45, DOI 10.1016/0891-5849(94)90007-8
   Stensberg MC, 2011, NANOMEDICINE-UK, V6, P879, DOI [10.2217/nnm.11.78, 10.2217/NNM.11.78]
   Thomas JK, 2014, AQUAT TOXICOL, V152, P20, DOI 10.1016/j.aquatox.2014.03.022
   Usami M, 2002, TERATOGEN CARCIN MUT, V22, P301, DOI 10.1002/tcm.10025
   USEPA, 1991, EPA600X92015 ENV CRI
   van der Oost R, 2003, ENVIRON TOXICOL PHAR, V13, P57, DOI 10.1016/S1382-6689(02)00126-6
   Villeneuve DL, 2011, ENVIRON TOXICOL CHEM, V30, P1, DOI 10.1002/etc.396
   Vinken M, 2014, ARCH TOXICOL, V88, P1, DOI 10.1007/s00204-013-1093-6
   Volz DC, 2011, TOXICOL SCI, V123, P349, DOI 10.1093/toxsci/kfr185
   Wang L, 2010, AQUAT TOXICOL, V99, P439, DOI 10.1016/j.aquatox.2010.06.002
   WILLETT K, 1995, COMP BIOCHEM PHYS B, V112, P93, DOI 10.1016/0305-0491(95)00034-6
   Wills LP, 2010, ENVIRON HEALTH PERSP, V118, P1376, DOI 10.1289/ehp.0901799
   Wise JP, 2010, AQUAT TOXICOL, V97, P34, DOI 10.1016/j.aquatox.2009.11.016
   Wu Y, 2012, AQUAT TOXICOL, V124, P238, DOI 10.1016/j.aquatox.2012.08.009
   Yang JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057186
   Yang JH, 2013, MOL BIOL REP, V40, P2927, DOI 10.1007/s11033-012-2308-2
   Yang JH, 2013, GENE, V518, P388, DOI 10.1016/j.gene.2012.12.101
   Yeo MK, 2008, MOL CELL TOXICOL, V4, P311
   Yokel RA, 2006, J TOXICOL ENV HEAL B, V9, P63, DOI 10.1080/15287390500196230
   Yoshinaga T, 2003, COMP BIOCHEM PHYS B, V136, P715, DOI 10.1016/S1096-4959(03)00286-0
   최진희, 2005, [Environmental Health and Toxicology, 환경독성보건학회지], V20, P1
NR 128
TC 30
Z9 30
U1 5
U2 72
PU SCIENCE PRESS
PI BEIJING
PA 16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA
SN 1001-0742
EI 1878-7320
J9 J ENVIRON SCI-CHINA
JI J. Environ. Sci.
PD SEP 1
PY 2015
VL 35
BP 115
EP 127
DI 10.1016/j.jes.2015.05.002
PG 13
WC Environmental Sciences
SC Environmental Sciences & Ecology
GA CT7GI
UT WOS:000362982300015
PM 26354700
DA 2019-10-23
ER

PT J
AU Burden, N
   Sewell, F
   Andersen, ME
   Boobis, A
   Chipman, JK
   Cronin, MTD
   Hutchinson, TH
   Kimber, I
   Whelan, M
AF Burden, Natalie
   Sewell, Fiona
   Andersen, Melvin E.
   Boobis, Alan
   Chipman, J. Kevin
   Cronin, Mark T. D.
   Hutchinson, Thomas H.
   Kimber, Ian
   Whelan, Maurice
TI Adverse Outcome Pathways can drive non-animal approaches for safety
   assessment
SO JOURNAL OF APPLIED TOXICOLOGY
LA English
DT Review
DE chemical; safety assessment; risk; pathway; AOP; mechanism of action;
   mode of action; toxicity; 3Rs
ID FRAMEWORK; MODE
AB Adverse Outcome Pathways (AOPs) provide an opportunity to develop new and more accurate safety assessment processes for drugs and other chemicals, and may ultimately play an important role in regulatory decision making. Not only can the development and application of AOPs pave the way for the development of improved evidence-based approaches for hazard and risk assessment, there is also the promise of a significant impact on animal welfare, with a reduced reliance on animal-based methods. The establishment of a useable and coherent knowledge framework under which AOPs will be developed and applied has been a first critical step towards realizing this opportunity. This article explores how the development of AOPs under this framework, and their application in practice, could benefit the science and practice of safety assessment, while in parallel stimulating a move away from traditional methods towards an increased acceptance of non-animal approaches. We discuss here the key areas where current, and future initiatives should be focused to enable the translation of AOPs into routine chemical safety assessment, and lasting 3Rs benefits. (c) 2015 The Authors. Journal of Applied Toxicology published by John Wiley & Sons Ltd.
C1 [Burden, Natalie; Sewell, Fiona] NC3Rs, London NW1 2BE, England.
   [Andersen, Melvin E.] Hamner Inst Hlth Sci, Res Triangle Pk, NC 27709 USA.
   [Boobis, Alan] Univ London Imperial Coll Sci Technol & Med, London W12 0NN, England.
   [Chipman, J. Kevin] Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England.
   [Cronin, Mark T. D.] Liverpool John Moores Univ, Sch Pharm & Biomol Sci, Liverpool L3 3AF, Merseyside, England.
   [Hutchinson, Thomas H.] Univ Plymouth, Sch Life Sci, Plymouth PL4 8AA, Devon, England.
   [Kimber, Ian] Univ Manchester, Manchester M13 9PT, Lancs, England.
   [Whelan, Maurice] European Commiss Joint Res Ctr, EU Reference Lab Alternat Anim Testing EURL ECVAM, I-20127 Ispra, VA, Italy.
RP Burden, N (reprint author), NC3Rs, Gibbs Bldg,215 Euston Rd, London NW1 2BE, England.
EM natalie.burden@nc3rs.org.uk
RI Boobis, Alan/E-1536-2018
OI Boobis, Alan/0000-0003-3371-386X; Andersen, Melvin/0000-0002-3894-4811;
   Sewell, Fiona/0000-0001-5589-9453
CR Meek ME, 2014, J APPL TOXICOL, V34, P1, DOI 10.1002/jat.2949
   NRC (National Research Council), 2007, TOX TEST 21 CENT VIS
   [OECD [OECD] Organization for Economic Cooperation and Development], 2012, OECD SER TEST ASS
   OECD, 2014, US HDB SUPPL GUID DO
   Organisation for Economic Co-operation and Development (OECD), 2013, OECD SER TEST ASS, V184
   Patlewicz G, 2014, REGUL TOXICOL PHARM, V69, P529, DOI 10.1016/j.yrtph.2014.06.001
   Popp JA, 2006, TOXICOL SCI, V89, P361, DOI 10.1093/toxsci/kfj016
   Sonich-Mullin C, 2001, REGUL TOXICOL PHARM, V34, P146, DOI 10.1006/rtph.2001.1493
   Wilkinson CF, 2000, REGUL TOXICOL PHARM, V31, P30, DOI 10.1006/rtph.1999.1361
NR 9
TC 31
Z9 31
U1 2
U2 28
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0260-437X
EI 1099-1263
J9 J APPL TOXICOL
JI J. Appl. Toxicol.
PD SEP
PY 2015
VL 35
IS 9
BP 971
EP 975
DI 10.1002/jat.3165
PG 5
WC Toxicology
SC Toxicology
GA CN8KA
UT WOS:000358687900001
PM 25943792
OA Green Published
DA 2019-10-23
ER

PT J
AU Tian, JJ
   Feng, Y
   Fu, HL
   Xie, HQ
   Jiang, JX
   Zhao, B
AF Tian, Jijing
   Feng, Yu
   Fu, Hualing
   Xie, Heidi Qunhui
   Jiang, Joy Xiaosong
   Zhao, Bin
TI The Aryl Hydrocarbon Receptor: A Key Bridging Molecule of External and
   Internal Chemical Signals
SO ENVIRONMENTAL SCIENCE & TECHNOLOGY
LA English
DT Review
ID INNATE LYMPHOID-CELLS; REGULATORY T-CELLS; DIOXIN-LIKE COMPOUNDS;
   ENVIRONMENTALLY RELEVANT CONCENTRATIONS; POLYCHLORINATED
   AROMATIC-HYDROCARBONS; HEPATIC STELLATE CELLS; ENDOGENOUS AHR LIGAND;
   GENE-EXPRESSION; IN-VITRO; CHICKEN EMBRYOS
AB The aryl hydrocarbon receptor (AhR) is a highly evolutionary conserved, ligand-activated transcription factor that is best known to mediate the toxicities of dioxins and dioxin-like compounds. Phenotype of AhR-null mice, together with the recent discovery of a variety of endogenous and plant-derived ligands, point to the integral roles of AhR in normal cell physiology, in addition to its roles in sensing the environmental chemicals. Here, we summarize the current knowledge about AhR signaling pathways, its ligands and AhR-mediated effects on cell specialization, host defense and detoxification. AhR-mediated health effects particularly in liver, immune, and nervous systems, as well as in tumorgenesis are discussed. Dioxin-initiated embryotoxicity and immunosuppressive effects in fish and birds are reviewed. Recent data demonstrate that AhR is a convergence point of multiple signaling pathways that inform the cell of its external and internal environments. As such, AhR pathway is a promising potential target for therapeutics targeting nervous, liver, and autoimmune diseases through AhR ligand-mediated interventions and other perturbations of AhR signaling. Additionally, using available laboratory data obtained on animal models, AhR-centered adverse outcome pathway analysis is useful in reexamining known and potential adverse outcomes of specific or mixed compounds on wildlife.
C1 [Tian, Jijing; Feng, Yu; Fu, Hualing; Xie, Heidi Qunhui; Zhao, Bin] Chinese Acad Sci, Ecoenvironm Sci Res Ctr, Beijing 100085, Peoples R China.
   [Tian, Jijing; Jiang, Joy Xiaosong] Univ Calif Davis, Dept Internal Med Gastroenterol & Hepatol, Sacramento, CA 95817 USA.
RP Jiang, JX (reprint author), Univ Calif Davis, Dept Internal Med Gastroenterol & Hepatol, Sacramento, CA 95817 USA.
EM joyjiang@ucdavis.edu; binzhao@rcees.ac.cn
FU Chinese Academy of SciencesChinese Academy of Sciences [XDB14030401,
   XDB14030402, YSW2013A01]; National Natural Science Foundation of
   ChinaNational Natural Science Foundation of China [21321004, 21277168];
   U.S. Department of Health and Human Services (National Institutes of
   Health-National Institute of Diabetes and Digestive and Kidney Diseases)
   [K01 DK090121]
FX This work was supported by Strategic Priority Research Program of the
   Chinese Academy of Sciences (XDB14030401, XDB14030402), the National
   Natural Science Foundation of China (Grants 21321004 and 21277168),
   YSW2013A01 from Chinese Academy of Sciences, and K01 DK090121 from U.S.
   Department of Health and Human Services (National Institutes of
   Health-National Institute of Diabetes and Digestive and Kidney
   Diseases). We thank Dr. Irina Krylova, Dr. Marjorie A. Phillips and
   Angela C. Zhang for discussion and comments during the manuscript
   preparation.
CR Alam MS, 2010, P NATL ACAD SCI USA, V107, P5943, DOI 10.1073/pnas.0911755107
   Alexander C, 2001, J ENDOTOXIN RES, V7, P167, DOI 10.1177/09680519010070030101
   Andreola F, 2004, HEPATOLOGY, V39, P157, DOI 10.1002/hep.20004
   Andreola F, 2004, J BIOL CHEM, V279, P3434, DOI 10.1074/jbc.M305832200
   Ankley GT, 2006, AQUAT TOXICOL, V78, P91, DOI 10.1016/j.aquatox.2006.01.018
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   ANKLEY GT, 1989, MAR ENVIRON RES, V28, P231, DOI 10.1016/0141-1136(89)90235-3
   Antkiewicz DS, 2005, TOXICOL SCI, V84, P368, DOI 10.1093/toxsci/kfi073
   Apetoh L, 2010, NAT IMMUNOL, V11, P854, DOI 10.1038/ni.1912
   Baccarelli A, 2002, ENVIRON HEALTH PERSP, V110, P1169, DOI 10.1289/ehp.021101169
   Barouki R, 2007, FEBS LETT, V581, P3608, DOI 10.1016/j.febslet.2007.03.046
   BERTAZZI PA, 1993, EPIDEMIOLOGY, V4, P398, DOI 10.1097/00001648-199309000-00004
   Bertazzi PA, 1997, EPIDEMIOLOGY, V8, P646, DOI 10.1097/00001648-199710000-00006
   Bessede A, 2014, NATURE, V511, P184, DOI 10.1038/nature13323
   Braune BM, 2003, ENVIRON SCI TECHNOL, V37, P3071, DOI 10.1021/es021082p
   Butler R, 2012, P NATL ACAD SCI USA, V109, P1122, DOI 10.1073/pnas.1120581109
   C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012
   Chang ET, 2014, EUR J EPIDEMIOL, V29, P667, DOI 10.1007/s10654-014-9931-2
   Chen I, 1996, BIOCHEM PHARMACOL, V51, P1069, DOI 10.1016/0006-2952(96)00060-3
   Choudhary M, 2015, J PATHOL, V235, P101, DOI 10.1002/path.4433
   Connor KT, 2006, J TOXICOL ENV HEAL B, V9, P147, DOI 10.1080/15287390500196487
   Cook PM, 2003, ENVIRON SCI TECHNOL, V37, P3864, DOI 10.1021/es034045m
   Cooper MD, 2006, CELL, V124, P815, DOI 10.1016/j.cell.2006.02.001
   Crews ST, 1998, GENE DEV, V12, P607, DOI 10.1101/gad.12.5.607
   Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800
   De Abrew KN, 2011, TOXICOL APPL PHARM, V252, P150, DOI 10.1016/j.taap.2011.01.020
   De Abrew KN, 2010, TOXICOL SCI, V118, P454, DOI 10.1093/toxsci/kfq265
   Denison MS, 2002, CHEM-BIOL INTERACT, V141, P3, DOI 10.1016/S0009-2797(02)00063-7
   Denison MS, 2003, ANNU REV PHARMACOL, V43, P309, DOI 10.1146/annurev.pharmtox.43.100901.135828
   DiNatale BC, 2012, MOL CANCER RES, V10, P1369, DOI 10.1158/1541-7786.MCR-12-0216
   DOLWICK KM, 1993, P NATL ACAD SCI USA, V90, P8566, DOI 10.1073/pnas.90.18.8566
   Dong W, 2002, TOXICOL SCI, V69, P191, DOI 10.1093/toxsci/69.1.191
   Duffy Jessica E, 2006, J Immunotoxicol, V3, P39, DOI 10.1080/15476910500514230
   Duncan DM, 1998, GENE DEV, V12, P1290, DOI 10.1101/gad.12.9.1290
   Elonen GE, 1998, ENVIRON TOXICOL CHEM, V17, P472, DOI 10.1002/etc.5620170319
   Fan YX, 2010, CANCER RES, V70, P212, DOI 10.1158/0008-5472.CAN-09-3090
   Fang CC, 2013, TOXICOLOGY, V304, P32, DOI 10.1016/j.tox.2012.11.018
   Farmahin R, 2013, TOXICOL SCI, V131, P139, DOI 10.1093/toxsci/kfs259
   FERNANDEZSALGUERO P, 1995, SCIENCE, V268, P722, DOI 10.1126/science.7732381
   FernandezSalguero PM, 1997, VET PATHOL, V34, P605, DOI 10.1177/030098589703400609
   Fox LL, 1999, J TOXICOL ENV HEAL A, V58, P233, DOI 10.1080/009841099157313
   Giesy JP, 2002, AQUAT TOXICOL, V59, P35, DOI 10.1016/S0166-445X(01)00235-1
   Goel HL, 2013, NAT REV CANCER, V13, P871, DOI 10.1038/nrc3627
   Goff KF, 2005, J TOXICOL ENV HEAL A, V68, P485, DOI 10.1080/15287390590903720
   Granberg L, 2003, ENVIRON TOXICOL CHEM, V22, P2393, DOI 10.1897/02-420
   Grasman KA, 2013, ENVIRON TOXICOL CHEM, V32, P548, DOI 10.1002/etc.2089
   Gu YZ, 2000, ANNU REV PHARMACOL, V40, P519, DOI 10.1146/annurev.pharmtox.40.1.519
   Hahn ME, 2002, CHEM-BIOL INTERACT, V141, P131, DOI 10.1016/S0009-2797(02)00070-4
   Hahn ME, 1997, P NATL ACAD SCI USA, V94, P13743, DOI 10.1073/pnas.94.25.13743
   Hahn ME, 2001, MAR BIOTECHNOL, V3, pS224, DOI 10.1007/s10126-001-0045-Y
   Hahn ME, 1998, COMP BIOCHEM PHYS C, V121, P23, DOI 10.1016/S0742-8413(98)10028-2
   Hawrylowicz CM, 2005, NAT REV IMMUNOL, V5, P271, DOI 10.1038/nri1589
   He JH, 2013, MOL CELL BIOL, V33, P2047, DOI 10.1128/MCB.01658-12
   He JH, 2011, EXP BIOL MED, V236, P1116, DOI 10.1258/ebm.2011.011128
   Head JA, 2006, ENVIRON TOXICOL CHEM, V25, P2981, DOI 10.1897/05-520R.1
   Henry EC, 2010, TOXICOL SCI, V114, P90, DOI 10.1093/toxsci/kfp285
   Hoffman DJ, 1998, ENVIRON TOXICOL CHEM, V17, P747, DOI 10.1002/etc.5620170432
   Hotchkiss AK, 2008, TOXICOL SCI, V105, P235, DOI 10.1093/toxsci/kfn030
   Hu P, 2013, P NATL ACAD SCI USA, V110, pE4069, DOI 10.1073/pnas.1307574110
   Huang P, 2000, TOXICOL APPL PHARM, V169, P159, DOI 10.1006/taap.2000.9064
   HUANG ZJ, 1993, NATURE, V364, P259, DOI 10.1038/364259a0
   HUFF J, 1994, ANNU REV PHARMACOL, V34, P343
   Innocentin YLS, 2011, CELL, V147, P629, DOI 10.1016/j.cell.2011.09.025
   Iwata H., 2010, INTERDISCIP STUD ENV, V4, P105
   Jain S, 1998, MECH DEVELOP, V73, P117, DOI 10.1016/S0925-4773(98)00038-0
   Janeway C.A.J., 2001, IMMUNOBIOLOGY IMMUNE
   Jin U.H., 2014, BMC CANCER, V14, P1
   Jin UH, 2014, MOL PHARMACOL, V85, P777, DOI 10.1124/mol.113.091165
   Jonsson ME, 2007, TOXICOL SCI, V100, P180, DOI 10.1093/toxsci/kfm207
   Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623
   Karchner SI, 2006, P NATL ACAD SCI USA, V103, P6252, DOI 10.1073/pnas.0509950103
   Katynski AL, 2004, COMP BIOCHEM PHYS C, V137, P81, DOI 10.1016/j.cca.2003.11.004
   Kennedy SW, 1996, TOXICOL APPL PHARM, V141, P214
   Kim SY, 2014, INVEST OPHTH VIS SCI, V55, P6031, DOI 10.1167/iovs.14-15091
   Kiss Elina A, 2012, Gut Microbes, V3, P577, DOI 10.4161/gmic.21865
   Kiss EA, 2011, SCIENCE, V334, P1561, DOI 10.1126/science.1214914
   Kremer JM, 2003, NEW ENGL J MED, V349, P1907, DOI 10.1056/NEJMoa035075
   Kubota A, 2005, ENVIRON SCI TECHNOL, V39, P3611, DOI 10.1021/es048771g
   Kubota A, 2010, ENVIRON SCI TECHNOL, V44, P3559, DOI 10.1021/es1000177
   Lee JS, 2012, NAT IMMUNOL, V13, P144, DOI 10.1038/ni.2187
   Lee JH, 2010, GASTROENTEROLOGY, V139, P653, DOI 10.1053/j.gastro.2010.03.033
   Lee YS, 2012, J GASTROEN HEPATOL, V27, P75, DOI 10.1111/j.1440-1746.2011.07007.x
   Lehmann GM, 2011, AM J PATHOL, V178, P1556, DOI 10.1016/j.ajpath.2010.12.025
   Lin CH, 2008, J NEUROCHEM, V104, P1415, DOI 10.1111/j.1471-4159.2007.05098.x
   Liu Q, 2013, AQUAT TOXICOL, V140, P356, DOI 10.1016/j.aquatox.2013.06.018
   Mandal PK, 2005, J COMP PHYSIOL B, V175, P221, DOI 10.1007/s00360-005-0483-3
   Matsubara T, 2012, CELL METAB, V16, P634, DOI 10.1016/j.cmet.2012.10.006
   Matulova M, 2013, VACCINE, V31, P3156, DOI 10.1016/j.vaccine.2013.05.002
   Maurice CF, 2013, CELL, V152, P39, DOI 10.1016/j.cell.2012.10.052
   McMillan BJ, 2007, P NATL ACAD SCI USA, V104, P1412, DOI 10.1073/pnas.0607296104
   Mimura J, 2003, BBA-GEN SUBJECTS, V1619, P263, DOI 10.1016/S0304-4165(02)00485-3
   Monteleone I, 2011, GASTROENTEROLOGY, V141, P237, DOI 10.1053/j.gastro.2011.04.007
   Moura-Alves P, 2014, NATURE, V512, P387, DOI 10.1038/nature13684
   Murray IA, 2008, J PHARMACOL EXP THER, V324, P1102, DOI 10.1124/jpet.107.132241
   Murray IA, 2014, NAT REV CANCER, V14, P801, DOI 10.1038/nrc3846
   Navid F, 2013, J INVEST DERMATOL, V133, P2763, DOI 10.1038/jid.2013.221
   Nebert DW, 2004, J BIOL CHEM, V279, P23847, DOI 10.1074/jbc.R400004200
   NIKOLAIDIS E, 1990, ACTA PHARM NORDICA, V2, P127
   O'Donnell EF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013128
   Oberg M, 2005, TOXICOL SCI, V85, P935, DOI 10.1093/toxsci/kfi154
   Oo YH, 2010, HEPATOL INT, V4, P475, DOI 10.1007/s12072-010-9183-5
   Opitz CA, 2011, NATURE, V478, P197, DOI 10.1038/nature10491
   Peden-Adams M, 1998, CHEMOSPHERE, V37, P1923, DOI 10.1016/S0045-6535(98)00259-8
   Pesatori AC, 2003, IND HEALTH, V41, P127, DOI 10.2486/indhealth.41.127
   Phelan D, 1998, ARCH BIOCHEM BIOPHYS, V357, P155, DOI 10.1006/abbi.1998.0814
   Pickup M, 2013, NAT REV CANCER, V13, P788, DOI 10.1038/nrc3603
   Pierre S, 2014, TOXICOL SCI, V137, P114, DOI 10.1093/toxsci/kft236
   Pocar P, 2005, REPRODUCTION, V129, P379, DOI 10.1530/rep.1.00294
   POLAND A, 1994, MOL PHARMACOL, V46, P915
   POLAND A, 1973, SCIENCE, V179, P476, DOI 10.1126/science.179.4072.476
   POLAND A, 1976, J BIOL CHEM, V251, P4936
   Powell-Coffman JA, 1998, P NATL ACAD SCI USA, V95, P2844, DOI 10.1073/pnas.95.6.2844
   Qin HT, 2004, DEV BIOL, V270, P64, DOI 10.1016/j.ydbio.2004.02.004
   Qiu J, 2012, IMMUNITY, V36, P92, DOI 10.1016/j.immuni.2011.11.011
   Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880
   Quintana FJ, 2013, PHARMACOL REV, V65, P1148, DOI 10.1124/pr.113.007823
   Quintana FJ, 2010, P NATL ACAD SCI USA, V107, P20768, DOI 10.1073/pnas.1009201107
   Rannug U, 2012, TOXICOL LETT, V211, pS14, DOI 10.1016/j.toxlet.2012.03.066
   Ridolfi R., 2014, INT J BIOL, V6, P82
   Robles R, 2000, ENDOCRINOLOGY, V141, P450, DOI 10.1210/en.141.1.450
   Rohlman D, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00223
   Ross P, 1996, TOXICOLOGY, V112, P157, DOI 10.1016/0300-483X(96)03396-3
   ROSS PS, 1995, ENVIRON HEALTH PERSP, V103, P162, DOI 10.2307/3432272
   Safe S, 2013, TOXICOL SCI, V135, P1, DOI 10.1093/toxsci/kft128
   Schroeder JC, 2010, BIOCHEMISTRY-US, V49, P393, DOI 10.1021/bi901786x
   Schulz VJ, 2012, TOXICOL LETT, V215, P100, DOI 10.1016/j.toxlet.2012.09.024
   Senthilkumar K, 2002, ARCH ENVIRON CON TOX, V42, P244, DOI 10.1007/s00244-001-0030-5
   SMIALOWICZ RJ, 1994, TOXICOL APPL PHARM, V124, P248, DOI 10.1006/taap.1994.1029
   Song JS, 2002, P NATL ACAD SCI USA, V99, P14694, DOI 10.1073/pnas.232562899
   Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365
   Spits H, 2012, IMMUNITY, V36, P5, DOI 10.1016/j.immuni.2012.01.004
   Suh YG, 2011, WORLD J GASTROENTERO, V17, P2543, DOI 10.3748/wjg.v17.i20.2543
   Luu VP, 2014, AUTOIMMUNITY, V47, P1, DOI 10.3109/08916934.2013.856006
   Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881
   Veldhoen M, 2009, J EXP MED, V206, P43, DOI 10.1084/jem.20081438
   Walisser JA, 2005, P NATL ACAD SCI USA, V102, P17858, DOI 10.1073/pnas.0504757102
   Walker JA, 2013, NAT REV IMMUNOL, V13, P75, DOI 10.1038/nri3349
   Wang K, 2013, CANCER LETT, V340, P63, DOI 10.1016/j.canlet.2013.06.026
   Warner M, 2011, ENVIRON HEALTH PERSP, V119, P1700, DOI 10.1289/ehp.1103720
   Wassenberg DM, 2004, ENVIRON HEALTH PERSP, V112, P1658, DOI 10.1289/ehp.7168
   Watanabe I, 2013, CIRC J, V77, P224, DOI 10.1253/circj.CJ-12-0647
   Weaver CT, 2009, NAT REV IMMUNOL, V9, P883, DOI 10.1038/nri2660
   WILSON R, 1994, NATURE, V368, P32, DOI 10.1038/368032a0
   Wincent E, 2012, P NATL ACAD SCI USA, V109, P4479, DOI 10.1073/pnas.1118467109
   Wojno EDT, 2012, CELL HOST MICROBE, V12, P445, DOI 10.1016/j.chom.2012.10.003
   Wynn TA, 2005, NAT IMMUNOL, V6, P1069, DOI 10.1038/ni1105-1069
   Xie HQH, 2013, ENVIRON HEALTH PERSP, V121, P613, DOI 10.1289/ehp.1206066
   Xu HM, 2014, J MOL NEUROSCI, V53, P417, DOI 10.1007/s12031-013-0167-5
   Xu ML, 2011, EUR J IMMUNOL, V41, P2828, DOI 10.1002/eji.201141291
   Xu Z, 2013, P NATL ACAD SCI USA, V110, P13097, DOI 10.1073/pnas.1304319110
   Yoshida T, 2012, BIOMED RES-TOKYO, V33, P67, DOI 10.2220/biomedres.33.67
   Zelante T, 2013, IMMUNITY, V39, P372, DOI 10.1016/j.immuni.2013.08.003
   Zhang HF, 2012, ALCOHOL CLIN EXP RES, V36, P1873, DOI 10.1111/j.1530-0277.2012.01787.x
   Zhang S, 2003, ENVIRON HEALTH PERSP, V111, P1877, DOI 10.1289/ehp.6322
   Zhou JG, 2003, MOL PHARMACOL, V63, P915, DOI 10.1124/mol.63.4.915
NR 155
TC 43
Z9 44
U1 5
U2 63
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0013-936X
EI 1520-5851
J9 ENVIRON SCI TECHNOL
JI Environ. Sci. Technol.
PD AUG 18
PY 2015
VL 49
IS 16
BP 9518
EP 9531
DI 10.1021/acs.est.5b00385
PG 14
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA CP4ZS
UT WOS:000359891700018
PM 26079192
OA Green Accepted
DA 2019-10-23
ER

PT J
AU Hardy, B
AF Hardy, Barry
TI Using OpenTox to map toxicity data to adverse outcome pathways
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
C1 [Hardy, Barry] Douglas Connect, Zeiningen, Switzerland.
EM barry.hardy@douglasconnect.com
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD AUG 16
PY 2015
VL 250
MA 135
PG 1
WC Chemistry, Multidisciplinary
SC Chemistry
GA VC2BR
UT WOS:000432475502854
DA 2019-10-23
ER

PT J
AU Tunkel, J
   Melia, J
   Salinas, K
   Morlacci, L
   Rhoades, J
   Kawa, M
   Rudisill, C
   Carlson-Lynch, H
AF Tunkel, Jay
   Melia, Julie
   Salinas, Kelly
   Morlacci, Laura
   Rhoades, Jennifer
   Kawa, Mary
   Rudisill, Catherine
   Carlson-Lynch, Heather
TI Using mode-of-action (MOA) data to guide the development of local
   quantitative structure-activity relationship (QSAR) models for molecular
   and early cellular events in an adverse outcome pathway (AOP)
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
C1 [Tunkel, Jay; Melia, Julie; Salinas, Kelly; Morlacci, Laura; Rhoades, Jennifer; Kawa, Mary; Rudisill, Catherine; Carlson-Lynch, Heather] SRC Inc, EHA, La Fayette, NY USA.
EM tunkel@srcinc.com
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD AUG 16
PY 2015
VL 250
MA 132
PG 2
WC Chemistry, Multidisciplinary
SC Chemistry
GA VC2BR
UT WOS:000432475502851
DA 2019-10-23
ER

PT J
AU Knapen, D
   Vergauwen, L
   Villeneuve, DL
   Ankley, GT
AF Knapen, Dries
   Vergauwen, Lucia
   Villeneuve, Daniel L.
   Ankley, Gerald T.
TI The potential of AOP networks for reproductive and developmental
   toxicity assay development
SO REPRODUCTIVE TOXICOLOGY
LA English
DT Article
DE Adverse outcome pathway; AOP network; Assay development; Reproduction;
   Embryonic and larval development
ID ADVERSE OUTCOME PATHWAYS; FRAMEWORK; ECOTOXICOLOGY; STRATEGY
AB Historically, the prediction of reproductive and developmental toxicity has largely relied on the use of animals. The adverse outcome pathway (AOP) framework forms a basis for the development of new non-animal test methods. It also provides biological context for mechanistic information from existing assays. However, a single AOP may not capture all events that contribute to any relevant toxic effect, even in single chemical exposure scenarios. AOP networks, defined as sets of AOPs sharing at least one common element, are capable of more realistically representing potential chemical effects. They provide information on interactions between AOPs and have the potential to reveal previously unknown links between biological pathways. Analysis of these AOP networks can aid the prioritization of assay development, whether the goal is to develop a single assay with predictive utility of multiple outcomes, or development of assays that are highly specific for a particular mode of action. This paper provides a brief overview of the AOPs related to reproductive and developmental toxicity currently available in the AOP Wiki (http://aopwiki.org), and gives an example of an AOP network based on five reproductive and developmental toxicity-related AOPs for fish to illustrate how AOP networks can be used for assay development and refinement. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Knapen, Dries; Vergauwen, Lucia] Univ Antwerp, Dept Vet Sci, Zebrafishlab, Vet Physiol & Biochem, B-2610 Antwerp, Belgium.
   [Villeneuve, Daniel L.; Ankley, Gerald T.] US EPA, Off Res & Dev, Midcontinent Ecol Div, Duluth, MN 55804 USA.
RP Knapen, D (reprint author), Univ Antwerp, Dept Vet Sci, Zebrafishlab, Vet Physiol & Biochem, Univ Pl 1, B-2610 Antwerp, Belgium.
EM dries.knapen@uantwerpen.be
OI Knapen, Dries/0000-0003-0472-8114; Vergauwen, Lucia/0000-0002-6534-7473
FU Cefic Long-range Research Initiative [LRI-ECO20-UA]; ECETOC
FX This work was partly funded by the Cefic Long-range Research Initiative
   (Development of an alternative testing strategy for the fish early
   life-stage test for predicting chronic toxicity; LRI-ECO20-UA) with
   support of ECETOC. The views expressed are those of the authors, and do
   not necessarily represent the views of the organizations the authors are
   affiliated with or the sponsors. Mention of trade names or commercial
   products does not constitute endorsement or recommendation for use.
CR Ankley GT, 2014, ENVIRON TOXICOL CHEM, V33, P2529, DOI 10.1002/etc.2708
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Groh KJ, 2015, CHEMOSPHERE, V120, P764, DOI 10.1016/j.chemosphere.2014.09.068
   Krewski D, 2010, J TOXICOL ENV HEAL B, V13, P51, DOI 10.1080/10937404.2010.483176
   Martin MT, 2011, BIOL REPROD, V85, P327, DOI 10.1095/biolreprod.111.090977
   OECD, 2011, TEST 234 FISH SEX DE
   OECD, 2013, OECD ENV HLTH SAF PU, V184
   Pratten M, 2012, Methods Mol Biol, V889, P115, DOI 10.1007/978-1-61779-867-2_9
   Tollefsen KE, 2014, REGUL TOXICOL PHARM, V70, P629, DOI 10.1016/j.yrtph.2014.09.009
   Villeneuve D, 2014, ENVIRON TOXICOL CHEM, V33, P158, DOI 10.1002/etc.2403
   Villeneuve DL, 2014, TOXICOL SCI, V142, P312, DOI 10.1093/toxsci/kfu199
   Villeneuve DL, 2014, TOXICOL SCI, V142, P321, DOI 10.1093/toxsci/kfu200
NR 12
TC 28
Z9 29
U1 2
U2 39
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0890-6238
J9 REPROD TOXICOL
JI Reprod. Toxicol.
PD AUG 15
PY 2015
VL 56
SI SI
BP 52
EP 55
DI 10.1016/j.reprotox.2015.04.003
PG 4
WC Reproductive Biology; Toxicology
SC Reproductive Biology; Toxicology
GA CO5EW
UT WOS:000359183400005
PM 25889759
DA 2019-10-23
ER

PT J
AU Walser, T
   Studer, C
AF Walser, Tobias
   Studer, Christoph
TI Sameness: The regulatory crux with nanomaterial identity and grouping
   schemes for hazard assessment
SO REGULATORY TOXICOLOGY AND PHARMACOLOGY
LA English
DT Editorial Material
DE Regulatory toxicology; Hazard assessment of nanomaterials; Grouping;
   Sameness; Identity of nanomaterials; Entity of nanomaterials; Testing
   strategy
AB Regulators and industry need clear rules for identification and grouping of nanomaterials for a streamlined quantitative hazard evaluation. Therefore, we provide convincing reasons for (i) why to introduce pragmatic definition of identities for nanomaterials, (ii) how to combine them into entities, and ultimately (iii) how the entities might be evaluated with testing strategies based on clouds of similar nanomaterials. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Walser, Tobias; Studer, Christoph] Fed Off Publ Hlth, CH-3003 Bern, Switzerland.
RP Walser, T (reprint author), Fed Off Publ Hlth, CH-3003 Bern, Switzerland.
OI Walser, Tobias/0000-0003-2904-9898
CR Arts J.H., 2015, REGUL TOXICOL PHARM
   Arts JHE, 2014, REGUL TOXICOL PHARM, V70, P492, DOI 10.1016/j.yrtph.2014.07.025
   Cohen JM, 2014, NANOTOXICOLOGY, V8, P216, DOI 10.3109/17435390.2013.879612
   Donaldson K, 2013, ADV DRUG DELIVER REV, V65, P2078, DOI 10.1016/j.addr.2013.07.014
   European Chemicals Agency, 2012, ECHA10B111EN
   European Commission, 2011, RNCRIPON3FPR1 EUR CO
   Godwin H, 2015, ACS NANO, V9, P3409, DOI 10.1021/acsnano.5b00941
   Lynch I, 2014, NANO TODAY, V9, P266, DOI 10.1016/j.nantod.2014.05.001
   NANO SUPPORT Project, 2012, SCI TECHN SUPP ASS N
   Nel AE, 2013, ACS NANO, V7, P6422, DOI 10.1021/nn4037927
   OECD, 2014, SER TEST ASS, V194
   Organisation for Economic Co-operation and Development OECD, 2013, REC COUNC SAF TEST A, VC, P107
   Rejman J, 2004, BIOCHEM J, V377, P159, DOI 10.1042/BJ20031253
   Schwirn Kathrin, 2014, Environmental Sciences Europe, V26, P4, DOI 10.1186/2190-4715-26-4
   Scott-Fordsmand JJ, 2014, NANO TODAY, V9, P546, DOI 10.1016/j.nantod.2014.07.001
   Thorley AJ, 2014, ACS NANO, V8, P11778, DOI 10.1021/nn505399e
   Zhang HY, 2012, ACS NANO, V6, P4349, DOI 10.1021/nn3010087
NR 17
TC 16
Z9 16
U1 0
U2 4
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0273-2300
EI 1096-0295
J9 REGUL TOXICOL PHARM
JI Regul. Toxicol. Pharmacol.
PD AUG
PY 2015
VL 72
IS 3
BP 569
EP 571
DI 10.1016/j.yrtph.2015.05.031
PG 3
WC Medicine, Legal; Pharmacology & Pharmacy; Toxicology
SC Legal Medicine; Pharmacology & Pharmacy; Toxicology
GA CP9ZZ
UT WOS:000360255700014
PM 26049104
DA 2019-10-23
ER

PT J
AU Cosme, MM
   Lister, AL
   Van Der Kraak, G
AF Cosme, Madelyne M.
   Lister, Andrea L.
   Van Der Kraak, Glen
TI Inhibition of spawning in zebrafish (Danio rerio): Adverse outcome
   pathways of quinacrine and ethinylestradiol
SO GENERAL AND COMPARATIVE ENDOCRINOLOGY
LA English
DT Article
DE Zebrafish; Endocrine disrupting compounds; Reproduction; Prostaglandins;
   Steroid hormones; Ovary
ID ENDOCRINE-DISRUPTING CHEMICALS; OOCYTE MATURATION; DRINKING-WATER;
   EXPRESSION; EXPOSURE; GROWTH; GENE; ETHYNYLESTRADIOL; PHARMACEUTICALS;
   TRANSCRIPTION
AB This study determined the effects of the estrogen receptor agonist ethinylestradiol (EE2) and the phospholipase A(2) inhibitor quinacrine (QUIN) on the pathways controlling follicular development, steroidogenesis, oocyte maturation, ovulation and spawning success in adult zebrafish. Both EE2 and QUIN inhibited spawning but did so through different mechanisms. EE2 affected follicular development (reduced ovarian size and reduction in the proportion of cortical alveolus, vitellogenic and mature follicle stages), steroidogenesis (reduced expression of aromatase), maturation (reduced luteinizing hormone receptor expression) and ovulation (reduced expression of cytosolic phospholipase A(2) and the nuclear progesterone receptor). Although EE2 alters the proportion of follicle stages within the ovary, the down-regulation of gene expression as a consequence of EE2 exposure was primarily due to a decline in expression of the genes of interest in vitellogenic and mature ovarian follicles. QUIN targeted ovulation via a reduction of the steroid 17 alpha,20 beta dihydroxy-4-prenen-3-one (17 alpha,20 beta-P) and decreased expression of the prostaglandin metabolizing enzyme cyclooxygenase 2. This study demonstrates the usefulness in defining the impacts of toxicants at the molecular and cellular, organ and whole organism level and how connections between these impacts can be used to describe the adverse outcome pathways (AOPs) that mediate toxicant action. Histological analysis and gene expression were effective tools in defining the AOPs of QUIN and EE2 while the measurement of reproductive hormones level did not provide much valuable information regarding the toxicant's mode of action. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Cosme, Madelyne M.; Van Der Kraak, Glen] Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada.
   [Lister, Andrea L.] Wilfrid Laurier Univ, Dept Biol, Waterloo, ON N2L 3C5, Canada.
RP Van Der Kraak, G (reprint author), Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada.
EM gvanderk@uoguelph.ca
FU NSERCNatural Sciences and Engineering Research Council of Canada;
   Canadian Water Network
FX This study was supported by grant to G.V.D.K from NSERC and the Canadian
   Water Network.
CR Ankley GT, 2007, ENVIRON SCI TECHNOL, V41, P8211, DOI 10.1021/es072658j
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   BERNDTSON AK, 1986, GEN COMP ENDOCR, V61, P134, DOI 10.1016/0016-6480(86)90258-3
   Carnevali O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010201
   Cheshenko K, 2008, GEN COMP ENDOCR, V155, P31, DOI 10.1016/j.ygcen.2007.03.005
   Clelland E, 2009, MOL CELL ENDOCRINOL, V312, P42, DOI 10.1016/j.mce.2009.04.009
   Ehsanian R, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-13
   ESPEY LL, 1982, FERTIL STERIL, V38, P238
   Hanna RN, 2010, BIOL REPROD, V82, P112, DOI 10.1095/biolreprod.109.078527
   Hill AJ, 2005, TOXICOL SCI, V86, P6, DOI 10.1093/toxsci/kfi110
   Hinfray N, 2006, ENVIRON TOXICOL, V21, P332, DOI 10.1002/tox.20203
   Hutchinson TH, 2006, ENVIRON HEALTH PERSP, V114, P106, DOI 10.1289/ehp.8062
   Ings JS, 2006, MOL REPROD DEV, V73, P943, DOI 10.1002/mrd.20490
   Irwin DA, 2012, GEN COMP ENDOCR, V177, P187, DOI 10.1016/j.ygcen.2012.03.006
   Jin YX, 2010, FISH SHELLFISH IMMUN, V28, P854, DOI 10.1016/j.fsi.2010.02.009
   Kwok HF, 2005, BIOL REPROD, V72, P1370, DOI 10.1095/biolreprod.104.038190
   Lister AL, 2008, GEN COMP ENDOCR, V159, P46, DOI 10.1016/j.ygcen.2008.07.017
   Lister A, 2009, AQUAT TOXICOL, V95, P320, DOI 10.1016/j.aquatox.2009.04.011
   Liu KC, 2013, GEN COMP ENDOCR, V192, P89, DOI 10.1016/j.ygcen.2013.06.023
   Metcalfe CD, 2013, SCI TOTAL ENVIRON, V454, P132, DOI 10.1016/j.scitotenv.2013.02.074
   Nagahama Y, 2008, DEV GROWTH DIFFER, V50, pS195, DOI 10.1111/j.1440-169X.2008.01019.x
   Nelson SN, 2010, GEN COMP ENDOCR, V168, P111, DOI 10.1016/j.ygcen.2010.04.020
   Pang YF, 2009, GEN COMP ENDOCR, V161, P58, DOI 10.1016/j.ygcen.2008.10.003
   Parker WJ, 2014, SCI TOTAL ENVIRON, V490, P360, DOI 10.1016/j.scitotenv.2014.05.023
   Pawlowski S., 2002, ECOTOX ENVIRON SAFE, V57, P330
   Peters REM, 2007, AQUAT TOXICOL, V85, P154, DOI 10.1016/j.aquatox.2007.08.010
   Rahman MF, 2009, J WATER HEALTH, V7, P224, DOI 10.2166/wh.2009.021
   Segner H, 2003, ECOTOX ENVIRON SAFE, V54, P302, DOI 10.1016/S0147-6513(02)00039-8
   SELMAN K, 1993, J MORPHOL, V218, P203, DOI 10.1002/jmor.1052180209
   Soares J, 2012, ECOTOXICOLOGY, V21, P1513, DOI 10.1007/s10646-012-0905-4
   Soffker M, 2012, CRIT REV TOXICOL, V42, P653, DOI 10.3109/10408444.2012.692114
   Tang RY, 2007, ACTA BIOCH BIOPH SIN, V39, P384, DOI 10.1111/j.1745-7270.2007.00283.x
   Urbatzka R, 2012, ENVIRON POLLUT, V164, P28, DOI 10.1016/j.envpol.2012.01.018
   Van den Belt K, 2002, ENVIRON TOXICOL CHEM, V21, P767, DOI 10.1002/etc.5620210412
   Van den Belt K, 2001, ARCH ENVIRON CON TOX, V41, P458, DOI 10.1007/s002440010272
   van den Heuvel MR, 2010, WATER QUAL RES J CAN, V45, P175
   Versonnen BJ, 2004, ENVIRON TOXICOL, V19, P198, DOI 10.1002/tox.20012
   Vogtherr M, 2003, J MED CHEM, V46, P3563, DOI 10.1021/jm034093h
   Vosges M, 2008, REPROD TOXICOL, V25, P161, DOI 10.1016/j.reprotox.2007.12.002
   Wang Y, 2004, BIOL REPROD, V71, P2056, DOI 10.1095/biolreprod.104.032649
   Wang YJ, 2002, GEN COMP ENDOCR, V127, P209, DOI 10.1016/S0016-6480(02)00041-2
   Weber LP, 2003, AQUAT TOXICOL, V63, P431, DOI 10.1016/S0166-445X(02)00208-4
   Zuo YG, 2013, ENVIRON SCI-PROC IMP, V15, P1529, DOI 10.1039/c3em00239j
NR 43
TC 5
Z9 5
U1 1
U2 43
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0016-6480
EI 1095-6840
J9 GEN COMP ENDOCR
JI Gen. Comp. Endocrinol.
PD AUG 1
PY 2015
VL 219
SI SI
BP 89
EP 101
DI 10.1016/j.ygcen.2015.01.013
PG 13
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA CN9GB
UT WOS:000358754100010
PM 25644209
DA 2019-10-23
ER

PT J
AU Becker, RA
   Ankley, GT
   Edwards, SW
   Kennedy, SW
   Linkov, I
   Meek, B
   Sachana, M
   Segner, H
   Van der Burg, B
   Villeneuve, DL
   Watanabe, H
   Barton-Maclaren, TS
AF Becker, Richard A.
   Ankley, Gerald T.
   Edwards, Stephen W.
   Kennedy, Sean W.
   Linkov, Igor
   Meek, Bette
   Sachana, Magdalini
   Segner, Helmut
   Van der Burg, Bart
   Villeneuve, Daniel L.
   Watanabe, Haruna
   Barton-Maclaren, Tara S.
TI Increasing Scientific Confidence in Adverse Outcome Pathways:
   Application of Tailored Bradford-Hill Considerations for Evaluating
   Weight of Evidence
SO REGULATORY TOXICOLOGY AND PHARMACOLOGY
LA English
DT Article
DE Adverse outcome pathway; Weight of evidence; Mode of action;
   Bradford-Hill considerations
ID ARYL-HYDROCARBON RECEPTOR; INDUCED DELAYED NEUROTOXICITY; OXIDATIVE
   STRESS-RESPONSE; HEXAVALENT CHROMIUM; ESTROGEN-RECEPTOR;
   GENE-EXPRESSION; REACTIVE OXYGEN; DRINKING-WATER; DAPHNIA-MAGNA; MOUSE
   DUODENUM
AB Systematic consideration of scientific support is a critical element in developing and, ultimately, using adverse outcome pathways (AOPs) for various regulatory applications. Though weight of evidence (WoE) analysis has been proposed as a basis for assessment of the maturity and level of confidence in an AOP, methodologies and tools are still being formalized. The Organization for Economic Co-operation and Development (OECD) Users' Handbook Supplement to the Guidance Document for Developing and Assessing AOPs (OECD 2014a; hereafter referred to as the OECD AOP Handbook) provides tailored Bradford-Hill (BH) considerations for systematic assessment of confidence in a given AOP. These considerations include (1) biological plausibility and (2) empirical support (dose-response, temporality, and incidence) for Key Event Relationships (KERs), and (3) essentiality of key events (KEs). Here, we test the application of these tailored BH considerations and the guidance outlined in the OECD AOP Handbook using a number of case examples to increase experience in more transparently documenting rationales for assigned levels of confidence to KEs and KERs, and to promote consistency in evaluation within and across AOPs. The major lessons learned from experience are documented, and taken together with the case examples, should contribute to better common understanding of the nature and form of documentation required to increase confidence in the application of AOPs for specific uses. Based on the tailored BH considerations and defining questions, a prototype quantitative model for assessing the WoE of an AOP using tools of multi-criteria decision analysis (MCDA) is described. The applicability of the approach is also demonstrated using the case example aromatase inhibition leading to reproductive dysfunction in fish. Following the acquisition of additional experience in the development and assessment of AOPs, further refinement of parameterization of the model through expert elicitation is recommended. Overall, the application of quantitative WoE approaches hold promise to enhance the rigor, transparency and reproducibility for AOP WoE determinations and may play an important role in delineating areas where research would have the greatest impact on improving the overall confidence in the AOP. (C) 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
C1 [Becker, Richard A.] Amer Chem Council, Washington, DC 20002 USA.
   [Ankley, Gerald T.; Villeneuve, Daniel L.] US EPA, Off Res & Dev, Midcontinent Ecol Div, Duluth, MN USA.
   [Edwards, Stephen W.] US EPA, Off Res & Dev, Integrated Syst Toxicol Div, Res Triangle Pk, NC 27711 USA.
   [Kennedy, Sean W.] Environm Canada, Natl Wildlife Res Ctr, Ottawa, ON K1A 0H3, Canada.
   [Linkov, Igor] US Army Corps Engineers, Engineer Res & Dev Ctr, Environm Lab, Concord, MA USA.
   [Meek, Bette] Univ Ottawa, Ottawa, ON, Canada.
   [Sachana, Magdalini] European Commiss, Joint Res Ctr, I-21027 Ispra, Italy.
   [Segner, Helmut] Univ Bern, Ctr Fish & Wildlife Hlth, Bern, Switzerland.
   [Van der Burg, Bart] BioDetect Syst BV, Amsterdam, Netherlands.
   [Watanabe, Haruna] Natl Inst Environm Studies, Ctr Environm Risk Res, Tsukuba, Ibaraki, Japan.
   [Barton-Maclaren, Tara S.] Hlth Canada, Existing Subst Risk Assessment Bur, Ottawa, ON K1A 0L2, Canada.
RP Becker, RA (reprint author), Amer Chem Council, 700 2nd St NE, Washington, DC 20002 USA.
EM ricic_becker@americanchemistry.com
FU Research Council of NorwayResearch Council of Norway [221455]
FX The content of this paper is the result of an international expert
   workshop on Advancing Adverse Outcome Pathways (AOPs) for Integrated
   Toxicology and Regulatory Applications held March 2-7, 2014 in Somma
   Lombardo, Italy. Support for the workshop was provided by the American
   Chemistry Council, BioDetection Systems, European Centre for
   Ecotoxicology and Toxicology of Chemicals, Environment Canada, European
   Commission Directorate General Joint Research Center, Human Toxicology
   Project Consortium, International Life Sciences Institute - Health and
   Environmental Science Institute, The Research Council of Norway (Grant
   no. 221455), Society for Environmental Toxicology and Chemistry, US Army
   Engineer Research and Development Center, and the US Environmental
   Protection Agency. The authors acknowledge the workshop organizing
   committee (Rick Becker, Natalia Garcia-Reyero, Ksenia Groh, Marlies
   Halder, Sean Kennedy, Teresa Lettieri, Edward Perkins, Knut Erik
   Tollefsen, Bart van der Burg, Dan Villeneuve, and Maurice Whelan), and
   all workshop participants for both plenary and informal discussions that
   influenced the content presented here. The views expressed are those of
   the authors, and do not necessarily represent the views of the
   organizations the authors are affiliated with or the sponsors. Mention
   of trade names or commercial products does not constitute endorsement or
   recommendation for use.
CR Abe R, 2015, AQUAT TOXICOL, V159, P44, DOI 10.1016/j.aquatox.2014.11.015
   ABOUDONIA MB, 1990, ANNU REV PHARMACOL, V30, P405
   ALSHARIF NZ, 1994, TOXICOLOGY, V92, P39, DOI 10.1016/0300-483X(94)90166-X
   Bal-Price A, 2015, CRIT REV TOXICOL, V45, P83, DOI 10.3109/10408444.2014.981331
   Beischlag TV, 2008, CRIT REV EUKAR GENE, V18, P207, DOI 10.1615/CritRevEukarGeneExpr.v18.i3.20
   Boobis AR, 2009, CRIT REV FOOD SCI, V49, P690, DOI 10.1080/10408390903098673
   Casarett L.J., 1922, CASARETT DOULLS TOXI
   Case RM, 2007, CELL CALCIUM, V42, P345, DOI 10.1016/j.ceca.2007.05.001
   Cheng L, 2003, WORLD J GASTROENTERO, V9, P2642
   Chia LA, 2010, PROG MOL BIOL TRANSL, V96, P157, DOI 10.1016/S1877-1173(10)96007-9
   Choudhary S, 2001, BIOCHEM PHARMACOL, V62, P1265, DOI 10.1016/S0006-2952(01)00762-6
   Cohen SM, 2011, TOXICOL SCI, V120, pS76, DOI 10.1093/toxsci/kfq365
   Cohen SM, 2010, CRIT REV TOXICOL, V40, P531, DOI 10.3109/10408441003742903
   Costa C, 2010, TOXICOLOGY, V271, P83, DOI 10.1016/j.tox.2010.02.014
   Curtis LR, 2011, TOXICOL APPL PHARM, V254, P1, DOI 10.1016/j.taap.2011.04.015
   Dalton TP, 2002, CHEM-BIOL INTERACT, V141, P77, DOI 10.1016/S0009-2797(02)00067-4
   De Flora S, 2000, CARCINOGENESIS, V21, P533, DOI 10.1093/carcin/21.4.533
   DeFlora S, 1997, CARCINOGENESIS, V18, P531, DOI 10.1093/carcin/18.3.531
   Deroo BJ, 2006, J CLIN INVEST, V116, P561, DOI 10.1172/JCI27987
   Doherty JD, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/70414
   EDSP, 2009, END DISR SCREEN PROG
   Emerick GL, 2012, CHEM-BIOL INTERACT, V199, P177, DOI 10.1016/j.cbi.2012.07.002
   Gielen S., 2005, ESTROGEN RECEPTOR SI
   GILLETTE JR, 1957, J PHARMACOL EXP THER, V119, P532
   Giorgi C, 2008, CURR MOL MED, V8, P119
   Gordon E, 2012, TOXICOL MECH METHOD, V22, P54, DOI 10.3109/15376516.2011.593054
   Hargreaves AJ, 2012, ADV EXP MED BIOL, V724, P189, DOI 10.1007/978-1-4614-0653-2_15
   Heldring N, 2007, PHYSIOL REV, V87, P905, DOI 10.1152/physrev.00026.2006
   Johnson L, 2013, GASTROINTESTINAL PHY
   JOHNSON MK, 1990, TOXICOL APPL PHARM, V102, P385, DOI 10.1016/0041-008X(90)90036-T
   Kalthoff S, 2010, J BIOL CHEM, V285, P5993, DOI 10.1074/jbc.M109.075770
   Kato Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001345
   Kato Y, 2010, GENOMICS, V95, P160, DOI 10.1016/j.ygeno.2009.12.005
   Kopf PG, 2010, TOXICOL APPL PHARM, V245, P91, DOI 10.1016/j.taap.2010.02.007
   Kopf PG, 2010, TOXICOL SCI, V117, P537, DOI 10.1093/toxsci/kfq218
   Kuiper GGJM, 1998, ENDOCRINOLOGY, V139, P4252, DOI 10.1210/en.139.10.4252
   LAPADULA DM, 1985, TOXICOL APPL PHARM, V79, P83, DOI 10.1016/0041-008X(85)90370-9
   Latchoumycandane C, 2002, ARCH TOXICOL, V76, P113
   LeBlanc GA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061715
   Legler J, 1999, TOXICOL SCI, V48, P55, DOI 10.1093/toxsci/48.1.55
   Lotti Marcello, 2005, Toxicol Rev, V24, P37, DOI 10.2165/00139709-200524010-00003
   Lu H, 2011, TOXICOL APPL PHARM, V256, P122, DOI 10.1016/j.taap.2011.07.019
   McLachlan JA, 2001, ENDOCR REV, V22, P319, DOI 10.1210/er.22.3.319
   Miyakawa H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2868
   Moggs JG, 2004, ENVIRON HEALTH PERSP, V112, P1589, DOI 10.1289/ehp.7345
   Moser M, 2000, MECH DEVELOP, V90, P279, DOI 10.1016/S0925-4773(99)00239-7
   Mou DL, 2006, INT J NEUROSCI, V116, P1303, DOI 10.1080/00207450500519655
   National Toxicology Program (NTP), 2007, TECHN RE TOX STUD SO
   National Toxicology Program (NTP), 2008, NAT TOX PROGR TECH R, P1
   Nebert DW, 2000, BIOCHEM PHARMACOL, V59, P65, DOI 10.1016/S0006-2952(99)00310-X
   O'Brien TJ, 2013, MUTAT RES-GEN TOX EN, V754, P15, DOI 10.1016/j.mrgentox.2013.03.008
   Oda S, 2005, CHEMOSPHERE, V60, P74, DOI 10.1016/j.chemosphere.2004.12.080
   OECD, 2009, TEST 455 STABL TRANS
   OECD, 2012, TEST 455 PERF BAS TE
   Olmstead AW, 2003, ENVIRON HEALTH PERSP, V111, P919, DOI 10.1289/ehp.5982
   Palace VP, 1996, ENVIRON TOXICOL CHEM, V15, P955, DOI 10.1002/etc.5620150618
   Paris M, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-219
   Pitot HC, 2000, ALIMENT PHARM THERAP, V14, P153, DOI 10.1046/j.1365-2036.2000.014s1153.x
   Proctor DM, 2012, CHEMOSPHERE, V89, P487, DOI 10.1016/j.chemosphere.2012.04.065
   Reichard John F., 2005, Dose-Response, V3, P306, DOI 10.2203/dose-response.003.03.003
   Richardson RJ, 2013, CHEM-BIOL INTERACT, V203, P238, DOI 10.1016/j.cbi.2012.10.024
   Schlezinger JJ, 1999, MOL PHARMACOL, V56, P588
   Schlezinger JJ, 2001, AQUAT TOXICOL, V52, P101, DOI 10.1016/S0166-445X(00)00141-7
   Schlosser PM, 2014, TOXICOL APPL PHARM, V280, P352, DOI 10.1016/j.taap.2014.08.010
   Senft AP, 2002, FREE RADICAL BIO MED, V33, P1268, DOI 10.1016/S0891-5849(02)01014-6
   Shaker A, 2010, TRANSL RES, V156, P180, DOI 10.1016/j.trsl.2010.06.003
   Shertzer HG, 1998, BIOCHEM BIOPH RES CO, V253, P44, DOI 10.1006/bbrc.1998.9753
   Slezak BP, 2000, TOXICOL SCI, V54, P390, DOI 10.1093/toxsci/54.2.390
   Sonneveld E, 2006, TOXICOL SCI, V89, P173, DOI 10.1093/toxsci/kfj009
   Takahashi M, 2004, CANCER SCI, V95, P475, DOI 10.1111/j.1349-7006.2004.tb03235.x
   Tatarazako N, 2003, CHEMOSPHERE, V53, P827, DOI 10.1016/S0045-6535(03)00761-6
   Thompson CM, 2015, TOXICOL SCI, V143, P16, DOI 10.1093/toxsci/kfu206
   Thompson CM, 2013, CRIT REV TOXICOL, V43, P244, DOI 10.3109/10408444.2013.768596
   Thompson CM, 2012, TOXICOL SCI, V125, P79, DOI 10.1093/toxsci/kfr280
   Thompson CM, 2011, TOXICOL SCI, V123, P58, DOI 10.1093/toxsci/kfr164
   Thornton JW, 2001, P NATL ACAD SCI USA, V98, P5671, DOI 10.1073/pnas.091553298
   Toyota K, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-239
   Tremblay A, 1998, ENDOCRINOLOGY, V139, P111, DOI 10.1210/en.139.1.111
   Tsuji G, 2011, J DERMATOL SCI, V62, P42, DOI 10.1016/j.jdermsci.2010.10.017
   VERONESI B, 1991, TOXICOL APPL PHARM, V108, P428, DOI 10.1016/0041-008X(91)90089-W
   Weiner ML, 1999, NEUROTOXICOLOGY, V20, P653
   Zangar RC, 2004, TOXICOL APPL PHARM, V199, P316, DOI 10.1016/j.taap.2004.01.018
NR 82
TC 76
Z9 81
U1 3
U2 38
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0273-2300
EI 1096-0295
J9 REGUL TOXICOL PHARM
JI Regul. Toxicol. Pharmacol.
PD AUG
PY 2015
VL 72
IS 3
BP 514
EP 537
DI 10.1016/j.yrtph.2015.04.004
PG 24
WC Medicine, Legal; Pharmacology & Pharmacy; Toxicology
SC Legal Medicine; Pharmacology & Pharmacy; Toxicology
GA CP9ZZ
UT WOS:000360255700010
PM 25863193
OA Other Gold
DA 2019-10-23
ER

PT J
AU Tonk, ECM
   Pennings, JLA
   Piersma, AH
AF Tonk, Elisa C. M.
   Pennings, Jeroen L. A.
   Piersma, Aldert H.
TI An adverse outcome pathway framework for neural tube and axial defects
   mediated by modulation of retinoic acid homeostasis
SO REPRODUCTIVE TOXICOLOGY
LA English
DT Review
DE Retinoic acid; Embryogenesis; Developmental toxicity; Malformations;
   Neural tube patterning; Axial patterning; Biomarkers; Gene expression
ID WHOLE-EMBRYO CULTURE; ZEBRAFISH EMBRYOTOXICITY TEST; DIFFERENTIAL
   GENE-EXPRESSION; STEM-CELL TEST; DEVELOPMENTAL TOXICITY; IN-VIVO;
   VERTEBRATE SEGMENTATION; TRANSCRIPTOMIC ANALYSIS; TERATOGENIC RISK;
   VALPROIC ACID
AB Developmental toxicity can be caused through a multitude of mechanisms and can therefore not be captured through a single simple mechanistic paradigm. However, it may be possible to define a selected group of overarching mechanisms that might allow detection of the vast majority of developmental toxicants. Against this background, we have explored the usefulness of retinoic acid mediated regulation of neural tube and axial patterning as a general mechanism that, when perturbed, may result in manifestations of developmental toxicity that may cover a large part of malformations known to occur in experimental animals and in man. Through a literature survey, we have identified key genes in the regulation of retinoic acid homeostasis, as well as marker genes of neural tube and axial patterning, that may be used to detect developmental toxicants in in vitro systems. A retinoic acid-neural tube/axial patterning adverse outcome pathway (RA-NTA AOP) framework was designed. The framework was tested against existing data of flusilazole exposure in the rat whole embryo culture, the zebrafish embryotoxicity test, and the embryonic stem cell test. Flusilazole is known to interact with retinoic acid homeostasis, and induced common and unique NTA marker gene changes in the three test systems. Flusilazole-induced changes were similar in directionality to gene expression responses after retinoic acid exposure. It is suggested that the RA-NTA framework may provide a general tool to define mechanistic pathways and biomarkers of developmental toxicity that may be used in alternative in vitro assays for the detection of embryotoxic compounds. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Tonk, Elisa C. M.; Pennings, Jeroen L. A.; Piersma, Aldert H.] Natl Inst Publ Hlth & Environm RIVM, Ctr Hlth Protect, NL-3720 BA Bilthoven, Netherlands.
   [Piersma, Aldert H.] Univ Utrecht, Inst Risk Assessment Sci, Utrecht, Netherlands.
RP Piersma, AH (reprint author), Natl Inst Publ Hlth & Environm RIVM, Ctr Hlth Protect, POB 1, NL-3720 BA Bilthoven, Netherlands.
EM aldert.piersma@rivm.nl
OI Pennings, Jeroen L.A./0000-0002-9188-6358
FU Netherlands Genomics Initiative (NGI)/Netherlands Organization for
   Scientific Research (NWO)Netherlands Organization for Scientific
   Research (NWO) [050-060-510]; Ministry of Infrastructure and the
   Environment; Commission of the European CommunitiesEuropean Union (EU)
   [GA244236]
FX This work was supported by the Netherlands Genomics Initiative
   (NGI)/Netherlands Organization for Scientific Research (NWO) [grant
   number 050-060-510] and the Ministry of Infrastructure and the
   Environment. This work was carried out with financial support from the
   Commission of the European Communities, the collaborative project
   ChemScreen (GA244236).
CR Abu-Abed S, 2001, GENE DEV, V15, P226, DOI 10.1101/gad.855001
   Alexander T, 2009, ANNU REV CELL DEV BI, V25, P431, DOI 10.1146/annurev.cellbio.042308.113423
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Aulehla A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000869
   Beissbarth T, 2006, METHOD ENZYMOL, V411, P340, DOI 10.1016/S0076-6879(06)11018-6
   Billings SE, 2013, FASEB J, V27, P4877, DOI 10.1096/fj.13-227967
   Burroughs-Garcia J, 2011, DEV DYNAM, V240, P828, DOI 10.1002/dvdy.22589
   Campo-Paysaa F, 2008, GENESIS, V46, P640, DOI 10.1002/dvg.20444
   Close R, 2002, MECH DEVELOP, V118, P269, DOI 10.1016/S0925-4773(02)00283-6
   Collins MD, 1999, ANNU REV PHARMACOL, V39, P399, DOI 10.1146/annurev.pharmtox.39.1.399
   Core N, 2007, DEV BIOL, V308, P407, DOI 10.1016/j.ydbio.2007.05.038
   COTARIU D, 1991, LIFE SCI, V48, P1341, DOI 10.1016/0024-3205(91)90430-J
   de Jong E, 2011, TOXICOL APPL PHARM, V253, P103, DOI 10.1016/j.taap.2011.03.014
   Drummond DL, 2013, BMC DEV BIOL, V13, DOI 10.1186/1471-213X-13-31
   DUESTER G, 1991, ALCOHOL CLIN EXP RES, V15, P568, DOI 10.1111/j.1530-0277.1991.tb00562.x
   Duester Gregg, 2007, Birth Defects Research, V81, P84, DOI 10.1002/bdrc.20092
   Enns GM, 1999, AM J MED GENET, V86, P237, DOI 10.1002/(SICI)1096-8628(19990917)86:3<237::AID-AJMG8>3.3.CO;2-M
   Galceran J, 2004, GENE DEV, V18, P2718, DOI 10.1101/gad.1249504
   GEELEN JAG, 1979, CRC CR REV TOXICOL, V6, P351, DOI 10.3109/10408447909043651
   Giavini E, 2010, TOXICOL LETT, V198, P106, DOI 10.1016/j.toxlet.2010.07.005
   Grinberg I, 2005, CLIN GENET, V67, P290, DOI 10.1111/j.1399-0004.2005.00418.x
   Hermsen SAB, 2013, TOXICOL APPL PHARM, V272, P161, DOI 10.1016/j.taap.2013.05.037
   Hermsen SAB, 2012, TOXICOL SCI, V127, P303, DOI 10.1093/toxsci/kfs092
   Houtmeyers R, 2013, CELL MOL LIFE SCI, V70, P3791, DOI 10.1007/s00018-013-1285-5
   Janer G, 2008, REGUL TOXICOL PHARM, V50, P206, DOI 10.1016/j.yrtph.2007.11.007
   Jergil M, 2011, TOXICOL SCI, V121, P328, DOI 10.1093/toxsci/kfr070
   Jouve C, 2000, DEVELOPMENT, V127, P1421
   Kleinjan DA, 1997, MECH DEVELOP, V67, P157, DOI 10.1016/S0925-4773(97)00116-0
   Knudsen TB, 2009, REPROD TOXICOL, V28, P209, DOI 10.1016/j.reprotox.2009.03.016
   Krol AJ, 2011, DEVELOPMENT, V138, P2783, DOI 10.1242/dev.063834
   Lammer E, 2009, COMP BIOCHEM PHYS C, V149, P196, DOI 10.1016/j.cbpc.2008.11.006
   LAMMER EJ, 1985, NEW ENGL J MED, V313, P837, DOI 10.1056/NEJM198510033131401
   Lara-Ramirez R, 2013, INT J BIOCHEM CELL B, V45, P1302, DOI 10.1016/j.biocel.2013.04.002
   Lickert H, 2005, DEVELOPMENT, V132, P2599, DOI 10.1242/dev.01842
   MacKay C, 2013, ALTEX-ALTERN ANIM EX, V30, P473, DOI 10.14573/altex.2013.4.473
   MacLean G, 2007, ENDOCRINOLOGY, V148, P4560, DOI 10.1210/en.2007-0492
   Maden M, 2007, NAT REV NEUROSCI, V8, P755, DOI 10.1038/nrn2212
   Maurus D, 2009, GENE DEV, V23, P1461, DOI 10.1101/gad.517009
   Menegola E, 2005, BIRTH DEFECTS RES B, V74, P185, DOI 10.1002/bdrb.20035
   Menegola E, 2005, TOXICOL IN VITRO, V19, P737, DOI 10.1016/j.tiv.2005.04.005
   Neijts R, 2014, DEV DYNAM, V243, P88, DOI 10.1002/dvdy.24027
   Niederreither K, 2008, NAT REV GENET, V9, P541, DOI 10.1038/nrg2340
   Oates AC, 2012, DEVELOPMENT, V139, P625, DOI 10.1242/dev.063735
   OECD (Organisation for Economic Cooperation and Development), 2001, PREN DEV TOX STUD
   Organisation for Economic Co-operation and Development (OECD), 2013, OECD SER TEST ASS, V184
   Paschaki M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062274
   Pennimpede T, 2010, BIRTH DEFECTS RES A, V88, P883, DOI 10.1002/bdra.20709
   Piersma AH, 2011, CRIT REV TOXICOL, V41, P545, DOI 10.3109/10408444.2011.554794
   Pourquie O, 2011, CELL, V145, P650, DOI 10.1016/j.cell.2011.05.011
   Reijntjes S, 2005, DEV BIOL, V285, P224, DOI 10.1016/j.ydbio.2005.06.019
   Rhinn M, 2012, DEVELOPMENT, V139, P843, DOI 10.1242/dev.065938
   Robinson JF, 2012, REPROD TOXICOL, V34, P275, DOI 10.1016/j.reprotox.2012.05.088
   Robinson JF, 2012, TOXICOL SCI, V126, P255, DOI 10.1093/toxsci/kfr343
   Robinson JF, 2012, TOXICOL SCI, V126, P242, DOI 10.1093/toxsci/kfr342
   ROSA FW, 1983, LANCET, V2, P513
   Sakai Y, 2001, GENE DEV, V15, P213, DOI 10.1101/gad.851501
   Sandell LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030698
   Satoh W, 2006, DEVELOPMENT, V133, P989, DOI 10.1242/dev.02274
   Schilling TF, 2012, CURR OPIN GENET DEV, V22, P562, DOI 10.1016/j.gde.2012.11.012
   Seth A, 2006, DEVELOPMENT, V133, P725, DOI 10.1242/dev.02244
   Shim JH, 2010, MOL CELLS, V29, P239, DOI 10.1007/s10059-010-0022-2
   Slob W, 2002, TOXICOL SCI, V66, P298, DOI 10.1093/toxsci/66.2.298
   Steinmetz PRH, 2011, EVOL DEV, V13, P72, DOI 10.1111/j.1525-142X.2010.00457.x
   Sturgeon K, 2011, DEVELOPMENT, V138, P65, DOI 10.1242/dev.058727
   Theunissen PT, 2011, TOXICOL SCI, V122, P437, DOI 10.1093/toxsci/kfr134
   Theveneau E, 2012, WIRES DEV BIOL, V1, P435, DOI 10.1002/wdev.28
   Tonk ECM, 2013, REPROD TOXICOL, V41, P57, DOI 10.1016/j.reprotox.2013.06.069
   USA NNAoS, 2007, TOX TEST 21 CENT VIS
   Vajda FJE, 2010, EPILEPSIA, V51, P805, DOI 10.1111/j.1528-1167.2009.02336.x
   van Dartel DAM, 2011, TOXICOL APPL PHARM, V251, P110, DOI 10.1016/j.taap.2010.12.008
   van Dartel DAM, 2010, TOXICOL SCI, V116, P130, DOI 10.1093/toxsci/kfq127
   Vinken M, 2013, TOXICOLOGY, V312, P158, DOI 10.1016/j.tox.2013.08.011
   Vitobello A, 2011, DEV CELL, V20, P469, DOI 10.1016/j.devcel.2011.03.011
   Wassef MA, 2008, DEVELOPMENT, V135, P3369, DOI 10.1242/dev.023614
   White RJ, 2007, PLOS BIOL, V5, P2522, DOI 10.1371/journal.pbio.0050304
   Wilm B, 2004, DEV BIOL, V271, P176, DOI 10.1016/j.ydbio.2004.03.034
   Yoon M, 2012, CRIT REV TOXICOL, V42, P633, DOI 10.3109/10408444.2012.692115
NR 77
TC 21
Z9 21
U1 2
U2 18
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0890-6238
J9 REPROD TOXICOL
JI Reprod. Toxicol.
PD AUG 1
PY 2015
VL 55
SI SI
BP 104
EP 113
DI 10.1016/j.reprotox.2014.10.008
PG 10
WC Reproductive Biology; Toxicology
SC Reproductive Biology; Toxicology
GA CM0IF
UT WOS:000357360900011
PM 25461899
DA 2019-10-23
ER

PT J
AU Lewin, G
   Escher, SE
   van der Burg, B
   Simetska, N
   Mangelsdorf, I
AF Lewin, Geertje
   Escher, Sylvia E.
   van der Burg, Bart
   Simetska, Nelly
   Mangelsdorf, Inge
TI Structural features of endocrine active chemicals - A comparison of in
   vivo and in vitro data
SO REPRODUCTIVE TOXICOLOGY
LA English
DT Article
DE Category approach; Estrogen receptor; Reproductive toxicity; Predictive
   screening; Toxicological databases; Structural features
ID RAT UTEROTROPHIC ASSAY; RISK-ASSESSMENT; READ-ACROSS; MODELS; TOXICITY;
   PATHWAY
AB Studies on reproductive toxicity need high numbers of test animals. Therefore, we investigated whether chemical structural features (SF) in combination with in vitro data on specific adverse outcome pathways (AOPs) may be used for predicting reproductive toxicity of untested chemicals. Using the OECD Toolbox and expert judgment, we identified 89 structure groups for 275 chemicals for which the results of prenatal developmental toxicity or multigeneration studies were present in the Fraunhofer database on Fertility and Developmental Toxicity in experimental animals (FeDTex) database. Likewise, we evaluated 220 chemicals which had been tested in reporter gene assays on endocrine ((anti)estrogenic and (anti)androgenic) properties in the CALUX(R) test battery. There was a large spread of effect levels for substances within the chemical structure groups for both, in vivo and in vitro results. The groups of highest concern (diphenyl derivatives, planar conjugated systems with fused rings, phenols and organophosphates) correlated quite well, however, between the in vivo and in vitro data on estrogenic activity. For the 56 chemicals represented in both databases, lowest effect doses in vivo correlated well with the estrogenic activity in vitro. These results suggest that a panel of assays covering relevant AOPs and data on metabolism and toxicokinetics may allow prediction of relative reproductive or development toxicity potency within the identified chemical structure groups. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Lewin, Geertje; Escher, Sylvia E.; Simetska, Nelly; Mangelsdorf, Inge] Fraunhofer Inst Toxicol & Expt Med ITEM, Hannover, Germany.
   [van der Burg, Bart] BioDetect Syst BV, Amsterdam, Netherlands.
RP Lewin, G (reprint author), Fraunhofer Inst Toxicol & Expt Med ITEM, Hannover, Germany.
EM g.lewin@web.de
FU Commission of the European Communities, collaborative project
   ChemScreenEuropean Union (EU) [GA244236]; CEFIC LRI
FX This work was carried out with financial support from the Commission of
   the European Communities, the collaborative project ChemScreen
   (GA244236). The development of the FeDTex database was supported by a
   grant from CEFIC LRI.
CR Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   [Anonymous], 2013, EFSA J PARM IT EUR F
   BAKKE JL, 1977, BIOL NEONATE, V31, P71
   Batke M, 2013, TOXICOL LETT, V218, P293, DOI 10.1016/j.toxlet.2012.09.002
   Benigni R, 2007, ENVIRON MOL MUTAGEN, V48, P754, DOI 10.1002/em.20355
   Dix DJ, 2012, TOXICOL SCI, V130, P440, DOI 10.1093/toxsci/kfs281
   ECHA, 2008, GUID INF REQ CHEM SA
   ECHA, 2012, GUID INF REQ CHEM SA
   Ema M, 2001, REPROD TOXICOL, V15, P505, DOI 10.1016/S0890-6238(01)00160-5
   Fabjan E, 2006, CRIT REV TOXICOL, V36, P695, DOI 10.1080/10408440600894914
   Hewitt M, 2013, CRIT REV TOXICOL, V43, P537, DOI 10.3109/10408444.2013.811215
   Hewitt M, 2010, REPROD TOXICOL, V30, P147, DOI 10.1016/j.reprotox.2009.12.003
   hoc-AG A., 2013, BUNDESGESUNDHEITSBLA, V56, P286
   Kortenkamp A., 2011, STATE ART ASSESSMENT
   Lynch H T, 1990, Int J Risk Saf Med, V1, P171, DOI 10.3233/JRS-1990-1301
   Mark M, 2006, ANNU REV PHARMACOL, V46, P451, DOI 10.1146/annurev.pharmtox.46.120604.141156
   McLachlan JA, 2001, APMIS, V109, P263, DOI 10.1034/j.1600-0463.2001.d01-119.x
   OECD, 2013, OECD SER TEST ASS, V184
   OECD, 2014, OECD SER TEST ASS
   OECD, 2011, OECD ENV HLTH SAFETY, P1
   OECD (Organisation for Economic Co-operation and Development), 2009, OECD SER TEST ASS
   Piersma AH, 2013, REPROD TOXICOL, V38, P53, DOI 10.1016/j.reprotox.2013.03.002
   ROSATO RR, 1992, ACTA ENDOCRINOL-COP, V127, P547, DOI 10.1530/acta.0.1270547
   Rotroff DM, 2014, ENVIRON SCI TECHNOL, V48, P8706, DOI 10.1021/es502676e
   Saldutti LP, 2013, ALTEX-ALTERN ANIM EX, V30, P353, DOI 10.14573/altex.2013.3.353
   Schaefer C, 2007, DRUGS DURING PREGNANCY AND LACTATION: TREATMENT OPTIONS AND RISK ASSESSMENT, 2ND EDITION, P1
   Schenk B, 2010, REPROD TOXICOL, V30, P200, DOI 10.1016/j.reprotox.2010.05.012
   Schulz F, 2014, TOXICOL LETT, V226, P245, DOI 10.1016/j.toxlet.2014.01.045
   Scialli AR, 2008, REGUL TOXICOL PHARM, V51, P244, DOI 10.1016/j.yrtph.2008.04.008
   Sonneveld E, 2006, TOXICOL SCI, V89, P173, DOI 10.1093/toxsci/kfj009
   van der Linden SC, 2014, MUTAT RES-GEN TOX EN, V760, P23, DOI 10.1016/j.mrgentox.2013.09.009
   Vinken M, 2013, TOXICOL SCI, V136, P97, DOI 10.1093/toxsci/kft177
   Wetmore BA, 2012, TOXICOL SCI, V125, P157, DOI 10.1093/toxsci/kfr254
   WHO, 2011, DDT IND RES SPRAYING
   Wibbertmann A, 2011, ECOTOX ENVIRON SAFE, V74, P1089, DOI 10.1016/j.ecoenv.2011.02.007
   Wu SD, 2010, REGUL TOXICOL PHARM, V56, P67, DOI 10.1016/j.yrtph.2009.09.006
   Yamasaki K, 2003, TOXICOLOGY, V183, P93, DOI 10.1016/S0300-483X(02)00445-6
   Yamasaki K, 2003, TOXICOL LETT, V142, P119, DOI 10.1016/S0378-4274(03)00019-5
NR 38
TC 4
Z9 4
U1 1
U2 29
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0890-6238
J9 REPROD TOXICOL
JI Reprod. Toxicol.
PD AUG 1
PY 2015
VL 55
SI SI
BP 81
EP 94
DI 10.1016/j.reprotox.2014.10.009
PG 14
WC Reproductive Biology; Toxicology
SC Reproductive Biology; Toxicology
GA CM0IF
UT WOS:000357360900009
PM 25461902
DA 2019-10-23
ER

PT J
AU Piroird, C
   Ovigne, JM
   Rousset, F
   Martinozzi-Teissier, S
   Gomes, C
   Cotovio, J
   Alepee, N
AF Piroird, Cecile
   Ovigne, Jean-Marc
   Rousset, Francoise
   Martinozzi-Teissier, Silvia
   Gomes, Charles
   Cotovio, Jose
   Alepee, Nathalie
TI The Myeloid U937 Skin Sensitization Test (U-SENS) addresses the
   activation of dendritic cell event in the adverse outcome pathway for
   skin sensitization
SO TOXICOLOGY IN VITRO
LA English
DT Article
DE Skin sensitization; Dendritic cells; CD86 induction; MUSST; U-SENS (TM);
   Predictivity
ID LYMPH-NODE ASSAY; TEST H-CLAT; SCREENING CONTACT ALLERGENS; IN-VITRO;
   PEPTIDE REACTIVITY; RISK-ASSESSMENT; END-POINTS; POTENCY; PREDICTION;
   CHEMICALS
AB The U-SENS(TM) assay, formerly known as MUSST (Myeloid U937 Skin Sensitization Test), is an in vitro method to assess skin sensitization. Dendritic cell activation following exposure to sensitizers was modelled in the U937 human myeloid cell line by measuring the induction of the expression of CD86 by flow cytometry. The predictive performance of U-SENS(TM) was assessed via a comprehensive comparison analysis with the available human and LLNA data of 175 substances. U-SENS(TM) showed 79% specificity, 90% sensitivity and 88% accuracy. A four laboratory ring study demonstrated the transferability, reliability and reproducibility of U-SENS(TM), with a reproducibility of 95% within laboratories and 79% between-laboratories, showing that the U-SENS(TM) assay is a promising tool in a skin sensitization risk assessment testing strategy. (C) 2015 Published by Elsevier Ltd.
C1 [Piroird, Cecile; Ovigne, Jean-Marc; Rousset, Francoise; Martinozzi-Teissier, Silvia; Gomes, Charles; Cotovio, Jose; Alepee, Nathalie] LOreal Res & Innovat, F-93600 Aulnay Sous Bois, France.
RP Alepee, N (reprint author), LOreal Res & Innovat, 1 Ave Eugene Schueller, F-93600 Aulnay Sous Bois, France.
EM nalepee@rd.loreal.com
FU L'Oreal Research Innovation
FX No external funding was received for this study. The organisation of the
   study and evaluation of the data were funded by L'Oreal Research &
   Innovation.
CR Ade Nadege, 2006, J Immunotoxicol, V3, P189, DOI 10.1080/15476910600978038
   Adler S, 2011, ARCH TOXICOL, V85, P367, DOI 10.1007/s00204-011-0693-2
   Aiba S, 1997, EUR J IMMUNOL, V27, P3031, DOI 10.1002/eji.1830271141
   [Anonymous], 2012, OECD SER TEST ASS, V168
   Api AM, 2008, REGUL TOXICOL PHARM, V52, P3, DOI 10.1016/j.yrtph.2007.10.008
   Aptula AO, 2006, CHEM RES TOXICOL, V19, P1097, DOI 10.1021/tx0601004
   Arts JHE, 2008, TOXICOL SCI, V106, P423, DOI 10.1093/toxsci/kfn199
   Ashikaga T, 2006, TOXICOL IN VITRO, V20, P767, DOI 10.1016/j.tiv.2005.10.012
   Balls M., 2000, ATLA-ALTERN LAB ANIM, V28, P366
   Basketter DA, 2005, CONTACT DERMATITIS, V53, P260, DOI 10.1111/j.0105-1873.2005.00707.x
   Basketter DA, 2003, CLIN EXP DERMATOL, V28, P218, DOI 10.1046/j.1365-2230.2003.01247.x
   Basketter DA, 2007, CONTACT DERMATITIS, V57, P70, DOI 10.1111/j.1600-0536.2007.01141.x
   Basketter DA, 2014, DERMATITIS, V25, P11, DOI 10.1097/DER.0000000000000003
   Bauch C, 2012, REGUL TOXICOL PHARM, V63, P489, DOI 10.1016/j.yrtph.2012.05.013
   Bauch C, 2011, TOXICOL IN VITRO, V25, P1162, DOI 10.1016/j.tiv.2011.05.030
   Bertrand F, 1997, CHEM RES TOXICOL, V10, P335, DOI 10.1021/tx960087v
   Coutant KD, 1999, TOXICOL SCI, V52, P189, DOI 10.1093/toxsci/52.2.189
   Dearman RJ, 1999, J APPL TOXICOL, V19, P149, DOI 10.1002/(SICI)1099-1263(199905/06)19:3<149::AID-JAT557>3.0.CO;2-L
   DEGROOT AC, 1988, J AM ACAD DERMATOL, V18, P350, DOI 10.1016/S0190-9622(88)70051-1
   Emter R, 2010, TOXICOL APPL PHARM, V245, P281, DOI 10.1016/j.taap.2010.03.009
   Estrada E, 2003, CHEM RES TOXICOL, V16, P1226, DOI 10.1021/tx034093k
   EURL ECVAM, 2013, JRC SCI POL REP
   EURL ECVAM, 2014, JRC SCI POL REP
   Gerberick GF, 2007, TOXICOL SCI, V97, P417, DOI 10.1093/toxsci/kfm064
   Gerberick GF, 2005, DERMATITIS, V16, P157, DOI 10.2310/6620.2005.05040
   Gerberick GF, 2004, TOXICOL SCI, V81, P332, DOI 10.1093/toxsci/kfh213
   Gomes C., 2012, COMPSTAT 20 INT C CO, P271
   Gomes C., 2014, ARTIF INTELL RES, V3, P52
   Hartung T, 2004, ATLA-ALTERN LAB ANIM, V32, P467, DOI 10.1177/026119290403200503
   ICCVAM, 2008, ICCVAM DAT
   Jaworska J., 2013, J APPL TOXICOL
   Jaworska J, 2011, ALTEX-ALTERN ANIM EX, V28, P211, DOI 10.14573/altex.2011.3.211
   Jowsey IR, 2006, J APPL TOXICOL, V26, P341, DOI 10.1002/jat.1146
   Kern PS, 2010, DERMATITIS, V21, P8, DOI 10.2310/6620.2009.09038
   Kimber I, 2003, FOOD CHEM TOXICOL, V41, P1799, DOI 10.1016/S0278-6915(03)00223-0
   Kimber I, 1995, TOXICOLOGY, V103, P63, DOI 10.1016/0300-483X(95)03114-U
   Kimber I, 2008, REGUL TOXICOL PHARM, V52, P39, DOI 10.1016/j.yrtph.2008.01.010
   Natsch A., 2013, J APPL TOXICOL
   Natsch A, 2009, TOXICOL SCI, V107, P106, DOI 10.1093/toxsci/kfn204
   NIH, 1999, NIH PUBL, P211
   Nukada Y, 2013, TOXICOL IN VITRO, V27, P609, DOI 10.1016/j.tiv.2012.11.006
   OECD, 2005, SIDS IN ASS REP PHTH
   OECD, 1992, OECD GUID TEST CHEM
   Organisation for Economic Cooperation and Development (OECD), 2010, OECD GUID TEST CHEM
   Patlewicz G, 2008, SAR QSAR ENVIRON RES, V19, P495, DOI 10.1080/10629360802083871
   Python F, 2007, TOXICOL APPL PHARM, V220, P113, DOI 10.1016/j.taap.2006.12.026
   Reisinger K, 2015, TOXICOL IN VITRO, V29, P259, DOI 10.1016/j.tiv.2014.10.018
   Roberts DW, 2011, CHEM RES TOXICOL, V24, P1003, DOI 10.1021/tx100420w
   Roberts DW, 2008, J APPL TOXICOL, V28, P443, DOI 10.1002/jat.1293
   Rousset F, 2000, DEV AN VET, V31, P635
   Ryan CA, 2002, FOOD CHEM TOXICOL, V40, P1719, DOI 10.1016/S0278-6915(02)00116-3
   Sakaguchi H, 2010, TOXICOL IN VITRO, V24, P1810, DOI 10.1016/j.tiv.2010.05.012
   Schlede E, 2003, TOXICOLOGY, V193, P219, DOI 10.1016/S0300-483X(03)00266-X
   SMITH CK, 2001, ALLERGIC CONTACT DER
   Smith-Pease C. K., 2003, CLIN EXP DERMATOL, V28, P177
   Takenouchi O, 2013, J TOXICOL SCI, V38, P599, DOI 10.2131/jts.38.599
   UN, 2011, GLOB HARM SYST CLA 3
   Urbisch D., 2014, REGUL TOXIC IN PRESS
   Warbrick EV, 1999, CONTACT DERMATITIS, V41, P325
NR 59
TC 38
Z9 41
U1 0
U2 3
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0887-2333
J9 TOXICOL IN VITRO
JI Toxicol. Vitro
PD AUG
PY 2015
VL 29
IS 5
BP 901
EP 916
DI 10.1016/j.tiv.2015.03.009
PG 16
WC Toxicology
SC Toxicology
GA CL5EB
UT WOS:000356981500010
PM 25820135
DA 2019-10-23
ER

PT J
AU Riedl, J
   Schreiber, R
   Otto, M
   Heilmeier, H
   Altenburger, R
   Schmitt-Jansen, M
AF Riedl, Janet
   Schreiber, Rene
   Otto, Matthias
   Heilmeier, Hermann
   Altenburger, Rolf
   Schmitt-Jansen, Mechthild
TI Metabolic Effect Level Index Links Multivariate Metabolic Fingerprints
   to Ecotoxicological Effect Assessment
SO ENVIRONMENTAL SCIENCE & TECHNOLOGY
LA English
DT Article
ID ORGANISM RESPONSES; TOXICOGENOMICS; HERBICIDE; TOXICITY; EXPOSURE;
   SUPPORT
AB A major goal of ecotoxicology is the prediction of adverse outcomes for populations from sensitive and early physiological responses. A snapshot of the physiological state of an organism can be provided by metabolic fingerprints. However, to inform chemical risk assessment, multivariate metabolic fingerprints need to be converted to readable end points suitable for effect estimation and comparison. The concentration- and time-dependent responsiveness of metabolic fingerprints to the PS-II inhibitor isoproturon was investigated by use of a Myriophyllum spicatum bioassay. Hydrophilic and lipophilic leaf extracts were analyzed with gas chromatography mass spectrometry (GC-MS) and prepro cessed with XCMS. Metabolic changes were aggregated in the quantitative metabolic effect level index (MELT), allowing effect estimation from Hill-based concentration response models. Hereby, the most sensitive response on the concentration scale was revealed by the hydrophilic MELT, followed by photosynthetic efficiency and, 1 order of magnitude higher, by the lipophilic MELI and shoot length change. In the hydrophilic MELT, 50% change compares to 30% inhibition of photosynthetic efficiency and 10% inhibition of dry weight change, indicating effect development on different response levels. In conclusion, aggregated metabolic fingerprints provide quantitative estimates and span a broad response spectrum, potentially valuable for establishing adverse outcome pathways of chemicals in environmental risk assessment.
C1 [Riedl, Janet; Schreiber, Rene; Altenburger, Rolf; Schmitt-Jansen, Mechthild] UFZ, Helmholtz Ctr Environm Res, D-04318 Leipzig, Germany.
   [Otto, Matthias; Heilmeier, Hermann] Tech Univ Bergakad Freiberg, D-09599 Freiberg, Germany.
RP Riedl, J (reprint author), UFZ, Helmholtz Ctr Environm Res, Permoserstr 15, D-04318 Leipzig, Germany.
EM janet.riedl@ufz.de; mechthild.schmitt@ufz.de
CR Ankley GT, 2006, ENVIRON SCI TECHNOL, V40, P4055, DOI 10.1021/es0630184
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   ASTM - American Society for Testing and Materials, 1999, ANN BOOK ASTM STAND, V11.05, P1434
   Beggel S, 2011, AQUAT TOXICOL, V105, P180, DOI 10.1016/j.aquatox.2011.06.004
   Blokhina O, 2003, ANN BOT-LONDON, V91, P179, DOI 10.1093/aob/mcf118
   Brown SAE, 2010, ENVIRON POLLUT, V158, P2117, DOI 10.1016/j.envpol.2010.02.023
   Burgoon LD, 2008, TOXICOL SCI, V104, P412, DOI 10.1093/toxsci/kfn083
   CASTELLUCCIO C, 1995, FEBS LETT, V368, P188, DOI 10.1016/0014-5793(95)00639-Q
   Dunn WB, 2011, CHEM SOC REV, V40, P387, DOI 10.1039/b906712b
   ELSHEEKH MM, 1994, ECOTOX ENVIRON SAFE, V29, P349, DOI 10.1016/0147-6513(94)90007-8
   Escher BI, 2014, ENVIRON SCI TECHNOL, V48, P1940, DOI 10.1021/es403899t
   FEDTKE C, 1974, NATURWISSENSCHAFTEN, V61, P272, DOI 10.1007/BF00595665
   FUERST EP, 1991, WEED SCI, V39, P458, DOI 10.1017/S0043174500073227
   Gou N, 2014, ENVIRON SCI TECHNOL, V48, P8855, DOI 10.1021/es501222t
   Gou N, 2011, ENVIRON SCI TECHNOL, V45, P5410, DOI 10.1021/es200455p
   Gundel U, 2012, ECOTOX ENVIRON SAFE, V76, P11, DOI 10.1016/j.ecoenv.2011.10.010
   Guo Q, 2009, METABOLOMICS, V5, P72, DOI 10.1007/s11306-008-0153-z
   Hock B., 1995, HERBICIDES DEV USE A
   Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425
   Hummel J, 2010, METABOLOMICS, V6, P322, DOI 10.1007/s11306-010-0198-7
   Kluender C, 2009, METABOLOMICS, V5, P59, DOI 10.1007/s11306-008-0139-x
   Kuster A, 2007, CHEMOSPHERE, V67, P194, DOI 10.1016/j.chemosphere.2006.08.023
   Lan JQ, 2014, ENVIRON SCI TECHNOL, V48, P12937, DOI 10.1021/es503065q
   Lankadurai BP, 2013, ENVIRON REV, V21, P180, DOI 10.1139/er-2013-0011
   Mohr S, 2013, ECOTOX ENVIRON SAFE, V97, P32, DOI 10.1016/j.ecoenv.2013.06.030
   Organization for Economic Cooperation and Development (OECD), 2006, SER TEST ASS
   Paules R, 2003, ENVIRON HEALTH PERSP, V111, pA338, DOI 10.1289/ehp.111-a338
   Pillai S, 2014, P NATL ACAD SCI USA, V111, P3490, DOI 10.1073/pnas.1319388111
   Poynton HC, 2008, ENVIRON SCI TECHNOL, V42, P6250, DOI 10.1021/es8010783
   R Development Core Team, 2013, R LANG ENV STAT COMP
   Riedl J, 2012, AQUAT BOT, V102, P34, DOI 10.1016/j.aquabot.2012.03.017
   Robertson DG, 2005, TOXICOL SCI, V85, P809, DOI 10.1093/toxsci/kfi102
   Sans-Piche F, 2010, MAR ENVIRON RES, V69, pS28, DOI 10.1016/j.marenvres.2009.12.004
   Schreiber R, 2011, J SOIL SEDIMENT, V11, P1419, DOI 10.1007/s11368-011-0410-z
   Smetanova S., 2015, ENV TOXICOL CHEM
   Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y
   Szabados L, 2010, TRENDS PLANT SCI, V15, P89, DOI 10.1016/j.tplants.2009.11.009
   Thomas RS, 2007, TOXICOL SCI, V98, P240, DOI 10.1093/toxsci/kfm092
   Thomas RS, 2011, TOXICOL SCI, V120, P194, DOI 10.1093/toxsci/kfq355
   UBA (Environmental Federal Institute), 2013, 36301294 UBA FKZ
   van Ravenzwaay B, 2012, MUTAT RES-GEN TOX EN, V746, P144, DOI 10.1016/j.mrgentox.2012.01.006
   Viant MR, 2007, MAR ECOL PROG SER, V332, P301, DOI 10.3354/meps332301
   Viant MR, 2005, METABOLOMICS, V1, P149, DOI 10.1007/s11306-005-4429-2
   Vidoudez C, 2012, METABOLOMICS, V8, P654, DOI 10.1007/s11306-011-0356-6
   Williams TD, 2009, ENVIRON SCI TECHNOL, V43, P6341, DOI 10.1021/es9008689
   WOLD S, 1978, TECHNOMETRICS, V20, P397, DOI 10.2307/1267639
NR 46
TC 8
Z9 8
U1 1
U2 26
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0013-936X
EI 1520-5851
J9 ENVIRON SCI TECHNOL
JI Environ. Sci. Technol.
PD JUL 7
PY 2015
VL 49
IS 13
BP 8096
EP 8104
DI 10.1021/acs.est.5b01386
PG 9
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA CM6ZN
UT WOS:000357840300072
PM 26020363
DA 2019-10-23
ER

PT J
AU Autrup, H
   Barile, FA
   Blaauboer, BJ
   Degen, GH
   Dekant, W
   Dietrich, D
   Domingo, JL
   Gori, GB
   Greim, H
   Hengstler, JG
   Kacew, S
   Marquardt, H
   Pelkonen, O
   Savolainen, K
   Vermeulen, NP
AF Autrup, Herman
   Barile, Frank A.
   Blaauboer, Bas J.
   Degen, Gisela H.
   Dekant, Wolfgang
   Dietrich, Daniel
   Domingo, Jose L.
   Gori, Gio Batta
   Greim, Helmuth
   Hengstler, Jan G.
   Kacew, Sam
   Marquardt, Hans
   Pelkonen, Olavi
   Savolainen, Kai
   Vermeulen, Nico P.
TI Principles of Pharmacology and Toxicology Also Govern Effects of
   Chemicals on the Endocrine System
SO TOXICOLOGICAL SCIENCES
LA English
DT Article
DE endocrine disruptors; endocrine toxicology; risk assessment;
   regulatory/policy; risk assessment
ID DIETARY 17-BETA-ESTRADIOL E2; HUMAN HEALTH; REPRODUCTIVE TOXICITY;
   RISK-ASSESSMENT; BISPHENOL-A; IN-UTERO; SCIENCE; METABOLITES; MYCOTOXIN;
   EXPOSURE
AB The present debate on chemicals with Hormonal activity, often termed 'endocrine disruptors', is highly controversial and includes challenges of the present paradigms used in toxicology and in hazard identification and risk characterization. In our opinion, chemicals with hormonal activity can be subjected to the well-evaluated health risk characterization approach used for many years including adverse outcome pathways. Many of the points arguing for a specific approach for risk characterization of chemicals with hormonal activity are based on highly speculative conclusions. These conclusions are not well supported when evaluating the available information.
C1 [Autrup, Herman] Univ Aarhus, Inst Publ Hlth, Int Union Toxicologists, Aarhus, Denmark.
   [Barile, Frank A.] St Johns Univ, Coll Pharm & Hlth Sci, Queens, NY USA.
   [Blaauboer, Bas J.] Univ Utrecht, Div Toxicol, Inst Risk Assessment Sci, Utrecht, Netherlands.
   [Degen, Gisela H.; Hengstler, Jan G.] TU Dortmund, Leibniz Res Ctr Working Environm & Human Factors, Dortmund, Germany.
   [Dekant, Wolfgang] Univ Wurzburg, Dept Toxicol, D-97078 Wurzburg, Germany.
   [Dietrich, Daniel] Univ Konstanz, Dept Biol, Constance, Germany.
   [Domingo, Jose L.] Univ Rovira & Virgili, IISPV, Sch Med, Lab Toxicol & Environm Hlth, E-43201 Reus, Spain.
   [Gori, Gio Batta] Ctr Hlth Policy, Bethesda, MD USA.
   [Greim, Helmuth] Tech Univ Munich, D-80290 Munich, Germany.
   [Kacew, Sam] Univ Ottawa, McLaughlin Ctr Risk Assessment, Ottawa, ON, Canada.
   [Pelkonen, Olavi] Univ Oulu, Dept Pharmacol & Toxicol, Oulu, Finland.
   [Savolainen, Kai] Finnish Inst Occupat Hlth, Nanosafety Res Ctr, Helsinki, Finland.
   [Vermeulen, Nico P.] Vrije Univ Amsterdam, Dept Chem & Pharmaceut Sci, Amsterdam, Netherlands.
RP Dekant, W (reprint author), Univ Wurzburg, Dept Toxicol, Versbacherstr 9, D-97078 Wurzburg, Germany.
EM dekant@toxi.uni-wuerzburg.de
RI Pelkonen, Olavi R/F-7740-2012; Domingo, Jose L/E-8327-2014
OI Domingo, Jose L/0000-0001-6647-9470; Vermeulen, Nico
   P.E./0000-0003-4194-6401; Blaauboer, Bas/0000-0002-0108-2402; Hengstler,
   Jan/0000-0002-1427-5246
CR Alexander J, 2013, EFSA J, V11, DOI 10.2903/j.efsa.2013.3132
   Belli P, 2010, FOOD CHEM TOXICOL, V48, P2818, DOI 10.1016/j.fct.2010.07.012
   Birnbaum LS, 2012, ENVIRON HEALTH PERSP, V120, P1640, DOI 10.1289/ehp.1205330
   Borgert CJ, 2013, REGUL TOXICOL PHARM, V67, P83, DOI 10.1016/j.yrtph.2013.06.007
   Carmichael N, 2011, CRIT REV TOXICOL, V41, P175, DOI 10.3109/10408444.2010.541225
   Dekant W, 2013, TOXICOL LETT, V223, P280, DOI 10.1016/j.toxlet.2013.03.022
   Delclos KB, 2009, REPROD TOXICOL, V27, P117, DOI 10.1016/j.reprotox.2008.12.005
   Dietrich DR, 2013, TOXICOL IN VITRO, V27, P2110, DOI 10.1016/j.tiv.2013.07.001
   Dietrich Daniel R, 2010, ALTEX, V27, P264
   EFSA, 2015, EFSA J, V13, DOI 10.2903/j.efsa.2015.4278
   EU-SCCS, 2014, 8 PLAN M
   Garwood J., 2014, LAB TIMES, V3, P38
   Golden RJ, 1998, CRIT REV TOXICOL, V28, P109, DOI 10.1080/10408449891344191
   Gore AC, 2013, ENDOCRINOLOGY, V154, P3955, DOI 10.1210/en.2013-1853
   Grandjean P, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-70
   Greim H, 2005, ANGEW CHEM INT EDIT, V44, P5568, DOI 10.1002/anie.200502138
   Hengstler J., 2014, LAB TIMES, V5, P45
   Hengstler J, 2014, LABTIMES, V3, P38
   Hoover RN, 2011, NEW ENGL J MED, V365, P1304, DOI 10.1056/NEJMoa1013961
   Horel S., 2013, ENV HLTH NEWES
   IGUCHI T, 1986, TOXICOLOGY, V42, P1, DOI 10.1016/0300-483X(86)90087-9
   IMPERATOMCGINLEY J, 1992, ENDOCRINOLOGY, V131, P1149, DOI 10.1210/en.131.3.1149
   Klaassen CD, 2013, CASARETT DOULLS TOXI
   Kortenkamp A, 2010, INT J ANDROL, V33, P463, DOI 10.1111/j.1365-2605.2009.01047.x
   Lamb JC, 2014, REGUL TOXICOL PHARM, V69, P22, DOI 10.1016/j.yrtph.2014.02.002
   Latendresse JR, 2009, REPROD TOXICOL, V28, P342, DOI 10.1016/j.reprotox.2009.04.006
   Lehman-McKeeman LD, 2013, TOXICOL SCI, V136, P1, DOI 10.1093/toxsci/kft201
   Mirmira P, 2014, TRANSL RES, V164, P13, DOI 10.1016/j.trsl.2014.03.003
   Myers JP, 2009, ENVIRON HEALTH PERSP, V117, P309, DOI 10.1289/ehp.0800173
   Newbold RR, 1997, CARCINOGENESIS, V18, P2293, DOI 10.1093/carcin/18.12.2293
   OECD, 2013, GUID DOC DEL ASS ADV
   Open-Letter, 2013, COMMUNICATION
   Palmer JR, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-37
   Reinen J, 2015, CURR MED CHEM, V22, P500
   Reinen J, 2011, XENOBIOTICA, V41, P59, DOI 10.3109/00498254.2010.525762
   Safe SH, 2000, ENVIRON HEALTH PERSP, V108, P487, DOI 10.2307/3454608
   SAFE SH, 1995, ENVIRON HEALTH PERSP, V103, P346, DOI 10.2307/3432287
   Testai E, 2013, TOXICOLOGY, V314, P51, DOI 10.1016/j.tox.2013.07.018
   Tyl RW, 2008, REPROD TOXICOL, V25, P144, DOI 10.1016/j.reprotox.2007.11.012
   Tyl RW, 2008, TOXICOL SCI, V102, P392, DOI 10.1093/toxsci/kfn002
   van Liempd SM, 2006, DRUG METAB DISPOS, V34, P1640, DOI 10.1124/dmd.106.010355
   Vandenberg LN, 2012, ENDOCR REV, V33, P378, DOI 10.1210/er.2011-1050
   Vandenberg LN, 2010, ENVIRON HEALTH PERSP, V118, P1051, DOI 10.1289/ehp.0901717
   Vandenberg LN, 2009, ENDOCR REV, V30, P75, DOI 10.1210/er.2008-0021
   WHO/ UNEP, 2002, WHOPCSEDC020
   WHO/UNEP, 2012, STAT SCI END DISR CH
   Zhao F, 2013, TOXICOL SCI, V132, P431, DOI 10.1093/toxsci/kfs343
   Zoeller RT, 2014, ENVIRON HEALTH-GLOB, V13, DOI 10.1186/1476-069X-13-118
NR 48
TC 11
Z9 12
U1 0
U2 15
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1096-6080
EI 1096-0929
J9 TOXICOL SCI
JI Toxicol. Sci.
PD JUL
PY 2015
VL 146
IS 1
BP 11
EP 15
DI 10.1093/toxsci/kfv082
PG 5
WC Toxicology
SC Toxicology
GA CP1IH
UT WOS:000359629000002
PM 26026993
OA Bronze
DA 2019-10-23
ER

PT J
AU Vinken, M
AF Vinken, Mathieu
TI Adverse Outcome Pathways and Drug-Induced Liver Injury Testing
SO CHEMICAL RESEARCH IN TOXICOLOGY
LA English
DT Review
ID SALT EXPORT PUMP; HEPATIC-FIBROSIS; RAT HEPATOCYTES; RISK-ASSESSMENT;
   MECHANISMS; TOXICITY; CHOLESTASIS; INSIGHTS; HEPATOTOXICITY; BIOMARKERS
AB Drug-induced liver injury is a prominent reason for premarketing and postmarketing drug withdrawal and can be manifested in a number of ways, such as cholestasis, steatosis, and fibrosis. The mechanisms driving these toxicological processes have been well characterized and have been emdedded in adverse outcome pathway frameworks in recent years. This review evaluates these constructs and simultaneously illustrates their use in the preclinical testing of drug-induced liver injury.
C1 Vrije Univ Brussel, Dept In Vitro Toxicol & Dermatocosmetol, Brussels, Belgium.
RP Vinken, M (reprint author), Vrije Univ Brussel, Dept In Vitro Toxicol & Dermatocosmetol, Brussels, Belgium.
EM mvinken@vub.ac.be
RI Vinken, Mathieu/H-7513-2013
OI Vinken, Mathieu/0000-0001-5115-8893; VUB, IVTD/0000-0002-5016-4789
FU European Research Council (CONNECT); European Union (FP7)European Union
   (EU); Cosmetics Europe (DETECTIVE); Fund for Scientific Research,
   Flanders (FWO-Vlaanderen)FWO; Sao, Paulo Research Foundation, Brazil
   (FAPESP); University of sao Paulo, Brazil (USP); University Hospital of
   the Vrije Universiteit Brussel, Belgium (Willy Gepts Fonds UZ - VUB);
   Cosmetics Europe (HeMiBio)
FX This work was financially supported by the grants of the University
   Hospital of the Vrije Universiteit Brussel, Belgium (Willy Gepts Fonds
   UZ - VUB), the University of sao Paulo, Brazil (USP), the Sao, Paulo
   Research Foundation, Brazil (FAPESP), the Fund for Scientific Research,
   Flanders (FWO-Vlaanderen), the European Research Council (project
   CONNECT), the European Union (FP7), and Cosmetics Europe (projects
   DETECTIVE and HeMiBio).
CR Adams DH, 2010, TOXICOL SCI, V115, P307, DOI 10.1093/toxsci/kfq009
   Amacher DE, 2011, EXPERT OPIN DRUG MET, V7, P949, DOI 10.1517/17425255.2011.577740
   Andersen M., 2012, REPLACEMENT IN VIVO, V2, P347
   Andrade RJ, 2009, CURR DRUG METAB, V10, P956, DOI 10.2174/138920009790711805
   Andrade RJ, 2009, PHARMACOGENOMICS, V10, P1467, DOI [10.2217/pgs.09.111, 10.2217/PGS.09.111]
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Aptula AO, 2006, CHEM RES TOXICOL, V19, P1097, DOI 10.1021/tx0601004
   Balls M, 2012, ADV EXP MED BIOL, V745, P221, DOI 10.1007/978-1-4614-3055-1_13
   Begriche K, 2011, J HEPATOL, V54, P773, DOI 10.1016/j.jhep.2010.11.006
   Bjornsson E, 2010, ALIMENT PHARM THER, V32, P3, DOI 10.1111/j.1365-2036.2010.04320.x
   Blomme EAG, 2009, TOXICOL LETT, V186, P22, DOI 10.1016/j.toxlet.2008.09.017
   Burden N., 2015, J APPL TOXICOL
   Chalasani N, 2010, GASTROENTEROLOGY, V138, P2246, DOI 10.1053/j.gastro.2010.04.001
   Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265
   Cui YX, 2010, PHARMACOGENOMICS, V11, P573, DOI [10.2217/pgs.10.37, 10.2217/PGS.10.37]
   Ellison CM, 2011, EXPERT OPIN DRUG MET, V7, P1481, DOI 10.1517/17425255.2011.629186
   Faa G, 2012, CURR MED CHEM, V19, P4581, DOI 10.2174/092986712803306385
   Friedman SL, 2010, NAT REV GASTRO HEPAT, V7, P425, DOI 10.1038/nrgastro.2010.97
   Guengerich FP, 2011, DRUG METAB PHARMACOK, V26, P3, DOI 10.2133/dmpk.DMPK-10-RV-062
   Hewitt M, 2013, CRIT REV TOXICOL, V43, P537, DOI 10.3109/10408444.2013.811215
   Hirano H, 2006, MOL PHARMACEUT, V3, P252, DOI 10.1021/mp060004w
   Hofmann A. F., 2009, LIVER BIOL PATHOBIOL, P289
   Holt MP, 2006, AAPS J, V8, pE48, DOI 10.1208/aapsj080106
   Honorio Kathia M, 2008, Open Med Chem J, V2, P87, DOI 10.2174/1874104500802010087
   Landesmann B., 2012, 75689 JRC, DOI [10.2788/71112, DOI 10.2788/71112]
   Landesmann B., 2015, PLOS ONE UNPUB
   Laverty HG, 2010, EUR J CLIN PHARMACOL, V66, P961, DOI 10.1007/s00228-010-0862-x
   Lee UE, 2011, BEST PRACT RES CL GA, V25, P195, DOI 10.1016/j.bpg.2011.02.005
   Lin C, 2015, EXPERT OPIN DRUG DIS, V10, P519, DOI 10.1517/17460441.2015.1032241
   OECD, 2013, SER TEST ASS, V184, P1
   Oorts M, 2015, J PHARMACOL TOX MET, V73, P63, DOI 10.1016/j.vascn.2015.03.002
   Ozer J, 2008, TOXICOLOGY, V245, P194, DOI 10.1016/j.tox.2007.11.021
   Padda MS, 2011, HEPATOLOGY, V53, P1377, DOI 10.1002/hep.24229
   Patlewicz G, 2015, REGUL TOXICOL PHARM, V71, P463, DOI 10.1016/j.yrtph.2015.02.011
   Przybylak KR, 2012, EXPERT OPIN DRUG MET, V8, P201, DOI 10.1517/17425255.2012.648613
   Ramachandran R, 2009, J CLIN PATHOL, V62, P481, DOI 10.1136/jcp.2008.058248
   Saito H, 2009, AAPS J, V11, P581, DOI 10.1208/s12248-009-9137-9
   Schoemaker MH, 2004, HEPATOLOGY, V39, P1563, DOI 10.1002/hep.20246
   Strahle U, 2012, REPROD TOXICOL, V33, P128, DOI 10.1016/j.reprotox.2011.06.121
   Tollefsen KE, 2014, REGUL TOXICOL PHARM, V70, P629, DOI 10.1016/j.yrtph.2014.09.009
   Trautwein C, 2015, J HEPATOL, V62, pS15, DOI 10.1016/j.jhep.2015.02.039
   Tujios S, 2011, NAT REV GASTRO HEPAT, V8, P202, DOI 10.1038/nrgastro.2011.22
   Uetrecht J, 2009, SEMIN LIVER DIS, V29, P383, DOI 10.1055/s-0029-1240007
   Verma S, 2009, GUT, V58, P1555, DOI 10.1136/gut.2008.163675
   Villeneuve DL, 2014, TOXICOL SCI, V142, P312, DOI 10.1093/toxsci/kfu199
   Villeneuve DL, 2014, TOXICOL SCI, V142, P321, DOI 10.1093/toxsci/kfu200
   Vinken M, 2013, CURR MED CHEM, V20, P3011, DOI 10.2174/0929867311320240006
   Vinken M, 2013, TOXICOL SCI, V136, P97, DOI 10.1093/toxsci/kft177
   Vinken M, 2013, TOXICOLOGY, V312, P158, DOI 10.1016/j.tox.2013.08.011
   Vinken M, 2012, ARCH TOXICOL, V86, P405, DOI 10.1007/s00204-011-0769-z
   Wagner M, 2009, J HEPATOL, V51, P565, DOI 10.1016/j.jhep.2009.05.012
   Warner DJ, 2012, DRUG METAB DISPOS, V40, P2332, DOI 10.1124/dmd.112.047068
   Willett C, 2014, ALTEX-ALTERN ANIM EX, V31, P407, DOI http://dx.doi.org/10.14573/altex.1401283
   Willett C, 2014, ALTEX-ALTERN ANIM EX, V31, P500, DOI http://dx.doi.org/10.14573/altex.1401281
   Woolbright BL, 2012, WORLD J GASTROENTERO, V18, P4985, DOI 10.3748/wjg.v18.i36.4985
   Zimmerman H J, 2000, Clin Liver Dis, V4, P73, DOI 10.1016/S1089-3261(05)70097-0
   Zollner G, 2006, WIEN MED WOCHENSCHR, V156, P380, DOI 10.1007/s10354-006-0312-7
   Zollner G, 2008, CLIN LIVER DIS, V12, P1, DOI 10.1016/j.cld.2007.11.010
NR 58
TC 27
Z9 27
U1 0
U2 15
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0893-228X
EI 1520-5010
J9 CHEM RES TOXICOL
JI Chem. Res. Toxicol.
PD JUL
PY 2015
VL 28
IS 7
BP 1391
EP 1397
DI 10.1021/acs.chemrestox.5b00208
PG 7
WC Chemistry, Medicinal; Chemistry, Multidisciplinary; Toxicology
SC Pharmacology & Pharmacy; Chemistry; Toxicology
GA CN6MF
UT WOS:000358548200002
PM 26119269
OA Green Accepted
DA 2019-10-23
ER

PT J
AU Miller, DH
   Tietge, JE
   McMaster, ME
   Munkittrick, KR
   Xia, XS
   Griesmer, DA
   Ankley, GT
AF Miller, David H.
   Tietge, Joseph E.
   McMaster, Mark E.
   Munkittrick, Kelly R.
   Xia, Xiangsheng
   Griesmer, David A.
   Ankley, Gerald T.
TI Linking mechanistic toxicology to population models in forecasting
   recovery from chemical stress: A case study from Jackfish Bay, Ontario,
   Canada
SO ENVIRONMENTAL TOXICOLOGY AND CHEMISTRY
LA English
DT Article
DE Adverse outcome pathway; Population model; White sucker; Pulp mill
   effluent
ID SUCKER CATOSTOMUS-COMMERSONI; PAPER-MILL EFFLUENTS; KRAFT PULP-MILL;
   ECOLOGICAL RISK-ASSESSMENT; ADVERSE OUTCOME PATHWAYS; DEPENDENT MATRIX
   MODEL; WHITE SUCKER; ENVIRONMENTAL IMPACTS; STEROID-LEVELS; SEX STEROIDS
AB Recovery of fish and wildlife populations after stressor mitigation serves as a basis for evaluating remediation success. Unfortunately, effectively monitoring population status on a routine basis can be difficult and costly. In the present study, the authors describe a framework that can be applied in conjunction with field monitoring efforts (e.g., through effects-based monitoring programs) to link chemically induced alterations in molecular and biochemical endpoints to adverse outcomes in whole organisms and populations. The approach employs a simple density-dependent logistic matrix model linked to adverse outcome pathways (AOPs) for reproductive effects in fish. Application of this framework requires a life table for the organism of interest, a measure of carrying capacity for the population of interest, and estimation of the effect of stressors on vital rates of organisms within the study population. The authors demonstrate the framework using linked AOPs and population models parameterized with long-term monitoring data for white sucker (Catostomus commersoni) collected from a study site at Jackfish Bay, Lake Superior, Canada. Individual responses of fish exposed to pulp mill effluent were used to demonstrate the framework's capability to project alterations in population status, both in terms of ongoing impact and subsequent recovery after stressor mitigation associated with process changes at the mill. The general approach demonstrated at the Jackfish Bay site can be applied to characterize population statuses of other species at a variety of impacted sites and can account for effects of multiple stressors (both chemical and nonchemical) and dynamics within complex landscapes (i.e., meta-populations including emigration and immigration processes). Environ Toxicol Chem 2015;34:1623-1633. (c) 2015 SETAC
C1 [Miller, David H.] US EPA, Midcontinent Ecol Div, Grosse Ile, MI 48138 USA.
   [Tietge, Joseph E.; Ankley, Gerald T.] US EPA, Midcontinent Ecol Div, Duluth, MN USA.
   [McMaster, Mark E.] Environm Canada, Aquat Contaminants Res Div, Burlington, ON L7R 4A6, Canada.
   [Munkittrick, Kelly R.] Univ New Brunswick, St John, NB E2L 4L5, Canada.
   [Xia, Xiangsheng; Griesmer, David A.] Comp Sci Corp, Grosse Ile, MI USA.
RP Miller, DH (reprint author), US EPA, Midcontinent Ecol Div, Grosse Ile, MI 48138 USA.
EM miller.davidh@epa.gov
RI Munkittrick, Kelly/AAB-8929-2019
FU Great Lakes Restoration Initiative
FX We thank 3 anonymous reviewers and D. Villeneuve, US Environmental
   Protection Agency (USEPA), Mid-Continent Ecology Division, for a
   valuable review of this manuscript. This work was supported, in part,
   through the Great Lakes Restoration Initiative coordinated through the
   USEPA Great Lakes National Program Office.
CR Ankley GT, 2008, AQUAT TOXICOL, V88, P69, DOI 10.1016/j.aquatox.2008.03.005
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Baird DJ, 2007, INTEGR ENVIRON ASSES, V3, P259, DOI 10.1897/IEAM_2006-031.1
   Baldwin DH, 2009, ECOL APPL, V19, P2004, DOI 10.1890/08-1891.1
   Barnthouse Lawrence W., 2009, Integrated Environmental Assessment and Management, V5, P435, DOI 10.1897/IEAM_2008-080.1
   Barnthouse Lawrence W., 2008, P1
   Barnthouse LW, 2004, ENVIRON TOXICOL CHEM, V23, P500, DOI 10.1897/02-521
   BAYLISS P, 1989, J APPL ECOL, V26, P913, DOI 10.2307/2403701
   Bowron LK, 2009, AQUAT TOXICOL, V95, P117, DOI 10.1016/j.aquatox.2009.08.009
   Brown AR, 2003, HUM ECOL RISK ASSESS, V9, P761, DOI 10.1080/713609966
   BURGMAN M, 1993, RISK ASSESSMENT CONS
   Caswell H, 2001, MATRIX POPULATION MO
   Cook PM, 2003, ENVIRON SCI TECHNOL, V37, P3864, DOI 10.1021/es034045m
   Doherty CA, 2005, WATER QUAL RES J CAN, V40, P361
   Doherty CA, 2010, T AM FISH SOC, V139, P1818, DOI 10.1577/T09-172.1
   Ekman DR, 2013, ENVIRON PRAC, V15, P409, DOI [10.1017/S1466046613000458, 10.1017/0S1466046613000458]
   FITZPATRICK MS, 1986, GEN COMP ENDOCR, V62, P437, DOI 10.1016/0016-6480(86)90054-7
   Forbes VE, 2008, ENVIRON TOXICOL CHEM, V27, P1987, DOI 10.1897/08-029.1
   Galic Nika, 2010, Integrated Environmental Assessment and Management, V6, P338, DOI 10.1002/ieam.68
   Garcia-Reyero N, 2015, ENVIRON SCI TECHNOL, V49, P3, DOI 10.1021/es504976d
   GOODMAN LA, 1969, BIOMETRICS, V25, P659, DOI 10.2307/2528566
   Gotelli N, 1998, PRIMER ECOLOGY
   Hanson N, 2011, ECOTOXICOLOGY, V20, P1268, DOI 10.1007/s10646-011-0675-4
   Hanson N, 2009, ECOL MODEL, V220, P2051, DOI 10.1016/j.ecolmodel.2009.04.053
   Hewitt LM, 2008, ENVIRON TOXICOL CHEM, V27, P682, DOI 10.1897/07-195.1
   Hewitt LM, 2006, J TOXICOL ENV HEAL B, V9, P341, DOI 10.1080/15287390500195976
   Hopfenberg R, 2003, POPUL ENVIRON, V25, P109, DOI 10.1023/B:POEN.0000015560.69479.c1
   Huggett R. J, 1992, SETAC SPECIAL PUBLIC
   JENSEN AL, 1995, ECOL MODEL, V77, P43, DOI 10.1016/0304-3800(93)E0081-D
   JENSEN AL, 1974, BIOMETRICS, V30, P547, DOI 10.2307/2529208
   Kovacs TG, 2013, J ENVIRON SCI HEAL A, V48, P1178, DOI 10.1080/10934529.2013.776440
   Kovacs TG, 2011, ENVIRON TOXICOL CHEM, V30, P1421, DOI 10.1002/etc.526
   Kramer VJ, 2011, ENVIRON TOXICOL CHEM, V30, P64, DOI 10.1002/etc.375
   Krebs C.J, 1985, ECOLOGY EXPT ANAL DI
   Leslie PH, 1945, BIOMETRIKA, V33, P183, DOI 10.1093/biomet/33.3.183
   Lewis EG, 1942, SANKHYA, V6, P93
   Martel PH, 2011, J ENVIRON SCI HEAL A, V46, P833, DOI 10.1080/10934529.2011.579850
   McMaster ME, 2006, J TOXICOL ENV HEAL B, V9, P319, DOI 10.1080/15287390500195869
   MCMASTER ME, 1991, AQUAT TOXICOL, V21, P199, DOI 10.1016/0166-445X(91)90073-I
   McMaster ME, 2005, WATER QUAL RES J CAN, V40, P299
   Miller DH, 2007, ENVIRON TOXICOL CHEM, V26, P521, DOI 10.1897/06-318R.1
   Miller DH, 2013, ENVIRON TOXICOL CHEM, V32, P1592, DOI 10.1002/etc.2218
   Miller DH, 2004, ECOTOX ENVIRON SAFE, V59, P1, DOI 10.1016/j.ecoenv.2004.05.005
   Miller DH, 2002, ECOL MODEL, V151, P271, DOI 10.1016/S0304-3800(01)00493-8
   Miller DH, 2001, THESIS U MICHIGAN AN
   MLADENOFF DJ, 1995, CONSERV BIOL, V9, P279, DOI 10.1046/j.1523-1739.1995.9020279.x
   Mladenoff DJ, 1997, BIOSCIENCE, V47, P21, DOI 10.2307/1313003
   MUNKITTRICK KR, 1991, CAN J FISH AQUAT SCI, V48, P1371, DOI 10.1139/f91-164
   Murphy CA, 2005, REPROD TOXICOL, V19, P395, DOI 10.1016/j.reprotox.2004.09.006
   Murphy CA, 2009, ENVIRON TOXICOL CHEM, V28, P1288, DOI 10.1897/08-304.1
   NORBERG B, 1989, GEN COMP ENDOCR, V75, P316, DOI 10.1016/0016-6480(89)90085-3
   Organisation for Economic Co-operation and Development, 2015, ADV OUTC PATHW KNOWL
   Organisation for Economic Co-operation and Development, 2015, ADV OUTC PATHW MOL S
   Rose KA, 2001, FISH FISH, V2, P293, DOI 10.1046/j.1467-2960.2001.00056.x
   SCOTT AP, 1984, GEN COMP ENDOCR, V56, P349, DOI 10.1016/0016-6480(84)90077-7
   SCOTT AP, 1983, GEN COMP ENDOCR, V49, P128, DOI 10.1016/0016-6480(83)90016-3
   Spromberg JA, 2005, INTEGR ENVIRON ASSES, V1, P9, DOI 10.1897/IEAM_2004a-005.1
   Spromberg Julann A., 2011, Integrated Environmental Assessment and Management, V7, P648, DOI 10.1002/ieam.219
   STREBEL DE, 1985, THEOR POPUL BIOL, V27, P1, DOI 10.1016/0040-5809(85)90013-9
   USHER MB, 1969, BIOMETRICS, V25, P309, DOI 10.2307/2528791
   VANDERKRAAK GJ, 1992, TOXICOL APPL PHARM, V115, P224, DOI 10.1016/0041-008X(92)90327-O
   Wilson EO, 1971, PRIMER POPULATION BI
   Zhang XW, 2008, ENVIRON SCI TECHNOL, V42, P6762, DOI 10.1021/es800591t
NR 63
TC 7
Z9 8
U1 0
U2 40
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0730-7268
EI 1552-8618
J9 ENVIRON TOXICOL CHEM
JI Environ. Toxicol. Chem.
PD JUL
PY 2015
VL 34
IS 7
BP 1623
EP 1633
DI 10.1002/etc.2972
PG 11
WC Environmental Sciences; Toxicology
SC Environmental Sciences & Ecology; Toxicology
GA CL5QC
UT WOS:000357013700025
PM 25943079
DA 2019-10-23
ER

PT J
AU Adeleye, Y
   Andersen, M
   Clewell, R
   Davies, M
   Denta, M
   Edwards, S
   Fowler, P
   Malcomber, S
   Nicol, B
   Scott, A
   Scott, S
   Sun, B
   Westmoreland, C
   White, A
   Zhang, Q
   Carmichael, PL
AF Adeleye, Yeyejide
   Andersen, Melvin
   Clewell, Rebecca
   Davies, Michael
   Dent, Matthew
   Edwards, Sue
   Fowler, Paul
   Malcomber, Sophie
   Nicol, Beate
   Scott, Andrew
   Scott, Sharon
   Sun, Bin
   Westmoreland, Carl
   White, Andrew
   Zhang, Qiang
   Carmichael, Paul L.
TI Implementing Toxicity Testing in the 21st Century (TT21C): Making safety
   decisions using toxicity pathways, and progress in a prototype risk
   assessment
SO TOXICOLOGY
LA English
DT Article
DE TT21C; AOP; Risk assessment; IVIVE; Quercetin; p53
ID EUROPEAN CONSUMER EXPOSURE; DNA-DAMAGE; COSMETIC PRODUCTS;
   EXCISION-REPAIR; HISTONE H2AX; QUERCETIN; P53; CELLS; INHIBITION;
   DYNAMICS
AB Risk assessment methodologies in toxicology have remained largely unchanged for decades. The default approach uses high dose animal studies, together with human exposure estimates, and conservative assessment (uncertainty) factors or linear extrapolations to determine whether a specific chemical exposure is 'safe' or 'unsafe'. Although some incremental changes have appeared over the years, results from all new approaches are still judged against this process of extrapolating high-dose effects in animals to low-dose exposures in humans. The US National Research Council blueprint for change, entitled Toxicity Testing in the 21st Century: A Vision and Strategy called for a transformation of toxicity testing from a system based on high-dose studies in laboratory animals to one founded primarily on in vitro methods that evaluate changes in normal cellular signalling pathways using human-relevant cells or tissues. More recently, this concept of pathways-based approaches to risk assessment has been expanded by the description of 'Adverse Outcome Pathways' (AOP5). The question, however, has been how to translate this AOP/TT21C vision into the practical tools that will be useful to those expected to make safety decisions. We have sought to provide a practical example of how the TT21C vision can be implemented to facilitate a safety assessment for a commercial chemical without the use of animal testing. To this end, the key elements of the TT21C vision have been broken down to a set of actions that can be brought together to achieve such a safety assessment. Such components of a pathways-based risk assessment have been widely discussed, however to-date, no worked examples of the entire risk assessment process exist. In order to begin to test the process, we have taken the approach of examining a prototype toxicity pathway (DNA damage responses mediated by the p53 network) and constructing a strategy for the development of a pathway based risk assessment for a specific chemical in a case study mode. This contribution represents a 'work-in-progress' and is meant to both highlight concepts that are well-developed and identify aspects of the overall process which require additional development. To guide our understanding of what a pathways-based risk assessment could look like in practice, we chose to work on a case study chemical (quercetin) with a defined human exposure and to bring a multidisciplinary team of chemists, biologists, modellers and risk assessors to work together towards a safety assessment. Our goal was to see if the in vitro dose response for quercetin could be sufficiently understood to construct a TT21C risk assessment without recourse to rodent carcinogenicity study data. The data presented include high throughput pathway biomarkers (p-H2AX, p-ATM, p-ATR, p-Chk2, p53, p-p53, MDM2 and Wip1) and markers of cell-cycle, apoptosis and micronuclei formation, plus gene transcription in HT1080 cells. Eighteen point dose response curves were generated using flow cytometry and imaging to determine the concentrations that resulted in significant perturbation. NOELs and BMDs were compared to the output from biokinetic modelling and the potential for in vitro to in vivo extrapolation explored. A first tier risk assessment was performed comparing the total quercetin concentration in the in vitro systems with the predicted total quercetin concentration in plasma and tissues. The shortcomings of this approach and recommendations for improvement are described.
   This paper therefore describes the current progress in an ongoing research effort aimed at providing a pathways-based, proof-of-concept in vitro-only safety assessment for a consumer use product. (C) 2014 The Authors. Published by Elsevier Ireland Ltd.
C1 [Adeleye, Yeyejide; Davies, Michael; Dent, Matthew; Edwards, Sue; Fowler, Paul; Malcomber, Sophie; Nicol, Beate; Scott, Andrew; Scott, Sharon; Westmoreland, Carl; White, Andrew; Carmichael, Paul L.] Safety & Environm Assurance Ctr, Sharnbrook MK44 1LQ, Beds, England.
   [Andersen, Melvin; Clewell, Rebecca; Sun, Bin; Zhang, Qiang] Hamner Inst Hlth Sci, Res Triangle Pk, NC 27709 USA.
RP Carmichael, PL (reprint author), Safety & Environm Assurance Ctr, Colworth Sci Pk, Sharnbrook MK44 1LQ, Beds, England.
EM paul.carmichael@unilever.com
OI Andersen, Melvin/0000-0002-3894-4811; fowler, paul/0000-0002-8705-3003
CR Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Batchelor E, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.20
   Bhana S, 2008, MUTAGENESIS, V23, P43, DOI 10.1093/mutage/gem041
   Bhattacharya S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020887
   Blaauboer BJ, 2010, J TOXICOL ENV HEAL B, V13, P242, DOI 10.1080/10937404.2010.483940
   Boekelheide Kim, 2010, ALTEX, V27, P243
   Cantero G, 2006, MUTAGENESIS, V21, P321, DOI 10.1093/mutage/gel033
   Carthew P, 2009, FOOD CHEM TOXICOL, V47, P1287, DOI 10.1016/j.fct.2009.02.024
   CARVER JH, 1983, MUTAT RES, V113, P45, DOI 10.1016/0165-1161(83)90240-6
   Clewell R.A., 2014, TOX SCI UNPUB
   Das L, 2012, BIOSCIENCE REP, V32, P161, DOI 10.1042/BSR20110043
   Davies M, 2011, TOXICOL SCI, V119, P308, DOI 10.1093/toxsci/kfq326
   EFSA, 2012, SCI OP EXPL OPT PROV
   Erster S, 2004, MOL CELL BIOL, V24, P6728, DOI 10.1128/MCB.24.15.6728-6741.2004
   European Commission's Scientific Committee on Consumer Safety, 2012, SCCS150112 EUR COMM
   Gonzalez-Segovia R, 2008, J GASTROENTEROL, V43, P441, DOI 10.1007/s00535-008-2184-7
   Groothuis F.A., 2013, TOXICOLOGY
   Gutsell S, 2013, TOXICOL RES-UK, V2, P299, DOI 10.1039/c3tx50024a
   Hall B, 2007, FOOD CHEM TOXICOL, V45, P2097, DOI 10.1016/j.fct.2007.06.017
   Hall B, 2011, FOOD CHEM TOXICOL, V49, P408, DOI 10.1016/j.fct.2010.11.016
   Harwood M, 2007, FOOD CHEM TOXICOL, V45, P2179, DOI 10.1016/j.fct.2007.05.015
   HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840
   Jagtap S, 2009, CURR MED CHEM, V16, P1451, DOI 10.2174/092986709787909578
   Judson RS, 2011, CHEM RES TOXICOL, V24, P451, DOI 10.1021/tx100428e
   Krewski D, 2010, J TOXICOL ENV HEAL B, V13, P51, DOI 10.1080/10937404.2010.483176
   Lahav G, 2004, NAT GENET, V36, P147, DOI 10.1038/ng1293
   Li Z, 2013, TOXICOL SCI
   Loretz LJ, 2005, FOOD CHEM TOXICOL, V43, P279, DOI 10.1016/j.fct.2004.09.016
   McNamara C, 2007, FOOD CHEM TOXICOL, V45, P2086, DOI 10.1016/j.fct.2007.06.037
   Min KM, 2009, FOOD CHEM TOXICOL, V47, P2716, DOI 10.1016/j.fct.2009.07.033
   Neumaier T, 2012, P NATL ACAD SCI USA, V109, P443, DOI 10.1073/pnas.1117849108
   NRC, 2007, TOX TEST 21 CENT AVI
   Obinaju B.E., 2010, AM J SCI IND RES, V1, P242
   OECD, 2011, OECD ENV HLTH SAF PU, V138, P8
   Organization for Economic Co-operation and Development (OECD), 2010, GUID TEST CHEM
   Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2
   Pendlington RU, 2008, CUTAN OCUL TOXICOL, V27, P283, DOI 10.1080/15569520802327005
   Polo SE, 2011, GENE DEV, V25, P409, DOI 10.1101/gad.2021311
   Powley IR, 2009, GENE DEV, V23, P1207, DOI 10.1101/gad.516509
   RASHEED S, 1974, CANCER, V33, P1027, DOI 10.1002/1097-0142(197404)33:4<1027::AID-CNCR2820330419>3.0.CO;2-Z
   SCCS, 2012, OP US THRESH TOX TIT
   Sokhansanj BA, 2005, P ANN INT IEEE EMBS, P7588, DOI 10.1109/IEMBS.2005.1616268
   Sun B, 2013, TOXICOL IN VITRO, V27, P1877, DOI 10.1016/j.tiv.2013.05.015
   Thomas AD, 2013, TOXICOL SCI, V132, P87, DOI 10.1093/toxsci/kfs341
   Turner ND, 2009, ACTA HORTIC, V841, P237
   Utesch D, 2008, MUTAT RES-GEN TOX EN, V654, P38, DOI 10.1016/j.mrgentox.2008.04.008
   van der Woude H, 2005, CHEM RES TOXICOL, V18, P1907, DOI 10.1021/tx050201m
   Vargas AJ, 2010, NUTR REV, V68, P418, DOI 10.1111/j.1753-4887.2010.00301.x
   Warringer J, 2010, MOL BIOL CELL, V21, P3080, DOI 10.1091/mbc.E10-01-0006
   Wetmore BA, 2012, TOXICOL SCI, V125, P157, DOI 10.1093/toxsci/kfr254
   Yang L., 2007, BMC GENOMICS, V25, P387
   Ye RQ, 2004, DNA REPAIR, V3, P235, DOI 10.1016/j.dnarep.2003.10.014
   Zair ZM, 2011, TOXICOL SCI, V119, P346, DOI 10.1093/toxsci/kfq341
   Zhang Q, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130031
NR 55
TC 63
Z9 68
U1 3
U2 38
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0300-483X
J9 TOXICOLOGY
JI Toxicology
PD JUN 5
PY 2015
VL 332
SI SI
BP 102
EP 111
DI 10.1016/j.tox.2014.02.007
PG 10
WC Pharmacology & Pharmacy; Toxicology
SC Pharmacology & Pharmacy; Toxicology
GA CK9FK
UT WOS:000356545800011
PM 24582757
OA Other Gold
DA 2019-10-23
ER

PT J
AU Kaplan, BLF
   Li, JZ
   LaPres, JJ
   Pruett, SB
   Karmaus, PWF
AF Kaplan, Barbara L. F.
   Li, Jinze
   LaPres, John J.
   Pruett, Stephen B.
   Karmaus, Peer W. F.
TI Contributions of Nonhematopoietic Cells and Mediators to Immune
   Responses: Implications For Immunotoxicology
SO TOXICOLOGICAL SCIENCES
LA English
DT Review
DE nonhematopoietic cells; immunotoxicology; xenobiotics
ID THYMIC STROMAL LYMPHOPOIETIN; CENTRAL-NERVOUS-SYSTEM;
   NECROSIS-FACTOR-ALPHA; INDUCED LIVER-INJURY; TRIMETHYLTIN-INDUCED
   NEUROTOXICITY; HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; FIBROBLASTIC RETICULAR
   CELLS; ALLERGIC AIRWAY INFLAMMATION; REGULATORY PROTEIN-ALPHA; ACID
   AMIDE HYDROLASE
AB Immunotoxicology assessments have historically focused on the effects that xenobiotics exhibit directly on immune cells. These studies are invaluable as they identify immune cell targets and help characterize mechanisms and/or adverse outcome pathways of xenobiotics within the immune system. However, leukocytes can receive environmental cues by cell-cell contact or via released mediators from cells of organs outside of the immune system. These organs include, but are not limited to, the mucosal areas such as the lung and the gut, the liver, and the central nervous system. Homeostatic perturbation in these organs induced directly by toxicants can initiate and alter the outcome of local and systemic immunity. This review will highlight some of the identified nonimmune influences on immune homeostasis and provide summaries of how immunotoxic mechanisms of selected xenobiotics involve nonimmune cells or mediators. Thus, this review will identify data gaps and provide possible alternative mechanisms by which xenobiotics alter immune function that could be considered during immunotoxicology safety assessment.
C1 [Kaplan, Barbara L. F.; Pruett, Stephen B.] Mississippi State Univ, Coll Vet Med, Dept Basic Sci, Ctr Environm Hlth Sci, Mississippi St, MS 39762 USA.
   [Li, Jinze] Genentech Inc, Safety Assessment, San Francisco, CA 94080 USA.
   [LaPres, John J.] Michigan State Univ, Dept Biochem & Mol Biol, Ctr Integrat Toxicol, E Lansing, MI 48824 USA.
   [Karmaus, Peer W. F.] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA.
RP Karmaus, PWF (reprint author), St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA.
EM peer.karmaus@stjude.org
FU NIH Center of Biomedical Research ExcellenceUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USA
   [P20GM103646-02]
FX SBP is funded by NIH Center of Biomedical Research Excellence Grant
   P20GM103646-02.
CR Abe J, 2014, J IMMUNOL, V193, P1636, DOI 10.4049/jimmunol.1302946
   Ahern GP, 2011, CURR OPIN PHARMACOL, V11, P29, DOI 10.1016/j.coph.2011.02.004
   Al-Shami A, 2005, J EXP MED, V202, P829, DOI 10.1084/jem.20050199
   Allan LL, 2003, TOXICOL SCI, V76, P357, DOI 10.1093/toxsci/kfg239
   Anderson JL, 2012, ALIMENT PHARM THER, V36, P503, DOI 10.1111/j.1365-2036.2012.05220.x
   Anthony BA, 2014, TRENDS IMMUNOL, V35, P32, DOI 10.1016/j.it.2013.10.002
   Antoine DJ, 2013, HEPATOLOGY, V58, P777, DOI 10.1002/hep.26294
   Auffray I, 1996, BLOOD, V88, P1608, DOI 10.1182/blood.V88.5.1608.bloodjournal8851608
   AUFFRAY I, 1994, EXP HEMATOL, V22, P417
   Awad WA, 2006, POULTRY SCI, V85, P974, DOI 10.1093/ps/85.6.974
   Bajenoff M, 2006, IMMUNITY, V25, P989, DOI 10.1016/j.immuni.2006.10.011
   Barclay AN, 2014, ANNU REV IMMUNOL, V32, P25, DOI 10.1146/annurev-immunol-032713-120142
   Bellinger DL, 2014, AUTON NEUROSCI-BASIC, V182, P15, DOI 10.1016/j.autneu.2014.01.006
   BERNUAU J, 1988, J HEPATOL, V6, P109, DOI 10.1016/S0168-8278(88)80469-0
   BIEGANOWSKA K, 1993, J NEUROIMMUNOL, V42, P33, DOI 10.1016/0165-5728(93)90209-H
   BILL J, 1989, NATURE, V341, P649, DOI 10.1038/341649a0
   Boyle NT, 2007, EUR J PHARMACOL, V572, P228, DOI 10.1016/j.ejphar.2007.07.020
   Boyle NT, 2010, BRIT J PHARMACOL, V161, P17, DOI 10.1111/j.1476-5381.2010.00899.x
   Buchweitz JP, 2008, J LEUKOCYTE BIOL, V83, P785, DOI 10.1189/jlb.0907618
   BUSSIERES JF, 1995, ANN PHARMACOTHER, V29, P875, DOI 10.1177/106002809502900910
   Buzas EI, 2014, NAT REV RHEUMATOL, V10, P356, DOI 10.1038/nrrheum.2014.19
   Camacho IA, 2005, J IMMUNOL, V175, P90, DOI 10.4049/jimmunol.175.1.90
   Camarasa J, 2010, IMMUNOPHARM IMMUNOT, V32, P265, DOI 10.3109/08923970903295104
   Cani PD, 2009, GUT, V58, P1091, DOI 10.1136/gut.2008.165886
   Cardona AE, 2006, NAT NEUROSCI, V9, P917, DOI 10.1038/nn1715
   Carson EJ, 1996, ALCOHOL CLIN EXP RES, V20, P132, DOI 10.1111/j.1530-0277.1996.tb01055.x
   Chang RCC, 2000, MOL BRAIN RES, V81, P197, DOI 10.1016/S0169-328X(00)00175-3
   Chang RCC, 2000, BRAIN RES, V853, P236, DOI 10.1016/S0006-8993(99)02255-6
   Chavarria A, 2013, FRONT INTEGR NEUROSC, V7, DOI 10.3389/fnint.2013.00064
   Choi JJ, 2012, TOXICOLOGY, V302, P212, DOI 10.1016/j.tox.2012.08.001
   Choi YJ, 2010, ENVIRON HEALTH PERSP, V118, P976, DOI 10.1289/ehp.0901751
   CLARKE JB, 1991, INT ARCH ALLER A IMM, V95, P369, DOI 10.1159/000235475
   Cohen JN, 2010, J EXP MED, V207, P681, DOI 10.1084/jem.20092465
   Cole JC, 2003, PHARMACOL THERAPEUT, V98, P35, DOI 10.1016/S0163-7258(03)00003-2
   Connor TJ, 2000, LIFE SCI, V67, P1601, DOI 10.1016/S0024-3205(00)00743-8
   Connor TJ, 2005, J PHARMACOL EXP THER, V312, P134, DOI 10.1124/jpet.104.073023
   Connor TJ, 1998, IMMUNOPHARMACOLOGY, V38, P253, DOI 10.1016/S0162-3109(97)00084-2
   Connor TJ, 2001, IMMUNOL LETT, V78, P67, DOI 10.1016/S0165-2478(01)00231-0
   Connor TJ, 2001, EUR J PHARMACOL, V418, P147, DOI 10.1016/S0014-2999(01)00928-1
   Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5
   Czlonkowska A, 1996, NEURODEGENERATION, V5, P137, DOI 10.1006/neur.1996.0020
   Daly AK, 2012, DRUG METAB REV, V44, P116, DOI 10.3109/03602532.2011.605790
   Daly AK, 2009, NAT GENET, V41, P816, DOI 10.1038/ng.379
   DEHEER C, 1994, EXP CLIN IMMUNOGENET, V11, P86
   Denieffe S, 2013, BRAIN BEHAV IMMUN, V34, P86, DOI 10.1016/j.bbi.2013.07.174
   DEWAAL EJ, 1992, TOXICOL APPL PHARM, V115, P80, DOI 10.1016/0041-008X(92)90370-8
   DEY PM, 1994, TOXICOL APPL PHARM, V126, P69, DOI 10.1006/taap.1994.1091
   Dey PM, 1997, NEUROTOXICOLOGY, V18, P633
   Dubrot J, 2014, J EXP MED, V211, P1153, DOI 10.1084/jem.20132000
   Dumitriu IE, 2007, J LEUKOCYTE BIOL, V81, P84, DOI 10.1189/jlb.0306171
   Endo A, 1999, JPN J PHYSIOL, V49, P463, DOI 10.2170/jjphysiol.49.463
   Enomoto N, 2001, ALCOHOL CLIN EXP RES, V25, p51S, DOI 10.1097/00000374-200106001-00012
   Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4
   Evankovich J, 2010, J BIOL CHEM, V285, P39888, DOI 10.1074/jbc.M110.128348
   Fava F, 2011, WORLD J GASTROENTERO, V17, P557, DOI 10.3748/wjg.v17.i5.557
   Filipov NM, 2005, TOXICOL SCI, V86, P324, DOI 10.1093/toxsci/kfi188
   FINE JS, 1990, J IMMUNOL, V144, P1169
   Foureau DM, 2015, CLIN EXP IMMUNOL, V180, P40, DOI 10.1111/cei.12558
   Fraites MJP, 2009, TOXICOL SCI, V112, P88, DOI 10.1093/toxsci/kfp194
   GANOUSIS LG, 1992, MOL PHARMACOL, V42, P1118
   Gauley J, 2009, AUTOIMMUNITY, V42, P299, DOI 10.1080/08916930902831522
   Gitik M, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-24
   Gough E, 2011, CLIN INFECT DIS, V53, P994, DOI 10.1093/cid/cir632
   Greenbaum A, 2013, NATURE, V495, P227, DOI 10.1038/nature11926
   GREENLEE WF, 1985, TOXICOL APPL PHARM, V79, P112, DOI 10.1016/0041-008X(85)90373-4
   Greenwood KK, 2012, AM J PHYSIOL-LUNG C, V302, pL455, DOI 10.1152/ajplung.00193.2011
   GRUBER J, 1994, EUR J IMMUNOL, V24, P1115, DOI 10.1002/eji.1830240516
   Gu YZ, 2000, ANNU REV PHARMACOL, V40, P519, DOI 10.1146/annurev.pharmtox.40.1.519
   Hammad H, 2008, NAT REV IMMUNOL, V8, P193, DOI 10.1038/nri2275
   Heidel SM, 1999, MOL PHARMACOL, V56, P1317
   Heidel SM, 1998, MOL PHARMACOL, V54, P1000
   Hernangomez M, 2014, CURR PHARM DESIGN, V20, P4707
   Hernangomez M, 2012, GLIA, V60, P1437, DOI 10.1002/glia.22366
   HIOE KM, 1984, TOXICOL LETT, V20, P317, DOI 10.1016/0378-4274(84)90166-8
   Hoarau JJ, 2011, CNS NEUROL DISORD-DR, V10, P25, DOI 10.2174/187152711794488601
   Hollingsworth John W, 2007, Proc Am Thorac Soc, V4, P240, DOI 10.1513/pats.200701-023AW
   HOUSE RV, 1995, TOXICOLOGY, V96, P59, DOI 10.1016/0300-483X(94)02955-T
   Iremonger KJ, 2013, TRENDS NEUROSCI, V36, P471, DOI 10.1016/j.tins.2013.04.007
   Isaksen DE, 2002, J IMMUNOL, V168, P3288, DOI 10.4049/jimmunol.168.7.3288
   Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796
   Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359
   Jang Y, 2013, J INVEST DERMATOL, V133, P2601, DOI 10.1038/jid.2013.203
   Jha MK, 2013, BBA-PROTEINS PROTEOM, V1834, P2418, DOI 10.1016/j.bbapap.2012.12.006
   Johnson LA, 2008, ANN NY ACAD SCI, V1131, P119, DOI 10.1196/annals.1413.011
   Judson R, 2013, ALTEX-ALTERN ANIM EX, V30, P51, DOI 10.14573/altex.2013.1.051
   Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000
   Kamath AB, 1997, TOXICOL APPL PHARM, V142, P367, DOI 10.1006/taap.1996.8049
   Kaplan BLF, 2013, PHARMACOL THERAPEUT, V137, P365, DOI 10.1016/j.pharmthera.2012.12.004
   Karmaus PWF, 2011, J LEUKOCYTE BIOL, V90, P983, DOI 10.1189/jlb.0511219
   Karsak M, 2007, SCIENCE, V316, P1494, DOI 10.1126/science.1142265
   Katakai T, 2004, J EXP MED, V200, P783, DOI 10.1084/jem.20040254
   Kawashima K, 2012, LIFE SCI, V91, P1027, DOI 10.1016/j.lfs.2012.05.006
   Kim J, 2014, ACTA HISTOCHEM, V116, P1490, DOI 10.1016/j.acthis.2014.09.003
   Klune JR, 2008, MOL MED, V14, P476, DOI 10.2119/2008-00034.Klune
   Kohutnicka M, 1998, IMMUNOPHARMACOLOGY, V39, P167, DOI 10.1016/S0162-3109(98)00022-8
   Koning N, 2007, ANN NEUROL, V62, P504, DOI 10.1002/ana.21220
   KREMER J, 1994, J IMMUNOL, V153, P2778
   KURL RN, 1993, TOXICOLOGY, V77, P103, DOI 10.1016/0300-483X(93)90141-E
   Laiosa MD, 2003, J IMMUNOL, V171, P4582, DOI 10.4049/jimmunol.171.9.4582
   Laiosa MD, 2010, MOL PHARMACOL, V77, P773, DOI 10.1124/mol.109.062497
   Lambrecht BN, 2009, IMMUNITY, V31, P412, DOI 10.1016/j.immuni.2009.08.008
   LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561
   LANGSTON JW, 1984, NEUROSCI LETT, V48, P87, DOI 10.1016/0304-3940(84)90293-3
   Laroui H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032084
   Laws SC, 2009, TOXICOL SCI, V112, P78, DOI 10.1093/toxsci/kfp190
   Lee JW, 2007, NAT IMMUNOL, V8, P181, DOI 10.1038/ni1427
   Leposavic G, 2008, AUTON NEUROSCI-BASIC, V144, P1, DOI 10.1016/j.autneu.2008.09.003
   Li FL, 2013, CELL MOL IMMUNOL, V10, P292, DOI 10.1038/cmi.2013.7
   Li JZ, 2010, J IMMUNOTOXICOL, V7, P157, DOI 10.3109/15476910903501748
   Link A, 2007, NAT IMMUNOL, V8, P1255, DOI 10.1038/ni1513
   Little AR, 2012, NEUROTOXICOL TERATOL, V34, P72, DOI 10.1016/j.ntt.2011.09.012
   Lloyd CM, 2010, NAT MED, V16, P273, DOI 10.1038/nm0310-273
   Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594
   Lu B, 2013, PROTEIN CELL, V4, P163, DOI 10.1007/s13238-012-2118-2
   Lukacs-Kornek V, 2011, NAT IMMUNOL, V12, P1096, DOI 10.1038/ni.2112
   Magnusson FC, 2008, GASTROENTEROLOGY, V134, P1028, DOI 10.1053/j.gastro.2008.01.070
   Malfitano AM, 2014, SEMIN IMMUNOL, V26, P369, DOI 10.1016/j.smim.2014.04.002
   Malhotra D, 2013, IMMUNOL REV, V251, P160, DOI 10.1111/imr.12023
   Marques R, 2011, CELL MOL LIFE SCI, V68, P3661, DOI 10.1007/s00018-011-0829-9
   Martis PC, 2006, DEVELOPMENT, V133, P1155, DOI 10.1242/dev.02273
   Masilamani M, 2012, IMMUNOL RES, V54, P95, DOI 10.1007/s12026-012-8331-5
   MATSUDA LA, 1990, NATURE, V346, P561, DOI 10.1038/346561a0
   MCCONKEY DJ, 1988, SCIENCE, V242, P256, DOI 10.1126/science.3262923
   McPherson CA, 2014, NEUROTOX RES, V25, P45, DOI 10.1007/s12640-013-9422-3
   Metushi I. G., J IMMUNOTOX IN PRESS
   Morganti JM, 2012, J NEUROSCI, V32, P14592, DOI 10.1523/JNEUROSCI.0539-12.2012
   Mott RT, 2004, GLIA, V46, P369, DOI 10.1002/glia.20009
   Mueller SN, 2008, IMMUNOL REV, V224, P284, DOI 10.1111/j.1600-065X.2008.00657.x
   Mueller SN, 2009, NAT REV IMMUNOL, V9, P618, DOI 10.1038/nri2588
   Muldoon LL, 2013, J CEREBR BLOOD F MET, V33, P13, DOI 10.1038/jcbfm.2012.153
   Sheridan GK, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130181
   Myers L Peyton, 2005, J Immunotoxicol, V2, P97, DOI 10.1080/15476910591006673
   Nabeshima R, 1997, EXP HEMATOL, V25, P509
   Nakagawa T, 2010, J PHARMACOL SCI, V114, P347, DOI 10.1254/jphs.10R04CP
   Nakayama S, 2009, DRUG METAB DISPOS, V37, P1970, DOI 10.1124/dmd.109.027797
   Nell S, 2010, NAT REV MICROBIOL, V8, P564, DOI 10.1038/nrmicro2403
   Nichols LA, 2007, J IMMUNOL, V179, P993, DOI 10.4049/jimmunol.179.2.993
   Ostapowicz G, 2002, ANN INTERN MED, V137, P947, DOI 10.7326/0003-4819-137-12-200212170-00007
   Pacheco R, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00117
   Pacifici R, 2004, J PHARMACOL EXP THER, V309, P285, DOI 10.1124/jpet.103.061374
   Pacifici R, 2002, ANN NY ACAD SCI, V965, P421
   Pacifici R, 2001, LIFE SCI, V69, P2931, DOI 10.1016/S0024-3205(01)01373-X
   PADGETT EL, 1992, J TOXICOL ENV HEALTH, V37, P559, DOI 10.1080/15287399209531693
   Parker D, 2011, AM J RESP CELL MOL, V45, P189, DOI 10.1165/rcmb.2011-0011RT
   Pennock JW, 2009, J INFECT DIS, V200, P1247, DOI 10.1086/605891
   Perl AKT, 2002, P NATL ACAD SCI USA, V99, P10482, DOI 10.1073/pnas.152238499
   Pestka J, 2006, TOXICOL SCI, V92, P445, DOI 10.1093/toxsci/kfl012
   Peterson LW, 2014, NAT REV IMMUNOL, V14, P141, DOI 10.1038/nri3608
   Pham THM, 2010, J EXP MED, V207, P17, DOI 10.1084/jem.20091619
   Podgrabinska S, 2002, P NATL ACAD SCI USA, V99, P16069, DOI 10.1073/pnas.242401399
   Proper SP, 2014, TOXICOL SCI, V137, P447, DOI 10.1093/toxsci/kft253
   Pruett SB, 2005, TOXICOL SCI, V87, P75, DOI 10.1093/toxsci/kfi215
   Pruett SB, 2003, TOXICOL SCI, V75, P343, DOI 10.1093/toxsci/kfg200
   PRUETT SB, 1992, FUND APPL TOXICOL, V18, P40, DOI 10.1016/0272-0590(92)90193-L
   Pruett SB, 2006, TOXICOL APPL PHARM, V213, P172, DOI 10.1016/j.taap.2005.10.004
   Pruett SB, 2009, TOXICOL SCI, V109, P265, DOI 10.1093/toxsci/kfp073
   Quentmeier H, 2001, LEUKEMIA, V15, P1286, DOI 10.1038/sj.leu.2402175
   Ransohoff RM, 2012, J CLIN INVEST, V122, P1164, DOI 10.1172/JCI58644
   Reyburn B, 2012, NEONATOLOGY, V101, P345, DOI 10.1159/000337355
   Rhee SH, 2011, J NEUROGASTROENTEROL, V17, P28, DOI 10.5056/jnm.2011.17.1.28
   Rhile MJ, 1996, TOXICOLOGY, V110, P153, DOI 10.1016/0300-483X(96)83962-X
   Riecke K, 2003, ARCH TOXICOL, V77, P358, DOI 10.1007/s00204-003-0445-z
   Rohl C, 2009, TOXICOL IN VITRO, V23, P1541, DOI 10.1016/j.tiv.2009.04.013
   Rogers JT, 2011, J NEUROSCI, V31, P16241, DOI 10.1523/JNEUROSCI.3667-11.2011
   Rohl C, 2005, TOXICOL APPL PHARM, V204, P36, DOI 10.1016/j.taap.2004.08.007
   Rooney AA, 2003, TOXICOL SCI, V76, P366, DOI 10.1093/toxsci/kfg250
   Roozendaal R, 2011, ANNU REV IMMUNOL, V29, P23, DOI 10.1146/annurev-immunol-031210-101357
   Saini Y, 2010, TOXICOL SCI, V116, P673, DOI 10.1093/toxsci/kfq155
   Saini Y, 2010, AM J PHYSIOL-LUNG C, V298, pL139, DOI 10.1152/ajplung.00252.2009
   Saini Y, 2008, J BIOL CHEM, V283, P33650, DOI 10.1074/jbc.M805927200
   Sanders VM, 2012, BRAIN BEHAV IMMUN, V26, P195, DOI 10.1016/j.bbi.2011.08.001
   Schajnovitz A, 2011, NAT IMMUNOL, V12, P391, DOI 10.1038/ni.2017
   Senkov O, 2012, INT J BIOCHEM CELL B, V44, P591, DOI 10.1016/j.biocel.2012.01.008
   Shan S, 2011, NEUROBIOL AGING, V32, P443, DOI 10.1016/j.neurobiolaging.2009.03.004
   Shepardson KM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004378
   Shi LZ, 2011, J EXP MED, V208, P1367, DOI 10.1084/jem.20110278
   Silverman MN, 2012, ANN NY ACAD SCI, V1261, P55, DOI 10.1111/j.1749-6632.2012.06633.x
   Singer JB, 2010, NAT GENET, V42, P711, DOI 10.1038/ng.632
   St-Pierre C, 2013, SCI REP-UK, V3, DOI 10.1038/srep01860
   STANDIFORD TJ, 1990, J CLIN INVEST, V86, P1945, DOI 10.1172/JCI114928
   Staples JE, 1998, J IMMUNOL, V160, P3844
   Sternberg EM, 2006, NAT REV IMMUNOL, V6, P318, DOI 10.1038/nri1810
   Su LP, 2009, GASTROENTEROLOGY, V136, P551, DOI 10.1053/j.gastro.2008.10.081
   Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016
   Suresh MV, 2014, CRIT CARE MED, V42, pE642, DOI 10.1097/CCM.0000000000000488
   Szabo G, 2010, WORLD J GASTROENTERO, V16, P1321, DOI 10.3748/wjg.v16.i11.1321
   Takamura T, 2010, IMMUNOL CELL BIOL, V88, P685, DOI 10.1038/icb.2010.35
   Tarcic N, 1998, J NEUROIMMUNOL, V82, P40, DOI 10.1016/S0165-5728(97)00186-0
   Teague JE, 2010, J IMMUNOL, V185, P3369, DOI 10.4049/jimmunol.0902541
   Thomas S, 2007, J IMMUNOL, V178, P5802, DOI 10.4049/jimmunol.178.9.5802
   Thomson AW, 2010, NAT REV IMMUNOL, V10, P753, DOI 10.1038/nri2858
   Thors L, 2008, BRIT J PHARMACOL, V155, P244, DOI 10.1038/bjp.2008.237
   Thors L, 2007, BRIT J PHARMACOL, V152, P744, DOI 10.1038/sj.bjp.0707401
   Thors L, 2007, BRIT J PHARMACOL, V150, P951, DOI 10.1038/sj.bjp.0707172
   Thors L, 2010, BRIT J PHARMACOL, V160, P549, DOI 10.1111/j.1476-5381.2010.00716.x
   Tian J, 2007, NAT IMMUNOL, V8, P487, DOI 10.1038/ni1457
   Twitchell W, 1997, J NEUROPHYSIOL, V78, P43
   Uetrecht J, 2009, SEMIN LIVER DIS, V29, P383, DOI 10.1055/s-0029-1240007
   Uetrecht JP, 1999, CHEM RES TOXICOL, V12, P387, DOI 10.1021/tx980249i
   Urbina M, 2014, NEUROIMMUNOMODULAT, V21, P240, DOI 10.1159/000357148
   Vaccari JPD, 2014, J CEREBR BLOOD F MET, V34, P369, DOI 10.1038/jcbfm.2013.227
   van Rijt LS, 2011, AM J RESP CRIT CARE, V184, P303, DOI 10.1164/rccm.201101-0019OC
   Wang HP, 2014, NAT IMMUNOL, V15, P393, DOI 10.1038/ni.2846
   Wang JH, 2014, BLOOD, V124, P555, DOI [10.1182/blood-2014-03562439, 10.1182/blood-2014-03-562439]
   Wang XF, 2013, HEPATOLOGY, V57, P373, DOI 10.1002/hep.25982
   Wright GJ, 2000, IMMUNITY, V13, P233, DOI 10.1016/S1074-7613(00)00023-6
   Wu DC, 2002, J NEUROSCI, V22, P1763, DOI 10.1523/JNEUROSCI.22-05-01763.2002
   Wu JX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077795
   Yamaguchi K, 1997, J IMMUNOL, V158, P2165
   Yellayi S, 2002, P NATL ACAD SCI USA, V99, P7616, DOI 10.1073/pnas.102650199
   Zhang SL, 2004, J IMMUNOL, V173, P6786, DOI 10.4049/jimmunol.173.11.6786
   Zhou BH, 2005, NAT IMMUNOL, V6, P1047, DOI 10.1038/ni1247
   Zhou L, 1996, DEV BIOL, V175, P227, DOI 10.1006/dbio.1996.0110
   Zhou ZX, 2003, AM J PATHOL, V163, P1137, DOI 10.1016/S0002-9440(10)63473-6
   Zujovic V, 2000, GLIA, V29, P305, DOI 10.1002/(SICI)1098-1136(20000215)29:4<305::AID-GLIA2>3.3.CO;2-M
NR 215
TC 4
Z9 4
U1 0
U2 18
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1096-6080
EI 1096-0929
J9 TOXICOL SCI
JI Toxicol. Sci.
PD JUN
PY 2015
VL 145
IS 2
BP 214
EP 232
DI 10.1093/toxsci/kfv060
PG 19
WC Toxicology
SC Toxicology
GA CJ7GS
UT WOS:000355663300001
PM 26008184
OA Green Published
DA 2019-10-23
ER

PT J
AU Tralau, T
   Luch, A
AF Tralau, Tewes
   Luch, Andreas
TI Moving from rats to cellular omics in regulatory toxicology: great
   challenge toward sustainability or "up-shit-creek without a paddle"?
SO ARCHIVES OF TOXICOLOGY
LA English
DT Editorial Material
ID HUMAN TOXOME
C1 [Tralau, Tewes; Luch, Andreas] German Fed Inst Risk Assessment BfR, Dept Chem & Prod Safety, D-10589 Berlin, Germany.
RP Luch, A (reprint author), German Fed Inst Risk Assessment BfR, Dept Chem & Prod Safety, Max Dohrn Str 8-10, D-10589 Berlin, Germany.
EM andreas.luch@bfr.bund.de
OI Tralau, Tewes/0000-0002-7857-4237
CR Adler S, 2011, ARCH TOXICOL, V85, P367, DOI 10.1007/s00204-011-0693-2
   Andersen ME, 2010, TOXICOL SCI, V117, P17, DOI 10.1093/toxsci/kfq188
   Bouhifd M, 2014, BASIC CLIN PHARMACOL, V115, P24, DOI 10.1111/bcpt.12198
   Calabrese EJ, 2011, ENVIRON TOXICOL CHEM, V30, P2658, DOI 10.1002/etc.687
   Hartung T, 2011, ALTEX-ALTERN ANIM EX, V28, P83, DOI 10.14573/altex.2011.2.083
   Hartung T, 2011, EUR J PHARM BIOPHARM, V77, P338, DOI 10.1016/j.ejpb.2010.12.027
   Hartung T, 2009, NATURE, V460, P208, DOI 10.1038/460208a
   Judson R, 2013, ALTEX-ALTERN ANIM EX, V30, P51, DOI 10.14573/altex.2013.1.051
   Judson RS, 2010, ENVIRON HEALTH PERSP, V118, P485, DOI 10.1289/ehp.0901392
   Kandarova Helena, 2011, Interdiscip Toxicol, V4, P107, DOI 10.2478/v10102-011-0018-6
   Kavlock R, 2012, CHEM RES TOXICOL, V25, P1287, DOI 10.1021/tx3000939
   Keller DA, 2012, TOXICOL SCI, V126, P291, DOI 10.1093/toxsci/kfr350
   Liebsch M, 2011, ARCH TOXICOL, V85, P841, DOI 10.1007/s00204-011-0718-x
   National Research Council, 2007, TOX TEST 21 CENT VIS
   OECD, 2012, ADV OUTC PATHW SKIN
   OECD (Organization for Economic Co-operation and Development), 2013, GUID DOC DEV ASS ADV
   OSER BL, 1987, REGUL TOXICOL PHARM, V7, P427, DOI 10.1016/0273-2300(87)90064-X
   Tralau T, 2012, ENVIRON HEALTH PERSP, V120, P1489, DOI 10.1289/ehp.1104782
   van der Jagt K, 2004, 21405 EUR EN EUR COM
   ZBINDEN G, 1993, REGUL TOXICOL PHARM, V17, P85, DOI 10.1006/rtph.1993.1009
NR 20
TC 6
Z9 6
U1 0
U2 9
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0340-5761
EI 1432-0738
J9 ARCH TOXICOL
JI Arch. Toxicol.
PD JUN
PY 2015
VL 89
IS 6
BP 819
EP 821
DI 10.1007/s00204-015-1511-z
PG 3
WC Toxicology
SC Toxicology
GA CI1AK
UT WOS:000354471800001
PM 25820918
OA Bronze
DA 2019-10-23
ER

PT J
AU Patlewicz, G
   Ball, N
   Boogaard, PJ
   Becker, RA
   Hubesch, B
AF Patlewicz, G.
   Ball, N.
   Boogaard, P. J.
   Becker, R. A.
   Hubesch, B.
TI Building scientific confidence in the development and evaluation of
   read-across
SO REGULATORY TOXICOLOGY AND PHARMACOLOGY
LA English
DT Article
DE Read-across; (Quantitative) Structure Activity Relationship (Q)SAR;
   Quantitative Mechanistic Models (QMM); Chemical categories; Analogue
   approach; Adverse Outcome Pathway (ADP); Scientific confidence
ID MECHANISTIC APPLICABILITY DOMAINS; NONANIMAL-BASED PREDICTION;
   TOXICOLOGICAL END-POINTS; SKIN SENSITIZATION; CELL-LINE; PEPTIDE
   REACTIVITY; FRAMEWORK; CLASSIFICATION; GENOTOXICITY; DERIVATION
AB Read-across is an alternative approach exploited to address information requirements for risk assessment and for regulatory programmes such as the European Union's REACH regulation. Whilst read-across approaches are accepted in principle, difficulties still remain in applying them consistently in practice. Recent work within Cefic LRI and ECETOC attempted to summarize the state-of-the-art and identify some of the barriers to broader acceptance of read-across approaches to overcome these. Acceptance is undoubtedly thwarted partly by the lack of a systematic framework to characterize the read-across justification and identify the uncertainties particularly for complex regulatory endpoints such as repeated-dose toxicity or prenatal developmental toxicity. Efforts are underway by the European Chemical's Agency (ECHA) to develop a Read-Across Assessment Framework (RAAF) and private sector experts have also considered the development of a similar framework. At the same time, mechanistic chemical categories are being proposed which are underpinned by Adverse Outcome Pathways (AOPs). Currently such frameworks are only focusing on discrete organic substances, though the AOP approach could conceivably be applied to evaluate more complex substances such as mixtures. Here we summarize the deliberations of the Cefic LRI read-across team in characterizing scientific confidence in the development and evaluation of read-across. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Patlewicz, G.] DuPont Haskell Global Ctr, Newark, DE 19711 USA.
   [Ball, N.] Dow Chem Co USA, TERC, Midland, MI 48674 USA.
   [Boogaard, P. J.] Shell Int Bv, Shell Hlth, NL-2501 AN The Hague, Netherlands.
   [Becker, R. A.] ACC, Regulatory & Tech Affairs Dept, Washington, DC 20002 USA.
   [Hubesch, B.] CEFIC European Chem Ind Council, B-1160 Brussels, Belgium.
   [Hubesch, B.] Hubesch Consult BVBA, B-1600 Sint Pieters Leeuw, Belgium.
RP Patlewicz, G (reprint author), US EPA, Natl Ctr Computat Toxicol, 109 T W Alexander Dr, Res Triangle Pk, NC 27711 USA.
EM patlewig@hotmail.com
RI Boogaard, Peter J/H-4890-2019
OI Boogaard, Peter J/0000-0002-6964-6681; Patlewicz,
   Grace/0000-0003-3863-9689
FU Cefic LRI
FX The authors had complete control over the design, conduct,
   interpretation, and reporting of the analyses included in this
   manuscript. The contents of this manuscript are solely the
   responsibility of the authors and do not necessarily reflect the views
   or policies of their employers. Richard Becker is employed by ACC, a
   trade association of U. S. chemical manufacturers. Bruno Hubesch is
   employed by Cefic, a trade association of the European chemical
   manufacturers. Nicholas Ball and Peter Boogaard are employed by
   companies engaged in chemical product manufacturing. At the time of the
   Cefic LRI discussions that form the basis of this work, Grace Patlewicz
   was employed by DuPont, a company engaged in chemical product
   manufacturing. She also acknowledges support from Cefic LRI for the
   read-across project AIMT4.
CR Aleksic M, 2009, TOXICOL SCI, V108, P401, DOI 10.1093/toxsci/kfp030
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Aptula AO, 2006, CHEM RES TOXICOL, V19, P1097, DOI 10.1021/tx0601004
   Ball N, 2014, REGUL TOXICOL PHARM, V68, P212, DOI 10.1016/j.yrtph.2013.12.007
   Blackburn K, 2014, REGUL TOXICOL PHARM, V68, P353, DOI 10.1016/j.yrtph.2014.01.004
   Blackburn K, 2011, REGUL TOXICOL PHARM, V60, P120, DOI 10.1016/j.yrtph.2011.03.002
   Dancik Y, 2013, ADV DRUG DELIVER REV, V65, P221, DOI 10.1016/j.addr.2012.01.006
   de Raat K, 2014, WORLD C AN ALT 24 28
   ECETOC, 2012, 116 ECETOC
   ECHA, 2008, GUID INF REQ CHEM SA
   ECHA, 2014, GUID INF REQ CHEM SA
   ECHA, 2014, EV REACH PROGR REP 2
   Emter R, 2013, TOXICOL IN VITRO, V27, P2225, DOI 10.1016/j.tiv.2013.09.009
   Emter R, 2010, TOXICOL APPL PHARM, V245, P281, DOI 10.1016/j.taap.2010.03.009
   Gerberick GF, 2007, TOXICOL SCI, V97, P417, DOI 10.1093/toxsci/kfm064
   Gerberick GF, 2004, TOXICOL SCI, V81, P332, DOI 10.1093/toxsci/kfh213
   JECFA, 1997, JOINT FAO WHO EXP CO
   Jennen D., 2014, INT J BIOTECHN UNPUB
   Klimisch HJ, 1997, REGUL TOXICOL PHARM, V25, P1, DOI 10.1006/rtph.1996.1076
   Mekenyan O, 2010, CHEM RES TOXICOL, V23, P1519, DOI 10.1021/tx100161j
   Mekenyan OG, 2012, CHEM RES TOXICOL, V25, P277, DOI 10.1021/tx200547s
   Natsch A, 2013, J APPL TOXICOL, V33, P1337, DOI 10.1002/jat.2868
   NPIRI, 1974, RAW MAT DAT HDB, V1, P6
   *NTP, 1986, TECHN REP TOX CARC S
   NTP, 1989, TECHN REP TOX CARC S
   OECD, 2012, SER TEST ASS
   OECD, 2015, TEST GUID 442C CHEM
   OECD, 2014, OECD SER TEST ASS, V194
   OECD, 2015, TEST GUID 442D VITR
   OECD, 2001, SIDS IN ASS REP 13 S
   OPDYKE DLJ, 1973, FOOD COSMET TOXICOL, V11, P1011, DOI 10.1016/0015-6264(73)90228-9
   Organisation for Economic Cooperation and Development (OECD), 2012, ADV OUTC PATHW SKI 2
   Patlewicz G, 2014, SAR QSAR ENVIRON RES, V25, P367, DOI 10.1080/1062936X.2014.900520
   Patlewicz G, 2014, ALTEX-ALTERN ANIM EX, V31, P387, DOI 10.14573/altex.1410071
   Patlewicz G, 2014, REGUL TOXICOL PHARM, V69, P529, DOI 10.1016/j.yrtph.2014.06.001
   Patlewicz G, 2013, REGUL TOXICOL PHARM, V67, P1, DOI 10.1016/j.yrtph.2013.06.002
   Patlewicz G, 2013, REGUL TOXICOL PHARM, V65, P226, DOI 10.1016/j.yrtph.2012.12.004
   Petkov PI, 2015, REGUL TOXICOL PHARM, V72, P17, DOI 10.1016/j.yrtph.2015.03.003
   Piroird C., 2015, TOXICOL IN VITRO
   Python F, 2007, TOXICOL APPL PHARM, V220, P113, DOI 10.1016/j.taap.2006.12.026
   Roberts DW, 2008, J APPL TOXICOL, V28, P443, DOI 10.1002/jat.1293
   Roberts DW, 2007, CHEM RES TOXICOL, V20, P44, DOI 10.1021/tx060121y
   Roberts DW, 2006, CHEM RES TOXICOL, V19, P1228, DOI 10.1021/tx060102o
   Roberts DW, 2014, J APPL TOXICOL, V34, P436, DOI 10.1002/jat.2943
   Sakaguchi H, 2007, TOXICOL LETT, V172, pS93, DOI 10.1016/j.toxlet.2007.05.257
   Schultz TW, 2005, SAR QSAR ENVIRON RES, V16, P313, DOI 10.1080/10659360500204152
   ten Berge W, 2009, CHEMOSPHERE, V75, P1440, DOI 10.1016/j.chemosphere.2009.02.043
   Tollefsen KE, 2014, REGUL TOXICOL PHARM, V70, P629, DOI 10.1016/j.yrtph.2014.09.009
   Wu SD, 2010, REGUL TOXICOL PHARM, V56, P67, DOI 10.1016/j.yrtph.2009.09.006
NR 49
TC 28
Z9 28
U1 0
U2 19
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0273-2300
EI 1096-0295
J9 REGUL TOXICOL PHARM
JI Regul. Toxicol. Pharmacol.
PD JUN
PY 2015
VL 72
IS 1
BP 117
EP 133
DI 10.1016/j.yrtph.2015.03.015
PG 17
WC Medicine, Legal; Pharmacology & Pharmacy; Toxicology
SC Legal Medicine; Pharmacology & Pharmacy; Toxicology
GA CG9WI
UT WOS:000353670400015
PM 25857293
DA 2019-10-23
ER

PT J
AU von Stackelberg, K
   Guzy, E
   Chu, T
   Henn, BC
AF von Stackelberg, Katherine
   Guzy, Elizabeth
   Chu, Tian
   Henn, Birgit Claus
TI Exposure to Mixtures of Metals and Neurodevelopmental Outcomes: A
   Multidisciplinary Review Using an Adverse Outcome Pathway Framework
SO RISK ANALYSIS
LA English
DT Article
DE Adverse outcome pathway; arsenic; cadmium; developmental; lead;
   manganese; metal mixtures; systematic review
ID AUTISM SPECTRUM DISORDER; ACTIVATED PROTEIN-KINASE; BLOOD LEAD LEVELS;
   IN-VIVO HAZARD; OXIDATIVE-STRESS; ENVIRONMENTAL-HEALTH; CONCURRENT
   EXPOSURE; MANGANESE EXPOSURE; PERINATAL EXPOSURE; ARSENIC EXPOSURE
AB Current risk assessment guidance calls for an individual chemical-by-chemical approach that fails to capture potential interactive effects of exposure to environmental mixtures and genetic variability. We conducted a review of the literature on relationships between prenatal and early life exposure to mixtures of lead (Pb), arsenic (As), cadmium (Cd), and manganese (Mn) with neurodevelopmental outcomes. We then used an adverse outcome pathway (AOP) framework to integrate lines of evidence from multiple disciplines based on evolving guidance developed by the Organization for Economic Cooperation and Development (OECD). Toxicological evidence suggests a greater than additive effect of combined exposures to As-Pb-Cd and to Mn with any other metal, and several epidemiologic studies also suggest synergistic effects from binary combinations of Pb-As, Pb-Cd, and Pb-Mn. The exposure levels reported in these epidemiologic studies largely fall at the high-end (e.g., 95th percentile) of biomonitoring data from the National Health and Nutrition Examination Survey (NHANES), suggesting a small but significant potential for high-end exposures. This review integrates multiple data sources using an AOP framework and provides an initial application of the OECD guidance in the context of potential neurodevelopmental toxicity of several metals, recognizing the evolving nature of regulatory interpretation and acceptance.
C1 [von Stackelberg, Katherine] Harvard Ctr Risk Anal, Boston, MA 02215 USA.
   [von Stackelberg, Katherine; Guzy, Elizabeth; Chu, Tian; Henn, Birgit Claus] Harvard Univ, TH Chan Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA.
   [Henn, Birgit Claus] Boston Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02215 USA.
RP von Stackelberg, K (reprint author), Harvard Ctr Risk Anal, 401 Pk Dr,Landmark 407, Boston, MA 02215 USA.
EM kvon@hsph.harvard.edu
RI von Stackelberg, Katherine/R-8183-2019
OI von Stackelberg, Katherine/0000-0002-9742-7398; Claus Henn,
   Birgit/0000-0001-7118-4327
FU National Institute of Environmental Health Sciences Superfund Research
   Program [P42ES16454]
FX Funded through a National Institute of Environmental Health Sciences
   Superfund Research Program Grant P42ES16454.
CR Adams JB, 2009, J TOXICOL, DOI 10.1155/2009/532640
   Agency for Toxic Substance and Disease Registry (ATSDR), 2007, TOX PROF LEAD
   Allen TEH, 2014, CHEM RES TOXICOL, V27, P2100, DOI 10.1021/tx500345j
   Amler RW, 2006, NEUROTOXICOLOGY, V27, P861, DOI 10.1016/j.neuro.2006.07.008
   Andrade V, 2014, BIOL TRACE ELEM RES, V158, P384, DOI 10.1007/s12011-014-9954-2
   Andrade V, 2013, NEUROTOXICOLOGY, V38, P33, DOI 10.1016/j.neuro.2013.06.003
   Antonio MT, 2002, TOXICOLOGY, V176, P59, DOI 10.1016/S0300-483X(02)00137-3
   Aschner M, 2007, TOXICOL APPL PHARM, V221, P131, DOI 10.1016/j.taap.2007.03.001
   [ATSDR CERCLA], 2004, INT PROF ARS CADM CH
   ATSDR, 2001, GUID MAN ASS JOINT T
   ATSDR, 2007, TOX PROF ARS
   ATSDR, 2001, GUID MAN PREP INT PR
   ATSDR (Agency for Toxic Substances and Disease Registry), 2012, TOX PROF CADM
   ATSDR P. H. S. U. S. Department of Health and Human Services, 2012, TOX PROF MANG
   Ayotte JD, 2003, ENVIRON SCI TECHNOL, V37, P2075, DOI 10.1021/es026211g
   Backhaus T, 2012, ENVIRON SCI TECHNOL, V46, P2564, DOI 10.1021/es2034125
   Bal-Price A, 2015, CRIT REV TOXICOL, V45, P83, DOI 10.3109/10408444.2014.981331
   Barker Alison J, 2008, Commun Integr Biol, V1, P207
   Bellinger DC, 2013, TOXICS, V1, DOI 10.3390/toxics1010001
   Ben Fredj F, 2010, ENVIRON TOXICOL CHEM, V29, P1637, DOI 10.1002/etc.178
   Betharia S, 2012, NEUROTOXICOLOGY, V33, P1117, DOI 10.1016/j.neuro.2012.06.002
   Billionnet C, 2012, ANN EPIDEMIOL, V22, P126, DOI 10.1016/j.annepidem.2011.11.004
   Bizarro P, 2003, REPROD TOXICOL, V17, P561, DOI 10.1016/S0890-6238(03)00096-0
   Braun JM, 2006, ENVIRON HEALTH PERSP, V114, P1904, DOI 10.1289/ehp.9478
   Breier JM, 2008, TOXICOL SCI, V105, P119, DOI 10.1093/toxsci/kfn115
   Calderon J, 2001, ENVIRON RES, V85, P69, DOI 10.1006/enrs.2000.4106
   Carfagna MA, 1996, CHEM-BIOL INTERACT, V100, P53, DOI 10.1016/0009-2797(95)03685-7
   CHANDRA S V, 1983, Industrial Health, V21, P273
   CHANDRA SV, 1984, ACTA PHARMACOL TOX, V54, P210
   CHANDRA SV, 1980, ARCH ENVIRON CON TOX, V9, P79, DOI 10.1007/BF01055501
   CHANDRA SV, 1981, ARCH TOXICOL, V49, P49, DOI 10.1007/BF00352071
   Chandravanshi LP, 2014, INT J DEV NEUROSCI, V38, P91, DOI 10.1016/j.ijdevneu.2014.08.009
   Chattopadhyay S, 2002, TOXICOL LETT, V136, P65, DOI 10.1016/S0378-4274(02)00282-5
   Chattopadhyay S, 2002, TOXICOL LETT, V128, P73, DOI 10.1016/S0378-4274(01)00535-5
   Chen LM, 2014, ENVIRON SCI POLLUT R, V21, P6170, DOI 10.1007/s11356-013-2465-4
   Choudhury H, 2001, J TOXICOL ENV HEAL A, V63, P321, DOI 10.1080/15287390152103643
   Clarke LE, 2013, NAT REV NEUROSCI, V14, P311, DOI 10.1038/nrn3484
   Conolly RB, 2001, TOXICOL SCI, V63, P1, DOI 10.1093/toxsci/63.1.1
   Cordova FM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033057
   Cordova FM, 2004, BRAIN RES, V998, P65, DOI 10.1016/j.brainres.2003.11.012
   Cory-Slechta DA, 2005, NEUROTOXICOLOGY, V26, P491, DOI 10.1016/j.neuro.2004.12.007
   Covelo A, 2015, NEUROSCIENCE, DOI 10.1016/j.neuroscience.2015.02.036
   Crittenden PL, 2011, J APPL TOXICOL, V31, P1, DOI 10.1002/jat.1552
   D'Amelio M, 2010, CELL DEATH DIFFER, V17, P1104, DOI 10.1038/cdd.2009.180
   Diacomanolis V, 2013, ENVIRON GEOCHEM HLTH, V35, P757, DOI 10.1007/s10653-013-9527-x
   El-Masri HA, 2008, J PHARMACOKINET PHAR, V35, P31, DOI 10.1007/s10928-007-9075-z
   ELSENHANS B, 1987, ECOTOX ENVIRON SAFE, V14, P275, DOI 10.1016/0147-6513(87)90071-6
   Eng LF, 2000, NEUROCHEM RES, V25, P1439, DOI 10.1023/A:1007677003387
   Eshel N, 2013, TRENDS COGN SCI, V17, P430, DOI 10.1016/j.tics.2013.06.010
   Fairhall LT, 1941, PUBLIC HEALTH REP, V56, P1610, DOI 10.2307/4583826
   Filipov NM, 2012, J APPL TOXICOL, V32, P310, DOI 10.1002/jat.1762
   Folch J, 2010, TOXICOL IN VITRO, V24, P465, DOI 10.1016/j.tiv.2009.09.023
   Fowler BA, 2004, BIOMETALS, V17, P567, DOI 10.1023/B:BIOM.0000045740.52182.9d
   Geier DA, 2012, INT J ENV RES PUB HE, V9, P4486, DOI 10.3390/ijerph9124486
   Gennings C, 1995, BIOMETRICS, V51, P1264, DOI 10.2307/2533258
   Gu CW, 2009, NEUROCHEM RES, V34, P1150, DOI 10.1007/s11064-008-9891-6
   Gundacker C, 2010, MUTAT RES-REV MUTAT, V705, P130, DOI 10.1016/j.mrrev.2010.06.003
   Haddad S, 1999, TOXICOL LETT, V108, P303, DOI 10.1016/S0378-4274(99)00102-2
   Haddad S, 2001, TOXICOL SCI, V63, P125, DOI 10.1093/toxsci/63.1.125
   Haynes EN, 2011, ENVIRON RES, V111, P1243, DOI 10.1016/j.envres.2011.08.008
   Hays SM, 2010, REGUL TOXICOL PHARM, V58, P1, DOI 10.1016/j.yrtph.2010.06.002
   Hazell AS, 2002, NEUROCHEM INT, V41, P271, DOI 10.1016/S0197-0186(02)00013-X
   Henn BC, 2014, CURR OPIN PEDIATR, V26, P223, DOI 10.1097/MOP.0000000000000067
   Henn BC, 2012, ENVIRON HEALTH PERSP, V120, P126, DOI 10.1289/ehp.1003300
   Henn BC, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-97
   Henn BC, 2010, EPIDEMIOLOGY, V21, P433, DOI 10.1097/EDE.0b013e3181df8e52
   Henson MC, 2004, EXP BIOL MED, V229, P383
   Hochadel JF, 1997, TOXICOLOGY, V116, P89, DOI 10.1016/S0300-483X(96)03536-6
   Hoffmann K, 2000, J EXPO ANAL ENV EPID, V10, P126, DOI 10.1038/sj.jea.7500081
   Hopkins MR, 2008, ENVIRON HEALTH PERSP, V116, P1261, DOI 10.1289/ehp.11233
   Hu H, 2007, PEDIATR CLIN N AM, V54, P155, DOI 10.1016/j.pcl.2006.11.009
   HUSSAIN T, 1987, J APPL TOXICOL, V7, P277, DOI 10.1002/jat.2550070409
   IPCS, 2009, WHO IPCS INT WORKSH
   Ischiropoulos H, 2003, J CLIN INVEST, V111, P163, DOI 10.1172/JCI200317638
   Ishitobi H, 2007, NEUROTOXICOLOGY, V28, P790, DOI 10.1016/j.neuro.2007.02.007
   Jadhav SH, 2007, ARCH ENVIRON CON TOX, V52, P145, DOI 10.1007/s00244-006-0053-z
   Kalia K, 1984, Ind Health, V22, P207
   Khalid M, 2011, J NEUROSCI METH, V202, P182, DOI 10.1016/j.jneumeth.2011.06.019
   Khan K, 2011, ENVIRON HEALTH PERSP, V119, P1501, DOI 10.1289/ehp.1003397
   Kim Y, 2013, NEUROTOXICOLOGY, V35, P15, DOI 10.1016/j.neuro.2012.11.006
   Kim Y, 2009, NEUROTOXICOLOGY, V30, P564, DOI 10.1016/j.neuro.2009.03.012
   KJELLSTROM T, 1978, ENVIRON RES, V16, P248, DOI 10.1016/0013-9351(78)90160-3
   Krauth D, 2013, ENVIRON HEALTH PERSP, V121, P985, DOI 10.1289/ehp.1206389
   LAI JCK, 1980, BIOCHEM PHARMACOL, V29, P141, DOI 10.1016/0006-2952(80)90321-4
   LAI JCK, 1981, BIOCHEM PHARMACOL, V30, P3123, DOI 10.1016/0006-2952(81)90504-9
   LAL S, 1980, TOXICOL LETT, V5, P203, DOI 10.1016/0378-4274(80)90060-0
   Lamb MR, 2008, ENVIRON RES, V106, P195, DOI 10.1016/j.envres.2007.09.012
   Lee DH, 2006, ENVIRON HEALTH PERSP, V114, P350, DOI 10.1289/ehp.8518
   Lee WC, 2005, NEUROCHEM RES, V30, P263, DOI 10.1007/s11064-005-2449-y
   Leret ML, 2003, TOXICOLOGY, V186, P125, DOI 10.1016/S0300-483X(02)00728-X
   Lidsky TI, 2003, BRAIN, V126, P5, DOI 10.1093/brain/awg014
   Lin CC, 2013, ENVIRON RES, V123, P52, DOI 10.1016/j.envres.2013.03.003
   Lohmann C, 2009, PROG BRAIN RES, V175, P443, DOI 10.1016/S0079-6123(09)17529-5
   Lu TH, 2014, TOXICOL LETT, V224, P130, DOI 10.1016/j.toxlet.2013.10.013
   Lucas RM, 2005, B WORLD HEALTH ORGAN, V83, P792
   Lucchini RG, 2012, ENVIRON RES, V118, P65, DOI 10.1016/j.envres.2012.08.003
   MacDonell MM, 2013, J TOXICOL, DOI 10.1155/2013/310904
   MAHAFFEY KR, 1981, J LAB CLIN MED, V98, P463
   MAHAFFEY KR, 1977, ENVIRON HEALTH PERSP, V19, P165, DOI 10.2307/3428470
   MALHOTRA KM, 1984, J APPL TOXICOL, V4, P22, DOI 10.1002/jat.2550040105
   MARLOWE M, 1985, ARCH ENVIRON HEALTH, V40, P221, DOI 10.1080/00039896.1985.10545922
   MARLOWE M, 1985, J ABNORM CHILD PSYCH, V13, P185, DOI 10.1007/BF00910641
   Mattson MP, 2000, NAT REV MOL CELL BIO, V1, P120, DOI 10.1038/35040009
   McDermott S, 2011, CHEMOSPHERE, V84, P31, DOI 10.1016/j.chemosphere.2011.02.088
   Meek ME, 2014, J APPL TOXICOL, V34, P595, DOI 10.1002/jat.2984
   Mejia JJ, 1997, NEUROTOXICOL TERATOL, V19, P489, DOI 10.1016/S0892-0362(97)00066-4
   Mendez-Armenta M, 2007, ENVIRON TOXICOL PHAR, V23, P350, DOI 10.1016/j.etap.2006.11.009
   Mennenga SE, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00294
   Michaelsen K, 2010, EUR J NEUROSCI, V32, P218, DOI 10.1111/j.1460-9568.2010.07341.x
   Middeldorp J, 2011, PROG NEUROBIOL, V93, P421, DOI 10.1016/j.pneurobio.2011.01.005
   Milatovic D, 2009, TOXICOL APPL PHARM, V240, P219, DOI 10.1016/j.taap.2009.07.004
   MOON C, 1985, J LEARN DISABIL, V18, P217, DOI 10.1177/002221948501800407
   Mora AM, 2014, ENVIRON SCI TECHNOL, V48, P3467, DOI 10.1021/es404279r
   Naess O, 2007, EPIDEMIOLOGY, V18, P686, DOI 10.1097/EDE.0b013e3181567d14
   Nampoothiri LP, 2008, J BIOCHEM MOL TOXIC, V22, P337, DOI 10.1002/jbt.20246
   NATION JR, 1990, NEUROTOXICOL TERATOL, V12, P99, DOI 10.1016/0892-0362(90)90119-W
   Navarrete M, 2013, CEREB CORTEX, V23, P1240, DOI 10.1093/cercor/bhs122
   Neal AP, 2012, DRUG METABOLISM TOXI, pS5
   Neal AP, 2010, MOL NEUROBIOL, V42, P151, DOI 10.1007/s12035-010-8146-0
   Nigg JT, 2008, BIOL PSYCHIAT, V63, P325, DOI 10.1016/j.biopsych.2007.07.013
   Obrenovich ME, 2011, BIOL TRACE ELEM RES, V144, P475, DOI 10.1007/s12011-011-9146-2
   OECD, 2011, OECD SER TEST ASS
   OECD, 2014, US HDB SUPPL GUID DO
   ONG CN, 1985, ARCH DIS CHILD, V60, P756, DOI 10.1136/adc.60.8.756
   Organisation for Economic Co-operation and Development (OECD), 2013, OECD SER TEST ASS, V184
   Parajuli RP, 2013, ENVIRON RES, V121, P45, DOI 10.1016/j.envres.2012.10.010
   Patlewicz G, 2015, REGUL TOXICOL PHARM, V71, P463, DOI 10.1016/j.yrtph.2015.02.011
   Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153
   Pillai A, 2003, FOOD CHEM TOXICOL, V41, P379, DOI 10.1016/S0278-6915(02)00247-8
   Pillai A, 2002, ARCH TOXICOL, V76, P671, DOI 10.1007/s00204-002-0399-6
   Pillai P, 2010, J BIOCHEM MOL TOXIC, V24, P384, DOI 10.1002/jbt.20351
   Pillai P, 2009, J BIOCHEM MOL TOXIC, V23, P419, DOI 10.1002/jbt.20305
   Pohl HR, 2003, CHEMOSPHERE, V53, P183, DOI 10.1016/S0045-6535(03)00436-3
   Rai A, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.514
   Rai A, 2013, TOXICOL MECH METHOD, V23, P99, DOI 10.3109/15376516.2012.721809
   Rai A, 2010, TOXICOL SCI, V118, P586, DOI 10.1093/toxsci/kfq266
   Rai NK, 2013, TOXICOL APPL PHARM, V273, P242, DOI 10.1016/j.taap.2013.05.003
   Rigon AP, 2008, NEUROTOXICOLOGY, V29, P727, DOI 10.1016/j.neuro.2008.04.017
   Roberts AL, 2013, ENVIRON HEALTH PERSP, V121, P978, DOI 10.1289/ehp.1206187
   Rocha RA, 2011, TOXICOL LETT, V203, P237, DOI 10.1016/j.toxlet.2011.03.023
   Rodrigues JL, 2008, SCI TOTAL ENVIRON, V405, P370, DOI 10.1016/j.scitotenv.2008.06.002
   Rodriguez VM, 1998, ENVIRON HEALTH PERSP, V106, P487, DOI 10.2307/3434181
   Rooney AA, 2014, ENVIRON HEALTH PERSP, V122, P711, DOI 10.1289/ehp.1307972
   Rosado JL, 2007, ENVIRON HEALTH PERSP, V115, P1371, DOI 10.1289/ehp.9961
   Roy A, 2013, NEUROTOXICOLOGY, V38, P17, DOI 10.1016/j.neuro.2013.05.005
   Rubenstein JLR, 2011, J CHILD PSYCHOL PSYC, V52, P339, DOI 10.1111/j.1469-7610.2010.02307.x
   Ruiz P, 2010, SAR QSAR ENVIRON RES, V21, P603, DOI 10.1080/1062936X.2010.528942
   Samuels IS, 2009, NEURON, V61, P160, DOI 10.1016/j.neuron.2009.01.001
   Sanders Talia, 2009, Reviews on Environmental Health, V24, P15
   Sannadi S, 2013, INT J DEV NEUROSCI, V31, P586, DOI 10.1016/j.ijdevneu.2013.07.003
   Schubert D, 2013, MOL PSYCHIATR, V2014, P1
   Sexton K, 2011, AM J PUBLIC HEALTH, V101, pS81, DOI 10.2105/AJPH.2011.300118
   Shraim A, 2003, TOXICOL LETT, V137, P35, DOI 10.1016/S0378-4274(02)00379-X
   SHUKLA GS, 1987, ARCH ENVIRON CON TOX, V16, P303, DOI 10.1007/BF01054947
   SHUKLA GS, 1982, TOXICOL LETT, V10, P163, DOI 10.1016/0378-4274(82)90069-8
   Smith E, 2012, J HAZARD MATER, V199, P453, DOI 10.1016/j.jhazmat.2011.11.016
   Sofroniew MV, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020420
   Stansfield KH, 2012, TOXICOL SCI, V127, P277, DOI 10.1093/toxsci/kfs090
   Stevens B, 2008, NEUROSIGNALS, V16, P278, DOI 10.1159/000123038
   Sun W, 2013, SCIENCE, V339, P197, DOI 10.1126/science.1226740
   Syapin PJ, 2008, BRIT J PHARMACOL, V155, P623, DOI 10.1038/bjp.2008.342
   Takuma K, 2004, PROG NEUROBIOL, V72, P111, DOI 10.1016/j.pneurobio.2004.02.001
   Taylor MD, 2012, J TOXICOL, DOI 10.1155/2012/791431
   Teeguarden JG, 2007, J TOXICOL ENV HEAL A, V70, P1493, DOI 10.1080/15287390701384601
   THATCHER RW, 1982, ARCH ENVIRON HEALTH, V37, P159, DOI 10.1080/00039896.1982.10667557
   Thomas RS, 2012, TOXICOL SCI, V128, P398, DOI 10.1093/toxsci/kfs159
   Tricco AC, 2011, J CLIN EPIDEMIOL, V64, P11, DOI 10.1016/j.jclinepi.2009.11.007
   Vahidnia A, 2007, HUM EXP TOXICOL, V26, P823, DOI 10.1177/0960327107084539
   Villeneuve DL, 2014, TOXICOL SCI, V142, P312, DOI 10.1093/toxsci/kfu199
   Villeneuve DL, 2014, TOXICOL SCI, V142, P321, DOI 10.1093/toxsci/kfu200
   Volterra A, 2014, NAT REV NEUROSCI, V15, P327, DOI 10.1038/nrn3725
   Wang B, 2013, OXID MED CELL LONGEV, DOI 10.1155/2013/898034
   Wang FT, 2007, ENVIRON HEALTH PERSP, V115, P1210, DOI 10.1289/ehp.9855
   Wang JY, 2003, J NEUROSCI RES, V72, P508, DOI 10.1002/jnr.10597
   Wasserman GA, 2011, NEUROTOXICOLOGY, V32, P450, DOI 10.1016/j.neuro.2011.03.009
   Wetmore BA, 2013, TOXICOL SCI, V132, P327, DOI 10.1093/toxsci/kft012
   Wright RO, 2006, NEUROTOXICOLOGY, V27, P210, DOI 10.1016/j.neuro.2005.10.001
   Xu B, 2013, TOXICOL LETT, V222, P239, DOI 10.1016/j.toxlet.2013.08.001
   Yamada K, 2002, LIFE SCI, V70, P735, DOI 10.1016/S0024-3205(01)01461-8
   Yang CS, 2008, J CELL BIOCHEM, V103, P825, DOI 10.1002/jcb.21452
   Yang RSH, 2007, TOXICOL APPL PHARM, V223, P133, DOI 10.1016/j.taap.2006.11.016
   Yen CC, 2011, ARCH TOXICOL, V85, P565, DOI 10.1007/s00204-011-0709-y
   Yoon M, 2012, CRIT REV TOXICOL, V42, P633, DOI 10.3109/10408444.2012.692115
   Yuan Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064330
   ZAREMBSKI PM, 1983, CLIN CHIM ACTA, V134, P35, DOI 10.1016/0009-8981(83)90182-1
   Zhang J, 2013, NEUROSCIENCE, V241, P52, DOI 10.1016/j.neuroscience.2013.03.014
   Zhang YM, 2009, BIOMED ENVIRON SCI, V22, P423, DOI 10.1016/S0895-3988(10)60021-9
   Zheng W, 2001, MICROSC RES TECHNIQ, V52, P89, DOI 10.1002/1097-0029(20010101)52:1<89::AID-JEMT11>3.3.CO;2-U
NR 188
TC 25
Z9 25
U1 8
U2 38
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0272-4332
EI 1539-6924
J9 RISK ANAL
JI Risk Anal.
PD JUN
PY 2015
VL 35
IS 6
SI SI
BP 971
EP 1016
DI 10.1111/risa.12425
PG 46
WC Public, Environmental & Occupational Health; Mathematics,
   Interdisciplinary Applications; Social Sciences, Mathematical Methods
SC Public, Environmental & Occupational Health; Mathematics; Mathematical
   Methods In Social Sciences
GA CN0SD
UT WOS:000358122800003
PM 26096925
OA Green Accepted
DA 2019-10-23
ER

PT J
AU Hala, D
   Petersen, LH
   Martinovic, D
   Huggett, DB
AF Hala, David
   Petersen, Lene H.
   Martinovic, Dalma
   Huggett, Duane B.
TI In Silico analysis of perturbed steroidogenesis and gonad growth in
   fathead minnows (P. promelas) exposed to 17 alpha-ethynylestradiol
SO SYSTEMS BIOLOGY IN REPRODUCTIVE MEDICINE
LA English
DT Article
DE 17 alpha-ethynylestradiol; fathead minnows; flux balance analysis; gonad
   growth; steroid hormones
ID ADVERSE OUTCOME PATHWAYS; ENDOCRINE DISRUPTING CHEMICALS; RELATIVE
   BINDING AFFINITIES; CONSTRAINT-BASED MODELS; GENE-EXPRESSION;
   ESCHERICHIA-COLI; HORMONE NEURONS; RAINBOW-TROUT;
   REPRODUCTIVE-PERFORMANCE; QUANTITATIVE PREDICTION
AB The multi-factorial nature of adverse reproductive effects mediated by endocrine disrupting compounds (or EDCs) makes understanding the mechanistic basis of reproductive dysfunction a highly pertinent area of research. As a consequence, a main motivator for continued research is to integrate 'multi-leveled' complexity (i.e., from genes to phenotype) using mathematical methods capable of encapsulating properties of physiological relevance. In this study, an in silica stoichiometric model of piscine steroidogenesis was augmented with a 'biomass' reaction associating the underlying stoichiometry of steroidogenesis with a reaction representative of gonad growth. The ability of the in silica model to predict perturbed steroidogenesis and subsequent effects on gonad growth was tested by exposing reproductively active male and female fathead minnows (Pimephales promelas) to 88 ng/L of the synthetic estrogen, 17 alpha-ethynylestradiol (EE2). The in silica model was parameterized (or constrained) with experimentally quantified concentrations of selected steroid hormones (using mass spectrometry) and fold changes in gene expression (using RT-qPCR) for selected steroidogenic enzyme genes, in gonads of male and female fish. Once constrained, the optimization framework of flux balance analysis (FBA) was used to calculate an optimal flux through the biomass reaction (analogous to gonad growth) and associated steroidogenic flux distributions required to generate biomass. FBA successfully predicted effects of EE2 exposure on fathead minnow gonad growth (%gonadosomatic index or %GSI) and perturbed production of steroid hormones. Specifically, FBA accurately predicted no effects of exposure on male %GSI and a significant reduction for female %GSI. Furthermore, in silica simulations accurately identified disrupted reaction fluxes catalyzing productions of androgens (in male fish) and progestogens (in female fish), an observation which agreed with in vivo experimentation. The analyses presented is the first-ever to successfully associate underlying flux properties of the steroidogenic network with gonad growth in fish, an approach which can incorporate in silico predictions with toxicological risk assessments.
C1 [Hala, David; Petersen, Lene H.; Huggett, Duane B.] Univ N Texas, Dept Biol, Denton, TX 76203 USA.
   [Hala, David; Petersen, Lene H.] Texas A&M Univ, Dept Marine Biol, Galveston, TX 77553 USA.
   [Martinovic, Dalma] Univ St Thomas, Dept Biol, St Paul, MN USA.
   [Huggett, Duane B.] Waterbome Environm Inc, Se Leesburg, VA USA.
RP Hala, D (reprint author), Univ N Texas, Dept Biol, Denton, TX 76203 USA.
EM david.hala@unt.edu
OI Martinovic-Weigelt, Dalma/0000-0002-9973-4965
CR Andersson C., 2007, THE INDIAN UPRISING, P1
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Ankley GT, 2001, ENVIRON TOXICOL CHEM, V20, P1276, DOI 10.1002/etc.5620200616
   Becker SA, 2007, NAT PROTOC, V2, P727, DOI 10.1038/nprot.2007.99
   Bhatta S, 2012, P NATL ACAD SCI USA, V109, P11408, DOI 10.1073/pnas.1118704109
   Bhattacharya D, 1997, BRIT J CANCER, V75, P554, DOI 10.1038/bjc.1997.97
   Blair RM, 2000, TOXICOL SCI, V54, P138, DOI 10.1093/toxsci/54.1.138
   Bonarius HPJ, 1997, TRENDS BIOTECHNOL, V15, P308, DOI 10.1016/S0167-7799(97)01067-6
   Breen MS, 2007, ANN BIOMED ENG, V35, P970, DOI 10.1007/s10439-007-9309-7
   Brian JV, 2007, ENVIRON SCI TECHNOL, V41, P337, DOI 10.1021/es0617439
   Cabas I, 2013, MAR DRUGS, V11, P4973, DOI 10.3390/md11124973
   Denny JS, 2005, ENVIRON TOXICOL CHEM, V24, P2948, DOI 10.1897/04-595R.1
   Estay F, 2012, SCI WORLD J, DOI 10.1100/2012/986590
   Feist AM, 2010, CURR OPIN MICROBIOL, V13, P344, DOI 10.1016/j.mib.2010.03.003
   Filby AL, 2008, BIOL REPROD, V78, P278, DOI 10.1095/biolreprod.107.063420
   Filby AL, 2007, AQUAT TOXICOL, V81, P219, DOI 10.1016/j.aquatox.2006.12.003
   Fong SS, 2005, BIOTECHNOL BIOENG, V91, P643, DOI 10.1002/bit.20542
   Fong SS, 2004, NAT GENET, V36, P1056, DOI 10.1038/ng1432
   Garcia-Reyero N, 2011, ENVIRON TOXICOL CHEM, V30, P265, DOI 10.1002/etc.401
   GOLDZIEHER JW, 1975, AM J OBSTET GYNECOL, V122, P625, DOI 10.1016/0002-9378(75)90062-9
   Griffitt RJ, 2009, TOXICOL SCI, V107, P404, DOI 10.1093/toxsci/kfn256
   Guillette LJ, 2012, SCIENCE, V337, P1614, DOI 10.1126/science.1226985
   Hala D, 2011, J CHROMATOGR B, V879, P591, DOI 10.1016/j.jchromb.2011.01.020
   Hala D, 2010, J BIOL SYST, V18, P669, DOI 10.1142/S0218339010003469
   Hala D, 2012, J EXP BIOL, V215, P1753, DOI 10.1242/jeb.066027
   Hammer O, 2001, PALAEONTOL ELECTRON, V4, P4, DOI DOI 10.1016/J.BCP.2008.05.025
   Harding LB, 2013, AQUAT TOXICOL, V142, P146, DOI 10.1016/j.aquatox.2013.07.020
   Harries JE, 2000, ENVIRON SCI TECHNOL, V34, P3003, DOI 10.1021/es991292a
   Hartung T, 2009, NATURE, V460, P208, DOI 10.1038/460208a
   Herbison AE, 2001, FRONT NEUROENDOCRIN, V22, P292, DOI 10.1006/frne.2001.0219
   Hoffmann JL, 2006, AQUAT TOXICOL, V79, P233, DOI 10.1016/j.aquatox.2006.06.009
   Holloway AC, 1999, COMP BIOCHEM PHYS B, V123, P251, DOI 10.1016/S0305-0491(99)00059-0
   Hong J., 2004, J CHROMATOGR A, V4, P1
   Ibarra RU, 2002, NATURE, V420, P186, DOI 10.1038/nature01149
   Jensen KM, 2001, COMP BIOCHEM PHYS C, V128, P127, DOI 10.1016/S1532-0456(00)00185-X
   Jimenez-Marin A., 2009, BMC P, V16, P1753
   Kaptaner B, 2009, FRESEN ENVIRON BULL, V18, P2366
   Kavlock RJ, 2008, TOXICOL SCI, V103, P14, DOI 10.1093/toxsci/kfm297
   KIME DE, 1993, REV FISH BIOL FISHER, V3, P160, DOI 10.1007/BF00045230
   King SR, 2012, FRONT BIOSCI-LANDMRK, V17, P824, DOI 10.2741/3959
   Kramer VJ, 2011, ENVIRON TOXICOL CHEM, V30, P64, DOI 10.1002/etc.375
   Kumar RS, 2000, BIOL REPROD, V63, P1676, DOI 10.1095/biolreprod63.6.1676
   Le Guevel R, 2001, HUM REPROD, V16, P1030, DOI 10.1093/humrep/16.5.1030
   Leino RL, 2005, ENVIRON TOXICOL PHAR, V19, P85, DOI 10.1016/j.etap.2004.05.010
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Miller HD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052479
   Miracle AL, 2005, REPROD TOXICOL, V19, P321, DOI 10.1016/j.reprotox.2004.06.007
   MOUTOS D, 1995, CONTRACEPTION, V52, P105, DOI 10.1016/S0010-7824(95)00137-9
   NAGAHAMA Y, 1994, INT J DEV BIOL, V38, P217
   Nash JP, 2004, ENVIRON HEALTH PERSP, V112, P1725, DOI 10.1289/ehp.7209
   Navas JM, 1995, J COMP NEUROL, V363, P461, DOI 10.1002/cne.903630309
   Nelson RE, 2004, CLIN CHEM, V50, P373, DOI 10.1373/clinchem.2003.025478
   OECD, 2012, TEST 229 FISH SHORT
   OMURA T, 1995, J STEROID BIOCHEM, V53, P19, DOI 10.1016/0960-0760(95)00036-Y
   Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614
   Petersen LH, 2015, ENVIRON TOXICOL CHEM, V34, P379, DOI 10.1002/etc.2816
   Petersen SL, 2003, BIOL REPROD, V69, P1771, DOI 10.1095/biolreprod.103.019745
   Price ND, 2004, NAT REV MICROBIOL, V2, P886, DOI 10.1038/nrmicro1023
   Sanderson JT, 2006, TOXICOL SCI, V94, P3, DOI 10.1093/toxsci/kfl051
   Santos LHMLM, 2010, J HAZARD MATER, V175, P45, DOI 10.1016/j.jhazmat.2009.10.100
   SAVINELL JM, 1992, J THEOR BIOL, V154, P421, DOI 10.1016/S0022-5193(05)80161-4
   Schellenberger J, 2011, NAT PROTOC, V6, P1290, DOI 10.1038/nprot.2011.308
   Schilling CH, 1999, BIOTECHNOL PROGR, V15, P296, DOI 10.1021/bp990048k
   Schilling CH, 1998, P NATL ACAD SCI USA, V95, P4193, DOI 10.1073/pnas.95.8.4193
   Schilling CH, 2000, BIOTECHNOL BIOENG, V71, P286, DOI 10.1002/1097-0290(2000)71:4<286::AID-BIT1018>3.0.CO;2-R
   Scholz S, 2000, AQUAT TOXICOL, V50, P363, DOI 10.1016/S0166-445X(00)00090-4
   Schug TT, 2011, J STEROID BIOCHEM, V127, P204, DOI 10.1016/j.jsbmb.2011.08.007
   Seki M, 2002, ENVIRON TOXICOL CHEM, V21, P1692, DOI [10.1897/1551-5028(2002)021<1692:EOEOTR>2.0.CO;2, 10.1002/etc.5620210822]
   Senthilkumaran B, 2004, MOL CELL ENDOCRINOL, V215, P11, DOI 10.1016/j.mce.2003.11.012
   Sewer M B, 2001, Rev Endocr Metab Disord, V2, P269, DOI 10.1023/A:1011516532335
   Sonnenschein C, 1998, J STEROID BIOCHEM, V65, P143, DOI 10.1016/S0960-0760(98)00027-2
   Sturla SJ, 2014, CHEM RES TOXICOL, V27, P314, DOI 10.1021/tx400410s
   SUMPTER JP, 1995, ENVIRON HEALTH PERSP, V103, P173, DOI 10.2307/3432529
   Tabb MM, 2006, MOL ENDOCRINOL, V20, P475, DOI 10.1210/me.2004-0513
   Thiele I, 2005, J BIOL CHEM, V280, P11683, DOI 10.1074/jbc.M409072200
   Van den Belt K, 2004, AQUAT TOXICOL, V66, P183, DOI 10.1016/j.aquatox.2003.09.004
   VARMA A, 1994, BIO-TECHNOL, V12, P994, DOI 10.1038/nbt1094-994
   Villeneuve DL, 2007, TOXICOL SCI, V98, P395, DOI 10.1093/toxsci/kfm124
   Villeneuve DL, 2012, MUTAT RES-GEN TOX EN, V746, P151, DOI 10.1016/j.mrgentox.2011.12.016
   Villeneuve DL, 2011, ENVIRON TOXICOL CHEM, V30, P1, DOI 10.1002/etc.396
   Volz DC, 2011, TOXICOL SCI, V123, P349, DOI 10.1093/toxsci/kfr185
   Waagmeester AS, 2008, GENES NUTR, V3, P139, DOI 10.1007/s12263-008-0098-x
   Watanabe KH, 2011, ENVIRON TOXICOL CHEM, V30, P9, DOI 10.1002/etc.373
   Williams TD, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002126
   Wintermantel TM, 2006, NEURON, V52, P271, DOI 10.1016/j.neuron.2006.07.023
   Yaron Z, 2011, ENCYCLOPEDIA OF FISH PHYSIOLOGY: FROM GENOME TO ENVIRONMENT, VOLS 1-3, P1500
   Yim H, 2011, NAT CHEM BIOL, V7, P445, DOI [10.1038/NCHEMBIO.580, 10.1038/nchembio.580]
   Zha JM, 2007, CHEMOSPHERE, V66, P488, DOI 10.1016/j.chemosphere.2006.05.071
   Zhu BT, 2006, ENDOCRINOLOGY, V147, P4132, DOI 10.1210/en.2006-0113
   Zohar Y, 2010, GEN COMP ENDOCR, V165, P438, DOI 10.1016/j.ygcen.2009.04.017
   Zou JJ, 1997, GEN COMP ENDOCR, V106, P102, DOI 10.1006/gcen.1996.6857
NR 91
TC 1
Z9 1
U1 0
U2 13
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1939-6368
EI 1939-6376
J9 SYST BIOL REPROD MED
JI Syst. Biol. Reprod. Med.
PD JUN
PY 2015
VL 61
IS 3
BP 122
EP 138
DI 10.3109/19396368.2015.1035817
PG 17
WC Andrology; Reproductive Biology
SC Endocrinology & Metabolism; Reproductive Biology
GA CJ7XY
UT WOS:000355714900002
PM 25910217
OA Bronze
DA 2019-10-23
ER

PT J
AU Emter, R
   Natsch, A
AF Emter, Roger
   Natsch, Andreas
TI A fast Resazurin-based live viability assay is equivalent to the
   MTT-test in the KeratinoSens assay
SO TOXICOLOGY IN VITRO
LA English
DT Article
DE PrestoBlue (R); Luciferase; MTT; KeratinoSens (TM); Reporter gene assay
ID VITRO; POTENCY
AB The KeratinoSens(TM) assay was the first cell-based in vitro test in the skin sensitisation adverse outcome pathway to be endorsed by an ECVAM statement. It includes a cell viability assessment, which serves two purposes: It forms part of the prediction model to exclude false-positive irritants and cytotoxicity provides some information on sensitizer potency of chemicals, which can feed into a multivariate potency model. In the KeratinoSens(TM) protocol, Nrf2-dependent luciferase induction and the MTT-viability assay are performed in parallel plates. Resazurin-based viability assays do not require cell lysis and are compatible with luciferase measurements in the same cells. Here, we performed detailed comparison of the tetrazolium-based MTT assay and the PrestoBlue(R) assay on 35 reference chemicals tested in the full KeratinoSens(TM) protocol. Log-transformed IC50 and IC30 values measured with both methods correlate with an R-2 of 0.97 and 0.95. A single chemical showed divergent results and analysis by four different viability assays indicated the PrestoBlue(R) read-out to be correct. The new more rapid and resource efficient approach has clear advantages: Dose-response curves show lower variability and the two endpoints are measured on the same cells. This approach is a valid addition to or replacement of the MTT-readout in the KeratinoSens(TM) assay and it is recommended as a general tool for luciferase-based reporter assays. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Emter, Roger; Natsch, Andreas] Givaudan Schweiz AG, CH-8600 Dubendorf, Switzerland.
RP Natsch, A (reprint author), Givaudan Schweiz AG, Ueberlandstr 138, CH-8600 Dubendorf, Switzerland.
EM andreas.natsch@givaudan.com
OI Natsch, Andreas/0000-0003-2231-2489
FU Givaudan Schweiz AG
FX This work was entirely funded by Givaudan Schweiz AG.
CR Boncler M, 2014, J PHARMACOL TOX MET, V69, P9, DOI 10.1016/j.vascn.2013.09.003
   dos Santos GG, 2011, TOXICOL IN VITRO, V25, P347, DOI 10.1016/j.tiv.2010.10.008
   ECVAM, 2014, KERATIONOSENS PROT D
   ECVAM, 2014, EURL ECVAM REC DIR P
   Emter R, 2010, TOXICOL APPL PHARM, V245, P281, DOI 10.1016/j.taap.2010.03.009
   Hartung T, 2013, ALTEX-ALTERN ANIM EX, V30, P3, DOI 10.14573/altex.2013.1.003
   Lall Namrita, 2013, Int J Microbiol, V2013, P420601, DOI 10.1155/2013/420601
   Lambrechts N, 2010, TOXICOL SCI, V116, P122, DOI 10.1093/toxsci/kfq108
   Natsch A., 2014, TOXICOL SCI
   Natsch A, 2013, J APPL TOXICOL, V33, P1337, DOI 10.1002/jat.2868
   Natsch A, 2011, TOXICOL IN VITRO, V25, P733, DOI 10.1016/j.tiv.2010.12.014
   Nukada Y, 2012, TOXICOL IN VITRO, V26, P1150, DOI 10.1016/j.tiv.2012.07.001
   OECD, 2012, OECD ENV HLTH SAF PU, P10
   Shukla SJ, 2010, DRUG DISCOV TODAY, V15, P997, DOI 10.1016/j.drudis.2010.07.007
   Uibel F, 2010, REPROD TOXICOL, V30, P103, DOI 10.1016/j.reprotox.2009.12.002
   Vandebriel RJ, 2010, CRIT REV TOXICOL, V40, P389, DOI 10.3109/10408440903524262
NR 16
TC 10
Z9 12
U1 0
U2 22
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0887-2333
J9 TOXICOL IN VITRO
JI Toxicol. Vitro
PD JUN
PY 2015
VL 29
IS 4
BP 688
EP 693
DI 10.1016/j.tiv.2015.02.003
PG 6
WC Toxicology
SC Toxicology
GA CH1AV
UT WOS:000353754400006
PM 25687527
DA 2019-10-23
ER

PT J
AU Petkov, PI
   Patlewicz, G
   Schultz, TW
   Honma, M
   Todorov, M
   Kotov, S
   Dimitrov, SD
   Donner, EM
   Mekenyan, OG
AF Petkov, Petko I.
   Patlewicz, Grace
   Schultz, Terry W.
   Honma, Masamitsu
   Todorov, Milen
   Kotov, Stefan
   Dimitrov, Sabcho D.
   Donner, E. Maria
   Mekenyan, Ovanes G.
TI A feasibility study: Can information collected to classify for
   mutagenicity be informative in predicting carcinogenicity?
SO REGULATORY TOXICOLOGY AND PHARMACOLOGY
LA English
DT Article
DE Carcinogenicity classification; Integrated Approaches to Testing and
   Assessment (IATA); (Q)SAR; Adverse Outcome Pathway (AOP)
ID DISCRIMINATE RODENT CARCINOGENS; VITRO GENOTOXICITY TESTS; RELATIVE
   PREDICTIVITY; GENETIC TOXICOLOGY; RISK-ASSESSMENT; ECVAM WORKSHOP; COMET
   ASSAY; DNA-DAMAGE; NONCARCINOGENS; STRATEGIES
AB Carcinogenicity is a complex endpoint of high concern yet the rodent bioassay still used is costly to run in terms of time, money and animals. Therefore carcinogenicity has been the subject of many different efforts to both develop short-term tests and non-testing approaches capable of predicting genotoxic carcinogenic potential. In our previous publication (Mekenyan et al., 2012) we presented an in vitro-in vivo extrapolation workflow to help investigate the differences between in vitro and in vivo genotoxicity tests. The outcomes facilitated the development of new (Q)SAR models and for directing testing. Here we have refined this workflow by grouping specific tests together on the basis of their ability to detect DNA and/or protein damage at different levels of biological organization. This revised workflow, akin to an Integrated Approach to Testing and Assessment (IATA) informed by mechanistic understanding was helpful in rationalizing inconsistent study outcomes and categorizing a test set of carcinogens with mutagenicity data on the basis of regulatory mutagenicity classifications. Rodent genotoxic carcinogens were found to be correctly predicted with a high sensitivity (90-100%) and a low rate of false positives (3-10%). The insights derived are useful to consider when developing future (non-)testing approaches to address regulatory purposes. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Petkov, Petko I.; Todorov, Milen; Kotov, Stefan; Dimitrov, Sabcho D.; Mekenyan, Ovanes G.] As Zlatarov Univ, LMC, Burgas, Bulgaria.
   [Patlewicz, Grace; Donner, E. Maria] DuPont Haskell Global Ctr Hlth & Environm Sci, Newark, DE 19711 USA.
   [Schultz, Terry W.] Univ Tennessee, Coll Vet Med, Knoxville, TN 37996 USA.
   [Honma, Masamitsu] Natl Inst Hlth Sci, Div Genet & Mutagenesis, Tokyo, Japan.
RP Patlewicz, G (reprint author), EPA ORD NCCT, 109 TW Alexander Dr B205-01, Res Triangle Pk, NC 27711 USA.
EM patlewig@hotmail.com
OI Patlewicz, Grace/0000-0003-3863-9689
CR AMES BN, 1973, P NATL ACAD SCI USA, V70, P2281, DOI 10.1073/pnas.70.8.2281
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Antunovic B, 2011, EFSA J, V9, DOI 10.2903/j.efsa.2011.2379
   Bateman A.J., 1984, HDB MUTAGENICITY TES, P471
   Benigni R, 2013, MUTAT RES-GEN TOX EN, V758, P56, DOI 10.1016/j.mrgentox.2013.09.006
   Benigni R, 2010, MUTAGENESIS, V25, P335, DOI 10.1093/mutage/geq010
   Cimino MC, 2006, ENVIRON MOL MUTAGEN, V47, P362, DOI 10.1002/em.20216
   Clements J, 2000, MUTAT RES-FUND MOL M, V455, P97, DOI 10.1016/S0027-5107(00)00066-X
   CLIVE D, 1979, MUTAT RES, V59, P61, DOI 10.1016/0027-5107(79)90195-7
   Collins AR, 2004, MOL BIOTECHNOL, V26, P249, DOI 10.1385/MB:26:3:249
   Combes R, 2007, ATLA-ALTERN LAB ANIM, V35, P267, DOI 10.1177/026119290703500201
   Dean B. J., 1984, MUTAGENICITY TESTING, P187
   Dearfield KL, 2002, MUTAT RES-GEN TOX EN, V521, P121, DOI 10.1016/S1383-5718(02)00236-X
   ECHA, 2014, GUID INF REQ CHEM SA
   GREEN S, 1985, MUTAT RES, V154, P49, DOI 10.1016/0165-1110(85)90009-0
   Grindon C, 2006, ATLA-ALTERN LAB ANIM, V34, P407, DOI 10.1177/026119290603400402
   Kirkland D, 2005, MUTAT RES-GEN TOX EN, V584, P1, DOI 10.1016/j.mrgentox.2005.02.004
   Kirkland DJ, 2007, MUTAGENESIS, V22, P161, DOI 10.1093/mutage/gem006
   Kirkland D, 2007, MUTAT RES-GEN TOX EN, V628, P31, DOI 10.1016/j.mrgentox.2006.11.008
   Kirkland D, 2006, MUTAT RES-GEN TOX EN, V608, P29, DOI 10.1016/j.mrgentox.2006.04.017
   Kirkland D, 2014, MUTAT RES-GEN TOX EN, V775, P55, DOI 10.1016/j.mrgentox.2014.10.005
   Kirkland D, 2011, MUTAT RES-GEN TOX EN, V721, P27, DOI 10.1016/j.mrgentox.2010.12.015
   Lambert LB, 2005, MUTAT RES-REV MUTAT, V590, P1, DOI 10.1016/j.mrrev.2005.04.002
   Matthews EJ, 2006, REGUL TOXICOL PHARM, V44, P83, DOI 10.1016/j.yrtph.2005.11.003
   Mekenyan OG, 2012, CHEM RES TOXICOL, V25, P277, DOI 10.1021/tx200547s
   Mortelmans K, 2000, MUTAT RES-FUND MOL M, V455, P29, DOI 10.1016/S0027-5107(00)00064-6
   Nohmi T, 2000, MUTAT RES-FUND MOL M, V455, P191, DOI 10.1016/S0027-5107(00)00077-4
   Olive PL, 2006, NAT PROTOC, V1, P23, DOI 10.1038/nprot.2006.5
   Tollefsen KE, 2014, REGUL TOXICOL PHARM, V70, P629, DOI 10.1016/j.yrtph.2014.09.009
   UN, 2013, GLOB HARM SYST CLASS
   Zeiger E, 1998, REGUL TOXICOL PHARM, V28, P85, DOI 10.1006/rtph.1998.1234
NR 31
TC 8
Z9 8
U1 0
U2 10
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0273-2300
EI 1096-0295
J9 REGUL TOXICOL PHARM
JI Regul. Toxicol. Pharmacol.
PD JUN
PY 2015
VL 72
IS 1
BP 17
EP 25
DI 10.1016/j.yrtph.2015.03.003
PG 9
WC Medicine, Legal; Pharmacology & Pharmacy; Toxicology
SC Legal Medicine; Pharmacology & Pharmacy; Toxicology
GA CG9WI
UT WOS:000353670400003
PM 25792138
DA 2019-10-23
ER

PT J
AU Shafer, T
AF Shafer, Timothy
TI Adverse outcome pathway on: Binding of pyrethroids to voltage-gated
   sodium channels induces acute neurotoxicity
SO NEUROTOXICOLOGY AND TERATOLOGY
LA English
DT Meeting Abstract
CT 39th Annual Meeting of the Neurobehavioral-Teratology-Society (NBTS) /
   15th Biennial Meeting of the International-Neurotoxicology-Association
   (INA) Held in Conjunction with the 55th Annual Meeting of the
   Teratology-Society
CY JUN 27-JUL 01, 2015
CL Montreal, CANADA
SP Neurobehavioral Teratol Soc, Int Neurotoxicol Assoc, Teratol Soc
C1 [Shafer, Timothy] US EPA, Washington, DC 20460 USA.
OI Shafer, Timothy/0000-0002-8069-9987
NR 0
TC 0
Z9 0
U1 0
U2 0
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0892-0362
EI 1872-9738
J9 NEUROTOXICOL TERATOL
JI Neurotoxicol. Teratol.
PD MAY-JUN
PY 2015
VL 49
MA NTX56
BP 118
EP 118
DI 10.1016/j.ntt.2015.04.062
PG 1
WC Neurosciences; Toxicology
SC Neurosciences & Neurology; Toxicology
GA CL7HI
UT WOS:000357142700066
DA 2019-10-23
ER

PT J
AU Piersma, AH
   Pennings, J
   Tonk, ECM
AF Piersma, A. H.
   Pennings, J.
   Tonk, E. C. M.
TI An Adverse Outcome Pathway Framework for Neural Tube and Axial Defects
   Mediated by Modulation of Retinoic Acid Homeostasis
SO BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY
LA English
DT Meeting Abstract
C1 [Piersma, A. H.; Pennings, J.; Tonk, E. C. M.] RIVM, Bilthoven, Netherlands.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1542-0752
EI 1542-0760
J9 BIRTH DEFECTS RES A
JI Birth Defects Res. Part A-Clin. Mol. Teratol.
PD MAY
PY 2015
VL 103
IS 5
MA 17
BP 384
EP 384
PG 1
WC Developmental Biology; Toxicology
SC Developmental Biology; Toxicology
GA CI4SD
UT WOS:000354742400066
DA 2019-10-23
ER

PT J
AU Nelms, MD
   Ates, G
   Madden, JC
   Vinken, M
   Cronin, MTD
   Rogiers, V
   Enoch, SJ
AF Nelms, M. D.
   Ates, G.
   Madden, J. C.
   Vinken, M.
   Cronin, M. T. D.
   Rogiers, V.
   Enoch, S. J.
TI Proposal of an in silico profiler for categorisation of repeat dose
   toxicity data of hair dyes
SO ARCHIVES OF TOXICOLOGY
LA English
DT Article
DE Structural alerts; Repeat dose toxicity; Hair dyes; AOP; Mitochondrial
   toxicity
ID STRUCTURAL ALERTS; CHEMICAL CATEGORIES; PROTEIN-BINDING;
   EXPERIMENTAL-VERIFICATION; MITOCHONDRIAL TOXICITY; SKIN SENSITIZATION;
   OXIDATIVE STRESS; READ-ACROSS; REDUCTION; DEFINITION
AB This study outlines the analysis of 94 chemicals with repeat dose toxicity data taken from Scientific Committee on Consumer Safety opinions for commonly used hair dyes in the European Union. Structural similarity was applied to group these chemicals into categories. Subsequent mechanistic analysis suggested that toxicity to mitochondria is potentially a key driver of repeat dose toxicity for chemicals within each of the categories. The mechanistic hypothesis allowed for an in silico profiler consisting of four mechanism-based structural alerts to be proposed. These structural alerts related to a number of important chemical classes such as quinones, anthraquinones, substituted nitrobenzenes and aromatic azos. This in silico profiler is intended for grouping chemicals into mechanism-based categories within the adverse outcome pathway paradigm.
C1 [Nelms, M. D.; Madden, J. C.; Cronin, M. T. D.; Enoch, S. J.] Liverpool John Moores Univ, Sch Pharm & Biomol Sci, Liverpool L3 3AF, Merseyside, England.
   [Ates, G.; Vinken, M.; Rogiers, V.] Vrije Univ Brussel, Dept Toxicol, Ctr Pharmaceut Res CePhar, B-1090 Brussels, Belgium.
RP Enoch, SJ (reprint author), Liverpool John Moores Univ, Sch Pharm & Biomol Sci, Byrom St, Liverpool L3 3AF, Merseyside, England.
EM s.j.enoch@ljmu.ac.uk
RI Vinken, Mathieu/H-7513-2013
OI Vinken, Mathieu/0000-0001-5115-8893; Nelms, Mark/0000-0003-2350-2743;
   Ates, Gamze/0000-0002-9323-3465
FU European CommunityEuropean Community (EC) [266835, 266777, 266838];
   Cosmetics Europe
FX The funding from the European Community's Seventh Framework Program
   (FP7/2007-2013) COSMOS (Grant Agreement No. 266835), HeMiBio (Grant
   Agreement No. 266777) and DETECTIVE (Grant Agreement No. 266838)
   Projects, and from Cosmetics Europe is gratefully acknowledged. See
   cosmostox.eu, hemibio.eu and detective.eu for more details.
CR Amacher DE, 2005, CURR MED CHEM, V12, P1829, DOI 10.2174/0929867054546663
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Aptula AO, 2009, CHEM RES TOXICOL, V22, P1541, DOI [10.1021/tx9000330, 10.1021/tx9000336]
   BIRONAITE DA, 1991, BIOCHIM BIOPHYS ACTA, V1060, P203, DOI 10.1016/S0005-2728(09)91008-8
   Chan Katie, 2005, Expert Opin Drug Metab Toxicol, V1, P655, DOI 10.1517/17425255.1.4.655
   Roldan M, 2008, FEMS MICROBIOL REV, V32, P474, DOI 10.1111/j.1574-6976.2008.00107.x
   Dykens J.A., 2008, DRUG INDUCED MITOCHO
   Dykens JA, 2007, DRUG DISCOV TODAY, V12, P777, DOI 10.1016/j.drudis.2007.07.013
   EC, 2007, REACH TECHN GUID
   Enoch SJ, 2013, ISSUES TOXICOL, V17, P30, DOI 10.1039/9781849734400-00030
   Enoch SJ, 2013, SAR QSAR ENVIRON RES, V24, P651, DOI 10.1080/1062936X.2013.773377
   Enoch SJ, 2012, CHEM RES TOXICOL, V25, P2490, DOI 10.1021/tx3003092
   Enoch SJ, 2012, SAR QSAR ENVIRON RES, V23, P649, DOI 10.1080/1062936X.2012.679691
   Enoch SJ, 2011, CRIT REV TOXICOL, V41, P783, DOI 10.3109/10408444.2011.598141
   Enoch SJ, 2013, CHEM TOXICITY PREDIC, V17
   Enoch SJ, 2011, ATLA-ALTERN LAB ANIM, V39, P131, DOI 10.1177/026119291103900206
   Enoch SJ, 2008, CHEM RES TOXICOL, V21, P513, DOI 10.1021/tx700322g
   Gago-Dominguez M, 2001, INT J CANCER, V91, P575, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1092>3.0.CO;2-S
   GORONTZY T, 1993, J GEN MICROBIOL, V139, P1331, DOI 10.1099/00221287-139-6-1331
   Gutsell S, 2013, TOXICOL RES-UK, V2, P299, DOI 10.1039/c3tx50024a
   HENRY TR, 1995, TOXICOL APPL PHARM, V134, P195, DOI 10.1006/taap.1995.1184
   Hewitt M, 2013, CRIT REV TOXICOL, V43, P537, DOI 10.3109/10408444.2013.811215
   Kalgutkar AS, 2005, CURR DRUG METAB, V6, P161, DOI 10.2174/1389200054021799
   KAPPUS H, 1986, BIOCHEM PHARMACOL, V35, P1, DOI 10.1016/0006-2952(86)90544-7
   KITANI A, 1981, J AM CHEM SOC, V103, P7636, DOI 10.1021/ja00415a036
   Kovacic P, 2001, CURR MED CHEM, V8, P773, DOI 10.2174/0929867013373084
   Kovacic P, 2001, CURR MED CHEM, V8, P863, DOI 10.2174/0929867013372878
   Montaigne D, 2012, BIOCHEM RES INT, DOI 10.1155/2012/951539
   MUNDAY R, 1992, CHEM-BIOL INTERACT, V82, P165, DOI 10.1016/0009-2797(92)90108-W
   Nam S, 2000, CHEMOSPHERE, V40, P351, DOI 10.1016/S0045-6535(99)00226-X
   Naven RT, 2013, TOXICOL SCI, V131, P271, DOI 10.1093/toxsci/kfs279
   Nelms MD, 2013, SAR QSAR ENVIRON RES, V24, P695, DOI 10.1080/1062936X.2013.792874
   Nikam A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066094
   Ohkuma Y, 2001, FREE RADICAL RES, V34, P595, DOI 10.1080/10715760100300491
   Pessayre D, 2012, DRUG METAB REV, V44, P34, DOI 10.3109/03602532.2011.604086
   Porceddu M, 2012, TOXICOL SCI, V129, P332, DOI 10.1093/toxsci/kfs197
   Przybylak KR, 2013, ISSUES TOXICOL, V17, P44, DOI 10.1039/9781849734400-00044
   Rodriguez-Sanchez N, 2013, SAR QSAR ENVIRON RES, V24, P963, DOI 10.1080/1062936X.2013.820793
   Sakuratani Y, 2013, SAR QSAR ENVIRON RES, V24, P617, DOI 10.1080/1062936X.2013.773375
   Sakuratani Y, 2013, SAR QSAR ENVIRON RES, V24, P35, DOI 10.1080/1062936X.2012.728995
   Scatena R, 2007, AM J PHYSIOL-CELL PH, V293, pC12, DOI 10.1152/ajpcell.00314.2006
   TERADA H, 1990, ENVIRON HEALTH PERSP, V87, P213, DOI 10.2307/3431027
   Vinken M, 2013, ARCH TOXICOL
   Vinken M, 2013, TOXICOLOGY, V312, P158, DOI 10.1016/j.tox.2013.08.011
   Wallace KB, 2000, ANNU REV PHARMACOL, V40, P353, DOI 10.1146/annurev.pharmtox.40.1.353
NR 45
TC 9
Z9 9
U1 0
U2 18
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0340-5761
EI 1432-0738
J9 ARCH TOXICOL
JI Arch. Toxicol.
PD MAY
PY 2015
VL 89
IS 5
BP 733
EP 741
DI 10.1007/s00204-014-1277-8
PG 9
WC Toxicology
SC Toxicology
GA CF7DY
UT WOS:000352717600006
PM 24888375
OA Green Accepted
DA 2019-10-23
ER

PT J
AU Barenys, M
   Gassmann, K
   Baksmeier, C
   Heinz, S
   Schmuck, M
   Sundaram, S
   Colomina, M
   Heuer, H
   Fritsche, E
AF Barenys, Marta
   Gassmann, Kathrin
   Baksmeier, Christine
   Heinz, Sabrina
   Schmuck, Martin
   Sundaram, Sivaraj
   Colomina, Maria
   Heuer, Heike
   Fritsche, Ellen
TI Binding of epigallocatechin gallate to the laminin-beta-integrin binding
   site decreases neural progenitor cell adhesion and migration: Adverse
   outcome pathway framework supporting neurodevelopmental toxicity
   research and risk assessment
SO NEUROTOXICOLOGY AND TERATOLOGY
LA English
DT Meeting Abstract
CT 39th Annual Meeting of the Neurobehavioral-Teratology-Society (NBTS) /
   15th Biennial Meeting of the International-Neurotoxicology-Association
   (INA) Held in Conjunction with the 55th Annual Meeting of the
   Teratology-Society
CY JUN 27-JUL 01, 2015
CL Montreal, CANADA
SP Neurobehavioral Teratol Soc, Int Neurotoxicol Assoc, Teratol Soc
C1 [Barenys, Marta; Gassmann, Kathrin; Baksmeier, Christine; Heinz, Sabrina; Schmuck, Martin; Sundaram, Sivaraj; Heuer, Heike; Fritsche, Ellen] IUF Liebniz Res Inst Environm, Dusseldorf, Germany.
   [Colomina, Maria] Univ Rovira & Virgili, E-43007 Tarragona, Spain.
RI Colomina, M.Teresa/A-5919-2011
OI Colomina, M.Teresa/0000-0002-5619-4874
NR 0
TC 0
Z9 0
U1 0
U2 0
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0892-0362
EI 1872-9738
J9 NEUROTOXICOL TERATOL
JI Neurotoxicol. Teratol.
PD MAY-JUN
PY 2015
VL 49
MA NTX55
BP 117
EP 118
DI 10.1016/j.ntt.2015.04.061
PG 2
WC Neurosciences; Toxicology
SC Neurosciences & Neurology; Toxicology
GA CL7HI
UT WOS:000357142700065
DA 2019-10-23
ER

PT J
AU Pisani, C
   Gaillard, JC
   Nouvel, V
   Odorico, M
   Armengaud, J
   Prat, O
AF Pisani, Cedric
   Gaillard, Jean-Charles
   Nouvel, Virginie
   Odorico, Michael
   Armengaud, Jean
   Prat, Odette
TI High-throughput, quantitative assessment of the effects of low-dose
   silica nanoparticles on lung cells: grasping complex toxicity with a
   great depth of field
SO BMC GENOMICS
LA English
DT Article
DE Transcriptomics; Proteomics; Toxicogenomics; Nanoparticles; Silica;
   Cytotoxicity; Adverse outcome pathways; Cellular impedance
ID AMORPHOUS SILICA; ALVEOLAR EPITHELIUM; CYTOKINE PRODUCTION; OXIDATIVE
   STRESS; SURFACE-AREA; EXPRESSION; SIZE; TOXICOGENOMICS; ACTIVATION;
   PROTEOMICS
AB Background: The toxicity of manufactured fumed silica nanoparticles (NPs) remains poorly investigated compared to that of crystalline silica NPs, which have been associated with lung diseases after inhalation. Amorphous silica NPs are a raw material for manufactured nanocomposites, such as cosmetics, foods, and drugs, raising concerns about their potential toxicity.
   Results: The size of the NPs was determined by dynamic light scattering and their shape was visualized by atomic force microscopy (10 +/- 4 nm). The pertinent toxicological concentration and dynamic ranges were determined using viability tests and cellular impedance. We combined transcriptomics and proteomics to assess the cellular and molecular effects of fumed silica in A549 human alveolar epithelial cells. The "no observed transcriptomic adverse effect level" (NOTEL) was set to 1.0 mu g/cm(2), and the "lowest observed adverse transcriptional effect level" (LOTEL) was set at 1.5 mu g/cm(2). We carried out genome-wide expression profiles with microarrays and identified, by shotgun proteomics, the exoproteome changes in lung cells after exposure to NP doses (0.1, 1.0, 1.5, 3.0, and 6.0 mu g/cm(2)) at two time points (24 h and 72 h). The data revealed a hierarchical, dose-dependent cellular response to silica NPs. At 1.5 mu g/cm(2), the Rho signaling cascade, actin cytoskeleton remodeling, and clathrin-mediated endocytosis were induced. At 3.0 mu g/cm(2), many inflammatory mediators were upregulated and the coagulation system pathway was triggered. Lastly, at 6.0 mu g/cm(2), oxidative stress was initiated. The proteins identified in the extracellular compartment were consistent with these findings.
   Conclusions: The alliance of two high-throughput technologies allowed the quantitative assessment of the cellular effects and molecular consequences of exposure of lung cells to low doses of NPs. These results were obtained using a pathway-driven analysis instead of isolated genes. As in photography, toxicogenomics allows, at the same time, the visualization of a wide spectrum of biological responses and a "zoom in" to the details with a great depth of field. This study illustrates how such an approach based on human cell culture models is a valuable predictive screening tool to evaluate the toxicity of many potentially harmful emerging substances, alone or in mixtures, in the framework of future regulatory reinforcements.
C1 [Pisani, Cedric; Gaillard, Jean-Charles; Nouvel, Virginie; Odorico, Michael; Armengaud, Jean; Prat, Odette] CEA, IBEB, SBTN, F-30207 Bagnols Sur Ceze, France.
   [Prat, Odette] Int Consortium Environm Implicat Nanotechnol iCEI, Aix En Provence, France.
RP Prat, O (reprint author), CEA, IBEB, SBTN, F-30207 Bagnols Sur Ceze, France.
EM odette.prat@cea.fr
OI ARMENGAUD, Jean/0000-0003-1589-445X
FU French ANR agencyFrench National Research Agency (ANR)
   [ANR-13-NANO-0007-03]; French Alternative Energies and Atomic Energy
   Commission
FX We thank Jerome Rose from CEREGE (Centre de Recherche et d'Enseignement
   de Geosciences de l'Environnement) F-13545Aix-en-Provence, France, for
   the gift of fumed silica AEROSIL <SUP>(R)</SUP> 200 NPs. This work was
   partially supported by the French ANR agency (Grant ANR-13-NANO-0007-03)
   and by the French Alternative Energies and Atomic Energy Commission.
CR Ankley GT, 2006, ENVIRON SCI TECHNOL, V40, P4055, DOI 10.1021/es0630184
   Armengaud J, 2012, EXPERT REV PROTEOMIC, V9, P561, DOI [10.1586/epr.12.52, 10.1586/EPR.12.52]
   Bastarache JA, 2007, THORAX, V62, P608, DOI 10.1136/thx.2006.063305
   Carvalho PC, 2012, CURR PROTOC BIOINFOR, DOI DOI 10.1002/0471250953.BI1319S40
   Cho WS, 2007, TOXICOL LETT, V175, P24, DOI 10.1016/j.toxlet.2007.09.008
   Clair G, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.013102
   Colvin VL, 2003, NAT BIOTECHNOL, V21, P1166, DOI 10.1038/nbt875
   EFSA, 2014, EFSA J, V4, P87
   Emmanuelawati I, 2013, NANOSCALE, V5, P6173, DOI 10.1039/c3nr01574b
   European Food Safety Authority, 2014, EFSA J, V12, DOI 10.2903/j.efsa.2014.3638
   Fisichella M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-700
   Fisichella M, 2012, PART FIBRE TOXICOL, V9, DOI 10.1186/1743-8977-9-18
   Fisichella M, 2009, TOXICOL IN VITRO, V23, P697, DOI 10.1016/j.tiv.2009.02.007
   Gualtieri M, 2012, NANOTOXICOLOGY, V6, P700, DOI 10.3109/17435390.2011.604441
   Hartung T, 2011, ALTEX, V28
   Hartung T, 2009, NATURE, V460, P208, DOI 10.1038/460208a
   Hussain S, 2009, TOXICOLOGY, V260, P142, DOI 10.1016/j.tox.2009.04.001
   Jennings P, 2013, ARCH TOXICOL, V87, P49, DOI 10.1007/s00204-012-0919-y
   Lee TL, 2012, NANOMED-NANOTECHNOL, V8, P599, DOI 10.1016/j.nano.2011.08.005
   Lee TL, 2009, ACS NANO, V3, P3830, DOI 10.1021/nn901155z
   Lobenhofer EK, 2004, TOXICOL PATHOL, V32, P482, DOI 10.1080/01926230490483324
   Lordan S, 2012, CELL BIOL INT, V36, P57, DOI 10.1042/CBI20100587
   Malard V, 2012, J PROTEOMICS, V75, P1043, DOI 10.1016/j.jprot.2011.10.025
   Meng H, 2009, ACS NANO, V3, P1620, DOI 10.1021/nn9005973
   Mohamed BM, 2011, J NANOBIOTECHNOL, V9, DOI 10.1186/1477-3155-9-29
   Napierska D, 2012, TOXICOL LETT, V211, P98, DOI 10.1016/j.toxlet.2012.03.002
   Napierska D, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-39
   Nel A, 2013, ACCOUNTS CHEM RES, V46, P607, DOI 10.1021/ar300022h
   Nemmar A, 2004, TOXICOL LETT, V149, P243, DOI 10.1016/j.toxlet.2003.12.061
   Nemmar A, 2003, TOXICOL APPL PHARM, V186, P38, DOI 10.1016/S0041-008X(02)00024-8
   Ory S, 2011, SEMIN CELL DEV BIOL, V22, P27, DOI 10.1016/j.semcdb.2010.12.002
   Panas A, 2013, NANOTOXICOLOGY, V7, P259, DOI 10.3109/17435390.2011.652206
   Perkins TN, 2012, PART FIBRE TOXICOL, V9, DOI 10.1186/1743-8977-9-6
   Prat O, 2011, ENVIRON INT, V37, P657, DOI 10.1016/j.envint.2011.01.004
   Rabolli V, 2010, NANOTOXICOLOGY, V4, P307, DOI 10.3109/17435390.2010.482749
   Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309
   REUZEL PGJ, 1991, FOOD CHEM TOXICOL, V29, P341, DOI 10.1016/0278-6915(91)90205-L
   Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006
   Venkatraman L, 2012, BIOPHYS J, V103, P1060, DOI 10.1016/j.bpj.2012.06.050
   Veranth John M, 2007, Part Fibre Toxicol, V4, P2, DOI 10.1186/1743-8977-4-2
   Wang L, 2007, AM J RESP CELL MOL, V36, P497, DOI 10.1165/rcmb.2005-0425OC
   Worle-Knirsch JM, 2006, NANO LETT, V6, P1261, DOI 10.1021/nl060177c
   Wright WR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030120
   Xiao GG, 2003, J BIOL CHEM, V278, P50781, DOI 10.1074/jbc.M306423200
   Xu Z, 2010, J HAZARD MATER, V180, P375, DOI 10.1016/j.jhazmat.2010.04.042
   Yu LR, 2011, J PROTEOMICS, V74, P2549, DOI 10.1016/j.jprot.2011.10.001
   Zarbl H, 2010, CHEM-BIOL INTERACT, V184, P273, DOI 10.1016/j.cbi.2010.01.031
   Zhang HY, 2012, J AM CHEM SOC, V134, P15790, DOI 10.1021/ja304907c
   Zhu Y, 2009, CARBON, V47, P1351, DOI 10.1016/j.carbon.2009.01.026
   Zivanovic Y, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r70
NR 50
TC 29
Z9 30
U1 3
U2 26
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2164
J9 BMC GENOMICS
JI BMC Genomics
PD APR 18
PY 2015
VL 16
AR 315
DI 10.1186/s12864-015-1521-5
PG 14
WC Biotechnology & Applied Microbiology; Genetics & Heredity
SC Biotechnology & Applied Microbiology; Genetics & Heredity
GA CG2LU
UT WOS:000353107000001
PM 25895662
OA DOAJ Gold, Green Published
DA 2019-10-23
ER

PT J
AU Alves, VM
   Muratov, E
   Fourches, D
   Strickland, J
   Kleinstreuer, N
   Andrade, CH
   Tropsha, A
AF Alves, Vinicius M.
   Muratov, Eugene
   Fourches, Denis
   Strickland, Judy
   Kleinstreuer, Nicole
   Andrade, Carolina H.
   Tropsha, Alexander
TI Predicting chemically-induced skin reactions. Part I: QSAR models of
   skin sensitization and their application to identify potentially
   hazardous compounds
SO TOXICOLOGY AND APPLIED PHARMACOLOGY
LA English
DT Article
DE Skin sensitization; QSAR; Virtual screening; Skin toxicants
ID LYMPH-NODE ASSAY; ALLERGIC CONTACT-DERMATITIS; ADVERSE OUTCOME PATHWAYS;
   QUANTITATIVE STRUCTURE; ALTERNATIVE METHODS; PEPTIDE REACTIVITY; GUINEA
   PIG; CLASSIFICATION; VALIDATION; TOXICITY
AB Repetitive exposure to a chemical agent can induce an immune reaction in inherently susceptible individuals that leads to skin sensitization. Although many chemicals have been reported as skin sensitizers, there have been very few rigorously validated QSAR models with defined applicability domains (AD) that were developed using a large group of chemically diverse compounds. In this study, we have aimed to compile, curate, and integrate the largest publicly available dataset related to chemically-induced skin sensitization, use this data to generate rigorously validated and QSAR models for skin sensitization, and employ these models as a virtual screening tool for identifying putative sensitizers among environmental chemicals. We followed best practices for model building and validation implemented with our predictive QSAR workflow using Random Forest modeling technique in combination with SiRMS and Dragon descriptors. The Correct Classification Rate (CCR) for QSAR models discriminating sensitizers from non-sensitizers was 71-88% when evaluated on several external validation sets, within a broad AD, with positive (for sensitizers) and negative (for non-sensitizers) predicted rates of 85% and 79% respectively. When compared to the skin sensitization module included in the OECD QSAR Toolbox as well as to the skin sensitization model in publicly available VEGA software, our models showed a significantly higher prediction accuracy for the same sets of external compounds as evaluated by Positive Predicted Rate, Negative Predicted Rate, and CCR. These models were applied to identify putative chemical hazards in the Scorecard database of possible skin or sense organ toxicants as primary candidates for experimental validation. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Alves, Vinicius M.; Andrade, Carolina H.] Univ Fed Goias, Fac Pharm, Lab Mol Modeling & Design, BR-74605220 Goiania, Go, Brazil.
   [Alves, Vinicius M.; Muratov, Eugene; Fourches, Denis; Tropsha, Alexander] Univ N Carolina, Eshelman Sch Pharm, Div Chem Biol & Med Chem, Lab Mol Modeling, Chapel Hill, NC 27599 USA.
   [Muratov, Eugene] NAS Ukraine, AV Bogatsky Phys Chem Inst, Lab Theoret Chem, UA-65080 Odessa, Ukraine.
   [Strickland, Judy; Kleinstreuer, Nicole] NICEATM, ILS Contractor Supporting, Res Triangle Pk, NC 27709 USA.
RP Tropsha, A (reprint author), Univ N Carolina, Eshelman Sch Pharm, 100K Beard Hall, Chapel Hill, NC 27599 USA.
EM alex_tropsha@unc.edu
RI Fourches, Denis/H-4336-2019; Kleinstreuer, Nicole/F-7203-2019; Muratov,
   Eugene/C-4454-2014; Alves, Vinicius M./G-7955-2015
OI Kleinstreuer, Nicole/0000-0002-7914-3682; Muratov,
   Eugene/0000-0003-4616-7036; Alves, Vinicius M./0000-0002-6182-1748;
   Fourches, Denis/0000-0001-5642-8303
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [GM66940, GM096967]; EPAUnited States
   Environmental Protection Agency [RD 83499901]; FAPEG [201310267001095];
   Russian Scientific FoundationRussian Science Foundation (RSF)
   [14-43-00024]; CNPqNational Council for Scientific and Technological
   Development (CNPq); Science without Borders program; STCU [P407]; CNPq
   (PVE) [400760/2014-2]; NIEHSUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Environmental Health Sciences (NIEHS) [N01-ES 35504]; Intramural
   Research Program of the NIEHSUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Environmental Health Sciences (NIEHS)
FX This study was supported in part by NIH (grants GM66940 and GM096967),
   EPA (grant RD 83499901), and FAPEG (grant 201310267001095). A.T.
   acknowledges partial support from the Russian Scientific Foundation
   (project 14-43-00024). V.A. thanks CNPq and Science without Borders
   program for the financial support of his visit to the University of
   North Carolina at Chapel Hill. E.M. acknowledges partial support from
   STCU (Grant P407). E.M., V.A., and C.H.A. acknowledge partial support
   from CNPq (PVE, Grant 400760/2014-2). N.K. and IS. are supported by the
   NIEHS contract N01-ES 35504 and the Intramural Research Program of the
   NIEHS. This article may be the work product of an employee or group of
   employees of the NIEHS, NIH, or other organizations; however, the
   statements, opinions, or conclusions contained therein do not
   necessarily represent the statements, opinions, or conclusions of NIEHS,
   NIH, the United States government, or other organizations. The use of
   commercial product names is for comparative purposes only and does not
   constitute endorsement by any of the authors, organizations, or
   agencies.
CR Adler S, 2011, ARCH TOXICOL, V85, P367, DOI 10.1007/s00204-011-0693-2
   Aeby P, 2010, TOXICOL IN VITRO, V24, P1465, DOI 10.1016/j.tiv.2010.07.005
   Alves VM, 2015, TOXICOL APPL PHARM, V284, P273, DOI 10.1016/j.taap.2014.12.013
   Anderson S.E., 2011, J ALLERGY, P1
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Artemenko AG, 2011, SAR QSAR ENVIRON RES, V22, P575, DOI 10.1080/1062936X.2011.569950
   Basketter DA, 2002, FOOD CHEM TOXICOL, V40, P593, DOI 10.1016/S0278-6915(01)00130-2
   BASKETTER DA, 1992, CONTACT DERMATITIS, V27, P137, DOI 10.1111/j.1600-0536.1992.tb05241.x
   Bos JD, 2000, EXP DERMATOL, V9, P165, DOI 10.1034/j.1600-0625.2000.009003165.x
   Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324
   Breiman L., 1984, CLASSIFICATION REGRE
   BUEHLER EV, 1965, ARCH DERMATOL, V91, P171, DOI 10.1001/archderm.1965.01600080079017
   Chaudhry Q, 2010, CHEM CENT J, V4, DOI 10.1186/1752-153X-4-S1-S5
   Chuprina A, 2010, J CHEM INF MODEL, V50, P470, DOI 10.1021/ci900464s
   Cronin M T, 1994, SAR QSAR Environ Res, V2, P159, DOI 10.1080/10629369408029901
   Dearman RJ, 2007, CONTACT DERMATITIS, V57, P242, DOI 10.1111/j.1600-0536.2007.01215.x
   Dearman RJ, 2001, CONTACT DERMATITIS, V44, P357, DOI 10.1034/j.1600-0536.2001.044006357.x
   Devillers J, 2000, TOXICOL METHOD, V10, P181, DOI 10.1080/10517230050121598
   Dickel Heinrich, 2002, Am J Clin Dermatol, V3, P283, DOI 10.2165/00128071-200203040-00006
   Downs G.M., 2003, REV COMPUTATIONAL CH, P1
   ECHA, 2010, CHLOROBENZENE
   ECHA, 2010, ETHYLENEDIAMINE
   ECHA, 2010, OX AC
   Egeghy PP, 2012, SCI TOTAL ENVIRON, V414, P159, DOI 10.1016/j.scitotenv.2011.10.046
   Estrada E, 2003, CHEM RES TOXICOL, V16, P1226, DOI 10.1021/tx034093k
   Fourches D, 2010, J CHEM INF MODEL, V50, P1189, DOI 10.1021/ci100176x
   Gerberick GF, 2009, TOXICOL SCI, V112, P164, DOI 10.1093/toxsci/kfp192
   Gerberick GF, 2005, DERMATITIS, V16, P157, DOI 10.2310/6620.2005.05040
   Gerberick GF, 2004, TOXICOL SCI, V81, P332, DOI 10.1093/toxsci/kfh213
   Gleeson MP, 2012, CURR PHARM DESIGN, V18, P1266
   Golbraikh A, 2002, J MOL GRAPH MODEL, V20, P269, DOI 10.1016/S1093-3263(01)00123-1
   Golla S, 2009, TOXICOL IN VITRO, V23, P454, DOI 10.1016/j.tiv.2008.12.025
   GRANDJEAN P, 1988, AM J IND MED, V14, P97, DOI 10.1002/ajim.4700140111
   Hennino Ana, 2005, An. Bras. Dermatol., V80, P335, DOI 10.1590/S0365-05962005000400003
   Hostynek JJ, 1997, TOXICOL IN VITRO, V11, P377, DOI 10.1016/S0887-2333(97)00031-3
   ICCVAM, 2009, RED MUR LOC LYMPH NO
   *ICCVAM, 1999, MUR LOC LYMPH NOD AS
   Jaworska J, 2011, ALTEX-ALTERN ANIM EX, V28, P211, DOI 10.14573/altex.2011.3.211
   Johansson H, 2014, BASIC CLIN PHARMACOL, V115, P110, DOI 10.1111/bcpt.12199
   Johansson H, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-399
   Karlberg AT, 2008, CHEM RES TOXICOL, V21, P53, DOI 10.1021/tx7002239
   Keegel T, 2009, INT J DERMATOL, V48, P571, DOI 10.1111/j.1365-4632.2009.04004.x
   Kern PS, 2010, DERMATITIS, V21, P8, DOI 10.2310/6620.2009.09038
   Kimber I, 2002, INT IMMUNOPHARMACOL, V2, P201, DOI 10.1016/S1567-5769(01)00173-4
   Kimber I, 2011, TOXICOL SCI, V120, pS238, DOI 10.1093/toxsci/kfq346
   Knudsen TB, 2011, BIRTH DEFECTS RES C, V93, P312, DOI 10.1002/bdrc.20223
   Kuz'min VE, 2008, J COMPUT AID MOL DES, V22, P403, DOI 10.1007/s10822-008-9179-6
   Kuz'min VE, 2007, J MED CHEM, V50, P4205, DOI 10.1021/jm0704806
   Lepoittevin JP, 2011, CONTACT DERMATITIS, FIFTH EDITION, P91, DOI 10.1007/978-3-642-03827-3_4
   Li SQ, 2005, J CHEM INF MODEL, V45, P952, DOI 10.1021/ci050049u
   Low Y, 2013, CHEM RES TOXICOL, V26, P1199, DOI 10.1021/tx400110f
   Low Y, 2011, CHEM RES TOXICOL, V24, P1251, DOI 10.1021/tx200148a
   MAGEE PS, 1994, QUANT STRUCT-ACT REL, V13, P22, DOI 10.1002/qsar.19940130106
   Maggiora GM, 2006, J CHEM INF MODEL, V46, P1535, DOI 10.1021/ci060117s
   MAGNUSSON B, 1969, J INVEST DERMATOL, V52, P268, DOI 10.1038/jid.1969.42
   Magnusson BM, 2004, PHARM RES-DORDR, V21, P1047, DOI 10.1023/B:PHAM.0000029295.38564.e1
   Matura M, 2005, CONTACT DERMATITIS, V52, P320, DOI 10.1111/j.0105-1873.2005.00605.x
   Mercier D., 2003, ELECT REV LINACRE CO
   Miller MD, 2005, J CHEM INF MODEL, V45, P924, DOI 10.1021/ci050018z
   Muir DCG, 2006, ENVIRON SCI TECHNOL, V40, P7157, DOI 10.1021/es061677a
   Muratov EN, 2010, FUTURE MED CHEM, V2, P1205, DOI 10.4155/FMC.10.194
   Nandy A, 2014, MOL SIMULAT, V40, P261, DOI 10.1080/08927022.2013.801076
   OECD, 2014, OECD QSAR TOOLB V 3
   OECD, 2010, 429 OECD
   OECD, 2004, OECD PRINC VAL REG P
   OECD, 2012, ADV OUCT PATHW SKI 1
   Polishchuk PG, 2009, J CHEM INF MODEL, V49, P2481, DOI 10.1021/ci900203n
   Raunio H, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00033
   Roberts DW, 2008, J APPL TOXICOL, V28, P377, DOI 10.1002/jat.1289
   Roberts DW, 2007, CHEM RES TOXICOL, V20, P1321, DOI 10.1021/tx700169w
   Roberts DW, 2007, CHEM RES TOXICOL, V20, P44, DOI 10.1021/tx060121y
   Saint-Mezard P, 2004, EUR J DERMATOL, V14, P284
   Schlede E, 2003, TOXICOLOGY, V193, P219, DOI 10.1016/S0300-483X(03)00266-X
   SCHOLES EW, 1992, J APPL TOXICOL, V12, P217, DOI 10.1002/jat.2550120312
   Scorecard, 2011, SKIN SENS ORG TOX
   Siegel PD, 2009, TOXICOL SCI, V107, P78, DOI 10.1093/toxsci/kfn212
   Strid Jessica, 2005, Current Drug Targets - Inflammation and Allergy, V4, P531, DOI 10.2174/156801005774322199
   Todeschini R, 2000, HDB MOL DESCRIPTORS
   Tropsha A, 2007, CURR PHARM DESIGN, V13, P3494, DOI 10.2174/138161207782794257
   Tropsha A, 2010, MOL INFORM, V29, P476, DOI 10.1002/minf.201000061
   Varnek A, 2007, SOLVENT EXTR ION EXC, V25, P1, DOI 10.1080/07366290601067481
   Varnek A, 2008, CURR COMPUT-AID DRUG, V4, P191, DOI 10.2174/157340908785747465
   VEGA, 2014, SKIN SENS MOD V 2 1
   Watanabe KH, 2011, ENVIRON TOXICOL CHEM, V30, P9, DOI 10.1002/etc.373
NR 84
TC 30
Z9 31
U1 1
U2 22
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0041-008X
EI 1096-0333
J9 TOXICOL APPL PHARM
JI Toxicol. Appl. Pharmacol.
PD APR 15
PY 2015
VL 284
IS 2
BP 262
EP 272
DI 10.1016/j.taap.2014.12.014
PG 11
WC Pharmacology & Pharmacy; Toxicology
SC Pharmacology & Pharmacy; Toxicology
GA CH2OH
UT WOS:000353864000017
PM 25560674
OA Green Accepted
DA 2019-10-23
ER

PT J
AU Lorenzetti, S
   Marcoccia, D
   Mantovani, A
AF Lorenzetti, Stefano
   Marcoccia, Daniele
   Mantovani, Alberto
TI Biomarkers of effect in endocrine disruption: how to link a functional
   assay to an adverse outcome pathway
SO ANNALI DELL ISTITUTO SUPERIORE DI SANITA
LA English
DT Article
DE endocrine disruptor; in vitro assay; risk assessment; toxicology;
   testing strategy
ID RISK-ASSESSMENT; SAFETY ASSESSMENT; COMMON-SENSE; CHEMICALS; TOXICOLOGY;
   FRAMEWORK; TOXICITY; SCIENCE
AB The development of in vitro testing strategies may achieve a cost-effective generation of comprehensive datasets on a large number of chemicals, according to the requirements of the European Regulation REACH. Much emphasis is placed on in vitro methods based on subcellular mechanisms (e.g., nuclear receptor interaction), but it is necessary to define the predictive value of molecular or biochemical changes within an adverse outcome pathway (AOP). AOP pivots on the description of the flow from a molecular initiating event through a cascade of intermediate events needed to produce a specific adverse effect at organism level: downstream responses at cell level are, therefore, essential to define an AOP. Several in vitro assays are based on human cell lines representative of endocrine-targeted tissues (e.g., prostate) and on functional biomarkers of clinical relevance (e.g., PSA secretion in human prostate epithelial cells). We discuss the implementation of such functional biomarkers in the AOP context.
C1 [Lorenzetti, Stefano; Marcoccia, Daniele; Mantovani, Alberto] Ist Super Sanita, Dipartimento Sanita Pubbl Vet & Sicurezza Aliment, I-00161 Rome, Italy.
RP Lorenzetti, S (reprint author), Ist Super Sanita, Dipartimento Sanita Pubbl Vet & Sicurezza Aliment, Viale Regina Elena 299, I-00161 Rome, Italy.
EM stefano.lorenzetti@iss.it
RI Marcoccia, Daniele/J-6418-2018; Marcoccia, Daniele/Z-3028-2019;
   LORENZETTI, STEFANO/C-6063-2015
OI Marcoccia, Daniele/0000-0003-0883-4184; LORENZETTI,
   STEFANO/0000-0001-5358-8002
CR Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Bergman A, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-69
   Boobis AR, 2008, CRIT REV TOXICOL, V38, P87, DOI 10.1080/10408440701749421
   Dekant W, 2013, TOXICOL LETT, V223, P280, DOI 10.1016/j.toxlet.2013.03.022
   Dietrich DR, 2013, ALTEX-ALTERN ANIM EX, V30, P381, DOI 10.14573/altex.2013.3.381
   Gocht T, 2015, ALTEX-ALTERN ANIM EX, V32, P9, DOI http://dx.doi.org/10.14573/altex.1408041
   Kleensang A, 2014, ALTEX-ALTERN ANIM EX, V31, P53, DOI 10.14573/altex.1309261
   Krewski D, 2010, J TOXICOL ENV HEAL B, V13, P51, DOI 10.1080/10937404.2010.483176
   Lorenzetti S, 2013, REDUCING REFINING RE, P330
   Lorenzetti S, 2011, ANN I SUPER SANITA, V47, P429, DOI 10.4415/ANN_11_04_16
   Marcoccia D, 2015, THESIS U ROMA TRE
   Rovida C, 2013, ALTEX-ALTERN ANIM EX, V30, P253, DOI 10.14573/altex.2013.2.253
   Schug TT, 2013, GREEN CHEM, V15, P181, DOI 10.1039/c2gc35055f
   Skakkebaek NE, 2001, HUM REPROD, V16, P972, DOI 10.1093/humrep/16.5.972
   Smeriglio A, 2014, ANTI-CANCER AGENT ME, V14, P1386, DOI 10.2174/1871520614666140624111011
   Soni MG, 2005, FOOD CHEM TOXICOL, V43, P985, DOI 10.1016/j.fct.2005.01.020
   Tollefsen KE, 2014, REGUL TOXICOL PHARM, V70, P629, DOI 10.1016/j.yrtph.2014.09.009
   Vandenberg LN, 2012, ENDOCR REV, V33, P378, DOI 10.1210/er.2011-1050
NR 18
TC 2
Z9 2
U1 0
U2 8
PU EDITRICE KURTIS S R L
PI MILAN
PA VIA LUIGI ZOJA 30, 20153 MILAN, ITALY
SN 0021-2571
J9 ANN I SUPER SANITA
JI Ann. Ist. Super. Sanita
PD APR-JUN
PY 2015
VL 51
IS 2
BP 167
EP 171
DI 10.4415/ANN_15_02_16
PG 5
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA CQ5YH
UT WOS:000360681100016
PM 26156189
OA DOAJ Gold
DA 2019-10-23
ER

PT J
AU Shen, H
   McHale, CM
   Smith, MT
   Zhang, LP
AF Shen, Hua
   McHale, Cliona M.
   Smith, Martyn T.
   Zhang, Luoping
TI Functional genomic screening approaches in mechanistic toxicology and
   potential future applications of CRISPR-Cas9
SO MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH
LA English
DT Review
DE Functional genomics; Toxicity testing; Yeast; Haploid KBM7 cells; RNAi;
   CRISPR-Cas9
ID EMBRYONIC STEM-CELLS; SEQUENCE-SPECIFIC CONTROL; ZINC-FINGER TARGETER;
   GENE-DELETION; RNAI SCREENS; DNA-DAMAGE; CAENORHABDITIS-ELEGANS; SYSTEMS
   TOXICOLOGY; BENZENE METABOLITE; MAMMALIAN-CELLS
AB Characterizing variability in the extent and nature of responses to environmental exposures is a critical aspect of human health risk assessment. Chemical toxicants act by many different mechanisms, however, and the genes involved in adverse outcome pathways (AOPs) and AOP networks are not yet characterized. Functional genomic approaches can reveal both toxicity pathways and susceptibility genes, through knockdown or knockout of all non-essential genes in a cell of interest, and identification of genes associated with a toxicity phenotype following toxicant exposure. Screening approaches in yeast and human near-haploid leukemic KBM7 cells have identified roles for genes and pathways involved in response to many toxicants but are limited by partial homology among yeast and human genes and limited relevance to normal diploid cells. RNA interference (RNAi) suppresses mRNA expression level but is limited by off-target effects (OTEs) and incomplete knockdown. The recently developed gene editing approach called clustered regularly interspaced short palindrome repeats-associated nuclease (CRISPR)-Cas9, can precisely knock-out most regions of the genome at the DNA level with fewer OTEs than RNAi, in multiple human cell types, thus overcoming the limitations of the other approaches. It has been used to identify genes involved in the response to chemical and microbial toxicants in several human cell types and could readily be extended to the systematic screening of large numbers of environmental chemicals. CRISPR-Cas9 can also repress and activate gene expression, including that of non-coding RNA, with near-saturation, thus offering the potential to more fully characterize AOPs and AOP networks. Finally, CRISPR-Cas9 can generate complex animal models in which to conduct preclinical toxicity testing at the level of individual genotypes or haplotypes. Therefore, CRISPR-Cas9 is a powerful and flexible functional genomic screening approach that can be harnessed to provide unprecedented mechanistic insight in the field of modern toxicology. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Shen, Hua; McHale, Cliona M.; Smith, Martyn T.; Zhang, Luoping] Univ Calif Berkeley, Sch Publ Hlth, Div Environm Hlth Sci, Superfund Res Program, Berkeley, CA 94720 USA.
RP Zhang, LP (reprint author), Univ Calif Berkeley, Sch Publ Hlth, 388 Li Ka Shing Ctr, Berkeley, CA 94720 USA.
EM luoping@berkeley.edu
FU U.S. National Institute of Environmental Health Sciences Superfund
   Research Program [P42 ES004705]; U.S. National Institute of HealthUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USA [R01ES017452]
FX We acknowledge Professor Chris Vulpe for his long-term collaboration
   with us on screening of environmental chemicals using functional
   genomics in the yeast. Dr. Hua Shen is a postdoctoral trainee in the
   Superfund Research Program at the University of California, Berkeley.
   This work was supported by the U.S. National Institute of Environmental
   Health Sciences Superfund Research Program P42 ES004705 (MTS and LZ) and
   by the U.S. National Institute of Health grant R01ES017452 (LZ).
CR Ali N, 2009, BLOOD, V113, P3690, DOI 10.1182/blood-2008-10-176396
   Andersen ME, 2009, TOXICOL SCI, V107, P324, DOI 10.1093/toxsci/kfn255
   ANDERSSON BS, 1987, CANCER GENET CYTOGEN, V24, P335, DOI 10.1016/0165-4608(87)90116-6
   Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140
   Bassett DE, 1996, NATURE, V379, P589, DOI 10.1038/379589a0
   Bassik MC, 2009, NAT METHODS, V6, P443, DOI [10.1038/NMETH.1330, 10.1038/nmeth.1330]
   Berns K, 2007, CANCER CELL, V12, P395, DOI 10.1016/j.ccr.2007.08.030
   Berns K, 2012, DRUG RESIST UPDATE, V15, P268, DOI 10.1016/j.drup.2012.10.002
   Birsoy K, 2013, NAT GENET, V45, P104, DOI 10.1038/ng.2471
   Blanchard AP, 1996, NAT BIOTECHNOL, V14, P1649, DOI 10.1038/nbt1296-1649
   Bonifacino JS, 2006, NAT REV MOL CELL BIO, V7, P568, DOI 10.1038/nrm1985
   Booker M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-50
   Botstein D, 2011, GENETICS, V189, P695, DOI 10.1534/genetics.111.130765
   Boutros M, 2004, SCIENCE, V303, P832, DOI 10.1126/science.1091266
   Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999
   Burckstummer T, 2013, NAT METHODS, V10, P965, DOI 10.1038/nmeth.2609
   Califano A, 2012, NAT GENET, V44, P841, DOI 10.1038/ng.2355
   Carette JE, 2011, NATURE, V477, P340, DOI 10.1038/nature10348
   Carette JE, 2011, NAT BIOTECHNOL, V29, P542, DOI 10.1038/nbt.1857
   Carette JE, 2010, BLOOD, V115, P4039, DOI 10.1182/blood-2009-07-231845
   Carette JE, 2009, SCIENCE, V326, P1231, DOI 10.1126/science.1178955
   Chen WW, 2014, CELL REP, V7, P27, DOI 10.1016/j.celrep.2014.02.046
   Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113
   Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143
   Costanzo MC, 2000, NUCLEIC ACIDS RES, V28, P73, DOI 10.1093/nar/28.1.73
   Cradick TJ, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.64
   de Graaf B, 2009, DNA REPAIR, V8, P1207, DOI 10.1016/j.dnarep.2009.06.007
   dos Santos Sandra C., 2012, Frontiers in Genetics, V3, P63, DOI 10.3389/fgene.2012.00063
   Duncan LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039651
   Edwards SW, 2008, TOXICOL SCI, V106, P312, DOI 10.1093/toxsci/kfn190
   Eggert US, 2004, PLOS BIOL, V2, P2135, DOI 10.1371/journal.pbio.0020379
   Elling U, 2011, CELL STEM CELL, V9, P563, DOI 10.1016/j.stem.2011.10.012
   Essletzbichler P, 2014, GENOME RES, V24, P2059, DOI 10.1101/gr.177220.114
   Fennell M., 2014, J BIOMOL SCREEN
   Fineran PC, 2012, VIROLOGY, V434, P202, DOI 10.1016/j.virol.2012.10.003
   Foury F, 1997, GENE, V195, P1, DOI 10.1016/S0378-1119(97)00140-6
   Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808
   Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623
   Galvan N, 2008, MUTAT RES-GEN TOX EN, V649, P54, DOI 10.1016/j.mrgentox.2007.07.011
   Gaytan BD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081253
   Gaytan BD, 2013, TOXICOL SCI, V132, P347, DOI 10.1093/toxsci/kft018
   GeCKO, 2014, GECKO BAS CHOIC VECT
   Giaever G, 1999, NAT GENET, V21, P278, DOI 10.1038/6791
   Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029
   Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044
   Gonzalez F, 2014, CELL STEM CELL, V15, P215, DOI 10.1016/j.stem.2014.05.018
   Gonzalez-Ramos D, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-48
   Guimaraes CP, 2011, J CELL BIOL, V195, P751, DOI 10.1083/jcb.201108103
   Harborth J, 2001, J CELL SCI, V114, P4557
   Harms D. W., 2014, CURR PROTOC HUM GENE, V83
   Heck D, 2014, NAT BIOTECHNOL, V32, P941, DOI 10.1038/nbt.2951
   Hieter P, 1997, SCIENCE, V278, P601, DOI 10.1126/science.278.5338.601
   Ho T. T., 2014, NUCL ACIDS RES
   Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010
   Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647
   Ideker T, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2011.99
   Jackson AL, 2006, RNA, V12, P1179, DOI 10.1261/rna.25706
   Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471
   Jo WJ, 2009, TOXICOL SCI, V111, P424, DOI 10.1093/toxsci/kfp162
   Jo WJ, 2009, TOXICOL APPL PHARM, V241, P294, DOI 10.1016/j.taap.2009.08.027
   Kaelin WG, 2012, SCIENCE, V337, P421, DOI 10.1126/science.1225787
   Karlsson C, 2014, CURR OPIN HEMATOL, V21, P283, DOI 10.1097/MOH.0000000000000053
   Kim Y, 2007, AGING CELL, V6, P489, DOI 10.1111/j.1474-9726.2007.00302.x
   Koike-Yusa H, 2014, NAT BIOTECHNOL, V32, P267, DOI 10.1038/nbt.2800
   Kotecki M, 1999, EXP CELL RES, V252, P273, DOI 10.1006/excr.1999.4656
   Krewski D, 2009, RISK ANAL, V29, P474, DOI 10.1111/j.1539-6924.2008.01150.x
   Larson MH, 2013, NAT PROTOC, V8, P2180, DOI 10.1038/nprot.2013.132
   Lee CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070339
   Leeb M, 2014, CELL STEM CELL, V14, P385, DOI 10.1016/j.stem.2013.12.008
   Leeb M, 2011, NATURE, V479, P131, DOI 10.1038/nature10448
   Li W, 2014, CELL STEM CELL, V14, P404, DOI 10.1016/j.stem.2013.11.016
   Li W, 2012, NATURE, V490, P407, DOI 10.1038/nature11435
   LORENZ MC, 1995, GENE, V158, P113, DOI 10.1016/0378-1119(95)00144-U
   Ma YW, 2014, CELL RES, V24, P122, DOI 10.1038/cr.2013.157
   Maddalo D, 2014, NATURE, V516, P423, DOI 10.1038/nature13902
   Maeda I, 2001, CURR BIOL, V11, P171, DOI 10.1016/S0960-9822(01)00052-5
   Mahadevan B, 2011, ENVIRON MOL MUTAGEN, V52, P339, DOI 10.1002/em.20653
   Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675
   Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033
   Marrone AK, 2014, EXPERT OPIN DRUG MET, V10, P1409, DOI 10.1517/17425255.2014.954312
   Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319
   Mitra S, 2013, CANCER BIOMARK, V13, P201, DOI 10.3233/CBM-130363
   Mohr SE, 2014, NAT REV MOL CELL BIO, V15, P591, DOI 10.1038/nrm3860
   Molinelli EJ, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003290
   Ngo VN, 2006, NATURE, V441, P106, DOI 10.1038/nature04687
   North M., 2011, TOXICOL SCI S, V120, P548
   North M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024205
   North M, 2010, INT J MOL SCI, V11, P4796, DOI 10.3390/ijms11124796
   O'Connell MR, 2014, NATURE, V516, P263, DOI 10.1038/nature13769
   O'Connor Sean Timothy Francis, 2013, Frontiers in Genetics, V3, DOI 10.3389/fgene.2012.00316
   Paddison PJ, 2004, NATURE, V428, P427, DOI 10.1038/nature02370
   Parsons Ainslie B, 2003, Prog Cell Cycle Res, V5, P159
   Pertea M, 2012, GENES-BASEL, V3, P344, DOI 10.3390/genes3030344
   Pettitt SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061520
   Pierce SE, 2007, NAT PROTOC, V2, P2958, DOI 10.1038/nprot.2007.427
   Pierce SE, 2009, METHODS MOL BIOL, V548, P115, DOI 10.1007/978-1-59745-540-4_7
   Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014
   Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022
   Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143
   Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021
   Rana TM, 2007, NAT REV MOL CELL BIO, V8, P23, DOI 10.1038/nrm2085
   Reiling JH, 2013, NAT CELL BIOL, V15, P1473, DOI 10.1038/ncb2865
   Reiling JH, 2011, P NATL ACAD SCI USA, V108, P11756, DOI 10.1073/pnas.1018098108
   Ren XF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014546
   Ren XF, 2011, ENVIRON HEALTH PERSP, V119, P771, DOI 10.1289/ehp.1002733
   Ren XF, 2009, TOXICOL SCI, V107, P367, DOI 10.1093/toxsci/kfn254
   Root DE, 2006, NAT METHODS, V3, P715, DOI 10.1038/NMETH924
   RossMacdonald P, 1997, P NATL ACAD SCI USA, V94, P190, DOI 10.1073/pnas.94.1.190
   SANDBERG AA, 1982, CANCER GENET CYTOGEN, V5, P293, DOI 10.1016/0165-4608(82)90095-4
   Sander JD, 2007, NUCLEIC ACIDS RES, V35, pW599, DOI 10.1093/nar/gkm349
   Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842
   Sander JD, 2010, NUCLEIC ACIDS RES, V38, pW462, DOI 10.1093/nar/gkq319
   Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047
   Scherens B, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-7-229
   Schmidt EE, 2013, NUCLEIC ACIDS RES, V41, pD1021, DOI 10.1093/nar/gks1170
   Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005
   Shoemaker DD, 1996, NAT GENET, V14, P450, DOI 10.1038/ng1296-450
   Singel SM, 2013, CLIN CANCER RES, V19, P2061, DOI 10.1158/1078-0432.CCR-13-0082
   Smith AM, 2009, GENOME RES, V19, P1836, DOI 10.1101/gr.093955.109
   Smith V, 1996, SCIENCE, V274, P2069, DOI 10.1126/science.274.5295.2069
   Steinmetz LM, 2002, NAT GENET, V31, P400, DOI 10.1038/ng929
   Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803
   Sturla SJ, 2014, CHEM RES TOXICOL, V27, P314, DOI 10.1021/tx400410s
   Swanton C, 2007, CANCER CELL, V11, P498, DOI 10.1016/j.ccr.2007.04.011
   Tanenbaum ME, 2014, CELL, V159, P635, DOI 10.1016/j.cell.2014.09.039
   Timms RT, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003772
   Torres R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4964
   Tsai S. Q., 2014, NAT BIOTECHNOL
   US Environmental Health Protection Agency, 2014, NEXT GEN RISK ASS IN
   van den Boomen DJH, 2014, P NATL ACAD SCI USA, V111, P11425, DOI 10.1073/pnas.1409099111
   Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981
   Waters MD, 2004, NAT REV GENET, V5, P936, DOI 10.1038/nrg1493
   Willingham AT, 2004, ONCOGENE, V23, P8392, DOI 10.1038/sj.onc.1208217
   Winter GE, 2014, NAT CHEM BIOL, V10, P768, DOI [10.1038/NCHEMBIO.1590, 10.1038/nchembio.1590]
   Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901
   Wolters NM, 2008, CELL DEATH DIFFER, V15, P809, DOI 10.1038/sj.cdd.4402311
   Wood AJ, 2011, SCIENCE, V333, P307, DOI 10.1126/science.1207773
   Xie CY, 2014, NUCLEIC ACIDS RES, V42, pD98, DOI 10.1093/nar/gkt1222
   Yang H, 2013, CELL RES, V23, P1187, DOI 10.1038/cr.2013.93
   Yang H, 2012, CELL, V149, P605, DOI 10.1016/j.cell.2012.04.002
   Zhao YC, 2014, SCI REP-UK, V4, DOI 10.1038/srep03943
   Zheng QP, 2014, BIOTECHNIQUES, V57, P115, DOI 10.2144/000114196
   Zhou YX, 2014, NATURE, V509, P487, DOI 10.1038/nature13166
NR 143
TC 6
Z9 6
U1 3
U2 38
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1383-5742
EI 1388-2139
J9 MUTAT RES-REV MUTAT
JI Mutat. Res.-Rev. Mutat. Res.
PD APR-JUN
PY 2015
VL 764
BP 31
EP 42
DI 10.1016/j.mrrev.2015.01.002
PG 12
WC Biotechnology & Applied Microbiology; Genetics & Heredity; Toxicology
SC Biotechnology & Applied Microbiology; Genetics & Heredity; Toxicology
GA CM0DX
UT WOS:000357349700003
PM 26041264
OA Green Accepted
DA 2019-10-23
ER

PT J
AU Angrish, MM
   Madden, MC
   Pleil, JD
AF Angrish, Michelle M.
   Madden, Michael C.
   Pleil, Joachim D.
TI Probe Molecule (PrM) Approach in Adverse Outcome Pathway (AOP) Based
   High-Throughput Screening (HTS): In Vivo Discovery for Developing in
   Vitro Target Methods
SO CHEMICAL RESEARCH IN TOXICOLOGY
LA English
DT Article
ID BUTYL ETHER MTBE; TOXICITY; EXPOSURE; TOXICOLOGY; LIVER;
   PHARMACOKINETICS; METABOLISM; EXPRESSION; DOSIMETRY; FRAMEWORK
AB Efficient and accurate adverse outcome pathway (AOP) based high-throughput screening (HTS) methods use a systems biology based approach to computationally model in vitro cellular and molecular data for rapid chemical prioritization; however, not all HTS assays are grounded by relevant in vivo exposure data. The challenge is to develop HTS assays with unambiguous quantitative links between in vitro responses and corresponding in vivo effects, which is complicated by metabolically insufficient systems, in vitro to in vivo extrapolation (IVIVE), cross-species comparisons, and other inherent issues correlating IVIVE findings. This article introduces the concept of ultrasensitive gas phase probe molecules (PrMs) to help bridge the current HTS assay IVIVE gap. The PrM concept assesses metabolic pathways that have already been well-defined from intact human or mammalian models. Specifically, the idea is to introduce a gas phase probe molecule into a system, observe normal steady state, add chemicals of interest, and quantitatively measure (from headspace gas) effects on PrM metabolism that can be directly linked back to a well-defined and corresponding in vivo effect. As an example, we developed the pharmacokinetic (PK) parameters and differential equations to estimate methyl tertiary butyl ether (MTBE) metabolism to tertiary butyl alcohol (TBA) via cytochrome (CYP) 2A6 in the liver from human empirical data. Because MTBE metabolic pathways are well characterized from in vivo data, we can use it as a PrM to explore direct and indirect chemical effects on CYP pathways. The PrM concept could be easily applied to in vitro and alternative models of disease and phenotype, and even test for volatile chemicals while avoiding liquid handling robotics. Furthermore, a PrM can be designed for any chemical with known empirical human exposure data and used to assess chemicals for which no information exists. Herein, we propose an elegant gas phase probe molecule-based approach to in vitro toxicity testing.
C1 [Angrish, Michelle M.] US EPA, Res Triangle Pk, NC 27711 USA.
   [Madden, Michael C.] US EPA, Environm Publ Hlth Div, NHEERL ORD, Chapel Hill, NC 27599 USA.
   [Pleil, Joachim D.] US EPA, Human Exposure & Atmospher Sci Div, NERL ORD, Res Triangle Pk, NC 27711 USA.
RP Pleil, JD (reprint author), US EPA, Human Exposure & Atmospher Sci Div, NERL ORD, Res Triangle Pk, NC 27711 USA.
EM pleil@email.unc.edu
FU appointment to the Research Participation Program for the U.S.
   Environmental Protection Agency, Office of Research and Development
FX This research was supported in part by an appointment to the Research
   Participation Program for the U.S. Environmental Protection Agency,
   Office of Research and Development, administered by the Oak Ridge
   Institute for Science and Education through an interagency agreement
   between the U.S. Department of Energy and the U.S. EPA.
CR Adeleye Y, 2015, TOXICOLOGY, V332, P102, DOI 10.1016/j.tox.2014.02.007
   Allen TEH, 2014, CHEM RES TOXICOL, V27, P2100, DOI 10.1021/tx500345j
   Andersen ME, 2010, J TOXICOL ENV HEAL B, V13, P163, DOI 10.1080/10937404.2010.483933
   Angrish MM, 2012, TOXICOL SCI, V128, P377, DOI 10.1093/toxsci/kfs155
   Angrish MM, 2011, TOXICOL SCI, V124, P299, DOI 10.1093/toxsci/kfr226
   Angrish MM, 2013, TOXICOL SCI, V131, P108, DOI 10.1093/toxsci/kfs277
   Aninat C, 2006, DRUG METAB DISPOS, V34, P75, DOI 10.1124/dmd.105.006759
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Blake RS, 2009, CHEM REV, V109, P861, DOI 10.1021/cr800364q
   Boekelheide K, 2010, TOXICOL SCI, V114, P20, DOI 10.1093/toxsci/kfp307
   Buckley TJ, 2001, FORENSIC SCI INT, V123, P111, DOI 10.1016/S0379-0738(01)00534-5
   Collins FS, 2008, SCIENCE, V319, P906, DOI 10.1126/science.1154619
   Croom EL, 2015, TOXICOL APPL PHARM, V283, P9, DOI 10.1016/j.taap.2014.11.006
   DARZYNKIEWICZ Z, 1994, METHOD CELL BIOL, V41, P15
   Dix DJ, 2007, TOXICOL SCI, V95, P5, DOI 10.1093/toxsci/kfl103
   Ebrahim-Zadeh M., 2008, NATO SCI PEACE SEC B, P535
   Edwards SW, 2008, TOXICOL SCI, V106, P312, DOI 10.1093/toxsci/kfn190
   Eisenbrand G, 2002, FOOD CHEM TOXICOL, V40, P193, DOI 10.1016/S0278-6915(01)00118-1
   EPA, 1999, TO17 EPA
   GE Healthcare Life Sciences, 2014, MICR CELL CULT PRINC
   Ghimenti S, 2013, J BREATH RES, V7, DOI 10.1088/1752-7155/7/3/036001
   Glaze WH, 1998, ENVIRON SCI TECHNOL, V32, p207A, DOI 10.1021/es983484w
   Guillouzo A, 2007, CHEM-BIOL INTERACT, V168, P66, DOI 10.1016/j.cbi.2006.12.003
   Guisan Jose M., 2006, V22, P1
   Herbig J, 2014, J BREATH RES, V8, DOI 10.1088/1752-7155/8/3/037101
   Herbig J, 2009, J BREATH RES, V3, DOI 10.1088/1752-7155/3/2/027004
   Hering P., 2008, ONLINE MONITORING EX, V3
   Hinson Jack A, 2010, Handb Exp Pharmacol, P369, DOI 10.1007/978-3-642-00663-0_12
   Houck KA, 2009, J BIOMOL SCREEN, V14, P1054, DOI 10.1177/1087057109345525
   Hubal EAC, 2009, TOXICOL SCI, V111, P226, DOI 10.1093/toxsci/kfp159
   Judson R, 2009, ENVIRON HEALTH PERSP, V117, P685, DOI 10.1289/ehp.0800168
   Judson RS, 2011, CHEM RES TOXICOL, V24, P451, DOI 10.1021/tx100428e
   Judson RS, 2010, ENVIRON HEALTH PERSP, V118, P485, DOI 10.1289/ehp.0901392
   KALTENBACH JP, 1958, EXP CELL RES, V15, P112, DOI 10.1016/0014-4827(58)90067-3
   Kavlock R, 2010, J TOXICOL ENV HEAL B, V13, P197, DOI 10.1080/10937404.2010.483935
   Kim D, 2007, TOXICOL LETT, V169, P222, DOI 10.1016/j.toxlet.2007.01.008
   Lindstrom AB, 1996, J AIR WASTE MANAGE, V46, P676, DOI 10.1080/10473289.1996.10467502
   Lindstrom AB, 1996, J AIR WASTE MANAGE, V46, P1058, DOI 10.1080/10473289.1996.10467541
   Lord HL, 2010, ANAL CHIM ACTA, V677, P3, DOI 10.1016/j.aca.2010.06.020
   McCurdy MR, 2007, J BREATH RES, V1, DOI 10.1088/1752-7155/1/1/014001
   Nasim H, 2013, LASER PHYS LETT, V10, DOI 10.1088/1612-2011/10/4/043001
   NRC (National Research Council), 2007, TOX TEST 21 CENT VIS
   OECD, 2013, ENVJMMONO20136 OECD
   Ono S, 1996, XENOBIOTICA, V26, P681, DOI 10.3109/00498259609046742
   Perkins EJ, 2011, ENVIRON TOXICOL CHEM, V30, P22, DOI 10.1002/etc.374
   Pleil JD, 2007, BIOMARKERS, V12, P331, DOI 10.1080/13547500701246334
   Pleil JD, 2008, J BREATH RES, V2, DOI 10.1088/1752-7155/2/2/026001
   Pleil JD, 2014, J BREATH RES, V8, DOI 10.1088/1752-7155/8/3/037107
   Pleil JD, 2014, J BREATH RES, V8, DOI 10.1088/1752-7155/8/2/029001
   Pleil JD, 2012, TOXICOL LETT, V215, P201, DOI 10.1016/j.toxlet.2012.10.011
   Pleil JD, 2011, BIOMARKERS, V16, P99, DOI 10.3109/1354750X.2010.541565
   Prah J, 2004, TOXICOL SCI, V77, P195, DOI 10.1093/toxsci/kfh009
   Raunio H, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00033
   Rodriguez-Antona C, 2002, XENOBIOTICA, V32, P505, DOI 10.1080/00498250210128675
   Rotroff DM, 2010, TOXICOL SCI, V117, P348, DOI 10.1093/toxsci/kfq220
   Schmidt CW, 2009, ENVIRON HEALTH PERSP, V117, pA348, DOI 10.1289/ehp.117-a348
   Shah F, 2014, CHEM RES TOXICOL, V27, P86, DOI 10.1021/tx400343t
   Shah I, 2010, J TOXICOL ENV HEAL B, V13, P314, DOI 10.1080/10937404.2010.483948
   Soldatow VY, 2013, TOXICOL RES-UK, V2, P23, DOI 10.1039/c2tx20051a
   Trefz P, 2012, J CHROMATOGR A, V1219, P29, DOI 10.1016/j.chroma.2011.10.077
   Wetmore BA, 2014, TOXICOL SCI, V142, P210, DOI 10.1093/toxsci/kfu169
   Wetmore BA, 2013, TOXICOL SCI, V132, P327, DOI 10.1093/toxsci/kft012
   Winkler K, 2013, J BREATH RES, V7, DOI 10.1088/1752-7155/7/3/036006
   Wysocki G., 2005, APPL PHYS B, V81, P9
   Yuan R, 2002, DRUG METAB DISPOS, V30, P1311, DOI 10.1124/dmd.30.12.1311
NR 65
TC 13
Z9 13
U1 1
U2 20
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0893-228X
EI 1520-5010
J9 CHEM RES TOXICOL
JI Chem. Res. Toxicol.
PD APR
PY 2015
VL 28
IS 4
BP 551
EP 559
DI 10.1021/acs.chemrestox.5b00024
PG 9
WC Chemistry, Medicinal; Chemistry, Multidisciplinary; Toxicology
SC Pharmacology & Pharmacy; Chemistry; Toxicology
GA CG6RK
UT WOS:000353429700001
PM 25692543
DA 2019-10-23
ER

PT J
AU Wood, RK
   Seidel, JS
   Martyniuk, CJ
AF Wood, Richard K.
   Seidel, Jason S.
   Martyniuk, Christopher J.
TI Transcripts involved in steroid biosynthesis and steroid receptor
   signaling are expressed early in development in the fathead minnow
   (Pimephales promelas)
SO COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY B-BIOCHEMISTRY & MOLECULAR
   BIOLOGY
LA English
DT Article
DE Aromatase; Doublesex and mab-3-related transcription factor 1; Estrogen;
   SRY HMG box related gene 9; Steroid biosynthesis
ID ZEBRAFISH DANIO-RERIO; ADVERSE OUTCOME PATHWAYS; ANDROGEN-RECEPTOR;
   GENE-EXPRESSION; SEX-DIFFERENTIATION; ESTROGEN-RECEPTORS;
   THYROID-HORMONES; LIFE-STAGES; FISH; MEDAKA
AB Sex differentiation in organisms is correlated to sex steroid production and receptor signaling pathways involving androgens and estrogens. Timing of expression is critical, and characterization of sensitive windows is needed to determine how environmental stressors may perturb sex differentiation. The objectives of this study were to determine whether genes related to steroid biosynthesis, steroid receptor signaling, and those related to sex differentiation were expressed in pre-differentiated fathead minnow (FHM) embryos, an ecotoxicological model. Transcripts were measured over two weeks (1 day post fertilization (dpf) to 14 days), prior to sex differentiation. The first three time points investigated (1, 3, and 5 dpf) corresponded to the neurula stage, dorsal swim bladder pigmentation, and pre-hatch. The fourth time point (6 dpf) was collected immediately post-hatch and the fifth time point investigated was after 8 days of larval growth (14 dpf). The majority of transcripts investigated, for example estrogen, androgen, and thyroid receptors as well as steroid biosynthesis transcripts, were expressed within the first 72 hours of development; exceptions were star (steroidogenic acute regulatory protein) and cyp19a, which did not have detectable expression until 5 dpf (pre-hatch). Transcripts that increased in relative mRNA abundance over the first two weeks of development included or, dax1, hsd11b2, hsd17b, cyp19a and thra. This study demonstrates that there is early expression of transcripts related to steroid biosynthesis, steroid receptor signaling, and sex differentiation in pre-hatch FHM embryos. Additional studies are required to determine their relative roles in male and female differentiation during these early developmental periods. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Wood, Richard K.; Seidel, Jason S.; Martyniuk, Christopher J.] Univ New Brunswick, Canadian Rivers Inst, St John, NB E2L 4L5, Canada.
   Univ New Brunswick, Dept Biol, St John, NB E2L 4L5, Canada.
RP Martyniuk, CJ (reprint author), Univ Florida, Genet Inst, Dept Physiol Sci, Gainesville, FL 32611 USA.
EM cmartyn@ufl.edu
FU NSERCNatural Sciences and Engineering Research Council of Canada; Canada
   Research ChairNatural Resources CanadaCanadian Forest ServiceCanada
   Research Chairs
FX The authors thank Josh Marr for the development of the fathead minnow
   primers for the 5-alpha reductases. This research was funded by a Canada
   Research Chair and a NSERC Discovery grant to CJM. We have no conflict
   of interest to declare.
CR Alsop D, 2009, COMP BIOCHEM PHYS A, V153, P49, DOI 10.1016/j.cbpa.2008.12.008
   Bardet PL, 2002, J MOL ENDOCRINOL, V28, P153, DOI 10.1677/jme.0.0280153
   Berishvili G, 2006, GEN COMP ENDOCR, V146, P204, DOI 10.1016/j.ygcen.2005.11.008
   Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797
   Celeghin A, 2011, GEN COMP ENDOCR, V172, P120, DOI 10.1016/j.ygcen.2010.12.020
   Chandrasekar G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009678
   Christenson LK, 2001, ARCH MED RES, V32, P576, DOI 10.1016/S0188-4409(01)00338-1
   de Waal PP, 2008, REPRODUCTION, V136, P225, DOI 10.1530/REP-08-0055
   Devlin E.W., 1996, EPA600R96079
   Devlin RH, 2002, AQUACULTURE, V208, P191, DOI 10.1016/S0044-8486(02)00057-1
   Feist G, 1996, GEN COMP ENDOCR, V102, P394, DOI 10.1006/gcen.1996.0083
   Gorelick DA, 2008, DEV DYNAM, V237, P2987, DOI 10.1002/dvdy.21700
   Guo YQ, 2005, BIOCHEM BIOPH RES CO, V330, P950, DOI 10.1016/j.bbrc.2005.03.066
   Hofsten J., 2005, REPROD BIOL ENDOCRIN, V3
   Hossain MS, 2008, BIOL REPROD, V78, P361, DOI 10.1095/biolreprod.107.062018
   Hsu Hwei-Jan, 2002, Gene Expression Patterns, V2, P219, DOI 10.1016/S1567-133X(02)00059-5
   Johns SM, 2009, ENVIRON TOXICOL CHEM, V28, P873, DOI 10.1897/08-213R.1
   KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302
   Kobayashi T, 2004, DEV DYNAM, V231, P518, DOI 10.1002/dvdy.20158
   Lassiter CS, 2002, GENE, V299, P141, DOI 10.1016/S0378-1119(02)01050-8
   Leet JK, 2013, SEX DEV, V7, P303, DOI 10.1159/000353877
   Leet JK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104190
   Liney KE, 2005, ENVIRON HEALTH PERSP, V113, P1299, DOI 10.1289/ehp.7921
   Liu YW, 2002, DIFFERENTIATION, V70, P36, DOI 10.1046/j.1432-0436.2002.700104.x
   Manfroid I, 2012, DEV BIOL, V366, P268, DOI 10.1016/j.ydbio.2012.04.002
   Marlatt VL, 2013, COMP BIOCHEM PHYS C, V157, P24, DOI 10.1016/j.cbpc.2012.09.001
   Martyniuk CJ, 2013, GEN COMP ENDOCR, V194, P264, DOI 10.1016/j.ygcen.2013.09.019
   Mindnich R, 2004, MOL CELL ENDOCRINOL, V215, P19, DOI 10.1016/j.mce.2003.11.010
   Mouriec K, 2009, DEV DYNAM, V238, P2641, DOI 10.1002/dvdy.22069
   Nagahama Y, 2005, FISH PHYSIOL BIOCHEM, V31, P105, DOI 10.1007/s10695-006-7590-2
   Nanda I, 2002, P NATL ACAD SCI USA, V99, P11778, DOI 10.1073/pnas.182314699
   Nelson ER, 2009, GEN COMP ENDOCR, V161, P90, DOI 10.1016/j.ygcen.2008.09.006
   NORBERG TJ, 1985, ENVIRON TOXICOL CHEM, V4, P711, DOI 10.1897/1552-8618(1985)4[711:ANFMPP]2.0.CO;2
   Ohmuro-Matsuyama Y, 2003, FISH PHYSIOL BIOCHEM, V28, P171, DOI 10.1023/B:FISH.0000030516.50047.f4
   Olmstead AW, 2011, ENVIRON SCI TECHNOL, V45, P3090, DOI 10.1021/es103327r
   Orban L, 2009, MOL CELL ENDOCRINOL, V312, P35, DOI 10.1016/j.mce.2009.04.014
   PIFERRER F, 1989, AQUACULTURE, V77, P251, DOI 10.1016/0044-8486(89)90207-X
   Piferrer F, 2008, REV FISH SCI, V16, P35, DOI 10.1080/10641260802324644
   Power DM, 2001, COMP BIOCHEM PHYS C, V130, P447, DOI 10.1016/S1532-0456(01)00271-X
   Reinecke M, 2010, BIOL REPROD, V82, P656, DOI 10.1095/biolreprod.109.080093
   Rodriguez-Mari A, 2005, GENE EXPR PATTERNS, V5, P655, DOI 10.1016/j.modgep.2005.02.008
   Scholz S, 2008, ENVIRON SCI POLLUT R, V15, P394, DOI 10.1007/s11356-008-0018-z
   Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3
   Seckl JR, 2001, ENDOCRINOLOGY, V142, P1371, DOI 10.1210/en.142.4.1371
   Stocco DM, 2001, ANNU REV PHYSIOL, V63, P193, DOI 10.1146/annurev.physiol.63.1.193
   Strushkevich N, 2011, P NATL ACAD SCI USA, V108, P10139, DOI 10.1073/pnas.1019441108
   Taylor S, 2010, METHODS, V50, pS1, DOI 10.1016/j.ymeth.2010.01.005
   Tingaud-Sequeira A, 2004, GENE EXPR PATTERNS, V4, P561, DOI 10.1016/j.modgep.2004.02.002
   To TT, 2007, MOL ENDOCRINOL, V21, P472, DOI 10.1210/me.2006-0216
   Trant JM, 2001, J EXP ZOOL, V290, P475, DOI 10.1002/jez.1090
   Uguz C, 2008, TISSUE CELL, V40, P299, DOI 10.1016/j.tice.2008.02.003
   van Aerle R, 2004, J FISH BIOL, V64, P355, DOI 10.1111/j.0022-1112.2004.00296.x
   van Aerle R, 2002, ECOTOXICOLOGY, V11, P423, DOI 10.1023/A:1021053217513
   Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034
   Villeneuve D, 2014, ENVIRON TOXICOL CHEM, V33, P158, DOI 10.1002/etc.2403
   Volz DC, 2011, TOXICOL SCI, V123, P349, DOI 10.1093/toxsci/kfr185
   Wang DS, 2002, BIOCHEM BIOPH RES CO, V297, P632, DOI 10.1016/S0006-291X(02)02252-0
   Yan YL, 2005, DEVELOPMENT, V132, P1069, DOI 10.1242/dev.01674
   Yeoh CG, 1996, GEN COMP ENDOCR, V103, P107, DOI 10.1006/gcen.1996.0099
   Yokoi H, 2009, DEV BIOL, V329, P1, DOI 10.1016/j.ydbio.2009.01.002
   Zucchi S, 2012, ENVIRON SCI TECHNOL, V46, P5183, DOI 10.1021/es300231y
NR 61
TC 5
Z9 5
U1 0
U2 22
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1096-4959
EI 1879-1107
J9 COMP BIOCHEM PHYS B
JI Comp. Biochem. Physiol. B-Biochem. Mol. Biol.
PD APR
PY 2015
VL 182
BP 64
EP 72
DI 10.1016/j.cbpb.2014.12.003
PG 9
WC Biochemistry & Molecular Biology; Zoology
SC Biochemistry & Molecular Biology; Zoology
GA CF7ON
UT WOS:000352746300008
PM 25546055
DA 2019-10-23
ER

PT J
AU Overturf, MD
   Huggett, DB
AF Overturf, Matthew D.
   Huggett, Duane B.
TI Responses to various exposure durations of levonorgestrel during
   early-life stages of fathead minnows (Pimephales promelas)
SO AQUATIC TOXICOLOGY
LA English
DT Article
DE Levonorgestrel; Early-life stage; mRNA expression; Fathead minnow
ID TANDEM MASS-SPECTROMETRY; ADVERSE OUTCOME PATHWAYS; RECEIVING RIVER
   WATERS; EMERGENCY CONTRACEPTION; GENE-EXPRESSION; ENDOCRINE DISRUPTORS;
   CONCEPTUAL-FRAMEWORK; SYNTHETIC PROGESTINS; OVARIAN-FUNCTION; TREATMENT
   PLANTS
AB Pharmaceuticals are routinely detected in the environment; and several of these compounds have been extensively researched due to their potential impacts to the endocrine system of aquatic organisms. The negative reproductive consequences of synthetic progestins in teleost species have only recently been investigated. The current study examined different exposure periods that may be most sensitive for levonorgestrel (LNG) in early-life stages of fathead minnow larvae. Larvae were exposed to a single concentration of LNG (125 ng/L) for different durations from fertilized egg through 28 days post hatch (dph) with growth and mRNA expression of FSH, 3 beta-HSD, 20 beta-HSD, and CYP19a1 measured. Regardless of the duration of exposure, LNG significantly decreased growth in the fathead minnow larvae at day 28. For both 20 beta-HSD and CYP19a1, mRNA expression was decreased following LNG exposure durations >= 7 days. 3 beta-HSD and FSH showed similar trends after exposure to LNG with later stages of development exhibiting decreased expression. 20 beta-HSD and 3 beta-HSD were the only transcripts to remain down regulated once larvae were moved to clean water after the 7-14 dph LNG exposure. This study is the first to investigate the effects of exposure time to a synthetic progestin on developing fish. Future research is needed to understand what impacts these changes have on adult stages of development. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Overturf, Matthew D.; Huggett, Duane B.] Univ N Texas, Dept Biol, Denton, TX 76203 USA.
RP Overturf, MD (reprint author), Univ Ontario, Fac Sci, Inst Technol, 2000 Simcoe St, North Oshawa, ON L1H 7K4, Canada.
EM Matthew.Overturf@uoit.ca
OI Overturf, Matthew/0000-0003-1519-8497
CR Africander D, 2011, STEROIDS, V76, P636, DOI 10.1016/j.steroids.2011.03.001
   Al-Odaini NA, 2010, J CHROMATOGR A, V1217, P6791, DOI 10.1016/j.chroma.2010.08.033
   Andersson J., 2005, 1 IVL, P1
   Ankley GT, 2007, ENVIRON SCI TECHNOL, V41, P8211, DOI 10.1021/es072658j
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   [Anonymous], 2010, REP WORKSH US MECH I, V138
   Bhatta S, 2012, P NATL ACAD SCI USA, V109, P11408, DOI 10.1073/pnas.1118704109
   Bus JS, 2009, TOXICOL SCI, V112, P297, DOI 10.1093/toxsci/kfp234
   Chang H, 2011, WATER RES, V45, P732, DOI 10.1016/j.watres.2010.08.046
   Corcoran J, 2010, CRIT REV TOXICOL, V40, P287, DOI 10.3109/10408440903373590
   Croxatto HB, 2004, CONTRACEPTION, V70, P442, DOI 10.1016/j.contraception.2004.05.007
   de Alda MJL, 2002, ANALYST, V127, P1299, DOI 10.1039/b207658f
   DeQuattro ZA, 2012, ENVIRON TOXICOL CHEM, V31, P851, DOI 10.1002/etc.1754
   Durand M, 2001, CONTRACEPTION, V64, P227, DOI 10.1016/S0010-7824(01)00250-5
   Govoroun M, 2001, J EXP ZOOL, V290, P558, DOI 10.1002/jez.1106
   Hala D, 2011, J CHROMATOGR B, V879, P591, DOI 10.1016/j.jchromb.2011.01.020
   Kidd KA, 2007, P NATL ACAD SCI USA, V104, P8897, DOI 10.1073/pnas.0609568104
   Kolpin D.W., 2002, ENVIRON SCI TECHNOL, V36, P1202
   Leet JK, 2011, J APPL TOXICOL, V31, P379, DOI 10.1002/jat.1682
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Lorenz C, 2011, TOXICOL SCI, V123, P94, DOI 10.1093/toxsci/kfr159
   Luckenbach JA, 2011, GEN COMP ENDOCR, V171, P52, DOI 10.1016/j.ygcen.2010.12.016
   Marions L, 2004, CONTRACEPTION, V69, P373, DOI 10.1016/j.contraception.2003.11.018
   Marions L, 2002, OBSTET GYNECOL, V100, P65, DOI 10.1016/S0029-7844(02)02006-9
   NRC (National Research Council), 2007, TOX TEST 21 CENT VIS
   Organization for Economic Co-Operation and Development (OECD), 1992, 210 FISH EARL LIF ST
   Overturf MD, 2012, ARCH ENVIRON CON TOX, V62, P455, DOI 10.1007/s00244-011-9723-6
   Overturf MD, 2014, AQUAT TOXICOL, V148, P152, DOI 10.1016/j.aquatox.2014.01.012
   Paulos P, 2010, AQUAT TOXICOL, V99, P256, DOI 10.1016/j.aquatox.2010.05.001
   Petrovic M, 2002, ENVIRON TOXICOL CHEM, V21, P2146, DOI 10.1002/etc.5620211018
   Runnalls TJ, 2013, ENVIRON SCI TECHNOL, V47, P2077, DOI 10.1021/es3048834
   Sitruk-Ware R., 2004, MATURITAS, V47, P247
   Skinner DC, 1998, P NATL ACAD SCI USA, V95, P10978, DOI 10.1073/pnas.95.18.10978
   van Aerle R, 2004, J FISH BIOL, V64, P355, DOI 10.1111/j.0022-1112.2004.00296.x
   van Aerle R, 2002, ECOTOXICOLOGY, V11, P423, DOI 10.1023/A:1021053217513
   Viglino L, 2008, TALANTA, V76, P1088, DOI 10.1016/j.talanta.2008.05.008
   Volz DC, 2011, TOXICOL SCI, V123, P349, DOI 10.1093/toxsci/kfr185
   Vulliet E, 2008, J CHROMATOGR A, V1210, P84, DOI 10.1016/j.chroma.2008.09.034
   Zeilinger J, 2009, ENVIRON TOXICOL CHEM, V28, P2663, DOI 10.1897/08-485.1
   Zucchi S, 2012, ENVIRON SCI TECHNOL, V46, P5183, DOI 10.1021/es300231y
NR 40
TC 6
Z9 7
U1 0
U2 30
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-445X
EI 1879-1514
J9 AQUAT TOXICOL
JI Aquat. Toxicol.
PD APR
PY 2015
VL 161
BP 33
EP 40
DI 10.1016/j.aquatox.2015.01.029
PG 8
WC Marine & Freshwater Biology; Toxicology
SC Marine & Freshwater Biology; Toxicology
GA CE9QC
UT WOS:000352177500005
PM 25661708
DA 2019-10-23
ER

PT J
AU Patlewicz, G
   Simon, TW
   Rowlands, JC
   Budinsky, RA
   Becker, RA
AF Patlewicz, Grace
   Simon, Ted W.
   Rowlands, J. Craig
   Budinsky, Robert A.
   Becker, Richard A.
TI Proposing a scientific confidence framework to help support the
   application of adverse outcome pathways for regulatory purposes
SO REGULATORY TOXICOLOGY AND PHARMACOLOGY
LA English
DT Article
DE Scientific confidence framework (SCF); Adverse outcome pathway (ADP);
   Mode of action (MoA); Integrated approaches to testing and assessment
   (IATA); (Q)SAR; Read-across; Exposure:activity ratio (EAR)
ID ARYL-HYDROCARBON RECEPTOR; MECHANISTIC APPLICABILITY DOMAINS;
   DOSE-RESPONSE FRAMEWORK; SPRAGUE-DAWLEY RATS; SKIN SENSITIZATION;
   IN-VITRO; READ-ACROSS; HUMAN RELEVANCE; OSIRIS WEIGHT; CELL-LINE
AB An adverse outcome pathway (ADP) describes the causal linkage between initial molecular events and an adverse outcome at individual or population levels. Whilst there has been considerable momentum in AOP development, far less attention has been paid to how AOPs might be practically applied for different regulatory purposes. This paper proposes a scientific confidence framework (SCF) for evaluating and applying a given AOP for different regulatory purposes ranging from prioritizing chemicals for further evaluation, to hazard prediction, and ultimately, risk assessment. The framework is illustrated using three different AOPs for several typical regulatory applications. The AOPs chosen are ones that have been recently developed and/or published, namely those for estrogenic effects, skin sensitisation, and rodent liver tumor promotion. The examples confirm how critical the data-richness of an AOP is for driving its practical application. In terms of performing risk assessment, human dosimetry methods are necessary to inform meaningful comparisons with human exposures; dosimetry is applied to effect levels based on non-testing approaches and in vitro data. Such a comparison is presented in the form of an exposure:activity ratio (EAR) to interpret biological activity in the context of exposure and to provide a basis for product stewardship and regulatory decision making. (C) 2015 The Authors. Published by Elsevier Inc.
C1 [Patlewicz, Grace] DuPont Haskell Global Ctr Hlth & Environm Sci, Newark, DE 19711 USA.
   [Simon, Ted W.] Ted Simon LLC, Winston, GA 30187 USA.
   [Rowlands, J. Craig; Budinsky, Robert A.] Dow Chem Co USA, Toxicol & Environm Res & Consulting, Midland, MI 48674 USA.
   [Becker, Richard A.] Amer Chem Council, Regulatory & Tech Affairs Dept, Washington, DC 20002 USA.
RP Patlewicz, G (reprint author), US EPA, Off Res & Dev, Natl Ctr Computat Toxicol, 109 TW Alexander Dr, Res Triangle Pk, NC 27711 USA.
EM patlewig@hotmail.com
RI Simon, Ted/M-9188-2013
OI Simon, Ted/0000-0001-9405-3020; Patlewicz, Grace/0000-0003-3863-9689
FU American Chemistry Council (ACC)
FX The authors had complete control over the design, conduct,
   interpretation, and reporting of the analyses included in this
   manuscript. The contents of this manuscript are solely the
   responsibility of the authors and do not necessarily reflect the views
   or policies of their employers. Ted Simon received funding to support
   this research from the American Chemistry Council (ACC). Robert
   Budinsky, Craig Rowlands, and Grace Patlewicz are or were employed by
   companies engaged in chemical product manufacturing. Richard Becker is
   employed by ACC, a trade association of U. S. chemical manufacturers.
CR Andersen ME, 1997, TOXICOL APPL PHARM, V144, P145, DOI 10.1006/taap.1996.8067
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Aptula AO, 2005, CHEM RES TOXICOL, V18, P1420, DOI 10.1021/tx050075m
   Aptula AO, 2006, CHEM RES TOXICOL, V19, P1097, DOI 10.1021/tx0601004
   Aylward LL, 2011, REGUL TOXICOL PHARM, V61, P44, DOI 10.1016/j.yrtph.2011.06.001
   Aylward LL, 2011, J APPL TOXICOL, V31, P741, DOI 10.1002/jat.1626
   Ball N, 2014, REGUL TOXICOL PHARM, V68, P212, DOI 10.1016/j.yrtph.2013.12.007
   Bauch C, 2012, REGUL TOXICOL PHARM, V63, P489, DOI 10.1016/j.yrtph.2012.05.013
   Becker R.A., 2014, REGUL TOXICOL UNPUB
   Becker R.A., 2014, ICCA JIRC WORKSH JUN
   Becker R.A., 2015, ADVERSE OUTCOM UNPUB
   Becker RA, 2014, BIRTH DEFECTS RES B, V101, P114, DOI 10.1002/bdrb.21085
   Becker RA, 2012, J TOXICOL, DOI 10.1155/2012/941082
   Boutros PC, 2011, TOXICOL APPL PHARM, V251, P119, DOI 10.1016/j.taap.2010.12.010
   Boverhof DR, 2006, TOXICOL SCI, V94, P398, DOI 10.1093/toxsci/kfl100
   Budinsky RA, 2014, CRIT REV TOXICOL, V44, P83, DOI 10.3109/10408444.2013.835787
   Buist H, 2013, REGUL TOXICOL PHARM, V67, P170, DOI 10.1016/j.yrtph.2013.01.002
   Cao F, 2013, ENVIRON TOXICOL PHAR, V36, P626, DOI 10.1016/j.etap.2013.06.004
   Chang H, 2005, J TOXICOL ENV HEAL A, V68, P1567, DOI 10.1080/15287390590967513
   Chopra M, 2011, CRIT REV TOXICOL, V41, P292, DOI 10.3109/10408444.2010.524635
   Conolly RB, 1997, TOXICOL APPL PHARM, V146, P281, DOI 10.1006/taap.1997.8248
   Cox LA, 2014, REGUL TOXICOL PHARM, V69, P443, DOI 10.1016/j.yrtph.2014.05.010
   Denison MS, 2011, TOXICOL SCI, V124, P1, DOI 10.1093/toxsci/kfr218
   Drewe W.C., SOC TOX MARCH 24 27
   Dupuis G., 1982, ALLERGIC CONTACT DER
   ECETOC, 2012, 116 ECETOC
   ECHA, 2008, GUID INF REQ CHEM SA
   Emter R, 2013, TOXICOL IN VITRO, V27, P2225, DOI 10.1016/j.tiv.2013.09.009
   Emter R, 2010, TOXICOL APPL PHARM, V245, P281, DOI 10.1016/j.taap.2010.03.009
   Fielden MR, 2008, TOXICOL SCI, V103, P28, DOI 10.1093/toxsci/kfn022
   Fletcher N, 2005, TOXICOL APPL PHARM, V207, P1, DOI 10.1016/j.taap.2004.12.003
   Forgacs AL, 2012, TOXICOL SCI, V125, P41, DOI 10.1093/toxsci/kfr262
   Gerberick GF, 2007, TOXICOL SCI, V97, P417, DOI 10.1093/toxsci/kfm064
   Gerberick GF, 2004, TOXICOL SCI, V81, P332, DOI 10.1093/toxsci/kfh213
   GODFREY HP, 1971, J IMMUNOL, V106, P431
   GOODMAN DG, 1992, REGUL TOXICOL PHARM, V15, P245, DOI 10.1016/0273-2300(92)90036-9
   Hailey JR, 2005, TOXICOL PATHOL, V33, P165, DOI 10.1080/01926230590888324
   Hartung T, 2011, ALTEX-ALTERN ANIM EX, V28, P183, DOI 10.14573/altex.2011.3.183
   Heise T, 2012, CURR MED CHEM, V19, P1721
   Hengstler JG, 2011, CRIT REV TOXICOL, V41, P263, DOI 10.3109/10408444.2011.558487
   Hubal EAC, 2010, J TOXICOL ENV HEAL B, V13, P299, DOI 10.1080/10937404.2010.483947
   IOM (Institute of Medicine), 2010, EV BIOM SURR ENDP CH
   Jaworska J, 2013, J APPL TOXICOL, V33, P1353, DOI 10.1002/jat.2869
   Jaworska J, 2011, ALTEX-ALTERN ANIM EX, V28, P211, DOI 10.14573/altex.2011.3.211
   Julien E, 2009, CRIT REV FOOD SCI, V49, P682, DOI 10.1080/10408390903110692
   Kennedy GD, 2014, TOXICOL SCI, V140, P135, DOI 10.1093/toxsci/kfu065
   Landsteiner K, 1936, J EXP MED, V64, P625, DOI 10.1084/jem.64.4.625
   Lorber M, 2009, CHEMOSPHERE, V77, P640, DOI 10.1016/j.chemosphere.2009.08.016
   Meek ME, 2014, J APPL TOXICOL, V34, P1, DOI 10.1002/jat.2949
   Meek MEB, 2008, ENVIRON MOL MUTAGEN, V49, P110, DOI 10.1002/em.20369
   Meek ME, 2014, J APPL TOXICOL, V34, P595, DOI 10.1002/jat.2984
   Meek ME, 2003, CRIT REV TOXICOL, V33, P591, DOI 10.1080/10408440390250136
   Moolgavkar SH, 1996, TOXICOL APPL PHARM, V138, P31, DOI 10.1006/taap.1996.0094
   Morgan RE, 2013, TOXICOL SCI, V136, P216, DOI 10.1093/toxsci/kft176
   Murk AJ, 2013, TOXICOL IN VITRO, V27, P1320, DOI 10.1016/j.tiv.2013.02.012
   National Research Council, 2012, EXP SCI 21 CENT VIS
   National Toxicology Programme, 2014, 584 NTP
   Natsch A, 2013, J APPL TOXICOL, V33, P1337, DOI 10.1002/jat.2868
   Nguyen LP, 2008, CHEM RES TOXICOL, V21, P102, DOI 10.1021/tx7001965
   NRC (National Research Council), 2007, TOX TEST 21 CENT VIS
   Nukada Y, 2013, TOXICOL IN VITRO, V27, P609, DOI 10.1016/j.tiv.2012.11.006
   OECD, 2015, TEST GUID 442C CHEM
   OECD, 2014, OECD SER TEST ASS, V194
   OECD, 2011, OECD SER TEST ASS
   OECD, 2014, US TOOLB AOP WORKFL
   OECD, 2015, ARENRF2 OECD
   OECD, 2004, ENVJMMONO200424 OECD
   OECD, 2007, OECD SER TEST ASS, V80
   OECD (Organisation for Economic Co operation and Development), 2012, ADV OUTC PATHW SKI 1
   OECD (Organization for Economic Co-operation and Development), 2013, GUID DOC DEV ASS ADV
   Organisation for Economic Cooperation and Development (OECD), 2012, ADV OUTC PATHW SKI 2
   Pande K, 2005, MOL PHARMACOL, V67, P1393, DOI 10.1124/mol.105.010983
   Pastoor TP, 2014, CRIT REV TOXICOL, V44, P1, DOI 10.3109/10408444.2014.931923
   Patlewicz G, 2014, SAR QSAR ENVIRON RES, V25, P367, DOI 10.1080/1062936X.2014.900520
   Patlewicz G, 2014, ALTEX-ALTERN ANIM EX, V31, P387, DOI 10.14573/altex.1410071
   Patlewicz G, 2014, REGUL TOXICOL PHARM, V69, P529, DOI 10.1016/j.yrtph.2014.06.001
   Patlewicz G, 2013, REGUL TOXICOL PHARM, V67, P1, DOI 10.1016/j.yrtph.2013.06.002
   Patlewicz G, 2013, REGUL TOXICOL PHARM, V65, P259, DOI 10.1016/j.yrtph.2012.12.008
   Pelkonen O, 2009, ALTEX-ALTERN TIEREXP, V26, P214
   Petkov PI, 2010, SAR QSAR ENVIRON RES, V21, P187, DOI 10.1080/10629360903570933
   Python F, 2007, TOXICOL APPL PHARM, V220, P113, DOI 10.1016/j.taap.2006.12.026
   Reisinger K, 2015, TOXICOL IN VITRO, V29, P259, DOI 10.1016/j.tiv.2014.10.018
   Roberts DW, 2008, J APPL TOXICOL, V28, P443, DOI 10.1002/jat.1293
   Roberts DW, 2014, J APPL TOXICOL, V34, P436, DOI 10.1002/jat.2943
   Roberts DW, 2009, CHEM RES TOXICOL, V22, P592, DOI 10.1021/tx800431x
   Rorije E, 2013, REGUL TOXICOL PHARM, V67, P146, DOI 10.1016/j.yrtph.2013.06.003
   Rotroff DM, 2013, ENVIRON HEALTH PERSP, V121, P7, DOI 10.1289/ehp.1205065
   Rotroff DM, 2010, TOXICOL SCI, V117, P348, DOI 10.1093/toxsci/kfq220
   Rowlands JC, 2011, CHEMOSPHERE, V85, P232, DOI 10.1016/j.chemosphere.2011.06.026
   Sakaguchi H, 2007, TOXICOL LETT, V172, pS93, DOI 10.1016/j.toxlet.2007.05.257
   Scholz S, 2013, REGUL TOXICOL PHARM, V67, P506, DOI 10.1016/j.yrtph.2013.10.003
   Schultz TW, 2005, SAR QSAR ENVIRON RES, V16, P313, DOI 10.1080/10659360500204152
   Shah I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014584
   Sheikh-Bahaei S, 2010, J THEOR BIOL, V265, P718, DOI 10.1016/j.jtbi.2010.06.011
   Simon T., 2014, CRIT REV TO IN PRESS
   Simon T, 2009, TOXICOL SCI, V112, P490, DOI 10.1093/toxsci/kfp232
   Teeguarden J, 2013, FOOD CHEM TOXICOL, V62, P949, DOI 10.1016/j.fct.2013.08.001
   Teeguarden JG, 2013, FOOD CHEM TOXICOL, V62, P935, DOI 10.1016/j.fct.2013.07.007
   Teeguarden JG, 2011, TOXICOL SCI, V123, P48, DOI 10.1093/toxsci/kfr160
   Thomas RS, 2012, TOXICOL SCI
   Thomas RS, 2013, TOXICOL SCI, V136, P4, DOI 10.1093/toxsci/kft178
   Tluczkiewicz I, 2013, REGUL TOXICOL PHARM, V67, P157, DOI 10.1016/j.yrtph.2013.02.004
   Tollefsen KE, 2014, REGUL TOXICOL PHARM, V70, P629, DOI 10.1016/j.yrtph.2014.09.009
   Tonnelier A., 2011, ARCH TOXICOL
   Urbisch D, 2015, REGUL TOXICOL PHARM, V71, P337, DOI 10.1016/j.yrtph.2014.12.008
   van der Veen JW, 2014, REGUL TOXICOL PHARM, V69, P371, DOI 10.1016/j.yrtph.2014.04.018
   van Leeuwen K, 2009, SAR QSAR ENVIRON RES, V20, P207, DOI 10.1080/10629360902949179
   Vezina CM, 2004, ENVIRON HEALTH PERSP, V112, P1636, DOI 10.1289/txg.7253
   Vinken M, 2013, TOXICOLOGY, V312, P158, DOI 10.1016/j.tox.2013.08.011
   Wambaugh JF, 2013, ENVIRON SCI TECHNOL, V47, P8479, DOI 10.1021/es400482g
   Wetmore BA, 2012, TOXICOL SCI, V125, P157, DOI 10.1093/toxsci/kfr254
   Yao CDQ, 2012, TOXICOL APPL PHARM, V260, P135, DOI 10.1016/j.taap.2012.02.001
   Zhao YY, 2008, CHEMOSPHERE, V73, P86, DOI 10.1016/j.chemosphere.2008.05.018
NR 113
TC 45
Z9 46
U1 0
U2 35
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0273-2300
EI 1096-0295
J9 REGUL TOXICOL PHARM
JI Regul. Toxicol. Pharmacol.
PD APR
PY 2015
VL 71
IS 3
BP 463
EP 477
DI 10.1016/j.yrtph.2015.02.011
PG 15
WC Medicine, Legal; Pharmacology & Pharmacy; Toxicology
SC Legal Medicine; Pharmacology & Pharmacy; Toxicology
GA CF8PG
UT WOS:000352823800012
PM 25707856
OA Other Gold
DA 2019-10-23
ER

PT J
AU Pauluhn, J
AF Pauluhn, Juergen
TI Analysis of the interrelationship of the pulmonary irritation and
   elicitation thresholds in rats sensitized with 1,6-hexamethylene
   diisocyanate (HDI)
SO INHALATION TOXICOLOGY
LA English
DT Article
DE Asthma rat bioassay; diisocyanate asthma; dose-response; neutrophilic
   inflammation; risk assessment
ID EXHALED NITRIC-OXIDE; INDUSTRIAL SPRAY PAINTERS; ADVERSE OUTCOME
   PATHWAY; CHEMICAL-INDUCED ASTHMA; REPAIR SHOP WORKERS; BROWN-NORWAY
   RATS; OCCUPATIONAL ASTHMA; HEXAMETHYLENE DIISOCYANATE; BRONCHOALVEOLAR
   LAVAGE; INHALATION TOXICITY
AB This paper summarizes a range of experimental data central for developing a science-based approach for hazard identification of monomeric and polymeric aliphatic 1,6-hexamethylene diisocyanate (HDI). The dose-response curve of HDI-induced pulmonary responses in naive or dermally sensitized rats after one or several inhalation priming exposures was examined in the Brown Norway (BN) rat asthma model. Emphasis was directed to demonstrate the need and the difficulty in selecting an appropriate pulmonary dose when much of the inhaled chemically reactive vapor may concentration dependently be retained in the upper airways of obligate nose-breathing rats. The course taken acknowledges the experimental challenges in identifying an elicitation threshold for HDI-monomer near or above the saturated vapor concentration or in the presence of a HDI-polymer aerosol. The inhalation threshold dose on elicitation was determined based on a fixed concentration (C) x variable exposure duration (t) protocol for improving inhalation dosimetry of the lower airways. Neutrophilic granulocytes (PMN) in bronchoalveolar lavage (BAL) fluid in equally inhalation primed naive and dermally sensitized rats were used to define the inhalation elicitation threshold C x t. Sensitized rats elaborated markedly increased PMN challenged sensitized rats relative to equally challenged naive rats at 5625mg HDI/m(3) x min (75 mg/m(3) for 75 min). PMN were essentially indistinguishable at 900mg HDI/m(3) x min. By applying adjustment factors accounting for both inter-species differences in inhalation dosimetry and intra-species susceptibility, the workplace human-equivalent threshold C x t was estimated to be in the range of the current ACGIH TLV (R) of HDI. Thus, this rat "asthma'' model was suitable to demonstrate elicitation thresholds for HDI-vapor after one or several inhalation priming exposures and seems to be suitable to derive occupational exposure values (OELs) for diisocyanates in general.
C1 [Pauluhn, Juergen] Bayer Pharma AG, Expt Toxicol, D-42096 Wuppertal, Germany.
   [Pauluhn, Juergen] Hannover Med Sch, Hannover, Germany.
RP Pauluhn, J (reprint author), Bayer Pharma AG, Expt Toxicol, D-42096 Wuppertal, Germany.
EM juergen.pauluhn@bayer.com
FU European Aliphatic Isocyanates Producers Association (ALIPA)
FX The author received support from the European Aliphatic Isocyanates
   Producers Association (ALIPA) for the preparation of this manuscript.
   Bayer MaterialScience is a producer of HDI. The manuscript reflects
   solely the opinion of the author and not of any other funding source.
   The author reports that he has no conflicts of interests.
CR Aalto-Korte K, 2012, CONTACT DERMATITIS, V67, P78, DOI 10.1111/j.1600-0536.2011.02049.x
   ALEXANDERSSON R, 1987, ARCH ENVIRON HEALTH, V42, P367, DOI 10.1080/00039896.1987.9934361
   [Anonymous], 2010, J EUR COMMUN L, V276, P33
   Arts JHE, 2008, TOXICOL SCI, V106, P423, DOI 10.1093/toxsci/kfn199
   BAUR X, 1994, INT ARCH OCC ENV HEA, V66, P141, DOI 10.1007/BF00380772
   Baur X, 2007, J ALLERGY CLIN IMMUN, V119, P757, DOI 10.1016/j.jaci.2006.10.037
   Bello D, 2004, AM J IND MED, V46, P480, DOI 10.1002/ajim.20076
   Bello D, 2007, ENVIRON HEALTH PERSP, V115, P328, DOI 10.1289/ehp.9557
   Boverhof DR, 2008, TOXICOL APPL PHARM, V226, P1, DOI 10.1016/j.taap.2007.10.008
   Cassidy LD, 2010, J OCCUP ENVIRON MED, V52, P988, DOI 10.1097/JOM.0b013e3181f2e086
   COCKCROFT DW, 1979, CAN MED ASSOC J, V121, P602
   De Vooght V, 2013, TOXICOL SCI, V131, P406, DOI 10.1093/toxsci/kfs308
   De Vooght V, 2011, TOXICOLOGY, V279, P85, DOI 10.1016/j.tox.2010.09.014
   DFG (Deutsche Forschungsgemeinschaft), 2014, MAK UND BAT WERT LIS
   ECHA, 2012, GUID INF REQ CHEM SA, P130
   Ewald-Kleimeier S, 2013, ADV EXP MED BIOL, V788, P255, DOI 10.1007/978-94-007-6627-3_36
   JANKO M, 1992, AM IND HYG ASSOC J, V53, P331, DOI 10.1202/0002-8894(1992)053<0331:OETDPI>2.0.CO;2
   Jatakanon A, 1999, AM J RESP CRIT CARE, V160, P1532, DOI 10.1164/ajrccm.160.5.9806170
   Jonaid BS, 2014, OCCUP ENVIRON MED, V71, P415, DOI 10.1136/oemed-2013-101672
   Kidd Parris, 2003, Altern Med Rev, V8, P223
   Kimber I, 2005, CURR OPIN ALLERGY CL, V5, P119, DOI 10.1097/01.all.0000162302.82233.93
   Kimber I, 2014, TOXICOLOGY, V318, P32, DOI 10.1016/j.tox.2014.02.001
   Laskin DL, 2011, ANNU REV PHARMACOL, V51, P267, DOI 10.1146/annurev.pharmtox.010909.105812
   Lemiere C, 2002, J ALLERGY CLIN IMMUN, V110, P641, DOI 10.1067/mai.2002.128806
   Leroyer C, 1998, THORAX, V53, P152, DOI 10.1136/thx.53.2.152
   Liu FF, 2013, TOXICOLOGY, V310, P104, DOI 10.1016/j.tox.2013.05.016
   Mahler M, 2014, LAB ANIM-UK, V48, P178, DOI 10.1177/0023677213516312
   Maitre A, 1996, AM IND HYG ASSOC J, V57, P153, DOI 10.1202/0002-8894(1996)057<0153:CBSSAI>2.0.CO;2
   MALO JL, 1991, AM REV RESPIR DIS, V143, P528, DOI 10.1164/ajrccm/143.3.528
   MYER HE, 1993, AM IND HYG ASSOC J, V54, P663, DOI 10.1202/0002-8894(1993)054<0663:ASOAHH>2.0.CO;2
   OECD, 2009, OECD SER TEST ASS, V39
   OECD, 1998, ENVMCCHEM9817 OECD, V1
   Pauluhn J, 2000, ARCH TOXICOL, V74, P257, DOI 10.1007/s002040000114
   PAULUHN J, 1994, TOXICOL IN VITRO, V8, P981, DOI 10.1016/0887-2333(94)90231-3
   Pauluhn J, 2005, INHAL TOXICOL, V17, P729, DOI 10.1080/08958370500224631
   Pauluhn J, 2005, INHAL TOXICOL, V17, P67, DOI 10.1080/08958370590898434
   Pauluhn J, 2002, INHAL TOXICOL, V14, P287, DOI 10.1080/08958370252809068
   Pauluhn J, 2002, TOXICOLOGY, V171, P147, DOI 10.1016/S0300-483X(01)00571-6
   Pauluhn J, 2001, INHAL TOXICOL, V13, P513, DOI 10.1080/08958370151131891
   Pauluhn J, 2008, TOXICOL SCI, V104, P320, DOI 10.1093/toxsci/kfn098
   Pauluhn J, 2007, J APPL TOXICOL, V27, P160, DOI 10.1002/jat.1188
   Pauluhn J, 2014, TOXICOLOGY, V319, P10, DOI 10.1016/j.tox.2014.02.006
   Pauluhn J, 2011, REGUL TOXICOL PHARM, V61, P351, DOI 10.1016/j.yrtph.2011.09.007
   Pauluhn J, 2011, TOXICOLOGY, V281, P15, DOI 10.1016/j.tox.2011.01.005
   Pauluhn M, 2005, EXP TOXICOL PATHOL, V56, P203, DOI 10.1016/j.etp.2004.10.002
   Pauluhn U, 2004, INHAL TOXICOL, V16, P159, DOI 10.1080/08958370490434060
   PISANIELLO DL, 1989, ANN OCCUP HYG, V33, P563, DOI 10.1093/annhyg/33.4.563
   Pronk A, 2006, OCCUP ENVIRON MED, V63, P624, DOI 10.1136/oem.2005.023226
   Pronk A, 2006, ANN OCCUP HYG, V50, P1, DOI 10.1093/annhyg/mei044
   Pronk A, 2007, AM J RESP CRIT CARE, V176, P1090, DOI 10.1164/rccm.200702-215OC
   Rando RJ, 1999, AM IND HYG ASSOC J, V60, P737, DOI 10.1080/00028899908984496
   Raulf-Heimsoth M, 2013, ADV EXP MED BIOL, V788, P293, DOI 10.1007/978-94-007-6627-3_40
   Redlich CA, 2002, AM J IND MED, V42, P511, DOI 10.1002/ajim.10143
   Redlich Carrie A, 2010, Proc Am Thorac Soc, V7, P134, DOI 10.1513/pats.201002-025RM
   Remiarz RJ, 1983, AEROSOLS MINING IND, P879
   Schroeter JD, 2013, INHAL TOXICOL, V25, P168, DOI 10.3109/08958378.2013.768314
   Shiba T, 2009, J NEUROIMMUNOL, V207, P66, DOI 10.1016/j.jneuroim.2008.12.001
   Shiotsuka RN, 2006, INHAL TOXICOL, V18, P659, DOI 10.1080/08958370600742730
   Shiotsuka RN, 2010, INHAL TOXICOL, V22, P875, DOI 10.3109/08958370903572862
   Thomasen JM, 2011, J OCCUP ENVIRON HYG, V8, P709, DOI 10.1080/15459624.2011.626744
   THORNE PS, 1987, TOXICOL APPL PHARM, V87, P155, DOI 10.1016/0041-008X(87)90093-7
   TORNLING G, 1990, AM J IND MED, V17, P299, DOI 10.1002/ajim.4700170302
   VANDENPLAS O, 1993, AM REV RESPIR DIS, V147, P1287, DOI 10.1164/ajrccm/147.5.1287
   VANDENPLAS O, 1993, J ALLERGY CLIN IMMUN, V91, P850, DOI 10.1016/0091-6749(93)90342-D
   VANDENPLAS O, 1993, BRIT J IND MED, V50, P213
   Vandenplas O, 2011, ALLERGY ASTHMA IMMUN, V3, P157, DOI 10.4168/aair.2011.3.3.157
   Vanoirbeek JAJ, 2008, J ALLERGY CLIN IMMUN, V121, P456, DOI 10.1016/j.jaci.2007.09.006
   Villeneuve DL, 2014, TOXICOL SCI, V142, P312, DOI 10.1093/toxsci/kfu199
NR 68
TC 3
Z9 3
U1 0
U2 3
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0895-8378
EI 1091-7691
J9 INHAL TOXICOL
JI Inhal. Toxicol.
PD MAR
PY 2015
VL 27
IS 4
BP 191
EP 206
DI 10.3109/08958378.2015.1026619
PG 16
WC Toxicology
SC Toxicology
GA CM2MD
UT WOS:000357513500001
PM 25924102
OA Green Published
DA 2019-10-23
ER

PT J
AU Tompsett, AR
   Higley, E
   Pryce, S
   Giesy, JP
   Hecker, M
   Wiseman, S
AF Tompsett, Amber R.
   Higley, Eric
   Pryce, Sara
   Giesy, John P.
   Hecker, Markus
   Wiseman, Steve
TI Transcriptional changes in African clawed frogs (Xenopus laevis) exposed
   to 17 alpha-ethynylestradiol during early development
SO ECOTOXICOLOGY
LA English
DT Article
DE Amphibian; Endocrine; Vitellogenin; Estrogen; Sexual differentiation;
   Adverse outcome pathways
ID WASTE-WATER CONTAMINANTS; SEXUAL-DIFFERENTIATION; NATIONAL
   RECONNAISSANCE; SYNTHETIC ESTROGEN; US STREAMS; HORMONES; LIVER; FISH;
   PHARMACEUTICALS; RECEPTORS
AB Although the past two decades have witnessed a significant increase in the number of studies investigating effects of estrogenic chemicals on amphibians, to date little is known about specific molecular interactions of estrogens with the hypothalamus-pituitary-gonadal-hepatic axis in developing amphibians. Here, tissue-specific functional sets of genes, derived previously from studies of fishes exposed to endocrine active chemicals, were evaluated in Xenopus laevis exposed to 17 alpha-ethynylestradiol (EE2) throughout their early development. Specifically, transcriptional responses of X. laevis exposed to 0.09, 0.84, or 8.81 mu g EE2/L were characterized during sexual differentiation [31 day post hatch (dph)] and after completion of metamorphosis during the juvenile stage (89 dph). While at 31 dph there were no consistent effects of EE2 on abundances of transcripts, at 89 dph X. laevis exhibited significant alterations in expression of genes involved in steroid signaling and metabolism, synthesis of cholesterol, and vitellogenesis. Specifically, expression of androgen receptor, farnesyl diphosphate synthase, estrogen receptor alpha, and vitellogenin A2 was significantly greater (>2-fold) than in controls while expression of farnesoid x-activated receptors alpha and beta was significantly less (>2-fold reduction) than in controls. These results support the hypothesis that sets of genes derived from studies in teleost fish can be extrapolated for use in amphibians during the juvenile stage but not in sexually undifferentiated individuals. Furthermore, changes in abundances of transcripts of the here utilized sets of genes in animals sampled post sexual differentiation were in accordance with developmental effects and alterations of gonadal histology reported in a parallel study. This set of genes might be useful for predicting potential adverse outcomes at later life-stages.
C1 [Tompsett, Amber R.; Higley, Eric; Pryce, Sara; Wiseman, Steve] Univ Saskatchewan, Toxicol Ctr, Saskatoon, SK S7N 5B3, Canada.
   [Giesy, John P.] Univ Saskatchewan, Dept Vet Biomed Sci, Saskatoon, SK S7N 5B3, Canada.
   [Giesy, John P.] Michigan State Univ, Dept Zool, E Lansing, MI 48824 USA.
   [Giesy, John P.] Michigan State Univ, Ctr Integrat Toxicol, E Lansing, MI 48824 USA.
   [Giesy, John P.] City Univ Hong Kong, Dept Biol & Chem, Kowloon, Hong Kong, Peoples R China.
   [Giesy, John P.] City Univ Hong Kong, State Key Lab Marine Pollut, Kowloon, Hong Kong, Peoples R China.
   [Giesy, John P.] Univ Hong Kong, Sch Biol Sci, Kowloon, Hong Kong, Peoples R China.
   [Giesy, John P.] Nanjing Univ, Sch Environm, State Key Lab Pollut Control & Resource Reuse, Nanjing 210008, Jiangsu, Peoples R China.
   [Giesy, John P.; Hecker, Markus] Univ Saskatchewan, Toxicol Ctr, Sch Environm & Sustainabil, Saskatoon, SK S7N 5B3, Canada.
RP Hecker, M (reprint author), Univ Saskatchewan, Toxicol Ctr, Sch Environm & Sustainabil, 44 Campus Dr, Saskatoon, SK S7N 5B3, Canada.
EM markus.hecker@usask.ca
OI Wiseman, Steve/0000-0002-8215-2272
FU Natural Science and Engineering Research Council of CanadaNatural
   Sciences and Engineering Research Council of Canada; Western Economic
   Diversification Canada [6578, 6807]; Canada Foundation for
   InnovationCanada Foundation for Innovation; Canada Research Chair
   programCanada Research Chairs; Distinguished visiting Professorship in
   the Department of Biology and Chemistry; State Key Laboratory in Marine
   Pollution, City University of Hong KongCity University of Hong Kong;
   "High Level Foreign Experts" program - State Administration of Foreign
   Experts Affairs, the P.R. China [GDW20123200120]; Chinese Academy of
   SciencesChinese Academy of Sciences
FX The authors wish to acknowledge the support by the Natural Science and
   Engineering Research Council of Canada (Discovery Grants), Grants from
   Western Economic Diversification Canada (Project # 6578 and 6807), and
   an instrumentation Grant from the Canada Foundation for Innovation to J.
   Giesy and M. Hecker. J. Giesy and M. Hecker were supported by the Canada
   Research Chair program. Furthermore, John Giesy was supported by
   Distinguished visiting Professorship in the Department of Biology and
   Chemistry and State Key Laboratory in Marine Pollution, City University
   of Hong Kong, the 2012 "High Level Foreign Experts" (# GDW20123200120)
   program, funded by the State Administration of Foreign Experts Affairs,
   the P.R. China to Nanjing University and the Einstein Professor Program
   of the Chinese Academy of Sciences. The authors would like to thank J.
   Doering, S. Beitel, B. Tendler, and T. Tse for their assistance.
CR Ankley GT, 2007, ENVIRON SCI TECHNOL, V41, P8211, DOI 10.1021/es072658j
   CHANG CY, 1955, P SOC EXP BIOL MED, V89, P150
   Chang H, 2010, J CHROMATOGR A, V1217, P506, DOI 10.1016/j.chroma.2009.11.076
   Corcoran J, 2010, CRIT REV TOXICOL, V40, P287, DOI 10.3109/10408440903373590
   Eick GN, 2011, MOL CELL ENDOCRINOL, V334, P31, DOI 10.1016/j.mce.2010.09.003
   Ekman DR, 2009, METABOLOMICS, V5, P22, DOI 10.1007/s11306-008-0138-y
   Gibson R, 2005, ENVIRON SCI TECHNOL, V39, P2461, DOI 10.1021/es048892g
   Hanselman TA, 2003, ENVIRON SCI TECHNOL, V37, P5471, DOI 10.1021/es034410+
   Henriquez-Hernandez LA, 2007, J PHARMACOL EXP THER, V320, P695, DOI 10.1124/jpet.106.113209
   Hogan NS, 2008, GEN COMP ENDOCR, V156, P515, DOI 10.1016/j.ygcen.2008.03.011
   Jarosova B, 2014, ENVIRON SCI POLLUT R, V21, P10970, DOI 10.1007/s11356-014-3056-8
   Jobling S, 1998, ENVIRON SCI TECHNOL, V32, P2498, DOI 10.1021/es9710870
   Kidd KA, 2007, P NATL ACAD SCI USA, V104, P8897, DOI 10.1073/pnas.0609568104
   Kolpin DW, 2002, ENVIRON SCI TECHNOL, V36, P4007, DOI 10.1021/es020136s
   Kolpin DW, 2002, ENVIRON SCI TECHNOL, V36, P1202, DOI 10.1021/es011055j
   Lutz I, 2008, ANAL BIOANAL CHEM, V390, P2031, DOI 10.1007/s00216-008-1973-4
   Martinez-Becerra P, 2012, PHARMACOL RES, V66, P419, DOI 10.1016/j.phrs.2012.07.005
   Miyata S, 1999, ZOOL SCI, V16, P335, DOI 10.2108/zsj.16.335
   Park BJ, 2005, ENVIRON TOXICOL CHEM, V24, P2027, DOI 10.1897/04-227R.1
   Pettersson I, 2007, ENVIRON TOXICOL CHEM, V26, P1005, DOI 10.1897/06-464R.1
   Reschly EJ, 2008, J STEROID BIOCHEM, V110, P83, DOI 10.1016/j.jsbmb.2008.02.007
   Rivas A, 2002, ENDOCRINOLOGY, V143, P4797, DOI 10.1210/en.2002-220531
   Rotchell JM, 2003, J TOXICOL ENV HEAL B, V6, P453, DOI [10.1080/10937400306476, 10.1080/10937400390223430]
   Rozen S, 2000, Methods Mol Biol, V132, P365
   Sharpe RL, 2007, COMP BIOCHEM PHYS C, V145, P507, DOI 10.1016/j.cbpc.2006.11.018
   Simon P, 2003, BIOINFORMATICS, V19, P1439, DOI 10.1093/bioinformatics/btg157
   SMITH DF, 1978, BIOCHEM J, V174, P353, DOI 10.1042/bj1740353
   TATA JR, 1993, J STEROID BIOCHEM, V46, P105, DOI 10.1016/0960-0760(93)90286-6
   Tompsett AR, 2013, ENVIRON SCI TECHNOL, V47, P4822, DOI 10.1021/es400436y
   Tompsett AR, 2013, AQUAT TOXICOL, V126, P42, DOI 10.1016/j.aquatox.2012.10.003
   Tompsett AR, 2012, COMP BIOCHEM PHYS C, V156, P202, DOI 10.1016/j.cbpc.2012.06.002
   VILLALPANDO I, 1990, International Journal of Developmental Biology, V34, P281
   Villeneuve DL, 2012, MUTAT RES-GEN TOX EN, V746, P151, DOI 10.1016/j.mrgentox.2011.12.016
   Watanabe KH, 2009, TOXICOL SCI, V109, P180, DOI 10.1093/toxsci/kfp069
   WITSCHI E, 1958, P SOC EXP BIOL MED, V97, P196
   Yoshimoto S, 2008, P NATL ACAD SCI USA, V105, P2469, DOI 10.1073/pnas.0712244105
   Zollner G, 2009, BRIT J PHARMACOL, V156, P7, DOI 10.1111/j.1476-5381.2008.00030.x
NR 37
TC 1
Z9 1
U1 1
U2 31
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0963-9292
EI 1573-3017
J9 ECOTOXICOLOGY
JI Ecotoxicology
PD MAR
PY 2015
VL 24
IS 2
BP 321
EP 329
DI 10.1007/s10646-014-1380-x
PG 9
WC Ecology; Environmental Sciences; Toxicology
SC Environmental Sciences & Ecology; Toxicology
GA CB0RI
UT WOS:000349334000007
PM 25427717
DA 2019-10-23
ER

PT J
AU Wang, X
   Duch, MC
   Mansukhani, N
   Ji, ZX
   Liao, YP
   Wang, MY
   Zhang, HY
   Sun, BB
   Chang, CH
   Li, RB
   Lin, SJ
   Meng, H
   Xia, T
   Hersam, MC
   Nel, AE
AF Wang, Xiang
   Duch, Matthew C.
   Mansukhani, Nikhita
   Ji, Zhaoxia
   Liao, Yu-Pei
   Wang, Meiying
   Zhang, Haiyuan
   Sun, Bingbing
   Chang, Chong Hyun
   Li, Ruibin
   Lin, Sijie
   Meng, Huan
   Xia, Tian
   Hersam, Mark C.
   Nel, Andre E.
TI Use of a Pro-Fibrogenic Mechanism-Based Predictive Toxicological
   Approach for Tiered Testing and Decision Analysis of Carbonaceous
   Nanomaterials
SO ACS NANO
LA English
DT Article
DE engineered carbonaceous nanomaterials; SWCNT; graphene; graphene oxide;
   NLRP3 inflammasome lung fibrosis
ID BIOCOMPATIBLE BLOCK-COPOLYMERS; GRAPHENE OXIDE; PULMONARY TOXICITY;
   OXIDATIVE STRESS; NANOTUBES; MICE; FIBROSIS; LUNG; RESPONSES; SURFACE
AB Engineered carbonaceous natiomateria Is (ECNs), including single-wall carbon nanotubes (SWCNTs), multiwall carbon nanotubes (MWCNTs), graphene, and graphene oxide (GO), are potentially hazardous to the lung. With incremental experience in the use of predictive toxicological approaches, seeking to relate ECN physicochemical properties to adverse outcome pathways (AOPs), it is logical to explore the existence of a common AOP that allows comparative analysis of broad ECN categories. We established an RN library comprising three different types of SWCNTs, graphene, and graphene oxide (two sizes) for comparative analysis according to a cellbased AOP that also plays a role in the pathogenesis of pulmonary fibrosis. SWCINITs synthesized by Hipco, arc discharge and Co Mo catalyst (CoMoCAT) methods were obtained in their as-prepared,(AP) state, following which they were further purified (PD) or coated with Pluronic F108 (PF108) or bovine serum albumin (BSA) to improve dispersal and colloidal stability. GO wasprepared as two sizes, GO-small (5) and GO-large (L), while the graphene samples were coated with BSA and PF108 to enable dispersion in aqueous solution. In vitro screening showed that AP- and PD-SWCNTs, irrespective of the method of synthesis, as well as graphene (BSA) and GO (S and L) could trigger interleukin-1 beta (IL-beta) and transforming growth factor-beta (TGF-beta 1) production in myeloid THP-1) and epithelial (BEAS-2B) cell lines, respectively. Oropharyngeal aspiration in mice confirmed that AP-Hipco tubes, graphene (BSA-dispersed), GO-S and GO-L could induce IL-1 beta and TGF-,61 production in the lung in parallel with lung fibrosis. Notably, GO-L was the most pro-fibrogenic material based on rapid kinetics of pulmonary injury. In contrast, PF108-dispersed SWCNTs and -graphene failed to exert fibrogenic effects. Collectively, these data indicate that the dispersal state and surface reactivity of ECNs play key roles in triggering a pro-fibrogenic AOP, which could prove helpful for hazard ranking and a proposed tiered testing approach for large ECN categories.
C1 [Wang, Xiang; Liao, Yu-Pei; Wang, Meiying; Sun, Bingbing; Li, Ruibin; Meng, Huan; Xia, Tian; Nel, Andre E.] Univ Calif Los Angeles, Dept Med, Div NanoMed, Los Angeles, CA 90095 USA.
   [Wang, Xiang; Ji, Zhaoxia; Zhang, Haiyuan; Chang, Chong Hyun; Lin, Sijie; Meng, Huan; Xia, Tian; Nel, Andre E.] Univ Calif Los Angeles, Calif NanoSyst Inst, Los Angeles, CA 90095 USA.
   [Duch, Matthew C.; Mansukhani, Nikhita; Hersam, Mark C.] Northwestern Univ, Dept Mat Sci & Engn, Evanston, IL 60208 USA.
   [Duch, Matthew C.; Mansukhani, Nikhita; Hersam, Mark C.] Northwestern Univ, Dept Chem, Evanston, IL 60208 USA.
   [Duch, Matthew C.; Mansukhani, Nikhita; Hersam, Mark C.] Northwestern Univ, Dept Engn, Evanston, IL 60208 USA.
RP Nel, AE (reprint author), Univ Calif Los Angeles, Dept Med, Div NanoMed, Los Angeles, CA 90095 USA.
EM anel@mednet.ucla.edu
RI Hersam, Mark/B-6739-2009; Lin, Sijie/S-8428-2016; Mansukhani,
   Nikhita/H-2328-2016; Wang, Xiang/J-2054-2014; Nel, Andre E/J-2808-2012;
   XIA, TIAN/C-3158-2013; Zhang, Haiyuan/F-4176-2015; Li,
   Ruibin/L-8285-2015; Meng, Huan/T-7954-2017; Zhang, Haiyuan/D-2095-2012;
   Li, Ruibin/H-6154-2016; Sun, Bingbing/I-8197-2012
OI Lin, Sijie/0000-0002-6970-8221; Mansukhani, Nikhita/0000-0001-6002-0132;
   Wang, Xiang/0000-0002-6647-0684; XIA, TIAN/0000-0003-0123-1305; Meng,
   Huan/0000-0001-8844-3938; Sun, Bingbing/0000-0002-5444-5078; Zhang,
   Haiyuan/0000-0003-4076-1771
FU National Institute of Environmental Health Sciences of the National
   Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Environmental Health Sciences (NIEHS) [RO1ES022698, U19ES019528];
   National Science Foundation and the Environmental Protection Agency
   [DBI-1266377]
FX Research reported in this publication was supported by the National
   Institute of Environmental Health Sciences of the National Institutes of
   Health under Award Number RO1ES022698 and U19ES019528. The content is
   solely the responsibility of the authors and does not necessarily
   represent the official views of the National Institutes of Health. This
   study is also based upon work supported by the National Science
   Foundation and the Environmental Protection Agency under Award No.
   DBI-1266377. Fluorescent microscopy was performed at the CNSI Advanced
   Light Microscopy/Spectroscopy Shared Facility at UCLA.
CR Antaris AL, 2010, ACS NANO, V4, P4725, DOI 10.1021/nn101363m
   Bianco A, 2013, ANGEW CHEM INT EDIT, V52, P4986, DOI 10.1002/anie.201209099
   Bonner J. C., 2010, TISSUE REPAIR, V3, P15
   Chowdhury I, 2013, ENVIRON SCI TECHNOL, V47, P6288, DOI 10.1021/es400483k
   Das S, 2013, PART PART SYST CHAR, V30, P148, DOI 10.1002/ppsc.201200066
   Duch MC, 2011, NANO LETT, V11, P5201, DOI 10.1021/nl202515a
   Feng LZ, 2011, NANOMEDICINE-UK, V6, P317, DOI [10.2217/nnm.10.158, 10.2217/NNM.10.158]
   Fubini B, 2011, NANOMEDICINE-UK, V6, P899, DOI [10.2217/nnm.11.80, 10.2217/NNM.11.80]
   Fubini B, 2010, NANOTOXICOLOGY, V4, P347, DOI 10.3109/17435390.2010.509519
   Ge CC, 2012, NANOTOXICOLOGY, V6, P526, DOI 10.3109/17435390.2011.587905
   Hung AH, 2014, ACS NANO, V8, P10168, DOI 10.1021/nn502986e
   Hung AH, 2013, J PHYS CHEM C, V117, P16263, DOI 10.1021/jp406909b
   Kagan V, 2004, FREE RADICAL BIO MED, V37, pS51
   Kayat J, 2011, NANOMED-NANOTECHNOL, V7, P40, DOI 10.1016/j.nano.2010.06.008
   Kostarelos K, 2014, SCIENCE, V344, P261, DOI 10.1126/science.1246736
   Li N, 2009, ENVIRON HEALTH PERSP, V117, P1116, DOI 10.1289/ehp.0800319
   Li RB, 2013, ACS NANO, V7, P2352, DOI 10.1021/nn305567s
   Li YF, 2013, P NATL ACAD SCI USA, V110, P12295, DOI 10.1073/pnas.1222276110
   Liu JH, 2015, TOXICOL RES-UK, V4, P83, DOI 10.1039/c4tx00044g
   Liu JH, 2012, NANOMEDICINE-UK, V7, P1801, DOI [10.2217/NNM.12.60, 10.2217/nnm.12.60]
   Liu Y, 2013, ACCOUNTS CHEM RES, V46, P702, DOI 10.1021/ar300028m
   Ma-Hock L., 2013, PART FIBRE TOXICOL, P10
   Mutlu GM, 2010, NANO LETT, V10, P1664, DOI 10.1021/nl9042483
   Qu GB, 2013, ACS NANO, V7, P5732, DOI 10.1021/nn402330b
   Seabra AB, 2014, CHEM RES TOXICOL, V27, P159, DOI 10.1021/tx400385x
   Seo JWT, 2011, J PHYS CHEM LETT, V2, P1004, DOI 10.1021/jz2003556
   Shvedova AA, 2008, AM J PHYSIOL-LUNG C, V295, pL552, DOI 10.1152/ajplung.90287.2008
   Shvedova AA, 2009, PHARMACOL THERAPEUT, V121, P192, DOI 10.1016/j.pharmthera.2008.10.009
   Shvedova AA, 2005, AM J PHYSIOL-LUNG C, V289, pL698, DOI 10.1152/ajplung.00084.2005
   Sun B., 2015, SMALL, DOI [10. 1002/sm11. 201402859, DOI 10.1002/SM11.201402859]
   Sun BB, 2013, SMALL, V9, P1595, DOI 10.1002/smll.201201962
   Wang X, 2012, NANO LETT, V12, P3050, DOI 10.1021/nl300895y
   Wang X, 2011, ACS NANO, V5, P9772, DOI 10.1021/nn2033055
   Wang X, 2010, ACS NANO, V4, P7241, DOI 10.1021/nn102112b
   Warheit DB, 2004, TOXICOL SCI, V77, P117, DOI 10.1093/toxsci/kfg228
   Zhang XY, 2011, CARBON, V49, P986, DOI 10.1016/j.carbon.2010.11.005
NR 36
TC 61
Z9 61
U1 0
U2 74
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1936-0851
EI 1936-086X
J9 ACS NANO
JI ACS Nano
PD MAR
PY 2015
VL 9
IS 3
BP 3032
EP 3043
DI 10.1021/nn507243w
PG 12
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary
SC Chemistry; Science & Technology - Other Topics; Materials Science
GA CE4HN
UT WOS:000351791800076
PM 25646681
OA Green Accepted
DA 2019-10-23
ER

PT J
AU Ba, Q
   Li, JY
   Huang, C
   Qiu, HL
   Li, JQ
   Chu, RA
   Zhang, W
   Xie, D
   Wu, YN
   Wang, H
AF Ba, Qian
   Li, Junyang
   Huang, Chao
   Qiu, Hongling
   Li, Jingquan
   Chu, Ruiai
   Zhang, Wei
   Xie, Dong
   Wu, Yongning
   Wang, Hui
TI Effects of Benzo[a]pyrene Exposure on Human Hepatocellular Carcinoma
   Cell Angiogenesis, Metastasis, and NF-kappa B Signaling
SO ENVIRONMENTAL HEALTH PERSPECTIVES
LA English
DT Article
ID POLYCYCLIC AROMATIC-HYDROCARBONS; IN-VITRO; ADDUCT FORMATION; LIVER;
   CARCINOGENESIS; PATHWAYS; INVASION; CANCER; RISK
AB BACKGROUND: Benzo[a] pyrene (B[a]P) is a common environmental and foodborne pollutant. Although the carcinogenicity of high-dose B[a]P has been extensively reported, the effects of long-term B[a]P exposure at lower environmental doses on cancer development are less understood.
   OBJECTIVES: We investigated the impact of B[a]P on human hepatocellular carcinoma (HCC) progression at various levels of exposure and identified a potential intervention target.
   METHODS: We used a model based on human HCC cells exposed to various concentrations of B[a]P (i.e., 0.01, 1, or 100 nM) for 1 month to examine the effects of B[a]P on cell growth, migration, invasion, and angiogenicity. A bioluminescent murine model was established to assess tumor metastasis in vivo.
   RESULTS: Chronic B[a]P exposure did not alter HCC cell growth but promoted cell migration and invasion both in vitro and in vivo. There was an negative association between B[a]P exposure and the survival of tumor-bearing mice. In addition, B[a]P-treated HCC cells recruited vascular endothelial cells and promoted tumor angiogenesis, possibly through elevating vascular endothelial growth factor secretion. Furthermore, the NF-kappa B pathway may be an adverse outcome pathway associated with the cumulative effects of B[a]P on HCC metastasis.
   CONCLUSIONS: These findings a) indicate that B[a]P has effects on HCC progression; b) identify a possible adverse outcome pathway; and c) contribute to a better understanding of the adverse effects of chronic exposure of B[a]P to human health.
C1 [Ba, Qian; Li, Junyang; Huang, Chao; Qiu, Hongling; Li, Jingquan; Chu, Ruiai; Xie, Dong; Wang, Hui] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Key Lab Food Safety Res, Shanghai 200031, Peoples R China.
   [Ba, Qian; Qiu, Hongling; Li, Jingquan; Chu, Ruiai; Xie, Dong; Wu, Yongning; Wang, Hui] Minist Hlth, Key Lab Food Safety Risk Assessment, Beijing, Peoples R China.
   [Zhang, Wei] IIT, Inst Food Safety & Hlth, Bedford Pk, IL USA.
   [Xie, Dong; Wang, Hui] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai, Peoples R China.
RP Wang, H (reprint author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Rm 2204,New Life Bldg A,320 Yueyang Rd, Shanghai 200031, Peoples R China.
EM wuyongning@cfsa.net.cn; huiwang@sibs.ac.cn
OI qiu, hong ling/0000-0002-1658-6865
FU Ministry of Science and Technology of ChinaMinistry of Science and
   Technology, China [2012BAK01B00, 2012CB720804]; National Natural Science
   Foundation of ChinaNational Natural Science Foundation of China
   [81125020, 31200569, 81328022, 31101261]; Key Research Program of the
   Chinese Academy of SciencesChinese Academy of Sciences [KSZD-EW-Z-021,
   KSZD-EW-Z-019]; Science and Technology Commission of Shanghai
   MunicipalityScience & Technology Commission of Shanghai Municipality
   (STCSM) [12431900500, 14391901800, 13ZR1446500]; Food Safety Research
   Center of the Institute for Nutritional Sciences, Shanghai Institutes
   for Biological Sciences, Chinese Academy of Sciences
FX This study was supported by grants from the Ministry of Science and
   Technology of China (2012BAK01B00 and 2012CB720804), the National
   Natural Science Foundation of China (81125020, 31200569, 81328022, and
   31101261), the Key Research Program (KSZD-EW-Z-021 and KSZD-EW-Z-019) of
   the Chinese Academy of Sciences, the Science and Technology Commission
   of Shanghai Municipality (12431900500, 14391901800, and 13ZR1446500),
   and the Food Safety Research Center of the Institute for Nutritional
   Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy
   of Sciences.
CR Adeleye Y, 2015, TOXICOLOGY, V332, P102, DOI 10.1016/j.tox.2014.02.007
   Arnaoutova I, 2010, NAT PROTOC, V5, P628, DOI 10.1038/nprot.2010.6
   Ba Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042703
   Ba Q, 2011, CLIN CANCER RES, V17, P7625, DOI 10.1158/1078-0432.CCR-10-3099
   Benford D, 2010, FOOD CHEM TOXICOL, V48, pS42, DOI 10.1016/j.fct.2009.09.039
   Bhattacharya S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020887
   Bonavida Benjamin, 2011, Critical Reviews in Oncogenesis, V16, P211
   Chen SY, 2002, INT J CANCER, V99, P14, DOI 10.1002/ijc.10291
   Davila DR, 1996, TOXICOL APPL PHARM, V139, P333, DOI 10.1006/taap.1996.0173
   Friesen MC, 2009, CANCER CAUSE CONTROL, V20, P905, DOI 10.1007/s10552-009-9329-8
   GELBOIN HV, 1980, PHYSIOL REV, V60, P1107
   Gibb Steven, 2008, Reprod Toxicol, V25, P136, DOI 10.1016/j.reprotox.2007.10.013
   Gilles C, 2012, IMAGEJ NEWS     1005
   Gunter MJ, 2007, CARCINOGENESIS, V28, P1426, DOI 10.1093/carcin/bgm022
   IARC, 2010, IARC MONOGR EVAL C S, V92, P33
   KITAGAWA T, 1980, TOXICOL LETT, V6, P167
   Li J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021816
   Lindeman TE, 2011, MUTAGENESIS, V26, P629, DOI 10.1093/mutage/ger024
   Mendola P, 2002, MENT RETARD DEV D R, V8, P188, DOI 10.1002/mrdd.10033
   Min LF, 2011, TOXICOL MECH METHOD, V21, P374, DOI 10.3109/15376516.2010.551555
   Neal MS, 2008, REPROD TOXICOL, V25, P100, DOI 10.1016/j.reprotox.2007.10.012
   Phillips DH, 1999, MUTAT RES-GEN TOX EN, V443, P139, DOI 10.1016/S1383-5742(99)00016-2
   PHILLIPS DH, 1983, NATURE, V303, P468, DOI 10.1038/303468a0
   RIVEDAL E, 1981, CANCER RES, V41, P2950
   Rubin H, 2001, CARCINOGENESIS, V22, P1903, DOI 10.1093/carcin/22.12.1903
   Srivastava SK, 2000, CANCER LETT, V153, P35, DOI 10.1016/S0304-3835(00)00333-5
   Srogi K, 2007, ENVIRON CHEM LETT, V5, P169, DOI 10.1007/s10311-007-0095-0
   Su YH, 2014, ANN EPIDEMIOL, V24, P98, DOI 10.1016/j.annepidem.2013.10.019
   TANG DL, 1995, CANCER EPIDEM BIOMAR, V4, P341
   Uka K, 2007, WORLD J GASTROENTERO, V13, P414, DOI 10.3748/wjg.v13.i3.414
   Umannova L, 2011, TOXICOL LETT, V206, P121, DOI 10.1016/j.toxlet.2011.06.029
   Van de Wiele T, 2005, ENVIRON HEALTH PERSP, V113, P6, DOI 10.1289/ehp.7259
   Wang W, 2008, CLIN CANCER RES, V14, P6804, DOI 10.1158/1078-0432.CCR-07-4820
   Wang YH, 2013, J EXP CLIN CANC RES, V32, DOI 10.1186/1756-9966-32-51
   Weis SM, 2011, NAT MED, V17, P1359, DOI 10.1038/nm.2537
   Wills LP, 2010, ENVIRON HEALTH PERSP, V118, P1376, DOI 10.1289/ehp.0901799
   Winnard PT, 2008, J NUCL MED, V49, p96S, DOI 10.2967/jnumed.107.045948
   WOLTERBEEK APM, 1995, CANCER LETT, V89, P107, DOI 10.1016/0304-3835(95)90165-5
   Wu HC, 2007, CANCER LETT, V252, P104, DOI 10.1016/j.canlet.2006.12.010
NR 39
TC 30
Z9 30
U1 1
U2 16
PU US DEPT HEALTH HUMAN SCIENCES PUBLIC HEALTH SCIENCE
PI RES TRIANGLE PK
PA NATL INST HEALTH, NATL INST ENVIRONMENTAL HEALTH SCIENCES, PO BOX 12233,
   RES TRIANGLE PK, NC 27709-2233 USA
SN 0091-6765
EI 1552-9924
J9 ENVIRON HEALTH PERSP
JI Environ. Health Perspect.
PD MAR
PY 2015
VL 123
IS 3
BP 246
EP 254
DI 10.1289/ehp.1408524
PG 9
WC Environmental Sciences; Public, Environmental & Occupational Health;
   Toxicology
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health; Toxicology
GA CE9MK
UT WOS:000352167900015
PM 25325763
OA DOAJ Gold, Green Published
DA 2019-10-23
ER

PT J
AU Urbisch, D
   Mehling, A
   Guth, K
   Ramirez, T
   Honarvar, N
   Kolle, S
   Landsiedel, R
   Jaworska, J
   Kern, PS
   Gerberick, F
   Natsch, A
   Emter, R
   Ashikaga, T
   Miyazawa, M
   Sakaguchi, H
AF Urbisch, Daniel
   Mehling, Annette
   Guth, Katharina
   Ramirez, Tzutzuy
   Honarvar, Naveed
   Kolle, Susanne
   Landsiedel, Robert
   Jaworska, Joanna
   Kern, Petra S.
   Gerberick, Frank
   Natsch, Andreas
   Emter, Roger
   Ashikaga, Takao
   Miyazawa, Masaaki
   Sakaguchi, Hitoshi
TI Assessing skin sensitization hazard in mice and men using non-animal
   test methods
SO REGULATORY TOXICOLOGY AND PHARMACOLOGY
LA English
DT Article
DE Skin sensitization; Allergic contact dermatitis (ACD); Adverse outcome
   pathway (AOP); DPRA; KeratinoSens (TM); LuSens; h-CLAT; (modified)
   MUSST; Database; Integrated testing strategy (ITS)
ID LYMPH-NODE ASSAY; APPLICABILITY DOMAIN CLASSIFICATION; IN-VITRO METHODS;
   TEST H-CLAT; CONTACT ALLERGENS; MAXIMIZATION TEST; GUINEA-PIG;
   CHEMICALS; IDENTIFICATION; POTENCY
AB Sensitization, the prerequisite event in the development of allergic contact dermatitis, is a key parameter in both hazard and risk assessments. The pathways involved have recently been formally described in the OECD adverse outcome pathway (AOP) for skin sensitization. One single non-animal test method will not be sufficient to fully address this AOP and in many cases the use of a battery of tests will be necessary. A number of methods are now fully developed and validated. In order to facilitate acceptance of these methods by both the regulatory and scientific communities, results of the single test methods (DPRA, KeratinoSens (TM), LuSens, h-CLAT, (m)MUSST) as well for a the simple '2 out of 3' ITS for 213 substances have been compiled and qualitatively compared to both animal and human data. The dataset was also used to define different mechanistic domains by probable protein-binding mechanisms. In general, the non-animal test methods exhibited good predictivities when compared to local lymph node assay (LLNA) data and even better predictivities when compared to human data. The '2 out of 3' prediction model achieved accuracies of 90% or 79% when compared to human or LLNA data, respectively and thereby even slightly exceeded that of the LLNA. (C) 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
C1 [Urbisch, Daniel; Guth, Katharina; Ramirez, Tzutzuy; Honarvar, Naveed; Kolle, Susanne; Landsiedel, Robert] BASF SE, Expt Toxicol & Ecol, Ludwigshafen, Germany.
   [Mehling, Annette] BASF Personal Care & Nutr GmbH, Dusseldorf, Germany.
   [Jaworska, Joanna] Procter & Gamble NV, B-1853 Strombeek Bever, Belgium.
   [Kern, Petra S.] Procter & Gamble Technol Beijing Co Ltd, Beijing, Peoples R China.
   [Gerberick, Frank] Procter & Gamble Co, Cincinnati, OH USA.
   [Natsch, Andreas; Emter, Roger] Givaudan Schweiz AG, CH-8600 Dubendorf, Switzerland.
   [Ashikaga, Takao] Shiseido Co Ltd, Shiseido Res Ctr, Tsuzuki Ku, Yokohama, Kanagawa 2248558, Japan.
   [Miyazawa, Masaaki; Sakaguchi, Hitoshi] Kao Corp, Safety Sci Res Labs, Haga, Tochigi 321349, Japan.
RP Landsiedel, R (reprint author), BASF SE, Expt Toxicol & Ecol, Ludwigshafen, Germany.
EM robert.landsiedel@basf.com
RI ; Landsiedel, Robert/D-1960-2012
OI Natsch, Andreas/0000-0003-2231-2489; Landsiedel,
   Robert/0000-0003-3756-1904
CR Ade Nadege, 2006, J Immunotoxicol, V3, P189, DOI 10.1080/15476910600978038
   Angers-Loustau A, 2011, REGUL TOXICOL PHARM, V60, P300, DOI 10.1016/j.yrtph.2011.04.006
   Aptula AO, 2005, CHEM RES TOXICOL, V18, P1420, DOI 10.1021/tx050075m
   Aptula AO, 2007, CONTACT DERMATITIS, V56, P54, DOI 10.1111/j.1600-0536.2007.00944.x
   Aptula AO, 2009, CHEM RES TOXICOL, V22, P1541, DOI [10.1021/tx9000330, 10.1021/tx9000336]
   Ashikaga T, 2006, TOXICOL IN VITRO, V20, P767, DOI 10.1016/j.tiv.2005.10.012
   Ball N, 2011, REGUL TOXICOL PHARM, V60, P389, DOI 10.1016/j.yrtph.2011.05.007
   Basketter D, 2013, REGUL TOXICOL PHARM, V67, P531, DOI 10.1016/j.yrtph.2013.10.002
   Basketter DA, 2006, CONTACT DERMATITIS, V55, P268, DOI 10.1111/j.1600-0536.2006.00930.x
   Basketter DA, 2014, DERMATITIS, V25, P11, DOI 10.1097/DER.0000000000000003
   Bauch C, 2012, REGUL TOXICOL PHARM, V63, P489, DOI 10.1016/j.yrtph.2012.05.013
   Bauch C, 2011, TOXICOL IN VITRO, V25, P1162, DOI 10.1016/j.tiv.2011.05.030
   Bruckner AL, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.1.e3
   COOPER JA, 1979, BRIT J CANCER, V39, P87, DOI 10.1038/bjc.1979.10
   Dearman RJ, 2013, J APPL TOXICOL, V33, P558, DOI 10.1002/jat.1758
   Emter R, 2013, TOXICOL IN VITRO, V27, P2225, DOI 10.1016/j.tiv.2013.09.009
   Emter R, 2010, TOXICOL APPL PHARM, V245, P281, DOI 10.1016/j.taap.2010.03.009
   Fabian E, 2013, ARCH TOXICOL, V87, P1683, DOI 10.1007/s00204-013-1090-9
   FOUSSEREAU J, 1983, CONTACT DERMATITIS, V9, P233, DOI 10.1111/j.1600-0536.1983.tb04373.x
   Gerberick F, 2008, ATLA-ALTERN LAB ANIM, V36, P215, DOI 10.1177/026119290803600210
   Gerberick GF, 2005, DERMATITIS, V16, P157, DOI 10.2310/6620.2005.05040
   Gerberick GF, 2004, TOXICOL SCI, V81, P332, DOI 10.1093/toxsci/kfh213
   Goebel C, 2012, REGUL TOXICOL PHARM, V63, P40, DOI 10.1016/j.yrtph.2012.02.007
   Griem P, 2003, REGUL TOXICOL PHARM, V38, P269, DOI 10.1016/j.yrtph.2003.07.001
   Hoffmann S., 2014, ALTEX P, V3
   Jackh C, 2012, J IMMUNOTOXICOL, V9, P426, DOI 10.3109/1547691X.2012.664578
   Jaworska J, 2013, J APPL TOXICOL, V33, P1353, DOI 10.1002/jat.2869
   Karlberg AT, 2013, CONTACT DERMATITIS, V69, P323, DOI 10.1111/cod.12127
   Kinsner-Ovaskainen A, 2012, ATLA-ALTERN LAB ANIM, V40, P175, DOI 10.1177/026119291204000310
   KLIGMAN AM, 1966, J INVEST DERMATOL, V47, P375, DOI 10.1038/jid.1966.159
   KLIGMAN AM, 1966, J INVEST DERMATOL, V47, P393, DOI 10.1038/jid.1966.160
   Kolle SN, 2013, REGUL TOXICOL PHARM, V65, P278, DOI 10.1016/j.yrtph.2012.12.006
   LoPachin RM, 2014, CHEM RES TOXICOL, V27, P1081, DOI 10.1021/tx5001046
   Mehling A, 2012, ARCH TOXICOL, V86, P1273, DOI 10.1007/s00204-012-0867-6
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Natsch A., TOXICOL SCI
   Natsch A, 2008, TOXICOL SCI, V102, P110, DOI 10.1093/toxsci/kfm259
   Natsch A, 2013, J APPL TOXICOL, V33, P1337, DOI 10.1002/jat.2868
   Natsch A, 2011, TOXICOL IN VITRO, V25, P733, DOI 10.1016/j.tiv.2010.12.014
   Nukada Y, 2013, TOXICOL IN VITRO, V27, P609, DOI 10.1016/j.tiv.2012.11.006
   Nukada Y, 2012, TOXICOL IN VITRO, V26, P1150, DOI 10.1016/j.tiv.2012.07.001
   Oesch F, 2014, ARCH TOXICOL, V88, P2135, DOI 10.1007/s00204-014-1382-8
   Patlewicz G, 2001, CONTACT DERMATITIS, V44, P331, DOI 10.1034/j.1600-0536.2001.044006331.x
   Patlewicz G, 2008, CHEM RES TOXICOL, V21, P521, DOI 10.1021/tx700338q
   Ramirez T, 2014, TOXICOL IN VITRO, V28, P1482, DOI 10.1016/j.tiv.2014.08.002
   Raunio H, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00033
   Roberts DW, 2014, CHEM RES TOXICOL, V27, P240, DOI 10.1021/tx400355n
   Roberts DW, 2007, CHEM RES TOXICOL, V20, P1019, DOI 10.1021/tx700024w
   Roberts DW, 2007, CHEM RES TOXICOL, V20, P44, DOI 10.1021/tx060121y
   Rovida C., 2014, INTEGRATED TESTING S
   Rudback J, 2014, CONTACT DERMATITIS, V70, P329, DOI 10.1111/cod.12234
   Schmidt M, 2010, NAT IMMUNOL, V11, P814, DOI 10.1038/ni.1919
   Schneider K, 2004, REGUL TOXICOL PHARM, V39, P245, DOI 10.1016/j.yrtph.2004.02.002
   Schnuch A, 2011, CONTACT DERMATITIS, V65, P167, DOI 10.1111/j.1600-0536.2011.01939.x
   Teubner W, 2013, REGUL TOXICOL PHARM, V67, P468, DOI 10.1016/j.yrtph.2013.09.007
   Thyssen JP, 2007, CONTACT DERMATITIS, V57, P287, DOI 10.1111/j.1600-0536.2007.01220.x
   Tsujita-Inoue K, 2014, TOXICOL IN VITRO, V28, P626, DOI 10.1016/j.tiv.2014.01.003
   van der Veen JW, 2014, REGUL TOXICOL PHARM, V69, P371, DOI 10.1016/j.yrtph.2014.04.018
NR 58
TC 108
Z9 110
U1 3
U2 28
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0273-2300
EI 1096-0295
J9 REGUL TOXICOL PHARM
JI Regul. Toxicol. Pharmacol.
PD MAR
PY 2015
VL 71
IS 2
BP 337
EP 351
DI 10.1016/j.yrtph.2014.12.008
PG 15
WC Medicine, Legal; Pharmacology & Pharmacy; Toxicology
SC Legal Medicine; Pharmacology & Pharmacy; Toxicology
GA CC7FH
UT WOS:000350532600026
PM 25541156
OA Other Gold
HC Y
HP N
DA 2019-10-23
ER

PT J
AU Ramirez, T
   Aumann, A
   Stein, N
   Wohrle, T
   Fehr, M
   Edwards, A
   Burleson, F
   Ryan, C
   Foertsch, L
   Wang, X
   Gerberick, F
   Norman, KG
   Mehling, A
   van Ravenzwaay, B
   Landsiedel, R
AF Ramirez, T.
   Aumann, A.
   Stein, N.
   Woehrle, T.
   Fehr, M.
   Edwards, A.
   Burleson, F.
   Ryan, C.
   Foertsch, L.
   Wang, X.
   Gerberick, F.
   Norman, K. G.
   Mehling, A.
   van Ravenzwaay, B.
   Landsiedel, R.
TI Intra- and Interlaboratory validation of the LuSens assay - an ARE-Nrf2
   luciferase based reporter gene assay for the detection of sensitizers
SO NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
LA English
DT Meeting Abstract
CT 81st Annual Meeting of the
   Deutsche-Gesellschaft-fur-Experimentelle-und-Klinische-Pharmakologie-und
   -Toxikologie-e-V
CY MAR 10-12, 2015
CL Kiel, GERMANY
SP Deutsch Gesell Experimentelle & Klinische Pharmakologie & Pharmakologie e V
ID SKIN SENSITIZATION; TESTING STRATEGIES
C1 [Ramirez, T.; Aumann, A.; Stein, N.; van Ravenzwaay, B.; Landsiedel, R.] BASF SE, Expt Toxicol & Ecol, Ludwigshafen, Germany.
   [Woehrle, T.; Fehr, M.] DSM Nutr Prod, Human Nutr & Hlth, Prod Safety, Dubendorf, Switzerland.
   [Edwards, A.; Burleson, F.] BRT Burleson Res Technol, Morrisville, NC USA.
   [Ryan, C.; Foertsch, L.; Wang, X.; Gerberick, F.] Procter & Gamble Co, Mason, OH USA.
   [Norman, K. G.] Inst In Vitro Sci, Gaithersburg, MD USA.
   [Mehling, A.] Personal Care & Nutr GmbH, Dusseldorf, Germany.
CR Basketter D, 2013, REGUL TOXICOL PHARM, V67, P531, DOI 10.1016/j.yrtph.2013.10.002
   Bauch C, 2012, REGUL TOXICOL PHARM, V63, P489, DOI 10.1016/j.yrtph.2012.05.013
   Mehling A, 2012, ARCH TOXICOL, V86, P1273, DOI 10.1007/s00204-012-0867-6
   Patlewicz G, 2014, REGUL TOXICOL PHARM, V69, P529, DOI 10.1016/j.yrtph.2014.06.001
   Ramirez T, 2014, TOXICOL IN VITRO, V28, P1482, DOI 10.1016/j.tiv.2014.08.002
   Rovida C., 2014, INTEGRATED TESTING S
NR 6
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0028-1298
EI 1432-1912
J9 N-S ARCH PHARMACOL
JI Naunyn-Schmiedebergs Arch. Pharmacol.
PD FEB
PY 2015
VL 388
SU 1
MA 305
BP S77
EP S77
PG 1
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA CP0AV
UT WOS:000359539100306
DA 2019-10-23
ER

PT J
AU Urbisch, D
   Honarvar, N
   Kolle, S
   Guth, K
   Mehling, A
   Natsch, A
   Jaworska, J
   Miyazawa, M
   Ashikaga, T
   Landsiedel, R
AF Urbisch, D.
   Honarvar, N.
   Kolle, S.
   Guth, K.
   Mehling, A.
   Natsch, A.
   Jaworska, J.
   Miyazawa, M.
   Ashikaga, T.
   Landsiedel, R.
TI Assessing skin sensitization hazard in mice and men using non-animal
   test methods
SO NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
LA English
DT Meeting Abstract
CT 81st Annual Meeting of the
   Deutsche-Gesellschaft-fur-Experimentelle-und-Klinische-Pharmakologie-und
   -Toxikologie-e-V
CY MAR 10-12, 2015
CL Kiel, GERMANY
SP Deutsch Gesell Experimentelle & Klinische Pharmakologie & Pharmakologie e V
C1 [Urbisch, D.; Honarvar, N.; Kolle, S.; Guth, K.; Mehling, A.; Landsiedel, R.] BASF SE, Expt Toxicol & Ecol, Ludwigshafen, Germany.
   [Natsch, A.] Givaudan Schweiz AG, Dubendorf, Switzerland.
   [Jaworska, J.] Procter & Gamble Co, Bever, Belgium.
   [Miyazawa, M.] Kao Corp, Safety Sci Res Labs, Haga, Japan.
   [Ashikaga, T.] Shiseido Co Ltd, Shiseido Res Ctr, Yokohama, Kanagawa, Japan.
CR Basketter D, 2013, REGUL TOXICOL PHARM, V67, P531, DOI 10.1016/j.yrtph.2013.10.002
   Bauch C, 2011, TOXICOL IN VITRO, V25, P1162, DOI 10.1016/j.tiv.2011.05.030
   Mehling A, 2012, ARCH TOXICOL, V86, P1273, DOI 10.1007/s00204-012-0867-6
NR 3
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0028-1298
EI 1432-1912
J9 N-S ARCH PHARMACOL
JI Naunyn-Schmiedebergs Arch. Pharmacol.
PD FEB
PY 2015
VL 388
SU 1
MA 306
BP S77
EP S77
PG 1
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA CP0AV
UT WOS:000359539100307
DA 2019-10-23
ER

PT J
AU Steinmetz, FP
   Mellor, CL
   Meinl, T
   Cronin, MTD
AF Steinmetz, F. P.
   Mellor, C. L.
   Meinl, T.
   Cronin, M. T. D.
TI Screening Chemicals for Receptor-Mediated Toxicological and
   Pharmacological Endpoints: Using Public Data to Build Screening Tools
   within a KNIME Workflow
SO MOLECULAR INFORMATICS
LA English
DT Article
DE Predictive toxicology; Drug discovery; Screening with KNIME;
   Receptor-mediated toxicity; Retinoids
ID ADVERSE OUTCOME PATHWAY; TRANS-RETINOIC ACID; BINDING; FRAMEWORK;
   KINETICS; DESIGN; READ
AB Assessing compounds for their pharmacological and toxicological properties is of great importance for industry and regulatory agencies. In this study an approach using open source software and open access databases to build screening tools for receptor-mediated effects is presented. The retinoic acid receptor (RAR), as a pharmacologically and toxicologically relevant target, was chosen for this study. RAR agonists are used in the treatment of a number of dermal conditions and specific types of cancer, such as acute promyelocytic leukemia. However, when administered chronically, there is strong evidence that RAR agonists cause hepatosteatosis and liver injury. After compiling information on ligand-protein-interactions, common substructures and physico-chemical properties of ligands were identified manually and coded into SMARTS strings. Based on these SMARTS strings and calculated physico-chemical features, a rule-based screening workflow was built within the KNIME platform. The workflow was evaluated on two datasets: one with RAR agonists exclusively and another large, chemically diverse dataset containing only a few RAR agonists. Possible modifications and applications of screening workflows, dependent on their purpose, are presented.
C1 [Steinmetz, F. P.; Mellor, C. L.; Cronin, M. T. D.] Liverpool John Moores Univ, Sch Pharm & Chem, Liverpool L3 3AF, Merseyside, England.
   [Meinl, T.] KNIME Com AG, CH-8005 Zurich, Switzerland.
RP Cronin, MTD (reprint author), Liverpool John Moores Univ, Sch Pharm & Chem, Byrom St, Liverpool L3 3AF, Merseyside, England.
EM M.T.Cronin@ljmu.ac.uk
FU European UnionEuropean Union (EU) [266835]; Cosmetics Europe
FX The research leading to these results has received funding from the
   European Union Seventh Framework Programme (FP7/2007-2013) COSMOS
   Project under Grant Agreement no 266835 and Cosmetics Europe.
CR ADAMS J, 1993, NEUROTOXICOL TERATOL, V15, P193, DOI 10.1016/0892-0362(93)90015-G
   Alizadeh F, 2014, INT IMMUNOPHARMACOL, V18, P43, DOI 10.1016/j.intimp.2013.10.027
   ALLEN JG, 1989, PHARMACOL THERAPEUT, V40, P1, DOI 10.1016/0163-7258(89)90071-5
   Allen TEH, 2014, CHEM RES TOXICOL, V27, P2100, DOI 10.1021/tx500345j
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   [Anonymous], 2013, KNIME NEWSLETTER
   Beard RL, 2002, BIOORG MED CHEM LETT, V12, P3145, DOI 10.1016/S0960-894X(02)00647-9
   Bento A. P., 2013, NUCLEIC ACIDS RES, V42, P1
   Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235
   Berthold M., 2007, KONSTANZ INFORM MINE, P1
   BIESALSKI HK, 1989, TOXICOLOGY, V57, P117, DOI 10.1016/0300-483X(89)90161-3
   Blackburn K, 2014, REGUL TOXICOL PHARM, V68, P353, DOI 10.1016/j.yrtph.2014.01.004
   CAMPBELL TJ, 1983, BRIT J PHARMACOL, V80, P33, DOI 10.1111/j.1476-5381.1983.tb11046.x
   COOPER JA, 1979, BRIT J CANCER, V39, P87, DOI 10.1038/bjc.1979.10
   Cronin MTD, 2013, TOXICOL LETT, V221, pS52, DOI 10.1016/j.toxlet.2013.06.190
   Czodrowski P, 2013, J CHEM INF MODEL, V53, P2240, DOI 10.1021/ci400308z
   Davis AM, 2004, CURR OPIN CHEM BIOL, V8, P378, DOI 10.1016/j.cbpa.2004.06.005
   DICKEN CH, 1984, J AM ACAD DERMATOL, V11, P541, DOI 10.1016/S0190-9622(84)70204-0
   ELMANSOURI S, 1995, DRUG METAB DISPOS, V23, P227
   Enoch SJ, 2011, CRIT REV TOXICOL, V41, P783, DOI 10.3109/10408444.2011.598141
   Fourches D, 2010, CHEM RES TOXICOL, V23, P171, DOI 10.1021/tx900326k
   Gutsell S, 2013, TOXICOL RES-UK, V2, P299, DOI 10.1039/c3tx50024a
   Johnson AT, 1999, BIOORG MED CHEM LETT, V9, P573, DOI 10.1016/S0960-894X(99)00047-5
   Klaholz BP, 2000, J MOL BIOL, V302, P155, DOI 10.1006/jmbi.2000.4032
   Kolsek K, 2014, J CHEM INF MODEL, V54, P1254, DOI 10.1021/ci400649p
   Leyden JJ, 2005, CLIN THER, V27, P216, DOI 10.1016/j.clinthera.2005.02.009
   Liu ZJ, 2014, SUBCELL BIOCHEM, V70, P203, DOI 10.1007/978-94-017-9050-5_10
   Moya M, 2010, CHEM-BIOL INTERACT, V184, P376, DOI 10.1016/j.cbi.2010.01.008
   Nettles KW, 2007, EMBO REP, V8, P563, DOI 10.1038/sj.embor.7400963
   Organisation for Economic Co-operation and Development, 2014, GUID GROUP CHEM
   Organisation for Economic Co-operation and Development, 2012, COLL WORK DEF
   Patlewicz G, 2013, REGUL TOXICOL PHARM, V67, P1, DOI 10.1016/j.yrtph.2013.06.002
   Richarz A.-N., 2013, TOXICOL LETT, V221, P81
   Saubern S, 2011, MOL INFORM, V30, P847, DOI 10.1002/minf.201100076
   Schinke C, 2010, LEUKEMIA LYMPHOMA, V51, P1108, DOI 10.3109/10428191003786766
   SHALITA AR, 1988, J AM ACAD DERMATOL, V19, P197, DOI 10.1016/S0190-9622(88)70164-4
   Tollefsen KE, 2014, REGUL TOXICOL PHARM, V70, P629, DOI 10.1016/j.yrtph.2014.09.009
   Vaz B, 2012, EXPERT OPIN DRUG DIS, V7, P1003, DOI 10.1517/17460441.2012.722992
   Vinken M, 2013, TOXICOL SCI, V136, P97, DOI 10.1093/toxsci/kft177
   Zhu H, 2014, CHEM RES TOXICOL, V27, P1643, DOI 10.1021/tx500145h
NR 40
TC 17
Z9 17
U1 1
U2 19
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1868-1743
EI 1868-1751
J9 MOL INFORM
JI Mol. Inf.
PD FEB
PY 2015
VL 34
IS 2-3
BP 171
EP 178
DI 10.1002/minf.201400188
PG 8
WC Chemistry, Medicinal; Computer Science, Interdisciplinary Applications;
   Mathematical & Computational Biology
SC Pharmacology & Pharmacy; Computer Science; Mathematical & Computational
   Biology
GA CC6LB
UT WOS:000350475300010
PM 27490039
OA Green Accepted
DA 2019-10-23
ER

PT J
AU Rouquie, D
   Heneweer, M
   Botham, J
   Ketelslegers, H
   Markell, L
   Pfister, T
   Steiling, W
   Strauss, V
   Hennes, C
AF Rouquie, David
   Heneweer, Marjoke
   Botham, Jane
   Ketelslegers, Hans
   Markell, Lauren
   Pfister, Thomas
   Steiling, Winfried
   Strauss, Volker
   Hennes, Christa
TI Contribution of new technologies to characterization and prediction of
   adverse effects
SO CRITICAL REVIEWS IN TOXICOLOGY
LA English
DT Review
DE adverse effect; in vitro testing; mode of action; omics; predictive
   toxicology
ID HUMAN RELEVANCE ANALYSIS; GENE-EXPRESSION CHANGES; EMBRYONIC STEM-CELLS;
   IN-VITRO; RISK-ASSESSMENT; DEVELOPMENTAL TOXICITY; TRANSCRIPTOMIC
   ALTERATIONS; METABOLOMICS APPROACH; CONCEPTUAL-FRAMEWORK; TESTICULAR
   TOXICITY
AB Identification of the potential hazards of chemicals has traditionally relied on studies in laboratory animals where changes in clinical pathology and histopathology compared to untreated controls defined an adverse effect. In the past decades, increased consistency in the definition of adversity with chemically-induced effects in laboratory animals, as well as in the assessment of human relevance has been reached. More recently, a paradigm shift in toxicity testing has been proposed, mainly driven by concerns over animal welfare but also thanks to the development of new methods. Currently, in vitro approaches, toxicogenomic technologies and computational tools, are available to provide mechanistic insight in toxicological Mode of Action (MOA) of the adverse effects observed in laboratory animals. The vision described as Tox21c (Toxicity Testing in the 21st century) aims at predicting in vivo toxicity using a bottom-up-approach, starting with understanding of MOA based on in vitro data to ultimately predict adverse effects in humans. At present, a practical application of the Tox21c vision is still far away. While moving towards toxicity prediction based on in vitro data, a stepwise reduction of in vivo testing is foreseen by combining in vitro with in vivo tests. Furthermore, newly developed methods will also be increasingly applied, in conjunction with established methods in order to gain trust in these new methods. This confidence is based on a critical scientific prerequisite: the establishment of a causal link between data obtained with new technologies and adverse effects manifested in repeated-dose in vivo toxicity studies. It is proposed to apply the principles described in the WHO/IPCS framework of MOA to obtain this link. Finally, an international database of known MOAs obtained in laboratory animals using data-rich chemicals will facilitate regulatory acceptance and could further help in the validation of the toxicity pathway and adverse outcome pathway concepts.
C1 [Rouquie, David] Bayer CropSci, Sophia Antipolis, France.
   [Heneweer, Marjoke] Shell Int BV, The Hague, Netherlands.
   [Botham, Jane] Syngenta, Jealotts Hill, England.
   [Ketelslegers, Hans] ExxonMobil, Petr & Chem Bvba, Brussels, Belgium.
   [Markell, Lauren] DuPont Haskell Global Ctr Hlth & Environm Sci, Newark, DE USA.
   [Pfister, Thomas] F Hoffmann La Roche, Basel, Switzerland.
   [Steiling, Winfried] Henkel AG & Co KGaA, Dusseldorf, Germany.
   [Strauss, Volker] BASF SE, Ludwigshafen, Germany.
   [Hennes, Christa] European Ctr Ecotoxicol & Toxicol Chem, Brussels, Belgium.
RP Rouquie, D (reprint author), Bayer SAS Bayer CropSci, 355 Rue Dostoievski,CS 90153, F-06906 Sophia Antipolis, France.
EM david.rouquie@bayer.com
OI Strauss, Volker/0000-0001-7363-9663
CR Adler S, 2008, TOXICOL IN VITRO, V22, P200, DOI 10.1016/j.tiv.2007.07.013
   Andersen ME, 2008, TOXICOL SCI, V105, P368, DOI 10.1093/toxsci/kfn097
   Andersen ME, 2010, TOXICOL SCI, V117, P17, DOI 10.1093/toxsci/kfq188
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   [Anonymous], 2004, OECD GUID TEST CHEM
   Aylward LL, 2011, J APPL TOXICOL, V31, P741, DOI 10.1002/jat.1626
   Balcke GU, 2011, TOXICOL LETT, V203, P200, DOI 10.1016/j.toxlet.2011.03.013
   Barrila J, 2010, NAT REV MICROBIOL, V8, P791, DOI 10.1038/nrmicro2423
   Bauch C, 2012, REGUL TOXICOL PHARM, V63, P489, DOI 10.1016/j.yrtph.2012.05.013
   Beyer RP, 2007, TOXICOL SCI, V99, P326, DOI 10.1093/toxsci/kfm150
   Blaauboer BJ, 2012, ALTEX-ALTERN ANIM EX, V29, P411, DOI 10.14573/altex.2012.4.411
   Blaauboer BJ, 2010, J TOXICOL ENV HEAL B, V13, P242, DOI 10.1080/10937404.2010.483940
   Blaauboer BJ, 1999, ATLA-ALTERN LAB ANIM, V27, P229, DOI 10.1177/026119299902700211
   Black MB, 2012, TOXICOL SCI, V127, P199, DOI 10.1093/toxsci/kfs069
   Boekelheide K, 2010, TOXICOL SCI, V114, P20, DOI 10.1093/toxsci/kfp307
   Boobis AR, 2006, CRIT REV TOXICOL, V36, P781, DOI 10.1080/10408440600977677
   Budinsky RA, 2014, CRIT REV TOXICOL, V44, P83, DOI 10.3109/10408444.2013.835787
   Bus JS, 2009, TOXICOL SCI, V112, P297, DOI 10.1093/toxsci/kfp234
   Bushel PR, 2007, P NATL ACAD SCI USA, V104, P18211, DOI 10.1073/pnas.0706987104
   Casciano DA, 2012, ADV EXP MED BIOL, V745, P210, DOI 10.1007/978-1-4614-3055-1_12
   Coecke S, 2006, ATLA-ALTERN LAB ANIM, V34, P49, DOI 10.1177/026119290603400113
   Corton JC, 2014, CRIT REV TOXICOL, V44, P1, DOI 10.3109/10408444.2013.835784
   Cunningham ML, 2003, ENVIRON HEALTH PERSP, V111, pA814, DOI 10.1289/ehp.111-a814
   ECETOC, 2008, 11 ECETOC
   ECETOC, 2013, 25 ECETOC
   ECETOC, 2010, 19 ECETOC
   ECETOC, 2002, 85 ECETOC
   ECETOC, 2006, 99 ECETOC
   *EDSTAC, 1998, EDSTAC FIN REP
   Elcombe CR, 2014, CRIT REV TOXICOL, V44, P64, DOI 10.3109/10408444.2013.835786
   Ellinger-Ziegelbauer H, 2005, MUTAT RES-FUND MOL M, V575, P61, DOI 10.1016/j.mrfmmm.2005.02.004
   Ellinger-Ziegelbauer H, 2008, MUTAT RES-FUND MOL M, V637, P23, DOI 10.1016/j.mrfmmm.2007.06.010
   Fannin RD, 2010, HEPATOLOGY, V51, P227, DOI 10.1002/hep.23330
   Forsby A, 2007, HUM EXP TOXICOL, V26, P333, DOI 10.1177/0960327106072994
   Gant Timothy W., 2003, Environmental Health Perspectives, V111, P37
   Groothuis FA, 2015, TOXICOLOGY, V332, P30, DOI 10.1016/j.tox.2013.08.012
   Gubbels-van Hal WMLG, 2005, REGUL TOXICOL PHARM, V42, P284, DOI 10.1016/j.yrtph.2005.05.002
   Hamadeh HK, 2004, MUTAT RES-FUND MOL M, V549, P169, DOI 10.1016/j.mrfmmm.2003.12.021
   Hamadeh HK, 2002, TOXICOL PATHOL, V30, P470, DOI 10.1080/01926230290105712
   Harrill JA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-546
   Heinloth AN, 2004, TOXICOL SCI, V80, P193, DOI 10.1093/toxsci/kfh145
   HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503
   Hoffmann D, 2010, TOXICOL SCI, V116, P8, DOI 10.1093/toxsci/kfq029
   Huh D, 2011, TRENDS CELL BIOL, V21, P745, DOI 10.1016/j.tcb.2011.09.005
   Jennen D, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-139
   Jennings P, 2012, ARCH TOXICOL, V86, P571, DOI 10.1007/s00204-011-0780-4
   Juberg DR, 2014, ALTEX-ALTERN ANIM EX, V31, P63, DOI 10.14573/altex.1309171
   Judson RS, 2010, ENVIRON HEALTH PERSP, V118, P485, DOI 10.1289/ehp.0901392
   Jung J, 2011, TOXICOL LETT, V200, P1, DOI 10.1016/j.toxlet.2010.09.020
   Kavlock R, 2012, CHEM RES TOXICOL, V25, P1287, DOI 10.1021/tx3000939
   Keller DA, 2012, TOXICOL SCI, V126, P291, DOI 10.1093/toxsci/kfr350
   Kleinstreuer NC, 2011, TOXICOL APPL PHARM, V257, P111, DOI 10.1016/j.taap.2011.08.025
   Kolle SN, 2012, REGUL TOXICOL PHARM, V63, P259, DOI 10.1016/j.yrtph.2012.04.004
   Kramer NI, 2012, CHEM RES TOXICOL, V25, P436, DOI 10.1021/tx200479k
   Kramer NI, 2010, CHEM RES TOXICOL, V23, P1806, DOI 10.1021/tx1002595
   Lewis RW, 2013, CRIT REV TOXICOL, V43, P185, DOI 10.3109/10408444.2013.764279
   Lobenhofer EK, 2004, TOXICOL PATHOL, V32, P482, DOI 10.1080/01926230490483324
   Louisse J, 2014, ARCH TOXICOL
   Louisse J, 2010, TOXICOL SCI, V118, P470, DOI 10.1093/toxsci/kfq270
   Ludwig S, 2011, TOXICOL SCI, V122, P52, DOI 10.1093/toxsci/kfr099
   Matheis KA, 2011, TOXICOL APPL PHARM, V252, P112, DOI 10.1016/j.taap.2010.11.006
   Meek ME, 2014, J APPL TOXICOL, V34, P1, DOI 10.1002/jat.2949
   Meek ME, 2014, J APPL TOXICOL, V34, P595, DOI 10.1002/jat.2984
   Meek ME, 2003, CRIT REV TOXICOL, V33, P591, DOI 10.1080/10408440390250136
   Moggs JG, 2004, ENVIRON HEALTH PERSP, V112, P1589, DOI 10.1289/ehp.7345
   Murk AJ, 2013, TOXICOL IN VITRO, V27, P1320, DOI 10.1016/j.tiv.2013.02.012
   NRC (National Research Council), 2007, TOX TEST 21 CENT VIS
   OECD, 2013, GUID TEST CHEM 437 B
   OECD, 2012, PROP TEMPL GUID DEV
   Paules R, 2003, ENVIRON HEALTH PERSP, V111, pA338, DOI 10.1289/ehp.111-a338
   Perla V, 2008, TOXICOL IN VITRO, V22, P515, DOI 10.1016/j.tiv.2007.11.008
   Rotroff D.M., 2012, ENV HLTH PERSPECT, V121, P7
   Rouquie D, 2014, REGUL TOXICOL PHARM, V70, P673, DOI 10.1016/j.yrtph.2014.10.003
   Rouquie D, 2009, TOXICOL SCI, V109, P59, DOI 10.1093/toxsci/kfp056
   Ruiz-Aracama A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-251
   Sawada H, 2005, TOXICOL SCI, V83, P282, DOI 10.1093/toxsci/kfh264
   Schmidt CW, 2003, ENVIRON HEALTH PERSP, V111, pA20, DOI 10.1289/ehp.111-a20
   Sonich-Mullin C, 2001, REGUL TOXICOL PHARM, V34, P146, DOI 10.1006/rtph.2001.1493
   Spielmann H, 1998, TOXICOL IN VITRO, V12, P305, DOI 10.1016/S0887-2333(98)00006-X
   Strigun A, 2011, TOXICOL APPL PHARM, V252, P183, DOI 10.1016/j.taap.2011.02.008
   Sturla SJ, 2014, CHEM RES TOXICOL, V27, P314, DOI 10.1021/tx400410s
   Thomas RS, 2013, TOXICOL SCI, V136, P4, DOI 10.1093/toxsci/kft178
   Thomas RS, 2012, MUTAT RES-GEN TOX EN, V746, P135, DOI 10.1016/j.mrgentox.2012.01.007
   Thomas RS, 2011, TOXICOL SCI, V120, P194, DOI 10.1093/toxsci/kfq355
   Tice RR, 2013, ENVIRON HEALTH PERSP, V121, P756, DOI 10.1289/ehp.1205784
   Tinwell H, 2014, REGUL TOXICOL PHARM, V70, P648, DOI 10.1016/j.yrtph.2014.09.011
   van Dartel DAM, 2009, REPROD TOXICOL, V27, P93, DOI 10.1016/j.reprotox.2008.12.009
   van Ravenzwaay B, 2014, TOXICOL LETT, V227, P20, DOI 10.1016/j.toxlet.2014.03.004
   van Ravenzwaay B, 2012, MUTAT RES-GEN TOX EN, V746, P144, DOI 10.1016/j.mrgentox.2012.01.006
   van Vliet E., 2007, THESIS U KONSTANZ
   Van Vliet E, 2008, NEUROTOXICOLOGY, V29, P1, DOI 10.1016/j.neuro.2007.09.007
   Vandebriel RJ, 2010, TOXICOL SCI, V117, P81, DOI 10.1093/toxsci/kfq182
   Verwei M, 2006, TOXICOL LETT, V165, P79, DOI 10.1016/j.toxlet.2006.01.017
   Vinken M, 2014, ARCH TOXICOL, V88, P1, DOI 10.1007/s00204-013-1093-6
   West PR, 2010, TOXICOL APPL PHARM, V247, P18, DOI 10.1016/j.taap.2010.05.007
   Wilmes A, 2013, J PROTEOMICS, V79, P180, DOI 10.1016/j.jprot.2012.11.022
   Yoon M, 2014, TOXICOL IN VITRO, V28, P164, DOI 10.1016/j.tiv.2013.10.023
NR 97
TC 17
Z9 17
U1 1
U2 36
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1040-8444
EI 1547-6898
J9 CRIT REV TOXICOL
JI Crit. Rev. Toxicol.
PD FEB
PY 2015
VL 45
IS 2
BP 172
EP 183
DI 10.3109/10408444.2014.986054
PG 12
WC Toxicology
SC Toxicology
GA CB5DO
UT WOS:000349647900004
PM 25615431
DA 2019-10-23
ER

PT J
AU Stiegel, MA
   Pleil, JD
   Sobus, JR
   Morgan, MK
   Madden, MC
AF Stiegel, Matthew A.
   Pleil, Joachim D.
   Sobus, Jon R.
   Morgan, Marsha K.
   Madden, Michael C.
TI Analysis of inflammatory cytokines in human blood, breath condensate,
   and urine using a multiplex immunoassay platform
SO BIOMARKERS
LA English
DT Article
DE Breath analysis; cytokines; ecotoxicology; environmental pollution;
   growth factors; immunotoxicity; inflammatory mediators
ID NEURODEGENERATIVE DISEASES; BIOMONITORING DATA; HUMAN EXPOSOME;
   AIR-POLLUTION; TERM EXPOSURE; BIOMARKERS; PROFILES; SUSTAINABILITY;
   SENSITIVITY; PERFORMANCE
AB A change in the expression of cytokines in human biological media indicates an inflammatory response to external stressors and reflects an early step along the adverse outcome pathway (AOP) for various health endpoints. To characterize and interpret this inflammatory response, methodology was developed for measuring a suite of 10 different cytokines in human blood, exhaled breath condensate (EBC), and urine using an electrochemiluminescent multiplex Th1/Th2 cytokine immunoassay platform. Measurement distributions and correlations for eight interleukins (IL) (1b, 2, 4, 5, 8, 10, 12p70 and 13), interferon-gamma (IFN-gamma), and tumor necrosis factor-a (TNF-alpha) were evaluated using 90 blood plasma, 77 EBC, and 400 urine samples collected from nominally healthy adults subjects in North Carolina in 2008-2012. The in vivo results show that there is sufficient sensitivity for characterizing all 10 cytokines at levels of 0.05-0.10 rho g/ml with a dynamic range up to 100 ng/ml across all three of these biological media. The measured in vivo results also show that the duplicate analysis of blood, EBC and urine samples have average estimated fold ranges of 2.21, 3.49, and 2.50, respectively, which are similar to the mean estimated fold range (2.88) for the lowest concentration (0.610 rho g/ml) from a series of spiked control samples; the cytokine method can be used for all three biological media. Nine out of the 10 cytokines measured in EBC were highly correlated within one another with Spearman rho coefficients ranging from 0.679 to 0.852, while the cytokines measured in blood had a mix of negative and positive correlations, ranging from -0.620 to 0.836. Almost all correlations between EBC and blood were positive. This work also represents the first successful within-and between-person evaluation of ultra trace-level inflammatory markers in blood, EBC, and urine.
C1 [Stiegel, Matthew A.] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Environm Sci & Engn, Chapel Hill, NC USA.
   [Pleil, Joachim D.; Sobus, Jon R.; Morgan, Marsha K.] US EPA, Human Exposure & Atmospher Sci Div, Natl Exposure Res Lab, Durham, NC 27709 USA.
   [Madden, Michael C.] US EPA, Environm Publ Hlth Div, Natl Hlth & Environm Effects Res Lab, Durham, NC USA.
RP Pleil, JD (reprint author), US EPA, Human Exposure & Atmospher Sci Div, Natl Exposure Res Lab, Durham, NC 27709 USA.
EM pleil.joachim@epa.gov; sobus.jon@epa.gov
OI Sobus, Jon/0000-0003-0740-6604
CR Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   [Anonymous], 2012, EXP SCI 21 CENT VIS
   Bastarache JA, 2014, J IMMUNOL METHODS, V408, P13, DOI 10.1016/j.jim.2014.04.006
   Bonisch U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039817
   Bomert M, 2011, CLIN CHEM LAB MED, V49, P1691, DOI 10.1515/CCLM.2011.631
   Boonpiyathad S, 2013, ALLERGY ASTHMA PROC, V34, pE35, DOI 10.2500/aap.2013.34.3680
   Campbell A, 2004, ANN NY ACAD SCI, V1035, P117, DOI 10.1196/annals.1332.008
   Candela JV, 1998, UROL RES, V26, P175, DOI 10.1007/s002400050043
   Cannas A, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-333
   Chowdhury F, 2009, J IMMUNOL METHODS, V340, P55, DOI 10.1016/j.jim.2008.10.002
   Chung KF, 1999, THORAX, V54, P825, DOI 10.1136/thx.54.9.825
   Cousins DJ, 2002, J IMMUNOL, V169, P2498, DOI 10.4049/jimmunol.169.5.2498
   DEVLIN RB, 1991, AM J RESP CELL MOL, V4, P72, DOI 10.1165/ajrcmb/4.1.72
   Devlin RB, 2012, CIRCULATION, V126, P104, DOI 10.1161/CIRCULATIONAHA.112.094359
   Duramad P, 2007, TOXICOL LETT, V172, P48, DOI 10.1016/j.toxlet.2007.05.017
   Dybing E, 2004, TOXICOLOGY, V198, P307, DOI 10.1016/j.tox.2004.02.007
   Elenkov IJ, 1999, TRENDS ENDOCRIN MET, V10, P359, DOI 10.1016/S1043-2760(99)00188-5
   Elshal MF, 2006, METHODS, V38, P317, DOI 10.1016/j.ymeth.2005.11.010
   Ghoniem G, 2011, INT UROGYNECOL J, V22, P953, DOI 10.1007/s00192-011-1401-8
   Goldbergova MP, 2012, BIOMARKERS, V17, P655, DOI 10.3109/1354750X.2012.719036
   Jacobs R, 2001, RHEUMATOLOGY, V40, P868, DOI 10.1093/rheumatology/40.8.868
   Kampa M, 2008, ENVIRON POLLUT, V151, P362, DOI 10.1016/j.envpol.2007.06.012
   Koh KB, 2008, BRAIN BEHAV IMMUN, V22, P1130, DOI 10.1016/j.bbi.2008.06.009
   Malekzadeh A, 2012, METHODS, V56, P508, DOI 10.1016/j.ymeth.2012.03.017
   Matsunaga K, 2006, J ALLERGY CLIN IMMUN, V118, P84, DOI 10.1016/j.jaci.2006.04.020
   Meso Scale Discovery, 2012, MSD BIOM ASS HUM TH1
   Murase T, 2013, CLIN CHEM LAB MED, V51, P421, DOI 10.1515/cclm-2012-0330
   Nakamura M, 2014, BIOMARKERS, V19, P368, DOI 10.3109/1354750X.2014.915342
   Ostrowski K, 1998, J PHYSIOL-LONDON, V513, P889, DOI 10.1111/j.1469-7793.1998.889ba.x
   Pleil JD, 2008, J BREATH RES, V2, DOI 10.1088/1752-7155/2/2/026001
   Pleil JD, 2014, J TOXICOL ENV HEAL B, V17, P341, DOI 10.1080/10937404.2014.956854
   Pleil JD, 2013, ANAL CHEM, V85, P9984, DOI 10.1021/ac402306f
   Pleil JD, 2013, J TOXICOL ENV HEAL A, V76, P747, DOI 10.1080/15287394.2013.821394
   Pleil JD, 2012, TOXICOL LETT, V215, P201, DOI 10.1016/j.toxlet.2012.10.011
   Pleil JD, 2012, J TOXICOL ENV HEAL B, V15, P264, DOI 10.1080/10937404.2012.672148
   Pleil JD, 2011, BIOMARKERS, V16, P99, DOI 10.3109/1354750X.2010.541565
   Pleil JD, 2009, BIOMARKERS, V14, P560, DOI 10.3109/13547500903186460
   Pope CA, 2004, CIRCULATION, V109, P71, DOI 10.1161/01.CIR.0000108927.80044.7F
   Rappaport S., 2008, QUANTITATIVE EXPOSUR
   RICHARDS FJ, 1959, J EXP BOT, V10, P290, DOI 10.1093/jxb/10.2.290
   Robroeks CMHHT, 2006, ANN ALLERG ASTHMA IM, V96, P349, DOI 10.1016/S1081-1206(10)61247-1
   Sack U, 2006, CYTOM PART A, V69A, P169, DOI 10.1002/cyto.a.20231
   Salvi S, 1999, AM J RESP CRIT CARE, V159, P702, DOI 10.1164/ajrccm.159.3.9709083
   Perez MJ, 2006, ALCOHOL ALCOHOLISM, V41, P593, DOI 10.1093/alcalc/agl077
   Selgrade M, 2006, TOXICOL SCI, V94, P108, DOI 10.1093/toxsci/kfl094
   Tighe P, 2013, METHODS, V61, P23, DOI 10.1016/j.ymeth.2013.01.003
   van Bussel BCT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058576
   Vinken M, 2013, TOXICOLOGY, V312, P158, DOI 10.1016/j.tox.2013.08.011
NR 48
TC 21
Z9 21
U1 0
U2 34
PU INFORMA HEALTHCARE
PI LONDON
PA TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND
SN 1354-750X
EI 1366-5804
J9 BIOMARKERS
JI Biomarkers
PD FEB
PY 2015
VL 20
IS 1
BP 35
EP 46
DI 10.3109/1354750X.2014.988646
PG 12
WC Biotechnology & Applied Microbiology; Toxicology
SC Biotechnology & Applied Microbiology; Toxicology
GA AZ7AC
UT WOS:000348369500006
PM 25495125
DA 2019-10-23
ER

PT J
AU Groh, KJ
   Carvalho, RN
   Chipman, JK
   Denslow, ND
   Halder, M
   Murphy, CA
   Roelofs, D
   Rolaki, A
   Schirmer, K
   Watanabe, KH
AF Groh, Ksenia J.
   Carvalho, Raquel N.
   Chipman, James K.
   Denslow, Nancy D.
   Halder, Marlies
   Murphy, Cheryl A.
   Roelofs, Dick
   Rolaki, Alexandra
   Schirmer, Kristin
   Watanabe, Karen H.
TI Development and application of the adverse outcome pathway framework for
   understanding and predicting chronic toxicity: II. A focus on growth
   impairment in fish
SO CHEMOSPHERE
LA English
DT Review
DE Adverse outcome pathway; 3R (replacement; reduction; refinement);
   Behavior; Pyrethroid; Selective serotonin reuptake inhibitor; Cadmium
ID TROUT ONCORHYNCHUS-MYKISS; TILAPIA OREOCHROMIS-MOSSAMBICUS; SEROTONIN
   REUPTAKE INHIBITORS; CHRONIC SUBLETHAL EXPOSURE; MESSENGER-RNA
   EXPRESSION; ZEBRAFISH DANIO-RERIO; CARP CYPRINUS-CARPIO; EARLY-LIFE
   STAGES; RAINBOW-TROUT; SELECTIVE SEROTONIN
AB Adverse outcome pathways (AOPs) organize knowledge on the progression of toxicity through levels of biological organization. By determining the linkages between toxicity events at different levels, AOPs lay the foundation for mechanism-based alternative testing approaches to hazard assessment. Here, we focus on growth impairment in fish to illustrate the initial stages in the process of AOP development for chronic toxicity outcomes. Growth is an apical endpoint commonly assessed in chronic toxicity tests for which a replacement is desirable. Based on several criteria, we identified reduction in food intake to be a suitable key event for initiation of middle-out AOP development. To start exploring the upstream and downstream links of this key event, we developed three AOP case studies, for pyrethroids, selective serotonin reuptake inhibitors (SSRls) and cadmium. Our analysis showed that the effect of pyrethroids and SSRIs on food intake is strongly linked to growth impairment, while cadmium causes a reduction in growth due to increased metabolic demands rather than changes in food intake. Locomotion impairment by pyrethroids is strongly linked to their effects on food intake and growth, while for SSRIs their direct influence on appetite may play a more important role. We further discuss which alternative tests could be used to inform on the predictive key events identified in the casp studies. In conclusion, our work demonstrates how the AOP concept can be used in practice to assess critically the knowledge available for specific chronic toxicity cases and to identify existing knowledge gaps and potential alternative tests. (c) 2014 The Authors. Published by Elsevier Ltd.
C1 [Groh, Ksenia J.; Schirmer, Kristin] Eawag, Swiss Fed Inst Aquat Sci & Technol, CH-8600 Dubendorf, Switzerland.
   [Groh, Ksenia J.] ETH, Dept Chem & Appl Biosci, CH-8093 Zurich, Switzerland.
   [Carvalho, Raquel N.] Commiss European Communities, Joint Res Ctr, Inst Environm & Sustainabil, Water Resources Unit, I-21027 Ispra, Italy.
   [Chipman, James K.] Univ Birmingham, Birmingham B15 2TT, W Midlands, England.
   [Denslow, Nancy D.] Univ Florida, Dept Physiol Sci, Ctr Environm & Human Toxicol, Gainesville, FL 32611 USA.
   [Denslow, Nancy D.] Univ Florida, Genet Inst, Gainesville, FL 32611 USA.
   [Halder, Marlies; Rolaki, Alexandra] Commiss European Communities, Joint Res Ctr, Inst Hlth & Consumer Protect, Syst Toxicol Unit, I-21027 Ispra, Italy.
   [Murphy, Cheryl A.] Michigan State Univ, Lyman Briggs Coll, E Lansing, MI 48824 USA.
   [Roelofs, Dick] Vrije Univ Amsterdam, Inst Ecol Sci, NL-1081 HV Amsterdam, Netherlands.
   [Schirmer, Kristin] ETH, Dept Environm Syst Sci, CH-8092 Zurich, Switzerland.
   [Schirmer, Kristin] EPF Lausanne, Sch Architecture Civil & Environm Engn, CH-1015 Lausanne, Switzerland.
   [Watanabe, Karen H.] Oregon Hlth & Sci Univ, Inst Environm Hlth, Div Environm & Biomol Syst, Portland, OR 97239 USA.
RP Groh, KJ (reprint author), Eawag, Ueberlandstr 133, CH-8600 Dubendorf, Switzerland.
EM ksenia.groh@eawag.ch
OI Roelofs, Dick/0000-0003-3954-3590; Groh, Ksenia/0000-0002-3778-4721
FU American Chemistry Council; BioDetection Systems; European Centre for
   Ecotoxicology and Toxicology of Chemicals; Environment Canada; European
   Commission Directorate General Joint Research Center; Human Toxicology
   Project Consortium; International Life Sciences Institute - Health and
   Environmental Science Institute; Research Council of NorwayResearch
   Council of Norway [221455]; Society for Environmental Toxicology and
   Chemistry; US Army Engineer Research and Development CenterUnited States
   Department of Defense; US Environmental Protection AgencyUnited States
   Environmental Protection Agency
FX We acknowledge the American Chemistry Council, BioDetection Systems,
   European Centre for Ecotoxicology and Toxicology of Chemicals,
   Environment Canada, European Commission Directorate General Joint
   Research Center, Human Toxicology Project Consortium, International Life
   Sciences Institute - Health and Environmental Science Institute, The
   Research Council of Norway (Grant no. 221455), Society for Environmental
   Toxicology and Chemistry, US Army Engineer Research and Development
   Center and the US Environmental Protection Agency that provided the
   support for the international expert workshop Advancing Adverse Outcome
   Pathways (AOPs) for Integrated Toxicology and Regulatory Applications,
   where the presented work has been initiated. The authors acknowledge the
   workshop organizing committee and all workshop participants for both
   plenary and informal discussions that influenced the content presented
   here.
CR Agatz A, 2013, ENVIRON SCI TECHNOL, V47, P2909, DOI 10.1021/es304784t
   Ahmad F, 2013, BEHAV PROCESS, V92, P88, DOI 10.1016/j.beproc.2012.10.014
   Airhart MJ, 2007, NEUROTOXICOL TERATOL, V29, P652, DOI 10.1016/j.ntt.2007.07.005
   Aksakal E, 2010, COMP BIOCHEM PHYS C, V152, P451, DOI 10.1016/j.cbpc.2010.07.004
   Ali S, 2014, ZEBRAFISH, V11, P129, DOI 10.1089/zeb.2013.0901
   Almeida JA, 2002, ENVIRON INT, V27, P673, DOI 10.1016/S0160-4120(01)00127-1
   Amweg EL, 2005, ENVIRON TOXICOL CHEM, V24, P966, DOI 10.1897/04-146R1.1
   Anetor John I, 2012, Niger J Physiol Sci, V27, P103
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Atli G, 2007, COMP BIOCHEM PHYS C, V145, P282, DOI 10.1016/j.cbpc.2006.12.012
   Baker RA, 1996, J NEUROENDOCRINOL, V8, P337, DOI 10.1046/j.1365-2826.1996.04422.x
   Baldwin DH, 2009, ECOL APPL, V19, P2004, DOI 10.1890/08-1891.1
   Barry MJ, 2013, ECOTOXICOLOGY, V22, P425, DOI 10.1007/s10646-012-1036-7
   Baser S, 2003, CHEMOSPHERE, V51, P469, DOI 10.1016/S0045-6535(03)00033-X
   Beggel S, 2011, AQUAT TOXICOL, V105, P180, DOI 10.1016/j.aquatox.2011.06.004
   Beggel S, 2010, SCI TOTAL ENVIRON, V408, P3169, DOI 10.1016/j.scitotenv.2010.04.004
   Belden JB, 2006, ENVIRON TOXICOL CHEM, V25, P623, DOI 10.1897/05-370R.1
   Benaduce APS, 2008, ARCH ENVIRON CON TOX, V54, P274, DOI 10.1007/s00244-007-9024-2
   Berntssen MHG, 2001, COMP BIOCHEM PHYS C, V128, P299, DOI 10.1016/S1532-0456(00)00204-0
   Bertin G, 2006, BIOCHIMIE, V88, P1549, DOI 10.1016/j.biochi.2006.10.001
   Beyer CE, 2008, EUR J PHARMACOL, V580, P350, DOI 10.1016/j.ejphar.2007.11.028
   Beyers DW, 1999, CAN J FISH AQUAT SCI, V56, P814, DOI 10.1139/cjfas-56-5-814
   Bianco IH, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00101
   Bisesi JH, 2014, AQUAT TOXICOL, V148, P130, DOI 10.1016/j.aquatox.2013.12.033
   BORGMANN U, 1986, ARCH ENVIRON CON TOX, V15, P473, DOI 10.1007/BF01056558
   BRADBURY SP, 1989, ENVIRON TOXICOL CHEM, V8, P373, DOI 10.1002/etc.5620080503
   Brinkman SF, 2007, ENVIRON TOXICOL CHEM, V26, P1666, DOI 10.1897/06-376R.1
   Brodin T, 2013, SCIENCE, V339, P814, DOI 10.1126/science.1226850
   Brooks BW, 2014, AQUAT TOXICOL, V151, P61, DOI 10.1016/j.aquatox.2014.01.007
   Brustein E, 2003, J PHYSIOL-PARIS, V97, P77, DOI 10.1016/j.jphysparis.2003.10.009
   Burger J, 2002, ENVIRON RES, V89, P85, DOI 10.1006/enrs.2002.4330
   Cao L, 2010, COMP BIOCHEM PHYS C, V151, P386, DOI 10.1016/j.cbpc.2010.01.004
   Cao L, 2009, ECOTOX ENVIRON SAFE, V72, P1966, DOI 10.1016/j.ecoenv.2009.06.002
   Carlsson G, 2013, AQUAT TOXICOL, V126, P30, DOI 10.1016/j.aquatox.2012.10.008
   Cattani O, 1996, COMP BIOCHEM PHYS C, V113, P193, DOI 10.1016/0742-8413(95)02087-X
   Chen WY, 2012, ECOTOXICOLOGY, V21, P2264, DOI 10.1007/s10646-012-0983-3
   Christensen BT, 2005, AQUAT TOXICOL, V73, P210, DOI 10.1016/j.aquatox.2005.03.011
   Chu S, 2007, J CHROMATOGR A, V1163, P112, DOI 10.1016/j.chroma.2007.06.014
   CLARK JR, 1985, ECOTOX ENVIRON SAFE, V10, P382, DOI 10.1016/0147-6513(85)90083-1
   Conners DE, 2009, ENVIRON TOXICOL CHEM, V28, P2671, DOI 10.1897/08-493.1
   Connon RE, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-608
   CROWDER LB, 1992, INDIVIDUAL-BASED MODELS AND APPROACHES IN ECOLOGY, P237
   CURTIS LR, 1985, J TOXICOL ENV HEALTH, V15, P445, DOI 10.1080/15287398509530671
   Das S, 2011, J HAZARD MATER, V185, P295, DOI 10.1016/j.jhazmat.2010.09.033
   De Smet H, 2001, ECOTOX ENVIRON SAFE, V48, P255, DOI 10.1006/eesa.2000.2011
   Denton DL, 2003, ENVIRON TOXICOL CHEM, V22, P336, DOI [10.1897/1551-5028(2003)022<0336:JATOEA>2.0.CO;2, 10.1002/etc.5620220214]
   DEPEDRO N, 1993, PHYSIOL BEHAV, V53, P517, DOI 10.1016/0031-9384(93)90146-7
   EATON JG, 1978, B ENVIRON CONTAM TOX, V19, P95, DOI 10.1007/BF01685772
   Eder KJ, 2004, MAR ENVIRON RES, V58, P809, DOI 10.1016/j.marenvres.2004.03.098
   Eissa BL, 2006, B ENVIRON CONTAM TOX, V77, P931, DOI 10.1007/s00128-006-1233-2
   Eissa BL, 2010, ARCH ENVIRON CON TOX, V58, P1032, DOI 10.1007/s00244-009-9434-4
   El-Sayed YS, 2008, BASIC CLIN PHARMACOL, V102, P293, DOI 10.1111/j.1742-7843.2007.00157.x
   ELLGAARD EG, 1978, J FISH BIOL, V12, P19, DOI 10.1111/j.1095-8649.1978.tb04146.x
   Espina S, 2000, WATER AIR SOIL POLL, V119, P1, DOI 10.1023/A:1005190428109
   EVANS DH, 1987, ENVIRON HEALTH PERSP, V71, P47, DOI 10.2307/3430412
   Eya JC, 2012, COMP BIOCHEM PHYS B, V163, P211, DOI 10.1016/j.cbpb.2012.05.019
   FAIRCHILD JF, 1992, ENVIRON TOXICOL CHEM, V11, P115, DOI 10.1002/etc.5620110111
   Ferrari L, 2011, FISH PHYSIOL BIOCHEM, V37, P853, DOI 10.1007/s10695-011-9483-2
   Ferrari L., 2005, ACTA TOXICOL ARGENT, V13, P18
   Floyd EY, 2008, ENVIRON TOXICOL CHEM, V27, P1780, DOI 10.1897/07-448.1
   Fong PP, 2014, AQUAT TOXICOL, V151, P4, DOI 10.1016/j.aquatox.2013.12.003
   Foster HR, 2010, ENVIRON TOXICOL CHEM, V29, P2845, DOI 10.1002/etc.345
   Francis MM, 2003, TRENDS NEUROSCI, V26, P90, DOI 10.1016/S0166-2236(02)00041-3
   FU H, 1990, AQUAT TOXICOL, V16, P257, DOI 10.1016/0166-445X(90)90040-V
   Fuentes EN, 2013, GEN COMP ENDOCR, V186, P172, DOI 10.1016/j.ygcen.2013.02.009
   Garcia-Santos S, 2011, ECOTOX ENVIRON SAFE, V74, P270, DOI 10.1016/j.ecoenv.2010.08.023
   Gaworecki KM, 2008, AQUAT TOXICOL, V88, P207, DOI 10.1016/j.aquatox.2008.04.011
   Gaworecki KM, 2012, TOXICOL SCI, V125, P522, DOI 10.1093/toxsci/kfr302
   Geist J, 2007, AQUAT TOXICOL, V85, P28, DOI 10.1016/j.aquatox.2007.07.011
   George SG, 1996, FUND APPL TOXICOL, V33, P91, DOI 10.1006/faat.1996.0146
   Gerlai R, 2010, BEHAV BRAIN RES, V207, P223, DOI 10.1016/j.bbr.2009.10.008
   Gould GG, 2007, BASIC CLIN PHARMACOL, V101, P203, DOI 10.1111/j.1742-7843.2007.00100.x
   Goulding AT, 2013, COMP BIOCHEM PHYS C, V157, P280, DOI 10.1016/j.cbpc.2013.01.001
   Groh K.J., 2014, CHEMOSPHERE IN PRESS
   Halford JCG, 2007, DRUGS, V67, P27, DOI 10.2165/00003495-200767010-00004
   HANSEN D J, 1983, Environmental Toxicology and Chemistry, V2, P251, DOI 10.1897/1552-8618(1983)2[251:EOTSPA]2.0.CO;2
   Hansen JA, 2002, ENVIRON TOXICOL CHEM, V21, P67, DOI 10.1002/etc.5620210110
   Hansen JA, 2002, AQUAT TOXICOL, V58, P165, DOI 10.1016/S0166-445X(01)00233-8
   Harwood AD, 2009, ENVIRON TOXICOL CHEM, V28, P1051, DOI 10.1897/08-291.1
   Hattink J, 2005, AQUAT TOXICOL, V75, P1, DOI 10.1016/j.aquatox.2005.06.007
   Hauser-Davis RA, 2012, REV ENVIRON CONTAM T, V218, P101, DOI 10.1007/978-1-4614-3137-4_2
   Haverinen J, 2014, COMP BIOCHEM PHYS C, V159, P1, DOI 10.1016/j.cbpc.2013.09.004
   Hazelton PD, 2014, AQUAT TOXICOL, V151, P27, DOI 10.1016/j.aquatox.2013.12.019
   He LM, 2008, REV ENVIRON CONTAM T, V195, P71, DOI 10.1007/978-0-387-77030-7_3
   Hedgespeth ML, 2014, AQUAT TOXICOL, V151, P84, DOI 10.1016/j.aquatox.2013.12.011
   Hellou J, 2011, ENVIRON SCI POLLUT R, V18, P1, DOI 10.1007/s11356-010-0367-2
   Henry TB, 2008, ARCH ENVIRON CON TOX, V54, P325, DOI 10.1007/s00244-007-9018-0
   Heydarnejad MS, 2013, IRISH VET J, V66, DOI 10.1186/2046-0481-66-11
   Hiemke C, 2000, PHARMACOL THERAPEUT, V85, P11, DOI 10.1016/S0163-7258(99)00048-0
   Huebert KB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098205
   Huggett DB, 2003, HUM ECOL RISK ASSESS, V9, P1789, DOI 10.1080/10807030390260498
   Huynh TT, 2010, ENVIRON TOXICOL CHEM, V29, P929, DOI 10.1002/etc.99
   Jager T, 2006, ECOTOXICOLOGY, V15, P305, DOI 10.1007/s10646-006-0060-x
   JARVINEN AW, 1988, ECOTOX ENVIRON SAFE, V15, P78, DOI 10.1016/0147-6513(88)90045-0
   Jawad L. A., 2000, Miscellania Zoologica (Barcelona), V23, P31
   Jin MQ, 2009, AQUAT TOXICOL, V95, P347, DOI 10.1016/j.aquatox.2009.10.003
   Jordaan MS, 2013, AQUAT TOXICOL, V144, P133, DOI 10.1016/j.aquatox.2013.10.007
   Jorgenson B, 2013, ENVIRON TOXICOL CHEM, V32, P2469, DOI 10.1002/etc.2352
   Kalman J, 2010, ECOTOX ENVIRON SAFE, V73, P306, DOI 10.1016/j.ecoenv.2009.10.013
   Kalueff AV, 2013, ZEBRAFISH, V10, P70, DOI 10.1089/zeb.2012.0861
   Kaviraj A, 2014, BIOMED RES INT, DOI 10.1155/2014/928063
   Kessabi K, 2013, J TOXICOL ENV HEAL A, V76, P1269, DOI 10.1080/15287394.2013.850136
   Kim JH, 2012, FISH PHYSIOL BIOCHEM, V38, P1331, DOI 10.1007/s10695-012-9621-5
   Kim MJ, 2008, BIOTECHNIQUES, V45, P331, DOI 10.2144/000112909
   King-Heiden TC, 2012, MOL CELL ENDOCRINOL, V354, P121, DOI 10.1016/j.mce.2011.09.027
   Kolath WH, 2006, J ANIM SCI, V84, P861
   Kooijman SALM, 1996, WATER RES, V30, P1633, DOI 10.1016/0043-1354(96)00057-7
   Kreke N, 2008, CRIT REV TOXICOL, V38, P215, DOI 10.1080/10408440801891057
   KUROSHIMA R, 1993, ECOTOX ENVIRON SAFE, V25, P300, DOI 10.1006/eesa.1993.1028
   Kwon JW, 2006, ENVIRON TOXICOL CHEM, V25, P2561, DOI 10.1897/05-613R.1
   LaLone CA, 2013, AQUAT TOXICOL, V144, P141, DOI 10.1016/j.aquatox.2013.09.004
   Lam Daniel D., 2007, Expert Reviews in Molecular Medicine, V9, DOI 10.1017/S1462399407000245
   Lange M., 2012, PLOS ONE, V8
   Langer-Jaesrich M, 2010, ECOTOXICOLOGY, V19, P1294, DOI 10.1007/s10646-010-0516-x
   Laskowski Dennis A, 2002, Rev Environ Contam Toxicol, V174, P49
   Law R, 2009, ECOLOGY, V90, P802, DOI 10.1890/07-1900.1
   Lee TH, 1996, ENVIRON BIOL FISH, V45, P95, DOI 10.1007/BF00000631
   Leon-Olea M, 2014, GEN COMP ENDOCR, V203, P158, DOI 10.1016/j.ygcen.2014.02.005
   Lin LY, 2006, AM J PHYSIOL-CELL PH, V290, pC371, DOI 10.1152/ajpcell.00281.2005
   Lionetto MG, 2000, AQUAT TOXICOL, V48, P561, DOI 10.1016/S0166-445X(99)00056-9
   LITTLE EE, 1993, ENVIRON TOXICOL CHEM, V12, P871, DOI 10.1002/etc.5620120511
   LITTLE EE, 1990, ENVIRON TOXICOL CHEM, V9, P13, DOI 10.1002/etc.5620090103
   LOWEJINDE L, 1984, ARCH ENVIRON CON TOX, V13, P759, DOI 10.1007/BF01055940
   LOZANO SJ, 1992, ENVIRON TOXICOL CHEM, V11, P35, DOI 10.1002/etc.5620110105
   Ma Y, 2009, ECOTOX ENVIRON SAFE, V72, P1913, DOI 10.1016/j.ecoenv.2009.07.005
   MAJEWSKI HS, 1981, WATER RES, V15, P1211, DOI 10.1016/0043-1354(81)90096-8
   McGeer JC, 2000, AQUAT TOXICOL, V50, P231, DOI 10.1016/S0166-445X(99)00105-8
   Melvin SD, 2013, CHEMOSPHERE, V93, P2217, DOI 10.1016/j.chemosphere.2013.07.036
   Mennigen JA, 2011, J TOXICOL ENV HEAL B, V14, P387, DOI 10.1080/10937404.2011.578559
   Mennigen JA, 2010, AQUAT TOXICOL, V100, P128, DOI 10.1016/j.aquatox.2010.07.022
   Mennigen JA, 2009, REGUL PEPTIDES, V155, P99, DOI 10.1016/j.regpep.2009.01.001
   Messaoudi I, 2009, J ENVIRON SCI-CHINA, V21, P1620, DOI 10.1016/S1001-0742(08)62464-X
   Metcalfe CD, 2010, ENVIRON TOXICOL CHEM, V29, P79, DOI 10.1002/etc.27
   MICHIBATA H, 1987, ENVIRON RES, V42, P321, DOI 10.1016/S0013-9351(87)80197-4
   Miliou H, 1998, ARCH ENVIRON CON TOX, V35, P58, DOI 10.1007/s002449900349
   Mittal P. K., 1994, Indian Journal of Malariology, V31, P43
   Monserrat JM, 2007, COMP BIOCHEM PHYS C, V146, P221, DOI 10.1016/j.cbpc.2006.08.012
   Moreira SM, 2010, ECOTOX ENVIRON SAFE, V73, P893, DOI 10.1016/j.ecoenv.2010.04.007
   MUIR DCG, 1994, AQUAT TOXICOL, V29, P223, DOI 10.1016/0166-445X(94)90070-1
   Murphy CA, 2008, AQUAT TOXICOL, V86, P470, DOI 10.1016/j.aquatox.2007.12.009
   Nakamura Y, 2008, CHEMOSPHERE, V70, P865, DOI 10.1016/j.chemosphere.2007.06.089
   Narahashi T, 2007, HUM EXP TOXICOL, V26, P361, DOI 10.1177/0960327106078408
   Narahashi T, 1998, NEUROTOXICOLOGY, V19, P581
   Niyogi S, 2004, J COMP PHYSIOL B, V174, P243, DOI 10.1007/s00360-003-0409-x
   Nyman AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062472
   Oliveira C, 2013, CHEMOSPHERE, V90, P936, DOI 10.1016/j.chemosphere.2012.06.036
   Oliveira C, 2012, AQUAT TOXICOL, V124, P209, DOI 10.1016/j.aquatox.2012.08.010
   Olsson Per-Erik, 1993, Biochemistry and Molecular Biology of Fishes, V2, P259
   Overli O, 1998, CAN J ZOOL, V76, P1366, DOI 10.1139/cjz-76-7-1366
   Padilla S, 2011, NEUROTOXICOL TERATOL, V33, P624, DOI 10.1016/j.ntt.2011.08.005
   Painter MM, 2009, ENVIRON TOXICOL CHEM, V28, P2677, DOI 10.1897/08-556.1
   Pan JL, 2010, ENVIRON GEOCHEM HLTH, V32, P1, DOI 10.1007/s10653-009-9273-2
   Parent LM, 2011, J ENVIRON SCI HEAL B, V46, P615, DOI 10.1080/03601234.2011.589316
   Paterson G, 2008, CHEMOSPHERE, V74, P125, DOI 10.1016/j.chemosphere.2008.08.022
   Peakall D, 2003, ECOTOX ENVIRON SAFE, V56, P110, DOI 10.1016/S0147-6513(03)00055-1
   Pekar S, 2012, PEST MANAG SCI, V68, P1438, DOI 10.1002/ps.3397
   Pereira CMS, 2013, SCI TOTAL ENVIRON, V443, P821, DOI 10.1016/j.scitotenv.2012.11.044
   PETERSON RH, 1983, ARCH ENVIRON CON TOX, V12, P37, DOI 10.1007/BF01054999
   Pettorelli N, 2011, OECOLOGIA, V167, P305, DOI 10.1007/s00442-011-2069-y
   Piechotta G, 1999, ECOTOX ENVIRON SAFE, V42, P50, DOI 10.1006/eesa.1998.1725
   Pierron F, 2007, AQUAT TOXICOL, V81, P304, DOI 10.1016/j.aquatox.2006.12.014
   Pieters BJ, 2005, ENVIRON TOXICOL CHEM, V24, P2254, DOI 10.1897/04-563R.1
   Polakof S, 2007, AM J PHYSIOL-REG I, V292, pR1657, DOI 10.1152/ajpregu.00525.2006
   Prashanth Mahanthinamatha Shankaraiah, 2011, Journal of Basic and Clinical Physiology and Pharmacology, V22, P115, DOI 10.1515/JBCPP.2011.020
   PRATAP HB, 1990, COMP BIOCHEM PHYS C, V95, P313, DOI 10.1016/0742-8413(90)90124-R
   PRATAP HB, 1993, AQUAT TOXICOL, V26, P133, DOI 10.1016/0166-445X(93)90010-X
   Pretto A, 2010, ARCH ENVIRON CON TOX, V58, P1008, DOI 10.1007/s00244-009-9419-3
   Quinn TP, 1996, CAN J FISH AQUAT SCI, V53, P1555, DOI 10.1139/cjfas-53-7-1555
   Rand-Weaver M, 2013, ENVIRON SCI TECHNOL, V47, P11384, DOI 10.1021/es402065a
   Rangsayatorn N, 2004, ENVIRON TOXICOL, V19, P585, DOI 10.1002/tox.20066
   Rendal C, 2011, ENVIRON TOXICOL CHEM, V30, P2395, DOI 10.1002/etc.641
   Reynders H, 2006, ENVIRON TOXICOL CHEM, V25, P1558, DOI 10.1897/05-239R.1
   Ricard AC, 1998, ARCH ENVIRON CON TOX, V34, P377, DOI 10.1007/s002449900333
   Rico EP, 2011, NEUROTOXICOL TERATOL, V33, P608, DOI 10.1016/j.ntt.2011.07.007
   Rideout RM, 2010, J FISH BIOL, V76, P1379, DOI 10.1111/j.1095-8649.2010.02570.x
   Robertson JD, 2000, CRIT REV TOXICOL, V30, P609, DOI 10.1080/10408440008951122
   ROMBOUGH PJ, 1982, CAN J ZOOL, V60, P2006, DOI 10.1139/z82-258
   Rose WL, 2006, AQUAT TOXICOL, V80, P298, DOI 10.1016/j.aquatox.2006.09.007
   Rose WL, 2005, ENVIRON TOXICOL CHEM, V24, P2612, DOI 10.1897/04-516R.1
   Saha S, 2013, TOXICOL IND HEALTH, V29, P468, DOI 10.1177/0748233712436642
   Salanki J, 2000, ACTA BIOL HUNG, V51, P287
   Satpute NS, 2007, J ECON ENTOMOL, V100, P357, DOI 10.1603/0022-0493(2007)100[357:TVITOI]2.0.CO;2
   Schnorr SJ, 2012, BEHAV BRAIN RES, V228, P367, DOI 10.1016/j.bbr.2011.12.016
   SCHOENMAKERS TJM, 1992, J MEMBRANE BIOL, V127, P161
   Scott GR, 2004, AQUAT TOXICOL, V68, P369, DOI 10.1016/j.aquatox.2004.03.016
   Selderslaghs IWT, 2013, NEUROTOXICOL TERATOL, V37, P44, DOI 10.1016/j.ntt.2013.01.003
   Selderslaghs IWT, 2010, NEUROTOXICOL TERATOL, V32, P460, DOI 10.1016/j.ntt.2010.03.002
   Shafer TJ, 2004, TOXICOL APPL PHARM, V196, P303, DOI 10.1016/j.taap.2003.12.013
   Sledge D, 2011, NEUROTOXICOL TERATOL, V33, P742, DOI 10.1016/j.ntt.2011.06.005
   Sloman KA, 2012, J FISH BIOL, V81, P2175, DOI 10.1111/j.1095-8649.2012.03435.x
   Smith EM, 2010, CHEMOSPHERE, V79, P26, DOI 10.1016/j.chemosphere.2010.01.058
   Soderlund DM, 2002, TOXICOLOGY, V171, P3, DOI 10.1016/S0300-483X(01)00569-8
   Souid G, 2013, ECOTOX ENVIRON SAFE, V89, P1, DOI 10.1016/j.ecoenv.2012.12.015
   Srikanth K, 2013, ENVIRON SCI POLLUT R, V20, P2133, DOI 10.1007/s11356-012-1459-y
   Stanley JK, 2007, CHEMOSPHERE, V69, P9, DOI 10.1016/j.chemosphere.2007.04.080
   Styrishave B, 2011, ENVIRON TOXICOL CHEM, V30, P254, DOI 10.1002/etc.372
   Sumpter JP, 2014, AQUAT TOXICOL, V151, P57, DOI 10.1016/j.aquatox.2013.12.010
   Sumpter JP, 2014, AQUAT TOXICOL, V146, P259, DOI 10.1016/j.aquatox.2013.11.021
   SURESH A, 1993, B ENVIRON CONTAM TOX, V51, P920
   Talent LG, 2005, ENVIRON TOXICOL CHEM, V24, P3113, DOI 10.1897/05-053R.1
   Tan FX, 2008, TOXICOL IN VITRO, V22, P164, DOI 10.1016/j.tiv.2007.08.020
   Tanner DK, 1996, ARCH ENVIRON CON TOX, V31, P244
   Teh SJ, 2005, MAR ENVIRON RES, V59, P203, DOI 10.1016/j.marenvres.2003.12.005
   Thomas CR, 2008, ARCH ENVIRON CON TOX, V55, P610, DOI 10.1007/s00244-008-9147-0
   Tierney KB, 2011, BBA-MOL BASIS DIS, V1812, P381, DOI 10.1016/j.bbadis.2010.10.011
   Tierney KB, 2010, AQUAT TOXICOL, V96, P2, DOI 10.1016/j.aquatox.2009.09.019
   Tiwari S, 2012, SCI WORLD J, DOI 10.1100/2012/291395
   Tsai JW, 2006, ARCH ENVIRON CON TOX, V50, P144, DOI 10.1007/s00244-005-1054-z
   Valenti TW, 2009, ENVIRON TOXICOL CHEM, V28, P2685, DOI 10.1897/08-546.1
   Vasskog T, 2008, J CHROMATOGR A, V1185, P194, DOI 10.1016/j.chroma.2008.01.063
   VERBOST PM, 1987, AM J PHYSIOL, V253, pR216
   Vijayavel K, 2007, ECOTOX ENVIRON SAFE, V66, P154, DOI 10.1016/j.ecoenv.2005.12.005
   VIJVERBERG HPM, 1990, CRIT REV TOXICOL, V21, P105, DOI 10.3109/10408449009089875
   Villeneuve D.L., TOX SCI IN PRESS
   Villeneuve D, 2014, ENVIRON TOXICOL CHEM, V33, P158, DOI 10.1002/etc.2403
   Volkoff H, 2005, GEN COMP ENDOCR, V142, P3, DOI 10.1016/j.ygcen.2004.11.001
   Volkoff H, 2000, BRAIN RES, V887, P125, DOI 10.1016/S0006-8993(00)03001-8
   Waisberg M, 2003, TOXICOLOGY, V192, P95, DOI 10.1016/S0300-483X(03)00305-6
   Wang HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065282
   Wang WX, 2008, COMP BIOCHEM PHYS C, V148, P315, DOI 10.1016/j.cbpc.2008.04.003
   Weinberger J, 2014, AQUAT TOXICOL, V151, P77, DOI 10.1016/j.aquatox.2013.10.012
   Weis JS, 2009, J ENVIRON SCI HEAL C, V27, P212, DOI 10.1080/10590500903310088
   Weitz JS, 2006, ECOL LETT, V9, P548, DOI 10.1111/j.1461-0248.2006.00900.x
   Werner I, 2002, B ENVIRON CONTAM TOX, V68, P29, DOI 10.1007/s00128-001-0215-7
   Werner I, 2008, ACS SYM SER, V991, P310
   Weston DP, 2013, CHEMOSPHERE, V90, P958, DOI 10.1016/j.chemosphere.2012.06.039
   Winder VL, 2012, J ENVIRON SCI HEAL B, V47, P51, DOI 10.1080/03601234.2012.607767
   Witeska M, 2014, FISH PHYSIOL BIOCHEM, V40, P151, DOI 10.1007/s10695-013-9832-4
   Wong CKC, 2000, AQUAT TOXICOL, V48, P517, DOI 10.1016/S0166-445X(99)00060-0
   WONG DT, 1995, LIFE SCI, V57, P411, DOI 10.1016/0024-3205(95)00209-O
   Wong RY, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-348
   WOODWORTH J, 1982, J FISH BIOL, V21, P47, DOI 10.1111/j.1095-8649.1982.tb02822.x
   Wu SM, 2000, PHYSIOL BIOCHEM ZOOL, V73, P531, DOI 10.1086/317754
   Wu SM, 2007, COMP BIOCHEM PHYS C, V145, P218, DOI 10.1016/j.cbpc.2006.12.003
   Yabe J, 2010, J VET MED SCI, V72, P1257, DOI 10.1292/jvms.10-0058
   Yoon S, 2008, J ENVIRON BIOL, V29, P1
   Yoshioka W, 2011, J STEROID BIOCHEM, V127, P96, DOI 10.1016/j.jsbmb.2010.12.005
   Zhao MR, 2010, ENVIRON POLLUT, V158, P1968, DOI 10.1016/j.envpol.2009.10.027
   Zhou QF, 2008, ANAL CHIM ACTA, V606, P135, DOI 10.1016/j.aca.2007.11.018
   Zucchi S, 2010, ENVIRON POLLUT, V158, P2746, DOI 10.1016/j.envpol.2010.04.012
NR 240
TC 37
Z9 38
U1 1
U2 81
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0045-6535
EI 1879-1298
J9 CHEMOSPHERE
JI Chemosphere
PD FEB
PY 2015
VL 120
BP 778
EP 792
DI 10.1016/j.chemosphere.2014.10.006
PG 15
WC Environmental Sciences
SC Environmental Sciences & Ecology
GA AZ1MN
UT WOS:000348003200105
PM 25456049
OA Other Gold, Green Published
DA 2019-10-23
ER

PT J
AU Bal-Price, A
   Crofton, KM
   Leist, M
   Allen, S
   Arand, M
   Buetler, T
   Delrue, N
   FitzGerald, RE
   Hartung, T
   Heinonen, T
   Hogberg, H
   Bennekou, SH
   Lichtensteiger, W
   Oggier, D
   Paparella, M
   Axelstad, M
   Piersma, A
   Rached, E
   Schilter, B
   Schmuck, G
   Stoppini, L
   Tongiorgi, E
   Tiramani, M
   Monnet-Tschudi, F
   Wilks, MF
   Ylikomi, T
   Fritsche, E
AF Bal-Price, Anna
   Crofton, Kevin M.
   Leist, Marcel
   Allen, Sandra
   Arand, Michael
   Buetler, Timo
   Delrue, Nathalie
   FitzGerald, Rex E.
   Hartung, Thomas
   Heinonen, Tuula
   Hogberg, Helena
   Bennekou, Susanne Hougaard
   Lichtensteiger, Walter
   Oggier, Daniela
   Paparella, Martin
   Axelstad, Marta
   Piersma, Aldert
   Rached, Eva
   Schilter, BenoIt
   Schmuck, Gabriele
   Stoppini, Luc
   Tongiorgi, Enrico
   Tiramani, Manuela
   Monnet-Tschudi, Florianne
   Wilks, Martin F.
   Ylikomi, Timo
   Fritsche, Ellen
TI International STakeholder NETwork (ISTNET): creating a developmental
   neurotoxicity (DNT) testing road map for regulatory purposes
SO ARCHIVES OF TOXICOLOGY
LA English
DT Article
DE Chemical screening; Developmental neurotoxicity; Regulatory
   requirements; Adverse outcome pathway; Key event; Environmental hazard
ID ADVERSE OUTCOME PATHWAYS; IN-VIVO HAZARD; OF-THE-ART;
   LOCOMOTOR-ACTIVITY; RISK-ASSESSMENT; ENVIRONMENTAL CHEMICALS;
   ALTERNATIVE METHODS; NEURONAL NETWORKS; TOXICITY; VITRO
AB A major problem in developmental neurotoxicity (DNT) risk assessment is the lack of toxicological hazard information for most compounds. Therefore, new approaches are being considered to provide adequate experimental data that allow regulatory decisions. This process requires a matching of regulatory needs on the one hand and the opportunities provided by new test systems and methods on the other hand. Alignment of academically and industrially driven assay development with regulatory needs in the field of DNT is a core mission of the International STakeholder NETwork (ISTNET) in DNT testing. The first meeting of ISTNET was held in Zurich on 23-24 January 2014 in order to explore the concept of adverse outcome pathway (AOP) to practical DNT testing. AOPs were considered promising tools to promote test systems development according to regulatory needs. Moreover, the AOP concept was identified as an important guiding principle to assemble predictive integrated testing strategies (ITSs) for DNT. The recommendations on a road map towards AOP-based DNT testing is considered a stepwise approach, operating initially with incomplete AOPs for compound grouping, and focussing on key events of neurodevelopment. Next steps to be considered in follow-up activities are the use of case studies to further apply the AOP concept in regulatory DNT testing, making use of AOP intersections (common key events) for economic development of screening assays, and addressing the transition from qualitative descriptions to quantitative network modelling.
C1 [Bal-Price, Anna] Commiss European Communities, Joint Res Ctr, Inst Hlth & Consumer Protect, Syst Toxicol Unit,EURL ECVAM, I-21026 Ispra, VA, Italy.
   [Crofton, Kevin M.] US EPA, Natl Ctr Computat Toxicol, RTP, Washington, NC USA.
   [Leist, Marcel] Univ Konstanz, CAAT Europe, Constance, Germany.
   [Allen, Sandra] Regulatory Sci Assoc, London, England.
   [Arand, Michael; Buetler, Timo] Univ Zurich, XeRR, Zurich, Switzerland.
   [Delrue, Nathalie] OECD, Paris, France.
   [FitzGerald, Rex E.; Wilks, Martin F.] Univ Basel, SCAHT, Basel, Switzerland.
   [Hartung, Thomas; Hogberg, Helena] Johns Hopkins Univ, CAAT, Baltimore, MD USA.
   [Heinonen, Tuula; Ylikomi, Timo] FICAM, Tampere, Finland.
   [Bennekou, Susanne Hougaard] Danish EPA, Copenhagen, Denmark.
   [Lichtensteiger, Walter] Green Toxicol, Zurich, Switzerland.
   [Oggier, Daniela] Fed Off Publ Hlth, Bern, Switzerland.
   [Paparella, Martin] Environm Agcy, Vienna, Austria.
   [Axelstad, Marta] Tech Univ Denmark, Natl Food Inst, Soborg, Denmark.
   [Piersma, Aldert] Natl Inst Publ Hlth & Environm RIVM, Utrecht, Holland, Netherlands.
   [Rached, Eva] Harlan Labs, CRO, Itingen, Switzerland.
   [Schilter, BenoIt] Nestle Res Ctr, Lausanne, Switzerland.
   [Schmuck, Gabriele] Bayer, Leverkusen, Germany.
   [Stoppini, Luc] Univ Appl Sci Western Switzerland, Geneva, Switzerland.
   [Tongiorgi, Enrico] Univ Trieste, Dept Life Sci, Trieste, Italy.
   [Tiramani, Manuela] EFSA, Parma, Italy.
   [Monnet-Tschudi, Florianne] SCAHT, Lausanne, Switzerland.
   [Monnet-Tschudi, Florianne] Univ Lausanne, Lausanne, Switzerland.
   [Fritsche, Ellen] IUF, Dusseldorf, Germany.
RP Bal-Price, A (reprint author), Commiss European Communities, Joint Res Ctr, Inst Hlth & Consumer Protect, Syst Toxicol Unit,EURL ECVAM, TP 580,Via Fermi 1, I-21026 Ispra, VA, Italy.
EM anna.price@jrc.ec.europa.eu
RI Wilks, Martin F/N-2150-2014; Arand, Michael/J-3926-2014; Crofton,
   Kevin/J-4798-2015; Leist, Marcel/D-2133-2010
OI Wilks, Martin F/0000-0003-3984-5935; Arand, Michael/0000-0003-2413-3177;
   Crofton, Kevin/0000-0003-1749-9971; Leist, Marcel/0000-0002-3778-8693;
   Petersen, Marta Axelstad/0000-0002-2375-0918; Bennekou, Susanne
   Hougaard/0000-0001-6129-6966
FU EPAA (The European Partnership for Alternatives to Animal Testing);
   CAAT; SCAHT (Swiss Centre for Applied Human Toxicology)
FX The workshop was sponsored by EPAA (The European Partnership for
   Alternatives to Animal Testing), CAAT and SCAHT (Swiss Centre for
   Applied Human Toxicology).
CR Aagaard A, 2013, EFSA J, V11, DOI 10.2903/j.efsa.2013.3471
   Alepee N, 2014, ALTEX-ALTERN ANIM EX, V31, P441, DOI 10.14573/altex.1406111
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Attene-Ramos MS, 2013, DRUG DISCOV TODAY, V18, P716, DOI 10.1016/j.drudis.2013.05.015
   Avila D, 2012, HUM EXP TOXICOL, V31, P236, DOI 10.1177/0960327110392084
   Baj G, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00018
   Bal-Price A, 2015, CRIT REV TOXICOL, V45, P83, DOI 10.3109/10408444.2014.981331
   Bal-Price AK, 2012, ALTEX-ALTERN ANIM EX, V29, P202, DOI 10.14573/altex.2012.2.202
   BALLS M, 1995, ATLA-ALTERN LAB ANIM, V23, P129
   Balmer NV, 2014, BASIC CLIN PHARMACOL, V115, P59, DOI 10.1111/bcpt.12203
   Baumann Jenny, 2014, Curr Protoc Toxicol, V59, DOI 10.1002/0471140856.tx1221s59
   Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920
   Ben-Ari Y, 2010, TRENDS NEUROSCI, V33, P485, DOI 10.1016/j.tins.2010.08.005
   Bhatia SN, 2014, NAT BIOTECHNOL, V32, P760, DOI 10.1038/nbt.2989
   Blaauboer BJ, 2012, ALTEX-ALTERN ANIM EX, V29, P411, DOI 10.14573/altex.2012.4.411
   Boekelheide Kim, 2010, ALTEX, V27, P243
   Burns CJ, 2013, J TOXICOL ENV HEAL B, V16, P127, DOI 10.1080/10937404.2013.783383
   Buzanska L, 2009, STEM CELLS, V27, P2591, DOI 10.1002/stem.179
   Caceres A, 2012, CURR OPIN CELL BIOL, V24, P547, DOI 10.1016/j.ceb.2012.05.011
   Cavallin JE, 2014, ENVIRON TOXICOL CHEM, V33, P1849, DOI 10.1002/etc.2627
   Chang LW, 1995, HDB NEUROTOXICOLOGY, V36, P48
   Charkhkar H, 2014, BIOSENS BIOELECTRON, V53, P316, DOI 10.1016/j.bios.2013.10.002
   Coecke S, 2007, ENVIRON HEALTH PERSP, V115, P924, DOI 10.1289/ehp.9427
   Cowden J, 2012, REPROD TOXICOL, V33, P165, DOI 10.1016/j.reprotox.2011.11.111
   Crofton KM, 2012, CONGENIT ANOM, V52, P140, DOI 10.1111/j.1741-4520.2012.00377.x
   Crofton KM, 2011, ALTEX-ALTERN ANIM EX, V28, P9
   Crofton KM, 2005, CRIT REV TOXICOL, V35, P757, DOI 10.1080/10408440591007304
   Cronin MTD, 1996, TOXICOL IN VITRO, V10, P103, DOI 10.1016/0887-2333(95)00109-3
   de Esch C, 2012, NEUROTOXICOL TERATOL, V34, P545, DOI 10.1016/j.ntt.2012.08.006
   ECHA, 2012, OP PROP HARM CLASS L
   Estrada E, 2001, SAR QSAR ENVIRON RES, V12, P445, DOI 10.1080/10629360108035384
   EU, 2013, COM2013135 EU
   Fritsche E, 2014, METHOD PHARMACOL TOX, P351, DOI 10.1007/978-1-4939-0521-8_16
   Fund ED, 1997, TOXIC IGNORANCE CONT
   Gassmann K, 2010, ENVIRON HEALTH PERSP, V118, P1571, DOI 10.1289/ehp.0901545
   Graham MJ, 2008, TOXICOLOGY, V254, P184, DOI 10.1016/j.tox.2008.09.002
   Grandjean P, 2006, LANCET, V368, P2167, DOI 10.1016/S0140-6736(06)69665-7
   Grandjean P, 2014, LANCET NEUROL, V13, P330, DOI 10.1016/S1474-4422(13)70278-3
   Harrill JA, 2011, TOXICOL APPL PHARM, V256, P268, DOI 10.1016/j.taap.2011.02.013
   Harrill JA, 2010, NEUROTOXICOLOGY, V31, P277, DOI 10.1016/j.neuro.2010.02.003
   Hartung T, 2004, ATLA-ALTERN LAB ANIM, V32, P467, DOI 10.1177/026119290403200503
   Hartung T, 2013, ALTEX-ALTERN ANIM EX, V30, P119, DOI 10.14573/altex.2013.2.119
   Hartung T, 2013, ALTEX-ALTERN ANIM EX, V30, P3, DOI 10.14573/altex.2013.1.003
   Hartung T, 2012, ALTEX-ALTERN ANIM EX, V29, P119, DOI 10.14573/altex.2012.2.119
   Hartung T, 2011, ALTEX-ALTERN ANIM EX, V28, P83, DOI 10.14573/altex.2011.2.083
   Hartung T, 2009, NATURE, V460, P208, DOI 10.1038/460208a
   Hayess K, 2013, TOXICOLOGY, V314, P135, DOI 10.1016/j.tox.2013.09.012
   Heuer H, 2013, BBA-GEN SUBJECTS, V1830, P3974, DOI 10.1016/j.bbagen.2012.04.009
   Hoelting L, 2013, ARCH TOXICOL, V87, P721, DOI 10.1007/s00204-012-0984-2
   Hogberg HT, 2011, NEUROTOXICOLOGY, V32, P158, DOI 10.1016/j.neuro.2010.10.007
   Hogberg HT, 2013, STUDIES, V13, P15
   Honegger P, 2011, METHODS MOL BIOL, V758, P81, DOI 10.1007/978-1-61779-170-3_6
   Horton MK, 2011, PEDIATRICS, V127, pE699, DOI 10.1542/peds.2010-0133
   Judson R, 2013, ALTEX-ALTERN ANIM EX, V30, P51, DOI 10.14573/altex.2013.1.051
   Judson R, 2009, ENVIRON HEALTH PERSP, V117, P685, DOI 10.1289/ehp.0800168
   Judson RS, 2011, CHEM RES TOXICOL, V24, P451, DOI 10.1021/tx100428e
   Kadereit S, 2012, FRONT BIOSCI-LANDMRK, V17, P2442, DOI 10.2741/4064
   Kapucu FE, 2012, FRONT COMPUT NEUROSC, V6, DOI 10.3389/fncom.2012.00038
   Kavlock R, 2012, CHEM RES TOXICOL, V25, P1287, DOI 10.1021/tx3000939
   Kienhuis AS, 2009, TOXICOL SCI, V107, P544, DOI 10.1093/toxsci/kfn237
   Kleensang A, 2014, ALTEX-ALTERN ANIM EX, V31, P53, DOI 10.14573/altex.1309261
   Kleinstreuer N, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002996
   Krug AK, 2013, ARCH TOXICOL, V87, P123, DOI 10.1007/s00204-012-0967-3
   Kuegler PB, 2009, ALTEX, V27, P17
   Landesmann B, 2013, ATLA-ALTERN LAB ANIM, V41, P461, DOI 10.1177/026119291304100609
   Leist M, 2013, ALTEX, V31, P341
   Leist M, 2008, ALTEX-ALTERN TIEREXP, V25, P103
   Leist M, 2013, ARCH TOXICOL, V87, P2037, DOI 10.1007/s00204-013-1154-x
   Leist M, 2012, TOXICOL RES-UK, V1, P8, DOI 10.1039/c2tx20011b
   Leist M, 2012, ALTEX-ALTERN ANIM EX, V29, P373, DOI 10.14573/altex.2012.4.373
   Leist M, 2010, ALTEX-ALTERN ANIM EX, V27, P309
   Li AA, 2010, NEUROTOXICOLOGY, V31, P247, DOI 10.1016/j.neuro.2010.02.001
   Lieberman JA, 2008, PHARMACOL REV, V60, P358, DOI 10.1124/pr.107.00107
   Truong L, 2014, TOXICOL SCI, V137, P212, DOI 10.1093/toxsci/kft235
   Makris SL, 2009, ENVIRON HEALTH PERSP, V117, P17, DOI 10.1289/ehp.11447
   Martin MT, 2011, BIOL REPROD, V85, P327, DOI 10.1095/biolreprod.111.090977
   Meek ME, 2014, J APPL TOXICOL, V34, P595, DOI 10.1002/jat.2984
   Monnet-Tschudi F, 2000, TOXICOL APPL PHARM, V165, P175, DOI 10.1006/taap.2000.8934
   Moors M, 2007, TOXICOL APPL PHARM, V221, P57, DOI 10.1016/j.taap.2007.02.018
   Moors M, 2009, ENVIRON HEALTH PERSP, V117, P1131, DOI 10.1289/ehp.0800207
   Novellino A, 2011, Front Neuroeng, V4, P4, DOI 10.3389/fneng.2011.00004
   NRC, 1984, TOX TEST STRAT DET N
   NRC (National Research Council), 2007, TOX TEST 21 CENT VIS
   OECD, 2007, DEV NEUR STUD
   OECD, 2013, OECD SER TEST ASS, V184
   OECD, 2008, SER TEST ASS, V407
   OECD, 2004, GUID DOC NEUR TEST
   OECD, 1998, TEST NO 408 REP DOS, V408
   OECD, 2011, EXT ON GEN REPR TOX
   OECD, 1997, NEUR STUD ROD, P424
   OECD, 2012, ADV OUTC PATHW SKIN
   OECD, 2005, OECD SER TEST ASS
   OECD (Organisation for Economic Co operation and Development), 2012, ADV OUTC PATHW SKI 1
   Padilla S, 2011, NEUROTOXICOL TERATOL, V33, P624, DOI 10.1016/j.ntt.2011.08.005
   Pallocca G, 2013, CELL BIOL TOXICOL, V29, P239, DOI 10.1007/s10565-013-9250-5
   Pamies D, 2014, EXP BIOL MED, V239, P1096, DOI 10.1177/1535370214537738
   Paparella M, 2012, ALTEX, V30, P131
   Patlewicz G, 2014, ALTEX IN PRESS, V31
   Ramirez T, 2013, ALTEX-ALTERN ANIM EX, V30, P209, DOI 10.14573/altex.2013.2.209
   Rauh V, 2011, ENVIRON HEALTH PERSP, V119, P1196, DOI 10.1289/ehp.1003160
   Rauh VA, 2012, P NATL ACAD SCI USA, V109, P7871, DOI 10.1073/pnas.1203396109
   REES DC, 1990, NEUROTOXICOLOGY, V11, P257
   REES DC, 1990, NEUROTOXICOL TERATOL, V12, P175, DOI 10.1016/0892-0362(90)90089-U
   Rice D, 2000, ENVIRON HEALTH PERSP, V108, P511, DOI 10.1289/ehp.00108s3511
   Roberts DW, 2014, J APPL TOXICOL, V34, P436, DOI 10.1002/jat.2943
   Robinette Brian L, 2011, Front Neuroeng, V4, P1, DOI 10.3389/fneng.2011.00001
   Rossini GP, 2012, ALTEX-ALTERN ANIM EX, V29, P359, DOI 10.14573/altex.2012.4.359
   Rotroff DM, 2013, ENVIRON HEALTH PERSP, V121, P7, DOI 10.1289/ehp.1205065
   Rovida C, 2009, ALTEX-ALTERN TIEREXP, V26, P187
   Schaumburg HH, 2000, NEUROL CLIN, V18, P517, DOI 10.1016/S0733-8619(05)70208-5
   Schilter B, 2014, REGUL TOXICOL PHARM, V68, P275, DOI 10.1016/j.yrtph.2013.08.018
   Selderslaghs IWT, 2013, NEUROTOXICOL TERATOL, V37, P44, DOI 10.1016/j.ntt.2013.01.003
   Sipes NS, 2011, TOXICOL SCI, V124, P109, DOI 10.1093/toxsci/kfr220
   Smirnova L, 2014, ALTEX-ALTERN ANIM EX, V31, P129, DOI http://dx.doi.org/10.14573/altex.1403271
   Theunissen PT, 2012, TOXICOL APPL PHARM, V262, P330, DOI 10.1016/j.taap.2012.05.011
   Theunissen PT, 2012, TOXICOL SCI, V125, P430, DOI 10.1093/toxsci/kfr293
   Thomas RS, 2013, TOXICOL SCI, V136, P4, DOI 10.1093/toxsci/kft178
   Tollefsen KE, 2014, REGUL TOXICOL PHARM, V70, P629, DOI 10.1016/j.yrtph.2014.09.009
   Tsuji R, 2012, CONGENIT ANOM, V52, P122, DOI 10.1111/j.1741-4520.2012.00374.x
   van Thriel C, 2012, NEUROTOXICOLOGY, V33, P911, DOI 10.1016/j.neuro.2011.10.002
   Vinken M, 2013, TOXICOLOGY, V312, P158, DOI 10.1016/j.tox.2013.08.011
   Watanabe KH, 2011, ENVIRON TOXICOL CHEM, V30, P9, DOI 10.1002/etc.373
   Wayman GA, 2012, ENVIRON HEALTH PERSP, V120, P1003, DOI 10.1289/ehp.1104833
   Wetmore BA, 2014, TOXICOL SCI, V142, P210, DOI 10.1093/toxsci/kfu169
   Wetmore BA, 2013, TOXICOL SCI, V132, P327, DOI 10.1093/toxsci/kft012
   WHO, 1999, PRINC ASS RISKS HUM
   Wu SD, 2010, REGUL TOXICOL PHARM, V56, P67, DOI 10.1016/j.yrtph.2009.09.006
   Yamada KM, 2007, CELL, V130, P601, DOI 10.1016/j.cell.2007.08.006
   Yla-Outinen Laura, 2010, Front Neuroeng, V3, DOI 10.3389/fneng.2010.00111
   Zimmer B, 2014, ARCH TOXICOL, V88, P1109, DOI 10.1007/s00204-014-1231-9
   Zimmer B, 2012, ENVIRON HEALTH PERSP, V120, P1116, DOI 10.1289/ehp.1104489
   Zoeller RT, 2005, CRIT REV TOXICOL, V35, P771, DOI 10.1080/10408440591007313
   Zurich MG, 2002, J NEUROSCI RES, V70, P108, DOI 10.1002/jnr.10367
NR 133
TC 67
Z9 67
U1 0
U2 25
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0340-5761
EI 1432-0738
J9 ARCH TOXICOL
JI Arch. Toxicol.
PD FEB
PY 2015
VL 89
IS 2
BP 269
EP 287
DI 10.1007/s00204-015-1464-2
PG 19
WC Toxicology
SC Toxicology
GA CA4ZR
UT WOS:000348917100013
PM 25618548
OA Green Published, Other Gold
DA 2019-10-23
ER

PT J
AU Groh, KJ
   Carvalho, RN
   Chipman, JK
   Denslow, ND
   Halder, M
   Murphy, CA
   Roelofs, D
   Rolaki, A
   Schirmer, K
   Watanabe, KH
AF Groh, Ksenia J.
   Carvalho, Raquel N.
   Chipman, James K.
   Denslow, Nancy D.
   Halder, Marlies
   Murphy, Cheryl A.
   Roelofs, Dick
   Rolaki, Alexandra
   Schirmer, Kristin
   Watanabe, Karen H.
TI Development and application of the adverse outcome pathway framework for
   understanding and predicting chronic toxicity: I. Challenges and
   research needs in ecotoxicology
SO CHEMOSPHERE
LA English
DT Review
DE Adverse Outcome Pathway (AOP); Ecotoxicological risk assessment; Chronic
   toxicity; Toxicokinetics; Extrapolation from individual to population;
   Cross-species extrapolation
ID ZEBRAFISH DANIO-RERIO; ENERGY BUDGET THEORY; STICKLEBACK
   GASTEROSTEUS-ACULEATUS; SPECIES SENSITIVITY DISTRIBUTIONS; CROAKER
   MICROPOGONIAS-UNDULATUS; HEPATIC BIOTRANSFORMATION DATA; MINNOW
   PIMEPHALES-PROMELAS; PITUITARY-GONADAL AXIS; EARLY FISH DEVELOPMENT;
   IN-VIVO EXTRAPOLATION
AB To elucidate the effects of chemicals on populations of different species in the environment, efficient testing and modeling approaches are needed that consider multiple stressors and allow reliable extrapolation of responses across species. An adverse outcome pathway (AOP) is a concept that provides a framework for organizing knowledge about the progression of toxicity events across scales of biological organization that lead to adverse outcomes relevant for risk assessment. In this paper, we focus on exploring how the AOP concept can be used to guide research aimed at improving both our understanding of chronic toxicity, including delayed toxicity as well as epigenetic and transgenerational effects of chemicals, and our ability to predict adverse outcomes. A better understanding of the influence of subtle toxicity on individual and population fitness would support a broader integration of sublethal endpoints into risk assessment frameworks. Detailed mechanistic knowledge would facilitate the development of alternative testing methods as well as help prioritize higher tier toxicity testing. We argue that targeted development of AOPs supports both of these aspects by promoting the elucidation of molecular mechanisms and their contribution to relevant toxicity outcomes across biological scales. We further discuss information requirements and challenges in application of AOPs for chemical- and site-specific risk assessment and for extrapolation across species. We provide recommendations for potential extension of the AOP framework to incorporate information on exposure, toxicokinetics and situation-specific ecological contexts, and discuss common interfaces that can be employed to couple AOPs with computational modeling approaches and with evolutionary life history theory. The extended AOP framework can serve as a venue for integration of knowledge derived from various sources, including empirical data as well as molecular, quantitative and evolutionary-based models describing species responses to toxicants. This will allow a more efficient application of AOP knowledge for quantitative chemical- and site-specific risk assessment as well as for extrapolation across species in the future. (c) 2014 The Authors. Published by Elsevier Ltd.
C1 [Groh, Ksenia J.; Schirmer, Kristin] Eawag, Swiss Fed Inst Aquat Sci & Technol, CH-8600 Dubendorf, Switzerland.
   [Groh, Ksenia J.] ETH, Dept Chem & Appl Biosci, CH-8093 Zurich, Switzerland.
   [Carvalho, Raquel N.] Commiss European Communities, Joint Res Ctr, Inst Environm & Sustainabil, Water Resources Unit, I-21027 Ispra, Italy.
   [Chipman, James K.] Univ Birmingham, Birmingham B15 2TT, W Midlands, England.
   [Denslow, Nancy D.] Univ Florida, Dept Physiol Sci, Ctr Environm & Human Toxicol, Gainesville, FL 32611 USA.
   [Denslow, Nancy D.] Univ Florida, Genet Inst, Gainesville, FL 32611 USA.
   [Halder, Marlies; Rolaki, Alexandra] Commiss European Communities, Joint Res Ctr, Inst Hlth & Consumer Protect, Syst Toxicol Unit, I-21027 Ispra, Italy.
   [Murphy, Cheryl A.] Michigan State Univ, Lyman Briggs Coll, E Lansing, MI 48824 USA.
   [Roelofs, Dick] Vrije Univ Amsterdam, Inst Ecol Sci, NL-1081 HV Amsterdam, Netherlands.
   [Schirmer, Kristin] ETH, Dept Environm Syst Sci, CH-8092 Zurich, Switzerland.
   [Schirmer, Kristin] EPF Lausanne, Sch Architecture Civil & Environm Engn, CH-1015 Lausanne, Switzerland.
   [Watanabe, Karen H.] Oregon Hlth & Sci Univ, Inst Environm Hlth, Div Environm & Biomol Syst, Portland, OR 97239 USA.
RP Groh, KJ (reprint author), Eawag, Ueberlandstr 133,POB 611, CH-8600 Dubendorf, Switzerland.
EM ksenia.groh@eawag.ch
OI Groh, Ksenia/0000-0002-3778-4721; Roelofs, Dick/0000-0003-3954-3590
FU American Chemistry Council; BioDetection Systems; European Centre for
   Ecotoxicology and Toxicology of Chemicals; Environment Canada; European
   Commission Directorate General Joint Research Center; Human Toxicology
   Project Consortium; International Life Sciences Institute - Health and
   Environmental Science Institute; Research Council of NorwayResearch
   Council of Norway [221455]; Society for Environmental Toxicology and
   Chemistry; US Army Engineer Research and Development CenterUnited States
   Department of Defense; US Environmental Protection AgencyUnited States
   Environmental Protection Agency
FX We thank Daniel Villeneuve (US EPA) for constructive comments on the
   earlier version of this manuscript. We acknowledge the American
   Chemistry Council, BioDetection Systems, European Centre for
   Ecotoxicology and Toxicology of Chemicals, Environment Canada, European
   Commission Directorate General Joint Research Center, Human Toxicology
   Project Consortium, International Life Sciences Institute - Health and
   Environmental Science Institute, The Research Council of Norway (Grant
   No. 221455), Society for Environmental Toxicology and Chemistry, US Army
   Engineer Research and Development Center and the US Environmental
   Protection Agency that provided the support for the international expert
   workshop Advancing Adverse Outcome Pathways (AOPs) for Integrated
   Toxicology and Regulatory Applications, where the presented work has
   been initiated. The authors acknowledge the workshop organizing
   committee and all workshop participants for both plenary and informal
   discussions that influenced the content presented here.
CR Alvarez MD, 2006, AQUAT TOXICOL, V80, P329, DOI 10.1016/j.aquatox.2006.09.010
   Aniagu SO, 2008, ENVIRON INT, V34, P310, DOI 10.1016/j.envint.2007.03.009
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Arnot JA, 2012, ENVIRON HEALTH PERSP, V120, P1565, DOI 10.1289/ehp.1205355
   Ashauer R, 2013, INTEGR ENVIRON ASSES, V9, pE27, DOI 10.1002/ieam.1421
   Ashauer R, 2011, ENVIRON TOXICOL CHEM, V30, P2519, DOI 10.1002/etc.639
   Ashauer R, 2010, ENVIRON SCI TECHNOL, V44, P3963, DOI 10.1021/es903478b
   Auperin B, 2008, GEN COMP ENDOCR, V158, P234, DOI 10.1016/j.ygcen.2008.07.002
   Baas J, 2010, SCI TOTAL ENVIRON, V408, P3735, DOI 10.1016/j.scitotenv.2009.10.066
   Bachman AN, 2006, TOXICOL SCI, V91, P406, DOI 10.1093/toxsci/kfj179
   Bard SM, 2000, AQUAT TOXICOL, V48, P357, DOI 10.1016/S0166-445X(00)00088-6
   Basu N, 2007, NEUROTOXICOLOGY, V28, P587, DOI 10.1016/j.neuro.2006.12.007
   Bates SE, 2001, J BIOENERG BIOMEMBR, V33, P503, DOI 10.1023/A:1012879205914
   Beitel SC, 2014, AQUAT TOXICOL, V152, P273, DOI 10.1016/j.aquatox.2014.04.013
   Bergmann S, 2004, PLOS BIOL, V2, P85, DOI 10.1371/journal.pbio.0020009
   Bernal AJ, 2010, BIRTH DEFECTS RES A, V88, P938, DOI 10.1002/bdra.20685
   Boehm T, 2012, ANNU REV GENOM HUM G, V13, P127, DOI 10.1146/annurev-genom-090711-163747
   Brausch JM, 2012, REV ENVIRON CONTAM T, V218, P1, DOI 10.1007/978-1-4614-3137-4_1
   Brodin T, 2013, SCIENCE, V339, P814, DOI 10.1126/science.1226850
   Celander MC, 2011, ENVIRON TOXICOL CHEM, V30, P52, DOI 10.1002/etc.382
   Chapman P.F., 2007, METHODS UNCERTAINTY
   Clark JS, 2003, ECOLOGY, V84, P1370, DOI 10.1890/0012-9658(2003)084[1370:UAVIDA]2.0.CO;2
   Crews D, 2006, ENDOCRINOLOGY, V147, pS4, DOI 10.1210/en.2005-1122
   CROWDER LB, 1992, INDIVIDUAL-BASED MODELS AND APPROACHES IN ECOLOGY, P237
   Dolinoy DC, 2008, ENVIRON MOL MUTAGEN, V49, P4, DOI 10.1002/em.20366
   Domingo G., 2010, ILLICIT DRUGS ENV OC, P53
   Ellegren H, 2008, NATURE, V452, P169, DOI 10.1038/nature06737
   Ellinger-Ziegelbauer H, 2005, MUTAT RES-FUND MOL M, V575, P61, DOI 10.1016/j.mrfmmm.2005.02.004
   Ellinger-Ziegelbauer H, 2009, TOXICOL LETT, V186, P36, DOI 10.1016/j.toxlet.2008.08.017
   Ellison CM, 2011, EXPERT OPIN DRUG MET, V7, P1481, DOI 10.1517/17425255.2011.629186
   Enoch SJ, 2012, MUTAT RES-GEN TOX EN, V743, P10, DOI 10.1016/j.mrgentox.2011.12.029
   Fang XF, 2013, ENVIRON TOXICOL PHAR, V36, P40, DOI 10.1016/j.etap.2013.02.014
   Faulk C, 2011, EPIGENETICS-US, V6, P791, DOI 10.4161/epi.6.7.16209
   Fay KA, 2014, XENOBIOTICA, V44, P345, DOI 10.3109/00498254.2013.845704
   Feliciello I, 2013, EPIGENETICS-US, V8, P534, DOI 10.4161/epi.24507
   Feng SH, 2010, SCIENCE, V330, P622, DOI 10.1126/science.1190614
   Feng XZ, 2013, J GENET GENOMICS, V40, P153, DOI 10.1016/j.jgg.2012.12.007
   Fielden MR, 2011, TOXICOL SCI, V124, P54, DOI 10.1093/toxsci/kfr202
   Fischer S, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-69
   Flatt T, 2011, MECHANISMS OF LIFE HISTORY EVOLUTION: THE GENETICS AND PHYSIOLOGY OF LIFE HISTORY TRAITS AND TRADE-OFFS, P1
   Forbes VE, 2002, PHILOS T ROY SOC B, V357, P1299, DOI 10.1098/rstb.2002.1129
   Fu WJ, 2009, ENVIRON TOXICOL CHEM, V28, P1372, DOI 10.1897/08-233.1
   Fuiman LA, 2006, ANIM BEHAV, V71, P1389, DOI 10.1016/j.anbehav.2005.11.013
   Galic N, 2014, ENVIRON TOXICOL CHEM, V33, P1476, DOI 10.1002/etc.2481
   Garcia-Reyero N, 2011, ECOTOXICOLOGY, V20, P580, DOI 10.1007/s10646-011-0623-3
   Garcia-Reyero N, 2011, ENVIRON TOXICOL CHEM, V30, P265, DOI 10.1002/etc.401
   GHOSHAL AK, 1984, CARCINOGENESIS, V5, P1367, DOI 10.1093/carcin/5.10.1367
   Gicquel C, 2008, BEST PRACT RES CL EN, V22, P1, DOI 10.1016/j.beem.2007.07.009
   Gleeson MP, 2008, J MED CHEM, V51, P817, DOI 10.1021/jm701122q
   Greally JM, 2013, ALTEX-ALTERN ANIM EX, V30, P445, DOI 10.14573/altex.2013.4.445
   Groh K.J., 2014, NANOTOXICOLOGY, V14, P1
   Groh KJ, 2015, CHEMOSPHERE, V120, P778, DOI 10.1016/j.chemosphere.2014.10.006
   Gunnarsson L, 2008, ENVIRON SCI TECHNOL, V42, P5807, DOI 10.1021/es8005173
   Head JA, 2010, ECOTOXICOLOGY, V19, P377, DOI 10.1007/s10646-009-0421-3
   Heijmans BT, 2008, P NATL ACAD SCI USA, V105, P17046, DOI 10.1073/pnas.0806560105
   Hendren CO, 2013, ENVIRON SCI TECHNOL, V47, P1190, DOI 10.1021/es302749u
   Herath NI, 2006, J GASTROEN HEPATOL, V21, P15, DOI 10.1111/j.1440-1746.2005.04043.x
   Heugens EHW, 2001, CRIT REV TOXICOL, V31, P247, DOI 10.1080/20014091111695
   Jager T, 2005, ENVIRON SCI TECHNOL, V39, P8307, DOI 10.1021/es050817y
   Jager T, 2014, ECOL MODEL, V280, P140, DOI 10.1016/j.ecolmodel.2013.06.024
   Jager T, 2011, ENVIRON SCI TECHNOL, V45, P2529, DOI 10.1021/es103092a
   Jeliazkova N, 2012, EXPERT OPIN DRUG MET, V8, P791, DOI 10.1517/17425255.2012.685158
   Jeon J, 2013, ENVIRON SCI TECHNOL, V47, P8809, DOI 10.1021/es400833g
   Knudsen TB, 2011, TOXICOLOGY, V282, P1, DOI 10.1016/j.tox.2010.12.010
   Kooijman SALM, 2008, BIOL REV, V83, P533, DOI 10.1111/j.1469-185X.2008.00053.x
   Kooijman SALM, 1996, WATER RES, V30, P1633, DOI 10.1016/0043-1354(96)00057-7
   Kramer VJ, 2011, ENVIRON TOXICOL CHEM, V30, P64, DOI 10.1002/etc.375
   Kretschmann A, 2012, ENVIRON TOXICOL CHEM, V31, P2014, DOI 10.1002/etc.1905
   Krewski D, 2010, J TOXICOL ENV HEAL B, V13, P51, DOI 10.1080/10937404.2010.483176
   Kucharski R, 2008, SCIENCE, V319, P1827, DOI 10.1126/science.1153069
   Kulkarni SA, 2005, XENOBIOTICA, V35, P955, DOI 10.1080/00498250500354402
   KURELEC B, 1992, CRIT REV TOXICOL, V22, P23, DOI 10.3109/10408449209145320
   Lagisz M, 2005, ARCH ENVIRON CON TOX, V48, P484, DOI 10.1007/s00244-004-0023-2
   LaLone CA, 2013, AQUAT TOXICOL, V144, P141, DOI 10.1016/j.aquatox.2013.09.004
   Laskowski R, 2010, SCI TOTAL ENVIRON, V408, P3763, DOI 10.1016/j.scitotenv.2010.01.043
   Li D, 2009, AQUAT TOXICOL, V91, P229, DOI 10.1016/j.aquatox.2008.11.007
   Li ZH, 2011, CAN J FISH AQUAT SCI, V68, P1528, DOI 10.1139/f2011-066
   Li ZH, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-63
   Lokke H, 2013, TOXICOLOGY, V313, P73, DOI 10.1016/j.tox.2012.11.009
   Lu Y, 2009, BIOINFORMATICS, V25, P1476, DOI 10.1093/bioinformatics/btp247
   Lyko F, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000506
   Lyko F, 2011, TRENDS GENET, V27, P127, DOI 10.1016/j.tig.2011.01.003
   Mackay D, 2003, SAR QSAR ENVIRON RES, V14, P7, DOI 10.1080/1062936021000058746
   Martin BT, 2013, ECOTOXICOLOGY, V22, P574, DOI 10.1007/s10646-013-1049-x
   McCarroll SA, 2004, NAT GENET, V36, P197, DOI 10.1038/ng1291
   Meredith-Williams M, 2012, ENVIRON POLLUT, V165, P250, DOI 10.1016/j.envpol.2011.11.029
   Miller DH, 2007, ENVIRON TOXICOL CHEM, V26, P521, DOI 10.1897/06-318R.1
   Miller DH, 2004, ECOTOX ENVIRON SAFE, V59, P1, DOI 10.1016/j.ecoenv.2004.05.005
   Mirbahai L., 2013, MUTAT RES, V764-765, P10
   Mirbahai L, 2013, J PROTEOME RES, V12, P2895, DOI 10.1021/pr400195u
   Mirbahai L, 2011, EPIGENETICS-US, V6, P1319, DOI 10.4161/epi.6.11.17890
   Morgan AJ, 2007, ENVIRON SCI TECHNOL, V41, P1085, DOI 10.1021/es061992x
   Morgan HD, 2005, HUM MOL GENET, V14, pR47, DOI 10.1093/hmg/ddi114
   Munns Wayne R. Jr., 2008, P179
   Murphy CA, 2005, REPROD TOXICOL, V19, P395, DOI 10.1016/j.reprotox.2004.09.006
   Murphy CA, 2008, AQUAT TOXICOL, V86, P470, DOI 10.1016/j.aquatox.2007.12.009
   Murphy CA, 2009, ENVIRON TOXICOL CHEM, V28, P1288, DOI 10.1897/08-304.1
   Nakamura Y, 2008, CHEMOSPHERE, V70, P865, DOI 10.1016/j.chemosphere.2007.06.089
   Nesan D, 2013, GEN COMP ENDOCR, V181, P35, DOI 10.1016/j.ygcen.2012.10.006
   Nesan D, 2012, MOL CELL ENDOCRINOL, V363, P85, DOI 10.1016/j.mce.2012.07.010
   Newbold RR, 2000, CARCINOGENESIS, V21, P1355, DOI 10.1093/carcin/21.7.1355
   Nichols JW, 2007, ENVIRON TOXICOL CHEM, V26, P1304, DOI 10.1897/06-259R.1
   Nichols JW, 2006, AQUAT TOXICOL, V78, P74, DOI 10.1016/j.aquatox.2006.01.017
   Nichols JW, 2013, ENVIRON TOXICOL CHEM, V32, P1611, DOI 10.1002/etc.2219
   Nichols JW, 2004, TOXICOL SCI, V77, P219, DOI 10.1093/toxsci/kfh032
   NICHOLS JW, 1990, TOXICOL APPL PHARM, V106, P433, DOI 10.1016/0041-008X(90)90338-U
   Nyman AM, 2014, ENVIRON SCI TECHNOL, V48, P5946, DOI 10.1021/es5005126
   Nyman AM, 2012, ECOTOXICOLOGY, V21, P1828, DOI 10.1007/s10646-012-0917-0
   Oliveira RF, 2012, J FISH BIOL, V81, P2127, DOI 10.1111/j.1095-8649.2012.03477.x
   Olsvik PA, 2014, COMP BIOCHEM PHYS C, V165, P17, DOI 10.1016/j.cbpc.2014.05.004
   Perkins E. J., 2014, TOXICOL SCI UNPUB
   Perkins EJ, 2013, ENVIRON HEALTH PERSP, V121, P1002, DOI 10.1289/ehp.1306638
   PIANKA ER, 1972, AM NAT, V106, P581, DOI 10.1086/282798
   Piechota P, 2013, J CHEM INF MODEL, V53, P1282, DOI 10.1021/ci400050v
   Pierron F, 2011, ECOTOXICOLOGY, V20, P1388, DOI 10.1007/s10646-011-0696-z
   Posthuma L, 2002, ENVIRON ECOL RISK AS, P3
   Qureshi IA, 2013, JAMA NEUROL, V70, P703, DOI 10.1001/jamaneurol.2013.1443
   Raimondo S., 2010, WEB BASED INTERSPECI
   Rana Brinda K, 2012, Methods Mol Biol, V897, P1, DOI 10.1007/978-1-61779-909-9_1
   Relyea R, 2006, ECOL LETT, V9, P1157, DOI 10.1111/j.1461-0248.2006.00966.x
   Rendal C, 2011, ENVIRON TOXICOL CHEM, V30, P2395, DOI 10.1002/etc.641
   Rodriguez-Cortez VC, 2011, EPIGENOMICS-UK, V3, P697, DOI [10.2217/EPI.11.99, 10.2217/epi.11.99]
   Roelofs D, 2010, EVOL ECOL, V24, P527, DOI 10.1007/s10682-009-9345-x
   Roelofs D, 2009, MOL ECOL, V18, P3227, DOI 10.1111/j.1365-294X.2009.04261.x
   Roff D. A., 2002, LIFE HIST EVOLUTION
   Rose KA, 2005, CAN J FISH AQUAT SCI, V62, P886, DOI 10.1139/F05-049
   Rubach MN, 2010, ENVIRON TOXICOL CHEM, V29, P2225, DOI 10.1002/etc.273
   Sebire M, 2011, AQUAT TOXICOL, V105, P78, DOI 10.1016/j.aquatox.2011.05.014
   Skinner MK, 2010, TRENDS ENDOCRIN MET, V21, P214, DOI 10.1016/j.tem.2009.12.007
   Sousa T, 2010, PHILOS T R SOC B, V365, P3413, DOI 10.1098/rstb.2010.0166
   Spromberg JA, 2005, ENVIRON TOXICOL CHEM, V24, P1532, DOI 10.1897/04-160.1
   Stadnicka J, 2012, ENVIRON SCI TECHNOL, V46, P3273, DOI 10.1021/es2043728
   Stadnicka-Michalak J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092303
   Stearns S.C., 1989, EVOLUTION LIFE HIST
   Stromqvist M, 2010, AQUAT TOXICOL, V98, P275, DOI 10.1016/j.aquatox.2010.02.023
   Sturla SJ, 2014, CHEM RES TOXICOL, V27, P314, DOI 10.1021/tx400410s
   Suter GW, 2002, ENVIRON ECOL RISK AS, P11
   Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341
   Svechnikov K, 2014, ASIAN J ANDROL, V16, P50, DOI 10.4103/1008-682X.122199
   Szyf M, 2009, BBA-GEN SUBJECTS, V1790, P878, DOI 10.1016/j.bbagen.2009.01.009
   TenBrook PL, 2010, REV ENVIRON CONTAM T, V209, P1, DOI 10.1007/978-1-4419-6883-8_1
   Thomas RS, 2007, TOXICOL SCI, V96, P40, DOI 10.1093/toxsci/kfl171
   Tirosh I, 2007, CURR OPIN BIOTECH, V18, P371, DOI 10.1016/j.copbio.2007.07.003
   Tirosh I, 2006, NAT GENET, V38, P830, DOI 10.1038/ng1819
   Vahter ME, 2007, J NUTR, V137, P2798
   Van Straalen N, 2003, ENVIRON SCI TECHNOL, V37, p324A
   Vandegehuchte MB, 2011, ECOTOXICOLOGY, V20, P607, DOI 10.1007/s10646-011-0634-0
   Varsamos S, 2006, FISH SHELLFISH IMMUN, V20, P83, DOI 10.1016/j.fsi.2005.04.005
   Vedani A, 2012, TOXICOL APPL PHARM, V261, P142, DOI 10.1016/j.taap.2012.03.018
   Villeneuve D.L., TOX SCI IN PRESS
   Villeneuve D, 2014, ENVIRON TOXICOL CHEM, V33, P158, DOI 10.1002/etc.2403
   Vinken M, 2013, TOXICOLOGY, V312, P158, DOI 10.1016/j.tox.2013.08.011
   Volz DC, 2011, TOXICOL SCI, V123, P349, DOI 10.1093/toxsci/kfr185
   Walker CH, 2008, ATLA-ALTERN LAB ANIM, V36, P103, DOI 10.1177/026119290803600111
   Wang YQ, 2009, AQUAT TOXICOL, V95, P93, DOI 10.1016/j.aquatox.2009.06.008
   Watanabe KH, 2009, TOXICOL SCI, V109, P180, DOI 10.1093/toxsci/kfp069
   Weaver ICG, 2007, EPIGENETICS, V2, P22, DOI 10.4161/epi.2.1.3881
   Wenger M, 2011, FISH SHELLFISH IMMUN, V31, P90, DOI 10.1016/j.fsi.2011.04.007
   Wetmore BA, 2012, TOXICOL SCI, V125, P157, DOI 10.1093/toxsci/kfr254
   Whitehead A, 2013, MOL ECOL, V22, P3780, DOI 10.1111/mec.12316
   Williams TD, 2014, BRIEF FUNCT GENOMICS, V13, P157, DOI 10.1093/bfgp/elt053
   Wu SD, 2013, CHEM RES TOXICOL, V26, P1840, DOI 10.1021/tx400226u
   Xie LT, 2004, ENVIRON TOXICOL CHEM, V23, P1499, DOI 10.1897/03-96
   Yang YD, 2012, J MED CHEM, V55, P3667, DOI 10.1021/jm201548z
   Yue Y., 2014, NANOTOXICOLOGY, V12, P1
   Zama AM, 2010, FRONT NEUROENDOCRIN, V31, P420, DOI 10.1016/j.yfrne.2010.06.003
   Zimmer EI, 2012, ECOTOXICOLOGY, V21, P2195, DOI 10.1007/s10646-012-0973-5
NR 167
TC 74
Z9 75
U1 6
U2 185
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0045-6535
EI 1879-1298
J9 CHEMOSPHERE
JI Chemosphere
PD FEB
PY 2015
VL 120
BP 764
EP 777
DI 10.1016/j.chemosphere.2014.09.068
PG 14
WC Environmental Sciences
SC Environmental Sciences & Ecology
GA AZ1MN
UT WOS:000348003200104
PM 25439131
OA Other Gold, Green Published
DA 2019-10-23
ER

PT J
AU Preston, RJ
AF Preston, R. Julian
TI INTEGRATING BASIC RADIOBIOLOGICAL SCIENCE AND EPIDEMIOLOGICAL STUDIES:
   WHY AND HOW
SO HEALTH PHYSICS
LA English
DT Article
DE National Council on Radiation Protection and Measurements; biological
   indicators; epidemiology; risk analysis
ID DOSE-RESPONSE; RADIATION-EXPOSURE; KEY EVENTS; RISK-ASSESSMENT;
   HEALTH-RISKS; CANCER-RISKS; MODE; CHILDHOOD; BIOLOGY; CARCINOGENS
AB There is quite an extensive set of epidemiology studies conducted for a range of different radiation exposure scenarios and in some cases at doses that can be considered to be in the low dose range (< 100 mGy). In addition, there is an extensive literature on the effects of radiation at animal and cellular levels, as well as expanding knowledge of the underlying mechanisms of disease formation (both cancer and non-cancer). A significant concern is that these two areas of study have been linked rarely to support each other-to enhance low dose/low dose-rate extrapolation and reduction of uncertainty in risk estimates. Research should provide specific types of data to support the epidemiology and thereby enhance the radiation risk assessment process. Such an approach is one that can be adapted from that used for chemical exposures. It is based on the concept of adverse outcome pathways for the formation of adverse health outcomes. The adverse outcome pathway conceptual framework is considered to be a logical sequence of events (so-called key events) or processes within biological systems that can be used to understand adverse effects and refine the current risk assessment practice. This approach, which has only been used currently for chemicals, shifts the risk assessment focus from traditional apical endpoints (e.g., cancer and cardiovascular disease) to the development of a mechanistic understanding of effects at a molecular and cellular level. The need is to further the knowledge of the key events in radiation-induced diseases and to provide information on the dose and dose-rate response for these. It is proposed that the key-event approach be used in conjunction with enhanced radiation epidemiology data to reduce overall uncertainty in low dose/low dose-rate cancer and non-cancer risk estimates.
C1 US EPA, Natl Hlth & Environm Effects Res Lab, Res Triangle Pk, NC 27711 USA.
RP Preston, RJ (reprint author), US EPA, Natl Hlth & Environm Effects Res Lab, Res Triangle Pk, NC 27711 USA.
EM preston.julian@epa.gov
CR Andersen ME, 2014, CRIT REV TOXICOL, V44, P50, DOI 10.3109/10408444.2013.835785
   Boobis AR, 2009, CRIT REV FOOD SCI, V49, P690, DOI 10.1080/10408390903098673
   Boss MK, 2014, RADIAT RES, V181, P561, DOI 10.1667/RR13675.1
   Conolly RB, 2004, TOXICOL SCI, V82, P279, DOI 10.1093/toxsci/kfh223
   Edwards SW, 2008, TOXICOL SCI, V106, P312, DOI 10.1093/toxsci/kfn190
   Greene-Schloesser D, 2012, NEURO-ONCOLOGY, V14, P37, DOI 10.1093/neuonc/nos196
   Gulati S, 2013, SEMIN CANCER BIOL, V23, P219, DOI 10.1016/j.semcancer.2013.05.002
   Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013
   International Commission on Radiological Protection, 2012, ANN ICRP, V41
   International Commission on Radiological Protection, 2007, ANN ICRP, V37
   Jarabek AM, 2009, CRIT REV TOXICOL, V39, P659, DOI 10.1080/10408440903164155
   Julien E, 2009, CRIT REV FOOD SCI, V49, P682, DOI 10.1080/10408390903110692
   Kendall GM, 2013, LEUKEMIA, V27, P3, DOI 10.1038/leu.2012.151
   Land CE, 2009, HEALTH PHYS, V97, P407, DOI 10.1097/HP.0b013e3181b1871b
   Little MP, 2010, MUTAT RES-FUND MOL M, V687, P17, DOI 10.1016/j.mrfmmm.2010.01.008
   Little MP, 2010, RADIAT ENVIRON BIOPH, V49, P139, DOI 10.1007/s00411-009-0250-z
   Little MP, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-19
   Little MP, 2007, RADIAT RES, V169, P99
   Luebeck EG, 2013, CANCER RES, V73, P1086, DOI 10.1158/0008-5472.CAN-12-2198
   Luke NS, 2010, TOXICOL SCI, V115, P253, DOI 10.1093/toxsci/kfq021
   Meek MEB, 2013, REGUL TOXICOL PHARM, V66, P234, DOI 10.1016/j.yrtph.2013.03.012
   MOOLGAVKAR SH, 1981, J NATL CANCER I, V66, P1037, DOI 10.1093/jnci/66.6.1037
   MOOLGAVKAR SH, 1979, MATH BIOSCI, V47, P55, DOI 10.1016/0025-5564(79)90005-1
   Morgan WF, 2013, RADIAT RES, V179, P501, DOI 10.1667/RR3306.1
   Muirhead CR, 2009, BRIT J CANCER, V100, P206, DOI 10.1038/sj.bjc.6604825
   National Academies/ National Research Council, 2007, TOX TEST 21 CENT VIS
   National Academies/National Research Council, 2006, HLTH RISKS EXP LOW L
   Organization for Economic Co-ordination and Development, 2014, TEST CHEM ADV OUTC P
   Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0
   Pinto R, 2014, CANCER BIOMARK, V14, P103, DOI 10.3233/CBM-130328
   Preston RJ, 2013, J RADIOL PROT, V33, P573, DOI 10.1088/0952-4746/33/3/573
   Preston RJ, 2005, CRIT REV TOXICOL, V35, P673, DOI 10.1080/10408440591007278
   Ruan J, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-711
   Russom CL, 2014, ENVIRON TOXICOL CHEM, V33, P2157, DOI 10.1002/etc.2662
   Seed J, 2005, CRIT REV TOXICOL, V35, P663, DOI 10.1080/10408440591007133
   Shuryak I, 2010, JNCI-J NATL CANCER I, V102, P1628, DOI 10.1093/jnci/djq346
   Stewart FA, 2013, CLIN ONCOL-UK, V25, P617, DOI 10.1016/j.clon.2013.06.012
   Thomas RS, 2012, MUTAT RES-GEN TOX EN, V746, P135, DOI 10.1016/j.mrgentox.2012.01.007
   Uncertainties in the estimation of radiation risks and probability of disease causation, 2012, 171 NCRP
   United Nations, 2008, UN SCI COMM EFF AT R
   US Environmental Protection Agency, 2005, EPA630P03001F
   Zhao YC, 2012, DOSE-RESPONSE, V10, P251, DOI 10.2203/dose-response.11-021.Zhao
NR 42
TC 22
Z9 24
U1 0
U2 15
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0017-9078
EI 1538-5159
J9 HEALTH PHYS
JI Health Phys.
PD FEB
PY 2015
VL 108
IS 2
BP 125
EP 130
DI 10.1097/HP.0000000000000224
PG 6
WC Environmental Sciences; Public, Environmental & Occupational Health;
   Nuclear Science & Technology; Radiology, Nuclear Medicine & Medical
   Imaging
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health; Nuclear Science & Technology; Radiology, Nuclear Medicine &
   Medical Imaging
GA AX6YN
UT WOS:000347064100007
PM 25551492
DA 2019-10-23
ER

PT J
AU Knudsen, TB
   Keller, DA
   Sander, M
   Carney, EW
   Doerrer, NG
   Eaton, DL
   Fitzpatrick, SC
   Hastings, KL
   Mendrick, DL
   Tice, RR
   Watkins, PB
   Whelan, M
AF Knudsen, Thomas B.
   Keller, Douglas A.
   Sander, Miriam
   Carney, Edward W.
   Doerrer, Nancy G.
   Eaton, David L.
   Fitzpatrick, Suzanne Compton
   Hastings, Kenneth L.
   Mendrick, Donna L.
   Tice, Raymond R.
   Watkins, Paul B.
   Whelan, Maurice
TI FutureTox II: In vitro Data and In Silico Models for Predictive
   Toxicology
SO TOXICOLOGICAL SCIENCES
LA English
DT Editorial Material
DE in vitro; in silico; modeling; predictive toxicology; risk assessment
ID CELL-DERIVED CARDIOMYOCYTES; ADVERSE OUTCOME PATHWAYS; RISK-ASSESSMENT;
   ENVIRONMENTAL CHEMICALS; CONCEPTUAL-FRAMEWORK; 21(ST) CENTURY;
   STEM-CELLS; 21ST-CENTURY; SYSTEMS; VISION
AB FutureTox II, a Society of Toxicology Contemporary Concepts in Toxicology workshop, was held in January, 2014. The meeting goals were to review and discuss the state of the science in toxicology in the context of implementing the NRC 21st century vision of predicting in vivo responses from in vitro and in silico data, and to define the goals for the future. Presentations and discussions were held on priority concerns such as predicting and modeling of metabolism, cell growth and differentiation, effects on sensitive subpopulations, and integrating data into risk assessment. Emerging trends in technologies such as stem cell-derived human cells, 3D organotypic culture models, mathematical modeling of cellular processes and morphogenesis, adverse outcome pathway development, and high-content imaging of in vivo systems were discussed. Although advances in moving towards an in vitro/in silico based risk assessment paradigm were apparent, knowledge gaps in these areas and limitations of technologies were identified. Specific recommendations were made for future directions and research needs in the areas of hepatotoxicity, cancer prediction, developmental toxicity, and regulatory toxicology.
C1 [Knudsen, Thomas B.] US EPA, Res Triangle Pk, NC 27711 USA.
   [Keller, Douglas A.] Sanofi, Bridgewater, NJ 08807 USA.
   [Sander, Miriam] Page One Editorial Serv, Boulder, CO 80304 USA.
   [Carney, Edward W.] Dow Chem Co USA, Midland, MI 48674 USA.
   [Doerrer, Nancy G.] Hlth & Environm Sci Inst, Washington, DC 20005 USA.
   [Eaton, David L.] Univ Washington, Seattle, WA 98105 USA.
   [Fitzpatrick, Suzanne Compton; Mendrick, Donna L.] US FDA, Silver Spring, MD 20993 USA.
   [Hastings, Kenneth L.] Sanofi, Bethesda, MD 20814 USA.
   [Tice, Raymond R.] NIEHS, Res Triangle Pk, NC 27709 USA.
   [Watkins, Paul B.] Univ N Carolina, Chapel Hill, NC 27599 USA.
   [Watkins, Paul B.] Hamner Inst, Res Triangle Pk, NC 27709 USA.
   [Whelan, Maurice] European Commiss Joint Res Ctr, I-21027 Ispra, Italy.
RP Keller, DA (reprint author), Sanofi, 55C 420A,55 Corp Dr, Bridgewater, NJ 08807 USA.
EM douglas.keller@sanofi.com
OI Keller, Douglas/0000-0002-6186-2881
CR Andersen ME, 2010, TOXICOL SCI, V117, P17, DOI 10.1093/toxsci/kfq188
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Boekelheide K, 2010, TOXICOL SCI, V114, P20, DOI 10.1093/toxsci/kfp307
   Bus JS, 2009, TOXICOL SCI, V112, P297, DOI 10.1093/toxsci/kfp234
   Chapin RE, 2009, TOXICOL SCI, V112, P17, DOI 10.1093/toxsci/kfp202
   Chi KR, 2013, NAT REV DRUG DISCOV, V12, P564, DOI 10.1038/nrd4083
   Chiu WHA, 2013, TOXICOL APPL PHARM, V271, P309, DOI 10.1016/j.taap.2010.03.019
   Collins FS, 2008, SCIENCE, V319, P906, DOI 10.1126/science.1154619
   Dash A, 2013, AM J PHYSIOL-CELL PH, V304, pC1053, DOI 10.1152/ajpcell.00331.2012
   French J. E., ENV HLTH PERSP, DOI [10.1289/ehp.1408202, DOI 10.1289/EHP.1408202]
   Golbraikh A, 2014, J CHEM INF MODEL, V54, P1, DOI 10.1021/ci400572x
   Guo L, 2011, TOXICOL SCI, V123, P281, DOI 10.1093/toxsci/kfr158
   Hou PP, 2013, SCIENCE, V341, P651, DOI 10.1126/science.1239278
   Iraqi FA, 2012, GENETICS, V190, P389, DOI 10.1534/genetics.111.132639
   Jonsson MKB, 2012, J MOL CELL CARDIOL, V52, P998, DOI 10.1016/j.yjmcc.2012.02.002
   Kang JS, 2012, J PHARMACOL EXP THER, V341, P510, DOI 10.1124/jpet.112.192609
   Kavlock R, 2012, CHEM RES TOXICOL, V25, P1287, DOI 10.1021/tx3000939
   Keller DA, 2012, TOXICOL SCI, V126, P291, DOI 10.1093/toxsci/kfr350
   Kleinstreuer NC, 2014, NAT BIOTECHNOL, V32, P583, DOI 10.1038/nbt.2914
   Knudsen TB, 2011, BIRTH DEFECTS RES C, V93, P312, DOI 10.1002/bdrc.20223
   Kokel D, 2012, TRENDS BIOTECHNOL, V30, P421, DOI 10.1016/j.tibtech.2012.05.001
   Kramer VJ, 2011, ENVIRON TOXICOL CHEM, V30, P64, DOI 10.1002/etc.375
   Lamb J, 2007, NAT REV CANCER, V7, P54, DOI 10.1038/nrc2044
   Low Y, 2011, CHEM RES TOXICOL, V24, P1251, DOI 10.1021/tx200148a
   MacDonald JS, 2009, TOXICOL SCI, V110, P40, DOI 10.1093/toxsci/kfp088
   McDermott JE, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-190
   Meek B, 2009, TOXICOL SCI, V108, P19, DOI 10.1093/toxsci/kfp008
   Meek ME, 2014, J APPL TOXICOL, V34, P1, DOI 10.1002/jat.2949
   Moore TJ, 2007, ARCH INTERN MED, V167, P1752, DOI 10.1001/archinte.167.16.1752
   Moretti A, 2010, NEW ENGL J MED, V363, P1397, DOI 10.1056/NEJMoa0908679
   NRC (National Research Council), 2007, APPL TOX TECHN PRED
   NRC (National Research Council), 2007, TOX TEST 21 CENT VIS
   Peck D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r61
   Rabinovich Peter M, 2013, Methods Mol Biol, V969, P3, DOI 10.1007/978-1-62703-260-5_1
   Rotroff DM, 2013, ENVIRON HEALTH PERSP, V121, P7, DOI 10.1289/ehp.1205065
   Rowlands JC, 2014, TOXICOL SCI, V137, P269, DOI 10.1093/toxsci/kft252
   Sturla SJ, 2014, CHEM RES TOXICOL, V27, P314, DOI 10.1021/tx400410s
   Sutherland ML, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt361
   Swat MH, 2012, METHOD CELL BIOL, V110, P325, DOI 10.1016/B978-0-12-388403-9.00013-8
   Thomas RS, 2013, TOXICOL SCI, V134, P180, DOI 10.1093/toxsci/kft094
   Tice RR, 2013, ENVIRON HEALTH PERSP, V121, P756, DOI 10.1289/ehp.1205784
   Villeneuve DL, 2009, ENVIRON HEALTH PERSP, V117, P624, DOI 10.1289/ehp.11891
   Vinken M, 2013, TOXICOLOGY, V312, P158, DOI 10.1016/j.tox.2013.08.011
   Volz DC, 2011, TOXICOL SCI, V123, P349, DOI 10.1093/toxsci/kfr185
   Walker NJ, 2009, TOXICOL SCI, V110, P251, DOI 10.1093/toxsci/kfp106
   Watanabe KH, 2011, ENVIRON TOXICOL CHEM, V30, P9, DOI 10.1002/etc.373
   Wetmore BA, 2013, TOXICOL SCI, V132, P327, DOI 10.1093/toxsci/kft012
   Wetmore BA, 2012, TOXICOL SCI, V125, P157, DOI 10.1093/toxsci/kfr254
   Wu SD, 2013, CHEM RES TOXICOL, V26, P1840, DOI 10.1021/tx400226u
   Zeise L, 2013, ENVIRON HEALTH PERSP, V121, P23, DOI 10.1289/ehp.1205687
NR 50
TC 43
Z9 43
U1 1
U2 41
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1096-6080
EI 1096-0929
J9 TOXICOL SCI
JI Toxicol. Sci.
PD FEB
PY 2015
VL 143
IS 2
BP 256
EP 267
DI 10.1093/toxsci/kfu234
PG 12
WC Toxicology
SC Toxicology
GA CC1LK
UT WOS:000350102000004
PM 25628403
OA Green Published, Bronze
DA 2019-10-23
ER

PT J
AU Reisinger, K
   Hoffmann, S
   Alepee, N
   Ashikaga, T
   Barroso, J
   Elcombe, C
   Gellatly, N
   Galbiati, V
   Gibbs, S
   Groux, H
   Hibatallah, J
   Keller, D
   Kern, P
   Klaric, M
   Kolle, S
   Kuehnl, J
   Lambrechts, N
   Lindstedt, M
   Millet, M
   Martinozzi-Teissier, S
   Natsch, A
   Petersohn, D
   Pike, I
   Sakaguchi, H
   Schepky, A
   Tailhardat, M
   Templier, M
   van Vliet, E
   Maxwell, G
AF Reisinger, Kerstin
   Hoffmann, Sebastian
   Alepee, Nathalie
   Ashikaga, Takao
   Barroso, Joao
   Elcombe, Cliff
   Gellatly, Nicola
   Galbiati, Valentina
   Gibbs, Susan
   Groux, Herve
   Hibatallah, Jalila
   Keller, Donald
   Kern, Petra
   Klaric, Martina
   Kolle, Susanne
   Kuehnl, Jochen
   Lambrechts, Nathalie
   Lindstedt, Malin
   Millet, Marion
   Martinozzi-Teissier, Silvia
   Natsch, Andreas
   Petersohn, Dirk
   Pike, Ian
   Sakaguchi, Hitoshi
   Schepky, Andreas
   Tailhardat, Magalie
   Templier, Marie
   van Vliet, Erwin
   Maxwell, Gavin
TI Systematic evaluation of non-animal test methods for skin sensitisation
   safety assessment
SO TOXICOLOGY IN VITRO
LA English
DT Article
DE Skin sensitisation; Testing strategy; Safety assessment; Non-animal test
   methods; Adverse Outcome Pathways
ID EPIDERMAL EQUIVALENT ASSAY; PEPTIDE REACTIVITY; CELL-LINE; CONTACT
   ALLERGENS; IL-18 PRODUCTION; POTENCY; REPRODUCIBILITY; ACTIVATION;
   SIGNATURE; STRATEGY
AB The need for non-animal data to assess skin sensitisation properties of substances, especially cosmetics ingredients, has spawned the development of many in vitro methods. As it is widely believed that no single method can provide a solution, the Cosmetics Europe Skin Tolerance Task Force has defined a three-phase framework for the development of a non-animal testing strategy for skin sensitisation potency prediction. The results of the first phase systematic evaluation of 16 test methods are presented here. This evaluation involved generation of data on a common set of ten substances in all methods and systematic collation of information including the level of standardisation, existing test data, potential for throughput, transferability and accessibility in cooperation with the test method developers. A workshop was held with the test method developers to review the outcome of this evaluation and to discuss the results. The evaluation informed the prioritisation of test methods for the next phase of the non-animal testing strategy development framework. Ultimately, the testing strategy combined with bioavailability and skin metabolism data and exposure consideration is envisaged to allow establishment of a data integration approach for skin sensitisation safety assessment of cosmetic ingredients. (C) 2014 The Authors. Published by Elsevier Ltd.
C1 [Reisinger, Kerstin; Petersohn, Dirk] Henkel AG & CO KGaA, D-40191 Dusseldorf, Germany.
   [Hoffmann, Sebastian] Seh Consulting Serv, D-33098 Paderborn, Germany.
   [Alepee, Nathalie; Martinozzi-Teissier, Silvia] LOreal Res Ea Innovat, F-93600 Aulnay Sous Bois, France.
   [Ashikaga, Takao] Shiseido Co Ltd, Qual Assurance Ctr, Kanagawa, Japan.
   [Barroso, Joao; Klaric, Martina] Cosmet Europe, B-1160 Brussels, Belgium.
   [Elcombe, Cliff] OCR Biosci Ltd, Dundee DD1 5JJ, Scotland.
   [Gellatly, Nicola; Maxwell, Gavin] Unilever Safety & Environm Assurance Ctr, Sharnbrook MK44 1LQ, Beds, England.
   [Galbiati, Valentina] Univ Milan, Toxicol Lab, I-20133 Milan, Italy.
   [Gibbs, Susan] Vrije Univ Amsterdam, Med Ctr, Dept Dermatol, NL-1081 HV Amsterdam, Netherlands.
   [Groux, Herve] ImmunoSearch, F-06130 Le Plan De Grasse, France.
   [Hibatallah, Jalila] Chanel, F-92521 Neuilly Sur Seine, France.
   [Keller, Donald] Cyprotex LLC, Kalamazoo, MI USA.
   [Kern, Petra] Procter & Gamble Technol Beijing Co Ltd, Global Product Stewardship, KongGang Dev Area Area B, Beijing 101312, Peoples R China.
   [Kolle, Susanne] BASF SE, Expt Toxicol & Ecol, D-67056 Ludwigshafen, Germany.
   [Kuehnl, Jochen; Schepky, Andreas] Beiersdorf AG, D-20245 Hamburg, Germany.
   [Lambrechts, Nathalie] VITO NV, B-2400 Mol, Belgium.
   [Lindstedt, Malin] Lund Univ, Dept Immunotechnol, S-22381 Lund, Sweden.
   [Millet, Marion; Templier, Marie] Inst Rech Pierre Fabre, CEPC, F-81106 Castres, France.
   [Natsch, Andreas] Givaudan Schweiz AG, CH-8600 Dubendorf, Switzerland.
   [Pike, Ian] Proteome Sci Plc, Cobham KT11 3EP, England.
   [Sakaguchi, Hitoshi] Kao Corp, Ichikai, Tochigi, Japan.
   [Tailhardat, Magalie] LVMH Rech, F-45804 St Jean De Braye, France.
   [van Vliet, Erwin] SeCAM, CH-6982 Agno, Switzerland.
RP Reisinger, K (reprint author), Henkel AG & CO KGaA, Henkelstr 67, D-40191 Dusseldorf, Germany.
EM kerstin.reisinger@henkel.com; sebastian.hoffmann@seh-cs.com;
   nalepee@rd.loreal.com; takao.ashikaga@to.shiseido.cojp;
   Joao.BARROSO@ec.europa.eu; CliffElcombe@cxrbiosciences.com;
   Nichola.Gellatly@unilever.com; valentine.galbiati@unimi.it;
   S.Gibbs@vumc.nl; hgroux@immunosearch.fr;
   jalila.hibatallah@chanel-corp.com; dkeller@ceetox.com; kern.ps@pg.com;
   mklaric@cosmeticseurope.eu; susanne.kolle@basf.com;
   jochen.kuehnl@beiersdorf.com; nathalie.lambrechts@vito.be;
   malinlindstedt@immunith.se; marion.millet@pierre-fabre.com;
   steissier@rdloreal.com; andreas.natsch@givaudan.com;
   ian.pike@proteomics.com; sakaguchi.hitoshi@kao.cojp;
   andreas.schepky@beiersdorf.com; mtailhardat@research.lvmh-pc.com;
   marie.templier@pierre-fabre.com; erwin.vanvliet@secam-ce.eu;
   Gavin.Maxwell@unilever.com
RI Lindstedt, Malin/A-3855-2009
OI Lindstedt, Malin/0000-0001-9136-1087; Natsch,
   Andreas/0000-0003-2231-2489; Hoffmann, Sebastian/0000-0002-3214-7678
CR Ade Nadege, 2006, J Immunotoxicol, V3, P189, DOI 10.1080/15476910600978038
   Adler S, 2011, ARCH TOXICOL, V85, P367, DOI 10.1007/s00204-011-0693-2
   Ainscough JS, 2013, J IMMUNOTOXICOL, V10, P223, DOI 10.3109/1547691X.2012.711782
   Ashikaga T, 2010, ATLA-ALTERN LAB ANIM, V38, P275, DOI 10.1177/026119291003800403
   Basketter DA, 2014, DERMATITIS, V25, P11, DOI 10.1097/DER.0000000000000003
   Bauch C, 2012, REGUL TOXICOL PHARM, V63, P489, DOI 10.1016/j.yrtph.2012.05.013
   Corsini E, 2009, TOXICOL IN VITRO, V23, P789, DOI 10.1016/j.tiv.2009.04.005
   Cottrez F., 2011, 8 WORLD C ALT MONTR
   dos Santos GG, 2011, TOXICOL IN VITRO, V25, P347, DOI 10.1016/j.tiv.2010.10.008
   Emter R, 2010, TOXICOL APPL PHARM, V245, P281, DOI 10.1016/j.taap.2010.03.009
   Galbiati V, 2011, TOXICOL IN VITRO, V25, P724, DOI 10.1016/j.tiv.2010.12.011
   Gerberick GF, 2007, TOXICOL SCI, V97, P417, DOI 10.1093/toxsci/kfm064
   Gerberick GF, 2009, TOXICOL SCI, V112, P164, DOI 10.1093/toxsci/kfp192
   Gerberick GF, 2005, DERMATITIS, V16, P157, DOI 10.2310/6620.2005.05040
   Gerberick GF, 2004, TOXICOL SCI, V81, P332, DOI 10.1093/toxsci/kfh213
   Gibbs S, 2013, TOXICOL APPL PHARM, V272, P529, DOI 10.1016/j.taap.2013.07.003
   Goebel C, 2012, REGUL TOXICOL PHARM, V63, P40, DOI 10.1016/j.yrtph.2012.02.007
   Gomes C, 2012, COMPST 2012 P, P271
   Hooyberghs J, 2008, TOXICOL APPL PHARM, V231, P103, DOI 10.1016/j.taap.2008.03.014
   Jaworska J., 2013, J APPL TOXICOL
   Jaworska J, 2011, ALTEX-ALTERN ANIM EX, V28, P211, DOI 10.14573/altex.2011.3.211
   Jaworska Joanna, 2010, ALTEX, V27, P231
   Johansson H, 2013, TOXICOL IN VITRO, V27, P1163, DOI 10.1016/j.tiv.2012.05.019
   Johansson H, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-399
   Jowsey IR, 2006, J APPL TOXICOL, V26, P341, DOI 10.1002/jat.1146
   Kimber I, 2012, CONTACT DERMATITIS, V67, P179, DOI 10.1111/j.1600-0536.2012.02148.x
   Lambrechts N, 2011, TOXICOL LETT, V203, P106, DOI 10.1016/j.toxlet.2011.02.015
   Lambrechts N, 2010, TOXICOL SCI, V116, P122, DOI 10.1093/toxsci/kfq108
   MacKay C, 2013, ALTEX-ALTERN ANIM EX, V30, P473, DOI 10.14573/altex.2013.4.473
   Martin SF, 2011, ALLERGY, V66, P1152, DOI 10.1111/j.1398-9995.2011.02652.x
   Maxwell G, 2011, ALTEX-ALTERN ANIM EX, V28, P50, DOI 10.14573/altex.2011.1.050
   McKim JM, 2012, CUTAN OCUL TOXICOL, V31, P292, DOI 10.3109/15569527.2012.667031
   Natsch A., 2013, J APPL TOXICOL
   Natsch A, 2008, TOXICOL SCI, V102, P110, DOI 10.1093/toxsci/kfm259
   Natsch A, 2011, TOXICOL IN VITRO, V25, P733, DOI 10.1016/j.tiv.2010.12.014
   Nukada Y, 2013, TOXICOL IN VITRO, V27, P609, DOI 10.1016/j.tiv.2012.11.006
   OECD, 2012, SER TEST ASS, V168
   Reuter H, 2011, TOXICOL IN VITRO, V25, P315, DOI 10.1016/j.tiv.2010.09.016
   Teunis M, 2013, TOXICOL IN VITRO, V27, P1135, DOI 10.1016/j.tiv.2012.06.004
   Teunis MAT, 2014, ALTEX-ALTERN ANIM EX, V31, P251, DOI http://dx.doi.org/10.14573/altex.1308021
   Thierse H.J., 2011, PROGR NOVEL TESTING, P145
   Toebak MJ, 2009, CONTACT DERMATITIS, V60, P2, DOI 10.1111/j.1600-0536.2008.01443.x
   van der Veen JWD, 2015, TOXICOL IN VITRO, V29, P81, DOI 10.1016/j.tiv.2014.08.010
   Wang XJ, 2006, CANCER RES, V66, P10983, DOI 10.1158/0008-5472.CAN-06-2298
NR 44
TC 65
Z9 68
U1 0
U2 31
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0887-2333
J9 TOXICOL IN VITRO
JI Toxicol. Vitro
PD FEB
PY 2015
VL 29
IS 1
BP 259
EP 270
DI 10.1016/j.tiv.2014.10.018
PG 12
WC Toxicology
SC Toxicology
GA AY7NL
UT WOS:000347746600034
PM 25448812
OA Other Gold, Green Published
DA 2019-10-23
ER

PT J
AU Garcia-Reyero, N
AF Garcia-Reyero, Natalia
TI Are Adverse Outcome Pathways Here to Stay?
SO ENVIRONMENTAL SCIENCE & TECHNOLOGY
LA English
DT Article
ID PRACTICAL APPLICATION; CONCEPTUAL-FRAMEWORK; RISK-ASSESSMENT; IPCS
   FRAMEWORK; MODE; ECOTOXICOLOGY; RELEVANCE; STRATEGY; VISION; HEALTH
AB Social pressure to minimize the use of animal testing and the ever-increasing concern on animal welfare, together with the need for more human-relevant and more predictive toxicity tests, are some of the drivers for new approaches to chemical screening. These approaches must also be able to accelerate the screening and assessment of the thousands of chemicals that are currently in use and in development for potential hazards to human and ecological health. Ideally, approaches are needed that decrease (or eliminate) animal testing while increasing predictivity. Efforts in many countries have focused on a toxicological pathway-based vision for human health assessments relying on in vitro systems and predictive models,(1) vision equally applicable to ecological risk assessment.(2) A pathway-based analysis of chemical effects opens numerous opportunities to apply nontraditional approaches for understanding the risks of chemical exposure. Conservation of molecular initiating and key events leading to adverse outcomes of regulatory concern provide a defensible framework for extrapolating chemical effects across species, even if the specific adverse outcomes differ between them.(3)
C1 Mississippi State Univ, Inst Gen Biocomp & Biotechnol, Starkville, MS 39762 USA.
RP Garcia-Reyero, N (reprint author), Mississippi State Univ, Inst Gen Biocomp & Biotechnol, Starkville, MS 39762 USA.
EM natalia@icnanotox.org
FU American Chemistry Council; BioDetection Systems; European Centre for
   Ecotoxicology and Toxicology of Chemicals; Environment Canada; European
   Commission Directorate General Joint Research Center; Human Toxicology
   Project Consortium; International Life Sciences Institute Health and
   Environmental Science Institute; Research Council of NorwayResearch
   Council of Norway [221455]; Society for Environmental Toxicology and
   Chemistry; US Army Engineer Research and Development CenterUnited States
   Department of Defense; U.S. Environmental Protection AgencyUnited States
   Environmental Protection Agency
FX The content of this Feature Article is the result of an international
   expert workshop on Advancing Adverse Outcome Pathways (AOPs) for
   Integrated Toxicology and Regulatory Applications. More information on
   the workshop, including products and papers, can be found at
   https://aopkb.org/saop/workshops/somma.html. Support for the workshop
   was provided by the American Chemistry Council, BioDetection Systems,
   European Centre for Ecotoxicology and Toxicology of Chemicals,
   Environment Canada, European Commission Directorate General Joint
   Research Center, Human Toxicology Project Consortium, International Life
   Sciences Institute Health and Environmental Science Institute, the
   Research Council of Norway (Grant no. 221455), Society for Environmental
   Toxicology and Chemistry, US Army Engineer Research and Development
   Center, and the U.S. Environmental Protection Agency. The author
   acknowledges the workshop organizing committee (Rick Becker, Ksenia
   Groh, Marlies Halder, Sean Kennedy, Teresa Lettieri, Edward Perkins,
   Knut Erik Tollefsen, Bart van der Burg, Dan Villeneuve, and Maurice
   Whelan), and all workshop participants for both plenary and informal
   discussions that influenced the content presented here. Also special
   thanks to Eva Ahs (JRC), Nikki Mayo (SETAC), and Greg Schiefer (SETAC).
   Without their help this workshop would not have been possible. I also
   thank Edward Perkins for critical comments on an earlier version of this
   manuscript. While this article is a product of the above-mentioned
   workshop, the contents do not necessarily reflect the views of the
   organizing committee, participants, nor sponsors, and I take full blame
   for them.
CR Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Bauer-Mehren A, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.47
   Boobis AR, 2008, CRIT REV TOXICOL, V38, P87, DOI 10.1080/10408440701749421
   Boobis AR, 2006, CRIT REV TOXICOL, V36, P781, DOI 10.1080/10408440600977677
   Burgess-Herbert SL, 2013, TOXICOL APPL PHARM, V271, P372, DOI 10.1016/j.taap.2011.11.011
   Carvunis AR, 2014, CELL, V157, P534, DOI 10.1016/j.cell.2014.03.009
   Celander MC, 2011, ENVIRON TOXICOL CHEM, V30, P52, DOI 10.1002/etc.382
   Collins FS, 2008, SCIENCE, V319, P906, DOI 10.1126/science.1154619
   Cote I, 2012, ENVIRON HEALTH PERSP, V120, P1499, DOI 10.1289/ehp.1104870
   Forbes VE, 2012, ENVIRON TOXICOL CHEM, V31, P2663, DOI 10.1002/etc.2009
   Forbes VE, 1999, ENVIRON TOXICOL CHEM, V18, P1544, DOI 10.1002/etc.5620180729
   Groh KJ, 2015, CHEMOSPHERE, V120, P764, DOI 10.1016/j.chemosphere.2014.09.068
   Groh KJ, 2015, CHEMOSPHERE, V120, P778, DOI 10.1016/j.chemosphere.2014.10.006
   Gunnarsson L, 2008, ENVIRON SCI TECHNOL, V42, P5807, DOI 10.1021/es8005173
   HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503
   Kavlock R, 2012, CHEM RES TOXICOL, V25, P1287, DOI 10.1021/tx3000939
   Kleinstreuer NC, 2014, NAT BIOTECHNOL, V32, P583, DOI 10.1038/nbt.2914
   Kostich MS, 2008, SCI TOTAL ENVIRON, V389, P329, DOI 10.1016/j.scitotenv.2007.09.008
   Kramer VJ, 2011, ENVIRON TOXICOL CHEM, V30, P64, DOI 10.1002/etc.375
   Krewski D, 2010, J TOXICOL ENV HEAL B, V13, P51, DOI 10.1080/10937404.2010.483176
   Meek B, 2003, TOXICOL LETT, V138, P151, DOI 10.1016/S0378-4274(02)00371-5
   Meek ME, 2014, J APPL TOXICOL, V34, P1, DOI 10.1002/jat.2949
   Nichols JW, 2011, ENVIRON TOXICOL CHEM, V30, P39, DOI 10.1002/etc.376
   NRC, 2007, VIS STRAT
   OECD, 2013, SER TEST ASS, V184, P145
   Perkins E. J., 2014, TOXICOL SCI UNPUB
   Perkins EJ, 2013, ENVIRON HEALTH PERSP, V121, P1002, DOI 10.1289/ehp.1306638
   Perkins EJ, 2011, ENVIRON TOXICOL CHEM, V30, P22, DOI 10.1002/etc.374
   Tollefsen K. E., 2014, REGUL TOXICOL PHARM, P1
   Villeneuve D, 2014, ENVIRON TOXICOL CHEM, V33, P158, DOI 10.1002/etc.2403
   Villeneuve DL, 2014, TOXICOL SCI, V142, P312, DOI 10.1093/toxsci/kfu199
   Villeneuve DL, 2011, ENVIRON TOXICOL CHEM, V30, P1, DOI 10.1002/etc.396
   Volz DC, 2011, TOXICOL SCI, V123, P349, DOI 10.1093/toxsci/kfr185
   Watanabe KH, 2011, ENVIRON TOXICOL CHEM, V30, P9, DOI 10.1002/etc.373
   Willett C, 2014, ALTEX-ALTERN ANIM EX, V31, P407, DOI http://dx.doi.org/10.14573/altex.1401283
   Willett C, 2014, ALTEX-ALTERN ANIM EX, V31, P500, DOI http://dx.doi.org/10.14573/altex.1401281
NR 36
TC 21
Z9 23
U1 1
U2 46
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0013-936X
EI 1520-5851
J9 ENVIRON SCI TECHNOL
JI Environ. Sci. Technol.
PD JAN 6
PY 2015
VL 49
IS 1
BP 3
EP 9
DI 10.1021/es504976d
PG 7
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA AY5BW
UT WOS:000347589300002
PM 25469516
OA Other Gold
DA 2019-10-23
ER

PT J
AU Lucero, ML
   Peither, A
   Ledo, F
AF Lucero, Maria Luisa
   Peither, Armin
   Ledo, Francisco
TI Bilastine: an environmental risk assessment
SO DRUG AND CHEMICAL TOXICOLOGY
LA English
DT Article
DE Antihistamine; biodegradability; ecotoxicology; toxicology
ID ADVERSE OUTCOME PATHWAYS; DOSE LEVELS
AB Context: Bilastine is a new oral selective, non-sedating histamine H-1 antagonist for the symptomatic treatment of allergic rhinoconjunctivitis and urticaria. The European Medicines Agency requires an Environmental Risk Assessment (ERA) for all novel medicines for human use. Objective: To calculate the bilastine predicted environmental concentration in surface water (PECsw; phase I ERA), and to determine the effects of bilastine on aquatic systems (phase II [ tier A]). Materials and methods: Bilastine PECsw was calculated using the maximum daily dosage (20 mg), assuming that all administered bilastine was released into the aquatic environment. A persistence, bioaccumulation and toxicity assessment was conducted using the log K-ow from the molecular structure. In phase II (tier A), a ready biodegradability test was performed, and bilastine's potential toxicity to various aquatic and sediment-dwelling micro-organisms was evaluated. Results: Bilastine PECsw was calculated as 0.1 mu gL(-1), and the compound was not readily biodegradable. Bilastine had no significant effects on Chironomus riparius midges, or on the respiration rate of activated sludge. For green algae, the bilastine no observed effect concentration (NOEC) was 22mgL(-1); bilastine had no effect on zebra fish development, or on the reproduction rate of daphnids. Discussion: Bilastine NOEC values against zebra fish, algae, daphnids, and aerobic organisms in activated sludge were at least 130 000-fold greater than the calculated PECsw value. Conclusion: No environmental concerns exist from bilastine use in patients with allergic rhinoconjunctivitis or urticaria.
C1 [Lucero, Maria Luisa; Ledo, Francisco] FAES Farma SA, Leioa 48940, Spain.
   [Peither, Armin] Harlan Labs Ltd, Itingen, Switzerland.
RP Ledo, F (reprint author), FAES Farma SA, Auton 10, Leioa 48940, Spain.
EM fledo@faes.es
FU FAES Farma S.A., Spain
FX The study was funded by FAES Farma S.A., Spain. FLG and MLL are employed
   by FAES Farma; AP is an employee of Harlan Laboratories Ltd.
CR Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   [Anonymous], 2006, OECD GUID TEST CHEM
   [Anonymous], 2004, OECD GUID TEST CHEM
   Berninger JP, 2011, ENVIRON TOXICOL CHEM, V30, P2065, DOI 10.1002/etc.590
   Berninger JP, 2010, TOXICOL LETT, V193, P69, DOI 10.1016/j.toxlet.2009.12.006
   Brausch JM, 2012, REV ENVIRON CONTAM T, V218, P1, DOI 10.1007/978-1-4614-3137-4_1
   Church MK, 2011, EXPERT OPIN DRUG SAF, V10, P779, DOI 10.1517/14740338.2011.604029
   ECHA, 2014, GUID INF REQ CHEM SA
   EMEA, 2006, GUID ENV RISK ASS ME
   FAES Farma SA, 2013, DAT ON FIL
   Kramer VJ, 2011, ENVIRON TOXICOL CHEM, V30, P64, DOI 10.1002/etc.375
   Ledo F, 2010, TOXICOL LETT, V196, pS123, DOI 10.1016/j.toxlet.2010.03.431
   Lucero ML, 2012, DRUG CHEM TOXICOL, V35, P18, DOI 10.3109/01480545.2012.682651
   Medicines-Compendium-UK, 2012, SUMM PROD CHAR IL 20
   OECD, 2012, OECD GUID TEST CHEM
   OECD, 1992, OECD GUID TEST CHEM
   OECD, 2002, OECD GUID TEST CHEM
   OSPAR, 1992, CONV PROT MAR ENV N
   Watanabe KH, 2011, ENVIRON TOXICOL CHEM, V30, P9, DOI 10.1002/etc.373
   WILLIAMS DA, 1971, BIOMETRICS, V27, P103, DOI 10.2307/2528930
   WILLIAMS DA, 1972, BIOMETRICS, V28, P519, DOI 10.2307/2556164
NR 21
TC 0
Z9 0
U1 0
U2 11
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0148-0545
EI 1525-6014
J9 DRUG CHEM TOXICOL
JI Drug Chem. Toxicol.
PY 2015
VL 38
IS 4
BP 460
EP 468
DI 10.3109/01480545.2014.992438
PG 9
WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy; Toxicology
SC Chemistry; Pharmacology & Pharmacy; Toxicology
GA DD4UR
UT WOS:000369918800012
PM 25609003
DA 2019-10-23
ER

PT S
AU Fritsche, E
AF Fritsche, Ellen
BE Roberts, SM
   Kehrer, JP
   Klotz, LO
TI The Neural Progenitor Cell (NPC) Niche in the Adult Brain Provides a
   Target for Neurotoxicity: A Putative Adverse Outcome Pathway for
   ROS-Induced NPC Dysfunction with Higher Sensitivity During Aging
SO STUDIES ON EXPERIMENTAL TOXICOLOGY AND PHARMACOLOGY
SE Oxidative Stress in Applied Basic Research and Clinical Practice
LA English
DT Article; Book Chapter
ID AGE-RELATED DECLINE; HIPPOCAMPAL NEUROGENESIS; OXIDATIVE STRESS;
   SUBVENTRICULAR ZONE; BHLH REPRESSORS; CANCER-THERAPY; LIFE-SPAN;
   PARAQUAT; SIRT1; MECHANISM
C1 [Fritsche, Ellen] IUF Leibniz Res Inst Environm Med, Aufm Hennekamp 50, D-40225 Dusseldorf, Germany.
RP Fritsche, E (reprint author), IUF Leibniz Res Inst Environm Med, Aufm Hennekamp 50, D-40225 Dusseldorf, Germany.
EM ellen.fritsche@iuf-duesseldorf.de
CR Abou-Donia MB, 2003, ARCH ENVIRON HEALTH, V58, P484, DOI 10.3200/AEOH.58.8.484-497
   Ahles TA, 2007, NAT REV CANCER, V7, P192, DOI 10.1038/nrc2073
   Aizawa K, 2011, NEUROBIOL AGING, V32, P140, DOI 10.1016/j.neurobiolaging.2008.12.011
   ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303
   Andreyev AI, 2005, BIOCHEMISTRY-MOSCOW+, V70, P200, DOI 10.1007/s10541-005-0102-7
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014
   Bal-Price A, 2015, ARCH TOXICOL, V89, P269, DOI 10.1007/s00204-015-1464-2
   Bal-Price A, 2015, CRIT REV TOXICOL, V45, P83, DOI 10.3109/10408444.2014.981331
   Basketter DA, 2004, CONTACT DERMATITIS, V51, P1, DOI 10.1111/j.0105-1873.2004.00385.x
   Belenky P, 2007, TRENDS BIOCHEM SCI, V32, P12, DOI 10.1016/j.tibs.2006.11.006
   Bolton JL, 2000, CHEM RES TOXICOL, V13, P135, DOI 10.1021/tx9902082
   Bottini AA, 2009, ALTEX-ALTERN TIEREXP, V26, P3
   Breunig JJ, 2007, P NATL ACAD SCI USA, V104, P20558, DOI 10.1073/pnas.0710156104
   Cameron HA, 1999, NAT NEUROSCI, V2, P894, DOI 10.1038/13197
   Chang YT, 2008, PSYCHONEUROENDOCRINO, V33, P1173, DOI 10.1016/j.psyneuen.2008.05.014
   Cheng JP, 2009, CHEMOSPHERE, V75, P963, DOI 10.1016/j.chemosphere.2009.01.004
   CLEJAN L, 1989, BIOCHEM PHARMACOL, V38, P1779, DOI 10.1016/0006-2952(89)90412-7
   Collins FS, 2008, SCIENCE, V319, P906, DOI 10.1126/science.1154619
   Dinis-Oliveira RJ, 2006, NEUROTOXICOLOGY, V27, P1110, DOI 10.1016/j.neuro.2006.05.012
   Drapeau E, 2003, P NATL ACAD SCI USA, V100, P14385, DOI 10.1073/pnas.2334169100
   Driscoll I, 2006, NEUROSCIENCE, V139, P1173, DOI 10.1016/j.neuroscience.2006.01.040
   Dupret D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001959
   Eisch AJ, 2012, SCIENCE, V338, P72, DOI 10.1126/science.1222941
   Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305
   FERNANDEZ Y, 1995, BIOL TRACE ELEM RES, V47, P9, DOI 10.1007/BF02790096
   FUKUSHIMA T, 1993, EXP TOXICOL PATHOL, V45, P345
   Gibson E, 2012, CURR OPIN ONCOL, V24, P672, DOI 10.1097/CCO.0b013e3283571a8e
   Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365
   Greene-Schloesser D, 2012, FRONT ONCOL, V2
   Harry GJ, 1998, ENVIRON HEALTH PERSP, V106, P131, DOI 10.1289/ehp.98106s1131
   Hartung T, 2011, EUR J PHARM BIOPHARM, V77, P338, DOI 10.1016/j.ejpb.2010.12.027
   Hartung T, 2009, NATURE, V460, P208, DOI 10.1038/460208a
   Heuer H, 2013, BBA-GEN SUBJECTS, V1830, P3974, DOI 10.1016/j.bbagen.2012.04.009
   HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503
   Holloway KR, 2010, P NATL ACAD SCI USA, V107, P9216, DOI 10.1073/pnas.0911325107
   Imai S, 2000, NATURE, V403, P795
   Ishibashi M, 1995, GENE DEV, V9, P3136, DOI 10.1101/gad.9.24.3136
   Joseph JA, 2009, J NUTR, V139, p1813S, DOI 10.3945/jn.109.108266
   Kempermann G, 1998, J NEUROSCI, V18, P3206
   Kempermann G, 2002, ANN NEUROL, V52, P135, DOI 10.1002/ana.10262
   Klempin F, 2013, J NEUROSCI, V33, P8270, DOI 10.1523/JNEUROSCI.5855-12.2013
   Knoth R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008809
   Kronenberg G, 2006, NEUROBIOL AGING, V27, P1505, DOI 10.1016/j.neurobiolaging.2005.09.016
   Kuhn HG, 1996, J NEUROSCI, V16, P2027
   Kukekov VG, 1999, EXP NEUROL, V156, P333, DOI 10.1006/exnr.1999.7028
   L'Episcopo F, 2013, J NEUROSCI, V33, P1462, DOI 10.1523/JNEUROSCI.3206-12.2013
   Lafenetre P, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00051
   LAI M, 1993, BIOCHEM PHARMACOL, V45, P927, DOI 10.1016/0006-2952(93)90178-Y
   Libert S, 2008, NAT CELL BIOL, V10, P373, DOI 10.1038/ncb0408-373
   Lin SJ, 2004, GENE DEV, V18, P12, DOI 10.1101/gad.1164804
   Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Maxwell G, 2014, TOXICOL IN VITRO, V28, P8, DOI 10.1016/j.tiv.2013.10.013
   Merzoug S, 2011, PHARMACOL BIOCHEM BE, V99, P639, DOI 10.1016/j.pbb.2011.06.015
   Michan S, 2010, J NEUROSCI, V30, P9695, DOI 10.1523/JNEUROSCI.0027-10.2010
   Milatovic D, 2009, TOXICOL APPL PHARM, V240, P219, DOI 10.1016/j.taap.2009.07.004
   Monje M, 2012, BEHAV BRAIN RES, V227, P376, DOI 10.1016/j.bbr.2011.05.012
   Montaron MF, 2006, NEUROBIOL AGING, V27, P645, DOI 10.1016/j.neurobiolaging.2005.02.014
   Moors M, 2009, ENV HLTH PERSPECT, V117
   Moors M, 2007, SCI DIRECT
   Nicolle MM, 2001, NEUROSCIENCE, V107, P415, DOI 10.1016/S0306-4522(01)00374-8
   Nieto M, 2001, NEURON, V29, P401, DOI 10.1016/S0896-6273(01)00214-8
   OECD, 2011, ENVJMMONO20118 OECD, V138
   OECD (Organization for Economic Co-operation and Development), 2013, GUID DOC DEV ASS ADV
   Ojha A, 2011, ENV TOXICOL
   Olgun A, 2009, BIOGERONTOLOGY, V10, P531, DOI 10.1007/s10522-008-9190-2
   Papandreou MA, 2011, BEHAV BRAIN RES, V219, P197, DOI 10.1016/j.bbr.2011.01.007
   Parras CM, 2004, EMBO J, V23, P4495, DOI 10.1038/sj.emboj.7600447
   Perreault M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062616
   REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558
   Robbins MEC, 2004, INT J RADIAT BIOL, V80, P251, DOI 10.1080/09553000410001692726
   Rosenberg MI, 2002, CELL, V109, P447, DOI 10.1016/S0092-8674(02)00732-8
   Saharan S, 2013, J NEUROSCI RES, V91, P642, DOI 10.1002/jnr.23199
   Sanders Talia, 2009, Reviews on Environmental Health, V24, P15
   Schwenk M, 2003, BUNDESGESUNDHEITSBLA, V46, P603
   Seki T, 1995, NEUROREPORT, V6, P2479, DOI 10.1097/00001756-199512150-00010
   Shih PH, 2007, BIOGERONTOLOGY, V8, P71, DOI 10.1007/s10522-006-9033-y
   Shimada H, 1998, ARCH BIOCHEM BIOPHYS, V351, P75, DOI 10.1006/abbi.1997.0557
   Shimada H, 2009, J BIOL CHEM, V284, P28642, DOI 10.1074/jbc.M109.033431
   Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584
   Suh JH, 2004, P NATL ACAD SCI USA, V101, P3381, DOI 10.1073/pnas.0400282101
   Takata T, 2003, BIOCHEM BIOPH RES CO, V301, P250, DOI 10.1016/S0006-291X(02)03020-6
   van Praag H, 2005, J NEUROSCI, V25, P8680, DOI 10.1523/JNEUROSCI.1731-05.2005
   van Wijngaarden P, 2013, DEVELOPMENT, V140, P2562, DOI 10.1242/dev.092262
   Watanabe KH, 2011, ENVIRON TOXICOL CHEM, V30, P9, DOI 10.1002/etc.373
   YAMADA K, 1993, EXP TOXICOL PATHOL, V45, P375
   Yamada KM, 2007, CELL, V130, P601, DOI 10.1016/j.cell.2007.08.006
   Zhao W, 2007, BRIT J RADIOL, V80, pS23, DOI 10.1259/bjr/18237646
   Zhu BZ, 2009, CHEM RES TOXICOL, V22, P969, DOI 10.1021/tx900030v
NR 89
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER INTERNATIONAL PUBLISHING AG
PI CHAM
PA GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND
SN 2197-7224
EI 2197-7232
BN 978-3-319-19096-9; 978-3-319-19095-2
J9 OXID STRESS APPL BAS
JI Oxid. Stress Appl. Basic Res. Clin. Pract.
PY 2015
BP 413
EP 425
DI 10.1007/978-3-319-19096-9_22
D2 10.1007/978-3-319-19096-9
PG 13
WC Pharmacology & Pharmacy; Toxicology
SC Pharmacology & Pharmacy; Toxicology
GA BE2MR
UT WOS:000369643500022
DA 2019-10-23
ER

PT J
AU Gong, P
   Hong, HX
   Perkins, EJ
AF Gong, Ping
   Hong, Huixiao
   Perkins, Edward J.
TI Ionotropic GABA receptor antagonism-induced adverse outcome pathways for
   potential neurotoxicity biomarkers
SO BIOMARKERS IN MEDICINE
LA English
DT Review
DE adverse outcome pathway; antagonist; chloride channel; cross-species
   extrapolation; epileptic seizure; ionotropic gamma-aminobutyric acid
   receptor; metabotropic GABA receptor; neurotransmission; neurotoxicity
   biomarker; risk assessment
ID GAMMA-AMINOBUTYRIC-ACID; GATED ION-CHANNEL; PITUITARY-ADRENAL AXIS;
   CENTRAL-NERVOUS-SYSTEM; CHARACTERIZE ADAPTIVE RESPONSES; REPRODUCTIVE
   ENDOCRINE AXIS; BENZODIAZEPINE BINDING-SITE; INDUCED STATUS EPILEPTICUS;
   RAT CEREBRAL-CORTEX; RISK-ASSESSMENT
AB Antagonism of ionotropic GABA receptors (iGABARs) can occur at three distinct types of receptor binding sites causing chemically induced epileptic seizures. Here we review three adverse outcome pathways, each characterized by a specific molecular initiating event where an antagonist competitively binds to active sites, negatively modulates allosteric sites or noncompetitively blocks ion channel on the iGABAR. This leads to decreased chloride conductance, followed by depolarization of affected neurons, epilepsy-related death and ultimately decreased population. Supporting evidence for causal linkages from the molecular to population levels is presented and differential sensitivity to iGABAR antagonists in different GABA receptors and organisms discussed. Adverse outcome pathways are poised to become important tools for linking mechanism-based biomarkers to regulated outcomes in next-generation risk assessment.
C1 [Gong, Ping; Perkins, Edward J.] US Army Engn Res & Dev Ctr, Environm Lab, Vicksburg, MS 39180 USA.
   [Hong, Huixiao] US FDA, Natl Ctr Toxicol Res, Div Bioinformat & Biostat, Jefferson, AR 72079 USA.
RP Gong, P (reprint author), US Army Engn Res & Dev Ctr, Environm Lab, 3909 Halls Ferry Rd, Vicksburg, MS 39180 USA.
EM ping.gong@usace.army.mil
FU US Army Environmental Quality and Installations Basic Research Program;
   "Rapid Hazard Risk Assessment" Focus Area Research Project
FX The authors (P Gong and EJ Perkins) would like to acknowledge the US
   Army Environmental Quality and Installations Basic Research Program and
   the "Rapid Hazard Risk Assessment" Focus Area Research Project for
   financial support. The authors have no other relevant affiliations or
   financial involvement with any organization or entity with a financial
   interest in or financial conflict with the subject matter or materials
   discussed in the manuscript apart from those disclosed.
CR Abadin H., 2012, TOXICOLOGICAL PROFIL
   Albin R. L., 2001, CURR PROTOC NEUROSCI
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Babot Z, 2007, J NEUROSCI RES, V85, P3687, DOI 10.1002/jnr.21433
   Banerjee PK, 1999, J PHARMACOL EXP THER, V291, P361
   Barnard EA, 1998, PHARMACOL REV, V50, P291
   Bebarova M, 2012, GEN PHYSIOL BIOPHYS, V31, P131, DOI 10.4149/gpb_2012_016
   Behrens CJ, 2007, EUR J NEUROSCI, V25, P2170, DOI 10.1111/j.1460-9568.2007.05462.x
   Biggs K, 2013, COMP BIOCHEM PHYS A, V166, P119, DOI 10.1016/j.cbpa.2013.05.005
   Bloomquist JR, 2003, ARCH INSECT BIOCHEM, V54, P145, DOI 10.1002/arch.10112
   Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462
   Bormann J, 2000, TRENDS PHARMACOL SCI, V21, P16, DOI 10.1016/S0165-6147(99)01413-3
   Breen M, 2013, TOXICOL SCI, V133, P234, DOI 10.1093/toxsci/kft067
   Buckingham SD, 2005, MOL PHARMACOL, V68, P942, DOI 10.1124/mol.105.015313
   Campagna-Slater V, 2007, J MOL GRAPH MODEL, V25, P721, DOI 10.1016/j.jmgm.2006.06.001
   Casida JE, 2013, ANNU REV ENTOMOL, V58, P99, DOI 10.1146/annurev-ento-120811-153645
   Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1
   Chang YC, 2010, PHARMACEUTICALS, V3, P2592, DOI 10.3390/ph3082592
   Chebib M, 1999, CLIN EXP PHARMACOL P, V26, P937, DOI 10.1046/j.1440-1681.1999.03151.x
   Chebib M, 2000, J MED CHEM, V43, P1427, DOI 10.1021/jm9904349
   Chen LG, 2006, P NATL ACAD SCI USA, V103, P5185, DOI 10.1073/pnas.0600370103
   Cheng J, 2009, J MOL MODEL, V15, P1145, DOI 10.1007/s00894-009-0477-2
   CHERUBINI E, 1991, TRENDS NEUROSCI, V14, P515, DOI 10.1016/0166-2236(91)90003-D
   Cleland TA, 1996, MOL NEUROBIOL, V13, P97, DOI 10.1007/BF02740637
   Connolly CN, 2004, BIOCHEM SOC T, V32, P529, DOI 10.1042/BST0320529
   Corbett EKA, 1999, NEUROREPORT, V10, P1177, DOI 10.1097/00001756-199904260-00004
   Cote I, 2012, ENVIRON HEALTH PERSP, V120, P1499, DOI 10.1289/ehp.1104870
   CURTIS DR, 1971, BRAIN RES, V32, P69, DOI 10.1016/0006-8993(71)90156-9
   DEDEYN PP, 1990, ACTA NEUROL BELG, V90, P65
   Dellisanti CD, 2007, NAT NEUROSCI, V10, P953, DOI 10.1038/nn1942
   Demuro A, 1999, BRIT J PHARMACOL, V127, P57, DOI 10.1038/sj.bjp.0702504
   Devlin CL, 2001, J EXP BIOL, V204, P887
   DICHTER MA, 1987, SCIENCE, V237, P157, DOI 10.1126/science.3037700
   DIMICCO JA, 1979, SCIENCE, V204, P1106, DOI 10.1126/science.451556
   Ellis P, 2014, MUTAGENESIS, V29, P73, DOI 10.1093/mutage/get057
   Engelmann M, 2004, FRONT NEUROENDOCRIN, V25, P132, DOI 10.1016/j.yfrne.2004.09.001
   Ernst M, 2005, MOL PHARMACOL, V68, P1291, DOI 10.1124/mol.105.015982
   Ernst M, 2003, NEUROSCIENCE, V119, P933, DOI 10.1016/S0306-4522(03)00288-4
   Garcia-Reyero N, 2011, ECOTOXICOLOGY, V20, P580, DOI 10.1007/s10646-011-0623-3
   Gong P, 2007, ENVIRON TOXICOL CHEM, V26, P954, DOI 10.1897/06-361R.1
   Gunasekara AS, 2007, J PESTIC SCI, V32, P189, DOI 10.1584/jpestics.R07-02
   Hainzl D, 1998, CHEM RES TOXICOL, V11, P1529, DOI 10.1021/tx980157t
   Hanrahan JR, 2003, BIOORG MED CHEM LETT, V13, P2281, DOI 10.1016/S0960-894X(03)00434-7
   Hansen RS, 2005, EUR J PHARMACOL, V519, P199, DOI 10.1016/j.ejphar.2005.06.036
   Hildreth CM, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-128
   Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717
   Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461
   HOFFMAN EJ, 1993, CLIN PHARMACY, V12, P641
   Holden JH, 2002, J BIOL CHEM, V277, P18785, DOI 10.1074/jbc.M111778200
   Hosie AM, 1997, TRENDS NEUROSCI, V20, P578, DOI 10.1016/S0166-2236(97)01127-2
   Hosie AM, 2003, NAT NEUROSCI, V6, P362, DOI 10.1038/nn1030
   Hsu DZ, 2004, TOXICOLOGY, V200, P213, DOI 10.1016/j.tox.2004.04.001
   Ihara Makoto, 2005, Invertebrate Neuroscience, V5, P157, DOI 10.1007/s10158-005-0008-5
   Ikeda T, 2003, NEUROTOXICOLOGY, V24, P807, DOI 10.1016/S0161-813X(03)00041-X
   Jackson D., 2009, FIPRONIL TECHNICAL F
   Jett DA, 2012, NEUROTOXICOLOGY, V33, P1473, DOI 10.1016/j.neuro.2012.10.005
   Johnston GAR, 2005, CURR PHARM DESIGN, V11, P1867, DOI 10.2174/1381612054021024
   Johnston GAR, 2013, BRIT J PHARMACOL, V169, P328, DOI 10.1111/bph.12127
   Johnston GAR, 2006, ADV PHARMACOL, V54, P285, DOI 10.1016/S1054-3589(06)54012-8
   Juarez E. H., 2014, Autonomic & Autacoid Pharmacology, V34, P1, DOI 10.1111/aap.12016
   Kato K, 2014, J ANAT, V224, P207, DOI 10.1111/joa.12144
   KIESSLING M, 1984, BRAIN RES, V296, P1, DOI 10.1016/0006-8993(84)90506-7
   KIESSLING M, 1981, ACTA NEUROPATHOL, V55, P157, DOI 10.1007/BF00699241
   KUME A, 1994, J NEUROCHEM, V62, P602
   Kuperman RG, 2013, ENVIRON TOXICOL CHEM, V32, P2648, DOI 10.1002/etc.2356
   LaLone CA, 2013, ENVIRON TOXICOL CHEM, V32, P2528, DOI 10.1002/etc.2330
   Lamsa K, 2003, J NEUROPHYSIOL, V90, P1983, DOI 10.1152/jn.00060.2003
   Li P, 2008, BRIT J PHARMACOL, V155, P783, DOI 10.1038/bjp.2008.309
   Liapakis G., 2001, CURR PROTOC NEUROSCI, P15
   Librizzi L, 2012, ANN NEUROL, V72, P82, DOI 10.1002/ana.23567
   Locatelli V, 2010, ENDOCR DEV, V17, P108, DOI 10.1159/000262533
   MACDONALD RL, 1994, ANNU REV NEUROSCI, V17, P569, DOI 10.1146/annurev.ne.17.030194.003033
   MacKay C, 2013, ALTEX-ALTERN ANIM EX, V30, P473, DOI 10.14573/altex.2013.4.473
   Maxwell G, 2014, TOXICOL IN VITRO, V28, P8, DOI 10.1016/j.tiv.2013.10.013
   MCLENNAN H, 1970, NATURE, V228, P674, DOI 10.1038/228674a0
   Mendu SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042959
   Metzeler K, 2004, ENDOCRINOLOGY, V145, P2402, DOI 10.1210/en.2003-1413
   Michels G, 2007, CRIT REV BIOCHEM MOL, V42, P3, DOI 10.1080/10409230601146219
   Narahashi T, 2007, HUM EXP TOXICOL, V26, P361, DOI 10.1177/0960327106078408
   Narahashi T, 1998, NEUROTOXICOLOGY, V19, P581
   National Research Council (US) Committee on Applications of Toxicogenomics to Cross-Species Extrapolation, 2005, APPL TOX CROSS SPEC
   NONOGAKI K, 1994, J NEUROENDOCRINOL, V6, P443, DOI 10.1111/j.1365-2826.1994.tb00605.x
   Nonogaki K, 1997, LIFE SCI, V60, P797, DOI 10.1016/S0024-3205(96)00596-6
   NOWAK LM, 1982, BRAIN RES, V244, P155, DOI 10.1016/0006-8993(82)90913-1
   Nury H, 2011, NATURE, V469, P428, DOI 10.1038/nature09647
   [OECD] Organization for Economic Co-operation and Development, 2011, WORKSH US MECH INF F, P1
   Olsen RW, 2008, PHARMACOL REV, V60, P243, DOI 10.1124/pr.108.00505
   Olsen RW, 2009, NEUROPHARMACOLOGY, V56, P141, DOI 10.1016/j.neuropharm.2008.07.045
   Ozoe Y, 2001, PEST MANAG SCI, V57, P923, DOI 10.1002/ps.375
   Peveling R, 2003, J APPL ECOL, V40, P729, DOI 10.1046/j.1365-2664.2003.00833.x
   Pirker S, 2000, NEUROSCIENCE, V101, P815, DOI 10.1016/S0306-4522(00)00442-5
   Ramerstorfer J, 2011, J NEUROSCI, V31, P870, DOI 10.1523/JNEUROSCI.5012-10.2011
   Ratra GS, 2001, TOXICOL APPL PHARM, V172, P233, DOI 10.1006/taap.2001.9154
   Raymond V, 2002, NAT REV DRUG DISCOV, V1, P427, DOI 10.1038/nrd821
   Raymond-Delpech Valerie, 2005, Invertebrate Neuroscience, V5, P119
   Richter L, 2012, NAT CHEM BIOL, V8, P455, DOI [10.1038/nchembio.917, 10.1038/NCHEMBIO.917]
   Robidoux PY, 2002, ARCH ENVIRON CON TOX, V43, P379, DOI 10.1007/s00244-002-1242-z
   Sander T, 2011, PROTEINS, V79, P1458, DOI 10.1002/prot.22975
   Sarto-Jackson I, 2008, MOL MEMBR BIOL, V25, P302, DOI 10.1080/09687680801914516
   Sibly RM, 2000, J APPL ECOL, V37, P540, DOI 10.1046/j.1365-2664.2000.00516.x
   SIEGHART W, 1995, PHARMACOL REV, V47, P181
   Sigel E, 2011, CURR TOP MED CHEM, V11, P241, DOI 10.2174/156802611794863562
   Silva MH, 2009, BIRTH DEFECTS RES B, V86, P1, DOI 10.1002/bdrb.20183
   Silva MRP, 1998, PHARMACOL BIOCHEM BE, V60, P203, DOI 10.1016/S0091-3057(97)00582-0
   Simon J, 2004, J BIOL CHEM, V279, P41422, DOI 10.1074/jbc.M401354200
   SMART TG, 1990, BRIT J PHARMACOL, V99, P643, DOI 10.1111/j.1476-5381.1990.tb12984.x
   SODERFELDT B, 1983, ACTA NEUROPATHOL, V62, P87
   SODERFELDT B, 1981, ACTA NEUROPATHOL, V54, P219
   Soto PL, 2013, NEUROPSYCHOPHARMACOL, V38, P2315, DOI 10.1038/npp.2013.137
   Spurny R, 2013, J BIOL CHEM, V288, P8355, DOI 10.1074/jbc.M112.424507
   Stehr CM, 2006, TOXICOL SCI, V92, P270, DOI 10.1093/toxsci/kfj185
   Taketo M, 2000, NEUROSCIENCE, V96, P507, DOI 10.1016/S0306-4522(99)00574-6
   Taylor AN, 2013, J NEUROTRAUM, V30, P1250, DOI 10.1089/neu.2012.2847
   Tingle CCD, 2003, REV ENVIRON CONTAM T, V176, P1
   Tsigos C, 2002, J PSYCHOSOM RES, V53, P865, DOI 10.1016/S0022-3999(02)00429-4
   Tsuji M, 2012, EXP NEUROL, V233, P214, DOI 10.1016/j.expneurol.2011.10.004
   Ueno S, 1997, J NEUROSCI, V17, P625
   van Zelm R, 2007, INTEGR ENVIRON ASSES, V3, P203, DOI 10.1897/IEAM_2006-013.1
   Vijayan RSK, 2012, J CHEM INF MODEL, V52, P2958, DOI [10.1021/ci3001092, 10.1021/ci300189a]
   Villeneuve DL, 2013, TOXICOL SCI, V133, P225, DOI 10.1093/toxsci/kft068
   Vinken M, 2013, TOXICOL SCI, V136, P97, DOI 10.1093/toxsci/kft177
   Vinken M, 2013, TOXICOLOGY, V312, P158, DOI 10.1016/j.tox.2013.08.011
   VOTEY SR, 1991, ANN EMERG MED, V20, P181, DOI 10.1016/S0196-0644(05)81219-3
   Walker CH, 1998, ECOTOXICOLOGY, V7, P185, DOI 10.1023/A:1008949025926
   Walker CH, 1999, ECOTOXICOLOGY, V8, P425, DOI 10.1023/A:1008995400871
   Watanabe M, 2002, INT REV CYTOL, V213, P1
   Weiss M, 2002, NEUROCHEM RES, V27, P1605, DOI 10.1023/A:1021674708556
   Werner FM, 2011, CURR MED CHEM, V18, P4933, DOI 10.2174/092986711797535191
   Williams LR, 2011, ENVIRON HEALTH PERSP, V119, P357, DOI 10.1289/ehp.1002588
   Yamada K, 1999, J NEUROPHYSIOL, V81, P2875
   Zhang JL, 2008, MOL PHARMACOL, V74, P941, DOI 10.1124/mol.108.048710
   Zhao XL, 2003, J PHARMACOL EXP THER, V306, P914, DOI 10.1124/jpet.103.051839
   Zheng TM, 1996, J PHARMACOL EXP THER, V277, P525
NR 133
TC 8
Z9 8
U1 0
U2 6
PU FUTURE MEDICINE LTD
PI LONDON
PA UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3
   1QB, ENGLAND
SN 1752-0363
EI 1752-0371
J9 BIOMARK MED
JI Biomark. Med.
PY 2015
VL 9
IS 11
BP 1225
EP 1239
DI 10.2217/bmm.15.58
PG 15
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA CX0RD
UT WOS:000365403400015
PM 26508561
OA Bronze
DA 2019-10-23
ER

PT B
AU Roggen, EL
AF Roggen, Erwin L.
BE Corsini, E
   VanLoveren, H
TI Breakdown of the Molecular Processes Driving the Adverse Outcome
   Pathways (AOPs) of Skin and Respiratory Sensitization Induction in
   Humans Exposed to Xenobiotics and Proteins
SO MOLECULAR IMMUNOTOXICOLOGY
LA English
DT Article; Book Chapter
ID TOLL-LIKE RECEPTORS; DENDRITIC CELLS; OXIDATIVE STRESS; T-CELLS;
   GENE-EXPRESSION; INNATE IMMUNITY; INFLAMMASOME; MIGRATION; LOCALIZATION;
   HYALURONAN
C1 [Roggen, Erwin L.] 3Rs Management & Consulting, ApS, DK-2800 Lyngby, Denmark.
   [Roggen, Erwin L.] Novozymes AS, Dept Toxicol & Product Safety, DK-2880 Bagsvaerd, Denmark.
RP Roggen, EL (reprint author), 3Rs Management & Consulting, ApS, Asavaenget 14, DK-2800 Lyngby, Denmark.
CR Adler S, 2011, ARCH TOXICOL, V85, P367, DOI 10.1007/s00204-011-0693-2
   Albanesi C, 2000, J INVEST DERMATOL, V115, P81, DOI 10.1046/j.1523-1747.2000.00041.x
   Albrekt AS, 2014, BMC PHARMACOL TOXICO, V15, DOI 10.1186/2050-6511-15-5
   Aleksic M, 2007, TOXICOL IN VITRO, V21, P723, DOI 10.1016/j.tiv.2007.01.008
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Antonopoulos C, 2008, J LEUKOCYTE BIOL, V83, P361, DOI 10.1189/jlb.0604352
   Aptula AO, 2006, TOXICOL IN VITRO, V20, P239, DOI 10.1016/j.tiv.2005.07.003
   ASHBY J, 1993, ENVIRON HEALTH PERSP, V101, P62, DOI 10.2307/3431573
   Bacsi A, 2005, J ALLERGY CLIN IMMUN, V116, P836, DOI 10.1016/j.jaci.2005.06.002
   Basketter DA, 2010, COMPREHENSIVE TOXICOLOGY, VOL 5: IMMUNE SYSTEM TOXICOLOGY, 2ND EDITION, P397
   Basketter D, 2007, ATLA-ALTERN LAB ANIM, V35, P137, DOI 10.1177/026119290703500124
   Beklen A, 2008, ORAL MICROBIOL IMMUN, V23, P425, DOI 10.1111/j.1399-302X.2008.00448.x
   Berg N, 2011, TOXICOL IN VITRO, V25, P874, DOI 10.1016/j.tiv.2011.02.008
   Besnard AG, 2012, J MOL CELL BIOL, V4, P3, DOI 10.1093/jmcb/mjr042
   Boldogh I, 2005, J CLIN INVEST, V115, P2169, DOI 10.1172/JCI24422
   Bousso P, 2003, NAT IMMUNOL, V4, P579, DOI 10.1038/ni928
   Byamba D, 2010, ANN DERMATOL, V22, P269, DOI 10.5021/ad.2010.22.3.269
   Cassel SL, 2009, SEMIN IMMUNOL, V21, P194, DOI 10.1016/j.smim.2009.05.002
   Chipinda Itai, 2011, J Allergy (Cairo), V2011, P839682, DOI 10.1155/2011/839682
   Chipinda I, 2010, CHEM RES TOXICOL, V23, P918, DOI 10.1021/tx100003w
   Cooper A, 2010, DRUG METAB DISPOS, V38, P2218, DOI 10.1124/dmd.110.034462
   Corsini E, 2013, FOOD CHEM TOXICOL, V61, P74, DOI 10.1016/j.fct.2013.02.038
   Corsini E, 2009, ATLA-ALTERN LAB ANIM, V37, P387, DOI 10.1177/026119290903700409
   Cruz CM, 2007, J BIOL CHEM, V282, P2871, DOI 10.1074/jbc.M608083200
   Davis BK, 2011, ANNU REV IMMUNOL, V29, P707, DOI 10.1146/annurev-immunol-031210-101405
   Dharajiya N, 2007, J ALLERGY CLIN IMMUN, V119, P646, DOI 10.1016/j.jaci.2006.11.634
   dos Santos GG, 2009, TOXICOL APPL PHARM, V236, P372, DOI 10.1016/j.taap.2009.02.004
   Eisenbarth SC, 2002, J EXP MED, V196, P1645, DOI 10.1084/jem.20021340
   Esser PR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041340
   Feldmeyer L, 2007, CURR BIOL, V17, P1140, DOI 10.1016/j.cub.2007.05.074
   Gariboldi S, 2008, J IMMUNOL, V181, P2103, DOI 10.4049/jimmunol.181.3.2103
   Gerberick F, 2008, ATLA-ALTERN LAB ANIM, V36, P215, DOI 10.1177/026119290803600210
   Gregory LG, 2011, TRENDS IMMUNOL, V32, P402, DOI 10.1016/j.it.2011.06.006
   Gruber A, 2004, J BIOL CHEM, V279, P28475, DOI 10.1074/jbc.M400993200
   Hammad H, 2009, NAT MED, V15, P410, DOI 10.1038/nm.1946
   Hartwig C, 2008, CYTOKINE, V42, P298, DOI 10.1016/j.cyto.2008.02.012
   Herrick CA, 2003, NAT REV IMMUNOL, V3, P405, DOI 10.1038/nri1084
   Inohara N, 2002, TRENDS BIOCHEM SCI, V27, P219, DOI 10.1016/S0968-0004(02)02084-4
   Islam T, 2009, THORAX, V64, P197, DOI 10.1136/thx.2008.099366
   Jelley-Gibbs DM, 2008, IMMUNOL CELL BIOL, V86, P343, DOI 10.1038/icb.2008.13
   Jia HP, 2004, AM J PHYSIOL-LUNG C, V287, pL428, DOI 10.1152/ajplung.00377.2003
   Jiang DH, 2011, PHYSIOL REV, V91, P221, DOI 10.1152/physrev.00052.2009
   Johansson H, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-399
   Johnson CD, 2004, ENVIRON HEALTH PERSP, V112, P403, DOI 10.1289/txg.6758
   Jordan JA, 2001, J IMMUNOL, V167, P7060, DOI 10.4049/jimmunol.167.12.7060
   Kool M, 2011, IMMUNITY, V34, P527, DOI 10.1016/j.immuni.2011.03.015
   Lalko JF, 2013, TOXICOL IN VITRO, V27, P651, DOI 10.1016/j.tiv.2012.10.016
   Larsson K, 2006, IMMUNOLOGY, V117, P156, DOI 10.1111/j.1365-2567.2005.02274.x
   Lee E, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000217
   Lefkovits I, 2000, ELECTROPHORESIS, V21, P2688, DOI 10.1002/1522-2683(20000701)21:13<2688::AID-ELPS2688>3.0.CO;2-T
   Liebler DC, 2008, CHEM RES TOXICOL, V21, P117, DOI 10.1021/tx700235t
   Lundberg K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052875
   MacKay C., 2013, ALTEX
   Manchanda T, 2002, MOL PHARMACOL, V62, P1011, DOI 10.1124/mol.62.5.1011
   Martin SF, 2011, ALLERGY, V66, P1152, DOI 10.1111/j.1398-9995.2011.02652.x
   Martin SF, 2008, J EXP MED, V205, P2151, DOI 10.1084/jem.20070509
   Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238
   Migdal C, 2013, TOXICOL SCI, V133, P259, DOI 10.1093/toxsci/kft075
   Monzon ME, 2010, J BIOL CHEM, V285, P26126, DOI 10.1074/jbc.M110.135194
   Nakae S, 2002, IMMUNITY, V17, P375, DOI 10.1016/S1074-7613(02)00391-6
   O'Neill LAJ, 2013, NAT REV IMMUNOL, V13, P453, DOI 10.1038/nri3446
   OECD, 2012, PROP TEMPL GUID DEV
   OECD (Organization for Economic Co-operation and Development), 2013, GUID DOC DEV ASS ADV
   OECD (Organization for Economic Co-operation and Development), 2013, SER TEST ASS, V168
   Okayama Yoshimichi, 2005, Current Drug Targets - Inflammation and Allergy, V4, P517, DOI 10.2174/1568010054526386
   Ouwehand K, 2011, TECH ADV, V90, P1028
   Ouwehand K, 2010, EUR J IMMUNOL, V40, P2026, DOI 10.1002/eji.200940150
   Ouwehand K, 2008, EUR J IMMUNOL, V38, P3050, DOI 10.1002/eji.200838384
   Page K, 2009, J IMMUNOL, V183, P3400, DOI 10.4049/jimmunol.0900838
   Palladino MA, 2008, AM J REPROD IMMUNOL, V60, P541, DOI 10.1111/j.1600-0897.2008.00654.x
   Pivarcsi A., 2004, Acta Microbiologica et Immunologica Hungarica, V51, P303, DOI 10.1556/AMicr.51.2004.3.8
   Pulendran B, 2001, J IMMUNOL, V167, P5067, DOI 10.4049/jimmunol.167.9.5067
   Randolph GJ, 2008, ANNU REV IMMUNOL, V26, P293, DOI 10.1146/annurev.immunol.26.021607.090254
   Rathinam VAK, 2012, NAT IMMUNOL, V13, P333, DOI 10.1038/ni.2237
   Ray PD, 2012, CELL SIGNAL, V24, P981, DOI 10.1016/j.cellsig.2012.01.008
   Roberts DW, 2010, CHEM RES TOXICOL, V23, P228, DOI [10.1021/tx90003648, 10.1021/tx9003648]
   Roberts DW, 2009, CHEM RES TOXICOL, V22, P592, DOI 10.1021/tx800431x
   Roggen EL, 2013, TOXICOL IN VITRO, V27, P1122, DOI 10.1016/j.tiv.2012.09.019
   Seya T, 2005, J ENDOTOXIN RES, V11, P369, DOI 10.1179/096805105X67292
   SMITH CK, 2001, ALLERGIC CONTACT DER
   Stoll S, 2002, SCIENCE, V296, P1873, DOI 10.1126/science.1071065
   Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004
   Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022
   Tan JKH, 2005, J LEUKOCYTE BIOL, V78, P319, DOI 10.1189/jlb.1104664
   Termeer C, 2002, J EXP MED, V195, P99, DOI 10.1084/jem.20001858
   Thomas WR, 2005, CURR ALLERGY ASTHM R, V5, P388, DOI 10.1007/s11882-005-0012-1
   Trompette A, 2009, NATURE, V457, P585, DOI 10.1038/nature07548
   Tronde A, 2003, J PHARM SCI, V92, P1216, DOI 10.1002/jps.10386
   U. S. National Research Council, 2007, TOX TEST 21 CENT VIS
   *US EPA, 2005, GUID CARC RISK ASS
   van Delft JHM, 2004, CARCINOGENESIS, V25, P1265, DOI 10.1093/carcin/bgh108
   Villablanca EJ, 2008, HISTOL HISTOPATHOL, V23, P897, DOI 10.14670/HH-23.897
   Wang BH, 1999, J LEUKOCYTE BIOL, V66, P33
   Wang JF, 2011, J CELL PHYSIOL, V226, P1265, DOI 10.1002/jcp.22454
   Watanabe H, 2007, J INVEST DERMATOL, V127, P1956, DOI 10.1038/sj.jid.5700819
   Xu H, 1996, J EXP MED, V183, P1001, DOI 10.1084/jem.183.3.1001
   Yozzo KL, 2013, AQUAT TOXICOL, V126, P346, DOI 10.1016/j.aquatox.2012.09.008
NR 97
TC 0
Z9 0
U1 0
U2 0
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PAPPELALLEE 3, W-69469 WEINHEIM, GERMANY
BN 978-3-527-67696-5; 978-3-527-33519-0
PY 2015
BP 67
EP 90
PG 24
WC Toxicology
SC Toxicology
GA BC7MJ
UT WOS:000354998200005
DA 2019-10-23
ER

PT J
AU Tatum-Gibbs, KR
   Mckee, JM
   Higuchi, M
   Bushnell, PJ
AF Tatum-Gibbs, K. R.
   Mckee, J. M.
   Higuchi, M.
   Bushnell, P. J.
TI Effects of toluene, acrolein and vinyl chloride on motor activity of
   Drosophila melanogaster
SO NEUROTOXICOLOGY AND TERATOLOGY
LA English
DT Article
DE Toxicity screening; Volatile organic compounds; Fruit fly; Sex
   difference; Narcosis
ID VOLATILE ORGANIC-COMPOUNDS; GENOME-WIDE ASSOCIATION; GENETIC REFERENCE
   PANEL; ODOR-GUIDED BEHAVIOR; LOCOMOTOR-ACTIVITY; NATURAL VARIATION;
   OLFACTORY BEHAVIOR; ARCHITECTURE; COMMUNICATION; INHALATION
AB The data generated by current high-throughput assays for chemical toxicity require information to link effects at molecular targets to adverse outcomes in whole animals. In addition, more efficient methods for testing volatile chemicals are needed. Here we begin to address these issues by determining the utility of measuring behavioral responses of Drosophila melanogaster to airborne volatile organic compounds (VOCs) as a potential model system for discovering adverse outcome pathways and as a method to test for toxicity. In these experiments, we measured motor activity in male and female flies to determine concentration-effect functions for three VOCs that differ in their mode of action: toluene, a narcotic; acrolein, an irritant; and vinyl chloride, a hepatocarcinogen. These experiments were conducted in Flyland, an outbred population of flies derived from 40 lines of the Drosophila Genetics Reference Panel (DGRP) (Mackay et al., 2012), in preparation for subsequent experiments with individual lines of the DGRP. Systematic, concentration-related changes in activity were observed with toluene, but not with acrolein; high concentrations of vinyl chloride reduced activity by a small amount. Despite higher activity levels in males than in females under control conditions, the sexes were equally sensitive to toluene. Transient increases in activity at the onset and offset of exposure to toluene and vinyl chloride suggested that the flies detected changes in air quality at concentrations that did not persistently suppress activity. The effects and potency of toluene are consistent with those observed in rodents. The lack of clear concentration-related changes in response to acrolein and vinyl chloride shows limitations of this method is for screening toxicity attributed to VOCs. This abstract does not reflect U.S. EPA policy. Published by Elsevier Inc.
C1 [Tatum-Gibbs, K. R.] Oak Ridge Inst Sci Educ, Oak Ridge, TN USA.
   [Mckee, J. M.; Higuchi, M.; Bushnell, P. J.] US EPA, Natl Hlth & Environm Effects Res Lab, RTP, Res Triangle Pk, NC 27711 USA.
RP Bushnell, PJ (reprint author), US EPA, Toxicol Assessment Div, Natl Hlth & Environm Effects Res Lab, MD B105-04, Res Triangle Pk, NC 27711 USA.
EM Bushnell.philip@epa.gov
RI Higuchi, Mark/I-4252-2017
OI Higuchi, Mark/0000-0001-6202-2369
CR Al-Anzi B, 2006, CURR BIOL, V16, P1034, DOI 10.1016/j.cub.2006.04.002
   Anholt RRH, 1996, GENETICS, V143, P293
   Benignus VA, 1998, TOXICOL SCI, V43, P186, DOI 10.1006/toxs.1998.2458
   Brown EB, 2013, GENES BRAIN BEHAV, V12, P503, DOI 10.1111/gbb.12048
   BUSHNELL PJ, 1985, FUND APPL TOXICOL, V5, P971, DOI 10.1016/0272-0590(85)90178-2
   Collins FS, 2008, SCIENCE, V319, P906, DOI 10.1126/science.1154619
   Dix DJ, 2008, TOXCAST
   Fernandez MP, 2013, J COMP PHYSIOL A, V199, P1065, DOI 10.1007/s00359-013-0851-5
   Firestone M, 2010, J TOXICOL ENV HEAL B, V13, P139, DOI 10.1080/10937404.2010.483178
   Gaudry Q, 2012, CURR OPIN NEUROBIOL, V22, P216, DOI 10.1016/j.conb.2011.12.010
   Harbison ST, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-281
   Herrero P, 2012, PEPTIDES, V38, P228, DOI 10.1016/j.peptides.2012.09.019
   HINMAN DJ, 1987, PHARMACOL BIOCHEM BE, V26, P65, DOI 10.1016/0091-3057(87)90535-1
   Huang W, 2014, GENOME RES, V24, P1193, DOI 10.1101/gr.171546.113
   Huang W, 2012, P NATL ACAD SCI USA, V109, P15553, DOI 10.1073/pnas.1213423109
   Huber R, 2004, SLEEP, V27, P628, DOI 10.1093/sleep/27.4.628
   Inamdar AA, 2014, ENVIRON TOXICOL, V29, P829, DOI 10.1002/tox.21825
   Inamdar AA, 2013, P NATL ACAD SCI USA, V110, P19561, DOI 10.1073/pnas.1318830110
   Jordan KW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038722
   Judson R., 2008, ENV HLTH PERSPECT, V117
   Judson R.S., 2009, ENV HLTH PERSPECT, V118
   Kang K, 2010, NATURE, V464, P597, DOI 10.1038/nature08848
   Kavlock R, 2012, CHEM RES TOXICOL, V25, P1287, DOI 10.1021/tx3000939
   Mackay TFC, 2012, NATURE, V482, P173, DOI 10.1038/nature10811
   Moore MS, 1998, CELL, V93, P997, DOI 10.1016/S0092-8674(00)81205-2
   Morozova TV, 2014, MOL GENET GENOMICS, V289, P253, DOI 10.1007/s00438-013-0808-y
   Morozova TV, 2011, GENETICS, V187, P1193, DOI 10.1534/genetics.110.125229
   NRC (National Research Council), 2007, TOX TEST 21 CENT VIS
   Parr J, 2001, J NEUROSCI METH, V107, P93, DOI 10.1016/S0165-0270(01)00357-0
   Rieger D, 2007, J BIOL RHYTHM, V22, P387, DOI 10.1177/0748730407306198
   Sambandan D, 2006, GENETICS, V174, P1349, DOI 10.1534/genetics.106.060574
   Scholz H, 2009, J NEUROGENET, V23, P111, DOI 10.1080/01677060802471676
   Shukla SJ, 2010, DRUG DISCOV TODAY, V15, P997, DOI 10.1016/j.drudis.2010.07.007
   Singh CM, 2000, ALCOHOL CLIN EXP RES, V24, P1127, DOI 10.1111/j.1530-0277.2000.tb02075.x
   Swarup S, 2013, P NATL ACAD SCI USA, V110, P1017, DOI 10.1073/pnas.1220168110
   TEGERIS JS, 1994, FUND APPL TOXICOL, V22, P240, DOI 10.1006/faat.1994.1028
   Tice RR, 2013, ENVIRON HEALTH PERSP, V121, P756, DOI 10.1289/ehp.1205784
   Tunstall NE, 2012, ADV EXP MED BIOL, V739, P59, DOI 10.1007/978-1-4614-1704-0_4
   U.S. Environmental Protection Agency E, 2005, TOX REV TOL CAS 108
   U.S. Environmental Protection Agency E, 2000, TOX REV VIN CHLOR
   *US EPA, 2003, TOX REV ACR
   *US EPA, 2009, US EPA STRAT PLAN EV
   VET LEM, 1983, PHYSIOL ENTOMOL, V8, P97, DOI 10.1111/j.1365-3032.1983.tb00338.x
   Vosshall LB, 2007, ANNU REV NEUROSCI, V30, P505, DOI 10.1146/annurev.neuro.30.051606.094306
   Wasserkort R, 1997, J APPL TOXICOL, V17, P119, DOI 10.1002/(SICI)1099-1263(199703)17:2<119::AID-JAT415>3.0.CO;2-9
   Weber AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034745
   Wolf FW, 2002, J NEUROSCI, V22, P11035
   WOOD RW, 1990, FUND APPL TOXICOL, V14, P6, DOI 10.1016/0272-0590(90)90226-A
   Zhou SS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002593
NR 49
TC 2
Z9 3
U1 1
U2 18
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0892-0362
EI 1872-9738
J9 NEUROTOXICOL TERATOL
JI Neurotoxicol. Teratol.
PD JAN-FEB
PY 2015
VL 47
BP 114
EP 124
DI 10.1016/j.ntt.2014.11.008
PG 11
WC Neurosciences; Toxicology
SC Neurosciences & Neurology; Toxicology
GA CA5NL
UT WOS:000348955000013
PM 25445728
DA 2019-10-23
ER

PT J
AU Basu, N
AF Basu, Niladri
TI APPLICATIONS AND IMPLICATIONS OF NEUROCHEMICAL BIOMARKERS IN
   ENVIRONMENTAL TOXICOLOGY
SO ENVIRONMENTAL TOXICOLOGY AND CHEMISTRY
LA English
DT Article
DE Review; Neurochemical biomarkers; Neurotoxicology; Ecotoxicology; Brain
ID WILD RIVER OTTERS; MINK MUSTELA-VISON; BIOCHEMICAL MARKERS;
   CEREBRAL-CORTEX; RECEPTOR-BINDING; CAPTIVE MINK;
   POLYCHLORINATED-BIPHENYLS; NEUROTRANSMITTER SYSTEMS; POSTMORTEM
   STABILITY; ELLIPTIO-COMPLANATA
AB Thousands of environmental contaminants have neurotoxic properties, but their ecological risk is poorly characterized. Contaminant-associated disruptions to animal behavior and reproduction, both of which are regulated by the nervous system, provide decision makers with compelling evidence of harm, but such apical endpoints are of limited predictive or harm-preventative value. Neurochemical biomarkers, which may be used to indicate subtle changes at the subcellular level, may help overcome these limitations. Neurochemical biomarkers have been used for decades in the human health sciences and are now gaining increased attention in the environmental realm. In the present review, the applications and implications of neurochemical biomarkers to the field of ecotoxicology are discussed. The review provides a brief introduction to neurochemistry, covers neurochemical-based adverse outcome pathways, discusses pertinent strengths and limitations of neurochemical biomarkers, and provides selected examples across invertebrate and vertebrate taxa (worms, bivalves, fish, terrestrial and marine mammals, and birds) to document contaminant-associated neurochemical disruption. With continued research and development, neurochemical biomarkers may increase understanding of the mechanisms that underlie injury to ecological organisms, complement other measures of neurological health, and be integrated into risk assessment practices. Environ Toxicol Chem 2015;34:22-29. (c) 2014 SETAC
C1 McGill Univ, Fac Agr & Environm Sci, Montreal, PQ, Canada.
RP Basu, N (reprint author), McGill Univ, Fac Agr & Environm Sci, Montreal, PQ, Canada.
EM niladri.basu@mcgill.ca
OI Basu, Niladri/0000-0002-2695-1037
CR Adams DH, 2010, SCI TOTAL ENVIRON, V408, P5808, DOI 10.1016/j.scitotenv.2010.08.019
   *AG TOX SUBST DIS, 2002, TOX PROF ALDR DIELDR
   Basu N, 2007, HUM EXP TOXICOL, V26, P213, DOI 10.1177/0960327107070570
   Basu N, 2006, TOXICOL SCI, V91, P202, DOI 10.1093/toxsci/kfj121
   Basu N, 2005, ENVIRON SCI TECHNOL, V39, P3585, DOI 10.1021/es0483746
   Basu N, 2005, TOXICOL APPL PHARM, V205, P71, DOI 10.1016/j.taap.2004.09.009
   Basu N, 2005, ENVIRON TOXICOL CHEM, V24, P1444, DOI 10.1897/04-048R.1
   Basu N, 2008, NEUROTOXICOLOGY, V29, P328, DOI 10.1016/j.neuro.2008.01.003
   Basu N, 2007, NEUROTOXICOLOGY, V28, P587, DOI 10.1016/j.neuro.2006.12.007
   Basu N, 2007, ENVIRON POLLUT, V149, P25, DOI 10.1016/j.envpol.2006.12.026
   Basu N, 2006, J TOXICOL ENV HEAL A, V69, P1133, DOI 10.1080/15287390500362394
   Basu N, 2010, COMP BIOCHEM PHYS C, V151, P379, DOI 10.1016/j.cbpc.2010.01.001
   Basu N, 2009, ENVIRON TOXICOL CHEM, V28, P133, DOI 10.1897/08-251.1
   Basu N, 2009, ENVIRON SCI TECHNOL, V43, P1635, DOI 10.1021/es802552m
   Bull K, 2007, TOXICOL SCI, V96, P115, DOI 10.1093/toxsci/kfl179
   BURKE RE, 1987, J NEUROCHEM, V49, P592, DOI 10.1111/j.1471-4159.1987.tb02904.x
   Clotfelter ED, 2010, FISH PHYSIOL BIOCHEM, V36, P933, DOI 10.1007/s10695-009-9370-2
   COSTA LG, 1995, TOXICOL LETT, V77, P137, DOI 10.1016/0378-4274(95)03283-5
   DEBOECK G, 1995, AQUAT TOXICOL, V33, P265, DOI 10.1016/0166-445X(95)00022-V
   Dekosky ST, 2003, SCIENCE, V302, P830, DOI 10.1126/science.1090349
   Gagne F, 2007, COMP BIOCHEM PHYS C, V146, P460, DOI 10.1016/j.cbpc.2007.04.006
   Gagne F, 2004, COMP BIOCHEM PHYS C, V138, P33, DOI 10.1016/j.cca.2004.04.006
   Gagne F, 2003, COMP BIOCHEM PHYS C, V136, P117, DOI 10.1016/S1532-0456(03)00171-6
   Gesto M, 2009, ECOTOX ENVIRON SAFE, V72, P191, DOI 10.1016/j.ecoenv.2008.03.007
   Gong P, 2010, ENVIRON SCI POLLUT R, V17, P181, DOI 10.1007/s11356-009-0117-5
   Hamilton M, 2011, ECOTOXICOLOGY, V20, P1677, DOI 10.1007/s10646-011-0754-6
   HEINZ GH, 1980, TOXICOL APPL PHARM, V53, P75, DOI 10.1016/0041-008X(80)90383-X
   Hoogesteijn AL, 2008, ENVIRON TOXICOL CHEM, V27, P2071, DOI 10.1897/07-484.1
   Iwaniuk AN, 2006, BEHAV BRAIN RES, V173, P1, DOI 10.1016/j.bbr.2006.05.026
   JETT DA, 1993, J TOXICOL ENV HEALTH, V39, P395, DOI 10.1080/15287399309531760
   Ji XL, 2005, J ENVIRON SCI-CHINA, V17, P256
   Kamata R, 2010, COMP BIOCHEM PHYS C, V152, P84, DOI 10.1016/j.cbpc.2010.03.002
   Kenow KP, 2010, ECOTOXICOLOGY, V19, P933, DOI 10.1007/s10646-010-0475-2
   Khan IA, 2000, MAR ENVIRON RES, V50, P119, DOI 10.1016/S0141-1136(00)00108-2
   Le Page Y, 2011, J TOXICOL ENV HEAL B, V14, P370, DOI 10.1080/10937404.2011.578558
   Lukkari T, 2005, ECOTOX ENVIRON SAFE, V62, P35, DOI 10.1016/j.ecoenv.2004.11.012
   Manzo L, 2001, ENVIRON RES, V85, P31, DOI 10.1006/enrs.2000.4039
   Manzo L, 1996, HUM EXP TOXICOL, V15, pS20
   MANZO L, 1995, TOXICOL LETT, V77, P63, DOI 10.1016/0378-4274(95)03273-8
   Markman S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001674
   Martyniuk CJ, 2010, NEUROTOXICOLOGY, V31, P356, DOI 10.1016/j.neuro.2010.04.008
   Mennigen JA, 2008, PHYSIOL GENOMICS, V35, P273, DOI 10.1152/physiolgenomics.90263.2008
   Mineau P., 1991, CHOLINESTERASE INHIB
   Myhrer T, 2003, BRAIN RES REV, V41, P268, DOI 10.1016/S0165-0173(02)00268-0
   Nam DH, 2010, AQUAT TOXICOL, V99, P351, DOI 10.1016/j.aquatox.2010.05.014
   *NAT RES COUNC, 1992, ENV NEUR
   Ottinger MA, 2011, J TOXICOL ENV HEAL B, V14, P413, DOI 10.1080/10937404.2011.578560
   Phillips TA, 2002, ARCH ENVIRON CON TOX, V43, P75, DOI 10.1007/s00244-002-1134-2
   Pilsner JR, 2010, MOL ECOL, V19, P307, DOI 10.1111/j.1365-294X.2009.04452.x
   PUYMIRAT J, 1979, J NEUROCHEM, V32, P449, DOI 10.1111/j.1471-4159.1979.tb00370.x
   Rico EP, 2011, NEUROTOXICOL TERATOL, V33, P608, DOI 10.1016/j.ntt.2011.07.007
   Rose SPR, 2000, LEARN MEMORY, V7, P1, DOI 10.1101/lm.7.1.1
   Rutkiewicz J, 2013, ECOTOX ENVIRON SAFE, V93, P77, DOI [10.1016/j.ecoenv2013.04.007, 10.1016/j.ecoenv.2013.04.007]
   Rutkiewicz J, 2012, ECOTOX ENVIRON SAFE, V84, P133, DOI 10.1016/j.ecoenv.2012.07.002
   Rutkiewicz J, 2011, ECOTOXICOLOGY, V20, P1669, DOI 10.1007/s10646-011-0730-1
   Rutkiewicz J, 2010, ENVIRON POLLUT, V158, P2733, DOI 10.1016/j.envpol.2010.04.018
   Scheuhammer AM, 2008, ECOTOXICOLOGY, V17, P93, DOI 10.1007/s10646-007-0170-0
   Scott GR, 2004, AQUAT TOXICOL, V68, P369, DOI 10.1016/j.aquatox.2004.03.016
   Shafer WR, 2005, CURR BIOL, V15, pR723
   SHARMA RP, 1976, ARCH ENVIRON CON TOX, V5, P43
   SIEGEL GJ, 2005, BASIC NEUROCHEMISTRY
   SILBERGELD EK, 1993, ENVIRON RES, V63, P274, DOI 10.1006/enrs.1993.1147
   Silvagni PA, 2005, VET PATHOL, V42, P184, DOI 10.1354/vp.42-2-184
   Stamler CJ, 2005, J TOXICOL ENV HEAL A, V68, P1413, DOI 10.1080/15287390590956560
   Tierney KB, 2008, ENVIRON SCI TECHNOL, V42, P4996, DOI 10.1021/es800240u
   Tilson HA, 1997, NEUROTOXICOLOGY, V18, P727
   TILSON HA, 1995, NEUROTOXICOLOGY, V16, P363
   Trudeau VL, 2000, BIOCHEM CELL BIOL, V78, P241, DOI 10.1139/bcb-78-3-241
   Villeneuve DL, 2011, ENVIRON TOXICOL CHEM, V30, P1, DOI 10.1002/etc.396
   Watanabe KH, 2011, ENVIRON TOXICOL CHEM, V30, P9, DOI 10.1002/etc.373
   Waye A, 2011, J TOXICOL ENV HEAL B, V14, P270, DOI 10.1080/10937404.2011.578273
   WEBER DN, 1991, AQUAT TOXICOL, V21, P71, DOI 10.1016/0166-445X(91)90006-U
   WILLIAMS RW, 1988, ANNU REV NEUROSCI, V11, P423, DOI 10.1146/annurev.neuro.11.1.423
   Yeardley RB, 1996, ENVIRON TOXICOL CHEM, V15, P1532, DOI 10.1002/etc.5620150916
   Zhang DP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005816
   Zuo ZH, 2009, AQUAT TOXICOL, V92, P44, DOI 10.1016/j.aquatox.2009.01.008
NR 76
TC 10
Z9 10
U1 3
U2 47
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0730-7268
EI 1552-8618
J9 ENVIRON TOXICOL CHEM
JI Environ. Toxicol. Chem.
PD JAN
PY 2015
VL 34
IS 1
BP 22
EP 29
DI 10.1002/etc.2783
PG 8
WC Environmental Sciences; Toxicology
SC Environmental Sciences & Ecology; Toxicology
GA AX2QT
UT WOS:000346789800004
PM 25331165
DA 2019-10-23
ER

PT J
AU Gocht, T
   Berggren, E
   Ahr, HJ
   Cotgreave, I
   Cronin, MTD
   Daston, G
   Hardy, B
   Heinzle, E
   Hescheler, J
   Knight, DJ
   Mahony, C
   Peschanski, M
   Schwarz, M
   Thomas, RS
   Verfaillie, C
   White, A
   Whelan, M
AF Gocht, Tilman
   Berggren, Elisabet
   Ahr, Hans Juergen
   Cotgreave, Ian
   Cronin, Mark T. D.
   Daston, George
   Hardy, Barry
   Heinzle, Elmar
   Hescheler, Juergen
   Knight, Derek J.
   Mahony, Catherine
   Peschanski, Marc
   Schwarz, Michael
   Thomas, Russell S.
   Verfaillie, Catherine
   White, Andrew
   Whelan, Maurice
TI The SEURAT-1 Approach towards Animal Free Human Safety Assessment
SO ALTEX-ALTERNATIVES TO ANIMAL EXPERIMENTATION
LA English
DT Article
DE alternatives to animal testing; integrated testing strategy;
   mode-of-action theory; proof-of-concept case studies; safety assessment
ID INTEGRATED TESTING STRATEGIES; STRESS-RESPONSE PATHWAYS; ADVERSE OUTCOME
   PATHWAY; ALTERNATIVE METHODS; RISK-ASSESSMENT; READ-ACROSS; IN-VITRO;
   TOXICITY; TOXICOLOGY; FRAMEWORK
AB SEURAT-1 is a European public-private research consortium that is working towards animal-free testing of chemical compounds and the highest level of consumer protection. A research strategy was formulated based on the guiding principle to adopt a toxicological mode-of-action framework to describe how any substance may adversely affect human health. The proof of the initiative will be in demonstrating the applicability of the concepts on which SEURAT-1 is built on three levels: (i) Theoretical prototypes for adverse outcome pathways are formulated based on knowledge already available in the scientific literature on investigating the toxicological modes-of-action leading to adverse outcomes (addressing mainly liver toxicity); (ii) adverse outcome pathway descriptions are used as a guide for the formulation of case studies to further elucidate the theoretical model and to develop integrated testing strategies for the prediction of certain toxicological effects (i.e., those related to the adverse outcome pathway descriptions); (iii) further case studies target the application of knowledge gained within SEURAT-1 in the context of safety assessment. The ultimate goal would be to perform ab initio predictions based on a complete understanding of toxicological mechanisms. In the near-term, it is more realistic that data from innovative testing methods will support read-across arguments. Both scenarios are addressed with case studies for improved safety assessment. A conceptual framework for a rational integrated assessment strategy emerged from designing the case studies and is discussed in the context of international developments focusing on alternative approaches for evaluating chemicals using the new 21st century tools for toxicity testing.
C1 [Gocht, Tilman; Schwarz, Michael] Univ Tubingen, Univ Hosp, Inst Expt & Clin Pharmacol & Toxicol, D-72074 Tubingen, Germany.
   [Berggren, Elisabet; Whelan, Maurice] IHCP, JRC, European Commiss, Ispra, Italy.
   [Berggren, Elisabet; Whelan, Maurice] EU Reference Lab Alternat Anim Testing EURL ECVAM, Ispra, Italy.
   [Ahr, Hans Juergen] Bayer AG, Dept Mol & Genet Toxicol, Wuppertal, Germany.
   [Cotgreave, Ian] Swedish Toxicol Sci, Res Ctr Swetox, Sodertalje, Sweden.
   [Cotgreave, Ian] Karolinska Inst, Inst Environm Med, Solna, Sweden.
   [Cronin, Mark T. D.] Liverpool John Moores Univ, Sch Pharm & Chem, Liverpool L3 3AF, Merseyside, England.
   [Daston, George] Procter & Gamble, Product Safety & Regulatory Affairs, Cincinnati, OH USA.
   [Hardy, Barry] Douglas Connect, Zeiningen, Switzerland.
   [Heinzle, Elmar] Univ Saarland, Saarbrucken, Germany.
   [Hescheler, Juergen] Univ Hosp Cologne, Inst Neurophysiol, Cologne, Germany.
   [Knight, Derek J.] European Chem Agcy, Helsinki, Finland.
   [Mahony, Catherine] Procter & Gamble, Cent Product Safety Dept, London, England.
   [Peschanski, Marc] I STEM AFM, INSERM UEVE 861, Evry, France.
   [Thomas, Russell S.] US EPA, Natl Ctr Computat Toxicol, Res Triangle Pk, NC 27711 USA.
   [Verfaillie, Catherine] Katholieke Univ Leuven, Interdept Stem Cell Inst, Leuven, Belgium.
   [White, Andrew] Unilever, Safety & Environm Assurance Ctr, Bedford, England.
RP Gocht, T (reprint author), Univ Tubingen, Univ Hosp, Inst Expt & Clin Pharmacol & Toxicol, Wilhelmstr 56, D-72074 Tubingen, Germany.
EM tilman.gocht@uni-tuebingen.de
RI Peschanski, Marc/N-5769-2017; Verfaillie, Catherine/H-5148-2013
OI Gocht, Tilma/0000-0002-2491-2050; Thomas, Russell/0000-0002-2340-0301;
   Verfaillie, Catherine/0000-0001-7564-4079
FU European Community's Seventh Framework Programme (FP7) (project acronym
   "COACH") [267044]; Cosmetics Europe; Open Access Publishing Fund of
   Tubingen University
FX This research work has received funding from the European Community's
   Seventh Framework Programme (FP7/2007-2013) under grant agreement no
   267044 (project acronym "COACH"), and has received financing from
   Cosmetics Europe. We acknowledge support by the Open Access Publishing
   Fund of Tubingen University.
CR Adler S, 2011, ARCH TOXICOL, V85, P367, DOI 10.1007/s00204-011-0693-2
   Amacher DE, 2011, EXPERT OPIN DRUG MET, V7, P949, DOI 10.1517/17425255.2011.577740
   Andersen ME, 2011, ALTEX-ALTERN ANIM EX, V28, P175, DOI 10.14573/altex.2011.3.175
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Basketter DA, 2012, ALTEX-ALTERN ANIM EX, V29, P5, DOI 10.14573/altex.2012.1.003
   Blaauboer BJ, 2012, ALTEX-ALTERN ANIM EX, V29, P411, DOI 10.14573/altex.2012.4.411
   Blaauboer BJ, 1999, ATLA-ALTERN LAB ANIM, V27, P229, DOI 10.1177/026119299902700211
   Blackburn K, 2011, REGUL TOXICOL PHARM, V60, P120, DOI 10.1016/j.yrtph.2011.03.002
   Boekelheide Kim, 2010, ALTEX, V27, P243
   Boobis AR, 2008, CRIT REV TOXICOL, V38, P87, DOI 10.1080/10408440701749421
   Brenner David A, 2009, Trans Am Clin Climatol Assoc, V120, P361
   Ducheix S, 2013, BIOCHEM PHARMACOL, V86, P96, DOI 10.1016/j.bcp.2013.03.016
   ECHA, 2013, ECHA13R02EN, P11
   Ellison CM, 2011, EXPERT OPIN DRUG MET, V7, P1481, DOI 10.1517/17425255.2011.629186
   EPAA, 2008, NEW PERSP SAF
   European Food Safety Authority, 2014, EFSA J, V12, DOI 10.2903/j.efsa.2014.3638
   Groothuis F. A., 2013, TOXICOLOGY IN PRESS
   Gubbels-van Hal WMLG, 2005, REGUL TOXICOL PHARM, V42, P284, DOI 10.1016/j.yrtph.2005.05.002
   Hardy B, 2012, ALTEX-ALTERN ANIM EX, V29, P129, DOI 10.14573/altex.2012.2.129
   Hartung T, 2013, ALTEX-ALTERN ANIM EX, V30, P119, DOI 10.14573/altex.2013.2.119
   Hartung T, 2013, ALTEX-ALTERN ANIM EX, V30, P3, DOI 10.14573/altex.2013.1.003
   Hartung T, 2011, ALTEX-ALTERN ANIM EX, V28, P183, DOI 10.14573/altex.2011.3.183
   Hartung T, 2011, ALTEX-ALTERN ANIM EX, V28, P83, DOI 10.14573/altex.2011.2.083
   Hoehme S, 2010, P NATL ACAD SCI USA, V107, P10371, DOI 10.1073/pnas.0909374107
   Jennings P, 2013, ARCH TOXICOL, V87, P13, DOI 10.1007/s00204-012-0974-4
   Kavlock R, 2012, CHEM RES TOXICOL, V25, P1287, DOI 10.1021/tx3000939
   Kimber I, 2011, J APPL TOXICOL, V31, P206, DOI 10.1002/jat.1666
   Kleensang A, 2014, ALTEX-ALTERN ANIM EX, V31, P53, DOI 10.14573/altex.1309261
   Kohonen P, 2014, BASIC CLIN PHARMACOL, V115, P50, DOI 10.1111/bcpt.12257
   Kongsbak K, 2014, ALTEX-ALTERN ANIM EX, V31, P11, DOI 10.14573/altex.1304241
   Krewski D, 2011, ANNU REV PUBL HEALTH, V32, P161, DOI 10.1146/annurev-publhealth-031210-101153
   Krewski D, 2010, J TOXICOL ENV HEAL B, V13, P51, DOI 10.1080/10937404.2010.483176
   Landesmann B., 2012, JRC75689
   Low Y, 2013, CHEM RES TOXICOL, V26, P1199, DOI 10.1021/tx400110f
   Niklas J, 2013, MOL INFORM, V32, P14, DOI 10.1002/minf.201200043
   NRC (National Research Council), 2007, APPL TOX TECHN PRED
   NRC (National Research Council), 2007, TOX TEST 21 CENT VIS
   OECD, 2014, OECD ENV HLTH SAF PU, V194
   OECD, 2013, OECD ENV HLTH SAF PU, V184
   Padda MS, 2011, HEPATOLOGY, V53, P1377, DOI 10.1002/hep.24229
   Patlewicz G, 2013, REGUL TOXICOL PHARM, V67, P1, DOI 10.1016/j.yrtph.2013.06.002
   Pery ARR, 2013, TOXICOL LETT, V220, P26, DOI 10.1016/j.toxlet.2013.03.032
   Pistollato F, 2012, EXPERT OPIN DRUG MET, V8, P239, DOI 10.1517/17425255.2012.639763
   Sturla SJ, 2014, CHEM RES TOXICOL, V27, P314, DOI 10.1021/tx400410s
   Thomas RS, 2013, TOXICOL SCI, V136, P4, DOI 10.1093/toxsci/kft178
   Thomson JP, 2013, NUCLEIC ACIDS RES, V41, P5639, DOI 10.1093/nar/gkt232
   ToxBank, 2014, COMP SUMM TABL
   Vinken M, 2013, TOXICOL SCI, V136, P97, DOI 10.1093/toxsci/kft177
   Vinken M, 2013, TOXICOLOGY, V312, P158, DOI 10.1016/j.tox.2013.08.011
   Vinken M, 2012, ARCH TOXICOL, V86, P405, DOI 10.1007/s00204-011-0769-z
   Wetmore BA, 2012, TOXICOL SCI, V125, P157, DOI 10.1093/toxsci/kfr254
   Wilmes A, 2013, J PROTEOMICS, V79, P180, DOI 10.1016/j.jprot.2012.11.022
   Wink S, 2014, CHEM RES TOXICOL, V27, P338, DOI 10.1021/tx4004038
   Wu SD, 2013, CHEM RES TOXICOL, V26, P1840, DOI 10.1021/tx400226u
   Wu SD, 2010, REGUL TOXICOL PHARM, V56, P67, DOI 10.1016/j.yrtph.2009.09.006
   Yoon M, 2012, CRIT REV TOXICOL, V42, P633, DOI 10.3109/10408444.2012.692115
   Zelcer N, 2006, J CLIN INVEST, V116, P607, DOI 10.1172/JCI27883
NR 57
TC 21
Z9 21
U1 1
U2 15
PU SPEKTRUM AKADEMISCHER VERLAG-SPRINGER-VERLAG GMBH
PI HEILDEBERG
PA TIERGARTENSTRASSE 17, HEILDEBERG, 69121, GERMANY
SN 1868-596X
EI 1868-8551
J9 ALTEX-ALTERN ANIM EX
JI ALTEX-Altern. Anim. Exp.
PY 2015
VL 32
IS 1
BP 9
EP 24
PG 16
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA CA5QM
UT WOS:000348962900003
PM 25372315
OA DOAJ Gold
DA 2019-10-23
ER

PT J
AU Rovida, C
   Alepee, N
   Api, AM
   Basketter, DA
   Bois, FY
   Caloni, F
   Corsini, E
   Daneshian, M
   Eskes, C
   Ezendam, J
   Fuchs, H
   Hayden, P
   Hegele-Hartung, C
   Hoffmann, S
   Hubesch, B
   Jacobs, MN
   Jaworska, J
   Kleensang, A
   Kleinstreuer, N
   Lalko, J
   Landsiedel, R
   Lebreux, F
   Luechtefeld, T
   Locatelli, M
   Mehling, A
   Natsch, A
   Pitchford, JW
   Prater, D
   Prieto, P
   Schepky, A
   Schuurmann, G
   Smirnova, L
   Toole, C
   van Vliet, E
   Weisensee, D
   Hartung, T
AF Rovida, Costanza
   Alepee, Nathalie
   Api, Anne M.
   Basketter, David A.
   Bois, Frederic Y.
   Caloni, Francesca
   Corsini, Emanuela
   Daneshian, Mardas
   Eskes, Chantra
   Ezendam, Janine
   Fuchs, Horst
   Hayden, Patrick
   Hegele-Hartung, Christa
   Hoffmann, Sebastian
   Hubesch, Bruno
   Jacobs, Miriam N.
   Jaworska, Joanna
   Kleensang, Andre
   Kleinstreuer, Nicole
   Lalko, Jon
   Landsiedel, Robert
   Lebreux, Frederic
   Luechtefeld, Thomas
   Locatelli, Monica
   Mehling, Annette
   Natsch, Andreas
   Pitchford, Jonathan W.
   Prater, Donald
   Prieto, Pilar
   Schepky, Andreas
   Schueuermann, Gerrit
   Smirnova, Lena
   Toole, Colleen
   van Vliet, Erwin
   Weisensee, Dirk
   Hartung, Thomas
TI Integrated Testing Strategies (ITS) for Safety Assessment
SO ALTEX-ALTERNATIVES TO ANIMAL EXPERIMENTATION
LA English
DT Article
DE in vitro methods; testing strategy; Tox21c; skin sensitization;
   computational toxicology
ID ACUTE ORAL TOXICITY; IN-SILICO METHODS; SKIN SENSITIZATION;
   RISK-ASSESSMENT; ECVAM WORKSHOP; ALTERNATIVE METHODS; OSIRIS WEIGHT;
   HAZARD IDENTIFICATION; VITRO METHODS; CELL-LINE
AB Integrated testing strategies (ITS), as opposed to a single definitive test or fixed batteries of tests, are expected to efficiently combine different information sources in a quantifiable fashion to satisfy an information need, in this case for regulatory safety assessments. With increasing awareness of the limitations of each individual tool and the development of highly targeted tests and predictions, the need for combining pieces of evidence increases. The discussions that took place during this workshop, which brought together a group of experts coming from different related areas, illustrate the current state of the art of ITS, as well as promising developments and identifiable challenges. The case of skin sensitization was taken as an example to understand how possible ITS can be constructed, optimized and validated. This will require embracing and developing new concepts such as adverse outcome pathways (AOP), advanced statistical learning algorithms and machine learning, mechanistic validation and "Good ITS Practices".
C1 [Rovida, Costanza; Daneshian, Mardas; Hartung, Thomas] Univ Konstanz, CAAT Europe, Constance, Germany.
   [Alepee, Nathalie] LOreal R&I, Aulnay Sous Bois, France.
   [Api, Anne M.; Lalko, Jon] Res Inst Fragrance Mat Inc, Woodcliff Lake, NJ 07677 USA.
   [Basketter, David A.] DABMEB Consultancy Ltd, Sharnbrook, Beds, England.
   [Bois, Frederic Y.] METO, VIVA, DRC, INERIS, Verneuil En Halatte, France.
   [Caloni, Francesca] Univ Milan, Dept Hlth Anim Sci & Food Safety VESPA, Milan, Italy.
   [Corsini, Emanuela] Univ Milan, Dept Pharmacol & Biomol Sci DISFEB, Milan, Italy.
   [Eskes, Chantra] European Soc Toxicol Vitro, Croix St Ouen, France.
   [Ezendam, Janine] Natl Inst Publ Hlth & Environm RIVM, Ctr Hlth Protect, Bilthoven, Netherlands.
   [Fuchs, Horst; Weisensee, Dirk] CellSyst GmbH, Troisdorf, Germany.
   [Hayden, Patrick] MatTek Corp, Ashland, MA USA.
   [Hegele-Hartung, Christa] Bayer AG, West Haven, CT USA.
   [Hoffmann, Sebastian] Seh Consulting Serv, Paderborn, Germany.
   [Hubesch, Bruno] Cef LRI & EPAA, Brussels, Belgium.
   [Hubesch, Bruno] Hubesch Consult BVBA, Sint Pieters Leeuw, Belgium.
   [Jacobs, Miriam N.] European Food Safety Author, Sci Comm & Emerging Risks Unit, Parma, Italy.
   [Jaworska, Joanna] Brussels Innovat Ctr, Procter & Gamble, Modelling & Simulat Biol Syst, Strombeek Bever, Belgium.
   [Kleinstreuer, Nicole] ILS NICEATM, Res Triangle Pk, NC USA.
   [Landsiedel, Robert; Mehling, Annette] BASF SE, Ludwigshafen, Germany.
   [Lebreux, Frederic] Ecole Polytech, CNRS, UMR 7652, Lab Synthese Organ, F-91128 Palaiseau, France.
   [Kleensang, Andre; Luechtefeld, Thomas; Smirnova, Lena; Hartung, Thomas] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, CAAT, Baltimore, MD USA.
   [Locatelli, Monica] REACH Mastery, Como, Italy.
   [Natsch, Andreas] Givaudan Schweiz AG, Dubendorf, Switzerland.
   [Pitchford, Jonathan W.] Univ York, Dept Biol & Math, York YO10 5DD, N Yorkshire, England.
   [Prater, Donald] European Bur, Food & Drug Adm, Brussels, Belgium.
   [Prieto, Pilar] Joint Res Ctr, EURL ECVAM, Inst Hlth & Consumer Protect, Syst Toxicol Unit,European Commiss, Ispra, Italy.
   [Schepky, Andreas] Beiersdorf AG, Hamburg, Germany.
   [Schueuermann, Gerrit] Helmholtz Ctr Environm Res, UFZ Dept Ecol Chem, Leipzig, Germany.
   [Schueuermann, Gerrit] Tech Univ Bergakad Freiberg, Inst Organ Chem, Freiberg, Germany.
   [Toole, Colleen] CeeTox Inc, Kalamazoo, MI USA.
   [van Vliet, Erwin] SeCAM Serv & Consultat Alternat Methods, Agno, Switzerland.
RP Rovida, C (reprint author), Univ Konstanz, CAAT Europe, Box 600, D-78457 Constance, Germany.
EM costanza.rovida@uni-konstanz.de
RI Bois, Frederic/E-9241-2012; Caloni, Francesca/I-5327-2017; Kleinstreuer,
   Nicole/F-7203-2019; Schuurmann, Gerrit/E-7962-2017; Leist,
   Marcel/D-2133-2010; Landsiedel, Robert/D-1960-2012
OI Bois, Frederic/0000-0002-4154-0391; Caloni,
   Francesca/0000-0003-2527-7754; Kleinstreuer, Nicole/0000-0002-7914-3682;
   Schuurmann, Gerrit/0000-0002-3789-1703; Kleensang,
   Andre/0000-0002-4564-7399; Leist, Marcel/0000-0002-3778-8693; Hoffmann,
   Sebastian/0000-0002-3214-7678; Landsiedel, Robert/0000-0003-3756-1904;
   Natsch, Andreas/0000-0003-2231-2489; Reif, David/0000-0001-7815-6767
FU NIEHS NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Environmental
   Health Sciences (NIEHS) [P42 ES005948]; National Centre for the
   Replacement, Refinement and Reduction of Animals in Research (NC3Rs)
   [NC/K001264/1]
CR Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Balls M, 1999, ATLA-ALTERN LAB ANIM, V27, P53
   Balls M, 2006, ATLA-ALTERN LAB ANIM, V34, P603, DOI 10.1177/026119290603400604
   BASKETTER DA, 1994, TOXICOL IN VITRO, V8, P855, DOI 10.1016/0887-2333(94)90086-8
   Basketter D, 2007, ATLA-ALTERN LAB ANIM, V35, P137, DOI 10.1177/026119290703500124
   Basketter D, 2013, REGUL TOXICOL PHARM, V67, P531, DOI 10.1016/j.yrtph.2013.10.002
   Basketter D, 2012, REGUL TOXICOL PHARM, V64, P9, DOI 10.1016/j.yrtph.2012.06.003
   Basketter DA, 2014, DERMATITIS, V25, P11, DOI 10.1097/DER.0000000000000003
   Basketter DA, 2012, ALTEX-ALTERN ANIM EX, V29, P5, DOI 10.14573/altex.2012.1.003
   Bauch C, 2012, REGUL TOXICOL PHARM, V63, P489, DOI 10.1016/j.yrtph.2012.05.013
   Bessems JG, 2014, REGUL TOXICOL PHARM, V68, P119, DOI 10.1016/j.yrtph.2013.11.008
   Blaauboer BJ, 2012, ALTEX-ALTERN ANIM EX, V29, P411, DOI 10.14573/altex.2012.4.411
   Blaauboer BJ, 1999, ATLA-ALTERN LAB ANIM, V27, P229, DOI 10.1177/026119299902700211
   Buist H, 2013, REGUL TOXICOL PHARM, V67, P170, DOI 10.1016/j.yrtph.2013.01.002
   Casati S, 2009, ATLA-ALTERN LAB ANIM, V37, P305, DOI 10.1177/026119290903700313
   Daneshian M, 2011, ALTEX-ALTERN ANIM EX, V28, P341, DOI 10.14573/altex.2011.4.341
   dos Santos GG, 2009, TOXICOL APPL PHARM, V236, P372, DOI 10.1016/j.taap.2009.02.004
   ECHA, 2014, ECHA14A07EN
   EPA, 2009, NON TEST APPR EP LAB
   Gerberick F, 2008, ATLA-ALTERN LAB ANIM, V36, P215, DOI 10.1177/026119290803600210
   Gerberick GF, 2007, TOXICOL SCI, V97, P417, DOI 10.1093/toxsci/kfm064
   Gibbs S, 2013, TOXICOL APPL PHARM, V272, P529, DOI 10.1016/j.taap.2013.07.003
   Guzelian PS, 2005, HUM EXP TOXICOL, V24, P161, DOI 10.1191/0960327105ht517oa
   Hartung T, 2004, ATLA-ALTERN LAB ANIM, V32, P467, DOI 10.1177/026119290403200503
   Hartung T, 2013, ALTEX-ALTERN ANIM EX, V30, P119, DOI 10.14573/altex.2013.2.119
   Hartung T, 2013, ALTEX-ALTERN ANIM EX, V30, P3, DOI 10.14573/altex.2013.1.003
   Hartung T, 2009, NATURE, V460, P1080, DOI 10.1038/4601080a
   Hoffmann S, 2006, HUM EXP TOXICOL, V25, P497, DOI 10.1191/0960327106het648oa
   Hooyberghs J, 2008, TOXICOL APPL PHARM, V231, P103, DOI 10.1016/j.taap.2008.03.014
   Jacobs MN, 2013, ALTEX-ALTERN ANIM EX, V30, P331, DOI 10.14573/altex.2013.3.331
   Jaworska J, 2013, J APPL TOXICOL, V33, P1353, DOI 10.1002/jat.2869
   Jaworska Joanna, 2010, ALTEX, V27, P231
   Johansson H, 2013, TOXICOL IN VITRO, V27, P1163, DOI 10.1016/j.tiv.2012.05.019
   Judson R, 2013, ALTEX-ALTERN ANIM EX, V30, P51, DOI 10.14573/altex.2013.1.051
   Kavlock R, 2012, CHEM RES TOXICOL, V25, P1287, DOI 10.1021/tx3000939
   Kinsner-Ovaskainen A, 2013, TOXICOL IN VITRO, V27, P1377, DOI 10.1016/j.tiv.2012.11.010
   Kinsner-Ovaskainen A, 2012, ATLA-ALTERN LAB ANIM, V40, P175, DOI 10.1177/026119291204000310
   Kinsner-Ovaskainen A, 2009, ATLA-ALTERN LAB ANIM, V37, P437, DOI 10.1177/026119290903700413
   Kleinstreuer NC, 2011, ENVIRON HEALTH PERSP, V119, P1596, DOI 10.1289/ehp.1103412
   Knudsen T. B., 2012, AXLR8 3 ALTERNATIVE, P193
   Kolle SN, 2013, REGUL TOXICOL PHARM, V65, P278, DOI 10.1016/j.yrtph.2012.12.006
   Kopp-Schneider A, 2013, TOXICOL IN VITRO, V27, P1395, DOI 10.1016/j.tiv.2012.08.016
   Leist M, 2014, ALTEX-ALTERN ANIM EX, V31, P341, DOI 10.14573/altex.1406091
   Martin MT, 2011, BIOL REPROD, V85, P327, DOI 10.1095/biolreprod.111.090977
   Maxwell G, 2014, TOXICOL IN VITRO, V28, P8, DOI 10.1016/j.tiv.2013.10.013
   Maxwell G, 2011, ALTEX-ALTERN ANIM EX, V28, P50, DOI 10.14573/altex.2011.1.050
   Natsch A, 2014, ISSUES TOXICOL, V19, P265
   Natsch A, 2013, J APPL TOXICOL, V33, P1337, DOI 10.1002/jat.2868
   Natsch A, 2011, TOXICOL IN VITRO, V25, P733, DOI 10.1016/j.tiv.2010.12.014
   Natsch A, 2010, TOXICOL SCI, V113, P284, DOI 10.1093/toxsci/kfp228
   Nendza M, 2013, REGUL TOXICOL PHARM, V66, P301, DOI 10.1016/j.yrtph.2013.05.007
   NIH, 1999, NIH PUBLICATION
   Norlen H, 2014, ATLA-ALTERN LAB ANIM, V42, P115, DOI 10.1177/026119291404200204
   NRC (National Research Council), 2007, TOX TEST 21 CENT VIS
   OECD, 2014, SER TEST ASS, V203
   OECD, 2012, SER TEST ASS, V168
   OECD, 2004, SKIN ABS IN VITR MET
   Patlewicz G, 2008, QSAR COMB SCI, V27, P60, DOI 10.1002/qsar.200710067
   Piersma AH, 2013, REPROD TOXICOL, V38, P53, DOI 10.1016/j.reprotox.2013.03.002
   Prieto P, 2013, TOXICOL IN VITRO, V27, P1357, DOI 10.1016/j.tiv.2012.07.013
   Python F, 2007, TOXICOL APPL PHARM, V220, P113, DOI 10.1016/j.taap.2006.12.026
   Reuter H, 2011, TOXICOL IN VITRO, V25, P315, DOI 10.1016/j.tiv.2010.09.016
   Richter A, 2013, TOXICOL IN VITRO, V27, P1180, DOI 10.1016/j.tiv.2012.08.007
   Rorije E, 2013, REGUL TOXICOL PHARM, V67, P146, DOI 10.1016/j.yrtph.2013.06.003
   Rovida C, 2013, ALTEX-ALTERN ANIM EX, V30, P231, DOI 10.14573/altex.2013.2.231
   Rovida C, 2009, ALTEX-ALTERN TIEREXP, V26, P187
   Sakaguchi H, 2009, CELL BIOL TOXICOL, V25, P109, DOI 10.1007/s10565-008-9059-9
   Scott L, 2010, TOXICOL IN VITRO, V24, P1, DOI 10.1016/j.tiv.2009.05.019
   Smirnova L, 2014, ALTEX-ALTERN ANIM EX, V31, P129, DOI http://dx.doi.org/10.14573/altex.1403271
   Sogorb MA, 2014, TOXICOL LETT, V230, P356, DOI 10.1016/j.toxlet.2014.01.037
   Tluczkiewicz I, 2013, REGUL TOXICOL PHARM, V67, P157, DOI 10.1016/j.yrtph.2013.02.004
   van der Veen JW, 2014, REGUL TOXICOL PHARM, V69, P371, DOI 10.1016/j.yrtph.2014.04.018
   van der Veen JW, 2013, TOXICOL IN VITRO, V27, P314, DOI 10.1016/j.tiv.2012.08.023
   van Loveren H, 2008, REGUL TOXICOL PHARM, V50, P155, DOI 10.1016/j.yrtph.2007.11.008
   Yoon M, 2012, CRIT REV TOXICOL, V42, P633, DOI 10.3109/10408444.2012.692115
NR 75
TC 81
Z9 84
U1 2
U2 21
PU SPEKTRUM AKADEMISCHER VERLAG-SPRINGER-VERLAG GMBH
PI HEILDEBERG
PA TIERGARTENSTRASSE 17, HEILDEBERG, 69121, GERMANY
SN 1868-596X
EI 1868-8551
J9 ALTEX-ALTERN ANIM EX
JI ALTEX-Altern. Anim. Exp.
PY 2015
VL 32
IS 1
BP 25
EP 40
DI 10.14573/altex.1411011
PG 16
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA CA5QM
UT WOS:000348962900004
PM 25413849
OA DOAJ Gold, Green Published
DA 2019-10-23
ER

PT J
AU Daston, G
   Knight, DJ
   Schwarz, M
   Gocht, T
   Thomas, RS
   Mahony, C
   Whelan, M
AF Daston, George
   Knight, Derek J.
   Schwarz, Michael
   Gocht, Tilman
   Thomas, Russell S.
   Mahony, Catherine
   Whelan, Maurice
TI SEURAT: Safety Evaluation Ultimately Replacing Animal
   Testing-Recommendations for future research in the field of predictive
   toxicology
SO ARCHIVES OF TOXICOLOGY
LA English
DT Article
DE Critical biological targets; Adverse outcome pathways; Safety
   assessment; Read-across; Ab initio prediction
ID HEALTH-RISK ASSESSMENT; TOXCAST PROGRAM; FRAMEWORK; CHEMICALS; UPDATE;
   READ
AB The development of non-animal methodology to evaluate the potential for a chemical to cause systemic toxicity is one of the grand challenges of modern science. The European research programme SEURAT is active in this field and will conclude its first phase, SEURAT-1, in December 2015. Drawing on the experience gained in SEURAT-1 and appreciating international advancement in both basic and regulatory science, we reflect here on how SEURAT should evolve and propose that further research and development should be directed along two complementary and interconnecting work streams. The first work stream would focus on developing new 'paradigm' approaches for regulatory science. The goal here is the identification of 'critical biological targets' relevant for toxicity and to test their suitability to be used as anchors for predicting toxicity. The second work stream would focus on integration and application of new approach methods for hazard (and risk) assessment within the current regulatory 'paradigm', aiming for acceptance of animal-free testing strategies by regulatory authorities (i.e. translating scientific achievements into regulation). Components for both work streams are discussed and may provide a structure for a future research programme in the field of predictive toxicology.
C1 [Daston, George] Procter & Gamble Co, Cent Prod Safety Dept, Mason, OH 45040 USA.
   [Knight, Derek J.] European Chem Agcy, Helsinki 00121, Finland.
   [Schwarz, Michael; Gocht, Tilman] Univ Tubingen, Dept Toxicol, Inst Expt & Clin Pharmacol & Toxicol, D-72074 Tubingen, Germany.
   [Thomas, Russell S.] US EPA, Natl Ctr Computat Toxicol, Res Triangle Pk, NC 27711 USA.
   [Mahony, Catherine] Procter & Gamble Tech Ctr Ltd, Egham TW20 9NW, Surrey, England.
   [Whelan, Maurice] Commiss European Communities, Joint Res Ctr, IHCP, I-21027 Ispra, VA, Italy.
RP Schwarz, M (reprint author), Univ Tubingen, Dept Toxicol, Inst Expt & Clin Pharmacol & Toxicol, Wilhelmstr 56, D-72074 Tubingen, Germany.
EM Michael.schwarz@uni-tuebingen.de
OI Gocht, Tilma/0000-0002-2491-2050
FU European CommunityEuropean Community (EC) [267044]; Cosmetics Europe
FX This work has received funding from the European Community's Seventh
   Framework Programme (FP7/2007-2013) under grant agreement no 267044
   (project acronym 'COACH') and has received financing from Cosmetics
   Europe.
CR Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   AXLR8, 2012, ALT TEST STRAT PROGR
   Bouhifd M, 2014, BASIC CLIN PHARMACOL, V115, P24, DOI 10.1111/bcpt.12198
   CLEWELL HJ, 1995, TOXICOL LETT, V79, P207, DOI 10.1016/0378-4274(95)03372-R
   Collins FS, 2008, SCIENCE, V319, P906, DOI 10.1126/science.1154619
   Dix DJ, 2007, TOXICOL SCI, V95, P5, DOI 10.1093/toxsci/kfl103
   Enoch SJ, 2008, CHEM RES TOXICOL, V21, P513, DOI 10.1021/tx700322g
   European Commission, 2013, COMM COMM EUR PARL C
   Gocht T, 2014, SEURAT 1 APPROACH AN, DOI 10.14573/altex.1408041
   Gocht T, 2014, REPLACEMENT IN VIVO
   Judson RS, 2011, CHEM RES TOXICOL, V24, P451, DOI 10.1021/tx100428e
   Kavlock R, 2012, CHEM RES TOXICOL, V25, P1287, DOI 10.1021/tx3000939
   Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939
   NRC (National Research Council), 2007, TOX TEST 21 CENT VIS
   OECD, 2013, OECD ENV HLTH SAF PU, V184
   Pastoor TP, 2014, CRIT REV TOXICOL, V44, P1, DOI 10.3109/10408444.2014.931923
   Patlewicz G, 2014, ALTEX-ALTERN ANIM EX, V31, P387, DOI 10.14573/altex.1410071
   Rotroff DM, 2010, TOXICOL SCI, V117, P348, DOI 10.1093/toxsci/kfq220
   Thomas RS, 2013, TOXICOL SCI, V136, P4, DOI 10.1093/toxsci/kft178
   Tice RR, 2013, ENVIRON HEALTH PERSP, V121, P756, DOI 10.1289/ehp.1205784
   WHO: World Health Organization, 2014, 11 WHO IPSC
   Wu SD, 2010, REGUL TOXICOL PHARM, V56, P67, DOI 10.1016/j.yrtph.2009.09.006
NR 22
TC 23
Z9 23
U1 0
U2 28
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0340-5761
EI 1432-0738
J9 ARCH TOXICOL
JI Arch. Toxicol.
PD JAN
PY 2015
VL 89
IS 1
BP 15
EP 23
DI 10.1007/s00204-014-1421-5
PG 9
WC Toxicology
SC Toxicology
GA AY0KZ
UT WOS:000347286700003
PM 25433540
DA 2019-10-23
ER

PT S
AU Perkins, E
   Garcia-Reyero, N
   Edwards, S
   Wittwehr, C
   Villeneuve, D
   Lyons, D
   Ankley, G
AF Perkins, Edward
   Garcia-Reyero, Natalia
   Edwards, Stephen
   Wittwehr, Clemens
   Villeneuve, Daniel
   Lyons, David
   Ankley, Gerald
BE Hoeng, J
   Peitsch, MC
TI The Adverse Outcome Pathway: A Conceptual Framework to Support Toxicity
   Testing in the Twenty-First Century
SO COMPUTATIONAL SYSTEMS TOXICOLOGY
SE Methods in Pharmacology and Toxicology
LA English
DT Article; Book Chapter
DE Predictive toxicology; Ecotoxicology; Key events; Computational biology;
   Network science; Risk assessment
ID HUMAN RELEVANCE FRAMEWORK; FATHEAD MINNOW; CANCER MODE; NETWORK
   INFERENCE; THYROID-HORMONE; RISK-ASSESSMENT; IPCS FRAMEWORK; IN-VIVO;
   THYROXINE; CHEMICALS
AB The need to rapidly characterize the risk of large numbers of chemicals has moved the traditional toxicological paradigm from animal testing to a pathway-based approach using in vitro assay systems and modeling where possible. Adverse Outcome Pathways (AOPs) provide a conceptual framework that can be used to link in vitro assay results to whole animal effects in a pathway context. AOPs are defined and examples are provided to demonstrate key characteristics of AOPs. To support development and application of AOPs, a knowledge base has been developed containing a Wiki site designed to permit documentation of AOPs in a crowd-sourced manner. Both empirical and computational methods are demonstrated to play a significant role in AOP development. The combination of computational approaches, including different modeling efforts, together with apical end points within the pathway-based framework will allow for a better understanding of the linkage of events from a molecular initiating event to a potential adverse outcome, therefore defi ning key events, AOPs, and even networks of AOPS. While these approaches are indeed very promising, the ability to understand and defi ne key events and key event relationships will remain one of the more complex and challenging efforts within AOP development. In order to make AOPs useful for risk assessment these challenges need to be understood and overcome. An interdisciplinary approach including apical and molecular measurements, computational, and modeling efforts is currently being one of the most promising approaches to ensure AOPs become the useful framework they were designed to be.
C1 [Perkins, Edward] US Army Engineer Res & Dev Ctr, Environm Lab, Vicksburg, MS USA.
   [Garcia-Reyero, Natalia] Mississippi State Univ, Inst Genom Biocomp & Biotechnol, Starkville, MS USA.
   [Edwards, Stephen; Lyons, David] US EPA, Natl Hlth & Environm Effects Res Lab, Res Triangle Pk, NC 27711 USA.
   [Wittwehr, Clemens] Commiss European Communities, Joint Res Ctr, Syst Toxicol Unit, I-21020 Ispra, Italy.
   [Villeneuve, Daniel; Ankley, Gerald] US EPA, Midcontinent Ecol Div, Duluth, MN USA.
RP Perkins, E (reprint author), US Army Engineer Res & Dev Ctr, Environm Lab, Vicksburg, MS USA.
RI Lyons, David/G-3459-2011
OI Lyons, David/0000-0002-2966-5634; Wittwehr, Clemens/0000-0003-2760-7702
CR Adverse Outcome Knowledge Base, 2014, ADV OUTC PATHW KNOWL
   Andersen ME, 2009, TOXICOL SCI, V107, P324, DOI 10.1093/toxsci/kfn255
   Ankley GT, 2006, AQUAT TOXICOL, V78, P91, DOI 10.1016/j.aquatox.2006.01.018
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Ankley GT, 2009, TOXICOL SCI, V112, P344, DOI 10.1093/toxsci/kfp227
   Ankley GT, 2005, TOXICOL SCI, V86, P300, DOI 10.1093/toxsci/kfi202
   [Anonymous], 2014, US HDB SUPPL GUID DE
   Basso K, 2005, NAT GENET, V37, P382, DOI 10.1038/ng1532
   Boobis AR, 2008, CRIT REV TOXICOL, V38, P87, DOI 10.1080/10408440701749421
   Boobis AR, 2006, CRIT REV TOXICOL, V36, P781, DOI 10.1080/10408440600977677
   Bradbury SP, 2004, ENVIRON SCI TECHNOL, V38, p463A, DOI 10.1021/es040675s
   Brucker-Davis F, 1998, THYROID, V8, P827, DOI 10.1089/thy.1998.8.827
   Capen CC, 1997, TOXICOL PATHOL, V25, P39, DOI 10.1177/019262339702500109
   Celander MC, 2011, ENVIRON TOXICOL CHEM, V30, P52, DOI 10.1002/etc.382
   Chiamolera MI, 2009, ENDOCRINOLOGY, V150, P1091, DOI 10.1210/en.2008-1795
   Cohen SM, 2006, CRIT REV TOXICOL, V36, P803, DOI 10.1080/10408440600977651
   Cote I, 2012, ENVIRON HEALTH PERSP, V120, P1499, DOI 10.1289/ehp.1104870
   Crofton KM, 2008, INT J ANDROL, V31, P209, DOI 10.1111/j.1365-2605.2007.00857.x
   Degitz SJ, 2005, TOXICOL SCI, V87, P353, DOI 10.1093/toxsci/kfi246
   Della Gatta G, 2012, NAT MED, V18, P436, DOI 10.1038/nm.2610
   Dellarco VL, 2006, CRIT REV TOXICOL, V36, P793, DOI 10.1080/10408440600975242
   DICKHOFF WW, 1978, GEN COMP ENDOCR, V36, P229, DOI 10.1016/0016-6480(78)90027-8
   Dodd M.H.I., 1976, P467
   European Chemicals Agency, 2014, INT UN CHEM INF DAT
   Garcia-Reyero N, 2014, GEN COMP ENDOCR, V203, P193, DOI 10.1016/j.ygcen.2014.03.022
   Garcia-Reyero N, 2014, ENVIRON SCI TECHNOL, V48, P4546, DOI 10.1021/es4042258
   Garcia-Reyero N, 2014, ENVIRON INT, V63, P216, DOI 10.1016/j.envint.2013.11.012
   Greenfield A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013397
   Hallen K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-51
   HAUX C, 1988, AMBIO, V17, P376
   HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503
   Hill RN, 1998, ENVIRON HEALTH PERSP, V106, P447, DOI 10.1289/ehp.98106447
   Hood A, 2000, TOXICOL SCI, V55, P78, DOI 10.1093/toxsci/55.1.78
   Hurley PM, 1998, ENVIRON HEALTH PERSP, V106, P437, DOI 10.1289/ehp.98106437
   Ideker T, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2011.99
   LELOUP J, 1977, CR ACAD SCI D NAT, V284, P2261
   Lingeman J, 2012, NETWORK INFERENCE MO
   MacKay C, 2013, ALTEX-ALTERN ANIM EX, V30, P473, DOI 10.14573/altex.2013.4.473
   Madar A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009803
   MCCLAIN RM, 1989, TOXICOL APPL PHARM, V99, P216, DOI 10.1016/0041-008X(89)90004-5
   Meek ME, 2014, J APPL TOXICOL, V34, P1, DOI 10.1002/jat.2949
   Miller DH, 2007, ENVIRON TOXICOL CHEM, V26, P521, DOI 10.1897/06-318R.1
   Mitra K, 2013, NAT REV GENET, V14, P719, DOI 10.1038/nrg3552
   National Institutes for Health, 2014, TOX21 PROGR NAT CTR
   Norris DO, 2013, VERTEBRATE ENDOCRINOLOGY, FIFTH EDITION, P1
   OECD Organization for Economic Co-operation and Development, 2013, GUID DOC DEV ASS ADV, V184 ENV/JM/MONO(2013) 6, P45
   OECD Organization for Economic Co-operation and Development, 2011, REP WORKSH US MECH I, V138, P45
   OPPENHEIMER JH, 1968, J CLIN INVEST, V47, P1399, DOI 10.1172/JCI105831
   Organization for Economic Co-operation and Development, 2011, TEST CHEM ADV OUTC P
   Paris M, 2008, GENESIS, V46, P657, DOI 10.1002/dvg.20443
   Perkins EJ, 2011, ENVIRON TOXICOL CHEM, V30, P22, DOI 10.1002/etc.374
   Perkins EJ, 2014, AOP XPLORER
   Power DM, 2001, COMP BIOCHEM PHYS C, V130, P447, DOI 10.1016/S1532-0456(01)00271-X
   Rattner BA, 2014, ENVIRON SCI TECHNOL, V48, P8433, DOI 10.1021/es501740n
   Rovida C, 2009, ALTEX-ALTERN TIEREXP, V26, P187
   Russom CL, 2014, ENVIRON TOXICOL CHEM, V33, P2157, DOI 10.1002/etc.2662
   Ryan CJ, 2012, MOL CELL, V46, P691, DOI 10.1016/j.molcel.2012.05.028
   Schiffelers MJWA, 2012, ALTEX-ALTERN ANIM EX, V29, P287, DOI 10.14573/altex.2012.3.287
   Skolness SY, 2013, TOXICOL SCI, V132, P284, DOI 10.1093/toxsci/kft010
   Tollefsen KE, 2014, REGUL TOXICOL PHARM, V70, P629, DOI 10.1016/j.yrtph.2014.09.009
   United States Code, 2012, FED INS FUNG ROD ACT
   United States Environmental Protection Agency, 2014, TSCA CHEM SUBST INV
   United States Environmental Protection Agency, 2014, AGGR COMP TOX RES AC
   United States Public Law, 1976, TOX SUBST CONTR ACT
   US National Research Council Committee on Toxicity, 2007, TOX TEST 21 CENT NAT
   Van Sande J, 2003, ENDOCRINOLOGY, V144, P247, DOI 10.1210/en.2002-220744
   Villeneuve D, 2014, ENVIRON TOXICOL CHEM, V33, P158, DOI 10.1002/etc.2403
   Villeneuve DL, 2007, ENVIRON SCI TECHNOL, V41, P321, DOI 10.1021/es061739x
   Villeneuve DL, 2014, TOXICOL SCI, V142, P312, DOI 10.1093/toxsci/kfu199
   Villeneuve DL, 2014, TOXICOL SCI, V142, P321, DOI 10.1093/toxsci/kfu200
   Villeneuve DL, 2011, ENVIRON TOXICOL CHEM, V30, P1, DOI 10.1002/etc.396
   Villeneuve DL, 2009, ENVIRON HEALTH PERSP, V117, P624, DOI 10.1289/ehp.11891
   Vinken M, 2013, TOXICOL SCI, V136, P97, DOI 10.1093/toxsci/kft177
   VISSER TJ, 1993, FEBS LETT, V324, P358, DOI 10.1016/0014-5793(93)80151-J
   Volz DC, 2011, TOXICOL SCI, V123, P349, DOI 10.1093/toxsci/kfr185
   Wang RL, 2010, AQUAT TOXICOL, V98, P230, DOI 10.1016/j.aquatox.2010.02.021
   Warner CM, 2012, ENVIRON SCI TECHNOL, V46, P7790, DOI 10.1021/es300495c
   Wilbanks MS, 2014, TOXICOL SCI, V141, P44, DOI 10.1093/toxsci/kfu104
   Williams TD, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002126
   Wolff J, 1998, PHARMACOL REV, V50, P89
   Yu J, 2004, BIOINFORMATICS, V20, P3594, DOI 10.1093/bioinformatics/bth448
   Zhang Q, 2014, ENVIRON HEALTH PERSP, V122, P1261, DOI 10.1289/ehp.1408244
   Zoeller RT, 2007, THYROID, V17, P811, DOI 10.1089/thy.2007.0107
   Zoppoli P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-154
NR 84
TC 5
Z9 6
U1 1
U2 17
PU HUMANA PRESS INC
PI TOTOWA
PA 999 RIVERVIEW DR, STE 208, TOTOWA, NJ 07512-1165 USA
SN 1557-2153
EI 1940-6053
BN 978-1-4939-2778-4; 978-1-4939-2777-7
J9 METHOD PHARMACOL TOX
JI Methods Pharmacol. Toxicol.
PY 2015
BP 1
EP 26
DI 10.1007/978-1-4939-2778-4_1
D2 10.1007/978-1-4939-2778-4
PG 26
WC Pharmacology & Pharmacy; Toxicology
SC Pharmacology & Pharmacy; Toxicology
GA BE1QP
UT WOS:000368400200002
DA 2019-10-23
ER

PT J
AU Bal-Price, A
   Crofton, KM
   Sachana, M
   Shafer, TJ
   Behl, M
   Forsby, A
   Hargreaves, A
   Landesmann, B
   Lein, PJ
   Louisse, J
   Monnet-Tschudi, F
   Paini, A
   Rolaki, A
   Schrattenholz, A
   Sunol, C
   van Thriel, C
   Whelan, M
   Fritsche, E
AF Bal-Price, Anna
   Crofton, Kevin M.
   Sachana, Magdalini
   Shafer, Timothy J.
   Behl, Mamta
   Forsby, Anna
   Hargreaves, Alan
   Landesmann, Brigitte
   Lein, Pamela J.
   Louisse, Jochem
   Monnet-Tschudi, Florianne
   Paini, Alicia
   Rolaki, Alexandra
   Schrattenholz, Andre
   Sunol, Cristina
   van Thriel, Christoph
   Whelan, Maurice
   Fritsche, Ellen
TI Putative adverse outcome pathways relevant to neurotoxicity
SO CRITICAL REVIEWS IN TOXICOLOGY
LA English
DT Review
DE adverse outcome pathway; in vitro testing; key events; molecular
   initiating event; pathways of neurotoxicity; predictive toxicology
ID POSTOPERATIVE COGNITIVE DYSFUNCTION; ESTROGEN-RECEPTOR BINDING;
   DEVELOPMENTAL NEUROTOXICITY; RISK-ASSESSMENT; NERVOUS-SYSTEM;
   ALTERNATIVE METHODS; MAGNETIC-RESONANCE; MATURE HIPPOCAMPUS; PROGENITOR
   CELLS; ANIMAL-MODELS
AB The Adverse Outcome Pathway (AOP) framework provides a template that facilitates understanding of complex biological systems and the pathways of toxicity that result in adverse outcomes (AOs). The AOP starts with an molecular initiating event (MIE) in which a chemical interacts with a biological target(s), followed by a sequential series of KEs, which are cellular, anatomical, and/or functional changes in biological processes, that ultimately result in an AO manifest in individual organisms and populations. It has been developed as a tool for a knowledge-based safety assessment that relies on understanding mechanisms of toxicity, rather than simply observing its adverse outcome. A large number of cellular and molecular processes are known to be crucial to proper development and function of the central (CNS) and peripheral nervous systems (PNS). However, there are relatively few examples of well-documented pathways that include causally linked MIEs and KEs that result in adverse outcomes in the CNS or PNS. As a first step in applying the AOP framework to adverse health outcomes associated with exposure to exogenous neurotoxic substances, the EU Reference Laboratory for Alternatives to Animal Testing (EURL ECVAM) organized a workshop (March 2013, Ispra, Italy) to identify potential AOPs relevant to neurotoxic and developmental neurotoxic outcomes. Although the AOPs outlined during the workshop are not fully described, they could serve as a basis for further, more detailed AOP development and evaluation that could be useful to support human health risk assessment in a variety of ways.
C1 [Bal-Price, Anna; Sachana, Magdalini; Landesmann, Brigitte; Louisse, Jochem; Paini, Alicia; Rolaki, Alexandra; Whelan, Maurice] European Commiss Joint Res Ctr, Inst Hlth & Consumer Protect, Ispra, Italy.
   [Crofton, Kevin M.; Shafer, Timothy J.] US EPA, Off Res & Dev, Natl Ctr Computat Toxicol, Res Triangle Pk, NC USA.
   [Behl, Mamta] Natl Inst Environm Hlth Sci, Div Natl Toxicol Program, Res Triangle Pk, NC USA.
   [Forsby, Anna] Stockholm Univ, Arrhenius Labs NaturalSci, Dept Neurochem, S-10691 Stockholm, Sweden.
   [Forsby, Anna] Swedish Toxicol Sci Res Ctr, Swetox, Sodertalje, Sweden.
   [Hargreaves, Alan] Nottingham Trent Univ, Nottingham, England.
   [Lein, Pamela J.] Univ Calif Davis, Sch Vet Med, Dept Mol Biosci, Davis, CA 95616 USA.
   [Monnet-Tschudi, Florianne] Univ Lausanne, Dept Physiol, Lausanne, Switzerland.
   [Monnet-Tschudi, Florianne] Univ Lausanne, SCAHT, Lausanne, Switzerland.
   [Schrattenholz, Andre] ProteoSys AG, Mainz, Germany.
   [Sunol, Cristina] CIBERESP, IDIBAPS, IIBB CSIC, Inst Invest Biomed Barcelona, Barcelona, Spain.
   [van Thriel, Christoph] IfADo Leibniz Res Ctr Working Environm & Human Fa, Dortmund, Germany.
   [Fritsche, Ellen] IUF Leibniz Res Inst Environm Med, Dusseldorf, Germany.
RP Bal-Price, A (reprint author), Commiss European Communities, Joint Res Ctr, Inst Hlth & Consumer Protect, Syst Toxicol Unit,EURL ECVAM, TP 580,Via Fermi 1, I-21026 Ispra, VA, Italy.
EM anna.price@jrc.ec.europa
RI Crofton, Kevin/J-4798-2015; Cristina, Sunol/K-8302-2014
OI Crofton, Kevin/0000-0003-1749-9971; van Thriel,
   Christoph/0000-0003-3215-9262; Lein, Pamela/0000-0001-7665-7584;
   Hargreaves, Alan/0000-0001-9754-5477; Forsby, Anna/0000-0001-6298-201X;
   Cristina, Sunol/0000-0001-9367-8483
FU European CommissionEuropean Commission Joint Research Centre
FX The employment affiliation of the authors is shown on the cover page.
   The authors have sole responsibility for the writing and content of this
   paper. The contributing authors were participants of the workshop
   organized by the EURL ECVAM. The external workshop participants were
   invited on the basis of a survey performed by EURL ECVAM neurotoxicity
   experts of the latest literature to identify those with specific
   expertise in the relevant research fields. The workshop organization was
   financially supported by the European Commission, including the cost of
   travelling and per diem of all invited external experts. The strategy
   for preparing the report, the literature selected for review, the
   conclusions drawn and the recommendations made are exclusively the
   collective scientific output of the workshop participants and do not
   necessarily represent the views of the participants' employers.
CR Adeleye Y., 2014, TOXICOLOGY
   Aldridge WN, 1996, MECH CONCEPTS TOXICO
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   [Anonymous], 2013, SER TEST ASS
   Bal-Price AK, 2012, ALTEX-ALTERN ANIM EX, V29, P202, DOI 10.14573/altex.2012.2.202
   Bal-Price AK, 2010, NEUROTOXICOLOGY, V31, P545, DOI 10.1016/j.neuro.2009.11.006
   BARONE S, 1995, NEUROBIOL AGING, V16, P723, DOI 10.1016/0197-4580(95)00089-W
   Barone S, 2000, NEUROTOXICOLOGY, V21, P15
   Bishop NA, 2010, NATURE, V464, P529, DOI 10.1038/nature08983
   Bloom Barbara, 2010, Vital Health Stat 10, P1
   BURBACHER TM, 1990, NEUROTOXICOL TERATOL, V12, P191, DOI 10.1016/0892-0362(90)90091-P
   Bushnell PJ, 2010, NEUROTOXICOL TERATOL, V32, P313, DOI 10.1016/j.ntt.2010.02.002
   Coecke S, 2007, ENVIRON HEALTH PERSP, V115, P924, DOI 10.1289/ehp.9427
   Collins FS, 2008, SCIENCE, V319, P906, DOI 10.1126/science.1154619
   Crofton KM, 2011, ALTEX-ALTERN ANIM EX, V28, P9
   Crofton KM, 2005, CRIT REV TOXICOL, V35, P757, DOI 10.1080/10408440591007304
   Ganguly K, 2001, CELL, V105, P521, DOI 10.1016/S0092-8674(01)00341-5
   Gassmann K, 2010, ENVIRON HEALTH PERSP, V118, P1571, DOI 10.1289/ehp.0901545
   Gemma C., 2007, BRAIN AGING MODELS M
   Giedd JN, 2008, J ADOLESCENT HEALTH, V42, P335, DOI 10.1016/j.jadohealth.2008.01.007
   Giedd JN, 2004, ANN NY ACAD SCI, V1021, P77, DOI 10.1196/annals.1308.009
   GRAHAM DG, 1995, CRIT REV TOXICOL, V25, P91, DOI 10.3109/10408449509021609
   Guerri C, 2010, ALCOHOL, V44, P15, DOI 10.1016/j.alcohol.2009.10.003
   Harrill JA, 2011, TOXICOL APPL PHARM, V256, P268, DOI 10.1016/j.taap.2011.02.013
   Hsieh HL, 2013, BIOMED RES INT, DOI 10.1155/2013/484613
   IPCS (International Programme on Chemical Safety), 2007, 4 IPCS WHO
   JENNER P, 1986, J NEURAL TRANSM, P11
   Jevtovic-Todorovic V, 2013, BRIT J ANAESTH, V111, P143, DOI 10.1093/bja/aet177
   Johnson T, 2002, ANESTHESIOLOGY, V96, P1351, DOI 10.1097/00000542-200206000-00014
   Kleinstreuer N, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002996
   Landrigan PJ, 2012, ENVIRON HEALTH PERSP, V120, pA258, DOI 10.1289/ehp.1104285
   Landrigan PJ, 2010, MT SINAI J MED, V77, P178, DOI 10.1002/msj.20173
   Lein P, 2005, ENVIRON TOXICOL PHAR, V19, P735, DOI 10.1016/j.etap.2004.12.035
   Lein P, 2007, ENVIRON HEALTH PERSP, V115, P764, DOI 10.1289/ehp.9841
   LoPachin RM, 2005, TOXICOL SCI, V86, P214, DOI 10.1093/toxsci/kfi197
   MacKay C, 2013, ALTEX-ALTERN ANIM EX, V30, P473, DOI 10.14573/altex.2013.4.473
   McDonald ME, 2010, ENVIRON SCI TECHNOL, V44, P2112, DOI 10.1021/es902057k
   Meek ME, 2014, J APPL TOXICOL, V34, P1, DOI 10.1002/jat.2949
   Meek ME, 2014, J APPL TOXICOL, V34, P595, DOI 10.1002/jat.2984
   Meek ME, 2010, CHEM-BIOL INTERACT, V184, P279, DOI 10.1016/j.cbi.2010.02.006
   Moller JT, 1998, LANCET, V351, P857, DOI 10.1016/S0140-6736(97)07382-0
   Mombelli E, 2012, SAR QSAR ENVIRON RES, V23, P37, DOI 10.1080/1062936X.2011.623325
   NRC (National Research Council), 2007, TOX TEST 21 CENT VIS
   Patlewicz Grace Yvonne, 2013, Front Biosci (Elite Ed), V5, P418
   Paus T, 2001, BRAIN RES BULL, V54, P255, DOI 10.1016/S0361-9230(00)00434-2
   Perluigi M, 2014, AGEING RES REV, V13, P75, DOI 10.1016/j.arr.2013.12.005
   Rao DB, 2014, ILAR J, V54, P315, DOI 10.1093/ilar/ilt058
   Rice D, 2000, ENVIRON HEALTH PERSP, V108, P511, DOI 10.1289/ehp.00108s3511
   Rohan D, 2005, CAN J ANAESTH, V52, P137, DOI 10.1007/BF03027718
   Sanders Talia, 2009, Reviews on Environmental Health, V24, P15
   Schmieder PK, 2004, ENVIRON SCI TECHNOL, V38, P6333, DOI 10.1021/es0495314
   Schmieder PK, 2003, ENVIRON TOXICOL CHEM, V22, P1844, DOI 10.1897/01-345
   Shafer TJ, 2005, ENVIRON HEALTH PERSP, V113, P123, DOI 10.1289/ehp.7254
   Stiles J, 2010, NEUROPSYCHOL REV, V20, P327, DOI 10.1007/s11065-010-9148-4
   Swartzwelder HS, 1995, ALCOHOL CLIN EXP RES, V19, P1480, DOI 10.1111/j.1530-0277.1995.tb01011.x
   SWARTZWELDER HS, 1995, ALCOHOL CLIN EXP RES, V19, P320, DOI 10.1111/j.1530-0277.1995.tb01509.x
   Thomas RS, 2013, TOXICOL SCI, V136, P4, DOI 10.1093/toxsci/kft178
   TIPTON KF, 1993, J NEUROCHEM, V61, P1191, DOI 10.1111/j.1471-4159.1993.tb13610.x
   van Wijngaarden P, 2013, DEVELOPMENT, V140, P2562, DOI 10.1242/dev.092262
   Villeneuve DL, 2014, TOXICOL SCI, V142, P312, DOI 10.1093/toxsci/kfu199
   Villeneuve DL, 2014, TOXICOL SCI, V142, P321, DOI 10.1093/toxsci/kfu200
   Vinken M, 2013, TOXICOLOGY, V312, P158, DOI 10.1016/j.tox.2013.08.011
   Walhovd KB, 2014, SCAND J PSYCHOL
   Watanabe KH, 2011, ENVIRON TOXICOL CHEM, V30, P9, DOI 10.1002/etc.373
   Westerholz S, 2010, NEUROSCIENCE, V168, P573, DOI 10.1016/j.neuroscience.2010.03.039
   Woodruff TJ, 2008, ENVIRON HEALTH PERSP, V116, P1568, DOI 10.1289/ehp.11516
NR 66
TC 49
Z9 49
U1 0
U2 42
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1040-8444
EI 1547-6898
J9 CRIT REV TOXICOL
JI Crit. Rev. Toxicol.
PD JAN
PY 2015
VL 45
IS 1
BP 83
EP 91
DI 10.3109/10408444.2014.981331
PG 9
WC Toxicology
SC Toxicology
GA AZ4NN
UT WOS:000348199100005
PM 25605028
OA Green Accepted
DA 2019-10-23
ER

PT J
AU Enoch, SJ
   Roberts, DW
   Madden, JC
   Cronin, MTD
AF Enoch, Steven J.
   Roberts, David W.
   Madden, Judith C.
   Cronin, Mark T. D.
TI Development of an In Silico Profiler for Respiratory Sensitisation
SO ATLA-ALTERNATIVES TO LABORATORY ANIMALS
LA English
DT Article
DE adverse outcome pathway; in silico; QSAR; read-across; respiratory
   sensitisation
ID ELECTROPHILIC REACTION CHEMISTRY; APPLICABILITY DOMAIN CLASSIFICATION;
   CHEMICAL CATEGORY FORMATION; NONANIMAL-BASED PREDICTION; TOXICOLOGICAL
   END-POINTS; ADVERSE OUTCOME PATHWAYS; COVALENT DNA-BINDING; LYMPH-NODE
   ASSAY; SKIN SENSITIZATION; STRUCTURAL ALERTS
AB In this article, we outline work that led the QSAR and Molecular Modelling Group at Liverpool John Moores University to be jointly awarded the 2013 Lush Science Prize. Our research focuses around the development of in silico profilers for category formation within the Adverse Outcome Pathway paradigm. The development of a well-defined chemical category allows toxicity to be predicted via read-across. This is the central approach used by the OECD QSAR Toolbox. The specific work for which we were awarded the Lush Prize was for the development of such an in silico profiler for respiratory sensitisation. The profiler was developed by an analysis of the mechanistic chemistry associated with covalent bond formation in the lung. The data analysed were collated from clinical reports of occupational asthma in humans. The impact of the development of in silico profilers on the Three Rs is also discussed.
C1 Liverpool John Moores Univ, Sch Pharm & Biomol Sci, QSAR, Liverpool L3 3AF, Merseyside, England.
   Liverpool John Moores Univ, Sch Pharm & Biomol Sci, Mol Modelling Grp, Liverpool L3 3AF, Merseyside, England.
RP Enoch, SJ (reprint author), Liverpool John Moores Univ, Sch Pharm & Biomol Sci, Liverpool L3 3AF, Merseyside, England.
EM s.j.enoch@ljmu.ac.uk
FU European Community's Seventh Framework Programme (FP7) COSMOS Project
   [266835]; Cosmetics Europe, European Chemicals Agency Service
   [ECHA/2008/20/ECA.203, 300000801]; Organisation for Economic
   Co-operation and Development (OECD)
FX Professor Raymond Agius, Dr Martin Seed and Dr Jill Stocks, from the
   Centre for Occupational and Environmental Health at the University of
   Manchester, UK, are gratefully acknowledged for their efforts in
   collating the original data set. The research outlined in this article
   was funded, in part, by the following: the European Community's Seventh
   Framework Programme (FP7/2007-2013) COSMOS Project under Grant Agreement
   Number 266835 and from Cosmetics Europe, European Chemicals Agency
   Service Contract No. ECHA/2008/20/ECA.203, and a framework con-tract
   (Agreement Number 300000801) with the Organisation for Economic
   Co-operation and Development (OECD).
CR Adler S, 2011, ARCH TOXICOL, V85, P367, DOI 10.1007/s00204-011-0693-2
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   [Anonymous], 2003, OFFICIAL J EUROPEA L, VL66, P26
   Aptula AO, 2006, CHEM RES TOXICOL, V19, P1097, DOI 10.1021/tx0601004
   Cronin M T, 1994, SAR QSAR Environ Res, V2, P159, DOI 10.1080/10629369408029901
   Cunningham AR, 2005, SAR QSAR ENVIRON RES, V16, P273, DOI 10.1080/10659360500036976
   Enoch SJ, 2008, SAR QSAR ENVIRON RES, V19, P555, DOI 10.1080/10629360802348985
   Enoch SJ, 2013, CHEM RES TOXICOL, V26, P767, DOI 10.1021/tx4000655
   Enoch SJ, 2012, CHEM RES TOXICOL, V25, P2490, DOI 10.1021/tx3003092
   Enoch SJ, 2012, MUTAT RES-GEN TOX EN, V743, P10, DOI 10.1016/j.mrgentox.2011.12.029
   Enoch SJ, 2011, CRIT REV TOXICOL, V41, P783, DOI 10.3109/10408444.2011.598141
   Enoch SJ, 2010, CHEM RES TOXICOL, V23, P1547, DOI 10.1021/tx100218h
   Enoch SJ, 2010, CRIT REV TOXICOL, V40, P728, DOI 10.3109/10408444.2010.494175
   Enoch SJ, 2011, ATLA-ALTERN LAB ANIM, V39, P131, DOI 10.1177/026119291103900206
   Enoch SJ, 2010, CHALL ADV COMPUT CHE, V8, P209, DOI 10.1007/978-1-4020-9783-6_7
   Enoch SJ, 2009, CHEM RES TOXICOL, V22, P1447, DOI 10.1021/tx9001463
   Enoch SJ, 2008, CHEM RES TOXICOL, V21, P513, DOI 10.1021/tx700322g
   Gerberick GF, 2005, DERMATITIS, V16, P157, DOI 10.2310/6620.2005.05040
   Graham C, 1997, REGUL TOXICOL PHARM, V26, P296, DOI 10.1006/rtph.1997.1170
   Holsapple MP, 2006, TOXICOL SCI, V91, P4, DOI 10.1093/toxsci/kfj074
   Kern PS, 2010, DERMATITIS, V21, P8, DOI 10.2310/6620.2009.09038
   Kimber I, 2002, INT IMMUNOPHARMACOL, V2, P201, DOI 10.1016/S1567-5769(01)00173-4
   Landesmann B, 2013, ATLA-ALTERN LAB ANIM, V41, P461, DOI 10.1177/026119291304100609
   Mekenyan O, 2014, CHEM RES TOXICOL, V27, P219, DOI 10.1021/tx400345b
   OECD (undated), TEST CHEM ADV OUTC P
   Patlewicz G, 2007, REGUL TOXICOL PHARM, V48, P225, DOI 10.1016/j.yrtph.2007.03.003
   Piirila P., 1997, EUROPEAN RESP J, V10, P1919
   Przybylak KR, 2013, ISSUES TOXICOL, V17, P44, DOI 10.1039/9781849734400-00044
   Roberts DW, 2007, CHEM RES TOXICOL, V20, P1321, DOI 10.1021/tx700169w
   Roberts DW, 2007, CHEM RES TOXICOL, V20, P1019, DOI 10.1021/tx700024w
   Roberts DW, 2007, CHEM RES TOXICOL, V20, P44, DOI 10.1021/tx060121y
   Roberts DW, 2006, CHEM RES TOXICOL, V19, P1228, DOI 10.1021/tx060102o
   Schultz TW, 2010, ISSUES TOXICOL, V7, P346
   Schultz T. W., 2011, ALT TEST STRAT PROGR, P288
   Seed MJ, 2008, CURR OPIN ALLERGY CL, V8, P103, DOI 10.1097/ACI.0b013e3282f4cadd
   Vinken M, 2013, TOXICOLOGY, V312, P158, DOI 10.1016/j.tox.2013.08.011
   Yeomans M., 2013, COSMETICS EUROPE REP
NR 37
TC 6
Z9 7
U1 0
U2 7
PU FRAME
PI NOTTINGHAM
PA RUSSELL & BURCH HOUSE 96-98 NORTH SHERWOOD ST, NOTTINGHAM NG1 4EE,
   NOTTS, ENGLAND
SN 0261-1929
J9 ATLA-ALTERN LAB ANIM
JI ATLA-Altern. Lab. Anim.
PD DEC
PY 2014
VL 42
IS 6
BP 367
EP 375
DI 10.1177/026119291404200606
PG 9
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA CB5DZ
UT WOS:000349649000003
PM 25635645
DA 2019-10-23
ER

PT J
AU Harrison, R
AF Harrison, Rob
TI 2013 Lush Science Prize
SO ATLA-ALTERNATIVES TO LABORATORY ANIMALS
LA English
DT Article
DE animal alternatives; Lush Prize; Replacement; pathways of toxicity
ID ENVIRONMENTAL CHEMICALS; SIGNALING PATHWAY; CELLS; TOXICITY; ACTIVATION;
   EXPRESSION; GENE; APPLICABILITY; NEUROTOXICITY; MECHANISMS
AB The annual Lush Science Prize is designed to reward outstanding contributions to 21st Century Toxicology Research. A Background Paper is prepared each year prior to the judging process, in order to provide the judging panel with a brief overview of current developments in the field of Replacement alternatives, particularly those relevant to the concept of toxicity pathways. The Background Paper includes information on some key institutional developments in the area - such as the OECD's Adverse Outcome Pathway Project, the Hamner Institute's work, and the Human Toxome Project, and on the phenomenon of collaborative computer systems relevant to the field. From the literature review that was also performed as part of the background research, the two papers receiving the highest score were recommended for consideration by the judges for the 2013 Science Prize.
C1 [Harrison, Rob] Lush Prize Team, London, England.
RP Harrison, R (reprint author), Eth Consumer Res Assoc, Unit 21,41 Old Birley St, Manchester M15 5RF, Lancs, England.
CR Attene-Ramos MS, 2013, CHEM RES TOXICOL, V26, P1323, DOI 10.1021/tx4001754
   AXLR8 Consortium, 2012, ALT TEST STRAT PROGR, P177
   AXLR8 Consortium, 2012, ALT TEST STRAT PROGR
   AXLR8 Consortium, 2012, ALT TEST STRAT PROGR, P142
   Baker B., 2013, NATURE, V494, P416
   Basketter DA, 2012, ALTEX-ALTERN ANIM EX, V29, P5, DOI 10.14573/altex.2012.1.003
   Bauch C, 2012, REGUL TOXICOL PHARM, V63, P489, DOI 10.1016/j.yrtph.2012.05.013
   Bhattacharya S, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00462
   Chairuangkitti P, 2013, TOXICOL IN VITRO, V27, P330, DOI 10.1016/j.tiv.2012.08.021
   Cinq-Frais C, 2013, BBA-MOL CELL BIOL L, V1831, P1344, DOI 10.1016/j.bbalip.2013.04.014
   EPAA, 2012, EPAA ANN C 2012 POST
   European Commission, 2013, 1 REL ADV OUTC PATHW
   Hoing S, 2012, CELL STEM CELL, V11, P620, DOI 10.1016/j.stem.2012.07.005
   Hoogendoorn B, 2012, INHAL TOXICOL, V24, P966, DOI 10.3109/08958378.2012.742600
   Kleinstreuer N, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002996
   Krug AK, 2013, ARCH TOXICOL, V87, P123, DOI 10.1007/s00204-012-0967-3
   Liu JN, 2013, INT J MOL SCI, V14, P5633, DOI 10.3390/ijms14035633
   Martinez-Hoyer S, 2013, BBA-MOL CELL RES, V1833, P2311, DOI 10.1016/j.bbamcr.2013.05.021
   McKim JM, 2012, CUTAN OCUL TOXICOL, V31, P292, DOI 10.3109/15569527.2012.667031
   Migdal C, 2013, TOXICOL SCI, V133, P259, DOI 10.1093/toxsci/kft075
   Morio Y, 2013, TOXICOL IN VITRO, V27, P1820, DOI 10.1016/j.tiv.2013.05.009
   OECD (undated), OTH ACT MOL SCR TOX
   Shukla SJ, 2012, ENVIRON HEALTH PERSP, V120, P1150, DOI 10.1289/ehp.1104709
   Su GY, 2013, ENVIRON SCI POLLUT R, V20, P803, DOI 10.1007/s11356-012-1280-7
   van der Veen JW, 2013, TOXICOL IN VITRO, V27, P314, DOI 10.1016/j.tiv.2012.08.023
   Vilasi A, 2013, J CELL PHYSIOL, V228, P1359, DOI 10.1002/jcp.24294
   Wang HH, 2013, TOXICOL IN VITRO, V27, P1043, DOI 10.1016/j.tiv.2013.01.012
   Wang S, 2013, ALTEX-ALTERN ANIM EX, V30, P145, DOI 10.14573/altex.2013.2.145
   Yue WM, 2013, REGUL PEPTIDES, V180, P33, DOI 10.1016/j.regpep.2012.10.005
NR 29
TC 1
Z9 1
U1 0
U2 1
PU FRAME
PI NOTTINGHAM
PA RUSSELL & BURCH HOUSE 96-98 NORTH SHERWOOD ST, NOTTINGHAM NG1 4EE,
   NOTTS, ENGLAND
SN 0261-1929
J9 ATLA-ALTERN LAB ANIM
JI ATLA-Altern. Lab. Anim.
PD DEC
PY 2014
VL 42
IS 6
BP 395
EP 402
DI 10.1177/026119291404200609
PG 8
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA CB5DZ
UT WOS:000349649000006
PM 25635648
DA 2019-10-23
ER

PT J
AU Yamada, T
   Tanaka, Y
   Hasegawa, R
   Sakuratani, Y
   Yamazoe, Y
   Ono, A
   Hirose, A
   Hayashi, M
AF Yamada, Takashi
   Tanaka, Yushiro
   Hasegawa, Ryuichi
   Sakuratani, Yuki
   Yamazoe, Yasushi
   Ono, Atsushi
   Hirose, Akihiko
   Hayashi, Makoto
TI Development of a category approach to predict the testicular toxicity of
   chemical substances structurally related to ethylene glycol methyl ether
SO REGULATORY TOXICOLOGY AND PHARMACOLOGY
LA English
DT Article
DE Category approach; Repeated-dose toxicity; Testicular toxicity;
   Methoxyacetic acid; Adverse outcome pathway
ID REPEATED-DOSE TOXICITY; ADULT MALE-RAT; MONOMETHYL ETHER; METHOXYACETIC
   ACID; SPERMATOCYTE APOPTOSIS; 2-METHOXYACETIC ACID; INHALATION TOXICITY;
   URINARY METABOLITES; DIETHYLENE GLYCOL; ANDROGEN RECEPTOR
AB We propose a category approach to assessing the testicular toxicity of chemicals with a similar structure to ethylene glycol methyl ether (EGME). Based on toxicity information for EGME and related chemicals and accompanied by adverse outcome pathway information on the testicular toxicity of EGME, this category was defined as chemicals that are metabolized to methoxy- or ethoxyacetic acid, a substance responsible for testicular toxicity. A Japanese chemical inventory was screened using the Hazard Evaluation Support System, which we have developed to support a category approach for predicting the repeated-dose toxicity of chemical substances. Quantitative metabolic information on the related chemicals was then considered, and seventeen chemicals were finally obtained from the inventory as a shortlist for the category. Available data in the literature shows that chemicals for which information is available on the metabolic formation of EGME, ethylene glycol ethyl ether, methoxy- or ethoxyacetic acid do in fact possess testicular toxicity, suggesting that testicular toxicity is a concern, due to metabolic activation, for the remaining chemicals. Our results clearly demonstrate practical utility of AOP-based category approach for predicting repeated-dose toxicity of chemicals. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Yamada, Takashi; Tanaka, Yushiro; Hasegawa, Ryuichi; Sakuratani, Yuki] Natl Inst Technol & Evaluat, Chem Management Ctr, Shibuya Ku, Tokyo 1510066, Japan.
   [Yamazoe, Yasushi] Food Safety Commiss Japan, Minato Ku, Tokyo 1076122, Japan.
   [Ono, Atsushi; Hirose, Akihiko] Natl Inst Hlth Sci, Biol Safety Res Ctr, Setagaya Ku, Tokyo 1588501, Japan.
   [Hayashi, Makoto] Biosafety Res Ctr, Iwata, Shizuoka 4371213, Japan.
RP Yamada, T (reprint author), Natl Inst Technol & Evaluat, Chem Management Ctr, Shibuya Ku, 2-49-10 Nishihara, Tokyo 1510066, Japan.
EM yamada-takashi@nite.go.jp
OI Ono, Atsushi/0000-0001-5056-0442
FU New Energy and Industrial Technology Development Organization (NEDO)New
   Energy and Industrial Technology Development Organization (NEDO);
   Ministry of Economy, Trade and industry (METI) for the Development of
   Hazard Assessment Techniques Using Structure-Activity Relationship
   Methods
FX This work was supported by grants provided by the New Energy and
   Industrial Technology Development Organization (NEDO) (2007-2010) and
   the Ministry of Economy, Trade and industry (METI) (2011) for the
   Development of Hazard Assessment Techniques Using Structure-Activity
   Relationship Methods.
CR Abe T., 2012, PHARM STAGE, V12, P39
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Bagchi G, 2008, INT J ANDROL, V31, P269, DOI 10.1111/j.1365-2605.2007.00846.x
   Bagchi G, 2009, TOXICOL APPL PHARM, V238, P101, DOI 10.1016/j.taap.2008.03.015
   Ball GL, 2012, CRIT REV TOXICOL, V42, P28, DOI 10.3109/10408444.2011.623149
   Ball N, 2014, REGUL TOXICOL PHARM, V68, P212, DOI 10.1016/j.yrtph.2013.12.007
   Blackburn K, 2011, REGUL TOXICOL PHARM, V60, P120, DOI 10.1016/j.yrtph.2011.03.002
   BOATMAN RJ, 1993, J AM COLL TOXICOL, V12, P145, DOI 10.3109/10915819309140633
   CHEEVER KL, 1989, TOXICOL IND HEALTH, V5, P1099
   CHEEVER KL, 1984, ENVIRON HEALTH PERSP, V57, P241, DOI 10.2307/3429922
   COOK RR, 1982, ARCH ENVIRON HEALTH, V37, P346, DOI 10.1080/00039896.1982.10667589
   Durner J, 2009, BIOMATERIALS, V30, P2066, DOI 10.1016/j.biomaterials.2008.12.061
   ECETOC, 2012, 116 ECETOC QSAR
   Environmental Protection Agency (EPA), 2007, 110714 EPA CAS
   European Chemical Agency (ECHA), 2013, CAND LIST SUBST VER
   Fabjan E, 2006, CRIT REV TOXICOL, V36, P695, DOI 10.1080/10408440600894914
   FOSTER PMD, 1987, TOXICOLOGY, V43, P17, DOI 10.1016/0300-483X(87)90071-0
   FOSTER PMD, 1983, TOXICOL APPL PHARM, V69, P385, DOI 10.1016/0041-008X(83)90262-4
   FOSTER PMD, 1984, ENVIRON HEALTH PERSP, V57, P207, DOI 10.2307/3429918
   GESSNER PK, 1961, BIOCHEM J, V79, P482, DOI 10.1042/bj0790482
   GHANAYEM BI, 1987, J PHARMACOL EXP THER, V242, P222
   GRAY TJB, 1985, TOXICOL APPL PHARM, V79, P490, DOI 10.1016/0041-008X(85)90146-2
   GROESENEKEN D, 1989, INT ARCH OCC ENV HEA, V61, P243, DOI 10.1007/BF00381421
   GUT I, 1988, ARCH TOXICOL, V62, P346, DOI 10.1007/BF00293621
   Hayashi M., 2011, NEW HORIZONS TOXICIT, P26
   Henley DV, 2006, ENDOCRINOLOGY, V147, pS25, DOI 10.1210/en.2005-1117
   HUTSON DH, 1972, XENOBIOTICA, V2, P107, DOI 10.3109/00498257209111042
   Jansen MS, 2004, P NATL ACAD SCI USA, V101, P7199, DOI 10.1073/pnas.0402014101
   Johanson G, 2000, CRIT REV TOXICOL, V30, P307, DOI 10.1080/10408440091159220
   Johnson W, 2002, INT J TOXICOL, V21, P9, DOI 10.1080/10915810290096388
   KATZ GV, 1984, ENVIRON HEALTH PERSP, V57, P165, DOI 10.2307/3429913
   KU WW, 1995, TOXICOL APPL PHARM, V134, P100, DOI 10.1006/taap.1995.1173
   Ladriere L, 1999, METABOLISM, V48, P102, DOI 10.1016/S0026-0495(99)90017-3
   LENK W, 1989, XENOBIOTICA, V19, P961, DOI 10.3109/00498258909043154
   Li LH, 1996, J ANDROL, V17, P538
   LINHART I, 1994, CHEM RES TOXICOL, V7, P1, DOI 10.1021/tx00037a001
   LINHART I, 1994, XENOBIOTICA, V24, P1043, DOI 10.3109/00498259409043301
   MILLER RR, 1983, FUND APPL TOXICOL, V3, P49, DOI 10.1016/S0272-0590(83)80172-9
   MILLER RR, 1984, ENVIRON HEALTH PERSP, V57, P233, DOI 10.2307/3429921
   MILLER RR, 1984, TOXICOL APPL PHARM, V75, P521, DOI 10.1016/0041-008X(84)90188-1
   Ministry of Health Labor and Welfare (MHLW), 2001, COMB REP DOS REPR DE
   Ministry of Health Labor and Welfare (MHLW), 2002, 28 DAY REP DOS OR TO
   Ministry of Health Labor and Welfare (MHLW), 1998, COMB REP DOS REPR DE
   MOSS EJ, 1985, TOXICOL APPL PHARM, V79, P480, DOI 10.1016/0041-008X(85)90145-0
   NAGANO K, 1984, ENVIRON HEALTH PERSP, V57, P75, DOI 10.2307/3429901
   National Institute for Occupational Safety and Health (NIOSH), 1991, CRIT REC STAND OCC E
   National Institute of Technology and Evaluation (NITE), 2007, 88 NITE
   National Toxicology Program (NTP), 1993, NTP TOX REP SER, V26
   OECD, 2014, OECD SER TEST ASS, V194
   Petrovic S, 2004, FASEB J, V18, pA318
   Poon R, 2005, TOXICOLOGY, V214, P99, DOI 10.1016/j.tox.2005.06.024
   Rao AVSK, 2002, FEBS LETT, V527, P133, DOI 10.1016/S0014-5793(02)03196-4
   RICHARDS DE, 1993, ARCH TOXICOL, V67, P531, DOI 10.1007/BF01969265
   RITTER EJ, 1985, TERATOLOGY, V32, P25, DOI 10.1002/tera.1420320105
   SABOURIN PJ, 1992, FUND APPL TOXICOL, V19, P124, DOI 10.1016/0272-0590(92)90036-H
   Sakuratani Y, 2013, SAR QSAR ENVIRON RES, V24, P617, DOI 10.1080/1062936X.2013.773375
   Schaafsma G, 2009, REGUL TOXICOL PHARM, V53, P70, DOI 10.1016/j.yrtph.2008.11.003
   Schultz T. W., 2010, SILICO TOXICOLOGY PR, P351
   SILVER EH, 1978, TOXICOL APPL PHARM, V45, P377, DOI 10.1016/0041-008X(78)90102-3
   STOTT WT, 1985, FUND APPL TOXICOL, V5, P399, DOI 10.1016/0272-0590(85)90088-0
   SUMNER SJ, 1995, TOXICOL APPL PHARM, V134, P139, DOI 10.1006/taap.1995.1177
   TAKAHASHI T, 1981, TOXICOLOGY, V22, P223, DOI 10.1016/0300-483X(81)90085-8
   Takei M, 2010, TOXICOL SCI, V118, P643, DOI 10.1093/toxsci/kfq211
   Tirado OM, 2003, BIOL REPROD, V68, P1437, DOI 10.1095/biolreprod.102.004937
   van Leeuwen K, 2009, SAR QSAR ENVIRON RES, V20, P207, DOI 10.1080/10629360902949179
   Wade MG, 2006, TOXICOL SCI, V89, P304, DOI 10.1093/toxsci/kfj002
   WELCH LS, 1988, AM J IND MED, V14, P509, DOI 10.1002/ajim.4700140503
   Wu SD, 2010, REGUL TOXICOL PHARM, V56, P67, DOI 10.1016/j.yrtph.2009.09.006
   Yamada T, 2013, REGUL TOXICOL PHARM, V65, P189, DOI 10.1016/j.yrtph.2012.12.001
   Yamada T, 2012, J TOXICOL SCI, V37, P503
   Yamamoto Toshinori, 2007, Journal of Toxicological Sciences, V32, P515, DOI 10.2131/jts.32.515
   Yamazoe Y, 2011, DRUG METAB REV, V43, P409, DOI 10.3109/03602532.2011.624103
   Yan W, 2000, MOL ENDOCRINOL, V14, P682, DOI 10.1210/me.14.5.682
NR 73
TC 2
Z9 2
U1 0
U2 8
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0273-2300
EI 1096-0295
J9 REGUL TOXICOL PHARM
JI Regul. Toxicol. Pharmacol.
PD DEC
PY 2014
VL 70
IS 3
BP 711
EP 719
DI 10.1016/j.yrtph.2014.10.011
PG 9
WC Medicine, Legal; Pharmacology & Pharmacy; Toxicology
SC Legal Medicine; Pharmacology & Pharmacy; Toxicology
GA AU7ZO
UT WOS:000345816900016
PM 25444998
DA 2019-10-23
ER

PT J
AU Allen, TEH
   Goodman, JM
   Gutsell, S
   Russell, PJ
AF Allen, Timothy E. H.
   Goodman, Jonathan M.
   Gutsell, Steve
   Russell, Paul J.
TI Defining Molecular Initiating Events in the Adverse Outcome Pathway
   Framework for Risk Assessment
SO CHEMICAL RESEARCH IN TOXICOLOGY
LA English
DT Article
ID AMIODARONE PULMONARY TOXICITY; DRUG-INDUCED PHOSPHOLIPIDOSIS;
   MITOCHONDRIAL BETA-OXIDATION; HERG POTASSIUM CHANNELS; INDUCED
   LIVER-INJURY; BREAST CANCER-CELLS; KAPPA-B ACTIVATION;
   TORSADE-DE-POINTES; IN-SILICO MODELS; VALPROIC ACID
AB Consumer and environmental safety decisions are based on exposure and hazard data, interpreted using risk assessment approaches. The adverse outcome pathway (AOP) conceptual framework has been presented as a logical sequence of events or processes within biological systems which can be used to understand adverse effects and refine current risk assessment practices in ecotoxicology. This framework can also be applied to human toxicology and is explored on the basis of investigating the molecular initiating events (MIEs) of compounds. The precise definition of the MIE has yet to reach general acceptance. In this work we present a unified MIE definition: an MIE is the initial interaction between a molecule and a biomolecule or biosystem that can be causally linked to an outcome via a pathway. Case studies are presented, and issues with current definitions are addressed. With the development of a unified MIE definition, the field can look toward defining, classifying, and characterizing more MIEs and using knowledge of the chemistry of these processes to aid AOP research and toxicity risk assessment. We also present the role of MIE research in the development of in vitro and in silico toxicology and suggest how, by using a combination of biological and chemical approaches, MIEs can be identified and characterized despite a lack of detailed reports, even for some of the most studied molecules in toxicology.
C1 [Allen, Timothy E. H.; Goodman, Jonathan M.] Univ Cambridge, Dept Chem, Ctr Mol Informat, Cambridge CB2 1EW, England.
   [Gutsell, Steve; Russell, Paul J.] Unilever Safety & Environm Assurance Ctr, Sharnbrook MK44 1LQ, Beds, England.
RP Goodman, JM (reprint author), Univ Cambridge, Dept Chem, Ctr Mol Informat, Lensfield Rd, Cambridge CB2 1EW, England.
EM jmg11@cam.ac.uk
RI Goodman, Jonathan M/A-2123-2008
OI Goodman, Jonathan M/0000-0002-8693-9136
FU Unilever
FX The authors acknowledge the financial support of Unilever.
CR Aardema MJ, 2002, MUTAT RES-FUND MOL M, V499, P13, DOI 10.1016/S0027-5107(01)00292-5
   Adams ML, 2001, MOL PHARMACOL, V60, P907
   Ahn KS, 2003, J DERMATOL SCI, V31, P193, DOI 10.1016/S0923-1811(03)00039-2
   ALBANO E, 1985, MOL PHARMACOL, V28, P306
   ALLEGRA CJ, 1987, J BIOL CHEM, V262, P13520
   Allen T. E. H., 2013, MIE DATABASE UNPUB
   ANDERSEN ME, 1987, TOXICOL APPL PHARM, V87, P185, DOI 10.1016/0041-008X(87)90281-X
   Andersen ME, 2005, TRENDS BIOTECHNOL, V23, P122, DOI 10.1016/j.tibtech.2005.01.007
   Anderson N, 2006, FEBS LETT, V580, P5533, DOI 10.1016/j.febslet.2006.08.061
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   AUER CM, 1990, ENVIRON HEALTH PERSP, V87, P183, DOI 10.2307/3431024
   BAGGOTT JE, 1979, BIOCHEMISTRY-US, V18, P1036, DOI 10.1021/bi00573a016
   BAGGOTT JE, 1986, BIOCHEM J, V236, P193, DOI 10.1042/bj2360193
   Bakhtyari NG, 2013, J ENVIRON SCI HEAL C, V31, P45, DOI 10.1080/10590501.2013.763576
   BARAM J, 1988, J BIOL CHEM, V263, P7105
   Bargout R, 2000, AM J PHYSIOL-LUNG C, V278, pL1039
   Bender A, 2010, NAT CHEM BIOL, V6, P309, DOI 10.1038/nchembio.354
   Benfenati E, 2009, J ENVIRON SCI HEAL C, V27, P57, DOI 10.1080/10590500902885593
   BLACK M, 1984, ANNU REV MED, V35, P577, DOI 10.1146/annurev.med.35.1.577
   Blaheta RA, 2002, MED RES REV, V22, P492, DOI 10.1002/med.10017
   Braiteh F, 2008, CLIN CANCER RES, V14, P6296, DOI 10.1158/1078-0432.CCR-08-1247
   Braun J, 2009, CURR OPIN RHEUMATOL, V21, P216, DOI 10.1097/BOR.0b013e328329c79d
   BUNNI M, 1988, CANCER RES, V48, P3398
   Burdock FA, 2001, REGUL TOXICOL PHARM, V33, P80, DOI 10.1006/rtph.2000.1442
   Carlsson L, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-362
   Chen J. S., 1991, J AGR FOOD CHEM, P39
   Chen J. S., 1991, J AGR FOOD CHEM, P9
   CHEN JS, 1991, J AGR FOOD CHEM, V39, P1396, DOI 10.1021/jf00008a008
   Cherkasov A, 2014, J MED CHEM, V57, P4977, DOI 10.1021/jm4004285
   Choi IS, 2002, TOXICOL LETT, V132, P47, DOI 10.1016/S0378-4274(02)00065-6
   CHU E, 1990, J BIOL CHEM, V265, P8470
   *COMM TOX TEST ASS, 2007, TOX TEST 21 CENT VIS
   Cotellessa C, 1999, DERMATOL SURG, V25, P450, DOI 10.1046/j.1524-4725.1999.08217.x
   Detich N, 2003, J BIOL CHEM, V278, P27586, DOI 10.1074/jbc.M303740200
   Di Matola T, 2000, J CLIN ENDOCR METAB, V85, P4323, DOI 10.1210/jc.85.11.4323
   DUSMAN RE, 1990, CIRCULATION, V82, P51, DOI 10.1161/01.CIR.82.1.51
   Eghbal MA, 2004, CHEM-BIOL INTERACT, V151, P43, DOI 10.1016/j.cbi.2004.10.005
   Eguchi Y, 1997, CANCER RES, V57, P1835
   El Golli-Bennour E, 2012, EXP TOXICOL PATHOL, V64, P425, DOI 10.1016/j.etp.2010.10.008
   Elting LS, 2003, CANCER, V98, P1531, DOI 10.1002/cncr.11671
   Fotoohi AK, 2008, LEUKEMIA LYMPHOMA, V49, P410, DOI 10.1080/10428190701824569
   FROMENTY B, 1990, J PHARMACOL EXP THER, V255, P1371
   FROMENTY B, 1990, J PHARMACOL EXP THER, V255, P1377
   FROMENTY B, 1995, PHARMACOL THERAPEUT, V67, P101, DOI 10.1016/0163-7258(95)00012-6
   Garcia-Manero G, 2006, BLOOD, V108, P3271, DOI 10.1182/blood-2006-03-009142
   Glassman AH, 2001, AM J PSYCHIAT, V158, P1774, DOI 10.1176/appi.ajp.158.11.1774
   Gottlicher M, 2001, EMBO J, V20, P6969, DOI 10.1093/emboj/20.24.6969
   Gottmann E, 2001, ENVIRON HEALTH PERSP, V109, P509, DOI 10.2307/3454710
   Grattagliano I, 2009, WORLD J GASTROENTERO, V15, P4865, DOI 10.3748/wjg.15.4865
   Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309
   Gupta A, 2007, AM HEART J, V153, P891, DOI 10.1016/j.ahj.2007.01.040
   Gurvich N, 2004, CANCER RES, V64, P1079, DOI 10.1158/0008-5472.CAN-03-0799
   Gurvich N, 2002, PHARMACOL THERAPEUT, V96, P45, DOI 10.1016/S0163-7258(02)00299-1
   Gutsell S, 2013, TOXICOL RES-UK, V2, P299, DOI 10.1039/c3tx50024a
   Halliwell WH, 1997, TOXICOL PATHOL, V25, P53, DOI 10.1177/019262339702500111
   Hanawa N, 2008, J BIOL CHEM, V283, P13565, DOI 10.1074/jbc.M708916200
   Hartung T, 2008, ALTEX-ALTERN TIEREXP, V25, P3
   Hartung T, 2009, NATURE, V460, P208, DOI 10.1038/460208a
   Hartung T, 2009, TOXICOL SCI, V109, P18, DOI 10.1093/toxsci/kfp059
   HAUTEKEETE ML, 1990, ACTA CLIN BELG, V45, P311, DOI 10.1080/17843286.1990.11718105
   HEATH MF, 1985, BRIT J EXP PATHOL, V66, P391
   Henry CJ, 2003, INT J TOXICOL, V22, P3, DOI 10.1080/10915810390181454
   Hofer T, 2004, ARCH TOXICOL, V78, P549, DOI 10.1007/s00204-004-0577-9
   Jaeschke H, 2006, TOXICOL SCI, V89, P31, DOI 10.1093/toxsci/kfi336
   Jaeschke H, 2011, LIFE SCI, V88, P737, DOI 10.1016/j.lfs.2011.01.025
   Jahovic N, 2003, J PINEAL RES, V34, P282, DOI 10.1034/j.1600-079X.2003.00043.x
   JOLIVET J, 1983, J CLIN INVEST, V72, P773, DOI 10.1172/JCI111048
   JOSHI UM, 1989, BIOCHIM BIOPHYS ACTA, V1004, P309, DOI 10.1016/0005-2760(89)90078-7
   JOSHI UM, 1988, J PHARMACOL EXP THER, V246, P150
   Kahn V, 1997, J AGR FOOD CHEM, V45, P4460, DOI 10.1021/jf9702858
   KASSAHUN K, 1991, DRUG METAB DISPOS, V19, P525
   Kaufmann P, 2005, HEPATOLOGY, V41, P925, DOI 10.1002/hep.20634
   Kennedy JA, 1996, BIOCHEM PHARMACOL, V52, P273, DOI 10.1016/0006-2952(96)00204-3
   Khan N, 2008, BIOCHEM J, V409, P581, DOI 10.1042/BJ20070779
   Kim H, 2012, ANN DERMATOL, V24, P1, DOI 10.5021/ad.2012.24.1.1
   Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492
   Kleensang A, 2014, ALTEX-ALTERN ANIM EX, V31, P53, DOI 10.14573/altex.1309261
   KODAVANTI UP, 1990, PHARMACOL REV, V42, P327
   Kramer OH, 2003, EMBO J, V22, P3411, DOI 10.1093/emboj/cdg315
   Kremer JM, 2008, ARTHRITIS RHEUM, V58, P3279, DOI 10.1002/art.24032
   Lampen A, 1999, TOXICOL APPL PHARM, V160, P238, DOI 10.1006/taap.1999.8770
   Lee IS, 1999, BIOCHEM PHARMACOL, V58, P1017, DOI 10.1016/S0006-2952(99)00181-1
   Leist M, 2008, ALTEX-ALTERN TIEREXP, V25, P103
   Letteron P, 2003, HEPATOLOGY, V38, P133, DOI 10.1053/jhep.2003.50309
   Limaye PB, 2003, TOXICOL APPL PHARM, V191, P211, DOI 10.1016/S0041-008X(03)00250-3
   Liu DY, 2013, BIOPHARM DRUG DISPOS, V34, P203, DOI 10.1002/bdd.1838
   LIU FLW, 1986, THORAX, V41, P100, DOI 10.1136/thx.41.2.100
   Liu XL, 2004, ANNU REV PHARMACOL, V44, P349, DOI 10.1146/annurev.pharmtox.44.101802.121804
   Loscher W, 1999, PROG NEUROBIOL, V58, P31, DOI 10.1016/S0301-0082(98)00075-6
   LOSCHER W, 1985, NEUROPHARMACOLOGY, V24, P427, DOI 10.1016/0028-3908(85)90028-0
   MacGregor JT, 2003, TOXICOL SCI, V75, P236, DOI 10.1093/toxsci/kfg197
   MAEDA K, 1991, J SOC COSMET CHEM, V42, P361
   Manyike PT, 2000, CLIN PHARMACOL THER, V67, P275, DOI 10.1067/mcp.2000.104736
   Marchant CA, 2008, TOXICOL MECH METHOD, V18, P177, DOI 10.1080/15376510701857320
   Martin TM, 2013, J CHEM INF MODEL, V53, P2229, DOI 10.1021/ci400267h
   MARTIN WJ, 1988, CHEST, V93, P1242, DOI 10.1378/chest.93.6.1242
   MARTIN WJ, 1988, CHEST, V93, P1067, DOI 10.1378/chest.93.5.1067
   Massart J, 2013, CURR PATHOBIOL REP, V1, P147, DOI DOI 10.1007/s40139-013-0022-y
   MATTHEWS RG, 1980, BIOCHEMISTRY-US, V19, P2040, DOI 10.1021/bi00551a005
   Maxwell G, 2014, TOXICOL IN VITRO, V28, P8, DOI 10.1016/j.tiv.2013.10.013
   MCBRYDE WA, 1961, CAN J CHEM, V39, P510, DOI 10.1139/v61-062
   McGill MR, 2012, J CLIN INVEST, V122, P1574, DOI 10.1172/JCI59755
   McGill MR, 2011, HEPATOLOGY, V53, P974, DOI 10.1002/hep.24132
   MCGUIRE JJ, 1981, MOL CELL BIOCHEM, V38, P19, DOI 10.1007/BF00235686
   Mitani H, 2001, EUR J PHARMACOL, V411, P169, DOI 10.1016/S0014-2999(00)00873-6
   Moon KY, 2001, ARCH PHARM RES, V24, P307, DOI 10.1007/BF02975097
   MORRISON PF, 1989, J BIOL CHEM, V264, P10552
   NAU H, 1986, FUND APPL TOXICOL, V6, P669, DOI 10.1016/0272-0590(86)90180-6
   Nelms MD, 2015, ARCH TOXICOL, V89, P733, DOI 10.1007/s00204-014-1277-8
   NEPTUNE M, 1978, J MED CHEM, V21, P362, DOI 10.1021/jm00202a010
   Nicolescu AC, 2008, TOXICOL APPL PHARM, V227, P370, DOI 10.1016/j.taap.2007.12.009
   NIWA Y, 1991, INFLAMMATION, V15, P303, DOI 10.1007/BF00917315
   OECD, 2012, PROP TEMPL GUID DEV
   Organisation for Economic Co-operation and Development, 2011, SERIES TEST ASS, V138, P8
   Phiel CJ, 2001, J BIOL CHEM, V276, P36734, DOI 10.1074/jbc.M101287200
   Piechota P, 2013, J CHEM INF MODEL, V53, P1282, DOI 10.1021/ci400050v
   Pognan F, 2004, PHARMACOGENOMICS, V5, P879, DOI 10.1517/14622416.5.7.879
   Rahiem, 2013, J CANC SCI THER, V5, P106, DOI DOI 10.4172/1948-5956.1000193
   RAKITA L, 1983, AM HEART J, V106, P906, DOI 10.1016/0002-8703(83)90015-7
   Range FT, 2013, CARDIOVASC DRUG THER, V27, P247, DOI 10.1007/s10557-013-6446-0
   Reasor MJ, 2001, EXP BIOL MED, V226, P825
   Reasor MJ, 1996, P SOC EXP BIOL MED, V212, P297
   Reilly JG, 2000, LANCET, V355, P1048, DOI 10.1016/S0140-6736(00)02035-3
   ROSENBAUM MB, 1976, AM J CARDIOL, V38, P934, DOI 10.1016/0002-9149(76)90807-9
   ROSENBAUM MB, 1974, AM J CARDIOL, V34, P215, DOI 10.1016/0002-9149(74)90200-8
   Russom CL, 1997, ENVIRON TOXICOL CHEM, V16, P948, DOI 10.1002/etc.5620160514
   Sanguinetti MC, 2006, NATURE, V440, P463, DOI 10.1038/nature04710
   Sawada H, 2005, TOXICOL SCI, V83, P282, DOI 10.1093/toxsci/kfh264
   SCHARDEIN JL, 1985, ENVIRON HEALTH PERSP, V61, P55, DOI 10.2307/3430062
   Seiler KP, 2008, NUCLEIC ACIDS RES, V36, pD351, DOI 10.1093/nar/gkm843
   Serviddio G, 2011, FREE RADICAL BIO MED, V51, P2234, DOI 10.1016/j.freeradbiomed.2011.09.004
   SEXTON K, 1995, TOXICOLOGY, V102, P3, DOI 10.1016/0300-483X(95)03033-C
   Silva MFB, 2008, J INHERIT METAB DIS, V31, P205, DOI 10.1007/s10545-008-0841-x
   Singh BN, 1996, AM J CARDIOL, V78, P41, DOI 10.1016/S0002-9149(96)00452-3
   Smith R, 2001, BRIT MED J, V322, P248, DOI 10.1136/bmj.322.7281.248
   Sonis ST, 2004, CANCER-AM CANCER SOC, V100, P1995, DOI 10.1002/cncr.20162
   Soriano AO, 2007, BLOOD, V110, P2302, DOI 10.1182/blood-2007-03-078576
   Spaniol M, 2001, J HEPATOL, V35, P628, DOI 10.1016/S0168-8278(01)00189-1
   Susin SA, 2000, J EXP MED, V192, P571, DOI 10.1084/jem.192.4.571
   Donato MT, 2009, CHEM-BIOL INTERACT, V181, P417, DOI 10.1016/j.cbi.2009.07.019
   Teubner W, 2013, REGUL TOXICOL PHARM, V67, P468, DOI 10.1016/j.yrtph.2013.09.007
   Thomas D, 2003, BRIT J PHARMACOL, V139, P567, DOI 10.1038/sj.bjp.0705283
   Tsakovska I, 2014, INT J MOL SCI, V15, P7651, DOI 10.3390/ijms15057651
   Uraz S, 2008, DIGEST DIS SCI, V53, P1071, DOI 10.1007/s10620-007-9949-3
   Valcheva-Kuzmanova S, 2012, J BIOMED CLIN RES, V5, P97
   van den Bongard HJGD, 2001, CANCER CHEMOTH PHARM, V47, P537
   Van den Hof WFPM, 2014, CHEM RES TOXICOL, V27, P433, DOI 10.1021/tx4004165
   van Loo G, 2001, CELL DEATH DIFFER, V8, P1136, DOI 10.1038/sj.cdd.4400944
   Van Triest B, 2000, ANN ONCOL, V11, P385, DOI 10.1023/A:1008351221345
   VERHAAR HJM, 1992, CHEMOSPHERE, V25, P471, DOI 10.1016/0045-6535(92)90280-5
   Villeneuve DL, 2011, ENVIRON TOXICOL CHEM, V30, P1, DOI 10.1002/etc.396
   Waldhauser KM, 2008, BRIT J PHARMACOL, V155, P585, DOI 10.1038/bjp.2008.287
   Waldhauser KM, 2006, J PHARMACOL EXP THER, V319, P1413, DOI 10.1124/jpet.106.108993
   Wang YL, 2009, NUCLEIC ACIDS RES, V37, pW623, DOI 10.1093/nar/gkp456
   WATSON RGP, 1988, J HEPATOL, V7, P72, DOI 10.1016/S0168-8278(88)80508-7
   Wen B, 2009, CHEM-BIOL INTERACT, V181, P220, DOI 10.1016/j.cbi.2009.05.014
   WENDEL A, 1979, BIOCHEM PHARMACOL, V28, P2051, DOI 10.1016/0006-2952(79)90223-5
   Wessels JAM, 2008, RHEUMATOLOGY, V47, P249, DOI 10.1093/rheumatology/kem279
   Westerink RHS, 2013, NEUROTOXICOLOGY, V39, P169, DOI 10.1016/j.neuro.2013.10.001
   Widemann BC, 2004, CANCER-AM CANCER SOC, V100, P2222, DOI 10.1002/cncr.20255
   Willett C., 2014, ALTEX, DOI 10.14573/altex.1401281
   Yang C., 2014, CHEMOTYPES CHEMOTYPE
   Yang H, 2005, LEUKEMIA RES, V29, P739, DOI 10.1016/j.leukres.2004.11.022
   Zamzami N, 2003, CURR BIOL, V13, pR71, DOI 10.1016/S0960-9822(02)01433-1
   Zhang YH, 2010, J ELECTROCARDIOL, V43, P440, DOI 10.1016/j.jelectrocard.2010.04.007
NR 165
TC 48
Z9 51
U1 3
U2 74
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0893-228X
EI 1520-5010
J9 CHEM RES TOXICOL
JI Chem. Res. Toxicol.
PD DEC
PY 2014
VL 27
IS 12
BP 2100
EP 2112
DI 10.1021/tx500345j
PG 13
WC Chemistry, Medicinal; Chemistry, Multidisciplinary; Toxicology
SC Pharmacology & Pharmacy; Chemistry; Toxicology
GA AW8XZ
UT WOS:000346543900012
PM 25354311
OA Green Accepted
DA 2019-10-23
ER

PT J
AU Tollefsen, KE
   Scholz, S
   Cronin, MT
   Edwards, SW
   de Knecht, J
   Crofton, K
   Garcia-Reyero, N
   Hartung, T
   Worth, A
   Patlewicz, G
AF Tollefsen, Knut Erik
   Scholz, Stefan
   Cronin, Mark T.
   Edwards, Stephen W.
   de Knecht, Joop
   Crofton, Kevin
   Garcia-Reyero, Natalia
   Hartung, Thomas
   Worth, Andrew
   Patlewicz, Grace
TI Applying Adverse Outcome Pathways (AOPs) to support Integrated
   Approaches to Testing and Assessment (IATA)
SO REGULATORY TOXICOLOGY AND PHARMACOLOGY
LA English
DT Article
DE Adverse Outcome Pathway (AOP); Integrated Approaches to Testing and
   Assessment (IATA); (Q)SAR; Read-across; High throughput screening (HTS);
   High content screening (HCS); Cross species extrapolation
ID SCREENING CONTACT ALLERGENS; ALKYLATED NON-PHENOLICS; IN-VITRO;
   RISK-ASSESSMENT; CELL-LINE; SKIN SENSITIZATION; ACETYLCHOLINESTERASE
   INHIBITION; DISRUPTING CHEMICALS; CONCEPTUAL-FRAMEWORK; PEPTIDE
   REACTIVITY
AB Chemical regulation is challenged by the large number of chemicals requiring assessment for potential human health and environmental impacts. Current approaches are too resource intensive in terms of time, money and animal use to evaluate all chemicals under development or already on the market. The need for timely and robust decision making demands that regulatory toxicity testing becomes more cost-effective and efficient. One way to realize this goal is by being more strategic in directing testing resources; focusing on chemicals of highest concern, limiting testing to the most probable hazards, or targeting the most vulnerable species. Hypothesis driven Integrated Approaches to Testing and Assessment (IATA) have been proposed as practical solutions to such strategic testing. In parallel, the development of the Adverse Outcome Pathway (AOP) framework, which provides information on the causal links between a molecular initiating event (MIE), intermediate key events (KEs) and an adverse outcome (AO) of regulatory concern, offers the biological context to facilitate development of IATA for regulatory decision making. This manuscript summarizes discussions at the Workshop entitled "Advancing AOPs for Integrated Toxicology and Regulatory Applications" with particular focus on the role AOPs play in informing the development of IATA for different regulatory purposes. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Tollefsen, Knut Erik] Norwegian Inst Water Res NIVA, N-0349 Oslo, Norway.
   [Scholz, Stefan] UFZ Helmholtz Ctr Environm Res, Dept Bioanalyt Ecotoxicol, D-04318 Leipzig, Germany.
   [Cronin, Mark T.] Liverpool John Moores Univ, Sch Pharm & Biomol Sci, Liverpool L3 3AF, Merseyside, England.
   [Edwards, Stephen W.; Crofton, Kevin] US EPA, Off Res & Dev, Res Triangle Pk, NC 27711 USA.
   [de Knecht, Joop] Org Econ Cooperat & Dev, Environm Directorate, Environm Hlth & Safety Div, F-75775 Paris 16, France.
   [Garcia-Reyero, Natalia] Mississippi State Univ, Inst Genom Biocomp & Biotechnol, Starkville, MS USA.
   [Hartung, Thomas] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Ctr Alternat Anim Testing, Baltimore, MD 21205 USA.
   [Worth, Andrew] European Commiss, Joint Res Ctr, Inst Hlth & Consumer Protect, Syst Toxicol Unit, Ispra, Varese, Italy.
   [Patlewicz, Grace] DuPont Haskell Global Ctr Hlth & Environm Sci, Newark, DE 19711 USA.
RP Patlewicz, G (reprint author), DuPont Haskell Global Ctr, Newark, DE 19711 USA.
EM knut.erik.tollefsen@niva.no; stefan.scholz@ufz.de;
   M.T.Cronin@ljmu.ac.uk; Edwards.Stephen@epa.gov; Joop.DEKNECHT@oecd.org;
   Crofton.Kevin@epa.gov; natalia@icnanotox.org; thartung@jhsph.edu;
   Andrew.WORTH@ec.europa.eu; patlewig@hotmail.com
RI Worth, Andrew Paul/O-3055-2019; Crofton, Kevin/J-4798-2015; Worth,
   Andrew/R-8495-2019; Scholz, Stefan/B-7776-2014
OI Worth, Andrew Paul/0000-0002-5303-0452; Crofton,
   Kevin/0000-0003-1749-9971; Scholz, Stefan/0000-0002-6990-4716;
   Patlewicz, Grace/0000-0003-3863-9689
FU American Chemistry Council (ACC); BioDetection Systems; European Centre
   for Ecotoxicology and Toxicology of Chemicals (ECETOC); Environment
   Canada; European Commission Directorate General Joint Research Centre;
   Human Toxicology Project Consortium; International Life Sciences
   Institute - Health and Environmental Science Institute; Research Council
   of NorwayResearch Council of Norway [221455]; Society for Environmental
   Toxicology and Chemistry (SETAC); US Army Engineer Research and
   Development CenterUnited States Department of Defense; U.S.
   Environmental Protection AgencyUnited States Environmental Protection
   Agency
FX The content of this paper is the result of an international expert
   workshop on Advancing Adverse Outcome Pathways (AOP5) for Integrated
   Toxicology and Regulatory Applications. Support for the workshop was
   provided by the American Chemistry Council (ACC), BioDetection Systems,
   European Centre for Ecotoxicology and Toxicology of Chemicals (ECETOC),
   Environment Canada, European Commission Directorate General Joint
   Research Centre, Human Toxicology Project Consortium, International Life
   Sciences Institute - Health and Environmental Science Institute, The
   Research Council of Norway (Grant No. 221455), Society for Environmental
   Toxicology and Chemistry (SETAC), US Army Engineer Research and
   Development Center, and the U.S. Environmental Protection Agency. The
   authors acknowledge the workshop organizing committee, and all workshop
   participants for both plenary and informal discussions that influenced
   the content presented here. The views expressed are those of the
   authors, and do not necessarily represent the views of the organizations
   the authors are affiliated with or the sponsors. Mention of trade names
   does not imply endorsement by any of the author organizations or
   sponsors.; The participation of Tatiana Netzeva and Alberto Martin
   Aparicio from the European Chemicals Agency (ECHA) in the discussions of
   the workshop is also acknowledged. The views expressed at the workshop
   represented the personal opinion of the experts as individual scientists
   and regulatory professionals and do not constitute an official position
   of ECHA.; The opinions expressed and arguments employed herein are those
   of the authors and do not necessarily reflect the official views of the
   OECD or the governments of its member countries.; The information in
   this document has been funded wholly (or in part) by the U.S.
   Environmental Protection Agency. It has been subjected to review by the
   National Health and Environmental Effects Research Laboratory (NHEERL)
   and approved for publication. Approval does not signify that the
   contents reflect the views of the Agency, nor does mention of trade
   names or commercial products constitute endorsement or recommendation
   for use.
CR Adler S, 2011, ARCH TOXICOL, V85, P367, DOI 10.1007/s00204-011-0693-2
   Ahlers J, 2008, ENVIRON SCI POLLUT R, V15, P565, DOI 10.1007/s11356-008-0043-y
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Ankley GT, 2005, TOXICOL SCI, V86, P300, DOI 10.1093/toxsci/kfi202
   [Anonymous], 2012, OECD CONC FRAM TEST
   Aptula AO, 2006, CHEM RES TOXICOL, V19, P1097, DOI 10.1021/tx0601004
   Aylward LL, 2011, J APPL TOXICOL, V31, P741, DOI 10.1002/jat.1626
   Balls M, 2006, ATLA-ALTERN LAB ANIM, V34, P603, DOI 10.1177/026119290603400604
   Barata C, 2004, AQUAT TOXICOL, V66, P125, DOI 10.1016/j.aquatox.2003.07.004
   Barton-Maclaren T., WEIGHT EVIDENC UNPUB
   Becker R.A., 2014, ICCA JRC WORKSH JUN
   Bhattacharya S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020887
   Bianco K, 2013, AQUAT TOXICOL, V144, P26, DOI 10.1016/j.aquatox.2013.09.025
   Blackburn K, 2014, REGUL TOXICOL PHARM, V68, P353, DOI 10.1016/j.yrtph.2014.01.004
   Bradbury Steven P., 2008, P417, DOI 10.1201/9780203647295.ch9
   Capen CC, 1997, TOXICOL PATHOL, V25, P39, DOI 10.1177/019262339702500109
   Costa LG, 2006, CLIN CHIM ACTA, V366, P1, DOI 10.1016/j.cca.2005.10.008
   Cox LA, 2014, REGUL TOXICOL PHARM, V69, P443, DOI 10.1016/j.yrtph.2014.05.010
   Crofton KM, 2008, INT J ANDROL, V31, P209, DOI 10.1111/j.1365-2605.2007.00857.x
   Crofton KM, 2005, CRIT REV TOXICOL, V35, P757, DOI 10.1080/10408440591007304
   Cronin MTD, 2009, ATLA-ALTERN LAB ANIM, V37, P513, DOI 10.1177/026119290903700508
   Cronin MTD, 2010, ISSUES TOXICOL, V7, P1, DOI 10.1039/9781849732093
   DEBRUIJN J, 1993, AQUAT TOXICOL, V24, P257, DOI 10.1016/0166-445X(93)90075-C
   EC, 2006, OFF J EUR UNION L, V396
   ECHA, 2008, GUID INF REQ CHEM SA
   Emter R, 2013, TOXICOL IN VITRO, V27, P2225, DOI 10.1016/j.tiv.2013.09.009
   Emter R, 2010, TOXICOL APPL PHARM, V245, P281, DOI 10.1016/j.taap.2010.03.009
   Escher BI, 2002, AQUAT SCI, V64, P20, DOI 10.1007/s00027-002-8052-2
   FUKUTO TR, 1990, ENVIRON HEALTH PERSP, V87, P245
   Fulton MH, 2001, ENVIRON TOXICOL CHEM, V20, P37, DOI [10.1897/1551-5028(2001)020<0037:AIIEFA>2.0.CO;2, 10.1002/etc.5620200104]
   Garcia-Reyero N, 2014, ENVIRON SCI TECHNOL, V48, P4546, DOI 10.1021/es4042258
   Garcia-Reyero N, 2014, ENVIRON INT, V63, P216, DOI 10.1016/j.envint.2013.11.012
   Gerberick GF, 2007, TOXICOL SCI, V97, P417, DOI 10.1093/toxsci/kfm064
   Gerberick GF, 2004, TOXICOL SCI, V81, P332, DOI 10.1093/toxsci/kfh213
   Hartung T, 2013, ALTEX-ALTERN ANIM EX, V30, P119, DOI 10.14573/altex.2013.2.119
   Hartung T, 2013, ALTEX-ALTERN ANIM EX, V30, P3, DOI 10.14573/altex.2013.1.003
   HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503
   Holth TF, 2012, AQUAT TOXICOL, V112, P92, DOI 10.1016/j.aquatox.2011.10.019
   HUNT KA, 1991, ARCH ENVIRON CON TOX, V21, P84, DOI 10.1007/BF01055561
   IOM (Institute of Medicine), 2010, EV BIOM SURR ENDP CH
   Irons TD, 2010, NEUROTOXICOL TERATOL, V32, P84, DOI 10.1016/j.ntt.2009.04.066
   Judson R, 2014, BASIC CLIN PHARMACOL, V115, P69, DOI 10.1111/bcpt.12239
   Judson R, 2013, ALTEX-ALTERN ANIM EX, V30, P51, DOI 10.14573/altex.2013.1.051
   Kavlock R. J., 2007, AATEX, V14, P623
   Kleinstreuer NC, 2014, NAT BIOTECHNOL, V32, P583, DOI 10.1038/nbt.2914
   Knudsen TB, 2011, TOXICOLOGY, V282, P1, DOI 10.1016/j.tox.2010.12.010
   KOBAYASHI H, 1985, TOXICOL LETT, V29, P153
   KOBAYASHI H, 1994, J APPL TOXICOL, V14, P185, DOI 10.1002/jat.2550140307
   Kokel D, 2010, NAT CHEM BIOL, V6, P231, DOI 10.1038/NCHEMBIO.307
   Korner W, 1998, CHEMOSPHERE, V37, P2395, DOI 10.1016/S0045-6535(98)00297-5
   LaLone CA, 2013, AQUAT TOXICOL, V144, P141, DOI 10.1016/j.aquatox.2013.09.004
   Legler J, 1999, TOXICOL SCI, V48, P55, DOI 10.1093/toxsci/48.1.55
   Lepoittevin J.-P., 1997, ALLERGIC CONTACT DER
   Leung MCK, 2008, TOXICOL SCI, V106, P5, DOI 10.1093/toxsci/kfn121
   Truong L, 2014, TOXICOL SCI, V137, P212, DOI 10.1093/toxsci/kft235
   Lo Piparo E., 2010, 24522 JRC EUR EN
   McHenery JG, 1997, AQUAT TOXICOL, V38, P125, DOI 10.1016/S0166-445X(96)00834-X
   MCKIM JM, 1987, ENVIRON TOXICOL CHEM, V6, P313, DOI 10.1002/etc.5620060408
   Meek ME, 2014, J APPL TOXICOL, V34, P1, DOI 10.1002/jat.2949
   Meek ME, 2014, J APPL TOXICOL, V34, P595, DOI 10.1002/jat.2984
   Miller MD, 2009, ENVIRON HEALTH PERSP, V117, P1033, DOI 10.1289/ehp.0800247
   Mombelli E, 2012, SAR QSAR ENVIRON RES, V23, P37, DOI 10.1080/1062936X.2011.623325
   Munn S., 2013, 25919 4RC E1R EN
   Murk AJ, 2013, TOXICOL IN VITRO, V27, P1320, DOI 10.1016/j.tiv.2013.02.012
   Nelms M.D, 2014, ARCH TOXICO IN PRESS
   Novic M, 2010, MOLECULES, V15, P1987, DOI 10.3390/molecules15031987
   OECD, 2008, OECD SER TEST ASS, V88
   OECD, 2014, SER TEST ASS, V203
   OECD, 2012, SER TEST ASS, V168
   OECD, 2014, SER TEST ASS, V194
   OECD, 2007, OECD SER TEST ASS, V69
   OECD, 2004, OECD PRINC VAL REG P
   OECD (Organization for Economic Co-operation and Development), 2013, GUID DOC DEV ASS ADV
   Opitz R, 2012, DEV BIOL, V372, P203, DOI 10.1016/j.ydbio.2012.09.011
   Organisation for Economic Cooperation and Development (OECD), 2012, ADV OUTC PATHW SKI 2
   OYAMA Y, 1989, BRIT J PHARMACOL, V96, P573, DOI 10.1111/j.1476-5381.1989.tb11855.x
   Patlewicz G., REG TOXICOL PH UNPUB
   Patlewicz G., BUILDING SCI C UNPUB
   Patlewicz G, 2014, REGUL TOXICOL PHARM, V69, P529, DOI 10.1016/j.yrtph.2014.06.001
   Patlewicz G, 2013, REGUL TOXICOL PHARM, V65, P259, DOI 10.1016/j.yrtph.2012.12.008
   Pease CKS, 2003, TOXICOLOGY, V192, P1, DOI 10.1016/S0300-483X(03)00246-4
   Perkins E. J., 2014, TOXICOL SCI UNPUB
   Perkins EJ, 2013, ENVIRON HEALTH PERSP, V121, P1002, DOI 10.1289/ehp.1306638
   Python F, 2007, TOXICOL APPL PHARM, V220, P113, DOI 10.1016/j.taap.2006.12.026
   Raldua D, 2009, ENVIRON SCI TECHNOL, V43, P6844, DOI 10.1021/es9012454
   Roberts DW, 2008, J APPL TOXICOL, V28, P443, DOI 10.1002/jat.1293
   Romanov S, 2008, NAT METHODS, V5, P253, DOI 10.1038/NMETH.1186
   Rostkowski P, 2011, ENVIRON SCI TECHNOL, V45, P10660, DOI 10.1021/es202966c
   Russom CL, 2014, ENVIRON TOXICOL CHEM, V33, P2157, DOI 10.1002/etc.2662
   Sakaguchi H, 2007, TOXICOL LETT, V172, pS93, DOI 10.1016/j.toxlet.2007.05.257
   Schmieder PK, 2003, ENVIRON TOXICOL CHEM, V22, P1844, DOI 10.1897/01-345
   Scholz S, 2013, ARCH TOXICOL, V87, P767, DOI 10.1007/s00204-013-1044-2
   Scholz S, 2013, REGUL TOXICOL PHARM, V67, P506, DOI 10.1016/j.yrtph.2013.10.003
   Schultz TW, 2005, SAR QSAR ENVIRON RES, V16, P313, DOI 10.1080/10659360500204152
   Schwobel JAH, 2011, CHEM REV, V111, P2562, DOI 10.1021/cr100098n
   Simmons SO, 2009, TOXICOL SCI, V111, P202, DOI 10.1093/toxsci/kfp140
   Thaens D, 2012, CHEM RES TOXICOL, V25, P2092, DOI 10.1021/tx3001412
   Thienpont B, 2011, ENVIRON SCI TECHNOL, V45, P7525, DOI 10.1021/es202248h
   Tollefsen KE, 2008, ECOTOX ENVIRON SAFE, V71, P370, DOI 10.1016/j.ecoenv.2007.10.006
   Tollefsen KE, 2008, ECOTOX ENVIRON SAFE, V69, P163, DOI 10.1016/j.ecoenv.2007.04.010
   U. S. Environmental Protection Agency, 2011, INT APPR TEST ASS ST
   Villeneuve DL, 2007, ECOTOX ENVIRON SAFE, V68, P20, DOI 10.1016/j.ecoenv.2007.03.001
   Vinggaard AM, 2000, TOXICOL IN VITRO, V14, P227, DOI 10.1016/S0887-2333(00)00018-7
   Volz DC, 2011, TOXICOL SCI, V123, P349, DOI 10.1093/toxsci/kfr185
   Wambaugh JF, 2013, ENVIRON SCI TECHNOL, V47, P8479, DOI 10.1021/es400482g
   Weinberg A M, 1971, Ciba Found Symp, V1, P105
   Wong KY, 2012, MINI-REV MED CHEM, V12, P936, DOI 10.2174/138955712802762365
   Worth A.P., 2014, VALIDATION ALTERNATI
   Wu SD, 2013, CHEM RES TOXICOL, V26, P1840, DOI 10.1021/tx400226u
   Yazal JE, 2001, TOXICOL SCI, V63, P223, DOI 10.1093/toxsci/63.2.223
   Zaldivar J.M., 2010, BIOL BASED DYNAMIC 1
   Zaldivar J.M., 2011, BIOL BASED DYNAMIC 2
   Zhao S, 2002, J AGR FOOD CHEM, V50, P3351, DOI 10.1021/jf0116294
NR 113
TC 122
Z9 126
U1 2
U2 73
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0273-2300
EI 1096-0295
J9 REGUL TOXICOL PHARM
JI Regul. Toxicol. Pharmacol.
PD DEC
PY 2014
VL 70
IS 3
BP 629
EP 640
DI 10.1016/j.yrtph.2014.09.009
PG 12
WC Medicine, Legal; Pharmacology & Pharmacy; Toxicology
SC Legal Medicine; Pharmacology & Pharmacy; Toxicology
GA AU7ZO
UT WOS:000345816900007
PM 25261300
OA Other Gold
HC Y
HP N
DA 2019-10-23
ER

PT J
AU Villeneuve, DL
   Crump, D
   Garcia-Reyero, N
   Hecker, M
   Hutchinson, TH
   LaLone, CA
   Landesmann, B
   Lettieri, T
   Munn, S
   Nepelska, M
   Ottinger, MA
   Vergauwen, L
   Whelan, M
AF Villeneuve, Daniel L.
   Crump, Doug
   Garcia-Reyero, Natalia
   Hecker, Markus
   Hutchinson, Thomas H.
   LaLone, Carlie A.
   Landesmann, Brigitte
   Lettieri, Teresa
   Munn, Sharon
   Nepelska, Malgorzata
   Ottinger, Mary Ann
   Vergauwen, Lucia
   Whelan, Maurice
TI Adverse Outcome Pathway (AOP) Development I: Strategies and Principles
SO TOXICOLOGICAL SCIENCES
LA English
DT Article
DE adverse outcome pathway; regulatory toxicology; predictive toxicology;
   extrapolation; knowledgebase
ID DISRUPTING CHEMICALS; CONCEPTUAL-FRAMEWORK; IPCS FRAMEWORK; MODE;
   IDENTIFICATION; PRIORITIZATION; RELEVANCE
AB An adverse outcome pathway (AOP) is a conceptual framework that organizes existing knowledge concerning biologically plausible, and empirically supported, links between molecular-level perturbation of a biological system and an adverse outcome at a level of biological organization of regulatory relevance. Systematic organization of information into AOP frameworks has potential to improve regulatory decision-making through greater integration and more meaningful use of mechanistic data. However, for the scientific community to collectively develop a useful AOP knowledgebase that encompasses toxicological contexts of concern to human health and ecological risk assessment, it is critical that AOPs be developed in accordance with a consistent set of core principles. Based on the experiences and scientific discourse among a group of AOP practitioners, we propose a set of five fundamental principles that guide AOP development: (1) AOPs are not chemical specific; (2) AOPs are modular and composed of reusable components-notably key events (KEs) and key event relationships (KERs); (3) an individual AOP, composed of a single sequence of KEs and KERs, is a pragmatic unit of AOP development and evaluation; (4) networks composed of multiple AOPs that share common KEs and KERs are likely to be the functional unit of prediction for most real-world scenarios; and (5) AOPs are living documents that will evolve over time as new knowledge is generated. The goal of the present article was to introduce some strategies for AOP development and detail the rationale behind these 5 key principles. Consideration of these principles addresses many of the current uncertainties regarding the AOP framework and its application and is intended to foster greater consistency in AOP development.
C1 [Villeneuve, Daniel L.; LaLone, Carlie A.] US EPA, Mid Continent Ecol Div, Duluth, MN 55804 USA.
   [Crump, Doug] Environm Canada, Ecotoxicol & Wildlife Hlth Div, Ottawa, ON K1A 0H3, Canada.
   [Garcia-Reyero, Natalia] Mississippi State Univ, Inst Genom Biocomp & Biotechnol, Starkville, MS 39762 USA.
   [Hecker, Markus] Univ Saskatchewan, Sch Environm & Sustainabil, Saskatoon, SK S7N 5B3, Canada.
   [Hecker, Markus] Univ Saskatchewan, Toxicol Ctr, Saskatoon, SK S7N 5B3, Canada.
   [Hutchinson, Thomas H.] Univ Plymouth, Sch Biol Sci, Plymouth PL4 8AA, Devon, England.
   [LaLone, Carlie A.] Univ Minnesota, Water Resources Ctr, St Paul, MN 55108 USA.
   [Landesmann, Brigitte; Lettieri, Teresa; Munn, Sharon; Nepelska, Malgorzata; Whelan, Maurice] Commiss European Communities, Joint Res Ctr, I-21027 Ispra, Italy.
   [Ottinger, Mary Ann] Univ Houston, Dept Biol & Biochem, Houston, TX 77004 USA.
   [Vergauwen, Lucia] Univ Antwerp, Dept Vet Sci, Zebrafishlab, B-2610 Antwerp, Belgium.
RP Villeneuve, DL (reprint author), US EPA, Mid Continent Ecol Div, 6201 Congdon Blvd, Duluth, MN 55804 USA.
EM villeneuve.dan@epa.gov
OI Vergauwen, Lucia/0000-0002-6534-7473
CR Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Ankley GT, 2009, AQUAT TOXICOL, V92, P168, DOI 10.1016/j.aquatox.2009.01.013
   Boobis AR, 2008, CRIT REV TOXICOL, V38, P87, DOI 10.1080/10408440701749421
   Boobis AR, 2006, CRIT REV TOXICOL, V36, P781, DOI 10.1080/10408440600977677
   Bradbury SP, 2004, ENVIRON SCI TECHNOL, V38, p463A, DOI 10.1021/es040675s
   Crofton KM, 2008, INT J ANDROL, V31, P209, DOI 10.1111/j.1365-2605.2007.00857.x
   Csete M, 2004, TRENDS BIOTECHNOL, V22, P446, DOI 10.1016/j.tibtech.2004.07.007
   Farmahin R, 2012, ENVIRON SCI TECHNOL, V46, P2967, DOI 10.1021/es2043992
   Kimber I, 2014, TOXICOLOGY, V318, P32, DOI 10.1016/j.tox.2014.02.001
   Knudsen TB, 2011, BIRTH DEFECTS RES C, V93, P312, DOI 10.1002/bdrc.20223
   Krewski D, 2010, J TOXICOL ENV HEAL B, V13, P51, DOI 10.1080/10937404.2010.483176
   Lalone C. A., 2013, SETAC N AM 34 ANN M
   Meek ME, 2014, J APPL TOXICOL, V34, P1, DOI 10.1002/jat.2949
   OECD, 2013, ENV HLTH SAF PUBL SE, V6, P45
   OECD, 2011, OECD SER TEST ASS, V156
   Pavlopoulos GA, 2011, BIODATA MIN, V4, DOI 10.1186/1756-0381-4-10
   Perkins EJ, 2011, ENVIRON TOXICOL CHEM, V30, P22, DOI 10.1002/etc.374
   Russom CL, 2014, ENVIRON TOXICOL CHEM, V33, P2157, DOI 10.1002/etc.2662
   Schmieder PK, 2004, ENVIRON SCI TECHNOL, V38, P6333, DOI 10.1021/es0495314
   Shiizaki K, 2014, J PHARMACOL TOX MET, V69, P245, DOI 10.1016/j.vascn.2014.01.007
   Tollefsen K. E., 2014, REG TOXICOL IN PRESS
   Villeneuve D. L., 2014, TOXICOL SCI
   Villeneuve D, 2014, ENVIRON TOXICOL CHEM, V33, P158, DOI 10.1002/etc.2403
   Volz DC, 2011, TOXICOL SCI, V123, P349, DOI 10.1093/toxsci/kfr185
   Zhang LY, 2013, TOXICOL APPL PHARM, V272, P67, DOI 10.1016/j.taap.2013.04.032
NR 25
TC 190
Z9 197
U1 14
U2 114
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1096-6080
EI 1096-0929
J9 TOXICOL SCI
JI Toxicol. Sci.
PD DEC
PY 2014
VL 142
IS 2
BP 312
EP 320
DI 10.1093/toxsci/kfu199
PG 9
WC Toxicology
SC Toxicology
GA AY5MZ
UT WOS:000347617800001
PM 25466378
OA Green Published
HC Y
HP N
DA 2019-10-23
ER

PT J
AU Villeneuve, DL
   Crump, D
   Garcia-Reyero, N
   Hecker, M
   Hutchinson, TH
   LaLone, CA
   Landesmann, B
   Lettieri, T
   Munn, S
   Nepelska, M
   Ottinger, MA
   Vergauwen, L
   Whelan, M
AF Villeneuve, Daniel L.
   Crump, Doug
   Garcia-Reyero, Natalia
   Hecker, Markus
   Hutchinson, Thomas H.
   LaLone, Carlie A.
   Landesmann, Brigitte
   Lettieri, Teresa
   Munn, Sharon
   Nepelska, Malgorzata
   Ottinger, Mary Ann
   Vergauwen, Lucia
   Whelan, Maurice
TI Adverse Outcome Pathway Development II: Best Practices
SO TOXICOLOGICAL SCIENCES
LA English
DT Article
DE adverse outcome pathway; regulatory toxicology; predictive toxicology;
   extrapolation; knowledgebase
ID GROWTH PROMOTER 17-BETA-TRENBOLONE; ENDOCRINE DISRUPTION;
   RISK-ASSESSMENT; IPCS FRAMEWORK; TOXICITY; CONSERVATION; TARGETS; MODE;
   21ST-CENTURY; REACTIVITY
AB Organization of existing and emerging toxicological knowledge into adverse outcome pathway (AOP) descriptions can facilitate greater application of mechanistic data, including those derived through high-throughput in vitro, high content omics and imaging, and biomarker approaches, in risk-based decision making. The previously ad hoc process of AOP development is being formalized through development of internationally harmonized guidance and principles. The goal of this article was to outline the information content desired for formal AOP description and some rules of thumb and best practices intended to facilitate reuse and connectivity of elements of an AOP description in a knowledgebase and network context. For example, key events (KEs) are measurements of change in biological state that are indicative of progression of a perturbation toward a specified adverse outcome. Best practices for KE description suggest that each KE should be defined as an independent measurement made at a particular level of biological organization. The concept of "functional equivalence" can help guide both decisions about how many KEs to include in an AOP and the specificity with which they are defined. Likewise, in describing both KEs and evidence that supports a causal linkage or statistical association between them (ie, a key event relationship; KER), best practice is to build from and contribute to existing KE or KER descriptions in the AOP knowledgebase rather than creating redundant descriptions. The best practices proposed address many of the challenges and uncertainties related to AOP development and help promote a consistent and reliable, yet flexible approach.
C1 [Villeneuve, Daniel L.; LaLone, Carlie A.] US EPA, Mid Continent Ecol Div, Duluth, MN 55804 USA.
   [Crump, Doug] Environm Canada, Ecotoxicol & Wildlife Hlth Div, Ottawa, ON K1A 0H3, Canada.
   [Garcia-Reyero, Natalia] Mississippi State Univ, Inst Genom Biocomp & Biotechnol, Starkville, MS 39762 USA.
   [Hecker, Markus] Univ Saskatchewan, Sch Environm & Sustainabil, Saskatoon, SK S7N 5B3, Canada.
   [Hecker, Markus] Univ Saskatchewan, Toxicol Ctr, Saskatoon, SK S7N 5B3, Canada.
   [Hutchinson, Thomas H.] Univ Plymouth, Sch Biol Sci, Plymouth PL4 8AA, Devon, England.
   [LaLone, Carlie A.] Univ Minnesota, Water Resources Ctr, St Paul, MN 55108 USA.
   [Landesmann, Brigitte; Lettieri, Teresa; Munn, Sharon; Nepelska, Malgorzata; Whelan, Maurice] Commiss European Communities, Joint Res Ctr, I-21027 Ispra, Italy.
   [Ottinger, Mary Ann] Univ Houston, Dept Biol & Biochem, Houston, TX 77004 USA.
   [Vergauwen, Lucia] Univ Antwerp, Dept Vet Sci, Zebrafishlab, B-2610 Antwerp, Belgium.
RP Villeneuve, DL (reprint author), US EPA, Mid Continent Ecol Div, 201 Congdon Blvd, Duluth, MN 55804 USA.
EM villeneuve.dan@epa.gov
OI Vergauwen, Lucia/0000-0002-6534-7473
CR Ankley GT, 2013, ENVIRON TOXICOL CHEM, V32, P1084, DOI 10.1002/etc.2151
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Ankley GT, 2003, ENVIRON TOXICOL CHEM, V22, P1350, DOI 10.1002/etc.5620220623
   Boekelheide Kim, 2010, ALTEX, V27, P243
   Boekelheide K, 2010, TOXICOL SCI, V114, P20, DOI 10.1093/toxsci/kfp307
   Boobis AR, 2008, CRIT REV TOXICOL, V38, P87, DOI 10.1080/10408440701749421
   Boobis AR, 2006, CRIT REV TOXICOL, V36, P781, DOI 10.1080/10408440600977677
   Celander MC, 2011, ENVIRON TOXICOL CHEM, V30, P52, DOI 10.1002/etc.382
   Codreanu SG, 2014, MOL CELL PROTEOMICS, V13, P849, DOI 10.1074/mcp.M113.032953
   Fent K, 2011, AQUAT TOXICOL, V105, P25, DOI 10.1016/j.aquatox.2011.06.008
   Gunnarsson L, 2008, ENVIRON SCI TECHNOL, V42, P5807, DOI 10.1021/es8005173
   Hutchinson TH, 2006, ENVIRON HEALTH PERSP, V114, P106, DOI 10.1289/ehp.8062
   Karlberg AT, 2008, CHEM RES TOXICOL, V21, P53, DOI 10.1021/tx7002239
   Krewski D, 2010, J TOXICOL ENV HEAL B, V13, P51, DOI 10.1080/10937404.2010.483176
   LaLone CA, 2013, AQUAT TOXICOL, V144, P141, DOI 10.1016/j.aquatox.2013.09.004
   LaLone CA, 2013, ENVIRON TOXICOL CHEM, V32, P2528, DOI 10.1002/etc.2330
   McRobb FM, 2014, ENVIRON SCI TECHNOL, V48, P1964, DOI 10.1021/es404568a
   Meek ME, 2014, J APPL TOXICOL, V34, P1, DOI 10.1002/jat.2949
   OECD, 2013, SER TEST ASS, V184, P45
   Regoli F, 2014, MAR ENVIRON RES, V93, P106, DOI 10.1016/j.marenvres.2013.07.006
   Russom CL, 2014, ENVIRON TOXICOL CHEM, V33, P2157, DOI 10.1002/etc.2662
   Schultz T. W., 1989, AM SOC TESTING MAT
   Schwobel JAH, 2011, CHEM REV, V111, P2562, DOI 10.1021/cr100098n
   Sone K, 2005, GEN COMP ENDOCR, V143, P151, DOI 10.1016/j.ygcen.2005.03.007
   Tanaka T, 2013, J EXP CLIN MED, V5, P203, DOI DOI 10.1016/J.JECM.2013.10.009
   Tollefsen K. E., 2014, REG TOXICO IN PRESS
   Villeneuve D. L., 2014, TOXICOL SCI
NR 27
TC 93
Z9 96
U1 3
U2 54
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1096-6080
EI 1096-0929
J9 TOXICOL SCI
JI Toxicol. Sci.
PD DEC
PY 2014
VL 142
IS 2
BP 321
EP 330
DI 10.1093/toxsci/kfu200
PG 10
WC Toxicology
SC Toxicology
GA AY5MZ
UT WOS:000347617800002
PM 25466379
OA Green Published
DA 2019-10-23
ER

PT J
AU Ramirez, T
   Mehling, A
   Kolle, SN
   Wruck, CJ
   Teubner, W
   Eltze, T
   Aumann, A
   Urbisch, D
   van Ravenzwaay, B
   Landsiedel, R
AF Ramirez, Tzutzuy
   Mehling, Annette
   Kolle, Susanne N.
   Wruck, Christoph J.
   Teubner, Wera
   Eltze, Tobias
   Aumann, Alexandra
   Urbisch, Daniel
   van Ravenzwaay, Ben
   Landsiedel, Robert
TI LuSens: A keratinocyte based ARE reporter gene assay for use in
   integrated testing strategies for skin sensitization hazard
   identification
SO TOXICOLOGY IN VITRO
LA English
DT Article
DE Skin sensitization; Antioxidant response element (ARE); In vitro;
   Adverse outcome pathway (AOP); Keratinocyte activation
ID LYMPH-NODE ASSAY; ALLERGIC CONTACT-DERMATITIS; MAXIMIZATION TEST;
   RISK-ASSESSMENT; CLASSIFICATION; CHEMICALS; PREDICTION; POTENCY;
   PATHWAY; ENZYMES
AB Allergic contact dermatitis can develop following repeated exposure to allergenic substances. To date, hazard identification is still based on animal studies as non-animal alternatives have not yet gained global regulatory acceptance. Several non-animal methods addressing key-steps of the adverse outcome pathway (OECD, 2012) will most likely be needed to fully address this effect. Among the initial cellular events is the activation of keratinocytes and currently only one method, the KeratinoSens (TM), has been formally validated to address this event. In this study, a further method, the LuSens assay, that uses a human keratinocyte cell line harbouring a reporter gene construct composed of the antioxidant response element (ARE) of the rat NADPH:quinone oxidoreductase 1 gene and the luciferase gene. The assay was validated in house using a selection of 74 substances which included the LLNA performance standards. The predictivity of the LuSens assay for skin sensitization hazard identification was comparable to other non-animal methods, in particular to the KeratinoSens (TM). When used as part of a testing battery based on the OECD adverse outcome pathway for skin sensitization, a combination of the LuSens assay, the DPRA and a dendritic cell line activation test attained predictivities similar to that of the LLNA. (C) 2014 The Authors. Published by Elsevier Ltd.
C1 [Ramirez, Tzutzuy; Kolle, Susanne N.; Aumann, Alexandra; Urbisch, Daniel; van Ravenzwaay, Ben; Landsiedel, Robert] BASF SE, Expt Toxicol & Ecol, Ludwigshafen, Germany.
   [Mehling, Annette] BASF Personal Care & Nutr GmbH, Monheim, Germany.
   [Wruck, Christoph J.] Rhein Westfal TH Aachen, Aachen, Germany.
   [Teubner, Wera] BASF Schweiz AG, Basel, Switzerland.
   [Eltze, Tobias] BASF SE, Paper Chem, Ludwigshafen, Germany.
RP Landsiedel, R (reprint author), BASF SE, Expt Toxicol & Ecol, Ludwigshafen, Germany.
EM robert.landsiedel@basf.com
CR Ade N, 2009, TOXICOL SCI, V107, P451, DOI 10.1093/toxsci/kfn243
   Andersen KE, 1997, CLIN DERMATOL, V15, P645, DOI 10.1016/S0738-081X(97)00066-7
   [Anonymous], 2010, KERATIONOSENS INVITT
   [Anonymous], 1992, 406 OECD TG
   [Anonymous], 2010, 429 OECD TG
   [Anonymous], 2008, INT J TOXICOL S4, V27, P1
   Aptula AO, 2006, CHEM RES TOXICOL, V19, P1097, DOI 10.1021/tx0601004
   Aptula AO, 2009, CHEM RES TOXICOL, V22, P1541, DOI [10.1021/tx9000330, 10.1021/tx9000336]
   Basketter D, 2008, SKIN PHARMACOL PHYS, V21, P191, DOI 10.1159/000135635
   Basketter DA, 1999, FOOD CHEM TOXICOL, V37, P1167, DOI 10.1016/S0278-6915(99)00112-X
   BASKETTER DA, 1994, FOOD CHEM TOXICOL, V32, P543, DOI 10.1016/0278-6915(94)90112-0
   Basketter DA, 1996, FOOD CHEM TOXICOL, V34, P985, DOI 10.1016/S0278-6915(96)00059-2
   Basketter D, 2013, REGUL TOXICOL PHARM, V67, P531, DOI 10.1016/j.yrtph.2013.10.002
   Basketter DA, 2014, DERMATITIS, V25, P11, DOI 10.1097/DER.0000000000000003
   Bauch C, 2012, REGUL TOXICOL PHARM, V63, P489, DOI 10.1016/j.yrtph.2012.05.013
   Casati S., 2013, EUR SCI TECHNICAL RE
   COOPER JA, 1979, BRIT J CANCER, V39, P87, DOI 10.1038/bjc.1979.10
   Emter R, 2010, TOXICOL APPL PHARM, V245, P281, DOI 10.1016/j.taap.2010.03.009
   ENV/JM/MONO, 2012, SER TEST ASS, V168
   EURL ECVAM, 2013, JRC SCI POL REP, P36
   Fabian E, 2013, ARCH TOXICOL, V87, P1683, DOI 10.1007/s00204-013-1090-9
   Gerberick F, 2008, ATLA-ALTERN LAB ANIM, V36, P215, DOI 10.1177/026119290803600210
   Gerberick G F, 2001, Am J Contact Dermat, V12, P156, DOI 10.1053/ajcd.2001.23926
   Gerberick GF, 2005, DERMATITIS, V16, P157, DOI 10.2310/6620.2005.05040
   Gotz C, 2012, EXP DERMATOL, V21, P364, DOI 10.1111/j.1600-0625.2012.01478.x
   Hahn S., 2005, ENV RES PLAN FED MIN
   Hansson C, 2003, SKIN PHARMACOL APPL, V16, P117, DOI 10.1159/000069027
   HAUSTEIN UF, 1985, CONTACT DERMATITIS, V13, P252, DOI 10.1111/j.1600-0536.1985.tb02559.x
   ICCVAM, NIH PUBL
   Jackh C, 2012, J IMMUNOTOXICOL, V9, P426, DOI 10.3109/1547691X.2012.664578
   Johnson JA, 2008, ANN NY ACAD SCI, V1147, P61, DOI 10.1196/annals.1427.036
   Kimber I, 2003, FOOD CHEM TOXICOL, V41, P1799, DOI 10.1016/S0278-6915(03)00223-0
   Kreiling R, 2008, FOOD CHEM TOXICOL, V46, P1896, DOI 10.1016/j.fct.2008.01.019
   Maibach H I, 1977, Contact Dermatitis, V3, P99, DOI 10.1111/j.1600-0536.1977.tb03608.x
   MARZULLI FN, 1974, INT J DERMATOL, V13, P397, DOI 10.1111/j.1365-4362.1974.tb05071.x
   Mehling A, 2012, ARCH TOXICOL, V86, P1273, DOI 10.1007/s00204-012-0867-6
   Menne T., 2009, CRITICAL REV METHODO
   Motohashi H, 2004, TRENDS MOL MED, V10, P549, DOI 10.1016/j.molmed.2004.09.003
   Natsch A, 2008, TOXICOL SCI, V102, P110, DOI 10.1093/toxsci/kfm259
   Natsch A, 2013, J APPL TOXICOL, V33, P1337, DOI 10.1002/jat.2868
   Natsch A, 2011, TOXICOL IN VITRO, V25, P733, DOI 10.1016/j.tiv.2010.12.014
   NIH, 1999, NIH PUBLICATION
   Nioi P, 2004, MUTAT RES-FUND MOL M, V555, P149, DOI 10.1016/j.mrfmmm.2004.05.023
   OECD, 2014, PERF STAND ASS PROP
   OECD, 2012, OECD ENV HLTH SAF 1, V168
   OECD, 2012, OCED ENV HLTH SAF PU, V168, P10
   Patlewicz G, 2008, CHEM RES TOXICOL, V21, P521, DOI 10.1021/tx700338q
   Patrizi A, 1999, Am J Contact Dermat, V10, P52, DOI 10.1016/S1046-199X(99)90099-4
   Promega, 2007, TECHN MAN ONE GLO LC, P17
   Roberts DW, 2007, CHEM RES TOXICOL, V20, P1019, DOI 10.1021/tx700024w
   ROBINSON MK, 1989, FOOD CHEM TOXICOL, V27, P479, DOI 10.1016/0278-6915(89)90036-7
   Ryan CA, 2000, CONTACT DERMATITIS, V43, P95, DOI 10.1034/j.1600-0536.2000.043002095.x
   SCCP, 2005, SCI COMM CONS PROD S, P30
   Schneider K, 2004, REGUL TOXICOL PHARM, V39, P245, DOI 10.1016/j.yrtph.2004.02.002
   Schnuch A, 1998, BRIT J DERMATOL, V138, P467
   Simmons Steven O, 2011, Curr Chem Genomics, V5, P1, DOI 10.2174/1875397301105010001
   Uter W, 2010, CONTACT DERMATITIS, V63, P254, DOI 10.1111/j.1600-0536.2010.01759.x
   Vandebriel RJ, 2010, TOXICOL SCI, V117, P81, DOI 10.1093/toxsci/kfq182
   Wasserman WW, 1997, ARCH BIOCHEM BIOPHYS, V344, P387, DOI 10.1006/abbi.1997.0215
NR 59
TC 50
Z9 53
U1 1
U2 5
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0887-2333
J9 TOXICOL IN VITRO
JI Toxicol. Vitro
PD DEC
PY 2014
VL 28
IS 8
BP 1482
EP 1497
DI 10.1016/j.tiv.2014.08.002
PG 16
WC Toxicology
SC Toxicology
GA AR5QT
UT WOS:000343639400017
PM 25172300
OA Other Gold
DA 2019-10-23
ER

PT J
AU LaLone, CA
   Berninger, JP
   Villeneuve, DL
   Ankley, GT
AF LaLone, Carlie A.
   Berninger, Jason P.
   Villeneuve, Daniel L.
   Ankley, Gerald T.
TI Leveraging existing data for prioritization of the ecological risks of
   human and veterinary pharmaceuticals to aquatic organisms
SO PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
LA English
DT Review
DE pharmacokinetics; SeqAPASS; adverse outcome pathway; read-across;
   molecular target conservation
ID MINNOW PIMEPHALES-PROMELAS; MEDAKA ORYZIAS-LATIPES; DOPAMINE-RECEPTOR
   ANTAGONIST; TERM REPRODUCTION ASSAY; MALE FATHEAD MINNOWS; EARLY-LIFE
   STAGES; JAPANESE MEDAKA; OREOCHROMIS-NILOTICUS; CURRENT PERSPECTIVES;
   GENE-EXPRESSION
AB Medicinal innovation has led to the discovery and use of thousands of human and veterinary drugs. With this comes the potential for unintended effects on non-target organisms exposed to pharmaceuticals inevitably entering the environment. The impracticality of generating whole-organism chronic toxicity data representative of all species in the environment has necessitated prioritization of drugs for focused empirical testing as well as field monitoring. Current prioritization strategies typically emphasize likelihood for exposure (i.e. predicted/measured environmental concentrations), while incorporating only rather limited consideration of potential effects of the drug to non-target organisms. However, substantial mammalian pharmacokinetic and mechanism/mode of action (MOA) data are produced during drug development to understand drug target specificity and efficacy for intended consumers. An integrated prioritization strategy for assessing risks of human and veterinary drugs would leverage available pharmacokinetic and toxicokinetic data for evaluation of the potential for adverse effects to non-target organisms. In this reiview, we demonstrate the utility of read-across approaches to leverage mammalian absorption, distribution, metabolism and elimination data; analyse cross-species molecular target conservation and translate therapeutic MOA to an adverse outcome pathway(s) relevant to aquatic organisms as a means to inform prioritization of drugs for focused toxicity testing and environmental monitoring.
C1 [LaLone, Carlie A.] Univ Minnesota, Coll Food Agr & Nat Resource Sci, Water Resources Ctr, St Paul, MN 55108 USA.
   [LaLone, Carlie A.; Villeneuve, Daniel L.; Ankley, Gerald T.] US EPA, Off Res & Dev, Natl Hlth & Environm Effects Res Lab, Midcontinent Ecol Div, Duluth, MN 55804 USA.
   [Berninger, Jason P.] CNR, Duluth, MN 55804 USA.
RP LaLone, CA (reprint author), Univ Minnesota, Coll Food Agr & Nat Resource Sci, Water Resources Ctr, 1985 Buford Ave, St Paul, MN 55108 USA.
EM lalone.carlie@epa.gov
RI Berninger, Jason/O-2401-2016
OI Berninger, Jason/0000-0003-3045-7899
CR Ankley GT, 2007, ENVIRON SCI TECHNOL, V41, P8211, DOI 10.1021/es072658j
   Ankley GT, 2007, ENVIRON TOXICOL CHEM, V26, P1214, DOI 10.1897/06-428R.1
   Ankley GT, 2013, ENVIRON TOXICOL CHEM, V32, P1084, DOI 10.1002/etc.2151
   Ankley GT, 2012, AQUAT TOXICOL, V114, P88, DOI 10.1016/j.aquatox.2012.02.012
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Ankley GT, 2005, TOXICOL SCI, V86, P300, DOI 10.1093/toxsci/kfi202
   Ankley GT, 2003, ENVIRON TOXICOL CHEM, V22, P1350, DOI 10.1002/etc.5620220623
   Ankley GT, 2002, TOXICOL SCI, V67, P121, DOI 10.1093/toxsci/67.1.121
   [Anonymous], 2013, PHYS DESK REFERENCE
   Arnold KE, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0492
   Berninger JP, 2010, TOXICOL LETT, V193, P69, DOI 10.1016/j.toxlet.2009.12.006
   Boxall ABA, 2012, ENVIRON HEALTH PERSP, V120, P1221, DOI 10.1289/ehp.1104477
   Brain RA, 2012, HUMAN PHARM ENV CURR, P139
   Brandao FP, 2013, AQUAT TOXICOL, V144, P218, DOI 10.1016/j.aquatox.2013.10.005
   Brown AR, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0576
   Caldwell DJ, 2008, ENVIRON SCI TECHNOL, V42, P7046, DOI 10.1021/es800633q
   Caldwell Dj, CHEMOSPHERE IN PRESS, DOI [10.1016/j.chemosphere.2014.01.021, DOI 10.1016/J.CHEMOSPHERE.2014.01.021]
   Cao DY, 2012, J CHEM INF MODEL, V52, P1132, DOI 10.1021/ci300112j
   Connors KA, 2013, ENVIRON TOXICOL CHEM, V32, P1810, DOI 10.1002/etc.2240
   Crane HM, 2006, TOXICOL SCI, V93, P278, DOI 10.1093/toxsci/kfl063
   Daughton C. G, 2011, ENV CONTAMINANTS BIO
   DeQuattro ZA, 2012, ENVIRON TOXICOL CHEM, V31, P851, DOI 10.1002/etc.1754
   Dey CJ, 2010, HORM BEHAV, V58, P599, DOI 10.1016/j.yhbeh.2010.06.016
   Diamond JM, 2011, ENVIRON TOXICOL CHEM, V30, P2385, DOI 10.1002/etc.667
   Ekman DR, 2011, ENVIRON TOXICOL CHEM, V30, P319, DOI 10.1002/etc.406
   Foran CM, 2004, ARCH ENVIRON CON TOX, V46, P511, DOI 10.1007/s00244-003-3042-5
   Giltrow E, 2009, AQUAT TOXICOL, V95, P195, DOI 10.1016/j.aquatox.2009.09.002
   Gunnarsson L, 2008, ENVIRON SCI TECHNOL, V42, P5807, DOI 10.1021/es8005173
   Hatef A, 2012, AQUAT TOXICOL, V122, P181, DOI 10.1016/j.aquatox.2012.06.009
   Huggett DB, 2003, HUM ECOL RISK ASSESS, V9, P1789, DOI 10.1080/10807030390260498
   Hutchinson TH, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0583
   Jensen KM, 2004, AQUAT TOXICOL, V70, P99, DOI 10.1016/j.aquatox.2004.06.012
   Kiparissis Y, 2003, AQUAT TOXICOL, V63, P391, DOI 10.1016/S0166-445X(02)00189-3
   Kitano T, 2007, MOL REPROD DEV, V74, P1171, DOI 10.1002/mrd.20603
   Knox C, 2011, NUCLEIC ACIDS RES, V39, pD1035, DOI 10.1093/nar/gkq1126
   Kolpin DW, 2002, ENVIRON SCI TECHNOL, V36, P1202, DOI 10.1021/es011055j
   Kostich MS, 2008, SCI TOTAL ENVIRON, V389, P329, DOI 10.1016/j.scitotenv.2007.09.008
   Kugathas S, 2013, ENVIRON SCI TECHNOL, V47, P9487, DOI 10.1021/es4019332
   Kugathas S, 2011, ENVIRON SCI TECHNOL, V45, P2377, DOI 10.1021/es104105e
   LaLone CA, 2013, AQUAT TOXICOL, V144, P141, DOI 10.1016/j.aquatox.2013.09.004
   LaLone CA, 2013, ENVIRON TOXICOL CHEM, V32, P2528, DOI 10.1002/etc.2330
   LaLone CA, 2012, ENVIRON TOXICOL CHEM, V31, P611, DOI 10.1002/etc.1729
   Lee J, 2011, ECOTOX ENVIRON SAFE, V74, P1216, DOI 10.1016/j.ecoenv.2011.03.014
   Lin JH, 1997, PHARMACOL REV, V49, P403
   Lister A, 2009, AQUAT TOXICOL, V95, P320, DOI 10.1016/j.aquatox.2009.04.011
   Liu YW, 2002, DIFFERENTIATION, V70, P36, DOI 10.1046/j.1432-0436.2002.700104.x
   Lorenzi V, 2012, AQUAT TOXICOL, V116, P8, DOI 10.1016/j.aquatox.2012.03.001
   Martinovic D, 2008, ENVIRON TOXICOL CHEM, V27, P478, DOI 10.1897/07-206R.1
   Martyniuk CJ, 2013, GEN COMP ENDOCR, V194, P264, DOI 10.1016/j.ygcen.2013.09.019
   McRobb FM, 2014, ENVIRON SCI TECHNOL, V48, P1964, DOI 10.1021/es404568a
   Mennigen JA, 2011, J TOXICOL ENV HEAL B, V14, P387, DOI 10.1080/10937404.2011.578559
   Miyagawa S, 2014, ENVIRON SCI TECHNOL, V48, P5254, DOI 10.1021/es5002659
   Moda TL, 2008, BIOINFORMATICS, V24, P2270, DOI 10.1093/bioinformatics/btn415
   Murack Patrick J, 2011, Aquat Toxicol, V104, P121, DOI 10.1016/j.aquatox.2011.04.006
   Nakamura A, 2014, J APPL TOXICOL, V34, P545, DOI 10.1002/jat.2934
   Nieschlag E, 2013, CONTRACEPTION, V87, P288, DOI 10.1016/j.contraception.2012.08.036
   Oaks JL, 2004, NATURE, V427, P630, DOI 10.1038/nature02317
   Obach RS, 2008, DRUG METAB DISPOS, V36, P1385, DOI 10.1124/dmd.108.020479
   Organisation of Economic Cooperation and Development, 2014, ADV OUTC PATHW MOL S
   Painter MM, 2009, ENVIRON TOXICOL CHEM, V28, P2677, DOI 10.1897/08-556.1
   Panter GH, 2012, AQUAT TOXICOL, V114, P31, DOI 10.1016/j.aquatox.2012.02.002
   Paulos P, 2010, AQUAT TOXICOL, V99, P256, DOI 10.1016/j.aquatox.2010.05.001
   Perkins EJ, 2013, ENVIRON HEALTH PERSP, V121, P1002, DOI 10.1289/ehp.1306638
   Purdom C.E., 1994, Chemistry and Ecology, V8, P275, DOI 10.1080/02757549408038554
   Raldua D, 2009, ENVIRON SCI TECHNOL, V43, P6844, DOI 10.1021/es9012454
   Rand-Weaver M, 2013, ENVIRON SCI TECHNOL, V47, P11384, DOI 10.1021/es402065a
   Rivero-Wendt CLG, 2013, GENET MOL RES, V12, P3862, DOI 10.4238/2013.September.23.4
   Roos V, 2012, SCI TOTAL ENVIRON, V421, P102, DOI 10.1016/j.scitotenv.2012.01.039
   Runnalls TJ, 2013, ENVIRON SCI TECHNOL, V47, P2077, DOI 10.1021/es3048834
   Sanchez-Hernandez M, 2013, J STEROID BIOCHEM, V138, P183, DOI 10.1016/j.jsbmb.2013.05.014
   Schultz MM, 2011, AQUAT TOXICOL, V104, P38, DOI 10.1016/j.aquatox.2011.03.011
   Schulz M, 2012, CRIT CARE, V16, DOI 10.1186/cc11441
   Sharma P, 2013, GEN COMP ENDOCR, V184, P111, DOI 10.1016/j.ygcen.2012.12.018
   Singh R, 2012, J ENVIRON BIOL, V33, P799
   Skolness SY, 2013, TOXICOL SCI, V132, P284, DOI 10.1093/toxsci/kft010
   Skolness SY, 2012, ENVIRON TOXICOL CHEM, V31, P2615, DOI 10.1002/etc.1989
   Stepanova S, 2013, ENVIRON TOXICOL PHAR, V35, P454, DOI 10.1016/j.etap.2012.09.011
   Sun LW, 2007, ENVIRON TOXICOL PHAR, V24, P23, DOI 10.1016/j.etap.2007.01.003
   Sun LW, 2009, AQUAT TOXICOL, V93, P83, DOI 10.1016/j.aquatox.2009.03.010
   Svensson J, 2013, ENVIRON SCI TECHNOL, V47, P2043, DOI 10.1021/es304305k
   Thomas MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032917
   Tousson E, 2016, TOXICOL IND HEALTH, V32, P177, DOI 10.1177/0748233713501365
   University of Hertfordshire, 2013, VET SUBST DAT VSDB D
   Valenti TW, 2012, ENVIRON SCI TECHNOL, V46, P2427, DOI 10.1021/es204164b
   van den Brandhof EJ, 2010, ECOTOX ENVIRON SAFE, V73, P1862, DOI 10.1016/j.ecoenv.2010.08.031
   Villeneuve DL, 2010, ECOTOX ENVIRON SAFE, V73, P478, DOI 10.1016/j.ecoenv.2009.09.018
   Villeneuve DL, 2010, ECOTOX ENVIRON SAFE, V73, P472, DOI 10.1016/j.ecoenv.2009.09.007
   Villeneuve DL, 2009, ENVIRON HEALTH PERSP, V117, P624, DOI 10.1289/ehp.11891
   Walker SD, 2013, CHEMOSPHERE, V93, P2568, DOI 10.1016/j.chemosphere.2013.09.074
   Williams TD, 2007, ENVIRON TOXICOL CHEM, V26, P695, DOI 10.1897/05-646R1.1
   Winter MJ, 2008, AQUAT TOXICOL, V86, P361, DOI 10.1016/j.aquatox.2007.11.017
   Zeilinger J, 2009, ENVIRON TOXICOL CHEM, V28, P2663, DOI 10.1897/08-485.1
NR 92
TC 30
Z9 30
U1 2
U2 46
PU ROYAL SOC
PI LONDON
PA 6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND
SN 0962-8436
EI 1471-2970
J9 PHILOS T R SOC B
JI Philos. Trans. R. Soc. B-Biol. Sci.
PD NOV 19
PY 2014
VL 369
IS 1656
AR 20140022
DI 10.1098/rstb.2014.0022
PG 10
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA AQ8VK
UT WOS:000343114500017
PM 25405975
OA Green Published, Bronze
DA 2019-10-23
ER

PT J
AU Madden, JC
   Rogiers, V
   Vinken, M
AF Madden, Judith C.
   Rogiers, Vera
   Vinken, Mathieu
TI Application of in silico and in vitro methods in the development of
   adverse outcome pathway constructs in wildlife
SO PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
LA English
DT Review
DE adverse outcome pathway; in silico modelling; in vitro techniques;
   predictive toxicology
ID ARYL-HYDROCARBON-RECEPTORS; RISK-ASSESSMENT; CHEMICALS; ASSESSMENTS;
   DISRUPTION; TOXICITY; ANDROGEN; BINDING; TCDD; TOOL
AB There is a long history of using both in silico and in vitro methods to predict adverse effects in humans and environmental species where toxicity data are lacking. Currently, there is a great deal of interest in applying these methods to the development of so-called 'adverse outcome pathway' (AOP) constructs. The AOP approach provides a framework for organizing information at the chemical and biological level, allowing evidence from both in silico and in vitro studies to be rationally combined to fill gaps in knowledge concerning toxicological events. Fundamental to this new paradigm is a greater understanding of the mechanisms of toxicity and, in particular, where these mechanisms may be conserved across taxa, such as between model animals and related wild species. This presents an opportunity to make predictions across diverse species, where empirical data are unlikely to become available as is the case for most species of wildlife.
C1 [Madden, Judith C.] Liverpool John Moores Univ, Sch Pharm & Biomol Sci, Liverpool L3 3AF, Merseyside, England.
   [Rogiers, Vera; Vinken, Mathieu] Vrije Univ Brussel, Pharmaceut Res Ctr, Dept Toxicol, B-1090 Brussels, Belgium.
RP Madden, JC (reprint author), Liverpool John Moores Univ, Sch Pharm & Biomol Sci, Byrom St, Liverpool L3 3AF, Merseyside, England.
EM j.madden@ljmu.ac.uk
RI Vinken, Mathieu/H-7513-2013
OI Vinken, Mathieu/0000-0001-5115-8893; VUB, IVTD/0000-0002-5016-4789
FU European UnionEuropean Union (EU); Cosmetics Europe [266835, 266777,
   266838]
FX This work was financially supported by the European Union (FP7) and
   Cosmetics Europe under grant agreement numbers 266835 (COSMOS project),
   266777 (HeMiBio project) and 266838 (DETECTIVE project).
CR Adler S, 2011, ARCH TOXICOL, V85, P367, DOI 10.1007/s00204-011-0693-2
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Antkiewicz DS, 2005, TOXICOL SCI, V84, P368, DOI 10.1093/toxsci/kfi073
   Baker ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075553
   Doyle MA, 2013, AQUAT TOXICOL, V134, P34, DOI 10.1016/j.aquatox.2013.03.001
   Enoch SJ, 2011, CRIT REV TOXICOL, V41, P783, DOI 10.3109/10408444.2011.598141
   Enoch SJ, 2010, CRIT REV TOXICOL, V40, P728, DOI 10.3109/10408444.2010.494175
   Gunnarsson L, 2008, ENVIRON SCI TECHNOL, V42, P5807, DOI 10.1021/es8005173
   Hahn ME, 2002, CHEM-BIOL INTERACT, V141, P131, DOI 10.1016/S0009-2797(02)00070-4
   HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503
   Kim M, 2012, J ENVIRON SCI HEAL C, V30, P323, DOI 10.1080/10590501.2012.731959
   LaLone CA, 2013, AQUAT TOXICOL, V144, P141, DOI 10.1016/j.aquatox.2013.09.004
   LaLone CA, 2013, ENVIRON TOXICOL CHEM, V32, P2528, DOI 10.1002/etc.2330
   Landesmann B, 2012, 75689 JRC PUBL OFF E
   Lavine JA, 2005, TOXICOL SCI, V88, P60, DOI 10.1093/toxsci/kfi228
   Madden JC, 2013, ISSUES TOXICOL, V17, P98, DOI 10.1039/9781849734400-00098
   Madden JC, 2013, ISSUES TOXICOL, V17, P72, DOI 10.1039/9781849734400-00072
   Mandal PK, 2005, J COMP PHYSIOL B, V175, P221, DOI 10.1007/s00360-005-0483-3
   OECD, 2007, OECD SER TEST ASS, V69
   OECD, 2012, PROP TEMPL GUID DEV
   Perkins EJ, 2013, ENVIRON HEALTH PERSP, V121, P1002, DOI 10.1289/ehp.1306638
   Safholm M, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0577
   Scholz S, 2013, CRIT REV TOXICOL, V43, P45, DOI 10.3109/10408444.2012.737762
   Schultz TW, 2010, ISSUES TOXICOL, V7, P346
   Stefanska B, 2012, ALTEX P WC8, V1, P173
   Takahashi A, 1999, PHYSIOL REV, V79, P1089
   Tyler CR, 1998, CRIT REV TOXICOL, V28, P319, DOI 10.1080/10408449891344236
   Vinken M, 2013, TOXICOL SCI, V136, P97, DOI 10.1093/toxsci/kft177
   Vinken M, 2013, TOXICOLOGY, V312, P158, DOI 10.1016/j.tox.2013.08.011
   Volz DC, 2011, TOXICOL SCI, V123, P349, DOI 10.1093/toxsci/kfr185
   Walker SD, 2013, CHEMOSPHERE, V93, P2568, DOI 10.1016/j.chemosphere.2013.09.074
   Watanabe KH, 2011, ENVIRON TOXICOL CHEM, V30, P9, DOI 10.1002/etc.373
   Wilson VS, 2013, TOXICOL APPL PHARM, V271, P299, DOI 10.1016/j.taap.2011.01.017
NR 33
TC 4
Z9 4
U1 0
U2 16
PU ROYAL SOC
PI LONDON
PA 6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND
SN 0962-8436
EI 1471-2970
J9 PHILOS T R SOC B
JI Philos. Trans. R. Soc. B-Biol. Sci.
PD NOV 19
PY 2014
VL 369
IS 1656
AR 20130584
DI 10.1098/rstb.2013.0584
PG 7
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA AQ8VK
UT WOS:000343114500013
PM 25405971
OA Green Published, Bronze
DA 2019-10-23
ER

PT J
AU Piersma, AH
   Ezendam, J
   Luijten, M
   Muller, JJA
   Rorije, E
   van der Ven, LTM
   van Benthem, J
AF Piersma, Aldert H.
   Ezendam, Janine
   Luijten, Mirjam
   Muller, J. J. Andre
   Rorije, Emiel
   van der Ven, Leo T. M.
   van Benthem, Jan
TI A critical appraisal of the process of regulatory implementation of
   novel in vivo and in vitro methods for chemical hazard and risk
   assessment
SO CRITICAL REVIEWS IN TOXICOLOGY
LA English
DT Review
DE alternative method; hazard assessment; in vitro assay; regulatory
   implementation; regulatory toxicology; test batteries; validation
ID LYMPH-NODE ASSAY; STEM-CELL TEST; GENERATION REPRODUCTIVE TOXICITY;
   ENUCLEATED EYE TEST; SKIN SENSITIZATION; AVAILABLE DATA; DEVELOPMENTAL
   TOXICITY; TRANSFORMATION ASSAYS; ALTERNATIVE MODELS; MAXIMIZATION TEST
AB Regulatory toxicology urgently needs applicable alternative test systems that reduce animal use, testing time, and cost. European regulation on cosmetic ingredients has already banned animal experimentation for hazard identification, and public awareness drives toward additional restrictions in other regulatory frameworks as well. In addition, scientific progress stimulates a more mechanistic approach of hazard identification. Nevertheless, the implementation of alternative methods is lagging far behind their development. In search for general bottlenecks for the implementation of alternative methods, this manuscript reviews the state of the art as to the development and implementation of 10 diverse test systems in various areas of toxicological hazard assessment. They vary widely in complexity and regulatory acceptance status. The assays are reviewed as to parameters assessed, biological system involved, standardization, interpretation of results, extrapolation to human hazard, position in testing strategies, and current regulatory acceptance status. Given the diversity of alternative methods in many aspects, no common bottlenecks could be identified that hamper implementation of individual alternative assays in general. However, specific issues for the regulatory acceptance and application were identified for each assay. Acceptance of one-in-one replacement of complex in vivo tests by relatively simple in vitro assays is not feasible. Rather, innovative approaches using test batteries are required together with metabolic information and in vitro to in vivo dose extrapolation to convincingly provide the same level of information of current in vivo tests. A mechanistically based alternative approach using the Adverse Outcome Pathway concept could stimulate further (regulatory) acceptance of non-animal tests.
C1 [Piersma, Aldert H.; Ezendam, Janine; Luijten, Mirjam; van der Ven, Leo T. M.; van Benthem, Jan] RIVM, Ctr Hlth Protect, NL-3720 BA Bilthoven, Netherlands.
   [Muller, J. J. Andre; Rorije, Emiel] RIVM, Ctr Safety Subst & Prod, NL-3720 BA Bilthoven, Netherlands.
RP Piersma, AH (reprint author), RIVM, Ctr Hlth Protect, Leeuwenhoeklaan 9, NL-3720 BA Bilthoven, Netherlands.
EM aldert.piersma@rivm.nl
OI Rorije, Emiel/0000-0003-1268-7770
FU RIVM
FX The authors are affiliated to the National Institute for Public Health
   and the Environment (RIVM), Bilthoven, The Netherlands. RIVM is a
   government agency under the Dutch Ministry of Health, Welfare and
   Sports. RIVM has fully sponsored the present piece of work. The design
   of the appraisal, the conduct of the appraisal and the conclusions drawn
   in the paper are the exclusive work product of the authors and may not
   necessarily be those of their employer, RIVM.
CR Adler S, 2011, ARCH TOXICOL, V85, P367, DOI 10.1007/s00204-011-0693-2
   [Anonymous], 2011, GUID STRAT GEN TEST
   Antunovic B, 2011, EFSA J, V9, DOI 10.2903/j.efsa.2011.2379
   Augustine-Rauch K, 2010, BIRTH DEFECTS RES C, V90, P87, DOI 10.1002/bdrc.20175
   Ball N, 2011, REGUL TOXICOL PHARM, V60, P389, DOI 10.1016/j.yrtph.2011.05.007
   Basketter DA, 2000, CONTACT DERMATITIS, V42, P344, DOI 10.1034/j.1600-0536.2000.042006344.x
   BASKETTER DA, 1994, FOOD CHEM TOXICOL, V32, P543, DOI 10.1016/0278-6915(94)90112-0
   Basketter DA, 1998, FOOD CHEM TOXICOL, V36, P327, DOI 10.1016/S0278-6915(97)00158-0
   Basketter D, 2008, ATLA-ALTERN LAB ANIM, V36, P243, DOI 10.1177/026119290803600211
   Basketter DA, 2011, REGUL TOXICOL PHARM, V61, P137, DOI 10.1016/j.yrtph.2011.07.004
   Bauch C, 2012, REGUL TOXICOL PHARM, V63, P489, DOI 10.1016/j.yrtph.2012.05.013
   Belanger SE, 2013, ENVIRON TOXICOL CHEM, V32, P1768, DOI 10.1002/etc.2244
   Boverhof DR, 2011, TOXICOL SCI, V121, P207, DOI 10.1093/toxsci/kfr075
   BRAUNBECK T, 2006, BACKGROUND PAPER ON
   CASATI S, 2013, EURL ECVAM STRATEGY, P23
   Cohen SM, 2001, TOXICOL PATHOL, V29, P183, DOI 10.1080/019262301753178609
   Corvi R, 2012, MUTAT RES-GEN TOX EN, V744, P12, DOI 10.1016/j.mrgentox.2011.11.009
   Cotovio J, 2007, AATEX, V354, P351
   DEPASS LR, 1982, J TOXICOL ENV HEALTH, V10, P297, DOI 10.1080/15287398209530252
   Eastin WC, 2001, TOXICOL PATHOL, V29, P60, DOI 10.1080/019262301753178483
   Eastmond DA, 2013, CRIT REV TOXICOL, V43, P611, DOI 10.3109/10408444.2013.822844
   ECHA, 2008, GUID INF REQ CHEM SA
   *ECVAM, 2009, SKINETHIC RHE SOP VE
   *ECVAM E, 2013, EURL ECVAM REC KERAT
   El Ali Z, 2013, TOXICOL SCI, V134, P39, DOI 10.1093/toxsci/kft084
   Emter R, 2010, TOXICOL APPL PHARM, V245, P281, DOI 10.1016/j.taap.2010.03.009
   *EPIDERM, 2009, SOP VERS 7 0 REV MAR
   *EPISKIN, 2009, SOP VERS 1 8 FEBR 20
   *ESAC, 2007, STAT CONCL ICCVAM RE
   Ezendam J, 2013, REGUL TOXICOL PHARM, V66, P66, DOI 10.1016/j.yrtph.2013.02.006
   Genschow E, 2004, ATLA-ALTERN LAB ANIM, V32, P209, DOI 10.1177/026119290403200305
   Gerberick G F, 2001, Am J Contact Dermat, V12, P156, DOI 10.1053/ajcd.2001.23926
   Gerberick G F, 2000, Am J Contact Dermat, V11, P3
   HALDER M, 2012, SETAC BERLIN P
   Hartung T, 2004, ATLA-ALTERN LAB ANIM, V32, P467, DOI 10.1177/026119290403200503
   HENDRICKX AG, 1993, FUND APPL TOXICOL, V20, P199, DOI 10.1006/faat.1993.1027
   HEUER J, 1993, TOXICOL IN VITRO, V7, P551, DOI 10.1016/0887-2333(93)90064-C
   ICCVAM, 1999, NIH PUBL, V99-4496
   *ICCVAM, 2007, NIH PUBL
   Jacobson-Kram David, 2004, Toxicol Pathol, V32 Suppl 1, P49, DOI 10.1080/01926230490424761
   *JACVAM, 2011, LABCYTE SPI MODEL24
   Jaworska J., 2013, J APPL TOXICOL
   Kavlock R, 2012, CHEM RES TOXICOL, V25, P1287, DOI 10.1021/tx3000939
   KIMBER I, 1994, TOXICOLOGY, V93, P13, DOI 10.1016/0300-483X(94)90193-7
   KIMBER I, 1991, TOXICOL LETT, V55, P203, DOI 10.1016/0378-4274(91)90135-S
   KLEIN KL, 1981, J EXP ZOOL, V216, P107, DOI 10.1002/jez.1402160111
   Kleinstreuer NC, 2011, TOXICOL APPL PHARM, V257, P111, DOI 10.1016/j.taap.2011.08.025
   Knobel M, 2012, ENVIRON SCI TECHNOL, V46, P9690, DOI 10.1021/es301729q
   Knudsen Thomas, 2013, Methods Mol Biol, V947, P343, DOI 10.1007/978-1-62703-131-8_26
   Lai DY, 2004, J ENVIRON SCI HEAL C, V22, P37, DOI 10.1081/GNC-120038005
   Lambert LB, 2005, MUTAT RES-REV MUTAT, V590, P1, DOI 10.1016/j.mrrev.2005.04.002
   Lammer E, 2009, COMP BIOCHEM PHYS C, V149, P196, DOI 10.1016/j.cbpc.2008.11.006
   MacKay C, 2013, ALTEX-ALTERN ANIM EX, V30, P473, DOI 10.14573/altex.2013.4.473
   Makris SL, 2009, ENVIRON HEALTH PERSP, V117, P17, DOI 10.1289/ehp.11447
   Mantovani A, 1999, CHEMOSPHERE, V39, P1293, DOI 10.1016/S0045-6535(99)00197-6
   Marx-Stoelting P, 2009, ATLA-ALTERN LAB ANIM, V37, P313, DOI 10.1177/026119290903700314
   Maurer JK, 2002, REGUL TOXICOL PHARM, V36, P106, DOI 10.1006/rtph.2002.1551
   Moore N, 2009, ATLA-ALTERN LAB ANIM, V37, P219, DOI 10.1177/026119290903700211
   Natsch A., 2013, J APPL TOXICOL
   Natsch A, 2011, TOXICOL IN VITRO, V25, P733, DOI 10.1016/j.tiv.2010.12.014
   Natsch A, 2010, TOXICOL SCI, V113, P284, DOI 10.1093/toxsci/kfp228
   OECD, 2013, TEST 438 IS CHICK EY
   OECD, 2012, PROP TEMPL GUID DEV
   OECD, 1992, OECD GUID TEST CHEM
   OECD, 2013, TEST 439 IN VITR SKI
   OECD, 2002, TEST 404 AC DERM IRR
   OECD, 2012, OECD ENV HLTH SAF PU, V168, P1
   OECD, 2012, OECD ENV HLTH SAF 2, V168, P47
   OECD, 2012, TEST 405 AC EYE IRR
   OECD (Organization for Economic Co-operation and Development), 2007, OECD SER TEST ASS, P2
   Organisation for Economic Co-operation and Development OECD , 2013, TEST 236 FISH EMBR A
   Organisation for Economic Cooperation and Development (OECD), 2010, OECD GUID TEST CHEM
   Paquette JA, 2008, BIRTH DEFECTS RES B, V83, P104, DOI 10.1002/bdrb.20148
   Piersma AH, 2013, REPROD TOXICOL, V38, P53, DOI 10.1016/j.reprotox.2013.03.002
   Piersma AH, 2011, REPROD TOXICOL, V31, P392, DOI 10.1016/j.reprotox.2010.11.013
   PRINSEN MK, 1993, FOOD CHEM TOXICOL, V31, P69, DOI 10.1016/0278-6915(93)90182-X
   Prinsen MK, 1996, FOOD CHEM TOXICOL, V34, P291, DOI 10.1016/0278-6915(95)00115-8
   Robinson DE, 2001, TOXICOL PATHOL, V29, P13, DOI 10.1080/019262301753178438
   Rorije E, 2011, REGUL TOXICOL PHARM, V61, P251, DOI 10.1016/j.yrtph.2011.08.005
   Russell WMS, 1959, PRINCIPLES HUMANE EX
   Schmidt M, 2010, NAT IMMUNOL, V11, P814, DOI 10.1038/ni.1919
   Schneider S, 2011, REGUL TOXICOL PHARM, V59, P91, DOI 10.1016/j.yrtph.2010.09.010
   SCHOLES EW, 1992, J APPL TOXICOL, V12, P217, DOI 10.1002/jat.2550120312
   Seiler AEM, 2011, NAT PROTOC, V6, P961, DOI 10.1038/nprot.2011.348
   Spielmann H, 2007, ATLA-ALTERN LAB ANIM, V35, P559, DOI 10.1177/026119290703500614
   Stephens ML, 2013, ALTEX-ALTERN ANIM EX, V30, P74, DOI 10.14573/altex.2013.1.074
   Storer RD, 2001, TOXICOL PATHOL, V29, P30, DOI 10.1080/019262301753178465
   Thybaud V, 2011, MUTAT RES-GEN TOX EN, V723, P121, DOI 10.1016/j.mrgentox.2010.09.002
   Tonk ECM, 2013, ARCH TOXICOL, V87, P323, DOI 10.1007/s00204-012-0940-1
   Tonk ECM, 2011, TOXICOL LETT, V204, P156, DOI 10.1016/j.toxlet.2011.04.027
   USA NNAoS, 2007, TOX TEST 21 CENT VIS
   Usui T, 2001, TOXICOL PATHOL, V29, P90, DOI 10.1080/019262301753178500
   van Dartel DAM, 2011, REPROD TOXICOL, V32, P235, DOI 10.1016/j.reprotox.2011.04.008
   van der Veen JW, 2013, ARCH TOXICOL, V87, P763, DOI 10.1007/s00204-012-0976-2
   van der Veen JW, 2013, TOXICOL IN VITRO, V27, P314, DOI 10.1016/j.tiv.2012.08.023
   van Kreijl CF, 2001, TOXICOL PATHOL, V29, P117, DOI 10.1080/019262301753178528
   van Wijngaarden P, 2005, INVEST OPHTH VIS SCI, V46, P1445, DOI 10.1167/iovs.04-0708
   Vasseur P, 2012, MUTAT RES-GEN TOX EN, V744, P8, DOI 10.1016/j.mrgentox.2011.11.007
   Vinken M, 2013, TOXICOLOGY, V312, P158, DOI 10.1016/j.tox.2013.08.011
NR 99
TC 12
Z9 13
U1 0
U2 25
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1040-8444
EI 1547-6898
J9 CRIT REV TOXICOL
JI Crit. Rev. Toxicol.
PD NOV
PY 2014
VL 44
IS 10
BP 876
EP 894
DI 10.3109/10408444.2014.940445
PG 19
WC Toxicology
SC Toxicology
GA AS8GK
UT WOS:000344487700004
PM 25058877
DA 2019-10-23
ER

PT J
AU Whelan, M
AF Whelan, Maurice
TI Using Adverse Outcome Pathways to support mechanistic based safety
   assessment
SO MUTAGENESIS
LA English
DT Meeting Abstract
C1 [Whelan, Maurice] Commiss European Communities, Joint Res Ctr, Syst Toxicol Unit, Milan, Italy.
   [Whelan, Maurice] EURL ECVAM, Ispra, Italy.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0267-8357
EI 1464-3804
J9 MUTAGENESIS
JI Mutagenesis
PD NOV
PY 2014
VL 29
IS 6
BP 534
EP 534
PG 1
WC Genetics & Heredity; Toxicology
SC Genetics & Heredity; Toxicology
GA AT0KI
UT WOS:000344624700128
DA 2019-10-23
ER

PT J
AU Dallas, LJ
   Di, YA
   Bean, TP
   Lyons, BP
   Turner, A
   Jha, AN
AF Dallas, Lorna J.
   Di, Yanan
   Bean, Tim P.
   Lyons, Brett P.
   Turner, Andrew
   Jha, Awadhesh N.
TI Adverse outcome pathways for metal and radionuclide exposure: an
   ecotoxicological perspective using mussels as a sentinel organism
SO MUTAGENESIS
LA English
DT Meeting Abstract
C1 [Dallas, Lorna J.; Di, Yanan; Jha, Awadhesh N.] Univ Plymouth, Sch Biol Sci, Plymouth PL4 8AA, Devon, England.
   [Bean, Tim P.; Lyons, Brett P.] Cefas Weymouth Lab, Weymouth, Dorset, England.
   [Turner, Andrew] Univ Plymouth, Sch Geog Earth & Environm Sci, Plymouth PL4 8AA, Devon, England.
RI Bean, Tim/H-6792-2014
OI Bean, Tim/0000-0002-2544-9918
NR 0
TC 0
Z9 0
U1 0
U2 0
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0267-8357
EI 1464-3804
J9 MUTAGENESIS
JI Mutagenesis
PD NOV
PY 2014
VL 29
IS 6
BP 541
EP 541
PG 1
WC Genetics & Heredity; Toxicology
SC Genetics & Heredity; Toxicology
GA AT0KI
UT WOS:000344624700148
DA 2019-10-23
ER

PT J
AU Chepelev, NL
   Meek, ME
   Yauk, CL
AF Chepelev, Nikolai L.
   Meek, M. E. (Bette)
   Yauk, Carole Lyn
TI Application of benchmark dose modeling to protein expression data in the
   development and analysis of mode of action/adverse outcome pathways for
   testicular toxicity
SO JOURNAL OF APPLIED TOXICOLOGY
LA English
DT Review
DE key events; risk assessment; human health; protein expression; benchmark
   dose; molecular endpoints; toxicity; mode of action; adverse outcome
ID HUMAN RELEVANCE; FRAMEWORK; BIOMARKER; PHTHALATE; EVOLUTION; EXPOSURE
AB Reliable quantification of gene and protein expression has potential to contribute significantly to the characterization of hypothesized modes of action (MOA) or adverse outcome pathways for critical effects of toxicants. Quantitative analysis of gene expression by benchmark dose (BMD) modeling has been facilitated by the development of effective software tools. In contrast, protein expression is still generally quantified by a less robust effect level (no or lowest [adverse] effect levels) approach, which minimizes its potential utility in the consideration of dose-response and temporal concordance for key events in hypothesized MOAs. BMD modeling is applied here to toxicological data on testicular toxicity to investigate its potential utility in analyzing protein expression relevant to the proposed MOA to inform human health risk assessment. The results illustrate how the BMD analysis of protein expression in animal tissues in response to toxicant exposure: (1) complements other toxicity data, and (2) contributes to consideration of the empirical concordance of dose-response relationships, as part of the weight of evidence for hypothesized MOAs to facilitate consideration and application in regulatory risk assessment. Lack of BMD analysis in proteomics has likely limited its use for these purposes. This paper illustrates the added value of BMD modeling to support and strengthen hypothetical MOAs as a basis to facilitate the translation and uptake of the results of proteomic research into risk assessment. Copyright (c) 2014 Her Majesty the Queen in Right of Canada. Journal of Applied Toxicology (c) 2014 John Wiley & Sons, Ltd.
C1 [Chepelev, Nikolai L.; Yauk, Carole Lyn] Hlth Canada, Environm & Radiat Hlth Sci Directorate, Ottawa, ON K1A 0K9, Canada.
   [Meek, M. E. (Bette)] Univ Ottawa, R Samuel McLaughlin Ctr Populat Hlth Risk Assessm, Ottawa, ON K1N 6N5, Canada.
RP Chepelev, NL (reprint author), Hlth Canada, Environm & Radiat Hlth Sci Directorate, Ottawa, ON K1A 0K9, Canada.
EM nikolai.chepelev@hc-sc.gc.ca
OI Yauk, Carole/0000-0003-4919-876X
FU Health Canada Genomics Research and Development Initiative (GRDI)
FX This research was funded by the Health Canada Genomics Research and
   Development Initiative (GRDI).
CR Bernard A, 1997, OCCUP ENVIRON MED, V54, P63, DOI 10.1136/oem.54.1.63
   Black MB, 2012, TOXICOL SCI, V127, P199, DOI 10.1093/toxsci/kfs069
   Chen YF, 2008, TOXICOLOGY, V251, P21, DOI 10.1016/j.tox.2008.06.015
   David RM, 2006, TOXICOL PATHOL, V34, P209, DOI 10.1080/01926230600642625
   Davis JA, 2011, TOXICOL APPL PHARM, V254, P181, DOI 10.1016/j.taap.2010.10.016
   DIETRICH DR, 1993, CRIT REV TOXICOL, V23, P77, DOI 10.3109/10408449309104075
   Flannery BM, 2013, TOXICOLOGY, V304, P192, DOI 10.1016/j.tox.2012.12.017
   Lehmann KP, 2004, TOXICOL SCI, V81, P60, DOI 10.1093/toxsci/kfh169
   Lis YJ, 2009, TOXICOL SCI, V108, P427
   Ludwig S, 2011, TOXICOL SCI, V122, P52, DOI 10.1093/toxsci/kfr099
   Meek ME, 2014, J APPL TOXICOL, V34, P1, DOI 10.1002/jat.2949
   Meek MEB, 2008, ENVIRON MOL MUTAGEN, V49, P110, DOI 10.1002/em.20369
   Meek ME, 2014, J APPL TOXICOL, V34, P595, DOI 10.1002/jat.2984
   OECD, 2012, PROP TEMPL GUID DEV
   Qius LL, 2013, TOXICOL LETT, V219, P116
   Rothkamm K, 2009, ANN I SUPER SANITA, V45, P265
   Setzer RW, 2003, PURE APPL CHEM, V75, P2151, DOI 10.1351/pac200375112151
   Sonich-Mullin C, 2001, REGUL TOXICOL PHARM, V34, P146, DOI 10.1006/rtph.2001.1493
   U.S. EPA, 2009, APPR US TOX DAT US E
   US EPA, 2012, EPA100R12001
   [US FDA] US Food and Drug Administration, 2008, REV SUBM QUAL 7 BIOM
   Wus X, 2012, TOXICOL SCI, V128, P524
   Yang LL, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-387
   Zhus Y, 2005, REGUL TOXICOL PHARM, V42, P190
NR 24
TC 5
Z9 5
U1 1
U2 27
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0260-437X
EI 1099-1263
J9 J APPL TOXICOL
JI J. Appl. Toxicol.
PD NOV
PY 2014
VL 34
IS 11
BP 1115
EP 1121
DI 10.1002/jat.3071
PG 7
WC Toxicology
SC Toxicology
GA AQ4GF
UT WOS:000342750800001
PM 25244189
DA 2019-10-23
ER

PT J
AU Caldwell, DJ
   Mastrocco, F
   Margiotta-Casaluci, L
   Brooks, BW
AF Caldwell, Daniel J.
   Mastrocco, Frank
   Margiotta-Casaluci, Luigi
   Brooks, Bryan W.
TI An integrated approach for prioritizing pharmaceuticals found in the
   environment for risk assessmerit, monitoring and advanced research
SO CHEMOSPHERE
LA English
DT Article
DE Environmental risk assessment; Pharmaceuticals in the environment;
   Prioritization; Adverse outcome pathways; Intelligent testing
ID ADVERSE OUTCOME PATHWAYS; PERSONAL CARE PRODUCTS; AQUATIC ENVIRONMENT;
   WASTE-WATER; CONCEPTUAL-FRAMEWORK; EMERGING CONCERN; FATHEAD MINNOWS;
   FISH; ECOTOXICOLOGY; CONTAMINANTS
AB Numerous active pharmaceutical ingredients (APIs), approved prior to enactment of detailed environmental risk assessment (ERA) guidance in the EU in 2006, have been detected in surface waters as a result of advancements in analytical technologies. Without adequate knowledge of the potential hazards these APIs may pose, assessing their environmental risk is challenging. As it would be impractical to commence hazard characterization and ERA en masse, several approaches to prioritizing substances for further attention have been published. Here, through the combination of three presentations given at a recent conference, "Pharmaceuticals in the Environment, Is there a problem?" (Nimes, France, June 2013) we review several of these approaches, identify salient components, and present available techniques and tools that could facilitate a pragmatic, scientifically sound approach to prioritizing APIs for advanced study or ERA and, where warranted, fill critical data gaps through targeted, intelligent testing. We further present a modest proposal to facilitate future prioritization efforts and advanced research studies that incorporates mammalian pharmacology data (e.g., adverse outcomes pathways and the fish plasma model) and modeled exposure data based on pharmaceutical use. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Caldwell, Daniel J.] Johnson & Johnson, New Brunswick, NJ 08901 USA.
   [Mastrocco, Frank] Pfizer Inc, New York, NY USA.
   [Margiotta-Casaluci, Luigi] Brunel Univ, Inst Environm, Uxbridge UB8 3PH, Middx, England.
   [Brooks, Bryan W.] Baylor Univ, Ctr Reservoir & Aquat Syst Res, Dept Environm Sci, Waco, TX 76798 USA.
RP Caldwell, DJ (reprint author), Johnson & Johnson, 410 George St, New Brunswick, NJ 08901 USA.
EM dcaldwel@its.jnj.com
RI Guenat, Heather/H-6528-2014; Brooks, Bryan W/B-2612-2010;
   Margiotta-Casaluci, Luigi/A-5402-2011; Caldwell, Daniel/V-4956-2019
OI Brooks, Bryan W/0000-0002-6277-9852; Margiotta-Casaluci,
   Luigi/0000-0001-6938-0396; Caldwell, Daniel/0000-0002-6878-349X
FU BBSRC Industrial Partnership Award [BB/I00646X/1]; AstraZeneca Safety
   Health and Environment Research Programme; Biotechnology and Biological
   Sciences Research CouncilBiotechnology and Biological Sciences Research
   Council (BBSRC) [BB/I00646X/1]
FX The Post-Doctoral research of L.M-C was supported by the BBSRC
   Industrial Partnership Award BB/I00646X/1 with AstraZeneca Safety Health
   and Environment Research Programme.
CR Anderson PD, 2004, ENVIRON SCI TECHNOL, V38, P838, DOI 10.1021/es034430b
   Ankley GT, 2007, ENVIRON SCI TECHNOL, V41, P8211, DOI 10.1021/es072658j
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Berninger J.P., 2011, THESIS BAYLOR U WACO
   Berninger JP, 2010, TOXICOL LETT, V193, P69, DOI 10.1016/j.toxlet.2009.12.006
   Boxall ABA, 2012, ENVIRON HEALTH PERSP, V120, P1221, DOI 10.1289/ehp.1104477
   Brain RA, 2008, ENVIRON SCI TECHNOL, V42, P8965, DOI 10.1021/es801611a
   Brausch JM, 2012, REV ENVIRON CONTAM T, V218, P1, DOI 10.1007/978-1-4614-3137-4_1
   Brooks BW, 2009, ACS SYM SER, V1018, P205
   Brooks BW, 2009, ENVIRON TOXICOL CHEM, V28, P2469, DOI 10.1897/09-325.1
   Brooks BW, 2003, TOXICOL LETT, V142, P169, DOI 10.1016/S0378-4274(03)00066-3
   Brooks BW, 2012, EMERGING TOPICS ECOT, P4
   Caldwell DJ, 2008, ENVIRON SCI TECHNOL, V42, P7046, DOI 10.1021/es800633q
   Christen V, 2010, AQUAT TOXICOL, V96, P167, DOI 10.1016/j.aquatox.2009.11.021
   Clubbs RL, 2007, ECOTOX ENVIRON SAFE, V67, P385, DOI 10.1016/j.ecoenv.2007.01.009
   Connors KA, 2013, ENVIRON TOXICOL CHEM, V32, P1810, DOI 10.1002/etc.2240
   de Voogt P, 2009, WATER SCI TECHNOL, V59, P39, DOI 10.2166/wst.2009.764
   De Wolf W, 2005, ENVIRON TOXICOL CHEM, V24, P479, DOI 10.1897/04-133R.1
   Delaware River Basin Commission, 2013, CONT EM TID DEL RIV
   Diamond JM, 2011, ENVIRON TOXICOL CHEM, V30, P2385, DOI 10.1002/etc.667
   Dong Z, 2013, REGUL TOXICOL PHARM, V65, P60, DOI 10.1016/j.yrtph.2012.07.003
   Du BW, 2014, SCI TOTAL ENVIRON, V466, P976, DOI 10.1016/j.scitotenv.2013.07.126
   *ECETOC, 2007, 102 ECETOC
   Europe Medicines Agency (EMA), 2006, PREAUTH EV MED HUM U
   Fent K, 2006, AQUAT TOXICOL, V76, P122, DOI 10.1016/j.aquatox.2005.09.009
   Fick J, 2010, ENVIRON SCI TECHNOL, V44, P2661, DOI 10.1021/es903440m
   Guidance for Industry, 1998, GUID IND ENV ASS HUM
   Gunnarsson L, 2008, ENVIRON SCI TECHNOL, V42, P5807, DOI 10.1021/es8005173
   Harris CA, 2011, ENVIRON HEALTH PERSP, V119, P306, DOI 10.1289/ehp.1002555
   Heberer T, 2002, TOXICOL LETT, V131, P5, DOI 10.1016/S0378-4274(02)00041-3
   Huggett DB, 2003, HUM ECOL RISK ASSESS, V9, P1789, DOI 10.1080/10807030390260498
   Johnson AC, 2013, ENVIRON SCI TECHNOL, V47, P12297, DOI 10.1021/es4030035
   KNAPPE (Knowledge and Need Assessment of Pharmaceutical Products in Environmental Waters), 2008, KNOWL NEED ASS PHARM
   Kostich MS, 2008, SCI TOTAL ENVIRON, V389, P329, DOI 10.1016/j.scitotenv.2007.09.008
   Kugathas S, 2013, ENVIRON SCI TECHNOL, V47, P9487, DOI 10.1021/es4019332
   Larsson DGJ, 2007, J HAZARD MATER, V148, P751, DOI 10.1016/j.jhazmat.2007.07.008
   Li D, 2008, ENVIRON TOXICOL CHEM, V27, P80, DOI 10.1897/07-080.1
   Lounkine E, 2012, NATURE, V486, P361, DOI 10.1038/nature11159
   Margiotta-Casaluci L, 2013, AQUAT TOXICOL, V128, P113, DOI 10.1016/j.aquatox.2012.12.003
   Moen M. A., 2007, SETAC N AM 29 ANN M
   OECD, 2011, OECD ENV HLTH SAF PU, V138, P8
   OECD, 2012, PROP TEMPL GUID DEV
   OECD, 2011, ADV OUTC PA IN PRESS
   Oldenkamp R, 2013, ENVIRON INT, V51, P13, DOI 10.1016/j.envint.2012.09.010
   Owen SF, 2009, AQUAT TOXICOL, V93, P217, DOI 10.1016/j.aquatox.2009.05.009
   Phillips PJ, 2010, ENVIRON SCI TECHNOL, V44, P4910, DOI 10.1021/es100356f
   Raimondo S, 2009, ENVIRON TOXICOL CHEM, V28, P2409, DOI 10.1897/08-540.1
   Rand-Weaver M, 2013, ENVIRON SCI TECHNOL, V47, P11384, DOI 10.1021/es402065a
   Rang HP, 2003, PHARMACOLOGY, P797
   Roos V, 2012, SCI TOTAL ENVIRON, V421, P102, DOI 10.1016/j.scitotenv.2012.01.039
   Runnalls TJ, 2013, ENVIRON SCI TECHNOL, V47, P2077, DOI 10.1021/es3048834
   Seiler JP, 2002, TOXICOL LETT, V131, P105, DOI 10.1016/S0378-4274(02)00045-0
   Small J., ENV TOXICOL CHEM
   Sumpter JP, 2013, ENVIRON TOXICOL CHEM, V32, P249, DOI 10.1002/etc.2084
   Valenti Theodore W., 2011, Integrated Environmental Assessment and Management, V7, P636, DOI 10.1002/ieam.202
   Valenti TW, 2012, ENVIRON SCI TECHNOL, V46, P2427, DOI 10.1021/es204164b
   VERHAAR HJM, 1992, CHEMOSPHERE, V25, P471, DOI 10.1016/0045-6535(92)90280-5
   Volz DC, 2011, TOXICOL SCI, V123, P349, DOI 10.1093/toxsci/kfr185
   Walker FR, 2013, NEUROPHARMACOLOGY, V67, P304, DOI 10.1016/j.neuropharm.2012.10.002
   Winter Matthew J., 2010, Integrated Environmental Assessment and Management, V6, P38, DOI 10.1897/IEAM_2009-044.1
   Zeilinger J, 2009, ENVIRON TOXICOL CHEM, V28, P2663, DOI 10.1897/08-485.1
NR 61
TC 42
Z9 43
U1 1
U2 74
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0045-6535
EI 1879-1298
J9 CHEMOSPHERE
JI Chemosphere
PD NOV
PY 2014
VL 115
SI SI
BP 4
EP 12
DI 10.1016/j.chemosphere.2014.01.021
PG 9
WC Environmental Sciences
SC Environmental Sciences & Ecology
GA AR1YU
UT WOS:000343381300002
PM 24636702
DA 2019-10-23
ER

PT J
AU FitzGerald, RE
   Wilks, MF
AF FitzGerald, R. E.
   Wilks, M. F.
TI Bisphenol A-Why an adverse outcome pathway framework needs to be applied
SO TOXICOLOGY LETTERS
LA English
DT Article
DE Bisphenol A; Human health risk assessment; Membrane-bound estrogen
   receptor; Adverse outcome pathway
ID ESTROGEN-RECEPTOR GPER; SPRAGUE-DAWLEY RATS; WIDESPREAD EXPOSURE;
   BREAST-CANCER; HUMAN HEALTH; IN-UTERO; ESTRADIOL; DIETHYLSTILBESTROL;
   ADENOCARCINOMA; TOXICITY
AB Bisphenol A (BPA) is one of the most widely used and extensively studied chemicals. Numerous studies have reported in vitro effects or animal adverse findings at BPA doses lower than the no observed adverse effect levels (NOAELs) established in regulatory toxicity studies and used for human health risk assessment. Intensive discussions on the adequacy and relevance of test systems have not satisfactorily resolved whether positive or negative animal and/or in vitro findings are more relevant for human health risk assessment purposes.
   BPA imperfectly mimics endogenous estrogens at membrane-bound estrogen receptors in the fM-nM concentration range, and may have downstream pleiotropic effects such as human seminoma proliferation and mammary gland hyperplasia after in utero exposure which are not detectable in regulatory toxicology studies. We argue that a structured approach like the OECD Adverse Outcome Pathway (AOP) framework is needed to help researchers in designing relevant studies, and risk assessors in evaluating them.
   The huge amount of experimental data generated for BPA has highlighted data gaps in basic biology and the shortcomings of current approaches to hazard characterization and risk assessment. Establishing AOPs for BPA, and other endocrine active chemicals, will require major scientific as well as training investments by all responsible stakeholders. (C) 2014 Elsevier Ireland Ltd. All rights reserved.
C1 [FitzGerald, R. E.; Wilks, M. F.] Univ Basel, Ctr Appl Human Toxicol SCAHT, CH-4056 Basel, Switzerland.
RP FitzGerald, RE (reprint author), Univ Basel, Ctr Appl Human Toxicol SCAHT, Klingelbergstr 61, CH-4056 Basel, Switzerland.
EM rex.fitzgerald@unibas.ch
RI Wilks, Martin F/N-2150-2014
OI Wilks, Martin F/0000-0003-3984-5935
FU Swiss Confederation; Universities of Basel, Geneva; Lausanne
FX The authors would like to thank Helen Hakansson and Lothar Aicher for
   critical and helpful comments on the manuscript. The Swiss Centre for
   Applied Human Toxicology is funded by the Swiss Confederation and the
   Universities of Basel, Geneva and Lausanne.
CR Acevedo N, 2013, ENVIRON HEALTH PERSP, V121, P1040, DOI 10.1289/ehp.1306734
   [Anonymous], 2013, SER TEST ASS
   ANSES (Agence Nationale de Securite sanitaire de l'alimentation de l'environement et du travail), 2011, EFF SAN BISPH RAPP E
   Banerjee S, 2014, STEROIDS, V81, P64, DOI 10.1016/j.steroids.2013.11.002
   Barton M, 2012, STEROIDS, V77, P935, DOI 10.1016/j.steroids.2012.04.001
   Beronius A, 2010, REPROD TOXICOL, V29, P132, DOI 10.1016/j.reprotox.2009.11.007
   Bondar G, 2009, J NEUROSCI, V29, P15323, DOI 10.1523/JNEUROSCI.2107-09.2009
   Boobis AR, 2009, CRIT REV FOOD SCI, V49, P690, DOI 10.1080/10408390903098673
   Bouskine A, 2009, ENVIRON HEALTH PERSP, V117, P1053, DOI 10.1289/ehp.0800367
   Chapin RE, 2008, BIRTH DEFECTS RES B, V83, P157, DOI 10.1002/bdrb.20147
   Chaudhri RA, 2014, STEROIDS, V81, P74, DOI 10.1016/j.steroids.2013.10.020
   Chaudhri RA, 2012, J BIOL CHEM, V287, P7169, DOI 10.1074/jbc.M111.292946
   Chevalier N, 2012, INT J CANCER, V130, P241, DOI 10.1002/ijc.25972
   Churchwell MI, 2014, TOXICOL SCI, V139, P4, DOI 10.1093/toxsci/kfu021
   Damstra T., 2002, WHOPCSEDC022
   Delclos KB, 2014, TOXICOL SCI, V139, P174, DOI 10.1093/toxsci/kfu022
   Dellarco V, 2012, J NUTR, V142, p2192S, DOI 10.3945/jn.111.157396
   EU, 2008, EU BISPH RISK ASS RE
   European Food Safety Authority, 2006, EFSA J, V428, P1, DOI DOI 10.2903/J.EFSA.2007A28
   European Food Safety Authority (EFSA), 2014, DRAFT SCI OP RISKS P
   Franco R, 2011, CANCER BIOL THER, V11, P609, DOI 10.4161/cbt.11.6.14672
   Geens T, 2012, FOOD CHEM TOXICOL, V50, P3725, DOI 10.1016/j.fct.2012.07.059
   Geens T, 2011, INT J HYG ENVIR HEAL, V214, P339, DOI 10.1016/j.ijheh.2011.04.005
   Hengstler JG, 2011, CRIT REV TOXICOL, V41, P263, DOI 10.3109/10408444.2011.558487
   HERBST AL, 1971, NEW ENGL J MED, V284, P878, DOI 10.1056/NEJM197104222841604
   HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503
   Hoover RN, 2011, NEW ENGL J MED, V365, P1304, DOI 10.1056/NEJMoa1013961
   Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124
   IPCS, 2004, IPCS RISK ASS TERM 1
   Jeng YJ, 2011, ENVIRON HEALTH PERSP, V119, P104, DOI 10.1289/ehp.1002512
   Kochukov MY, 2009, ENVIRON HEALTH PERSP, V117, P723, DOI 10.1289/ehp.0800182
   Kuzutani K, 2012, J TOXICOL PATHOL, V25, P221, DOI 10.1293/tox.25.221
   Langer G, 2010, STEROIDS, V75, P603, DOI 10.1016/j.steroids.2009.12.006
   Meek ME, 2014, J APPL TOXICOL, V34, P1, DOI 10.1002/jat.2949
   Micevych P, 2012, FRONT NEUROENDOCRIN, V33, P331, DOI 10.1016/j.yfrne.2012.07.003
   Micevych P, 2010, NEUROENDOCRINOLOGY, V91, P211, DOI 10.1159/000289568
   Mitchell RT, 2012, J CLIN ENDOCR METAB, V97, pE341, DOI 10.1210/jc.2011-2411
   Molina-Molina JM, 2013, TOXICOL APPL PHARM, V272, P127, DOI 10.1016/j.taap.2013.05.015
   NEWBOLD RR, 1982, CANCER RES, V42, P2003
   Prossnitz ER, 2011, NAT REV ENDOCRINOL, V7, P715, DOI 10.1038/nrendo.2011.122
   Rago V, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-135
   Rochester JR, 2013, REPROD TOXICOL, V42, P132, DOI 10.1016/j.reprotox.2013.08.008
   Rubin BS, 2011, J STEROID BIOCHEM, V127, P27, DOI 10.1016/j.jsbmb.2011.05.002
   Sinchak K, 2012, FRONT NEUROENDOCRIN, V33, P342, DOI 10.1016/j.yfrne.2012.08.004
   Skakkebaek NE, 1998, APMIS, V106, P3, DOI 10.1111/j.1699-0463.1998.tb01314.x
   Soto AM, 2013, J MAMMARY GLAND BIOL, V18, P199, DOI 10.1007/s10911-013-9293-5
   Teeguarden J, 2013, FOOD CHEM TOXICOL, V62, P949, DOI 10.1016/j.fct.2013.08.001
   Troisi R, 2007, INT J CANCER, V121, P356, DOI 10.1002/ijc.22631
   Tyl RW, 2008, TOXICOL SCI, V104, P362, DOI 10.1093/toxsci/kfn084
   Vandenberg L. N., 2013, ENDOCR DISRUPTORS, V1, P1, DOI DOI 10.4161/ENDO.26490
   Vandenberg Laura N., 2013, Reviews on Environmental Health, V28, P37, DOI 10.1515/reveh-2012-0034
   Vandenberg LN, 2012, ENDOCR REV, V33, P378, DOI 10.1210/er.2011-1050
   Vandenberg LN, 2010, ENVIRON HEALTH PERSP, V118, P1055, DOI 10.1289/ehp.0901716
   Vinken M, 2013, TOXICOLOGY, V312, P158, DOI 10.1016/j.tox.2013.08.011
   Vokel W, 2002, CHEM RES TOXICOL, V15, P1281, DOI 10.1021/tx025548t
   Wang DF, 2010, ENDOCRINE, V38, P29, DOI 10.1007/s12020-010-9363-z
   Watson C. S., 2013, STEROIDS
   Watson CS, 2011, J STEROID BIOCHEM, V127, P44, DOI 10.1016/j.jsbmb.2011.01.015
   Willhite CC, 2008, J TOXICOL ENV HEAL B, V11, P69, DOI 10.1080/10937400701724303
   Zsarnovszky A, 2005, ENDOCRINOLOGY, V146, P5388, DOI 10.1210/en.2005-0565
NR 60
TC 17
Z9 17
U1 0
U2 32
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0378-4274
EI 1879-3169
J9 TOXICOL LETT
JI Toxicol. Lett.
PD OCT 15
PY 2014
VL 230
IS 2
BP 368
EP 374
DI 10.1016/j.toxlet.2014.05.002
PG 7
WC Toxicology
SC Toxicology
GA AP2CV
UT WOS:000341881000029
PM 24831966
DA 2019-10-23
ER

PT J
AU Russom, CL
   LaLone, CA
   Villeneuve, DL
   Ankley, GT
AF Russom, Christine L.
   LaLone, Carlie A.
   Villeneuve, Daniel L.
   Ankley, Gerald T.
TI DEVELOPMENT OF AN ADVERSE OUTCOME PATHWAY FOR ACETYLCHOLINESTERASE
   INHIBITION LEADING TO ACUTE MORTALITY
SO ENVIRONMENTAL TOXICOLOGY AND CHEMISTRY
LA English
DT Review
DE Acetylcholinesterase inhibition; Adverse outcome pathway; Ecotoxicology;
   Species sensitivity
ID RECOVERY FOLLOWING ACUTE; ACUTE TOXICITY; ANTICHOLINESTERASE ACTIVITY;
   CHOLINESTERASE INHIBITION; CHLORPYRIFOS EXPOSURE; IPCS FRAMEWORK;
   FATHEAD MINNOW; DAPHNIA-MAGNA; RAT STRIATUM; ORGANOPHOSPHORUS
AB Adverse outcome pathways (AOPs) are designed to describe linkages of key events within a biological pathway that result in an adverse outcome associated with chemical perturbation of a well-defined molecular initiating event. Risk assessors have traditionally relied on data from apical endpoints (e.g., mortality, growth, reproduction) to derive benchmark values for use in determining the potential adverse impacts of chemicals. One goal in building reliable and well-characterized AOPs is to identify relevant in vitro assays and/or in vivo biomarkers that could be used in screening the potential hazard of substances, thereby reducing costs and increasing the number of chemicals that can be evaluated in a timely fashion. The purpose of this review article is to build an AOP for substances with a molecular initiating event of acetylcholinesterase inhibition leading to acute mortality following guidance developed by the Organisation for Economic Cooperation and Development. In contrast to most other AOPs developed to date, in which coverage is for a relatively limited taxonomic group or life stage, this AOP is applicable to a wide range of species at multiple life stages. Furthermore, while development of most AOPs has relied on data for a few model chemicals, the AOP described in the present review captures information from a large number of studies with a diversity of organophosphate and carbamate insecticides. Environ Toxicol Chem 2014;33:2157-2169. Published 2014 Wiley Periodicals Inc. on behalf of SETAC. This article is a US government work and, as such, is in the public domain in the United States of America.
C1 [Russom, Christine L.; Villeneuve, Daniel L.; Ankley, Gerald T.] US EPA, Natl Hlth & Environm Effects Res Lab, Off Res & Dev, Midcontinent Ecol Div, Duluth, MN 55804 USA.
   [LaLone, Carlie A.] Univ Minnesota, Water Resources Ctr, Coll Food Agr & Nat Resource Sci, St Paul, MN 55108 USA.
RP Ankley, GT (reprint author), US EPA, Natl Hlth & Environm Effects Res Lab, Off Res & Dev, Midcontinent Ecol Div, Duluth, MN 55804 USA.
EM ankley.gerald@epa.gov
CR Al-Zubaidy MHI, 2011, ARH HIG RADA TOKSIKO, V62, P317, DOI 10.2478/10004-1254-62-2011-2139
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   ANKLEY GT, 1995, COMP BIOCHEM PHYS C, V110, P149, DOI 10.1016/0742-8413(94)00098-U
   AUGUSTINSSON K B, 1957, Methods Biochem Anal, V5, P1
   Barata C, 2004, AQUAT TOXICOL, V66, P125, DOI 10.1016/j.aquatox.2003.07.004
   Bencic DC, 2013, ENVIRON TOXICOL CHEM, V32, P1828, DOI 10.1002/etc.2254
   BERMAN HA, 1987, DEV BIOL, V120, P154, DOI 10.1016/0012-1606(87)90113-8
   Bianco K, 2013, AQUAT TOXICOL, V144, P26, DOI 10.1016/j.aquatox.2013.09.025
   Boobis AR, 2008, CRIT REV TOXICOL, V38, P87, DOI 10.1080/10408440701749421
   Boobis AR, 2006, CRIT REV TOXICOL, V36, P781, DOI 10.1080/10408440600977677
   CALL DJ, 1989, PESTICIDES IN TERRESTRIAL AND AQUATIC ENVIRONMENTS, P317
   Campos B, 2013, ENVIRON SCI TECHNOL, V47, P9434, DOI 10.1021/es4012299
   Celander MC, 2011, ENVIRON TOXICOL CHEM, V30, P52, DOI 10.1002/etc.382
   Cowman DF, 2000, ECOTOXICOLOGY OF AMPHIBIANS AND REPTILES, P233
   Dasgupta R, 2012, J ENVIRON SCI HEAL B, V47, P99, DOI 10.1080/03601234.2012.616771
   DEBRUIJN J, 1993, AQUAT TOXICOL, V24, P257, DOI 10.1016/0166-445X(93)90075-C
   Duangsawasdi M, 1977, THESIS U MANITOBA MA
   Duangsawasdi M, 1979, AQUAT TOXICOL, V2, P35
   ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9
   Ferrari A, 2004, ECOTOX ENVIRON SAFE, V57, P420, DOI 10.1016/S0147-6513(02)00069-6
   FLEISCHER M, 2007, J BUSINESS CHEM, V4, P96
   FUKUTO TR, 1990, ENVIRON HEALTH PERSP, V87, P245
   Fulton MH, 2001, ENVIRON TOXICOL CHEM, V20, P37, DOI [10.1897/1551-5028(2001)020<0037:AIIEFA>2.0.CO;2, 10.1002/etc.5620200104]
   Futagawa H, 1997, TOXICOLOGY, V117, P163, DOI 10.1016/S0300-483X(96)03568-8
   Grue C.E., 1991, Chemicals in Agriculture, V2, P151
   Grue CE, 1997, AM ZOOL, V37, P369
   GRUE CE, 1984, ENVIRON RES, V35, P454, DOI 10.1016/0013-9351(84)90152-X
   GRUE CE, 1981, B ENVIRON CONTAM TOX, V26, P544, DOI 10.1007/BF01622134
   HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503
   HILL EF, 1988, J WILDLIFE DIS, V24, P51, DOI 10.7589/0090-3558-24.1.51
   HOFFMAN DJ, 1981, ENVIRON RES, V26, P472, DOI 10.1016/0013-9351(81)90222-X
   Hooper MJ, 2013, ENVIRON TOXICOL CHEM, V32, P32, DOI 10.1002/etc.2043
   Hudson R. H., 1984, RESOURCE PUBLICATION, V153
   HUNT KA, 1991, ARCH ENVIRON CON TOX, V21, P84, DOI 10.1007/BF01055561
   JARVINEN AW, 1983, ECOTOX ENVIRON SAFE, V7, P423, DOI 10.1016/0147-6513(83)90008-8
   JOHNSON CD, 1975, ANAL BIOCHEM, V64, P229, DOI 10.1016/0003-2697(75)90423-6
   Karanth S, 2003, NEUROTOXICOL TERATOL, V25, P599, DOI 10.1016/S0892-0362(03)00049-7
   Karanth S, 2006, TOXICOL APPL PHARM, V216, P150, DOI 10.1016/j.taap.2006.04.006
   Karen DJ, 2001, AQUAT TOXICOL, V52, P285, DOI 10.1016/S0166-445X(00)00164-8
   KOBAYASHI H, 1988, JPN J PHARMACOL, V47, P21, DOI 10.1254/jjp.47.21
   KOBAYASHI H, 1985, TOXICOL LETT, V29, P153
   KOBAYASHI H, 1994, J APPL TOXICOL, V14, P185, DOI 10.1002/jat.2550140307
   KOBAYASHI H, 1983, TOXICOLOGY, V28, P219, DOI 10.1016/0300-483X(83)90119-1
   Kramer VJ, 2011, ENVIRON TOXICOL CHEM, V30, P64, DOI 10.1002/etc.375
   LaLone CA, 2013, AQUAT TOXICOL, V144, P141, DOI 10.1016/j.aquatox.2013.09.004
   LaLone CA, 2013, ENVIRON TOXICOL CHEM, V32, P2528, DOI 10.1002/etc.2330
   Lu YH, 2012, SCI REP-UK, V2, DOI 10.1038/srep00288
   Ludke J L, 1975, Arch Environ Contam Toxicol, V3, P1
   Lushington GH, 2006, CURR TOP MED CHEM, V6, P57, DOI 10.2174/156802606775193293
   MCKIM JM, 1987, ENVIRON TOXICOL CHEM, V6, P313, DOI 10.1002/etc.5620060408
   Meek ME, 2014, J APPL TOXICOL, V34, P1, DOI 10.1002/jat.2949
   Mileson BE, 1998, TOXICOL SCI, V41, P8
   Monserrat JM, 2001, BRAZ ARCH BIOL TECHN, V44, P63, DOI 10.1590/S1516-89132001000100009
   National Research Council, 2007, TOX TEST 21 CENT VIS
   NAYEEMUNNISA, 1986, CURR SCI INDIA, V55, P546
   Nichols JW, 2011, ENVIRON TOXICOL CHEM, V30, P39, DOI 10.1002/etc.376
   *ORG EC CO OP DEV, 2012, PROP TEMPL GUID DEV
   OYAMA Y, 1989, BRIT J PHARMACOL, V96, P573, DOI 10.1111/j.1476-5381.1989.tb11855.x
   Parkash R, 1982, P INDIAN NAT SCI A B, VB48, P659
   Perkins EJ, 2013, ENVIRON HEALTH PERSP, V121, P1002, DOI 10.1289/ehp.1306638
   Perkins EJ, 2011, ENVIRON TOXICOL CHEM, V30, P22, DOI 10.1002/etc.374
   Phillips TA, 2002, ENVIRON TOXICOL CHEM, V21, P1469, DOI [10.1897/1551-5028(2002)021<1469:ATACII>2.0.CO;2, 10.1002/etc.5620210719]
   Rajini PS, 2008, J TOXICOL ENV HEAL A, V71, P1043, DOI 10.1080/15287390801989002
   Rao J. Venkateswara, 2008, Environmental Bioindicators, V3, P11, DOI 10.1080/15555270701779478
   RAO KSP, 1984, TOXICOL LETT, V22, P351, DOI 10.1016/0378-4274(84)90113-9
   Rattner Barnett A., 1991, Chemicals in Agriculture, V2, P89
   REDDY MS, 1990, BIOCHEM INT, V22, P769
   Reddy NC, 2008, ECOTOX ENVIRON SAFE, V71, P574, DOI 10.1016/j.ecoenv.2008.01.003
   ROBERTS DK, 1988, B ENVIRON CONTAM TOX, V41, P26, DOI 10.1007/BF01689055
   ROSE RL, 1984, PESTIC BIOCHEM PHYS, V22, P69, DOI 10.1016/0048-3575(84)90011-7
   Russom CL, 1997, P AIR WAST MAN ASS C, P387
   Schuurmann G, 1992, RATIONAL APPROACHES, P485
   Sipes NS, 2013, CHEM RES TOXICOL, V26, P878, DOI [10.1021/tx400021f, 10.1021/tx400021]
   Sogorb MA, 2002, TOXICOL LETT, V128, P215, DOI 10.1016/S0378-4274(01)00543-4
   Soreq H, 2001, NAT REV NEUROSCI, V2, P294, DOI 10.1038/35067589
   Stavinoha W B, 1969, Ann N Y Acad Sci, V160, P378, DOI 10.1111/j.1749-6632.1969.tb15859.x
   Stenersen J, 2004, CHEM PESTICIDES MODE, P73
   TAKIMOTO Y, 1984, J PESTIC SCI, V9, P463
   Taylor P., 2011, GOODMAN GILMANS PHAR, P255
   TRETYN A, 1991, BOT REV, V57, P33, DOI 10.1007/BF02858764
   TSIM KWK, 1988, EMBO J, V7, P2451, DOI 10.1002/j.1460-2075.1988.tb03091.x
   US EPA, 2006, ORG CUM RISK ASS 200
   Venturino A, 2001, PESTIC BIOCHEM PHYS, V70, P142, DOI 10.1006/pest.2001.2550
   Villeneuve D, 2014, ENVIRON TOXICOL CHEM, V33, P158, DOI 10.1002/etc.2403
   Vinken M, 2013, TOXICOLOGY, V312, P158, DOI 10.1016/j.tox.2013.08.011
   WALLACE KB, 1991, CHEM RES TOXICOL, V4, P41, DOI 10.1021/tx00019a006
   WALLACE KB, 1992, ORGANOPHOSPHATES CHE, P79
   Watanabe KH, 2011, ENVIRON TOXICOL CHEM, V30, P9, DOI 10.1002/etc.373
   Wilson BW, 2010, HAYES' HANDBOOK OF PESTICIDE TOXICOLOGY, VOLS 1 AND 2, 3RD EDITION, P1457, DOI 10.1016/B978-0-12-374367-1.00068-9
   Wilson BW, 1996, J TOXICOL ENV HEALTH, V48, P187, DOI 10.1080/009841096161429
   Zapata Agustin, 2009, Curr Protoc Neurosci, VChapter 7, DOI 10.1002/0471142301.ns0704s48
NR 91
TC 42
Z9 42
U1 2
U2 69
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0730-7268
EI 1552-8618
J9 ENVIRON TOXICOL CHEM
JI Environ. Toxicol. Chem.
PD OCT
PY 2014
VL 33
IS 10
BP 2157
EP 2169
DI 10.1002/etc.2662
PG 13
WC Environmental Sciences; Toxicology
SC Environmental Sciences & Ecology; Toxicology
GA AQ2LZ
UT WOS:000342619100001
PM 24922588
DA 2019-10-23
ER

PT J
AU Poynton, HC
   Robinson, WE
   Blalock, BJ
   Hannigan, RE
AF Poynton, Helen C.
   Robinson, William E.
   Blalock, Bonnie J.
   Hannigan, Robyn E.
TI Correlation of transcriptomic responses and metal bioaccumulation in
   Mytilus edulis L. reveals early indicators of stress
SO AQUATIC TOXICOLOGY
LA English
DT Article
DE Toxicogenomics; Tissue residue approach; Mytilus edulis; Lead; Cadmium;
   Quantitative RT-PCR
ID ENDOPLASMIC-RETICULUM STRESS; ADVERSE OUTCOME PATHWAYS;
   OXIDATIVE-STRESS; METALLOTHIONEIN ISOFORMS; TISSUE-RESIDUE; PCR
   ANALYSIS; HEAT-STRESS; CADMIUM; MUSSELS; EXPRESSION
AB Marine biomonitoring programs in the U.S. and Europe have historically relied on monitoring tissue concentrations of bivalves to monitor contaminant levels and ecosystem health. By integrating 'omic methods with these tissue residue approaches we can uncover mechanistic insight to link tissue concentrations to potential toxic effects. In an effort to identify novel biomarkers and better understand the molecular toxicology of metal bioaccumulation in bivalves, we exposed the blue mussel, Mytilus edulis L, to sub-lethal concentrations (0.54 mu M) of cadmium, lead, and a Cd + Pb mixture. Metal concentrations were measured in gill tissues at 1, 2, and 4 weeks, and increased linearly over the 4 week duration. In addition, there was evidence that Pb interfered with Cd uptake in the mixture treatment. Using a 3025 sequence microarray for M. edulis, we performed transcriptomic analysis, identifying 57 differentially expressed sequences. Hierarchical clustering of these sequences successfully distinguished the different treatment groups demonstrating that the expression profiles were reproducible among the treatments. Enrichment analysis of gene ontology terms identified several biological processes that were perturbed by the treatments, including nucleoside phosphate biosynthetic processes, mRNA metabolic processes, and response to stress. To identify transcripts whose expression level correlated with metal bioaccumulation, we performed Pearson correlation analysis. Several transcripts correlated with gill metal concentrations including mt10, mt20, and contig 48, an unknown transcript containing a wsc domain. In addition, three transcripts directly involved in the unfolded protein response (UPR) were induced in the metal treatments at 2 weeks and were further up-regulated at 4 weeks. Overall, correlation of tissue concentrations and gene expression responses indicates that as mussels accumulate higher concentrations of metals, initial stress responses are mobilized to protect tissues. However, given the role of UPR in apoptosis, it serves as an early indicator of stress, which once overwhelmed will result in adverse physiological effects. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Poynton, Helen C.; Robinson, William E.; Blalock, Bonnie J.; Hannigan, Robyn E.] Univ Massachusetts, Sch Environm, Boston, MA 02125 USA.
RP Poynton, HC (reprint author), Univ Massachusetts, Sch Environm, 100 Morrissey Blvd, Boston, MA 02125 USA.
EM helen.poynton@umb.edu
RI Hannigan, Robyn/F-8628-2010
OI Hannigan, Robyn/0000-0003-4782-1124
FU University of Massachusetts Boston; MIT Sea Grant College Program, under
   NOAA [NA14OAR4170077]; MIT SG Project [2014-R/RCM-37]
FX Support for this study was provided by faculty start-up funds and a
   Healey Research Grant from the University of Massachusetts Boston to
   H.C.P. This publication is partially the result of research sponsored by
   The MIT Sea Grant College Program, under NOAA Grant number
   NA14OAR4170077, MIT SG Project Number 2014-R/RCM-37 to H.C.P and W.E.R.
CR Adams William J., 2011, Integrated Environmental Assessment and Management, V7, P75, DOI 10.1002/ieam.108
   Allison J.D., 1991, USEPA600391021
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Banni M, 2007, BIOMARKERS, V12, P369, DOI 10.1080/13547500701217061
   Barsyte D, 1999, COMP BIOCHEM PHYS C, V122, P287
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289
   Bevington P. R., 1992, DATA REDUCTION ERROR
   Blackmore G, 2003, ENVIRON TOXICOL CHEM, V22, P388, DOI 10.1002/etc.5620220221
   BOUTIER B, 1993, ESTUAR COAST SHELF S, V36, P133, DOI 10.1006/ecss.1993.1009
   Boyce M, 2006, CELL DEATH DIFFER, V13, P363, DOI 10.1038/sj.cdd.4401817
   BRULAND KW, 1979, ANAL CHIM ACTA, V105, P233, DOI 10.1016/S0003-2670(01)83754-5
   BUSH KT, 1994, BIOCHEM J, V303, P705, DOI 10.1042/bj3030705
   Canesi L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019803
   Cantillo AY, 1998, MAR POLLUT BULL, V36, P712, DOI 10.1016/S0025-326X(98)00049-6
   Cao SS, 2012, CURR BIOL, V22, pR622, DOI 10.1016/j.cub.2012.07.004
   CARPENE E, 1981, MOL PHYSIOL, V1, P23
   Chapman PM, 1997, MAR POLLUT BULL, V34, P282, DOI 10.1016/S0025-326X(97)00001-5
   Chora S, 2008, MAR ENVIRON RES, V66, P95, DOI 10.1016/j.marenvres.2008.02.034
   Chora S, 2009, AQUAT TOXICOL, V94, P300, DOI 10.1016/j.aquatox.2009.07.014
   Ciocan CM, 2004, ENVIRON SCI TECHNOL, V38, P1073, DOI 10.1021/es030110g
   Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610
   Decaprio AP, 1997, ENVIRON SCI TECHNOL, V31, P1837, DOI 10.1021/es960920a
   Domouhtsidou GP, 2000, ARCH ENVIRON CON TOX, V38, P472, DOI 10.1007/s002449910062
   Dondero F, 2005, GENE, V345, P259, DOI 10.1016/j.gene.2004.11.031
   Dondero F, 2006, AQUAT TOXICOL, V78, pS13, DOI 10.1016/j.aquatox.2006.02.025
   Dondero F, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-195
   Dondero F, 2010, SCI TOTAL ENVIRON, V408, P3775, DOI 10.1016/j.scitotenv.2010.03.040
   ELLIOTT NG, 1986, MAR BIOL, V93, P395, DOI 10.1007/BF00401107
   Fabbri E., 2008, ISJ, V5, P135
   Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243
   Franzellitti S, 2010, COMP BIOCHEM PHYS C, V152, P24, DOI 10.1016/j.cbpc.2010.02.010
   Galloway TS, 2006, MAR POLLUT BULL, V53, P186, DOI 10.1016/j.marpolbul.2005.09.036
   GOLDBERG ED, 1986, ENVIRON MONIT ASSESS, V7, P91, DOI 10.1007/BF00398031
   Gong P, 2012, ENVIRON SCI TECHNOL, V46, P19, DOI 10.1021/es201187u
   Gorman AM, 2012, PHARMACOL THERAPEUT, V134, P306, DOI 10.1016/j.pharmthera.2012.02.003
   Gutsell S, 2013, TOXICOL RES-UK, V2, P299, DOI 10.1039/c3tx50024a
   Hampton RY, 2012, CURR OPIN CELL BIOL, V24, P460, DOI 10.1016/j.ceb.2012.05.010
   Hirakawa S, 2011, AQUAT TOXICOL, V105, P89, DOI 10.1016/j.aquatox.2011.05.007
   Huning A, 2013, MAR BIOL, V160, P1845, DOI 10.1007/s00227-012-1930-9
   Hutchinson TH, 2013, MAR POLLUT BULL, V74, P517, DOI 10.1016/j.marpolbul.2013.06.012
   JACKIM E, 1977, MAR BIOL, V40, P303, DOI 10.1007/BF00395722
   Jiann KT, 2005, MAR CHEM, V96, P293, DOI 10.1016/j.marchem.2005.03.001
   Kimbrough KL, 2008, 74 NOAA NOS NCCOS
   Kitamura M, 2010, BIOMETALS, V23, P941, DOI 10.1007/s10534-010-9296-2
   Kramer VJ, 2011, ENVIRON TOXICOL CHEM, V30, P64, DOI 10.1002/etc.375
   Lemoine S, 2000, MAR BIOTECHNOL, V2, P195
   Liu FJ, 2012, ENVIRON TOXICOL CHEM, V31, P1292, DOI 10.1002/etc.1823
   Lockwood BL, 2011, MOL ECOL, V20, P517, DOI 10.1111/j.1365-294X.2010.04973.x
   Lockwood BL, 2010, J EXP BIOL, V213, P3548, DOI 10.1242/jeb.046094
   Lodder AL, 1999, GENETICS, V152, P1487
   Luoma SN, 2005, ENVIRON SCI TECHNOL, V39, P1921, DOI 10.1021/es048947e
   Manfrin C, 2010, ENVIRON SCI TECHNOL, V44, P8276, DOI 10.1021/es102213f
   MCCARTY LS, 1993, ENVIRON SCI TECHNOL, V27, P1719
   Meador JP, 2008, J ENVIRON MONITOR, V10, P1486, DOI 10.1039/b814041n
   Mohamed B, 2014, AQUAT TOXICOL, V148, P104, DOI 10.1016/j.aquatox.2014.01.004
   Nakayama K, 2006, ENVIRON SCI TECHNOL, V40, P1076, DOI 10.1021/es051386m
   Norwood WP, 2003, HUM ECOL RISK ASSESS, V9, P795, DOI 10.1080/713610010
   Philipp EER, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033091
   PHILLIPS DJH, 1976, MAR BIOL, V38, P59, DOI 10.1007/BF00391486
   Poynton HC, 2007, ENVIRON SCI TECHNOL, V41, P1044, DOI 10.1021/es0615573
   Poynton HC, 2009, J AM WATER RESOUR AS, V45, P83, DOI 10.1111/j.1752-1688.2008.00291.x
   Rainbow PS, 2002, ENVIRON POLLUT, V120, P497, DOI 10.1016/S0269-7491(02)00238-5
   RITZ DA, 1982, AUST J MAR FRESH RES, V33, P491, DOI 10.1071/MF9820491
   Rozen S, 2000, Methods Mol Biol, V132, P365
   Schettino T., 2012, Open Environmental Sciences, V6, P20, DOI 10.2174/1876325101206010020
   SELYE H, 1950, BRIT MED J, V1, P1383, DOI 10.1136/bmj.1.4667.1383
   Shaw JP, 2011, MAR ENVIRON RES, V72, P13, DOI 10.1016/j.marenvres.2011.05.003
   Sheir SK, 2013, ARCH ENVIRON CON TOX, V64, P701, DOI 10.1007/s00244-012-9868-y
   Snape JR, 2004, AQUAT TOXICOL, V67, P143, DOI 10.1016/j.aquatox.2003.11.011
   Soazig L, 2003, MAR POLLUT BULL, V46, P1450, DOI 10.1016/S0025-326X(03)00283-2
   STROMGREN T, 1982, MAR BIOL, V72, P69, DOI 10.1007/BF00393949
   Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1
   Veldhoen N, 2012, ECOTOX ENVIRON SAFE, V76, P23, DOI 10.1016/j.ecoenv.2011.10.005
   Venier P, 2006, MUTAT RES-FUND MOL M, V602, P121, DOI 10.1016/j.mrfmmm.2006.08.007
   Venier P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-69
   Vercauteren K, 1999, MAR BIOL, V135, P615, DOI 10.1007/s002270050662
   Viarengo A, 1999, AM J PHYSIOL-REG I, V277, pR1612
   Viarengo A, 2007, COMP BIOCHEM PHYS C, V146, P281, DOI 10.1016/j.cbpc.2007.04.011
   Viarengo A, 1999, BIOMARKERS, V4, P455, DOI 10.1080/135475099230615
   VIARENGO A, 1991, AQUACULTURE, V94, P225, DOI 10.1016/0044-8486(91)90120-V
   Vijver MG, 2011, ENVIRON TOXICOL CHEM, V30, P1482, DOI 10.1002/etc.499
   Vijver MG, 2004, ENVIRON SCI TECHNOL, V38, P4705, DOI 10.1021/es040354g
   Vlahogianni TH, 2007, CHEM ECOL, V23, P361, DOI 10.1080/02757540701653285
   Wu HF, 2010, AQUAT TOXICOL, V100, P339, DOI 10.1016/j.aquatox.2010.08.005
   Yap CK, 2004, ENVIRON INT, V29, P1097, DOI 10.1016/S0160-4120(03)00141-7
NR 85
TC 9
Z9 9
U1 2
U2 61
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-445X
EI 1879-1514
J9 AQUAT TOXICOL
JI Aquat. Toxicol.
PD OCT
PY 2014
VL 155
BP 129
EP 141
DI 10.1016/j.aquatox.2014.06.015
PG 13
WC Marine & Freshwater Biology; Toxicology
SC Marine & Freshwater Biology; Toxicology
GA AP7GH
UT WOS:000342245300015
PM 25016106
DA 2019-10-23
ER

PT J
AU Benigni, R
   de Knecht, J
AF Benigni, Romualdo
   de Knecht, Joop
TI The future of the QSAR Toolbox: Moving to less uncertainty in predictive
   toxicology
SO TOXICOLOGY LETTERS
LA English
DT Meeting Abstract
CT 50th Congress of the European-Societies-of-Toxicology
CY SEP 07-10, 2014
CL Edinburgh, SCOTLAND
SP European Soc Toxicol, British Toxicol Soc, Soc Toxicol
C1 [Benigni, Romualdo; de Knecht, Joop] OECD, Paris, France.
NR 0
TC 0
Z9 0
U1 1
U2 13
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0378-4274
EI 1879-3169
J9 TOXICOL LETT
JI Toxicol. Lett.
PD SEP 10
PY 2014
VL 229
SU S
MA PS3.1-O1
BP S7
EP S7
DI 10.1016/j.toxlet.2014.06.051
PG 1
WC Toxicology
SC Toxicology
GA AO2FY
UT WOS:000341134000019
DA 2019-10-23
ER

PT J
AU Berg, E
   Polokoff, M
   O'Mahony, A
   Yang, J
AF Berg, Ellen
   Polokoff, Mark
   O'Mahony, Alison
   Yang, Jian
TI Elucidating adverse outcome pathways with phenotypic data from primary
   human cell systems
SO TOXICOLOGY LETTERS
LA English
DT Meeting Abstract
CT 50th Congress of the European-Societies-of-Toxicology
CY SEP 07-10, 2014
CL Edinburgh, SCOTLAND
SP European Soc Toxicol, British Toxicol Soc, Soc Toxicol
C1 [Berg, Ellen; Polokoff, Mark; O'Mahony, Alison; Yang, Jian] BioSeek, San Francisco, CA USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0378-4274
EI 1879-3169
J9 TOXICOL LETT
JI Toxicol. Lett.
PD SEP 10
PY 2014
VL 229
SU S
MA P-1.47
BP S55
EP S55
DI 10.1016/j.toxlet.2014.06.227
PG 1
WC Toxicology
SC Toxicology
GA AO2FY
UT WOS:000341134000175
DA 2019-10-23
ER

PT J
AU Boobis, A
AF Boobis, Alan
TI Conclusions and discussion
SO TOXICOLOGY LETTERS
LA English
DT Meeting Abstract
CT 50th Congress of the European-Societies-of-Toxicology
CY SEP 07-10, 2014
CL Edinburgh, SCOTLAND
SP European Soc Toxicol, British Toxicol Soc, Soc Toxicol
C1 [Boobis, Alan] Univ London Imperial Coll Sci Technol & Med, London, England.
RI Boobis, Alan/E-1536-2018
OI Boobis, Alan/0000-0003-3371-386X
NR 0
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0378-4274
EI 1879-3169
J9 TOXICOL LETT
JI Toxicol. Lett.
PD SEP 10
PY 2014
VL 229
SU S
MA PS4.1-O5
BP S11
EP S11
DI 10.1016/j.toxlet.2014.06.067
PG 1
WC Toxicology
SC Toxicology
GA AO2FY
UT WOS:000341134000033
DA 2019-10-23
ER

PT J
AU Maxwell, G
   Cubberley, R
   Dhadra, S
   Gellatly, N
   Jacquoilleot, S
   Moore, C
   Pendlington, R
   Pickles, J
   Saib, O
   Sheffield, D
   Stark, R
   Summerfield, V
   MacKay, C
AF Maxwell, Gavin
   Cubberley, Richard
   Dhadra, Seraya
   Gellatly, Nichola
   Jacquoilleot, Sandrine
   Moore, Craig
   Pendlington, Ruth
   Pickles, Juliette
   Saib, Ouarda
   Sheffield, David
   Stark, Richard
   Summerfield, Vicki
   MacKay, Cameron
TI Applying the skin sensitisation AOP to human health risk assessment
SO TOXICOLOGY LETTERS
LA English
DT Meeting Abstract
CT 50th Congress of the European-Societies-of-Toxicology
CY SEP 07-10, 2014
CL Edinburgh, SCOTLAND
SP European Soc Toxicol, British Toxicol Soc, Soc Toxicol
C1 [Maxwell, Gavin; Cubberley, Richard; Dhadra, Seraya; Gellatly, Nichola; Jacquoilleot, Sandrine; Moore, Craig; Pendlington, Ruth; Pickles, Juliette; Saib, Ouarda; Sheffield, David; Stark, Richard; Summerfield, Vicki; MacKay, Cameron] SEAC, Sharnbrook, Beds, England.
OI Sheffield, David/0000-0002-4592-5248
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0378-4274
EI 1879-3169
J9 TOXICOL LETT
JI Toxicol. Lett.
PD SEP 10
PY 2014
VL 229
SU S
MA PS4.1-O4
BP S10
EP S11
DI 10.1016/j.toxlet.2014.06.066
PG 2
WC Toxicology
SC Toxicology
GA AO2FY
UT WOS:000341134000032
DA 2019-10-23
ER

PT J
AU Meek, ME
AF Meek, M. E. (Bette)
TI Evolution of mode of action/adverse outcome pathway analyses
SO TOXICOLOGY LETTERS
LA English
DT Meeting Abstract
CT 50th Congress of the European-Societies-of-Toxicology
CY SEP 07-10, 2014
CL Edinburgh, SCOTLAND
SP European Soc Toxicol, British Toxicol Soc, Soc Toxicol
C1 Univ Ottawa, Ottawa, ON, Canada.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0378-4274
EI 1879-3169
J9 TOXICOL LETT
JI Toxicol. Lett.
PD SEP 10
PY 2014
VL 229
SU S
MA PS4.1-O1
BP S10
EP S10
DI 10.1016/j.toxlet.2014.06.063
PG 1
WC Toxicology
SC Toxicology
GA AO2FY
UT WOS:000341134000029
DA 2019-10-23
ER

PT J
AU Munn, S
AF Munn, Sharon
TI Low dose effects: The wider consequences for risk assessment
SO TOXICOLOGY LETTERS
LA English
DT Meeting Abstract
CT 50th Congress of the European-Societies-of-Toxicology
CY SEP 07-10, 2014
CL Edinburgh, SCOTLAND
SP European Soc Toxicol, British Toxicol Soc, Soc Toxicol
C1 [Munn, Sharon] Commiss European Communities, Joint Res Ctr, I-21020 Ispra, Italy.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0378-4274
EI 1879-3169
J9 TOXICOL LETT
JI Toxicol. Lett.
PD SEP 10
PY 2014
VL 229
SU S
MA PS7.3-O5
BP S37
EP S37
DI 10.1016/j.toxlet.2014.06.172
PG 1
WC Toxicology
SC Toxicology
GA AO2FY
UT WOS:000341134000120
DA 2019-10-23
ER

PT J
AU Rouquie, D
AF Rouquie, David
TI Bradford Hill criteria still needed: Applications to MoA elucidation,
   low dose evaluation and adverse outcome pathway
SO TOXICOLOGY LETTERS
LA English
DT Meeting Abstract
CT 50th Congress of the European-Societies-of-Toxicology
CY SEP 07-10, 2014
CL Edinburgh, SCOTLAND
SP European Soc Toxicol, British Toxicol Soc, Soc Toxicol
C1 [Rouquie, David] Bayer CropSci, Sophia Antipolis, France.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0378-4274
EI 1879-3169
J9 TOXICOL LETT
JI Toxicol. Lett.
PD SEP 10
PY 2014
VL 229
SU S
MA PS4.1-O3
BP S10
EP S10
DI 10.1016/j.toxlet.2014.06.065
PG 1
WC Toxicology
SC Toxicology
GA AO2FY
UT WOS:000341134000031
DA 2019-10-23
ER

PT J
AU Schmidt, F
   Amberg, A
   Mulliner, D
   Stolte, M
   Matter, H
   Hessler, G
   Dietrich, A
   Remez, N
   Vidal, D
   Mestres, J
   Czich, A
AF Schmidt, Friedemann
   Amberg, Alexander
   Mulliner, Denis
   Stolte, Manuela
   Matter, Hans
   Hessler, Gerhard
   Dietrich, Axel
   Remez, Nikita
   Vidal, David
   Mestres, Jordi
   Czich, Andreas
TI Computational prediction of off-target related safety liabilities of
   molecules: Cardiotoxicity, hepatotoxicity and reproductive toxicity
SO TOXICOLOGY LETTERS
LA English
DT Meeting Abstract
CT 50th Congress of the European-Societies-of-Toxicology
CY SEP 07-10, 2014
CL Edinburgh, SCOTLAND
SP European Soc Toxicol, British Toxicol Soc, Soc Toxicol
C1 [Schmidt, Friedemann; Amberg, Alexander; Mulliner, Denis; Stolte, Manuela; Czich, Andreas] Sanofi, Preclin Safety, Frankfurt, Germany.
   [Matter, Hans; Hessler, Gerhard; Dietrich, Axel] Struct Design & Informat, Frankfurt, Germany.
   [Remez, Nikita; Vidal, David; Mestres, Jordi] Chemotargets, Barcelona, Spain.
RI Vidal, David/E-4876-2017; Gasull, Martina/J-4076-2019; Remez,
   Nikita/N-9804-2015
OI Vidal, David/0000-0002-2658-5313; Remez, Nikita/0000-0002-6033-7137
NR 0
TC 0
Z9 0
U1 0
U2 8
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0378-4274
EI 1879-3169
J9 TOXICOL LETT
JI Toxicol. Lett.
PD SEP 10
PY 2014
VL 229
SU S
MA P-3.54
BP S164
EP S164
DI 10.1016/j.toxlet.2014.06.564
PG 1
WC Toxicology
SC Toxicology
GA AO2FY
UT WOS:000341134000516
DA 2019-10-23
ER

PT J
AU Mellor, C
   Cronin, M
   Evenseth, L
   Sylte, I
   Kristiansen, K
   Tollefsen, KE
AF Mellor, Claire
   Cronin, Mark
   Evenseth, Linn
   Sylte, Ingebrigt
   Kristiansen, Kurt
   Tollefsen, Knut Erik
TI Integrating computational modelling of receptor binding into
   mechanistically based risk assessment for endocrine disruptors
SO TOXICOLOGY LETTERS
LA English
DT Meeting Abstract
CT 50th Congress of the European-Societies-of-Toxicology
CY SEP 07-10, 2014
CL Edinburgh, SCOTLAND
SP European Soc Toxicol, British Toxicol Soc, Soc Toxicol
C1 [Mellor, Claire; Cronin, Mark] Liverpool John Moores Univ, Liverpool L3 5UX, Merseyside, England.
   [Evenseth, Linn; Sylte, Ingebrigt; Kristiansen, Kurt] Univ Tromso, Tromso, Norway.
   [Tollefsen, Knut Erik] Norwegian Inst Water Res NIVA, Oslo, Norway.
RI Evenseth, Linn M/V-6125-2018
NR 0
TC 1
Z9 1
U1 0
U2 2
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0378-4274
EI 1879-3169
J9 TOXICOL LETT
JI Toxicol. Lett.
PD SEP 10
PY 2014
VL 229
SU S
MA P-3.49
BP S162
EP S163
DI 10.1016/j.toxlet.2014.06.559
PG 2
WC Toxicology
SC Toxicology
GA AO2FY
UT WOS:000341134000511
DA 2019-10-23
ER

PT J
AU Wilbanks, MS
   Gust, KA
   Atwa, S
   Sunesara, I
   Johnson, D
   Ang, CY
   Meyer, SA
   Perkins, EJ
AF Wilbanks, Mitchell S.
   Gust, Kurt A.
   Atwa, Sahar
   Sunesara, Imran
   Johnson, David
   Ang, Choo Yaw
   Meyer, Sharon A.
   Perkins, Edward J.
TI Validation of a Genomics-Based Hypothetical Adverse Outcome Pathway:
   2,4-Dinitrotoluene Perturbs PPAR Signaling Thus Impairing Energy
   Metabolism and Exercise Endurance
SO TOXICOLOGICAL SCIENCES
LA English
DT Article
DE dinitrotoluene; energy; adverse outcome pathway; PPAR
ID PROLIFERATOR-ACTIVATED RECEPTORS; NORTHERN BOBWHITE; CHRONIC TOXICITY;
   GENE-EXPRESSION; FATTY-ACIDS; MICE; ALPHA; RATS; EXPOSURE; BINDING
AB 2,4-dinitrotoluene (2,4-DNT) is a nitroaromatic used in industrial dyes and explosives manufacturing processes that is found as a contaminant in the environment. Previous studies have implicated antagonism of PPAR alpha signaling as a principal process affected by 2,4-DNT. Here, we test the hypothesis that 2,4-DNT-induced perturbations in PPAR alpha signaling and resultant downstream deficits in energy metabolism, especially from lipids, cause organism-level impacts on exercise endurance. PPAR nuclear activation bioassays demonstrated inhibition of PPAR alpha signaling by 2,4-DNT whereas PPAR alpha signaling increased. PPAR alpha (-/-) and wild-type (WT) female mice were exposed for 14 days to vehicle or 2,4-DNT (134 mg/kg/day) and performed a forced swim to exhaustion 1 day after the last dose. 2,4-DNT significantly decreased body weights and swim times in WTs, but effects were significantly mitigated in PPAR alpha (-/-) mice. 2,4-DNT decreased transcript expression for genes downstream in the PPAR alpha signaling pathway, principally genes involved in fatty acid transport. Results indicate that PPAR alpha signaling increased resulting in enhanced cycling of lipid and carbohydrate substrates into glycolytic/gluconeogenic pathways favoring energy production versus storage in 2,4-DNT-exposed WT and PPAR alpha (-/-) mice. PPAR alpha (-/-) mice appear to have compensated for the loss of PPAR alpha by shifting energy metabolism to PPAR alpha-independent pathways resulting in lower sensitivity to 2,4-DNT when compared with WT mice. Our results validate 2,4-DNT-induced perturbation of PPAR alpha signaling as the molecular initiating event for impaired energy metabolism, weight loss, and decreased exercise performance.
C1 [Wilbanks, Mitchell S.; Gust, Kurt A.; Johnson, David; Perkins, Edward J.] Army Engn Res & Dev Ctr, Vicksburg, MS 39180 USA.
   [Atwa, Sahar; Meyer, Sharon A.] Univ Louisiana, Monroe, LA 71201 USA.
   [Sunesara, Imran] Univ Mississippi, Med Ctr, Jackson, MS 39216 USA.
   [Johnson, David] Conestoga Rovers & Associates, Dallas, TX 75234 USA.
   [Ang, Choo Yaw] Badger Tech Serv, San Antonio, TX USA.
RP Wilbanks, MS (reprint author), US Army, Engn Res & Dev Ctr, 3909 Halls Ferry Rd, Vicksburg, MS 39180 USA.
EM mitchell.s.wilbanks@usace.army.mil
FU U.S. Army Environmental Quality and Installations applied research
   program
FX U.S. Army Environmental Quality and Installations applied research
   program. Permission was granted by the Chief of the U.S. Army Corps of
   Engineers to publish this information.
CR Allison PD, 2001, SAGE U PAPERS SERIES
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   ATSDR Agency for Toxic Substances and Disease Registry, 1998, TOX PROF 2 4 2 6 DIN
   Baillie AGS, 1996, J MEMBRANE BIOL, V153, P75, DOI 10.1007/s002329900111
   Deng YP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014662
   Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649
   DILLEY JV, 1982, J TOXICOL ENV HEALTH, V9, P565, DOI 10.1080/15287398209530188
   Dongol B, 2007, J LIPID RES, V48, P1781, DOI 10.1194/jlr.M700119-JLR200
   ELLIS HV, 1979, ADA077692 US ARM MED
   ELLIS HV, 1978, 6 MIDW RES I
   Feige JN, 2010, ENVIRON HEALTH PERSP, V118, P234, DOI 10.1289/ehp.0901217
   Gomez-Valades AG, 2008, DIABETES, V57, P2199, DOI 10.2337/db07-1087
   HONG CB, 1985, J AM COLL TOXICOL, V4, P257, DOI 10.3109/10915818509078678
   Huber PJ, 1967, P 5 BERK S MATH STAT, V1, P221, DOI DOI 10.3238/ARZTEBL.2011.0523A
   Hunt MC, 2002, PROG LIPID RES, V41, P99, DOI 10.1016/S0163-7827(01)00017-0
   Ito Y, 2012, PPAR RES, DOI 10.1155/2012/201284
   Jin HM, 2011, INT J MOL SCI, V12, P4770, DOI 10.3390/ijms12084770
   Johnson MS, 2007, ENVIRON POLLUT, V147, P604, DOI 10.1016/j.envpol.2006.10.007
   JOHNSON MS, 2005, INT J TOXICOL, V24, P264
   Kanehisa M., 2000, POSTGENOME INFORM
   KOZUKA H, 1979, Journal of Toxicological Sciences, V4, P221
   LEE CC, 1985, J AM COLL TOXICOL, V4, P243, DOI 10.3109/10915818509078677
   LEE CC, 1978, 3 US ARM MED BIOENG
   LEE CC, 1975, 1 MIDW RES I
   Lefebvre P, 2006, J CLIN INVEST, V116, P571, DOI 10.1172/JCI27989
   Lent EM, 2012, INT J TOXICOL, V31, P143, DOI 10.1177/1091581811434645
   LEVINE BS, 1984, TOXICOLOGY, V32, P253, DOI 10.1016/0300-483X(84)90078-7
   Mandard S, 2004, CELL MOL LIFE SCI, V61, P393, DOI 10.1007/s00018-003-3216-3
   McFarland CA, 2012, ECOTOXICOLOGY, V21, P2372, DOI 10.1007/s10646-012-0993-1
   McGee Lemuel C, 1942, AMER JOUR DIGEST DIS, V9, P329
   Millward CA, 2010, J LIPID RES, V51, P1452, DOI 10.1194/jlr.M005363
   Muoio DM, 2002, J BIOL CHEM, V277, P26089, DOI 10.1074/jbc.M203997200
   National Research Council (US) Committee, 2011, GUIDE CARE USE LAB A
   Patsouris D, 2004, J CLIN INVEST, V114, P94, DOI 10.1172/JC1200420468
   Pontius N.L., 1997, OPFLOW, V23, P8
   Powell Emily, 2007, PPAR Res, V2007, P53843
   Pruett SB, 2009, TOXICOL SCI, V109, P265, DOI 10.1093/toxsci/kfp073
   Quinn MJ, 2007, ENVIRON TOXICOL CHEM, V26, P2202, DOI 10.1897/07-123R.1
   Rakhshandehroo M, 2010, PPAR RES, DOI 10.1155/2010/612089
   Rawat A, 2010, PHYSIOL GENOMICS, V42, P219, DOI 10.1152/physiolgenomics.00022.2010
   RICKERT DE, 1981, DRUG METAB DISPOS, V9, P226
   SHARP PE, 1998, LAB RAT
   Stahl A, 2004, PFLUG ARCH EUR J PHY, V447, P722, DOI 10.1007/s00424-003-1106-z
   Storch J, 2000, BBA-MOL CELL BIOL L, V1486, P28, DOI 10.1016/S1388-1981(00)00046-9
   Takeda K, 2011, J NUTR SCI VITAMINOL, V57, P246, DOI 10.3177/jnsv.57.246
   TRANSLAVINA RP, 2010, J AM ASSOC LAB ANIM, V49, P316
   VACCA LL, 1985, LABORATORY MANUAL HI, P182
   VEMOT EH, 1977, TOXICOL APPL PHARM, V42, P417
   Voet D., 1999, FUNDAMENTALS BIOCH
   WHITE H, 1980, ECONOMETRICA, V48, P817, DOI 10.2307/1912934
   Wintz H, 2006, TOXICOL SCI, V94, P71, DOI 10.1093/toxsci/kfl080
   Wolfrum C, 2001, P NATL ACAD SCI USA, V98, P2323, DOI 10.1073/pnas.051619898
   Xu JB, 2012, J HAZARD MATER, V203, P299, DOI 10.1016/j.jhazmat.2011.12.025
   Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206
NR 54
TC 13
Z9 14
U1 0
U2 8
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1096-6080
EI 1096-0929
J9 TOXICOL SCI
JI Toxicol. Sci.
PD SEP
PY 2014
VL 141
IS 1
BP 44
EP 58
DI 10.1093/toxsci/kfu104
PG 15
WC Toxicology
SC Toxicology
GA AQ7JP
UT WOS:000342990200010
PM 24893713
OA Green Published
DA 2019-10-23
ER

PT J
AU Pleil, JD
   Stiegel, MA
   Fent, KW
AF Pleil, Joachim D.
   Stiegel, Matthew A.
   Fent, Kenneth W.
TI Exploratory breath analyses for assessing toxic dermal exposures of
   firefighters during suppression of structural burns
SO JOURNAL OF BREATH RESEARCH
LA English
DT Article
DE adverse outcome pathway; exposome; firefighter; JP-8 jet fuel; PAHs;
   benzene; heatmap
ID EXHALED BREATH; BIOMARKERS; RISK
AB Firefighters wear fireproof clothing and self-contained breathing apparatus (SCBA) during rescue and fire suppression activities to protect against acute effects from heat and toxic chemicals. Fire services are also concerned about long-term health outcomes from chemical exposures over a working lifetime, in particular about low-level exposures that might serve as initiating events for adverse outcome pathways (AOP) leading to cancer. As part of a larger US National Institute for Occupational Safety and Health (NIOSH) study of dermal exposure protection from safety gear used by the City of Chicago firefighters, we collected pre- and post-fire fighting breath samples and analyzed for single-ring and polycyclic aromatic hydrocarbons as bioindicators of occupational exposure to gas-phase toxicants. Under the assumption that SCBA protects completely against inhalation exposures, any changes in the exhaled profile of combustion products were attributed to dermal exposures from gas and particle penetration through the protective clothing. Two separate rounds of firefighting activity were performed each with 15 firefighters per round. Exhaled breath samples were collected onto adsorbent tubes and analyzed with gas-chromatography-mass spectrometry (GC-MS) with a targeted approach using selective ion monitoring. We found that single ring aromatics and some PAHs were statistically elevated in post-firefighting samples of some individuals, suggesting that fire protective gear may allow for dermal exposures to airborne contaminants. However, in comparison to a previous occupational study of Air Force maintenance personnel where similar compounds were measured, these exposures are much lower suggesting that firefighters' gear is very effective. This study suggests that exhaled breath sampling and analysis for specific targeted compounds is a suitable method for assessing systemic dermal exposure in a simple and non-invasive manner.
C1 [Pleil, Joachim D.] US EPA, Human Exposure & Atmospher Sci Div, NERL ORD, Res Triangle Pk, NC 27711 USA.
   [Stiegel, Matthew A.] Univ N Carolina, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA.
   [Fent, Kenneth W.] NIOSH, Div Surveillance Hazard Evaluat & Field Studies, Cincinnati, OH 45226 USA.
RP Pleil, JD (reprint author), US EPA, Human Exposure & Atmospher Sci Div, NERL ORD, Res Triangle Pk, NC 27711 USA.
EM pleil.joachim@epa.gov
FU NIOSHUnited States Department of Health & Human ServicesCenters for
   Disease Control & Prevention - USANational Institute for Occupational
   Safety & Health (NIOSH)
FX The authors are thankful for the volunteer subjects from the Chicago
   Fire Department. This research has been subjected to EPA review and
   approved for publication. This study was internally funded by NIOSH and
   approved by the NIOSH Human Subjects Review Board. The findings and
   conclusions in this paper are those of the authors and do not
   necessarily represent the views of NIOSH.
CR Amann A, 2009, J BREATH RES, V4
   Beauchamp JD, 2013, J BREATH RES, V7, DOI 10.1088/1752-7155/7/4/042001
   Braun PX, 2012, IEEE SENS J, V12, P3258, DOI 10.1109/JSEN.2012.2210403
   Cone David C, 2005, Prehosp Emerg Care, V9, P8, DOI 10.1080/10903120590891912
   Corradi M, 2012, J BREATH RES, V6, DOI 10.1088/1752-7155/6/2/020201
   Davis CE, 2013, J BREATH RES, V7, DOI 10.1088/1752-7155/7/3/039001
   Dunn K, 2009, INHAL TOXICOL, V21, P55, DOI [10.1080/08958370802207300, 10.1080/08958370802207300 ]
   Dweik RA, 2011, J BREATH RES, V5, DOI 10.1088/1752-7155/5/3/030201
   Fent K W, 2013, 201001563196 NAT I O
   Ghio AJ, 2012, SWISS MED WKLY, V142, DOI 10.4414/smw.2012.13597
   Hubbard HF, 2009, J CHROMATOGR B, V877, P3652, DOI 10.1016/j.jchromb.2009.09.008
   Karter M J, 2011, US FIR DEP PROF 2010
   Kim D, 2007, ENVIRON HEALTH PERSP, V115, P894, DOI 10.1289/ehp.9778
   Lorber M, 2007, RISK ANAL, V27, P1203, DOI 10.1111/j.1539-6924.2007.00956.x
   Lu SS, 2014, BIOMARKERS, V19, P332, DOI 10.3109/1354750X.2014.910553
   Miekisch W, 2012, J BREATH RES, V6, DOI 10.1088/1752-7155/6/3/036007
   Miranda AI, 2012, J TOXICOL ENV HEAL A, V75, P831, DOI 10.1080/15287394.2012.690686
   [NFPA (National Fire Protection Agency) M A Quincy], 2007, NFPA 1971 STAND PROT
   [NFPA (National Fire Protection Agency) M A Quincy], 2007, NFPA 1981 STAND OP C
   Pleil J D, 2013, MATH STAT APPROACHES
   Pleil JD, 2006, ENVIRON SCI TECHNOL, V40, P1172, DOI 10.1021/es0517015
   Pleil JD, 2004, P NATL ACAD SCI USA, V101, P11685, DOI 10.1073/pnas.0404499101
   PLEIL JD, 1991, J AIR WASTE MANAGE, V41, P287, DOI 10.1080/10473289.1991.10466845
   PLEIL JD, 1995, J CHROMATOGR B, V665, P271, DOI 10.1016/0378-4347(94)00545-G
   Pleil JD, 2000, ENVIRON HEALTH PERSP, V108, P183, DOI 10.2307/3454432
   Pleil JD, 1998, RISK ANAL, V18, P585, DOI 10.1111/j.1539-6924.1998.tb00372.x
   Pleil JD, 2008, J TOXICOL ENV HEAL B, V11, P613, DOI 10.1080/10937400701724329
   Pleil JD, 2013, ANAL CHEM, V85, P9984, DOI 10.1021/ac402306f
   Pleil JD, 2013, J TOXICOL ENV HEAL A, V76, P747, DOI 10.1080/15287394.2013.821394
   Pleil JD, 2013, J BREATH RES, V7, DOI 10.1088/1752-7155/7/2/029001
   Pleil JD, 2012, TOXICOL LETT, V215, P201, DOI 10.1016/j.toxlet.2012.10.011
   Pleil JD, 2012, J BREATH RES, V6, DOI 10.1088/1752-7155/6/1/019001
   Pleil JD, 2011, J BREATH RES, V5, DOI 10.1088/1752-7155/5/4/046005
   Pleil JD, 2011, J BREATH RES, V5, DOI 10.1088/1752-7155/5/3/037104
   Pleil JD, 2011, BIOMARKERS, V16, P99, DOI 10.3109/1354750X.2010.541565
   Pleil JD, 2009, BIOMARKERS, V14, P560, DOI 10.3109/13547500903186460
   Risby TH, 2006, APPL PHYS B-LASERS O, V85, P421, DOI 10.1007/s00340-006-2280-4
   Sinues PML, 2013, CHEST, V144, P746, DOI 10.1378/chest.13-1106
   Sobus JR, 2011, SCI TOTAL ENVIRON, V409, P4875, DOI 10.1016/j.scitotenv.2011.07.046
   Sobus JR, 2010, TOXICOL LETT, V199, P247, DOI 10.1016/j.toxlet.2010.09.006
   Tan YM, 2012, J TOXICOL ENV HEAL B, V15, P22, DOI 10.1080/10937404.2012.632360
NR 41
TC 19
Z9 19
U1 0
U2 32
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1752-7155
EI 1752-7163
J9 J BREATH RES
JI J. Breath Res.
PD SEP
PY 2014
VL 8
IS 3
SI SI
AR 037107
DI 10.1088/1752-7155/8/3/037107
PG 9
WC Biochemical Research Methods; Respiratory System
SC Biochemistry & Molecular Biology; Respiratory System
GA AP0SO
UT WOS:000341774500012
PM 25190461
DA 2019-10-23
ER

PT J
AU Stevens, JL
AF Stevens, J. L.
TI Reading the Toxicogenomic MAP (TXG-MAP): Modular Gene Expression Changes
   Associated with Pathogenesis.
SO ENVIRONMENTAL AND MOLECULAR MUTAGENESIS
LA English
DT Meeting Abstract
CT 45th Annual Meeting of the
   Environmental-Mutagenesis-and-Genomics-Society (EMGS)
CY SEP 13-17, 2014
CL Orlando, FL
SP Environm Mutagenesis & Genom Soc
C1 [Stevens, J. L.] Eli Lilly & Co, Lilly Res Lab, Indianapolis, IN 46285 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0893-6692
EI 1098-2280
J9 ENVIRON MOL MUTAGEN
JI Environ. Mol. Mutagen.
PD SEP
PY 2014
VL 55
SU 1
MA S52
BP S31
EP S31
PG 1
WC Environmental Sciences; Genetics & Heredity; Toxicology
SC Environmental Sciences & Ecology; Genetics & Heredity; Toxicology
GA AO2ST
UT WOS:000341176900061
DA 2019-10-23
ER

PT J
AU Tal, TL
   McCollum, CW
   Harris, PS
   Olin, J
   Kleinstreuer, N
   Wood, CE
   Hans, C
   Shah, S
   Merchant, FA
   Bondesson, M
   Knudsen, TB
   Padilla, S
   Hemmer, MJ
AF Tal, T. L.
   McCollum, C. W.
   Harris, P. S.
   Olin, J.
   Kleinstreuer, N.
   Wood, C. E.
   Hans, C.
   Shah, S.
   Merchant, F. A.
   Bondesson, M.
   Knudsen, T. B.
   Padilla, S.
   Hemmer, M. J.
TI Immediate and long-term consequences of vascular toxicity during
   zebrafish development
SO REPRODUCTIVE TOXICOLOGY
LA English
DT Article
DE Adverse outcome pathway; EGFR; Intersegmental vessel; VEGFR2
ID GENOMIC REGULATORY BLOCKS; SCREENING ASSAY; MICE LACKING; RECEPTOR;
   GROWTH; IDENTIFICATION; DISRUPTION; CHEMICALS; OUTGROWTH; DEFECTS
AB Proper formation of the vascular system is necessary for embryogenesis, and chemical disruption of vascular development may be a key event driving developmental toxicity. In order to test the effect of environmental chemicals on this critical process, we evaluated a quantitative assay in transgenic zebrafish using angiogenesis inhibitors that target VEGFR2 (PTK787) or EGFR (AG1478). Both PTK787 and AG1478 exposure impaired intersegmental vessel (ISV) sprouting, while AG1478 also produced caudal and pectoral fin defects at concentrations below those necessary to blunt ISV morphogenesis. The functional consequences of vessel toxicity during early development included decreased body length and survival in juvenile cohorts developmentally exposed to inhibitor concentrations sufficient to completely block ISV sprouting angiogenesis. These data show that concentration-dependent disruption of the presumed targets for these inhibitors produce adverse outcomes at advanced life stages. Published by Elsevier Inc.
C1 [Tal, T. L.; Olin, J.; Wood, C. E.; Padilla, S.] US EPA, Integrated Syst Toxicol Div, NHEERL, Res Triangle Pk, NC 27711 USA.
   [McCollum, C. W.; Bondesson, M.] Univ Houston, Dept Biol & Biochem, Ctr Nucl Receptors & Cell Signaling, Houston, TX USA.
   [Harris, P. S.; Hemmer, M. J.] US EPA, Gulf Ecol Div, NHEERL, Gulf Breeze, FL USA.
   [Kleinstreuer, N.; Knudsen, T. B.] US EPA, Natl Ctr Computat Toxicol, Res Triangle Pk, NC 27711 USA.
   [Hans, C.; Merchant, F. A.] Univ Houston, Dept Comp Sci, Houston, TX 77204 USA.
   [Shah, S.; Merchant, F. A.] Univ Houston, Dept Engn Technol, Houston, TX USA.
RP Tal, TL (reprint author), US EPA, Integrated Syst Toxicol Div, Natl Hlth & Environm Effects Res Lab, 109 TW Alexander Dr,B105-03, Res Triangle Pk, NC 27711 USA.
EM tal.tamara@epa.gov
RI Kleinstreuer, Nicole/F-7203-2019; Padilla, Stephanie/G-3568-2017; Tal,
   Tamara/O-5414-2019; Bondesson, Maria/H-3027-2012
OI Kleinstreuer, Nicole/0000-0002-7914-3682; Padilla,
   Stephanie/0000-0002-7310-3209; Tal, Tamara/0000-0001-8365-9385;
   McCollum, Catherine/0000-0002-2238-803X; Bondesson,
   Maria/0000-0001-6358-5788; Merchant, Fatima/0000-0002-8218-9454
FU EPA Texas-Indiana University Virtual STAR Grant [R834289]
FX We are grateful to Alisha Palekar for measuring blinded images. We
   greatly appreciate Earl Puckett for fabricating the lateral orientation
   tool and stage adaptor. The authors thank Gabriele Daniels for her
   technical assistance with the juvenile studies and Alan Tennant for
   microscopy and imaging assistance. We thank Kim Howard, Ned Collins and
   Leslie Martin for fish husbandry and Jeffrey Wolf at Experimental
   Pathology Laboratories, INC. for histopathology peer review. We thank
   the Zebrafish International Resource Center (RR12546) for providing
   Tg(kdrl:EGFP)<SUP>s843/+</SUP> zebrafish embryos. CWM and MB were
   supported by the EPA Texas-Indiana University Virtual STAR Grant
   (R834289). We are grateful to William Mundy and E. Sidney Hunter for
   their critical review of the manuscript. This manuscript has been
   reviewed by the U.S. Environmental Protection Agency and approved for
   publication. Approval does not signify that the contents reflect the
   views of the Agency, nor does mention of trade names or commercial
   products constitute endorsement or recommendation for use.
CR Allard P, 2013, ENVIRON HEALTH PERSP, V121, P717, DOI 10.1289/ehp.1206301
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Bonventre JA, 2011, AQUAT TOXICOL, V105, P29, DOI 10.1016/j.aquatox.2011.05.006
   Bradbury SP, 2003, ENVIRON TOXICOL CHEM, V22, P1789, DOI 10.1897/01-234
   Chan J, 2002, CANCER CELL, V1, P257, DOI 10.1016/S1535-6108(02)00042-9
   Chandler KJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018540
   Chung AS, 2011, ANNU REV CELL DEV BI, V27, P563, DOI 10.1146/annurev-cellbio-092910-154002
   Cumming G, 2007, J CELL BIOL, V177, P7, DOI 10.1083/jcb.200611141
   Ellertsdottir E, 2010, DEV BIOL, V341, P56, DOI 10.1016/j.ydbio.2009.10.035
   FONG GH, 1995, NATURE, V376, P66, DOI 10.1038/376066a0
   Goishi K, 2003, MECH DEVELOP, V120, P811, DOI 10.1016/S0925-4773(03)00068-6
   Grandel H, 1998, MECH DEVELOP, V79, P99, DOI 10.1016/S0925-4773(98)00176-2
   Grandel H, 2000, DEVELOPMENT, V127, P4169
   Grandel H, 2011, DEV DYNAM, V240, P1116, DOI 10.1002/dvdy.22461
   Grush J, 2004, ZEBRAFISH, V1, P46, DOI 10.1089/154585404774101671
   Gunnarsson L, 2008, ENVIRON SCI TECHNOL, V42, P5807, DOI 10.1021/es8005173
   Hans C, 2013, IEEE ENG MED BIO, P3004, DOI 10.1109/EMBC.2013.6610172
   Hans C, 2011, IEEE ENG MED BIO, P5969, DOI 10.1109/IEMBS.2011.6091475
   Herbert SP, 2011, NAT REV MOL CELL BIO, V12, P551, DOI 10.1038/nrm3176
   Howe K, 2013, NATURE, V496, P498, DOI 10.1038/nature12111
   Ito T, 2010, SCIENCE, V327, P1345, DOI 10.1126/science.1177319
   Jacob E, 2002, AM J PHYSIOL-REG I, V283, pR911, DOI 10.1152/ajpregu.00673.2001
   Jahrling N, 2009, ORGANOGENESIS, V5, P227, DOI 10.4161/org.5.4.10403
   Jinn SW, 2005, DEVELOPMENT, V132, P5199, DOI 10.1242/dev.02087
   Kikuta H, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-S1-S4
   Kikuta H, 2007, GENOME RES, V17, P545, DOI 10.1101/gr.6086307
   Kleinstreuer NC, 2011, ENVIRON HEALTH PERSP, V119, P1596, DOI 10.1289/ehp.1103412
   Knudsen TB, 2011, BIRTH DEFECTS RES C, V93, P312, DOI 10.1002/bdrc.20223
   LENZ W, 1988, TERATOLOGY, V38, P203, DOI 10.1002/tera.1420380303
   Li CH, 1998, PATTERN RECOGN LETT, V19, P771, DOI 10.1016/S0167-8655(98)00057-9
   Lin C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031708
   McCollum CW, 2014, AQUAT TOXICOL, V152, P152, DOI 10.1016/j.aquatox.2014.04.006
   MIETTINEN PJ, 1995, NATURE, V376, P337, DOI 10.1038/376337a0
   Navratilova P, 2009, DEV BIOL, V327, P526, DOI 10.1016/j.ydbio.2008.10.044
   Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911
   Omi M, 2005, DEV DYNAM, V233, P288, DOI 10.1002/dvdy.20353
   Padilla S, 2012, REPROD TOXICOL, V33, P174, DOI 10.1016/j.reprotox.2011.10.018
   Peravali R, 2011, BIOTECHNIQUES, V50, P319, DOI 10.2144/000113669
   Postlethwait JH, 2000, GENOME RES, V10, P1890, DOI 10.1101/gr.164800
   Rombough PJ, 1998, J EXP BIOL, V201, P1763
   Schmieder PK, 2004, ENVIRON SCI TECHNOL, V38, P6333, DOI 10.1021/es0495314
   SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0
   SIBILIA M, 1995, SCIENCE, V269, P234, DOI 10.1126/science.7618085
   SMITHELL.RW, 1965, P ROY SOC MED, V58, P491, DOI 10.1177/003591576505800708
   SMITHELLS RW, 1992, J MED GENET, V29, P716, DOI 10.1136/jmg.29.10.716
   Therapontos C, 2009, P NATL ACAD SCI USA, V106, P8573, DOI 10.1073/pnas.0901505106
   THREADGILL DW, 1995, SCIENCE, V269, P230, DOI 10.1126/science.7618084
   Tran TC, 2007, CANCER RES, V67, P11386, DOI 10.1158/0008-5472.CAN-07-3126
   Wang SH, 2000, GENE DEV, V14, P2271, DOI 10.1101/gad.827000
   Westerfield M., 2007, ZEBRAFISH BOOK
   Wood JM, 2000, CANCER RES, V60, P2178
   Yano T, 2012, DEVELOPMENT, V139, P2916, DOI 10.1242/dev.075572
   Yeh CH, 2012, DRUG CHEM TOXICOL, V35, P361, DOI 10.3109/01480545.2011.627864
   Yozzo KL, 2013, ENVIRON SCI TECHNOL, V47, P11302, DOI 10.1021/es403360y
NR 54
TC 13
Z9 13
U1 0
U2 19
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0890-6238
J9 REPROD TOXICOL
JI Reprod. Toxicol.
PD SEP
PY 2014
VL 48
SI SI
BP 51
EP 61
DI 10.1016/j.reprotox.2014.05.014
PG 11
WC Reproductive Biology; Toxicology
SC Reproductive Biology; Toxicology
GA AO4WK
UT WOS:000341341900006
PM 24907688
DA 2019-10-23
ER

PT J
AU Valdivia, P
   Martin, M
   LeFew, WR
   Ross, J
   Houck, KA
   Shafer, TJ
AF Valdivia, Pablo
   Martin, Matt
   LeFew, William R.
   Ross, James
   Houck, Keith A.
   Shafer, Timothy J.
TI Multi-well microelectrode array recordings detect neuroactivity of
   ToxCast compounds
SO NEUROTOXICOLOGY
LA English
DT Article
DE Screening; ToxCast; Microelectrode arrays; Electrophysiology
ID ADVERSE OUTCOME PATHWAYS; PYRETHROID INSECTICIDES; DEVELOPMENTAL
   TOXICITY; SODIUM-CHANNELS; NEUROTOXICITY; CHEMICALS; NEURONS; BINDING;
   MECHANISMS; FUNGICIDES
AB Spontaneous activity in neuronal cultures on microelectrode arrays (MEAs) is sensitive to effects of drugs, chemicals, and particles. Multi-well MEA (mwMEA) systems have increased throughput of MEAs, enabling their use for chemical screening. The present experiments examined a subset of EPA's ToxCast compounds for effects on spontaneous neuronal activity in primary cortical cultures using 48-well MEA plates. A first cohort of 68 compounds was selected from the ToxCast Phase I and II libraries; 37 were positive in one or more of 20 individual ToxCast Novascreen assays related to ion channels (NVS_IC), with the remainder selected based on known neuroactivity. A second cohort of 25 compounds was then tested with 20 originating from the ToxCast Phase I and II libraries (not hits in NVS_IC assays) and 5 known negatives from commercial vendors. Baseline activity (1 h) was recorded prior to exposing the networks to compounds for 1 h, and the weighted mean firing rate (wMFR) was determined in the absence and presence of each compound. Compounds that altered activity by greater than the weighted change of DMSO-treated wells plus 2SD were considered "hits". Of the first set of 68 compounds, 54 altered wMFR by more than the threshold, while in the second set, 13/25 compounds were hits. MEAs detected 30 of 37 (81.1%) compounds that were hits in NVS_IC assays, as well as detected known neurotoxicants that were negative in NVS_IC assays, primarily pyrethroids and GABA(A) receptor antagonists. Conversely, wMFR of cortical neuronal networks on MEAs was insensitive to nicotinic compounds, as only one neonicotinoid was detected by MEAs; this accounts for the bulk of non-concordant compounds between MEA and NVS_IC assays. These data demonstrate that mwMEAs can be used to screen chemicals efficiently for potential neurotoxicity, and that the results are concordant with predictions from ToxCast NVS_IC assays for interactions with ion channels. Published by Elsevier Inc.
C1 [Valdivia, Pablo; Ross, James] Axion Biosyst, Atlanta, GA USA.
   [Martin, Matt; Houck, Keith A.] US EPA, Natl Ctr Computat Toxicol, ORD, Res Triangle Pk, NC 27711 USA.
   [LeFew, William R.; Shafer, Timothy J.] US EPA, Integrated Syst Toxicol Div, NHEERL, ORD, Res Triangle Pk, NC 27711 USA.
RP Shafer, TJ (reprint author), US EPA, Integrated Syst Toxicol Div, MD-B105-03, Res Triangle Pk, NC 27711 USA.
EM Shafer.tim@epa.gov
RI Houck, Keith/G-8654-2014
OI Houck, Keith/0000-0002-0055-2249; Shafer, Timothy/0000-0002-8069-9987
FU US EPA Office of Research and DevelopmentUnited States Environmental
   Protection Agency; Axion Biosystems [CRADA 644-11]; U.S. Environmental
   Protection AgencyUnited States Environmental Protection Agency
FX This work was conducted as part of a Cooperative Research and
   Development Agreement between the US EPA Office of Research and
   Development and Axion Biosystems (CRADA 644-11). Preparation of this
   document has been funded by the U.S. Environmental Protection Agency.
   This document has been reviewed by the National Health and Environmental
   Effects Research Laboratory and approved for publication. Approval does
   not signify that the contents reflect the views of the Agency, nor does
   mention of trade names or commercial products constitute endorsement or
   recommendation for use.
CR Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Biffi E, 2010, COMPUT INTEL NEUROSC, V2010, P1
   BROWN GB, 1988, MOL PHARMACOL, V34, P54
   Chandler KJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018540
   COATS JR, 1990, ENVIRON HEALTH PERSP, V87, P255, DOI 10.2307/3431033
   CREVELING CR, 1983, MOL PHARMACOL, V23, P350
   Crofton KM, 1996, TOXICOL LETT, V84, P155, DOI 10.1016/0378-4274(95)03618-0
   DeFranchi E, 2011, FRONT NEUROENG, V4, P1
   Dix DJ, 2007, TOXICOL SCI, V95, P5, DOI 10.1093/toxsci/kfl103
   EFSA (European Food Safety Authority), 2008, 1462008 EFSA, V146, P1
   Gartlon J, 2006, TOXICOL IN VITRO, V20, P1569, DOI 10.1016/j.tiv.2006.07.009
   Harrill JA, 2013, NEUROTOXICOLOGY, V34, P61, DOI 10.1016/j.neuro.2012.10.013
   Harrill JA, 2011, TOXICOL IN VITRO, V25, P368, DOI 10.1016/j.tiv.2010.10.011
   Hayess K, 2013, TOXICOLOGY, V314, P135, DOI 10.1016/j.tox.2013.09.012
   Heusinkveld HJ, 2013, TOXICOL SCI, V134, P374, DOI 10.1093/toxsci/kft119
   Johnstone AFM, 2010, NEUROTOXICOLOGY, V31, P331, DOI 10.1016/j.neuro.2010.04.001
   Judson RS, 2010, ENVIRON HEALTH PERSP, V118, P485, DOI 10.1289/ehp.0901392
   Kleinstreuer NC, 2011, TOXICOL APPL PHARM, V257, P111, DOI 10.1016/j.taap.2011.08.025
   Kleinstreuer N, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002996
   Kleinstreuer NC, 2011, ENVIRON HEALTH PERSP, V119, P1596, DOI 10.1289/ehp.1103412
   Krug AK, 2013, ARCH TOXICOL, V87, P2215, DOI 10.1007/s00204-013-1072-y
   Lu Q, 2008, COMB CHEM HIGH T SCR, V11, P185, DOI 10.2174/138620708783877735
   Mack CM, 2014, NEUROTOXICOLOGY, V40, P75, DOI 10.1016/j.neuro.2013.11.008
   McConnell ER, 2012, NEUROTOXICOLOGY, V33, P1048, DOI 10.1016/j.neuro.2012.05.001
   Meijer M., 2014, NEUROTOXICOLOGY
   Meyer DA, 2008, NEUROTOXICOLOGY, V29, P213, DOI 10.1016/j.neuro.2007.11.005
   Michels G, 2008, FRONT NEUROENDOCRIN, V29, P182, DOI 10.1016/j.yfrne.2007.08.004
   Mundy WR, 2000, NEUROTOXICOLOGY, V21, P1135
   Narahashi T, 2002, MINI-REV MED CHEM, V2, P419, DOI 10.2174/1389557023405927
   Novellino A, 2011, Front Neuroeng, V4, P4, DOI 10.3389/fneng.2011.00004
   NRC (National Research Council), 2007, TOX TEST 21 CENT VIS
   Pope C, 2005, ENVIRON TOXICOL PHAR, V19, P433, DOI 10.1016/j.etap.2004.12.048
   Robinette Brian L, 2011, Front Neuroeng, V4, P1, DOI 10.3389/fneng.2011.00001
   Rotroff DM, 2013, ENVIRON HEALTH PERSP, V121, P7, DOI 10.1289/ehp.1205065
   Scelfo B, 2012, TOXICOLOGY, V299, P172, DOI 10.1016/j.tox.2012.05.020
   Sipes NS, 2011, TOXICOL SCI, V124, P109, DOI 10.1093/toxsci/kfr220
   Tomizawa M, 2005, ANNU REV PHARMACOL, V45, P247, DOI 10.1146/annurev.pharmtox.45.120403.095930
   Trainer VL, 1997, MOL PHARMACOL, V51, P651
   Verstraelen P, 2014, CELL MOL NEUROBIOL
   Watanabe KH, 2011, ENVIRON TOXICOL CHEM, V30, P9, DOI 10.1002/etc.373
   Wilson MS, 2014, NEUROTOXICOLOGY, V42, P33, DOI 10.1016/j.neuro.2014.03.013
NR 41
TC 56
Z9 56
U1 0
U2 20
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0161-813X
EI 1872-9711
J9 NEUROTOXICOLOGY
JI Neurotoxicology
PD SEP
PY 2014
VL 44
BP 204
EP 217
DI 10.1016/j.neuro.2014.06.012
PG 14
WC Neurosciences; Pharmacology & Pharmacy; Toxicology
SC Neurosciences & Neurology; Pharmacology & Pharmacy; Toxicology
GA AQ2XY
UT WOS:000342654500023
PM 24997244
DA 2019-10-23
ER

PT J
AU Bo, J
   Gopalakrishnan, S
   Chen, FY
   Wang, KJ
AF Bo, Jun
   Gopalakrishnan, Singaram
   Chen, Fang-Yi
   Wang, Ke-Jian
TI Benzo[a]pyrene modulates the biotransformation, DNA damage and cortisol
   level of red sea bream challenged with lipopolysaccharide
SO MARINE POLLUTION BULLETIN
LA English
DT Article; Proceedings Paper
CT 7th International Conference on Marine Pollution and Ecotoxicology
CY JUN 17-21, 2013
CL Hong Kong, PEOPLES R CHINA
DE Benzo[a]pyrene; DNA damage; EROD activity; Cytochrome P4501A1; Adverse
   outcome pathway
ID POLYCYCLIC AROMATIC-HYDROCARBONS; TROUT ONCORHYNCHUS-MYKISS; MEDAKA
   ORYZIAS-LATIPES; CARP CYPRINUS-CARPIO; RAINBOW-TROUT;
   BETA-NAPHTHOFLAVONE; CYTOCHROME-P450 ACTIVITIES; BENZO(A)PYRENE
   TREATMENT; ORGANIC CONTAMINANTS; CYP1A EXPRESSION
AB In animals, biotransformation and the immune system interact with each other, however, knowledge of the toxic mechanism of benzo[a]pyrene (BaP) on these two systems is not well known. The present study investigated the toxic effects of BaP on the biotransformation system, cortisol level and DNA integrity of red sea bream (Pagrus major). The results showed that cortisol level was induced under the challenge of lipopolysaccharide (LPS). Short-term exposure (96 h) of BaP at environmental concentration significantly increased the cortisol level, hepatic EROD activity and CYP1A1 mRNA expression. When P. major was exposed to BaP for 14 d followed by LPS challenge this increased the cortisol level, EROD activity and hepatic DNA damage except CYP1A1 mRNA expression. Combined with our previous data, which showed that BaP exposure can modulate the immunologic response in P. major challenged with LPS, a hypothetical adverse outcome pathway of BaP on fish was suggested. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Bo, Jun] State Ocean Adm, Inst Oceanog 3, Xiamen 361005, Fujian, Peoples R China.
   [Gopalakrishnan, Singaram; Chen, Fang-Yi; Wang, Ke-Jian] Xiamen Univ, Coll Ocean & Earth Sci, State Key Lab Marine Environm Sci, Xiamen 361005, Fujian, Peoples R China.
RP Wang, KJ (reprint author), Xiamen Univ, Coll Ocean & Earth Sci, State Key Lab Marine Environm Sci, Xiamen 361005, Fujian, Peoples R China.
EM wkjian@xmu.edu.cn
RI Wang, KJ/G-4609-2010
CR Abrahamson A, 2007, AQUAT TOXICOL, V85, P1, DOI 10.1016/j.aquatox.2007.07.013
   Aluru N, 2004, AQUAT TOXICOL, V67, P273, DOI 10.1016/j.aquatox.2004.01.010
   An LH, 2011, MAR POLLUT BULL, V62, P718, DOI 10.1016/j.marpolbul.2011.01.019
   Arkoosh MR, 2010, AQUAT TOXICOL, V98, P51, DOI 10.1016/j.aquatox.2010.01.013
   Bo J., 2012, ENV TOXICOL
   Bo Jun, 2010, Acta Scientiarum Naturalium Universitatis Sunyatseni, V49, P93
   Brown M, 2006, MAR ENVIRON RES, V62, pS128, DOI 10.1016/j.marenvres.2006.04.057
   BURKE MD, 1974, DRUG METAB DISPOS, V2, P583
   Carlson EA, 2004, MAR ENVIRON RES, V58, P731, DOI 10.1016/j.marenvres.2004.03.023
   Carlson EA, 2004, TOXICOL APPL PHARM, V201, P40, DOI 10.1016/j.taap.2004.04.018
   Carlson EA, 2002, AQUAT TOXICOL, V56, P289, DOI 10.1016/S0166-445X(01)00223-5
   Celander M, 1996, ARCH BIOCHEM BIOPHYS, V329, P113, DOI 10.1006/abbi.1996.0198
   Celander Malin, 1999, P246
   Circu ML, 2010, FREE RADICAL BIO MED, V48, P749, DOI 10.1016/j.freeradbiomed.2009.12.022
   dos Anjos NA, 2011, AQUAT TOXICOL, V103, P46, DOI 10.1016/j.aquatox.2011.02.004
   Gesto M, 2008, AQUAT TOXICOL, V86, P341, DOI 10.1016/j.aquatox.2007.11.014
   Gopalakrishnan S, 2009, CHEMOSPHERE, V75, P389, DOI 10.1016/j.chemosphere.2008.12.027
   Jonsson EM, 2002, ENVIRON SCI TECHNOL, V36, P3340, DOI 10.1021/es015859a
   Kramer VJ, 2011, ENVIRON TOXICOL CHEM, V30, P64, DOI 10.1002/etc.375
   KUCKLICK JR, 1994, MAR ENVIRON RES, V37, P63, DOI 10.1016/0141-1136(94)90063-9
   Levine SL, 1999, AQUAT TOXICOL, V46, P279, DOI 10.1016/S0166-445X(98)00124-6
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Manoli E, 1999, TRAC-TREND ANAL CHEM, V18, P417, DOI 10.1016/S0165-9936(99)00111-9
   Marionnet D, 2006, FISH SHELLFISH IMMUN, V21, P80, DOI 10.1016/j.fsi.2005.10.006
   Marionnet D, 1998, ECOTOX ENVIRON SAFE, V41, P189, DOI 10.1006/eesa.1998.1697
   Maskaoui K, 2002, ENVIRON POLLUT, V118, P109, DOI 10.1016/S0269-7491(01)00208-1
   Monostory K, 2009, DRUG METAB REV, V41, P547, DOI [10.3109/03602530903112284, 10.1080/03602530903112284]
   Navas JM, 2001, CHEM-BIOL INTERACT, V138, P285, DOI 10.1016/S0009-2797(01)00280-0
   Ortiz-Delgado JB, 2008, ECOTOX ENVIRON SAFE, V69, P80, DOI 10.1016/j.ecoenv.2006.12.021
   Reynaud S, 2006, AQUAT TOXICOL, V77, P229, DOI 10.1016/j.aquatox.2005.10.018
   Reynaud S, 2005, ECOTOX ENVIRON SAFE, V62, P355, DOI 10.1016/j.ecoenv.2004.12.013
   Reynaud S, 2008, AQUAT TOXICOL, V87, P139, DOI 10.1016/j.aquatox.2008.01.013
   Shelley LK, 2009, AQUAT TOXICOL, V92, P95, DOI 10.1016/j.aquatox.2009.01.005
   Thilagam H, 2010, ECOTOXICOLOGY, V19, P1258, DOI 10.1007/s10646-010-0510-3
   Thilagam H, 2009, ENVIRON TOXICOL CHEM, V28, P1722, DOI 10.1897/08-642.1
   Tintos A, 2008, ECOTOX ENVIRON SAFE, V69, P180, DOI 10.1016/j.ecoenv.2007.03.009
   van der Oost R, 2003, ENVIRON TOXICOL PHAR, V13, P57, DOI 10.1016/S1382-6689(02)00126-6
   Van Metre PC, 2003, CHEMOSPHERE, V52, P1727, DOI 10.1016/S0045-6535(03)00454-5
   Van Metre PC, 2005, ENVIRON SCI TECHNOL, V39, P5567, DOI 10.1021/es0503175
   VIJAYAN MM, 1990, J ENDOCRINOL, V124, P311, DOI 10.1677/joe.0.1240311
   Wang KJ, 2009, MAR ENVIRON RES, V67, P159, DOI 10.1016/j.marenvres.2008.12.008
   Watanabe KH, 2011, ENVIRON TOXICOL CHEM, V30, P9, DOI 10.1002/etc.373
   Williams DE, 1998, MUTAT RES-FUND MOL M, V399, P179, DOI 10.1016/S0027-5107(97)00255-8
NR 43
TC 9
Z9 10
U1 0
U2 12
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0025-326X
EI 1879-3363
J9 MAR POLLUT BULL
JI Mar. Pollut. Bull.
PD AUG 30
PY 2014
VL 85
IS 2
SI SI
BP 463
EP 470
DI 10.1016/j.marpolbul.2014.05.023
PG 8
WC Environmental Sciences; Marine & Freshwater Biology
SC Environmental Sciences & Ecology; Marine & Freshwater Biology
GA AO7TS
UT WOS:000341556100021
PM 24882445
DA 2019-10-23
ER

PT J
AU Murphy, C
   Schmitt, B
   Armstrong, B
   Mora, F
   Carvan, M
   Basu, N
   Head, J
AF Murphy, Cheryl
   Schmitt, Benjamin
   Armstrong, Brandon
   Mora, Francisco
   Carvan, Michael
   Basu, Nil
   Head, Jessica
TI Development of an adverse outcome pathway for neurobehavior in larval
   fish to predict effects of contaminants within a multiple stressor
   context
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
CT 248th National Meeting of the American-Chemical-Society (ACS)
CY AUG 10-14, 2014
CL San Francisco, CA
SP Amer Chem Soc
C1 [Murphy, Cheryl; Schmitt, Benjamin; Armstrong, Brandon] Michigan State Univ, Dept Fisheries & Wildlife, E Lansing, MI 48824 USA.
   [Mora, Francisco; Carvan, Michael] Univ Wisconsin, Sch Freshwater Sci, Milwaukee, WI 53204 USA.
   [Basu, Nil; Head, Jessica] McGill Univ, Fac Agr & Environm Sci, Montreal, PQ H9X 3V9, Canada.
EM camurphy@msu.edu
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD AUG 10
PY 2014
VL 248
MA 195-AGRO
PG 1
WC Chemistry, Multidisciplinary
SC Chemistry
GA CA8JN
UT WOS:000349165100560
DA 2019-10-23
ER

PT J
AU Watanabe, KH
AF Watanabe, Karen H.
TI Mechanistic models and adverse outcome pathways: Research needs for risk
   assessment
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
CT 248th National Meeting of the American-Chemical-Society (ACS)
CY AUG 10-14, 2014
CL San Francisco, CA
SP Amer Chem Soc
C1 [Watanabe, Karen H.] Oregon Hlth & Sci Univ, Div Environm & Biomol Syst, Portland, OR 97239 USA.
EM watanabk@ohsu.edu
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD AUG 10
PY 2014
VL 248
MA 196-AGRO
PG 1
WC Chemistry, Multidisciplinary
SC Chemistry
GA CA8JN
UT WOS:000349165100561
DA 2019-10-23
ER

PT J
AU Rattner, BA
   Lazarus, RS
   Elliott, JE
   Shore, RF
   van den Brink, N
AF Rattner, Barnett A.
   Lazarus, Rebecca S.
   Elliott, John E.
   Shore, Richard F.
   van den Brink, Nico
TI Adverse Outcome Pathway and Risks of Anticoagulant Rodenticides to
   Predatory Wildlife
SO ENVIRONMENTAL SCIENCE & TECHNOLOGY
LA English
DT Review
ID EASTERN SCREECH-OWLS; POLECATS MUSTELA-PUTORIUS; RATS RATTUS-NORVEGICUS;
   KITES MILVUS-MILVUS; NONTARGET WILDLIFE; BRODIFACOUM BAIT; BONE-DENSITY;
   PEST-CONTROL; EXPOSURE; DIPHACINONE
AB Despite a long history of successful use, routine application of some anticoagulant rodenticides (ARs) may be at a crossroad due to new regulatory guidelines intended to mitigate risk. An adverse outcome pathway for ARs was developed to identify information gaps and end points to assess the effectiveness of regulations. This framework describes chemical properties of ARs, established macromolecular interactions by inhibition of vitamin K epoxide reductase, cellular responses including altered dotting factor processing and coagulopathy, organ level effects such as hemorrhage, organism responses with linkages to reduced fitness and mortality, and potential consequences to predator populations. Risk assessments have led to restrictions affecting use of some second-generation ARs (SGARs) in North America. While the European regulatory community highlighted significant or unacceptable risk of ARs to nontarget wildlife, use of SGARs in most EU member states remains authorized due to public health concerns and the absence of safe alternatives. For purposes of conservation and restoration of island habitats, SGARs remain a mainstay for eradication of invasive species. There are significant data gaps related to exposure pathways, comparative species sensitivity, consequences of sublethal effects, potential hazards of greater AR residues in genetically resistant prey, effects of low-level exposure to multiple rodenticides, and quantitative data on the magnitude of nontarget wildlife mortality.
C1 [Rattner, Barnett A.; Lazarus, Rebecca S.] US Geol Survey, Patuxent Wildlife Res Ctr, Beltsville, MD 20705 USA.
   [Elliott, John E.] Environm Canada, Pacific Wildlife Res Ctr, Delta, BC V4K 3N2, Canada.
   [Shore, Richard F.] NERC, Ctr Ecol & Hydrol, LEC, Lancaster LA1 4AP, England.
   [van den Brink, Nico] Wageningen Univ, Div Toxicol, NL-6700 EA Wageningen, Netherlands.
RP Rattner, BA (reprint author), US Geol Survey, Patuxent Wildlife Res Ctr, Beltsville, MD 20705 USA.
EM brattner@usgs.gov
RI Shore, Richard/A-2638-2012
OI Shore, Richard/0000-0002-9337-8883
CR Albert CA, 2010, ARCH ENVIRON CON TOX, V58, P451, DOI 10.1007/s00244-009-9402-z
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   [Anonymous], 2005, EPAHQOPP201107180085
   [Anonymous], 2009, WAL MARTS 2009 PESP
   [Anonymous], 2014, ROD BIOC LEG
   [Anonymous], 2014, HLTH SAF EX UK
   [Anonymous], 2013, GUID BEST PRACT US R
   [Anonymous], 2012, DAT ISL INV SPEC ER
   [Anonymous], 1998, 738R007 EPA
   [Anonymous], 2012, NEW US RESTR COMM CL
   [Anonymous], 2014, ROD PROD CONS
   [Anonymous], 2014, RAC DEL 16 CLH OP
   [Anonymous], 2012, FIN BIOL OP ROZ US B
   [Anonymous], 2013, CAMP RESP ROD US
   [Anonymous], 2010, RAT ISL RAT ER PROJ
   [Anonymous], 2008, EPAHQOPP200609550764
   [Anonymous], 2012, FIN RISK MIT DEC 10
   [Anonymous], 2011, EPAHQOPP201107180006
   [Anonymous], 2012, MEM 2 GEN ANT ROD
   [Anonymous], 2011, SET SCI ISS BEING CO
   Atterby H, 2005, ENVIRON TOXICOL CHEM, V24, P318, DOI 10.1897/04-022R.1
   Barnes C, 2005, PEDIATR RES, V57, P578, DOI 10.1203/01.PDR.0000155943.07244.04
   Berny P, 2008, J WILDLIFE DIS, V44, P417, DOI 10.7589/0090-3558-44.2.417
   Berny PJ, 1997, CHEMOSPHERE, V35, P1817, DOI 10.1016/S0045-6535(97)00242-7
   Blackie HM, 2014, PEST MANAG SCI, V70, P345, DOI 10.1002/ps.3627
   Booth L. H., 2001, LIT REV ACUTE TOXICI, V177
   Bowie MH, 2006, NEW ZEAL J ECOL, V30, P219
   Brakes CR, 2005, J APPL ECOL, V42, P118, DOI 10.1111/j.1365-2664.2005.00997.x
   Buckle A, 2013, PEST MANAG SCI, V69, P334, DOI 10.1002/ps.3309
   Buckle AP, 2012, PEST MANAG SCI, V68, P1579, DOI 10.1002/ps.3352
   Burn A.J., 2002, Aspects of Applied Biology, V67, P203
   Christensen TK, 2012, ARCH ENVIRON CON TOX, V63, P437, DOI 10.1007/s00244-012-9771-6
   Coeurdassier M, 2012, IBIS, V154, P136, DOI 10.1111/j.1474-919X.2011.01193.x
   COLVIN B A, 1988, Bulletin OEPP, V18, P301
   Dargaud Y, 2013, J THROMB HAEMOST, V11, P1043, DOI 10.1111/jth.12244
   Dawson A., 2004, PEST US SUR185 DEP E
   Dawson A., 2003, 175 DEP ENV FODO RUR
   Dolmella A, 1999, J MOL STRUCT, V513, P177, DOI 10.1016/S0022-2860(99)00119-2
   Dowding CV, 2010, ENVIRON POLLUT, V158, P161, DOI 10.1016/j.envpol.2009.07.017
   Eason C. T., 2009, DEP CONSERVATION RES, V312
   Eason C, 2010, NEW ZEAL J ZOOL, V37, P175, DOI 10.1080/03014223.2010.482976
   Eason CT, 2010, INT J PEST MANAGE, V56, P109, DOI 10.1080/09670870903243463
   Eason CT, 1995, NEW ZEAL J ZOOL, V22, P371, DOI 10.1080/03014223.1995.9518055
   Eason CT, 2002, ECOTOXICOLOGY, V11, P35, DOI 10.1023/A:1013793029831
   EICHBAUM FW, 1979, N-S ARCH PHARMACOL, V307, P185, DOI 10.1007/BF00498462
   Eisemann John D., 2006, Proceedings of the Vertebrate Pest Conference, V22, P413
   Elliott JE, 2014, ENVIRON MONIT ASSESS, V186, P895, DOI 10.1007/s10661-013-3422-x
   Elmeros M, 2011, SCI TOTAL ENVIRON, V409, P2373, DOI 10.1016/j.scitotenv.2011.03.006
   Elsmore R, 2010, CHIM OGGI, V28, P34
   Erickson W., 2004, POTENTIAL RISKS 9 RO
   Fournier-Chambrillon C, 2004, J WILDLIFE DIS, V40, P688, DOI 10.7589/0090-3558-40.4.688
   Furie B, 1999, BLOOD, V93, P1798, DOI 10.1182/blood.V93.6.1798.406k22_1798_1808
   Gomez-Canela C, 2014, ANAL BIOANAL CHEM, V406, P345, DOI 10.1007/s00216-013-7449-1
   Grandemange A, 2010, PEST MANAG SCI, V66, P270, DOI 10.1002/ps.1869
   GREAVES J H, 1973, Laboratory Animals (London), V7, P141, DOI 10.1258/002367773781008614
   Gutsell S, 2013, TOXICOL RES-UK, V2, P299, DOI 10.1039/c3tx50024a
   Hadler MR, 1992, P VERT PEST C, P149
   Head JA, 2008, ENVIRON SCI TECHNOL, V42, P7535, DOI 10.1021/es801082a
   HEGDAL PL, 1988, ENVIRON TOXICOL CHEM, V7, P245, DOI 10.1002/etc.5620070309
   Hoare JM, 2006, NEW ZEAL J ECOL, V30, P157
   Hodroge A, 2011, ARCH BIOCHEM BIOPHYS, V515, P14, DOI 10.1016/j.abb.2011.08.010
   Hoffman M, 2001, THROMB HAEMOSTASIS, V85, P958
   Howald GR, 1999, ECOTOXICOLOGY, V8, P431, DOI 10.1023/A:1008951701780
   Howald G, 2007, CONSERV BIOL, V21, P1258, DOI 10.1111/j.1523-1739.2007.00755.x
   Huang A. C., 2013, RAPT RES FDN ANN M B
   HUCKLE KR, 1988, XENOBIOTICA, V18, P1465, DOI 10.3109/00498258809042269
   HUCKLE KR, 1989, XENOBIOTICA, V19, P51, DOI 10.3109/00498258909034676
   Hughes J, 2013, ECOTOXICOLOGY, V22, P974, DOI 10.1007/s10646-013-1074-9
   Ishizuka M, 2007, DRUG METAB DISPOS, V35, P62, DOI 10.1124/dmd.106.011775
   Jacob J., 2010, RODENT OUTBREAKS ECO, P207
   Jakel T, 1996, J PARASITOL, V82, P280, DOI 10.2307/3284161
   Joermann G., 1998, Bulletin OEPP, V28, P157
   Johnston JJ, 2005, ENVIRON TOXICOL CHEM, V24, P1557, DOI 10.1897/04-255R.1
   Kater AP, 2002, CLIN DIAGN LAB IMMUN, V9, P1396, DOI 10.1128/CDLI.9.6.1396-1397.2002
   Kaukeinen D., 1982, Proceedings of the Vertebrate Pest Conference, V10, P151
   Kaukeinen DE, 2000, PROC VERTEBR PEST C, P245
   Knopper LD, 2007, B ENVIRON CONTAM TOX, V78, P249, DOI 10.1007/s00128-007-9122-x
   Kramer VJ, 2011, ENVIRON TOXICOL CHEM, V30, P64, DOI 10.1002/etc.375
   LaLone CA, 2013, AQUAT TOXICOL, V144, P141, DOI 10.1016/j.aquatox.2013.09.004
   Langford KH, 2013, SCI TOTAL ENVIRON, V450, P205, DOI 10.1016/j.scitotenv.2013.01.100
   Last JA, 2002, TOXICOL SCI, V66, P4, DOI 10.1093/toxsci/66.1.4
   Lee M, 2006, HAEMOPHILIA, V12, P1, DOI 10.1111/j.1365-2516.2006.01253.x
   LIMA L. L, 2010, P VERTEBR PEST C, P199
   Lodal J., 2002, HUMAN ENV EXPOSURE R
   Masuda BM, 2014, NEW ZEAL J ECOL, V38, P110
   Mcdonald RA, 2000, MAMMAL REV, V30, P57, DOI 10.1046/j.1365-2907.2000.00053.x
   McRobb FM, 2014, ENVIRON SCI TECHNOL, V48, P1964, DOI 10.1021/es404568a
   MERSON MH, 1984, J WILDLIFE MANAGE, V48, P212, DOI 10.2307/3808474
   MOSTERD JJ, 1991, BRIT J PHARMACOL, V104, P531, DOI 10.1111/j.1476-5381.1991.tb12463.x
   MOUNT ME, 1983, AM J VET RES, V44, P2009
   MOUNT ME, 1988, VET CLIN N AM-SMALL, V18, P115, DOI 10.1016/S0195-5616(88)50012-8
   Murray M, 2008, J AVIAN MED SURG, V22, P41, DOI 10.1647/2007-012R.1
   Murray M, 2011, J ZOO WILDLIFE MED, V42, P88, DOI 10.1638/2010-0188.1
   Naim M., 2011, DYN BIOCH PROCESS BI, V5, P5
   Newton I., 1999, ADV VERTEBRATE PEST, P347
   Parkes John, 2011, Conservation Evidence, V8, P100
   Paz A, 2013, PEST MANAG SCI, V69, P444, DOI 10.1002/ps.3289
   Pelz HJ, 2005, GENETICS, V170, P1839, DOI 10.1534/genetics.104.040360
   Ponczek MB, 2008, J THROMB HAEMOST, V6, P1876, DOI 10.1111/j.1538-7836.2008.03143.x
   Pospischil Reiner, 1994, Proceedings of the Vertebrate Pest Conference, V16, P180
   Rattner B. A., 2012, P VERT PEST C, V25, P124
   Rattner BA, 2014, ENVIRON TOXICOL CHEM, V33, P74, DOI 10.1002/etc.2390
   Rattner BA, 2012, ECOTOXICOLOGY, V21, P832, DOI 10.1007/s10646-011-0844-5
   Rattner BA, 2011, ENVIRON TOXICOL CHEM, V30, P1213, DOI 10.1002/etc.490
   Rattner BA, 2010, ECOTOX ENVIRON SAFE, V73, P1159, DOI 10.1016/j.ecoenv.2010.05.021
   Riley SPD, 2007, J WILDLIFE MANAGE, V71, P1874, DOI 10.2193/2005-615
   Sage M, 2010, ENVIRON RES, V110, P664, DOI 10.1016/j.envres.2010.07.009
   Salim H., 2013, P AGR AN 2013, P243
   Sanchez-Barbudo IS, 2012, SCI TOTAL ENVIRON, V420, P280, DOI 10.1016/j.scitotenv.2012.01.028
   Shlosberg A, 2006, VET CLIN TREATMENT V
   Shore R. F., 2014, RODENT PEST IN PRESS
   Shore RF, 1996, ENVIRON POLLUT, V91, P279, DOI 10.1016/0269-7491(95)00074-7
   Shore RF, 2003, ENVIRON POLLUT, V122, P183, DOI 10.1016/S0269-7491(02)00297-X
   Singleton G. R, 2010, RODENT OUTBREAKS ECO
   Smith R. H., 1999, ADV VERTEBRATE PEST, P331
   Smith S, 2010, SCHALMS VET HEMATOLO, P635
   Spurr EB, 1999, NEW ZEAL J ECOL, V23, P167
   Stephenson BH, 1999, NEW ZEAL J ECOL, V23, P233
   Stone WB, 2003, B ENVIRON CONTAM TOX, V70, P34, DOI 10.1007/s00128-002-0152-0
   Stone WB, 1999, J WILDLIFE DIS, V35, P187, DOI 10.7589/0090-3558-35.2.187
   Stroud RK, 2012, VET J, V194, P278, DOI 10.1016/j.tvjl.2012.06.006
   SUTCLIFFE F A, 1987, Reviews on Drug Metabolism and Drug Interactions, V5, P225
   Tanaka KD, 2012, PESTIC BIOCHEM PHYS, V103, P144, DOI 10.1016/j.pestbp.2012.04.011
   THIJSSEN HHW, 1995, PESTIC SCI, V43, P73, DOI 10.1002/ps.2780430112
   Thomas P.J., 2011, ENVIRON INT, V40, P256
   Thomas PJ, 2011, ENVIRON INT, V37, P914, DOI 10.1016/j.envint.2011.03.010
   Tie JK, 2008, VITAM HORM, V78, P103, DOI 10.1016/S0083-6729(07)00006-4
   Tosh DG, 2011, ENVIRON POLLUT, V159, P3106, DOI 10.1016/j.envpol.2011.03.028
   Tosh DG, 2012, ECOTOXICOLOGY, V21, P1325, DOI 10.1007/s10646-012-0886-3
   Tosh DG, 2011, J ENVIRON MANAGE, V92, P1503, DOI 10.1016/j.jenvman.2010.12.014
   VANDENBERG G, 1975, BIOCHEM PHARMACOL, V24, P815, DOI 10.1016/0006-2952(75)90125-2
   Vein J, 2013, PEST MANAG SCI, V69, P397, DOI 10.1002/ps.3367
   Vidal D, 2009, SCI TOTAL ENVIRON, V408, P267, DOI 10.1016/j.scitotenv.2009.10.001
   Vyas N. B., 2013, DRAKE J AGR LAW, V18, P335
   Vyas NB, 2012, HUM ECOL RISK ASSESS, V18, P1069, DOI 10.1080/10807039.2012.707934
   Walker L. A., 2013, ANTICOAGULANT RODENT
   Walker LA, 2008, SCI TOTAL ENVIRON, V392, P93, DOI 10.1016/j.scitotenv.2007.10.061
   Watanabe KP, 2010, COMP BIOCHEM PHYS C, V152, P114, DOI 10.1016/j.cbpc.2010.03.006
   Watt Barbara E, 2005, Toxicol Rev, V24, P259, DOI 10.2165/00139709-200524040-00005
   Witmer G., 2007, P 12 WILDL DAM MAN C, V12, P160
   Yanagita M, 1999, J AM SOC NEPHROL, V10, P2503
   Young John, 1997, Australian Bird Watcher, V17, P160
NR 142
TC 50
Z9 51
U1 4
U2 91
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0013-936X
EI 1520-5851
J9 ENVIRON SCI TECHNOL
JI Environ. Sci. Technol.
PD AUG 5
PY 2014
VL 48
IS 15
SI SI
BP 8433
EP 8445
DI 10.1021/es501740n
PG 13
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA AM7WY
UT WOS:000340080600016
PM 24968307
OA Green Accepted, Green Published
DA 2019-10-23
ER

PT J
AU van der Veen, JW
   Soeteman-Hernandez, LG
   Ezendam, J
   Stierum, R
   Kuper, FC
   van Loveren, H
AF van der Veen, Jochem W.
   Soeteman-Hernandez, Lya G.
   Ezendam, Janine
   Stierum, Rob
   Kuper, Frieke C.
   van Loveren, Henk
TI Anchoring molecular mechanisms to the adverse outcome pathway for skin
   sensitization: Analysis of existing data
SO CRITICAL REVIEWS IN TOXICOLOGY
LA English
DT Review
DE allergic contact dermatitis; adverse outcome pathway; human in vitro
   systems; mechanisms of toxicity; molecular map; skin sensitization
ID ALLERGIC CONTACT-DERMATITIS; OF-FUNCTION MUTATIONS; PATCH-TEST
   REACTIONS; TOLL-LIKE RECEPTORS; LYMPH-NODE ASSAY; GENE-EXPRESSION;
   CELL-LINE; DENDRITIC CELLS; FILAGGRIN GENE; CHEMICAL SENSITIZERS
AB Allergic contact dermatitis (ACD) is a hypersensitivity immune response induced by small protein-reactive chemicals. Currently, the murine local lymph node assay (LLNA) provides hazard identification and quantitative estimation of sensitizing potency. Given the complexity of ACD, a single alternative method cannot replace the LLNA, but it is necessary to combine methods through an integrated testing strategy (ITS). In the development of an ITS, information regarding mechanisms and molecular processes involved in skin sensitization is crucial. The recently published adverse outcome pathway (AOP) for skin sensitization captures mechanistic knowledge into key events that lead to ACD. To understand the molecular processes in ACD, a systematic review of murine in vivo studies was performed and an ACD molecular map was constructed. In addition, comparing the molecular map to the limited human in vivo toxicogenomic data available suggests that certain processes are similarly triggered in mice and humans, but additional human data will be needed to confirm these findings and identify differences. To gain insight in the molecular mechanisms represented by various human in vitro systems, the map was compared to in vitro toxicogenomic data. This analysis allows for comparison of emerging in vitro methods on a molecular basis, in addition to mathematical predictive value. Finally, a survey of the current in silico, in chemico, and in vitro methods was used to indicate which AOP key event is modeled by each method. By anchoring emerging classification methods to the AOP and the ACD molecular map, complementing methods can be identified, which provides a cornerstone for the development of a testing strategy that accurately reflects the key events in skin sensitization.
C1 [van der Veen, Jochem W.; Soeteman-Hernandez, Lya G.; Ezendam, Janine; van Loveren, Henk] Natl Inst Publ Hlth & Environm RIVM, Ctr Hlth Protect, NL-3720 BA Bilthoven, Netherlands.
   [Stierum, Rob; Kuper, Frieke C.] TNO, NL-3700 AJ Zeist, Netherlands.
   [van der Veen, Jochem W.; van Loveren, Henk] Maastricht Univ, Dept Toxicogen, Maastricht, Netherlands.
RP van der Veen, JW (reprint author), Natl Inst Publ Hlth & Environm RIVM, POB 1, NL-3720 BA Bilthoven, Netherlands.
EM Lya.Hernandez@rivm.nl
OI Kuper, Frieke/0000-0001-8273-2915; Soeteman-Hernandez, Lya
   G./0000-0003-3529-3694
FU Netherlands Organisation for Health research and development (ZonMW)
   through the 'Data lntegration & Mining Towards Risk Assessment
   [165600002]; Enabling Technology Systems Biology program; 3R research
   program
FX The author's affiliation is as shown on the cover page. The authors have
   sole responsibility for the writing and content of the paper. This work
   was funded by the Netherlands Organisation for Health research and
   development (ZonMW) through the 'Data lntegration & Mining Towards Risk
   Assessment (project number: 165600002)' project. TNO internal funding
   was provided from Enabling Technology Systems Biology and 3R research
   programs.
CR Ade N, 2009, TOXICOL SCI, V107, P451, DOI 10.1093/toxsci/kfn243
   Adler S, 2011, ARCH TOXICOL, V85, P367, DOI 10.1007/s00204-011-0693-2
   Aeby P, 2010, TOXICOL IN VITRO, V24, P1465, DOI 10.1016/j.tiv.2010.07.005
   Albanesi C, 2010, CURR OPIN ALLERGY CL, V10, P452, DOI 10.1097/ACI.0b013e32833e08ae
   Ashikaga T, 2006, TOXICOL IN VITRO, V20, P767, DOI 10.1016/j.tiv.2005.10.012
   Basketter DA, 2010, COMP TOXICOLOGY, V5
   Basketter David A, 2007, Cutan Ocul Toxicol, V26, P293, DOI 10.1080/15569520701556647
   Bauch C, 2012, REGUL TOXICOL PHARM, V63, P489, DOI 10.1016/j.yrtph.2012.05.013
   Boehme KW, 2004, J VIROL, V78, P7867, DOI 10.1128/JVI.78.15.7867-7873.2004
   Boorsma A, 2005, NUCLEIC ACIDS RES, V33, pW592, DOI 10.1093/nar/gki484
   Bos JD, 1989, ACTA DERM-VENEREOL, V151, P84
   Bos JD, 1989, ACTA DERM-VENEREOL, V151, P106
   Cavani A, 2007, CURR OPIN ALLERGY CL, V7, P404, DOI 10.1097/ACI.0b013e3282ef6923
   Cavani A, 2010, CURR DRUG METAB, V11, P228, DOI 10.2174/138920010791196300
   Clark SC, 2009, DERMATOL CLIN, V27, P365, DOI 10.1016/j.det.2009.05.002
   Clemmensen A, 2010, J INVEST DERMATOL, V130, P2201, DOI 10.1038/jid.2010.102
   Corsini E, 2009, TOXICOL IN VITRO, V23, P789, DOI 10.1016/j.tiv.2009.04.005
   Dancik Y, 2013, ADV DRUG DELIVER REV, V65, P221, DOI 10.1016/j.addr.2012.01.006
   Davis BK, 2011, ANNU REV IMMUNOL, V29, P707, DOI 10.1146/annurev-immunol-031210-101405
   de Jongh CM, 2008, BRIT J DERMATOL, V159, P621, DOI 10.1111/j.1365-2133.2008.08730.x
   dos Santos GG, 2009, TOXICOL APPL PHARM, V236, P372, DOI 10.1016/j.taap.2009.02.004
   EC-JRC, 2013, EURL ECVAM REC DIR P
   El Ali Z, 2013, TOXICOL SCI, V134, P39, DOI 10.1093/toxsci/kft084
   Emter R, 2010, TOXICOL APPL PHARM, V245, P281, DOI 10.1016/j.taap.2010.03.009
   ENK AH, 1992, J INVEST DERMATOL, V99, pS39, DOI 10.1111/1523-1747.ep12668608
   ENK AH, 1992, P NATL ACAD SCI USA, V89, P1398, DOI 10.1073/pnas.89.4.1398
   Enoch SJ, 2011, CRIT REV TOXICOL, V41, P783, DOI 10.3109/10408444.2011.598141
   Ermertcan AT, 2011, J EUR ACAD DERMATOL, V25, P997, DOI 10.1111/j.1468-3083.2011.04049.x
   Esser PR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041340
   Feldmeyer L, 2010, EUR J CELL BIOL, V89, P638, DOI 10.1016/j.ejcb.2010.04.008
   Freudenberg MA, 2009, GIORN ITAL DERMAT V, V144, P173
   Gerberick GF, 2005, DERMATITIS, V16, P157, DOI 10.2310/6620.2005.05040
   Gibbs S, 2012, TOXICOL IN VITRO
   Gibbs S, 2013, TOXICOL APPL PHARM, V272, P529, DOI 10.1016/j.taap.2013.07.003
   Hamilton Tatyana, 2011, Skin Therapy Lett, V16, P1
   Hansen MB, 2005, CONTACT DERMATITIS, V53, P100, DOI 10.1111/j.0105-1873.2005.00658.x
   Hartung T, 2013, ALTEX-ALTERN ANIM EX, V30, P119, DOI 10.14573/altex.2013.2.119
   Hewitt NJ, 2013, TOXICOL SCI, V133, P209, DOI 10.1093/toxsci/kft080
   Hirota M, 2006, TOXICOL IN VITRO, V20, P736, DOI 10.1016/j.tiv.2005.10.013
   Jaworska J., 2013, J APPL TOXICOL
   Jaworska J, 2011, ALTEX-ALTERN ANIM EX, V28, P211, DOI 10.14573/altex.2011.3.211
   Johansson H, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-399
   Karlberg AT, 2008, CHEM RES TOXICOL, V21, P53, DOI 10.1021/tx7002239
   Kelder T, 2012, NUCLEIC ACIDS RES, V40, pD1301, DOI 10.1093/nar/gkr1074
   Kimber I, 1995, TOXICOL LETT, V82-3, P491, DOI 10.1016/0378-4274(95)03497-8
   KIMBER I, 1992, TOXICOL APPL PHARM, V117, P137, DOI 10.1016/0041-008X(92)90230-P
   Kimber I, 2011, TOXICOLOGY
   Lalko JF, 2012, TOXICOL IN VITRO
   Li J, 2005, TOXICOL SCI, V83, P313, DOI 10.1093/toxsci/kfi027
   Martin SF, 2011, ALLERGY, V21, P1398
   Martin SF, 2010, CELL MOL LIFE SCI, V67, P4171, DOI 10.1007/s00018-010-0495-3
   McKim JM, 2010, CUTAN OCUL TOXICOL, V29, P171, DOI 10.3109/15569527.2010.483869
   McNeilly AD, 2012, DRUG METAB DISPOS, V40, P283, DOI 10.1124/dmd.111.042085
   Montelius J, 1998, ACTA DERM-VENEREOL, V78, P433
   Mortz CG, 2001, BRIT J DERMATOL, V144, P523, DOI 10.1046/j.1365-2133.2001.04078.x
   Mortz CG, 2008, CURR OPIN ALLERGY CL, V8, P428, DOI 10.1097/ACI.0b013e32830d84ec
   Nacak M, 2006, INT J DERMATOL, V45, P323, DOI 10.1111/j.1365-4632.2004.02464.x
   Najim RA, 2005, ANN SAUDI MED, V25, P473, DOI 10.5144/0256-4947.2005.473
   Natsch A., 2013, J APPL TOXICOL
   Nielsen NH, 2001, ACTA DERM-VENEREOL, V81, P31, DOI 10.1080/000155501750208155
   Nosbaum A, 2009, EUR J DERMATOL, V19, P325, DOI 10.1684/ejd.2009.0686
   Novak N, 2008, J INVEST DERMATOL, V128, P1430, DOI 10.1038/sj.jid.5701190
   Nukada Y, 2013, TOXICOL IN VITRO, V27, P609, DOI 10.1016/j.tiv.2012.11.006
   OECD, 2012, ADV OUTC PATHW SKI 1, V168
   *OECD, 2004, 428 OECD
   OECD, 2010, 429 OECD
   *OECD, 1992, 406 OECD
   OECD, 2012, ENVJMMONO201210PART2
   Ouwehand K, 2010, TOXICOL IN VITRO, V24, P578, DOI 10.1016/j.tiv.2009.10.014
   Patlewicz G, 2007, REGUL TOXICOL PHARM, V48, P225, DOI 10.1016/j.yrtph.2007.03.003
   Pedersen MB, 2007, J INVEST DERMATOL, V127, P2585, DOI 10.1038/sj.jid.5700902
   Saint-Mezard P, 2004, EUR J DERMATOL, V14, P284
   Scheitza S, 2012, J TOXICOL ENV HEAL A, V75, P471, DOI 10.1080/15287394.2012.674915
   Schmidt M, 2010, NAT IMMUNOL, V11, P814, DOI 10.1038/ni.1919
   Schnuch A, 1998, CONTACT DERMATITIS, V38, P209, DOI 10.1111/j.1600-0536.1998.tb05709.x
   Schnuch A, 2011, CONTACT DERMATITIS, V64, P2, DOI 10.1111/j.1600-0536.2010.01800.x
   Schoeters E, 2006, TOXICOL APPL PHARM, V216, P131, DOI 10.1016/j.taap.2006.04.009
   Stutz A, 2009, J CLIN INVEST, V119, P3502, DOI 10.1172/JCI40599
   Thyssen JP, 2009, BRIT J DERMATOL, V161, P1124, DOI 10.1111/j.1365-2133.2009.09325.x
   Thyssen JP, 2008, DERMATITIS, V19, P303, DOI 10.2310/6620.2008.08022
   Toebak MJ, 2009, CONTACT DERMATITIS, V60, P2, DOI 10.1111/j.1600-0536.2008.01443.x
   Trompezinski S, 2008, TOXICOL APPL PHARM, V230, P397, DOI 10.1016/j.taap.2008.03.012
   van der Veen JW, 2013, ARCH TOXICOL, V87, P763, DOI 10.1007/s00204-012-0976-2
   van der Veen JW, 2013, TOXICOL IN VITRO, V27, P314, DOI 10.1016/j.tiv.2012.08.023
   van Iersel MP, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-399
   van Loveren H, 2008, REGUL TOXICOL PHARM, V50, P155, DOI 10.1016/j.yrtph.2007.11.008
   Vandebriel RJ, 2010, TOXICOL SCI, V117, P81, DOI 10.1093/toxsci/kfq182
   Vandebriel RJ, 2010, CRIT REV TOXICOL, V40, P389, DOI 10.3109/10408440903524262
   Vocanson M, 2009, ALLERGY, V64, P1699, DOI 10.1111/j.1398-9995.2009.02082.x
   Vocanson Marc, 2014, Exp Suppl, V104, P89, DOI 10.1007/978-3-0348-0726-5_7
   Wang J, 2010, NEUROPSYCHOPHARMACOL, V35, P702, DOI 10.1038/npp.2009.178
   Wang XT, 2007, HUM MOL GENET, V16, P1188, DOI 10.1093/hmg/ddm066
   Warshaw EM, 2009, DERMATITIS, V20, P14, DOI 10.2310/6620.2008.08039
   Warshaw EM, 2009, J AM ACAD DERMATOL, V60, P23, DOI 10.1016/j.jaad.2008.07.056
   Watanabe H, 2007, J INVEST DERMATOL, V127, P1956, DOI 10.1038/sj.jid.5700819
   Westphal GA, 2000, INT ARCH OCC ENV HEA, V73, P384, DOI 10.1007/s004200000159
   Yamashita K, 2014, J TOXICOL SCI, V39, P147, DOI 10.2131/jts.39.147
   Yazdi AS, 2007, J INVEST DERMATOL, V127, P1853, DOI 10.1038/sj.jid.5700815
   Yoshikawa Y, 2010, J BIOCHEM MOL TOXIC, V24, P10, DOI 10.1002/jbt.20307
   Zug KA, 2009, DERMATITIS, V20, P149, DOI 10.2310/6620.2009.08097
NR 100
TC 9
Z9 10
U1 0
U2 5
PU INFORMA HEALTHCARE
PI LONDON
PA TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND
SN 1040-8444
EI 1547-6898
J9 CRIT REV TOXICOL
JI Crit. Rev. Toxicol.
PD AUG
PY 2014
VL 44
IS 7
BP 590
EP 599
DI 10.3109/10408444.2014.925425
PG 10
WC Toxicology
SC Toxicology
GA AN1QZ
UT WOS:000340360000004
PM 25000333
DA 2019-10-23
ER

PT J
AU Connors, KA
   Voutchkova-Kostal, AM
   Kostal, J
   Anastas, P
   Zimmerman, JB
   Brooks, BW
AF Connors, Kristin A.
   Voutchkova-Kostal, Adelina M.
   Kostal, Jakub
   Anastas, Paul
   Zimmerman, Julie B.
   Brooks, Bryan W.
TI REDUCING AQUATIC HAZARDS OF INDUSTRIAL CHEMICALS: PROBABILISTIC
   ASSESSMENT OF SUSTAINABLE MOLECULAR DESIGN GUIDELINES
SO ENVIRONMENTAL TOXICOLOGY AND CHEMISTRY
LA English
DT Article
DE Hazard/risk assessment; Ecotoxicology; Computational toxicology;
   Probabilistic hazard assessment; Green chemistry
ID TROUT ONCORHYNCHUS-MYKISS; PIMEPHALES-PROMELAS; RISK-ASSESSMENT;
   RAINBOW-TROUT; DAPHNIA-MAGNA; TOXICITY DISTRIBUTIONS; FATHEAD MINNOW;
   IN-VITRO; THRESHOLD; REACH
AB Basic toxicological information is lacking for the majority of industrial chemicals. In addition to increasing empirical toxicity data through additional testing, prospective computational approaches to drug development aim to serve as a rational basis for the design of chemicals with reduced toxicity. Recent work has resulted in the derivation of a "rule of 2," wherein chemicals with an octanol-water partition coefficient (log P) less than 2 and a difference between the lowest unoccupied molecular orbital and the highest occupied molecular orbital (Delta E) greater than 9 (log P < 2 and Delta E > 9 eV) are predicted to be 4 to 5 times less likely to elicit acute or chronic toxicity to model aquatic organisms. The present study examines potential reduction of aquatic toxicity hazards from industrial chemicals if these 2 molecular design guidelines were employed. Probabilistic hazard assessment approaches were used to model the likelihood of encountering industrial chemicals exceeding toxicological categories of concern both with and without the rule of 2. Modeling predicted that utilization of these molecular design guidelines for log P and Delta E would appreciably decrease the number of chemicals that would be designated to be of "high" and "very high" concern for acute and chronic toxicity to standard model aquatic organisms and end points as defined by the US Environmental Protection Agency. For example, 14.5% of chemicals were categorized as having high and very high acute toxicity to the fathead minnow model, whereas only 3.3% of chemicals conforming to the design guidelines were predicted to be in these categories. Considerations of specific chemical classes (e.g., aldehydes), chemical attributes (e.g., ionization), and adverse outcome pathways in representative species (e.g., receptor-mediated responses) could be used to derive future property guidelines for broader classes of contaminants. (c) 2014 SETAC
C1 [Connors, Kristin A.; Brooks, Bryan W.] Baylor Univ, Dept Environm Sci, Waco, TX 76798 USA.
   [Connors, Kristin A.; Brooks, Bryan W.] Baylor Univ, Ctr Reservoir & Aquat Syst Res, Waco, TX 76798 USA.
   [Connors, Kristin A.; Brooks, Bryan W.] Baylor Univ, Inst Biomed Studies, Waco, TX 76798 USA.
   [Voutchkova-Kostal, Adelina M.] George Washington Univ, Washington, DC USA.
   [Kostal, Jakub; Anastas, Paul; Zimmerman, Julie B.] Yale Univ, New Haven, CT USA.
RP Connors, KA (reprint author), Baylor Univ, Dept Environm Sci, Waco, TX 76798 USA.
EM Kristin_Connors@Baylor.edu
RI Zimmerman, Julie/K-9572-2013; Guenat, Heather/H-6528-2014; Brooks, Bryan
   W/B-2612-2010; Anastas, Paul/L-3258-2013; Kostal, Jakub/O-2625-2018
OI Brooks, Bryan W/0000-0002-6277-9852; Anastas, Paul/0000-0003-4777-5172;
   Kostal, Jakub/0000-0001-9727-0477; Zimmerman, Julie/0000-0002-5392-312X;
   Connors, Kristin/0000-0002-4887-8408
FU Glasscock Fund for Excellence in Environmental Science; Department of
   Environmental Science at Baylor University
FX Support for the present study was provided by a grant from the Glasscock
   Fund for Excellence in Environmental Science to K. A. Connors and the
   Department of Environmental Science at Baylor University. We thank C.
   Gaskill for technical assistance.
CR Allanou R., 1999, PUBLIC AVAILABILITY
   Anastas P. T., 1998, GREEN CHEM THEORY PR
   Anastas PT, 2012, ENVIRON SCI TECHNOL, V46, P580, DOI 10.1021/es203881e
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Bearden AP, 1997, ENVIRON TOXICOL CHEM, V16, P1311, DOI 10.1002/etc.5620160629
   Berninger JP, 2011, ENVIRON TOXICOL CHEM, V30, P2065, DOI 10.1002/etc.590
   Berninger JP, 2011, ENVIRON TOXICOL CHEM, V30, P1704, DOI 10.1002/etc.532
   Berninger JP, 2010, TOXICOL LETT, V193, P69, DOI 10.1016/j.toxlet.2009.12.006
   Blackburn K, 2005, REGUL TOXICOL PHARM, V43, P249, DOI 10.1016/j.yrtph.2005.08.007
   BRADBURY SP, 2004, ENVIRON SCI TECHNOL, V38, P463, DOI DOI 10.1021/ES040675S
   Brain RA, 2006, ECOTOX ENVIRON SAFE, V64, P128, DOI 10.1016/j.ecoenv.2005.08.007
   Connors KA, 2013, CHIRALITY, V25, P763, DOI 10.1002/chir.22211
   De Wolf W, 2005, ENVIRON TOXICOL CHEM, V24, P479, DOI 10.1897/04-133R.1
   Dobbins LL, 2009, ENVIRON TOXICOL CHEM, V28, P2744, DOI 10.1897/08-523.1
   Dobbins LL, 2008, ENVIRON TOXICOL CHEM, V27, P2608, DOI 10.1897/08-126.1
   Environmental Defense Fund, 1997, TOX IGN CONT ABS BAS
   Franco A, 2010, INT J LIFE CYCLE ASS, V15, P321, DOI 10.1007/s11367-010-0165-6
   Garrett RL, 1996, ACS SYM SER, V640, P2
   Gonzalez-Doncel M, 2006, CHEMOSPHERE, V63, P835, DOI 10.1016/j.chemosphere.2005.07.060
   Japanese Ministry of Environment, RES EC TESTS CHEM CO
   Konwick BJ, 2006, ENVIRON SCI TECHNOL, V40, P2930, DOI 10.1021/es0600678
   Konwick BJ, 2006, AQUAT TOXICOL, V80, P372, DOI 10.1016/j.aquatox.2006.10.003
   Kroes R, 2005, TOXICOL SCI, V86, P226, DOI 10.1093/toxsci/kfi169
   MCFARLAND JW, 1970, J MED CHEM, V13, P1192, DOI 10.1021/jm00300a040
   Munro IC, 2008, TOXICOL LETT, V180, P151, DOI 10.1016/j.toxlet.2008.05.006
   Munro IC, 1996, FOOD CHEM TOXICOL, V34, P829, DOI 10.1016/S0278-6915(96)00049-X
   National Industrial Chemicals Notification and Assessment Scheme, 1 LRCC
   Netzeva TI, 2008, QSAR COMB SCI, V27, P77, DOI 10.1002/qsar.200710099
   Rand G., 1995, FUNDAMENTALS AQUATIC
   Rendal C, 2011, ENVIRON TOXICOL CHEM, V30, P2395, DOI 10.1002/etc.641
   Rovida C, 2009, ALTEX-ALTERN TIEREXP, V26, P187
   Russom CL, 1997, ENVIRON TOXICOL CHEM, V16, P948, DOI 10.1002/etc.5620160514
   Schaafsma G, 2009, REGUL TOXICOL PHARM, V53, P70, DOI 10.1016/j.yrtph.2008.11.003
   Solomon KR, 2002, SPECIES SENSITIVITY
   Stanley JK, 2007, CHEMOSPHERE, V69, P9, DOI 10.1016/j.chemosphere.2007.04.080
   Stanley JK, 2006, ENVIRON TOXICOL CHEM, V25, P1780, DOI 10.1897/05-298R1.1
   SUTER GW, 2007, ECOLOGICAL RISK ASSE
   U.S. Environmental Protection Agency, 1998, CHEM HAZ DAT AV STUD
   US Environmental Protection Agency, 2012, CRIT US PBT PROF
   US EPA, 2010, TECHN OV EC RISK ASS
   Valenti Theodore W., 2011, Integrated Environmental Assessment and Management, V7, P636, DOI 10.1002/ieam.202
   Valenti TW, 2012, ENVIRON SCI TECHNOL, V46, P2427, DOI 10.1021/es204164b
   Valenti TW, 2009, ENVIRON TOXICOL CHEM, V28, P2685, DOI 10.1897/08-546.1
   VEITH GD, 1983, CAN J FISH AQUAT SCI, V40, P743, DOI 10.1139/f83-096
   VERHAAR HJM, 1992, CHEMOSPHERE, V25, P471, DOI 10.1016/0045-6535(92)90280-5
   Voutchkova AM, 2011, GREEN CHEM, V13, P2373, DOI 10.1039/c1gc15651a
   Voutchkova AM, 2010, CHEM REV, V110, P5845, DOI 10.1021/cr9003105
   Voutchkova-Kostal AM, 2012, GREEN CHEM, V14, P1001, DOI 10.1039/c2gc16385c
   Wang LM, 2007, ENVIRON SCI TECHNOL, V41, P6124, DOI 10.1021/es070220d
   Williams ES, 2011, ENVIRON TOXICOL CHEM, V30, P1943, DOI 10.1002/etc.583
   Williams ES, 2009, CRIT REV TOXICOL, V39, P553, DOI 10.1080/10408440903036056
   Zvinavashe E, 2006, ENVIRON TOXICOL CHEM, V25, P2313, DOI 10.1897/05-678R.1
   Zvinavashe E, 2009, CHEMOSPHERE, V75, P1531, DOI 10.1016/j.chemosphere.2009.01.081
NR 53
TC 15
Z9 15
U1 1
U2 26
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0730-7268
EI 1552-8618
J9 ENVIRON TOXICOL CHEM
JI Environ. Toxicol. Chem.
PD AUG
PY 2014
VL 33
IS 8
BP 1894
EP 1902
DI 10.1002/etc.2614
PG 9
WC Environmental Sciences; Toxicology
SC Environmental Sciences & Ecology; Toxicology
GA AN4DD
UT WOS:000340536900030
PM 24839109
DA 2019-10-23
ER

PT J
AU Riffle, BW
   Klinefelter, GR
   Cooper, RL
   Winnik, WM
   Swank, A
   Jayaraman, S
   Suarez, J
   Best, D
   Laws, SC
AF Riffle, Brandy W.
   Klinefelter, Gary R.
   Cooper, Ralph L.
   Winnik, Witold M.
   Swank, Adam
   Jayaraman, Saro
   Suarez, Juan
   Best, Deborah
   Laws, Susan C.
TI Novel molecular events associated with altered steroidogenesis induced
   by exposure to atrazine in the intact and castrate male rat
SO REPRODUCTIVE TOXICOLOGY
LA English
DT Article
DE Atrazine; Steroidogenesis; Hypothalamic-pituitary-adrenal (HPA) axis;
   Corticosterone; Proteomics
ID PROGESTERONE-BINDING SITE(S); PERIPUBERTAL MALE RATS; MALE WISTAR RATS;
   PUBERTAL DEVELOPMENT; PESTICIDE EXPOSURE; THYROID-FUNCTION;
   STRESS-RESPONSE; DRINKING-WATER; ADRENAL-CORTEX; SEMEN QUALITY
AB Toxicology is increasingly focused on molecular events comprising adverse outcome pathways. Atrazine activates the hypothalamic-pituitary adrenal axis, but relationships to gonadal alterations are unknown. We characterized hormone profiles and adrenal (intact and castrate) and testis (intact) proteomes in rats after 3 days of exposure. The adrenal accounted for most of the serum progesterone and all of the corticosterone increases in intact and castrated males. Serum luteinizing hormone, androstenedione, and testosterone in intact males shared a non-monotonic response suggesting transition from an acute stimulatory to a latent inhibitory response to exposure. Eight adrenal proteins were significantly altered with dose. There were unique proteomic changes between the adrenals of intact and castrated males. Six testis proteins in intact males had non-monotonic responses that significantly correlated with serum testosterone. Different dose-response curves for steroids and proteins in the adrenal and testis reveal novel adverse outcome pathways in intact and castrated male rats. Published by Elsevier Inc.
C1 [Riffle, Brandy W.] Oak Ridge Inst Sci & Educ, Res Participat Program, Oak Ridge, TN 37831 USA.
   [Klinefelter, Gary R.; Cooper, Ralph L.; Suarez, Juan; Best, Deborah; Laws, Susan C.] US EPA, Tox Assessment Div, Natl Hlth & Environm Effects Res Lab, Off Res & Dev, Res Triangle Pk, NC 27711 USA.
   [Winnik, Witold M.; Swank, Adam] US EPA, Prote Res Core, NHEERL, ORD, Res Triangle Pk, NC 27711 USA.
   [Jayaraman, Saro] US EPA, Atlantic Ecol Div, NHEERL, ORD, Narragansett, RI 02882 USA.
RP Laws, SC (reprint author), US EPA, NHEERL, Tox Assessment Div MD-B105,109 TW Alexander Dr, Res Triangle Pk, NC 27711 USA.
EM laws.susan@epa.gov
FU Office of Research and Development, U.S. Environmental Protection
   Agency, Washington, DC
FX This research was funded entirely by the Office of Research and
   Development, U.S. Environmental Protection Agency, Washington, DC 20406.
CR Ace Christopher I, 2004, Reprod Biol Endocrinol, V2, P54, DOI 10.1186/1477-7827-2-54
   Battaglin WA, 2003, J AM WATER RESOUR AS, V39, P743, DOI 10.1111/j.1752-1688.2003.tb04402.x
   BLAKE MJ, 1991, P NATL ACAD SCI USA, V88, P9873, DOI 10.1073/pnas.88.21.9873
   BLAKE MJ, 1994, J PHARMACOL EXP THER, V268, P522
   Bringolf RB, 2004, ENVIRON TOXICOL CHEM, V23, P1019, DOI 10.1897/03-180
   Brzezicki JM, 2003, J ANAL TOXICOL, V27, P569, DOI 10.1093/jat/27.8.569
   Cooper RL, 2007, BIRTH DEFECTS RES B, V80, P98, DOI 10.1002/bdrb.20110
   Cragin LA, 2011, ENVIRON RES, V111, P1293, DOI 10.1016/j.envres.2011.09.009
   Dehkhargani SF, 2011, IRAN J TOXICOL, V5, P426
   Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243
   Fraites MJP, 2009, TOXICOL SCI, V112, P88, DOI 10.1093/toxsci/kfp194
   Friedmann AS, 2002, REPROD TOXICOL, V16, P275, DOI 10.1016/S0890-6238(02)00019-9
   Gojmerac T, 1996, TOXICOL LETT, V85, P9, DOI 10.1016/0378-4274(96)03631-4
   Golmerac T, 2004, VET HUM TOXICOL, V46, P245
   Graziano N, 2006, ENVIRON SCI TECHNOL, V40, P1163, DOI 10.1021/es051586y
   Higley EB, 2010, ENVIRON SCI POLLUT R, V17, P1137, DOI 10.1007/s11356-009-0285-3
   Hotchkiss MG, 2012, NEUROTOXICOL TERATOL, V34, P295, DOI 10.1016/j.ntt.2012.03.001
   Kaydos EH, 2004, TOXICOL SCI, V81, P430, DOI 10.1093/toxsci/kfh218
   KELLO D, 1989, FOOD ADDIT CONTAM, V6, pS79
   Kniewald J, 2000, J APPL TOXICOL, V20, P61
   Lange CA, 2004, MOL ENDOCRINOL, V18, P269, DOI 10.1210/me.2004-0331
   Laws SC, 2000, TOXICOL SCI, V58, P366, DOI 10.1093/toxsci/58.2.366
   Laws SC, 2009, TOXICOL SCI, V112, P78, DOI 10.1093/toxsci/kfp190
   Maguire M, 2002, CELL STRESS CHAPERON, V7, P317, DOI 10.1379/1466-1268(2002)007<0317:CUISOC>2.0.CO;2
   Mariman ECM, 2009, EXPERT REV PROTEOMIC, V6, P337, DOI 10.1586/EPR.09.50
   Meyer C, 1998, EUR J PHARMACOL, V347, P293, DOI 10.1016/S0014-2999(98)00103-4
   Meyer C, 1996, EUR J BIOCHEM, V239, P726, DOI 10.1111/j.1432-1033.1996.0726u.x
   NAIR DR, 1992, ENVIRON SCI TECHNOL, V26, P2298, DOI 10.1021/es00035a032
   Nilsson EE, 2006, REPRODUCTION, V132, P877, DOI 10.1530/REP-06-0045
   Pogrmic K, 2009, TOXICOL SCI, V111, P189, DOI 10.1093/toxsci/kfp135
   Pogrmic-Majkic K, 2010, TOXICOL SCI, V118, P52, DOI 10.1093/toxsci/kfq227
   Riffle BW, 2013, J PHARMACOL TOX MET, V68, P314, DOI 10.1016/j.vascn.2013.07.003
   Rohe HJ, 2009, PHARMACOL THERAPEUT, V121, P14, DOI 10.1016/j.pharmthera.2008.09.006
   Shimizu K, 1997, BIOCHEM BIOPH RES CO, V233, P550, DOI 10.1006/bbrc.1997.6418
   Spano L, 2004, AQUAT TOXICOL, V66, P369, DOI 10.1016/j.aquatox.2003.10.009
   Stoker TE, 2000, TOXICOL SCI, V58, P50, DOI 10.1093/toxsci/58.1.50
   Suzawa M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002117
   Swan SH, 2006, INT J ANDROL, V29, P62, DOI 10.1111/j.1365-2605.2005.00620.x
   Swan SH, 2003, ENVIRON HEALTH PERSP, V111, P1478, DOI 10.1289/ehp.6417
   Tillitt DE, 2010, AQUAT TOXICOL, V99, P149, DOI 10.1016/j.aquatox.2010.04.011
   Tinfo NS, 2011, REPROD TOXICOL, V31, P184, DOI 10.1016/j.reprotox.2010.11.005
   Trentacoste SV, 2001, J ANDROL, V22, P142
   UDELSMAN R, 1994, SURGERY, V115, P611
   Vijayaraghavan Srinivasan, 2007, Soc Reprod Fertil Suppl, V63, P111
   Wallace AD, 2001, J BIOL CHEM, V276, P42714, DOI 10.1074/jbc.M106033200
   Wang P, 2009, PROTEOMICS, V9, P2955, DOI 10.1002/pmic.200800826
   Wilhelms KW, 2006, ARCH ENVIRON CON TOX, V51, P117, DOI 10.1007/s00244-005-0165-x
   Yao B, 2012, J REPROD DEVELOP, V54, P259
   Yao B., 2012, TRANSL ANDROL UROL, V1, P2223
NR 49
TC 9
Z9 9
U1 1
U2 25
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0890-6238
J9 REPROD TOXICOL
JI Reprod. Toxicol.
PD AUG
PY 2014
VL 47
BP 59
EP 69
DI 10.1016/j.reprotox.2014.05.008
PG 11
WC Reproductive Biology; Toxicology
SC Reproductive Biology; Toxicology
GA AM2RE
UT WOS:000339697700009
PM 24887032
DA 2019-10-23
ER

PT J
AU Cox, LA
   Popken, D
   Marty, MS
   Rowlands, JC
   Patlewicz, G
   Goyak, KO
   Becker, RA
AF Cox, Louis Anthony (Tony)
   Popken, Douglas
   Marty, M. Sue
   Rowlands, J. Craig
   Patlewicz, Grace
   Goyak, Katy O.
   Becker, Richard A.
TI Developing scientific confidence in HTS-derived prediction models:
   Lessons learned from an endocrine case study
SO REGULATORY TOXICOLOGY AND PHARMACOLOGY
LA English
DT Article
DE Validation framework; High throughput/high content assays; Prediction
   models; Adverse outcome pathways; Endocrine
ID SCREENING ASSAYS; TOXICITY; VALIDATION; EXPOSURE
AB High throughput (HTS) and high content (HCS) screening methods show great promise in changing how hazard and risk assessments are undertaken, but scientific confidence in such methods and associated prediction models needs to be established prior to regulatory use. Using a case study of HTS-derived models for predicting in vivo androgen (A), estrogen (E), thyroid (T) and steroidogenesis (S) endpoints in endocrine screening assays, we compare classification (fitting) models to cross validation (prediction) models. The more robust cross validation models (based on a set of endocrine ToxCast (TM) assays and guideline in vivo endocrine screening studies) have balanced accuracies from 79% to 85% for A and E, but only 23% to 50% for T and S. Thus, for E and A, HTS results appear promising for initial use in setting priorities for endocrine screening. However, continued research is needed to expand the domain of applicability and to develop more robust HTS/HCS-based prediction models prior to their use in other regulatory applications. Based on the lessons learned, we propose a framework for documenting scientific confidence in HTS assays and the prediction models derived therefrom. The documentation, transparency and the scientific rigor involved in addressing the elements in the proposed Scientific Confidence Framework could aid in discussions and decisions about the prediction accuracy needed for different applications. (C) 2014 The Authors. Published by Elsevier Inc.
C1 [Cox, Louis Anthony (Tony); Popken, Douglas] Cox Associates, Denver, CO 80218 USA.
   [Marty, M. Sue; Rowlands, J. Craig] Dow Chem Co USA, Toxicol & Environm Res & Consulting, Midland, MI 48674 USA.
   [Patlewicz, Grace] DuPont Haskell Global Ctr Hlth & Environm Sci, Newark, DE 19711 USA.
   [Goyak, Katy O.] ExxonMobil Biomed Sci Inc, Annandale, NJ 08801 USA.
   [Becker, Richard A.] Amer Chem Council, Regulatory & Tech Affairs Dept, Washington, DC 20002 USA.
RP Becker, RA (reprint author), Amer Chem Council, Regulatory & Tech Affairs Dept, 700 2nd St NE, Washington, DC 20002 USA.
EM tcoxdenver@aol.com; doug@cox-associates.com; MSMarty@dow.com;
   JCRowlands@dow.com; patlewig@hotmail.com; katy.o.goyak@exxonmobil.com;
   Rick_Becker@americanchemistry.com
OI Patlewicz, Grace/0000-0003-3863-9689; Goyak, Katy/0000-0001-9655-7740
FU American Chemistry Council (ACC)
FX The authors had complete control over the design, conduct,
   interpretation, and reporting of the analyses included in this
   manuscript. The contents of this manuscript are solely the
   responsibility of the authors and do not necessarily reflect the views
   or policies of their employers. Tony Cox and Douglas Popken received
   funding to support this research from the American Chemistry Council
   (ACC). Sue Marty, Craig Rowlands, Grace Patlewicz and Katy Goyak are
   employed by companies engaged in chemical product manufacturing. Richard
   Becker is employed by ACC, a trade association of U. S. chemical
   manufacturers.
CR Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Becker RA, 2014, BIRTH DEFECTS RES B, V101, P114, DOI 10.1002/bdrb.21085
   Bhattacharya S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020887
   Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324
   Chandler KJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018540
   Dix DJ, 2012, TOXICOL SCI, V130, P440, DOI 10.1093/toxsci/kfs281
   EPA, 2009, FED REGISTER, V74, P17560
   EPA, 2013, PRIOR EDSP UNIV CHEM
   EPA, 2011, END DISR SCREEN PROG
   EPA, 2013, END DISR SCREEN PROG
   Fielden MR, 2011, TOXICOL SCI, V124, P54, DOI 10.1093/toxsci/kfr202
   Hartung T, 2013, ALTEX-ALTERN ANIM EX, V30, P119, DOI 10.14573/altex.2013.2.119
   IOM (Institute of Medicine), 2010, EV BIOM SURR ENDP CH
   Judson R, 2013, ALTEX-ALTERN ANIM EX, V30, P51, DOI 10.14573/altex.2013.1.051
   Kleinstreuer N, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002996
   Kleinstreuer NC, 2013, TOXICOL SCI, V131, P40, DOI 10.1093/toxsci/kfs285
   Martin MT, 2011, BIOL REPROD, V85, P327, DOI 10.1095/biolreprod.111.090977
   McMullen PD, 2014, CHEM-BIOL INTERACT, V209, P14, DOI 10.1016/j.cbi.2013.11.006
   NRC (National Research Council), 2007, TOX TEST 21 CENT VIS
   Patlewicz G, 2013, REGUL TOXICOL PHARM, V65, P259, DOI 10.1016/j.yrtph.2012.12.008
   Reif D., 2010, ENV HLTH PERSPECT, V118, P2, DOI DOI 10.1289/EHP.1002180
   Rotroff DM, 2013, ENVIRON HEALTH PERSP, V121, P7, DOI 10.1289/ehp.1205065
   Shah I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014584
   Sipes NS, 2011, TOXICOL SCI, V124, P109, DOI 10.1093/toxsci/kfr220
   Thomas RS, 2013, TOXICOL SCI, V136, P4, DOI 10.1093/toxsci/kft178
   Thomas RS, 2012, TOXICOL SCI, V128, P398, DOI 10.1093/toxsci/kfs159
   Wetmore BA, 2012, TOXICOL SCI, V125, P157, DOI 10.1093/toxsci/kfr254
NR 27
TC 20
Z9 20
U1 0
U2 6
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0273-2300
EI 1096-0295
J9 REGUL TOXICOL PHARM
JI Regul. Toxicol. Pharmacol.
PD AUG
PY 2014
VL 69
IS 3
BP 443
EP 450
DI 10.1016/j.yrtph.2014.05.010
PG 8
WC Medicine, Legal; Pharmacology & Pharmacy; Toxicology
SC Legal Medicine; Pharmacology & Pharmacy; Toxicology
GA AL4SZ
UT WOS:000339126400019
PM 24845243
OA Other Gold
DA 2019-10-23
ER

PT J
AU Patlewicz, G
   Kuseva, C
   Kesoya, A
   Popova, L
   Zhechev, T
   Pavlov, T
   Roberts, DW
   Mekenyan, O
AF Patlewicz, Grace
   Kuseva, Chanita
   Kesoya, Antonia
   Popova, Loanna
   Zhechev, Teodor
   Pavlov, Todor
   Roberts, David W.
   Mekenyan, Ovanes
TI Towards AOP application - Implementation of an integrated approach to
   testing and assessment (IATA) into a pipeline tool for skin
   sensitization
SO REGULATORY TOXICOLOGY AND PHARMACOLOGY
LA English
DT Article
DE Adverse Outcome Pathway (AOP); Integrated Approaches to Testing and;
   Assessment (IATA); Expert systems; TIMES-SS; (Q)SAR; Read-across
ID LYMPH-NODE ASSAY; MECHANISTIC APPLICABILITY DOMAINS; GENE-EXPRESSION
   CHANGES; INCORPORATING MOLECULAR FLEXIBILITY; SCREENING CONTACT
   ALLERGENS; NONANIMAL-BASED PREDICTION; TOXICOLOGICAL END-POINTS; ADVERSE
   OUTCOME PATHWAYS; RISK-ASSESSMENT; CELL-LINE
AB Since the OECD published the Adverse Outcome Pathway (AOP) for skin sensitization, many efforts have focused on how to integrate and interpret nonstandard information generated for key events in a manner that can be practically useful for decision making. These types of frameworks are known as Integrated Approaches to Testing and Assessment (IATA). Here we have outlined an IATA for skin sensitization which focuses on existing information including non testing approaches such as QSAR and read-across. The IATA was implemented into a pipeline tool using OASIS technology to provide a means of systematically collating and compiling relevant information which could be used in an assessment of skin sensitization potential. A test set of 100 substances with available skin sensitization information was profiled using the pipeline IATA. In silica and in chemico profiling information alone was able to correctly predict skin sensitization potential, with a preliminary accuracy of 73.85%. Information from other relevant endpoints (e.g., Ames mutagenicity) was found to improve the accuracy (to 87.6%) when coupled with a reaction chemistry mechanistic understanding. This pipeline platform could be useful in the assessment of skin sensitization potential and marks a step change in how non testing approaches can be practically applied. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Patlewicz, Grace] DuPont Haskell Global Ctr Hlth & Environm Sci, Newark, DE 19711 USA.
   [Kuseva, Chanita; Kesoya, Antonia; Popova, Loanna; Zhechev, Teodor; Pavlov, Todor; Mekenyan, Ovanes] Univ Prof As Zlatarov, Lab Math Chem, Burgas, Bulgaria.
   [Roberts, David W.] Liverpool John Moores Univ, Sch Pharm & Biomol Sci, Liverpool L3 3AF, Merseyside, England.
RP Patlewicz, G (reprint author), DuPont Haskell Global Ctr Hlth & Environm Sci, 1090 Elkton Rd, Newark, DE 19711 USA.
EM patlewig@hotmail.com
OI Patlewicz, Grace/0000-0003-3863-9689
CR Adler S, 2011, ARCH TOXICOL, V85, P367, DOI 10.1007/s00204-011-0693-2
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Aptula AO, 2005, CHEM RES TOXICOL, V18, P1420, DOI 10.1021/tx050075m
   Aptula AO, 2006, CHEM RES TOXICOL, V19, P1097, DOI 10.1021/tx0601004
   Ashby J, 1995, TOXICOLOGY, V103, P177, DOI 10.1016/0300-483X(95)03132-Y
   Ball N, 2011, REGUL TOXICOL PHARM, V60, P389, DOI 10.1016/j.yrtph.2011.05.007
   Basketter D, 2013, REGUL TOXICOL PHARM, V67, P531, DOI 10.1016/j.yrtph.2013.10.002
   Basketter D, 2012, REGUL TOXICOL PHARM, V64, P9, DOI 10.1016/j.yrtph.2012.06.003
   Dimitrov SD, 2005, INT J TOXICOL, V24, P189, DOI 10.1080/10915810591000631
   Draize JH, 1944, J PHARMACOL EXP THER, V82, P377
   ECETOC, 1995, 066 ECETOC
   ECHA, 2008, GUID INF REQ CHEM SA
   Emter R, 2013, TOXICOL IN VITRO, V27, P2225, DOI 10.1016/j.tiv.2013.09.009
   Emter R, 2010, TOXICOL APPL PHARM, V245, P281, DOI 10.1016/j.taap.2010.03.009
   Enoch SJ, 2008, SAR QSAR ENVIRON RES, V19, P555, DOI 10.1080/10629360802348985
   EPA, 2013, INT ASS DOC DISCR CH
   Gerberick GF, 2007, TOXICOL SCI, V97, P417, DOI 10.1093/toxsci/kfm064
   Gerberick GF, 2005, DERMATITIS, V16, P157, DOI 10.2310/6620.2005.05040
   Gerberick GF, 2004, TOXICOL SCI, V81, P332, DOI 10.1093/toxsci/kfh213
   Gildea LA, 2006, J INVEST DERMATOL, V126, P1813, DOI 10.1038/sj.jid.5700319
   Jaworska J, 2013, J APPL TOXICOL, V33, P1353, DOI 10.1002/jat.2869
   Joint Research Centre (JRC), 2014, 89085 JRC ICCR
   Kalgutkar AS, 2005, CURR DRUG METAB, V6, P161, DOI 10.2174/1389200054021799
   Kleinstreuer N., 2014, FUTURETOX 2
   Lepoittevin J.-P., 1997, ALLERGIC CONTACT DER
   Meek M.E., 2013, J APPL TOXICOL
   Mekenyan O., 2014, CHEM RES TOXICOL
   Mekenyan O, 2010, CHEM RES TOXICOL, V23, P1519, DOI 10.1021/tx100161j
   Mekenyan OG, 2012, CHEM RES TOXICOL, V25, P277, DOI 10.1021/tx200547s
   Mekenyan O, 2007, CHEM RES TOXICOL, V20, P1927, DOI 10.1021/tx700249q
   Mutlib AE, 2002, CHEM RES TOXICOL, V15, P1190, DOI 10.1021/tx020063q
   Natsch A, 2013, J APPL TOXICOL, V33, P1337, DOI 10.1002/jat.2868
   Netzeva TI, 2005, ATLA-ALTERN LAB ANIM, V33, P155, DOI 10.1177/026119290503300209
   OECD, 2014, US TOOLB AOP WORKFL
   [OECD [OECD] Organization for Economic Cooperation and Development], 2012, OECD SER TEST ASS
   OECD, 2004, ENVJMMONO200424 OECD
   OECD, 2011, OECD SER TEST ASS, V156
   Patlewicz G, 2014, SAR QSAR ENVIRON RES, V25, P367, DOI 10.1080/1062936X.2014.900520
   Patlewicz G, 2010, SAR QSAR ENVIRON RES, V21, P619, DOI 10.1080/1062936X.2010.528447
   Patlewicz G, 2007, REGUL TOXICOL PHARM, V48, P225, DOI 10.1016/j.yrtph.2007.03.003
   Pease CKS, 2003, TOXICOLOGY, V192, P1, DOI 10.1016/S0300-483X(03)00246-4
   Przybylak KR, 2013, ISSUES TOXICOL, V17, P44, DOI 10.1039/9781849734400-00044
   Python F, 2007, TOXICOL APPL PHARM, V220, P113, DOI 10.1016/j.taap.2006.12.026
   Roberts DW, 2014, CHEM RES TOXICOL, V27, P240, DOI 10.1021/tx400355n
   Roberts DW, 2011, CHEM RES TOXICOL, V24, P1003, DOI 10.1021/tx100420w
   Roberts DW, 2008, J APPL TOXICOL, V28, P443, DOI 10.1002/jat.1293
   Roberts DW, 2007, CHEM RES TOXICOL, V20, P1321, DOI 10.1021/tx700169w
   Roberts DW, 2007, CHEM RES TOXICOL, V20, P1019, DOI 10.1021/tx700024w
   Roberts DW, 2007, CHEM RES TOXICOL, V20, P44, DOI 10.1021/tx060121y
   Roberts DW, 2006, CHEM RES TOXICOL, V19, P1228, DOI 10.1021/tx060102o
   Roberts DW, 2014, J APPL TOXICOL, V34, P436, DOI 10.1002/jat.2943
   Roberts DW, 2009, CHEM RES TOXICOL, V22, P592, DOI 10.1021/tx800431x
   Roberts DW, 2009, ECOTOXICOLOGY MODELI, P61, DOI DOI 10.1007/978-1-4419-0197-2_3
   Rorije E, 2013, REGUL TOXICOL PHARM, V67, P146, DOI 10.1016/j.yrtph.2013.06.003
   Ryan CA, 2004, TOXICOL LETT, V150, P301, DOI 10.1016/j.toxlet.2004.02.002
   Sakaguchi H, 2007, TOXICOL LETT, V172, pS93, DOI 10.1016/j.toxlet.2007.05.257
   Schelde ., 2003, TOXICOLOGY, V193, P219
   Schultz TW, 2006, SAR QSAR ENVIRON RES, V17, P413, DOI 10.1080/10629360600884371
   Schultz TW, 2005, SAR QSAR ENVIRON RES, V16, P313, DOI 10.1080/10659360500204152
   Serafimova R, 2007, CHEM RES TOXICOL, V20, P662, DOI 10.1021/tx6003369
   Teubner W, 2013, REGUL TOXICOL PHARM, V67, P468, DOI 10.1016/j.yrtph.2013.09.007
   Yusubov MS, 2011, ARKIVOC, P370
NR 62
TC 56
Z9 59
U1 0
U2 12
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0273-2300
EI 1096-0295
J9 REGUL TOXICOL PHARM
JI Regul. Toxicol. Pharmacol.
PD AUG
PY 2014
VL 69
IS 3
BP 529
EP 545
DI 10.1016/j.yrtph.2014.06.001
PG 17
WC Medicine, Legal; Pharmacology & Pharmacy; Toxicology
SC Legal Medicine; Pharmacology & Pharmacy; Toxicology
GA AL4SZ
UT WOS:000339126400027
PM 24928565
DA 2019-10-23
ER

PT J
AU Scholz, S
   Ortmann, J
   Kluver, N
   Leonard, M
AF Scholz, Stefan
   Ortmann, Julia
   Kluever, Nils
   Leonard, Marc
TI Extensive review of fish embryo acute toxicities for the prediction of
   GHS acute systemic toxicity categories
SO REGULATORY TOXICOLOGY AND PHARMACOLOGY
LA English
DT Review
DE Acute systemic toxicity; 3Rs; LD50; Global harmonisation system; Fish
   embryo test; Animal experiments
ID ADVERSE OUTCOME PATHWAYS; DEVELOPMENTAL TOXICITY; ALTERNATIVE METHOD;
   ZEBRAFISH EMBRYOS; LIFE STAGES; MODEL; ASSAY; ETHERS; VALUES
AB Distribution and marketing of chemicals require appropriate labelling of health, physical and environmental hazards according to the United Nations global harmonisation system (GHS). Labelling for (human) acute toxicity categories is based on experimental findings usually obtained by oral, dermal or inhalative exposure of rodents. There is a strong societal demand for replacing animal experiments conducted for safety assessment of chemicals. Fish embryos are considered as alternative to animal testing and are proposed as predictive model both for environmental and human health effects. Therefore, we tested whether LC(50)s of the fish embryo acute toxicity test would allow effectively predicting of acute mammalian toxicity categories. A database of published fish embryo LC50 containing 641 compounds was established. For these compounds corresponding rat oral LD50 were identified resulting in 364 compounds for which both fish embryo LC50 and rat LD50 was available. Only a weak correlation of fish embryo LC50 and rat oral LD50 was obtained. Fish embryos were also not able to effectively predict GHS oral acute toxicity categories. We concluded that due to fundamental exposure protocol differences (single oral dose versus water-borne exposure) a reverse dosimetry approach is needed to explore the predictive capacity of fish embryos. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Scholz, Stefan; Ortmann, Julia; Kluever, Nils] UFZ Helmholtz Ctr Environm Res, Dept Bioanalyt Ecotoxicol, D-04318 Leipzig, Germany.
   [Leonard, Marc] LOREAL Adv Res, Environm Res Dept, F-93601 Aulnay Sous Bois, France.
RP Scholz, S (reprint author), UFZ Helmholtz Ctr Environm Res, Dept Bioanalyt Ecotoxicol, Permoserstr 15, D-04318 Leipzig, Germany.
EM stefan.scholz@ufz.de
RI Kluver, Nils/D-8678-2015; Scholz, Stefan/B-7776-2014
OI Scholz, Stefan/0000-0002-6990-4716
FU L'Oreal
FX The study was funded by L'Oreal for a contract research study jointly
   conducted with the UFZ. We acknowledge critical discussion of
   pharmacokinetics with Jos Bessems, RIVM and GHS labeling with Thomas
   Gildemeister, REACH-ChemConsult. Stephanie Padilla, US EPA, is thanked
   for providing raw data for calculation of fish embryo LC<INF>50</INF>.
   Ralf-Uwe Ebert, UFZ, Department of Chemical Ecology, is acknowledged for
   support with batch analysis for the prediction of a narcosis mode of
   action using the software ChemProp. We thank the anonymous reviewers for
   their critical and helpful comments.
CR Ali S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021076
   Baumann L., 2008, THESIS U HEIDELBERG, P91
   Belanger SE, 2013, ENVIRON TOXICOL CHEM, V32, P1768, DOI 10.1002/etc.2244
   Brannen KC, 2010, BIRTH DEFECTS RES B, V89, P66, DOI 10.1002/bdrb.20223
   Brion F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036069
   Carlsson G, 2013, AQUAT TOXICOL, V126, P30, DOI 10.1016/j.aquatox.2012.10.008
   ChemProp, 2012, CHEM PROP EST SOFTW
   Cheng JP, 2007, ENVIRON TOXICOL CHEM, V26, P708, DOI 10.1897/06-272R.1
   Clements R.G., 1994, EPA748R93002 OFF POL
   Creton R, 2004, DEV BRAIN RES, V151, P33, DOI 10.1016/j.devbrainres.2004.03.016
   Creton S, 2010, CRIT REV TOXICOL, V40, P50, DOI 10.3109/10408440903401511
   Ekwall B, 1998, ATLA-ALTERN LAB ANIM, V26, P617
   Embry MR, 2010, AQUAT TOXICOL, V97, P79, DOI 10.1016/j.aquatox.2009.12.008
   Foerster F., 2008, THESIS U HEIDELBERG, P75
   GROTH G, 1993, B ENVIRON CONTAM TOX, V50, P878
   Gustafson AL, 2012, REPROD TOXICOL, V33, P155, DOI 10.1016/j.reprotox.2011.12.004
   Halder Marlies, 2010, Integrated Environmental Assessment and Management, V6, P484, DOI 10.1002/ieam.48
   Henn K, 2011, COMP BIOCHEM PHYS C, V153, P91, DOI 10.1016/j.cbpc.2010.09.003
   Kais B, 2013, AQUAT TOXICOL, V140, P229, DOI 10.1016/j.aquatox.2013.05.022
   Kinsner-Ovaskainen A, 2009, TOXICOL IN VITRO, V23, P1535, DOI 10.1016/j.tiv.2009.07.004
   Knobel M, 2012, ENVIRON SCI TECHNOL, V46, P9690, DOI 10.1021/es301729q
   Lammer E, 2009, COMP BIOCHEM PHYS C, V149, P196, DOI 10.1016/j.cbpc.2008.11.006
   Louisse J, 2010, TOXICOL SCI, V118, P470, DOI 10.1093/toxsci/kfq270
   Mhadhbi L, 2012, INT J ENVIRON RES, V6, P139
   Mhadhbi L, 2012, WATER AIR SOIL POLL, V223, P5917, DOI 10.1007/s11270-012-1328-9
   Mhadhbi L, 2012, ENVIRON SCI POLLUT R, V19, P708, DOI 10.1007/s11356-011-0602-5
   Moore NP, 2013, REGUL TOXICOL PHARM, V66, P30, DOI 10.1016/j.yrtph.2013.02.005
   Noorlander C., 2008, CCRIHCPC432921XO
   Padilla S, 2012, REPROD TOXICOL, V33, P174, DOI 10.1016/j.reprotox.2011.10.018
   Parng C, 2002, ASSAY DRUG DEV TECHN, V1, P41, DOI 10.1089/154065802761001293
   Robinson S, 2008, REGUL TOXICOL PHARM, V50, P345, DOI 10.1016/j.yrtph.2007.11.009
   Russom CL, 1997, ENVIRON TOXICOL CHEM, V16, P948, DOI 10.1002/etc.5620160514
   Scholz S, 2013, ARCH TOXICOL, V87, P767, DOI 10.1007/s00204-013-1044-2
   Seidle T, 2011, ALTEX-ALTERN ANIM EX, V28, P95, DOI 10.14573/altex.2011.2.095
   Seidle T, 2010, TOXICOL SCI, V116, P382, DOI 10.1093/toxsci/kfq143
   Selderslaghs IWT, 2012, REPROD TOXICOL, V33, P142, DOI 10.1016/j.reprotox.2011.08.003
   Sjostrom M, 2008, TOXICOL IN VITRO, V22, P1405, DOI 10.1016/j.tiv.2008.04.017
   Strahle U, 2012, REPROD TOXICOL, V33, P128, DOI 10.1016/j.reprotox.2011.06.121
   Strecker R, 2011, COMP BIOCHEM PHYS C, V153, P318, DOI 10.1016/j.cbpc.2010.12.002
   Thienpont B, 2011, ENVIRON SCI TECHNOL, V45, P7525, DOI 10.1021/es202248h
   Ton C, 2006, BIRTH DEFECTS RES A, V76, P553, DOI 10.1002/bdra.20281
   UN, 2011, GLOB HARM SYST CLASS
   Vaughan M, 2010, ATLA-ALTERN LAB ANIM, V38, P231, DOI 10.1177/026119291003800310
   VERHAAR HJM, 1992, CHEMOSPHERE, V25, P471, DOI 10.1016/0045-6535(92)90280-5
   Villeneuve D, 2014, ENVIRON TOXICOL CHEM, V33, P158, DOI 10.1002/etc.2403
   Volz DC, 2011, TOXICOL SCI, V123, P349, DOI 10.1093/toxsci/kfr185
   Weigt S, 2011, TOXICOLOGY, V281, P25, DOI 10.1016/j.tox.2011.01.004
NR 47
TC 18
Z9 18
U1 1
U2 32
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0273-2300
EI 1096-0295
J9 REGUL TOXICOL PHARM
JI Regul. Toxicol. Pharmacol.
PD AUG
PY 2014
VL 69
IS 3
BP 572
EP 579
DI 10.1016/j.yrtph.2014.06.004
PG 8
WC Medicine, Legal; Pharmacology & Pharmacy; Toxicology
SC Legal Medicine; Pharmacology & Pharmacy; Toxicology
GA AL4SZ
UT WOS:000339126400030
PM 24929227
DA 2019-10-23
ER

PT J
AU van der Veen, JW
   Rorije, E
   Emter, R
   Natsch, A
   van Loveren, H
   Ezendam, J
AF van der Veen, Jochem W.
   Rorije, Emiel
   Emter, Roger
   Natsch, Andreas
   van Loveren, Henk
   Ezendam, Janine
TI Evaluating the performance of integrated approaches for hazard
   identification of skin sensitizing chemicals
SO REGULATORY TOXICOLOGY AND PHARMACOLOGY
LA English
DT Article
DE Skin sensitization; Integrated testing strategy; Keratinocytes; Allergic
   contact dermatitis; Animal-free testing; LLNA; QSAR; DPRA; Adverse
   outcome pathway
ID LYMPH-NODE ASSAY; TEST H-CLAT; SCREENING CONTACT ALLERGENS; KERATINOCYTE
   CELL-LINE; PEPTIDE REACTIVITY; IL-18 PRODUCTION; GENE-EXPRESSION;
   POTENCY; PREDICT; MODELS
AB The currently available animal-free methods for the detection of skin sensitizing potential of chemicals seem promising. However, no single method is able to comprehensively represent the complexity of the processes involved in skin sensitization. To ensure a mechanistic basis and cover the complexity, multiple methods should be integrated into a testing strategy, in accordance with the adverse outcome pathway that describes all key events in skin sensitization. Although current majority voting testing strategies have proven effective, the performance of individual methods is not taken into account. To that end, we designed a tiered strategy based on complementary characteristics of the included methods, and compared it to a majority voting approach. This tiered testing strategy was able to correctly identify all 41 chemicals tested. In terms of total number of experiments required, the tiered testing strategy requires less experiments compared to the majority voting approach. On the other hand, this tiered strategy is more complex due the number of different alternative methods required, and predicted costs are similar for both strategies. Both the tiered and majority voting strategies provide a mechanistic basis for skin sensitization testing, but the strategy most suitable for regulatory decision-making remains to be determined. (C) 2014 Elsevier Inc. All rights reserved.
C1 [van der Veen, Jochem W.; van Loveren, Henk] Maastricht Univ, Dept Toxicogenom, NL-6200 MD Maastricht, Netherlands.
   [van der Veen, Jochem W.; Rorije, Emiel; van Loveren, Henk; Ezendam, Janine] Natl Inst Publ Hlth & Environm RIVM, NL-3720 BA Bilthoven, Netherlands.
   [Emter, Roger; Natsch, Andreas] Givaudan Schweiz AG, CH-8600 Dubendorf, Switzerland.
RP Ezendam, J (reprint author), Natl Inst Publ Hlth & Environm RIVM, POB 1, NL-3720 BA Bilthoven, Netherlands.
EM Janine.ezendam@rivm.nl
OI Rorije, Emiel/0000-0003-1268-7770; Natsch, Andreas/0000-0003-2231-2489
FU Netherlands Genomics Initiative/Netherlands Organization for Scientific
   Research (NWO)Netherlands Organization for Scientific Research (NWO)
   [050-060-510]; Dutch Ministry of Infrastructure and the Environment
FX We would like to acknowledge H. Hodemaekers and E. Gremmer of the RIVM
   for their excellent technical support. We also thank Dr. S. Casati of
   the European Union Reference Laboratory for alternatives to animal
   testing, and Dr. T. Ashikaga of the Shiseido Company for providing
   additional information regarding the costs of the methods used in this
   study. This study was funded by a grant of the Netherlands Genomics
   Initiative/Netherlands Organization for Scientific Research (NWO) No.:
   050-060-510. In addition, the Dutch Ministry of Infrastructure and the
   Environment is acknowledged for supporting this work.
CR Adler S, 2011, ARCH TOXICOL, V85, P367, DOI 10.1007/s00204-011-0693-2
   Ashikaga T, 2006, TOXICOL IN VITRO, V20, P767, DOI 10.1016/j.tiv.2005.10.012
   Ashikaga T, 2010, ATLA-ALTERN LAB ANIM, V38, P275, DOI 10.1177/026119291003800403
   Bauch C, 2012, REGUL TOXICOL PHARM, V63, P489, DOI 10.1016/j.yrtph.2012.05.013
   Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324
   Chaudhry Q, 2010, CHEM CENT J, V4, DOI 10.1186/1752-153X-4-S1-S5
   COOPER JA, 1979, BRIT J CANCER, V39, P87, DOI 10.1038/bjc.1979.10
   Corsini E, 2009, TOXICOL IN VITRO, V23, P789, DOI 10.1016/j.tiv.2009.04.005
   DTU, 2013, DAN QSAR DAT
   EC-JRC, 2013, EURL ECVAM REC KER A
   EC-JRC, 2013, EURL ECVAM REC DIR P
   Emter R, 2010, TOXICOL APPL PHARM, V245, P281, DOI 10.1016/j.taap.2010.03.009
   Enoch SJ, 2008, SAR QSAR ENVIRON RES, V19, P555, DOI 10.1080/10629360802348985
   Enoch SJ, 2013, CHEM RES TOXICOL, V26, P767, DOI 10.1021/tx4000655
   Fabian E, 2013, ARCH TOXICOL, V87, P1683, DOI 10.1007/s00204-013-1090-9
   Galbiati V, 2011, TOXICOL IN VITRO, V25, P724, DOI 10.1016/j.tiv.2010.12.011
   Gerberick GF, 2007, TOXICOL SCI, V97, P417, DOI 10.1093/toxsci/kfm064
   Gerberick GF, 2009, TOXICOL SCI, V112, P164, DOI 10.1093/toxsci/kfp192
   Gerberick GF, 2005, DERMATITIS, V16, P157, DOI 10.2310/6620.2005.05040
   Gerberick GF, 2004, TOXICOL SCI, V81, P332, DOI 10.1093/toxsci/kfh213
   Gibbs S, 2013, TOXICOL APPL PHARM, V272, P529, DOI 10.1016/j.taap.2013.07.003
   Hewitt NJ, 2013, TOXICOL SCI, V133, P209, DOI 10.1093/toxsci/kft080
   Jaworska J., 2013, J APPL TOXICOL
   KIMBER I, 1994, TOXICOLOGY, V93, P13, DOI 10.1016/0300-483X(94)90193-7
   Kimber I, 2010, METHODS MOL BIOL, V598, P221, DOI 10.1007/978-1-60761-401-2_16
   Klopman G, 2005, PREDICTIVE TOXICOLOGY, P423
   Lalko JF, 2012, TOXICOL IN VITRO
   Lhasa, 2013, NEXUS 1 5 KNOWL SUIT
   Martin SF, 2010, CELL MOL LIFE SCI, V67, P4171, DOI 10.1007/s00018-010-0495-3
   McKim JM, 2010, CUTAN OCUL TOXICOL, V29, P171, DOI 10.3109/15569527.2010.483869
   Natsch A., 2013, J APPL TOXICOL
   Natsch A, 2013, TOXICOL SCI, V135, P356, DOI 10.1093/toxsci/kft160
   Natsch A, 2011, TOXICOL IN VITRO, V25, P733, DOI 10.1016/j.tiv.2010.12.014
   NICEATM-ICCVAM, 1999, NIH PUBL
   Nukada Y, 2011, CONTACT DERMATITIS, V65, P343, DOI 10.1111/j.1600-0536.2011.01952.x
   OECD, 2013, TOOLB GROUP CHEM CAT
   OECD, 2012, SCI EV SER TEST ASS, V168
   Rifkin R, 2003, SIAM REV, V45, P706, DOI 10.1137/S0036144502411986
   Rorije E., 2013, REGUL TOXICOL PHARM
   Rovida C, 2013, ALTEX-ALTERN ANIM EX, V30, P231, DOI 10.14573/altex.2013.2.231
   Saito K., 2013, TOXICOL IN VITRO
   Teubner W, 2013, REGUL TOXICOL PHARM, V67, P468, DOI 10.1016/j.yrtph.2013.09.007
   Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299
   van der Veen JW, 2013, TOXICOL IN VITRO, V27, P314, DOI 10.1016/j.tiv.2012.08.023
   Van Och FMM, 2005, TOXICOLOGY, V210, P95, DOI 10.1016/j.tox.2005.01.004
   Vandebriel RJ, 2010, CRIT REV TOXICOL, V40, P389, DOI 10.3109/10408440903524262
   Zuang V, 2013, EURL ECVAM PROGR REP
NR 47
TC 46
Z9 50
U1 0
U2 6
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0273-2300
EI 1096-0295
J9 REGUL TOXICOL PHARM
JI Regul. Toxicol. Pharmacol.
PD AUG
PY 2014
VL 69
IS 3
BP 371
EP 379
DI 10.1016/j.yrtph.2014.04.018
PG 9
WC Medicine, Legal; Pharmacology & Pharmacy; Toxicology
SC Legal Medicine; Pharmacology & Pharmacy; Toxicology
GA AL4SZ
UT WOS:000339126400011
PM 24813372
DA 2019-10-23
ER

PT J
AU Hewitt, PG
   Singh, PK
   Kumar, A
   Gnewuch, C
   Liebisch, G
   Schmitz, G
   Borlak, J
AF Hewitt, Philip G.
   Singh, Prafull Kumar
   Kumar, Arun
   Gnewuch, Carsten
   Liebisch, Gerhard
   Schmitz, Gerd
   Borlak, Juergen
TI A rat toxicogenomics study with the calcium sensitizer EMD82571 reveals
   a pleiotropic cause of teratogenicity
SO REPRODUCTIVE TOXICOLOGY
LA English
DT Article
DE Calcium sensitizer; Osteocalcin; Teratogen; EMD82571; Exencephaly;
   Agnathia; Adverse outcome pathway (AOP)
ID RETINOIC ACID; EXPRESSION; BONE; DIFFERENTIATION; ASSOCIATION; MECHANISM
AB The calcium sensitizer and PDEIII inhibitor EMD82571 caused exencephaly, micrognathia, agnathia and facial cleft in 58% of fetuses. In pursue of mechanisms and to define adverse outcome pathways pregnant Wistar rats were dosed daily with either EMD82571 (50 or 150 mg/kg/day) or retinoic acid (12 mg/kg/day) on gestational days 6-11 and 6-17, respectively. Hypothesis driven and whole genome microarray experiments were performed with whole embryo, maternal liver, embryonic liver and malformed bone at gestational days 12 and 20. This revealed regulation of genes critically involved in osteogenesis, odontogenesis, differentiation and development and extracellular matrix. Importantly, repression of osteocalcin and members of TGF-beta/BMP signaling hampered osteo- and odontogenesis. Furthermore, EMD82571 impaired neurulation by inhibiting mid hinge point formation to cause neural tube defects. Taken collectively, a molecular rationale for the observed teratogenicity induced by EMD82571 is presented that links molecular initiating events with AOPs. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Hewitt, Philip G.] Merck Serono, Nonclin Safety, D-64283 Darmstadt, Germany.
   [Singh, Prafull Kumar; Kumar, Arun; Borlak, Juergen] Hannover Med Sch, Ctr Pharmacol & Toxicol, D-30625 Hannover, Germany.
   [Gnewuch, Carsten; Liebisch, Gerhard; Schmitz, Gerd] Univ Regensburg, Med Ctr, Inst Clin Chem & Lab Med, D-93053 Regensburg, Germany.
RP Borlak, J (reprint author), Hannover Med Sch, Ctr Pharmacol & Toxicol, Carl Neuberg Str 1, D-30625 Hannover, Germany.
EM philip.hewitt@merckgroup.com; Singh.Prafull@mh-hannover.de;
   Kumar.Arun@mh-hannover.de; carsten.gnewuch@ukr.de;
   gerhard.liebisch@ukr.de; gerd.schmitz@ukr.de;
   Borlak.Juergen@mh-hannover.de
RI Liebisch, Gerhard/G-6130-2010
OI Liebisch, Gerhard/0000-0003-4886-0811
FU Ministry of Culture and Sciences, Lower Saxony, Germany
   [25A.5-7251-99-3/00]; Virtual Liver Network (VLN) of the German Ministry
   of Science and Education (BMBF) [031 6154]
FX This work was supported by the Ministry of Culture and Sciences, Lower
   Saxony, Germany [Grant number 25A.5-7251-99-3/00 to JB] and the Virtual
   Liver Network (VLN) of the German Ministry of Science and Education
   (BMBF) [Grant number: 031 6154 to JB]. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR ADAMS JC, 1993, DEVELOPMENT, V117, P1183
   ATTILI AF, 1986, MED HYPOTHESES, V19, P57, DOI 10.1016/0306-9877(86)90137-4
   Bosshardt DD, 1998, J HISTOCHEM CYTOCHEM, V46, P135, DOI 10.1177/002215549804600201
   Brites Dora, 2002, Ann Hepatol, V1, P20
   Chai Y, 2003, CRIT REV ORAL BIOL M, V14, P78, DOI 10.1177/154411130301400202
   Chang H, 2002, ENDOCR REV, V23, P787, DOI 10.1210/er.2002-0003
   Chen S, 2008, J BIOL CHEM, V283, P19359, DOI 10.1074/jbc.M709492200
   Copp AJ, 1998, CURR OPIN NEUROL, V11, P97, DOI 10.1097/00019052-199804000-00003
   CUNNINGHAM ML, 1994, DEV DYNAM, V200, P227, DOI 10.1002/aja.1002000305
   Dawson EB, 1999, AM J PERINAT, V16, P373, DOI 10.1055/s-2007-993887
   Ducy P, 1996, NATURE, V382, P448, DOI 10.1038/382448a0
   Emmanouil-Nikoloussi EN, 2000, EXP TOXICOL PATHOL, V52, P445, DOI 10.1016/S0940-2993(00)80080-9
   Francis-West PH, 2003, ADV ANAT EMBRYOL CEL, V169, P1
   Gnewuch C, 2009, WORLD J GASTROENTERO, V15, P3134, DOI 10.3748/wjg.15.3134
   HAY ED, 1981, J CELL BIOL, V91, pS205, DOI 10.1083/jcb.91.3.205s
   Hewitt PG, 2005, HANDBOOK OF TOXICOGENOMICS: STRATEGIES AND APPLICATIONS, P435, DOI 10.1002/3527603719.ch18
   Holson RR, 1999, NEUROTOXICOL TERATOL, V21, P393, DOI 10.1016/S0892-0362(99)00007-0
   Karsenty G, 2012, NATURE, V481, P314, DOI 10.1038/nature10763
   Kass DA, 2006, CIRCULATION, V113, P305, DOI 10.1161/CIRCULATIONAHA.105.542407
   Krane SM, 2008, BONE, V43, P7, DOI 10.1016/j.bone.2008.03.020
   Kultima K, 2004, ENVIRON HEALTH PERSP, V112, P1225, DOI 10.1289/txg.7034
   Lee SK, 1996, INT J DEV BIOL, V40, P1141
   Liem KF, 1997, CELL, V91, P127, DOI 10.1016/S0092-8674(01)80015-5
   Mulder GB, 2000, TERATOLOGY, V62, P214, DOI 10.1002/1096-9926(200010)62:4<214::AID-TERA7>3.0.CO;2-N
   Murshed M, 2004, J CELL BIOL, V165, P625, DOI 10.1083/jcb.200402046
   Nie XG, 2006, INT J DEV BIOL, V50, P511, DOI 10.1387/ijdb.052101.xn
   Oury F, 2013, CELL, V155, P228, DOI 10.1016/j.cell.2013.08.042
   PAULI RM, 1987, AM J HUM GENET, V41, P566
   Poirier K, 2010, HUM MOL GENET, V19, P4462, DOI 10.1093/hmg/ddq377
   SAKAI A, 1992, DIFFERENTIATION, V52, P19, DOI 10.1111/j.1432-0436.1992.tb00496.x
   Sarkar AA, 2013, JOVE-J VIS EXP, DOI 10.3791/4245
   Sasaki T, 2006, DEVELOPMENT, V133, P371, DOI 10.1242/dev.02200
   Shimizu E, 2005, J PERIODONTOL, V76, P1482, DOI 10.1902/jop.2005.76.9.1482
   Thum T, 2008, ARCH TOXICOL, V82, P89, DOI 10.1007/s00204-007-0234-1
   Whitaker M, 2008, PHILOS T R SOC B, V363, P1401, DOI 10.1098/rstb.2008.2259
   Williamson C, 2011, DIGEST DIS, V29, P58, DOI 10.1159/000324130
   Yamaguchi Y, 2013, CELL MOL LIFE SCI, V70, P3171, DOI 10.1007/s00018-012-1227-7
   Zhou G, 2009, SCAND J GASTROENTERO, V44, P926, DOI 10.1080/00365520902998661
   ZUSMAN I, 1990, ACTA ANAT, V138, P144
NR 39
TC 1
Z9 1
U1 0
U2 14
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0890-6238
J9 REPROD TOXICOL
JI Reprod. Toxicol.
PD AUG
PY 2014
VL 47
BP 89
EP 101
DI 10.1016/j.reprotox.2014.06.006
PG 13
WC Reproductive Biology; Toxicology
SC Reproductive Biology; Toxicology
GA AM2RE
UT WOS:000339697700013
PM 24977338
DA 2019-10-23
ER

PT J
AU Furr, JR
   Lambright, CS
   Wilson, VS
   Foster, PM
   Gray, LE
AF Furr, Johnathan R.
   Lambright, Christy S.
   Wilson, Vickie S.
   Foster, Paul M.
   Gray, Leon E., Jr.
TI A Short-term In Vivo Screen Using Fetal Testosterone Production, a Key
   Event in the Phthalate Adverse Outcome Pathway, to Predict Disruption of
   Sexual Differentiation
SO TOXICOLOGICAL SCIENCES
LA English
DT Article
DE Phthalate Syndrome; Fetal endocrine biomarkers; Phthalate adverse
   outcome pathway; testosterone production; fetal rat testis
ID N-BUTYL PHTHALATE; SPRAGUE-DAWLEY RAT; ANDROGEN-RECEPTOR ANTAGONIST;
   INDUCED TESTICULAR ATROPHY; REPRODUCTIVE DEVELOPMENT; DEVELOPMENTAL
   TOXICITY; DIISOBUTYL PHTHALATE; GENE-EXPRESSION; DIETHYLHEXYL PHTHALATE;
   DI(N-BUTYL) PHTHALATE
AB This study was designed to develop and validate a short-term in vivo protocol termed the Fetal Phthalate Screen (FPS) to detect phthalate esters (PEs) and other chemicals that disrupt fetal testosterone synthesis and testis gene expression in rats. We propose that the FPS can be used to screen chemicals that produce adverse developmental outcomes via disruption of the androgen synthesis pathway more rapidly and efficiently, and with fewer animals than a postnatal one-generation study. Pregnant rats were dosed from gestational day (GD) 14 to 18 at one dose level with one of 27 chemicals including PEs, PE alternatives, pesticides known to inhibit steroidogenesis, an estrogen and a potent PPAR alpha agonist and ex vivo testis testosterone production (T Prod) was measured on GD 18. We also included some chemicals with "unknown" activity including DMEP, DHeP, DHEH, DPHCH, DAP, TOTM, tetrabromodiethyl hexyl phthalate (BrDEHP), and a relatively potent environmental estrogen BPAF. Dose-response studies also were conducted with this protocol with 11 of the above chemicals to determine their relative potencies. CD-1 mice also were exposed to varying dose levels of DPeP from GD 13 to 17 to determine if DPeP reduced T Prod in this species since there is a discrepancy among the results of in utero studies of PEs in mice. Compared to the known male reproductive effects of the PEs in rats the FPS correctly identified all known "positives" and "negatives" tested. Seven of eight "unknowns" tested were "negatives", they did not reduce T Prod, whereas DAP produced an "equivocal" response. Finally, a dose-response study with DPeP in CD-1 mice revealed that fetal T Prod can be inhibited by exposure to a PE in utero in this species, but at a higher dose level than required in rats. Key words. Phthalate Syndrome, Fetal endocrine biomarkers, Phthalate adverse outcome pathway, testosterone production, fetal rat testis.
C1 [Furr, Johnathan R.; Lambright, Christy S.; Wilson, Vickie S.; Gray, Leon E., Jr.] US EPA, Reprod Toxicol Branch, TAD, NHEERL,ORD, Res Triangle Pk, NC 27711 USA.
   [Foster, Paul M.] NIEHS, Natl Toxicol Program, NIH, DHHS, Res Triangle Pk, NC 27709 USA.
RP Gray, LE (reprint author), Mail Code B105-04,109 TW Alexander Dr, Res Triangle Pk, NC 27711 USA.
EM gray.ear@epa.gov
OI Wilson, Vickie/0000-0003-1661-8481; gray jr, leon
   earl/0000-0002-1111-4754
FU National Institute of Environmental Health Sciences, National Institutes
   of HealthUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Environmental
   Health Sciences (NIEHS); National Institute of Environmental Health
   Sciences (NIEHS), National Institutes of Health (NIH)United States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Environmental Health Sciences (NIEHS);
   NTP/NIEHS IA [RW7592285501-1]
FX Intramural Research Program of the National Institute of Environmental
   Health Sciences, National Institutes of Health (in part); National
   Institute of Environmental Health Sciences (NIEHS), National Institutes
   of Health (NIH); NTP/NIEHS IA (RW7592285501-1).
CR Adibi JJ, 2008, ENVIRON HEALTH PERSP, V116, P467, DOI 10.1289/ehp.10749
   Adibi JJ, 2003, ENVIRON HEALTH PERSP, V111, P1719, DOI 10.1289/ehp.6235
   [Anonymous], 2006, EFSA J, P395
   Bermudez DS, 2010, TOXICOL SCI, V116, P477, DOI 10.1093/toxsci/kfq156
   Bility MT, 2004, TOXICOL SCI, V82, P170, DOI 10.1093/toxsci/kfh253
   Blount BC, 2000, ENVIRON HEALTH PERSP, V108, P979, DOI 10.1289/ehp.00108979
   Blystone CR, 2007, TOXICOL SCI, V97, P65, DOI 10.1093/toxsci/kfm004
   Blystone CR, 2010, TOXICOL SCI, V116, P640, DOI 10.1093/toxsci/kfq147
   Boberg J, 2008, TOXICOLOGY, V250, P75, DOI 10.1016/j.tox.2008.05.020
   Borch J, 2004, REPROD TOXICOL, V18, P53, DOI 10.1016/j.reprotox.2003.10.011
   Carruthers CM, 2005, BIRTH DEFECTS RES B, V74, P277, DOI 10.1002/bdrb.20050
   CREASY DM, 1983, J PATHOL, V139, P309, DOI 10.1002/path.1711390307
   Exxon Mobil Biomedical Sciences Inc, 2001, EPA 2001 UNPUB, P553
   Fabjan E, 2006, CRIT REV TOXICOL, V36, P695, DOI 10.1080/10408440600894914
   FOSTER PMD, 1983, DRUG METAB DISPOS, V11, P59
   Foster PMD, 2006, INT J ANDROL, V29, P140, DOI 10.1111/j.1365-2605.2005.00563.x
   FOSTER PMD, 1982, TOXICOL APPL PHARM, V63, P120, DOI 10.1016/0041-008X(82)90031-X
   FOSTER PMD, 1982, ADV EXP MED BIOL, V136, P445
   Gaido KW, 2007, TOXICOL SCI, V97, P491, DOI 10.1093/toxsci/kfm049
   Gray L E Jr, 1988, Reprod Toxicol, V2, P281, DOI 10.1016/0890-6238(88)90032-9
   Gray LE, 2001, HUM REPROD UPDATE, V7, P248, DOI 10.1093/humupd/7.3.248
   Gray LE, 2000, TOXICOL SCI, V58, P350, DOI 10.1093/toxsci/58.2.350
   Gray T J, 1980, Arch Toxicol Suppl, V4, P452
   HABERT R, 1986, J ENDOCRINOL, V108, P361, DOI 10.1677/joe.0.1080361
   Hannas BR, 2012, TOXICOL SCI, V125, P544, DOI 10.1093/toxsci/kfr315
   Hannas BR, 2011, TOXICOL SCI, V123, P206, DOI 10.1093/toxsci/kfr146
   Hannas BR, 2011, TOXICOL SCI, V120, P184, DOI 10.1093/toxsci/kfq386
   HEINDEL JJ, 1989, FUND APPL TOXICOL, V12, P508, DOI 10.1016/0272-0590(89)90024-9
   Hosokawa Shunji, 1993, Journal of Toxicological Sciences, V18, P83
   Howdeshell KL, 2008, ENVIRON RES, V108, P168, DOI 10.1016/j.envres.2008.08.009
   Howdeshell KL, 2008, TOXICOL SCI, V105, P153, DOI 10.1093/toxsci/kfn077
   Johnson KJ, 2012, TOXICOL SCI, V129, P235, DOI 10.1093/toxsci/kfs206
   KELCE WR, 1994, TOXICOL APPL PHARM, V126, P276, DOI 10.1006/taap.1994.1117
   Knudsen Thomas, 2013, Methods Mol Biol, V947, P343, DOI 10.1007/978-1-62703-131-8_26
   Kondo F, 2010, B ENVIRON CONTAM TOX, V85, P92, DOI 10.1007/s00128-010-0051-8
   LAKE BG, 1984, TOXICOL APPL PHARM, V72, P46, DOI 10.1016/0041-008X(84)90248-5
   Lambright C, 2000, TOXICOL SCI, V56, P389, DOI 10.1093/toxsci/56.2.389
   Lehmann KP, 2004, TOXICOL SCI, V81, P60, DOI 10.1093/toxsci/kfh169
   Liu X, 2009, J OCCUP HEALTH, V51, P57, DOI 10.1539/joh.L8091
   MANGHAM BA, 1981, TOXICOL APPL PHARM, V61, P205, DOI 10.1016/0041-008X(81)90410-5
   Martin MT, 2011, BIOL REPROD, V85, P327, DOI 10.1095/biolreprod.111.090977
   McIntyre BS, 2001, TOXICOL SCI, V62, P236, DOI 10.1093/toxsci/62.2.236
   McKee RH, 2006, REPROD TOXICOL, V21, P241, DOI 10.1016/j.reprotox.2005.09.002
   Miyata Kaori, 2002, J Toxicol Sci, V27, P19, DOI 10.2131/jts.27.19
   Moody S, 2013, ENDOCRINOLOGY, V154, P3460, DOI 10.1210/en.2012-2227
   Mylchreest E, 2000, TOXICOL APPL PHARM, V168, P174, DOI 10.1006/taap.2000.9032
   Mylchreest E, 1999, TOXICOL APPL PHARM, V156, P81, DOI 10.1006/taap.1999.8643
   Mylchreest E, 2002, REPROD TOXICOL, V16, P19, DOI 10.1016/S0890-6238(01)00201-5
   Mylchreest E, 1998, TOXICOL SCI, V43, P47, DOI 10.1093/toxsci/43.1.47
   Nagao T, 2000, REPROD TOXICOL, V14, P513, DOI 10.1016/S0890-6238(00)00105-2
   Noriega N., 2004, TOXICOLOGIST, V73
   Noriega NC, 2005, BIOL REPROD, V72, P1324, DOI 10.1095/biolreprod.104.031385
   OISHI S, 1993, TOXICOL LETT, V66, P47, DOI 10.1016/0378-4274(93)90078-C
   Ostby J, 1999, TOXICOL IND HEALTH, V15, P80
   Parks LG, 2000, TOXICOL SCI, V58, P339, DOI 10.1093/toxsci/58.2.339
   Do RP, 2012, REPROD TOXICOL, V34, P614, DOI 10.1016/j.reprotox.2012.09.006
   Saillenfait AM, 2008, FOOD CHEM TOXICOL, V46, P2150, DOI 10.1016/j.fct.2008.02.012
   Saillenfait AM, 2006, TOXICOL LETT, V165, P39, DOI 10.1016/j.toxlet.2006.01.013
   Saillenfait AM, 2008, REPROD TOXICOL, V26, P107, DOI 10.1016/j.reprotox.2008.07.006
   Saillenfait AM, 2011, REPROD TOXICOL, V32, P268, DOI 10.1016/j.reprotox.2011.08.001
   Saillenfait AM, 2009, REPROD TOXICOL, V28, P468, DOI 10.1016/j.reprotox.2009.06.013
   Saillenfait AM, 2009, J APPL TOXICOL, V29, P510, DOI 10.1002/jat.1436
   Scott HM, 2008, ENDOCRINOLOGY, V149, P5280, DOI 10.1210/en.2008-0413
   Silva MJ, 2011, CHEMOSPHERE, V82, P431, DOI 10.1016/j.chemosphere.2010.09.052
   Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723
   Skakkebaek NE, 2002, HORM RES, V57, P43, DOI 10.1159/000058100
   Song XF, 2008, J INT MED RES, V36, P512, DOI 10.1177/147323000803600316
   Song Xiao-feng, 2006, Zhonghua Nan Ke Xue, V12, P775
   Struve MF, 2009, BIRTH DEFECTS RES B, V86, P345, DOI 10.1002/bdrb.20199
   Tyl RW, 2004, REPROD TOXICOL, V18, P241, DOI 10.1016/j.reprotox.2003.10.006
   Vinggaard AM, 2006, INT J ANDROL, V29, P186, DOI 10.1111/j.1365-2605.2005.00604.x
   Wang W., 2004, ZHONGJUA NAN KE XUE, V10, P814
   Wang Wei, 2004, Zhonghua Nan Ke Xue, V10, P807
   WARREN DW, 1972, BIOL REPROD, V7, P94, DOI 10.1093/biolreprod/7.1.94
   Wilson VS, 2009, TOXICOL LETT, V186, P73, DOI [10.1016/j.toxlet.2008.12.017, 10.1016/j.toxiet.2008.12.017]
   Wilson VS, 2004, TOXICOL LETT, V146, P207, DOI 10.1016/j.toxlet.2003.09.012
   Wolf CJ, 2000, TOXICOL SCI, V55, P152, DOI 10.1093/toxsci/55.1.152
   WONG CI, 1995, J BIOL CHEM, V270, P19998, DOI 10.1074/jbc.270.34.19998
   Wu SD, 2010, INT J TOXICOL, V29, P193, DOI 10.1177/1091581809355488
   Yamasaki K, 2005, TOXICOLOGY, V209, P47, DOI 10.1016/j.tox.2004.12.004
   Zota A. R., 2014, ENV HLTH PERSPECT
NR 81
TC 49
Z9 49
U1 3
U2 33
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1096-6080
EI 1096-0929
J9 TOXICOL SCI
JI Toxicol. Sci.
PD AUG
PY 2014
VL 140
IS 2
BP 403
EP 424
DI 10.1093/toxsci/kfu081
PG 22
WC Toxicology
SC Toxicology
GA AN6DL
UT WOS:000340684100014
PM 24798384
OA Green Published
DA 2019-10-23
ER

PT J
AU Silva, A
   Nunes, C
   Martins, J
   Dinis, TCP
   Lopes, C
   Neves, B
   Cruz, T
AF Silva, Ana
   Nunes, Carla
   Martins, Joao
   Dinis, Teresa C. P.
   Lopes, Celeste
   Neves, Bruno
   Cruz, Teresa
TI Respiratory sensitizer hexamethylene diisocyanate inhibits SOD 1 and
   induces ERK-dependent detoxifying and maturation pathways in
   dendritic-like cells
SO FREE RADICAL BIOLOGY AND MEDICINE
LA English
DT Article
DE Respiratory allergy; Mitochondria; ROS; SOD; ERK; MDR1; THP-1 dendritic
   cells; Free radicals
ID SUPEROXIDE-DISMUTASE; CONTACT SENSITIZERS; OXIDATIVE STRESS; IN-VITRO;
   SIGNALING PATHWAY; PROTEIN-KINASE; HUMAN ALBUMIN; EARLY EVENTS; THP-1
   CELLS; TNF-ALPHA
AB Respiratory allergy to low-molecular-weight chemicals is a current concern in the context of occupational health, and a certified method to identify respiratory allergens is still under investigation. The aim of this work was to unveil some of the poorly understood initial molecular events and toxicity pathways underlying respiratory sensitization, which might be crucial to disclosing the key building blocks of new testing strategies and may contribute to the development of a valid in vitro method for the identification of respiratory allergens. Immortalized human dendritic cell (DC)-like THP-1 cells were exposed to the respiratory allergen hexamethylene diisocyanate (HDI) for 6 h, and the activation of several signaling pathways was analyzed. Mitochondrial membrane potential (MMP) alterations, superoxide anion (O-2(-)) production, and gene expression modulation in HDI-treated cells were also evaluated. According to our results, HDI induces O-2(-) increase (P < 0.001) through enzymatic inhibition of cytoplasmic superoxide dismutase I (P < 0.05), which might reduce MMP, further leading to mitochondrial O-2(-) production. Increased O-2(-) levels promote ERK phosphorylation (approx sixfold compared to control; P < 0.001) and downstream transcriptional increase of several genes: HMOX1 (P < 0.05), involved in the protection of chemical reactive species; MDR1 (P < 0.01), responsible for the efflux of xenobiotics in the cell; and CD83 (P < 0.05), a DC maturation marker. These results raise new perspectives on the action of respiratory allergens in DCs and point out key molecular events that are crucial for the development of the so-called adverse outcome pathways, particularly regarding O-2(-) increase through enzymatic inhibition, and important for ERK activation. Furthermore, our results highlight the role of ERK signaling, but not p38 MAPK, in the activation of vital mechanisms in cells exposed to a respiratory allergen, such as cell detoxification, migration, and maturation. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Silva, Ana; Nunes, Carla; Martins, Joao; Dinis, Teresa C. P.; Lopes, Celeste; Cruz, Teresa] Univ Coimbra, Ctr Neurosci & Cell Biol, P-3004517 Coimbra, Portugal.
   [Nunes, Carla; Martins, Joao; Dinis, Teresa C. P.; Lopes, Celeste; Cruz, Teresa] Univ Coimbra, Fac Pharm, P-3000548 Coimbra, Portugal.
   [Neves, Bruno] Univ Aveiro, QOPNA, Mass Spectrometry Ctr, Dept Chem, P-3810193 Aveiro, Portugal.
RP Cruz, T (reprint author), Univ Coimbra, Ctr Neurosci & Cell Biol, P-3004517 Coimbra, Portugal.
EM trosete@ff.uc.pt
RI Nunes, Carla/L-3456-2017; Rosete, Maria teresa Cruz/F-5288-2013; Neves,
   Bruno/L-2557-2016
OI Nunes, Carla/0000-0002-7452-1592; Rosete, Maria teresa
   Cruz/0000-0001-9846-6754; Neves, Bruno/0000-0001-7391-3124; Dinis,
   Teresa/0000-0001-6350-5741; Silva, Ana/0000-0002-4041-0376
FU Fundacao para a Ciencia e Tecnologia and Fundo Comunitario Europeu
   [PEst-C/SAU/LA0001/2011]; Programa Operacional Tematico Factores de
   Competitividade [PTDC/SAU-OSM/099762/2008, SFRH/BD/73065/2010]; Centro
   de Neurociencias e Biologia Celular [PEst-C/SAU/LA0001/2013-2014]; Johns
   Hopkins Center for Alternatives to Animal Testing
FX This work was supported by the Fundacao para a Ciencia e Tecnologia and
   Fundo Comunitario Europeu (PEst-C/SAU/LA0001/2011), Programa Operacional
   Tematico Factores de Competitividade (PTDC/SAU-OSM/099762/2008 and
   SFRH/BD/73065/2010 to J.M.), Centro de Neurociencias e Biologia Celular
   (PEst-C/SAU/LA0001/2013-2014), and The Johns Hopkins Center for
   Alternatives to Animal Testing (2014-07).
CR Ade N, 2009, TOXICOL SCI, V107, P451, DOI 10.1093/toxsci/kfn243
   Arrighi JF, 2001, J IMMUNOL, V166, P3837, DOI 10.4049/jimmunol.166.6.3837
   Boisleve F, 2005, TOXICOLOGY, V206, P233, DOI 10.1016/j.tox.2004.08.015
   Bruchhausen S, 2003, J INVEST DERMATOL, V121, P1039, DOI 10.1046/j.1523-1747.2003.12510.x
   Buettner GR, 2011, ANTI-CANCER AGENT ME, V11, P341
   Campo P, 2007, CLIN EXP ALLERGY, V37, P1095, DOI 10.1111/j.1365-2222.2007.02745.x
   Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000
   Chipinda Itai, 2011, J Allergy (Cairo), V2011, P839682, DOI 10.1155/2011/839682
   Cocker J, 2007, OCCUP MED-OXFORD, V57, P391, DOI 10.1093/occmed/kql148
   Comhair SAA, 2005, AM J RESP CRIT CARE, V172, P306, DOI 10.1164/rccm.200502-180OC
   Comhair SAA, 2005, AM J PATHOL, V166, P663, DOI 10.1016/S0002-9440(10)62288-2
   Comhair SAA, 2000, LANCET, V355, P624, DOI 10.1016/S0140-6736(99)04736-4
   Comhair SAA, 2002, AM J PHYSIOL-LUNG C, V283, pL246, DOI 10.1152/ajplung.00491.2001
   DEARMAN RJ, 1991, IMMUNOLOGY, V72, P563
   DEARMAN RJ, 2002, FOOD CHEM TOXICOL, V40, P107
   DeRaeve HR, 1997, AM J PHYSIOL-LUNG C, V272, pL148
   dos Santos GG, 2009, TOXICOL APPL PHARM, V236, P372, DOI 10.1016/j.taap.2009.02.004
   European Commission, 1986, OFF J EUR COMMUNITIE, V1358, P1
   Frank MH, 2001, J IMMUNOL, V166, P2451, DOI 10.4049/jimmunol.166.4.2451
   Frank S, 1999, FASEB J, V13, P869
   FRIDOVICH I, 1995, ANNU REV BIOCHEM, V64, P97, DOI 10.1146/annurev.bi.64.070195.000525
   Fridovich I, 1997, J BIOL CHEM, V272, P18515, DOI 10.1074/jbc.272.30.18515
   GOTTESMAN MM, 1993, ANNU REV BIOCHEM, V62, P385, DOI 10.1146/annurev.bi.62.070193.002125
   Granucci F, 1999, MICROBES INFECT, V1, P1079, DOI 10.1016/S1286-4579(99)00209-9
   HALLIWELL B, 1994, LANCET, V344, P721, DOI 10.1016/S0140-6736(94)92211-X
   Hirota M, 2009, J TOXICOL SCI, V34, P139, DOI 10.2131/jts.34.139
   Kagatani S, 2010, J INVEST DERMATOL, V130, P175, DOI 10.1038/jid.2009.229
   KESKINEN H, 1988, CLIN ALLERGY, V18, P597, DOI 10.1111/j.1365-2222.1988.tb02911.x
   Lambrecht BN, 2010, LANCET, V376, P835, DOI 10.1016/S0140-6736(10)61226-3
   Landsteiner K, 1936, J EXP MED, V64, P625, DOI 10.1084/jem.64.4.625
   Matos TJ, 2005, IMMUNOL CELL BIOL, V83, P607, DOI 10.1111/j.1440-1711.2005.01378.x
   Mitjans M, 2008, TOXICOL IN VITRO, V22, P386, DOI 10.1016/j.tiv.2007.10.005
   Miyazawa M, 2007, TOXICOL IN VITRO, V21, P428, DOI 10.1016/j.tiv.2006.10.005
   Miyazawa M, 2008, J TOXICOL SCI, V33, P51, DOI 10.2131/jts.33.51
   Mizuashi M, 2005, J INVEST DERMATOL, V124, P579, DOI 10.1111/j.0022-202X.2005.23624.x
   National Research Council, 2007, TOX TEST 21 CENT VIS
   Neves BM, 2013, CHEM RES TOXICOL, V26, P368, DOI 10.1021/tx300472d
   O'Brien J, 2000, EUR J BIOCHEM, V267, P5421, DOI 10.1046/j.1432-1327.2000.01606.x
   Ott M, 2007, APOPTOSIS, V12, P913, DOI 10.1007/s10495-007-0756-2
   Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085
   Puig-Kroger A, 2001, BLOOD, V98, P2175, DOI 10.1182/blood.V98.7.2175
   Randolph GJ, 1998, P NATL ACAD SCI USA, V95, P6924, DOI 10.1073/pnas.95.12.6924
   Riedl MA, 2008, CURR OPIN ALLERGY CL, V8, P49, DOI 10.1097/ACI.0b013e3282f3d913
   RONINSON IB, 1991, MOL CELLULAR BIOL MU
   Russell WMS, 1959, PRINCIPLES HUMANE EX
   Schmidt CW, 2009, ENVIRON HEALTH PERSP, V117, pA348, DOI 10.1289/ehp.117-a348
   Smith LJ, 1997, FREE RADICAL BIO MED, V22, P1301, DOI 10.1016/S0891-5849(96)00550-3
   Stowe DF, 2009, ANTIOXID REDOX SIGN, V11, P1373, DOI 10.1089/ARS.2008.2331
   Suzuki M, 2009, TOXICOL IN VITRO, V23, P687, DOI 10.1016/j.tiv.2009.02.002
   Tee RD, 1998, J ALLERGY CLIN IMMUN, V101, P709, DOI 10.1016/S0091-6749(98)70181-2
   Trompezinski S, 2008, TOXICOL APPL PHARM, V230, P397, DOI 10.1016/j.taap.2008.03.012
   Wisnewski AV, 2008, CLIN EXP ALLERGY, V38, P957, DOI 10.1111/j.1365-2222.2008.02982.x
   Wisnewski AV, 2013, TOXICOL IN VITRO, V27, P662, DOI 10.1016/j.tiv.2012.11.013
   Wisnewski AV, 2011, CHEM RES TOXICOL, V24, P1686, DOI 10.1021/tx2002433
   Wisnewski AV, 2000, AM J RESP CRIT CARE, V162, P2330, DOI 10.1164/ajrccm.162.6.2002086
   ZHOU LJ, 1995, J IMMUNOL, V154, P3821
NR 56
TC 6
Z9 6
U1 0
U2 8
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0891-5849
EI 1873-4596
J9 FREE RADICAL BIO MED
JI Free Radic. Biol. Med.
PD JUL
PY 2014
VL 72
BP 238
EP 246
DI 10.1016/j.freeradbiomed.2014.04.005
PG 9
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA AJ4OS
UT WOS:000337656300022
PM 24742817
DA 2019-10-23
ER

PT J
AU Roggen, EL
AF Roggen, Erwin L.
TI In Vitro Approaches for Detection of Chemical Sensitization
SO BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
LA English
DT Review
ID TOLL-LIKE RECEPTOR; EPIDERMAL EQUIVALENT ASSAY; DENDRITIC
   CELL-MIGRATION; TEST H-CLAT; SKIN SENSITIZATION; T-CELLS;
   IDENTIFICATION; ACTIVATION; IL-18; GAMMA
AB Concerns, legislation and research needs have precipitated developments such as the mode of action concept, the Tox21 strategy, the concept of pathways of toxicity and the adverse outcome pathway framework. New technologies and paradigms are currently transforming these concepts into applicable animal-free toxicity testing systems. The adverse outcome pathway framework provides a structure for collecting, organizing and evaluating the available data that describe the compound and the events resulting in an adverse outcome at a biological level of organization. The current chapter intends to provide a non-exhaustive review of (i) our current understanding of the molecular mechanisms driven the key events of the mode of action for sensitization induction by chemicals, (ii) the tools that were developed on the basis of the available knowledge and (iii) the major gaps that need to be filled.
C1 Novozymes AS, DK-2880 Bagsvaerd, Denmark.
RP Roggen, EL (reprint author), Novozymes AS, Krogshoejvej 36, DK-2880 Bagsvaerd, Denmark.
EM elro@novozymes.com
CR Adler S, 2011, ARCH TOXICOL, V85, P367, DOI 10.1007/s00204-011-0693-2
   Albanesi C, 2000, J INVEST DERMATOL, V115, P81, DOI 10.1046/j.1523-1747.2000.00041.x
   Albrekt AS, 2014, BMC PHARM T IN PRESS
   Antonopoulos C, 2008, J LEUKOCYTE BIOL, V83, P361, DOI 10.1189/jlb.0604352
   Ashikaga T, 2006, TOXICOL IN VITRO, V20, P767, DOI 10.1016/j.tiv.2005.10.012
   Ashikaga T, 2010, ATLA-ALTERN LAB ANIM, V38, P275, DOI 10.1177/026119291003800403
   Basketter D, 2007, ATLA-ALTERN LAB ANIM, V35, P137, DOI 10.1177/026119290703500124
   Boldogh I, 2005, J CLIN INVEST, V115, P2169, DOI 10.1172/JCI24422
   Boverhof DR, 2008, TOXICOL APPL PHARM, V226, P1, DOI 10.1016/j.taap.2007.10.008
   Chipinda Itai, 2011, J Allergy (Cairo), V2011, P839682, DOI 10.1155/2011/839682
   Chipinda I, 2010, CHEM RES TOXICOL, V23, P918, DOI 10.1021/tx100003w
   Cooper A, 2010, DRUG METAB DISPOS, V38, P2218, DOI 10.1124/dmd.110.034462
   Corsini E, 2013, FOOD CHEM TOXICOL, V61, P74, DOI 10.1016/j.fct.2013.02.038
   Corsini E, 2013, TOXICOL IN VITRO, V27, P1127, DOI 10.1016/j.tiv.2012.05.018
   dos Santos GG, 2011, TOXICOL IN VITRO, V25, P347, DOI 10.1016/j.tiv.2010.10.008
   Emter R, 2013, TOXICOL IN VITRO, V27, P2225, DOI 10.1016/j.tiv.2013.09.009
   Esser PR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041340
   Gerberick F, 2008, ATLA-ALTERN LAB ANIM, V36, P215, DOI 10.1177/026119290803600210
   Gerberick GF, 2009, TOXICOL SCI, V112, P164, DOI 10.1093/toxsci/kfp192
   Gibbs S, 2013, TOXICOL APPL PHARM, V272, P529, DOI 10.1016/j.taap.2013.07.003
   Hammad H, 2009, NAT MED, V15, P410, DOI 10.1038/nm.1946
   Hartwig C, 2008, CYTOKINE, V42, P298, DOI 10.1016/j.cyto.2008.02.012
   Jelley-Gibbs DM, 2008, IMMUNOL CELL BIOL, V86, P343, DOI 10.1038/icb.2008.13
   Johansson H, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-399
   Kool M, 2011, IMMUNITY, V34, P527, DOI 10.1016/j.immuni.2011.03.015
   Lalko JF, 2013, TOXICOL IN VITRO, V27, P651, DOI 10.1016/j.tiv.2012.10.016
   Lundberg K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052875
   MacKay C, 2013, ALTEX ONLINE
   Manchanda T, 2002, MOL PHARMACOL, V62, P1011, DOI 10.1124/mol.62.5.1011
   Martin SF, 2008, J EXP MED, V205, P2151, DOI 10.1084/jem.20070509
   Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238
   Migdal C, 2013, TOXICOL SCI, V133, P259, DOI 10.1093/toxsci/kft075
   Monzon ME, 2010, J BIOL CHEM, V285, P26126, DOI 10.1074/jbc.M110.135194
   Nakae S, 2002, IMMUNITY, V17, P375, DOI 10.1016/S1074-7613(02)00391-6
   Natsch A, 2013, J APPL TOXICOL, V33, P1337, DOI 10.1002/jat.2868
   Organization for Economic Co-operation and Development, 2013, SER TEST ASS, V168
   Ouwehand K, 2011, TECH ADV, V90, P1028
   Ouwehand K, 2010, EUR J IMMUNOL, V40, P2026, DOI 10.1002/eji.200940150
   Page K, 2009, J IMMUNOL, V183, P3400, DOI 10.4049/jimmunol.0900838
   Ray PD, 2012, CELL SIGNAL, V24, P981, DOI 10.1016/j.cellsig.2012.01.008
   Rees B, 2011, TOXICOL IN VITRO, V25, P2124, DOI 10.1016/j.tiv.2011.09.021
   Richter A, 2013, TOXICOL IN VITRO, V27, P1180, DOI 10.1016/j.tiv.2012.08.007
   Smith CK, 2001, ALLERGIC CONTACT DER, DOI [10.1034/j.1600-0536.2001.450224-2.x, DOI 10.1034/J.1600-0536.2001.450224-2.X]
   Tan JKH, 2005, J LEUKOCYTE BIOL, V78, P319, DOI 10.1189/jlb.1104664
   Thomas WR, 2005, CURR ALLERGY ASTHM R, V5, P388, DOI 10.1007/s11882-005-0012-1
   Thyssen JP, 2012, CONTACT DERMATITIS, V66, P11, DOI 10.1111/j.1600-0536.2011.02004_2.x
   Trompette A, 2009, NATURE, V457, P585, DOI 10.1038/nature07548
   Villablanca EJ, 2008, HISTOL HISTOPATHOL, V23, P897, DOI 10.14670/HH-23.897
   Vocanson M, 2008, J INVEST DERMATOL, V128, P2119, DOI 10.1038/jid.2008.15
   Watanabe H, 2007, J INVEST DERMATOL, V127, P1956, DOI 10.1038/sj.jid.5700819
   Xu H, 1996, J EXP MED, V183, P1001, DOI 10.1084/jem.183.3.1001
   Yozzo KL, 2013, AQUAT TOXICOL, V126, P346, DOI 10.1016/j.aquatox.2012.09.008
NR 52
TC 17
Z9 18
U1 0
U2 13
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1742-7835
EI 1742-7843
J9 BASIC CLIN PHARMACOL
JI Basic Clin. Pharmacol. Toxicol.
PD JUL
PY 2014
VL 115
IS 1
BP 32
EP 40
DI 10.1111/bcpt.12202
PG 9
WC Pharmacology & Pharmacy; Toxicology
SC Pharmacology & Pharmacy; Toxicology
GA AJ3QY
UT WOS:000337583400005
PM 24472442
OA Bronze
DA 2019-10-23
ER

PT J
AU Kupsco, A
   Schlenk, D
AF Kupsco, Allison
   Schlenk, Daniel
TI Mechanisms of Selenomethionine Developmental Toxicity and the Impacts of
   Combined Hypersaline Conditions on Japanese Medaka (Oryzias latipes)
SO ENVIRONMENTAL SCIENCE & TECHNOLOGY
LA English
DT Article
ID UNFOLDED PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM STRESS; TRANSCRIPTION
   FACTOR XBP-1; TROUT ONCORHYNCHUS-MYKISS; OXIDATIVE STRESS;
   RAINBOW-TROUT; MONOOXYGENASE ACTIVITY; MEDIATED APOPTOSIS; ORGANIC
   SELENIUM; ER STRESS
AB Selenium (Se) is an essential micronutrient that can cause embryotoxicty at levels 7-30 times above essential selenomethionine (Se Met) decreased embryo hatch and depleted glutathione in Japanese medaka embryos without affecting Se accumulation. To better understand the impacts of nonchemical stressors on developmental toxicity of Se in fish, several adverse outcome pathways were evaluated in the Japanese medaka (Oryzias latipes). We treated medaka embryos at 12 h post fertilization with 50 mu M Se Met for 12 hours in freshwater or in 13 ppth hypersalinity and evaluated the contributions of oxidative stress, the unfolded protein response and apoptosis to reduced hatch. Exposure to Se Met and hypersalinity decreased embryo hatch to 3.7% +/- 1.95, and induced teratogenesis in 100% +/- 0 of hatched embryos. In contrast, treatments of freshwater, saltwater, and Se Met in freshwater resulted in 89.8% +/- 3.91-86.7% +/- 3.87 hatch, and no significant increase in deformities. We found no significant differences in lipid peroxidation, indicating that oxidative stress may not be responsible for the observed toxicity in embryos at this time point (24 h). Although significant changes in apoptosis were not observed, we witnessed up to 100 fold increases in transcripts of the endoplasmic reticulum (ER) chaperone, immunoglobulin binding protein (BiP) and trends toward increasing downstream signals, activating transcription factor 4 (ATF4) and ATF6 indicating potential contributions of the unfolded protein response to the effects of Se Met and hypersaline conditions. These data indicate that multiple adverse outcome pathways may be responsible for the developmental toxicity of Se and salinity, and these pathways may be time dependent.
C1 [Kupsco, Allison; Schlenk, Daniel] Univ Calif Riverside, Dept Environm Sci, Riverside, CA 92507 USA.
RP Kupsco, A (reprint author), Univ Calif Riverside, Dept Environm Sci, Riverside, CA 92507 USA.
EM allison.kupsco@email.ucr.edu
FU University of California-Riverside/Agricultural Experiment Station
   Resource Allocation Program; University of Washington Superfund Basic
   Research Program [NIEHS P42ESO4696]
FX We acknowledge Rodney Johnson at the U.S. EPA, Duluth, MN for providing
   us with the mature Japanese medaka for this study. Funding Source:
   University of California-Riverside/Agricultural Experiment Station
   Resource Allocation Program and the University of Washington Superfund
   Basic Research Program [NIEHS P42ESO4696].
CR Benbrook D. M., 2012, Experimental Oncology, V34, P286
   CHEN GP, 1994, ARCH BIOCHEM BIOPHYS, V312, P566, DOI 10.1006/abbi.1994.1346
   Cribb AE, 2005, DRUG METAB REV, V37, P405, DOI 10.1080/03602530500205135
   Cullinan SB, 2006, INT J BIOCHEM CELL B, V38, P317, DOI 10.1016/j.biocel.2005.09.018
   DuRose JB, 2006, MOL BIOL CELL, V17, P3095, DOI 10.1091/mbc.E06-01-0055
   EL-Alfy A, 2002, MAR ENVIRON RES, V54, P275, DOI 10.1016/S0141-1136(02)00183-6
   Enright C., 2010, SAN FRANCISCO ESTUAR, V7
   Fan TWM, 2002, AQUAT TOXICOL, V57, P65, DOI 10.1016/S0166-445X(01)00261-2
   Farwell A, 2006, ARCH ENVIRON CON TOX, V51, P600, DOI 10.1007/s00244-005-0319-x
   HACKETT C, 1988, CLIN CHEM, V34, P208
   Han XF, 2013, CELL SIGNAL, V25, P2136, DOI 10.1016/j.cellsig.2013.06.011
   Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270
   Hoffman DJ, 1996, ARCH ENVIRON CON TOX, V31, P120
   Cornejo VH, 2013, IUBMB LIFE, V65, P962, DOI 10.1002/iub.1224
   Inoue K, 2002, ZOOL SCI, V19, P727, DOI 10.2108/zsj.19.727
   Ishikawa T, 2013, MOL BIOL CELL, V24, P1387, DOI 10.1091/mbc.E12-11-0830
   Ishikawa T, 2011, CELL STRUCT FUNCT, V36, P247, DOI 10.1247/csf.11036
   Jentzsch AM, 1996, FREE RADICAL BIO MED, V20, P251, DOI 10.1016/0891-5849(95)02043-8
   Kirchen R. V., JAPANESE MEDAKA ITS
   Lavado R, 2011, AQUAT TOXICOL, V108, P18
   Lemly AD, 2002, AQUAT TOXICOL, V57, P39, DOI 10.1016/S0166-445X(01)00264-8
   Lemly AD, 1997, ECOTOX ENVIRON SAFE, V37, P259, DOI 10.1006/eesa.1997.1554
   lijima N., 2007, ACTA HISTOCHEM CYTOC, V40, P1
   Luoma SN, 2005, ENVIRON SCI TECHNOL, V39, P1921, DOI 10.1021/es048947e
   Miller LL, 2007, AQUAT TOXICOL, V83, P263, DOI 10.1016/j.aquatox.2007.05.001
   Misra S, 2012, TOXICOL IN VITRO, V26, P621, DOI 10.1016/j.tiv.2012.02.001
   Muscatello JR, 2006, ENVIRON SCI TECHNOL, V40, P6506, DOI 10.1021/es060661h
   Nair S, 2007, TOXICOL LETT, V168, P21, DOI 10.1016/j.toxlet.2006.10.012
   Nijhawan D, 2000, ANNU REV NEUROSCI, V23, P73, DOI 10.1146/annurev.neuro.23.1.73
   Outridge P. M., 1999, Environmental Reviews, V7, P81, DOI 10.1139/er-7-2-81
   Palace VP, 2004, ECOTOX ENVIRON SAFE, V58, P17, DOI 10.1016/j.ecoenv.2003.08.019
   Phibbs J, 2011, ECOTOX ENVIRON SAFE, V74, P1855, DOI 10.1016/j.ecoenv.2011.06.015
   Presser TS, 2004, HAND EXPL G, V8, P299
   Ramirez P, 2002, ARCH ENVIRON CON TOX, V42, P431, DOI 10.1007/s00244-001-0037-y
   Reimold AM, 2000, GENE DEV, V14, P152
   Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509
   Saito A, 2011, J BIOL CHEM, V286, P4809, DOI 10.1074/jbc.M110.152900
   Schlenk D, 1996, BIOCHEM PHARMACOL, V52, P815, DOI 10.1016/0006-2952(96)00358-9
   Schlenk D, 2003, TOXICOL SCI, V75, P309, DOI 10.1093/toxsci/kfg184
   Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73
   Sha HB, 2009, CELL METAB, V9, P556, DOI 10.1016/j.cmet.2009.04.009
   Spallholz JE, 2004, BIOCHEM PHARMACOL, V67, P547, DOI 10.1016/j.bcp.2003.09.004
   [USEPA] US Environmental Protection Agency, 2004, AQ LIF WAT IN PRESS
   Wang ZS, 2002, MOL CARCINOGEN, V34, P113, DOI 10.1002/mc.10056
   Wen HJ, 2007, ATMOS ENVIRON, V41, P7151, DOI 10.1016/j.atmosenv.2007.07.035
   Weng WC, 2011, J FORMOS MED ASSOC, V110, P428, DOI 10.1016/S0929-6646(11)60064-8
   Wu MH, 2011, COMP BIOCHEM PHYS C, V153, P159, DOI 10.1016/j.cbpc.2010.10.002
   Wu Y, 2005, CANCER RES, V65, P9073, DOI 10.1158/0008-5472.CAN-05-2016
   Wu Y, 2012, AQUAT TOXICOL, V124, P238, DOI 10.1016/j.aquatox.2012.08.009
   Zhao S, 2005, J COMPUT BIOL, V12, P1047, DOI 10.1089/cmb.2005.12.1047
NR 50
TC 14
Z9 16
U1 3
U2 26
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0013-936X
EI 1520-5851
J9 ENVIRON SCI TECHNOL
JI Environ. Sci. Technol.
PD JUN 17
PY 2014
VL 48
IS 12
BP 7062
EP 7068
DI 10.1021/es5019948
PG 7
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA AJ4KU
UT WOS:000337646000065
PM 24856650
OA Bronze, Green Published
DA 2019-10-23
ER

PT J
AU Kleinstreuer, NC
   Yang, J
   Berg, EL
   Knudsen, TB
   Richard, AM
   Martin, MT
   Reif, DM
   Judson, RS
   Polokoff, M
   Dix, DJ
   Kavlock, RJ
   Houck, KA
AF Kleinstreuer, Nicole C.
   Yang, Jian
   Berg, Ellen L.
   Knudsen, Thomas B.
   Richard, Ann M.
   Martin, Matthew T.
   Reif, David M.
   Judson, Richard S.
   Polokoff, Mark
   Dix, David J.
   Kavlock, Robert J.
   Houck, Keith A.
TI Phenotypic screening of the ToxCast chemical library to classify toxic
   and therapeutic mechanisms
SO NATURE BIOTECHNOLOGY
LA English
DT Article
ID MAP KINASE INHIBITOR; DRUG DISCOVERY; PERFLUOROOCTANE SULFONATE;
   ENVIRONMENTAL CHEMICALS; RHEUMATOID-ARTHRITIS; PREDICTIVE MODELS;
   BIOLOGY APPROACH; BIOMAP ANALYSIS; BREAST-CANCER; RECEPTOR
AB Addressing the safety aspects of drugs and environmental chemicals has historically been undertaken through animal testing. However, the quantity of chemicals in need of assessment and the challenges of species extrapolation require the development of alternative approaches. Our approach, the US Environmental Protection Agency's ToxCast program, utilizes a large suite of in vitro and model organism assays to interrogate important chemical libraries and computationally analyze bioactivity profiles. Here we evaluated one component of the ToxCast program, the use of primary human cell systems, by screening for chemicals that disrupt physiologically important pathways. Chemical-response signatures for 87 endpoints covering molecular functions relevant to toxic and therapeutic pathways were generated in eight cell systems for 641 environmental chemicals and 135 reference pharmaceuticals and failed drugs. Computational clustering of the profiling data provided insights into the polypharmacology and potential off-target effects for many chemicals that have limited or no toxicity information. The endpoints measured can be closely linked to in vivo outcomes, such as the upregulation of tissue factor in endothelial cell systems by compounds linked to the risk of thrombosis in vivo. Our results demonstrate that assaying complex biological pathways in primary human cells can identify potential chemical targets, toxicological liabilities and mechanisms useful for elucidating adverse outcome pathways.
C1 [Kleinstreuer, Nicole C.; Knudsen, Thomas B.; Richard, Ann M.; Martin, Matthew T.; Reif, David M.; Judson, Richard S.; Dix, David J.; Kavlock, Robert J.; Houck, Keith A.] US EPA, Natl Ctr Computat Toxicol, Off Res & Dev, Res Triangle Pk, NC 27711 USA.
   [Yang, Jian; Berg, Ellen L.; Polokoff, Mark] Div DiscoveRx Inc, BioSeek, San Francisco, CA USA.
RP Houck, KA (reprint author), US EPA, Natl Ctr Computat Toxicol, Off Res & Dev, Res Triangle Pk, NC 27711 USA.
EM houck.keith@epa.gov
RI Houck, Keith/G-8654-2014; Kleinstreuer, Nicole/F-7203-2019; Berg,
   Ellen/D-9076-2014
OI Houck, Keith/0000-0002-0055-2249; Kleinstreuer,
   Nicole/0000-0002-7914-3682; Berg, Ellen/0000-0001-5149-6665; Judson,
   Richard/0000-0002-2348-9633; Reif, David/0000-0001-7815-6767
CR AIZUYOKOTA E, 1994, CARCINOGENESIS, V15, P1875, DOI 10.1093/carcin/15.9.1875
   Arredondo J, 2001, LAB INVEST, V81, P1653, DOI 10.1038/labinvest.3780379
   Arrowsmith J, 2011, NAT REV DRUG DISCOV, V10, P1, DOI 10.1038/nrd3375
   Attene-Ramos MS, 2013, DRUG DISCOV TODAY, V18, P716, DOI 10.1016/j.drudis.2013.05.015
   Augustine-Rauch KA, 2004, BIRTH DEFECTS RES A, V70, P789, DOI 10.1002/bdra.20076
   Ayala A, 1996, J BIOL CHEM, V271, P23105, DOI 10.1074/jbc.271.38.23105
   Barna TM, 2001, J MOL BIOL, V310, P433, DOI 10.1006/jmbi.2001.4779
   Barua RS, 2013, ARTERIOSCL THROM VAS, V33, P1460, DOI 10.1161/ATVBAHA.112.300154
   Berg EL, 2005, IEE P SYST BIOL, V152, P201, DOI 10.1049/ip-syb:20050036
   Berg Ellen L., 2006, Journal of Pharmacological and Toxicological Methods, V53, P67, DOI 10.1016/j.vascn.2005.06.003
   Berg EL, 2013, J BIOMOL SCREEN, V18, P1260, DOI 10.1177/1087057113505324
   Berg EL, 2010, J PHARMACOL TOX MET, V61, P3, DOI 10.1016/j.vascn.2009.10.001
   Bogdanska J, 2011, TOXICOLOGY, V284, P54, DOI 10.1016/j.tox.2011.03.014
   Bowes J, 2012, NAT REV DRUG DISCOV, V11, P909, DOI 10.1038/nrd3845
   Camici GG, 2010, EUR HEART J, V31, P236, DOI 10.1093/eurheartj/ehp259
   Chen Y, 2009, NAT CHEM BIOL, V5, P358, DOI 10.1038/nchembio.155
   Clark RD, 2000, J MOL GRAPH MODEL, V18, P404, DOI 10.1016/S1093-3263(00)00065-6
   Cohen SB, 2009, ARTHRITIS RHEUM, V60, P335, DOI 10.1002/art.24266
   Cummings SR, 1999, JAMA-J AM MED ASSOC, V281, P2189, DOI 10.1001/jama.281.23.2189
   Ding CH, 2006, CURR OPIN INVESTIG D, V7, P1020
   Dix DJ, 2007, TOXICOL SCI, V95, P5, DOI 10.1093/toxsci/kfl103
   Fell MJ, 2010, NEUROPHARMACOLOGY, V58, P632, DOI 10.1016/j.neuropharm.2009.11.014
   Houck KA, 2008, TOXICOL APPL PHARM, V227, P163, DOI 10.1016/j.taap.2007.10.022
   Houck KA, 2009, J BIOMOL SCREEN, V14, P1054, DOI 10.1177/1087057109345525
   Judson R, 2009, ENVIRON HEALTH PERSP, V117, P685, DOI 10.1289/ehp.0800168
   Kavlock R, 2012, CHEM RES TOXICOL, V25, P1287, DOI 10.1021/tx3000939
   Khaidakov M, 2009, BIOCHEM BIOPH RES CO, V387, P543, DOI 10.1016/j.bbrc.2009.07.057
   Kirkiacharian S., 1999, Annales Pharmaceutiques Francaises, V57, P332
   Kitchen DB, 2004, NAT REV DRUG DISCOV, V3, P935, DOI 10.1038/nrd1549
   Kleinstreuer N, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002996
   Kleinstreuer NC, 2011, ENVIRON HEALTH PERSP, V119, P1596, DOI 10.1289/ehp.1103412
   Kohonen T, 2013, NEURAL NETWORKS, V37, P52, DOI 10.1016/j.neunet.2012.09.018
   Kunkel EJ, 2004, ASSAY DRUG DEV TECHN, V2, P431, DOI 10.1089/1540658041850607
   Kunkel EJ, 2004, FASEB J, V18, P1279, DOI 10.1096/fj.04-1538fje
   Lau C, 2003, TOXICOL SCI, V74, P382, DOI 10.1093/toxsci/kfg122
   LIPTON A, 1984, CANCER TREAT REP, V68, P887
   Lounkine E, 2012, NATURE, V486, P361, DOI 10.1038/nature11159
   Martin MT, 2011, BIOL REPROD, V85, P327, DOI 10.1095/biolreprod.111.090977
   McCann FE, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3041
   Melrose J, 1998, J IMMUNOL, V161, P2457
   Murotani T, 2011, NEUROPHARMACOLOGY, V61, P228, DOI 10.1016/j.neuropharm.2011.04.003
   National Research Council, 2007, TOX TEST 21 CENT VIS
   Ouattara B, 2010, NEUROSCIENCE, V167, P1160, DOI 10.1016/j.neuroscience.2010.03.022
   Owens AP, 2012, CURR ATHEROSCLER REP, V14, P394, DOI 10.1007/s11883-012-0269-5
   Plavec I, 2004, P NATL ACAD SCI USA, V101, P1223, DOI 10.1073/pnas.0308221100
   Robichaud A, 2002, BRIT J PHARMACOL, V135, P113, DOI 10.1038/sj.bjp.0704457
   Sipes NS, 2011, TOXICOL SCI, V124, P109, DOI 10.1093/toxsci/kfr220
   Thiede A, 2012, BBA-BIOENERGETICS, V1817, P1747, DOI 10.1016/j.bbabio.2012.02.034
   Tice RR, 2013, ENVIRON HEALTH PERSP, V121, P756, DOI 10.1289/ehp.1205784
   US EPA, 2014, US ENV PROT AG END D
   Viguerie N, 2012, PHYSIOL GENOMICS, V44, P141, DOI 10.1152/physiolgenomics.00032.2011
   Williams O, 2010, CHEM BIOL, V17, P123, DOI 10.1016/j.chembiol.2010.01.010
NR 52
TC 93
Z9 96
U1 3
U2 59
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1087-0156
EI 1546-1696
J9 NAT BIOTECHNOL
JI Nat. Biotechnol.
PD JUN
PY 2014
VL 32
IS 6
BP 583
EP +
DI 10.1038/nbt.2914
PG 12
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA AI9EV
UT WOS:000337233800022
PM 24837663
DA 2019-10-23
ER

PT J
AU Franzellitti, S
   Buratti, S
   Capolupo, M
   Du, BW
   Haddad, SP
   Chambliss, CK
   Brooks, BW
   Fabbri, E
AF Franzellitti, Silvia
   Buratti, Sara
   Capolupo, Marco
   Du, Bowen
   Haddad, Samuel P.
   Chambliss, C. Kevin
   Brooks, Bryan W.
   Fabbri, Elena
TI An exploratory investigation of various modes of action and potential
   adverse outcomes of fluoxetine in marine mussels
SO AQUATIC TOXICOLOGY
LA English
DT Article
DE Marine mussel; Fluoxetine; Mode of action; cAMP signaling; Biomarkers;
   Adverse outcome pathway
ID PERSONAL CARE PRODUCTS; SEROTONIN REUPTAKE INHIBITORS; PRESSURIZED
   LIQUID EXTRACTION; SOLID-PHASE EXTRACTION; MEDAKA ORYZIAS-LATIPES;
   REAL-TIME PCR; HUMAN PHARMACEUTICALS; STRESS SYNDROME; RISK-ASSESSMENT;
   SURFACE WATERS
AB The present study investigated possible adverse outcome pathways (AOPs) of the antidepressant fluoxetine (FX) in the marine mussel Mytilus galloprovincialis. An evaluation of molecular endpoints involved in modes of action (MOAs) of FX and biomarkers for sub-lethal toxicity were explored in mussels after a 7-day administration of nominal FX concentrations encompassing a range of environmentally relevant values (0.03-300 ng/L). FX bioaccumulated in mussel tissues after treatment with 30 and 300 ng/L FX, resulting in bioconcentration factor (BCF) values ranging from 200 to 800, which were higher than expected based solely on hydrophobic partitioning models. Because FX acts as a selective serotonin (5-HT) re-uptake inhibitor increasing serotonergic neurotransmission at mammalian synapses, cell signaling alterations triggered by 5-HT receptor occupations were assessed, cAMP levels and PICA activities were decreased in digestive gland and mantle/gonads of FX-treated mussels, consistent with an increased occupation of 5-HT1 receptors negatively coupled to the CAMP/PKA pathway. mRNA levels of a ABCB gene encoding the P-glycoprotein were also significantly down-regulated. This membrane transporter acts in detoxification towards xenobiotics and in altering pharmacokinetics of antidepressants; moreover, it is under a cAMP/PKA transcriptional regulation in mussels. Potential stress effects of FX were investigated using a battery of biomarkers for mussel health status that included lysosomal parameters, antioxidant enzyme activities, lipid peroxidation, and acetylcholinesterase activity. FX reduced the health status of mussels and induced lysosomal alterations, as suggested by reduction of lysosomal membrane stability in haemocytes and by lysosomal accumulation of neutral lipids in digestive gland. No clear antioxidant responses to FX were detected in digestive gland, while gills displayed significant increases of catalase and glutathione-s-transferase activities and a significant decrease of acetylcholinesterase activity. Though AOPs associated with mammalian therapeutic MOAs remain important during assessments of pharmaceutical hazards in the environment, this study highlights the importance of considering additional MOAs and AOPs for FX, particularly in marine mussels. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Franzellitti, Silvia; Buratti, Sara; Capolupo, Marco; Fabbri, Elena] Univ Bologna, Interdept Ctr Environm Sci Res, I-48123 Ravenna, Italy.
   [Franzellitti, Silvia; Fabbri, Elena] Univ Bologna, Dept Biol Geol & Environm Sci, I-40100 Bologna, Italy.
   [Du, Bowen; Haddad, Samuel P.; Brooks, Bryan W.] Baylor Univ, Dept Environm Sci, Waco, TX 76798 USA.
   [Chambliss, C. Kevin] Baylor Univ, Dept Chem & Biochem, Waco, TX 76798 USA.
RP Franzellitti, S (reprint author), Univ Bologna, Interdept Ctr Environm Sci Res, Via S Alberto 163, I-48123 Ravenna, Italy.
EM silvia.franzellitti@unibo.it
RI Guenat, Heather/H-6528-2014; Brooks, Bryan W/B-2612-2010
OI Brooks, Bryan W/0000-0002-6277-9852; Franzellitti,
   Silvia/0000-0001-6104-7812; Chambliss, Kevin/0000-0003-3888-6890;
   FABBRI, Elena/0000-0002-9957-8202
FU MEECE EU-FP7 Project; Italian Ministry of University and
   ResearchMinistero dell' Istruzione, dell' Universita e della Ricerca
   (MIUR)
FX The research has been funded by MEECE EU-FP7 Project, and Italian
   Ministry of University and Research to E.F.
CR Akamine Y, 2012, CNS DRUGS, V26, P959, DOI 10.1007/s40263-012-0008-z
   Angers A, 1998, J NEUROSCI, V18, P5586
   Ankley GT, 2007, ENVIRON SCI TECHNOL, V41, P8211, DOI 10.1021/es072658j
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Baker DR, 2011, J CHROMATOGR A, V1218, P7901, DOI 10.1016/j.chroma.2011.08.092
   Banni M, 2007, BIOMARKERS, V12, P369, DOI 10.1080/13547500701217061
   Bard SM, 2000, AQUAT TOXICOL, V48, P357, DOI 10.1016/S0166-445X(00)00088-6
   Berninger JP, 2011, ENVIRON TOXICOL CHEM, V30, P2065, DOI 10.1002/etc.590
   Berninger JP, 2010, TOXICOL LETT, V193, P69, DOI 10.1016/j.toxlet.2009.12.006
   Boxall ABA, 2012, ENVIRON HEALTH PERSP, V120, P1221, DOI 10.1289/ehp.1104477
   Brausch JM, 2012, REV ENVIRON CONTAM T, V218, P1, DOI 10.1007/978-1-4614-3137-4_1
   Bringolf RB, 2010, ENVIRON TOXICOL CHEM, V29, P1311, DOI 10.1002/etc.157
   Brooks BW, 2009, ENVIRON TOXICOL CHEM, V28, P2469, DOI 10.1897/09-325.1
   Brooks BW, 2005, ENVIRON TOXICOL CHEM, V24, P464, DOI 10.1897/04-081R.1
   Brooks BW, 2003, CHEMOSPHERE, V52, P135, DOI 10.1016/S0045-6535(03)00103-6
   Brooks BW, 2003, TOXICOL LETT, V142, P169, DOI 10.1016/S0378-4274(03)00066-3
   Brooks BW, 2012, HUMAN PHARM ENV CURR, P1, DOI DOI 10.1007/978-1-4614-3473-3_1
   Brown N.J., 2001, GOODMAN GILMANS PHAR, P656
   Catterson ML, 1996, PHARMACOL TOXICOL, V78, P203, DOI 10.1111/j.1600-0773.1996.tb00206.x
   Chu S, 2007, J CHROMATOGR A, V1163, P112, DOI 10.1016/j.chroma.2007.06.014
   Conley JM, 2008, CHEMOSPHERE, V73, P1178, DOI 10.1016/j.chemosphere.2008.07.062
   Cubero-Leon E, 2010, AQUAT TOXICOL, V98, P178, DOI 10.1016/j.aquatox.2010.02.007
   Daniel WA, 2003, PROG NEURO-PSYCHOPH, V27, P65, DOI 10.1016/S0278-5846(02)00317-2
   Daniel WA, 1997, PHARMACOL TOXICOL, V80, P62, DOI 10.1111/j.1600-0773.1997.tb00285.x
   Daughton CG, 2011, ENV CONTAMINANTS WIL, P281
   Djordjevic J, 2011, EUR J PHARMACOL, V659, P61, DOI 10.1016/j.ejphar.2011.03.003
   Donnini F, 2007, ENVIRON INT, V33, P919, DOI 10.1016/j.envint.2007.05.002
   Du B, 2012, J CHROMATOGR A, V1253, P177, DOI 10.1016/j.chroma.2012.07.026
   Du BW, 2014, SCI TOTAL ENVIRON, V466, P976, DOI 10.1016/j.scitotenv.2013.07.126
   ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9
   Ericson H, 2010, AQUAT TOXICOL, V99, P223, DOI 10.1016/j.aquatox.2010.04.017
   Fabbri E, 2010, J EXP ZOOL PART A, V313A, P179, DOI 10.1002/jez.592
   Fisher NS, 1996, ENVIRON SCI TECHNOL, V30, P3232, DOI 10.1021/es960009u
   Fong P, 2008, B ENVIRON CONTAM TOX, V81, P535, DOI 10.1007/s00128-008-9558-7
   Fong PP, 1998, BIOL BULL, V194, P143, DOI 10.2307/1543044
   Fong PP, 2003, J EXP ZOOL PART A, V298A, P67, DOI 10.1002/a.10279
   Foran CM, 2004, ARCH ENVIRON CON TOX, V46, P511, DOI 10.1007/s00244-003-3042-5
   Franzellitti S, 2013, AQUAT TOXICOL, V140, P249, DOI 10.1016/j.aquatox.2013.06.005
   Franzellitti S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061634
   Franzellitti S, 2011, AQUAT TOXICOL, V101, P299, DOI 10.1016/j.aquatox.2010.11.001
   Franzellitti S, 2010, COMP BIOCHEM PHYS C, V152, P24, DOI 10.1016/j.cbpc.2010.02.010
   Gonzalez-Rey M, 2013, ENVIRON POLLUT, V173, P200, DOI 10.1016/j.envpol.2012.10.018
   Gorbi S, 2012, CHEMOSPHERE, V89, P623, DOI 10.1016/j.chemosphere.2012.05.064
   Gros M, 2006, TALANTA, V70, P678, DOI 10.1016/j.talanta.2006.05.024
   Gunnarsson L, 2008, ENVIRON SCI TECHNOL, V42, P5807, DOI 10.1021/es8005173
   Hannon J, 2008, BEHAV BRAIN RES, V195, P198, DOI 10.1016/j.bbr.2008.03.020
   Hazelton PD, 2013, SCI TOTAL ENVIRON, V445, P94, DOI 10.1016/j.scitotenv.2012.12.026
   Huggett DB, 2003, HUM ECOL RISK ASSESS, V9, P1789, DOI 10.1080/10807030390260498
   Klosterhaus SL, 2013, ENVIRON INT, V54, P92, DOI 10.1016/j.envint.2013.01.009
   Kolpin DW, 2002, ENVIRON SCI TECHNOL, V36, P1202, DOI 10.1021/es011055j
   Kreke N, 2008, CRIT REV TOXICOL, V38, P215, DOI 10.1080/10408440801891057
   Kwon JW, 2006, ENVIRON TOXICOL CHEM, V25, P2561, DOI 10.1897/05-613R.1
   Lazzara R, 2012, AQUAT TOXICOL, V106, P123, DOI 10.1016/j.aquatox.2011.11.003
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Martin-Diaz L, 2009, AQUAT TOXICOL, V94, P177, DOI 10.1016/j.aquatox.2009.06.015
   Martinez-Gomez C, 2008, J ENVIRON MONITOR, V10, P490, DOI 10.1039/b800441m
   Meredith-Williams M, 2012, ENVIRON POLLUT, V165, P250, DOI 10.1016/j.envpol.2011.11.029
   Metcalfe CD, 2003, ENVIRON TOXICOL CHEM, V22, P2881, DOI 10.1897/02-627
   Mimeault C, 2006, TOXICOLOGY, V228, P140, DOI 10.1016/j.tox.2006.08.025
   Minier C, 2000, AQUAT TOXICOL, V50, P167, DOI 10.1016/S0166-445X(99)00104-6
   Moore MN, 2007, AQUAT TOXICOL, V84, P80, DOI 10.1016/j.aquatox.2007.06.007
   MOORE MN, 1976, CELL TISSUE RES, V175, P279
   Moore MN, 2006, AUTOPHAGY, V2, P217, DOI 10.4161/auto.2663
   Moore MN, 2004, MAR ENVIRON RES, V58, P603, DOI 10.1016/j.marenvres.2004.03.049
   MOORE MN, 1982, HISTOCHEM J, V14, P713, DOI 10.1007/BF01033620
   Muller TC, 2002, BBA-MOL BASIS DIS, V1587, P92, DOI 10.1016/S0925-4439(02)00071-6
   Nakamura Y, 2008, CHEMOSPHERE, V70, P865, DOI 10.1016/j.chemosphere.2007.06.089
   Oakes Ken D., 2010, Integrated Environmental Assessment and Management, V6, P524, DOI 10.1002/ieam.77
   Overmyer JP, 2010, ENVIRON TOXICOL, V25, P28, DOI 10.1002/tox.20471
   Park JW, 2012, ENVIRON POLLUT, V167, P163, DOI 10.1016/j.envpol.2012.03.039
   PEROUTKA SJ, 1994, NEUROCHEM INT, V25, P533, DOI 10.1016/0197-0186(94)90151-1
   Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36
   Ram JL, 1996, AM ZOOL, V36, P326
   Ramirez AJ, 2007, ANAL CHEM, V79, P3155, DOI 10.1021/ac062215i
   Ramirez AJ, 2009, ENVIRON TOXICOL CHEM, V28, P2587, DOI 10.1897/08-561.1
   Regoli F, 2013, MAR ENVIRON RES, V1136, P121
   Schmitt Heike, 2010, Integrated Environmental Assessment and Management, V6, P588, DOI 10.1897/IEAM_2009-053.1
   Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73
   Seiler JP, 2002, TOXICOL LETT, V131, P105, DOI 10.1016/S0378-4274(02)00045-0
   Stanley JK, 2007, CHEMOSPHERE, V69, P9, DOI 10.1016/j.chemosphere.2007.04.080
   Tierney AJ, 2001, COMP BIOCHEM PHYS A, V128, P791, DOI 10.1016/S1095-6433(00)00320-2
   Tiu SHK, 2005, GENE, V353, P41, DOI 10.1016/j.gene.2005.03.037
   *UNEP RAMOGE, 1999, MAN BIOM REC MED POL
   Valbonesi P, 2004, J EXP ZOOL PART A, V301A, P952, DOI 10.1002/jez.a.101
   Valbonesi P, 2003, SCI TOTAL ENVIRON, V312, P79, DOI 10.1016/S0048-9697(03)00227-4
   Valenti TW, 2012, ENVIRON SCI TECHNOL, V46, P2427, DOI 10.1021/es204164b
   Valenti TW, 2009, ENVIRON TOXICOL CHEM, V28, P2685, DOI 10.1897/08-546.1
   van der Ven K, 2006, ENVIRON TOXICOL CHEM, V25, P2645, DOI 10.1897/05-495R.1
   Vanderford BJ, 2006, ENVIRON SCI TECHNOL, V40, P7312, DOI 10.1021/es0613198
   Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034
   Vasskog T, 2008, J CHROMATOGR A, V1185, P194, DOI 10.1016/j.chroma.2008.01.063
   VEITH GD, 1979, J FISH RES BOARD CAN, V36, P1040, DOI 10.1139/f79-146
   Viarengo A, 2007, COMP BIOCHEM PHYS C, V146, P281, DOI 10.1016/j.cbpc.2007.04.011
   Vidal-Linan L, 2013, SCI TOTAL ENVIRON, V461, P56, DOI 10.1016/j.scitotenv.2013.04.079
   WHO, 2012, TECHNICAL REPORT, P52
   Wong DT, 2005, NAT REV DRUG DISCOV, V4, P764, DOI 10.1038/nrd1821
NR 96
TC 61
Z9 63
U1 2
U2 86
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-445X
EI 1879-1514
J9 AQUAT TOXICOL
JI Aquat. Toxicol.
PD JUN
PY 2014
VL 151
SI SI
BP 14
EP 26
DI 10.1016/j.aquatox.2013.11.016
PG 13
WC Marine & Freshwater Biology; Toxicology
SC Marine & Freshwater Biology; Toxicology
GA AH5RG
UT WOS:000336188000003
PM 24361074
DA 2019-10-23
ER

PT J
AU Brooks, BW
AF Brooks, Bryan W.
TI Fish on Prozac (and Zoloft): Ten years later
SO AQUATIC TOXICOLOGY
LA English
DT Article
DE Contaminants of emerging concern; Comparative pharmacology and
   toxicology; Urbanization; Water resources; Hazard assessment; Risk
   assessment; Ionization; Chirality; Adverse outcome pathways; Therapeutic
   hazard value
ID SEROTONIN REUPTAKE INHIBITORS; ENVIRONMENTAL RISK-ASSESSMENT; PERSONAL
   CARE PRODUCTS; TROUT ONCORHYNCHUS-MYKISS; TANDEM MASS-SPECTROMETRY;
   MEDAKA ORYZIAS-LATIPES; RATIONAL MOLECULAR DESIGN; HUMAN
   PHARMACEUTICALS; AQUATIC TOXICITY; WATER-QUALITY
AB A decade has now passed since our research group initially reported several adverse effects of fluoxetine to aquatic organisms commonly employed for developing environmental quality criteria, evaluating whole effluent toxicity, and monitoring ambient toxicity of surface waters and sediments. Our subsequent observation of fluoxetine, sertraline and their active metabolites (norfluoxetine and desmethylsertraline, respectively) accumulating in muscle, liver and brain tissues of three different fish species from an effluent-dominated stream was termed "Fish on Prozac." Here I briefly review some scientific lessons learned from our study of antidepressants and the environment, including opportunities for research, management, environmental education and public outreach. Intrinsic chemical properties of antidepressants and other pharmaceuticals have afforded research in areas ranging from analytical chemistry and comparative pharmacology, to influences of ionization, chirality and adverse outcome pathways on hazard and risk assessment, and further promises to support sustainable molecular design of less hazardous chemicals. Using probabilistic hazard assessment and fish plasma modeling approaches, selective serotonin reuptake inhibitors and tricyclic antidepressants are predicted to result in therapeutic hazard to fish (internal fish plasma level equaling mammalian therapeutic dose) when exposed to water (inhalational) at or below 1 mu g/L, a common trigger value for environmental assessments. Though many questions remain unanswered, studies of antidepressants in urbanizing aquatic systems have provided, and will continue to develop, an advanced understanding of environmental hazards and risks from pharmaceuticals and other contaminants. (C) 2014 Elsevier B.V. All rights reserved.
C1 Baylor Univ, Dept Environm Sci, Inst Biomed Studies, Ctr Reservoir & Aquat Syst Res, Waco, TX 76798 USA.
RP Brooks, BW (reprint author), Baylor Univ, Dept Environm Sci, Inst Biomed Studies, Ctr Reservoir & Aquat Syst Res, Waco, TX 76798 USA.
EM Bryan_Brooks@Baylor.edu
RI Brooks, Bryan W/B-2612-2010; Guenat, Heather/H-6528-2014
OI Brooks, Bryan W/0000-0002-6277-9852; 
CR Ankley GT, 2007, ENVIRON SCI TECHNOL, V41, P8211, DOI 10.1021/es072658j
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Berninger JP, 2011, ENVIRON TOXICOL CHEM, V30, P2065, DOI 10.1002/etc.590
   Berninger JP, 2010, TOXICOL LETT, V193, P69, DOI 10.1016/j.toxlet.2009.12.006
   Bisesi J.H., 2014, AQUATIC TOXICOLOGY
   Boxall ABA, 2012, ENVIRON HEALTH PERSP, V120, P1221, DOI 10.1289/ehp.1104477
   Brain R.A., 2006, ENVIRON SCI TECHNOL, V40, P5117
   Brain RA, 2008, REV ENVIRON CONTAM T, V192, P67, DOI 10.1007/978-0-387-71724-1_3
   Brain RA, 2008, ENVIRON SCI TECHNOL, V42, P8965, DOI 10.1021/es801611a
   Brausch JM, 2012, REV ENVIRON CONTAM T, V218, P1, DOI 10.1007/978-1-4614-3137-4_1
   Brooks BW, 2012, PROG MOL BIOL TRANSL, V112, P231, DOI 10.1016/B978-0-12-415813-9.00008-8
   Brooks BW, 2009, ACS SYM SER, V1018, P205
   Brooks BW, 2009, ENVIRON TOXICOL CHEM, V28, P2469, DOI 10.1897/09-325.1
   Brooks BW, 2005, ENVIRON TOXICOL CHEM, V24, P464, DOI 10.1897/04-081R.1
   Brooks BW, 2003, CHEMOSPHERE, V52, P135, DOI 10.1016/S0045-6535(03)00103-6
   Brooks BW, 2006, HYDROBIOLOGIA, V556, P365, DOI 10.1007/s10750-004-0189-7
   Brooks BW, 2003, TOXICOL LETT, V142, P169, DOI 10.1016/S0378-4274(03)00066-3
   Brooks BW, 2012, HUMAN PHARM ENV CURR, P1, DOI DOI 10.1007/978-1-4614-3473-3_1
   Brown JN, 2007, ENVIRON TOXICOL PHAR, V24, P267, DOI 10.1016/j.etap.2007.06.005
   Caldwell D.J., CHEMOSPHERE IN PRESS
   Christensen AM, 2007, ENVIRON TOXICOL CHEM, V26, P85, DOI 10.1897/06-219R.1
   Chu S, 2007, J CHROMATOGR A, V1163, P112, DOI 10.1016/j.chroma.2007.06.014
   Clubbs RL, 2007, ECOTOX ENVIRON SAFE, V67, P385, DOI 10.1016/j.ecoenv.2007.01.009
   Conners DE, 2009, ENVIRON TOXICOL CHEM, V28, P2671, DOI 10.1897/08-493.1
   Connors K.A., 2014, AQUATIC TOXICOLOGY
   Connors KA, 2013, CHIRALITY, V25, P763, DOI 10.1002/chir.22211
   Connors KA, 2013, ENVIRON TOXICOL CHEM, V32, P1810, DOI 10.1002/etc.2240
   Du B, 2012, J CHROMATOGR A, V1253, P177, DOI 10.1016/j.chroma.2012.07.026
   Du BW, 2014, SCI TOTAL ENVIRON, V466, P976, DOI 10.1016/j.scitotenv.2013.07.126
   Fick J, 2010, ENVIRON SCI TECHNOL, V44, P2661, DOI 10.1021/es903440m
   Fitzsimmons PN, 2001, AQUAT TOXICOL, V55, P23, DOI 10.1016/S0166-445X(01)00174-6
   Fong P.P., 2014, AQUATIC TOXICOLOGY
   Fong PP, 1998, J EXP ZOOL, V280, P260, DOI 10.1002/(SICI)1097-010X(19980215)280:3<260::AID-JEZ7>3.0.CO;2-L
   Foran CM, 2004, ARCH ENVIRON CON TOX, V46, P511, DOI 10.1007/s00244-003-3042-5
   Franco A, 2010, INT J LIFE CYCLE ASS, V15, P321, DOI 10.1007/s11367-010-0165-6
   Franzellitti S., 2014, AQUATIC TOXICOLOGY
   FRAZER A, 1997, J CLIN PSYCHOPHAR S1, V17, P2
   Gaworecki KM, 2008, AQUAT TOXICOL, V88, P207, DOI 10.1016/j.aquatox.2008.04.011
   Gould GG, 2007, BASIC CLIN PHARMACOL, V101, P203, DOI 10.1111/j.1742-7843.2007.00100.x
   Guler Y, 2010, AQUAT TOXICOL, V99, P397, DOI 10.1016/j.aquatox.2010.05.019
   Gunnarsson L, 2008, ENVIRON SCI TECHNOL, V42, P5807, DOI 10.1021/es8005173
   Hazelton P.D., 2014, AQUATIC TOXICOLOGY
   Henry TB, 2004, ENVIRON TOXICOL CHEM, V23, P2229, DOI 10.1897/03-278
   Huggett DB, 2003, HUM ECOL RISK ASSESS, V9, P1789, DOI 10.1080/10807030390260498
   Jacobsen NW, 2012, REGUL TOXICOL PHARM, V62, P441, DOI 10.1016/j.yrtph.2012.02.003
   Kwon JW, 2004, ENVIRON TOXICOL CHEM, V23, P1394, DOI 10.1897/03-319
   Larsson DGJ, 2007, J HAZARD MATER, V148, P751, DOI 10.1016/j.jhazmat.2007.07.008
   Lynn SE, 2007, ADV PHYSIOL EDUC, V31, P358, DOI 10.1152/advan.00024.2007
   Margiotta-Casaluci L, 2013, AQUAT TOXICOL, V128, P113, DOI 10.1016/j.aquatox.2012.12.003
   McRobb FM, 2014, ENVIRON SCI TECHNOL, V48, P1964, DOI 10.1021/es404568a
   Mennigen JA, 2011, J TOXICOL ENV HEAL B, V14, P387, DOI 10.1080/10937404.2011.578559
   Mennigen JA, 2010, AQUAT TOXICOL, V100, P354, DOI 10.1016/j.aquatox.2010.08.016
   Mennigen JA, 2010, AQUAT TOXICOL, V100, P128, DOI 10.1016/j.aquatox.2010.07.022
   Meredith-Williams M, 2012, ENVIRON POLLUT, V165, P250, DOI 10.1016/j.envpol.2011.11.029
   Monteiro SC, 2009, ENVIRON TOXICOL CHEM, V28, P2546, DOI 10.1897/08-657.1
   Nakamura Y, 2008, CHEMOSPHERE, V70, P865, DOI 10.1016/j.chemosphere.2007.06.089
   Nentwig G, 2007, ARCH ENVIRON CON TOX, V52, P163, DOI 10.1007/s00244-005-7190-7
   Oakes Ken D., 2010, Integrated Environmental Assessment and Management, V6, P524, DOI 10.1002/ieam.77
   Painter M.M., 2009, ENVIRON TOXICOL CHEM, V28, P2677
   Paterson G, 2008, CHEMOSPHERE, V74, P125, DOI 10.1016/j.chemosphere.2008.08.022
   Perkins EJ, 2013, ENVIRON HEALTH PERSP, V121, P1002, DOI 10.1289/ehp.1306638
   Ramirez AJ, 2007, ANAL CHEM, V79, P3155, DOI 10.1021/ac062215i
   Ramirez AJ, 2009, ENVIRON TOXICOL CHEM, V28, P2587, DOI 10.1897/08-561.1
   Rand-Weaver M, 2013, ENVIRON SCI TECHNOL, V47, P11384, DOI 10.1021/es402065a
   Roos V, 2012, SCI TOTAL ENVIRON, V421, P102, DOI 10.1016/j.scitotenv.2012.01.039
   Schultz M.M., 2008, ANAL CHEM, V80, P1756
   Schulz M, 2012, CRIT CARE, V16, DOI 10.1186/cc11441
   Seiler JP, 2002, TOXICOL LETT, V131, P105, DOI 10.1016/S0378-4274(02)00045-0
   Smith EM, 2010, CHEMOSPHERE, V79, P26, DOI 10.1016/j.chemosphere.2010.01.058
   Stanley JK, 2007, CHEMOSPHERE, V69, P9, DOI 10.1016/j.chemosphere.2007.04.080
   Stanley Jacob K., 2009, Integrated Environmental Assessment and Management, V5, P364, DOI 10.1897/IEAM_2008-076.1
   Subedi B, 2012, ENVIRON SCI TECHNOL, V46, P9047, DOI 10.1021/es301359t
   Valenti Theodore W., 2011, Integrated Environmental Assessment and Management, V7, P636, DOI 10.1002/ieam.202
   Valenti TW, 2012, ENVIRON SCI TECHNOL, V46, P2427, DOI 10.1021/es204164b
   Valenti TW, 2009, ENVIRON TOXICOL CHEM, V28, P2685, DOI 10.1897/08-546.1
   Voutchkova AM, 2011, GREEN CHEM, V13, P2373, DOI 10.1039/c1gc15651a
   Voutchkova-Kostal AM, 2012, GREEN CHEM, V14, P1001, DOI 10.1039/c2gc16385c
   Weinberger J., 2014, AQUATIC TOXICOLOGY
   Zhang X, 2010, ENVIRON SCI TECHNOL, V44, P3417, DOI 10.1021/es903064t
   Zhou SN, 2008, ENVIRON SCI TECHNOL, V42, P6073, DOI 10.1021/es8001162
NR 80
TC 89
Z9 91
U1 4
U2 165
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-445X
EI 1879-1514
J9 AQUAT TOXICOL
JI Aquat. Toxicol.
PD JUN
PY 2014
VL 151
SI SI
BP 61
EP 67
DI 10.1016/j.aquatox.2014.01.007
PG 7
WC Marine & Freshwater Biology; Toxicology
SC Marine & Freshwater Biology; Toxicology
GA AH5RG
UT WOS:000336188000008
PM 24503458
HC Y
HP N
DA 2019-10-23
ER

PT J
AU Sundling, K
   Craciun, G
   Schultz, I
   Hook, S
   Nagler, J
   Cavileer, T
   Verducci, J
   Liu, YS
   Kim, J
   Hayton, W
AF Sundling, Kaitlin
   Craciun, Gheorghe
   Schultz, Irvin
   Hook, Sharon
   Nagler, James
   Cavileer, Tim
   Verducci, Joseph
   Liu, Yushi
   Kim, Jonghan
   Hayton, William
TI MODELING THE ENDOCRINE CONTROL OF VITELLOGENIN PRODUCTION IN FEMALE
   RAINBOW TROUT
SO MATHEMATICAL BIOSCIENCES AND ENGINEERING
LA English
DT Article
DE Endocrine control; vitellogenin; pharmacokinetic/pharmacodynamic model
ID ADVERSE OUTCOME PATHWAYS; ONCORHYNCHUS-MYKISS; ESTROGEN-RECEPTOR;
   SALMO-GAIRDNERI; GENE-EXPRESSION; FUNCTIONAL-CHARACTERIZATION;
   OVARIAN-FOLLICLES; ER-BETA; PHOTOPERIOD; 17-ALPHA-ETHYNYLESTRADIOL
AB The rainbow trout endocrine system is sensitive to changes in annual day length, which is likely the principal environmental cue controlling its reproductive cycle. This study focuses on the endocrine regulation of vitellogenin (Vg) protein synthesis, which is the major egg yolk precursor in this fish species. We present a model of Vg production in female rainbow trout which incorporates a biological pathway beginning with sex steroid estradiol-17 beta levels in the plasma and concluding with Vg secretion by the liver and sequestration in the oocytes. Numerical simulation results based on this model are compared with experimental data for estrogen receptor mRNA, Vg mRNA, and Vg in the plasma from female rainbow trout over a normal annual reproductive cycle. We also analyze the response of the model to parameter changes. The model is subsequently tested against experimental data from female trout under a compressed photoperiod regime. Comparison of numerical and experimental results suggests the possibility of a time-dependent change in oocyte Vg uptake rate. This model is part of a larger effort that is developing a mathematical description of the endocrine control of reproduction in female rainbow trout. We anticipate that these mathematical and computational models will play an important role in future regulatory toxicity assessments and in the prediction of ecological risk.
C1 [Sundling, Kaitlin] Univ Wisconsin, Biophys Program & Med Scientist Training Program, Madison, WI 53706 USA.
   [Craciun, Gheorghe] Univ Wisconsin, Dept Math, Madison, WI 53706 USA.
   [Craciun, Gheorghe] Univ Wisconsin, Dept Biomol Chem, Madison, WI 53706 USA.
   [Schultz, Irvin; Hook, Sharon] Battelle Pacific Northwest Natl Lab, Marine Sci Lab, Sequim, WA 98382 USA.
   [Nagler, James; Cavileer, Tim] Univ Idaho, Dept Biol Sci, Moscow, ID 83844 USA.
   [Nagler, James; Cavileer, Tim] Univ Idaho, Ctr Reprod Biol, Moscow, ID 83844 USA.
   [Verducci, Joseph; Liu, Yushi] Ohio State Univ, Dept Stat, Columbus, OH 43210 USA.
   [Kim, Jonghan] Northeastern Univ, Dept Pharmaceut Sci, Boston, MA 02115 USA.
   [Hayton, William] Ohio State Univ, Div Pharmaceut, Columbus, OH 43210 USA.
RP Sundling, K (reprint author), Univ Wisconsin, Biophys Program & Med Scientist Training Program, Madison, WI 53706 USA.
EM ksundling@wisc.edu; craciun@math.wisc.edu; irv.schultz@pnnl.gov;
   sharon.hook@csiro.au; jamesn@uidaho.edu; tcavi@uidaho.edu;
   jsv@stat.osu.edu; liuyushi@gmail.com; j.kim@neu.edu; hayton.1@osu.edu
RI Hook, Sharon/D-9067-2011; Sundling, Kaitlin/H-7975-2019
OI Sundling, Kaitlin/0000-0001-5531-0573
FU National Science FoundationNational Science Foundation (NSF)
   [DMS-054069377]; National Institutes of HealthUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USA
   [T32GM08349]; University of Wisconsin Medical Scientist Training Program
FX We thank the National Science Foundation for support under grant
   DMS-054069377. Kaitlin Sundling was supported by National Institutes of
   Health training grant T32GM08349 (Biotechnology Training Program) and
   the University of Wisconsin Medical Scientist Training Program.
CR Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Bon E, 1999, FISH PHYSIOL BIOCHEM, V20, P143, DOI 10.1023/A:1007783708432
   Boyce-Derricott J, 2010, DNA CELL BIOL, V29, P229, DOI 10.1089/dna.2009.0998
   Bromage N, 2001, AQUACULTURE, V197, P63, DOI 10.1016/S0044-8486(01)00583-X
   Bromage N., 1993, AQUACULTURE FUNDAMEN, P81
   Choi S, 2010, ZOOL SCI, V27, P24, DOI 10.2108/zsj.27.24
   Cunningham K. S., P NATL ACAD SCI US, V97
   Davies B, 1999, GEN COMP ENDOCR, V115, P155, DOI 10.1006/gcen.1999.7301
   DUSTON J, 1988, J COMP PHYSIOL A, V164, P259, DOI 10.1007/BF00603956
   DUSTON J, 1986, FISH PHYSIOL BIOCHEM, V2, P35, DOI 10.1007/BF02264072
   Flouriot G, 1996, MOL CELL ENDOCRINOL, V124, P173, DOI 10.1016/S0303-7207(96)03960-3
   Hook S., GENE EXPRESSIO UNPUB
   Jin JY, 2003, J PHARMACOL EXP THER, V307, P93, DOI 10.1124/jpet.103.053256
   JUSKO WJ, 1994, CLIN PHARMACOL THER, V56, P406, DOI 10.1038/clpt.1994.155
   Katsu Y, 2013, J APPL TOXICOL, V33, P41, DOI 10.1002/jat.1707
   Kim J., 2004, THESIS OHIO STATE U
   Kim J, 2006, MAR ENVIRON RES, V62, pS426, DOI 10.1016/j.marenvres.2006.04.022
   Kramer VJ, 2011, ENVIRON TOXICOL CHEM, V30, P64, DOI 10.1002/etc.375
   Leanos-Castaneda O, 2007, TOXICOL APPL PHARM, V224, P116, DOI 10.1016/j.taap.2007.06.017
   LIU Y, 2009, STAT ANAL DATA MININ, V2, P192
   Mao CJ, 2006, ANAL BIOCHEM, V350, P222, DOI 10.1016/j.ab.2005.12.010
   Murphy CA, 2005, REPROD TOXICOL, V19, P395, DOI 10.1016/j.reprotox.2004.09.006
   Murphy CA, 2009, ENVIRON TOXICOL CHEM, V28, P1288, DOI 10.1897/08-304.1
   Nagler JJ, 2007, GENE, V392, P164, DOI 10.1016/j.gene.2006.12.030
   Nagler JJ, 2010, GEN COMP ENDOCR, V167, P326, DOI 10.1016/j.ygcen.2010.03.022
   Nelson ER, 2010, ENDOCRINOLOGY, V151, P1668, DOI 10.1210/en.2009-1447
   OPRESKO LK, 1987, J BIOL CHEM, V262, P4109
   Perazzolo LM, 1999, BIOL REPROD, V60, P1057, DOI 10.1095/biolreprod60.5.1057
   PIFERRER F, 1994, FISH PHYSIOL BIOCHEM, V13, P219, DOI 10.1007/BF00004360
   Rodriguez JN, 1996, J EXP ZOOL, V274, P163, DOI 10.1002/(SICI)1097-010X(19960215)274:3<163::AID-JEZ3>3.0.CO;2-M
   Schultz IR, 2001, AQUAT TOXICOL, V51, P305, DOI 10.1016/S0166-445X(00)00118-1
   Skillman AD, 2006, ENVIRON TOXICOL CHEM, V25, P2997, DOI 10.1897/05-565R.1
   TAYLOR CM, 1984, J STEROID BIOCHEM, V20, P1083, DOI 10.1016/0022-4731(84)90347-9
   Tyler CR, 1996, REV FISH BIOL FISHER, V6, P287, DOI 10.1007/BF00122584
   TYLER CR, 1988, J EXP ZOOL, V246, P171, DOI 10.1002/jez.1402460209
   TYLER CR, 1988, J EXP ZOOL, V248, P199, DOI 10.1002/jez.1402480211
   TYLER CR, 1990, FISH PHYSIOL BIOCHEM, V8, P211, DOI 10.1007/BF00004460
   Watanabe K. H., 2009, TOXICOLOGICAL SCI
   Watanabe KH, 2011, ENVIRON TOXICOL CHEM, V30, P9, DOI 10.1002/etc.373
   Zohar Y, 2010, GEN COMP ENDOCR, V165, P438, DOI 10.1016/j.ygcen.2009.04.017
NR 40
TC 5
Z9 5
U1 1
U2 52
PU AMER INST MATHEMATICAL SCIENCES
PI SPRINGFIELD
PA PO BOX 2604, SPRINGFIELD, MO 65801-2604 USA
SN 1547-1063
EI 1551-0018
J9 MATH BIOSCI ENG
JI Math. Biosci. Eng.
PD JUN
PY 2014
VL 11
IS 3
BP 621
EP 639
DI 10.3934/mbe.2014.11.621
PG 19
WC Mathematical & Computational Biology
SC Mathematical & Computational Biology
GA 286VP
UT WOS:000329497700010
PM 24506554
OA Green Accepted, Other Gold
DA 2019-10-23
ER

PT J
AU Tsakovska, I
   Al Sharif, M
   Alov, P
   Diukendjieva, A
   Fioravanzo, E
   Cronin, MTD
   Pajeva, I
AF Tsakovska, Ivanka
   Al Sharif, Merilin
   Alov, Petko
   Diukendjieva, Antonia
   Fioravanzo, Elena
   Cronin, Mark T. D.
   Pajeva, Ilza
TI Molecular Modelling Study of the PPAR gamma Receptor in Relation to the
   Mode of Action/Adverse Outcome Pathway Framework for Liver Steatosis
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Article
DE PPAR gamma; liver steatosis; mode of action; molecular modelling;
   pharmacophore
ID LIGAND-BINDING; ALPHA/GAMMA AGONIST; STRUCTURAL BIOLOGY; BIOCHEMICAL
   BASIS; DESIGN; ACIDS; SELECTIVITY; ALPHA; POTENT; ACTIVATION
AB The comprehensive understanding of the precise mode of action and/or adverse outcome pathway (MoA/AOP) of chemicals has become a key step toward the development of a new generation of predictive toxicology tools. One of the challenges of this process is to test the feasibility of the molecular modelling approaches to explore key molecular initiating events (MIE) within the integrated strategy of MoA/AOP characterisation. The description of MoAs leading to toxicity and liver damage has been the focus of much interest. Growing evidence underlines liver PPAR gamma ligand-dependent activation as a key MIE in the elicitation of liver steatosis. Synthetic PPAR gamma full agonists are of special concern, since they may trigger a number of adverse effects not observed with partial agonists. In this study, molecular modelling was performed based on the PPAR gamma complexes with full agonists extracted from the Protein Data Bank. The receptor binding pocket was analysed, and the specific ligand-receptor interactions were identified for the most active ligands. A pharmacophore model was derived, and the most important pharmacophore features were outlined and characterised in relation to their specific role for PPAR gamma activation. The results are useful for the characterisation of the chemical space of PPAR gamma full agonists and could facilitate the development of preliminary filtering rules for the effective virtual ligand screening of compounds with PPAR gamma full agonistic activity.
C1 [Tsakovska, Ivanka; Al Sharif, Merilin; Alov, Petko; Diukendjieva, Antonia; Pajeva, Ilza] Inst Biophys & Biomed Engn BAS, Sofia 1113, Bulgaria.
   [Fioravanzo, Elena] Soluz Informat Srl, I-36100 Vicenza, Italy.
   [Cronin, Mark T. D.] Liverpool John Moores Univ, Sch Pharm & Biomol Sci, Liverpool L3 3AF, Merseyside, England.
RP Tsakovska, I (reprint author), Inst Biophys & Biomed Engn BAS, Acad G Bonchev Str,Bl 105, Sofia 1113, Bulgaria.
EM ITsakovska@biomed.bas.bg; merilin.al@biomed.bas.bg;
   petko@biophys.bas.bg; antonia.diuk@gmail.com; elena.fioravanzo@s-in.it;
   M.T.Cronin@ljmu.ac.uk; pajeva@biomed.bas.bg
OI Tsakovska, Ivanka/0000-0003-1389-1685
FU European CommunityEuropean Community (EC) [266835]; Cosmetics Europe
FX The funding from the European Community's 7th Framework Program
   (FP7/2007-2013) COSMOS Project under grant agreement No. 266835 and from
   Cosmetics Europe is gratefully acknowledged.
CR Al Sharif M, 2014, PPAR RES, DOI 10.1155/2014/432647
   Al Sharif M, 2013, TOXICOL LETT, V221, pS85, DOI 10.1016/j.toxlet.2013.05.099
   [Anonymous], 2013, MOE MOL OP ENV VERS
   [Anonymous], 2013, SER TEST ASS
   Benardeau A, 2009, BIOORG MED CHEM LETT, V19, P2468, DOI 10.1016/j.bmcl.2009.03.036
   Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235
   Bruning JB, 2007, STRUCTURE, V15, P1258, DOI 10.1016/j.str.2007.07.014
   Casimiro-Garcia A, 2008, BIOORGAN MED CHEM, V16, P4883, DOI 10.1016/j.bmc.2008.03.043
   Casimiro-Garcia A, 2009, BIOORGAN MED CHEM, V17, P7113, DOI 10.1016/j.bmc.2009.09.001
   Chandra V, 2008, NATURE, V456, P350, DOI 10.1038/nature07413
   Costa V, 2010, PPAR RES, DOI 10.1155/2010/409168
   Cronet P, 2001, STRUCTURE, V9, P699, DOI 10.1016/S0969-2126(01)00634-7
   Cronin M. T. D., 2012, REPLACEMENT IN VIVO, V2, P284
   Day C, 1999, DIABETIC MED, V16, P179, DOI 10.1046/j.1464-5491.1999.00023.x
   Ebdrup S, 2003, J MED CHEM, V46, P1306, DOI 10.1021/jm021027r
   Fioravanzo E, 2013, TOXICOL LETT, V221, pS83, DOI 10.1016/j.toxlet.2013.05.092
   Gampe RT, 2000, MOL CELL, V5, P545, DOI 10.1016/S1097-2765(00)80448-7
   Gaulton A, 2012, NUCLEIC ACIDS RES, V40, pD1100, DOI 10.1093/nar/gkr777
   Grether U, 2009, CHEMMEDCHEM, V4, P951, DOI 10.1002/cmdc.200800425
   Guasch L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050816
   Itoh T, 2008, NAT STRUCT MOL BIOL, V15, P924, DOI 10.1038/nsmb.1474
   Kouskoumvekaki I, 2013, J CHEM INF MODEL, V53, P923, DOI 10.1021/ci3006148
   Kuhn B, 2006, BIOORG MED CHEM LETT, V16, P4016, DOI 10.1016/j.bmcl.2006.05.007
   Kuwabara N, 2012, J MED CHEM, V55, P893, DOI 10.1021/jm2014293
   Landesmann B., 2012, 25631 EUR EN JOINT R
   Li Y, 2005, P NATL ACAD SCI USA, V102, P9505, DOI 10.1073/pnas.0501204102
   Li Y, 2008, NAT STRUCT MOL BIOL, V15, P865, DOI 10.1038/nsmb.1447
   Li Y, 2008, J BIOL CHEM, V283, P19132, DOI 10.1074/jbc.M802040200
   Liberato MV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036297
   Lin CH, 2009, J MED CHEM, V52, P2618, DOI 10.1021/jm801594x
   Mahindroo N, 2005, J MED CHEM, V48, P8194, DOI 10.1021/jm0506930
   Mahindroo N, 2006, J MED CHEM, V49, P1212, DOI 10.1021/jm0510373
   Mahindroo N, 2006, J MED CHEM, V49, P6421, DOI 10.1021/jm060663c
   Moya M, 2010, CHEM-BIOL INTERACT, V184, P376, DOI 10.1016/j.cbi.2010.01.008
   Mueller J.J., 2011, BINDING DIVERS UNPUB
   Nolte RT, 1998, NATURE, V395, P137
   Ohashi M, 2011, J MED CHEM, V54, P331, DOI 10.1021/jm101233f
   Oyama T, 2009, ACTA CRYSTALLOGR D, V65, P786, DOI 10.1107/S0907444909015935
   Pan HJ, 2006, VASC PHARMACOL, V45, P65, DOI 10.1016/j.vph.2005.11.011
   Pencheva T, 2013, CURR COMPUT-AID DRUG, V9, P83
   Sauerberg P, 2002, J MED CHEM, V45, P789, DOI 10.1021/jm010964g
   Waku T, 2010, EMBO J, V29, P3395, DOI 10.1038/emboj.2010.197
   Xu HE, 2001, P NATL ACAD SCI USA, V98, P13919, DOI 10.1073/pnas.241410198
   Zhang H, 2009, BIOORG MED CHEM LETT, V19, P1451, DOI 10.1016/j.bmcl.2009.01.030
NR 44
TC 16
Z9 17
U1 0
U2 19
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1661-6596
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD MAY
PY 2014
VL 15
IS 5
BP 7651
EP 7666
DI 10.3390/ijms15057651
PG 16
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA AI4NJ
UT WOS:000336841800037
PM 24857909
OA DOAJ Gold, Green Published
DA 2019-10-23
ER

PT J
AU Hoberman, AM
AF Hoberman, A. M.
TI Industry Perspective: What Are the Implications to Industry of Changing
   the Default Paradigm of Two Species Developmental Toxicity Testing?
SO BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY
LA English
DT Meeting Abstract
C1 [Hoberman, A. M.] Charles River, Horsham, PA USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1542-0752
EI 1542-0760
J9 BIRTH DEFECTS RES A
JI Birth Defects Res. Part A-Clin. Mol. Teratol.
PD MAY
PY 2014
VL 100
IS 5
SI SI
BP 365
EP 365
PG 1
WC Developmental Biology; Toxicology
SC Developmental Biology; Toxicology
GA AH7AG
UT WOS:000336283800013
DA 2019-10-23
ER

PT J
AU Faustman, EM
AF Faustman, E. M.
TI 3-D In Vitro Models and Systems Biology: The Phthalate Syndrome As a
   Case Example
SO BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY
LA English
DT Meeting Abstract
C1 [Faustman, E. M.] Univ Washington, Seattle, WA 98195 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1542-0752
EI 1542-0760
J9 BIRTH DEFECTS RES A
JI Birth Defects Res. Part A-Clin. Mol. Teratol.
PD MAY
PY 2014
VL 100
IS 5
SI SI
BP 375
EP 375
PG 1
WC Developmental Biology; Toxicology
SC Developmental Biology; Toxicology
GA AH7AG
UT WOS:000336283800032
DA 2019-10-23
ER

PT J
AU Leung, MCK
   Hutson, MS
   Belmonte, JM
   Swat, M
   Sipes, N
   Baker, NC
   Spencer, RM
   Seifert, AW
   Perreault, SD
   Glazier, JA
   Knudsen, TB
AF Leung, M. C. K.
   Hutson, M. S.
   Belmonte, J. M.
   Swat, M.
   Sipes, N.
   Baker, N. C.
   Spencer, R. M.
   Seifert, A. W.
   Perreault, S. D.
   Glazier, J. A.
   Knudsen, T. B.
TI Computational Embryology and Predictive Toxicology of Hypospadias
SO BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY
LA English
DT Meeting Abstract
C1 [Leung, M. C. K.; Sipes, N.; Perreault, S. D.; Knudsen, T. B.] US EPA, Res Triangle Pk, NC 27711 USA.
   [Hutson, M. S.] Vanderbilt Univ, Nashville, TN 37235 USA.
   [Belmonte, J. M.; Swat, M.; Glazier, J. A.] Indiana Univ, Bloomington, IN USA.
   [Baker, N. C.; Spencer, R. M.] Lockheed Martin, Res Triangle Pk, NC USA.
   [Seifert, A. W.] Univ Kentucky, Lexington, KY USA.
NR 0
TC 0
Z9 0
U1 0
U2 6
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1542-0752
EI 1542-0760
J9 BIRTH DEFECTS RES A
JI Birth Defects Res. Part A-Clin. Mol. Teratol.
PD MAY
PY 2014
VL 100
IS 5
SI SI
BP 375
EP 375
PG 1
WC Developmental Biology; Toxicology
SC Developmental Biology; Toxicology
GA AH7AG
UT WOS:000336283800031
DA 2019-10-23
ER

PT J
AU Wood, CE
   Jokinen, MP
   Johnson, CL
   Olson, GR
   Hester, S
   George, M
   Chorley, BN
   Carswell, G
   Carter, JH
   Wood, CR
   Bhat, VS
   Corton, JC
   DeAngelo, AB
AF Wood, Charles E.
   Jokinen, Micheal P.
   Johnson, Crystal L.
   Olson, Greg R.
   Hester, Susan
   George, Michael
   Chorley, Brian N.
   Carswell, Gleta
   Carter, Julia H.
   Wood, Carmen R.
   Bhat, Virunya S.
   Corton, J. Christopher
   DeAngelo, Anthony B.
TI Comparative Time Course Profiles of Phthalate Stereoisomers in Mice
SO TOXICOLOGICAL SCIENCES
LA English
DT Article
DE phthalate; mode of action; adverse outcome pathway; carcinogenesis;
   bioassay; peroxisome proliferator; PPAR alpha; liver; benchmark dose;
   di(2-ethylhexyl) phthalate (DEHP)
ID PROLIFERATOR-ACTIVATED RECEPTORS; PEROXISOME PROLIFERATION;
   DI(2-ETHYLHEXYL)PHTHALATE DEHP; CARCINOGENIC-POTENCY; REGULATED GENES;
   LIVER-TUMORS; RODENT; MOUSE; RISK; TOXICITY
AB More efficient models are needed to assess potential carcinogenicity hazard of environmental chemicals based on early events in tumorigenesis. Here, we investigated time course profiles for key events in an established cancer mode of action. Using a case study approach, we evaluated two reference phthalates, di(2-ethylhexyl) phthalate (DEHP) and its stereoisomer di-n-octyl phthalate (DNOP), across the span of a two-year carcinogenicity bioassay. Male B6C3F1 mice received diets with no phthalate added (control), DEHP at 0.12, 0.60, or 1.20%, or DNOP at 0.10, 0.50, or 1.00% (n = 80-83/group) for up to 104 weeks with six interim evaluations starting at week 4. Mean phthalate doses were 139, 845, and 3147 mg/kg/day for DEHP and 113, 755, and 1281 mg/kg/day for DNOP groups, respectively. Incidence and number of hepatocellular tumors (adenoma and/or carcinoma) were greater at >= 60 weeks for all DEHP groups with time and dose trends, whereas DNOP had no significant effects. Key events supported a peroxisome proliferator-activated receptor alpha (PPAR alpha) mode of action for DEHP, with secondary cytotoxicity at the high dose, whereas DNOP induced modest increases in PPAR alpha activity without proliferative or cytotoxic effects. Threshold estimates for later tumorigenic effects were identified at week 4 for relative liver weight (+ 24%) and PPAR alpha activity (+ 79%) relative to the control group. Benchmark doses (BMDs) for these measures at week 4 clearly distinguished DEHP and DNOP and showed strong concordance with values at later time points and tumorigenic BMDs. Other target sites included testis and kidney, which showed degenerative changes at higher doses of DEHP but not DNOP. Our results highlight marked differences in the chronic toxicity profiles of structurally similar phthalates and demonstrate quantitative relationships between early bioindicators and later tumor outcomes.
C1 [Wood, Charles E.; Hester, Susan; George, Michael; Chorley, Brian N.; Carswell, Gleta; Wood, Carmen R.; Corton, J. Christopher; DeAngelo, Anthony B.] US EPA, Natl Hlth & Environm Effects Res Lab, Res Triangle Pk, NC 27709 USA.
   [Jokinen, Micheal P.] Expt Pathol Labs, Res Triangle Pk, NC 27709 USA.
   [Johnson, Crystal L.] Charles River Labs Pathol Associates, Durham, NC 27703 USA.
   [Olson, Greg R.] Toxicol Pathol Associates, Jefferson, AR 72079 USA.
   [Carter, Julia H.] Wood Hudson Canc Res Lab, Newport, KY 41071 USA.
   [Bhat, Virunya S.] Univ Calif Riverside, Environm Toxicol Grad Program, Riverside, CA 92521 USA.
RP Wood, CE (reprint author), US EPA, MD-B105-03,109 TW Alexander Dr, Res Triangle Pk, NC 27709 USA.
EM wood.charles@epa.gov
FU U.S. Environmental Protection Agency Office of Research and
   DevelopmentUnited States Environmental Protection Agency
FX U.S. Environmental Protection Agency Office of Research and Development.
CR Abbott BD, 2012, REPROD TOXICOL, V33, P491, DOI 10.1016/j.reprotox.2011.11.005
   Allen DG, 2004, TOXICOL PATHOL, V32, P393, DOI 10.1080/01926230490440934
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   [Anonymous], 2000, IARC Monogr Eval Carcinog Risks Hum, V77, P41
   [Anonymous], 1982, IARC Monogr Eval Carcinog Risk Chem Hum, V29, P269
   Bility MT, 2004, TOXICOL SCI, V82, P170, DOI 10.1093/toxsci/kfh253
   Boobis AR, 2006, CRIT REV TOXICOL, V36, P781, DOI 10.1080/10408440600977677
   Boobis AR, 2009, TOXICOL PATHOL, V37, P714, DOI 10.1177/0192623309343779
   Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055
   Carter JH, 1995, TOXICOL LETT, V81, P55, DOI 10.1016/0378-4274(95)03409-9
   Corton JC, 2014, CRIT REV TOXICOL, V44, P1, DOI 10.3109/10408444.2013.835784
   Corton JC, 2005, TOXICOL SCI, V83, P4, DOI 10.1093/toxsci/kfi011
   David RM, 1999, TOXICOL SCI, V50, P195, DOI 10.1093/toxsci/50.2.195
   David RM, 2000, TOXICOL SCI, V58, P377, DOI 10.1093/toxsci/58.2.377
   DEANGELO AB, 1986, TOXICOLOGY, V41, P279, DOI 10.1016/0300-483X(86)90182-4
   DEANGELO AB, 1989, TOXICOL APPL PHARM, V101, P285, DOI 10.1016/0041-008X(89)90277-9
   Doull J, 1999, REGUL TOXICOL PHARM, V29, P327, DOI 10.1006/rtph.1999.1296
   Elcombe CR, 2002, ENVIRON HEALTH PERSP, V110, P363, DOI 10.1289/ehp.02110363
   EPA, 2009, TOX REL INV TRI PROG
   EPA (U. S. Environmental Protection Agency), 2012, EPA100R12001
   Food and Drug Administration HHS, 2013, Fed Regist, V78, P16681
   Gold LS, 2005, TOXICOL SCI, V85, P747, DOI 10.1093/toxsci/kfi161
   Grosse Y, 2011, LANCET ONCOL, V12, P328, DOI 10.1016/S1470-2045(11)70088-2
   Guyton KZ, 2009, ENVIRON HEALTH PERSP, V117, P1664, DOI 10.1289/ehp.0900758
   Holsapple MP, 2006, TOXICOL SCI, V89, P51, DOI 10.1093/toxsci/kfj001
   Huff J, 1999, ANN NY ACAD SCI, V895, P56, DOI 10.1111/j.1749-6632.1999.tb08077.x
   Ito Y, 2007, J OCCUP HEALTH, V49, P172, DOI 10.1539/joh.49.172
   Kamendulis LM, 2002, J TOXICOL ENV HEAL A, V65, P569, DOI 10.1080/152873902317349736
   Kavlock R, 2002, REPROD TOXICOL, V16, P721, DOI 10.1016/S0890-6238(02)00031-X
   Klaunig JE, 2003, CRIT REV TOXICOL, V33, P655, DOI 10.1080/10408440390250154
   Kleinstreuer NC, 2013, TOXICOL SCI, V131, P40, DOI 10.1093/toxsci/kfs285
   KLUWE WM, 1982, J TOXICOL ENV HEALTH, V10, P797, DOI 10.1080/15287398209530296
   KREWSKI D, 1993, RISK ANAL, V13, P383, DOI 10.1111/j.1539-6924.1993.tb00738.x
   PORTIER CJ, 1989, FUND APPL TOXICOL, V12, P731, DOI 10.1016/0272-0590(89)90004-3
   Ren HZ, 2010, TOXICOL SCI, V113, P45, DOI 10.1093/toxsci/kfp251
   Shelby M. D., 2006, NTP CERHR MONOG, V18
   Sistare FD, 2011, TOXICOL PATHOL, V39, P716, DOI 10.1177/0192623311406935
   TENNANT RW, 1995, ENVIRON HEALTH PERSP, V103, P942, DOI 10.2307/3432740
   Thoolen B, 2010, TOXICOL PATHOL, V38, p5S, DOI 10.1177/0192623310386499
   U.S. Environmental Protection Agency (EPA), 1999, INT RISK INF SYST IR
   Ward JM, 1998, TOXICOL PATHOL, V26, P240, DOI 10.1177/019262339802600208
NR 41
TC 8
Z9 10
U1 0
U2 8
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1096-6080
EI 1096-0929
J9 TOXICOL SCI
JI Toxicol. Sci.
PD MAY
PY 2014
VL 139
IS 1
BP 21
EP 34
DI 10.1093/toxsci/kfu025
PG 14
WC Toxicology
SC Toxicology
GA AG0ZN
UT WOS:000335144600003
PM 24496636
DA 2019-10-23
ER

PT J
AU Kimber, I
   Dearman, RJ
   Basketter, DA
   Boverhof, DR
AF Kimber, Ian
   Dearman, Rebecca J.
   Basketter, David A.
   Boverhof, Darrell R.
TI Chemical respiratory allergy: Reverse engineering an adverse outcome
   pathway
SO TOXICOLOGY
LA English
DT Review
DE Sensitisation of the respiratory tract; Respiratory allergy;
   Occupational asthma; Adverse outcome pathway
ID EPIDERMAL LANGERHANS CELLS; PEPTIDE REACTIVITY ASSAY; LYMPH-NODE ASSAY;
   DENDRITIC CELLS; OCCUPATIONAL ASTHMA; IN-VITRO; GUINEA-PIGS;
   INTERFERON-GAMMA; IMMUNE-RESPONSE; TH2 RESPONSES
AB Allergic sensitisation of the respiratory tract by chemicals is associated with rhinitis and asthma and remains an important occupational health issue. Although less than 80 chemicals have been confirmed as respiratory allergens the adverse health effects can be serious, and in rare instances can be fatal, and there are, in addition, related socioeconomic issues. The challenges that chemical respiratory allergy pose for toxicologists are substantial. No validated methods are available for hazard identification and characterisation, and this is due in large part to the fact that there remains considerable uncertainty and debate about the mechanisms through which sensitisation of the respiratory tract is acquired. Despite that uncertainty, there is a need to establish some common understanding of the key events and processes that are involved in respiratory sensitisation to chemicals and that might in turn provide the foundations for novel approaches to safety assessment. In recent years the concept of adverse outcome pathways (AOP) has gained some considerable interest among the toxicology community as a basis for outlining the key steps leading to an adverse health outcome, while also providing a framework for focusing future research, and for developing alternative paradigms for hazard characterisation. Here we explore application of the same general principles to an examination of the induction by chemicals of respiratory sensitisation. In this instance, however, we have chosen to adopt a reverse engineering approach and to model a possible AOP for chemical respiratory allergy working backwards from the elicitation of adverse health effects to the cellular and molecular mechanisms that are implicated in the acquisition of sensitisation. (C) 2014 Elsevier Ireland Ltd. All rights reserved.
C1 [Kimber, Ian; Dearman, Rebecca J.] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England.
   [Basketter, David A.] DABMEB Consultancy Ltd, Sharnbrook, Beds, England.
   [Boverhof, Darrell R.] Dow Chem Co USA, Toxicol & Environm Res & Consulting, Midland, MI 48674 USA.
RP Kimber, I (reprint author), Univ Manchester, Fac Life Sci, Michael Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.
EM ian.kimber@manchester.ac.uk
CR Ainscough JS, 2013, J IMMUNOTOXICOL, V10, P223, DOI 10.3109/1547691X.2012.711782
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Bakerly ND, 2008, OCCUP MED-OXFORD, V58, P169, DOI 10.1093/occmed/kqn007
   Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588
   BANKS PR, 1995, BIOCONJUGATE CHEM, V6, P447, DOI 10.1021/bc00034a015
   Basketter DA, 2011, REGUL TOXICOL PHARM, V61, P365, DOI 10.1016/j.yrtph.2011.10.001
   Baur X, 2013, J OCCUP MED TOXICOL, V8, P1
   Bell BD, 2013, NAT IMMUNOL, V14, P364, DOI 10.1038/ni.2541
   Bello D, 2007, ENVIRON HEALTH PERSP, V115, P328, DOI 10.1289/ehp.9557
   BENTLEY AM, 1992, J ALLERGY CLIN IMMUN, V89, P821, DOI 10.1016/0091-6749(92)90437-7
   BOTHAM PA, 1989, TOXICOL LETT, V47, P25, DOI 10.1016/0378-4274(89)90083-0
   Boverhof DR, 2008, TOXICOL APPL PHARM, V226, P1, DOI 10.1016/j.taap.2007.10.008
   Campo P, 2007, CLIN EXP ALLERGY, V37, P1095, DOI 10.1111/j.1365-2222.2007.02745.x
   Caron G, 2001, J IMMUNOL, V167, P3682, DOI 10.4049/jimmunol.167.7.3682
   CARTIER A, 1989, J ALLERGY CLIN IMMUN, V84, P507, DOI 10.1016/0091-6749(89)90364-3
   Constant SL, 1997, ANNU REV IMMUNOL, V15, P297, DOI 10.1146/annurev.immunol.15.1.297
   Cullinan P, 1998, CLIN EXP ALLERGY, V28, P668
   Cumberbatch M, 2005, J IMMUNOL, V175, P43, DOI 10.4049/jimmunol.175.1.43
   d'Ostiani CF, 2000, J EXP MED, V191, P1661, DOI 10.1084/jem.191.10.1661
   de Jong EC, 2002, J IMMUNOL, V168, P1704, DOI 10.4049/jimmunol.168.4.1704
   Dearman RJ, 2001, J APPL TOXICOL, V21, P153, DOI 10.1002/jat.743
   deGroot AC, 2008, PATCH TESTING
   Edwards AD, 2002, J IMMUNOL, V169, P3652, DOI 10.4049/jimmunol.169.7.3652
   Eisenbarth SC, 2003, CURR OPIN IMMUNOL, V15, P620, DOI 10.1016/j.coi.2003.09.003
   Enoch SJ, 2012, CHEM RES TOXICOL, V25, P2490, DOI 10.1021/tx3003092
   Geginat J, 2013, SEMIN IMMUNOL, V25, P252, DOI 10.1016/j.smim.2013.10.012
   Gerberick GF, 2007, TOXICOL SCI, V97, P417, DOI 10.1093/toxsci/kfm064
   Gerberick GF, 2004, TOXICOL SCI, V81, P332, DOI 10.1093/toxsci/kfh213
   Ghaemmaghami AM, 2002, CLIN EXP ALLERGY, V32, P1468, DOI 10.1046/j.1365-2745.2002.01504.x
   Holsapple MP, 2006, TOXICOL SCI, V91, P4, DOI 10.1093/toxsci/kfj074
   Hopkins JE, 2005, CHEM RES TOXICOL, V18, P375, DOI 10.1021/tx049688+
   HOWE W, 1983, J ALLERGY CLIN IMMUN, V71, P5, DOI 10.1016/0091-6749(83)90539-0
   Isola D, 2008, J APPL TOXICOL, V28, P249, DOI 10.1002/jat.1336
   Johannesson G, 2001, CLIN EXP ALLERGY, V31, P1021, DOI 10.1046/j.1365-2222.2001.01109.x
   Jones MG, 2006, J ALLERGY CLIN IMMUN, V117, P663, DOI 10.1016/j.jaci.2005.09.053
   JONSSON BAG, 1995, TOXICOL APPL PHARM, V135, P156, DOI 10.1006/taap.1995.1218
   KAROL MH, 1981, TOXICOL APPL PHARM, V58, P221, DOI 10.1016/0041-008X(81)90426-9
   Kimber I, 2005, CURR OPIN ALLERGY CL, V5, P119, DOI 10.1097/01.all.0000162302.82233.93
   Kimber I, 2002, TOXICOLOGY, V181, P311, DOI 10.1016/S0300-483X(02)00299-8
   Kimber I, 2002, BRIT J DERMATOL, V147, P613, DOI 10.1046/j.1365-2133.2002.48776.x
   Kimber I, 2002, CONTACT DERMATITIS, V46, P1, DOI 10.1034/j.1600-0536.2002.460101.x
   Kimber I, 1997, CLIN REV ALLERG IMMU, V15, P145, DOI 10.1007/BF02826584
   Kimber I, 1998, HUM EXP TOXICOL, V17, P537, DOI 10.1191/096032798678907964
   Kimber I., 1997, TOXICOLOGY CHEM RESP, P1
   Kimber I, 2007, ATLA-ALTERN LAB ANIM, V35, P243, DOI 10.1177/026119290703500212
   Kimber I, 2011, TOXICOL SCI, V120, pS238, DOI 10.1093/toxsci/kfq346
   Klechevsky E, 2008, IMMUNITY, V29, P497, DOI 10.1016/j.immuni.2008.07.013
   Kristiansson MH, 2003, BIOMARKERS, V8, P343, DOI 10.1080/13547500310001607836
   Lalko JF, 2013, J IMMUNOTOXICOL, V10, P292, DOI 10.3109/1547691X.2012.725784
   Lalko JF, 2012, TOXICOL SCI, V129, P421, DOI 10.1093/toxsci/kfs205
   Lalko JF, 2011, TOXICOL IN VITRO, V25, P433, DOI 10.1016/j.tiv.2010.11.007
   Langenkamp A, 2000, NAT IMMUNOL, V1, P311, DOI 10.1038/79758
   Liu YJ, 2001, NAT IMMUNOL, V2, P585, DOI 10.1038/89726
   Maldonado-Lopez R, 1999, J EXP MED, V189, P587, DOI 10.1084/jem.189.3.587
   Mamessier E, 2007, ALLERGY, V62, P162, DOI 10.1111/j.1398-9995.2006.01288.x
   Mapp CE, 2005, AM J RESP CRIT CARE, V172, P280, DOI 10.1164/rccm.200311-1575SO
   Martin SF, 2010, ALLERGOLOGIE, V33, P66
   Martin SF, 2008, CURR OPIN ALLERGY CL, V8, P289, DOI 10.1097/ACI.0b013e3283088cf9
   Matzinger P, 1998, SEMIN IMMUNOL, V10, P399, DOI 10.1006/smim.1998.0143
   MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.immunol.12.1.991
   McFadden JP, 2000, CONTACT DERMATITIS, V42, P123, DOI 10.1034/j.1600-0536.2000.042003123.x
   Murphy KM, 2013, ADV IMMUNOL, V120, P239, DOI 10.1016/B978-0-12-417028-5.00009-0
   Natsch A, 2008, TOXICOL SCI, V106, P464, DOI 10.1093/toxsci/kfn194
   Natsch A, 2008, TOXICOL SCI, V102, P110, DOI 10.1093/toxsci/kfm259
   Natsch A, 2010, TOXICOL SCI, V113, P284, DOI 10.1093/toxsci/kfp228
   Newell L, 2013, J INVEST DERMATOL, V133, P2372, DOI 10.1038/jid.2013.148
   O'Shea JJ, 2010, SCIENCE, V327, P1098, DOI 10.1126/science.1178334
   Oppenheim JJ, 2007, ADV EXP MED BIOL, V601, P185
   Organisation for Economic Cooperation and Development (OECD), 2012, 10 OECD ENVJMMONO
   Ouyang B, 2013, TOXICOL SCI, V133, P218, DOI 10.1093/toxsci/kft079
   Pulendran B, 1999, P NATL ACAD SCI USA, V96, P1036, DOI 10.1073/pnas.96.3.1036
   Pulendran B, 2010, NAT IMMUNOL, V11, P647, DOI 10.1038/ni.1894
   RATTRAY NJ, 1994, TOXICOLOGY, V88, P15, DOI 10.1016/0300-483X(94)90108-2
   Redlich CA, 2008, CURR OPIN ALLERGY CL, V8, P115, DOI 10.1097/ACI.0b013e3282f85a31
   Redlich Carrie A, 2010, Proc Am Thorac Soc, V7, P134, DOI 10.1513/pats.201002-025RM
   Romagnani S, 2004, J ALLERGY CLIN IMMUN, V113, P395, DOI 10.1016/j.jaci.2003.11.025
   Ross DJ, 1996, ANN OCCUP HYG, V40, P645, DOI 10.1016/S0003-4878(96)00022-1
   Sastre J, 2003, EUR RESPIR J, V22, P364, DOI 10.1183/09031936.03.00045103
   Soumelis V, 2002, NAT IMMUNOL, V3, P673, DOI 10.1038/ni805
   Stumbles PA, 1998, J EXP MED, V188, P2019, DOI 10.1084/jem.188.11.2019
   Tang H, 2010, NAT IMMUNOL, V11, P608, DOI 10.1038/ni.1883
   Tarlo SM, 1999, J ALLERGY CLIN IMMUN, V103, P739, DOI 10.1016/S0091-6749(99)70413-6
   Tarlo SM, 2006, EUR RESPIR J, V27, P607, DOI 10.1183/09031936.06.00062105
   Tee RD, 1998, J ALLERGY CLIN IMMUN, V101, P709, DOI 10.1016/S0091-6749(98)70181-2
   Traidl-Hoffmann C, 2005, J EXP MED, V201, P627, DOI 10.1084/jem.20041065
   Van Och FMM, 2002, TOXICOL APPL PHARM, V184, P46, DOI 10.1006/taap.2002.9473
   Vandebriel RJ, 2000, TOXICOL APPL PHARM, V162, P77, DOI 10.1006/taap.1999.8841
   VANDENPLAS O, 1993, J ALLERGY CLIN IMMUN, V91, P850, DOI 10.1016/0091-6749(93)90342-D
   Vento KL, 1996, CELL IMMUNOL, V172, P246, DOI 10.1006/cimm.1996.0239
   Vinken M, 2013, TOXICOLOGY, V312, P158, DOI 10.1016/j.tox.2013.08.011
   Whelan M, 2000, J IMMUNOL, V164, P6453, DOI 10.4049/jimmunol.164.12.6453
NR 91
TC 29
Z9 30
U1 0
U2 20
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0300-483X
J9 TOXICOLOGY
JI Toxicology
PD APR 6
PY 2014
VL 318
BP 32
EP 39
DI 10.1016/j.tox.2014.02.001
PG 8
WC Pharmacology & Pharmacy; Toxicology
SC Pharmacology & Pharmacy; Toxicology
GA AG4ZQ
UT WOS:000335429300004
PM 24534103
DA 2019-10-23
ER

PT J
CA European Food Safety Authority
TI Modern methodologies and tools for human hazard assessment of chemicals
SO EFSA JOURNAL
LA English
DT Article
DE mode of action; adverse outcome pathway; integrated testing strategy;
   physiologically-based models; in silico; OMICs
ID IN-VIVO EXTRAPOLATION; HEALTH-RISK ASSESSMENT; SPRAGUE-DAWLEY RATS;
   ADVERSE OUTCOME PATHWAYS; BIOKINETIC PBBK MODEL; ALLURA RED AC;
   ENVIRONMENTAL CHEMICALS; PHARMACOKINETIC MODEL; DRUG ABSORPTION;
   GENE-EXPRESSION
AB This scientific report provides a review of modern methodologies and tools to depict toxicokinetic and toxicodynamic processes and their application for the human hazard assessment of chemicals. The application of these methods is illustrated with examples drawn from the literature and international efforts in the field. First, the concepts of mode of action/adverse outcome pathway are discussed together with their associated terminology and recent international developments dealing with human hazard assessment of chemicals. Then modern methodologies and tools are presented including in vitro systems, physiologically-based models, in silico tools and OMICs technologies at the level of DNA/RNA (transcriptomics), proteins (proteomics) and the whole metabolome (metabolomics). Future perspectives for the potential applications of these modern methodologies and tools in the context of prioritisation of chemicals, integrated test strategies and the future of risk assessment are discussed. The report concludes with recommendations for future work and research formulated from consultations of EFSA staff, expert Panels and other international organisations. (C) European Food Safety Authority, 2014.
C1 [European Food Safety Authority] EFSA, Parma, Italy.
RP EFSA, Parma, Italy.
CR Abass KM, 2013, PESTIC BIOCHEM PHYS, V107, P258, DOI 10.1016/j.pestbp.2013.08.003
   Aguilar F, 2009, EFSA J, V7, DOI 10.2903/j.efsa.2009.1327
   Aguilar F, 2013, EFSA J, V11, DOI 10.2903/j.efsa.2013.3234
   Al-Subeihi AAA, 2011, TOXICOL IN VITRO, V25, P267, DOI 10.1016/j.tiv.2010.08.019
   Aliferis KA, 2011, PESTIC BIOCHEM PHYS, V100, P105, DOI 10.1016/j.pestbp.2011.03.004
   Allen BC, 2007, RISK ANAL, V27, P947, DOI 10.1111/j.1539-6924.2007.00934.x
   Alqahtani S, 2013, EXPERT OPIN DRUG MET, V9, P1241, DOI 10.1517/17425255.2013.802772
   Alyea RA, 2014, ENVIRON MOL MUTAGEN, V55, P292, DOI 10.1002/em.21831
   Amacher DE, 2010, TOXICOL APPL PHARM, V245, P134, DOI 10.1016/j.taap.2010.02.011
   Amzal B, 2009, ENVIRON HEALTH PERSP, V117, P1293, DOI 10.1289/ehp.0800317
   Andersen V, 2012, WORLD J GASTROENTERO, V18, P4091, DOI 10.3748/wjg.v18.i31.4091
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   [Anonymous], 2009, EFSA J, V7, DOI 10.2903/j.efsa.2009.980
   Antoine DJ, 2013, HEPATOLOGY, V58, P777, DOI 10.1002/hep.26294
   Antunovic B, 2012, EFSA J, V10, DOI 10.2903/j.efsa.2012.2750
   Anway MD, 2005, SCIENCE, V308, P1466, DOI 10.1126/science.1108190
   Attene-Ramos MS, 2013, DRUG DISCOV TODAY, V18, P716, DOI 10.1016/j.drudis.2013.05.015
   Aylward LL, 2011, REGUL TOXICOL PHARM, V60, P189, DOI 10.1016/j.yrtph.2011.03.014
   Bartels M, 2012, COMPUT METH PROG BIO, V108, P773, DOI 10.1016/j.cmpb.2012.04.014
   Basketter DA, 2012, ARCH TOXICOL, V86, P1159, DOI 10.1007/s00204-012-0901-8
   Benfenati E, 2009, J ENVIRON SCI HEAL C, V27, P57, DOI 10.1080/10590500902885593
   Berger B, 2013, NAT REV GENET, V14, P333, DOI 10.1038/nrg3433
   Bernillon P, 2000, ENVIRON HEALTH PERSP, V108, P883, DOI 10.2307/3454322
   Blaauboer BJ, 2010, J TOXICOL ENV HEAL B, V13, P242, DOI 10.1080/10937404.2010.483940
   Blackburn K, 2011, REGUL TOXICOL PHARM, V60, P120, DOI 10.1016/j.yrtph.2011.03.002
   Boccard J, 2010, J SEP SCI, V33, P290, DOI 10.1002/jssc.200900609
   Boesten J, 2012, EFSA J, V10, DOI 10.2903/j.efsa.2012.2799
   Bois FY, 2010, TOXICOLOGY, V278, P256, DOI 10.1016/j.tox.2010.06.007
   Boitier E, 2011, TOXICOL APPL PHARM, V252, P85, DOI 10.1016/j.taap.2011.01.021
   Boobis AR, 2005, TOXICOL LETT, V158, pS30
   Boobis AR, 2008, CRIT REV TOXICOL, V38, P87, DOI 10.1080/10408440701749421
   Boobis AR, 2006, TOXICOL LETT, V164, pS254, DOI 10.1016/j.toxlet.2006.07.189
   Bouhifd M, 2013, J APPL TOXICOL, V33, P1365, DOI 10.1002/jat.2874
   Bow DAJ, 2006, J PHARMACOL EXP THER, V316, P349, DOI 10.1124/jpet.105.093070
   Bueters T, 2013, XENOBIOTICA, V43, P607, DOI 10.3109/00498254.2012.752117
   Burgess-Herbert SL, 2013, TOXICOL APPL PHARM, V271, P372, DOI 10.1016/j.taap.2011.11.011
   Caldwell JC, 2012, J TOXICOL, DOI 10.1155/2012/852384
   Cecconi D, 2011, TRAC-TREND ANAL CHEM, V30, P346, DOI 10.1016/j.trac.2010.10.016
   Chadeau-Hyam M, 2013, ENVIRON MOL MUTAGEN, V54, P542, DOI 10.1002/em.21797
   Chaudhry AS, 2010, J PHARMACOL EXP THER, V332, P599, DOI 10.1124/jpet.109.161026
   Chen Y, 2011, DRUG METAB DISPOS, V39, P2085, DOI 10.1124/dmd.111.040634
   Cheng FX, 2012, J CHEM INF MODEL, V52, P3099, DOI 10.1021/ci300367a
   Cheng S, 2011, ENVIRON HEALTH PERSP, V119, P1712, DOI [10.1289/ehp.1103510, 10.1299/ehp.1103510]
   Chiu WA, 2006, ARCH TOXICOL, V80, P382, DOI 10.1007/s00204-006-0061-9
   Choi K, 2014, TISSUE ENG PART C-ME, V20, P641, DOI [10.1089/ten.tec.2013.0562, 10.1089/ten.TEC.2013.0562]
   Clewell HJ, 2004, TOXICOL SCI, V79, P381, DOI 10.1093/toxsci/kfh109
   Clewell HJ, 2000, FUEL PROCESS TECHNOL, V65, P43, DOI 10.1016/S0378-3820(99)00075-2
   Clewell RA, 2008, REGUL TOXICOL PHARM, V50, P129, DOI 10.1016/j.yrtph.2007.10.012
   Coecke S, 2006, ATLA-ALTERN LAB ANIM, V34, P49, DOI 10.1177/026119290603400113
   Coecke S, 2013, TOXICOL IN VITRO, V27, P1570, DOI 10.1016/j.tiv.2012.06.012
   Collins BC, 2012, MOL CELL PROTEOMICS, V11, P394, DOI 10.1074/mcp.M111.016493
   Com E, 2012, TOXICOL APPL PHARM, V258, P124, DOI 10.1016/j.taap.2011.10.015
   Conolly Rory B, 2005, Toxicol Appl Pharmacol, V207, P570, DOI 10.1016/j.taap.2005.04.027
   Covington TR, 2007, REGUL TOXICOL PHARM, V47, P1, DOI 10.1016/j.yrtph.2006.06.008
   Crowell SR, 2011, TOXICOL LETT, V205, P154, DOI 10.1016/j.toxlet.2011.05.1036
   Crump KS, 2010, ENVIRON HEALTH PERSP, V118, P585, DOI 10.1289/ehp.0901249
   Culleres DB, 2008, EFSA J, V6, DOI 10.2903/j.efsa.2008.704
   Darwich AS, 2010, CURR DRUG METAB, V11, P716
   David RM, 2006, REGUL TOXICOL PHARM, V45, P55, DOI 10.1016/j.yrtph.2005.12.003
   Davies MN, 2010, BRIEF FUNCT GENOMICS, V9, P385, DOI 10.1093/bfgp/elq021
   Dennison JE, 2003, INHAL TOXICOL, V15, P961, DOI 10.1080/08958370390215749
   DeWoskin RS, 2001, HUM ECOL RISK ASSESS, V7, P1091, DOI 10.1080/20018091094871
   Doerge DR, 2008, J AGR FOOD CHEM, V56, P6031, DOI 10.1021/jf073042g
   Doerge DR, 2010, TOXICOL APPL PHARM, V248, P1, DOI 10.1016/j.taap.2010.07.009
   Doring B, 2014, DRUG METABOLISM REV
   Dorne JLCM, 2010, TOXICOLOGY, V268, P156, DOI 10.1016/j.tox.2009.11.004
   Dorne Jean Lou, 2012, Methods Mol Biol, V929, P521
   Draghici S, 2003, BIOINFORMATICS, V19, P1348, DOI 10.1093/bioinformatics/btg165
   Du LF, 2013, TOXICOL SCI, V134, P195, DOI 10.1093/toxsci/kft091
   *ECHA, 2008, REACH GUID INF REQ C
   EFSA, 2005, EFSA J, V282, P1, DOI DOI 10.2903/J.EFSA.2005.282
   EFSA European Food Safety Authority, 2009, EFSA J, V1150, P1, DOI DOI 10.2903/J.EFSA.2009.1150
   EFSA (European Food Safety Authority), 2014, EFSA SUPP PUBL
   EFSA (European Food Safety Authority), 2009, EFSA SCI REPORT, V254, P1
   Ellinger-Ziegelbauer H, 2011, TOXICOL APPL PHARM, V252, P97, DOI 10.1016/j.taap.2010.09.022
   Enoch SJ, 2010, CHEM RES TOXICOL, V23, P1547, DOI 10.1021/tx100218h
   European Food Safety Authority, 2013, EFSA J, V11, DOI 10.2903/j.efsa.2013.3313
   European Food Safety Authority, 2014, EFSA J, V12, DOI 10.2903/j.efsa.2014.3594
   Eustache F, 2009, ENVIRON HEALTH PERSP, V117, P1272, DOI 10.1289/ehp.0800158
   Faller LD, 2008, ARCH BIOCHEM BIOPHYS, V476, P12, DOI 10.1016/j.abb.2008.05.017
   Fan JH, 2010, CURR DRUG METAB, V11, P743, DOI 10.2174/138920010794328931
   Feng ZJ, 2012, CHEM-BIOL INTERACT, V199, P143, DOI 10.1016/j.cbi.2012.07.004
   Fiehn O, 2007, METABOLOMICS, V3, P175, DOI 10.1007/s11306-007-0070-6
   Fisher JW, 2011, TOXICOL APPL PHARM, V257, P122, DOI 10.1016/j.taap.2011.08.026
   Forgacs AL, 2013, TOXICOL SCI, V133, P54, DOI 10.1093/toxsci/kft028
   Fountoulakis M, 2000, ELECTROPHORESIS, V21, P2148, DOI 10.1002/1522-2683(20000601)21:11<2148::AID-ELPS2148>3.0.CO;2-X
   Gangwal S, 2012, SCI TOTAL ENVIRON, V435, P316, DOI 10.1016/j.scitotenv.2012.06.086
   Gentry PR, 2002, TOXICOL SCI, V70, P120, DOI 10.1093/toxsci/70.1.120
   GERLOWSKI LE, 1983, J PHARM SCI, V72, P1103, DOI 10.1002/jps.2600721003
   Gissi A, 2014, ALTEX-ALTERN ANIM EX, V31, P23, DOI 10.14573/altex.1305221
   Goldstone JV, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-643
   Goodman JE, 2014, REGUL TOXICOL PHARM, V68, P160, DOI 10.1016/j.yrtph.2013.12.002
   Govarts E, 2012, ENVIRON HEALTH PERSP, V120, P162, DOI 10.1289/ehp.1103767
   Groothuis GMM, 2013, CURR DRUG METAB, V14, P112
   Haddad S, 1999, TOXICOL APPL PHARM, V161, P249, DOI 10.1006/taap.1999.8803
   Haddad S, 2001, TOXICOL SCI, V63, P125, DOI 10.1093/toxsci/63.1.125
   Haug K, 2013, NUCLEIC ACIDS RES, V41, pD781, DOI 10.1093/nar/gks1004
   Herrero M, 2012, MASS SPECTROM REV, V31, P49, DOI 10.1002/mas.20335
   Hillgren KM, 2013, CLIN PHARMACOL THER, V94, P52, DOI 10.1038/clpt.2013.74
   Hinderliter PM, 2011, REGUL TOXICOL PHARM, V61, P82, DOI 10.1016/j.yrtph.2011.06.004
   Hood L, 2012, SCIENCE, V336, P1209, DOI 10.1126/science.1225475
   IEH (Institute of Environment and Health), 2013, PRED APPR CHEM HAZ I
   Illig T, 2010, NAT GENET, V42, P137, DOI 10.1038/ng.507
   Ishii M, 2012, YAKUGAKU ZASSHI, V132, P301, DOI 10.1248/yakushi.132.301
   Jamei M, 2009, EXPERT OPIN DRUG MET, V5, P211, DOI [10.1517/17425250802691074 , 10.1517/17425250802691074]
   Jayaraman R, 2011, DRUG METAB DISPOS, V39, P2219, DOI 10.1124/dmd.111.041558
   Jongeneelen FJ, 2011, ANN OCCUP HYG, V55, P841, DOI 10.1093/annhyg/mer075
   Jourdan F, 2010, METABOLOMICS, V6, P312, DOI 10.1007/s11306-009-0196-9
   JRC (Joint Research Center), 2011, APPL QSAR AN EV DEV
   JRC (Joint Research Centre), 2010, APPL QSAR A IN PRESS
   Kamp H, 2012, BIOANALYSIS, V4, P2291, DOI [10.4155/BIO.12.214, 10.4155/bio.12.214]
   Keane TM, 2011, NATURE, V477, P289, DOI 10.1038/nature10413
   Kim TH, 2012, ARCH TOXICOL, V86, P1885, DOI 10.1007/s00204-012-0910-7
   Kleinstreuer NC, 2011, TOXICOL APPL PHARM, V257, P111, DOI 10.1016/j.taap.2011.08.025
   Knaak JB, 2008, REV ENVIRON CONTAM T, V193, P53, DOI 10.1007/978-0-387-73163-6_3
   Knaak JB, 2004, CRIT REV TOXICOL, V34, P143, DOI 10.1080/10408440490432250
   Knudsen AD, 2014, J PROTEOMICS, V103, P261, DOI 10.1016/j.jprot.2014.02.001
   Koen YM, 2007, CHEM RES TOXICOL, V20, P511, DOI 10.1021/tx6003166
   Kopec AK, 2013, TOXICOL SCI, V135, P465, DOI 10.1093/toxsci/kft156
   Koulman A, 2009, ANAL BIOANAL CHEM, V394, P663, DOI 10.1007/s00216-009-2690-3
   Krewski D, 2011, ANNU REV PUBL HEALTH, V32, P161, DOI 10.1146/annurev-publhealth-031210-101153
   Kroes R, 2005, TOXICOL SCI, V86, P226, DOI 10.1093/toxsci/kfi169
   Kroes R, 2004, FOOD CHEM TOXICOL, V42, P65, DOI 10.1016/j.fct.2003.08.006
   Kumar V, 2012, CANCER CHEMOTH PHARM, V69, P229, DOI 10.1007/s00280-011-1687-8
   Kusuhara H, 2009, DRUG METAB PHARMACOK, V24, P37, DOI 10.2133/dmpk.24.37
   Lafond M, 2011, BRIT J NUTR, V106, P264, DOI 10.1017/S0007114511000134
   Lan K, 2013, EVID-BASED COMPL ALT, DOI 10.1155/2013/819147
   Lapenna S, 2011, 24898 EN EUR JRC
   Law F C, 1997, Yao Xue Xue Bao, V32, P151
   Lee MY, 2010, METHODS MOL BIOL, V632, P221, DOI 10.1007/978-1-60761-663-4_14
   Lee S, 2011, J TOXICOL ENV HEAL A, V74, P1334, DOI 10.1080/15287394.2011.567958
   Lee S, 2010, CHEM-BIOL INTERACT, V184, P449, DOI 10.1016/j.cbi.2010.01.024
   LEUNG HW, 1991, J TOXICOL ENV HEALTH, V32, P247, DOI 10.1080/15287399109531480
   Li F, 2013, J PROTEOME RES, V12, P1369, DOI 10.1021/pr301023x
   Li JS, 2013, CHEM-BIOL INTERACT, V206, P337, DOI 10.1016/j.cbi.2013.10.004
   Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091
   Truong L, 2014, TOXICOL SCI, V137, P212, DOI 10.1093/toxsci/kft235
   Liu Y.Q., 2014, J ANAL METHODS CHEM, V2014, P9, DOI DOI 10.1371/J0URNAL.P0NE.0085323
   Lo Piparo E, 2011, REGUL TOXICOL PHARM, V60, P354, DOI 10.1016/j.yrtph.2011.05.003
   Loccisano AE, 2011, REGUL TOXICOL PHARM, V59, P157, DOI 10.1016/j.yrtph.2010.12.004
   Loizou G, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00056
   Lyons MA, 2008, ENVIRON HEALTH PERSP, V116, P1040, DOI 10.1289/ehp.11079
   Martati E, 2011, CHEM RES TOXICOL, V24, P818, DOI 10.1021/tx200032m
   Mattes WB, 2013, BIOMED RES INT, DOI 10.1155/2013/202497
   Mays C, 2012, CHEM CENT J, V6, DOI 10.1186/1752-153X-6-159
   McGettigan PA, 2013, CURR OPIN CHEM BIOL, V17, P4, DOI 10.1016/j.cbpa.2012.12.008
   Meek ME, 2014, J APPL TOXICOL, V34, P1, DOI 10.1002/jat.2949
   Meek ME, 2011, REGUL TOXICOL PHARM, V60, pS1, DOI 10.1016/j.yrtph.2011.03.010
   Meganathan K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044228
   Meng ZJ, 2011, J PROTEOMICS, V74, P2650, DOI 10.1016/j.jprot.2011.04.011
   Menni C, 2013, METABOLOMICS, V9, P506, DOI 10.1007/s11306-012-0469-6
   Merrick BA, 2004, CURR OPIN MOL THER, V6, P600
   Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626
   Meyer MR, 2013, TOXICOL LETT, V217, P137, DOI 10.1016/j.toxlet.2012.12.012
   Milreu PV, 2014, BIOINFORMATICS, V30, P61, DOI 10.1093/bioinformatics/btt597
   Mirfazaelian A, 2006, TOXICOL SCI, V93, P432, DOI 10.1093/toxsci/kfl056
   Mitra P, 2011, J PHARM SCI-US, V100, P4258, DOI 10.1002/jps.22596
   Montoya GA, 2014, TOXICOL LETT, V225, P240, DOI 10.1016/j.toxlet.2013.12.010
   Kobayashi CAN, 2011, J BIOCHEM MOL TOXIC, V25, P8, DOI 10.1002/jbt.20353
   Nault R, 2013, TOXICOL LETT, V223, P52, DOI 10.1016/j.toxlet.2013.08.013
   Nault R, 2013, TOXICOL APPL PHARM, V267, P184, DOI 10.1016/j.taap.2012.11.028
   Nicholson JK, 1999, XENOBIOTICA, V29, P1181, DOI 10.1080/004982599238047
   Nicholson JK, 2003, NAT REV DRUG DISCOV, V2, P668, DOI 10.1038/nrd1157
   Nossol C, 2011, HISTOCHEM CELL BIOL, V136, P103, DOI 10.1007/s00418-011-0826-y
   NRC, 2007, TOXICITY TESTING 21
   NRC, 2009, SCI DEC ADV RISK ASS
   NTP, 2004, NAT TOX PROGR 21 CEN
   Nuwaysir EF, 1999, MOL CARCINOGEN, V24, P153, DOI 10.1002/(SICI)1098-2744(199903)24:3<153::AID-MC1>3.0.CO;2-P
   OECD, 2011, SER TEST ASS
   OECD, 2013, SER TEST ASS, V184
   OECD, 2009, SER TEST ASS
   OECD (Organisation for Economic Co-operation and Development), 2004, REP EXP GROUP QSARS
   OECD (Organisation for Economic Co-Operation and Development), 2012, QSAR TOOLB US MAN GE
   OECD (Organization for Economic Cooperation and Development), 2007, SER TEST ASS
   Oliver S, 2003, MOL CELL, V12, P1343, DOI 10.1016/S1097-2765(03)00501-X
   Ozdemir V., 2009, Current Pharmacogenomics & Personalized Medicine, V7, P225
   Padhi BK, 2008, TOXICOL LETT, V176, P93, DOI 10.1016/j.toxlet.2007.08.016
   Paini A, 2012, MUTAGENESIS, V27, P653, DOI 10.1093/mutage/ges031
   Pan TL, 2012, FOOD CHEM TOXICOL, V50, P3892, DOI 10.1016/j.fct.2012.07.005
   Pargent W, 2000, MAMM GENOME, V11, P590, DOI 10.1007/s003350010112
   Patlewicz G, 2008, SAR QSAR ENVIRON RES, V19, P495, DOI 10.1080/10629360802083871
   Patti GJ, 2012, NAT PROTOC, V7, P508, DOI 10.1038/nprot.2011.454
   Pelekis M, 2009, ENVIRON TOXICOL PHAR, V28, P179, DOI 10.1016/j.etap.2009.04.002
   Peng SY, 2013, J PHARMACEUT BIOMED, V86, P56, DOI 10.1016/j.jpba.2013.07.014
   Perkins EJ, 2013, ENVIRON HEALTH PERSP, V121, P1002, DOI 10.1289/ehp.1306638
   Pery ARR, 2013, TOXICOL LETT, V220, P26, DOI 10.1016/j.toxlet.2013.03.032
   Pery ARR, 2009, INHAL TOXICOL, V21, P1099, DOI 10.3109/08958370902748542
   Pevsner, 2009, BIOINFORMATICS FUNCT
   Peyret T, 2010, TOXICOL APPL PHARM, V249, P197, DOI 10.1016/j.taap.2010.09.010
   Pielaat A, 2013, EFSA SUPPORTING PUBL
   Pietu G, 1999, GENOME RES, V9, P195
   Poet TS, 2004, NEUROTOXICOLOGY, V25, P1013, DOI 10.1016/j.neuro.2004.03.002
   Potera C, 2014, ENVIRON HEALTH PERSP, V122, pA82, DOI 10.1289/ehp.122-A82
   Poulin P, 2013, J PHARM SCI-US, V102, P2806, DOI 10.1002/jps.23602
   Price PS, 2009, RISK ANAL, V29, P1534, DOI 10.1111/j.1539-6924.2009.01300.x
   Punt A, 2008, TOXICOL APPL PHARM, V231, P248, DOI 10.1016/j.taap.2008.04.011
   Punt A, 2011, REGUL TOXICOL PHARM, V61, P105, DOI 10.1016/j.yrtph.2011.06.007
   Rabinowitz JR, 2008, ENVIRON HEALTH PERSP, V116, P573, DOI 10.1289/ehp.11077
   Rakyan VK, 2011, NAT REV GENET, V12, P529, DOI 10.1038/nrg3000
   Ramirez T, 2013, ALTEX-ALTERN ANIM EX, V30, P209, DOI 10.14573/altex.2013.2.209
   Rappaport SM, 2010, SCIENCE, V330, P460, DOI 10.1126/science.1192603
   Reif DM, 2013, BIOINFORMATICS, V29, P402, DOI 10.1093/bioinformatics/bts686
   Reif DM, 2010, ENVIRON HEALTH PERSP, V118, P1714, DOI 10.1289/ehp.1002180
   Reinartz Jeannette, 2002, Briefings in Functional Genomics & Proteomics, V1, P95, DOI 10.1093/bfgp/1.1.95
   Robertson DG, 2011, TOXICOL SCI, V120, pS146, DOI 10.1093/toxsci/kfq358
   Rodriguez-Suarez E, 2013, MASS SPECTROM REV, V32, P1, DOI 10.1002/mas.21347
   Roncaglioni A, 2013, CURR OPIN PHARMACOL, V13, P802, DOI 10.1016/j.coph.2013.06.001
   Rostami-Hodjegan A, 2007, NAT REV DRUG DISCOV, V6, P140, DOI 10.1038/nrd2173
   Rostkowski M, 2013, BIOINFORMATICS, V29, P2051, DOI 10.1093/bioinformatics/btt325
   Rotroff DM, 2010, TOXICOL SCI, V117, P348, DOI 10.1093/toxsci/kfq220
   Rowland M, 2013, CPT Pharmacometrics Syst Pharmacol, V2, pe55, DOI 10.1038/psp.2013.29
   Ruiz P, 2010, TOXICOL LETT, V198, P44, DOI 10.1016/j.toxlet.2010.04.022
   Rusyn I, 2010, ENVIRON HEALTH PERSP, V118, P1047, DOI 10.1289/ehp.1001925
   Sabido E, 2012, CURR OPIN BIOTECH, V23, P591, DOI 10.1016/j.copbio.2011.11.014
   Santoriello C, 2012, J CLIN INVEST, V122, P2337, DOI 10.1172/JCI60434
   Sasso AF, 2012, J TOXICOL, DOI 10.1155/2012/895391
   Sasso AF, 2010, THEOR BIOL MED MODEL, V7, DOI 10.1186/1742-4682-7-17
   SCCS (Scientific Committee on Consumer Safety) SCENHIR (Scientific Committee on Emerging and Newly Identified Health Risks) and SCHER (Scientific Committee on Health and Environmental Risks), 2012, TOX ASS CHEM MIXT
   Schilter B, 2014, REGUL TOXICOL PHARM, V68, P275, DOI 10.1016/j.yrtph.2013.08.018
   Schmidt CW, 2009, ENVIRON HEALTH PERSP, V117, pA348, DOI 10.1289/ehp.117-a348
   Schnackenberg LK, 2012, FOOD CHEM TOXICOL, V50, P3978, DOI 10.1016/j.fct.2012.08.010
   Scholz S, 2013, ARCH TOXICOL, V87, P767, DOI 10.1007/s00204-013-1044-2
   Scholz S, 2013, REGUL TOXICOL PHARM, V67, P506, DOI 10.1016/j.yrtph.2013.10.003
   Setzer RW, 2001, TOXICOL SCI, V59, P49, DOI 10.1093/toxsci/59.1.49
   Shi Q, 2013, BIOMARK MED, V7, P307, DOI [10.2217/BMM.13.9, 10.2217/bmm.13.9]
   Shin KH, 2013, CLIN PHARMACOL THER, V94, P601, DOI 10.1038/clpt.2013.128
   SHUEY DL, 1994, TOXICOL APPL PHARM, V126, P129, DOI 10.1006/taap.1994.1099
   Shukla SJ, 2010, DRUG DISCOV TODAY, V15, P997, DOI 10.1016/j.drudis.2010.07.007
   Sipes NS, 2013, CHEM RES TOXICOL, V26, P878, DOI [10.1021/tx400021f, 10.1021/tx400021]
   Sjogren E, 2013, EUR J PHARM SCI, V49, P679, DOI 10.1016/j.ejps.2013.05.019
   Sommer F, 2013, NAT REV MICROBIOL, V11, P227, DOI 10.1038/nrmicro2974
   Song L, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-5
   Squassina A, 2010, PHARMACOGENOMICS, V11, P1149, DOI 10.2217/PGS.10.97
   Steinbeck C, 2012, METABOLOMICS, V8, P757, DOI 10.1007/s11306-012-0462-0
   Stierum Rob, 2005, Toxicol Appl Pharmacol, V207, P179, DOI 10.1016/j.taap.2005.01.050
   Sturla SJ, 2014, CHEM RES TOXICOL, V27, P314, DOI 10.1021/tx400410s
   Sumner LW, 2007, METABOLOMICS, V3, P211, DOI 10.1007/s11306-007-0082-2
   Sun BY, 2013, J PROTEOME RES, V12, P2034, DOI 10.1021/pr301178a
   Sun YJ, 2012, J PROTEOME RES, V11, P2544, DOI 10.1021/pr2012329
   Supic G, 2013, NUTR CANCER, V65, P781, DOI 10.1080/01635581.2013.805794
   Sysi-Aho M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-93
   Taylor JA, 2011, ENVIRON HEALTH PERSP, V119, P422, DOI 10.1289/ehp.1002514
   Teeguarden JG, 2004, RISK ANAL, V24, P751, DOI 10.1111/j.0272-4332.2004.00473.x
   Teschendorff AE, 2012, BIOINFORMATICS, V28, P1487, DOI 10.1093/bioinformatics/bts170
   Thelen K, 2009, J PHARM PHARMACOL, V61, P541, DOI 10.1211/jpp/61.05.0002
   Thomas RS, 2013, TOXICOL SCI, V136, P4, DOI 10.1093/toxsci/kft178
   Thomas RS, 2013, TOXICOL SCI, V134, P180, DOI 10.1093/toxsci/kft094
   Thomas RS, 2012, MUTAT RES-GEN TOX EN, V746, P135, DOI 10.1016/j.mrgentox.2012.01.007
   Thomas RS, 2011, TOXICOL SCI, V120, P194, DOI 10.1093/toxsci/kfq355
   Tice R, 2011, TOX21 TRANSF ENV HLT
   Tice RR, 2013, ENVIRON HEALTH PERSP, V121, P756, DOI 10.1289/ehp.1205784
   Timchalk C, 2008, NEUROTOXICOLOGY, V29, P428, DOI 10.1016/j.neuro.2008.02.004
   Tonnelier A, 2012, ARCH TOXICOL, V86, P393, DOI 10.1007/s00204-011-0768-0
   Tornero-Velez R, 2010, TOXICOL APPL PHARM, V244, P208, DOI 10.1016/j.taap.2009.12.034
   Tseng YJ, 2012, J COMPUT AID MOL DES, V26, P39, DOI 10.1007/s10822-011-9511-4
   Turco L, 2011, TOXICOL IN VITRO, V25, P13, DOI 10.1016/j.tiv.2010.08.009
   U.S. Environmental Protection Agency, 2004, POT IMPL GEN REG RIS
   U.S. EPA, 2002, INT POL GEN
   *US EPA, 2005, GUID CARC RISK ASS
   US EPA (US Environmental Protection Agency), 1996, FED REGISTER, V61, P17960
   US-EPA (U. S. Environmental Protection Agency), 2013, NEXT GEN RISK ASS IN
   US-EPA (U. S. Environmental Protection Agency), 2009, EFF BAS EXP IN PRESS
   Valcke M, 2014, J APPL TOXICOL, V34, P227, DOI 10.1002/jat.2919
   van den Berg SJPL, 2013, FOOD CHEM TOXICOL, V62, P32, DOI 10.1016/j.fct.2013.08.019
   van der Merwe D, 2006, TOXICOL SCI, V89, P188, DOI 10.1093/toxsci/kfj014
   van Ravenzwaay B, 2012, MUTAT RES-GEN TOX EN, V746, P144, DOI 10.1016/j.mrgentox.2012.01.006
   Van Summeren A, 2012, TOXICOL IN VITRO, V26, P373, DOI 10.1016/j.tiv.2012.01.012
   Vasdev N, 2011, BIOORGAN MED CHEM, V19, P2959, DOI 10.1016/j.bmc.2011.03.032
   Vedani A, 2000, PROG DRUG RES, V55, P105
   Vedani A, 2006, BASIC CLIN PHARMACOL, V99, P195, DOI 10.1111/j.1742-7843.2006.pto_471.x
   Verner MA, 2013, ENVIRON HEALTH PERSP, V121, P1219, DOI 10.1289/ehp.1206457
   Verner MA, 2012, TOXICOL LETT, V213, P299, DOI 10.1016/j.toxlet.2012.05.024
   Verner MA, 2009, ENVIRON HEALTH PERSP, V117, P481, DOI 10.1289/ehp.0800047
   Villeneuve D, 2014, ENVIRON TOXICOL CHEM, V33, P158, DOI 10.1002/etc.2403
   Vinken M, 2013, TOXICOL SCI, V136, P97, DOI 10.1093/toxsci/kft177
   Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484
   Washburn MP, 2003, ANAL CHEM, V75, P5054, DOI 10.1021/ac034120b
   West PR, 2010, TOXICOL APPL PHARM, V247, P18, DOI 10.1016/j.taap.2010.05.007
   Wetmore BA, 2013, TOXICOL SCI, V132, P327, DOI 10.1093/toxsci/kft012
   Wetmore BA, 2012, TOXICOL SCI, V125, P157, DOI 10.1093/toxsci/kfr254
   WHO, 2010, CHAR APPL PHYS BAS P
   WHO, 2005, INT PROGR CHEM SAF C
   WHO (World Health Organization), 2002, GEN WORLD HLTH ADV C
   Wiklund S, 2008, ANAL CHEM, V80, P115, DOI 10.1021/ac0713510
   Wild CP, 2013, ENVIRON MOL MUTAGEN, V54, P480, DOI 10.1002/em.21777
   Wild CP, 2012, INT J EPIDEMIOL, V41, P24, DOI 10.1093/ije/dyr236
   Wild CP, 2005, CANCER EPIDEM BIOMAR, V14, P1847, DOI 10.1158/1055-9965.EPI-05-0456
   Wilkins MR, 1996, BIOTECHNOL GENET ENG, V13, P19, DOI 10.1080/02648725.1996.10647923
   Williams TD, 2014, BRIEF FUNCT GENOMICS, V13, P157, DOI 10.1093/bfgp/elt053
   Wilmes A, 2013, J PROTEOMICS, V79, P180, DOI 10.1016/j.jprot.2012.11.022
   Wishart DS, 2007, NUCLEIC ACIDS RES, V35, pD521, DOI 10.1093/nar/gkl923
   Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065
   Worth A, 2011, 24748 EN EUR JRC
   Wu BJ, 2013, CURR TOP MED CHEM, V13, P1343
   Wu SD, 2010, REGUL TOXICOL PHARM, V56, P67, DOI 10.1016/j.yrtph.2009.09.006
   Xie GX, 2010, J PROTEOME RES, V9, P125, DOI 10.1021/pr900333h
   Yeo KR, 2013, EUR J CLIN PHARMACOL, V69, P1311, DOI 10.1007/s00228-012-1467-3
   Yokoi T, 2013, ANNU REV PHARMACOL, V53, P377, DOI 10.1146/annurev-pharmtox-011112-140250
   Yoon M, 2014, TOXICOL IN VITRO, V28, P164, DOI 10.1016/j.tiv.2013.10.023
   Yoon M, 2012, CRIT REV TOXICOL, V42, P633, DOI 10.3109/10408444.2012.692115
   Young JF, 2007, CHEM RES TOXICOL, V20, P388, DOI 10.1021/tx600287w
   Yu LR, 2011, J PROTEOMICS, V74, P2549, DOI 10.1016/j.jprot.2011.10.001
   Zaldivar Comenges JM, 2011, 24898 EN EUR JRC
   Zaldivar J.M., 2010, 24374 EN EUR 1
   Zhang X, 2007, TOXICOL SCI, V100, P345, DOI 10.1093/toxsci/kfm232
   Zhu H, 2009, CHEM RES TOXICOL, V22, P1913, DOI 10.1021/tx900189p
   Zhu XW, 2013, PHARM RES-DORDR, V30, P1790, DOI 10.1007/s11095-013-1023-6
NR 307
TC 33
Z9 33
U1 0
U2 0
PU EUROPEAN FOOD SAFETY AUTHORITY-EFSA
PI PARMA
PA EUROPEAN FOOD SAFETY AUTHORITY-EFSA, PARMA, 00000, ITALY
EI 1831-4732
J9 EFSA J
JI EFSA J.
PD APR
PY 2014
VL 12
IS 4
AR UNSP 3638
DI 10.2903/j.efsa.2014.3638
PG 87
WC Food Science & Technology
SC Food Science & Technology
GA V9R3P
UT WOS:000409104000020
OA DOAJ Gold
DA 2019-10-23
ER

PT J
AU De Coninck, DIM
   Asselman, J
   Glaholt, S
   Janssen, CR
   Colhourne, JK
   Shaw, JR
   De Schamphelaere, KAC
AF De Coninck, Dieter I. M.
   Asselman, Jana
   Glaholt, Stephen
   Janssen, Colin R.
   Colhourne, John K.
   Shaw, Joseph R.
   De Schamphelaere, Karel A. C.
TI Genome-Wide Transcription Profiles Reveal Genotype-Dependent Responses
   of Biological Pathways and Gene-Families in Daphnia Exposed to Single
   and Mixed Stressors
SO ENVIRONMENTAL SCIENCE & TECHNOLOGY
LA English
DT Article
ID ADVERSE OUTCOME PATHWAYS; MICROCYSTIS-AERUGINOSA; OXIDATIVE STRESS;
   MAGNA; CADMIUM; TOLERANCE; CYANOBACTERIUM; POPULATIONS; ACTIVATION;
   CLIMATE
AB The present study investigated the possibilities and limitations of implementing a genome-wide transcription-based approach that takes into account genetic and environmental variation to better understand the response of natural populations to stressors. When exposing two different Daphnia pulex genotypes (a cadmium-sensitive and a cadmium-tolerant one) to cadmium, the toxic cyanobacteria Microcystis aeruginosa, and their mixture, we found that observations at the transcriptomic level do not always explain observations at a higher level (growth, reproduction). For example, although cadmium elicited an adverse effect at the organismal level, almost no genes were differentially expressed after cadmium exposure. In addition, we identified oxidative stress and polyunsaturated fatty acid metabolism-related pathways, as well as trypsin and neurexin IV gene-families as candidates for the underlying causes of genotypic differences in tolerance to Microcystis. Furthermore, the whole-genome transcriptomic data of a stressor mixture allowed a better understanding of mixture responses by evaluating interactions between two stressors at the gene-expression level against the independent action baseline model. This approach has indicated that ubiquinone pathway and the MAPK serine-threonine protein kinase and collagens gene-families were enriched with genes showing an interactive effect in expression response to exposure to the mixture of the stressors, while transcription and translation-related pathways and gene-families were mostly related with genotypic differences in interactive responses to this mixture. Collectively, our results indicate that the methods we employed may improve further characterization of the possibilities and limitations of transcriptomics approaches in the adverse outcome pathway framework and in predictions of multistressor effects on natural populations.
C1 [De Coninck, Dieter I. M.; Asselman, Jana; Janssen, Colin R.; De Schamphelaere, Karel A. C.] Univ Ghent, Lab Environm Toxicol & Aquat Ecol, B-9000 Ghent, Belgium.
   [Glaholt, Stephen] Indiana Univ, Sch Publ & Environm Affairs, Bloomington, IN USA.
   [Colhourne, John K.; Shaw, Joseph R.] Indiana Univ, Ctr Genom & Bioinformat, Bloomington, IN USA.
   [Colhourne, John K.; Shaw, Joseph R.] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England.
RP De Coninck, DIM (reprint author), Univ Ghent, Lab Environm Toxicol & Aquat Ecol, B-9000 Ghent, Belgium.
EM dieter.deconinck@ugent.be
RI Janssen, Colin/H-3122-2015; De Schamphelaere, Karel AC/A-1600-2008;
   Colbourne, John/L-7748-2014
OI De Schamphelaere, Karel AC/0000-0002-5063-922X; Asselman,
   Jana/0000-0003-0185-6516; Colbourne, John/0000-0002-6966-2972
FU Ghent University Special Research Fund (BOF)Ghent University [01N01211,
   01SB1910U]; Research Foundation Flanders (FWO)FWO [1.5.269.11,
   G.0229.09, G.0614.11]; Environmental Health Science [R01ES019324];
   Interuniversity Attraction Pole project AquaStress (BELSPO) [P7/31];
   METACyt Initiative of Indiana University; Lilly Endowment, Inc.
FX We thank Jacqueline Lopez for the technical assistance. Funding for this
   research was provided by the Ghent University Special Research Fund (BOF
   Projects 01N01211 and 01SB1910U), the Research Foundation Flanders (FWO
   Projects 1.5.269.11, G.0229.09, and G.0614.11), the European Science
   Foundation (EuroEEFG project STRESSFLEA), the National Institute of
   Environmental Health Science (R01ES019324 awarded to J.R.S.), and the
   Interuniversity Attraction Pole project AquaStress (BELSPO, project
   P7/31). This work was also supported in part by the METACyt Initiative
   of Indiana University, funded through a major grant from the Lilly
   Endowment, Inc. This research benefits from, and contributes to, the
   Daphnia Genomics Consortium.
CR Agrawal MK, 2005, ENVIRON TOXICOL, V20, P314, DOI 10.1002/tox.20123
   Altenburger R, 2012, ENVIRON SCI TECHNOL, V46, P2508, DOI 10.1021/es2038036
   Altincicek B, 2009, BIOL CHEM, V390, P1303, DOI 10.1515/BC.2009.128
   Amado LL, 2010, ENVIRON INT, V36, P226, DOI 10.1016/j.envint.2009.10.010
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   [Anonymous], 2007, EUR UN EU RISK ASS C
   ASHHURST DE, 1980, EUR J BIOCHEM, V103, P75, DOI 10.1111/j.1432-1033.1980.tb04290.x
   Asselman J, 2013, AQUAT TOXICOL, V142, P422, DOI 10.1016/j.aquatox.2013.09.010
   Asselman J, 2012, ENVIRON SCI TECHNOL, V46, P8448, DOI 10.1021/es301100j
   Barata C, 2002, AQUAT TOXICOL, V60, P85, DOI 10.1016/S0166-445X(01)00275-2
   Barata C., 2009, ENVIRON TOXICOL CHEM, V21, P1058
   Burkewitz K, 2011, AM J PHYSIOL-CELL PH, V301, pC566, DOI 10.1152/ajpcell.00030.2011
   Chen J, 2009, TOXICOL APPL PHARM, V241, P81, DOI 10.1016/j.taap.2009.07.038
   Choe KP, 2008, AM J PHYSIOL-CELL PH, V295, pC1488, DOI 10.1152/ajpcell.00450.2008
   Colbourne JK, 2011, SCIENCE, V331, P555, DOI 10.1126/science.1197761
   Connon R, 2008, ENVIRON SCI TECHNOL, V42, P2181, DOI 10.1021/es702469b
   Cook JC, 2007, Genomic Approaches for Cross-Species Extrapolation in Toxicology, P1
   David RM, 2011, AQUAT TOXICOL, V104, P192, DOI 10.1016/j.aquatox.2011.04.016
   De Coninck DIM, 2013, AQUAT TOXICOL, V140, P425, DOI 10.1016/j.aquatox.2013.07.005
   De Schamphelaere Karel A. C., 2011, Integrated Environmental Assessment and Management, V7, P141, DOI 10.1002/ieam.149
   DeCoen WM, 1997, CHEMOSPHERE, V35, P1053, DOI 10.1016/S0045-6535(97)00172-0
   DeMott WR, 1997, FRESHWATER BIOL, V38, P649, DOI 10.1046/j.1365-2427.1997.00222.x
   EU, 2007, RISK ASS CADM MET CA
   Evrard E, 2010, COMP BIOCHEM PHYS C, V152, P321, DOI 10.1016/j.cbpc.2010.05.009
   Fristachi A., 2008, ADV EXPT MED BIOL, V619, P43
   Garcia-Reyero N, 2012, ENVIRON SCI TECHNOL, V46, P42, DOI 10.1021/es201245b
   Garrett H., 2008, BIOCHEMISTRY
   HANEY JF, 1994, ARCH HYDROBIOL, V132, P1
   He XQ, 2008, CHEM RES TOXICOL, V21, P1375, DOI 10.1021/tx800019a
   Heckmann LH, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r40
   HERSKOWITZ I, 1995, CELL, V80, P187, DOI 10.1016/0092-8674(95)90402-6
   Hockner M, 2009, J EXP ZOOL PART A, V311A, P776, DOI 10.1002/jez.564
   Jonker MJ, 2005, ENVIRON TOXICOL CHEM, V24, P2701, DOI 10.1897/04-431R.1
   Jos A, 2005, AQUAT TOXICOL, V72, P261, DOI 10.1016/j.aquatox.2005.01.003
   Klaassen C.D., 2010, CASARETT DOULLS ESSE
   Lampert W., 2011, EXCELLENCE ECOLOGY, V21
   Latta LC, 2012, ECOL LETT, V15, P794, DOI 10.1111/j.1461-0248.2012.01799.x
   Lurling M, 2003, ENVIRON TOXICOL, V18, P202, DOI 10.1002/tox.10.1002/tox.10115
   MAEDA T, 1995, SCIENCE, V269, P554, DOI 10.1126/science.7624781
   Messiaen M, 2013, AQUAT TOXICOL, V144, P322, DOI 10.1016/j.aquatox.2013.10.016
   Moe SJ, 2013, ENVIRON TOXICOL CHEM, V32, P49, DOI 10.1002/etc.2045
   Munger C, 1999, AQUAT TOXICOL, V44, P195
   Nriagu JO, 1998, SCI TOTAL ENVIRON, V223, P99, DOI 10.1016/S0048-9697(98)00284-8
   OECD - Organization for Economic Cooperation and Development, 2008, GUID TEST CHEM DAPHN
   Paerl HW, 2008, SCIENCE, V320, P57, DOI 10.1126/science.1155398
   Perkins EJ, 2011, ENVIRON TOXICOL CHEM, V30, P22, DOI 10.1002/etc.374
   Pflugmacher S, 2004, AQUAT TOXICOL, V70, P169, DOI 10.1016/j.aquatox.2004.06.010
   Poynton HC, 2007, ENVIRON SCI TECHNOL, V41, P1044, DOI 10.1021/es0615573
   Poynton HC, 2011, ENVIRON SCI TECHNOL, V45, P762, DOI 10.1021/es102501z
   Poynton HC, 2009, J AM WATER RESOUR AS, V45, P83, DOI 10.1111/j.1752-1688.2008.00291.x
   Schirmer K, 2010, ANAL BIOANAL CHEM, V397, P917, DOI 10.1007/s00216-010-3662-3
   Schwarzenberger Anke, 2010, BMC Physiology, V10, P6, DOI 10.1186/1472-6793-10-6
   Shanker AK, 2008, TRACE ELEMENTS NUTR, P525
   Shaw JR, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-477
   SHAW JR, 2008, RECENT ADV EXPT BIOL, V2, P165
   Soazig L, 2003, MAR POLLUT BULL, V46, P1450, DOI 10.1016/S0025-326X(03)00283-2
   Soetaert A, 2007, AQUAT TOXICOL, V83, P212, DOI 10.1016/j.aquatox.2007.04.010
   Stewart D, 2003, J BIOL CHEM, V278, P2396, DOI 10.1074/jbc.M209195200
   van Apeldoorn ME, 2007, MOL NUTR FOOD RES, V51, P7, DOI 10.1002/mnfr.200600185
   Vandenbrouck T, 2010, ENVIRON INT, V36, P254, DOI 10.1016/j.envint.2009.12.006
   Vandenbrouck T, 2009, AQUAT TOXICOL, V92, P18, DOI 10.1016/j.aquatox.2008.12.012
   Villeneuve DL, 2007, ENVIRON SCI TECHNOL, V41, P321, DOI 10.1021/es061739x
   Villeneuve DL, 2011, ENVIRON TOXICOL CHEM, V30, P1, DOI 10.1002/etc.396
   Vinebrooke RD, 2004, OIKOS, V104, P451, DOI 10.1111/j.0030-1299.2004.13255.x
   Watanabe KH, 2011, ENVIRON TOXICOL CHEM, V30, P9, DOI 10.1002/etc.373
   Widmann C, 1999, PHYSIOL REV, V79, P143
   Winter JG, 2011, LAKE RESERV MANAGE, V27, P107, DOI 10.1080/07438141.2011.557765
NR 67
TC 21
Z9 21
U1 0
U2 65
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0013-936X
EI 1520-5851
J9 ENVIRON SCI TECHNOL
JI Environ. Sci. Technol.
PD MAR 18
PY 2014
VL 48
IS 6
BP 3513
EP 3522
DI 10.1021/es4053363
PG 10
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA AE2AP
UT WOS:000333776000051
PM 24552364
OA Bronze, Green Accepted, Green Published
DA 2019-10-23
ER

PT J
AU Pillai, S
   Behra, R
   Nestler, H
   Suter, MJF
   Sigg, L
   Schirmer, K
AF Pillai, Smitha
   Behra, Renata
   Nestler, Holger
   Suter, Marc J-F
   Sigg, Laura
   Schirmer, Kristin
TI Linking toxicity and adaptive responses across the transcriptome,
   proteome, and phenotype of Chlamydomonas reinhardtii exposed to silver
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE toxicity response; adaptive pathway; algae; systems biology; adverse
   outcome pathway
ID ADVERSE OUTCOME PATHWAYS; ESCHERICHIA-COLI; OXIDATIVE STRESS;
   PHOTOSYSTEM-II; EXPRESSION; COMPLEX; COPPER; WATER; BIOACCUMULATION;
   QUANTIFICATION
AB Understanding mechanistic and cellular events underlying a toxicological outcome allows the prediction of impact of environmental stressors to organisms living in different habitats. A systems-based approach aids in characterizing molecular events, and thereby the cellular pathways that have been perturbed. However, mapping only adverse outcomes of a toxicant falls short of describing the stress or adaptive response that is mounted to maintain homeostasis on perturbations and may confer resistance to the toxic insult. Silver is a potential threat to aquatic organisms because of the increasing use of silver-based nanomaterials, which release free silver ions. The effects of silver were investigated at the transcriptome, proteome, and cellular levels of Chlamydomonas reinhardtii. The cells instigate a fast transcriptome and proteome response, including perturbations in copper transport system and detoxification mechanisms. Silver causes an initial toxic insult, which leads to a plummeting of ATP and photosynthesis and damage because of oxidative stress. In response, the cells mount a defense response to combat oxidative stress and to eliminate silver via efflux transporters. From the analysis of the perturbations of the cell's functions, we derived a detailed mechanistic understanding of temporal dynamics of toxicity and adaptive response pathways for C. reinhardtii exposed to silver.
C1 [Pillai, Smitha; Behra, Renata; Nestler, Holger; Suter, Marc J-F; Sigg, Laura; Schirmer, Kristin] Eawag, Swiss Fed Inst Aquat Sci & Technol, Dept Environm Toxicol, CH-8600 Dubendorf, Switzerland.
   [Pillai, Smitha; Behra, Renata; Suter, Marc J-F; Sigg, Laura; Schirmer, Kristin] ETH, Dept Environm Syst Sci, CH-8092 Zurich, Switzerland.
   [Schirmer, Kristin] Ecole Polytech Fed Lausanne, Sch Architecture Civil & Environm Engn, CH-1015 Lausanne, Switzerland.
RP Pillai, S (reprint author), Eawag, Swiss Fed Inst Aquat Sci & Technol, Dept Environm Toxicol, CH-8600 Dubendorf, Switzerland.
EM smitha.pillai@eawag.ch; Kristin.Schirmer@eawag.ch
RI Sigg, Laura/K-8558-2012; Suter, Marc/I-2074-2013
OI Sigg, Laura/0000-0002-2210-2951; Suter, Marc/0000-0003-3762-3490
FU Eawag; National Research Programm 64 of Swiss National Research
   Foundation
FX The authors thank Bettina Wagner for the help with Chlamydomonas
   reinhardtii cultures; Rene Schonenberger for the help with
   multidimensional protein identification; and David Kistler for the
   inductively coupled plasma-MS analysis. This work was supported in part
   by Eawag and the National Research Programm 64 of Swiss National
   Research Foundation.
CR Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Armstrong N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053186
   Benn TM, 2008, ENVIRON SCI TECHNOL, V42, P4133, DOI 10.1021/es7032718
   Bianchini A, 2003, ENVIRON TOXICOL CHEM, V22, P1361, DOI [10.1897/1551-5028(2003)022<1361:MOASTI>2.0.CO;2, 10.1002/etc.5620220624]
   Bianchini A, 2002, ENVIRON SCI TECHNOL, V36, P1763, DOI 10.1021/es011028t
   Caricato R, 2010, COMP BIOCHEM PHYS C, V152, P241, DOI 10.1016/j.cbpc.2010.04.011
   Cuypers A, 2000, PHYSIOL PLANTARUM, V110, P512, DOI 10.1111/j.1399-3054.2000.1100413.x
   Fischer BB, 2006, PLANTA, V223, P583, DOI 10.1007/s00425-005-0108-9
   Fortin C, 2000, ENVIRON TOXICOL CHEM, V19, P2769, DOI 10.1002/etc.5620191123
   Friedrich T, 1998, BBA-BIOENERGETICS, V1364, P134, DOI 10.1016/S0005-2728(98)00024-3
   Hogstrand C, 1998, ENVIRON TOXICOL CHEM, V17, P547, DOI 10.1002/etc.5620170405
   Jennings P, 2013, ARCH TOXICOL, V87, P13, DOI 10.1007/s00204-012-0974-4
   Kovtun Y, 2000, P NATL ACAD SCI USA, V97, P2940, DOI 10.1073/pnas.97.6.2940
   Le Faucheur S, 2005, ENVIRON TOXICOL CHEM, V24, P1731, DOI 10.1897/04-394R.1
   Lee DY, 2005, AQUAT TOXICOL, V75, P127, DOI 10.1016/j.aquatox.2005.06.011
   Li YT, 2010, METAB ENG, V12, P387, DOI 10.1016/j.ymben.2010.02.002
   Lopez D, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-282
   Marri L, 2009, MOL PLANT, V2, P259, DOI 10.1093/mp/ssn061
   May P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-209
   Mckim SM, 2006, PLANT PHYSIOL BIOCH, V44, P857, DOI 10.1016/j.plaphy.2006.10.018
   Miller R, 2010, PLANT PHYSIOL, V154, P1737, DOI 10.1104/pp.110.165159
   Molen TA, 2006, PHYSIOL PLANTARUM, V127, P74, DOI 10.1111/j.1399-3054.2006.00643.x
   Morgan IJ, 1997, AQUAT TOXICOL, V38, P145, DOI 10.1016/S0166-445X(96)00835-1
   Navarro E, 2008, ENVIRON SCI TECHNOL, V42, P8959, DOI 10.1021/es801785m
   Nestler H, 2012, J PROTEOMICS, V75, P5370, DOI 10.1016/j.jprot.2012.06.017
   Nestler H, 2012, AQUAT TOXICOL, V110, P214, DOI 10.1016/j.aquatox.2012.01.014
   Nishiyama Y, 2004, BIOCHEMISTRY-US, V43, P11321, DOI 10.1021/bi036178q
   Park HJ, 2009, WATER RES, V43, P1027, DOI 10.1016/j.watres.2008.12.002
   Piccapietra F, 2012, ENVIRON SCI TECHNOL, V46, P7390, DOI 10.1021/es300734m
   Purcell TW, 1998, ENVIRON TOXICOL CHEM, V17, P539, DOI 10.1002/etc.5620170404
   Qiu YP, 2009, ENVIRON EXP BOT, V65, P35, DOI 10.1016/j.envexpbot.2008.07.002
   Ratte HT, 1999, ENVIRON TOXICOL CHEM, V18, P89, DOI 10.1002/etc.5620180112
   Sarkar N, 2005, EUKARYOT CELL, V4, P262, DOI 10.1128/EC.4.2.262-273.2005
   Schirmer K, 2010, ANAL BIOANAL CHEM, V397, P917, DOI 10.1007/s00216-010-3662-3
   Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098
   Soldo D, 2005, AQUAT TOXICOL, V71, P307, DOI 10.1016/j.aquatox.2004.11.011
   SOLIOZ M, 1995, J BIOL CHEM, V270, P9217, DOI 10.1074/jbc.270.16.9217
   Stevenson LM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074456
   Sujak A, 2005, ACTA PHYSIOL PLANT, V27, P61, DOI 10.1007/s11738-005-0037-z
   Szivak I, 2009, J PHYCOL, V45, P427, DOI 10.1111/j.1529-8817.2009.00663.x
   Van Aggelen G, 2010, ENVIRON HEALTH PERSP, V118, P1, DOI 10.1289/ehp.0900985
   Veltman K, 2008, ENVIRON SCI TECHNOL, V42, P852, DOI 10.1021/es071331f
   Wang ZT, 2009, EUKARYOT CELL, V8, P1856, DOI 10.1128/EC.00272-09
   Wienkoop S, 2010, MOL BIOSYST, V6, P1018, DOI 10.1039/b920913a
   Xu FF, 2012, APPL ENVIRON MICROB, V78, P3614, DOI 10.1128/AEM.07368-11
   Zhang B, 2006, J PROTEOME RES, V5, P2909, DOI 10.1021/pr0600273
NR 46
TC 93
Z9 96
U1 5
U2 117
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD MAR 4
PY 2014
VL 111
IS 9
BP 3490
EP 3495
DI 10.1073/pnas.1319388111
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AC5KR
UT WOS:000332560300068
PM 24550482
OA Green Published
DA 2019-10-23
ER

PT J
AU Overturf, MD
   Overturf, CL
   Carty, DR
   Hala, D
   Huggett, DB
AF Overturf, Matthew D.
   Overturf, Carmen L.
   Carty, Dennis R.
   Hala, David
   Huggett, Duane B.
TI Levonorgestrel exposure to fathead minnows (Pimephales promelas) alters
   survival, growth, steroidogenic gene expression and hormone production
SO AQUATIC TOXICOLOGY
LA English
DT Article
DE Early-life Stage; Fish; Endocrine; Levonorgestrel
ID ENDOCRINE-DISRUPTING CHEMICALS; TILAPIA OREOCHROMIS-NILOTICUS;
   NONMONOTONIC DOSE-RESPONSES; ADVERSE OUTCOME PATHWAYS; TANDEM
   MASS-SPECTROMETRY; SEWAGE-TREATMENT PLANTS; ZEBRAFISH DANIO-RERIO;
   WASTE-WATER; EMERGENCY CONTRACEPTION; AROMATASE INHIBITOR
AB Human pharmaceuticals are commonly detected in the environment. Concern over these compounds in the environment center around the potential for pharmaceuticals to interfere with the endocrine system of aquatic organisms. The main focus of endocrine disruption research has centered on how estrogenic and androgenic compounds interact with-the endocrine system to elicit reproductive effects. Other classes of compounds, such as progestins, have been overlooked. Recently, studies have investigated the potential for synthetic progestins to impair reproduction and growth in aquatic organisms. The present study utilizes the OECD 210 Early-life Stage (ELS) study to investigate the impacts levonorgestrel (LNG), a synthetic progestin, on fathead minnow (FHM) survival and growth. After 28 days post-hatch, survival of larval FHM was impacted at 462 ng/L, while growth was significantly reduced at 86.9 ng/L. Further analysis was conducted by measuring specific endocrine related mRNA transcript profiles in FHM larvae following the 28 day ELS exposure to LNG. Transcripts of 3 beta-HSD, 20 beta-HSD, CYP17, AR, ER alpha, and FSH were significantly down-regulated following 28 d exposure to 16.3 ng/L LNG, while exposure to 86.9 ng/L significantly down-regulated 3 beta-HSD, 20 beta-HSD, CYP19A, and FSH. At 2392 ng/L of LNG, a significant down-regulation occurred with CYP19A and ER beta transcripts, while mPR alpha and mPR beta profiles were significantly induced. No significant changes occurred in 11 beta-HSD, CYP11A, StAR, LH beta, and VTG mRNA expression following LNG exposure. An ex vivo steroidogenesis assay was conducted with sexually mature female FHM following a 7 day exposure 100 ng/L LNG with significant reductions observed in pregnenolone, 17 alpha,20 beta-dihydroxy-4-pregnen-3-one (17,20-DHP), testosterone, and 11-ketotestosterone. Together these data suggest LNG can negatively impact FHM larval survival and growth, with significant alterations in endocrine related responses. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Overturf, Matthew D.; Overturf, Carmen L.; Carty, Dennis R.; Hala, David; Huggett, Duane B.] Univ N Texas, Dept Biol, Denton, TX 76203 USA.
RP Overturf, MD (reprint author), Univ Ontario, Inst Technol, Fac Sci, 2000 Simcoe St North, Oshawa, ON L1H 7K4, Canada.
EM Matthew.Overturf@uoit.ca
OI Overturf, Matthew/0000-0003-1519-8497
CR Ankley GT, 2007, ENVIRON SCI TECHNOL, V41, P8211, DOI 10.1021/es072658j
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   BECK P, 1977, ANN NY ACAD SCI, V286, P434, DOI 10.1111/j.1749-6632.1977.tb29435.x
   Bellet V, 2012, WATER RES, V46, P1912, DOI 10.1016/j.watres.2012.01.013
   Bhatta S, 2012, P NATL ACAD SCI USA, V109, P11408, DOI 10.1073/pnas.1118704109
   Caldwell DJ, 2008, ENVIRON SCI TECHNOL, V42, P7046, DOI 10.1021/es800633q
   Contardo-Jara V, 2011, ENVIRON POLLUT, V159, P38, DOI 10.1016/j.envpol.2010.09.028
   Corcoran J, 2010, CRIT REV TOXICOL, V40, P287, DOI 10.3109/10408440903373590
   Crockett AB, 2005, NURS CLIN N AM, V40, P33, DOI 10.1016/j.cnur.2004.08.012
   Croxatto HB, 2004, CONTRACEPTION, V70, P442, DOI 10.1016/j.contraception.2004.05.007
   de Alda MJL, 2002, ANALYST, V127, P1299, DOI 10.1039/b207658f
   do Nascimento JAA, 2007, HUM REPROD, V22, P2190, DOI 10.1093/humrep/dem119
   Durand M, 2001, CONTRACEPTION, V64, P227, DOI 10.1016/S0010-7824(01)00250-5
   Ekman DR, 2012, ENVIRON SCI TECHNOL, V46, P9673, DOI 10.1021/es3014634
   Erkkola R, 2005, ACTA OBSTET GYN SCAN, V84, P207, DOI 10.1111/j.0001-6349.2005.00759.x
   Fenske M, 2004, AQUAT TOXICOL, V67, P105, DOI 10.1016/j.aquatox.2003.10.008
   Fick J, 2010, ENVIRON SCI TECHNOL, V44, P2661, DOI 10.1021/es903440m
   Govoroun M, 2001, J EXP ZOOL, V290, P558, DOI 10.1002/jez.1106
   Gross-Sorokin MY, 2006, ENVIRON HEALTH PERSP, V114, P147, DOI 10.1289/ehp.8068
   Guiguen Y, 1999, MOL REPROD DEV, V54, P154, DOI 10.1002/(SICI)1098-2795(199910)54:2<154::AID-MRD7>3.0.CO;2-5
   Gunnarsson L, 2008, ENVIRON SCI TECHNOL, V42, P5807, DOI 10.1021/es8005173
   Hala D, 2011, J CHROMATOGR B, V879, P591, DOI 10.1016/j.jchromb.2011.01.020
   Hala D, 2012, J EXP BIOL, V215, P1753, DOI 10.1242/jeb.066027
   Hoffmann F, 2012, GEN COMP ENDOCR, V176, P385, DOI 10.1016/j.ygcen.2012.02.009
   Huggett DB, 2003, HUM ECOL RISK ASSESS, V9, P1789, DOI 10.1080/10807030390260498
   Kidd KA, 2007, P NATL ACAD SCI USA, V104, P8897, DOI 10.1073/pnas.0609568104
   Kirk LA, 2002, ENVIRON TOXICOL CHEM, V21, P972, DOI 10.1002/etc.5620210511
   Kitano T, 2000, MOL REPROD DEV, V56, P1, DOI 10.1002/(SICI)1098-2795(200005)56:1<1::AID-MRD1>3.0.CO;2-3
   Kobayashi T, 2003, CYTOGENET GENOME RES, V101, P289, DOI 10.1159/000074351
   Kolpin DW, 2002, ENVIRON SCI TECHNOL, V36, P1202, DOI 10.1021/es011055j
   Kramer VJ, 2011, ENVIRON TOXICOL CHEM, V30, P64, DOI 10.1002/etc.375
   Kvarnryd M, 2011, AQUAT TOXICOL, V103, P18, DOI 10.1016/j.aquatox.2011.02.003
   Kwon JY, 2000, J EXP ZOOL, V287, P46, DOI 10.1002/1097-010X(20000615)287:1<46::AID-JEZ6>3.3.CO;2-O
   Lange R, 2001, ENVIRON TOXICOL CHEM, V20, P1216, DOI 10.1002/etc.5620200610
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Lorenz C, 2011, TOXICOL SCI, V124, P311, DOI 10.1093/toxsci/kfr241
   Lorenz C, 2011, TOXICOL SCI, V123, P94, DOI 10.1093/toxsci/kfr159
   Luckenbach JA, 2011, GEN COMP ENDOCR, V171, P52, DOI 10.1016/j.ygcen.2010.12.016
   Marions L, 2004, CONTRACEPTION, V69, P373, DOI 10.1016/j.contraception.2003.11.018
   Marions L, 2002, OBSTET GYNECOL, V100, P65, DOI 10.1016/S0029-7844(02)02006-9
   Miguel-Queralt S, 2008, ENDOCRINOLOGY, V149, P4269, DOI 10.1210/en.2008-0384
   Miura T, 2006, P NATL ACAD SCI USA, V103, P7333, DOI 10.1073/pnas.0508419103
   Nagahama Y, 1997, STEROIDS, V62, P190, DOI 10.1016/S0039-128X(96)00180-8
   National Research Council (NRC), 2007, TOX TEST 25 CENT VIS
   Nelson RE, 2004, CLIN CHEM, V50, P373, DOI 10.1373/clinchem.2003.025478
   OECD, 2011, WORKSH US MECH INF F
   Okewole IA, 2007, CONTRACEPTION, V75, P372, DOI 10.1016/j.contraception.2007.01.019
   Organization for Economic Co-Operation and Development (OECD), 1992, 210 FISH EARL LIF ST
   Overturf MD, 2012, ARCH ENVIRON CON TOX, V62, P455, DOI 10.1007/s00244-011-9723-6
   Paulos P, 2010, AQUAT TOXICOL, V99, P256, DOI 10.1016/j.aquatox.2010.05.001
   Petrovic M, 2002, ENVIRON TOXICOL CHEM, V21, P2146, DOI 10.1002/etc.5620211018
   Petrovic M., 2003, TRENDS ANAL CHEM, V22, P686
   PIFERRER F, 1994, J EXP ZOOL, V270, P255, DOI 10.1002/jez.1402700304
   Rhomberg LR, 2012, REGUL TOXICOL PHARM, V64, P130, DOI 10.1016/j.yrtph.2012.06.015
   Rostkowski P, 2011, ENVIRON SCI TECHNOL, V45, P10660, DOI 10.1021/es202966c
   Runnalls TJ, 2013, ENVIRON SCI TECHNOL, V47, P2077, DOI 10.1021/es3048834
   Safholm M, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.097378
   Santillan R, 2001, EUR J PHARMACOL, V427, P167, DOI 10.1016/S0014-2999(01)01263-8
   SHIRLING D, 1981, J ENDOCRINOL, V90, P285, DOI 10.1677/joe.0.0900285
   Sitruk-Ware R., 2004, MATURITAS, V47, P247
   SORENSEN PW, 1987, J COMP PHYSIOL A, V160, P305, DOI 10.1007/BF00613020
   Stelmanska E, 2012, J STEROID BIOCHEM, V132, P160, DOI 10.1016/j.jsbmb.2012.05.005
   Tokumoto M, 2006, GEN COMP ENDOCR, V145, P101, DOI 10.1016/j.ygcen.2005.07.002
   US EPA, 2002, SHORT TERM METH EST
   Vandenberg LN, 2012, ENDOCR REV, V33, P378, DOI 10.1210/er.2011-1050
   Volz DC, 2011, TOXICOL SCI, V123, P349, DOI 10.1093/toxsci/kfr185
   Vulliet E, 2008, J CHROMATOGR A, V1210, P84, DOI 10.1016/j.chroma.2008.09.034
   Vulliet E, 2007, ANAL BIOANAL CHEM, V387, P2143, DOI 10.1007/s00216-006-1084-z
   Welshons WV, 2003, ENVIRON HEALTH PERSP, V111, P994, DOI 10.1289/ehp.5494
   Yeung WSB, 2002, CONTRACEPTION, V66, P453, DOI 10.1016/S0010-7824(02)00408-0
   Yi KW, 2008, OBESITY, V16, P2393, DOI 10.1038/oby.2008.389
   Zeilinger J, 2009, ENVIRON TOXICOL CHEM, V28, P2663, DOI 10.1897/08-485.1
   Zucchi S, 2012, ENVIRON SCI TECHNOL, V46, P5183, DOI 10.1021/es300231y
NR 73
TC 37
Z9 40
U1 2
U2 76
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-445X
EI 1879-1514
J9 AQUAT TOXICOL
JI Aquat. Toxicol.
PD MAR
PY 2014
VL 148
BP 152
EP 161
DI 10.1016/j.aquatox.2014.01.012
PG 10
WC Marine & Freshwater Biology; Toxicology
SC Marine & Freshwater Biology; Toxicology
GA AD8DH
UT WOS:000333496200017
PM 24503577
DA 2019-10-23
ER

PT J
AU Williams, TD
   Mirbahai, L
   Chipman, JK
AF Williams, Tim D.
   Mirbahai, Leda
   Chipman, J. Kevin
TI The toxicological application of transcriptomics and epigenomics in
   zebrafish and other teleosts
SO BRIEFINGS IN FUNCTIONAL GENOMICS
LA English
DT Article
DE toxico-genomics; zebrafish; transcriptomics; epigenetics; environment;
   toxicology
ID GENE-EXPRESSION CHANGES; ENVIRONMENTAL RISK-ASSESSMENT; STICKLEBACK
   GASTEROSTEUS-ACULEATUS; FLOUNDER PLATICHTHYS-FLESUS; GENOMIC METHYLATION
   LEVELS; ADVERSE OUTCOME PATHWAYS; DANIO-RERIO LIVER; PRONE B6C3F1 MICE;
   DNA METHYLATION; AQUATIC TOXICOLOGY
AB Zebrafish (Danio rerio) is one of a number of teleost fish species frequently employed in toxicology. Toxico-genomics determines global transcriptomic responses to chemical exposures and can predict their effects. It has been applied successfully within aquatic toxicology to assist in chemical testing, determination of mechanisms and environmental monitoring. Moreover, the related field of toxico-epigenomics, that determines chemical-induced changes in DNA methylation, histone modifications and micro-RNA expression, is emerging as a valuable contribution to understanding mechanisms of both adaptive and adverse responses. Zebrafish has proven a useful and convenient model species for both transcriptomic and epigenetic toxicological studies. Despite zebrafish's dominance in other areas of fish biology, alternative fish species are used extensively in toxico-genomics. The main reason for this is that environmental monitoring generally focuses on species native to the region of interest. We are starting to see advances in the integration of high-throughput screening, omics techniques and bioinformatics together with more traditional indicator endpoints that are relevant to regulators. Integration of such approaches with high-throughput testing of zebrafish embryos, leading to the discovery of adverse outcome pathways, promises to make a major contribution to ensuring the safety of chemicals in the environment.
C1 [Chipman, J. Kevin] Int Union Toxicol, Reston, VA 20190 USA.
RP Williams, TD (reprint author), Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England.
EM t.d.williams@bham.ac.uk
OI Williams, Timothy/0000-0002-5857-3851
FU UK Natural Environment Research CouncilNERC Natural Environment Research
   Council; European UnionEuropean Union (EU); Natural Environment Research
   CouncilNERC Natural Environment Research Council [NE/C507710/1,
   NE/C507661/1, NE/C50767X/1, NE/C507702/1, NE/C507688/1]
FX The authors thank the UK Natural Environment Research Council and the
   European Union for funding their primary research relevant to this
   review.
CR Alestrom P, 2006, TRENDS BIOTECHNOL, V24, P15, DOI 10.1016/j.tibtech.2005.11.004
   Alexeyenko A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010465
   Andersen IS, 2013, CURR TOP DEV BIOL, V104, P85, DOI 10.1016/B978-0-12-416027-9.00003-6
   Andreasen EA, 2006, TOXICOL SCI, V92, P254, DOI 10.1093/toxsci/kfj118
   Anelli V, 2009, ZEBRAFISH, V6, P417, DOI 10.1089/zeb.2009.0612
   Aniagu SO, 2008, ENVIRON INT, V34, P310, DOI 10.1016/j.envint.2007.03.009
   Ankley GT, 2006, ENVIRON SCI TECHNOL, V40, P4055, DOI 10.1021/es0630184
   Ankley GT, 2009, AQUAT TOXICOL, V92, P168, DOI 10.1016/j.aquatox.2009.01.013
   Baccarelli A, 2009, CURR OPIN PEDIATR, V21, P243, DOI 10.1097/MOP.0b013e32832925cc
   Bachman AN, 2006, TOXICOL SCI, V91, P393, DOI 10.1093/toxsci/kfj155
   Balagopal V, 2009, CURR OPIN CELL BIOL, V21, P403, DOI 10.1016/j.ceb.2009.03.005
   Bird A, 2011, NAT GENET, V43, P1050, DOI 10.1038/ng.987
   Bliss CI, 1939, ANN APPL BIOL, V26, P585, DOI 10.1111/j.1744-7348.1939.tb06990.x
   Bogdanovic O, 2013, METHODS, V62, P207, DOI 10.1016/j.ymeth.2013.04.011
   Bonasio R, 2010, SCIENCE, V330, P612, DOI 10.1126/science.1191078
   Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365
   Bui A, 2012, AQUAT TOXICOL, V108, P23, DOI 10.1016/j.aquatox.2011.09.025
   Calzolai L, 2007, COMP BIOCHEM PHYS D, V2, P245, DOI 10.1016/j.cbd.2007.04.007
   Carlsson G, 2009, ENVIRON TOXICOL CHEM, V28, P2656, DOI 10.1897/08-524.1
   Carney SA, 2006, MOL PHARMACOL, V70, P549, DOI 10.1124/mol.106.025304
   Celander MC, 2011, AQUAT TOXICOL, V105, P72, DOI 10.1016/j.aquatox.2011.06.002
   Contractor RG, 2004, J TOXICOL ENV HEAL A, V67, P1, DOI 10.1080/15287390490253633
   Cossins AR, 2005, NAT REV GENET, V6, P324, DOI 10.1038/nrg1590
   Costa FF, 2008, GENE, V410, P9, DOI 10.1016/j.gene.2007.12.008
   COVERDALE LE, 2004, CURR GENOMICS, V5, P299
   Craig PM, 2009, PHYSIOL GENOMICS, V40, P23, DOI 10.1152/physiolgenomics.00089.2009
   Crawford DL, 2001, GENOME BIOL, V2
   Davis AP, 2009, NUCLEIC ACIDS RES, V37, pD786, DOI 10.1093/nar/gkn580
   De Wit M, 2008, CHEMOSPHERE, V74, P96, DOI 10.1016/j.chemosphere.2008.09.030
   Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60
   Denslow ND, 2007, MOL BIOSYST, V3, P172, DOI 10.1039/b612802p
   Douglas SE, 2006, OMICS, V10, P474, DOI 10.1089/omi.2006.10.474
   Driessen M, 2013, ARCH TOXICOL, V87, P807, DOI 10.1007/s00204-013-1039-z
   ENDO Y, 1987, J BIOL CHEM, V262, P8128
   Falciani F, 2008, AQUAT TOXICOL, V90, P92, DOI 10.1016/j.aquatox.2008.07.020
   Fang XF, 2013, ENVIRON TOXICOL PHAR, V36, P40, DOI 10.1016/j.etap.2013.02.014
   Feng SH, 2010, P NATL ACAD SCI USA, V107, P8689, DOI 10.1073/pnas.1002720107
   Fent K, 2011, AQUAT TOXICOL, V105, P25, DOI 10.1016/j.aquatox.2011.06.008
   Flicek P, 2013, NUCLEIC ACIDS RES, V41, pD48, DOI 10.1093/nar/gks1236
   Garcia TI, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-474
   Garcia-Reyero N, 2008, J FISH BIOL, V72, P2354, DOI 10.1111/j.1095-8649.2008.01904.x
   Garcia-Reyero N, 2011, ENVIRON TOXICOL CHEM, V30, P265, DOI 10.1002/etc.401
   Goldstone JV, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-643
   Goll MG, 2009, GENETICS, V182, P747, DOI 10.1534/genetics.109.102079
   Goodale BC, 2013, TOXICOL APPL PHARM, V272, P656, DOI 10.1016/j.taap.2013.04.024
   Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176
   Gracey AY, 2001, P NATL ACAD SCI USA, V98, P1993, DOI 10.1073/pnas.98.4.1993
   Greenbaum D, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-117
   Griffitt RJ, 2013, AQUAT TOXICOL, V130, P192, DOI 10.1016/j.aquatox.2013.01.010
   Haider S, 2013, CURR GENOMICS, V14, P91, DOI 10.2174/1389202911314020003
   Hawliczek A, 2012, REPROD TOXICOL, V33, P213, DOI 10.1016/j.reprotox.2011.11.001
   Heinloth AN, 2004, TOXICOL SCI, V80, P193, DOI 10.1093/toxsci/kfh145
   Helenius IT, 2012, J CELL BIOCHEM, V113, P2208, DOI 10.1002/jcb.24120
   Henry TB, 2007, ENVIRON HEALTH PERSP, V115, P1059, DOI 10.1289/ehp.9757
   Herceg Z, 2011, EPIGENETICS-US, V6, P804, DOI 10.4161/epi.6.7.16262
   Hermsen SAB, 2013, TOXICOL APPL PHARM, V272, P161, DOI 10.1016/j.taap.2013.05.037
   Hermsen SAB, 2012, REPROD TOXICOL, V34, P216, DOI 10.1016/j.reprotox.2012.05.093
   Hermsen SAB, 2012, TOXICOL SCI, V127, P303, DOI 10.1093/toxsci/kfs092
   Hermsen SAB, 2011, REPROD TOXICOL, V32, P245, DOI 10.1016/j.reprotox.2011.05.010
   Hinton DE, 2005, MAR POLLUT BULL, V51, P635, DOI 10.1016/j.marpolbul.2005.07.020
   Hoffmann JL, 2006, AQUAT TOXICOL, V79, P233, DOI 10.1016/j.aquatox.2006.06.009
   Hogstrand C, 2002, COMP BIOCHEM PHYS B, V133, P523, DOI 10.1016/S1096-4959(02)00125-2
   Hogstrand C, 2008, BIOCHEM SOC T, V36, P1252, DOI 10.1042/BST0361252
   Holth TF, 2008, AQUAT TOXICOL, V90, P277, DOI 10.1016/j.aquatox.2008.08.020
   Hommen Udo, 2010, Integrated Environmental Assessment and Management, V6, P325, DOI 10.1002/ieam.69
   Hook SE, 2010, J FISH BIOL, V77, P1999, DOI 10.1111/j.1095-8649.2010.02814.x
   Hook SE, 2006, MAR ENVIRON RES, V62, pS151, DOI 10.1016/j.marenvres.2006.04.056
   Howe K, 2013, NATURE, V496, P498, DOI 10.1038/nature12111
   Hoyt PR, 2003, ECOTOXICOLOGY, V12, P469, DOI 10.1023/B:ECTX.0000003032.14044.c8
   Hutchinson TH, 2013, MAR POLLUT BULL, V74, P517, DOI 10.1016/j.marpolbul.2013.06.012
   Iguchi T, 2006, ENVIRON HEALTH PERSP, V114, P101, DOI 10.1289/ehp.8061
   Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045
   Jovanovic B, 2011, ECOTOX ENVIRON SAFE, V74, P1518, DOI 10.1016/j.ecoenv.2011.04.012
   Katsiadaki I, 2010, AQUAT TOXICOL, V97, P174, DOI 10.1016/j.aquatox.2009.07.005
   Kausch U, 2008, ENVIRON TOXICOL, V23, P15, DOI 10.1002/tox.20306
   Kavlock R, 2012, CHEM RES TOXICOL, V25, P1287, DOI 10.1021/tx3000939
   Kily LJM, 2008, J EXP BIOL, V211, P1623, DOI 10.1242/jeb.014399
   Knudsen TB, 2011, BIRTH DEFECTS RES B, V92, P413, DOI 10.1002/bdrb.20315
   Koskinen H, 2004, BIOCHEM BIOPH RES CO, V320, P745, DOI 10.1016/j.bbrc.2004.06.024
   Kosmehl T, 2012, REPROD TOXICOL, V33, P245, DOI 10.1016/j.reprotox.2012.01.005
   Kreiling JA, 2007, J TOXICOL ENV HEAL A, V70, P1005, DOI 10.1080/15287390601171868
   Lam SH, 2006, NAT BIOTECHNOL, V24, P73, DOI 10.1038/nbt1169
   Lam SH, 2006, PHYSIOL GENOMICS, V27, P351, DOI 10.1152/physiolgenomics.00201.2005
   Lam SH, 2013, BBA-GEN SUBJECTS, V1830, P4778, DOI 10.1016/j.bbagen.2013.06.008
   Lam SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028273
   Lam SH, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-41
   Lam SH, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000121
   Larkin P, 2002, COMP BIOCHEM PHYS B, V133, P543, DOI 10.1016/S1096-4959(02)00155-0
   Leaver MJ, 2010, AQUAT TOXICOL, V96, P234, DOI 10.1016/j.aquatox.2009.10.025
   Lee Kyoung-Mu, 2005, Toxicol Appl Pharmacol, V207, P200, DOI 10.1016/j.taap.2005.01.045
   Lee TF, 2010, P NATL ACAD SCI USA, V107, P9027, DOI 10.1073/pnas.1005440107
   Lefebvre KA, 2009, TOXICOL SCI, V107, P65, DOI 10.1093/toxsci/kfn207
   Lempiainen H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018216
   Lettieri T, 2006, ENVIRON HEALTH PERSP, V114, P4, DOI 10.1289/ehp.8194
   Levi L, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-141
   Liu Q, 2013, ECOTOXICOLOGY, V22, P740, DOI 10.1007/s10646-013-1066-9
   Lyche JL, 2011, AQUAT TOXICOL, V102, P197, DOI 10.1016/j.aquatox.2011.01.017
   MacKay AB, 2007, GENOME, V50, P778, DOI 10.1139/G07-055
   Martin CC, 1999, DEV BIOL, V206, P189, DOI 10.1006/dbio.1998.9105
   Martyniuk CJ, 2011, ENVIRON TOXICOL CHEM, V30, P263, DOI 10.1002/etc.428
   Martyniuk CJ, 2007, AQUAT TOXICOL, V84, P38, DOI 10.1016/j.aquatox.2007.05.012
   Mattingly CJ, 2009, ENVIRON HEALTH PERSP, V117, P981, DOI 10.1289/ehp.0900555
   Mattingly CJ, 2001, DEV DYNAM, V222, P645, DOI 10.1002/dvdy.1215
   Mehinto Alvine C., 2012, Frontiers in Genetics, V3, P62, DOI 10.3389/fgene.2012.00062
   Mhanni AA, 2004, DEV GENES EVOL, V214, P412, DOI 10.1007/s00427-004-0418-0
   Mirbahai L, 2014, MUTAT RES-GEN TOX EN, V764, P10, DOI 10.1016/j.mrgentox.2013.10.003
   Mirbahai L, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-3
   Moggs JG, 2004, TOXICOL APPL PHARM, V196, P422, DOI 10.1016/j.taap.2004.01.009
   Mudbhary R, 2011, BIRTH DEFECTS RES C, V93, P194, DOI 10.1002/bdrc.20207
   NRC (National Research Council), 2007, TOX TEST 21 CENT VIS
   OECD, 1981, OECD GUID TEST CHEM, P1
   OECD-DAC, 2013, OECD GUID TEST CHEM, P1, DOI [DOI 10.1787/9789264203709-EN, 10.1787/]
   Olsvik PA, 2007, INT J ENVIRON AN CH, V87, P195, DOI 10.1080/03067310600959164
   Pan Y, 2011, BEHAV BRAIN RES, V216, P66, DOI 10.1016/j.bbr.2010.07.017
   Park JW, 2012, ENVIRON POLLUT, V167, P163, DOI 10.1016/j.envpol.2012.03.039
   Paul S, 2011, MOL CELL TOXICOL, V7, P259, DOI 10.1007/s13273-011-0032-y
   Pei YF, 2009, ACTA BIOCH BIOPH SIN, V41, P1, DOI 10.1093/abbs/gmn001
   Perkins EJ, 2011, ENVIRON TOXICOL CHEM, V30, P22, DOI 10.1002/etc.374
   Peterson RT, 2012, ANNU REV PHARMACOL, V52, P433, DOI 10.1146/annurev-pharmtox-010611-134751
   Phillips JM, 2009, TOXICOL SCI, V109, P193, DOI 10.1093/toxsci/kfp050
   Pomati F, 2007, CHEMOSPHERE, V70, P65, DOI 10.1016/j.chemosphere.2007.07.048
   Prins GS, 2008, ENDOCRINOLOGY, V149, P5919, DOI 10.1210/en.2008-1266
   Probst AV, 2009, NAT REV MOL CELL BIO, V10, P192, DOI 10.1038/nrm2640
   Richter CA, 2011, ENVIRON TOXICOL CHEM, V30, P301, DOI 10.1002/etc.409
   Robbens J, 2007, TRENDS BIOTECHNOL, V25, P460, DOI 10.1016/j.tibtech.2007.08.005
   Ruden Douglas Mark, 2011, Frontiers in Genetics, V2, P12, DOI 10.3389/fgene.2011.00012
   Ruggeri B, 2008, GEN COMP ENDOCR, V158, P138, DOI 10.1016/j.ygcen.2008.05.012
   Santos EM, 2007, AQUAT TOXICOL, V83, P134, DOI 10.1016/j.aquatox.2007.03.019
   Sawle AD, 2010, TOXICOL SCI, V118, P128, DOI 10.1093/toxsci/kfq237
   Schaafsma G, 2009, REGUL TOXICOL PHARM, V53, P70, DOI 10.1016/j.yrtph.2008.11.003
   SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467
   Scholz S, 2008, ENVIRON SCI POLLUT R, V15, P394, DOI 10.1007/s11356-008-0018-z
   SHUGART LR, 1990, ENVIRON TOXICOL CHEM, V9, P205, DOI 10.1002/etc.5620090210
   Sipes NS, 2011, BIRTH DEFECTS RES C, V93, P256, DOI 10.1002/bdrc.20214
   Smirnova Lena, 2012, Exp Suppl, V101, P499, DOI 10.1007/978-3-7643-8340-4_18
   Snape JR, 2004, AQUAT TOXICOL, V67, P143, DOI 10.1016/j.aquatox.2003.11.011
   Snell TW, 2003, ECOTOXICOLOGY, V12, P475, DOI 10.1023/B:ECTX.0000003033.09923.a8
   Soares AR, 2012, TOXICOL SCI, V127, P18, DOI 10.1093/toxsci/kfs068
   Spence R, 2008, BIOL REV, V83, P13, DOI 10.1111/j.1469-185X.2007.00030.x
   Spitsbergen JM, 2012, ILAR J, V53, P114, DOI 10.1093/ilar.53.2.114
   Spitsbergen Jan M., 2003, Toxicologic Pathology, V31, P62, DOI 10.1080/01926230309774
   Steinberg CEW, 2008, SCI TOTAL ENVIRON, V400, P142, DOI 10.1016/j.scitotenv.2008.07.023
   Stromqvist M, 2010, AQUAT TOXICOL, V98, P275, DOI 10.1016/j.aquatox.2010.02.023
   Subramanian A, 2007, BIOINFORMATICS, V23, P3251, DOI 10.1093/bioinformatics/btm369
   Sukardi H, 2012, BBA-GEN SUBJECTS, V1820, P33, DOI 10.1016/j.bbagen.2011.10.009
   Sukardi H, 2010, ZEBRAFISH, V7, P41, DOI 10.1089/zeb.2009.0636
   Tilton FA, 2011, AQUAT TOXICOL, V102, P205, DOI 10.1016/j.aquatox.2011.01.012
   Timme-Laragy AR, 2013, FREE RADICAL BIO MED, V65, P89, DOI 10.1016/j.freeradbiomed.2013.06.011
   Trevino V, 2006, BIOINFORMATICS, V22, P1154, DOI 10.1093/bioinformatics/btl074
   Turner C, 2012, ENVIRON TOXICOL CHEM, V31, P593, DOI 10.1002/etc.1718
   Ung CY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-212
   Usenko CY, 2008, TOXICOL APPL PHARM, V229, P44, DOI 10.1016/j.taap.2007.12.030
   Van Aggelen G, 2010, ENVIRON HEALTH PERSP, V118, P1, DOI 10.1289/ehp.0900985
   Van Boxtel AL, 2008, ENVIRON SCI TECHNOL, V42, P1773, DOI 10.1021/es0720863
   van der Oost R, 2003, ENVIRON TOXICOL PHAR, V13, P57, DOI 10.1016/S1382-6689(02)00126-6
   van der Ven K, 2005, COMP BIOCHEM PHYS B, V141, P408, DOI 10.1016/j.cbpc.2005.05.004
   van der Ven K, 2006, ENVIRON TOXICOL CHEM, V25, P2645, DOI 10.1897/05-495R.1
   Varriale A, 2006, GENE, V385, P111, DOI 10.1016/j.gene.2006.05.031
   Villeneuve DL, 2012, ENVIRON SCI TECHNOL, V46, P51, DOI 10.1021/es201150a
   Villeneuve DL, 2009, ENVIRON TOXICOL CHEM, V28, P1767, DOI 10.1897/08-653.1
   Voelker D, 2007, AQUAT TOXICOL, V81, P355, DOI 10.1016/j.aquatox.2006.12.013
   Wallace K, 2010, TOXICOLOGY, V278, P277, DOI 10.1016/j.tox.2010.05.008
   Wang L, 2013, ENVIRON SCI TECHNOL, V47, P7466, DOI 10.1021/es400615q
   Wang RL, 2008, ENVIRON TOXICOL CHEM, V27, P664, DOI 10.1897/07-192.1
   Wang YQ, 2009, AQUAT TOXICOL, V95, P93, DOI 10.1016/j.aquatox.2009.06.008
   Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484
   Waring JF, 2002, TOXICOLOGY, V181, P537, DOI 10.1016/S0300-483X(02)00477-8
   Weber GJ, 2013, TOXICOL SCI, V132, P458, DOI 10.1093/toxsci/kft017
   Wei LL, 2014, TOXICOL IND HEALTH, V30, P777, DOI 10.1177/0748233712462443
   Welcomme RL, 1988, INT INTRO INL AQ SPE
   Williams TD, 2003, AQUAT TOXICOL, V65, P141, DOI 10.1016/S0166-445X(03)00119-X
   Williams TD, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002126
   Williams TD, 2009, ENVIRON SCI TECHNOL, V43, P6341, DOI 10.1021/es9008689
   Wong RY, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-348
   Xiong KM, 2008, MOL PHARMACOL, V74, P1544, DOI 10.1124/mol.108.050435
   Yang LX, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r227
   Zhang L, 2011, J APPL TOXICOL, V31, P210, DOI 10.1002/jat.1583
   Zheng DL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-553
   Zheng WL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053562
   Zhou XW, 2001, J ENV SCI CHINA, V21, P549
   Zucchi S, 2011, ENVIRON POLLUT, V159, P3086, DOI 10.1016/j.envpol.2011.04.013
NR 181
TC 30
Z9 30
U1 0
U2 62
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 2041-2649
EI 2041-2657
J9 BRIEF FUNCT GENOMICS
JI Brief. Funct. Genomics
PD MAR
PY 2014
VL 13
IS 2
SI SI
BP 157
EP 171
DI 10.1093/bfgp/elt053
PG 15
WC Biotechnology & Applied Microbiology; Genetics & Heredity
SC Biotechnology & Applied Microbiology; Genetics & Heredity
GA AD2EU
UT WOS:000333047300008
PM 24397978
OA Bronze
DA 2019-10-23
ER

PT J
AU Mekenyan, O
   Patlewicz, G
   Kuseva, C
   Popova, I
   Mehmed, A
   Kotov, S
   Zhechev, T
   Pavlov, T
   Temelkov, S
   Roberts, DW
AF Mekenyan, Ovanes
   Patlewicz, Grace
   Kuseva, Chanita
   Popova, Ioanna
   Mehmed, Aycel
   Kotov, Stefan
   Zhechev, Teodor
   Pavlov, Todor
   Temelkov, Stanislav
   Roberts, David W.
TI A Mechanistic Approach to Modeling Respiratory Sensitization
SO CHEMICAL RESEARCH IN TOXICOLOGY
LA English
DT Article
ID APPLICABILITY DOMAIN CLASSIFICATION; PEPTIDE REACTIVITY ASSAY;
   LYMPH-NODE ASSAY; OCCUPATIONAL ASTHMA; SKIN SENSITIZATION; RAT-LIVER;
   SOFT ACIDS; CHEMICAL METABOLISM; HAZARD; ALLERGENS
AB Chemical respiratory sensitization is an important occupational health problem which may lead to severely incapacitated human health, yet there are currently no validated or widely accepted models for identifying and characterizing the potential of a chemical to induce respiratory sensitization. This is in part due to the ongoing uncertainty about the immunological mechanisms through which respiratory sensitization may be acquired. Despite the lack of test method, regulations such as REACH still require an assessment of respiratory sensitization for risk assessment and/or for the purposes of classification and labeling. The REACH guidance describes an integrated evaluation strategy to characterize what information sources could be available to facilitate such an assessment. The components of this include a consideration of well-established structural alerts and existing data (whether it be derived from read-across, (quantitative) structure-activity relationships ((Q)SAR), in vivo studies etc.). There has been some progress in developing SARs as well as a handful of empirical QSARs. More recently, efforts have been focused on exploring whether the reaction chemistry mechanistic domains first characterized for skin sensitization are relevant for respiratory sensitization and to what extent modifications or refinements are needed to rationalize the differences between the two end points as far as their chemistry is concerned. This study has built upon the adverse outcome pathway (AOP) for skin sensitization that was developed and published by the OECD in 2012. We have structured a workflow to characterize the initiating events that are relevant in driving respiratory sensitization. OASIS pipeline technology was used to encode these events as components in a software platform to enable a prediction of respiratory sensitization potential to be made for new untested chemicals. This prediction platform could be useful in the assessment of respiratory sensitization potential or for grouping chemicals for subsequent read-across.
C1 [Mekenyan, Ovanes; Kuseva, Chanita; Popova, Ioanna; Mehmed, Aycel; Kotov, Stefan; Zhechev, Teodor; Pavlov, Todor; Temelkov, Stanislav] Univ Prof As Zlatarov, Lab Math Chem, Burgas, Bulgaria.
   [Patlewicz, Grace] DuPont Haskell Global Ctr Hlth & Environm Sci, Newark, DE 19711 USA.
   [Roberts, David W.] Liverpool John Moores Univ, Sch Pharm & Biomol Sci, Liverpool L3 3AF, Merseyside, England.
RP Patlewicz, G (reprint author), DuPont Haskell Global Ctr Hlth & Environm Sci, 1090 Elkton Rd, Newark, DE 19711 USA.
EM patlewig@hotmail.com
OI Patlewicz, Grace/0000-0003-3863-9689
CR AGIUS RM, 1994, OCCUP MED-OXFORD, V44, P34, DOI 10.1093/occmed/44.1.34
   AGIUS RM, 1991, ANN OCCUP HYG, V35, P129, DOI 10.1093/annhyg/35.2.129
   [Anonymous], 2012, OECD SER TEST ASS, V168
   Aptula AO, 2007, CONTACT DERMATITIS, V56, P54, DOI 10.1111/j.1600-0536.2007.00944.x
   Aptula AO, 2006, CHEM RES TOXICOL, V19, P1097, DOI 10.1021/tx0601004
   Aptula AO, 2009, CHEM RES TOXICOL, V22, P1541, DOI [10.1021/tx9000330, 10.1021/tx9000336]
   AUTRUP H, 1975, CHEM-BIOL INTERACT, V11, P329, DOI 10.1016/0009-2797(75)90002-2
   Basketter DA, 1996, FOOD CHEM TOXICOL, V34, P985, DOI 10.1016/S0278-6915(96)00059-2
   Basketter DA, 2011, REGUL TOXICOL PHARM, V61, P365, DOI 10.1016/j.yrtph.2011.10.001
   Bastow TP, 2003, ORG GEOCHEM, V34, P1103, DOI 10.1016/S0146-6380(03)00067-6
   BLITT CD, 1981, ANESTH ANALG, V60, P129
   Bodin A, 2002, J SURFACTANTS DETERG, V5, P107, DOI 10.1007/s11743-002-0208-y
   Borak J, 2011, CRIT REV TOXICOL, V41, P230, DOI 10.3109/10408444.2010.532768
   Carlson GP, 1995, BIOCHEM MOL BIOL INT, V37, P65
   COHEN GM, 1990, ENVIRON HEALTH PERSP, V85, P31, DOI 10.2307/3430663
   Dearman RJ, 2013, J APPL TOXICOL, V33, P558, DOI 10.1002/jat.1758
   Dimitrov S, 2005, J CHEM INF MODEL, V45, P839, DOI 10.1021/ci0500381
   Dimitrov S, 2011, SAR QSAR ENVIRON RES, V22, P719, DOI 10.1080/1062936X.2011.623322
   Dimitrov SD, 2005, INT J TOXICOL, V24, P189, DOI 10.1080/10915810591000631
   ECHA, 2008, GUID INF REQ CHEM SA
   Enoch SJ, 2012, CHEM RES TOXICOL, V25, P2490, DOI 10.1021/tx3003092
   Enoch SJ, 2010, CHEM RES TOXICOL, V23, P1547, DOI 10.1021/tx100218h
   Enoch SJ, 2009, CHEM RES TOXICOL, V22, P1447, DOI 10.1021/tx9001463
   Gerberick GF, 2007, TOXICOL SCI, V97, P417, DOI 10.1093/toxsci/kfm064
   Gerberick GF, 2009, TOXICOL SCI, V112, P164, DOI 10.1093/toxsci/kfp192
   Gerberick GF, 2004, TOXICOL SCI, V81, P332, DOI 10.1093/toxsci/kfh213
   Goutet M, 2012, TOXICOL APPL PHARM, V260, P95, DOI 10.1016/j.taap.2012.02.009
   Graham C, 1997, REGUL TOXICOL PHARM, V26, P296, DOI 10.1006/rtph.1997.1170
   Guibas GV, 2012, CLIN EXP ALLERGY, V42, P1552, DOI 10.1111/j.1365-2222.2012.03974.x
   HERLINGER E, 1995, J CHEM SOC PERK T 2, P259, DOI 10.1039/p29950000259
   Holsapple MP, 2006, TOXICOL SCI, V91, P4, DOI 10.1093/toxsci/kfj074
   Isola D, 2008, J APPL TOXICOL, V28, P249, DOI 10.1002/jat.1336
   Jarvis J, 2005, OCCUP ENVIRON MED, V62, P243, DOI 10.1136/oem.2004.016402
   Karol MH, 1996, TOXICOL LETT, V86, P187, DOI 10.1016/0378-4274(96)03689-2
   Kimber I, 2007, ATLA-ALTERN LAB ANIM, V35, P243, DOI 10.1177/026119290703500212
   Lalko JF, 2013, TOXICOL IN VITRO, V27, P651, DOI 10.1016/j.tiv.2012.10.016
   Lalko JF, 2013, J IMMUNOTOXICOL, V10, P292, DOI 10.3109/1547691X.2012.725784
   Lalko JF, 2012, TOXICOL SCI, V129, P421, DOI 10.1093/toxsci/kfs205
   Lalko JF, 2011, TOXICOL IN VITRO, V25, P433, DOI 10.1016/j.tiv.2010.11.007
   Lepoittevin J.-P., 2004, DERMATOTOXICOLOGY, P265
   Lepoittevin JP, 2006, CONTACT DERMATITIS, V54, P73, DOI 10.1111/j.0105-1873.2006.00795.x
   LEVINE WG, 1991, DRUG METAB REV, V23, P253, DOI 10.3109/03602539109029761
   LITTERST CL, 1975, DRUG METAB DISPOS, V3, P259
   MANAUTOU JE, 1992, J TOXICOL ENV HEALTH, V35, P7, DOI 10.1080/15287399209531589
   MCCRACKEN NW, 1993, BIOCHEM PHARMACOL, V45, P31, DOI 10.1016/0006-2952(93)90373-5
   Mekenyan O, 2012, SAR QSAR ENVIRON RES, V23, P553, DOI 10.1080/1062936X.2012.679689
   Mekenyan OG, 2004, CURR PHARM DESIGN, V10, P1273, DOI 10.2174/1381612043452596
   Mekenyan OG, 2012, CHEM RES TOXICOL, V25, P277, DOI 10.1021/tx200547s
   MENGER FM, 1968, J AM CHEM SOC, V90, P4387, DOI 10.1021/ja01018a033
   Musso H., 1963, ANGEW CHEM INT EDIT, V2, P723, DOI DOI 10.1002/ANIE.196307231
   Netzeva TI, 2005, ATLA-ALTERN LAB ANIM, V33, P155, DOI 10.1177/026119290503300209
   OECD, 2004, OECD PRINC VAL REG P
   Park M., 2006, 320105002 RIVM
   PATEL JM, 1980, DRUG METAB DISPOS, V8, P305
   Patlewicz G, 2007, REGUL TOXICOL PHARM, V48, P225, DOI 10.1016/j.yrtph.2007.03.003
   PEARSON RG, 1963, J AM CHEM SOC, V85, P3533, DOI 10.1021/ja00905a001
   PEARSON RG, 1968, J CHEM EDUC, V45, P581, DOI 10.1021/ed045p581
   PEARSON RG, 1966, SCIENCE, V151, P172, DOI 10.1126/science.151.3707.172
   PEARSON RG, 1967, J AM CHEM SOC, V89, P1827, DOI 10.1021/ja00984a014
   ROBERTS AE, 1989, DRUG METAB DISPOS, V17, P481
   Roberts D. W., 1997, ALLERGIC CONTACT DER, P81
   Roberts D. W., 2013, J APPL TOXICOL, V33, P1
   Roberts DW, 2007, CHEM RES TOXICOL, V20, P1019, DOI 10.1021/tx700024w
   Roberts DW, 2007, CHEM RES TOXICOL, V20, P44, DOI 10.1021/tx060121y
   Rodford R, 2003, ENVIRON TOXICOL CHEM, V22, P1855, DOI 10.1897/01-438
   SARLO K, 1992, FUND APPL TOXICOL, V18, P107, DOI 10.1016/0272-0590(92)90202-S
   Sastre J, 2003, EUR RESPIR J, V22, P364, DOI 10.1183/09031936.03.00045103
   Seed MJ, 2008, CURR OPIN ALLERGY CL, V8, P103, DOI 10.1097/ACI.0b013e3282f4cadd
   Spracklin DK, 1997, J PHARMACOL EXP THER, V281, P400
   WADA E, 1959, ARCH BIOCHEM BIOPHYS, V79, P124, DOI 10.1016/0003-9861(59)90385-6
   Warne MA, 2009, SAR QSAR ENVIRON RES, V20, P429, DOI 10.1080/10629360903278768
   WASS U, 1990, SCAND J WORK ENV HEA, V16, P208, DOI 10.5271/sjweh.1802
NR 72
TC 18
Z9 19
U1 1
U2 27
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0893-228X
EI 1520-5010
J9 CHEM RES TOXICOL
JI Chem. Res. Toxicol.
PD FEB
PY 2014
VL 27
IS 2
BP 219
EP 239
DI 10.1021/tx400345b
PG 21
WC Chemistry, Medicinal; Chemistry, Multidisciplinary; Toxicology
SC Pharmacology & Pharmacy; Chemistry; Toxicology
GA AB1YY
UT WOS:000331591400009
PM 24422459
DA 2019-10-23
ER

PT J
AU Garcia-Reyero, N
   Escalon, BL
   Prats, E
   Stanley, JK
   Thienpont, B
   Melby, NL
   Baron, E
   Eljarrat, E
   Barcelo, D
   Mestres, J
   Babin, PJ
   Perkins, EJ
   Raldua, D
AF Garcia-Reyero, Natalia
   Escalon, B. Lynn
   Prats, Eva
   Stanley, Jacob K.
   Thienpont, Benedicte
   Melby, Nicolas L.
   Baron, Enrique
   Eljarrat, Ethel
   Barcelo, Damia
   Mestres, Jordi
   Babin, Patrick J.
   Perkins, Edward J.
   Raldua, Demetrio
TI Effects of BDE-209 contaminated sediments on zebrafish development and
   potential implications to human health
SO ENVIRONMENT INTERNATIONAL
LA English
DT Article
DE Zebrafish; BDE-209; Microarrays; Behavior; Neurotoxicity;
   Acetylcholinesterase
ID POLYBROMINATED DIPHENYL ETHERS; ADVERSE OUTCOME PATHWAYS; POU-DOMAIN
   PROTEINS; DECABROMODIPHENYL ETHER; FLAME RETARDANTS;
   CONCEPTUAL-FRAMEWORK; BREAST-MILK; EXPOSURE; FISH; SAMPLES
AB Polybrominated diphenyl ethers are compounds widely used as flame-retardants, which are of increasing environmental concern due to their persistence, and potential adverse effects. This study had two objectives. First we assessed if BDE-209 in sediment was bioavailable and bioaccumulated into zebrafish embryos. Secondly, we assessed the potential impact on human and environmental health of bioavailable BDE-209 using human in vitro cell assays and zebrafish embryos. Zebrafish were exposed from 4 h to 8 days post-fertilization to sediments spiked with 125 mg/kg of BDE-209. Zebrafish larvae accumulated ten fold more BDE-209 than controls in unspiked sediment after 8 days. BDE-209 impacted expression of neurological pathways and altered behavior of larvae, although BDE-209 had no visible affect on thyroid function or motoneuron and neuromast development. Zebrafish data and in silico predictions suggested that BDE-209 would also interact with key human transcription factors and receptors. We therefore tested these predictions using mammalian in vitro assays. BDE-209 activated human aryl hydrocarbon receptor, peroxisome proliferator activating receptors, CF/b-cat, activator protein I, Oct-MLP, and the estrogen receptor-related alpha (ERR alpha) receptor in cell-based assays. BDE-209 also inhibited human acetylcholinesterase activity. The observation that BDE-209 can be bioaccumulated from contaminated sediment highlights the need to consider this as a potential environmental exposure route. Once accumulated, our data also show that BDE-209 has the potential to cause impacts on both human and environmental health. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Garcia-Reyero, Natalia] Mississippi State Univ, Inst Genom Biocomp & Biotechnol, Starkville, MS USA.
   [Escalon, B. Lynn; Stanley, Jacob K.; Melby, Nicolas L.; Perkins, Edward J.] US Army, Engineer Res & Dev Ctr, Environm Lab, Vicksburg, MS USA.
   [Prats, Eva] CID CSIC, Ctr Invest & Desarrollo, Barcelona, Catalonia, Spain.
   [Thienpont, Benedicte; Baron, Enrique; Eljarrat, Ethel; Barcelo, Damia; Raldua, Demetrio] IDAEA CSIC, Dept Environm Chem, Barcelona, Catalonia, Spain.
   [Mestres, Jordi] Univ Pompeu Fabra, IMIM Hosp del Mar, Chemotargets, Barcelona, Catalonia, Spain.
   [Babin, Patrick J.] Univ Bordeaux, Talence, France.
RP Garcia-Reyero, N (reprint author), 3909 Halls Ferry Rd, Vicksburg, MS 39180 USA.
EM nvinas@igbb.msstate.edu
RI Raldua, Demetrio/N-9910-2019; Raldua, Demetrio/K-6661-2014; Gasull,
   Martina/J-4076-2019; Prats, Eva/K-6434-2014; Babin, Patrick/N-8794-2013;
   Mestres, Jordi/B-3673-2009
OI Raldua, Demetrio/0000-0001-5256-1641; Raldua,
   Demetrio/0000-0001-5256-1641; Prats, Eva/0000-0001-7838-2027; Mestres,
   Jordi/0000-0002-5202-4501; Barcelo, Damia/0000-0002-8873-0491; ELJARRAT,
   ETHEL/0000-0002-0814-6579; Babin, Patrick/0000-0002-7411-2297
FU US Army Environmental Quality Research Program [BAA 11-4838]; Spanish
   MICINNMinistry of Science and Innovation, Spain (MICINN)
   [CTM2011-30471-C02-01]
FX This work was partly funded by the US Army Environmental Quality
   Research Program (including BAA 11-4838). Permission for publishing this
   information has been granted by the Chief of Engineers. DR was supported
   by the Spanish MICINN grant CTM2011-30471-C02-01. The monoclonal
   antibodies znp-1, zn-8 antibodies (developed by B. Trevarrow) and SV2
   (developed by K.M. Buckley) were obtained from the Developmental Studies
   Hybridoma Bank developed under the auspices of the NICHD and maintained
   by The University of Iowa, Department of Biology, Iowa City, IA 52242.
CR Allen JG, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-17
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   BARON E, SCI TOTAL ENV, P461
   Bartrons M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041829
   Benedusi V, 2012, J BIOL CHEM, V287, P35899, DOI 10.1074/jbc.M112.366419
   Brown DJ, 2004, CHEMOSPHERE, V55, P1509, DOI 10.1016/j.chemosphere.2003.10.019
   Chao HR, 2011, PEDIATR RES, V70, P596, DOI 10.1203/PDR.0b013e3182320b9b
   Chen D, 2010, ENVIRON INT, V36, P800, DOI 10.1016/j.envint.2010.05.013
   Dam K, 2000, DEV BRAIN RES, V121, P179, DOI 10.1016/S0165-3806(00)00044-4
   de la Cal A, 2003, J CHROMATOGR A, V1021, P165, DOI 10.1016/j.chroma.2003.09.023
   DIRTU AC, 2010, ENV INT, V49
   Eljarrat E, 2007, CHEMOSPHERE, V69, P1278, DOI 10.1016/j.chemosphere.2007.05.052
   Feng MB, 2013, AQUAT TOXICOL, V140, P314, DOI 10.1016/j.aquatox.2013.07.001
   Feng MB, 2013, ECOTOXICOLOGY, V22, P1101, DOI 10.1007/s10646-013-1097-2
   Gascon M, 2012, ENVIRON HEALTH PERSP, V120, P1760, DOI 10.1289/ehp.1205266
   Gentes ML, 2012, ENVIRON SCI TECHNOL, V46, P9735, DOI 10.1021/es302099f
   Goodman JE, 2009, REGUL TOXICOL PHARM, V54, P91, DOI 10.1016/j.yrtph.2009.02.006
   Gregori-Puigjane E, 2006, J CHEM INF MODEL, V46, P1615, DOI 10.1021/ci0600509
   He JH, 2011, ECOTOXICOLOGY, V20, P1813, DOI 10.1007/s10646-011-0720-3
   HENDRIKS HS, TOXICOL LETT, V213
   Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211
   Huang SPC, 2010, TOXICOL SCI, V114, P124, DOI 10.1093/toxsci/kfp296
   Ikonomou MG, 2002, CHEMOSPHERE, V46, P649, DOI 10.1016/S0045-6535(01)00229-6
   IRONS TD, NEUROTOX TERATOL, V32
   Jin J, 2009, ENVIRON INT, V35, P1048, DOI 10.1016/j.envint.2009.05.006
   Johansson N, 2008, NEUROTOXICOLOGY, V29, P911, DOI 10.1016/j.neuro.2008.09.008
   Kuo YM, 2010, ECOTOXICOLOGY, V19, P751, DOI 10.1007/s10646-009-0451-x
   Lee E, 2010, J TOXICOL SCI, V35, P535, DOI 10.2131/jts.35.535
   McEvilly RJ, 2000, PROG NUCLEIC ACID RE, V63, P223, DOI 10.1016/S0079-6603(08)60724-2
   Munoz-Arnanz J, 2011, ENVIRON INT, V37, P572, DOI 10.1016/j.envint.2010.11.013
   Norstrom RJ, 2002, ENVIRON SCI TECHNOL, V36, P4783, DOI 10.1021/es025831e
   Noyes PD, 2013, ENVIRON SCI TECHNOL, V47, P10012, DOI 10.1021/es402650x
   Noyes PD, 2011, TOXICOL SCI, V122, P265, DOI 10.1093/toxsci/kfr105
   Perkins EJ, 2013, ENVIRON HEALTH PERSP, V121, P1002, DOI 10.1289/ehp.1306638
   Raldua D, 2008, CHEMOSPHERE, V73, P56, DOI 10.1016/j.chemosphere.2008.05.037
   Raldua D, 2009, ENVIRON SCI TECHNOL, V43, P6844, DOI 10.1021/es9012454
   Romanov S, 2008, NAT METHODS, V5, P253, DOI 10.1038/NMETH.1186
   Ruckart PZ, 2004, ENVIRON HEALTH PERSP, V112, P46, DOI 10.1289/ehp.6430
   SALVADO JA, ENV POLLUT, V168
   Sellstrom U, 1998, ENVIRON TOXICOL CHEM, V17, P1065, DOI 10.1002/etc.5620170612
   Shi SX, 2013, ENVIRON MONIT ASSESS, V185, P4887, DOI 10.1007/s10661-012-2910-8
   Stapleton HM, 2008, ENVIRON SCI TECHNOL, V42, P3329, DOI 10.1021/es7029625
   Thienpont B, 2011, ENVIRON SCI TECHNOL, V45, P7525, DOI 10.1021/es202248h
   Tingaud-Sequeira A, 2004, GENE EXPR PATTERNS, V4, P561, DOI 10.1016/j.modgep.2004.02.002
   *US EPA OIRISD, 1163195 US EPA OIRIS
   Vidal D, 2011, METHODS MOL BIOL, V672, P489, DOI 10.1007/978-1-60761-839-3_19
   VIZCAINO E, ENV INT, V37
   Volz DC, 2011, TOXICOL SCI, V123, P349, DOI 10.1093/toxsci/kfr185
   Wegner M, 1993, CURR OPIN CELL BIOL, V5, P488, DOI 10.1016/0955-0674(93)90015-I
   Wikoff DS, 2011, HANDB ENVIRON CHEM, V16, P19, DOI 10.1007/698_2010_97
   Wu MH, 2013, ENVIRON SCI POLLUT R, V20, P2651, DOI 10.1007/s11356-012-1163-y
   Zhang CF, 2010, INT J DEV NEUROSCI, V28, P497, DOI 10.1016/j.ijdevneu.2010.06.002
NR 52
TC 24
Z9 25
U1 2
U2 82
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0160-4120
EI 1873-6750
J9 ENVIRON INT
JI Environ. Int.
PD FEB
PY 2014
VL 63
BP 216
EP 223
DI 10.1016/j.envint.2013.11.012
PG 8
WC Environmental Sciences
SC Environmental Sciences & Ecology
GA AA2FG
UT WOS:000330909900026
PM 24317228
DA 2019-10-23
ER

PT J
AU Maxwell, G
   MacKay, C
   Cubberley, R
   Davies, M
   Gellatly, N
   Glavin, S
   Gouin, T
   Jacquoilleot, S
   Moore, C
   Pendlington, R
   Saib, O
   Sheffield, D
   Stark, R
   Summerfield, V
AF Maxwell, Gavin
   MacKay, Cameron
   Cubberley, Richard
   Davies, Michael
   Gellatly, Nichola
   Glavin, Stephen
   Gouin, Todd
   Jacquoilleot, Sandrine
   Moore, Craig
   Pendlington, Ruth
   Saib, Ouarda
   Sheffield, David
   Stark, Richard
   Summerfield, Vicki
TI Applying the skin sensitisation adverse outcome pathway (AOP) to
   quantitative risk assessment
SO TOXICOLOGY IN VITRO
LA English
DT Article
DE Skin sensitisation; Adverse outcome pathway; Risk assessment;
   Mathematical modelling
ID ALLERGIC CONTACT-DERMATITIS; NAIVE T-CELLS; PROLIFERATION; STRATEGY
AB As documented in the recent OECD report the adverse outcome pathway for skin sensitisation initiated by covalent binding to proteins' (OECD, 2012), the chemical and biological events driving the induction of human skin sensitisation have been investigated for many years and are now well understood. Several non-animal test methods have been developed to predict sensitiser potential by measuring the impact of chemical sensitisers on these key events (Adler et al., 2011; Maxwell et al., 2011); however our ability to use these non-animal datasets for risk assessment decision-making (i.e. to establish a safe level of human exposure for a sensitising chemical) remains limited and a more mechanistic approach to data integration is required to address this challenge.
   Informed by our previous efforts to model the induction of skin sensitisation (Maxwell and MacKay, 2008) we are now developing two mathematical models ('total haptenated protein' model and 'CD8(+) T cell response' model) that will be linked to provide predictions of the human CD8(+) T cell response for a defined skin exposure to a sensitising chemical. Mathematical model development is underpinned by focussed clinical or human-relevant research activities designed to inform/challenge model predictions whilst also increasing our fundamental understanding of human skin sensitisation. With this approach, we aim to quantify the relationship between the dose of sensitiser applied to the skin and the extent of the hapten-specific T cell response that would result. Furthermore, by benchmarking our mathematical model predictions against clinical datasets (e.g. human diagnostic patch test data), instead of animal test data, we propose that this approach could represent a new paradigm for mechanistic toxicology. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Maxwell, Gavin; MacKay, Cameron; Cubberley, Richard; Davies, Michael; Gellatly, Nichola; Glavin, Stephen; Gouin, Todd; Jacquoilleot, Sandrine; Moore, Craig; Pendlington, Ruth; Saib, Ouarda; Sheffield, David; Stark, Richard; Summerfield, Vicki] Unilever, Safety & Environm Assurance Ctr SEAC Colworth, Sharnbrook MK44 1LQ, Beds, England.
RP Maxwell, G (reprint author), Unilever, Safety & Environm Assurance Ctr SEAC Colworth, Colworth Sci Pk, Sharnbrook MK44 1LQ, Beds, England.
EM gavin.maxwell@unilever.com
OI Sheffield, David/0000-0002-4592-5248; Gouin, Todd/0000-0003-2854-6032
CR Adler S, 2011, ARCH TOXICOL, V85, P367, DOI 10.1007/s00204-011-0693-2
   Antia R, 2003, J THEOR BIOL, V221, P585, DOI 10.1006/jtbi.2003.3208
   Asquith B, 2007, IMMUNOL CELL BIOL, V85, P280, DOI 10.1038/sj.icb.7100050
   Bauch C, 2012, REGUL TOXICOL PHARM, V63, P489, DOI 10.1016/j.yrtph.2012.05.013
   Chao DL, 2004, J THEOR BIOL, V228, P227, DOI 10.1016/j.jtbi.2003.12.011
   Christensson JB, 2010, CONTACT DERMATITIS, V62, P32, DOI 10.1111/j.1600-0536.2009.01657.x
   Davies M, 2011, TOXICOL SCI, V119, P308, DOI 10.1093/toxsci/kfq326
   Felter SP, 2002, CONTACT DERMATITIS, V47, P257, DOI 10.1034/j.1600-0536.2002.470502.x
   Gibbs S, 2007, CURR DRUG METAB, V8, P758, DOI 10.2174/138920007782798225
   Hagvall L, 2008, TOXICOL APPL PHARM, V233, P308, DOI 10.1016/j.taap.2008.08.014
   Jaworska J, 2011, ALTEX-ALTERN ANIM EX, V28, P211, DOI 10.14573/altex.2011.3.211
   Kaech SM, 2001, NAT IMMUNOL, V2, P415
   Karlberg AT, 2008, CHEM RES TOXICOL, V21, P53, DOI 10.1021/tx7002239
   Kimber I, 2012, TOXICOLOGY, V291, P18, DOI 10.1016/j.tox.2011.11.007
   Magnusson BM, 2004, J INVEST DERMATOL, V122, P993, DOI 10.1111/j.0022-202X.2004.22413.x
   Maxwell G, 2008, ATLA-ALTERN LAB ANIM, V36, P521, DOI 10.1177/026119290803600510
   Maxwell G, 2011, ALTEX-ALTERN ANIM EX, V28, P50, DOI 10.14573/altex.2011.1.050
   MCLEAN AR, 1995, P NATL ACAD SCI USA, V92, P3707, DOI 10.1073/pnas.92.9.3707
   Mitragotri S, 2003, J CONTROL RELEASE, V86, P69, DOI 10.1016/S0168-3659(02)00321-8
   Murray JM, 2003, IMMUNOL CELL BIOL, V81, P487, DOI 10.1046/j.1440-1711.2003.01191.x
   [OECD [OECD] Organization for Economic Cooperation and Development], 2012, OECD SER TEST ASS
   Pease CKS, 2003, CLIN EXP DERMATOL, V28, P177, DOI 10.1046/j.1365-2230.2003.01239.x
   Perelson AS, 1997, REV MOD PHYS, V69, P1219, DOI 10.1103/RevModPhys.69.1219
   POTTS RO, 1992, PHARMACEUT RES, V9, P663, DOI 10.1023/A:1015810312465
   van Eijl S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041721
   Vrisekoop N, 2008, P NATL ACAD SCI USA, V105, P6115, DOI 10.1073/pnas.0709713105
   Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889
NR 27
TC 40
Z9 43
U1 0
U2 22
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0887-2333
J9 TOXICOL IN VITRO
JI Toxicol. Vitro
PD FEB
PY 2014
VL 28
IS 1
SI SI
BP 8
EP 12
DI 10.1016/j.tiv.2013.10.013
PG 5
WC Toxicology
SC Toxicology
GA 285TE
UT WOS:000329417100003
PM 24184331
DA 2019-10-23
ER

PT S
AU Amann, A
   Miekisch, W
   Schubert, J
   Buszewski, B
   Ligor, T
   Jezierski, T
   Pleil, J
   Risby, T
AF Amann, Anton
   Miekisch, Wolfram
   Schubert, Jochen
   Buszewski, Boguslaw
   Ligor, Tomasz
   Jezierski, Tadeusz
   Pleil, Joachim
   Risby, Terence
BE Cooks, RG
   Pemberton, JE
TI Analysis of Exhaled Breath for Disease Detection
SO ANNUAL REVIEW OF ANALYTICAL CHEMISTRY, VOL 7
SE Annual Review of Analytical Chemistry
LA English
DT Article; Book Chapter
DE gas chromatography; proton-transfer-reaction time-of-flight mass
   spectrometry; ion mobility spectrometry; laser spectrometry;
   personalized medicine; human exposome; preclinical effects;
   environmental health
ID VOLATILE ORGANIC-COMPOUNDS; MEDIATED LIPID-PEROXIDATION;
   MASS-SPECTROMETRIC ANALYSIS; ION MOBILITY SPECTROMETRY; CANINE SCENT
   DETECTION; TRAP MICRO-EXTRACTION; HUMAN SKIN EMANATIONS; LUNG-CANCER;
   GAS-CHROMATOGRAPHY; NITRIC-OXIDE
AB Breath analysis is a young field of research with great clinical potential. As a result of this interest, researchers have developed new analytical techniques that permit real-time analysis of exhaled breath with breath-to-breath resolution in addition to the conventional central laboratory methods using gas chromatography-mass spectrometry. Breath tests are based on endogenously produced volatiles, metabolites of ingested precursors, metabolites produced by bacteria in the gut or the airways, or volatiles appearing after environmental exposure. The composition of exhaled breath may contain valuable information for patients presenting with asthma, renal and liver diseases, lung cancer, chronic obstructive pulmonary disease, inflammatory lung disease, or metabolic disorders. In addition, oxidative stress status may be monitored via volatile products of lipid peroxidation. Measurement of enzyme activity provides phenotypic information important in personalized medicine, whereas breath measurements provide insight into perturbations of the human exposome and can be interpreted as preclinical signals of adverse outcome pathways.
C1 [Amann, Anton] Univ Innsbruck, Breath Res Inst, A-6850 Dornbirn, Austria.
   [Amann, Anton] Med Univ Innsbruck, Univ Clin Anesthesia, A-6020 Innsbruck, Austria.
   [Miekisch, Wolfram; Schubert, Jochen] Univ Rostock, Dept Anaesthesiol & Intens Care, D-18057 Rostock, Germany.
   [Buszewski, Boguslaw; Ligor, Tomasz] Nicholas Copernicus Univ, Dept Environm Chem & Bioanalyt, PL-87100 Torun, Poland.
   [Jezierski, Tadeusz] Polish Acad Sci, Inst Genet & Anim Breeding, Dept Anim Behav, PL-05552 Magdalenka, Poland.
   [Pleil, Joachim] US EPA, Natl Exposure Res Lab, Off Res & Dev, Res Triangle Pk, NC 27703 USA.
   [Risby, Terence] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD 21205 USA.
RP Amann, A (reprint author), Univ Innsbruck, Breath Res Inst, A-6850 Dornbirn, Austria.
EM anton.amann@i-med.ac.at; wolfram.miekisch@medizin.uni-rostock.de;
   jochen.schubert@uni-rostock.de; bbusz@chem.uni.torun.pl;
   msd2501@chem.umk.pl; t.jezierski@ighz.pl; pleil.joachim@epa.gov;
   trisby1@jhu.edu
RI Schubert, Jochen/F-4788-2016; Miekisch, Wolfram/I-1300-2019; Buszewski,
   Boguslaw/A-3187-2009; Jezierski, T./F-8614-2010
OI Schubert, Jochen/0000-0002-0956-9506; Jezierski, T./0000-0003-3891-9058;
   Miekisch, Wolfram/0000-0003-1619-0315
CR Adrover R, 2012, DIGEST DIS SCI, V57, P189, DOI 10.1007/s10620-011-1858-9
   Aghdassi E, 2003, AM J GASTROENTEROL, V98, P348, DOI 10.1016/S0002-9270(02)05894-X
   AL-Kateb H, 2013, J BREATH RES, V7, DOI 10.1088/1752-7155/7/3/036004
   ALVING K, 1993, EUR RESPIR J, V6, P1368
   Amann A, 2005, Breath Analysis: for Clinical Diagnosis and ATherapeutic Monitoring, P305, DOI 10.1142/9789812701954_0020
   Amann A, 2010, EUR RESPIR MONOGR, P96, DOI 10.1183/1025448x.00018509
   AMANN A, 2005, BREATH ANAL CLIN DIA
   Amann A, 2013, J BREATH RES, V8
   Amann A, 2013, VOLATILE BIOMARKERS: NON-INVASIVE DIAGNOSIS IN PHYSIOLOGY AND MEDICINE, pXXVII
   Andreoni KA, 1999, FREE RADICAL BIO MED, V26, P439, DOI 10.1016/S0891-5849(98)00220-2
   [Anonymous], 2005, AM J RESP CRIT CARE, V171, P912, DOI 10.1164/rccm.200406-710ST
   Bajtarevic A, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-348
   Baumbach JI, 2005, Breath Analysis: for Clinical Diagnosis and ATherapeutic Monitoring, P53, DOI 10.1142/9789812701954_0004
   Beauchamp J, 2010, J BREATH RES, V4, DOI 10.1088/1752-7155/4/2/026006
   Bernier UR, 1999, ANAL CHEM, V71, P1, DOI 10.1021/ac980990v
   Bernier UR, 2000, ANAL CHEM, V72, P747, DOI 10.1021/ac990963k
   Boshier PR, 2011, ANALYST, V136, P3233, DOI 10.1039/c1an15356k
   Brown RH, 2002, DIS MARKERS EXHALED, V218, P281
   Brown RH, 2009, J BREATH RES, V3, DOI 10.1088/1752-7155/3/1/016003
   Buettner A, 2007, FLAVOUR FRAG J, V22, P465, DOI 10.1002/ffj.1822
   Buszewski B, 2007, BIOMED CHROMATOGR, V21, P553, DOI 10.1002/bmc.835
   Buszewski B, 2012, TRAC-TREND ANAL CHEM, V38, P1, DOI 10.1016/j.trac.2012.03.019
   Chalmers RA, 2006, J INHERIT METAB DIS, V29, P162, DOI 10.1007/s10545-006-0158-6
   Church J, 2001, LANCET, V358, P930, DOI 10.1016/S0140-6736(01)06065-2
   CONKLE JP, 1975, ARCH ENVIRON HEALTH, V30, P290, DOI 10.1080/00039896.1975.10666702
   Cope Keary A, 2002, J Perianesth Nurs, V17, P240, DOI 10.1053/jpan.2002.34167
   Cornu JN, 2011, EUR UROL, V59, P197, DOI 10.1016/j.eururo.2010.10.006
   Corradi M, 2003, AM J RESP CRIT CARE, V167, P1380, DOI 10.1164/rccm.200210-1253OC
   Costello BPJD, 2013, J BREATH RES, V7, DOI 10.1088/1752-7155/7/2/024001
   Costello BD, 2013, VOLATILE BIOMARKERS: NON-INVASIVE DIAGNOSIS IN PHYSIOLOGY AND MEDICINE, P405, DOI 10.1016/B978-0-44-462613-4.00022-2
   DENERIS ES, 1985, J BIOL CHEM, V260, P1382
   Desta Z, 2009, J PHARMACOL EXP THER, V329, P297, DOI 10.1124/jpet.108.147751
   DILLARD CJ, 1977, LIPIDS, V12, P109, DOI 10.1007/BF02532981
   Dryahina K, 2013, RAPID COMMUN MASS SP, V27, P1983, DOI 10.1002/rcm.6660
   DUMELIN EE, 1977, LIPIDS, V12, P894, DOI 10.1007/BF02533308
   Ehmann R, 2012, EUR RESPIR J, V39, P669, DOI 10.1183/09031936.00051711
   Eisenmann A, 2008, J BREATH RES, V2, DOI 10.1088/1752-7155/2/4/046002
   Endre ZH, 2011, PHYSIOL MEAS, V32, P115, DOI 10.1088/0967-3334/32/1/008
   Erhart S, 2009, J BREATH RES, V3, DOI 10.1088/1752-7155/3/1/016004
   Ezzeldin HH, 2009, J BREATH RES, V3, DOI 10.1088/1752-7155/3/4/047002
   FARHI LE, 1967, RESP PHYSIOL, V3, P1, DOI 10.1016/0034-5687(67)90018-7
   Filipiak W, 2012, J BREATH RES, V6, DOI 10.1088/1752-7155/6/3/036008
   Filipiak W, 2014, J BREATH RES, V8, DOI 10.1088/1752-7155/8/2/027111
   Filipiak W, 2013, VOLATILE BIOMARKERS: NON-INVASIVE DIAGNOSIS IN PHYSIOLOGY AND MEDICINE, P463, DOI 10.1016/B978-0-44-462613-4.00023-4
   Filipiak W, 2012, MICROBIOL-SGM, V158, P3044, DOI 10.1099/mic.0.062687-0
   Filipiak W, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-113
   Filipiak W, 2010, CANCER EPIDEM BIOMAR, V19, P182, DOI 10.1158/1055-9965.EPI-09-0162
   Filipiak W, 2008, CANCER CELL INT, V8, DOI 10.1186/1475-2867-8-17
   Filser JG, 1996, TOXICOLOGY, V113, P278, DOI 10.1016/0300-483X(96)03457-9
   Foster WM, 1996, J APPL PHYSIOL, V80, P706
   Fuchs D, 2012, J BREATH RES, V6, DOI 10.1088/1752-7155/6/2/027101
   Fuchs P, 2010, INT J CANCER, V126, P2663, DOI 10.1002/ijc.24970
   Furton KG, 2001, TALANTA, V54, P487, DOI 10.1016/S0039-9140(00)00546-4
   Gallagher M, 2008, BRIT J DERMATOL, V159, P780, DOI 10.1111/j.1365-2133.2008.08748.x
   GELMONT D, 1981, BIOCHEM BIOPH RES CO, V99, P1456, DOI 10.1016/0006-291X(81)90782-8
   George SC, 2004, J APPL PHYSIOL, V96, P831, DOI 10.1152/japplphysiol.00950.2003
   Giannini EG, 2005, CLIN GASTROENTEROL H, V3, P279, DOI 10.1016/S1542-3565(04)00720-7
   Gilchrist FJ, 2013, J BREATH RES, V7, DOI 10.1088/1752-7155/7/2/026010
   Gordon RT, 2008, J ALTERN COMPLEM MED, V14, P61, DOI 10.1089/acm.2006.6408
   Gorham KA, 2009, BIOMARKERS, V14, P17, DOI 10.1080/13547500902730680
   Grabowska-Polanowska B, 2013, J CHROMATOGR A, V1301, P179, DOI 10.1016/j.chroma.2013.05.012
   Grossherr M, 2009, BRIT J ANAESTH, V102, P608, DOI 10.1093/bja/aep053
   Haick H, 2014, CHEM SOC REV, V43, P1423, DOI 10.1039/c3cs60329f
   Hakim M, 2012, CHEM REV, V112, P5949, DOI 10.1021/cr300174a
   Harren FJM, 1999, APPL PHYS LETT, V74, P1761, DOI 10.1063/1.123680
   Harrison GR, 2003, BRIT J ANAESTH, V91, P797, DOI 10.1093/bja/aeg271
   HENDERSON MJ, 1952, DIABETES, V1, P188, DOI 10.2337/diab.1.3.188
   Hogman M, 1997, ACTA PHYSIOL SCAND, V159, P345, DOI 10.1046/j.1365-201X.1997.00101.x
   Hogman M, 2012, J BREATH RES, V6, DOI 10.1088/1752-7155/6/4/047103
   HOLT DW, 1994, J HEART LUNG TRANSPL, V13, P1147
   Horvath G, 2008, INTEGR CANCER THER, V7, P76, DOI 10.1177/1534735408319058
   Ingelman-Sundberg M, 2001, MUTAT RES-FUND MOL M, V482, P11, DOI 10.1016/S0027-5107(01)00205-6
   JANSSON BO, 1969, J LAB CLIN MED, V74, P961
   Kamysek S, 2011, ANAL BIOANAL CHEM, V401, P2093, DOI 10.1007/s00216-011-5099-8
   KAZUI M, 1992, FREE RADICAL BIO MED, V13, P509, DOI 10.1016/0891-5849(92)90145-7
   KAZUI M, 1994, J VASC SURG, V19, P473, DOI 10.1016/S0741-5214(94)70074-5
   Kharitonov S, 1997, EUR RESPIR J, V10, P1683, DOI 10.1183/09031936.97.10071683
   Kim D, 2007, TOXICOL LETT, V169, P222, DOI 10.1016/j.toxlet.2007.01.008
   Kim SR, 2007, ENVIRON SCI TECHNOL, V41, P1662, DOI 10.1021/es062362y
   King J, 2012, BIOCHEM BIOPH RES CO, V423, P526, DOI 10.1016/j.bbrc.2012.05.159
   King J, 2012, J BREATH RES, V6, DOI 10.1088/1752-7155/6/1/016005
   King J, 2010, PHYSIOL MEAS, V31, P1169, DOI 10.1088/0967-3334/31/9/008
   King J, 2009, J BREATH RES, V3, DOI 10.1088/1752-7155/3/2/027006
   King J, 2013, VOLATILE BIOMARKERS: NON-INVASIVE DIAGNOSIS IN PHYSIOLOGY AND MEDICINE, P27, DOI 10.1016/B978-0-44-462613-4.00003-9
   King J, 2012, PHYSIOL MEAS, V33, P413, DOI 10.1088/0967-3334/33/3/413
   King J, 2010, J THEOR BIOL, V267, P626, DOI 10.1016/j.jtbi.2010.09.028
   Kischkel S, 2012, EUR RESPIR J, V40, P706, DOI 10.1183/09031936.00125411
   Kneepkens C. M., 1994, BIOL MED, V17, P127, DOI DOI 10.1016/0891-5849(94)90110-4
   KNEEPKENS CMF, 1992, CLIN INVEST MED, V15, P163
   Koc H, 2011, J BREATH RES, V5, DOI 10.1088/1752-7155/5/3/037102
   KOHLMULLER D, 1993, ANAL BIOCHEM, V210, P268, DOI 10.1006/abio.1993.1195
   Lalazar G, 2009, WORLD J GASTROENTERO, V15, P966, DOI 10.3748/wjg.15.966
   LARSSON BT, 1965, ACTA CHEM SCAND, V19, P159, DOI 10.3891/acta.chem.scand.19-0159
   LAWRENCE GD, 1982, ANAL BIOCHEM, V122, P283, DOI 10.1016/0003-2697(82)90282-2
   LAWRENCE GD, 1984, METHOD ENZYMOL, V105, P305
   LIEBERMAN M, 1964, NATURE, V204, P343, DOI 10.1038/204343a0
   LIEBERMAN M, 1966, SCIENCE, V152, P213, DOI 10.1126/science.152.3719.213
   Lindstrom AB, 1997, ENVIRON HEALTH PERSP, V105, P636
   Liu SM, 1999, J CHROMATOGR B, V728, P193, DOI 10.1016/S0378-4347(99)00109-7
   LOCHNER A, 1986, J CHROMATOGR, V378, P267, DOI 10.1016/S0378-4347(00)80724-0
   Lorenzo N, 2003, ANAL BIOANAL CHEM, V376, P1212, DOI 10.1007/s00216-003-2018-7
   MANOLIS A, 1983, CLIN CHEM, V29, P5
   Marczin N, 2002, DIS MARKERS EXHALED
   McCulloch M, 2006, INTEGR CANCER THER, V5, P30, DOI 10.1177/1534735405285096
   MCKEE HC, 1962, PUBLIC HEALTH REP, V77, P553, DOI 10.2307/4591551
   MEIGH DF, 1962, NATURE, V196, P345, DOI 10.1038/196345a0
   MENDIS S, 1995, FREE RADICAL BIO MED, V19, P679, DOI 10.1016/0891-5849(95)00053-Z
   Miekisch W, 2004, CLIN CHIM ACTA, V347, P25, DOI 10.1016/j.cccn.2004.04.023
   Miekisch W, 2001, CLIN CHEM, V47, P1053
   Miekisch W, 2008, CLIN CHIM ACTA, V395, P32, DOI 10.1016/j.cca.2008.04.021
   Miekisch W, 2012, J BREATH RES, V6, DOI 10.1088/1752-7155/6/3/036007
   Miekisch W, 2010, IEEE SENS J, V10, P211, DOI 10.1109/JSEN.2009.2035757
   Miekisch W, 2008, J BREATH RES, V2, DOI 10.1088/1752-7155/2/2/026007
   Mieth M, 2010, ANAL CHEM, V82, P2541, DOI 10.1021/ac100061k
   Mieth M, 2009, ANAL CHEM, V81, P5851, DOI 10.1021/ac9009269
   Mochalski P, 2013, ANALYST, V138, P2134, DOI 10.1039/c3an36756h
   Mochalski P, 2014, ANAL CHEM, V86, P3915, DOI 10.1021/ac404242q
   Mochalski P, 2013, J BREATH RES, V7, DOI 10.1088/1752-7155/7/2/026002
   Mochalski P, 2012, TOXICOL MECH METHOD, V22, P502, DOI 10.3109/15376516.2012.682664
   Mochalski P, 2012, INT J TOXICOL, V31, P267, DOI 10.1177/1091581812442689
   Mochalski P, 2011, J BREATH RES, V5, DOI 10.1088/1752-7155/5/4/046010
   Modak A, 2009, J BREATH RES, V3, DOI 10.1088/1752-7155/3/4/040201
   Modak AS, 2013, VOLATILE BIOMARKERS: NON-INVASIVE DIAGNOSIS IN PHYSIOLOGY AND MEDICINE, P245, DOI 10.1016/B978-0-44-462613-4.00014-3
   Mueller J, 1898, ARCH EXP PATHOL PH, V40, P315
   Olopade CO, 1997, CHEST, V111, P1500, DOI 10.1378/chest.111.6.1500
   Olopade CO, 1997, CHEST, V111, P862, DOI 10.1378/chest.111.4.862
   Opdam FL, 2013, CLIN PHARMACOKINET, V52, P919, DOI 10.1007/s40262-013-0099-9
   Ozsoylu S, 1996, J PEDIATR-US, V129, P485, DOI 10.1016/S0022-3476(96)70106-3
   Pabst F, 2007, J CARDIOTHORAC SURG, V2, DOI 10.1186/1749-8090-2-37
   Parameswaran KR, 2009, APPL OPTICS, V48, pB73, DOI 10.1364/AO.48.000B73
   Paredi P, 2000, AM J RESP CRIT CARE, V162, P1450, DOI 10.1164/ajrccm.162.4.2003064
   Paredi P, 2000, AM J RESP CRIT CARE, V162, P369, DOI 10.1164/ajrccm.162.2.9909025
   Paredi P, 2002, AM J RESP CRIT CARE, V166, pS31, DOI 10.1164/rccm.2206012
   Patterson CS, 2007, J BREATH RES, V1, DOI 10.1088/1752-7155/1/2/026005
   Peng G, 2009, NAT NANOTECHNOL, V4, P669, DOI 10.1038/nnano.2009.235
   Phillips M, 1999, LANCET, V353, P1930, DOI 10.1016/S0140-6736(98)07552-7
   Phillips M, 1999, J CHROMATOGR B, V729, P75, DOI 10.1016/S0378-4347(99)00127-9
   PHILLIPS M, 1992, SCI AM, V267, P74, DOI 10.1038/scientificamerican0792-74
   Phillips M, 2004, AM J CARDIOL, V94, P1593, DOI 10.1016/j.amjcard.2004.08.052
   Phillips M, 2003, CHEST, V123, P2115, DOI 10.1378/chest.123.6.2115
   Phillips M, 2008, CLIN CHIM ACTA, V393, P76, DOI 10.1016/j.cca.2008.02.021
   Phillips Michael, 2007, Cancer Biomarkers, V3, P95
   Pickel D, 2004, APPL ANIM BEHAV SCI, V89, P107, DOI 10.1016/j.applanim.2004.04.008
   Pike K, 2013, CLIN RESPIR J, V7, P204, DOI 10.1111/j.1752-699X.2012.00306.x
   Pleil JD, 2007, BIOMARKERS, V12, P331, DOI 10.1080/13547500701246334
   Pleil JD, 1997, CLIN CHEM, V43, P723
   Pleil JD, 2000, ENVIRON HEALTH PERSP, V108, P183, DOI 10.2307/3454432
   Pleil JD, 1998, RISK ANAL, V18, P585, DOI 10.1111/j.1539-6924.1998.tb00372.x
   Pleil JD, 2008, J TOXICOL ENV HEAL B, V11, P613, DOI 10.1080/10937400701724329
   Pleil JD, 2013, ANAL CHEM, V85, P9984, DOI 10.1021/ac402306f
   Pleil JD, 2013, J BREATH RES, V7, DOI 10.1088/1752-7155/7/1/017107
   Pleil JD, 2011, J BREATH RES, V5, DOI 10.1088/1752-7155/5/4/046005
   Pleil JD, 2011, J BREATH RES, V5, DOI 10.1088/1752-7155/5/3/037104
   Poli D, 2010, J CHROMATOGR B, V878, P2643, DOI 10.1016/j.jchromb.2010.01.022
   POUNDER RE, 1995, ALIMENT PHARM THERAP, V9, P33
   RIELY CA, 1974, SCIENCE, V183, P208, DOI 10.1126/science.183.4121.208
   Risby TH, 2010, OPT ENG, V49, DOI 10.1117/1.3498768
   Risby TH, 2002, NATO SCI SER I LIFE, V346, P113
   RISBY TH, 1994, SURGERY, V115, P94
   Risby TH, 1999, J APPL PHYSIOL, V86, P617
   Risby TH, 1999, FREE RADICAL BIO MED, V27, P1182, DOI 10.1016/S0891-5849(99)00212-9
   ROOTH G, 1966, LANCET, V2, P1102, DOI 10.1016/S0140-6736(66)92194-5
   Ruzsanyi V, 2005, J CHROMATOGR A, V1084, P145, DOI 10.1016/j.chroma.2005.01.055
   Ruzsanyi V, 2013, J CHROMATOGR A, V1316, P112, DOI 10.1016/j.chroma.2013.09.072
   Ruzsanyi V, 2012, J CHROMATOGR B, V911, P84, DOI 10.1016/j.jchromb.2012.10.028
   SAGAI M, 1980, LIFE SCI, V27, P731, DOI 10.1016/0024-3205(80)90326-4
   Scholpp J, 2002, CLIN CHEM LAB MED, V40, P587, DOI 10.1515/CCLM.2002.101
   Schubert J K, 1999, Technol Health Care, V7, P29
   Schubert JK, 2005, BIOMARKERS, V10, P138, DOI 10.1080/13547500500050259
   Schubert JK, 2004, EXPERT REV MOL DIAGN, V4, P619, DOI 10.1586/14737159.4.5.619
   Schubert JK, 2001, J APPL PHYSIOL, V90, P486
   Schubert JK, 1998, INTENS CARE MED, V24, P415, DOI 10.1007/s001340050589
   Schubert R, 2012, METABOLOMICS, V8, P1069, DOI 10.1007/s11306-012-0408-6
   Schwoebel H, 2011, ANAL BIOANAL CHEM, V401, P2079, DOI 10.1007/s00216-011-5173-2
   Sehnert SS, 2002, BIOMARKERS, V7, P174, DOI 10.1080/13547500110118184
   Selgrad M, 2008, CURR OPIN PHARMACOL, V8, P593, DOI 10.1016/j.coph.2008.04.010
   Shorter JH, 2011, J BREATH RES, V5, DOI 10.1088/1752-7155/5/3/037108
   Silkoff PE, 1997, AM J RESP CRIT CARE, V155, P260, DOI 10.1164/ajrccm.155.1.9001322
   SIMENHOFF ML, 1977, NEW ENGL J MED, V297, P132, DOI 10.1056/NEJM197707212970303
   Simpson Jodie L, 2008, Expert Opin Med Diagn, V2, P607, DOI 10.1517/17530059.2.6.607
   SOBOTKA PA, 1994, J HEART LUNG TRANSPL, V13, P224
   Soini HA, 2010, J CHEM ECOL, V36, P1035, DOI 10.1007/s10886-010-9846-7
   Solga SF, 2013, VOLATILE BIOMARKERS: NON-INVASIVE DIAGNOSIS IN PHYSIOLOGY AND MEDICINE, P19, DOI 10.1016/B978-0-44-462613-4.00002-7
   Sonoda H, 2011, GUT, V60, P814, DOI 10.1136/gut.2010.218305
   Spanel P, 2007, EUR J MASS SPECTROM, V13, P77, DOI 10.1255/ejms.843
   Spanel P, 2000, J AM SOC MASS SPECTR, V11, P866, DOI 10.1016/S1044-0305(00)00157-4
   Sponring A, 2010, CANCER BIOMARK, V7, P153, DOI 10.3233/CBM-2010-0182
   Sponring A, 2009, ANTICANCER RES, V29, P419
   Studer SM, 2001, J HEART LUNG TRANSPL, V20, P1158, DOI 10.1016/S1053-2498(01)00343-6
   Taucher J, 1997, RAPID COMMUN MASS SP, V11, P1230
   TERANISHI R, 1972, ANAL CHEM, V44, P18, DOI 10.1021/ac60309a012
   Thelen S, 2008, ANAL CHEM, V80, P2768, DOI 10.1021/ac702282q
   Tomikawa Morimitsu, 2013, World Allergy Organ J, V6 Suppl 1, pP5, DOI 10.1186/1939-4551-6-S1-P5
   Trefz P, 2013, ANAL CHEM, V85, P10321, DOI 10.1021/ac402298v
   Trefz P, 2013, ANAL BIOANAL CHEM, V405, P3105, DOI 10.1007/s00216-013-6781-9
   Trefz P, 2012, J CHROMATOGR A, V1219, P29, DOI 10.1016/j.chroma.2011.10.077
   Tu RH, 2004, AVIAT SPACE ENVIR MD, V75, P49
   Van Berkel JJBN, 2010, RESP MED, V104, P557, DOI 10.1016/j.rmed.2009.10.018
   van de Kant KDG, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-117
   VANGOSSUM A, 1989, EUR RESPIR J, V2, P787
   Vul E, 2009, PERSPECT PSYCHOL SCI, V4, P274, DOI 10.1111/j.1745-6924.2009.01125.x
   Wagenstaller M, 2013, METABOLOMICS, V9, P9, DOI 10.1007/s11306-012-0425-5
   Wehinger A, 2007, INT J MASS SPECTROM, V265, P49, DOI 10.1016/j.ijms.2007.05.012
   Westhoff M, 2005, CHEST, V128, p155S, DOI 10.1378/chest.128.4_MeetingAbstracts.155S-a
   WILLIAMS H, 1989, LANCET, V1, P734
   Willis CM, 2004, BRIT MED J, V329, P712, DOI 10.1136/bmj.329.7468.712
   Wzorek B, 2010, J BREATH RES, V4, DOI 10.1088/1752-7155/4/2/026002
   Xu ZQ, 2013, BRIT J CANCER, V108, P941, DOI 10.1038/bjc.2013.44
   Xue RY, 2008, RAPID COMMUN MASS SP, V22, P1181, DOI 10.1002/rcm.3466
   Zhu JJ, 2013, J BREATH RES, V7, DOI 10.1088/1752-7155/7/3/037106
   Zschocke J, 1999, LANCET, V354, P834
NR 211
TC 69
Z9 69
U1 1
U2 91
PU ANNUAL REVIEWS
PI PALO ALTO
PA 4139 EL CAMINO WAY, PO BOX 10139, PALO ALTO, CA 94303-0897 USA
SN 1936-1327
BN 978-0-8243-4407-8
J9 ANNU REV ANAL CHEM
JI Annu. Rev. Anal. Chem.
PY 2014
VL 7
BP 455
EP 482
DI 10.1146/annurev-anchem-071213-020043
D2 10.1146/annurev-anchem-062012-092557
PG 28
WC Chemistry, Analytical
SC Chemistry
GA BB9KY
UT WOS:000348429100021
PM 25014347
DA 2019-10-23
ER

PT J
AU Willett, C
   Rae, JC
   Goyak, KO
   Minsavage, G
   Westmoreland, C
   Andersen, M
   Avigan, M
   Duche, D
   Harris, G
   Hartung, T
   Jaeschke, H
   Kleensang, A
   Landesmann, B
   Martos, S
   Matevia, M
   Toole, C
   Rowan, A
   Schultz, T
   Seed, J
   Senior, J
   Shah, I
   Subramanian, K
   Vinken, M
   Watkins, P
AF Willett, Catherine
   Rae, Jessica Caverly
   Goyak, Katy O.
   Minsavage, Gary
   Westmoreland, Carl
   Andersen, Melvin
   Avigan, Mark
   Duche, Daniel
   Harris, Georgina
   Hartung, Thomas
   Jaeschke, Hartmut
   Kleensang, Andre
   Landesmann, Brigitte
   Martos, Suzanne
   Matevia, Marilyn
   Toole, Colleen
   Rowan, Andrew
   Schultz, Terry
   Seed, Jennifer
   Senior, John
   Shah, Imran
   Subramanian, Kalyanasundaram
   Vinken, Mathieu
   Watkins, Paul
TI Building Shared Experience to Advance Practical Application of
   Pathway-Based Toxicology: Liver Toxicity Mode-of-Action
SO ALTEX-ALTERNATIVES TO ANIMAL EXPERIMENTATION
LA English
DT Article
DE systems toxicology; pathways of toxicity; adverse outcome pathways; in
   vitro toxicology; liver toxicity
ID ADVERSE OUTCOME PATHWAY; IPCS FRAMEWORK; 21ST-CENTURY; VISION;
   INHIBITION; MECHANISMS; RELEVANCE; FIBROSIS; THOUGHT; FOOD
AB A workshop sponsored by the Human Toxicology Project Consortium (HTPC), "Building Shared Experience to Advance Practical Application of Pathway-Based Toxicology: Liver Toxicity Mode-of-Action" brought together experts from a wide range of perspectives to inform the process of pathway development and to advance two prototype pathways initially developed by the European Commission Joint Research Center (JRC): liver-specific fibrosis and steatosis. The first half of the workshop focused on the theory and practice of pathway development; the second on liver disease and the two prototype pathways. Participants agreed pathway development is extremely useful for organizing information and found that focusing the theoretical discussion on a specific AOP is helpful. It is important to include several perspectives during pathway development, including information specialists, pathologists, human health and environmental risk assessors, and chemical and product manufacturers, to ensure the biology is well captured and end use is considered.
C1 [Willett, Catherine; Matevia, Marilyn; Rowan, Andrew] Humane Soc United States, Washington, DC 20037 USA.
   [Rae, Jessica Caverly] DuPont Haskell Global Ctr Hlth & Environm Sci, Newark, DE USA.
   [Goyak, Katy O.; Minsavage, Gary] ExxonMobil Biomed Sci Inc, Annandale, NJ USA.
   [Westmoreland, Carl] Unilever Res Labs, Safety & Environm Assurance Ctr, Sharnbrook, Beds, England.
   [Andersen, Melvin] Hamner Inst Hlth Sci, Res Triangle Pk, NC USA.
   [Avigan, Mark; Senior, John] Ctr Drug Evaluat & Res Food & Drug Adm, Silver Spring, MD USA.
   [Duche, Daniel] LOreal Res & Innovat, Aulnay Sous Bois, France.
   [Harris, Georgina; Hartung, Thomas; Kleensang, Andre; Martos, Suzanne] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, CAAT, Baltimore, MD USA.
   [Harris, Georgina; Hartung, Thomas; Kleensang, Andre; Martos, Suzanne] Univ Konstanz, CAAT Europe, Constance, Germany.
   [Jaeschke, Hartmut] Univ Kansas, Med Ctr, Kansas City, KS 66103 USA.
   [Landesmann, Brigitte] European Commiss, Inst Hlth & Consumer Protect, Joint Res Ctr, Ispra, Italy.
   [Toole, Colleen] CeeTox Inc, Kalamazoo, MI USA.
   [Schultz, Terry] Univ Tennessee, Knoxville, TN USA.
   [Schultz, Terry] OECD Secretariat, Paris, France.
   [Seed, Jennifer] Environm Protect Agcy, Off Pollut Prevent & Tox, Risk Assessment Div, Washington, DC USA.
   [Shah, Imran] Environm Protect Agcy, Natl Ctr Computat Toxicol, Res Triangle Pk, NC USA.
   [Subramanian, Kalyanasundaram] Strand Life Sci, Bangalore, Karnataka, India.
   [Vinken, Mathieu] Vrije Univ Brussel, Brussels, Belgium.
   [Watkins, Paul] Hamner Inst Hlth Sci, Res Triangle Pk, NC USA.
   [Watkins, Paul] Univ N Carolina, Inst Drug Safety Sci, Chapel Hill, NC USA.
RP Willett, C (reprint author), Humane Soc United States, 2100 L St NW, Washington, DC 20037 USA.
EM kwillett@humanesociety.org
RI Shah, Syed I/B-8275-2011; Vinken, Mathieu/H-7513-2013
OI Vinken, Mathieu/0000-0001-5115-8893; VUB, IVTD/0000-0002-5016-4789;
   Shah, Imran/0000-0003-0808-0140; Kleensang, Andre/0000-0002-4564-7399;
   Andersen, Melvin/0000-0002-3894-4811
FU NIEHS NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Environmental
   Health Sciences (NIEHS) [T32 ES007141]
CR Andersen ME, 2013, ARCH TOXICOL, V87, P7, DOI 10.1007/s00204-012-0980-6
   Andersen ME, 2011, ALTEX-ALTERN ANIM EX, V28, P175, DOI 10.14573/altex.2011.3.175
   Andersen ME, 2010, TOXICOL SCI, V117, P17, DOI 10.1093/toxsci/kfq188
   Bhattacharya S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020887
   Boobis AR, 2008, CRIT REV TOXICOL, V38, P87, DOI 10.1080/10408440701749421
   Boobis AR, 2006, CRIT REV TOXICOL, V36, P781, DOI 10.1080/10408440600977677
   Bottini AA, 2009, ALTEX-ALTERN TIEREXP, V26, P3
   Cooper S, 2010, NATURE, V466, P756, DOI 10.1038/nature09304
   European Commission, 2005, REACH NEED INT TEST
   Hartung T, 2013, ALTEX-ALTERN ANIM EX, V30, P119, DOI 10.14573/altex.2013.2.119
   Hartung T, 2013, ALTEX-ALTERN ANIM EX, V30, P3, DOI 10.14573/altex.2013.1.003
   Hartung T, 2009, ATLA-ALTERN LAB ANIM, V37, P45, DOI 10.1177/026119290903702S10
   Hoffmann S, 2012, MUTAT RES-GEN TOX EN, V744, P36, DOI 10.1016/j.mrgentox.2011.12.002
   Jaeschke H, 2012, DRUG METAB REV, V44, P88, DOI 10.3109/03602532.2011.602688
   Jaeschke H, 2012, LIVER INT, V32, P8, DOI 10.1111/j.1478-3231.2011.02501.x
   Jaworska Joanna, 2010, ALTEX, V27, P231
   Kis E, 2012, TOXICOL IN VITRO, V26, P1294, DOI 10.1016/j.tiv.2011.11.002
   Kleensang A., 2013, ALTEX, V31, P53
   Krewski D, 2010, J TOXICOL ENV HEAL B, V13, P51, DOI 10.1080/10937404.2010.483176
   Kwekel JC, 2005, PHYSIOL GENOMICS, V23, P327, DOI 10.1152/physiolgenomics.00175.2005
   Landesmann B., 2012, JRC SCI POLICY REPOR
   MacKay C, 2013, ALTEX-ALTERN ANIM EX, V30, P473, DOI 10.14573/altex.2013.4.473
   McMullen PD, 2014, CHEM-BIOL INTERACT, V209, P14, DOI 10.1016/j.cbi.2013.11.006
   NRC (National Research Council), 2007, TOX TEST 21 CENT VIS
   OECD (Organization for Economic Co-operation and Development), 2013, GUID DOC DEV ASS ADV
   Poynard T, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-40
   Russmann S, 2009, CURR MED CHEM, V16, P3041, DOI 10.2174/092986709788803097
   Shah I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014584
   Stephens ML, 2013, ALTEX-ALTERN ANIM EX, V30, P74, DOI 10.14573/altex.2013.1.074
   Stephens ML, 2012, TOXICOL SCI, V125, P327, DOI 10.1093/toxsci/kfr248
   Sun B, 2013, TOXICOL IN VITRO, V27, P1877, DOI 10.1016/j.tiv.2013.05.015
   Thomas RS, 2013, TOXICOL SCI, V136, P4, DOI 10.1093/toxsci/kft178
   Vinken M, 2013, TOXICOL SCI, V136, P97, DOI 10.1093/toxsci/kft177
   Wilkening S, 2003, J BIOCHEM MOL TOXIC, V17, P207, DOI 10.1002/jbt.10085
   Willett C, 2014, ALTEX-ALTERN ANIM EX, V31, P407, DOI http://dx.doi.org/10.14573/altex.1401283
   Zhang Q, 2007, PLOS COMPUT BIOL, V3, P345, DOI 10.1371/journal.pcbi.0030024
   Zhang QA, 2010, J TOXICOL ENV HEAL B, V13, P253, DOI 10.1080/10937404.2010.483943
NR 37
TC 10
Z9 10
U1 0
U2 9
PU SPEKTRUM AKADEMISCHER VERLAG-SPRINGER-VERLAG GMBH
PI HEILDEBERG
PA TIERGARTENSTRASSE 17, HEILDEBERG, 69121, GERMANY
SN 1868-596X
EI 1868-8551
J9 ALTEX-ALTERN ANIM EX
JI ALTEX-Altern. Anim. Exp.
PY 2014
VL 31
IS 4
BP 500
EP 519
PG 20
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA AU0JU
UT WOS:000345310000011
PM 24535319
OA DOAJ Gold
DA 2019-10-23
ER

PT J
AU [Anonymous]
AF [Anonymous]
TI INT: OECD launches knowledge base on adverse outcome pathways
SO ALTEX-ALTERNATIVES TO ANIMAL EXPERIMENTATION
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SPEKTRUM AKADEMISCHER VERLAG-SPRINGER-VERLAG GMBH
PI HEILDEBERG
PA TIERGARTENSTRASSE 17, HEILDEBERG, 69121, GERMANY
SN 1868-596X
EI 1868-8551
J9 ALTEX-ALTERN ANIM EX
JI ALTEX-Altern. Anim. Exp.
PY 2014
VL 31
IS 4
BP 542
EP 543
PG 2
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA AU0JU
UT WOS:000345310000020
OA DOAJ Gold
DA 2019-10-23
ER

PT S
AU Hartung, T
AF Hartung, Thomas
BE BalPrice, A
   Jennings, P
TI Immunotoxicity
SO IN VITRO TOXICOLOGY SYSTEMS
SE Methods in Pharmacology and Toxicology
LA English
DT Article; Book Chapter
DE Immune system; Chemical effects; Xenobiotics; Toxicity testing;
   Alternative methods; Toxicology for the twenty-first century
ID HUMAN WHOLE-BLOOD; IN-VITRO; INTERNATIONAL VALIDATION; REPRODUCTIVE
   TOXICITY; CYTOKINE RESPONSE; DENDRITIC CELLS; ANIMAL-MODELS;
   LIVER-INJURY; TOXICOLOGY; THOUGHT
AB Immunotoxicology has been discussed but little addressed in practice of toxicity testing over the last two decades. Current guidance relies on animal tests, which include some immune endpoints in repeated dose tests and call for dedicated tests only when certain alerts indicate a problem, which cannot be evaluated on the evidence obtained so far. At the same time, a wealth of in vitro approaches has been developed in basic and clinical immunology as well as pharmacological agent discovery, but little has been adopted for routine testing. The extent to which immunotoxicity of chemicals represents a health problem for the human population is not clear. It appears that responses of healthy individuals to immunological challenges differ widely and most immunomodulators have little adverse effects, except when coinciding with an infectious or malignant challenge, where the odds of progressing into infection and autoimmune diseases as well as cancer can be changed. The enormous overcapacity of immune defense and their fast restoration contribute to limiting health threats for the individual, though on a population level also minor immunomodulations might result in increased morbidities. In vitro alternative approaches might offer an opportunity to screen for problematic substances and prioritizing them for testing. New approaches emerge from mapping of pathways of immunotoxicity. Increasingly, the contribution of inflammatory and infectious components to the adverse outcome pathways of chemicals for various hazards is recognized, urging to include tests for proinflammatory and immunomodulatory properties into integrated testing strategies.
C1 Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA.
RP Hartung, T (reprint author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA.
CR Basketter DA, 2012, ALTEX-ALTERN ANIM EX, V29, P5, DOI 10.14573/altex.2012.1.003
   BLOEMENA E, 1989, J IMMUNOL METHODS, V122, P161, DOI 10.1016/0022-1759(89)90260-3
   Blom WM, 2009, INT IMMUNOPHARMACOL, V9, P746, DOI 10.1016/j.intimp.2009.02.017
   Bremer S, 2007, CURR PHARM DESIGN, V13, P3047, DOI 10.2174/138161207782110462
   Burns-Naas LA, 2008, INT J TOXICOL, V27, P223, DOI 10.1080/10915810801978110
   Casati S, 2005, ATLA-ALTERN LAB ANIM, V33, P47, DOI 10.1177/026119290503300108
   Collinge M, 2012, J IMMUNOTOXICOL, V9, P210, DOI 10.3109/1547691X.2012.661486
   Corsini E, 2013, TOXICOLOGY, V307, P123, DOI 10.1016/j.tox.2012.10.009
   Corsini E, 2006, TOXICOL LETT, V164, pS313, DOI 10.1016/j.toxlet.2006.07.316
   Corsini E, 2011, J IMMUNOTOXICOL, V8, P251, DOI 10.3109/1547691X.2011.598885
   Corsini E, 2009, ATLA-ALTERN LAB ANIM, V37, P387, DOI 10.1177/026119290903700409
   Coutant KD, 1999, TOXICOL SCI, V52, P189, DOI 10.1093/toxsci/52.2.189
   CZAJA MJ, 1994, HEPATOLOGY, V19, P1282, DOI 10.1016/0270-9139(94)90878-8
   Dal Negro G, 2001, CELL BIOL TOXICOL, V17, P95, DOI 10.1023/A:1010958121396
   Daneshian M, 2009, NAT PROTOC, V4, P1709, DOI 10.1038/nprot.2009.159
   Dean J. H., 1994, IMMUNOTOXICOLOGY IMM
   Dean JH, 2007, PRINCIPLES METHODS T, P1755
   Descotes J, 2004, IMMUNOTOXICOLOGY DRU, P55
   Descotes J, 2006, EXPERT OPIN DRUG MET, V2, P249, DOI 10.1517/17425255.2.2.249
   Descotes Jacques, 2005, Expert Rev Clin Immunol, V1, P603, DOI 10.1586/1744666X.1.4.603
   DeWitt JC, 2012, TOXICOL PATHOL, V40, P230, DOI 10.1177/0192623311427709
   Diaz HG, 2003, CHEM RES TOXICOL, V16, P1318, DOI 10.1021/tx0256432
   Dietert RR, 2008, J IMMUNOTOXICOL, V5, P401, DOI 10.1080/15476910802483324
   Dietert RR, 2010, METHODS MOL BIOL, V598, P1, DOI 10.1007/978-1-60761-401-2
   DIPIETRO LA, 1995, SHOCK, V4, P233, DOI 10.1097/00024382-199510000-00001
   DUTTON RW, 1967, J EXP MED, V126, P443, DOI 10.1084/jem.126.3.443
   EDF, 1997, TOX IGN, P1
   ELSASSERBEILE U, 1993, CANCER IMMUNOL IMMUN, V37, P169, DOI 10.1007/BF01525431
   Feingold BJ, 2010, ENVIRON HEALTH PERSP, V118, P1165, DOI 10.1289/ehp.0901866
   Ferrario D, 2012, ALTEX-ALTERN ANIM EX, V29, P157, DOI 10.14573/altex.2012.2.157
   FLETCHER MA, 1987, DIAGN CLIN IMMUNOL, V5, P69
   Galbiati V, 2010, J IMMUNOTOXICOL, V7, P255, DOI 10.3109/1547691X.2010.509848
   Garbe E, 2007, EXPERT OPIN DRUG SAF, V6, P323, DOI 10.1517/14740338.6.3.323
   Gatt M, 2007, ALIMENT PHARM THER, V25, P741, DOI 10.1111/j.1365-2036.2006.03174.x
   Gennari A, 2004, ATLA-ALTERN LAB ANIM, V32, P437, DOI 10.1177/026119290403200417
   Gennari Alessandra, 2005, J Immunotoxicol, V2, P61, DOI 10.1080/15476910590965832
   Germolec D, 2012, J AUTOIMMUN, V39, P285, DOI 10.1016/j.jaut.2012.05.020
   Germolec DR, 2004, TOXICOL LETT, V149, P109, DOI 10.1016/j.toxlet.2003.12.025
   Goebels N, 2007, ALTEX-ALTERN TIEREXP, V24, P85
   Hareng L, 2002, BIOL CHEM, V383, P1501, DOI 10.1515/BC.2002.172
   Hartung T, 1999, REV PHYSIOL BIOCH P, V136, P1, DOI 10.1007/BFb0032323
   Hartung T, 2001, ATLA-ALTERN LAB ANIM, V29, P99, DOI 10.1177/026119290102900203
   HARTUNG T, 1995, BLOOD, V85, P2482, DOI 10.1182/blood.V85.9.2482.bloodjournal8592482
   Hartung T., 1995, ALTEX, V12, P70
   Hartung T, 2008, ALTEX-ALTERN TIEREXP, V25, P3
   Hartung T, 2013, ALTEX-ALTERN ANIM EX, V30, P411, DOI 10.14573/altex.2013.4.411
   Hartung T, 2013, ALTEX-ALTERN ANIM EX, V30, P3, DOI 10.14573/altex.2013.1.003
   Hartung T, 2012, ALTEX-ALTERN ANIM EX, V29, P251, DOI 10.14573/altex.2012.3.251
   Hartung T, 2012, ALTEX-ALTERN ANIM EX, V29, P119, DOI 10.14573/altex.2012.2.119
   Hartung T, 2011, ALTEX-ALTERN ANIM EX, V28, P83, DOI 10.14573/altex.2011.2.083
   Hartung T, 2011, EUR J PHARM BIOPHARM, V77, P338, DOI 10.1016/j.ejpb.2010.12.027
   Hartung T, 2010, J TOXICOL ENV HEAL B, V13, P277, DOI 10.1080/10937404.2010.483945
   Hartung T, 2009, NATURE, V460, P1080, DOI 10.1038/4601080a
   Hartung T, 2009, NATURE, V460, P208, DOI 10.1038/460208a
   Hartung T, 2009, TOXICOL SCI, V109, P18, DOI 10.1093/toxsci/kfp059
   Hermann C, 2003, J IMMUNOL METHODS, V275, P69, DOI 10.1016/S0022-1759(03)00003-6
   Hoffmann S, 2005, J IMMUNOL METHODS, V298, P161, DOI 10.1016/j.jim.2005.01.010
   Holsapple MP, 2005, TOXICOL SCI, V83, P18, DOI 10.1093/toxsci/kfh299
   Holsapple MP, 2002, TOXICOL LETT, V127, P101, DOI 10.1016/S0378-4274(01)00489-1
   House R.V., 2006, IMMUNOTOXICOLOGY IMM
   House RV, 2010, METHODS MOL BIOL, V598, P363, DOI 10.1007/978-1-60761-401-2_24
   House Robert V., 1995, P159
   Hymery N, 2006, CELL BIOL TOXICOL, V22, P243, DOI 10.1007/s10565-006-0180-3
   Ilback NG, 2007, CRIT REV FOOD SCI, V47, P499, DOI 10.1080/10408390600919015
   Institoris L, 1998, HUM EXP TOXICOL, V17, P206, DOI 10.1191/096032798678908576
   Jones CF, 2009, ADV DRUG DELIVER REV, V61, P438, DOI 10.1016/j.addr.2009.03.005
   Kadow S, 2009, FUTURE MED CHEM, V1, P1583, DOI 10.4155/FMC.09.125
   Kaminski NE, 2007, CASARETT DOULLS TOXI, P485
   Kilburn KH, 1994, IMMUNOTOXICOLOGY IMM, P523
   Kim GG, 2007, J IMMUNOL METHODS, V325, P51, DOI 10.1016/j.jim.2007.05.013
   Kirkwood TBL, 2008, NATURE, V451, P644, DOI 10.1038/451644a
   Knutsen B Jr, 1978, Tidsskr Nor Laegeforen, V98, P888
   KOSUDA LL, 1996, EXPT IMMUNOTOXICOLOG, P419
   Lam-Tse WK, 2002, SPRINGER SEMIN IMMUN, V24, P297, DOI 10.1007/s00281-002-0110-2
   Langezaal I, 2002, ATLA-ALTERN LAB ANIM, V30, P581, DOI 10.1177/026119290203000605
   Langezaal I, 2001, TOXICOL IN VITRO, V15, P313, DOI 10.1016/S0887-2333(01)00028-5
   Lankveld DPK, 2010, METHODS MOL BIOL, V598, P401, DOI 10.1007/978-1-60761-401-2_26
   LASKIN DL, 1995, ANNU REV PHARMACOL, V35, P655, DOI 10.1146/annurev.pharmtox.35.1.655
   Leist M, 1998, Rev Physiol Biochem Pharmacol, V133, P109
   Leist M, 1997, GASTROENTEROLOGY, V112, P923, DOI 10.1053/gast.1997.v112.pm9041255
   Luebke R, 2012, TOXICOL PATHOL, V40, P294, DOI 10.1177/0192623311427572
   Luster MI, 2001, TOXICOL LETT, V120, P317, DOI 10.1016/S0378-4274(01)00284-3
   Luster MI, 2010, METHODS MOL BIOL, V598, P3, DOI 10.1007/978-1-60761-401-2_1
   Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205
   MISHELL RI, 1967, J EXP MED, V126, P423, DOI 10.1084/jem.126.3.423
   MORALES A, 1983, CANCER, V52, P667, DOI 10.1002/1097-0142(19830815)52:4<667::AID-CNCR2820520417>3.0.CO;2-C
   Nolan JP, 2010, HEPATOLOGY, V52, P1829, DOI 10.1002/hep.23917
   Pessina A, 2001, TOXICOL IN VITRO, V15, P729, DOI 10.1016/S0887-2333(01)00085-6
   Pfaller T, 2010, NANOTOXICOLOGY, V4, P52, DOI 10.3109/17435390903374001
   Philip M, 2004, SEMIN CANCER BIOL, V14, P433, DOI 10.1016/j.semcancer.2004.06.006
   Pieters R, 2007, METHODS, V41, P112, DOI 10.1016/j.ymeth.2006.09.005
   Ponti J, 2007, INT J IMMUNOPATH PH, V20, P673, DOI 10.1177/039463200702000403
   Reuben SH, 2010, REDUCING ENV CANC RI
   RODER JC, 1980, NATURE, V284, P553, DOI 10.1038/284553a0
   Rooney Andrew A, 2012, Exp Suppl, V101, P251, DOI 10.1007/978-3-7643-8340-4_9
   Rovida C, 2011, ALTEX-ALTERN ANIM EX, V28, P273, DOI 10.14573/altex.2011.4.273
   Rovida C, 2009, ALTEX-ALTERN TIEREXP, V26, P187
   Schindler S, 2004, J IMMUNOL METHODS, V294, P89, DOI 10.1016/j.jim.2004.08.019
   Schindler S, 2006, J IMMUNOL METHODS, V316, P42, DOI 10.1016/j.jim.2006.07.023
   Schindler S, 2009, ALTEX-ALTERN TIEREXP, V26, P265
   Schneider M, 2001, IMMUNOL LETT, V75, P163, DOI 10.1016/S0165-2478(00)00299-6
   Sodemann U, 2011, DAN MED BULL, V58
   Su GL, 2002, AM J PHYSIOL-GASTR L, V283, pG256, DOI 10.1152/ajpgi.00550.2001
   SUNDWALL A, 1994, TOXICOL IN VITRO, V8, P1067, DOI 10.1016/0887-2333(94)90246-1
   van der Star BJ, 2012, CNS NEUROL DISORD-DR, V11, P570
   von Aulock S, 2004, J PHARMACOL EXP THER, V308, P754, DOI 10.1124/jpet.103.058198
   Wakelin SJ, 2006, IMMUNOL LETT, V106, P1, DOI 10.1016/j.imlet.2006.04.007
   Weir Genevieve M, 2011, Cancers (Basel), V3, P3114, DOI 10.3390/cancers3033114
   WOOD SC, 1992, FUND APPL TOXICOL, V18, P450, DOI 10.1016/0272-0590(92)90143-6
   Zitvogel L, 2008, NAT REV IMMUNOL, V8, P59, DOI 10.1038/nri2216
NR 110
TC 0
Z9 0
U1 0
U2 5
PU HUMANA PRESS INC
PI TOTOWA
PA 999 RIVERVIEW DR, STE 208, TOTOWA, NJ 07512-1165 USA
SN 1557-2153
EI 1940-6053
BN 978-1-4939-0521-8; 978-1-4939-0520-1
J9 METHOD PHARMACOL TOX
JI Methods Pharmacol. Toxicol.
PY 2014
BP 241
EP 267
DI 10.1007/978-1-4939-0521-8_11
D2 10.1007/978-1-4939-0521-8
PG 27
WC Pharmacology & Pharmacy; Toxicology
SC Pharmacology & Pharmacy; Toxicology
GA BB0ES
UT WOS:000340129200013
DA 2019-10-23
ER

PT J
AU Sullivan, KM
   Manuppello, JR
   Willett, CE
AF Sullivan, K. M.
   Manuppello, J. R.
   Willett, C. E.
TI Building on a solid foundation: SAR and QSAR as a fundamental strategy
   to reduce animal testing
SO SAR AND QSAR IN ENVIRONMENTAL RESEARCH
LA English
DT Article
DE Animal testing; (Q)SAR; read-across; safety assessment; visionary
ID CHEMICAL CATEGORIES; PREDICTING MODES; TOXIC ACTION; TIMES-SS; HAZARD;
   TOOL; REACTIVITY; CHEMISTRY; FRAMEWORK; EVALUATE
AB The development of more efficient, ethical, and effective means of assessing the effects of chemicals on human health and the environment was a lifetime goal of Gilman Veith. His work has provided the foundation for the use of chemical structure for informing toxicological assessment by regulatory agencies the world over. Veith's scientific work influenced the early development of the SAR models in use today at the US Environmental Protection Agency. He was the driving force behind the Organisation for Economic Co-operation and Development QSAR Toolbox. Veith was one of a few early pioneers whose vision led to the linkage of chemical structure and biological activity as a means of predicting adverse apical outcomes (known as a mode of action, or an adverse outcome pathway approach), and he understood at an early stage the power that could be harnessed when combining computational and mechanistic biological approaches as a means of avoiding animal testing. Through the International QSAR Foundation he organized like-minded experts to develop non-animal methods and frameworks for the assessment of chemical hazard and risk for the benefit of public and environmental health. Avoiding animal testing was Gil's passion, and his work helped to initiate the paradigm shift in toxicology that is now rendering this feasible.
C1 [Sullivan, K. M.] Phys Comm Responsible Med, Washington, DC 20016 USA.
   [Manuppello, J. R.] People Eth Treatment Anim, Regulatory Testing Div, Norfolk, VA 23510 USA.
   [Willett, C. E.] Humane Soc United States, Washington, DC 20037 USA.
RP Sullivan, KM (reprint author), Phys Comm Responsible Med, 5100 Wisconsin Ave NW,Suite 400, Washington, DC 20016 USA.
EM ksullivan@pcrm.org
CR Al Sharif M, 2013, TOXICOL LETT, V221, pS85, DOI 10.1016/j.toxlet.2013.05.099
   [Anonymous], 2013, QMRF ED 2 0 0
   [Anonymous], 2013, OECD QSAR TOOLB 3 2
   [Anonymous], 2012, EC STRUCT ACT REL EC
   [Anonymous], 2013, ONCOLOGIC COMP SYST
   [Anonymous], 2013, EFF ONL ENC ADV EFF
   Benigni R, 2013, MUTAT RES-GEN TOX EN, V758, P56, DOI 10.1016/j.mrgentox.2013.09.006
   Bhattacharya S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020887
   Bishop PL, 2012, ENVIRON HEALTH PERSP, V120, P1631, DOI 10.1289/ehp.1104666
   Blackburn K, 2011, REGUL TOXICOL PHARM, V60, P120, DOI 10.1016/j.yrtph.2011.03.002
   Dix DJ, 2007, TOXICOL SCI, V95, P5, DOI 10.1093/toxsci/kfl103
   Ellison CM, 2011, EXPERT OPIN DRUG MET, V7, P1481, DOI 10.1517/17425255.2011.629186
   European Chemicals Agency press memo, 2012, RES ECHAS EX TEST PR
   Fioravanzo E, 2013, TOXICOL LETT, V221, pS83, DOI 10.1016/j.toxlet.2013.05.092
   Hewitt M, 2013, CRIT REV TOXICOL, V43, P537, DOI 10.3109/10408444.2013.811215
   Jaworska J, 2002, SAR QSAR ENVIRON RES, V13, P307, DOI 10.1080/10629360290002794
   Mekenyan O, 2003, SAR QSAR ENVIRON RES, V14, P361, DOI 10.1080/10629360310001623953
   Morgott D, 2014, INT J TOXICOL, V33, p181S, DOI 10.1177/1091581813504227
   National Research Council, 2007, TOX TEST 21 CENT VIS
   OECD Extended Advisory Group, 2013, 2013 WORKPL PROJ 1 8
   Organization for Economic Coordination and Development (OECD), 2007, ENV HLTH SAF PUBL SE, V69
   Patlewicz G, 2007, REGUL TOXICOL PHARM, V48, P225, DOI 10.1016/j.yrtph.2007.03.003
   Reif DM, 2013, BIOINFORMATICS, V29, P402, DOI 10.1093/bioinformatics/bts686
   Roberts DW, 2007, CHEM RES TOXICOL, V20, P1321, DOI 10.1021/tx700169w
   Rovida C., 2013, EUSAAT LINZ AUSTR
   Russom CL, 2013, ENVIRON TOXICOL CHEM, V32, P1441, DOI 10.1002/etc.2249
   Russom CL, 1997, ENVIRON TOXICOL CHEM, V16, P948, DOI 10.1002/etc.5620160514
   Schaafsma G, 2009, REGUL TOXICOL PHARM, V53, P70, DOI 10.1016/j.yrtph.2008.11.003
   Schmieder PK, 2004, ENVIRON SCI TECHNOL, V38, P6333, DOI 10.1021/es0495314
   Schultz TW, 2006, SAR QSAR ENVIRON RES, V17, P413, DOI 10.1080/10629360600884371
   Sedykh A, 2011, ENVIRON HEALTH PERSP, V119, P364, DOI 10.1289/ehp.1002476
   Spielmann H, 2011, ATLA-ALTERN LAB ANIM, V39, P481, DOI 10.1177/026119291103900509
   Taylor K., EXPERIENCES REACH TE
   van Leeuwen K, 2009, SAR QSAR ENVIRON RES, V20, P207, DOI 10.1080/10629360902949179
   VANDERJAGT K, 2004, ALTERNATIVE APPROACH
   Veith GD, 2009, SAR QSAR ENVIRON RES, V20, P567, DOI 10.1080/10629360903278669
   Veith GD, 2004, SAR QSAR ENVIRON RES, V15, P323, DOI 10.1080/10629360412331297380
   Vinken M, 2013, TOXICOLOGY, V312, P158, DOI 10.1016/j.tox.2013.08.011
   Wu SD, 2010, REGUL TOXICOL PHARM, V56, P67, DOI 10.1016/j.yrtph.2009.09.006
NR 39
TC 10
Z9 10
U1 1
U2 21
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1062-936X
EI 1029-046X
J9 SAR QSAR ENVIRON RES
JI SAR QSAR Environ. Res.
PY 2014
VL 25
IS 5
SI SI
BP 357
EP 365
DI 10.1080/1062936X.2014.907203
PG 9
WC Chemistry, Multidisciplinary; Computer Science, Interdisciplinary
   Applications; Environmental Sciences; Mathematical & Computational
   Biology; Toxicology
SC Chemistry; Computer Science; Environmental Sciences & Ecology;
   Mathematical & Computational Biology; Toxicology
GA AJ4VV
UT WOS:000337677600002
PM 24773450
DA 2019-10-23
ER

PT J
AU Al Sharif, M
   Alov, P
   Vitcheva, V
   Pajeva, I
   Tsakovska, I
AF Al Sharif, Merilin
   Alov, Petko
   Vitcheva, Vessela
   Pajeva, Ilza
   Tsakovska, Ivanka
TI Modes-of-Action Related to Repeated Dose Toxicity: Tissue-Specific
   Biological Roles of PPAR gamma Ligand-Dependent Dysregulation in
   Nonalcoholic Fatty Liver Disease
SO PPAR RESEARCH
LA English
DT Review
ID ACTIVATED RECEPTOR-GAMMA; HEPATIC STEATOSIS; ADIPOSE-TISSUE;
   LIPID-ACCUMULATION; INSULIN-RESISTANCE; PHYSIOLOGICAL-ROLE;
   GENE-EXPRESSION; DOWN-REGULATION; EFFECTOR C; STEATOHEPATITIS
AB Comprehensive understanding of the precise mode of action/adverse outcome pathway (MoA/AOP) of chemicals becomes a key step towards superseding the current repeated dose toxicity testing methodology with new generation predictive toxicology tools. The description and characterization of the toxicological MoA leading to non-alcoholic fatty liver disease (NAFLD) are of specific interest, due to its increasing incidence in the modern society. Growing evidence stresses on the PPAR gamma ligand-dependent dysregulation as a key molecular initiating event (MIE) for this adverse effect. The aim of this work was to analyze and systematize the numerous scientific data about the steatogenic role of PPAR gamma. Over 300 papers were ranked according to preliminary defined criteria and used as reliable and significant sources of data about the PPAR gamma-dependent prosteatotic MoA. A detailed analysis was performed regarding proteins which PPAR gamma-mediated expression changes had been confirmed to be prosteatotic by most experimental evidence. Two probable toxicological MoAs from PPAR gamma ligand binding to NAFLD were described according to the Organisation for Economic Cooperation and Development (OECD) concepts: (i) PPAR gamma activation in hepatocytes and (ii) PPAR gamma inhibition in adipocytes. The possible events at different levels of biological organization starting from the MIE to the organ response and the connections between them were described in details.
C1 [Al Sharif, Merilin; Alov, Petko; Vitcheva, Vessela; Pajeva, Ilza; Tsakovska, Ivanka] Bulgarian Acad Sci, Inst Biophys & Biomed Engn, BU-1113 Sofia, Bulgaria.
RP Pajeva, I (reprint author), Bulgarian Acad Sci, Inst Biophys & Biomed Engn, Acad G Bonchev St,Bldg 105, BU-1113 Sofia, Bulgaria.
EM pajeva@biomed.bas.bg; itsakovska@biomed.bas.bg
OI Tsakovska, Ivanka/0000-0003-1389-1685
FU European CommunityEuropean Community (EC) [266835]; Cosmetics Europe
FX The funding from the European Community's 7th Framework Program
   (FP7/2007-2013) COSMOS Project under Grant agreement no. 266835 and from
   Cosmetics Europe is gratefully acknowledged.
CR Ahmadian M, 2013, NAT MED, V19, P557, DOI 10.1038/nm.3159
   Anderson N, 2008, PHARMACOL REV, V60, P311, DOI 10.1124/pr.108.00001
   [Anonymous], 2013, SER TEST ASS
   Azhar S, 2010, FUTUR CARDIOL, V6, P657, DOI [10.2217/fca.10.86, 10.2217/FCA.10.86]
   Bai LA, 2011, HEPATOLOGY, V53, P1164, DOI 10.1002/hep.24155
   Bugge A, 2010, PPAR RES, DOI 10.1155/2010/169506
   Burgermeister E, 2007, CELL CYCLE, V6, P1539, DOI 10.4161/cc.6.13.4453
   Chabowski A, 2007, PROSTAG LEUKOTR ESS, V77, P345, DOI 10.1016/j.plefa.2007.10.017
   Chandra V, 2008, NATURE, V456, P350, DOI 10.1038/nature07413
   Chen H, 2013, J STEROID BIOCHEM, V138, P445, DOI 10.1016/j.jsbmb.2013.08.013
   Chen WQ, 2012, MOL CELL BIOL, V32, P1099, DOI 10.1128/MCB.06465-11
   Costa V, 2010, PPAR RES, DOI 10.1155/2010/409168
   Cronin M. T. D., 2012, REPLACEMENT IN VIVO, V2, P284
   Ehehalt R, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-45
   European Chemicals Agency (ECHA), 2013, GUID INF REQ CHEM SA
   Flach RJR, 2011, J BIOL CHEM, V286, P22195, DOI 10.1074/jbc.M110.210237
   Fournier T, 2007, PLACENTA, V28, P65, DOI 10.1016/j.placenta.2006.04.009
   Gaemers IC, 2011, BBA-MOL BASIS DIS, V1812, P447, DOI 10.1016/j.bbadis.2011.01.003
   Greenberg AS, 2011, J CLIN INVEST, V121, P2102, DOI 10.1172/JCI46069
   Guo Y, 2009, J CELL SCI, V122, P749, DOI 10.1242/jcs.037630
   Gwon SY, 2012, J NUTR SCI VITAMINOL, V58, P393, DOI 10.3177/jnsv.58.393
   Handberg A, 2012, J INTERN MED, V271, P294, DOI 10.1111/j.1365-2796.2011.02442.x
   He JH, 2011, EXP BIOL MED, V236, P1116, DOI 10.1258/ebm.2011.011128
   He Z, 2013, P NATL ACAD SCI USA, V110, pE79, DOI 10.1073/pnas.1213000110
   Houck K. A., 2013, HIGH THROUGHPUT SCRE, P1
   Kang SI, 2010, J NUTR BIOCHEM, V21, P1251, DOI 10.1016/j.jnutbio.2009.11.008
   Kawano Y, 2013, J GASTROENTEROL, V48, P434, DOI 10.1007/s00535-013-0758-5
   Kim E, 2008, J HEPATOL, V49, P787, DOI 10.1016/j.jhep.2008.06.029
   Kumadaki S, 2011, J BIOL CHEM, V286, P40835, DOI 10.1074/jbc.M111.235283
   Kursawe R, 2010, OBESITY, V18, P1911, DOI 10.1038/oby.2010.23
   Landesmann B., 2012, DESCRIPTION PROTOTYP
   Larter CZ, 2008, J HEPATOL, V49, P407, DOI 10.1016/j.jhep.2008.03.026
   Larter CZ, 2009, J GASTROEN HEPATOL, V24, P1658, DOI 10.1111/j.1440-1746.2009.05996.x
   Lee YJ, 2012, P NATL ACAD SCI USA, V109, P13656, DOI 10.1073/pnas.1203218109
   Lefils-Lacourtablaise J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063997
   Li Y, 2013, ARTERIOSCL THROM VAS, V33, P1513, DOI 10.1161/ATVBAHA.113.301498
   Liao ZL, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-110
   Luconi M, 2010, STEROIDS, V75, P585, DOI 10.1016/j.steroids.2009.10.012
   Magliano DC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064258
   Manteiga S, 2013, WIRES SYST BIOL MED, V5, P425, DOI 10.1002/wsbm.1213
   Matsusue K, 2012, YAKUGAKU ZASSHI, V132, P823, DOI 10.1248/yakushi.132.823
   Matsusue K, 2010, BIOL PHARM BULL, V33, P346, DOI 10.1248/bpb.33.346
   Moran-Salvador E, 2011, FASEB J, V25, P2538, DOI 10.1096/fj.10-173716
   Musso G, 2009, PROG LIPID RES, V48, P1, DOI 10.1016/j.plipres.2008.08.001
   Nagasaka H, 2012, MOL GENET METAB, V107, P542, DOI 10.1016/j.ymgme.2012.08.004
   Neuschwander-Tetri BA, 2010, HEPATOLOGY, V52, P774, DOI 10.1002/hep.23719
   Noh JR, 2013, FOOD CHEM, V141, P723, DOI 10.1016/j.foodchem.2013.04.036
   NRC (National Research Council), 2007, TOX TEST 21 CENT VIS
   Okumura T, 2011, J PHYSIOL BIOCHEM, V67, P629, DOI 10.1007/s13105-011-0110-6
   Panasyuk G, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1667
   Park CY, 2012, J DIABETES INVEST, V3, P93, DOI 10.1111/j.2040-1124.2012.00204.x
   Park JE, 2013, BIOMED RES INT, DOI 10.1155/2013/460927
   Polvani S, 2012, PPAR RES, DOI 10.1155/2012/641087
   Prieto P., 2011, REPLACEMENT IN VIVO, V1, P38
   Ring A, 2006, BBA-MOL CELL BIOL L, V1761, P416, DOI 10.1016/j.bbalip.2006.03.016
   Rogue A, 2010, PPAR RES, DOI 10.1155/2010/325183
   Sass DA, 2005, DIGEST DIS SCI, V50, P171, DOI 10.1007/s10620-005-1267-z
   Satoh H, 2013, BIOL PHARM BULL, V36, P616
   Schupp M, 2010, J BIOL CHEM, V285, P40409, DOI 10.1074/jbc.R110.182451
   Semple RK, 2006, J CLIN INVEST, V116, P581, DOI 10.1172/JCI28003
   Serviddio G, 2013, FREE RADICAL BIO MED, V65, P952, DOI [10.1016/j.freeradbiomed.2013.08.11/44, 10.1016/j.freeradbiomed.2013.08.174]
   Sos BC, 2011, J CLIN INVEST, V121, P1412, DOI 10.1172/JCI42894
   Su X, 2009, TRENDS ENDOCRIN MET, V20, P72, DOI 10.1016/j.tem.2008.11.001
   Tsukahara T, 2010, MOL CELL, V39, P421, DOI 10.1016/j.molcel.2010.07.022
   Videla LA, 2012, PPAR RES, DOI 10.1155/2012/107434
   Virtue S, 2010, BBA-MOL CELL BIOL L, V1801, P338, DOI 10.1016/j.bbalip.2009.12.006
   Wang ZG, 2012, MOL CELL ENDOCRINOL, V349, P222, DOI 10.1016/j.mce.2011.10.027
   Weismann D, 2011, DIABETOLOGIA, V54, P935, DOI 10.1007/s00125-010-1984-5
   Xu JL, 2012, DIABETES, V61, P3208, DOI 10.2337/db11-1716
   Xu S, 2013, BIOCHEMISTRY-US, V52, P7254, DOI 10.1021/bi400914c
   Yamazaki T, 2011, J NUTR BIOCHEM, V22, P543, DOI 10.1016/j.jnutbio.2010.04.009
   Zhu LX, 2011, METABOLISM, V60, P1001, DOI 10.1016/j.metabol.2010.10.003
NR 72
TC 14
Z9 14
U1 0
U2 8
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 1687-4757
EI 1687-4765
J9 PPAR RES
JI PPAR Res.
PY 2014
AR 432647
DI 10.1155/2014/432647
PG 13
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA AE0YK
UT WOS:000333692100001
PM 24772164
OA DOAJ Gold, Green Published
DA 2019-10-23
ER

PT J
AU Kongsbak, K
   Vinggaard, AM
   Hadrup, N
   Audouze, K
AF Kongsbak, Kristine
   Vinggaard, Anne Marie
   Hadrup, Niels
   Audouze, Karine
TI A Computational Approach to Mechanistic and Predictive Toxicology of
   Pesticides
SO ALTEX-ALTERNATIVES TO ANIMAL EXPERIMENTATION
LA English
DT Article
DE computational tool; pesticides; grouping; systems biology; testicular
   dys genesis syndrome
ID LOW-DOSE EXPOSURE; SEXUAL-DIFFERENTIATION; DEVELOPMENTAL TOXICITY;
   FUNGICIDE MANCOZEB; GENE-EXPRESSION; SEMEN QUALITY; BREAST-MILK;
   MALE-RAT; MIXTURE; CRYPTORCHIDISM
AB Emerging challenges of managing and interpreting large amounts of complex biological data have given rise to the growing field of computational biology. We investigated the applicability of an integrated systems toxicology approach on five selected pesticides to get an overview of their modes of action in humans, to group them according to their modes of action, and to hypothesize on their potential effects on human health.
   We extracted human proteins associated with prochloraz, tebuconazole, epoxiconazole, procymidone, and mancozeb and enriched each protein set by using a high confidence human protein interactome. Then we explored modes of action of the chemicals by integrating protein-disease information into the resulting protein networks. The dominating resulting human adverse effects were reproductive disorders followed by adrenal diseases.
   Our results indicated that prochloraz, tebuconazole, and procymidone exert their effects mainly via interference with steroido genesis and nuclear receptors. Prochloraz was associated with a large number of human diseases and, together with tebuconazole, showed several significant associations with testicular dysgenesis syndrome. Mancozeb showed a differential mode of action involving inflammatory processes. This method provides an efficient way of overviewing data and grouping chemicals according to their mode of action and potential human adverse effects. Such information is valuable when dealing with predictions of mixture effects of chemicals and may contribute to the development of adverse outcome pathways.
C1 [Kongsbak, Kristine; Audouze, Karine] Tech Univ Denmark, Ctr Biol Sequence Anal, Dept Syst Biol, DK-2800 Kongens Lyngby, Denmark.
   [Kongsbak, Kristine; Vinggaard, Anne Marie; Hadrup, Niels] Tech Univ Denmark, Natl Food Inst, Div Toxicol & Risk Assessment, DK-2860 Soborg, Denmark.
RP Kongsbak, K (reprint author), Tech Univ Denmark, Natl Food Inst, Div Toxicol & Risk Assessment, Morkhoj Bygade 19,Bldg G,Room 118, DK-2860 Soborg, Denmark.
EM kgko@food.dtu.dk
OI Vinggaard, Anne Marie/0000-0002-6822-3572; Audouze,
   Karine/0000-0001-7525-4089; Hadrup, Niels/0000-0002-1188-445X
FU Ministry of Food, Agriculture and Fisheries of Denmark; Danish
   Veterinary and Food Administration; Villum Kann Rasmussen Foundation
FX The Ministry of Food, Agriculture and Fisheries of Denmark and the
   Danish Veterinary and Food Administration are acknowledged for their
   financial support. The Villum Kann Rasmussen Foundation contributed
   financially to development of the systems toxicology approach.
CR Andersen HH, 2002, NUCL INSTRUM METH B, V187, P1
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Audouze K, 2011, ENVIRON HEALTH PERSP, V119, P1754, DOI 10.1289/ehp.1103533
   Axelstad M, 2011, TOXICOL SCI, V120, P439, DOI 10.1093/toxsci/kfr006
   Christiansen S, 2008, INT J ANDROL, V31, P241, DOI 10.1111/j.1365-2605.2008.00866.x
   Christiansen S, 2009, ENVIRON HEALTH PERSP, V117, P1839, DOI 10.1289/ehp.0900689
   Cooney MA, 2010, REPROD TOXICOL, V30, P365, DOI 10.1016/j.reprotox.2010.05.011
   Damgaard IN, 2006, ENVIRON HEALTH PERSP, V114, P1133, DOI 10.1289/ehp.8741
   Davis AP, 2011, NUCLEIC ACIDS RES, V39, pD1067, DOI 10.1093/nar/gkq813
   Domico LM, 2007, NEUROTOXICOLOGY, V28, P1079, DOI 10.1016/j.neuro.2007.04.008
   Dreisig K, 2013, ALTEX-ALTERN ANIM EX, V30, P319, DOI 10.14573/altex.2013.3.319
   EC-European Commision, 2005, OFFICIAL J EUROPEAN, V396, P1
   European Food Safety Authority, 2013, EFSA J, V11, DOI 10.2903/j.efsa.2013.3143
   GIWERCMAN A, 1993, ENVIRON HEALTH PERSP, V101, P65, DOI 10.2307/3431378
   Goldner WS, 2010, AM J EPIDEMIOL, V171, P455, DOI 10.1093/aje/kwp404
   Grandjean P, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-96
   Gray LE, 1999, TOXICOL IND HEALTH, V15, P94, DOI 10.1191/074823399678846664
   Hadrup N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070490
   Hass U, 2007, ENVIRON HEALTH PERSP, V115, P122, DOI 10.1289/ehp.9360
   Hass U, 2012, REPROD TOXICOL, V34, P261, DOI 10.1016/j.reprotox.2012.05.090
   HERMENS J, 1984, ECOTOX ENVIRON SAFE, V8, P388, DOI 10.1016/0147-6513(84)90007-1
   Hosokawa Shunji, 1993, Journal of Toxicological Sciences, V18, P83
   Jacobsen PR, 2012, REPROD TOXICOL, V34, P237, DOI 10.1016/j.reprotox.2012.05.099
   Jorgensen N, 2006, INT J ANDROL, V29, P54, DOI 10.1111/j.1365-2605.2005.00635.x
   Kjaerstad MB, 2010, INT J ANDROL, V33, P425, DOI 10.1111/j.1365-2605.2009.01034.x
   Kjaerulff SK, 2013, NUCLEIC ACIDS RES, V41, pD464, DOI 10.1093/nar/gks1166
   Knudsen Thomas, 2013, Methods Mol Biol, V947, P343, DOI 10.1007/978-1-62703-131-8_26
   KONEMANN H, 1981, TOXICOLOGY, V19, P229, DOI 10.1016/0300-483X(81)90132-3
   Kortenkamp A., 2009, STATE ART REV MIXTUR
   Krysiak-Baltyn K, 2012, INT J ANDROL, V35, P294, DOI 10.1111/j.1365-2605.2012.01268.x
   Krysiak-Baltyn K, 2010, INT J ANDROL, V33, P270, DOI 10.1111/j.1365-2605.2009.00996.x
   Lage K, 2007, NAT BIOTECHNOL, V25, P309, DOI 10.1038/nbt1295
   Lage K, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.36
   Lage K, 2008, P NATL ACAD SCI USA, V105, P20870, DOI 10.1073/pnas.0810772105
   Laier P, 2006, TOXICOL APPL PHARM, V213, P160, DOI 10.1016/j.taap.2005.10.013
   Louis GMB, 2011, J DEV ORIG HLTH DIS, V2, P25, DOI 10.1017/S2040174410000693
   Matzuk MM, 2008, NAT MED, V14, P1197, DOI 10.1038/nm.f.1895
   Metzdorff SB, 2007, TOXICOL SCI, V98, P87, DOI 10.1093/toxsci/kfm079
   Nellemann C, 2003, TOXICOL SCI, V71, P251, DOI 10.1093/toxsci/71.2.251
   Ostby J, 1999, TOXICOL IND HEALTH, V15, P80
   Porpora MG, 2009, ENVIRON HEALTH PERSP, V117, P1070, DOI 10.1289/ehp.0800273
   Rajapakse N, 2002, ENVIRON HEALTH PERSP, V110, P917, DOI 10.1289/ehp.02110917
   Safran M, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq020
   Silva E, 2002, ENVIRON SCI TECHNOL, V36, P1751, DOI 10.1021/es0101227
   Skakkebaek NE, 2001, HUM REPROD, V16, P972, DOI 10.1093/humrep/16.5.972
   Steenland K, 1997, ENVIRON HEALTH PERSP, V105, P1126, DOI 10.1289/ehp.971051126
   Swan SH, 2005, ENVIRON HEALTH PERSP, V113, P1056, DOI 10.1289/ehp.8100
   Swan SH, 2003, ENVIRON HEALTH PERSP, V111, P1478, DOI 10.1289/ehp.6417
   US EPA, 2005, EPA MANC FACTS PREV
   Vinggaard AM, 2005, TOXICOL SCI, V85, P886, DOI 10.1093/toxsci/kfi150
   Weidner IS, 1998, ENVIRON HEALTH PERSP, V106, P793, DOI 10.2307/3434122
   Wohlfahrt-Veje C, 2012, INT J ANDROL, V35, P265, DOI 10.1111/j.1365-2605.2012.01252.x
   Wohlfahrt-Veje C, 2009, INT J ANDROL, V32, P423, DOI [10.1111/j.1365-2605.2008.00946.x, 10.1111/j.1365-2605.2009.00946.x]
NR 53
TC 12
Z9 12
U1 0
U2 18
PU SPEKTRUM AKADEMISCHER VERLAG-SPRINGER-VERLAG GMBH
PI HEILDEBERG
PA TIERGARTENSTRASSE 17, HEILDEBERG, 69121, GERMANY
SN 1868-596X
EI 1868-8551
J9 ALTEX-ALTERN ANIM EX
JI ALTEX-Altern. Anim. Exp.
PY 2014
VL 31
IS 1
BP 11
EP 22
PG 12
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA 304MF
UT WOS:000330750300003
PM 24037280
OA DOAJ Gold
DA 2019-10-23
ER

PT J
AU Kleensang, A
   Maertens, A
   Rosenberg, M
   Fitzpatrick, S
   Lamb, J
   Auerbach, S
   Brennan, R
   Crofton, KM
   Gordon, B
   Fornace, AJ
   Gaido, K
   Gerhold, D
   Haw, R
   Henney, A
   Ma'ayan, A
   McBride, M
   Monti, S
   Ochs, MF
   Pandey, A
   Sharan, R
   Stierum, R
   Tugendreich, S
   Willett, C
   Wittwehr, C
   Xia, JG
   Patton, GW
   Arvidson, K
   Bouhifd, M
   Hogberg, HT
   Luechtefeld, T
   Smirnova, L
   Zhao, L
   Adeleye, Y
   Kanehisa, M
   Carmichael, P
   Andersen, ME
   Hartung, T
AF Kleensang, Andre
   Maertens, Alexandra
   Rosenberg, Michael
   Fitzpatrick, Suzanne
   Lamb, Justin
   Auerbach, Scott
   Brennan, Richard
   Crofton, Kevin M.
   Gordon, Ben
   Fornace, Albert J., Jr.
   Gaido, Kevin
   Gerhold, David
   Haw, Robin
   Henney, Adrian
   Ma'ayan, Avi
   McBride, Mary
   Monti, Stefano
   Ochs, Michael F.
   Pandey, Akhilesh
   Sharan, Roded
   Stierum, Rob
   Tugendreich, Stuart
   Willett, Catherine
   Wittwehr, Clemens
   Xia, Jianguo
   Patton, Geoffrey W.
   Arvidson, Kirk
   Bouhifd, Mounir
   Hogberg, Helena T.
   Luechtefeld, Thomas
   Smirnova, Lena
   Zhao, Liang
   Adeleye, Yeyejide
   Kanehisa, Minoru
   Carmichael, Paul
   Andersen, Melvin E.
   Hartung, Thomas
TI Pathways of Toxicity
SO ALTEX-ALTERNATIVES TO ANIMAL EXPERIMENTATION
LA English
DT Article
DE systems toxicology; pathways of toxicity; adverse outcome pathways; in
   vitro toxicology; human toxome
ID TOXICOLOGY; THOUGHT; FOOD; 21ST-CENTURY; TOXICOGENOMICS; INTEGRATION;
   VALIDATION; DOSIMETRY; EVOLUTION; RESPONSES
AB Despite wide-spread consensus on the need to transform toxicology and risk assessment in order to keep pace with technological and computational changes that have revolutionized the life sciences, there remains much work to be done to achieve the vision of toxicology based on a mechanistic foundation. A workshop was organized to explore one key aspect of this transformation the development of Pathways of Toxicity (PoT) as a key tool for hazard identification based on systems biology. Several issues were discussed in depth in the workshop: The first was the challenge of formally defining the concept of a PoT as distinct from, but complementary to, other toxicological pathway concepts such as mode of action (MoA). The workshop came up with a preliminary definition of PoT as "A molecular definition of cellular processes shown to mediate adverse outcomes of toxicants". It is further recognized that normal physiological pathways exist that maintain homeostasis and these, sufficiently perturbed, can become PoT. Second, the workshop sought to define the adequate public and commercial resources for PoT information, including data, visualization, analyses, tools, and use-cases, as well as the kinds of efforts that will be necessary to enable the creation of such a resource. Third, the workshop explored ways in which systems biology approaches could inform pathway annotation, and which resources are needed and available that can provide relevant PoT information to the diverse user communities.
C1 [Kleensang, Andre; Maertens, Alexandra; Bouhifd, Mounir; Hogberg, Helena T.; Luechtefeld, Thomas; Smirnova, Lena; Zhao, Liang; Hartung, Thomas] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Ctr Alternat Anim Testing, Baltimore, MD USA.
   [Rosenberg, Michael; McBride, Mary] Agilent Technol, Santa Clara, CA USA.
   [Fitzpatrick, Suzanne; Gaido, Kevin] US FDA, Ctr Food Safety & Appl Nutr, College Pk, MD USA.
   [Lamb, Justin] Genometry Inc, Cambridge, MA USA.
   [Auerbach, Scott] NIEHS, Div Natl Toxicol Program, NIH, Res Triangle Pk, NC 27709 USA.
   [Brennan, Richard] Thomson Reuters Inc, Carlsbad, CA USA.
   [Crofton, Kevin M.] US EPA, Off Res & Dev, Natl Ctr Computat Toxicol, Res Triangle Pk, NC 27711 USA.
   [Gordon, Ben] MIT, Dept Biol Engn, Cambridge, MA 02139 USA.
   [Fornace, Albert J., Jr.] Georgetown Univ, Dept Biochem & Mol & Cellular Biol, Washington, DC USA.
   [Fornace, Albert J., Jr.] Georgetown Univ, Lombardi Comprehens Canc Ctr, Washington, DC USA.
   [Gerhold, David] NIH, Natl Ctr Adv Translat Sci, Rockville, MD USA.
   [Haw, Robin] Ontario Inst Canc Res, Reactome, Toronto, ON, Canada.
   [Henney, Adrian] Heidelberg Univ, German Virtual Liver Network, Heidelberg, Germany.
   [Ma'ayan, Avi] Icahn Sch Med Mt Sinai, Dept Pharmacol & Syst Therapeut, New York, NY USA.
   [Monti, Stefano] Boston Univ, Sch Med, Sect Computat Biomed, Boston, MA 02118 USA.
   [Ochs, Michael F.] Johns Hopkins Univ, Sch Med, Ctr Oncol, Baltimore, MD 21205 USA.
   [Pandey, Akhilesh] Johns Hopkins Univ, Sch Med, Inst Med Genet, Baltimore, MD USA.
   [Pandey, Akhilesh] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA.
   [Pandey, Akhilesh] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA.
   [Pandey, Akhilesh] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA.
   [Sharan, Roded] Tel Aviv Univ, Blavatnik Sch Comp Sci, IL-69978 Tel Aviv, Israel.
   [Stierum, Rob] TNO Hlth Living Microbiol & Syst Biol, Zeist, Netherlands.
   [Tugendreich, Stuart] Ingenu Syst Inc, Redwood City, CA USA.
   [Willett, Catherine] Humane Soc United States, Washington, DC USA.
   [Wittwehr, Clemens] Commiss European Communities, Joint Res Ctr, Syst Toxicol Unit, I-21020 Ispra, Italy.
   [Xia, Jianguo] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V5Z 1M9, Canada.
   [Patton, Geoffrey W.; Arvidson, Kirk] US FDA, Ctr Food Safety & Appl Nutr, Off Food Addit Safety, College Pk, MD USA.
   [Adeleye, Yeyejide; Carmichael, Paul] Unilever, Safety & Environm Assurance Ctr, Sharnbrook, Beds, England.
   [Kanehisa, Minoru] Kyoto Univ, Inst Chem Res, Kyoto 606, Japan.
   [Andersen, Melvin E.] Hamner Inst Hlth Sci, Res Triangle Pk, NC USA.
   [Hartung, Thomas] Univ Konstanz, CAAT Europe, Constance, Germany.
RP Hartung, T (reprint author), Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Alternat Anim Testing, 615 North Wolfe St,W7032, Baltimore, MD 21205 USA.
EM thartung@jhsph.edu
RI Xia, Jianguo/Z-1935-2019; Crofton, Kevin/J-4798-2015; Zhao,
   Liang/I-4777-2015; Kanehisa, Minoru/R-3081-2018; Haw, Robin/D-1393-2009;
   Fornace, Albert/A-7407-2008
OI Xia, Jianguo/0000-0003-2040-2624; Crofton, Kevin/0000-0003-1749-9971;
   Zhao, Liang/0000-0002-2126-6778; Wittwehr, Clemens/0000-0003-2760-7702;
   Kleensang, Andre/0000-0002-4564-7399; Ma'ayan, Avi/0000-0002-6904-1017;
   Haw, Robin/0000-0002-2013-7835; Monti, Stefano/0000-0002-9376-0660;
   Andersen, Melvin/0000-0002-3894-4811; Fornace,
   Albert/0000-0001-9695-085X
FU Unilever; NIH transformative research project on "Mapping the Human
   Toxome by Systems Toxicology" [R01ES020750]; FDA grant "DNTox-21c
   Identification of pathways of developmental neurotoxicity for high
   throughput testing by metabolomics" [U01FD004230]
FX This CAAT workshop on Pathways of Toxicity was made possible by support
   from Unilever and the extensive discussions and experiences of the NIH
   transformative research project on "Mapping the Human Toxome by Systems
   Toxicology" (R01ES020750) and FDA grant "DNTox-21c Identification of
   pathways of developmental neurotoxicity for high throughput testing by
   metabolomics" (U01FD004230).
CR Alon U., 2007, CHAPMAN HALL CRC MAT
   Andersen ME, 2013, ARCH TOXICOL, V87, P7, DOI 10.1007/s00204-012-0980-6
   Andersen ME, 2010, TOXICOL SCI, V117, P17, DOI 10.1093/toxsci/kfq188
   Ankley GT, 2006, ENVIRON SCI TECHNOL, V40, P4055, DOI 10.1021/es0630184
   Aranda B, 2011, NAT METHODS, V8, P528, DOI 10.1038/nmeth.1637
   Bhattacharya S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020887
   Bouhifd M, 2013, J APPL TOXICOL, V33, P1365, DOI 10.1002/jat.2874
   Cases M, 2013, MOL INFORM, V32, P24, DOI 10.1002/minf.201200099
   Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324
   Croft D, 2011, NUCLEIC ACIDS RES, V39, pD691, DOI 10.1093/nar/gkq1018
   Dyson F. J., 2006, SCI REBEL
   Firestone M, 2010, J TOXICOL ENV HEAL B, V13, P139, DOI 10.1080/10937404.2010.483178
   Funahashi Akira, 2003, Biosilico, V1, P159, DOI 10.1016/S1478-5382(03)02370-9
   Gaulton A, 2012, NUCLEIC ACIDS RES, V40, pD1100, DOI 10.1093/nar/gkr777
   GRUBER TR, 1993, KNOWL ACQUIS, V5, P199, DOI 10.1006/knac.1993.1008
   Hamburg MA, 2011, SCIENCE, V331, P987, DOI 10.1126/science.1204432
   Hardy B, 2012, ALTEX-ALTERN ANIM EX, V29, P139, DOI 10.14573/altex.2012.2.139
   Hardy B, 2012, ALTEX-ALTERN ANIM EX, V29, P129, DOI 10.14573/altex.2012.2.129
   Hartung T, 2008, ALTEX-ALTERN TIEREXP, V25, P91
   Hartung T, 2013, ALTEX-ALTERN ANIM EX, V30, P119, DOI 10.14573/altex.2013.2.119
   Hartung T, 2013, ALTEX-ALTERN ANIM EX, V30, P3, DOI 10.14573/altex.2013.1.003
   Hartung T, 2012, ALTEX-ALTERN ANIM EX, V29, P119, DOI 10.14573/altex.2012.2.119
   Hartung T, 2011, ALTEX-ALTERN ANIM EX, V28, P83, DOI 10.14573/altex.2011.2.083
   Hartung T, 2010, ALTEX-ALTERN ANIM EX, V27, P253
   Hartung T, 2010, ALTEX-ALTERN ANIM EX, V27, P87
   Hartung T, 2009, ALTEX-ALTERN TIEREXP, V26, P307
   Hartung T, 2009, NATURE, V460, P1080, DOI 10.1038/4601080a
   Hartung T, 2009, TOXICOL SCI, V109, P18, DOI 10.1093/toxsci/kfp059
   Hartung T, 2008, ATLA-ALTERN LAB ANIM, V36, P635, DOI 10.1177/026119290803600607
   Judson R, 2013, ALTEX-ALTERN ANIM EX, V30, P51, DOI 10.14573/altex.2013.1.051
   Judson RS, 2010, ENVIRON SCI TECHNOL, V44, P5979, DOI 10.1021/es102150z
   Junker BH, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-109
   Kafka Franz, 1931, BEIM BAU CHINESISCHE
   Kelder T, 2012, NUCLEIC ACIDS RES, V40, pD1301, DOI 10.1093/nar/gkr1074
   Kholodenko B, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002961
   Knox C, 2011, NUCLEIC ACIDS RES, V39, pD1035, DOI 10.1093/nar/gkq1126
   Knudsen TB, 2011, BIRTH DEFECTS RES B, V92, P413, DOI 10.1002/bdrb.20315
   Krewski D, 2010, J TOXICOL ENV HEAL B, V13, P51, DOI 10.1080/10937404.2010.483176
   Le Novere N, 2009, NAT BIOTECHNOL, V27, P735, DOI 10.1038/nbt.1558
   Letunic I, 2008, TRENDS BIOCHEM SCI, V33, P101, DOI 10.1016/j.tibs.2008.01.001
   Lim E, 2010, NUCLEIC ACIDS RES, V38, pD781, DOI 10.1093/nar/gkp934
   MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040
   Milacic Marija, 2012, Cancers (Basel), V4, P1180, DOI 10.3390/cancers4041180
   National Research Council, 2007, TOX TEST 21 CENT VIS
   OECD, 2012, HLTH SAF PUBL SER TE, V178, P23
   Pico AR, 2008, PLOS BIOL, V6, P1403, DOI 10.1371/journal.pbio.0060184
   Rotroff DM, 2010, TOXICOL SCI, V117, P348, DOI 10.1093/toxsci/kfq220
   Rovida C, 2009, ALTEX-ALTERN TIEREXP, V26, P187
   Seidle T, 2009, TOXICOL IN VITRO, V23, P1576, DOI 10.1016/j.tiv.2009.06.012
   Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110
   Tang HL, 2012, BIOCHEM BIOPH RES CO, V424, P7, DOI 10.1016/j.bbrc.2012.06.085
   Taylor IW, 2012, PROTEOMICS, V12, P1706, DOI 10.1002/pmic.201100594
   van Iersel MP, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-399
   van Vliet E, 2011, ALTEX-ALTERN ANIM EX, V28, P17, DOI 10.14573/altex.2011.1.017
   Wetmore BA, 2012, TOXICOL SCI, V125, P157, DOI 10.1093/toxsci/kfr254
   Wu GM, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-12-r112
   Xu EY, 2008, CHEM RES TOXICOL, V21, P1548, DOI 10.1021/tx800061w
   Zurlo J, 2011, ALTEX, V28, P152
NR 58
TC 53
Z9 54
U1 0
U2 14
PU SPEKTRUM AKADEMISCHER VERLAG-SPRINGER-VERLAG GMBH
PI HEILDEBERG
PA TIERGARTENSTRASSE 17, HEILDEBERG, 69121, GERMANY
SN 1868-596X
EI 1868-8551
J9 ALTEX-ALTERN ANIM EX
JI ALTEX-Altern. Anim. Exp.
PY 2014
VL 31
IS 1
BP 53
EP 61
DI 10.14573/altex.1309261
PG 9
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA 304MF
UT WOS:000330750300007
PM 24127042
OA DOAJ Gold, Green Accepted
DA 2019-10-23
ER

PT J
AU Vinken, M
   Whelan, M
   Rogiers, V
AF Vinken, Mathieu
   Whelan, Maurice
   Rogiers, Vera
TI Adverse outcome pathways: hype or hope?
SO ARCHIVES OF TOXICOLOGY
LA English
DT Editorial Material
C1 [Vinken, Mathieu; Rogiers, Vera] Vrije Univ Brussel, Fac Med & Pharm, Pharmaceut Res Ctr, Dept Toxicol, B-1090 Brussels, Belgium.
   [Whelan, Maurice] Commiss European Communities, Joint Res Ctr, Syst Toxicol Unit, Inst Hlth & Consumer Protect, I-21020 Ispra, Italy.
RP Vinken, M (reprint author), Vrije Univ Brussel, Fac Med & Pharm, Pharmaceut Res Ctr, Dept Toxicol, Laarbeeklaan 103, B-1090 Brussels, Belgium.
EM mvinken@vub.ac.be
RI Vinken, Mathieu/H-7513-2013
OI Vinken, Mathieu/0000-0001-5115-8893; VUB, IVTD/0000-0002-5016-4789
CR Andersen M., 2012, REPLACEMENT IN VIVO, V2, P347
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   [Anonymous], 2012, OECD SER TEST ASS, V168
   HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503
   Jennings P, 2013, ARCH TOXICOL, V87, P13, DOI 10.1007/s00204-012-0974-4
   LANDESMANN B, 2012, 75689 JRC
   NRC (National Research Council), 2007, TOX TEST 21 CENT VIS
   OECD, 2011, OECD SER TEST ASS
   OECD, 2012, PROP TEMPL GUID DEV
   Pauwels M, 2010, TOXICOL APPL PHARM, V243, P260, DOI 10.1016/j.taap.2009.12.007
   *US EPA, 2005, GUID CARC RISK ASS
   Vinken M, 2013, TOXICOL SCI UNPUB
   Vinken M, 2012, ARCH TOXICOL, V86, P405, DOI 10.1007/s00204-011-0769-z
NR 13
TC 8
Z9 9
U1 0
U2 18
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0340-5761
EI 1432-0738
J9 ARCH TOXICOL
JI Arch. Toxicol.
PD JAN
PY 2014
VL 88
IS 1
BP 1
EP 2
DI 10.1007/s00204-013-1093-6
PG 2
WC Toxicology
SC Toxicology
GA 283CY
UT WOS:000329223700001
PM 23868017
DA 2019-10-23
ER

PT J
AU Villeneuve, D
   Volz, DC
   Embry, MR
   Ankley, GT
   Belanger, SE
   Leonard, M
   Schirmer, K
   Tanguay, R
   Truong, L
   Wehmas, L
AF Villeneuve, Daniel
   Volz, David C.
   Embry, Michelle R.
   Ankley, Gerald T.
   Belanger, Scott E.
   Leonard, Marc
   Schirmer, Kristin
   Tanguay, Robert
   Truong, Lisa
   Wehmas, Leah
TI INVESTIGATING ALTERNATIVES TO THE FISH EARLY-LIFE STAGE TEST: A STRATEGY
   FOR DISCOVERING AND ANNOTATING ADVERSE OUTCOME PATHWAYS FOR EARLY FISH
   DEVELOPMENT
SO ENVIRONMENTAL TOXICOLOGY AND CHEMISTRY
LA English
DT Article
DE Adverse outcome pathways; Aquatic toxicology; Risk assessment; Mode of
   action; Swim bladder; Fish early-life stage toxicity; Animal alternative
ID GAS GLAND-CELLS; CONCEPTUAL-FRAMEWORK; BLADDER INFLATION; SIGNALING
   PATHWAY; SMALL MOLECULES; IPCS FRAMEWORK; ZEBRAFISH; SWIMBLADDER;
   ECOTOXICOLOGY; GROWTH
AB The fish early-life stage (FELS) test (Organisation for Economic Co-operation and Development [OECD] test guideline 210) is the primary test used internationally to estimate chronic fish toxicity in support of ecological risk assessments and chemical management programs. As part of an ongoing effort to develop efficient and cost-effective alternatives to the FELS test, there is a need to identify and describe potential adverse outcome pathways (AOPs) relevant to FELS toxicity. To support this endeavor, the authors outline and illustrate an overall strategy for the discovery and annotation of FELS AOPs. Key events represented by major developmental landmarks were organized into a preliminary conceptual model of fish development. Using swim bladder inflation as an example, a weight-of-evidence-based approach was used to support linkage of key molecular initiating events to adverse phenotypic outcomes and reduced young-of-year survival. Based on an iterative approach, the feasibility of using key events as the foundation for expanding a network of plausible linkages and AOP knowledge was explored and, in the process, important knowledge gaps were identified. Given the scope and scale of the task, prioritization of AOP development was recommended and key research objectives were defined relative to factors such as current animal-use restrictions in the European Union and increased demands for fish toxicity data in chemical management programs globally. The example and strategy described are intended to guide collective efforts to define FELS-related AOPs and develop resource-efficient predictive assays that address the toxicological domain of the OECD 210 test. Environ Toxicol Chem 2014;33:158-169. (c) 2013 The Authors. Environmental Toxicology and Chemistry published by Wiley Periodicals, Inc. on behalf of SETAC. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited.
C1 [Villeneuve, Daniel; Ankley, Gerald T.] US EPA, Duluth, MN USA.
   [Volz, David C.] Univ S Carolina, Arnold Sch Publ Hlth, Columbia, SC 29208 USA.
   [Embry, Michelle R.] Hlth & Environm Sci Inst, Int Life Sci Inst, Washington, DC 20005 USA.
   [Belanger, Scott E.] Procter & Gamble Co, Cincinnati, OH USA.
   [Leonard, Marc] LOreal, Res & Innovat, Aulnay Sous Bois, France.
   [Schirmer, Kristin] Eawag, Swiss Fed Inst Aquat Sci & Technol, Dubendorf, Switzerland.
   [Schirmer, Kristin] EPF Lausanne, Sch Architecture Civil & Environm Engn, Lausanne, Switzerland.
   [Schirmer, Kristin] ETH, Inst Biogeochem & Pollutant Dynam, Zurich, Switzerland.
   [Tanguay, Robert; Truong, Lisa; Wehmas, Leah] Oregon State Univ, Corvallis, OR 97331 USA.
RP Embry, MR (reprint author), Hlth & Environm Sci Inst, Int Life Sci Inst, Washington, DC 20005 USA.
EM membry@ilsi.org
OI Truong, Lisa/0000-0003-1751-4617; Belanger, Scott/0000-0003-0369-9673
FU NIEHS NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Environmental
   Health Sciences (NIEHS) [P30 ES000210]
CR Ankley GT, 2008, AQUAT TOXICOL, V88, P69, DOI 10.1016/j.aquatox.2008.03.005
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Ankley GT, 2009, AQUAT TOXICOL, V92, P168, DOI 10.1016/j.aquatox.2009.01.013
   BAILEY HC, 1995, AQUACULTURE, V131, P135, DOI 10.1016/0044-8486(94)00215-A
   Belanger SE, 2010, AQUAT TOXICOL, V97, P88, DOI 10.1016/j.aquatox.2009.11.020
   Boobis AR, 2008, CRIT REV TOXICOL, V38, P87, DOI 10.1080/10408440701749421
   Boobis AR, 2006, CRIT REV TOXICOL, V36, P781, DOI 10.1080/10408440600977677
   Breen M, 2013, TOXICOL SCI, V133, P234, DOI 10.1093/toxsci/kft067
   Burns CG, 2005, NAT CHEM BIOL, V1, P263, DOI 10.1038/nchembio732
   CHATAIN B, 1992, AQUACULTURE, V107, P81, DOI 10.1016/0044-8486(92)90051-L
   CHATAIN B, 1989, ADV TROPICAL AQUACUL, V9, P699
   Chu J, 2009, HEPATOLOGY, V50, P1656, DOI 10.1002/hep.23157
   Czesny SJ, 2005, T AM FISH SOC, V134, P1011, DOI 10.1577/T04-016.1
   Daston GP, 2010, COMPREHENSIVE TOXICOLOGY, VOL 12: DEVELOPMENTAL TOXICOLOGY, 2ND EDITION, P3
   Dumbarton TC, 2010, J EXP BIOL, V213, P2536, DOI 10.1242/jeb.039792
   Egloff M, 1996, AQUAT SCI, V58, P15, DOI 10.1007/BF00877637
   Embry MR, 2010, AQUAT TOXICOL, V97, P79, DOI 10.1016/j.aquatox.2009.12.008
   Fairbairn EA, 2012, AQUAT TOXICOL, V124, P188, DOI 10.1016/j.aquatox.2012.08.017
   Halder Marlies, 2010, Integrated Environmental Assessment and Management, V6, P484, DOI 10.1002/ieam.48
   HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503
   Kavlock R, 2012, CHEM RES TOXICOL, V25, P1287, DOI 10.1021/tx3000939
   Kleinstreuer NC, 2011, ENVIRON HEALTH PERSP, V119, P1596, DOI 10.1289/ehp.1103412
   Knobel M, 2012, ENVIRON SCI TECHNOL, V46, P9690, DOI 10.1021/es301729q
   Kokel D, 2010, NAT CHEM BIOL, V6, P231, DOI 10.1038/NCHEMBIO.307
   Li J, 2011, ENVIRON SCI TECHNOL, V45, P9750, DOI 10.1021/es202420g
   Li ZH, 2011, CAN J FISH AQUAT SCI, V68, P1528, DOI 10.1139/f2011-066
   Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126
   MacPhail RC, 2009, NEUROTOXICOLOGY, V30, P52, DOI 10.1016/j.neuro.2008.09.011
   MCKIM JM, 1977, J FISH RES BOARD CAN, V34, P1148, DOI 10.1139/f77-172
   MCKIM JM, 1985, FUNDAMENTALS AQUATIC, P328
   Milan DJ, 2003, CIRCULATION, V107, P1355, DOI 10.1161/01.CIR.0000061912.88753.87
   Miller DH, 2007, ENVIRON TOXICOL CHEM, V26, P521, DOI 10.1897/06-318R.1
   Munakata K, 2012, BIOCHEM BIOPH RES CO, V417, P564, DOI 10.1016/j.bbrc.2011.12.006
   National Research Council, 2000, SCI FRONT DEV TOX RI
   National Research Council, 2007, TOX TEST 21 CENT VIS
   *ORG EC CO OP DEV, 2006, GUID FISH E IN PRESS
   *ORG EC CO OP DEV, 2013, OTH ACT MOL SCREEN T
   *ORG EC CO OP DEV, 2012, PROP TEMPL GUID DEV
   *ORG EC CO OP DEV, 2013, SER TEST ASS, V184
   *ORG EC CO OP DEV, 1992, GUID 210 FISH EARL S
   Oris JT, 2012, ENVIRON TOXICOL CHEM, V31, P370, DOI 10.1002/etc.747
   Padilla S, 2012, REPROD TOXICOL, V33, P174, DOI 10.1016/j.reprotox.2011.10.018
   Pelster B, 2004, RESP PHYSIOL NEUROBI, V144, P179, DOI 10.1016/j.resp.2004.03.019
   Prem C, 2000, AM J PHYSIOL-REG I, V279, pR2336
   Rihel J, 2010, SCIENCE, V327, P348, DOI 10.1126/science.1183090
   Robertson GN, 2007, J MORPHOL, V268, P967, DOI 10.1002/jmor.10558
   Sonich-Mullin C, 2001, REGUL TOXICOL PHARM, V34, P146, DOI 10.1006/rtph.2001.1493
   STEPHAN CE, 1989, AQUATIC TOXICOLOGY E, V11, P263
   Strahle U, 2012, REPROD TOXICOL, V33, P128, DOI 10.1016/j.reprotox.2011.06.121
   Teoh PH, 2010, DEV DYNAM, V239, P865, DOI 10.1002/dvdy.22221
   Trotter AJ, 2001, AQUACULTURE, V198, P41, DOI 10.1016/S0044-8486(00)00594-9
   Truong L, 2011, METHODS MOL BIOL, V691, P271, DOI 10.1007/978-1-60761-849-2_16
   *U OR, 2013, ZEBR MOD ORG DAT
   Umezawa T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034579
   *US EPA, 2013, TOXCASTDB
   Villeneuve DL, 2011, ENVIRON TOXICOL CHEM, V30, P1, DOI 10.1002/etc.396
   Volz DC, 2011, TOXICOL SCI, V123, P349, DOI 10.1093/toxsci/kfr185
   Winata CL, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-3
   Winata CL, 2009, DEV BIOL, V331, P222, DOI 10.1016/j.ydbio.2009.04.035
   WOLTERING DM, 1984, AQUAT TOXICOL, V5, P1, DOI 10.1016/0166-445X(84)90028-6
   Woolley LD, 2010, REV AQUACULT, V2, P181, DOI 10.1111/j.1753-5131.2010.01035.x
   Yin A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018431
NR 62
TC 42
Z9 43
U1 1
U2 69
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0730-7268
EI 1552-8618
J9 ENVIRON TOXICOL CHEM
JI Environ. Toxicol. Chem.
PD JAN
PY 2014
VL 33
IS 1
BP 158
EP 169
DI 10.1002/etc.2403
PG 12
WC Environmental Sciences; Toxicology
SC Environmental Sciences & Ecology; Toxicology
GA 274HQ
UT WOS:000328597800022
PM 24115264
OA Green Published, Green Accepted
DA 2019-10-23
ER

PT J
AU Ellis, P
   Fowler, P
   Booth, E
   Kidd, D
   Howe, J
   Doherty, A
   Scott, A
AF Ellis, Patricia
   Fowler, Paul
   Booth, Ewan
   Kidd, Darren
   Howe, Jonathan
   Doherty, Ann
   Scott, Andrew
TI Where will genetic toxicology testing be in 30 years time? Summary
   report of the 25th Industrial Genotoxicity Group Meeting, Royal Society
   of Medicine, London, November 9, 2011
SO MUTAGENESIS
LA English
DT Article
ID DISCRIMINATE RODENT CARCINOGENS; IN-VITRO; RELATIVE PREDICTIVITY;
   TOXICITY; NONCARCINOGENS; WORKSHOP; BATTERY; ABILITY
AB A number of influences including legislation, industry and academia have encouraged advances in computational toxicology and high-throughput testing to probe more broadly putative toxicity pathways. The aim of the 25th United Kingdom Mutagen Society (UKEMS) Industrial Genotoxicity Group Annual Meeting 2011 was to explore current and upcoming research tools that may provide new cancer risk estimation approaches and discuss the genotoxicity testing paradigm of the future. The meeting considered whether computer modelling, molecular biology systems and/or adverse outcome pathway approaches can provide more accurate toxicity predictions and whether high-content study data, pluripotent stem cells or new scientific disciplines, such as epigenetics and adductomics, could be integrated into the risk assessment process. With close collaboration between industry, academia and regulators next generation predictive models and high-content tools have the potential to transform genetic toxicology testing in the 21st century.
C1 [Ellis, Patricia] Kimberly Clark, Reigate RH2 9QP, Surrey, England.
   [Fowler, Paul; Scott, Andrew] Unilever, Safety & Environm Assurance Ctr, Sharnbrook MK44 1LQ, Beds, England.
   [Booth, Ewan] Syngenta Ltd, Jealotts Hill Int Res Ctr, Bracknell RG42 6EY, Berks, England.
   [Kidd, Darren] Covance Labs Ltd, Harrogate HG3 1PY, England.
   [Howe, Jonathan] GlaxoSmithKline R&D, Ware SG12 0DP, Herts, England.
   [Doherty, Ann] AstraZeneca, Safety Assessment, Alderley Pk SK10 4TG, Cheshire, England.
RP Ellis, P (reprint author), Kimberly Clark, 40 London House,Douglas Rd, Reigate RH2 9QP, Surrey, England.
EM patricia.ellis@kcc.com
OI fowler, paul/0000-0002-8705-3003
CR Coleman MA, 2011, MUTAT RES-GEN TOX EN, V722, P93, DOI 10.1016/j.mrgentox.2011.02.001
   Dix DJ, 2007, TOXICOL SCI, V95, P5, DOI 10.1093/toxsci/kfl103
   Kaminen-Ahola N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000811
   Kirkland D, 2005, MUTAT RES-GEN TOX EN, V584, P1, DOI 10.1016/j.mrgentox.2005.02.004
   Kirkland D, 2007, MUTAT RES-GEN TOX EN, V628, P31, DOI 10.1016/j.mrgentox.2006.11.008
   Kirkland D, 2006, MUTAT RES-GEN TOX EN, V608, P29, DOI 10.1016/j.mrgentox.2006.04.017
   Krewski D, 2010, J TOXICOL ENV HEAL B, V13, P51, DOI 10.1080/10937404.2010.483176
   Lu K, 2011, CHEM RES TOXICOL, V24, P159, DOI 10.1021/tx1003886
   Lu K, 2010, TOXICOL SCI, V116, P441, DOI 10.1093/toxsci/kfq061
   Matthews EJ, 2006, REGUL TOXICOL PHARM, V44, P97, DOI 10.1016/j.yrtph.2005.10.004
   Moeller BC, 2011, CHEM RES TOXICOL, V24, P162, DOI 10.1021/tx1004166
   NRC (National Research Council), 2007, TOX TEST 21 CENT VIS
   Pfuhler S, 2011, MUTAT RES-GEN TOX EN, V723, P101, DOI 10.1016/j.mrgentox.2011.03.013
   Swenberg JA, 2011, TOXICOL SCI, V120, pS130, DOI 10.1093/toxsci/kfq371
   Tweats DJ, 2007, MUTAGENESIS, V22, P5, DOI 10.1093/mutage/gel052
NR 15
TC 3
Z9 3
U1 0
U2 6
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0267-8357
EI 1464-3804
J9 MUTAGENESIS
JI Mutagenesis
PD JAN
PY 2014
VL 29
IS 1
BP 73
EP 77
DI 10.1093/mutage/get057
PG 5
WC Genetics & Heredity; Toxicology
SC Genetics & Heredity; Toxicology
GA 280VJ
UT WOS:000329058600009
PM 24334751
OA Bronze
DA 2019-10-23
ER

PT J
AU Pirone, JR
   Smith, M
   Kleinstreuer, NC
   Burns, TA
   Strickland, J
   Dancik, Y
   Morris, R
   Rinckel, LA
   Casey, W
   Jaworska, JS
AF Pirone, Jason R.
   Smith, Marjolein
   Kleinstreuer, Nicole C.
   Burns, Thomas A.
   Strickland, Judy
   Dancik, Yuri
   Morris, Richard
   Rinckel, Lori A.
   Casey, Warren
   Jaworska, Joanna S.
TI Open Source Software Implementation of an Integrated Testing Strategy
   for Skin Sensitization Potency Based on a Bayesian Network
SO ALTEX-ALTERNATIVES TO ANIMAL EXPERIMENTATION
LA English
DT Article
DE skin sensitization; integrated testing strategy; allergic contact
   dermatitis; Bayesian network; R
ID REPRODUCIBLE RESEARCH; PACKAGE
AB An open source implementation of a previously published integrated testing strategy (ITS) for skin sensitization using a Bayesian network has been developed using R, a free and open source statistical computing language. The ITS model provides probabilistic predictions of skin sensitization potency based on in silico and in vitro information as well as skin penetration characteristics from a published bioavailability model (Kasting et al., 2008). The structure of the Bayesian network was designed to be consistent with the adverse outcome pathway published by the OECD (Jaworska et al., 2011, 2013). In this paper, the previously published data set (Jaworska et al., 2013) is improved by two data corrections and a modified application of the Kasting model. The new data set implemented in the original commercial software package and the new R version produced consistent results. The data and a fully documented version of the code are publicly available (http://ntp.niehs.nih.gov/go/its).
C1 [Pirone, Jason R.; Smith, Marjolein; Morris, Richard] Social & Sci Syst Inc, Durham, NC USA.
   [Kleinstreuer, Nicole C.; Burns, Thomas A.; Strickland, Judy; Rinckel, Lori A.] Integrated Lab Syst Inc, Morrisville, NC USA.
   [Dancik, Yuri; Jaworska, Joanna S.] Procter & Gamble NV, Strombeek Bever, Belgium.
   [Casey, Warren] NIEHS, Natl Toxicol Program, Interagency Ctr Evaluat Alternat Toxicol Methods, Div Natl Toxicol Program, Res Triangle Pk, NC 27709 USA.
RP Casey, W (reprint author), NIEHS, NICEATM, POB 12233,Mail Stop K2-16, Res Triangle Pk, NC 27709 USA.
EM warren.casey@nih.gov
RI Kleinstreuer, Nicole/F-7203-2019
OI Kleinstreuer, Nicole/0000-0002-7914-3682; Dancik,
   Yuri/0000-0002-3652-9673
CR Dancik Y, 2013, ADV DRUG DELIVER REV, V65, P221, DOI 10.1016/j.addr.2012.01.006
   Dethlefsen C., 2005, J STAT SOFTW, V14, P1, DOI [10.1002/dev.20059, DOI 10.1002/DEV.20059]
   Dimitrov SD, 2005, INT J TOXICOL, V24, P189, DOI 10.1080/10915810591000631
   Fomel S, 2009, COMPUT SCI ENG, V11, P5, DOI 10.1109/MCSE.2009.14
   Hojsgaard S, 2012, J STAT SOFTW, V46, P1
   Jaworska J, 2013, J APPL TOXICOL, V33, P1353, DOI 10.1002/jat.2869
   Jaworska J, 2011, ALTEX-ALTERN ANIM EX, V28, P211, DOI 10.14573/altex.2011.3.211
   Jaworska Joanna, 2010, ALTEX, V27, P231
   Kasting G. B., 2008, DERMATOLOGIC COSMECE
   Kim H., 2012, DISCRETIZATION DATA
   Koenker R, 2009, J APPL ECONOMET, V24, P833, DOI 10.1002/jae.1083
   Leisch F., 2002, COMPST 2002 P COMP S
   Linzer DA, 2011, J STAT SOFTW, V42, P1
   NIEHS, 2013, FED REGISTER, V78, P68076
   OECD Publishing, 2012, OECD SER TEST ASS 1, V168
   Organisation for Economic Cooperation and Development (OECD), 2010, OECD GUID TEST CHEM
   Peng RD, 2009, BIOSTATISTICS, V10, P405, DOI 10.1093/biostatistics/kxp014
   Walters WP, 2013, J CHEM INF MODEL, V53, P1529, DOI 10.1021/ci400197w
NR 18
TC 16
Z9 17
U1 0
U2 5
PU SPEKTRUM AKADEMISCHER VERLAG-SPRINGER-VERLAG GMBH
PI HEILDEBERG
PA TIERGARTENSTRASSE 17, HEILDEBERG, 69121, GERMANY
SN 1868-596X
EI 1868-8551
J9 ALTEX-ALTERN ANIM EX
JI ALTEX-Altern. Anim. Exp.
PY 2014
VL 31
IS 3
BP 336
EP 340
DI 10.14573/altex.1310151
PG 5
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA AL9NU
UT WOS:000339468800009
PM 24687303
OA DOAJ Gold
DA 2019-10-23
ER

PT J
AU Leist, M
   Hasiwa, N
   Rovida, C
   Daneshian, M
   Basketter, D
   Kimber, I
   Clewell, H
   Gocht, T
   Goldberg, A
   Busquet, F
   Rossi, AM
   Schwarz, M
   Stephens, M
   Taalman, R
   Knudsen, TB
   McKim, J
   Harris, G
   Pamies, D
   Hartung, T
AF Leist, Marcel
   Hasiwa, Nina
   Rovida, Costanza
   Daneshian, Mardas
   Basketter, David
   Kimber, Ian
   Clewell, Harvey
   Gocht, Tilman
   Goldberg, Alan
   Busquet, Francois
   Rossi, Anna-Maria
   Schwarz, Michael
   Stephens, Martin
   Taalman, Rob
   Knudsen, Thomas B.
   McKim, James
   Harris, Georgina
   Pamies, David
   Hartung, Thomas
TI Consensus Report on the Future of Animal-Free Systemic Toxicity Testing
SO ALTEX-ALTERNATIVES TO ANIMAL EXPERIMENTATION
LA English
DT Article
DE safety testing; animal-free testing; systemic toxicity; adverse outcome
   pathways
ID ALTERNATIVE NONANIMAL METHODS; IN-VITRO METHODS; STEM-CELL TEST; TEST
   H-CLAT; DEVELOPMENTAL NEUROTOXICITY; MODULAR APPROACH; RISK-ASSESSMENT;
   SAFETY ASSESSMENT; HAZARD ASSESSMENT; TOXCAST PROGRAM
AB Since March 2013, animal use for cosmetics testing for the European market has been banned. This requires a renewed view on risk assessment in this field. However, in other fields as well, traditional animal experimentation does not always satisfy requirements in safety testing, as the need for human-relevant information is ever increasing. A general strategy for animal-free test approaches was outlined by the US National Research Council's vision document for Toxicity Testing in the 21st Century in 2007. It is now possible to provide a more defined roadmap on how to implement this vision for the four principal areas of systemic toxicity evaluation: repeat dose organ toxicity, carcinogenicity, reproductive toxicity and allergy induction (skin sensitization), as well as for the evaluation of toxicant metabolism (toxicokinetics) (Fig. 1). CAAT-Europe assembled experts from Europe, America and Asia to design a scientific roadmap for future risk assessment approaches and the outcome was then further discussed and refined in two consensus meetings with over 200 stakeholders. The key recommendations include: focusing on improving existing methods rather than favoring de novo design; combining hazard testing with toxicokinetics predictions; developing integrated test strategies; incorporating new high content endpoints to classical assays; evolving test validation procedures; promoting collaboration and data-sharing of different industrial sectors; integrating new disciplines, such as systems biology and high throughput screening; and involving regulators early on in the test development process. A focus on data quality, combined with increased attention to the scientific background of a test method, will be important drivers. Information from each test system should be mapped along adverse outcome pathways. Finally, quantitative information on all factors and key events will be fed into systems biology models that allow a probabilistic risk assessment with flexible adaptation to exposure scenarios and individual risk factors.
C1 [Leist, Marcel; Hasiwa, Nina; Rovida, Costanza; Daneshian, Mardas; Busquet, Francois; Rossi, Anna-Maria; Hartung, Thomas] Univ Konstanz, CAAT Europe, Ctr Alternat Anim Testing, D-78457 Constance, Germany.
   [Leist, Marcel] Univ Konstanz, Doerenkamp Zbinden Chair In Vitro Toxicol & Biome, D-78457 Constance, Germany.
   [Basketter, David] DABMEB Consultancy Ltd, Sharnbrook, Beds, England.
   [Kimber, Ian] Univ Manchester, Fac Life Sci, Manchester, Lancs, England.
   [Clewell, Harvey] Hamner Inst Hlth Sci, Res Triangle Pk, NC USA.
   [Gocht, Tilman; Schwarz, Michael] Univ Tubingen, Tubingen, Germany.
   [Goldberg, Alan; Stephens, Martin; Harris, Georgina; Pamies, David; Hartung, Thomas] Johns Hopkins Univ, CAAT, Ctr Alternat Anim Testing, Baltimore, MD USA.
   [Taalman, Rob] Cosmet Europe, Brussels, Belgium.
   [Knudsen, Thomas B.] US EPA, Res Triangle Pk, NC 27711 USA.
   [McKim, James] CeeTox, Kalamazoo, MI USA.
RP Leist, M (reprint author), Univ Konstanz, Box M657, D-78457 Constance, Germany.
EM marcel.leist@uni.konstanz.de
RI Leist, Marcel/D-2133-2010
OI Leist, Marcel/0000-0002-3778-8693; busquet,
   francois/0000-0002-9894-3714; Gocht, Tilma/0000-0002-2491-2050; Pamies,
   David/0000-0002-1224-573X
FU Doerenkamp-Zbinden Foundation
FX a report of t<SUP>4</SUP> - the transatlantic think tank for toxicology,
   a collaboration of the toxicologically oriented chairs in Baltimore,
   Konstanz and Utrecht, sponsored by the Doerenkamp-Zbinden Foundation.
CR Adler S, 2011, ARCH TOXICOL, V85, P367, DOI 10.1007/s00204-011-0693-2
   Alden CL, 1996, TOXICOL PATHOL, V24, P722, DOI 10.1177/019262339602400610
   Aldenberg T., 2010, IN SILICO TOXICOLOGY
   Ames BN, 2000, MUTAT RES-FUND MOL M, V447, P3, DOI 10.1016/S0027-5107(99)00194-3
   Andersen ME, 2011, ALTEX-ALTERN ANIM EX, V28, P175, DOI 10.14573/altex.2011.3.175
   Ashikaga T, 2010, ATLA-ALTERN LAB ANIM, V38, P275, DOI 10.1177/026119291003800403
   Bal-Price AK, 2012, ALTEX-ALTERN ANIM EX, V29, P202, DOI 10.14573/altex.2012.2.202
   Basketter DA, 2012, ALTEX-ALTERN ANIM EX, V29, P5, DOI 10.14573/altex.2012.1.003
   Bauch C, 2012, REGUL TOXICOL PHARM, V63, P489, DOI 10.1016/j.yrtph.2012.05.013
   Bauch C, 2011, TOXICOL IN VITRO, V25, P1162, DOI 10.1016/j.tiv.2011.05.030
   Bessems JG, 2014, REGUL TOXICOL PHARM, V68, P119, DOI 10.1016/j.yrtph.2013.11.008
   Blaauboer BJ, 2012, ALTEX-ALTERN ANIM EX, V29, P411, DOI 10.14573/altex.2012.4.411
   Boekelheide Kim, 2010, ALTEX, V27, P243
   Bouhifd M, 2014, BASIC CLIN PHARMACOL, V115, P24, DOI 10.1111/bcpt.12198
   Carney EW, 2011, BIRTH DEFECTS RES B, V92, P395, DOI 10.1002/bdrb.20318
   Chen MJ, 2014, BIOMARK MED, V8, P201, DOI 10.2217/bmm.13.146
   Crofton KM, 2012, CONGENIT ANOM, V52, P140, DOI 10.1111/j.1741-4520.2012.00377.x
   Dix DJ, 2007, TOXICOL SCI, V95, P5, DOI 10.1093/toxsci/kfl103
   Gebhardt R, 2003, DRUG METAB REV, V35, P145, DOI 10.1081/DMR-120023684
   Gottmann E, 2001, ENVIRON HEALTH PERSP, V109, P509, DOI 10.2307/3454710
   Hareng L, 2005, REPROD TOXICOL, V20, P441, DOI 10.1016/j.reprotox.2005.04.003
   Hartung T, 2004, ATLA-ALTERN LAB ANIM, V32, P467, DOI 10.1177/026119290403200503
   Hartung T, 2008, ALTEX-ALTERN TIEREXP, V25, P147
   Hartung T, 2008, ALTEX-ALTERN TIEREXP, V25, P91
   Hartung T, 2013, ALTEX-ALTERN ANIM EX, V30, P119, DOI 10.14573/altex.2013.2.119
   Hartung T, 2013, ALTEX-ALTERN ANIM EX, V30, P3, DOI 10.14573/altex.2013.1.003
   Hartung T, 2012, ALTEX-ALTERN ANIM EX, V29, P119, DOI 10.14573/altex.2012.2.119
   Hartung T, 2011, ALTEX-ALTERN ANIM EX, V28, P183, DOI 10.14573/altex.2011.3.183
   Hartung T, 2011, ALTEX-ALTERN ANIM EX, V28, P83, DOI 10.14573/altex.2011.2.083
   Hartung T, 2009, NATURE, V460, P208, DOI 10.1038/460208a
   Hengstler JG, 2012, ARCH TOXICOL, V86, P13, DOI 10.1007/s00204-011-0798-7
   Hengstler JG, 1999, DRUG METAB REV, V31, P917, DOI 10.1081/DMR-100101946
   Hester SD, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002155
   Hoffmann S, 2006, HUM EXP TOXICOL, V25, P497, DOI 10.1191/0960327106het648oa
   Hoffmann S, 2006, ATLA-ALTERN LAB ANIM, V34, P177, DOI 10.1177/026119290603400209
   Jaworska J, 2011, ALTEX-ALTERN ANIM EX, V28, P211, DOI 10.14573/altex.2011.3.211
   Jaworska Joanna, 2010, ALTEX, V27, P231
   Jaworska J, 2010, REGUL TOXICOL PHARM, V57, P157, DOI 10.1016/j.yrtph.2010.02.003
   Jennings P, 2013, ARCH TOXICOL, V87, P49, DOI 10.1007/s00204-012-0919-y
   Judson R, 2014, BASIC CLIN PHARMACOL, V115, P69, DOI 10.1111/bcpt.12239
   Judson R, 2013, ALTEX-ALTERN ANIM EX, V30, P51, DOI 10.14573/altex.2013.1.051
   Judson RS, 2012, MOL BIOSYST, V8, P531, DOI 10.1039/c1mb05303e
   Judson RS, 2010, ENVIRON HEALTH PERSP, V118, P485, DOI 10.1289/ehp.0901392
   Kavlock R, 2012, CHEM RES TOXICOL, V25, P1287, DOI 10.1021/tx3000939
   Kleensang A, 2014, ALTEX-ALTERN ANIM EX, V31, P53, DOI 10.14573/altex.1309261
   Kleinstreuer N, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002996
   Kleinstreuer NC, 2014, NAT BIOTECHNOL, V32, P583, DOI 10.1038/nbt.2914
   Knight A, 2007, ALTEX-ALTERN TIEREXP, V24, P320, DOI 10.14573/altex.2007.4.320
   Knudsen LE, 2013, ATLA-ALTERN LAB ANIM, V41, P443, DOI 10.1177/026119291304100606
   Knudsen Thomas, 2013, Methods Mol Biol, V947, P343, DOI 10.1007/978-1-62703-131-8_26
   Knudsen TB, 2011, BIRTH DEFECTS RES B, V92, P413, DOI 10.1002/bdrb.20315
   Krug AK, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.166
   Leist M, 2008, ALTEX-ALTERN TIEREXP, V25, P103
   Leist M, 2008, ALTEX-ALTERN TIEREXP, V25, P17
   Leist M, 2013, ARCH TOXICOL, V87, P2037, DOI 10.1007/s00204-013-1154-x
   Leist M, 2013, ALTEX-ALTERN ANIM EX, V30, P227, DOI 10.14573/altex.2013.2.227
   Leist M, 2012, TOXICOL RES-UK, V1, P8, DOI 10.1039/c2tx20011b
   Leist M, 2012, ALTEX-ALTERN ANIM EX, V29, P373, DOI 10.14573/altex.2012.4.373
   Leist M, 2010, ALTEX-ALTERN ANIM EX, V27, P309
   Li Y, 2007, TOXICOL SCI, V99, P532, DOI 10.1093/toxsci/kfm185
   Truong L, 2014, TOXICOL SCI, V137, P212, DOI 10.1093/toxsci/kft235
   Makris SL, 2011, BIRTH DEFECTS RES B, V92, P384, DOI 10.1002/bdrb.20335
   McDowell RM, 2002, SAR QSAR ENVIRON RES, V13, P111, DOI 10.1080/10629360290002280
   Moore N, 2009, ATLA-ALTERN LAB ANIM, V37, P219, DOI 10.1177/026119290903700211
   Natsch A, 2011, TOXICOL IN VITRO, V25, P733, DOI 10.1016/j.tiv.2010.12.014
   Natsch A, 2010, TOXICOL SCI, V113, P284, DOI 10.1093/toxsci/kfp228
   NRC (National Research Council), 2007, TOX TEST 21 CENT VIS
   Oliveira PA, 2007, AN ACAD BRAS CIENC, V79, P593, DOI 10.1590/S0001-37652007000400004
   Olson H, 2000, REGUL TOXICOL PHARM, V32, P56, DOI 10.1006/rtph.2000.1399
   Padilla S, 2012, REPROD TOXICOL, V33, P174, DOI 10.1016/j.reprotox.2011.10.018
   Paparella M, 2013, ALTEX-ALTERN ANIM EX, V30, P131, DOI 10.14573/altex.2013.2.131
   Peiser M, 2012, CELL MOL LIFE SCI, V69, P763, DOI 10.1007/s00018-011-0846-8
   Pfaller W, 2001, Altern Lab Anim, V29, P393
   Pfuhler S, 2010, REGUL TOXICOL PHARM, V57, P315, DOI 10.1016/j.yrtph.2010.03.012
   Piersma AH, 2013, REPROD TOXICOL, V38, P53, DOI 10.1016/j.reprotox.2013.03.002
   Piersma AH, 2010, REPROD TOXICOL, V30, P1, DOI 10.1016/j.reprotox.2010.05.008
   Ramirez T, 2013, ALTEX-ALTERN ANIM EX, V30, P209, DOI 10.14573/altex.2013.2.209
   Ray HJ, 2012, DEVELOPMENT, V139, P1701, DOI 10.1242/dev.068338
   Rossini GP, 2012, ALTEX-ALTERN ANIM EX, V29, P359, DOI 10.14573/altex.2012.4.359
   Rovida C, 2009, ALTEX-ALTERN TIEREXP, V26, P187
   Sakaguchi H, 2006, TOXICOL IN VITRO, V20, P774, DOI 10.1016/j.tiv.2005.10.014
   Schenk B, 2010, REPROD TOXICOL, V30, P200, DOI 10.1016/j.reprotox.2010.05.012
   Seiler AEM, 2011, NAT PROTOC, V6, P961, DOI 10.1038/nprot.2011.348
   Selderslaghs IWT, 2012, REPROD TOXICOL, V33, P142, DOI 10.1016/j.reprotox.2011.08.003
   Shirinifard A, 2013, DEV DYNAM, V242, P518, DOI 10.1002/dvdy.23946
   Smirnova L, 2014, ALTEX-ALTERN ANIM EX, V31, P129, DOI http://dx.doi.org/10.14573/altex.1403271
   Stephens ML, 2013, ALTEX-ALTERN ANIM EX, V30, P74, DOI 10.14573/altex.2013.1.074
   Sturla SJ, 2014, CHEM RES TOXICOL, V27, P314, DOI 10.1021/tx400410s
   Taylor K, 2011, ALTEX-ALTERN ANIM EX, V28, P131, DOI 10.14573/altex.2011.2.131
   van Dartel DAM, 2011, REPROD TOXICOL, V32, P235, DOI 10.1016/j.reprotox.2011.04.008
   van Thriel C, 2012, NEUROTOXICOLOGY, V33, P911, DOI 10.1016/j.neuro.2011.10.002
   Vanparys P, 2011, ALTEX-ALTERN ANIM EX, V28, P56, DOI 10.14573/altex.2011.1.056
   Vinci B, 2012, BIOTECHNOL J, V7, P117, DOI 10.1002/biot.201100177
   Zimmer B, 2014, ARCH TOXICOL, V88, P1109, DOI 10.1007/s00204-014-1231-9
NR 94
TC 76
Z9 78
U1 2
U2 36
PU SPEKTRUM AKADEMISCHER VERLAG-SPRINGER-VERLAG GMBH
PI HEILDEBERG
PA TIERGARTENSTRASSE 17, HEILDEBERG, 69121, GERMANY
SN 1868-596X
EI 1868-8551
J9 ALTEX-ALTERN ANIM EX
JI ALTEX-Altern. Anim. Exp.
PY 2014
VL 31
IS 3
BP 341
EP 356
DI 10.14573/altex.1406091
PG 16
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA AL9NU
UT WOS:000339468800010
PM 25061899
OA DOAJ Gold
DA 2019-10-23
ER

PT J
AU Patlewicz, G
   Ball, N
   Becker, RA
   Booth, ED
   Cronin, MTD
   Kroese, D
   Steup, D
   van Ravenzwaay, B
   Hartung, T
AF Patlewicz, Grace
   Ball, Nicholas
   Becker, Richard A.
   Booth, Ewan D.
   Cronin, Mark T. D.
   Kroese, Dinant
   Steup, David
   van Ravenzwaay, Ben
   Hartung, Thomas
TI Food for Thought ... Read-Across Approaches - Misconceptions, Promises
   and Challenges Ahead
SO ALTEX-ALTERNATIVES TO ANIMAL EXPERIMENTATION
LA English
DT Article
DE analogue approach; category approach; (Q)SARs; adverse outcome pathways
   (AOP); scientific confidence framework
ID EVIDENCE-BASED TOXICOLOGY; SKIN SENSITIZATION; METABOLOMICS; TOXICITY;
   FRAMEWORK; VALIDATION; TOOL; UNCERTAINTY; ASSESSMENTS; SIMILARITY
AB Read-across is a data gap filling technique used within category and analogue approaches. It has been utilized as an alternative approach to address information requirements under various past and present regulatory programs such as the OECD High Production Volume Programme as well as the EU's Registration, Evaluation, Authorisation and restriction of CHemicals (REACH) regulation. Although read-across raises a number of expectations, many misconceptions still remain around what it truly represents; how to address its associated justification in a robust and scientifically credible manner; what challenges/issues exist in terms of its application and acceptance; and what future efforts are needed to resolve them. In terms of future enhancements, read-across is likely to embrace more biologically-orientated approaches consistent with the Toxicity in the 21st Century vision (Tox-21c). This Food for Thought article, which is notably not a consensus report, aims to discuss a number of these aspects and, in doing so, to raise awareness of the ongoing efforts and activities to enhance read-across. It also intends to set the agenda for a CAAT read-across initiative in 2014-2015 to facilitate the proper use of this technique.
C1 [Patlewicz, Grace] DuPont Haskell Global Ctr Hlth & Environm Sci, Newark, DE USA.
   [Ball, Nicholas] Dow Chem Co USA, TERC, Midland, MI 48674 USA.
   [Becker, Richard A.] Amer Chem Council, Regulatory & Tech Affairs Dept, Washington, DC USA.
   [Booth, Ewan D.] Syngenta Ltd, Jealotts Hill Int Res Ctr, Bracknell, Berks, England.
   [Cronin, Mark T. D.] Liverpool John Moores Univ, Sch Pharm & Biomol Sci, Liverpool L3 5UX, Merseyside, England.
   [Kroese, Dinant] TNO, NL-3700 AJ Zeist, Netherlands.
   [Steup, David] Shell Oil Co, Shell Hlth Risk Sci Team, Houston, TX USA.
   [van Ravenzwaay, Ben] BASF Aktiengesellschaft Expt Toxicol & Ecol, Ludwigshafen, Germany.
   [Hartung, Thomas] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, CAAT, Baltimore, MD USA.
   [Hartung, Thomas] Univ Konstanz, CAAT Europe, Constance, Germany.
RP Hartung, T (reprint author), Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Alternat Anim Testing, 615 North Wolfe St,W7032, Baltimore, MD 21205 USA.
EM thartung@jhsph.edu
OI Patlewicz, Grace/0000-0003-3863-9689
FU American Chemical Council (ACC)
FX The perspectives and discussion in this manuscript represent those from
   individual members of the Johns Hopkins Center for Alternatives to
   Animal Testing (CAAT) read-across steering group chaired by Grace
   Patlewicz of DuPont and Thomas Hartung of CAAT. We thank all members for
   their insights and contributions. We would like to particularly thank
   Katy Goyak and Jim Freeman of Exxon Mobil, Volker Strauss of BASF, as
   well as Karen Blackburn and Jorge Naciff of P&G for their contributions.
   A number of the authors are employees of chemical companies or of the
   American Chemical Council (ACC), and received no other compensation but
   their salary for this work.
CR Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   [Anonymous], 2012, OECD SER TEST ASS, V168
   Aptula AO, 2006, CHEM RES TOXICOL, V19, P1097, DOI 10.1021/tx0601004
   Balcke GU, 2011, TOXICOL LETT, V203, P200, DOI 10.1016/j.toxlet.2011.03.013
   Ball N, 2014, REGUL TOXICOL PHARM, V68, P212, DOI 10.1016/j.yrtph.2013.12.007
   Basketter DA, 2012, ALTEX-ALTERN ANIM EX, V29, P5, DOI 10.14573/altex.2012.1.003
   Blackburn K, 2014, REGUL TOXICOL PHARM, V68, P353, DOI 10.1016/j.yrtph.2014.01.004
   Blackburn K, 2011, REGUL TOXICOL PHARM, V60, P120, DOI 10.1016/j.yrtph.2011.03.002
   Bouhifd M, 2013, J APPL TOXICOL, V33, P1365, DOI 10.1002/jat.2874
   Cox LA, 2014, REGUL TOXICOL PHARM, V69, P443, DOI 10.1016/j.yrtph.2014.05.010
   Dancik Y, 2013, ADV DRUG DELIVER REV, V65, P221, DOI 10.1016/j.addr.2012.01.006
   ECETOC, 2010, 109 ECETOC
   ECETOC, 2012, 116 ECETOC QSAR
   ECHA, 2008, GUID INF REQ CHEM SA
   Environmental Protection Agency United States (EPA), 2004, STAT FUT DIR HIGH PR
   Ferrario D, 2014, ALTEX-ALTERN ANIM EX, V31, P319, DOI 10.14573/altex.1403311
   Hanway R. H., 2000, Toxicology Letters (Shannon), V116, P61
   Hartung T, 2004, ATLA-ALTERN LAB ANIM, V32, P467, DOI 10.1177/026119290403200503
   Hartung T, 2007, ALTEX-ALTERN TIEREXP, V24, P143
   Hartung T, 2013, ALTEX-ALTERN ANIM EX, V30, P119, DOI 10.14573/altex.2013.2.119
   Hartung T, 2013, ALTEX-ALTERN ANIM EX, V30, P3, DOI 10.14573/altex.2013.1.003
   Hartung T, 2010, ALTEX-ALTERN ANIM EX, V27, P3
   Hartung T, 2009, ALTEX-ALTERN TIEREXP, V26, P75
   Hoffmann S, 2006, HUM EXP TOXICOL, V25, P497, DOI 10.1191/0960327106het648oa
   Klimisch HJ, 1997, REGUL TOXICOL PHARM, V25, P1, DOI 10.1006/rtph.1996.1076
   Kroese E. D., 2014, REPROD TOXI IN PRESS
   Leist M, 2014, ALTEX-ALTERN ANIM EX, V31, P341, DOI 10.14573/altex.1406091
   OECD, 2002, MAN INV HPV CHEM SEC
   OECD, 2014, OECD SER TEST ASS, V194
   OECD, 2011, OECD SER TEST ASS
   OECD, 2014, US TOOLB AOP WORKFL
   OECD, 2007, OECD SER TEST ASS, V80
   Patlewicz G, 2014, SAR QSAR ENVIRON RES, V25, P367, DOI 10.1080/1062936X.2014.900520
   Patlewicz G., 2008, 23225 EUR EN JRC IHC
   Patlewicz G, 2014, REGUL TOXICOL PHARM, V69, P529, DOI 10.1016/j.yrtph.2014.06.001
   Patlewicz G, 2013, REGUL TOXICOL PHARM, V67, P1, DOI 10.1016/j.yrtph.2013.06.002
   Patlewicz G, 2013, REGUL TOXICOL PHARM, V65, P226, DOI 10.1016/j.yrtph.2012.12.004
   Patlewicz G, 2013, REGUL TOXICOL PHARM, V65, P259, DOI 10.1016/j.yrtph.2012.12.008
   Ramirez T, 2013, ALTEX-ALTERN ANIM EX, V30, P209, DOI 10.14573/altex.2013.2.209
   Reif D., 2010, ENV HLTH PERSPECT, V118, P2, DOI DOI 10.1289/EHP.1002180
   Roberts DW, 2008, J APPL TOXICOL, V28, P443, DOI 10.1002/jat.1293
   Rovida C, 2011, ALTEX-ALTERN ANIM EX, V28, P273, DOI 10.14573/altex.2011.4.273
   Rovida C, 2009, ALTEX-ALTERN TIEREXP, V26, P187
   Schneider K, 2009, TOXICOL LETT, V189, P138, DOI 10.1016/j.toxlet.2009.05.013
   TANIMOTO T, 1957, IBM INTERNAL REPORT
   ten Berge W, 2009, CHEMOSPHERE, V75, P1440, DOI 10.1016/j.chemosphere.2009.02.043
   Tollefsen K. E., 2014, REG TOXICOL IN PRESS
   U. S. Environmental Protection Agency, 2010, TSCA NEW CHEM PROGR
   van Ravenzwaay B, 2007, TOXICOL LETT, V172, P21, DOI 10.1016/j.toxlet.2007.05.021
   van Ravenzwaay B, 2012, MUTAT RES-GEN TOX EN, V746, P144, DOI 10.1016/j.mrgentox.2012.01.006
   van Ravenzwaay B, 2010, TOXICOL LETT, V198, P159, DOI 10.1016/j.toxlet.2010.06.009
   van Woudenberg AB, 2013, REPROD TOXICOL, V41, P35, DOI 10.1016/j.reprotox.2013.06.067
   VansLeeuwen CJ, 2007, RISK ASSESSMENT CHEM, P467
   Willett P, 1998, J CHEM INF COMP SCI, V38, P983, DOI 10.1021/ci9800211
   Wu SD, 2010, REGUL TOXICOL PHARM, V56, P67, DOI 10.1016/j.yrtph.2009.09.006
NR 55
TC 63
Z9 64
U1 0
U2 10
PU SPEKTRUM AKADEMISCHER VERLAG-SPRINGER-VERLAG GMBH
PI HEILDEBERG
PA TIERGARTENSTRASSE 17, HEILDEBERG, 69121, GERMANY
SN 1868-596X
EI 1868-8551
J9 ALTEX-ALTERN ANIM EX
JI ALTEX-Altern. Anim. Exp.
PY 2014
VL 31
IS 4
BP 387
EP 396
DI 10.14573/altex.1410071
PG 10
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA AU0JU
UT WOS:000345310000001
PM 25368965
OA DOAJ Gold
DA 2019-10-23
ER

PT J
AU Willett, C
   Rae, JC
   Goyak, KO
   Landesmann, B
   Minsavage, G
   Westmoreland, C
AF Willett, Catherine
   Rae, Jessica Caverly
   Goyak, Katy O.
   Landesmann, Brigitte
   Minsavage, Gary
   Westmoreland, Carl
TI Pathway-Based Toxicity: History, Current Approaches and Liver Fibrosis
   and Steatosis as Prototypes
SO ALTEX-ALTERNATIVES TO ANIMAL EXPERIMENTATION
LA English
DT Article
ID ADVERSE OUTCOME PATHWAYS; IPCS FRAMEWORK; MODE; INFORMATION; RELEVANCE;
   ECOTOXICOLOGY; STRATEGY
AB The Human Toxicology Project Consortium (HTPC) was created to accelerate implementation of the science and policies required to achieve a pathway-based foundation for toxicology as articulated in the 2007 National Research Council report, Toxicity Testing in the 21st Century: a Vision and a Strategy. The HTPC held a workshop, "Building Shared Experience to Advance Practical Application of Pathway-Based Toxicology: Liver Toxicity Mode-of-Action," in January, 2013, in Baltimore, MD, to further the science of pathway-based approaches to liver toxicity. This review was initiated as a thought-starter for this workshop and has since been updated to include insights from the workshop and other activities occurring in 2013. The report of the workshop has been published in the same issue of this journal (Willett et al., 2014).
C1 [Willett, Catherine] Humane Soc United States, Gaithersburg, MD 20879 USA.
   [Rae, Jessica Caverly] DuPont Haskell Global Ctr Hlth & Environm Sci, Newark, DE USA.
   [Goyak, Katy O.; Minsavage, Gary] ExxonMobil Biomed Sci Inc, Annandale, NJ USA.
   [Landesmann, Brigitte] Commiss European Communities, Joint Res Ctr, Inst Hlth & Consumer Protect, I-21020 Ispra, Italy.
   [Westmoreland, Carl] Unilever Res Labs, Safety & Environm Assurance Ctr, Sharnbrook, Beds, England.
RP Willett, C (reprint author), Humane Soc United States, 700 Professional Dr, Gaithersburg, MD 20879 USA.
EM KWillett@humanesociety.org
CR Aeby P, 2010, TOXICOL IN VITRO, V24, P1465, DOI 10.1016/j.tiv.2010.07.005
   Andersen M., 2012, RES PLAN CASE STUDY
   Andersen M., 2012, REPLACEMENT IN VIVO, V2, P347
   Andersen ME, 2013, ARCH TOXICOL, V87, P7, DOI 10.1007/s00204-012-0980-6
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   [Anonymous], 2012, OECD SER TEST ASS, V168
   Au JS, 2011, ALIMENT PHARM THER, V34, P11, DOI 10.1111/j.1365-2036.2011.04674.x
   Bauch C, 2011, TOXICOL IN VITRO, V25, P1162, DOI 10.1016/j.tiv.2011.05.030
   Boobis AR, 2008, CRIT REV TOXICOL, V38, P87, DOI 10.1080/10408440701749421
   Boobis AR, 2006, CRIT REV TOXICOL, V36, P781, DOI 10.1080/10408440600977677
   Bradbury SP, 2004, ENVIRON SCI TECHNOL, V38, p463A, DOI 10.1021/es040675s
   Carmichael N, 2011, CRIT REV TOXICOL, V41, P175, DOI 10.3109/10408444.2010.541225
   Celander MC, 2011, ENVIRON TOXICOL CHEM, V30, P52, DOI 10.1002/etc.382
   CLEWELL HJ, 1995, CHEMOSPHERE, V31, P2561, DOI 10.1016/0045-6535(95)00124-Q
   EC, 2014, EURL ECVAM REC KER S
   EC, 2013, EURL ECVAM STRAT REP
   EC-European Commission, 2013, EURL ECVAM REC DIR P
   *ECETOC, 2007, 102 ECETOC
   Goodman ZD, 2007, MODERN PATHOL, V20, pS49, DOI 10.1038/modpathol.3800682
   Guengerich FP, 2008, CHEM RES TOXICOL, V21, P70, DOI 10.1021/tx700079z
   HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503
   Holt MP, 2006, AAPS J, V8, pE48, DOI 10.1208/aapsj080106
   Iorio F, 2010, P NATL ACAD SCI USA, V107, P14621, DOI 10.1073/pnas.1000138107
   Jaworska J, 2011, ALTEX-ALTERN ANIM EX, V28, P211, DOI 10.14573/altex.2011.3.211
   Kaplowitz N, 2005, NAT REV DRUG DISCOV, V4, P489, DOI 10.1038/nrd1750
   Kleensang A, 2014, ALTEX-ALTERN ANIM EX, V31, P53, DOI 10.14573/altex.1309261
   Kramer VJ, 2011, ENVIRON TOXICOL CHEM, V30, P64, DOI 10.1002/etc.375
   Lambrechts N, 2010, TOXICOL SCI, V116, P122, DOI 10.1093/toxsci/kfq108
   Landesmann B., 2012, 75689 JRC EUR COMM
   McKim JM, 2012, CUTAN OCUL TOXICOL, V31, P292, DOI 10.3109/15569527.2012.667031
   Meek ME, 2014, J APPL TOXICOL, V34, P1, DOI 10.1002/jat.2949
   Meek ME, 2003, CRIT REV TOXICOL, V33, P591, DOI 10.1080/10408440390250136
   Natsch A, 2013, J APPL TOXICOL, V33, P1337, DOI 10.1002/jat.2868
   Nichols JW, 2011, ENVIRON TOXICOL CHEM, V30, P39, DOI 10.1002/etc.376
   NRC (National Research Council), 2007, TOX TEST 21 CENT VIS
   OECD, 2011, OECD SER TEST ASS
   OECD, 2009, OECD SER TEST ASS, V111
   OECD-Organization for Economic Coordination and Development, 2008, OECD ENV HLTH SAF PU, V100, P35
   Organisation for Economic Co-operation and Development (OECD), 2013, OECD SER TEST ASS, V184
   Parsons T., 2011, CAAT RECEIVES 6 MILL
   Perkins EJ, 2011, ENVIRON TOXICOL CHEM, V30, P22, DOI 10.1002/etc.374
   Rao MS, 2004, HEPATOLOGY, V40, P783, DOI 10.1002/hep.20453
   Schadt EE, 2006, J LIPID RES, V47, P2601, DOI 10.1194/jlr.R600026-JLR200
   Schmieder PK, 2004, ENVIRON SCI TECHNOL, V38, P6333, DOI 10.1021/es0495314
   *US EPA, 2007, FRAM DET MUT MOD ACT
   US EPA-US Environmental Protection Agency, 2006, 39 JOINT M CHEM COMM
   US Food and Drug Administration, 2009, GUID IND DRUG IND LI
   Villeneuve DL, 2011, ENVIRON TOXICOL CHEM, V30, P1, DOI 10.1002/etc.396
   Watanabe KH, 2011, ENVIRON TOXICOL CHEM, V30, P9, DOI 10.1002/etc.373
   Willett C, 2014, ALTEX-ALTERN ANIM EX, V31, P500, DOI http://dx.doi.org/10.14573/altex.1401281
NR 50
TC 13
Z9 14
U1 1
U2 9
PU SPEKTRUM AKADEMISCHER VERLAG-SPRINGER-VERLAG GMBH
PI HEILDEBERG
PA TIERGARTENSTRASSE 17, HEILDEBERG, 69121, GERMANY
SN 1868-596X
EI 1868-8551
J9 ALTEX-ALTERN ANIM EX
JI ALTEX-Altern. Anim. Exp.
PY 2014
VL 31
IS 4
BP 407
EP 421
PG 15
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA AU0JU
UT WOS:000345310000003
PM 24954301
OA DOAJ Gold
DA 2019-10-23
ER

PT J
AU Jin, XW
   Wang, YY
   Giesy, JP
   Richardson, KL
   Wang, ZJ
AF Jin, Xiaowei
   Wang, Yeyao
   Giesy, John P.
   Richardson, Kristine L.
   Wang, Zijian
TI Development of aquatic life criteria in China: viewpoint on the
   challenge
SO ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH
LA English
DT Article
DE Water quality criteria; Prioritization of pollutants; Representative
   species; Adverse outcome pathway analyses; Ecological risk assessment;
   Asia
ID ECOLOGICAL RISK-ASSESSMENT; WATER-QUALITY CRITERIA; SPECIES SENSITIVITY
   DISTRIBUTIONS; MINNOW GOBIOCYPRIS-RARUS; NO-EFFECT CONCENTRATIONS;
   AMERICAN GREAT-LAKES; RANKING SYSTEM; CHEMICAL-SUBSTANCES;
   TOXIC-SUBSTANCES; EFFECT RATIO
AB While more developed countries have a well-established systems to develop water quality criteria (WQC), little research has been done on the adequacy of the current WQC to protect endemic species of China. In order to maintain the health of aquatic ecosystems in China, a series of projects to establish national WQC based on regional characteristics has recently been initiated. However, the establishment of a completely novel methodology would be costly and time consuming. Also, due to the similarities in physiologies and natural histories of classes of aquatic organisms, there is no reason to believe that WQC would not be sufficient to protect unique species in China. This review was undertaken to identify key outstanding issues regarding establishment of aquatic life criteria (ALC) to be applied in China, including prioritization of chemicals, test species, mode of action, field/semi-field data, and methods of aggregating the information and calculating the ALC. This was used to identify the principle issues that need to be addressed in order to better understand the methods for development of criteria for the protection of aquatic life and provide a reference to China and other developing countries committed to the establishment of their own WQC system.
C1 [Jin, Xiaowei; Wang, Yeyao] China Natl Environm Monitoring Ctr, Dept Analyt Tech, Beijing 100012, Peoples R China.
   [Jin, Xiaowei; Wang, Zijian] Chinese Acad Sci, Ecoenvironm Sci Res Ctr, State Key Lab Environm Aquat Chem, Beijing 100085, Peoples R China.
   [Giesy, John P.] Univ Saskatchewan, Dept Vet Biomed Sci, Saskatoon, SK, Canada.
   [Giesy, John P.] Univ Saskatchewan, Toxicol Ctr, Saskatoon, SK, Canada.
   [Giesy, John P.] Nanjing Univ, Sch Environm, State Key Lab Pollut Control & Resources Reuse, Nanjing 210046, Jiangsu, Peoples R China.
   [Giesy, John P.] Michigan State Univ, Dept Zool, Ctr Integrat Toxicol, E Lansing, MI 48824 USA.
   [Giesy, John P.] Univ Hong Kong, Sch Biol Sci, Hong Kong, Hong Kong, Peoples R China.
   [Giesy, John P.] City Univ Hong Kong, State Key Lab Marine Pollut, Dept Biol & Chem, Hong Kong, Hong Kong, Peoples R China.
   [Richardson, Kristine L.] Univ Calif Riverside, Dept Environm Sci, Environm Toxicol Program, Riverside, CA 92521 USA.
RP Wang, ZJ (reprint author), Chinese Acad Sci, Ecoenvironm Sci Res Ctr, State Key Lab Environm Aquat Chem, Shuangqing Rd 18, Beijing 100085, Peoples R China.
EM wangzj@rcees.ac.cn
RI Wang, Zijian/A-1538-2009
OI Wang, Zijian/0000-0002-9847-9691
FU National Basic Research Program of ChinaNational Basic Research Program
   of China [2007CB407301]; Ministry of Environmental Protection of the
   People's Republic of China [201009032]; National Major S&T Program for
   Water Pollution Control and Treatment [2013ZX07502001]; program of "High
   Level Foreign Experts" [GDW20123200120]; State Administration of Foreign
   Experts Affairs, the People's Republic of China; Einstein Professor
   Program of the Chinese Academy of Sciences; Canada Research Chair
   programCanada Research Chairs
FX This research was financially supported by the National Basic Research
   Program of China (2007CB407301), Ministry of Environmental Protection of
   the People's Republic of China (201009032), and National Major S&T
   Program for Water Pollution Control and Treatment (2013ZX07502001).
   Professor Giesy was supported by the program of 2012 "High Level Foreign
   Experts" (#GDW20123200120) funded by the State Administration of Foreign
   Experts Affairs, the People's Republic of China to Nanjing University,
   and the Einstein Professor Program of the Chinese Academy of Sciences.
   He was also supported by the Canada Research Chair program and an at
   large Chair Professorship at the Department of Biology and Chemistry and
   State Key Laboratory in Marine Pollution, City University of Hong Kong.
   We also would like to thank Prof. Xiaowei Zhang (State Key Laboratory of
   Pollution Control and Resource Reuse and School of the Environmental,
   Nanjing University, China), Dr. Gensen Kai (Los Angeles Regional Water
   Quality Control Board, California Environmental Protection Agency, USA),
   and Dr. Qingwei Bu (School of Environment, Tsinghua University, China)
   for the assistance with manuscript and valuable comments.
CR Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Arnot JA, 2008, ENVIRON SCI TECHNOL, V42, P4648, DOI 10.1021/es800106g
   Bosker T, 2010, AQUAT TOXICOL, V100, P9, DOI 10.1016/j.aquatox.2010.07.003
   Boxall ABA, 2012, ENVIRON HEALTH PERSP, V120, P1221, DOI 10.1289/ehp.1104477
   Bu QW, 2013, CRIT REV ENV SCI TEC, V43, P1011, DOI 10.1080/10934529.2011.627030
   Canadian Council of Ministers of the Environment (CCME), 1999, PROT DER WAT QUAL GU
   Chapman PM, 1998, ENVIRON TOXICOL CHEM, V17, P99, DOI 10.1002/etc.5620170112
   Daginnus K, 2011, INT J ENV RES PUB HE, V8, P435, DOI 10.3390/ijerph8020435
   Ela WP, 2011, ENVIRON HEALTH PERSP, V119, P6, DOI 10.1289/ehp.1002497
   Fang L, 1991, ENV POLLUTION CONTRO, V13, P8
   Fedorenkova A, 2010, ENVIRON SCI TECHNOL, V44, P4328, DOI 10.1021/es9037287
   Giesy Jr J.P., 1980, MICROCOSMS ECOLOGICA, V52, P1
   Guillen D, 2012, SCI TOTAL ENVIRON, V440, P236, DOI 10.1016/j.scitotenv.2012.06.064
   Hartung T, 2009, NATURE, V460, P208, DOI 10.1038/460208a
   Hose GC, 2004, ARCH ENVIRON CON TOX, V47, P511, DOI 10.1007/s00244-003-3212-5
   Hutchinson TH, 2006, ENVIRON HEALTH PERSP, V114, P106, DOI 10.1289/ehp.8062
   Jagoe RH, 1997, ECOTOXICOLOGY, V6, P293, DOI 10.1023/A:1018639113818
   Jin Xiao-wei, 2009, Asian Journal of Ecotoxicology, V4, P609
   Jin XW, 2012, ENVIRON SCI POLLUT R, V19, P609, DOI 10.1007/s11356-011-0594-1
   Jin XW, 2012, CHEMOSPHERE, V86, P17, DOI 10.1016/j.chemosphere.2011.08.040
   Jin XW, 2011, CHEMOSPHERE, V84, P1506, DOI 10.1016/j.chemosphere.2011.04.033
   Ke RH, 2007, ENVIRON SCI TECHNOL, V41, P6698, DOI 10.1021/es0707355
   Kumar A, 2010, SCI TOTAL ENVIRON, V408, P5972, DOI 10.1016/j.scitotenv.2010.08.048
   Kwok KWH, 2007, INTEGR ENVIRON ASSES, V3, P49, DOI 10.1002/ieam.5630030105
   Leung KMY, 2001, MAR POLLUT BULL, V42, P1007, DOI 10.1016/S0025-326X(01)00135-7
   Lin BL, 2005, ENVIRON SCI TECHNOL, V39, P4833, DOI 10.1021/es0489893
   Maltby L, 2005, ENVIRON TOXICOL CHEM, V24, P379, DOI 10.1897/04-025R.1
   Mitchell RR, 2002, HUM ECOL RISK ASSESS, V8, P537
   Munoz I, 2008, CHEMOSPHERE, V74, P37, DOI 10.1016/j.chemosphere.2008.09.029
   Murray KE, 2010, ENVIRON POLLUT, V158, P3462, DOI 10.1016/j.envpol.2010.08.009
   Naito W, 2002, WATER RES, V36, P1, DOI 10.1016/S0043-1354(01)00200-7
   OECD, 1995, ORG EC COOP DEV
   Park RA, 2008, ECOL MODEL, V213, P1, DOI 10.1016/j.ecolmodel.2008.01.015
   Rand GM, 2000, ECOTOXICOLOGY, V9, P169, DOI 10.1023/A:1008986519187
   Sanderson H, 2002, ENVIRON SCI POLLUT R, V9, P429, DOI 10.1065/espr2001.09.085
   Snyder EM, 2000, ENVIRON SCI POLLUT R, V7, P176, DOI 10.1065/espr199910.011
   Song R, 1992, CHINA ENV SCI, V12, P276
   Traas Tp, 2001, 601501012 RIVM
   USEPA, 1985, ENV PROTECTION
   Versteeg DJ, 1999, ENVIRON TOXICOL CHEM, V18, P1329, DOI 10.1002/etc.5620180636
   Wang WG, 1991, ENVIRON CHEM, V10, P54
   Welsh PG, 2009, ENVIRON TOXICOL CHEM, V19, P1616
   Wheeler JR, 2002, MAR POLLUT BULL, V45, P192, DOI 10.1016/S0025-326X(01)00327-7
   Wu F., 2012, ENVIRON SCI TECHNOL, V47, P446
   Wu FC, 2010, ENVIRON SCI TECHNOL, V44, P7992, DOI 10.1021/es1029365
   Xia Q, 2004, WATER QUALITY CRITER
   Yan ZG, 2012, ENVIRON POLLUT, V162, P86, DOI 10.1016/j.envpol.2011.11.007
   Yang SW, 2012, ENVIRON POLLUT, V169, P59, DOI 10.1016/j.envpol.2012.05.023
   Zha JM, 2008, TOXICOL APPL PHARM, V226, P298, DOI 10.1016/j.taap.2007.10.006
   Zha JM, 2007, CHEMOSPHERE, V66, P488, DOI 10.1016/j.chemosphere.2006.05.071
   Zhang XW, 2008, ENVIRON SCI TECHNOL, V42, P6762, DOI 10.1021/es800591t
NR 51
TC 9
Z9 14
U1 0
U2 26
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0944-1344
EI 1614-7499
J9 ENVIRON SCI POLLUT R
JI Environ. Sci. Pollut. Res.
PD JAN
PY 2014
VL 21
IS 1
BP 61
EP 66
DI 10.1007/s11356-013-1667-0
PG 6
WC Environmental Sciences
SC Environmental Sciences & Ecology
GA 281IV
UT WOS:000329095300007
PM 23546856
DA 2019-10-23
ER

PT B
AU Marteel-Parrish, AE
   Abraham, MA
AF Marteel-Parrish, Anne E.
   Abraham, Martin A.
BA MarteelParrish, AE
   Abraham, MA
BF MarteelParrish, AE
   Abraham, MA
TI GREEN CHEMISTRY AND TOXICOLOGY
SO GREEN CHEMISTRY AND ENGINEERING: A PATHWAY TO SUSTAINABILITY
LA English
DT Article; Book Chapter
ID HUMAN RELEVANCE; RISK-ASSESSMENT; IPCS FRAMEWORK; CANCER MODE;
   INFORMATION; NEOPLASIA; HAZARD
C1 [Marteel-Parrish, Anne E.] Washington Coll, Dept Chem, Chestertown, MD 21620 USA.
   [Abraham, Martin A.] Youngstown State Univ, Coll Sci Technol Engn & Math, Youngstown, OH 44555 USA.
RP Marteel-Parrish, AE (reprint author), Washington Coll, Dept Chem, Chestertown, MD 21620 USA.
CR ALISON RH, 1994, TOXICOL PATHOL, V22, P179, DOI 10.1177/019262339402200211
   Anastas PT, 2002, ACCOUNTS CHEM RES, V35, P686, DOI 10.1021/ar010065m
   Benigni R., 2009, INITIAL ONTOLOGIES T
   Boobis AR, 2008, CRIT REV TOXICOL, V38, P87, DOI 10.1080/10408440701749421
   Boobis AR, 2006, CRIT REV TOXICOL, V36, P781, DOI 10.1080/10408440600977677
   Canadian Report, 2012, INTEGRATING EMERGING
   CAPEN CC, 1989, TOXICOL PATHOL, V17, P266, DOI 10.1177/019262338901700205
   Chiu WHA, 2013, TOXICOL APPL PHARM, V271, P309, DOI 10.1016/j.taap.2010.03.019
   Committee on the Institutional Means for Assessment of Risks to Public Health National Research Council, 1983, RISK ASSESSMENT FEDE
   CRAMER GM, 1978, FOOD COSMET TOXICOL, V16, P255, DOI 10.1016/S0015-6264(76)80522-6
   Davis AP, 2011, NUCLEIC ACIDS RES, V39, pD1067, DOI 10.1093/nar/gkq813
   Dellarco VL, 2006, CRIT REV TOXICOL, V36, P793, DOI 10.1080/10408440600975242
   Dellarco VL, 2005, TOXICOL SCI, V86, P1, DOI 10.1093/toxsci/kfi133
   Dethloff L, 2000, TOXICOL SCI, V55, P52, DOI 10.1093/toxsci/55.1.52
   Enoch SJ, 2010, CRIT REV TOXICOL, V40, P728, DOI 10.3109/10408444.2010.494175
   European Commission, 2007, REACH BRIEF
   Greene N, 2009, CURR OPIN DRUG DISC, V12, P90
   Johnson D E, 2001, Curr Opin Drug Discov Devel, V4, P92
   Johnson D. E., 2007, COMPUTATIONAL TOXICO, P725
   Johnson D. E., 1997, COMPREHENSIVE TOXICO, V2, P169
   Johnson Dale E., 2001, Current Topics in Medicinal Chemistry, V1, P233, DOI 10.2174/1568026013395128
   Johnson DE, 2000, DRUG DISCOV TODAY, V5, P445, DOI 10.1016/S1359-6446(00)01559-2
   Johnson DE., 2012, J DRUG METABOL TOXIC, V3, P1
   Johnson DL, 2012, GEOL SOC AM SPEC PAP, V490, P1, DOI 10.1130/2012.2490(00)
   Judson R, 2010, J TOXICOL ENV HEAL B, V13, P218, DOI 10.1080/10937404.2010.483937
   Kavlock R, 2010, J TOXICOL ENV HEAL B, V13, P197, DOI 10.1080/10937404.2010.483935
   Klaassen CD, 2008, CASARETT DOULLS TOXI
   Klaunig JE, 2003, CRIT REV TOXICOL, V33, P655, DOI 10.1080/10408440390250154
   Larson H., 2012, COMPUTATIONAL TOXICO, VII, P253, DOI [10.1007/978-1-62703-059-5_11, DOI 10.1007/978-1-62703-059-5_]
   LONGNECKER D, 1990, B CANCER, V77, P27
   MacDonald JS, 2009, TOXICOL SCI, V110, P40, DOI 10.1093/toxsci/kfp088
   McClain RM, 1995, MUTAT RES-FUND MOL M, V333, P131, DOI 10.1016/0027-5107(95)00139-5
   Meek ME, 2003, CRIT REV TOXICOL, V33, P591, DOI 10.1080/10408440390250136
   Mortensen HM, 2013, TOXICOL APPL PHARM, V271, P395, DOI 10.1016/j.taap.2011.01.015
   Munro IC, 2008, TOXICOL LETT, V180, P151, DOI 10.1016/j.toxlet.2008.05.006
   RAO KN, 1980, CANCER RES, V40, P592
   Raunio H, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00033
   REACH Implementation Project, 2004, REACH PROP PROC DESC
   Richard AM, 2008, TOXICOL MECH METHOD, V18, P103, DOI 10.1080/15376510701857452
   Schultz T. W., 2010, SILICO TOXICOLOGY PR, P351
   Seed J, 2005, CRIT REV TOXICOL, V35, P663, DOI 10.1080/10408440591007133
   Tucker JL, 2006, ORG PROCESS RES DEV, V10, P315, DOI 10.1021/op050227k
   Voutchkova AM, 2010, CHEM REV, V110, P5845, DOI 10.1021/cr9003105
   Ward JM, 2007, J TOXICOL PATHOL, V20, P13, DOI DOI 10.1293/T0X.20.13
   WATANAPA P, 1993, BRIT J CANCER, V67, P877, DOI 10.1038/bjc.1993.165
   Zvinavashe E, 2008, CHEM RES TOXICOL, V21, P2229, DOI 10.1021/tx800252e
NR 46
TC 0
Z9 0
U1 0
U2 0
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
BN 978-1-118-72001-1; 978-0-470-41326-5
PY 2014
BP 325
EP 353
D2 10.1002/9781118720011
PG 29
WC Green & Sustainable Science & Technology; Engineering, Environmental
SC Science & Technology - Other Topics; Engineering
GA BM0PE
UT WOS:000458972300012
DA 2019-10-23
ER

PT J
AU Meek, ME
   Boobis, A
   Cote, I
   Dellarco, V
   Fotakis, G
   Munn, S
   Seed, J
   Vickers, C
AF Meek, M. E.
   Boobis, A.
   Cote, I.
   Dellarco, V.
   Fotakis, G.
   Munn, S.
   Seed, J.
   Vickers, C.
TI New developments in the evolution and application of the WHO/IPCS
   framework on mode of action/species concordance analysis
SO JOURNAL OF APPLIED TOXICOLOGY
LA English
DT Review
DE human relevance framework; molecular target; weight of evidence
   approach; cellular response; mode of action; key events; tissue
   response; adverse outcome pathway; modified Bradford Hill
   considerations; species concordance analysis
ID HUMAN RELEVANCE FRAMEWORK; CANCER MODE; CONCEPTUAL-FRAMEWORK; IPCS
   FRAMEWORK; CONTEXT; PRIORITIZATION; INFORMATION; METABOLISM; MECHANISMS;
   CHEMICALS
AB The World Health Organization/International Programme on Chemical Safety mode of action/human relevance framework has been updated to reflect the experience acquired in its application and extend its utility to emerging areas in toxicity testing and non-testing methods. The underlying principles have not changed, but the framework's scope has been extended to enable integration of information at different levels of biological organization and reflect evolving experience in a much broader range of potential applications. Mode of action/species concordance analysis can also inform hypothesis-based data generation and research priorities in support of risk assessment. The modified framework is incorporated within a roadmap, with feedback loops encouraging continuous refinement of fit-for-purpose testing strategies and risk assessment. Important in this construct is consideration of dose-response relationships and species concordance analysis in weight of evidence. The modified Bradford Hill considerations have been updated and additionally articulated to reflect increasing experience in application for cases where the toxicological outcome of chemical exposure is known. The modified framework can be used as originally intended, where the toxicological effects of chemical exposure are known, or in hypothesizing effects resulting from chemical exposure, using information on putative key events in established modes of action from appropriate in vitro or in silico systems and other lines of evidence. This modified mode of action framework and accompanying roadmap and case examples are expected to contribute to improving transparency in explicitly addressing weight of evidence considerations in mode of action/species concordance analysis based on both conventional data sources and evolving methods. Copyright (c) 2013 John Wiley & Sons, Ltd. The World Health Organization retains copyright and all other rights in the manuscript of this article as submitted for publication.
C1 [Meek, M. E.] McLaughlin Ctr Populat Hlth Risk Assessment, Ottawa, ON K1N 6N5, Canada.
   [Boobis, A.] Univ London Imperial Coll Sci Technol & Med, Dept Med, London W12 0NN, England.
   [Cote, I.] US EPA, Natl Ctr Environm Assessment, Washington, DC 20460 USA.
   [Dellarco, V.] US EPA, Off Pesticide Programs, Washington, DC 20460 USA.
   [Fotakis, G.] European Chem Agcy, Helsinki 00120, Finland.
   [Munn, S.] Commiss European Communities, Joint Res Ctr, Inst Hlth & Consumer Protect, Syst Toxicol Unit, I-21027 Ispra, VA, Italy.
   [Seed, J.] US EPA, Off Pollut Prevent & Tox, Washington, DC 20460 USA.
   [Vickers, C.] World Hlth Org, Int Programme Chem Safety, CH-1211 Geneva 27, Switzerland.
RP Vickers, C (reprint author), World Hlth Org, Int Programme Chem Safety, 20 Ave Appia, CH-1211 Geneva 27, Switzerland.
EM vickersc@who.int
RI Boobis, Alan/E-1536-2018
OI Boobis, Alan/0000-0003-3371-386X
FU United States Environmental Protection AgencyUnited States Environmental
   Protection Agency
FX The authors gratefully acknowledge the European Commission Joint
   Research Centre for providing for a drafting group meeting and the
   United States Environmental Protection Agency for its support of the
   project. The authors also thank Kathy Hughes for contributing to the
   discussion and conclusions section and acknowledge Marla Sheffer for
   technical editing of the manuscript.
CR Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Boobis AR, 2008, CRIT REV TOXICOL, V38, P87, DOI 10.1080/10408440701749421
   Boobis AR, 2006, CRIT REV TOXICOL, V36, P781, DOI 10.1080/10408440600977677
   Boobis AR, 2009, CRIT REV FOOD SCI, V49, P690, DOI 10.1080/10408390903098673
   Cao ZY, 2011, ENVIRON HEALTH PERSP, V119, P1239, DOI 10.1289/ehp.1003394
   Cao ZY, 2011, J PHARMACOL EXP THER, V336, P197, DOI 10.1124/jpet.110.171850
   Carmichael N, 2011, CRIT REV TOXICOL, V41, P175, DOI 10.3109/10408444.2010.541225
   Clark JM, 2012, TOP CURR CHEM, V314, P49, DOI 10.1007/128_2011_268
   Cohen SM, 2007, TOXICOL APPL PHARM, V222, P258, DOI 10.1016/j.taap.2006.10.010
   Cohen SM, 2006, CRIT REV TOXICOL, V36, P803, DOI 10.1080/10408440600977651
   Cohen SM, 2006, CRIT REV TOXICOL, V36, P99, DOI 10.1080/10408440500534230
   Council of Labor Affairs Taiwan, 2012, EX CHEM SUBST INV
   Dellarco V, 2010, J TOXICOL ENV HEAL B, V13, P347, DOI 10.1080/10937404.2010.483950
   Dellarco VL, 2006, CRIT REV TOXICOL, V36, P793, DOI 10.1080/10408440600975242
   *EUR CHEM BUR, 2004, EUR UN RISK ASS REP
   Gocht T, 2013, SEURAT 1 DEV RES STR
   HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503
   Hou TJ, 2009, COMB CHEM HIGH T SCR, V12, P497, DOI 10.2174/138620709788489082
   Hughes K, 2009, REGUL TOXICOL PHARM, V55, P382, DOI 10.1016/j.yrtph.2009.09.007
   Julien E, 2009, CRIT REV FOOD SCI, V49, P682, DOI 10.1080/10408390903110692
   Knaak JB, 2012, REV ENVIRON CONTAM T, V219, P1, DOI 10.1007/978-1-4614-3281-4_1
   Lowell Center for Sustainable Production, 2012, CHEM POL OTH NAT
   McConnell ER, 2012, NEUROTOXICOLOGY, V33, P1048, DOI 10.1016/j.neuro.2012.05.001
   McGregor D, 2006, CRIT REV TOXICOL, V36, P821, DOI 10.1080/10408440600977669
   Meek M. E., 2007, RISK ASSESSMENT CHEM, P591
   Meek M.E., 2009, THESIS UTRECHT U NET
   Meek ME, 2008, J TOXICOL ENV HEAL B, V11, P681, DOI 10.1080/10937400801985648
   Meek MEB, 2008, ENVIRON MOL MUTAGEN, V49, P110, DOI 10.1002/em.20369
   Meek ME, 2011, REGUL TOXICOL PHARM, V60, pS1, DOI 10.1016/j.yrtph.2011.03.010
   Meek ME, 2010, CHEM-BIOL INTERACT, V184, P279, DOI 10.1016/j.cbi.2010.02.006
   Meek ME, 2003, CRIT REV TOXICOL, V33, P591, DOI 10.1080/10408440390250136
   Meek ME, APPL TOXICOL UNPUB
   NRC (National Research Council), 2007, TOX TEST 21 CENT VIS
   *OECD, 2009, REP EXP CONS EV ESTR
   OECD, 2012, PROP TEMPL GUID DEV
   Schmieder P, 2003, PURE APPL CHEM, V75, P2389, DOI 10.1351/pac200375112389
   Schmieder PK, 2004, ENVIRON SCI TECHNOL, V38, P6333, DOI 10.1021/es0495314
   Scollon EJ, 2009, DRUG METAB DISPOS, V37, P221, DOI 10.1124/dmd.108.022343
   Seed J, 2005, CRIT REV TOXICOL, V35, P663, DOI 10.1080/10408440591007133
   Soderlund DM, 2012, ARCH TOXICOL, V86, P165, DOI 10.1007/s00204-011-0726-x
   Sonich-Mullin C, 2001, REGUL TOXICOL PHARM, V34, P146, DOI 10.1006/rtph.2001.1493
   The European Parliament and the Council of the European Union, 2006, OFFICIAL J EUROPEA L, P1
   U.S. EPA, 2009, EPA600R08139F
   U.S. EPA, 2005, SCI ISS PAP MOD CARC
   U.S. EPA, 2009, EFF BAS EXP SYST PRE
   *US EPA, 2005, GUID CARC RISK ASS
   US EPA (US Environmental Protection Agency), 1996, FED REGISTER, V61, P17960
NR 47
TC 116
Z9 122
U1 2
U2 34
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0260-437X
EI 1099-1263
J9 J APPL TOXICOL
JI J. Appl. Toxicol.
PD JAN
PY 2014
VL 34
IS 1
BP 1
EP 18
DI 10.1002/jat.2949
PG 18
WC Toxicology
SC Toxicology
GA AD9JR
UT WOS:000333581700001
PM 24166207
OA Green Accepted
HC Y
HP N
DA 2019-10-23
ER

PT J
AU Seidle, T
AF Seidle, Troy
TI Humane Society International's Global Campaign to End Animal Testing
SO ATLA-ALTERNATIVES TO LABORATORY ANIMALS
LA English
DT Article
DE adverse outcome pathway; animal testing; AXLR8; chemical; cosmetic; data
   requirements; Horizon 2020; HSI; Human Toxicology Project; OECD;
   pesticide; REACH; regulatory alignment; Three R best practices
ID MOUSE MODELS
AB The Research & Toxicology Department of Humane Society International (HSI) operates a multifaceted and science-driven global programme aimed at ending the use of animals in toxicity testing and research. The key strategic objectives include: a) ending cosmetics animal testing worldwide, via the multinational Be Cruelty-Free campaign; b) achieving near-term reductions in animal testing requirements through revision of product sector regulations; and c) advancing humane science by exposing failing animal models of human disease and shifting science funding toward human biology-based research and testing tools fit for the 21st century. HSI was instrumental in ensuring the implementation of the March 2013 European sales ban for newly animal-tested cosmetics, in achieving the June 2013 cosmetics animal testing ban in India as well as major cosmetics regulatory policy shifts in China and South Korea, and in securing precedent-setting reductions in in vivo data requirements for pesticides in the EU through the revision of biocides and plant protection product regulations, among others. HSI is currently working to export these life-saving measures to more than a dozen industrial and emerging economies.
C1 [Seidle, Troy] Humane Soc Int, Res & Toxicol Dept, Toronto, ON, Canada.
RP Seidle, T (reprint author), Humane Soc Int, 506-460 St Catherine Ouest, Montreal, PQ H3B 1A7, Canada.
EM tseidle@hsi.org
OI Seidle, Troy/0000-0002-1341-2181
FU Lush Cosmetics; European CommissionEuropean Commission Joint Research
   Centre [241958]; World Society for the Protection of Animals; WSPA
FX HSI would like to thank Lush Cosmetics for its generous financial and
   campaign support for Be Cruelty-Free, and all our regional Be
   Cruelty-Free partners around the globe for their collaboration. AXLR8 is
   a coordination and support project funded by the European Commission
   under the 7th European Framework Programme on Research and Innovation
   (Grant No. 241958). All work on Horizon 2020 political negotiations was
   carried out by using grant funds generously provided by the World
   Society for the Protection of Animals. HSI would also like to thank WSPA
   for funding a portion of its disease models initiative.
CR *AG NAC VIG SAN, 2012, GUIA AV SEG PROD COS
   Buckland GL, 2011, DRUG DISCOV TODAY, V16, P914, DOI 10.1016/j.drudis.2011.08.005
   Collins FS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002747
   Cryan JF, 2004, MOL PSYCHIATR, V9, P326, DOI 10.1038/sj.mp.4001457
   DATTA PTJ, 2013, HINDU BUSINESS  0629
   Ehrnhoefer DE, 2009, DIS MODEL MECH, V2, P123, DOI 10.1242/dmm.002451
   *EU SME CTR, 2012, IMP COSM PROD CHIN
   *HUM SOC INT, 2013, GLOB POLLS REV CONS
   Lamontagne F, 2010, CRIT CARE MED, V38, P2401, DOI 10.1097/CCM.0b013e3181fa0468
   LANGLEY G, 2012, ADV SAF SCI HLTH RES
   MacKay C, 2013, ALTEX-ALTERN ANIM EX, V30, P473, DOI 10.14573/altex.2013.4.473
   MCMANUS R, 2013, NIH RECORD, V65
   *RISK POL AN LTD, 2004, COMP STUD COSM LEG E
   Seidle T, 2011, ALTEX-ALTERN ANIM EX, V28, P95, DOI 10.14573/altex.2011.2.095
   Sena ES, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000344
   Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110
   Sriram S, 2005, ANN NEUROL, V58, P939, DOI 10.1002/ana.20743
   U. S. National Research Council, 2007, TOX TEST 21 CENT VIS
   WEISE E, 2008, US TODAY
NR 19
TC 3
Z9 4
U1 0
U2 31
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0261-1929
EI 2632-3559
J9 ATLA-ALTERN LAB ANIM
JI ATLA-Altern. Lab. Anim.
PD DEC
PY 2013
VL 41
IS 6
BP 453
EP 459
DI 10.1177/026119291304100608
PG 7
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA AR7GD
UT WOS:000343746600010
PM 24512229
DA 2019-10-23
ER

PT J
AU Landesmann, B
   Mennecozzi, M
   Berggren, E
   Whelan, M
AF Landesmann, Brigitte
   Mennecozzi, Milena
   Berggren, Elisabet
   Whelan, Maurice
TI Adverse Outcome Pathway-based Screening Strategies for an Animal-free
   Safety Assessment of Chemicals
SO ATLA-ALTERNATIVES TO LABORATORY ANIMALS
LA English
DT Article
DE Adverse Outcome Pathway; chemical risk assessment; HepaRG cells;
   high-content analysis; high-throughput screening; integrated testing
   strategies; in vitro hepatotoxicity; mode-of-action; predictive
   toxicology; SEURAT-1
ID HEPATOMA HEPARG CELLS; ACUTE LIVER-FAILURE; RISK-ASSESSMENT;
   CONCEPTUAL-FRAMEWORK; CYTOCHROMES P450; IPCS FRAMEWORK; MECHANISMS;
   TOXICITY; MODE; HEPATOTOXICITY
AB Currently, the assessment of risk to human health from exposure to manufactured chemicals is mainly based on experiments performed on living animals (in vivo). Substantial efforts are being undertaken to develop alternative solutions to in vivo toxicity testing. This new paradigm, based on the Mode-of-Action (MoA) framework, postulates that any adverse human health effect caused by exposure to an exogenous substance can be described by a series of causally-linked biochemical or biological key events with measurable parameters. The elaboration of mechanistic knowledge through literature research is necessary for a MoA-driven design of integrated testing strategies using in vitro methods for in vivo predictions. The objective of our ongoing research is to demonstrate the feasibility of an integrated approach to predict human toxicity following the Adverse Outcome Pathway (AOP) framework. In our previous work on MoA with the HepaRG cell model, we developed a strategy to identify chemicals that were hepatotoxic. This pioneered an innovative way of using data from in vitro experiments to group chemicals based on their MoA, which is likely to be an important step in a toxicity testing strategy.
C1 Joint Res Ctr, Inst Hlth & Consumer Protect, Syst Toxicol Unit, I-21027 Ispra, VA, Italy.
   Commiss European Communities, Joint Res Ctr, Inst Hlth & Consumer Protect, Syst Toxicol Unit, I-21020 Ispra, Italy.
   Commiss European Communities, Joint Res Ctr, Inst Hlth & Consumer Protect, EU Reference Lab Alternat Anim Testing EURL ECVAM, I-21020 Ispra, Italy.
RP Landesmann, B (reprint author), Joint Res Ctr, Inst Hlth & Consumer Protect, Syst Toxicol Unit, TP 202,Via E Fermi 2749, I-21027 Ispra, VA, Italy.
EM brigitte.landesmann@ec.europa.eu
CR Andrade RJ, 2005, GASTROENTEROLOGY, V129, P512, DOI 10.1053/j.gastro.2005.05.006
   Aninat C, 2006, DRUG METAB DISPOS, V34, P75, DOI 10.1124/dmd.105.006759
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   [Anonymous], 2007, TOXICITY TESTING FOR
   [Anonymous], 2013, SEURAT 1 SAFETY EVAL
   [Anonymous], 2013, EUROPEAN UNION REFER
   Antherieu S, 2010, DRUG METAB DISPOS, V38, P516, DOI 10.1124/dmd.109.030197
   Berg N, 2011, TOXICOL IN VITRO, V25, P874, DOI 10.1016/j.tiv.2011.02.008
   Boobis AR, 2008, CRIT REV TOXICOL, V38, P87, DOI 10.1080/10408440701749421
   Boobis AR, 2006, CRIT REV TOXICOL, V36, P781, DOI 10.1080/10408440600977677
   COACH Consortium, 2011, SEURAT 1 ANNUAL REPO, V1, P49
   COACH Consortium, 2012, SEURAT 1 ANNUAL REPO, V2, P48
   Edwards SW, 2008, TOXICOL SCI, V106, P312, DOI 10.1093/toxsci/kfn190
   Gripon P, 2002, P NATL ACAD SCI USA, V99, P15655, DOI 10.1073/pnas.232137699
   Guengerich FP, 2007, CHEM RES TOXICOL, V20, P344, DOI 10.1021/tx600260a
   Guillouzo A, 2007, CHEM-BIOL INTERACT, V168, P66, DOI 10.1016/j.cbi.2006.12.003
   HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503
   Jaeschke H, 2002, TOXICOL SCI, V65, P166, DOI 10.1093/toxsci/65.2.166
   Jaeschke H, 2011, J HEPATOL, V55, P227, DOI 10.1016/j.jhep.2011.01.006
   Kaplowitz N, 2002, SEMIN LIVER DIS, V22, P137, DOI 10.1055/s-2002-30100
   Landesmann B., 2012, JRC SCIENTIFIC POLIC
   Larrey D, 2002, SEMIN LIVER DIS, V22, P145, DOI 10.1055/s-2002-30101
   Lasser KE, 2002, JAMA-J AM MED ASSOC, V287, P2215, DOI 10.1001/jama.287.17.2215
   Le Vee M, 2006, EUR J PHARM SCI, V28, P109, DOI 10.1016/j.ejps.2006.01.004
   Lee WM, 2003, SEMIN LIVER DIS, V23, P217
   Liebler DC, 2005, NAT REV DRUG DISCOV, V4, P410, DOI 10.1038/nrd1720
   Lipscomb JC, 2012, ADV EXP MED BIOL, V745, P76, DOI 10.1007/978-1-4614-3055-1_6
   Mennecozzi M, 2012, ALTEX PROC, V1, P193
   O'Brien PJ, 2006, ARCH TOXICOL, V80, P580, DOI 10.1007/s00204-006-0091-3
   OECD, LISTS OF PROJECTS ON
   OECD, 2013, SERIES ON TESTING AN, V164
   OECD, OECD EXTENDED ADVISO
   Reuben A, 2010, HEPATOLOGY, V52, P2065, DOI 10.1002/hep.23937
   Russmann S, 2009, CURR MED CHEM, V16, P3041, DOI 10.2174/092986709788803097
   Simmons SO, 2009, TOXICOL SCI, V111, P202, DOI 10.1093/toxsci/kfp140
   Sonich-Mullin C, 2001, REGUL TOXICOL PHARM, V34, P146, DOI 10.1006/rtph.2001.1493
   Turpeinen M, 2009, TOXICOL IN VITRO, V23, P748, DOI 10.1016/j.tiv.2009.03.008
   Vinken M, 2013, TOXICOL SCI, V136, P97, DOI 10.1093/toxsci/kft177
NR 38
TC 14
Z9 14
U1 0
U2 4
PU FRAME
PI NOTTINGHAM
PA RUSSELL & BURCH HOUSE 96-98 NORTH SHERWOOD ST, NOTTINGHAM NG1 4EE,
   NOTTS, ENGLAND
SN 0261-1929
J9 ATLA-ALTERN LAB ANIM
JI ATLA-Altern. Lab. Anim.
PD DEC
PY 2013
VL 41
IS 6
BP 461
EP 471
DI 10.1177/026119291304100609
PG 11
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA AR7GD
UT WOS:000343746600011
PM 24512230
DA 2019-10-23
ER

PT J
AU Wu, SD
   Fisher, J
   Naciff, J
   Laufersweiler, M
   Lester, C
   Daston, G
   Blackburn, K
AF Wu, Shengde
   Fisher, Joan
   Naciff, Jorge
   Laufersweiler, Michael
   Lester, Cathy
   Daston, George
   Blackburn, Karen
TI Framework for Identifying Chemicals with Structural Features Associated
   with the Potential to Act as Developmental or Reproductive Toxicants
SO CHEMICAL RESEARCH IN TOXICOLOGY
LA English
DT Article
ID IN-VITRO; LONG-TERM; RECEPTOR ANTAGONISTS; ENDOCRINE DISRUPTION;
   ALKYLATING-AGENTS; RAT EMBRYOS; READ-ACROSS; DIVERSE SET; QSAR MODELS;
   TOXICITY
AB Developmental and reproductive toxicity (DART) end points are important hazard end points that need to be addressed in the risk assessment of chemicals to determine whether or not they are the critical effects in the overall risk assessment. These hazard end points are difficult to predict using current in silico tools because of the diversity of mechanisms of action that elicit DART effects and the potential for narrow windows of vulnerability. DART end points have been projected to consume the majority of animals used for compliance with REACH; thus, additional nonanimal predictive tools are urgently needed. This article presents an empirically based decision tree for determining whether or not a chemical has receptor-binding properties and structural features that are consistent with chemical structures known to have toxicity for DART end points. The decision tree is based on a detailed review of 716 chemicals (664 positive, 16 negative, and 36 with insufficient data) that have DART end-point data and are grouped into defined receptor binding and chemical domains. When tested against a group of chemicals not included in the training set, the decision tree is shown to identify a high percentage of chemicals with known DART effects. It is proposed that this decision tree could be used both as a component of a screening system to identify chemicals of potential concern and as a component of weight-of-evidence decisions based on structure activity relationships (SAR) to fill data gaps without generating additional test data. In addition, the chemical groupings generated could be used as a starting point for the development of hypotheses for in vitro testing to elucidate mode of action and ultimately in the development of refined SAR principles for DART that incorporate mode of action (adverse outcome pathways).
C1 [Wu, Shengde; Fisher, Joan; Naciff, Jorge; Laufersweiler, Michael; Lester, Cathy; Daston, George; Blackburn, Karen] Procter & Gamble Co, Cent Prod Safety Dept, Mason, OH 45040 USA.
RP Wu, SD (reprint author), Procter & Gamble Co, Cent Prod Safety Dept, 8700 Mason Montgomery Rd, Mason, OH 45040 USA.
EM wu.s.3@pg.com
CR Agency for Toxic Substances and Disease Registry (ATSDR), 2004, TOX PROF POL BIPH PO
   [Anonymous], REPRORISK SYST VERS
   Arena VC, 2004, SAR QSAR ENVIRON RES, V15, P1, DOI 10.1080/1062936032000169633
   ASTDR, 1999, TOX PROF HEX HCCPD
   ATSDR Agency for Toxic Substances and Disease Registry, 2000, TOX PROF POL BIPH PC
   Bagchi G, 2008, INT J ANDROL, V31, P269, DOI 10.1111/j.1365-2605.2007.00846.x
   BARCELLONA PS, 1987, TERATOGEN CARCIN MUT, V7, P159, DOI 10.1002/tcm.1770070206
   BARILYAK I. R., 1965, FARMAKOL TOKSIKOL, V28, P616
   Belsito D, 2010, FOOD CHEM TOXICOL, V48, pS1, DOI 10.1016/j.fct.2010.05.046
   Blackburn K, 2011, REGUL TOXICOL PHARM, V60, P120, DOI 10.1016/j.yrtph.2011.03.002
   BROWN NA, 1982, TOXICOL APPL PHARM, V64, P271, DOI 10.1016/0041-008X(82)90223-X
   BURKHARDT JE, 1992, VET PATHOL, V29, P230, DOI 10.1177/030098589202900307
   BURROUGHS CD, 1985, J TOXICOL ENV HEALTH, V15, P51, DOI 10.1080/15287398509530635
   Bursi R, 2000, EUR J MED CHEM, V35, P787, DOI 10.1016/S0223-5234(00)00168-9
   Carney EW, 1999, TOXICOL SCI, V50, P117, DOI 10.1093/toxsci/50.1.117
   Cassano A, 2010, CHEM CENT J, V4, DOI 10.1186/1752-153X-4-S1-S4
   Chang Louis W., 1992, Biomedical and Environmental Sciences, V5, P293
   Costanza R, 2009, ALTEX, V26, P187
   Cristofol C, 1997, TOXICOL APPL PHARM, V144, P56, DOI 10.1006/taap.1997.8114
   Cronin MTD, 2008, QSAR COMB SCI, V27, P91, DOI 10.1002/qsar.200710118
   Danielsson C, 2007, BIRTH DEFECTS RES A, V79, P595, DOI 10.1002/bdra.20378
   DICARLO FJ, 1990, DRUG METAB REV, V22, P411, DOI 10.3109/03602539008991446
   Dieter M., 1993, TOXIC REP SER, V26, P1
   Domingo JL, 1998, REPROD TOXICOL, V12, P499, DOI 10.1016/S0890-6238(98)00036-7
   EFSA, 2005, EFSA SCI REP, V43, P1, DOI DOI 10.2903/J.EFSA.2005.43R
   Enoch SJ, 2009, QSAR COMB SCI, V28, P696, DOI 10.1002/qsar.200960011
   *EUR COMM, 2003, OFFICIAL J EUR UNI L, V66, P26
   Fang H, 2003, CHEM RES TOXICOL, V16, P1338, DOI 10.1021/tx030011g
   Fang H, 2001, CHEM RES TOXICOL, V14, P280, DOI 10.1021/tx000208y
   FAO, 2001, FAO SPEC EV PLANT PR
   FAUSTMAN EM, 1989, TERATOLOGY, V40, P199, DOI 10.1002/tera.1420400303
   Feldman M., 2000, CYTOKINE REFERENCE, P835
   GAUNT IF, 1976, FOOD COSMET TOXICOL, V14, P255, DOI 10.1016/S0015-6264(76)80287-8
   Gerenutti M, 2006, PHARMAZIE, V61, P79
   GIAMARELLOU H, 1989, AM J MED, V87, pS49, DOI 10.1016/0002-9343(89)90021-1
   Gofflot F, 2003, HUM MOL GENET, V12, P1187, DOI 10.1093/hmg/ddg129
   Golub MS, 2006, METALS, FERTILITY, AND REPRODUCTIVE TOXICITY, P1
   Gondry E., 1973, J EUR TOXICOL, V5, P227
   Gupta RC, 2011, REPRODUCTIVE AND DEVELOPMENTAL TOXICOLOGY, P471, DOI 10.1016/B978-0-12-382032-7.10037-2
   Hagenaars A, 2011, CHEMOSPHERE, V82, P764, DOI 10.1016/j.chemosphere.2010.10.076
   HARDIN BD, 1983, TOXICOLOGY, V27, P91, DOI 10.1016/0300-483X(83)90014-8
   HEGER W, 1994, TERATOGEN CARCIN MUT, V14, P115, DOI 10.1002/tcm.1770140303
   Herman JP, 1998, J NEUROSCI, V18, P7462
   Hewitt M, 2010, REPROD TOXICOL, V30, P147, DOI 10.1016/j.reprotox.2009.12.003
   HUANG PHT, 1992, TERATOGEN CARCIN MUT, V12, P135, DOI 10.1002/tcm.1770120305
   Hurtt ME, 2003, FOOD CHEM TOXICOL, V41, P611, DOI 10.1016/S0278-6915(02)00326-5
   Incardona JP, 2000, CELL MOL LIFE SCI, V57, P1709, DOI 10.1007/PL00000653
   IPCS, 1992, ENV HLTH CRIT 2
   Jensen GE, 2008, SAR QSAR ENVIRON RES, V19, P631, DOI 10.1080/10629360802550473
   Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317
   KEELER RF, 1978, CLIN TOXICOL, V12, P49, DOI 10.3109/15563657809149583
   Kroes R, 2004, FOOD CHEM TOXICOL, V42, P65, DOI 10.1016/j.fct.2003.08.006
   Laufersweiler MC, 2012, REGUL TOXICOL PHARM, V62, P160, DOI 10.1016/j.yrtph.2011.09.004
   Lozo E., 1996, Teratology, V53, p32A
   Lu LL, 2010, INT J NEUROPSYCHOPH, V13, P877, DOI 10.1017/S1461145709990757
   Luo ZP, 2012, CHEM RES TOXICOL, V25, P990, DOI 10.1021/tx300112p
   MACHERA K, 1995, B ENVIRON CONTAM TOX, V54, P363
   Maglankiewicz L., 2005, 6012000052005 RIVM
   Magoulas GE, 2011, EUR J MED CHEM, V46, P721, DOI 10.1016/j.ejmech.2010.12.008
   Mahgoub AA, 2001, PHARMACOL RES, V44, P73, DOI 10.1006/phrs.2001.0816
   MANSON JM, 1986, ENVIRON HEALTH PERSP, V70, P137, DOI 10.2307/3430350
   McGinty D, 2010, FOOD CHEM TOXICOL, V48, pS115, DOI 10.1016/j.fct.2010.05.042
   MIRKES PE, 1985, TERATOLOGY, V32, P241, DOI 10.1002/tera.1420320212
   Moon HJ, 2009, ARCH TOXICOL, V83, P601, DOI 10.1007/s00204-008-0400-0
   MORIMOTO RI, 1974, TERATOLOGY, V9, pA29
   Morinaga Tagahiko, 1996, Journal of Toxicological Sciences, V21, P187
   NAGANO K, 1984, ENVIRON HEALTH PERSP, V57, P75, DOI 10.2307/3429901
   Nakagawa Y., 2006, TOXICOLOGY ORGANOPHO, V1, P447
   NAROTSKY MG, 1994, FUND APPL TOXICOL, V22, P251, DOI 10.1006/faat.1994.1029
   National Industrial Chemicals Notification and Assessment Scheme (NICNAS):, 2000, 12 NICNAS
   Navarro M, 1999, REPROD TOXICOL, V13, P295, DOI 10.1016/S0890-6238(99)00013-1
   NELSON BK, 1984, ENVIRON HEALTH PERSP, V57, P261, DOI 10.2307/3429925
   Nguyen TL, 2005, J MED CHEM, V48, P6107, DOI 10.1021/jm050502t
   Nogueira AC, 1995, LIFE SCI, V58, P337, DOI 10.1016/0024-3205(95)02293-7
   Novic M, 2010, MOLECULES, V15, P1987, DOI 10.3390/molecules15031987
   NTP, 1991, FIN REP DEV TOX 2 ET
   OCKENFELS VH, 1977, ARZNEIMITTEL-FORSCH, V27, P126
   OJASOO T, 1987, J STEROID BIOCHEM, V27, P255, DOI 10.1016/0022-4731(87)90317-7
   OSER BL, 1976, TOXICOLOGY, V6, P47, DOI 10.1016/0300-483X(76)90007-X
   Ozawa S, 2000, J Toxicol Sci, V25 Spec No, P155
   Petersen SL, 2006, ENDOCRINOLOGY, V147, pS33, DOI 10.1210/en.2005-1157
   PLATZEK T, 1994, TERATOGEN CARCIN MUT, V14, P65, DOI 10.1002/tcm.1770140203
   Puga A., 1999, MOL BIOL TOXIC RESPO, P439
   RAWLINGS SJ, 1985, TOXICOL LETT, V28, P49, DOI 10.1016/0378-4274(85)90008-6
   Rogerson FM, 2003, J MOL ENDOCRINOL, V31, P573, DOI 10.1677/jme.0.0310573
   Rosiak K, 1997, TOXICOLOGY, V121, P191, DOI 10.1016/S0300-483X(97)00066-8
   Ross SA, 2000, PHYSIOL REV, V80, P1021
   Roux C, 2000, AM J CLIN NUTR, V71, p1270S, DOI 10.1093/ajcn/71.5.1270s
   Ruberte J., 1995, Teratology, V51, p29A
   Safe S, 2003, CHEM RES TOXICOL, V16, P807, DOI 10.1021/tx034036r
   Saillenfait AM, 2000, TOXICOL APPL PHARM, V163, P149, DOI 10.1006/taap.1999.8839
   Sakata T, 2011, CHEM SOC REV, V40, P4318, DOI 10.1039/c1cs15019g
   Schardein J. L., 2000, CHEM INDUCED BIRTH D
   Scott HM, 2009, ENDOCR REV, V30, P883, DOI 10.1210/er.2009-0016
   Serreau R, 2005, BJOG-INT J OBSTET GY, V112, P710, DOI 10.1111/j.1471-0528.2004.00525.x
   Shepard T., 2010, SHEPARDS CATALOG TER
   Singh SM, 2000, CURR MED CHEM, V7, P211, DOI 10.2174/0929867003375371
   Sloboda DM, 2005, CURR PHARM DESIGN, V11, P1459, DOI 10.2174/1381612053507873
   Smith R. L., 1965, EMBRYOPATHIC ACTIVIT, P194
   SPINDLE AI, 1977, J REPROD FERTIL, V51, P145
   Stephens TD, 2000, BIOCHEM PHARMACOL, V59, P1489, DOI 10.1016/S0006-2952(99)00388-3
   TAKAYAMA S, 1986, ARZNEIMITTEL-FORSCH, V36-2, P1244
   TURBOW MM, 1968, TERATOLOGY, V1, P103, DOI 10.1002/tera.1420010111
   U. S. EPA, 2000, EPA738F00021
   U.S. EPA, 2009, EPAHQOPP200903220002
   U. S. EPA, 2005, EPAHQOPP200505050004
   U. S. EPA, INT RISK INF SYST RE
   Vinggaard AM, 2006, INT J ANDROL, V29, P186, DOI 10.1111/j.1365-2605.2005.00604.x
   Vinson RK, 2002, MUTAT RES-FUND MOL M, V509, P79, DOI 10.1016/S0027-5107(02)00223-3
   Wade MG, 1997, REPROD TOXICOL, V11, P791, DOI 10.1016/S0890-6238(97)00062-2
   WATANABE T, 1992, ARZNEIMITTEL-FORSCH, V42-1, P374
   Weston Andrea D., 2003, Birth Defects Research, V69, P156, DOI 10.1002/bdrc.10010
   WHITTAKER SG, 1992, TOXICOL APPL PHARM, V113, P144, DOI 10.1016/0041-008X(92)90019-O
   WHO/FAO, 1979, PEST RES FOOD
   WILK AL, 1970, J PHARMACOL EXP THER, V171, P118
   Willhite C., 1998, TOXICOL APPL PHARM, V95, P122
   WILLHITE CC, 1984, TOXICOL APPL PHARM, V74, P397, DOI 10.1016/0041-008X(84)90293-X
   WILLHITE CC, 1992, TOXICOL APPL PHARM, V112, P144, DOI 10.1016/0041-008X(92)90290-9
   WILLHITE CC, 1986, TOXICOL APPL PHARM, V83, P563, DOI 10.1016/0041-008X(86)90239-5
   Willhite CC, 1996, DRUG METAB REV, V28, P105, DOI 10.3109/03602539608993994
   Wu SD, 2010, REGUL TOXICOL PHARM, V56, P67, DOI 10.1016/j.yrtph.2009.09.006
   Yeung S.-C., 2009, MED CARE CANC PATIEN, P18
   Zielinsky P, 2010, EXPERT REV CARDIOVAS, V8, P291, DOI [10.1586/erc.09.174, 10.1586/ERC.09.174]
NR 123
TC 59
Z9 59
U1 0
U2 16
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0893-228X
EI 1520-5010
J9 CHEM RES TOXICOL
JI Chem. Res. Toxicol.
PD DEC
PY 2013
VL 26
IS 12
BP 1840
EP 1861
DI 10.1021/tx400226u
PG 22
WC Chemistry, Medicinal; Chemistry, Multidisciplinary; Toxicology
SC Pharmacology & Pharmacy; Chemistry; Toxicology
GA 275IE
UT WOS:000328668700008
PM 24206190
DA 2019-10-23
ER

PT J
AU Scholz, S
   Sela, E
   Blaha, L
   Braunbeck, T
   Galay-Burgos, M
   Garcia-Franco, M
   Guinea, J
   Kluver, N
   Schirmer, K
   Tanneberger, K
   Tobor-Kaplon, M
   Witters, H
   Belanger, S
   Benfenati, E
   Creton, S
   Cronin, MTD
   Eggen, RIL
   Embry, M
   Ekman, D
   Gourmelon, A
   Halder, M
   Hardy, B
   Hartung, T
   Hubesch, B
   Jungmann, D
   Lampi, MA
   Lee, L
   Leonard, M
   Kuster, E
   Lillicrap, A
   Luckenbach, T
   Murk, AJ
   Navas, JM
   Peijnenburg, W
   Repetto, G
   Salinas, E
   Schuurmann, G
   Spielmann, H
   Tollefsen, KE
   Walter-Rohde, S
   Whale, G
   Wheeler, JR
   Winter, MJ
AF Scholz, Stefan
   Sela, Erika
   Blaha, Ludek
   Braunbeck, Thomas
   Galay-Burgos, Malyka
   Garcia-Franco, Mauricio
   Guinea, Joaquin
   Kluever, Nils
   Schirmer, Kristin
   Tanneberger, Katrin
   Tobor-Kaplon, Marysia
   Witters, Hilda
   Belanger, Scott
   Benfenati, Emilio
   Creton, Stuart
   Cronin, Mark T. D.
   Eggen, Rik I. L.
   Embry, Michelle
   Ekman, Drew
   Gourmelon, Anne
   Halder, Marlies
   Hardy, Barry
   Hartung, Thomas
   Hubesch, Bruno
   Jungmann, Dirk
   Lampi, Mark A.
   Lee, Lucy
   Leonard, Marc
   Kuester, Eberhard
   Lillicrap, Adam
   Luckenbach, Till
   Murk, Albertinka J.
   Navas, Jose M.
   Peijnenburg, Willie
   Repetto, Guillermo
   Salinas, Edward
   Schueuermann, Gerrit
   Spielmann, Horst
   Tollefsen, Knut Erik
   Walter-Rohde, Susanne
   Whale, Graham
   Wheeler, James R.
   Winter, Matthew J.
TI A European perspective on alternatives to animal testing for
   environmental hazard identification and risk assessment
SO REGULATORY TOXICOLOGY AND PHARMACOLOGY
LA English
DT Article
DE Cell lines; 3Rs; QSAR; Read-across; Exposure-based waiving; Fish embryo
   test; Acute toxicity; Chronic toxicity; Endocrine disruption;
   Bioconcentration
ID ZEBRAFISH DANIO-RERIO; MESSENGER-RNA EXPRESSION; ADVERSE OUTCOME
   PATHWAYS; ACUTE FISH TOXICITY; IN-VITRO; TOXICOLOGICAL CONCERN;
   APPLICABILITY DOMAIN; TRANSGENIC ZEBRAFISH; CONCEPTUAL-FRAMEWORK;
   ACCEPTOR REACTIVITY
AB Tests with vertebrates are an integral part of environmental hazard identification and risk assessment of chemicals, plant protection products, pharmaceuticals, biocides, feed additives and effluents. These tests raise ethical and economic concerns and are considered as inappropriate for assessing all of the substances and effluents that require regulatory testing. Hence, there is a strong demand for replacement, reduction and refinement strategies and methods. However, until now alternative approaches have only rarely been used in regulatory settings. This review provides an overview on current regulations of chemicals and the requirements for animal tests in environmental hazard and risk assessment. It aims to highlight the potential areas for alternative approaches in environmental hazard identification and risk assessment. Perspectives and limitations of alternative approaches to animal tests using vertebrates in environmental toxicology, i.e. mainly fish and amphibians, are discussed. Free access to existing (proprietary) animal test data, availability of validated alternative methods and a practical implementation of conceptual approaches such as the Adverse Outcome Pathways and Integrated Testing Strategies were identified as major requirements towards the successful development and implementation of alternative approaches. Although this article focusses on European regulations, its considerations and conclusions are of global relevance. (C) 2013 Elsevier Inc. All rights reserved.
C1 [Scholz, Stefan] UFZ Helmholtz Ctr Environm Res, Dept Bioanalyt Ecotoxicol, D-04318 Leipzig, Germany.
   [Sela, Erika; Garcia-Franco, Mauricio; Guinea, Joaquin] ZF Biolabs, Tres Cantos 28760, Madrid, Spain.
   [Blaha, Ludek] Masaryk Univ, Fac Sci RECETOX Res Ctr Tox Cpds Environm, Brno 62500, Czech Republic.
   [Braunbeck, Thomas] Heidelberg Univ, COS Ctr Organismal Studies, D-69120 Heidelberg, Germany.
   [Galay-Burgos, Malyka] ECETOC European Ctr Ecotoxicol & Toxicol Chem, B-1160 Brussels, Belgium.
   [Schirmer, Kristin; Tanneberger, Katrin] Eawag, Swiss Fed Inst Aquat Sci & Technol, Dept Environm Toxicol, CH-8600 Dubendorf, Switzerland.
   [Schirmer, Kristin] EPF Lausanne, Sch Architecture Civil & Environm Engn, CH-1015 Lausanne, Switzerland.
   [Schirmer, Kristin; Eggen, Rik I. L.] ETH, Dept Environm Syst Sci, CH-8092 Zurich, Switzerland.
   [Tobor-Kaplon, Marysia] WIL Res Europe BV, NL-5231 DD sHertogenbosch, Netherlands.
   [Witters, Hilda] Flemish Inst Technol Res Vito, Team Appl Bio & Mol Syst ABS, B-2400 Mol, Belgium.
   [Belanger, Scott] Procter & Gamble Co, Global Prod Stewardship, Mason, OH 45040 USA.
   [Benfenati, Emilio] IRCCS Ist Ric Farmacol, Mario Negri Lab Environm Chem & Toxicol, I-20156 Milan, Italy.
   [Creton, Stuart] Natl Ctr Replacement Refinement & Reduct Anim Res, London NW1 2BE, England.
   [Cronin, Mark T. D.] Liverpool John Moores Univ, Sch Pharm & Biomol Sci, Liverpool L3 3AF, Merseyside, England.
   [Eggen, Rik I. L.] Eawag, Swiss Fed Inst Aquat Sci & Technol, CH-8600 Dubendorf, Switzerland.
   [Embry, Michelle] ILSI Hlth & Environm Sci Inst HESI, Washington, DC 20005 USA.
   [Ekman, Drew] US EPA, Ecosyst Res Div, Natl Exposure Res Lab, Off Res & Dev, Athens, GA 30605 USA.
   [Gourmelon, Anne] OECD, F-75016 Paris, France.
   [Halder, Marlies] Commiss European Communities, Joint Res Ctr, Inst Hlth & Consumer Protect, EURL ECVAM, I-21027 Ispra, Varese, Italy.
   [Hardy, Barry] Douglas Connect, CH-4314 Zeiningen, Switzerland.
   [Hartung, Thomas] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, CAAT, Baltimore, MD 21205 USA.
   [Hubesch, Bruno] CEFIC European Chem Ind Council, B-1160 Brussels, Belgium.
   [Jungmann, Dirk] Tech Univ Dresden, Fak Umweltwissensch, D-01062 Dresden, Germany.
   [Lampi, Mark A.] ExxonMobil Petr & Chem, B-1831 Machelen, Belgium.
   [Lee, Lucy] Univ Fraser Valley, Dept Biol, Abbotsford, BC, Canada.
   [Leonard, Marc] LOREAL Res & Innovat, Environm Res Dept, F-93601 Aulnay Sous Bois, France.
   [Lillicrap, Adam; Tollefsen, Knut Erik] Norwegian Inst Water Res NIVA, N-0349 Oslo, Norway.
   [Murk, Albertinka J.] Wageningen Univ, Environm Technol Dept, NL-6700 AA Wageningen, Netherlands.
   [Murk, Albertinka J.] Wageningen IMARES Inst Marine Resources & Ecosyst, NL-6700 AA Wageningen, Netherlands.
   [Navas, Jose M.] Natl Inst Agr & Food Res & Technol INIA, Dept Environm, E-28040 Madrid, Spain.
   [Peijnenburg, Willie] RIVM, Ctr Subst & Prod, NL-3720 BA Bilthoven, Netherlands.
   [Peijnenburg, Willie] Leiden Univ, Ctr Environm Sci, Leiden, Netherlands.
   [Repetto, Guillermo] Univ Pablo Olavide, Area Toxicol, Dep Biol Mol & Ingn, Seville 41013, Spain.
   [Salinas, Edward] Expt Toxicol & Ecol GV TC, BASF SE, GVTC Z570, D-67056 Ludwigshafen, Germany.
   [Schueuermann, Gerrit] UFZ Helmholtz Ctr Environm Res, Dept Ecol Chem, D-04318 Leipzig, Germany.
   [Schueuermann, Gerrit] Tech Univ Bergakad Freiberg, Inst Organ Chem, D-09596 Freiberg, Germany.
   [Spielmann, Horst] Free Univ Berlin, Fac Biol, D-14195 Berlin, Germany.
   [Walter-Rohde, Susanne] Fed Environm Agcy UBA, Int Chem Management, D-06813 Dessau Rosslau, Germany.
   [Whale, Graham] Shell Hlth, Shell Technol Ctr, Chester CH1 3SH, Cheshire, England.
   [Wheeler, James R.] Syngenta Ltd, Environm Safety, Jealotts Hill Int Res Ctr, Bracknell RG42 6EY, Berks, England.
   [Winter, Matthew J.] AstraZeneca UK Ltd, Brixham Environm Lab, Freshwater Quarry, Brixham TQS 8BA, Devon, England.
RP Scholz, S (reprint author), UFZ Helmholtz Ctr Environm Res, Dept Bioanalyt Ecotoxicol, D-04318 Leipzig, Germany.
EM stefan.scholz@ufz.de; esela@zfbiolabs.com; blaha@recetox.muni.cz;
   braunbeck@uni-hd.de; malyka.galay-burgos@ecetoc.org;
   mgarcia@zfbiolabs.com; jguinea@gbiolabs.com; nils.kluever@ufz.de;
   kristin.schirmer@eawag.ch; marysia.tobor-kaplon@wilresearch.com;
   hilda.witters@vito.be; belanger.se@pg.com; benfenati@marionegri.it;
   stuart.creton@nc3rs.org.uk; m.t.cronin@ljmu.ac.uk; rik.eggen@eawag.ch;
   membry@ilsi.org; ekman.drew@epa.gov; anne.gourmelon@oecd.org;
   marlies.halder@ec.europa.eu; barry.hardy@douglasconnect.com;
   thartung@jhsph.edu; bhu@cefic.be; dirkjungmann@tu-dresden.de;
   mark.a.lampi@exxonmobil.com; lucy.lee@ufv.ca; mleonard@rd.loreal.com;
   eberhard.kuester@ufz.de; adam.lillicrap@niva.no; till.luckenbach@ufz.de;
   tinka.murk@wur.nl; jmnavas@inia.es; willie.pefinenburg@rivm.nl;
   grepkuh@upo.es; edward.salinas@basf.com; gerrit.schuurmann@ufz.de;
   horst.spielmann@fu-berlin.de; knut.erik.tollefsen@niva.no;
   susanne.walter-rohde@uba.de; graham.whale@shell.com;
   james.wheeler@syngenta.com; matthew.winter@astrazeneca.com
RI Scholz, Stefan/B-7776-2014; Luckenbach, Till/G-6482-2015; Repetto,
   Guillermo/G-9748-2015; Witters, Hilda/V-5754-2019; Schuurmann,
   Gerrit/E-7962-2017; Navas, Jose M/I-9328-2012; Kluver, Nils/D-8678-2015;
   Kramer, Nynke I./A-9417-2015; Peijnenburg, Willie J.G.M/E-1120-2014;
   Blaha, Ludek/N-6343-2013; Lampi, Mark/H-1410-2019; Lee, Lucy
   EJ/B-8849-2016
OI Scholz, Stefan/0000-0002-6990-4716; Luckenbach,
   Till/0000-0001-6204-1033; Repetto, Guillermo/0000-0003-1394-8207;
   Witters, Hilda/0000-0002-2026-3962; Schuurmann,
   Gerrit/0000-0002-3789-1703; Navas, Jose M/0000-0002-7644-8499; Kramer,
   Nynke I./0000-0002-3281-1815; Peijnenburg, Willie
   J.G.M/0000-0003-2958-9149; Blaha, Ludek/0000-0002-7314-7455; Lampi,
   Mark/0000-0001-9936-7408; Kuster, Eberhard/0000-0002-6062-2755; Winter,
   Matthew/0000-0002-3668-6564; Lillicrap, Adam/0000-0002-4548-9052;
   Belanger, Scott/0000-0003-0369-9673; Lee, Lucy EJ/0000-0003-1796-0588;
   GARCIA-FRANCO, MAURICIO/0000-0001-7647-8551
FU EUROECOTOX; European CommissionEuropean Commission Joint Research Centre
   [265.260]
FX This review was stimulated by an expert meeting held in October 2011 at
   the Helmholtz Centre for Environmental Research - UFZ, Leipzig, Germany,
   with about 40 international experts with a background in research,
   industry or regulation. The meeting was organized and supported by
   EUROECOTOX, a coordination action funded within the European Commission
   7th Framework Programme (Grant agreement no 265.260). The aim of this
   meeting was to discuss the perspectives of alternatives to animal tests
   in environmental risk assessment.
CR Ahlers J, 2006, ENVIRON TOXICOL CHEM, V25, P2937, DOI 10.1897/05-701R.1
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   [Anonymous], 2007, 15088 ISO
   Anselmo HMR, 2011, ECOTOX ENVIRON SAFE, V74, P2182, DOI 10.1016/j.ecoenv.2011.07.037
   ANSELMO HMR, 2012, THESIS WAGENINGEN U
   Archer G, 1997, ATLA-ALTERN LAB ANIM, V25, P505
   Arnot JA, 2006, ENVIRON REV, V14, P257, DOI 10.1139/A06-005
   BALLS M, 1995, ATLA-ALTERN LAB ANIM, V23, P129
   Balls M, 2006, ATLA-ALTERN LAB ANIM, V34, P603, DOI 10.1177/026119290603400604
   BANERJEE S, 1984, ENVIRON SCI TECHNOL, V18, P79, DOI 10.1021/es00120a005
   Baron MG, 2012, ECOTOXICOLOGY, V21, P2419, DOI 10.1007/s10646-012-0965-5
   Bars R, 2012, REGUL TOXICOL PHARM, V64, P143, DOI 10.1016/j.yrtph.2012.06.013
   Bars R, 2011, REGUL TOXICOL PHARM, V59, P37, DOI 10.1016/j.yrtph.2010.09.003
   Belanger SE, 2013, ENVIRON TOXICOL CHEM, V32, P1768, DOI 10.1002/etc.2244
   Beresford N, 2000, TOXICOL APPL PHARM, V162, P22, DOI 10.1006/taap.1999.8817
   Blackburn K, 2011, REGUL TOXICOL PHARM, V60, P120, DOI 10.1016/j.yrtph.2011.03.002
   Blaschke U, 2012, CHEM RES TOXICOL, V25, P170, DOI 10.1021/tx200395k
   Bohme A, 2010, CHEM RES TOXICOL, V23, P1905, DOI 10.1021/tx100226n
   Bols NC, 2005, BIOCH MOLEC, V6, P43
   Brion F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036069
   Broeders JJW, 2013, TOXICOL IN VITRO, V27, P1057, DOI 10.1016/j.tiv.2013.01.010
   Brown RS, 2001, ENVIRON SCI TECHNOL, V35, P4097, DOI 10.1021/es010708t
   Buist H, 2013, REGUL TOXICOL PHARM, V67, P170, DOI 10.1016/j.yrtph.2013.01.002
   Busquet F, 2008, TOXICOL SCI, V104, P177, DOI 10.1093/toxsci/kfn065
   Carmichael N, 2011, CRIT REV TOXICOL, V41, P175, DOI 10.3109/10408444.2010.541225
   CCAC, 2012, 2010 CCAC SURV AN US
   Chapman K, 2009, MABS-AUSTIN, V1, P505, DOI 10.4161/mabs.1.5.9676
   Chapman KL, 2012, REGUL TOXICOL PHARM, V62, P347, DOI 10.1016/j.yrtph.2011.10.016
   Chapman KL, 2010, DRUG DISCOV TODAY, V15, P235, DOI 10.1016/j.drudis.2010.01.002
   ChemProp, 2012, CHEM PROP EST SOFTW
   *COHIBA, 2010, WHOL EFFL ASS WEA PR
   Collins FS, 2008, SCIENCE, V319, P906, DOI 10.1126/science.1154619
   Cowan-Ellsberry CE, 2008, CHEMOSPHERE, V70, P1804, DOI 10.1016/j.chemosphere.2007.08.030
   Crane Mark, 2010, Integrated Environmental Assessment and Management, V6, P378, DOI 10.1002/ieam.43
   CRETON S, 2013, CHEMOSPHERE IN PRESS
   Creton S, 2013, CHEMOSPHERE, V90, P1300, DOI 10.1016/j.chemosphere.2012.09.029
   Creton S, 2010, TOXICOL LETT, V199, P111, DOI 10.1016/j.toxlet.2010.08.019
   Crump D, 2011, COMP BIOCHEM PHYS C, V154, P129, DOI 10.1016/j.cbpc.2011.04.005
   CURREN RD, 1995, ATLA-ALTERN LAB ANIM, V23, P211
   De Wolf W, 2005, ENVIRON TOXICOL CHEM, V24, P479, DOI 10.1897/04-133R.1
   de Zwart D, 2002, ENVIRON ECOL RISK AS, P133
   Dimitrov S, 2005, J CHEM INF MODEL, V45, P839, DOI 10.1021/ci0500381
   Dix DJ, 2012, TOXICOL SCI, V130, P440, DOI 10.1093/toxsci/kfs281
   *ECETOC, 2013, 120 ECETOC
   *ECETOC, 2007, 102 ECETOC
   *ECHA, 2010, PRACT GUID 4 REP DAT
   ECHA, 2012, EXP WORKSH READ ACR
   ECHA, 2008, GUID INF REQ CHEM SA
   ECHA, 2011, ECHA11R0042EN
   *ECHA, 2010, PRACT GUID 6 REP REA
   EMA (European Medicines Agency), 2008, EMEACVMPERA418282200
   Embry MR, 2010, AQUAT TOXICOL, V97, P79, DOI 10.1016/j.aquatox.2009.12.008
   EMEA/CHMP, 2006, EMEACHMPSWP444700
   Epel D, 2008, ENVIRON SCI TECHNOL, V42, P3914, DOI 10.1021/es087187v
   Escher BI, 2011, CHEM RES TOXICOL, V24, P1134, DOI 10.1021/tx200114y
   *EU, 2010, 6 EU SEC, P1107
   European Chemicals Agency (ECHA), 2010, PRACT GUID 2 REP WEI
   [FDA] US Food and Drug Administration, 1998, GUID IND ENV ASS HUM
   Ferrari T, 2013, SAR QSAR ENVIRON RES, V24, P631, DOI 10.1080/1062936X.2013.773376
   Fini JB, 2012, ENDOCRINOLOGY, V153, P5068, DOI 10.1210/en.2012-1463
   Fischer S, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-69
   Fischer S, 2011, AQUAT TOXICOL, V101, P438, DOI 10.1016/j.aquatox.2010.11.010
   Foekema EM, 2012, ENVIRON TOXICOL CHEM, V31, P1381, DOI 10.1002/etc.1836
   Freyberger A, 2010, REPROD TOXICOL, V30, P9, DOI 10.1016/j.reprotox.2009.10.002
   *GAO, 2007, GAO07825
   Gobas Frank A. P. C., 2009, Integrated Environmental Assessment and Management, V5, P624, DOI 10.1897/IEAM_2008-089.1
   Goldstone JV, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-643
   Gonzalez-Doncel M, 2011, AQUAT TOXICOL, V105, P421, DOI 10.1016/j.aquatox.2011.07.015
   Grindon C, 2006, ATLA-ALTERN LAB ANIM, V34, P651, DOI 10.1177/026119290603400607
   Gross Melanie, 2010, Integrated Environmental Assessment and Management, V6, P2, DOI 10.1897/IEAM_2008-092.1
   Gunnarsson L, 2008, ENVIRON SCI TECHNOL, V42, P5807, DOI 10.1021/es8005173
   Hamers T, 2008, MOL NUTR FOOD RES, V52, P284, DOI 10.1002/mnfr.200700104
   Hardy B, 2010, J CHEMINFORMATICS, V2, DOI 10.1186/1758-2946-2-7
   Hartung T, 2004, ATLA-ALTERN LAB ANIM, V32, P467, DOI 10.1177/026119290403200503
   Hartung T, 2013, ALTEX-ALTERN ANIM EX, V30, P119, DOI 10.14573/altex.2013.2.119
   Hartung T, 2013, ALTEX-ALTERN ANIM EX, V30, P3, DOI 10.14573/altex.2013.1.003
   Hartung T, 2009, NATURE, V460, P1080, DOI 10.1038/4601080a
   Hennes EC, 2012, TOXICOL LETT, V211, P296, DOI 10.1016/j.toxlet.2012.03.795
   Hewitt M, 2010, ISSUES TOXICOL, V7, P301
   HOEGER B, 2006, SETAC EUR 16 ANN M 7
   Hoekzema CC, 2006, ENVIRON TOXICOL CHEM, V25, P1322, DOI 10.1897/05-293R2.1
   Hrovat M, 2009, REGUL TOXICOL PHARM, V54, P294, DOI 10.1016/j.yrtph.2009.05.013
   Huggett DB, 2003, HUM ECOL RISK ASSESS, V9, P1789, DOI 10.1080/10807030390260498
   Hutchinson TH, 2003, ENVIRON TOXICOL CHEM, V22, P3031, DOI 10.1897/02-558
   Jager T, 2012, ENVIRON TOXICOL CHEM, V31, P228, DOI 10.1002/etc.746
   Jeram S, 2005, REGUL TOXICOL PHARM, V42, P218, DOI 10.1016/j.yrtph.2005.04.005
   Ji C, 2012, TOXICOL APPL PHARM, V262, P149, DOI 10.1016/j.taap.2012.04.029
   JOHANNING K, 2001, CURR PROTOCOLS TOXIC, P1
   Jones SP, 2009, TOXICOL SCI, V109, P66, DOI 10.1093/toxsci/kfp039
   Judson RS, 2010, ENVIRON SCI TECHNOL, V44, P5979, DOI 10.1021/es102150z
   Kaiser KLE, 1999, WATER QUAL RES J CAN, V34, P179, DOI 10.2166/wqrj.1999.006
   Kavlock R. J., 2007, AATEX, V14, P623
   KENAGA E E, 1982, Environmental Toxicology and Chemistry, V1, P347, DOI 10.1897/1552-8618(1982)1[347:POCTFA]2.0.CO;2
   Knacker Thomas, 2010, Integrated Environmental Assessment and Management, V6, P653, DOI 10.1002/ieam.92
   Knobel M, 2012, ENVIRON SCI TECHNOL, V46, P9690, DOI 10.1021/es301729q
   Koeter HBWM, 2003, TOXICOL LETT, V140, P11, DOI 10.1016/S0378-4274(02)00491-5
   Kohonen P, 2013, MOL INFORM, V32, P47, DOI 10.1002/minf.201200114
   Kokel D, 2010, NAT CHEM BIOL, V6, P231, DOI 10.1038/NCHEMBIO.307
   Kortenkamp A, 2009, STATE ART REPORT MIX
   Kramer NI, 2010, CHEM RES TOXICOL, V23, P1806, DOI 10.1021/tx1002595
   Kramer NI, 2009, TOXICOL IN VITRO, V23, P1372, DOI 10.1016/j.tiv.2009.07.029
   Kramer VJ, 2011, ENVIRON TOXICOL CHEM, V30, P64, DOI 10.1002/etc.375
   Kroes R, 2005, TOXICOL SCI, V86, P226, DOI 10.1093/toxsci/kfi169
   Kroes R, 2004, FOOD CHEM TOXICOL, V42, P65, DOI 10.1016/j.fct.2003.08.006
   Kuhne R, 2009, J CHEM INF MODEL, V49, P2660, DOI 10.1021/ci900313u
   Kuhnert A, 2013, ENVIRON TOXICOL CHEM, V32, P1819, DOI 10.1002/etc.2239
   Lammer E, 2009, TOXICOL IN VITRO, V23, P1436, DOI 10.1016/j.tiv.2009.05.014
   Lammer E, 2009, COMP BIOCHEM PHYS C, V149, P196, DOI 10.1016/j.cbpc.2008.11.006
   Landis Wayne G., 2011, Integrated Environmental Assessment and Management, V7, pVI, DOI 10.1002/ieam.249
   Leist M, 2012, TOXICOL RES-UK, V1, P8, DOI 10.1039/c2tx20011b
   MCELROY K, 2011, FORDHAM ENV LAW REV, V2, P29
   McGrath JA, 2009, ENVIRON TOXICOL CHEM, V28, P1130, DOI 10.1897/08-271.1
   Montano M, 2012, TOXICOL SCI, V130, P94, DOI 10.1093/toxsci/kfs228
   Mulliner D, 2011, ORG BIOMOL CHEM, V9, P8400, DOI 10.1039/c1ob06065a
   Munn S, 2013, JRC SCI POLICY REPOR
   Murk AJ, 2013, TOXICOL IN VITRO, V27, P1320, DOI 10.1016/j.tiv.2013.02.012
   Nagel R, 2002, ALTEX-ALTERN TIEREXP, V19, P38
   *NAT, 2010, KEM BIOL KAR PUNKT T
   Netzeva TI, 2005, ATLA-ALTERN LAB ANIM, V33, P155, DOI 10.1177/026119290503300209
   Nichols JW, 2006, AQUAT TOXICOL, V78, P74, DOI 10.1016/j.aquatox.2006.01.017
   Nichols JW, 2013, ENVIRON TOXICOL CHEM, V32, P1611, DOI 10.1002/etc.2219
   Noury P, 2006, ENVIRON TOXICOL, V21, P324, DOI 10.1002/tox.20184
   *OECD, 2009, OECD GUID 456 TEST C
   OECD, 1984, OECD GUID TEST CHEM
   OECD, 2012, INF OECD WORK REL EN
   OECD, 2012, SER TEST ASS
   OECD, 2012, 443 OECD TG
   *OECD, 2007, ENVIMMONO20072 OECD
   OECD, 2013, 236 OECD
   OECD, 2007, SER TEST ASS, V80
   *OECD, 2009, 455 OECD TG
   OECD, 2012, PROP TEMPL GUID DEV
   OECD, 1992, OECD GUID TEST CHEM
   *OECD, 2012, SER TEST ASS, V179
   *OECD, 2010, 126 OECD TG
   OECD, 2005, OECD SER TEST ASS
   *OECD, 2012, SER TEST ASS, V171
   OECD TG 305, 2012, 305 OECD TG, V305
   Opitz R, 2012, DEV BIOL, V372, P203, DOI 10.1016/j.ydbio.2012.09.011
   Organisation for Economic Co-operation and Development (OECD), 1996, OECD WORKSH HARM VAL
   Oris JT, 2012, ENVIRON TOXICOL CHEM, V31, P370, DOI 10.1002/etc.747
   OSIRIS, 2011, OPT STRAT RISK ASS I
   *OSPAR, 2007, PRACT GUID DOC WHOL
   *OSPAR, 2000, 117 OSPAR
   *OSPAR, 2012, OSPAR GUID COMPL HAR
   PARKERTON T, 2012, SETAC GLOBE, V13
   Parkerton Thomas F., 2008, Integrated Environmental Assessment and Management, V4, P139, DOI 10.1897/IEAM_2007-057.1
   Porte C, 2006, COMP BIOCHEM PHYS C, V143, P303, DOI 10.1016/j.cbpc.2006.03.004
   Punt A, 2013, TOXICOL IN VITRO, V27, P44, DOI 10.1016/j.tiv.2012.09.014
   Raimondo S, 2007, ENVIRON TOXICOL CHEM, V26, P2019, DOI 10.1897/07-069R.1
   RAVINDRA PKV, 2006, J IMMUNOTOXICOL, V3, P101
   Redman AD, 2012, ENVIRON TOXICOL CHEM, V31, P2498, DOI 10.1002/etc.1982
   Riedl J, 2007, CHEMOSPHERE, V67, P2210, DOI 10.1016/j.chemosphere.2006.12.022
   Robinson S, 2008, REGUL TOXICOL PHARM, V50, P345, DOI 10.1016/j.yrtph.2007.11.009
   Rorije E, 2013, REGUL TOXICOL PHARM, V67, P146, DOI 10.1016/j.yrtph.2013.06.003
   Rufli H, 2011, ENVIRON TOXICOL CHEM, V30, P1006, DOI 10.1002/etc.465
   Russell WMS, 1959, PRINCIPLES HUMANE EX
   Russom CL, 1997, ENVIRON TOXICOL CHEM, V16, P948, DOI 10.1002/etc.5620160514
   Sand S, 2006, TOXICOL SCI, V90, P241, DOI 10.1093/toxsci/kfj057
   Schirmer K, 1997, TOXICOL IN VITRO, V11, P107, DOI 10.1016/S0887-2333(97)00002-7
   Schirmer K, 2006, TOXICOLOGY, V224, P163, DOI 10.1016/j.tox.2006.04.042
   Schirmer K, 2010, ANAL BIOANAL CHEM, V397, P917, DOI 10.1007/s00216-010-3662-3
   Schmidt CW, 2009, ENVIRON HEALTH PERSP, V117, pA348, DOI 10.1289/ehp.117-a348
   Scholz S, 2013, CRIT REV TOXICOL, V43, P45, DOI 10.3109/10408444.2012.737762
   Scholz S, 2010, ENVIRON POLLUT SER, V16, P227, DOI 10.1007/978-90-481-3509-7_13
   Schramm F, 2011, ENVIRON SCI TECHNOL, V45, P5812, DOI 10.1021/es200081n
   Schreiber R, 2011, REGUL TOXICOL PHARM, V61, P261, DOI 10.1016/j.yrtph.2011.08.006
   Schreiber R, 2009, CHEMOSPHERE, V77, P928, DOI 10.1016/j.chemosphere.2009.08.038
   Schreiber R, 2008, ENVIRON TOXICOL CHEM, V27, P1676, DOI 10.1897/07-504
   Schuurmann G, 2011, ENVIRON SCI TECHNOL, V45, P4616, DOI 10.1021/es200361r
   Schuurmann G, 1997, SETAC SP P, P93
   SCHUURMANN G, 2007, RISK ASSESSMENT CHEM, P375
   Schwobel JAH, 2010, CHEM RES TOXICOL, V23, P1576, DOI 10.1021/tx100172x
   Seidle T, 2010, TOXICOL SCI, V116, P382, DOI 10.1093/toxsci/kfq143
   Selderslaghs IWT, 2013, NEUROTOXICOL TERATOL, V37, P44, DOI 10.1016/j.ntt.2013.01.003
   Smith KEC, 2010, AQUAT TOXICOL, V98, P15, DOI 10.1016/j.aquatox.2010.01.007
   Smith KEC, 2010, CHEM RES TOXICOL, V23, P55, DOI 10.1021/tx900274j
   SPIELMANN H, 2007, AATEX, V14, P795
   Spielmann H, 2011, ATLA-ALTERN LAB ANIM, V39, P481, DOI 10.1177/026119291103900509
   Sun HM, 2012, AAPS J, V14, P473, DOI 10.1208/s12248-012-9358-1
   Sunderam RM, 2004, B ENVIRON CONTAM TOX, V72, P873, DOI 10.1007/s00128-004-0325-0
   Tanneberger K, 2013, ENVIRON SCI TECHNOL, V47, P1110, DOI 10.1021/es303505z
   Tanneberger K, 2010, ENVIRON SCI TECHNOL, V44, P4775, DOI 10.1021/es100045y
   Thibaut R, 2009, CELL BIOL TOXICOL, V25, P611, DOI 10.1007/s10565-008-9116-4
   Thienpont B, 2011, ENVIRON SCI TECHNOL, V45, P7525, DOI 10.1021/es202248h
   TLUCZKIEWICZ I, 2013, REGUL TOXIC IN PRESS
   *UK ENV AG, 2006, INT POLL PREV CONTR
   UN, 2011, GLOB HARM SYST CLASS
   *UNEP, 2012, STAT SCI END DISR CH
   US Environmental Protection Agency, 2002, EPA821R02012
   *US EPA, 2012, EPA712C023
   US EPA, 2011, END DISR SCREEN PROG
   *US EPA, 2004, DET REV PAP IN PRESS
   *US EPA, 1998, EPA600881011
   US EPA, 2013, EST PROGR INT SUIT M
   *US EPA, 1996, EPA712C96122
   *US EPA, 1996, 8501075 US EPA OPPTS
   *US EPA, 2009, 8901350 US EPA OPPTS
   *US EPA, 2005, EPA748B04001 OPPT
   den Brink PJ, 2006, HUM ECOL RISK ASSESS, V12, P645, DOI 10.1080/10807030500430559
   van der Jagt K., 2004, 21405 EUR EN
   VERHAAR HJM, 1992, CHEMOSPHERE, V25, P471, DOI 10.1016/0045-6535(92)90280-5
   VILLENEUVE D, 2013, ENV TOXICOL IN PRESS, DOI DOI 10.1002/ETC.2403)
   Villeneuve DL, 2011, ENVIRON TOXICOL CHEM, V30, P1, DOI 10.1002/etc.396
   Voelker D, 2007, AQUAT TOXICOL, V81, P355, DOI 10.1016/j.aquatox.2006.12.013
   Volz DC, 2011, TOXICOL SCI, V123, P349, DOI 10.1093/toxsci/kfr185
   von der Ohe PC, 2005, CHEM RES TOXICOL, V18, P536, DOI 10.1021/tx0497954
   Vongphachan V, 2011, TOXICOL SCI, V120, P392, DOI 10.1093/toxsci/kfq395
   Weigt S, 2012, REPROD TOXICOL, V33, P133, DOI 10.1016/j.reprotox.2011.07.001
   Weigt S, 2011, TOXICOLOGY, V281, P25, DOI 10.1016/j.tox.2011.01.004
   Weigt S, 2010, TOXICOLOGY, V275, P36, DOI 10.1016/j.tox.2010.05.012
   Weil M, 2009, ENVIRON TOXICOL CHEM, V28, P1970, DOI 10.1897/08-627.1
   Weisbrod AV, 2009, ENVIRON TOXICOL CHEM, V28, P86, DOI 10.1897/08-015.1
   WELTJE L, 2013, TOXICOL LET IN PRESS, DOI DOI 10.1016/J.T0XLET.2013.02.019)
   Wheeler JR, 2013, CHEMOSPHERE, V92, P1067, DOI 10.1016/j.chemosphere.2013.01.102
   Williams ES, 2011, ENVIRON TOXICOL CHEM, V30, P1943, DOI 10.1002/etc.583
   Witters H, 2010, REPROD TOXICOL, V30, P60, DOI 10.1016/j.reprotox.2010.02.008
   Wittwehr C, 2011, CHEM UNSERER ZEIT, V45, P122, DOI 10.1002/ciuz.201100546
   Worth AP, 2007, SAR QSAR ENVIRON RES, V18, P111, DOI 10.1080/10629360601054255
   Zvinavashe E, 2009, TOXICOL LETT, V184, P67, DOI 10.1016/j.toxlet.2008.10.030
   Zvinavashe E, 2008, CHEM RES TOXICOL, V21, P2229, DOI 10.1021/tx800252e
   2005, FEDERAL LAW GAZETE 1, V2005
NR 222
TC 78
Z9 79
U1 5
U2 156
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0273-2300
EI 1096-0295
J9 REGUL TOXICOL PHARM
JI Regul. Toxicol. Pharmacol.
PD DEC
PY 2013
VL 67
IS 3
BP 506
EP 530
DI 10.1016/j.yrtph.2013.10.003
PG 25
WC Medicine, Legal; Pharmacology & Pharmacy; Toxicology
SC Legal Medicine; Pharmacology & Pharmacy; Toxicology
GA 257VG
UT WOS:000327415300020
PM 24161465
DA 2019-10-23
ER

PT J
AU Teubner, W
   Mehling, A
   Schuster, PX
   Guth, K
   Worth, A
   Burton, J
   van Ravenzwaay, B
   Landsiedel, R
AF Teubner, Wera
   Mehling, Anette
   Schuster, Paul Xaver
   Guth, Katharina
   Worth, Andrew
   Burton, Julien
   van Ravenzwaay, Bennard
   Landsiedel, Robert
TI Computer models versus reality: How well do in silico models currently
   predict the sensitization potential of a substance
SO REGULATORY TOXICOLOGY AND PHARMACOLOGY
LA English
DT Article
DE Case Ultra; GHS; OECD toolbox; Adverse outcome pathway; (Q)SAR; Skin
   sensitization; TIMES-SS; TOPKAT; Toxtree; Vega
ID LYMPH-NODE ASSAY; PIG MAXIMIZATION TEST; APPLICABILITY DOMAINS; VITRO
   METHODS; SKIN; IDENTIFICATION; PERFORMANCE; VALIDATION; METABOLISM; LLNA
AB National legislations for the assessment of the skin sensitization potential of chemicals are increasingly based on the globally harmonized system (GHS). In this study, experimental data on 55 non-sensitizing and 45 sensitizing chemicals were evaluated according to GHS criteria and used to test the performance of computer (in silico) models for the prediction of skin sensitization. Statistic models (Vega, Case Ultra, TOPKAT), mechanistic models (Toxtree, OECD (Q)SAR toolbox, DEREK) or a hybrid model (TIMES-SS) were evaluated. Between three and nine of the substances evaluated were found in the individual training sets of various models. Mechanism based models performed better than statistical models and gave better predictivities depending on the stringency of the domain definition. Best performance was achieved by TIMES-SS, with a perfect prediction, whereby only 16% of the substances were within its reliability domain. Some models offer modules for potency; however predictions did not correlate well with the GHS sensitization subcategory derived from the experimental data. In conclusion, although mechanistic models can be used to a certain degree under well-defined conditions, at the present, the in silico models are not sufficiently accurate for broad application to predict skin sensitization potentials. (C) 2013 Elsevier Inc. All rights reserved.
C1 [Teubner, Wera] BASF Schweiz AG, CH-4057 Basel, Switzerland.
   [Mehling, Anette] BASF Personal Care & Nutr GmbH, Dusseldorf, Germany.
   [Schuster, Paul Xaver; Guth, Katharina; van Ravenzwaay, Bennard; Landsiedel, Robert] BASF SE, Ludwigshafen, Germany.
   [Worth, Andrew; Burton, Julien] Commiss European Communities, Joint Res Ctr, Inst Hlth & Consumer Protect, I-21020 Ispra, Italy.
RP Teubner, W (reprint author), BASF Schweiz AG, Prod Safety Switzerland, Klybeckstr 141, CH-4057 Basel, Switzerland.
EM wera.teubner@basf.com
RI Worth, Andrew/R-8495-2019; Worth, Andrew Paul/O-3055-2019; Landsiedel,
   Robert/D-1960-2012
OI Worth, Andrew Paul/0000-0002-5303-0452; Landsiedel,
   Robert/0000-0003-3756-1904
CR Andersen KE, 1997, CLIN DERMATOL, V15, P645, DOI 10.1016/S0738-081X(97)00066-7
   Aptula AO, 2007, CONTACT DERMATITIS, V56, P54, DOI 10.1111/j.1600-0536.2007.00944.x
   Aptula AO, 2006, CHEM RES TOXICOL, V19, P1097, DOI 10.1021/tx0601004
   Ball N, 2011, REGUL TOXICOL PHARM, V60, P389, DOI 10.1016/j.yrtph.2011.05.007
   BARRATT MD, 1994, TOXICOL IN VITRO, V8, P1053, DOI 10.1016/0887-2333(94)90244-5
   Basketter DA, 1999, FOOD CHEM TOXICOL, V37, P1167, DOI 10.1016/S0278-6915(99)00112-X
   Basketter DA, 1998, FOOD CHEM TOXICOL, V36, P327, DOI 10.1016/S0278-6915(97)00158-0
   Basketter D, 2012, J APPL TOXICOL, V32, P590, DOI 10.1002/jat.1684
   Bauch C, 2012, REGUL TOXICOL PHARM, V63, P489, DOI 10.1016/j.yrtph.2012.05.013
   Chakravarti SK, 2012, J CHEM INF MODEL, V52, P2609, DOI [10.1021/ci300111r, 10.1021/ci300111rl]
   Chaudhry Q, 2010, CHEM CENT J, V4, DOI 10.1186/1752-153X-4-S1-S5
   Chipinda Itai, 2011, J Allergy (Cairo), V2011, P839682, DOI 10.1155/2011/839682
   Dupuis G., 1982, ALLERGIC CONTACT DER
   Ellison CM, 2009, ATLA-ALTERN LAB ANIM, V37, P533, DOI 10.1177/026119290903700510
   Enoch SJ, 2008, SAR QSAR ENVIRON RES, V19, P555, DOI 10.1080/10629360802348985
   Gamer AO, 2008, REGUL TOXICOL PHARM, V52, P290, DOI 10.1016/j.yrtph.2008.08.018
   Gerberick GF, 2005, DERMATITIS, V16, P157, DOI 10.2310/6620.2005.05040
   Graham C, 1996, QUANT STRUCT-ACT REL, V15, P224, DOI 10.1002/qsar.19960150307
   IGHRC, 2013, PRED APPR CHEM HAZ I
   Jackh C, 2012, J IMMUNOTOXICOL, V9, P426, DOI 10.3109/1547691X.2012.664578
   Karlsson I, 2011, CONTACT DERMATITIS, V64, P343, DOI 10.1111/j.1600-0536.2011.01899.x
   Kayser D., 2001, CHEM KONT BEW ZUS
   Kern PS, 2010, DERMATITIS, V21, P8, DOI 10.2310/6620.2009.09038
   Kinsner-Ovaskainen A, 2012, ATLA-ALTERN LAB ANIM, V40, P175, DOI 10.1177/026119291204000310
   Kreiling R, 2008, FOOD CHEM TOXICOL, V46, P1896, DOI 10.1016/j.fct.2008.01.019
   Landsteiner K, 1936, J EXP MED, V64, P625, DOI 10.1084/jem.64.4.625
   Lepoittevin JP, 2006, CONTACT DERMATITIS, V54, P73, DOI 10.1111/j.0105-1873.2006.00795.x
   MAGNUSSON B, 1969, J INVEST DERMATOL, V52, P268, DOI 10.1038/jid.1969.42
   Mehling A, 2012, ARCH TOXICOL, V86, P1273, DOI 10.1007/s00204-012-0867-6
   Mekenyan O, 2012, SAR QSAR ENVIRON RES, V23, P553, DOI 10.1080/1062936X.2012.679689
   Oesch F, 2007, DRUG METAB REV, V39, P659, DOI 10.1080/03602530701690366
   Patlewicz G., 2008, JRC SCI TECHNICAL RE
   Roberts DW, 2007, CHEM RES TOXICOL, V20, P1321, DOI 10.1021/tx700169w
   ROBINSON MK, 1989, J INVEST DERMATOL, V92, P860, DOI 10.1111/1523-1747.ep12696880
   Warshaw EM, 2009, DERMATITIS, V20, P14, DOI 10.2310/6620.2008.08039
NR 35
TC 30
Z9 31
U1 0
U2 12
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0273-2300
EI 1096-0295
J9 REGUL TOXICOL PHARM
JI Regul. Toxicol. Pharmacol.
PD DEC
PY 2013
VL 67
IS 3
BP 468
EP 485
DI 10.1016/j.yrtph.2013.09.007
PG 18
WC Medicine, Legal; Pharmacology & Pharmacy; Toxicology
SC Legal Medicine; Pharmacology & Pharmacy; Toxicology
GA 257VG
UT WOS:000327415300017
PM 24090701
DA 2019-10-23
ER

PT J
AU Basketter, D
   Alepee, N
   Casati, S
   Crozier, J
   Eigler, D
   Griem, P
   Hubesch, B
   de Knecht, J
   Landsiedel, R
   Louekari, K
   Manou, I
   Maxwell, G
   Mehling, A
   Netzeva, T
   Petry, T
   Rossi, LH
AF Basketter, David
   Alepee, Nathalie
   Casati, Silvia
   Crozier, Jonathan
   Eigler, Dorothea
   Griem, Peter
   Hubesch, Bruno
   de Knecht, Joop
   Landsiedel, Robert
   Louekari, Kimmo
   Manou, Irene
   Maxwell, Gavin
   Mehling, Annette
   Netzeva, Tatiana
   Petry, Thomas
   Rossi, Laura H.
TI Skin sensitisation - Moving forward with non-animal testing strategies
   for regulatory purposes in the EU
SO REGULATORY TOXICOLOGY AND PHARMACOLOGY
LA English
DT Article
DE Skin sensitisation; In vitro alternatives; Hazard classification; Hazard
   characterisation
ID IN-VITRO METHODS; CHEMICALS; ASSAYS; PREDICTION; BATTERY
AB In a previous EPAA-Cefic LRI workshop in 2011, issues surrounding the use and interpretation of results from the local lymph node assay were addressed. At the beginning of 2013 a second joint workshop focused greater attention on the opportunities to make use of non-animal test data, not least since a number of in vitro assays have progressed to an advanced position in terms of their formal validation. It is already recognised that information produced from non-animal assays can be used in regulatory decision-making, notably in terms of classifying a substance as a skin sensitiser. The evolution into a full replacement for hazard identification, where the decision is not to classify, requires the generation of confidence in the in vitro alternative, e.g. via formal validation, the existence of peer reviewed publications and the knowledge that the assay(s) are founded on key elements of the Adverse Outcome Pathway for skin sensitisation. It is foreseen that the validated in vitro assays and relevant QSAR models can be organised into formal testing strategies to be applied for regulatory purposes by the industry. To facilitate progress, the European Partnership for Alternative Approaches to animal testing (EPAA) provided the platform for cross-industry and regulatory dialogue, enabling an essential and open debate on the acceptability of an in vitro based integrated strategy. Based on these considerations, a follow up activity was agreed upon to explore an example of an Integrated Testing Strategy for skin sensitisation hazard identification purposes in the context of REACH submissions. (C) 2013 Elsevier Inc. All rights reserved.
C1 [Basketter, David] DABMEB Consultancy Ltd, Sharnbrook MK44 1PR, Beds, England.
   [Alepee, Nathalie] LOreal Res & Innovat, Aulnay Sous Bois, France.
   [Casati, Silvia] Commiss European Communities, Joint Res Ctr, EURL ECVAM, I-21020 Ispra, Italy.
   [Crozier, Jonathan; Manou, Irene] European Partnership Alternat Approaches Anim Tes, Brussels, Belgium.
   [Eigler, Dorothea] Evon Ind AG, Essen, Germany.
   [Griem, Peter] Symrise AG, D-37603 Holzminden, Germany.
   [Hubesch, Bruno] CEFIC, Brussels, Belgium.
   [Hubesch, Bruno] Hubesch Consult BVBA, Sint Pieters Leeuw, Belgium.
   [de Knecht, Joop] OECD, Paris, France.
   [Landsiedel, Robert] BASF SE, Expt Toxicol & Ecol, Ludwigshafen, Germany.
   [Louekari, Kimmo; Netzeva, Tatiana] European Chem Agcy, Helsinki, Finland.
   [Maxwell, Gavin] Unilever, Bedford, England.
   [Mehling, Annette] Personal Care & Nutr GmbH, BASF, Dusseldorf, Germany.
   [Petry, Thomas] BVBA, Toxminds, Brussels, Belgium.
RP Basketter, D (reprint author), DABMEB Consultancy Ltd, Sharnbrook MK44 1PR, Beds, England.
EM dabmebconsultancyltd@me.com
RI Landsiedel, Robert/D-1960-2012
OI Landsiedel, Robert/0000-0003-3756-1904
FU EPAA
FX DAB was paid by the EPAA for the preparation of this workshop report.
   The remaining authors are paid employees of their respective
   organisations.
CR Adler S, 2011, ARCH TOXICOL, V85, P367, DOI 10.1007/s00204-011-0693-2
   Basketter D.A., 2013, DERMATITIS IN PRESS
   Basketter D, 2012, REGUL TOXICOL PHARM, V64, P9, DOI 10.1016/j.yrtph.2012.06.003
   Basketter DA, 2007, CONTACT DERMATITIS, V56, P1, DOI 10.1111/j.1600-0536.2007.01009.x
   Basketter DA, 2012, ALTEX-ALTERN ANIM EX, V29, P5, DOI 10.14573/altex.2012.1.003
   Basketter DA, 2009, J APPL TOXICOL, V29, P545, DOI 10.1002/jat.1443
   Bauch C, 2012, REGUL TOXICOL PHARM, V63, P489, DOI 10.1016/j.yrtph.2012.05.013
   Bauch C, 2011, TOXICOL IN VITRO, V25, P1162, DOI 10.1016/j.tiv.2011.05.030
   Casati S, 2009, ATLA-ALTERN LAB ANIM, V37, P305, DOI 10.1177/026119290903700313
   Chipinda I, 2011, TOXICOLOGY, V280, P135, DOI 10.1016/j.tox.2010.12.004
   Eskes C., 2012, DERMATOTOXICOL, P285
   EURL ECVAM, 2013, EURL ECVAMSS NETW PR
   EURL ECVAM, 2013, ESTAF ECVAM STAK FOR
   Hennen J, 2011, TOXICOL SCI, V123, P501, DOI 10.1093/toxsci/kfr174
   Jirova D, 2010, CONTACT DERMATITIS, V62, P109, DOI 10.1111/j.1600-0536.2009.01640.x
   KIMBER I, 1992, FOOD CHEM TOXICOL, V30, P165, DOI 10.1016/0278-6915(92)90153-C
   Natsch A., 2013, J APPL TOXICOL
   Natsch A, 2009, TOXICOL SCI, V107, P106, DOI 10.1093/toxsci/kfn204
   Nukada Y, 2013, TOXICOL IN VITRO, V27, P609, DOI 10.1016/j.tiv.2012.11.006
   OECD, 2002, LOC LYMPH NOD ASS
   OECD, 2012, ADV OUTC PATHW SKIN
   Russell WMS, 1959, PRINCIPLES HUMANE EX
   Schrage A, 2011, ATLA-ALTERN LAB ANIM, V39, P37, DOI 10.1177/026119291103900119
   Schrage A, 2010, ATLA-ALTERN LAB ANIM, V38, P39, DOI 10.1177/026119291003800109
NR 24
TC 24
Z9 24
U1 0
U2 11
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0273-2300
EI 1096-0295
J9 REGUL TOXICOL PHARM
JI Regul. Toxicol. Pharmacol.
PD DEC
PY 2013
VL 67
IS 3
BP 531
EP 535
DI 10.1016/j.yrtph.2013.10.002
PG 5
WC Medicine, Legal; Pharmacology & Pharmacy; Toxicology
SC Legal Medicine; Pharmacology & Pharmacy; Toxicology
GA 257VG
UT WOS:000327415300021
PM 24140884
DA 2019-10-23
ER

PT J
AU LaLone, CA
   Villeneuve, DL
   Burgoon, LD
   Russom, CL
   Helgen, HW
   Berninger, JP
   Tietge, JE
   Severson, MN
   Cavallin, JE
   Ankley, GT
AF LaLone, Carlie A.
   Villeneuve, Daniel L.
   Burgoon, Lyle D.
   Russom, Christine L.
   Helgen, Henry W.
   Berninger, Jason P.
   Tietge, Joseph E.
   Severson, Megan N.
   Cavallin, Jenna E.
   Ankley, Gerald T.
TI Molecular target sequence similarity as a basis for species
   extrapolation to assess the ecological risk of chemicals with known
   modes of action
SO AQUATIC TOXICOLOGY
LA English
DT Article
DE Predictive toxicology; Protein sequence similarity; Molecular target;
   Relative intrinsic susceptibility; Conserved functional domains
ID ZEBRAFISH DANIO-RERIO; LIFE-CYCLE TEST; ENVIRONMENTAL ESTROGENS;
   INSECTICIDE RESISTANCE; ENDOCRINE DISRUPTERS; PIMEPHALES-PROMELAS;
   GOBIOCYPRIS-RARUS; JAPANESE MEDAKA; SODIUM-CHANNELS; FATHEAD MINNOW
AB It is not feasible to conduct toxicity tests with all species that may be impacted by chemical exposures. Therefore, cross-species extrapolation is fundamental to environmental risk assessment. Recognition of the impracticality of generating empirical, whole organism, toxicity data for the extensive universe of chemicals in commerce has been an impetus driving the field of predictive toxicology. We describe a strategy that leverages expanding databases of molecular sequence information together with identification of specific molecular chemical targets whose perturbation can lead to adverse outcomes to support predictive species extrapolation. This approach can be used to predict which species may be more (or less) susceptible to effects following exposure to chemicals with known modes of action (e.g., pharmaceuticals, pesticides). Primary amino acid sequence alignments are combined with more detailed analyses of conserved functional domains to derive the predictions. This methodology employs bioinformatic approaches to automate, collate, and calculate quantitative metrics associated with cross-species sequence similarity of key molecular initiating events (MIEs). Case examples focused on the actions of (a) 17 alpha-ethinyl estradiol on the human (Homo sapiens) estrogen receptor; (b) permethrin on the mosquito (Aedes aegypti)voltage-gated para-like sodium channel; and (c) 17 beta-trenbolone on the bovine (Bos taurus) androgen receptor are presented to demonstrate the potential predictive utility of this species extrapolation strategy. The examples compare empirical toxicity data to cross-species predictions of intrinsic susceptibility based on analyses of sequence similarity relevant to the MIEs of defined adverse outcome pathways. Through further refinement, and definition of appropriate domains of applicability, we envision practical and routine utility for the molecular target similarity-based predictive method in chemical risk assessment, particularly where testing resources are limited. Published by Elsevier B.V.
C1 [LaLone, Carlie A.; Villeneuve, Daniel L.; Russom, Christine L.; Tietge, Joseph E.; Severson, Megan N.; Ankley, Gerald T.] US EPA, Off Res & Dev, Natl Hlth & Environm Effects Res Lab, Midcontinent Ecol Div, Duluth, MN 55804 USA.
   [Burgoon, Lyle D.] US EPA, Off Res & Dev, Natl Ctr Environm Assessment, Res Triangle Pk, NC 27709 USA.
   [Helgen, Henry W.] Comp Sci Corp, North Amer Publ Sect, Duluth, MN 55804 USA.
   [Berninger, Jason P.] CNR, Duluth, MN 55804 USA.
   [Cavallin, Jenna E.] US EPA, ORISE Res Participat Program, Off Res & Dev, Natl Hlth & Environm Effects Res Lab,Midcontinent, Duluth, MN 55804 USA.
RP LaLone, CA (reprint author), US EPA, Off Res & Dev, Natl Hlth & Environm Effects Res Lab, Midcontinent Ecol Div, 6201 Congdon Blvd, Duluth, MN 55804 USA.
EM LaLone.Carlie@epa.gov
RI Berninger, Jason/O-2401-2016; Burgoon, Lyle D./I-2894-2019
OI Berninger, Jason/0000-0003-3045-7899; Burgoon, Lyle
   D./0000-0003-4977-5352
CR Ankley GT, 2013, ENVIRON TOXICOL CHEM, V32, P1084, DOI 10.1002/etc.2151
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Ankley GT, 2003, ENVIRON TOXICOL CHEM, V22, P1350, DOI 10.1002/etc.5620220623
   Bauer ERS, 2000, APMIS, V108, P838, DOI 10.1111/j.1600-0463.2000.tb00007.x
   Boland LA, 2010, J FELINE MED SURG, V12, P61, DOI 10.1016/j.jfms.2009.09.018
   Cevasco A, 2008, COMP BIOCHEM PHYS C, V147, P241, DOI 10.1016/j.cbpc.2007.10.001
   Davies TGE, 2007, IUBMB LIFE, V59, P151, DOI 10.1080/15216540701352042
   Dourson M L, 1983, Regul Toxicol Pharmacol, V3, P224, DOI 10.1016/0273-2300(83)90030-2
   Durhan EJ, 2006, ENVIRON HEALTH PERSP, V114, P65, DOI 10.1289/ehp.8055
   Eick GN, 2011, MOL CELL ENDOCRINOL, V334, P31, DOI 10.1016/j.mce.2010.09.003
   Goto T, 2003, MAR POLLUT BULL, V47, P139, DOI 10.1016/S0025-326X(03)00052-3
   Gunnarsson L, 2008, ENVIRON SCI TECHNOL, V42, P5807, DOI 10.1021/es8005173
   Haussler D, 2009, J HERED, V100, P659, DOI 10.1093/jhered/esp086
   Hegyi H, 2001, GENOME RES, V11, P1632, DOI 10.1101/gr. 183801
   Hill RL, 2003, AQUAT TOXICOL, V63, P417, DOI 10.1016/S0166-445X(02)00207-2
   Hoang TC, 2011, ENVIRON TOXICOL CHEM, V30, P997, DOI 10.1002/etc.462
   Holbech H, 2006, COMP BIOCHEM PHYS C, V144, P57, DOI 10.1016/j.cbpc.2006.05.006
   Hoss S., 2001, ORGANOHALOGEN COMPOU, V53, P106
   Hult EF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023416
   Hutchinson TH, 1999, SCI TOTAL ENVIRON, V233, P167, DOI 10.1016/S0048-9697(99)00223-5
   Irwin LK, 2001, AQUAT TOXICOL, V55, P49, DOI 10.1016/S0166-445X(01)00159-X
   Jaser W, 2003, ENVIRON INT, V28, P633, DOI 10.1016/S0160-4120(02)00101-0
   Jobling S, 2004, AQUAT TOXICOL, V66, P205, DOI 10.1016/j.aquatox.2004.01.001
   Jobling S, 2003, AQUAT TOXICOL, V65, P205, DOI 10.1016/S0166-445X(03)00134-6
   Jukosky JA, 2008, B ENVIRON CONTAM TOX, V81, P230, DOI 10.1007/s00128-008-9462-1
   Karchner SI, 2006, P NATL ACAD SCI USA, V103, P6252, DOI 10.1073/pnas.0509950103
   Katsu Y, 2010, GEN COMP ENDOCR, V168, P496, DOI 10.1016/j.ygcen.2010.06.010
   Knox C, 2011, NUCLEIC ACIDS RES, V39, pD1035, DOI 10.1093/nar/gkq1126
   Kostich MS, 2008, SCI TOTAL ENVIRON, V389, P329, DOI 10.1016/j.scitotenv.2007.09.008
   Kristensen DM, 2011, BRIEF BIOINFORM, V12, P379, DOI 10.1093/bib/bbr030
   LaLone C.A., 2013, ENV TOXICOL CHEM
   Liu H, 2004, J MED ENTOMOL, V41, P946, DOI 10.1603/0022-2585-41.5.946
   Ma TW, 2005, CHEMOSPHERE, V59, P281, DOI 10.1016/j.chemosphere.2004.11.033
   Maack G, 2004, COMP BIOCHEM PHYS C, V139, P47, DOI 10.1016/j.cca.2004.09.004
   Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454
   Markov GV, 2011, MOL CELL ENDOCRINOL, V334, P21, DOI 10.1016/j.mce.2010.10.017
   Meteyer CU, 2005, J WILDLIFE DIS, V41, P707, DOI 10.7589/0090-3558-41.4.707
   Meyer J.L., 2013, J WILDL DIS IN PRESS
   Millam JR, 2001, HORM BEHAV, V40, P542, DOI 10.1006/hbeh.2001.1724
   Moreno-Hagelsieb G, 2008, BIOINFORMATICS, V24, P319, DOI 10.1093/bioinformatics/btm585
   Nielsen L, 2006, AQUAT TOXICOL, V80, P140, DOI 10.1016/j.aquatox.2006.08.004
   Park B.J., 2003, EFFECTS ENV ESTROGEN
   Park K, 2010, CHEMOSPHERE, V79, P934, DOI 10.1016/j.chemosphere.2010.03.002
   Perkins E.J., 2013, ENV HLTH PERSPECT
   Peters REM, 2007, AQUAT TOXICOL, V85, P154, DOI 10.1016/j.aquatox.2007.08.010
   Planello R, 2008, CHEMOSPHERE, V71, P1870, DOI 10.1016/j.chemosphere.2008.01.033
   Pounds NA, 2002, MAR ENVIRON RES, V54, P709, DOI 10.1016/S0141-1136(02)00113-7
   Raimondo S., 2010, EPA600R10004
   Ramsey M, 2007, SEX DEV, V1, P181, DOI 10.1159/000102107
   Reinhardt C, 2007, VET CLIN N AM-FOOD A, V23, P309, DOI 10.1016/j.cvfa.2007.03.004
   Salierno JD, 2009, ENVIRON TOXICOL CHEM, V28, P953, DOI 10.1897/08-111.1
   Santos EM, 2007, AQUAT TOXICOL, V83, P134, DOI 10.1016/j.aquatox.2007.03.019
   Savan R, 2009, CYTOKINE GROWTH F R, V20, P115, DOI 10.1016/j.cytogfr.2009.02.006
   Sayers EW, 2012, NUCLEIC ACIDS RES, V40, pD13, DOI 10.1093/nar/gkr1184
   Schreiber R, 2011, REGUL TOXICOL PHARM, V61, P261, DOI 10.1016/j.yrtph.2011.08.006
   Schultz IR, 2003, ENVIRON TOXICOL CHEM, V22, P1272, DOI 10.1002/etc.5620220613
   Seki M, 2006, ENVIRON TOXICOL CHEM, V25, P2742, DOI 10.1897/05-647R.1
   Stephen C. E., 1985, GUIDELINES DERIVING
   Stevenson BJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001595
   Tillmann M, 2001, ECOTOXICOLOGY, V10, P373, DOI 10.1023/A:1012279231373
   [US Environmental Protection Agency U.S. Environmental Protection Agency], 2006, 738R06017 EPA OFF PE, P195
   US Environmental Protection Agency, 2007, ECOTOX US GUID ECOTO
   US Environmental Protection Agency Office of Water/Office of Research and Development, 2010, AQ LIF CRIT CONT EM
   US Food and Drug Administration Center for Drug Evaluation and Research Center for Biologics Evaluation and Research, 1998, GUID IND ENV ASS HUM
   US Food and Drug Administration Center for Veterinary Medicine, 2006, GUID IND ENV IMP ASS
   Vais H, 2001, PEST MANAG SCI, V57, P877, DOI 10.1002/ps.392
   van Aerle R, 2002, ECOTOXICOLOGY, V11, P423, DOI 10.1023/A:1021053217513
   Van den Belt K, 2003, SCI TOTAL ENVIRON, V309, P127, DOI 10.1016/S0048-9697(03)00046-9
   VSDB, 2011, VET SUBST DAT VSDB A
   Weisbrod CJ, 2007, TOXICOL APPL PHARM, V225, P255, DOI 10.1016/j.taap.2007.08.004
   Zha JM, 2008, ECOTOX ENVIRON SAFE, V71, P390, DOI 10.1016/j.ecoenv.2007.11.017
   Zha JM, 2008, TOXICOL APPL PHARM, V226, P298, DOI 10.1016/j.taap.2007.10.006
   Zhang XW, 2008, AQUAT TOXICOL, V88, P173, DOI 10.1016/j.aquatox.2008.04.009
   Zillioux EJ, 2001, ENVIRON TOXICOL CHEM, V20, P1968, DOI 10.1002/etc.5620200915
NR 74
TC 52
Z9 52
U1 2
U2 66
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-445X
EI 1879-1514
J9 AQUAT TOXICOL
JI Aquat. Toxicol.
PD NOV 15
PY 2013
VL 144
BP 141
EP 154
DI 10.1016/j.aquatox.2013.09.004
PG 14
WC Marine & Freshwater Biology; Toxicology
SC Marine & Freshwater Biology; Toxicology
GA AA0WD
UT WOS:000330817200016
PM 24177217
DA 2019-10-23
ER

PT J
AU Murugesan, K
   Baumann, S
   Wissenbach, DK
   Kliemt, S
   Kalkhof, S
   Otto, W
   Mogel, I
   Kohajda, T
   von Bergen, M
   Tomm, JM
AF Murugesan, Kalaimathi
   Baumann, Sven
   Wissenbach, Dirk K.
   Kliemt, Stefanie
   Kalkhof, Stefan
   Otto, Wolfgang
   Moegel, Iljana
   Kohajda, Tibor
   von Bergen, Martin
   Tomm, Janina M.
TI Subtoxic and toxic concentrations of benzene and toluene induce
   Nrf2-mediated antioxidative stress response and affect the central
   carbon metabolism in lung epithelial cells A549
SO PROTEOMICS
LA English
DT Article
DE Benzene plus toluene; Molecular toxicity; Two-dimensional differential
   gel electrophoresis; Western blot
ID ARYL-HYDROCARBON RECEPTOR; OXIDATIVE STRESS; FACTOR NRF2; PROTEINS;
   PATHWAY; STYRENE; TOXICOGENOMICS; PROTEOMICS; EXPOSURE; ENZYMES
AB Since people in industrialized countries spend most of their time indoors, the effects of indoor contaminants such as volatile organic compounds become more and more relevant. Benzene and toluene are among the most abundant compounds in the highly heterogeneous group of indoor volatile organic compounds. In order to understand their effects on lung epithelial cells (A549) representing lung's first line of defense, we chose a global proteome and a targeted metabolome approach in order to detect adverse outcome pathways caused by exposure to benzene and toluene. Using a DIGE approach, 93 of 469 detected protein spots were found to be differentially expressed after exposure to benzene, and 79 of these spots were identified by MS. Pathway analysis revealed an enrichment of proteins involved in Nrf2-mediated and oxidative stress response glycolysis/gluconeogenesis. The occurrence of oxidative stress at nonacute toxic concentrations of benzene and toluene was confirmed by the upregulation of the stress related proteins NQO1 and SOD1. The changes in metabolism were validated by ion chromatography MS/MS analysis revealing significant changes of glucose-6-phosphate, fructose-6-phosphate, 3-phosphoglycerate, and NADPH. The molecular alterations identified as a result of benzene and toluene exposure demonstrate the detrimental effect of nonacute toxic concentrations on lung epithelial cells. The data provided here will allow for a targeted validation in in vivo models.
C1 [Murugesan, Kalaimathi; Kliemt, Stefanie; Kalkhof, Stefan; Otto, Wolfgang; von Bergen, Martin; Tomm, Janina M.] Helmholtz Ctr Environm Res, Dept Prote, D-04318 Leipzig, Germany.
   [Baumann, Sven; Wissenbach, Dirk K.; Kohajda, Tibor; von Bergen, Martin] Helmholtz Ctr Environm Res, Dept Metabol, D-04318 Leipzig, Germany.
   [Moegel, Iljana] Helmholtz Ctr Environm Res, Dept Environm Immunol, D-04318 Leipzig, Germany.
   [von Bergen, Martin] Aalborg Univ, Dept Biotechnol Chem & Environm Engn, Aalborg, Denmark.
RP Tomm, JM (reprint author), Helmholtz Ctr Environm Res, Dept Prote, Permoserstr 15, D-04318 Leipzig, Germany.
EM janina.tomm@ufz.de
RI Tomm, Janina/F-8888-2014; von Bergen, Martin/D-7960-2011; Baumann,
   Sven/M-2177-2013; Kalkhof, Stefan/Z-2000-2019
OI Tomm, Janina/0000-0001-8161-1812; von Bergen,
   Martin/0000-0003-2732-2977; Baumann, Sven/0000-0002-3453-5308; Kalkhof,
   Stefan/0000-0001-6121-7105
CR Balls M, 1995, ATLA-ALTERN LAB ANIM, V23, P838
   Bastida F, 2010, FEMS MICROBIOL ECOL, V73, P370, DOI 10.1111/j.1574-6941.2010.00889.x
   Benndorf D, 2007, ISME J, V1, P224, DOI 10.1038/ismej.2007.39
   Burgess K, 2011, RAPID COMMUN MASS SP, V25, P3447, DOI 10.1002/rcm.5247
   Ganter B, 2008, PHARMACOGENOMICS, V9, P35, DOI 10.2217/14622416.9.1.35
   Gasiewicz TA, 2010, CHEM-BIOL INTERACT, V184, P246, DOI 10.1016/j.cbi.2009.10.019
   Georgieva D, 2008, J PROTEOME RES, V7, P866, DOI 10.1021/pr070376c
   Heijne WHM, 2005, EXPERT REV PROTEOMIC, V2, P767, DOI 10.1586/14789450.2.5.767
   Iwanari M, 2002, ARCH TOXICOL, V76, P287, DOI 10.1007/s00204-002-0340-z
   Jehmlich N, 2008, RAPID COMMUN MASS SP, V22, P2889, DOI 10.1002/rcm.3684
   Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27
   Kim H, 1997, XENOBIOTICA, V27, P657, DOI 10.1080/004982597240253
   Lee JM, 2003, J BIOL CHEM, V278, P12029, DOI 10.1074/jbc.M211558200
   Lehmann I, 2001, INT J HYG ENVIR HEAL, V204, P211, DOI 10.1078/1438-4639-00100
   LIEBER M, 1976, INT J CANCER, V17, P62, DOI 10.1002/ijc.2910170110
   Liebsch M, 2011, ARCH TOXICOL, V85, P841, DOI 10.1007/s00204-011-0718-x
   Ma Q, 2004, DRUG METAB REV, V36, P146
   Miao WM, 2005, J BIOL CHEM, V280, P20340, DOI 10.1074/jbc.M412081200
   Mogel I, 2011, TOXICOLOGY, V289, P28, DOI 10.1016/j.tox.2011.07.006
   Morbt N, 2011, J PROTEOME RES, V10, P363, DOI 10.1021/pr1005718
   Morbt N, 2009, PROTEOMICS, V9, P4920, DOI 10.1002/pmic.200800836
   Muller SA, 2010, ANAL BIOANAL CHEM, V398, P2867, DOI 10.1007/s00216-010-4093-x
   Murugaiyan J, 2013, TOXICOL APPL PHARM, V269, P307, DOI 10.1016/j.taap.2013.03.032
   Nebert DW, 1997, BIOCHEM PHARMACOL, V53, P249, DOI 10.1016/S0006-2952(96)00740-X
   Petrak J, 2008, PROTEOMICS, V8, P1744, DOI 10.1002/pmic.200700919
   Rehwagen M, 2003, INDOOR AIR, V13, P283, DOI 10.1034/j.1600-0668.2003.00206.x
   Robertson DG, 2005, TOXICOL SCI, V85, P809, DOI 10.1093/toxsci/kfi102
   Shen GX, 2009, BIOPHARM DRUG DISPOS, V30, P345, DOI 10.1002/bdd.680
   Shin S, 2007, MOL CELL BIOL, V27, P7188, DOI 10.1128/MCB.00915-07
   Snyder R, 1996, ENVIRON HEALTH PERSP, V104, P1165, DOI 10.2307/3433158
   Snyder R, 2002, CRIT REV TOXICOL, V32, P155, DOI 10.1080/20024091064219
   Yoon B, 2002, EXP HEMATOL, V30, P123
NR 32
TC 13
Z9 14
U1 0
U2 12
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1615-9853
EI 1615-9861
J9 PROTEOMICS
JI Proteomics
PD NOV
PY 2013
VL 13
IS 21
BP 3211
EP 3221
DI 10.1002/pmic.201300126
PG 11
WC Biochemical Research Methods; Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 297JM
UT WOS:000330251700015
PM 24108694
DA 2019-10-23
ER

PT J
AU LaLone, CA
   Villeneuve, DL
   Cavallin, JE
   Kahl, MD
   Durhan, EJ
   Makynen, EA
   Jensen, KM
   Stevens, KE
   Severson, MN
   Blanksma, CA
   Flynn, KM
   Hartig, PC
   Woodard, JS
   Berninger, JP
   Norberg-King, TJ
   Johnson, RD
   Ankley, GT
AF LaLone, Carlie A.
   Villeneuve, Daniel L.
   Cavallin, Jenna E.
   Kahl, Michael D.
   Durhan, Elizabeth J.
   Makynen, Elizabeth A.
   Jensen, Kathleen M.
   Stevens, Kyle E.
   Severson, Megan N.
   Blanksma, Chad A.
   Flynn, Kevin M.
   Hartig, Philip C.
   Woodard, Jonne S.
   Berninger, Jason P.
   Norberg-King, Teresa J.
   Johnson, Rodney D.
   Ankley, Gerald T.
TI CROSS-SPECIES SENSITIVITY TO A NOVEL ANDROGEN RECEPTOR AGONIST OF
   POTENTIAL ENVIRONMENTAL CONCERN, SPIRONOLACTONE
SO ENVIRONMENTAL TOXICOLOGY AND CHEMISTRY
LA English
DT Article
DE Adverse outcome pathway; Spironolactone; Pharmaceutical; Endocrine
   disruption; Reproductive toxicity
ID MINNOW PIMEPHALES-PROMELAS; FATHEAD MINNOW; AQUATIC ENVIRONMENT;
   RISK-ASSESSMENT; HEART-FAILURE; DAPHNIA-MAGNA; BISPHENOL-A; CELL-LINE;
   FISH; VITELLOGENIN
AB Spironolactone is a pharmaceutical that in humans is used to treat conditions like hirsutism, various dermatologic afflictions, and female-pattern hair loss through antagonism of the androgen receptor. Although not routinely monitored in the environment, spironolactone has been detected downstream of a pharmaceutical manufacturer, indicating a potential for exposure of aquatic species. Furthermore, spironolactone has been reported to cause masculinization of female western mosquitofish, a response indicative of androgen receptor activation. Predictive methods to identify homologous proteins to the human and western mosquitofish androgen receptor suggest that vertebrates would be more susceptible to adverse effects mediated by chemicals like spironolactone that target the androgen receptor compared with invertebrate species that lack a relevant homolog. In addition, an adverse outcome pathway previously developed for activation of the androgen receptor suggests that androgen mimics can lead to reproductive toxicity in fish. To assess this, 21-d reproduction studies were conducted with 2 fish species, fathead minnow and Japanese medaka, and the invertebrate Daphnia magna. Spironolactone significantly reduced the fecundity of medaka and fathead minnows at 50g/L, whereas daphnia reproduction was not affected by concentrations as large as 500g/L. Phenotypic masculinization of females of both fish species was observed at 5g/L as evidenced by formation of tubercles in fathead minnows and papillary processes in Japanese medaka. Effects in fish occurred at concentrations below those reported in the environment. These results demonstrate how a priori knowledge of an adverse outcome pathway and the conservation of a key molecular target across vertebrates can be utilized to identify potential chemicals of concern in terms of monitoring and highlight potentially sensitive species and endpoints for testing. Environ Toxicol Chem 2013;32:2528-2541. (c) 2013 SETAC
C1 [LaLone, Carlie A.; Villeneuve, Daniel L.; Kahl, Michael D.; Durhan, Elizabeth J.; Makynen, Elizabeth A.; Jensen, Kathleen M.; Severson, Megan N.; Flynn, Kevin M.; Norberg-King, Teresa J.; Johnson, Rodney D.; Ankley, Gerald T.] US EPA, Off Res & Dev, Natl Hlth & Environm Effects Res Lab, Midcontinent Ecol Div, Duluth, MN USA.
   [Cavallin, Jenna E.; Stevens, Kyle E.; Blanksma, Chad A.] US EPA, Oak Ridge Inst Sci, Off Res & Dev, Natl Hlth & Environm Effects Res Lab,Midcontinent, Duluth, MN USA.
   [Cavallin, Jenna E.; Stevens, Kyle E.; Blanksma, Chad A.] US EPA, Educ Res Participat Program, Off Res & Dev, Natl Hlth & Environm Effects Res Lab,Midcontinent, Duluth, MN USA.
   [Hartig, Philip C.] US EPA, Off Res & Dev, Natl Hlth & Environm Effects Res Lab, Toxic Assessment Div, Res Triangle Pk, NC 27711 USA.
   [Woodard, Jonne S.] US EPA, Off Res & Dev, Natl Hlth & Environm Effects Res Lab, Integrated Syst Toxicol Div, Res Triangle Pk, NC 27711 USA.
   [Berninger, Jason P.] CNR, Duluth, MN USA.
RP LaLone, CA (reprint author), US EPA, Off Res & Dev, Natl Hlth & Environm Effects Res Lab, Midcontinent Ecol Div, Duluth, MN USA.
EM LaLone.Carlie@epa.gov
RI Norberg-King, Teresa J/E-5553-2013; Berninger, Jason/O-2401-2016
OI Norberg-King, Teresa J/0000-0001-6831-9040; Berninger,
   Jason/0000-0003-3045-7899
CR Ankley GT, 2007, ENVIRON TOXICOL CHEM, V26, P1214, DOI 10.1897/06-428R.1
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Ankley GT, 2003, ENVIRON TOXICOL CHEM, V22, P1350, DOI 10.1002/etc.5620220623
   Ankley GT, 2001, ENVIRON TOXICOL CHEM, V20, P1276, DOI 10.1002/etc.5620200616
   Biales AD, 2007, ENVIRON TOXICOL CHEM, V26, P287, DOI 10.1897/06-213R.1
   Blake LS, 2010, ENVIRON TOXICOL CHEM, V29, P1367, DOI 10.1002/etc.166
   Connon RE, 2012, SENSORS-BASEL, V12, P12741, DOI 10.3390/s120912741
   Crissman JW, 2004, TOXICOL PATHOL, V32, P126, DOI 10.1080/01926230490268756
   Deepinder F, 2012, EXPERT OPIN DRUG SAF, V11, P779, DOI 10.1517/14740338.2012.712109
   Ekman DR, 2012, ENVIRON SCI TECHNOL, V46, P9673, DOI 10.1021/es3014634
   Gilbert N, 2011, NATURE, V476, P265, DOI 10.1038/476265a
   Gunnarsson L, 2008, ENVIRON SCI TECHNOL, V42, P5807, DOI 10.1021/es8005173
   Guyonnet J, 2010, J VET PHARMACOL THER, V33, P260, DOI 10.1111/j.1365-2885.2009.01130.x
   Hannas BR, 2011, AQUAT TOXICOL, V101, P351, DOI 10.1016/j.aquatox.2010.11.006
   HOWELL WM, 1994, PROG FISH CULT, V56, P51, DOI 10.1577/1548-8640(1994)056<0051:PMOFWM>2.3.CO;2
   Jayasankar V, 2002, J EXP ZOOL, V293, P675, DOI 10.1002/jez.10167
   Jensen KM, 2001, COMP BIOCHEM PHYS C, V128, P127, DOI 10.1016/S1532-0456(00)00185-X
   Johnson R., 2009, OECD GUIDANCE DOCUME
   Knox C, 2011, NUCLEIC ACIDS RES, V39, pD1035, DOI 10.1093/nar/gkq1126
   Kostich MS, 2008, SCI TOTAL ENVIRON, V389, P329, DOI 10.1016/j.scitotenv.2007.09.008
   LaLone CA, 2012, TOXICOLOGIST, V126, P180
   LeBlanc GA, 2007, ECOTOXICOLOGY, V16, P61, DOI 10.1007/s10646-006-0115-z
   Mantero F, 2000, ANN ENDOCRINOL-PARIS, V61, P52
   Maron BA, 2008, CURR OPIN INVEST DR, V9, P963
   Martyniuk CJ, 2012, J PROTEOME RES, V11, P4147, DOI 10.1021/pr3002468
   Matozzo V, 2008, ENVIRON INT, V34, P531, DOI 10.1016/j.envint.2007.09.008
   McMaster ME, 1995, CAN TECH REP FISH AQ, P1
   Mu XY, 2002, GEN COMP ENDOCR, V129, P127, DOI 10.1016/S0016-6480(02)00518-X
   Organisation for Economic Co-operation and Development, 2008, OECD GUID TEST CHEM
   Rathnayake D, 2010, DERMATOL CLIN, V28, P611, DOI 10.1016/j.det.2010.03.011
   Raut SA, 2011, ENVIRON TOXICOL CHEM, V30, P1376, DOI 10.1002/etc.504
   SADEE W, 1973, J PHARMACOL EXP THER, V185, P686
   Sanchez W, 2011, ENVIRON INT, V37, P1342, DOI 10.1016/j.envint.2011.06.002
   Sayers EW, 2012, NUCLEIC ACIDS RES, V40, pD13, DOI 10.1093/nar/gkr1184
   Searle GD, 2012, ALDACTONE US PHYS PR
   Seki M, 2006, ENVIRON TOXICOL CHEM, V25, P2742, DOI 10.1897/05-647R.1
   Shaw JC, 2002, J CUTAN MED SURG, V6, P541, DOI 10.1007/s10227-001-0152-4
   Sica D, 2005, HEART FAIL REV, V10, P23, DOI 10.1007/s10741-005-2345-1
   Sica Domenic A, 2006, J Clin Hypertens (Greenwich), V8, P467, DOI 10.1111/j.1524-6175.2006.05155.x
   SUMPTER JP, 1995, ENVIRON HEALTH PERSP, V103, P173, DOI 10.2307/3432529
   U. S. Food and Drug Administration, 2013, DRUGS FDA APPR DRUG
   US Environmental Protection Agency, 2002, EPA821R02013
   US Environmental Protection Agency, 2002, SHORT TERM TEST METH
   Villeneuve DL, 2007, TOXICOL SCI, V98, P395, DOI 10.1093/toxsci/kfm124
   Villeneuve DL, 2012, ENVIRON SCI TECHNOL, V46, P51, DOI 10.1021/es201150a
   Wilson VS, 2002, TOXICOL SCI, V66, P69, DOI 10.1093/toxsci/66.1.69
NR 46
TC 25
Z9 25
U1 1
U2 50
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0730-7268
EI 1552-8618
J9 ENVIRON TOXICOL CHEM
JI Environ. Toxicol. Chem.
PD NOV
PY 2013
VL 32
IS 11
BP 2528
EP 2541
DI 10.1002/etc.2330
PG 14
WC Environmental Sciences; Toxicology
SC Environmental Sciences & Ecology; Toxicology
GA 232HE
UT WOS:000325482700014
PM 23881739
DA 2019-10-23
ER

PT J
AU Vinken, M
   Landesmann, B
   Goumenou, M
   Vinken, S
   Shah, I
   Jaeschke, H
   Willett, C
   Whelan, M
   Rogiers, V
AF Vinken, Mathieu
   Landesmann, Brigitte
   Goumenou, Marina
   Vinken, Stefanie
   Shah, Imran
   Jaeschke, Hartmut
   Willett, Catherine
   Whelan, Maurice
   Rogiers, Vera
TI Development of an Adverse Outcome Pathway From Drug-Mediated Bile Salt
   Export Pump Inhibition to Cholestatic Liver Injury
SO TOXICOLOGICAL SCIENCES
LA English
DT Article
DE drug-induced liver injury; cholestasis; adverse outcome pathway
ID PREGNANE-X-RECEPTOR; CONSTITUTIVE ANDROSTANE RECEPTOR; ORPHAN NUCLEAR
   RECEPTOR; MESSENGER-RNA LEVELS; DUCT-LIGATED MICE;
   OBSTRUCTIVE-CHOLESTASIS; ADAPTIVE RESPONSE; GENE-EXPRESSION;
   INTRAHEPATIC CHOLESTASIS; PERMEABILITY TRANSITION
AB Adverse outcome pathways (AOPs) have been recently introduced in human risk assessment as pragmatic tools with multiple applications. As such, AOPs intend to provide a clear-cut mechanistic representation of pertinent toxicological effects. AOPs are typically composed of a molecular initiating event, a series of intermediate steps and key events, and an adverse outcome. In this study, an AOP framework is proposed for cholestasis triggered by drug-mediated inhibition of the bile salt export pump transporter protein. For this purpose, an in-depth survey of relevant scientific literature was carried out in order to identify intermediate steps and key events. The latter include bile accumulation, the induction of oxidative stress and inflammation, and the activation of specific nuclear receptors. Collectively, these mechanisms drive both a deteriorative cellular response, which underlies directly caused cholestatic injury, and an adaptive cellular response, which is aimed at counteracting cholestatic insults. AOP development was performed according to Organisation for Economic Co-operation and Development (OECD) guidance, including critical consideration of the Bradford Hill criteria for weight of evidence assessment and the OECD key questions for evaluating AOP confidence. The postulated AOP is expected to serve as the basis for the development of new in vitro tests and the characterization of novel biomarkers of drug-induced cholestasis.
C1 [Vinken, Mathieu; Rogiers, Vera] Vrije Univ Brussel, Pharmaceut Res Ctr, Dept Toxicol, B-1090 Brussels, Belgium.
   [Landesmann, Brigitte; Goumenou, Marina; Whelan, Maurice] European Commiss, Joint Res Ctr, Inst Hlth & Consumer Protect, Syst Toxicol Unit, I-21027 Ispra, Italy.
   [Vinken, Stefanie] Algemeen Stedelijk Ziekenhuis, Dept Endocrinol, B-9300 Aalst, Belgium.
   [Shah, Imran] US EPA, Natl Ctr Computat Toxicol, Off Res & Dev, Durham, NC 27709 USA.
   [Jaeschke, Hartmut] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66160 USA.
   [Willett, Catherine] Humane Soc United States, Washington, DC 20037 USA.
RP Vinken, M (reprint author), Vrije Univ Brussel, Fac Med & Pharm, Dept Toxicol, Pharmaceut Res Ctr, Laarbeeklaan 103, B-1090 Brussels, Belgium.
EM mvinken@vub.ac.be
RI Vinken, Mathieu/H-7513-2013; Shah, Syed I/B-8275-2011
OI Vinken, Mathieu/0000-0001-5115-8893; Shah, Imran/0000-0003-0808-0140;
   Goumenou, Marina/0000-0003-3545-0637; VUB, IVTD/0000-0002-5016-4789
FU European UnionEuropean Union (EU) [HEALTH-F5-2010-266838,
   HEALTH-F5-2010-266777]
FX European Union (FP7/Cosmetics Europe projects DETECTIVE and HeMiBio
   [HEALTH-F5-2010-266838 and HEALTH-F5-2010-266777, respectively]).
CR Allen K, 2011, AM J PATHOL, V178, P175, DOI 10.1016/j.ajpath.2010.11.026
   Andersen M., 2012, REPLACEMENT IN VIVO, V2, P347
   Andersen ME, 2013, ARCH TOXICOL, V87, P7, DOI 10.1007/s00204-012-0980-6
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Barbier O, 2003, GASTROENTEROLOGY, V124, P1926, DOI 10.1016/S0016-5085(03)00388-3
   Bernstein H, 2005, MUTAT RES-REV MUTAT, V589, P47, DOI 10.1016/j.mrrev.2004.08.001
   Bjornsson E, 2005, HEPATOLOGY, V42, P481, DOI 10.1002/hep.20800
   Blomme EAG, 2009, TOXICOL LETT, V186, P22, DOI 10.1016/j.toxlet.2008.09.017
   Bogdanffy MS, 2001, TOXICOL SCI, V61, P18, DOI 10.1093/toxsci/61.1.18
   BOTLA R, 1995, J PHARMACOL EXP THER, V272, P930
   Boyer JL, 2006, AM J PHYSIOL-GASTR L, V290, pG1124, DOI 10.1152/ajpgi.00539.2005
   BOYER LB, 2009, LIVER BIOL PATHOBIOL, P681
   Chen HL, 2005, J HEPATOL, V43, P472, DOI 10.1016/j.jhep.2005.02.030
   Cheng X, 2007, BIOCHEM PHARMACOL, V74, P1665, DOI 10.1016/j.bcp.2007.08.014
   Cherrington NJ, 2004, DRUG METAB DISPOS, V32, P734, DOI 10.1124/dmd.32.7.734
   Dawson S, 2012, DRUG METAB DISPOS, V40, P130, DOI 10.1124/dmd.111.040758
   Denson LA, 2001, GASTROENTEROLOGY, V121, P140, DOI 10.1053/gast.2001.25503
   Echchgadda I, 2007, MOL ENDOCRINOL, V21, P2099, DOI 10.1210/me.2007-0002
   Elferink RPJO, 2006, GASTROENTEROLOGY, V130, P908, DOI 10.1053/j.gastro.2005.08.052
   Eloranta JJ, 2005, ARCH BIOCHEM BIOPHYS, V433, P397, DOI 10.1016/j.abb.2004.09.019
   *EU, 2003, OFFICIAL J EUROPEA L, V66, P26
   Fattinger K, 2001, CLIN PHARMACOL THER, V69, P223, DOI 10.1067/mcp.2001.114667
   Faucette SR, 2006, J PHARMACOL EXP THER, V317, P1200, DOI 10.1124/jpet.105.098160
   Feingold KR, 1996, J LIPID RES, V37, P223
   Funk C, 2001, TOXICOLOGY, V167, P83, DOI 10.1016/S0300-483X(01)00460-7
   Gnerre C, 2004, PHARMACOGENETICS, V14, P635, DOI 10.1097/00008571-200410000-00001
   Gollamudi R, 2008, CURR DRUG METAB, V9, P611, DOI 10.2174/138920008785821701
   Goodwin B, 2000, MOL CELL, V6, P517, DOI 10.1016/S1097-2765(00)00051-4
   Gores GJ, 1998, BBA-BIOENERGETICS, V1366, P167, DOI 10.1016/S0005-2728(98)00111-X
   Green RM, 2000, GENE, V241, P117, DOI 10.1016/S0378-1119(99)00460-6
   Gu XS, 2006, J BIOL CHEM, V281, P17882, DOI 10.1074/jbc.M601302200
   Gujral JS, 2004, AM J PHYSIOL-GASTR L, V286, pG499, DOI 10.1152/ajpgi.00318.2003
   Gujral JS, 2003, HEPATOLOGY, V38, P355, DOI 10.1053/jhep.2003.50341
   HEUMAN DM, 1989, J LIPID RES, V30, P719
   HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503
   Hofmann A. F., 2009, LIVER BIOL PATHOBIOL, P289
   Lucena MI, 2009, HEPATOLOGY, V49, P2001, DOI 10.1002/hep.22895
   Jaeschke H, 2006, LIVER INT, V26, P912, DOI 10.1111/j.1478-3231.2006.01327.x
   Jara P, 2009, NEW ENGL J MED, V361, P1359, DOI 10.1056/NEJMoa0901075
   Jemnitz K, 2010, TOXICOL SCI, V115, P80, DOI 10.1093/toxsci/kfq044
   Julien E, 2009, CRIT REV FOOD SCI, V49, P682, DOI 10.1080/10408390903110692
   Jung D, 2007, LIVER INT, V27, P137, DOI 10.1111/j.1478-3231.2006.01393.x
   Jung D, 2006, J BIOL CHEM, V281, P19081, DOI 10.1074/jbc.M600116200
   Kast HR, 2002, J BIOL CHEM, V277, P2908, DOI 10.1074/jbc.M109326200
   Keitel V, 2009, HEPATOLOGY, V50, P510, DOI 10.1002/hep.23083
   Kim MS, 2004, AM J PHYSIOL-ENDOC M, V287, pE731, DOI 10.1152/ajpendo.00130.2004
   Kis E, 2012, TOXICOL IN VITRO, V26, P1294, DOI 10.1016/j.tiv.2011.11.002
   Knisely AS, 2006, HEPATOLOGY, V44, P478, DOI 10.1002/hep.21287
   Kocarek TA, 2002, J PHARMACOL TOXICOL, V47, P177, DOI 10.1016/S1056-8719(03)00002-9
   Kostrubsky VE, 2001, DRUG METAB DISPOS, V29, P1561
   Krasowski MD, 2005, MOL ENDOCRINOL, V19, P1720, DOI 10.1210/me.2004-0427
   KUNTZ E, 2008, HEPATOLOGY TXB ATLAS, P235
   LANDESMANN B, 2012, 75689 JRC
   Lang C, 2007, PHARMACOGENET GENOM, V17, P47, DOI 10.1097/01.fpc.0000230418.28091.76
   Lang T, 2006, DRUG METAB DISPOS, V34, P1582, DOI 10.1124/dmd.105.008854
   Lecureur V, 2000, MOL PHARMACOL, V57, P24
   Lee J, 2001, GASTROENTEROLOGY, V121, P1473, DOI 10.1053/gast.2001.29608
   Li F, 2012, J LIPID RES, V53, P1625, DOI 10.1194/jlr.M027433
   Maher JM, 2005, DRUG METAB DISPOS, V33, P956, DOI 10.1124/dmd.105.003798
   Mazzon E, 2003, CELL MOL BIOL, V49, P45
   Meek ME, 2003, CRIT REV TOXICOL, V33, P591, DOI 10.1080/10408440390250136
   Meier Y, 2006, HEPATOLOGY, V44, P62, DOI 10.1002/hep.21214
   Mennone A, 2010, DRUG METAB DISPOS, V38, P1673, DOI 10.1124/dmd.110.034512
   Morgan RE, 2010, TOXICOL SCI, V118, P485, DOI 10.1093/toxsci/kfq269
   Morotti RA, 2011, SEMIN LIVER DIS, V31, P3, DOI 10.1055/s-0031-1272831
   NRC (National Research Council), 2007, TOX TEST 21 CENT VIS
   OECD, 2011, SER TEST ASS, V138
   OECD, 2012, PROP TEMPL GUID DEV
   *OECD, 2012, SER TEST ASS, V138
   Ozer J, 2008, TOXICOLOGY, V245, P194, DOI 10.1016/j.tox.2007.11.021
   Padda MS, 2011, HEPATOLOGY, V53, P1377, DOI 10.1002/hep.24229
   Pagani R, 2003, HISTOL HISTOPATHOL, V18, P837, DOI 10.14670/HH-18.837
   Pauli-Magnus C, 2006, HEPATOLOGY, V44, P778, DOI 10.1002/hep.21359
   Pauwels M, 2010, TOXICOL APPL PHARM, V243, P260, DOI 10.1016/j.taap.2009.12.007
   ROMAN ID, 1990, HEPATOLOGY, V12, P83, DOI 10.1002/hep.1840120114
   SALGIA R, 1993, MOL CELL BIOCHEM, V121, P143, DOI 10.1007/BF00925973
   Schoemaker MH, 2004, HEPATOLOGY, V39, P1563, DOI 10.1002/hep.20246
   Seed J, 2005, CRIT REV TOXICOL, V35, P663, DOI 10.1080/10408440591007133
   Sekine S, 2010, BIOCHEM BIOPH RES CO, V399, P279, DOI 10.1016/j.bbrc.2010.07.069
   Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110
   Sokol TJ, 2005, J PEDIATR GASTR NUTR, V41, P235, DOI 10.1097/01.MPG.0000170600.80640.88
   Tong LM, 2001, DRUG METAB DISPOS, V29, P252
   Trauner M, 1998, NEW ENGL J MED, V339, P1217, DOI 10.1056/NEJM199810223391707
   Trauner M, 1998, J CLIN INVEST, V101, P2092, DOI 10.1172/JCI1680
   *US EPA, 2005, GUID CARC RISK ASS
   Vinken M, 2012, ARCH TOXICOL, V86, P405, DOI 10.1007/s00204-011-0769-z
   Vuppalanchi R, 2006, AM J SURG PATHOL, V30, P1619, DOI 10.1097/01.pas.0000213342.78475.48
   Wagner M, 2009, J HEPATOL, V51, P565, DOI 10.1016/j.jhep.2009.05.012
   Woolbright BL, 2012, WORLD J GASTROENTERO, V18, P4985, DOI 10.3748/wjg.v18.i36.4985
   Yang K, 2013, J PHARM SCI-US, V102, P3037, DOI 10.1002/jps.23584
   Yasumiba S, 2001, BIOCHEM J, V354, P591, DOI 10.1042/0264-6021:3540591
   Yoshikado T, 2011, MOL PHARMACOL, V79, P241, DOI 10.1124/mol.110.067256
   Zhang YC, 2012, LIVER INT, V32, P58, DOI 10.1111/j.1478-3231.2011.02662.x
   Zollner G, 2006, AM J PHYSIOL-GASTR L, V290, pG923, DOI 10.1152/ajpgi.00490.2005
   Zollner G, 2006, WIEN MED WOCHENSCHR, V156, P380, DOI 10.1007/s10354-006-0312-7
   Zollner G, 2006, MOL PHARMACEUT, V3, P231, DOI 10.1021/mp060010s
   Zollner G, 2010, PHARMACOL THERAPEUT, V126, P228, DOI 10.1016/j.pharmthera.2010.03.005
   Zollner G, 2008, CLIN LIVER DIS, V12, P1, DOI 10.1016/j.cld.2007.11.010
NR 98
TC 60
Z9 61
U1 0
U2 19
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1096-6080
EI 1096-0929
J9 TOXICOL SCI
JI Toxicol. Sci.
PD NOV
PY 2013
VL 136
IS 1
BP 97
EP 106
DI 10.1093/toxsci/kft177
PG 10
WC Toxicology
SC Toxicology
GA 258KQ
UT WOS:000327458600010
PM 23945500
OA Green Published
DA 2019-10-23
ER

PT J
AU Vinken, M
AF Vinken, Mathieu
TI The adverse outcome pathway concept: A pragmatic tool in toxicology
SO TOXICOLOGY
LA English
DT Review
DE Adverse outcome pathway; Mechanistic toxicology; Chemical risk
   assessment; In vitro test development; Prioritization strategies;
   Quantitative structure-activity relationship
ID SALT EXPORT PUMP; HUMAN CELL-LINES; TEST H-CLAT; SKIN SENSITIZATION;
   RISK-ASSESSMENT; HEPATIC FIBROGENESIS; CONTACT ALLERGENS; LIVER-DISEASE;
   MECHANISMS; CHOLESTASIS
AB Adverse outcome pathways (AOPs) are novel tools in toxicology and human risk assessment with broad potential. AOPs are designed to provide a clear-cut mechanistic representation of critical toxicological effects that span over different layers of biological organization. AOPs share a common structure consisting of a molecular initiating event, a series of intermediate steps and key events, and an adverse outcome. Development of AOPs ideally complies with OECD guidelines. This also holds true for AOP evaluation, which includes consideration of the Bradford Hill criteria for weight-of-evidence assessment and meeting a set of key questions defined by the OECD. Elaborate AOP frameworks have yet been proposed for chemical-induced skin sensitization, cholestasis, liver fibrosis and liver steatosis. These newly postulated AOPs can serve a number of ubiquitous purposes, including the establishment of (quantitative) structure-activity relationships, the development of novel in vitro toxicity screening tests and the elaboration of prioritization strategies. (C) 2013 Elsevier Ireland Ltd. All rights reserved.
C1 [Vinken, Mathieu] Vrije Univ Brussel, Dept Toxicol, Ctr Pharmaceut Res CePhar, B-1090 Brussels, Belgium.
RP Vinken, M (reprint author), Vrije Univ Brussel, Fac Med & Pharm, Pharmaceut Res Ctr, Dept Toxicol, Laarbeeklaan 103, B-1090 Brussels, Belgium.
EM mvinken@vub.ac.be
RI Vinken, Mathieu/H-7513-2013
OI Vinken, Mathieu/0000-0001-5115-8893; VUB, IVTD/0000-0002-5016-4789
FU European UnionEuropean Union (EU)
FX This work was financially supported by the grants of the European Union
   (FP7/Cosmetics Europe projects DETECTIVE and HeMiBio).
CR Adler S, 2011, ARCH TOXICOL, V85, P367, DOI 10.1007/s00204-011-0693-2
   Amacher DE, 2011, EXPERT OPIN DRUG MET, V7, P949, DOI 10.1517/17425255.2011.577740
   Andersen M., 2012, REPLACEMENT IN VIVO, V2, P347
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   [Anonymous], 2012, OECD SER TEST ASS, V168
   Ashikaga T, 2006, TOXICOL IN VITRO, V20, P767, DOI 10.1016/j.tiv.2005.10.012
   Begriche K, 2011, J HEPATOL, V54, P773, DOI 10.1016/j.jhep.2010.11.006
   Bogdanffy MS, 2001, TOXICOL SCI, V61, P18, DOI 10.1093/toxsci/61.1.18
   Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265
   Enoch SJ, 2008, SAR QSAR ENVIRON RES, V19, P555, DOI 10.1080/10629360802348985
   Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003
   Friedman SL, 2010, NAT REV GASTRO HEPAT, V7, P425, DOI 10.1038/nrgastro.2010.97
   Gerberick F, 2008, ATLA-ALTERN LAB ANIM, V36, P215, DOI 10.1177/026119290803600210
   Gerberick GF, 2007, TOXICOL SCI, V97, P417, DOI 10.1093/toxsci/kfm064
   Gerner I, 2004, ATLA-ALTERN LAB ANIM, V32, P487, DOI 10.1177/026119290403200505
   HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503
   Hirano H, 2006, MOL PHARMACEUT, V3, P252, DOI 10.1021/mp060004w
   Hofmann A. F., 2009, LIVER BIOL PATHOBIOL, P289
   Honorio Kathia M, 2008, Open Med Chem J, V2, P87, DOI 10.2174/1874104500802010087
   Judson R, 2013, ALTEX-ALTERN ANIM EX, V30, P51, DOI 10.14573/altex.2013.1.051
   Julien E, 2009, CRIT REV FOOD SCI, V49, P682, DOI 10.1080/10408390903110692
   Kavlock R, 2010, J TOXICOL ENV HEAL B, V13, P197, DOI 10.1080/10937404.2010.483935
   Kimber I, 2001, TOXICOL SCI, V59, P198, DOI 10.1093/toxsci/59.2.198
   LANDESMANN B, 2012, 75689 JRC
   Lee UE, 2011, BEST PRACT RES CL GA, V25, P195, DOI 10.1016/j.bpg.2011.02.005
   Maxwell G, 2011, ALTEX-ALTERN ANIM EX, V28, P50, DOI 10.14573/altex.2011.1.050
   Meek ME, 2003, CRIT REV TOXICOL, V33, P591, DOI 10.1080/10408440390250136
   NRC (National Research Council), 2007, TOX TEST 21 CENT VIS
   OECD, 2012, PROP TEMPL GUID DEV
   Padda MS, 2011, HEPATOLOGY, V53, P1377, DOI 10.1002/hep.24229
   Python F, 2007, TOXICOL APPL PHARM, V220, P113, DOI 10.1016/j.taap.2006.12.026
   Ramachandran R, 2009, J CLIN PATHOL, V62, P481, DOI 10.1136/jcp.2008.058248
   Roberts DW, 2008, J APPL TOXICOL, V28, P443, DOI 10.1002/jat.1293
   Saito H, 2009, AAPS J, V11, P581, DOI 10.1208/s12248-009-9137-9
   Sakaguchi H, 2006, TOXICOL IN VITRO, V20, P774, DOI 10.1016/j.tiv.2005.10.014
   Schoemaker MH, 2004, HEPATOLOGY, V39, P1563, DOI 10.1002/hep.20246
   Seed J, 2005, CRIT REV TOXICOL, V35, P663, DOI 10.1080/10408440591007133
   Simon-Hettich B, 2006, TOXICOLOGY, V224, P156, DOI 10.1016/j.tox.2006.04.032
   *US EPA, 2005, GUID CARC RISK ASS
   Uter W, 2013, CONTACT DER IN PRESS
   Vinken M., 2013, TOXICOL SCI IN PRESS
   Vinken M, 2012, ARCH TOXICOL, V86, P405, DOI 10.1007/s00204-011-0769-z
   Vocanson M, 2009, ALLERGY, V64, P1699, DOI 10.1111/j.1398-9995.2009.02082.x
   Wagner M, 2009, J HEPATOL, V51, P565, DOI 10.1016/j.jhep.2009.05.012
   Warner DJ, 2012, DRUG METAB DISPOS, V40, P2332, DOI 10.1124/dmd.112.047068
   Watanabe KH, 2011, ENVIRON TOXICOL CHEM, V30, P9, DOI 10.1002/etc.373
   Woolbright BL, 2012, WORLD J GASTROENTERO, V18, P4985, DOI 10.3748/wjg.v18.i36.4985
   Yozzo KL, 2013, AQUAT TOXICOL, V126, P346, DOI 10.1016/j.aquatox.2012.09.008
   Zimmerman H J, 2000, Clin Liver Dis, V4, P73, DOI 10.1016/S1089-3261(05)70097-0
   Zollner G, 2006, WIEN MED WOCHENSCHR, V156, P380, DOI 10.1007/s10354-006-0312-7
   Zollner G, 2008, CLIN LIVER DIS, V12, P1, DOI 10.1016/j.cld.2007.11.010
NR 51
TC 168
Z9 174
U1 7
U2 139
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0300-483X
J9 TOXICOLOGY
JI Toxicology
PD OCT 4
PY 2013
VL 312
BP 158
EP 165
DI 10.1016/j.tox.2013.08.011
PG 8
WC Pharmacology & Pharmacy; Toxicology
SC Pharmacology & Pharmacy; Toxicology
GA 252LD
UT WOS:000327005300019
PM 23978457
HC Y
HP N
DA 2019-10-23
ER

PT J
AU Yozzo, KL
   Isales, GM
   Raftery, TD
   Volz, DC
AF Yozzo, Krysde L.
   Isales, Gregory M.
   Raftery, Tara D.
   Volz, David C.
TI High-Content Screening Assay for Identification of Chemicals Impacting
   Cardiovascular Function in Zebrafish Embryos
SO ENVIRONMENTAL SCIENCE & TECHNOLOGY
LA English
DT Article
ID ARYL-HYDROCARBON RECEPTOR; ADVERSE OUTCOME PATHWAYS; TRANSGENIC
   ZEBRAFISH; RISK-ASSESSMENT; THROUGHPUT; ECOTOXICOLOGY; 21ST-CENTURY;
   VISION; MODEL; LIFE
AB Targeted assays are needed to better evaluate effects of chemicals on organogenesis and begin classification of chemicals by toxicologically relevant modes-of-action. Using transgenic zebrafish (fli1:egfp) that stably express eGFP within vascular endothelial cells, we have developed and optimized a 384-well-based high-content screening (HCS) assay that enables us to screen and identify chemicals affecting cardiovascular function at sublethal, nonteratogenic concentrations. Following static exposure of one embryo per well from 5 to 72 h postfertilization (hpf), automated image acquisition procedures and custom image analysis protocols are used to quantify body length, circulation, heart rate, pericardial area (a biomarker for cardiac looping defects), and intersegmental vessel area within freshly hatched live embryos. After optimizing 72 hpf anesthetization procedures, we evaluated each end point across four independent control plates containing 384 initial embryos per plate. Survival and imaging success rates across these plates ranged from 93 to 99% and 42 to 74%, respectively. Criteria were then defined for assay success and analysis of treatments, and 10 chemicals were screened for targeted effects on cardiovascular function. Compared to existing zebrafish-based assays, this method provides a comprehensive discovery platform with (1) increased sample sizes; (2) broad concentration-response format; and (3) the ability to identify chemicals that target cardiovascular function at nonteratogenic concentrations.
C1 [Yozzo, Krysde L.; Isales, Gregory M.; Raftery, Tara D.; Volz, David C.] Univ S Carolina, Arnold Sch Publ Hlth, Dept Environm Hlth Sci, Columbia, SC 29208 USA.
RP Volz, DC (reprint author), Univ S Carolina, Arnold Sch Publ Hlth, Dept Environm Hlth Sci, Columbia, SC 29208 USA.
EM volz@mailbox.sc.edu
RI Catron, Tara/J-2009-2019
OI Catron, Tara/0000-0003-1193-9366
FU U.S. Environmental Protection Agency Science to Achieve Results
   (STAR)United States Environmental Protection Agency [R835169]
FX Funding was provided by a U.S. Environmental Protection Agency Science
   to Achieve Results (STAR) Grant No. R835169 to D.C.V. The contents of
   this manuscript are solely the responsibility of D.C.V. and do not
   necessarily represent the official views of the U.S. EPA. Further, the
   U.S. EPA does not endorse the purchase of any commercial products or
   services mentioned in the publication. We gratefully thank Dr. Robert
   Tanguay (Oregon State University) for providing founder fish to
   establish our fli1:egfp zebrafish colony, Sylvia de Bruin (Molecular
   Devices) for providing technical assistance during custom journal script
   development, and David Catron for providing custom Microsoft Excel
   macros for FFT analysis.
CR Andersen ME, 2009, TOXICOL SCI, V107, P324, DOI 10.1093/toxsci/kfn255
   Antkiewicz DS, 2005, TOXICOL SCI, V84, P368, DOI 10.1093/toxsci/kfi073
   Belanger SE, 2010, AQUAT TOXICOL, V97, P88, DOI 10.1016/j.aquatox.2009.11.020
   Bradbury SP, 2004, ENVIRON SCI TECHNOL, V38, p463A, DOI 10.1021/es040675s
   Burns CG, 2005, NAT CHEM BIOL, V1, P263, DOI 10.1038/nchembio732
   Carney SA, 2006, MOL PHARMACOL, V70, P549, DOI 10.1124/mol.106.025304
   Casarett L. J., 2008, CASARETT DOULLS TOXI, P1310
   Embry MR, 2010, AQUAT TOXICOL, V97, P79, DOI 10.1016/j.aquatox.2009.12.008
   Halder Marlies, 2010, Integrated Environmental Assessment and Management, V6, P484, DOI 10.1002/ieam.48
   Ingebretson JJ, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00109
   KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302
   Kleinstreuer NC, 2011, ENVIRON HEALTH PERSP, V119, P1596, DOI 10.1289/ehp.1103412
   Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711
   Lin SJ, 2013, SMALL, V9, P1776, DOI 10.1002/smll.201202128
   McGee SP, 2013, TOXICOL SCI, V133, P144, DOI 10.1093/toxsci/kft020
   Mirat O, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00107
   NIH, 2013, GUID US ZEBR NIH INT
   *NRC, 2007, TOX TEST 21 CENT VIS, P196
   Padilla S, 2012, REPROD TOXICOL, V33, P174, DOI 10.1016/j.reprotox.2011.10.018
   Renquist BJ, 2013, ZEBRAFISH, V10, P343, DOI 10.1089/zeb.2012.0841
   Scholz S, 2008, ENVIRON SCI POLLUT R, V15, P394, DOI 10.1007/s11356-008-0018-z
   Spomer W, 2012, JALA-J LAB AUTOM, V17, P435, DOI 10.1177/2211068212464223
   Teixido E, 2013, TOXICOL IN VITRO, V27, P469, DOI 10.1016/j.tiv.2012.07.010
   Tran TC, 2007, CANCER RES, V67, P11386, DOI 10.1158/0008-5472.CAN-07-3126
   Veneman WJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-255
   Villeneuve DL, 2011, ENVIRON TOXICOL CHEM, V30, P1, DOI 10.1002/etc.396
   Volz DC, 2011, TOXICOL SCI, V123, P349, DOI 10.1093/toxsci/kfr185
   Wen DS, 2012, J APPL TOXICOL, V32, P834, DOI 10.1002/jat.2755
   Yozzo KL, 2013, AQUAT TOXICOL, V126, P346, DOI 10.1016/j.aquatox.2012.09.008
NR 29
TC 33
Z9 34
U1 0
U2 25
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0013-936X
EI 1520-5851
J9 ENVIRON SCI TECHNOL
JI Environ. Sci. Technol.
PD OCT 1
PY 2013
VL 47
IS 19
BP 11302
EP 11310
DI 10.1021/es403360y
PG 9
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA 295CT
UT WOS:000330094900069
PM 24015875
OA Bronze
DA 2019-10-23
ER

PT J
AU Paul, KB
   Thompson, JT
   Simmons, SO
   Vanden Heuvel, JP
   Crofton, KM
AF Paul, Katie B.
   Thompson, Jerry T.
   Simmons, Steven O.
   Vanden Heuvel, John P.
   Crofton, Kevin M.
TI Evidence for triclosan-induced activation of human and rodent xenobiotic
   nuclear receptors
SO TOXICOLOGY IN VITRO
LA English
DT Article
DE Triclosan; Pregnane-X receptor; Constitutive androstane receptor;
   Thyroid disruption; Hepatic catabolism
ID PREGNANE-X-RECEPTOR; CONSTITUTIVE-ANDROSTANE RECEPTOR; MICROSOMAL-ENZYME
   INDUCERS; GLUCURONOSYLTRANSFERASE MESSENGER-RNA; ANION-TRANSPORTING
   POLYPEPTIDE-2; THYROID-HORMONE METABOLISM; CYP2B6 GENE-EXPRESSION;
   MATERNAL HYPOTHYROXINEMIA; RAT-LIVER; IN-VIVO
AB The bacteriostat triclosan (2,4,4'-trichloro-2'-hydroxydiphenylether) (TCS) decreases rat serum thyroxine via putative nuclear receptor (NR) interaction(s) and subsequent transcriptional up-regulation of hepatic catabolism and clearance. However, due to the evolutionary divergence of the constitutive androstane and pregnane-X receptors (CAR, PXR), TCS-mediated downstream effects may be species-dependent. To test the hypothesis that TCS activates xenobiotic NRs across species, cell-based NR reporter assays were employed to assess potential activation of rat, mouse, and human PXR, and rat, mouse, and three splice variants of human CAR. TCS activated hPXR, acted as an inverse agonist of hCAR1, and as a weak agonist of hCAR3. TCS failed to activate rPXR in full-length receptor reporter assays, and instead acted as a modest inverse agonist of rCAR. Consistent with the rat data, TCS also failed to activate mPXR and was a modest inverse agonist of mCAR. These data suggest that TCS may interact with multiple NRs, including hPXR, hCAR1, hCAR3, and rCAR in order to potentially affect hepatic catabolism. Overall these data support the conclusion that TCS may interact with NRs to regulate hepatic catabolism and downstream thyroid hormone homeostasis in both rat and human models, though perhaps by divergent mechanisms. Published by Elsevier Ltd.
C1 [Paul, Katie B.] Univ N Carolina, Chapel Hill, NC 27599 USA.
   [Thompson, Jerry T.; Vanden Heuvel, John P.] Penn State Univ, Dept Vet & Biomed Sci, University Pk, PA 16802 USA.
   [Vanden Heuvel, John P.] INDIGO BioSci, State Coll, PA 16801 USA.
   [Crofton, Kevin M.] US EPA, Natl Ctr Computat Toxicol, Off Res & Dev, RTP, Res Triangle Pk, NC 27711 USA.
RP Crofton, KM (reprint author), US EPA, Natl Ctr Computat Toxicol, Off Res & Dev, RTP, Res Triangle Pk, NC 27711 USA.
EM crofton.kevin@epa.gov
RI Simmons, Steven O./R-4669-2018; Crofton, Kevin/J-4798-2015; Friedman,
   Katie Paul/L-5657-2019
OI Simmons, Steven O./0000-0001-9079-1069; Crofton,
   Kevin/0000-0003-1749-9971; Friedman, Katie Paul/0000-0002-2710-1691
FU PhRMA Foundation Predoctoral Pharmacology/Toxicology Fellowship; EPA/UNC
   Toxicology Research Program [CR833237]; National Institute of
   Environmental Health Science Training Grant [T32-ES07126]
FX The authors would like to thank to Joan M. Hedge for support of this
   work; Drs. Miriam N. Jacobs and Mary Gilbert for review of previous
   versions of this manuscript; and Drs. Kim L. R. Brouwer, Michael J.
   DeVito, Philip C. Smith, and James A. Swenberg for review throughout
   this project. Triclosan was a generous gift from Drs. Edgar Liebold,
   James Plautz, and Lisa Navarro of BASF/Ciba Specialty Chemicals. K.B.
   Paul was funded by a PhRMA Foundation Predoctoral
   Pharmacology/Toxicology Fellowship, the EPA/UNC Toxicology Research
   Program Training Agreement (CR833237), and the National Institute of
   Environmental Health Science Training Grant (T32-ES07126) during this
   work.
CR Allmyr M, 2009, BASIC CLIN PHARMACOL, V105, P339, DOI 10.1111/j.1742-7843.2009.00455.x
   Auerbach SS, 2003, NUCLEIC ACIDS RES, V31, P3194, DOI 10.1093/nar/gkg419
   Auso E, 2004, ENDOCRINOLOGY, V145, P4037, DOI 10.1210/en.2004-0274
   Baldwin W.S., 2008, TOXICOLOGICAL SCI
   BARTER RA, 1994, TOXICOL APPL PHARM, V128, P9, DOI 10.1006/taap.1994.1174
   Boobis AR, 2008, CRIT REV TOXICOL, V38, P87, DOI 10.1080/10408440701749421
   Buckley DB, 2009, DRUG METAB DISPOS, V37, P847, DOI 10.1124/dmd.108.024190
   Burk O, 2005, MOL PHARMACOL, V67, P1954, DOI 10.1124/mol.104.009019
   CAPELIER C, 1994, RECH AEROSPATIALE, P173
   Chang TKH, 2006, DRUG METAB REV, V38, P51, DOI 10.1080/03602530600569828
   Chen C, 2003, DRUG METAB DISPOS, V31, P908, DOI 10.1124/dmd.31.7.908
   Chen T, 2010, J PHARMACOL EXP THER, V332, P106, DOI 10.1124/jpet.109.159210
   Cheng XG, 2005, DRUG METAB DISPOS, V33, P1276, DOI 10.1124/dmd.105.003988
   Cheng XG, 2006, DRUG METAB DISPOS, V34, P1863, DOI 10.1124/dmd.106.010520
   Cooper BW, 2008, TOXICOL SCI, V103, P268, DOI 10.1093/toxsci/kfn047
   Crofton KM, 2007, ENVIRON TOXICOL PHAR, V24, P194, DOI 10.1016/j.etap.2007.04.008
   Crofton KM, 2005, CRIT REV TOXICOL, V35, P757, DOI 10.1080/10408440591007304
   Cullinan MP, 2012, SCI TOTAL ENVIRON, V416, P75, DOI 10.1016/j.scitotenv.2011.11.063
   DeKeyser JG, 2009, MOL PHARMACOL, V75, P1005, DOI 10.1124/mol.108.053702
   DeVito M, 1999, ENVIRON HEALTH PERSP, V107, P407, DOI 10.2307/3434545
   Faucette SR, 2006, J PHARMACOL EXP THER, V317, P1200, DOI 10.1124/jpet.105.098160
   Faucette SR, 2007, J PHARMACOL EXP THER, V320, P72, DOI 10.1124/jpet.106.112136
   Fery Y, 2010, TOXICOLOGY, V277, P11, DOI 10.1016/j.tox.2010.08.008
   Geick A, 2001, J BIOL CHEM, V276, P14581, DOI 10.1074/jbc.M010173200
   Gilbert ME, 2000, TOXICOL SCI, V57, P102, DOI 10.1093/toxsci/57.1.102
   Gilbert ME, 2006, BRAIN RES, V1069, P10, DOI 10.1016/j.brainres.2005.10.049
   Gillies PJ, 2012, J LIPID RES, V53, P1679, DOI 10.1194/jlr.M022657
   Goldey ES, 1998, TOXICOL SCI, V45, P94, DOI 10.1006/toxs.1998.2495
   GOLDEY ES, 1995, TOXICOL APPL PHARM, V135, P67, DOI 10.1006/taap.1995.1209
   Goodwin B, 2001, MOL PHARMACOL, V60, P427
   Guo GL, 2003, J BIOL CHEM, V278, P45062, DOI 10.1074/jbc.M307145200
   Guo GL, 2002, MOL PHARMACOL, V61, P832, DOI 10.1124/mol.61.4.832
   Guo GL, 2002, DRUG METAB DISPOS, V30, P283, DOI 10.1124/dmd.30.3.283
   Haddow JE, 1999, NEW ENGL J MED, V341, P549, DOI 10.1056/NEJM199908193410801
   Hanioka N, 1997, CHEMOSPHERE, V34, P719, DOI 10.1016/S0045-6535(97)00464-5
   HEUVEL JPV, 2006, TOXICOL SCI, V92, P476
   Hill RN, 1998, ENVIRON HEALTH PERSP, V106, P447, DOI 10.1289/ehp.98106447
   Hood A, 2003, TOXICOL APPL PHARM, V188, P6, DOI 10.1016/S0041-008X(02)00071-6
   Istrate MA, 2010, BIOCHEM BIOPH RES CO, V393, P688, DOI 10.1016/j.bbrc.2010.02.058
   Jacobs MN, 2005, TOXICOL APPL PHARM, V209, P123, DOI 10.1016/j.taap.2005.03.015
   Jansen J, 2005, THYROID, V15, P757, DOI 10.1089/thy.2005.15.757
   Jinno H, 1997, XENOBIOTICA, V27, P681, DOI 10.1080/004982597240271
   Jinno H, 2004, MOL PHARMACOL, V65, P496, DOI 10.1124/mol.65.3.496
   Jones SA, 2000, MOL ENDOCRINOL, V14, P27, DOI 10.1210/me.14.1.27
   Judson RS, 2010, ENVIRON HEALTH PERSP, V118, P485, DOI 10.1289/ehp.0901392
   Konno Y, 2008, DRUG METAB PHARMACOK, V23, P8, DOI 10.2133/dmpk.23.8
   Kretschmer XC, 2005, CHEM-BIOL INTERACT, V155, P111, DOI 10.1016/j.cbi.2005.06.003
   Lavado-Autric R, 2003, J CLIN INVEST, V111, P1073, DOI 10.1172/JCI200316262
   LeCluyse EL, 2001, CHEM-BIOL INTERACT, V134, P283, DOI 10.1016/S0009-2797(01)00163-6
   Lehmann JM, 1998, J CLIN INVEST, V102, P1016, DOI 10.1172/JCI3703
   LIU J, 1995, J PHARMACOL EXP THER, V273, P977
   Luo G, 2002, DRUG METAB DISPOS, V30, P795, DOI 10.1124/dmd.30.7.795
   Maglich JM, 2004, J BIOL CHEM, V279, P19832, DOI 10.1074/jbc.M313601200
   Maglich JM, 2003, J BIOL CHEM, V278, P17277, DOI 10.1074/jbc.M300138200
   Maglich JM, 2002, MOL PHARMACOL, V62, P638, DOI 10.1124/mol.62.3.638
   Maglich JM, 2009, J LIPID RES, V50, P439, DOI 10.1194/jlr.M800226-JLR200
   Mitro N, 2007, FEBS LETT, V581, P1721, DOI 10.1016/j.febslet.2007.03.047
   Moore LB, 2000, J BIOL CHEM, V275, P15122, DOI 10.1074/jbc.M001215200
   Moore LB, 2002, MOL ENDOCRINOL, V16, P977, DOI 10.1210/me.16.5.977
   Mutoh S, 2009, J BIOL CHEM, V284, P34785, DOI 10.1074/jbc.M109.048108
   Opazo MC, 2008, ENDOCRINOLOGY, V149, P5097, DOI 10.1210/en.2008-0560
   Paul KB, 2012, TOXICOLOGY, V300, P31, DOI 10.1016/j.tox.2012.05.023
   Paul KB, 2010, ENVIRON TOXICOL CHEM, V29, P2840, DOI 10.1002/etc.339
   Paul KB, 2010, TOXICOL SCI, V113, P367, DOI 10.1093/toxsci/kfp271
   Pop VJ, 2003, CLIN ENDOCRINOL, V59, P282, DOI 10.1046/j.1365-2265.2003.01822.x
   Pop VJ, 1999, CLIN ENDOCRINOL, V50, P149, DOI 10.1046/j.1365-2265.1999.00639.x
   Qatanani M, 2005, ENDOCRINOLOGY, V146, P995, DOI 10.1210/en.2004-1350
   Qatanani M, 2005, CURR DRUG METAB, V6, P329, DOI 10.2174/1389200054633899
   Raucy J, 2002, J PHARMACOL EXP THER, V303, P412, DOI 10.1124/jpet.102.038653
   Raucy JL, 2003, DRUG METAB DISPOS, V31, P533, DOI 10.1124/dmd.31.5.533
   Ren HZ, 2010, TOXICOL SCI, V113, P45, DOI 10.1093/toxsci/kfp251
   Ross J, 2010, TOXICOL SCI, V116, P452, DOI 10.1093/toxsci/kfq118
   Rotroff DM, 2010, TOXICOL SCI, V117, P348, DOI 10.1093/toxsci/kfq220
   Savkur RS, 2003, MOL GENET METAB, V80, P216, DOI 10.1016/j.ymgme.2003.08.013
   Schuur AG, 1997, ENDOCRINOLOGY, V138, P3727, DOI 10.1210/en.138.9.3727
   Sinz Michael W, 2007, Drug Metab Lett, V1, P147, DOI 10.2174/187231207780363561
   Smirlis D, 2001, J BIOL CHEM, V276, P12822, DOI 10.1074/jbc.M005930200
   Sueyoshi T, 2001, ANNU REV PHARMACOL, V41, P123, DOI 10.1146/annurev.pharmtox.41.1.123
   Sueyoshi T, 1999, J BIOL CHEM, V274, P6043, DOI 10.1074/jbc.274.10.6043
   Tien E.S., 2006, PPAR RES, V2006
   Tzameli I, 2000, MOL CELL BIOL, V20, P2951, DOI 10.1128/MCB.20.9.2951-2958.2000
   Urquhart BL, 2007, J CLIN PHARMACOL, V47, P566, DOI 10.1177/0091270007299930
   Vansell NR, 2002, DRUG METAB DISPOS, V30, P240, DOI 10.1124/dmd.30.3.240
   Vansell NR, 2001, TOXICOL APPL PHARM, V176, P187, DOI 10.1006/taap.2001.9278
   Wang HB, 2004, J BIOL CHEM, V279, P29295, DOI 10.1074/jbc.M400580200
   Wang HB, 2003, CLIN PHARMACOKINET, V42, P1331, DOI 10.2165/00003088-200342150-00003
   Wang HB, 2003, J BIOL CHEM, V278, P14146, DOI 10.1074/jbc.M212482200
   Wang LQ, 2006, CURR DRUG METAB, V7, P83, DOI 10.2174/138920006774832596
   Watkins RE, 2003, BIOCHEMISTRY-US, V42, P1430, DOI 10.1021/bi0268753
   Wei P., 2002, Pharmacogenomics Journal, V2, P117, DOI 10.1038/sj.tpj.6500087
   Yen PM, 2001, PHYSIOL REV, V81, P1097
   Yueh MF, 2005, DRUG METAB DISPOS, V33, P38, DOI 10.1124/dmd.104.001594
   Zhou J, 2005, CURR DRUG METAB, V6, P289, DOI 10.2174/1389200054633853
   Zoeller RT, 2007, CRIT REV TOXICOL, V37, P11, DOI 10.1080/10408440601123446
   Zorrilla LM, 2009, TOXICOL SCI, V107, P56, DOI 10.1093/toxsci/kfn225
NR 95
TC 32
Z9 33
U1 1
U2 37
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0887-2333
J9 TOXICOL IN VITRO
JI Toxicol. Vitro
PD OCT
PY 2013
VL 27
IS 7
BP 2049
EP 2060
DI 10.1016/j.tiv.2013.07.008
PG 12
WC Toxicology
SC Toxicology
GA 244BB
UT WOS:000326361000004
PM 23899473
DA 2019-10-23
ER

PT J
AU Hutchinson, TH
   Lyons, BP
   Thain, JE
   Law, RJ
AF Hutchinson, Thomas H.
   Lyons, Brett P.
   Thain, John E.
   Law, Robin J.
TI Evaluating legacy contaminants and emerging chemicals in marine
   environments using adverse outcome pathways and biological
   effects-directed analysis
SO MARINE POLLUTION BULLETIN
LA English
DT Article
DE Biomarkers; Bioassays; Chemical mixtures; Mode of action; Marine
   Strategy Framework Directive; Water Framework Directive
ID BROMINATED FLAME RETARDANTS; POLYCYCLIC AROMATIC-HYDROCARBONS;
   POLYBROMINATED DIPHENYL ETHER; FLOUNDER PLATICHTHYS-FLESUS; VERTEBRATE
   SEX STEROIDS; PERSONAL CARE PRODUCTS; DECABROMODIPHENYL ETHER;
   UNITED-KINGDOM; UK ESTUARIES; NORTH-SEA
AB Natural and synthetic chemicals are essential to our daily lives, food supplies, health care, industries and safe sanitation. At the same time protecting marine ecosystems and seafood resources from the adverse effects of chemical contaminants remains an important issue. Since the 1970s, monitoring of persistent, bioaccumulative and toxic (FBI) chemicals using analytical chemistry has provided important spatial and temporal trend data in three important contexts; relating to human health protection from seafood contamination, addressing threats to marine top predators and finally providing essential evidence to better protect the biodiversity of commercial and non-commercial marine species. A number of regional conventions have led to controls on certain PBT chemicals over several years (termed 'legacy contaminants'; e.g. cadmium, lindane, polycyclic aromatic hydrocarbons [PAHs] and polychlorinated biphenyls [PCBs]). Analytical chemistry plays a key role in evaluating to what extent such regulatory steps have been effective in leading to reduced emissions of these legacy contaminants into marine environments. In parallel, the application of biomarkers (e.g. DNA adducts, CYP1A-EROD, vitellogenin) and bioassays integrated with analytical chemistry has strengthened the evidence base to support an ecosystem approach to manage marine pollution problems. In recent years, however, the increased sensitivity of analytical chemistry, toxicity alerts and wider environmental awareness has led to a focus on emerging chemical contaminants (defined as chemicals that have been detected in the environment, but which are currently not included in regulatory monitoring programmes and whose fate and biological impacts are poorly understood). It is also known that natural chemicals (e.g. algal biotoxins) may also pose a threat to marine species and seafood quality. Hence complex mixtures of legacy contaminants, emerging chemicals and natural biotoxins in marine ecosystems represent important scientific, economic and health challenges. In order to meet these challenges and pursue cost-effective scientific approaches that can provide evidence necessary to support policy needs (e.g. the European Marine Strategy Framework Directive), it is widely recognised that there is a need to (i) provide marine exposure assessments for priority contaminants using a range of validated models, passive samplers and biomarkers; (ii) integrate chemical monitoring data with biological effects data across spatial and temporal scales (including quality controls); and (iii) strengthen the evidence base to understand the relationship between exposure to complex chemical mixtures, biological and ecological impacts through integrated approaches and molecular data (e.g. genomics, proteomics and metabolomics). Additionally, we support the widely held view that (iv) that rather than increasing the analytical chemistry monitoring of large number of emerging contaminants, it will be important to target analytical chemistry towards key groups of chemicals of concern using effects-directed analysis. It is also important to evaluate to what extent existing biomarkers and bioassays can address various classes of emerging chemicals using the adverse outcome pathway (AOP) approach now being developed by the Organization for Economic Cooperation and Development (OECD) with respect to human toxicology and ecotoxicology. Crown Copyright (C) 2013 Published by Elsevier Ltd. All rights reserved.
C1 [Hutchinson, Thomas H.; Lyons, Brett P.; Thain, John E.] Weymouth Lab, Ctr Environm Fisheries & Aquaculture Sci, Weymouth DT4 8UB, Dorset, England.
   [Law, Robin J.] Lowestoft Lab, Cefas, Lowestoft NR33 0HT, Suffolk, England.
RP Hutchinson, TH (reprint author), Weymouth Lab, Ctr Environm Fisheries & Aquaculture Sci, Barrack Rd, Weymouth DT4 8UB, Dorset, England.
EM tom.hutchinson@cefas.co.uk
OI Hutchinson, Tom/0000-0001-8823-5442; Lyons, Brett/0000-0003-3681-9344
FU Kaplan Foundation; Pew Charitable Trusts
FX We wish to thank CEFAS and ICES colleagues who have contributed to the
   successful development of various chemical and biological monitoring
   techniques and to the editors for inviting our manuscript submission.
   Our thanks also to the referees for their helpful comments on the draft
   manuscript. This is a contribution arising out of two meetings organised
   by the International Programme on the State of the Ocean (IPSO) and held
   at Somerville College, University of Oxford. These were the
   International Earth System Expert Workshop on Ocean Stresses and Impacts
   held on the, 11th-13th April, 2011 and the International Earth System
   Expert Workshop on Integrated Solutions for Synergistic Ocean 523
   Stresses and Impacts, 2nd-4th April, 2012. These meetings were supported
   by the Kaplan Foundation and the Pew Charitable Trusts.
CR Alaee M, 2003, ENVIRON INT, V29, P683, DOI 10.1016/S0160-4120(03)00121-1
   Allan IJ, 2006, TALANTA, V69, P302, DOI 10.1016/j.talanta.2005.09.043
   Allen Y, 1999, SCI TOTAL ENVIRON, V233, P5, DOI 10.1016/S0048-9697(99)00175-8
   Altenburger R, 2012, ENVIRON SCI TECHNOL, V46, P2508, DOI 10.1021/es2038036
   Andresen JA, 2007, ENVIRON TOXICOL CHEM, V26, P1081, DOI 10.1897/06-416R.1
   [Anonymous], 2010, WALL STREET J
   Arp HPH, 2012, ENVIRON SCI TECHNOL, V46, P4259, DOI 10.1021/es301074u
   Balaam JL, 2009, ENVIRON TOXICOL CHEM, V28, P1159, DOI 10.1897/08-488.1
   BBC, 2012, BBC
   Benotti MJ, 2007, ENVIRON SCI TECHNOL, V41, P5795, DOI 10.1021/es0629965
   Brack W, 2003, ANAL BIOANAL CHEM, V377, P397, DOI 10.1007/s00216-003-2139-z
   Brausch JM, 2011, CHEMOSPHERE, V82, P1518, DOI 10.1016/j.chemosphere.2010.11.018
   Cai MF, 2011, PROCEDIA ENGINEER, V18, DOI 10.1016/j.proeng.2011.11.008
   Celander MC, 2011, AQUAT TOXICOL, V105, P72, DOI 10.1016/j.aquatox.2011.06.002
   Celander MC, 2011, ENVIRON TOXICOL CHEM, V30, P52, DOI 10.1002/etc.382
   Chapman PM, 2007, ENVIRON INT, V33, P492, DOI 10.1016/j.envint.2006.09.001
   Chen Q., 2012, AQUAT TOXICOL, P110
   Ciparis S, 2005, ENVIRON TOXICOL CHEM, V24, P916, DOI 10.1897/04-179R.1
   Claessens M., MARINE POLL IN PRESS
   Clark R., 1997, MARINE POLLUTION
   Cole M, 2011, MAR POLLUT BULL, V62, P2588, DOI 10.1016/j.marpolbul.2011.09.025
   Coquery M, 2005, TRAC-TREND ANAL CHEM, V24, P117, DOI 10.1016/j.trac.2004.11.004
   Costanza R, 1999, ECOL ECON, V31, P199, DOI 10.1016/S0921-8009(99)00079-8
   Covaci A, 2011, ENVIRON INT, V37, P532, DOI 10.1016/j.envint.2010.11.007
   Crain DA, 2000, ENVIRONMENTAL ENDOCRINE DISRUPTERS: AN EVOLUTIONARY PERSPECTIVE, P1
   Defra, 2010, CHART PROGR 2 STAT U
   Dominguez AA, 2011, HANDB ENVIRON CHEM, V16, P141, DOI 10.1007/698_2010_95
   *ECETOC, 2007, 102 ECETOC
   EEA, 2011, HAZ SUBST EUR FRESH, P61
   Eljarrat E, 2011, HANDB ENVIRON CHEM, V16, P187, DOI 10.1007/698_2010_96
   Epstein FH, 2005, EXP BIOL MED, V230, P1
   Escher BI, 2002, ENVIRON SCI TECHNOL, V36, P4201, DOI 10.1021/es015848h
   ESF, 2011, MON CHEM POLL EUR SE, P104
   Farkas J, 2011, AQUAT TOXICOL, V101, P117, DOI 10.1016/j.aquatox.2010.09.010
   Feng CL, 2010, J ENVIRON SCI-CHINA, V22, P1425, DOI 10.1016/S1001-0742(09)60271-0
   Field JA, 2006, ENVIRON SCI TECHNOL, V40, P7105, DOI 10.1021/es062982z
   Fux E, 2009, HARMFUL ALGAE, V8, P523, DOI 10.1016/j.hal.2008.10.007
   Grote M, 2005, ENVIRON TOXICOL, V20, P475, DOI 10.1002/tox.20135
   Grung M, 2011, J TOXICOL ENV HEAL A, V74, P439, DOI 10.1080/15287394.2011.550555
   Guerra P, 2011, HANDB ENVIRON CHEM, V16, P1, DOI 10.1007/698_2010_93
   Gunnarsson L, 2008, ENVIRON SCI TECHNOL, V42, P5807, DOI 10.1021/es8005173
   Hall AJ, 2010, HARMFUL ALGAE, V9, P489, DOI 10.1016/j.hal.2010.03.004
   Hanke G.Angelidis, 2010, 24335 EUR EN, P171
   HARADA M, 1995, CRIT REV TOXICOL, V25, P1, DOI 10.3109/10408449509089885
   Haug LS, 2010, ENVIRON INT, V36, P772, DOI 10.1016/j.envint.2010.05.016
   He JH, 2011, ECOTOXICOLOGY, V20, P1813, DOI 10.1007/s10646-011-0720-3
   He MJ, 2012, SCI TOTAL ENVIRON, V419, P109, DOI 10.1016/j.scitotenv.2011.12.035
   Houde M, 2011, ENVIRON SCI TECHNOL, V45, P7962, DOI 10.1021/es104326w
   Hurst MR, 2004, MAR POLLUT BULL, V49, P648, DOI 10.1016/j.marpolbul.2004.04.012
   ICES/OSPAR, 2011, 2011ACOM30 ICESOSPAR, P263
   Jorundsdottir H, 2009, SCI TOTAL ENVIRON, V407, P4174, DOI 10.1016/j.scitotenv.2009.03.026
   Kemmlein S, 2009, J CHROMATOGR A, V1216, P320, DOI 10.1016/j.chroma.2008.05.085
   Kirby MF, 2004, MAR POLLUT BULL, V49, P71, DOI 10.1016/j.marpolbul.2004.01.009
   Kramer VJ, 2011, ENVIRON TOXICOL CHEM, V30, P64, DOI 10.1002/etc.375
   Kwon YK, 2012, MAR POLLUT BULL, V64, P1874, DOI 10.1016/j.marpolbul.2012.06.012
   la Farre M, 2008, TRAC-TREND ANAL CHEM, V27, P991, DOI 10.1016/j.trac.2008.09.010
   Laane RWPM, 2012, ESTUAR COAST SHELF S, V96, P31, DOI 10.1016/j.ecss.2011.06.020
   Langford KH, 2011, J ENVIRON MONITOR, V13, P2284, DOI 10.1039/c1em10260e
   Law RJ, 1997, MAR POLLUT BULL, V34, P306, DOI 10.1016/S0025-326X(96)00096-3
   Law RJ, 2008, CHEMOSPHERE, V73, P223, DOI 10.1016/j.chemosphere.2008.02.066
   Law RJ, 2012, MAR POLLUT BULL, V64, P1485, DOI 10.1016/j.marpolbul.2012.05.024
   Law RJ, 2011, HANDB ENVIRON CHEM, V16, P123, DOI 10.1007/698_2010_82
   Law RJ, 2009, MAR POLLUT BULL, V58, P459, DOI 10.1016/j.marpolbul.2009.02.023
   Lebeuf M, 2006, ENVIRON SCI TECHNOL, V40, P3211, DOI 10.1021/es0521829
   LeBlanc GA, 2000, ENVIRONMENTAL ENDOCRINE DISRUPTERS: AN EVOLUTIONARY PERSPECTIVE, P126
   Leslie HA, 2011, CHEMOSPHERE, V82, P88, DOI 10.1016/j.chemosphere.2010.09.073
   Loureiro ML, 2009, ENVIRON RESOUR ECON, V44, P537, DOI 10.1007/s10640-009-9300-x
   Lyons BP, 2010, MAR POLLUT BULL, V60, P1647, DOI 10.1016/j.marpolbul.2010.06.005
   Lyons BP, 2004, MAR ENVIRON RES, V58, P757, DOI 10.1016/j.marenvres.2004.03.091
   Lyons BP, 2004, MUTAT RES-FUND MOL M, V552, P177, DOI 10.1016/j.mrfmmm.2004.06.016
   Madureira TV, 2010, SCI TOTAL ENVIRON, V408, P5513, DOI 10.1016/j.scitotenv.2010.07.069
   Martinez ML, 2007, ECOL ECON, V63, P254, DOI 10.1016/j.ecolecon.2006.10.022
   Matthiessen P, 2002, ENVIRON POLLUT, V120, P739, DOI 10.1016/S0269-7491(02)00175-6
   Matthiessen P, 1998, ENVIRON TOXICOL CHEM, V17, P37, DOI 10.1002/etc.5620170106
   Millennium Ecosystem Assessment (Program), 2005, EC HUM WELL BEING SY
   Myers MS, 2008, AQUAT TOXICOL, V88, P277, DOI 10.1016/j.aquatox.2008.05.005
   Namiesnik J, 2005, ANAL BIOANAL CHEM, V381, P279, DOI 10.1007/s00216-004-2830-8
   Nishikawa J, 2004, ENVIRON SCI TECHNOL, V38, P6271, DOI 10.1021/es049593u
   Papachlimitzou A, 2012, J CHROMATOGR A, V1219, P15, DOI 10.1016/j.chroma.2011.11.029
   Puget Sound Partnership, 2010, STAT SOUND REP 2009, P156
   Raymond-Delpech Valerie, 2005, Invertebrate Neuroscience, V5, P119
   Reid MJ, 2011, DRUG ALCOHOL DEPEN, V119, P179, DOI 10.1016/j.drugalcdep.2011.06.007
   Rewitz KF, 2006, COMP BIOCHEM PHYS C, V143, P363, DOI 10.1016/j.cbpc.2006.04.001
   Richardson BJ, 2005, MAR POLLUT BULL, V50, P913, DOI 10.1016/j.marpolbul.2005.06.034
   Ringius L, 2000, EUR J INT RELAT, V6, P513
   Roberts PH, 2006, J CHROMATOGR A, V1134, P143, DOI 10.1016/j.chroma.2006.08.093
   Ross PS, 2009, MAR POLLUT BULL, V58, P7, DOI 10.1016/j.marpolbul.2008.09.002
   Ruddock PJ, 2003, SCI TOTAL ENVIRON, V301, P105, DOI 10.1016/S0048-9697(02)00292-9
   Rumney H.S., 2012, CEFAS LOWESTOFT, V63, P32
   SCHER, 2011, TOX ASS CHEM MIXT WA
   Scott AP, 2013, STEROIDS, V78, P268, DOI 10.1016/j.steroids.2012.11.006
   Scott AP, 2012, STEROIDS, V77, P1450, DOI 10.1016/j.steroids.2012.08.009
   Snape JR, 2004, AQUAT TOXICOL, V67, P143, DOI 10.1016/j.aquatox.2003.11.011
   Stapleton HM, 2008, ENVIRON TOXICOL CHEM, V27, P306, DOI 10.1897/07-301R.1
   Stapleton HM, 2006, ENVIRON SCI TECHNOL, V40, P4653, DOI 10.1021/es060573x
   Stapleton HM, 2004, ENVIRON SCI TECHNOL, V38, P112, DOI 10.1021/es034746j
   Stentiford GD, 2003, MAR ENVIRON RES, V55, P137, DOI 10.1016/S0141-1136(02)00212-X
   Sumpter JP, 2005, ENVIRON SCI TECHNOL, V39, P4321, DOI 10.1021/es048504a
   TANABE S, 1994, SCI TOTAL ENVIRON, V154, P163, DOI 10.1016/0048-9697(94)90086-8
   Thain JE, 2008, ICES J MAR SCI, V65, P1508, DOI 10.1093/icesjms/fsn120
   Thomas KV, 2009, ENVIRON SCI TECHNOL, V43, P8066, DOI 10.1021/es9014212
   Thomas KV, 1999, MAR POLLUT BULL, V38, P925, DOI 10.1016/S0025-326X(99)00102-2
   Thomas KV, 2003, CHEMOSPHERE, V53, P1105, DOI 10.1016/S0045-6535(03)00611-8
   Tiedeken JA, 2010, ENVIRON HEALTH PERSP, V118, P545, DOI 10.1289/ehp.0901301
   Tiedeken JA, 2009, ENVIRON HEALTH PERSP, V117, P68, DOI 10.1289/ehp.11685
   Vane CH, 2007, MAR POLLUT BULL, V54, P1301, DOI 10.1016/j.marpolbul.2007.04.005
   Vane CH, 2011, PHILOS T R SOC A, V369, P1085, DOI 10.1098/rsta.2010.0298
   Veldhoen N, 2012, ECOTOX ENVIRON SAFE, V76, P23, DOI 10.1016/j.ecoenv.2011.10.005
   Volz DC, 2011, TOXICOL SCI, V123, P349, DOI 10.1093/toxsci/kfr185
   Walsh PJ, 2008, OCEANS HUMAN HLTH RI
   Weigel S, 2002, SCI TOTAL ENVIRON, V295, P131, DOI 10.1016/S0048-9697(02)00064-5
   Williams TD, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002126
   Wolschke H, 2011, WATER RES, V45, P6259, DOI 10.1016/j.watres.2011.09.028
   Woodhead RJ, 1999, MAR POLLUT BULL, V38, P773, DOI 10.1016/S0025-326X(99)00039-9
   Zarbl H, 2010, CHEM-BIOL INTERACT, V184, P273, DOI 10.1016/j.cbi.2010.01.031
   Zhang GF, 2012, NATURE, V490, P49, DOI 10.1038/nature11413
   Zhu XS, 2011, ENVIRON SCI TECHNOL, V45, P3753, DOI 10.1021/es103779h
NR 117
TC 36
Z9 37
U1 2
U2 162
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0025-326X
EI 1879-3363
J9 MAR POLLUT BULL
JI Mar. Pollut. Bull.
PD SEP 30
PY 2013
VL 74
IS 2
BP 517
EP 525
DI 10.1016/j.marpolbul.2013.06.012
PG 9
WC Environmental Sciences; Marine & Freshwater Biology
SC Environmental Sciences & Ecology; Marine & Freshwater Biology
GA 257WK
UT WOS:000327418300004
PM 23820191
DA 2019-10-23
ER

PT J
AU Bienstock, RJ
   Yang, CH
   Rathman, J
   Richard, AM
AF Bienstock, Rochelle J.
   Yang, Chihae
   Rathman, Jim
   Richard, Ann M.
TI Chemotype approach to mapping the chemical landscape and exploring
   chemical-biological interactions within EPA's ToxCast project
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
CT 246th National Meeting of the American-Chemical-Society (ACS)
CY SEP 08-12, 2013
CL Indianapolis, IN
SP Amer Chem Soc
C1 [Bienstock, Rochelle J.] US EPA, IS & GS Civil, EPA Natl Ctr Computat Toxicol NCCT, Off Res & Dev, Res Triangle Pk, NC 27711 USA.
   [Yang, Chihae; Rathman, Jim] Altamira LLC, Columbus, OH 43235 USA.
   [Richard, Ann M.] Natl Ctr Computat Toxicol, Res Triangle Pk, NC 27709 USA.
EM bienstock.rachelle@epa.gov
NR 0
TC 0
Z9 0
U1 0
U2 4
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD SEP 8
PY 2013
VL 246
MA 117-CINF
PG 1
WC Chemistry, Multidisciplinary
SC Chemistry
GA 288NJ
UT WOS:000329618402022
DA 2019-10-23
ER

PT J
AU Shafer, TJ
AF Shafer, Timothy J.
TI Adverse outcome pathways for neurotoxicity: An example using pyrethroid
   insecticides
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
CT 246th National Meeting of the American-Chemical-Society (ACS)
CY SEP 08-12, 2013
CL Indianapolis, IN
SP Amer Chem Soc
C1 [Shafer, Timothy J.] US EPA, Integrated Syst Toxicol Div, Res Triangle Pk, NC 27711 USA.
EM shafer.tim@epa.gov
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD SEP 8
PY 2013
VL 246
MA 81-AGRO
PG 1
WC Chemistry, Multidisciplinary
SC Chemistry
GA 288NJ
UT WOS:000329618400356
DA 2019-10-23
ER

PT J
AU DeMarini, D
AF DeMarini, D.
TI International Activities for Assessing and Evaluating Agents As Human
   Germ-Cell Mutagens.
SO ENVIRONMENTAL AND MOLECULAR MUTAGENESIS
LA English
DT Meeting Abstract
CT 44th Annual Meeting of the
   Environmental-Mutagenesis-and-Genomics-Society (EMGS)
CY SEP 21-25, 2013
CL Monterey, CA
SP Environm Mutagenesis & Genom Soc (EMGS)
C1 [DeMarini, D.] US EPA, Res Triangle Pk, NC 27711 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0893-6692
J9 ENVIRON MOL MUTAGEN
JI Environ. Mol. Mutagen.
PD SEP
PY 2013
VL 54
SU 1
BP S15
EP S15
PG 1
WC Environmental Sciences; Genetics & Heredity; Toxicology
SC Environmental Sciences & Ecology; Genetics & Heredity; Toxicology
GA 205FV
UT WOS:000323429400012
DA 2019-10-23
ER

PT J
AU Ottinger, MA
   Carro, T
   Bohannon, M
   Baltos, L
   Marcell, AM
   McKernan, M
   Dean, KM
   Lavoie, E
   Abdelnabi, M
AF Ottinger, Mary Ann
   Carro, Tiffany
   Bohannon, Meredith
   Baltos, Leah
   Marcell, Allegra M.
   McKernan, Moira
   Dean, Karen M.
   Lavoie, Emma
   Abdelnabi, Mahmoud
TI Assessing effects of environmental chemicals on neuroendocrine systems:
   Potential mechanisms and functional outcomes
SO GENERAL AND COMPARATIVE ENDOCRINOLOGY
LA English
DT Article
DE Japanese quail; Endocrine disrupting chemicals; Sexual differentiation;
   Male sexual behavior; Neuroendocrine systems; Avian reproduction
ID ENDOCRINE-DISRUPTING CHEMICALS; QUAIL COTURNIX-JAPONICA; IN-OVO
   EXPOSURE; CHICKEN GALLUS-GALLUS; DIPHENYL ETHERS PBDES; DARK-EYED JUNCO;
   JAPANESE-QUAIL; SEXUAL-DIFFERENTIATION; CONTAMINANT EXPOSURE; ZEBRA
   FINCHES
AB Environmental pollutants encompass a vast array of compounds. Most studies in birds have focused on toxicological effects, with little attention to non-lethal effects. Consequently, it has proven difficult to assess potential risk associated with exposure to endocrine disrupting chemicals (EDCs). Assessing potential adverse effects due to exposure is further complicated by the great variation that occurs across avian species. These include variations in reproductive strategies, life span, sexual differentiation, and migration. Differences in reproductive strategies, particularly in the developmental patterns and mechanisms for precocial and altricial chicks, predispose birds to wide variations in response to steroids and steroid-like EDCs. We have investigated the effects of EDCs in precocial birds including Japanese quail (Coturnix japonica) and mallard ducks (Anas platyrhynchos) as well as in wild altricial songbirds. Studies in Japanese quail characterized endogenous steroid hormone changes during development and have demonstrated that the developing embryo uses the yolk as a 'steroid hormone depot'. It appears that actual embryonic exposure is quantitatively lower than indicated by the treatment in egg injections and that the true amount of compound necessary for bioactivity may be quite low relative to the actual dosage delivered. Additionally, embryonic exposure to specific EDCs adversely affected sexual differentiation in quail, especially impacting male sexual behavior as well as neural systems, immune response, and thyroid hormones. Many of these studies considered single compounds; however, wild birds are exposed to complex mixtures and multiple compounds. We tested complex mixtures of polychlorinated biphenyls (PCBs) at concentrations that bracketed those found in eggs in contaminated regions. Results indicated that the predictive value of the toxic equivalency (TEQ), based on comparative activation of the aryl hydrocarbon receptor (AhR) relative to dioxin was not as accurate as expected. We discuss the potential of developing an endocrine disruption index (EDI) to bridge the inconsistencies observed between responses predicted by the TEQ and those observed in vivo following exposure to EDCs. Further, we will discuss how an EDI would complement the adverse outcome pathways analyses to consider the range of effects of endocrine disruptors in birds. (C) 2013 Elsevier Inc. All rights reserved.
C1 [Ottinger, Mary Ann; Carro, Tiffany; Bohannon, Meredith; Baltos, Leah; Marcell, Allegra M.; McKernan, Moira; Dean, Karen M.; Lavoie, Emma; Abdelnabi, Mahmoud] Univ Maryland, Dept Anim & Avian Sci, College Pk, MD 20742 USA.
RP Ottinger, MA (reprint author), Univ Maryland, Dept Anim & Avian Sci, 3115 Anim Sci Bldg, College Pk, MD 20706 USA.
EM maotting@umd.edu
FU EPAUnited States Environmental Protection Agency [R826134010,
   R-82877801]; NRI [92-37203]; NSFNational Science Foundation (NSF)
   [9817024]; MAES; University of Maryland, College Park; Fish and Wildlife
   ServiceUS Fish & Wildlife Service
FX This review reflects some of the studies that have been supported by EPA
   grants # R826134010 (Star Grant) and R-82877801; Battelle contract for
   EPA-EDSTAC validation studies, NRI #92-37203 and NSF #9817024; MAES,
   University of Maryland, College Park; Fish and Wildlife Service. Views
   expressed herein are those of the authors and do not necessarily reflect
   those of the United States Fish and Wildlife Service.
CR Abdelnabi MA, 2003, GEN COMP ENDOCR, V130, P13, DOI 10.1016/S0016-6480(02)00524-5
   Abdelnabi MA, 2000, POULTRY SCI, V79, P564, DOI 10.1093/ps/79.4.564
   ADKINSREGAN E, 1994, J NEUROBIOL, V25, P865, DOI 10.1002/neu.480250710
   ADKINSREGAN E, 1990, GEN COMP ENDOCR, V78, P93, DOI 10.1016/0016-6480(90)90051-M
   ADKINSREGAN E, 1990, BRAIN RES, V514, P320, DOI 10.1016/0006-8993(90)91427-I
   ADKINSREGAN E, 1995, J EXP ZOOL, V271, P466, DOI 10.1002/jez.1402710608
   ADKINSREGAN E, 1990, HORM BEHAV, V24, P114, DOI 10.1016/0018-506X(90)90031-R
   Bars R, 2012, REGUL TOXICOL PHARM, V64, P143, DOI 10.1016/j.yrtph.2012.06.013
   Berg C, 1999, SCI TOTAL ENVIRON, V233, P57, DOI 10.1016/S0048-9697(99)00179-5
   Berg C, 1998, TOXICOL LETT, V103, P671, DOI 10.1016/S0378-4274(98)00285-9
   Best DA, 2010, ENVIRON TOXICOL CHEM, V29, P1581, DOI 10.1002/etc.195
   Bowerman WW, 2000, CHEMOSPHERE, V41, P1569, DOI 10.1016/S0045-6535(00)00014-X
   Brunstrom B, 1998, COMP BIOCHEM PHYS C, V121, P213, DOI 10.1016/S0742-8413(98)10042-7
   Cohen-Barnhouse AM, 2011, TOXICOL SCI, V119, P93, DOI 10.1093/toxsci/kfq289
   Corbitt C, 2007, GEN COMP ENDOCR, V154, P16, DOI 10.1016/j.ygcen.2007.06.026
   Custer CM, 2010, ENVIRON TOXICOL CHEM, V29, P2286, DOI [10.1002/276, 10.1002/etc.276]
   Custer T. W., 2002, ENVIRON POLLUT, V119, P1
   Custer TW, 2010, ENVIRON TOXICOL CHEM, V29, P99, DOI 10.1002/etc.26
   Darnerud PO, 2003, ENVIRON INT, V29, P841, DOI 10.1016/S0160-4120(03)00107-7
   EDSTAC, 1998, END DISR SCREEN TEST
   Farmahin R, 2013, TOXICOL SCI, V131, P139, DOI 10.1093/toxsci/kfs259
   Farmahin R, 2012, ENVIRON SCI TECHNOL, V46, P2967, DOI 10.1021/es2043992
   Fernie KJ, 2008, TOXICOL SCI, V102, P171, DOI 10.1093/toxsci/kfm295
   Fernie KJ, 2006, J TOXICOL ENV HEAL A, V69, P1541, DOI 10.1080/15287390500468753
   Fernie KJ, 2005, TOXICOL SCI, V88, P375, DOI 10.1093/toxsci/kfi295
   Fernie KJ, 2005, ENVIRON POLLUT, V138, P485, DOI 10.1016/j.envpol.2005.04.008
   Fox LL, 1999, J TOXICOL ENV HEAL A, V58, P233, DOI 10.1080/009841099157313
   Franceschini MD, 2008, ENVIRON TOXICOL CHEM, V27, P2326, DOI 10.1897/07-602.1
   Fry M., 1993, ENVIRON HEALTH PER S, V103, P165
   Gauthier LT, 2008, ENVIRON SCI TECHNOL, V42, P1524, DOI 10.1021/es702382k
   Gee JM, 2004, B ENVIRON CONTAM TOX, V73, P607, DOI 10.1007/s00128-004-0471-4
   Golden NH, 2003, B ENVIRON CONTAM TOX, V70, P385, DOI 10.1007/s00128-002-0203-6
   Grasman KA, 2001, ECOTOXICOLOGY, V10, P101, DOI 10.1023/A:1008950025622
   Halldin K, 2005, DOMEST ANIM ENDOCRIN, V29, P420, DOI 10.1016/j.domaniend.2005.02.036
   Halldin K, 2005, BRAIN RES BULL, V65, P211, DOI 10.1016/j.brainresbull.2004.11.020
   Halldin K, 2003, ARCH TOXICOL, V77, P116, DOI 10.1007/s00204-002-0417-8
   Halldin K, 2001, ARCH TOXICOL, V75, P597, DOI 10.1007/s002040100277
   Halldin K, 1999, ENVIRON HEALTH PERSP, V107, P861, DOI 10.2307/3454472
   Head JA, 2008, ENVIRON SCI TECHNOL, V42, P7535, DOI 10.1021/es801082a
   Hoogesteijn AL, 2008, ENVIRON TOXICOL CHEM, V27, P2071, DOI 10.1897/07-484.1
   Hotchkiss AK, 2008, TOXICOL SCI, V105, P235, DOI 10.1093/toxsci/kfn030
   Ishihara A, 2003, GEN COMP ENDOCR, V134, P36, DOI 10.1016/S0016-6480(03)00197-7
   Iwaniuk AN, 2006, BEHAV BRAIN RES, V173, P1, DOI 10.1016/j.bbr.2006.05.026
   Kavlock RJ, 1996, ENVIRON HEALTH PERSP, V104, P715, DOI 10.2307/3432708
   Kavlock R, 2012, CHEM RES TOXICOL, V25, P1287, DOI 10.1021/tx3000939
   Lavoie ET, 2007, J TOXICOL ENV HEAL A, V70, P547, DOI 10.1080/15287390600882226
   McGary S, 2001, ENVIRON TOXICOL CHEM, V20, P2487, DOI [10.1897/1551-5028(2001)020<2487:IOVORB>2.0.CO;2, 10.1002/etc.5620201114]
   Mckernan MA, 2007, ENVIRON TOXICOL CHEM, V26, P2724, DOI 10.1897/07-291.1
   McKernan MA, 2009, ENVIRON TOXICOL CHEM, V28, P1007, DOI 10.1897/08-318.1
   McKernan MA, 2010, CHEMOSPHERE, V79, P100, DOI 10.1016/j.chemosphere.2009.12.023
   McNabb FMA, 2003, EVOL DEV, V5, P76, DOI 10.1046/j.1525-142X.2003.03012.x
   Oshima A, 2012, ENVIRON TOXICOL CHEM, V31, P1091, DOI 10.1002/etc.1787
   Ottinger M.A., 2009, GEN COMP ENDOCRINOL, V163
   Ottinger MA, 2001, POULTRY SCI, V80, P795, DOI 10.1093/ps/80.6.795
   Ottinger MA, 2008, BRAIN RES REV, V57, P376, DOI 10.1016/j.brainresrev.2007.08.011
   Ottinger MA, 2009, J ENVIRON SCI HEAL C, V27, P286, DOI 10.1080/10590500903310229
   Panzica GC, 2007, FRONT NEUROENDOCRIN, V28, P179, DOI 10.1016/j.yfrne.2007.07.001
   Quinn MJ, 2008, HORM BEHAV, V53, P249, DOI 10.1016/j.yhbeh.2007.10.004
   Quinn Michael J. Jr, 2006, Journal of Poultry Science, V43, P1
   Quinn MJ, 2007, CHEMOSPHERE, V66, P1191, DOI 10.1016/j.chemosphere.2006.07.085
   Quinn MJ, 2007, J TOXICOL ENV HEAL A, V70, P88, DOI 10.1080/15287390600755026
   Quinn MJ, 2009, J EXP ZOOL PART A, V311A, P91, DOI 10.1002/jez.504
   Quinn MJ, 2005, ECOTOXICOLOGY, V14, P637, DOI 10.1007/s10646-005-0013-9
   Rattner BA, 2004, ARCH ENVIRON CON TOX, V47, P126, DOI 10.1007/s00244-003-3160-0
   Rattner BA, 2000, ENVIRON MONIT ASSESS, V63, P131, DOI 10.1023/A:1006458811235
   RATTNER BA, 1986, COMP BIOCHEM PHYS C, V83, P451, DOI 10.1016/0742-8413(86)90153-2
   Rochester JR, 2010, PHYSIOL BEHAV, V101, P13, DOI 10.1016/j.physbeh.2010.04.002
   Rochester JR, 2009, COMP BIOCHEM PHYS A, V154, P279, DOI 10.1016/j.cbpa.2009.06.017
   Satre D, 2009, ENVIRON RES, V109, P400, DOI 10.1016/j.envres.2009.01.004
   Smits JE, 2002, ARCH ENVIRON CON TOX, V43, P338, DOI 10.1007/s00244-002-1200-9
   THOMPSON RR, 1992, DEV BRAIN RES, V70, P231, DOI 10.1016/0165-3806(92)90202-8
   Toschik PC, 2005, ENVIRON TOXICOL CHEM, V24, P617, DOI 10.1897/04-141R.1
   Touart LW, 2004, ILAR J, V45, P462, DOI 10.1093/ilar.45.4.462
   Venier M, 2010, CHEMOSPHERE, V80, P1234, DOI 10.1016/j.chemosphere.2010.05.043
   Wade J, 2004, ANN NY ACAD SCI, V1016, P540, DOI 10.1196/annals.1298.015
   WATSON JT, 1990, GEN COMP ENDOCR, V77, P229, DOI 10.1016/0016-6480(90)90307-8
   Wilhelms KW, 2006, CHEMOSPHERE, V65, P674, DOI 10.1016/j.chemosphere.2006.01.045
   Yamashita R, 2011, J TOXICOL SCI, V36, P43, DOI 10.2131/jts.36.43
   Zoeller RT, 2012, ENDOCRINOLOGY, V153, P4097, DOI 10.1210/en.2012-1422
NR 79
TC 15
Z9 15
U1 0
U2 74
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0016-6480
EI 1095-6840
J9 GEN COMP ENDOCR
JI Gen. Comp. Endocrinol.
PD SEP 1
PY 2013
VL 190
BP 194
EP 202
DI 10.1016/j.ygcen.2013.06.004
PG 9
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 204WA
UT WOS:000323400800028
PM 23773971
DA 2019-10-23
ER

PT J
AU Al Sharif, M
   Alov, P
   Cronin, M
   Fioravanzo, E
   Tsakovska, I
   Vitcheva, V
   Worth, A
   Yang, CH
   Pajeva, I
AF Al Sharif, Merilin
   Alov, Petko
   Cronin, Mark
   Fioravanzo, Elena
   Tsakovska, Ivanka
   Vitcheva, Vessela
   Worth, Andrew
   Yang, Chihae
   Pajeva, Ilza
TI Toward better understanding of liver steatosis MoA: Molecular modelling
   study of PPAR gamma receptor
SO TOXICOLOGY LETTERS
LA English
DT Meeting Abstract
CT 49th Congress of the European-Societies-of-Toxicology (EUROTOX)
CY SEP 01-04, 2013
CL Interlaken, SWITZERLAND
SP European Soc Toxicol (EUROTOX), ECETOC, Roche, Syngenta, AstraZeneca, Sanofi, Basilea Pharmaceutica, ACEA Biosciences Inc, European Crop Protect, Bioservice Sci Labs GmbH, Oekotoxzentrum Ctr Ecotox, Swiss Confederat, Fed Dept Home Affairs, Fed Off Publ Hlth (FOPH), BASF, SCAHT, Johnson & Johnson, Janssen Pharmaceut Co, Natl Ctr Replacement, Refinement & Reduct Anim Res, ILSI, SERVIER, RCC, Nestle, Suva Pro, Interpharma, Covance, Novartis, Merck, BioReliance
C1 [Al Sharif, Merilin; Alov, Petko; Tsakovska, Ivanka] Inst Biophys & Biomed Engn, Sofia, Bulgaria.
   [Cronin, Mark] Liverpool John Moores Univ, Liverpool L3 5UX, Merseyside, England.
   [Fioravanzo, Elena] S IN Soluzioni Informat SRL, Vicenza, Italy.
   [Vitcheva, Vessela] US FDA, CFSAN, College Pk, MD USA.
   [Worth, Andrew] European Commiss, Joint Res Ctr, Inst Hlth & Consumer Protect, Ispra, Italy.
   [Yang, Chihae] Altamira LLC, Columbus, OH USA.
   [Pajeva, Ilza] Bulgarian Acad Sci, Inst Biophys & Biomed Engn, BU-1113 Sofia, Bulgaria.
RI Worth, Andrew/R-8495-2019; Worth, Andrew Paul/O-3055-2019
OI Worth, Andrew Paul/0000-0002-5303-0452
NR 0
TC 2
Z9 2
U1 0
U2 3
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0378-4274
J9 TOXICOL LETT
JI Toxicol. Lett.
PD AUG 28
PY 2013
VL 221
SU S
BP S85
EP S85
DI 10.1016/j.toxlet.2013.05.099
PG 1
WC Toxicology
SC Toxicology
GA 210WO
UT WOS:000323865800258
DA 2019-10-23
ER

PT J
AU Conolly, R
   McMullin, T
   Hines, RN
   Sheets, LP
   Cohen, SM
AF Conolly, R.
   McMullin, T.
   Hines, R. N.
   Sheets, L. P.
   Cohen, S. M.
TI In Vitro to In Vivo Extrapolation (IVIVE) for human health risk
   assessment
SO TOXICOLOGY LETTERS
LA English
DT Meeting Abstract
CT 49th Congress of the European-Societies-of-Toxicology (EUROTOX)
CY SEP 01-04, 2013
CL Interlaken, SWITZERLAND
SP European Soc Toxicol (EUROTOX), ECETOC, Roche, Syngenta, AstraZeneca, Sanofi, Basilea Pharmaceutica, ACEA Biosciences Inc, European Crop Protect, Bioservice Sci Labs GmbH, Oekotoxzentrum Ctr Ecotox, Swiss Confederat, Fed Dept Home Affairs, Fed Off Publ Hlth (FOPH), BASF, SCAHT, Johnson & Johnson, Janssen Pharmaceut Co, Natl Ctr Replacement, Refinement & Reduct Anim Res, ILSI, SERVIER, RCC, Nestle, Suva Pro, Interpharma, Covance, Novartis, Merck, BioReliance
C1 [McMullin, T.] Dow Corning Corp, Midland, MI USA.
   [Sheets, L. P.] Bayer CropSci, Res Triangle Pk, NC USA.
   [Cohen, S. M.] Univ Nebraska Med Ctr, Omaha, NE USA.
NR 0
TC 0
Z9 0
U1 0
U2 2
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0378-4274
J9 TOXICOL LETT
JI Toxicol. Lett.
PD AUG 28
PY 2013
VL 221
SU S
BP S14
EP S14
DI 10.1016/j.toxlet.2013.06.051
PG 1
WC Toxicology
SC Toxicology
GA 210WO
UT WOS:000323865800041
DA 2019-10-23
ER

PT J
AU Cronin, MTD
   Madden, JC
   Richarz, AN
   Nelms, MD
   Steinmetz, F
AF Cronin, Mark T. D.
   Madden, Judith C.
   Richarz, Andrea-N.
   Nelms, Mark D.
   Steinmetz, F.
TI Applying read-across for quantitative chronic toxicity prediction
SO TOXICOLOGY LETTERS
LA English
DT Meeting Abstract
CT 49th Congress of the European-Societies-of-Toxicology (EUROTOX)
CY SEP 01-04, 2013
CL Interlaken, SWITZERLAND
SP European Soc Toxicol (EUROTOX), ECETOC, Roche, Syngenta, AstraZeneca, Sanofi, Basilea Pharmaceutica, ACEA Biosciences Inc, European Crop Protect, Bioservice Sci Labs GmbH, Oekotoxzentrum Ctr Ecotox, Swiss Confederat, Fed Dept Home Affairs, Fed Off Publ Hlth (FOPH), BASF, SCAHT, Johnson & Johnson, Janssen Pharmaceut Co, Natl Ctr Replacement, Refinement & Reduct Anim Res, ILSI, SERVIER, RCC, Nestle, Suva Pro, Interpharma, Covance, Novartis, Merck, BioReliance
C1 [Cronin, Mark T. D.; Madden, Judith C.; Richarz, Andrea-N.; Nelms, Mark D.; Steinmetz, F.] Liverpool John Moores Univ, Sch Pharm & Chem, Liverpool L3 3AF, Merseyside, England.
OI Nelms, Mark/0000-0003-2350-2743
NR 0
TC 1
Z9 1
U1 0
U2 2
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0378-4274
J9 TOXICOL LETT
JI Toxicol. Lett.
PD AUG 28
PY 2013
VL 221
SU S
BP S52
EP S52
DI 10.1016/j.toxlet.2013.06.190
PG 1
WC Toxicology
SC Toxicology
GA 210WO
UT WOS:000323865800160
DA 2019-10-23
ER

PT J
AU Fioravanzo, E
   Bassan, A
   Cronin, MTD
   Kovarich, S
   Manelfi, C
   Richarz, AN
   Tsakovska, I
   Worth, AP
AF Fioravanzo, E.
   Bassan, A.
   Cronin, M. T. D.
   Kovarich, S.
   Manelfi, C.
   Richarz, A. -N.
   Tsakovska, I.
   Worth, A. P.
TI Molecular modelling of LXR binding to evaluate the potential for liver
   steatosis
SO TOXICOLOGY LETTERS
LA English
DT Meeting Abstract
CT 49th Congress of the European-Societies-of-Toxicology (EUROTOX)
CY SEP 01-04, 2013
CL Interlaken, SWITZERLAND
SP European Soc Toxicol (EUROTOX), ECETOC, Roche, Syngenta, AstraZeneca, Sanofi, Basilea Pharmaceutica, ACEA Biosciences Inc, European Crop Protect, Bioservice Sci Labs GmbH, Oekotoxzentrum Ctr Ecotox, Swiss Confederat, Fed Dept Home Affairs, Fed Off Publ Hlth (FOPH), BASF, SCAHT, Johnson & Johnson, Janssen Pharmaceut Co, Natl Ctr Replacement, Refinement & Reduct Anim Res, ILSI, SERVIER, RCC, Nestle, Suva Pro, Interpharma, Covance, Novartis, Merck, BioReliance
C1 [Fioravanzo, E.; Bassan, A.; Kovarich, S.; Manelfi, C.] Soluz Informat Srl, Vicenza, Italy.
   [Cronin, M. T. D.; Richarz, A. -N.] Liverpool John Moores Univ, Liverpool L3 5UX, Merseyside, England.
   [Tsakovska, I.] Inst Biophys & Biomed Engn, Sofia, Bulgaria.
   [Worth, A. P.] European Commiss, Joint Res Ctr, Inst Hlth & Consumer Protect, Ispra, Italy.
RI Worth, Andrew Paul/O-3055-2019; Worth, Andrew/R-8495-2019
OI Worth, Andrew Paul/0000-0002-5303-0452; 
NR 0
TC 2
Z9 2
U1 0
U2 2
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0378-4274
J9 TOXICOL LETT
JI Toxicol. Lett.
PD AUG 28
PY 2013
VL 221
SU S
BP S83
EP S83
DI 10.1016/j.toxlet.2013.05.092
PG 1
WC Toxicology
SC Toxicology
GA 210WO
UT WOS:000323865800251
DA 2019-10-23
ER

PT J
AU Teunis, MAT
   Fiechter, D
   Mika, P
   Theunissen, PT
   Hendriks, G
   Krul, CAM
   Piersma, AH
AF Teunis, Marc A. T.
   Fiechter, Danielle
   Mika, Paulina
   Theunissen, Peter T.
   Hendriks, Giel
   Krul, Cyrille A. M.
   Piersma, Alden H.
TI Using adverse outcome pathway genes to assess developmental toxicity of
   compounds in a mouse stem cell system
SO TOXICOLOGY LETTERS
LA English
DT Meeting Abstract
CT 49th Congress of the European-Societies-of-Toxicology (EUROTOX)
CY SEP 01-04, 2013
CL Interlaken, SWITZERLAND
SP European Soc Toxicol (EUROTOX), ECETOC, Roche, Syngenta, AstraZeneca, Sanofi, Basilea Pharmaceutica, ACEA Biosciences Inc, European Crop Protect, Bioservice Sci Labs GmbH, Oekotoxzentrum Ctr Ecotox, Swiss Confederat, Fed Dept Home Affairs, Fed Off Publ Hlth (FOPH), BASF, SCAHT, Johnson & Johnson, Janssen Pharmaceut Co, Natl Ctr Replacement, Refinement & Reduct Anim Res, ILSI, SERVIER, RCC, Nestle, Suva Pro, Interpharma, Covance, Novartis, Merck, BioReliance
C1 [Teunis, Marc A. T.; Fiechter, Danielle; Mika, Paulina; Theunissen, Peter T.] Univ Appl Sci, Utrecht, Netherlands.
   [Hendriks, Giel] Leiden Univ, Med Ctr, Leiden, Netherlands.
   [Krul, Cyrille A. M.] TNO Innovat Life, Zeist, Netherlands.
   [Piersma, Alden H.] Natl Inst Publ Hlth & Environm, NL-3720 BA Bilthoven, Netherlands.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0378-4274
J9 TOXICOL LETT
JI Toxicol. Lett.
PD AUG 28
PY 2013
VL 221
SU S
BP S216
EP S216
DI 10.1016/j.toxlet.2013.05.517
PG 1
WC Toxicology
SC Toxicology
GA 210WO
UT WOS:000323865800665
DA 2019-10-23
ER

PT J
AU Vergauwen, L
   Blust, R
   Witters, H
   Verstraelen, S
   Villeneuve, DL
   Ankley, GT
   Knapen, D
AF Vergauwen, Lucia
   Blust, Ronny
   Witters, Hilda
   Verstraelen, Sandra
   Villeneuve, Daniel L.
   Ankley, Gerald T.
   Knapen, Dries
TI Development of an alternative testing strategy for the fish early life
   stage test for predicting chronic toxicity
SO TOXICOLOGY LETTERS
LA English
DT Meeting Abstract
CT 49th Congress of the European-Societies-of-Toxicology (EUROTOX)
CY SEP 01-04, 2013
CL Interlaken, SWITZERLAND
SP European Soc Toxicol (EUROTOX), ECETOC, Roche, Syngenta, AstraZeneca, Sanofi, Basilea Pharmaceutica, ACEA Biosciences Inc, European Crop Protect, Bioservice Sci Labs GmbH, Oekotoxzentrum Ctr Ecotox, Swiss Confederat, Fed Dept Home Affairs, Fed Off Publ Hlth (FOPH), BASF, SCAHT, Johnson & Johnson, Janssen Pharmaceut Co, Natl Ctr Replacement, Refinement & Reduct Anim Res, ILSI, SERVIER, RCC, Nestle, Suva Pro, Interpharma, Covance, Novartis, Merck, BioReliance
C1 [Vergauwen, Lucia; Knapen, Dries] Univ Antwerp, Dept Vet Sci, Zebrafishlab, B-2610 Antwerp, Belgium.
   [Blust, Ronny] Univ Antwerp, Dept Biol, Syst Physiol & Ecotoxicol Res SPHERE, B-2020 Antwerp, Belgium.
   [Witters, Hilda; Verstraelen, Sandra] Flemish Inst Technol Res VITO NV, B-2400 Mol, Belgium.
   [Villeneuve, Daniel L.; Ankley, Gerald T.] US EPA, Off Res & Dev, Natl Hlth & Environm Effects Res Lab, Midcontinent Ecol Div, Duluth, MN 55804 USA.
RI Witters, Hilda/V-5754-2019
OI Witters, Hilda/0000-0002-2026-3962; Verstraelen,
   Sandra/0000-0003-0529-8208
NR 0
TC 0
Z9 0
U1 0
U2 4
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0378-4274
J9 TOXICOL LETT
JI Toxicol. Lett.
PD AUG 28
PY 2013
VL 221
SU S
BP S104
EP S104
DI 10.1016/j.toxlet.2013.05.159
PG 1
WC Toxicology
SC Toxicology
GA 210WO
UT WOS:000323865800316
DA 2019-10-23
ER

PT J
AU Verstraelen, S
   Covaci, A
   Maho, W
   Berckmans, P
   Peers, B
   Witters, H
AF Verstraelen, S.
   Covaci, A.
   Maho, W.
   Berckmans, P.
   Peers, B.
   Witters, H.
TI Evaluation of zebrafish larvae as alternative test system to predict
   hepatotoxicity
SO TOXICOLOGY LETTERS
LA English
DT Meeting Abstract
CT 49th Congress of the European-Societies-of-Toxicology (EUROTOX)
CY SEP 01-04, 2013
CL Interlaken, SWITZERLAND
SP European Soc Toxicol (EUROTOX), ECETOC, Roche, Syngenta, AstraZeneca, Sanofi, Basilea Pharmaceutica, ACEA Biosciences Inc, European Crop Protect, Bioservice Sci Labs GmbH, Oekotoxzentrum Ctr Ecotox, Swiss Confederat, Fed Dept Home Affairs, Fed Off Publ Hlth (FOPH), BASF, SCAHT, Johnson & Johnson, Janssen Pharmaceut Co, Natl Ctr Replacement, Refinement & Reduct Anim Res, ILSI, SERVIER, RCC, Nestle, Suva Pro, Interpharma, Covance, Novartis, Merck, BioReliance
C1 [Verstraelen, S.; Berckmans, P.; Witters, H.] VITO NV, B-2400 Mol, Belgium.
   [Covaci, A.; Maho, W.] Univ Antwerp, B-2610 Antwerp, Belgium.
   [Peers, B.] Univ Liege, GIGA R, B-4000 Liege, Belgium.
RI Witters, Hilda/V-5754-2019; Covaci, Adrian/A-9058-2008
OI Witters, Hilda/0000-0002-2026-3962; Covaci, Adrian/0000-0003-0527-1136;
   Verstraelen, Sandra/0000-0003-0529-8208
NR 0
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0378-4274
J9 TOXICOL LETT
JI Toxicol. Lett.
PD AUG 28
PY 2013
VL 221
SU S
BP S235
EP S235
DI 10.1016/j.toxlet.2013.05.574
PG 1
WC Toxicology
SC Toxicology
GA 210WO
UT WOS:000323865800722
DA 2019-10-23
ER

PT J
AU Campos, B
   Garcia-Reyero, N
   Rivetti, C
   Escalon, L
   Habib, T
   Tauler, R
   Tsakovski, S
   Pina, B
   Barata, C
AF Campos, Bruno
   Garcia-Reyero, Natalia
   Rivetti, Claudia
   Escalon, Lynn
   Habib, Tanwir
   Tauler, Roma
   Tsakovski, Stefan
   Pina, Benjamin
   Barata, Carlos
TI Identification of Metabolic Pathways in Daphnia magna Explaining
   Hormetic Effects of Selective Serotonin Reuptake Inhibitors and
   4-Nonylphenol Using Transcriptomic and Phenotypic Responses
SO ENVIRONMENTAL SCIENCE & TECHNOLOGY
LA English
DT Article
ID ADVERSE OUTCOME PATHWAYS; BIOMARKER DISCOVERY; WASTE-WATER; EXPRESSION;
   EXPOSURE; ECOTOXICOGENOMICS; PHARMACEUTICALS; ECOTOXICOLOGY;
   CONTAMINANTS; FLUOXETINE
AB The molecular mechanisms explaining hormetic effects of selective serotonin reuptake inhibitors (SSRIs) and 4-nonylphenol in Daphnia magna reproduction were studied in juveniles and adults. Transcriptome analyses showed changes in mRNA levels for 1796 genes in juveniles and 1214 genes in adults (out of 15 000 total probes) exposed to two SSRIs (fluoxetine and fluvoxamine) or to 4-nonylphenol. Functional annotation of affected genes was improved by assuming the annotations of putatively homologous Drosophila genes. Self-organizing map analysis and partial least-square regression coupled with selectivity ratio procedures analyses allowed to define groups of genes with specific responses to the different treatments. Differentially expressed genes were analyzed for functional enrichment using Gene Ontology and Kyoto Encyclopaedia of Genes and Genomes databases. Serotonin metabolism, neuronal developmental processes, and carbohydrates and lipid metabolism functional categories appeared as selectively affected by SSRI treatment, whereas 4-nonylphenol deregulated genes from the carbohydrate metabolism and the ecdysone regulatory pathway. These changes in functional and metabolic pathways are consistent with previously reported SSRIs and 4-nonylphenol hormetic effects in D. magna, including a decrease in reserve carbohydrates and an increase in respiratory metabolism.
C1 [Campos, Bruno; Rivetti, Claudia; Tauler, Roma; Pina, Benjamin; Barata, Carlos] Inst Environm Assessment & Water Res IDAEA CSIC, Barcelona 08034, Spain.
   [Garcia-Reyero, Natalia] Mississippi State Univ, Inst Genom Biocomp & Biotechnol, Starkville, MS 39759 USA.
   [Escalon, Lynn] US Army, Engineer Res & Dev Ctr, Environm Lab, Vicksburg, MS 39180 USA.
   [Habib, Tanwir] Badger Tech Serv, San Antonio, TX 78216 USA.
   [Tsakovski, Stefan] Univ Sofia, Fac Chem, Dept Analyt Chem, Sofia 1164, Bulgaria.
RP Barata, C (reprint author), Inst Environm Assessment & Water Res IDAEA CSIC, Jordi Girona 18, Barcelona 08034, Spain.
EM cbmqam@cid.csic.es
RI Pina, Benjamin/A-1671-2011; Barata, Carlos/K-8232-2014; Campos,
   Bruno/K-9213-2014; Rivetti, Claudia/L-1105-2014
OI Pina, Benjamin/0000-0001-9216-2768; Barata, Carlos/0000-0002-3360-0729;
   Campos, Bruno/0000-0002-3701-4858; Rivetti, Claudia/0000-0002-8801-0718;
   Habib, Tanwir/0000-0002-2301-2704
FU Spanish MICINNMinistry of Science and Innovation, Spain (MICINN)
   [CGL2008-01898/BOS, CTM2011-30471-C02-01]; MICINNMinistry of Science and
   Innovation, Spain (MICINN) [FPI BES-2009-022741]; U.S. Army
   Environmental Quality Research Program [BAA 11-4838]; 
   [ERC-2012-AdG-320737]
FX This work was supported by the Spanish MICINN grants (CGL2008-01898/BOS
   and CTM2011-30471-C02-01) and by the Advance Grant ERC-2012-AdG-320737.
   B.C. was supported by a fellowship from the MICINN (FPI
   BES-2009-022741). This work was also partly funded by the U.S. Army
   Environmental Quality Research Program (including BAA 11-4838).
   Permission for publishing this information has been granted by the Chief
   of Engineers.
CR Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Ankley GT, 2009, AQUAT TOXICOL, V92, P168, DOI 10.1016/j.aquatox.2009.01.013
   Asselman J, 2012, ENVIRON SCI TECHNOL, V46, P8448, DOI 10.1021/es301100j
   Baldwin WS, 1997, ENVIRON TOXICOL CHEM, V16, P1905, DOI 10.1002/etc.5620160920
   Barata C, 2000, AQUAT TOXICOL, V48, P195, DOI 10.1016/S0166-445X(99)00038-7
   Barata C, 2004, ECOTOXICOLOGY, V13, P511, DOI 10.1023/B:ECTX.0000037188.09072.de
   Barata C, 2001, OECOLOGIA, V129, P220, DOI 10.1007/s004420100712
   Campos B, 2012, AQUAT TOXICOL, V109, P100, DOI 10.1016/j.aquatox.2011.12.003
   Campos B, 2012, ENVIRON SCI TECHNOL, V46, P2943, DOI 10.1021/es203157f
   Choi MR, 2012, J CHEM NEUROANAT, V43, P96, DOI 10.1016/j.jchemneu.2012.01.001
   Coelho WS, 2012, INT J BIOCHEM CELL B, V44, P150, DOI 10.1016/j.biocel.2011.10.010
   Colbourne JK, 2011, SCIENCE, V331, P555, DOI 10.1126/science.1197761
   D'Avino PP, 2000, DEV BIOL, V220, P211, DOI 10.1006/dbio.2000.9650
   Daughton CG, 1999, ENVIRON HEALTH PERSP, V107, P907, DOI 10.2307/3434573
   De Schamphelaere KAC, 2008, COMP BIOCHEM PHYS D, V3, P307, DOI 10.1016/j.cbd.2008.09.001
   Dom N, 2012, ENVIRON SCI TECHNOL, V46, P10, DOI 10.1021/es201095r
   EBERT D, 1994, OIKOS, V69, P309, DOI 10.2307/3546152
   Fent K, 2006, AQUAT TOXICOL, V76, P122, DOI 10.1016/j.aquatox.2005.09.009
   Garcia-Reyero N, 2012, ENVIRON SCI TECHNOL, V46, P42, DOI 10.1021/es201245b
   Garcia-Reyero N, 2009, ENVIRON SCI TECHNOL, V43, P4188, DOI 10.1021/es803702a
   Ha MH, 2009, ARCH ENVIRON CON TOX, V57, P330, DOI 10.1007/s00244-007-9079-0
   Hammers-Wirtz M, 2000, ENVIRON TOXICOL CHEM, V19, P1856, DOI 10.1002/etc.5620190720
   Hannun YA, 2002, J BIOL CHEM, V277, P25847, DOI 10.1074/jbc.R200008200
   Hansen LK, 2008, AQUAT TOXICOL, V86, P99, DOI 10.1016/j.aquatox.2007.10.005
   Heckmann LH, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r40
   Hodgetts RB, 2006, ANNU REV ENTOMOL, V51, P259, DOI 10.1146/annurev.ento.51.110104.151143
   Kolpin DW, 2002, ENVIRON SCI TECHNOL, V36, P1202, DOI 10.1021/es011055j
   LeBlanc GA, 2000, ENVIRON HEALTH PERSP, V108, P1133, DOI 10.2307/3434824
   Liu XJ, 2008, BBA-PROTEINS PROTEOM, V1784, P1742, DOI 10.1016/j.bbapap.2008.06.018
   Metcalfe CD, 2010, ENVIRON TOXICOL CHEM, V29, P79, DOI 10.1002/etc.27
   Navarro A, 2009, ENVIRON POLLUT, V157, P698, DOI 10.1016/j.envpol.2008.08.007
   Nogueira AJA, 2004, ANN LIMNOL-INT J LIM, V40, P257, DOI 10.1051/limn/2004024
   Pal A, 2010, SCI TOTAL ENVIRON, V408, P6062, DOI 10.1016/j.scitotenv.2010.09.026
   Pereira JL, 2010, AQUAT TOXICOL, V97, P268, DOI 10.1016/j.aquatox.2009.12.023
   Pina B, 2011, AQUAT TOXICOL, V105, P40, DOI 10.1016/j.aquatox.2011.06.006
   Poynton HC, 2008, ENVIRON SCI TECHNOL, V42, P6257, DOI 10.1021/es800262k
   Poynton HC, 2007, ENVIRON SCI TECHNOL, V41, P1044, DOI 10.1021/es0615573
   Poynton HC, 2012, ENVIRON SCI TECHNOL, V46, P6288, DOI 10.1021/es3001618
   Rajalahti T, 2009, CHEMOMETR INTELL LAB, V95, P35, DOI 10.1016/j.chemolab.2008.08.004
   Rider MH, 2004, BIOCHEM J, V381, P561, DOI 10.1042/BJ20040752
   Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01
   Soetaert A, 2006, COMP BIOCHEM PHYS C, V142, P66, DOI 10.1016/j.cbpc.2005.10.009
   Soetaert A, 2007, CHEMOSPHERE, V67, P60, DOI 10.1016/j.chemosphere.2006.09.076
   Tanneberger K, 2013, ENVIRON SCI TECHNOL, V47, P1110, DOI 10.1021/es303505z
   Vandenbrouck T, 2011, COMP BIOCHEM PHYS D, V6, P271, DOI 10.1016/j.cbd.2011.06.001
   Vandenbrouck T, 2010, ENVIRON INT, V36, P254, DOI 10.1016/j.envint.2009.12.006
   Vasskog T, 2008, J CHROMATOGR A, V1185, P194, DOI 10.1016/j.chroma.2008.01.063
   Wold S, 2001, CHEMOMETR INTELL LAB, V58, P109, DOI 10.1016/S0169-7439(01)00155-1
   Yozzo KL, 2013, AQUAT TOXICOL, V126, P346, DOI 10.1016/j.aquatox.2012.09.008
NR 49
TC 33
Z9 33
U1 2
U2 71
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0013-936X
EI 1520-5851
J9 ENVIRON SCI TECHNOL
JI Environ. Sci. Technol.
PD AUG 20
PY 2013
VL 47
IS 16
BP 9434
EP 9443
DI 10.1021/es4012299
PG 10
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA 205VA
UT WOS:000323471700054
PM 23855649
DA 2019-10-23
ER

PT J
AU Bencic, DC
   Villeneuve, DL
   Biales, AD
   Blake, L
   Durhan, EJ
   Jensen, KM
   Kahl, MD
   Makynen, EA
   Martinovic-Weigelt, D
   Ankley, GT
AF Bencic, David C.
   Villeneuve, Daniel L.
   Biales, Adam D.
   Blake, Lindsey
   Durhan, Elizabeth J.
   Jensen, Kathleen M.
   Kahl, Michael D.
   Makynen, Elizabeth A.
   Martinovic-Weigelt, Dalma
   Ankley, Gerald T.
TI Effects of the insecticide fipronil on reproductive endocrinology in the
   fathead minnow
SO ENVIRONMENTAL TOXICOLOGY AND CHEMISTRY
LA English
DT Article
DE Pesticide; Endocrine disruption; Neurotransmitter; Fish; Fecundity
ID DOPAMINE-RECEPTOR ANTAGONIST; ADVERSE OUTCOME PATHWAYS;
   GAMMA-AMINOBUTYRIC-ACID; PIMEPHALES-PROMELAS; DEVELOPMENTAL
   NEUROTOXICITY; GONADOTROPIN-RELEASE; CONCEPTUAL-FRAMEWORK; FISH
   GONADOTROPINS; CHLORIDE CHANNEL; GABA-RECEPTORS
AB Gamma-aminobutyric acid (GABA) and GABA receptors play an important role in neuroendocrine regulation in fish. Disruption of the GABAergic system by environmental contaminants could interfere with normal regulation of the hypothalamic-pituitary-gonadal axis, leading to impaired fish reproduction. The present study used a 21-d fathead minnow (Pimephales promelas) reproduction assay to investigate the reproductive toxicity of fipronil (FIP), a broad-spectrum phenylpyrazole insecticide that acts as a noncompetitive blocker of GABA receptor-gated chloride channels. Continuous exposure up to 5 mu g FIP/L had no significant effect on most of the endpoints measured, including fecundity, secondary sexual characteristics, plasma steroid and vitellogenin concentrations, ex vivo steroid production, and targeted gene expression in gonads or brain. The gonad mass, gonadosomatic index, and histological stage of the gonad were all significantly different in females exposed to 0.5 mu g FIP/L compared with those exposed to 5.0 mu g FIP/L; however, there were no other significant effects on these measurements in the controls or any of the other treatments in either males and females. Overall, the results do not support a hypothesized adverse outcome pathway linking FIP antagonism of the GABA receptor(s) to reproductive impairment in fish. Environ Toxicol Chem 2013;32:1828-1834. (c) 2013 SETAC
C1 [Bencic, David C.; Biales, Adam D.] US EPA, Ecol Exposure Res Div, Natl Exposure Res Lab, Off Res & Dev, Cincinnati, OH 45268 USA.
   [Villeneuve, Daniel L.; Blake, Lindsey; Durhan, Elizabeth J.; Jensen, Kathleen M.; Kahl, Michael D.; Makynen, Elizabeth A.; Martinovic-Weigelt, Dalma; Ankley, Gerald T.] US EPA, Midcontinent Ecol Div, Natl Hlth & Environm Effects Res Lab, Off Res & Dev, Duluth, MN USA.
RP Bencic, DC (reprint author), US EPA, Ecol Exposure Res Div, Natl Exposure Res Lab, Off Res & Dev, Cincinnati, OH 45268 USA.
EM bencic.david@epa.gov
OI Martinovic-Weigelt, Dalma/0000-0002-9973-4965
FU USEPA National Center for Computational Toxicology
FX The authors thank Experimental Pathologies Laboratories for assistance
   with histological analyses and R. Flick and H. Schoenfuss for providing
   valuable comments on an earlier version of this manuscript. The present
   study was supported in part by the USEPA National Center for
   Computational Toxicology.
CR Ankley GT, 2007, ENVIRON TOXICOL CHEM, V26, P1214, DOI 10.1897/06-428R.1
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Ankley GT, 2009, AQUAT TOXICOL, V92, P168, DOI 10.1016/j.aquatox.2009.01.013
   Ankley GT, 2005, TOXICOL SCI, V86, P300, DOI 10.1093/toxsci/kfi202
   Ankley GT, 2003, ENVIRON TOXICOL CHEM, V22, P1350, DOI 10.1002/etc.5620220623
   Ankley GT, 2002, TOXICOL SCI, V67, P121, DOI 10.1093/toxsci/67.1.121
   Ankley GT, 2001, ENVIRON TOXICOL CHEM, V20, P1276, DOI 10.1002/etc.5620200616
   Baird S, 2013, ENVIRON TOXICOL CHEM, V32, P222, DOI 10.1002/etc.2041
   Basu N, 2012, SCI TOTAL ENVIRON, V414, P205, DOI 10.1016/j.scitotenv.2011.10.061
   Basu N, 2009, ENVIRON SCI TECHNOL, V43, P1635, DOI 10.1021/es802552m
   Beggel S, 2012, SCI TOTAL ENVIRON, V426, P160, DOI 10.1016/j.scitotenv.2012.04.005
   Beggel S, 2010, SCI TOTAL ENVIRON, V408, P3169, DOI 10.1016/j.scitotenv.2010.04.004
   Bieniarz K, 1992, J Physiol Pharmacol, V43, P215
   Bosma PT, 1999, MOL BIOL EVOL, V16, P397, DOI 10.1093/oxfordjournals.molbev.a026120
   Carnevali O, 2006, GEN COMP ENDOCR, V146, P195, DOI 10.1016/j.ygcen.2005.12.007
   Charon S, 2011, J AGR FOOD CHEM, V59, P2803, DOI 10.1021/jf102468n
   Clasen B, 2012, ECOTOX ENVIRON SAFE, V77, P45, DOI 10.1016/j.ecoenv.2011.10.001
   COLE LM, 1993, PESTIC BIOCHEM PHYS, V46, P47, DOI 10.1006/pest.1993.1035
   Das PC, 2006, CHEM-BIOL INTERACT, V164, P200, DOI 10.1016/j.cbi.2006.09.013
   Demcheck D.K., 2002, FIPRONIL DEGRADATION
   Dufour S, 2005, ANN NY ACAD SCI, V1040, P9, DOI 10.1196/annals.1327.002
   Eykelbosh AJ, 2010, COMP BIOCHEM PHYS A, V156, P218, DOI 10.1016/j.cbpa.2010.02.005
   Gan J, 2012, ENVIRON SCI TECHNOL, V46, P1489, DOI 10.1021/es202904x
   Goodyear JJ, 1994, 42918617 MRID US EPA
   Hainzl D, 1998, CHEM RES TOXICOL, V11, P1529, DOI 10.1021/tx980157t
   Hayasaka D, 2012, ECOTOX ENVIRON SAFE, V80, P355, DOI 10.1016/j.ecoenv.2012.04.004
   Hayasaka D, 2012, ECOTOXICOLOGY, V21, P191, DOI 10.1007/s10646-011-0778-y
   Jensen KM, 2004, AQUAT TOXICOL, V70, P99, DOI 10.1016/j.aquatox.2004.06.012
   Jensen KM, 2001, COMP BIOCHEM PHYS C, V128, P127, DOI 10.1016/S1532-0456(00)00185-X
   Joy KP, 1999, COMP BIOCHEM PHYS A, V123, P369, DOI 10.1016/S1095-6433(99)00075-6
   KAH O, 1992, NEUROENDOCRINOLOGY, V55, P396, DOI 10.1159/000126150
   Kanbara K, 2005, J ANDROL, V26, P485, DOI 10.2164/jandrol.04185
   Khan IA, 1999, NEUROENDOCRINOLOGY, V69, P261, DOI 10.1159/000054427
   Kitulagodage M, 2011, CHEMOSPHERE, V83, P524, DOI 10.1016/j.chemosphere.2010.12.057
   Lassiter TL, 2009, BRAIN RES BULL, V78, P313, DOI 10.1016/j.brainresbull.2008.09.020
   Law RJ, 2008, INT J NEUROSCI, V118, P705, DOI 10.1080/00207450701750216
   Levavi-Sivan B, 2010, GEN COMP ENDOCR, V165, P412, DOI 10.1016/j.ygcen.2009.07.019
   Maffucci JA, 2009, INT REV CEL MOL BIO, V274, P69, DOI 10.1016/S1937-6448(08)02002-9
   Martin SC, 1998, J COMP NEUROL, V396, P253
   Martinovic D, 2008, ENVIRON TOXICOL CHEM, V27, P478, DOI 10.1897/07-206R.1
   MCMASTER ME, 1995, PROTOCOL MEASURING I
   Mize SV, 2008, ENVIRON POLLUT, V152, P491, DOI 10.1016/j.envpol.2007.03.021
   Nillos MG, 2009, ENVIRON TOXICOL CHEM, V28, P1825, DOI 10.1897/08-658.1
   Ohi M, 2004, TOXICOL LETT, V146, P121, DOI 10.1016/j.toxlet.2003.08.008
   ONG J, 1990, LIFE SCI, V46, P1489, DOI 10.1016/0024-3205(90)90421-M
   Parks LG, 1999, COMP BIOCHEM PHYS C, V123, P113, DOI 10.1016/S0742-8413(99)00010-9
   Perret P, 1999, J BIOL CHEM, V274, P25350, DOI 10.1074/jbc.274.36.25350
   Popesku JT, 2008, MOL CELL ENDOCRINOL, V293, P43, DOI 10.1016/j.mce.2008.06.017
   Ratra GS, 2001, TOXICOL LETT, V122, P215, DOI 10.1016/S0378-4274(01)00366-6
   Ritta MN, 1998, MOL HUM REPROD, V4, P769, DOI 10.1093/molehr/4.8.769
   Sidiropoulou E, 2011, TOXICOL LETT, V201, P86, DOI 10.1016/j.toxlet.2010.12.009
   Stavola A., 1994, 42918614 MRID US EPA
   Stehr CM, 2006, TOXICOL SCI, V92, P270, DOI 10.1093/toxsci/kfj185
   Trudeau V L, 1997, Rev Reprod, V2, P55, DOI 10.1530/ror.0.0020055
   Trudeau VL, 2000, BIOCHEM CELL BIOL, V78, P241, DOI 10.1139/bcb-78-3-241
   TRUDEAU VL, 1993, J NEUROENDOCRINOL, V5, P129, DOI 10.1111/j.1365-2826.1993.tb00372.x
   TRUDEAU VL, 1993, AM J PHYSIOL, V265, pR348
   United States Environmental Protection Agency (US.EPA), 1996, 737F96005 US EPA, P1
   US Environmental Protection Agency, 2002, 600R01067 US EPA
   Villeneuve DL, 2008, TOXICOL SCI, V104, P113, DOI 10.1093/toxsci/kfn073
   Villeneuve DL, 2007, TOXICOL SCI, V98, P395, DOI 10.1093/toxsci/kfm124
   Villeneuve DL, 2007, COMP BIOCHEM PHYS C, V145, P171, DOI 10.1016/j.cbpc.2006.11.003
   Villeneuve DL, 2010, ECOTOX ENVIRON SAFE, V73, P478, DOI 10.1016/j.ecoenv.2009.09.018
   Villeneuve DL, 2010, ECOTOX ENVIRON SAFE, V73, P472, DOI 10.1016/j.ecoenv.2009.09.007
   Volz DC, 2011, TOXICOL SCI, V123, P349, DOI 10.1093/toxsci/kfr185
   Wang XX, 2010, J ENVIRON SCI HEAL B, V45, P648, DOI 10.1080/03601234.2010.502435
   Wirth EF, 2004, ENVIRON POLLUT, V131, P365, DOI 10.1016/j.envpol.2004.03.012
   Wullimann MF, 2009, INTEGR ZOOL, V4, P123, DOI 10.1111/j.1749-4877.2008.00140.x
   Yaron Z, 2003, INT REV CYTOL, V225, P131, DOI 10.1016/S0074-7696(05)25004-0
NR 69
TC 12
Z9 12
U1 0
U2 78
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0730-7268
EI 1552-8618
J9 ENVIRON TOXICOL CHEM
JI Environ. Toxicol. Chem.
PD AUG
PY 2013
VL 32
IS 8
BP 1828
EP 1834
DI 10.1002/etc.2254
PG 7
WC Environmental Sciences; Toxicology
SC Environmental Sciences & Ecology; Toxicology
GA 179VI
UT WOS:000321549200019
PM 23625624
DA 2019-10-23
ER

PT J
AU Pery, ARR
   Schuurmann, G
   Ciffroy, P
   Faust, M
   Backhaus, T
   Aicher, L
   Mombelli, E
   Tebby, C
   Cronin, MTD
   Tissot, S
   Andres, S
   Brignon, JM
   Frewer, L
   Georgiou, S
   Mattas, K
   Vergnaud, JC
   Peijnenburg, W
   Capri, E
   Marchis, A
   Wilks, MF
AF Pery, A. R. R.
   Schueuermann, G.
   Ciffroy, P.
   Faust, M.
   Backhaus, T.
   Aicher, L.
   Mombelli, E.
   Tebby, C.
   Cronin, M. T. D.
   Tissot, S.
   Andres, S.
   Brignon, J. M.
   Frewer, L.
   Georgiou, S.
   Mattas, K.
   Vergnaud, J. C.
   Peijnenburg, W.
   Capri, E.
   Marchis, A.
   Wilks, M. F.
TI Perspectives for integrating human and environmental risk assessment and
   synergies with socio-economic analysis
SO SCIENCE OF THE TOTAL ENVIRONMENT
LA English
DT Article
DE Human risk assessment; Environmental risk assessment; Socio-economic
   analysis; Hazard assessment; Chemical exposure; Integration
ID TESTING STRATEGIES; STRUCTURAL ALERTS; EXCESS TOXICITY;
   OCCUPATIONAL-EXPOSURE; CONCEPTUAL-FRAMEWORK; ORGANIC-COMPOUNDS;
   HEALTH-RISK; REACTIVITY; APPLICABILITY; UNCERTAINTY
AB For more than a decade, the integration of human and environmental risk assessment (RA) has become an attractive vision. At the same time, existing European regulations of chemical substances such as REACH (EC Regulation No. 1907/2006), the Plant Protection Products Regulation (EC regulation 1107/2009) and Biocide Regulation (EC Regulation 528/2012) continue to ask for sector-specific RAs, each of which have their individual information requirements regarding exposure and hazard data, and also use different methodologies for the ultimate risk quantification. In response to this difference between the vision for integration and the current scientific and regulatory practice, the present paper outlines five medium-term opportunities for integrating human and environmental RA, followed by detailed discussions of the associated major components and their state of the art. Current hazard assessment approaches are analyzed in terms of data availability and quality, and covering non-test tools, the integrated testing strategy (ITS) approach, the adverse outcome pathway (AOP) concept methods for assessing uncertainty, and the issue of explicitly treating mixture toxicity. With respect to exposure, opportunities for integrating exposure assessment are discussed, taking into account the uncertainty, standardization and validation of exposure modeling as well as the availability of exposure data. A further focus is on ways to complement RA by a soda-economic assessment (SEA) in order to better inform about risk management options. In this way, the present analysis, developed as part of the EU FP7 project HEROIC, may contribute to paving the way for integrating, where useful and possible, human and environmental RA in a manner suitable for its coupling with SEA. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Pery, A. R. R.; Mombelli, E.; Tebby, C.; Andres, S.; Brignon, J. M.] INERIS, F-60550 Verneuil En Halatte, France.
   [Schueuermann, G.] Helmholtz Ctr Environm Res, UFZ Dept Ecol Chem, D-04318 Leipzig, Germany.
   [Schueuermann, G.] Tech Univ Bergakad Freiberg, Inst Organ Chem, D-09596 Freiberg, Germany.
   [Ciffroy, P.] EDF, Div Rech & Dev, Chatou, France.
   [Faust, M.; Backhaus, T.] Faust & Backhaus Environm Consulting GbR, D-28359 Bremen, Germany.
   [Aicher, L.; Wilks, M. F.] Univ Basel, Swiss Ctr Appl Human Toxicol, CH-4003 Basel, Switzerland.
   [Cronin, M. T. D.] Liverpool John Moores Univ, Sch Pharm & Chem, Liverpool L3 3AF, Merseyside, England.
   [Tissot, S.] SYNGENTA Crop Protect AG, CH-4058 Basel, Switzerland.
   [Frewer, L.] Newcastle Univ, Sch Agr Food & Rural Dev, Food & Soc Ctr Rural Econ, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
   [Georgiou, S.] Chem Regulat Directorate, London SE1 9HS, England.
   [Mattas, K.] Aristotle Univ Thessaloniki, Sch Agr, Dept Agr Econ, Thessaloniki 54124, Greece.
   [Vergnaud, J. C.] Univ Paris 01, Ctr Econ Sorbonne, F-75231 Paris 05, France.
   [Peijnenburg, W.] RIVM Natl Inst Publ Hlth & Environm, Lab Ecol Risk Assessment, Bilthoven, Netherlands.
   [Capri, E.; Marchis, A.] Univ Cattolica Sacro Cuore, OPERA Res Ctr, I-29100 Piacenza, Italy.
RP Pery, ARR (reprint author), INERIS, Parc Alata,BP2, F-60550 Verneuil En Halatte, France.
EM alexandre.pery@ineris.fr
RI Tebby, Cleo/R-3354-2018; Peijnenburg, Willie/M-4110-2013; Peijnenburg,
   Willie J.G.M/E-1120-2014; MOMBELLI, Enrico/R-5306-2018; Schuurmann,
   Gerrit/E-7962-2017; Wilks, Martin F/N-2150-2014; Backhaus,
   Thomas/E-7375-2014
OI Tebby, Cleo/0000-0003-3470-157X; Peijnenburg, Willie
   J.G.M/0000-0003-2958-9149; MOMBELLI, Enrico/0000-0001-7006-0680;
   Schuurmann, Gerrit/0000-0002-3789-1703; Wilks, Martin
   F/0000-0003-3984-5935; Backhaus, Thomas/0000-0001-9643-1662; Vergnaud,
   Jean-Christophe/0000-0001-6604-4186
FU European Commission through the Project HEROIC [FP7-282896]
FX This work was supported by the European Commission through the Project
   HEROIC (FP7-282896) (Coordination Action funded under the 7th Framework
   Program). The authors would also like to thank two anonymous reviewers
   who helped to improve the manuscript, and all contributors to the first
   HEROIC expert meeting and HEROIC members for fruitful discussions on
   topics related to the contents of this manuscript: S. Ait Aissa, D.
   Barcelo, A. Boobis, R Beaudouin, M. Bisson, F. Bois, R. Bonnard, J.
   Bridges, F. Brion, N. Carmichael, A. Crepet D. Demortain, M. Farre, R.
   Fautz, T. Frische, L. Geoffroy, T. Ginebreda, R. Glass, P. Grasso, M.
   Grote, M. Jacobs, A. James, M. Junghans, C. Kairo, A. Kortenkamp, D.
   Kroese, K. Kyriakopoulou, C. Legind, G. Loizou, K. Machera, M.
   Montforts, L. Posthuma, L. Papadaki, N. Pucheux, A. Ragas, S. Ronga, B.
   Richard, N. Roth, R. Smolders, L. Sparfel, T. Tanaka, J. Tarazona, T.
   Vermeire, P. Wiedemann, F. Zeman. HEROIC consortium member R. Glass
   kindly provided editorial feedback for the manuscript.
CR Ahlers J, 2008, ENVIRON SCI POLLUT R, V15, P565, DOI 10.1007/s11356-008-0043-y
   Altenburger R, 2012, ENVIRON SCI TECHNOL, V46, P2508, DOI 10.1021/es2038036
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Backhaus T, 2012, ENVIRON SCI TECHNOL, V46, P2564, DOI 10.1021/es2034125
   Benigni R, 2011, CHEM REV, V111, P2507, DOI 10.1021/cr100222q
   Bhattacharya S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020887
   Blaschke U, 2012, CHEM RES TOXICOL, V25, P170, DOI 10.1021/tx200395k
   Boedeker W, 2010, EUR J EPIDEMIOL, V25, P539, DOI 10.1007/s10654-010-9464-2
   Bohme A, 2010, CHEM RES TOXICOL, V23, P1905, DOI 10.1021/tx100226n
   Boobis A, 2011, CRIT REV TOXICOL, V41, P369, DOI 10.3109/10408444.2010.543655
   Bradbury SP, 2004, ENVIRON SCI TECHNOL, V38, p463A, DOI 10.1021/es040675s
   Briggs DJ, 2009, ENVIRON GEOCHEM HLTH, V31, P189, DOI 10.1007/s10653-008-9214-5
   Briggs K, 2012, INT J MOL SCI, V13, P3820, DOI 10.3390/ijms13033820
   Buist H, 2013, REGUL TOXIC IN PRESS, DOI DOI 10.1016/J.YRTPH.2013.01.002.[IN
   Combes R, 2005, ATLA-ALTERN LAB ANIM, V33, P289, DOI 10.1177/026119290503300302
   Davis JA, 2011, TOXICOL APPL PHARM, V254, P181, DOI 10.1016/j.taap.2010.10.016
   Dimitrov S, 2005, J CHEM INF MODEL, V45, P839, DOI 10.1021/ci0500381
   Dreyer M., 2010, Food Control, V21, P1620
   EC, 2012, COM2012252
   EC, 2011, TOX ASS CHEM MIXT FI
   ECETOC, 2011, TECHNICAL REPORT
   ECETOC, 2012, TECHNICAL REPORT
   ECETOC, 2006, 99 ECETOC
   ECHA, 2008, GUID SOC AN RESTR
   ECHA (European Chemicals Agency), 2012, ECHA12G23EN
   FAO, 2012, STAT FOOD INS WORLD
   Foundation for EU Democracy, 2009, LISB TREAT READ VERS
   Gezondheidsraad (Health Council of the Netherlands), 2008, PRUD PREC
   Gupta N, 2012, J NANOPART RES, V14, DOI 10.1007/s11051-012-0857-x
   Hays SM, 2007, REGUL TOXICOL PHARM, V47, P96, DOI 10.1016/j.yrtph.2006.08.004
   HEIMSTA, 2009, CONC FRAM SCOP REP U
   Janer G, 2007, REPROD TOXICOL, V24, P103, DOI 10.1016/j.reprotox.2007.05.004
   Jaworska J, 2010, REGUL TOXICOL PHARM, V57, P157, DOI 10.1016/j.yrtph.2010.02.003
   Ji L, 2013, ANGEW CHEM INT EDIT, V52, P744, DOI 10.1002/anie.201204116
   Ji L, 2012, J PHYS CHEM B, V116, P903, DOI 10.1021/jp206570n
   Kortenkamp A, 2009, STATE ART REPORT MIX
   Krishnan Kannan, 1994, P399
   Kuhne R, 2009, J CHEM INF MODEL, V49, P2660, DOI 10.1021/ci900313u
   Lalko JF, 2011, TOXICOL IN VITRO, V25, P433, DOI 10.1016/j.tiv.2010.11.007
   Meek ME, 2011, REGUL TOXICOL PHARM, V60, pS1, DOI 10.1016/j.yrtph.2011.03.010
   Mekenyan O, 2010, CHEM RES TOXICOL, V23, P1519, DOI 10.1021/tx100161j
   Millennium Ecosystem Assessment (Program), 2005, EC HUM WELL BEING SY
   Mulliner D, 2011, ORG BIOMOL CHEM, V9, P8400, DOI 10.1039/c1ob06065a
   Nendza M, 2013, REGUL TOXICOL UNPUB
   Nestorov I, 2003, CLIN PHARMACOKINET, V42, P883, DOI 10.2165/00003088-200342100-00002
   OECD, 2010, SER TEST ASS OECD, V138
   OECD, 2007, OECD ENV HLTH SAF PU
   OECD, 2009, OECD ENV HLTH SAF PU
   OECD. Appendix, COLL WORK DEF
   OSIRIS, OPT STRAT RISK ASS I
   Pery A, 2009, QSAR COMB SCI, V28, P338, DOI 10.1002/qsar.200860116
   Pery ARR, 2010, REGUL TOXICOL PHARM, V56, P82, DOI 10.1016/j.yrtph.2009.09.009
   Pohl HR, 2009, REGUL TOXICOL PHARM, V54, P264, DOI 10.1016/j.yrtph.2009.05.003
   Price K, 2011, SAR QSAR ENVIRON RES, V22, P107, DOI 10.1080/1062936X.2010.548350
   Punt A, 2011, REGUL TOXICOL PHARM, V61, P105, DOI 10.1016/j.yrtph.2011.06.007
   Ramachandran G, 2008, ANN OCCUP HYG, V52, P297, DOI 10.1093/annhyg/men025
   Satterfield T, 2009, NAT NANOTECHNOL, V4, P752, DOI [10.1038/nnano.2009.265, 10.1038/NNANO.2009.265]
   [SCHER SCENIHR SCCS], 2011, IMPR RISK ASS VIEW N
   Schramm F, 2011, ENVIRON SCI TECHNOL, V45, P5812, DOI 10.1021/es200081n
   Schuurmann G, 2011, ENVIRON SCI TECHNOL, V45, P4616, DOI 10.1021/es200361r
   Schultz TW, 2007, QSAR COMB SCI, V26, P238, DOI 10.1002/qsar.200630020
   SCHUURMANN G, 2007, RISK ASSESSMENT CHEM, P375
   Schwobel JAH, 2011, CHEM REV, V111, P2562, DOI 10.1021/cr100098n
   Sottas PE, 2009, STAT MED, V28, P75, DOI 10.1002/sim.3411
   Spielmann H, 2011, ATLA-ALTERN LAB ANIM, V39, P481, DOI 10.1177/026119291103900509
   Tebby C, 2012, MOL INFORM, V31, P741, DOI 10.1002/minf.201200053
   Thaens D, 2012, CHEM RES TOXICOL, V25, P2092, DOI 10.1021/tx3001412
   Thalheim T, 2010, J CHEM INF MODEL, V50, P1223, DOI 10.1021/ci1001179
   Tielemans E, 2007, J EXPO SCI ENV EPID, V17, pS72, DOI 10.1038/sj.jes.7500604
   Tluczkiewicz I, 2013, REGUL TOXIC IN PRESS, DOI DOI 10.1016/J.YRTPH2013.02.004.[IN
   Verhaar Henk J. M., 1997, Environmental Health Perspectives, V105, P179, DOI 10.2307/3433406
   Verhoeven JK, 2012, 6013530022012 RIVM
   von der Ohe PC, 2005, CHEM RES TOXICOL, V18, P536, DOI 10.1021/tx0497954
   WCA environment, 2011, REF ENV RISK ASS OPU
   Weed LW, 2005, RISK ANAL, V25, P1545
   WHO, UNC DAT QUAL EXP ASS
   WHO World Health Organization, 2001, INT RISK ASS REP PRE
   Wondrousch D, 2010, J PHYS CHEM LETT, V1, P1605, DOI 10.1021/jz100247x
NR 78
TC 21
Z9 22
U1 1
U2 64
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0048-9697
J9 SCI TOTAL ENVIRON
JI Sci. Total Environ.
PD JUL 1
PY 2013
VL 456
BP 307
EP 316
DI 10.1016/j.scitotenv.2013.03.099
PG 10
WC Environmental Sciences
SC Environmental Sciences & Ecology
GA 163NH
UT WOS:000320343700035
PM 23624004
DA 2019-10-23
ER

PT J
AU Sipes, NS
   Martin, MT
   Kothiya, P
   Reif, DM
   Judson, RS
   Richard, AM
   Houck, KA
   Dix, DJ
   Kavlock, RJ
   Knudsen, TB
AF Sipes, Nisha S.
   Martin, Matthew T.
   Kothiya, Parth
   Reif, David M.
   Judson, Richard S.
   Richard, Ann M.
   Houck, Keith A.
   Dix, David J.
   Kavlock, Robert J.
   Knudsen, Thomas B.
TI Profiling 976 ToxCast Chemicals across 331 Enzymatic and Receptor
   Signaling Assays
SO CHEMICAL RESEARCH IN TOXICOLOGY
LA English
DT Article
ID IN-VITRO; PHARMACOLOGICAL CHARACTERIZATION; ANTIPSYCHOTIC-DRUGS;
   PREDICTIVE MODELS; GENE-EXPRESSION; BINDING; ESTROGEN; TOXICITY;
   AGONIST; POTENT
AB Understanding potential health risks is a significant challenge due to the large numbers of diverse chemicals with poorly characterized exposures and mechanisms of toxicities. The present study analyzes 976 chemicals (including failed pharmaceuticals, alternative plasticizers, food additives, and pesticides) in Phases I and II of the U.S. EPA's ToxCast project across 331 cell-free enzymatic and ligand-binding high-throughput screening (HTS) assays. Half-maximal activity concentrations (AC50) were identified for 729 chemicals in 256 assays (7,135 chemical-assay pairs). Some of the most commonly affected assays were CYPs (CYP2C9 and CYP2C19), transporters (mitochondria] TSPO, norepinephrine, and dopaminergic), and GPCRs (aminergic). Heavy metals, surfactants, and dithiocarbamate fungicides showed promiscuous but distinctly different patterns of activity, whereas many of the pharmaceutical compounds showed promiscuous activity across GPCRs. Literature analysis confirmed >50% of the activities for the most potent chemical-assay pairs (54) but also revealed 10 missed interactions. Twenty-two chemicals with known estrogenic activity were correctly identified for the majority (77%), missing only the weaker interactions. In many cases, novel findings for previously unreported chemical- target combinations clustered with known chemical-target interactions. Results from this large inventory of chemical-biological interactions can inform read-across methods as well as link potential targets to molecular initiating events in adverse outcome pathways for diverse toxicities.
C1 [Sipes, Nisha S.; Martin, Matthew T.; Kothiya, Parth; Reif, David M.; Judson, Richard S.; Richard, Ann M.; Houck, Keith A.; Dix, David J.; Kavlock, Robert J.; Knudsen, Thomas B.] US EPA, Natl Ctr Computat Toxicol, Off Res & Dev, Res Triangle Pk, NC 27711 USA.
RP Sipes, NS (reprint author), US EPA, Natl Ctr Computat Toxicol B205 01, Off Res & Dev, Res Triangle Pk, NC 27711 USA.
EM sipes.nisha@epa.gov; knudsen.thomas@epa.gov
RI Houck, Keith/G-8654-2014
OI Houck, Keith/0000-0002-0055-2249; Reif, David/0000-0001-7815-6767;
   Judson, Richard/0000-0002-2348-9633; Kothiya, Parth/0000-0002-5495-9597
CR Amitai G, 1998, BIOCHEM PHARMACOL, V56, P293, DOI 10.1016/S0006-2952(98)00035-5
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Arnt J, 1998, NEUROPSYCHOPHARMACOL, V18, P63, DOI 10.1016/S0893-133X(97)00112-7
   Ashcroft FJ, 2011, GENE, V477, P42, DOI 10.1016/j.gene.2011.01.009
   Bednar M., 2004, CLIN PHARMACOL THER, V75, P90
   Berg Ellen L., 2006, Journal of Pharmacological and Toxicological Methods, V53, P67, DOI 10.1016/j.vascn.2005.06.003
   Blair RM, 2000, TOXICOL SCI, V54, P138, DOI 10.1093/toxsci/54.1.138
   Bromidge SM, 2000, J MED CHEM, V43, P1123, DOI 10.1021/jm990388c
   BUTLER S, 1950, J LAB CLIN MED, V36, P806
   Chandler KJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018540
   Chen X, 2003, CLIN CANCER RES, V9, P3115
   Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324
   Collins FS, 2008, SCIENCE, V319, P906, DOI 10.1126/science.1154619
   Croci T, 2007, J PHARMACOL EXP THER, V321, P1118, DOI 10.1124/jpet.106.119123
   Dalvie D, 2008, DRUG METAB DISPOS, V36, P1869, DOI 10.1124/dmd.108.022566
   Del Valle EMM, 2004, PROCESS BIOCHEM, V39, P1033, DOI 10.1016/S0032-9592(03)00258-9
   Di Gennaro A, 2012, ADV IMMUNOL, V116, P51, DOI 10.1016/B978-0-12-394300-2.00002-8
   Dix DJ, 2012, TOXICOL SCI, V130, P440, DOI 10.1093/toxsci/kfs281
   DUAX WL, 1988, J STEROID BIOCHEM, V31, P481, DOI 10.1016/0022-4731(88)90002-7
   DUBOIS KP, 1961, TOXICOL APPL PHARM, V3, P236, DOI 10.1016/S0041-008X(61)80009-4
   EmondsAlt X, 1997, NEUROPEPTIDES, V31, P449, DOI 10.1016/S0143-4179(97)90039-1
   Gaido KW, 1999, ENDOCRINOLOGY, V140, P5746, DOI 10.1210/en.140.12.5746
   Gauthier DR, 2005, J ORG CHEM, V70, P5938, DOI 10.1021/jo0507035
   Giuliano KA, 2006, METHOD ENZYMOL, V414, P601, DOI 10.1016/S0076-6879(06)14031-8
   Gray JA, 2007, MOL PSYCHIATR, V12, P904, DOI 10.1038/sj.mp.4002062
   HALS PA, 1988, LIFE SCI, V43, P405, DOI 10.1016/0024-3205(88)90519-X
   HARADA M, 1995, CRIT REV TOXICOL, V25, P1, DOI 10.3109/10408449509089885
   Haroon M, 2012, J RHEUMATOL, V39, P7, DOI 10.3899/jrheum.120232
   Huang RL, 2011, ENVIRON HEALTH PERSP, V119, P1142, DOI 10.1289/ehp.1002952
   HUERTABAHENA J, 1983, MOL PHARMACOL, V23, P67
   Ihaka R., 1996, J COMPUTATIONAL GRAP, V5, P299, DOI DOI 10.1080/10618600.1996.10474713
   Inglese J, 2006, P NATL ACAD SCI USA, V103, P11473, DOI 10.1073/pnas.0604348103
   Ishizaki H., 2009, ORAL MED PATHOL, V13, P135, DOI DOI 10.1002/JMRI.24787
   Jensen K, 2012, N-S ARCH PHARMACOL, V385, P519, DOI 10.1007/s00210-011-0719-6
   Jiaravuthisan MM, 2007, J AM ACAD DERMATOL, V57, P1, DOI 10.1016/j.jaad.2005.07.073
   Judson RS, 2012, INT J MOL SCI, V13, P1805, DOI 10.3390/ijms13021805
   Judson RS, 2010, ENVIRON HEALTH PERSP, V118, P485, DOI 10.1289/ehp.0901392
   Kavlock R, 2012, CHEM RES TOXICOL, V25, P1287, DOI 10.1021/tx3000939
   Keil DE, 2008, TOXICOL SCI, V103, P77, DOI 10.1093/toxsci/kfn015
   Keiser MJ, 2009, NATURE, V462, P175, DOI 10.1038/nature08506
   Kelly J., 2009, PRINCIPLES CNS DRUG, P287
   Kleinstreuer N. C., 2011, DEV REPROD TOXICOLOG, P578
   Kleinstreuer N, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002996
   Knight AR, 2004, N-S ARCH PHARMACOL, V370, P114, DOI 10.1007/s00210-004-0951-4
   Knudsen TB, 2011, BIRTH DEFECTS RES C, V93, P312, DOI 10.1002/bdrc.20223
   Knudsen TB, 2011, TOXICOLOGY, V282, P1, DOI 10.1016/j.tox.2010.12.010
   LaFrate AL, 2009, BIOORGAN MED CHEM, V17, P3528, DOI 10.1016/j.bmc.2009.04.016
   LEFUR G, 1983, LIFE SCI, V33, P449, DOI 10.1016/0024-3205(83)90794-4
   Lounkine E, 2012, NATURE, V486, P361, DOI 10.1038/nature11159
   Luo G, 2002, DRUG METAB DISPOS, V30, P795, DOI 10.1124/dmd.30.7.795
   Martin MT, 2011, BIOL REPROD, V85, P327, DOI 10.1095/biolreprod.111.090977
   Martin MT, 2010, CHEM RES TOXICOL, V23, P578, DOI 10.1021/tx900325g
   McCort G, 2001, BIOORGAN MED CHEM, V9, P2129, DOI 10.1016/S0968-0896(01)00118-3
   McLean S, 1996, J PHARMACOL EXP THER, V277, P900
   Mente S, 2008, BIOORG MED CHEM LETT, V18, P6088, DOI 10.1016/j.bmcl.2008.10.028
   Metro TX, 2011, J ORG CHEM, V76, P2594, DOI 10.1021/jo102471r
   Middleton DS, 2008, BIOORG MED CHEM LETT, V18, P5303, DOI 10.1016/j.bmcl.2008.08.040
   MILLER DB, 1982, NEUROBEH TOXICOL TER, V4, P779
   NRC, 1984, TOX TEST STRAT DET N
   NRC (National Research Council), 2007, TOX TEST 21 CENT VIS
   O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-33
   OCARROLL RE, 1995, BRIT J PSYCHIAT, V167, P95, DOI 10.1192/bjp.167.1.95
   Oishi K, 2008, CHEMOSPHERE, V73, P1788, DOI 10.1016/j.chemosphere.2008.08.038
   Paolini GV, 2006, NAT BIOTECHNOL, V24, P805, DOI 10.1038/nbt1228
   PASTERNAK GW, 1975, MOL PHARMACOL, V11, P735
   Planting A, 2005, CANCER CHEMOTH PHARM, V55, P136, DOI 10.1007/s00280-004-0905-z
   R Development Core Team, 2012, R LANG ENV STAT COMP
   Rago B, 2011, J PHARMACEUT BIOMED, V55, P1201, DOI 10.1016/j.jpba.2011.03.025
   Reigart J. R., 1999, RECOGNITION MANAGEME, P48
   Rider CV, 2009, ENVIRON TOXICOL CHEM, V28, P2175, DOI 10.1897/09-018.1
   Rotroff DM, 2010, J TOXICOL ENV HEAL B, V13, P329, DOI 10.1080/10937404.2010.483949
   SCHMIDT CJ, 1992, EUR J PHARMACOL, V223, P65, DOI 10.1016/0014-2999(92)90819-P
   Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1
   SHOWELL HJ, 1995, J PHARMACOL EXP THER, V273, P176
   Shukla SJ, 2010, DRUG DISCOV TODAY, V15, P997, DOI 10.1016/j.drudis.2010.07.007
   Sipes NS, 2011, TOXICOL SCI, V124, P109, DOI 10.1093/toxsci/kfr220
   Tabira Y, 1999, EUR J BIOCHEM, V262, P240, DOI 10.1046/j.1432-1327.1999.00422.x
   TAM SW, 1984, P NATL ACAD SCI-BIOL, V81, P5618, DOI 10.1073/pnas.81.17.5618
   Tickner JA, 2001, AM J IND MED, V39, P100, DOI 10.1002/1097-0274(200101)39:1<100::AID-AJIM10>3.0.CO;2-Q
   Trichard C, 1998, AM J PSYCHIAT, V155, P505, DOI 10.1176/ajp.155.4.505
   Tuppurainen H, 2009, PSYCHIAT CLIN NEUROS, V63, P529, DOI 10.1111/j.1440-1819.2009.01982.x
   U.S. Consumer Product Safety Commission, 2010, REV EXP TOX DAT PHTH
   Vilches-Herrera M, 2009, BIOORGAN MED CHEM, V17, P2452, DOI 10.1016/j.bmc.2009.01.074
   Walsh SL, 2001, PSYCHOPHARMACOLOGY, V157, P151, DOI 10.1007/s002130100788
   WATSON N, 1995, EUR J PHARMACOL, V285, P135, DOI 10.1016/0014-2999(95)00394-Z
   Watson N, 1999, BRIT J PHARMACOL, V127, P590, DOI 10.1038/sj.bjp.0702551
   Wetmore BA, 2012, TOXICOL SCI, V125, P157, DOI 10.1093/toxsci/kfr254
   Williams SP, 1998, NATURE, V393, P392, DOI 10.1038/30775
   Witorsch RJ, 2010, CRIT REV TOXICOL, V40, P1, DOI 10.3109/10408444.2010.515563
   Worth Andrew P, 2013, Methods Mol Biol, V930, P125, DOI 10.1007/978-1-62703-059-5_6
   Xie L, 2011, CURR OPIN STRUC BIOL, V21, P189, DOI 10.1016/j.sbi.2011.01.004
   Yap CW, 2011, J COMPUT CHEM, V32, P1466, DOI 10.1002/jcc.21707
   Yeh SY, 1998, P NATL ACAD SCI USA, V95, P5527, DOI 10.1073/pnas.95.10.5527
   YORK DH, 1972, BRAIN RES, V37, P91, DOI 10.1016/0006-8993(72)90348-4
   Zhu C, 2008, BIOORG MED CHEM LETT, V18, P4393, DOI 10.1016/j.bmcl.2008.06.057
NR 95
TC 84
Z9 86
U1 1
U2 54
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0893-228X
EI 1520-5010
J9 CHEM RES TOXICOL
JI Chem. Res. Toxicol.
PD JUN
PY 2013
VL 26
IS 6
BP 878
EP 895
DI 10.1021/tx400021
PG 18
WC Chemistry, Medicinal; Chemistry, Multidisciplinary; Toxicology
SC Pharmacology & Pharmacy; Chemistry; Toxicology
GA 168EU
UT WOS:000320689300005
PM 23611293
DA 2019-10-23
ER

PT J
AU Crofton, KM
AF Crofton, K. M.
TI Adverse Outcome Pathways and Their Unifying Role in Developmental
   Toxicology
SO BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY
LA English
DT Meeting Abstract
C1 [Crofton, K. M.] US EPA, Natl Ctr Computat Toxicol, ORD, Res Triangle Pk, NC 27711 USA.
NR 0
TC 0
Z9 0
U1 1
U2 4
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1542-0752
EI 1542-0760
J9 BIRTH DEFECTS RES A
JI Birth Defects Res. Part A-Clin. Mol. Teratol.
PD MAY
PY 2013
VL 97
IS 5
SI SI
BP 277
EP 277
PG 1
WC Developmental Biology; Toxicology
SC Developmental Biology; Toxicology
GA 171MB
UT WOS:000320932100012
DA 2019-10-23
ER

PT J
AU Carney, EW
AF Carney, E. W.
TI Application of Adverse Outcome Pathway Approaches to Improve
   Reproductive and Developmental Toxicity Safety Assessment of Industrial
   and Agricultural Chemicals
SO BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY
LA English
DT Meeting Abstract
C1 [Carney, E. W.] Dow Chem Co USA, Midland, MI 48674 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1542-0752
EI 1542-0760
J9 BIRTH DEFECTS RES A
JI Birth Defects Res. Part A-Clin. Mol. Teratol.
PD MAY
PY 2013
VL 97
IS 5
SI SI
BP 278
EP 278
PG 1
WC Developmental Biology; Toxicology
SC Developmental Biology; Toxicology
GA 171MB
UT WOS:000320932100015
DA 2019-10-23
ER

PT J
AU Kleinstreuer, NC
AF Kleinstreuer, N. C.
TI Adverse Outcome Pathways in Computational Toxicology
SO BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY
LA English
DT Meeting Abstract
C1 [Kleinstreuer, N. C.] Integrated Syst Lab, Res Triangle Pk, NC USA.
RI Kleinstreuer, Nicole/F-7203-2019
OI Kleinstreuer, Nicole/0000-0002-7914-3682
NR 0
TC 0
Z9 0
U1 0
U2 6
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1542-0752
EI 1542-0760
J9 BIRTH DEFECTS RES A
JI Birth Defects Res. Part A-Clin. Mol. Teratol.
PD MAY
PY 2013
VL 97
IS 5
SI SI
BP 278
EP 278
PG 1
WC Developmental Biology; Toxicology
SC Developmental Biology; Toxicology
GA 171MB
UT WOS:000320932100014
DA 2019-10-23
ER

PT J
AU Enoch, SJ
   Cronin, MTD
   Schultz, TW
AF Enoch, S. J.
   Cronin, M. T. D.
   Schultz, T. W.
TI The definition of the toxicologically relevant applicability domain for
   the SNAr reaction for substituted pyridines and pyrimidines
SO SAR AND QSAR IN ENVIRONMENTAL RESEARCH
LA English
DT Article
DE in chemico; SNAr; structural alerts; electrophilic reaction chemistry;
   adverse outcome pathways
ID READ-ACROSS; SKIN SENSITIZATION; CATEGORY FORMATION; PREDICTION; BINDING
AB This study outlines how results from a glutathione reactivity assay (so-called in chemico data) can be used to define the applicability domain for the nucleophilic aromatic substitution (SNAr) reaction for nitrogen-containing aromatic compounds. SNAr is one of the six mechanistic domains that have been shown to be important in toxicological endpoints in which the ability to bind covalently to a protein is a key molecular initiating event. This study has analysed experimental data (2 h RC50 values), allowing a clear and interpretable structure-activity relationship to be developed for pyridines and pyrimidines which reside within the SNAr domain. The in-ring nitrogen(s) act as activating groups in the SNAr reaction. The position(s) of the in-ring nitrogen(s) as well as other activating groups, especially in relationship to the leaving group, affect reactive potency. The experimentally defined applicability domain has resulted in a series of structural alerts. These results build on early work on the benzene derivatives residing in the SNAr domain. The definition of the applicability domain for the SNAr reaction and the resulting structural alerts are likely to be beneficial in the development of computational tools for category formation and read-across in hazard identification, and the development of adverse outcome pathways.
C1 [Enoch, S. J.; Cronin, M. T. D.] Liverpool John Moores Univ, Sch Pharm & Chem, Liverpool L3 5UX, Merseyside, England.
   [Schultz, T. W.] Univ Tennessee, Coll Vet Med, Knoxville, TN USA.
RP Enoch, SJ (reprint author), Liverpool John Moores Univ, Sch Pharm & Chem, Liverpool L3 5UX, Merseyside, England.
EM s.j.enoch@ljmu.ac.uk
FU European Chemicals Agency Service [ECHA/2008/20/ECA.203]; Defra through
   the Sustainable Arable Link Program; European CommunityEuropean
   Community (EC) [266835]; Cosmetics Europe
FX The funding of the European Chemicals Agency Service Contract No.
   ECHA/2008/20/ECA.203 is gratefully acknowledged. The project was
   sponsored by Defra through the Sustainable Arable Link Program. The
   research leading to these results has received funding from the European
   Community's Seventh Framework Program (FP7/2007-2013) COSMOS Project
   under grant agreement number 266835 and from Cosmetics Europe.
CR Aptula AO, 2006, CHEM RES TOXICOL, V19, P1097, DOI 10.1021/tx0601004
   BUNNETT JF, 1958, Q REV CHEM SOC, V12, P1, DOI 10.1039/qr9581200001
   Combes R, 2005, ATLA-ALTERN LAB ANIM, V33, P289, DOI 10.1177/026119290503300302
   Diderich R, 2010, ISSUES TOXICOL, V7, P385
   Dimitrov S, 2010, ISSUES TOXICOL, V7, P372
   Enoch SJ, 2012, SAR QSAR ENVIRON RES, V23, P649, DOI 10.1080/1062936X.2012.679691
   Enoch SJ, 2011, CRIT REV TOXICOL, V41, P783, DOI 10.3109/10408444.2011.598141
   Enoch SJ, 2010, CHEM RES TOXICOL, V23, P1547, DOI 10.1021/tx100218h
   Enoch SJ, 2010, CRIT REV TOXICOL, V40, P728, DOI 10.3109/10408444.2010.494175
   Enoch SJ, 2011, ATLA-ALTERN LAB ANIM, V39, P131, DOI 10.1177/026119291103900206
   Enoch SJ, 2010, CHALL ADV COMPUT CHE, V8, P209, DOI 10.1007/978-1-4020-9783-6_7
   OECD, 2012, OECD ENV HLTH SAF PU, P10
   OECD, 2007, GUID GROUP CHEM
   OECD, OECD QSAR APPL TOOLB
   OECD - Organization for Economic Co-Operation and Development Environment, 2011, WORKSH US MECH INF F
   Schultz TW, 2010, ISSUES TOXICOL, V7, P346
   Schultz TW, 2007, CHEM RES TOXICOL, V20, P1359, DOI 10.1021/tx700212u
   Schultz TW, 2009, CONTACT DERMATITIS, V60, P21, DOI 10.1111/j.1600-0536.2008.01473.x
   Schwobel JAH, 2011, CHEM REV, V111, P2562, DOI 10.1021/cr100098n
   The Organisation for Economic Co-operation and Development (OECD), 2012, OECD ENV HLTH SAF PU, V169
NR 20
TC 4
Z9 4
U1 0
U2 8
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1062-936X
EI 1029-046X
J9 SAR QSAR ENVIRON RES
JI SAR QSAR Environ. Res.
PD MAY 1
PY 2013
VL 24
IS 5
SI SI
BP 651
EP 658
DI 10.1080/1062936X.2013.773377
PG 8
WC Chemistry, Multidisciplinary; Computer Science, Interdisciplinary
   Applications; Environmental Sciences; Mathematical & Computational
   Biology; Toxicology
SC Chemistry; Computer Science; Environmental Sciences & Ecology;
   Mathematical & Computational Biology; Toxicology
GA 161II
UT WOS:000320185900003
PM 23710886
DA 2019-10-23
ER

PT J
AU Vogs, C
   Bandow, N
   Altenburger, R
AF Vogs, Carolina
   Bandow, Nicole
   Altenburger, Rolf
TI EFFECT PROPAGATION IN A TOXICOKINETIC/TOXICODYNAMIC MODEL EXPLAINS
   DELAYED EFFECTS ON THE GROWTH OF UNICELLULAR GREEN ALGAE SCENEDESMUS
   VACUOLATUS
SO ENVIRONMENTAL TOXICOLOGY AND CHEMISTRY
LA English
DT Article
DE Phytotoxicity; Hazard assessment; Mechanistic effect model; Adverse
   outcome pathway; Mixture toxicity
ID ORGANIC-CHEMICALS; CONCEPTUAL-FRAMEWORK; RISK-ASSESSMENT; END-POINTS;
   TOXICITY; KINETICS; EXPOSURE; BIOCONCENTRATION; BIOACCUMULATION;
   MECHANISMS
AB Ecotoxicological standard tests assess toxic effects by exposing an organism to high concentrations over defined periods of time. To evaluate toxicity under field conditions such as fluctuating and pulsed exposures, process-based toxicokinetic/toxicodynamic (TK/TD) models may be used for extrapolation from the existing evidence. A TK/TD model was developed that simulates the effect on growth of the green algae Scenedesmus vacuolatus continuously exposed to the model chemicals norflurazon, triclosan, and N-phenyl-2-naphthylamine. A pharmacological timeresponse model describing the effects of anticancer treatments on cancer cell growth was adapted and modified to model the affected growth of synchronized algae cells. The TK/TD model simulates the temporal effect course by linking the ambient concentration of a chemical to the observable adverse effect via an internal concentration and a sequence of biological events in the organism. The parameters of the toxicodynamic model are related to the growth characteristics of algae cells, a no effect concentration, the chemical efficacy as well as the ability of recovery and repair, and the delay during damage propagation. The TK/TD model fits well to the observed algae growth. The effect propagation through cumulative cell damage explained the observed delayed responses better than just the toxicokinetics. The TK/TD model could facilitate the link between several effect levels within damage propagation, which prospectively may be helpful to model adverse outcome pathways and time-dependent mixture effects. Environ. Toxicol. Chem. 2013;32:11611172. (c) 2013 SETAC
C1 [Vogs, Carolina; Bandow, Nicole; Altenburger, Rolf] Helmholtz Ctr Environm Res, Dept Bioanalyt Ecotoxicol, Leipzig, Germany.
   [Bandow, Nicole] Univ Koblenz Landau, Dept Environm & Soil Chem, Landau, Germany.
RP Vogs, C (reprint author), Helmholtz Ctr Environm Res, Dept Bioanalyt Ecotoxicol, Leipzig, Germany.
EM carolina.vogs@ufz.de
RI Bandow, Nicole/A-7272-2013
OI Bandow, Nicole/0000-0003-4082-6125
FU German Federal Ministry of Research [FKZ 0315399]; Helmholtz Impulse and
   Networking Fund through the Helmholtz Interdisciplinary Graduate School
   for Environmental Research; Helmholtz program CITE-Chemicals in the
   environment
FX We acknowledge funding by the German Federal Ministry of Research (FKZ
   0315399). The present study was kindly supported by Helmholtz Impulse
   and Networking Fund through the Helmholtz Interdisciplinary Graduate
   School for Environmental Research and the Helmholtz program
   CITE-Chemicals in the environment. We also thank J. Kruger and T.G.
   Nicholls for technical support and two reviewers for their constructive
   comments.
CR Adler NE, 2007, ENVIRON TOXICOL CHEM, V26, P297, DOI 10.1897/06-1636R.1
   Altenburger R, 2004, ENVIRON SCI TECHNOL, V38, P6353, DOI 10.1021/es049528k
   Altenburger R, 2008, J ENVIRON QUAL, V37, P16, DOI 10.2134/jeq2006.0556
   Altenburger R, 2006, ENVIRON SCI TECHNOL, V40, P6163, DOI 10.1021/es060338e
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Ashauer R, 2008, ENVIRON TOXICOL CHEM, V27, P1817, DOI 10.1897/07-642
   Ashauer R, 2007, ENVIRON SCI TECHNOL, V41, P1480, DOI 10.1021/es061727b
   Ashauer R, 2012, ENVIRON SCI TECHNOL, V46, P3498, DOI 10.1021/es204611h
   Ashauer R, 2011, ENVIRON TOXICOL CHEM, V30, P2519, DOI 10.1002/etc.639
   Bandow N, 2010, CHEMOSPHERE, V79, P1070, DOI 10.1016/j.chemosphere.2010.03.021
   Dahl SG, 2010, BASIC CLIN PHARMACOL, V106, P2, DOI 10.1111/j.1742-7843.2009.00456.x
   Dann AB, 2011, J APPL TOXICOL, V31, P285, DOI 10.1002/jat.1660
   Escher Beate I., 2011, Integrated Environmental Assessment and Management, V7, P28, DOI 10.1002/ieam.100
   Franz S, 2008, AQUAT TOXICOL, V90, P102, DOI 10.1016/j.aquatox.2008.08.003
   GEYER H, 1984, CHEMOSPHERE, V13, P269, DOI 10.1016/0045-6535(84)90134-6
   Heckmann LH, 2010, ENVIRON TOXICOL CHEM, V29, P1396, DOI 10.1002/etc.163
   Jager T, 2006, ECOTOXICOLOGY, V15, P305, DOI 10.1007/s10646-006-0060-x
   Jager T, 2011, ENVIRON SCI TECHNOL, V45, P2529, DOI 10.1021/es103092a
   Kretschmann A, 2011, ENVIRON SCI TECHNOL, V45, P4995, DOI 10.1021/es104324v
   KRUPINSKA K, 1994, J PHOTOCH PHOTOBIO B, V26, P217, DOI 10.1016/1011-1344(94)07069-5
   LAHAM S, 1984, CHEMOSPHERE, V13, P657, DOI 10.1016/0045-6535(84)90202-9
   Mager DE, 2001, J PHARMACOKINET PHAR, V28, P507, DOI 10.1023/A:1014414520282
   Mittag M, 2005, PLANT PHYSIOL, V137, P399, DOI 10.1104/pp.104.052415
   Neuwoehner J, 2008, AQUAT TOXICOL, V90, P8, DOI 10.1016/j.aquatox.2008.07.010
   Reinert KH, 2002, ENVIRON TOXICOL CHEM, V21, P1977, DOI [10.1897/1551-5028(2002)021<1977:EAOTVO>2.0.CO;2, 10.1002/etc.5620210928]
   Ritz C, 2005, J STAT SOFTW, V12, P1
   Rozman KK, 2000, TOXICOLOGY, V144, P169, DOI 10.1016/S0300-483X(99)00204-8
   Schwarzenbach RP, 2006, SCIENCE, V313, P1072, DOI 10.1126/science.1127291
   Sevoviova A, 2008, BIOLOGIA, V63, P952
   Sijm DTHM, 1998, ENVIRON TOXICOL CHEM, V17, P1695, DOI 10.1002/etc.5620170908
   Simeoni M, 2004, CANCER RES, V64, P1094, DOI 10.1158/0008-5472.CAN-03-2524
   Skoglund RS, 1996, ENVIRON SCI TECHNOL, V30, P2113, DOI 10.1021/es950206d
   SPACIE A, 1982, Environmental Toxicology and Chemistry, V1, P309, DOI 10.1897/1552-8618(1982)1[309:AMFDTB]2.0.CO;2
   Sun YN, 1998, J PHARM SCI, V87, P732, DOI 10.1021/js970414z
   SWACKHAMER DL, 1993, ENVIRON TOXICOL CHEM, V12, P831, DOI 10.1002/etc.5620120506
   Tang J, 1998, ENVIRON TOXICOL CHEM, V17, P1085, DOI 10.1002/etc.5620170614
   Thies F, 1996, PLANT PHYSIOL, V112, P361, DOI 10.1104/pp.112.1.361
   Vallotton N, 2008, ENVIRON TOXICOL CHEM, V27, P1399, DOI [10.1897/07-197.1, 10.1897/07-197]
   Vallotton N, 2009, ARCH ENVIRON CON TOX, V56, P442, DOI 10.1007/s00244-008-9200-z
   Weiner JA, 2004, AQUAT TOXICOL, V68, P121, DOI 10.1016/j.aquatox.2004.03.004
NR 40
TC 10
Z9 10
U1 0
U2 54
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0730-7268
J9 ENVIRON TOXICOL CHEM
JI Environ. Toxicol. Chem.
PD MAY
PY 2013
VL 32
IS 5
BP 1161
EP 1172
DI 10.1002/etc.2139
PG 12
WC Environmental Sciences; Toxicology
SC Environmental Sciences & Ecology; Toxicology
GA 129PC
UT WOS:000317852700025
PM 23359135
DA 2019-10-23
ER

PT J
AU Yamada, T
   Tanaka, Y
   Hasegawa, R
   Sakuratani, Y
   Yamada, J
   Kamata, E
   Ono, A
   Hirose, A
   Yamazoe, Y
   Mekenyan, O
   Hayashi, M
AF Yamada, Takashi
   Tanaka, Yushiro
   Hasegawa, Ryuichi
   Sakuratani, Yuki
   Yamada, Jun
   Kamata, Eiichi
   Ono, Atsushi
   Hirose, Akihiko
   Yamazoe, Yasushi
   Mekenyan, Ovanes
   Hayashi, Makoto
TI A category approach to predicting the repeated-dose hepatotoxicity of
   allyl esters
SO REGULATORY TOXICOLOGY AND PHARMACOLOGY
LA English
DT Article
DE Category approach; Repeated-dose toxicity; Allyl ester; Hepatotoxicity;
   Adverse outcome pathway
ID ISOLATED RAT HEPATOCYTES; ACROLEIN; ALCOHOL; TOXICITY; LIVER; MICE;
   HYDROLYSIS; THIOLS; ACIDS
AB We tested a category approach to predict the hepatotoxic effects of repeated doses of allyl esters using a new database for repeated-dose toxicity. Based on information on hepatotoxic mechanism of allyl acetate, the category was defined as allyl esters that are hydrolyzed to allyl alcohol. Allyl alcohol is readily oxidized to acrolein in the liver, causing hepatotoxicity. Seventeen marketed allyl esters were obtained and grouped into category by identifying or predicting allyl alcohol formation. Allyl esters with a saturated straight alkyl carboxylic acid moiety (allyl acetate, hexanoate and heptanoate as tested species, and allyl butyrate, pentanoate, octanoate, nonanoate and decanoate as untested species) are likely similar in rate of ester hydrolysis, thereby defining subcategory 1. NOAEL and LOAEL for the hepatotoxic effects were estimated at 0.12 and 0.25 mmol/kg/d for the untested species, based on those of allyl acetate. The remaining nine allyl esters with other alkyl or aromatic carboxylic acid moieties were placed in subcategory 2: their hepatotoxicity levels were not predictable due to an unclear match between their degree of structural complexity and rate of hydrolysis. Our results demonstrate the usefulness of the category approach for predicting the hepatotoxicity of untested allyl esters with saturated straight alkyl chains. (C) 2012 Elsevier Inc. All rights reserved.
C1 [Yamada, Takashi; Tanaka, Yushiro; Hasegawa, Ryuichi; Sakuratani, Yuki; Yamada, Jun] Natl Inst Technol & Evaluat, Chem Management Ctr, Shibuya Ku, Tokyo 1510066, Japan.
   [Kamata, Eiichi; Ono, Atsushi; Hirose, Akihiko] Natl Inst Hlth Sci, Biol Safety Res Ctr, Setagaya Ku, Tokyo 1588501, Japan.
   [Yamazoe, Yasushi] Tohoku Univ, Grad Sch Pharmaceut Sci, Aoba Ku, Sendai, Miyagi 9808578, Japan.
   [Mekenyan, Ovanes] Univ Prof Assen Zlatarov Bourgas, Lab Math Chem, Burgas 8010, Bulgaria.
   [Hayashi, Makoto] Biosafety Res Ctr, Iwata, Shizuoka 4371213, Japan.
RP Yamada, T (reprint author), Natl Inst Technol & Evaluat, Chem Management Ctr, Shibuya Ku, 2-49-10 Nishihara, Tokyo 1510066, Japan.
EM yamada-takashi@nite.go.jp
OI Ono, Atsushi/0000-0001-5056-0442
FU New Energy and Industrial Technology Development Organization (NEDO)New
   Energy and Industrial Technology Development Organization (NEDO);
   Ministry of Economy, Trade and Industry (METI)
FX This work was supported by grants provided by the New Energy and
   Industrial Technology Development Organization (NEDO) (2007-2010) and
   the Ministry of Economy, Trade and Industry (METI) (2011) for the
   Development of Hazard Assessment Techniques Using Structure-Activity
   Relationship Methods.
CR ATZORI L, 1989, Drug Metabolism and Drug Interactions, V7, P295
   Auerbach SS, 2008, TOXICOLOGY, V253, P79, DOI 10.1016/j.tox.2008.08.014
   Ball GL, 2012, CRIT REV TOXICOL, V42, P28, DOI 10.3109/10408444.2011.623149
   BELINSKY SA, 1985, HEPATOLOGY, V5, P1179, DOI 10.1002/hep.1840050619
   Blackburn K, 2011, REGUL TOXICOL PHARM, V60, P120, DOI 10.1016/j.yrtph.2011.03.002
   Butterworth K.R., 1975, BR J PHARM, V54, p268P
   COOPER KO, 1992, FUND APPL TOXICOL, V19, P343, DOI 10.1016/0272-0590(92)90172-E
   EIGENBERG DA, 1986, TOXICOL APPL PHARM, V86, P12, DOI 10.1016/0041-008X(86)90395-9
   Fabjan E, 2006, CRIT REV TOXICOL, V36, P695, DOI 10.1080/10408440600894914
   Fenaroli G., 1971, FENAROLIS HDB FLAVOR
   Ghilarducci DP, 1995, REV ENVIRON CONTAM T, V144, P95
   HAGAN E. C., 1967, FOOD COSMET TOXICOL, V5, P141, DOI 10.1016/S0015-6264(67)82961-4
   HAGAN EC, 1965, TOXICOL APPL PHARM, V7, P18, DOI 10.1016/0041-008X(65)90069-4
   Hayashi M., 2011, NEW HORIZONS TOXICIT, P26
   JAESCHKE H, 1987, BIOCHEM PHARMACOL, V36, P51, DOI 10.1016/0006-2952(87)90381-9
   *JECFA, 1991, WHO FOOD ADD SER, V28
   KAYE CM, 1973, BIOCHEM J, V134, P1093, DOI 10.1042/bj1341093
   Liebert M.A., 1988, INT J TOXICOL, V7, P837
   LONGLAND RC, 1977, TOXICOLOGY, V8, P197, DOI 10.1016/0300-483X(77)90008-7
   MATTSON FH, 1969, J LIPID RES, V10, P271
   MICCADEI S, 1988, ARCH BIOCHEM BIOPHYS, V265, P302, DOI 10.1016/0003-9861(88)90132-4
   National toxicology program (NTP), 1983, NTP TECHN REP SER, V253
   National toxicology program (NTP), 2006, NTP TOX REP SER, V48
   National toxicology program (NTP), 1985, NTP TECHN REP SER, V284
   OECD, 2007, OECD SER TEST ASS, V80
   OHNO Y, 1985, TOXICOL APPL PHARM, V78, P169, DOI 10.1016/0041-008X(85)90281-9
   SERAFINI.F, 1972, BIOCHEM J, V128, P1103, DOI 10.1042/bj1281103
   SILVA JM, 1989, ARCH BIOCHEM BIOPHYS, V275, P551, DOI 10.1016/0003-9861(89)90401-3
   SILVER EH, 1978, TOXICOL APPL PHARM, V45, P377, DOI 10.1016/0041-008X(78)90102-3
   Sun LJ, 2006, MITOCHONDRION, V6, P136, DOI 10.1016/j.mito.2006.04.003
   Tanel A, 2007, FREE RADICAL BIO MED, V42, P798, DOI 10.1016/j.freeradbiomed.2006.12.009
   TSUCHIYA T, 1984, MUTAT RES, V130, P267, DOI 10.1016/0165-1161(84)90102-X
   WATANABE M, 1992, GASTROENTEROL JPN, V27, P199, DOI 10.1007/BF02777723
   Wu SD, 2010, REGUL TOXICOL PHARM, V56, P67, DOI 10.1016/j.yrtph.2009.09.006
   Yamada T, 2012, J TOXICOL SCI, V37, P503
NR 35
TC 6
Z9 6
U1 0
U2 12
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0273-2300
J9 REGUL TOXICOL PHARM
JI Regul. Toxicol. Pharmacol.
PD MAR
PY 2013
VL 65
IS 2
BP 189
EP 195
DI 10.1016/j.yrtph.2012.12.001
PG 7
WC Medicine, Legal; Pharmacology & Pharmacy; Toxicology
SC Legal Medicine; Pharmacology & Pharmacy; Toxicology
GA 096UG
UT WOS:000315429200002
PM 23246603
DA 2019-10-23
ER

PT J
AU Patlewicz, G
   Simon, T
   Goyak, K
   Phillips, RD
   Rowlands, JC
   Seidel, SD
   Becker, RA
AF Patlewicz, Grace
   Simon, Ted
   Goyak, Katy
   Phillips, Richard D.
   Rowlands, J. Craig
   Seidel, Shawn D.
   Becker, Richard A.
TI Use and validation of HT/HC assays to support 21st century toxicity
   evaluations
SO REGULATORY TOXICOLOGY AND PHARMACOLOGY
LA English
DT Article
DE Risk assessment; In vitro testing; Validation; Biomarkers;
   High-throughput/high content (HT/HC) assays; Dosimetry; (Q)SAR;
   Predictive model; ToxCast
ID IN-VITRO; SYSTEMATIC REVIEWS; BISPHENOL-A; FRAMEWORK; EXPOSURE
AB Advances in high throughput and high content (HT/HC) methods such as those used in the fields of toxicogenomics, bioinformatics, and computational toxicology have the potential to improve both the efficiency and effectiveness of toxicity evaluations and risk assessments. However, prior to use, scientific confidence in these methods should be formally established. Traditional validation approaches that define relevance, reliability, sensitivity and specificity may not be readily applicable. HT/HC methods are not exact replacements for in vivo testing, and although run individually, these assays are likely to be used as a group or battery for decision making and use robotics, which may be unique in each laboratory setting. Building on the frameworks developed in the 2010 Institute of Medicine Report on Biomarkers and the OECD 2007 Report on (Q)SAR Validation, we present constructs that can be adapted to address the validation challenges of HT/HC methods. These are flexible, transparent, and require explicit specification of context and purpose of use such that scientific confidence (validation) can be defined to meet different regulatory applications. Using these constructs, we discuss how anchoring the assays and their prediction models to Adverse Outcome Pathways (AOPs) could facilitate the interpretation of results and support scientifically defensible fit-for-purpose applications. (C) 2012 Elsevier Inc. All rights reserved.
C1 [Patlewicz, Grace] DuPont Haskell Global Ctr Hlth & Environm Sci, Newark, DE 19711 USA.
   [Simon, Ted] Ted Simon LLC, Winston, GA 30187 USA.
   [Goyak, Katy; Phillips, Richard D.] ExxonMobil Biomedical Sci Inc, Annandale, NJ 08801 USA.
   [Rowlands, J. Craig] Dow Chem Co USA, Toxicol & Environm Res & Consulting, Midland, MI 48674 USA.
   [Seidel, Shawn D.] Dow Corning Corp, Midland, MI 48686 USA.
   [Becker, Richard A.] ACC, Regulatory & Tech Affairs Dept, Washington, DC 20002 USA.
RP Patlewicz, G (reprint author), DuPont Haskell Global Ctr Hlth & Environm Sci, 1090 Elkton Rd, Newark, DE 19711 USA.
EM patlewig@hotmail.com
RI ; Simon, Ted/M-9188-2013
OI Patlewicz, Grace/0000-0003-3863-9689; Goyak, Katy/0000-0001-9655-7740;
   Simon, Ted/0000-0001-9405-3020
FU American Chemistry Council (ACC)
FX The employment affiliations of the authors are as shown on the cover
   page. Ted Simon is principal of Ted Simon LLC, a private firm that
   offers scientific consultation and research in human and environmental
   health. The American Chemistry Council (ACC) provided funding to Ted
   Simon LLC to support preparation of this manuscript. The authors have
   sole responsibility for the content and the writing of the paper,
   and-the interpretations and views expressed in the paper are not
   necessarily those of the ACC or the authors' employers or clients.
CR Akahori Y., 2008, TOXICOL IN VITRO, V22, P664
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Balls M, 2006, ATLA-ALTERN LAB ANIM, V34, P603, DOI 10.1177/026119290603400604
   Boobis AR, 2009, CRIT REV FOOD SCI, V49, P690, DOI 10.1080/10408390903098673
   CHALMERS I, 1994, BMJ-BRIT MED J, V309, P862, DOI 10.1136/bmj.309.6958.862
   CHALMERS I, 1993, ANN NY ACAD SCI, V703, P156, DOI 10.1111/j.1749-6632.1993.tb26345.x
   Doull J, 2007, FOOD CHEM TOXICOL, V45, P759, DOI 10.1016/j.fct.2006.10.025
   Eriksson L, 2003, ENVIRON HEALTH PERSP, V111, P1361, DOI 10.1289/ehp.5758
   European Chemicals Agency, 2008, GUID INF REQ CHEM SA
   Gorbunova V, 2007, NUCLEIC ACIDS RES, V35, P7466, DOI 10.1093/nar/gkm756
   Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9
   Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013
   Hartung T., 2011, ALTEX, V28, P82
   Hengstler JG, 2011, CRIT REV TOXICOL, V41, P263, DOI 10.3109/10408444.2011.558487
   ICCVAM, 2006, NIH PUBL, V07-4518
   ICCVAM, 2003, NIH PUBL
   IOM (Institute of Medicine), 2010, EV BIOM SURR ENDP CH
   Judson R., ALTEX IN PRESS
   Judson RS, 2010, ENVIRON HEALTH PERSP, V118, P485, DOI 10.1289/ehp.0901392
   Julien E, 2009, CRIT REV FOOD SCI, V49, P682, DOI 10.1080/10408390903110692
   Keller DA, 2012, TOXICOL SCI, V126, P291, DOI 10.1093/toxsci/kfr350
   Knudsen TB, 2011, TOXICOLOGY, V282, P1, DOI 10.1016/j.tox.2010.12.010
   Matthews JB, 2001, CHEM RES TOXICOL, V14, P149, DOI 10.1021/tx0001833
   Mayr E., 1982, GROWTH BIOL THOUGHT
   *NIEHS, 1997, NIH PUBL
   NRC (National Research Council), 2007, TOX TEST 21 CENT VIS
   OECD, 2011, SER TEST ASS, V138
   *OECD, 2007, GUID DOC VAL QUANT S
   Ong KM, 2010, P NATL ACAD SCI USA, V107, P7107, DOI 10.1073/pnas.0911095107
   Preston BD, 2010, SEMIN CANCER BIOL, V20, P281, DOI 10.1016/j.semcancer.2010.10.009
   Reif DM, 2010, ENVIRON HEALTH PERSP, V118, P1714, DOI 10.1289/ehp.1002180
   Seed J, 2005, CRIT REV TOXICOL, V35, P663, DOI 10.1080/10408440591007133
   Slikker W, 2004, TOXICOL APPL PHARM, V201, P203, DOI 10.1016/j.taap.2004.06.019
   Sobus JR, 2011, SCI TOTAL ENVIRON, V409, P4875, DOI 10.1016/j.scitotenv.2011.07.046
   Stephens ML, 2013, ALTEX-ALTERN ANIM EX, V30, P74, DOI 10.14573/altex.2013.1.074
   Stephens ML, 2012, TOXICOL SCI, V125, P327, DOI 10.1093/toxsci/kfr248
   Thomas RS, 2012, TOXICOL SCI, V128, P398, DOI 10.1093/toxsci/kfs159
   United States Environmental Protection Agency (USEPA), 2007, 120R07002A USEPA
   USEPA (United States Environmental Protection Agency), 2005, EPA630P03001B
   VANDEKAR M, 1971, B WORLD HEALTH ORGAN, V44, P241
   Willhite CC, 2008, J TOXICOL ENV HEAL B, V11, P69, DOI 10.1080/10937400701724303
   Worth AP, 2007, SAR QSAR ENVIRON RES, V18, P111, DOI 10.1080/10629360601054255
   Worth AP, 2005, 21866 EUR EN
   Zhang Y, 1999, J NUTR, V129, P399
NR 44
TC 25
Z9 26
U1 0
U2 22
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0273-2300
EI 1096-0295
J9 REGUL TOXICOL PHARM
JI Regul. Toxicol. Pharmacol.
PD MAR
PY 2013
VL 65
IS 2
BP 259
EP 268
DI 10.1016/j.yrtph.2012.12.008
PG 10
WC Medicine, Legal; Pharmacology & Pharmacy; Toxicology
SC Legal Medicine; Pharmacology & Pharmacy; Toxicology
GA 096UG
UT WOS:000315429200010
PM 23291301
OA Other Gold
DA 2019-10-23
ER

PT J
AU Yauk, CL
   Bishop, J
   Dearfield, KL
   Douglas, GR
   Hales, BF
   Luijten, M
   O'Brien, JM
   Robaire, B
   Sram, R
   van Benthem, J
   Wade, MG
   White, PA
   Marchetti, F
AF Yauk, Carole L.
   Bishop, Jack
   Dearfield, Kerry L.
   Douglas, George R.
   Hales, Barbara F.
   Luijten, Mirjam
   O'Brien, Jason M.
   Robaire, Bernard
   Sram, Radim
   van Benthem, Jan
   Wade, Mike G.
   White, Paul A.
   Marchetti, Francesco
TI The development of adverse outcome pathways for mutagenic effects for
   the organization for economic co-operation and development
SO ENVIRONMENTAL AND MOLECULAR MUTAGENESIS
LA English
DT Editorial Material
DE germ cells; mutagenesis; genotoxicity testing
ID GERM-CELL MUTAGENS; CHALLENGES; GUIDELINES; REACH
C1 [Yauk, Carole L.; Douglas, George R.; O'Brien, Jason M.; Wade, Mike G.; White, Paul A.; Marchetti, Francesco] Hlth Canada, Environm Hlth Sci & Res Bur, Ottawa, ON K1A 0L2, Canada.
   [Bishop, Jack] NIEHS, Natl Toxicol Program, Res Triangle Pk, NC 27709 USA.
   [Dearfield, Kerry L.] US Food Safety & Inspect Serv, USDA, Washington, DC 20250 USA.
   [Hales, Barbara F.; Robaire, Bernard] McGill Univ, Dept Obstet & Gynecol, Dept Pharmacol & Therapeut, Montreal, PQ H3A 2T5, Canada.
   [Luijten, Mirjam; van Benthem, Jan] Natl Inst Publ Hlth & Environm, NL-3720 BA Bilthoven, Netherlands.
   [Sram, Radim] Acad Sci Czech Republic, Inst Expt Med, Prague, Czech Republic.
RP Yauk, CL (reprint author), Hlth Canada, Environm Hlth Sci & Res Bur, Ottawa, ON K1A 0L2, Canada.
EM carole.yauk@hc-sc.gc.ca
RI Douglas, George/V-8276-2019; Sram, Radim/H-2455-2014
OI Sram, Radim/0000-0003-4256-3816; Marchetti,
   Francesco/0000-0002-9435-4867; white, paul/0000-0001-5853-4759; Yauk,
   Carole/0000-0003-4919-876X; Wade, Michael/0000-0002-7331-3839; Sram,
   Radim/0000-0002-2500-4572
CR Ahlers J, 2008, ENVIRON SCI POLLUT R, V15, P565, DOI 10.1007/s11356-008-0043-y
   Cimino MC, 2006, ENVIRON MOL MUTAGEN, V47, P362, DOI 10.1002/em.20216
   CLAYSON DB, 1993, ENVIRON MOL MUTAGEN, V21, P15
   DEARFIELD KL, 1991, MUTAT RES, V258, P259, DOI 10.1016/0165-1110(91)90012-K
   DeMarini DM, 2012, ENVIRON MOL MUTAGEN, V53, P166, DOI 10.1002/em.21685
   Health Canada, 1994, CAN HLTH RISK ASS PR
   Health Canada, 1986, ENVIRON MOL MUTAGEN, V11, p[261, 304, 261]
   Kavlock R, 2012, CHEM RES TOXICOL, V25, P1287, DOI 10.1021/tx3000939
   Lynch M, 2010, P NATL ACAD SCI USA, V107, P961, DOI 10.1073/pnas.0912629107
   NRC (National Research Council), 2007, TOX TEST 21 CENT VIS
   Schoeters G, 2010, J TOXICOL ENV HEAL B, V13, P232, DOI 10.1080/10937404.2010.483938
   Singer TM, 2010, ENVIRON MOL MUTAGEN, V51, P919, DOI 10.1002/em.20613
   USEPA (United States Environmental Protection Agency), 1986, FED REGISTER, V51, p[34006, 34012]
   Yauk CL, 2013, MUTAT RES-REV MUTAT, V752, P6, DOI 10.1016/j.mrrev.2012.08.002
NR 14
TC 9
Z9 9
U1 0
U2 14
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0893-6692
J9 ENVIRON MOL MUTAGEN
JI Environ. Mol. Mutagen.
PD MAR
PY 2013
VL 54
IS 2
BP 79
EP 81
DI 10.1002/em.21757
PG 3
WC Environmental Sciences; Genetics & Heredity; Toxicology
SC Environmental Sciences & Ecology; Genetics & Heredity; Toxicology
GA 085EB
UT WOS:000314595400001
PM 23355186
DA 2019-10-23
ER

PT J
AU Lewin, G
   Batke, M
   Escher, S
   Mangelsdorf, I
AF Lewin, G.
   Batke, M.
   Escher, S.
   Mangelsdorf, I
TI Analysis of the indicative value of repeated dose toxicity studies for
   reproductive toxicity
SO NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
LA English
DT Meeting Abstract
C1 [Lewin, G.; Batke, M.; Escher, S.; Mangelsdorf, I] Fraunhofer Inst Toxicol & Expt Med ITEM, D-30625 Hannover, Germany.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0028-1298
EI 1432-1912
J9 N-S ARCH PHARMACOL
JI Naunyn-Schmiedebergs Arch. Pharmacol.
PD FEB
PY 2013
VL 386
SU 1
MA 017
BP S6
EP S7
PG 2
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA V40KB
UT WOS:000209476400018
DA 2019-10-23
ER

PT J
AU Yozzo, KL
   McGee, SP
   Volz, DC
AF Yozzo, Krystle L.
   McGee, Sean P.
   Volz, David C.
TI Adverse outcome pathways during zebrafish embryogenesis: A case study
   with paraoxon
SO AQUATIC TOXICOLOGY
LA English
DT Article
DE Adverse outcome pathway (AOP); Developmental toxicity; Zebrafish;
   Paraoxon; Spontaneous behavior
ID IDENTIFIED MOTONEURONS; CONCEPTUAL-FRAMEWORK; CHLORPYRIFOS-OXON;
   RISK-ASSESSMENT; ACETYLCHOLINESTERASE; INHIBITION; EXPRESSION;
   PARATHION; EMBRYOS; GROWTH
AB Using paraoxon as a reference acetylcholinesterase (AChE) inhibitor, the objective of this study was to develop an adverse outcome pathway (AOF) that provided quantitative linkages across levels of biological organization during zebrafish embryogenesis. Within normal zebrafish embryos, we first demonstrated that ache transcripts and AChE activity increased in a stage-dependent manner following segmentation. We then showed that static exposure of embryos to paraoxon (31.2-500 nM) from 5 to 96 hpf resulted in significant stage- and concentration-dependent AChE inhibition, albeit these effects were fully reversible within 48 h following transfer to clean water. However, even in the presence of significant AChE inhibition, exposure to non-teratogenic paraoxon concentrations (<= 250 nM) did not adversely impact secondary motoneuron development at 96 hpf. Therefore, we investigated the potential effects of paraoxon exposure on spontaneous tail contractions at 26 hpf - an early locomotor behavior that results from innervation of primary (not secondary) motoneuron axons to target axial muscles. Based on these studies, the frequency of spontaneous tail contractions at 26 hpf - a developmental stage with minimal AChE expression and activity - was significantly higher following exposure to paraoxon concentrations as low as 31.2 nM. Overall, our data suggest that (1) normal AChE activity is not required for secondary motoneuron development and (2) spontaneous tail contractions at 26 hpf are sensitive to paraoxon exposure, an effect that may be independent of AChE inhibition. Using a well-studied reference chemical, this study highlights the potential challenges in developing quantitative AOPs to support chemical screening and prioritization strategies. (C) 2012 Elsevier B.V. All rights reserved.
C1 [Yozzo, Krystle L.; McGee, Sean P.; Volz, David C.] Univ S Carolina, Dept Environm Hlth Sci, Arnold Sch Publ Hlth, Columbia, SC 29208 USA.
RP Volz, DC (reprint author), Univ S Carolina, Dept Environm Hlth Sci, Arnold Sch Publ Hlth, Columbia, SC 29208 USA.
EM volz@mailbox.sc.edu
FU Arnold School Fellowship; Promising Investigator Research Award; US
   Environmental Protection Agency Science to Achieve Results (STAR)United
   States Environmental Protection Agency [83516901]
FX Funding was provided in part by an Arnold School Fellowship to K.L.Y. as
   well as departmental start-up funds, Promising Investigator Research
   Award, and US Environmental Protection Agency Science to Achieve Results
   (STAR) Grant #83516901 to D.C.V. The contents of this manuscript are
   solely the responsibility of D.C.V. and do not necessarily represent the
   official views of the US EPA. Further, the US EPA does not endorse the
   purchase of any commercial products or services mentioned in the
   publication. We gratefully thank the University of South Carolina's
   Environmental Genomics Core Facility (engencore.sc.edu) for use of the
   Applied Biosystems 7900HT Fast Real-Time PCR System; Dr. Robert Tanguay
   (Oregon State University) for providing founder fish to establish our
   wild-type (5D) zebrafish colony; and Dr. G. Thomas Chandler (University
   of South Carolina) for use of the Olympus FluoView FVX IX70
   laser-scanning confocal microscope.
CR Adewusi EA, 2011, ASIAN PAC J TROP MED, V4, P829, DOI 10.1016/S1995-7645(11)60203-4
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Arduini F, 2007, ANAL CHEM, V79, P3409, DOI 10.1021/ac061819j
   Behra M, 2002, NAT NEUROSCI, V5, P111, DOI 10.1038/nn788
   Belanger SE, 2010, AQUAT TOXICOL, V97, P88, DOI 10.1016/j.aquatox.2009.11.020
   Bertrand C, 2001, J BIOL CHEM, V276, P464, DOI 10.1074/jbc.M006308200
   Brustein E, 2003, J PHYSIOL-PARIS, V97, P77, DOI 10.1016/j.jphysparis.2003.10.009
   CORRELL L, 1991, FUND APPL TOXICOL, V16, P110, DOI 10.1016/0272-0590(91)90140-Y
   Downes GB, 2004, DEV BIOL, V270, P232, DOI 10.1016/j.ydbio.2004.02.027
   ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9
   Embry MR, 2010, AQUAT TOXICOL, V97, P79, DOI 10.1016/j.aquatox.2009.12.008
   Halder Marlies, 2010, Integrated Environmental Assessment and Management, V6, P484, DOI 10.1002/ieam.48
   HANNEMAN E, 1989, J COMP NEUROL, V284, P350, DOI 10.1002/cne.902840303
   Hill AJ, 2005, TOXICOL SCI, V86, P6, DOI 10.1093/toxsci/kfi110
   Jacobson SM, 2010, AQUAT TOXICOL, V100, P101, DOI 10.1016/j.aquatox.2010.07.015
   Jiang W, 2012, TOXICOLOGY, V295, P15, DOI 10.1016/j.tox.2012.03.001
   Katz EJ, 1997, TOXICOL APPL PHARM, V146, P227, DOI 10.1006/taap.1997.8201
   KIMMEL CB, 1974, DEV PSYCHOBIOL, V7, P47, DOI 10.1002/dev.420070109
   KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302
   Kuster E, 2006, BIOMARKERS, V11, P341, DOI 10.1080/13547500600742136
   Kuster E, 2005, AQUAT TOXICOL, V75, P76, DOI 10.1016/j.aquatox.2005.07.005
   Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091
   McCurley AT, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-102
   MYERS PZ, 1986, J NEUROSCI, V6, P2278
   NRC (National Research Council), 2007, TOX TEST 21 CENT VIS
   Padilla S, 2012, REPROD TOXICOL, V33, P174, DOI 10.1016/j.reprotox.2011.10.018
   Pope CN, 1999, J TOXICOL ENV HEAL B, V2, P161, DOI 10.1080/109374099281205
   Saint-Amant L, 2000, J NEUROSCI, V20, P3964
   Saint-Amant L, 2001, NEURON, V31, P1035, DOI 10.1016/S0896-6273(01)00416-0
   Saint-Amant L, 1998, J NEUROBIOL, V37, P622, DOI 10.1002/(SICI)1097-4695(199812)37:4<622::AID-NEU10>3.0.CO;2-S
   Scholz S, 2008, ENVIRON SCI POLLUT R, V15, P394, DOI 10.1007/s11356-008-0018-z
   Thomas LT, 2009, TOXICOL APPL PHARM, V239, P1, DOI 10.1016/j.taap.2008.08.023
   TREVARROW B, 1990, NEURON, V4, P669, DOI 10.1016/0896-6273(90)90194-K
   Volz DC, 2011, TOXICOL SCI, V123, P349, DOI 10.1093/toxsci/kfr185
   WESTERFIELD M, 1986, J NEUROSCI, V6, P2267
   Yang DR, 2011, TOXICOL SCI, V121, P146, DOI 10.1093/toxsci/kfr028
   Yen J, 2011, NEUROTOXICOL TERATOL, V33, P735, DOI 10.1016/j.ntt.2011.10.004
   Zon LI, 2005, NAT REV DRUG DISCOV, V4, P35, DOI 10.1038/nrd1606
NR 38
TC 19
Z9 19
U1 1
U2 42
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0166-445X
EI 1879-1514
J9 AQUAT TOXICOL
JI Aquat. Toxicol.
PD JAN 15
PY 2013
VL 126
BP 346
EP 354
DI 10.1016/j.aquatox.2012.09.008
PG 9
WC Marine & Freshwater Biology; Toxicology
SC Marine & Freshwater Biology; Toxicology
GA 092MB
UT WOS:000315125600037
PM 23046524
DA 2019-10-23
ER

PT J
AU Tanneberger, K
   Knobel, M
   Busser, FJM
   Sinnige, TL
   Hermens, JLM
   Schirmer, K
AF Tanneberger, Katrin
   Knoebel, Melanie
   Busser, Frans J. M.
   Sinnige, Theo L.
   Hermens, Joop L. M.
   Schirmer, Kristin
TI Predicting Fish Acute Toxicity Using a Fish Gill Cell Line-Based
   Toxicity Assay
SO ENVIRONMENTAL SCIENCE & TECHNOLOGY
LA English
DT Article
ID WATER PARTITION-COEFFICIENTS; GOLDFISH GFS CELLS; IN-VITRO;
   RAINBOW-TROUT; REFERENCE CHEMICALS; RTG-2 CYTOTOXICITY; GABA(A)
   RECEPTORS; CULTURES; EXPOSURE; ALTERNATIVES
AB The OECD test guideline 203 for determination of fish acute toxicity requires substantial numbers of fish and uses death as an apical end point. One potential alternative are fish cell lines; however, several studies indicated that these appear up to several orders of magnitude less sensitive than fish. We developed a fish gill cell line-based (RTgill-W1) assay, using several measures to improve sensitivity. The optimized assay was applied to determine the toxicity of 35 organic chemicals, having a wide range of toxicity to fish, mode of action and physicochemical properties. We found a very good agreement between in vivo and in vitro effective concentrations. For up to 73% of the tested compounds, the difference between the two approaches was less than 5-fold, covering baseline toxicants but as well compounds with presumed specific modes of action, including reactivity, inhibition of acetylcholine esterase or uncoupling of oxidative phosphorylation. Accounting for measured chemical concentrations eliminated two outliers, the hydrophobic 4-decylaniline and the volatile 2,3-dimethyl-1,3-butadiene, with an outlier being operationally defined as a substance showing a more than 10-fold difference between in vivo/in vitro effect concentrations. Few outliers remained. The most striking were allyl alcohol (2700-fold), which likely needs to be metabolically activated, and permethrin (190-fold) and lindane (63-fold), compounds acting, respectively, on sodium and chloride channels in the brain of fish. We discuss further developments of this assay and suggest its use beyond predicting acute toxicity to fish, for example, as part of adverse outcome pathways to replace, reduce, or refine chronic fish tests.
C1 [Tanneberger, Katrin; Knoebel, Melanie; Schirmer, Kristin] Eawag, Swiss Fed Inst Aquat Sci & Technol, CH-8600 Dubendorf, Switzerland.
   [Busser, Frans J. M.; Sinnige, Theo L.; Hermens, Joop L. M.] Univ Utrecht, Inst Risk Assessment Sci, NL-3508 TD Utrecht, Netherlands.
   [Schirmer, Kristin] ETH, Dept Environm Syst Sci, CH-8092 Zurich, Switzerland.
   [Schirmer, Kristin] EPF Lausanne, Sch Architecture Civil & Environm Engn, CH-1015 Lausanne, Switzerland.
RP Schirmer, K (reprint author), Eawag, Swiss Fed Inst Aquat Sci & Technol, CH-8600 Dubendorf, Switzerland.
EM Kristin.Schirmer@eawag.ch
FU European Chemical Industry Council-Long Range Research Initiative
   (CEFIC-LRI); United Kingdom-Department for Environment, Food and Rural
   Affairs (UK-DEFRA)
FX This work was funded by The European Chemical Industry Council-Long
   Range Research Initiative (CEFIC-LRI) and United Kingdom-Department for
   Environment, Food and Rural Affairs (UK-DEFRA) (CEllSens - ECO8 and
   ECO8.2). The authors would like to thank Stefan Scholz for critical
   discussions and reviewing of the manuscript.
CR Auerbach SS, 2008, TOXICOLOGY, V253, P79, DOI 10.1016/j.tox.2008.08.014
   BOLS NC, 1994, J FISH DIS, V17, P601, DOI 10.1111/j.1365-2761.1994.tb00258.x
   BOLS NC, 2005, BIOCH MOL BIOL FISHE, V6
   Bolton JL, 2000, CHEM RES TOXICOL, V13, P135, DOI 10.1021/tx9902082
   BORENFREUND E, 1985, TOXICOL LETT, V24, P119, DOI 10.1016/0378-4274(85)90046-3
   BRUSCHWEILER BJ, 1995, AQUAT TOXICOL, V32, P143, DOI 10.1016/0166-445X(94)00087-7
   Carr RL, 1999, J TOXICOL ENV HEAL A, V56, P543, DOI 10.1080/009841099157881
   Castano A, 1996, CHEMOSPHERE, V32, P2141, DOI 10.1016/0045-6535(96)00126-9
   Castano A., 2003, ATLA-ALTERN LAB ANIM, V31, P317
   Clemedson C, 1998, ATLA-ALTERN LAB ANIM, V26, P131
   Commission of the European Communities, 2010, SIXTH REPORT ON THE
   Dayeh VR, 2004, ECOTOX ENVIRON SAFE, V57, P375, DOI 10.1016/S0147-6513(03)00083-6
   Dayeh VR, 2002, WATER RES, V36, P3727, DOI 10.1016/S0043-1354(02)00078-7
   DEBRUIJN J, 1993, AQUAT TOXICOL, V24, P257, DOI 10.1016/0166-445X(93)90075-C
   Fent K, 1996, MAR ENVIRON RES, V42, P377, DOI 10.1016/0141-1136(95)00043-7
   Ganassin R. C., 2000, THE HANDBOOK OF EXPE
   Gulden M, 2005, AQUAT TOXICOL, V72, P327, DOI 10.1016/j.aquatox.2005.02.002
   Halle W, 2003, ATLA-ALTERN LAB ANIM, V31, P89, DOI 10.1177/026119290303100204
   Hong SK, 2000, TOXICOL LETT, V114, P125, DOI 10.1016/S0378-4274(99)00287-8
   Knobel M, 2012, ENVIRON SCI TECHNOL, V46, P9690, DOI 10.1021/es301729q
   Kramer NI, 2010, CHEM RES TOXICOL, V23, P1806, DOI 10.1021/tx1002595
   Kramer NI, 2009, TOXICOL IN VITRO, V23, P1372, DOI 10.1016/j.tiv.2009.07.029
   LANGE M, 1995, CHEMOSPHERE, V30, P2087, DOI 10.1016/0045-6535(95)00088-P
   O'Brien J, 2000, EUR J BIOCHEM, V267, P5421, DOI 10.1046/j.1432-1327.2000.01606.x
   OBRIEN PJ, 1991, CHEM-BIOL INTERACT, V80, P1, DOI 10.1016/0009-2797(91)90029-7
   OECD, 1992, OECD GUIDELINE FOR T
   RACHLIN JW, 1968, WATER RES, V2, P409, DOI 10.1016/0043-1354(68)90060-2
   Riedl J, 2007, CHEMOSPHERE, V67, P2210, DOI 10.1016/j.chemosphere.2006.12.022
   Russom CL, 1997, ENVIRON TOXICOL CHEM, V16, P948, DOI 10.1002/etc.5620160514
   SAITO H, 1993, CHEMOSPHERE, V26, P1015, DOI 10.1016/0045-6535(93)90374-E
   SAITO H, 1993, CHEMOSPHERE, V27, P1553, DOI 10.1016/0045-6535(93)90249-5
   SAITO H, 1991, CHEMOSPHERE, V23, P525, DOI 10.1016/0045-6535(91)90202-O
   Schirmer K, 1997, TOXICOL IN VITRO, V11, P107, DOI 10.1016/S0887-2333(97)00002-7
   Schirmer K, 1998, TOXICOLOGY, V127, P129, DOI 10.1016/S0300-483X(98)00030-4
   Schirmer K, 2006, TOXICOLOGY, V224, P163, DOI 10.1016/j.tox.2006.04.042
   Schirmer K, 2008, AQUAT TOXICOL, V90, P128, DOI 10.1016/j.aquatox.2008.08.005
   Shi D, 2003, CELL MOL NEUROBIOL, V23, P331, DOI 10.1023/A:1023688604792
   Smith KEC, 2010, CHEM RES TOXICOL, V23, P55, DOI 10.1021/tx900274j
   Spacie A., 1981, ACUTE AND CHRONIC PA
   Tanneberger K, 2010, ENVIRON SCI TECHNOL, V44, P4775, DOI 10.1021/es100045y
   Tollefsen KE, 2008, ECOTOX ENVIRON SAFE, V69, P64, DOI 10.1016/j.ecoenv.2006.12.005
   Volz DC, 2011, TOXICOL SCI, V123, P349, DOI 10.1093/toxsci/kfr185
   Wolansky MJ, 2006, TOXICOL SCI, V89, P271, DOI 10.1093/toxsci/kfj020
   Yadav A, 2009, ECOTOXICOLOGY, V18, P325, DOI 10.1007/s10646-008-0286-x
NR 44
TC 53
Z9 53
U1 3
U2 105
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0013-936X
J9 ENVIRON SCI TECHNOL
JI Environ. Sci. Technol.
PD JAN 15
PY 2013
VL 47
IS 2
BP 1110
EP 1119
DI 10.1021/es303505z
PG 10
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA 072JO
UT WOS:000313667400055
PM 23227966
DA 2019-10-23
ER

PT J
AU Hartung, T
   Corsini, E
AF Hartung, Thomas
   Corsini, Emanuela
TI Immunotoxicology: Challenges in the 21st century and In Vitro
   Opportunities
SO ALTEX-ALTERNATIVES TO ANIMAL EXPERIMENTATION
LA English
DT Article
DE immune system; xenobiotics; toxicity testing; alternative methods;
   toxicology for the 21st century
ID HUMAN WHOLE-BLOOD; INTERNATIONAL VALIDATION; REPRODUCTIVE TOXICITY;
   ALTERNATIVE METHODS; CYTOKINE PRODUCTION; DENDRITIC CELLS;
   RISK-ASSESSMENT; ANIMAL-MODELS; LIVER-INJURY; IMMUNE
AB Over the last two decades, little has changed in the practice of immunotoxicity testing for regulatory purposes, especially for immunosuppression, and autoimmunity is still a challenge. Current guidelines still rely on animal tests, which include some immune endpoints in repeated dose tests and trigger dedicated tests only when certain alerts indicate a problem. At the same time, however, a wealth of in vitro approaches has been developed, but few have been adopted for routine testing. The extent to which immunotoxicity of chemicals represents a health problem for the human population at low levels of exposure is unclear: it appears that responses of healthy individuals to immunological challenges differ widely and most immunomodulators have few adverse effects except when they coincide with an infectious or malignant challenge or when early in life exposure is expected, in which cases the odds of progressing into infection, autoimmune diseases, or cancer can be changed. The enormous overcapacity of immune defense, the presence of compensatory mechanisms, and their fast restoration each contribute to limiting health threats for the individual, though on a population base also minor immunomodulation may result in increased morbidity. In vitro alternative approaches may allow screening for problematic substances and prioritize them for in vivo testing. New approaches are emerging from mapping pathways of immunotoxicity. Increasingly, the contribution of inflammatory and infectious components to the adverse outcome pathways of chemicals is recognized for various hazards, urging inclusion of tests for proinflammatory and immunomodulatory properties of chemicals into integrated testing strategies.
C1 [Hartung, Thomas] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, CAAT, Baltimore, MD USA.
   [Hartung, Thomas] Univ Konstanz, CAAT Europe, Constance, Germany.
   [Corsini, Emanuela] Univ Milan, Toxicol Lab, DiSFeB, Milan, Italy.
RP Hartung, T (reprint author), Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Alternat Anim Testing, 615 North Wolfe St,W7032, Baltimore, MD 21205 USA.
EM thartung@jhsph.edu
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [3R01ES018845-04S1, 1R01ES020750]
FX The discussions and work with the ECVAM taskforce on immunotoxicology
   and the participants of the respective BC YAM workshop is gratefully
   appreciated. TH holds patents on the whole blood pyrogen test and
   cryopreserved blood mentioned above and is supported also by NIH
   (3R01ES018845-04S1). The work on pathway of toxicity mapping referred to
   is financed by NIH (1R01ES020750).
CR Adler S, 2011, ARCH TOXICOL, V85, P367, DOI 10.1007/s00204-011-0693-2
   Basketter DA, 2012, ALTEX-ALTERN ANIM EX, V29, P5, DOI 10.14573/altex.2012.1.003
   BLOEMENA E, 1989, J IMMUNOL METHODS, V122, P161, DOI 10.1016/0022-1759(89)90260-3
   Blom WM, 2009, INT IMMUNOPHARMACOL, V9, P746, DOI 10.1016/j.intimp.2009.02.017
   Bremer S, 2007, CURR PHARM DESIGN, V13, P3047, DOI 10.2174/138161207782110462
   Burns-Naas LA, 2008, INT J TOXICOL, V27, P223, DOI 10.1080/10915810801978110
   Carfi M, 2007, TOXICOLOGY, V229, P11, DOI 10.1016/j.tox.2006.09.003
   Casati S, 2005, ATLA-ALTERN LAB ANIM, V33, P47, DOI 10.1177/026119290503300108
   Collinge M, 2012, J IMMUNOTOXICOL, V9, P210, DOI 10.3109/1547691X.2012.661486
   Colosio C, 2005, Toxicol Appl Pharmacol, V207, P320, DOI 10.1016/j.taap.2005.01.025
   Corsini E, 2005, TOXICOL APPL PHARM, V208, P178, DOI 10.1016/j.taap.2005.02.011
   Corsini E, 2013, TOXICOLOGY, V307, P123, DOI 10.1016/j.tox.2012.10.009
   Corsini E, 2006, TOXICOL LETT, V164, pS313, DOI 10.1016/j.toxlet.2006.07.316
   Corsini E, 2011, J IMMUNOTOXICOL, V8, P251, DOI 10.3109/1547691X.2011.598885
   Corsini E, 2009, ATLA-ALTERN LAB ANIM, V37, P387, DOI 10.1177/026119290903700409
   Corsini E, 2007, TOXICOL APPL PHARM, V222, P202, DOI 10.1016/j.taap.2007.04.017
   Coutant KD, 1999, TOXICOL SCI, V52, P189, DOI 10.1093/toxsci/52.2.189
   CZAJA MJ, 1994, HEPATOLOGY, V19, P1282, DOI 10.1016/0270-9139(94)90878-8
   Dal Negro G, 2001, CELL BIOL TOXICOL, V17, P95, DOI 10.1023/A:1010958121396
   Daneshian M, 2009, NAT PROTOC, V4, P1709, DOI 10.1038/nprot.2009.159
   Dean J. H., 1994, IMMUNOTOXICOLOGY IMM
   Dean JH, 2007, PRINCIPLES METHODS T, P1755
   Descotes J, 2004, IMMUNOTOXICOLOGY DRU, P55
   Descotes J, 2006, EXPERT OPIN DRUG MET, V2, P249, DOI 10.1517/17425255.2.2.249
   Descotes Jacques, 2005, Expert Rev Clin Immunol, V1, P603, DOI 10.1586/1744666X.1.4.603
   DeWitt JC, 2012, TOXICOL PATHOL, V40, P230, DOI 10.1177/0192623311427709
   Diaz HG, 2003, CHEM RES TOXICOL, V16, P1318, DOI 10.1021/tx0256432
   Dietert RR, 2008, J IMMUNOTOXICOL, V5, P401, DOI 10.1080/15476910802483324
   Dietert RR, 2010, METHODS MOL BIOL, V598, P1, DOI 10.1007/978-1-60761-401-2
   DIPIETRO LA, 1995, SHOCK, V4, P233, DOI 10.1097/00024382-199510000-00001
   DUTTON RW, 1967, J EXP MED, V126, P443, DOI 10.1084/jem.126.3.443
   ELSASSERBEILE U, 1993, CANCER IMMUNOL IMMUN, V37, P169, DOI 10.1007/BF01525431
   Environmental Defense Fund, 1997, TOX SUBST MAN POL SH, P1
   Feingold BJ, 2010, ENVIRON HEALTH PERSP, V118, P1165, DOI 10.1289/ehp.0901866
   Ferrario D, 2012, ALTEX-ALTERN ANIM EX, V29, P157, DOI 10.14573/altex.2012.2.157
   FLETCHER MA, 1987, DIAGN CLIN IMMUNOL, V5, P69
   Galbiati V, 2010, J IMMUNOTOXICOL, V7, P255, DOI 10.3109/1547691X.2010.509848
   Gallagher MP, 2010, J AM SOC NEPHROL, V21, P852, DOI 10.1681/ASN.2009101043
   Ganey PE, 2001, TOXICOLOGY, V169, P195, DOI 10.1016/S0300-483X(01)00523-6
   Garbe E, 2007, EXPERT OPIN DRUG SAF, V6, P323, DOI 10.1517/14740338.6.3.323
   Gennari A, 2004, ATLA-ALTERN LAB ANIM, V32, P437, DOI 10.1177/026119290403200417
   Gennari Alessandra, 2005, J Immunotoxicol, V2, P61, DOI 10.1080/15476910590965832
   Germolec D, 2012, J AUTOIMMUN, V39, P285, DOI 10.1016/j.jaut.2012.05.020
   Germolec DR, 2004, TOXICOL LETT, V149, P109, DOI 10.1016/j.toxlet.2003.12.025
   Goebels N, 2007, ALTEX-ALTERN TIEREXP, V24, P85
   Grandjean P, 2012, JAMA-J AM MED ASSOC, V307, P391, DOI 10.1001/jama.2011.2034
   Granum B, 2013, J IMMUNOTOXICOL, V10, P373, DOI 10.3109/1547691X.2012.755580
   Hareng L, 2002, BIOL CHEM, V383, P1501, DOI 10.1515/BC.2002.172
   Hartung T, 1999, REV PHYSIOL BIOCH P, V136, P1, DOI 10.1007/BFb0032323
   Hartung T, 2001, ATLA-ALTERN LAB ANIM, V29, P99, DOI 10.1177/026119290102900203
   HARTUNG T, 1995, BLOOD, V85, P2482, DOI 10.1182/blood.V85.9.2482.bloodjournal8592482
   Hartung T., 1995, ALTEX, V12, P70
   Hartung T, 2008, ALTEX-ALTERN TIEREXP, V25, P3
   Hartung T, 2013, ALTEX-ALTERN ANIM EX, V30, P3, DOI 10.14573/altex.2013.1.003
   Hartung T, 2012, ALTEX-ALTERN ANIM EX, V29, P251, DOI 10.14573/altex.2012.3.251
   Hartung T, 2012, ALTEX-ALTERN ANIM EX, V29, P119, DOI 10.14573/altex.2012.2.119
   Hartung T, 2011, WIRES NANOMED NANOBI, V3, P545, DOI 10.1002/wnan.153
   Hartung T, 2011, ALTEX-ALTERN ANIM EX, V28, P83, DOI 10.14573/altex.2011.2.083
   Hartung T, 2011, EUR J PHARM BIOPHARM, V77, P338, DOI 10.1016/j.ejpb.2010.12.027
   Hartung T, 2010, ALTEX-ALTERN ANIM EX, V27, P87
   Hartung T, 2010, J TOXICOL ENV HEAL B, V13, P277, DOI 10.1080/10937404.2010.483945
   Hartung T, 2009, NATURE, V460, P1080, DOI 10.1038/4601080a
   Hartung T, 2009, NATURE, V460, P208, DOI 10.1038/460208a
   Hartung T, 2009, TOXICOL SCI, V109, P18, DOI 10.1093/toxsci/kfp059
   Hermann C, 2003, J IMMUNOL METHODS, V275, P69, DOI 10.1016/S0022-1759(03)00003-6
   Hochstenbach K, 2010, TOXICOL SCI, V118, P19, DOI 10.1093/toxsci/kfq239
   Hoffmann S, 2005, J IMMUNOL METHODS, V298, P161, DOI 10.1016/j.jim.2005.01.010
   Holsapple MP, 2005, TOXICOL SCI, V83, P18, DOI 10.1093/toxsci/kfh299
   Holsapple MP, 2002, TOXICOL LETT, V127, P101, DOI 10.1016/S0378-4274(01)00489-1
   House R.V., 2006, IMMUNOTOXICOLOGY IMM
   House RV, 2010, METHODS MOL BIOL, V598, P363, DOI 10.1007/978-1-60761-401-2_24
   House Robert V., 1995, P159
   Hymery N, 2006, CELL BIOL TOXICOL, V22, P243, DOI 10.1007/s10565-006-0180-3
   Ilback NG, 2007, CRIT REV FOOD SCI, V47, P499, DOI 10.1080/10408390600919015
   Institoris L, 1998, HUM EXP TOXICOL, V17, P206, DOI 10.1191/096032798678908576
   Jaworska J, 2011, ALTEX-ALTERN ANIM EX, V28, P211, DOI 10.14573/altex.2011.3.211
   Jones CF, 2009, ADV DRUG DELIVER REV, V61, P438, DOI 10.1016/j.addr.2009.03.005
   Kadow S, 2009, FUTURE MED CHEM, V1, P1583, DOI 10.4155/FMC.09.125
   Kaminski NE, 2007, CASARETT DOULLS TOXI, P485
   Kilburn KH, 1994, IMMUNOTOXICOLOGY IMM, P523
   Kim GG, 2007, J IMMUNOL METHODS, V325, P51, DOI 10.1016/j.jim.2007.05.013
   Kirkwood TBL, 2008, NATURE, V451, P644, DOI 10.1038/451644a
   Knutsen B Jr, 1978, Tidsskr Nor Laegeforen, V98, P888
   Koeper LM, 2009, FOOD CHEM TOXICOL, V47, P110, DOI 10.1016/j.fct.2008.10.025
   KOSUDA LL, 1996, EXPT IMMUNOTOXICOLOG, P419
   Lam-Tse WK, 2002, SPRINGER SEMIN IMMUN, V24, P297, DOI 10.1007/s00281-002-0110-2
   Langezaal I, 2002, ATLA-ALTERN LAB ANIM, V30, P581, DOI 10.1177/026119290203000605
   Langezaal I, 2001, TOXICOL IN VITRO, V15, P313, DOI 10.1016/S0887-2333(01)00028-5
   Lankveld DPK, 2010, METHODS MOL BIOL, V598, P401, DOI 10.1007/978-1-60761-401-2_26
   LASKIN DL, 1995, ANNU REV PHARMACOL, V35, P655, DOI 10.1146/annurev.pharmtox.35.1.655
   Leist M, 1998, Rev Physiol Biochem Pharmacol, V133, P109
   Leist M, 1997, GASTROENTEROLOGY, V112, P923, DOI 10.1053/gast.1997.v112.pm9041255
   Luebke R, 2012, TOXICOL PATHOL, V40, P294, DOI 10.1177/0192623311427572
   LUSTER MI, 1992, FUND APPL TOXICOL, V18, P200, DOI 10.1016/0272-0590(92)90047-L
   LUSTER MI, 1993, ENVIRON HEALTH PERSP, V100, P219, DOI 10.2307/3431528
   LUSTER MI, 1993, FUND APPL TOXICOL, V21, P71, DOI 10.1006/faat.1993.1074
   Luster MI, 2001, TOXICOL LETT, V120, P317, DOI 10.1016/S0378-4274(01)00284-3
   Luster MI, 2010, METHODS MOL BIOL, V598, P3, DOI 10.1007/978-1-60761-401-2_1
   Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205
   MISHELL RI, 1967, J EXP MED, V126, P423, DOI 10.1084/jem.126.3.423
   MORALES A, 1983, CANCER, V52, P667, DOI 10.1002/1097-0142(19830815)52:4<667::AID-CNCR2820520417>3.0.CO;2-C
   Nolan JP, 2010, HEPATOLOGY, V52, P1829, DOI 10.1002/hep.23917
   Pessina A, 2001, TOXICOL IN VITRO, V15, P729, DOI 10.1016/S0887-2333(01)00085-6
   Pfaller T, 2010, NANOTOXICOLOGY, V4, P52, DOI 10.3109/17435390903374001
   Philip M, 2004, SEMIN CANCER BIOL, V14, P433, DOI 10.1016/j.semcancer.2004.06.006
   Pieters R, 2007, METHODS, V41, P112, DOI 10.1016/j.ymeth.2006.09.005
   Reuben SH, 2010, REDUCING ENV CANC RI
   Riminton DS, 2011, CURR OPIN NEUROL, V24, P217, DOI 10.1097/WCO.0b013e328346d47d
   RODER JC, 1980, NATURE, V284, P553, DOI 10.1038/284553a0
   Rooney Andrew A, 2012, Exp Suppl, V101, P251, DOI 10.1007/978-3-7643-8340-4_9
   Rovida C, 2011, ALTEX-ALTERN ANIM EX, V28, P273, DOI 10.14573/altex.2011.4.273
   Rovida C, 2009, ALTEX-ALTERN TIEREXP, V26, P187
   Schindler S, 2004, J IMMUNOL METHODS, V294, P89, DOI 10.1016/j.jim.2004.08.019
   Schindler S, 2006, J IMMUNOL METHODS, V316, P42, DOI 10.1016/j.jim.2006.07.023
   Schindler S, 2009, ALTEX-ALTERN TIEREXP, V26, P265
   Schneider M, 2001, IMMUNOL LETT, V75, P163, DOI 10.1016/S0165-2478(00)00299-6
   Shao J., 2013, TOXICOL SCI
   Sodemann U, 2011, DAN MED BULL, V58
   Su GL, 2002, AM J PHYSIOL-GASTR L, V283, pG256, DOI 10.1152/ajpgi.00550.2001
   SUNDWALL A, 1994, TOXICOL IN VITRO, V8, P1067, DOI 10.1016/0887-2333(94)90246-1
   van der Star BJ, 2012, CNS NEUROL DISORD-DR, V11, P570
   von Aulock S, 2004, J PHARMACOL EXP THER, V308, P754, DOI 10.1124/jpet.103.058198
   Wakelin SJ, 2006, IMMUNOL LETT, V106, P1, DOI 10.1016/j.imlet.2006.04.007
   Weir Genevieve M, 2011, Cancers (Basel), V3, P3114, DOI 10.3390/cancers3033114
   WOOD SC, 1992, FUND APPL TOXICOL, V18, P450, DOI 10.1016/0272-0590(92)90143-6
   Zitvogel L, 2008, NAT REV IMMUNOL, V8, P59, DOI 10.1038/nri2216
NR 126
TC 17
Z9 21
U1 0
U2 9
PU SPEKTRUM AKADEMISCHER VERLAG-SPRINGER-VERLAG GMBH
PI HEILDEBERG
PA TIERGARTENSTRASSE 17, HEILDEBERG, 69121, GERMANY
SN 1868-596X
EI 1868-8551
J9 ALTEX-ALTERN ANIM EX
JI ALTEX-Altern. Anim. Exp.
PY 2013
VL 30
IS 4
BP 411
EP 426
DI 10.14573/altex.2013.4.411
PG 16
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA 264TE
UT WOS:000327903100002
PM 24173166
OA DOAJ Gold
DA 2019-10-23
ER

PT J
AU Greally, JM
   Jacobs, MN
AF Greally, John M.
   Jacobs, Miriam N.
TI In Vitro and In Vivo Testing Methods of Epigenomic Endpoints for
   Evaluating Endocrine Disruptors
SO ALTEX-ALTERNATIVES TO ANIMAL EXPERIMENTATION
LA English
DT Article
DE endocrine disruptors; endocrine active substances; epigenome; regulatory
   methods; toxicity testing
ID EPIGENETIC TRANSGENERATIONAL ACTIONS; INDUCED DNA HYPOMETHYLATION; H3
   LYSINE-9 METHYLATION; GENOME-WIDE ANALYSIS; BISPHENOL-A; CHROMATIN
   IMMUNOPRECIPITATION; STEM-CELLS; DI-2-(ETHYLHEXYL) PHTHALATE;
   DEVELOPMENTAL TOXICITY; MATERNAL EXPOSURE
AB Epigenetic modulations underlie critical developmental processes and contribute to determining adult phenotype. Alterations to the phenotype, due to exposure to environmental insults during sensitive periods of development, are mediated through alterations in epigenetic programming in affected tissues. Originally prepared for the Organisation of Economic Cooperation and Development (OECD), this detailed review evaluates the potential role of chemical-induced epigenetic modifications to endocrine signaling pathways during sensitive windows of exposure as a mechanism of endocrine disruption, along with the examination of potential methods for assessing such disruption. Potential targets of disruption along putative adverse outcome pathways associated with the signaling pathways are identified, along with assays that show promise in evaluating the target in a screening and testing program such that in vitro methods are used where possible, and animal experiments only where in vitro methods are not available. Monitoring such epigenetic marks in response to toxicant exposure may in future provide a valuable tool for predicting adverse outcomes, but a more robust basis for Test Guideline recommendations is still needed. Although there is evidence to suggest that epigenomic dysregulation might mediate effects of exposures to endocrine disruptors, it is uncertain as to whether these changes are truly predictive of adverse outcome(s). Adverse effects observed in the OECD transgenerational assays could be used to inform future tests specifically designed to investigate the epigenetic mechanism of action. Follow-up studies should include both an epigenetic as well as a genomic component to differentiate between the contributions of potentially compensatory mechanisms.
C1 [Greally, John M.] Albert Einstein Coll Med, Ctr Epigen, Bronx, NY 10467 USA.
   [Jacobs, Miriam N.] European Food Safety Author EFSA, Sci Comm & Emerging Risks Unit, Sci Comm Unit, I-43126 Parma, Italy.
RP Jacobs, MN (reprint author), European Food Safety Author EFSA, Sci Comm & Emerging Risks Unit, Via Carlo Magno 1A, I-43126 Parma, Italy.
EM miriamjacobs@efsa.europa.eu
OI Greally, John/0000-0001-6069-7960
FU OECD/European Commission
FX The authors gratefully acknowledge the close cooperation, support and
   review of the members of the OECD Endocrine Disruptor Testing and
   Assessment Advisory Group (EDTA-AG), the European Commission, the OECD
   Secretariat Administrator, Nathalie Delrue, and the helpful comments of
   the anonymous manuscript reviewers. JMG was supported by an
   OECD/European Commission funded consultancy for the preparation of this
   paper.
CR Adli M, 2010, NAT METHODS, V7, P615, DOI [10.1038/NMETH.1478, 10.1038/nmeth.1478]
   Allegrucci C, 2007, HUM MOL GENET, V16, P1253, DOI 10.1093/hmg/ddm074
   Alleman M, 2006, NATURE, V442, P295, DOI 10.1038/nature04884
   Ang YS, 2011, TRENDS PHARMACOL SCI, V32, P394, DOI 10.1016/j.tips.2011.03.002
   Anglim PP, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-81
   Anway MD, 2006, ENDOCRINOLOGY, V147, pS43, DOI 10.1210/en.2005-1058
   Anway MD, 2005, SCIENCE, V308, P1466, DOI 10.1126/science.1108190
   Ashe A, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-12-r182
   Augustine-Rauch K, 2010, BIRTH DEFECTS RES C, V90, P87, DOI 10.1002/bdrc.20175
   Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533
   Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22
   Barrero MJ, 2010, CELL STEM CELL, V7, P565, DOI 10.1016/j.stem.2010.10.009
   Beckerman R, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000935
   Beiter T, 2009, CELL MOL LIFE SCI, V66, P94, DOI 10.1007/s00018-008-8381-y
   Bernstein E, 2008, P NATL ACAD SCI USA, V105, P1533, DOI 10.1073/pnas.0711632105
   Bibikova M, 2011, GENOMICS, V98, P288, DOI 10.1016/j.ygeno.2011.07.007
   Birney E, 2010, HUM MOL GENET, V19, pR204, DOI 10.1093/hmg/ddq404
   Boyle AP, 2009, EPIGENOMICS-UK, V1, P319, DOI 10.2217/EP1.09.29
   Bromer JG, 2010, FASEB J, V24, P2273, DOI 10.1096/fj.09-140533
   Calafat AM, 2008, ENVIRON HEALTH PERSP, V116, P39, DOI 10.1289/ehp.10753
   Carone BR, 2010, CELL, V143, P1084, DOI 10.1016/j.cell.2010.12.008
   Celeghin A, 2011, GEN COMP ENDOCR, V172, P120, DOI 10.1016/j.ygcen.2010.12.020
   Chandler VL, 2007, CELL, V128, P641, DOI 10.1016/j.cell.2007.02.007
   Chaturvedi NK, 2010, MOL CELL BIOCHEM, V345, P291, DOI 10.1007/s11010-010-0583-6
   Christensen BC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000602
   Claus R, 2003, ONCOGENE, V22, P6489, DOI 10.1038/sj.onc.1206814
   Clement TM, 2010, REPROD TOXICOL, V30, P353, DOI 10.1016/j.reprotox.2010.05.086
   Crews D, 2007, P NATL ACAD SCI USA, V104, P5942, DOI 10.1073/pnas.0610410104
   Damstra T, 2002, WHOPCSEDC022
   Dang ZC, 2010, TOXICOL LETT, V192, P298, DOI 10.1016/j.toxlet.2009.11.004
   De Bustos C, 2009, EPIGENET CHROMATIN, V2, DOI 10.1186/1756-8935-2-7
   Delaval K, 2004, CURR OPIN GENET DEV, V14, P188, DOI 10.1016/j.gde.2004.01.005
   Doherty Leo F., 2010, Hormones & Cancer, V1, P146, DOI 10.1007/s12672-010-0015-9
   Dolinoy DC, 2008, NUTR REV, V66, pS7, DOI 10.1111/j.1753-4887.2008.00056.x
   Dolinoy DC, 2007, P NATL ACAD SCI USA, V104, P13056, DOI 10.1073/pnas.0703739104
   Dolinoy DC, 2006, ENVIRON HEALTH PERSP, V114, P567, DOI 10.1289/ehp.8700
   Down TA, 2008, NAT BIOTECHNOL, V26, P779, DOI 10.1038/nbt1414
   Ehrich M, 2005, P NATL ACAD SCI USA, V102, P15785, DOI 10.1073/pnas.0507816102
   Ernst J, 2010, NAT BIOTECHNOL, V28, P817, DOI 10.1038/nbt.1662
   EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939
   Fakhrai-Rad H, 2002, HUM MUTAT, V19, P479, DOI 10.1002/humu.10078
   Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102
   Francis NJ, 2009, CELL, V137, P110, DOI 10.1016/j.cell.2009.02.017
   Gertz J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002228
   Gluckman Peter D, 2004, Semin Fetal Neonatal Med, V9, P419, DOI 10.1016/j.siny.2004.03.001
   Goodman JI, 2010, TOXICOL SCI, V116, P375, DOI 10.1093/toxsci/kfq133
   Goyal R, 2006, NUCLEIC ACIDS RES, V34, P1182, DOI 10.1093/nar/gkl002
   Grafodatskaya D, 2010, GENOMICS, V95, P73, DOI 10.1016/j.ygeno.2009.12.001
   Guerrero-Bosagna C, 2012, REPROD TOXICOL, V34, P694, DOI 10.1016/j.reprotox.2012.09.005
   Guerrero-Bosagna CM, 2009, SEMIN REPROD MED, V27, P403, DOI 10.1055/s-0029-1237428
   Hansen RS, 1999, P NATL ACAD SCI USA, V96, P14412, DOI 10.1073/pnas.96.25.14412
   Harris RA, 2010, NAT BIOTECHNOL, V28, P1097, DOI 10.1038/nbt.1682
   Hartley PD, 2009, CELL, V137, P445, DOI 10.1016/j.cell.2009.02.043
   Hawliczek A, 2012, REPROD TOXICOL, V33, P213, DOI 10.1016/j.reprotox.2011.11.001
   He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944
   Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966
   Hiragami-Hamada K, 2009, EPIGENET CHROMATIN, V2, DOI 10.1186/1756-8935-2-14
   Ho SM, 2006, CANCER RES, V66, P5624, DOI 10.1158/0008-5472.CAN-06-0516
   Hoque MO, 2008, CANCER RES, V68, P2661, DOI 10.1158/0008-5472.CAN-07-5913
   Hsu PY, 2010, GENOME RES, V20, P733, DOI 10.1101/gr.101923.109
   Hsu PY, 2009, CANCER RES, V69, P5936, DOI 10.1158/0008-5472.CAN-08-4914
   Inawaka K, 2009, TOXICOL APPL PHARM, V237, P178, DOI 10.1016/j.taap.2009.03.004
   Jia D, 2007, NATURE, V449, P248, DOI 10.1038/nature06146
   Jin VX, 2004, NUCLEIC ACIDS RES, V32, P6627, DOI 10.1093/nar/gkh1005
   Jing HI, 2008, MOL CELL, V29, P232, DOI 10.1016/j.molcel.2007.11.020
   Kacem S, 2009, MAMM GENOME, V20, P544, DOI 10.1007/s00335-009-9223-4
   Kahn SD, 2011, SCIENCE, V331, P728, DOI 10.1126/science.1197891
   Karimi M, 2006, EPIGENETICS-US, V1, P45
   Karpf AR, 2005, CANCER RES, V65, P8635, DOI 10.1158/0008-5472
   Kasowski M, 2010, SCIENCE, V328, P232, DOI 10.1126/science.1183621
   Kato S, 2011, BIOSCI BIOTECH BIOCH, V75, P410, DOI 10.1271/bbb.100807
   Kauppi L, 2004, NAT REV GENET, V5, P413, DOI 10.1038/nrg1346
   Kim DH, 2006, NAT STRUCT MOL BIOL, V13, P793, DOI 10.1038/nsmb1142
   Kim JH, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-33
   Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008
   Krauss V, 2011, PROG MOL BIOL TRANSL, V101, P177, DOI 10.1016/B978-0-12-387685-0.00003-2
   LaSalle JM, 1996, SCIENCE, V272, P725, DOI 10.1126/science.272.5262.725
   Laurent L, 2010, GENOME RES, V20, P320, DOI 10.1101/gr.101907.109
   LeBaron MJ, 2010, MUTAT RES-REV MUTAT, V705, P83, DOI 10.1016/j.mrrev.2010.04.003
   Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015
   Lin ZH, 2007, CANCER RES, V67, P5017, DOI 10.1158/0008-5472.CAN-06-3696
   Lindeman LC, 2009, METHODS MOL BIOL, V567, P75, DOI 10.1007/978-1-60327-414-2_5
   Linney E, 2011, NEUROTOXICOL TERATOL, V33, P631, DOI 10.1016/j.ntt.2011.06.006
   Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514
   Manikkam M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055387
   Mardis ER, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-112
   McCollum CW, 2011, BIRTH DEFECTS RES C, V93, P67, DOI 10.1002/bdrc.20210
   McDaniell R, 2010, SCIENCE, V328, P235, DOI 10.1126/science.1184655
   Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107
   Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008
   Mishima Y, 2012, DEV GROWTH DIFFER, V54, P55, DOI 10.1111/j.1440-169X.2011.01306.x
   Morris KV, 2004, SCIENCE, V305, P1289, DOI 10.1126/science.1101372
   Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441
   Niculescu MD, 2002, J NUTR, V132, p2333S, DOI 10.1093/jn/132.8.2333S
   O'Malley BW, 2008, CURR OPIN CELL BIOL, V20, P310, DOI 10.1016/j.ceb.2008.04.005
   OECD, 2012, SER TEST ASS
   OECD, 2011, SER TEST ASS, V157
   OECD (Organization for Economic Cooperation and Development), 2013, FISH EMBR AC TOX FET
   Peters AHFM, 2002, NAT GENET, V30, P77, DOI 10.1038/ng789
   Pikaard CS, 2006, COLD SPRING HARB SYM, V71, P473, DOI 10.1101/sqb.2006.71.046
   Pogribny IP, 2008, MUTAT RES-FUND MOL M, V644, P17, DOI 10.1016/j.mrfmmm.2008.06.009
   Prins GS, 2011, REPROD TOXICOL, V31, P1, DOI 10.1016/j.reprotox.2010.09.009
   Ptashne M, 2013, FASEB J, V27, P1, DOI 10.1096/fj.13-0101ufm
   Rasoulpour RJ, 2011, TOXICOL MECH METHOD, V21, P298, DOI 10.3109/15376516.2011.557883
   Rassoulzadegan M, 2006, NATURE, V441, P469, DOI 10.1038/nature04674
   Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443
   Renner R, 2009, ENVIRON SCI TECHNOL, V43, P8009, DOI 10.1021/es902777p
   Rohwedel J, 2001, TOXICOL IN VITRO, V15, P741, DOI 10.1016/S0887-2333(01)00074-1
   Ronis MJJ, 2011, J NUTR, V141, P10, DOI 10.3945/jn.110.127423
   Rosenfeld CS, 2013, P NATL ACAD SCI USA, V110, P537, DOI 10.1073/pnas.1220230110
   Roy D, 2008, MOL CELL BIOL, V28, P50, DOI 10.1128/MCB.01251-07
   Rozowsky J, 2009, NAT BIOTECHNOL, V27, P66, DOI 10.1038/nbt.1518
   Santenard A, 2010, NAT CELL BIOL, V12, P853, DOI 10.1038/ncb2089
   SAPIENZA C, 1989, DEVELOPMENT, V107, P165
   Sarter B, 2005, HUM GENET, V117, P402, DOI 10.1007/s00439-005-1317-9
   Sboner A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-125
   Schmieder PK, 2004, ENVIRON SCI TECHNOL, V38, P6333, DOI 10.1021/es0495314
   Schneider S, 2008, REPROD TOXICOL, V25, P352, DOI 10.1016/j.reprotox.2008.04.001
   Schwartz S, 2010, EMBO J, V29, P1629, DOI 10.1038/emboj.2010.71
   Sigurdsson MI, 2009, GENOME RES, V19, P581, DOI 10.1101/gr.086181.108
   Simmons R, 2008, SEMIN PERINATOL, V32, P371, DOI 10.1053/j.semperi.2008.08.004
   Skinner MK, 2008, REPROD TOXICOL, V25, P2, DOI 10.1016/j.reprotox.2007.09.001
   Song Lingyun, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.prot5384
   Stokes WS, 2004, ILAR J, V45, P387, DOI 10.1093/ilar.45.4.387
   Stouder C, 2010, REPRODUCTION, V139, P373, DOI 10.1530/REP-09-0340
   Sugii S, 2011, FEBS LETT, V585, P2121, DOI 10.1016/j.febslet.2011.05.007
   Sugiura-Ogasawara M, 2005, HUM REPROD, V20, P2325, DOI 10.1093/humrep/deh888
   Susiarjo M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003401
   Suzuki M, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-4-r36
   Tang WY, 2012, ENDOCRINOLOGY, V153, P42, DOI 10.1210/en.2011-1308
   Thompson RF, 2010, AGING CELL, V9, P506, DOI 10.1111/j.1474-9726.2010.00577.x
   Thompson RF, 2010, J BIOL CHEM, V285, P15111, DOI 10.1074/jbc.M109.095133
   Tilgner H, 2009, NAT STRUCT MOL BIOL, V16, P996, DOI 10.1038/nsmb.1658
   Udvadia AJ, 2003, DEV BIOL, V256, P1, DOI 10.1016/S0012-1606(02)00083-0
   Vakoc CR, 2005, MOL CELL, V19, P381, DOI 10.1016/j.molcel.2005.06.011
   Vandegehuchte MB, 2011, ECOTOXICOLOGY, V20, P607, DOI 10.1007/s10646-011-0634-0
   vom Saal FS, 2005, ENVIRON HEALTH PERSP, V113, P926, DOI 10.1289/ehp.7713
   Waddington C. H., 1942, Endeavour London, V1, P18
   Waterland RA, 2003, MOL CELL BIOL, V23, P5293, DOI 10.1128/MCB.23.15.5293-5300.2003
   Waterland RA, 2006, GENESIS, V44, P401, DOI 10.1002/dvg.20230
   Weng YI, 2010, TOXICOL APPL PHARM, V248, P111, DOI 10.1016/j.taap.2010.07.014
   Whitehead J, 2009, BBA-GEN SUBJECTS, V1790, P936, DOI 10.1016/j.bbagen.2008.10.007
   WHO/UNEP - World Health Organization/United Nations Environment Programme, 2013, STAT SCI END DISR CH, P296
   Wild L, 2010, CARCINOGENESIS, V31, P1854, DOI 10.1093/carcin/bgq080
   Wu SF, 2011, METHOD CELL BIOL, V104, P327, DOI 10.1016/B978-0-12-374814-0.00018-5
   Wu SD, 2010, INT J TOXICOL, V29, P193, DOI 10.1177/1091581809355488
   Wu SD, 2010, BASIC CLIN PHARMACOL, V106, P118, DOI 10.1111/j.1742-7843.2009.00483.x
   Yamashita S, 2009, DNA RES, V16, P275, DOI 10.1093/dnares/dsp017
   Yang AS, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh032
   Yaoi T, 2008, BIOCHEM BIOPH RES CO, V376, P563, DOI 10.1016/j.bbrc.2008.09.028
   Yeo M, 2013, P NATL ACAD SCI USA, V110, P4315, DOI 10.1073/pnas.1300959110
   Zama AM, 2009, ENDOCRINOLOGY, V150, P4681, DOI 10.1210/en.2009-0499
   Zhang JS, 2000, ANNU REV PHYSIOL, V62, P439, DOI 10.1146/annurev.physiol.62.1.439
   Zhang JJ, 2011, ANAL BIOCHEM, V413, P164, DOI 10.1016/j.ab.2011.01.029
   Zhang XA, 2011, J MOL ENDOCRINOL, V46, pR11, DOI 10.1677/JME-10-0053
   Zilberman D, 2007, DEVELOPMENT, V134, P3959, DOI 10.1242/dev.001131
   Zofall M, 2006, COLD SPRING HARB SYM, V71, P487, DOI 10.1101/sqb.2006.71.059
NR 157
TC 23
Z9 24
U1 0
U2 15
PU SPEKTRUM AKADEMISCHER VERLAG-SPRINGER-VERLAG GMBH
PI HEILDEBERG
PA TIERGARTENSTRASSE 17, HEILDEBERG, 69121, GERMANY
SN 1868-596X
EI 1868-8551
J9 ALTEX-ALTERN ANIM EX
JI ALTEX-Altern. Anim. Exp.
PY 2013
VL 30
IS 4
BP 445
EP 471
DI 10.14573/altex.2013.4.445
PG 27
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA 264TE
UT WOS:000327903100004
PM 24173168
OA DOAJ Gold
DA 2019-10-23
ER

PT J
AU MacKay, C
   Davies, M
   Summerfield, V
   Maxwell, G
AF MacKay, Cameron
   Davies, Michael
   Summerfield, Vicki
   Maxwell, Gavin
TI From Pathways to People: Applying the Adverse Outcome Pathway (AOP) for
   Skin Sensitization to Risk Assessment
SO ALTEX-ALTERNATIVES TO ANIMAL EXPERIMENTATION
LA English
DT Article
DE adverse outcome pathway; skin sensitization; toxicokinetics;
   toxicodynamics; models
ID ALLERGIC CONTACT-DERMATITIS; CD8(+) T-CELLS; IN-VITRO; PHARMACOKINETIC
   MODELS; DEVELOPMENTAL TOXICITY; XENOBIOTIC METABOLISM; EPIDERMAL
   DISPOSITION; LCMV INFECTION; EFFECTOR; DYNAMICS
AB Consumer safety risk assessment of skin sensitization requires information on both consumer exposure to the ingredient through product use and the hazardous properties of the ingredient. Significant progress has been made in determining the hazard potential of ingredients without animal testing. However, hazard identification is insufficient for risk assessment, and an understanding of the dose-response is needed. Obtaining such knowledge without animal testing is challenging and requires applying available mechanistic knowledge to both assay development and the integration of these data. The recent OECD report "The Adverse Outcome Pathway for Skin Sensitization Initiated by Covalent Binding to Proteins" presents the available mechanistic knowledge of the sensitization response within an adverse outcome pathway (AOP). We propose to use this AOP as the mechanistic basis for physiologically- and mechanistically-based toxicokinetic-toxicodynamic models of the sensitization response. The approach would be informed by non-animal data, provide predictions of the dose-response required for risk assessment, and would be evaluated against human clinical data.
C1 [MacKay, Cameron; Davies, Michael; Summerfield, Vicki; Maxwell, Gavin] Unilever, Safety & Environm Assurance Ctr, Sharnbrook MK44 1LQ, Beds, England.
RP MacKay, C (reprint author), Unilever, Safety & Environm Assurance Ctr, Colworth Sci Pk, Sharnbrook MK44 1LQ, Beds, England.
EM cameron.mackay@unilever.com
CR Adler S, 2011, ARCH TOXICOL, V85, P367, DOI 10.1007/s00204-011-0693-2
   Ahmed R, 2011, IMMUNOL CELL BIOL, V89, P340, DOI 10.1038/icb.2010.155
   Ahmed R, 2009, NAT REV IMMUNOL, V9, P662, DOI 10.1038/nri2619
   Alden K, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002916
   Andersen ME, 2003, TOXICOL LETT, V138, P9, DOI 10.1016/S0378-4274(02)00375-2
   Andrews P. S., 2010, COSMOS PROCESS VERSI, P453
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Antia R, 2003, J THEOR BIOL, V221, P585, DOI 10.1006/jtbi.2003.3208
   Api AM, 2008, REGUL TOXICOL PHARM, V52, P3, DOI 10.1016/j.yrtph.2007.10.008
   Ashauer R, 2011, ENVIRON TOXICOL CHEM, V30, P2519, DOI 10.1002/etc.639
   Asquith B, 2003, P ROY SOC B-BIOL SCI, V270, P1651, DOI 10.1098/rspb.2003.2386
   Asquith B, 2007, IMMUNOL CELL BIOL, V85, P280, DOI 10.1038/sj.icb.7100050
   BASKETTER D, 1995, CONTACT DERMATITIS, V32, P65, DOI 10.1111/j.1600-0536.1995.tb00748.x
   Basketter DA, 2010, COMPREHENSIVE TOXICOLOGY, VOL 5: IMMUNE SYSTEM TOXICOLOGY, 2ND EDITION, P397
   Basketter DA, 2002, FOOD CHEM TOXICOL, V40, P593, DOI 10.1016/S0278-6915(01)00130-2
   Basketter D, 2007, ATLA-ALTERN LAB ANIM, V35, P137, DOI 10.1177/026119290703500124
   Bauch C, 2012, REGUL TOXICOL PHARM, V63, P489, DOI 10.1016/j.yrtph.2012.05.013
   Bauer B, 2011, CHEM RES TOXICOL, V24, P737, DOI 10.1021/tx200030y
   Ben Dror L, 2010, ARTHRITIS RHEUM-US, V62, P420, DOI 10.1002/art.27257
   Bhattacharya S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020887
   Bhattacharya S, 2010, TOXICOL SCI, V115, P51, DOI 10.1093/toxsci/kfq035
   Bocharov G, 2003, J THEOR BIOL, V221, P349, DOI 10.1006/jtbi.2003.3180
   Bocharov GA, 1998, J THEOR BIOL, V192, P283, DOI 10.1006/jtbi.1997.0612
   Bohme A, 2009, CHEM RES TOXICOL, V22, P742, DOI 10.1021/tx800492x
   Bonnist EYM, 2011, SKIN PHARMACOL PHYS, V24, P274, DOI 10.1159/000328729
   Boroujerdi M., 2001, PHARMACOKINETICS PRI
   Butler NS, 2011, CELL MICROBIOL, V13, P925, DOI 10.1111/j.1462-5822.2011.01594.x
   Carreno LJ, 2006, IMMUNOBIOLOGY, V211, P47, DOI 10.1016/j.imbio.2005.09.003
   Chao DL, 2004, J THEOR BIOL, V228, P227, DOI 10.1016/j.jtbi.2003.12.011
   Chipinda I, 2010, CHEM RES TOXICOL, V23, P918, DOI 10.1021/tx100003w
   Christensson JB, 2010, CONTACT DERMATITIS, V62, P32, DOI 10.1111/j.1600-0536.2009.01657.x
   Dancik Y, 2013, ADV DRUG DELIVER REV, V65, P221, DOI 10.1016/j.addr.2012.01.006
   Davies M, 2011, TOXICOL SCI, V119, P308, DOI 10.1093/toxsci/kfq326
   Felter SP, 2003, REGUL TOXICOL PHARM, V37, P1, DOI 10.1016/S0273-2300(02)00021-1
   Felter SP, 2002, CONTACT DERMATITIS, V47, P257, DOI 10.1034/j.1600-0536.2002.470502.x
   Gebreselassie D, 2006, HUM IMMUNOL, V67, P894, DOI 10.1016/j.humimm.2006.08.294
   Gibbs S, 2007, CURR DRUG METAB, V8, P758, DOI 10.2174/138920007782798225
   Gill C, 2011, AAPS J, V13, P309, DOI 10.1208/s12248-011-9269-6
   Gotz C, 2012, EXP DERMATOL, V21, P364, DOI 10.1111/j.1600-0625.2012.01478.x
   Hagvall L, 2008, TOXICOL APPL PHARM, V233, P308, DOI 10.1016/j.taap.2008.08.014
   Herkenne C, 2008, PHARM RES-DORDR, V25, P87, DOI 10.1007/s11095-007-9429-7
   Hickman HD, 2004, J IMMUNOL, V172, P2944, DOI 10.4049/jimmunol.172.5.2944
   Holmgaard R, 2010, SKIN PHARMACOL PHYS, V23, P225, DOI 10.1159/000314698
   Hoof I, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002517
   Ibrahim R, 2012, J PHARM SCI-US, V101, P2094, DOI 10.1002/jps.23106
   Jacques C, 2010, TOXICOL LETT, V199, P22, DOI 10.1016/j.toxlet.2010.08.001
   Jaworska J, 2013, J APPL TOXICOL, V33, P1353, DOI 10.1002/jat.2869
   Jaworska J, 2011, ALTEX-ALTERN ANIM EX, V28, P211, DOI 10.14573/altex.2011.3.211
   Johnson KL, 2009, VACCINE, V28, P38, DOI 10.1016/j.vaccine.2009.09.126
   Jowsey IR, 2006, J APPL TOXICOL, V26, P341, DOI 10.1002/jat.1146
   Judson RS, 2011, CHEM RES TOXICOL, V24, P451, DOI 10.1021/tx100428e
   Kaech SM, 2001, NAT IMMUNOL, V2, P415
   Kaech SM, 2012, NAT REV IMMUNOL, V12, P749, DOI 10.1038/nri3307
   Karlberg AT, 2008, CHEM RES TOXICOL, V21, P53, DOI 10.1021/tx7002239
   Kimber I, 2003, ANN ALLERG ASTHMA IM, V90, P28, DOI 10.1016/S1081-1206(10)61645-6
   Kimber I, 2002, CONTACT DERMATITIS, V46, P1, DOI 10.1034/j.1600-0536.2002.460101.x
   Kimber I, 1999, FOOD CHEM TOXICOL, V37, P553, DOI 10.1016/S0278-6915(99)00048-4
   Kimber I, 2012, TOXICOLOGY, V291, P18, DOI 10.1016/j.tox.2011.11.007
   Kimber I, 2011, TOXICOL SCI, V120, pS238, DOI 10.1093/toxsci/kfq346
   Krewski D, 2010, J TOXICOL ENV HEAL B, V13, P51, DOI 10.1080/10937404.2010.483176
   Landsteiner K, 1938, J EXP MED, V68, P505, DOI 10.1084/jem.68.4.505
   Lau C, 2000, REGUL TOXICOL PHARM, V31, P190, DOI 10.1006/rtph.1999.1360
   Lepoittevin J. P., 2011, ALLERGIC CONTACT DER
   Louisse J, 2010, TOXICOL SCI, V118, P470, DOI 10.1093/toxsci/kfq270
   Magnusson BM, 2004, J INVEST DERMATOL, V122, P993, DOI 10.1111/j.0022-202X.2004.22413.x
   MARTIN S, 1994, INT ARCH ALLERGY IMM, V104, P10, DOI 10.1159/000236703
   Martin S, 2000, J INVEST DERMATOL, V115, P260, DOI 10.1046/j.1523-1747.2000.00038.x
   Maxwell G, 2008, ATLA-ALTERN LAB ANIM, V36, P521, DOI 10.1177/026119290803600510
   McCarley KD, 2001, J PHARM SCI, V90, P1699, DOI 10.1002/jps.1120
   MCLEAN AR, 1995, P NATL ACAD SCI USA, V92, P3707, DOI 10.1073/pnas.92.9.3707
   Mitragotri S, 2003, J CONTROL RELEASE, V86, P69, DOI 10.1016/S0168-3659(02)00321-8
   Mitragotri S, 2011, INT J PHARMACEUT, V418, P115, DOI 10.1016/j.ijpharm.2011.02.023
   Morris GP, 2012, NAT IMMUNOL, V13, P121, DOI 10.1038/ni.2190
   Murray JM, 2003, IMMUNOL CELL BIOL, V81, P487, DOI 10.1046/j.1440-1711.2003.01191.x
   Nedorost S T, 2001, Curr Allergy Asthma Rep, V1, P323, DOI 10.1007/s11882-001-0043-1
   Notman R, 2013, ADV DRUG DELIVER REV, V65, P237, DOI 10.1016/j.addr.2012.02.011
   OECD, 2011, OECD ENV HLTH SAFETY, P1
   [Organisation of Economic Cooperation and Development (OECD) OECD], 2012, OECD GUID TEST CHEM, P1, DOI DOI 10.1787/9789264185203-EN
   Ostrov DA, 2012, P NATL ACAD SCI USA, V109, P9959, DOI 10.1073/pnas.1207934109
   Otto A., 2009, International Journal of Cosmetic Science, V31, P1, DOI 10.1111/j.1468-2494.2008.00467.x
   Pendlington RU, 2008, CUTAN OCUL TOXICOL, V27, P283, DOI 10.1080/15569520802327005
   Perelson AS, 2002, NAT REV IMMUNOL, V2, P28, DOI 10.1038/nri700
   Perelson AS, 1997, REV MOD PHYS, V69, P1219, DOI 10.1103/RevModPhys.69.1219
   Pickard C, 2009, J IMMUNOL, V183, P7576, DOI 10.4049/jimmunol.0901064
   POTTS RO, 1992, PHARMACEUT RES, V9, P663, DOI 10.1023/A:1015810312465
   Reddy MB, 2005, PHYSIOLOGICALLY BASED PHARMACOKINETICS MODELING: SCIENCE AND APPLICATIONS, P1, DOI 10.1002/0471478768
   Rim JE, 2009, ANN BIOMED ENG, V37, P1217, DOI 10.1007/s10439-009-9678-1
   Roberts DW, 2009, CHEM RES TOXICOL, V22, P592, DOI 10.1021/tx800431x
   Rotroff DM, 2010, TOXICOL SCI, V117, P348, DOI 10.1093/toxsci/kfq220
   SHUEY DL, 1995, TOXICOLOGY, V102, P207, DOI 10.1016/0300-483X(95)03049-L
   Simonsson C, 2011, J INVEST DERMATOL, V131, P1486, DOI 10.1038/jid.2010.422
   Singh Gurcharan, 2010, Int J Trichology, V2, P36, DOI 10.4103/0974-7753.66911
   Stone JD, 2009, IMMUNOLOGY, V126, P165, DOI 10.1111/j.1365-2567.2008.03015.x
   Thompson CM, 2008, J TOXICOL ENV HEAL B, V11, P519, DOI 10.1080/10937400701724337
   Tridane A, 2010, MATH BIOSCI ENG, V7, P171, DOI 10.3934/mbe.2010.7.171
   USEPA, 2005, EPA630P03001F
   van Eijl S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041721
   Vita R, 2010, NUCLEIC ACIDS RES, V38, pD854, DOI 10.1093/nar/gkp1004
   Vrisekoop N, 2008, P NATL ACAD SCI USA, V105, P6115, DOI 10.1073/pnas.0709713105
   Wang BH, 2000, J IMMUNOL, V165, P6783, DOI 10.4049/jimmunol.165.12.6783
   Wang CY, 2011, CUTAN OCUL TOXICOL, V30, P1, DOI 10.3109/15569527.2010.517230
   Wang TF, 2006, J PHARM SCI-US, V95, P620, DOI 10.1002/jps.20509
   Watanabe KH, 2011, ENVIRON TOXICOL CHEM, V30, P9, DOI 10.1002/etc.373
   Welling P. G, 1997, PHARMACOKINETICS PRO
   Weltzien HU, 1996, TOXICOLOGY, V107, P141, DOI 10.1016/0300-483X(95)03253-C
   Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889
   White JML, 2012, CLIN EXP ALLERGY, V42, P180, DOI 10.1111/j.1365-2222.2011.03862.x
   WODARZ D, 2006, INTERDISCIPLINARY AP
   Xu H, 1996, J EXP MED, V183, P1001, DOI 10.1084/jem.183.3.1001
   Yoon H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015423
   Yoon M, 2012, CRIT REV TOXICOL, V42, P633, DOI 10.3109/10408444.2012.692115
   Zalko D, 2011, CHEMOSPHERE, V82, P424, DOI 10.1016/j.chemosphere.2010.09.058
NR 112
TC 54
Z9 55
U1 0
U2 11
PU SPEKTRUM AKADEMISCHER VERLAG-SPRINGER-VERLAG GMBH
PI HEILDEBERG
PA TIERGARTENSTRASSE 17, HEILDEBERG, 69121, GERMANY
SN 1868-596X
EI 1868-8551
J9 ALTEX-ALTERN ANIM EX
JI ALTEX-Altern. Anim. Exp.
PY 2013
VL 30
IS 4
BP 473
EP 486
DI 10.14573/altex.2013.4.473
PG 14
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA 264TE
UT WOS:000327903100005
PM 24173169
OA DOAJ Gold
DA 2019-10-23
ER

PT S
AU Przybylak, KR
   Schultz, TW
AF Przybylak, K. R.
   Schultz, T. W.
BA Cronin, MTD
   Madden, JC
   Enoch, SJ
   Roberts, DW
BF Cronin, MTD
   Madden, JC
   Enoch, SJ
   Roberts, DW
TI Informing Chemical Categories through the Development of Adverse Outcome
   Pathways
SO CHEMICAL TOXICITY PREDICTION: CATEGORY FORMATION AND READ-ACROSS
SE Issues in Toxicology
LA English
DT Article; Book Chapter
ID HISTONE DEACETYLASE; CONCEPTUAL-FRAMEWORK; VALPROIC ACID; CONVERGENT
   EXTENSION; XENOPUS EMBRYOS; BETA-CATENIN; TOXICITY; IDENTIFICATION; MODE
C1 [Przybylak, K. R.] Liverpool John Moores Univ, Sch Pharm & Chem, Liverpool L3 3AF, Merseyside, England.
   [Schultz, T. W.] Univ Tennessee, Coll Vet Med, Knoxville, TN 37996 USA.
RP Przybylak, KR (reprint author), Liverpool John Moores Univ, Sch Pharm & Chem, Byrom St, Liverpool L3 3AF, Merseyside, England.
EM k.r.przybylak@ljmu.ac.uk
CR Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Behrens J., 2003, WNT SIGNALING DEV, P1
   Brown N. A., 1987, APPROACHES ELUCIDATE, P17
   Ciossek T, 2008, ANAL BIOCHEM, V372, P72, DOI 10.1016/j.ab.2007.07.024
   CLEWELL HJ, 1995, CHEMOSPHERE, V31, P2561, DOI 10.1016/0045-6535(95)00124-Q
   Dawson DA, 1996, TERATOGEN CARCIN MUT, V16, P109, DOI 10.1002/(SICI)1520-6866(1996)16:2<109::AID-TCM5>3.0.CO;2-M
   DICARLO FJ, 1990, DRUG METAB REV, V22, P411, DOI 10.3109/03602539008991446
   Enoch SJ, 2011, CRIT REV TOXICOL, V41, P783, DOI 10.3109/10408444.2011.598141
   Finnell RH, 2002, ANNU REV PHARMACOL, V42, P181, DOI 10.1146/annurev.pharmtox.42.083001.110955
   Fuller LC, 2002, REPROD TOXICOL, V16, P825, DOI 10.1016/S0890-6238(02)00059-X
   Heltweg B, 2005, METHODS, V36, P332, DOI 10.1016/j.ymeth.2005.03.003
   HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503
   Hooyberghs J, 2008, TOXICOL APPL PHARM, V231, P103, DOI 10.1016/j.taap.2008.03.014
   International Programme on Chemical Safety (IPCS), 2008, MOD ACT FRAM
   Keller DA, 2012, TOXICOL SCI, V126, P291, DOI 10.1093/toxsci/kfr350
   Khan N, 2008, BIOCHEM J, V409, P581, DOI 10.1042/BJ20070779
   Kliecker C., 2001, DEVELOPMENT, V128, P4189
   Mehnert JM, 2007, CANCER J, V13, P23, DOI 10.1097/PPO.0b013e31803c72ba
   NAROTSKY MG, 1994, FUND APPL TOXICOL, V22, P251, DOI 10.1006/faat.1994.1029
   NARUSE I, 1988, TERATOLOGY, V38, P87, DOI 10.1002/tera.1420380113
   NRC (National Research Council), 2007, TOX TEST 21 CENT VIS
   OECD, 2012, OECD ENV HLTH SAF PU, P10
   OECD, 2012, PROP TEMPL GUID DEV
   Phiel CJ, 2001, J BIOL CHEM, V276, P36734, DOI 10.1074/jbc.M101287200
   ROBERT E, 1982, LANCET, V2, P937
   ROBERT E, 1983, LANCET, V2, P1142
   Sakuratani Y, 2013, SAR QSAR ENVIRON RES, V24, P35, DOI 10.1080/1062936X.2012.728995
   Schultz T. W., 2005, SILICO TOXICOLOGY PR, P346
   Schultz T. W., 2011, ALT TEST STRAT PROGR, P288
   SHUEY DL, 1995, TOXICOLOGY, V102, P207, DOI 10.1016/0300-483X(95)03049-L
   Sonich-Mullin C, 2001, REGUL TOXICOL PHARM, V34, P146, DOI 10.1006/rtph.2001.1493
   The Organisation for Economic Co-operation and Development (OECD), 2011, PROV KNOWL INF HAZ A
   The Organisation for Economic Co-operation and Development (OECD), 2011, OECD ENV HLTH SAF PU, V138
   The Organisation for Economic Co-operation and Development (OECD), 2012, OECD ENV HLTH SAF PU, V169
   Tsakovska I, 2011, ADV PROTEIN CHEM STR, V85, P217, DOI 10.1016/B978-0-12-386485-7.00006-5
   Volz DC, 2011, TOXICOL SCI, V123, P349, DOI 10.1093/toxsci/kfr185
   Wallingford JB, 2002, DEVELOPMENT, V129, P5815, DOI 10.1242/dev.00123
   Wang JB, 2006, DEVELOPMENT, V133, P1767, DOI 10.1242/dev.02347
   Watanabe KH, 2011, ENVIRON TOXICOL CHEM, V30, P9, DOI 10.1002/etc.373
   Wiltse J, 2005, CRIT REV TOXICOL, V35, P727, DOI 10.1080/10408440591007403
   Yost C, 1996, GENE DEV, V10, P1443, DOI 10.1101/gad.10.12.1443
   Yozzo KL, 2013, AQUAT TOXICOL, V126, P346, DOI 10.1016/j.aquatox.2012.09.008
NR 42
TC 5
Z9 5
U1 0
U2 3
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, CAMBRIDGE CB4 4WF, CAMBS, ENGLAND
SN 1757-7179
BN 978-1-84973-440-0; 978-1-84973-384-7
J9 ISSUES TOXICOL
PY 2013
VL 17
BP 44
EP 71
DI 10.1039/9781849734400-00044
D2 10.1039/9781849734400
PG 28
WC Toxicology
SC Toxicology
GA BHT71
UT WOS:000326643400004
DA 2019-10-23
ER

PT J
AU Jacobs, MN
   Laws, SC
   Willett, K
   Schmieder, P
   Odum, J
   Bovee, TF
AF Jacobs, Miriam N.
   Laws, Susan C.
   Willett, Kate
   Schmieder, Pat
   Odum, Jenny
   Bovee, Toine F.
TI In Vitro Metabolism and Bioavailability Tests for Endocrine Active
   Substances: What is Needed Next for Regulatory Purposes?
SO ALTEX-ALTERNATIVES TO ANIMAL EXPERIMENTATION
LA English
DT Article
DE regulatory testing; metabolism; endocrine active substances; alternative
   methods
ID ESTROGEN-RECEPTOR-ALPHA; E-SCREEN ASSAY; ENGINEERED CELL-LINES;
   GENE-EXPRESSION; RISK-ASSESSMENT; RAINBOW-TROUT; BISPHENOL-A;
   LIVER-MICROSOMES; DIGESTION MODEL; CHEMICALS
AB Legislation and prospective legislative proposals internationally (may) require that chemicals be tested for their ability to disrupt the hormonal systems of mammals. Chemicals found to test positive in vitro are considered to be endocrine active substances (EAS) and may be putative endocrine disruptors (EDs) in vivo. While there is a growing body of international in vitro test guidelines addressing EAS mechanisms and modes of action, to date there are still few or no standardized methods to incorporate metabolic and toxicokinetic aspects into these in vitro tests for EAS. In vitro assays for EAS should incorporate metabolic enzyme systems to better address the relevance of EAS tests to in vivo adverse outcome pathways, and a previous OECD review paper indicated how this could be done. This paper revisits those recommendations, addressing where research and funding efforts are needed to expedite the development of suitable in vitro metabolism systems to improve the accuracy of in vitro assays for identifying EAS and EDs. Recommendations are made for projects to support short, medium, and long-term goals. The complexity of in vivo metabolism presents major challenges for the development of predictive models suitable for the extrapolation of data from in silico/in vitro approaches to models that can occur in vivo. Therefore, the long-term recommendations are intended to foster an international harmonization of databases, delineation of metabolic pathways, and development of predictive tools that will provide a fundamental understanding of the processes by which metabolism occurs, increasing the predictive accuracy of in silico/in vitro methods.
C1 [Jacobs, Miriam N.] European Food Safety Author, Sci Comm & Emerging Risks Unit, I-43126 Parma, Italy.
   [Laws, Susan C.] US EPA, Natl Hlth & Environm Effects Res Lab, Tox Assessment Div, Endocrinol Branch MD 72, Res Triangle Pk, NC 27711 USA.
   [Willett, Kate] Humane Soc United States, Washington, DC USA.
   [Schmieder, Pat] US EPA, Natl Hlth & Environm Effects Res Lab, Midcontinent Ecol Div, Duluth, MN USA.
   [Odum, Jenny] Regulatory Sci Associates, Dunoon, Argyll, Scotland.
   [Bovee, Toine F.] Univ Wageningen & Res Ctr, RIKILT Inst Food Safety, Wageningen, Netherlands.
RP Jacobs, MN (reprint author), European Food Safety Author, Sci Comm & Emerging Risks Unit, Via Carlo Magno 1-A, I-43126 Parma, Italy.
EM Miriam.JACOBS@efsa.europa.eu
CR Akahori Y, 2005, SAR QSAR ENVIRON RES, V16, P323, DOI 10.1080/10659360500204442
   Andersen ME, 2003, TOXICOL LETT, V138, P9, DOI 10.1016/S0378-4274(02)00375-2
   [Anonymous], 1996, EUR WORKSH IMP END D
   Benet LZ, 2001, ADV DRUG DELIVER REV, V50, pS3, DOI 10.1016/S0169-409X(01)00178-8
   Bergman A., 2013, STAT SCI END DISR CH
   Bernauer U, 2002, IARC Sci Publ, V156, P487
   Bernauer U, 1999, ARCH TOXICOL, V73, P189, DOI 10.1007/s002040050605
   Bernauer U, 2003, REGUL TOXICOL PHARM, V37, P318, DOI 10.1016/S0273-2300(03)00012-6
   Bernauer U, 2000, ARCH TOXICOL, V73, P618, DOI 10.1007/s002040050016
   Bitsch N, 2002, ARCH ENVIRON CON TOX, V43, P257, DOI 10.1007/s00244-002-1192-5
   Bovee TFH, 2009, J CHROMATOGR A, V1216, P8035, DOI 10.1016/j.chroma.2009.03.045
   Bovee TFH, 2006, FOOD ADDIT CONTAM, V23, P556, DOI 10.1080/02652030600557163
   Bovee TFH, 2008, J STEROID BIOCHEM, V108, P121, DOI 10.1016/j.jsbmb.2007.05.035
   Bovee TFH, 2008, ANAL BIOANAL CHEM, V390, P1111, DOI 10.1007/s00216-007-1772-3
   Bovee TFH, 2010, J STEROID BIOCHEM, V118, P85, DOI 10.1016/j.jsbmb.2009.10.007
   Bull S, 2001, ATLA-ALTERN LAB ANIM, V29, P703, DOI 10.1177/026119290102900601
   Carlson DL, 2005, ENVIRON SCI TECHNOL, V39, P7389, DOI 10.1021/es048023r
   Chalbot S, 2005, DRUG METAB DISPOS, V33, P563, DOI 10.1124/dmd.104.003004
   Clewell RA, 2008, REGUL TOXICOL PHARM, V50, P129, DOI 10.1016/j.yrtph.2007.10.012
   Coecke S, 2006, ATLA-ALTERN LAB ANIM, V34, P49, DOI 10.1177/026119290603400113
   Coecke S, 2002, ATLA-ALTERN LAB ANIM, V30, P115, DOI 10.1177/026119290203002S18
   Coldham NG, 2002, FOOD ADDIT CONTAM, V19, P1138, DOI 10.1080/0265203021000014789
   Cunat S, 2005, J STEROID BIOCHEM, V93, P15, DOI 10.1016/j.jsbmb.2004.10.021
   Dang ZC, 2011, TOXICOL LETT, V201, P152, DOI 10.1016/j.toxlet.2010.12.020
   DAVIES DS, 1974, BRIT J CLIN PHARMACO, V1, P129, DOI 10.1111/j.1365-2125.1974.tb00221.x
   de Graaf IAM, 2007, CRYOBIOLOGY, V54, P1, DOI 10.1016/j.cryobiol.2006.09.002
   De Rijke E., FOOD ADDIT IN PRESS
   DEFLORA S, 1982, TOXICOL LETT, V10, P345, DOI 10.1016/0378-4274(82)90228-4
   DENOBEL JG, 1991, YEAST, V7, P313, DOI 10.1002/yea.320070402
   Desdoits-Lethimonier C, 2012, HUM REPROD, V27, P1451, DOI 10.1093/humrep/des069
   Escher BI, 2011, CHEM RES TOXICOL, V24, P1134, DOI 10.1021/tx200114y
   Gomez CF, 2011, B ENVIRON CONTAM TOX, V86, P247, DOI 10.1007/s00128-011-0200-8
   Graham MJ, 2008, TOXICOLOGY, V254, P184, DOI 10.1016/j.tox.2008.09.002
   Greally J., 2013, ALTEX
   Gregory PA, 2004, TOXICOL APPL PHARM, V199, P354, DOI 10.1016/j.taap.2004.01.008
   Gutendorf B, 2001, TOXICOLOGY, V166, P79, DOI 10.1016/S0300-483X(01)00437-1
   Gutleb AC, 2005, ENVIRON TOXICOL PHAR, V19, P231, DOI 10.1016/j.etap.2004.06.003
   Han X, 2009, ENVIRON TOXICOL CHEM, V28, P481, DOI 10.1897/08-269.1
   Harimoto M, 2002, J BIOMED MATER RES, V62, P464, DOI 10.1002/jbm.10228
   Hecker M, 2007, ENVIRON SCI POLLUT R, V14, P23, DOI 10.1065/espr2007.03.402
   Heringa MB, 2004, ENVIRON SCI TECHNOL, V38, P6263, DOI 10.1021/es049285w
   Hoogenboom LAP, 2002, ENVIRON TOXICOL PHAR, V11, P273, DOI 10.1016/S1382-6689(02)00013-3
   Hoogenboom LAP, 2001, APMIS, V109, P101, DOI 10.1034/j.1600-0463.2001.d01-110.x
   ICCVAM, 2003, NIH PUBLICATION
   Jacobs MN, 2008, CURR DRUG METAB, V9, P796, DOI 10.2174/138920008786049294
   Jacobs MN, 2002, ENVIRON SCI TECHNOL, V36, P2797, DOI 10.1021/es011287i
   Johanning K., 2012, CURR PROT
   Kawai S, 2003, PURE APPL CHEM, V75, P2335, DOI 10.1351/pac200375112335
   Kolanczyk RC, 2012, REGUL TOXICOL PHARM, V63, P84, DOI 10.1016/j.yrtph.2012.02.013
   Krul C, 2000, FOOD CHEM TOXICOL, V38, P783, DOI 10.1016/S0278-6915(00)00071-5
   Kuuranne T, 2008, DRUG METAB DISPOS, V36, P571, DOI 10.1124/dmd.107.017954
   Lachmann A, 2010, BIOINFORMATICS, V26, P2438, DOI 10.1093/bioinformatics/btq466
   Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939
   Laws SC, 2000, TOXICOL SCI, V54, P154, DOI 10.1093/toxsci/54.1.154
   Lewis DFV, 1996, CYTOCHROMES P450 STR
   Li J, 2011, BIOMED ENVIRON SCI, V24, P132, DOI 10.3967/0895-3988.2011.02.007
   Matthews JB, 2001, CHEM RES TOXICOL, V14, P149, DOI 10.1021/tx0001833
   Mekenyan OG, 2004, CURR PHARM DESIGN, V10, P1273, DOI 10.2174/1381612043452596
   Mitea C, 2008, GUT, V57, P25, DOI 10.1136/gut.2006.111609
   Morohoshi K, 2005, TOXICOL IN VITRO, V19, P457, DOI 10.1016/j.tiv.2005.01.004
   NAS National Academy of Sciences, 2007, TOX TEST 21 CENT VIS
   Ochsner SA, 2009, CANCER RES, V69, P23, DOI 10.1158/0008-5472.CAN-08-3492
   OECD, 2008, OECD SER TEST ASS, V97
   OECD, 2010, OECD SER TEST ASS, V135
   OECD, 2009, SER TEST ASS, V111, P33
   OECD, 2005, SER TEST ASS
   OECD, 2001, OECD GUID TEST CHEM
   OECD, 2012, OECD GUID TEST CHEM
   OECD, 2006, OECD SER TEST ASS, V57
   OECD, 2011, OECD GUID TEST CHEM
   OECD, 1996, OECD GUID TEST CHEM
   OECD, 2012, OECD GUID TEST CHEM
   OECD (Organisation for Economic Co-operation and Development), 2012, SER TEST ASS, V150, P22
   OECD (Organisation for Economic Co-operation and Development), 2012, SER TEST ASS, V178
   Oomen AG, 2003, ARCH ENVIRON CON TOX, V44, P281, DOI 10.1007/s00244-002-1278-0
   Pagliara P., 2003, COMP HEPATOL, V2, P8
   Peyret T, 2010, TOXICOL APPL PHARM, V249, P197, DOI 10.1016/j.taap.2010.09.010
   Plant N, 2004, DRUG DISCOV TODAY, V9, P328, DOI 10.1016/S1359-6446(03)03019-8
   Prins GS, 2011, REPROD TOXICOL, V31, P1, DOI 10.1016/j.reprotox.2010.09.009
   Punt A, 2011, REGUL TOXICOL PHARM, V61, P105, DOI 10.1016/j.yrtph.2011.06.007
   Rasmussen TH, 2002, BIOMARKERS, V7, P322, DOI 10.1080/13547500210132907
   Rasmussen Thomas Hoj, 2003, Environ Health, V2, P12, DOI 10.1186/1476-069X-2-12
   Rider CV, 2010, INT J ANDROL, V33, P443, DOI 10.1111/j.1365-2605.2009.01049.x
   Rijk JCW, 2008, ANAL BIOANAL CHEM, V392, P417, DOI 10.1007/s00216-008-2275-6
   Rijk JCW, 2012, TOXICOL IN VITRO, V26, P1014, DOI 10.1016/j.tiv.2012.04.012
   Roy P, 1999, DRUG METAB DISPOS, V27, P655
   SCHERRER R, 1974, J BACTERIOL, V118, P534
   Schmieder PK, 2004, ENVIRON SCI TECHNOL, V38, P6333, DOI 10.1021/es0495314
   Setchell KDR, 2010, J NUTR, V140, p1363S, DOI 10.3945/jn.109.119784
   SOTO AM, 1995, ENVIRON HEALTH PERSP, V103, P113, DOI 10.1289/ehp.95103s7113
   Sung E, 2012, INT J ANDROL, V35, P407, DOI 10.1111/j.1365-2605.2012.01254.x
   Swart JC, 2009, J IMMUNOASS IMMUNOCH, V30, P150, DOI 10.1080/15321810902782855
   Swedenborg E, 2009, J MOL ENDOCRINOL, V43, P1, DOI 10.1677/JME-08-0132
   Tan KAL, 2006, HUM REPROD, V21, P896, DOI 10.1093/humrep/dei421
   Taxvig C, 2011, TOXICOL APPL PHARM, V250, P263, DOI 10.1016/j.taap.2010.10.029
   TEGNER K, 1984, EUR J RESPIR DIS, V65, P93
   Thummel KE, 1997, ADV DRUG DELIVER REV, V27, P99, DOI 10.1016/S0169-409X(97)00039-2
   Tyl RW, 2002, TOXICOL SCI, V68, P121, DOI 10.1093/toxsci/68.1.121
   US Environmental Protection Agency, 2009, END DISR SCREEN PROG
   US EPA FIFRA SAP, 2013, M REP FED INS FUNG R
   US EPA FIFRA SAP, 2009, EFF BAS EXP SYST PRE
   Valerio Luis G Jr, 2010, Curr Drug Discov Technol, V7, P170
   van de Kerkhof EG, 2006, DRUG METAB DISPOS, V34, P1893, DOI 10.1124/dmd.106.011148
   van den Berg M, 2003, PURE APPL CHEM, V75, P1917, DOI 10.1351/pac200375111917
   van der Burg B, 2010, REPROD TOXICOL, V30, P73, DOI 10.1016/j.reprotox.2010.04.007
   VANDERREST ME, 1995, MICROBIOL REV, V59, P304
   Versantvoort CHM, 2005, FOOD CHEM TOXICOL, V43, P31, DOI 10.1016/j.fct.2004.08.007
   Verwei M, 2005, EUR J NUTR, V44, P242, DOI 10.1007/s00394-004-0516-9
   VILLALOBOS M, 1995, ENVIRON HEALTH PERSP, V103, P844, DOI 10.2307/3432398
   Volotinen M, 2007, DRUG METAB DISPOS, V35, P1135, DOI 10.1124/dmd.106.012906
   Wagner J, 2008, ADV EXP MED BIOL, V617, P625, DOI 10.1007/978-0-387-69080-3_65
   Wagner M, 2011, J STEROID BIOCHEM, V127, P128, DOI 10.1016/j.jsbmb.2010.10.007
   Wang S, 2012, J STEROID BIOCHEM, V128, P98, DOI 10.1016/j.jsbmb.2011.11.009
   Waring RH, 2012, INT J ANDROL, V35, P415, DOI 10.1111/j.1365-2605.2012.01248.x
   Weiss TS, 2002, CELL PROLIFERAT, V35, P257, DOI 10.1046/j.1365-2184.2002.00248.x
   Westerink WMA, 2007, TOXICOL IN VITRO, V21, P1592, DOI 10.1016/j.tiv.2007.06.017
   WHO, 2002, WHOPCSEDC022
   Wiebel FJ, 1997, ATLA-ALTERN LAB ANIM, V25, P625
   Wilson VS, 2004, ENVIRON SCI TECHNOL, V38, P6314, DOI 10.1021/es049771j
   Ye XY, 2011, ANAL BIOANAL CHEM, V399, P1071, DOI 10.1007/s00216-010-4344-x
NR 120
TC 18
Z9 18
U1 0
U2 4
PU SPEKTRUM AKADEMISCHER VERLAG-SPRINGER-VERLAG GMBH
PI HEILDEBERG
PA TIERGARTENSTRASSE 17, HEILDEBERG, 69121, GERMANY
SN 1868-596X
EI 1868-8551
J9 ALTEX-ALTERN ANIM EX
JI ALTEX-Altern. Anim. Exp.
PY 2013
VL 30
IS 3
BP 331
EP 351
DI 10.14573/altex.2013.3.331
PG 21
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA 197OR
UT WOS:000322861000006
PM 23861078
OA DOAJ Gold
DA 2019-10-23
ER

PT J
AU Cronin, MTD
   Enoch, SJ
   Nelms, MD
   Madden, JC
   Richarz, AN
   Yang, C
AF Cronin, M. T. D.
   Enoch, S. J.
   Nelms, M. D.
   Madden, J. C.
   Richarz, A-N
   Yang, C.
TI Linking Chemical Categories to Adverse Outcome Pathways for Chronic
   Toxicity
SO INTERNATIONAL JOURNAL OF TOXICOLOGY
LA English
DT Meeting Abstract
CT 33rd Annual Meeting of the American-College-of-Toxicology
CY NOV 04-07, 2012
CL FL
SP Amer Coll Toxicol
C1 [Cronin, M. T. D.; Enoch, S. J.; Nelms, M. D.; Madden, J. C.; Richarz, A-N] Liverpool John Moores Univ, Liverpool L3 5UX, Merseyside, England.
   [Yang, C.] Altamira LLC, Columbus, OH USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1091-5818
J9 INT J TOXICOL
JI Int. J. Toxicol.
PD JAN-FEB
PY 2013
VL 32
IS 1
BP 65
EP 65
PG 1
WC Pharmacology & Pharmacy; Toxicology
SC Pharmacology & Pharmacy; Toxicology
GA 085BW
UT WOS:000314586700028
DA 2019-10-23
ER

PT J
AU Richarz, AN
   Berthold, MR
   Fioravanzo, E
   Neagu, D
   Yang, C
   Zaldivar-Comenges, JM
   Cronin, MTD
AF Richarz, A-N.
   Berthold, M. R.
   Fioravanzo, E.
   Neagu, D.
   Yang, C.
   Zaldivar-Comenges, J-M.
   Cronin, M. T. D.
TI Integrated In Silico Modeling for the Prediction of Chronic Toxicity
SO INTERNATIONAL JOURNAL OF TOXICOLOGY
LA English
DT Meeting Abstract
CT 33rd Annual Meeting of the American-College-of-Toxicology
CY NOV 04-07, 2012
CL FL
SP Amer Coll Toxicol
C1 [Richarz, A-N.; Cronin, M. T. D.] Liverpool John Moores Univ, Liverpool L3 5UX, Merseyside, England.
   [Neagu, D.] Univ Bradford, Bradford BD7 1DP, W Yorkshire, England.
   [Yang, C.] Altamira LLC, Columbus, OH USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1091-5818
J9 INT J TOXICOL
JI Int. J. Toxicol.
PD JAN-FEB
PY 2013
VL 32
IS 1
BP 72
EP 73
PG 2
WC Pharmacology & Pharmacy; Toxicology
SC Pharmacology & Pharmacy; Toxicology
GA 085BW
UT WOS:000314586700048
DA 2019-10-23
ER

PT J
AU Jennings, P
AF Jennings, Paul
TI Stress response pathways, toxicity pathways and adverse outcome pathways
SO ARCHIVES OF TOXICOLOGY
LA English
DT Editorial Material
ID NRF2
C1 Innsbruck Med Univ, Div Physiol, Dept Physiol & Med Phys, A-6020 Innsbruck, Austria.
RP Jennings, P (reprint author), Innsbruck Med Univ, Div Physiol, Dept Physiol & Med Phys, Fritz Pregl Str 3-1, A-6020 Innsbruck, Austria.
EM paul.jennings@i-med.ac.at
RI Jennings, Paul/A-8670-2010
OI Jennings, Paul/0000-0002-6860-2898
CR Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Crunkhorn S, 2012, NAT REV DRUG DISCOV, V11, P96, DOI 10.1038/nrd3655
   Enomoto A, 2001, TOXICOL SCI, V59, P169, DOI 10.1093/toxsci/59.1.169
   Jennings P, 2013, ARCH TOXICOL, V87, P49, DOI 10.1007/s00204-012-0919-y
   Krewski D, 2010, J TOXICOL ENV HEAL B, V13, P51, DOI 10.1080/10937404.2010.483176
   NRC (National Research Council), 2007, TOX TEST 21 CENT VIS
   Sporn MB, 2012, NAT REV CANCER, V12, P564, DOI 10.1038/nrc3278
   Stegh AH, 2012, EXPERT OPIN THER TAR, V16, P67, DOI 10.1517/14728222.2011.643299
NR 8
TC 27
Z9 27
U1 0
U2 29
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0340-5761
J9 ARCH TOXICOL
JI Arch. Toxicol.
PD JAN
PY 2013
VL 87
IS 1
BP 13
EP 14
DI 10.1007/s00204-012-0974-4
PG 2
WC Toxicology
SC Toxicology
GA 063RQ
UT WOS:000313018000005
PM 23149676
OA Bronze
DA 2019-10-23
ER

PT J
AU Sakuratani, Y
   Zhang, HQ
   Nishikawa, S
   Yamazaki, K
   Yamada, T
   Yamada, J
   Hayashi, M
AF Sakuratani, Y.
   Zhang, H. Q.
   Nishikawa, S.
   Yamazaki, K.
   Yamada, T.
   Yamada, J.
   Hayashi, M.
TI Categorization of nitrobenzenes for repeated dose toxicity based on
   adverse outcome pathways
SO SAR AND QSAR IN ENVIRONMENTAL RESEARCH
LA English
DT Article
DE repeated dose toxicity; nitrobenzene; category approach; read across;
   adverse outcome pathway
ID BINDING; RATS
AB Adoption of the data-gap filling method for complex endpoints such as repeated dose toxicity (RDT) and reproductive/developmental toxicity is one of the most important issues affecting international chemical management at present. A categorization method based on adverse outcome pathways (AOPs) has recently been investigated for such complex endpoints. In this paper, we report results of the categorization of nitrobenzenes for RDT based on the AOPs obtained by analysing the detailed RDT test reports for 24 different nitrobenzenes already evaluated. In most RDT testing of nitrobenzenes without hydroxyl groups or acid groups, findings related to haemolytic anaemia and liver effects were observed at low dosages. It was, therefore, possible to assume common AOPs for haemolytic anaemia and liver effects induced by these nitrobenzenes. As a result, a group of nitrobenzenes was defined as a single category for both haemolytic anaemia and liver effects, respectively, based on these AOPs.
C1 [Sakuratani, Y.; Zhang, H. Q.; Nishikawa, S.; Yamazaki, K.; Yamada, T.; Yamada, J.] Natl Inst Technol & Evaluat, Chem Management Ctr, Tokyo, Japan.
   [Hayashi, M.] Biosafety Res Ctr, Iwata, Japan.
RP Sakuratani, Y (reprint author), Natl Inst Technol & Evaluat, Chem Management Ctr, Tokyo, Japan.
EM sakuratani-yuki@nite.go.jp
FU New Energy and Industrial Technology Development Organization (NEDO)New
   Energy and Industrial Technology Development Organization (NEDO);
   Ministry of Economy, Trade and Industry (METI)
FX This work was supported by a New Energy and Industrial Technology
   Development Organization (NEDO) and Ministry of Economy, Trade and
   Industry (METI) grant for the "Development of Hazard Assessment
   Technology Using Structure-activity Methods".
CR Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   [Anonymous], COMB REP DOS REPR DE
   [Anonymous], SHORT TERM STUD
   [Anonymous], LONG TERM STUD
   BRADSHAW TP, 1995, FREE RADICAL BIO MED, V18, P279, DOI 10.1016/0891-5849(94)E0136-7
   ECHA, 2008, GUID INF REQ CHEM SA
   FACCHINI V, 1981, BIOCHEM PHARMACOL, V30, P931, DOI 10.1016/0006-2952(81)90036-8
   FRENCH CL, 1995, J APPL TOXICOL, V15, P167, DOI 10.1002/jat.2550150306
   Hayashi M., 2011, NEW HORIZONS TOXICIT, P26
   Hayashi M., 2011, WORKSH US MECH INF F, V138, P140
   Kiese M., 1974, METHEMOGLOBINEMIA CO
   Mitsumori Kunitoshi, 1994, Journal of Toxicological Sciences, V19, P141
   OBRIEN PJ, 1990, XENOBIOTICA, V20, P945, DOI 10.3109/00498259009046910
   OECD, 2011, OECD ENV HLTH SAF PU
   OECD, 2007, OECD ENV HLTH SAF PU
   OECD [Organisation for Economic Cooperation and Development], 2009, OECD ENV HLTH SAF PU
   Organization for Economic Co-operation and Development (OECD), OECD QSAR TOOLB VERS
   Organization for Economic Co-operation and Development (OECD), 2010, OECD ENV Q SAR APPL
   Patlewicz G, 2011, SAR QSAR ENVIRON RES, V22, P67, DOI 10.1080/1062936X.2010.528448
   RICKERT DE, 1984, CHEM-BIOL INTERACT, V52, P131, DOI 10.1016/0009-2797(84)90067-X
   SABBIONI G, 1994, CHEM RES TOXICOL, V7, P267, DOI 10.1021/tx00038a021
   Sakuratani Y, 2008, SAR QSAR ENVIRON RES, V19, P681, DOI 10.1080/10629360802550689
   Schultz T.W., 2010, IN SILICO TOXICOLOGY, P67
   SHEETZ MP, 1976, J CELL BIOL, V70, P247, DOI 10.1083/jcb.70.1.247
   Shimo T, 1994, Eisei Shikenjo Hokoku, P71
   van Leeuwen K, 2009, SAR QSAR ENVIRON RES, V20, P207, DOI 10.1080/10629360902949179
NR 26
TC 7
Z9 7
U1 0
U2 9
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1062-936X
EI 1029-046X
J9 SAR QSAR ENVIRON RES
JI SAR QSAR Environ. Res.
PD JAN 1
PY 2013
VL 24
IS 1
BP 35
EP 46
DI 10.1080/1062936X.2012.728995
PG 12
WC Chemistry, Multidisciplinary; Computer Science, Interdisciplinary
   Applications; Environmental Sciences; Mathematical & Computational
   Biology; Toxicology
SC Chemistry; Computer Science; Environmental Sciences & Ecology;
   Mathematical & Computational Biology; Toxicology
GA 054IV
UT WOS:000312338100003
PM 23039897
DA 2019-10-23
ER

PT B
AU Fowler, BA
AF Fowler, Bruce A.
BE Fowler, BA
TI COMPUTATIONAL TOXICOLOGY METHODS AND APPLICATIONS FOR RISK ASSESSMENT
   Introduction
SO COMPUTATIONAL TOXICOLOGY: METHODS AND APPLICATIONS FOR RISK ASSESSMENT
LA English
DT Editorial Material; Book Chapter
C1 ICF Int, Fairfax, VA USA.
RP Fowler, BA (reprint author), ICF Int, Fairfax, VA USA.
NR 0
TC 3
Z9 3
U1 0
U2 1
PU ELSEVIER ACADEMIC PRESS INC
PI SAN DIEGO
PA 525 B STREET, SUITE 1900, SAN DIEGO, CA 92101-4495 USA
BN 978-0-12-396508-0
PY 2013
BP 1
EP 4
PG 4
WC Mathematical & Computational Biology; Toxicology
SC Mathematical & Computational Biology; Toxicology
GA BFR29
UT WOS:000321041500002
DA 2019-10-23
ER

PT J
AU Hooper, MJ
   Ankley, GT
   Cristol, DA
   Maryoung, LA
   Noyes, PD
   Pinkerton, KE
AF Hooper, Michael J.
   Ankley, Gerald T.
   Cristol, Daniel A.
   Maryoung, Lindley A.
   Noyes, Pamela D.
   Pinkerton, Kent E.
TI Interactions between chemical and climate stressors: A role for
   mechanistic toxicology in assessing climate change risks
SO ENVIRONMENTAL TOXICOLOGY AND CHEMISTRY
LA English
DT Review
DE Adverse outcome pathway; Acclimation; Weather
ID BEARS URSUS-MARITIMUS; TROUT ONCORHYNCHUS-MYKISS; POLYCYCLIC
   AROMATIC-HYDROCARBONS; BROMINATED FLAME RETARDANTS; ADVERSE OUTCOME
   PATHWAYS; FEMALE POLAR BEARS; OC EXPOSURE IMPAIR; THYROID-HORMONE;
   AMPHIBIAN METAMORPHOSIS; ENDOCRINE DISRUPTION
AB Incorporation of global climate change (GCC) effects into assessments of chemical risk and injury requires integrated examinations of chemical and nonchemical stressors. Environmental variables altered by GCC (temperature, precipitation, salinity, pH) can influence the toxicokinetics of chemical absorption, distribution, metabolism, and excretion as well as toxicodynamic interactions between chemicals and target molecules. In addition, GCC challenges processes critical for coping with the external environment (water balance, thermoregulation, nutrition, and the immune, endocrine, and neurological systems), leaving organisms sensitive to even slight perturbations by chemicals when pushed to the limits of their physiological tolerance range. In simplest terms, GCC can make organisms more sensitive to chemical stressors, while alternatively, exposure to chemicals can make organisms more sensitive to GCC stressors. One challenge is to identify potential interactions between nonchemical and chemical stressors affecting key physiological processes in an organism. We employed adverse outcome pathways, constructs depicting linkages between mechanism-based molecular initiating events and impacts on individuals or populations, to assess how chemical- and climate-specific variables interact to lead to adverse outcomes. Case examples are presented for prospective scenarios, hypothesizing potential chemicalGCC interactions, and retrospective scenarios, proposing mechanisms for demonstrated chemicalclimate interactions in natural populations. Understanding GCC interactions along adverse outcome pathways facilitates extrapolation between species or other levels of organization, development of hypotheses and focal areas for further research, and improved inputs for risk and resource injury assessments. Environ. Toxicol. Chem. 2013;32:3248. (c) 2012 SETAC
C1 [Hooper, Michael J.] US Geol Survey, Columbia Environm Res Ctr, Columbia, MO USA.
   [Ankley, Gerald T.] US EPA, Off Res & Dev, Natl Hlth & Environm Effects Res Lab, Midcontinent Ecol Div, Duluth, MN USA.
   [Cristol, Daniel A.] Coll William & Mary, Dept Biol, Inst Integrat Bird Behav Studies, Williamsburg, VA 23185 USA.
   [Maryoung, Lindley A.] Univ Calif Riverside, Dept Environm Sci, Riverside, CA 92521 USA.
   [Noyes, Pamela D.] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA.
   [Pinkerton, Kent E.] Univ Calif Davis, Ctr Hlth & Environm, Davis, CA 95616 USA.
RP Hooper, MJ (reprint author), US Geol Survey, Columbia Environm Res Ctr, Columbia, MO USA.
EM mhooper@usgs.gov
OI Hooper, Michael/0000-0002-4161-8961
CR Albers PH, 2007, ENVIRON TOXICOL CHEM, V26, P1856, DOI 10.1897/06-592R.1
   Ankley G. T., 2003, PAHS ECOTOXICOLOGICA, P275
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Ankley GT, 2009, AQUAT TOXICOL, V92, P168, DOI 10.1016/j.aquatox.2009.01.013
   ANKLEY GT, 1995, ENVIRON SCI TECHNOL, V29, P2828, DOI 10.1021/es00011a019
   ATKINSON SN, 1995, FUNCT ECOL, V9, P559, DOI 10.2307/2390145
   Azad MAK, 2010, COMP BIOCHEM PHYS A, V157, P266, DOI 10.1016/j.cbpa.2010.07.011
   Balch GC, 2006, CHEMOSPHERE, V64, P328, DOI 10.1016/j.chemosphere.2005.12.019
   Bale JS, 2002, GLOBAL CHANGE BIOL, V8, P1, DOI 10.1046/j.1365-2486.2002.00451.x
   Bawardi O, 2007, PESTIC BIOCHEM PHYS, V88, P321, DOI 10.1016/j.pestbp.2007.01.008
   Boas M, 2006, EUR J ENDOCRINOL, V154, P599, DOI 10.1530/eje.1.02128
   Both C, 2006, NATURE, V441, P81, DOI 10.1038/nature04539
   BOWLING JW, 1983, AQUAT TOXICOL, V3, P79, DOI 10.1016/0166-445X(83)90008-5
   Braathen M, 2004, ENVIRON HEALTH PERSP, V112, P826, DOI 10.1289/ehp.6809
   Bradbury SP, 2004, ENVIRON SCI TECHNOL, V38, p463A, DOI 10.1021/es040675s
   Brasso RL, 2008, ECOTOXICOLOGY, V17, P133, DOI 10.1007/s10646-007-0163-z
   Brian JV, 2008, SCI TOTAL ENVIRON, V397, P72, DOI 10.1016/j.scitotenv.2008.02.036
   Brouwer A, 1998, TOXICOL IND HEALTH, V14, P59, DOI 10.1177/074823379801400107
   Buckman AH, 2007, ENVIRON SCI TECHNOL, V41, P3856, DOI 10.1021/es062437y
   Carr JA, 2011, GEN COMP ENDOCR, V170, P299, DOI 10.1016/j.ygcen.2010.06.001
   Carrie J, 2010, ENVIRON SCI TECHNOL, V44, P316, DOI 10.1021/es902582y
   Carvalho MC, 2008, TOXICOL SCI, V106, P180, DOI 10.1093/toxsci/kfn158
   Celander MC, 2011, ENVIRON TOXICOL CHEM, V30, P52, DOI 10.1002/etc.382
   Chan WK, 1999, J BIOL CHEM, V274, P12115, DOI 10.1074/jbc.274.17.12115
   Cheek AO, 2009, MAR ECOL PROG SER, V392, P211, DOI 10.3354/meps08182
   Committee on Environment and Natural Resources, 2010, SCI ASS HYPOX US COA
   Cox G.W., 2010, BIRD MIGRATION GLOBA
   Daufresne M, 2004, GLOBAL CHANGE BIOL, V10, P124, DOI 10.1046/j.1529-8817.2003.00720.x
   Dawson W.R., 2000, P343, DOI 10.1016/B978-012747605-6/50015-8
   Degitz SJ, 2005, TOXICOL SCI, V87, P353, DOI 10.1093/toxsci/kfi246
   Delorenzo ME, 2009, J ENVIRON SCI HEAL B, V44, P455, DOI 10.1080/03601230902935121
   Denison MS, 2003, ANNU REV PHARMACOL, V43, P309, DOI 10.1146/annurev.pharmtox.43.100901.135828
   Denver RJ, 1998, ECOLOGY, V79, P1859, DOI 10.2307/176694
   Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401
   Erickson RJ, 1999, TOXICOL APPL PHARM, V154, P97, DOI 10.1006/taap.1998.8563
   Evers DC, 2008, ECOTOXICOLOGY, V17, P69, DOI 10.1007/s10646-007-0168-7
   Fallacara DM, 2011, ENVIRON TOXICOL CHEM, V30, P1328, DOI 10.1002/etc.519
   Farina M, 2011, TOXICOL APPL PHARM, V256, P405, DOI 10.1016/j.taap.2011.05.001
   Farina M, 2011, LIFE SCI, V89, P555, DOI 10.1016/j.lfs.2011.05.019
   Fort DJ, 2004, TOXICOL SCI, V81, P443, DOI 10.1093/toxsci/kfh230
   Fort DJ, 2000, J APPL TOXICOL, V20, P419, DOI 10.1002/1099-1263(200009/10)20:5<419::AID-JAT708>3.0.CO;2-A
   Galloy V, 2010, ACTA OECOL, V36, P179, DOI 10.1016/j.actao.2009.12.002
   Gervasi SS, 2008, FUNCT ECOL, V22, P100, DOI 10.1111/j.1365-2435.2007.01340.x
   Goto Y, 2006, J HEALTH SCI, V52, P160, DOI 10.1248/jhs.52.160
   Gouin T, 2013, ENVIRON TOXICOL CHEM, V32, P20, DOI 10.1002/etc.2044
   Gray JS, 2002, MAR ECOL PROG SER, V238, P249, DOI 10.3354/meps238249
   Greer MA, 2002, ENVIRON HEALTH PERSP, V110, P927, DOI 10.1289/ehp.02110927
   Haave M, 2003, ENVIRON HEALTH PERSP, V111, P431, DOI 10.1289/ehp.5553
   Hader DP, 2011, PHOTOCH PHOTOBIO SCI, V10, P242, DOI 10.1039/c0pp90036b
   Hallinger KK, 2011, ECOTOXICOLOGY, V20, P1368, DOI 10.1007/s10646-011-0694-1
   Hamers T, 2008, MOL NUTR FOOD RES, V52, P284, DOI 10.1002/mnfr.200700104
   Hansen J, 2012, P NATL ACAD SCI USA, V109, pE2415, DOI 10.1073/pnas.1205276109
   Harley CDG, 2006, ECOL LETT, V9, P228, DOI 10.1111/j.1461-0248.2005.00871.x
   Harwood AD, 2009, ENVIRON TOXICOL CHEM, V28, P1051, DOI 10.1897/08-291.1
   Heino J, 2009, BIOL REV, V84, P39, DOI 10.1111/j.1469-185X.2008.00060.x
   Holmstrup M, 2010, SCI TOTAL ENVIRON, V408, P3746, DOI 10.1016/j.scitotenv.2009.10.067
   Hood A, 2000, TOXICOL SCI, V55, P78, DOI 10.1093/toxsci/55.1.78
   INTERGOVERNMENTAL PANEL ON CLIMATE CHANGE, 2007, CLIM CHANG 2007 SYNT
   IPCC, 2007, CONTRIBUTION WORKING
   Iwamuro S, 2006, LIFE SCI, V79, P2165, DOI 10.1016/j.lfs.2006.07.013
   Jin YX, 2011, AQUAT TOXICOL, V101, P254, DOI 10.1016/j.aquatox.2010.10.005
   Jin YX, 2009, AQUAT TOXICOL, V92, P38, DOI 10.1016/j.aquatox.2009.01.003
   Kashiwagi A, 2008, J HEALTH SCI, V54, P273, DOI 10.1248/jhs.54.273
   Kidd KA, 2007, P NATL ACAD SCI USA, V104, P8897, DOI 10.1073/pnas.0609568104
   Kiesecker JM, 2002, P NATL ACAD SCI USA, V99, P9900, DOI 10.1073/pnas.152098899
   Kitamura S, 2008, J HEALTH SCI, V54, P607, DOI 10.1248/jhs.54.607
   Knowles N, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014339
   Korner O, 2008, AQUAT TOXICOL, V90, P188, DOI 10.1016/j.aquatox.2008.08.012
   Kraemer LD, 2004, COMP BIOCHEM PHYS C, V139, P23, DOI 10.1016/j.cca.2004.08.015
   Kramer VJ, 2011, ENVIRON TOXICOL CHEM, V30, P64, DOI 10.1002/etc.375
   Laberge F, 2001, BRAIN RES REV, V36, P46, DOI 10.1016/S0165-0173(01)00064-9
   Landis WG, 2013, ENVIRON TOXICOL CHEM, V32, P79, DOI 10.1002/etc.2047
   Landry CA, 2007, COMP BIOCHEM PHYS A, V148, P317, DOI 10.1016/j.cbpa.2007.04.023
   LARSON RA, 1988, ENVIRON SCI TECHNOL, V22, P354, DOI 10.1021/es00169a001
   Lavado R, 2011, ENVIRON SCI TECHNOL, V45, P4623, DOI 10.1021/es200451j
   Lavado R, 2009, TOXICOL APPL PHARM, V235, P143, DOI 10.1016/j.taap.2008.11.017
   Layton AC, 2002, TOXICOL APPL PHARM, V180, P157, DOI 10.1006/taap.2002.9395
   Lema SC, 2008, ENVIRON HEALTH PERSP, V116, P1694, DOI 10.1289/ehp.11570
   Letcher RJ, 2010, SCI TOTAL ENVIRON, V408, P2995, DOI 10.1016/j.scitotenv.2009.10.038
   Lie E, 2005, J TOXICOL ENV HEAL A, V68, P457, DOI 10.1080/15287390590903685
   Lie E, 2004, J TOXICOL ENV HEAL A, V67, P555, DOI 10.1080/15287390490425597
   Lydy MJ, 1999, ARCH ENVIRON CON TOX, V37, P542, DOI 10.1007/s002449900550
   Macdonald RW, 2003, HUM ECOL RISK ASSESS, V9, P643, DOI 10.1080/713609959
   Martinovic D, 2009, AQUAT TOXICOL, V95, P258, DOI 10.1016/j.aquatox.2008.08.021
   MATERNA EJ, 1995, ENVIRON TOXICOL CHEM, V14, P613, DOI 10.1002/etc.5620140409
   Matson CW, 2008, CHEMOSPHERE, V74, P149, DOI 10.1016/j.chemosphere.2008.08.016
   McKinney MA, 2011, ENVIRON SCI TECHNOL, V45, P896, DOI 10.1021/es102781b
   Mckinney MA, 2009, ENVIRON SCI TECHNOL, V43, P4334, DOI 10.1021/es900471g
   Meerts IATM, 2000, TOXICOL SCI, V56, P95, DOI 10.1093/toxsci/56.1.95
   MEKENYAN OG, 1994, CHEMOSPHERE, V28, P567, DOI 10.1016/0045-6535(94)90299-2
   Miller MD, 2009, ENVIRON HEALTH PERSP, V117, P1033, DOI 10.1289/ehp.0800247
   Moe SJ, 2013, ENVIRON TOXICOL CHEM, V32, P49, DOI 10.1002/etc.2045
   Moriyama K, 2002, J CLIN ENDOCR METAB, V87, P5185, DOI 10.1210/jc.2002-020209
   Munday PL, 2008, FISH FISH, V9, P261, DOI 10.1111/j.1467-2979.2008.00281.x
   Murphy CA, 2009, ENVIRON TOXICOL CHEM, V28, P1288, DOI 10.1897/08-304.1
   National Research Council, 2007, TOX TEST 21 CENT VIS
   National Research Council, 2008, EST MORT RISK RED EC
   Newton I, 2008, MIGRATION ECOLOGY OF BIRDS, P1
   Nichols JW, 2011, ENVIRON TOXICOL CHEM, V30, P39, DOI 10.1002/etc.376
   Norris DO, 2007, VERTEBRATE ENDOCRINO
   Noyes PD, 2011, TOXICOL SCI, V122, P265, DOI 10.1093/toxsci/kfr105
   Noyes PD, 2009, ENVIRON INT, V35, P971, DOI 10.1016/j.envint.2009.02.006
   Organization for Economic Cooperation and Development, 2010, WORKSH OECD COUNTR A
   Oskam IC, 2003, J TOXICOL ENV HEAL A, V66, P2119, DOI 10.1080/15287390390211342
   Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100
   Perkins EJ, 2011, ENVIRON TOXICOL CHEM, V30, P22, DOI 10.1002/etc.374
   Perry RI, 2011, J AGR SCI, V149, P63, DOI 10.1017/S0021859610000961
   Pickford DB, 2010, CRIT REV TOXICOL, V40, P845, DOI 10.3109/10408444.2010.494250
   Pinkerton Kent E, 2012, Proc Am Thorac Soc, V9, P3, DOI 10.1513/pats.201201-015ST
   Polischuk SC, 2002, ENVIRON POLLUT, V118, P29, DOI 10.1016/S0269-7491(01)00278-0
   Post E, 2009, SCIENCE, V325, P1355, DOI 10.1126/science.1173113
   Prasch AL, 2004, TOXICOL SCI, V78, P68, DOI 10.1093/toxsci/kfh053
   Rabalais NN, 2007, ESTUAR COAST, V30, P753, DOI 10.1007/BF02841332
   Rabalais NN, 2010, BIOGEOSCIENCES, V7, P585, DOI 10.5194/bg-7-585-2010
   Ratushnyak AA, 2005, RIV BIOL-BIOL FORUM, V98, P349
   Regehr EV, 2007, J WILDLIFE MANAGE, V71, P2673, DOI 10.2193/2006-180
   Rijnsdorp AD, 2009, ICES J MAR SCI, V66, P1570, DOI 10.1093/icesjms/fsp056
   Sabates A, 2006, GLOBAL CHANGE BIOL, V12, P2209, DOI 10.1111/j.1365-2486.2006.01246.x
   Sandahl JF, 2004, CAN J FISH AQUAT SCI, V61, P404, DOI [10.1139/f04-011, 10.1139/F04-011]
   Shang EHH, 2006, ENVIRON SCI TECHNOL, V40, P3118, DOI 10.1021/es0522579
   Solomon S, 2007, CONTRIBUTION WORKING, P996
   Stahl RG, 2013, ENVIRON TOXICOL CHEM, V32, P13, DOI 10.1002/etc.2037
   Steiner UK, 2008, J EVOLUTION BIOL, V21, P97, DOI 10.1111/j.1420-9101.2007.01463.x
   Stirling I, 1999, ARCTIC, V52, P294
   Strussmann CA, 2010, J FISH BIOL, V77, P1818, DOI 10.1111/j.1095-8649.2010.02780.x
   Szabo DT, 2009, TOXICOL SCI, V107, P27, DOI 10.1093/toxsci/kfn230
   Tejedo M, 2010, CLIM RES, V43, P31, DOI 10.3354/cr00878
   Thiemann GW, 2008, ECOL MONOGR, V78, P591, DOI 10.1890/07-1050.1
   Thiemann GW, 2011, OIKOS, V120, P1469, DOI 10.1111/j.1600-0706.2011.19277.x
   Thomas P, 2007, P R SOC B, V274, P2693, DOI 10.1098/rspb.2007.0921
   Thomas P, 2006, MAR ENVIRON RES, V62, pS249, DOI 10.1016/j.marenvres.2006.04.031
   Thomas P, 2009, ENVIRON SCI TECHNOL, V43, P4175, DOI 10.1021/es9000399
   Tietge JE, 2005, ENVIRON TOXICOL CHEM, V24, P926, DOI 10.1897/04-105R.1
   Van den Berg M, 1998, ENVIRON HEALTH PERSP, V106, P775, DOI 10.1289/ehp.98106775
   Villeneuve DL, 2011, ENVIRON TOXICOL CHEM, V30, P1, DOI 10.1002/etc.396
   Wada H, 2009, ENVIRON SCI TECHNOL, V43, P6031, DOI 10.1021/es803707f
   WADLEIGH RW, 1991, J ECON ENTOMOL, V84, P1433, DOI 10.1093/jee/84.5.1433
   Walsh PT, 2008, J THERM BIOL, V33, P244, DOI 10.1016/j.jtherbio.2008.02.002
   Wang J, 2001, TOXICOL SCI, V64, P200, DOI 10.1093/toxsci/64.2.200
   Wassmann P, 2011, GLOBAL CHANGE BIOL, V17, P1235, DOI 10.1111/j.1365-2486.2010.02311.x
   Watanabe KH, 2011, ENVIRON TOXICOL CHEM, V30, P9, DOI 10.1002/etc.373
   Wu RSS, 2003, ENVIRON SCI TECHNOL, V37, P1137, DOI 10.1021/es0258327
   Wu RSS, 2002, MAR POLLUT BULL, V45, P35, DOI 10.1016/S0025-326X(02)00061-9
   Zhou T, 2002, TOXICOL SCI, V66, P105, DOI 10.1093/toxsci/66.1.105
NR 144
TC 121
Z9 122
U1 4
U2 189
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0730-7268
EI 1552-8618
J9 ENVIRON TOXICOL CHEM
JI Environ. Toxicol. Chem.
PD JAN
PY 2013
VL 32
IS 1
BP 32
EP 48
DI 10.1002/etc.2043
PG 17
WC Environmental Sciences; Toxicology
SC Environmental Sciences & Ecology; Toxicology
GA 057EQ
UT WOS:000312545700007
PM 23136056
OA Green Published
DA 2019-10-23
ER

PT J
AU Gutsell, S
   Russell, P
AF Gutsell, Steve
   Russell, Paul
TI The role of chemistry in developing understanding of adverse outcome
   pathways and their application in risk assessment
SO TOXICOLOGY RESEARCH
LA English
DT Review
ID SOLID-PHASE MICROEXTRACTION; IN-VITRO; SKIN SENSITIZATION;
   PROTEIN-BINDING; TOXICITY; PREDICTION; SUBSTANCES; TOXICOLOGY;
   BIOASSAYS; CULTURE
AB The Adverse Outcome Pathway (AOP) conceptual framework has been presented as a logical sequence of events or processes within biological systems which can be used to understand adverse effects and refine the current risk assessment practice. This approach shifts the risk assessment focus from traditional apical endpoints to the development of a mechanistic understanding of a chemicals effect at a molecular and cellular level. In order to obtain this level of detail, chemistry in all its disciplines has a key role to play. Measurement techniques will be important in understanding chemical characterisation, free concentration and exposure at the site of interest. Such measurements will be vital in developing structure-based toxicological alerts and informing predictive models. This paper explores the areas where chemistry will be influential in the development of AOPs.
C1 [Gutsell, Steve; Russell, Paul] Unilever Safety & Environm Assurance Ctr, Sharnbrook MK44 1LQ, Beds, England.
RP Gutsell, S (reprint author), Unilever Safety & Environm Assurance Ctr, Colworth Sci Pk, Sharnbrook MK44 1LQ, Beds, England.
EM steve.gutsell@unilever.com
CR Adler S, 2011, ARCH TOXICOL, V85, P367, DOI 10.1007/s00204-011-0693-2
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   [Anonymous], TOXTR EST TOX HAZ DE
   [Anonymous], 2012, DER NEXUS V 3 0 1
   Basketter DA, 2009, CONTACT DERMATITIS, V60, P65, DOI 10.1111/j.1600-0536.2008.01444.x
   Blaauboer BJ, 2012, ALTEX-ALTERN ANIM EX, V29, P411, DOI 10.14573/altex.2012.4.411
   Blaauboer BJ, 2010, J TOXICOL ENV HEAL B, V13, P242, DOI 10.1080/10937404.2010.483940
   Blaauboer BJ, 1999, ATLA-ALTERN LAB ANIM, V27, P229, DOI 10.1177/026119299902700211
   BRADBURY SP, 1995, TOXICOL LETT, V79, P229, DOI 10.1016/0378-4274(95)03374-T
   Brown AC, 1868, T ROY SOC EDINBURGH, V25, P151, DOI 10.1017/s0080456800028155
   Caldwell JC, 2012, J TOXICOL, DOI 10.1155/2012/852384
   *COMM TOX TEST ASS, 2007, TOX TEST 21 CENT VIS
   Cronin MTD, 2003, J MOL STRUC-THEOCHEM, V622, P39, DOI 10.1016/S0166-1280(02)00616-4
   Dancik Y, 2013, ADV DRUG DELIVER REV, V65, P221, DOI 10.1016/j.addr.2012.01.006
   Davies M, 2011, TOXICOL SCI, V119, P308, DOI 10.1093/toxsci/kfq326
   DeVries JW, 2006, FOOD SAFETY MAGAZINE
   Ekwall B, 1999, TOXICOL IN VITRO, V13, P665, DOI 10.1016/S0887-2333(99)00061-2
   Enoch SJ, 2011, CRIT REV TOXICOL, V41, P783, DOI 10.3109/10408444.2011.598141
   Gulden M, 2002, TOXICOLOGY, V175, P201, DOI 10.1016/S0300-483X(02)00085-9
   Heringa MB, 2004, ENVIRON SCI TECHNOL, V38, P6263, DOI 10.1021/es049285w
   Hestermann EV, 2000, TOXICOL SCI, V53, P316, DOI 10.1093/toxsci/53.2.316
   Interdepartment Group on Health Risks from Chemicals Uncertainty Factors: Their use in human health risk assessment by UK Government, 2003, UNC FACT THEIR US HU
   Kavlock R, 2009, NEUROTOXICOL TERATOL, V31, P237, DOI 10.1016/j.ntt.2009.04.007
   Kramer NI, 2012, CHEM RES TOXICOL, V25, P436, DOI 10.1021/tx200479k
   Kramer VJ, 2011, ENVIRON TOXICOL CHEM, V30, P64, DOI 10.1002/etc.375
   Kroes R, 2005, TOXICOL SCI, V86, P226, DOI 10.1093/toxsci/kfi169
   Lapenna S., JRC SCI TECHNICAL RE
   Lord H, 2000, J CHROMATOGR A, V885, P153, DOI 10.1016/S0021-9673(00)00535-5
   MacKay C., COMMUNICATION
   Marx U, 2012, ATLA-ALTERN LAB ANIM, V40, P235, DOI 10.1177/026119291204000504
   Murk AJ, 2013, TOXICOL IN VITRO, V27, P1320, DOI 10.1016/j.tiv.2013.02.012
   Natsch A, 2010, TOXICOL IN VITRO, V24, P411, DOI 10.1016/j.tiv.2009.10.015
   OECD, 2012, OECD SER TEST ASS, V168, P27
   OECD, 2011, OECD ENV HLTH SAFETY, V138
   OECD, PROP A TEMPL GUID DE
   Patlewicz G, 2008, QSAR COMB SCI, V27, P60, DOI 10.1002/qsar.200710067
   Peyret T, 2011, SAR QSAR ENVIRON RES, V22, P129, DOI 10.1080/1062936X.2010.548351
   Reddy M., 2005, PHYSL BASED PHARMCOK
   Riedl J, 2007, CHEMOSPHERE, V67, P2210, DOI 10.1016/j.chemosphere.2006.12.022
   Roberts DW, 2007, SAR QSAR ENVIRON RES, V18, P343, DOI 10.1080/10629360701306118
   Russom CL, 1997, ENVIRON TOXICOL CHEM, V16, P948, DOI 10.1002/etc.5620160514
   SCCS, 2012, JOINT OP US THRESH T
   SCENIHR (Scientific Committee on Emerging and Newly Identified Health Risks) SCHER (Scientific Committee on Health and Environmental Risks) SCCS (Scientific Committee on Consumer Safety), 2012, PREL REP ADDR NEW CH
   Schirmer K, 1997, TOXICOL IN VITRO, V11, P107, DOI 10.1016/S0887-2333(97)00002-7
   Schreiber R, 2008, ENVIRON TOXICOL CHEM, V27, P1676, DOI 10.1897/07-504
   Schultz T. W., 2010, SILICO TOXICOLOGY PR, P351
   Seibert H, 2002, TOXICOL IN VITRO, V16, P289, DOI 10.1016/S0887-2333(02)00014-0
   Soldatow VY, 2013, TOXICOL RES-UK, V2, P23, DOI 10.1039/c2tx20051a
   U.S. Department of Health and Human Services Food and Drug Administration, 2008, ICH GUID IND REP Q3A
   Ulrich S, 2000, J CHROMATOGR A, V902, P167, DOI 10.1016/S0021-9673(00)00934-1
   VERHAAR HJM, 1992, CHEMOSPHERE, V25, P471, DOI 10.1016/0045-6535(92)90280-5
   Worth AP, 2004, ATLA-ALTERN LAB ANIM, V32, P703, DOI 10.1177/026119290403201s117
   Yoon M, 2012, CRIT REV TOXICOL, V42, P633, DOI 10.3109/10408444.2012.692115
NR 53
TC 16
Z9 16
U1 1
U2 22
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2045-452X
J9 TOXICOL RES-UK
JI Toxicol. Res.
PY 2013
VL 2
IS 5
BP 299
EP 307
DI 10.1039/c3tx50024a
PG 9
WC Toxicology
SC Toxicology
GA 195XR
UT WOS:000322737600002
DA 2019-10-23
ER

PT J
AU Pleil, JD
   Williams, MA
   Sobus, JR
AF Pleil, Joachim D.
   Williams, Marc A.
   Sobus, Jon R.
TI Chemical Safety for Sustainability (CSS): Human in vivo biomonitoring
   data for complementing results from in vitro toxicology-A commentary
SO TOXICOLOGY LETTERS
LA English
DT Review
DE Exposure science; Toxicological risk; Computational toxicology;
   Biomonitoring; Systems biology; High-throughput screening
ID ADVERSE OUTCOME PATHWAYS; TERTIARY-BUTYL ETHER; AMBIENT PARTICULATE
   MATTER; VOLATILE ORGANIC-COMPOUNDS; LIQUID-LIQUID-EXTRACTION;
   RISK-ASSESSMENT; EXPOSURE ASSESSMENT; HUMAN BLOOD; JET FUEL;
   ENVIRONMENTAL CHEMICALS
AB The U.S. Environmental Protection Agency (EPA) has instituted the Chemical Safety for Sustainability (CSS) research program for assessing the health and environmental impact of manufactured chemicals. This is a broad program wherein one of the tasks is to develop high throughput screening (HTS) methods and follow-up confirmation for toxicity at realistic environmental exposure levels. The main tools under this task are in vitro toxicity testing, in silico molecular modeling, and in vivo (systemic) measurements documentation. The in vivo research component is intended to support and corroborate in vitro chemical toxicity prioritization with observations of systemic perturbations and statistical parameters derived from intact (living) organisms. Based on EPA's Biomonitoring Framework for human health research, such observations are intended to link environmental exposures to a cascade of biomarker chemicals to help identify and clarify adverse outcome pathways within the context of systems biology. This commentary discusses the issues regarding interpretation of in vitro changes from HTS as an adverse result, an adaptive (non-adverse) response, or a random/irrelevant occurrence. A second goal is to inform in vitro strategies as to relevant dosing (potency) levels at the cellular level that reflect realistic systemic exposures. Although we recognize the high value of in vivo animal toxicity testing, herein we focus on observational (minimally invasive) human biomonitoring methods and propose complementary in vivo testing that could help guide the design of high-throughput analyses and the ultimate interpretation of their outcomes. Published by Elsevier Ireland Ltd.
C1 [Pleil, Joachim D.; Sobus, Jon R.] US EPA, Human Exposure & Atmospher Sci Div, Natl Exposure Res Lab, Res Triangle Pk, NC 27711 USA.
   [Williams, Marc A.] US EPA, Environm Publ Hlth Div, Natl Hlth & Environm Effects Lab, Res Triangle Pk, NC 27711 USA.
RP Pleil, JD (reprint author), US EPA, Human Exposure & Atmospher Sci Div, Natl Exposure Res Lab, Res Triangle Pk, NC 27711 USA.
EM pleil.joachim@epa.gov
OI Sobus, Jon/0000-0003-0740-6604; Pleil, Joachim/0000-0001-8211-0796
FU US EPAUnited States Environmental Protection Agency; United States
   Environmental Protection Agency through its Office of Research and
   DevelopmentUnited States Environmental Protection Agency
FX All funding is provided by the US EPA as part of my normal research
   employment.; The United States Environmental Protection Agency through
   its Office of Research and Development funded and managed the research
   described here. This research has been subjected to (EPA) Agency review
   and approved for publication.
CR Alexeeff SE, 2008, OCCUP ENVIRON MED, V65, P736, DOI 10.1136/oem.2007.035253
   Andersen ME, 2010, J TOXICOL ENV HEAL B, V13, P163, DOI 10.1080/10937404.2010.483933
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Aylward LL, 2011, J APPL TOXICOL, V31, P741, DOI 10.1002/jat.1626
   Bhattacharya S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020887
   Birnbaum LS, 2010, ENVIRON HEALTH PERSP, V118, pA152, DOI 10.1289/ehp.1002015
   Blaauboer BJ, 2008, TOXICOL LETT, V180, P81, DOI 10.1016/j.toxlet.2008.05.008
   Boekelheide K, 2010, TOXICOL SCI, V114, P20, DOI 10.1093/toxsci/kfp307
   Brown EA, 1998, RISK ANAL, V18, P205, DOI 10.1111/j.1539-6924.1998.tb00932.x
   Buckley TJ, 2001, FORENSIC SCI INT, V123, P111, DOI 10.1016/S0379-0738(01)00534-5
   Buschmann J, 2006, REPROD TOXICOL, V22, P157, DOI 10.1016/j.reprotox.2006.03.012
   Campisi J, 2003, NAT REV CANCER, V3, P339, DOI 10.1038/nrc1073
   Collins FS, 2008, SCIENCE, V319, P906, DOI 10.1126/science.1154619
   Dietert RR, 2009, CHEM RES TOXICOL, V22, P17, DOI 10.1021/tx800198m
   Dix DJ, 2007, TOXICOL SCI, V95, P5, DOI 10.1093/toxsci/kfl103
   Edwards SW, 2008, TOXICOL SCI, V106, P312, DOI 10.1093/toxsci/kfn190
   Egeghy PP, 2011, INT J ENV RES PUB HE, V8, P1727, DOI 10.3390/ijerph8051727
   Egeghy PP, 2005, J EXPO ANAL ENV EPID, V15, P388, DOI 10.1038/sj.jea.7500415
   Feil R, 2012, NAT REV GENET, V13, P97, DOI 10.1038/nrg3142
   Furtaw EJ, 2001, TOXICOL IND HEALTH, V17, P302, DOI 10.1191/0748233701th107oa
   Ginsberg G, 2004, ENVIRON HEALTH PERSP, V112, P272, DOI 10.1289/ehp.6013
   Goldsmith MR, 2010, J PHARMACOKINET PHAR, V37, P277, DOI 10.1007/s10928-010-9160-6
   Hartnett L, 2012, CARCINOGENESIS, V33, P723, DOI 10.1093/carcin/bgs006
   Hubal EAC, 2010, J TOXICOL ENV HEAL B, V13, P299, DOI 10.1080/10937404.2010.483947
   Hubal EAC, 2009, TOXICOL SCI, V111, P226, DOI 10.1093/toxsci/kfp159
   Hubbard HF, 2009, J CHROMATOGR B, V877, P3652, DOI 10.1016/j.jchromb.2009.09.008
   Jafri AB, 2011, CLIN GERIATR MED, V27, P609, DOI 10.1016/j.cger.2011.07.007
   Judson RS, 2011, CHEM RES TOXICOL, V24, P451, DOI 10.1021/tx100428e
   Judson RS, 2010, ENVIRON HEALTH PERSP, V118, P485, DOI 10.1289/ehp.0901392
   Kavlock R, 2010, J TOXICOL ENV HEAL B, V13, P197, DOI 10.1080/10937404.2010.483935
   Kim D, 2007, TOXICOL LETT, V169, P222, DOI 10.1016/j.toxlet.2007.01.008
   Landrigan PJ, 2011, HEALTH AFFAIR, V30, P842, DOI 10.1377/hlthaff.2011.0151
   Lin Y S, 2005, Occup Environ Med, V62, P750, DOI 10.1136/oem.2004.013102
   Lin YS, 2006, BIOMARKERS, V11, P14, DOI 10.1080/13547500500382975
   Lindstrom AB, 1997, ENVIRON HEALTH PERSP, V105, P636
   Lindstrom AB, 1996, J AIR WASTE MANAGE, V46, P676, DOI 10.1080/10473289.1996.10467502
   Lindstrom AB, 1996, J AIR WASTE MANAGE, V46, P1058, DOI 10.1080/10473289.1996.10467541
   Lioy PJ, 2011, ENVIRON HEALTH PERSP, V119, pA466, DOI 10.1289/ehp.1104387
   Lipscomb JC, 2012, ADV EXP MED BIOL, V745, P76, DOI 10.1007/978-1-4614-3055-1_6
   Liu SM, 1999, J CHROMATOGR B, V728, P193, DOI 10.1016/S0378-4347(99)00109-7
   Liu SM, 2001, J CHROMATOGR B, V752, P159, DOI 10.1016/S0378-4347(00)00537-5
   Lorber M, 2011, ENVIRON SCI TECHNOL, V45, P8006, DOI 10.1021/es103718h
   Mays-Hoopes LL, 2010, NAT ED, V3, P55
   Morgan MK, 2008, J EXPO SCI ENV EPID, V18, P486, DOI 10.1038/sj.jes.7500641
   Morgan MK, 2007, ENVIRON RES, V104, P266, DOI 10.1016/j.envres.2006.11.011
   Morgan MK, 2005, J EXPO ANAL ENV EPID, V15, P297, DOI 10.1038/sj.jea.7500406
   Murcray CE, 2011, GENET EPIDEMIOL, V35, P201, DOI 10.1002/gepi.20569
   Naeher LP, 2010, SCI TOTAL ENVIRON, V408, P1145, DOI 10.1016/j.scitotenv.2009.10.022
   NRC, 1993, PEST DIETS INF CHILD
   NRC (National Research Council), 2007, TOX TEST 21 CENT VIS
   Patel CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010746
   Peretz C, 2002, ANN OCCUP HYG, V46, P69, DOI 10.1093/annhyg/mef009
   Perkins EJ, 2011, ENVIRON TOXICOL CHEM, V30, P22, DOI 10.1002/etc.374
   Pleil JD, 2007, BIOMARKERS, V12, P331, DOI 10.1080/13547500701246334
   Pleil JD, 2010, J CHROMATOGR B, V878, P1753, DOI 10.1016/j.jchromb.2010.04.035
   Pleil JD, 1997, CLIN CHEM, V43, P723
   Pleil JD, 1998, ENVIRON HEALTH PERSP, V106, P573, DOI 10.1289/ehp.98106573
   Pleil JD, 2000, ENVIRON HEALTH PERSP, V108, P183, DOI 10.2307/3454432
   Pleil JD, 2012, J TOXICOL ENV HEAL B, V15, P264, DOI 10.1080/10937404.2012.672148
   Pleil JD, 2012, CHEM-BIOL INTERACT, V196, P68, DOI 10.1016/j.cbi.2011.02.020
   Pleil JD, 2011, BIOMARKERS, V16, P99, DOI 10.3109/1354750X.2010.541565
   Pleil JD, 2009, BIOMARKERS, V14, P560, DOI 10.3109/13547500903186460
   Pollard KM, 2012, J AUTOIMMUN, V38, pJ177, DOI 10.1016/j.jaut.2011.11.007
   Pollard KM, 2010, CHEM RES TOXICOL, V23, P455, DOI 10.1021/tx9003787
   Prah J, 2004, TOXICOL SCI, V77, P195, DOI 10.1093/toxsci/kfh009
   Rakyan VK, 2011, NAT REV GENET, V12, P529, DOI 10.1038/nrg3000
   Rappaport SM, 2012, J EPIDEMIOL COMMUN H, V66, P99, DOI 10.1136/jech-2011-200726
   Rappaport SM, 2010, SCIENCE, V330, P460, DOI 10.1126/science.1192603
   Raunio H, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00033
   Ross SA, 2011, ADV NUTR, V2, P472, DOI 10.3945/an.111.001206
   Rusyn I, 2012, TOXICOL SCI, V127, P1, DOI 10.1093/toxsci/kfs095
   Sacks JD, 2011, ENVIRON HEALTH PERSP, V119, P446, DOI 10.1289/ehp.1002255
   Sahmel J, 2010, CRIT REV TOXICOL, V40, P799, DOI 10.3109/10408444.2010.501052
   Samet JM, 2007, INHAL TOXICOL, V19, P29, DOI 10.1080/08958370701492706
   Sandoval J, 2012, CURR OPIN GENET DEV, V22, P50, DOI 10.1016/j.gde.2012.02.008
   Sartorius GA, 2010, HUM REPROD UPDATE, V16, P65, DOI 10.1093/humupd/dmp027
   Sawyer K, 2008, J BREATH RES, V2, DOI 10.1088/1752-7155/2/3/037019
   Schmidt CW, 2009, ENVIRON HEALTH PERSP, V117, pA348, DOI 10.1289/ehp.117-a348
   Schug TT, 2011, J STEROID BIOCHEM, V127, P204, DOI 10.1016/j.jsbmb.2011.08.007
   Sobus JR, 2011, SCI TOTAL ENVIRON, V409, P4875, DOI 10.1016/j.scitotenv.2011.07.046
   Sobus JR, 2010, TOXICOL LETT, V199, P247, DOI 10.1016/j.toxlet.2010.09.006
   Stephens ML, 2012, TOXICOL SCI, V125, P327, DOI 10.1093/toxsci/kfr248
   Tan YM, 2012, J TOXICOL ENV HEAL B, V15, P22, DOI 10.1080/10937404.2012.632360
   Thomas D, 2010, NAT REV GENET, V11, P259, DOI 10.1038/nrg2764
   Thomas KW, 2010, J EXPO SCI ENV EPID, V20, P119, DOI 10.1038/jes.2009.6
   Tulve NS, 2008, J EXPO SCI ENV EPID, V18, P31, DOI 10.1038/sj.jes.7500600
   USEPA, 2011, FRAM EPA CHEM SAF SU
   Wang L, 2010, SEMIN RESP CRIT CARE, V31, P539, DOI 10.1055/s-0030-1265895
   Watanabe KH, 2011, ENVIRON TOXICOL CHEM, V30, P9, DOI 10.1002/etc.373
   Williams M. A., 2011, ALLERGENS RESP POLLU
   Williams MA, 2008, J IMMUNOL, V181, P4545, DOI 10.4049/jimmunol.181.7.4545
   Williams MA, 2007, BIOMARK INSIGHTS, V2, P226
   Williams R, 2000, J EXPO ANAL ENV EPID, V10, P533, DOI 10.1038/sj.jea.7500108
   Williams R, 2009, J EXPO SCI ENV EPID, V19, P643, DOI 10.1038/jes.2008.61
   Woodruff TJ, 2011, HEALTH AFFAIR, V30, P957, DOI 10.1377/hlthaff.2011.0194
NR 95
TC 17
Z9 17
U1 0
U2 35
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0378-4274
EI 1879-3169
J9 TOXICOL LETT
JI Toxicol. Lett.
PD DEC 17
PY 2012
VL 215
IS 3
BP 201
EP 207
DI 10.1016/j.toxlet.2012.10.011
PG 7
WC Toxicology
SC Toxicology
GA 047KR
UT WOS:000311839900007
PM 23116968
DA 2019-10-23
ER

PT J
AU Forbes, VE
   Calow, P
AF Forbes, Valery E.
   Calow, Peter
TI Promises and problems for the new paradigm for risk assessment and an
   alternative approach involving predictive systems models
SO ENVIRONMENTAL TOXICOLOGY AND CHEMISTRY
LA English
DT Editorial Material
DE Adverse outcome pathways; Agent-based models; Cost-benefit analysis; Key
   events dose-response framework; Mechanistic effect models
ID FRAMEWORK; LESSONS
AB The need for cost-effective risk assessment of chemicals is leading to the development of a reductionist paradigm that tries to assess impacts on humans and ecosystems from molecular changes. However, the biggest challenge for this paradigm comes from the emergence of properties that arise out of the interactions of the parts that are not included and yet which are key for assessing likely impacts. Although identifying key events and adverse outcome pathways can shed light on the involvement of important metabolic processes in toxicity, this does not mean that particular molecular initiating events are likely to be robust or accurate predictors of impacts that matter. There are even greater challenges for the new paradigm applied to ecological systems than to human health because of the need to link across more levels of biological organization. The present study argues for a predictive systems approach that makes the linkages through systems models in a mechanistic way that allows for emergence and that also has the potential for reducing the costs and use of animals in ecological risk assessments. Environ. Toxicol. Chem. 2012; 31: 26632671. (c) 2012 SETAC
C1 [Forbes, Valery E.] Univ Nebraska, Sch Biol Sci, Lincoln, NE 68588 USA.
   [Calow, Peter] Univ Nebraska, Off Res & Econ Dev, Lincoln, NE USA.
RP Forbes, VE (reprint author), Univ Nebraska, Sch Biol Sci, Lincoln, NE 68588 USA.
EM vforbes3@unl.edu
RI Forbes, Valery/P-9360-2019
OI Forbes, Valery/0000-0001-9819-9385
CR Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Benton TG, 2012, PHILOS T R SOC B, V367, P200, DOI 10.1098/rstb.2011.0168
   Dalkvist T, 2009, ECOTOX ENVIRON SAFE, V72, P1663, DOI 10.1016/j.ecoenv.2008.10.002
   European Centre for Ecotoxicological and Toxicology of Chemicals, 2011, 113 EUR CTR EC TOX C
   Evans MR, 2012, PHILOS T R SOC B, V367, P181, DOI 10.1098/rstb.2011.0172
   Forbes VE, 2006, ENVIRON TOXICOL CHEM, V25, P272, DOI 10.1897/05-257R.1
   Forbes VE, 1999, ENVIRON TOXICOL CHEM, V18, P1544, DOI 10.1002/etc.5620180729
   Forbes VE, 2002, BIOSCIENCE, V52, P249, DOI 10.1641/0006-3568(2002)052[0249:EIERAB]2.0.CO;2
   Grimm V, 2005, SCIENCE, V310, P987, DOI 10.1126/science.1116681
   Grimm V, 2010, ECOL MODEL, V221, P2760, DOI 10.1016/j.ecolmodel.2010.08.019
   Holcombe M, 2012, INTEGR BIOL-UK, V4, P53, DOI 10.1039/c1ib00042j
   Julien E, 2009, CRIT REV FOOD SCI, V49, P682, DOI 10.1080/10408390903110692
   Lancashire LJ, 2009, BRIEF BIOINFORM, V10, P315, DOI 10.1093/bib/bbp012
   Martin BT, 2012, METHODS ECOL EVOL, V3, P445, DOI 10.1111/j.2041-210X.2011.00168.x
   Mehinto Alvine C., 2012, Frontiers in Genetics, V3, P62, DOI 10.3389/fgene.2012.00062
   National Academy of Sciences, 2009, SCI DEC
   Railsback SF, 2012, AG BAS IND BAS MOD P
   van Straalen NM, 2012, ENVIRON SCI TECHNOL, V46, P3, DOI 10.1021/es2034153
NR 18
TC 31
Z9 31
U1 0
U2 62
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0730-7268
EI 1552-8618
J9 ENVIRON TOXICOL CHEM
JI Environ. Toxicol. Chem.
PD DEC
PY 2012
VL 31
IS 12
BP 2663
EP 2671
DI 10.1002/etc.2009
PG 9
WC Environmental Sciences; Toxicology
SC Environmental Sciences & Ecology; Toxicology
GA 040AO
UT WOS:000311291200001
PM 23165997
DA 2019-10-23
ER

PT J
AU Dix, DJ
   Houck, KA
   Judson, RS
   Kleinstreuer, NC
   Knudsen, TB
   Martin, MT
   Reif, DM
   Richard, AM
   Shah, I
   Sipes, NS
   Kavlock, RJ
AF Dix, David J.
   Houck, Keith A.
   Judson, Richard S.
   Kleinstreuer, Nicole C.
   Knudsen, Thomas B.
   Martin, Matthew T.
   Reif, David M.
   Richard, Ann M.
   Shah, Imran
   Sipes, Nisha S.
   Kavlock, Robert J.
TI Incorporating Biological, Chemical, and Toxicological Knowledge Into
   Predictive Models of Toxicity
SO TOXICOLOGICAL SCIENCES
LA English
DT Letter
ID ENVIRONMENTAL CHEMICALS; REPRODUCTIVE TOXICITY; VASCULAR DEVELOPMENT;
   TOXCAST PROGRAM; THROUGHPUT
C1 [Dix, David J.] US EPA, Natl Ctr Computat Toxicol, Off Res & Dev, Res Triangle Pk, NC 27711 USA.
RP Dix, DJ (reprint author), US EPA, Natl Ctr Computat Toxicol, Off Res & Dev, Res Triangle Pk, NC 27711 USA.
EM dix.david@epa.gov
RI Shah, Syed I/B-8275-2011; Houck, Keith/G-8654-2014; Martin,
   Matthew/A-1982-2013; Kleinstreuer, Nicole/F-7203-2019
OI Houck, Keith/0000-0002-0055-2249; Martin, Matthew/0000-0002-8096-9908;
   Kleinstreuer, Nicole/0000-0002-7914-3682; Shah,
   Imran/0000-0003-0808-0140; Reif, David/0000-0001-7815-6767; Judson,
   Richard/0000-0002-2348-9633
CR ALMUALLIM H, 1991, PROCEEDINGS : NINTH NATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE, VOLS 1 AND 2, P547
   Dix DJ, 2007, TOXICOL SCI, V95, P5, DOI 10.1093/toxsci/kfl103
   Judson R, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-241
   Judson RS, 2011, CHEM RES TOXICOL, V24, P451, DOI 10.1021/tx100428e
   Judson RS, 2010, ENVIRON HEALTH PERSP, V118, P485, DOI 10.1289/ehp.0901392
   Kavlock R, 2012, CHEM RES TOXICOL, V25, P1287, DOI 10.1021/tx3000939
   Kleinstreuer NC, 2011, ENVIRON HEALTH PERSP, V119, P1596, DOI 10.1289/ehp.1103412
   Knudsen TB, 2011, BIRTH DEFECTS RES C, V93, P312, DOI 10.1002/bdrc.20223
   Knudsen TB, 2009, REPROD TOXICOL, V28, P209, DOI 10.1016/j.reprotox.2009.03.016
   Martin MT, 2011, BIOL REPROD, V85, P327, DOI 10.1095/biolreprod.111.090977
   Martin MT, 2009, TOXICOL SCI, V110, P181, DOI 10.1093/toxsci/kfp080
   Martin MT, 2009, ENVIRON HEALTH PERSP, V117, P392, DOI 10.1289/ehp.0800074
   Nel A., ACCT CHEM R IN PRESS
   Reif DM, 2010, ENVIRON HEALTH PERSP, V118, P1714, DOI 10.1289/ehp.1002180
   Sipes NS, 2011, TOXICOL SCI, V124, P109, DOI 10.1093/toxsci/kfr220
   Thomas RS, 2012, TOXICOL SCI, V128, P398, DOI 10.1093/toxsci/kfs159
NR 16
TC 16
Z9 17
U1 0
U2 34
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1096-6080
J9 TOXICOL SCI
JI Toxicol. Sci.
PD DEC
PY 2012
VL 130
IS 2
BP 440
EP 441
DI 10.1093/toxsci/kfs281
PG 2
WC Toxicology
SC Toxicology
GA 040FN
UT WOS:000311307600021
PM 22982683
OA Bronze
DA 2019-10-23
ER

PT J
AU Thomas, RS
   Black, MB
   Li, LL
   Healy, E
   Chu, TM
   Bao, WJ
   Andersen, ME
   Wolfinger, RD
AF Thomas, Russell S.
   Black, Michael B.
   Li, Lili
   Healy, Eric
   Chu, Tzu-Ming
   Bao, Wenjun
   Andersen, Melvin E.
   Wolfinger, Russell D.
TI Response to Incorporating Biological, Chemical, and Toxicological
   Knowledge Into Predictive Models of Toxicity
SO TOXICOLOGICAL SCIENCES
LA English
DT Letter
C1 [Thomas, Russell S.; Black, Michael B.; Healy, Eric; Andersen, Melvin E.] Hamner Inst Hlth Sci, Res Triangle Pk, NC 27709 USA.
   [Li, Lili; Chu, Tzu-Ming; Bao, Wenjun; Wolfinger, Russell D.] SAS Inst Inc, Cary, NC 27513 USA.
RP Thomas, RS (reprint author), Hamner Inst Hlth Sci, 6 Davis Dr, Res Triangle Pk, NC 27709 USA.
EM rthomas@thehamner.org
OI Andersen, Melvin/0000-0002-3894-4811; Thomas,
   Russell/0000-0002-2340-0301; Black, Michael/0000-0002-7314-5441
CR Martin MT, 2011, BIOL REPROD, V85, P327, DOI 10.1095/biolreprod.111.090977
   Molinaro AM, 2005, BIOINFORMATICS, V21, P3301, DOI 10.1093/bioinformatics/bti499
   Shi LM, 2010, NAT BIOTECHNOL, V28, P827, DOI 10.1038/nbt.1665
   Sipes NS, 2011, TOXICOL SCI, V124, P109, DOI 10.1093/toxsci/kfr220
   Thomas RS, 2012, TOXICOL SCI, V128, P398, DOI 10.1093/toxsci/kfs159
NR 5
TC 4
Z9 4
U1 1
U2 7
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1096-6080
J9 TOXICOL SCI
JI Toxicol. Sci.
PD DEC
PY 2012
VL 130
IS 2
BP 442
EP 443
DI 10.1093/toxsci/kfs284
PG 2
WC Toxicology
SC Toxicology
GA 040FN
UT WOS:000311307600022
OA Bronze
DA 2019-10-23
ER

PT J
AU Lapenna, S
   Gabbert, S
   Worth, A
AF Lapenna, Silvia
   Gabbert, Silke
   Worth, Andrew
TI Training Needs for Toxicity Testing in the 21st Century: A
   Survey-informed Analysis
SO ATLA-ALTERNATIVES TO LABORATORY ANIMALS
LA English
DT Article
DE alternative method; hazard and risk assessment of chemicals; qualitative
   data analysis; stakeholder requirements; training
AB Current training needs on the use of alternative methods in predictive toxicology, including new approaches based on mode-of-action (MoA) and adverse outcome pathway (AOP) concepts, are expected to evolve rapidly. In order to gain insight into stakeholder preferences for training, the European Commission's Joint Research Centre (JRC) conducted a single-question survey with twelve experts in regulatory agencies, industry, national research organisations, NGOs and consultancies. Stakeholder responses were evaluated by means of theory-based qualitative data analysis. Overall, a set of training topics were identified that relate both to general background information and to guidance for applying alternative testing methods. In particular, for the use of in silico methods, stakeholders emphasised the need for training on data integration and evaluation, in order to increase confidence in applying these methods for regulatory purposes. Although the survey does not claim to offer an exhaustive overview of the training requirements, its findings support the conclusion that the development of well-targeted and tailor-made training opportunities that inform about the usefulness of alternative methods, in particular those that offer practical experience in the application of in silico methods, deserves more attention. This should be complemented by transparent information and guidance on the interpretation of the results generated by these methods and software tools.
C1 [Lapenna, Silvia; Worth, Andrew] Commiss European Communities, Joint Res Ctr, Inst Hlth & Consumer Protect, Syst Toxicol Unit, Ispra, Varese, Italy.
   [Gabbert, Silke] Wageningen Univ, Dept Social Sci, Environm Econ & Nat Resources Grp, NL-6700 AP Wageningen, Netherlands.
RP Worth, A (reprint author), Commiss European Communities, Joint Res Ctr, Inst Hlth & Consumer Protect, Syst Toxicol Unit, Ispra, Varese, Italy.
EM andrew.worth@ec.europa.eu
RI Worth, Andrew Paul/O-3055-2019; Worth, Andrew/R-8495-2019
OI Worth, Andrew Paul/0000-0002-5303-0452; 
FU European UnionEuropean Union (EU)
FX This work was partly funded by the European Union FP6 integrated project
   OSIRIS (http://www.osiris-reach.eu/).
CR Andersen ME, 2010, J TOXICOL ENV HEAL B, V13, P163, DOI 10.1080/10937404.2010.483933
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Boekelheide Kim, 2010, ALTEX, V27, P243
   Charmaz K, 2006, INTRO QUALITATIVE ME
   Collins FS, 2008, SCIENCE, V319, P906, DOI 10.1126/science.1154619
   Gabbert S, 2012, J RISK RES, V15, P583, DOI 10.1080/13669877.2011.646291
   GEORGOPOULOS P, 2008, WATER AIR SOIL POLL, V8, P3, DOI DOI 10.1007/S11267-007-9137-7
   Glaser B. G., 1967, DISCOVERY GROUNDED T
   Hallberg L.R.-M., 2006, INT J QUALITATIVE ST, V1, P141, DOI DOI 10.1080/17482620600858399
   Hartung T, 2011, ALTEX-ALTERN ANIM EX, V28, P83, DOI 10.14573/altex.2011.2.083
   Krewski D, 2011, ANNU REV PUBL HEALTH, V32, P161, DOI 10.1146/annurev-publhealth-031210-101153
   NRC (National Research Council), 2007, TOX TEST 21 CENT VIS
   Pavan M, 2008, SAR QSAR ENVIRON RES, V19, P785, DOI 10.1080/10629360802550390
   Ritchie J, 2002, ANAL QUALITATIVE DAT, V573, P305, DOI DOI 10.4324/9780203413081_CHAPTER_9
   Schultz TW, 2010, ISSUES TOXICOL, V7, P346
   US EPA Risk Assessment Forum, 2005, GUID CARC RISK ASS
NR 16
TC 4
Z9 4
U1 0
U2 4
PU FRAME
PI NOTTINGHAM
PA RUSSELL & BURCH HOUSE 96-98 NORTH SHERWOOD ST, NOTTINGHAM NG1 4EE,
   NOTTS, ENGLAND
SN 0261-1929
J9 ATLA-ALTERN LAB ANIM
JI ATLA-Altern. Lab. Anim.
PD DEC
PY 2012
VL 40
IS 6
BP 313
EP 320
DI 10.1177/026119291204000604
PG 8
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA V30YW
UT WOS:000208852300015
PM 23398336
DA 2019-10-23
ER

PT J
AU Connon, RE
   Geist, J
   Werner, I
AF Connon, Richard E.
   Geist, Juergen
   Werner, Inge
TI Effect-Based Tools for Monitoring and Predicting the Ecotoxicological
   Effects of Chemicals in the Aquatic Environment
SO SENSORS
LA English
DT Review
DE bioassays; biomarkers; toxicity identification; ecosystem effects;
   ecotoxicogenomics; ecotoxicology; aquatic toxicology; ecological
   monitoring; adverse outcome pathways; systems biology
ID POLYCYCLIC AROMATIC-HYDROCARBONS; ENDOCRINE-DISRUPTING CHEMICALS;
   INDUCED COMMUNITY TOLERANCE; IN-SITU; PROTEOMIC ANALYSIS; SYSTEMS
   BIOLOGY; RISK-ASSESSMENT; INVERTEBRATE COMMUNITIES; LUCIFERASE REPORTER;
   METAL CONTAMINATION
AB Ecotoxicology faces the challenge of assessing and predicting the effects of an increasing number of chemical stressors on aquatic species and ecosystems. Herein we review currently applied tools in ecological risk assessment, combining information on exposure with expected biological effects or environmental water quality standards; currently applied effect-based tools are presented based on whether exposure occurs in a controlled laboratory environment or in the field. With increasing ecological relevance the reproducibility, specificity and thus suitability for standardisation of methods tends to diminish. We discuss the use of biomarkers in ecotoxicology including ecotoxicogenomics-based endpoints, which are becoming increasingly important for the detection of sublethal effects. Carefully selected sets of biomarkers allow an assessment of exposure to and effects of toxic chemicals, as well as the health status of organisms and, when combined with chemical analysis, identification of toxicant(s). The promising concept of "adverse outcome pathways (AOP)" links mechanistic responses on the cellular level with whole organism, population, community and potentially ecosystem effects and services. For most toxic mechanisms, however, practical application of AOPs will require more information and the identification of key links between responses, as well as key indicators, at different levels of biological organization, ecosystem functioning and ecosystem services.
C1 [Geist, Juergen] Tech Univ Munich, Dept Ecol & Ecosyst Management, Aquat Syst Biol Unit, D-85354 Freising Weihenstephan, Germany.
   [Connon, Richard E.] Univ Calif Davis, Sch Vet Med, Dept Anat Physiol & Cell Biol, Davis, CA 95616 USA.
   [Werner, Inge] Swiss Ctr Appl Ecotoxicol Eawag EPFL, CH-8600 Dubendorf, Switzerland.
RP Geist, J (reprint author), Tech Univ Munich, Dept Ecol & Ecosyst Management, Aquat Syst Biol Unit, Muhlenweg 22, D-85354 Freising Weihenstephan, Germany.
EM geist@wzw.tum.de
RI Geist, Juergen/C-4933-2008
OI Geist, Juergen/0000-0001-7698-3443
CR Altenburger R, 2012, ENVIRON SCI TECHNOL, V46, P2508, DOI 10.1021/es2038036
   Ankley G. T., 2008, GENOMICS REGULATORY
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Ankley GT, 2009, AQUAT TOXICOL, V92, P168, DOI 10.1016/j.aquatox.2009.01.013
   [Anonymous], 2006, UN GLOB HARM SYST CL
   [Anonymous], 1993, EP600R92080
   Araujo CVM, 2010, ENVIRON INT, V36, P637, DOI 10.1016/j.envint.2010.04.017
   Aufartova J, 2011, ANAL CHIM ACTA, V704, P33, DOI 10.1016/j.aca.2011.07.030
   Babin-Fenske JJ, 2012, CAN J ZOOL, V90, P624, DOI [10.1139/Z2012-028, 10.1139/z2012-028]
   BACKHAUS T, 2008, ECOTOXICOLOGY PHARM, P257
   Backhaus T, 2012, ENVIRON SCI TECHNOL, V46, P2564, DOI 10.1021/es2034125
   Baird DJ, 2007, INTEGR ENVIRON ASSES, V3, P259, DOI 10.1897/IEAM_2006-031.1
   Baird DJ, 2007, INTEGR ENVIRON ASSES, V3, P275, DOI 10.1897/IEAM_2006-030.1
   Bandow N, 2009, ENVIRON SCI TECHNOL, V43, P7343, DOI 10.1021/es901351z
   Barbour MT, 1999, RAPID BIOASSESSMENT
   BAUMANN PC, 1995, ENVIRON HEALTH PERSP, V103, P168, DOI 10.2307/3432273
   Beggel S, 2011, AQUAT TOXICOL, V105, P180, DOI 10.1016/j.aquatox.2011.06.004
   Beketov MA, 2009, ENVIRON POLLUT, V157, P1841, DOI 10.1016/j.envpol.2009.01.021
   Biales AD, 2011, AQUAT TOXICOL, V101, P196, DOI 10.1016/j.aquatox.2010.09.019
   Blanck H, 2002, HUM ECOL RISK ASSESS, V8, P1003, DOI 10.1080/1080-700291905792
   BLANCK H, 1988, CAN J FISH AQUAT SCI, V45, P1816, DOI 10.1139/f88-213
   Blasco C, 2009, TRAC-TREND ANAL CHEM, V28, P745, DOI 10.1016/j.trac.2009.04.010
   BORENFREUND E, 1985, TOXICOL LETT, V24, P119, DOI 10.1016/0378-4274(85)90046-3
   Brack W, 2003, ANAL BIOANAL CHEM, V377, P397, DOI 10.1007/s00216-003-2139-z
   BROEG K, 2008, MAR ENV RES, V66, P55
   Burton GA, 2005, ENVIRON POLLUT, V134, P133, DOI 10.1016/j.envpol.2004.07.008
   Campos A, 2012, J PROTEOMICS, V75, P4346, DOI 10.1016/j.jprot.2012.04.027
   Connon R, 2008, ENVIRON SCI TECHNOL, V42, P2181, DOI 10.1021/es702469b
   Connon RE, 2012, ENVIRON SCI TECHNOL, V46, P6081, DOI 10.1021/es3005128
   Connon RE, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-608
   Crane M, 2007, INTEGR ENVIRON ASSES, V3, P290, DOI 10.1897/IEAM_2006-045.1
   Dagnino A, 2007, BIOMARKERS, V12, P155, DOI 10.1080/13547500601037171
   de Jong FMW, 2005, HUM ECOL RISK ASSESS, V11, P1157, DOI 10.1080/10807030500278644
   De Laender F, 2008, CHEMOSPHERE, V71, P529, DOI 10.1016/j.chemosphere.2007.09.052
   Delignette-Muller ML, 2011, ENVIRON TOXICOL CHEM, V30, P2888, DOI 10.1002/etc.686
   Depledge MH, 2005, FRONT ECOL ENVIRON, V3, P251
   Depledge MH, 2009, OCEAN COAST MANAGE, V52, P336, DOI 10.1016/j.ocecoaman.2009.04.001
   Diamond J., 2005, COLLAPSE SOC CHOOSE
   Eder KJ, 2008, FISH SHELLFISH IMMUN, V25, P508, DOI 10.1016/j.fsi.2008.07.003
   Ekman DR, 2008, ENVIRON SCI TECHNOL, V42, P4188, DOI 10.1021/es8000618
   ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9
   Escher B, 2012, BIOANALYTICAL TOOLS IN WATER QUALITY ASSESSMENT, P1
   Escher BI, 2008, J ENVIRON MONITOR, V10, P612, DOI 10.1039/b800949j
   Floyd EY, 2008, ENVIRON TOXICOL CHEM, V27, P1780, DOI 10.1897/07-448.1
   Forbes VE, 2006, ENVIRON TOXICOL CHEM, V25, P272, DOI 10.1897/05-257R.1
   FRIEDRICH G, 1990, Z WASSER ABWASS FOR, V23, P141
   Garcia-Reyero N, 2011, ENVIRON TOXICOL CHEM, V30, P265, DOI 10.1002/etc.401
   Garcia-Reyero N, 2011, AQUAT TOXICOL, V101, P38, DOI 10.1016/j.aquatox.2010.08.014
   Garcia-Reyero N, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S11-S11
   Garcia-Reyero N, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-308
   Geist J, 2007, AQUAT TOXICOL, V85, P28, DOI 10.1016/j.aquatox.2007.07.011
   Geist J, 2011, ECOL INDIC, V11, P1507, DOI 10.1016/j.ecolind.2011.04.002
   Gilliom RJ, 1999, ENVIRON SCI TECHNOL, V33, p164A, DOI 10.1021/es992770k
   Gutleb AC, 2005, ENVIRON TOXICOL PHAR, V19, P231, DOI 10.1016/j.etap.2004.06.003
   Hahn ME, 2011, AQUAT TOXICOL, V105, P67, DOI 10.1016/j.aquatox.2011.06.001
   Hamers T, 2000, TOXICOL SCI, V58, P60, DOI 10.1093/toxsci/58.1.60
   Hamers T, 1997, ECOTOX ENVIRON SAFE, V37, P203, DOI 10.1006/eesa.1997.1557
   Harris KDM, 2012, GENET RES INT, DOI 10.1155/2012/147892
   Head Jessica A, 2012, Environ Toxicol Chem, V31, P221, DOI 10.1002/etc.1707
   Heckmann LH, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r40
   HICKEY JJ, 1968, SCIENCE, V162, P271, DOI 10.1126/science.162.3850.271
   HINTON DE, 1992, SETAC SP P, P155
   Hooper HL, 2003, OIKOS, V102, P515, DOI 10.1034/j.1600-0706.2003.12536.x
   Horii Y, 2009, ENVIRON SCI TECHNOL, V43, P2159, DOI 10.1021/es8030402
   Hostetter NJ, 2011, T AM FISH SOC, V140, P1158, DOI 10.1080/00028487.2011.613303
   Huggett RJ, 1992, BIOMARKERS BIOCH PHY
   Jobling S, 1998, ENVIRON SCI TECHNOL, V32, P2498, DOI 10.1021/es9710870
   Johnson AC, 2004, ENVIRON SCI TECHNOL, V38, P3649, DOI 10.1021/es035342u
   KARR JR, 1991, ECOL APPL, V1, P66, DOI 10.2307/1941848
   Kellert S. R., 1996, VALUE LIFE BIOL DIVE
   Kennedy JH, 1999, ENVIRON TOXICOL CHEM, V18, P113, DOI 10.1002/etc.5620180204
   Kidd KA, 2007, P NATL ACAD SCI USA, V104, P8897, DOI 10.1073/pnas.0609568104
   Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492
   Kramer VJ, 2011, ENVIRON TOXICOL CHEM, V30, P64, DOI 10.1002/etc.375
   Legler J, 1999, TOXICOL SCI, V48, P55, DOI 10.1093/toxsci/48.1.55
   Legler Juliette, 2010, Integrated Environmental Assessment and Management, V6, P314, DOI 10.1002/ieam.40
   Leusch FDL, 2010, ENVIRON SCI TECHNOL, V44, P3853, DOI 10.1021/es903899d
   Liess M, 2005, ENVIRON TOXICOL CHEM, V24, P954, DOI 10.1897/03-652.1
   Liess M, 2008, SCI TOTAL ENVIRON, V406, P484, DOI 10.1016/j.scitotenv.2008.05.054
   Liess M, 2012, ECOTOXICOLOGY, V21, P300, DOI 10.1007/s10646-011-0840-9
   Liess M, 2011, ECOTOXICOLOGY, V20, P1328, DOI 10.1007/s10646-011-0689-y
   Lin CY, 2006, J PESTIC SCI, V31, P245, DOI 10.1584/jpestics.31.245
   Lopes I, 2005, CHEMOSPHERE, V61, P1189, DOI 10.1016/j.chemosphere.2005.02.072
   Lowe DM, 1995, MAR ECOL PROG SER, V129, P189, DOI 10.3354/meps129189
   Ludwig C, 2010, PHYTOCHEM ANALYSIS, V21, P22, DOI 10.1002/pca.1186
   Malecot M, 2009, AQUAT TOXICOL, V94, P153, DOI 10.1016/j.aquatox.2009.06.012
   Martinovic D, 2007, ENVIRON TOXICOL CHEM, V26, P271, DOI 10.1897/06-065R.1
   Martyniuk CJ, 2012, INTEGR COMP BIOL, V52, P695, DOI 10.1093/icb/ics072
   Martyniuk CJ, 2010, TOXICOL SCI, V117, P190, DOI 10.1093/toxsci/kfq192
   Meek ME, 2011, REGUL TOXICOL PHARM, V60, pS1, DOI 10.1016/j.yrtph.2011.03.010
   Miller KM, 2011, SCIENCE, V331, P214, DOI 10.1126/science.1196901
   Morgan AJ, 2007, ENVIRON SCI TECHNOL, V41, P1085, DOI 10.1021/es061992x
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Nagy SR, 2002, TOXICOL SCI, V65, P200, DOI 10.1093/toxsci/65.2.200
   Oehlers LP, 2007, COMP BIOCHEM PHYS C, V145, P120, DOI 10.1016/j.cbpc.2006.06.005
   Perkins EJ, 2011, ENVIRON TOXICOL CHEM, V30, P22, DOI 10.1002/etc.374
   Pfau W, 1997, BIOMARKERS, V2, P145, DOI 10.1080/135475097231670
   Poynton HC, 2011, ENVIRON SCI TECHNOL, V45, P3710, DOI 10.1021/es1037222
   Rempel MA, 2008, INT REV CEL MOL BIO, V267, P207, DOI 10.1016/S1937-6448(08)00605-9
   Roesijadi G., 1994, AQUATIC TOXICOLOGY M, P387
   Rotchell JM, 2003, J TOXICOL ENV HEAL B, V6, P453, DOI [10.1080/10937400306476, 10.1080/10937400390223430]
   Routledge EJ, 1996, ENVIRON TOXICOL CHEM, V15, P241, DOI 10.1002/etc.5620150303
   Sanderson H, 2002, ENVIRON SCI POLLUT R, V9, P429, DOI 10.1065/espr2001.09.085
   Schafer RB, 2012, ENVIRON SCI TECHNOL, V46, P5134, DOI 10.1021/es2039882
   Schwarzenbach RP, 2006, SCIENCE, V313, P1072, DOI 10.1126/science.1127291
   Shaw Jennifer L., 1994, P85
   SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0
   Sohoni P, 1998, J ENDOCRINOL, V158, P327, DOI 10.1677/joe.0.1580327
   Soto A.M., 1995, ENV HLTH PERSPECT, V103, pS113
   Spromberg JA, 2005, INTEGR ENVIRON ASSES, V1, P9, DOI 10.1897/IEAM_2004a-005.1
   Stagg RM, 2000, ENVIRON TOXICOL CHEM, V19, P2797, DOI 10.1002/etc.5620191126
   STEGEMAN JJ, 1992, SETAC SP P, P235
   Sumpter J.P., 1995, ENVIRON HEALTH PER S, V103, pS173
   Sumpter JP, 2005, ACTA HYDROCH HYDROB, V33, P9, DOI 10.1002/aheh.200400555
   Thompson EL, 2012, ENVIRON POLLUT, V170, P102, DOI 10.1016/j.envpol.2012.06.015
   Triebskorn R, 2003, HUM ECOL RISK ASSESS, V9, P171, DOI 10.1080/713609858
   TRUHAUT R, 1977, ECOTOX ENVIRON SAFE, V1, P151, DOI 10.1016/0147-6513(77)90033-1
   U. S. Environmental Protection Agency, 2002, SHORT TERM METH MEAS
   *US EPA, 1991, EPA600691003
   *US EPA, 2002, METH MEAS AC TOX EFF
   Van Aggelen G, 2010, ENVIRON HEALTH PERSP, V118, P1, DOI 10.1289/ehp.0900985
   Van den Brink PJ, 2012, ECOTOXICOLOGY, V21, P297, DOI 10.1007/s10646-011-0825-8
   Van den Brink PJ, 1999, ENVIRON TOXICOL CHEM, V18, P138, DOI 10.1002/etc.5620180207
   Van der Linden SC, 2008, ENVIRON SCI TECHNOL, V42, P5814, DOI 10.1021/es702897y
   van der Oost R, 2003, ENVIRON TOXICOL PHAR, V13, P57, DOI 10.1016/S1382-6689(02)00126-6
   Vandegehuchte MB, 2011, ECOTOXICOLOGY, V20, P607, DOI 10.1007/s10646-011-0634-0
   Vandegehuchte MB, 2010, COMP BIOCHEM PHYS C, V151, P278, DOI 10.1016/j.cbpc.2009.11.007
   Vandegehuchte MB, 2009, ENVIRON INT, V35, P700, DOI 10.1016/j.envint.2009.01.002
   Vandenberg LN, 2012, ENDOCR REV, V33, P378, DOI 10.1210/er.2011-1050
   Viant MR, 2006, AQUAT TOXICOL, V77, P359, DOI 10.1016/j.aquatox.2006.01.009
   Viant MR, 2013, METABOLOMICS, V9, pS144, DOI 10.1007/s11306-012-0412-x
   Villeneuve D.L., 2011, APPL TOXICOGENOMICS, P207
   Vos JG, 2000, CRIT REV TOXICOL, V30, P71, DOI 10.1080/10408440091159176
   Wang MH, 2010, TOXICOL SCI, V113, P60, DOI 10.1093/toxsci/kfp248
   Weeks B.A., 1992, BIOMARKERS BIOCH PHY
   Weiss JM, 2009, TOXICOL SCI, V109, P206, DOI 10.1093/toxsci/kfp055
   Werner I, 2002, MAR ENVIRON RES, V54, P609, DOI 10.1016/S0141-1136(02)00151-4
   Werner I, 2000, ENVIRON TOXICOL CHEM, V19, P215, DOI 10.1002/etc.5620190126
   Werner I, 2010, ENVIRON TOXICOL CHEM, V29, P2859, DOI 10.1002/etc.356
   WESTER PW, 1994, TOXICOLOGY, V86, P213, DOI 10.1016/0300-483X(94)90005-1
   Weston AD, 2004, J PROTEOME RES, V3, P179, DOI 10.1021/pr0499693
   Wharfe J, 2007, INTEGR ENVIRON ASSES, V3, P268, DOI 10.1897/IEAM_2006-024.1
   Wheelock CE, 2005, AQUAT TOXICOL, V74, P172, DOI 10.1016/j.aquatox.2005.05.009
   Whitton B., 1991, P INT S DUSS GERM 26, P193
   Wilson VS, 2004, TOXICOL SCI, V81, P69, DOI 10.1093/toxsci/kfh180
   WINSTON GW, 1991, AQUAT TOXICOL, V19, P137, DOI 10.1016/0166-445X(91)90033-6
NR 146
TC 105
Z9 106
U1 2
U2 200
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1424-8220
J9 SENSORS-BASEL
JI Sensors
PD SEP
PY 2012
VL 12
IS 9
BP 12741
EP 12771
DI 10.3390/s120912741
PG 31
WC Chemistry, Analytical; Engineering, Electrical & Electronic; Instruments
   & Instrumentation
SC Chemistry; Engineering; Instruments & Instrumentation
GA 012XL
UT WOS:000309269900078
PM 23112741
OA DOAJ Gold, Green Published, Green Accepted
DA 2019-10-23
ER

PT J
AU Warner, CM
   Gust, KA
   Stanley, JK
   Habib, T
   Wilbanks, MS
   Garcia-Reyero, N
   Perkins, EJ
AF Warner, Christopher M.
   Gust, Kurt A.
   Stanley, Jacob K.
   Habib, Tanwir
   Wilbanks, Mitchell S.
   Garcia-Reyero, Natalia
   Perkins, Edward J.
TI A Systems Toxicology Approach to Elucidate the Mechanisms Involved in
   RDX Species-Specific Sensitivity
SO ENVIRONMENTAL SCIENCE & TECHNOLOGY
LA English
DT Article
ID ADVERSE OUTCOME PATHWAYS; FATHEAD MINNOW;
   HEXAHYDRO-1,3,5-TRINITRO-1,3,5-TRIAZINE RDX; GENE-EXPRESSION; TOXICITY;
   BRAIN; BIODEGRADATION; BIOMARKERS; RESPONSES; EXPOSURE
AB Interspecies uncertainty factors in ecological risk assessment provide conservative estimates of risk where limited or no toxicity data is available. We quantitatively examined the validity of interspecies uncertainty factors by comparing the responses of zebrafish (Danio rerio) and fathead minnow (Pimephales promelas) to the energetic compound 1,3,5-trinitroperhydro-1,3,5-triazine (RDX), a known neurotoxicant. Relative toxicity was measured through transcriptional, morphological, and behavioral end points in zebrafish and fathead minnow fry exposed for 96 h to RDX concentrations ranging from 0.9 to 27.7 mg/L. Spinal deformities and lethality occurred at 1.8 and 3.5 mg/L RDX respectively for fathead minnow and at 13.8 and 27.7 mg/L for zebrafish, indicating that zebrafish have an 8-fold greater tolerance for RDX than fathead minnow fry. The number and magnitude of differentially expressed transcripts increased with increasing RDX concentration for both species. Differentially expressed genes were enriched in functions related to neurological disease, oxidative stress, acute phase response, vitamin/mineral metabolism and skeletal/muscular disorders Decreased expression of collagen coding transcripts were associated with spinal deformity and likely involved in sensitivity to RDX. Our work provides a mechanistic explanation for species specific sensitivity to RDX where zebrafish responded at lower concentrations with greater numbers of functions related to RDX tolerance than fathead minnow. While the 10 fold interspecies uncertainty factor does provide a reasonable cross species estimate of toxicity in the present study, the observation that the responses between ZF and FHM are markedly different does initiate a call for concern regarding establishment of broad ecotoxicological conclusions based on model species such as zebrafish.
C1 [Warner, Christopher M.; Gust, Kurt A.; Stanley, Jacob K.; Wilbanks, Mitchell S.; Perkins, Edward J.] USA, Engineer Res & Dev Ctr, Environm Lab, Vicksburg, MS USA.
   [Warner, Christopher M.] Keck Grad Inst, Claremont, CA USA.
   [Habib, Tanwir] Badger Tech Serv, San Antonio, TX USA.
   [Garcia-Reyero, Natalia] Mississippi State Univ, Starkville, MS USA.
RP Gust, KA (reprint author), USA, Engineer Res & Dev Ctr, Environm Lab, Vicksburg, MS USA.
EM kurt.a.gust@usace.army.mil
OI Habib, Tanwir/0000-0002-2301-2704
FU U.S. Army Environmental Quality Research Program [BAA 08-4379]
FX This work was funded by the U.S. Army Environmental Quality Research
   Program (including BAA 08-4379). Permission for publishing this
   information has been granted by the Chief of Engineers.
CR Ankley GT, 2006, ENVIRON SCI TECHNOL, V40, P4055, DOI 10.1021/es0630184
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Bannon DI, 2009, CHEM RES TOXICOL, V22, P620, DOI 10.1021/tx800444k
   Bayne CJ, 2001, DEV COMP IMMUNOL, V25, P725, DOI 10.1016/S0145-305X(01)00033-7
   Bhushan B, 2003, APPL ENVIRON MICROB, V69, P1347, DOI 10.1128/AEM.69.3.1347-1351.2003
   Card R.E., 1998, TREATMENT HMX RDX CO
   Chen F, 1999, CLIN CHEM, V45, P7
   Chen Y, 2005, J BIOL CHEM, V280, P33766, DOI 10.1074/jbc.M504604200
   Cowles EA, 1998, CALCIFIED TISSUE INT, V62, P74, DOI 10.1007/s002239900397
   Ek H, 2005, AQUAT TOXICOL, V72, P221, DOI 10.1016/j.aquatox.2005.01.001
   Faust R. A., 1994, TOXICITY SUMMARY HEX
   Fedorenkova A, 2010, ENVIRON SCI TECHNOL, V44, P9241, DOI 10.1021/es103077x
   Freedman JE, 2008, ARTERIOSCL THROM VAS, V28, pS11, DOI 10.1161/ATVBAHA.107.159178
   Garcia-Reyero N, 2011, ECOTOXICOLOGY, V20, P580, DOI 10.1007/s10646-011-0623-3
   Gong P, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S1-S15
   GREEN DE, 1945, J BIOL CHEM, V161, P559
   Gust KA, 2011, ENVIRON TOXICOL CHEM, V30, P1852, DOI 10.1002/etc.558
   Gust KA, 2011, AQUAT TOXICOL, V101, P135, DOI 10.1016/j.aquatox.2010.09.011
   Gust KA, 2009, TOXICOL SCI, V110, P168, DOI 10.1093/toxsci/kfp091
   HAMILTON MA, 1977, ENVIRON SCI TECHNOL, V11, P714, DOI 10.1021/es60130a004
   HAMILTON MA, 1978, ENVIRON SCI TECHNOL, V12, P417, DOI 10.1021/es60140a017
   Hara N, 2003, J BIOL CHEM, V278, P10914, DOI 10.1074/jbc.M209203200
   Health Effects, 1995, TOX PROF RDX
   Hebels DGAJ, 2010, TOXICOL SCI, V116, P194, DOI 10.1093/toxsci/kfq121
   Iwama GK, 1998, REV FISH BIOL FISHER, V8, P35, DOI 10.1023/A:1008812500650
   Jenkins T.F., 2001, TR015 US ARM COLD RE
   KAPLAN AS, 1965, ARCH ENVIRON HEALTH, V10, P877, DOI 10.1080/00039896.1965.10664112
   Klassen C. D., 2001, CASARETT DOULLS TOXI
   Krishnan K, 2009, J APPL TOXICOL, V29, P629, DOI 10.1002/jat.1455
   Lee JM, 2004, J BIOCHEM MOL BIOL, V37, P139
   LIM C, 1978, J NUTR, V108, P1137
   Marin MP, 2005, J NUTR, V135, P695
   Meldrum BS, 2000, J NUTR, V130, p1007S, DOI 10.1093/jn/130.4.1007S
   Miliukiene V, 2008, Z NATURFORSCH C, V63, P519
   Miller DH, 2007, ENVIRON TOXICOL CHEM, V26, P521, DOI 10.1897/06-318R.1
   Mukhi S, 2005, CHEMOSPHERE, V61, P178, DOI 10.1016/j.chemosphere.2005.02.067
   Murphy CA, 2009, ENVIRON TOXICOL CHEM, V28, P1288, DOI 10.1897/08-304.1
   Perkins E.J., 2006, BMC BIOINFORMATIC S4, V7, P22
   PETERS GT, 1991, ENVIRON TOXICOL CHEM, V10, P1073, DOI 10.1002/etc.5620100812
   Quinn MJ, 2009, ENVIRON TOXICOL CHEM, V28, P1266, DOI 10.1897/08-418.1
   Rao MR, 2009, FUNCT INTEGR GENOMIC, V9, P537, DOI 10.1007/s10142-009-0125-z
   Reddy G, 2005, INT J TOXICOL, V24, P427, DOI 10.1080/10915810500366922
   Sanderson H, 2009, ENVIRON TOXICOL CHEM, V28, P1359, DOI 10.1897/09-119.1
   Small M.J., 1974, TECHNICAL REPORT 740
   Sobotkova A, 2009, FREE RADICAL BIO MED, V47, P1707, DOI 10.1016/j.freeradbiomed.2009.09.015
   United States Environmental Protection Agency, 2002, METH 1003 0 SHORT TE
   United States Environmental Protection Agency, 2007, SW486 US EPA
   Villeneuve DL, 2012, ENVIRON SCI TECHNOL, V46, P51, DOI 10.1021/es201150a
   Violi F., 2008, ARTERIOSCLER THROMB, V28, ps11
   Watanabe KH, 2011, ENVIRON TOXICOL CHEM, V30, P9, DOI 10.1002/etc.373
   Widmann RF, 1999, SPINE, V24, P1673, DOI 10.1097/00007632-199908150-00008
   Williams LR, 2011, ENVIRON HEALTH PERSP, V119, P357, DOI 10.1289/ehp.1002588
NR 52
TC 10
Z9 10
U1 0
U2 21
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0013-936X
EI 1520-5851
J9 ENVIRON SCI TECHNOL
JI Environ. Sci. Technol.
PD JUL 17
PY 2012
VL 46
IS 14
BP 7790
EP 7798
DI 10.1021/es300495c
PG 9
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA 974MZ
UT WOS:000306441000047
PM 22697906
DA 2019-10-23
ER

PT J
AU Rhomberg, LR
   Goodman, JE
   Foster, WG
   Borgert, CJ
   Van Der Kraak, G
AF Rhomberg, Lorenz R.
   Goodman, Julie E.
   Foster, Warren G.
   Borgert, Christopher J.
   Van Der Kraak, Glen
TI A critique of the European Commission Document, "State of the Art
   Assessment of Endocrine Disrupters"
SO CRITICAL REVIEWS IN TOXICOLOGY
LA English
DT Review
DE Endocrine active; endocrine disruptor; WHO/IPCS; weight of evidence;
   state of science
ID HYPOTHESIS-BASED WEIGHT; ARYL-HYDROCARBON RECEPTOR; BISPHENOL-A;
   LABORATORY MEDICINE; SYSTEMATIC REVIEWS; FRAMEWORK; EXPOSURE;
   CRYPTORCHIDISM; HUMANS; RAT
AB In this commentary, we critique a recently finalized document titled "State of the Art Assessment of Endocrine Disrupters" (SOA Assessment). The SOA Assessment was commissioned by the European Union Directorate-General for the Environment to provide a basis for developing scientific criteria for identifying endocrine disruptors and reviewing and possibly revising the European Community Strategy on Endocrine Disrupters. In our view, the SOA Assessment takes an anecdotal approach rather than attempting a comprehensive assessment of the state of the art or synthesis of current knowledge. To do the latter, the document would have had to (i) distinguish between apparent associations of outcomes with exposure and the inference of an endocrine-disruption (ED) basis for those outcomes; (ii) constitute a complete and unbiased survey of new literature since 2002 (when the WHO/IPCS document, "Global Assessment of the State-of-the-Science of Endocrine Disruptors" was published); (iii) consider strengths and weaknesses and issues in interpretation of the cited literature; (iv) follow a weight-of-evidence methodology to evaluate evidence of ED; (v) document the evidence for its conclusions or the reasoning behind them; and (vi) present the evidence for or reasoning behind why conclusions that differ from those drawn in the 2002 WHO/IPCS document need to be changed. In its present form, the SOA Assessment fails to provide a balanced and critical assessment or synthesis of literature relevant to ED. We urge further evidence-based evaluations to develop the needed scientific basis to support future policy decisions.
C1 [Rhomberg, Lorenz R.; Goodman, Julie E.] Gradient, Cambridge, MA 02138 USA.
   [Foster, Warren G.] McMaster Univ, Dept Obstet & Gynecol, Hamilton, ON, Canada.
   [Borgert, Christopher J.] Appl Pharmacol & Toxicol Inc, Gainesville, FL USA.
   [Borgert, Christopher J.] Univ Florida, Coll Vet Med, Dept Physiol Sci, Gainesville, FL 32610 USA.
   [Van Der Kraak, Glen] Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada.
RP Rhomberg, LR (reprint author), Gradient, 20 Univ Rd, Cambridge, MA 02138 USA.
EM lrhomberg@gradientcorp.com
FU American Chemistry Council (ACC)
FX The employment affiliations of the authors are as shown on the cover
   page. Lorenz Rhomberg and Julie Goodman are employees of Gradient, a
   private consulting firm that provides services to both private and
   public organizations on toxicological and human health risk assessment
   issues. Christopher Borgert is an employee of Applied Pharmacology and
   Toxicology, Inc., a private firm that offers scientific consultation and
   research in human and environmental health. Warren Foster is on the
   faculty of McMaster University and, as an independent consultant, has
   provided technical advice to industry and government organizations on
   the health impacts associated with exposure to environmental
   contaminants on an occasional contractual basis. Glen Van Der Kraak has
   served as a consultant to Sygenta on the effects of triazines on
   wildlife. The American Chemistry Council (ACC) provided funding to
   support preparation of this review. ACC was provided the opportunity to
   review a draft of the paper and offer comments for consideration by the
   authors. The authors have sole responsibility for the content and the
   writing of the paper. The interpretations and views expressed in the
   paper are not necessarily those of the ACC or the authors' employers or
   clients.
CR Adami HO, 2011, TOXICOL SCI, V122, P223, DOI 10.1093/toxsci/kfr113
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Boobis AR, 2008, CRIT REV TOXICOL, V38, P87, DOI 10.1080/10408440701749421
   Boobis AR, 1995, INT S PRINCESS TAKAM, V23, P134
   Borgert CJ, 2012, REGUL TOXICOL PHARM, V62, P313, DOI 10.1016/j.yrtph.2011.10.012
   Borgert CJ, 2011, REGUL TOXICOL PHARM, V61, P185, DOI 10.1016/j.yrtph.2011.07.007
   Brucker-Davis F, 2008, HUM REPROD, V23, P1708, DOI 10.1093/humrep/den186
   Cortes D, 2008, J UROLOGY, V179, P314, DOI 10.1016/j.juro.2007.08.158
   Doerge DR, 2011, TOXICOL LETT, V207, P298, DOI 10.1016/j.toxlet.2011.09.020
   Doerge DR, 2010, TOXICOL APPL PHARM, V248, P1, DOI 10.1016/j.taap.2010.07.009
   European Commission Joint Research Centre, 2003, 80057 CAS EUR COMM J, V37
   Farquhar C, 2006, CURR OPIN OBSTET GYN, V18, P433, DOI 10.1097/01.gco.0000233939.44178.4b
   Fisch H, 2010, J PEDIATR UROL, V6, P37, DOI 10.1016/j.jpurol.2009.05.005
   Fisher JW, 2011, TOXICOL APPL PHARM, V257, P122, DOI 10.1016/j.taap.2011.08.026
   Goodman JE, 2006, CRIT REV TOXICOL, V36, P387, DOI 10.1080/10408440600758317
   Goodman J, 2009, CRIT REV TOXICOL, V39, P1, DOI [10.1080/10408440802157839, 10.3109/10408440903279946]
   Gronseth Gary S, 2004, NeuroRx, V1, P331, DOI 10.1007/BF03206618
   Guzelian PS, 2005, HUM EXP TOXICOL, V24, P161, DOI 10.1191/0960327105ht517oa
   Hengstler JG, 2011, CRIT REV TOXICOL, V41, P263, DOI 10.3109/10408444.2011.558487
   HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503
   Hosie S, 2000, EUR J PEDIATR SURG, V10, P304, DOI 10.1055/s-2008-1072381
   Jana NR, 1998, BIOCHEM BIOPH RES CO, V248, P554, DOI 10.1006/bbrc.1998.9010
   Klimisch HJ, 1997, REGUL TOXICOL PHARM, V25, P1, DOI 10.1006/rtph.1996.1076
   Korkalainen M, 2004, BIOCHEM BIOPH RES CO, V315, P123, DOI 10.1016/j.bbrc.2004.01.028
   Korkalainen M, 2001, BIOCHEM BIOPH RES CO, V285, P1121, DOI 10.1006/bbrc.2001.5317
   Kortenkamp A., 2011, STATE ART ASSESSMENT
   LIGGINS GC, 1994, REPROD FERT DEVELOP, V6, P141, DOI 10.1071/RD9940141
   Martignoni M, 2006, EXPERT OPIN DRUG MET, V2, P875, DOI 10.1517/17425255.2.6.875
   Matthews SG, 2000, PEDIATR RES, V47, P291, DOI 10.1203/00006450-200003000-00003
   McGlynn KA, 2009, ENVIRON HEALTH PERSP, V117, P1472, DOI 10.1289/ehp.0800389
   McQueen MJ, 2001, CLIN CHEM, V47, P1536
   Mol NM, 2002, EUR J ENDOCRINOL, V146, P357, DOI 10.1530/eje.0.1460357
   Ng PC, 2000, ARCH DIS CHILD, V82, pF250, DOI 10.1136/fn.82.3.F250
   Oosterhuis WP, 2004, CLIN CHEM, V50, P806, DOI 10.1373/clinchem.2003.025528
   Prueitt RL, 2011, CRIT REV TOXICOL, V41, P822, DOI 10.3109/10408444.2011.616877
   Rhomberg LR, 2011, CRIT REV TOXICOL, V41, P555, DOI 10.3109/10408444.2011.560140
   Rhomberg LR, 2010, CRIT REV TOXICOL, V40, P671, DOI 10.3109/10408444.2010.499504
   Ricci S, 2006, NEUROL SCI, V27, pS228, DOI 10.1007/s10072-006-0623-x
   Sharpe RM, 2003, INT J ANDROL, V26, P2, DOI 10.1046/j.1365-2605.2003.00367.x
   Smyth R L, 2000, Paediatr Respir Rev, V1, P287, DOI 10.1053/prrv.2000.0061
   Teeguarden JG, 2011, TOXICOL SCI, V123, P48, DOI 10.1093/toxsci/kfr160
   Thorup J, 2010, J PEDIATR SURG, V45, P2074, DOI 10.1016/j.jpedsurg.2010.07.030
   Turpeinen M, 2007, XENOBIOTICA, V37, P1367, DOI 10.1080/00498250701658312
   Weed DL, 2005, RISK ANAL, V25, P1545, DOI 10.1111/j.1539-6924.2005.00699.x
   WHO, 2002, GLOB ASS STAT OF THE
   Witorsch RJ, 2002, FOOD CHEM TOXICOL, V40, P905, DOI 10.1016/S0278-6915(02)00069-8
   Zaza S, 2000, AM J PREV MED, V18, P44, DOI 10.1016/S0749-3797(99)00122-1
NR 47
TC 18
Z9 18
U1 0
U2 34
PU INFORMA HEALTHCARE
PI LONDON
PA TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND
SN 1040-8444
J9 CRIT REV TOXICOL
JI Crit. Rev. Toxicol.
PD JUL
PY 2012
VL 42
IS 6
BP 465
EP 473
DI 10.3109/10408444.2012.690367
PG 9
WC Toxicology
SC Toxicology
GA 958OC
UT WOS:000305247900001
PM 22630047
OA Green Published, Bronze
DA 2019-10-23
ER

PT J
AU Chipman, K
AF Chipman, Kevin
TI Analysis of the transcriptome and epigenome-state of the art and
   application to the detection of toxic responses in aquatic sentinel
   species
SO TOXICOLOGY LETTERS
LA English
DT Meeting Abstract
CT 48th Congress of the European-Societies-of-Toxicology (EUROTOX)
CY JUN 17-20, 2012
CL Stockholm, SWEDEN
SP European Soc Toxicol (EUROTOX), Molnlycke Hlth Care, Ferring Pharmaceut, AstraZeneca, Agilent Technol
C1 [Chipman, Kevin] Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0378-4274
J9 TOXICOL LETT
JI Toxicol. Lett.
PD JUN 17
PY 2012
VL 211
SU S
BP S30
EP S30
DI 10.1016/j.toxlet.2012.03.803
PG 1
WC Toxicology
SC Toxicology
GA 957PB
UT WOS:000305173900097
DA 2019-10-23
ER

PT J
AU Kuper, CF
AF Kuper, C. Frieke
TI Cells and tissues encountered in the airways after inhalation of
   chemical respiratory sensitizers
SO TOXICOLOGY LETTERS
LA English
DT Meeting Abstract
CT 48th Congress of the European-Societies-of-Toxicology (EUROTOX)
CY JUN 17-20, 2012
CL Stockholm, SWEDEN
SP European Soc Toxicol (EUROTOX), Molnlycke Hlth Care, Ferring Pharmaceut, AstraZeneca, Agilent Technol
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0378-4274
J9 TOXICOL LETT
JI Toxicol. Lett.
PD JUN 17
PY 2012
VL 211
SU S
BP S5
EP S5
DI 10.1016/j.toxlet.2012.03.030
PG 1
WC Toxicology
SC Toxicology
GA 957PB
UT WOS:000305173900013
DA 2019-10-23
ER

PT J
AU Landsiedel, R
   Oomen, A
   Bos, P
   Migliori, L
   Wick, P
   Scott-Fordsmand, J
   von der Kammer, F
   Fernandez, T
   Hund-Rinke, K
AF Landsiedel, Robert
   Oomen, Agnes
   Bos, Peter
   Migliori, Lucia
   Wick, Peter
   Scott-Fordsmand, Janeck
   von der Kammer, Frank
   Fernandez, Theresa
   Hund-Rinke, Kerstin
TI NanoSafetyVision: Toxicity testing strategy for nanomaterials
SO TOXICOLOGY LETTERS
LA English
DT Meeting Abstract
CT 48th Congress of the European-Societies-of-Toxicology (EUROTOX)
CY JUN 17-20, 2012
CL Stockholm, SWEDEN
SP European Soc Toxicol (EUROTOX), Molnlycke Hlth Care, Ferring Pharmaceut, AstraZeneca, Agilent Technol
C1 [Migliori, Lucia] Iniversita Pisa, Pisa, Italy.
   [Scott-Fordsmand, Janeck] Aarhus Univ, DK-8000 Aarhus C, Denmark.
   [von der Kammer, Frank] Univ Vienna, A-1010 Vienna, Austria.
   [Fernandez, Theresa] Heriot Watt Univ, Edinburgh EH14 4AS, Midlothian, Scotland.
   [Hund-Rinke, Kerstin] Fraunhofer Inst, Aachen, Germany.
RI Scott-Fordsmand, Janeck/J-6019-2013; von der Kammer, Frank/B-3743-2013
OI Scott-Fordsmand, Janeck/0000-0002-2260-1224; von der Kammer,
   Frank/0000-0002-8653-6687
NR 0
TC 0
Z9 0
U1 0
U2 9
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0378-4274
J9 TOXICOL LETT
JI Toxicol. Lett.
PD JUN 17
PY 2012
VL 211
SU S
BP S179
EP S179
DI 10.1016/j.toxlet.2012.03.646
PG 1
WC Toxicology
SC Toxicology
GA 957PB
UT WOS:000305173900585
DA 2019-10-23
ER

PT J
AU Kadereit, S
   Zimmer, B
   van Thriel, C
   Hengstler, JG
   Leist, M
AF Kadereit, Suzanne
   Zimmer, Bastian
   van Thriel, Christoph
   Hengstler, Jan G.
   Leist, Marcel
TI Compound selection for in vitro modeling of developmental neurotoxicity
SO FRONTIERS IN BIOSCIENCE-LANDMARK
LA English
DT Article
DE In vitro; Developmental toxicity; Embryonic stem cells; Compound
   selection; Toxicology; Neural development; Review
ID EMBRYONIC STEM-CELLS; PERSISTENT ORGANOCHLORINE PESTICIDES; KINASE
   INHIBITOR PROTEIN; ADVERSE OUTCOME PATHWAYS; NEURITE OUTGROWTH; NEURAL
   DIFFERENTIATION; PC12 CELLS; ALTERNATIVE METHODS; ANTIEPILEPTIC
   MEDICATIONS; NEURONAL DIFFERENTIATION
AB Development of in vitro systems, such as those based on embryonic stem cell differentiation, depends on the selection of adequate test and training compounds. We recommend the use of two classes of positive controls, the "gold standard compounds" for which developmental neurotoxicity (DNT) has been proven in man, and the "pathway compounds" that are known to disrupt signaling pathways and key processes relevant for neuronal differentiation. We introduce the concept of toxicity endophenotypes (TEP) as changes in neuronal connectivity resulting from exposure to developmental toxicants. Thus, TEPs provide the scientific rationale for modeling DNT with simple in vitro models of key neurodevelopmental events. In this context, we discuss scientific and technical aspects of the test compound selection process. We suggest to include compounds with unspecific toxicity, besides negative control compounds, and we recommend tandem approaches to determine relative toxicities instead of absolute measures. Finally, we discuss how to avoid pitfalls by distinguishing between unspecific forms of cytotoxicity and specific developmental neurotoxicity. A compilation of compound lists corresponding to the above-discussed principles supplement this review.
C1 [Kadereit, Suzanne; Zimmer, Bastian; Leist, Marcel] Univ Konstanz, Dept Biol, Doerenkamp Zbinden Chair In Vitro Toxicol & Biome, D-78457 Constance, Germany.
   [van Thriel, Christoph; Hengstler, Jan G.] Leibniz Res Ctr Working Environm & Human Factors, D-44139 Dortmund, Germany.
RP Kadereit, S (reprint author), Univ Konstanz, Dept Biol, Doerenkamp Zbinden Chair In Vitro Toxicol & Biome, Box 657, D-78457 Constance, Germany.
EM suzanne.kadereit@uni-konstanz.de
RI Leist, Marcel/D-2133-2010; Hengstler, Jan G./O-1415-2013
OI Leist, Marcel/0000-0002-3778-8693; van Thriel,
   Christoph/0000-0003-3215-9262; Hengstler, Jan/0000-0002-1427-5246;
   Zimmer, Bastian/0000-0003-0004-4890
FU Doerenkamp-Zbinden Foundation; FP7 Embryonic Stem cell-based Novel
   Alternative Testing Strategies (ESNATS); DFGGerman Research Foundation
   (DFG); BMBFFederal Ministry of Education & Research (BMBF) [0315545B]
FX Suzanne Kadereit and Bastian Zimmer contributed equally to this work.
   The authors whish to thank Brigitte Schanze for editorial help, the
   Doerenkamp-Zbinden Foundation and the FP7 Embryonic Stem cell-based
   Novel Alternative Testing Strategies (ESNATS) project for generous
   funding as well as the IRTG1331 graduate school funded by the DFG, and
   BMBF grant 0315545B (CvT).
CR Abranches E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006286
   Andersen ME, 2011, ALTEX-ALTERN ANIM EX, V28, P175, DOI 10.14573/altex.2011.3.175
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Apati A, 2008, BBA-BIOMEMBRANES, V1778, P2700, DOI 10.1016/j.bbamem.2008.08.010
   Barberi T, 2003, NAT BIOTECHNOL, V21, P1200, DOI 10.1038/nbt870
   BARDE YA, 1989, NEURON, V2, P1525, DOI 10.1016/0896-6273(89)90040-8
   Becchetti A, 2010, ADV EXP MED BIOL, V674, P107
   Belmonte MK, 2006, NAT NEUROSCI, V9, P1221, DOI 10.1038/nn1765
   Berti V, 2011, Q J NUCL MED MOL IM, V55, P225
   Blomgren K, 2007, APOPTOSIS, V12, P993, DOI 10.1007/s10495-007-0754-4
   BONDESSON I, 1989, CELL BIOL TOXICOL, V5, P331, DOI 10.1007/BF01795360
   Boulet SL, 2009, ARCH PEDIAT ADOL MED, V163, P19, DOI 10.1001/archpediatrics.2008.506
   Bove J, 2011, NAT REV NEUROSCI, V12, P437, DOI 10.1038/nrn3068
   Briz V, 2011, TOXICOL SCI, V120, P413, DOI 10.1093/toxsci/kfr019
   Cezar GG, 2007, STEM CELLS DEV, V16, P869, DOI 10.1089/scd.2007.0022
   Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529
   Chandler KJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018540
   Ciaroni S, 2002, MECH AGEING DEV, V123, P1341, DOI 10.1016/S0047-6374(02)00070-2
   Cimadamore F, 2009, STEM CELLS, V27, P1772, DOI 10.1002/stem.107
   Clancy B, 2007, NEUROTOXICOLOGY, V28, P931, DOI 10.1016/j.neuro.2007.01.014
   Coecke S, 2007, ENVIRON HEALTH PERSP, V115, P924, DOI 10.1289/ehp.9427
   Colleoni S., 2011, TOXICOLOGIC IN PRESS
   *COMM TOX TEST ASS, 2007, TOX TEST 21 CENT VIS
   Conti L, 2010, NAT REV NEUROSCI, V11, P176, DOI 10.1038/nrn2761
   Costa LG, 2007, NEUROTOXICOLOGY, V28, P1047, DOI 10.1016/j.neuro.2007.08.007
   Crofton KM, 2011, ALTEX-ALTERN ANIM EX, V28, P9
   de Jong E, 2011, REPROD TOXICOL, V31, P375, DOI 10.1016/j.reprotox.2010.11.012
   Ding S, 2003, P NATL ACAD SCI USA, V100, P7632, DOI 10.1073/pnas.0732087100
   Drachman DA, 2005, NEUROLOGY, V64, P2004, DOI 10.1212/01.WNL.0000166914.38327.BB
   Elkabetz Y, 2008, COLD SH Q B, V73, P377, DOI 10.1101/sqb.2008.73.052
   EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0
   Falsig J, 2006, J NEUROCHEM, V96, P893, DOI 10.1111/j.1471-4159.2005.03622.x
   Falsig J, 2004, J IMMUNOL, V173, P2762, DOI 10.4049/jimmunol.173.4.2762
   FARLIE PG, 1995, P NATL ACAD SCI USA, V92, P4397, DOI 10.1073/pnas.92.10.4397
   Fasano CA, 2010, CELL STEM CELL, V6, P336, DOI 10.1016/j.stem.2010.03.001
   Faustman EM, 2002, ENVIRON HEALTH PERSP, V110, P859, DOI 10.1289/ehp.02110s5859
   FRIED PA, 1992, NEUROTOXICOL TERATOL, V14, P299, DOI 10.1016/0892-0362(92)90036-A
   Garner CC, 2002, TRENDS NEUROSCI, V25, P243, DOI 10.1016/S0166-2236(02)02152-5
   Gaspard N, 2008, NATURE, V455, P351, DOI 10.1038/nature07287
   Gossrau G, 2007, STEM CELLS, V25, P939, DOI 10.1634/stemcells.2006-0299
   Gottesman II, 2003, AM J PSYCHIAT, V160, P636, DOI 10.1176/appi.ajp.160.4.636
   Gould TD, 2006, GENES BRAIN BEHAV, V5, P113, DOI 10.1111/j.1601-183X.2005.00186.x
   Grandjean P, 2006, LANCET, V368, P2167, DOI 10.1016/S0140-6736(06)69665-7
   Hammer TB, 2011, INT J NEUROPSYCHOPH, V14, P913, DOI 10.1017/S1461145711000034
   Hansson O, 2000, EXP NEUROL, V164, P102, DOI 10.1006/exnr.2000.7406
   Haramoto M, 2008, J HEALTH SCI, V54, P43, DOI 10.1248/jhs.54.43
   Harrill JA, 2010, NEUROTOXICOLOGY, V31, P277, DOI 10.1016/j.neuro.2010.02.003
   Hartung T, 2011, ALTEX-ALTERN ANIM EX, V28, P83, DOI 10.14573/altex.2011.2.083
   Hasler G, 2011, MOL PSYCHIATR, V16, P604, DOI 10.1038/mp.2011.23
   Jagtap S, 2011, BRIT J PHARMACOL, V162, P1743, DOI 10.1111/j.1476-5381.2010.01197.x
   Johansson C, 2007, NEUROTOX RES, V11, P241, DOI 10.1007/BF03033570
   Jung JW, 2010, CELL MOL LIFE SCI, V67, P1165, DOI 10.1007/s00018-009-0242-9
   Kalgutkar AS, 2004, DRUG METAB DISPOS, V32, P943
   Kaltezioti V, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000565
   KEELER RF, 1978, LIPIDS, V13, P708, DOI 10.1007/BF02533750
   KIMURA K, 1994, J BIOL CHEM, V269, P18961
   Kiryushko D, 2004, ANN NY ACAD SCI, V1014, P140, DOI 10.1196/annals.1294.015
   Krencik R, 2006, CURR OPIN CHEM BIOL, V10, P592, DOI 10.1016/j.cbpa.2006.10.002
   Kuegler P., GLIA IN PRESS
   Kuegler PB, 2010, ALTEX-ALTERN ANIM EX, V27, P17
   Kurosaka Satoshi, 2008, Birth Defects Research, V84, P102, DOI 10.1002/bdrc.20125
   Lange C, 2011, NEUROSCI LETT, V488, P36, DOI 10.1016/j.neulet.2010.10.076
   Lee G, 2009, NATURE, V461, P402, DOI 10.1038/nature08320
   Leist M, 2008, ALTEX-ALTERN TIEREXP, V25, P163
   Leist M, 2008, ALTEX-ALTERN TIEREXP, V25, P103
   Leist M, 2008, ALTEX-ALTERN TIEREXP, V25, P17
   Leist M, 2010, ALTEX-ALTERN ANIM EX, V27, P309
   Li J, 2011, J CEREBR BLOOD F MET, V31, P413, DOI 10.1038/jcbfm.2010.181
   Louvi A, 2006, NAT REV NEUROSCI, V7, P93, DOI 10.1038/nrn1847
   Lund S, 2006, J NEUROIMMUNOL, V180, P71, DOI 10.1016/j.jneuroim.2006.07.007
   LYMAN GH, 1976, NATURE, V262, P360, DOI 10.1038/262360a0
   Makris SL, 2009, ENVIRON HEALTH PERSP, V117, P17, DOI 10.1289/ehp.11447
   MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634
   Mc Henry KT, 2008, J CELL BIOCHEM, V103, P972, DOI 10.1002/jcb.21470
   Meador KJ, 2009, NEW ENGL J MED, V360, P1597, DOI 10.1056/NEJMoa0803531
   Middaugh LD, 2003, TOXICOL SCI, V76, P250, DOI 10.1093/toxsci/kfg211
   Monastyrska I, 2008, MOL BIOL CELL, V19, P1962, DOI 10.1091/mbc.E07-09-0892
   Moors M, 2009, ENVIRON HEALTH PERSP, V117, P1131, DOI 10.1289/ehp.0800207
   Moser VC, 1999, NEUROTOXICOL TERATOL, V21, P719, DOI 10.1016/S0892-0362(99)00029-X
   Munno DW, 2003, J PHYSIOL-LONDON, V552, P1, DOI 10.1113/jphysiol.2003.045062
   Munoz-Sanjuan I, 2002, NAT REV NEUROSCI, V3, P271, DOI 10.1038/nrn786
   NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4
   Nolen BJ, 2009, NATURE, V460, P1031, DOI 10.1038/nature08231
   Parran DK, 2003, DEV BRAIN RES, V141, P71, DOI 10.1016/S0165-3806(02)00644-2
   Parvez F., 2011, ENV HLTH PERSPECT
   Patapoutian A, 2000, CURR OPIN NEUROBIOL, V10, P392, DOI 10.1016/S0959-4388(00)00100-8
   Pazos P, 2010, REPROD TOXICOL, V30, P161, DOI 10.1016/j.reprotox.2010.04.001
   Penagarikano O, 2011, CELL, V147, P235, DOI 10.1016/j.cell.2011.08.040
   Perrier AL, 2004, P NATL ACAD SCI USA, V101, P12543, DOI 10.1073/pnas.0404700101
   Powell EM, 1997, CELL TISSUE RES, V290, P385, DOI 10.1007/s004410050945
   Prockop L D, 1995, J Spinal Cord Med, V18, P221
   Radio NM, 2008, NEUROTOXICOLOGY, V29, P361, DOI 10.1016/j.neuro.2008.02.011
   Radio NM, 2008, TOXICOL SCI, V105, P106, DOI 10.1093/toxsci/kfn114
   Radio NM, 2010, NEUROTOXICOL TERATOL, V32, P25, DOI 10.1016/j.ntt.2009.06.003
   Rao M, 2004, J NEUROTRAUM, V21, P415, DOI 10.1089/089771504323004566
   Rauh V, 2011, ENVIRON HEALTH PERSP, V119, P1196, DOI 10.1289/ehp.1003160
   Roegge CS, 2000, TOXICOL SCI, V57, P121, DOI 10.1093/toxsci/57.1.121
   Roussos P, 2011, BIOL PSYCHIAT, V69, P479, DOI 10.1016/j.biopsych.2010.09.009
   Ruhrberg C, 2010, CELL ADHES MIGR, V4, P622, DOI 10.4161/cam.4.4.13502
   San Martin N, 2011, STEM CELLS, V29, P1064, DOI 10.1002/stem.654
   Schildknecht S, 2011, J BIOL CHEM, V286, P4991, DOI 10.1074/jbc.M110.169565
   Schildknecht S, 2009, TOXICOL APPL PHARM, V241, P23, DOI 10.1016/j.taap.2009.07.027
   Sherer TB, 2007, J NEUROCHEM, V100, P1469, DOI 10.1111/j.1471-4159.2006.04333.x
   Sjostrom M, 2008, TOXICOL IN VITRO, V22, P1405, DOI 10.1016/j.tiv.2008.04.017
   SPENCER PS, 2000, EXPT CLIN NEUROTOXIC
   Stehr CM, 2006, TOXICOL SCI, V92, P270, DOI 10.1093/toxsci/kfj185
   Stiegler NV, 2011, TOXICOL SCI, V121, P73, DOI 10.1093/toxsci/kfr034
   Stummanna TC, 2009, TOXICOLOGY, V257, P117, DOI 10.1016/j.tox.2008.12.018
   Takahashi T, 2003, CIRCULATION, V107, P1912, DOI 10.1161/01.CIR.0000064899.53876.A3
   Takser L, 2003, NEUROTOXICOLOGY, V24, P667, DOI 10.1016/S0161-813X(03)00058-5
   Tarone G, 2000, INT J DEV BIOL, V44, P725
   Theunissen PT, 2011, TOXICOL SCI, V122, P437, DOI 10.1093/toxsci/kfr134
   Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145
   Tomson T, 2009, NEUROL CLIN, V27, P993, DOI 10.1016/j.ncl.2009.06.006
   Uyanikgil Y, 2004, CHILD NERV SYST, V20, P176, DOI 10.1007/s00381-003-0901-3
   Valiente M, 2010, CURR OPIN NEUROBIOL, V20, P68, DOI 10.1016/j.conb.2009.12.003
   van Thriel C., 2011, NEUROTOXICO IN PRESS
   Vinken M, 2008, MUTAT RES-REV MUTAT, V659, P202, DOI 10.1016/j.mrrev.2008.04.006
   Vo NK, 2010, CURR OPIN NEUROBIOL, V20, P457, DOI 10.1016/j.conb.2010.04.002
   Walkowiak J, 2001, LANCET, V358, P1602, DOI 10.1016/S0140-6736(01)06654-5
   WANG H, 1993, CELL PROLIFERAT, V26, P55, DOI 10.1111/j.1365-2184.1993.tb00006.x
   Watanabe KH, 2011, ENVIRON TOXICOL CHEM, V30, P9, DOI 10.1002/etc.373
   Weisskopf MG, 2010, NEUROLOGY, V74, P1055, DOI 10.1212/WNL.0b013e3181d76a93
   Werler MM, 2011, ANN EPIDEMIOL, V21, P842, DOI 10.1016/j.annepidem.2011.08.002
   West PR, 2010, TOXICOL APPL PHARM, V247, P18, DOI 10.1016/j.taap.2010.05.007
   Wilson L, 2005, DEV BIOL, V282, P1, DOI 10.1016/j.ydbio.2005.02.027
   Yan Y, 2009, CELL, V138, P1209, DOI 10.1016/j.cell.2009.06.042
   Yoshimura T, 2006, J NEUROSCI, V26, P10626, DOI 10.1523/JNEUROSCI.3824-06.2006
   Zeng XM, 2006, NEUROPSYCHOPHARMACOL, V31, P2708, DOI 10.1038/sj.npp.1301125
   Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129
   Zhu ST, 2005, CHEM BIOL, V12, P981, DOI 10.1016/j.chembiol.2005.07.007
   Zimmer B, 2011, CELL DEATH DIFFER, V18, P383, DOI 10.1038/cdd.2010.109
   Zimmer B, 2011, TOXICOL SCI, V121, P357, DOI 10.1093/toxsci/kfr054
NR 133
TC 50
Z9 50
U1 0
U2 17
PU FRONTIERS IN BIOSCIENCE INC
PI IRVINE
PA 16471 SCIENTIFIC WAY, IRVINE, CA 92618 USA
SN 1093-9946
EI 1093-4715
J9 FRONT BIOSCI-LANDMRK
JI Front. Biosci.
PD JUN 1
PY 2012
VL 17
BP 2442
EP 2460
DI 10.2741/4064
PG 19
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 048BX
UT WOS:000311886300006
PM 22652791
DA 2019-10-23
ER

PT J
AU Ellis-Hutchings, RG
   Settivari, RS
   Mccoy, AT
   Kleinstreuer, NC
   Marshall, VA
   Knudsen, TB
   Carney, EW
AF Ellis-Hutchings, R. G.
   Settivari, R. S.
   Mccoy, A. T.
   Kleinstreuer, N. C.
   Marshall, V. A.
   Knudsen, T. B.
   Carney, E. W.
TI Linking ToxCast (TM) Signatures with Functional Consequences:
   Proof-of-Concept Study Using Known Inhibitors of Vascular Development
SO BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY
LA English
DT Meeting Abstract
C1 [Ellis-Hutchings, R. G.; Settivari, R. S.; Mccoy, A. T.; Marshall, V. A.; Carney, E. W.] Dow Chem Co USA, Midland, MI 48674 USA.
   [Kleinstreuer, N. C.; Knudsen, T. B.] US EPA, NCCT, Res Triangle Pk, NC 27711 USA.
RI Settivari, Raja/I-5200-2012; Kleinstreuer, Nicole/F-7203-2019
OI Settivari, Raja/0000-0001-9003-5917; Kleinstreuer,
   Nicole/0000-0002-7914-3682
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1542-0752
EI 1542-0760
J9 BIRTH DEFECTS RES A
JI Birth Defects Res. Part A-Clin. Mol. Teratol.
PD MAY
PY 2012
VL 94
IS 5
SI SI
BP 331
EP 331
PG 1
WC Developmental Biology; Toxicology
SC Developmental Biology; Toxicology
GA 956FF
UT WOS:000305074800075
DA 2019-10-23
ER

PT J
AU Martyniuk, CJ
   Popesku, JT
   Chown, B
   Denslow, ND
   Trudeau, VL
AF Martyniuk, Christopher J.
   Popesku, Jason T.
   Chown, Brittany
   Denslow, Nancy D.
   Trudeau, Vance L.
TI Quantitative proteomics in teleost fish: Insights and challenges for
   neuroendocrine and neurotoxicology research
SO GENERAL AND COMPARATIVE ENDOCRINOLOGY
LA English
DT Review
DE Neuroproteome; Neurotoxicology; Hypothalamus; Microarray; Gene-protein
   relationship; Network analysis
ID GOLDFISH CARASSIUS-AURATUS; ZEBRAFISH DANIO-RERIO; T-CELLS; PROTEIN;
   BRAIN; MODEL; 17-ALPHA-ETHINYLESTRADIOL; IDENTIFICATION; TOXICOLOGY;
   ORGANISMS
AB Neuroendocrine systems integrate both extrinsic and intrinsic signals to regulate virtually all aspects of an animal's physiology. In aquatic toxicology, studies have shown that pollutants are capable of disrupting the neuroendocrine system of teleost fish, and many chemicals found in the environment can also have a neurotoxic mode of action. Omics approaches are now used to better understand cell signaling cascades underlying fish neurophysiology and the control of pituitary hormone release, in addition to identifying adverse effects of pollutants in the teleostean central nervous system. For example, both high throughput genomics and proteomic investigations of molecular signaling cascades for both neurotransmitter and nuclear receptor agonists/antagonists have been reported. This review highlights recent studies that have utilized quantitative proteomics methods such as 2D differential in-gel electrophoresis (DICE) and isobaric tagging for relative and absolute quantitation (iTRAQ) in neuroendocrine regions and uses these examples to demonstrate the challenges of using proteomics in neuroendocrinology and neurotoxicology research. To begin to characterize the teleost neuroproteome, we functionally annotated 623 unique proteins found in the fish hypothalamus and telencephalon. These proteins have roles in biological processes that include synaptic transmission, ATP production, receptor activity, cell structure and integrity, and stress responses. The biological processes most represented by proteins detected in the teleost neuroendocrine brain included transport (8.4%), metabolic process (5.5%), and glycolysis (4.8%). We provide an example of using sub-network enrichment analysis (SNEA) to identify protein networks in the fish hypothalamus in response to dopamine receptor signaling. Dopamine signaling altered the abundance of proteins that are binding partners of microfilaments, integrins, and intermediate filaments, consistent with data suggesting dopaminergic regulation of neuronal stability and structure. Lastly, for fish neuroendocrine studies using both high-throughput genomics and proteomics, we compare gene and protein relationships in the hypothalamus and demonstrate that correlation is often poor for single time point experiments. These studies highlight the need for additional time course analyses to better understand gene-protein relationships and adverse outcome pathways. This is important if both transcriptomics and proteomics are to be used together to investigate neuroendocrine signaling pathways or as bio-monitoring tools in ecotoxicology. (C) 2011 Elsevier Inc. All rights reserved.
C1 [Martyniuk, Christopher J.; Chown, Brittany] Univ New Brunswick, Dept Biol, St John, NB E2L 4L5, Canada.
   [Martyniuk, Christopher J.; Chown, Brittany] Univ New Brunswick, Canadian Rivers Inst, St John, NB E2L 4L5, Canada.
   [Popesku, Jason T.] Univ British Columbia, Child & Family Res Inst, Dept Obstet & Gynaecol, Vancouver, BC V5Z 4H4, Canada.
   [Denslow, Nancy D.] Univ Florida, Dept Physiol Sci, Gainesville, FL 32611 USA.
   [Denslow, Nancy D.] Univ Florida, Ctr Environm & Human Toxicol, Gainesville, FL 32611 USA.
   [Trudeau, Vance L.] Univ Ottawa, Dept Biol, Ottawa, ON K1N 6N5, Canada.
RP Martyniuk, CJ (reprint author), Univ New Brunswick, Dept Biol, St John, NB E2L 4L5, Canada.
EM cmartyn@unb.ca
RI Trudeau, Vance L./P-5542-2019
OI Trudeau, Vance L./0000-0002-0845-9444
FU Canada Research Chair programCanada Research Chairs; NIHUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [RO1 ES015449]; EPA STARUnited States Environmental Protection
   Agency [R831848]; NSERCNatural Sciences and Engineering Research Council
   of Canada
FX The current and former members of the Proteomics Research Group (C.
   Diaz, S. Chen, and S. McClung) at the University of Florida are
   acknowledged and appreciated for their expertise in quantitative
   proteomics. We would also like to acknowledge and thank D. Barber for
   his expertise and advice in quantitative proteomics. This research was
   supported and funded by the Canada Research Chair program (CJM), NIH RO1
   ES015449 Grant and EPA STAR Grant (R831848) (NDD) and NSERC Discovery
   Grant program (CJM and VLT).
CR Abreu RD, 2009, MOL BIOSYST, V5, P1512, DOI 10.1039/b908315d
   Ando H, 2005, DEV BIOL, V287, P456, DOI 10.1016/j.ydbio.2005.09.023
   Bassett D, 2004, CLIN EXP PHARMACOL P, V31, P537, DOI 10.1111/j.1440-1681.2004.04030.x
   Boschetti E, 2009, PROTEOMICS, V9, P1492, DOI 10.1002/pmic.200800389
   Chuang HY, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100180
   Damodaran S, 2006, EUR J PHARMACOL, V547, P75, DOI 10.1016/j.ejphar.2006.08.005
   De Wit M, 2010, GEN COMP ENDOCR, V167, P190, DOI 10.1016/j.ygcen.2010.03.003
   Denslow ND, 2005, BIOCH MOLEC, V6, P85
   Fang YJ, 2010, TOXICOL LETT, V199, P69, DOI 10.1016/j.toxlet.2010.08.008
   Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985
   Forne I, 2010, PROTEOMICS, V10, P858, DOI 10.1002/pmic.200900609
   Gunnarsson L, 2008, ENVIRON SCI TECHNOL, V42, P5807, DOI 10.1021/es8005173
   HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915
   Levite M, 2001, EUR J IMMUNOL, V31, P3504, DOI 10.1002/1521-4141(200112)31:12<3504::AID-IMMU3504>3.0.CO;2-F
   Malyala A, 2004, NEUROCHEM RES, V29, P1189, DOI 10.1023/B:NERE.0000023606.13670.1d
   Marlatt VL, 2008, MOL CELL ENDOCRINOL, V283, P38, DOI 10.1016/j.mce.2007.10.013
   Martyniuk CJ, 2007, AQUAT TOXICOL, V84, P38, DOI 10.1016/j.aquatox.2007.05.012
   Martyniuk CJ, 2006, PHYSIOL GENOMICS, V27, P328, DOI 10.1152/physiolgenomics.00090.2006
   Martyniuk CJ, 2010, TOXICOL SCI, V117, P190, DOI 10.1093/toxsci/kfq192
   Martyniuk CJ, 2010, AQUAT TOXICOL, V98, P344, DOI 10.1016/j.aquatox.2010.03.007
   Martyniuk CJ, 2009, GEN COMP ENDOCR, V164, P135, DOI 10.1016/j.ygcen.2009.01.023
   Martyniuk CJ, 2009, J PROTEOME RES, V8, P2186, DOI 10.1021/pr800627n
   Matsui H, 2009, NEUROSCI RES, V65, P263, DOI 10.1016/j.neures.2009.07.010
   McCarthy FM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-229
   Mennigen JA, 2008, PHYSIOL GENOMICS, V35, P273, DOI 10.1152/physiolgenomics.90263.2008
   Miracle A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004491
   Na HK, 2008, CHIN J CHROMATOGR, V26, P662, DOI 10.1016/S1872-2059(08)60030-9
   POLLARD HB, 1993, ANN NY ACAD SCI, V679, P317, DOI 10.1111/j.1749-6632.1993.tb18314.x
   Popesku JT, 2008, MOL CELL ENDOCRINOL, V293, P43, DOI 10.1016/j.mce.2008.06.017
   Popesku JT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012338
   Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200
   Ruggeri B, 2008, GEN COMP ENDOCR, V158, P138, DOI 10.1016/j.ygcen.2008.05.012
   Sammut SJ, 2008, BRIEF BIOINFORM, V9, P210, DOI 10.1093/bib/bbn010
   Sanchez BC, 2011, ENVIRON TOXICOL CHEM, V30, P274, DOI 10.1002/etc.402
   Shojaie A, 2010, STAT APPL GENET MOL, V9, DOI 10.2202/1544-6115.1483
   Singh S. K., 2010, J PROTEOM BIOINFORM, V3, P135
   Villeneuve DL, 2010, AQUAT TOXICOL, V98, P354, DOI 10.1016/j.aquatox.2010.03.006
   Volkel P, 2010, BIOCHEM SOC T, V38, P883, DOI 10.1042/BST0380883
   Watanabe Y, 2006, J IMMUNOL, V176, P848, DOI 10.4049/jimmunol.176.2.848
   Waye A, 2011, J TOXICOL ENV HEAL B, V14, P270, DOI 10.1080/10937404.2011.578273
   Xi YW, 2011, CURR NEUROL NEUROSCI, V11, P274, DOI 10.1007/s11910-011-0182-2
   Yamamoto T, 2003, ZOOL SCI, V20, P181, DOI 10.1023/A:1022662927574
   Zhu JY, 2006, AQUAT TOXICOL, V78, P127, DOI 10.1016/j.aquatox.2006.02.010
NR 43
TC 19
Z9 19
U1 2
U2 73
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0016-6480
EI 1095-6840
J9 GEN COMP ENDOCR
JI Gen. Comp. Endocrinol.
PD MAY 1
PY 2012
VL 176
IS 3
BP 314
EP 320
DI 10.1016/j.ygcen.2011.12.006
PG 7
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 937YU
UT WOS:000303700900007
PM 22202605
OA Green Accepted
DA 2019-10-23
ER

PT S
AU Golden, NH
   Noguchi, GE
   Paul, KA
   Buford, DJ
AF Golden, Nancy H.
   Noguchi, George E.
   Paul, Keith A.
   Buford, Daniel J.
BE Racke, KD
   McGaughey, BD
   Cowles, JL
   Hall, AT
   Jackson, SH
   Jenkins, JJ
   Johnston, JJ
TI Consideration of Nontraditional Endpoints in the Assessment of
   Ecological Risk under the Endangered Species Act
SO PESTICIDE REGULATION AND THE ENDANGERED SPECIES ACT
SE ACS Symposium Series
LA English
DT Proceedings Paper
CT Symposium on the Endangered Species Act and Pesticide Regulation:
   Scientific and Process Improvements / 242nd Meeting of the
   American-Chemical-Society
CY AUG 30-SEP 01, 2011
CL Denver, CO
SP Amer Chem Soc, AGRO Div, Dow AgroScienes, CropLife Amer, Intrinsik Environm Sci
ID ADVERSE OUTCOME PATHWAYS; ECOTOXICOLOGY; PESTICIDES; FRAMEWORK;
   RESPONSES; FISH
AB As the field of environmental toxicology progresses, research is revealing effects on species that expand beyond the traditional endpoints of survival, growth, and reproduction as measured in single organism lab studies. Exposure to contaminants can result in adverse effects to endocrine function, olfaction, behavior, and other physiological impairments that may be exacerbated in combination with ecological stressors. Decisions regarding the management of species listed under the Endangered Species Act necessitate an examination of the best available data regarding all the effects of stressors on the conservation of those species, as well as treatment of uncertainty that is inclusive of all potential risks and is commensurate with their protected status. Analysis of potential linkages between sublethal responses of pesticides to higher-order responses in individuals and populations often requires extrapolation of incomplete data sets to provide protection to vulnerable species facing a myriad of potential threats. The adverse outcome pathway model provides a useful framework for the incorporation and use of currently available data, as well as a means to identify vital data gaps to be filled through future research and monitoring.
C1 [Golden, Nancy H.; Noguchi, George E.; Paul, Keith A.; Buford, Daniel J.] US Fish & Wildlife Serv, Arlington, VA 22203 USA.
RP Golden, NH (reprint author), US Fish & Wildlife Serv, 4401 North Fairfax Dr, Arlington, VA 22203 USA.
EM Nancy_Golden@fws.gov
CR Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Baldwin DH, 2009, ECOL APPL, V19, P2004, DOI 10.1890/08-1891.1
   Carson R., 1962, SILENT SPRING
   Celander MC, 2011, ENVIRON TOXICOL CHEM, V30, P52, DOI 10.1002/etc.382
   Clements WH, 2009, ENVIRON TOXICOL CHEM, V28, P1789, DOI 10.1897/09-140.1
   FRIEND M, 1970, Journal of Wildlife Diseases, V6, P335
   Grue CE, 1997, AM ZOOL, V37, P369
   Heugens EHW, 2001, CRIT REV TOXICOL, V31, P247, DOI 10.1080/20014091111695
   Kasumyan A. O., 2004, J ICHTHYOL S2, V44, pS180
   Kasumyan A. O, 1993, J ICHTHYOL, V33, P271
   Kasumyan AO, 1999, J APPL ICHTHYOL, V15, P228, DOI 10.1111/j.1439-0426.1999.tb00240.x
   Kramer VJ, 2011, ENVIRON TOXICOL CHEM, V30, P64, DOI 10.1002/etc.375
   Miller DH, 2007, ENVIRON TOXICOL CHEM, V26, P521, DOI 10.1897/06-318R.1
   National Research Council, 2007, TOX TEST 21 CENT VIS, P196
   Nichols JW, 2011, ENVIRON TOXICOL CHEM, V30, P39, DOI 10.1002/etc.376
   Perkins EJ, 2011, ENVIRON TOXICOL CHEM, V30, P22, DOI 10.1002/etc.374
   Relyea R, 2006, ECOL LETT, V9, P1157, DOI 10.1111/j.1461-0248.2006.00966.x
   Rohr JR, 2006, TRENDS ECOL EVOL, V21, P606, DOI 10.1016/j.tree.2006.07.002
   Scott GR, 2004, AQUAT TOXICOL, V68, P369, DOI 10.1016/j.aquatox.2004.03.016
   U.S. Environmental Protection Agency, 2006, POT ATR US CHES BAY
   U.S. Fish and Wildlife Service, 2008, REPL INF CONS EFF AT
   Villeneuve DL, 2011, ENVIRON TOXICOL CHEM, V30, P1, DOI 10.1002/etc.396
   Vyas NB, 1999, TOXICOL IND HEALTH, V15, P186, DOI 10.1191/074823399678846628
   Walker CH, 2003, ECOTOXICOLOGY, V12, P307, DOI 10.1023/A:1022523331343
   Watanabe KH, 2011, ENVIRON TOXICOL CHEM, V30, P9, DOI 10.1002/etc.373
NR 25
TC 0
Z9 0
U1 0
U2 3
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 SIXTEENTH ST NW, WASHINGTON, DC 20036 USA
SN 0097-6156
EI 1947-5918
BN 978-0-8412-2703-3
J9 ACS SYM SER
JI ACS Symp. Ser.
PY 2012
VL 1111
BP 271
EP 282
PG 12
WC Agriculture, Multidisciplinary; Environmental Sciences
SC Agriculture; Environmental Sciences & Ecology
GA BEO32
UT WOS:000317550400020
DA 2019-10-23
ER

PT B
AU Escher, B
   Leusch, F
   Chapman, H
   Poulsen, A
AF Escher, Beate
   Leusch, Frederic
   Chapman, Heather
   Poulsen, Anita
BA Escher, B
   Leusch, F
BF Escher, B
   Leusch, F
TI Toxicity pathways of chemicals in aquatic organisms
SO BIOANALYTICAL TOOLS IN WATER QUALITY ASSESSMENT
LA English
DT Article; Book Chapter
RI Leusch, Frederic/A-2806-2011
OI Leusch, Frederic/0000-0002-6934-4587
NR 0
TC 0
Z9 0
U1 0
U2 4
PU IWA PUBLISHING
PI LONDON
PA ALLIANCE HOUSE, 12 CAXTON ST, LONDON SW1H 0QS, ENGLAND
BN 978-1-84339-368-9
PY 2012
BP 87
EP 94
PG 8
WC Biochemical Research Methods; Toxicology; Water Resources
SC Biochemistry & Molecular Biology; Toxicology; Water Resources
GA BDQ92
UT WOS:000314502900007
DA 2019-10-23
ER

PT J
AU Enoch, SJ
   Schultz, TW
   Cronin, MTD
AF Enoch, S. J.
   Schultz, T. W.
   Cronin, M. T. D.
TI The definition of the applicability domain relevant to skin
   sensitization for the aromatic nucleophilic substitution mechanism
SO SAR AND QSAR IN ENVIRONMENTAL RESEARCH
LA English
DT Article
DE in chemico; SNAr; structural alerts; electrophilic reaction chemistry;
   adverse outcome pathways
ID LYMPH-NODE ASSAY; READ-ACROSS; CATEGORY FORMATION; GENE-EXPRESSION;
   PREDICTION; REACTIVITY; IDENTIFICATION; BINDING; CHEMICALS; ANIMALS
AB This study outlines how a glutathione reactivity assay (so-called in chemico data) can be used to define the applicability domain for the nucleophilic aromatic substitution (SNAr) reaction for benzenes. This reaction is one of the six mechanistic domains that have been shown to be important in toxicological endpoints in which the ability to bind covalently to a protein is a key molecular initiating event. This study has analysed the experimental data, allowing a clear and interpretable structure-activity relationship to be developed for the SNAr domain. The applicability domain has resulted in a series of structural alerts. The definition of the applicability domain for the SNAr reaction and the resulting structural alerts are likely to be beneficial in the development of computational tools for category formation and read-across. The study concludes with how this information can be used in the development of adverse outcome pathways.
C1 [Enoch, S. J.; Cronin, M. T. D.] Liverpool John Moores Univ, Sch Pharm & Chem, Liverpool L3 5UX, Merseyside, England.
   [Schultz, T. W.] Univ Tennessee, Coll Vet Med, Dept Comparat Med, Knoxville, TN USA.
RP Cronin, MTD (reprint author), Liverpool John Moores Univ, Sch Pharm & Chem, Liverpool L3 5UX, Merseyside, England.
EM m.t.cronin@ljmu.ac.uk
FU European Chemicals Agency Service [ECHA/2008/20/ECA.203]; Defra through
   the Sustainable Arable Link ProgrammeDepartment for Environment, Food &
   Rural Affairs (DEFRA)
FX The funding of the European Chemicals Agency Service Contract No.
   ECHA/2008/20/ECA.203 is gratefully acknowledged. The project was
   sponsored by Defra through the Sustainable Arable Link Programme.
CR Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Aptula AO, 2006, TOXICOL IN VITRO, V20, P239, DOI 10.1016/j.tiv.2005.07.003
   Aptula AO, 2005, CHEM RES TOXICOL, V18, P1420, DOI 10.1021/tx050075m
   Aptula AO, 2006, CHEM RES TOXICOL, V19, P1097, DOI 10.1021/tx0601004
   Ashikaga T, 2010, ATLA-ALTERN LAB ANIM, V38, P275, DOI 10.1177/026119291003800403
   Basketter DA, 1996, FOOD CHEM TOXICOL, V34, P985, DOI 10.1016/S0278-6915(96)00059-2
   BUEHLER EV, 1965, ARCH DERMATOL, V91, P171, DOI 10.1001/archderm.1965.01600080079017
   Combes R, 2005, ATLA-ALTERN LAB ANIM, V33, P289, DOI 10.1177/026119290503300302
   Diderich R, 2010, ISSUES TOXICOL, V7, P385
   Dimitrov S, 2010, ISSUES TOXICOL, V7, P372
   dos Santos GG, 2009, TOXICOL APPL PHARM, V236, P372, DOI 10.1016/j.taap.2009.02.004
   dos Santos GG, 2011, TOXICOL IN VITRO, V25, P347, DOI 10.1016/j.tiv.2010.10.008
   Emter R, 2010, TOXICOL APPL PHARM, V245, P281, DOI 10.1016/j.taap.2010.03.009
   Enoch SJ, 2008, SAR QSAR ENVIRON RES, V19, P555, DOI 10.1080/10629360802348985
   Enoch SJ, 2010, CHEM RES TOXICOL, V23, P1547, DOI 10.1021/tx100218h
   Enoch SJ, 2011, ATLA-ALTERN LAB ANIM, V39, P131, DOI 10.1177/026119291103900206
   Enoch SJ, 2010, CHALL ADV COMPUT CHE, V8, P209, DOI 10.1007/978-1-4020-9783-6_7
   Gerberick F, 2008, ATLA-ALTERN LAB ANIM, V36, P215, DOI 10.1177/026119290803600210
   Gerberick GF, 2005, DERMATITIS, V16, P157, DOI 10.2310/6620.2005.05040
   Karlberg AT, 2008, CHEM RES TOXICOL, V21, P53, DOI 10.1021/tx7002239
   Kern PS, 2010, DERMATITIS, V21, P8, DOI 10.2310/6620.2009.09038
   Kimber I, 2002, INT IMMUNOPHARMACOL, V2, P201, DOI 10.1016/S1567-5769(01)00173-4
   Landsteiner K, 1935, J EXP MED, V61, P643, DOI 10.1084/jem.61.5.643
   Landsteiner K, 1936, J EXP MED, V64, P625, DOI 10.1084/jem.64.4.625
   MAGNUSSON B, 1969, J INVEST DERMATOL, V52, P268, DOI 10.1038/jid.1969.42
   McKim JM, 2010, CUTAN OCUL TOXICOL, V29, P171, DOI 10.3109/15569527.2010.483869
   Natsch A, 2008, TOXICOL SCI, V106, P464, DOI 10.1093/toxsci/kfn194
   Natsch A, 2008, TOXICOL SCI, V102, P110, DOI 10.1093/toxsci/kfm259
   OECD, 2007, GUID GROUP CHEM
   OECD, OECD QSAR APPL TOOLB
   Roberts DW, 2011, CHEM RES TOXICOL, V24, P1003, DOI 10.1021/tx100420w
   Roberts DW, 2007, CHEM RES TOXICOL, V20, P1019, DOI 10.1021/tx700024w
   Roberts DW, 2009, CHEM RES TOXICOL, V22, P592, DOI 10.1021/tx800431x
   ROBERTS DW, 1995, CHEM RES TOXICOL, V8, P545, DOI 10.1021/tx00046a008
   Schultz TW, 2010, ISSUES TOXICOL, V7, P346
   Schultz TW, 2007, CHEM RES TOXICOL, V20, P1359, DOI 10.1021/tx700212u
   Schultz TW, 2009, CONTACT DERMATITIS, V60, P21, DOI 10.1111/j.1600-0536.2008.01473.x
   Schwobel JAH, 2011, CHEM REV, V111, P2562, DOI 10.1021/cr100098n
   Vandebriel RJ, 2010, TOXICOL SCI, V117, P81, DOI 10.1093/toxsci/kfq182
NR 39
TC 10
Z9 10
U1 0
U2 12
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1062-936X
EI 1029-046X
J9 SAR QSAR ENVIRON RES
JI SAR QSAR Environ. Res.
PY 2012
VL 23
IS 7-8
BP 649
EP 663
DI 10.1080/1062936X.2012.679691
PG 15
WC Chemistry, Multidisciplinary; Computer Science, Interdisciplinary
   Applications; Environmental Sciences; Mathematical & Computational
   Biology; Toxicology
SC Chemistry; Computer Science; Environmental Sciences & Ecology;
   Mathematical & Computational Biology; Toxicology
GA 034EE
UT WOS:000310852100003
PM 22647056
DA 2019-10-23
ER

PT J
AU Blaauboer, BJ
   Boekelheide, K
   Clewell, HJ
   Daneshian, M
   Dingemans, MML
   Goldberg, AM
   Heneweer, M
   Jaworska, J
   Kramer, NI
   Leist, M
   Seibert, H
   Testai, E
   Vandebriel, RJ
   Yager, JD
   Zurlo, J
AF Blaauboer, Bas J.
   Boekelheide, Kim
   Clewell, Harvey J.
   Daneshian, Mardas
   Dingemans, Milou M. L.
   Goldberg, Alan M.
   Heneweer, Marjoke
   Jaworska, Joanna
   Kramer, Nynke I.
   Leist, Marcel
   Seibert, Hasso
   Testai, Emanuela
   Vandebriel, Rob J.
   Yager, James D.
   Zurlo, Joanne
TI The Use of Biomarkers of Toxicity for Integrating In Vitro Hazard
   Estimates Into Risk Assessment for Humans
SO ALTEX-ALTERNATIVES TO ANIMAL EXPERIMENTATION
LA English
DT Article
DE biomarker of toxicity; integrated testing strategies; quantitative in
   vitro-in vivo extrapolations
ID SOLID-PHASE MICROEXTRACTION; NOMINAL EFFECTIVE CONCENTRATIONS; ADVERSE
   OUTCOME PATHWAYS; EMBRYONIC STEM-CELLS; TESTING STRATEGIES; ALTERNATIVE
   METHODS; ECVAM WORKSHOP; SERUM CONCENTRATIONS; VIVO EXTRAPOLATION;
   CYTOTOXIC POTENCY
AB The role that in vitro systems can play in toxicological risk assessment is determined by the appropriateness of the chosen methods, with respect to the way in which in vitro data can be extrapolated to the in vivo situation. This report presents the results of a workshop aimed at better defining the use of in vitro-derived biomarkers of toxicity (BoT) and determining the place these data can have in human risk assessment. As a result, a conceptual framework is presented for the incorporation of in vitro-derived toxicity data into the risk assessment process. The selection of BoT takes into account that they need to distinguish adverse and adaptive changes in cells. The framework defines the place of in vitro systems in the context of data on exposure, structural and physico-chemical properties, and toxicodynamic and biokinetic modeling. It outlines the determination of a proper point-of-departure (PoD) for in vitro-in vivo extrapolation, allowing implementation in risk assessment procedures. A BoT will need to take into account both the dynamics and the kinetics of the compound in the in vitro systems. For the implementation of the proposed framework it will be necessary to collect and collate data from existing literature and new in vitro test systems, as well as to categorize biomarkers of toxicity and their relation to pathways-of-toxicity. Moreover, data selection and integration need to be driven by their usefulness in a quantitative in vitro-in vivo extrapolation (QIVIVE).
C1 [Blaauboer, Bas J.] Univ Utrecht, Inst Risk Assessment Sci, Div Toxicol, Doerenkamp Zbinden Chair Alternat Anim Testing To, NL-3508 TD Utrecht, Netherlands.
   [Boekelheide, Kim] Brown Univ, Dept Pathol & Lab Med, Providence, RI 02912 USA.
   [Clewell, Harvey J.] Hamner Inst Hlth Sci, Res Triangle Pk, NC USA.
   [Daneshian, Mardas; Leist, Marcel] Univ Konstanz, Ctr Alternat Anim Testing Europe, Constance, Germany.
   [Goldberg, Alan M.; Zurlo, Joanne] Johns Hopkins Univ, Ctr Alternat Anim Testing, Baltimore, MD USA.
   [Heneweer, Marjoke] Shell Int Petr Maatschappij BV, The Hague, Netherlands.
   [Jaworska, Joanna] Procter & Gamble, Cent Prod Safety, Strombeek Bever, Belgium.
   [Leist, Marcel] Univ Konstanz, Doerenkamp Zbinden Chair Vitro Toxicol & Biomed, Fac Sci & Math, Constance, Germany.
   [Seibert, Hasso] Univ Med Sch Schleswig Holstein, Inst Toxicol & Pharmacol Nat Scientists, Kiel, Germany.
   [Testai, Emanuela] Ist Super Sanita, Environm & Primary Prevent Dept, Mech Tox Unit, I-00161 Rome, Italy.
   [Vandebriel, Rob J.] Natl Inst Publ Hlth & Environm, Lab Hlth Protect Res, NL-3720 BA Bilthoven, Netherlands.
   [Yager, James D.; Zurlo, Joanne] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD USA.
RP Blaauboer, BJ (reprint author), Univ Utrecht, Inst Risk Assessment Sci, Div Toxicol, Doerenkamp Zbinden Chair Alternat Anim Testing To, POB 80-177, NL-3508 TD Utrecht, Netherlands.
EM b.blaauboer@uu.nl
RI Leist, Marcel/D-2133-2010; Vandebriel, Rob/P-6769-2019
OI Leist, Marcel/0000-0002-3778-8693; Vandebriel, Rob/0000-0001-9140-952X;
   Blaauboer, Bas/0000-0002-0108-2402
FU Doerenkamp-Zbinden Foundation; CAAT-Europe
FX We gratefully acknowledge the Doerenkamp-Zbinden Foundation and
   CAAT-Europe for their support of this workshop.
CR Adler S, 2011, ARCH TOXICOL, V85, P367, DOI 10.1007/s00204-011-0693-2
   Aldridge BB, 2006, NAT CELL BIOL, V8, P1195, DOI 10.1038/ncb1497
   Andersen M. E., 1987, PHARMACOKINETICS RIS, V8
   ANDERSEN ME, 1987, TOXICOL APPL PHARM, V87, P185, DOI 10.1016/0041-008X(87)90281-X
   ANDERSEN ME, 1987, AM IND HYG ASSOC J, V48, P335, DOI 10.1080/15298668791384850
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Balmer NV, 2012, HUM MOL GENET, V21, P4104, DOI 10.1093/hmg/dds239
   Basketter DA, 2012, ALTEX-ALTERN ANIM EX, V29, P5, DOI 10.14573/altex.2012.1.003
   Benford DJ, 2000, ATLA-ALTERN LAB ANIM, V28, P119, DOI 10.1177/026119290002800104
   Bhattacharya S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020887
   Blaauboer BJ, 2008, TOXICOL LETT, V180, P81, DOI 10.1016/j.toxlet.2008.05.008
   Blaauboer BJ, 2007, ARCH TOXICOL, V81, P385, DOI 10.1007/s00204-006-0175-0
   Blaauboer BJ, 2010, J TOXICOL ENV HEAL B, V13, P242, DOI 10.1080/10937404.2010.483940
   Blaauboer BJ, 1999, ATLA-ALTERN LAB ANIM, V27, P229, DOI 10.1177/026119299902700211
   Boekelheide K, 2012, TOXICOL SCI, V129, P249, DOI 10.1093/toxsci/kfs200
   Boekelheide Kim, 2010, ALTEX, V27, P243
   Bosgra S, 2009, TOXICOL APPL PHARM, V236, P1, DOI 10.1016/j.taap.2009.01.002
   Broeders JJW, 2011, J CHROMATOGR A, V1218, P8529, DOI 10.1016/j.chroma.2011.09.064
   Bushnell PJ, 2005, ENVIRON TOXICOL PHAR, V19, P607, DOI 10.1016/j.etap.2004.12.026
   Caldwell JC, 2012, J TOXICOL, DOI 10.1155/2012/852384
   Canton I, 2010, BIOTECHNOL BIOENG, V106, P794, DOI 10.1002/bit.22742
   Catania JM, 2007, TOXICOL IN VITRO, V21, P956, DOI 10.1016/j.tiv.2007.02.001
   Clewell HJ, 2008, TOXICOL LETT, V180, P100, DOI 10.1016/j.toxlet.2008.06.002
   Clewell HJ, 2002, ENVIRON HEALTH PERSP, V110, P85, DOI 10.1289/ehp.0211085
   Coecke S, 2006, ATLA-ALTERN LAB ANIM, V34, P49, DOI 10.1177/026119290603400113
   Coecke S, 2013, TOXICOL IN VITRO, V27, P1570, DOI 10.1016/j.tiv.2012.06.012
   Combes RD, 2011, ATLA-ALTERN LAB ANIM, V39, P213, DOI 10.1177/026119291103900303
   Crofton KM, 2011, ALTEX-ALTERN ANIM EX, V28, P9
   Crump KS, 2009, ENVIRON ECOL STAT, V16, P13, DOI 10.1007/s10651-007-0077-1
   d'Yvoire MB, 2012, ADV EXP MED BIOL, V745, P154, DOI 10.1007/978-1-4614-3055-1_10
   Daneshian M, 2011, ALTEX-ALTERN ANIM EX, V28, P341, DOI 10.14573/altex.2011.4.341
   Daneshian M, 2010, ALTEX-ALTERN ANIM EX, V27, P63
   DeJongh J, 1999, TOXICOL APPL PHARM, V158, P261, DOI 10.1006/taap.1999.8670
   Demchuk E, 2011, TOXICOL APPL PHARM, V254, P192, DOI 10.1016/j.taap.2010.10.017
   Dix DJ, 2012, TOXICOL SCI, V130, P440, DOI 10.1093/toxsci/kfs281
   Eisenbrand G, 2002, FOOD CHEM TOXICOL, V40, P193, DOI 10.1016/S0278-6915(01)00118-1
   Ellison CM, 2011, EXPERT OPIN DRUG MET, V7, P1481, DOI 10.1517/17425255.2011.629186
   Falsig J, 2004, J NEUROCHEM, V88, P181, DOI 10.1046/j.1471-4159.2003.02144.x
   Forsby A, 2007, HUM EXP TOXICOL, V26, P333, DOI 10.1177/0960327106072994
   Gabbert S, 2012, J RISK RES, V15, P583, DOI 10.1080/13669877.2011.646291
   Gulden M, 2010, FREE RADICAL BIO MED, V49, P1298, DOI 10.1016/j.freeradbiomed.2010.07.015
   Gulden M, 2003, TOXICOLOGY, V189, P211, DOI 10.1016/S0300-483X(03)00146-X
   Gulden M, 2002, TOXICOLOGY, V175, P201, DOI 10.1016/S0300-483X(02)00085-9
   Gulden M, 2001, TOXICOL IN VITRO, V15, P233, DOI 10.1016/S0887-2333(01)00008-X
   Gulden M., 2006, ALTEX, V23, P218
   Gulden M, 2006, TOXICOL IN VITRO, V20, P1114, DOI 10.1016/j.tiv.2006.02.002
   Hakansson H, 2011, TOXICOL LETT, V205, pS262, DOI 10.1016/j.toxlet.2011.05.890
   Hallier-Vanuxeem D, 2009, TOXICOL IN VITRO, V23, P447, DOI 10.1016/j.tiv.2008.12.011
   Hartung T, 2012, ALTEX-ALTERN ANIM EX, V29, P251, DOI 10.14573/altex.2012.3.251
   Hartung T, 2011, ALTEX-ALTERN ANIM EX, V28, P83, DOI 10.14573/altex.2011.2.083
   Hartung T, 2011, EUR J PHARM BIOPHARM, V77, P338, DOI 10.1016/j.ejpb.2010.12.027
   Hartung T, 2009, ALTEX-ALTERN TIEREXP, V26, P75
   HCN - Health Council of the Netherlands, 2001, HCN HLTH COUNC NETH
   Health Council of the Netherlands (HCN), 2008, HCN PUBL
   Heneweer M, 2005, TOXICOL SCI, V83, P257, DOI 10.1093/toxsci/kfi025
   Henn A, 2011, J IMMUNOL, V186, P3237, DOI 10.4049/jimmunol.1002787
   Henn A, 2009, ALTEX-ALTERN TIEREXP, V26, P83
   Heringa MB, 2004, ENVIRON SCI TECHNOL, V38, P6263, DOI 10.1021/es049285w
   Jaworska J, 2011, ALTEX-ALTERN ANIM EX, V28, P211, DOI 10.14573/altex.2011.3.211
   Jaworska Joanna, 2010, ALTEX, V27, P231
   Jaworska J, 2010, REGUL TOXICOL PHARM, V57, P157, DOI 10.1016/j.yrtph.2010.02.003
   Judson RS, 2012, INT J MOL SCI, V13, P1805, DOI 10.3390/ijms13021805
   Judson RS, 2011, CHEM RES TOXICOL, V24, P451, DOI 10.1021/tx100428e
   Kadereit S, 2012, FRONT BIOSCI-LANDMRK, V17, P2442, DOI 10.2741/4064
   Kienhuis AS, 2011, TOXICOL APPL PHARM, V250, P96, DOI 10.1016/j.taap.2010.10.013
   Kinsner-Ovaskainen A, 2012, ATLA-ALTERN LAB ANIM, V40, P175, DOI 10.1177/026119291204000310
   Kramer NI, 2007, ANAL CHEM, V79, P6941, DOI 10.1021/ac070574n
   Kramer NI, 2012, CHEM RES TOXICOL, V25, P436, DOI 10.1021/tx200479k
   Kramer NI, 2010, CHEM RES TOXICOL, V23, P1806, DOI 10.1021/tx1002595
   Krewski D, 2010, J TOXICOL ENV HEAL B, V13, P51, DOI 10.1080/10937404.2010.483176
   Krewski D, 2009, RISK ANAL, V29, P474, DOI 10.1111/j.1539-6924.2008.01150.x
   Kroes R, 2007, FOOD CHEM TOXICOL, V45, P2533, DOI 10.1016/j.fct.2007.06.021
   Kuegler PB, 2010, ALTEX-ALTERN ANIM EX, V27, P17
   Latta M, 2000, J EXP MED, V191, P1975, DOI 10.1084/jem.191.11.1975
   Leist M, 2008, ALTEX-ALTERN TIEREXP, V25, P163
   Leist M, 2008, ALTEX-ALTERN TIEREXP, V25, P103
   Leist M, 2010, ALTEX-ALTERN ANIM EX, V27, P309
   Leite SB, 2011, TOXICOL IN VITRO, V25, P825, DOI 10.1016/j.tiv.2011.02.002
   Li AP, 2012, CHEM-BIOL INTERACT, V199, P1, DOI 10.1016/j.cbi.2012.05.003
   Lock EF, 2012, TOXICOL SCI, V126, P578, DOI 10.1093/toxsci/kfs023
   Lotharius J, 2005, J NEUROSCI, V25, P6329, DOI 10.1523/JNEUROSCI.1746-05.2005
   Louisse J, 2010, TOXICOL APPL PHARM, V245, P236, DOI 10.1016/j.taap.2010.03.005
   Marchant CA, 2008, TOXICOL MECH METHOD, V18, P177, DOI 10.1080/15376510701857320
   Maxwell G, 2008, ATLA-ALTERN LAB ANIM, V36, P557, DOI 10.1177/026119290803600511
   Meganathan K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044228
   National Institute of Environmental Health Sciences (NIEHS), 2001, NIH PUBL
   NRC (National Research Council), 2007, TOX TEST 21 CENT VIS
   OECD, 2012, OECD ENV HLTH SAF PU, P10
   Oravcova J, 1996, J CHROMATOGR B, V677, P1, DOI 10.1016/0378-4347(95)00425-4
   Paini A, 2010, TOXICOL APPL PHARM, V245, P57, DOI 10.1016/j.taap.2010.01.016
   Perkel JM, 2012, SCIENCE, V335, P1122, DOI DOI 10.1126/SCIENCE.335.6072.1122
   Poltl D, 2012, NEUROTOXICOLOGY, V33, P769, DOI 10.1016/j.neuro.2011.12.007
   Prot JM, 2012, ANN BIOMED ENG, V40, P1228, DOI 10.1007/s10439-011-0480-5
   Punt A, 2011, REGUL TOXICOL PHARM, V61, P105, DOI 10.1016/j.yrtph.2011.06.007
   Renwick AG, 1998, REGUL TOXICOL PHARM, V27, P3, DOI 10.1006/rtph.1997.1195
   Russell WMS, 1959, PRINCIPLES HUMANE EX
   Sand S, 2012, J APPL TOXICOL, V32, P843, DOI 10.1002/jat.2757
   Schildknecht S, 2012, ALTEX-ALTERN ANIM EX, V29, P261, DOI 10.14573/altex.2012.3.261
   Schildknecht S, 2011, J BIOL CHEM, V286, P4991, DOI 10.1074/jbc.M110.169565
   Schildknecht S, 2009, TOXICOL APPL PHARM, V241, P23, DOI 10.1016/j.taap.2009.07.027
   Schuurmann G, 2011, ENVIRON SCI TECHNOL, V45, P4616, DOI 10.1021/es200361r
   Seibert H, 2002, TOXICOL IN VITRO, V16, P289, DOI 10.1016/S0887-2333(02)00014-0
   Sipes NS, 2011, TOXICOL SCI, V124, P109, DOI 10.1093/toxsci/kfr220
   Sipes NS, 2011, BIRTH DEFECTS RES C, V93, P256, DOI 10.1002/bdrc.20214
   Stiegler NV, 2011, TOXICOL SCI, V121, P73, DOI 10.1093/toxsci/kfr034
   Tralau T., 2012, ENV HLTH PERSPECT
   Vaes WHJ, 1997, CHEM RES TOXICOL, V10, P1067, DOI 10.1021/tx970109t
   van de Bovenkamp M, 2005, TOXICOL SCI, V85, P632, DOI 10.1093/toxsci/kfi127
   van Leeuwen K, 2009, SAR QSAR ENVIRON RES, V20, P207, DOI 10.1080/10629360902949179
   van Midwoud PM, 2010, BIOTECHNOL BIOENG, V105, P184, DOI 10.1002/bit.22516
   Van Summeren A, 2012, TOXICOL IN VITRO, V26, P373, DOI 10.1016/j.tiv.2012.01.012
   van Thriel C, 2012, NEUROTOXICOLOGY, V33, P911, DOI 10.1016/j.neuro.2011.10.002
   Venkatapathy R, 2004, J CHEM INF COMP SCI, V44, P1623, DOI 10.1021/ci049903s
   Vink SR, 2010, REGUL TOXICOL PHARM, V58, P64, DOI 10.1016/j.yrtph.2010.04.004
   Watanabe KH, 2011, ENVIRON TOXICOL CHEM, V30, P9, DOI 10.1002/etc.373
   Wobus AM, 2011, ARCH TOXICOL, V85, P79, DOI 10.1007/s00204-010-0641-6
   Worth A. P., 2002, ATLA S1, V30, P1
   Yoon M, 2012, CRIT REV TOXICOL, V42, P633, DOI 10.3109/10408444.2012.692115
   Zanella F, 2010, TRENDS BIOTECHNOL, V28, P237, DOI 10.1016/j.tibtech.2010.02.005
   Zimmer B, 2011, CELL DEATH DIFFER, V18, P383, DOI 10.1038/cdd.2010.109
   Zimmer B, 2012, ENVIRON HEALTH PERSP, V120, P1116, DOI 10.1289/ehp.1104489
NR 121
TC 64
Z9 65
U1 0
U2 23
PU SPEKTRUM AKADEMISCHER VERLAG-SPRINGER-VERLAG GMBH
PI HEILDEBERG
PA TIERGARTENSTRASSE 17, HEILDEBERG, 69121, GERMANY
SN 1868-596X
EI 1868-8551
J9 ALTEX-ALTERN ANIM EX
JI ALTEX-Altern. Anim. Exp.
PY 2012
VL 29
IS 4
BP 411
EP 425
DI 10.14573/altex.2012.4.411
PG 15
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA 045OC
UT WOS:000311705100006
PM 23138511
OA DOAJ Gold
DA 2019-10-23
ER

PT J
AU Sanderson, H
AF Sanderson, Hans
TI Challenges and Directions for Regulatory Use of QSARs for Predicting
   Active Pharmaceutical Ingredients Environmental Toxicity
SO CURRENT DRUG SAFETY
LA English
DT Article
DE AOP; API; acute; chronic; aquatic; environmental toxicity
AB Regulators globally are facing increasing challenges to make decisions regarding subtle effects and risks of pharmacodynamic compounds found in the environment. There is a recognized need for rapid screening tools as well as development of methods to support the further prioritization and testing of these compounds. It is becoming evident that the current standardized experimental designs and predictive models are not specific enough to predict the chronic and long term toxicity of active pharmaceutical ingredients. Novel approaches to firstly screen and prioritize the compounds e.g. by (quantitative) structure-activity relationship modeling and inter-species extrapolation tools are currently proving difficult to develop for chronic effects. Novel toxicogenomic high through-put screening tools may be useful for more rapidly developing toxicogenomic hypothesis and molecular initiating events especially for pharmacodynamic compounds with relatively well described mechanisms of action. The molecular initiating events can then be entered into the proposed adverse outcome pathway which can then indicate the relevant test design to demonstrate the anticipated adverse chronic effects.
C1 [Sanderson, Hans] Aarhus Univ, Dept Environm Sci, 399 Frederiksborgvej, DK-4000 Roskilde, Denmark.
RP Sanderson, H (reprint author), Aarhus Univ, Dept Environm Sci, 399 Frederiksborgvej, DK-4000 Roskilde, Denmark.
EM hasa@dmu.dk
OI Sanderson, Hans/0000-0002-3765-4310
CR Ankley GT, 2007, ENVIRON SCI TECHNOL, V41, P8211, DOI 10.1021/es072658j
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Berninger JP, 2010, TOXICOL LETT, V193, P69, DOI 10.1016/j.toxlet.2009.12.006
   Brain RA, 2012, HUMAN PHARM ENV CURR, P139
   Brooks BW, 2009, ACS SYM SER, V1018, P205
   Das RN, 2012, B ENV CONTAM TOXICOL
   Davis AP, 2011, COMP TOXICOGENOMICS, V34
   EU, 2001, 12062001D01 PMP EU
   Gunnarsson L, 2008, ENVIRON SCI TECHNOL, V42, P5807, DOI 10.1021/es8005173
   Huang RL, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001862
   Huggett DB, 2003, HUM ECOL RISK ASSESS, V9, P1789, DOI 10.1080/10807030390260498
   Kar S, 2010, CHEMOSPHERE, V81, P738, DOI 10.1016/j.chemosphere.2010.07.019
   Sanderson H, 2004, REGUL TOXICOL PHARM, V39, P158, DOI 10.1016/j.yrtph.2003.12.006
   Sanderson H, 2007, B ENVIRON CONTAM TOX, V79, P331, DOI 10.1007/s00128-007-9249-9
   Sanderson H, 2009, ENVIRON TOXICOL CHEM, V28, P1359, DOI 10.1897/09-119.1
   Sanderson H, 2009, TOXICOL LETT, V187, P84, DOI 10.1016/j.toxlet.2009.02.003
   Seiler JP, 2002, TOXICOL LETT, V131, P105, DOI 10.1016/S0378-4274(02)00045-0
NR 17
TC 3
Z9 3
U1 1
U2 8
PU BENTHAM SCIENCE PUBL
PI BUSUM
PA PO BOX 294, BUSUM, 1400 AG, NETHERLANDS
SN 1574-8863
EI 2212-3911
J9 CURR DRUG SAF
JI Curr. Drug Saf.
PY 2012
VL 7
IS 4
BP 309
EP 312
DI 10.2174/157488612804096597
PG 4
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA V3J1B
UT WOS:000218302200008
PM 23062243
DA 2019-10-23
ER

PT J
AU Knudsen, TB
   Kleinstreuer, NC
AF Knudsen, Thomas B.
   Kleinstreuer, Nicole C.
TI Disruption of embryonic vascular development in predictive toxicology
SO BIRTH DEFECTS RESEARCH PART C-EMBRYO TODAY-REVIEWS
LA English
DT Review
DE angiogenesis; vascular development; developmental toxicity; predictive
   toxicology; adverse outcome pathway
ID BLOOD-VESSEL FORMATION; GROWTH-FACTOR VEGF; REPRODUCTIVE TOXICITY;
   ENDOTHELIAL-CELLS; MOUSE EMBRYO; BISPHENOL-A; ANGIOGENESIS; THALIDOMIDE;
   EXPRESSION; VASCULOGENESIS
AB Toxicity testing in the 21st century is moving toward using high-throughput screening assays to rapidly test thousands of chemicals against hundreds of molecular targets and biological pathways, and to provide mechanistic information on chemical effects in human cells and small model organisms. First-generation predictive models for prenatal developmental toxicity have revealed a complex web of biological processes with many connections to vasculogenesis and angiogenesis. This review examines disruption of embryonic vascular development as a potential adverse outcome pathway leading to developmental toxicity. We briefly review embryonic vascular development and important signals for vascular development (local growth factors and cytokines such as vascular endothelial growth factor-A and TGF-beta, components in the plasminogen activator system, and chemotactic chemokines). Genetic studies have shown that perturbing these signals can lead to varying degrees of adverse consequences, ranging from congenital angiodysplasia to fetal malformations and embryolethality. The molecular targets and cellular behaviors required for vascular development, stabilization and remodeling are amenable to in vitro evaluation. Evidence for chemical disruption of these processes is available for thalidomide, estrogens, endothelins, dioxin, retinoids, cigarette smoke, and metals among other compounds. Although not all compounds with developmental toxicity show an in vitro vascular bioactivity signature, many putative vascular disruptor compounds invoke adverse developmental consequences. As such, an adverse outcome pathway perspective of embryonic vascular development can help identify useful information for assessing adverse outcomes relevant to risk assessment and efficient use of resources for validation. Birth Defects Research (Part C) 93:312323, 2011. (C) 2012 Wiley Periodicals, Inc.
C1 [Knudsen, Thomas B.; Kleinstreuer, Nicole C.] US EPA, Natl Ctr Computat Toxicol, Off Res & Dev, Res Triangle Pk, NC 27711 USA.
RP Knudsen, TB (reprint author), US EPA, Natl Ctr Computat Toxicol B205 01, Res Triangle Pk, NC 27711 USA.
EM knudsen.thomas@epa.gov
RI Kleinstreuer, Nicole/F-7203-2019
OI Kleinstreuer, Nicole/0000-0002-7914-3682
CR Abbott BD, 2000, DEV DYNAM, V219, P526, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1080>3.0.CO;2-N
   Ambler CA, 2001, DEV BIOL, V234, P352, DOI 10.1006/dbio.2001.0267
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Bosquiazzo VL, 2010, BIOL REPROD, V82, P86, DOI 10.1095/biolreprod.109.078543
   Boyd NL, 2011, TISSUE ENG PT A, V17, P1537, DOI [10.1089/ten.tea.2010.0397, 10.1089/ten.TEA.2010.0397]
   Bredhult C, 2007, REPROD TOXICOL, V23, P550, DOI 10.1016/j.reprotox.2007.03.006
   Brouillard P, 2007, HUM MOL GENET, V16, pR140, DOI 10.1093/hmg/ddm211
   Carney EW, 2007, BIRTH DEFECTS RES B, V80, P213, DOI 10.1002/bdrb.20118
   Cha Young Ryun, 2007, Birth Defects Research, V81, P286, DOI 10.1002/bdrc.20103
   Chung AS, 2011, ANNU REV CELL DEV BI, V27, P563, DOI 10.1146/annurev-cellbio-092910-154002
   Collins FS, 2008, SCIENCE, V319, P906, DOI 10.1126/science.1154619
   Coultas L, 2005, NATURE, V438, P937, DOI 10.1038/nature04479
   DAMATO RJ, 1994, P NATL ACAD SCI USA, V91, P4082, DOI 10.1073/pnas.91.9.4082
   Dix DJ, 2007, TOXICOL SCI, V95, P5, DOI 10.1093/toxsci/kfl103
   Drake Christopher J, 2007, Novartis Found Symp, V283, P61
   DUMONT DJ, 1995, DEV DYNAM, V203, P80, DOI 10.1002/aja.1002030109
   Durando M, 2011, J STEROID BIOCHEM, V127, P35, DOI 10.1016/j.jsbmb.2011.04.001
   Ema M, 2010, REPROD TOXICOL, V29, P49, DOI 10.1016/j.reprotox.2009.09.003
   Eshkar-Oren I, 2009, DEVELOPMENT, V136, P1263, DOI 10.1242/dev.034199
   Fantin A, 2010, BLOOD, V116, P829, DOI 10.1182/blood-2009-12-257832
   Furuyama T, 2004, J BIOL CHEM, V279, P34741, DOI 10.1074/jbc.M314214200
   Gaengel K, 2009, ARTERIOSCL THROM VAS, V29, P630, DOI 10.1161/ATVBAHA.107.161521
   GAGLIARDI A, 1993, CANCER RES, V53, P533
   Hanahan D, 1997, SCIENCE, V277, P48, DOI 10.1126/science.277.5322.48
   Hartung T, 2009, NATURE, V460, P208, DOI 10.1038/460208a
   Herbert SP, 2011, NAT REV MOL CELL BIO, V12, P551, DOI 10.1038/nrm3176
   Hiratsuka S, 2005, MOL CELL BIOL, V25, P346, DOI 10.1128/MCB.25.1.346-354.2005
   Hurtt ME, 2003, FOOD CHEM TOXICOL, V41, P611, DOI 10.1016/S0278-6915(02)00326-5
   Ishimura R, 2006, TOXICOL SCI, V91, P265, DOI 10.1093/toxsci/kfj138
   Ito T, 2010, SCIENCE, V327, P1345, DOI 10.1126/science.1177319
   Judson RS, 2010, ENVIRON HEALTH PERSP, V118, P485, DOI 10.1289/ehp.0901392
   Kajio F, 1997, HEART VESSELS, V12, P300, DOI 10.1007/BF02766807
   Kappas NC, 2008, J CELL BIOL, V181, P847, DOI 10.1083/jcb.200709114
   Keeley EC, 2008, ARTERIOSCL THROM VAS, V28, P1928, DOI 10.1161/ATVBAHA.108.162925
   Kimmel CA, 2006, DEV REPROD TOXICOLOG
   Kitambi SS, 2009, MECH DEVELOP, V126, P464, DOI 10.1016/j.mod.2009.01.002
   Kleinstreuer NC, 2011, ENVIRON HEALTH PERSP, V119, P1596, DOI 10.1289/ehp.1103412
   Knudsen TB, 2011, BIRTH DEFECTS RES B, V92, P413, DOI 10.1002/bdrb.20315
   Knudsen TB, 2009, REPROD TOXICOL, V28, P209, DOI 10.1016/j.reprotox.2009.03.016
   Kuhnert F, 2010, SCIENCE, V330, P985, DOI 10.1126/science.1196554
   le Noble F, 2005, CARDIOVASC RES, V65, P619, DOI 10.1016/j.cardiores.2004.09.018
   Lebrin F, 2010, NAT MED, V16, P420, DOI 10.1038/nm.2131
   Long X, 2001, EXP BIOL MED, V226, P477
   Lucitti JL, 2007, DEVELOPMENT, V134, P3317, DOI 10.1242/dev.02883
   Maltepe E, 1998, J MOL MED-JMM, V76, P391, DOI 10.1007/s001090050231
   Martin MT, 2011, BIOL REPROD, V85, P327, DOI 10.1095/biolreprod.111.090977
   Martin MT, 2009, TOXICOL SCI, V110, P181, DOI 10.1093/toxsci/kfp080
   Martin MT, 2009, ENVIRON HEALTH PERSP, V117, P392, DOI 10.1289/ehp.0800074
   May SR, 2004, DEV BIOL, V270, P31, DOI 10.1016/j.ydbio.2004.02.006
   McCollum CW, 2011, BIRTH DEFECTS RES C, V93, P67, DOI 10.1002/bdrc.20210
   Melkonian G, 2003, TOXICOL SCI, V75, P393, DOI 10.1093/toxsci/kfg123
   Melkonian G, 2002, TOXICOL SCI, V68, P237, DOI 10.1093/toxsci/68.1.237
   Mueller MD, 2000, P NATL ACAD SCI USA, V97, P10972, DOI 10.1073/pnas.200377097
   National Research Council, 2007, TOX TEST 21 CENT VIS
   Ng SSW, 2003, CANCER RES, V63, P3189
   Noguchi T, 2005, BIOORG MED CHEM LETT, V15, P5509, DOI 10.1016/j.bmcl.2005.08.086
   Potente M, 2011, CELL, V146, P873, DOI 10.1016/j.cell.2011.08.039
   Pudliszewski M, 2005, INT J DEV BIOL, V49, P355, DOI 10.1387/ijdb.041956mp
   Reif DM, 2010, ENVIRON HEALTH PERSP, V118, P1714, DOI 10.1289/ehp.1002180
   Rogers JM, 2003, TOXICOL SCI, V75, P227, DOI 10.1093/toxsci/kfg215
   Sarkanen JR, 2011, FRONT PHARMACOL, V1, DOI 10.3389/fphar.2010.00147
   Sauer H, 2000, AM J PATHOL, V156, P151, DOI 10.1016/S0002-9440(10)64714-1
   Semenza GL, 2006, EXP PHYSIOL, V91, P803, DOI 10.1113/expphysiol.2006.033498
   Shah I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014584
   Sipes NS, 2011, TOXICOL SCI, V124, P109, DOI 10.1093/toxsci/kfr220
   Spence S, 1999, REPROD TOXICOL, V13, P15, DOI 10.1016/S0890-6238(98)00064-1
   Stenman JM, 2008, SCIENCE, V322, P1247, DOI 10.1126/science.1164594
   Stephens TD, 2000, BIOCHEM PHARMACOL, V59, P1489, DOI 10.1016/S0006-2952(99)00388-3
   Suzuki Y, 2004, BLOOD, V104, P166, DOI 10.1182/blood-2003-09-3293
   Therapontos C, 2009, P NATL ACAD SCI USA, V106, P8573, DOI 10.1073/pnas.0901505106
   Treinen KA, 1999, TERATOLOGY, V59, P51, DOI 10.1002/(SICI)1096-9926(199901)59:1<51::AID-TERA10>3.0.CO;2-I
   van Hinsbergh VWM, 2006, ARTERIOSCL THROM VAS, V26, P716, DOI 10.1161/01.ATV.0000209518.58252.17
   Vargesson N, 2009, BIOESSAYS, V31, P1327, DOI 10.1002/bies.200900103
   Walls JR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002853
   Xia MH, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-117
   Yabu T, 2005, BLOOD, V106, P125, DOI 10.1182/blood-2004-09-3679
   Yang SJ, 2006, BIRTH DEFECTS RES B, V77, P445, DOI 10.1002/bdrb.20096
NR 77
TC 48
Z9 50
U1 0
U2 32
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1542-975X
EI 1542-9768
J9 BIRTH DEFECTS RES C
JI Birth Defects Res. Part C-Embryo Today-Rev.
PD DEC
PY 2011
VL 93
IS 4
SI SI
BP 312
EP 323
DI 10.1002/bdrc.20223
PG 12
WC Developmental Biology; Reproductive Biology
SC Developmental Biology; Reproductive Biology
GA 880NS
UT WOS:000299414700004
PM 22271680
DA 2019-10-23
ER

PT J
AU Ashauer, R
   Agatz, A
   Albert, C
   Ducrot, V
   Galic, N
   Hendriks, J
   Jager, T
   Kretschmann, A
   O'Connor, I
   Rubach, MN
   Nyman, AM
   Schmitt, W
   Stadnicka, J
   van den Brink, PJ
   Preuss, TG
AF Ashauer, Roman
   Agatz, Annika
   Albert, Carlo
   Ducrot, Virginie
   Galic, Nika
   Hendriks, Jan
   Jager, Tjalling
   Kretschmann, Andreas
   O'Connor, Isabel
   Rubach, Mascha Nadine
   Nyman, Anna-Maija
   Schmitt, Walter
   Stadnicka, Julita
   van den Brink, Paul J.
   Preuss, Thomas G.
TI TOXICOKINETIC-TOXICODYNAMIC MODELING OF QUANTAL AND GRADED SUBLETHAL
   ENDPOINTS: A BRIEF DISCUSSION OF CONCEPTS
SO ENVIRONMENTAL TOXICOLOGY AND CHEMISTRY
LA English
DT Article
DE Toxicity; Dynamic energy budget; Dose-response; Adverse outcome pathway;
   Mechanistic effect model
ID BIOLOGY-BASED APPROACH; ORGANIC-CHEMICALS; MIXTURE TOXICITY;
   BINARY-MIXTURES; GAMMARUS-PULEX; PULSE-EXPOSURE; DAPHNIA-MAGNA;
   SURVIVAL; TIME; INVERTEBRATES
AB We report on the advantages and problems of using toxicokinetic-toxicodynamic (TKTD) models for the analysis, understanding, and simulation of sublethal effects. Only a few toxicodynamic approaches for sublethal effects are available. These differ in their effect mechanism and emphasis on linkages between endpoints. We discuss how the distinction between quantal and graded endpoints and the type of linkage between endpoints can guide model design and selection. Strengths and limitations of two main approaches and possible ways forward are outlined. Environ. Toxicol. Chem. 2011;30:2519-2524. (C) 2011 SETAC
C1 [Ashauer, Roman; Albert, Carlo; Kretschmann, Andreas; O'Connor, Isabel; Nyman, Anna-Maija; Stadnicka, Julita] Eawag, Swiss Fed Inst Aquat Sci & Technol, Dubendorf, Switzerland.
   [Agatz, Annika] Univ York, York YO10 5DD, N Yorkshire, England.
   [Ducrot, Virginie] INRA, Equipe Ecotoxicol & Qual Milieux Aquat, F-35042 Rennes, France.
   [Galic, Nika; Rubach, Mascha Nadine; van den Brink, Paul J.] Alterra, Wageningen, Netherlands.
   [Galic, Nika; Rubach, Mascha Nadine; van den Brink, Paul J.] Wageningen Univ, Wageningen, Netherlands.
   [Hendriks, Jan; O'Connor, Isabel] Radboud Univ Nijmegen, NL-6525 ED Nijmegen, Netherlands.
   [Jager, Tjalling] Vrije Univ Amsterdam, Amsterdam, Netherlands.
   [Rubach, Mascha Nadine] Syngenta Crop Protect, Basel, Switzerland.
   [Nyman, Anna-Maija; Stadnicka, Julita] Swiss Fed Inst Technol, Inst Biogeochem & Pollutant Dynam, Zurich, Switzerland.
   Bayer CropSci, Monheim, Germany.
   [Schmitt, Walter; Preuss, Thomas G.] Rhein Westfal TH Aachen, Aachen, Germany.
RP Ashauer, R (reprint author), Eawag, Swiss Fed Inst Aquat Sci & Technol, Dubendorf, Switzerland.
EM roman.ashauer@eawag.ch
RI Preuss, Thomas G./A-7926-2009; Agatz, Annika/F-5805-2012; van den Brink,
   Paul/E-8315-2013; Ashauer, Roman/E-6640-2010; Hendriks,
   J.C.M./L-4363-2015; Hendriks, Aalbert Jan/C-6767-2013; Jager,
   Tjalling/D-8168-2011
OI Preuss, Thomas G./0000-0001-6249-6003; Ashauer,
   Roman/0000-0002-9579-8793; Jager, Tjalling/0000-0002-4424-1442; Galic,
   Nika/0000-0002-4344-3464; Schmitt, Walter/0000-0001-6983-6525; van den
   brink, Paul/0000-0002-7241-4347
FU Eawag; European UnionEuropean Union (EU) [PITN-GA-2009-238148]; Swiss
   Federal Office for the Environment [09.033.PJ / I362-1602, 09.0012.PJ]
FX We thank Eawag for funding the first international TKTD modeling
   workshop. This research has received financial support from the European
   Union under the 7th Framework Programme (project CREAM, contract number
   PITN-GA-2009-238148) and the Swiss Federal Office for the Environment
   (grants 09.033.PJ / I362-1602 and 09.0012.PJ).
CR Abbas R, 1997, TOXICOL APPL PHARM, V145, P192, DOI 10.1006/taap.1997.8168
   Albert C, 2012, J STAT PLAN INFER, V142, P263, DOI 10.1016/j.jspi.2011.07.014
   Alvarez OA, 2006, ENVIRON SCI TECHNOL, V40, P2478, DOI 10.1021/es052260s
   Ashauer R, 2008, ENVIRON TOXICOL CHEM, V27, P1817, DOI 10.1897/07-642
   Ashauer R, 2007, ENVIRON SCI TECHNOL, V41, P5535, DOI 10.1021/es070283w
   Ashauer R, 2007, ENVIRON SCI TECHNOL, V41, P5528, DOI 10.1021/es062977v
   Ashauer R, 2007, ENVIRON SCI TECHNOL, V41, P1480, DOI 10.1021/es061727b
   Ashauer R, 2010, J ENVIRON MONITOR, V12, P2056, DOI 10.1039/c0em00234h
   Ashauer R, 2010, ENVIRON SCI TECHNOL, V44, P3963, DOI 10.1021/es903478b
   Baas J, 2007, ENVIRON TOXICOL CHEM, V26, P1320, DOI 10.1897/06-437R.1
   Cold A, 2004, AQUAT TOXICOL, V67, P287, DOI 10.1016/j.aquatox.2004.01.015
   Derendorf H, 1999, PHARMACEUT RES, V16, P176, DOI 10.1023/A:1011907920641
   Escher BI, 2002, ENVIRON SCI TECHNOL, V36, P4201, DOI 10.1021/es015848h
   Hendriks AJ, 2001, ENVIRON TOXICOL CHEM, V20, P1399, DOI 10.1002/etc.5620200703
   Jager T, 2005, ENVIRON SCI TECHNOL, V39, P8307, DOI 10.1021/es050817y
   Jager T, 2004, ENVIRON SCI TECHNOL, V38, P2894, DOI 10.1021/es0352348
   Jager T, 2006, ECOTOXICOLOGY, V15, P305, DOI 10.1007/s10646-006-0060-x
   Jager T, 2011, ENVIRON SCI TECHNOL, V45, P2529, DOI 10.1021/es103092a
   Jager T, 2010, PHILOS T R SOC B, V365, P3531, DOI 10.1098/rstb.2010.0137
   Jager T, 2010, ECOTOXICOLOGY, V19, P351, DOI 10.1007/s10646-009-0417-z
   Jager T, 2009, ECOTOXICOLOGY, V18, P187, DOI 10.1007/s10646-008-0271-4
   Kooijman SALM, 1996, WATER RES, V30, P1711, DOI 10.1016/0043-1354(96)00054-1
   LeBlanc GA, 1999, SETAC TECH PUBLICAT, P23
   Lee JH, 2006, ENVIRON SCI TECHNOL, V40, P1341, DOI 10.1021/es051120f
   Mackay D, 2000, ENVIRON POLLUT, V110, P375, DOI 10.1016/S0269-7491(00)00162-7
   Maltby L, 2002, ENVIRON TOXICOL CHEM, V21, P361, DOI 10.1002/etc.5620210219
   MANCINI JL, 1983, WATER RES, V17, P1355, DOI 10.1016/0043-1354(83)90264-6
   Matida Y., 1960, Bulletin of the Freshwater Fisheries Research Laboratory Tokyo, V9, P1
   MCCARTY LS, 1993, ENVIRON SCI TECHNOL, V27, P1719
   NICHOLS JW, 1990, TOXICOL APPL PHARM, V106, P433, DOI 10.1016/0041-008X(90)90338-U
   Nisbet RM, 2000, J ANIM ECOL, V69, P913, DOI 10.1046/j.1365-2656.2000.00448.x
   Nuutinen S, 2003, ARCH ENVIRON CON TOX, V44, P467, DOI 10.1007/s00244-002-2127-x
   Organisation for Economic Cooperation and Development, 2006, OECD SER TEST ASS, V54
   Pery ARR, 2001, WATER RES, V35, P3825, DOI 10.1016/S0043-1354(01)00106-3
   Pieters BJ, 2006, ECOTOXICOLOGY, V15, P601, DOI 10.1007/s10646-006-0100-6
   Preuss TG, 2010, J ENVIRON MONITOR, V12, P2070, DOI 10.1039/c0em00096e
   Preuss TG, 2008, ENVIRON POLLUT, V156, P1211, DOI 10.1016/j.envpol.2008.03.018
   Preuss TG, 2009, ECOL MODEL, V220, P310, DOI 10.1016/j.ecolmodel.2008.09.018
   Rozman KK, 2000, TOXICOLOGY, V144, P169, DOI 10.1016/S0300-483X(99)00204-8
   Rubach Mascha N., 2011, Integrated Environmental Assessment and Management, V7, P172, DOI 10.1002/ieam.105
   Schmolke A, 2010, TRENDS ECOL EVOL, V25, P479, DOI 10.1016/j.tree.2010.05.001
   Schuler LJ, 2004, ENVIRON SCI TECHNOL, V38, P6247, DOI 10.1021/es049844z
   Schulz R, 2000, CHEMOSPHERE, V41, P1511, DOI 10.1016/S0045-6535(00)00107-7
   Steevens JA, 2001, AQUAT TOXICOL, V51, P377, DOI 10.1016/S0166-445X(00)00127-2
   Toutain PL, 2004, J VET PHARMACOL THER, V27, P467, DOI 10.1111/j.1365-2885.2004.00613.x
   Van den Brink PJ, 2007, ENVIRON TOXICOL CHEM, V26, P2226, DOI 10.1897/07-022R.1
   Watanabe KH, 2009, TOXICOL SCI, V109, P180, DOI 10.1093/toxsci/kfp069
   ZITKO V, 1979, CHEMOSPHERE, V8, P47, DOI 10.1016/0045-6535(79)90048-1
NR 48
TC 53
Z9 53
U1 0
U2 61
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0730-7268
EI 1552-8618
J9 ENVIRON TOXICOL CHEM
JI Environ. Toxicol. Chem.
PD NOV
PY 2011
VL 30
IS 11
BP 2519
EP 2524
DI 10.1002/etc.639
PG 6
WC Environmental Sciences; Toxicology
SC Environmental Sciences & Ecology; Toxicology
GA 837UQ
UT WOS:000296230300016
PM 21805502
DA 2019-10-23
ER

PT J
AU Volz, DC
   Belanger, S
   Embry, M
   Padilla, S
   Sanderson, H
   Schirmer, K
   Scholz, S
   Villeneuvejjjj, D
AF Volz, David C.
   Belanger, Scott
   Embry, Michelle
   Padilla, Stephanie
   Sanderson, Hans
   Schirmer, Kristin
   Scholz, Stefan
   Villeneuvejjjj, Daniel
TI Adverse Outcome Pathways during Early Fish Development: A Conceptual
   Framework for Identification of Chemical Screening and Prioritization
   Strategies
SO TOXICOLOGICAL SCIENCES
LA English
DT Editorial Material
DE adverse outcome pathway; high-throughput screening; zebrafish embryo;
   fish early life-stage test
ID ARYL-HYDROCARBON RECEPTORS; LIFE STAGE TOXICITY; LIVER-CELL LINE;
   RAINBOW-TROUT; RISK-ASSESSMENT; CHLORPYRIFOS EXPOSURE; BEHAVIORAL
   ALTERATIONS; AQUATIC ORGANISMS; ZEBRAFISH EMBRYO; PRIMARY CULTURES
AB The fish early life-stage (FELS) test guideline (OECD 210 or OCSPP 850.1400) is the most frequently used bioassay for predicting chronic fish toxicity and supporting aquatic ecological risk assessments around the world. For each chemical, the FELS test requires a minimum of 360 fish and 1 to 3 months from test initiation to termination. Although valuable for predicting fish full life-cycle toxicity, FELS tests are labor and resource intensive and, due to an emphasis on apical endpoints, provide little to no information about chemical mode of action. Therefore, the development and implementation of alternative testing strategies for screening and prioritizing chemicals has the potential to reduce the cost and number of animals required for estimating FELS toxicity and, at the same time, provides insights into mechanisms of toxicity. Using three reference chemicals with well-established yet distinct adverse outcome pathways (AOPs) in early life stages of fish, we proposed FELS-specific AOPs as conceptual frameworks for identifying useful chemical screening and prioritization strategies. The reference chemicals selected as case studies were a cardiotoxic aryl hydrocarbon receptor agonist (2,3,7,8-tetrachlorodibenzo-p-dioxin), neurotoxic acetylcholinesterase inhibitor (chlorpyrifos), and narcotic surfactant (linear alkylbenzene sulfonate). Using qualitative descriptions for each chemical during early fish development, we developed generalized AOPs and, based on these examples, proposed a three-tiered testing strategy for screening and prioritizing chemicals for FELS testing. Linked with biologically based concentration-response models, a tiered testing strategy may help reduce the reliance on long-term and costly FELS tests required for assessing the hazard of thousands of chemicals currently in commerce.
C1 [Volz, David C.] Univ S Carolina, Dept Environm Hlth Sci, Arnold Sch Publ Hlth, Columbia, SC 29208 USA.
   [Belanger, Scott] Procter & Gamble Co, Cincinnati, OH USA.
   [Embry, Michelle] ILSI Hlth & Environm Sci Inst, Washington, DC USA.
   [Padilla, Stephanie] US EPA, Res Triangle Pk, NC 27711 USA.
   [Sanderson, Hans] Aarhus Univ, Inst Environm Sci, Roskilde, Denmark.
   [Schirmer, Kristin] Eawag, Swiss Fed Inst Aquat Sci & Technol, Dubendorf, Switzerland.
   [Scholz, Stefan] UFZ Helmholtz Ctr Environm Res, Leipzig, Germany.
   [Villeneuvejjjj, Daniel] US EPA, Duluth, MN USA.
RP Volz, DC (reprint author), Univ S Carolina, Dept Environm Hlth Sci, Arnold Sch Publ Hlth, Columbia, SC 29208 USA.
EM volz@mailbox.sc.edu
RI Scholz, Stefan/B-7776-2014; Padilla, Stephanie/G-3568-2017
OI Scholz, Stefan/0000-0002-6990-4716; Padilla,
   Stephanie/0000-0002-7310-3209; Sanderson, Hans/0000-0002-3765-4310;
   Belanger, Scott/0000-0003-0369-9673
CR Abnet CC, 1999, TOXICOL APPL PHARM, V159, P41, DOI 10.1006/taap.1999.8719
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   [Anonymous], 1998, TOX PROF CHLOR DIB P
   Antkiewicz DS, 2005, TOXICOL SCI, V84, P368, DOI 10.1093/toxsci/kfi073
   Behra M, 2002, NAT NEUROSCI, V5, P111, DOI 10.1038/nn788
   Behrens A, 2001, ENVIRON TOXICOL CHEM, V20, P632, DOI 10.1002/etc.5620200324
   Belanger SE, 2010, AQUAT TOXICOL, V97, P88, DOI 10.1016/j.aquatox.2009.11.020
   Bernhard MJ, 2005, ENVIRON TOXICOL CHEM, V24, P1738, DOI 10.1897/04-234R.1
   BOLS NC, 1994, J FISH DIS, V17, P601, DOI 10.1111/j.1365-2761.1994.tb00258.x
   Bradbury SP, 2004, ENVIRON SCI TECHNOL, V38, p463A, DOI 10.1021/es040675s
   Burns CG, 2005, NAT CHEM BIOL, V1, P263, DOI 10.1038/nchembio732
   Cook PM, 2003, ENVIRON SCI TECHNOL, V37, P3864, DOI 10.1021/es034045m
   Dam K, 2000, DEV BRAIN RES, V121, P179, DOI 10.1016/S0165-3806(00)00044-4
   Das KP, 1999, TOXICOL APPL PHARM, V160, P217, DOI 10.1006/taap.1999.8767
   Dayeh VR, 2004, ECOTOX ENVIRON SAFE, V57, P375, DOI 10.1016/S0147-6513(03)00083-6
   Denison MS, 1998, B ENVIRON CONTAM TOX, V61, P557, DOI 10.1007/PL00002973
   Devito Michael J., 1994, P139
   Eaton DL, 2008, CRIT REV TOXICOL, V38, P1, DOI [10.1080/10408440802272158, 10.1080/10408440802272158 ]
   Embry MR, 2010, AQUAT TOXICOL, V97, P79, DOI 10.1016/j.aquatox.2009.12.008
   Hahn ME, 2002, CHEM-BIOL INTERACT, V141, P131, DOI 10.1016/S0009-2797(02)00070-4
   Halder Marlies, 2010, Integrated Environmental Assessment and Management, V6, P484, DOI 10.1002/ieam.48
   Henry TR, 1997, TOXICOL APPL PHARM, V142, P56, DOI 10.1006/taap.1996.8024
   *HUM ENV RISK ASS, 2009, LIN ALK SULPH VERS 4
   Icenogle LM, 2004, NEUROTOXICOL TERATOL, V26, P95, DOI 10.1016/j.ntt.2003.09.001
   Jacobson SM, 2010, AQUAT TOXICOL, V100, P101, DOI 10.1016/j.aquatox.2010.07.015
   Jiang W, 2010, TOXICOL SCI, V115, P183, DOI 10.1093/toxsci/kfq032
   Johnson FO, 2009, TOXICOL SCI, V109, P132, DOI 10.1093/toxsci/kfp053
   King Heiden TC, 2009, TOXICOL SCI, V109, P75, DOI 10.1093/toxsci/kfp048
   Kokel D, 2010, NAT CHEM BIOL, V6, P231, DOI 10.1038/NCHEMBIO.307
   LEE LEJ, 1993, CELL BIOL TOXICOL, V9, P279, DOI 10.1007/BF00755606
   Levin ED, 2004, NEUROTOXICOL TERATOL, V26, P719, DOI 10.1016/j.ntt.2004.06.013
   Levin ED, 2003, NEUROTOXICOL TERATOL, V25, P51, DOI 10.1016/S0892-0362(02)00322-7
   Levin ED, 2002, NEUROTOXICOL TERATOL, V24, P733, DOI 10.1016/S0892-0362(02)00272-6
   Li WW, 1998, TOXICOL LETT, V98, P139, DOI 10.1016/S0378-4274(98)00116-7
   MacPhail RC, 2009, NEUROTOXICOLOGY, V30, P52, DOI 10.1016/j.neuro.2008.09.011
   Mallett MJ, 1997, ENVIRON TOXICOL CHEM, V16, P528, DOI 10.1002/etc.5620160319
   MCKIM JM, 1977, J FISH RES BOARD CAN, V34, P1148, DOI 10.1139/f77-172
   MCKIM JM, 1975, B ENVIRON CONTAM TOX, V14, P1, DOI 10.1007/BF01685589
   Milan DJ, 2003, CIRCULATION, V107, P1355, DOI 10.1161/01.CIR.0000061912.88753.87
   National Research Council, 2007, TOX TEST 21 CENT VIS
   Nebert DW, 2000, BIOCHEM PHARMACOL, V59, P65, DOI 10.1016/S0006-2952(99)00310-X
   PADILLA S, 2009, TOXICITY SCREENING T
   PICKERING QH, 1970, J WATER POLLUT CON F, V42, P243
   Prasch AL, 2003, TOXICOL SCI, V76, P138, DOI 10.1093/toxsci/kfg202
   Rihel J, 2010, SCIENCE, V327, P348, DOI 10.1126/science.1183090
   Romani R, 2003, CHEM-BIOL INTERACT, V145, P321, DOI 10.1016/S0009-2797(03)00058-9
   Rosen MJ, 2001, ENVIRON SCI TECHNOL, V35, P954, DOI 10.1021/es0015141
   Schirmer K, 1997, TOXICOL IN VITRO, V11, P107, DOI 10.1016/S0887-2333(97)00002-7
   Schirmer K, 1998, TOXICOLOGY, V127, P129, DOI 10.1016/S0300-483X(98)00030-4
   Schirmer K, 2008, AQUAT TOXICOL, V90, P128, DOI 10.1016/j.aquatox.2008.08.005
   Scholz S, 2008, ENVIRON SCI POLLUT R, V15, P394, DOI 10.1007/s11356-008-0018-z
   Slotkin TA, 1999, ENVIRON HEALTH PERSP, V107, P71, DOI 10.2307/3434474
   Teraoka H, 2003, BIOCHEM BIOPH RES CO, V304, P223, DOI 10.1016/S0006-291X(03)00576-X
   Tolls J, 2000, ENVIRON TOXICOL CHEM, V19, P2394, DOI 10.1002/etc.5620191002
   Versteeg DJ, 2003, ARCH ENVIRON CON TOX, V44, P237, DOI 10.1007/s00244-002-2017-2
   Villeneuve DL, 2011, ENVIRON TOXICOL CHEM, V30, P1, DOI 10.1002/etc.396
   Wu JF, 2006, ECOTOX ENVIRON SAFE, V65, P230, DOI 10.1016/j.ecoenv.2005.08.002
   Yang DR, 2011, TOXICOL SCI, V121, P146, DOI 10.1093/toxsci/kfr028
NR 58
TC 54
Z9 54
U1 1
U2 58
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1096-6080
EI 1096-0929
J9 TOXICOL SCI
JI Toxicol. Sci.
PD OCT
PY 2011
VL 123
IS 2
BP 349
EP 358
DI 10.1093/toxsci/kfr185
PG 10
WC Toxicology
SC Toxicology
GA 828VW
UT WOS:000295532900003
PM 21750347
OA Green Published, Bronze
DA 2019-10-23
ER

PT J
AU Sipes, NS
   Padilla, S
   Knudsen, TB
AF Sipes, Nisha S.
   Padilla, Stephanie
   Knudsen, Thomas B.
TI Zebrafish-As an Integrative Model for Twenty-first Century Toxicity
   Testing
SO BIRTH DEFECTS RESEARCH PART C-EMBRYO TODAY-REVIEWS
LA English
DT Review
DE zebrafish embryo; developmental toxicity; ToxCast; ToxRefDB
ID VERTEBRATE PAIRED APPENDAGES; DEVELOPMENTAL TOXICITY; REPRODUCTIVE
   TOXICITY; RISK-ASSESSMENT; DANIO-RERIO; TOXICOLOGY; CHEMICALS; EMBRYOS;
   RECONSTRUCTION; MICROSCOPY
AB The zebrafish embryo is a useful small model for investigating vertebrate development because of its transparency, low cost, transgenic and morpholino capabilities, conservation of cell signaling, and concordance with mammalian developmental phenotypes. From these advantages, the zebrafish embryo has been considered as an alternative model for traditional in vivo developmental toxicity screening. The use of this organism in conjunction with traditional in vivo developmental toxicity testing has the potential to reduce cost and increase throughput of testing the chemical universe, prioritize chemicals for targeted toxicity testing, generate predictive models of developmental toxicants, and elucidate mechanisms and adverse outcome pathways for abnormal development. This review gives an overview of the zebrafish embryo for predictive toxicology and 21st century toxicity testing. Developmental eye defects were selected as an example to evaluate data from the U. S. Environmental Protection Agency's ToxCast program comparing responses in zebrafish embryos with those from pregnant rats and rabbits for a subset of 24 environmental chemicals across >600 in vitro assay targets. Cross-species comparisons implied a common basis for biological pathways associated with neuronal defects, extracellular matrix remodeling, and mitotic arrest. Birth Defects Research (Part C) 93: 256-267, 2011. (C) 2011 Wiley-Liss, Inc.
C1 [Sipes, Nisha S.; Knudsen, Thomas B.] US EPA, Natl Ctr Computat Toxicol, Res Triangle Pk, NC 27711 USA.
   [Padilla, Stephanie] US EPA, Natl Hlth & Environm Effects Res Lab, Res Triangle Pk, NC 27711 USA.
RP Sipes, NS (reprint author), US EPA, Natl Ctr Computat Toxicol B205 01, Off Res & Dev, Res Triangle Pk, NC 27711 USA.
EM sipes.nisha@epa.gov
RI Padilla, Stephanie/G-3568-2017
OI Padilla, Stephanie/0000-0002-7310-3209
CR Ahn D, 2008, DEV BIOL, V322, P220, DOI 10.1016/j.ydbio.2008.06.032
   Bill BR, 2009, ZEBRAFISH, V6, P69, DOI 10.1089/zeb.2008.0555
   Brannen KC, 2010, BIRTH DEFECTS RES B, V89, P66, DOI 10.1002/bdrb.20223
   Buckles GR, 2004, MECH DEVELOP, V121, P437, DOI 10.1016/j.mod.2004.03.026
   Busquet F, 2008, TOXICOL SCI, V104, P177, DOI 10.1093/toxsci/kfn065
   Carney SA, 2006, MOL PHARMACOL, V70, P549, DOI 10.1124/mol.106.025304
   Chandler KJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018540
   Chen HL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009318
   Chen J, 2008, PHYSIOL GENOMICS, V33, P148, DOI 10.1152/physiolgenomics.00214.2007
   Das BC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010004
   Dix DJ, 2007, TOXICOL SCI, V95, P5, DOI 10.1093/toxsci/kfl103
   Ekker SC, 2000, YEAST, V17, P302, DOI 10.1002/1097-0061(200012)17:4<302::AID-YEA53>3.0.CO;2-#
   FRANKOS VH, 1985, FUND APPL TOXICOL, V5, P615, DOI 10.1016/0272-0590(85)90185-X
   Green ML, 2007, DEV DYNAM, V236, P613, DOI 10.1002/dvdy.21048
   Gunnarsson L, 2008, ENVIRON SCI TECHNOL, V42, P5807, DOI 10.1021/es8005173
   Hartung T, 2010, J TOXICOL ENV HEAL B, V13, P277, DOI 10.1080/10937404.2010.483945
   Hartung T, 2009, NATURE, V460, P208, DOI 10.1038/460208a
   Henn K, 2011, COMP BIOCHEM PHYS C, V153, P91, DOI 10.1016/j.cbpc.2010.09.003
   Hermsen SAB, 2011, TOXICOL IN VITRO, V25, P745, DOI 10.1016/j.tiv.2011.01.005
   Hill AJ, 2005, TOXICOL SCI, V86, P6, DOI 10.1093/toxsci/kfi110
   HILL AJ, 2011, INT J TOXICOL, V30, P105
   Hurtt ME, 2003, FOOD CHEM TOXICOL, V41, P611, DOI 10.1016/S0278-6915(02)00326-5
   Jonz MG, 2005, J EXP BIOL, V208, P1537, DOI 10.1242/jeb.01564
   Judson RS, 2010, ENVIRON HEALTH PERSP, V118, P485, DOI 10.1289/ehp.0901392
   Keller PJ, 2008, SCIENCE, V322, P1065, DOI 10.1126/science.1162493
   Kitambi SS, 2009, MECH DEVELOP, V126, P464, DOI 10.1016/j.mod.2009.01.002
   Kleinstreuer NC, 2011, ENVIRON HEALTH PERSP, V119, P1596, DOI 10.1289/ehp.1103412
   Knudsen TB, 2009, REPROD TOXICOL, V28, P209, DOI 10.1016/j.reprotox.2009.03.016
   Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091
   Lin TT, 2006, CELL RES, V16, P857, DOI 10.1038/sj.cr.7310107
   Makris SL, 2009, REPROD TOXICOL, V28, P371, DOI 10.1016/j.reprotox.2009.06.010
   Malicki J, 1996, DEVELOPMENT, V123, P263
   Martin MT, 2011, BIOL REPROD, V85, P327, DOI 10.1095/biolreprod.111.090977
   Martin MT, 2009, TOXICOL SCI, V110, P181, DOI 10.1093/toxsci/kfp080
   Martin MT, 2009, ENVIRON HEALTH PERSP, V117, P392, DOI 10.1289/ehp.0800074
   Nemeth KA, 2005, TOXICOL APPL PHARM, V206, P219, DOI 10.1016/j.taap.2004.12.013
   *NIEHS, 1997, VAL REG ACC TOX METH
   NRC (National Research Council), 2007, TOX TEST 21 CENT VIS
   Olivier N, 2010, SCIENCE, V329, P967, DOI 10.1126/science.1189428
   Olson H, 2000, REGUL TOXICOL PHARM, V32, P56, DOI 10.1006/rtph.2000.1399
   PADILLA S, NEUROTOXICO IN PRESS
   Pardo-Martin C, 2010, NAT METHODS, V7, P634, DOI [10.1038/nmeth.1481, 10.1038/NMETH.1481]
   Parng C, 2002, ASSAY DRUG DEV TECHN, V1, P41, DOI 10.1089/154065802761001293
   Peal DS, 2010, J CARDIOVASC TRANSL, V3, P454, DOI 10.1007/s12265-010-9212-8
   Rovida C, 2009, ALTEX-ALTERN TIEREXP, V26, P187
   Scholz S, 2008, ENVIRON SCI POLLUT R, V15, P394, DOI 10.1007/s11356-008-0018-z
   Selderslaghs IWT, 2009, REPROD TOXICOL, V28, P308, DOI 10.1016/j.reprotox.2009.05.004
   Serbedzija G N, 1999, Angiogenesis, V3, P353, DOI 10.1023/A:1026598300052
   SIPES NS, TOXICOL SCI IN PRESS
   Sordino P, 1996, TRENDS ECOL EVOL, V11, P114, DOI 10.1016/0169-5347(96)81089-5
   Tandon A, 2009, EYE, V23, P1269, DOI 10.1038/eye.2009.30
   Taylor KL, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-11
   Thomas LT, 2009, TOXICOL APPL PHARM, V239, P1, DOI 10.1016/j.taap.2008.08.023
   Torregroza I, 2009, CHEM BIOL DRUG DES, V73, P339, DOI 10.1111/j.1747-0285.2009.00782.x
   Weigt S, 2011, TOXICOLOGY, V281, P25, DOI 10.1016/j.tox.2011.01.004
NR 55
TC 144
Z9 159
U1 1
U2 58
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1542-975X
J9 BIRTH DEFECTS RES C
JI Birth Defects Res. Part C-Embryo Today-Rev.
PD SEP
PY 2011
VL 93
IS 3
SI SI
BP 256
EP 267
DI 10.1002/bdrc.20214
PG 12
WC Developmental Biology; Reproductive Biology
SC Developmental Biology; Reproductive Biology
GA 845VY
UT WOS:000296854800005
PM 21932434
DA 2019-10-23
ER

PT J
AU Williams, TD
   Turan, N
   Diab, AM
   Wu, HF
   Mackenzie, C
   Bartie, KL
   Hrydziuszko, O
   Lyons, BP
   Stentiford, GD
   Herbert, JM
   Abraham, JK
   Katsiadaki, I
   Leaver, MJ
   Taggart, JB
   George, SG
   Viant, MR
   Chipman, KJ
   Falciani, F
AF Williams, Tim D.
   Turan, Nil
   Diab, Amer M.
   Wu, Huifeng
   Mackenzie, Carolynn
   Bartie, Katie L.
   Hrydziuszko, Olga
   Lyons, Brett P.
   Stentiford, Grant D.
   Herbert, John M.
   Abraham, Joseph K.
   Katsiadaki, Ioanna
   Leaver, Michael J.
   Taggart, John B.
   George, Stephen G.
   Viant, Mark R.
   Chipman, Kevin J.
   Falciani, Francesco
TI Towards a System Level Understanding of Non-Model Organisms Sampled from
   the Environment: A Network Biology Approach
SO PLOS COMPUTATIONAL BIOLOGY
LA English
DT Article
ID FLOUNDER PLATICHTHYS-FLESUS; HISTOPATHOLOGICAL BIOMARKERS; ENDOCRINE
   DISRUPTION; GENE-EXPRESSION; LIVER FIBROSIS; RECEPTOR; FISH; MICROARRAY;
   RESPONSES; DISEASE
AB The acquisition and analysis of datasets including multi-level omics and physiology from non-model species, sampled from field populations, is a formidable challenge, which so far has prevented the application of systems biology approaches. If successful, these could contribute enormously to improving our understanding of how populations of living organisms adapt to environmental stressors relating to, for example, pollution and climate. Here we describe the first application of a network inference approach integrating transcriptional, metabolic and phenotypic information representative of wild populations of the European flounder fish, sampled at seven estuarine locations in northern Europe with different degrees and profiles of chemical contaminants. We identified network modules, whose activity was predictive of environmental exposure and represented a link between molecular and morphometric indices. These sub-networks represented both known and candidate novel adverse outcome pathways representative of several aspects of human liver pathophysiology such as liver hyperplasia, fibrosis, and hepatocellular carcinoma. At the molecular level these pathways were linked to TNF alpha, TGF beta, PDGF, AGT and VEGF signalling. More generally, this pioneering study has important implications as it can be applied to model molecular mechanisms of compensatory adaptation to a wide range of scenarios in wild populations.
C1 [Williams, Tim D.; Turan, Nil; Wu, Huifeng; Hrydziuszko, Olga; Herbert, John M.; Viant, Mark R.; Chipman, Kevin J.; Falciani, Francesco] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England.
   [Diab, Amer M.; Mackenzie, Carolynn; Bartie, Katie L.; Leaver, Michael J.; Taggart, John B.; George, Stephen G.] Univ Stirling, Inst Aquaculture, Stirling FK9 4LA, Scotland.
   [Wu, Huifeng] Acad Sci, Yantai Inst Coastal Zone Res, Yantai, Peoples R China.
   [Lyons, Brett P.; Stentiford, Grant D.; Katsiadaki, Ioanna] Weymouth Lab, Weymouth, Dorset, England.
   [Abraham, Joseph K.] Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA.
   [Abraham, Joseph K.] Iowa State Univ, Dept Anim Sci, Ames, IA USA.
RP Williams, TD (reprint author), Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England.
EM f.falciani@bham.ac.uk
RI Katsiadaki, Ioanna/Y-1059-2019; Leaver, Michael/B-5518-2012; Stentiford,
   Grant/I-5567-2019; Williams, Tim/G-1180-2010; Wu, Huifeng/E-4886-2016;
   Viant, Mark/B-6339-2009
OI Leaver, Michael/0000-0002-3155-0844; Stentiford,
   Grant/0000-0001-6597-5413; Viant, Mark/0000-0001-5898-4119; Bartie,
   Kerry/0000-0003-3037-5295; Lyons, Brett/0000-0003-3681-9344; Williams,
   Timothy/0000-0002-5857-3851; Taggart, John/0000-0002-3843-9663;
   Dethlefsen, Olga/0000-0003-0502-1401; Katsiadaki,
   Ioanna/0000-0001-8649-2795; Wu, Huifeng/0000-0002-4042-8103
FU UK NERCNERC Natural Environment Research Council [NE/C507661/1]; UK
   BBSRCBiotechnology and Biological Sciences Research Council (BBSRC);
   EUEuropean Union (EU) [EKV-2001-0057]; BBSRCBiotechnology and Biological
   Sciences Research Council (BBSRC) [6/JIF 13209]; Department for
   Environment, Food and Rural Affairs (Defra)Department for Environment,
   Food & Rural Affairs (DEFRA);  [G.4500017]; Natural Environment Research
   CouncilNERC Natural Environment Research Council [NE/C50767X/1,
   NE/C507710/1, NE/C507688/1, NE/C507702/1, NE/C507661/1]
FX This work was funded by UK NERC Post-genomic and Proteomic programme
   grant NE/C507661/1, UK BBSRC and EU GENIPOL programme grant
   EKV-2001-0057, Birmingham functional genomics facilities by BBSRC grant
   6/JIF 13209 and bioinformatics by MRC infrastructure grant G.4500017.
   Flounder collection and chemical analysis was supported by the
   Department for Environment, Food and Rural Affairs (Defra) Clean Safe
   Seas Environmental Monitoring Programme (CSEMP)
   (http://www.bodc.ac.uk/projects/uk/merman/project_overview/). The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Abraham K, 2009, IMPROVING FUNCTIONAL, P110
   Andoh T, 2007, GEN COMP ENDOCR, V151, P308, DOI 10.1016/j.ygcen.2007.01.015
   Baker ME, 2009, ENVIRON HEALTH PERSP, V117, P223, DOI 10.1289/ehp.11627
   Basso K, 2005, NAT GENET, V37, P382, DOI 10.1038/ng1532
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289
   Bierie B, 2010, CYTOKINE GROWTH F R, V21, P49, DOI 10.1016/j.cytogfr.2009.11.008
   BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911
   BLUMBERG PM, 1988, CANCER RES, V48, P1
   Bluthgen Nils, 2005, Genome Inform, V16, P106
   Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610
   Daub CO, 2003, BIOINFORMATICS, V19, P2332, DOI 10.1093/bioinformatics/btg321
   Davis AP, 2009, NUCLEIC ACIDS RES, V37, pD786, DOI 10.1093/nar/gkn580
   Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60
   Diab AM, 2008, J FISH BIOL, V72, P2154, DOI 10.1111/j.1095-8649.2008.01888.x
   Falciani F, 2008, AQUAT TOXICOL, V90, P92, DOI 10.1016/j.aquatox.2008.07.020
   Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934
   Feist S. W., 2004, ICES TECH MAR ENV SC, V38, P42
   Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X
   Fernandez M, 2009, J HEPATOL, V50, P604, DOI 10.1016/j.jhep.2008.12.011
   Fisher MA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-108
   Fricke B, 2007, EMBO REP, V8, P1170, DOI 10.1038/sj.embor.7401091
   GEORGE SG, 1986, COMP BIOCHEM PHYS C, V83, P37, DOI 10.1016/0742-8413(86)90010-1
   Golotvin S, 2000, J MAGN RESON, V146, P122, DOI 10.1006/jmre.2000.2121
   Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176
   Herbert JMJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-490
   Hook SE, 2010, AQUAT TOXICOL, V99, P320, DOI 10.1016/j.aquatox.2010.05.011
   Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211
   Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868
   Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037
   Jonsson JR, 2001, GASTROENTEROLOGY, V121, P148, DOI 10.1053/gast.2001.25480
   Katsiadaki I, 2010, AQUAT TOXICOL, V97, P174, DOI 10.1016/j.aquatox.2009.07.005
   Kiersch K, 2010, CHEMOSPHERE, V79, P745, DOI 10.1016/j.chemosphere.2010.02.041
   Kirby MF, 2004, ENVIRON TOXICOL CHEM, V23, P748, DOI 10.1897/03-166
   Koehler A, 2004, AQUAT TOXICOL, V70, P257, DOI 10.1016/j.aquatox.2004.07.002
   Larsen PF, 2008, HEREDITY, V101, P247, DOI 10.1038/hdy.2008.54
   Larsen PF, 2007, MOL ECOL, V16, P4674, DOI 10.1111/j.1365-294X.2007.03530.x
   Leaver MJ, 2010, AQUAT TOXICOL, V96, P234, DOI 10.1016/j.aquatox.2009.10.025
   Leaver MJ, 2005, ENDOCRINOLOGY, V146, P3150, DOI 10.1210/en.2004-1638
   Leaver MJ, 1997, BIOCHEM J, V321, P405, DOI 10.1042/bj3210405
   Lyons BP, 2010, MAR POLLUT BULL, V60, P1647, DOI 10.1016/j.marpolbul.2010.06.005
   Lyons BP, 2004, MUTAT RES-FUND MOL M, V552, P177, DOI 10.1016/j.mrfmmm.2004.06.016
   Maass T, 2011, INT J CANCER, V128, P1259, DOI 10.1002/ijc.25469
   Moran PW, 2007, ENVIRON SCI TECHNOL, V41, P6591, DOI 10.1021/es070550y
   Pistocchi A, 2009, ENVIRON SCI TECHNOL, V43, P9237, DOI 10.1021/es901246d
   RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573
   Roling JA, 2007, ENVIRON TOXICOL CHEM, V26, P1205, DOI 10.1897/06-421R.1
   Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5
   Santiago-Josefat B, 2001, MOL CELL BIOL, V21, P1700, DOI 10.1128/MCB.21.5.1700-1709.2001
   Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303
   Small HJ, 2010, DIS AQUAT ORGAN, V88, P127, DOI 10.3354/dao02148
   Southam AD, 2008, J PROTEOME RES, V7, P5277, DOI 10.1021/pr800353t
   Stentiford GD, 2009, MAR ECOL PROG SER, V381, P1, DOI 10.3354/meps07947
   Stentiford GD, 2003, MAR ENVIRON RES, V55, P137, DOI 10.1016/S0141-1136(02)00212-X
   Sun B, 2008, ONCOGENE, V27, P6228, DOI 10.1038/onc.2008.300
   Thangavel P, 2005, CHEMOSPHERE, V61, P1083, DOI 10.1016/j.chemosphere.2005.03.045
   Tijet N, 2006, MOL PHARMACOL, V69, P140, DOI 10.1124/mol.105.018705
   Trevino V, 2006, BIOINFORMATICS, V22, P1154, DOI 10.1093/bioinformatics/btl074
   Van Aggelen G, 2010, ENVIRON HEALTH PERSP, V118, P1, DOI 10.1289/ehp.0900985
   Warner FJ, 2007, CLIN SCI, V113, P109, DOI 10.1042/CS20070026
   Williams TD, 2000, MAR ENVIRON RES, V50, P1, DOI 10.1016/S0141-1136(00)00053-2
   Williams TD, 2006, ENVIRON SCI TECHNOL, V40, P6479, DOI 10.1021/es061142h
   Williams TD, 2008, AQUAT TOXICOL, V90, P83, DOI 10.1016/j.aquatox.2008.07.019
   Wiseman SB, 2007, COMP BIOCHEM PHYS C, V146, P484, DOI 10.1016/j.cbpc.2007.05.006
   Wu HF, 2008, ANAL BIOCHEM, V372, P204, DOI 10.1016/j.ab.2007.10.002
   Yamamoto Y, 2006, J BIOL CHEM, V281, P16625, DOI 10.1074/jbc.M602723200
   Yazawa R, 2005, DEV COMP IMMUNOL, V29, P73, DOI 10.1016/j.dci.2004.06.002
   Yoshiji H, 2001, HEPATOLOGY, V34, P745, DOI 10.1053/jhep.20001.28231
NR 67
TC 57
Z9 57
U1 0
U2 38
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
EI 1553-7358
J9 PLOS COMPUT BIOL
JI PLoS Comput. Biol.
PD AUG
PY 2011
VL 7
IS 8
AR e1002126
DI 10.1371/journal.pcbi.1002126
PG 20
WC Biochemical Research Methods; Mathematical & Computational Biology
SC Biochemistry & Molecular Biology; Mathematical & Computational Biology
GA 812NH
UT WOS:000294299700010
PM 21901081
OA DOAJ Gold, Green Published
DA 2019-10-23
ER

PT J
AU Watanabe, KH
   Andersen, ME
   Basu, N
   Carvan, MJ
   Crofton, KM
   King, KA
   Sunol, C
   Tiffany-Castiglioni, E
   Schultz, IR
AF Watanabe, Karen H.
   Andersen, Melvin E.
   Basu, Niladri
   Carvan, Michael J., III
   Crofton, Kevin M.
   King, Kerensa A.
   Sunol, Cristina
   Tiffany-Castiglioni, Evelyn
   Schultz, Irvin R.
TI DEFINING AND MODELING KNOWN ADVERSE OUTCOME PATHWAYS DOMOIC ACID AND
   NEURONAL SIGNALING AS A CASE STUDY
SO ENVIRONMENTAL TOXICOLOGY AND CHEMISTRY
LA English
DT Article; Proceedings Paper
CT SETAC Pellston Workshop
CY APR 18-23, 2009
CL Forest Grove, OR
SP SETAC
DE Hippocampus; Neurobehavioral; Algal; Toxin; Calcium
ID LIONS ZALOPHUS-CALIFORNIANUS; CEREBELLAR GRANULE NEURONS; TISSUE
   DISTRIBUTION; SEA LIONS; RECEPTOR-BINDING; AMINO-ACID; HIPPOCAMPAL
   DAMAGE; NITZSCHIA-PUNGENS; PRIMARY CULTURES; VINYL-CHLORIDE
AB An adverse outcome pathway (AOP) is a sequence of key events from a molecular-level initiating event and an ensuing cascade of steps to an adverse outcome with population level significance To implement a predictive strategy for ecotoxicology the multiscale nature of an AOP requires computational models to link salient processes (e g in chemical uptake toxicokinetics to toxicodynamic and population dynamics) A case study with domoic acid was used to demonstrate strategies and enable generic recommendations for developing computational models in an effort to move toward a toxicity testing paradigm focused on toxicity pathway perturbations applicable to ecological risk assessment Domoic acid an algal toxin with adverse effects on both wildlife and humans is a potent agonise for kainate receptors (ionotropic glutamate receptors whose activation leads to the influx of Na+ and Ca2+) Increased Ca2+ concentrations result in neuronal excitotoxicity and cell death primarily in the hippocampus which produces seizures impairs learning and memory and alters behavior in some species Altered neuronal Ca2+ is a key process in domoic acid toxicity which can be evaluated in vitro Furthermore results of these assays would be amenable to mechanistic modeling for identifying domoic acid concentrations and Ca2+ perturbations that are normal adaptive or clearly toxic In vitro assays with outputs amenable to measurement in exposed populations can link in vitro to in vivo conditions and toxicokinetic information will aid in linking in vitro results to the individual organism Development of an AOP required an iterative process with three important outcomes a critically reviewed stressor specific AOP identification of key processes suitable for evaluation with in vitro assays and strategies for model development Environ Toxicol Chem 2011 30 9-21 (C) 2010 SETAC
C1 [Schultz, Irvin R.] Battelle Pacific NW Natl Lab, Sequim, WA USA.
   [Watanabe, Karen H.] Oregon Hlth & Sci Univ, Beaverton, OR USA.
   [Andersen, Melvin E.] Hamner Inst Hlth Res, Res Triangle Pk, NC USA.
   [Basu, Niladri] Univ Michigan, Ann Arbor, MI 48109 USA.
   [Carvan, Michael J., III] Univ Wisconsin, Milwaukee, WI 53201 USA.
   [Crofton, Kevin M.] US EPA, Res Triangle Pk, NC 27711 USA.
   [King, Kerensa A.] Univ Washington, Seattle, WA 98195 USA.
   [Sunol, Cristina] Inst Invest Biomed, Barcelona, Spain.
   [Tiffany-Castiglioni, Evelyn] Texas A&M Univ, College Stn, TX USA.
RP Schultz, IR (reprint author), Battelle Pacific NW Natl Lab, Sequim, WA USA.
RI Crofton, Kevin/J-4798-2015; Cristina, Sunol/K-8302-2014
OI Crofton, Kevin/0000-0003-1749-9971; Andersen,
   Melvin/0000-0002-3894-4811; Cristina, Sunol/0000-0001-9367-8483; Carvan,
   Michael/0000-0002-9190-9417; Basu, Niladri/0000-0002-2695-1037
CR Adams AL, 2009, PHYSIOL BEHAV, V96, P505, DOI 10.1016/j.physbeh.2008.11.019
   Amzil Z, 2001, TOXICON, V39, P1245, DOI 10.1016/S0041-0101(01)00096-4
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Arevalo F.F., 1998, HARMFUL ALGAE, P499
   Armstrong CM, 2007, ANNU REV PHYSIOL, V69, P1, DOI 10.1146/annurev.physiol.69.120205.124448
   Babot Z, 2005, EUR J NEUROSCI, V21, P103, DOI 10.1111/j.1460-9568.2004.03848.x
   Babot Z, 2007, J NEUROSCI RES, V85, P3687, DOI 10.1002/jnr.21433
   Banville DL, 2009, CURR OPIN DRUG DISC, V12, P376
   Basu N, 2005, ENVIRON SCI TECHNOL, V39, P3585, DOI 10.1021/es0483746
   Basu N, 2005, TOXICOL APPL PHARM, V205, P71, DOI 10.1016/j.taap.2004.09.009
   Basu N, 2005, ENVIRON TOXICOL CHEM, V24, P1444, DOI 10.1897/04-048R.1
   Basu N, 2007, NEUROTOXICOLOGY, V28, P587, DOI 10.1016/j.neuro.2006.12.007
   Basu N, 2006, J TOXICOL ENV HEAL A, V69, P1133, DOI 10.1080/15287390500362394
   Basu N, 2009, ENVIRON TOXICOL CHEM, V28, P133, DOI 10.1897/08-251.1
   BATES SS, 1989, CAN J FISH AQUAT SCI, V46, P1203, DOI 10.1139/f89-156
   Bejarano AC, 2008, HUM ECOL RISK ASSESS, V14, P544, DOI 10.1080/10807030802074220
   Berman FW, 1997, J NEUROCHEM, V69, P693
   BHARGAVA HK, 1986, NEUROCHEM RES, V11, P1473, DOI 10.1007/BF00966226
   Blanco J, 2002, AQUAT LIVING RESOUR, V15, P53, DOI 10.1016/S0990-7440(01)01139-1
   Blanco J, 2002, AQUAT TOXICOL, V60, P111, DOI 10.1016/S0166-445X(01)00274-0
   Burt MA, 2008, PHYSIOL BEHAV, V93, P327, DOI 10.1016/j.physbeh.2007.09.003
   Campbell DA, 2001, J SHELLFISH RES, V20, P75
   Carvan MJ, 2004, NEUROTOXICOL TERATOL, V26, P757, DOI 10.1016/j.ntt.2004.06.016
   CASTIGLIONI ET, 2005, TOXICOL ORGANOPHOSPH, P315
   Celander MC, 2011, ENVIRON TOXICOL CHEM, V30, P52, DOI 10.1002/etc.382
   Clayton EC, 1999, TOXICON, V37, P1025, DOI 10.1016/S0041-0101(98)00230-X
   CLEWELL HJ, 1995, CHEMOSPHERE, V31, P2561, DOI 10.1016/0045-6535(95)00124-Q
   Colman JR, 2005, NEUROTOXICOL TERATOL, V27, P753, DOI 10.1016/j.ntt.2005.06.009
   Colombo M, 2000, NEUROSCI BIOBEHAV R, V24, P465, DOI 10.1016/S0149-7634(00)00016-6
   Costa PR, 2005, AQUAT TOXICOL, V74, P82, DOI 10.1016/j.aquatox.2005.01.011
   Costa PR, 2004, MAR BIOL, V144, P971, DOI 10.1007/s00227-003-1258-6
   Cusack CK, 2002, J PHYCOL, V38, P1106, DOI 10.1046/j.1529-8817.2002.01054.x
   Doucette TA, 2004, NEUROTOX RES, V6, P555, DOI 10.1007/BF03033451
   Doucette TA, 2003, NEUROTOXICOL TERATOL, V25, P473, DOI 10.1016/S0892-0362(03)00034-5
   Doucette TA, 2000, NEUROTOXICOL TERATOL, V22, P863, DOI 10.1016/S0892-0362(00)00110-0
   DRUM AS, 1993, J SHELLFISH RES, V12, P443
   Fayazi AH, 1996, AM J PHYSIOL-HEART C, V270, pH1972
   FOX GA, 1991, J TOXICOL ENV HEALTH, V33, P359, DOI 10.1080/15287399109531535
   Gagliardo A, 1999, J NEUROSCI, V19, P311
   GALLACHER S, 2001, HARMFUL ALGAL BLOOMS, P30
   Galofre M, 2010, NEUROTOXICOL TERATOL, V32, P52, DOI 10.1016/j.ntt.2009.01.010
   Giordano G, 2006, MOL PHARMACOL, V70, P2116, DOI 10.1124/mol.106.027748
   Giordano G, 2007, TOXICOL SCI, V100, P433, DOI 10.1093/toxsci/kfm236
   Goldstein T, 2008, P ROY SOC B-BIOL SCI, V275, P267, DOI 10.1098/rspb.2007.1221
   GONZALEZ CV, 2006, J NEUROSCI RES, V84, P326
   Groth P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-136
   Gulland FMD, 2002, VET REC, V150, P475
   Gust KA, 2009, TOXICOL SCI, V110, P168, DOI 10.1093/toxsci/kfp091
   HASLE GR, 1995, J PHYCOL, V31, P428, DOI 10.1111/j.0022-3646.1995.00428.x
   Head JA, 2008, ENVIRON SCI TECHNOL, V42, P7535, DOI 10.1021/es801082a
   HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503
   HODGKIN AL, 1990, B MATH BIOL, V52, P25, DOI 10.1016/S0092-8240(05)80004-7
   HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764
   Iverson F., 1990, TOXICOL PATHOL, V18, P431
   Jakobsen B, 2002, AMINO ACIDS, V23, P37, DOI 10.1007/s00726-001-0107-5
   Jeffery B, 2004, FOOD CHEM TOXICOL, V42, P545, DOI 10.1016/j.fct.2003.11.010
   Jones MB, 2006, ANNU REV ECOL EVOL S, V37, P519, DOI 10.1146/annurev.ecolsys.37.091305.110031
   JONES TO, 1995, TOXICON, V33, P347, DOI 10.1016/0041-0101(94)00170-D
   KARMER VJ, 2011, ENVIRON TOXICOL CHEM, V30, P64
   Kim J, 2006, MAR ENVIRON RES, V62, pS426, DOI 10.1016/j.marenvres.2006.04.022
   KORNHUBER J, 1988, NEUROSCI LETT, V93, P312, DOI 10.1016/0304-3940(88)90101-2
   Kotaki Y, 2005, TOXICON, V46, P946, DOI 10.1016/j.toxicon.2005.09.004
   KOTAKI Y, 1996, HARMFUL TOXIC ALGAL, P143
   Lefebvre KA, 2002, TOXICON, V40, P971, DOI 10.1016/S0041-0101(02)00093-4
   Lefebvre KA, 2001, MAR BIOL, V138, P693, DOI 10.1007/s002270000509
   Lefebvre KA, 2007, AQUAT TOXICOL, V81, P266, DOI 10.1016/j.aquatox.2006.12.009
   Lefebvre KA, 2009, TOXICOL SCI, V107, P65, DOI 10.1093/toxsci/kfn207
   Lerma J, 2003, NAT REV NEUROSCI, V4, P481, DOI 10.1038/nrn1118
   LEVIN ED, 1991, PHARMACOL BIOCHEM BE, V38, P243, DOI 10.1016/0091-3057(91)90272-4
   Levin ED, 2006, NEUROTOXICOL TERATOL, V28, P673, DOI 10.1016/j.ntt.2006.08.005
   Lund JAK, 1997, J SHELLFISH RES, V16, P225
   LUNDHOLM N, 1994, PHYCOLOGIA, V33, P475, DOI 10.2216/i0031-8884-33-6-475.1
   Madin JS, 2008, TRENDS ECOL EVOL, V23, P159, DOI 10.1016/j.tree.2007.11.007
   Miguez A., 1996, HARMFUL TOXIC ALGAL, P143
   Miller DH, 2007, ENVIRON TOXICOL CHEM, V26, P521, DOI 10.1897/06-318R.1
   Miller DH, 2004, ECOTOX ENVIRON SAFE, V59, P1, DOI 10.1016/j.ecoenv.2004.05.005
   Mizuhashi S, 2000, NEUROSCI RES, V38, P35, DOI 10.1016/S0168-0102(00)00137-1
   MULLIN CS, 2001, REGUL TOXICOL PHARM, V34, P146
   Munday R, 2008, TOXICON, V52, P954, DOI 10.1016/j.toxicon.2008.10.005
   Murphy CA, 2005, REPROD TOXICOL, V19, P395, DOI 10.1016/j.reprotox.2004.09.006
   Murphy CA, 2009, ENVIRON TOXICOL CHEM, V28, P1288, DOI 10.1897/08-304.1
   National Research Council, 2007, TOX TEST 21 CENT VIS
   National Research Council (US) Steering Committee on Identification of Toxic and Potentially Toxic Chemicals for Consideration by the National Toxicology Program, 1984, TOX TEST STRAT DET N
   Neville KR, 1999, NEUROREPORT, V10, P3711, DOI 10.1097/00001756-199911260-00045
   NOBLE D, 1966, PHYSIOL REV, V46, P1
   NOVACZEK I, 1991, AQUAT TOXICOL, V21, P103, DOI 10.1016/0166-445X(91)90009-X
   PENG YG, 1994, NEUROREPORT, V5, P981, DOI 10.1097/00001756-199404000-00032
   Perry MA, 2009, PHYSIOL BEHAV, V98, P53, DOI 10.1016/j.physbeh.2009.04.009
   PETRIE BF, 1992, PHARMACOL BIOCHEM BE, V41, P211, DOI 10.1016/0091-3057(92)90084-S
   Portavella M, 2002, BRAIN RES BULL, V57, P397, DOI 10.1016/S0361-9230(01)00699-2
   Pulido OM, 2008, MAR DRUGS, V6, P180, DOI 10.3390/md20080010
   Qiu SF, 2006, TOXICOL SCI, V89, P243, DOI 10.1093/toxsci/kfj008
   Qiu SF, 2006, NEUROTOXICOL TERATOL, V28, P354, DOI 10.1016/j.ntt.2006.01.012
   Reitz RH, 1996, TOXICOL APPL PHARM, V137, P253, DOI 10.1006/taap.1996.0079
   Rhodes L., 1996, HARMFUL TOXIC ALGAL, P155
   SAINANI K, 2008, BIOMEDICAL COMPUTATI, V3, P16
   Scallet AC, 2005, NEUROTOXICOL TERATOL, V27, P745, DOI 10.1016/j.ntt.2005.06.018
   SCALLET AC, 1993, BRAIN RES, V627, P307, DOI 10.1016/0006-8993(93)90335-K
   Scheuhammer AM, 2008, ECOTOXICOLOGY, V17, P93, DOI 10.1007/s10646-007-0170-0
   Scholin CA, 2000, NATURE, V403, P80, DOI 10.1038/47481
   Schultz IR, 2001, AQUAT TOXICOL, V51, P305, DOI 10.1016/S0166-445X(00)00118-1
   SHERRY DF, 1989, BEHAV NEUROSCI, V103, P308, DOI 10.1037/0735-7044.103.2.308
   Silvagni PA, 2005, VET PATHOL, V42, P184, DOI 10.1354/vp.42-2-184
   Sobotka TJ, 1996, NEUROTOXICOL TERATOL, V18, P659, DOI 10.1016/S0892-0362(96)00120-1
   Sonnewald U, 2004, J NEUROCHEM, V91, P796, DOI 10.1111/j.1471-4159.2004.02794.x
   Spencer D., 2006, 4 MODES SEEKING INFO
   SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195
   STRAIN SM, 1991, NEUROSCIENCE, V44, P343, DOI 10.1016/0306-4522(91)90059-W
   Sunol C, 2008, TOXICOL IN VITRO, V22, P1350, DOI 10.1016/j.tiv.2008.03.009
   SUTHERLAND RJ, 1990, NEUROSCI LETT, V120, P221, DOI 10.1016/0304-3940(90)90043-9
   SUZUKI CAM, 1993, FOOD CHEM TOXICOL, V31, P701, DOI 10.1016/0278-6915(93)90140-T
   Takemoto T., 1958, CHEM PHARM BULL, V6, P578, DOI DOI 10.1248/CPB.6.578B]
   TASKER RA, 1991, CAN J PHYSIOL PHARM, V69, P378, DOI 10.1139/y91-057
   TEITELBAUM JS, 1990, NEW ENGL J MED, V322, P1781, DOI 10.1056/NEJM199006213222505
   Tiedeken JA, 2005, NEUROTOXICOL TERATOL, V27, P711, DOI 10.1016/j.ntt.2005.06.013
   TODD ECD, 1993, J FOOD PROTECT, V56, P69, DOI 10.4315/0362-028X-56.1.69
   TRUELOVE J, 1994, B ENVIRON CONTAM TOX, V52, P479
   Truelove J, 1996, FOOD CHEM TOXICOL, V34, P525, DOI 10.1016/0278-6915(96)81814-X
   Vale P, 2001, TOXICON, V39, P893, DOI 10.1016/S0041-0101(00)00229-4
   Vale P., 1998, HARMFUL ALGAE, P503
   Villeneuve DL, 2011, ENVIRON TOXICOL CHEM, V30, P1, DOI 10.1002/etc.396
   Watanabe KH, 2009, TOXICOL SCI, V109, P180, DOI 10.1093/toxsci/kfp069
   WEATHERLY LS, 1996, BRAIN RES, V716, P29
   WRIGHT JLC, 1989, CAN J CHEM, V67, P481, DOI 10.1139/v89-075
   Xi Dan, 1997, Natural Toxins, V5, P74, DOI 10.1002/(SICI)(1997)5:2<74::AID-NT4>3.0.CO;2-I
NR 125
TC 46
Z9 47
U1 0
U2 27
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0730-7268
EI 1552-8618
J9 ENVIRON TOXICOL CHEM
JI Environ. Toxicol. Chem.
PD JAN
PY 2011
VL 30
IS 1
BP 9
EP 21
DI 10.1002/etc.373
PG 13
WC Environmental Sciences; Toxicology
SC Environmental Sciences & Ecology; Toxicology
GA 701JM
UT WOS:000285814200002
PM 20963854
OA Green Published
DA 2019-10-23
ER

PT J
AU Perkins, EJ
   Chipman, JK
   Edwards, S
   Habib, T
   Falciani, F
   Taylor, R
   Van Aggelen, G
   Vulpe, C
   Antczak, P
   Loguinov, A
AF Perkins, Edward J.
   Chipman, J. Kevin
   Edwards, Stephen
   Habib, Tanwir
   Falciani, Francesco
   Taylor, Ronald
   Van Aggelen, Graham
   Vulpe, Chris
   Antczak, Philipp
   Loguinov, Alexandre
TI REVERSE ENGINEERING ADVERSE OUTCOME PATHWAYS
SO ENVIRONMENTAL TOXICOLOGY AND CHEMISTRY
LA English
DT Article; Proceedings Paper
CT SETAC Pellston Workshop
CY APR 18-23, 2009
CL Forest Grove, OR
SP SETAC
DE Mechanism of action; Toxicology; Microarray; Network inference; Adverse
   outcome pathway
ID GENE-EXPRESSION PROFILES; UNDERSTAND MECHANISMS; MOLECULAR NETWORKS;
   IN-VITRO; TOXICITY; MODE; FLUTAMIDE; TOXICOGENOMICS; RECONSTRUCTION;
   INTEGRATION
AB The toxicological effects of many stressors are mediated through unknown or incompletely characterized mechanisms of action The application of reverse engineering complex interaction networks from high dimensional miles data (gene protein metabolic signaling) can be used to overcome these limitations This approach was used to characterize adverse outcome pathways (AOPs) for chemicals that disrupt the hypothalamus-pituitary gonadal endocrine axis in fathead minnows (FHM Pimephales promelas) Gene expression changes in FHM ovaries in response to seven different chemicals over different times doses and in vivo versus in vitro conditions were captured in a large data set of 868 arrays Potential AOPs of the antiandrogen flutamide were examined using two mutual information based methods to infer gene regulatory networks and potential AOPs Representative networks from these studies were used to predict network paths from stressor to adverse outcome as candidate AOPs The relationship of individual chemicals to an adverse outcome can be determined by following perturbations through the network in response to chemical treatment thus leading to the nodes associated with the adverse outcome Identification of candidate pathways allows for formation of testable hypotheses about key biological processes biomarkers or alternative endpoints that can be used to monitor an AOP Finally the unique challenges facing the application of this approach in ecotoxicology were identified and a road map for the utilization of these tools presented Environ Toxicol Chem 2011,30 22-38 (C) 2010 SETAC
C1 [Perkins, Edward J.] USA, Engn Res & Dev Ctr, Vicksburg, MS USA.
   [Chipman, J. Kevin; Falciani, Francesco; Antczak, Philipp] Univ Birmingham, Birmingham, W Midlands, England.
   [Edwards, Stephen] US EPA, Res Triangle Pk, NC 27711 USA.
   [Habib, Tanwir] Univ So Mississippi, Hattiesburg, MS 39406 USA.
   [Taylor, Ronald] Pacific NW Natl Lab, Richland, WA 99352 USA.
   [Van Aggelen, Graham] Environm Canada, Vancouver, BC, Canada.
   [Vulpe, Chris; Loguinov, Alexandre] Univ Calif Berkeley, Berkeley, CA 94720 USA.
RP Perkins, EJ (reprint author), USA, Engn Res & Dev Ctr, Vicksburg, MS USA.
RI Edwards, Stephen W/G-4482-2011; Antczak, Philipp/L-5879-2019
OI Antczak, Philipp/0000-0001-9600-7757; Vulpe, Chris/0000-0001-5134-8929;
   Taylor, Ronald/0000-0001-9777-9767; Habib, Tanwir/0000-0002-2301-2704
FU Natural Environment Research CouncilNERC Natural Environment Research
   Council [NE/D000793/1]
CR Alessi DR, 2006, ANNU REV BIOCHEM, V75, P137, DOI 10.1146/annurev.biochem.75.103004.142702
   Andersen ME, 2009, TOXICOL SCI, V107, P324, DOI 10.1093/toxsci/kfn255
   Anderson LA, 2002, DIABETES OBES METAB, V4, P209, DOI 10.1046/j.1463-1326.2002.00214.x
   Ankley GT, 2008, AQUAT TOXICOL, V88, P69, DOI 10.1016/j.aquatox.2008.03.005
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Ankley GT, 2009, AQUAT TOXICOL, V92, P168, DOI 10.1016/j.aquatox.2009.01.013
   Ankley GT, 2004, ENVIRON SCI TECHNOL, V38, P6322, DOI 10.1021/es040022b
   Aoki Koji, 2008, V468, P307, DOI 10.1007/978-1-59745-249-6_24
   Avila-Campillo I, 2007, BIOINFORMATICS, V23, P392, DOI 10.1093/bioinformatics/btl604
   Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2
   Bansal M, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100120
   Bayer Travis S, 2009, J Biol Eng, V3, P1, DOI 10.1186/1754-1611-3-1
   Becker CG, 2003, J NEUROSCI, V23, P6232
   Berggard T, 2007, PROTEOMICS, V7, P2833, DOI 10.1002/pmic.200700131
   Bill BR, 2009, ZEBRAFISH, V6, P69, DOI 10.1089/zeb.2008.0555
   Blomme EAG, 2009, TOXICOL LETT, V186, P22, DOI 10.1016/j.toxlet.2008.09.017
   Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185
   Bonneau R, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r36
   Boobis AR, 2008, CRIT REV TOXICOL, V38, P87, DOI 10.1080/10408440701749421
   Buck Wayne R., 2008, V460, P23, DOI 10.1007/978-1-60327-048-9_2
   BurkhardtHolm P, 1996, J NEUROSCI RES, V46, P385, DOI 10.1002/(SICI)1097-4547(19961101)46:3<385::AID-JNR12>3.0.CO;2-0
   Bussemaker HJ, 2007, ANNU REV BIOPH BIOM, V36, P329, DOI 10.1146/annurev.biophys.36.040306.132725
   Calkins MJ, 2005, P NATL ACAD SCI USA, V102, P244, DOI 10.1073/pnas.0408487101
   Cantone I, 2009, CELL, V137, P172, DOI 10.1016/j.cell.2009.01.055
   Chang JP, 2009, GEN COMP ENDOCR, V161, P42, DOI 10.1016/j.ygcen.2008.09.005
   Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324
   Cover T. M., 1991, ELEMENTS INFORM THEO
   D'haeseleer P, 2000, BIOINFORMATICS, V16, P707, DOI 10.1093/bioinformatics/16.8.707
   Daub CO, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-118
   de la Fuente A, 2002, TRENDS GENET, V18, P395, DOI 10.1016/S0168-9525(02)02692-6
   Dix DJ, 2007, TOXICOL SCI, V95, P5, DOI 10.1093/toxsci/kfl103
   Duarte NC, 2007, P NATL ACAD SCI USA, V104, P1777, DOI 10.1073/pnas.0610772104
   Edwards SW, 2008, TOXICOL SCI, V106, P312, DOI 10.1093/toxsci/kfn190
   Faith JJ, 2007, PLOS BIOL, V5, P54, DOI 10.1371/journal.pbio.0050008
   Garcia Reyero N, 2009, ENVIRON SCI TECHNOL, V43, P2614
   Goetz AK, 2009, TOXICOL SCI, V110, P449, DOI 10.1093/toxsci/kfp098
   Gong P, 2007, ENVIRON SCI TECHNOL, V41, P8195, DOI 10.1021/es0716352
   Grzegorczyk Marco, 2007, Proteomics, V7 Suppl 1, P51, DOI 10.1002/pmic.200700466
   Gust KA, 2009, TOXICOL SCI, V110, P168, DOI 10.1093/toxsci/kfp091
   Hallen K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-51
   Han J., 2001, DATA MINING CONCEPTS
   Han JDJ, 2008, CELL RES, V18, P224, DOI 10.1038/cr.2008.16
   Hayete B, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100118
   Hecker M, 2009, BIOSYSTEMS, V96, P86, DOI 10.1016/j.biosystems.2008.12.004
   Heckmann LH, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r40
   Hultin-Rosenberg L, 2006, XENOBIOTICA, V36, P1122, DOI 10.1080/00498250600861801
   Iorio F, 2009, J COMPUT BIOL, V16, P241, DOI 10.1089/cmb.2008.10TT
   Jensen FV, 2001, BAYESIAN NETWORKS DE
   Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037
   Jordan M.I., 1998, LEARNING GRAPHICAL M
   Judson R, 2009, ENVIRON HEALTH PERSP, V117, P685, DOI 10.1289/ehp.0800168
   Kashimshetty R, 2009, TOXICOL APPL PHARM, V238, P150, DOI 10.1016/j.taap.2009.05.007
   Kilpinen S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r139
   Lan F, 2008, J BIOL CHEM, V283, P27628, DOI 10.1074/jbc.M805711200
   Lee I, 2008, NAT GENET, V40, P181, DOI 10.1038/ng.2007.70
   Lehar J, 2008, NAT CHEM BIOL, V4, P674, DOI 10.1038/nchembio.120
   Li P, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S7-S13
   Lim WK, 2007, BIOINFORMATICS, V23, pI282, DOI 10.1093/bioinformatics/btm201
   Lu PY, 2005, ADV GENET, V54, P117, DOI 10.1016/S0065-2660(05)54006-9
   Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7
   Meek MEB, 2008, ENVIRON MOL MUTAGEN, V49, P110, DOI 10.1002/em.20369
   Meyer BK, 1998, MOL CELL BIOL, V18, P978, DOI 10.1128/MCB.18.2.978
   Meyer PE, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-461
   Miller CT, 2000, DEVELOPMENT, V127, P3815
   Miller DH, 2007, ENVIRON TOXICOL CHEM, V26, P521, DOI 10.1897/06-318R.1
   Mo ML, 2009, TRENDS BIOTECHNOL, V27, P37, DOI 10.1016/j.tibtech.2008.09.007
   Morange M, 2006, HANDB EXP PHARM, V172, P153
   Morano KA, 1999, GENE EXPRESSION, V7, P271
   Murphy KP, 2001, COMPUTING SCI STAT, V33, P1024
   National Academies/ National Research Council, 2007, TOX TEST 21 CENT VIS
   Neapolitan RE, 2004, LEARNING BAYESIAN NE
   Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200
   Ohbuchi M, 2009, DRUG METAB DISPOS, V37, P97, DOI 10.1124/dmd.108.021964
   Ortega F, 2008, PHILOS T R SOC A, V366, P3067, DOI 10.1098/rsta.2008.0085
   Pe er D, 2005, SCI STKE, V281, P14
   Pillai Smitha, 2009, V523, P341, DOI 10.1007/978-1-59745-190-1_23
   Pledgie A, 2005, J BIOL CHEM, V280, P39843, DOI 10.1074/jbc.M508177200
   Poynton HC, 2007, ENVIRON SCI TECHNOL, V41, P1044, DOI 10.1021/es0615573
   Price ND, 2007, CURR OPIN BIOTECH, V18, P365, DOI 10.1016/j.copbio.2007.07.009
   Ramsey SA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000021
   Rangel C, 2004, BIOINFORMATICS, V20, P1361, DOI 10.1093/bioinformatics/bth093
   Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068
   Rockman MV, 2008, NATURE, V456, P738, DOI 10.1038/nature07633
   Sachs K, 2005, SCIENCE, V308, P523, DOI 10.1126/science.1105809
   Schadt EE, 2009, NATURE, V461, P218, DOI 10.1038/nature08454
   Shih AY, 2005, J BIOL CHEM, V280, P22925, DOI 10.1074/jbc.M414635200
   Singh SM, 2000, CURR MED CHEM, V7, P211, DOI 10.2174/0929867003375371
   Stephen LJ, 2007, DEV BIOL, V302, P66, DOI 10.1016/j.ydbio.2006.08.058
   Stolovitzky G, 2009, ANN NY ACAD SCI, V1158, P159, DOI 10.1111/j.1749-6632.2009.04497.x
   Suderman M, 2007, BIOINFORMATICS, V23, P2651, DOI 10.1093/bioinformatics/btm401
   Taylor RC, 2006, BIOINFORMATICS, V22, P2706, DOI 10.1093/bioinformatics/btl444
   Taylor RC, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000166
   van Someren EP, 2006, BIOINFORMATICS, V22, P477, DOI 10.1093/bioinformatics/bti816
   Waring JF, 2001, TOXICOL LETT, V120, P359, DOI 10.1016/S0378-4274(01)00267-3
   Win MN, 2009, CHEM BIOL, V16, P298, DOI 10.1016/j.chembiol.2009.02.011
   Wintz H, 2006, TOXICOL SCI, V94, P71, DOI 10.1093/toxsci/kfl080
   Xing HM, 2006, NAT PROTOC, V1, P2551, DOI 10.1038/nprot.2006.300
NR 97
TC 49
Z9 51
U1 0
U2 36
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0730-7268
EI 1552-8618
J9 ENVIRON TOXICOL CHEM
JI Environ. Toxicol. Chem.
PD JAN
PY 2011
VL 30
IS 1
BP 22
EP 38
DI 10.1002/etc.374
PG 17
WC Environmental Sciences; Toxicology
SC Environmental Sciences & Ecology; Toxicology
GA 701JM
UT WOS:000285814200003
PM 20963852
DA 2019-10-23
ER

PT J
AU Kramer, VJ
   Etterson, MA
   Hecker, M
   Murphy, CA
   Roesijadi, G
   Spade, DJ
   Spromberg, JA
   Wang, M
   Ankley, GT
AF Kramer, Vincent J.
   Etterson, Matthew A.
   Hecker, Markus
   Murphy, Cheryl A.
   Roesijadi, Guritno
   Spade, Daniel J.
   Spromberg, Julann A.
   Wang, Magnus
   Ankley, Gerald T.
TI ADVERSE OUTCOME PATHWAYS AND ECOLOGICAL RISK ASSESSMENT BRIDGING TO
   POPULATION-LEVEL EFFECTS
SO ENVIRONMENTAL TOXICOLOGY AND CHEMISTRY
LA English
DT Article; Proceedings Paper
CT SETAC Pellston Workshop
CY APR 18-23, 2009
CL Forest Grove, OR
SP SETAC
DE Risk assessment; Chemical toxicity; Adverse outcome pathway; Population
   model; Pellston workshop
ID CYCLODIENE INSECTICIDE RESISTANCE; CROAKER MICROPOGONIAS-UNDULATUS;
   ARYL-HYDROCARBON RECEPTOR; LIFE-HISTORY STRATEGIES; INDIVIDUAL-BASED
   MODEL; FRESH-WATER GASTROPOD; ENDOCRINE DISRUPTION; FISH POPULATIONS; 2
   STRAINS; ECOSYSTEMS
AB Maintaining the viability of populations of plants and animals is a key focus for environmental regulation Population level responses integrate the cumulative effects of chemical stressors on individuals as those individuals interact with and are affected by their conspecifics, competitors predators, prey habitat and other biotic and abiotic factors Models of population level effects of contaminants can integrate information from lower levels of biological organization and feed that information into higher level community and ecosystem models As individual level endpoints are used to predict population responses this requires that biological responses at lower levels of organization be translated Into a form that is usable by the population modeler In the current study we describe how mechanistic data as captured in adverse outcome pathways (AOPs) can be translated Into modeling focused on population level risk assessments First we describe the regulatory context surrounding population modeling, risk assessment and the emerging role of AOPs Then we present a succinct overview of different approaches to population modeling and discuss the types of data needed for these models We describe how different key biological processes measured at the level of the individual serve as the linkage or bridge between AOPs and predictions of population status including consideration of community level interactions and genetic adaptation Several case examples illustrate the potential for use of AOPs in population modeling and predictive ecotoxicology Finally we make recommendations for focusing toxicity studies to produce the quantitative data needed to define AOPs and to facilitate their incorporation into population modeling Environ Toxicol Chem 2011 30 64-76 (C) 2010 SETAC
C1 [Kramer, Vincent J.] Dow AgroSci, Indianapolis, IN 46268 USA.
   [Etterson, Matthew A.; Ankley, Gerald T.] US EPA, Duluth, MN USA.
   [Hecker, Markus] ENTRIX, Saskatoon, SK, Canada.
   [Murphy, Cheryl A.] Michigan State Univ, E Lansing, MI 48824 USA.
   [Roesijadi, Guritno] Pacific NW Natl Lab, Sequim, WA USA.
   [Spade, Daniel J.] Univ Florida, Gainesville, FL USA.
   [Spromberg, Julann A.] Natl Ocean & Atmospher Adm Fisheries, Seattle, WA USA.
   [Wang, Magnus] RIFCON, Heidelberg, Germany.
RP Kramer, VJ (reprint author), Dow AgroSci, Indianapolis, IN 46268 USA.
CR Alvarez MD, 2006, AQUAT TOXICOL, V80, P329, DOI 10.1016/j.aquatox.2006.09.010
   Andrewartha HG, 1954, DISTRIBUTION ABUNDAN
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Ankley GT, 2009, AQUAT TOXICOL, V92, P168, DOI 10.1016/j.aquatox.2009.01.013
   ANTONOVICS J., 1971, Advances in Ecological Research, V7, P1, DOI 10.1016/S0065-2504(08)60202-0
   Baldwin DH, 2009, ECOL APPL, V19, P2004, DOI 10.1890/08-1891.1
   Barnthouse L. W., 2007, POPULATION LEVEL ECO
   BART J, 1995, ECOL APPL, V5, P411, DOI 10.2307/1942032
   Bennett RS, 2007, INTEGR ENVIRON ASSES, V3, P498, DOI 10.1897/IEAM_2007-029.1
   Bennett RS, 2006, HUM ECOL RISK ASSESS, V12, P762, DOI 10.1080/10807030500531489
   BONNER JC, 1988, ARCH TOXICOL, V62, P311, DOI 10.1007/BF00332493
   Bradbury SP, 2004, ENVIRON SCI TECHNOL, V38, p463A, DOI 10.1021/es040675s
   Bradbury SP, 2003, ENVIRON TOXICOL CHEM, V22, P1789, DOI 10.1897/01-234
   Brausch JM, 2009, ECOTOXICOLOGY, V18, P600, DOI 10.1007/s10646-009-0318-1
   Bus JS, 2007, GENOMIC APPROACHES FOR CROSS-SPECIES EXTRAPOLATION IN TOXICOLOGY, P151
   Castro LFC, 2007, AQUAT TOXICOL, V85, P57, DOI 10.1016/j.aquatox.2007.07.016
   Caswell H, 2001, MATRIX POPULATION MO
   Caswell H., 2000, DEMOGRAPHY ECOTOXICO, P43
   CHURCHFIELD S, 1995, ACTA THERIOL, V40, P53, DOI 10.4098/AT.arch.95-7
   CLARK I, 2003, ECOLOGY, V84, P1370
   Clark J. S., 2007, MODELS ECOLOGICAL DA
   Cook PM, 2003, ENVIRON SCI TECHNOL, V37, P3864, DOI 10.1021/es034045m
   COWARDIN LM, 1979, J WILDLIFE MANAGE, V43, P18, DOI 10.2307/3800632
   Daborn PJ, 2002, SCIENCE, V297, P2253, DOI 10.1126/science.1074170
   DeAngelis DL, 2005, ANNU REV ECOL EVOL S, V36, P147, DOI 10.1146/annurev.ecolsys.36.102003.152644
   Ellis JB, 2000, CHEMOSPHERE, V41, P85, DOI 10.1016/S0045-6535(99)00393-8
   Etterson MA, 2007, AUK, V124, P432, DOI 10.1642/0004-8038(2007)124[432:PRADCO]2.0.CO;2
   Fleeger JW, 2003, SCI TOTAL ENVIRON, V317, P207, DOI 10.1016/S0048-9697(03)00141-4
   GIBBS P, 1987, OCEANS, V19, P1482, DOI DOI 10.1109/OCEANS.1987.1160635
   GRIMM V, 2009, ECOLOGICAL MODELS RE, P77
   Hahn M.E., 1998, REV TOXICOL, V2, P395
   Iguchi T, 2006, ENVIRON HEALTH PERSP, V114, P101, DOI 10.1289/ehp.8061
   Jacob A, 2009, ANIM BEHAV, V77, P823, DOI 10.1016/j.anbehav.2008.12.006
   Jager T, 2006, ECOTOXICOLOGY, V15, P305, DOI 10.1007/s10646-006-0060-x
   Johnson KR, 2008, ENVIRON TOXICOL CHEM, V27, P397, DOI 10.1897/07-185R1.1
   Karchner SI, 2006, P NATL ACAD SCI USA, V103, P6252, DOI 10.1073/pnas.0509950103
   KHAN HM, 1982, ARCH ENVIRON CON TOX, V11, P627, DOI 10.1007/BF01056372
   Krewski D., 2007, TOXICITY TESTING 21
   Leeuwen C. Jv., 2007, RISK ASSESSMENT CHEM
   LINCER JL, 1975, J APPL ECOL, V12, P781, DOI 10.2307/2402090
   Lynch M, 2003, SCIENCE, V302, P1401, DOI 10.1126/science.1089370
   MACIOROWSKI H, 1980, STP, V715, P36
   MACNAIR MR, 1991, GENETICA, V84, P213, DOI 10.1007/BF00127250
   Macneale KH, 2010, FRONT ECOL ENVIRON, V8, P475, DOI 10.1890/090142
   MARONI G, 1987, GENETICS, V117, P739
   MESA MG, 1994, J FISH BIOL, V45, P81, DOI 10.1111/j.1095-8649.1994.tb01085.x
   Meyer JN, 2003, ECOL APPL, V13, P490, DOI 10.1890/1051-0761(2003)013[0490:HAAFCI]2.0.CO;2
   Miller DH, 2007, ENVIRON TOXICOL CHEM, V26, P521, DOI 10.1897/06-318R.1
   Morand S, 2000, P ROY SOC B-BIOL SCI, V267, P1999, DOI 10.1098/rspb.2000.1241
   MOUCHES C, 1986, SCIENCE, V233, P778, DOI 10.1126/science.3755546
   Munns Wayne R. Jr., 2008, P179
   Murphy CA, 2005, REPROD TOXICOL, V19, P395, DOI 10.1016/j.reprotox.2004.09.006
   Murphy CA, 2008, AQUAT TOXICOL, V86, P470, DOI 10.1016/j.aquatox.2007.12.009
   Murphy CA, 2009, ENVIRON TOXICOL CHEM, V28, P1288, DOI 10.1897/08-304.1
   MUTERO A, 1994, P NATL ACAD SCI USA, V91, P5922, DOI 10.1073/pnas.91.13.5922
   Nisbet RM, 2000, J ANIM ECOL, V69, P913, DOI 10.1046/j.1365-2656.2000.00448.x
   Oehlmann J, 1996, FRESEN J ANAL CHEM, V354, P540
   Oehlmann J, 2007, ECOTOXICOLOGY, V16, P29, DOI 10.1007/s10646-006-0109-x
   Pastorok R.A., 2002, ECOLOGICAL MODELING
   Pastorok RA, 2003, HUM ECOL RISK ASSESS, V9, P939, DOI 10.1080/713610017
   Pease CM, 1995, AUK, V112, P343, DOI 10.2307/4088722
   Perkins EJ, 2011, ENVIRON TOXICOL CHEM, V30, P22, DOI 10.1002/etc.374
   Railsback SF, 2002, ECOLOGY, V83, P1817, DOI 10.1890/0012-9658(2002)083[1817:AOHSRU]2.0.CO;2
   REITER L, 2005, 600R04050 EPA
   Relyea RA, 2003, ECOL APPL, V13, P1515, DOI 10.1890/02-5298
   RICKER W. E., 1954, JOUR FISH RES BD CANADA, V11, P559
   ROSE KA, 2009, J EXP MAR BIOL ECOL, V381, pS1883
   ROUSH RT, 1987, ANNU REV ENTOMOL, V32, P361, DOI 10.1146/annurev.ento.32.1.361
   Salice CJ, 2009, ARCH ENVIRON CON TOX, V56, P785, DOI 10.1007/s00244-008-9203-9
   Salice CJ, 2002, ENVIRON TOXICOL CHEM, V21, P1398, DOI [10.1897/1551-5028(2002)021<1398:RTCAPI>2.0.CO;2, 10.1002/etc.5620210710]
   Sandahl JF, 2005, ENVIRON TOXICOL CHEM, V24, P136, DOI 10.1897/04-195R.1
   Spromberg JA, 2005, ENVIRON TOXICOL CHEM, V24, P1532, DOI 10.1897/04-160.1
   Stark JD, 2004, P NATL ACAD SCI USA, V101, P732, DOI 10.1073/pnas.0304903101
   Stark JD, 2007, J ECON ENTOMOL, V100, P1027, DOI 10.1603/0022-0493(2007)100[1027:IERMOP]2.0.CO;2
   Strong D. R., 1986, COMMUNITY ECOLOGY, P257
   SUTER GW, 2000, ECOLOGICAL RISK ASSE
   Thorbek P., 2009, ECOLOGICAL MODELS RE
   Turchin P., 1995, POPULATION DYNAMICS
   U.S. EPA, 1998, EPA630R95002F
   U. S. Fish & Wildlife Service, 1999, FED REGISTER, V64, P60727
   US Environmental Protection Agency, 1993, 600R93055 EPA
   US Fish and Wildlife Service National Marine Fisheries Service [FWS & NMFS], 1994, FED REGISTER, V59, P34272
   Villeneuve DL, 2011, ENVIRON TOXICOL CHEM, V30, P1, DOI 10.1002/etc.396
   Wang M, 2007, ECOL MODEL, V205, P397, DOI 10.1016/j.ecolmodel.2007.03.003
   Wang M, 2010, ENVIRON TOXICOL CHEM, V29, P1292, DOI 10.1002/etc.151
   Watanabe KH, 2011, ENVIRON TOXICOL CHEM, V30, P9, DOI 10.1002/etc.373
   Whitham TG, 2008, SCIENCE, V320, P492, DOI 10.1126/science.1153918
   Whitham TG, 2006, NAT REV GENET, V7, P510, DOI 10.1038/nrg1877
   Wiegand T, 2004, BIODIVERS CONSERV, V13, P53, DOI 10.1023/B:BIOC.0000004313.86836.ab
   Wirgin I, 2004, MUTAT RES-FUND MOL M, V552, P73, DOI 10.1016/j.mrfmmm.2004.06.005
   Xie LT, 2004, ENVIRON TOXICOL CHEM, V23, P1499, DOI 10.1897/03-96
   YARBROUGH JD, 1986, EXPERIENTIA, V42, P851, DOI 10.1007/BF01941551
   Zabel RW, 2004, ECOLOGY, V85, P795, DOI 10.1890/02-0719
   Zhang XW, 2008, ENVIRON SCI TECHNOL, V42, P6762, DOI 10.1021/es800591t
   Zheng WB, 1997, J EXP BIOL, V200, P2833
   Zhu J, 2008, NAT GENET, V40, P854, DOI 10.1038/ng.167
NR 96
TC 112
Z9 121
U1 7
U2 112
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0730-7268
J9 ENVIRON TOXICOL CHEM
JI Environ. Toxicol. Chem.
PD JAN
PY 2011
VL 30
IS 1
BP 64
EP 76
DI 10.1002/etc.375
PG 13
WC Environmental Sciences; Toxicology
SC Environmental Sciences & Ecology; Toxicology
GA 701JM
UT WOS:000285814200006
PM 20963853
DA 2019-10-23
ER

PT J
AU Ankley, GT
   Bennett, RS
   Erickson, RJ
   Hoff, DJ
   Hornung, MW
   Johnson, RD
   Mount, DR
   Nichols, JW
   Russom, CL
   Schmieder, PK
   Serrrano, JA
   Tietge, JE
   Villeneuve, DL
AF Ankley, Gerald T.
   Bennett, Richard S.
   Erickson, Russell J.
   Hoff, Dale J.
   Hornung, Michael W.
   Johnson, Rodney D.
   Mount, David R.
   Nichols, John W.
   Russom, Christine L.
   Schmieder, Patricia K.
   Serrrano, Jose A.
   Tietge, Joseph E.
   Villeneuve, Daniel L.
TI ADVERSE OUTCOME PATHWAYS: A CONCEPTUAL FRAMEWORK TO SUPPORT
   ECOTOXICOLOGY RESEARCH AND RISK ASSESSMENT
SO ENVIRONMENTAL TOXICOLOGY AND CHEMISTRY
LA English
DT Article
DE Toxic chemicals; Ecological effects; Adverse outcomes; Risk assessment
ID POLYCYCLIC AROMATIC-HYDROCARBONS; MINNOW PIMEPHALES-PROMELAS; FATHEAD
   MINNOW; ACUTE TOXICITY; ENVIRONMENTAL-POLLUTANTS; INDUSTRIAL-CHEMICALS;
   NARCOTIC CHEMICALS; TECHNICAL BASIS; DAPHNIA-MAGNA; IN-VITRO
AB Ecological risk assessors face increasing demands to assess more chemicals, with greater speed and accuracy, and to do so using fewer resources and experimental animals. New approaches in biological and computational sciences may be able to generate mechanistic information that could help in meeting these challenges. However, to use mechanistic data to support chemical assessments, there is a need for effective translation of this information into endpoints meaningful to ecological risk-effects on survival, development, and reproduction in individual organisms and, by extension, impacts on populations. Here we discuss a framework designed for this purpose, the adverse outcome pathway (AOP). An AOP is a conceptual construct that portrays existing knowledge concerning the linkage between a direct molecular initiating event and an adverse outcome at a biological level of organization relevant to risk assessment. The practical utility of AOPs for ecological risk assessment of chemicals is illustrated using five case examples. The examples demonstrate how the AOP concept can focus toxicity testing in terms of species and endpoint selection, enhance across-chemical extrapolation, and support prediction of mixture effects. The examples also show how AOPs facilitate use of molecular or biochemical endpoints (sometimes referred to as biomarkers) for forecasting chemical impacts on individuals and populations. In the concluding sections of the paper, we discuss how AOPs can help to guide research that supports chemical risk assessments and advocate for the incorporation of this approach into a broader systems biology framework. Environ. Toxicol. Chem. 2010;29:730-741. (C) 2009 SETAC
C1 [Ankley, Gerald T.; Bennett, Richard S.; Erickson, Russell J.; Hoff, Dale J.; Hornung, Michael W.; Johnson, Rodney D.; Mount, David R.; Nichols, John W.; Russom, Christine L.; Schmieder, Patricia K.; Serrrano, Jose A.; Tietge, Joseph E.; Villeneuve, Daniel L.] US EPA, Off Res & Dev, Natl Hlth & Environm Effects Res Lab, Midcontinent Ecol Div, Duluth, MN 55804 USA.
RP Ankley, GT (reprint author), US EPA, Off Res & Dev, Natl Hlth & Environm Effects Res Lab, Midcontinent Ecol Div, 6201 Condon Blvd, Duluth, MN 55804 USA.
EM ankley.gerald@epa.gov
CR Andersen ME, 2009, TOXICOL SCI, V107, P324, DOI 10.1093/toxsci/kfn255
   Ankley G. T., 2003, PAHS ECOTOXICOLOGICA, P275
   Ankley GT, 2009, AQUAT TOXICOL, V92, P168, DOI 10.1016/j.aquatox.2009.01.013
   Ankley GT, 2004, ILAR J, V45, P469, DOI 10.1093/ilar.45.4.469
   Ankley GT, 2003, ENVIRON TOXICOL CHEM, V22, P1350, DOI 10.1002/etc.5620220623
   Ankley GT, 1997, AQUAT TOXICOL, V37, P37, DOI 10.1016/S0166-445X(96)00803-X
   Barnthouse Lawrence W., 1993, P247
   Barnthouse LW, 2007, POPULATION LEVEL RIS
   Bennett RS, 2006, HUM ECOL RISK ASSESS, V12, P762, DOI 10.1080/10807030500531489
   Blair RM, 2000, TOXICOL SCI, V54, P138, DOI 10.1093/toxsci/54.1.138
   Borgert CJ, 2004, TOXICOL APPL PHARM, V201, P85, DOI 10.1016/j.taap.2004.05.005
   BOWLING JW, 1983, AQUAT TOXICOL, V3, P79, DOI 10.1016/0166-445X(83)90008-5
   Bradbury SP, 2004, ENVIRON SCI TECHNOL, V38, p463A, DOI 10.1021/es040675s
   Caldwell DJ, 2008, ENVIRON SCI TECHNOL, V42, P7046, DOI 10.1021/es800633q
   Cook PM, 2003, ENVIRON SCI TECHNOL, V37, P3864, DOI 10.1021/es034045m
   Di Toro DM, 2000, ENVIRON TOXICOL CHEM, V19, P1951, DOI 10.1002/etc.5620190803
   Di Toro DM, 2000, ENVIRON TOXICOL CHEM, V19, P1971, DOI 10.1002/etc.5620190804
   *ECETOC, 2007, 102 ECETOC
   Elonen GE, 1998, ENVIRON TOXICOL CHEM, V17, P472, DOI 10.1002/etc.5620170319
   Erickson RJ, 1999, TOXICOL APPL PHARM, V154, P97, DOI 10.1006/taap.1998.8563
   Erickson Russell J., 2008, P9, DOI 10.1201/9780203647295.ch2
   Escher BI, 2004, ENVIRON SCI TECHNOL, V38, p455A, DOI 10.1021/es0406740
   Ferguson J, 1939, PROC R SOC SER B-BIO, V127, P387, DOI 10.1098/rspb.1939.0030
   FernandezSalguero PM, 1996, TOXICOL APPL PHARM, V140, P173, DOI 10.1006/taap.1996.0210
   Hahn ME, 2002, CHEM-BIOL INTERACT, V141, P131, DOI 10.1016/S0009-2797(02)00070-4
   Head JA, 2008, ENVIRON SCI TECHNOL, V42, P7535, DOI 10.1021/es801082a
   Heringa MB, 2004, ENVIRON SCI TECHNOL, V38, P6263, DOI 10.1021/es049285w
   Hewitt LM, 2008, ENVIRON TOXICOL CHEM, V27, P682, DOI 10.1897/07-195.1
   Jobling S, 1998, ENVIRON SCI TECHNOL, V32, P2498, DOI 10.1021/es9710870
   Kidd KA, 2007, P NATL ACAD SCI USA, V104, P8897, DOI 10.1073/pnas.0609568104
   Kleinow Kevin M., 2008, P55, DOI 10.1201/9780203647295.ch3
   KONEMANN H, 1981, TOXICOLOGY, V19, P209, DOI 10.1016/0300-483X(81)90130-X
   LARSON RA, 1988, ENVIRON SCI TECHNOL, V22, P354, DOI 10.1021/es00169a001
   Lavine JA, 2005, TOXICOL SCI, V88, P60, DOI 10.1093/toxsci/kfi228
   MacDonald D, 2002, SAR QSAR ENVIRON RES, V13, P43, DOI 10.1080/10629360290002082
   Mackay D, 2009, SAR QSAR ENVIRON RES, V20, P393, DOI 10.1080/10629360902949153
   MCCARTY LS, 1993, ENVIRON SCI TECHNOL, V27, P1719
   MCKIM JM, 1987, ENVIRON TOXICOL CHEM, V6, P295, DOI 10.1002/etc.5620060407
   MCKIM JM, 1991, BIOACCUMULATION AQUA, P167
   MCMASTER ME, 1991, AQUAT TOXICOL, V21, P199, DOI 10.1016/0166-445X(91)90073-I
   Mekenyan O.G., 1995, SAR QSAR ENVIRON RES, V4, P139
   MEKENYAN OG, 1994, CHEMOSPHERE, V28, P567, DOI 10.1016/0045-6535(94)90299-2
   Miller DH, 2007, ENVIRON TOXICOL CHEM, V26, P521, DOI 10.1897/06-318R.1
   National Research Council, 2007, TOX TEST 21 CENT VIS
   NEWSTED J L, 1987, Environmental Toxicology and Chemistry, V6, P445, DOI 10.1897/1552-8618(1987)6[445:PMFPAT]2.0.CO;2
   *ORG EC COOP DEV, 2009, ENVJMHARD1 OECD TASK
   *ORG EC COOP DEV, 2009, OECD SER TEST ASS, V102
   ORIS JT, 1985, AQUAT TOXICOL, V6, P133, DOI 10.1016/0166-445X(85)90012-8
   OVERTON CE, 2001, STUDIEN NARKOSE
   Panter GH, 2002, ENVIRON TOXICOL CHEM, V21, P319, DOI 10.1002/etc.5620210213
   PETERSON RE, 1993, CRIT REV TOXICOL, V23, P283, DOI 10.3109/10408449309105013
   POLAND A, 1982, ANNU REV PHARMACOL, V22, P517, DOI 10.1146/annurev.pa.22.040182.002505
   Prasch AL, 2003, TOXICOL SCI, V76, P138, DOI 10.1093/toxsci/kfg202
   Reuschenbach P, 2008, CHEMOSPHERE, V71, P1986, DOI 10.1016/j.chemosphere.2007.12.006
   Russom CL, 1997, ENVIRON TOXICOL CHEM, V16, P948, DOI 10.1002/etc.5620160514
   Sanderson H, 2009, ENVIRON TOXICOL CHEM, V28, P1359, DOI 10.1897/09-119.1
   Schmidt JV, 1996, ANNU REV CELL DEV BI, V12, P55, DOI 10.1146/annurev.cellbio.12.1.55
   Schmieder P, 2003, PURE APPL CHEM, V75, P2389, DOI 10.1351/pac200375112389
   Schmieder PK, 2004, ENVIRON SCI TECHNOL, V38, P6333, DOI 10.1021/es0495314
   Shelby MD, 1996, ENVIRON HEALTH PERSP, V104, P1296, DOI 10.2307/3432965
   Tyler CR, 1996, REV FISH BIOL FISHER, V6, P287, DOI 10.1007/BF00122584
   US Environmental Protection Agency, 2008, AQ LIF CRIT CONT E 2
   *US EPA, 2009, ECOSAR
   US EPA, 2008, EPA100R08004 OFF SCI
   VAN WEZEL A, 1995, CRIT REV TOXICOL, V25, P255, DOI 10.3109/10408449509089890
   VEITH GD, 1995, ENVIRON SCI TECHNOL, V29, P1267, DOI 10.1021/es00005a019
   VEITH GD, 1983, CAN J FISH AQUAT SCI, V40, P743, DOI 10.1139/f83-096
   VERHAAR HJM, 1992, CHEMOSPHERE, V25, P471, DOI 10.1016/0045-6535(92)90280-5
   Walker MK, 1996, FUND APPL TOXICOL, V30, P178, DOI 10.1006/faat.1996.0054
   Wheeler JR, 2005, TOXICOL MECH METHOD, V15, P293, DOI 10.1080/15376520590968789
   *WHO, 2002, INT PROGR CHEM SAF
   Yamakura T, 2001, ANNU REV PHARMACOL, V41, P23, DOI 10.1146/annurev.pharmtox.41.1.23
NR 72
TC 981
Z9 1008
U1 24
U2 467
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0730-7268
EI 1552-8618
J9 ENVIRON TOXICOL CHEM
JI Environ. Toxicol. Chem.
PD MAR 10
PY 2010
VL 29
IS 3
BP 730
EP 741
DI 10.1002/etc.34
PG 12
WC Environmental Sciences; Toxicology
SC Environmental Sciences & Ecology; Toxicology
GA 566KH
UT WOS:000275368600034
PM 20821501
HC Y
HP N
DA 2019-10-23
ER

PT S
AU Schultz, TW
AF Schultz, T. W.
BE Cronin, MTD
   Madden, JC
TI Adverse Outcome Pathways: A Way of Linking Chemical Structure to In Vivo
   Toxicological Hazards
SO IN SILICO TOXICOLOGY: PRINCIPLES AND APPLICATIONS
SE Issues in Toxicology
LA English
DT Article; Book Chapter
ID ACUTE TOXICITY SYNDROMES; RESPIRATORY-CARDIOVASCULAR RESPONSES; PEPTIDE
   REACTIVITY ASSAY; TROUT SALMO-GAIRDNERI; VITELLOGENIN INDUCTION;
   CONCEPTUAL-FRAMEWORK; SKIN SENSITIZERS; GENE-EXPRESSION; FATHEAD MINNOW;
   VITRO
C1 Univ Tennessee, Dept Comparat Med, Coll Vet Med, Knoxville, TN 37996 USA.
RP Schultz, TW (reprint author), Univ Tennessee, Dept Comparat Med, Coll Vet Med, 2407 River Dr, Knoxville, TN 37996 USA.
CR Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   [Anonymous], 2007, OECD ENV HLTH SAF PU
   Aptula AO, 2006, CHEM RES TOXICOL, V19, P1097, DOI 10.1021/tx0601004
   Blaikie FH, 2006, BIOSCIENCE REP, V26, P231, DOI 10.1007/s10540-006-9018-8
   Borgert CJ, 2004, TOXICOL APPL PHARM, V201, P85, DOI 10.1016/j.taap.2004.05.005
   BRADBURY SP, 1900, PRACTICAL APPL QUANT, P295
   BUEHLER EV, 1965, ARCH DERMATOL, V91, P171, DOI 10.1001/archderm.1965.01600080079017
   CAJINAQUEZADA M, 1990, AQUAT TOXICOL, V17, P239, DOI 10.1016/0166-445X(90)90066-X
   Dix DJ, 2007, TOXICOL SCI, V95, P5, DOI 10.1093/toxsci/kfl103
   Dupuis G., 1982, ALLERGIC CONTACT DER
   Ecobichon D.J., 2001, CASARETT DOULLS TOXI, P763
   Enoch SJ, 2008, SAR QSAR ENVIRON RES, V19, P555, DOI 10.1080/10629360802348985
   Enoch SJ, 2008, CHEM RES TOXICOL, V21, P513, DOI 10.1021/tx700322g
   Fielden MR, 2007, TOXICOL SCI, V99, P90, DOI 10.1093/toxsci/kfm156
   Gerberick F, 2008, ATLA-ALTERN LAB ANIM, V36, P215, DOI 10.1177/026119290803600210
   Gerberick GF, 2005, DERMATITIS, V16, P157, DOI 10.2310/6620.2005.05040
   Gerberick GF, 2004, TOXICOL SCI, V81, P332, DOI 10.1093/toxsci/kfh213
   Hamblen EL, 2003, CHEMOSPHERE, V52, P1173, DOI 10.1016/S0045-6535(03)00333-3
   Ideker T, 2001, ANNU REV GENOM HUM G, V2, P343, DOI 10.1146/annurev.genom.2.1.343
   Jowsey IR, 2006, J APPL TOXICOL, V26, P341, DOI 10.1002/jat.1146
   Katzenellenbogen JA, 2003, PURE APPL CHEM, V75, P2397, DOI 10.1351/pac200375112397
   Kimber I, 2002, CONTACT DERMATITIS, V47, P315, DOI 10.1034/j.1600-0536.2002.470601.x
   Kimber I, 2002, INT IMMUNOPHARMACOL, V2, P201, DOI 10.1016/S1567-5769(01)00173-4
   Knudsen TB, 2009, REPROD TOXICOL, V28, P209, DOI 10.1016/j.reprotox.2009.03.016
   Landsteiner K, 1936, J EXP MED, V64, P625, DOI 10.1084/jem.64.4.625
   Laws SC, 1996, TOXICOLOGY, V112, P173, DOI 10.1016/0300-483X(96)03354-9
   LOOMIS WF, 1948, J BIOL CHEM, V173, P807
   Martin MT, 2009, TOXICOL SCI, V110, P181, DOI 10.1093/toxsci/kfp080
   Martin MT, 2009, ENVIRON HEALTH PERSP, V117, P392, DOI 10.1289/ehp.0800074
   MCKIM JM, 1987, ENVIRON HEALTH PERSP, V71, P171, DOI 10.2307/3430424
   MCKIM JM, 1987, ENVIRON TOXICOL CHEM, V6, P295, DOI 10.1002/etc.5620060407
   MCKIM JM, 1987, ENVIRON TOXICOL CHEM, V6, P313, DOI 10.1002/etc.5620060408
   MCLAUGHLIN SGA, 1980, PHYSIOL REV, V60, P825
   MITCHELL P, 1966, BIOL REV, V41, P445, DOI 10.1111/j.1469-185X.1966.tb01501.x
   National Research Council, 2007, TOX TEST 21 CENT VIS
   Natsch A, 2007, TOXICOL IN VITRO, V21, P1220, DOI 10.1016/j.tiv.2007.03.016
   Natsch A, 2008, TOXICOL SCI, V102, P110, DOI 10.1093/toxsci/kfm259
   Natsch A, 2009, TOXICOL SCI, V107, P106, DOI 10.1093/toxsci/kfn204
   O'Brien PJ, 2006, ARCH TOXICOL, V80, P580, DOI 10.1007/s00204-006-0091-3
   *ORG EC COOP DEV, 2007, OECD ENV HLTH SAF PU, V80
   *ORG EC COOP DEV, 2002, GUID TEST CHEM, V429
   PAYNE MP, 1994, J CHEM INF COMP SCI, V34, P154, DOI 10.1021/ci00017a019
   Rabow AA, 2002, J MED CHEM, V45, P818, DOI 10.1021/jm010385b
   Roberts DW, 2008, J APPL TOXICOL, V28, P377, DOI 10.1002/jat.1289
   Russom CL, 1997, ENVIRON TOXICOL CHEM, V16, P948, DOI 10.1002/etc.5620160514
   RUSSOM CL, 1988, B ENVIRON CONTAM TOX, V41, P589, DOI 10.1007/BF02021005
   Ryan CA, 2001, TOXICOL IN VITRO, V15, P43, DOI 10.1016/S0887-2333(00)00059-X
   Sanseverino J, 2009, TOXICOL SCI, V107, P122, DOI 10.1093/toxsci/kfn229
   Schmieder PK, 2004, ENVIRON SCI TECHNOL, V38, P6333, DOI 10.1021/es0495314
   Schultz TW, 2006, SAR QSAR ENVIRON RES, V17, P413, DOI 10.1080/10629360600884371
   Schultz TW, 2007, CHEM RES TOXICOL, V20, P1359, DOI 10.1021/tx700212u
   Schultz TW, 2009, CONTACT DERMATITIS, V60, P21, DOI 10.1111/j.1600-0536.2008.01473.x
   Schultz TW, 2005, SAR QSAR ENVIRON RES, V16, P313, DOI 10.1080/10659360500204152
   Schultz TW, 2002, ENVIRON TOXICOL, V17, P14, DOI 10.1002/tox.10027
   Seki M, 2003, ENVIRON TOXICOL CHEM, V22, P1507, DOI 10.1002/etc.5620220712
   SMITH CK, 2001, ALLERGIC CONTACT DER
   Sumpter JP, 2005, ACTA HYDROCH HYDROB, V33, P9, DOI 10.1002/aheh.200400555
   TERADA H, 1990, ENVIRON HEALTH PERSP, V87, P213, DOI 10.2307/3431027
   *US EPA, TOXREFDB PROGR
   van Aerle R, 2002, ECOTOXICOLOGY, V11, P423, DOI 10.1023/A:1021053217513
   van Leeuwen K, 2009, SAR QSAR ENVIRON RES, V20, P207, DOI 10.1080/10629360902949179
   Wallace KB, 2000, ANNU REV PHARMACOL, V40, P353, DOI 10.1146/annurev.pharmtox.40.1.353
   Waring JF, 2003, ENVIRON HEALTH PERSP, V111, P863, DOI 10.1289/txg.5998
   Waters M, 2003, ENVIRON HEALTH PERSP, V111, P811, DOI 10.1289/txg.5971
   Wiltse J, 2005, CRIT REV TOXICOL, V35, P727, DOI 10.1080/10408440591007403
   Wong HL, 2008, CHEM RES TOXICOL, V21, P796, DOI 10.1021/tx700433m
   Zha JM, 2007, CHEMOSPHERE, V66, P488, DOI 10.1016/j.chemosphere.2006.05.071
   Zidek N, 2007, TOXICOL SCI, V99, P289, DOI 10.1093/toxsci/kfm131
   Zimmerman H.J., 1999, HEPATOTOXICITY
   2007, OFF J EUR UNION L, V136, P3
NR 70
TC 23
Z9 23
U1 0
U2 2
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, CAMBRIDGE CB4 4WF, CAMBS, ENGLAND
SN 1757-7179
BN 978-1-84973-004-4
J9 ISSUES TOXICOL
PY 2010
VL 7
BP 346
EP 371
D2 10.1039/9781849732093
PG 26
WC Toxicology
SC Toxicology
GA BSW49
UT WOS:000285957900014
DA 2019-10-23
ER

PT J
AU Hay, WW
AF Hay, William W., Jr.
TI Strategies for Feeding the Preterm Infant
SO NEONATOLOGY
LA English
DT Review
DE Nutrition; Feeding; Preterm infant; Oxygen; Glucose; Amino acids;
   Lipids; Insulin; Minimal enteral nutrition; Intravenous feeding;
   Intrauterine growth restriction
ID LOW-BIRTH-WEIGHT; EXTREMELY PREMATURE-INFANTS; DONOR HUMAN-MILK;
   NECROTIZING ENTEROCOLITIS; PROTEIN-SYNTHESIS; RANDOMIZED-TRIAL; GROWTH;
   FORMULA; METABOLISM; PREVENTION
AB According to many experts in neonatal nutrition, the goal for nutrition of the preterm infant should be to achieve a postnatal growth rate approximating that of the normal fetus of the same gestational age. Unfortunately, most preterm infants, especially those born very preterm with extremely low birth weight, are not fed sufficient amounts of nutrients to produce normal fetal rates of growth and, as a result, end up growth-restricted during their hospital period after birth. Growth restriction is a significant problem, as numerous studies have shown definitively that undernutrition, especially of protein, at critical stages of development produces long-term short stature, organ growth failure, and both neuronal deficits of number and dendritic connections as well as later behavioral and cognitive outcomes. Furthermore, clinical follow-up studies have shown that among infants fed formulas, the nutrient content of the formula is directly and positively related to mental and motor outcomes later in life. Nutritional requirements do not stop at birth. Thus, delaying nutrition after birth 'until the infant is stable' ignores the fundamental point that without nutrition starting immediately after birth, the infant enters a catabolic condition, and catabolism does not contribute to normal development and growth. Oxygen is necessary for all metabolic processes. Recent trends to limit oxygen supply to prevent oxygen toxicity have the potential, particularly when the blood hemoglobin concentration falls to less than 8 g/dl, to develop growth failure. Glucose should be provided at 6-8 mg/min/kg as soon after birth as possible and adjusted according to frequent measurements of plasma glucose to achieve and maintain concentrations >45 mg/dl but <120 mg/dl to avoid the frequent problems of hyperglycemia and hypoglycemia. Similarly , lipid is required to provide at least 0.5 g/kg/day to prevent essential fatty acid deficiency. However, the high rate of carbohydrate and lipid supply that preterm infants often get, based on the incomplete assumption that this is necessary to promote protein growth, tends to produce increased fat in organs like the liver and heart as well as adipose tissue. More and better essential fatty acid nutrition is valuable, but more organ and adipose fat has no known benefit and many problems. Amino acids and protein are essential not only for body growth but for metabolic signaling, protein synthesis, and protein accretion. 3.5-4.0 g/kg/day are necessary to produce normal protein balance and growth in very preterm infants. Attempts to promote protein growth with insulin has many problems - it is ineffective while contributing to even further organ and adipose tissue fat deposition. Enteral feeding always is indicated and to date nearly all studies have shown that minimal enteral feeding approaches (e. g., 'trophic feeds') promote the capacity to feed enterally. Milk has distinct advantages over formulas in avoiding necrotizing enterocolitis (NEC), and while feeding is associated with NEC, minimal enteral feeding regimens produce less NEC than those geared towards more aggressive introduction of enteral feeding. Finally, overfeeding has the definite potential to produce adipose tissue, or obesity, which then leads to insulin resistance, glucose intolerance, and diabetes. This scenario occurs more commonly as infants are fed more and gain weight more rapidly after birth, regardless of their birth weight.
   Infants with IUGR and postnatal growth failure may be uniquely 'set up' for this outcome, while infants with in utero obesit, such as infants of diabetic mothers, already are well along this adverse outcome pathway. Copyright (C) 2008 S. Karger AG, Basel
C1 Univ Colorado Denver, Univ Colorado Sch Med, Colorado Clin Translat Sci Inst, Dept Pediat,Perinatal Res Ctr, Aurora, CO 80045 USA.
RP Hay, WW (reprint author), Univ Colorado Denver, Univ Colorado Sch Med, Colorado Clin Translat Sci Inst, Dept Pediat,Perinatal Res Ctr, 13243 E 23rd Ave,POB 6508, Aurora, CO 80045 USA.
EM bill.hay@uchsc.edu
FU NICHD NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National
   Institute of Child Health & Human Development (NICHD) [R01 HD028794-08,
   R01 HD042815-05, R01 HD028794, R01 HD042815]
CR Aldoretta PW, 1998, BIOL NEONATE, V73, P375, DOI 10.1159/000014000
   ALVERSON DC, 1995, CLIN PERINATOL, V22, P609
   American Academy of Pediatrics, 1985, PEDIATRICS, V76, P976
   Barker DJP, 2004, J AM COLL NUTR, V23, p588S, DOI 10.1080/07315724.2004.10719428
   BATTAGLIA FC, 1986, INTRO FETAL PHYSL, P100
   Berseth CL, 2003, PEDIATRICS, V111, P529, DOI 10.1542/peds.111.3.529
   Boyd CA, 2007, ARCH DIS CHILD-FETAL, V92, pF169, DOI 10.1136/adc.2005.089490
   BROWN LD, 2006, PED RES PAS ANN M MA
   Carlson S E, 2001, Semin Neonatol, V6, P437, DOI 10.1053/siny.2001.0093
   Carlson S J, 1998, J Perinatol, V18, P252
   CARLSON SE, 1993, AM J CLIN NUTR, V58, P35
   DANCIS J, 1948, J PEDIATR, V33, P570, DOI 10.1016/S0022-3476(48)80269-6
   Das UG, 1999, AM J PHYSIOL-REG I, V276, pR809
   De Boo HA, 2005, PEDIATR RES, V58, P270, DOI 10.1203/01.PDR.0000169977.48609.55
   Denne SC, 2007, SEMIN PERINATOL, V31, P56, DOI 10.1053/j.semperi.2007.02.005
   Deshpande G, 2007, LANCET, V369, P1614, DOI 10.1016/S0140-6736(07)60748-X
   Dinerstein A, 2006, J PERINATOL, V26, P436, DOI 10.1038/sj.jp.7211539
   Ehrenkranz RA, 2000, CLIN PERINATOL, V27, P325, DOI 10.1016/S0095-5108(05)70024-5
   Gordon PV, 2007, J PERINATOL, V27, P661, DOI 10.1038/sj.jp.7211782
   Hay Jr W. W., 2003, NUTR PEDIAT BASIC SC, P449
   Hay WW, 2006, J PERINATOL, V26, pS13, DOI 10.1038/sj.jp.7211426
   Hay WW, 2007, J PEDIATR GASTR NUTR, V45, pS163, DOI 10.1097/01.mpg.0000302965.93546.b8
   HAY WW, 2008, NUTR PREMATURE INFAN, P141
   HAY WW, 2008, FETAL NEONA IN PRESS
   HAY WW, 2008, NUTR PEDIAT BASIC SC, P311
   HAY WW, 2003, TXB DIABETES PREGNAN, P201
   HEIRD WC, 1988, PEDIATRICS, V81, P41
   HELMS RA, 1990, JPEN-PARENTER ENTER, V14, P448, DOI 10.1177/0148607190014005448
   Huppi PS, 2008, PEDIATR RES, V63, P229, DOI 10.1203/PDR.0b013e318168c6d1
   Innis SM, 2005, PLACENTA, V26, pS70, DOI 10.1016/j.placenta.2005.01.005
   ISAACS EB, 2008, PEDIATR RES, V63, P229
   Kamitsuka MD, 2000, PEDIATRICS, V105, P379, DOI 10.1542/peds.105.2.379
   KASHYAP S, 1987, J PEDIATR-US, V110, P815, DOI 10.1016/S0022-3476(87)80032-X
   KENNEDY KA, 2004, COCHRANE LIB, V3
   KITANAKA T, 1989, AM J PHYSIOL, V256, pR1348
   Land MH, 2005, PEDIATRICS, V115, P178, DOI 10.1542/peds.2004-2137
   Liu LP, 2004, CANCER BIOL THER, V3, P492, DOI 10.4161/cbt.3.6.1010
   Lodygensky GA, 2008, PEDIATR RES, V63, P438, DOI 10.1203/PDR.0b013e318165c005
   LUCAS A, 1986, ACTA PAEDIATR SCAND, V75, P719, DOI 10.1111/j.1651-2227.1986.tb10280.x
   LUCAS A, 1988, BRIT MED J, V297, P1304, DOI 10.1136/bmj.297.6659.1304
   LUCAS A, 1990, LANCET, V336, P1519, DOI 10.1016/0140-6736(90)93304-8
   McGuire W, 2003, ARCH DIS CHILD, V88, P11
   MEIER PR, 1981, AM J PHYSIOL, V240, pE320
   Micheli J-L, 1993, NUTR NEEDS PRETERM I, P29
   Milley JR, 1998, AM J PHYSIOL-ENDOC M, V274, pE618
   Neu J, 2007, NUTR CLIN PRACT, V22, P174, DOI 10.1177/0115426507022002174
   Neu J, 2007, AM J CLIN NUTR, V85, p629S
   Parish A, 2008, J PERINATOL, V28, pS18, DOI 10.1038/jp.2008.45
   Perapoch J, 2000, EUR J CLIN MICROBIOL, V19, P468, DOI 10.1007/s100960000295
   Pietz J, 2007, PEDIATRICS, V119, pE164, DOI 10.1542/peds.2006-0521
   Poindexter BB, 1998, J PEDIATR-US, V132, P948, DOI 10.1016/S0022-3476(98)70389-0
   Reynolds RM, 2008, J PEDIATR, V152, P63, DOI 10.1016/j.jpeds.2007.05.042
   Ridout Erick, 2005, J Perinatol, V25, P130, DOI 10.1038/sj.jp.7211215
   Ronnestad A, 2005, PEDIATRICS, V115, pE269, DOI 10.1542/peds.2004-1833
   Ross JC, 1996, AM J PHYSIOL-ENDOC M, V270, pE491
   Satoh Y, 2007, INT J PROBIOT PREBIO, V2, P149
   Say L, 2003, COCHRANE DATABASE SY
   Schanler RJ, 1999, PEDIATRICS, V103, P1150, DOI 10.1542/peds.103.6.1150
   Schanler RJ, 2005, PEDIATRICS, V116, P400, DOI 10.1542/peds.2004-1974
   Schanler RJ, 1999, PEDIATRICS, V103, P434, DOI 10.1542/peds.103.2.434
   Sellmayer A, 1999, LIPIDS, V34, P199, DOI 10.1007/s11745-999-0354-z
   Sisk PM, 2007, J PERINATOL, V27, P428, DOI 10.1038/sj.jp.7211758
   SMART JL, 1991, CIBA F SYMP, V156, P109
   SMART JL, 1990, UPSALA J MED SCI, P21
   SPRITZER R, 1988, ACTA PAEDIATR SCAND, V77, P909, DOI 10.1111/j.1651-2227.1988.tb10778.x
   Stettler N, 2003, AM J CLIN NUTR, V77, P1374
   STOCKMAN JA, 1984, AM J DIS CHILD, V138, P828, DOI 10.1001/archpedi.1984.02140470028009
   STOLL B, 2008, PED AC SOC ANN M
   Sunehag AL, 2003, PEDIATR RES, V54, P480, DOI 10.1203/01.PDR.0000081298.06751.76
   Thureen PJ, 2003, PEDIATR RES, V53, P24, DOI 10.1203/01.PDR.0000042441.34920.77
   Thureen PJ, 2008, GASTROENTEROLOGY NUT, P208
   Tin W, 2002, PEDIATRICS, V110, P615, DOI 10.1542/peds.110.3.615
   TYSON JE, 2005, COCHRANE LIB, V4
   Watterberg KL, 2004, PEDIATRICS, V114, P1649, DOI 10.1542/peds.2004-1159
   Ziegler EE, 2002, CLIN PERINATOL, V29, P225, DOI 10.1016/S0095-5108(02)00007-6
   ZIEGLER EE, 1976, GROWTH, V40, P329
NR 76
TC 133
Z9 142
U1 0
U2 23
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 1661-7800
EI 1661-7819
J9 NEONATOLOGY
JI Neonatology
PY 2008
VL 94
IS 4
BP 245
EP 254
DI 10.1159/000151643
PG 10
WC Pediatrics
SC Pediatrics
GA 369GJ
UT WOS:000260682200002
PM 18836284
OA Bronze, Green Accepted
DA 2019-10-23
ER

EF